id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
1407963|NCT03704376|3447514|P2|NOT COMPLETED|Overall Study||4
1407964|NCT03704376|3447515|P1|NOT COMPLETED|Overall Study||4
1407965|NCT03704376|3447514|P2|COMPLETED|Overall Study||40
1407966|NCT03704376|3447515|P1|COMPLETED|Overall Study||38
1407967|NCT03704376|3447514|P2|STARTED|Overall Study||44
1407968|NCT03704376|3447515|P1|STARTED|Overall Study||42
1407969|NCT03670537|3447557|P1|NOT COMPLETED|Overall Study||1
1407970|NCT03670537|3447557|P1|COMPLETED|Overall Study||101
1407971|NCT03670537|3447557|P1|STARTED|Overall Study||102
1407972|NCT03651856|3447561|P1|NOT COMPLETED|Overall Study||0
1407973|NCT03651856|3447561|P1|COMPLETED|Overall Study||10
1407974|NCT03651856|3447561|P1|STARTED|Overall Study||10
1407975|NCT03648983|3447565|P1|NOT COMPLETED|Overall Study||95
1407976|NCT03648983|3447565|P1|COMPLETED|Overall Study||0
1407977|NCT03648983|3447565|P1|STARTED|Overall Study||95
1407978|NCT03647033|3447573|P2|NOT COMPLETED|Overall Study||0
1407979|NCT03647033|3447574|P1|NOT COMPLETED|Overall Study||0
1407980|NCT03647033|3447573|P2|COMPLETED|Overall Study||16
1407981|NCT03647033|3447574|P1|COMPLETED|Overall Study||16
1407982|NCT03647033|3447573|P2|STARTED|Overall Study||16
1407983|NCT03647033|3447574|P1|STARTED|Overall Study||16
1407984|NCT03615534|3447586|P4|NOT COMPLETED|Overall Study||1
1407985|NCT03615534|3447587|P3|NOT COMPLETED|Overall Study||0
1407986|NCT03615534|3447588|P2|NOT COMPLETED|Overall Study||0
1407987|NCT03615534|3447589|P1|NOT COMPLETED|Overall Study||2
1407988|NCT03615534|3447586|P4|COMPLETED|Overall Study||13
1407989|NCT03615534|3447587|P3|COMPLETED|Overall Study||14
1407990|NCT03615534|3447588|P2|COMPLETED|Overall Study||15
1407991|NCT03615534|3447589|P1|COMPLETED|Overall Study||12
1407992|NCT03615534|3447586|P4|STARTED|Overall Study||14
1407993|NCT03615534|3447587|P3|STARTED|Overall Study||14
1407994|NCT03615534|3447588|P2|STARTED|Overall Study||15
1407995|NCT03615534|3447589|P1|STARTED|Overall Study||14
1407996|NCT03585504|3447633|P2|NOT COMPLETED|Overall Study||29
1407997|NCT03585504|3447634|P1|NOT COMPLETED|Overall Study||26
1407998|NCT03585504|3447633|P2|COMPLETED|Overall Study||11
1407999|NCT03585504|3447634|P1|COMPLETED|Overall Study||15
1408000|NCT03585504|3447633|P2|STARTED|Overall Study||40
1408001|NCT03585504|3447634|P1|STARTED|Overall Study||41
1408002|NCT03582943|3447646|P2|NOT COMPLETED|Analyzed||1
1408003|NCT03582943|3447647|P1|NOT COMPLETED|Analyzed||4
1408004|NCT03582943|3447646|P2|COMPLETED|Analyzed||36
1408005|NCT03582943|3447647|P1|COMPLETED|Analyzed||33
1408006|NCT03582943|3447646|P2|STARTED|Analyzed||37
1408007|NCT03582943|3447647|P1|STARTED|Analyzed||37
1408008|NCT03582943|3447646|P2|NOT COMPLETED|Intervention and Follow up||2
1408009|NCT03582943|3447647|P1|NOT COMPLETED|Intervention and Follow up||4
1408010|NCT03582943|3447646|P2|COMPLETED|Intervention and Follow up||37
1408011|NCT03582943|3447647|P1|COMPLETED|Intervention and Follow up||37
1408012|NCT03582943|3447646|P2|STARTED|Intervention and Follow up||39
1408013|NCT03582943|3447647|P1|STARTED|Intervention and Follow up||41
1408014|NCT03582943|3447646|P2|NOT COMPLETED|Allocated to Groups||1
1408015|NCT03582943|3447647|P1|NOT COMPLETED|Allocated to Groups||1
1408016|NCT03582943|3447646|P2|COMPLETED|Allocated to Groups||39
1408017|NCT03582943|3447647|P1|COMPLETED|Allocated to Groups||41
1408018|NCT03582943|3447646|P2|STARTED|Allocated to Groups||40
1408019|NCT03582943|3447647|P1|STARTED|Allocated to Groups||42
1408020|NCT03578146|3447659|P6|NOT COMPLETED|Overall Study||3
1408021|NCT03578146|3447660|P5|NOT COMPLETED|Overall Study||0
1408022|NCT03578146|3447661|P4|NOT COMPLETED|Overall Study||0
1408023|NCT03578146|3447662|P3|NOT COMPLETED|Overall Study||1
1408024|NCT03578146|3447663|P2|NOT COMPLETED|Overall Study||1
1408025|NCT03578146|3447664|P1|NOT COMPLETED|Overall Study||1
1408026|NCT03578146|3447659|P6|COMPLETED|Overall Study||5
1408027|NCT03578146|3447660|P5|COMPLETED|Overall Study||6
1408028|NCT03578146|3447661|P4|COMPLETED|Overall Study||6
1408029|NCT03578146|3447662|P3|COMPLETED|Overall Study||5
1408030|NCT03578146|3447663|P2|COMPLETED|Overall Study||5
1408031|NCT03578146|3447664|P1|COMPLETED|Overall Study||15
1408032|NCT03578146|3447659|P6|STARTED|Overall Study||8
1408033|NCT03578146|3447660|P5|STARTED|Overall Study||6
1408034|NCT03578146|3447661|P4|STARTED|Overall Study||6
1408035|NCT03578146|3447662|P3|STARTED|Overall Study||6
1408036|NCT03578146|3447663|P2|STARTED|Overall Study||6
1408037|NCT03578146|3447664|P1|STARTED|Overall Study||16
1408038|NCT03551743|3447730|P4|NOT COMPLETED|Overall Study||0
1408039|NCT03551743|3447731|P3|NOT COMPLETED|Overall Study||0
1408040|NCT03551743|3447732|P2|NOT COMPLETED|Overall Study||0
1408041|NCT03551743|3447733|P1|NOT COMPLETED|Overall Study||2
1408042|NCT03551743|3447730|P4|COMPLETED|Overall Study||6
1408043|NCT03551743|3447731|P3|COMPLETED|Overall Study||6
1408044|NCT03551743|3447732|P2|COMPLETED|Overall Study||6
1408045|NCT03551743|3447733|P1|COMPLETED|Overall Study||8
1408046|NCT03551743|3447730|P4|STARTED|Overall Study||6
1408047|NCT03551743|3447731|P3|STARTED|Overall Study||6
1408048|NCT03551743|3447732|P2|STARTED|Overall Study||6
1408049|NCT03551743|3447733|P1|STARTED|Overall Study||10
1408050|NCT03551730|3447779|P4|NOT COMPLETED|Overall Study||0
1408051|NCT03551730|3447780|P3|NOT COMPLETED|Overall Study||0
1408052|NCT03551730|3447781|P2|NOT COMPLETED|Overall Study||0
1408053|NCT03551730|3447782|P1|NOT COMPLETED|Overall Study||1
1408054|NCT03551730|3447779|P4|COMPLETED|Overall Study||6
1408055|NCT03551730|3447780|P3|COMPLETED|Overall Study||6
1408056|NCT03551730|3447781|P2|COMPLETED|Overall Study||6
1408057|NCT03551730|3447782|P1|COMPLETED|Overall Study||8
1408058|NCT03551730|3447779|P4|STARTED|Overall Study||6
1408059|NCT03551730|3447780|P3|STARTED|Overall Study||6
1408060|NCT03551730|3447781|P2|STARTED|Overall Study||6
1408061|NCT03551730|3447782|P1|STARTED|Overall Study||9
1408062|NCT03549130|3447822|P2|NOT COMPLETED|Overall Study||2
1408063|NCT03549130|3447823|P1|NOT COMPLETED|Overall Study||0
1408064|NCT03549130|3447822|P2|COMPLETED|Overall Study||64
1408065|NCT03549130|3447823|P1|COMPLETED|Overall Study||64
1408066|NCT03549130|3447822|P2|STARTED|Overall Study||66
1408067|NCT03549130|3447823|P1|STARTED|Overall Study||64
1408068|NCT03549117|3447841|P2|NOT COMPLETED|Overall Study||0
1408069|NCT03549117|3447842|P1|NOT COMPLETED|Overall Study||1
1408070|NCT03549117|3447841|P2|COMPLETED|Overall Study||70
1408071|NCT03549117|3447842|P1|COMPLETED|Overall Study||69
1408072|NCT03549117|3447841|P2|STARTED|Overall Study||70
1408073|NCT03549117|3447842|P1|STARTED|Overall Study||70
1408074|NCT03546192|3447870|P2|NOT COMPLETED|Overall Study||0
1408075|NCT03546192|3447871|P1|NOT COMPLETED|Overall Study||0
1408076|NCT03546192|3447870|P2|COMPLETED|Overall Study||60
1408077|NCT03546192|3447871|P1|COMPLETED|Overall Study||60
1408078|NCT03546192|3447870|P2|STARTED|Overall Study||60
1408079|NCT03546192|3447871|P1|STARTED|Overall Study||60
1408080|NCT03545412|3447887|P1|NOT COMPLETED|Overall Study||0
1408081|NCT03545412|3447887|P1|COMPLETED|Overall Study||25
1408082|NCT03545412|3447887|P1|STARTED|Overall Study||25
1408083|NCT03536923|3447897|P1|NOT COMPLETED|Overall Study||0
1408084|NCT03536923|3447897|P1|COMPLETED|Overall Study||23
1408085|NCT03536923|3447897|P1|STARTED|Overall Study||23
1408086|NCT03534986|3447907|P3|NOT COMPLETED|Overall Study||2
1408087|NCT03534986|3447908|P2|NOT COMPLETED|Overall Study||0
1408088|NCT03534986|3447909|P1|NOT COMPLETED|Overall Study||0
1408089|NCT03534986|3447907|P3|COMPLETED|Overall Study||10
1408090|NCT03534986|3447908|P2|COMPLETED|Overall Study||10
1408091|NCT03534986|3447909|P1|COMPLETED|Overall Study||10
1408092|NCT03534986|3447907|P3|STARTED|Overall Study||12
1408093|NCT03534986|3447908|P2|STARTED|Overall Study||10
1408094|NCT03534986|3447909|P1|STARTED|Overall Study||10
1408095|NCT03523988|3447932|P3|NOT COMPLETED|Overall Study||18
1408096|NCT03523988|3447933|P2|NOT COMPLETED|Overall Study||16
1408097|NCT03523988|3447934|P1|NOT COMPLETED|Overall Study||17
1408098|NCT03523988|3447932|P3|COMPLETED|Overall Study||7
1408099|NCT03523988|3447933|P2|COMPLETED|Overall Study||8
1408100|NCT03523988|3447934|P1|COMPLETED|Overall Study||7
1408101|NCT03523988|3447932|P3|STARTED|Overall Study||25
1408102|NCT03523988|3447933|P2|STARTED|Overall Study||24
1408103|NCT03523988|3447934|P1|STARTED|Overall Study||24
1408104|NCT03509766|3447948|P1|NOT COMPLETED|Overall Study||0
1408105|NCT03509766|3447948|P1|COMPLETED|Overall Study||24
1408106|NCT03509766|3447948|P1|STARTED|Overall Study||24
1408107|NCT03496987|3447956|P2|NOT COMPLETED|Overall Study||0
1408108|NCT03496987|3447957|P1|NOT COMPLETED|Overall Study||0
1408109|NCT03496987|3447956|P2|COMPLETED|Overall Study||51
1408110|NCT03496987|3447957|P1|COMPLETED|Overall Study||49
1408111|NCT03496987|3447956|P2|STARTED|Overall Study||51
1408112|NCT03496987|3447957|P1|STARTED|Overall Study||49
1408113|NCT03494985|3447979|P4|NOT COMPLETED|Overall Study||5
1408114|NCT03494985|3447980|P3|NOT COMPLETED|Overall Study||6
1408115|NCT03494985|3447981|P2|NOT COMPLETED|Overall Study||6
1408116|NCT03494985|3447982|P1|NOT COMPLETED|Overall Study||5
1408117|NCT03494985|3447979|P4|COMPLETED|Overall Study||94
1408118|NCT03494985|3447980|P3|COMPLETED|Overall Study||92
1408119|NCT03494985|3447981|P2|COMPLETED|Overall Study||92
1408120|NCT03494985|3447982|P1|COMPLETED|Overall Study||96
1408121|NCT03494985|3447979|P4|STARTED|Overall Study||99
1408122|NCT03494985|3447980|P3|STARTED|Overall Study||98
1408123|NCT03494985|3447981|P2|STARTED|Overall Study||98
1408124|NCT03494985|3447982|P1|STARTED|Overall Study||101
1408125|NCT03493828|3448019|P3|NOT COMPLETED|Overall Study||0
1408126|NCT03493828|3448020|P2|NOT COMPLETED|Overall Study||0
1408127|NCT03493828|3448021|P1|NOT COMPLETED|Overall Study||0
1408128|NCT03493828|3448019|P3|COMPLETED|Overall Study||20
1408129|NCT03493828|3448020|P2|COMPLETED|Overall Study||20
1408130|NCT03493828|3448021|P1|COMPLETED|Overall Study||20
1408131|NCT03493828|3448019|P3|STARTED|Overall Study||20
1408132|NCT03493828|3448020|P2|STARTED|Overall Study||20
1408133|NCT03493828|3448021|P1|STARTED|Overall Study||20
1408134|NCT03491228|3448029|P1|NOT COMPLETED|Overall Study||0
1408135|NCT03491228|3448029|P1|COMPLETED|Overall Study||107
1408136|NCT03491228|3448029|P1|STARTED|Overall Study||107
1408137|NCT03489551|3448035|P1|NOT COMPLETED|Overall Study||2
1408138|NCT03489551|3448035|P1|COMPLETED|Overall Study||15
1408139|NCT03489551|3448035|P1|STARTED|Overall Study||17
1408140|NCT03489304|3448039|P1|NOT COMPLETED|Overall Study||4
1408141|NCT03489304|3448039|P1|COMPLETED|Overall Study||16
1408142|NCT03489304|3448039|P1|STARTED|Overall Study||20
1408143|NCT03479216|3448047|P2|NOT COMPLETED|Overall Study||5
1408144|NCT03479216|3448048|P1|NOT COMPLETED|Overall Study||5
1408145|NCT03479216|3448047|P2|COMPLETED|Overall Study||26
1408146|NCT03479216|3448048|P1|COMPLETED|Overall Study||26
1408147|NCT03479216|3448047|P2|STARTED|Overall Study||31
1408148|NCT03479216|3448048|P1|STARTED|Overall Study||31
1408149|NCT03478891|3448069|P3|NOT COMPLETED|Overall Study||11
1408150|NCT03478891|3448070|P2|NOT COMPLETED|Overall Study||5
1408151|NCT03478891|3448071|P1|NOT COMPLETED|Overall Study||3
1408152|NCT03478891|3448069|P3|COMPLETED|Overall Study||0
1408153|NCT03478891|3448070|P2|COMPLETED|Overall Study||0
1408154|NCT03478891|3448071|P1|COMPLETED|Overall Study||0
1408249|NCT03364335|3448314|P2|STARTED|Overall Study||51
1408155|NCT03478891|3448069|P3|Received MAb114|Overall Study|Grp 3 subj had suboptimal IV access following enrollment and discontinued prior to MAb114 infusion|10
1408156|NCT03478891|3448070|P2|Received MAb114|Overall Study||5
1408157|NCT03478891|3448071|P1|Received MAb114|Overall Study||3
1408158|NCT03478891|3448069|P3|STARTED|Overall Study||11
1408159|NCT03478891|3448070|P2|STARTED|Overall Study||5
1408160|NCT03478891|3448071|P1|STARTED|Overall Study||3
1408161|NCT03478644|3448087|P2|NOT COMPLETED|Phase 2||1
1408162|NCT03478644|3448088|P1|NOT COMPLETED|Phase 2||3
1408163|NCT03478644|3448087|P2|COMPLETED|Phase 2||75
1408164|NCT03478644|3448088|P1|COMPLETED|Phase 2||73
1408165|NCT03478644|3448087|P2|STARTED|Phase 2||76
1408166|NCT03478644|3448088|P1|STARTED|Phase 2||76
1408167|NCT03478644|3448087|P2|NOT COMPLETED|Phase 1||0
1408168|NCT03478644|3448088|P1|NOT COMPLETED|Phase 1||0
1408169|NCT03478644|3448087|P2|COMPLETED|Phase 1||0
1408170|NCT03478644|3448088|P1|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
1408171|NCT03478644|3448087|P2|STARTED|Phase 1||0
1408172|NCT03478644|3448088|P1|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
1408173|NCT03447821|3448103|P3|NOT COMPLETED|Overall Study||1
1408174|NCT03447821|3448104|P2|NOT COMPLETED|Overall Study||1
1408175|NCT03447821|3448105|P1|NOT COMPLETED|Overall Study||1
1408176|NCT03447821|3448103|P3|COMPLETED|Overall Study||12
1408177|NCT03447821|3448104|P2|COMPLETED|Overall Study||12
1408178|NCT03447821|3448105|P1|COMPLETED|Overall Study||13
1408179|NCT03447821|3448103|P3|STARTED|Overall Study||13
1408180|NCT03447821|3448104|P2|STARTED|Overall Study||13
1408181|NCT03447821|3448105|P1|STARTED|Overall Study||14
1408182|NCT03447353|3448128|P1|NOT COMPLETED|Overall Study||10
1408183|NCT03447353|3448128|P1|COMPLETED|Overall Study||8
1408184|NCT03447353|3448128|P1|STARTED|Overall Study||18
1408185|NCT03446690|3448144|P2|NOT COMPLETED|Overall Study||0
1408186|NCT03446690|3448145|P1|NOT COMPLETED|Overall Study||7
1408187|NCT03446690|3448144|P2|COMPLETED|Overall Study||29
1408188|NCT03446690|3448145|P1|COMPLETED|Overall Study||26
1408189|NCT03446690|3448144|P2|STARTED|Overall Study||29
1408190|NCT03446690|3448145|P1|STARTED|Overall Study||33
1408191|NCT03417713|3448151|P1|NOT COMPLETED|Overall Study||3
1408192|NCT03417713|3448151|P1|COMPLETED|Overall Study||30
1408193|NCT03417713|3448151|P1|STARTED|Overall Study||33
1408194|NCT03410628|3448156|P1|NOT COMPLETED|Overall Study||6
1408195|NCT03410628|3448156|P1|COMPLETED|Overall Study||15
1408196|NCT03410628|3448156|P1|STARTED|Overall Study||21
1408197|NCT03407612|3448163|P2|NOT COMPLETED|Overall Study||0
1408198|NCT03407612|3448164|P1|NOT COMPLETED|Overall Study||0
1408199|NCT03407612|3448163|P2|COMPLETED|Overall Study||23
1408200|NCT03407612|3448164|P1|COMPLETED|Overall Study||19
1408201|NCT03407612|3448163|P2|STARTED|Overall Study||23
1408202|NCT03407612|3448164|P1|STARTED|Overall Study||19
1408203|NCT03407430|3448176|P2|NOT COMPLETED|Second Intervention||0
1408204|NCT03407430|3448177|P1|NOT COMPLETED|Second Intervention||0
1408205|NCT03407430|3448176|P2|COMPLETED|Second Intervention||3
1408206|NCT03407430|3448177|P1|COMPLETED|Second Intervention||4
1408207|NCT03407430|3448176|P2|STARTED|Second Intervention||3
1408208|NCT03407430|3448177|P1|STARTED|Second Intervention||4
1408209|NCT03407430|3448176|P2|NOT COMPLETED|Washout||0
1408210|NCT03407430|3448177|P1|NOT COMPLETED|Washout||1
1408211|NCT03407430|3448176|P2|COMPLETED|Washout||3
1408212|NCT03407430|3448177|P1|COMPLETED|Washout||4
1408213|NCT03407430|3448176|P2|STARTED|Washout||3
1408214|NCT03407430|3448177|P1|STARTED|Washout||5
1408215|NCT03407430|3448176|P2|NOT COMPLETED|First Intervention||0
1408216|NCT03407430|3448177|P1|NOT COMPLETED|First Intervention||0
1408217|NCT03407430|3448176|P2|COMPLETED|First Intervention||3
1408218|NCT03407430|3448177|P1|COMPLETED|First Intervention||5
1408219|NCT03407430|3448176|P2|STARTED|First Intervention||3
1408220|NCT03407430|3448177|P1|STARTED|First Intervention||5
1408221|NCT03405818|3448209|P1|NOT COMPLETED|Overall Study||8
1408222|NCT03405818|3448209|P1|COMPLETED|Overall Study||47
1408223|NCT03405818|3448209|P1|STARTED|Overall Study||55
1408224|NCT03400475|3448252|P2|NOT COMPLETED|Overall Study||0
1408225|NCT03400475|3448253|P1|NOT COMPLETED|Overall Study||0
1408226|NCT03400475|3448252|P2|COMPLETED|Overall Study||22
1408227|NCT03400475|3448253|P1|COMPLETED|Overall Study||24
1408228|NCT03400475|3448252|P2|STARTED|Overall Study||22
1408229|NCT03400475|3448253|P1|STARTED|Overall Study||24
1408230|NCT03365011|3448295|P2|NOT COMPLETED|Overall Study||2
1408231|NCT03365011|3448296|P1|NOT COMPLETED|Overall Study||1
1408232|NCT03365011|3448295|P2|COMPLETED|Overall Study||18
1408233|NCT03365011|3448296|P1|COMPLETED|Overall Study||19
1408234|NCT03365011|3448295|P2|STARTED|Overall Study||20
1408235|NCT03365011|3448296|P1|STARTED|Overall Study||20
1408236|NCT03364335|3448311|P5|NOT COMPLETED|Overall Study||11
1408237|NCT03364335|3448312|P4|NOT COMPLETED|Overall Study||13
1408238|NCT03364335|3448313|P3|NOT COMPLETED|Overall Study||11
1408239|NCT03364335|3448314|P2|NOT COMPLETED|Overall Study||11
1408240|NCT03364335|3448315|P1|NOT COMPLETED|Overall Study||10
1408241|NCT03364335|3448311|P5|COMPLETED|Overall Study||41
1408242|NCT03364335|3448312|P4|COMPLETED|Overall Study||37
1408243|NCT03364335|3448313|P3|COMPLETED|Overall Study||42
1408244|NCT03364335|3448314|P2|COMPLETED|Overall Study||40
1408245|NCT03364335|3448315|P1|COMPLETED|Overall Study||42
1408246|NCT03364335|3448311|P5|STARTED|Overall Study||52
1408247|NCT03364335|3448312|P4|STARTED|Overall Study||50
1408248|NCT03364335|3448313|P3|STARTED|Overall Study||53
1408250|NCT03364335|3448315|P1|STARTED|Overall Study||52
1408251|NCT03363633|3448387|P1|NOT COMPLETED|Overall Study||12
1408252|NCT03363633|3448387|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
1408253|NCT03363633|3448387|P1|STARTED|Overall Study||12
1408254|NCT03350724|3448397|P2|NOT COMPLETED|Overall Study||0
1408255|NCT03350724|3448398|P1|NOT COMPLETED|Overall Study||0
1408256|NCT03350724|3448397|P2|COMPLETED|Overall Study||17
1408257|NCT03350724|3448398|P1|COMPLETED|Overall Study||17
1408258|NCT03350724|3448397|P2|STARTED|Overall Study||17
1408259|NCT03350724|3448398|P1|STARTED|Overall Study||17
1408260|NCT03349099|3448454|P2|NOT COMPLETED|Overall Study||4
1408261|NCT03349099|3448455|P1|NOT COMPLETED|Overall Study||4
1408262|NCT03349099|3448454|P2|COMPLETED|Overall Study||43
1408263|NCT03349099|3448455|P1|COMPLETED|Overall Study||44
1408264|NCT03349099|3448454|P2|STARTED|Overall Study||47
1408265|NCT03349099|3448455|P1|STARTED|Overall Study||48
1408266|NCT03346902|3448467|P2|NOT COMPLETED|Overall Study||0
1408267|NCT03346902|3448468|P1|NOT COMPLETED|Overall Study||0
1408268|NCT03346902|3448467|P2|COMPLETED|Overall Study||8
1408269|NCT03346902|3448468|P1|COMPLETED|Overall Study||4
1408270|NCT03346902|3448467|P2|STARTED|Overall Study||8
1408271|NCT03346902|3448468|P1|STARTED|Overall Study||4
1408272|NCT03346759|3448476|P2|NOT COMPLETED|Third Menstrual Cycle||0
1408273|NCT03346759|3448477|P1|NOT COMPLETED|Third Menstrual Cycle||0
1408274|NCT03346759|3448476|P2|COMPLETED|Third Menstrual Cycle||10
1408275|NCT03346759|3448477|P1|COMPLETED|Third Menstrual Cycle||11
1408276|NCT03346759|3448476|P2|STARTED|Third Menstrual Cycle||10
1408277|NCT03346759|3448477|P1|STARTED|Third Menstrual Cycle||11
1408278|NCT03346759|3448476|P2|NOT COMPLETED|Second Menstrual Cycle||0
1408279|NCT03346759|3448477|P1|NOT COMPLETED|Second Menstrual Cycle||1
1408280|NCT03346759|3448476|P2|COMPLETED|Second Menstrual Cycle||10
1408281|NCT03346759|3448477|P1|COMPLETED|Second Menstrual Cycle||11
1408282|NCT03346759|3448476|P2|STARTED|Second Menstrual Cycle||10
1408283|NCT03346759|3448477|P1|STARTED|Second Menstrual Cycle||12
1408284|NCT03346759|3448476|P2|NOT COMPLETED|First Menstrual Cycle||0
1408285|NCT03346759|3448477|P1|NOT COMPLETED|First Menstrual Cycle||1
1408286|NCT03346759|3448476|P2|COMPLETED|First Menstrual Cycle||10
1408287|NCT03346759|3448477|P1|COMPLETED|First Menstrual Cycle||12
1408288|NCT03346759|3448476|P2|STARTED|First Menstrual Cycle||10
1408289|NCT03346759|3448477|P1|STARTED|First Menstrual Cycle||13
1408290|NCT03346759|3448476|P2|NOT COMPLETED|Enrollment to Baseline Data Collected||3
1408291|NCT03346759|3448477|P1|NOT COMPLETED|Enrollment to Baseline Data Collected||2
1408292|NCT03346759|3448476|P2|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
1408293|NCT03346759|3448477|P1|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
1408294|NCT03346759|3448476|P2|STARTED|Enrollment to Baseline Data Collected||13
1408295|NCT03346759|3448477|P1|STARTED|Enrollment to Baseline Data Collected||15
1408296|NCT03338556|3448490|P4|NOT COMPLETED|Overall Study||2
1408297|NCT03338556|3448491|P3|NOT COMPLETED|Overall Study||2
1408298|NCT03338556|3448492|P2|NOT COMPLETED|Overall Study||4
1408299|NCT03338556|3448493|P1|NOT COMPLETED|Overall Study||2
1408300|NCT03338556|3448490|P4|COMPLETED|Overall Study||24
1408301|NCT03338556|3448491|P3|COMPLETED|Overall Study||22
1408302|NCT03338556|3448492|P2|COMPLETED|Overall Study||23
1408303|NCT03338556|3448493|P1|COMPLETED|Overall Study||23
1408304|NCT03338556|3448490|P4|STARTED|Overall Study||26
1408305|NCT03338556|3448491|P3|STARTED|Overall Study||24
1408306|NCT03338556|3448492|P2|STARTED|Overall Study||27
1408307|NCT03338556|3448493|P1|STARTED|Overall Study||25
1408308|NCT03335566|3448513|P2|NOT COMPLETED|Overall Study||3
1408309|NCT03335566|3448514|P1|NOT COMPLETED|Overall Study||4
1408310|NCT03335566|3448513|P2|COMPLETED|Overall Study||203
1408311|NCT03335566|3448514|P1|COMPLETED|Overall Study||214
1408312|NCT03335566|3448513|P2|STARTED|Overall Study||206
1408313|NCT03335566|3448514|P1|STARTED|Overall Study||218
1408314|NCT03331315|3448528|P2|NOT COMPLETED|Overall Study||14
1408315|NCT03331315|3448529|P1|NOT COMPLETED|Overall Study||18
1408316|NCT03331315|3448528|P2|COMPLETED|Overall Study||68
1408317|NCT03331315|3448529|P1|COMPLETED|Overall Study||70
1408318|NCT03331315|3448528|P2|STARTED|Overall Study||82
1408319|NCT03331315|3448529|P1|STARTED|Overall Study||88
1408320|NCT03330275|3448549|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408321|NCT03330275|3448550|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408322|NCT03330275|3448551|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408323|NCT03330275|3448552|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408324|NCT03330275|3448553|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408325|NCT03330275|3448554|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408326|NCT03330275|3448555|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408327|NCT03330275|3448556|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408328|NCT03330275|3448557|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408329|NCT03330275|3448558|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408330|NCT03330275|3448549|P10|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1408331|NCT03330275|3448550|P9|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1408332|NCT03330275|3448551|P8|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1408333|NCT03330275|3448552|P7|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1408334|NCT03330275|3448553|P6|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1408335|NCT03330275|3448554|P5|COMPLETED|Visits 2, 3 and 4 - Period 3||4
1408336|NCT03330275|3448555|P4|COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408337|NCT03330275|3448556|P3|COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408338|NCT03330275|3448557|P2|COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408339|NCT03330275|3448558|P1|COMPLETED|Visits 2, 3 and 4 - Period 3||0
1408340|NCT03330275|3448549|P10|STARTED|Visits 2, 3 and 4 - Period 3||4
1408341|NCT03330275|3448550|P9|STARTED|Visits 2, 3 and 4 - Period 3||4
1408342|NCT03330275|3448551|P8|STARTED|Visits 2, 3 and 4 - Period 3||4
1408343|NCT03330275|3448552|P7|STARTED|Visits 2, 3 and 4 - Period 3||4
1408344|NCT03330275|3448553|P6|STARTED|Visits 2, 3 and 4 - Period 3||4
1408345|NCT03330275|3448554|P5|STARTED|Visits 2, 3 and 4 - Period 3||4
1408346|NCT03330275|3448555|P4|STARTED|Visits 2, 3 and 4 - Period 3||0
1408347|NCT03330275|3448556|P3|STARTED|Visits 2, 3 and 4 - Period 3||0
1408348|NCT03330275|3448557|P2|STARTED|Visits 2, 3 and 4 - Period 3||0
1408349|NCT03330275|3448558|P1|STARTED|Visits 2, 3 and 4 - Period 3||0
1408350|NCT03330275|3448549|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408351|NCT03330275|3448550|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408352|NCT03330275|3448551|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408353|NCT03330275|3448552|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408354|NCT03330275|3448553|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408355|NCT03330275|3448554|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408356|NCT03330275|3448555|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408357|NCT03330275|3448556|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408358|NCT03330275|3448557|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408359|NCT03330275|3448558|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408360|NCT03330275|3448549|P10|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1408361|NCT03330275|3448550|P9|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1408362|NCT03330275|3448551|P8|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1408363|NCT03330275|3448552|P7|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1408364|NCT03330275|3448553|P6|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1408365|NCT03330275|3448554|P5|COMPLETED|Visits 2, 3 and 4 - Period 2||4
1408366|NCT03330275|3448555|P4|COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408367|NCT03330275|3448556|P3|COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408368|NCT03330275|3448557|P2|COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408369|NCT03330275|3448558|P1|COMPLETED|Visits 2, 3 and 4 - Period 2||0
1408370|NCT03330275|3448549|P10|STARTED|Visits 2, 3 and 4 - Period 2||4
1408371|NCT03330275|3448550|P9|STARTED|Visits 2, 3 and 4 - Period 2||4
1408372|NCT03330275|3448551|P8|STARTED|Visits 2, 3 and 4 - Period 2||4
1408373|NCT03330275|3448552|P7|STARTED|Visits 2, 3 and 4 - Period 2||4
1408374|NCT03330275|3448553|P6|STARTED|Visits 2, 3 and 4 - Period 2||4
1408375|NCT03330275|3448554|P5|STARTED|Visits 2, 3 and 4 - Period 2||4
1408376|NCT03330275|3448555|P4|STARTED|Visits 2, 3 and 4 - Period 2||0
1408377|NCT03330275|3448556|P3|STARTED|Visits 2, 3 and 4 - Period 2||0
1408378|NCT03330275|3448557|P2|STARTED|Visits 2, 3 and 4 - Period 2||0
1408379|NCT03330275|3448558|P1|STARTED|Visits 2, 3 and 4 - Period 2||0
1408380|NCT03330275|3448549|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408381|NCT03330275|3448550|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408382|NCT03330275|3448551|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408383|NCT03330275|3448552|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408384|NCT03330275|3448553|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408385|NCT03330275|3448554|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408386|NCT03330275|3448555|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408387|NCT03330275|3448556|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408388|NCT03330275|3448557|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408389|NCT03330275|3448558|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408390|NCT03330275|3448549|P10|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1408391|NCT03330275|3448550|P9|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1408392|NCT03330275|3448551|P8|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1408393|NCT03330275|3448552|P7|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1408394|NCT03330275|3448553|P6|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1408395|NCT03330275|3448554|P5|COMPLETED|Visits 2, 3 and 4 - Period 1||4
1408396|NCT03330275|3448555|P4|COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408397|NCT03330275|3448556|P3|COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408398|NCT03330275|3448557|P2|COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408399|NCT03330275|3448558|P1|COMPLETED|Visits 2, 3 and 4 - Period 1||0
1408400|NCT03330275|3448549|P10|STARTED|Visits 2, 3 and 4 - Period 1||4
1408401|NCT03330275|3448550|P9|STARTED|Visits 2, 3 and 4 - Period 1||4
1408402|NCT03330275|3448551|P8|STARTED|Visits 2, 3 and 4 - Period 1||4
1408403|NCT03330275|3448552|P7|STARTED|Visits 2, 3 and 4 - Period 1||4
1408404|NCT03330275|3448553|P6|STARTED|Visits 2, 3 and 4 - Period 1||4
1408405|NCT03330275|3448554|P5|STARTED|Visits 2, 3 and 4 - Period 1||4
1408406|NCT03330275|3448555|P4|STARTED|Visits 2, 3 and 4 - Period 1||0
1408407|NCT03330275|3448556|P3|STARTED|Visits 2, 3 and 4 - Period 1||0
1408408|NCT03330275|3448557|P2|STARTED|Visits 2, 3 and 4 - Period 1||0
1408409|NCT03330275|3448558|P1|STARTED|Visits 2, 3 and 4 - Period 1||0
1408410|NCT03330275|3448549|P10|NOT COMPLETED|Visit 1 - Period 2||0
1408411|NCT03330275|3448550|P9|NOT COMPLETED|Visit 1 - Period 2||0
1408412|NCT03330275|3448551|P8|NOT COMPLETED|Visit 1 - Period 2||0
1408413|NCT03330275|3448552|P7|NOT COMPLETED|Visit 1 - Period 2||0
1408414|NCT03330275|3448553|P6|NOT COMPLETED|Visit 1 - Period 2||0
1408415|NCT03330275|3448554|P5|NOT COMPLETED|Visit 1 - Period 2||0
1408416|NCT03330275|3448555|P4|NOT COMPLETED|Visit 1 - Period 2||0
1408417|NCT03330275|3448556|P3|NOT COMPLETED|Visit 1 - Period 2||0
1408418|NCT03330275|3448557|P2|NOT COMPLETED|Visit 1 - Period 2||0
1408419|NCT03330275|3448558|P1|NOT COMPLETED|Visit 1 - Period 2||0
1408420|NCT03330275|3448549|P10|COMPLETED|Visit 1 - Period 2||0
1408421|NCT03330275|3448550|P9|COMPLETED|Visit 1 - Period 2||0
1408422|NCT03330275|3448551|P8|COMPLETED|Visit 1 - Period 2||0
1408423|NCT03330275|3448552|P7|COMPLETED|Visit 1 - Period 2||0
1408424|NCT03330275|3448553|P6|COMPLETED|Visit 1 - Period 2||0
1408425|NCT03330275|3448554|P5|COMPLETED|Visit 1 - Period 2||0
1408426|NCT03330275|3448555|P4|COMPLETED|Visit 1 - Period 2||6
1408427|NCT03330275|3448556|P3|COMPLETED|Visit 1 - Period 2||6
1408428|NCT03330275|3448557|P2|COMPLETED|Visit 1 - Period 2||6
1408429|NCT03330275|3448558|P1|COMPLETED|Visit 1 - Period 2||6
1408430|NCT03330275|3448549|P10|STARTED|Visit 1 - Period 2||0
1408431|NCT03330275|3448550|P9|STARTED|Visit 1 - Period 2||0
1408432|NCT03330275|3448551|P8|STARTED|Visit 1 - Period 2||0
1408433|NCT03330275|3448552|P7|STARTED|Visit 1 - Period 2||0
1408434|NCT03330275|3448553|P6|STARTED|Visit 1 - Period 2||0
1408435|NCT03330275|3448554|P5|STARTED|Visit 1 - Period 2||0
1408436|NCT03330275|3448555|P4|STARTED|Visit 1 - Period 2||6
1408437|NCT03330275|3448556|P3|STARTED|Visit 1 - Period 2||6
1408438|NCT03330275|3448557|P2|STARTED|Visit 1 - Period 2||6
1408439|NCT03330275|3448558|P1|STARTED|Visit 1 - Period 2||6
1408440|NCT03330275|3448549|P10|NOT COMPLETED|Visit 1 - Period 1||0
1408441|NCT03330275|3448550|P9|NOT COMPLETED|Visit 1 - Period 1||0
1408442|NCT03330275|3448551|P8|NOT COMPLETED|Visit 1 - Period 1||0
1408443|NCT03330275|3448552|P7|NOT COMPLETED|Visit 1 - Period 1||0
1408444|NCT03330275|3448553|P6|NOT COMPLETED|Visit 1 - Period 1||0
1408445|NCT03330275|3448554|P5|NOT COMPLETED|Visit 1 - Period 1||0
1408446|NCT03330275|3448555|P4|NOT COMPLETED|Visit 1 - Period 1||0
1408447|NCT03330275|3448556|P3|NOT COMPLETED|Visit 1 - Period 1||0
1408448|NCT03330275|3448557|P2|NOT COMPLETED|Visit 1 - Period 1||0
1408449|NCT03330275|3448558|P1|NOT COMPLETED|Visit 1 - Period 1||0
1408450|NCT03330275|3448549|P10|COMPLETED|Visit 1 - Period 1||0
1408451|NCT03330275|3448550|P9|COMPLETED|Visit 1 - Period 1||0
1408452|NCT03330275|3448551|P8|COMPLETED|Visit 1 - Period 1||0
1408453|NCT03330275|3448552|P7|COMPLETED|Visit 1 - Period 1||0
1408454|NCT03330275|3448553|P6|COMPLETED|Visit 1 - Period 1||0
1408455|NCT03330275|3448554|P5|COMPLETED|Visit 1 - Period 1||0
1408456|NCT03330275|3448555|P4|COMPLETED|Visit 1 - Period 1||6
1408457|NCT03330275|3448556|P3|COMPLETED|Visit 1 - Period 1||6
1408458|NCT03330275|3448557|P2|COMPLETED|Visit 1 - Period 1||6
1408459|NCT03330275|3448558|P1|COMPLETED|Visit 1 - Period 1||6
1408460|NCT03330275|3448549|P10|STARTED|Visit 1 - Period 1||0
1408461|NCT03330275|3448550|P9|STARTED|Visit 1 - Period 1||0
1408462|NCT03330275|3448551|P8|STARTED|Visit 1 - Period 1||0
1408463|NCT03330275|3448552|P7|STARTED|Visit 1 - Period 1||0
1408464|NCT03330275|3448553|P6|STARTED|Visit 1 - Period 1||0
1408465|NCT03330275|3448554|P5|STARTED|Visit 1 - Period 1||0
1408466|NCT03330275|3448555|P4|STARTED|Visit 1 - Period 1||6
1408467|NCT03330275|3448556|P3|STARTED|Visit 1 - Period 1||6
1408468|NCT03330275|3448557|P2|STARTED|Visit 1 - Period 1||6
1408469|NCT03330275|3448558|P1|STARTED|Visit 1 - Period 1||6
1408470|NCT03317431|3448584|P1|NOT COMPLETED|Overall Study||0
1408471|NCT03317431|3448584|P1|COMPLETED|Overall Study||46
1408472|NCT03317431|3448584|P1|STARTED|Overall Study||46
1408473|NCT03308825|3448596|P4|NOT COMPLETED|Overall Study||0
1408474|NCT03308825|3448597|P3|NOT COMPLETED|Overall Study||1
1408475|NCT03308825|3448598|P2|NOT COMPLETED|Overall Study||4
1408476|NCT03308825|3448599|P1|NOT COMPLETED|Overall Study||2
1408477|NCT03308825|3448596|P4|COMPLETED|Overall Study||60
1408478|NCT03308825|3448597|P3|COMPLETED|Overall Study||59
1408479|NCT03308825|3448598|P2|COMPLETED|Overall Study||57
1408480|NCT03308825|3448599|P1|COMPLETED|Overall Study||57
1408481|NCT03308825|3448596|P4|STARTED|Overall Study||60
1408482|NCT03308825|3448597|P3|STARTED|Overall Study||60
1408483|NCT03308825|3448598|P2|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
1408484|NCT03308825|3448599|P1|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
1408485|NCT03295201|3448627|P2|NOT COMPLETED|Overall Study||2
1408486|NCT03295201|3448628|P1|NOT COMPLETED|Overall Study||1
1408487|NCT03295201|3448627|P2|COMPLETED|Overall Study||9
1408488|NCT03295201|3448628|P1|COMPLETED|Overall Study||10
1408489|NCT03295201|3448627|P2|STARTED|Overall Study||11
1408490|NCT03295201|3448628|P1|STARTED|Overall Study||11
1408491|NCT03294629|3448682|P2|NOT COMPLETED|Second Intervention (2 Weeks)||2
1408492|NCT03294629|3448683|P1|NOT COMPLETED|Second Intervention (2 Weeks)||2
1408493|NCT03294629|3448682|P2|COMPLETED|Second Intervention (2 Weeks)||13
1408494|NCT03294629|3448683|P1|COMPLETED|Second Intervention (2 Weeks)||12
1408495|NCT03294629|3448682|P2|STARTED|Second Intervention (2 Weeks)||15
1408496|NCT03294629|3448683|P1|STARTED|Second Intervention (2 Weeks)||14
1408497|NCT03294629|3448682|P2|NOT COMPLETED|First Intervention (2 Weeks)||4
1408498|NCT03294629|3448683|P1|NOT COMPLETED|First Intervention (2 Weeks)||2
1408499|NCT03294629|3448682|P2|COMPLETED|First Intervention (2 Weeks)||15
1408500|NCT03294629|3448683|P1|COMPLETED|First Intervention (2 Weeks)||14
1408501|NCT03294629|3448682|P2|STARTED|First Intervention (2 Weeks)||19
1408502|NCT03294629|3448683|P1|STARTED|First Intervention (2 Weeks)||16
1408503|NCT03292692|3448713|P2|NOT COMPLETED|Overall Study||38
1408504|NCT03292692|3448714|P1|NOT COMPLETED|Overall Study||38
1408505|NCT03292692|3448713|P2|COMPLETED|Overall Study||260
1408506|NCT03292692|3448714|P1|COMPLETED|Overall Study||264
1408507|NCT03292692|3448713|P2|STARTED|Overall Study||298
1408508|NCT03292692|3448714|P1|STARTED|Overall Study||302
1408509|NCT03285984|3448726|P1|NOT COMPLETED|Overall Study||0
1408510|NCT03285984|3448726|P1|COMPLETED|Overall Study||56
1408511|NCT03285984|3448726|P1|Received Test Product 4|Overall Study||56
1408512|NCT03285984|3448726|P1|Received Test Product 3|Overall Study||56
1408513|NCT03285984|3448726|P1|Received Test Product 2|Overall Study||56
1408514|NCT03285984|3448726|P1|Received Test Product 1|Overall Study||56
1408515|NCT03285984|3448726|P1|STARTED|Overall Study||56
1408516|NCT03279458|3448738|P1|NOT COMPLETED|Overall Study||0
1408517|NCT03279458|3448738|P1|COMPLETED|Overall Study||40
1408518|NCT03279458|3448738|P1|STARTED|Overall Study||40
1408519|NCT03274453|3448748|P4|NOT COMPLETED|Overall Study||4
1408520|NCT03274453|3448749|P3|NOT COMPLETED|Overall Study||4
1408521|NCT03274453|3448750|P2|NOT COMPLETED|Overall Study||6
1408522|NCT03274453|3448751|P1|NOT COMPLETED|Overall Study||4
1408523|NCT03274453|3448748|P4|COMPLETED|Overall Study||25
1408524|NCT03274453|3448749|P3|COMPLETED|Overall Study||28
1408525|NCT03274453|3448750|P2|COMPLETED|Overall Study||24
1408526|NCT03274453|3448751|P1|COMPLETED|Overall Study||34
1408527|NCT03274453|3448748|P4|STARTED|Overall Study||29
1408528|NCT03274453|3448749|P3|STARTED|Overall Study||32
1408529|NCT03274453|3448750|P2|STARTED|Overall Study||30
1408530|NCT03274453|3448751|P1|STARTED|Overall Study||38
1408531|NCT03271424|3448764|P3|NOT COMPLETED|April-May 2016||0
1408532|NCT03271424|3448765|P2|NOT COMPLETED|April-May 2016||0
1408533|NCT03271424|3448766|P1|NOT COMPLETED|April-May 2016||0
1408534|NCT03271424|3448764|P3|COMPLETED|April-May 2016||40
1408535|NCT03271424|3448765|P2|COMPLETED|April-May 2016||0
1408536|NCT03271424|3448766|P1|COMPLETED|April-May 2016||0
1408537|NCT03271424|3448764|P3|STARTED|April-May 2016||40
1408538|NCT03271424|3448765|P2|STARTED|April-May 2016||0
1408539|NCT03271424|3448766|P1|STARTED|April-May 2016||0
1408540|NCT03271424|3448764|P3|NOT COMPLETED|December 2015||0
1408541|NCT03271424|3448765|P2|NOT COMPLETED|December 2015||0
1408542|NCT03271424|3448766|P1|NOT COMPLETED|December 2015||0
1408543|NCT03271424|3448764|P3|COMPLETED|December 2015||0
1408544|NCT03271424|3448765|P2|COMPLETED|December 2015||35
1408545|NCT03271424|3448766|P1|COMPLETED|December 2015||0
1408546|NCT03271424|3448764|P3|STARTED|December 2015||0
1408547|NCT03271424|3448765|P2|STARTED|December 2015||35
1408548|NCT03271424|3448766|P1|STARTED|December 2015||0
1408549|NCT03271424|3448764|P3|NOT COMPLETED|November 2015||0
1408550|NCT03271424|3448765|P2|NOT COMPLETED|November 2015||0
1408551|NCT03271424|3448766|P1|NOT COMPLETED|November 2015||0
1408552|NCT03271424|3448764|P3|COMPLETED|November 2015||0
1408553|NCT03271424|3448765|P2|COMPLETED|November 2015||0
1408554|NCT03271424|3448766|P1|COMPLETED|November 2015||20
1408555|NCT03271424|3448764|P3|STARTED|November 2015||0
1408556|NCT03271424|3448765|P2|STARTED|November 2015||0
1408557|NCT03271424|3448766|P1|STARTED|November 2015||20
1408558|NCT03263806|3448778|P2|NOT COMPLETED|Overall Study||7
1408559|NCT03263806|3448779|P1|NOT COMPLETED|Overall Study||6
1408560|NCT03263806|3448778|P2|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
1408561|NCT03263806|3448779|P1|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
1408562|NCT03263806|3448778|P2|STARTED|Overall Study||7
1408563|NCT03263806|3448779|P1|STARTED|Overall Study||6
1408564|NCT03256552|3448791|P1|NOT COMPLETED|Overall Study||5
1408565|NCT03256552|3448791|P1|COMPLETED|Overall Study||61
1408566|NCT03256552|3448791|P1|Placebo MDI|Overall Study||65
1408567|NCT03256552|3448791|P1|GP MDI 7.2 µg|Overall Study||62
1408568|NCT03256552|3448791|P1|GP MDI 14.4 µg|Overall Study||63
1408569|NCT03256552|3448791|P1|GP MDI 28.8 µg|Overall Study||61
1408570|NCT03256552|3448791|P1|STARTED|Overall Study||66
1408571|NCT03255733|3448813|P1|NOT COMPLETED|Overall Study||4
1408572|NCT03255733|3448813|P1|COMPLETED|Overall Study||25
1408573|NCT03255733|3448813|P1|STARTED|Overall Study||29
1408574|NCT03255655|3448820|P2|NOT COMPLETED|Overall Study||4
1408575|NCT03255655|3448821|P1|NOT COMPLETED|Overall Study||7
1408576|NCT03255655|3448820|P2|COMPLETED|Overall Study||8
1408577|NCT03255655|3448821|P1|COMPLETED|Overall Study||22
1408578|NCT03255655|3448820|P2|STARTED|Overall Study||12
1408579|NCT03255655|3448821|P1|STARTED|Overall Study||29
1408580|NCT03254602|3448829|P1|NOT COMPLETED|Overall Study||4
1408581|NCT03254602|3448829|P1|COMPLETED|Overall Study||29
1408582|NCT03254602|3448829|P1|STARTED|Overall Study||33
1408583|NCT03254459|3448837|P2|NOT COMPLETED|Overall Study||23
1408584|NCT03254459|3448838|P1|NOT COMPLETED|Overall Study||10
1408585|NCT03254459|3448837|P2|COMPLETED|Overall Study||27
1408586|NCT03254459|3448838|P1|COMPLETED|Overall Study||40
1408587|NCT03254459|3448837|P2|STARTED|Overall Study||50
1408588|NCT03254459|3448838|P1|STARTED|Overall Study||50
1408589|NCT03247985|3448858|P2|NOT COMPLETED|Overall Study||0
1408590|NCT03247985|3448859|P1|NOT COMPLETED|Overall Study||0
1408591|NCT03247985|3448858|P2|COMPLETED|Overall Study||19
1408592|NCT03247985|3448859|P1|COMPLETED|Overall Study||19
1408593|NCT03247985|3448858|P2|STARTED|Overall Study||19
1408594|NCT03247985|3448859|P1|STARTED|Overall Study||19
1408595|NCT03243084|3448875|P2|NOT COMPLETED|Session 2||0
1408596|NCT03243084|3448876|P1|NOT COMPLETED|Session 2||0
1408597|NCT03243084|3448875|P2|COMPLETED|Session 2||10
1408598|NCT03243084|3448876|P1|COMPLETED|Session 2||10
1408599|NCT03243084|3448875|P2|STARTED|Session 2||10
1408600|NCT03243084|3448876|P1|STARTED|Session 2||10
1408601|NCT03243084|3448875|P2|NOT COMPLETED|Washout (1-3 Weeks)||0
1408602|NCT03243084|3448876|P1|NOT COMPLETED|Washout (1-3 Weeks)||1
1408603|NCT03243084|3448875|P2|COMPLETED|Washout (1-3 Weeks)||10
1408604|NCT03243084|3448876|P1|COMPLETED|Washout (1-3 Weeks)||10
1408605|NCT03243084|3448875|P2|STARTED|Washout (1-3 Weeks)||10
1408606|NCT03243084|3448876|P1|STARTED|Washout (1-3 Weeks)||11
1408607|NCT03243084|3448875|P2|NOT COMPLETED|Session 1||0
1408608|NCT03243084|3448876|P1|NOT COMPLETED|Session 1||0
1408609|NCT03243084|3448875|P2|COMPLETED|Session 1||10
1408610|NCT03243084|3448876|P1|COMPLETED|Session 1||11
1408611|NCT03243084|3448875|P2|STARTED|Session 1||10
1408612|NCT03243084|3448876|P1|STARTED|Session 1||11
1408613|NCT03238924|3448888|P2|NOT COMPLETED|Overall Study||2
1408614|NCT03238924|3448889|P1|NOT COMPLETED|Overall Study||2
1408615|NCT03238924|3448888|P2|COMPLETED|Overall Study||7
1408616|NCT03238924|3448889|P1|COMPLETED|Overall Study||6
1408617|NCT03238924|3448888|P2|STARTED|Overall Study||9
1408618|NCT03238924|3448889|P1|STARTED|Overall Study||8
1408619|NCT03238352|3448902|P3|NOT COMPLETED|Overall Study||1
1408620|NCT03238352|3448903|P2|NOT COMPLETED|Overall Study||3
1408621|NCT03238352|3448904|P1|NOT COMPLETED|Overall Study||0
1408622|NCT03238352|3448902|P3|COMPLETED|Overall Study||22
1408623|NCT03238352|3448903|P2|COMPLETED|Overall Study||20
1408624|NCT03238352|3448904|P1|COMPLETED|Overall Study||43
1408625|NCT03238352|3448902|P3|STARTED|Overall Study||23
1408626|NCT03238352|3448903|P2|STARTED|Overall Study||23
1408627|NCT03238352|3448904|P1|STARTED|Overall Study||43
1408628|NCT03238001|3448915|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
1408629|NCT03238001|3448915|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
1408630|NCT03238001|3448915|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
1408631|NCT03238001|3448915|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
1408632|NCT03238001|3448915|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
1408633|NCT03238001|3448915|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
1408634|NCT03235817|3448941|P3|NOT COMPLETED|Overall Study||2
1408635|NCT03235817|3448942|P2|NOT COMPLETED|Overall Study||1
1408636|NCT03235817|3448943|P1|NOT COMPLETED|Overall Study||3
1408637|NCT03235817|3448941|P3|COMPLETED|Overall Study||11
1408638|NCT03235817|3448942|P2|COMPLETED|Overall Study||12
1408639|NCT03235817|3448943|P1|COMPLETED|Overall Study||10
1408640|NCT03235817|3448941|P3|STARTED|Overall Study||13
1408641|NCT03235817|3448942|P2|STARTED|Overall Study||13
1408642|NCT03235817|3448943|P1|STARTED|Overall Study||13
1408643|NCT03235115|3448960|P6|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1408644|NCT03235115|3448961|P5|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1408645|NCT03235115|3448962|P4|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1408646|NCT03235115|3448963|P3|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1408647|NCT03235115|3448964|P2|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1408648|NCT03235115|3448965|P1|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
1408649|NCT03235115|3448960|P6|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
1408650|NCT03235115|3448961|P5|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
1408651|NCT03235115|3448962|P4|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
1408652|NCT03235115|3448963|P3|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
1408653|NCT03235115|3448964|P2|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
1408654|NCT03235115|3448965|P1|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
1408655|NCT03235115|3448960|P6|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
1408656|NCT03235115|3448961|P5|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
1408657|NCT03235115|3448962|P4|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
1408658|NCT03235115|3448963|P3|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
1408659|NCT03235115|3448964|P2|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
1408660|NCT03235115|3448965|P1|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
1408661|NCT03235115|3448960|P6|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1408662|NCT03235115|3448961|P5|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1408663|NCT03235115|3448962|P4|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1408664|NCT03235115|3448963|P3|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1408665|NCT03235115|3448964|P2|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1408666|NCT03235115|3448965|P1|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
1408667|NCT03235115|3448960|P6|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
1408668|NCT03235115|3448961|P5|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
1408669|NCT03235115|3448962|P4|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
1408670|NCT03235115|3448963|P3|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
1408671|NCT03235115|3448964|P2|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
1408672|NCT03235115|3448965|P1|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
1408673|NCT03235115|3448960|P6|STARTED|Second Intervention (1 Hour, Visit 4)||5
1408674|NCT03235115|3448961|P5|STARTED|Second Intervention (1 Hour, Visit 4)||6
1408675|NCT03235115|3448962|P4|STARTED|Second Intervention (1 Hour, Visit 4)||6
1408676|NCT03235115|3448963|P3|STARTED|Second Intervention (1 Hour, Visit 4)||7
1408677|NCT03235115|3448964|P2|STARTED|Second Intervention (1 Hour, Visit 4)||6
1408678|NCT03235115|3448965|P1|STARTED|Second Intervention (1 Hour, Visit 4)||9
1408679|NCT03235115|3448960|P6|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
1408680|NCT03235115|3448961|P5|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1408681|NCT03235115|3448962|P4|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1408682|NCT03235115|3448963|P3|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1408683|NCT03235115|3448964|P2|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1408684|NCT03235115|3448965|P1|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
1408685|NCT03235115|3448960|P6|COMPLETED|First Intervention (1 Hour, Visit 2)||5
1408686|NCT03235115|3448961|P5|COMPLETED|First Intervention (1 Hour, Visit 2)||6
1408687|NCT03235115|3448962|P4|COMPLETED|First Intervention (1 Hour, Visit 2)||6
1408688|NCT03235115|3448963|P3|COMPLETED|First Intervention (1 Hour, Visit 2)||7
1408689|NCT03235115|3448964|P2|COMPLETED|First Intervention (1 Hour, Visit 2)||6
1408690|NCT03235115|3448965|P1|COMPLETED|First Intervention (1 Hour, Visit 2)||9
1408691|NCT03235115|3448960|P6|STARTED|First Intervention (1 Hour, Visit 2)||6
1408692|NCT03235115|3448961|P5|STARTED|First Intervention (1 Hour, Visit 2)||6
1408693|NCT03235115|3448962|P4|STARTED|First Intervention (1 Hour, Visit 2)||6
1408694|NCT03235115|3448963|P3|STARTED|First Intervention (1 Hour, Visit 2)||7
1408695|NCT03235115|3448964|P2|STARTED|First Intervention (1 Hour, Visit 2)||6
1408696|NCT03235115|3448965|P1|STARTED|First Intervention (1 Hour, Visit 2)||9
1408697|NCT03233009|3448985|P1|NOT COMPLETED|Overall Study||1
1408698|NCT03233009|3448985|P1|COMPLETED|Overall Study||39
1408699|NCT03233009|3448985|P1|Reference Product|Overall Study||39
1408700|NCT03233009|3448985|P1|Test Product 4|Overall Study||39
1408701|NCT03233009|3448985|P1|Test Product 3|Overall Study||39
1408702|NCT03233009|3448985|P1|Test Product 2|Overall Study||39
1408703|NCT03233009|3448985|P1|Test Product 1|Overall Study||39
1408704|NCT03233009|3448985|P1|STARTED|Overall Study||40
1408705|NCT03231371|3449028|P1|NOT COMPLETED|Overall Study||13
1408706|NCT03231371|3449028|P1|COMPLETED|Overall Study||9
1408707|NCT03231371|3449028|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
1408708|NCT03231371|3449028|P1|STARTED|Overall Study||22
1408709|NCT03228212|3449033|P2|NOT COMPLETED|Period 3||0
1408710|NCT03228212|3449034|P1|NOT COMPLETED|Period 3||0
1408711|NCT03228212|3449033|P2|COMPLETED|Period 3||64
1408712|NCT03228212|3449034|P1|COMPLETED|Period 3||63
1408713|NCT03228212|3449033|P2|STARTED|Period 3||64
1408714|NCT03228212|3449034|P1|STARTED|Period 3||63
1408715|NCT03228212|3449033|P2|NOT COMPLETED|Period 2||0
1408716|NCT03228212|3449034|P1|NOT COMPLETED|Period 2||1
1408717|NCT03228212|3449033|P2|COMPLETED|Period 2||64
1408718|NCT03228212|3449034|P1|COMPLETED|Period 2||63
1408719|NCT03228212|3449033|P2|STARTED|Period 2||64
1408720|NCT03228212|3449034|P1|STARTED|Period 2||64
1408721|NCT03228212|3449033|P2|NOT COMPLETED|Period 1||1
1408722|NCT03228212|3449034|P1|NOT COMPLETED|Period 1||1
1408723|NCT03228212|3449033|P2|COMPLETED|Period 1||64
1408724|NCT03228212|3449034|P1|COMPLETED|Period 1||64
1408725|NCT03228212|3449033|P2|STARTED|Period 1||65
1408726|NCT03228212|3449034|P1|STARTED|Period 1||65
1408727|NCT03225001|3449050|P1|NOT COMPLETED|Overall Study||9
1408728|NCT03225001|3449050|P1|COMPLETED|Overall Study||188
1408729|NCT03225001|3449050|P1|Valve-Implanted|Overall Study||195
1408730|NCT03225001|3449050|P1|STARTED|Overall Study||197
1408731|NCT03223662|3449055|P1|NOT COMPLETED|Overall Study||2
1408732|NCT03223662|3449055|P1|COMPLETED|Overall Study||0
1408733|NCT03223662|3449055|P1|STARTED|Overall Study||2
1408734|NCT03222141|3449065|P1|NOT COMPLETED|Overall Study||18
1408735|NCT03222141|3449065|P1|COMPLETED|Overall Study||565
1408736|NCT03222141|3449065|P1|STARTED|Overall Study||583
1408737|NCT03222128|3449071|P1|NOT COMPLETED|Overall Study||106
1408738|NCT03222128|3449071|P1|COMPLETED|Overall Study||968
1408739|NCT03222128|3449071|P1|Valve-Implanted|Overall Study||1069
1408740|NCT03222128|3449071|P1|STARTED|Overall Study||1074
1408741|NCT03222037|3449076|P2|NOT COMPLETED|Period 1||0
1408742|NCT03222037|3449077|P1|NOT COMPLETED|Period 1||0
1408743|NCT03222037|3449076|P2|COMPLETED|Period 1||22
1408744|NCT03222037|3449077|P1|COMPLETED|Period 1||21
1408745|NCT03222037|3449076|P2|STARTED|Period 1||22
1408746|NCT03222037|3449077|P1|STARTED|Period 1||21
1408747|NCT03222037|3449076|P2|NOT COMPLETED|Period 2||0
1408748|NCT03222037|3449077|P1|NOT COMPLETED|Period 2||0
1408749|NCT03222037|3449076|P2|COMPLETED|Period 2||22
1408750|NCT03222037|3449077|P1|COMPLETED|Period 2||21
1408751|NCT03222037|3449076|P2|STARTED|Period 2||22
1408752|NCT03222037|3449077|P1|STARTED|Period 2||21
1408753|NCT03218163|3449085|P1|NOT COMPLETED|Overall Study||1
1408754|NCT03218163|3449085|P1|COMPLETED|Overall Study||0
1408755|NCT03218163|3449085|P1|STARTED|Overall Study||1
1408756|NCT03217968|3449089|P1|NOT COMPLETED|Overall Study||11
1408757|NCT03217968|3449089|P1|COMPLETED|Overall Study||48
1408758|NCT03217968|3449089|P1|STARTED|Overall Study||59
1408759|NCT03206216|3449100|P2|NOT COMPLETED|Overall Study||1
1408760|NCT03206216|3449101|P1|NOT COMPLETED|Overall Study||0
1408761|NCT03206216|3449100|P2|COMPLETED|Overall Study||0
1408762|NCT03206216|3449101|P1|COMPLETED|Overall Study||0
1408763|NCT03206216|3449100|P2|STARTED|Overall Study||1
1408764|NCT03206216|3449101|P1|STARTED|Overall Study||0
1408765|NCT03198767|3449116|P7|NOT COMPLETED|Overall Study||0
1408766|NCT03198767|3449117|P6|NOT COMPLETED|Overall Study||0
1408767|NCT03198767|3449118|P5|NOT COMPLETED|Overall Study||0
1408768|NCT03198767|3449119|P4|NOT COMPLETED|Overall Study||6
1408769|NCT03198767|3449120|P3|NOT COMPLETED|Overall Study||0
1408770|NCT03198767|3449121|P2|NOT COMPLETED|Overall Study||0
1408771|NCT03198767|3449122|P1|NOT COMPLETED|Overall Study||0
1408772|NCT03198767|3449116|P7|COMPLETED|Overall Study||8
1408773|NCT03198767|3449117|P6|COMPLETED|Overall Study||8
1408774|NCT03198767|3449118|P5|COMPLETED|Overall Study||8
1408775|NCT03198767|3449119|P4|COMPLETED|Overall Study||0
1408776|NCT03198767|3449120|P3|COMPLETED|Overall Study||8
1408777|NCT03198767|3449121|P2|COMPLETED|Overall Study||8
1408778|NCT03198767|3449122|P1|COMPLETED|Overall Study||8
1408779|NCT03198767|3449116|P7|STARTED|Overall Study||8
1408780|NCT03198767|3449117|P6|STARTED|Overall Study||8
1408781|NCT03198767|3449118|P5|STARTED|Overall Study||8
1408782|NCT03198767|3449119|P4|STARTED|Overall Study||6
1408783|NCT03198767|3449120|P3|STARTED|Overall Study||8
1408784|NCT03198767|3449121|P2|STARTED|Overall Study||8
1408785|NCT03198767|3449122|P1|STARTED|Overall Study||8
1408786|NCT03198000|3449158|P3|NOT COMPLETED|Overall Study||0
1408787|NCT03198000|3449159|P2|NOT COMPLETED|Overall Study||0
1408788|NCT03198000|3449160|P1|NOT COMPLETED|Overall Study||0
1408789|NCT03198000|3449158|P3|COMPLETED|Overall Study||41
1408790|NCT03198000|3449159|P2|COMPLETED|Overall Study||38
1408791|NCT03198000|3449160|P1|COMPLETED|Overall Study||41
1408792|NCT03198000|3449158|P3|STARTED|Overall Study||41
1408793|NCT03198000|3449159|P2|STARTED|Overall Study||38
1408794|NCT03198000|3449160|P1|STARTED|Overall Study||41
1408795|NCT03196635|3449267|P1|NOT COMPLETED|Overall Study||1
1408796|NCT03196635|3449267|P1|COMPLETED|Overall Study||30
1408797|NCT03196635|3449267|P1|STARTED|Overall Study||31
1408798|NCT03192306|3449287|P2|NOT COMPLETED|Overall Study||145
1408799|NCT03192306|3449288|P1|NOT COMPLETED|Overall Study||152
1408800|NCT03192306|3449287|P2|COMPLETED|Overall Study||79
1408801|NCT03192306|3449288|P1|COMPLETED|Overall Study||75
1408802|NCT03192306|3449287|P2|Modified Intent to Treat (MITT)|Overall Study||80
1408803|NCT03192306|3449288|P1|Modified Intent to Treat (MITT)|Overall Study||76
1408804|NCT03192306|3449287|P2|STARTED|Overall Study||224
1408805|NCT03192306|3449288|P1|STARTED|Overall Study||227
1408806|NCT03191552|3449309|P3|NOT COMPLETED|Overall Study||0
1408807|NCT03191552|3449310|P2|NOT COMPLETED|Overall Study||1
1408808|NCT03191552|3449311|P1|NOT COMPLETED|Overall Study||1
1408809|NCT03191552|3449309|P3|COMPLETED|Overall Study||8
1408810|NCT03191552|3449310|P2|COMPLETED|Overall Study||8
1408811|NCT03191552|3449311|P1|COMPLETED|Overall Study||8
1408812|NCT03191552|3449309|P3|STARTED|Overall Study||8
1408813|NCT03191552|3449310|P2|STARTED|Overall Study||9
1408814|NCT03191552|3449311|P1|STARTED|Overall Study||9
1408815|NCT03184441|3449362|P1|NOT COMPLETED|Overall Study||1
1408816|NCT03184441|3449362|P1|COMPLETED|Overall Study|Last subject completed study|10
1408817|NCT03184441|3449362|P1|STARTED|Overall Study||11
1408818|NCT03184077|3449372|P2|NOT COMPLETED|Overall Study||21
1408819|NCT03184077|3449373|P1|NOT COMPLETED|Overall Study||21
1408820|NCT03184077|3449372|P2|COMPLETED|Overall Study||131
1408821|NCT03184077|3449373|P1|COMPLETED|Overall Study||145
1408822|NCT03184077|3449372|P2|STARTED|Overall Study||152
1408823|NCT03184077|3449373|P1|STARTED|Overall Study||166
1408824|NCT03182582|3449383|P2|NOT COMPLETED|Treatment 2||0
1408825|NCT03182582|3449384|P1|NOT COMPLETED|Treatment 2||0
1408826|NCT03182582|3449383|P2|COMPLETED|Treatment 2||10
1408827|NCT03182582|3449384|P1|COMPLETED|Treatment 2||12
1408828|NCT03182582|3449383|P2|STARTED|Treatment 2||10
1408829|NCT03182582|3449384|P1|STARTED|Treatment 2||12
1408830|NCT03182582|3449383|P2|NOT COMPLETED|Treatment 1||0
1408831|NCT03182582|3449384|P1|NOT COMPLETED|Treatment 1||0
1408832|NCT03182582|3449383|P2|COMPLETED|Treatment 1||10
1408833|NCT03182582|3449384|P1|COMPLETED|Treatment 1||12
1408834|NCT03182582|3449383|P2|STARTED|Treatment 1||10
1408835|NCT03182582|3449384|P1|STARTED|Treatment 1||12
1408836|NCT03180138|3449402|P3|NOT COMPLETED|Overall Study||24
1408837|NCT03180138|3449403|P2|NOT COMPLETED|Overall Study||13
1408838|NCT03180138|3449404|P1|NOT COMPLETED|Overall Study||22
1408839|NCT03180138|3449402|P3|COMPLETED|Overall Study||179
1408840|NCT03180138|3449403|P2|COMPLETED|Overall Study||188
1408841|NCT03180138|3449404|P1|COMPLETED|Overall Study||182
1408842|NCT03180138|3449402|P3|STARTED|Overall Study||203
1408843|NCT03180138|3449403|P2|STARTED|Overall Study||201
1408844|NCT03180138|3449404|P1|STARTED|Overall Study||204
1408845|NCT03178344|3449415|P2|NOT COMPLETED|Second Session||0
1408846|NCT03178344|3449416|P1|NOT COMPLETED|Second Session||0
1408847|NCT03178344|3449415|P2|COMPLETED|Second Session||10
1408848|NCT03178344|3449416|P1|COMPLETED|Second Session||10
1408849|NCT03178344|3449415|P2|STARTED|Second Session||10
1408850|NCT03178344|3449416|P1|STARTED|Second Session||10
1408851|NCT03178344|3449415|P2|NOT COMPLETED|Washout Period (5-9 Days)||0
1408852|NCT03178344|3449416|P1|NOT COMPLETED|Washout Period (5-9 Days)||0
1408853|NCT03178344|3449415|P2|COMPLETED|Washout Period (5-9 Days)||10
1408854|NCT03178344|3449416|P1|COMPLETED|Washout Period (5-9 Days)||10
1408855|NCT03178344|3449415|P2|STARTED|Washout Period (5-9 Days)||10
1408856|NCT03178344|3449416|P1|STARTED|Washout Period (5-9 Days)||10
1408857|NCT03178344|3449415|P2|NOT COMPLETED|First Session||0
1408858|NCT03178344|3449416|P1|NOT COMPLETED|First Session||0
1408859|NCT03178344|3449415|P2|COMPLETED|First Session||10
1408860|NCT03178344|3449416|P1|COMPLETED|First Session||10
1408861|NCT03178344|3449415|P2|STARTED|First Session||10
1408862|NCT03178344|3449416|P1|STARTED|First Session||10
1408863|NCT03168542|3449430|P3|NOT COMPLETED|Overall Study||0
1408864|NCT03168542|3449431|P2|NOT COMPLETED|Overall Study||0
1408865|NCT03168542|3449432|P1|NOT COMPLETED|Overall Study||0
1408866|NCT03168542|3449430|P3|COMPLETED|Overall Study||9
1408867|NCT03168542|3449431|P2|COMPLETED|Overall Study||5
1408868|NCT03168542|3449432|P1|COMPLETED|Overall Study||7
1408869|NCT03168542|3449430|P3|STARTED|Overall Study||9
1408870|NCT03168542|3449431|P2|STARTED|Overall Study||5
1408871|NCT03168542|3449432|P1|STARTED|Overall Study||7
1408872|NCT03166618|3449449|P2|NOT COMPLETED|Overall Study||1
1408873|NCT03166618|3449450|P1|NOT COMPLETED|Overall Study||0
1408874|NCT03166618|3449449|P2|COMPLETED|Overall Study||0
1408875|NCT03166618|3449450|P1|COMPLETED|Overall Study||0
1408876|NCT03166618|3449449|P2|STARTED|Overall Study||1
1408877|NCT03166618|3449450|P1|STARTED|Overall Study||0
1408878|NCT03163134|3449462|P2|NOT COMPLETED|Overall Study||0
1408879|NCT03163134|3449463|P1|NOT COMPLETED|Overall Study||0
1408880|NCT03163134|3449462|P2|COMPLETED|Overall Study||85
1408881|NCT03163134|3449463|P1|COMPLETED|Overall Study||85
1408882|NCT03163134|3449462|P2|STARTED|Overall Study||85
1408883|NCT03163134|3449463|P1|STARTED|Overall Study||85
1408884|NCT03162458|3449473|P2|NOT COMPLETED|Overall Study||0
1408885|NCT03162458|3449474|P1|NOT COMPLETED|Overall Study||0
1408886|NCT03162458|3449473|P2|COMPLETED|Overall Study||71
1408887|NCT03162458|3449474|P1|COMPLETED|Overall Study||71
1408888|NCT03162458|3449473|P2|STARTED|Overall Study||71
1408889|NCT03162458|3449474|P1|STARTED|Overall Study||71
1408890|NCT03161327|3449498|P1|NOT COMPLETED|Overall Study||0
1408891|NCT03161327|3449498|P1|COMPLETED|Overall Study||238
1408892|NCT03161327|3449498|P1|STARTED|Overall Study||238
1408893|NCT03159143|3449503|P1|NOT COMPLETED|Overall Study||0
1408894|NCT03159143|3449503|P1|COMPLETED|Overall Study||22
1408895|NCT03159143|3449503|P1|STARTED|Overall Study||22
1408896|NCT03157232|3449510|P1|NOT COMPLETED|Overall Study||0
1408897|NCT03157232|3449510|P1|COMPLETED|Overall Study||18
1408898|NCT03157232|3449510|P1|STARTED|Overall Study||18
1408899|NCT03154047|3449514|P1|NOT COMPLETED|Overall Study||80
1408900|NCT03154047|3449514|P1|COMPLETED|Overall Study||0
1408901|NCT03154047|3449514|P1|Number of Patients Dosed|Overall Study||80
1408902|NCT03154047|3449514|P1|STARTED|Overall Study||80
1408903|NCT03151226|3449518|P1|NOT COMPLETED|Overall Study||3
1408904|NCT03151226|3449518|P1|COMPLETED|Overall Study||0
1408905|NCT03151226|3449518|P1|STARTED|Overall Study||3
1408906|NCT03150485|3449522|P6|NOT COMPLETED|Overall Study||0
1408907|NCT03150485|3449523|P5|NOT COMPLETED|Overall Study||0
1408908|NCT03150485|3449524|P4|NOT COMPLETED|Overall Study||0
1408909|NCT03150485|3449525|P3|NOT COMPLETED|Overall Study||0
1408910|NCT03150485|3449526|P2|NOT COMPLETED|Overall Study||1
1408911|NCT03150485|3449527|P1|NOT COMPLETED|Overall Study||0
1408912|NCT03150485|3449522|P6|COMPLETED|Overall Study||1
1408913|NCT03150485|3449523|P5|COMPLETED|Overall Study||2
1408914|NCT03150485|3449524|P4|COMPLETED|Overall Study||5
1408915|NCT03150485|3449525|P3|COMPLETED|Overall Study||4
1408916|NCT03150485|3449526|P2|COMPLETED|Overall Study||8
1408917|NCT03150485|3449527|P1|COMPLETED|Overall Study||2
1408918|NCT03150485|3449522|P6|STARTED|Overall Study||1
1408919|NCT03150485|3449523|P5|STARTED|Overall Study||2
1408920|NCT03150485|3449524|P4|STARTED|Overall Study||5
1408921|NCT03150485|3449525|P3|STARTED|Overall Study||4
1408922|NCT03150485|3449526|P2|STARTED|Overall Study||9
1408923|NCT03150485|3449527|P1|STARTED|Overall Study||2
1408924|NCT03150082|3449542|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
1408925|NCT03150082|3449543|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
1408926|NCT03150082|3449542|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
1408927|NCT03150082|3449543|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
1408928|NCT03150082|3449542|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
1408929|NCT03150082|3449543|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
1408930|NCT03150082|3449542|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
1408931|NCT03150082|3449543|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
1408932|NCT03150082|3449542|P2|COMPLETED|Washout Period (Up to 4 Weeks)||13
1408933|NCT03150082|3449543|P1|COMPLETED|Washout Period (Up to 4 Weeks)||12
1408934|NCT03150082|3449542|P2|STARTED|Washout Period (Up to 4 Weeks)||13
1408935|NCT03150082|3449543|P1|STARTED|Washout Period (Up to 4 Weeks)||12
1408936|NCT03150082|3449542|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
1408937|NCT03150082|3449543|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
1408938|NCT03150082|3449542|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
1408939|NCT03150082|3449543|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
1408940|NCT03150082|3449542|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
1408941|NCT03150082|3449543|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
1408942|NCT03148756|3449599|P2|NOT COMPLETED|Overall Study||1
1408943|NCT03148756|3449600|P1|NOT COMPLETED|Overall Study||0
1408944|NCT03148756|3449599|P2|COMPLETED|Overall Study||1
1408945|NCT03148756|3449600|P1|COMPLETED|Overall Study||0
1408946|NCT03148756|3449599|P2|STARTED|Overall Study||2
1408947|NCT03148756|3449600|P1|STARTED|Overall Study||0
1408948|NCT03148262|3449632|P2|NOT COMPLETED|Overall Study||1
1408949|NCT03148262|3449633|P1|NOT COMPLETED|Overall Study||3
1408950|NCT03148262|3449632|P2|COMPLETED|Overall Study||31
1408951|NCT03148262|3449633|P1|COMPLETED|Overall Study||28
1408952|NCT03148262|3449632|P2|STARTED|Overall Study||32
1408953|NCT03148262|3449633|P1|STARTED|Overall Study||31
1408954|NCT03143101|3449642|P3|NOT COMPLETED|Overall Study||0
1408955|NCT03143101|3449643|P2|NOT COMPLETED|Overall Study||3
1408956|NCT03143101|3449644|P1|NOT COMPLETED|Overall Study||2
1408957|NCT03143101|3449642|P3|COMPLETED|Overall Study||67
1408958|NCT03143101|3449643|P2|COMPLETED|Overall Study||63
1408959|NCT03143101|3449644|P1|COMPLETED|Overall Study||65
1408960|NCT03143101|3449642|P3|STARTED|Overall Study||67
1408961|NCT03143101|3449643|P2|STARTED|Overall Study||66
1408962|NCT03143101|3449644|P1|STARTED|Overall Study||67
1408963|NCT03142932|3449699|P2|NOT COMPLETED|Overall Study||11
1408964|NCT03142932|3449700|P1|NOT COMPLETED|Overall Study||2
1408965|NCT03142932|3449699|P2|COMPLETED|Overall Study||39
1408966|NCT03142932|3449700|P1|COMPLETED|Overall Study||50
1408967|NCT03142932|3449699|P2|STARTED|Overall Study||50
1408968|NCT03142932|3449700|P1|STARTED|Overall Study||52
1408969|NCT03141372|3449716|P2|NOT COMPLETED|Overall Study||2
1408970|NCT03141372|3449717|P1|NOT COMPLETED|Overall Study||0
1408971|NCT03141372|3449716|P2|COMPLETED|Overall Study||40
1408972|NCT03141372|3449717|P1|COMPLETED|Overall Study||42
1408973|NCT03141372|3449716|P2|STARTED|Overall Study||42
1408974|NCT03141372|3449717|P1|STARTED|Overall Study||42
1408975|NCT03140631|3449737|P2|NOT COMPLETED|Overall Study||0
1408976|NCT03140631|3449738|P1|NOT COMPLETED|Overall Study||0
1408977|NCT03140631|3449737|P2|COMPLETED|Overall Study||77
1408978|NCT03140631|3449738|P1|COMPLETED|Overall Study||73
1408979|NCT03140631|3449737|P2|STARTED|Overall Study||77
1408980|NCT03140631|3449738|P1|STARTED|Overall Study||73
1408981|NCT03139578|3449746|P4|NOT COMPLETED|Period 2||0
1408982|NCT03139578|3449747|P3|NOT COMPLETED|Period 2||0
1408983|NCT03139578|3449748|P2|NOT COMPLETED|Period 2||0
1408984|NCT03139578|3449749|P1|NOT COMPLETED|Period 2||0
1408985|NCT03139578|3449746|P4|COMPLETED|Period 2||13
1408986|NCT03139578|3449747|P3|COMPLETED|Period 2||12
1408987|NCT03139578|3449748|P2|COMPLETED|Period 2||13
1408988|NCT03139578|3449749|P1|COMPLETED|Period 2||12
1408989|NCT03139578|3449746|P4|Discontinued|Period 2||0
1408990|NCT03139578|3449747|P3|Discontinued|Period 2||0
1408991|NCT03139578|3449748|P2|Discontinued|Period 2||0
1408992|NCT03139578|3449749|P1|Discontinued|Period 2||0
1408993|NCT03139578|3449746|P4|STARTED|Period 2||13
1408994|NCT03139578|3449747|P3|STARTED|Period 2||12
1408995|NCT03139578|3449748|P2|STARTED|Period 2||13
1408996|NCT03139578|3449749|P1|STARTED|Period 2||12
1408997|NCT03139578|3449746|P4|NOT COMPLETED|Period 1||0
1408998|NCT03139578|3449747|P3|NOT COMPLETED|Period 1||0
1408999|NCT03139578|3449748|P2|NOT COMPLETED|Period 1||0
1409000|NCT03139578|3449749|P1|NOT COMPLETED|Period 1||0
1409001|NCT03139578|3449746|P4|COMPLETED|Period 1||13
1409002|NCT03139578|3449747|P3|COMPLETED|Period 1||12
1409003|NCT03139578|3449748|P2|COMPLETED|Period 1||13
1409004|NCT03139578|3449749|P1|COMPLETED|Period 1||12
1409005|NCT03139578|3449746|P4|Discontinued|Period 1||0
1409006|NCT03139578|3449747|P3|Discontinued|Period 1||0
1409007|NCT03139578|3449748|P2|Discontinued|Period 1||0
1409008|NCT03139578|3449749|P1|Discontinued|Period 1||0
1409009|NCT03139578|3449746|P4|STARTED|Period 1||13
1409010|NCT03139578|3449747|P3|STARTED|Period 1||12
1409011|NCT03139578|3449748|P2|STARTED|Period 1||13
1409012|NCT03139578|3449749|P1|STARTED|Period 1||12
1409013|NCT03139552|3449783|P1|NOT COMPLETED|Overall Study||3
1409014|NCT03139552|3449783|P1|COMPLETED|Overall Study||147
1409015|NCT03139552|3449783|P1|STARTED|Overall Study||150
1409016|NCT03138798|3449826|P2|NOT COMPLETED|Overall Study||4
1409017|NCT03138798|3449827|P1|NOT COMPLETED|Overall Study||6
1409018|NCT03138798|3449826|P2|COMPLETED|Overall Study||171
1409019|NCT03138798|3449827|P1|COMPLETED|Overall Study||167
1409020|NCT03138798|3449826|P2|Randomized But Did Not Meet Eligibility|Overall Study||4
1409021|NCT03138798|3449827|P1|Randomized But Did Not Meet Eligibility|Overall Study||6
1409022|NCT03138798|3449826|P2|STARTED|Overall Study||175
1409023|NCT03138798|3449827|P1|STARTED|Overall Study||173
1409024|NCT03135379|3449852|P2|NOT COMPLETED|Overall Study||3
1409025|NCT03135379|3449853|P1|NOT COMPLETED|Overall Study||1
1409026|NCT03135379|3449852|P2|COMPLETED|Overall Study||59
1409027|NCT03135379|3449853|P1|COMPLETED|Overall Study||61
1409028|NCT03135379|3449852|P2|STARTED|Overall Study||62
1409029|NCT03135379|3449853|P1|STARTED|Overall Study||62
1409030|NCT03134326|3449861|P1|NOT COMPLETED|Overall Study||0
1409031|NCT03134326|3449861|P1|COMPLETED|Overall Study||21
1409032|NCT03134326|3449861|P1|STARTED|Overall Study||21
1409033|NCT03134313|3449865|P1|NOT COMPLETED|Overall Study||0
1409034|NCT03134313|3449865|P1|COMPLETED|Overall Study||25
1409035|NCT03134313|3449865|P1|STARTED|Overall Study||25
1409036|NCT03134248|3449869|P6|NOT COMPLETED|Week 3||0
1409037|NCT03134248|3449870|P5|NOT COMPLETED|Week 3||0
1409038|NCT03134248|3449871|P4|NOT COMPLETED|Week 3||0
1409039|NCT03134248|3449872|P3|NOT COMPLETED|Week 3||0
1409040|NCT03134248|3449873|P2|NOT COMPLETED|Week 3||0
1409041|NCT03134248|3449874|P1|NOT COMPLETED|Week 3||0
1409042|NCT03134248|3449869|P6|COMPLETED|Week 3||9
1409043|NCT03134248|3449870|P5|COMPLETED|Week 3||9
1409044|NCT03134248|3449871|P4|COMPLETED|Week 3||7
1409045|NCT03134248|3449872|P3|COMPLETED|Week 3||9
1409046|NCT03134248|3449873|P2|COMPLETED|Week 3||8
1409047|NCT03134248|3449874|P1|COMPLETED|Week 3||7
1409048|NCT03134248|3449869|P6|STARTED|Week 3||9
1409049|NCT03134248|3449870|P5|STARTED|Week 3||9
1409050|NCT03134248|3449871|P4|STARTED|Week 3||7
1409051|NCT03134248|3449872|P3|STARTED|Week 3||9
1409052|NCT03134248|3449873|P2|STARTED|Week 3||8
1409053|NCT03134248|3449874|P1|STARTED|Week 3||7
1409054|NCT03134248|3449869|P6|NOT COMPLETED|Week 2||0
1409055|NCT03134248|3449870|P5|NOT COMPLETED|Week 2||0
1409056|NCT03134248|3449871|P4|NOT COMPLETED|Week 2||0
1409057|NCT03134248|3449872|P3|NOT COMPLETED|Week 2||0
1409058|NCT03134248|3449873|P2|NOT COMPLETED|Week 2||0
1409059|NCT03134248|3449874|P1|NOT COMPLETED|Week 2||0
1409060|NCT03134248|3449869|P6|COMPLETED|Week 2||9
1409061|NCT03134248|3449870|P5|COMPLETED|Week 2||9
1409062|NCT03134248|3449871|P4|COMPLETED|Week 2||7
1409063|NCT03134248|3449872|P3|COMPLETED|Week 2||9
1409064|NCT03134248|3449873|P2|COMPLETED|Week 2||8
1409065|NCT03134248|3449874|P1|COMPLETED|Week 2||7
1409066|NCT03134248|3449869|P6|STARTED|Week 2||9
1409067|NCT03134248|3449870|P5|STARTED|Week 2||9
1409068|NCT03134248|3449871|P4|STARTED|Week 2||7
1409069|NCT03134248|3449872|P3|STARTED|Week 2||9
1409070|NCT03134248|3449873|P2|STARTED|Week 2||8
1409071|NCT03134248|3449874|P1|STARTED|Week 2||7
1409072|NCT03134248|3449869|P6|NOT COMPLETED|Week 1||0
1409073|NCT03134248|3449870|P5|NOT COMPLETED|Week 1||0
1409074|NCT03134248|3449871|P4|NOT COMPLETED|Week 1||0
1409075|NCT03134248|3449872|P3|NOT COMPLETED|Week 1||0
1409076|NCT03134248|3449873|P2|NOT COMPLETED|Week 1||0
1409077|NCT03134248|3449874|P1|NOT COMPLETED|Week 1||0
1409078|NCT03134248|3449869|P6|COMPLETED|Week 1||9
1409079|NCT03134248|3449870|P5|COMPLETED|Week 1||9
1409080|NCT03134248|3449871|P4|COMPLETED|Week 1||7
1409081|NCT03134248|3449872|P3|COMPLETED|Week 1||9
1409082|NCT03134248|3449873|P2|COMPLETED|Week 1||8
1409083|NCT03134248|3449874|P1|COMPLETED|Week 1||7
1409084|NCT03134248|3449869|P6|STARTED|Week 1||9
1409085|NCT03134248|3449870|P5|STARTED|Week 1||9
1409086|NCT03134248|3449871|P4|STARTED|Week 1||7
1409087|NCT03134248|3449872|P3|STARTED|Week 1||9
1409088|NCT03134248|3449873|P2|STARTED|Week 1||8
1409089|NCT03134248|3449874|P1|STARTED|Week 1||7
1409090|NCT03134183|3449892|P2|NOT COMPLETED|Overall Study||1
1409091|NCT03134183|3449893|P1|NOT COMPLETED|Overall Study||1
1409092|NCT03134183|3449892|P2|COMPLETED|Overall Study||33
1409093|NCT03134183|3449893|P1|COMPLETED|Overall Study||35
1409094|NCT03134183|3449892|P2|STARTED|Overall Study||34
1409095|NCT03134183|3449893|P1|STARTED|Overall Study||36
1409096|NCT03133767|3449903|P2|NOT COMPLETED|Overall Study||25
1409097|NCT03133767|3449904|P1|NOT COMPLETED|Overall Study||38
1409098|NCT03133767|3449903|P2|COMPLETED|Overall Study||53
1409099|NCT03133767|3449904|P1|COMPLETED|Overall Study||41
1409100|NCT03133767|3449903|P2|STARTED|Overall Study||78
1409101|NCT03133767|3449904|P1|STARTED|Overall Study||79
1409102|NCT03129321|3449921|P3|NOT COMPLETED|Overall Study||55
1409103|NCT03129321|3449922|P2|NOT COMPLETED|Overall Study||109
1409104|NCT03129321|3449923|P1|NOT COMPLETED|Overall Study||98
1409105|NCT03129321|3449921|P3|COMPLETED|Overall Study||120
1409106|NCT03129321|3449922|P2|COMPLETED|Overall Study||241
1409107|NCT03129321|3449923|P1|COMPLETED|Overall Study||253
1409108|NCT03129321|3449921|P3|STARTED|Overall Study||175
1409109|NCT03129321|3449922|P2|STARTED|Overall Study||350
1409110|NCT03129321|3449923|P1|STARTED|Overall Study||351
1409111|NCT03128723|3449943|P1|NOT COMPLETED|Overall Study||2
1409112|NCT03128723|3449943|P1|COMPLETED|Overall Study||43
1409113|NCT03128723|3449943|P1|STARTED|Overall Study||45
1409114|NCT03128372|3449958|P1|NOT COMPLETED|Overall Study||0
1409115|NCT03128372|3449958|P1|COMPLETED|Overall Study||32
1409116|NCT03128372|3449958|P1|STARTED|Overall Study||32
1409117|NCT03128307|3449962|P1|NOT COMPLETED|Overall Study||34
1409118|NCT03128307|3449962|P1|COMPLETED|Overall Study||570
1409119|NCT03128307|3449962|P1|STARTED|Overall Study||604
1409120|NCT03125031|3449967|P2|NOT COMPLETED|Overall Study||0
1409121|NCT03125031|3449968|P1|NOT COMPLETED|Overall Study||0
1409122|NCT03125031|3449967|P2|COMPLETED|Overall Study||44
1409123|NCT03125031|3449968|P1|COMPLETED|Overall Study||44
1409124|NCT03125031|3449967|P2|STARTED|Overall Study||44
1409125|NCT03125031|3449968|P1|STARTED|Overall Study||44
1409126|NCT03125018|3449973|P1|NOT COMPLETED|Overall Study||0
1409127|NCT03125018|3449973|P1|COMPLETED|Overall Study||13
1409128|NCT03125018|3449973|P1|STARTED|Overall Study||13
1409129|NCT03125005|3449977|P1|NOT COMPLETED|Overall Study||0
1409130|NCT03125005|3449977|P1|COMPLETED|Overall Study||51
1409131|NCT03125005|3449977|P1|STARTED|Overall Study||51
1409132|NCT03124979|3449981|P1|NOT COMPLETED|Overall Study||0
1409133|NCT03124979|3449981|P1|COMPLETED|Overall Study||13
1409134|NCT03124979|3449981|P1|STARTED|Overall Study||13
1409135|NCT03124966|3449985|P1|NOT COMPLETED|Overall Study||0
1409136|NCT03124966|3449985|P1|COMPLETED|Overall Study||118
1409137|NCT03124966|3449985|P1|STARTED|Overall Study||118
1409138|NCT03124927|3449989|P1|NOT COMPLETED|Overall Study||0
1409139|NCT03124927|3449989|P1|COMPLETED|Overall Study||25
1409140|NCT03124927|3449989|P1|STARTED|Overall Study||25
1409141|NCT03124901|3449993|P1|NOT COMPLETED|Overall Study||0
1409142|NCT03124901|3449993|P1|COMPLETED|Overall Study||147
1409143|NCT03124901|3449993|P1|STARTED|Overall Study||147
1409144|NCT03124836|3449997|P1|NOT COMPLETED|Overall Study||0
1409145|NCT03124836|3449997|P1|COMPLETED|Overall Study||28
1409146|NCT03124836|3449997|P1|STARTED|Overall Study||28
1409147|NCT03124823|3450001|P1|NOT COMPLETED|Overall Study||0
1409148|NCT03124823|3450001|P1|COMPLETED|Overall Study||11
1409149|NCT03124823|3450001|P1|STARTED|Overall Study||11
1409150|NCT03124797|3450005|P1|NOT COMPLETED|Overall Study||0
1409151|NCT03124797|3450005|P1|COMPLETED|Overall Study||18
1409152|NCT03124797|3450005|P1|STARTED|Overall Study||18
1409153|NCT03124784|3450009|P1|NOT COMPLETED|Overall Study||2
1409154|NCT03124784|3450009|P1|COMPLETED|Overall Study||25
1409155|NCT03124784|3450009|P1|STARTED|Overall Study||27
1409156|NCT03124771|3450013|P1|NOT COMPLETED|Overall Study||0
1409157|NCT03124771|3450013|P1|COMPLETED|Overall Study||132
1409158|NCT03124771|3450013|P1|STARTED|Overall Study||132
1409159|NCT03124758|3450017|P1|NOT COMPLETED|Overall Study||0
1409160|NCT03124758|3450017|P1|COMPLETED|Overall Study||354
1409161|NCT03124758|3450017|P1|STARTED|Overall Study||354
1409162|NCT03124693|3450021|P1|NOT COMPLETED|Overall Study||0
1409163|NCT03124693|3450021|P1|COMPLETED|Overall Study||90
1409164|NCT03124693|3450021|P1|STARTED|Overall Study||90
1409165|NCT03124381|3450027|P2|NOT COMPLETED|Overall Study||6
1409166|NCT03124381|3450028|P1|NOT COMPLETED|Overall Study||9
1409167|NCT03124381|3450027|P2|COMPLETED|Overall Study||55
1409168|NCT03124381|3450028|P1|COMPLETED|Overall Study||56
1409169|NCT03124381|3450027|P2|STARTED|Overall Study||61
1409170|NCT03124381|3450028|P1|STARTED|Overall Study||65
1409171|NCT03124199|3450118|P1|NOT COMPLETED|Overall Study||4
1409172|NCT03124199|3450118|P1|COMPLETED|Overall Study||36
1409173|NCT03124199|3450118|P1|STARTED|Overall Study||40
1409174|NCT03123848|3450124|P1|NOT COMPLETED|Overall Study||0
1409175|NCT03123848|3450124|P1|COMPLETED|Overall Study||8
1409176|NCT03123848|3450124|P1|STARTED|Overall Study||8
1409177|NCT03123354|3450146|P1|NOT COMPLETED|Overall Study||6
1409178|NCT03123354|3450146|P1|COMPLETED|Overall Study||38
1409179|NCT03123354|3450146|P1|STARTED|Overall Study||44
1409180|NCT03121820|3450152|P2|NOT COMPLETED|Second Period (After Washout)||0
1409181|NCT03121820|3450153|P1|NOT COMPLETED|Second Period (After Washout)||0
1409182|NCT03121820|3450152|P2|COMPLETED|Second Period (After Washout)||9
1409183|NCT03121820|3450153|P1|COMPLETED|Second Period (After Washout)||9
1409184|NCT03121820|3450152|P2|STARTED|Second Period (After Washout)||9
1409185|NCT03121820|3450153|P1|STARTED|Second Period (After Washout)||9
1409186|NCT03121820|3450152|P2|NOT COMPLETED|First Period||0
1409187|NCT03121820|3450153|P1|NOT COMPLETED|First Period||0
1409188|NCT03121820|3450152|P2|COMPLETED|First Period||9
1409189|NCT03121820|3450153|P1|COMPLETED|First Period||9
1409190|NCT03121820|3450152|P2|STARTED|First Period||9
1409191|NCT03121820|3450153|P1|STARTED|First Period||9
1409192|NCT03119831|3450164|P3|NOT COMPLETED|Overall Study||0
1409193|NCT03119831|3450165|P2|NOT COMPLETED|Overall Study||0
1409194|NCT03119831|3450166|P1|NOT COMPLETED|Overall Study||0
1409195|NCT03119831|3450164|P3|COMPLETED|Overall Study||14
1409196|NCT03119831|3450165|P2|COMPLETED|Overall Study||14
1409197|NCT03119831|3450166|P1|COMPLETED|Overall Study||14
1409198|NCT03119831|3450164|P3|STARTED|Overall Study||14
1409199|NCT03119831|3450165|P2|STARTED|Overall Study||14
1409200|NCT03119831|3450166|P1|STARTED|Overall Study||14
1409201|NCT03119649|3450188|P5|NOT COMPLETED|Overall Study||0
1409202|NCT03119649|3450189|P4|NOT COMPLETED|Overall Study||0
1409203|NCT03119649|3450190|P3|NOT COMPLETED|Overall Study||0
1409204|NCT03119649|3450191|P2|NOT COMPLETED|Overall Study||0
1409205|NCT03119649|3450192|P1|NOT COMPLETED|Overall Study||0
1409206|NCT03119649|3450188|P5|COMPLETED|Overall Study||14
1409207|NCT03119649|3450189|P4|COMPLETED|Overall Study||14
1409208|NCT03119649|3450190|P3|COMPLETED|Overall Study||10
1409209|NCT03119649|3450191|P2|COMPLETED|Overall Study||10
1409210|NCT03119649|3450192|P1|COMPLETED|Overall Study||11
1409211|NCT03119649|3450188|P5|STARTED|Overall Study||14
1409212|NCT03119649|3450189|P4|STARTED|Overall Study||14
1409213|NCT03119649|3450190|P3|STARTED|Overall Study||10
1409214|NCT03119649|3450191|P2|STARTED|Overall Study||10
1409215|NCT03119649|3450192|P1|STARTED|Overall Study||11
1409216|NCT03118934|3450238|P6|NOT COMPLETED|Overall Study||2
1409217|NCT03118934|3450239|P5|NOT COMPLETED|Overall Study||2
1409218|NCT03118934|3450240|P4|NOT COMPLETED|Overall Study||1
1409219|NCT03118934|3450241|P3|NOT COMPLETED|Overall Study||1
1409220|NCT03118934|3450242|P2|NOT COMPLETED|Overall Study||1
1409221|NCT03118934|3450243|P1|NOT COMPLETED|Overall Study||0
1409222|NCT03118934|3450238|P6|COMPLETED|Overall Study||23
1409223|NCT03118934|3450239|P5|COMPLETED|Overall Study||27
1409224|NCT03118934|3450240|P4|COMPLETED|Overall Study||28
1409225|NCT03118934|3450241|P3|COMPLETED|Overall Study||33
1409226|NCT03118934|3450242|P2|COMPLETED|Overall Study||30
1409227|NCT03118934|3450243|P1|COMPLETED|Overall Study||34
1409228|NCT03118934|3450238|P6|Safety Analysis Set|Overall Study||25
1409229|NCT03118934|3450239|P5|Safety Analysis Set|Overall Study||26
1409230|NCT03118934|3450240|P4|Safety Analysis Set|Overall Study||29
1409231|NCT03118934|3450241|P3|Safety Analysis Set|Overall Study||34
1409232|NCT03118934|3450242|P2|Safety Analysis Set|Overall Study||29
1409233|NCT03118934|3450243|P1|Safety Analysis Set|Overall Study||34
1409234|NCT03118934|3450238|P6|STARTED|Overall Study||25
1409235|NCT03118934|3450239|P5|STARTED|Overall Study||29
1409236|NCT03118934|3450240|P4|STARTED|Overall Study||29
1409237|NCT03118934|3450241|P3|STARTED|Overall Study||34
1409238|NCT03118934|3450242|P2|STARTED|Overall Study||31
1409239|NCT03118934|3450243|P1|STARTED|Overall Study||34
1409240|NCT03118297|3450255|P2|NOT COMPLETED|Overall Study||2
1409241|NCT03118297|3450256|P1|NOT COMPLETED|Overall Study||0
1409242|NCT03118297|3450255|P2|COMPLETED|Overall Study||31
1409243|NCT03118297|3450256|P1|COMPLETED|Overall Study||32
1409244|NCT03118297|3450255|P2|STARTED|Overall Study||33
1409245|NCT03118297|3450256|P1|STARTED|Overall Study||32
1409246|NCT03117140|3450274|P4|NOT COMPLETED|Overall Study||0
1409247|NCT03117140|3450275|P3|NOT COMPLETED|Overall Study||0
1409248|NCT03117140|3450276|P2|NOT COMPLETED|Overall Study||0
1409249|NCT03117140|3450277|P1|NOT COMPLETED|Overall Study||0
1409250|NCT03117140|3450274|P4|COMPLETED|Overall Study||40
1409251|NCT03117140|3450275|P3|COMPLETED|Overall Study||40
1409252|NCT03117140|3450276|P2|COMPLETED|Overall Study||40
1409253|NCT03117140|3450277|P1|COMPLETED|Overall Study||40
1409254|NCT03117140|3450274|P4|STARTED|Overall Study||40
1409255|NCT03117140|3450275|P3|STARTED|Overall Study||40
1409256|NCT03117140|3450276|P2|STARTED|Overall Study||40
1409257|NCT03117140|3450277|P1|STARTED|Overall Study||40
1409258|NCT03115853|3450343|P1|NOT COMPLETED|Overall Study||0
1409259|NCT03115853|3450343|P1|COMPLETED|Overall Study||31
1409260|NCT03115853|3450343|P1|STARTED|Overall Study||31
1409261|NCT03115177|3450363|P2|NOT COMPLETED|Overall Study||0
1409262|NCT03115177|3450364|P1|NOT COMPLETED|Overall Study||0
1409263|NCT03115177|3450363|P2|COMPLETED|Overall Study||29
1409264|NCT03115177|3450364|P1|COMPLETED|Overall Study||27
1409265|NCT03115177|3450363|P2|STARTED|Overall Study||29
1409266|NCT03115177|3450364|P1|STARTED|Overall Study||27
1409267|NCT03114995|3450373|P3|NOT COMPLETED|Overall Study||0
1409268|NCT03114995|3450374|P2|NOT COMPLETED|Overall Study||1
1409269|NCT03114995|3450375|P1|NOT COMPLETED|Overall Study||1
1409270|NCT03114995|3450373|P3|COMPLETED|Overall Study||78
1409271|NCT03114995|3450374|P2|COMPLETED|Overall Study||30
1409272|NCT03114995|3450375|P1|COMPLETED|Overall Study||30
1409273|NCT03114995|3450373|P3|STARTED|Overall Study||78
1409274|NCT03114995|3450374|P2|STARTED|Overall Study||31
1409275|NCT03114995|3450375|P1|STARTED|Overall Study||31
1409276|NCT03110900|3450388|P2|NOT COMPLETED|Overall Study||1
1409277|NCT03110900|3450389|P1|NOT COMPLETED|Overall Study||1
1409278|NCT03110900|3450388|P2|COMPLETED|Overall Study||0
1409279|NCT03110900|3450389|P1|COMPLETED|Overall Study||0
1409280|NCT03110900|3450388|P2|STARTED|Overall Study||1
1409281|NCT03110900|3450389|P1|STARTED|Overall Study||1
1409282|NCT03110003|3450397|P2|NOT COMPLETED|Overall Study||0
1409283|NCT03110003|3450398|P1|NOT COMPLETED|Overall Study||0
1409284|NCT03110003|3450397|P2|COMPLETED|Overall Study||24
1409285|NCT03110003|3450398|P1|COMPLETED|Overall Study||21
1409286|NCT03110003|3450397|P2|STARTED|Overall Study||24
1409287|NCT03110003|3450398|P1|STARTED|Overall Study||21
1409288|NCT03109769|3450416|P2|NOT COMPLETED|Overall Study||0
1409289|NCT03109769|3450417|P1|NOT COMPLETED|Overall Study||0
1409290|NCT03109769|3450416|P2|COMPLETED|Overall Study||22
1409291|NCT03109769|3450417|P1|COMPLETED|Overall Study||22
1409292|NCT03109769|3450416|P2|STARTED|Overall Study||22
1409293|NCT03109769|3450417|P1|STARTED|Overall Study||22
1409294|NCT03106870|3450427|P2|NOT COMPLETED|Overall Study||0
1409295|NCT03106870|3450428|P1|NOT COMPLETED|Overall Study||0
1409296|NCT03106870|3450427|P2|COMPLETED|Overall Study||31
1409297|NCT03106870|3450428|P1|COMPLETED|Overall Study||31
1409298|NCT03106870|3450427|P2|STARTED|Overall Study||31
1409299|NCT03106870|3450428|P1|STARTED|Overall Study||31
1409300|NCT03106337|3450438|P1|NOT COMPLETED|Overall Study||0
1409301|NCT03106337|3450438|P1|COMPLETED|Overall Study||35
1409302|NCT03106337|3450438|P1|STARTED|Overall Study||35
1409303|NCT03105518|3450443|P1|NOT COMPLETED|Overall Study||0
1409304|NCT03105518|3450443|P1|COMPLETED|Overall Study||100
1409305|NCT03105518|3450443|P1|STARTED|Overall Study||100
1409306|NCT03104985|3450450|P2|NOT COMPLETED|Overall Study||0
1409307|NCT03104985|3450451|P1|NOT COMPLETED|Overall Study||0
1409308|NCT03104985|3450450|P2|COMPLETED|Overall Study||34
1409309|NCT03104985|3450451|P1|COMPLETED|Overall Study||34
1409310|NCT03104985|3450450|P2|STARTED|Overall Study||34
1409311|NCT03104985|3450451|P1|STARTED|Overall Study||34
1409312|NCT03104738|3450459|P2|NOT COMPLETED|Overall Study||0
1409313|NCT03104738|3450460|P1|NOT COMPLETED|Overall Study||0
1409314|NCT03104738|3450459|P2|COMPLETED|Overall Study||20
1409315|NCT03104738|3450460|P1|COMPLETED|Overall Study||20
1409316|NCT03104738|3450459|P2|STARTED|Overall Study||20
1409317|NCT03104738|3450460|P1|STARTED|Overall Study||20
1409318|NCT03104647|3450486|P1|NOT COMPLETED|Overall Study||0
1409319|NCT03104647|3450486|P1|COMPLETED|Overall Study||20
1409320|NCT03104647|3450486|P1|STARTED|Overall Study||20
1409321|NCT03101150|3450493|P2|NOT COMPLETED|Overall Study||10
1409322|NCT03101150|3450494|P1|NOT COMPLETED|Overall Study||5
1409323|NCT03101150|3450493|P2|COMPLETED|Overall Study||83
1409324|NCT03101150|3450494|P1|COMPLETED|Overall Study||81
1409325|NCT03101150|3450493|P2|STARTED|Overall Study||93
1409326|NCT03101150|3450494|P1|STARTED|Overall Study||86
1409327|NCT03101033|3450506|P2|NOT COMPLETED|Overall Study||9
1409328|NCT03101033|3450507|P1|NOT COMPLETED|Overall Study||5
1409329|NCT03101033|3450506|P2|COMPLETED|Overall Study||51
1409330|NCT03101033|3450507|P1|COMPLETED|Overall Study||27
1409331|NCT03101033|3450506|P2|STARTED|Overall Study||60
1409332|NCT03101033|3450507|P1|STARTED|Overall Study||32
1409333|NCT03099096|3450527|P1|NOT COMPLETED|Overall Study||2
1409334|NCT03099096|3450527|P1|COMPLETED|Overall Study||157
1409335|NCT03099096|3450527|P1|STARTED|Overall Study||159
1409336|NCT03098966|3450534|P1|NOT COMPLETED|Overall Study||0
1409337|NCT03098966|3450534|P1|COMPLETED|Overall Study||368
1409338|NCT03098966|3450534|P1|STARTED|Overall Study||368
1409339|NCT03097614|3450540|P1|NOT COMPLETED|Overall Study||3
1409340|NCT03097614|3450540|P1|COMPLETED|Overall Study||54
1409341|NCT03097614|3450540|P1|STARTED|Overall Study||57
1409342|NCT03097289|3450544|P1|NOT COMPLETED|Overall Study||6
1409343|NCT03097289|3450544|P1|COMPLETED|Overall Study||26
1409344|NCT03097289|3450544|P1|STARTED|Overall Study||32
1409345|NCT03095638|3450553|P8|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409346|NCT03095638|3450554|P7|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409347|NCT03095638|3450555|P6|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409348|NCT03095638|3450556|P5|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409349|NCT03095638|3450557|P4|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409350|NCT03095638|3450558|P3|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409351|NCT03095638|3450559|P2|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409352|NCT03095638|3450560|P1|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409353|NCT03095638|3450553|P8|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1409354|NCT03095638|3450554|P7|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1409355|NCT03095638|3450555|P6|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1409356|NCT03095638|3450556|P5|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1409357|NCT03095638|3450557|P4|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1409358|NCT03095638|3450558|P3|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
1409359|NCT03095638|3450559|P2|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409360|NCT03095638|3450560|P1|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
1409361|NCT03095638|3450553|P8|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1409362|NCT03095638|3450554|P7|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1409363|NCT03095638|3450555|P6|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1409364|NCT03095638|3450556|P5|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1409365|NCT03095638|3450557|P4|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1409366|NCT03095638|3450558|P3|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
1409367|NCT03095638|3450559|P2|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
1409368|NCT03095638|3450560|P1|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
1409369|NCT03095638|3450553|P8|NOT COMPLETED|P2: Period 3 (4 Days)||0
1409370|NCT03095638|3450554|P7|NOT COMPLETED|P2: Period 3 (4 Days)||0
1409371|NCT03095638|3450555|P6|NOT COMPLETED|P2: Period 3 (4 Days)||0
1409372|NCT03095638|3450556|P5|NOT COMPLETED|P2: Period 3 (4 Days)||0
1409373|NCT03095638|3450557|P4|NOT COMPLETED|P2: Period 3 (4 Days)||0
1409374|NCT03095638|3450558|P3|NOT COMPLETED|P2: Period 3 (4 Days)||0
1409375|NCT03095638|3450559|P2|NOT COMPLETED|P2: Period 3 (4 Days)||0
1409376|NCT03095638|3450560|P1|NOT COMPLETED|P2: Period 3 (4 Days)||0
1409377|NCT03095638|3450553|P8|COMPLETED|P2: Period 3 (4 Days)||4
1409378|NCT03095638|3450554|P7|COMPLETED|P2: Period 3 (4 Days)||4
1409379|NCT03095638|3450555|P6|COMPLETED|P2: Period 3 (4 Days)||4
1409380|NCT03095638|3450556|P5|COMPLETED|P2: Period 3 (4 Days)||4
1409381|NCT03095638|3450557|P4|COMPLETED|P2: Period 3 (4 Days)||4
1409382|NCT03095638|3450558|P3|COMPLETED|P2: Period 3 (4 Days)||4
1409383|NCT03095638|3450559|P2|COMPLETED|P2: Period 3 (4 Days)||0
1409384|NCT03095638|3450560|P1|COMPLETED|P2: Period 3 (4 Days)||0
1409385|NCT03095638|3450553|P8|STARTED|P2: Period 3 (4 Days)||4
1409386|NCT03095638|3450554|P7|STARTED|P2: Period 3 (4 Days)||4
1409387|NCT03095638|3450555|P6|STARTED|P2: Period 3 (4 Days)||4
1409388|NCT03095638|3450556|P5|STARTED|P2: Period 3 (4 Days)||4
1409389|NCT03095638|3450557|P4|STARTED|P2: Period 3 (4 Days)||4
1409390|NCT03095638|3450558|P3|STARTED|P2: Period 3 (4 Days)||4
1409391|NCT03095638|3450559|P2|STARTED|P2: Period 3 (4 Days)||0
1409392|NCT03095638|3450560|P1|STARTED|P2: Period 3 (4 Days)||0
1409393|NCT03095638|3450553|P8|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409394|NCT03095638|3450554|P7|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409395|NCT03095638|3450555|P6|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409396|NCT03095638|3450556|P5|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409397|NCT03095638|3450557|P4|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409398|NCT03095638|3450558|P3|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409399|NCT03095638|3450559|P2|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409400|NCT03095638|3450560|P1|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409401|NCT03095638|3450553|P8|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1409402|NCT03095638|3450554|P7|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1409403|NCT03095638|3450555|P6|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1409404|NCT03095638|3450556|P5|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1409405|NCT03095638|3450557|P4|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1409406|NCT03095638|3450558|P3|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
1409407|NCT03095638|3450559|P2|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409408|NCT03095638|3450560|P1|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
1409409|NCT03095638|3450553|P8|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1409410|NCT03095638|3450554|P7|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1409411|NCT03095638|3450555|P6|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1409412|NCT03095638|3450556|P5|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1409413|NCT03095638|3450557|P4|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1409414|NCT03095638|3450558|P3|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
1409415|NCT03095638|3450559|P2|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
1409416|NCT03095638|3450560|P1|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
1409417|NCT03095638|3450553|P8|NOT COMPLETED|P2: Period 2 (4 Days)||0
1409418|NCT03095638|3450554|P7|NOT COMPLETED|P2: Period 2 (4 Days)||0
1409419|NCT03095638|3450555|P6|NOT COMPLETED|P2: Period 2 (4 Days)||0
1409420|NCT03095638|3450556|P5|NOT COMPLETED|P2: Period 2 (4 Days)||0
1409421|NCT03095638|3450557|P4|NOT COMPLETED|P2: Period 2 (4 Days)||0
1409422|NCT03095638|3450558|P3|NOT COMPLETED|P2: Period 2 (4 Days)||0
1409423|NCT03095638|3450559|P2|NOT COMPLETED|P2: Period 2 (4 Days)||0
1409424|NCT03095638|3450560|P1|NOT COMPLETED|P2: Period 2 (4 Days)||0
1409425|NCT03095638|3450553|P8|COMPLETED|P2: Period 2 (4 Days)||4
1409426|NCT03095638|3450554|P7|COMPLETED|P2: Period 2 (4 Days)||4
1409427|NCT03095638|3450555|P6|COMPLETED|P2: Period 2 (4 Days)||4
1409428|NCT03095638|3450556|P5|COMPLETED|P2: Period 2 (4 Days)||4
1409429|NCT03095638|3450557|P4|COMPLETED|P2: Period 2 (4 Days)||4
1409430|NCT03095638|3450558|P3|COMPLETED|P2: Period 2 (4 Days)||4
1409431|NCT03095638|3450559|P2|COMPLETED|P2: Period 2 (4 Days)||0
1409432|NCT03095638|3450560|P1|COMPLETED|P2: Period 2 (4 Days)||0
1409433|NCT03095638|3450553|P8|STARTED|P2: Period 2 (4 Days)||4
1409434|NCT03095638|3450554|P7|STARTED|P2: Period 2 (4 Days)||4
1409435|NCT03095638|3450555|P6|STARTED|P2: Period 2 (4 Days)||4
1409436|NCT03095638|3450556|P5|STARTED|P2: Period 2 (4 Days)||4
1409437|NCT03095638|3450557|P4|STARTED|P2: Period 2 (4 Days)||4
1409438|NCT03095638|3450558|P3|STARTED|P2: Period 2 (4 Days)||4
1409439|NCT03095638|3450559|P2|STARTED|P2: Period 2 (4 Days)||0
1409440|NCT03095638|3450560|P1|STARTED|P2: Period 2 (4 Days)||0
1409441|NCT03095638|3450553|P8|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409442|NCT03095638|3450554|P7|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409443|NCT03095638|3450555|P6|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409444|NCT03095638|3450556|P5|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409445|NCT03095638|3450557|P4|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409446|NCT03095638|3450558|P3|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409447|NCT03095638|3450559|P2|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409448|NCT03095638|3450560|P1|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409449|NCT03095638|3450553|P8|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1409450|NCT03095638|3450554|P7|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1409451|NCT03095638|3450555|P6|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1409452|NCT03095638|3450556|P5|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1409453|NCT03095638|3450557|P4|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1409454|NCT03095638|3450558|P3|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
1409455|NCT03095638|3450559|P2|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409456|NCT03095638|3450560|P1|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
1409457|NCT03095638|3450553|P8|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1409458|NCT03095638|3450554|P7|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1409459|NCT03095638|3450555|P6|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1409460|NCT03095638|3450556|P5|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1409461|NCT03095638|3450557|P4|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1409462|NCT03095638|3450558|P3|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
1409463|NCT03095638|3450559|P2|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
1409464|NCT03095638|3450560|P1|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
1409465|NCT03095638|3450553|P8|NOT COMPLETED|P2: Period 1 (4 Days)||0
1409466|NCT03095638|3450554|P7|NOT COMPLETED|P2: Period 1 (4 Days)||0
1409467|NCT03095638|3450555|P6|NOT COMPLETED|P2: Period 1 (4 Days)||0
1409468|NCT03095638|3450556|P5|NOT COMPLETED|P2: Period 1 (4 Days)||0
1409469|NCT03095638|3450557|P4|NOT COMPLETED|P2: Period 1 (4 Days)||0
1409470|NCT03095638|3450558|P3|NOT COMPLETED|P2: Period 1 (4 Days)||0
1409471|NCT03095638|3450559|P2|NOT COMPLETED|P2: Period 1 (4 Days)||0
1409472|NCT03095638|3450560|P1|NOT COMPLETED|P2: Period 1 (4 Days)||0
1409473|NCT03095638|3450553|P8|COMPLETED|P2: Period 1 (4 Days)||4
1409474|NCT03095638|3450554|P7|COMPLETED|P2: Period 1 (4 Days)||4
1409475|NCT03095638|3450555|P6|COMPLETED|P2: Period 1 (4 Days)||4
1409476|NCT03095638|3450556|P5|COMPLETED|P2: Period 1 (4 Days)||4
1409477|NCT03095638|3450557|P4|COMPLETED|P2: Period 1 (4 Days)||4
1409478|NCT03095638|3450558|P3|COMPLETED|P2: Period 1 (4 Days)||4
1409479|NCT03095638|3450559|P2|COMPLETED|P2: Period 1 (4 Days)||0
1409480|NCT03095638|3450560|P1|COMPLETED|P2: Period 1 (4 Days)||0
1409481|NCT03095638|3450553|P8|STARTED|P2: Period 1 (4 Days)||4
1409482|NCT03095638|3450554|P7|STARTED|P2: Period 1 (4 Days)||4
1409483|NCT03095638|3450555|P6|STARTED|P2: Period 1 (4 Days)||4
1409484|NCT03095638|3450556|P5|STARTED|P2: Period 1 (4 Days)||4
1409485|NCT03095638|3450557|P4|STARTED|P2: Period 1 (4 Days)||4
1409486|NCT03095638|3450558|P3|STARTED|P2: Period 1 (4 Days)||4
1409487|NCT03095638|3450559|P2|STARTED|P2: Period 1 (4 Days)||0
1409488|NCT03095638|3450560|P1|STARTED|P2: Period 1 (4 Days)||0
1409489|NCT03095638|3450553|P8|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409490|NCT03095638|3450554|P7|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409491|NCT03095638|3450555|P6|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409492|NCT03095638|3450556|P5|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409493|NCT03095638|3450557|P4|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409494|NCT03095638|3450558|P3|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409495|NCT03095638|3450559|P2|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409496|NCT03095638|3450560|P1|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409497|NCT03095638|3450553|P8|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409498|NCT03095638|3450554|P7|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409499|NCT03095638|3450555|P6|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409500|NCT03095638|3450556|P5|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409501|NCT03095638|3450557|P4|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409502|NCT03095638|3450558|P3|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
1409503|NCT03095638|3450559|P2|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
1409504|NCT03095638|3450560|P1|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
1409505|NCT03095638|3450553|P8|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1409506|NCT03095638|3450554|P7|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1409507|NCT03095638|3450555|P6|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1409508|NCT03095638|3450556|P5|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1409509|NCT03095638|3450557|P4|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1409510|NCT03095638|3450558|P3|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
1409511|NCT03095638|3450559|P2|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
1409512|NCT03095638|3450560|P1|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
1409513|NCT03095638|3450553|P8|NOT COMPLETED|P1: Period 2 (4 Days)||0
1409514|NCT03095638|3450554|P7|NOT COMPLETED|P1: Period 2 (4 Days)||0
1409515|NCT03095638|3450555|P6|NOT COMPLETED|P1: Period 2 (4 Days)||0
1409516|NCT03095638|3450556|P5|NOT COMPLETED|P1: Period 2 (4 Days)||0
1409517|NCT03095638|3450557|P4|NOT COMPLETED|P1: Period 2 (4 Days)||0
1409518|NCT03095638|3450558|P3|NOT COMPLETED|P1: Period 2 (4 Days)||0
1409519|NCT03095638|3450559|P2|NOT COMPLETED|P1: Period 2 (4 Days)||0
1409520|NCT03095638|3450560|P1|NOT COMPLETED|P1: Period 2 (4 Days)||0
1409521|NCT03095638|3450553|P8|COMPLETED|P1: Period 2 (4 Days)||0
1409522|NCT03095638|3450554|P7|COMPLETED|P1: Period 2 (4 Days)||0
1409523|NCT03095638|3450555|P6|COMPLETED|P1: Period 2 (4 Days)||0
1409524|NCT03095638|3450556|P5|COMPLETED|P1: Period 2 (4 Days)||0
1409525|NCT03095638|3450557|P4|COMPLETED|P1: Period 2 (4 Days)||0
1409526|NCT03095638|3450558|P3|COMPLETED|P1: Period 2 (4 Days)||0
1409527|NCT03095638|3450559|P2|COMPLETED|P1: Period 2 (4 Days)||7
1409528|NCT03095638|3450560|P1|COMPLETED|P1: Period 2 (4 Days)||7
1409529|NCT03095638|3450553|P8|STARTED|P1: Period 2 (4 Days)||0
1409530|NCT03095638|3450554|P7|STARTED|P1: Period 2 (4 Days)||0
1409531|NCT03095638|3450555|P6|STARTED|P1: Period 2 (4 Days)||0
1409532|NCT03095638|3450556|P5|STARTED|P1: Period 2 (4 Days)||0
1409533|NCT03095638|3450557|P4|STARTED|P1: Period 2 (4 Days)||0
1409534|NCT03095638|3450558|P3|STARTED|P1: Period 2 (4 Days)||0
1409535|NCT03095638|3450559|P2|STARTED|P1: Period 2 (4 Days)||7
1409536|NCT03095638|3450560|P1|STARTED|P1: Period 2 (4 Days)||7
1409537|NCT03095638|3450553|P8|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409538|NCT03095638|3450554|P7|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409539|NCT03095638|3450555|P6|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409540|NCT03095638|3450556|P5|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409541|NCT03095638|3450557|P4|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409542|NCT03095638|3450558|P3|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409543|NCT03095638|3450559|P2|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409544|NCT03095638|3450560|P1|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409545|NCT03095638|3450553|P8|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409546|NCT03095638|3450554|P7|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409547|NCT03095638|3450555|P6|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409548|NCT03095638|3450556|P5|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409549|NCT03095638|3450557|P4|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409550|NCT03095638|3450558|P3|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
1409551|NCT03095638|3450559|P2|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
1409552|NCT03095638|3450560|P1|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
1409553|NCT03095638|3450553|P8|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1409554|NCT03095638|3450554|P7|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1409555|NCT03095638|3450555|P6|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1409556|NCT03095638|3450556|P5|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1409557|NCT03095638|3450557|P4|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1409558|NCT03095638|3450558|P3|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
1409559|NCT03095638|3450559|P2|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
1409560|NCT03095638|3450560|P1|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
1409561|NCT03095638|3450553|P8|NOT COMPLETED|P1: Period 1 (4 Days)||0
1409562|NCT03095638|3450554|P7|NOT COMPLETED|P1: Period 1 (4 Days)||0
1409563|NCT03095638|3450555|P6|NOT COMPLETED|P1: Period 1 (4 Days)||0
1409564|NCT03095638|3450556|P5|NOT COMPLETED|P1: Period 1 (4 Days)||0
1409565|NCT03095638|3450557|P4|NOT COMPLETED|P1: Period 1 (4 Days)||0
1409566|NCT03095638|3450558|P3|NOT COMPLETED|P1: Period 1 (4 Days)||0
1409567|NCT03095638|3450559|P2|NOT COMPLETED|P1: Period 1 (4 Days)||0
1409568|NCT03095638|3450560|P1|NOT COMPLETED|P1: Period 1 (4 Days)||0
1409569|NCT03095638|3450553|P8|COMPLETED|P1: Period 1 (4 Days)||0
1409570|NCT03095638|3450554|P7|COMPLETED|P1: Period 1 (4 Days)||0
1409571|NCT03095638|3450555|P6|COMPLETED|P1: Period 1 (4 Days)||0
1409572|NCT03095638|3450556|P5|COMPLETED|P1: Period 1 (4 Days)||0
1409573|NCT03095638|3450557|P4|COMPLETED|P1: Period 1 (4 Days)||0
1409574|NCT03095638|3450558|P3|COMPLETED|P1: Period 1 (4 Days)||0
1409575|NCT03095638|3450559|P2|COMPLETED|P1: Period 1 (4 Days)||7
1409576|NCT03095638|3450560|P1|COMPLETED|P1: Period 1 (4 Days)||7
1409577|NCT03095638|3450553|P8|STARTED|P1: Period 1 (4 Days)||0
1409578|NCT03095638|3450554|P7|STARTED|P1: Period 1 (4 Days)||0
1409579|NCT03095638|3450555|P6|STARTED|P1: Period 1 (4 Days)||0
1409580|NCT03095638|3450556|P5|STARTED|P1: Period 1 (4 Days)||0
1409581|NCT03095638|3450557|P4|STARTED|P1: Period 1 (4 Days)||0
1409582|NCT03095638|3450558|P3|STARTED|P1: Period 1 (4 Days)||0
1409583|NCT03095638|3450559|P2|STARTED|P1: Period 1 (4 Days)||7
1409584|NCT03095638|3450560|P1|STARTED|P1: Period 1 (4 Days)||7
1409585|NCT03095456|3450708|P2|NOT COMPLETED|Overall Study||8
1409586|NCT03095456|3450709|P1|NOT COMPLETED|Overall Study||4
1409587|NCT03095456|3450708|P2|COMPLETED|Overall Study||96
1409588|NCT03095456|3450709|P1|COMPLETED|Overall Study||99
1409589|NCT03095456|3450708|P2|STARTED|Overall Study||104
1409590|NCT03095456|3450709|P1|STARTED|Overall Study||103
1409591|NCT03094806|3450727|P2|NOT COMPLETED|Overall Study||0
1409592|NCT03094806|3450728|P1|NOT COMPLETED|Overall Study||0
1409593|NCT03094806|3450727|P2|COMPLETED|Overall Study||47
1409594|NCT03094806|3450728|P1|COMPLETED|Overall Study||44
1409595|NCT03094806|3450727|P2|STARTED|Overall Study||47
1409596|NCT03094806|3450728|P1|STARTED|Overall Study||44
1409597|NCT03091751|3450746|P1|NOT COMPLETED|Overall Study||0
1409598|NCT03091751|3450746|P1|COMPLETED|Overall Study||22
1409599|NCT03091751|3450746|P1|STARTED|Overall Study||22
1409600|NCT03091673|3450757|P2|NOT COMPLETED|Second Dose||0
1409601|NCT03091673|3450758|P1|NOT COMPLETED|Second Dose||0
1409602|NCT03091673|3450757|P2|COMPLETED|Second Dose||11
1409603|NCT03091673|3450758|P1|COMPLETED|Second Dose||0
1409604|NCT03091673|3450757|P2|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
1409605|NCT03091673|3450758|P1|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
1409606|NCT03091673|3450757|P2|NOT COMPLETED|First Dose||0
1409607|NCT03091673|3450758|P1|NOT COMPLETED|First Dose||0
1409608|NCT03091673|3450757|P2|COMPLETED|First Dose||0
1409609|NCT03091673|3450758|P1|COMPLETED|First Dose||31
1409610|NCT03091673|3450757|P2|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
1409611|NCT03091673|3450758|P1|STARTED|First Dose||31
1409612|NCT03091439|3450780|P2|NOT COMPLETED|Overall Study||0
1409613|NCT03091439|3450781|P1|NOT COMPLETED|Overall Study||1
1409614|NCT03091439|3450780|P2|COMPLETED|Overall Study||0
1409615|NCT03091439|3450781|P1|COMPLETED|Overall Study||0
1409616|NCT03091439|3450780|P2|STARTED|Overall Study||0
1409617|NCT03091439|3450781|P1|STARTED|Overall Study||1
1409618|NCT03090958|3450803|P1|NOT COMPLETED|Overall Study||0
1409619|NCT03090958|3450803|P1|COMPLETED|Overall Study||20
1409620|NCT03090958|3450803|P1|STARTED|Overall Study||20
1409621|NCT03087604|3450817|P2|NOT COMPLETED|Overall Study||0
1409622|NCT03087604|3450818|P1|NOT COMPLETED|Overall Study||0
1409623|NCT03087604|3450817|P2|COMPLETED|Overall Study||50
1409624|NCT03087604|3450818|P1|COMPLETED|Overall Study||50
1409625|NCT03087604|3450817|P2|STARTED|Overall Study||50
1409626|NCT03087604|3450818|P1|STARTED|Overall Study||50
1409627|NCT03086447|3450830|P2|NOT COMPLETED|Overall Study||20
1409628|NCT03086447|3450831|P1|NOT COMPLETED|Overall Study||11
1409629|NCT03086447|3450830|P2|COMPLETED|Overall Study||110
1409630|NCT03086447|3450831|P1|COMPLETED|Overall Study||121
1409631|NCT03086447|3450830|P2|STARTED|Overall Study||130
1409632|NCT03086447|3450831|P1|STARTED|Overall Study||132
1409633|NCT03083483|3450854|P3|NOT COMPLETED|Overall Study||3
1409634|NCT03083483|3450855|P2|NOT COMPLETED|Overall Study||2
1409635|NCT03083483|3450856|P1|NOT COMPLETED|Overall Study||4
1409636|NCT03083483|3450854|P3|COMPLETED|Overall Study||20
1409637|NCT03083483|3450855|P2|COMPLETED|Overall Study||20
1409638|NCT03083483|3450856|P1|COMPLETED|Overall Study||20
1409639|NCT03083483|3450854|P3|STARTED|Overall Study||23
1409640|NCT03083483|3450855|P2|STARTED|Overall Study||22
1409641|NCT03083483|3450856|P1|STARTED|Overall Study||24
1409642|NCT03083379|3450872|P2|NOT COMPLETED|Overall Study||0
1409643|NCT03083379|3450873|P1|NOT COMPLETED|Overall Study||0
1409644|NCT03083379|3450872|P2|COMPLETED|Overall Study||15
1409645|NCT03083379|3450873|P1|COMPLETED|Overall Study||15
1409646|NCT03083379|3450872|P2|STARTED|Overall Study||15
1409647|NCT03083379|3450873|P1|STARTED|Overall Study||15
1409648|NCT03073798|3450879|P1|NOT COMPLETED|Overall Study||2
1409649|NCT03073798|3450879|P1|COMPLETED|Overall Study||10
1409650|NCT03073798|3450879|P1|STARTED|Overall Study||12
1409651|NCT03072875|3450890|P1|NOT COMPLETED|Overall Study||1
1409652|NCT03072875|3450890|P1|COMPLETED|Overall Study||25
1409653|NCT03072875|3450890|P1|STARTED|Overall Study||26
1409654|NCT03072719|3450897|P2|NOT COMPLETED|Overall Study||1
1409655|NCT03072719|3450898|P1|NOT COMPLETED|Overall Study||1
1409656|NCT03072719|3450897|P2|COMPLETED|Overall Study||59
1409657|NCT03072719|3450898|P1|COMPLETED|Overall Study||59
1409658|NCT03072719|3450897|P2|STARTED|Overall Study||60
1409659|NCT03072719|3450898|P1|STARTED|Overall Study||60
1409660|NCT03070730|3450911|P3|NOT COMPLETED|Overall Study||0
1409661|NCT03070730|3450912|P2|NOT COMPLETED|Overall Study||0
1409662|NCT03070730|3450913|P1|NOT COMPLETED|Overall Study||0
1409663|NCT03070730|3450911|P3|COMPLETED|Overall Study||0
1409664|NCT03070730|3450912|P2|COMPLETED|Overall Study||0
1409665|NCT03070730|3450913|P1|COMPLETED|Overall Study||0
1409666|NCT03070730|3450911|P3|STARTED|Overall Study||0
1409667|NCT03070730|3450912|P2|STARTED|Overall Study||0
1409668|NCT03070730|3450913|P1|STARTED|Overall Study||0
1409669|NCT03070548|3451044|P1|NOT COMPLETED|Overall Study||0
1409670|NCT03070548|3451044|P1|COMPLETED|Overall Study||6
1409671|NCT03070548|3451044|P1|STARTED|Overall Study||6
1409672|NCT03070002|3451080|P1|NOT COMPLETED|Follow up for 2 Years||1
1409673|NCT03070002|3451080|P1|COMPLETED|Follow up for 2 Years||0
1409674|NCT03070002|3451080|P1|STARTED|Follow up for 2 Years||1
1409675|NCT03070002|3451080|P1|NOT COMPLETED|3 Cycles of Treatment||0
1409676|NCT03070002|3451080|P1|COMPLETED|3 Cycles of Treatment||1
1409677|NCT03070002|3451080|P1|STARTED|3 Cycles of Treatment||1
1409678|NCT03069313|3451086|P1|NOT COMPLETED|Overall Study||5
1409679|NCT03069313|3451086|P1|COMPLETED|Overall Study||36
1409680|NCT03069313|3451086|P1|STARTED|Overall Study||41
1409681|NCT03067948|3451093|P1|NOT COMPLETED|Overall Study||0
1409682|NCT03067948|3451093|P1|COMPLETED|Overall Study||32
1409683|NCT03067948|3451093|P1|STARTED|Overall Study||32
1409684|NCT03065933|3451098|P1|NOT COMPLETED|Overall Study||5
1409685|NCT03065933|3451098|P1|COMPLETED|Overall Study||0
1409686|NCT03065933|3451098|P1|STARTED|Overall Study||5
1409687|NCT03063476|3451102|P1|NOT COMPLETED|Overall Study||0
1409688|NCT03063476|3451102|P1|COMPLETED|Overall Study||2
1409689|NCT03063476|3451102|P1|STARTED|Overall Study||2
1409690|NCT03061513|3451109|P2|NOT COMPLETED|Overall Study||1
1409691|NCT03061513|3451110|P1|NOT COMPLETED|Overall Study||0
1409692|NCT03061513|3451109|P2|COMPLETED|Overall Study||4
1409693|NCT03061513|3451110|P1|COMPLETED|Overall Study||6
1409694|NCT03061513|3451109|P2|STARTED|Overall Study||5
1409695|NCT03061513|3451110|P1|STARTED|Overall Study||6
1409696|NCT03061331|3451120|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1409697|NCT03061331|3451121|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1409698|NCT03061331|3451120|P2|COMPLETED|Treatment Period 2 (8 Weeks)||9
1409699|NCT03061331|3451121|P1|COMPLETED|Treatment Period 2 (8 Weeks)||8
1409700|NCT03061331|3451120|P2|STARTED|Treatment Period 2 (8 Weeks)||9
1409701|NCT03061331|3451121|P1|STARTED|Treatment Period 2 (8 Weeks)||8
1409702|NCT03061331|3451120|P2|NOT COMPLETED|Washout Period (8 Weeks)||1
1409703|NCT03061331|3451121|P1|NOT COMPLETED|Washout Period (8 Weeks)||2
1409704|NCT03061331|3451120|P2|COMPLETED|Washout Period (8 Weeks)||9
1409705|NCT03061331|3451121|P1|COMPLETED|Washout Period (8 Weeks)||8
1409706|NCT03061331|3451120|P2|STARTED|Washout Period (8 Weeks)||10
1409707|NCT03061331|3451121|P1|STARTED|Washout Period (8 Weeks)||10
1409708|NCT03061331|3451120|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
1409709|NCT03061331|3451121|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
1409710|NCT03061331|3451120|P2|COMPLETED|Treatment Period 1 (8 Weeks)||10
1409711|NCT03061331|3451121|P1|COMPLETED|Treatment Period 1 (8 Weeks)||10
1409712|NCT03061331|3451120|P2|STARTED|Treatment Period 1 (8 Weeks)||10
1409713|NCT03061331|3451121|P1|STARTED|Treatment Period 1 (8 Weeks)||10
1409714|NCT03060512|3451129|P2|NOT COMPLETED|Overall Study||9
1409715|NCT03060512|3451130|P1|NOT COMPLETED|Overall Study||7
1409716|NCT03060512|3451129|P2|COMPLETED|Overall Study||130
1409717|NCT03060512|3451130|P1|COMPLETED|Overall Study||130
1409718|NCT03060512|3451129|P2|Treated With PEG 3350|Overall Study||138
1409719|NCT03060512|3451130|P1|Treated With PEG 3350|Overall Study||130
1409720|NCT03060512|3451129|P2|Treated With Movantik|Overall Study||135
1409721|NCT03060512|3451130|P1|Treated With Movantik|Overall Study||136
1409722|NCT03060512|3451129|P2|STARTED|Overall Study||139
1409723|NCT03060512|3451130|P1|STARTED|Overall Study||137
1409724|NCT03060486|3451147|P1|NOT COMPLETED|Overall Study||0
1409725|NCT03060486|3451147|P1|COMPLETED|Overall Study||15
1409726|NCT03060486|3451147|P1|STARTED|Overall Study||15
1409727|NCT03059901|3451153|P2|NOT COMPLETED|Overall Study||2
1409728|NCT03059901|3451154|P1|NOT COMPLETED|Overall Study||4
1409729|NCT03059901|3451153|P2|COMPLETED|Overall Study||28
1409730|NCT03059901|3451154|P1|COMPLETED|Overall Study||26
1409731|NCT03059901|3451153|P2|STARTED|Overall Study||30
1409732|NCT03059901|3451154|P1|STARTED|Overall Study||30
1409733|NCT03057704|3451162|P2|NOT COMPLETED|Overall Study||0
1409734|NCT03057704|3451163|P1|NOT COMPLETED|Overall Study||0
1409735|NCT03057704|3451162|P2|COMPLETED|Overall Study||25
1409736|NCT03057704|3451163|P1|COMPLETED|Overall Study||25
1409737|NCT03057704|3451162|P2|STARTED|Overall Study||25
1409738|NCT03057704|3451163|P1|STARTED|Overall Study||25
1409739|NCT03056352|3451173|P1|NOT COMPLETED|Overall Study||1
1409740|NCT03056352|3451173|P1|COMPLETED|Overall Study||20
1409741|NCT03056352|3451173|P1|STARTED|Overall Study||21
1409742|NCT03056300|3451179|P1|NOT COMPLETED|Overall Study||3
1409743|NCT03056300|3451179|P1|COMPLETED|Overall Study||47
1409744|NCT03056300|3451179|P1|STARTED|Overall Study||50
1409745|NCT03055338|3451187|P3|NOT COMPLETED|Overall Study||12
1409746|NCT03055338|3451188|P2|NOT COMPLETED|Overall Study||11
1409747|NCT03055338|3451189|P1|NOT COMPLETED|Overall Study||18
1409748|NCT03055338|3451187|P3|COMPLETED|Overall Study||77
1409749|NCT03055338|3451188|P2|COMPLETED|Overall Study||34
1409750|NCT03055338|3451189|P1|COMPLETED|Overall Study||72
1409751|NCT03055338|3451187|P3|STARTED|Overall Study||89
1409752|NCT03055338|3451188|P2|STARTED|Overall Study||45
1409753|NCT03055338|3451189|P1|STARTED|Overall Study||90
1409754|NCT03055221|3451206|P1|NOT COMPLETED|Overall Study||16
1409755|NCT03055221|3451206|P1|COMPLETED|Overall Study||0
1409756|NCT03055221|3451206|P1|STARTED|Overall Study||16
1409757|NCT03055195|3451213|P2|NOT COMPLETED|Overall Study||14
1409758|NCT03055195|3451214|P1|NOT COMPLETED|Overall Study||12
1409759|NCT03055195|3451213|P2|COMPLETED|Overall Study||4
1409760|NCT03055195|3451214|P1|COMPLETED|Overall Study||4
1409761|NCT03055195|3451213|P2|STARTED|Overall Study||18
1409762|NCT03055195|3451214|P1|STARTED|Overall Study||16
1409763|NCT03054857|3451268|P2|NOT COMPLETED|Overall Study||0
1409764|NCT03054857|3451269|P1|NOT COMPLETED|Overall Study||1
1409765|NCT03054857|3451268|P2|COMPLETED|Overall Study||50
1409766|NCT03054857|3451269|P1|COMPLETED|Overall Study||49
1409767|NCT03054857|3451268|P2|STARTED|Overall Study||50
1409768|NCT03054857|3451269|P1|STARTED|Overall Study||50
1409769|NCT03054740|3451285|P2|NOT COMPLETED|Overall Study||0
1409770|NCT03054740|3451286|P1|NOT COMPLETED|Overall Study||0
1409771|NCT03054740|3451285|P2|COMPLETED|Overall Study||15
1409772|NCT03054740|3451286|P1|COMPLETED|Overall Study||15
1409773|NCT03054740|3451285|P2|STARTED|Overall Study||15
1409774|NCT03054740|3451286|P1|STARTED|Overall Study||15
1409775|NCT03054103|3451303|P3|NOT COMPLETED|Overall Study||0
1409776|NCT03054103|3451304|P2|NOT COMPLETED|Overall Study||0
1409777|NCT03054103|3451305|P1|NOT COMPLETED|Overall Study||0
1409778|NCT03054103|3451303|P3|COMPLETED|Overall Study||35
1409779|NCT03054103|3451304|P2|COMPLETED|Overall Study||29
1409780|NCT03054103|3451305|P1|COMPLETED|Overall Study||41
1409781|NCT03054103|3451303|P3|STARTED|Overall Study||35
1409782|NCT03054103|3451304|P2|STARTED|Overall Study||29
1409783|NCT03054103|3451305|P1|STARTED|Overall Study||41
1409784|NCT03054077|3451324|P2|NOT COMPLETED|Overall Study||0
1409785|NCT03054077|3451325|P1|NOT COMPLETED|Overall Study||0
1409786|NCT03054077|3451324|P2|COMPLETED|Overall Study||12
1409787|NCT03054077|3451325|P1|COMPLETED|Overall Study||12
1409788|NCT03054077|3451324|P2|STARTED|Overall Study||12
1409789|NCT03054077|3451325|P1|STARTED|Overall Study||12
1409790|NCT03052530|3451331|P1|NOT COMPLETED|Overall Study||0
1409791|NCT03052530|3451331|P1|COMPLETED|Overall Study||61
1409792|NCT03052530|3451331|P1|STARTED|Overall Study||61
1409793|NCT03051646|3451340|P2|NOT COMPLETED|Overall Study||0
1409794|NCT03051646|3451341|P1|NOT COMPLETED|Overall Study||0
1409795|NCT03051646|3451340|P2|COMPLETED|Overall Study||6
1409796|NCT03051646|3451341|P1|COMPLETED|Overall Study||6
1409797|NCT03051646|3451340|P2|STARTED|Overall Study||6
1409798|NCT03051646|3451341|P1|STARTED|Overall Study||6
1409799|NCT03051165|3451349|P1|NOT COMPLETED|Overall Study||13
1409800|NCT03051165|3451349|P1|COMPLETED|Overall Study||0
1409801|NCT03051165|3451349|P1|Completed Some Day 137 Assessments|Overall Study||0
1409802|NCT03051165|3451349|P1|Began HGNS Treatment Withdrawal|Overall Study||0
1409803|NCT03051165|3451349|P1|Completed Some Day 105 Assessments|Overall Study||1
1409804|NCT03051165|3451349|P1|Completed Some Baseline Assessments|Overall Study||1
1409805|NCT03051165|3451349|P1|STARTED|Overall Study||13
1409806|NCT03050775|3451363|P2|NOT COMPLETED|Overall Study||0
1409807|NCT03050775|3451364|P1|NOT COMPLETED|Overall Study||0
1409808|NCT03050775|3451363|P2|COMPLETED|Overall Study||35
1409809|NCT03050775|3451364|P1|COMPLETED|Overall Study||35
1409810|NCT03050775|3451363|P2|STARTED|Overall Study||35
1409811|NCT03050775|3451364|P1|STARTED|Overall Study||35
1409812|NCT03050541|3451385|P3|NOT COMPLETED|Overall Study||8
1409813|NCT03050541|3451386|P2|NOT COMPLETED|Overall Study||8
1409814|NCT03050541|3451387|P1|NOT COMPLETED|Overall Study||8
1409815|NCT03050541|3451385|P3|COMPLETED|Overall Study||20
1409816|NCT03050541|3451386|P2|COMPLETED|Overall Study||20
1409817|NCT03050541|3451387|P1|COMPLETED|Overall Study||20
1409818|NCT03050541|3451385|P3|STARTED|Overall Study||28
1409819|NCT03050541|3451386|P2|STARTED|Overall Study||28
1409820|NCT03050541|3451387|P1|STARTED|Overall Study||28
1409821|NCT03050320|3451400|P2|NOT COMPLETED|Overall Study||1
1409822|NCT03050320|3451401|P1|NOT COMPLETED|Overall Study||1
1409823|NCT03050320|3451400|P2|COMPLETED|Overall Study||21
1409824|NCT03050320|3451401|P1|COMPLETED|Overall Study||20
1409825|NCT03050320|3451400|P2|STARTED|Overall Study||22
1409826|NCT03050320|3451401|P1|STARTED|Overall Study||21
1409827|NCT03050294|3451435|P4|NOT COMPLETED|Overall Study||0
1409828|NCT03050294|3451436|P3|NOT COMPLETED|Overall Study||0
1409829|NCT03050294|3451437|P2|NOT COMPLETED|Overall Study||0
1409830|NCT03050294|3451438|P1|NOT COMPLETED|Overall Study||0
1409831|NCT03050294|3451435|P4|COMPLETED|Overall Study||6
1409832|NCT03050294|3451436|P3|COMPLETED|Overall Study||6
1409833|NCT03050294|3451437|P2|COMPLETED|Overall Study||6
1409834|NCT03050294|3451438|P1|COMPLETED|Overall Study||6
1409835|NCT03050294|3451435|P4|STARTED|Overall Study||6
1409836|NCT03050294|3451436|P3|STARTED|Overall Study||6
1409837|NCT03050294|3451437|P2|STARTED|Overall Study||6
1409838|NCT03050294|3451438|P1|STARTED|Overall Study||6
1409839|NCT03048383|3451463|P3|NOT COMPLETED|Overall Study||12
1409840|NCT03048383|3451464|P2|NOT COMPLETED|Overall Study||8
1409841|NCT03048383|3451465|P1|NOT COMPLETED|Overall Study||13
1409842|NCT03048383|3451463|P3|COMPLETED|Overall Study||10
1409843|NCT03048383|3451464|P2|COMPLETED|Overall Study||13
1409844|NCT03048383|3451465|P1|COMPLETED|Overall Study||15
1409845|NCT03048383|3451463|P3|STARTED|Overall Study||22
1409846|NCT03048383|3451464|P2|STARTED|Overall Study||21
1409847|NCT03048383|3451465|P1|STARTED|Overall Study||28
1409848|NCT03048058|3451478|P2|NOT COMPLETED|Overall Study||4
1409849|NCT03048058|3451479|P1|NOT COMPLETED|Overall Study||4
1409850|NCT03048058|3451478|P2|COMPLETED|Overall Study||6
1409851|NCT03048058|3451479|P1|COMPLETED|Overall Study||6
1409852|NCT03048058|3451478|P2|STARTED|Overall Study||10
1409853|NCT03048058|3451479|P1|STARTED|Overall Study||10
1409854|NCT03048006|3451497|P1|NOT COMPLETED|Overall Study||0
1409855|NCT03048006|3451497|P1|COMPLETED|Overall Study||44456
1409856|NCT03048006|3451497|P1|STARTED|Overall Study||44456
1409857|NCT03047447|3451506|P3|NOT COMPLETED|Overall Study||0
1409858|NCT03047447|3451507|P2|NOT COMPLETED|Overall Study||0
1409859|NCT03047447|3451508|P1|NOT COMPLETED|Overall Study||0
1409860|NCT03047447|3451506|P3|COMPLETED|Overall Study||10
1409861|NCT03047447|3451507|P2|COMPLETED|Overall Study||10
1409862|NCT03047447|3451508|P1|COMPLETED|Overall Study||10
1409863|NCT03047447|3451506|P3|STARTED|Overall Study||10
1409864|NCT03047447|3451507|P2|STARTED|Overall Study||10
1409865|NCT03047447|3451508|P1|STARTED|Overall Study||10
1409866|NCT03046225|3451530|P2|NOT COMPLETED|Overall Study||0
1409867|NCT03046225|3451531|P1|NOT COMPLETED|Overall Study||0
1409868|NCT03046225|3451530|P2|COMPLETED|Overall Study||13
1409869|NCT03046225|3451531|P1|COMPLETED|Overall Study||13
1409870|NCT03046225|3451530|P2|STARTED|Overall Study||13
1409871|NCT03046225|3451531|P1|STARTED|Overall Study||13
1409872|NCT03046212|3451543|P2|NOT COMPLETED|Overall Study||0
1409873|NCT03046212|3451544|P1|NOT COMPLETED|Overall Study||0
1409874|NCT03046212|3451543|P2|COMPLETED|Overall Study||15
1409875|NCT03046212|3451544|P1|COMPLETED|Overall Study||15
1409876|NCT03046212|3451543|P2|STARTED|Overall Study||15
1409877|NCT03046212|3451544|P1|STARTED|Overall Study||15
1409878|NCT03044431|3451554|P1|NOT COMPLETED|Overall Study||59
1409879|NCT03044431|3451554|P1|COMPLETED|Overall Study||148
1409880|NCT03044431|3451554|P1|STARTED|Overall Study||207
1409881|NCT03043885|3451568|P4|NOT COMPLETED|Overall Study||0
1409882|NCT03043885|3451569|P3|NOT COMPLETED|Overall Study||0
1409883|NCT03043885|3451570|P2|NOT COMPLETED|Overall Study||0
1409884|NCT03043885|3451571|P1|NOT COMPLETED|Overall Study||0
1409885|NCT03043885|3451568|P4|COMPLETED|Overall Study||10
1409886|NCT03043885|3451569|P3|COMPLETED|Overall Study||10
1409887|NCT03043885|3451570|P2|COMPLETED|Overall Study||10
1409888|NCT03043885|3451571|P1|COMPLETED|Overall Study||10
1409889|NCT03043885|3451568|P4|STARTED|Overall Study||10
1409890|NCT03043885|3451569|P3|STARTED|Overall Study||10
1409891|NCT03043885|3451570|P2|STARTED|Overall Study||10
1409892|NCT03043885|3451571|P1|STARTED|Overall Study||10
1409893|NCT03043534|3451587|P2|NOT COMPLETED|Overall Study||0
1409894|NCT03043534|3451588|P1|NOT COMPLETED|Overall Study||0
1409895|NCT03043534|3451587|P2|COMPLETED|Overall Study||14
1409896|NCT03043534|3451588|P1|COMPLETED|Overall Study||15
1409897|NCT03043534|3451587|P2|STARTED|Overall Study||14
1409898|NCT03043534|3451588|P1|STARTED|Overall Study||15
1409899|NCT03042780|3451602|P1|NOT COMPLETED|Overall Study||0
1409900|NCT03042780|3451602|P1|COMPLETED|Overall Study||2
1409901|NCT03042780|3451602|P1|STARTED|Overall Study||2
1409902|NCT03042702|3451608|P1|NOT COMPLETED|Overall Study||0
1409903|NCT03042702|3451608|P1|COMPLETED|Overall Study||2
1409904|NCT03042702|3451608|P1|STARTED|Overall Study||2
1409905|NCT03042299|3451619|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1409906|NCT03042299|3451620|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1409907|NCT03042299|3451619|P2|COMPLETED|Intervention Period 2 (6 Days)||7
1409908|NCT03042299|3451620|P1|COMPLETED|Intervention Period 2 (6 Days)||7
1409909|NCT03042299|3451619|P2|STARTED|Intervention Period 2 (6 Days)||7
1409910|NCT03042299|3451620|P1|STARTED|Intervention Period 2 (6 Days)||7
1409911|NCT03042299|3451619|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||0
1409912|NCT03042299|3451620|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
1409913|NCT03042299|3451619|P2|COMPLETED|Washout Period (at Least 6 Days)||7
1409914|NCT03042299|3451620|P1|COMPLETED|Washout Period (at Least 6 Days)||7
1409915|NCT03042299|3451619|P2|STARTED|Washout Period (at Least 6 Days)||7
1409916|NCT03042299|3451620|P1|STARTED|Washout Period (at Least 6 Days)||7
1409917|NCT03042299|3451619|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1409918|NCT03042299|3451620|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1409919|NCT03042299|3451619|P2|COMPLETED|Intervention Period 1 (6 Days)||7
1409920|NCT03042299|3451620|P1|COMPLETED|Intervention Period 1 (6 Days)||7
1409921|NCT03042299|3451619|P2|STARTED|Intervention Period 1 (6 Days)||7
1409922|NCT03042299|3451620|P1|STARTED|Intervention Period 1 (6 Days)||7
1409923|NCT03041298|3451646|P1|NOT COMPLETED|Overall Study||0
1409924|NCT03041298|3451646|P1|COMPLETED|Overall Study||1537
1409925|NCT03041298|3451646|P1|STARTED|Overall Study||1537
1409926|NCT03039543|3451656|P2|NOT COMPLETED|Overall Study||3
1409927|NCT03039543|3451657|P1|NOT COMPLETED|Overall Study||1
1409928|NCT03039543|3451656|P2|COMPLETED|Overall Study||51
1409929|NCT03039543|3451657|P1|COMPLETED|Overall Study||53
1409930|NCT03039543|3451656|P2|STARTED|Overall Study||54
1409931|NCT03039543|3451657|P1|STARTED|Overall Study||54
1409932|NCT03039179|3451673|P2|NOT COMPLETED|Overall Study||0
1409933|NCT03039179|3451674|P1|NOT COMPLETED|Overall Study||0
1409934|NCT03039179|3451673|P2|COMPLETED|Overall Study||42
1409935|NCT03039179|3451674|P1|COMPLETED|Overall Study||38
1409936|NCT03039179|3451673|P2|STARTED|Overall Study||42
1409937|NCT03039179|3451674|P1|STARTED|Overall Study||38
1409938|NCT03039088|3451684|P2|NOT COMPLETED|Overall Study||0
1409939|NCT03039088|3451685|P1|NOT COMPLETED|Overall Study||0
1409940|NCT03039088|3451684|P2|COMPLETED|Overall Study||316
1409941|NCT03039088|3451685|P1|COMPLETED|Overall Study||192
1409942|NCT03039088|3451684|P2|STARTED|Overall Study||316
1409943|NCT03039088|3451685|P1|STARTED|Overall Study||192
1409944|NCT03037905|3451693|P2|NOT COMPLETED|Overall Study||0
1409945|NCT03037905|3451694|P1|NOT COMPLETED|Overall Study||0
1409946|NCT03037905|3451693|P2|COMPLETED|Overall Study||50
1409947|NCT03037905|3451694|P1|COMPLETED|Overall Study||50
1409948|NCT03037905|3451693|P2|STARTED|Overall Study||50
1409949|NCT03037905|3451694|P1|STARTED|Overall Study||50
1409950|NCT03037541|3451708|P2|NOT COMPLETED|Overall Study||0
1409951|NCT03037541|3451709|P1|NOT COMPLETED|Overall Study||0
1409952|NCT03037541|3451708|P2|COMPLETED|Overall Study||30
1409953|NCT03037541|3451709|P1|COMPLETED|Overall Study||30
1409954|NCT03037541|3451708|P2|STARTED|Overall Study||30
1409955|NCT03037541|3451709|P1|STARTED|Overall Study||30
1409956|NCT03037307|3451717|P6|NOT COMPLETED|Period 3||0
1409957|NCT03037307|3451718|P5|NOT COMPLETED|Period 3||0
1409958|NCT03037307|3451719|P4|NOT COMPLETED|Period 3||0
1409959|NCT03037307|3451720|P3|NOT COMPLETED|Period 3||0
1409960|NCT03037307|3451721|P2|NOT COMPLETED|Period 3||0
1409961|NCT03037307|3451722|P1|NOT COMPLETED|Period 3||0
1409962|NCT03037307|3451717|P6|COMPLETED|Period 3||8
1409963|NCT03037307|3451718|P5|COMPLETED|Period 3||7
1409964|NCT03037307|3451719|P4|COMPLETED|Period 3||6
1409965|NCT03037307|3451720|P3|COMPLETED|Period 3||8
1409966|NCT03037307|3451721|P2|COMPLETED|Period 3||7
1409967|NCT03037307|3451722|P1|COMPLETED|Period 3||7
1409968|NCT03037307|3451717|P6|STARTED|Period 3||8
1409969|NCT03037307|3451718|P5|STARTED|Period 3||7
1409970|NCT03037307|3451719|P4|STARTED|Period 3||6
1409971|NCT03037307|3451720|P3|STARTED|Period 3||8
1409972|NCT03037307|3451721|P2|STARTED|Period 3||7
1409973|NCT03037307|3451722|P1|STARTED|Period 3||7
1409974|NCT03037307|3451717|P6|NOT COMPLETED|Wash Out Period 2||0
1409975|NCT03037307|3451718|P5|NOT COMPLETED|Wash Out Period 2||0
1409976|NCT03037307|3451719|P4|NOT COMPLETED|Wash Out Period 2||0
1409977|NCT03037307|3451720|P3|NOT COMPLETED|Wash Out Period 2||0
1409978|NCT03037307|3451721|P2|NOT COMPLETED|Wash Out Period 2||0
1409979|NCT03037307|3451722|P1|NOT COMPLETED|Wash Out Period 2||0
1409980|NCT03037307|3451717|P6|COMPLETED|Wash Out Period 2||8
1409981|NCT03037307|3451718|P5|COMPLETED|Wash Out Period 2||7
1409982|NCT03037307|3451719|P4|COMPLETED|Wash Out Period 2||6
1409983|NCT03037307|3451720|P3|COMPLETED|Wash Out Period 2||8
1409984|NCT03037307|3451721|P2|COMPLETED|Wash Out Period 2||7
1409985|NCT03037307|3451722|P1|COMPLETED|Wash Out Period 2||7
1409986|NCT03037307|3451717|P6|STARTED|Wash Out Period 2||8
1409987|NCT03037307|3451718|P5|STARTED|Wash Out Period 2||7
1409988|NCT03037307|3451719|P4|STARTED|Wash Out Period 2||6
1409989|NCT03037307|3451720|P3|STARTED|Wash Out Period 2||8
1409990|NCT03037307|3451721|P2|STARTED|Wash Out Period 2||7
1409991|NCT03037307|3451722|P1|STARTED|Wash Out Period 2||7
1409992|NCT03037307|3451717|P6|NOT COMPLETED|Period 2||0
1409993|NCT03037307|3451718|P5|NOT COMPLETED|Period 2||0
1409994|NCT03037307|3451719|P4|NOT COMPLETED|Period 2||0
1409995|NCT03037307|3451720|P3|NOT COMPLETED|Period 2||0
1409996|NCT03037307|3451721|P2|NOT COMPLETED|Period 2||0
1409997|NCT03037307|3451722|P1|NOT COMPLETED|Period 2||0
1409998|NCT03037307|3451717|P6|COMPLETED|Period 2||8
1409999|NCT03037307|3451718|P5|COMPLETED|Period 2||7
1410000|NCT03037307|3451719|P4|COMPLETED|Period 2||6
1410001|NCT03037307|3451720|P3|COMPLETED|Period 2||8
1410002|NCT03037307|3451721|P2|COMPLETED|Period 2||7
1410003|NCT03037307|3451722|P1|COMPLETED|Period 2||7
1410004|NCT03037307|3451717|P6|STARTED|Period 2||8
1410005|NCT03037307|3451718|P5|STARTED|Period 2||7
1410006|NCT03037307|3451719|P4|STARTED|Period 2||6
1410007|NCT03037307|3451720|P3|STARTED|Period 2||8
1410008|NCT03037307|3451721|P2|STARTED|Period 2||7
1410009|NCT03037307|3451722|P1|STARTED|Period 2||7
1410010|NCT03037307|3451717|P6|NOT COMPLETED|Wash Out Period 1||0
1410011|NCT03037307|3451718|P5|NOT COMPLETED|Wash Out Period 1||0
1410012|NCT03037307|3451719|P4|NOT COMPLETED|Wash Out Period 1||0
1410013|NCT03037307|3451720|P3|NOT COMPLETED|Wash Out Period 1||0
1410014|NCT03037307|3451721|P2|NOT COMPLETED|Wash Out Period 1||0
1410015|NCT03037307|3451722|P1|NOT COMPLETED|Wash Out Period 1||0
1410016|NCT03037307|3451717|P6|COMPLETED|Wash Out Period 1||8
1410017|NCT03037307|3451718|P5|COMPLETED|Wash Out Period 1||7
1410018|NCT03037307|3451719|P4|COMPLETED|Wash Out Period 1||6
1410019|NCT03037307|3451720|P3|COMPLETED|Wash Out Period 1||8
1410020|NCT03037307|3451721|P2|COMPLETED|Wash Out Period 1||7
1410021|NCT03037307|3451722|P1|COMPLETED|Wash Out Period 1||7
1410022|NCT03037307|3451717|P6|STARTED|Wash Out Period 1||8
1410023|NCT03037307|3451718|P5|STARTED|Wash Out Period 1||7
1410024|NCT03037307|3451719|P4|STARTED|Wash Out Period 1||6
1410025|NCT03037307|3451720|P3|STARTED|Wash Out Period 1||8
1410026|NCT03037307|3451721|P2|STARTED|Wash Out Period 1||7
1410027|NCT03037307|3451722|P1|STARTED|Wash Out Period 1||7
1410028|NCT03037307|3451717|P6|NOT COMPLETED|Period 1||0
1410029|NCT03037307|3451718|P5|NOT COMPLETED|Period 1||0
1410030|NCT03037307|3451719|P4|NOT COMPLETED|Period 1||1
1410031|NCT03037307|3451720|P3|NOT COMPLETED|Period 1||0
1410032|NCT03037307|3451721|P2|NOT COMPLETED|Period 1||0
1410033|NCT03037307|3451722|P1|NOT COMPLETED|Period 1||0
1410034|NCT03037307|3451717|P6|COMPLETED|Period 1||8
1410035|NCT03037307|3451718|P5|COMPLETED|Period 1||7
1410036|NCT03037307|3451719|P4|COMPLETED|Period 1||6
1410037|NCT03037307|3451720|P3|COMPLETED|Period 1||8
1410038|NCT03037307|3451721|P2|COMPLETED|Period 1||7
1410039|NCT03037307|3451722|P1|COMPLETED|Period 1||7
1410040|NCT03037307|3451717|P6|STARTED|Period 1||8
1410041|NCT03037307|3451718|P5|STARTED|Period 1||7
1410042|NCT03037307|3451719|P4|STARTED|Period 1||7
1410043|NCT03037307|3451720|P3|STARTED|Period 1||8
1410044|NCT03037307|3451721|P2|STARTED|Period 1||7
1410045|NCT03037307|3451722|P1|STARTED|Period 1||7
1410046|NCT03036735|3451732|P1|NOT COMPLETED|Overall Study||10
1410047|NCT03036735|3451732|P1|COMPLETED|Overall Study||0
1410048|NCT03036735|3451732|P1|STARTED|Overall Study||10
1410049|NCT03036215|3451738|P2|NOT COMPLETED|Overall Study||3
1410050|NCT03036215|3451739|P1|NOT COMPLETED|Overall Study||2
1410051|NCT03036215|3451738|P2|COMPLETED|Overall Study||36
1410052|NCT03036215|3451739|P1|COMPLETED|Overall Study||39
1410053|NCT03036215|3451738|P2|STARTED|Overall Study||39
1410054|NCT03036215|3451739|P1|STARTED|Overall Study||41
1410055|NCT03035955|3451751|P2|NOT COMPLETED|Overall Study||1
1410056|NCT03035955|3451752|P1|NOT COMPLETED|Overall Study||1
1410057|NCT03035955|3451751|P2|COMPLETED|Overall Study||9
1410058|NCT03035955|3451752|P1|COMPLETED|Overall Study||9
1410059|NCT03035955|3451751|P2|STARTED|Overall Study||10
1410060|NCT03035955|3451752|P1|STARTED|Overall Study||10
1410061|NCT03035916|3451761|P3|NOT COMPLETED|Overall Study||0
1410062|NCT03035916|3451762|P2|NOT COMPLETED|Overall Study||2
1410063|NCT03035916|3451763|P1|NOT COMPLETED|Overall Study||0
1410064|NCT03035916|3451761|P3|COMPLETED|Overall Study||31
1410065|NCT03035916|3451762|P2|COMPLETED|Overall Study||28
1410066|NCT03035916|3451763|P1|COMPLETED|Overall Study||30
1410067|NCT03035916|3451761|P3|STARTED|Overall Study||31
1410068|NCT03035916|3451762|P2|STARTED|Overall Study||30
1410069|NCT03035916|3451763|P1|STARTED|Overall Study||30
1410070|NCT03034954|3451812|P2|NOT COMPLETED|Overall Study||0
1410071|NCT03034954|3451813|P1|NOT COMPLETED|Overall Study||1
1410072|NCT03034954|3451812|P2|COMPLETED|Overall Study||21
1410073|NCT03034954|3451813|P1|COMPLETED|Overall Study||20
1410074|NCT03034954|3451812|P2|STARTED|Overall Study||21
1410075|NCT03034954|3451813|P1|STARTED|Overall Study||21
1410076|NCT03032965|3451867|P2|NOT COMPLETED|Overall Study||0
1410077|NCT03032965|3451868|P1|NOT COMPLETED|Overall Study||0
1410078|NCT03032965|3451867|P2|COMPLETED|Overall Study||68
1410079|NCT03032965|3451868|P1|COMPLETED|Overall Study||61
1410080|NCT03032965|3451867|P2|STARTED|Overall Study||68
1410081|NCT03032965|3451868|P1|STARTED|Overall Study||61
1410082|NCT03032263|3451892|P2|NOT COMPLETED|Overall Study||0
1410083|NCT03032263|3451893|P1|NOT COMPLETED|Overall Study||0
1410084|NCT03032263|3451892|P2|COMPLETED|Overall Study||6
1410085|NCT03032263|3451893|P1|COMPLETED|Overall Study||6
1410086|NCT03032263|3451892|P2|STARTED|Overall Study||6
1410087|NCT03032263|3451893|P1|STARTED|Overall Study||6
1410088|NCT03031899|3451907|P1|NOT COMPLETED|Overall Study||2
1410089|NCT03031899|3451907|P1|COMPLETED|Overall Study||25
1410090|NCT03031899|3451907|P1|STARTED|Overall Study||27
1410091|NCT03031795|3451917|P2|NOT COMPLETED|Overall Study||1
1410092|NCT03031795|3451918|P1|NOT COMPLETED|Overall Study||0
1410093|NCT03031795|3451917|P2|COMPLETED|Overall Study||35
1410094|NCT03031795|3451918|P1|COMPLETED|Overall Study||35
1410095|NCT03031795|3451917|P2|STARTED|Overall Study||36
1410096|NCT03031795|3451918|P1|STARTED|Overall Study||35
1410097|NCT03031496|3451924|P2|NOT COMPLETED|Period 2||0
1410098|NCT03031496|3451925|P1|NOT COMPLETED|Period 2||0
1410099|NCT03031496|3451924|P2|COMPLETED|Period 2||19
1410100|NCT03031496|3451925|P1|COMPLETED|Period 2||19
1410101|NCT03031496|3451924|P2|STARTED|Period 2||19
1410102|NCT03031496|3451925|P1|STARTED|Period 2||19
1410103|NCT03031496|3451924|P2|NOT COMPLETED|Period 1||2
1410104|NCT03031496|3451925|P1|NOT COMPLETED|Period 1||2
1410105|NCT03031496|3451924|P2|COMPLETED|Period 1||19
1410106|NCT03031496|3451925|P1|COMPLETED|Period 1||19
1410107|NCT03031496|3451924|P2|STARTED|Period 1||21
1410108|NCT03031496|3451925|P1|STARTED|Period 1||21
1410109|NCT03031340|3451963|P2|NOT COMPLETED|Overall Study||1
1410110|NCT03031340|3451964|P1|NOT COMPLETED|Overall Study||2
1410111|NCT03031340|3451963|P2|COMPLETED|Overall Study||0
1410112|NCT03031340|3451964|P1|COMPLETED|Overall Study||0
1410113|NCT03031340|3451963|P2|STARTED|Overall Study||1
1410114|NCT03031340|3451964|P1|STARTED|Overall Study||2
1410115|NCT03029819|3451982|P2|NOT COMPLETED|Overall Study||6
1410116|NCT03029819|3451983|P1|NOT COMPLETED|Overall Study||3
1410117|NCT03029819|3451982|P2|COMPLETED|Overall Study||33
1410118|NCT03029819|3451983|P1|COMPLETED|Overall Study||30
1410119|NCT03029819|3451982|P2|STARTED|Overall Study||39
1410120|NCT03029819|3451983|P1|STARTED|Overall Study||33
1410121|NCT03029780|3451997|P2|NOT COMPLETED|Overall Study||11
1410122|NCT03029780|3451998|P1|NOT COMPLETED|Overall Study||6
1410123|NCT03029780|3451997|P2|COMPLETED|Overall Study||41
1410124|NCT03029780|3451998|P1|COMPLETED|Overall Study||46
1410125|NCT03029780|3451997|P2|STARTED|Overall Study||52
1410126|NCT03029780|3451998|P1|STARTED|Overall Study||52
1410127|NCT03029650|3452010|P2|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
1410128|NCT03029650|3452011|P1|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
1410129|NCT03029650|3452010|P2|COMPLETED|2nd Intervention (3 - 6 Days)||10
1410130|NCT03029650|3452011|P1|COMPLETED|2nd Intervention (3 - 6 Days)||13
1410131|NCT03029650|3452010|P2|STARTED|2nd Intervention (3 - 6 Days)||10
1410132|NCT03029650|3452011|P1|STARTED|2nd Intervention (3 - 6 Days)||13
1410133|NCT03029650|3452010|P2|NOT COMPLETED|Washout (1 Week)||2
1410134|NCT03029650|3452011|P1|NOT COMPLETED|Washout (1 Week)||1
1410135|NCT03029650|3452010|P2|COMPLETED|Washout (1 Week)||10
1410136|NCT03029650|3452011|P1|COMPLETED|Washout (1 Week)||13
1410137|NCT03029650|3452010|P2|STARTED|Washout (1 Week)||12
1410138|NCT03029650|3452011|P1|STARTED|Washout (1 Week)||14
1410139|NCT03029650|3452010|P2|NOT COMPLETED|First Intervention (3 - 6 Days)||0
1410140|NCT03029650|3452011|P1|NOT COMPLETED|First Intervention (3 - 6 Days)||0
1410141|NCT03029650|3452010|P2|COMPLETED|First Intervention (3 - 6 Days)||12
1410142|NCT03029650|3452011|P1|COMPLETED|First Intervention (3 - 6 Days)||14
1410143|NCT03029650|3452010|P2|STARTED|First Intervention (3 - 6 Days)||12
1410144|NCT03029650|3452011|P1|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
1410145|NCT03029000|3452026|P1|NOT COMPLETED|Overall Study||0
1410146|NCT03029000|3452026|P1|COMPLETED|Overall Study||1
1410147|NCT03029000|3452026|P1|STARTED|Overall Study||1
1410148|NCT03028987|3452039|P2|NOT COMPLETED|Overall Study||0
1410149|NCT03028987|3452040|P1|NOT COMPLETED|Overall Study||0
1410150|NCT03028987|3452039|P2|COMPLETED|Overall Study||5
1410151|NCT03028987|3452040|P1|COMPLETED|Overall Study||5
1410152|NCT03028987|3452039|P2|STARTED|Overall Study||5
1410153|NCT03028987|3452040|P1|STARTED|Overall Study||5
1410154|NCT03028974|3452053|P7|NOT COMPLETED|2017-2018||0
1410155|NCT03028974|3452054|P6|NOT COMPLETED|2017-2018||0
1410156|NCT03028974|3452055|P5|NOT COMPLETED|2017-2018||0
1410157|NCT03028974|3452056|P4|NOT COMPLETED|2017-2018||0
1410158|NCT03028974|3452057|P3|NOT COMPLETED|2017-2018||0
1410159|NCT03028974|3452058|P2|NOT COMPLETED|2017-2018||0
1410160|NCT03028974|3452059|P1|NOT COMPLETED|2017-2018||0
1410161|NCT03028974|3452053|P7|COMPLETED|2017-2018||5
1410162|NCT03028974|3452054|P6|COMPLETED|2017-2018||0
1410163|NCT03028974|3452055|P5|COMPLETED|2017-2018||0
1410164|NCT03028974|3452056|P4|COMPLETED|2017-2018||5
1410165|NCT03028974|3452057|P3|COMPLETED|2017-2018||0
1410166|NCT03028974|3452058|P2|COMPLETED|2017-2018||0
1410167|NCT03028974|3452059|P1|COMPLETED|2017-2018||0
1410168|NCT03028974|3452053|P7|STARTED|2017-2018|5 new participants were enrolled.|5
1410169|NCT03028974|3452054|P6|STARTED|2017-2018||0
1410170|NCT03028974|3452055|P5|STARTED|2017-2018||0
1410171|NCT03028974|3452056|P4|STARTED|2017-2018||5
1410172|NCT03028974|3452057|P3|STARTED|2017-2018||0
1410173|NCT03028974|3452058|P2|STARTED|2017-2018||0
1410174|NCT03028974|3452059|P1|STARTED|2017-2018||0
1410175|NCT03028974|3452053|P7|NOT COMPLETED|2016-2017||0
1410176|NCT03028974|3452054|P6|NOT COMPLETED|2016-2017||0
1410177|NCT03028974|3452055|P5|NOT COMPLETED|2016-2017||0
1410178|NCT03028974|3452056|P4|NOT COMPLETED|2016-2017||0
1410179|NCT03028974|3452057|P3|NOT COMPLETED|2016-2017||0
1410180|NCT03028974|3452058|P2|NOT COMPLETED|2016-2017||0
1410181|NCT03028974|3452059|P1|NOT COMPLETED|2016-2017||0
1410182|NCT03028974|3452053|P7|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
1410183|NCT03028974|3452054|P6|COMPLETED|2016-2017||0
1410184|NCT03028974|3452055|P5|COMPLETED|2016-2017|2 participants did not continue to the next period|2
1410185|NCT03028974|3452056|P4|COMPLETED|2016-2017||4
1410186|NCT03028974|3452057|P3|COMPLETED|2016-2017||0
1410187|NCT03028974|3452058|P2|COMPLETED|2016-2017||0
1410188|NCT03028974|3452059|P1|COMPLETED|2016-2017||0
1410189|NCT03028974|3452053|P7|STARTED|2016-2017|18 new participants were enrolled.|18
1410190|NCT03028974|3452054|P6|STARTED|2016-2017||0
1410191|NCT03028974|3452055|P5|STARTED|2016-2017|2 new participants were enrolled.|2
1410192|NCT03028974|3452056|P4|STARTED|2016-2017|1 new participant was enrolled.|4
1410193|NCT03028974|3452057|P3|STARTED|2016-2017||0
1410194|NCT03028974|3452058|P2|STARTED|2016-2017||0
1410195|NCT03028974|3452059|P1|STARTED|2016-2017||0
1410196|NCT03028974|3452053|P7|NOT COMPLETED|2015-2016||0
1410197|NCT03028974|3452054|P6|NOT COMPLETED|2015-2016||0
1410198|NCT03028974|3452055|P5|NOT COMPLETED|2015-2016||0
1410199|NCT03028974|3452056|P4|NOT COMPLETED|2015-2016||0
1410200|NCT03028974|3452057|P3|NOT COMPLETED|2015-2016||0
1410201|NCT03028974|3452058|P2|NOT COMPLETED|2015-2016||0
1410202|NCT03028974|3452059|P1|NOT COMPLETED|2015-2016||0
1410203|NCT03028974|3452053|P7|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
1410204|NCT03028974|3452054|P6|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
1410205|NCT03028974|3452055|P5|COMPLETED|2015-2016||0
1410206|NCT03028974|3452056|P4|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
1410207|NCT03028974|3452057|P3|COMPLETED|2015-2016||0
1410208|NCT03028974|3452058|P2|COMPLETED|2015-2016||0
1410209|NCT03028974|3452059|P1|COMPLETED|2015-2016||0
1410210|NCT03028974|3452053|P7|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
1410211|NCT03028974|3452054|P6|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
1410212|NCT03028974|3452055|P5|STARTED|2015-2016||0
1410213|NCT03028974|3452056|P4|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
1410214|NCT03028974|3452057|P3|STARTED|2015-2016||0
1410215|NCT03028974|3452058|P2|STARTED|2015-2016||0
1410216|NCT03028974|3452059|P1|STARTED|2015-2016||0
1410217|NCT03028974|3452053|P7|NOT COMPLETED|2014-2015||0
1410218|NCT03028974|3452054|P6|NOT COMPLETED|2014-2015||0
1410219|NCT03028974|3452055|P5|NOT COMPLETED|2014-2015||0
1410220|NCT03028974|3452056|P4|NOT COMPLETED|2014-2015||0
1410221|NCT03028974|3452057|P3|NOT COMPLETED|2014-2015||0
1410222|NCT03028974|3452058|P2|NOT COMPLETED|2014-2015||0
1410223|NCT03028974|3452059|P1|NOT COMPLETED|2014-2015||0
1410224|NCT03028974|3452053|P7|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
1410225|NCT03028974|3452054|P6|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
1410226|NCT03028974|3452055|P5|COMPLETED|2014-2015||0
1410227|NCT03028974|3452056|P4|COMPLETED|2014-2015||3
1410228|NCT03028974|3452057|P3|COMPLETED|2014-2015||0
1410229|NCT03028974|3452058|P2|COMPLETED|2014-2015||0
1410230|NCT03028974|3452059|P1|COMPLETED|2014-2015||1
1410231|NCT03028974|3452053|P7|STARTED|2014-2015||13
1410232|NCT03028974|3452054|P6|STARTED|2014-2015||11
1410233|NCT03028974|3452055|P5|STARTED|2014-2015||0
1410234|NCT03028974|3452056|P4|STARTED|2014-2015||3
1410235|NCT03028974|3452057|P3|STARTED|2014-2015||0
1410236|NCT03028974|3452058|P2|STARTED|2014-2015||0
1410237|NCT03028974|3452059|P1|STARTED|2014-2015||1
1410238|NCT03028896|3452078|P2|NOT COMPLETED|Overall Study||0
1410239|NCT03028896|3452079|P1|NOT COMPLETED|Overall Study||3
1410240|NCT03028896|3452078|P2|COMPLETED|Overall Study||66
1410241|NCT03028896|3452079|P1|COMPLETED|Overall Study||63
1410242|NCT03028896|3452078|P2|STARTED|Overall Study||66
1410243|NCT03028896|3452079|P1|STARTED|Overall Study||66
1410244|NCT03028870|3452089|P4|NOT COMPLETED|Overall Study||9
1410245|NCT03028870|3452090|P3|NOT COMPLETED|Overall Study||16
1410246|NCT03028870|3452091|P2|NOT COMPLETED|Overall Study||10
1410247|NCT03028870|3452092|P1|NOT COMPLETED|Overall Study||17
1410248|NCT03028870|3452089|P4|COMPLETED|Overall Study||65
1410249|NCT03028870|3452090|P3|COMPLETED|Overall Study||60
1410250|NCT03028870|3452091|P2|COMPLETED|Overall Study||57
1410251|NCT03028870|3452092|P1|COMPLETED|Overall Study||57
1410252|NCT03028870|3452089|P4|STARTED|Overall Study||74
1410253|NCT03028870|3452090|P3|STARTED|Overall Study||76
1410254|NCT03028870|3452091|P2|STARTED|Overall Study||67
1410255|NCT03028870|3452092|P1|STARTED|Overall Study||74
1410256|NCT03028025|3452172|P2|NOT COMPLETED|Overall Study||1
1410257|NCT03028025|3452173|P1|NOT COMPLETED|Overall Study||3
1410258|NCT03028025|3452172|P2|COMPLETED|Overall Study||93
1410259|NCT03028025|3452173|P1|COMPLETED|Overall Study||87
1410260|NCT03028025|3452172|P2|STARTED|Overall Study||94
1410261|NCT03028025|3452173|P1|STARTED|Overall Study||90
1410262|NCT03027661|3452183|P2|NOT COMPLETED|Overall Study||0
1410263|NCT03027661|3452184|P1|NOT COMPLETED|Overall Study||0
1410264|NCT03027661|3452183|P2|COMPLETED|Overall Study||21
1410265|NCT03027661|3452184|P1|COMPLETED|Overall Study||20
1410266|NCT03027661|3452183|P2|STARTED|Overall Study||21
1410267|NCT03027661|3452184|P1|STARTED|Overall Study||20
1410268|NCT03026803|3452192|P1|NOT COMPLETED|Overall Study||0
1410269|NCT03026803|3452192|P1|COMPLETED|Overall Study||4
1410270|NCT03026803|3452192|P1|STARTED|Overall Study||4
1410271|NCT03026530|3452198|P2|NOT COMPLETED|Overall Study||29
1410272|NCT03026530|3452199|P1|NOT COMPLETED|Overall Study||21
1410273|NCT03026530|3452198|P2|COMPLETED|Overall Study||71
1410274|NCT03026530|3452199|P1|COMPLETED|Overall Study||79
1410275|NCT03026530|3452198|P2|STARTED|Overall Study||100
1410276|NCT03026530|3452199|P1|STARTED|Overall Study||100
1410277|NCT03026257|3452213|P6|NOT COMPLETED|Overall Study||0
1410278|NCT03026257|3452214|P5|NOT COMPLETED|Overall Study||1
1410279|NCT03026257|3452215|P4|NOT COMPLETED|Overall Study||1
1410280|NCT03026257|3452216|P3|NOT COMPLETED|Overall Study||0
1410281|NCT03026257|3452217|P2|NOT COMPLETED|Overall Study||1
1410282|NCT03026257|3452218|P1|NOT COMPLETED|Overall Study||6
1410283|NCT03026257|3452213|P6|COMPLETED|Overall Study||46
1410284|NCT03026257|3452214|P5|COMPLETED|Overall Study||22
1410285|NCT03026257|3452215|P4|COMPLETED|Overall Study||24
1410286|NCT03026257|3452216|P3|COMPLETED|Overall Study||34
1410287|NCT03026257|3452217|P2|COMPLETED|Overall Study||63
1410288|NCT03026257|3452218|P1|COMPLETED|Overall Study||54
1410289|NCT03026257|3452213|P6|Treated|Overall Study||47
1410290|NCT03026257|3452214|P5|Treated|Overall Study||23
1410291|NCT03026257|3452215|P4|Treated|Overall Study||24
1410292|NCT03026257|3452216|P3|Treated|Overall Study||35
1410293|NCT03026257|3452217|P2|Treated|Overall Study||65
1410294|NCT03026257|3452218|P1|Treated|Overall Study||58
1410295|NCT03026257|3452213|P6|STARTED|Overall Study||46
1410296|NCT03026257|3452214|P5|STARTED|Overall Study||23
1410297|NCT03026257|3452215|P4|STARTED|Overall Study||25
1410298|NCT03026257|3452216|P3|STARTED|Overall Study||34
1410299|NCT03026257|3452217|P2|STARTED|Overall Study||64
1410300|NCT03026257|3452218|P1|STARTED|Overall Study||60
1410301|NCT03025945|3452234|P2|NOT COMPLETED|Overall Study||0
1410302|NCT03025945|3452235|P1|NOT COMPLETED|Overall Study||0
1410303|NCT03025945|3452234|P2|COMPLETED|Overall Study||331
1410304|NCT03025945|3452235|P1|COMPLETED|Overall Study||331
1410305|NCT03025945|3452234|P2|STARTED|Overall Study||331
1410306|NCT03025945|3452235|P1|STARTED|Overall Study||331
1410307|NCT03024606|3452243|P2|NOT COMPLETED|Overall Study||10
1410308|NCT03024606|3452244|P1|NOT COMPLETED|Overall Study||9
1410309|NCT03024606|3452243|P2|COMPLETED|Overall Study||16
1410310|NCT03024606|3452244|P1|COMPLETED|Overall Study||14
1410311|NCT03024606|3452243|P2|STARTED|Overall Study||26
1410312|NCT03024606|3452244|P1|STARTED|Overall Study||23
1410313|NCT03024112|3452252|P2|NOT COMPLETED|Overall Study||0
1410314|NCT03024112|3452253|P1|NOT COMPLETED|Overall Study||7
1410315|NCT03024112|3452252|P2|COMPLETED|Overall Study||26
1410316|NCT03024112|3452253|P1|COMPLETED|Overall Study||18
1410317|NCT03024112|3452252|P2|STARTED|Overall Study||26
1410318|NCT03024112|3452253|P1|STARTED|Overall Study||25
1410319|NCT03023709|3452267|P2|NOT COMPLETED|Overall Study||0
1410320|NCT03023709|3452268|P1|NOT COMPLETED|Overall Study||0
1410321|NCT03023709|3452267|P2|COMPLETED|Overall Study||0
1410322|NCT03023709|3452268|P1|COMPLETED|Overall Study||3
1410323|NCT03023709|3452267|P2|STARTED|Overall Study||0
1410324|NCT03023709|3452268|P1|STARTED|Overall Study||3
1410325|NCT03023683|3452278|P2|NOT COMPLETED|Overall Study||1
1410326|NCT03023683|3452279|P1|NOT COMPLETED|Overall Study||0
1410327|NCT03023683|3452278|P2|COMPLETED|Overall Study||17
1410328|NCT03023683|3452279|P1|COMPLETED|Overall Study||0
1410329|NCT03023683|3452278|P2|STARTED|Overall Study||18
1410330|NCT03023683|3452279|P1|STARTED|Overall Study||0
1410331|NCT03023553|3452289|P2|NOT COMPLETED|Overall Study||1
1410332|NCT03023553|3452290|P1|NOT COMPLETED|Overall Study||0
1410333|NCT03023553|3452289|P2|COMPLETED|Overall Study||8
1410334|NCT03023553|3452290|P1|COMPLETED|Overall Study||4
1410335|NCT03023553|3452289|P2|STARTED|Overall Study||9
1410336|NCT03023553|3452290|P1|STARTED|Overall Study||4
1410337|NCT03023488|3452298|P1|NOT COMPLETED|Overall Study||0
1410338|NCT03023488|3452298|P1|COMPLETED|Overall Study||46
1410339|NCT03023488|3452298|P1|STARTED|Overall Study||46
1410340|NCT03023176|3452311|P1|NOT COMPLETED|Overall Study||0
1410341|NCT03023176|3452311|P1|COMPLETED|Overall Study||20
1410342|NCT03023176|3452311|P1|STARTED|Overall Study||20
1410343|NCT03023137|3452318|P2|NOT COMPLETED|Overall Study||9
1410344|NCT03023137|3452319|P1|NOT COMPLETED|Overall Study||4
1410345|NCT03023137|3452318|P2|COMPLETED|Overall Study||162
1410346|NCT03023137|3452319|P1|COMPLETED|Overall Study||174
1410347|NCT03023137|3452318|P2|STARTED|Overall Study||171
1410348|NCT03023137|3452319|P1|STARTED|Overall Study||178
1410349|NCT03022435|3452350|P5|NOT COMPLETED|Overall Study||0
1410350|NCT03022435|3452351|P4|NOT COMPLETED|Overall Study||0
1410351|NCT03022435|3452352|P3|NOT COMPLETED|Overall Study||0
1410352|NCT03022435|3452353|P2|NOT COMPLETED|Overall Study||0
1410353|NCT03022435|3452354|P1|NOT COMPLETED|Overall Study||0
1410354|NCT03022435|3452350|P5|COMPLETED|Overall Study||3
1410355|NCT03022435|3452351|P4|COMPLETED|Overall Study||3
1410356|NCT03022435|3452352|P3|COMPLETED|Overall Study||6
1410357|NCT03022435|3452353|P2|COMPLETED|Overall Study||5
1410358|NCT03022435|3452354|P1|COMPLETED|Overall Study||5
1410359|NCT03022435|3452350|P5|STARTED|Overall Study||3
1410360|NCT03022435|3452351|P4|STARTED|Overall Study||3
1410361|NCT03022435|3452352|P3|STARTED|Overall Study||6
1410362|NCT03022435|3452353|P2|STARTED|Overall Study||5
1410363|NCT03022435|3452354|P1|STARTED|Overall Study||5
1410364|NCT03022422|3452377|P6|NOT COMPLETED|Overall Study||0
1410365|NCT03022422|3452378|P5|NOT COMPLETED|Overall Study||0
1410366|NCT03022422|3452379|P4|NOT COMPLETED|Overall Study||0
1410367|NCT03022422|3452380|P3|NOT COMPLETED|Overall Study||3
1410368|NCT03022422|3452381|P2|NOT COMPLETED|Overall Study||0
1410369|NCT03022422|3452382|P1|NOT COMPLETED|Overall Study||0
1410370|NCT03022422|3452377|P6|COMPLETED|Overall Study||5
1410371|NCT03022422|3452378|P5|COMPLETED|Overall Study||5
1410372|NCT03022422|3452379|P4|COMPLETED|Overall Study||12
1410373|NCT03022422|3452380|P3|COMPLETED|Overall Study||20
1410374|NCT03022422|3452381|P2|COMPLETED|Overall Study||10
1410375|NCT03022422|3452382|P1|COMPLETED|Overall Study||8
1410376|NCT03022422|3452377|P6|STARTED|Overall Study||5
1410377|NCT03022422|3452378|P5|STARTED|Overall Study||5
1410378|NCT03022422|3452379|P4|STARTED|Overall Study||12
1410379|NCT03022422|3452380|P3|STARTED|Overall Study||23
1410380|NCT03022422|3452381|P2|STARTED|Overall Study||10
1410381|NCT03022422|3452382|P1|STARTED|Overall Study||8
1410382|NCT03022396|3452408|P6|NOT COMPLETED|Overall Study||0
1410383|NCT03022396|3452409|P5|NOT COMPLETED|Overall Study||0
1410384|NCT03022396|3452410|P4|NOT COMPLETED|Overall Study||0
1410385|NCT03022396|3452411|P3|NOT COMPLETED|Overall Study||0
1410386|NCT03022396|3452412|P2|NOT COMPLETED|Overall Study||0
1410387|NCT03022396|3452413|P1|NOT COMPLETED|Overall Study||0
1410388|NCT03022396|3452408|P6|COMPLETED|Overall Study||8
1410389|NCT03022396|3452409|P5|COMPLETED|Overall Study||14
1410390|NCT03022396|3452410|P4|COMPLETED|Overall Study||20
1410391|NCT03022396|3452411|P3|COMPLETED|Overall Study||10
1410392|NCT03022396|3452412|P2|COMPLETED|Overall Study||14
1410393|NCT03022396|3452413|P1|COMPLETED|Overall Study||16
1410394|NCT03022396|3452408|P6|STARTED|Overall Study||8
1410395|NCT03022396|3452409|P5|STARTED|Overall Study||14
1410396|NCT03022396|3452410|P4|STARTED|Overall Study||20
1410397|NCT03022396|3452411|P3|STARTED|Overall Study||10
1410398|NCT03022396|3452412|P2|STARTED|Overall Study||14
1410399|NCT03022396|3452413|P1|STARTED|Overall Study||16
1410400|NCT03021343|3452435|P2|NOT COMPLETED|Overall Study||7
1410401|NCT03021343|3452436|P1|NOT COMPLETED|Overall Study||5
1410402|NCT03021343|3452435|P2|COMPLETED|Overall Study||174
1410403|NCT03021343|3452436|P1|COMPLETED|Overall Study||174
1410404|NCT03021343|3452435|P2|STARTED|Overall Study||181
1410405|NCT03021343|3452436|P1|STARTED|Overall Study||179
1410406|NCT03021304|3452444|P1|NOT COMPLETED|Overall Study||1
1410407|NCT03021304|3452444|P1|COMPLETED|Overall Study||55
1410408|NCT03021304|3452444|P1|STARTED|Overall Study||56
1410409|NCT03020576|3452451|P2|NOT COMPLETED|Overall Study||2
1410410|NCT03020576|3452452|P1|NOT COMPLETED|Overall Study||1
1410411|NCT03020576|3452451|P2|COMPLETED|Overall Study||14
1410412|NCT03020576|3452452|P1|COMPLETED|Overall Study||14
1410413|NCT03020576|3452451|P2|STARTED|Overall Study||16
1410414|NCT03020576|3452452|P1|STARTED|Overall Study||15
1410415|NCT03020537|3452474|P2|NOT COMPLETED|Overall Study||0
1410416|NCT03020537|3452475|P1|NOT COMPLETED|Overall Study||0
1410417|NCT03020537|3452474|P2|COMPLETED|Overall Study||7
1410418|NCT03020537|3452475|P1|COMPLETED|Overall Study||1
1410419|NCT03020537|3452474|P2|STARTED|Overall Study||7
1410420|NCT03020537|3452475|P1|STARTED|Overall Study||1
1410421|NCT03020498|3452486|P3|NOT COMPLETED|Overall Study||0
1410422|NCT03020498|3452487|P2|NOT COMPLETED|Overall Study||3
1410423|NCT03020498|3452488|P1|NOT COMPLETED|Overall Study||0
1410424|NCT03020498|3452486|P3|COMPLETED|Overall Study||36
1410425|NCT03020498|3452487|P2|COMPLETED|Overall Study||38
1410426|NCT03020498|3452488|P1|COMPLETED|Overall Study||14
1410427|NCT03020498|3452486|P3|STARTED|Overall Study||36
1410428|NCT03020498|3452487|P2|STARTED|Overall Study||41
1410429|NCT03020498|3452488|P1|STARTED|Overall Study||14
1410430|NCT03020472|3452499|P1|NOT COMPLETED|Overall Study||0
1410431|NCT03020472|3452499|P1|COMPLETED|Overall Study||6
1410432|NCT03020472|3452499|P1|STARTED|Overall Study||6
1410433|NCT03020160|3452507|P2|NOT COMPLETED|Overall Study||41
1410434|NCT03020160|3452508|P1|NOT COMPLETED|Overall Study||7
1410435|NCT03020160|3452507|P2|COMPLETED|Overall Study||0
1410436|NCT03020160|3452508|P1|COMPLETED|Overall Study||0
1410437|NCT03020160|3452507|P2|Completed 24 Weeks in the Study|Overall Study||41
1410438|NCT03020160|3452508|P1|Completed 24 Weeks in the Study|Overall Study||7
1410439|NCT03020160|3452507|P2|STARTED|Overall Study||41
1410440|NCT03020160|3452508|P1|STARTED|Overall Study||7
1410441|NCT03020004|3452561|P1|NOT COMPLETED|Overall Study||1
1410442|NCT03020004|3452561|P1|COMPLETED|Overall Study||69
1410443|NCT03020004|3452561|P1|STARTED|Overall Study||70
1410444|NCT03019783|3452567|P2|NOT COMPLETED|Overall Study||0
1410445|NCT03019783|3452568|P1|NOT COMPLETED|Overall Study||0
1410446|NCT03019783|3452567|P2|COMPLETED|Overall Study||31
1410447|NCT03019783|3452568|P1|COMPLETED|Overall Study||29
1410448|NCT03019783|3452567|P2|STARTED|Overall Study||31
1410449|NCT03019783|3452568|P1|STARTED|Overall Study||29
1410450|NCT03019744|3452578|P2|NOT COMPLETED|Overall Study||8
1410451|NCT03019744|3452579|P1|NOT COMPLETED|Overall Study||6
1410452|NCT03019744|3452578|P2|COMPLETED|Overall Study||36
1410453|NCT03019744|3452579|P1|COMPLETED|Overall Study||32
1410454|NCT03019744|3452578|P2|STARTED|Overall Study||44
1410455|NCT03019744|3452579|P1|STARTED|Overall Study||38
1410456|NCT03018106|3452595|P2|NOT COMPLETED|Overall Study||1
1410457|NCT03018106|3452596|P1|NOT COMPLETED|Overall Study||0
1410458|NCT03018106|3452595|P2|COMPLETED|Overall Study||0
1410459|NCT03018106|3452596|P1|COMPLETED|Overall Study||0
1410460|NCT03018106|3452595|P2|STARTED|Overall Study||1
1410461|NCT03018106|3452596|P1|STARTED|Overall Study||0
1410462|NCT03017612|3452604|P1|NOT COMPLETED|Overall Study||2
1410463|NCT03017612|3452604|P1|COMPLETED|Overall Study||11
1410464|NCT03017612|3452604|P1|STARTED|Overall Study||13
1410465|NCT03017235|3452614|P2|NOT COMPLETED|Overall Study||14
1410466|NCT03017235|3452615|P1|NOT COMPLETED|Overall Study||12
1410467|NCT03017235|3452614|P2|COMPLETED|Overall Study||447
1410468|NCT03017235|3452615|P1|COMPLETED|Overall Study||444
1410469|NCT03017235|3452614|P2|STARTED|Overall Study||461
1410470|NCT03017235|3452615|P1|STARTED|Overall Study||456
1410471|NCT03017040|3452665|P2|NOT COMPLETED|Overall Study||1
1410472|NCT03017040|3452666|P1|NOT COMPLETED|Overall Study||1
1410473|NCT03017040|3452665|P2|COMPLETED|Overall Study||0
1410474|NCT03017040|3452666|P1|COMPLETED|Overall Study||0
1410475|NCT03017040|3452665|P2|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
1410476|NCT03017040|3452666|P1|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
1410477|NCT03016078|3452676|P1|NOT COMPLETED|Overall Study||2
1410478|NCT03016078|3452676|P1|COMPLETED|Overall Study||19
1410479|NCT03016078|3452676|P1|STARTED|Overall Study||21
1410480|NCT03014674|3452690|P3|NOT COMPLETED|Overall Study||0
1410481|NCT03014674|3452691|P2|NOT COMPLETED|Overall Study||0
1410482|NCT03014674|3452692|P1|NOT COMPLETED|Overall Study||1
1410483|NCT03014674|3452690|P3|COMPLETED|Overall Study||80
1410484|NCT03014674|3452691|P2|COMPLETED|Overall Study||79
1410485|NCT03014674|3452692|P1|COMPLETED|Overall Study||84
1410486|NCT03014674|3452690|P3|STARTED|Overall Study||80
1410487|NCT03014674|3452691|P2|STARTED|Overall Study||79
1410488|NCT03014674|3452692|P1|STARTED|Overall Study||85
1410489|NCT03011099|3452756|P2|NOT COMPLETED|Overall Study||2
1410490|NCT03011099|3452757|P1|NOT COMPLETED|Overall Study||0
1410491|NCT03011099|3452756|P2|COMPLETED|Overall Study||3
1410492|NCT03011099|3452757|P1|COMPLETED|Overall Study||6
1410493|NCT03011099|3452756|P2|STARTED|Overall Study||5
1410494|NCT03011099|3452757|P1|STARTED|Overall Study||6
1410495|NCT03010800|3452783|P2|NOT COMPLETED|Cross Over||0
1410496|NCT03010800|3452784|P1|NOT COMPLETED|Cross Over||0
1410497|NCT03010800|3452783|P2|COMPLETED|Cross Over||4
1410498|NCT03010800|3452784|P1|COMPLETED|Cross Over||4
1410499|NCT03010800|3452783|P2|STARTED|Cross Over||4
1410500|NCT03010800|3452784|P1|STARTED|Cross Over||4
1410501|NCT03010800|3452783|P2|NOT COMPLETED|Initial Assignment||0
1410502|NCT03010800|3452784|P1|NOT COMPLETED|Initial Assignment||0
1410503|NCT03010800|3452783|P2|COMPLETED|Initial Assignment||4
1410504|NCT03010800|3452784|P1|COMPLETED|Initial Assignment||4
1410505|NCT03010800|3452783|P2|STARTED|Initial Assignment||4
1410506|NCT03010800|3452784|P1|STARTED|Initial Assignment||4
1410507|NCT03005067|3452792|P2|NOT COMPLETED|Overall Study||7
1410508|NCT03005067|3452793|P1|NOT COMPLETED|Overall Study||10
1410509|NCT03005067|3452792|P2|COMPLETED|Overall Study||74
1410510|NCT03005067|3452793|P1|COMPLETED|Overall Study||80
1410511|NCT03005067|3452792|P2|STARTED|Overall Study||81
1410512|NCT03005067|3452793|P1|STARTED|Overall Study||90
1410513|NCT03005041|3452805|P2|NOT COMPLETED|Period 2||0
1410514|NCT03005041|3452806|P1|NOT COMPLETED|Period 2||0
1410515|NCT03005041|3452805|P2|COMPLETED|Period 2||27
1410516|NCT03005041|3452806|P1|COMPLETED|Period 2||28
1410517|NCT03005041|3452805|P2|STARTED|Period 2||27
1410518|NCT03005041|3452806|P1|STARTED|Period 2||28
1410519|NCT03005041|3452805|P2|NOT COMPLETED|Washout Period 1||0
1410520|NCT03005041|3452806|P1|NOT COMPLETED|Washout Period 1||0
1410521|NCT03005041|3452805|P2|COMPLETED|Washout Period 1||27
1410522|NCT03005041|3452806|P1|COMPLETED|Washout Period 1||28
1410523|NCT03005041|3452805|P2|STARTED|Washout Period 1||27
1410524|NCT03005041|3452806|P1|STARTED|Washout Period 1||28
1410525|NCT03005041|3452805|P2|NOT COMPLETED|Period 1||0
1410526|NCT03005041|3452806|P1|NOT COMPLETED|Period 1||0
1410527|NCT03005041|3452805|P2|COMPLETED|Period 1||27
1410528|NCT03005041|3452806|P1|COMPLETED|Period 1||28
1410529|NCT03005041|3452805|P2|STARTED|Period 1||27
1410530|NCT03005041|3452806|P1|STARTED|Period 1||28
1410531|NCT03004638|3452824|P6|NOT COMPLETED|Overall Study||0
1410532|NCT03004638|3452825|P5|NOT COMPLETED|Overall Study||0
1410533|NCT03004638|3452826|P4|NOT COMPLETED|Overall Study||0
1410534|NCT03004638|3452827|P3|NOT COMPLETED|Overall Study||0
1410535|NCT03004638|3452828|P2|NOT COMPLETED|Overall Study||0
1410536|NCT03004638|3452829|P1|NOT COMPLETED|Overall Study||0
1410537|NCT03004638|3452824|P6|COMPLETED|Overall Study||7
1410538|NCT03004638|3452825|P5|COMPLETED|Overall Study||1
1410539|NCT03004638|3452826|P4|COMPLETED|Overall Study||6
1410540|NCT03004638|3452827|P3|COMPLETED|Overall Study||6
1410541|NCT03004638|3452828|P2|COMPLETED|Overall Study||6
1410542|NCT03004638|3452829|P1|COMPLETED|Overall Study||6
1410543|NCT03004638|3452824|P6|STARTED|Overall Study||7
1410544|NCT03004638|3452825|P5|STARTED|Overall Study||1
1410545|NCT03004638|3452826|P4|STARTED|Overall Study||6
1410546|NCT03004638|3452827|P3|STARTED|Overall Study||6
1410547|NCT03004638|3452828|P2|STARTED|Overall Study||6
1410548|NCT03004638|3452829|P1|STARTED|Overall Study||6
1410549|NCT03002623|3452937|P2|NOT COMPLETED|Overall Study||1
1410550|NCT03002623|3452938|P1|NOT COMPLETED|Overall Study||2
1410551|NCT03002623|3452937|P2|COMPLETED|Overall Study||2
1410552|NCT03002623|3452938|P1|COMPLETED|Overall Study||2
1410553|NCT03002623|3452937|P2|STARTED|Overall Study||3
1410554|NCT03002623|3452938|P1|STARTED|Overall Study||4
1410555|NCT03002454|3452952|P1|NOT COMPLETED|Overall Study||0
1410556|NCT03002454|3452952|P1|COMPLETED|Overall Study||4
1410557|NCT03002454|3452952|P1|STARTED|Overall Study||4
1410558|NCT03001778|3452959|P2|NOT COMPLETED|Overall Study||0
1410559|NCT03001778|3452960|P1|NOT COMPLETED|Overall Study||0
1410560|NCT03001778|3452959|P2|COMPLETED|Overall Study||46
1410561|NCT03001778|3452960|P1|COMPLETED|Overall Study||21
1410562|NCT03001778|3452959|P2|STARTED|Overall Study||46
1410563|NCT03001778|3452960|P1|STARTED|Overall Study||21
1410564|NCT03001674|3452968|P2|NOT COMPLETED|Overall Study||0
1410565|NCT03001674|3452969|P1|NOT COMPLETED|Overall Study||0
1410566|NCT03001674|3452968|P2|COMPLETED|Overall Study||5
1410567|NCT03001674|3452969|P1|COMPLETED|Overall Study||10
1410568|NCT03001674|3452968|P2|STARTED|Overall Study||5
1410569|NCT03001674|3452969|P1|STARTED|Overall Study||10
1410570|NCT03001453|3452977|P2|NOT COMPLETED|Overall Study||0
1410571|NCT03001453|3452978|P1|NOT COMPLETED|Overall Study||0
1410572|NCT03001453|3452977|P2|COMPLETED|Overall Study||57
1410573|NCT03001453|3452978|P1|COMPLETED|Overall Study||50
1410574|NCT03001453|3452977|P2|STARTED|Overall Study||57
1410575|NCT03001453|3452978|P1|STARTED|Overall Study||50
1410576|NCT03001258|3452995|P3|NOT COMPLETED|Overall Study||0
1410577|NCT03001258|3452996|P2|NOT COMPLETED|Overall Study||0
1410578|NCT03001258|3452997|P1|NOT COMPLETED|Overall Study||0
1410579|NCT03001258|3452995|P3|COMPLETED|Overall Study||485
1410580|NCT03001258|3452996|P2|COMPLETED|Overall Study||751
1410581|NCT03001258|3452997|P1|COMPLETED|Overall Study||765
1410582|NCT03001258|3452995|P3|STARTED|Overall Study||485
1410583|NCT03001258|3452996|P2|STARTED|Overall Study||751
1410584|NCT03001258|3452997|P1|STARTED|Overall Study||765
1410585|NCT03000452|3453005|P1|NOT COMPLETED|Follow-Up Period||7
1410586|NCT03000452|3453005|P1|COMPLETED|Follow-Up Period||10
1410587|NCT03000452|3453005|P1|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
1410588|NCT03000452|3453005|P1|NOT COMPLETED|Treatment Period||18
1410589|NCT03000452|3453005|P1|COMPLETED|Treatment Period||0
1410590|NCT03000452|3453005|P1|STARTED|Treatment Period||18
1410591|NCT03000088|3453023|P2|NOT COMPLETED|Overall Study||0
1410592|NCT03000088|3453024|P1|NOT COMPLETED|Overall Study||0
1410593|NCT03000088|3453023|P2|COMPLETED|Overall Study||70
1410594|NCT03000088|3453024|P1|COMPLETED|Overall Study||70
1410595|NCT03000088|3453023|P2|STARTED|Overall Study||70
1410596|NCT03000088|3453024|P1|STARTED|Overall Study||70
1410597|NCT02998684|3453032|P2|NOT COMPLETED|Overall Study||1
1410598|NCT02998684|3453033|P1|NOT COMPLETED|Overall Study||3
1410599|NCT02998684|3453032|P2|COMPLETED|Overall Study||6
1410600|NCT02998684|3453033|P1|COMPLETED|Overall Study||4
1410601|NCT02998684|3453032|P2|STARTED|Overall Study||7
1410602|NCT02998684|3453033|P1|STARTED|Overall Study||7
1410603|NCT02997904|3453043|P2|NOT COMPLETED|Overall Study||0
1410604|NCT02997904|3453044|P1|NOT COMPLETED|Overall Study||0
1410605|NCT02997904|3453043|P2|COMPLETED|Overall Study||49
1410606|NCT02997904|3453044|P1|COMPLETED|Overall Study||51
1410607|NCT02997904|3453043|P2|STARTED|Overall Study||49
1410608|NCT02997904|3453044|P1|STARTED|Overall Study||51
1410609|NCT02995967|3453056|P2|NOT COMPLETED|Overall Study||0
1410610|NCT02995967|3453057|P1|NOT COMPLETED|Overall Study||0
1410611|NCT02995967|3453056|P2|COMPLETED|Overall Study||2
1410612|NCT02995967|3453057|P1|COMPLETED|Overall Study||1
1410613|NCT02995967|3453056|P2|STARTED|Overall Study||2
1410614|NCT02995967|3453057|P1|STARTED|Overall Study||1
1410615|NCT02992691|3453065|P1|NOT COMPLETED|Overall Study||3
1410616|NCT02992691|3453065|P1|COMPLETED|Overall Study||53
1410617|NCT02992691|3453065|P1|Received Negative Control|Overall Study||55
1410618|NCT02992691|3453065|P1|Received Positive Control|Overall Study||55
1410619|NCT02992691|3453065|P1|Received Test Product 3|Overall Study||52
1410620|NCT02992691|3453065|P1|Received Test Product 2|Overall Study||55
1410621|NCT02992691|3453065|P1|Received Test Product 1|Overall Study||55
1410622|NCT02992691|3453065|P1|STARTED|Overall Study||56
1410623|NCT02991820|3453084|P2|NOT COMPLETED|Overall Study||0
1410624|NCT02991820|3453085|P1|NOT COMPLETED|Overall Study||0
1410625|NCT02991820|3453084|P2|COMPLETED|Overall Study||31
1410626|NCT02991820|3453085|P1|COMPLETED|Overall Study||12
1410627|NCT02991820|3453084|P2|STARTED|Overall Study||31
1410628|NCT02991820|3453085|P1|STARTED|Overall Study||12
1410629|NCT02990910|3453095|P2|NOT COMPLETED|Overall Study||10
1410630|NCT02990910|3453096|P1|NOT COMPLETED|Overall Study||6
1410631|NCT02990910|3453095|P2|COMPLETED|Overall Study||130
1410632|NCT02990910|3453096|P1|COMPLETED|Overall Study||134
1410633|NCT02990910|3453095|P2|STARTED|Overall Study||140
1410634|NCT02990910|3453096|P1|STARTED|Overall Study||140
1410635|NCT02988882|3453106|P2|NOT COMPLETED|Overall Study||2
1410636|NCT02988882|3453107|P1|NOT COMPLETED|Overall Study||3
1410637|NCT02988882|3453106|P2|COMPLETED|Overall Study||40
1410638|NCT02988882|3453107|P1|COMPLETED|Overall Study||41
1410639|NCT02988882|3453106|P2|STARTED|Overall Study||42
1410640|NCT02988882|3453107|P1|STARTED|Overall Study||44
1410641|NCT02988622|3453117|P1|NOT COMPLETED|Overall Study||17
1410642|NCT02988622|3453117|P1|COMPLETED|Overall Study||83
1410643|NCT02988622|3453117|P1|STARTED|Overall Study||100
1410644|NCT02988349|3453141|P2|NOT COMPLETED|Overall Study||0
1410645|NCT02988349|3453142|P1|NOT COMPLETED|Overall Study||0
1410646|NCT02988349|3453141|P2|COMPLETED|Overall Study||21
1410647|NCT02988349|3453142|P1|COMPLETED|Overall Study||21
1410648|NCT02988349|3453141|P2|STARTED|Overall Study||21
1410649|NCT02988349|3453142|P1|STARTED|Overall Study||21
1410650|NCT02988219|3453152|P2|NOT COMPLETED|Overall Study||3
1410651|NCT02988219|3453153|P1|NOT COMPLETED|Overall Study||1
1410652|NCT02988219|3453152|P2|COMPLETED|Overall Study||22
1410653|NCT02988219|3453153|P1|COMPLETED|Overall Study||24
1410654|NCT02988219|3453152|P2|STARTED|Overall Study||25
1410655|NCT02988219|3453153|P1|STARTED|Overall Study||25
1410656|NCT02987868|3453161|P2|NOT COMPLETED|Second Intervention||0
1410657|NCT02987868|3453162|P1|NOT COMPLETED|Second Intervention||0
1410658|NCT02987868|3453161|P2|COMPLETED|Second Intervention||8
1410659|NCT02987868|3453162|P1|COMPLETED|Second Intervention||8
1410660|NCT02987868|3453161|P2|STARTED|Second Intervention||8
1410661|NCT02987868|3453162|P1|STARTED|Second Intervention||8
1410662|NCT02987868|3453161|P2|NOT COMPLETED|Wash Out Period 1 Week||0
1410663|NCT02987868|3453162|P1|NOT COMPLETED|Wash Out Period 1 Week||0
1410664|NCT02987868|3453161|P2|COMPLETED|Wash Out Period 1 Week||8
1410665|NCT02987868|3453162|P1|COMPLETED|Wash Out Period 1 Week||8
1410666|NCT02987868|3453161|P2|STARTED|Wash Out Period 1 Week||8
1410667|NCT02987868|3453162|P1|STARTED|Wash Out Period 1 Week||8
1410668|NCT02987868|3453161|P2|NOT COMPLETED|First Intervention||0
1410669|NCT02987868|3453162|P1|NOT COMPLETED|First Intervention||0
1410670|NCT02987868|3453161|P2|COMPLETED|First Intervention||8
1410671|NCT02987868|3453162|P1|COMPLETED|First Intervention||8
1410672|NCT02987868|3453161|P2|STARTED|First Intervention||8
1410673|NCT02987868|3453162|P1|STARTED|First Intervention||8
1410674|NCT02987374|3453168|P1|NOT COMPLETED|Overall Study||0
1410675|NCT02987374|3453168|P1|COMPLETED|Overall Study||10
1410676|NCT02987374|3453168|P1|STARTED|Overall Study||10
1410677|NCT02987205|3453173|P1|NOT COMPLETED|Overall Study||4
1410678|NCT02987205|3453173|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
1410679|NCT02987205|3453173|P1|Treated - Bilateral NLF Injection|Overall Study||163
1410680|NCT02987205|3453173|P1|STARTED|Overall Study||163
1410681|NCT02986958|3453183|P2|NOT COMPLETED|Overall Study||0
1410682|NCT02986958|3453184|P1|NOT COMPLETED|Overall Study||0
1410683|NCT02986958|3453183|P2|COMPLETED|Overall Study||44
1410684|NCT02986958|3453184|P1|COMPLETED|Overall Study||49
1410685|NCT02986958|3453183|P2|STARTED|Overall Study||44
1410686|NCT02986958|3453184|P1|STARTED|Overall Study||49
1410687|NCT02986854|3453207|P3|NOT COMPLETED|Overall Study||3
1410688|NCT02986854|3453208|P2|NOT COMPLETED|Overall Study||12
1410689|NCT02986854|3453209|P1|NOT COMPLETED|Overall Study||3
1410690|NCT02986854|3453207|P3|COMPLETED|Overall Study||97
1410691|NCT02986854|3453208|P2|COMPLETED|Overall Study||288
1410692|NCT02986854|3453209|P1|COMPLETED|Overall Study||298
1410693|NCT02986854|3453207|P3|STARTED|Overall Study||100
1410694|NCT02986854|3453208|P2|STARTED|Overall Study||300
1410695|NCT02986854|3453209|P1|STARTED|Overall Study||301
1410696|NCT02986711|3453284|P2|NOT COMPLETED|Overall Study||10
1410697|NCT02986711|3453285|P1|NOT COMPLETED|Overall Study||8
1410698|NCT02986711|3453284|P2|COMPLETED|Overall Study||70
1410699|NCT02986711|3453285|P1|COMPLETED|Overall Study||70
1410700|NCT02986711|3453284|P2|STARTED|Overall Study||80
1410701|NCT02986711|3453285|P1|STARTED|Overall Study||78
1410702|NCT02986282|3453293|P1|NOT COMPLETED|Overall Study||16
1410703|NCT02986282|3453293|P1|COMPLETED|Overall Study||99
1410704|NCT02986282|3453293|P1|STARTED|Overall Study||115
1410705|NCT02986139|3453300|P2|NOT COMPLETED|Overall Study||4
1410706|NCT02986139|3453301|P1|NOT COMPLETED|Overall Study||1
1410707|NCT02986139|3453300|P2|COMPLETED|Overall Study||51
1410708|NCT02986139|3453301|P1|COMPLETED|Overall Study||55
1410709|NCT02986139|3453300|P2|Received Etanercept|Overall Study||53
1410710|NCT02986139|3453301|P1|Received Etanercept|Overall Study||56
1410711|NCT02986139|3453300|P2|STARTED|Overall Study||55
1410712|NCT02986139|3453301|P1|STARTED|Overall Study||56
1410713|NCT02985840|3453315|P2|NOT COMPLETED|Overall Study||0
1410714|NCT02985840|3453316|P1|NOT COMPLETED|Overall Study||0
1410715|NCT02985840|3453315|P2|COMPLETED|Overall Study||63
1410716|NCT02985840|3453316|P1|COMPLETED|Overall Study||64
1410717|NCT02985840|3453315|P2|STARTED|Overall Study||63
1410718|NCT02985840|3453316|P1|STARTED|Overall Study||64
1410719|NCT02985827|3453326|P2|NOT COMPLETED|Overall Study||0
1410720|NCT02985827|3453327|P1|NOT COMPLETED|Overall Study||0
1410721|NCT02985827|3453326|P2|COMPLETED|Overall Study||15
1410722|NCT02985827|3453327|P1|COMPLETED|Overall Study||33
1410723|NCT02985827|3453326|P2|STARTED|Overall Study||15
1410724|NCT02985827|3453327|P1|STARTED|Overall Study||33
1410725|NCT02984878|3453337|P2|NOT COMPLETED|Overall Study||0
1410726|NCT02984878|3453338|P1|NOT COMPLETED|Overall Study||0
1410727|NCT02984878|3453337|P2|COMPLETED|Overall Study||41
1410728|NCT02984878|3453338|P1|COMPLETED|Overall Study||30
1410729|NCT02984878|3453337|P2|STARTED|Overall Study||41
1410730|NCT02984878|3453338|P1|STARTED|Overall Study||30
1410731|NCT02984267|3453350|P2|NOT COMPLETED|Overall Study||1
1410732|NCT02984267|3453351|P1|NOT COMPLETED|Overall Study||1
1410733|NCT02984267|3453350|P2|COMPLETED|Overall Study||9
1410734|NCT02984267|3453351|P1|COMPLETED|Overall Study||7
1410735|NCT02984267|3453350|P2|STARTED|Overall Study||10
1410736|NCT02984267|3453351|P1|STARTED|Overall Study||8
1410737|NCT02983981|3453375|P1|NOT COMPLETED|Overall Study||0
1410738|NCT02983981|3453375|P1|COMPLETED|Overall Study||20
1410739|NCT02983981|3453375|P1|STARTED|Overall Study||20
1410740|NCT02982863|3453387|P5|NOT COMPLETED|Overall Study||492
1410741|NCT02982863|3453388|P4|NOT COMPLETED|Overall Study||1400
1410742|NCT02982863|3453389|P3|NOT COMPLETED|Overall Study||1852
1410743|NCT02982863|3453390|P2|NOT COMPLETED|Overall Study||4261
1410744|NCT02982863|3453391|P1|NOT COMPLETED|Overall Study||809
1410745|NCT02982863|3453387|P5|COMPLETED|Overall Study||2268
1410746|NCT02982863|3453388|P4|COMPLETED|Overall Study||8758
1410747|NCT02982863|3453389|P3|COMPLETED|Overall Study||11386
1410748|NCT02982863|3453390|P2|COMPLETED|Overall Study||12484
1410749|NCT02982863|3453391|P1|COMPLETED|Overall Study||4936
1410750|NCT02982863|3453387|P5|STARTED|Overall Study||2760
1410751|NCT02982863|3453388|P4|STARTED|Overall Study||10158
1410752|NCT02982863|3453389|P3|STARTED|Overall Study||13238
1410753|NCT02982863|3453390|P2|STARTED|Overall Study||16745
1410754|NCT02982863|3453391|P1|STARTED|Overall Study||5745
1410755|NCT02982018|3453450|P2|NOT COMPLETED|Overall Study||3
1410756|NCT02982018|3453451|P1|NOT COMPLETED|Overall Study||5
1410757|NCT02982018|3453450|P2|COMPLETED|Overall Study||61
1410758|NCT02982018|3453451|P1|COMPLETED|Overall Study||62
1410759|NCT02982018|3453450|P2|STARTED|Overall Study||64
1410760|NCT02982018|3453451|P1|STARTED|Overall Study||67
1410761|NCT02979639|3453465|P1|NOT COMPLETED|Overall Study||0
1410762|NCT02979639|3453465|P1|COMPLETED|Overall Study||401
1410763|NCT02979639|3453465|P1|STARTED|Overall Study||401
1410764|NCT02978833|3453483|P2|NOT COMPLETED|Overall Study||1
1410765|NCT02978833|3453484|P1|NOT COMPLETED|Overall Study||1
1410766|NCT02978833|3453483|P2|COMPLETED|Overall Study||0
1410767|NCT02978833|3453484|P1|COMPLETED|Overall Study||0
1410768|NCT02978833|3453483|P2|STARTED|Overall Study||1
1410769|NCT02978833|3453484|P1|STARTED|Overall Study||1
1410770|NCT02977572|3453502|P2|NOT COMPLETED|Overall Study||2
1410771|NCT02977572|3453503|P1|NOT COMPLETED|Overall Study||2
1410772|NCT02977572|3453502|P2|COMPLETED|Overall Study||54
1410773|NCT02977572|3453503|P1|COMPLETED|Overall Study||56
1410774|NCT02977572|3453502|P2|STARTED|Overall Study||56
1410775|NCT02977572|3453503|P1|STARTED|Overall Study||58
1410776|NCT02977507|3453525|P2|NOT COMPLETED|Overall Study||0
1410777|NCT02977507|3453526|P1|NOT COMPLETED|Overall Study||2
1410778|NCT02977507|3453525|P2|COMPLETED|Overall Study||10
1410779|NCT02977507|3453526|P1|COMPLETED|Overall Study||6
1410780|NCT02977507|3453525|P2|STARTED|Overall Study||10
1410781|NCT02977507|3453526|P1|STARTED|Overall Study||8
1410782|NCT02974543|3453551|P2|NOT COMPLETED|Overall Study||0
1410783|NCT02974543|3453552|P1|NOT COMPLETED|Overall Study||1
1410784|NCT02974543|3453551|P2|COMPLETED|Overall Study||10
1410785|NCT02974543|3453552|P1|COMPLETED|Overall Study||10
1410786|NCT02974543|3453551|P2|Began Crossover Assignment|Overall Study||10
1410787|NCT02974543|3453552|P1|Began Crossover Assignment|Overall Study||10
1410788|NCT02974543|3453551|P2|Began Washout Period|Overall Study||10
1410789|NCT02974543|3453552|P1|Began Washout Period|Overall Study||10
1410790|NCT02974543|3453551|P2|STARTED|Overall Study||10
1410791|NCT02974543|3453552|P1|STARTED|Overall Study||11
1410792|NCT02974140|3453572|P1|NOT COMPLETED|Overall Study||39
1410793|NCT02974140|3453572|P1|COMPLETED|Overall Study||0
1410794|NCT02974140|3453572|P1|Manual (Fellow Eye)|Overall Study||38
1410795|NCT02974140|3453572|P1|CRS (Left or Right Eye)|Overall Study||38
1410796|NCT02974140|3453572|P1|STARTED|Overall Study||39
1410797|NCT02974114|3453588|P3|NOT COMPLETED|Overall Study||2
1410798|NCT02974114|3453589|P2|NOT COMPLETED|Overall Study||1
1410799|NCT02974114|3453590|P1|NOT COMPLETED|Overall Study||0
1410800|NCT02974114|3453588|P3|COMPLETED|Overall Study||6
1410801|NCT02974114|3453589|P2|COMPLETED|Overall Study||6
1410802|NCT02974114|3453590|P1|COMPLETED|Overall Study||6
1410803|NCT02974114|3453588|P3|STARTED|Overall Study||8
1410804|NCT02974114|3453589|P2|STARTED|Overall Study||7
1410805|NCT02974114|3453590|P1|STARTED|Overall Study||6
1410806|NCT02973100|3453635|P4|NOT COMPLETED|Overall Study||7
1410807|NCT02973100|3453636|P3|NOT COMPLETED|Overall Study||4
1410808|NCT02973100|3453637|P2|NOT COMPLETED|Overall Study||8
1410809|NCT02973100|3453638|P1|NOT COMPLETED|Overall Study||7
1410810|NCT02973100|3453635|P4|COMPLETED|Overall Study||69
1410811|NCT02973100|3453636|P3|COMPLETED|Overall Study||75
1410812|NCT02973100|3453637|P2|COMPLETED|Overall Study||73
1410813|NCT02973100|3453638|P1|COMPLETED|Overall Study||75
1410814|NCT02973100|3453635|P4|Received at Least 1 Dose of Study Drug|Overall Study||76
1410815|NCT02973100|3453636|P3|Received at Least 1 Dose of Study Drug|Overall Study||79
1410816|NCT02973100|3453637|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
1410817|NCT02973100|3453638|P1|Received at Least 1 Dose of Study Drug|Overall Study||81
1410818|NCT02973100|3453635|P4|STARTED|Overall Study||76
1410819|NCT02973100|3453636|P3|STARTED|Overall Study||79
1410820|NCT02973100|3453637|P2|STARTED|Overall Study||81
1410821|NCT02973100|3453638|P1|STARTED|Overall Study||82
1410822|NCT02972554|3453676|P2|NOT COMPLETED|Overall Study||0
1410823|NCT02972554|3453677|P1|NOT COMPLETED|Overall Study||0
1410824|NCT02972554|3453676|P2|COMPLETED|Overall Study||48
1410825|NCT02972554|3453677|P1|COMPLETED|Overall Study||44
1410826|NCT02972554|3453676|P2|STARTED|Overall Study||48
1410827|NCT02972554|3453677|P1|STARTED|Overall Study||44
1410828|NCT02972515|3453693|P1|NOT COMPLETED|Overall Study||78
1410829|NCT02972515|3453693|P1|COMPLETED|Overall Study||88
1410830|NCT02972515|3453693|P1|STARTED|Overall Study||166
1410831|NCT02972502|3453702|P2|NOT COMPLETED|Overall Study||2
1410832|NCT02972502|3453703|P1|NOT COMPLETED|Overall Study||4
1410833|NCT02972502|3453702|P2|COMPLETED|Overall Study||29
1410834|NCT02972502|3453703|P1|COMPLETED|Overall Study||31
1410835|NCT02972502|3453702|P2|STARTED|Overall Study||31
1410836|NCT02972502|3453703|P1|STARTED|Overall Study||35
1410837|NCT02971670|3453717|P4|NOT COMPLETED|Overall Study||2
1410838|NCT02971670|3453718|P3|NOT COMPLETED|Overall Study||1
1410839|NCT02971670|3453719|P2|NOT COMPLETED|Overall Study||1
1410840|NCT02971670|3453720|P1|NOT COMPLETED|Overall Study||4
1410841|NCT02971670|3453717|P4|COMPLETED|Overall Study||1
1410842|NCT02971670|3453718|P3|COMPLETED|Overall Study||4
1410843|NCT02971670|3453719|P2|COMPLETED|Overall Study||1
1410844|NCT02971670|3453720|P1|COMPLETED|Overall Study||9
1410845|NCT02971670|3453717|P4|STARTED|Overall Study||3
1410846|NCT02971670|3453718|P3|STARTED|Overall Study||5
1410847|NCT02971670|3453719|P2|STARTED|Overall Study||2
1410848|NCT02971670|3453720|P1|STARTED|Overall Study||13
1410849|NCT02971007|3453741|P3|NOT COMPLETED|Overall Study||1
1410850|NCT02971007|3453742|P2|NOT COMPLETED|Overall Study||3
1410851|NCT02971007|3453743|P1|NOT COMPLETED|Overall Study||2
1410852|NCT02971007|3453741|P3|COMPLETED|Overall Study||45
1410853|NCT02971007|3453742|P2|COMPLETED|Overall Study||42
1410854|NCT02971007|3453743|P1|COMPLETED|Overall Study||44
1410855|NCT02971007|3453741|P3|STARTED|Overall Study||46
1410856|NCT02971007|3453742|P2|STARTED|Overall Study||45
1410857|NCT02971007|3453743|P1|STARTED|Overall Study||46
1410858|NCT02970812|3453762|P2|NOT COMPLETED|Overall Study||2
1410859|NCT02970812|3453763|P1|NOT COMPLETED|Overall Study||8
1410860|NCT02970812|3453762|P2|COMPLETED|Overall Study||28
1410861|NCT02970812|3453763|P1|COMPLETED|Overall Study||22
1410862|NCT02970812|3453762|P2|STARTED|Overall Study||30
1410863|NCT02970812|3453763|P1|STARTED|Overall Study||30
1410864|NCT02970162|3453771|P2|NOT COMPLETED|Overall Study||0
1410865|NCT02970162|3453772|P1|NOT COMPLETED|Overall Study||0
1410866|NCT02970162|3453771|P2|COMPLETED|Overall Study||13
1410867|NCT02970162|3453772|P1|COMPLETED|Overall Study||13
1410868|NCT02970162|3453771|P2|STARTED|Overall Study||13
1410869|NCT02970162|3453772|P1|STARTED|Overall Study||13
1410870|NCT02969863|3453784|P6|NOT COMPLETED|Overall Study||0
1410871|NCT02969863|3453785|P5|NOT COMPLETED|Overall Study||0
1410872|NCT02969863|3453786|P4|NOT COMPLETED|Overall Study||0
1410873|NCT02969863|3453787|P3|NOT COMPLETED|Overall Study||0
1410874|NCT02969863|3453788|P2|NOT COMPLETED|Overall Study||0
1410875|NCT02969863|3453789|P1|NOT COMPLETED|Overall Study||1
1410876|NCT02969863|3453784|P6|COMPLETED|Overall Study||4
1410877|NCT02969863|3453785|P5|COMPLETED|Overall Study||4
1410878|NCT02969863|3453786|P4|COMPLETED|Overall Study||4
1410879|NCT02969863|3453787|P3|COMPLETED|Overall Study||4
1410880|NCT02969863|3453788|P2|COMPLETED|Overall Study||4
1410881|NCT02969863|3453789|P1|COMPLETED|Overall Study||3
1410882|NCT02969863|3453784|P6|STARTED|Overall Study||4
1410883|NCT02969863|3453785|P5|STARTED|Overall Study||4
1410884|NCT02969863|3453786|P4|STARTED|Overall Study||4
1410885|NCT02969863|3453787|P3|STARTED|Overall Study||4
1410886|NCT02969863|3453788|P2|STARTED|Overall Study||4
1410887|NCT02969863|3453789|P1|STARTED|Overall Study||4
1410888|NCT02969044|3453805|P2|NOT COMPLETED|Overall Study||6
1410889|NCT02969044|3453806|P1|NOT COMPLETED|Overall Study||5
1410890|NCT02969044|3453805|P2|COMPLETED|Overall Study||22
1410891|NCT02969044|3453806|P1|COMPLETED|Overall Study||37
1410892|NCT02969044|3453805|P2|STARTED|Overall Study||28
1410893|NCT02969044|3453806|P1|STARTED|Overall Study||42
1410894|NCT02968173|3453846|P1|NOT COMPLETED|Overall Study||1
1410895|NCT02968173|3453846|P1|COMPLETED|Overall Study||49
1410896|NCT02968173|3453846|P1|STARTED|Overall Study||50
1410897|NCT02968134|3453858|P1|NOT COMPLETED|Overall Study||0
1410898|NCT02968134|3453858|P1|COMPLETED|Overall Study||8
1410899|NCT02968134|3453858|P1|STARTED|Overall Study||8
1410900|NCT02967393|3453865|P2|NOT COMPLETED|Overall Study||0
1410901|NCT02967393|3453866|P1|NOT COMPLETED|Overall Study||0
1410902|NCT02967393|3453865|P2|COMPLETED|Overall Study||20
1410903|NCT02967393|3453866|P1|COMPLETED|Overall Study||20
1410904|NCT02967393|3453865|P2|STARTED|Overall Study||20
1410905|NCT02967393|3453866|P1|STARTED|Overall Study||20
1410906|NCT02967354|3453896|P5|NOT COMPLETED|Overall Study||0
1410907|NCT02967354|3453897|P4|NOT COMPLETED|Overall Study||0
1410908|NCT02967354|3453898|P3|NOT COMPLETED|Overall Study||0
1410909|NCT02967354|3453899|P2|NOT COMPLETED|Overall Study||0
1410910|NCT02967354|3453900|P1|NOT COMPLETED|Overall Study||0
1410911|NCT02967354|3453896|P5|COMPLETED|Overall Study||8
1410912|NCT02967354|3453897|P4|COMPLETED|Overall Study||7
1410913|NCT02967354|3453898|P3|COMPLETED|Overall Study||9
1410914|NCT02967354|3453899|P2|COMPLETED|Overall Study||7
1410915|NCT02967354|3453900|P1|COMPLETED|Overall Study||8
1410916|NCT02967354|3453896|P5|STARTED|Overall Study||8
1410917|NCT02967354|3453897|P4|STARTED|Overall Study||7
1410918|NCT02967354|3453898|P3|STARTED|Overall Study||9
1410919|NCT02967354|3453899|P2|STARTED|Overall Study||7
1410920|NCT02967354|3453900|P1|STARTED|Overall Study||8
1410921|NCT02966509|3453934|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
1410922|NCT02966509|3453935|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
1410923|NCT02966509|3453934|P2|COMPLETED|End of Life Utilization and Cost 15month||60
1410924|NCT02966509|3453935|P1|COMPLETED|End of Life Utilization and Cost 15month||60
1410925|NCT02966509|3453934|P2|STARTED|End of Life Utilization and Cost 15month||108
1410926|NCT02966509|3453935|P1|STARTED|End of Life Utilization and Cost 15month||105
1410927|NCT02966509|3453934|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
1410928|NCT02966509|3453935|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
1410929|NCT02966509|3453934|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
1410930|NCT02966509|3453935|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
1410931|NCT02966509|3453934|P2|STARTED|End of Life Utilization and Cost 6 Month||108
1410932|NCT02966509|3453935|P1|STARTED|End of Life Utilization and Cost 6 Month||105
1410933|NCT02966509|3453934|P2|NOT COMPLETED|15-Month Utilization and Cost||0
1410934|NCT02966509|3453935|P1|NOT COMPLETED|15-Month Utilization and Cost||0
1410935|NCT02966509|3453934|P2|COMPLETED|15-Month Utilization and Cost||108
1410936|NCT02966509|3453935|P1|COMPLETED|15-Month Utilization and Cost||105
1410937|NCT02966509|3453934|P2|STARTED|15-Month Utilization and Cost||108
1410938|NCT02966509|3453935|P1|STARTED|15-Month Utilization and Cost||105
1410939|NCT02966509|3453934|P2|NOT COMPLETED|6-Month Utilization and Cost||0
1410940|NCT02966509|3453935|P1|NOT COMPLETED|6-Month Utilization and Cost||0
1410941|NCT02966509|3453934|P2|COMPLETED|6-Month Utilization and Cost||108
1410942|NCT02966509|3453935|P1|COMPLETED|6-Month Utilization and Cost||105
1410943|NCT02966509|3453934|P2|STARTED|6-Month Utilization and Cost||108
1410944|NCT02966509|3453935|P1|STARTED|6-Month Utilization and Cost||105
1410945|NCT02966509|3453934|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
1410946|NCT02966509|3453935|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
1410947|NCT02966509|3453934|P2|COMPLETED|6 Month Satisfaction Survey||60
1410948|NCT02966509|3453935|P1|COMPLETED|6 Month Satisfaction Survey||58
1410949|NCT02966509|3453934|P2|STARTED|6 Month Satisfaction Survey||108
1410950|NCT02966509|3453935|P1|STARTED|6 Month Satisfaction Survey||105
1410951|NCT02966509|3453934|P2|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
1410952|NCT02966509|3453935|P1|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
1410953|NCT02966509|3453934|P2|COMPLETED|6 Month Satisfaction Decision Survey||77
1410954|NCT02966509|3453935|P1|COMPLETED|6 Month Satisfaction Decision Survey||80
1410955|NCT02966509|3453934|P2|STARTED|6 Month Satisfaction Decision Survey||108
1410956|NCT02966509|3453935|P1|STARTED|6 Month Satisfaction Decision Survey||105
1410957|NCT02966509|3453934|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
1410958|NCT02966509|3453935|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
1410959|NCT02966509|3453934|P2|COMPLETED|Baseline Satisfaction Survey||101
1410960|NCT02966509|3453935|P1|COMPLETED|Baseline Satisfaction Survey||101
1410961|NCT02966509|3453934|P2|STARTED|Baseline Satisfaction Survey||108
1410962|NCT02966509|3453935|P1|STARTED|Baseline Satisfaction Survey||105
1410963|NCT02966275|3453959|P1|NOT COMPLETED|Overall Study||0
1410964|NCT02966275|3453959|P1|COMPLETED|Overall Study||10
1410965|NCT02966275|3453959|P1|STARTED|Overall Study||10
1410966|NCT02966015|3453996|P2|NOT COMPLETED|Test Period||0
1410967|NCT02966015|3453997|P1|NOT COMPLETED|Test Period||0
1410968|NCT02966015|3453996|P2|COMPLETED|Test Period||55
1410969|NCT02966015|3453997|P1|COMPLETED|Test Period||87
1410970|NCT02966015|3453996|P2|STARTED|Test Period||55
1410971|NCT02966015|3453997|P1|STARTED|Test Period||87
1410972|NCT02966015|3453996|P2|NOT COMPLETED|Inclusion Visit||3
1410973|NCT02966015|3453997|P1|NOT COMPLETED|Inclusion Visit||8
1410974|NCT02966015|3453996|P2|COMPLETED|Inclusion Visit||55
1410975|NCT02966015|3453997|P1|COMPLETED|Inclusion Visit||87
1410976|NCT02966015|3453996|P2|STARTED|Inclusion Visit||58
1410977|NCT02966015|3453997|P1|STARTED|Inclusion Visit||95
1410978|NCT02966002|3454003|P1|NOT COMPLETED|Overall Study||4
1410979|NCT02966002|3454003|P1|COMPLETED|Overall Study||5
1410980|NCT02966002|3454003|P1|STARTED|Overall Study||9
1410981|NCT02965846|3454013|P3|NOT COMPLETED|Overall Study||33
1410982|NCT02965846|3454014|P2|NOT COMPLETED|Overall Study||5
1410983|NCT02965846|3454015|P1|NOT COMPLETED|Overall Study||5
1410984|NCT02965846|3454013|P3|COMPLETED|Overall Study||0
1410985|NCT02965846|3454014|P2|COMPLETED|Overall Study||0
1410986|NCT02965846|3454015|P1|COMPLETED|Overall Study||0
1410987|NCT02965846|3454013|P3|STARTED|Overall Study||33
1410988|NCT02965846|3454014|P2|STARTED|Overall Study||5
1410989|NCT02965846|3454015|P1|STARTED|Overall Study||5
1410990|NCT02965833|3454023|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
1410991|NCT02965833|3454024|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
1410992|NCT02965833|3454023|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
1410993|NCT02965833|3454024|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
1410994|NCT02965833|3454023|P2|STARTED|Period 2, Second 30 Days of Wear||52
1410995|NCT02965833|3454024|P1|STARTED|Period 2, Second 30 Days of Wear||64
1410996|NCT02965833|3454023|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
1410997|NCT02965833|3454024|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
1410998|NCT02965833|3454023|P2|COMPLETED|Period 1, First 30 Days of Wear||52
1410999|NCT02965833|3454024|P1|COMPLETED|Period 1, First 30 Days of Wear||64
1411000|NCT02965833|3454023|P2|STARTED|Period 1, First 30 Days of Wear||54
1411001|NCT02965833|3454024|P1|STARTED|Period 1, First 30 Days of Wear||67
1411002|NCT02965820|3454030|P2|NOT COMPLETED|Period 2, Second 30 Days||1
1411003|NCT02965820|3454031|P1|NOT COMPLETED|Period 2, Second 30 Days||1
1411004|NCT02965820|3454030|P2|COMPLETED|Period 2, Second 30 Days||61
1411005|NCT02965820|3454031|P1|COMPLETED|Period 2, Second 30 Days||57
1411006|NCT02965820|3454030|P2|STARTED|Period 2, Second 30 Days||62
1411007|NCT02965820|3454031|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
1411008|NCT02965820|3454030|P2|NOT COMPLETED|Period 1, First 30 Days||0
1411009|NCT02965820|3454031|P1|NOT COMPLETED|Period 1, First 30 Days||0
1411010|NCT02965820|3454030|P2|COMPLETED|Period 1, First 30 Days||62
1411011|NCT02965820|3454031|P1|COMPLETED|Period 1, First 30 Days||59
1411012|NCT02965820|3454030|P2|STARTED|Period 1, First 30 Days||62
1411013|NCT02965820|3454031|P1|STARTED|Period 1, First 30 Days||59
1411014|NCT02964767|3454039|P2|NOT COMPLETED|Overall Study||0
1411015|NCT02964767|3454040|P1|NOT COMPLETED|Overall Study||0
1411016|NCT02964767|3454039|P2|COMPLETED|Overall Study||48
1411017|NCT02964767|3454040|P1|COMPLETED|Overall Study||171
1411018|NCT02964767|3454039|P2|STARTED|Overall Study||48
1411019|NCT02964767|3454040|P1|STARTED|Overall Study||171
1411020|NCT02963701|3454049|P2|NOT COMPLETED|Period 2 (2 Days)||0
1411021|NCT02963701|3454050|P1|NOT COMPLETED|Period 2 (2 Days)||0
1411022|NCT02963701|3454049|P2|COMPLETED|Period 2 (2 Days)||28
1411023|NCT02963701|3454050|P1|COMPLETED|Period 2 (2 Days)||27
1411024|NCT02963701|3454049|P2|STARTED|Period 2 (2 Days)||28
1411025|NCT02963701|3454050|P1|STARTED|Period 2 (2 Days)||27
1411026|NCT02963701|3454049|P2|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
1411027|NCT02963701|3454050|P1|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
1411028|NCT02963701|3454049|P2|COMPLETED|Period 1 (Including Washout) (2 Days)||28
1411029|NCT02963701|3454050|P1|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
1411030|NCT02963701|3454049|P2|STARTED|Period 1 (Including Washout) (2 Days)||28
1411031|NCT02963701|3454050|P1|STARTED|Period 1 (Including Washout) (2 Days)||28
1411032|NCT02962882|3454080|P1|NOT COMPLETED|Overall Study||36
1411033|NCT02962882|3454080|P1|COMPLETED|Overall Study||14
1411034|NCT02962882|3454080|P1|STARTED|Overall Study||50
1411035|NCT02961244|3454091|P2|NOT COMPLETED|Overall Study||9
1411036|NCT02961244|3454092|P1|NOT COMPLETED|Overall Study||1
1411037|NCT02961244|3454091|P2|COMPLETED|Overall Study||55
1411038|NCT02961244|3454092|P1|COMPLETED|Overall Study||63
1411039|NCT02961244|3454091|P2|Patients Excluded During Randomization|Overall Study||1
1411040|NCT02961244|3454092|P1|Patients Excluded During Randomization|Overall Study||0
1411041|NCT02961244|3454091|P2|STARTED|Overall Study||64
1411042|NCT02961244|3454092|P1|STARTED|Overall Study||64
1411043|NCT02959996|3454102|P2|NOT COMPLETED|Overall Study||0
1411044|NCT02959996|3454103|P1|NOT COMPLETED|Overall Study||0
1411045|NCT02959996|3454102|P2|COMPLETED|Overall Study||39
1411046|NCT02959996|3454103|P1|COMPLETED|Overall Study||40
1411047|NCT02959996|3454102|P2|STARTED|Overall Study||39
1411048|NCT02959996|3454103|P1|STARTED|Overall Study||40
1411049|NCT02959840|3454128|P3|NOT COMPLETED|Overall Study||0
1411050|NCT02959840|3454129|P2|NOT COMPLETED|Overall Study||0
1411051|NCT02959840|3454130|P1|NOT COMPLETED|Overall Study||0
1411052|NCT02959840|3454128|P3|COMPLETED|Overall Study||60
1411053|NCT02959840|3454129|P2|COMPLETED|Overall Study||60
1411054|NCT02959840|3454130|P1|COMPLETED|Overall Study||60
1411055|NCT02959840|3454128|P3|STARTED|Overall Study||60
1411056|NCT02959840|3454129|P2|STARTED|Overall Study||60
1411057|NCT02959840|3454130|P1|STARTED|Overall Study||60
1411058|NCT02958995|3454173|P2|NOT COMPLETED|Overall Study||0
1411059|NCT02958995|3454174|P1|NOT COMPLETED|Overall Study||0
1411060|NCT02958995|3454173|P2|COMPLETED|Overall Study||107495
1411061|NCT02958995|3454174|P1|COMPLETED|Overall Study||2630666
1411062|NCT02958995|3454173|P2|STARTED|Overall Study||107495
1411063|NCT02958995|3454174|P1|STARTED|Overall Study||2630666
1411064|NCT02958956|3454184|P2|NOT COMPLETED|Overall Study||0
1411065|NCT02958956|3454185|P1|NOT COMPLETED|Overall Study||0
1411066|NCT02958956|3454184|P2|COMPLETED|Overall Study||198317
1411067|NCT02958956|3454185|P1|COMPLETED|Overall Study||38190
1411068|NCT02958956|3454184|P2|STARTED|Overall Study||198317
1411069|NCT02958956|3454185|P1|STARTED|Overall Study||38190
1411070|NCT02958787|3454198|P1|NOT COMPLETED|Overall Study||0
1411071|NCT02958787|3454198|P1|COMPLETED|Overall Study||135
1411072|NCT02958787|3454198|P1|STARTED|Overall Study||135
1411073|NCT02958345|3454204|P2|NOT COMPLETED|Overall Study||1
1411074|NCT02958345|3454205|P1|NOT COMPLETED|Overall Study||1
1411075|NCT02958345|3454204|P2|COMPLETED|Overall Study||13
1411076|NCT02958345|3454205|P1|COMPLETED|Overall Study||13
1411077|NCT02958345|3454204|P2|STARTED|Overall Study||14
1411078|NCT02958345|3454205|P1|STARTED|Overall Study||14
1411079|NCT02956837|3454217|P4|NOT COMPLETED|Overall Study||3
1411080|NCT02956837|3454218|P3|NOT COMPLETED|Overall Study||2
1411081|NCT02956837|3454219|P2|NOT COMPLETED|Overall Study||3
1411082|NCT02956837|3454220|P1|NOT COMPLETED|Overall Study||0
1411083|NCT02956837|3454217|P4|COMPLETED|Overall Study||99
1411084|NCT02956837|3454218|P3|COMPLETED|Overall Study||97
1411085|NCT02956837|3454219|P2|COMPLETED|Overall Study||96
1411086|NCT02956837|3454220|P1|COMPLETED|Overall Study||100
1411087|NCT02956837|3454217|P4|STARTED|Overall Study||102
1411088|NCT02956837|3454218|P3|STARTED|Overall Study||99
1411089|NCT02956837|3454219|P2|STARTED|Overall Study||99
1411090|NCT02956837|3454220|P1|STARTED|Overall Study||100
1411091|NCT02956629|3454316|P6|NOT COMPLETED|Overall Study||1
1411092|NCT02956629|3454317|P5|NOT COMPLETED|Overall Study||0
1411093|NCT02956629|3454318|P4|NOT COMPLETED|Overall Study||1
1411094|NCT02956629|3454319|P3|NOT COMPLETED|Overall Study||4
1411095|NCT02956629|3454320|P2|NOT COMPLETED|Overall Study||6
1411096|NCT02956629|3454321|P1|NOT COMPLETED|Overall Study||5
1411097|NCT02956629|3454316|P6|COMPLETED|Overall Study||21
1411098|NCT02956629|3454317|P5|COMPLETED|Overall Study||18
1411099|NCT02956629|3454318|P4|COMPLETED|Overall Study||55
1411100|NCT02956629|3454319|P3|COMPLETED|Overall Study||57
1411101|NCT02956629|3454320|P2|COMPLETED|Overall Study||41
1411102|NCT02956629|3454321|P1|COMPLETED|Overall Study||73
1411103|NCT02956629|3454316|P6|STARTED|Overall Study||22
1411104|NCT02956629|3454317|P5|STARTED|Overall Study||18
1411105|NCT02956629|3454318|P4|STARTED|Overall Study||56
1411106|NCT02956629|3454319|P3|STARTED|Overall Study||61
1411107|NCT02956629|3454320|P2|STARTED|Overall Study||47
1411108|NCT02956629|3454321|P1|STARTED|Overall Study||78
1411109|NCT02956460|3454385|P2|NOT COMPLETED|Lens 2||0
1411110|NCT02956460|3454386|P1|NOT COMPLETED|Lens 2||0
1411111|NCT02956460|3454385|P2|COMPLETED|Lens 2||34
1411112|NCT02956460|3454386|P1|COMPLETED|Lens 2||29
1411113|NCT02956460|3454385|P2|STARTED|Lens 2||34
1411114|NCT02956460|3454386|P1|STARTED|Lens 2||29
1411115|NCT02956460|3454385|P2|NOT COMPLETED|Lens 1||0
1411116|NCT02956460|3454386|P1|NOT COMPLETED|Lens 1||1
1411117|NCT02956460|3454385|P2|COMPLETED|Lens 1||34
1411118|NCT02956460|3454386|P1|COMPLETED|Lens 1||29
1411119|NCT02956460|3454385|P2|STARTED|Lens 1||34
1411120|NCT02956460|3454386|P1|STARTED|Lens 1||30
1411121|NCT02954601|3454416|P4|NOT COMPLETED|Third Intervention (Five Days)||0
1411122|NCT02954601|3454417|P3|NOT COMPLETED|Third Intervention (Five Days)||0
1411123|NCT02954601|3454418|P2|NOT COMPLETED|Third Intervention (Five Days)||0
1411124|NCT02954601|3454419|P1|NOT COMPLETED|Third Intervention (Five Days)||0
1411125|NCT02954601|3454416|P4|COMPLETED|Third Intervention (Five Days)||8
1411126|NCT02954601|3454417|P3|COMPLETED|Third Intervention (Five Days)||6
1411127|NCT02954601|3454418|P2|COMPLETED|Third Intervention (Five Days)||8
1411128|NCT02954601|3454419|P1|COMPLETED|Third Intervention (Five Days)||9
1411129|NCT02954601|3454416|P4|STARTED|Third Intervention (Five Days)||8
1411130|NCT02954601|3454417|P3|STARTED|Third Intervention (Five Days)||6
1411131|NCT02954601|3454418|P2|STARTED|Third Intervention (Five Days)||8
1411132|NCT02954601|3454419|P1|STARTED|Third Intervention (Five Days)||9
1411133|NCT02954601|3454416|P4|NOT COMPLETED|Second Intervention (Five Days)||0
1411134|NCT02954601|3454417|P3|NOT COMPLETED|Second Intervention (Five Days)||0
1411135|NCT02954601|3454418|P2|NOT COMPLETED|Second Intervention (Five Days)||0
1411136|NCT02954601|3454419|P1|NOT COMPLETED|Second Intervention (Five Days)||0
1411137|NCT02954601|3454416|P4|COMPLETED|Second Intervention (Five Days)||6
1411138|NCT02954601|3454417|P3|COMPLETED|Second Intervention (Five Days)||8
1411139|NCT02954601|3454418|P2|COMPLETED|Second Intervention (Five Days)||6
1411140|NCT02954601|3454419|P1|COMPLETED|Second Intervention (Five Days)||11
1411141|NCT02954601|3454416|P4|STARTED|Second Intervention (Five Days)||6
1411142|NCT02954601|3454417|P3|STARTED|Second Intervention (Five Days)||8
1411143|NCT02954601|3454418|P2|STARTED|Second Intervention (Five Days)||6
1411144|NCT02954601|3454419|P1|STARTED|Second Intervention (Five Days)||11
1411145|NCT02954601|3454416|P4|NOT COMPLETED|First Intervention (Five Days)||0
1411146|NCT02954601|3454417|P3|NOT COMPLETED|First Intervention (Five Days)||1
1411147|NCT02954601|3454418|P2|NOT COMPLETED|First Intervention (Five Days)||0
1411148|NCT02954601|3454419|P1|NOT COMPLETED|First Intervention (Five Days)||0
1411149|NCT02954601|3454416|P4|COMPLETED|First Intervention (Five Days)||7
1411150|NCT02954601|3454417|P3|COMPLETED|First Intervention (Five Days)||7
1411151|NCT02954601|3454418|P2|COMPLETED|First Intervention (Five Days)||6
1411152|NCT02954601|3454419|P1|COMPLETED|First Intervention (Five Days)||11
1411153|NCT02954601|3454416|P4|STARTED|First Intervention (Five Days)||7
1411154|NCT02954601|3454417|P3|STARTED|First Intervention (Five Days)||8
1411155|NCT02954601|3454418|P2|STARTED|First Intervention (Five Days)||6
1411156|NCT02954601|3454419|P1|STARTED|First Intervention (Five Days)||11
1411157|NCT02954354|3454444|P3|NOT COMPLETED|Overall Study||16
1411158|NCT02954354|3454445|P2|NOT COMPLETED|Overall Study||20
1411159|NCT02954354|3454446|P1|NOT COMPLETED|Overall Study||34
1411160|NCT02954354|3454444|P3|COMPLETED|Overall Study||498
1411161|NCT02954354|3454445|P2|COMPLETED|Overall Study||290
1411162|NCT02954354|3454446|P1|COMPLETED|Overall Study||578
1411163|NCT02954354|3454444|P3|Intention to Treat Infected Population|Overall Study||377
1411164|NCT02954354|3454445|P2|Intention to Treat Infected Population|Overall Study||231
1411165|NCT02954354|3454446|P1|Intention to Treat Infected Population|Overall Study||456
1411166|NCT02954354|3454444|P3|Received Study Drug|Overall Study||513
1411167|NCT02954354|3454445|P2|Received Study Drug|Overall Study||309
1411168|NCT02954354|3454446|P1|Received Study Drug|Overall Study||610
1411169|NCT02954354|3454444|P3|STARTED|Overall Study||514
1411170|NCT02954354|3454445|P2|STARTED|Overall Study||310
1411171|NCT02954354|3454446|P1|STARTED|Overall Study||612
1411172|NCT02953886|3454530|P1|NOT COMPLETED|Overall Study||0
1411173|NCT02953886|3454530|P1|COMPLETED|Overall Study||20
1411174|NCT02953886|3454530|P1|STARTED|Overall Study||20
1411175|NCT02952261|3454538|P2|NOT COMPLETED|Overall Study||5
1411176|NCT02952261|3454539|P1|NOT COMPLETED|Overall Study||5
1411177|NCT02952261|3454538|P2|COMPLETED|Overall Study||95
1411178|NCT02952261|3454539|P1|COMPLETED|Overall Study||95
1411179|NCT02952261|3454538|P2|STARTED|Overall Study||100
1411180|NCT02952261|3454539|P1|STARTED|Overall Study||100
1411181|NCT02951884|3454554|P3|NOT COMPLETED|Overall Study||0
1411182|NCT02951884|3454555|P2|NOT COMPLETED|Overall Study||0
1411183|NCT02951884|3454556|P1|NOT COMPLETED|Overall Study||0
1411184|NCT02951884|3454554|P3|COMPLETED|Overall Study||1
1411185|NCT02951884|3454555|P2|COMPLETED|Overall Study||1
1411186|NCT02951884|3454556|P1|COMPLETED|Overall Study||0
1411187|NCT02951884|3454554|P3|STARTED|Overall Study||1
1411188|NCT02951884|3454555|P2|STARTED|Overall Study||1
1411189|NCT02951884|3454556|P1|STARTED|Overall Study||0
1411190|NCT02951767|3454567|P1|NOT COMPLETED|Overall Study||119
1411191|NCT02951767|3454567|P1|COMPLETED|Overall Study||0
1411192|NCT02951767|3454567|P1|STARTED|Overall Study||119
1411193|NCT02951702|3454586|P2|NOT COMPLETED|Overall Study||0
1411194|NCT02951702|3454587|P1|NOT COMPLETED|Overall Study||0
1411195|NCT02951702|3454586|P2|COMPLETED|Overall Study||17
1411196|NCT02951702|3454587|P1|COMPLETED|Overall Study||34
1411197|NCT02951702|3454586|P2|STARTED|Overall Study||17
1411198|NCT02951702|3454587|P1|STARTED|Overall Study||34
1411199|NCT02951312|3454601|P4|NOT COMPLETED|Study Part 2||0
1411200|NCT02951312|3454602|P3|NOT COMPLETED|Study Part 2||0
1411201|NCT02951312|3454603|P2|NOT COMPLETED|Study Part 2||0
1411202|NCT02951312|3454604|P1|NOT COMPLETED|Study Part 2||0
1411203|NCT02951312|3454601|P4|COMPLETED|Study Part 2||6
1411204|NCT02951312|3454602|P3|COMPLETED|Study Part 2||6
1411205|NCT02951312|3454603|P2|COMPLETED|Study Part 2||0
1411206|NCT02951312|3454604|P1|COMPLETED|Study Part 2||0
1411207|NCT02951312|3454601|P4|STARTED|Study Part 2||6
1411208|NCT02951312|3454602|P3|STARTED|Study Part 2||6
1411209|NCT02951312|3454603|P2|STARTED|Study Part 2||0
1411210|NCT02951312|3454604|P1|STARTED|Study Part 2||0
1411211|NCT02951312|3454601|P4|NOT COMPLETED|Study Part 1||0
1411212|NCT02951312|3454602|P3|NOT COMPLETED|Study Part 1||0
1411213|NCT02951312|3454603|P2|NOT COMPLETED|Study Part 1||0
1411214|NCT02951312|3454604|P1|NOT COMPLETED|Study Part 1||0
1411215|NCT02951312|3454601|P4|COMPLETED|Study Part 1||0
1411216|NCT02951312|3454602|P3|COMPLETED|Study Part 1||0
1411217|NCT02951312|3454603|P2|COMPLETED|Study Part 1||6
1411218|NCT02951312|3454604|P1|COMPLETED|Study Part 1||6
1411219|NCT02951312|3454601|P4|STARTED|Study Part 1||0
1411220|NCT02951312|3454602|P3|STARTED|Study Part 1||0
1411221|NCT02951312|3454603|P2|STARTED|Study Part 1||6
1411222|NCT02951312|3454604|P1|STARTED|Study Part 1||6
1411223|NCT02951273|3454724|P1|NOT COMPLETED|Overall Study||3
1411224|NCT02951273|3454724|P1|COMPLETED|Overall Study||27
1411225|NCT02951273|3454724|P1|STARTED|Overall Study||30
1411226|NCT02949674|3454742|P3|NOT COMPLETED|Overall Study||0
1411227|NCT02949674|3454743|P2|NOT COMPLETED|Overall Study||0
1411228|NCT02949674|3454744|P1|NOT COMPLETED|Overall Study||0
1411229|NCT02949674|3454742|P3|COMPLETED|Overall Study||31
1411230|NCT02949674|3454743|P2|COMPLETED|Overall Study||31
1411231|NCT02949674|3454744|P1|COMPLETED|Overall Study||31
1411232|NCT02949674|3454742|P3|STARTED|Overall Study||31
1411233|NCT02949674|3454743|P2|STARTED|Overall Study||31
1411234|NCT02949674|3454744|P1|STARTED|Overall Study||31
1411235|NCT02949141|3454752|P1|NOT COMPLETED|Overall Study||0
1411236|NCT02949141|3454752|P1|COMPLETED|Overall Study||62
1411237|NCT02949141|3454752|P1|STARTED|Overall Study||62
1411238|NCT02948582|3454759|P6|NOT COMPLETED|Wshout Period 6||0
1411239|NCT02948582|3454760|P5|NOT COMPLETED|Wshout Period 6||0
1411240|NCT02948582|3454761|P4|NOT COMPLETED|Wshout Period 6||0
1411241|NCT02948582|3454762|P3|NOT COMPLETED|Wshout Period 6||0
1411242|NCT02948582|3454763|P2|NOT COMPLETED|Wshout Period 6||0
1411243|NCT02948582|3454764|P1|NOT COMPLETED|Wshout Period 6||0
1411244|NCT02948582|3454759|P6|COMPLETED|Wshout Period 6||6
1411245|NCT02948582|3454760|P5|COMPLETED|Wshout Period 6||7
1411246|NCT02948582|3454761|P4|COMPLETED|Wshout Period 6||6
1411247|NCT02948582|3454762|P3|COMPLETED|Wshout Period 6||6
1411248|NCT02948582|3454763|P2|COMPLETED|Wshout Period 6||4
1411249|NCT02948582|3454764|P1|COMPLETED|Wshout Period 6||6
1411250|NCT02948582|3454759|P6|STARTED|Wshout Period 6||6
1411251|NCT02948582|3454760|P5|STARTED|Wshout Period 6||7
1411252|NCT02948582|3454761|P4|STARTED|Wshout Period 6||6
1411253|NCT02948582|3454762|P3|STARTED|Wshout Period 6||6
1411254|NCT02948582|3454763|P2|STARTED|Wshout Period 6||4
1411255|NCT02948582|3454764|P1|STARTED|Wshout Period 6||6
1411256|NCT02948582|3454759|P6|NOT COMPLETED|Treatment Period 6||0
1411257|NCT02948582|3454760|P5|NOT COMPLETED|Treatment Period 6||0
1411258|NCT02948582|3454761|P4|NOT COMPLETED|Treatment Period 6||0
1411259|NCT02948582|3454762|P3|NOT COMPLETED|Treatment Period 6||0
1411260|NCT02948582|3454763|P2|NOT COMPLETED|Treatment Period 6||0
1411261|NCT02948582|3454764|P1|NOT COMPLETED|Treatment Period 6||0
1411262|NCT02948582|3454759|P6|COMPLETED|Treatment Period 6||6
1411263|NCT02948582|3454760|P5|COMPLETED|Treatment Period 6||7
1411264|NCT02948582|3454761|P4|COMPLETED|Treatment Period 6||6
1411265|NCT02948582|3454762|P3|COMPLETED|Treatment Period 6||6
1411266|NCT02948582|3454763|P2|COMPLETED|Treatment Period 6||4
1411267|NCT02948582|3454764|P1|COMPLETED|Treatment Period 6||6
1411268|NCT02948582|3454759|P6|STARTED|Treatment Period 6||6
1411269|NCT02948582|3454760|P5|STARTED|Treatment Period 6||7
1411270|NCT02948582|3454761|P4|STARTED|Treatment Period 6||6
1411271|NCT02948582|3454762|P3|STARTED|Treatment Period 6||6
1411272|NCT02948582|3454763|P2|STARTED|Treatment Period 6||4
1411273|NCT02948582|3454764|P1|STARTED|Treatment Period 6||6
1411274|NCT02948582|3454759|P6|NOT COMPLETED|Washout Period 5||0
1411275|NCT02948582|3454760|P5|NOT COMPLETED|Washout Period 5||0
1411276|NCT02948582|3454761|P4|NOT COMPLETED|Washout Period 5||0
1411277|NCT02948582|3454762|P3|NOT COMPLETED|Washout Period 5||0
1411278|NCT02948582|3454763|P2|NOT COMPLETED|Washout Period 5||0
1411279|NCT02948582|3454764|P1|NOT COMPLETED|Washout Period 5||0
1411280|NCT02948582|3454759|P6|COMPLETED|Washout Period 5||6
1411281|NCT02948582|3454760|P5|COMPLETED|Washout Period 5||7
1411282|NCT02948582|3454761|P4|COMPLETED|Washout Period 5||6
1411283|NCT02948582|3454762|P3|COMPLETED|Washout Period 5||6
1411284|NCT02948582|3454763|P2|COMPLETED|Washout Period 5||4
1411285|NCT02948582|3454764|P1|COMPLETED|Washout Period 5||6
1411286|NCT02948582|3454759|P6|STARTED|Washout Period 5||6
1411287|NCT02948582|3454760|P5|STARTED|Washout Period 5||7
1411288|NCT02948582|3454761|P4|STARTED|Washout Period 5||6
1411289|NCT02948582|3454762|P3|STARTED|Washout Period 5||6
1411290|NCT02948582|3454763|P2|STARTED|Washout Period 5||4
1411291|NCT02948582|3454764|P1|STARTED|Washout Period 5||6
1411292|NCT02948582|3454759|P6|NOT COMPLETED|Treatment Period 5||0
1411293|NCT02948582|3454760|P5|NOT COMPLETED|Treatment Period 5||0
1411294|NCT02948582|3454761|P4|NOT COMPLETED|Treatment Period 5||0
1411295|NCT02948582|3454762|P3|NOT COMPLETED|Treatment Period 5||0
1411296|NCT02948582|3454763|P2|NOT COMPLETED|Treatment Period 5||0
1411297|NCT02948582|3454764|P1|NOT COMPLETED|Treatment Period 5||0
1411298|NCT02948582|3454759|P6|COMPLETED|Treatment Period 5||6
1411299|NCT02948582|3454760|P5|COMPLETED|Treatment Period 5||7
1411300|NCT02948582|3454761|P4|COMPLETED|Treatment Period 5||6
1411301|NCT02948582|3454762|P3|COMPLETED|Treatment Period 5||6
1411302|NCT02948582|3454763|P2|COMPLETED|Treatment Period 5||4
1411303|NCT02948582|3454764|P1|COMPLETED|Treatment Period 5||6
1411304|NCT02948582|3454759|P6|STARTED|Treatment Period 5||6
1411305|NCT02948582|3454760|P5|STARTED|Treatment Period 5||7
1411306|NCT02948582|3454761|P4|STARTED|Treatment Period 5||6
1411307|NCT02948582|3454762|P3|STARTED|Treatment Period 5||6
1411308|NCT02948582|3454763|P2|STARTED|Treatment Period 5||4
1411309|NCT02948582|3454764|P1|STARTED|Treatment Period 5||6
1411310|NCT02948582|3454759|P6|NOT COMPLETED|Washout Period 4||0
1411311|NCT02948582|3454760|P5|NOT COMPLETED|Washout Period 4||0
1411312|NCT02948582|3454761|P4|NOT COMPLETED|Washout Period 4||0
1411313|NCT02948582|3454762|P3|NOT COMPLETED|Washout Period 4||1
1411314|NCT02948582|3454763|P2|NOT COMPLETED|Washout Period 4||0
1411315|NCT02948582|3454764|P1|NOT COMPLETED|Washout Period 4||1
1411316|NCT02948582|3454759|P6|COMPLETED|Washout Period 4||6
1411317|NCT02948582|3454760|P5|COMPLETED|Washout Period 4||7
1411318|NCT02948582|3454761|P4|COMPLETED|Washout Period 4||6
1411319|NCT02948582|3454762|P3|COMPLETED|Washout Period 4||6
1411320|NCT02948582|3454763|P2|COMPLETED|Washout Period 4||4
1411321|NCT02948582|3454764|P1|COMPLETED|Washout Period 4||6
1411322|NCT02948582|3454759|P6|STARTED|Washout Period 4||6
1411323|NCT02948582|3454760|P5|STARTED|Washout Period 4||7
1411324|NCT02948582|3454761|P4|STARTED|Washout Period 4||6
1411325|NCT02948582|3454762|P3|STARTED|Washout Period 4||7
1411326|NCT02948582|3454763|P2|STARTED|Washout Period 4||4
1411327|NCT02948582|3454764|P1|STARTED|Washout Period 4||7
1411328|NCT02948582|3454759|P6|NOT COMPLETED|Treatment Period 4||0
1411329|NCT02948582|3454760|P5|NOT COMPLETED|Treatment Period 4||0
1411330|NCT02948582|3454761|P4|NOT COMPLETED|Treatment Period 4||0
1411331|NCT02948582|3454762|P3|NOT COMPLETED|Treatment Period 4||0
1411332|NCT02948582|3454763|P2|NOT COMPLETED|Treatment Period 4||0
1411333|NCT02948582|3454764|P1|NOT COMPLETED|Treatment Period 4||0
1411334|NCT02948582|3454759|P6|COMPLETED|Treatment Period 4||6
1411335|NCT02948582|3454760|P5|COMPLETED|Treatment Period 4||7
1411336|NCT02948582|3454761|P4|COMPLETED|Treatment Period 4||6
1411337|NCT02948582|3454762|P3|COMPLETED|Treatment Period 4||7
1411338|NCT02948582|3454763|P2|COMPLETED|Treatment Period 4||4
1411339|NCT02948582|3454764|P1|COMPLETED|Treatment Period 4||7
1411340|NCT02948582|3454759|P6|STARTED|Treatment Period 4||6
1411341|NCT02948582|3454760|P5|STARTED|Treatment Period 4||7
1411342|NCT02948582|3454761|P4|STARTED|Treatment Period 4||6
1411343|NCT02948582|3454762|P3|STARTED|Treatment Period 4||7
1411344|NCT02948582|3454763|P2|STARTED|Treatment Period 4||4
1411345|NCT02948582|3454764|P1|STARTED|Treatment Period 4||7
1411346|NCT02948582|3454759|P6|NOT COMPLETED|Washout Period 3||0
1411347|NCT02948582|3454760|P5|NOT COMPLETED|Washout Period 3||0
1411348|NCT02948582|3454761|P4|NOT COMPLETED|Washout Period 3||0
1411349|NCT02948582|3454762|P3|NOT COMPLETED|Washout Period 3||0
1411350|NCT02948582|3454763|P2|NOT COMPLETED|Washout Period 3||0
1411351|NCT02948582|3454764|P1|NOT COMPLETED|Washout Period 3||0
1411352|NCT02948582|3454759|P6|COMPLETED|Washout Period 3||6
1411353|NCT02948582|3454760|P5|COMPLETED|Washout Period 3||7
1411354|NCT02948582|3454761|P4|COMPLETED|Washout Period 3||6
1411355|NCT02948582|3454762|P3|COMPLETED|Washout Period 3||7
1411356|NCT02948582|3454763|P2|COMPLETED|Washout Period 3||4
1411357|NCT02948582|3454764|P1|COMPLETED|Washout Period 3||7
1411358|NCT02948582|3454759|P6|STARTED|Washout Period 3||6
1411359|NCT02948582|3454760|P5|STARTED|Washout Period 3||7
1411360|NCT02948582|3454761|P4|STARTED|Washout Period 3||6
1411361|NCT02948582|3454762|P3|STARTED|Washout Period 3||7
1411362|NCT02948582|3454763|P2|STARTED|Washout Period 3||4
1411363|NCT02948582|3454764|P1|STARTED|Washout Period 3||7
1411364|NCT02948582|3454759|P6|NOT COMPLETED|Treatment Period 3||0
1411365|NCT02948582|3454760|P5|NOT COMPLETED|Treatment Period 3||0
1411366|NCT02948582|3454761|P4|NOT COMPLETED|Treatment Period 3||0
1411367|NCT02948582|3454762|P3|NOT COMPLETED|Treatment Period 3||0
1411368|NCT02948582|3454763|P2|NOT COMPLETED|Treatment Period 3||0
1411369|NCT02948582|3454764|P1|NOT COMPLETED|Treatment Period 3||0
1411370|NCT02948582|3454759|P6|COMPLETED|Treatment Period 3||6
1411371|NCT02948582|3454760|P5|COMPLETED|Treatment Period 3||7
1411372|NCT02948582|3454761|P4|COMPLETED|Treatment Period 3||6
1411373|NCT02948582|3454762|P3|COMPLETED|Treatment Period 3||7
1411374|NCT02948582|3454763|P2|COMPLETED|Treatment Period 3||4
1411375|NCT02948582|3454764|P1|COMPLETED|Treatment Period 3||7
1411376|NCT02948582|3454759|P6|STARTED|Treatment Period 3||6
1411377|NCT02948582|3454760|P5|STARTED|Treatment Period 3||7
1411378|NCT02948582|3454761|P4|STARTED|Treatment Period 3||6
1411379|NCT02948582|3454762|P3|STARTED|Treatment Period 3||7
1411380|NCT02948582|3454763|P2|STARTED|Treatment Period 3||4
1411381|NCT02948582|3454764|P1|STARTED|Treatment Period 3||7
1411382|NCT02948582|3454759|P6|NOT COMPLETED|Washout Period 2||0
1411383|NCT02948582|3454760|P5|NOT COMPLETED|Washout Period 2||0
1411384|NCT02948582|3454761|P4|NOT COMPLETED|Washout Period 2||1
1411385|NCT02948582|3454762|P3|NOT COMPLETED|Washout Period 2||0
1411386|NCT02948582|3454763|P2|NOT COMPLETED|Washout Period 2||1
1411387|NCT02948582|3454764|P1|NOT COMPLETED|Washout Period 2||0
1411388|NCT02948582|3454759|P6|COMPLETED|Washout Period 2||6
1411389|NCT02948582|3454760|P5|COMPLETED|Washout Period 2||7
1411390|NCT02948582|3454761|P4|COMPLETED|Washout Period 2||6
1411391|NCT02948582|3454762|P3|COMPLETED|Washout Period 2||7
1411392|NCT02948582|3454763|P2|COMPLETED|Washout Period 2||4
1411393|NCT02948582|3454764|P1|COMPLETED|Washout Period 2||7
1411394|NCT02948582|3454759|P6|STARTED|Washout Period 2||6
1411395|NCT02948582|3454760|P5|STARTED|Washout Period 2||7
1411396|NCT02948582|3454761|P4|STARTED|Washout Period 2||7
1411397|NCT02948582|3454762|P3|STARTED|Washout Period 2||7
1411398|NCT02948582|3454763|P2|STARTED|Washout Period 2||5
1411399|NCT02948582|3454764|P1|STARTED|Washout Period 2||7
1411400|NCT02948582|3454759|P6|NOT COMPLETED|Treatment Period 2||0
1411401|NCT02948582|3454760|P5|NOT COMPLETED|Treatment Period 2||0
1411402|NCT02948582|3454761|P4|NOT COMPLETED|Treatment Period 2||0
1411403|NCT02948582|3454762|P3|NOT COMPLETED|Treatment Period 2||0
1411404|NCT02948582|3454763|P2|NOT COMPLETED|Treatment Period 2||0
1411405|NCT02948582|3454764|P1|NOT COMPLETED|Treatment Period 2||0
1411406|NCT02948582|3454759|P6|COMPLETED|Treatment Period 2||6
1411407|NCT02948582|3454760|P5|COMPLETED|Treatment Period 2||7
1411408|NCT02948582|3454761|P4|COMPLETED|Treatment Period 2||7
1411409|NCT02948582|3454762|P3|COMPLETED|Treatment Period 2||7
1411410|NCT02948582|3454763|P2|COMPLETED|Treatment Period 2||5
1411411|NCT02948582|3454764|P1|COMPLETED|Treatment Period 2||7
1411412|NCT02948582|3454759|P6|STARTED|Treatment Period 2||6
1411413|NCT02948582|3454760|P5|STARTED|Treatment Period 2||7
1411414|NCT02948582|3454761|P4|STARTED|Treatment Period 2||7
1411415|NCT02948582|3454762|P3|STARTED|Treatment Period 2||7
1411416|NCT02948582|3454763|P2|STARTED|Treatment Period 2||5
1411417|NCT02948582|3454764|P1|STARTED|Treatment Period 2||7
1411418|NCT02948582|3454759|P6|NOT COMPLETED|Washout Period 1||1
1411419|NCT02948582|3454760|P5|NOT COMPLETED|Washout Period 1||0
1411420|NCT02948582|3454761|P4|NOT COMPLETED|Washout Period 1||0
1411421|NCT02948582|3454762|P3|NOT COMPLETED|Washout Period 1||0
1411422|NCT02948582|3454763|P2|NOT COMPLETED|Washout Period 1||2
1411423|NCT02948582|3454764|P1|NOT COMPLETED|Washout Period 1||0
1411424|NCT02948582|3454759|P6|COMPLETED|Washout Period 1||6
1411425|NCT02948582|3454760|P5|COMPLETED|Washout Period 1||7
1411426|NCT02948582|3454761|P4|COMPLETED|Washout Period 1||7
1411427|NCT02948582|3454762|P3|COMPLETED|Washout Period 1||7
1411428|NCT02948582|3454763|P2|COMPLETED|Washout Period 1||5
1411429|NCT02948582|3454764|P1|COMPLETED|Washout Period 1||7
1411430|NCT02948582|3454759|P6|STARTED|Washout Period 1||7
1411431|NCT02948582|3454760|P5|STARTED|Washout Period 1||7
1411432|NCT02948582|3454761|P4|STARTED|Washout Period 1||7
1411433|NCT02948582|3454762|P3|STARTED|Washout Period 1||7
1411434|NCT02948582|3454763|P2|STARTED|Washout Period 1||7
1411435|NCT02948582|3454764|P1|STARTED|Washout Period 1||7
1411436|NCT02948582|3454759|P6|NOT COMPLETED|Treatment Period 1||0
1411437|NCT02948582|3454760|P5|NOT COMPLETED|Treatment Period 1||0
1411438|NCT02948582|3454761|P4|NOT COMPLETED|Treatment Period 1||0
1411439|NCT02948582|3454762|P3|NOT COMPLETED|Treatment Period 1||0
1411440|NCT02948582|3454763|P2|NOT COMPLETED|Treatment Period 1||0
1411441|NCT02948582|3454764|P1|NOT COMPLETED|Treatment Period 1||0
1411442|NCT02948582|3454759|P6|COMPLETED|Treatment Period 1||7
1411443|NCT02948582|3454760|P5|COMPLETED|Treatment Period 1||7
1411444|NCT02948582|3454761|P4|COMPLETED|Treatment Period 1||7
1411445|NCT02948582|3454762|P3|COMPLETED|Treatment Period 1||7
1411446|NCT02948582|3454763|P2|COMPLETED|Treatment Period 1||7
1411447|NCT02948582|3454764|P1|COMPLETED|Treatment Period 1||7
1411448|NCT02948582|3454759|P6|STARTED|Treatment Period 1||7
1411449|NCT02948582|3454760|P5|STARTED|Treatment Period 1||7
1411450|NCT02948582|3454761|P4|STARTED|Treatment Period 1||7
1411451|NCT02948582|3454762|P3|STARTED|Treatment Period 1||7
1411452|NCT02948582|3454763|P2|STARTED|Treatment Period 1||7
1411453|NCT02948582|3454764|P1|STARTED|Treatment Period 1||7
1411454|NCT02947984|3454859|P2|NOT COMPLETED|Overall Study||0
1411455|NCT02947984|3454860|P1|NOT COMPLETED|Overall Study||0
1411456|NCT02947984|3454859|P2|COMPLETED|Overall Study||22
1411457|NCT02947984|3454860|P1|COMPLETED|Overall Study||22
1411458|NCT02947984|3454859|P2|STARTED|Overall Study||22
1411459|NCT02947984|3454860|P1|STARTED|Overall Study||22
1411460|NCT02947022|3454872|P1|NOT COMPLETED|Overall Study||1
1411461|NCT02947022|3454872|P1|COMPLETED|Overall Study||0
1411462|NCT02947022|3454872|P1|STARTED|Overall Study||1
1411463|NCT02946229|3454891|P1|NOT COMPLETED|Overall Study||0
1411464|NCT02946229|3454891|P1|COMPLETED|Overall Study||142
1411465|NCT02946229|3454891|P1|STARTED|Overall Study||142
1411466|NCT02945657|3454895|P1|NOT COMPLETED|Overall Study||4
1411467|NCT02945657|3454895|P1|COMPLETED|Overall Study||28
1411468|NCT02945657|3454895|P1|STARTED|Overall Study||32
1411469|NCT02945254|3454914|P2|NOT COMPLETED|Overall Study||0
1411470|NCT02945254|3454915|P1|NOT COMPLETED|Overall Study||2
1411471|NCT02945254|3454914|P2|COMPLETED|Overall Study||10
1411472|NCT02945254|3454915|P1|COMPLETED|Overall Study||8
1411473|NCT02945254|3454914|P2|STARTED|Overall Study||10
1411474|NCT02945254|3454915|P1|STARTED|Overall Study||10
1411475|NCT02943226|3454925|P2|NOT COMPLETED|Overall Study||0
1411476|NCT02943226|3454926|P1|NOT COMPLETED|Overall Study||0
1411477|NCT02943226|3454925|P2|COMPLETED|Overall Study||30
1411478|NCT02943226|3454926|P1|COMPLETED|Overall Study||31
1411479|NCT02943226|3454925|P2|STARTED|Overall Study||30
1411480|NCT02943226|3454926|P1|STARTED|Overall Study||31
1411481|NCT02943213|3454942|P1|NOT COMPLETED|Treatment Period 2||0
1411482|NCT02943213|3454942|P1|COMPLETED|Treatment Period 2||20
1411483|NCT02943213|3454942|P1|STARTED|Treatment Period 2||20
1411484|NCT02943213|3454942|P1|NOT COMPLETED|Treatment Period 1||0
1411485|NCT02943213|3454942|P1|COMPLETED|Treatment Period 1||20
1411486|NCT02943213|3454942|P1|STARTED|Treatment Period 1||20
1411487|NCT02941692|3454972|P2|NOT COMPLETED|Overall Study||0
1411488|NCT02941692|3454973|P1|NOT COMPLETED|Overall Study||0
1411489|NCT02941692|3454972|P2|COMPLETED|Overall Study||34
1411490|NCT02941692|3454973|P1|COMPLETED|Overall Study||32
1411491|NCT02941692|3454972|P2|STARTED|Overall Study||34
1411492|NCT02941692|3454973|P1|STARTED|Overall Study||32
1411493|NCT02941640|3454985|P4|NOT COMPLETED|Overall Study||0
1411494|NCT02941640|3454986|P3|NOT COMPLETED|Overall Study||0
1411495|NCT02941640|3454987|P2|NOT COMPLETED|Overall Study||0
1411496|NCT02941640|3454988|P1|NOT COMPLETED|Overall Study||0
1411497|NCT02941640|3454985|P4|COMPLETED|Overall Study||30
1411498|NCT02941640|3454986|P3|COMPLETED|Overall Study||30
1411499|NCT02941640|3454987|P2|COMPLETED|Overall Study||30
1411500|NCT02941640|3454988|P1|COMPLETED|Overall Study||30
1411501|NCT02941640|3454985|P4|STARTED|Overall Study||30
1411502|NCT02941640|3454986|P3|STARTED|Overall Study||30
1411503|NCT02941640|3454987|P2|STARTED|Overall Study||30
1411504|NCT02941640|3454988|P1|STARTED|Overall Study||30
1411505|NCT02940522|3455020|P2|NOT COMPLETED|Overall Study||2
1411506|NCT02940522|3455021|P1|NOT COMPLETED|Overall Study||2
1411507|NCT02940522|3455020|P2|COMPLETED|Overall Study||59
1411508|NCT02940522|3455021|P1|COMPLETED|Overall Study||57
1411509|NCT02940522|3455020|P2|STARTED|Overall Study||61
1411510|NCT02940522|3455021|P1|STARTED|Overall Study||59
1411511|NCT02939170|3455039|P2|NOT COMPLETED|Overall Study||0
1411512|NCT02939170|3455040|P1|NOT COMPLETED|Overall Study||0
1411513|NCT02939170|3455039|P2|COMPLETED|Overall Study||40
1411514|NCT02939170|3455040|P1|COMPLETED|Overall Study||40
1411515|NCT02939170|3455039|P2|STARTED|Overall Study||40
1411516|NCT02939170|3455040|P1|STARTED|Overall Study||40
1411517|NCT02938052|3455051|P1|NOT COMPLETED|Overall Study||1
1411518|NCT02938052|3455051|P1|COMPLETED|Overall Study||10
1411519|NCT02938052|3455051|P1|STARTED|Overall Study||11
1411520|NCT02937870|3455070|P1|NOT COMPLETED|Overall Study||3
1411521|NCT02937870|3455070|P1|COMPLETED|Overall Study||20
1411522|NCT02937870|3455070|P1|Received no Adhesive|Overall Study||20
1411523|NCT02937870|3455070|P1|Received Positive Control Adhesive|Overall Study||21
1411524|NCT02937870|3455070|P1|Received Test Adhesive 2|Overall Study||22
1411525|NCT02937870|3455070|P1|Received Test Adhesive 1|Overall Study||21
1411526|NCT02937870|3455070|P1|STARTED|Overall Study||23
1411527|NCT02937766|3455088|P2|NOT COMPLETED|Overall Study||0
1411528|NCT02937766|3455089|P1|NOT COMPLETED|Overall Study||7
1411529|NCT02937766|3455088|P2|COMPLETED|Overall Study||30
1411530|NCT02937766|3455089|P1|COMPLETED|Overall Study||23
1411531|NCT02937766|3455088|P2|STARTED|Overall Study||30
1411532|NCT02937766|3455089|P1|STARTED|Overall Study||30
1411533|NCT02937623|3455101|P2|NOT COMPLETED|Overall Study||0
1411534|NCT02937623|3455102|P1|NOT COMPLETED|Overall Study||0
1411535|NCT02937623|3455101|P2|COMPLETED|Overall Study||60
1411536|NCT02937623|3455102|P1|COMPLETED|Overall Study||60
1411537|NCT02937623|3455101|P2|STARTED|Overall Study||60
1411538|NCT02937623|3455102|P1|STARTED|Overall Study||60
1411539|NCT02937506|3455116|P2|NOT COMPLETED|Overall Study||0
1411540|NCT02937506|3455117|P1|NOT COMPLETED|Overall Study||0
1411541|NCT02937506|3455116|P2|COMPLETED|Overall Study||300
1411542|NCT02937506|3455117|P1|COMPLETED|Overall Study||300
1411543|NCT02937506|3455116|P2|STARTED|Overall Study||300
1411544|NCT02937506|3455117|P1|STARTED|Overall Study||300
1411545|NCT02936648|3455123|P1|NOT COMPLETED|Overall Study||0
1411546|NCT02936648|3455123|P1|COMPLETED|Overall Study||2209
1411547|NCT02936648|3455123|P1|STARTED|Overall Study||2209
1411548|NCT02935894|3455127|P1|NOT COMPLETED|Overall Study||1
1411549|NCT02935894|3455127|P1|COMPLETED|Overall Study||13
1411550|NCT02935894|3455127|P1|STARTED|Overall Study||14
1411551|NCT02935036|3455140|P2|NOT COMPLETED|Overall Study||11
1411552|NCT02935036|3455141|P1|NOT COMPLETED|Overall Study||10
1411553|NCT02935036|3455140|P2|COMPLETED|Overall Study||136
1411554|NCT02935036|3455141|P1|COMPLETED|Overall Study||137
1411555|NCT02935036|3455140|P2|STARTED|Overall Study||147
1411556|NCT02935036|3455141|P1|STARTED|Overall Study||147
1411557|NCT02934698|3455151|P1|NOT COMPLETED|Overall Study||0
1411558|NCT02934698|3455151|P1|COMPLETED|Overall Study||2
1411559|NCT02934698|3455151|P1|STARTED|Overall Study||2
1411560|NCT02934347|3455159|P2|NOT COMPLETED|Overall Study||0
1411561|NCT02934347|3455160|P1|NOT COMPLETED|Overall Study||0
1411562|NCT02934347|3455159|P2|COMPLETED|Overall Study||407
1411563|NCT02934347|3455160|P1|COMPLETED|Overall Study||374
1411564|NCT02934347|3455159|P2|STARTED|Overall Study||407
1411565|NCT02934347|3455160|P1|STARTED|Overall Study||374
1411566|NCT02933879|3455175|P3|NOT COMPLETED|Overall Study||17
1411567|NCT02933879|3455176|P2|NOT COMPLETED|Overall Study||14
1411568|NCT02933879|3455177|P1|NOT COMPLETED|Overall Study||16
1411569|NCT02933879|3455175|P3|COMPLETED|Overall Study||41
1411570|NCT02933879|3455176|P2|COMPLETED|Overall Study||48
1411571|NCT02933879|3455177|P1|COMPLETED|Overall Study||48
1411572|NCT02933879|3455175|P3|STARTED|Overall Study||58
1411573|NCT02933879|3455176|P2|STARTED|Overall Study||62
1411574|NCT02933879|3455177|P1|STARTED|Overall Study||64
1411575|NCT02933866|3455213|P2|NOT COMPLETED|Overall Study||9
1411576|NCT02933866|3455214|P1|NOT COMPLETED|Overall Study||12
1411577|NCT02933866|3455213|P2|COMPLETED|Overall Study||176
1411578|NCT02933866|3455214|P1|COMPLETED|Overall Study||174
1411579|NCT02933866|3455213|P2|STARTED|Overall Study||185
1411580|NCT02933866|3455214|P1|STARTED|Overall Study||186
1411581|NCT02933528|3455220|P1|NOT COMPLETED|Overall Study||2
1411582|NCT02933528|3455220|P1|COMPLETED|Overall Study||22
1411583|NCT02933528|3455220|P1|STARTED|Overall Study||24
1411584|NCT02933502|3455224|P1|NOT COMPLETED|Overall Study||0
1411585|NCT02933502|3455224|P1|COMPLETED|Overall Study||3
1411586|NCT02933502|3455224|P1|STARTED|Overall Study||3
1411587|NCT02933476|3455228|P1|NOT COMPLETED|Overall Study||0
1411588|NCT02933476|3455228|P1|COMPLETED|Overall Study||5
1411589|NCT02933476|3455228|P1|STARTED|Overall Study||5
1411590|NCT02932904|3455239|P4|NOT COMPLETED|Overall Study||14
1411591|NCT02932904|3455240|P3|NOT COMPLETED|Overall Study||23
1411592|NCT02932904|3455241|P2|NOT COMPLETED|Overall Study||18
1411593|NCT02932904|3455242|P1|NOT COMPLETED|Overall Study||16
1411594|NCT02932904|3455239|P4|COMPLETED|Overall Study||79
1411595|NCT02932904|3455240|P3|COMPLETED|Overall Study||68
1411596|NCT02932904|3455241|P2|COMPLETED|Overall Study||67
1411597|NCT02932904|3455242|P1|COMPLETED|Overall Study||76
1411598|NCT02932904|3455239|P4|Treated|Overall Study||91
1411599|NCT02932904|3455240|P3|Treated|Overall Study||91
1411600|NCT02932904|3455241|P2|Treated|Overall Study||84
1411601|NCT02932904|3455242|P1|Treated|Overall Study||91
1411602|NCT02932904|3455239|P4|STARTED|Overall Study||93
1411603|NCT02932904|3455240|P3|STARTED|Overall Study||91
1411604|NCT02932904|3455241|P2|STARTED|Overall Study||85
1411605|NCT02932904|3455242|P1|STARTED|Overall Study||92
1411606|NCT02932891|3455277|P1|NOT COMPLETED|Overall Study||4
1411607|NCT02932891|3455277|P1|COMPLETED|Overall Study||24
1411608|NCT02932891|3455277|P1|STARTED|Overall Study||28
1411609|NCT02932878|3455283|P2|NOT COMPLETED|Overall Study||1
1411610|NCT02932878|3455284|P1|NOT COMPLETED|Overall Study||2
1411611|NCT02932878|3455283|P2|COMPLETED|Overall Study||0
1411612|NCT02932878|3455284|P1|COMPLETED|Overall Study||13
1411613|NCT02932878|3455283|P2|STARTED|Overall Study||1
1411614|NCT02932878|3455284|P1|STARTED|Overall Study||15
1411615|NCT02932462|3455292|P2|NOT COMPLETED|Overall Study||13
1411616|NCT02932462|3455293|P1|NOT COMPLETED|Overall Study||7
1411617|NCT02932462|3455292|P2|COMPLETED|Overall Study||176
1411618|NCT02932462|3455293|P1|COMPLETED|Overall Study||177
1411619|NCT02932462|3455292|P2|STARTED|Overall Study||189
1411620|NCT02932462|3455293|P1|STARTED|Overall Study||184
1411621|NCT02930590|3455303|P6|NOT COMPLETED|Third Intervention (2 Hours)||0
1411622|NCT02930590|3455304|P5|NOT COMPLETED|Third Intervention (2 Hours)||0
1411623|NCT02930590|3455305|P4|NOT COMPLETED|Third Intervention (2 Hours)||0
1411624|NCT02930590|3455306|P3|NOT COMPLETED|Third Intervention (2 Hours)||0
1411625|NCT02930590|3455307|P2|NOT COMPLETED|Third Intervention (2 Hours)||0
1411626|NCT02930590|3455308|P1|NOT COMPLETED|Third Intervention (2 Hours)||0
1411627|NCT02930590|3455303|P6|COMPLETED|Third Intervention (2 Hours)||2
1411628|NCT02930590|3455304|P5|COMPLETED|Third Intervention (2 Hours)||2
1411629|NCT02930590|3455305|P4|COMPLETED|Third Intervention (2 Hours)||2
1411630|NCT02930590|3455306|P3|COMPLETED|Third Intervention (2 Hours)||3
1411631|NCT02930590|3455307|P2|COMPLETED|Third Intervention (2 Hours)||3
1411632|NCT02930590|3455308|P1|COMPLETED|Third Intervention (2 Hours)||3
1411633|NCT02930590|3455303|P6|STARTED|Third Intervention (2 Hours)||2
1411634|NCT02930590|3455304|P5|STARTED|Third Intervention (2 Hours)||2
1411635|NCT02930590|3455305|P4|STARTED|Third Intervention (2 Hours)||2
1411636|NCT02930590|3455306|P3|STARTED|Third Intervention (2 Hours)||3
1411637|NCT02930590|3455307|P2|STARTED|Third Intervention (2 Hours)||3
1411638|NCT02930590|3455308|P1|STARTED|Third Intervention (2 Hours)||3
1411639|NCT02930590|3455303|P6|NOT COMPLETED|Second Intervention (2 Hours)||0
1411640|NCT02930590|3455304|P5|NOT COMPLETED|Second Intervention (2 Hours)||0
1411641|NCT02930590|3455305|P4|NOT COMPLETED|Second Intervention (2 Hours)||0
1411642|NCT02930590|3455306|P3|NOT COMPLETED|Second Intervention (2 Hours)||0
1411643|NCT02930590|3455307|P2|NOT COMPLETED|Second Intervention (2 Hours)||0
1411644|NCT02930590|3455308|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
1411645|NCT02930590|3455303|P6|COMPLETED|Second Intervention (2 Hours)||2
1411646|NCT02930590|3455304|P5|COMPLETED|Second Intervention (2 Hours)||2
1411647|NCT02930590|3455305|P4|COMPLETED|Second Intervention (2 Hours)||2
1411648|NCT02930590|3455306|P3|COMPLETED|Second Intervention (2 Hours)||3
1411649|NCT02930590|3455307|P2|COMPLETED|Second Intervention (2 Hours)||3
1411650|NCT02930590|3455308|P1|COMPLETED|Second Intervention (2 Hours)||3
1411651|NCT02930590|3455303|P6|STARTED|Second Intervention (2 Hours)||2
1411652|NCT02930590|3455304|P5|STARTED|Second Intervention (2 Hours)||2
1411653|NCT02930590|3455305|P4|STARTED|Second Intervention (2 Hours)||2
1411654|NCT02930590|3455306|P3|STARTED|Second Intervention (2 Hours)||3
1411655|NCT02930590|3455307|P2|STARTED|Second Intervention (2 Hours)||3
1411656|NCT02930590|3455308|P1|STARTED|Second Intervention (2 Hours)||3
1411657|NCT02930590|3455303|P6|NOT COMPLETED|First Intervention (2 Hours)||0
1411658|NCT02930590|3455304|P5|NOT COMPLETED|First Intervention (2 Hours)||0
1411659|NCT02930590|3455305|P4|NOT COMPLETED|First Intervention (2 Hours)||0
1411660|NCT02930590|3455306|P3|NOT COMPLETED|First Intervention (2 Hours)||0
1411661|NCT02930590|3455307|P2|NOT COMPLETED|First Intervention (2 Hours)||0
1411662|NCT02930590|3455308|P1|NOT COMPLETED|First Intervention (2 Hours)||0
1411663|NCT02930590|3455303|P6|COMPLETED|First Intervention (2 Hours)||2
1411664|NCT02930590|3455304|P5|COMPLETED|First Intervention (2 Hours)||2
1411665|NCT02930590|3455305|P4|COMPLETED|First Intervention (2 Hours)||2
1411666|NCT02930590|3455306|P3|COMPLETED|First Intervention (2 Hours)||3
1411667|NCT02930590|3455307|P2|COMPLETED|First Intervention (2 Hours)||3
1411668|NCT02930590|3455308|P1|COMPLETED|First Intervention (2 Hours)||3
1411669|NCT02930590|3455303|P6|STARTED|First Intervention (2 Hours)||2
1411670|NCT02930590|3455304|P5|STARTED|First Intervention (2 Hours)||2
1411671|NCT02930590|3455305|P4|STARTED|First Intervention (2 Hours)||2
1411672|NCT02930590|3455306|P3|STARTED|First Intervention (2 Hours)||3
1411673|NCT02930590|3455307|P2|STARTED|First Intervention (2 Hours)||3
1411674|NCT02930590|3455308|P1|STARTED|First Intervention (2 Hours)||3
1411675|NCT02929823|3455586|P3|NOT COMPLETED|Overall Study||4
1411676|NCT02929823|3455587|P2|NOT COMPLETED|Overall Study||6
1411677|NCT02929823|3455588|P1|NOT COMPLETED|Overall Study||3
1411678|NCT02929823|3455586|P3|COMPLETED|Overall Study||38
1411679|NCT02929823|3455587|P2|COMPLETED|Overall Study||40
1411680|NCT02929823|3455588|P1|COMPLETED|Overall Study||39
1411681|NCT02929823|3455586|P3|STARTED|Overall Study||42
1411682|NCT02929823|3455587|P2|STARTED|Overall Study||46
1411683|NCT02929823|3455588|P1|STARTED|Overall Study||42
1411684|NCT02928380|3455596|P6|NOT COMPLETED|Period 3||0
1411685|NCT02928380|3455597|P5|NOT COMPLETED|Period 3||0
1411686|NCT02928380|3455598|P4|NOT COMPLETED|Period 3||0
1411687|NCT02928380|3455599|P3|NOT COMPLETED|Period 3||0
1411688|NCT02928380|3455600|P2|NOT COMPLETED|Period 3||0
1411689|NCT02928380|3455601|P1|NOT COMPLETED|Period 3||0
1411690|NCT02928380|3455596|P6|COMPLETED|Period 3||14
1411691|NCT02928380|3455597|P5|COMPLETED|Period 3||14
1411692|NCT02928380|3455598|P4|COMPLETED|Period 3||14
1411693|NCT02928380|3455599|P3|COMPLETED|Period 3||14
1411694|NCT02928380|3455600|P2|COMPLETED|Period 3||14
1411695|NCT02928380|3455601|P1|COMPLETED|Period 3||13
1411696|NCT02928380|3455596|P6|STARTED|Period 3||14
1411697|NCT02928380|3455597|P5|STARTED|Period 3||14
1411698|NCT02928380|3455598|P4|STARTED|Period 3||14
1411699|NCT02928380|3455599|P3|STARTED|Period 3||14
1411700|NCT02928380|3455600|P2|STARTED|Period 3||14
1411701|NCT02928380|3455601|P1|STARTED|Period 3||13
1411702|NCT02928380|3455596|P6|NOT COMPLETED|Wash Out Period 2||0
1411703|NCT02928380|3455597|P5|NOT COMPLETED|Wash Out Period 2||0
1411704|NCT02928380|3455598|P4|NOT COMPLETED|Wash Out Period 2||0
1411705|NCT02928380|3455599|P3|NOT COMPLETED|Wash Out Period 2||0
1411706|NCT02928380|3455600|P2|NOT COMPLETED|Wash Out Period 2||0
1411707|NCT02928380|3455601|P1|NOT COMPLETED|Wash Out Period 2||0
1411708|NCT02928380|3455596|P6|COMPLETED|Wash Out Period 2||14
1411709|NCT02928380|3455597|P5|COMPLETED|Wash Out Period 2||14
1411710|NCT02928380|3455598|P4|COMPLETED|Wash Out Period 2||14
1411711|NCT02928380|3455599|P3|COMPLETED|Wash Out Period 2||14
1411712|NCT02928380|3455600|P2|COMPLETED|Wash Out Period 2||14
1411713|NCT02928380|3455601|P1|COMPLETED|Wash Out Period 2||13
1411714|NCT02928380|3455596|P6|STARTED|Wash Out Period 2||14
1411715|NCT02928380|3455597|P5|STARTED|Wash Out Period 2||14
1411716|NCT02928380|3455598|P4|STARTED|Wash Out Period 2||14
1411717|NCT02928380|3455599|P3|STARTED|Wash Out Period 2||14
1411718|NCT02928380|3455600|P2|STARTED|Wash Out Period 2||14
1411719|NCT02928380|3455601|P1|STARTED|Wash Out Period 2||13
1411720|NCT02928380|3455596|P6|NOT COMPLETED|Period 2||0
1411721|NCT02928380|3455597|P5|NOT COMPLETED|Period 2||0
1411722|NCT02928380|3455598|P4|NOT COMPLETED|Period 2||0
1411723|NCT02928380|3455599|P3|NOT COMPLETED|Period 2||0
1411724|NCT02928380|3455600|P2|NOT COMPLETED|Period 2||0
1411725|NCT02928380|3455601|P1|NOT COMPLETED|Period 2||0
1411726|NCT02928380|3455596|P6|COMPLETED|Period 2||14
1411727|NCT02928380|3455597|P5|COMPLETED|Period 2||14
1411728|NCT02928380|3455598|P4|COMPLETED|Period 2||14
1411729|NCT02928380|3455599|P3|COMPLETED|Period 2||14
1411730|NCT02928380|3455600|P2|COMPLETED|Period 2||14
1411731|NCT02928380|3455601|P1|COMPLETED|Period 2||13
1411732|NCT02928380|3455596|P6|STARTED|Period 2||14
1411733|NCT02928380|3455597|P5|STARTED|Period 2||14
1411734|NCT02928380|3455598|P4|STARTED|Period 2||14
1411735|NCT02928380|3455599|P3|STARTED|Period 2||14
1411736|NCT02928380|3455600|P2|STARTED|Period 2||14
1411737|NCT02928380|3455601|P1|STARTED|Period 2||13
1411738|NCT02928380|3455596|P6|NOT COMPLETED|Wash Out Period 1||0
1411739|NCT02928380|3455597|P5|NOT COMPLETED|Wash Out Period 1||0
1411740|NCT02928380|3455598|P4|NOT COMPLETED|Wash Out Period 1||0
1411741|NCT02928380|3455599|P3|NOT COMPLETED|Wash Out Period 1||0
1411742|NCT02928380|3455600|P2|NOT COMPLETED|Wash Out Period 1||0
1411743|NCT02928380|3455601|P1|NOT COMPLETED|Wash Out Period 1||0
1411744|NCT02928380|3455596|P6|COMPLETED|Wash Out Period 1||14
1411745|NCT02928380|3455597|P5|COMPLETED|Wash Out Period 1||14
1411746|NCT02928380|3455598|P4|COMPLETED|Wash Out Period 1||14
1411747|NCT02928380|3455599|P3|COMPLETED|Wash Out Period 1||14
1411748|NCT02928380|3455600|P2|COMPLETED|Wash Out Period 1||14
1411749|NCT02928380|3455601|P1|COMPLETED|Wash Out Period 1||13
1411750|NCT02928380|3455596|P6|STARTED|Wash Out Period 1||14
1411751|NCT02928380|3455597|P5|STARTED|Wash Out Period 1||14
1411752|NCT02928380|3455598|P4|STARTED|Wash Out Period 1||14
1411753|NCT02928380|3455599|P3|STARTED|Wash Out Period 1||14
1411754|NCT02928380|3455600|P2|STARTED|Wash Out Period 1||14
1411755|NCT02928380|3455601|P1|STARTED|Wash Out Period 1||13
1411756|NCT02928380|3455596|P6|NOT COMPLETED|Period 1||0
1411757|NCT02928380|3455597|P5|NOT COMPLETED|Period 1||0
1411758|NCT02928380|3455598|P4|NOT COMPLETED|Period 1||0
1411759|NCT02928380|3455599|P3|NOT COMPLETED|Period 1||0
1411760|NCT02928380|3455600|P2|NOT COMPLETED|Period 1||0
1411761|NCT02928380|3455601|P1|NOT COMPLETED|Period 1||0
1411762|NCT02928380|3455596|P6|COMPLETED|Period 1||14
1411763|NCT02928380|3455597|P5|COMPLETED|Period 1||14
1411764|NCT02928380|3455598|P4|COMPLETED|Period 1||14
1411765|NCT02928380|3455599|P3|COMPLETED|Period 1||14
1411766|NCT02928380|3455600|P2|COMPLETED|Period 1||14
1411767|NCT02928380|3455601|P1|COMPLETED|Period 1||13
1411768|NCT02928380|3455596|P6|STARTED|Period 1||14
1411769|NCT02928380|3455597|P5|STARTED|Period 1||14
1411770|NCT02928380|3455598|P4|STARTED|Period 1||14
1411771|NCT02928380|3455599|P3|STARTED|Period 1||14
1411772|NCT02928380|3455600|P2|STARTED|Period 1||14
1411773|NCT02928380|3455601|P1|STARTED|Period 1||13
1411774|NCT02927431|3455624|P3|NOT COMPLETED|Overall Study||1
1411775|NCT02927431|3455625|P2|NOT COMPLETED|Overall Study||0
1411776|NCT02927431|3455626|P1|NOT COMPLETED|Overall Study||0
1411777|NCT02927431|3455624|P3|COMPLETED|Overall Study||3
1411778|NCT02927431|3455625|P2|COMPLETED|Overall Study||4
1411779|NCT02927431|3455626|P1|COMPLETED|Overall Study||2
1411780|NCT02927431|3455624|P3|STARTED|Overall Study||4
1411781|NCT02927431|3455625|P2|STARTED|Overall Study||4
1411782|NCT02927431|3455626|P1|STARTED|Overall Study||2
1411783|NCT02927327|3455704|P2|NOT COMPLETED|Overall Study||0
1411784|NCT02927327|3455705|P1|NOT COMPLETED|Overall Study||0
1411785|NCT02927327|3455704|P2|COMPLETED|Overall Study||31
1411786|NCT02927327|3455705|P1|COMPLETED|Overall Study||30
1411787|NCT02927327|3455704|P2|STARTED|Overall Study||31
1411788|NCT02927327|3455705|P1|STARTED|Overall Study||30
1411789|NCT02926573|3455719|P2|NOT COMPLETED|Overall Study||9
1411790|NCT02926573|3455720|P1|NOT COMPLETED|Overall Study||11
1411791|NCT02926573|3455719|P2|COMPLETED|Overall Study||46
1411792|NCT02926573|3455720|P1|COMPLETED|Overall Study||44
1411793|NCT02926573|3455719|P2|STARTED|Overall Study||55
1411794|NCT02926573|3455720|P1|STARTED|Overall Study||55
1411795|NCT02924350|3455740|P2|NOT COMPLETED|Overall Study||2
1411796|NCT02924350|3455741|P1|NOT COMPLETED|Overall Study||0
1411797|NCT02924350|3455740|P2|COMPLETED|Overall Study||100
1411798|NCT02924350|3455741|P1|COMPLETED|Overall Study||102
1411799|NCT02924350|3455740|P2|STARTED|Overall Study||102
1411800|NCT02924350|3455741|P1|STARTED|Overall Study||102
1411801|NCT02923895|3455753|P2|NOT COMPLETED|Overall Study||0
1411802|NCT02923895|3455754|P1|NOT COMPLETED|Overall Study||0
1411803|NCT02923895|3455753|P2|COMPLETED|Overall Study||95
1411804|NCT02923895|3455754|P1|COMPLETED|Overall Study||97
1411805|NCT02923895|3455753|P2|STARTED|Overall Study||95
1411806|NCT02923895|3455754|P1|STARTED|Overall Study||97
1411807|NCT02923245|3455768|P2|NOT COMPLETED|Overall Study||1
1411808|NCT02923245|3455769|P1|NOT COMPLETED|Overall Study||2
1411809|NCT02923245|3455768|P2|COMPLETED|Overall Study||59
1411810|NCT02923245|3455769|P1|COMPLETED|Overall Study||58
1411811|NCT02923245|3455768|P2|STARTED|Overall Study||60
1411812|NCT02923245|3455769|P1|STARTED|Overall Study||60
1411813|NCT02922985|3455788|P2|NOT COMPLETED|Overall Study||0
1411814|NCT02922985|3455789|P1|NOT COMPLETED|Overall Study||0
1411815|NCT02922985|3455788|P2|COMPLETED|Overall Study||60
1411816|NCT02922985|3455789|P1|COMPLETED|Overall Study||60
1411817|NCT02922985|3455788|P2|STARTED|Overall Study||60
1411818|NCT02922985|3455789|P1|STARTED|Overall Study||60
1411819|NCT02922868|3455801|P2|NOT COMPLETED|Overall Study||0
1411820|NCT02922868|3455802|P1|NOT COMPLETED|Overall Study||0
1411821|NCT02922868|3455801|P2|COMPLETED|Overall Study||30
1411822|NCT02922868|3455802|P1|COMPLETED|Overall Study||30
1411823|NCT02922868|3455801|P2|STARTED|Overall Study||30
1411824|NCT02922868|3455802|P1|STARTED|Overall Study||30
1411825|NCT02921425|3455820|P1|NOT COMPLETED|Overall Study||9
1411826|NCT02921425|3455820|P1|COMPLETED|Overall Study||38
1411827|NCT02921425|3455820|P1|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
1411828|NCT02921425|3455820|P1|STARTED|Overall Study||47
1411829|NCT02921412|3455834|P1|NOT COMPLETED|Overall Study||0
1411830|NCT02921412|3455834|P1|COMPLETED|Overall Study||36
1411831|NCT02921412|3455834|P1|STARTED|Overall Study||36
1411832|NCT02921386|3455857|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
1411833|NCT02921386|3455857|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
1411834|NCT02921386|3455857|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
1411835|NCT02921386|3455857|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
1411836|NCT02921386|3455857|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
1411837|NCT02921386|3455857|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
1411838|NCT02921386|3455857|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
1411839|NCT02921386|3455857|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
1411840|NCT02921386|3455857|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
1411841|NCT02921386|3455857|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
1411842|NCT02921386|3455857|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
1411843|NCT02921386|3455857|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
1411844|NCT02921386|3455857|P1|NOT COMPLETED|Sequence A: Fasting||0
1411845|NCT02921386|3455857|P1|COMPLETED|Sequence A: Fasting||18
1411846|NCT02921386|3455857|P1|STARTED|Sequence A: Fasting||18
1411847|NCT02921295|3455880|P1|NOT COMPLETED|Conventional Prostheses||0
1411848|NCT02921295|3455880|P1|COMPLETED|Conventional Prostheses||1
1411849|NCT02921295|3455880|P1|STARTED|Conventional Prostheses||1
1411850|NCT02921295|3455880|P1|NOT COMPLETED|Sidekicks||0
1411851|NCT02921295|3455880|P1|COMPLETED|Sidekicks||1
1411852|NCT02921295|3455880|P1|STARTED|Sidekicks||1
1411853|NCT02920957|3455890|P2|NOT COMPLETED|Second Intervention: 1 Month||1
1411854|NCT02920957|3455891|P1|NOT COMPLETED|Second Intervention: 1 Month||0
1411855|NCT02920957|3455890|P2|COMPLETED|Second Intervention: 1 Month||40
1411856|NCT02920957|3455891|P1|COMPLETED|Second Intervention: 1 Month||42
1411857|NCT02920957|3455890|P2|STARTED|Second Intervention: 1 Month||41
1411858|NCT02920957|3455891|P1|STARTED|Second Intervention: 1 Month||42
1411859|NCT02920957|3455890|P2|NOT COMPLETED|First Intervention : 1 Month||0
1411860|NCT02920957|3455891|P1|NOT COMPLETED|First Intervention : 1 Month||4
1411861|NCT02920957|3455890|P2|COMPLETED|First Intervention : 1 Month||41
1411862|NCT02920957|3455891|P1|COMPLETED|First Intervention : 1 Month||42
1411863|NCT02920957|3455890|P2|STARTED|First Intervention : 1 Month||41
1411864|NCT02920957|3455891|P1|STARTED|First Intervention : 1 Month||46
1411865|NCT02920749|3455947|P4|NOT COMPLETED|Overall Study||0
1411866|NCT02920749|3455948|P3|NOT COMPLETED|Overall Study||0
1411867|NCT02920749|3455949|P2|NOT COMPLETED|Overall Study||0
1411868|NCT02920749|3455950|P1|NOT COMPLETED|Overall Study||0
1411869|NCT02920749|3455947|P4|COMPLETED|Overall Study||30
1411870|NCT02920749|3455948|P3|COMPLETED|Overall Study||30
1411871|NCT02920749|3455949|P2|COMPLETED|Overall Study||30
1411872|NCT02920749|3455950|P1|COMPLETED|Overall Study||30
1411873|NCT02920749|3455947|P4|STARTED|Overall Study||30
1411874|NCT02920749|3455948|P3|STARTED|Overall Study||30
1411875|NCT02920749|3455949|P2|STARTED|Overall Study||30
1411876|NCT02920749|3455950|P1|STARTED|Overall Study||30
1411877|NCT02919657|3455964|P2|NOT COMPLETED|Overall Study||0
1411878|NCT02919657|3455965|P1|NOT COMPLETED|Overall Study||0
1411879|NCT02919657|3455964|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
1411880|NCT02919657|3455965|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
1411881|NCT02919657|3455964|P2|STARTED|Overall Study|10 Participants|10
1411882|NCT02919657|3455965|P1|STARTED|Overall Study|10 Participants|10
1411883|NCT02919007|3455971|P1|NOT COMPLETED|Overall Study||0
1411884|NCT02919007|3455971|P1|COMPLETED|Overall Study||25
1411885|NCT02919007|3455971|P1|STARTED|Overall Study||25
1411886|NCT02918773|3455977|P2|NOT COMPLETED|Overall Study||0
1411887|NCT02918773|3455978|P1|NOT COMPLETED|Overall Study||0
1411888|NCT02918773|3455977|P2|COMPLETED|Overall Study||11
1411889|NCT02918773|3455978|P1|COMPLETED|Overall Study||11
1411890|NCT02918773|3455977|P2|STARTED|Overall Study||11
1411891|NCT02918773|3455978|P1|STARTED|Overall Study||11
1411892|NCT02918630|3455991|P2|NOT COMPLETED|Overall Study||0
1411893|NCT02918630|3455992|P1|NOT COMPLETED|Overall Study||0
1411894|NCT02918630|3455991|P2|COMPLETED|Overall Study||3
1411895|NCT02918630|3455992|P1|COMPLETED|Overall Study||4
1411896|NCT02918630|3455991|P2|STARTED|Overall Study||3
1411897|NCT02918630|3455992|P1|STARTED|Overall Study||4
1411898|NCT02918617|3456015|P9|NOT COMPLETED|Overall Study||0
1411899|NCT02918617|3456016|P8|NOT COMPLETED|Overall Study||1
1411900|NCT02918617|3456017|P7|NOT COMPLETED|Overall Study||0
1411901|NCT02918617|3456018|P6|NOT COMPLETED|Overall Study||0
1411902|NCT02918617|3456019|P5|NOT COMPLETED|Overall Study||0
1411903|NCT02918617|3456020|P4|NOT COMPLETED|Overall Study||0
1411904|NCT02918617|3456021|P3|NOT COMPLETED|Overall Study||3
1411905|NCT02918617|3456022|P2|NOT COMPLETED|Overall Study||0
1411906|NCT02918617|3456023|P1|NOT COMPLETED|Overall Study||1
1411907|NCT02918617|3456015|P9|COMPLETED|Overall Study||26
1411908|NCT02918617|3456016|P8|COMPLETED|Overall Study||25
1411909|NCT02918617|3456017|P7|COMPLETED|Overall Study||22
1411910|NCT02918617|3456018|P6|COMPLETED|Overall Study||20
1411911|NCT02918617|3456019|P5|COMPLETED|Overall Study||24
1411912|NCT02918617|3456020|P4|COMPLETED|Overall Study||22
1411913|NCT02918617|3456021|P3|COMPLETED|Overall Study||19
1411914|NCT02918617|3456022|P2|COMPLETED|Overall Study||20
1411915|NCT02918617|3456023|P1|COMPLETED|Overall Study||20
1411916|NCT02918617|3456015|P9|STARTED|Overall Study||26
1411917|NCT02918617|3456016|P8|STARTED|Overall Study||26
1411918|NCT02918617|3456017|P7|STARTED|Overall Study||22
1411919|NCT02918617|3456018|P6|STARTED|Overall Study||20
1411920|NCT02918617|3456019|P5|STARTED|Overall Study||24
1411921|NCT02918617|3456020|P4|STARTED|Overall Study||22
1411922|NCT02918617|3456021|P3|STARTED|Overall Study||22
1411923|NCT02918617|3456022|P2|STARTED|Overall Study||20
1411924|NCT02918617|3456023|P1|STARTED|Overall Study||21
1411925|NCT02918396|3456073|P3|NOT COMPLETED|Overall Study||0
1411926|NCT02918396|3456074|P2|NOT COMPLETED|Overall Study||0
1411927|NCT02918396|3456075|P1|NOT COMPLETED|Overall Study||0
1411928|NCT02918396|3456073|P3|COMPLETED|Overall Study||2
1411929|NCT02918396|3456074|P2|COMPLETED|Overall Study||1
1411930|NCT02918396|3456075|P1|COMPLETED|Overall Study||2
1411931|NCT02918396|3456073|P3|STARTED|Overall Study||2
1411932|NCT02918396|3456074|P2|STARTED|Overall Study||1
1411933|NCT02918396|3456075|P1|STARTED|Overall Study||2
1411934|NCT02918071|3456083|P1|NOT COMPLETED|Overall Study||3
1411935|NCT02918071|3456083|P1|COMPLETED|Overall Study||118
1411936|NCT02918071|3456083|P1|STARTED|Overall Study||121
1411937|NCT02917642|3456095|P2|NOT COMPLETED|Overall Study||0
1411938|NCT02917642|3456096|P1|NOT COMPLETED|Overall Study||0
1411939|NCT02917642|3456095|P2|COMPLETED|Overall Study||25
1411940|NCT02917642|3456096|P1|COMPLETED|Overall Study||25
1411941|NCT02917642|3456095|P2|STARTED|Overall Study||25
1411942|NCT02917642|3456096|P1|STARTED|Overall Study||25
1411943|NCT02915978|3456107|P3|NOT COMPLETED|Overall Study||0
1411944|NCT02915978|3456108|P2|NOT COMPLETED|Overall Study||1
1411945|NCT02915978|3456109|P1|NOT COMPLETED|Overall Study||2
1411946|NCT02915978|3456107|P3|COMPLETED|Overall Study||15
1411947|NCT02915978|3456108|P2|COMPLETED|Overall Study||14
1411948|NCT02915978|3456109|P1|COMPLETED|Overall Study||13
1411949|NCT02915978|3456107|P3|STARTED|Overall Study||15
1411950|NCT02915978|3456108|P2|STARTED|Overall Study||15
1411951|NCT02915978|3456109|P1|STARTED|Overall Study||15
1411952|NCT02915302|3456161|P2|NOT COMPLETED|Overall Study||78
1411953|NCT02915302|3456162|P1|NOT COMPLETED|Overall Study||65
1411954|NCT02915302|3456161|P2|COMPLETED|Overall Study||917
1411955|NCT02915302|3456162|P1|COMPLETED|Overall Study||890
1411956|NCT02915302|3456161|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
1411957|NCT02915302|3456162|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
1411958|NCT02915302|3456161|P2|STARTED|Overall Study||995
1411959|NCT02915302|3456162|P1|STARTED|Overall Study||955
1411960|NCT02914236|3456172|P1|NOT COMPLETED|Overall Study||1
1411961|NCT02914236|3456172|P1|COMPLETED|Overall Study||49
1411962|NCT02914236|3456172|P1|26-week Follow-up Visit|Overall Study||49
1411963|NCT02914236|3456172|P1|12-week Follow-up Visit|Overall Study||50
1411964|NCT02914236|3456172|P1|4-week Follow-up Visit|Overall Study||50
1411965|NCT02914236|3456172|P1|STARTED|Overall Study||50
1411966|NCT02912650|3456184|P4|NOT COMPLETED|Overall Study||5
1411967|NCT02912650|3456185|P3|NOT COMPLETED|Overall Study||2
1411968|NCT02912650|3456186|P2|NOT COMPLETED|Overall Study||0
1411969|NCT02912650|3456187|P1|NOT COMPLETED|Overall Study||1
1411970|NCT02912650|3456184|P4|COMPLETED|Overall Study||160
1411971|NCT02912650|3456185|P3|COMPLETED|Overall Study||173
1411972|NCT02912650|3456186|P2|COMPLETED|Overall Study||172
1411973|NCT02912650|3456187|P1|COMPLETED|Overall Study||55
1411974|NCT02912650|3456184|P4|STARTED|Overall Study||165
1411975|NCT02912650|3456185|P3|STARTED|Overall Study||175
1411976|NCT02912650|3456186|P2|STARTED|Overall Study||172
1411977|NCT02912650|3456187|P1|STARTED|Overall Study||56
1411978|NCT02911857|3456272|P3|NOT COMPLETED|Overall Study||0
1411979|NCT02911857|3456273|P2|NOT COMPLETED|Overall Study||0
1411980|NCT02911857|3456274|P1|NOT COMPLETED|Overall Study||0
1411981|NCT02911857|3456272|P3|COMPLETED|Overall Study||1
1411982|NCT02911857|3456273|P2|COMPLETED|Overall Study||1
1411983|NCT02911857|3456274|P1|COMPLETED|Overall Study||2
1411984|NCT02911857|3456272|P3|STARTED|Overall Study||1
1411985|NCT02911857|3456273|P2|STARTED|Overall Study||1
1411986|NCT02911857|3456274|P1|STARTED|Overall Study||2
1411987|NCT02910739|3456284|P4|NOT COMPLETED|Overall Study||0
1411988|NCT02910739|3456285|P3|NOT COMPLETED|Overall Study||0
1411989|NCT02910739|3456286|P2|NOT COMPLETED|Overall Study||0
1411990|NCT02910739|3456287|P1|NOT COMPLETED|Overall Study||1
1411991|NCT02910739|3456284|P4|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
1411992|NCT02910739|3456285|P3|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
1411993|NCT02910739|3456286|P2|COMPLETED|Overall Study||8
1411994|NCT02910739|3456287|P1|COMPLETED|Overall Study||7
1411995|NCT02910739|3456284|P4|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
1411996|NCT02910739|3456285|P3|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
1411997|NCT02910739|3456286|P2|STARTED|Overall Study||8
1411998|NCT02910739|3456287|P1|STARTED|Overall Study||8
1411999|NCT02910362|3456315|P2|NOT COMPLETED|Overall Study||0
1412000|NCT02910362|3456316|P1|NOT COMPLETED|Overall Study||0
1412001|NCT02910362|3456315|P2|COMPLETED|Overall Study||7
1412002|NCT02910362|3456316|P1|COMPLETED|Overall Study||8
1412003|NCT02910362|3456315|P2|STARTED|Overall Study||7
1412004|NCT02910362|3456316|P1|STARTED|Overall Study||8
1412005|NCT02908269|3456325|P3|NOT COMPLETED|Overall Study||0
1412006|NCT02908269|3456326|P2|NOT COMPLETED|Overall Study||0
1412007|NCT02908269|3456327|P1|NOT COMPLETED|Overall Study||0
1412008|NCT02908269|3456325|P3|COMPLETED|Overall Study||60
1412009|NCT02908269|3456326|P2|COMPLETED|Overall Study||60
1412010|NCT02908269|3456327|P1|COMPLETED|Overall Study||60
1412011|NCT02908269|3456325|P3|STARTED|Overall Study||60
1412012|NCT02908269|3456326|P2|STARTED|Overall Study||60
1412013|NCT02908269|3456327|P1|STARTED|Overall Study||60
1412014|NCT02907892|3456343|P2|NOT COMPLETED|Overall Study||40
1412015|NCT02907892|3456344|P1|NOT COMPLETED|Overall Study||27
1412016|NCT02907892|3456343|P2|COMPLETED|Overall Study||236
1412017|NCT02907892|3456344|P1|COMPLETED|Overall Study||250
1412018|NCT02907892|3456343|P2|STARTED|Overall Study||276
1412019|NCT02907892|3456344|P1|STARTED|Overall Study||277
1412020|NCT02907268|3456352|P2|NOT COMPLETED|Overall Study||0
1412021|NCT02907268|3456353|P1|NOT COMPLETED|Overall Study||0
1412022|NCT02907268|3456352|P2|COMPLETED|Overall Study||5
1412023|NCT02907268|3456353|P1|COMPLETED|Overall Study||5
1412024|NCT02907268|3456352|P2|STARTED|Overall Study||5
1412025|NCT02907268|3456353|P1|STARTED|Overall Study||5
1412026|NCT02906917|3456362|P2|NOT COMPLETED|Intensification Period (Week 26-38)||7
1412027|NCT02906917|3456363|P1|NOT COMPLETED|Intensification Period (Week 26-38)||9
1412028|NCT02906917|3456362|P2|COMPLETED|Intensification Period (Week 26-38)||247
1412029|NCT02906917|3456363|P1|COMPLETED|Intensification Period (Week 26-38)||252
1412030|NCT02906917|3456362|P2|STARTED|Intensification Period (Week 26-38)||254
1412031|NCT02906917|3456363|P1|STARTED|Intensification Period (Week 26-38)||261
1412032|NCT02906917|3456362|P2|NOT COMPLETED|Initiation Period (Week 0-26)||11
1412033|NCT02906917|3456363|P1|NOT COMPLETED|Initiation Period (Week 0-26)||6
1412034|NCT02906917|3456362|P2|COMPLETED|Initiation Period (Week 0-26)||254
1412035|NCT02906917|3456363|P1|COMPLETED|Initiation Period (Week 0-26)||261
1412036|NCT02906917|3456362|P2|Exposed|Initiation Period (Week 0-26)||263
1412037|NCT02906917|3456363|P1|Exposed|Initiation Period (Week 0-26)||265
1412038|NCT02906917|3456362|P2|STARTED|Initiation Period (Week 0-26)||265
1412039|NCT02906917|3456363|P1|STARTED|Initiation Period (Week 0-26)||267
1412040|NCT02906813|3456394|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1412041|NCT02906813|3456395|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1412042|NCT02906813|3456396|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1412043|NCT02906813|3456394|P3|COMPLETED|Intervention Period 3 (3 Days)||3
1412044|NCT02906813|3456395|P2|COMPLETED|Intervention Period 3 (3 Days)||3
1412045|NCT02906813|3456396|P1|COMPLETED|Intervention Period 3 (3 Days)||3
1412046|NCT02906813|3456394|P3|STARTED|Intervention Period 3 (3 Days)||3
1412047|NCT02906813|3456395|P2|STARTED|Intervention Period 3 (3 Days)||3
1412048|NCT02906813|3456396|P1|STARTED|Intervention Period 3 (3 Days)||3
1412049|NCT02906813|3456394|P3|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
1412050|NCT02906813|3456395|P2|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
1412051|NCT02906813|3456396|P1|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
1412052|NCT02906813|3456394|P3|COMPLETED|Washout Period 2 (at Least 3 Days)||3
1412053|NCT02906813|3456395|P2|COMPLETED|Washout Period 2 (at Least 3 Days)||3
1412054|NCT02906813|3456396|P1|COMPLETED|Washout Period 2 (at Least 3 Days)||3
1412055|NCT02906813|3456394|P3|STARTED|Washout Period 2 (at Least 3 Days)||3
1412056|NCT02906813|3456395|P2|STARTED|Washout Period 2 (at Least 3 Days)||3
1412057|NCT02906813|3456396|P1|STARTED|Washout Period 2 (at Least 3 Days)||3
1412058|NCT02906813|3456394|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1412059|NCT02906813|3456395|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1412060|NCT02906813|3456396|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1412061|NCT02906813|3456394|P3|COMPLETED|Intervention Period 2 (3 Days)||3
1412062|NCT02906813|3456395|P2|COMPLETED|Intervention Period 2 (3 Days)||3
1412063|NCT02906813|3456396|P1|COMPLETED|Intervention Period 2 (3 Days)||3
1412064|NCT02906813|3456394|P3|STARTED|Intervention Period 2 (3 Days)||3
1412065|NCT02906813|3456395|P2|STARTED|Intervention Period 2 (3 Days)||3
1412066|NCT02906813|3456396|P1|STARTED|Intervention Period 2 (3 Days)||3
1412067|NCT02906813|3456394|P3|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
1412068|NCT02906813|3456395|P2|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
1412069|NCT02906813|3456396|P1|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
1412070|NCT02906813|3456394|P3|COMPLETED|Washout Period 1 (at Least 3 Days)||3
1412071|NCT02906813|3456395|P2|COMPLETED|Washout Period 1 (at Least 3 Days)||3
1412072|NCT02906813|3456396|P1|COMPLETED|Washout Period 1 (at Least 3 Days)||3
1412073|NCT02906813|3456394|P3|STARTED|Washout Period 1 (at Least 3 Days)||3
1412074|NCT02906813|3456395|P2|STARTED|Washout Period 1 (at Least 3 Days)||3
1412075|NCT02906813|3456396|P1|STARTED|Washout Period 1 (at Least 3 Days)||3
1412076|NCT02906813|3456394|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1412077|NCT02906813|3456395|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1412078|NCT02906813|3456396|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1412079|NCT02906813|3456394|P3|COMPLETED|Intervention Period 1 (3 Days)||3
1412080|NCT02906813|3456395|P2|COMPLETED|Intervention Period 1 (3 Days)||3
1412081|NCT02906813|3456396|P1|COMPLETED|Intervention Period 1 (3 Days)||3
1412082|NCT02906813|3456394|P3|STARTED|Intervention Period 1 (3 Days)||3
1412083|NCT02906813|3456395|P2|STARTED|Intervention Period 1 (3 Days)||3
1412084|NCT02906813|3456396|P1|STARTED|Intervention Period 1 (3 Days)||3
1412085|NCT02906358|3456424|P2|NOT COMPLETED|Overall Study||22
1412086|NCT02906358|3456425|P1|NOT COMPLETED|Overall Study||22
1412087|NCT02906358|3456424|P2|COMPLETED|Overall Study||31
1412088|NCT02906358|3456425|P1|COMPLETED|Overall Study||36
1412089|NCT02906358|3456424|P2|Completed 3 Month Measures|Overall Study||33
1412090|NCT02906358|3456425|P1|Completed 3 Month Measures|Overall Study||36
1412091|NCT02906358|3456424|P2|STARTED|Overall Study||53
1412092|NCT02906358|3456425|P1|STARTED|Overall Study||58
1412093|NCT02905825|3456453|P1|NOT COMPLETED|Overall Study||12
1412094|NCT02905825|3456453|P1|COMPLETED|Overall Study||41
1412095|NCT02905825|3456453|P1|STARTED|Overall Study||53
1412096|NCT02905331|3456461|P3|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
1412097|NCT02905331|3456462|P2|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
1412098|NCT02905331|3456463|P1|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
1412099|NCT02905331|3456461|P3|COMPLETED|Active Treatment and Follow up (wk16-40)||13
1412100|NCT02905331|3456462|P2|COMPLETED|Active Treatment and Follow up (wk16-40)||53
1412101|NCT02905331|3456463|P1|COMPLETED|Active Treatment and Follow up (wk16-40)||0
1412102|NCT02905331|3456461|P3|STARTED|Active Treatment and Follow up (wk16-40)||13
1412103|NCT02905331|3456462|P2|STARTED|Active Treatment and Follow up (wk16-40)||61
1412104|NCT02905331|3456463|P1|STARTED|Active Treatment and Follow up (wk16-40)||0
1412105|NCT02905331|3456461|P3|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
1412106|NCT02905331|3456462|P2|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
1412107|NCT02905331|3456463|P1|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
1412108|NCT02905331|3456461|P3|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
1412109|NCT02905331|3456462|P2|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
1412110|NCT02905331|3456463|P1|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
1412111|NCT02905331|3456461|P3|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
1412112|NCT02905331|3456462|P2|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
1412113|NCT02905331|3456463|P1|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
1412114|NCT02904915|3456491|P2|NOT COMPLETED|Overall Study||0
1412115|NCT02904915|3456492|P1|NOT COMPLETED|Overall Study||0
1412116|NCT02904915|3456491|P2|COMPLETED|Overall Study||25
1412117|NCT02904915|3456492|P1|COMPLETED|Overall Study||25
1412118|NCT02904915|3456491|P2|STARTED|Overall Study||25
1412119|NCT02904915|3456492|P1|STARTED|Overall Study||25
1412120|NCT02903394|3456504|P2|NOT COMPLETED|Overall Study||0
1412121|NCT02903394|3456505|P1|NOT COMPLETED|Overall Study||0
1412122|NCT02903394|3456504|P2|COMPLETED|Overall Study||50
1412123|NCT02903394|3456505|P1|COMPLETED|Overall Study||5
1412124|NCT02903394|3456504|P2|STARTED|Overall Study||50
1412125|NCT02903394|3456505|P1|STARTED|Overall Study||5
1412126|NCT02903238|3456515|P1|NOT COMPLETED|Overall Study||4
1412127|NCT02903238|3456515|P1|COMPLETED|Overall Study||17
1412128|NCT02903238|3456515|P1|STARTED|Overall Study||21
1412129|NCT02902172|3456526|P2|NOT COMPLETED|Overall Study||0
1412130|NCT02902172|3456527|P1|NOT COMPLETED|Overall Study||0
1412131|NCT02902172|3456526|P2|COMPLETED|Overall Study||20
1412132|NCT02902172|3456527|P1|COMPLETED|Overall Study||16
1412133|NCT02902172|3456526|P2|STARTED|Overall Study||20
1412134|NCT02902172|3456527|P1|STARTED|Overall Study||16
1412135|NCT02901951|3456535|P1|NOT COMPLETED|Overall Study||0
1412136|NCT02901951|3456535|P1|COMPLETED|Overall Study||103
1412137|NCT02901951|3456535|P1|STARTED|Overall Study||103
1412138|NCT02901054|3456546|P1|NOT COMPLETED|Overall Study||4
1412139|NCT02901054|3456546|P1|COMPLETED|Overall Study||15
1412140|NCT02901054|3456546|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
1412141|NCT02899338|3456552|P2|NOT COMPLETED|Overall Study||2
1412142|NCT02899338|3456553|P1|NOT COMPLETED|Overall Study||3
1412143|NCT02899338|3456552|P2|COMPLETED|Overall Study||79
1412144|NCT02899338|3456553|P1|COMPLETED|Overall Study||78
1412145|NCT02899338|3456552|P2|STARTED|Overall Study||81
1412146|NCT02899338|3456553|P1|STARTED|Overall Study||81
1412147|NCT02898116|3456565|P1|NOT COMPLETED|Overall Study||2
1412148|NCT02898116|3456565|P1|COMPLETED|Overall Study||0
1412149|NCT02898116|3456565|P1|STARTED|Overall Study||2
1412150|NCT02897141|3456573|P2|NOT COMPLETED|Overall Study||1
1412151|NCT02897141|3456574|P1|NOT COMPLETED|Overall Study||3
1412152|NCT02897141|3456573|P2|COMPLETED|Overall Study||39
1412153|NCT02897141|3456574|P1|COMPLETED|Overall Study||37
1412154|NCT02897141|3456573|P2|STARTED|Overall Study||40
1412155|NCT02897141|3456574|P1|STARTED|Overall Study||40
1412156|NCT02896296|3456581|P1|NOT COMPLETED|Overall Study||42
1412157|NCT02896296|3456581|P1|COMPLETED|Overall Study||166
1412158|NCT02896296|3456581|P1|STARTED|Overall Study||208
1412159|NCT02895347|3456589|P2|NOT COMPLETED|Overall Study||1
1412160|NCT02895347|3456590|P1|NOT COMPLETED|Overall Study||3
1412161|NCT02895347|3456589|P2|COMPLETED|Overall Study||19
1412162|NCT02895347|3456590|P1|COMPLETED|Overall Study||17
1412163|NCT02895347|3456589|P2|STARTED|Overall Study||20
1412164|NCT02895347|3456590|P1|STARTED|Overall Study||20
1412165|NCT02894840|3456603|P4|NOT COMPLETED|Overall Study||0
1412166|NCT02894840|3456604|P3|NOT COMPLETED|Overall Study||3
1412167|NCT02894840|3456605|P2|NOT COMPLETED|Overall Study||0
1412168|NCT02894840|3456606|P1|NOT COMPLETED|Overall Study||1
1412169|NCT02894840|3456603|P4|COMPLETED|Overall Study||100
1412170|NCT02894840|3456604|P3|COMPLETED|Overall Study||197
1412171|NCT02894840|3456605|P2|COMPLETED|Overall Study||20
1412172|NCT02894840|3456606|P1|COMPLETED|Overall Study||19
1412173|NCT02894840|3456603|P4|STARTED|Overall Study||100
1412174|NCT02894840|3456604|P3|STARTED|Overall Study||200
1412175|NCT02894840|3456605|P2|STARTED|Overall Study||20
1412176|NCT02894840|3456606|P1|STARTED|Overall Study||20
1412177|NCT02891863|3456628|P1|NOT COMPLETED|Overall Study||0
1412178|NCT02891863|3456628|P1|COMPLETED|Overall Study||9
1412179|NCT02891863|3456628|P1|STARTED|Overall Study||9
1412180|NCT02890381|3456635|P2|NOT COMPLETED|Overall Study||0
1412181|NCT02890381|3456636|P1|NOT COMPLETED|Overall Study||0
1412182|NCT02890381|3456635|P2|COMPLETED|Overall Study||6
1412183|NCT02890381|3456636|P1|COMPLETED|Overall Study||11
1412184|NCT02890381|3456635|P2|STARTED|Overall Study||6
1412185|NCT02890381|3456636|P1|STARTED|Overall Study||11
1412186|NCT02890303|3456662|P1|NOT COMPLETED|Overall Study||0
1412187|NCT02890303|3456662|P1|COMPLETED|Overall Study||100
1412188|NCT02890303|3456662|P1|STARTED|Overall Study||100
1412189|NCT02889289|3456666|P1|NOT COMPLETED|Overall Study||0
1412190|NCT02889289|3456666|P1|COMPLETED|Overall Study||1
1412191|NCT02889289|3456666|P1|STARTED|Overall Study||1
1412192|NCT02887989|3456677|P2|NOT COMPLETED|Overall Study||11
1412193|NCT02887989|3456678|P1|NOT COMPLETED|Overall Study||9
1412194|NCT02887989|3456677|P2|COMPLETED|Overall Study||59
1412195|NCT02887989|3456678|P1|COMPLETED|Overall Study||61
1412196|NCT02887989|3456677|P2|STARTED|Overall Study||70
1412197|NCT02887989|3456678|P1|STARTED|Overall Study||70
1412198|NCT02886715|3456691|P3|NOT COMPLETED|Overall Study||20
1412199|NCT02886715|3456692|P2|NOT COMPLETED|Overall Study||55
1412200|NCT02886715|3456693|P1|NOT COMPLETED|Overall Study||64
1412201|NCT02886715|3456691|P3|COMPLETED|Overall Study||203
1412202|NCT02886715|3456692|P2|COMPLETED|Overall Study||390
1412203|NCT02886715|3456693|P1|COMPLETED|Overall Study||378
1412204|NCT02886715|3456691|P3|Per Protocol (PP) Population|Overall Study||176
1412205|NCT02886715|3456692|P2|Per Protocol (PP) Population|Overall Study||351
1412206|NCT02886715|3456693|P1|Per Protocol (PP) Population|Overall Study||346
1412207|NCT02886715|3456691|P3|Modified ITT (mITT)|Overall Study||217
1412208|NCT02886715|3456692|P2|Modified ITT (mITT)|Overall Study||418
1412209|NCT02886715|3456693|P1|Modified ITT (mITT)|Overall Study||421
1412210|NCT02886715|3456691|P3|STARTED|Overall Study||223
1412211|NCT02886715|3456692|P2|STARTED|Overall Study||445
1412212|NCT02886715|3456693|P1|STARTED|Overall Study||442
1412213|NCT02886702|3456710|P3|NOT COMPLETED|Overall Study||53
1412214|NCT02886702|3456711|P2|NOT COMPLETED|Overall Study||51
1412215|NCT02886702|3456712|P1|NOT COMPLETED|Overall Study||48
1412216|NCT02886702|3456710|P3|COMPLETED|Overall Study||232
1412217|NCT02886702|3456711|P2|COMPLETED|Overall Study||235
1412218|NCT02886702|3456712|P1|COMPLETED|Overall Study||236
1412219|NCT02886702|3456710|P3|Per-Protocol Population (PP)|Overall Study||201
1412220|NCT02886702|3456711|P2|Per-Protocol Population (PP)|Overall Study||209
1412221|NCT02886702|3456712|P1|Per-Protocol Population (PP)|Overall Study||208
1412222|NCT02886702|3456710|P3|Modified Intent-to Treat (mITT)|Overall Study||275
1412223|NCT02886702|3456711|P2|Modified Intent-to Treat (mITT)|Overall Study||266
1412224|NCT02886702|3456712|P1|Modified Intent-to Treat (mITT)|Overall Study||263
1412225|NCT02886702|3456710|P3|STARTED|Overall Study||285
1412226|NCT02886702|3456711|P2|STARTED|Overall Study||286
1412227|NCT02886702|3456712|P1|STARTED|Overall Study||284
1412228|NCT02886338|3456726|P1|NOT COMPLETED|Overall Study||1
1412229|NCT02886338|3456726|P1|COMPLETED|Overall Study||9
1412230|NCT02886338|3456726|P1|STARTED|Overall Study||10
1412231|NCT02885181|3456734|P4|NOT COMPLETED|Overall Study||3
1412232|NCT02885181|3456735|P3|NOT COMPLETED|Overall Study||0
1412233|NCT02885181|3456736|P2|NOT COMPLETED|Overall Study||1
1412234|NCT02885181|3456737|P1|NOT COMPLETED|Overall Study||0
1412235|NCT02885181|3456734|P4|COMPLETED|Overall Study||19
1412236|NCT02885181|3456735|P3|COMPLETED|Overall Study||21
1412237|NCT02885181|3456736|P2|COMPLETED|Overall Study||19
1412238|NCT02885181|3456737|P1|COMPLETED|Overall Study||20
1412239|NCT02885181|3456734|P4|STARTED|Overall Study||22
1412240|NCT02885181|3456735|P3|STARTED|Overall Study||21
1412241|NCT02885181|3456736|P2|STARTED|Overall Study||20
1412242|NCT02885181|3456737|P1|STARTED|Overall Study||20
1412243|NCT02884492|3456765|P2|NOT COMPLETED|Overall Study||0
1412244|NCT02884492|3456766|P1|NOT COMPLETED|Overall Study||0
1412245|NCT02884492|3456765|P2|COMPLETED|Overall Study||10
1412246|NCT02884492|3456766|P1|COMPLETED|Overall Study||7
1412247|NCT02884492|3456765|P2|STARTED|Overall Study||10
1412248|NCT02884492|3456766|P1|STARTED|Overall Study||7
1412249|NCT02884427|3456775|P3|NOT COMPLETED|Overall Study||0
1412250|NCT02884427|3456776|P2|NOT COMPLETED|Overall Study||0
1412251|NCT02884427|3456777|P1|NOT COMPLETED|Overall Study||0
1412252|NCT02884427|3456775|P3|COMPLETED|Overall Study||50
1412253|NCT02884427|3456776|P2|COMPLETED|Overall Study||52
1412254|NCT02884427|3456777|P1|COMPLETED|Overall Study||48
1412255|NCT02884427|3456775|P3|STARTED|Overall Study||50
1412256|NCT02884427|3456776|P2|STARTED|Overall Study||52
1412257|NCT02884427|3456777|P1|STARTED|Overall Study||48
1412258|NCT02884089|3456791|P4|NOT COMPLETED|Follow-up Visit||1
1412259|NCT02884089|3456792|P3|NOT COMPLETED|Follow-up Visit||0
1412260|NCT02884089|3456793|P2|NOT COMPLETED|Follow-up Visit||0
1412261|NCT02884089|3456794|P1|NOT COMPLETED|Follow-up Visit||1
1412262|NCT02884089|3456791|P4|COMPLETED|Follow-up Visit||6
1412263|NCT02884089|3456792|P3|COMPLETED|Follow-up Visit||7
1412264|NCT02884089|3456793|P2|COMPLETED|Follow-up Visit||6
1412265|NCT02884089|3456794|P1|COMPLETED|Follow-up Visit||6
1412266|NCT02884089|3456791|P4|STARTED|Follow-up Visit||7
1412267|NCT02884089|3456792|P3|STARTED|Follow-up Visit||7
1412268|NCT02884089|3456793|P2|STARTED|Follow-up Visit||6
1412269|NCT02884089|3456794|P1|STARTED|Follow-up Visit||7
1412270|NCT02884089|3456791|P4|NOT COMPLETED|Period 4||0
1412271|NCT02884089|3456792|P3|NOT COMPLETED|Period 4||0
1412272|NCT02884089|3456793|P2|NOT COMPLETED|Period 4||1
1412273|NCT02884089|3456794|P1|NOT COMPLETED|Period 4||1
1412274|NCT02884089|3456791|P4|COMPLETED|Period 4||7
1412275|NCT02884089|3456792|P3|COMPLETED|Period 4||7
1412276|NCT02884089|3456793|P2|COMPLETED|Period 4||6
1412277|NCT02884089|3456794|P1|COMPLETED|Period 4||7
1412278|NCT02884089|3456791|P4|STARTED|Period 4||7
1412279|NCT02884089|3456792|P3|STARTED|Period 4||7
1412280|NCT02884089|3456793|P2|STARTED|Period 4||7
1412281|NCT02884089|3456794|P1|STARTED|Period 4||8
1412282|NCT02884089|3456791|P4|NOT COMPLETED|Washout Period 3||1
1412283|NCT02884089|3456792|P3|NOT COMPLETED|Washout Period 3||1
1412284|NCT02884089|3456793|P2|NOT COMPLETED|Washout Period 3||0
1412285|NCT02884089|3456794|P1|NOT COMPLETED|Washout Period 3||0
1412286|NCT02884089|3456791|P4|COMPLETED|Washout Period 3||7
1412287|NCT02884089|3456792|P3|COMPLETED|Washout Period 3||7
1412288|NCT02884089|3456793|P2|COMPLETED|Washout Period 3||7
1412289|NCT02884089|3456794|P1|COMPLETED|Washout Period 3||8
1412290|NCT02884089|3456791|P4|STARTED|Washout Period 3||8
1412291|NCT02884089|3456792|P3|STARTED|Washout Period 3||8
1412292|NCT02884089|3456793|P2|STARTED|Washout Period 3||7
1412293|NCT02884089|3456794|P1|STARTED|Washout Period 3||8
1412294|NCT02884089|3456791|P4|NOT COMPLETED|Period 3||0
1412295|NCT02884089|3456792|P3|NOT COMPLETED|Period 3||1
1412296|NCT02884089|3456793|P2|NOT COMPLETED|Period 3||0
1412297|NCT02884089|3456794|P1|NOT COMPLETED|Period 3||0
1412298|NCT02884089|3456791|P4|COMPLETED|Period 3||8
1412299|NCT02884089|3456792|P3|COMPLETED|Period 3||8
1412300|NCT02884089|3456793|P2|COMPLETED|Period 3||7
1412301|NCT02884089|3456794|P1|COMPLETED|Period 3||8
1412302|NCT02884089|3456791|P4|STARTED|Period 3||8
1412303|NCT02884089|3456792|P3|STARTED|Period 3||9
1412304|NCT02884089|3456793|P2|STARTED|Period 3||7
1412305|NCT02884089|3456794|P1|STARTED|Period 3||8
1412306|NCT02884089|3456791|P4|NOT COMPLETED|Washout Period 2||0
1412307|NCT02884089|3456792|P3|NOT COMPLETED|Washout Period 2||0
1412308|NCT02884089|3456793|P2|NOT COMPLETED|Washout Period 2||0
1412309|NCT02884089|3456794|P1|NOT COMPLETED|Washout Period 2||0
1412310|NCT02884089|3456791|P4|COMPLETED|Washout Period 2||8
1412311|NCT02884089|3456792|P3|COMPLETED|Washout Period 2||9
1412312|NCT02884089|3456793|P2|COMPLETED|Washout Period 2||7
1412313|NCT02884089|3456794|P1|COMPLETED|Washout Period 2||8
1412314|NCT02884089|3456791|P4|STARTED|Washout Period 2||8
1412315|NCT02884089|3456792|P3|STARTED|Washout Period 2||9
1412316|NCT02884089|3456793|P2|STARTED|Washout Period 2||7
1412317|NCT02884089|3456794|P1|STARTED|Washout Period 2||8
1412318|NCT02884089|3456791|P4|NOT COMPLETED|Period 2||0
1412319|NCT02884089|3456792|P3|NOT COMPLETED|Period 2||0
1412320|NCT02884089|3456793|P2|NOT COMPLETED|Period 2||0
1412321|NCT02884089|3456794|P1|NOT COMPLETED|Period 2||1
1412322|NCT02884089|3456791|P4|COMPLETED|Period 2||8
1412323|NCT02884089|3456792|P3|COMPLETED|Period 2||9
1412324|NCT02884089|3456793|P2|COMPLETED|Period 2||7
1412325|NCT02884089|3456794|P1|COMPLETED|Period 2||8
1412326|NCT02884089|3456791|P4|STARTED|Period 2||8
1412327|NCT02884089|3456792|P3|STARTED|Period 2||9
1412328|NCT02884089|3456793|P2|STARTED|Period 2||7
1412329|NCT02884089|3456794|P1|STARTED|Period 2||9
1412330|NCT02884089|3456791|P4|NOT COMPLETED|Washout Period 1||1
1412331|NCT02884089|3456792|P3|NOT COMPLETED|Washout Period 1||0
1412332|NCT02884089|3456793|P2|NOT COMPLETED|Washout Period 1||2
1412333|NCT02884089|3456794|P1|NOT COMPLETED|Washout Period 1||0
1412334|NCT02884089|3456791|P4|COMPLETED|Washout Period 1||8
1412335|NCT02884089|3456792|P3|COMPLETED|Washout Period 1||9
1412336|NCT02884089|3456793|P2|COMPLETED|Washout Period 1||7
1412337|NCT02884089|3456794|P1|COMPLETED|Washout Period 1||9
1412338|NCT02884089|3456791|P4|STARTED|Washout Period 1||9
1412339|NCT02884089|3456792|P3|STARTED|Washout Period 1||9
1412340|NCT02884089|3456793|P2|STARTED|Washout Period 1||9
1412341|NCT02884089|3456794|P1|STARTED|Washout Period 1||9
1412342|NCT02884089|3456791|P4|NOT COMPLETED|Period 1||0
1412343|NCT02884089|3456792|P3|NOT COMPLETED|Period 1||0
1412344|NCT02884089|3456793|P2|NOT COMPLETED|Period 1||2
1412345|NCT02884089|3456794|P1|NOT COMPLETED|Period 1||2
1412346|NCT02884089|3456791|P4|COMPLETED|Period 1||9
1412347|NCT02884089|3456792|P3|COMPLETED|Period 1||9
1412348|NCT02884089|3456793|P2|COMPLETED|Period 1||9
1412349|NCT02884089|3456794|P1|COMPLETED|Period 1||9
1412350|NCT02884089|3456791|P4|Received at Least One Dose of Study Drug|Period 1||9
1412351|NCT02884089|3456792|P3|Received at Least One Dose of Study Drug|Period 1||9
1412352|NCT02884089|3456793|P2|Received at Least One Dose of Study Drug|Period 1||11
1412353|NCT02884089|3456794|P1|Received at Least One Dose of Study Drug|Period 1||11
1412354|NCT02884089|3456791|P4|STARTED|Period 1||9
1412355|NCT02884089|3456792|P3|STARTED|Period 1||9
1412356|NCT02884089|3456793|P2|STARTED|Period 1||11
1412357|NCT02884089|3456794|P1|STARTED|Period 1||11
1412358|NCT02883244|3456810|P2|NOT COMPLETED|Overall Study||1
1412359|NCT02883244|3456811|P1|NOT COMPLETED|Overall Study||0
1412360|NCT02883244|3456810|P2|COMPLETED|Overall Study||25
1412361|NCT02883244|3456811|P1|COMPLETED|Overall Study||24
1412362|NCT02883244|3456810|P2|STARTED|Overall Study||26
1412363|NCT02883244|3456811|P1|STARTED|Overall Study||24
1412364|NCT02882152|3456829|P2|NOT COMPLETED|Overall Study||0
1412365|NCT02882152|3456830|P1|NOT COMPLETED|Overall Study||1
1412366|NCT02882152|3456829|P2|COMPLETED|Overall Study||20
1412367|NCT02882152|3456830|P1|COMPLETED|Overall Study||19
1412368|NCT02882152|3456829|P2|STARTED|Overall Study||20
1412369|NCT02882152|3456830|P1|STARTED|Overall Study||20
1412370|NCT02881658|3456840|P2|NOT COMPLETED|Overall Study||5
1412371|NCT02881658|3456841|P1|NOT COMPLETED|Overall Study||2
1412372|NCT02881658|3456840|P2|COMPLETED|Overall Study||96
1412373|NCT02881658|3456841|P1|COMPLETED|Overall Study||98
1412374|NCT02881658|3456840|P2|STARTED|Overall Study||101
1412375|NCT02881658|3456841|P1|STARTED|Overall Study||100
1412376|NCT02881008|3456881|P6|NOT COMPLETED|Overall Study||0
1412377|NCT02881008|3456882|P5|NOT COMPLETED|Overall Study||0
1412378|NCT02881008|3456883|P4|NOT COMPLETED|Overall Study||0
1412379|NCT02881008|3456884|P3|NOT COMPLETED|Overall Study||0
1412380|NCT02881008|3456885|P2|NOT COMPLETED|Overall Study||0
1412381|NCT02881008|3456886|P1|NOT COMPLETED|Overall Study||0
1412382|NCT02881008|3456881|P6|COMPLETED|Overall Study||8
1412383|NCT02881008|3456882|P5|COMPLETED|Overall Study||8
1412384|NCT02881008|3456883|P4|COMPLETED|Overall Study||8
1412385|NCT02881008|3456884|P3|COMPLETED|Overall Study||8
1412386|NCT02881008|3456885|P2|COMPLETED|Overall Study||8
1412387|NCT02881008|3456886|P1|COMPLETED|Overall Study||8
1412388|NCT02881008|3456881|P6|STARTED|Overall Study||8
1412389|NCT02881008|3456882|P5|STARTED|Overall Study||8
1412390|NCT02881008|3456883|P4|STARTED|Overall Study||8
1412391|NCT02881008|3456884|P3|STARTED|Overall Study||8
1412392|NCT02881008|3456885|P2|STARTED|Overall Study||8
1412393|NCT02881008|3456886|P1|STARTED|Overall Study||8
1412394|NCT02880852|3456919|P1|NOT COMPLETED|Overall Study||0
1412395|NCT02880852|3456919|P1|COMPLETED|Overall Study||20
1412396|NCT02880852|3456919|P1|STARTED|Overall Study||20
1412397|NCT02880514|3456945|P2|NOT COMPLETED|Overall Study||0
1412398|NCT02880514|3456946|P1|NOT COMPLETED|Overall Study||0
1412399|NCT02880514|3456945|P2|COMPLETED|Overall Study||50
1412400|NCT02880514|3456946|P1|COMPLETED|Overall Study||50
1412401|NCT02880514|3456945|P2|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
1412402|NCT02880514|3456946|P1|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
1412403|NCT02878590|3456953|P1|NOT COMPLETED|Overall Study||2
1412404|NCT02878590|3456953|P1|COMPLETED|Overall Study||10
1412405|NCT02878590|3456953|P1|STARTED|Overall Study||12
1412406|NCT02877927|3456959|P2|NOT COMPLETED|Overall Study||57
1412407|NCT02877927|3456960|P1|NOT COMPLETED|Overall Study||54
1412408|NCT02877927|3456959|P2|COMPLETED|Overall Study||310
1412409|NCT02877927|3456960|P1|COMPLETED|Overall Study||314
1412410|NCT02877927|3456959|P2|STARTED|Overall Study||367
1412411|NCT02877927|3456960|P1|STARTED|Overall Study||368
1412412|NCT02877732|3456972|P2|NOT COMPLETED|Overall Study||6
1412413|NCT02877732|3456973|P1|NOT COMPLETED|Overall Study||6
1412414|NCT02877732|3456972|P2|COMPLETED|Overall Study||0
1412415|NCT02877732|3456973|P1|COMPLETED|Overall Study||0
1412416|NCT02877732|3456972|P2|STARTED|Overall Study||6
1412417|NCT02877732|3456973|P1|STARTED|Overall Study||6
1412418|NCT02877082|3456989|P1|NOT COMPLETED|Overall Study||5
1412419|NCT02877082|3456989|P1|COMPLETED|Overall Study||0
1412420|NCT02877082|3456989|P1|STARTED|Overall Study||5
1412421|NCT02876757|3456999|P2|NOT COMPLETED|Overall Study||0
1412422|NCT02876757|3457000|P1|NOT COMPLETED|Overall Study||0
1412423|NCT02876757|3456999|P2|COMPLETED|Overall Study||93197
1412424|NCT02876757|3457000|P1|COMPLETED|Overall Study||93197
1412425|NCT02876757|3456999|P2|STARTED|Overall Study||93197
1412426|NCT02876757|3457000|P1|STARTED|Overall Study||93197
1412427|NCT02876159|3457012|P2|NOT COMPLETED|Overall Study||0
1412428|NCT02876159|3457013|P1|NOT COMPLETED|Overall Study||0
1412429|NCT02876159|3457012|P2|COMPLETED|Overall Study||10
1412430|NCT02876159|3457013|P1|COMPLETED|Overall Study||10
1412431|NCT02876159|3457012|P2|STARTED|Overall Study||10
1412432|NCT02876159|3457013|P1|STARTED|Overall Study||10
1412433|NCT02875977|3457031|P2|NOT COMPLETED|Overall Study||29
1412434|NCT02875977|3457032|P1|NOT COMPLETED|Overall Study||42
1412435|NCT02875977|3457031|P2|COMPLETED|Overall Study||71
1412436|NCT02875977|3457032|P1|COMPLETED|Overall Study||58
1412437|NCT02875977|3457031|P2|STARTED|Overall Study||100
1412438|NCT02875977|3457032|P1|STARTED|Overall Study||100
1412439|NCT02875340|3457046|P1|NOT COMPLETED|Overall Study||8
1412440|NCT02875340|3457046|P1|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
1412441|NCT02875340|3457046|P1|STARTED|Overall Study||8
1412442|NCT02874924|3457071|P3|NOT COMPLETED|Overall Study||0
1412443|NCT02874924|3457072|P2|NOT COMPLETED|Overall Study||0
1412444|NCT02874924|3457073|P1|NOT COMPLETED|Overall Study||3
1412445|NCT02874924|3457071|P3|COMPLETED|Overall Study||6
1412446|NCT02874924|3457072|P2|COMPLETED|Overall Study||14
1412447|NCT02874924|3457073|P1|COMPLETED|Overall Study||11
1412448|NCT02874924|3457071|P3|STARTED|Overall Study||6
1412449|NCT02874924|3457072|P2|STARTED|Overall Study||14
1412450|NCT02874924|3457073|P1|STARTED|Overall Study||14
1412451|NCT02874846|3457095|P2|NOT COMPLETED|Overall Study||0
1412452|NCT02874846|3457096|P1|NOT COMPLETED|Overall Study||0
1412453|NCT02874846|3457095|P2|COMPLETED|Overall Study||4
1412454|NCT02874846|3457096|P1|COMPLETED|Overall Study||8
1412455|NCT02874846|3457095|P2|STARTED|Overall Study||4
1412456|NCT02874846|3457096|P1|STARTED|Overall Study||8
1412457|NCT02873754|3457104|P1|NOT COMPLETED|Overall Study||6
1412458|NCT02873754|3457104|P1|COMPLETED|Overall Study||5
1412459|NCT02873754|3457104|P1|STARTED|Overall Study||11
1412460|NCT02873481|3457121|P2|NOT COMPLETED|Overall Study||0
1412461|NCT02873481|3457122|P1|NOT COMPLETED|Overall Study||0
1412462|NCT02873481|3457121|P2|COMPLETED|Overall Study||17
1412463|NCT02873481|3457122|P1|COMPLETED|Overall Study||15
1412464|NCT02873481|3457121|P2|STARTED|Overall Study||17
1412465|NCT02873481|3457122|P1|STARTED|Overall Study||15
1412466|NCT02873429|3457139|P2|NOT COMPLETED|16 Weeks||2
1412467|NCT02873429|3457140|P1|NOT COMPLETED|16 Weeks||5
1412468|NCT02873429|3457139|P2|COMPLETED|16 Weeks||96
1412469|NCT02873429|3457140|P1|COMPLETED|16 Weeks||100
1412470|NCT02873429|3457139|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
1412471|NCT02873429|3457140|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
1412472|NCT02873429|3457139|P2|NOT COMPLETED|6-8 Weeks||1
1412473|NCT02873429|3457140|P1|NOT COMPLETED|6-8 Weeks||10
1412474|NCT02873429|3457139|P2|COMPLETED|6-8 Weeks||97
1412475|NCT02873429|3457140|P1|COMPLETED|6-8 Weeks||95
1412476|NCT02873429|3457139|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
1412477|NCT02873429|3457140|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
1412478|NCT02873429|3457139|P2|NOT COMPLETED|Baseline||0
1412479|NCT02873429|3457140|P1|NOT COMPLETED|Baseline||0
1412480|NCT02873429|3457139|P2|COMPLETED|Baseline||100
1412481|NCT02873429|3457140|P1|COMPLETED|Baseline||109
1412482|NCT02873429|3457139|P2|STARTED|Baseline||100
1412483|NCT02873429|3457140|P1|STARTED|Baseline||109
1412484|NCT02873104|3457152|P2|NOT COMPLETED|Overall Study||0
1412485|NCT02873104|3457153|P1|NOT COMPLETED|Overall Study||1
1412486|NCT02873104|3457152|P2|COMPLETED|Overall Study||23
1412487|NCT02873104|3457153|P1|COMPLETED|Overall Study||46
1412488|NCT02873104|3457152|P2|STARTED|Overall Study||23
1412489|NCT02873104|3457153|P1|STARTED|Overall Study||47
1412490|NCT02871570|3457167|P2|NOT COMPLETED|Overall Study||0
1412491|NCT02871570|3457168|P1|NOT COMPLETED|Overall Study||0
1412492|NCT02871570|3457167|P2|COMPLETED|Overall Study||8
1412493|NCT02871570|3457168|P1|COMPLETED|Overall Study||8
1412494|NCT02871570|3457167|P2|STARTED|Overall Study||8
1412495|NCT02871570|3457168|P1|STARTED|Overall Study||8
1412496|NCT02871375|3457196|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
1412497|NCT02871375|3457197|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
1412498|NCT02871375|3457196|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
1412499|NCT02871375|3457197|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
1412500|NCT02871375|3457196|P2|STARTED|Period 2, Second 14 Days of Wear||76
1412501|NCT02871375|3457197|P1|STARTED|Period 2, Second 14 Days of Wear||89
1412502|NCT02871375|3457196|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
1412503|NCT02871375|3457197|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
1412504|NCT02871375|3457196|P2|COMPLETED|Period 1, First 14 Days of Wear||76
1412505|NCT02871375|3457197|P1|COMPLETED|Period 1, First 14 Days of Wear||89
1412506|NCT02871375|3457196|P2|STARTED|Period 1, First 14 Days of Wear||77
1412507|NCT02871375|3457197|P1|STARTED|Period 1, First 14 Days of Wear||89
1412508|NCT02870205|3457210|P4|NOT COMPLETED|Overall Study||7
1412509|NCT02870205|3457211|P3|NOT COMPLETED|Overall Study||7
1412510|NCT02870205|3457212|P2|NOT COMPLETED|Overall Study||5
1412511|NCT02870205|3457213|P1|NOT COMPLETED|Overall Study||10
1412512|NCT02870205|3457210|P4|COMPLETED|Overall Study||287
1412513|NCT02870205|3457211|P3|COMPLETED|Overall Study||287
1412514|NCT02870205|3457212|P2|COMPLETED|Overall Study||289
1412515|NCT02870205|3457213|P1|COMPLETED|Overall Study||284
1412516|NCT02870205|3457210|P4|STARTED|Overall Study||294
1412517|NCT02870205|3457211|P3|STARTED|Overall Study||294
1412518|NCT02870205|3457212|P2|STARTED|Overall Study||294
1412519|NCT02870205|3457213|P1|STARTED|Overall Study||294
1412520|NCT02869451|3457223|P1|NOT COMPLETED|Overall Study||0
1412521|NCT02869451|3457223|P1|COMPLETED|Overall Study||5
1412522|NCT02869451|3457223|P1|STARTED|Overall Study||5
1412523|NCT02868892|3457245|P1|NOT COMPLETED|Overall Study||6
1412524|NCT02868892|3457245|P1|COMPLETED|Overall Study||0
1412525|NCT02868892|3457245|P1|STARTED|Overall Study||6
1412526|NCT02867150|3457251|P1|NOT COMPLETED|Overall Study||0
1412527|NCT02867150|3457251|P1|COMPLETED|Overall Study||58
1412528|NCT02867150|3457251|P1|STARTED|Overall Study||58
1412529|NCT02865720|3457257|P2|NOT COMPLETED|Overall Study||0
1412530|NCT02865720|3457258|P1|NOT COMPLETED|Overall Study||0
1412531|NCT02865720|3457257|P2|COMPLETED|Overall Study||8
1412532|NCT02865720|3457258|P1|COMPLETED|Overall Study||0
1412533|NCT02865720|3457257|P2|STARTED|Overall Study||8
1412534|NCT02865720|3457258|P1|STARTED|Overall Study||0
1412535|NCT02865083|3457283|P2|NOT COMPLETED|Overall Study||1
1412536|NCT02865083|3457284|P1|NOT COMPLETED|Overall Study||3
1412537|NCT02865083|3457283|P2|COMPLETED|Overall Study||0
1412538|NCT02865083|3457284|P1|COMPLETED|Overall Study||0
1412539|NCT02865083|3457283|P2|STARTED|Overall Study||1
1412540|NCT02865083|3457284|P1|STARTED|Overall Study||3
1412541|NCT02864732|3457304|P2|NOT COMPLETED|Overall Study||2
1412542|NCT02864732|3457305|P1|NOT COMPLETED|Overall Study||2
1412543|NCT02864732|3457304|P2|COMPLETED|Overall Study||13
1412544|NCT02864732|3457305|P1|COMPLETED|Overall Study||13
1412545|NCT02864732|3457304|P2|STARTED|Overall Study||15
1412546|NCT02864732|3457305|P1|STARTED|Overall Study||15
1412547|NCT02864342|3457322|P2|NOT COMPLETED|Overall Study||19
1412548|NCT02864342|3457323|P1|NOT COMPLETED|Overall Study||15
1412549|NCT02864342|3457322|P2|COMPLETED|Overall Study||49
1412550|NCT02864342|3457323|P1|COMPLETED|Overall Study||55
1412551|NCT02864342|3457322|P2|Full Analysis Set (FAS)|Overall Study||67
1412552|NCT02864342|3457323|P1|Full Analysis Set (FAS)|Overall Study||70
1412553|NCT02864342|3457322|P2|STARTED|Overall Study||68
1412554|NCT02864342|3457323|P1|STARTED|Overall Study||70
1412555|NCT02863198|3457340|P2|NOT COMPLETED|Overall Study||0
1412556|NCT02863198|3457341|P1|NOT COMPLETED|Overall Study||0
1412557|NCT02863198|3457340|P2|COMPLETED|Overall Study||60
1412558|NCT02863198|3457341|P1|COMPLETED|Overall Study||60
1412559|NCT02863198|3457340|P2|STARTED|Overall Study||60
1412560|NCT02863198|3457341|P1|STARTED|Overall Study||60
1412561|NCT02862730|3457357|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1412562|NCT02862730|3457358|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1412563|NCT02862730|3457359|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1412564|NCT02862730|3457360|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1412565|NCT02862730|3457361|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1412566|NCT02862730|3457362|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1412567|NCT02862730|3457363|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
1412568|NCT02862730|3457357|P7|COMPLETED|Fourth Intervention (84 Hours)||1
1412569|NCT02862730|3457358|P6|COMPLETED|Fourth Intervention (84 Hours)||1
1412570|NCT02862730|3457359|P5|COMPLETED|Fourth Intervention (84 Hours)||4
1412571|NCT02862730|3457360|P4|COMPLETED|Fourth Intervention (84 Hours)||4
1412572|NCT02862730|3457361|P3|COMPLETED|Fourth Intervention (84 Hours)||6
1412573|NCT02862730|3457362|P2|COMPLETED|Fourth Intervention (84 Hours)||1
1412574|NCT02862730|3457363|P1|COMPLETED|Fourth Intervention (84 Hours)||3
1412575|NCT02862730|3457357|P7|STARTED|Fourth Intervention (84 Hours)||1
1412576|NCT02862730|3457358|P6|STARTED|Fourth Intervention (84 Hours)||1
1412577|NCT02862730|3457359|P5|STARTED|Fourth Intervention (84 Hours)||4
1412578|NCT02862730|3457360|P4|STARTED|Fourth Intervention (84 Hours)||4
1412579|NCT02862730|3457361|P3|STARTED|Fourth Intervention (84 Hours)||6
1412580|NCT02862730|3457362|P2|STARTED|Fourth Intervention (84 Hours)||1
1412581|NCT02862730|3457363|P1|STARTED|Fourth Intervention (84 Hours)||3
1412582|NCT02862730|3457357|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1412583|NCT02862730|3457358|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1412584|NCT02862730|3457359|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1412585|NCT02862730|3457360|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1412586|NCT02862730|3457361|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1412587|NCT02862730|3457362|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1412588|NCT02862730|3457363|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
1412589|NCT02862730|3457357|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
1412590|NCT02862730|3457358|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
1412591|NCT02862730|3457359|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
1412592|NCT02862730|3457360|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
1412593|NCT02862730|3457361|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
1412594|NCT02862730|3457362|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
1412595|NCT02862730|3457363|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
1412596|NCT02862730|3457357|P7|STARTED|Fourth Rest Period (7-45 Days)||1
1412597|NCT02862730|3457358|P6|STARTED|Fourth Rest Period (7-45 Days)||1
1412598|NCT02862730|3457359|P5|STARTED|Fourth Rest Period (7-45 Days)||4
1412599|NCT02862730|3457360|P4|STARTED|Fourth Rest Period (7-45 Days)||4
1412600|NCT02862730|3457361|P3|STARTED|Fourth Rest Period (7-45 Days)||6
1412601|NCT02862730|3457362|P2|STARTED|Fourth Rest Period (7-45 Days)||1
1412602|NCT02862730|3457363|P1|STARTED|Fourth Rest Period (7-45 Days)||3
1412603|NCT02862730|3457357|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
1412604|NCT02862730|3457358|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
1412605|NCT02862730|3457359|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
1412606|NCT02862730|3457360|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
1412607|NCT02862730|3457361|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
1412608|NCT02862730|3457362|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
1412609|NCT02862730|3457363|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
1412610|NCT02862730|3457357|P7|COMPLETED|Third Intervention (84 Hours)||1
1412611|NCT02862730|3457358|P6|COMPLETED|Third Intervention (84 Hours)||1
1412612|NCT02862730|3457359|P5|COMPLETED|Third Intervention (84 Hours)||4
1412613|NCT02862730|3457360|P4|COMPLETED|Third Intervention (84 Hours)||4
1412614|NCT02862730|3457361|P3|COMPLETED|Third Intervention (84 Hours)||6
1412615|NCT02862730|3457362|P2|COMPLETED|Third Intervention (84 Hours)||1
1412616|NCT02862730|3457363|P1|COMPLETED|Third Intervention (84 Hours)||3
1412617|NCT02862730|3457357|P7|STARTED|Third Intervention (84 Hours)||1
1412618|NCT02862730|3457358|P6|STARTED|Third Intervention (84 Hours)||1
1412619|NCT02862730|3457359|P5|STARTED|Third Intervention (84 Hours)||4
1412620|NCT02862730|3457360|P4|STARTED|Third Intervention (84 Hours)||5
1412621|NCT02862730|3457361|P3|STARTED|Third Intervention (84 Hours)||6
1412622|NCT02862730|3457362|P2|STARTED|Third Intervention (84 Hours)||1
1412623|NCT02862730|3457363|P1|STARTED|Third Intervention (84 Hours)||3
1412624|NCT02862730|3457357|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1412625|NCT02862730|3457358|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1412626|NCT02862730|3457359|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
1412627|NCT02862730|3457360|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1412628|NCT02862730|3457361|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
1412629|NCT02862730|3457362|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1412630|NCT02862730|3457363|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
1412631|NCT02862730|3457357|P7|COMPLETED|Third Rest Period (7-45 Days)||1
1412632|NCT02862730|3457358|P6|COMPLETED|Third Rest Period (7-45 Days)||1
1412633|NCT02862730|3457359|P5|COMPLETED|Third Rest Period (7-45 Days)||4
1412634|NCT02862730|3457360|P4|COMPLETED|Third Rest Period (7-45 Days)||5
1412635|NCT02862730|3457361|P3|COMPLETED|Third Rest Period (7-45 Days)||6
1412636|NCT02862730|3457362|P2|COMPLETED|Third Rest Period (7-45 Days)||1
1412637|NCT02862730|3457363|P1|COMPLETED|Third Rest Period (7-45 Days)||3
1412638|NCT02862730|3457357|P7|STARTED|Third Rest Period (7-45 Days)||1
1412639|NCT02862730|3457358|P6|STARTED|Third Rest Period (7-45 Days)||1
1412640|NCT02862730|3457359|P5|STARTED|Third Rest Period (7-45 Days)||5
1412641|NCT02862730|3457360|P4|STARTED|Third Rest Period (7-45 Days)||5
1412642|NCT02862730|3457361|P3|STARTED|Third Rest Period (7-45 Days)||7
1412643|NCT02862730|3457362|P2|STARTED|Third Rest Period (7-45 Days)||1
1412644|NCT02862730|3457363|P1|STARTED|Third Rest Period (7-45 Days)||3
1412645|NCT02862730|3457357|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
1412646|NCT02862730|3457358|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
1412647|NCT02862730|3457359|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
1412648|NCT02862730|3457360|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
1412649|NCT02862730|3457361|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
1412650|NCT02862730|3457362|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
1412651|NCT02862730|3457363|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
1412652|NCT02862730|3457357|P7|COMPLETED|Second Intervention (84 Hours)||1
1412653|NCT02862730|3457358|P6|COMPLETED|Second Intervention (84 Hours)||1
1412654|NCT02862730|3457359|P5|COMPLETED|Second Intervention (84 Hours)||5
1412655|NCT02862730|3457360|P4|COMPLETED|Second Intervention (84 Hours)||5
1412656|NCT02862730|3457361|P3|COMPLETED|Second Intervention (84 Hours)||7
1412657|NCT02862730|3457362|P2|COMPLETED|Second Intervention (84 Hours)||1
1412658|NCT02862730|3457363|P1|COMPLETED|Second Intervention (84 Hours)||3
1412659|NCT02862730|3457357|P7|STARTED|Second Intervention (84 Hours)||1
1412660|NCT02862730|3457358|P6|STARTED|Second Intervention (84 Hours)||1
1412661|NCT02862730|3457359|P5|STARTED|Second Intervention (84 Hours)||5
1412662|NCT02862730|3457360|P4|STARTED|Second Intervention (84 Hours)||5
1412663|NCT02862730|3457361|P3|STARTED|Second Intervention (84 Hours)||7
1412664|NCT02862730|3457362|P2|STARTED|Second Intervention (84 Hours)||1
1412665|NCT02862730|3457363|P1|STARTED|Second Intervention (84 Hours)||4
1412666|NCT02862730|3457357|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1412667|NCT02862730|3457358|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1412668|NCT02862730|3457359|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1412669|NCT02862730|3457360|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1412670|NCT02862730|3457361|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1412671|NCT02862730|3457362|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1412672|NCT02862730|3457363|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
1412673|NCT02862730|3457357|P7|COMPLETED|Second Rest Period (7-45 Days)||1
1412674|NCT02862730|3457358|P6|COMPLETED|Second Rest Period (7-45 Days)||1
1412675|NCT02862730|3457359|P5|COMPLETED|Second Rest Period (7-45 Days)||5
1412676|NCT02862730|3457360|P4|COMPLETED|Second Rest Period (7-45 Days)||5
1412677|NCT02862730|3457361|P3|COMPLETED|Second Rest Period (7-45 Days)||7
1412678|NCT02862730|3457362|P2|COMPLETED|Second Rest Period (7-45 Days)||1
1412679|NCT02862730|3457363|P1|COMPLETED|Second Rest Period (7-45 Days)||4
1412680|NCT02862730|3457357|P7|STARTED|Second Rest Period (7-45 Days)||1
1412681|NCT02862730|3457358|P6|STARTED|Second Rest Period (7-45 Days)||1
1412682|NCT02862730|3457359|P5|STARTED|Second Rest Period (7-45 Days)||5
1412683|NCT02862730|3457360|P4|STARTED|Second Rest Period (7-45 Days)||5
1412684|NCT02862730|3457361|P3|STARTED|Second Rest Period (7-45 Days)||7
1412685|NCT02862730|3457362|P2|STARTED|Second Rest Period (7-45 Days)||1
1412686|NCT02862730|3457363|P1|STARTED|Second Rest Period (7-45 Days)||4
1412687|NCT02862730|3457357|P7|NOT COMPLETED|First Intervention (84 Hours)||0
1412688|NCT02862730|3457358|P6|NOT COMPLETED|First Intervention (84 Hours)||0
1412689|NCT02862730|3457359|P5|NOT COMPLETED|First Intervention (84 Hours)||0
1412690|NCT02862730|3457360|P4|NOT COMPLETED|First Intervention (84 Hours)||0
1412691|NCT02862730|3457361|P3|NOT COMPLETED|First Intervention (84 Hours)||0
1412692|NCT02862730|3457362|P2|NOT COMPLETED|First Intervention (84 Hours)||0
1412693|NCT02862730|3457363|P1|NOT COMPLETED|First Intervention (84 Hours)||0
1412694|NCT02862730|3457357|P7|COMPLETED|First Intervention (84 Hours)||1
1412695|NCT02862730|3457358|P6|COMPLETED|First Intervention (84 Hours)||1
1412696|NCT02862730|3457359|P5|COMPLETED|First Intervention (84 Hours)||5
1412697|NCT02862730|3457360|P4|COMPLETED|First Intervention (84 Hours)||5
1412698|NCT02862730|3457361|P3|COMPLETED|First Intervention (84 Hours)||7
1412699|NCT02862730|3457362|P2|COMPLETED|First Intervention (84 Hours)||1
1412700|NCT02862730|3457363|P1|COMPLETED|First Intervention (84 Hours)||4
1412701|NCT02862730|3457357|P7|STARTED|First Intervention (84 Hours)||1
1412702|NCT02862730|3457358|P6|STARTED|First Intervention (84 Hours)||1
1412703|NCT02862730|3457359|P5|STARTED|First Intervention (84 Hours)||5
1412704|NCT02862730|3457360|P4|STARTED|First Intervention (84 Hours)||5
1412705|NCT02862730|3457361|P3|STARTED|First Intervention (84 Hours)||7
1412706|NCT02862730|3457362|P2|STARTED|First Intervention (84 Hours)||1
1412707|NCT02862730|3457363|P1|STARTED|First Intervention (84 Hours)||4
1412708|NCT02862730|3457357|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1412709|NCT02862730|3457358|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1412710|NCT02862730|3457359|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1412711|NCT02862730|3457360|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1412712|NCT02862730|3457361|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1412713|NCT02862730|3457362|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1412714|NCT02862730|3457363|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
1412715|NCT02862730|3457357|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
1412716|NCT02862730|3457358|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
1412717|NCT02862730|3457359|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
1412718|NCT02862730|3457360|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
1412719|NCT02862730|3457361|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
1412720|NCT02862730|3457362|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
1412721|NCT02862730|3457363|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
1412722|NCT02862730|3457357|P7|STARTED|First Rest Period (1-12 Weeks)||1
1412723|NCT02862730|3457358|P6|STARTED|First Rest Period (1-12 Weeks)||1
1412724|NCT02862730|3457359|P5|STARTED|First Rest Period (1-12 Weeks)||5
1412725|NCT02862730|3457360|P4|STARTED|First Rest Period (1-12 Weeks)||5
1412726|NCT02862730|3457361|P3|STARTED|First Rest Period (1-12 Weeks)||7
1412727|NCT02862730|3457362|P2|STARTED|First Rest Period (1-12 Weeks)||1
1412728|NCT02862730|3457363|P1|STARTED|First Rest Period (1-12 Weeks)||4
1412729|NCT02862730|3457357|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1412730|NCT02862730|3457358|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1412731|NCT02862730|3457359|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1412732|NCT02862730|3457360|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1412733|NCT02862730|3457361|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
1412734|NCT02862730|3457362|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1412735|NCT02862730|3457363|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
1412736|NCT02862730|3457357|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
1412737|NCT02862730|3457358|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
1412738|NCT02862730|3457359|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
1412739|NCT02862730|3457360|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
1412740|NCT02862730|3457361|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
1412741|NCT02862730|3457362|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
1412742|NCT02862730|3457363|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
1412743|NCT02862730|3457357|P7|STARTED|Tslim Training Visit (2 Weeks)||1
1412744|NCT02862730|3457358|P6|STARTED|Tslim Training Visit (2 Weeks)||1
1412745|NCT02862730|3457359|P5|STARTED|Tslim Training Visit (2 Weeks)||5
1412746|NCT02862730|3457360|P4|STARTED|Tslim Training Visit (2 Weeks)||5
1412747|NCT02862730|3457361|P3|STARTED|Tslim Training Visit (2 Weeks)||8
1412748|NCT02862730|3457362|P2|STARTED|Tslim Training Visit (2 Weeks)||1
1412749|NCT02862730|3457363|P1|STARTED|Tslim Training Visit (2 Weeks)||4
1412750|NCT02862600|3457418|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
1412751|NCT02862600|3457418|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
1412752|NCT02862600|3457418|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
1412753|NCT02862600|3457418|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
1412754|NCT02862600|3457418|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
1412755|NCT02862600|3457418|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
1412756|NCT02862574|3457428|P3|NOT COMPLETED|Open-Label Treatment Period||1
1412757|NCT02862574|3457429|P2|NOT COMPLETED|Open-Label Treatment Period||3
1412758|NCT02862574|3457430|P1|NOT COMPLETED|Open-Label Treatment Period||2
1412759|NCT02862574|3457428|P3|COMPLETED|Open-Label Treatment Period||0
1412760|NCT02862574|3457429|P2|COMPLETED|Open-Label Treatment Period||0
1412761|NCT02862574|3457430|P1|COMPLETED|Open-Label Treatment Period||0
1412762|NCT02862574|3457428|P3|STARTED|Open-Label Treatment Period||1
1412763|NCT02862574|3457429|P2|STARTED|Open-Label Treatment Period||3
1412764|NCT02862574|3457430|P1|STARTED|Open-Label Treatment Period||2
1412765|NCT02862574|3457428|P3|NOT COMPLETED|Double-Blind Treatment Period||4
1412766|NCT02862574|3457429|P2|NOT COMPLETED|Double-Blind Treatment Period||2
1412767|NCT02862574|3457430|P1|NOT COMPLETED|Double-Blind Treatment Period||3
1412768|NCT02862574|3457428|P3|COMPLETED|Double-Blind Treatment Period||1
1412769|NCT02862574|3457429|P2|COMPLETED|Double-Blind Treatment Period||3
1412770|NCT02862574|3457430|P1|COMPLETED|Double-Blind Treatment Period||2
1412771|NCT02862574|3457428|P3|STARTED|Double-Blind Treatment Period||5
1412772|NCT02862574|3457429|P2|STARTED|Double-Blind Treatment Period||5
1412773|NCT02862574|3457430|P1|STARTED|Double-Blind Treatment Period||5
1412774|NCT02862106|3457454|P2|NOT COMPLETED|Overall Study||6
1412775|NCT02862106|3457455|P1|NOT COMPLETED|Overall Study||38
1412776|NCT02862106|3457454|P2|COMPLETED|Overall Study||20
1412777|NCT02862106|3457455|P1|COMPLETED|Overall Study||145
1412778|NCT02862106|3457454|P2|STARTED|Overall Study||26
1412779|NCT02862106|3457455|P1|STARTED|Overall Study||183
1412780|NCT02861664|3457515|P2|NOT COMPLETED|Overall Study||1
1412781|NCT02861664|3457516|P1|NOT COMPLETED|Overall Study||0
1412782|NCT02861664|3457515|P2|COMPLETED|Overall Study||67
1412783|NCT02861664|3457516|P1|COMPLETED|Overall Study||67
1412784|NCT02861664|3457515|P2|STARTED|Overall Study||68
1412785|NCT02861664|3457516|P1|STARTED|Overall Study||67
1412786|NCT02858050|3457528|P2|NOT COMPLETED|Overall Study||0
1412787|NCT02858050|3457529|P1|NOT COMPLETED|Overall Study||0
1412788|NCT02858050|3457528|P2|COMPLETED|Overall Study||20
1412789|NCT02858050|3457529|P1|COMPLETED|Overall Study||20
1412790|NCT02858050|3457528|P2|STARTED|Overall Study||20
1412791|NCT02858050|3457529|P1|STARTED|Overall Study||20
1412792|NCT02857816|3457535|P1|NOT COMPLETED|Overall Study||38
1412793|NCT02857816|3457535|P1|COMPLETED|Overall Study||116
1412794|NCT02857816|3457535|P1|Subjects Qualified and Treated With PTNM|Overall Study||120
1412795|NCT02857816|3457535|P1|STARTED|Overall Study||154
1412796|NCT02856880|3457541|P1|NOT COMPLETED|Overall Study||1
1412797|NCT02856880|3457541|P1|COMPLETED|Overall Study||44
1412798|NCT02856880|3457541|P1|Received SLS Negative Control|Overall Study||44
1412799|NCT02856880|3457541|P1|Received Non-SLS Negative Control|Overall Study||44
1412800|NCT02856880|3457541|P1|Received Positive Control|Overall Study||45
1412801|NCT02856880|3457541|P1|Received Test Zinc Non-IPMP|Overall Study||44
1412802|NCT02856880|3457541|P1|Received Test Zinc-IPMP|Overall Study||44
1412803|NCT02856880|3457541|P1|STARTED|Overall Study||45
1412804|NCT02855541|3457565|P1|NOT COMPLETED|Overall Study||4
1412805|NCT02855541|3457565|P1|COMPLETED|Overall Study||21
1412806|NCT02855541|3457565|P1|STARTED|Overall Study||25
1412807|NCT02855411|3457576|P1|NOT COMPLETED|Overall Study||35
1412808|NCT02855411|3457576|P1|COMPLETED|Overall Study||0
1412809|NCT02855411|3457576|P1|Assigned to Study Treatment|Overall Study||0
1412810|NCT02855411|3457576|P1|STARTED|Overall Study||35
1412811|NCT02855086|3457598|P2|NOT COMPLETED|Overall Study||0
1412812|NCT02855086|3457599|P1|NOT COMPLETED|Overall Study||0
1412813|NCT02855086|3457598|P2|COMPLETED|Overall Study||1
1412814|NCT02855086|3457599|P1|COMPLETED|Overall Study||2
1412815|NCT02855086|3457598|P2|STARTED|Overall Study||1
1412816|NCT02855086|3457599|P1|STARTED|Overall Study||2
1412817|NCT02854527|3457617|P10|NOT COMPLETED|Overall Study||0
1412818|NCT02854527|3457618|P9|NOT COMPLETED|Overall Study||0
1412819|NCT02854527|3457619|P8|NOT COMPLETED|Overall Study||0
1412820|NCT02854527|3457620|P7|NOT COMPLETED|Overall Study||0
1412821|NCT02854527|3457621|P6|NOT COMPLETED|Overall Study||0
1412822|NCT02854527|3457622|P5|NOT COMPLETED|Overall Study||1
1412823|NCT02854527|3457623|P4|NOT COMPLETED|Overall Study||1
1412824|NCT02854527|3457624|P3|NOT COMPLETED|Overall Study||0
1412825|NCT02854527|3457625|P2|NOT COMPLETED|Overall Study||0
1412826|NCT02854527|3457626|P1|NOT COMPLETED|Overall Study||0
1412827|NCT02854527|3457617|P10|COMPLETED|Overall Study||3
1412828|NCT02854527|3457618|P9|COMPLETED|Overall Study||3
1412829|NCT02854527|3457619|P8|COMPLETED|Overall Study||3
1412830|NCT02854527|3457620|P7|COMPLETED|Overall Study||3
1412831|NCT02854527|3457621|P6|COMPLETED|Overall Study||3
1412832|NCT02854527|3457622|P5|COMPLETED|Overall Study||2
1412833|NCT02854527|3457623|P4|COMPLETED|Overall Study||2
1412834|NCT02854527|3457624|P3|COMPLETED|Overall Study||3
1412835|NCT02854527|3457625|P2|COMPLETED|Overall Study||3
1412836|NCT02854527|3457626|P1|COMPLETED|Overall Study||3
1412837|NCT02854527|3457617|P10|Received T|Overall Study||3
1412838|NCT02854527|3457618|P9|Received T|Overall Study||3
1412839|NCT02854527|3457619|P8|Received T|Overall Study||3
1412840|NCT02854527|3457620|P7|Received T|Overall Study||3
1412841|NCT02854527|3457621|P6|Received T|Overall Study||3
1412842|NCT02854527|3457622|P5|Received T|Overall Study||2
1412843|NCT02854527|3457623|P4|Received T|Overall Study||2
1412844|NCT02854527|3457624|P3|Received T|Overall Study||3
1412845|NCT02854527|3457625|P2|Received T|Overall Study||3
1412846|NCT02854527|3457626|P1|Received T|Overall Study||3
1412847|NCT02854527|3457617|P10|Received R4|Overall Study||3
1412848|NCT02854527|3457618|P9|Received R4|Overall Study||3
1412849|NCT02854527|3457619|P8|Received R4|Overall Study||3
1412850|NCT02854527|3457620|P7|Received R4|Overall Study||3
1412851|NCT02854527|3457621|P6|Received R4|Overall Study||3
1412852|NCT02854527|3457622|P5|Received R4|Overall Study||3
1412853|NCT02854527|3457623|P4|Received R4|Overall Study||2
1412854|NCT02854527|3457624|P3|Received R4|Overall Study||3
1412855|NCT02854527|3457625|P2|Received R4|Overall Study||3
1412856|NCT02854527|3457626|P1|Received R4|Overall Study||3
1412857|NCT02854527|3457617|P10|Received R3|Overall Study||3
1412858|NCT02854527|3457618|P9|Received R3|Overall Study||3
1412859|NCT02854527|3457619|P8|Received R3|Overall Study||3
1412860|NCT02854527|3457620|P7|Received R3|Overall Study||3
1412861|NCT02854527|3457621|P6|Received R3|Overall Study||3
1412862|NCT02854527|3457622|P5|Received R3|Overall Study||3
1412863|NCT02854527|3457623|P4|Received R3|Overall Study||2
1412864|NCT02854527|3457624|P3|Received R3|Overall Study||3
1412865|NCT02854527|3457625|P2|Received R3|Overall Study||3
1412866|NCT02854527|3457626|P1|Received R3|Overall Study||3
1412867|NCT02854527|3457617|P10|Received R2|Overall Study||3
1412868|NCT02854527|3457618|P9|Received R2|Overall Study||3
1412869|NCT02854527|3457619|P8|Received R2|Overall Study||3
1412870|NCT02854527|3457620|P7|Received R2|Overall Study||3
1412871|NCT02854527|3457621|P6|Received R2|Overall Study||3
1412872|NCT02854527|3457622|P5|Received R2|Overall Study||3
1412873|NCT02854527|3457623|P4|Received R2|Overall Study||3
1412874|NCT02854527|3457624|P3|Received R2|Overall Study||3
1412875|NCT02854527|3457625|P2|Received R2|Overall Study||3
1412876|NCT02854527|3457626|P1|Received R2|Overall Study||3
1412877|NCT02854527|3457617|P10|Received R1|Overall Study||3
1412878|NCT02854527|3457618|P9|Received R1|Overall Study||3
1412879|NCT02854527|3457619|P8|Received R1|Overall Study||3
1412880|NCT02854527|3457620|P7|Received R1|Overall Study||3
1412881|NCT02854527|3457621|P6|Received R1|Overall Study||3
1412882|NCT02854527|3457622|P5|Received R1|Overall Study||2
1412883|NCT02854527|3457623|P4|Received R1|Overall Study||2
1412884|NCT02854527|3457624|P3|Received R1|Overall Study||3
1412885|NCT02854527|3457625|P2|Received R1|Overall Study||3
1412886|NCT02854527|3457626|P1|Received R1|Overall Study||3
1412887|NCT02854527|3457617|P10|STARTED|Overall Study||3
1412888|NCT02854527|3457618|P9|STARTED|Overall Study||3
1412889|NCT02854527|3457619|P8|STARTED|Overall Study||3
1412890|NCT02854527|3457620|P7|STARTED|Overall Study||3
1412891|NCT02854527|3457621|P6|STARTED|Overall Study||3
1412892|NCT02854527|3457622|P5|STARTED|Overall Study||3
1412893|NCT02854527|3457623|P4|STARTED|Overall Study||3
1412894|NCT02854527|3457624|P3|STARTED|Overall Study||3
1412895|NCT02854527|3457625|P2|STARTED|Overall Study||3
1412896|NCT02854527|3457626|P1|STARTED|Overall Study||3
1412897|NCT02853435|3457660|P6|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1412898|NCT02853435|3457661|P5|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1412899|NCT02853435|3457662|P4|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1412900|NCT02853435|3457663|P3|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1412901|NCT02853435|3457664|P2|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1412902|NCT02853435|3457665|P1|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
1412903|NCT02853435|3457660|P6|COMPLETED|Part 3, Period 3 (3 Days)||2
1412904|NCT02853435|3457661|P5|COMPLETED|Part 3, Period 3 (3 Days)||9
1412905|NCT02853435|3457662|P4|COMPLETED|Part 3, Period 3 (3 Days)||0
1412906|NCT02853435|3457663|P3|COMPLETED|Part 3, Period 3 (3 Days)||0
1412907|NCT02853435|3457664|P2|COMPLETED|Part 3, Period 3 (3 Days)||0
1412908|NCT02853435|3457665|P1|COMPLETED|Part 3, Period 3 (3 Days)||0
1412909|NCT02853435|3457660|P6|STARTED|Part 3, Period 3 (3 Days)||2
1412910|NCT02853435|3457661|P5|STARTED|Part 3, Period 3 (3 Days)||9
1412911|NCT02853435|3457662|P4|STARTED|Part 3, Period 3 (3 Days)||0
1412912|NCT02853435|3457663|P3|STARTED|Part 3, Period 3 (3 Days)||0
1412913|NCT02853435|3457664|P2|STARTED|Part 3, Period 3 (3 Days)||0
1412914|NCT02853435|3457665|P1|STARTED|Part 3, Period 3 (3 Days)||0
1412915|NCT02853435|3457660|P6|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1412916|NCT02853435|3457661|P5|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
1412917|NCT02853435|3457662|P4|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1412918|NCT02853435|3457663|P3|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1412919|NCT02853435|3457664|P2|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1412920|NCT02853435|3457665|P1|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1412921|NCT02853435|3457660|P6|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
1412922|NCT02853435|3457661|P5|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
1412923|NCT02853435|3457662|P4|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1412924|NCT02853435|3457663|P3|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1412925|NCT02853435|3457664|P2|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1412926|NCT02853435|3457665|P1|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
1412927|NCT02853435|3457660|P6|STARTED|Part 3, Washout Period 2 (3 Days)||2
1412928|NCT02853435|3457661|P5|STARTED|Part 3, Washout Period 2 (3 Days)||10
1412929|NCT02853435|3457662|P4|STARTED|Part 3, Washout Period 2 (3 Days)||0
1412930|NCT02853435|3457663|P3|STARTED|Part 3, Washout Period 2 (3 Days)||0
1412931|NCT02853435|3457664|P2|STARTED|Part 3, Washout Period 2 (3 Days)||0
1412932|NCT02853435|3457665|P1|STARTED|Part 3, Washout Period 2 (3 Days)||0
1412933|NCT02853435|3457660|P6|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1412934|NCT02853435|3457661|P5|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1412935|NCT02853435|3457662|P4|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1412936|NCT02853435|3457663|P3|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1412937|NCT02853435|3457664|P2|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1412938|NCT02853435|3457665|P1|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
1412939|NCT02853435|3457660|P6|COMPLETED|Part 3, Period 2 (3 Days)||2
1412940|NCT02853435|3457661|P5|COMPLETED|Part 3, Period 2 (3 Days)||10
1412941|NCT02853435|3457662|P4|COMPLETED|Part 3, Period 2 (3 Days)||0
1412942|NCT02853435|3457663|P3|COMPLETED|Part 3, Period 2 (3 Days)||0
1412943|NCT02853435|3457664|P2|COMPLETED|Part 3, Period 2 (3 Days)||0
1412944|NCT02853435|3457665|P1|COMPLETED|Part 3, Period 2 (3 Days)||0
1412945|NCT02853435|3457660|P6|STARTED|Part 3, Period 2 (3 Days)||2
1412946|NCT02853435|3457661|P5|STARTED|Part 3, Period 2 (3 Days)||10
1412947|NCT02853435|3457662|P4|STARTED|Part 3, Period 2 (3 Days)||0
1412948|NCT02853435|3457663|P3|STARTED|Part 3, Period 2 (3 Days)||0
1412949|NCT02853435|3457664|P2|STARTED|Part 3, Period 2 (3 Days)||0
1412950|NCT02853435|3457665|P1|STARTED|Part 3, Period 2 (3 Days)||0
1412951|NCT02853435|3457660|P6|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412952|NCT02853435|3457661|P5|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412953|NCT02853435|3457662|P4|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412954|NCT02853435|3457663|P3|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412955|NCT02853435|3457664|P2|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412956|NCT02853435|3457665|P1|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412957|NCT02853435|3457660|P6|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
1412958|NCT02853435|3457661|P5|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
1412959|NCT02853435|3457662|P4|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412960|NCT02853435|3457663|P3|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412961|NCT02853435|3457664|P2|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412962|NCT02853435|3457665|P1|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
1412963|NCT02853435|3457660|P6|STARTED|Part 3, Washout Period 1 (3 Days)||2
1412964|NCT02853435|3457661|P5|STARTED|Part 3, Washout Period 1 (3 Days)||10
1412965|NCT02853435|3457662|P4|STARTED|Part 3, Washout Period 1 (3 Days)||0
1412966|NCT02853435|3457663|P3|STARTED|Part 3, Washout Period 1 (3 Days)||0
1412967|NCT02853435|3457664|P2|STARTED|Part 3, Washout Period 1 (3 Days)||0
1412968|NCT02853435|3457665|P1|STARTED|Part 3, Washout Period 1 (3 Days)||0
1412969|NCT02853435|3457660|P6|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1412970|NCT02853435|3457661|P5|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1412971|NCT02853435|3457662|P4|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1412972|NCT02853435|3457663|P3|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1412973|NCT02853435|3457664|P2|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1412974|NCT02853435|3457665|P1|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
1412975|NCT02853435|3457660|P6|COMPLETED|Part 3, Period 1 (3 Days)||2
1412976|NCT02853435|3457661|P5|COMPLETED|Part 3, Period 1 (3 Days)||10
1412977|NCT02853435|3457662|P4|COMPLETED|Part 3, Period 1 (3 Days)||0
1412978|NCT02853435|3457663|P3|COMPLETED|Part 3, Period 1 (3 Days)||0
1412979|NCT02853435|3457664|P2|COMPLETED|Part 3, Period 1 (3 Days)||0
1412980|NCT02853435|3457665|P1|COMPLETED|Part 3, Period 1 (3 Days)||0
1412981|NCT02853435|3457660|P6|STARTED|Part 3, Period 1 (3 Days)||2
1412982|NCT02853435|3457661|P5|STARTED|Part 3, Period 1 (3 Days)||10
1412983|NCT02853435|3457662|P4|STARTED|Part 3, Period 1 (3 Days)||0
1412984|NCT02853435|3457663|P3|STARTED|Part 3, Period 1 (3 Days)||0
1412985|NCT02853435|3457664|P2|STARTED|Part 3, Period 1 (3 Days)||0
1412986|NCT02853435|3457665|P1|STARTED|Part 3, Period 1 (3 Days)||0
1412987|NCT02853435|3457660|P6|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1412988|NCT02853435|3457661|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1412989|NCT02853435|3457662|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1412990|NCT02853435|3457663|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1412991|NCT02853435|3457664|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1412992|NCT02853435|3457665|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
1412993|NCT02853435|3457660|P6|COMPLETED|Part 2, Period 2 (3 Days)||0
1412994|NCT02853435|3457661|P5|COMPLETED|Part 2, Period 2 (3 Days)||0
1412995|NCT02853435|3457662|P4|COMPLETED|Part 2, Period 2 (3 Days)||10
1412996|NCT02853435|3457663|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
1412997|NCT02853435|3457664|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
1412998|NCT02853435|3457665|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
1412999|NCT02853435|3457660|P6|STARTED|Part 2, Period 2 (3 Days)||0
1413000|NCT02853435|3457661|P5|STARTED|Part 2, Period 2 (3 Days)||0
1413001|NCT02853435|3457662|P4|STARTED|Part 2, Period 2 (3 Days)||10
1413002|NCT02853435|3457663|P3|STARTED|Part 2, Period 2 (3 Days)||0
1413003|NCT02853435|3457664|P2|STARTED|Part 2, Period 2 (3 Days)||0
1413004|NCT02853435|3457665|P1|STARTED|Part 2, Period 2 (3 Days)||0
1413005|NCT02853435|3457660|P6|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413006|NCT02853435|3457661|P5|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413007|NCT02853435|3457662|P4|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413008|NCT02853435|3457663|P3|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413009|NCT02853435|3457664|P2|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413010|NCT02853435|3457665|P1|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413011|NCT02853435|3457660|P6|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413012|NCT02853435|3457661|P5|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413013|NCT02853435|3457662|P4|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
1413014|NCT02853435|3457663|P3|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413015|NCT02853435|3457664|P2|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413016|NCT02853435|3457665|P1|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
1413017|NCT02853435|3457660|P6|STARTED|Part 2, Washout Period 1 (3 Days)||0
1413018|NCT02853435|3457661|P5|STARTED|Part 2, Washout Period 1 (3 Days)||0
1413019|NCT02853435|3457662|P4|STARTED|Part 2, Washout Period 1 (3 Days)||10
1413020|NCT02853435|3457663|P3|STARTED|Part 2, Washout Period 1 (3 Days)||0
1413021|NCT02853435|3457664|P2|STARTED|Part 2, Washout Period 1 (3 Days)||0
1413022|NCT02853435|3457665|P1|STARTED|Part 2, Washout Period 1 (3 Days)||0
1413023|NCT02853435|3457660|P6|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1413024|NCT02853435|3457661|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1413025|NCT02853435|3457662|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1413026|NCT02853435|3457663|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1413027|NCT02853435|3457664|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1413028|NCT02853435|3457665|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
1413029|NCT02853435|3457660|P6|COMPLETED|Part 2, Period 1 (3 Days)||0
1413030|NCT02853435|3457661|P5|COMPLETED|Part 2, Period 1 (3 Days)||0
1413031|NCT02853435|3457662|P4|COMPLETED|Part 2, Period 1 (3 Days)||10
1413032|NCT02853435|3457663|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
1413033|NCT02853435|3457664|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
1413034|NCT02853435|3457665|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
1413035|NCT02853435|3457660|P6|STARTED|Part 2, Period 1 (3 Days)||0
1413036|NCT02853435|3457661|P5|STARTED|Part 2, Period 1 (3 Days)||0
1413037|NCT02853435|3457662|P4|STARTED|Part 2, Period 1 (3 Days)||10
1413038|NCT02853435|3457663|P3|STARTED|Part 2, Period 1 (3 Days)||0
1413039|NCT02853435|3457664|P2|STARTED|Part 2, Period 1 (3 Days)||0
1413040|NCT02853435|3457665|P1|STARTED|Part 2, Period 1 (3 Days)||0
1413041|NCT02853435|3457660|P6|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1413042|NCT02853435|3457661|P5|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1413043|NCT02853435|3457662|P4|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1413044|NCT02853435|3457663|P3|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1413045|NCT02853435|3457664|P2|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1413046|NCT02853435|3457665|P1|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
1413047|NCT02853435|3457660|P6|COMPLETED|Part 1a, Period 3 (3 Days)||0
1413048|NCT02853435|3457661|P5|COMPLETED|Part 1a, Period 3 (3 Days)||0
1413049|NCT02853435|3457662|P4|COMPLETED|Part 1a, Period 3 (3 Days)||0
1413050|NCT02853435|3457663|P3|COMPLETED|Part 1a, Period 3 (3 Days)||8
1413051|NCT02853435|3457664|P2|COMPLETED|Part 1a, Period 3 (3 Days)||9
1413052|NCT02853435|3457665|P1|COMPLETED|Part 1a, Period 3 (3 Days)||9
1413053|NCT02853435|3457660|P6|STARTED|Part 1a, Period 3 (3 Days)||0
1413054|NCT02853435|3457661|P5|STARTED|Part 1a, Period 3 (3 Days)||0
1413055|NCT02853435|3457662|P4|STARTED|Part 1a, Period 3 (3 Days)||0
1413056|NCT02853435|3457663|P3|STARTED|Part 1a, Period 3 (3 Days)||8
1413057|NCT02853435|3457664|P2|STARTED|Part 1a, Period 3 (3 Days)||9
1413058|NCT02853435|3457665|P1|STARTED|Part 1a, Period 3 (3 Days)||9
1413059|NCT02853435|3457660|P6|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1413060|NCT02853435|3457661|P5|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1413061|NCT02853435|3457662|P4|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1413062|NCT02853435|3457663|P3|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1413063|NCT02853435|3457664|P2|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1413064|NCT02853435|3457665|P1|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1413065|NCT02853435|3457660|P6|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1413066|NCT02853435|3457661|P5|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1413067|NCT02853435|3457662|P4|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
1413068|NCT02853435|3457663|P3|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
1413069|NCT02853435|3457664|P2|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
1413070|NCT02853435|3457665|P1|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
1413071|NCT02853435|3457660|P6|STARTED|Part 1a, Washout Period 2 (3 Days)||0
1413072|NCT02853435|3457661|P5|STARTED|Part 1a, Washout Period 2 (3 Days)||0
1413073|NCT02853435|3457662|P4|STARTED|Part 1a, Washout Period 2 (3 Days)||0
1413074|NCT02853435|3457663|P3|STARTED|Part 1a, Washout Period 2 (3 Days)||8
1413075|NCT02853435|3457664|P2|STARTED|Part 1a, Washout Period 2 (3 Days)||9
1413076|NCT02853435|3457665|P1|STARTED|Part 1a, Washout Period 2 (3 Days)||9
1413077|NCT02853435|3457660|P6|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1413078|NCT02853435|3457661|P5|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1413079|NCT02853435|3457662|P4|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1413080|NCT02853435|3457663|P3|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1413081|NCT02853435|3457664|P2|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1413082|NCT02853435|3457665|P1|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
1413083|NCT02853435|3457660|P6|COMPLETED|Part 1a, Period 2 (3 Days)||0
1413084|NCT02853435|3457661|P5|COMPLETED|Part 1a, Period 2 (3 Days)||0
1413085|NCT02853435|3457662|P4|COMPLETED|Part 1a, Period 2 (3 Days)||0
1413086|NCT02853435|3457663|P3|COMPLETED|Part 1a, Period 2 (3 Days)||8
1413087|NCT02853435|3457664|P2|COMPLETED|Part 1a, Period 2 (3 Days)||9
1413088|NCT02853435|3457665|P1|COMPLETED|Part 1a, Period 2 (3 Days)||9
1413089|NCT02853435|3457660|P6|STARTED|Part 1a, Period 2 (3 Days)||0
1413090|NCT02853435|3457661|P5|STARTED|Part 1a, Period 2 (3 Days)||0
1413091|NCT02853435|3457662|P4|STARTED|Part 1a, Period 2 (3 Days)||0
1413092|NCT02853435|3457663|P3|STARTED|Part 1a, Period 2 (3 Days)||8
1413093|NCT02853435|3457664|P2|STARTED|Part 1a, Period 2 (3 Days)||9
1413094|NCT02853435|3457665|P1|STARTED|Part 1a, Period 2 (3 Days)||9
1413095|NCT02853435|3457660|P6|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1413096|NCT02853435|3457661|P5|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1413097|NCT02853435|3457662|P4|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1413098|NCT02853435|3457663|P3|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1413099|NCT02853435|3457664|P2|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1413100|NCT02853435|3457665|P1|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1413101|NCT02853435|3457660|P6|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1413102|NCT02853435|3457661|P5|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1413103|NCT02853435|3457662|P4|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
1413104|NCT02853435|3457663|P3|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
1413105|NCT02853435|3457664|P2|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
1413106|NCT02853435|3457665|P1|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
1413107|NCT02853435|3457660|P6|STARTED|Part 1a, Washout Period 1 (3 Days)||0
1413108|NCT02853435|3457661|P5|STARTED|Part 1a, Washout Period 1 (3 Days)||0
1413109|NCT02853435|3457662|P4|STARTED|Part 1a, Washout Period 1 (3 Days)||0
1413110|NCT02853435|3457663|P3|STARTED|Part 1a, Washout Period 1 (3 Days)||8
1413111|NCT02853435|3457664|P2|STARTED|Part 1a, Washout Period 1 (3 Days)||9
1413112|NCT02853435|3457665|P1|STARTED|Part 1a, Washout Period 1 (3 Days)||9
1413113|NCT02853435|3457660|P6|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1413114|NCT02853435|3457661|P5|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1413115|NCT02853435|3457662|P4|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1413116|NCT02853435|3457663|P3|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1413117|NCT02853435|3457664|P2|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1413118|NCT02853435|3457665|P1|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
1413119|NCT02853435|3457660|P6|COMPLETED|Part 1a, Period 1 (3 Days)||0
1413120|NCT02853435|3457661|P5|COMPLETED|Part 1a, Period 1 (3 Days)||0
1413121|NCT02853435|3457662|P4|COMPLETED|Part 1a, Period 1 (3 Days)||0
1413122|NCT02853435|3457663|P3|COMPLETED|Part 1a, Period 1 (3 Days)||8
1413123|NCT02853435|3457664|P2|COMPLETED|Part 1a, Period 1 (3 Days)||9
1413124|NCT02853435|3457665|P1|COMPLETED|Part 1a, Period 1 (3 Days)||9
1413125|NCT02853435|3457660|P6|STARTED|Part 1a, Period 1 (3 Days)||0
1413126|NCT02853435|3457661|P5|STARTED|Part 1a, Period 1 (3 Days)||0
1413127|NCT02853435|3457662|P4|STARTED|Part 1a, Period 1 (3 Days)||0
1413128|NCT02853435|3457663|P3|STARTED|Part 1a, Period 1 (3 Days)||8
1413129|NCT02853435|3457664|P2|STARTED|Part 1a, Period 1 (3 Days)||9
1413130|NCT02853435|3457665|P1|STARTED|Part 1a, Period 1 (3 Days)||9
1413131|NCT02852434|3457975|P2|NOT COMPLETED|Overall Study||1
1413132|NCT02852434|3457976|P1|NOT COMPLETED|Overall Study||2
1413133|NCT02852434|3457975|P2|COMPLETED|Overall Study||35
1413134|NCT02852434|3457976|P1|COMPLETED|Overall Study||34
1413135|NCT02852434|3457975|P2|STARTED|Overall Study||36
1413136|NCT02852434|3457976|P1|STARTED|Overall Study||36
1413137|NCT02852265|3457992|P2|NOT COMPLETED|6-month Follow-up||0
1413138|NCT02852265|3457993|P1|NOT COMPLETED|6-month Follow-up||0
1413139|NCT02852265|3457992|P2|COMPLETED|6-month Follow-up||9
1413140|NCT02852265|3457993|P1|COMPLETED|6-month Follow-up||9
1413141|NCT02852265|3457992|P2|STARTED|6-month Follow-up||9
1413142|NCT02852265|3457993|P1|STARTED|6-month Follow-up||9
1413143|NCT02852265|3457992|P2|NOT COMPLETED|3-month Follow-up||1
1413144|NCT02852265|3457993|P1|NOT COMPLETED|3-month Follow-up||1
1413145|NCT02852265|3457992|P2|COMPLETED|3-month Follow-up||9
1413146|NCT02852265|3457993|P1|COMPLETED|3-month Follow-up||9
1413147|NCT02852265|3457992|P2|STARTED|3-month Follow-up||10
1413148|NCT02852265|3457993|P1|STARTED|3-month Follow-up||10
1413149|NCT02852265|3457992|P2|NOT COMPLETED|1-month Follow-up||0
1413150|NCT02852265|3457993|P1|NOT COMPLETED|1-month Follow-up||0
1413151|NCT02852265|3457992|P2|COMPLETED|1-month Follow-up||10
1413152|NCT02852265|3457993|P1|COMPLETED|1-month Follow-up||10
1413153|NCT02852265|3457992|P2|STARTED|1-month Follow-up||10
1413154|NCT02852265|3457993|P1|STARTED|1-month Follow-up||10
1413155|NCT02851823|3458009|P1|NOT COMPLETED|Overall Study||0
1413156|NCT02851823|3458009|P1|COMPLETED|Overall Study||25
1413157|NCT02851823|3458009|P1|3 Months|Overall Study||25
1413158|NCT02851823|3458009|P1|1 Month|Overall Study||25
1413159|NCT02851823|3458009|P1|STARTED|Overall Study||25
1413160|NCT02850159|3458019|P2|NOT COMPLETED|Overall Study||0
1413161|NCT02850159|3458020|P1|NOT COMPLETED|Overall Study||0
1413162|NCT02850159|3458019|P2|COMPLETED|Overall Study||16
1413163|NCT02850159|3458020|P1|COMPLETED|Overall Study||16
1413164|NCT02850159|3458019|P2|STARTED|Overall Study||16
1413165|NCT02850159|3458020|P1|STARTED|Overall Study||16
1413166|NCT02849678|3458028|P2|NOT COMPLETED|Overall Study||6
1413167|NCT02849678|3458029|P1|NOT COMPLETED|Overall Study||3
1413168|NCT02849678|3458028|P2|COMPLETED|Overall Study||18
1413169|NCT02849678|3458029|P1|COMPLETED|Overall Study||17
1413170|NCT02849678|3458028|P2|STARTED|Overall Study||24
1413171|NCT02849678|3458029|P1|STARTED|Overall Study||20
1413172|NCT02848326|3458053|P6|NOT COMPLETED|Safety Follow-up Period||5
1413173|NCT02848326|3458054|P5|NOT COMPLETED|Safety Follow-up Period||1
1413174|NCT02848326|3458055|P4|NOT COMPLETED|Safety Follow-up Period||0
1413175|NCT02848326|3458056|P3|NOT COMPLETED|Safety Follow-up Period||3
1413176|NCT02848326|3458057|P2|NOT COMPLETED|Safety Follow-up Period||1
1413177|NCT02848326|3458058|P1|NOT COMPLETED|Safety Follow-up Period||4
1413178|NCT02848326|3458053|P6|COMPLETED|Safety Follow-up Period||77
1413179|NCT02848326|3458054|P5|COMPLETED|Safety Follow-up Period||76
1413180|NCT02848326|3458055|P4|COMPLETED|Safety Follow-up Period||169
1413181|NCT02848326|3458056|P3|COMPLETED|Safety Follow-up Period||153
1413182|NCT02848326|3458057|P2|COMPLETED|Safety Follow-up Period||83
1413183|NCT02848326|3458058|P1|COMPLETED|Safety Follow-up Period||157
1413184|NCT02848326|3458053|P6|STARTED|Safety Follow-up Period||82
1413185|NCT02848326|3458054|P5|STARTED|Safety Follow-up Period||77
1413186|NCT02848326|3458055|P4|STARTED|Safety Follow-up Period||169
1413187|NCT02848326|3458056|P3|STARTED|Safety Follow-up Period||156
1413188|NCT02848326|3458057|P2|STARTED|Safety Follow-up Period||84
1413189|NCT02848326|3458058|P1|STARTED|Safety Follow-up Period||161
1413190|NCT02848326|3458053|P6|NOT COMPLETED|Treatment Period||20
1413191|NCT02848326|3458054|P5|NOT COMPLETED|Treatment Period||19
1413192|NCT02848326|3458055|P4|NOT COMPLETED|Treatment Period||23
1413193|NCT02848326|3458056|P3|NOT COMPLETED|Treatment Period||36
1413194|NCT02848326|3458057|P2|NOT COMPLETED|Treatment Period||14
1413195|NCT02848326|3458058|P1|NOT COMPLETED|Treatment Period||38
1413196|NCT02848326|3458053|P6|COMPLETED|Treatment Period||73
1413197|NCT02848326|3458054|P5|COMPLETED|Treatment Period||70
1413198|NCT02848326|3458055|P4|COMPLETED|Treatment Period||164
1413199|NCT02848326|3458056|P3|COMPLETED|Treatment Period||149
1413200|NCT02848326|3458057|P2|COMPLETED|Treatment Period||80
1413201|NCT02848326|3458058|P1|COMPLETED|Treatment Period||148
1413202|NCT02848326|3458053|P6|Safety Population: Received Study Drug|Treatment Period||91
1413203|NCT02848326|3458054|P5|Safety Population: Received Study Drug|Treatment Period||86
1413204|NCT02848326|3458055|P4|Safety Population: Received Study Drug|Treatment Period||186
1413205|NCT02848326|3458056|P3|Safety Population: Received Study Drug|Treatment Period||183
1413206|NCT02848326|3458057|P2|Safety Population: Received Study Drug|Treatment Period||93
1413207|NCT02848326|3458058|P1|Safety Population: Received Study Drug|Treatment Period||186
1413208|NCT02848326|3458053|P6|STARTED|Treatment Period||93
1413209|NCT02848326|3458054|P5|STARTED|Treatment Period||89
1413210|NCT02848326|3458055|P4|STARTED|Treatment Period||187
1413211|NCT02848326|3458056|P3|STARTED|Treatment Period||185
1413212|NCT02848326|3458057|P2|STARTED|Treatment Period||94
1413213|NCT02848326|3458058|P1|STARTED|Treatment Period||186
1413214|NCT02848222|3458093|P3|NOT COMPLETED|Overall Study||0
1413215|NCT02848222|3458094|P2|NOT COMPLETED|Overall Study||1
1413216|NCT02848222|3458095|P1|NOT COMPLETED|Overall Study||7
1413217|NCT02848222|3458093|P3|COMPLETED|Overall Study||17
1413218|NCT02848222|3458094|P2|COMPLETED|Overall Study||17
1413219|NCT02848222|3458095|P1|COMPLETED|Overall Study||18
1413220|NCT02848222|3458093|P3|STARTED|Overall Study||17
1413221|NCT02848222|3458094|P2|STARTED|Overall Study||18
1413222|NCT02848222|3458095|P1|STARTED|Overall Study||25
1413223|NCT02847637|3458107|P4|NOT COMPLETED|Overall Study||63
1413224|NCT02847637|3458108|P3|NOT COMPLETED|Overall Study||35
1413225|NCT02847637|3458109|P2|NOT COMPLETED|Overall Study||35
1413226|NCT02847637|3458110|P1|NOT COMPLETED|Overall Study||17
1413227|NCT02847637|3458107|P4|COMPLETED|Overall Study||0
1413228|NCT02847637|3458108|P3|COMPLETED|Overall Study||0
1413229|NCT02847637|3458109|P2|COMPLETED|Overall Study||1
1413230|NCT02847637|3458110|P1|COMPLETED|Overall Study||1
1413231|NCT02847637|3458107|P4|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
1413232|NCT02847637|3458108|P3|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
1413233|NCT02847637|3458109|P2|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
1413234|NCT02847637|3458110|P1|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
1413235|NCT02847637|3458107|P4|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
1413236|NCT02847637|3458108|P3|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
1413237|NCT02847637|3458109|P2|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
1413238|NCT02847637|3458110|P1|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
1413239|NCT02847637|3458107|P4|Completed 24 Weeks on No Prophylaxis|Overall Study||0
1413240|NCT02847637|3458108|P3|Completed 24 Weeks on No Prophylaxis|Overall Study||0
1413241|NCT02847637|3458109|P2|Completed 24 Weeks on No Prophylaxis|Overall Study||0
1413242|NCT02847637|3458110|P1|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
1413243|NCT02847637|3458107|P4|STARTED|Overall Study||63
1413244|NCT02847637|3458108|P3|STARTED|Overall Study||35
1413245|NCT02847637|3458109|P2|STARTED|Overall Study||36
1413246|NCT02847637|3458110|P1|STARTED|Overall Study||18
1413247|NCT02847260|3458222|P1|NOT COMPLETED|Overall Study||7
1413248|NCT02847260|3458222|P1|COMPLETED|Overall Study||32
1413249|NCT02847260|3458222|P1|STARTED|Overall Study||39
1413250|NCT02847169|3458234|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1413251|NCT02847169|3458235|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1413252|NCT02847169|3458234|P2|COMPLETED|Second Intervention (1 Week)||15
1413253|NCT02847169|3458235|P1|COMPLETED|Second Intervention (1 Week)||15
1413254|NCT02847169|3458234|P2|STARTED|Second Intervention (1 Week)||15
1413255|NCT02847169|3458235|P1|STARTED|Second Intervention (1 Week)||15
1413256|NCT02847169|3458234|P2|NOT COMPLETED|First Intervention (1 Week)||0
1413257|NCT02847169|3458235|P1|NOT COMPLETED|First Intervention (1 Week)||0
1413258|NCT02847169|3458234|P2|COMPLETED|First Intervention (1 Week)||15
1413259|NCT02847169|3458235|P1|COMPLETED|First Intervention (1 Week)||15
1413260|NCT02847169|3458234|P2|STARTED|First Intervention (1 Week)||15
1413261|NCT02847169|3458235|P1|STARTED|First Intervention (1 Week)||15
1413262|NCT02846558|3458273|P4|NOT COMPLETED|Overall Study||2
1413263|NCT02846558|3458274|P3|NOT COMPLETED|Overall Study||2
1413264|NCT02846558|3458275|P2|NOT COMPLETED|Overall Study||4
1413265|NCT02846558|3458276|P1|NOT COMPLETED|Overall Study||8
1413266|NCT02846558|3458273|P4|COMPLETED|Overall Study||11
1413267|NCT02846558|3458274|P3|COMPLETED|Overall Study||12
1413268|NCT02846558|3458275|P2|COMPLETED|Overall Study||8
1413269|NCT02846558|3458276|P1|COMPLETED|Overall Study||7
1413270|NCT02846558|3458273|P4|3 Month Study Visit|Overall Study||11
1413271|NCT02846558|3458274|P3|3 Month Study Visit|Overall Study||12
1413272|NCT02846558|3458275|P2|3 Month Study Visit|Overall Study||8
1413273|NCT02846558|3458276|P1|3 Month Study Visit|Overall Study||7
1413274|NCT02846558|3458273|P4|Baseline Study Visit|Overall Study||12
1413275|NCT02846558|3458274|P3|Baseline Study Visit|Overall Study||14
1413276|NCT02846558|3458275|P2|Baseline Study Visit|Overall Study||9
1413277|NCT02846558|3458276|P1|Baseline Study Visit|Overall Study||10
1413278|NCT02846558|3458273|P4|STARTED|Overall Study||13
1413279|NCT02846558|3458274|P3|STARTED|Overall Study||14
1413280|NCT02846558|3458275|P2|STARTED|Overall Study||12
1413281|NCT02846558|3458276|P1|STARTED|Overall Study||15
1413282|NCT02845674|3458314|P2|NOT COMPLETED|Overall Study||50
1413283|NCT02845674|3458315|P1|NOT COMPLETED|Overall Study||18
1413284|NCT02845674|3458314|P2|COMPLETED|Overall Study||79
1413285|NCT02845674|3458315|P1|COMPLETED|Overall Study||111
1413286|NCT02845674|3458314|P2|STARTED|Overall Study||129
1413287|NCT02845674|3458315|P1|STARTED|Overall Study||129
1413288|NCT02844998|3458324|P3|NOT COMPLETED|Overall Study||4
1413289|NCT02844998|3458325|P2|NOT COMPLETED|Overall Study||4
1413290|NCT02844998|3458326|P1|NOT COMPLETED|Overall Study||7
1413291|NCT02844998|3458324|P3|COMPLETED|Overall Study||35
1413292|NCT02844998|3458325|P2|COMPLETED|Overall Study||35
1413293|NCT02844998|3458326|P1|COMPLETED|Overall Study||35
1413294|NCT02844998|3458324|P3|STARTED|Overall Study||39
1413295|NCT02844998|3458325|P2|STARTED|Overall Study||39
1413296|NCT02844998|3458326|P1|STARTED|Overall Study||42
1413297|NCT02844543|3458337|P1|NOT COMPLETED|Overall Study||5
1413298|NCT02844543|3458337|P1|COMPLETED|Overall Study||150
1413299|NCT02844543|3458337|P1|STARTED|Overall Study||155
1413300|NCT02843659|3458347|P3|NOT COMPLETED|Overall Study||5
1413301|NCT02843659|3458348|P2|NOT COMPLETED|Overall Study||6
1413302|NCT02843659|3458349|P1|NOT COMPLETED|Overall Study||4
1413303|NCT02843659|3458347|P3|COMPLETED|Overall Study||2
1413304|NCT02843659|3458348|P2|COMPLETED|Overall Study||0
1413305|NCT02843659|3458349|P1|COMPLETED|Overall Study||1
1413306|NCT02843659|3458347|P3|STARTED|Overall Study||7
1413307|NCT02843659|3458348|P2|STARTED|Overall Study||6
1413308|NCT02843659|3458349|P1|STARTED|Overall Study||5
1413309|NCT02842073|3458414|P1|NOT COMPLETED|Overall Study||1
1413310|NCT02842073|3458414|P1|COMPLETED|Overall Study||11
1413311|NCT02842073|3458414|P1|STARTED|Overall Study||12
1413312|NCT02841787|3458425|P3|NOT COMPLETED|Overall Study||0
1413313|NCT02841787|3458426|P2|NOT COMPLETED|Overall Study||4
1413314|NCT02841787|3458427|P1|NOT COMPLETED|Overall Study||3
1413315|NCT02841787|3458425|P3|COMPLETED|Overall Study||12
1413316|NCT02841787|3458426|P2|COMPLETED|Overall Study||19
1413317|NCT02841787|3458427|P1|COMPLETED|Overall Study||9
1413318|NCT02841787|3458425|P3|STARTED|Overall Study||12
1413319|NCT02841787|3458426|P2|STARTED|Overall Study||23
1413320|NCT02841787|3458427|P1|STARTED|Overall Study||12
1413321|NCT02840916|3458443|P2|NOT COMPLETED|Overall Study||3
1413322|NCT02840916|3458444|P1|NOT COMPLETED|Overall Study||1
1413323|NCT02840916|3458443|P2|COMPLETED|Overall Study||30
1413324|NCT02840916|3458444|P1|COMPLETED|Overall Study||32
1413325|NCT02840916|3458443|P2|STARTED|Overall Study||33
1413326|NCT02840916|3458444|P1|STARTED|Overall Study||33
1413327|NCT02840253|3458454|P1|NOT COMPLETED|Overall Study||4
1413328|NCT02840253|3458454|P1|COMPLETED|Overall Study||19
1413329|NCT02840253|3458454|P1|STARTED|Overall Study||23
1413330|NCT02839772|3458461|P2|NOT COMPLETED|Overall Study||0
1413331|NCT02839772|3458462|P1|NOT COMPLETED|Overall Study||1
1413332|NCT02839772|3458461|P2|COMPLETED|Overall Study||96
1413333|NCT02839772|3458462|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
1413334|NCT02839772|3458461|P2|STARTED|Overall Study||96
1413335|NCT02839772|3458462|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
1413336|NCT02838901|3458501|P2|NOT COMPLETED|Overall Study||2
1413337|NCT02838901|3458502|P1|NOT COMPLETED|Overall Study||2
1413338|NCT02838901|3458501|P2|COMPLETED|Overall Study||7
1413339|NCT02838901|3458502|P1|COMPLETED|Overall Study||7
1413340|NCT02838901|3458501|P2|STARTED|Overall Study||9
1413341|NCT02838901|3458502|P1|STARTED|Overall Study||9
1413342|NCT02837952|3458532|P2|NOT COMPLETED|Overall Study||6
1413343|NCT02837952|3458533|P1|NOT COMPLETED|Overall Study||5
1413344|NCT02837952|3458532|P2|COMPLETED|Overall Study||76
1413345|NCT02837952|3458533|P1|COMPLETED|Overall Study||36
1413346|NCT02837952|3458532|P2|STARTED|Overall Study||82
1413347|NCT02837952|3458533|P1|STARTED|Overall Study||41
1413348|NCT02837913|3458547|P2|NOT COMPLETED|Overall Study||0
1413349|NCT02837913|3458548|P1|NOT COMPLETED|Overall Study||0
1413350|NCT02837913|3458547|P2|COMPLETED|Overall Study||9
1413351|NCT02837913|3458548|P1|COMPLETED|Overall Study||10
1413352|NCT02837913|3458547|P2|STARTED|Overall Study||9
1413353|NCT02837913|3458548|P1|STARTED|Overall Study||10
1413354|NCT02836249|3458558|P2|NOT COMPLETED|Overall Study||58
1413355|NCT02836249|3458559|P1|NOT COMPLETED|Overall Study||123
1413356|NCT02836249|3458558|P2|COMPLETED|Overall Study||0
1413357|NCT02836249|3458559|P1|COMPLETED|Overall Study||0
1413358|NCT02836249|3458558|P2|STARTED|Overall Study||58
1413359|NCT02836249|3458559|P1|STARTED|Overall Study||123
1413360|NCT02836236|3458577|P2|NOT COMPLETED|Overall Study||50
1413361|NCT02836236|3458578|P1|NOT COMPLETED|Overall Study||105
1413362|NCT02836236|3458577|P2|COMPLETED|Overall Study||0
1413363|NCT02836236|3458578|P1|COMPLETED|Overall Study||0
1413364|NCT02836236|3458577|P2|STARTED|Overall Study||50
1413365|NCT02836236|3458578|P1|STARTED|Overall Study||105
1413366|NCT02834624|3458594|P2|NOT COMPLETED|Overall Study||0
1413367|NCT02834624|3458595|P1|NOT COMPLETED|Overall Study||0
1413368|NCT02834624|3458594|P2|COMPLETED|Overall Study||15
1413369|NCT02834624|3458595|P1|COMPLETED|Overall Study||15
1413370|NCT02834624|3458594|P2|STARTED|Overall Study||15
1413371|NCT02834624|3458595|P1|STARTED|Overall Study||15
1413372|NCT02832674|3458605|P1|NOT COMPLETED|Overall Study||5
1413373|NCT02832674|3458605|P1|COMPLETED|Overall Study||67
1413374|NCT02832674|3458605|P1|STARTED|Overall Study||72
1413375|NCT02832375|3458616|P2|NOT COMPLETED|Overall Study||0
1413376|NCT02832375|3458617|P1|NOT COMPLETED|Overall Study||2
1413377|NCT02832375|3458616|P2|COMPLETED|Overall Study||121
1413378|NCT02832375|3458617|P1|COMPLETED|Overall Study||119
1413379|NCT02832375|3458616|P2|STARTED|Overall Study||121
1413380|NCT02832375|3458617|P1|STARTED|Overall Study||121
1413381|NCT02832284|3458627|P1|NOT COMPLETED|Overall Study||0
1413382|NCT02832284|3458627|P1|COMPLETED|Overall Study||23
1413383|NCT02832284|3458627|P1|STARTED|Overall Study||23
1413384|NCT02831660|3458635|P1|NOT COMPLETED|Overall Study||0
1413385|NCT02831660|3458635|P1|COMPLETED|Overall Study||1
1413386|NCT02831660|3458635|P1|STARTED|Overall Study||1
1413387|NCT02831569|3458639|P1|NOT COMPLETED|Overall Study||0
1413388|NCT02831569|3458639|P1|COMPLETED|Overall Study||80
1413389|NCT02831569|3458639|P1|STARTED|Overall Study||80
1413390|NCT02831387|3458646|P2|NOT COMPLETED|Overall Study||2
1413391|NCT02831387|3458647|P1|NOT COMPLETED|Overall Study||1
1413392|NCT02831387|3458646|P2|COMPLETED|Overall Study||22
1413393|NCT02831387|3458647|P1|COMPLETED|Overall Study||22
1413394|NCT02831387|3458646|P2|STARTED|Overall Study||24
1413395|NCT02831387|3458647|P1|STARTED|Overall Study||23
1413396|NCT02830087|3458671|P6|NOT COMPLETED|Overall Study||3
1413397|NCT02830087|3458672|P5|NOT COMPLETED|Overall Study||3
1413398|NCT02830087|3458673|P4|NOT COMPLETED|Overall Study||3
1413399|NCT02830087|3458674|P3|NOT COMPLETED|Overall Study||4
1413400|NCT02830087|3458675|P2|NOT COMPLETED|Overall Study||4
1413401|NCT02830087|3458676|P1|NOT COMPLETED|Overall Study||4
1413402|NCT02830087|3458671|P6|COMPLETED|Overall Study||0
1413403|NCT02830087|3458672|P5|COMPLETED|Overall Study||0
1413404|NCT02830087|3458673|P4|COMPLETED|Overall Study||0
1413405|NCT02830087|3458674|P3|COMPLETED|Overall Study||0
1413406|NCT02830087|3458675|P2|COMPLETED|Overall Study||0
1413407|NCT02830087|3458676|P1|COMPLETED|Overall Study||0
1413408|NCT02830087|3458671|P6|STARTED|Overall Study||3
1413409|NCT02830087|3458672|P5|STARTED|Overall Study||3
1413410|NCT02830087|3458673|P4|STARTED|Overall Study||3
1413411|NCT02830087|3458674|P3|STARTED|Overall Study||4
1413412|NCT02830087|3458675|P2|STARTED|Overall Study||4
1413413|NCT02830087|3458676|P1|STARTED|Overall Study||4
1413414|NCT02829996|3458743|P5|NOT COMPLETED|Overall Study||0
1413415|NCT02829996|3458744|P4|NOT COMPLETED|Overall Study||0
1413416|NCT02829996|3458745|P3|NOT COMPLETED|Overall Study||0
1413417|NCT02829996|3458746|P2|NOT COMPLETED|Overall Study||0
1413418|NCT02829996|3458747|P1|NOT COMPLETED|Overall Study||1
1413419|NCT02829996|3458743|P5|COMPLETED|Overall Study||42
1413420|NCT02829996|3458744|P4|COMPLETED|Overall Study||41
1413421|NCT02829996|3458745|P3|COMPLETED|Overall Study||40
1413422|NCT02829996|3458746|P2|COMPLETED|Overall Study||39
1413423|NCT02829996|3458747|P1|COMPLETED|Overall Study||38
1413424|NCT02829996|3458743|P5|STARTED|Overall Study||42
1413425|NCT02829996|3458744|P4|STARTED|Overall Study||41
1413426|NCT02829996|3458745|P3|STARTED|Overall Study||40
1413427|NCT02829996|3458746|P2|STARTED|Overall Study||39
1413428|NCT02829996|3458747|P1|STARTED|Overall Study||39
1413429|NCT02829983|3458761|P2|NOT COMPLETED|Overall Study||0
1413430|NCT02829983|3458762|P1|NOT COMPLETED|Overall Study||0
1413431|NCT02829983|3458761|P2|COMPLETED|Overall Study||20
1413432|NCT02829983|3458762|P1|COMPLETED|Overall Study||20
1413433|NCT02829983|3458761|P2|STARTED|Overall Study||20
1413434|NCT02829983|3458762|P1|STARTED|Overall Study||20
1413435|NCT02829775|3458770|P1|NOT COMPLETED|Overall Study||5
1413436|NCT02829775|3458770|P1|COMPLETED|Overall Study||4
1413437|NCT02829775|3458770|P1|STARTED|Overall Study||9
1413438|NCT02829463|3458777|P2|NOT COMPLETED|Overall Study||0
1413439|NCT02829463|3458778|P1|NOT COMPLETED|Overall Study||0
1413440|NCT02829463|3458777|P2|COMPLETED|Overall Study||62
1413441|NCT02829463|3458778|P1|COMPLETED|Overall Study||59
1413442|NCT02829463|3458777|P2|STARTED|Overall Study||62
1413443|NCT02829463|3458778|P1|STARTED|Overall Study||59
1413444|NCT02829320|3458784|P1|NOT COMPLETED|Overall Study||0
1413445|NCT02829320|3458784|P1|COMPLETED|Overall Study||28
1413446|NCT02829320|3458784|P1|STARTED|Overall Study||28
1413447|NCT02829307|3458821|P1|NOT COMPLETED|Overall Study||0
1413448|NCT02829307|3458821|P1|COMPLETED|Overall Study||8
1413449|NCT02829307|3458821|P1|STARTED|Overall Study||8
1413450|NCT02829138|3458846|P2|NOT COMPLETED|Overall Study||0
1413451|NCT02829138|3458847|P1|NOT COMPLETED|Overall Study||1
1413452|NCT02829138|3458846|P2|COMPLETED|Overall Study||28
1413453|NCT02829138|3458847|P1|COMPLETED|Overall Study||28
1413454|NCT02829138|3458846|P2|STARTED|Overall Study||28
1413455|NCT02829138|3458847|P1|STARTED|Overall Study||29
1413456|NCT02828137|3458860|P3|NOT COMPLETED|Overall Study||0
1413457|NCT02828137|3458861|P2|NOT COMPLETED|Overall Study||0
1413458|NCT02828137|3458862|P1|NOT COMPLETED|Overall Study||0
1413459|NCT02828137|3458860|P3|COMPLETED|Overall Study||41
1413460|NCT02828137|3458861|P2|COMPLETED|Overall Study||41
1413461|NCT02828137|3458862|P1|COMPLETED|Overall Study||41
1413462|NCT02828137|3458860|P3|STARTED|Overall Study||41
1413463|NCT02828137|3458861|P2|STARTED|Overall Study||41
1413464|NCT02828137|3458862|P1|STARTED|Overall Study||41
1413465|NCT02826551|3458872|P2|NOT COMPLETED|Overall Study||0
1413466|NCT02826551|3458873|P1|NOT COMPLETED|Overall Study||0
1413467|NCT02826551|3458872|P2|COMPLETED|Overall Study||12
1413468|NCT02826551|3458873|P1|COMPLETED|Overall Study||11
1413469|NCT02826551|3458872|P2|STARTED|Overall Study||12
1413470|NCT02826551|3458873|P1|STARTED|Overall Study||11
1413471|NCT02826421|3458885|P4|NOT COMPLETED|Overall Study||2
1413472|NCT02826421|3458886|P3|NOT COMPLETED|Overall Study||2
1413473|NCT02826421|3458887|P2|NOT COMPLETED|Overall Study||3
1413474|NCT02826421|3458888|P1|NOT COMPLETED|Overall Study||3
1413475|NCT02826421|3458885|P4|COMPLETED|Overall Study||28
1413476|NCT02826421|3458886|P3|COMPLETED|Overall Study||26
1413477|NCT02826421|3458887|P2|COMPLETED|Overall Study||26
1413478|NCT02826421|3458888|P1|COMPLETED|Overall Study||19
1413479|NCT02826421|3458885|P4|Treated|Overall Study||28
1413480|NCT02826421|3458886|P3|Treated|Overall Study||26
1413481|NCT02826421|3458887|P2|Treated|Overall Study||26
1413482|NCT02826421|3458888|P1|Treated|Overall Study||19
1413483|NCT02826421|3458885|P4|STARTED|Overall Study||30
1413484|NCT02826421|3458886|P3|STARTED|Overall Study||28
1413485|NCT02826421|3458887|P2|STARTED|Overall Study||29
1413486|NCT02826421|3458888|P1|STARTED|Overall Study||22
1413487|NCT02825550|3458900|P1|NOT COMPLETED|Overall Study||1
1413488|NCT02825550|3458900|P1|COMPLETED|Overall Study||12
1413489|NCT02825550|3458900|P1|STARTED|Overall Study||13
1413490|NCT02825251|3458908|P2|NOT COMPLETED|Overall Study||6
1413491|NCT02825251|3458909|P1|NOT COMPLETED|Overall Study||3
1413492|NCT02825251|3458908|P2|COMPLETED|Overall Study||230
1413493|NCT02825251|3458909|P1|COMPLETED|Overall Study||233
1413494|NCT02825251|3458908|P2|STARTED|Overall Study||236
1413495|NCT02825251|3458909|P1|STARTED|Overall Study||236
1413496|NCT02824913|3459097|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1413497|NCT02824913|3459098|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1413498|NCT02824913|3459097|P2|COMPLETED|Second Intervention (1 Day)||0
1413499|NCT02824913|3459098|P1|COMPLETED|Second Intervention (1 Day)||1
1413500|NCT02824913|3459097|P2|STARTED|Second Intervention (1 Day)||0
1413501|NCT02824913|3459098|P1|STARTED|Second Intervention (1 Day)||1
1413502|NCT02824913|3459097|P2|NOT COMPLETED|Washout (7-14 Days)||0
1413503|NCT02824913|3459098|P1|NOT COMPLETED|Washout (7-14 Days)||0
1413504|NCT02824913|3459097|P2|COMPLETED|Washout (7-14 Days)||0
1413505|NCT02824913|3459098|P1|COMPLETED|Washout (7-14 Days)||1
1413506|NCT02824913|3459097|P2|STARTED|Washout (7-14 Days)||0
1413507|NCT02824913|3459098|P1|STARTED|Washout (7-14 Days)||1
1413508|NCT02824913|3459097|P2|NOT COMPLETED|First Intervention (1 Day)||0
1413509|NCT02824913|3459098|P1|NOT COMPLETED|First Intervention (1 Day)||0
1413510|NCT02824913|3459097|P2|COMPLETED|First Intervention (1 Day)||0
1413511|NCT02824913|3459098|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
1413512|NCT02824913|3459097|P2|STARTED|First Intervention (1 Day)||0
1413513|NCT02824913|3459098|P1|STARTED|First Intervention (1 Day)||1
1413514|NCT02824562|3459112|P2|NOT COMPLETED|Overall Study||5
1413515|NCT02824562|3459113|P1|NOT COMPLETED|Overall Study||3
1413516|NCT02824562|3459112|P2|COMPLETED|Overall Study||17
1413517|NCT02824562|3459113|P1|COMPLETED|Overall Study||19
1413518|NCT02824562|3459112|P2|STARTED|Overall Study||22
1413519|NCT02824562|3459113|P1|STARTED|Overall Study||22
1413520|NCT02823964|3459120|P1|NOT COMPLETED|Overall Study||5
1413521|NCT02823964|3459120|P1|COMPLETED|Overall Study||20
1413522|NCT02823964|3459120|P1|STARTED|Overall Study||25
1413523|NCT02823600|3459124|P1|NOT COMPLETED|Overall Study||0
1413524|NCT02823600|3459124|P1|COMPLETED|Overall Study||68
1413525|NCT02823600|3459124|P1|STARTED|Overall Study||68
1413526|NCT02823470|3459134|P2|NOT COMPLETED|Overall Study||15
1413527|NCT02823470|3459135|P1|NOT COMPLETED|Overall Study||9
1413528|NCT02823470|3459134|P2|COMPLETED|Overall Study||0
1413529|NCT02823470|3459135|P1|COMPLETED|Overall Study||0
1413530|NCT02823470|3459134|P2|STARTED|Overall Study||15
1413531|NCT02823470|3459135|P1|STARTED|Overall Study||9
1413532|NCT02823431|3459149|P2|NOT COMPLETED|Overall Study||0
1413533|NCT02823431|3459150|P1|NOT COMPLETED|Overall Study||0
1413534|NCT02823431|3459149|P2|COMPLETED|Overall Study||12
1413535|NCT02823431|3459150|P1|COMPLETED|Overall Study||11
1413536|NCT02823431|3459149|P2|STARTED|Overall Study||12
1413537|NCT02823431|3459150|P1|STARTED|Overall Study||11
1413538|NCT02823080|3459164|P2|NOT COMPLETED|Overall Study||0
1413539|NCT02823080|3459165|P1|NOT COMPLETED|Overall Study||0
1413540|NCT02823080|3459164|P2|COMPLETED|Overall Study||24
1413541|NCT02823080|3459165|P1|COMPLETED|Overall Study||24
1413542|NCT02823080|3459164|P2|STARTED|Overall Study||24
1413543|NCT02823080|3459165|P1|STARTED|Overall Study||24
1413544|NCT02822885|3459183|P1|NOT COMPLETED|Overall Study||0
1413545|NCT02822885|3459183|P1|COMPLETED|Overall Study||70
1413546|NCT02822885|3459183|P1|STARTED|Overall Study||70
1413547|NCT02822794|3459195|P2|NOT COMPLETED|Overall Study||0
1413548|NCT02822794|3459196|P1|NOT COMPLETED|Overall Study||1
1413549|NCT02822794|3459195|P2|COMPLETED|Overall Study||60
1413550|NCT02822794|3459196|P1|COMPLETED|Overall Study||56
1413551|NCT02822794|3459195|P2|STARTED|Overall Study||60
1413552|NCT02822794|3459196|P1|STARTED|Overall Study||57
1413553|NCT02822287|3459254|P1|NOT COMPLETED|Overall Study||0
1413554|NCT02822287|3459254|P1|COMPLETED|Overall Study||57
1413555|NCT02822287|3459254|P1|STARTED|Overall Study||57
1413556|NCT02821455|3459264|P1|NOT COMPLETED|Overall Study||0
1413557|NCT02821455|3459264|P1|COMPLETED|Overall Study||19
1413558|NCT02821455|3459264|P1|STARTED|Overall Study||19
1413559|NCT02821403|3459271|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
1413560|NCT02821403|3459272|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
1413561|NCT02821403|3459271|P2|COMPLETED|"Third Intervention (1 Month)"||40
1413562|NCT02821403|3459272|P1|COMPLETED|"Third Intervention (1 Month)"||40
1413563|NCT02821403|3459271|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
1413564|NCT02821403|3459272|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
1413565|NCT02821403|3459271|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
1413566|NCT02821403|3459272|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
1413567|NCT02821403|3459271|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
1413568|NCT02821403|3459272|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
1413569|NCT02821403|3459271|P2|STARTED|"Third Intervention (1 Month)"||40
1413570|NCT02821403|3459272|P1|STARTED|"Third Intervention (1 Month)"||40
1413571|NCT02821403|3459271|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
1413572|NCT02821403|3459272|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
1413573|NCT02821403|3459271|P2|COMPLETED|"Second Intervention (1 Month)"||40
1413574|NCT02821403|3459272|P1|COMPLETED|"Second Intervention (1 Month)"||40
1413575|NCT02821403|3459271|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
1413576|NCT02821403|3459272|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
1413577|NCT02821403|3459271|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
1413578|NCT02821403|3459272|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
1413579|NCT02821403|3459271|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
1413580|NCT02821403|3459272|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
1413581|NCT02821403|3459271|P2|STARTED|"Second Intervention (1 Month)"||40
1413582|NCT02821403|3459272|P1|STARTED|"Second Intervention (1 Month)"||40
1413583|NCT02821403|3459271|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
1413584|NCT02821403|3459272|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
1413585|NCT02821403|3459271|P2|COMPLETED|"First Intervention (1 Month)"||40
1413586|NCT02821403|3459272|P1|COMPLETED|"First Intervention (1 Month)"||40
1413587|NCT02821403|3459271|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
1413588|NCT02821403|3459272|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
1413589|NCT02821403|3459271|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
1413590|NCT02821403|3459272|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
1413591|NCT02821403|3459271|P2|Used Clear Lens|"First Intervention (1 Month)"||13
1413592|NCT02821403|3459272|P1|Used Clear Lens|"First Intervention (1 Month)"||13
1413593|NCT02821403|3459271|P2|STARTED|"First Intervention (1 Month)"||40
1413594|NCT02821403|3459272|P1|STARTED|"First Intervention (1 Month)"||40
1413595|NCT02818244|3459294|P4|NOT COMPLETED|Overall Study||0
1413596|NCT02818244|3459295|P3|NOT COMPLETED|Overall Study||0
1413597|NCT02818244|3459296|P2|NOT COMPLETED|Overall Study||0
1413598|NCT02818244|3459297|P1|NOT COMPLETED|Overall Study||0
1413599|NCT02818244|3459294|P4|COMPLETED|Overall Study||25
1413600|NCT02818244|3459295|P3|COMPLETED|Overall Study||25
1413601|NCT02818244|3459296|P2|COMPLETED|Overall Study||25
1413602|NCT02818244|3459297|P1|COMPLETED|Overall Study||25
1413603|NCT02818244|3459294|P4|STARTED|Overall Study||25
1413604|NCT02818244|3459295|P3|STARTED|Overall Study||25
1413605|NCT02818244|3459296|P2|STARTED|Overall Study||25
1413606|NCT02818244|3459297|P1|STARTED|Overall Study||25
1413607|NCT02817763|3459309|P2|NOT COMPLETED|Overall Study||0
1413608|NCT02817763|3459310|P1|NOT COMPLETED|Overall Study||0
1413609|NCT02817763|3459309|P2|COMPLETED|Overall Study||20
1413610|NCT02817763|3459310|P1|COMPLETED|Overall Study||20
1413611|NCT02817763|3459309|P2|STARTED|Overall Study||20
1413612|NCT02817763|3459310|P1|STARTED|Overall Study||20
1413613|NCT02816138|3459318|P1|NOT COMPLETED|Overall Study||1
1413614|NCT02816138|3459318|P1|COMPLETED|Overall Study||14
1413615|NCT02816138|3459318|P1|STARTED|Overall Study||15
1413616|NCT02815982|3459335|P4|NOT COMPLETED|Overall Study||0
1413617|NCT02815982|3459336|P3|NOT COMPLETED|Overall Study||0
1413618|NCT02815982|3459337|P2|NOT COMPLETED|Overall Study||0
1413619|NCT02815982|3459338|P1|NOT COMPLETED|Overall Study||0
1413620|NCT02815982|3459335|P4|COMPLETED|Overall Study||26
1413621|NCT02815982|3459336|P3|COMPLETED|Overall Study||27
1413622|NCT02815982|3459337|P2|COMPLETED|Overall Study||26
1413623|NCT02815982|3459338|P1|COMPLETED|Overall Study||27
1413624|NCT02815982|3459335|P4|STARTED|Overall Study||26
1413625|NCT02815982|3459336|P3|STARTED|Overall Study||27
1413626|NCT02815982|3459337|P2|STARTED|Overall Study||26
1413627|NCT02815982|3459338|P1|STARTED|Overall Study||27
1413628|NCT02815735|3459364|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
1413629|NCT02815735|3459365|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
1413630|NCT02815735|3459364|P2|COMPLETED|Second Intervention (4 Weeks)||37
1413631|NCT02815735|3459365|P1|COMPLETED|Second Intervention (4 Weeks)||33
1413632|NCT02815735|3459364|P2|STARTED|Second Intervention (4 Weeks)||37
1413633|NCT02815735|3459365|P1|STARTED|Second Intervention (4 Weeks)||34
1413634|NCT02815735|3459364|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
1413635|NCT02815735|3459365|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
1413636|NCT02815735|3459364|P2|COMPLETED|First Intervention (4 Weeks)||37
1413637|NCT02815735|3459365|P1|COMPLETED|First Intervention (4 Weeks)||34
1413638|NCT02815735|3459364|P2|STARTED|First Intervention (4 Weeks)||38
1413639|NCT02815735|3459365|P1|STARTED|First Intervention (4 Weeks)||36
1413640|NCT02815644|3459382|P2|NOT COMPLETED|Treatment Period 2||0
1413641|NCT02815644|3459383|P1|NOT COMPLETED|Treatment Period 2||0
1413642|NCT02815644|3459382|P2|COMPLETED|Treatment Period 2||11
1413643|NCT02815644|3459383|P1|COMPLETED|Treatment Period 2||11
1413644|NCT02815644|3459382|P2|STARTED|Treatment Period 2||11
1413645|NCT02815644|3459383|P1|STARTED|Treatment Period 2||11
1413646|NCT02815644|3459382|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
1413647|NCT02815644|3459383|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
1413648|NCT02815644|3459382|P2|COMPLETED|Treatment Period 1 + Washout||11
1413649|NCT02815644|3459383|P1|COMPLETED|Treatment Period 1 + Washout||11
1413650|NCT02815644|3459382|P2|STARTED|Treatment Period 1 + Washout||11
1413651|NCT02815644|3459383|P1|STARTED|Treatment Period 1 + Washout||11
1413652|NCT02815397|3459401|P1|NOT COMPLETED|Overall Study||2
1413653|NCT02815397|3459401|P1|COMPLETED|Overall Study||0
1413654|NCT02815397|3459401|P1|STARTED|Overall Study||2
1413655|NCT02814643|3459410|P2|NOT COMPLETED|Overall Study||3
1413656|NCT02814643|3459411|P1|NOT COMPLETED|Overall Study||1
1413657|NCT02814643|3459410|P2|COMPLETED|Overall Study||49
1413658|NCT02814643|3459411|P1|COMPLETED|Overall Study||50
1413659|NCT02814643|3459410|P2|STARTED|Overall Study||52
1413660|NCT02814643|3459411|P1|STARTED|Overall Study||51
1413661|NCT02814448|3459438|P5|NOT COMPLETED|Overall Study||2
1413662|NCT02814448|3459439|P4|NOT COMPLETED|Overall Study||0
1413663|NCT02814448|3459440|P3|NOT COMPLETED|Overall Study||1
1413664|NCT02814448|3459441|P2|NOT COMPLETED|Overall Study||0
1413665|NCT02814448|3459442|P1|NOT COMPLETED|Overall Study||0
1413666|NCT02814448|3459438|P5|COMPLETED|Overall Study||26
1413667|NCT02814448|3459439|P4|COMPLETED|Overall Study||25
1413668|NCT02814448|3459440|P3|COMPLETED|Overall Study||25
1413669|NCT02814448|3459441|P2|COMPLETED|Overall Study||24
1413670|NCT02814448|3459442|P1|COMPLETED|Overall Study||27
1413671|NCT02814448|3459438|P5|STARTED|Overall Study||28
1413672|NCT02814448|3459439|P4|STARTED|Overall Study||25
1413673|NCT02814448|3459440|P3|STARTED|Overall Study||26
1413674|NCT02814448|3459441|P2|STARTED|Overall Study||24
1413675|NCT02814448|3459442|P1|STARTED|Overall Study||27
1413676|NCT02814279|3459461|P2|NOT COMPLETED|Overall Study||0
1413677|NCT02814279|3459462|P1|NOT COMPLETED|Overall Study||0
1413678|NCT02814279|3459461|P2|COMPLETED|Overall Study||21
1413679|NCT02814279|3459462|P1|COMPLETED|Overall Study||21
1413680|NCT02814279|3459461|P2|STARTED|Overall Study||21
1413681|NCT02814279|3459462|P1|STARTED|Overall Study||21
1413682|NCT02814227|3459470|P1|NOT COMPLETED|Overall Study||0
1413683|NCT02814227|3459470|P1|COMPLETED|Overall Study||52
1413684|NCT02814227|3459470|P1|STARTED|Overall Study||52
1413685|NCT02813070|3459480|P3|NOT COMPLETED|Overall Study||11
1413686|NCT02813070|3459481|P2|NOT COMPLETED|Overall Study||3
1413687|NCT02813070|3459482|P1|NOT COMPLETED|Overall Study||3
1413688|NCT02813070|3459480|P3|COMPLETED|Overall Study||25
1413689|NCT02813070|3459481|P2|COMPLETED|Overall Study||20
1413690|NCT02813070|3459482|P1|COMPLETED|Overall Study||25
1413691|NCT02813070|3459480|P3|Treated (Safety Population)|Overall Study||25
1413692|NCT02813070|3459481|P2|Treated (Safety Population)|Overall Study||20
1413693|NCT02813070|3459482|P1|Treated (Safety Population)|Overall Study||25
1413694|NCT02813070|3459480|P3|STARTED|Overall Study||36
1413695|NCT02813070|3459481|P2|STARTED|Overall Study||23
1413696|NCT02813070|3459482|P1|STARTED|Overall Study||28
1413697|NCT02812342|3459491|P1|NOT COMPLETED|Overall Study||0
1413698|NCT02812342|3459491|P1|COMPLETED|Overall Study||10
1413699|NCT02812342|3459491|P1|STARTED|Overall Study||10
1413700|NCT02811965|3459496|P1|NOT COMPLETED|Overall Study||0
1413701|NCT02811965|3459496|P1|COMPLETED|Overall Study||21
1413702|NCT02811965|3459496|P1|STARTED|Overall Study||21
1413703|NCT02810873|3459521|P2|NOT COMPLETED|Overall Study||0
1413704|NCT02810873|3459522|P1|NOT COMPLETED|Overall Study||0
1413705|NCT02810873|3459521|P2|COMPLETED|Overall Study||13
1413706|NCT02810873|3459522|P1|COMPLETED|Overall Study||6
1413707|NCT02810873|3459521|P2|STARTED|Overall Study||13
1413708|NCT02810873|3459522|P1|STARTED|Overall Study||6
1413709|NCT02809911|3459532|P2|NOT COMPLETED|Overall Study||0
1413710|NCT02809911|3459533|P1|NOT COMPLETED|Overall Study||0
1413711|NCT02809911|3459532|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
1413803|NCT02801396|3459775|P2|NOT COMPLETED|Period 3||0
1413712|NCT02809911|3459533|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
1413713|NCT02809911|3459532|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
1413714|NCT02809911|3459533|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
1413715|NCT02809833|3459541|P1|NOT COMPLETED|Overall Study||300
1413716|NCT02809833|3459541|P1|COMPLETED|Overall Study||550
1413717|NCT02809833|3459541|P1|STARTED|Overall Study||850
1413718|NCT02808390|3459618|P3|NOT COMPLETED|Overall Study||3
1413719|NCT02808390|3459619|P2|NOT COMPLETED|Overall Study||6
1413720|NCT02808390|3459620|P1|NOT COMPLETED|Overall Study||2
1413721|NCT02808390|3459618|P3|COMPLETED|Overall Study||4
1413722|NCT02808390|3459619|P2|COMPLETED|Overall Study||2
1413723|NCT02808390|3459620|P1|COMPLETED|Overall Study||2
1413724|NCT02808390|3459618|P3|STARTED|Overall Study||7
1413725|NCT02808390|3459619|P2|STARTED|Overall Study||8
1413726|NCT02808390|3459620|P1|STARTED|Overall Study||4
1413727|NCT02808130|3459634|P6|NOT COMPLETED|Overall Study||0
1413728|NCT02808130|3459635|P5|NOT COMPLETED|Overall Study||0
1413729|NCT02808130|3459636|P4|NOT COMPLETED|Overall Study||0
1413730|NCT02808130|3459637|P3|NOT COMPLETED|Overall Study||0
1413731|NCT02808130|3459638|P2|NOT COMPLETED|Overall Study||0
1413732|NCT02808130|3459639|P1|NOT COMPLETED|Overall Study||0
1413733|NCT02808130|3459634|P6|COMPLETED|Overall Study||15
1413734|NCT02808130|3459635|P5|COMPLETED|Overall Study||15
1413735|NCT02808130|3459636|P4|COMPLETED|Overall Study||15
1413736|NCT02808130|3459637|P3|COMPLETED|Overall Study||15
1413737|NCT02808130|3459638|P2|COMPLETED|Overall Study||15
1413738|NCT02808130|3459639|P1|COMPLETED|Overall Study||15
1413739|NCT02808130|3459634|P6|STARTED|Overall Study||15
1413740|NCT02808130|3459635|P5|STARTED|Overall Study||15
1413741|NCT02808130|3459636|P4|STARTED|Overall Study||15
1413742|NCT02808130|3459637|P3|STARTED|Overall Study||15
1413743|NCT02808130|3459638|P2|STARTED|Overall Study||15
1413744|NCT02808130|3459639|P1|STARTED|Overall Study||15
1413745|NCT02807376|3459667|P2|NOT COMPLETED|Overall Study||1
1413746|NCT02807376|3459668|P1|NOT COMPLETED|Overall Study||3
1413747|NCT02807376|3459667|P2|COMPLETED|Overall Study||130
1413748|NCT02807376|3459668|P1|COMPLETED|Overall Study||136
1413749|NCT02807376|3459667|P2|STARTED|Overall Study||131
1413750|NCT02807376|3459668|P1|STARTED|Overall Study||139
1413751|NCT02806869|3459678|P2|NOT COMPLETED|Second Intervention (1 Day)||2
1413752|NCT02806869|3459679|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1413753|NCT02806869|3459678|P2|COMPLETED|Second Intervention (1 Day)||5
1413754|NCT02806869|3459679|P1|COMPLETED|Second Intervention (1 Day)||7
1413755|NCT02806869|3459678|P2|STARTED|Second Intervention (1 Day)||7
1413756|NCT02806869|3459679|P1|STARTED|Second Intervention (1 Day)||7
1413757|NCT02806869|3459678|P2|NOT COMPLETED|Washout (7 Days)||0
1413758|NCT02806869|3459679|P1|NOT COMPLETED|Washout (7 Days)||0
1413759|NCT02806869|3459678|P2|COMPLETED|Washout (7 Days)||7
1413760|NCT02806869|3459679|P1|COMPLETED|Washout (7 Days)||7
1413761|NCT02806869|3459678|P2|STARTED|Washout (7 Days)||7
1413762|NCT02806869|3459679|P1|STARTED|Washout (7 Days)||7
1413763|NCT02806869|3459678|P2|NOT COMPLETED|First Intervention (1 Day)||12
1413764|NCT02806869|3459679|P1|NOT COMPLETED|First Intervention (1 Day)||11
1413765|NCT02806869|3459678|P2|COMPLETED|First Intervention (1 Day)||12
1413766|NCT02806869|3459679|P1|COMPLETED|First Intervention (1 Day)||13
1413767|NCT02806869|3459678|P2|STARTED|First Intervention (1 Day)||24
1413768|NCT02806869|3459679|P1|STARTED|First Intervention (1 Day)||24
1413769|NCT02806544|3459689|P1|NOT COMPLETED|Overall Study||4
1413770|NCT02806544|3459689|P1|COMPLETED|Overall Study||31
1413771|NCT02806544|3459689|P1|STARTED|Overall Study||35
1413772|NCT02806505|3459700|P2|NOT COMPLETED|Overall Study||11
1413773|NCT02806505|3459701|P1|NOT COMPLETED|Overall Study||10
1413774|NCT02806505|3459700|P2|COMPLETED|Overall Study||32
1413775|NCT02806505|3459701|P1|COMPLETED|Overall Study||28
1413776|NCT02806505|3459700|P2|STARTED|Overall Study||43
1413777|NCT02806505|3459701|P1|STARTED|Overall Study||38
1413778|NCT02805907|3459713|P2|NOT COMPLETED|Overall Study||3
1413779|NCT02805907|3459714|P1|NOT COMPLETED|Overall Study||3
1413780|NCT02805907|3459713|P2|COMPLETED|Overall Study||53
1413781|NCT02805907|3459714|P1|COMPLETED|Overall Study||53
1413782|NCT02805907|3459713|P2|STARTED|Overall Study||56
1413783|NCT02805907|3459714|P1|STARTED|Overall Study||56
1413784|NCT02802878|3459728|P2|NOT COMPLETED|Overall Study||3
1413785|NCT02802878|3459729|P1|NOT COMPLETED|Overall Study||4
1413786|NCT02802878|3459728|P2|COMPLETED|Overall Study||18
1413787|NCT02802878|3459729|P1|COMPLETED|Overall Study||17
1413788|NCT02802878|3459728|P2|STARTED|Overall Study||21
1413789|NCT02802878|3459729|P1|STARTED|Overall Study||21
1413790|NCT02802592|3459743|P1|NOT COMPLETED|Overall Study||4
1413791|NCT02802592|3459743|P1|COMPLETED|Overall Study||0
1413792|NCT02802592|3459743|P1|STARTED|Overall Study||4
1413793|NCT02802449|3459754|P2|NOT COMPLETED|Overall Study||17
1413794|NCT02802449|3459755|P1|NOT COMPLETED|Overall Study||9
1413795|NCT02802449|3459754|P2|COMPLETED|Overall Study||202
1413796|NCT02802449|3459755|P1|COMPLETED|Overall Study||102
1413797|NCT02802449|3459754|P2|STARTED|Overall Study||219
1413798|NCT02802449|3459755|P1|STARTED|Overall Study||111
1413799|NCT02801396|3459771|P6|NOT COMPLETED|Period 3||0
1413800|NCT02801396|3459772|P5|NOT COMPLETED|Period 3||0
1413801|NCT02801396|3459773|P4|NOT COMPLETED|Period 3||0
1413802|NCT02801396|3459774|P3|NOT COMPLETED|Period 3||0
1413804|NCT02801396|3459776|P1|NOT COMPLETED|Period 3||0
1413805|NCT02801396|3459771|P6|COMPLETED|Period 3||17
1413806|NCT02801396|3459772|P5|COMPLETED|Period 3||16
1413807|NCT02801396|3459773|P4|COMPLETED|Period 3||16
1413808|NCT02801396|3459774|P3|COMPLETED|Period 3||17
1413809|NCT02801396|3459775|P2|COMPLETED|Period 3||17
1413810|NCT02801396|3459776|P1|COMPLETED|Period 3||17
1413811|NCT02801396|3459771|P6|STARTED|Period 3||17
1413812|NCT02801396|3459772|P5|STARTED|Period 3||16
1413813|NCT02801396|3459773|P4|STARTED|Period 3||16
1413814|NCT02801396|3459774|P3|STARTED|Period 3||17
1413815|NCT02801396|3459775|P2|STARTED|Period 3||17
1413816|NCT02801396|3459776|P1|STARTED|Period 3||17
1413817|NCT02801396|3459771|P6|NOT COMPLETED|Period 2||0
1413818|NCT02801396|3459772|P5|NOT COMPLETED|Period 2||0
1413819|NCT02801396|3459773|P4|NOT COMPLETED|Period 2||0
1413820|NCT02801396|3459774|P3|NOT COMPLETED|Period 2||0
1413821|NCT02801396|3459775|P2|NOT COMPLETED|Period 2||0
1413822|NCT02801396|3459776|P1|NOT COMPLETED|Period 2||0
1413823|NCT02801396|3459771|P6|COMPLETED|Period 2||17
1413824|NCT02801396|3459772|P5|COMPLETED|Period 2||16
1413825|NCT02801396|3459773|P4|COMPLETED|Period 2||16
1413826|NCT02801396|3459774|P3|COMPLETED|Period 2||17
1413827|NCT02801396|3459775|P2|COMPLETED|Period 2||17
1413828|NCT02801396|3459776|P1|COMPLETED|Period 2||17
1413829|NCT02801396|3459771|P6|STARTED|Period 2||17
1413830|NCT02801396|3459772|P5|STARTED|Period 2||16
1413831|NCT02801396|3459773|P4|STARTED|Period 2||16
1413832|NCT02801396|3459774|P3|STARTED|Period 2||17
1413833|NCT02801396|3459775|P2|STARTED|Period 2||17
1413834|NCT02801396|3459776|P1|STARTED|Period 2||17
1413835|NCT02801396|3459771|P6|NOT COMPLETED|Period 1||0
1413836|NCT02801396|3459772|P5|NOT COMPLETED|Period 1||1
1413837|NCT02801396|3459773|P4|NOT COMPLETED|Period 1||0
1413838|NCT02801396|3459774|P3|NOT COMPLETED|Period 1||0
1413839|NCT02801396|3459775|P2|NOT COMPLETED|Period 1||0
1413840|NCT02801396|3459776|P1|NOT COMPLETED|Period 1||0
1413841|NCT02801396|3459771|P6|COMPLETED|Period 1||17
1413842|NCT02801396|3459772|P5|COMPLETED|Period 1||16
1413843|NCT02801396|3459773|P4|COMPLETED|Period 1||16
1413844|NCT02801396|3459774|P3|COMPLETED|Period 1||17
1413845|NCT02801396|3459775|P2|COMPLETED|Period 1||17
1413846|NCT02801396|3459776|P1|COMPLETED|Period 1||17
1413847|NCT02801396|3459771|P6|STARTED|Period 1||17
1413848|NCT02801396|3459772|P5|STARTED|Period 1||17
1413849|NCT02801396|3459773|P4|STARTED|Period 1||16
1413850|NCT02801396|3459774|P3|STARTED|Period 1||17
1413851|NCT02801396|3459775|P2|STARTED|Period 1||17
1413852|NCT02801396|3459776|P1|STARTED|Period 1||17
1413853|NCT02801006|3459793|P2|NOT COMPLETED|Lens 2||0
1413854|NCT02801006|3459794|P1|NOT COMPLETED|Lens 2||0
1413855|NCT02801006|3459793|P2|COMPLETED|Lens 2||19
1413856|NCT02801006|3459794|P1|COMPLETED|Lens 2||22
1413857|NCT02801006|3459793|P2|STARTED|Lens 2||19
1413858|NCT02801006|3459794|P1|STARTED|Lens 2||22
1413859|NCT02801006|3459793|P2|NOT COMPLETED|Lens 1||0
1413860|NCT02801006|3459794|P1|NOT COMPLETED|Lens 1||0
1413861|NCT02801006|3459793|P2|COMPLETED|Lens 1||19
1413862|NCT02801006|3459794|P1|COMPLETED|Lens 1||22
1413863|NCT02801006|3459793|P2|STARTED|Lens 1||19
1413864|NCT02801006|3459794|P1|STARTED|Lens 1||22
1413865|NCT02800213|3459812|P2|NOT COMPLETED|Second Intervention||0
1413866|NCT02800213|3459813|P1|NOT COMPLETED|Second Intervention||0
1413867|NCT02800213|3459812|P2|COMPLETED|Second Intervention||35
1413868|NCT02800213|3459813|P1|COMPLETED|Second Intervention||35
1413869|NCT02800213|3459812|P2|STARTED|Second Intervention||35
1413870|NCT02800213|3459813|P1|STARTED|Second Intervention||35
1413871|NCT02800213|3459812|P2|NOT COMPLETED|First Intervention||0
1413872|NCT02800213|3459813|P1|NOT COMPLETED|First Intervention||0
1413873|NCT02800213|3459812|P2|COMPLETED|First Intervention||35
1413874|NCT02800213|3459813|P1|COMPLETED|First Intervention||35
1413875|NCT02800213|3459812|P2|STARTED|First Intervention||35
1413876|NCT02800213|3459813|P1|STARTED|First Intervention||35
1413877|NCT02799784|3459819|P2|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
1413878|NCT02799784|3459820|P1|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
1413879|NCT02799784|3459819|P2|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
1413880|NCT02799784|3459820|P1|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
1413881|NCT02799784|3459819|P2|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
1413882|NCT02799784|3459820|P1|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
1413883|NCT02799784|3459819|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
1413884|NCT02799784|3459820|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
1413885|NCT02799784|3459819|P2|COMPLETED|Washout Period (3 Weeks)||118
1413886|NCT02799784|3459820|P1|COMPLETED|Washout Period (3 Weeks)||111
1413887|NCT02799784|3459819|P2|STARTED|Washout Period (3 Weeks)||118
1413888|NCT02799784|3459820|P1|STARTED|Washout Period (3 Weeks)||111
1413889|NCT02799784|3459819|P2|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
1413890|NCT02799784|3459820|P1|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
1413891|NCT02799784|3459819|P2|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
1413892|NCT02799784|3459820|P1|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
1413893|NCT02799784|3459819|P2|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
1413894|NCT02799784|3459820|P1|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
1413895|NCT02799472|3459828|P2|NOT COMPLETED|Overall Study||5
1413896|NCT02799472|3459829|P1|NOT COMPLETED|Overall Study||4
1413897|NCT02799472|3459828|P2|COMPLETED|Overall Study||23
1413898|NCT02799472|3459829|P1|COMPLETED|Overall Study||7
1413899|NCT02799472|3459828|P2|STARTED|Overall Study||28
1413900|NCT02799472|3459829|P1|STARTED|Overall Study||11
1413901|NCT02799082|3459889|P2|NOT COMPLETED|Overall Study||4
1413902|NCT02799082|3459890|P1|NOT COMPLETED|Overall Study||4
1413903|NCT02799082|3459889|P2|COMPLETED|Overall Study||77
1413904|NCT02799082|3459890|P1|COMPLETED|Overall Study||37
1413905|NCT02799082|3459889|P2|STARTED|Overall Study||81
1413906|NCT02799082|3459890|P1|STARTED|Overall Study||41
1413907|NCT02799069|3459927|P3|NOT COMPLETED|Overall Study||7
1413908|NCT02799069|3459928|P2|NOT COMPLETED|Overall Study||7
1413909|NCT02799069|3459929|P1|NOT COMPLETED|Overall Study||8
1413910|NCT02799069|3459927|P3|COMPLETED|Overall Study||240
1413911|NCT02799069|3459928|P2|COMPLETED|Overall Study||241
1413912|NCT02799069|3459929|P1|COMPLETED|Overall Study||68
1413913|NCT02799069|3459927|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
1413914|NCT02799069|3459928|P2|ITT/Safety|Overall Study||248
1413915|NCT02799069|3459929|P1|ITT/Safety|Overall Study||76
1413916|NCT02799069|3459927|P3|STARTED|Overall Study||247
1413917|NCT02799069|3459928|P2|STARTED|Overall Study||248
1413918|NCT02799069|3459929|P1|STARTED|Overall Study||76
1413919|NCT02798315|3460039|P1|NOT COMPLETED|Overall Study||1
1413920|NCT02798315|3460039|P1|COMPLETED|Overall Study||39
1413921|NCT02798315|3460039|P1|STARTED|Overall Study||40
1413922|NCT02798289|3460053|P1|NOT COMPLETED|Overall Study||0
1413923|NCT02798289|3460053|P1|COMPLETED|Overall Study||55
1413924|NCT02798289|3460053|P1|STARTED|Overall Study||55
1413925|NCT02797821|3460060|P3|NOT COMPLETED|Overall Study||0
1413926|NCT02797821|3460061|P2|NOT COMPLETED|Overall Study||0
1413927|NCT02797821|3460062|P1|NOT COMPLETED|Overall Study||0
1413928|NCT02797821|3460060|P3|COMPLETED|Overall Study||9
1413929|NCT02797821|3460061|P2|COMPLETED|Overall Study||10
1413930|NCT02797821|3460062|P1|COMPLETED|Overall Study||8
1413931|NCT02797821|3460060|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
1413932|NCT02797821|3460061|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
1413933|NCT02797821|3460062|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
1413934|NCT02797821|3460060|P3|STARTED|Overall Study||9
1413935|NCT02797821|3460061|P2|STARTED|Overall Study||10
1413936|NCT02797821|3460062|P1|STARTED|Overall Study||8
1413937|NCT02797522|3460084|P11|NOT COMPLETED|Overall Study||1
1413938|NCT02797522|3460085|P10|NOT COMPLETED|Overall Study||4
1413939|NCT02797522|3460086|P9|NOT COMPLETED|Overall Study||2
1413940|NCT02797522|3460087|P8|NOT COMPLETED|Overall Study||4
1413941|NCT02797522|3460088|P7|NOT COMPLETED|Overall Study||0
1413942|NCT02797522|3460089|P6|NOT COMPLETED|Overall Study||0
1413943|NCT02797522|3460090|P5|NOT COMPLETED|Overall Study||0
1413944|NCT02797522|3460091|P4|NOT COMPLETED|Overall Study||0
1413945|NCT02797522|3460092|P3|NOT COMPLETED|Overall Study||0
1413946|NCT02797522|3460093|P2|NOT COMPLETED|Overall Study||0
1413947|NCT02797522|3460094|P1|NOT COMPLETED|Overall Study||0
1413948|NCT02797522|3460084|P11|COMPLETED|Overall Study||0
1413949|NCT02797522|3460085|P10|COMPLETED|Overall Study||0
1413950|NCT02797522|3460086|P9|COMPLETED|Overall Study||0
1413951|NCT02797522|3460087|P8|COMPLETED|Overall Study||0
1413952|NCT02797522|3460088|P7|COMPLETED|Overall Study||12
1413953|NCT02797522|3460089|P6|COMPLETED|Overall Study||4
1413954|NCT02797522|3460090|P5|COMPLETED|Overall Study||4
1413955|NCT02797522|3460091|P4|COMPLETED|Overall Study||4
1413956|NCT02797522|3460092|P3|COMPLETED|Overall Study||4
1413957|NCT02797522|3460093|P2|COMPLETED|Overall Study||4
1413958|NCT02797522|3460094|P1|COMPLETED|Overall Study||4
1413959|NCT02797522|3460084|P11|STARTED|Overall Study||1
1413960|NCT02797522|3460085|P10|STARTED|Overall Study||4
1413961|NCT02797522|3460086|P9|STARTED|Overall Study||2
1413962|NCT02797522|3460087|P8|STARTED|Overall Study||4
1413963|NCT02797522|3460088|P7|STARTED|Overall Study||12
1413964|NCT02797522|3460089|P6|STARTED|Overall Study||4
1413965|NCT02797522|3460090|P5|STARTED|Overall Study||4
1413966|NCT02797522|3460091|P4|STARTED|Overall Study||4
1413967|NCT02797522|3460092|P3|STARTED|Overall Study||4
1413968|NCT02797522|3460093|P2|STARTED|Overall Study||4
1413969|NCT02797522|3460094|P1|STARTED|Overall Study||4
1413970|NCT02797132|3460200|P1|NOT COMPLETED|Part B (24 Weeks)||3
1413971|NCT02797132|3460200|P1|COMPLETED|Part B (24 Weeks)||57
1413972|NCT02797132|3460200|P1|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
1413973|NCT02797132|3460200|P1|Part B (<14 kg Weight)|Part B (24 Weeks)||19
1413974|NCT02797132|3460200|P1|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
1413975|NCT02797132|3460200|P1|NOT COMPLETED|Part A (15 Days)||1
1413976|NCT02797132|3460200|P1|COMPLETED|Part A (15 Days)||11
1413977|NCT02797132|3460200|P1|Part A (>=14 kg Weight)|Part A (15 Days)||8
1413978|NCT02797132|3460200|P1|Part A (<14 kg Weight)|Part A (15 Days)||4
1413979|NCT02797132|3460200|P1|STARTED|Part A (15 Days)||12
1413980|NCT02797080|3460252|P1|NOT COMPLETED|Overall Study||2
1413981|NCT02797080|3460252|P1|COMPLETED|Overall Study||36
1413982|NCT02797080|3460252|P1|STARTED|Overall Study||38
1413983|NCT02797054|3460259|P3|NOT COMPLETED|Follow-up||285
1413984|NCT02797054|3460260|P2|NOT COMPLETED|Follow-up||228
1413985|NCT02797054|3460261|P1|NOT COMPLETED|Follow-up||209
1413986|NCT02797054|3460259|P3|COMPLETED|Follow-up||150
1413987|NCT02797054|3460260|P2|COMPLETED|Follow-up||155
1413988|NCT02797054|3460261|P1|COMPLETED|Follow-up||178
1413989|NCT02797054|3460259|P3|STARTED|Follow-up||435
1413990|NCT02797054|3460260|P2|STARTED|Follow-up||383
1413991|NCT02797054|3460261|P1|STARTED|Follow-up||387
1413992|NCT02797054|3460259|P3|NOT COMPLETED|Post-test||348
1413993|NCT02797054|3460260|P2|NOT COMPLETED|Post-test||11
1413994|NCT02797054|3460261|P1|NOT COMPLETED|Post-test||7
1413995|NCT02797054|3460259|P3|COMPLETED|Post-test||87
1413996|NCT02797054|3460260|P2|COMPLETED|Post-test||372
1413997|NCT02797054|3460261|P1|COMPLETED|Post-test||380
1413998|NCT02797054|3460259|P3|STARTED|Post-test||435
1413999|NCT02797054|3460260|P2|STARTED|Post-test||383
1414000|NCT02797054|3460261|P1|STARTED|Post-test||387
1414001|NCT02796963|3460294|P4|NOT COMPLETED|Overall Study||72
1414002|NCT02796963|3460295|P3|NOT COMPLETED|Overall Study||69
1414003|NCT02796963|3460296|P2|NOT COMPLETED|Overall Study||76
1414004|NCT02796963|3460297|P1|NOT COMPLETED|Overall Study||89
1414005|NCT02796963|3460294|P4|COMPLETED|Overall Study||282
1414006|NCT02796963|3460295|P3|COMPLETED|Overall Study||247
1414007|NCT02796963|3460296|P2|COMPLETED|Overall Study||252
1414008|NCT02796963|3460297|P1|COMPLETED|Overall Study||294
1414009|NCT02796963|3460294|P4|HIV Sero Converted|Overall Study||19
1414010|NCT02796963|3460295|P3|HIV Sero Converted|Overall Study||11
1414011|NCT02796963|3460296|P2|HIV Sero Converted|Overall Study||19
1414012|NCT02796963|3460297|P1|HIV Sero Converted|Overall Study||19
1414013|NCT02796963|3460294|P4|Fourth Follow up|Overall Study||263
1414014|NCT02796963|3460295|P3|Fourth Follow up|Overall Study||236
1414015|NCT02796963|3460296|P2|Fourth Follow up|Overall Study||233
1414016|NCT02796963|3460297|P1|Fourth Follow up|Overall Study||275
1414017|NCT02796963|3460294|P4|Third Follow up|Overall Study||286
1414018|NCT02796963|3460295|P3|Third Follow up|Overall Study||245
1414019|NCT02796963|3460296|P2|Third Follow up|Overall Study||237
1414020|NCT02796963|3460297|P1|Third Follow up|Overall Study||276
1414021|NCT02796963|3460294|P4|Second Follow up|Overall Study||293
1414022|NCT02796963|3460295|P3|Second Follow up|Overall Study||255
1414023|NCT02796963|3460296|P2|Second Follow up|Overall Study||260
1414024|NCT02796963|3460297|P1|Second Follow up|Overall Study||280
1414025|NCT02796963|3460294|P4|First Follow up|Overall Study||291
1414026|NCT02796963|3460295|P3|First Follow up|Overall Study||257
1414027|NCT02796963|3460296|P2|First Follow up|Overall Study||279
1414028|NCT02796963|3460297|P1|First Follow up|Overall Study||293
1414029|NCT02796963|3460294|P4|STARTED|Overall Study||354
1414030|NCT02796963|3460295|P3|STARTED|Overall Study||316
1414031|NCT02796963|3460296|P2|STARTED|Overall Study||328
1414032|NCT02796963|3460297|P1|STARTED|Overall Study||383
1414033|NCT02796677|3460363|P4|NOT COMPLETED|Overall Study||74
1414034|NCT02796677|3460364|P3|NOT COMPLETED|Overall Study||53
1414035|NCT02796677|3460365|P2|NOT COMPLETED|Overall Study||73
1414036|NCT02796677|3460366|P1|NOT COMPLETED|Overall Study||38
1414037|NCT02796677|3460363|P4|COMPLETED|Overall Study||405
1414038|NCT02796677|3460364|P3|COMPLETED|Overall Study||267
1414039|NCT02796677|3460365|P2|COMPLETED|Overall Study||405
1414040|NCT02796677|3460366|P1|COMPLETED|Overall Study||279
1414041|NCT02796677|3460363|P4|Completed Treatment and Follow-up|Overall Study||403
1414042|NCT02796677|3460364|P3|Completed Treatment and Follow-up|Overall Study||267
1414043|NCT02796677|3460365|P2|Completed Treatment and Follow-up|Overall Study||405
1414044|NCT02796677|3460366|P1|Completed Treatment and Follow-up|Overall Study||279
1414045|NCT02796677|3460363|P4|STARTED|Overall Study||479
1414046|NCT02796677|3460364|P3|STARTED|Overall Study||320
1414047|NCT02796677|3460365|P2|STARTED|Overall Study||478
1414048|NCT02796677|3460366|P1|STARTED|Overall Study||317
1414049|NCT02796651|3460390|P1|NOT COMPLETED|Overall Study||26
1414050|NCT02796651|3460390|P1|COMPLETED|Overall Study||106
1414051|NCT02796651|3460390|P1|Placebo (Lactose Monohydrate)|Overall Study||38
1414052|NCT02796651|3460390|P1|Perforomist 40 μg|Overall Study||108
1414053|NCT02796651|3460390|P1|Perforomist 20 μg|Overall Study||118
1414054|NCT02796651|3460390|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
1414055|NCT02796651|3460390|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
1414056|NCT02796651|3460390|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
1414057|NCT02796651|3460390|P1|STARTED|Overall Study||132
1414058|NCT02796352|3460419|P1|NOT COMPLETED|Overall Study||0
1414059|NCT02796352|3460419|P1|COMPLETED|Overall Study||1
1414060|NCT02796352|3460419|P1|STARTED|Overall Study||1
1414061|NCT02796092|3460428|P2|NOT COMPLETED|Overall Study||0
1414062|NCT02796092|3460429|P1|NOT COMPLETED|Overall Study||0
1414063|NCT02796092|3460428|P2|COMPLETED|Overall Study||50
1414064|NCT02796092|3460429|P1|COMPLETED|Overall Study||50
1414065|NCT02796092|3460428|P2|STARTED|Overall Study||50
1414066|NCT02796092|3460429|P1|STARTED|Overall Study||50
1414067|NCT02794974|3460463|P2|NOT COMPLETED|Overall Study||1
1414068|NCT02794974|3460464|P1|NOT COMPLETED|Overall Study||0
1414069|NCT02794974|3460463|P2|COMPLETED|Overall Study||14
1414070|NCT02794974|3460464|P1|COMPLETED|Overall Study||14
1414071|NCT02794974|3460463|P2|STARTED|Overall Study||15
1414072|NCT02794974|3460464|P1|STARTED|Overall Study||14
1414073|NCT02794870|3460480|P2|NOT COMPLETED|Overall Study||0
1414074|NCT02794870|3460481|P1|NOT COMPLETED|Overall Study||2
1414075|NCT02794870|3460480|P2|COMPLETED|Overall Study||11
1414076|NCT02794870|3460481|P1|COMPLETED|Overall Study||20
1414077|NCT02794870|3460480|P2|Received Inoculation|Overall Study||11
1414078|NCT02794870|3460481|P1|Received Inoculation|Overall Study||21
1414079|NCT02794870|3460480|P2|STARTED|Overall Study||11
1414080|NCT02794870|3460481|P1|STARTED|Overall Study||22
1414081|NCT02794844|3460507|P1|NOT COMPLETED|Overall Study||5
1414082|NCT02794844|3460507|P1|COMPLETED|Overall Study||23
1414083|NCT02794844|3460507|P1|STARTED|Overall Study||28
1414084|NCT02794480|3460517|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
1414085|NCT02794480|3460518|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
1414086|NCT02794480|3460519|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
1414087|NCT02794480|3460520|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
1414088|NCT02794480|3460517|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
1414089|NCT02794480|3460518|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
1414090|NCT02794480|3460519|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
1414091|NCT02794480|3460520|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
1414092|NCT02794480|3460517|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
1414093|NCT02794480|3460518|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
1414094|NCT02794480|3460519|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
1414095|NCT02794480|3460520|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
1414096|NCT02794480|3460517|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
1414097|NCT02794480|3460518|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
1414098|NCT02794480|3460519|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
1414099|NCT02794480|3460520|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
1414100|NCT02794480|3460517|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
1414101|NCT02794480|3460518|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
1414102|NCT02794480|3460519|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
1414103|NCT02794480|3460520|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
1414104|NCT02794480|3460517|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
1414105|NCT02794480|3460518|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
1414106|NCT02794480|3460519|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
1414107|NCT02794480|3460520|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
1414108|NCT02793947|3460540|P2|NOT COMPLETED|Overall Study||5
1414109|NCT02793947|3460541|P1|NOT COMPLETED|Overall Study||2
1414110|NCT02793947|3460540|P2|COMPLETED|Overall Study||50
1414111|NCT02793947|3460541|P1|COMPLETED|Overall Study||45
1414112|NCT02793947|3460540|P2|STARTED|Overall Study||55
1414113|NCT02793947|3460541|P1|STARTED|Overall Study||47
1414114|NCT02793674|3460553|P2|NOT COMPLETED|Overall Study||0
1414115|NCT02793674|3460554|P1|NOT COMPLETED|Overall Study||0
1414116|NCT02793674|3460553|P2|COMPLETED|Overall Study||12
1414117|NCT02793674|3460554|P1|COMPLETED|Overall Study||9
1414118|NCT02793674|3460553|P2|STARTED|Overall Study||12
1414119|NCT02793674|3460554|P1|STARTED|Overall Study||9
1414120|NCT02793232|3460575|P9|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1414121|NCT02793232|3460576|P8|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1414122|NCT02793232|3460577|P7|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1414123|NCT02793232|3460578|P6|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1414124|NCT02793232|3460579|P5|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1414125|NCT02793232|3460580|P4|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1414126|NCT02793232|3460581|P3|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1414127|NCT02793232|3460582|P2|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1414128|NCT02793232|3460583|P1|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
1414129|NCT02793232|3460575|P9|COMPLETED|Period 4 (Part A: 5 Days)||0
1414130|NCT02793232|3460576|P8|COMPLETED|Period 4 (Part A: 5 Days)||0
1414131|NCT02793232|3460577|P7|COMPLETED|Period 4 (Part A: 5 Days)||0
1414132|NCT02793232|3460578|P6|COMPLETED|Period 4 (Part A: 5 Days)||0
1414133|NCT02793232|3460579|P5|COMPLETED|Period 4 (Part A: 5 Days)||0
1414134|NCT02793232|3460580|P4|COMPLETED|Period 4 (Part A: 5 Days)||2
1414135|NCT02793232|3460581|P3|COMPLETED|Period 4 (Part A: 5 Days)||2
1414136|NCT02793232|3460582|P2|COMPLETED|Period 4 (Part A: 5 Days)||2
1414137|NCT02793232|3460583|P1|COMPLETED|Period 4 (Part A: 5 Days)||2
1414138|NCT02793232|3460575|P9|STARTED|Period 4 (Part A: 5 Days)||0
1414139|NCT02793232|3460576|P8|STARTED|Period 4 (Part A: 5 Days)||0
1414140|NCT02793232|3460577|P7|STARTED|Period 4 (Part A: 5 Days)||0
1414141|NCT02793232|3460578|P6|STARTED|Period 4 (Part A: 5 Days)||0
1414142|NCT02793232|3460579|P5|STARTED|Period 4 (Part A: 5 Days)||0
1414143|NCT02793232|3460580|P4|STARTED|Period 4 (Part A: 5 Days)||2
1414144|NCT02793232|3460581|P3|STARTED|Period 4 (Part A: 5 Days)||2
1414145|NCT02793232|3460582|P2|STARTED|Period 4 (Part A: 5 Days)||2
1414146|NCT02793232|3460583|P1|STARTED|Period 4 (Part A: 5 Days)||2
1414147|NCT02793232|3460575|P9|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414148|NCT02793232|3460576|P8|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414149|NCT02793232|3460577|P7|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414150|NCT02793232|3460578|P6|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414151|NCT02793232|3460579|P5|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414152|NCT02793232|3460580|P4|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414153|NCT02793232|3460581|P3|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414154|NCT02793232|3460582|P2|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414155|NCT02793232|3460583|P1|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414156|NCT02793232|3460575|P9|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414157|NCT02793232|3460576|P8|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414158|NCT02793232|3460577|P7|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414159|NCT02793232|3460578|P6|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414160|NCT02793232|3460579|P5|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
1414161|NCT02793232|3460580|P4|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
1414162|NCT02793232|3460581|P3|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
1414163|NCT02793232|3460582|P2|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
1414164|NCT02793232|3460583|P1|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
1414165|NCT02793232|3460575|P9|STARTED|Washout Period 3(Part A:at Least 10days)||0
1414166|NCT02793232|3460576|P8|STARTED|Washout Period 3(Part A:at Least 10days)||0
1414167|NCT02793232|3460577|P7|STARTED|Washout Period 3(Part A:at Least 10days)||0
1414168|NCT02793232|3460578|P6|STARTED|Washout Period 3(Part A:at Least 10days)||0
1414169|NCT02793232|3460579|P5|STARTED|Washout Period 3(Part A:at Least 10days)||0
1414170|NCT02793232|3460580|P4|STARTED|Washout Period 3(Part A:at Least 10days)||2
1414171|NCT02793232|3460581|P3|STARTED|Washout Period 3(Part A:at Least 10days)||2
1414172|NCT02793232|3460582|P2|STARTED|Washout Period 3(Part A:at Least 10days)||2
1414173|NCT02793232|3460583|P1|STARTED|Washout Period 3(Part A:at Least 10days)||2
1414174|NCT02793232|3460575|P9|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1414175|NCT02793232|3460576|P8|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1414176|NCT02793232|3460577|P7|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1414177|NCT02793232|3460578|P6|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1414178|NCT02793232|3460579|P5|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1414179|NCT02793232|3460580|P4|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1414180|NCT02793232|3460581|P3|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1414181|NCT02793232|3460582|P2|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1414182|NCT02793232|3460583|P1|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
1414183|NCT02793232|3460575|P9|COMPLETED|Period 3 (Part A: 5 Days)||0
1414184|NCT02793232|3460576|P8|COMPLETED|Period 3 (Part A: 5 Days)||0
1414185|NCT02793232|3460577|P7|COMPLETED|Period 3 (Part A: 5 Days)||0
1414186|NCT02793232|3460578|P6|COMPLETED|Period 3 (Part A: 5 Days)||0
1414187|NCT02793232|3460579|P5|COMPLETED|Period 3 (Part A: 5 Days)||0
1414188|NCT02793232|3460580|P4|COMPLETED|Period 3 (Part A: 5 Days)||2
1414189|NCT02793232|3460581|P3|COMPLETED|Period 3 (Part A: 5 Days)||2
1414190|NCT02793232|3460582|P2|COMPLETED|Period 3 (Part A: 5 Days)||2
1414191|NCT02793232|3460583|P1|COMPLETED|Period 3 (Part A: 5 Days)||2
1414192|NCT02793232|3460575|P9|STARTED|Period 3 (Part A: 5 Days)||0
1414193|NCT02793232|3460576|P8|STARTED|Period 3 (Part A: 5 Days)||0
1414194|NCT02793232|3460577|P7|STARTED|Period 3 (Part A: 5 Days)||0
1414195|NCT02793232|3460578|P6|STARTED|Period 3 (Part A: 5 Days)||0
1414196|NCT02793232|3460579|P5|STARTED|Period 3 (Part A: 5 Days)||0
1414197|NCT02793232|3460580|P4|STARTED|Period 3 (Part A: 5 Days)||2
1414198|NCT02793232|3460581|P3|STARTED|Period 3 (Part A: 5 Days)||2
1414199|NCT02793232|3460582|P2|STARTED|Period 3 (Part A: 5 Days)||2
1414200|NCT02793232|3460583|P1|STARTED|Period 3 (Part A: 5 Days)||2
1414201|NCT02793232|3460575|P9|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414202|NCT02793232|3460576|P8|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414203|NCT02793232|3460577|P7|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414204|NCT02793232|3460578|P6|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414205|NCT02793232|3460579|P5|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414206|NCT02793232|3460580|P4|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414207|NCT02793232|3460581|P3|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414208|NCT02793232|3460582|P2|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414209|NCT02793232|3460583|P1|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414210|NCT02793232|3460575|P9|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414211|NCT02793232|3460576|P8|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414212|NCT02793232|3460577|P7|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414213|NCT02793232|3460578|P6|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414214|NCT02793232|3460579|P5|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
1414215|NCT02793232|3460580|P4|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
1414216|NCT02793232|3460581|P3|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
1414217|NCT02793232|3460582|P2|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
1414218|NCT02793232|3460583|P1|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
1414219|NCT02793232|3460575|P9|STARTED|Washout Period 2(Part A:at Least 10days)||0
1414220|NCT02793232|3460576|P8|STARTED|Washout Period 2(Part A:at Least 10days)||0
1414221|NCT02793232|3460577|P7|STARTED|Washout Period 2(Part A:at Least 10days)||0
1414222|NCT02793232|3460578|P6|STARTED|Washout Period 2(Part A:at Least 10days)||0
1414223|NCT02793232|3460579|P5|STARTED|Washout Period 2(Part A:at Least 10days)||0
1414224|NCT02793232|3460580|P4|STARTED|Washout Period 2(Part A:at Least 10days)||2
1414225|NCT02793232|3460581|P3|STARTED|Washout Period 2(Part A:at Least 10days)||2
1414226|NCT02793232|3460582|P2|STARTED|Washout Period 2(Part A:at Least 10days)||2
1414227|NCT02793232|3460583|P1|STARTED|Washout Period 2(Part A:at Least 10days)||2
1414228|NCT02793232|3460575|P9|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1414229|NCT02793232|3460576|P8|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1414230|NCT02793232|3460577|P7|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1414231|NCT02793232|3460578|P6|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1414232|NCT02793232|3460579|P5|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1414233|NCT02793232|3460580|P4|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1414234|NCT02793232|3460581|P3|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1414235|NCT02793232|3460582|P2|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1414236|NCT02793232|3460583|P1|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
1414237|NCT02793232|3460575|P9|COMPLETED|Period 2 (Part A: 5 Days)||0
1414238|NCT02793232|3460576|P8|COMPLETED|Period 2 (Part A: 5 Days)||0
1414239|NCT02793232|3460577|P7|COMPLETED|Period 2 (Part A: 5 Days)||0
1414240|NCT02793232|3460578|P6|COMPLETED|Period 2 (Part A: 5 Days)||0
1414241|NCT02793232|3460579|P5|COMPLETED|Period 2 (Part A: 5 Days)||0
1414242|NCT02793232|3460580|P4|COMPLETED|Period 2 (Part A: 5 Days)||2
1414243|NCT02793232|3460581|P3|COMPLETED|Period 2 (Part A: 5 Days)||2
1414244|NCT02793232|3460582|P2|COMPLETED|Period 2 (Part A: 5 Days)||2
1414245|NCT02793232|3460583|P1|COMPLETED|Period 2 (Part A: 5 Days)||2
1414246|NCT02793232|3460575|P9|STARTED|Period 2 (Part A: 5 Days)||0
1414247|NCT02793232|3460576|P8|STARTED|Period 2 (Part A: 5 Days)||0
1414248|NCT02793232|3460577|P7|STARTED|Period 2 (Part A: 5 Days)||0
1414249|NCT02793232|3460578|P6|STARTED|Period 2 (Part A: 5 Days)||0
1414250|NCT02793232|3460579|P5|STARTED|Period 2 (Part A: 5 Days)||0
1414251|NCT02793232|3460580|P4|STARTED|Period 2 (Part A: 5 Days)||2
1414252|NCT02793232|3460581|P3|STARTED|Period 2 (Part A: 5 Days)||2
1414253|NCT02793232|3460582|P2|STARTED|Period 2 (Part A: 5 Days)||2
1414254|NCT02793232|3460583|P1|STARTED|Period 2 (Part A: 5 Days)||2
1414255|NCT02793232|3460575|P9|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414256|NCT02793232|3460576|P8|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414257|NCT02793232|3460577|P7|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414258|NCT02793232|3460578|P6|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414259|NCT02793232|3460579|P5|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414260|NCT02793232|3460580|P4|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414261|NCT02793232|3460581|P3|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414262|NCT02793232|3460582|P2|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414263|NCT02793232|3460583|P1|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414264|NCT02793232|3460575|P9|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414265|NCT02793232|3460576|P8|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414266|NCT02793232|3460577|P7|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414267|NCT02793232|3460578|P6|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414268|NCT02793232|3460579|P5|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
1414269|NCT02793232|3460580|P4|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
1414270|NCT02793232|3460581|P3|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
1414271|NCT02793232|3460582|P2|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
1414272|NCT02793232|3460583|P1|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
1414273|NCT02793232|3460575|P9|STARTED|Washout Period 1(Part A:at Least 10days)||0
1414274|NCT02793232|3460576|P8|STARTED|Washout Period 1(Part A:at Least 10days)||0
1414275|NCT02793232|3460577|P7|STARTED|Washout Period 1(Part A:at Least 10days)||0
1414276|NCT02793232|3460578|P6|STARTED|Washout Period 1(Part A:at Least 10days)||0
1414277|NCT02793232|3460579|P5|STARTED|Washout Period 1(Part A:at Least 10days)||0
1414278|NCT02793232|3460580|P4|STARTED|Washout Period 1(Part A:at Least 10days)||2
1414279|NCT02793232|3460581|P3|STARTED|Washout Period 1(Part A:at Least 10days)||2
1414280|NCT02793232|3460582|P2|STARTED|Washout Period 1(Part A:at Least 10days)||2
1414281|NCT02793232|3460583|P1|STARTED|Washout Period 1(Part A:at Least 10days)||2
1414282|NCT02793232|3460575|P9|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1414283|NCT02793232|3460576|P8|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1414284|NCT02793232|3460577|P7|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
1414285|NCT02793232|3460578|P6|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1414286|NCT02793232|3460579|P5|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
1414287|NCT02793232|3460580|P4|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1414288|NCT02793232|3460581|P3|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1414289|NCT02793232|3460582|P2|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1414290|NCT02793232|3460583|P1|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
1414291|NCT02793232|3460575|P9|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
1414292|NCT02793232|3460576|P8|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414293|NCT02793232|3460577|P7|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
1414294|NCT02793232|3460578|P6|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
1414295|NCT02793232|3460579|P5|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
1414296|NCT02793232|3460580|P4|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414297|NCT02793232|3460581|P3|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414298|NCT02793232|3460582|P2|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414299|NCT02793232|3460583|P1|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414300|NCT02793232|3460575|P9|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
1414301|NCT02793232|3460576|P8|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414302|NCT02793232|3460577|P7|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
1414303|NCT02793232|3460578|P6|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
1414304|NCT02793232|3460579|P5|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
1414305|NCT02793232|3460580|P4|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414306|NCT02793232|3460581|P3|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414307|NCT02793232|3460582|P2|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414308|NCT02793232|3460583|P1|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
1414309|NCT02793154|3460768|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1414310|NCT02793154|3460769|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1414311|NCT02793154|3460770|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1414312|NCT02793154|3460768|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1414313|NCT02793154|3460769|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1414314|NCT02793154|3460770|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
1414315|NCT02793154|3460768|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
1414316|NCT02793154|3460769|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
1414317|NCT02793154|3460770|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
1414318|NCT02793154|3460768|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
1414319|NCT02793154|3460769|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
1414320|NCT02793154|3460770|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
1414321|NCT02793154|3460768|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
1414322|NCT02793154|3460769|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
1414323|NCT02793154|3460770|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
1414324|NCT02793154|3460768|P3|STARTED|Part A (Single Group-up to 12 Days)||0
1414325|NCT02793154|3460769|P2|STARTED|Part A (Single Group-up to 12 Days)||0
1414326|NCT02793154|3460770|P1|STARTED|Part A (Single Group-up to 12 Days)||4
1414327|NCT02792517|3460836|P1|NOT COMPLETED|Overall Study||20
1414328|NCT02792517|3460836|P1|COMPLETED|Overall Study||21
1414329|NCT02792517|3460836|P1|Received Erenumab|Overall Study||24
1414330|NCT02792517|3460836|P1|STARTED|Overall Study||41
1414331|NCT02792062|3460856|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1414332|NCT02792062|3460857|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1414333|NCT02792062|3460858|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1414334|NCT02792062|3460859|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1414335|NCT02792062|3460860|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1414336|NCT02792062|3460861|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
1414337|NCT02792062|3460856|P6|COMPLETED|Intervention Period 3 (6 Days)||2
1414338|NCT02792062|3460857|P5|COMPLETED|Intervention Period 3 (6 Days)||2
1414339|NCT02792062|3460858|P4|COMPLETED|Intervention Period 3 (6 Days)||2
1414340|NCT02792062|3460859|P3|COMPLETED|Intervention Period 3 (6 Days)||2
1414341|NCT02792062|3460860|P2|COMPLETED|Intervention Period 3 (6 Days)||2
1414342|NCT02792062|3460861|P1|COMPLETED|Intervention Period 3 (6 Days)||1
1414343|NCT02792062|3460856|P6|STARTED|Intervention Period 3 (6 Days)||2
1414344|NCT02792062|3460857|P5|STARTED|Intervention Period 3 (6 Days)||2
1414345|NCT02792062|3460858|P4|STARTED|Intervention Period 3 (6 Days)||2
1414346|NCT02792062|3460859|P3|STARTED|Intervention Period 3 (6 Days)||2
1414347|NCT02792062|3460860|P2|STARTED|Intervention Period 3 (6 Days)||2
1414348|NCT02792062|3460861|P1|STARTED|Intervention Period 3 (6 Days)||1
1414349|NCT02792062|3460856|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414350|NCT02792062|3460857|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414351|NCT02792062|3460858|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414352|NCT02792062|3460859|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414353|NCT02792062|3460860|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414354|NCT02792062|3460861|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
1414355|NCT02792062|3460856|P6|COMPLETED|Washout Period (at Least 14 Days)||2
1414356|NCT02792062|3460857|P5|COMPLETED|Washout Period (at Least 14 Days)||2
1414357|NCT02792062|3460858|P4|COMPLETED|Washout Period (at Least 14 Days)||2
1414358|NCT02792062|3460859|P3|COMPLETED|Washout Period (at Least 14 Days)||2
1414359|NCT02792062|3460860|P2|COMPLETED|Washout Period (at Least 14 Days)||2
1414360|NCT02792062|3460861|P1|COMPLETED|Washout Period (at Least 14 Days)||1
1414361|NCT02792062|3460856|P6|STARTED|Washout Period (at Least 14 Days)||2
1414362|NCT02792062|3460857|P5|STARTED|Washout Period (at Least 14 Days)||2
1414363|NCT02792062|3460858|P4|STARTED|Washout Period (at Least 14 Days)||2
1414364|NCT02792062|3460859|P3|STARTED|Washout Period (at Least 14 Days)||2
1414365|NCT02792062|3460860|P2|STARTED|Washout Period (at Least 14 Days)||2
1414366|NCT02792062|3460861|P1|STARTED|Washout Period (at Least 14 Days)||2
1414367|NCT02792062|3460856|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1414368|NCT02792062|3460857|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1414369|NCT02792062|3460858|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1414370|NCT02792062|3460859|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1414371|NCT02792062|3460860|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1414372|NCT02792062|3460861|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1414373|NCT02792062|3460856|P6|COMPLETED|Intervention Period 2 (6 Days)||2
1414374|NCT02792062|3460857|P5|COMPLETED|Intervention Period 2 (6 Days)||2
1414375|NCT02792062|3460858|P4|COMPLETED|Intervention Period 2 (6 Days)||2
1414376|NCT02792062|3460859|P3|COMPLETED|Intervention Period 2 (6 Days)||2
1414377|NCT02792062|3460860|P2|COMPLETED|Intervention Period 2 (6 Days)||2
1414378|NCT02792062|3460861|P1|COMPLETED|Intervention Period 2 (6 Days)||2
1414379|NCT02792062|3460856|P6|STARTED|Intervention Period 2 (6 Days)||2
1414380|NCT02792062|3460857|P5|STARTED|Intervention Period 2 (6 Days)||2
1414381|NCT02792062|3460858|P4|STARTED|Intervention Period 2 (6 Days)||2
1414382|NCT02792062|3460859|P3|STARTED|Intervention Period 2 (6 Days)||2
1414383|NCT02792062|3460860|P2|STARTED|Intervention Period 2 (6 Days)||2
1414384|NCT02792062|3460861|P1|STARTED|Intervention Period 2 (6 Days)||2
1414385|NCT02792062|3460856|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414386|NCT02792062|3460857|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414387|NCT02792062|3460858|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414388|NCT02792062|3460859|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414389|NCT02792062|3460860|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414390|NCT02792062|3460861|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1414391|NCT02792062|3460856|P6|COMPLETED|Washout Period (at Least 14 Days)||2
1414392|NCT02792062|3460857|P5|COMPLETED|Washout Period (at Least 14 Days)||2
1414393|NCT02792062|3460858|P4|COMPLETED|Washout Period (at Least 14 Days)||2
1414394|NCT02792062|3460859|P3|COMPLETED|Washout Period (at Least 14 Days)||2
1414395|NCT02792062|3460860|P2|COMPLETED|Washout Period (at Least 14 Days)||2
1414396|NCT02792062|3460861|P1|COMPLETED|Washout Period (at Least 14 Days)||2
1414397|NCT02792062|3460856|P6|STARTED|Washout Period (at Least 14 Days)||2
1414398|NCT02792062|3460857|P5|STARTED|Washout Period (at Least 14 Days)||2
1414399|NCT02792062|3460858|P4|STARTED|Washout Period (at Least 14 Days)||2
1414400|NCT02792062|3460859|P3|STARTED|Washout Period (at Least 14 Days)||2
1414401|NCT02792062|3460860|P2|STARTED|Washout Period (at Least 14 Days)||2
1414402|NCT02792062|3460861|P1|STARTED|Washout Period (at Least 14 Days)||2
1414403|NCT02792062|3460856|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1414404|NCT02792062|3460857|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1414405|NCT02792062|3460858|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1414406|NCT02792062|3460859|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1414407|NCT02792062|3460860|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1414408|NCT02792062|3460861|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1414409|NCT02792062|3460856|P6|COMPLETED|Intervention Period 1 (6 Days)||2
1414410|NCT02792062|3460857|P5|COMPLETED|Intervention Period 1 (6 Days)||2
1414411|NCT02792062|3460858|P4|COMPLETED|Intervention Period 1 (6 Days)||2
1414412|NCT02792062|3460859|P3|COMPLETED|Intervention Period 1 (6 Days)||2
1414413|NCT02792062|3460860|P2|COMPLETED|Intervention Period 1 (6 Days)||2
1414414|NCT02792062|3460861|P1|COMPLETED|Intervention Period 1 (6 Days)||2
1414415|NCT02792062|3460856|P6|STARTED|Intervention Period 1 (6 Days)||2
1414416|NCT02792062|3460857|P5|STARTED|Intervention Period 1 (6 Days)||2
1414417|NCT02792062|3460858|P4|STARTED|Intervention Period 1 (6 Days)||2
1414418|NCT02792062|3460859|P3|STARTED|Intervention Period 1 (6 Days)||2
1414419|NCT02792062|3460860|P2|STARTED|Intervention Period 1 (6 Days)||2
1414420|NCT02792062|3460861|P1|STARTED|Intervention Period 1 (6 Days)||2
1414421|NCT02792049|3460895|P2|NOT COMPLETED|Overall Study||0
1414422|NCT02792049|3460896|P1|NOT COMPLETED|Overall Study||0
1414423|NCT02792049|3460895|P2|COMPLETED|Overall Study||35
1414424|NCT02792049|3460896|P1|COMPLETED|Overall Study||35
1414425|NCT02792049|3460895|P2|STARTED|Overall Study||35
1414426|NCT02792049|3460896|P1|STARTED|Overall Study||35
1414427|NCT02791659|3460912|P2|NOT COMPLETED|Overall Study||1
1414428|NCT02791659|3460913|P1|NOT COMPLETED|Overall Study||0
1414429|NCT02791659|3460912|P2|COMPLETED|Overall Study||27
1414430|NCT02791659|3460913|P1|COMPLETED|Overall Study||27
1414431|NCT02791659|3460912|P2|STARTED|Overall Study||28
1414432|NCT02791659|3460913|P1|STARTED|Overall Study||27
1414433|NCT02791269|3460921|P2|NOT COMPLETED|Overall Study||1
1414434|NCT02791269|3460922|P1|NOT COMPLETED|Overall Study||0
1414435|NCT02791269|3460921|P2|COMPLETED|Overall Study||19
1414436|NCT02791269|3460922|P1|COMPLETED|Overall Study||4
1414437|NCT02791269|3460921|P2|STARTED|Overall Study||20
1414438|NCT02791269|3460922|P1|STARTED|Overall Study||4
1414439|NCT02790736|3460938|P2|NOT COMPLETED|Overall Study||0
1414440|NCT02790736|3460939|P1|NOT COMPLETED|Overall Study||0
1414441|NCT02790736|3460938|P2|COMPLETED|Overall Study||1
1414442|NCT02790736|3460939|P1|COMPLETED|Overall Study||5
1414443|NCT02790736|3460938|P2|STARTED|Overall Study||1
1414444|NCT02790736|3460939|P1|STARTED|Overall Study||5
1414445|NCT02790281|3460947|P1|NOT COMPLETED|Overall Study||0
1414446|NCT02790281|3460947|P1|COMPLETED|Overall Study||33
1414447|NCT02790281|3460947|P1|STARTED|Overall Study||33
1414448|NCT02788357|3460955|P2|NOT COMPLETED|Overall Study||0
1414449|NCT02788357|3460956|P1|NOT COMPLETED|Overall Study||3
1414450|NCT02788357|3460955|P2|COMPLETED|Overall Study||6
1414451|NCT02788357|3460956|P1|COMPLETED|Overall Study||3
1414452|NCT02788357|3460955|P2|STARTED|Overall Study||6
1414453|NCT02788357|3460956|P1|STARTED|Overall Study||6
1414454|NCT02788188|3460975|P7|NOT COMPLETED|Overall Study||0
1414455|NCT02788188|3460976|P6|NOT COMPLETED|Overall Study||0
1414456|NCT02788188|3460977|P5|NOT COMPLETED|Overall Study||0
1414457|NCT02788188|3460978|P4|NOT COMPLETED|Overall Study||0
1414458|NCT02788188|3460979|P3|NOT COMPLETED|Overall Study||0
1414459|NCT02788188|3460980|P2|NOT COMPLETED|Overall Study||0
1414460|NCT02788188|3460981|P1|NOT COMPLETED|Overall Study||0
1414461|NCT02788188|3460975|P7|COMPLETED|Overall Study||10
1414462|NCT02788188|3460976|P6|COMPLETED|Overall Study||8
1414463|NCT02788188|3460977|P5|COMPLETED|Overall Study||8
1414464|NCT02788188|3460978|P4|COMPLETED|Overall Study||4
1414465|NCT02788188|3460979|P3|COMPLETED|Overall Study||4
1414466|NCT02788188|3460980|P2|COMPLETED|Overall Study||2
1414467|NCT02788188|3460981|P1|COMPLETED|Overall Study||2
1414468|NCT02788188|3460975|P7|STARTED|Overall Study||10
1414469|NCT02788188|3460976|P6|STARTED|Overall Study||8
1414470|NCT02788188|3460977|P5|STARTED|Overall Study||8
1414471|NCT02788188|3460978|P4|STARTED|Overall Study||4
1414472|NCT02788188|3460979|P3|STARTED|Overall Study||4
1414473|NCT02788188|3460980|P2|STARTED|Overall Study||2
1414474|NCT02788188|3460981|P1|STARTED|Overall Study||2
1414475|NCT02788097|3460999|P2|NOT COMPLETED|Overall Study||0
1414476|NCT02788097|3461000|P1|NOT COMPLETED|Overall Study||0
1414477|NCT02788097|3460999|P2|COMPLETED|Overall Study||69
1414478|NCT02788097|3461000|P1|COMPLETED|Overall Study||61
1414479|NCT02788097|3460999|P2|STARTED|Overall Study||69
1414480|NCT02788097|3461000|P1|STARTED|Overall Study||61
1414481|NCT02787564|3461008|P2|NOT COMPLETED|Overall Study||2
1414482|NCT02787564|3461009|P1|NOT COMPLETED|Overall Study||7
1414483|NCT02787564|3461008|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
1414484|NCT02787564|3461009|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
1414485|NCT02787564|3461008|P2|STARTED|Overall Study||29
1414486|NCT02787564|3461009|P1|STARTED|Overall Study||32
1414487|NCT02786927|3461025|P1|NOT COMPLETED|Overall Study||5
1414488|NCT02786927|3461025|P1|COMPLETED|Overall Study||207
1414489|NCT02786927|3461025|P1|STARTED|Overall Study||212
1414490|NCT02786810|3461032|P1|NOT COMPLETED|Overall Study||0
1414491|NCT02786810|3461032|P1|COMPLETED|Overall Study||10
1414492|NCT02786810|3461032|P1|STARTED|Overall Study||10
1414493|NCT02786771|3461039|P2|NOT COMPLETED|Overall Study||6
1414494|NCT02786771|3461040|P1|NOT COMPLETED|Overall Study||10
1414495|NCT02786771|3461039|P2|COMPLETED|Overall Study||56
1414496|NCT02786771|3461040|P1|COMPLETED|Overall Study||53
1414497|NCT02786771|3461039|P2|STARTED|Overall Study||62
1414498|NCT02786771|3461040|P1|STARTED|Overall Study||63
1414499|NCT02786355|3461046|P1|NOT COMPLETED|Overall Study||0
1414500|NCT02786355|3461046|P1|COMPLETED|Overall Study||35
1414501|NCT02786355|3461046|P1|STARTED|Overall Study||35
1414502|NCT02786004|3461055|P2|NOT COMPLETED|Overall Study||1
1414503|NCT02786004|3461056|P1|NOT COMPLETED|Overall Study||0
1414504|NCT02786004|3461055|P2|COMPLETED|Overall Study||9
1414505|NCT02786004|3461056|P1|COMPLETED|Overall Study||14
1414506|NCT02786004|3461055|P2|STARTED|Overall Study||10
1414507|NCT02786004|3461056|P1|STARTED|Overall Study||14
1414508|NCT02785900|3461066|P2|NOT COMPLETED|Overall Study||123
1414509|NCT02785900|3461067|P1|NOT COMPLETED|Overall Study||117
1414510|NCT02785900|3461066|P2|COMPLETED|Overall Study||0
1414511|NCT02785900|3461067|P1|COMPLETED|Overall Study||0
1414512|NCT02785900|3461066|P2|STARTED|Overall Study||123
1414513|NCT02785900|3461067|P1|STARTED|Overall Study||117
1414514|NCT02785770|3461091|P4|NOT COMPLETED|Intervention Period 4 (1 Day)||0
1414515|NCT02785770|3461092|P3|NOT COMPLETED|Intervention Period 4 (1 Day)||0
1414516|NCT02785770|3461093|P2|NOT COMPLETED|Intervention Period 4 (1 Day)||0
1414517|NCT02785770|3461094|P1|NOT COMPLETED|Intervention Period 4 (1 Day)||0
1414518|NCT02785770|3461091|P4|COMPLETED|Intervention Period 4 (1 Day)||10
1414519|NCT02785770|3461092|P3|COMPLETED|Intervention Period 4 (1 Day)||10
1414520|NCT02785770|3461093|P2|COMPLETED|Intervention Period 4 (1 Day)||10
1414521|NCT02785770|3461094|P1|COMPLETED|Intervention Period 4 (1 Day)||11
1414522|NCT02785770|3461091|P4|STARTED|Intervention Period 4 (1 Day)||10
1414523|NCT02785770|3461092|P3|STARTED|Intervention Period 4 (1 Day)||10
1414524|NCT02785770|3461093|P2|STARTED|Intervention Period 4 (1 Day)||10
1414525|NCT02785770|3461094|P1|STARTED|Intervention Period 4 (1 Day)||11
1414526|NCT02785770|3461091|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
1414527|NCT02785770|3461092|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
1414528|NCT02785770|3461093|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
1414529|NCT02785770|3461094|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
1414530|NCT02785770|3461091|P4|COMPLETED|Washout Period 3 (7 Days)||10
1414531|NCT02785770|3461092|P3|COMPLETED|Washout Period 3 (7 Days)||10
1414532|NCT02785770|3461093|P2|COMPLETED|Washout Period 3 (7 Days)||10
1414533|NCT02785770|3461094|P1|COMPLETED|Washout Period 3 (7 Days)||11
1414534|NCT02785770|3461091|P4|STARTED|Washout Period 3 (7 Days)||10
1414535|NCT02785770|3461092|P3|STARTED|Washout Period 3 (7 Days)||10
1414536|NCT02785770|3461093|P2|STARTED|Washout Period 3 (7 Days)||10
1414537|NCT02785770|3461094|P1|STARTED|Washout Period 3 (7 Days)||11
1414538|NCT02785770|3461091|P4|NOT COMPLETED|Intervention Period 3 (1 Day)||1
1414539|NCT02785770|3461092|P3|NOT COMPLETED|Intervention Period 3 (1 Day)||0
1414540|NCT02785770|3461093|P2|NOT COMPLETED|Intervention Period 3 (1 Day)||0
1414541|NCT02785770|3461094|P1|NOT COMPLETED|Intervention Period 3 (1 Day)||0
1414542|NCT02785770|3461091|P4|COMPLETED|Intervention Period 3 (1 Day)||10
1414543|NCT02785770|3461092|P3|COMPLETED|Intervention Period 3 (1 Day)||10
1414544|NCT02785770|3461093|P2|COMPLETED|Intervention Period 3 (1 Day)||10
1414545|NCT02785770|3461094|P1|COMPLETED|Intervention Period 3 (1 Day)||11
1414546|NCT02785770|3461091|P4|STARTED|Intervention Period 3 (1 Day)||11
1414547|NCT02785770|3461092|P3|STARTED|Intervention Period 3 (1 Day)||10
1414548|NCT02785770|3461093|P2|STARTED|Intervention Period 3 (1 Day)||10
1414549|NCT02785770|3461094|P1|STARTED|Intervention Period 3 (1 Day)||11
1414550|NCT02785770|3461091|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1414551|NCT02785770|3461092|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1414552|NCT02785770|3461093|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1414553|NCT02785770|3461094|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1414554|NCT02785770|3461091|P4|COMPLETED|Washout Period 2 (7 Days)||11
1414555|NCT02785770|3461092|P3|COMPLETED|Washout Period 2 (7 Days)||10
1414556|NCT02785770|3461093|P2|COMPLETED|Washout Period 2 (7 Days)||10
1414557|NCT02785770|3461094|P1|COMPLETED|Washout Period 2 (7 Days)||11
1414558|NCT02785770|3461091|P4|STARTED|Washout Period 2 (7 Days)||11
1414559|NCT02785770|3461092|P3|STARTED|Washout Period 2 (7 Days)||10
1414560|NCT02785770|3461093|P2|STARTED|Washout Period 2 (7 Days)||10
1414561|NCT02785770|3461094|P1|STARTED|Washout Period 2 (7 Days)||11
1414562|NCT02785770|3461091|P4|NOT COMPLETED|Intervention Period 2 (1 Day)||0
1414563|NCT02785770|3461092|P3|NOT COMPLETED|Intervention Period 2 (1 Day)||1
1414564|NCT02785770|3461093|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||1
1414565|NCT02785770|3461094|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
1414566|NCT02785770|3461091|P4|COMPLETED|Intervention Period 2 (1 Day)||11
1414567|NCT02785770|3461092|P3|COMPLETED|Intervention Period 2 (1 Day)||10
1414568|NCT02785770|3461093|P2|COMPLETED|Intervention Period 2 (1 Day)||10
1414569|NCT02785770|3461094|P1|COMPLETED|Intervention Period 2 (1 Day)||11
1414570|NCT02785770|3461091|P4|STARTED|Intervention Period 2 (1 Day)||11
1414571|NCT02785770|3461092|P3|STARTED|Intervention Period 2 (1 Day)||11
1414572|NCT02785770|3461093|P2|STARTED|Intervention Period 2 (1 Day)||11
1414573|NCT02785770|3461094|P1|STARTED|Intervention Period 2 (1 Day)||11
1414574|NCT02785770|3461091|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1414575|NCT02785770|3461092|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1414576|NCT02785770|3461093|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1414577|NCT02785770|3461094|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1414578|NCT02785770|3461091|P4|COMPLETED|Washout Period 1 (7 Days)||11
1414579|NCT02785770|3461092|P3|COMPLETED|Washout Period 1 (7 Days)||11
1414580|NCT02785770|3461093|P2|COMPLETED|Washout Period 1 (7 Days)||11
1414581|NCT02785770|3461094|P1|COMPLETED|Washout Period 1 (7 Days)||11
1414582|NCT02785770|3461091|P4|STARTED|Washout Period 1 (7 Days)||11
1414583|NCT02785770|3461092|P3|STARTED|Washout Period 1 (7 Days)||11
1414584|NCT02785770|3461093|P2|STARTED|Washout Period 1 (7 Days)||11
1414585|NCT02785770|3461094|P1|STARTED|Washout Period 1 (7 Days)||11
1414586|NCT02785770|3461091|P4|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1414587|NCT02785770|3461092|P3|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1414588|NCT02785770|3461093|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1414589|NCT02785770|3461094|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
1414590|NCT02785770|3461091|P4|COMPLETED|Intervention Period 1 (1 Day)||11
1414591|NCT02785770|3461092|P3|COMPLETED|Intervention Period 1 (1 Day)||11
1414592|NCT02785770|3461093|P2|COMPLETED|Intervention Period 1 (1 Day)||11
1414593|NCT02785770|3461094|P1|COMPLETED|Intervention Period 1 (1 Day)||11
1414594|NCT02785770|3461091|P4|STARTED|Intervention Period 1 (1 Day)||11
1414595|NCT02785770|3461092|P3|STARTED|Intervention Period 1 (1 Day)||11
1414596|NCT02785770|3461093|P2|STARTED|Intervention Period 1 (1 Day)||11
1414597|NCT02785770|3461094|P1|STARTED|Intervention Period 1 (1 Day)||11
1414598|NCT02785354|3461164|P3|NOT COMPLETED|Overall Study||0
1414599|NCT02785354|3461165|P2|NOT COMPLETED|Overall Study||0
1414600|NCT02785354|3461166|P1|NOT COMPLETED|Overall Study||0
1414601|NCT02785354|3461164|P3|COMPLETED|Overall Study||44653
1414602|NCT02785354|3461165|P2|COMPLETED|Overall Study||31388
1414603|NCT02785354|3461166|P1|COMPLETED|Overall Study||27060
1414604|NCT02785354|3461164|P3|STARTED|Overall Study||44653
1414605|NCT02785354|3461165|P2|STARTED|Overall Study||31388
1414606|NCT02785354|3461166|P1|STARTED|Overall Study||27060
1414607|NCT02784925|3461195|P1|NOT COMPLETED|Overall Study||0
1414608|NCT02784925|3461195|P1|COMPLETED|Overall Study||30
1414609|NCT02784925|3461195|P1|STARTED|Overall Study||30
1414610|NCT02784275|3461203|P4|NOT COMPLETED|Overall Study||1
1414611|NCT02784275|3461204|P3|NOT COMPLETED|Overall Study||1
1414612|NCT02784275|3461205|P2|NOT COMPLETED|Overall Study||0
1414613|NCT02784275|3461206|P1|NOT COMPLETED|Overall Study||1
1414614|NCT02784275|3461203|P4|COMPLETED|Overall Study||14
1414615|NCT02784275|3461204|P3|COMPLETED|Overall Study||16
1414616|NCT02784275|3461205|P2|COMPLETED|Overall Study||16
1414617|NCT02784275|3461206|P1|COMPLETED|Overall Study||15
1414618|NCT02784275|3461203|P4|STARTED|Overall Study||15
1414619|NCT02784275|3461204|P3|STARTED|Overall Study||17
1414620|NCT02784275|3461205|P2|STARTED|Overall Study||16
1414621|NCT02784275|3461206|P1|STARTED|Overall Study||16
1414622|NCT02784106|3461250|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
1414623|NCT02784106|3461251|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
1414624|NCT02784106|3461252|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
1414625|NCT02784106|3461253|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
1414626|NCT02784106|3461250|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
1414627|NCT02784106|3461251|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
1414628|NCT02784106|3461252|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
1414629|NCT02784106|3461253|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
1414630|NCT02784106|3461250|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
1414631|NCT02784106|3461251|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
1414632|NCT02784106|3461252|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
1414633|NCT02784106|3461253|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
1414634|NCT02784106|3461250|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
1414635|NCT02784106|3461251|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
1414636|NCT02784106|3461252|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
1414637|NCT02784106|3461253|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
1414638|NCT02784106|3461250|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
1414639|NCT02784106|3461251|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
1414640|NCT02784106|3461252|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
1414641|NCT02784106|3461253|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
1414642|NCT02784106|3461250|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
1414643|NCT02784106|3461251|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
1414644|NCT02784106|3461252|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
1414645|NCT02784106|3461253|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
1414646|NCT02782676|3461314|P2|NOT COMPLETED|Overall Study||1
1414647|NCT02782676|3461315|P1|NOT COMPLETED|Overall Study||0
1414648|NCT02782676|3461314|P2|COMPLETED|Overall Study||209
1414649|NCT02782676|3461315|P1|COMPLETED|Overall Study||211
1414650|NCT02782676|3461314|P2|STARTED|Overall Study||210
1414651|NCT02782676|3461315|P1|STARTED|Overall Study||211
1414652|NCT02782169|3461345|P2|NOT COMPLETED|Overall Study||2
1414653|NCT02782169|3461346|P1|NOT COMPLETED|Overall Study||1
1414654|NCT02782169|3461345|P2|COMPLETED|Overall Study||52
1414655|NCT02782169|3461346|P1|COMPLETED|Overall Study||55
1414656|NCT02782169|3461345|P2|STARTED|Overall Study||54
1414657|NCT02782169|3461346|P1|STARTED|Overall Study||56
1414658|NCT02781818|3461363|P3|NOT COMPLETED|Overall Study||1
1414659|NCT02781818|3461364|P2|NOT COMPLETED|Overall Study||2
1414660|NCT02781818|3461365|P1|NOT COMPLETED|Overall Study||4
1414661|NCT02781818|3461363|P3|COMPLETED|Overall Study||16
1414662|NCT02781818|3461364|P2|COMPLETED|Overall Study||16
1414663|NCT02781818|3461365|P1|COMPLETED|Overall Study||16
1414664|NCT02781818|3461363|P3|STARTED|Overall Study||17
1414665|NCT02781818|3461364|P2|STARTED|Overall Study||18
1414666|NCT02781818|3461365|P1|STARTED|Overall Study||20
1414667|NCT02781649|3461382|P3|NOT COMPLETED|Overall Study||0
1414668|NCT02781649|3461383|P2|NOT COMPLETED|Overall Study||0
1414669|NCT02781649|3461384|P1|NOT COMPLETED|Overall Study||0
1414670|NCT02781649|3461382|P3|COMPLETED|Overall Study||3
1414671|NCT02781649|3461383|P2|COMPLETED|Overall Study||0
1414672|NCT02781649|3461384|P1|COMPLETED|Overall Study||7
1414673|NCT02781649|3461382|P3|STARTED|Overall Study||3
1414674|NCT02781649|3461383|P2|STARTED|Overall Study||0
1414675|NCT02781649|3461384|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
1414676|NCT02781571|3461410|P1|NOT COMPLETED|Overall Study||0
1414677|NCT02781571|3461410|P1|COMPLETED|Overall Study||79
1414678|NCT02781571|3461410|P1|STARTED|Overall Study||79
1414679|NCT02781558|3461431|P2|NOT COMPLETED|Overall Study||2
1414680|NCT02781558|3461432|P1|NOT COMPLETED|Overall Study||3
1414681|NCT02781558|3461431|P2|COMPLETED|Overall Study||101
1414682|NCT02781558|3461432|P1|COMPLETED|Overall Study||98
1414683|NCT02781558|3461431|P2|STARTED|Overall Study||103
1414684|NCT02781558|3461432|P1|STARTED|Overall Study||101
1414685|NCT02780869|3461470|P2|NOT COMPLETED|Overall Study||9
1414686|NCT02780869|3461471|P1|NOT COMPLETED|Overall Study||13
1414687|NCT02780869|3461470|P2|COMPLETED|Overall Study||74
1414688|NCT02780869|3461471|P1|COMPLETED|Overall Study||162
1414689|NCT02780869|3461470|P2|STARTED|Overall Study||83
1414690|NCT02780869|3461471|P1|STARTED|Overall Study||175
1414691|NCT02780765|3461483|P2|NOT COMPLETED|Overall Study||0
1414692|NCT02780765|3461484|P1|NOT COMPLETED|Overall Study||0
1414693|NCT02780765|3461483|P2|COMPLETED|Overall Study||30
1414694|NCT02780765|3461484|P1|COMPLETED|Overall Study||30
1414695|NCT02780765|3461483|P2|STARTED|Overall Study||30
1414696|NCT02780765|3461484|P1|STARTED|Overall Study||30
1414697|NCT02780700|3461492|P1|NOT COMPLETED|Overall Study||1
1414698|NCT02780700|3461492|P1|COMPLETED|Overall Study||0
1414699|NCT02780700|3461492|P1|STARTED|Overall Study||1
1414700|NCT02780661|3461500|P2|NOT COMPLETED|Period 2||0
1414701|NCT02780661|3461501|P1|NOT COMPLETED|Period 2||0
1414702|NCT02780661|3461500|P2|COMPLETED|Period 2||9
1414703|NCT02780661|3461501|P1|COMPLETED|Period 2||10
1414704|NCT02780661|3461500|P2|STARTED|Period 2||9
1414705|NCT02780661|3461501|P1|STARTED|Period 2||10
1414706|NCT02780661|3461500|P2|NOT COMPLETED|Wash Out Period||0
1414707|NCT02780661|3461501|P1|NOT COMPLETED|Wash Out Period||0
1414708|NCT02780661|3461500|P2|COMPLETED|Wash Out Period||9
1414709|NCT02780661|3461501|P1|COMPLETED|Wash Out Period||10
1414710|NCT02780661|3461500|P2|STARTED|Wash Out Period||9
1414711|NCT02780661|3461501|P1|STARTED|Wash Out Period||10
1414712|NCT02780661|3461500|P2|NOT COMPLETED|Period 1||0
1414713|NCT02780661|3461501|P1|NOT COMPLETED|Period 1||0
1414714|NCT02780661|3461500|P2|COMPLETED|Period 1||9
1414715|NCT02780661|3461501|P1|COMPLETED|Period 1||10
1414716|NCT02780661|3461500|P2|STARTED|Period 1||9
1414717|NCT02780661|3461501|P1|STARTED|Period 1||10
1414718|NCT02780622|3461517|P2|NOT COMPLETED|Treatment Period 2||0
1414719|NCT02780622|3461518|P1|NOT COMPLETED|Treatment Period 2||0
1414720|NCT02780622|3461517|P2|COMPLETED|Treatment Period 2||10
1414721|NCT02780622|3461518|P1|COMPLETED|Treatment Period 2||10
1414722|NCT02780622|3461517|P2|STARTED|Treatment Period 2||10
1414723|NCT02780622|3461518|P1|STARTED|Treatment Period 2||10
1414724|NCT02780622|3461517|P2|NOT COMPLETED|Treatment Period 1||0
1414725|NCT02780622|3461518|P1|NOT COMPLETED|Treatment Period 1||0
1414726|NCT02780622|3461517|P2|COMPLETED|Treatment Period 1||10
1414727|NCT02780622|3461518|P1|COMPLETED|Treatment Period 1||10
1414728|NCT02780622|3461517|P2|STARTED|Treatment Period 1||10
1414729|NCT02780622|3461518|P1|STARTED|Treatment Period 1||10
1414730|NCT02780349|3461556|P1|NOT COMPLETED|Overall Study||2
1414731|NCT02780349|3461556|P1|COMPLETED|Overall Study||101
1414732|NCT02780349|3461556|P1|STARTED|Overall Study||103
1414733|NCT02780167|3461565|P5|NOT COMPLETED|Overall Study||17
1414734|NCT02780167|3461566|P4|NOT COMPLETED|Overall Study||19
1414735|NCT02780167|3461567|P3|NOT COMPLETED|Overall Study||24
1414736|NCT02780167|3461568|P2|NOT COMPLETED|Overall Study||22
1414737|NCT02780167|3461569|P1|NOT COMPLETED|Overall Study||28
1414738|NCT02780167|3461565|P5|COMPLETED|Overall Study||38
1414739|NCT02780167|3461566|P4|COMPLETED|Overall Study||37
1414740|NCT02780167|3461567|P3|COMPLETED|Overall Study||27
1414741|NCT02780167|3461568|P2|COMPLETED|Overall Study||27
1414742|NCT02780167|3461569|P1|COMPLETED|Overall Study||28
1414743|NCT02780167|3461565|P5|STARTED|Overall Study||55
1414744|NCT02780167|3461566|P4|STARTED|Overall Study||56
1414745|NCT02780167|3461567|P3|STARTED|Overall Study||51
1414746|NCT02780167|3461568|P2|STARTED|Overall Study||49
1414747|NCT02780167|3461569|P1|STARTED|Overall Study||56
1414748|NCT02777931|3461703|P2|NOT COMPLETED|Overall Study||13
1414749|NCT02777931|3461704|P1|NOT COMPLETED|Overall Study||12
1414750|NCT02777931|3461703|P2|COMPLETED|Overall Study||39
1414751|NCT02777931|3461704|P1|COMPLETED|Overall Study||37
1414752|NCT02777931|3461703|P2|Modified Intent to Treat Population|Overall Study||50
1414753|NCT02777931|3461704|P1|Modified Intent to Treat Population|Overall Study||46
1414754|NCT02777931|3461703|P2|Safety Population|Overall Study||50
1414755|NCT02777931|3461704|P1|Safety Population|Overall Study||47
1414756|NCT02777931|3461703|P2|STARTED|Overall Study||52
1414757|NCT02777931|3461704|P1|STARTED|Overall Study||49
1414758|NCT02777268|3461712|P1|NOT COMPLETED|Overall Study||0
1414759|NCT02777268|3461712|P1|COMPLETED|Overall Study||16
1414760|NCT02777268|3461712|P1|STARTED|Overall Study||16
1414761|NCT02777242|3461738|P1|NOT COMPLETED|Overall Study||6
1414762|NCT02777242|3461738|P1|COMPLETED|Overall Study||59
1414763|NCT02777242|3461738|P1|STARTED|Overall Study||65
1414764|NCT02777125|3461744|P2|NOT COMPLETED|Overall Study||47
1414765|NCT02777125|3461745|P1|NOT COMPLETED|Overall Study||43
1414766|NCT02777125|3461744|P2|COMPLETED|Overall Study||445
1414767|NCT02777125|3461745|P1|COMPLETED|Overall Study||445
1414768|NCT02777125|3461744|P2|STARTED|Overall Study||492
1414769|NCT02777125|3461745|P1|STARTED|Overall Study||488
1414770|NCT02774343|3461761|P2|NOT COMPLETED|Overall Study||3
1414771|NCT02774343|3461762|P1|NOT COMPLETED|Overall Study||6
1414772|NCT02774343|3461761|P2|COMPLETED|Overall Study||12
1414773|NCT02774343|3461762|P1|COMPLETED|Overall Study||9
1414774|NCT02774343|3461761|P2|Received at Least One Capsule|Overall Study||14
1414775|NCT02774343|3461762|P1|Received at Least One Capsule|Overall Study||12
1414776|NCT02774343|3461761|P2|STARTED|Overall Study||15
1414777|NCT02774343|3461762|P1|STARTED|Overall Study||15
1414778|NCT02774278|3461798|P1|NOT COMPLETED|Overall Study||264
1414779|NCT02774278|3461798|P1|COMPLETED|Overall Study||0
1414780|NCT02774278|3461798|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
1414781|NCT02774278|3461798|P1|STARTED|Overall Study||264
1414782|NCT02774265|3461808|P2|NOT COMPLETED|Overall Study||6
1414783|NCT02774265|3461809|P1|NOT COMPLETED|Overall Study||13
1414784|NCT02774265|3461808|P2|COMPLETED|Overall Study||159
1414785|NCT02774265|3461809|P1|COMPLETED|Overall Study||151
1414786|NCT02774265|3461808|P2|STARTED|Overall Study||165
1414787|NCT02774265|3461809|P1|STARTED|Overall Study||164
1414788|NCT02774148|3461821|P2|NOT COMPLETED|Overall Study||0
1414789|NCT02774148|3461822|P1|NOT COMPLETED|Overall Study||0
1414790|NCT02774148|3461821|P2|COMPLETED|Overall Study||0
1414791|NCT02774148|3461822|P1|COMPLETED|Overall Study||0
1414792|NCT02774148|3461821|P2|STARTED|Overall Study||0
1414793|NCT02774148|3461822|P1|STARTED|Overall Study||0
1414794|NCT02773758|3461838|P2|NOT COMPLETED|Overall Study||0
1414795|NCT02773758|3461839|P1|NOT COMPLETED|Overall Study||0
1414796|NCT02773758|3461838|P2|COMPLETED|Overall Study||70
1414797|NCT02773758|3461839|P1|COMPLETED|Overall Study||71
1414798|NCT02773758|3461838|P2|STARTED|Overall Study||70
1414799|NCT02773758|3461839|P1|STARTED|Overall Study||71
1414800|NCT02773446|3461855|P6|NOT COMPLETED|Second Admission||0
1414801|NCT02773446|3461856|P5|NOT COMPLETED|Second Admission||0
1414802|NCT02773446|3461857|P4|NOT COMPLETED|Second Admission||0
1414803|NCT02773446|3461858|P3|NOT COMPLETED|Second Admission||0
1414804|NCT02773446|3461859|P2|NOT COMPLETED|Second Admission||0
1414805|NCT02773446|3461860|P1|NOT COMPLETED|Second Admission||0
1414806|NCT02773446|3461855|P6|COMPLETED|Second Admission||19
1414807|NCT02773446|3461856|P5|COMPLETED|Second Admission||11
1414808|NCT02773446|3461857|P4|COMPLETED|Second Admission||0
1414809|NCT02773446|3461858|P3|COMPLETED|Second Admission||0
1414810|NCT02773446|3461859|P2|COMPLETED|Second Admission||0
1414811|NCT02773446|3461860|P1|COMPLETED|Second Admission||0
1414812|NCT02773446|3461855|P6|STARTED|Second Admission||19
1414813|NCT02773446|3461856|P5|STARTED|Second Admission||11
1414814|NCT02773446|3461857|P4|STARTED|Second Admission||0
1414815|NCT02773446|3461858|P3|STARTED|Second Admission||0
1414816|NCT02773446|3461859|P2|STARTED|Second Admission||0
1414817|NCT02773446|3461860|P1|STARTED|Second Admission||0
1414818|NCT02773446|3461855|P6|NOT COMPLETED|First Admission||0
1414819|NCT02773446|3461856|P5|NOT COMPLETED|First Admission||0
1414820|NCT02773446|3461857|P4|NOT COMPLETED|First Admission||1
1414821|NCT02773446|3461858|P3|NOT COMPLETED|First Admission||0
1414822|NCT02773446|3461859|P2|NOT COMPLETED|First Admission||0
1414823|NCT02773446|3461860|P1|NOT COMPLETED|First Admission||1
1414824|NCT02773446|3461855|P6|COMPLETED|First Admission||0
1414825|NCT02773446|3461856|P5|COMPLETED|First Admission||0
1414826|NCT02773446|3461857|P4|COMPLETED|First Admission||6
1414827|NCT02773446|3461858|P3|COMPLETED|First Admission||7
1414828|NCT02773446|3461859|P2|COMPLETED|First Admission||7
1414829|NCT02773446|3461860|P1|COMPLETED|First Admission||6
1414830|NCT02773446|3461855|P6|STARTED|First Admission||0
1414831|NCT02773446|3461856|P5|STARTED|First Admission||0
1414832|NCT02773446|3461857|P4|STARTED|First Admission||7
1414833|NCT02773446|3461858|P3|STARTED|First Admission||7
1414834|NCT02773446|3461859|P2|STARTED|First Admission||7
1414835|NCT02773446|3461860|P1|STARTED|First Admission||7
1414836|NCT02773368|3461901|P2|NOT COMPLETED|Overall Study||4
1414837|NCT02773368|3461902|P1|NOT COMPLETED|Overall Study||10
1414838|NCT02773368|3461901|P2|COMPLETED|Overall Study||206
1414839|NCT02773368|3461902|P1|COMPLETED|Overall Study||200
1414840|NCT02773368|3461901|P2|Exposed|Overall Study||210
1414841|NCT02773368|3461902|P1|Exposed|Overall Study||209
1414842|NCT02773368|3461901|P2|STARTED|Overall Study||210
1414843|NCT02773368|3461902|P1|STARTED|Overall Study||210
1414844|NCT02772666|3461972|P1|NOT COMPLETED|SFT Then O-Glass||0
1414845|NCT02772666|3461972|P1|COMPLETED|SFT Then O-Glass||44
1414846|NCT02772666|3461972|P1|STARTED|SFT Then O-Glass||44
1414847|NCT02772666|3461972|P1|NOT COMPLETED|O-Glas Then SFT||0
1414848|NCT02772666|3461972|P1|COMPLETED|O-Glas Then SFT||44
1414849|NCT02772666|3461972|P1|STARTED|O-Glas Then SFT||44
1414850|NCT02771145|3461977|P1|NOT COMPLETED|Overall Study||4
1414851|NCT02771145|3461977|P1|COMPLETED|Overall Study||86
1414852|NCT02771145|3461977|P1|STARTED|Overall Study||90
1414853|NCT02771093|3462018|P2|NOT COMPLETED|Overall Study||0
1414854|NCT02771093|3462019|P1|NOT COMPLETED|Overall Study||0
1414855|NCT02771093|3462018|P2|COMPLETED|Overall Study||14
1414856|NCT02771093|3462019|P1|COMPLETED|Overall Study||13
1414857|NCT02771093|3462018|P2|STARTED|Overall Study||14
1414858|NCT02771093|3462019|P1|STARTED|Overall Study||13
1414859|NCT02770625|3462071|P1|NOT COMPLETED|Overall Study||0
1414860|NCT02770625|3462071|P1|COMPLETED|Overall Study||8
1414861|NCT02770625|3462071|P1|STARTED|Overall Study||8
1414862|NCT02770248|3462086|P2|NOT COMPLETED|Overall Study||2
1414863|NCT02770248|3462087|P1|NOT COMPLETED|Overall Study||0
1414864|NCT02770248|3462086|P2|COMPLETED|Overall Study||61
1414865|NCT02770248|3462087|P1|COMPLETED|Overall Study||62
1414866|NCT02770248|3462086|P2|STARTED|Overall Study||63
1414867|NCT02770248|3462087|P1|STARTED|Overall Study||62
1414868|NCT02769858|3462099|P1|NOT COMPLETED|Overall Study||2
1414869|NCT02769858|3462099|P1|COMPLETED|Overall Study||8
1414870|NCT02769858|3462099|P1|STARTED|Overall Study||10
1414871|NCT02769702|3462105|P1|NOT COMPLETED|Overall Study||0
1414872|NCT02769702|3462105|P1|COMPLETED|Overall Study||2
1414873|NCT02769702|3462105|P1|STARTED|Overall Study||2
1414874|NCT02769442|3462112|P2|NOT COMPLETED|Overall Study||0
1414875|NCT02769442|3462113|P1|NOT COMPLETED|Overall Study||0
1414876|NCT02769442|3462112|P2|COMPLETED|Overall Study||291
1414877|NCT02769442|3462113|P1|COMPLETED|Overall Study||309
1414878|NCT02769442|3462112|P2|STARTED|Overall Study||291
1414879|NCT02769442|3462113|P1|STARTED|Overall Study||309
1414880|NCT02769247|3462125|P4|NOT COMPLETED|Overall Study||1
1414881|NCT02769247|3462126|P3|NOT COMPLETED|Overall Study||1
1414882|NCT02769247|3462127|P2|NOT COMPLETED|Overall Study||0
1414883|NCT02769247|3462128|P1|NOT COMPLETED|Overall Study||2
1414884|NCT02769247|3462125|P4|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
1414885|NCT02769247|3462126|P3|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
1414886|NCT02769247|3462127|P2|COMPLETED|Overall Study||40
1414887|NCT02769247|3462128|P1|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
1414888|NCT02769247|3462125|P4|STARTED|Overall Study||40
1414889|NCT02769247|3462126|P3|STARTED|Overall Study||40
1414890|NCT02769247|3462127|P2|STARTED|Overall Study||40
1414891|NCT02769247|3462128|P1|STARTED|Overall Study||40
1414892|NCT02768194|3462166|P6|NOT COMPLETED|Period 3||0
1414893|NCT02768194|3462167|P5|NOT COMPLETED|Period 3||0
1414894|NCT02768194|3462168|P4|NOT COMPLETED|Period 3||0
1414895|NCT02768194|3462169|P3|NOT COMPLETED|Period 3||0
1414896|NCT02768194|3462170|P2|NOT COMPLETED|Period 3||1
1414897|NCT02768194|3462171|P1|NOT COMPLETED|Period 3||0
1414898|NCT02768194|3462166|P6|COMPLETED|Period 3||4
1414899|NCT02768194|3462167|P5|COMPLETED|Period 3||4
1414900|NCT02768194|3462168|P4|COMPLETED|Period 3||3
1414901|NCT02768194|3462169|P3|COMPLETED|Period 3||4
1414902|NCT02768194|3462170|P2|COMPLETED|Period 3||3
1414903|NCT02768194|3462171|P1|COMPLETED|Period 3||3
1414904|NCT02768194|3462166|P6|STARTED|Period 3||4
1414905|NCT02768194|3462167|P5|STARTED|Period 3||4
1414906|NCT02768194|3462168|P4|STARTED|Period 3||3
1414907|NCT02768194|3462169|P3|STARTED|Period 3||4
1414908|NCT02768194|3462170|P2|STARTED|Period 3||4
1414909|NCT02768194|3462171|P1|STARTED|Period 3||3
1414910|NCT02768194|3462166|P6|NOT COMPLETED|Period 2||0
1414911|NCT02768194|3462167|P5|NOT COMPLETED|Period 2||0
1414912|NCT02768194|3462168|P4|NOT COMPLETED|Period 2||0
1414913|NCT02768194|3462169|P3|NOT COMPLETED|Period 2||0
1414914|NCT02768194|3462170|P2|NOT COMPLETED|Period 2||0
1414915|NCT02768194|3462171|P1|NOT COMPLETED|Period 2||1
1414916|NCT02768194|3462166|P6|COMPLETED|Period 2||4
1414917|NCT02768194|3462167|P5|COMPLETED|Period 2||4
1414918|NCT02768194|3462168|P4|COMPLETED|Period 2||3
1414919|NCT02768194|3462169|P3|COMPLETED|Period 2||4
1414920|NCT02768194|3462170|P2|COMPLETED|Period 2||4
1414921|NCT02768194|3462171|P1|COMPLETED|Period 2||3
1414922|NCT02768194|3462166|P6|STARTED|Period 2||4
1414923|NCT02768194|3462167|P5|STARTED|Period 2||4
1414924|NCT02768194|3462168|P4|STARTED|Period 2||3
1414925|NCT02768194|3462169|P3|STARTED|Period 2||4
1414926|NCT02768194|3462170|P2|STARTED|Period 2||4
1414927|NCT02768194|3462171|P1|STARTED|Period 2||4
1414928|NCT02768194|3462166|P6|NOT COMPLETED|Period 1||0
1414929|NCT02768194|3462167|P5|NOT COMPLETED|Period 1||0
1414930|NCT02768194|3462168|P4|NOT COMPLETED|Period 1||1
1414931|NCT02768194|3462169|P3|NOT COMPLETED|Period 1||0
1414932|NCT02768194|3462170|P2|NOT COMPLETED|Period 1||0
1414933|NCT02768194|3462171|P1|NOT COMPLETED|Period 1||0
1414934|NCT02768194|3462166|P6|COMPLETED|Period 1||4
1414935|NCT02768194|3462167|P5|COMPLETED|Period 1||4
1414936|NCT02768194|3462168|P4|COMPLETED|Period 1||3
1414937|NCT02768194|3462169|P3|COMPLETED|Period 1||4
1414938|NCT02768194|3462170|P2|COMPLETED|Period 1||4
1414939|NCT02768194|3462171|P1|COMPLETED|Period 1||4
1414940|NCT02768194|3462166|P6|STARTED|Period 1||4
1414941|NCT02768194|3462167|P5|STARTED|Period 1||4
1414942|NCT02768194|3462168|P4|STARTED|Period 1||4
1414943|NCT02768194|3462169|P3|STARTED|Period 1||4
1414944|NCT02768194|3462170|P2|STARTED|Period 1||4
1414945|NCT02768194|3462171|P1|STARTED|Period 1||4
1414946|NCT02767843|3462182|P1|NOT COMPLETED|Overall Study||0
1414947|NCT02767843|3462182|P1|COMPLETED|Overall Study||4
1414948|NCT02767843|3462182|P1|STARTED|Overall Study||4
1414949|NCT02767765|3462188|P1|NOT COMPLETED|Overall Study||11
1414950|NCT02767765|3462188|P1|COMPLETED|Overall Study||50
1414951|NCT02767765|3462188|P1|STARTED|Overall Study||61
1414952|NCT02766400|3462199|P2|NOT COMPLETED|Overall Study||2
1414953|NCT02766400|3462200|P1|NOT COMPLETED|Overall Study||2
1414954|NCT02766400|3462199|P2|COMPLETED|Overall Study||20
1414955|NCT02766400|3462200|P1|COMPLETED|Overall Study||19
1414956|NCT02766400|3462199|P2|STARTED|Overall Study||22
1414957|NCT02766400|3462200|P1|STARTED|Overall Study||21
1414958|NCT02766283|3462206|P1|NOT COMPLETED|Overall Study||27
1414959|NCT02766283|3462206|P1|COMPLETED|Overall Study||816
1414960|NCT02766283|3462206|P1|STARTED|Overall Study||843
1414961|NCT02766244|3462230|P1|NOT COMPLETED|Overall Study||0
1414962|NCT02766244|3462230|P1|COMPLETED|Overall Study||3
1414963|NCT02766244|3462230|P1|STARTED|Overall Study||3
1414964|NCT02765269|3462241|P2|NOT COMPLETED|Overall Study||0
1414965|NCT02765269|3462242|P1|NOT COMPLETED|Overall Study||0
1414966|NCT02765269|3462241|P2|COMPLETED|Overall Study||21
1414967|NCT02765269|3462242|P1|COMPLETED|Overall Study||25
1414968|NCT02765269|3462241|P2|STARTED|Overall Study||21
1414969|NCT02765269|3462242|P1|STARTED|Overall Study||25
1414970|NCT02764970|3462256|P2|NOT COMPLETED|Overall Study||0
1414971|NCT02764970|3462257|P1|NOT COMPLETED|Overall Study||0
1414972|NCT02764970|3462256|P2|COMPLETED|Overall Study||47
1414973|NCT02764970|3462257|P1|COMPLETED|Overall Study||65
1414974|NCT02764970|3462256|P2|STARTED|Overall Study||47
1414975|NCT02764970|3462257|P1|STARTED|Overall Study||65
1414976|NCT02764697|3462269|P1|NOT COMPLETED|Overall Study||3
1414977|NCT02764697|3462269|P1|COMPLETED|Overall Study||2
1414978|NCT02764697|3462269|P1|STARTED|Overall Study||5
1414979|NCT02763189|3462276|P2|NOT COMPLETED|Overall Study||2
1414980|NCT02763189|3462277|P1|NOT COMPLETED|Overall Study||0
1414981|NCT02763189|3462276|P2|COMPLETED|Overall Study||2
1414982|NCT02763189|3462277|P1|COMPLETED|Overall Study||4
1414983|NCT02763189|3462276|P2|STARTED|Overall Study||4
1414984|NCT02763189|3462277|P1|STARTED|Overall Study||4
1414985|NCT02762799|3462289|P4|NOT COMPLETED|Overall Study||0
1414986|NCT02762799|3462290|P3|NOT COMPLETED|Overall Study||1
1414987|NCT02762799|3462291|P2|NOT COMPLETED|Overall Study||0
1414988|NCT02762799|3462292|P1|NOT COMPLETED|Overall Study||0
1414989|NCT02762799|3462289|P4|COMPLETED|Overall Study||12
1414990|NCT02762799|3462290|P3|COMPLETED|Overall Study||11
1414991|NCT02762799|3462291|P2|COMPLETED|Overall Study||18
1414992|NCT02762799|3462292|P1|COMPLETED|Overall Study||18
1414993|NCT02762799|3462289|P4|STARTED|Overall Study||12
1414994|NCT02762799|3462290|P3|STARTED|Overall Study||12
1414995|NCT02762799|3462291|P2|STARTED|Overall Study||18
1414996|NCT02762799|3462292|P1|STARTED|Overall Study||18
1414997|NCT02762578|3462364|P2|NOT COMPLETED|Overall Study||10
1414998|NCT02762578|3462365|P1|NOT COMPLETED|Overall Study||15
1414999|NCT02762578|3462364|P2|COMPLETED|Overall Study||172
1415000|NCT02762578|3462365|P1|COMPLETED|Overall Study||346
1415001|NCT02762578|3462364|P2|Exposed|Overall Study||181
1415002|NCT02762578|3462365|P1|Exposed|Overall Study||360
1415003|NCT02762578|3462364|P2|STARTED|Overall Study||182
1415004|NCT02762578|3462365|P1|STARTED|Overall Study||361
1415005|NCT02762370|3462467|P2|NOT COMPLETED|Overall Study||0
1415006|NCT02762370|3462468|P1|NOT COMPLETED|Overall Study||1
1415007|NCT02762370|3462467|P2|COMPLETED|Overall Study||15
1415008|NCT02762370|3462468|P1|COMPLETED|Overall Study||17
1415009|NCT02762370|3462467|P2|STARTED|Overall Study||15
1415010|NCT02762370|3462468|P1|STARTED|Overall Study||18
1415011|NCT02761980|3462490|P4|NOT COMPLETED|Overall Study||6
1415012|NCT02761980|3462491|P3|NOT COMPLETED|Overall Study||6
1415013|NCT02761980|3462492|P2|NOT COMPLETED|Overall Study||7
1415014|NCT02761980|3462493|P1|NOT COMPLETED|Overall Study||4
1415015|NCT02761980|3462490|P4|COMPLETED|Overall Study||81
1415016|NCT02761980|3462491|P3|COMPLETED|Overall Study||81
1415017|NCT02761980|3462492|P2|COMPLETED|Overall Study||80
1415018|NCT02761980|3462493|P1|COMPLETED|Overall Study||25
1415019|NCT02761980|3462490|P4|STARTED|Overall Study||87
1415020|NCT02761980|3462491|P3|STARTED|Overall Study||87
1415021|NCT02761980|3462492|P2|STARTED|Overall Study||87
1415022|NCT02761980|3462493|P1|STARTED|Overall Study||29
1415023|NCT02761733|3462527|P4|NOT COMPLETED|Overall Study||15
1415024|NCT02761733|3462528|P3|NOT COMPLETED|Overall Study||27
1415025|NCT02761733|3462529|P2|NOT COMPLETED|Overall Study||21
1415026|NCT02761733|3462530|P1|NOT COMPLETED|Overall Study||30
1415027|NCT02761733|3462527|P4|COMPLETED|Overall Study||45
1415028|NCT02761733|3462528|P3|COMPLETED|Overall Study||33
1415029|NCT02761733|3462529|P2|COMPLETED|Overall Study||39
1415030|NCT02761733|3462530|P1|COMPLETED|Overall Study||30
1415031|NCT02761733|3462527|P4|9/30/2015|Overall Study||50
1415032|NCT02761733|3462528|P3|9/30/2015|Overall Study||33
1415033|NCT02761733|3462529|P2|9/30/2015|Overall Study||44
1415034|NCT02761733|3462530|P1|9/30/2015|Overall Study||40
1415035|NCT02761733|3462527|P4|3/31/2015|Overall Study||50
1415036|NCT02761733|3462528|P3|3/31/2015|Overall Study||43
1415037|NCT02761733|3462529|P2|3/31/2015|Overall Study||47
1415038|NCT02761733|3462530|P1|3/31/2015|Overall Study||48
1415039|NCT02761733|3462527|P4|9/30/2014|Overall Study||55
1415040|NCT02761733|3462528|P3|9/30/2014|Overall Study||48
1415041|NCT02761733|3462529|P2|9/30/2014|Overall Study||56
1415042|NCT02761733|3462530|P1|9/30/2014|Overall Study||53
1415043|NCT02761733|3462527|P4|STARTED|Overall Study||60
1415044|NCT02761733|3462528|P3|STARTED|Overall Study||60
1415045|NCT02761733|3462529|P2|STARTED|Overall Study||60
1415046|NCT02761733|3462530|P1|STARTED|Overall Study||60
1415047|NCT02761642|3462560|P1|NOT COMPLETED|Overall Study||70
1415048|NCT02761642|3462560|P1|COMPLETED|Overall Study||130
1415049|NCT02761642|3462560|P1|Treated|Overall Study||197
1415050|NCT02761642|3462560|P1|STARTED|Overall Study||200
1415051|NCT02761629|3462573|P2|NOT COMPLETED|Overall Study||32
1415052|NCT02761629|3462574|P1|NOT COMPLETED|Overall Study||27
1415053|NCT02761629|3462573|P2|COMPLETED|Overall Study||58
1415054|NCT02761629|3462574|P1|COMPLETED|Overall Study||63
1415055|NCT02761629|3462573|P2|Treated|Overall Study||86
1415056|NCT02761629|3462574|P1|Treated|Overall Study||82
1415057|NCT02761629|3462573|P2|STARTED|Overall Study||90
1415058|NCT02761629|3462574|P1|STARTED|Overall Study||90
1415059|NCT02760927|3462594|P1|NOT COMPLETED|Overall Study||1
1415060|NCT02760927|3462594|P1|COMPLETED|Overall Study||3
1415061|NCT02760927|3462594|P1|STARTED|Overall Study||4
1415062|NCT02760810|3462602|P1|NOT COMPLETED|Overall Study||1
1415063|NCT02760810|3462602|P1|COMPLETED|Overall Study||29
1415064|NCT02760810|3462602|P1|STARTED|Overall Study||30
1415065|NCT02760654|3462610|P2|NOT COMPLETED|Overall Study||6
1415066|NCT02760654|3462611|P1|NOT COMPLETED|Overall Study||7
1415067|NCT02760654|3462610|P2|COMPLETED|Overall Study||24
1415068|NCT02760654|3462611|P1|COMPLETED|Overall Study||23
1415069|NCT02760654|3462610|P2|STARTED|Overall Study||30
1415070|NCT02760654|3462611|P1|STARTED|Overall Study||30
1415071|NCT02760602|3462637|P2|NOT COMPLETED|Overall Study||13
1415072|NCT02760602|3462638|P1|NOT COMPLETED|Overall Study||13
1415073|NCT02760602|3462637|P2|COMPLETED|Overall Study||0
1415074|NCT02760602|3462638|P1|COMPLETED|Overall Study||0
1415075|NCT02760602|3462637|P2|STARTED|Overall Study||13
1415076|NCT02760602|3462638|P1|STARTED|Overall Study||13
1415077|NCT02760056|3462678|P2|NOT COMPLETED|Overall Study||0
1415078|NCT02760056|3462679|P1|NOT COMPLETED|Overall Study||0
1415079|NCT02760056|3462678|P2|COMPLETED|Overall Study||5
1415080|NCT02760056|3462679|P1|COMPLETED|Overall Study||10
1415081|NCT02760056|3462678|P2|STARTED|Overall Study||5
1415082|NCT02760056|3462679|P1|STARTED|Overall Study||10
1415083|NCT02759692|3462687|P2|NOT COMPLETED|Period 3||0
1415084|NCT02759692|3462688|P1|NOT COMPLETED|Period 3||0
1415085|NCT02759692|3462687|P2|COMPLETED|Period 3||139
1415086|NCT02759692|3462688|P1|COMPLETED|Period 3||137
1415087|NCT02759692|3462687|P2|STARTED|Period 3||139
1415088|NCT02759692|3462688|P1|STARTED|Period 3||137
1415089|NCT02759692|3462687|P2|NOT COMPLETED|Period 2||1
1415090|NCT02759692|3462688|P1|NOT COMPLETED|Period 2||1
1415091|NCT02759692|3462687|P2|COMPLETED|Period 2||139
1415092|NCT02759692|3462688|P1|COMPLETED|Period 2||137
1415093|NCT02759692|3462687|P2|STARTED|Period 2||140
1415094|NCT02759692|3462688|P1|STARTED|Period 2||138
1415095|NCT02759692|3462687|P2|NOT COMPLETED|Period 1||2
1415096|NCT02759692|3462688|P1|NOT COMPLETED|Period 1||3
1415097|NCT02759692|3462687|P2|COMPLETED|Period 1||140
1415098|NCT02759692|3462688|P1|COMPLETED|Period 1||138
1415099|NCT02759692|3462687|P2|STARTED|Period 1||142
1415100|NCT02759692|3462688|P1|STARTED|Period 1||141
1415101|NCT02759562|3462706|P2|NOT COMPLETED|Open-Label Treatment Period||2
1415102|NCT02759562|3462707|P1|NOT COMPLETED|Open-Label Treatment Period||2
1415103|NCT02759562|3462706|P2|COMPLETED|Open-Label Treatment Period||0
1415104|NCT02759562|3462707|P1|COMPLETED|Open-Label Treatment Period||0
1415105|NCT02759562|3462706|P2|STARTED|Open-Label Treatment Period||2
1415106|NCT02759562|3462707|P1|STARTED|Open-Label Treatment Period||2
1415107|NCT02759562|3462706|P2|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
1415108|NCT02759562|3462707|P1|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
1415109|NCT02759562|3462706|P2|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
1415110|NCT02759562|3462707|P1|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
1415111|NCT02759562|3462706|P2|STARTED|Double-Blind Treatment Period (8 Weeks)||3
1415112|NCT02759562|3462707|P1|STARTED|Double-Blind Treatment Period (8 Weeks)||3
1415113|NCT02759471|3462720|P1|NOT COMPLETED|Overall Study||2
1415114|NCT02759471|3462720|P1|COMPLETED|Overall Study||52
1415115|NCT02759471|3462720|P1|STARTED|Overall Study||54
1415116|NCT02759315|3462735|P5|NOT COMPLETED|Overall Study||1
1415117|NCT02759315|3462736|P4|NOT COMPLETED|Overall Study||1
1415118|NCT02759315|3462737|P3|NOT COMPLETED|Overall Study||10
1415119|NCT02759315|3462738|P2|NOT COMPLETED|Overall Study||1
1415120|NCT02759315|3462739|P1|NOT COMPLETED|Overall Study||4
1415121|NCT02759315|3462735|P5|COMPLETED|Overall Study||2
1415122|NCT02759315|3462736|P4|COMPLETED|Overall Study||19
1415123|NCT02759315|3462737|P3|COMPLETED|Overall Study||29
1415124|NCT02759315|3462738|P2|COMPLETED|Overall Study||28
1415125|NCT02759315|3462739|P1|COMPLETED|Overall Study||65
1415126|NCT02759315|3462735|P5|STARTED|Overall Study||3
1415127|NCT02759315|3462736|P4|STARTED|Overall Study||20
1415128|NCT02759315|3462737|P3|STARTED|Overall Study||39
1415129|NCT02759315|3462738|P2|STARTED|Overall Study||29
1415130|NCT02759315|3462739|P1|STARTED|Overall Study||69
1415131|NCT02758613|3462787|P4|NOT COMPLETED|Follow-up||0
1415132|NCT02758613|3462788|P3|NOT COMPLETED|Follow-up||0
1415133|NCT02758613|3462789|P2|NOT COMPLETED|Follow-up||0
1415134|NCT02758613|3462790|P1|NOT COMPLETED|Follow-up||0
1415135|NCT02758613|3462787|P4|COMPLETED|Follow-up||8
1415136|NCT02758613|3462788|P3|COMPLETED|Follow-up||8
1415137|NCT02758613|3462789|P2|COMPLETED|Follow-up||8
1415138|NCT02758613|3462790|P1|COMPLETED|Follow-up||6
1415139|NCT02758613|3462787|P4|STARTED|Follow-up||8
1415140|NCT02758613|3462788|P3|STARTED|Follow-up||8
1415141|NCT02758613|3462789|P2|STARTED|Follow-up||8
1415142|NCT02758613|3462790|P1|STARTED|Follow-up||6
1415143|NCT02758613|3462787|P4|NOT COMPLETED|Treatment||0
1415144|NCT02758613|3462788|P3|NOT COMPLETED|Treatment||1
1415145|NCT02758613|3462789|P2|NOT COMPLETED|Treatment||0
1415146|NCT02758613|3462790|P1|NOT COMPLETED|Treatment||2
1415147|NCT02758613|3462787|P4|COMPLETED|Treatment||8
1415148|NCT02758613|3462788|P3|COMPLETED|Treatment||8
1415149|NCT02758613|3462789|P2|COMPLETED|Treatment||8
1415150|NCT02758613|3462790|P1|COMPLETED|Treatment||6
1415151|NCT02758613|3462787|P4|Received at Least One Dose of Study Drug|Treatment||8
1415152|NCT02758613|3462788|P3|Received at Least One Dose of Study Drug|Treatment||9
1415153|NCT02758613|3462789|P2|Received at Least One Dose of Study Drug|Treatment||8
1415154|NCT02758613|3462790|P1|Received at Least One Dose of Study Drug|Treatment||8
1415155|NCT02758613|3462787|P4|STARTED|Treatment||8
1415156|NCT02758613|3462788|P3|STARTED|Treatment||9
1415157|NCT02758613|3462789|P2|STARTED|Treatment||8
1415158|NCT02758613|3462790|P1|STARTED|Treatment||8
1415159|NCT02758210|3462806|P1|NOT COMPLETED|Overall Study||0
1415160|NCT02758210|3462806|P1|COMPLETED|Overall Study||20
1415161|NCT02758210|3462806|P1|STARTED|Overall Study||20
1415162|NCT02758171|3462817|P2|NOT COMPLETED|Treatment Period 2||0
1415163|NCT02758171|3462818|P1|NOT COMPLETED|Treatment Period 2||0
1415164|NCT02758171|3462817|P2|COMPLETED|Treatment Period 2||28
1415165|NCT02758171|3462818|P1|COMPLETED|Treatment Period 2||26
1415166|NCT02758171|3462817|P2|STARTED|Treatment Period 2||28
1415167|NCT02758171|3462818|P1|STARTED|Treatment Period 2||26
1415168|NCT02758171|3462817|P2|NOT COMPLETED|Wash-out||0
1415169|NCT02758171|3462818|P1|NOT COMPLETED|Wash-out||2
1415170|NCT02758171|3462817|P2|COMPLETED|Wash-out||28
1415171|NCT02758171|3462818|P1|COMPLETED|Wash-out||26
1415172|NCT02758171|3462817|P2|STARTED|Wash-out||28
1415173|NCT02758171|3462818|P1|STARTED|Wash-out||28
1415174|NCT02758171|3462817|P2|NOT COMPLETED|Treatment Period 1||0
1415175|NCT02758171|3462818|P1|NOT COMPLETED|Treatment Period 1||0
1415176|NCT02758171|3462817|P2|COMPLETED|Treatment Period 1||28
1415177|NCT02758171|3462818|P1|COMPLETED|Treatment Period 1||28
1415178|NCT02758171|3462817|P2|STARTED|Treatment Period 1||28
1415179|NCT02758171|3462818|P1|STARTED|Treatment Period 1||28
1415180|NCT02757625|3462838|P4|NOT COMPLETED|Overall Study||0
1415181|NCT02757625|3462839|P3|NOT COMPLETED|Overall Study||2
1415182|NCT02757625|3462840|P2|NOT COMPLETED|Overall Study||0
1415183|NCT02757625|3462841|P1|NOT COMPLETED|Overall Study||0
1415184|NCT02757625|3462838|P4|COMPLETED|Overall Study||12
1415185|NCT02757625|3462839|P3|COMPLETED|Overall Study||17
1415186|NCT02757625|3462840|P2|COMPLETED|Overall Study||18
1415187|NCT02757625|3462841|P1|COMPLETED|Overall Study||14
1415188|NCT02757625|3462838|P4|STARTED|Overall Study||12
1415189|NCT02757625|3462839|P3|STARTED|Overall Study||19
1415190|NCT02757625|3462840|P2|STARTED|Overall Study||18
1415191|NCT02757625|3462841|P1|STARTED|Overall Study||14
1415192|NCT02757105|3462995|P2|NOT COMPLETED|Overall Study||11
1415193|NCT02757105|3462996|P1|NOT COMPLETED|Overall Study||12
1415194|NCT02757105|3462995|P2|COMPLETED|Overall Study||41
1415195|NCT02757105|3462996|P1|COMPLETED|Overall Study||63
1415196|NCT02757105|3462995|P2|Treated|Overall Study||51
1415197|NCT02757105|3462996|P1|Treated|Overall Study||75
1415198|NCT02757105|3462995|P2|STARTED|Overall Study||52
1415199|NCT02757105|3462996|P1|STARTED|Overall Study||75
1415200|NCT02757053|3463018|P2|NOT COMPLETED|Overall Study||5
1415201|NCT02757053|3463019|P1|NOT COMPLETED|Overall Study||3
1415202|NCT02757053|3463018|P2|COMPLETED|Overall Study||0
1415203|NCT02757053|3463019|P1|COMPLETED|Overall Study||0
1415204|NCT02757053|3463018|P2|STARTED|Overall Study||5
1415205|NCT02757053|3463019|P1|STARTED|Overall Study||3
1415206|NCT02756637|3463033|P2|NOT COMPLETED|Overall Study||54
1415207|NCT02756637|3463034|P1|NOT COMPLETED|Overall Study||87
1415208|NCT02756637|3463033|P2|COMPLETED|Overall Study||263
1415209|NCT02756637|3463034|P1|COMPLETED|Overall Study||230
1415210|NCT02756637|3463033|P2|Completed Curative Treatment|Overall Study||0
1415211|NCT02756637|3463034|P1|Completed Curative Treatment|Overall Study||230
1415212|NCT02756637|3463033|P2|Had NLR Value|Overall Study||263
1415213|NCT02756637|3463034|P1|Had NLR Value|Overall Study||263
1415214|NCT02756637|3463033|P2|Eligible for SWOG 8710|Overall Study||307
1415215|NCT02756637|3463034|P1|Eligible for SWOG 8710|Overall Study||307
1415216|NCT02756637|3463033|P2|STARTED|Overall Study||317
1415217|NCT02756637|3463034|P1|STARTED|Overall Study||317
1415218|NCT02756624|3463042|P2|NOT COMPLETED|Overall Study||7
1415219|NCT02756624|3463043|P1|NOT COMPLETED|Overall Study||16
1415220|NCT02756624|3463042|P2|COMPLETED|Overall Study||166
1415221|NCT02756624|3463043|P1|COMPLETED|Overall Study||327
1415222|NCT02756624|3463042|P2|STARTED|Overall Study||173
1415223|NCT02756624|3463043|P1|STARTED|Overall Study||343
1415224|NCT02756351|3463057|P2|NOT COMPLETED|Overall Study||0
1415225|NCT02756351|3463058|P1|NOT COMPLETED|Overall Study||0
1415226|NCT02756351|3463057|P2|COMPLETED|Overall Study||24
1415227|NCT02756351|3463058|P1|COMPLETED|Overall Study||24
1415228|NCT02756351|3463057|P2|STARTED|Overall Study||24
1415229|NCT02756351|3463058|P1|STARTED|Overall Study||24
1415230|NCT02756338|3463066|P1|NOT COMPLETED|Overall Study||5
1415231|NCT02756338|3463066|P1|COMPLETED|Overall Study||72
1415232|NCT02756338|3463066|P1|STARTED|Overall Study||77
1415233|NCT02756078|3463075|P2|NOT COMPLETED|Period 2||7
1415234|NCT02756078|3463076|P1|NOT COMPLETED|Period 2||6
1415235|NCT02756078|3463075|P2|COMPLETED|Period 2||57
1415236|NCT02756078|3463076|P1|COMPLETED|Period 2||70
1415237|NCT02756078|3463075|P2|STARTED|Period 2||64
1415238|NCT02756078|3463076|P1|STARTED|Period 2||76
1415239|NCT02756078|3463075|P2|NOT COMPLETED|Period 1||22
1415240|NCT02756078|3463076|P1|NOT COMPLETED|Period 1||9
1415241|NCT02756078|3463075|P2|COMPLETED|Period 1||64
1415242|NCT02756078|3463076|P1|COMPLETED|Period 1||76
1415243|NCT02756078|3463075|P2|STARTED|Period 1||86
1415244|NCT02756078|3463076|P1|STARTED|Period 1||85
1415245|NCT02755935|3463094|P1|NOT COMPLETED|Overall Study||2
1415246|NCT02755935|3463094|P1|COMPLETED|Overall Study||22
1415247|NCT02755935|3463094|P1|STARTED|Overall Study||24
1415248|NCT02755805|3463101|P2|NOT COMPLETED|Overall Study||4
1415249|NCT02755805|3463102|P1|NOT COMPLETED|Overall Study||2
1415250|NCT02755805|3463101|P2|COMPLETED|Overall Study||11
1415251|NCT02755805|3463102|P1|COMPLETED|Overall Study||13
1415252|NCT02755805|3463101|P2|STARTED|Overall Study||15
1415253|NCT02755805|3463102|P1|STARTED|Overall Study||15
1415254|NCT02755090|3463116|P2|NOT COMPLETED|Overall Study||0
1415255|NCT02755090|3463117|P1|NOT COMPLETED|Overall Study||1
1415256|NCT02755090|3463116|P2|COMPLETED|Overall Study||20
1415257|NCT02755090|3463117|P1|COMPLETED|Overall Study||18
1415258|NCT02755090|3463116|P2|STARTED|Overall Study||20
1415259|NCT02755090|3463117|P1|STARTED|Overall Study||19
1415260|NCT02754492|3463129|P4|NOT COMPLETED|Overall Study||23
1415261|NCT02754492|3463130|P3|NOT COMPLETED|Overall Study||2
1415262|NCT02754492|3463131|P2|NOT COMPLETED|Overall Study||2
1415263|NCT02754492|3463132|P1|NOT COMPLETED|Overall Study||4
1415264|NCT02754492|3463129|P4|COMPLETED|Overall Study||0
1415265|NCT02754492|3463130|P3|COMPLETED|Overall Study||93
1415266|NCT02754492|3463131|P2|COMPLETED|Overall Study||93
1415267|NCT02754492|3463132|P1|COMPLETED|Overall Study||93
1415268|NCT02754492|3463129|P4|STARTED|Overall Study||23
1415269|NCT02754492|3463130|P3|STARTED|Overall Study||95
1415270|NCT02754492|3463131|P2|STARTED|Overall Study||95
1415271|NCT02754492|3463132|P1|STARTED|Overall Study||97
1415272|NCT02754440|3463148|P4|NOT COMPLETED|Overall Study||35
1415273|NCT02754440|3463149|P3|NOT COMPLETED|Overall Study||7
1415274|NCT02754440|3463150|P2|NOT COMPLETED|Overall Study||8
1415275|NCT02754440|3463151|P1|NOT COMPLETED|Overall Study||6
1415276|NCT02754440|3463148|P4|COMPLETED|Overall Study||0
1415277|NCT02754440|3463149|P3|COMPLETED|Overall Study||93
1415278|NCT02754440|3463150|P2|COMPLETED|Overall Study||93
1415279|NCT02754440|3463151|P1|COMPLETED|Overall Study||93
1415280|NCT02754440|3463148|P4|STARTED|Overall Study||35
1415281|NCT02754440|3463149|P3|STARTED|Overall Study||100
1415282|NCT02754440|3463150|P2|STARTED|Overall Study||101
1415283|NCT02754440|3463151|P1|STARTED|Overall Study||99
1415284|NCT02753946|3463165|P2|NOT COMPLETED|Overall Study||9
1415285|NCT02753946|3463166|P1|NOT COMPLETED|Overall Study||14
1415286|NCT02753946|3463165|P2|COMPLETED|Overall Study||222
1415287|NCT02753946|3463166|P1|COMPLETED|Overall Study||219
1415288|NCT02753946|3463165|P2|STARTED|Overall Study||231
1415289|NCT02753946|3463166|P1|STARTED|Overall Study||233
1415290|NCT02753920|3463178|P2|NOT COMPLETED|Overall Study||0
1415291|NCT02753920|3463179|P1|NOT COMPLETED|Overall Study||0
1415292|NCT02753920|3463178|P2|COMPLETED|Overall Study||86
1415293|NCT02753920|3463179|P1|COMPLETED|Overall Study||87
1415294|NCT02753920|3463178|P2|STARTED|Overall Study||86
1415295|NCT02753920|3463179|P1|STARTED|Overall Study||87
1415296|NCT02753699|3463192|P3|NOT COMPLETED|Overall Study||23
1415297|NCT02753699|3463193|P2|NOT COMPLETED|Overall Study||43
1415298|NCT02753699|3463194|P1|NOT COMPLETED|Overall Study||14
1415299|NCT02753699|3463192|P3|COMPLETED|Overall Study||139
1415300|NCT02753699|3463193|P2|COMPLETED|Overall Study||354
1415301|NCT02753699|3463194|P1|COMPLETED|Overall Study||150
1415302|NCT02753699|3463192|P3|STARTED|Overall Study||162
1415303|NCT02753699|3463193|P2|STARTED|Overall Study||397
1415304|NCT02753699|3463194|P1|STARTED|Overall Study||164
1415305|NCT02753413|3463210|P2|NOT COMPLETED|Overall Study||0
1415306|NCT02753413|3463211|P1|NOT COMPLETED|Overall Study||0
1415307|NCT02753413|3463210|P2|COMPLETED|Overall Study||51
1415308|NCT02753413|3463211|P1|COMPLETED|Overall Study||49
1415309|NCT02753413|3463210|P2|STARTED|Overall Study||51
1415310|NCT02753413|3463211|P1|STARTED|Overall Study||49
1415311|NCT02753075|3463246|P3|NOT COMPLETED|Overall Study||3
1415312|NCT02753075|3463247|P2|NOT COMPLETED|Overall Study||3
1415313|NCT02753075|3463248|P1|NOT COMPLETED|Overall Study||8
1415314|NCT02753075|3463246|P3|COMPLETED|Overall Study||78
1415315|NCT02753075|3463247|P2|COMPLETED|Overall Study||77
1415316|NCT02753075|3463248|P1|COMPLETED|Overall Study||71
1415317|NCT02753075|3463246|P3|STARTED|Overall Study||81
1415318|NCT02753075|3463247|P2|STARTED|Overall Study||80
1415319|NCT02753075|3463248|P1|STARTED|Overall Study||79
1415320|NCT02752958|3463273|P1|NOT COMPLETED|Overall Study||9
1415321|NCT02752958|3463273|P1|COMPLETED|Overall Study||66
1415322|NCT02752958|3463273|P1|STARTED|Overall Study||75
1415323|NCT02752802|3463344|P2|NOT COMPLETED|Overall Study||0
1415324|NCT02752802|3463345|P1|NOT COMPLETED|Overall Study||1
1415325|NCT02752802|3463344|P2|COMPLETED|Overall Study||48
1415326|NCT02752802|3463345|P1|COMPLETED|Overall Study||47
1415327|NCT02752802|3463344|P2|STARTED|Overall Study||48
1415328|NCT02752802|3463345|P1|STARTED|Overall Study||48
1415329|NCT02752633|3463354|P1|NOT COMPLETED|Overall Study||1
1415330|NCT02752633|3463354|P1|COMPLETED|Overall Study||8
1415331|NCT02752633|3463354|P1|STARTED|Overall Study||9
1415332|NCT02752490|3463360|P2|NOT COMPLETED|Overall Study||0
1415333|NCT02752490|3463361|P1|NOT COMPLETED|Overall Study||0
1415334|NCT02752490|3463360|P2|COMPLETED|Overall Study||435
1415335|NCT02752490|3463361|P1|COMPLETED|Overall Study||409
1415336|NCT02752490|3463360|P2|STARTED|Overall Study||435
1415337|NCT02752490|3463361|P1|STARTED|Overall Study||409
1415338|NCT02751450|3463383|P2|NOT COMPLETED|Overall Study||0
1415339|NCT02751450|3463384|P1|NOT COMPLETED|Overall Study||1
1415340|NCT02751450|3463383|P2|COMPLETED|Overall Study||116
1415341|NCT02751450|3463384|P1|COMPLETED|Overall Study||116
1415342|NCT02751450|3463383|P2|STARTED|Overall Study||116
1415343|NCT02751450|3463384|P1|STARTED|Overall Study||117
1415344|NCT02751424|3463405|P9|NOT COMPLETED|Part 2||0
1415345|NCT02751424|3463406|P8|NOT COMPLETED|Part 2||5
1415346|NCT02751424|3463407|P7|NOT COMPLETED|Part 2||0
1415347|NCT02751424|3463408|P6|NOT COMPLETED|Part 2||0
1415348|NCT02751424|3463409|P5|NOT COMPLETED|Part 2||0
1415349|NCT02751424|3463410|P4|NOT COMPLETED|Part 2||0
1415350|NCT02751424|3463411|P3|NOT COMPLETED|Part 2||0
1415351|NCT02751424|3463412|P2|NOT COMPLETED|Part 2||0
1415352|NCT02751424|3463413|P1|NOT COMPLETED|Part 2||0
1415353|NCT02751424|3463405|P9|COMPLETED|Part 2||3
1415354|NCT02751424|3463406|P8|COMPLETED|Part 2||6
1415355|NCT02751424|3463407|P7|COMPLETED|Part 2||0
1415356|NCT02751424|3463408|P6|COMPLETED|Part 2||0
1415357|NCT02751424|3463409|P5|COMPLETED|Part 2||0
1415358|NCT02751424|3463410|P4|COMPLETED|Part 2||0
1415359|NCT02751424|3463411|P3|COMPLETED|Part 2||0
1415360|NCT02751424|3463412|P2|COMPLETED|Part 2||0
1415361|NCT02751424|3463413|P1|COMPLETED|Part 2||0
1415362|NCT02751424|3463405|P9|STARTED|Part 2||3
1415363|NCT02751424|3463406|P8|STARTED|Part 2||11
1415364|NCT02751424|3463407|P7|STARTED|Part 2||0
1415365|NCT02751424|3463408|P6|STARTED|Part 2||0
1415366|NCT02751424|3463409|P5|STARTED|Part 2||0
1415367|NCT02751424|3463410|P4|STARTED|Part 2||0
1415368|NCT02751424|3463411|P3|STARTED|Part 2||0
1415369|NCT02751424|3463412|P2|STARTED|Part 2||0
1415370|NCT02751424|3463413|P1|STARTED|Part 2||0
1415371|NCT02751424|3463405|P9|NOT COMPLETED|Part 1||0
1415372|NCT02751424|3463406|P8|NOT COMPLETED|Part 1||0
1415373|NCT02751424|3463407|P7|NOT COMPLETED|Part 1||0
1415374|NCT02751424|3463408|P6|NOT COMPLETED|Part 1||0
1415375|NCT02751424|3463409|P5|NOT COMPLETED|Part 1||0
1415376|NCT02751424|3463410|P4|NOT COMPLETED|Part 1||0
1415377|NCT02751424|3463411|P3|NOT COMPLETED|Part 1||0
1415378|NCT02751424|3463412|P2|NOT COMPLETED|Part 1||0
1415379|NCT02751424|3463413|P1|NOT COMPLETED|Part 1||0
1415380|NCT02751424|3463405|P9|COMPLETED|Part 1||0
1415381|NCT02751424|3463406|P8|COMPLETED|Part 1||0
1415382|NCT02751424|3463407|P7|COMPLETED|Part 1||12
1415383|NCT02751424|3463408|P6|COMPLETED|Part 1||6
1415384|NCT02751424|3463409|P5|COMPLETED|Part 1||6
1415385|NCT02751424|3463410|P4|COMPLETED|Part 1||6
1415386|NCT02751424|3463411|P3|COMPLETED|Part 1||6
1415387|NCT02751424|3463412|P2|COMPLETED|Part 1||6
1415388|NCT02751424|3463413|P1|COMPLETED|Part 1||6
1415389|NCT02751424|3463405|P9|STARTED|Part 1||0
1415390|NCT02751424|3463406|P8|STARTED|Part 1||0
1415391|NCT02751424|3463407|P7|STARTED|Part 1||12
1415392|NCT02751424|3463408|P6|STARTED|Part 1||6
1415393|NCT02751424|3463409|P5|STARTED|Part 1||6
1415394|NCT02751424|3463410|P4|STARTED|Part 1||6
1415395|NCT02751424|3463411|P3|STARTED|Part 1||6
1415396|NCT02751424|3463412|P2|STARTED|Part 1||6
1415397|NCT02751424|3463413|P1|STARTED|Part 1||6
1415398|NCT02751320|3463556|P1|NOT COMPLETED|Overall Study||3
1415399|NCT02751320|3463556|P1|COMPLETED|Overall Study||42
1415400|NCT02751320|3463556|P1|Received Reference Product 3|Overall Study||28
1415401|NCT02751320|3463556|P1|Received Reference Product 2|Overall Study||28
1415402|NCT02751320|3463556|P1|Received Reference Product 1|Overall Study||29
1415403|NCT02751320|3463556|P1|Received Test Prodcut 3|Overall Study||28
1415404|NCT02751320|3463556|P1|Received Test Prodcut 2|Overall Study||28
1415405|NCT02751320|3463556|P1|Received Test Product 1|Overall Study||29
1415406|NCT02751320|3463556|P1|STARTED|Overall Study||45
1415407|NCT02750943|3463594|P2|NOT COMPLETED|Overall Study||9
1415408|NCT02750943|3463595|P1|NOT COMPLETED|Overall Study||6
1415409|NCT02750943|3463594|P2|COMPLETED|Overall Study||119
1415410|NCT02750943|3463595|P1|COMPLETED|Overall Study||119
1415411|NCT02750943|3463594|P2|STARTED|Overall Study||128
1415412|NCT02750943|3463595|P1|STARTED|Overall Study||125
1415413|NCT02750930|3463609|P1|NOT COMPLETED|Overall Study||8
1415414|NCT02750930|3463609|P1|COMPLETED|Overall Study||0
1415415|NCT02750930|3463609|P1|STARTED|Overall Study||8
1415416|NCT02750813|3463621|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
1415417|NCT02750813|3463622|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
1415418|NCT02750813|3463621|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
1415419|NCT02750813|3463622|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
1415420|NCT02750813|3463621|P2|STARTED|Period 2, Second 14 Days of Wear||120
1415421|NCT02750813|3463622|P1|STARTED|Period 2, Second 14 Days of Wear||124
1415422|NCT02750813|3463621|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
1415423|NCT02750813|3463622|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
1415424|NCT02750813|3463621|P2|COMPLETED|Period 1, First 14 Days of Wear||120
1415425|NCT02750813|3463622|P1|COMPLETED|Period 1, First 14 Days of Wear||124
1415426|NCT02750813|3463621|P2|STARTED|Period 1, First 14 Days of Wear||121
1415427|NCT02750813|3463622|P1|STARTED|Period 1, First 14 Days of Wear||125
1415428|NCT02750709|3463631|P6|NOT COMPLETED|Treatment Period 3||0
1415429|NCT02750709|3463632|P5|NOT COMPLETED|Treatment Period 3||0
1415430|NCT02750709|3463633|P4|NOT COMPLETED|Treatment Period 3||0
1415431|NCT02750709|3463634|P3|NOT COMPLETED|Treatment Period 3||0
1415432|NCT02750709|3463635|P2|NOT COMPLETED|Treatment Period 3||0
1415433|NCT02750709|3463636|P1|NOT COMPLETED|Treatment Period 3||0
1415434|NCT02750709|3463631|P6|COMPLETED|Treatment Period 3||3
1415435|NCT02750709|3463632|P5|COMPLETED|Treatment Period 3||4
1415436|NCT02750709|3463633|P4|COMPLETED|Treatment Period 3||4
1415437|NCT02750709|3463634|P3|COMPLETED|Treatment Period 3||4
1415438|NCT02750709|3463635|P2|COMPLETED|Treatment Period 3||4
1415439|NCT02750709|3463636|P1|COMPLETED|Treatment Period 3||4
1415440|NCT02750709|3463631|P6|STARTED|Treatment Period 3||3
1415441|NCT02750709|3463632|P5|STARTED|Treatment Period 3||4
1415442|NCT02750709|3463633|P4|STARTED|Treatment Period 3||4
1415443|NCT02750709|3463634|P3|STARTED|Treatment Period 3||4
1415444|NCT02750709|3463635|P2|STARTED|Treatment Period 3||4
1415445|NCT02750709|3463636|P1|STARTED|Treatment Period 3||4
1415446|NCT02750709|3463631|P6|NOT COMPLETED|Treatment Period 2||0
1415447|NCT02750709|3463632|P5|NOT COMPLETED|Treatment Period 2||0
1415448|NCT02750709|3463633|P4|NOT COMPLETED|Treatment Period 2||0
1415449|NCT02750709|3463634|P3|NOT COMPLETED|Treatment Period 2||0
1415450|NCT02750709|3463635|P2|NOT COMPLETED|Treatment Period 2||0
1415451|NCT02750709|3463636|P1|NOT COMPLETED|Treatment Period 2||0
1415452|NCT02750709|3463631|P6|COMPLETED|Treatment Period 2||3
1415453|NCT02750709|3463632|P5|COMPLETED|Treatment Period 2||4
1415454|NCT02750709|3463633|P4|COMPLETED|Treatment Period 2||4
1415455|NCT02750709|3463634|P3|COMPLETED|Treatment Period 2||4
1415456|NCT02750709|3463635|P2|COMPLETED|Treatment Period 2||4
1415457|NCT02750709|3463636|P1|COMPLETED|Treatment Period 2||4
1415458|NCT02750709|3463631|P6|STARTED|Treatment Period 2||3
1415459|NCT02750709|3463632|P5|STARTED|Treatment Period 2||4
1415460|NCT02750709|3463633|P4|STARTED|Treatment Period 2||4
1415461|NCT02750709|3463634|P3|STARTED|Treatment Period 2||4
1415462|NCT02750709|3463635|P2|STARTED|Treatment Period 2||4
1415463|NCT02750709|3463636|P1|STARTED|Treatment Period 2||4
1415464|NCT02750709|3463631|P6|NOT COMPLETED|Treatment Period 1||1
1415465|NCT02750709|3463632|P5|NOT COMPLETED|Treatment Period 1||0
1415466|NCT02750709|3463633|P4|NOT COMPLETED|Treatment Period 1||0
1415467|NCT02750709|3463634|P3|NOT COMPLETED|Treatment Period 1||0
1415468|NCT02750709|3463635|P2|NOT COMPLETED|Treatment Period 1||0
1415469|NCT02750709|3463636|P1|NOT COMPLETED|Treatment Period 1||0
1415470|NCT02750709|3463631|P6|COMPLETED|Treatment Period 1||3
1415471|NCT02750709|3463632|P5|COMPLETED|Treatment Period 1||4
1415472|NCT02750709|3463633|P4|COMPLETED|Treatment Period 1||4
1415473|NCT02750709|3463634|P3|COMPLETED|Treatment Period 1||4
1415474|NCT02750709|3463635|P2|COMPLETED|Treatment Period 1||4
1415475|NCT02750709|3463636|P1|COMPLETED|Treatment Period 1||4
1415476|NCT02750709|3463631|P6|STARTED|Treatment Period 1||4
1415477|NCT02750709|3463632|P5|STARTED|Treatment Period 1||4
1415478|NCT02750709|3463633|P4|STARTED|Treatment Period 1||4
1415479|NCT02750709|3463634|P3|STARTED|Treatment Period 1||4
1415480|NCT02750709|3463635|P2|STARTED|Treatment Period 1||4
1415481|NCT02750709|3463636|P1|STARTED|Treatment Period 1||4
1415482|NCT02750618|3463662|P1|NOT COMPLETED|Overall Study||0
1415483|NCT02750618|3463662|P1|COMPLETED|Overall Study||13
1415484|NCT02750618|3463662|P1|STARTED|Overall Study||13
1415485|NCT02750501|3463678|P1|NOT COMPLETED|Overall Study||8
1415486|NCT02750501|3463678|P1|COMPLETED|Overall Study||36
1415487|NCT02750501|3463678|P1|Treated|Overall Study||39
1415488|NCT02750501|3463678|P1|Enrolled|Overall Study||44
1415489|NCT02750501|3463678|P1|STARTED|Overall Study||44
1415490|NCT02750345|3463690|P6|NOT COMPLETED|Intervention 3||0
1415491|NCT02750345|3463691|P5|NOT COMPLETED|Intervention 3||0
1415492|NCT02750345|3463692|P4|NOT COMPLETED|Intervention 3||0
1415493|NCT02750345|3463693|P3|NOT COMPLETED|Intervention 3||0
1415494|NCT02750345|3463694|P2|NOT COMPLETED|Intervention 3||0
1415495|NCT02750345|3463695|P1|NOT COMPLETED|Intervention 3||0
1415496|NCT02750345|3463690|P6|COMPLETED|Intervention 3||4
1415497|NCT02750345|3463691|P5|COMPLETED|Intervention 3||3
1415498|NCT02750345|3463692|P4|COMPLETED|Intervention 3||4
1415499|NCT02750345|3463693|P3|COMPLETED|Intervention 3||4
1415500|NCT02750345|3463694|P2|COMPLETED|Intervention 3||4
1415501|NCT02750345|3463695|P1|COMPLETED|Intervention 3||4
1415502|NCT02750345|3463690|P6|STARTED|Intervention 3||4
1415503|NCT02750345|3463691|P5|STARTED|Intervention 3||3
1415504|NCT02750345|3463692|P4|STARTED|Intervention 3||4
1415505|NCT02750345|3463693|P3|STARTED|Intervention 3||4
1415506|NCT02750345|3463694|P2|STARTED|Intervention 3||4
1415507|NCT02750345|3463695|P1|STARTED|Intervention 3||4
1415508|NCT02750345|3463690|P6|NOT COMPLETED|Intervention 2||0
1415509|NCT02750345|3463691|P5|NOT COMPLETED|Intervention 2||0
1415510|NCT02750345|3463692|P4|NOT COMPLETED|Intervention 2||0
1415511|NCT02750345|3463693|P3|NOT COMPLETED|Intervention 2||0
1415512|NCT02750345|3463694|P2|NOT COMPLETED|Intervention 2||0
1415513|NCT02750345|3463695|P1|NOT COMPLETED|Intervention 2||0
1415514|NCT02750345|3463690|P6|COMPLETED|Intervention 2||4
1415515|NCT02750345|3463691|P5|COMPLETED|Intervention 2||3
1415516|NCT02750345|3463692|P4|COMPLETED|Intervention 2||4
1415517|NCT02750345|3463693|P3|COMPLETED|Intervention 2||4
1415518|NCT02750345|3463694|P2|COMPLETED|Intervention 2||4
1415519|NCT02750345|3463695|P1|COMPLETED|Intervention 2||4
1415520|NCT02750345|3463690|P6|STARTED|Intervention 2||4
1415521|NCT02750345|3463691|P5|STARTED|Intervention 2||3
1415522|NCT02750345|3463692|P4|STARTED|Intervention 2||4
1415523|NCT02750345|3463693|P3|STARTED|Intervention 2||4
1415524|NCT02750345|3463694|P2|STARTED|Intervention 2||4
1415525|NCT02750345|3463695|P1|STARTED|Intervention 2||4
1415526|NCT02750345|3463690|P6|NOT COMPLETED|Intervention 1||0
1415527|NCT02750345|3463691|P5|NOT COMPLETED|Intervention 1||1
1415528|NCT02750345|3463692|P4|NOT COMPLETED|Intervention 1||0
1415529|NCT02750345|3463693|P3|NOT COMPLETED|Intervention 1||0
1415530|NCT02750345|3463694|P2|NOT COMPLETED|Intervention 1||0
1415531|NCT02750345|3463695|P1|NOT COMPLETED|Intervention 1||0
1415532|NCT02750345|3463690|P6|COMPLETED|Intervention 1||4
1415533|NCT02750345|3463691|P5|COMPLETED|Intervention 1||3
1415534|NCT02750345|3463692|P4|COMPLETED|Intervention 1||4
1415535|NCT02750345|3463693|P3|COMPLETED|Intervention 1||4
1415536|NCT02750345|3463694|P2|COMPLETED|Intervention 1||4
1415537|NCT02750345|3463695|P1|COMPLETED|Intervention 1||4
1415538|NCT02750345|3463690|P6|STARTED|Intervention 1||4
1415539|NCT02750345|3463691|P5|STARTED|Intervention 1||4
1415540|NCT02750345|3463692|P4|STARTED|Intervention 1||4
1415541|NCT02750345|3463693|P3|STARTED|Intervention 1||4
1415542|NCT02750345|3463694|P2|STARTED|Intervention 1||4
1415543|NCT02750345|3463695|P1|STARTED|Intervention 1||4
1415544|NCT02750332|3463721|P2|NOT COMPLETED|Treatment Period 2||0
1415545|NCT02750332|3463722|P1|NOT COMPLETED|Treatment Period 2||0
1415546|NCT02750332|3463721|P2|COMPLETED|Treatment Period 2||9
1415547|NCT02750332|3463722|P1|COMPLETED|Treatment Period 2||10
1415548|NCT02750332|3463721|P2|STARTED|Treatment Period 2||9
1415549|NCT02750332|3463722|P1|STARTED|Treatment Period 2||10
1415550|NCT02750332|3463721|P2|NOT COMPLETED|Treatment Period 1||1
1415551|NCT02750332|3463722|P1|NOT COMPLETED|Treatment Period 1||0
1415552|NCT02750332|3463721|P2|COMPLETED|Treatment Period 1||9
1415553|NCT02750332|3463722|P1|COMPLETED|Treatment Period 1||10
1415554|NCT02750332|3463721|P2|STARTED|Treatment Period 1||10
1415555|NCT02750332|3463722|P1|STARTED|Treatment Period 1||10
1415556|NCT02750267|3463742|P2|NOT COMPLETED|Overall Study||0
1415557|NCT02750267|3463743|P1|NOT COMPLETED|Overall Study||0
1415558|NCT02750267|3463742|P2|COMPLETED|Overall Study||6
1415559|NCT02750267|3463743|P1|COMPLETED|Overall Study||6
1415560|NCT02750267|3463742|P2|STARTED|Overall Study||6
1415561|NCT02750267|3463743|P1|STARTED|Overall Study||6
1415562|NCT02749370|3463781|P1|NOT COMPLETED|Overall Study||14
1415563|NCT02749370|3463781|P1|COMPLETED|Overall Study||66
1415564|NCT02749370|3463781|P1|STARTED|Overall Study||80
1415565|NCT02748889|3463810|P2|NOT COMPLETED|Overall Study||0
1415566|NCT02748889|3463811|P1|NOT COMPLETED|Overall Study||0
1415567|NCT02748889|3463810|P2|COMPLETED|Overall Study||1
1415568|NCT02748889|3463811|P1|COMPLETED|Overall Study||0
1415569|NCT02748889|3463810|P2|STARTED|Overall Study||1
1415570|NCT02748889|3463811|P1|STARTED|Overall Study||0
1415571|NCT02748785|3463819|P4|NOT COMPLETED|Visit 3- Visit 4||2
1415572|NCT02748785|3463820|P3|NOT COMPLETED|Visit 3- Visit 4||2
1415573|NCT02748785|3463821|P2|NOT COMPLETED|Visit 3- Visit 4||1
1415574|NCT02748785|3463822|P1|NOT COMPLETED|Visit 3- Visit 4||1
1415575|NCT02748785|3463819|P4|COMPLETED|Visit 3- Visit 4||50
1415576|NCT02748785|3463820|P3|COMPLETED|Visit 3- Visit 4||47
1415577|NCT02748785|3463821|P2|COMPLETED|Visit 3- Visit 4||43
1415578|NCT02748785|3463822|P1|COMPLETED|Visit 3- Visit 4||53
1415579|NCT02748785|3463819|P4|STARTED|Visit 3- Visit 4||52
1415580|NCT02748785|3463820|P3|STARTED|Visit 3- Visit 4||49
1415581|NCT02748785|3463821|P2|STARTED|Visit 3- Visit 4||44
1415582|NCT02748785|3463822|P1|STARTED|Visit 3- Visit 4||54
1415583|NCT02748785|3463819|P4|NOT COMPLETED|Visit 2-Visit 3||11
1415584|NCT02748785|3463820|P3|NOT COMPLETED|Visit 2-Visit 3||8
1415585|NCT02748785|3463821|P2|NOT COMPLETED|Visit 2-Visit 3||5
1415586|NCT02748785|3463822|P1|NOT COMPLETED|Visit 2-Visit 3||5
1415587|NCT02748785|3463819|P4|COMPLETED|Visit 2-Visit 3||52
1415588|NCT02748785|3463820|P3|COMPLETED|Visit 2-Visit 3||49
1415589|NCT02748785|3463821|P2|COMPLETED|Visit 2-Visit 3||44
1415590|NCT02748785|3463822|P1|COMPLETED|Visit 2-Visit 3||54
1415591|NCT02748785|3463819|P4|STARTED|Visit 2-Visit 3||63
1415592|NCT02748785|3463820|P3|STARTED|Visit 2-Visit 3||57
1415593|NCT02748785|3463821|P2|STARTED|Visit 2-Visit 3||49
1415594|NCT02748785|3463822|P1|STARTED|Visit 2-Visit 3||59
1415595|NCT02748785|3463819|P4|NOT COMPLETED|Visit 1- Visit 2||6
1415596|NCT02748785|3463820|P3|NOT COMPLETED|Visit 1- Visit 2||14
1415597|NCT02748785|3463821|P2|NOT COMPLETED|Visit 1- Visit 2||19
1415598|NCT02748785|3463822|P1|NOT COMPLETED|Visit 1- Visit 2||10
1415599|NCT02748785|3463819|P4|COMPLETED|Visit 1- Visit 2||63
1415600|NCT02748785|3463820|P3|COMPLETED|Visit 1- Visit 2||57
1415601|NCT02748785|3463821|P2|COMPLETED|Visit 1- Visit 2||49
1415602|NCT02748785|3463822|P1|COMPLETED|Visit 1- Visit 2||59
1415603|NCT02748785|3463819|P4|STARTED|Visit 1- Visit 2||69
1415604|NCT02748785|3463820|P3|STARTED|Visit 1- Visit 2||71
1415605|NCT02748785|3463821|P2|STARTED|Visit 1- Visit 2||68
1415606|NCT02748785|3463822|P1|STARTED|Visit 1- Visit 2||69
1415607|NCT02748213|3463870|P2|NOT COMPLETED|Overall Study||112
1415608|NCT02748213|3463871|P1|NOT COMPLETED|Overall Study||113
1415609|NCT02748213|3463870|P2|COMPLETED|Overall Study||0
1415610|NCT02748213|3463871|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
1415611|NCT02748213|3463870|P2|Treated|Overall Study||110
1415612|NCT02748213|3463871|P1|Treated|Overall Study||112
1415613|NCT02748213|3463870|P2|STARTED|Overall Study||112
1415614|NCT02748213|3463871|P1|STARTED|Overall Study||113
1415615|NCT02748057|3463889|P2|NOT COMPLETED|Overall Study||2
1415616|NCT02748057|3463890|P1|NOT COMPLETED|Overall Study||5
1415617|NCT02748057|3463889|P2|COMPLETED|Overall Study||19
1415618|NCT02748057|3463890|P1|COMPLETED|Overall Study||109
1415619|NCT02748057|3463889|P2|STARTED|Overall Study||21
1415620|NCT02748057|3463890|P1|STARTED|Overall Study||114
1415621|NCT02747186|3463900|P2|NOT COMPLETED|Second Intervention||0
1415622|NCT02747186|3463901|P1|NOT COMPLETED|Second Intervention||0
1415623|NCT02747186|3463900|P2|COMPLETED|Second Intervention||12
1415624|NCT02747186|3463901|P1|COMPLETED|Second Intervention||12
1415625|NCT02747186|3463900|P2|STARTED|Second Intervention||12
1415626|NCT02747186|3463901|P1|STARTED|Second Intervention||12
1415627|NCT02747186|3463900|P2|NOT COMPLETED|Washout (1 Week)||0
1415628|NCT02747186|3463901|P1|NOT COMPLETED|Washout (1 Week)||0
1415629|NCT02747186|3463900|P2|COMPLETED|Washout (1 Week)||12
1415630|NCT02747186|3463901|P1|COMPLETED|Washout (1 Week)||12
1415631|NCT02747186|3463900|P2|STARTED|Washout (1 Week)||12
1415632|NCT02747186|3463901|P1|STARTED|Washout (1 Week)||12
1415633|NCT02747186|3463900|P2|NOT COMPLETED|First Intervention||0
1415634|NCT02747186|3463901|P1|NOT COMPLETED|First Intervention||0
1415635|NCT02747186|3463900|P2|COMPLETED|First Intervention||12
1415636|NCT02747186|3463901|P1|COMPLETED|First Intervention||12
1415637|NCT02747186|3463900|P2|STARTED|First Intervention||12
1415638|NCT02747186|3463901|P1|STARTED|First Intervention||12
1415639|NCT02746809|3463909|P1|NOT COMPLETED|Baseline-6 Months||5
1415640|NCT02746809|3463909|P1|COMPLETED|Baseline-6 Months||54
1415641|NCT02746809|3463909|P1|STARTED|Baseline-6 Months||59
1415642|NCT02746809|3463909|P1|NOT COMPLETED|Baseline- 30 Days||1
1415643|NCT02746809|3463909|P1|COMPLETED|Baseline- 30 Days||59
1415644|NCT02746809|3463909|P1|STARTED|Baseline- 30 Days||60
1415645|NCT02746679|3463929|P2|NOT COMPLETED|Overall Study||6
1415646|NCT02746679|3463930|P1|NOT COMPLETED|Overall Study||4
1415647|NCT02746679|3463929|P2|COMPLETED|Overall Study||75
1415648|NCT02746679|3463930|P1|COMPLETED|Overall Study||76
1415649|NCT02746679|3463929|P2|STARTED|Overall Study||81
1415650|NCT02746679|3463930|P1|STARTED|Overall Study||80
1415651|NCT02746406|3463960|P1|NOT COMPLETED|Overall Study||0
1415652|NCT02746406|3463960|P1|COMPLETED|Overall Study||5
1415653|NCT02746406|3463960|P1|STARTED|Overall Study||5
1415654|NCT02746107|3463964|P1|NOT COMPLETED|Overall Study||0
1415655|NCT02746107|3463964|P1|COMPLETED|Overall Study||968
1415656|NCT02746107|3463964|P1|CHA2DS2-VASC Score = 5|Overall Study||192
1415657|NCT02746107|3463964|P1|CHA2DS2-VASC Score = 4|Overall Study||197
1415658|NCT02746107|3463964|P1|CHA2DS2-VASC Score = 3|Overall Study||195
1415659|NCT02746107|3463964|P1|CHA2DS2-VASC Score = 2|Overall Study||189
1415660|NCT02746107|3463964|P1|CHA2DS2-VASC Score = 1|Overall Study||195
1415661|NCT02746107|3463964|P1|Target=Physician|Overall Study||482
1415662|NCT02746107|3463964|P1|Target=Patient|Overall Study||486
1415663|NCT02746107|3463964|P1|5year Risk Estimate|Overall Study||485
1415664|NCT02746107|3463964|P1|1year Risk Estimate|Overall Study||483
1415665|NCT02746107|3463964|P1|1 Diagram DA|Overall Study||486
1415666|NCT02746107|3463964|P1|2 Diagrams DA|Overall Study||482
1415667|NCT02746107|3463964|P1|STARTED|Overall Study||968
1415668|NCT02745626|3463982|P3|NOT COMPLETED|Overall Study||3
1415669|NCT02745626|3463983|P2|NOT COMPLETED|Overall Study||6
1415670|NCT02745626|3463984|P1|NOT COMPLETED|Overall Study||3
1415671|NCT02745626|3463982|P3|COMPLETED|Overall Study||19
1415672|NCT02745626|3463983|P2|COMPLETED|Overall Study||16
1415673|NCT02745626|3463984|P1|COMPLETED|Overall Study||21
1415674|NCT02745626|3463982|P3|STARTED|Overall Study||22
1415675|NCT02745626|3463983|P2|STARTED|Overall Study||22
1415676|NCT02745626|3463984|P1|STARTED|Overall Study||24
1415677|NCT02745392|3464014|P4|NOT COMPLETED|Overall Study||0
1415678|NCT02745392|3464015|P3|NOT COMPLETED|Overall Study||0
1415679|NCT02745392|3464016|P2|NOT COMPLETED|Overall Study||1
1415680|NCT02745392|3464017|P1|NOT COMPLETED|Overall Study||0
1415681|NCT02745392|3464014|P4|COMPLETED|Overall Study||92
1415682|NCT02745392|3464015|P3|COMPLETED|Overall Study||92
1415683|NCT02745392|3464016|P2|COMPLETED|Overall Study||89
1415684|NCT02745392|3464017|P1|COMPLETED|Overall Study||91
1415685|NCT02745392|3464014|P4|STARTED|Overall Study||92
1415686|NCT02745392|3464015|P3|STARTED|Overall Study||92
1415687|NCT02745392|3464016|P2|STARTED|Overall Study||90
1415688|NCT02745392|3464017|P1|STARTED|Overall Study||91
1415689|NCT02744755|3464033|P2|NOT COMPLETED|Study Period 2||8
1415690|NCT02744755|3464034|P1|NOT COMPLETED|Study Period 2||14
1415691|NCT02744755|3464033|P2|COMPLETED|Study Period 2||158
1415692|NCT02744755|3464034|P1|COMPLETED|Study Period 2||145
1415693|NCT02744755|3464033|P2|STARTED|Study Period 2||166
1415694|NCT02744755|3464034|P1|STARTED|Study Period 2||159
1415695|NCT02744755|3464033|P2|NOT COMPLETED|Study Period 1||8
1415696|NCT02744755|3464034|P1|NOT COMPLETED|Study Period 1||14
1415697|NCT02744755|3464033|P2|COMPLETED|Study Period 1||168
1415698|NCT02744755|3464034|P1|COMPLETED|Study Period 1||163
1415699|NCT02744755|3464033|P2|STARTED|Study Period 1||176
1415700|NCT02744755|3464034|P1|STARTED|Study Period 1||177
1415701|NCT02744066|3464090|P2|NOT COMPLETED|Overall Study||5
1415702|NCT02744066|3464091|P1|NOT COMPLETED|Overall Study||0
1415703|NCT02744066|3464090|P2|COMPLETED|Overall Study||25
1415704|NCT02744066|3464091|P1|COMPLETED|Overall Study||25
1415705|NCT02744066|3464090|P2|STARTED|Overall Study||30
1415706|NCT02744066|3464091|P1|STARTED|Overall Study||25
1415707|NCT02743962|3464101|P2|NOT COMPLETED|Overall Study||0
1415708|NCT02743962|3464102|P1|NOT COMPLETED|Overall Study||1
1415709|NCT02743962|3464101|P2|COMPLETED|Overall Study||5
1415710|NCT02743962|3464102|P1|COMPLETED|Overall Study||4
1415711|NCT02743962|3464101|P2|STARTED|Overall Study||5
1415712|NCT02743962|3464102|P1|STARTED|Overall Study||5
1415713|NCT02743936|3464123|P2|NOT COMPLETED|Overall Study||0
1415714|NCT02743936|3464124|P1|NOT COMPLETED|Overall Study||0
1415715|NCT02743936|3464123|P2|COMPLETED|Overall Study||32
1415716|NCT02743936|3464124|P1|COMPLETED|Overall Study||32
1415717|NCT02743936|3464123|P2|STARTED|Overall Study||32
1415718|NCT02743936|3464124|P1|STARTED|Overall Study||32
1415719|NCT02743780|3464137|P5|NOT COMPLETED|Part 3 (7 Days)||0
1415720|NCT02743780|3464138|P4|NOT COMPLETED|Part 3 (7 Days)||0
1415721|NCT02743780|3464139|P3|NOT COMPLETED|Part 3 (7 Days)||1
1415722|NCT02743780|3464140|P2|NOT COMPLETED|Part 3 (7 Days)||0
1415723|NCT02743780|3464141|P1|NOT COMPLETED|Part 3 (7 Days)||0
1415724|NCT02743780|3464137|P5|COMPLETED|Part 3 (7 Days)||25
1415725|NCT02743780|3464138|P4|COMPLETED|Part 3 (7 Days)||0
1415726|NCT02743780|3464139|P3|COMPLETED|Part 3 (7 Days)||24
1415727|NCT02743780|3464140|P2|COMPLETED|Part 3 (7 Days)||0
1415728|NCT02743780|3464141|P1|COMPLETED|Part 3 (7 Days)||0
1415729|NCT02743780|3464137|P5|STARTED|Part 3 (7 Days)||25
1415730|NCT02743780|3464138|P4|STARTED|Part 3 (7 Days)||0
1415731|NCT02743780|3464139|P3|STARTED|Part 3 (7 Days)||25
1415732|NCT02743780|3464140|P2|STARTED|Part 3 (7 Days)||0
1415733|NCT02743780|3464141|P1|STARTED|Part 3 (7 Days)||0
1415734|NCT02743780|3464137|P5|NOT COMPLETED|Part 2 (8 Days)||0
1415735|NCT02743780|3464138|P4|NOT COMPLETED|Part 2 (8 Days)||0
1415736|NCT02743780|3464139|P3|NOT COMPLETED|Part 2 (8 Days)||0
1415737|NCT02743780|3464140|P2|NOT COMPLETED|Part 2 (8 Days)||0
1415738|NCT02743780|3464141|P1|NOT COMPLETED|Part 2 (8 Days)||0
1415739|NCT02743780|3464137|P5|COMPLETED|Part 2 (8 Days)||4
1415740|NCT02743780|3464138|P4|COMPLETED|Part 2 (8 Days)||0
1415741|NCT02743780|3464139|P3|COMPLETED|Part 2 (8 Days)||6
1415742|NCT02743780|3464140|P2|COMPLETED|Part 2 (8 Days)||6
1415743|NCT02743780|3464141|P1|COMPLETED|Part 2 (8 Days)||0
1415744|NCT02743780|3464137|P5|STARTED|Part 2 (8 Days)||4
1415745|NCT02743780|3464138|P4|STARTED|Part 2 (8 Days)||0
1415746|NCT02743780|3464139|P3|STARTED|Part 2 (8 Days)||6
1415747|NCT02743780|3464140|P2|STARTED|Part 2 (8 Days)||6
1415748|NCT02743780|3464141|P1|STARTED|Part 2 (8 Days)||0
1415749|NCT02743780|3464137|P5|NOT COMPLETED|Part 1 (3 Days)||0
1415750|NCT02743780|3464138|P4|NOT COMPLETED|Part 1 (3 Days)||0
1415751|NCT02743780|3464139|P3|NOT COMPLETED|Part 1 (3 Days)||0
1415752|NCT02743780|3464140|P2|NOT COMPLETED|Part 1 (3 Days)||0
1415753|NCT02743780|3464141|P1|NOT COMPLETED|Part 1 (3 Days)||0
1415754|NCT02743780|3464137|P5|COMPLETED|Part 1 (3 Days)||8
1415755|NCT02743780|3464138|P4|COMPLETED|Part 1 (3 Days)||6
1415756|NCT02743780|3464139|P3|COMPLETED|Part 1 (3 Days)||6
1415757|NCT02743780|3464140|P2|COMPLETED|Part 1 (3 Days)||6
1415758|NCT02743780|3464141|P1|COMPLETED|Part 1 (3 Days)||6
1415759|NCT02743780|3464137|P5|STARTED|Part 1 (3 Days)||8
1415760|NCT02743780|3464138|P4|STARTED|Part 1 (3 Days)||6
1415761|NCT02743780|3464139|P3|STARTED|Part 1 (3 Days)||6
1415762|NCT02743780|3464140|P2|STARTED|Part 1 (3 Days)||6
1415763|NCT02743780|3464141|P1|STARTED|Part 1 (3 Days)||6
1415764|NCT02743702|3464188|P2|NOT COMPLETED|Overall Study||0
1415765|NCT02743702|3464189|P1|NOT COMPLETED|Overall Study||0
1415766|NCT02743702|3464188|P2|COMPLETED|Overall Study||10
1415767|NCT02743702|3464189|P1|COMPLETED|Overall Study||11
1415768|NCT02743702|3464188|P2|STARTED|Overall Study||10
1415769|NCT02743702|3464189|P1|STARTED|Overall Study||11
1415770|NCT02743312|3464197|P2|NOT COMPLETED|Overall Study||0
1415771|NCT02743312|3464198|P1|NOT COMPLETED|Overall Study||0
1415772|NCT02743312|3464197|P2|COMPLETED|Overall Study||2
1415773|NCT02743312|3464198|P1|COMPLETED|Overall Study||3
1415774|NCT02743312|3464197|P2|STARTED|Overall Study||2
1415775|NCT02743312|3464198|P1|STARTED|Overall Study||3
1415776|NCT02743117|3464231|P2|NOT COMPLETED|Overall Study||1
1415777|NCT02743117|3464232|P1|NOT COMPLETED|Overall Study||1
1415778|NCT02743117|3464231|P2|COMPLETED|Overall Study||240
1415779|NCT02743117|3464232|P1|COMPLETED|Overall Study||59
1415780|NCT02743117|3464231|P2|Treated|Overall Study||241
1415781|NCT02743117|3464232|P1|Treated|Overall Study||59
1415782|NCT02743117|3464231|P2|STARTED|Overall Study||241
1415783|NCT02743117|3464232|P1|STARTED|Overall Study||60
1415784|NCT02742987|3464248|P2|NOT COMPLETED|Overall Study||0
1415785|NCT02742987|3464249|P1|NOT COMPLETED|Overall Study||0
1415786|NCT02742987|3464248|P2|COMPLETED|Overall Study||21
1415787|NCT02742987|3464249|P1|COMPLETED|Overall Study||21
1415788|NCT02742987|3464248|P2|STARTED|Overall Study||21
1415789|NCT02742987|3464249|P1|STARTED|Overall Study||21
1415790|NCT02742818|3464257|P2|NOT COMPLETED|Overall Study||2
1415791|NCT02742818|3464258|P1|NOT COMPLETED|Overall Study||0
1415792|NCT02742818|3464257|P2|COMPLETED|Overall Study||23
1415793|NCT02742818|3464258|P1|COMPLETED|Overall Study||25
1415794|NCT02742818|3464257|P2|STARTED|Overall Study||25
1415795|NCT02742818|3464258|P1|STARTED|Overall Study||25
1415796|NCT02742649|3464275|P5|NOT COMPLETED|Open-Label Period||1
1415797|NCT02742649|3464276|P4|NOT COMPLETED|Open-Label Period||0
1415798|NCT02742649|3464277|P3|NOT COMPLETED|Open-Label Period||0
1415799|NCT02742649|3464278|P2|NOT COMPLETED|Open-Label Period||0
1415800|NCT02742649|3464279|P1|NOT COMPLETED|Open-Label Period||0
1415801|NCT02742649|3464275|P5|COMPLETED|Open-Label Period||48
1415802|NCT02742649|3464276|P4|COMPLETED|Open-Label Period||0
1415803|NCT02742649|3464277|P3|COMPLETED|Open-Label Period||0
1415804|NCT02742649|3464278|P2|COMPLETED|Open-Label Period||0
1415805|NCT02742649|3464279|P1|COMPLETED|Open-Label Period||0
1415806|NCT02742649|3464275|P5|STARTED|Open-Label Period||49
1415807|NCT02742649|3464276|P4|STARTED|Open-Label Period||0
1415808|NCT02742649|3464277|P3|STARTED|Open-Label Period||0
1415809|NCT02742649|3464278|P2|STARTED|Open-Label Period||0
1415810|NCT02742649|3464279|P1|STARTED|Open-Label Period||0
1415811|NCT02742649|3464275|P5|NOT COMPLETED|Double-Blind Treatment Period||0
1415812|NCT02742649|3464276|P4|NOT COMPLETED|Double-Blind Treatment Period||0
1415813|NCT02742649|3464277|P3|NOT COMPLETED|Double-Blind Treatment Period||0
1415814|NCT02742649|3464278|P2|NOT COMPLETED|Double-Blind Treatment Period||1
1415815|NCT02742649|3464279|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1415816|NCT02742649|3464275|P5|COMPLETED|Double-Blind Treatment Period||0
1415817|NCT02742649|3464276|P4|COMPLETED|Double-Blind Treatment Period||16
1415818|NCT02742649|3464277|P3|COMPLETED|Double-Blind Treatment Period||17
1415819|NCT02742649|3464278|P2|COMPLETED|Double-Blind Treatment Period||16
1415820|NCT02742649|3464279|P1|COMPLETED|Double-Blind Treatment Period||0
1415821|NCT02742649|3464275|P5|STARTED|Double-Blind Treatment Period||0
1415822|NCT02742649|3464276|P4|STARTED|Double-Blind Treatment Period||16
1415823|NCT02742649|3464277|P3|STARTED|Double-Blind Treatment Period||17
1415824|NCT02742649|3464278|P2|STARTED|Double-Blind Treatment Period||17
1415825|NCT02742649|3464279|P1|STARTED|Double-Blind Treatment Period||0
1415826|NCT02742649|3464275|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
1415827|NCT02742649|3464276|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
1415828|NCT02742649|3464277|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
1415829|NCT02742649|3464278|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
1415830|NCT02742649|3464279|P1|NOT COMPLETED|Pre-Randomization Washout Period||5
1415831|NCT02742649|3464275|P5|COMPLETED|Pre-Randomization Washout Period||0
1415832|NCT02742649|3464276|P4|COMPLETED|Pre-Randomization Washout Period||0
1415833|NCT02742649|3464277|P3|COMPLETED|Pre-Randomization Washout Period||0
1415834|NCT02742649|3464278|P2|COMPLETED|Pre-Randomization Washout Period||0
1415835|NCT02742649|3464279|P1|COMPLETED|Pre-Randomization Washout Period||50
1415836|NCT02742649|3464275|P5|STARTED|Pre-Randomization Washout Period||0
1415837|NCT02742649|3464276|P4|STARTED|Pre-Randomization Washout Period||0
1415838|NCT02742649|3464277|P3|STARTED|Pre-Randomization Washout Period||0
1415839|NCT02742649|3464278|P2|STARTED|Pre-Randomization Washout Period||0
1415840|NCT02742649|3464279|P1|STARTED|Pre-Randomization Washout Period||55
1415841|NCT02742519|3464307|P3|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
1415842|NCT02742519|3464308|P2|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1415843|NCT02742519|3464309|P1|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1415844|NCT02742519|3464307|P3|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1415845|NCT02742519|3464308|P2|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1415846|NCT02742519|3464309|P1|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
1415847|NCT02742519|3464307|P3|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
1415848|NCT02742519|3464308|P2|STARTED|Part 2 Open Label Period (32 Weeks)||0
1415849|NCT02742519|3464309|P1|STARTED|Part 2 Open Label Period (32 Weeks)||0
1415850|NCT02742519|3464307|P3|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
1415851|NCT02742519|3464308|P2|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
1415852|NCT02742519|3464309|P1|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
1415853|NCT02742519|3464307|P3|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
1415854|NCT02742519|3464308|P2|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
1415855|NCT02742519|3464309|P1|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
1415856|NCT02742519|3464307|P3|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
1415857|NCT02742519|3464308|P2|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
1415858|NCT02742519|3464309|P1|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
1415859|NCT02742519|3464307|P3|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
1415860|NCT02742519|3464308|P2|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
1415861|NCT02742519|3464309|P1|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
1415862|NCT02742519|3464307|P3|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
1415863|NCT02742519|3464308|P2|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
1415864|NCT02742519|3464309|P1|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
1415865|NCT02742519|3464307|P3|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
1415866|NCT02742519|3464308|P2|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
1415867|NCT02742519|3464309|P1|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
1415868|NCT02742441|3464329|P2|NOT COMPLETED|Overall Study||8
1415869|NCT02742441|3464330|P1|NOT COMPLETED|Overall Study||6
1415870|NCT02742441|3464329|P2|COMPLETED|Overall Study||196
1415871|NCT02742441|3464330|P1|COMPLETED|Overall Study||199
1415872|NCT02742441|3464329|P2|STARTED|Overall Study||204
1415873|NCT02742441|3464330|P1|STARTED|Overall Study||205
1415874|NCT02741713|3464348|P2|NOT COMPLETED|Overall Study||1
1415875|NCT02741713|3464349|P1|NOT COMPLETED|Overall Study||2
1415876|NCT02741713|3464348|P2|COMPLETED|Overall Study||19
1415877|NCT02741713|3464349|P1|COMPLETED|Overall Study||18
1415878|NCT02741713|3464348|P2|STARTED|Overall Study||20
1415879|NCT02741713|3464349|P1|STARTED|Overall Study||20
1415880|NCT02741687|3464364|P2|NOT COMPLETED|Overall Study||0
1415881|NCT02741687|3464365|P1|NOT COMPLETED|Overall Study||0
1415882|NCT02741687|3464364|P2|COMPLETED|Overall Study||44
1415883|NCT02741687|3464365|P1|COMPLETED|Overall Study||36
1415884|NCT02741687|3464364|P2|STARTED|Overall Study||44
1415885|NCT02741687|3464365|P1|STARTED|Overall Study||36
1415886|NCT02741284|3464391|P2|NOT COMPLETED|Overall Study||9
1415887|NCT02741284|3464392|P1|NOT COMPLETED|Overall Study||6
1415888|NCT02741284|3464391|P2|COMPLETED|Overall Study||48
1415889|NCT02741284|3464392|P1|COMPLETED|Overall Study||51
1415890|NCT02741284|3464391|P2|STARTED|Overall Study||57
1415891|NCT02741284|3464392|P1|STARTED|Overall Study||57
1415892|NCT02741245|3464413|P5|NOT COMPLETED|Overall Study||2
1415893|NCT02741245|3464414|P4|NOT COMPLETED|Overall Study||4
1415894|NCT02741245|3464415|P3|NOT COMPLETED|Overall Study||0
1415895|NCT02741245|3464416|P2|NOT COMPLETED|Overall Study||1
1415896|NCT02741245|3464417|P1|NOT COMPLETED|Overall Study||0
1415897|NCT02741245|3464413|P5|COMPLETED|Overall Study||70
1415898|NCT02741245|3464414|P4|COMPLETED|Overall Study||67
1415899|NCT02741245|3464415|P3|COMPLETED|Overall Study||71
1415900|NCT02741245|3464416|P2|COMPLETED|Overall Study||71
1415901|NCT02741245|3464417|P1|COMPLETED|Overall Study||35
1415902|NCT02741245|3464413|P5|STARTED|Overall Study||72
1415903|NCT02741245|3464414|P4|STARTED|Overall Study||71
1415904|NCT02741245|3464415|P3|STARTED|Overall Study||71
1415905|NCT02741245|3464416|P2|STARTED|Overall Study||72
1415906|NCT02741245|3464417|P1|STARTED|Overall Study||35
1415907|NCT02739997|3464519|P1|NOT COMPLETED|Overall Study||2
1415908|NCT02739997|3464519|P1|COMPLETED|Overall Study||98
1415909|NCT02739997|3464519|P1|STARTED|Overall Study||100
1415910|NCT02739984|3464533|P2|NOT COMPLETED|Overall Study||2
1415911|NCT02739984|3464534|P1|NOT COMPLETED|Overall Study||5
1415912|NCT02739984|3464533|P2|COMPLETED|Overall Study||279
1415913|NCT02739984|3464534|P1|COMPLETED|Overall Study||138
1415914|NCT02739984|3464533|P2|Received Study Drug|Overall Study||280
1415915|NCT02739984|3464534|P1|Received Study Drug|Overall Study||141
1415916|NCT02739984|3464533|P2|STARTED|Overall Study||281
1415917|NCT02739984|3464534|P1|STARTED|Overall Study||143
1415918|NCT02739698|3464584|P2|NOT COMPLETED|Overall Study||5
1415919|NCT02739698|3464585|P1|NOT COMPLETED|Overall Study||6
1415920|NCT02739698|3464584|P2|COMPLETED|Overall Study||16
1415921|NCT02739698|3464585|P1|COMPLETED|Overall Study||16
1415922|NCT02739698|3464584|P2|STARTED|Overall Study||21
1415923|NCT02739698|3464585|P1|STARTED|Overall Study||22
1415924|NCT02739594|3464593|P2|NOT COMPLETED|Overall Study||28
1415925|NCT02739594|3464594|P1|NOT COMPLETED|Overall Study||25
1415926|NCT02739594|3464593|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
1415927|NCT02739594|3464594|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
1415928|NCT02739594|3464593|P2|Completed at Week 96|Overall Study||10
1415929|NCT02739594|3464594|P1|Completed at Week 96|Overall Study||10
1415930|NCT02739594|3464593|P2|Completed at Week 44|Overall Study||5
1415931|NCT02739594|3464594|P1|Completed at Week 44|Overall Study||11
1415932|NCT02739594|3464593|P2|STARTED|Overall Study||43
1415933|NCT02739594|3464594|P1|STARTED|Overall Study||46
1415934|NCT02739321|3464626|P2|NOT COMPLETED|Overall Study||4
1415935|NCT02739321|3464627|P1|NOT COMPLETED|Overall Study||3
1415936|NCT02739321|3464626|P2|COMPLETED|Overall Study||18
1415937|NCT02739321|3464627|P1|COMPLETED|Overall Study||20
1415938|NCT02739321|3464626|P2|STARTED|Overall Study||22
1415939|NCT02739321|3464627|P1|STARTED|Overall Study||23
1415940|NCT02738853|3464671|P1|NOT COMPLETED|30 Days- 6 Months||2
1415941|NCT02738853|3464671|P1|COMPLETED|30 Days- 6 Months||57
1415942|NCT02738853|3464671|P1|STARTED|30 Days- 6 Months||59
1415943|NCT02738853|3464671|P1|NOT COMPLETED|Baseline -30 Days||1
1415944|NCT02738853|3464671|P1|COMPLETED|Baseline -30 Days||59
1415945|NCT02738853|3464671|P1|STARTED|Baseline -30 Days||60
1415946|NCT02738333|3464690|P3|NOT COMPLETED|Overall Study||0
1415947|NCT02738333|3464691|P2|NOT COMPLETED|Overall Study||0
1415948|NCT02738333|3464692|P1|NOT COMPLETED|Overall Study||2
1415949|NCT02738333|3464690|P3|COMPLETED|Overall Study||25
1415950|NCT02738333|3464691|P2|COMPLETED|Overall Study||108
1415951|NCT02738333|3464692|P1|COMPLETED|Overall Study||104
1415952|NCT02738333|3464690|P3|STARTED|Overall Study||25
1415953|NCT02738333|3464691|P2|STARTED|Overall Study||108
1415954|NCT02738333|3464692|P1|STARTED|Overall Study||106
1415955|NCT02738255|3464768|P2|NOT COMPLETED|Overall Study||1
1415956|NCT02738255|3464769|P1|NOT COMPLETED|Overall Study||0
1415957|NCT02738255|3464768|P2|COMPLETED|Overall Study||14
1415958|NCT02738255|3464769|P1|COMPLETED|Overall Study||11
1415959|NCT02738255|3464768|P2|STARTED|Overall Study||15
1415960|NCT02738255|3464769|P1|STARTED|Overall Study||11
1415961|NCT02738203|3464781|P2|NOT COMPLETED|Overall Study||3
1415962|NCT02738203|3464782|P1|NOT COMPLETED|Overall Study||2
1415963|NCT02738203|3464781|P2|COMPLETED|Overall Study||107
1415964|NCT02738203|3464782|P1|COMPLETED|Overall Study||108
1415965|NCT02738203|3464781|P2|STARTED|Overall Study||110
1415966|NCT02738203|3464782|P1|STARTED|Overall Study||110
1415967|NCT02738151|3464798|P2|NOT COMPLETED|Overall Study||31
1415968|NCT02738151|3464799|P1|NOT COMPLETED|Overall Study||23
1415969|NCT02738151|3464798|P2|COMPLETED|Overall Study||432
1415970|NCT02738151|3464799|P1|COMPLETED|Overall Study||443
1415971|NCT02738151|3464798|P2|Treated|Overall Study||462
1415972|NCT02738151|3464799|P1|Treated|Overall Study||462
1415973|NCT02738151|3464798|P2|STARTED|Overall Study||463
1415974|NCT02738151|3464799|P1|STARTED|Overall Study||466
1415975|NCT02738138|3464843|P2|NOT COMPLETED|Overall Study||1
1415976|NCT02738138|3464844|P1|NOT COMPLETED|Overall Study||3
1415977|NCT02738138|3464843|P2|COMPLETED|Overall Study||15
1415978|NCT02738138|3464844|P1|COMPLETED|Overall Study||134
1415979|NCT02738138|3464843|P2|STARTED|Overall Study||16
1415980|NCT02738138|3464844|P1|STARTED|Overall Study||137
1415981|NCT02737852|3464851|P1|NOT COMPLETED|Overall Study||2
1415982|NCT02737852|3464851|P1|COMPLETED|Overall Study||30
1415983|NCT02737852|3464851|P1|STARTED|Overall Study||32
1415984|NCT02737631|3464856|P1|NOT COMPLETED|Overall Study||0
1415985|NCT02737631|3464856|P1|COMPLETED|Overall Study||222
1415986|NCT02737631|3464856|P1|STARTED|Overall Study||222
1415987|NCT02737618|3464861|P1|NOT COMPLETED|Overall Study||9
1415988|NCT02737618|3464861|P1|COMPLETED|Overall Study||34
1415989|NCT02737618|3464861|P1|STARTED|Overall Study||43
1415990|NCT02737592|3464866|P1|NOT COMPLETED|Overall Study||1
1415991|NCT02737592|3464866|P1|COMPLETED|Overall Study||33
1415992|NCT02737592|3464866|P1|STARTED|Overall Study||34
1415993|NCT02737397|3464871|P1|NOT COMPLETED|Overall Study||0
1415994|NCT02737397|3464871|P1|COMPLETED|Overall Study||13
1415995|NCT02737397|3464871|P1|Placebo|Overall Study||13
1415996|NCT02737397|3464871|P1|SJP-223|Overall Study||13
1415997|NCT02737397|3464871|P1|SJP-304|Overall Study||12
1415998|NCT02737397|3464871|P1|JMI-001|Overall Study||13
1415999|NCT02737397|3464871|P1|STARTED|Overall Study||13
1416000|NCT02736955|3464888|P3|NOT COMPLETED|Overall Study||2
1416001|NCT02736955|3464889|P2|NOT COMPLETED|Overall Study||14
1416002|NCT02736955|3464890|P1|NOT COMPLETED|Overall Study||7
1416003|NCT02736955|3464888|P3|COMPLETED|Overall Study||6
1416004|NCT02736955|3464889|P2|COMPLETED|Overall Study||103
1416005|NCT02736955|3464890|P1|COMPLETED|Overall Study||29
1416006|NCT02736955|3464888|P3|STARTED|Overall Study||8
1416007|NCT02736955|3464889|P2|STARTED|Overall Study||117
1416008|NCT02736955|3464890|P1|STARTED|Overall Study||36
1416009|NCT02736721|3464904|P1|NOT COMPLETED|Overall Study||16
1416010|NCT02736721|3464904|P1|COMPLETED|Overall Study||25
1416011|NCT02736721|3464904|P1|STARTED|Overall Study||41
1416012|NCT02736175|3464915|P2|NOT COMPLETED|Overall Study||1
1416013|NCT02736175|3464916|P1|NOT COMPLETED|Overall Study||2
1416014|NCT02736175|3464915|P2|COMPLETED|Overall Study||221
1416015|NCT02736175|3464916|P1|COMPLETED|Overall Study||214
1416016|NCT02736175|3464915|P2|STARTED|Overall Study||222
1416017|NCT02736175|3464916|P1|STARTED|Overall Study||216
1416018|NCT02735200|3464926|P2|NOT COMPLETED|Overall Study||5
1416019|NCT02735200|3464927|P1|NOT COMPLETED|Overall Study||8
1416020|NCT02735200|3464926|P2|COMPLETED|Overall Study||345
1416021|NCT02735200|3464927|P1|COMPLETED|Overall Study||192
1416022|NCT02735200|3464926|P2|STARTED|Overall Study||350
1416023|NCT02735200|3464927|P1|STARTED|Overall Study||200
1416024|NCT02734953|3464933|P1|NOT COMPLETED|Overall Study||0
1416025|NCT02734953|3464933|P1|COMPLETED|Overall Study||10
1416026|NCT02734953|3464933|P1|STARTED|Overall Study||10
1416027|NCT02734940|3464950|P2|NOT COMPLETED|Overall Study||0
1416028|NCT02734940|3464951|P1|NOT COMPLETED|Overall Study||0
1416029|NCT02734940|3464950|P2|COMPLETED|Overall Study||0
1416030|NCT02734940|3464951|P1|COMPLETED|Overall Study||0
1416031|NCT02734940|3464950|P2|STARTED|Overall Study||0
1416032|NCT02734940|3464951|P1|STARTED|Overall Study||0
1416033|NCT02734810|3464975|P2|NOT COMPLETED|Overall Study||0
1416034|NCT02734810|3464976|P1|NOT COMPLETED|Overall Study||2
1416035|NCT02734810|3464975|P2|COMPLETED|Overall Study||0
1416036|NCT02734810|3464976|P1|COMPLETED|Overall Study||13
1416037|NCT02734810|3464975|P2|STARTED|Overall Study||0
1416038|NCT02734810|3464976|P1|STARTED|Overall Study||15
1416039|NCT02734355|3464984|P2|NOT COMPLETED|Overall Study||0
1416040|NCT02734355|3464985|P1|NOT COMPLETED|Overall Study||0
1416041|NCT02734355|3464984|P2|COMPLETED|Overall Study||30
1416042|NCT02734355|3464985|P1|COMPLETED|Overall Study||34
1416043|NCT02734355|3464984|P2|STARTED|Overall Study||30
1416044|NCT02734355|3464985|P1|STARTED|Overall Study||34
1416045|NCT02734212|3465017|P2|NOT COMPLETED|Overall Study||10
1416046|NCT02734212|3465018|P1|NOT COMPLETED|Overall Study||5
1416047|NCT02734212|3465017|P2|COMPLETED|Overall Study||18
1416048|NCT02734212|3465018|P1|COMPLETED|Overall Study||24
1416049|NCT02734212|3465017|P2|STARTED|Overall Study||28
1416050|NCT02734212|3465018|P1|STARTED|Overall Study||29
1416051|NCT02734056|3465030|P2|NOT COMPLETED|Overall Study||1
1416052|NCT02734056|3465031|P1|NOT COMPLETED|Overall Study||0
1416053|NCT02734056|3465030|P2|COMPLETED|Overall Study||49
1416054|NCT02734056|3465031|P1|COMPLETED|Overall Study||50
1416055|NCT02734056|3465030|P2|STARTED|Overall Study||50
1416056|NCT02734056|3465031|P1|STARTED|Overall Study||50
1416057|NCT02733653|3465037|P1|NOT COMPLETED|Overall Study||1
1416058|NCT02733653|3465037|P1|COMPLETED|Overall Study||49
1416059|NCT02733653|3465037|P1|STARTED|Overall Study||50
1416060|NCT02733588|3465043|P1|NOT COMPLETED|Overall Study||0
1416061|NCT02733588|3465043|P1|COMPLETED|Overall Study||7
1416062|NCT02733588|3465043|P1|STARTED|Overall Study||7
1416063|NCT02732899|3465052|P2|NOT COMPLETED|Overall Study||0
1416064|NCT02732899|3465053|P1|NOT COMPLETED|Overall Study||0
1416065|NCT02732899|3465052|P2|COMPLETED|Overall Study||10
1416066|NCT02732899|3465053|P1|COMPLETED|Overall Study||10
1416067|NCT02732899|3465052|P2|STARTED|Overall Study||10
1416068|NCT02732899|3465053|P1|STARTED|Overall Study||10
1416069|NCT02732639|3465061|P1|NOT COMPLETED|Overall Study||1
1416070|NCT02732639|3465061|P1|COMPLETED|Overall Study||30
1416071|NCT02732639|3465061|P1|STARTED|Overall Study||31
1416072|NCT02732561|3465074|P2|NOT COMPLETED|Overall Study||1
1416073|NCT02732561|3465075|P1|NOT COMPLETED|Overall Study||2
1416074|NCT02732561|3465074|P2|COMPLETED|Overall Study||4
1416075|NCT02732561|3465075|P1|COMPLETED|Overall Study||3
1416076|NCT02732561|3465074|P2|STARTED|Overall Study||5
1416077|NCT02732561|3465075|P1|STARTED|Overall Study||5
1416078|NCT02732327|3465085|P2|NOT COMPLETED|Overall Study||1
1416079|NCT02732327|3465086|P1|NOT COMPLETED|Overall Study||0
1416080|NCT02732327|3465085|P2|COMPLETED|Overall Study||1
1416081|NCT02732327|3465086|P1|COMPLETED|Overall Study||0
1416082|NCT02732327|3465085|P2|STARTED|Overall Study||2
1416083|NCT02732327|3465086|P1|STARTED|Overall Study||0
1416084|NCT02732210|3465094|P2|NOT COMPLETED|Overall Study||294
1416085|NCT02732210|3465095|P1|NOT COMPLETED|Overall Study||85
1416086|NCT02732210|3465094|P2|COMPLETED|Overall Study||338
1416087|NCT02732210|3465095|P1|COMPLETED|Overall Study||218
1416088|NCT02732210|3465094|P2|STARTED|Overall Study||632
1416089|NCT02732210|3465095|P1|STARTED|Overall Study||303
1416090|NCT02731833|3465113|P2|NOT COMPLETED|Overall Study||0
1416091|NCT02731833|3465114|P1|NOT COMPLETED|Overall Study||0
1416092|NCT02731833|3465113|P2|COMPLETED|Overall Study||111
1416093|NCT02731833|3465114|P1|COMPLETED|Overall Study||111
1416094|NCT02731833|3465113|P2|STARTED|Overall Study||111
1416095|NCT02731833|3465114|P1|STARTED|Overall Study||111
1416096|NCT02731313|3465126|P1|NOT COMPLETED|Overall Study||0
1416097|NCT02731313|3465126|P1|COMPLETED|Overall Study||367
1416098|NCT02731313|3465126|P1|STARTED|Overall Study||367
1416099|NCT02731300|3465136|P2|NOT COMPLETED|Overall Study||0
1416100|NCT02731300|3465137|P1|NOT COMPLETED|Overall Study||0
1416101|NCT02731300|3465136|P2|COMPLETED|Overall Study||7
1416102|NCT02731300|3465137|P1|COMPLETED|Overall Study||15
1416103|NCT02731300|3465136|P2|STARTED|Overall Study||7
1416104|NCT02731300|3465137|P1|STARTED|Overall Study||15
1416105|NCT02731131|3465147|P2|NOT COMPLETED|Overall Study||2
1416106|NCT02731131|3465148|P1|NOT COMPLETED|Overall Study||0
1416107|NCT02731131|3465147|P2|COMPLETED|Overall Study||4
1416108|NCT02731131|3465148|P1|COMPLETED|Overall Study||6
1416109|NCT02731131|3465147|P2|STARTED|Overall Study||6
1416110|NCT02731131|3465148|P1|STARTED|Overall Study||6
1416111|NCT02730819|3465164|P1|NOT COMPLETED|Overall Study||9
1416112|NCT02730819|3465164|P1|COMPLETED|Overall Study||10
1416113|NCT02730819|3465164|P1|Follow-up Week 20|Overall Study||10
1416114|NCT02730819|3465164|P1|Follow-up Week 16|Overall Study||11
1416115|NCT02730819|3465164|P1|Follow-up Week 12|Overall Study||11
1416116|NCT02730819|3465164|P1|Follow-up Week 8|Overall Study||14
1416117|NCT02730819|3465164|P1|Follow-up Week 4|Overall Study||16
1416118|NCT02730819|3465164|P1|Follow-up Week 2|Overall Study||15
1416119|NCT02730819|3465164|P1|STARTED|Overall Study||19
1416120|NCT02730728|3465173|P3|NOT COMPLETED|Overall Study||1
1416121|NCT02730728|3465174|P2|NOT COMPLETED|Overall Study||2
1416122|NCT02730728|3465175|P1|NOT COMPLETED|Overall Study||0
1416123|NCT02730728|3465173|P3|COMPLETED|Overall Study||52
1416124|NCT02730728|3465174|P2|COMPLETED|Overall Study||51
1416125|NCT02730728|3465175|P1|COMPLETED|Overall Study||53
1416126|NCT02730728|3465173|P3|STARTED|Overall Study||53
1416127|NCT02730728|3465174|P2|STARTED|Overall Study||53
1416128|NCT02730728|3465175|P1|STARTED|Overall Study||53
1416129|NCT02730598|3465194|P2|NOT COMPLETED|Overall Study||4
1416130|NCT02730598|3465195|P1|NOT COMPLETED|Overall Study||4
1416131|NCT02730598|3465194|P2|COMPLETED|Overall Study||10
1416132|NCT02730598|3465195|P1|COMPLETED|Overall Study||10
1416133|NCT02730598|3465194|P2|STARTED|Overall Study||14
1416134|NCT02730598|3465195|P1|STARTED|Overall Study||14
1416135|NCT02730351|3465215|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1416136|NCT02730351|3465216|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
1416137|NCT02730351|3465215|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
1416138|NCT02730351|3465216|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
1416139|NCT02730351|3465215|P2|STARTED|Treatment Period 2 (2 Weeks)||36
1416140|NCT02730351|3465216|P1|STARTED|Treatment Period 2 (2 Weeks)||35
1416141|NCT02730351|3465215|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
1416142|NCT02730351|3465216|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
1416143|NCT02730351|3465215|P2|COMPLETED|Wash-out Period (2 Weeks)||36
1416144|NCT02730351|3465216|P1|COMPLETED|Wash-out Period (2 Weeks)||35
1416145|NCT02730351|3465215|P2|STARTED|Wash-out Period (2 Weeks)||37
1416146|NCT02730351|3465216|P1|STARTED|Wash-out Period (2 Weeks)||36
1416147|NCT02730351|3465215|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1416148|NCT02730351|3465216|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
1416149|NCT02730351|3465215|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
1416150|NCT02730351|3465216|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
1416151|NCT02730351|3465215|P2|STARTED|Treatment Period 1 (2 Weeks)||37
1416152|NCT02730351|3465216|P1|STARTED|Treatment Period 1 (2 Weeks)||37
1416153|NCT02730260|3465230|P2|NOT COMPLETED|Overall Study||75
1416154|NCT02730260|3465231|P1|NOT COMPLETED|Overall Study||82
1416155|NCT02730260|3465230|P2|COMPLETED|Overall Study||185
1416156|NCT02730260|3465231|P1|COMPLETED|Overall Study||176
1416157|NCT02730260|3465230|P2|STARTED|Overall Study||260
1416158|NCT02730260|3465231|P1|STARTED|Overall Study||258
1416159|NCT02729753|3465239|P2|NOT COMPLETED|Overall Study||1
1416160|NCT02729753|3465240|P1|NOT COMPLETED|Overall Study||0
1416161|NCT02729753|3465239|P2|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
1416162|NCT02729753|3465240|P1|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
1416163|NCT02729753|3465239|P2|STARTED|Overall Study|First patient enrolled April 2016|7
1416164|NCT02729753|3465240|P1|STARTED|Overall Study|First patient enrolled April 2016|3
1416165|NCT02729038|3465256|P4|NOT COMPLETED|Part 2 (Up to 50 Days)||0
1416166|NCT02729038|3465257|P3|NOT COMPLETED|Part 2 (Up to 50 Days)||0
1416167|NCT02729038|3465258|P2|NOT COMPLETED|Part 2 (Up to 50 Days)||0
1416168|NCT02729038|3465259|P1|NOT COMPLETED|Part 2 (Up to 50 Days)||0
1416169|NCT02729038|3465256|P4|COMPLETED|Part 2 (Up to 50 Days)||8
1416170|NCT02729038|3465257|P3|COMPLETED|Part 2 (Up to 50 Days)||0
1416171|NCT02729038|3465258|P2|COMPLETED|Part 2 (Up to 50 Days)||0
1416172|NCT02729038|3465259|P1|COMPLETED|Part 2 (Up to 50 Days)||0
1416173|NCT02729038|3465256|P4|STARTED|Part 2 (Up to 50 Days)||8
1416174|NCT02729038|3465257|P3|STARTED|Part 2 (Up to 50 Days)||0
1416175|NCT02729038|3465258|P2|STARTED|Part 2 (Up to 50 Days)||0
1416176|NCT02729038|3465259|P1|STARTED|Part 2 (Up to 50 Days)||0
1416177|NCT02729038|3465256|P4|NOT COMPLETED|Part 1 (Up to 44 Days)||0
1416178|NCT02729038|3465257|P3|NOT COMPLETED|Part 1 (Up to 44 Days)||0
1416179|NCT02729038|3465258|P2|NOT COMPLETED|Part 1 (Up to 44 Days)||0
1416180|NCT02729038|3465259|P1|NOT COMPLETED|Part 1 (Up to 44 Days)||0
1416181|NCT02729038|3465256|P4|COMPLETED|Part 1 (Up to 44 Days)||0
1416182|NCT02729038|3465257|P3|COMPLETED|Part 1 (Up to 44 Days)||8
1416183|NCT02729038|3465258|P2|COMPLETED|Part 1 (Up to 44 Days)||8
1416184|NCT02729038|3465259|P1|COMPLETED|Part 1 (Up to 44 Days)||8
1416185|NCT02729038|3465256|P4|STARTED|Part 1 (Up to 44 Days)||0
1416186|NCT02729038|3465257|P3|STARTED|Part 1 (Up to 44 Days)||8
1416187|NCT02729038|3465258|P2|STARTED|Part 1 (Up to 44 Days)||8
1416188|NCT02729038|3465259|P1|STARTED|Part 1 (Up to 44 Days)||8
1416189|NCT02728089|3465378|P1|NOT COMPLETED|Overall Study||3
1416190|NCT02728089|3465378|P1|COMPLETED|Overall Study||112
1416191|NCT02728089|3465378|P1|Treated|Overall Study||114
1416192|NCT02728089|3465378|P1|STARTED|Overall Study||115
1416193|NCT02727842|3465393|P1|NOT COMPLETED|Overall Study||0
1416194|NCT02727842|3465393|P1|COMPLETED|Overall Study||30
1416195|NCT02727842|3465393|P1|STARTED|Overall Study||30
1416196|NCT02727816|3465397|P1|NOT COMPLETED|Overall Study||0
1416197|NCT02727816|3465397|P1|COMPLETED|Overall Study||35
1416198|NCT02727816|3465397|P1|STARTED|Overall Study||35
1416199|NCT02726971|3465446|P2|NOT COMPLETED|Overall Study||9
1416200|NCT02726971|3465447|P1|NOT COMPLETED|Overall Study||11
1416201|NCT02726971|3465446|P2|COMPLETED|Overall Study||62
1416202|NCT02726971|3465447|P1|COMPLETED|Overall Study||59
1416203|NCT02726971|3465446|P2|STARTED|Overall Study||71
1416204|NCT02726971|3465447|P1|STARTED|Overall Study||70
1416205|NCT02726178|3465459|P2|NOT COMPLETED|Overall Study||0
1416206|NCT02726178|3465460|P1|NOT COMPLETED|Overall Study||0
1416207|NCT02726178|3465459|P2|COMPLETED|Overall Study||28
1416208|NCT02726178|3465460|P1|COMPLETED|Overall Study||28
1416209|NCT02726178|3465459|P2|STARTED|Overall Study||28
1416210|NCT02726178|3465460|P1|STARTED|Overall Study||28
1416211|NCT02726022|3465468|P1|NOT COMPLETED|Overall Study||36
1416212|NCT02726022|3465468|P1|COMPLETED|Overall Study||78
1416213|NCT02726022|3465468|P1|STARTED|Overall Study||114
1416214|NCT02725788|3465479|P2|NOT COMPLETED|Overall Study||2
1416215|NCT02725788|3465480|P1|NOT COMPLETED|Overall Study||1
1416216|NCT02725788|3465479|P2|COMPLETED|Overall Study||122
1416217|NCT02725788|3465480|P1|COMPLETED|Overall Study||122
1416218|NCT02725788|3465479|P2|STARTED|Overall Study||124
1416219|NCT02725788|3465480|P1|STARTED|Overall Study||123
1416220|NCT02725476|3465488|P2|NOT COMPLETED|Overall Study||1
1416221|NCT02725476|3465489|P1|NOT COMPLETED|Overall Study||3
1416222|NCT02725476|3465488|P2|COMPLETED|Overall Study||4
1416223|NCT02725476|3465489|P1|COMPLETED|Overall Study||12
1416224|NCT02725476|3465488|P2|STARTED|Overall Study||5
1416225|NCT02725476|3465489|P1|STARTED|Overall Study||15
1416226|NCT02724644|3465499|P2|NOT COMPLETED|Overall Study||4
1416227|NCT02724644|3465500|P1|NOT COMPLETED|Overall Study||21
1416228|NCT02724644|3465499|P2|COMPLETED|Overall Study||182
1416229|NCT02724644|3465500|P1|COMPLETED|Overall Study||168
1416230|NCT02724644|3465499|P2|STARTED|Overall Study||186
1416231|NCT02724644|3465500|P1|STARTED|Overall Study||189
1416232|NCT02724449|3465528|P1|NOT COMPLETED|Overall Study||0
1416233|NCT02724449|3465528|P1|COMPLETED|Overall Study||16
1416234|NCT02724449|3465528|P1|STARTED|Overall Study||16
1416235|NCT02724111|3465534|P2|NOT COMPLETED|Overall Study||5
1416236|NCT02724111|3465535|P1|NOT COMPLETED|Overall Study||2
1416237|NCT02724111|3465534|P2|COMPLETED|Overall Study||40
1416238|NCT02724111|3465535|P1|COMPLETED|Overall Study||43
1416239|NCT02724111|3465534|P2|STARTED|Overall Study||45
1416240|NCT02724111|3465535|P1|STARTED|Overall Study||45
1416241|NCT02723201|3465558|P3|NOT COMPLETED|Fourth Intervention Period||0
1416242|NCT02723201|3465559|P2|NOT COMPLETED|Fourth Intervention Period||0
1416243|NCT02723201|3465560|P1|NOT COMPLETED|Fourth Intervention Period||0
1416244|NCT02723201|3465558|P3|COMPLETED|Fourth Intervention Period||0
1416245|NCT02723201|3465559|P2|COMPLETED|Fourth Intervention Period||0
1416246|NCT02723201|3465560|P1|COMPLETED|Fourth Intervention Period||9
1416247|NCT02723201|3465558|P3|STARTED|Fourth Intervention Period||0
1416248|NCT02723201|3465559|P2|STARTED|Fourth Intervention Period||0
1416249|NCT02723201|3465560|P1|STARTED|Fourth Intervention Period||9
1416250|NCT02723201|3465558|P3|NOT COMPLETED|Washout Period 3||0
1416251|NCT02723201|3465559|P2|NOT COMPLETED|Washout Period 3||0
1416252|NCT02723201|3465560|P1|NOT COMPLETED|Washout Period 3||0
1416253|NCT02723201|3465558|P3|COMPLETED|Washout Period 3||0
1416254|NCT02723201|3465559|P2|COMPLETED|Washout Period 3||0
1416255|NCT02723201|3465560|P1|COMPLETED|Washout Period 3||9
1416256|NCT02723201|3465558|P3|STARTED|Washout Period 3||0
1416257|NCT02723201|3465559|P2|STARTED|Washout Period 3||0
1416258|NCT02723201|3465560|P1|STARTED|Washout Period 3||9
1416259|NCT02723201|3465558|P3|NOT COMPLETED|Third Intervention Period||0
1416260|NCT02723201|3465559|P2|NOT COMPLETED|Third Intervention Period||0
1416261|NCT02723201|3465560|P1|NOT COMPLETED|Third Intervention Period||0
1416262|NCT02723201|3465558|P3|COMPLETED|Third Intervention Period||0
1416263|NCT02723201|3465559|P2|COMPLETED|Third Intervention Period||0
1416264|NCT02723201|3465560|P1|COMPLETED|Third Intervention Period||9
1416265|NCT02723201|3465558|P3|STARTED|Third Intervention Period||0
1416266|NCT02723201|3465559|P2|STARTED|Third Intervention Period||0
1416267|NCT02723201|3465560|P1|STARTED|Third Intervention Period||9
1416268|NCT02723201|3465558|P3|NOT COMPLETED|Washout Period 2||0
1416269|NCT02723201|3465559|P2|NOT COMPLETED|Washout Period 2||0
1416270|NCT02723201|3465560|P1|NOT COMPLETED|Washout Period 2||0
1416271|NCT02723201|3465558|P3|COMPLETED|Washout Period 2||0
1416272|NCT02723201|3465559|P2|COMPLETED|Washout Period 2||0
1416273|NCT02723201|3465560|P1|COMPLETED|Washout Period 2||9
1416274|NCT02723201|3465558|P3|STARTED|Washout Period 2||0
1416275|NCT02723201|3465559|P2|STARTED|Washout Period 2||0
1416276|NCT02723201|3465560|P1|STARTED|Washout Period 2||9
1416277|NCT02723201|3465558|P3|NOT COMPLETED|Second Intervention Period||0
1416278|NCT02723201|3465559|P2|NOT COMPLETED|Second Intervention Period||0
1416279|NCT02723201|3465560|P1|NOT COMPLETED|Second Intervention Period||2
1416280|NCT02723201|3465558|P3|COMPLETED|Second Intervention Period||7
1416281|NCT02723201|3465559|P2|COMPLETED|Second Intervention Period||7
1416282|NCT02723201|3465560|P1|COMPLETED|Second Intervention Period||9
1416283|NCT02723201|3465558|P3|STARTED|Second Intervention Period||7
1416284|NCT02723201|3465559|P2|STARTED|Second Intervention Period||7
1416285|NCT02723201|3465560|P1|STARTED|Second Intervention Period||11
1416286|NCT02723201|3465558|P3|NOT COMPLETED|Washout Period 1||0
1416287|NCT02723201|3465559|P2|NOT COMPLETED|Washout Period 1||0
1416288|NCT02723201|3465560|P1|NOT COMPLETED|Washout Period 1||0
1416289|NCT02723201|3465558|P3|COMPLETED|Washout Period 1||7
1416290|NCT02723201|3465559|P2|COMPLETED|Washout Period 1||7
1416291|NCT02723201|3465560|P1|COMPLETED|Washout Period 1||11
1416292|NCT02723201|3465558|P3|STARTED|Washout Period 1||7
1416293|NCT02723201|3465559|P2|STARTED|Washout Period 1||7
1416294|NCT02723201|3465560|P1|STARTED|Washout Period 1||11
1416295|NCT02723201|3465558|P3|NOT COMPLETED|First Intervention Period||0
1416296|NCT02723201|3465559|P2|NOT COMPLETED|First Intervention Period||0
1416297|NCT02723201|3465560|P1|NOT COMPLETED|First Intervention Period||0
1416298|NCT02723201|3465558|P3|COMPLETED|First Intervention Period||7
1416299|NCT02723201|3465559|P2|COMPLETED|First Intervention Period||7
1416300|NCT02723201|3465560|P1|COMPLETED|First Intervention Period||11
1416301|NCT02723201|3465558|P3|STARTED|First Intervention Period||7
1416302|NCT02723201|3465559|P2|STARTED|First Intervention Period||7
1416303|NCT02723201|3465560|P1|STARTED|First Intervention Period||11
1416304|NCT02723188|3465619|P3|NOT COMPLETED|Overall Study||0
1416305|NCT02723188|3465620|P2|NOT COMPLETED|Overall Study||0
1416306|NCT02723188|3465621|P1|NOT COMPLETED|Overall Study||1
1416307|NCT02723188|3465619|P3|COMPLETED|Overall Study||15
1416308|NCT02723188|3465620|P2|COMPLETED|Overall Study||15
1416309|NCT02723188|3465621|P1|COMPLETED|Overall Study||14
1416310|NCT02723188|3465619|P3|STARTED|Overall Study||15
1416311|NCT02723188|3465620|P2|STARTED|Overall Study||15
1416312|NCT02723188|3465621|P1|STARTED|Overall Study||15
1416313|NCT02723175|3465634|P2|NOT COMPLETED|Overall Study||3
1416314|NCT02723175|3465635|P1|NOT COMPLETED|Overall Study||4
1416315|NCT02723175|3465634|P2|COMPLETED|Overall Study||4
1416316|NCT02723175|3465635|P1|COMPLETED|Overall Study||4
1416317|NCT02723175|3465634|P2|STARTED|Overall Study||7
1416318|NCT02723175|3465635|P1|STARTED|Overall Study||8
1416319|NCT02722967|3465678|P3|NOT COMPLETED|Overall Study||4
1416320|NCT02722967|3465679|P2|NOT COMPLETED|Overall Study||2
1416321|NCT02722967|3465680|P1|NOT COMPLETED|Overall Study||5
1416322|NCT02722967|3465678|P3|COMPLETED|Overall Study||11
1416323|NCT02722967|3465679|P2|COMPLETED|Overall Study||10
1416324|NCT02722967|3465680|P1|COMPLETED|Overall Study||17
1416325|NCT02722967|3465678|P3|STARTED|Overall Study||15
1416326|NCT02722967|3465679|P2|STARTED|Overall Study||12
1416327|NCT02722967|3465680|P1|STARTED|Overall Study||22
1416328|NCT02722837|3465688|P1|NOT COMPLETED|Overall Study||0
1416329|NCT02722837|3465688|P1|COMPLETED|Overall Study||119
1416330|NCT02722837|3465688|P1|STARTED|Overall Study||119
1416331|NCT02722564|3465706|P1|NOT COMPLETED|Overall Study||0
1416332|NCT02722564|3465706|P1|COMPLETED|Overall Study||55
1416333|NCT02722564|3465706|P1|STARTED|Overall Study||55
1416334|NCT02722278|3465712|P2|NOT COMPLETED|Overall Study||7
1416335|NCT02722278|3465713|P1|NOT COMPLETED|Overall Study||12
1416336|NCT02722278|3465712|P2|COMPLETED|Overall Study||49
1416337|NCT02722278|3465713|P1|COMPLETED|Overall Study||154
1416338|NCT02722278|3465712|P2|STARTED|Overall Study||56
1416339|NCT02722278|3465713|P1|STARTED|Overall Study||166
1416340|NCT02722239|3465723|P2|NOT COMPLETED|Overall Study||0
1416341|NCT02722239|3465724|P1|NOT COMPLETED|Overall Study||0
1416342|NCT02722239|3465723|P2|COMPLETED|Overall Study||20
1416343|NCT02722239|3465724|P1|COMPLETED|Overall Study||20
1416344|NCT02722239|3465723|P2|Second Intervention (1 Day)|Overall Study||20
1416345|NCT02722239|3465724|P1|Second Intervention (1 Day)|Overall Study||20
1416346|NCT02722239|3465723|P2|Washout (7 Days)|Overall Study||20
1416347|NCT02722239|3465724|P1|Washout (7 Days)|Overall Study||20
1416348|NCT02722239|3465723|P2|First Intervention (1 Day)|Overall Study||20
1416349|NCT02722239|3465724|P1|First Intervention (1 Day)|Overall Study||20
1416350|NCT02722239|3465723|P2|STARTED|Overall Study||20
1416351|NCT02722239|3465724|P1|STARTED|Overall Study||20
1416352|NCT02722044|3465737|P1|NOT COMPLETED|Overall Study||5
1416353|NCT02722044|3465737|P1|COMPLETED|Overall Study||28
1416354|NCT02722044|3465737|P1|STARTED|Overall Study||33
1416355|NCT02721875|3465766|P2|NOT COMPLETED|Overall Study||0
1416356|NCT02721875|3465767|P1|NOT COMPLETED|Overall Study||1
1416357|NCT02721875|3465766|P2|COMPLETED|Overall Study||0
1416358|NCT02721875|3465767|P1|COMPLETED|Overall Study||0
1416359|NCT02721875|3465766|P2|STARTED|Overall Study||0
1416360|NCT02721875|3465767|P1|STARTED|Overall Study||1
1416361|NCT02721641|3465780|P1|NOT COMPLETED|Overall Study||0
1416362|NCT02721641|3465780|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
1416363|NCT02721641|3465780|P1|STARTED|Overall Study||69
1416364|NCT02721277|3465786|P1|NOT COMPLETED|Overall Study||0
1416365|NCT02721277|3465786|P1|COMPLETED|Overall Study||2
1416366|NCT02721277|3465786|P1|STARTED|Overall Study||2
1416367|NCT02721147|3465818|P3|NOT COMPLETED|Overall Study||0
1416368|NCT02721147|3465819|P2|NOT COMPLETED|Overall Study||0
1416369|NCT02721147|3465820|P1|NOT COMPLETED|Overall Study||2
1416370|NCT02721147|3465818|P3|COMPLETED|Overall Study||31
1416371|NCT02721147|3465819|P2|COMPLETED|Overall Study||18
1416372|NCT02721147|3465820|P1|COMPLETED|Overall Study||38
1416373|NCT02721147|3465818|P3|STARTED|Overall Study||31
1416374|NCT02721147|3465819|P2|STARTED|Overall Study||18
1416375|NCT02721147|3465820|P1|STARTED|Overall Study||40
1416376|NCT02720952|3465855|P1|NOT COMPLETED|Overall Study||0
1416377|NCT02720952|3465855|P1|COMPLETED|Overall Study||24
1416378|NCT02720952|3465855|P1|STARTED|Overall Study||24
1416379|NCT02720510|3465866|P2|NOT COMPLETED|Overall Study||3
1416380|NCT02720510|3465867|P1|NOT COMPLETED|Overall Study||3
1416381|NCT02720510|3465866|P2|COMPLETED|Overall Study||0
1416382|NCT02720510|3465867|P1|COMPLETED|Overall Study||0
1416383|NCT02720510|3465866|P2|STARTED|Overall Study||3
1416384|NCT02720510|3465867|P1|STARTED|Overall Study||3
1416385|NCT02720224|3465885|P1|NOT COMPLETED|Overall Study||0
1416386|NCT02720224|3465885|P1|COMPLETED|Overall Study||6
1416387|NCT02720224|3465885|P1|STARTED|Overall Study||6
1416388|NCT02720081|3465909|P2|NOT COMPLETED|Overall Study||4
1416389|NCT02720081|3465910|P1|NOT COMPLETED|Overall Study||4
1416390|NCT02720081|3465909|P2|COMPLETED|Overall Study||66
1416391|NCT02720081|3465910|P1|COMPLETED|Overall Study||68
1416392|NCT02720081|3465909|P2|Treated|Overall Study||69
1416393|NCT02720081|3465910|P1|Treated|Overall Study||70
1416394|NCT02720081|3465909|P2|STARTED|Overall Study||70
1416395|NCT02720081|3465910|P1|STARTED|Overall Study||72
1416396|NCT02718898|3465968|P2|NOT COMPLETED|Overall Study||1
1416397|NCT02718898|3465969|P1|NOT COMPLETED|Overall Study||9
1416398|NCT02718898|3465968|P2|COMPLETED|Overall Study||74
1416399|NCT02718898|3465969|P1|COMPLETED|Overall Study||65
1416400|NCT02718898|3465968|P2|STARTED|Overall Study||75
1416401|NCT02718898|3465969|P1|STARTED|Overall Study||74
1416402|NCT02718248|3465997|P1|NOT COMPLETED|Overall Study||0
1416403|NCT02718248|3465997|P1|COMPLETED|Overall Study||7
1416404|NCT02718248|3465997|P1|STARTED|Overall Study||7
1416405|NCT02718157|3466013|P1|NOT COMPLETED|Overall Study||162
1416406|NCT02718157|3466013|P1|COMPLETED|Overall Study||609
1416407|NCT02718157|3466013|P1|STARTED|Overall Study||771
1416408|NCT02718118|3466022|P2|NOT COMPLETED|Overall Study||1
1416409|NCT02718118|3466023|P1|NOT COMPLETED|Overall Study||2
1416410|NCT02718118|3466022|P2|COMPLETED|Overall Study||29
1416411|NCT02718118|3466023|P1|COMPLETED|Overall Study||28
1416412|NCT02718118|3466022|P2|STARTED|Overall Study||30
1416413|NCT02718118|3466023|P1|STARTED|Overall Study||30
1416414|NCT02718040|3466057|P1|NOT COMPLETED|Overall Study||0
1416415|NCT02718040|3466057|P1|COMPLETED|Overall Study||30
1416416|NCT02718040|3466057|P1|STARTED|Overall Study||30
1416417|NCT02717754|3466076|P6|NOT COMPLETED|Overall Study||20
1416418|NCT02717754|3466077|P5|NOT COMPLETED|Overall Study||20
1416419|NCT02717754|3466078|P4|NOT COMPLETED|Overall Study||10
1416420|NCT02717754|3466079|P3|NOT COMPLETED|Overall Study||0
1416421|NCT02717754|3466080|P2|NOT COMPLETED|Overall Study||0
1416422|NCT02717754|3466081|P1|NOT COMPLETED|Overall Study||0
1416423|NCT02717754|3466076|P6|COMPLETED|Overall Study||0
1416424|NCT02717754|3466077|P5|COMPLETED|Overall Study||0
1416425|NCT02717754|3466078|P4|COMPLETED|Overall Study||0
1416426|NCT02717754|3466079|P3|COMPLETED|Overall Study||20
1416427|NCT02717754|3466080|P2|COMPLETED|Overall Study||19
1416428|NCT02717754|3466081|P1|COMPLETED|Overall Study||10
1416429|NCT02717754|3466076|P6|STARTED|Overall Study||20
1416430|NCT02717754|3466077|P5|STARTED|Overall Study||20
1416431|NCT02717754|3466078|P4|STARTED|Overall Study||10
1416432|NCT02717754|3466079|P3|STARTED|Overall Study||20
1416433|NCT02717754|3466080|P2|STARTED|Overall Study||19
1416434|NCT02717754|3466081|P1|STARTED|Overall Study||10
1416435|NCT02717273|3466111|P2|NOT COMPLETED|Overall Study||2
1416436|NCT02717273|3466112|P1|NOT COMPLETED|Overall Study||3
1416437|NCT02717273|3466111|P2|COMPLETED|Overall Study||48
1416438|NCT02717273|3466112|P1|COMPLETED|Overall Study||49
1416439|NCT02717273|3466111|P2|STARTED|Overall Study||50
1416440|NCT02717273|3466112|P1|STARTED|Overall Study||52
1416441|NCT02716779|3466133|P3|NOT COMPLETED|Combination Therapy||1
1416442|NCT02716779|3466134|P2|NOT COMPLETED|Combination Therapy||2
1416443|NCT02716779|3466135|P1|NOT COMPLETED|Combination Therapy||0
1416444|NCT02716779|3466133|P3|COMPLETED|Combination Therapy||25
1416445|NCT02716779|3466134|P2|COMPLETED|Combination Therapy||23
1416446|NCT02716779|3466135|P1|COMPLETED|Combination Therapy||14
1416447|NCT02716779|3466133|P3|STARTED|Combination Therapy||26
1416448|NCT02716779|3466134|P2|STARTED|Combination Therapy||25
1416449|NCT02716779|3466135|P1|STARTED|Combination Therapy||14
1416450|NCT02716779|3466133|P3|NOT COMPLETED|Monotherapy||1
1416451|NCT02716779|3466134|P2|NOT COMPLETED|Monotherapy||1
1416452|NCT02716779|3466135|P1|NOT COMPLETED|Monotherapy||0
1416453|NCT02716779|3466133|P3|COMPLETED|Monotherapy||26
1416454|NCT02716779|3466134|P2|COMPLETED|Monotherapy||25
1416455|NCT02716779|3466135|P1|COMPLETED|Monotherapy||14
1416456|NCT02716779|3466133|P3|STARTED|Monotherapy||27
1416457|NCT02716779|3466134|P2|STARTED|Monotherapy||26
1416458|NCT02716779|3466135|P1|STARTED|Monotherapy||14
1416459|NCT02716714|3466181|P2|NOT COMPLETED|Overall Study||2
1416460|NCT02716714|3466182|P1|NOT COMPLETED|Overall Study||12
1416461|NCT02716714|3466181|P2|COMPLETED|Overall Study||8
1416462|NCT02716714|3466182|P1|COMPLETED|Overall Study||55
1416463|NCT02716714|3466181|P2|STARTED|Overall Study||10
1416464|NCT02716714|3466182|P1|STARTED|Overall Study||67
1416465|NCT02716298|3466208|P2|NOT COMPLETED|Second Intervention (1 Month)||0
1416466|NCT02716298|3466209|P1|NOT COMPLETED|Second Intervention (1 Month)||0
1416467|NCT02716298|3466208|P2|COMPLETED|Second Intervention (1 Month)||23
1416468|NCT02716298|3466209|P1|COMPLETED|Second Intervention (1 Month)||24
1416469|NCT02716298|3466208|P2|STARTED|Second Intervention (1 Month)||23
1416470|NCT02716298|3466209|P1|STARTED|Second Intervention (1 Month)||24
1416471|NCT02716298|3466208|P2|NOT COMPLETED|First Intervention (1 Month)||1
1416472|NCT02716298|3466209|P1|NOT COMPLETED|First Intervention (1 Month)||1
1416473|NCT02716298|3466208|P2|COMPLETED|First Intervention (1 Month)||23
1416474|NCT02716298|3466209|P1|COMPLETED|First Intervention (1 Month)||24
1416475|NCT02716298|3466208|P2|STARTED|First Intervention (1 Month)||24
1416476|NCT02716298|3466209|P1|STARTED|First Intervention (1 Month)||25
1416477|NCT02716194|3466227|P3|NOT COMPLETED|Period 2 - BAX 826||0
1416478|NCT02716194|3466228|P2|NOT COMPLETED|Period 2 - BAX 826||0
1416479|NCT02716194|3466229|P1|NOT COMPLETED|Period 2 - BAX 826||0
1416480|NCT02716194|3466227|P3|COMPLETED|Period 2 - BAX 826||13
1416481|NCT02716194|3466228|P2|COMPLETED|Period 2 - BAX 826||15
1416482|NCT02716194|3466229|P1|COMPLETED|Period 2 - BAX 826||10
1416483|NCT02716194|3466227|P3|STARTED|Period 2 - BAX 826||13
1416484|NCT02716194|3466228|P2|STARTED|Period 2 - BAX 826||15
1416485|NCT02716194|3466229|P1|STARTED|Period 2 - BAX 826||10
1416486|NCT02716194|3466227|P3|NOT COMPLETED|Period 1 - ADVATE||0
1416487|NCT02716194|3466228|P2|NOT COMPLETED|Period 1 - ADVATE||1
1416488|NCT02716194|3466229|P1|NOT COMPLETED|Period 1 - ADVATE||1
1416489|NCT02716194|3466227|P3|COMPLETED|Period 1 - ADVATE||13
1416490|NCT02716194|3466228|P2|COMPLETED|Period 1 - ADVATE||15
1416491|NCT02716194|3466229|P1|COMPLETED|Period 1 - ADVATE||10
1416492|NCT02716194|3466227|P3|STARTED|Period 1 - ADVATE||13
1416493|NCT02716194|3466228|P2|STARTED|Period 1 - ADVATE||16
1416494|NCT02716194|3466229|P1|STARTED|Period 1 - ADVATE||11
1416495|NCT02714504|3466309|P2|NOT COMPLETED|Overall Study||0
1416496|NCT02714504|3466310|P1|NOT COMPLETED|Overall Study||0
1416497|NCT02714504|3466309|P2|COMPLETED|Overall Study||178
1416498|NCT02714504|3466310|P1|COMPLETED|Overall Study||61
1416499|NCT02714504|3466309|P2|STARTED|Overall Study||178
1416500|NCT02714504|3466310|P1|STARTED|Overall Study||61
1416501|NCT02714062|3466319|P3|NOT COMPLETED|Overall Study||3
1416502|NCT02714062|3466320|P2|NOT COMPLETED|Overall Study||1
1416503|NCT02714062|3466321|P1|NOT COMPLETED|Overall Study||1
1416504|NCT02714062|3466319|P3|COMPLETED|Overall Study||10
1416505|NCT02714062|3466320|P2|COMPLETED|Overall Study||14
1416506|NCT02714062|3466321|P1|COMPLETED|Overall Study||13
1416507|NCT02714062|3466319|P3|STARTED|Overall Study||13
1416508|NCT02714062|3466320|P2|STARTED|Overall Study||15
1416509|NCT02714062|3466321|P1|STARTED|Overall Study||14
1416510|NCT02713698|3466368|P3|NOT COMPLETED|Overall Study||0
1416511|NCT02713698|3466369|P2|NOT COMPLETED|Overall Study||0
1416512|NCT02713698|3466370|P1|NOT COMPLETED|Overall Study||0
1416513|NCT02713698|3466368|P3|COMPLETED|Overall Study||20
1416514|NCT02713698|3466369|P2|COMPLETED|Overall Study||20
1416515|NCT02713698|3466370|P1|COMPLETED|Overall Study||20
1416516|NCT02713698|3466368|P3|STARTED|Overall Study||20
1416517|NCT02713698|3466369|P2|STARTED|Overall Study||20
1416518|NCT02713698|3466370|P1|STARTED|Overall Study||20
1416519|NCT02713594|3466380|P2|NOT COMPLETED|Overall Study||396
1416520|NCT02713594|3466381|P1|NOT COMPLETED|Overall Study||390
1416521|NCT02713594|3466380|P2|COMPLETED|Overall Study||552
1416522|NCT02713594|3466381|P1|COMPLETED|Overall Study||562
1416523|NCT02713594|3466380|P2|STARTED|Overall Study||948
1416524|NCT02713594|3466381|P1|STARTED|Overall Study||952
1416525|NCT02713256|3466391|P1|NOT COMPLETED|Overall Study||0
1416526|NCT02713256|3466391|P1|COMPLETED|Overall Study||15
1416527|NCT02713256|3466391|P1|STARTED|Overall Study||15
1416528|NCT02712333|3466399|P2|NOT COMPLETED|Second Period||0
1416529|NCT02712333|3466400|P1|NOT COMPLETED|Second Period||0
1416530|NCT02712333|3466399|P2|COMPLETED|Second Period||24
1416531|NCT02712333|3466400|P1|COMPLETED|Second Period||31
1416532|NCT02712333|3466399|P2|STARTED|Second Period||24
1416533|NCT02712333|3466400|P1|STARTED|Second Period||31
1416534|NCT02712333|3466399|P2|NOT COMPLETED|First Period||2
1416535|NCT02712333|3466400|P1|NOT COMPLETED|First Period||3
1416536|NCT02712333|3466399|P2|COMPLETED|First Period||24
1416537|NCT02712333|3466400|P1|COMPLETED|First Period||31
1416538|NCT02712333|3466399|P2|STARTED|First Period||26
1416539|NCT02712333|3466400|P1|STARTED|First Period||34
1416540|NCT02712320|3466418|P1|NOT COMPLETED|Overall Study||5
1416541|NCT02712320|3466418|P1|COMPLETED|Overall Study||25
1416542|NCT02712320|3466418|P1|STARTED|Overall Study||30
1416543|NCT02712099|3466428|P2|NOT COMPLETED|Overall Study||0
1416544|NCT02712099|3466429|P1|NOT COMPLETED|Overall Study||0
1416545|NCT02712099|3466428|P2|COMPLETED|Overall Study||20
1416546|NCT02712099|3466429|P1|COMPLETED|Overall Study||30
1416547|NCT02712099|3466428|P2|STARTED|Overall Study||20
1416548|NCT02712099|3466429|P1|STARTED|Overall Study||30
1416549|NCT02712047|3466445|P2|NOT COMPLETED|Treatment Period 2 (35 Days)||0
1416550|NCT02712047|3466446|P1|NOT COMPLETED|Treatment Period 2 (35 Days)||0
1416551|NCT02712047|3466445|P2|COMPLETED|Treatment Period 2 (35 Days)||13
1416552|NCT02712047|3466446|P1|COMPLETED|Treatment Period 2 (35 Days)||14
1416553|NCT02712047|3466445|P2|STARTED|Treatment Period 2 (35 Days)||13
1416554|NCT02712047|3466446|P1|STARTED|Treatment Period 2 (35 Days)||14
1416555|NCT02712047|3466445|P2|NOT COMPLETED|Washout Period (21 Days)||0
1416556|NCT02712047|3466446|P1|NOT COMPLETED|Washout Period (21 Days)||0
1416557|NCT02712047|3466445|P2|COMPLETED|Washout Period (21 Days)||13
1416558|NCT02712047|3466446|P1|COMPLETED|Washout Period (21 Days)||14
1416559|NCT02712047|3466445|P2|STARTED|Washout Period (21 Days)||13
1416560|NCT02712047|3466446|P1|STARTED|Washout Period (21 Days)||14
1416561|NCT02712047|3466445|P2|NOT COMPLETED|Treatment Period 1 (35 Days)||0
1416562|NCT02712047|3466446|P1|NOT COMPLETED|Treatment Period 1 (35 Days)||0
1416563|NCT02712047|3466445|P2|COMPLETED|Treatment Period 1 (35 Days)||13
1416564|NCT02712047|3466446|P1|COMPLETED|Treatment Period 1 (35 Days)||14
1416565|NCT02712047|3466445|P2|STARTED|Treatment Period 1 (35 Days)||13
1416566|NCT02712047|3466446|P1|STARTED|Treatment Period 1 (35 Days)||14
1416567|NCT02712008|3466461|P8|NOT COMPLETED|From Week 12 up to Week 36||4
1416568|NCT02712008|3466462|P7|NOT COMPLETED|From Week 12 up to Week 36||5
1416569|NCT02712008|3466463|P6|NOT COMPLETED|From Week 12 up to Week 36||0
1416570|NCT02712008|3466464|P5|NOT COMPLETED|From Week 12 up to Week 36||2
1416571|NCT02712008|3466465|P4|NOT COMPLETED|From Week 12 up to Week 36||2
1416572|NCT02712008|3466466|P3|NOT COMPLETED|From Week 12 up to Week 36||0
1416573|NCT02712008|3466467|P2|NOT COMPLETED|From Week 12 up to Week 36||0
1416574|NCT02712008|3466468|P1|NOT COMPLETED|From Week 12 up to Week 36||1
1416575|NCT02712008|3466461|P8|COMPLETED|From Week 12 up to Week 36||45
1416576|NCT02712008|3466462|P7|COMPLETED|From Week 12 up to Week 36||43
1416577|NCT02712008|3466463|P6|COMPLETED|From Week 12 up to Week 36||46
1416578|NCT02712008|3466464|P5|COMPLETED|From Week 12 up to Week 36||50
1416579|NCT02712008|3466465|P4|COMPLETED|From Week 12 up to Week 36||42
1416580|NCT02712008|3466466|P3|COMPLETED|From Week 12 up to Week 36||0
1416581|NCT02712008|3466467|P2|COMPLETED|From Week 12 up to Week 36||0
1416582|NCT02712008|3466468|P1|COMPLETED|From Week 12 up to Week 36||44
1416583|NCT02712008|3466461|P8|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
1416584|NCT02712008|3466462|P7|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
1416585|NCT02712008|3466463|P6|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
1416586|NCT02712008|3466464|P5|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
1416587|NCT02712008|3466465|P4|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
1416588|NCT02712008|3466466|P3|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
1416589|NCT02712008|3466467|P2|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
1416590|NCT02712008|3466468|P1|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
1416591|NCT02712008|3466461|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1416592|NCT02712008|3466462|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1416593|NCT02712008|3466463|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1416594|NCT02712008|3466464|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1416595|NCT02712008|3466465|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
1416596|NCT02712008|3466466|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
1416597|NCT02712008|3466467|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
1416598|NCT02712008|3466468|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
1416599|NCT02712008|3466461|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
1416600|NCT02712008|3466462|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
1416601|NCT02712008|3466463|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
1416602|NCT02712008|3466464|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
1416603|NCT02712008|3466465|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
1416604|NCT02712008|3466466|P3|COMPLETED|Baseline (Day 1) up to Week 12||148
1416605|NCT02712008|3466467|P2|COMPLETED|Baseline (Day 1) up to Week 12||97
1416606|NCT02712008|3466468|P1|COMPLETED|Baseline (Day 1) up to Week 12||46
1416607|NCT02712008|3466461|P8|STARTED|Baseline (Day 1) up to Week 12||0
1416608|NCT02712008|3466462|P7|STARTED|Baseline (Day 1) up to Week 12||0
1416609|NCT02712008|3466463|P6|STARTED|Baseline (Day 1) up to Week 12||0
1416610|NCT02712008|3466464|P5|STARTED|Baseline (Day 1) up to Week 12||0
1416611|NCT02712008|3466465|P4|STARTED|Baseline (Day 1) up to Week 12||0
1416612|NCT02712008|3466466|P3|STARTED|Baseline (Day 1) up to Week 12||152
1416613|NCT02712008|3466467|P2|STARTED|Baseline (Day 1) up to Week 12||100
1416614|NCT02712008|3466468|P1|STARTED|Baseline (Day 1) up to Week 12||50
1416615|NCT02711995|3466500|P1|NOT COMPLETED|Second Intervention (30 Days)||0
1416616|NCT02711995|3466500|P1|COMPLETED|Second Intervention (30 Days)||7
1416617|NCT02711995|3466500|P1|STARTED|Second Intervention (30 Days)||7
1416618|NCT02711995|3466500|P1|NOT COMPLETED|Washout (90 Days)||1
1416619|NCT02711995|3466500|P1|COMPLETED|Washout (90 Days)||7
1416620|NCT02711995|3466500|P1|STARTED|Washout (90 Days)||8
1416621|NCT02711995|3466500|P1|NOT COMPLETED|First Intervention (30 Days)||0
1416622|NCT02711995|3466500|P1|COMPLETED|First Intervention (30 Days)||8
1416623|NCT02711995|3466500|P1|STARTED|First Intervention (30 Days)||8
1416624|NCT02710630|3466527|P5|NOT COMPLETED|Period 6||0
1416625|NCT02710630|3466528|P4|NOT COMPLETED|Period 6||0
1416626|NCT02710630|3466529|P3|NOT COMPLETED|Period 6||0
1416627|NCT02710630|3466530|P2|NOT COMPLETED|Period 6||0
1416628|NCT02710630|3466531|P1|NOT COMPLETED|Period 6||0
1416629|NCT02710630|3466527|P5|COMPLETED|Period 6||7
1416630|NCT02710630|3466528|P4|COMPLETED|Period 6||7
1416631|NCT02710630|3466529|P3|COMPLETED|Period 6||7
1416632|NCT02710630|3466530|P2|COMPLETED|Period 6||7
1416633|NCT02710630|3466531|P1|COMPLETED|Period 6||7
1416634|NCT02710630|3466527|P5|STARTED|Period 6||7
1416635|NCT02710630|3466528|P4|STARTED|Period 6||7
1416636|NCT02710630|3466529|P3|STARTED|Period 6||7
1416637|NCT02710630|3466530|P2|STARTED|Period 6||7
1416638|NCT02710630|3466531|P1|STARTED|Period 6||7
1416639|NCT02710630|3466527|P5|NOT COMPLETED|Period 5||0
1416640|NCT02710630|3466528|P4|NOT COMPLETED|Period 5||0
1416641|NCT02710630|3466529|P3|NOT COMPLETED|Period 5||0
1416642|NCT02710630|3466530|P2|NOT COMPLETED|Period 5||0
1416643|NCT02710630|3466531|P1|NOT COMPLETED|Period 5||0
1416644|NCT02710630|3466527|P5|COMPLETED|Period 5||7
1416645|NCT02710630|3466528|P4|COMPLETED|Period 5||7
1416646|NCT02710630|3466529|P3|COMPLETED|Period 5||7
1416647|NCT02710630|3466530|P2|COMPLETED|Period 5||7
1416648|NCT02710630|3466531|P1|COMPLETED|Period 5||7
1416649|NCT02710630|3466527|P5|STARTED|Period 5||7
1416650|NCT02710630|3466528|P4|STARTED|Period 5||7
1416651|NCT02710630|3466529|P3|STARTED|Period 5||7
1416652|NCT02710630|3466530|P2|STARTED|Period 5||7
1416653|NCT02710630|3466531|P1|STARTED|Period 5||7
1416654|NCT02710630|3466527|P5|NOT COMPLETED|Period 4||0
1416655|NCT02710630|3466528|P4|NOT COMPLETED|Period 4||0
1416656|NCT02710630|3466529|P3|NOT COMPLETED|Period 4||0
1416657|NCT02710630|3466530|P2|NOT COMPLETED|Period 4||0
1416658|NCT02710630|3466531|P1|NOT COMPLETED|Period 4||0
1416659|NCT02710630|3466527|P5|COMPLETED|Period 4||7
1416660|NCT02710630|3466528|P4|COMPLETED|Period 4||7
1416661|NCT02710630|3466529|P3|COMPLETED|Period 4||7
1416662|NCT02710630|3466530|P2|COMPLETED|Period 4||7
1416663|NCT02710630|3466531|P1|COMPLETED|Period 4||7
1416664|NCT02710630|3466527|P5|STARTED|Period 4||7
1416665|NCT02710630|3466528|P4|STARTED|Period 4||7
1416666|NCT02710630|3466529|P3|STARTED|Period 4||7
1416667|NCT02710630|3466530|P2|STARTED|Period 4||7
1416668|NCT02710630|3466531|P1|STARTED|Period 4||7
1416669|NCT02710630|3466527|P5|NOT COMPLETED|Period 3||0
1416670|NCT02710630|3466528|P4|NOT COMPLETED|Period 3||0
1416671|NCT02710630|3466529|P3|NOT COMPLETED|Period 3||0
1416672|NCT02710630|3466530|P2|NOT COMPLETED|Period 3||0
1416673|NCT02710630|3466531|P1|NOT COMPLETED|Period 3||0
1416674|NCT02710630|3466527|P5|COMPLETED|Period 3||7
1416675|NCT02710630|3466528|P4|COMPLETED|Period 3||7
1416676|NCT02710630|3466529|P3|COMPLETED|Period 3||7
1416677|NCT02710630|3466530|P2|COMPLETED|Period 3||7
1416678|NCT02710630|3466531|P1|COMPLETED|Period 3||7
1416679|NCT02710630|3466527|P5|STARTED|Period 3||7
1416680|NCT02710630|3466528|P4|STARTED|Period 3||7
1416681|NCT02710630|3466529|P3|STARTED|Period 3||7
1416682|NCT02710630|3466530|P2|STARTED|Period 3||7
1416683|NCT02710630|3466531|P1|STARTED|Period 3||7
1416684|NCT02710630|3466527|P5|NOT COMPLETED|Period 2||0
1416685|NCT02710630|3466528|P4|NOT COMPLETED|Period 2||0
1416686|NCT02710630|3466529|P3|NOT COMPLETED|Period 2||0
1416687|NCT02710630|3466530|P2|NOT COMPLETED|Period 2||0
1416688|NCT02710630|3466531|P1|NOT COMPLETED|Period 2||0
1416689|NCT02710630|3466527|P5|COMPLETED|Period 2||7
1416690|NCT02710630|3466528|P4|COMPLETED|Period 2||7
1416691|NCT02710630|3466529|P3|COMPLETED|Period 2||7
1416692|NCT02710630|3466530|P2|COMPLETED|Period 2||7
1416693|NCT02710630|3466531|P1|COMPLETED|Period 2||7
1416694|NCT02710630|3466527|P5|Not Treated|Period 2||0
1416695|NCT02710630|3466528|P4|Not Treated|Period 2||0
1416696|NCT02710630|3466529|P3|Not Treated|Period 2||0
1416697|NCT02710630|3466530|P2|Not Treated|Period 2||0
1416698|NCT02710630|3466531|P1|Not Treated|Period 2||1
1416699|NCT02710630|3466527|P5|STARTED|Period 2||7
1416700|NCT02710630|3466528|P4|STARTED|Period 2||7
1416701|NCT02710630|3466529|P3|STARTED|Period 2||7
1416702|NCT02710630|3466530|P2|STARTED|Period 2||7
1416703|NCT02710630|3466531|P1|STARTED|Period 2||7
1416704|NCT02710630|3466527|P5|NOT COMPLETED|Period 1||0
1416705|NCT02710630|3466528|P4|NOT COMPLETED|Period 1||0
1416706|NCT02710630|3466529|P3|NOT COMPLETED|Period 1||0
1416707|NCT02710630|3466530|P2|NOT COMPLETED|Period 1||0
1416708|NCT02710630|3466531|P1|NOT COMPLETED|Period 1||0
1416709|NCT02710630|3466527|P5|COMPLETED|Period 1||7
1416710|NCT02710630|3466528|P4|COMPLETED|Period 1||7
1416711|NCT02710630|3466529|P3|COMPLETED|Period 1||7
1416712|NCT02710630|3466530|P2|COMPLETED|Period 1||7
1416713|NCT02710630|3466531|P1|COMPLETED|Period 1||7
1416714|NCT02710630|3466527|P5|STARTED|Period 1||7
1416715|NCT02710630|3466528|P4|STARTED|Period 1||7
1416716|NCT02710630|3466529|P3|STARTED|Period 1||7
1416717|NCT02710630|3466530|P2|STARTED|Period 1||7
1416718|NCT02710630|3466531|P1|STARTED|Period 1||7
1416719|NCT02710292|3466575|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
1416720|NCT02710292|3466576|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
1416721|NCT02710292|3466575|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
1416722|NCT02710292|3466576|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
1416723|NCT02710292|3466575|P2|STARTED|Period 2, Second 10 Days of Wear||49
1416724|NCT02710292|3466576|P1|STARTED|Period 2, Second 10 Days of Wear||46
1416725|NCT02710292|3466575|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
1416726|NCT02710292|3466576|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
1416727|NCT02710292|3466575|P2|COMPLETED|Period 1, First 10 Days of Wear||49
1416728|NCT02710292|3466576|P1|COMPLETED|Period 1, First 10 Days of Wear||46
1416729|NCT02710292|3466575|P2|STARTED|Period 1, First 10 Days of Wear||52
1416730|NCT02710292|3466576|P1|STARTED|Period 1, First 10 Days of Wear||47
1416731|NCT02710136|3466585|P2|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
1416732|NCT02710136|3466586|P1|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
1416733|NCT02710136|3466585|P2|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
1416734|NCT02710136|3466586|P1|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
1416735|NCT02710136|3466585|P2|STARTED|Phase 2 [Refer to Arm/Group Description]||25
1416736|NCT02710136|3466586|P1|STARTED|Phase 2 [Refer to Arm/Group Description]||0
1416737|NCT02710136|3466585|P2|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
1416738|NCT02710136|3466586|P1|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
1416739|NCT02710136|3466585|P2|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
1416740|NCT02710136|3466586|P1|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
1416741|NCT02710136|3466585|P2|STARTED|Phase 1b[Refer to Arm/Group Description]||0
1416742|NCT02710136|3466586|P1|STARTED|Phase 1b[Refer to Arm/Group Description]||4
1416743|NCT02710136|3466585|P2|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
1416744|NCT02710136|3466586|P1|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
1416745|NCT02710136|3466585|P2|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
1416746|NCT02710136|3466586|P1|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
1416747|NCT02710136|3466585|P2|STARTED|Phase 1a[Refer to Arm/Group Description]||0
1416748|NCT02710136|3466586|P1|STARTED|Phase 1a[Refer to Arm/Group Description]||10
1416749|NCT02710136|3466585|P2|NOT COMPLETED|Study Enrollment||0
1416750|NCT02710136|3466586|P1|NOT COMPLETED|Study Enrollment||0
1416751|NCT02710136|3466585|P2|COMPLETED|Study Enrollment||25
1416752|NCT02710136|3466586|P1|COMPLETED|Study Enrollment||10
1416753|NCT02710136|3466585|P2|STARTED|Study Enrollment||25
1416754|NCT02710136|3466586|P1|STARTED|Study Enrollment||10
1416755|NCT02709785|3466612|P3|NOT COMPLETED|Overall Study||1
1416756|NCT02709785|3466613|P2|NOT COMPLETED|Overall Study||2
1416757|NCT02709785|3466614|P1|NOT COMPLETED|Overall Study||1
1416758|NCT02709785|3466612|P3|COMPLETED|Overall Study||27
1416759|NCT02709785|3466613|P2|COMPLETED|Overall Study||26
1416760|NCT02709785|3466614|P1|COMPLETED|Overall Study||23
1416761|NCT02709785|3466612|P3|6 Weeks|Overall Study||27
1416762|NCT02709785|3466613|P2|6 Weeks|Overall Study||26
1416763|NCT02709785|3466614|P1|6 Weeks|Overall Study||23
1416764|NCT02709785|3466612|P3|3 Weeks|Overall Study||27
1416765|NCT02709785|3466613|P2|3 Weeks|Overall Study||27
1416766|NCT02709785|3466614|P1|3 Weeks|Overall Study||23
1416767|NCT02709785|3466612|P3|STARTED|Overall Study||28
1416768|NCT02709785|3466613|P2|STARTED|Overall Study||28
1416769|NCT02709785|3466614|P1|STARTED|Overall Study||24
1416770|NCT02709577|3466636|P4|NOT COMPLETED|Overall Study||0
1416771|NCT02709577|3466637|P3|NOT COMPLETED|Overall Study||2
1416772|NCT02709577|3466638|P2|NOT COMPLETED|Overall Study||5
1416773|NCT02709577|3466639|P1|NOT COMPLETED|Overall Study||2
1416774|NCT02709577|3466636|P4|COMPLETED|Overall Study||5
1416775|NCT02709577|3466637|P3|COMPLETED|Overall Study||4
1416776|NCT02709577|3466638|P2|COMPLETED|Overall Study||8
1416777|NCT02709577|3466639|P1|COMPLETED|Overall Study||10
1416778|NCT02709577|3466636|P4|STARTED|Overall Study||5
1416779|NCT02709577|3466637|P3|STARTED|Overall Study||6
1416780|NCT02709577|3466638|P2|STARTED|Overall Study||13
1416781|NCT02709577|3466639|P1|STARTED|Overall Study||12
1416782|NCT02709538|3466654|P3|NOT COMPLETED|Overall Study||20
1416783|NCT02709538|3466655|P2|NOT COMPLETED|Overall Study||28
1416784|NCT02709538|3466656|P1|NOT COMPLETED|Overall Study||113
1416785|NCT02709538|3466654|P3|COMPLETED|Overall Study||81
1416786|NCT02709538|3466655|P2|COMPLETED|Overall Study||72
1416787|NCT02709538|3466656|P1|COMPLETED|Overall Study||287
1416788|NCT02709538|3466654|P3|STARTED|Overall Study||101
1416789|NCT02709538|3466655|P2|STARTED|Overall Study||100
1416790|NCT02709538|3466656|P1|STARTED|Overall Study||400
1416791|NCT02709330|3466664|P2|NOT COMPLETED|Overall Study||0
1416792|NCT02709330|3466665|P1|NOT COMPLETED|Overall Study||13
1416793|NCT02709330|3466664|P2|COMPLETED|Overall Study||10
1416794|NCT02709330|3466665|P1|COMPLETED|Overall Study||37
1416795|NCT02709330|3466664|P2|STARTED|Overall Study||10
1416796|NCT02709330|3466665|P1|STARTED|Overall Study||50
1416797|NCT02709096|3466679|P2|NOT COMPLETED|Overall Study||1
1416798|NCT02709096|3466680|P1|NOT COMPLETED|Overall Study||1
1416799|NCT02709096|3466679|P2|COMPLETED|Overall Study||10
1416800|NCT02709096|3466680|P1|COMPLETED|Overall Study||21
1416801|NCT02709096|3466679|P2|STARTED|Overall Study||11
1416802|NCT02709096|3466680|P1|STARTED|Overall Study||22
1416803|NCT02709083|3466686|P1|NOT COMPLETED|Overall Study||7
1416804|NCT02709083|3466686|P1|COMPLETED|Overall Study||0
1416805|NCT02709083|3466686|P1|STARTED|Overall Study||7
1416806|NCT02709005|3466699|P2|NOT COMPLETED|Overall Study||1
1416807|NCT02709005|3466700|P1|NOT COMPLETED|Overall Study||4
1416808|NCT02709005|3466699|P2|COMPLETED|Overall Study||35
1416809|NCT02709005|3466700|P1|COMPLETED|Overall Study||69
1416810|NCT02709005|3466699|P2|STARTED|Overall Study||36
1416811|NCT02709005|3466700|P1|STARTED|Overall Study||73
1416812|NCT02708524|3466732|P4|NOT COMPLETED|Overall Study||0
1416813|NCT02708524|3466733|P3|NOT COMPLETED|Overall Study||3
1416814|NCT02708524|3466734|P2|NOT COMPLETED|Overall Study||6
1416815|NCT02708524|3466735|P1|NOT COMPLETED|Overall Study||4
1416816|NCT02708524|3466732|P4|COMPLETED|Overall Study||136
1416817|NCT02708524|3466733|P3|COMPLETED|Overall Study||134
1416818|NCT02708524|3466734|P2|COMPLETED|Overall Study||130
1416819|NCT02708524|3466735|P1|COMPLETED|Overall Study||135
1416820|NCT02708524|3466732|P4|STARTED|Overall Study||136
1416821|NCT02708524|3466733|P3|STARTED|Overall Study||137
1416822|NCT02708524|3466734|P2|STARTED|Overall Study||136
1416823|NCT02708524|3466735|P1|STARTED|Overall Study||139
1416824|NCT02708485|3466783|P2|NOT COMPLETED|Overall Study||2
1416825|NCT02708485|3466784|P1|NOT COMPLETED|Overall Study||3
1416826|NCT02708485|3466783|P2|COMPLETED|Overall Study||10
1416827|NCT02708485|3466784|P1|COMPLETED|Overall Study||0
1416828|NCT02708485|3466783|P2|STARTED|Overall Study||12
1416829|NCT02708485|3466784|P1|STARTED|Overall Study||3
1416830|NCT02708433|3466792|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
1416831|NCT02708433|3466793|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
1416832|NCT02708433|3466792|P2|COMPLETED|Second Intervention (Visit 2)||11
1416833|NCT02708433|3466793|P1|COMPLETED|Second Intervention (Visit 2)||12
1416834|NCT02708433|3466792|P2|STARTED|Second Intervention (Visit 2)||11
1416835|NCT02708433|3466793|P1|STARTED|Second Intervention (Visit 2)||12
1416836|NCT02708433|3466792|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
1416837|NCT02708433|3466793|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
1416838|NCT02708433|3466792|P2|COMPLETED|Washout (at Least 1 Week)||11
1416839|NCT02708433|3466793|P1|COMPLETED|Washout (at Least 1 Week)||12
1416840|NCT02708433|3466792|P2|STARTED|Washout (at Least 1 Week)||11
1416841|NCT02708433|3466793|P1|STARTED|Washout (at Least 1 Week)||12
1416842|NCT02708433|3466792|P2|NOT COMPLETED|First Intervention (Visit 1)||0
1416843|NCT02708433|3466793|P1|NOT COMPLETED|First Intervention (Visit 1)||0
1416844|NCT02708433|3466792|P2|COMPLETED|First Intervention (Visit 1)||11
1416845|NCT02708433|3466793|P1|COMPLETED|First Intervention (Visit 1)||12
1416846|NCT02708433|3466792|P2|STARTED|First Intervention (Visit 1)||11
1416847|NCT02708433|3466793|P1|STARTED|First Intervention (Visit 1)||12
1416848|NCT02708355|3466804|P3|NOT COMPLETED|Overall Study||0
1416849|NCT02708355|3466805|P2|NOT COMPLETED|Overall Study||0
1416850|NCT02708355|3466806|P1|NOT COMPLETED|Overall Study||1
1416851|NCT02708355|3466804|P3|COMPLETED|Overall Study||12
1416852|NCT02708355|3466805|P2|COMPLETED|Overall Study||22
1416853|NCT02708355|3466806|P1|COMPLETED|Overall Study||20
1416854|NCT02708355|3466804|P3|STARTED|Overall Study||12
1416855|NCT02708355|3466805|P2|STARTED|Overall Study||22
1416856|NCT02708355|3466806|P1|STARTED|Overall Study||21
1416857|NCT02708277|3466819|P2|NOT COMPLETED|Overall Study||4
1416858|NCT02708277|3466820|P1|NOT COMPLETED|Overall Study||7
1416859|NCT02708277|3466819|P2|COMPLETED|Overall Study||39
1416860|NCT02708277|3466820|P1|COMPLETED|Overall Study||43
1416861|NCT02708277|3466819|P2|STARTED|Overall Study||43
1416862|NCT02708277|3466820|P1|STARTED|Overall Study||50
1416863|NCT02708238|3466835|P3|NOT COMPLETED|Overall Study||3
1416864|NCT02708238|3466836|P2|NOT COMPLETED|Overall Study||1
1416865|NCT02708238|3466837|P1|NOT COMPLETED|Overall Study||0
1416866|NCT02708238|3466835|P3|COMPLETED|Overall Study||57
1416867|NCT02708238|3466836|P2|COMPLETED|Overall Study||59
1416868|NCT02708238|3466837|P1|COMPLETED|Overall Study||60
1416869|NCT02708238|3466835|P3|STARTED|Overall Study||60
1416870|NCT02708238|3466836|P2|STARTED|Overall Study||60
1416871|NCT02708238|3466837|P1|STARTED|Overall Study||60
1416872|NCT02708212|3466850|P2|NOT COMPLETED|Overall Study||0
1416873|NCT02708212|3466851|P1|NOT COMPLETED|Overall Study||0
1416874|NCT02708212|3466850|P2|COMPLETED|Overall Study||60
1416875|NCT02708212|3466851|P1|COMPLETED|Overall Study||60
1416876|NCT02708212|3466850|P2|STARTED|Overall Study||60
1416877|NCT02708212|3466851|P1|STARTED|Overall Study||60
1416878|NCT02708095|3466864|P3|NOT COMPLETED|Overall Study||18
1416879|NCT02708095|3466865|P2|NOT COMPLETED|Overall Study||19
1416880|NCT02708095|3466866|P1|NOT COMPLETED|Overall Study||22
1416881|NCT02708095|3466864|P3|COMPLETED|Overall Study||86
1416882|NCT02708095|3466865|P2|COMPLETED|Overall Study||86
1416883|NCT02708095|3466866|P1|COMPLETED|Overall Study||83
1416884|NCT02708095|3466864|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
1416885|NCT02708095|3466865|P2|Received at Least 1 Dose of Study Drug|Overall Study||105
1416886|NCT02708095|3466866|P1|Received at Least 1 Dose of Study Drug|Overall Study||105
1416887|NCT02708095|3466864|P3|STARTED|Overall Study||104
1416888|NCT02708095|3466865|P2|STARTED|Overall Study||105
1416889|NCT02708095|3466866|P1|STARTED|Overall Study||105
1416890|NCT02707952|3466891|P4|NOT COMPLETED|Overall Study||0
1416891|NCT02707952|3466892|P3|NOT COMPLETED|Overall Study||2
1416892|NCT02707952|3466893|P2|NOT COMPLETED|Overall Study||1
1416893|NCT02707952|3466894|P1|NOT COMPLETED|Overall Study||2
1416894|NCT02707952|3466891|P4|COMPLETED|Overall Study||10
1416895|NCT02707952|3466892|P3|COMPLETED|Overall Study||101
1416896|NCT02707952|3466893|P2|COMPLETED|Overall Study||52
1416897|NCT02707952|3466894|P1|COMPLETED|Overall Study||127
1416898|NCT02707952|3466891|P4|Participants Who Received Study Drug|Overall Study||10
1416899|NCT02707952|3466892|P3|Participants Who Received Study Drug|Overall Study||103
1416900|NCT02707952|3466893|P2|Participants Who Received Study Drug|Overall Study||52
1416901|NCT02707952|3466894|P1|Participants Who Received Study Drug|Overall Study||129
1416902|NCT02707952|3466891|P4|STARTED|Overall Study||10
1416903|NCT02707952|3466892|P3|STARTED|Overall Study||103
1416904|NCT02707952|3466893|P2|STARTED|Overall Study||53
1416905|NCT02707952|3466894|P1|STARTED|Overall Study||129
1416906|NCT02707640|3466915|P2|NOT COMPLETED|Overall Study||7
1416907|NCT02707640|3466916|P1|NOT COMPLETED|Overall Study||9
1416908|NCT02707640|3466915|P2|COMPLETED|Overall Study||55
1416909|NCT02707640|3466916|P1|COMPLETED|Overall Study||52
1416910|NCT02707640|3466915|P2|STARTED|Overall Study||62
1416911|NCT02707640|3466916|P1|STARTED|Overall Study||61
1416912|NCT02707601|3466936|P2|NOT COMPLETED|Overall Study||4
1416913|NCT02707601|3466937|P1|NOT COMPLETED|Overall Study||4
1416914|NCT02707601|3466936|P2|COMPLETED|Overall Study||70
1416915|NCT02707601|3466937|P1|COMPLETED|Overall Study||72
1416916|NCT02707601|3466936|P2|STARTED|Overall Study||74
1416917|NCT02707601|3466937|P1|STARTED|Overall Study||76
1416918|NCT02707172|3466951|P1|NOT COMPLETED|2nd Set of Experiment||0
1416919|NCT02707172|3466951|P1|COMPLETED|2nd Set of Experiment||28
1416920|NCT02707172|3466951|P1|STARTED|2nd Set of Experiment||28
1416921|NCT02707172|3466951|P1|NOT COMPLETED|Wash Out||0
1416922|NCT02707172|3466951|P1|COMPLETED|Wash Out||28
1416923|NCT02707172|3466951|P1|STARTED|Wash Out||28
1416924|NCT02707172|3466951|P1|NOT COMPLETED|1st Set of Experiment||0
1416925|NCT02707172|3466951|P1|COMPLETED|1st Set of Experiment||28
1416926|NCT02707172|3466951|P1|STARTED|1st Set of Experiment||28
1416927|NCT02706899|3466958|P2|NOT COMPLETED|Overall Study||6
1416928|NCT02706899|3466959|P1|NOT COMPLETED|Overall Study||13
1416929|NCT02706899|3466958|P2|COMPLETED|Overall Study||0
1416930|NCT02706899|3466959|P1|COMPLETED|Overall Study||0
1416931|NCT02706899|3466958|P2|STARTED|Overall Study||6
1416932|NCT02706899|3466959|P1|STARTED|Overall Study||13
1416933|NCT02706834|3466978|P11|NOT COMPLETED|Overall Study||1
1416934|NCT02706834|3466979|P10|NOT COMPLETED|Overall Study||1
1416935|NCT02706834|3466980|P9|NOT COMPLETED|Overall Study||0
1416936|NCT02706834|3466981|P8|NOT COMPLETED|Overall Study||0
1416937|NCT02706834|3466982|P7|NOT COMPLETED|Overall Study||0
1416938|NCT02706834|3466983|P6|NOT COMPLETED|Overall Study||0
1416939|NCT02706834|3466984|P5|NOT COMPLETED|Overall Study||1
1416940|NCT02706834|3466985|P4|NOT COMPLETED|Overall Study||0
1416941|NCT02706834|3466986|P3|NOT COMPLETED|Overall Study||1
1416942|NCT02706834|3466987|P2|NOT COMPLETED|Overall Study||1
1416943|NCT02706834|3466988|P1|NOT COMPLETED|Overall Study||2
1416944|NCT02706834|3466978|P11|COMPLETED|Overall Study||3
1416945|NCT02706834|3466979|P10|COMPLETED|Overall Study||3
1416946|NCT02706834|3466980|P9|COMPLETED|Overall Study||4
1416947|NCT02706834|3466981|P8|COMPLETED|Overall Study||3
1416948|NCT02706834|3466982|P7|COMPLETED|Overall Study||3
1416949|NCT02706834|3466983|P6|COMPLETED|Overall Study||3
1416950|NCT02706834|3466984|P5|COMPLETED|Overall Study||2
1416951|NCT02706834|3466985|P4|COMPLETED|Overall Study||3
1416952|NCT02706834|3466986|P3|COMPLETED|Overall Study||2
1416953|NCT02706834|3466987|P2|COMPLETED|Overall Study||2
1416954|NCT02706834|3466988|P1|COMPLETED|Overall Study|Completed = completed study drug|1
1416955|NCT02706834|3466978|P11|STARTED|Overall Study||4
1416956|NCT02706834|3466979|P10|STARTED|Overall Study||4
1416957|NCT02706834|3466980|P9|STARTED|Overall Study||4
1416958|NCT02706834|3466981|P8|STARTED|Overall Study||3
1416959|NCT02706834|3466982|P7|STARTED|Overall Study||3
1416960|NCT02706834|3466983|P6|STARTED|Overall Study||3
1416961|NCT02706834|3466984|P5|STARTED|Overall Study||3
1416962|NCT02706834|3466985|P4|STARTED|Overall Study||3
1416963|NCT02706834|3466986|P3|STARTED|Overall Study||3
1416964|NCT02706834|3466987|P2|STARTED|Overall Study||3
1416965|NCT02706834|3466988|P1|STARTED|Overall Study||3
1416966|NCT02706717|3467132|P2|NOT COMPLETED|Overall Study||11
1416967|NCT02706717|3467133|P1|NOT COMPLETED|Overall Study||1
1416968|NCT02706717|3467132|P2|COMPLETED|Overall Study||35
1416969|NCT02706717|3467133|P1|COMPLETED|Overall Study||46
1416970|NCT02706717|3467132|P2|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
1416971|NCT02706717|3467133|P1|STARTED|Overall Study||47
1416972|NCT02706327|3467154|P3|NOT COMPLETED|Overall Study||2
1416973|NCT02706327|3467155|P2|NOT COMPLETED|Overall Study||1
1416974|NCT02706327|3467156|P1|NOT COMPLETED|Overall Study||1
1416975|NCT02706327|3467154|P3|COMPLETED|Overall Study||21
1416976|NCT02706327|3467155|P2|COMPLETED|Overall Study||21
1416977|NCT02706327|3467156|P1|COMPLETED|Overall Study||21
1416978|NCT02706327|3467154|P3|STARTED|Overall Study||23
1416979|NCT02706327|3467155|P2|STARTED|Overall Study||22
1416980|NCT02706327|3467156|P1|STARTED|Overall Study||22
1416981|NCT02705807|3467176|P1|NOT COMPLETED|Overall Study||0
1416982|NCT02705807|3467176|P1|COMPLETED|Overall Study||10
1416983|NCT02705807|3467176|P1|STARTED|Overall Study||10
1416984|NCT02705716|3467208|P2|NOT COMPLETED|Overall Study||2
1416985|NCT02705716|3467209|P1|NOT COMPLETED|Overall Study||4
1416986|NCT02705716|3467208|P2|COMPLETED|Overall Study||68
1416987|NCT02705716|3467209|P1|COMPLETED|Overall Study||68
1416988|NCT02705716|3467208|P2|STARTED|Overall Study||70
1416989|NCT02705716|3467209|P1|STARTED|Overall Study||72
1416990|NCT02705365|3467221|P2|NOT COMPLETED|Overall Study||0
1416991|NCT02705365|3467222|P1|NOT COMPLETED|Overall Study||0
1416992|NCT02705365|3467221|P2|COMPLETED|Overall Study||800
1416993|NCT02705365|3467222|P1|COMPLETED|Overall Study||400
1416994|NCT02705365|3467221|P2|STARTED|Overall Study||800
1416995|NCT02705365|3467222|P1|STARTED|Overall Study||400
1416996|NCT02704702|3467236|P6|NOT COMPLETED|Overall Study||2
1416997|NCT02704702|3467237|P5|NOT COMPLETED|Overall Study||2
1416998|NCT02704702|3467238|P4|NOT COMPLETED|Overall Study||1
1416999|NCT02704702|3467239|P3|NOT COMPLETED|Overall Study||0
1417000|NCT02704702|3467240|P2|NOT COMPLETED|Overall Study||0
1417001|NCT02704702|3467241|P1|NOT COMPLETED|Overall Study||1
1417002|NCT02704702|3467236|P6|COMPLETED|Overall Study||4
1417003|NCT02704702|3467237|P5|COMPLETED|Overall Study||4
1417004|NCT02704702|3467238|P4|COMPLETED|Overall Study||5
1417005|NCT02704702|3467239|P3|COMPLETED|Overall Study||6
1417006|NCT02704702|3467240|P2|COMPLETED|Overall Study||6
1417007|NCT02704702|3467241|P1|COMPLETED|Overall Study||5
1417008|NCT02704702|3467236|P6|STARTED|Overall Study||6
1417009|NCT02704702|3467237|P5|STARTED|Overall Study||6
1417010|NCT02704702|3467238|P4|STARTED|Overall Study||6
1417011|NCT02704702|3467239|P3|STARTED|Overall Study||6
1417012|NCT02704702|3467240|P2|STARTED|Overall Study||6
1417013|NCT02704702|3467241|P1|STARTED|Overall Study||6
1417014|NCT02704689|3467273|P1|NOT COMPLETED|Overall Study||3
1417015|NCT02704689|3467273|P1|COMPLETED|Overall Study||6
1417016|NCT02704689|3467273|P1|STARTED|Overall Study||9
1417017|NCT02704104|3467290|P1|NOT COMPLETED|Overall Study||0
1417018|NCT02704104|3467290|P1|COMPLETED|Overall Study||46
1417019|NCT02704104|3467290|P1|STARTED|Overall Study||46
1417020|NCT02703948|3467304|P1|NOT COMPLETED|Overall Study||3
1417021|NCT02703948|3467304|P1|COMPLETED|Overall Study||57
1417022|NCT02703948|3467304|P1|STARTED|Overall Study||60
1417023|NCT02703909|3467312|P4|NOT COMPLETED|Overall Study||0
1417024|NCT02703909|3467313|P3|NOT COMPLETED|Overall Study||0
1417025|NCT02703909|3467314|P2|NOT COMPLETED|Overall Study||0
1417026|NCT02703909|3467315|P1|NOT COMPLETED|Overall Study||0
1417027|NCT02703909|3467312|P4|COMPLETED|Overall Study||35
1417028|NCT02703909|3467313|P3|COMPLETED|Overall Study||36
1417029|NCT02703909|3467314|P2|COMPLETED|Overall Study||37
1417030|NCT02703909|3467315|P1|COMPLETED|Overall Study||36
1417031|NCT02703909|3467312|P4|STARTED|Overall Study||35
1417032|NCT02703909|3467313|P3|STARTED|Overall Study||36
1417033|NCT02703909|3467314|P2|STARTED|Overall Study||37
1417034|NCT02703909|3467315|P1|STARTED|Overall Study||36
1417035|NCT02702999|3467333|P2|NOT COMPLETED|Overall Study||0
1417036|NCT02702999|3467334|P1|NOT COMPLETED|Overall Study||0
1417037|NCT02702999|3467333|P2|COMPLETED|Overall Study||104
1417038|NCT02702999|3467334|P1|COMPLETED|Overall Study||102
1417039|NCT02702999|3467333|P2|STARTED|Overall Study||104
1417040|NCT02702999|3467334|P1|STARTED|Overall Study||102
1417041|NCT02702921|3467352|P2|NOT COMPLETED|Overall Study||8
1417042|NCT02702921|3467353|P1|NOT COMPLETED|Overall Study||14
1417043|NCT02702921|3467352|P2|COMPLETED|Overall Study||95
1417044|NCT02702921|3467353|P1|COMPLETED|Overall Study||84
1417045|NCT02702921|3467352|P2|STARTED|Overall Study||103
1417046|NCT02702921|3467353|P1|STARTED|Overall Study||98
1417047|NCT02702193|3467363|P2|NOT COMPLETED|12 Month Follow up||18
1417048|NCT02702193|3467364|P1|NOT COMPLETED|12 Month Follow up||17
1417049|NCT02702193|3467363|P2|COMPLETED|12 Month Follow up||69
1417050|NCT02702193|3467364|P1|COMPLETED|12 Month Follow up||69
1417051|NCT02702193|3467363|P2|STARTED|12 Month Follow up||87
1417052|NCT02702193|3467364|P1|STARTED|12 Month Follow up||86
1417053|NCT02702193|3467363|P2|NOT COMPLETED|8 Month Follow up||18
1417054|NCT02702193|3467364|P1|NOT COMPLETED|8 Month Follow up||15
1417055|NCT02702193|3467363|P2|COMPLETED|8 Month Follow up||69
1417056|NCT02702193|3467364|P1|COMPLETED|8 Month Follow up||71
1417057|NCT02702193|3467363|P2|STARTED|8 Month Follow up||87
1417058|NCT02702193|3467364|P1|STARTED|8 Month Follow up||86
1417059|NCT02702193|3467363|P2|NOT COMPLETED|4 Month Follow up||18
1417060|NCT02702193|3467364|P1|NOT COMPLETED|4 Month Follow up||18
1417061|NCT02702193|3467363|P2|COMPLETED|4 Month Follow up||69
1417062|NCT02702193|3467364|P1|COMPLETED|4 Month Follow up||68
1417063|NCT02702193|3467363|P2|STARTED|4 Month Follow up||87
1417064|NCT02702193|3467364|P1|STARTED|4 Month Follow up||86
1417065|NCT02702193|3467363|P2|NOT COMPLETED|Baseline Assessment/Randomization||0
1417066|NCT02702193|3467364|P1|NOT COMPLETED|Baseline Assessment/Randomization||1
1417067|NCT02702193|3467363|P2|COMPLETED|Baseline Assessment/Randomization||87
1417068|NCT02702193|3467364|P1|COMPLETED|Baseline Assessment/Randomization||85
1417069|NCT02702193|3467363|P2|STARTED|Baseline Assessment/Randomization||87
1417070|NCT02702193|3467364|P1|STARTED|Baseline Assessment/Randomization||86
1417071|NCT02702011|3467392|P4|NOT COMPLETED|Overall Study||0
1417072|NCT02702011|3467393|P3|NOT COMPLETED|Overall Study||0
1417073|NCT02702011|3467394|P2|NOT COMPLETED|Overall Study||1
1417074|NCT02702011|3467395|P1|NOT COMPLETED|Overall Study||0
1417075|NCT02702011|3467392|P4|COMPLETED|Overall Study||12
1417076|NCT02702011|3467393|P3|COMPLETED|Overall Study||12
1417077|NCT02702011|3467394|P2|COMPLETED|Overall Study||12
1417078|NCT02702011|3467395|P1|COMPLETED|Overall Study||11
1417079|NCT02702011|3467392|P4|STARTED|Overall Study|Started are the treated patients.|12
1417080|NCT02702011|3467393|P3|STARTED|Overall Study|Started are the treated patients.|12
1417081|NCT02702011|3467394|P2|STARTED|Overall Study|Started are the treated patients.|13
1417082|NCT02702011|3467395|P1|STARTED|Overall Study|Started are the treated patients.|11
1417083|NCT02701985|3467407|P2|NOT COMPLETED|Overall Study||6
1417084|NCT02701985|3467408|P1|NOT COMPLETED|Overall Study||3
1417085|NCT02701985|3467407|P2|COMPLETED|Overall Study||32
1417086|NCT02701985|3467408|P1|COMPLETED|Overall Study||34
1417087|NCT02701985|3467407|P2|STARTED|Overall Study||38
1417088|NCT02701985|3467408|P1|STARTED|Overall Study||37
1417089|NCT02701634|3467451|P2|NOT COMPLETED|Overall Study||31
1417090|NCT02701634|3467452|P1|NOT COMPLETED|Overall Study||32
1417091|NCT02701634|3467451|P2|COMPLETED|Overall Study||2
1417092|NCT02701634|3467452|P1|COMPLETED|Overall Study||1
1417093|NCT02701634|3467451|P2|STARTED|Overall Study||33
1417094|NCT02701634|3467452|P1|STARTED|Overall Study||33
1417095|NCT02701556|3467482|P2|NOT COMPLETED|Overall Study||20
1417096|NCT02701556|3467483|P1|NOT COMPLETED|Overall Study||23
1417097|NCT02701556|3467482|P2|COMPLETED|Overall Study||178
1417098|NCT02701556|3467483|P1|COMPLETED|Overall Study||175
1417099|NCT02701556|3467482|P2|STARTED|Overall Study||198
1417100|NCT02701556|3467483|P1|STARTED|Overall Study||198
1417101|NCT02701387|3467489|P1|NOT COMPLETED|Overall Study||0
1417102|NCT02701387|3467489|P1|COMPLETED|Overall Study||7
1417103|NCT02701387|3467489|P1|STARTED|Overall Study||7
1417104|NCT02701361|3467497|P3|NOT COMPLETED|Overall Study||2
1417105|NCT02701361|3467498|P2|NOT COMPLETED|Overall Study||3
1417106|NCT02701361|3467499|P1|NOT COMPLETED|Overall Study||9
1417107|NCT02701361|3467497|P3|COMPLETED|Overall Study||16
1417108|NCT02701361|3467498|P2|COMPLETED|Overall Study||28
1417109|NCT02701361|3467499|P1|COMPLETED|Overall Study||22
1417110|NCT02701361|3467497|P3|STARTED|Overall Study||18
1417111|NCT02701361|3467498|P2|STARTED|Overall Study||31
1417112|NCT02701361|3467499|P1|STARTED|Overall Study||31
1417113|NCT02701296|3467540|P2|NOT COMPLETED|Overall Study||2
1417114|NCT02701296|3467541|P1|NOT COMPLETED|Overall Study||0
1417115|NCT02701296|3467540|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
1417116|NCT02701296|3467541|P1|COMPLETED|Overall Study||42
1417117|NCT02701296|3467540|P2|STARTED|Overall Study||38
1417118|NCT02701296|3467541|P1|STARTED|Overall Study||42
1417119|NCT02701270|3467557|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
1417120|NCT02701270|3467558|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
1417121|NCT02701270|3467559|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
1417122|NCT02701270|3467560|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
1417123|NCT02701270|3467557|P4|COMPLETED|Fourth Intervention at Visit 4||3
1417124|NCT02701270|3467558|P3|COMPLETED|Fourth Intervention at Visit 4||3
1417125|NCT02701270|3467559|P2|COMPLETED|Fourth Intervention at Visit 4||3
1417126|NCT02701270|3467560|P1|COMPLETED|Fourth Intervention at Visit 4||2
1417127|NCT02701270|3467557|P4|STARTED|Fourth Intervention at Visit 4||3
1417128|NCT02701270|3467558|P3|STARTED|Fourth Intervention at Visit 4||3
1417129|NCT02701270|3467559|P2|STARTED|Fourth Intervention at Visit 4||3
1417130|NCT02701270|3467560|P1|STARTED|Fourth Intervention at Visit 4||2
1417131|NCT02701270|3467557|P4|NOT COMPLETED|Third Intervention at Visit 3||0
1417132|NCT02701270|3467558|P3|NOT COMPLETED|Third Intervention at Visit 3||0
1417133|NCT02701270|3467559|P2|NOT COMPLETED|Third Intervention at Visit 3||0
1417134|NCT02701270|3467560|P1|NOT COMPLETED|Third Intervention at Visit 3||0
1417135|NCT02701270|3467557|P4|COMPLETED|Third Intervention at Visit 3||3
1417136|NCT02701270|3467558|P3|COMPLETED|Third Intervention at Visit 3||3
1417137|NCT02701270|3467559|P2|COMPLETED|Third Intervention at Visit 3||3
1417138|NCT02701270|3467560|P1|COMPLETED|Third Intervention at Visit 3||2
1417139|NCT02701270|3467557|P4|STARTED|Third Intervention at Visit 3||3
1417140|NCT02701270|3467558|P3|STARTED|Third Intervention at Visit 3||3
1417141|NCT02701270|3467559|P2|STARTED|Third Intervention at Visit 3||3
1417142|NCT02701270|3467560|P1|STARTED|Third Intervention at Visit 3||2
1417143|NCT02701270|3467557|P4|NOT COMPLETED|Second Intervention at Visit 2||0
1417144|NCT02701270|3467558|P3|NOT COMPLETED|Second Intervention at Visit 2||0
1417145|NCT02701270|3467559|P2|NOT COMPLETED|Second Intervention at Visit 2||0
1417146|NCT02701270|3467560|P1|NOT COMPLETED|Second Intervention at Visit 2||0
1417147|NCT02701270|3467557|P4|COMPLETED|Second Intervention at Visit 2||3
1417148|NCT02701270|3467558|P3|COMPLETED|Second Intervention at Visit 2||3
1417149|NCT02701270|3467559|P2|COMPLETED|Second Intervention at Visit 2||3
1417150|NCT02701270|3467560|P1|COMPLETED|Second Intervention at Visit 2||2
1417151|NCT02701270|3467557|P4|STARTED|Second Intervention at Visit 2||3
1417152|NCT02701270|3467558|P3|STARTED|Second Intervention at Visit 2||3
1417153|NCT02701270|3467559|P2|STARTED|Second Intervention at Visit 2||3
1417154|NCT02701270|3467560|P1|STARTED|Second Intervention at Visit 2||2
1417155|NCT02701270|3467557|P4|NOT COMPLETED|First Intervention at Visit 1||0
1417156|NCT02701270|3467558|P3|NOT COMPLETED|First Intervention at Visit 1||0
1417157|NCT02701270|3467559|P2|NOT COMPLETED|First Intervention at Visit 1||0
1417158|NCT02701270|3467560|P1|NOT COMPLETED|First Intervention at Visit 1||0
1417159|NCT02701270|3467557|P4|COMPLETED|First Intervention at Visit 1||3
1417160|NCT02701270|3467558|P3|COMPLETED|First Intervention at Visit 1||3
1417161|NCT02701270|3467559|P2|COMPLETED|First Intervention at Visit 1||3
1417162|NCT02701270|3467560|P1|COMPLETED|First Intervention at Visit 1||2
1417163|NCT02701270|3467557|P4|STARTED|First Intervention at Visit 1||3
1417164|NCT02701270|3467558|P3|STARTED|First Intervention at Visit 1||3
1417165|NCT02701270|3467559|P2|STARTED|First Intervention at Visit 1||3
1417166|NCT02701270|3467560|P1|STARTED|First Intervention at Visit 1||2
1417167|NCT02701049|3467577|P3|NOT COMPLETED|Overall Study||0
1417168|NCT02701049|3467578|P2|NOT COMPLETED|Overall Study||0
1417169|NCT02701049|3467579|P1|NOT COMPLETED|Overall Study||0
1417170|NCT02701049|3467577|P3|COMPLETED|Overall Study|Total patients included in analysis|198
1417171|NCT02701049|3467578|P2|COMPLETED|Overall Study|Total patients included in analysis|342
1417172|NCT02701049|3467579|P1|COMPLETED|Overall Study|Total patients included in analysis|209
1417173|NCT02701049|3467577|P3|STARTED|Overall Study|Patients who completed a follow-up survey|198
1417174|NCT02701049|3467578|P2|STARTED|Overall Study|Patients who completed a follow-up survey|342
1417175|NCT02701049|3467579|P1|STARTED|Overall Study|Patients who completed a follow-up survey|209
1417176|NCT02700997|3467591|P1|NOT COMPLETED|Overall Study||2
1417177|NCT02700997|3467591|P1|COMPLETED|Overall Study||15
1417178|NCT02700997|3467591|P1|STARTED|Overall Study||17
1417179|NCT02699892|3467595|P1|NOT COMPLETED|Overall Study||36
1417180|NCT02699892|3467595|P1|COMPLETED|Overall Study||94
1417181|NCT02699892|3467595|P1|STARTED|Overall Study||130
1417182|NCT02699684|3467600|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
1417183|NCT02699684|3467601|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
1417184|NCT02699684|3467600|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
1417185|NCT02699684|3467601|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
1417186|NCT02699684|3467600|P2|STARTED|Period 2, Second 30 Days of Wear||38
1417187|NCT02699684|3467601|P1|STARTED|Period 2, Second 30 Days of Wear||37
1417188|NCT02699684|3467600|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
1417189|NCT02699684|3467601|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
1417190|NCT02699684|3467600|P2|COMPLETED|Period 1, First 30 Days of Wear||38
1417191|NCT02699684|3467601|P1|COMPLETED|Period 1, First 30 Days of Wear||37
1417192|NCT02699684|3467600|P2|STARTED|Period 1, First 30 Days of Wear||38
1417193|NCT02699684|3467601|P1|STARTED|Period 1, First 30 Days of Wear||37
1417194|NCT02699632|3467611|P1|NOT COMPLETED|Overall Study||2
1417195|NCT02699632|3467611|P1|COMPLETED|Overall Study||358
1417196|NCT02699632|3467611|P1|STARTED|Overall Study||360
1417197|NCT02699593|3467618|P2|NOT COMPLETED|Period 2||2
1417198|NCT02699593|3467619|P1|NOT COMPLETED|Period 2||2
1417199|NCT02699593|3467618|P2|COMPLETED|Period 2||60
1417200|NCT02699593|3467619|P1|COMPLETED|Period 2||65
1417201|NCT02699593|3467618|P2|STARTED|Period 2||62
1417202|NCT02699593|3467619|P1|STARTED|Period 2||67
1417203|NCT02699593|3467618|P2|NOT COMPLETED|Period 1||7
1417204|NCT02699593|3467619|P1|NOT COMPLETED|Period 1||5
1417205|NCT02699593|3467618|P2|COMPLETED|Period 1||62
1417206|NCT02699593|3467619|P1|COMPLETED|Period 1||67
1417207|NCT02699593|3467618|P2|STARTED|Period 1||69
1417208|NCT02699593|3467619|P1|STARTED|Period 1||72
1417209|NCT02698566|3467627|P2|NOT COMPLETED|Overall Study||0
1417210|NCT02698566|3467628|P1|NOT COMPLETED|Overall Study||0
1417211|NCT02698566|3467627|P2|COMPLETED|Overall Study||3
1417212|NCT02698566|3467628|P1|COMPLETED|Overall Study||35
1417213|NCT02698566|3467627|P2|STARTED|Overall Study||3
1417214|NCT02698566|3467628|P1|STARTED|Overall Study||35
1417215|NCT02698436|3467636|P2|NOT COMPLETED|Overall Study||7
1417216|NCT02698436|3467637|P1|NOT COMPLETED|Overall Study||7
1417217|NCT02698436|3467636|P2|COMPLETED|Overall Study||51
1417218|NCT02698436|3467637|P1|COMPLETED|Overall Study||52
1417219|NCT02698436|3467636|P2|STARTED|Overall Study||58
1417220|NCT02698436|3467637|P1|STARTED|Overall Study||59
1417221|NCT02698423|3467677|P2|NOT COMPLETED|Overall Study||24
1417222|NCT02698423|3467678|P1|NOT COMPLETED|Overall Study||19
1417223|NCT02698423|3467677|P2|COMPLETED|Overall Study||307
1417224|NCT02698423|3467678|P1|COMPLETED|Overall Study||317
1417225|NCT02698423|3467677|P2|STARTED|Overall Study||331
1417226|NCT02698423|3467678|P1|STARTED|Overall Study||336
1417227|NCT02698176|3467689|P4|NOT COMPLETED|Overall Study||0
1417228|NCT02698176|3467690|P3|NOT COMPLETED|Overall Study||1
1417229|NCT02698176|3467691|P2|NOT COMPLETED|Overall Study||3
1417230|NCT02698176|3467692|P1|NOT COMPLETED|Overall Study||9
1417231|NCT02698176|3467689|P4|COMPLETED|Overall Study||0
1417232|NCT02698176|3467690|P3|COMPLETED|Overall Study||0
1417233|NCT02698176|3467691|P2|COMPLETED|Overall Study||0
1417234|NCT02698176|3467692|P1|COMPLETED|Overall Study||0
1417235|NCT02698176|3467689|P4|STARTED|Overall Study|No participants were enrolled in Part B.|0
1417236|NCT02698176|3467690|P3|STARTED|Overall Study||1
1417237|NCT02698176|3467691|P2|STARTED|Overall Study||3
1417238|NCT02698176|3467692|P1|STARTED|Overall Study||9
1417239|NCT02697890|3467729|P2|NOT COMPLETED|Overall Study||0
1417240|NCT02697890|3467730|P1|NOT COMPLETED|Overall Study||0
1417241|NCT02697890|3467729|P2|COMPLETED|Overall Study||14
1417242|NCT02697890|3467730|P1|COMPLETED|Overall Study||14
1417243|NCT02697890|3467729|P2|STARTED|Overall Study||14
1417244|NCT02697890|3467730|P1|STARTED|Overall Study||14
1417245|NCT02697188|3467742|P1|NOT COMPLETED|TE Period 5 - 800 mg BID||0
1417246|NCT02697188|3467742|P1|COMPLETED|TE Period 5 - 800 mg BID||12
1417247|NCT02697188|3467742|P1|STARTED|TE Period 5 - 800 mg BID||12
1417248|NCT02697188|3467742|P1|NOT COMPLETED|TU Period 4 - 400 BID||0
1417249|NCT02697188|3467742|P1|COMPLETED|TU Period 4 - 400 BID||12
1417250|NCT02697188|3467742|P1|STARTED|TU Period 4 - 400 BID||12
1417251|NCT02697188|3467742|P1|NOT COMPLETED|TU Period 3 - 200 mg BID||0
1417252|NCT02697188|3467742|P1|COMPLETED|TU Period 3 - 200 mg BID||12
1417253|NCT02697188|3467742|P1|STARTED|TU Period 3 - 200 mg BID||12
1417254|NCT02697188|3467742|P1|NOT COMPLETED|TU Period 2 – 200 mg QD||0
1417255|NCT02697188|3467742|P1|COMPLETED|TU Period 2 – 200 mg QD||12
1417256|NCT02697188|3467742|P1|STARTED|TU Period 2 – 200 mg QD||12
1417257|NCT02697188|3467742|P1|NOT COMPLETED|TE Period 1 - 400 mg QD||0
1417258|NCT02697188|3467742|P1|COMPLETED|TE Period 1 - 400 mg QD||12
1417259|NCT02697188|3467742|P1|STARTED|TE Period 1 - 400 mg QD||12
1417260|NCT02696317|3467751|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
1417261|NCT02696317|3467752|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
1417262|NCT02696317|3467751|P2|COMPLETED|Period 2, 10 Days of Wear||36
1417263|NCT02696317|3467752|P1|COMPLETED|Period 2, 10 Days of Wear||39
1417264|NCT02696317|3467751|P2|STARTED|Period 2, 10 Days of Wear||36
1417265|NCT02696317|3467752|P1|STARTED|Period 2, 10 Days of Wear||40
1417266|NCT02696317|3467751|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
1417267|NCT02696317|3467752|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
1417268|NCT02696317|3467751|P2|COMPLETED|Period 1, 10 Days of Wear||36
1417269|NCT02696317|3467752|P1|COMPLETED|Period 1, 10 Days of Wear||40
1417270|NCT02696317|3467751|P2|STARTED|Period 1, 10 Days of Wear||36
1417271|NCT02696317|3467752|P1|STARTED|Period 1, 10 Days of Wear||40
1417272|NCT02696317|3467751|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
1417273|NCT02696317|3467752|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
1417274|NCT02696317|3467751|P2|COMPLETED|Habitual, 10 Days of Wear||36
1417275|NCT02696317|3467752|P1|COMPLETED|Habitual, 10 Days of Wear||40
1417276|NCT02696317|3467751|P2|STARTED|Habitual, 10 Days of Wear||40
1417277|NCT02696317|3467752|P1|STARTED|Habitual, 10 Days of Wear||42
1417278|NCT02696291|3467768|P2|NOT COMPLETED|Overall Study||0
1417279|NCT02696291|3467769|P1|NOT COMPLETED|Overall Study||0
1417280|NCT02696291|3467768|P2|COMPLETED|Overall Study||2
1417281|NCT02696291|3467769|P1|COMPLETED|Overall Study||5
1417282|NCT02696291|3467768|P2|STARTED|Overall Study||2
1417283|NCT02696291|3467769|P1|STARTED|Overall Study||5
1417284|NCT02696226|3467796|P4|NOT COMPLETED|Overall Study||0
1417285|NCT02696226|3467797|P3|NOT COMPLETED|Overall Study||2
1417286|NCT02696226|3467798|P2|NOT COMPLETED|Overall Study||0
1417287|NCT02696226|3467799|P1|NOT COMPLETED|Overall Study||1
1417288|NCT02696226|3467796|P4|COMPLETED|Overall Study||0
1417289|NCT02696226|3467797|P3|COMPLETED|Overall Study||0
1417290|NCT02696226|3467798|P2|COMPLETED|Overall Study||0
1417291|NCT02696226|3467799|P1|COMPLETED|Overall Study||0
1417292|NCT02696226|3467796|P4|STARTED|Overall Study||0
1417293|NCT02696226|3467797|P3|STARTED|Overall Study||2
1417294|NCT02696226|3467798|P2|STARTED|Overall Study||0
1417295|NCT02696226|3467799|P1|STARTED|Overall Study||1
1417296|NCT02696083|3467809|P1|NOT COMPLETED|Overall Study||6
1417297|NCT02696083|3467809|P1|COMPLETED|Overall Study||13
1417298|NCT02696083|3467809|P1|STARTED|Overall Study||19
1417299|NCT02696070|3467820|P2|NOT COMPLETED|Overall Study||2
1417300|NCT02696070|3467821|P1|NOT COMPLETED|Overall Study||1
1417301|NCT02696070|3467820|P2|COMPLETED|Overall Study||12
1417302|NCT02696070|3467821|P1|COMPLETED|Overall Study||7
1417303|NCT02696070|3467820|P2|STARTED|Overall Study||14
1417304|NCT02696070|3467821|P1|STARTED|Overall Study||8
1417305|NCT02695719|3467829|P2|NOT COMPLETED|Overall Study||10
1417306|NCT02695719|3467830|P1|NOT COMPLETED|Overall Study||3
1417307|NCT02695719|3467829|P2|COMPLETED|Overall Study||72
1417308|NCT02695719|3467830|P1|COMPLETED|Overall Study||71
1417309|NCT02695719|3467829|P2|STARTED|Overall Study||82
1417310|NCT02695719|3467830|P1|STARTED|Overall Study||74
1417311|NCT02695446|3467848|P1|NOT COMPLETED|Overall Study||0
1417312|NCT02695446|3467848|P1|COMPLETED|Overall Study||12
1417313|NCT02695446|3467848|P1|STARTED|Overall Study||12
1417314|NCT02695290|3467853|P1|NOT COMPLETED|Overall Study||0
1417315|NCT02695290|3467853|P1|COMPLETED|Overall Study||1
1417316|NCT02695290|3467853|P1|STARTED|Overall Study||1
1417317|NCT02694978|3467861|P2|NOT COMPLETED|Overall Study||60
1417318|NCT02694978|3467862|P1|NOT COMPLETED|Overall Study||71
1417319|NCT02694978|3467861|P2|COMPLETED|Overall Study||948
1417320|NCT02694978|3467862|P1|COMPLETED|Overall Study||935
1417321|NCT02694978|3467861|P2|Received at Least 1 Dose of Study Drug|Overall Study||1000
1417322|NCT02694978|3467862|P1|Received at Least 1 Dose of Study Drug|Overall Study||997
1417323|NCT02694978|3467861|P2|STARTED|Overall Study||1008
1417324|NCT02694978|3467862|P1|STARTED|Overall Study||1006
1417325|NCT02694744|3467876|P2|NOT COMPLETED|Overall Study||5
1417326|NCT02694744|3467877|P1|NOT COMPLETED|Overall Study||6
1417327|NCT02694744|3467876|P2|COMPLETED|Overall Study||52
1417328|NCT02694744|3467877|P1|COMPLETED|Overall Study||51
1417329|NCT02694744|3467876|P2|ITT|Overall Study||55
1417330|NCT02694744|3467877|P1|ITT|Overall Study||57
1417331|NCT02694744|3467876|P2|Safety Population|Overall Study||56
1417332|NCT02694744|3467877|P1|Safety Population|Overall Study||57
1417333|NCT02694744|3467876|P2|STARTED|Overall Study||57
1417334|NCT02694744|3467877|P1|STARTED|Overall Study||57
1417335|NCT02694718|3467885|P1|NOT COMPLETED|Overall Study||2
1417336|NCT02694718|3467885|P1|COMPLETED|Overall Study||58
1417337|NCT02694718|3467885|P1|STARTED|Overall Study||60
1417338|NCT02694601|3467895|P1|NOT COMPLETED|Overall Study||0
1417339|NCT02694601|3467895|P1|COMPLETED|Overall Study||10
1417340|NCT02694601|3467895|P1|STARTED|Overall Study||10
1417341|NCT02694549|3467915|P1|NOT COMPLETED|Overall Study||2
1417342|NCT02694549|3467915|P1|COMPLETED|Overall Study||10
1417343|NCT02694549|3467915|P1|STARTED|Overall Study||12
1417344|NCT02694536|3467921|P1|NOT COMPLETED|Overall Study||80
1417345|NCT02694536|3467921|P1|COMPLETED|Overall Study||0
1417346|NCT02694536|3467921|P1|STARTED|Overall Study||80
1417347|NCT02694315|3467930|P1|NOT COMPLETED|Overall Study||0
1417348|NCT02694315|3467930|P1|COMPLETED|Overall Study||200
1417349|NCT02694315|3467930|P1|STARTED|Overall Study||200
1417350|NCT02694198|3467935|P1|NOT COMPLETED|Overall Study||0
1417351|NCT02694198|3467935|P1|COMPLETED|Overall Study||135
1417352|NCT02694198|3467935|P1|STARTED|Overall Study||135
1417353|NCT02693704|3467944|P4|NOT COMPLETED|Overall Study||0
1417354|NCT02693704|3467945|P3|NOT COMPLETED|Overall Study||0
1417355|NCT02693704|3467946|P2|NOT COMPLETED|Overall Study||0
1417356|NCT02693704|3467947|P1|NOT COMPLETED|Overall Study||0
1417357|NCT02693704|3467944|P4|COMPLETED|Overall Study||10
1417358|NCT02693704|3467945|P3|COMPLETED|Overall Study||10
1417359|NCT02693704|3467946|P2|COMPLETED|Overall Study||10
1417360|NCT02693704|3467947|P1|COMPLETED|Overall Study||10
1417361|NCT02693704|3467944|P4|STARTED|Overall Study||10
1417362|NCT02693704|3467945|P3|STARTED|Overall Study||10
1417363|NCT02693704|3467946|P2|STARTED|Overall Study||10
1417364|NCT02693704|3467947|P1|STARTED|Overall Study||10
1417365|NCT02693132|3467968|P3|NOT COMPLETED|Overall Study||1
1417366|NCT02693132|3467969|P2|NOT COMPLETED|Overall Study||1
1417367|NCT02693132|3467970|P1|NOT COMPLETED|Overall Study||1
1417368|NCT02693132|3467968|P3|COMPLETED|Overall Study||17
1417369|NCT02693132|3467969|P2|COMPLETED|Overall Study||16
1417370|NCT02693132|3467970|P1|COMPLETED|Overall Study||16
1417371|NCT02693132|3467968|P3|STARTED|Overall Study||18
1417372|NCT02693132|3467969|P2|STARTED|Overall Study||17
1417373|NCT02693132|3467970|P1|STARTED|Overall Study||17
1417374|NCT02693002|3467992|P2|NOT COMPLETED|Overall Study||0
1417375|NCT02693002|3467993|P1|NOT COMPLETED|Overall Study||1
1417376|NCT02693002|3467992|P2|COMPLETED|Overall Study||2
1417377|NCT02693002|3467993|P1|COMPLETED|Overall Study||1
1417378|NCT02693002|3467992|P2|STARTED|Overall Study||2
1417379|NCT02693002|3467993|P1|STARTED|Overall Study||2
1417380|NCT02692859|3468007|P2|NOT COMPLETED|Overall Study||95
1417381|NCT02692859|3468008|P1|NOT COMPLETED|Overall Study||84
1417382|NCT02692859|3468007|P2|COMPLETED|Overall Study||901
1417383|NCT02692859|3468008|P1|COMPLETED|Overall Study||912
1417384|NCT02692859|3468007|P2|STARTED|Overall Study||996
1417385|NCT02692859|3468008|P1|STARTED|Overall Study||996
1417386|NCT02692703|3468014|P1|NOT COMPLETED|Overall Study||2
1417387|NCT02692703|3468014|P1|COMPLETED|Overall Study||98
1417388|NCT02692703|3468014|P1|STARTED|Overall Study||100
1417389|NCT02692560|3468022|P2|NOT COMPLETED|Overall Study||6
1417390|NCT02692560|3468023|P1|NOT COMPLETED|Overall Study||0
1417391|NCT02692560|3468022|P2|COMPLETED|Overall Study||25
1417392|NCT02692560|3468023|P1|COMPLETED|Overall Study||29
1417393|NCT02692560|3468022|P2|STARTED|Overall Study||31
1417394|NCT02692560|3468023|P1|STARTED|Overall Study||29
1417395|NCT02692495|3468045|P2|NOT COMPLETED|Overall Study||0
1417396|NCT02692495|3468046|P1|NOT COMPLETED|Overall Study||0
1417397|NCT02692495|3468045|P2|COMPLETED|Overall Study||4
1417398|NCT02692495|3468046|P1|COMPLETED|Overall Study||12
1417399|NCT02692495|3468045|P2|STARTED|Overall Study||4
1417400|NCT02692495|3468046|P1|STARTED|Overall Study||12
1417401|NCT02691702|3468072|P11|NOT COMPLETED|Overall Study||2
1417402|NCT02691702|3468073|P10|NOT COMPLETED|Overall Study||2
1417403|NCT02691702|3468074|P9|NOT COMPLETED|Overall Study||2
1417404|NCT02691702|3468075|P8|NOT COMPLETED|Overall Study||0
1417405|NCT02691702|3468076|P7|NOT COMPLETED|Overall Study||3
1417406|NCT02691702|3468077|P6|NOT COMPLETED|Overall Study||3
1417407|NCT02691702|3468078|P5|NOT COMPLETED|Overall Study||0
1417408|NCT02691702|3468079|P4|NOT COMPLETED|Overall Study||0
1417409|NCT02691702|3468080|P3|NOT COMPLETED|Overall Study||1
1417410|NCT02691702|3468081|P2|NOT COMPLETED|Overall Study||1
1417411|NCT02691702|3468082|P1|NOT COMPLETED|Overall Study||2
1417412|NCT02691702|3468072|P11|COMPLETED|Overall Study||6
1417413|NCT02691702|3468073|P10|COMPLETED|Overall Study||6
1417414|NCT02691702|3468074|P9|COMPLETED|Overall Study||6
1417415|NCT02691702|3468075|P8|COMPLETED|Overall Study||12
1417416|NCT02691702|3468076|P7|COMPLETED|Overall Study||5
1417417|NCT02691702|3468077|P6|COMPLETED|Overall Study||5
1417418|NCT02691702|3468078|P5|COMPLETED|Overall Study||8
1417419|NCT02691702|3468079|P4|COMPLETED|Overall Study||8
1417420|NCT02691702|3468080|P3|COMPLETED|Overall Study||7
1417421|NCT02691702|3468081|P2|COMPLETED|Overall Study||10
1417422|NCT02691702|3468082|P1|COMPLETED|Overall Study||8
1417423|NCT02691702|3468072|P11|STARTED|Overall Study||8
1417424|NCT02691702|3468073|P10|STARTED|Overall Study||8
1417425|NCT02691702|3468074|P9|STARTED|Overall Study||8
1417426|NCT02691702|3468075|P8|STARTED|Overall Study||12
1417427|NCT02691702|3468076|P7|STARTED|Overall Study||8
1417428|NCT02691702|3468077|P6|STARTED|Overall Study||8
1417429|NCT02691702|3468078|P5|STARTED|Overall Study||8
1417430|NCT02691702|3468079|P4|STARTED|Overall Study||8
1417431|NCT02691702|3468080|P3|STARTED|Overall Study||8
1417432|NCT02691702|3468081|P2|STARTED|Overall Study||11
1417433|NCT02691702|3468082|P1|STARTED|Overall Study||10
1417434|NCT02691572|3468368|P2|NOT COMPLETED|Overall Study||1
1417435|NCT02691572|3468369|P1|NOT COMPLETED|Overall Study||1
1417436|NCT02691572|3468368|P2|COMPLETED|Overall Study||39
1417437|NCT02691572|3468369|P1|COMPLETED|Overall Study||39
1417438|NCT02691572|3468368|P2|STARTED|Overall Study||40
1417439|NCT02691572|3468369|P1|STARTED|Overall Study||40
1417440|NCT02691507|3468377|P2|NOT COMPLETED|Overall Study||1
1417441|NCT02691507|3468378|P1|NOT COMPLETED|Overall Study||0
1417442|NCT02691507|3468377|P2|COMPLETED|Overall Study||12
1417443|NCT02691507|3468378|P1|COMPLETED|Overall Study||40
1417444|NCT02691507|3468377|P2|STARTED|Overall Study||13
1417445|NCT02691507|3468378|P1|STARTED|Overall Study||40
1417446|NCT02691416|3468510|P2|NOT COMPLETED|Overall Study||0
1417447|NCT02691416|3468511|P1|NOT COMPLETED|Overall Study||0
1417448|NCT02691416|3468510|P2|COMPLETED|Overall Study||30
1417449|NCT02691416|3468511|P1|COMPLETED|Overall Study||30
1417450|NCT02691416|3468510|P2|STARTED|Overall Study||30
1417451|NCT02691416|3468511|P1|STARTED|Overall Study||30
1417452|NCT02691143|3468533|P2|NOT COMPLETED|Overall Study||0
1417453|NCT02691143|3468534|P1|NOT COMPLETED|Overall Study||0
1417454|NCT02691143|3468533|P2|COMPLETED|Overall Study||23
1417455|NCT02691143|3468534|P1|COMPLETED|Overall Study||27
1417456|NCT02691143|3468533|P2|STARTED|Overall Study||23
1417457|NCT02691143|3468534|P1|STARTED|Overall Study||27
1417458|NCT02690935|3468544|P2|NOT COMPLETED|Overall Study||0
1417459|NCT02690935|3468545|P1|NOT COMPLETED|Overall Study||0
1417460|NCT02690935|3468544|P2|COMPLETED|Overall Study|Count of participants|51
1417461|NCT02690935|3468545|P1|COMPLETED|Overall Study|Count of participants|51
1417462|NCT02690935|3468544|P2|STARTED|Overall Study|Count of participants|51
1417463|NCT02690935|3468545|P1|STARTED|Overall Study|Count of participants|51
1417464|NCT02690727|3468553|P2|NOT COMPLETED|Overall Study||2
1417465|NCT02690727|3468554|P1|NOT COMPLETED|Overall Study||2
1417466|NCT02690727|3468553|P2|COMPLETED|Overall Study||7
1417467|NCT02690727|3468554|P1|COMPLETED|Overall Study||7
1417468|NCT02690727|3468553|P2|STARTED|Overall Study||9
1417469|NCT02690727|3468554|P1|STARTED|Overall Study||9
1417470|NCT02690194|3468567|P3|NOT COMPLETED|Overall Study||0
1417471|NCT02690194|3468568|P2|NOT COMPLETED|Overall Study||4
1417472|NCT02690194|3468569|P1|NOT COMPLETED|Overall Study||1
1417473|NCT02690194|3468567|P3|COMPLETED|Overall Study||19
1417474|NCT02690194|3468568|P2|COMPLETED|Overall Study||14
1417475|NCT02690194|3468569|P1|COMPLETED|Overall Study||16
1417476|NCT02690194|3468567|P3|STARTED|Overall Study||19
1417477|NCT02690194|3468568|P2|STARTED|Overall Study||18
1417478|NCT02690194|3468569|P1|STARTED|Overall Study||17
1417479|NCT02690181|3468618|P6|NOT COMPLETED|Overall Study||0
1417480|NCT02690181|3468619|P5|NOT COMPLETED|Overall Study||0
1417481|NCT02690181|3468620|P4|NOT COMPLETED|Overall Study||0
1417482|NCT02690181|3468621|P3|NOT COMPLETED|Overall Study||0
1417483|NCT02690181|3468622|P2|NOT COMPLETED|Overall Study||0
1417484|NCT02690181|3468623|P1|NOT COMPLETED|Overall Study||0
1417485|NCT02690181|3468618|P6|COMPLETED|Overall Study||21
1417486|NCT02690181|3468619|P5|COMPLETED|Overall Study||6
1417487|NCT02690181|3468620|P4|COMPLETED|Overall Study||10
1417488|NCT02690181|3468621|P3|COMPLETED|Overall Study||15
1417489|NCT02690181|3468622|P2|COMPLETED|Overall Study||14
1417490|NCT02690181|3468623|P1|COMPLETED|Overall Study||14
1417491|NCT02690181|3468618|P6|STARTED|Overall Study||21
1417492|NCT02690181|3468619|P5|STARTED|Overall Study||6
1417493|NCT02690181|3468620|P4|STARTED|Overall Study||10
1417494|NCT02690181|3468621|P3|STARTED|Overall Study||15
1417495|NCT02690181|3468622|P2|STARTED|Overall Study||14
1417496|NCT02690181|3468623|P1|STARTED|Overall Study||14
1417497|NCT02689973|3468683|P4|NOT COMPLETED|Overall Study||53
1417498|NCT02689973|3468684|P3|NOT COMPLETED|Overall Study||72
1417499|NCT02689973|3468685|P2|NOT COMPLETED|Overall Study||49
1417500|NCT02689973|3468686|P1|NOT COMPLETED|Overall Study||54
1417501|NCT02689973|3468683|P4|COMPLETED|Overall Study||232
1417502|NCT02689973|3468684|P3|COMPLETED|Overall Study||279
1417503|NCT02689973|3468685|P2|COMPLETED|Overall Study||221
1417504|NCT02689973|3468686|P1|COMPLETED|Overall Study||257
1417505|NCT02689973|3468683|P4|STARTED|Overall Study||285
1417506|NCT02689973|3468684|P3|STARTED|Overall Study||351
1417507|NCT02689973|3468685|P2|STARTED|Overall Study||270
1417508|NCT02689973|3468686|P1|STARTED|Overall Study||311
1417509|NCT02689804|3468710|P2|NOT COMPLETED|Overall Study||0
1417510|NCT02689804|3468711|P1|NOT COMPLETED|Overall Study||2
1417511|NCT02689804|3468710|P2|COMPLETED|Overall Study||16
1417512|NCT02689804|3468711|P1|COMPLETED|Overall Study||16
1417513|NCT02689804|3468710|P2|STARTED|Overall Study||16
1417514|NCT02689804|3468711|P1|STARTED|Overall Study||18
1417515|NCT02689206|3468742|P5|NOT COMPLETED|Overall Study||8
1417516|NCT02689206|3468743|P4|NOT COMPLETED|Overall Study||4
1417517|NCT02689206|3468744|P3|NOT COMPLETED|Overall Study||4
1417518|NCT02689206|3468745|P2|NOT COMPLETED|Overall Study||1
1417519|NCT02689206|3468746|P1|NOT COMPLETED|Overall Study||3
1417520|NCT02689206|3468742|P5|COMPLETED|Overall Study||14
1417521|NCT02689206|3468743|P4|COMPLETED|Overall Study||17
1417522|NCT02689206|3468744|P3|COMPLETED|Overall Study||16
1417523|NCT02689206|3468745|P2|COMPLETED|Overall Study||19
1417524|NCT02689206|3468746|P1|COMPLETED|Overall Study||17
1417525|NCT02689206|3468742|P5|STARTED|Overall Study||22
1417526|NCT02689206|3468743|P4|STARTED|Overall Study||21
1417527|NCT02689206|3468744|P3|STARTED|Overall Study||20
1417528|NCT02689206|3468745|P2|STARTED|Overall Study||20
1417529|NCT02689206|3468746|P1|STARTED|Overall Study||20
1417530|NCT02688933|3468952|P2|NOT COMPLETED|Overall Study||37
1417531|NCT02688933|3468953|P1|NOT COMPLETED|Overall Study||29
1417532|NCT02688933|3468952|P2|COMPLETED|Overall Study||281
1417533|NCT02688933|3468953|P1|COMPLETED|Overall Study||291
1417534|NCT02688933|3468952|P2|STARTED|Overall Study||318
1417535|NCT02688933|3468953|P1|STARTED|Overall Study||320
1417536|NCT02688153|3468975|P2|NOT COMPLETED|Overall Study||7
1417537|NCT02688153|3468976|P1|NOT COMPLETED|Overall Study||15
1417538|NCT02688153|3468975|P2|COMPLETED|Overall Study||51
1417539|NCT02688153|3468976|P1|COMPLETED|Overall Study||47
1417540|NCT02688153|3468975|P2|Final Randomized Arm/Group|Overall Study||61
1417541|NCT02688153|3468976|P1|Final Randomized Arm/Group|Overall Study||59
1417542|NCT02688153|3468975|P2|STARTED|Overall Study||58
1417543|NCT02688153|3468976|P1|STARTED|Overall Study||62
1417544|NCT02687542|3469039|P5|NOT COMPLETED|Overall Study||20
1417545|NCT02687542|3469040|P4|NOT COMPLETED|Overall Study||10
1417546|NCT02687542|3469041|P3|NOT COMPLETED|Overall Study||14
1417547|NCT02687542|3469042|P2|NOT COMPLETED|Overall Study||12
1417548|NCT02687542|3469043|P1|NOT COMPLETED|Overall Study||8
1417549|NCT02687542|3469039|P5|COMPLETED|Overall Study||24
1417550|NCT02687542|3469040|P4|COMPLETED|Overall Study||3
1417551|NCT02687542|3469041|P3|COMPLETED|Overall Study||1
1417552|NCT02687542|3469042|P2|COMPLETED|Overall Study||1
1417553|NCT02687542|3469043|P1|COMPLETED|Overall Study||15
1417554|NCT02687542|3469039|P5|STARTED|Overall Study||44
1417555|NCT02687542|3469040|P4|STARTED|Overall Study||13
1417556|NCT02687542|3469041|P3|STARTED|Overall Study||15
1417557|NCT02687542|3469042|P2|STARTED|Overall Study||13
1417558|NCT02687542|3469043|P1|STARTED|Overall Study||23
1417559|NCT02687217|3469117|P2|NOT COMPLETED|Overall Study||0
1417560|NCT02687217|3469118|P1|NOT COMPLETED|Overall Study||0
1417561|NCT02687217|3469117|P2|COMPLETED|Overall Study||30
1417562|NCT02687217|3469118|P1|COMPLETED|Overall Study||30
1417563|NCT02687217|3469117|P2|STARTED|Overall Study||30
1417564|NCT02687217|3469118|P1|STARTED|Overall Study||30
1417565|NCT02687126|3469128|P1|NOT COMPLETED|Data Analysis||0
1417566|NCT02687126|3469128|P1|COMPLETED|Data Analysis||106
1417567|NCT02687126|3469128|P1|STARTED|Data Analysis||106
1417568|NCT02687126|3469128|P1|NOT COMPLETED|Data Collection||0
1417569|NCT02687126|3469128|P1|COMPLETED|Data Collection||106
1417570|NCT02687126|3469128|P1|STARTED|Data Collection||106
1417571|NCT02686437|3469137|P2|NOT COMPLETED|Overall Study||8
1417572|NCT02686437|3469138|P1|NOT COMPLETED|Overall Study||3
1417573|NCT02686437|3469137|P2|COMPLETED|Overall Study||12
1417574|NCT02686437|3469138|P1|COMPLETED|Overall Study||13
1417575|NCT02686437|3469137|P2|STARTED|Overall Study||20
1417576|NCT02686437|3469138|P1|STARTED|Overall Study||16
1417577|NCT02685488|3469148|P2|NOT COMPLETED|Overall Study||1
1417578|NCT02685488|3469149|P1|NOT COMPLETED|Overall Study||0
1417579|NCT02685488|3469148|P2|COMPLETED|Overall Study||13
1417580|NCT02685488|3469149|P1|COMPLETED|Overall Study||12
1417581|NCT02685488|3469148|P2|STARTED|Overall Study||14
1417582|NCT02685488|3469149|P1|STARTED|Overall Study||12
1417583|NCT02685202|3469163|P1|NOT COMPLETED|Overall Study||9
1417584|NCT02685202|3469163|P1|COMPLETED|Overall Study||0
1417585|NCT02685202|3469163|P1|STARTED|Overall Study||9
1417586|NCT02684942|3469169|P6|NOT COMPLETED|Overall Study||0
1417587|NCT02684942|3469170|P5|NOT COMPLETED|Overall Study||0
1417588|NCT02684942|3469171|P4|NOT COMPLETED|Overall Study||0
1417589|NCT02684942|3469172|P3|NOT COMPLETED|Overall Study||0
1417590|NCT02684942|3469173|P2|NOT COMPLETED|Overall Study||0
1417591|NCT02684942|3469174|P1|NOT COMPLETED|Overall Study||0
1417592|NCT02684942|3469169|P6|COMPLETED|Overall Study||6
1417593|NCT02684942|3469170|P5|COMPLETED|Overall Study||6
1417594|NCT02684942|3469171|P4|COMPLETED|Overall Study||7
1417595|NCT02684942|3469172|P3|COMPLETED|Overall Study||7
1417596|NCT02684942|3469173|P2|COMPLETED|Overall Study||7
1417597|NCT02684942|3469174|P1|COMPLETED|Overall Study||7
1417598|NCT02684942|3469169|P6|STARTED|Overall Study||6
1417599|NCT02684942|3469170|P5|STARTED|Overall Study||6
1417600|NCT02684942|3469171|P4|STARTED|Overall Study||7
1417601|NCT02684942|3469172|P3|STARTED|Overall Study||7
1417602|NCT02684942|3469173|P2|STARTED|Overall Study||7
1417603|NCT02684942|3469174|P1|STARTED|Overall Study||7
1417604|NCT02684630|3469190|P2|NOT COMPLETED|Overall Study||3
1417605|NCT02684630|3469191|P1|NOT COMPLETED|Overall Study||5
1417606|NCT02684630|3469190|P2|COMPLETED|Overall Study||60
1417607|NCT02684630|3469191|P1|COMPLETED|Overall Study||60
1417608|NCT02684630|3469190|P2|STARTED|Overall Study||63
1417609|NCT02684630|3469191|P1|STARTED|Overall Study||65
1417610|NCT02684604|3469201|P2|NOT COMPLETED|Overall Study||0
1417611|NCT02684604|3469202|P1|NOT COMPLETED|Overall Study||0
1417612|NCT02684604|3469201|P2|COMPLETED|Overall Study||44
1417613|NCT02684604|3469202|P1|COMPLETED|Overall Study||44
1417614|NCT02684604|3469201|P2|STARTED|Overall Study||44
1417615|NCT02684604|3469202|P1|STARTED|Overall Study||44
1417616|NCT02684396|3469214|P6|NOT COMPLETED|Overall Study||0
1417617|NCT02684396|3469215|P5|NOT COMPLETED|Overall Study||0
1417618|NCT02684396|3469216|P4|NOT COMPLETED|Overall Study||0
1417619|NCT02684396|3469217|P3|NOT COMPLETED|Overall Study||0
1417620|NCT02684396|3469218|P2|NOT COMPLETED|Overall Study||0
1417621|NCT02684396|3469219|P1|NOT COMPLETED|Overall Study||0
1417622|NCT02684396|3469214|P6|COMPLETED|Overall Study||10
1417623|NCT02684396|3469215|P5|COMPLETED|Overall Study||5
1417624|NCT02684396|3469216|P4|COMPLETED|Overall Study||6
1417625|NCT02684396|3469217|P3|COMPLETED|Overall Study||6
1417626|NCT02684396|3469218|P2|COMPLETED|Overall Study||6
1417627|NCT02684396|3469219|P1|COMPLETED|Overall Study||6
1417628|NCT02684396|3469214|P6|STARTED|Overall Study||10
1417629|NCT02684396|3469215|P5|STARTED|Overall Study||5
1417630|NCT02684396|3469216|P4|STARTED|Overall Study||6
1417631|NCT02684396|3469217|P3|STARTED|Overall Study||6
1417632|NCT02684396|3469218|P2|STARTED|Overall Study||6
1417633|NCT02684396|3469219|P1|STARTED|Overall Study||6
1417634|NCT02684188|3469273|P2|NOT COMPLETED|Overall Study||3
1417635|NCT02684188|3469274|P1|NOT COMPLETED|Overall Study||2
1417636|NCT02684188|3469273|P2|COMPLETED|Overall Study||47
1417637|NCT02684188|3469274|P1|COMPLETED|Overall Study||75
1417638|NCT02684188|3469273|P2|STARTED|Overall Study||50
1417639|NCT02684188|3469274|P1|STARTED|Overall Study||77
1417640|NCT02683954|3469300|P2|NOT COMPLETED|Overall Study||0
1417641|NCT02683954|3469301|P1|NOT COMPLETED|Overall Study||0
1417642|NCT02683954|3469300|P2|COMPLETED|Overall Study||30
1417643|NCT02683954|3469301|P1|COMPLETED|Overall Study||30
1417644|NCT02683954|3469300|P2|STARTED|Overall Study||30
1417645|NCT02683954|3469301|P1|STARTED|Overall Study||30
1417646|NCT02683785|3469309|P2|NOT COMPLETED|Overall Study||4
1417647|NCT02683785|3469310|P1|NOT COMPLETED|Overall Study||1
1417648|NCT02683785|3469309|P2|COMPLETED|Overall Study||18
1417649|NCT02683785|3469310|P1|COMPLETED|Overall Study||21
1417650|NCT02683785|3469309|P2|STARTED|Overall Study||22
1417651|NCT02683785|3469310|P1|STARTED|Overall Study||22
1417652|NCT02683746|3469349|P2|NOT COMPLETED|Overall Study||14
1417653|NCT02683746|3469350|P1|NOT COMPLETED|Overall Study||16
1417654|NCT02683746|3469349|P2|COMPLETED|Overall Study||140
1417655|NCT02683746|3469350|P1|COMPLETED|Overall Study||138
1417656|NCT02683746|3469349|P2|STARTED|Overall Study||154
1417657|NCT02683746|3469350|P1|STARTED|Overall Study||154
1417658|NCT02683707|3469380|P2|NOT COMPLETED|Overall Study||0
1417659|NCT02683707|3469381|P1|NOT COMPLETED|Overall Study||0
1417660|NCT02683707|3469380|P2|COMPLETED|Overall Study||107
1417661|NCT02683707|3469381|P1|COMPLETED|Overall Study||105
1417662|NCT02683707|3469380|P2|STARTED|Overall Study||107
1417663|NCT02683707|3469381|P1|STARTED|Overall Study||105
1417664|NCT02683577|3469396|P3|NOT COMPLETED|Overall Study||0
1417665|NCT02683577|3469397|P2|NOT COMPLETED|Overall Study||0
1417666|NCT02683577|3469398|P1|NOT COMPLETED|Overall Study||0
1417667|NCT02683577|3469396|P3|COMPLETED|Overall Study||8
1417668|NCT02683577|3469397|P2|COMPLETED|Overall Study||8
1417669|NCT02683577|3469398|P1|COMPLETED|Overall Study||8
1417670|NCT02683577|3469396|P3|STARTED|Overall Study||8
1417671|NCT02683577|3469397|P2|STARTED|Overall Study||8
1417672|NCT02683577|3469398|P1|STARTED|Overall Study||8
1417673|NCT02683161|3469444|P1|NOT COMPLETED|Overall Study||0
1417674|NCT02683161|3469444|P1|COMPLETED|Overall Study||5
1417675|NCT02683161|3469444|P1|STARTED|Overall Study||5
1417676|NCT02683109|3469450|P2|NOT COMPLETED|Overall Study||0
1417677|NCT02683109|3469451|P1|NOT COMPLETED|Overall Study||1
1417678|NCT02683109|3469450|P2|COMPLETED|Overall Study||111
1417679|NCT02683109|3469451|P1|COMPLETED|Overall Study||109
1417680|NCT02683109|3469450|P2|STARTED|Overall Study||111
1417681|NCT02683109|3469451|P1|STARTED|Overall Study||110
1417682|NCT02682498|3469464|P2|NOT COMPLETED|Overall Study||0
1417683|NCT02682498|3469465|P1|NOT COMPLETED|Overall Study||0
1417684|NCT02682498|3469464|P2|COMPLETED|Overall Study||20
1417685|NCT02682498|3469465|P1|COMPLETED|Overall Study||18
1417686|NCT02682498|3469464|P2|STARTED|Overall Study||20
1417687|NCT02682498|3469465|P1|STARTED|Overall Study||18
1417688|NCT02682381|3469482|P3|NOT COMPLETED|Overall Study||0
1417689|NCT02682381|3469483|P2|NOT COMPLETED|Overall Study||0
1417690|NCT02682381|3469484|P1|NOT COMPLETED|Overall Study||0
1417691|NCT02682381|3469482|P3|COMPLETED|Overall Study||9
1417692|NCT02682381|3469483|P2|COMPLETED|Overall Study||26
1417693|NCT02682381|3469484|P1|COMPLETED|Overall Study||24
1417694|NCT02682381|3469482|P3|STARTED|Overall Study||9
1417695|NCT02682381|3469483|P2|STARTED|Overall Study||26
1417696|NCT02682381|3469484|P1|STARTED|Overall Study||24
1417697|NCT02681510|3469549|P1|NOT COMPLETED|Overall Study||10
1417698|NCT02681510|3469549|P1|COMPLETED|Overall Study||26
1417699|NCT02681510|3469549|P1|STARTED|Overall Study||36
1417700|NCT02681458|3469558|P2|NOT COMPLETED|Overall Study||656
1417701|NCT02681458|3469559|P1|NOT COMPLETED|Overall Study||645
1417702|NCT02681458|3469558|P2|COMPLETED|Overall Study||62
1417703|NCT02681458|3469559|P1|COMPLETED|Overall Study||73
1417704|NCT02681458|3469558|P2|STARTED|Overall Study||718
1417705|NCT02681458|3469559|P1|STARTED|Overall Study||718
1417706|NCT02681172|3469565|P1|NOT COMPLETED|Overall Study||13
1417707|NCT02681172|3469565|P1|COMPLETED|Overall Study||205
1417708|NCT02681172|3469565|P1|Per Protocol Set|Overall Study||205
1417709|NCT02681172|3469565|P1|Full Analysis Set|Overall Study||205
1417710|NCT02681172|3469565|P1|Safety Analysis Set|Overall Study||205
1417711|NCT02681172|3469565|P1|STARTED|Overall Study||218
1417712|NCT02681094|3469579|P3|NOT COMPLETED|2 - Enrolled Participants Set||54
1417713|NCT02681094|3469580|P2|NOT COMPLETED|2 - Enrolled Participants Set||41
1417714|NCT02681094|3469581|P1|NOT COMPLETED|2 - Enrolled Participants Set||40
1417715|NCT02681094|3469579|P3|COMPLETED|2 - Enrolled Participants Set||248
1417716|NCT02681094|3469580|P2|COMPLETED|2 - Enrolled Participants Set||261
1417717|NCT02681094|3469581|P1|COMPLETED|2 - Enrolled Participants Set||261
1417718|NCT02681094|3469579|P3|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
1417719|NCT02681094|3469580|P2|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
1417720|NCT02681094|3469581|P1|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
1417721|NCT02681094|3469579|P3|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
1417722|NCT02681094|3469580|P2|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
1417723|NCT02681094|3469581|P1|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
1417724|NCT02681094|3469579|P3|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
1417725|NCT02681094|3469580|P2|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
1417726|NCT02681094|3469581|P1|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
1417727|NCT02681094|3469579|P3|COMPLETED|1 -Modified Enrolled Participants Set||243
1417728|NCT02681094|3469580|P2|COMPLETED|1 -Modified Enrolled Participants Set||255
1417729|NCT02681094|3469581|P1|COMPLETED|1 -Modified Enrolled Participants Set||256
1417730|NCT02681094|3469579|P3|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
1417731|NCT02681094|3469580|P2|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
1417732|NCT02681094|3469581|P1|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
1417733|NCT02681094|3469579|P3|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
1417734|NCT02681094|3469580|P2|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
1417735|NCT02681094|3469581|P1|STARTED|1 -Modified Enrolled Participants Set||293
1417736|NCT02680847|3469600|P3|NOT COMPLETED|Overall Study||3
1417737|NCT02680847|3469601|P2|NOT COMPLETED|Overall Study||3
1417738|NCT02680847|3469602|P1|NOT COMPLETED|Overall Study||5
1417739|NCT02680847|3469600|P3|COMPLETED|Overall Study||4
1417740|NCT02680847|3469601|P2|COMPLETED|Overall Study||6
1417741|NCT02680847|3469602|P1|COMPLETED|Overall Study||11
1417742|NCT02680847|3469600|P3|STARTED|Overall Study||7
1417743|NCT02680847|3469601|P2|STARTED|Overall Study||9
1417744|NCT02680847|3469602|P1|STARTED|Overall Study||16
1417745|NCT02680301|3469639|P2|NOT COMPLETED|Overall Study||1
1417746|NCT02680301|3469640|P1|NOT COMPLETED|Overall Study||0
1417747|NCT02680301|3469639|P2|COMPLETED|Overall Study||17
1417748|NCT02680301|3469640|P1|COMPLETED|Overall Study||22
1417749|NCT02680301|3469639|P2|STARTED|Overall Study||18
1417750|NCT02680301|3469640|P1|STARTED|Overall Study||22
1417751|NCT02679976|3469647|P1|NOT COMPLETED|Overall Study||0
1417752|NCT02679976|3469647|P1|COMPLETED|Overall Study||30
1417753|NCT02679976|3469647|P1|Myopes|Overall Study||14
1417754|NCT02679976|3469647|P1|Hyperopes|Overall Study||16
1417755|NCT02679976|3469647|P1|STARTED|Overall Study||30
1417756|NCT02679911|3469656|P1|NOT COMPLETED|Overall Study||0
1417757|NCT02679911|3469656|P1|COMPLETED|Overall Study||20
1417758|NCT02679911|3469656|P1|STARTED|Overall Study|Intra-individual study|20
1417759|NCT02679729|3469672|P9|NOT COMPLETED|Overall Study||0
1417760|NCT02679729|3469673|P8|NOT COMPLETED|Overall Study||0
1417761|NCT02679729|3469674|P7|NOT COMPLETED|Overall Study||1
1417762|NCT02679729|3469675|P6|NOT COMPLETED|Overall Study||0
1417763|NCT02679729|3469676|P5|NOT COMPLETED|Overall Study||1
1417764|NCT02679729|3469677|P4|NOT COMPLETED|Overall Study||0
1417765|NCT02679729|3469678|P3|NOT COMPLETED|Overall Study||0
1417766|NCT02679729|3469679|P2|NOT COMPLETED|Overall Study||2
1417767|NCT02679729|3469680|P1|NOT COMPLETED|Overall Study||0
1417768|NCT02679729|3469672|P9|COMPLETED|Overall Study||6
1417769|NCT02679729|3469673|P8|COMPLETED|Overall Study||14
1417770|NCT02679729|3469674|P7|COMPLETED|Overall Study||5
1417771|NCT02679729|3469675|P6|COMPLETED|Overall Study||6
1417772|NCT02679729|3469676|P5|COMPLETED|Overall Study||5
1417773|NCT02679729|3469677|P4|COMPLETED|Overall Study||6
1417774|NCT02679729|3469678|P3|COMPLETED|Overall Study||6
1417775|NCT02679729|3469679|P2|COMPLETED|Overall Study||5
1417776|NCT02679729|3469680|P1|COMPLETED|Overall Study||6
1417777|NCT02679729|3469672|P9|STARTED|Overall Study||6
1417778|NCT02679729|3469673|P8|STARTED|Overall Study||14
1417779|NCT02679729|3469674|P7|STARTED|Overall Study||6
1417780|NCT02679729|3469675|P6|STARTED|Overall Study||6
1417781|NCT02679729|3469676|P5|STARTED|Overall Study||6
1417782|NCT02679729|3469677|P4|STARTED|Overall Study||6
1417783|NCT02679729|3469678|P3|STARTED|Overall Study||6
1417784|NCT02679729|3469679|P2|STARTED|Overall Study||7
1417785|NCT02679729|3469680|P1|STARTED|Overall Study||6
1417786|NCT02679469|3469784|P1|NOT COMPLETED|Overall Study||0
1417787|NCT02679469|3469784|P1|COMPLETED|Overall Study||7
1417788|NCT02679469|3469784|P1|STARTED|Overall Study||7
1417789|NCT02678923|3469792|P2|NOT COMPLETED|Overall Study||5
1417790|NCT02678923|3469793|P1|NOT COMPLETED|Overall Study||6
1417791|NCT02678923|3469792|P2|COMPLETED|Overall Study||62
1417792|NCT02678923|3469793|P1|COMPLETED|Overall Study||53
1417793|NCT02678923|3469792|P2|mITT Population|Overall Study||61
1417794|NCT02678923|3469793|P1|mITT Population|Overall Study||52
1417795|NCT02678923|3469792|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
1417796|NCT02678923|3469793|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
1417797|NCT02678923|3469792|P2|STARTED|Overall Study||67
1417798|NCT02678923|3469793|P1|STARTED|Overall Study||59
1417799|NCT02678676|3469809|P2|NOT COMPLETED|Overall Study||872
1417800|NCT02678676|3469810|P1|NOT COMPLETED|Overall Study||888
1417801|NCT02678676|3469809|P2|COMPLETED|Overall Study||907
1417802|NCT02678676|3469810|P1|COMPLETED|Overall Study||932
1417803|NCT02678676|3469809|P2|STARTED|Overall Study||1779
1417804|NCT02678676|3469810|P1|STARTED|Overall Study||1820
1417805|NCT02678286|3469820|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
1417806|NCT02678286|3469821|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
1417807|NCT02678286|3469820|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
1417808|NCT02678286|3469821|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
1417809|NCT02678286|3469820|P2|STARTED|Study Overall (28 Day Follow-Up)||109
1417810|NCT02678286|3469821|P1|STARTED|Study Overall (28 Day Follow-Up)||110
1417811|NCT02678286|3469820|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
1417812|NCT02678286|3469821|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
1417813|NCT02678286|3469820|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
1417814|NCT02678286|3469821|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
1417815|NCT02678286|3469820|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
1417816|NCT02678286|3469821|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
1417817|NCT02678039|3469853|P2|NOT COMPLETED|Overall Study||0
1417818|NCT02678039|3469854|P1|NOT COMPLETED|Overall Study||0
1417819|NCT02678039|3469853|P2|COMPLETED|Overall Study||47
1417820|NCT02678039|3469854|P1|COMPLETED|Overall Study||53
1417821|NCT02678039|3469853|P2|STARTED|Overall Study||47
1417822|NCT02678039|3469854|P1|STARTED|Overall Study||53
1417823|NCT02677844|3469870|P7|NOT COMPLETED|Period 7||0
1417824|NCT02677844|3469871|P6|NOT COMPLETED|Period 7||0
1417825|NCT02677844|3469872|P5|NOT COMPLETED|Period 7||0
1417826|NCT02677844|3469873|P4|NOT COMPLETED|Period 7||0
1417827|NCT02677844|3469874|P3|NOT COMPLETED|Period 7||0
1417828|NCT02677844|3469875|P2|NOT COMPLETED|Period 7||0
1417829|NCT02677844|3469876|P1|NOT COMPLETED|Period 7||0
1417830|NCT02677844|3469870|P7|COMPLETED|Period 7||4
1417831|NCT02677844|3469871|P6|COMPLETED|Period 7||4
1417832|NCT02677844|3469872|P5|COMPLETED|Period 7||7
1417833|NCT02677844|3469873|P4|COMPLETED|Period 7||0
1417834|NCT02677844|3469874|P3|COMPLETED|Period 7||0
1417835|NCT02677844|3469875|P2|COMPLETED|Period 7||0
1417836|NCT02677844|3469876|P1|COMPLETED|Period 7||0
1417837|NCT02677844|3469870|P7|STARTED|Period 7||4
1417838|NCT02677844|3469871|P6|STARTED|Period 7||4
1417839|NCT02677844|3469872|P5|STARTED|Period 7||7
1417840|NCT02677844|3469873|P4|STARTED|Period 7||0
1417841|NCT02677844|3469874|P3|STARTED|Period 7||0
1417842|NCT02677844|3469875|P2|STARTED|Period 7||0
1417843|NCT02677844|3469876|P1|STARTED|Period 7||0
1417844|NCT02677844|3469870|P7|NOT COMPLETED|Period 6||0
1417845|NCT02677844|3469871|P6|NOT COMPLETED|Period 6||0
1417846|NCT02677844|3469872|P5|NOT COMPLETED|Period 6||0
1417847|NCT02677844|3469873|P4|NOT COMPLETED|Period 6||0
1417848|NCT02677844|3469874|P3|NOT COMPLETED|Period 6||0
1417849|NCT02677844|3469875|P2|NOT COMPLETED|Period 6||0
1417850|NCT02677844|3469876|P1|NOT COMPLETED|Period 6||0
1417851|NCT02677844|3469870|P7|COMPLETED|Period 6||4
1417852|NCT02677844|3469871|P6|COMPLETED|Period 6||4
1417853|NCT02677844|3469872|P5|COMPLETED|Period 6||7
1417854|NCT02677844|3469873|P4|COMPLETED|Period 6||0
1417855|NCT02677844|3469874|P3|COMPLETED|Period 6||0
1417856|NCT02677844|3469875|P2|COMPLETED|Period 6||0
1417857|NCT02677844|3469876|P1|COMPLETED|Period 6||0
1417858|NCT02677844|3469870|P7|STARTED|Period 6||4
1417859|NCT02677844|3469871|P6|STARTED|Period 6||4
1417860|NCT02677844|3469872|P5|STARTED|Period 6||7
1417861|NCT02677844|3469873|P4|STARTED|Period 6||0
1417862|NCT02677844|3469874|P3|STARTED|Period 6||0
1417863|NCT02677844|3469875|P2|STARTED|Period 6||0
1417864|NCT02677844|3469876|P1|STARTED|Period 6||0
1417865|NCT02677844|3469870|P7|NOT COMPLETED|Period 5||0
1417866|NCT02677844|3469871|P6|NOT COMPLETED|Period 5||0
1417867|NCT02677844|3469872|P5|NOT COMPLETED|Period 5||0
1417868|NCT02677844|3469873|P4|NOT COMPLETED|Period 5||0
1417869|NCT02677844|3469874|P3|NOT COMPLETED|Period 5||0
1417870|NCT02677844|3469875|P2|NOT COMPLETED|Period 5||0
1417871|NCT02677844|3469876|P1|NOT COMPLETED|Period 5||0
1417872|NCT02677844|3469870|P7|COMPLETED|Period 5||4
1417873|NCT02677844|3469871|P6|COMPLETED|Period 5||4
1417874|NCT02677844|3469872|P5|COMPLETED|Period 5||7
1417875|NCT02677844|3469873|P4|COMPLETED|Period 5||0
1417876|NCT02677844|3469874|P3|COMPLETED|Period 5||0
1417877|NCT02677844|3469875|P2|COMPLETED|Period 5||0
1417878|NCT02677844|3469876|P1|COMPLETED|Period 5||0
1417879|NCT02677844|3469870|P7|STARTED|Period 5||4
1417880|NCT02677844|3469871|P6|STARTED|Period 5||4
1417881|NCT02677844|3469872|P5|STARTED|Period 5||7
1417882|NCT02677844|3469873|P4|STARTED|Period 5||0
1417883|NCT02677844|3469874|P3|STARTED|Period 5||0
1417884|NCT02677844|3469875|P2|STARTED|Period 5||0
1417885|NCT02677844|3469876|P1|STARTED|Period 5||0
1417886|NCT02677844|3469870|P7|NOT COMPLETED|Period 4 (DDI)||0
1417887|NCT02677844|3469871|P6|NOT COMPLETED|Period 4 (DDI)||0
1417888|NCT02677844|3469872|P5|NOT COMPLETED|Period 4 (DDI)||0
1417889|NCT02677844|3469873|P4|NOT COMPLETED|Period 4 (DDI)||0
1417890|NCT02677844|3469874|P3|NOT COMPLETED|Period 4 (DDI)||0
1417891|NCT02677844|3469875|P2|NOT COMPLETED|Period 4 (DDI)||0
1417892|NCT02677844|3469876|P1|NOT COMPLETED|Period 4 (DDI)||0
1417893|NCT02677844|3469870|P7|COMPLETED|Period 4 (DDI)||4
1417894|NCT02677844|3469871|P6|COMPLETED|Period 4 (DDI)||4
1417895|NCT02677844|3469872|P5|COMPLETED|Period 4 (DDI)||7
1417896|NCT02677844|3469873|P4|COMPLETED|Period 4 (DDI)||0
1417897|NCT02677844|3469874|P3|COMPLETED|Period 4 (DDI)||0
1417898|NCT02677844|3469875|P2|COMPLETED|Period 4 (DDI)||0
1417899|NCT02677844|3469876|P1|COMPLETED|Period 4 (DDI)||0
1417900|NCT02677844|3469870|P7|STARTED|Period 4 (DDI)||4
1417901|NCT02677844|3469871|P6|STARTED|Period 4 (DDI)||4
1417902|NCT02677844|3469872|P5|STARTED|Period 4 (DDI)||7
1417903|NCT02677844|3469873|P4|STARTED|Period 4 (DDI)||0
1417904|NCT02677844|3469874|P3|STARTED|Period 4 (DDI)||0
1417905|NCT02677844|3469875|P2|STARTED|Period 4 (DDI)||0
1417906|NCT02677844|3469876|P1|STARTED|Period 4 (DDI)||0
1417907|NCT02677844|3469870|P7|NOT COMPLETED|Period 4||0
1417908|NCT02677844|3469871|P6|NOT COMPLETED|Period 4||0
1417909|NCT02677844|3469872|P5|NOT COMPLETED|Period 4||0
1417910|NCT02677844|3469873|P4|NOT COMPLETED|Period 4||0
1417911|NCT02677844|3469874|P3|NOT COMPLETED|Period 4||0
1417912|NCT02677844|3469875|P2|NOT COMPLETED|Period 4||0
1417913|NCT02677844|3469876|P1|NOT COMPLETED|Period 4||0
1417914|NCT02677844|3469870|P7|COMPLETED|Period 4||0
1417915|NCT02677844|3469871|P6|COMPLETED|Period 4||0
1417916|NCT02677844|3469872|P5|COMPLETED|Period 4||0
1417917|NCT02677844|3469873|P4|COMPLETED|Period 4||4
1417918|NCT02677844|3469874|P3|COMPLETED|Period 4||5
1417919|NCT02677844|3469875|P2|COMPLETED|Period 4||5
1417920|NCT02677844|3469876|P1|COMPLETED|Period 4||5
1417921|NCT02677844|3469870|P7|STARTED|Period 4||0
1417922|NCT02677844|3469871|P6|STARTED|Period 4||0
1417923|NCT02677844|3469872|P5|STARTED|Period 4||0
1417924|NCT02677844|3469873|P4|STARTED|Period 4||4
1417925|NCT02677844|3469874|P3|STARTED|Period 4||5
1417926|NCT02677844|3469875|P2|STARTED|Period 4||5
1417927|NCT02677844|3469876|P1|STARTED|Period 4||5
1417928|NCT02677844|3469870|P7|NOT COMPLETED|Period 3||0
1417929|NCT02677844|3469871|P6|NOT COMPLETED|Period 3||0
1417930|NCT02677844|3469872|P5|NOT COMPLETED|Period 3||0
1417931|NCT02677844|3469873|P4|NOT COMPLETED|Period 3||1
1417932|NCT02677844|3469874|P3|NOT COMPLETED|Period 3||0
1417933|NCT02677844|3469875|P2|NOT COMPLETED|Period 3||0
1417934|NCT02677844|3469876|P1|NOT COMPLETED|Period 3||0
1417935|NCT02677844|3469870|P7|COMPLETED|Period 3||0
1417936|NCT02677844|3469871|P6|COMPLETED|Period 3||0
1417937|NCT02677844|3469872|P5|COMPLETED|Period 3||0
1417938|NCT02677844|3469873|P4|COMPLETED|Period 3||4
1417939|NCT02677844|3469874|P3|COMPLETED|Period 3||5
1417940|NCT02677844|3469875|P2|COMPLETED|Period 3||5
1417941|NCT02677844|3469876|P1|COMPLETED|Period 3||5
1417942|NCT02677844|3469870|P7|STARTED|Period 3||0
1417943|NCT02677844|3469871|P6|STARTED|Period 3||0
1417944|NCT02677844|3469872|P5|STARTED|Period 3||0
1417945|NCT02677844|3469873|P4|STARTED|Period 3||5
1417946|NCT02677844|3469874|P3|STARTED|Period 3||5
1417947|NCT02677844|3469875|P2|STARTED|Period 3||5
1417948|NCT02677844|3469876|P1|STARTED|Period 3||5
1417949|NCT02677844|3469870|P7|NOT COMPLETED|Period 2||0
1417950|NCT02677844|3469871|P6|NOT COMPLETED|Period 2||0
1417951|NCT02677844|3469872|P5|NOT COMPLETED|Period 2||0
1417952|NCT02677844|3469873|P4|NOT COMPLETED|Period 2||0
1417953|NCT02677844|3469874|P3|NOT COMPLETED|Period 2||0
1417954|NCT02677844|3469875|P2|NOT COMPLETED|Period 2||0
1417955|NCT02677844|3469876|P1|NOT COMPLETED|Period 2||0
1417956|NCT02677844|3469870|P7|COMPLETED|Period 2||0
1417957|NCT02677844|3469871|P6|COMPLETED|Period 2||0
1417958|NCT02677844|3469872|P5|COMPLETED|Period 2||0
1417959|NCT02677844|3469873|P4|COMPLETED|Period 2||5
1417960|NCT02677844|3469874|P3|COMPLETED|Period 2||5
1417961|NCT02677844|3469875|P2|COMPLETED|Period 2||5
1417962|NCT02677844|3469876|P1|COMPLETED|Period 2||5
1417963|NCT02677844|3469870|P7|STARTED|Period 2||0
1417964|NCT02677844|3469871|P6|STARTED|Period 2||0
1417965|NCT02677844|3469872|P5|STARTED|Period 2||0
1417966|NCT02677844|3469873|P4|STARTED|Period 2||5
1417967|NCT02677844|3469874|P3|STARTED|Period 2||5
1417968|NCT02677844|3469875|P2|STARTED|Period 2||5
1417969|NCT02677844|3469876|P1|STARTED|Period 2||5
1417970|NCT02677844|3469870|P7|NOT COMPLETED|Period 1||0
1417971|NCT02677844|3469871|P6|NOT COMPLETED|Period 1||0
1417972|NCT02677844|3469872|P5|NOT COMPLETED|Period 1||0
1417973|NCT02677844|3469873|P4|NOT COMPLETED|Period 1||0
1417974|NCT02677844|3469874|P3|NOT COMPLETED|Period 1||0
1417975|NCT02677844|3469875|P2|NOT COMPLETED|Period 1||0
1417976|NCT02677844|3469876|P1|NOT COMPLETED|Period 1||0
1417977|NCT02677844|3469870|P7|COMPLETED|Period 1||0
1417978|NCT02677844|3469871|P6|COMPLETED|Period 1||0
1417979|NCT02677844|3469872|P5|COMPLETED|Period 1||0
1417980|NCT02677844|3469873|P4|COMPLETED|Period 1||5
1417981|NCT02677844|3469874|P3|COMPLETED|Period 1||5
1417982|NCT02677844|3469875|P2|COMPLETED|Period 1||5
1417983|NCT02677844|3469876|P1|COMPLETED|Period 1||5
1417984|NCT02677844|3469870|P7|STARTED|Period 1||0
1417985|NCT02677844|3469871|P6|STARTED|Period 1||0
1417986|NCT02677844|3469872|P5|STARTED|Period 1||0
1417987|NCT02677844|3469873|P4|STARTED|Period 1||5
1417988|NCT02677844|3469874|P3|STARTED|Period 1||5
1417989|NCT02677844|3469875|P2|STARTED|Period 1||5
1417990|NCT02677844|3469876|P1|STARTED|Period 1||5
1417991|NCT02677779|3469906|P2|NOT COMPLETED|Overall Study||0
1417992|NCT02677779|3469907|P1|NOT COMPLETED|Overall Study||0
1417993|NCT02677779|3469906|P2|COMPLETED|Overall Study||10
1417994|NCT02677779|3469907|P1|COMPLETED|Overall Study||10
1417995|NCT02677779|3469906|P2|STARTED|Overall Study||10
1417996|NCT02677779|3469907|P1|STARTED|Overall Study||10
1417997|NCT02677493|3469924|P3|NOT COMPLETED|Overall Study||3
1417998|NCT02677493|3469925|P2|NOT COMPLETED|Overall Study||2
1417999|NCT02677493|3469926|P1|NOT COMPLETED|Overall Study||11
1418000|NCT02677493|3469924|P3|COMPLETED|Overall Study||296
1418001|NCT02677493|3469925|P2|COMPLETED|Overall Study||296
1418002|NCT02677493|3469926|P1|COMPLETED|Overall Study||1186
1418003|NCT02677493|3469924|P3|STARTED|Overall Study||299
1418004|NCT02677493|3469925|P2|STARTED|Overall Study||298
1418005|NCT02677493|3469926|P1|STARTED|Overall Study||1197
1418006|NCT02675907|3469939|P2|NOT COMPLETED|Study Overall||4
1418007|NCT02675907|3469940|P1|NOT COMPLETED|Study Overall||3
1418008|NCT02675907|3469939|P2|COMPLETED|Study Overall||97
1418009|NCT02675907|3469940|P1|COMPLETED|Study Overall||97
1418010|NCT02675907|3469939|P2|STARTED|Study Overall||101
1418011|NCT02675907|3469940|P1|STARTED|Study Overall||100
1418012|NCT02675907|3469939|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
1418013|NCT02675907|3469940|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
1418014|NCT02675907|3469939|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
1418015|NCT02675907|3469940|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
1418016|NCT02675907|3469939|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
1418017|NCT02675907|3469940|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
1418018|NCT02675764|3469972|P2|NOT COMPLETED|Overall Study||0
1418019|NCT02675764|3469973|P1|NOT COMPLETED|Overall Study||0
1418020|NCT02675764|3469972|P2|COMPLETED|Overall Study||6
1418021|NCT02675764|3469973|P1|COMPLETED|Overall Study||6
1418022|NCT02675764|3469972|P2|STARTED|Overall Study||6
1418023|NCT02675764|3469973|P1|STARTED|Overall Study||6
1418024|NCT02675634|3469985|P6|NOT COMPLETED|Test Period 3||0
1418025|NCT02675634|3469986|P5|NOT COMPLETED|Test Period 3||0
1418026|NCT02675634|3469987|P4|NOT COMPLETED|Test Period 3||0
1418027|NCT02675634|3469988|P3|NOT COMPLETED|Test Period 3||0
1418028|NCT02675634|3469989|P2|NOT COMPLETED|Test Period 3||0
1418029|NCT02675634|3469990|P1|NOT COMPLETED|Test Period 3||0
1418030|NCT02675634|3469985|P6|COMPLETED|Test Period 3||8
1418031|NCT02675634|3469986|P5|COMPLETED|Test Period 3||10
1418032|NCT02675634|3469987|P4|COMPLETED|Test Period 3||8
1418033|NCT02675634|3469988|P3|COMPLETED|Test Period 3||8
1418034|NCT02675634|3469989|P2|COMPLETED|Test Period 3||7
1418035|NCT02675634|3469990|P1|COMPLETED|Test Period 3||9
1418036|NCT02675634|3469985|P6|STARTED|Test Period 3||8
1418037|NCT02675634|3469986|P5|STARTED|Test Period 3||10
1418038|NCT02675634|3469987|P4|STARTED|Test Period 3||8
1418039|NCT02675634|3469988|P3|STARTED|Test Period 3||8
1418040|NCT02675634|3469989|P2|STARTED|Test Period 3||7
1418041|NCT02675634|3469990|P1|STARTED|Test Period 3||9
1418042|NCT02675634|3469985|P6|NOT COMPLETED|Test Period 2||1
1418043|NCT02675634|3469986|P5|NOT COMPLETED|Test Period 2||0
1418044|NCT02675634|3469987|P4|NOT COMPLETED|Test Period 2||0
1418045|NCT02675634|3469988|P3|NOT COMPLETED|Test Period 2||0
1418046|NCT02675634|3469989|P2|NOT COMPLETED|Test Period 2||0
1418047|NCT02675634|3469990|P1|NOT COMPLETED|Test Period 2||1
1418048|NCT02675634|3469985|P6|COMPLETED|Test Period 2||8
1418049|NCT02675634|3469986|P5|COMPLETED|Test Period 2||10
1418050|NCT02675634|3469987|P4|COMPLETED|Test Period 2||8
1418051|NCT02675634|3469988|P3|COMPLETED|Test Period 2||8
1418052|NCT02675634|3469989|P2|COMPLETED|Test Period 2||7
1418053|NCT02675634|3469990|P1|COMPLETED|Test Period 2||9
1418054|NCT02675634|3469985|P6|STARTED|Test Period 2||9
1418055|NCT02675634|3469986|P5|STARTED|Test Period 2||10
1418056|NCT02675634|3469987|P4|STARTED|Test Period 2||8
1418057|NCT02675634|3469988|P3|STARTED|Test Period 2||8
1418058|NCT02675634|3469989|P2|STARTED|Test Period 2||7
1418059|NCT02675634|3469990|P1|STARTED|Test Period 2||10
1418060|NCT02675634|3469985|P6|NOT COMPLETED|Test Period 1||0
1418061|NCT02675634|3469986|P5|NOT COMPLETED|Test Period 1||0
1418062|NCT02675634|3469987|P4|NOT COMPLETED|Test Period 1||1
1418063|NCT02675634|3469988|P3|NOT COMPLETED|Test Period 1||1
1418064|NCT02675634|3469989|P2|NOT COMPLETED|Test Period 1||1
1418065|NCT02675634|3469990|P1|NOT COMPLETED|Test Period 1||0
1418066|NCT02675634|3469985|P6|COMPLETED|Test Period 1||9
1418067|NCT02675634|3469986|P5|COMPLETED|Test Period 1||10
1418068|NCT02675634|3469987|P4|COMPLETED|Test Period 1||8
1418069|NCT02675634|3469988|P3|COMPLETED|Test Period 1||8
1418070|NCT02675634|3469989|P2|COMPLETED|Test Period 1||7
1418071|NCT02675634|3469990|P1|COMPLETED|Test Period 1||10
1418072|NCT02675634|3469985|P6|STARTED|Test Period 1||9
1418073|NCT02675634|3469986|P5|STARTED|Test Period 1||10
1418074|NCT02675634|3469987|P4|STARTED|Test Period 1||9
1418075|NCT02675634|3469988|P3|STARTED|Test Period 1||9
1418076|NCT02675634|3469989|P2|STARTED|Test Period 1||8
1418077|NCT02675634|3469990|P1|STARTED|Test Period 1||10
1418078|NCT02675543|3470000|P2|NOT COMPLETED|Overall Study||0
1418079|NCT02675543|3470001|P1|NOT COMPLETED|Overall Study||0
1418080|NCT02675543|3470000|P2|COMPLETED|Overall Study||20
1418081|NCT02675543|3470001|P1|COMPLETED|Overall Study||15
1418082|NCT02675543|3470000|P2|STARTED|Overall Study||20
1418083|NCT02675543|3470001|P1|STARTED|Overall Study||15
1418084|NCT02675517|3470007|P1|NOT COMPLETED|Overall Study||159
1418085|NCT02675517|3470007|P1|COMPLETED|Overall Study||1578
1418086|NCT02675517|3470007|P1|STARTED|Overall Study||1737
1418087|NCT02674412|3470016|P2|NOT COMPLETED|Overall Study||0
1418088|NCT02674412|3470017|P1|NOT COMPLETED|Overall Study||0
1418089|NCT02674412|3470016|P2|COMPLETED|Overall Study||5
1418090|NCT02674412|3470017|P1|COMPLETED|Overall Study||5
1418091|NCT02674412|3470016|P2|STARTED|Overall Study||5
1418092|NCT02674412|3470017|P1|STARTED|Overall Study||5
1418093|NCT02674334|3470029|P2|NOT COMPLETED|Overall Study||3
1418094|NCT02674334|3470030|P1|NOT COMPLETED|Overall Study||7
1418095|NCT02674334|3470029|P2|COMPLETED|Overall Study||40
1418096|NCT02674334|3470030|P1|COMPLETED|Overall Study||40
1418097|NCT02674334|3470029|P2|STARTED|Overall Study||43
1418098|NCT02674334|3470030|P1|STARTED|Overall Study||47
1418099|NCT02673944|3470038|P1|NOT COMPLETED|Overall Study||0
1418100|NCT02673944|3470038|P1|COMPLETED|Overall Study||10
1418101|NCT02673944|3470038|P1|STARTED|Overall Study||10
1418102|NCT02673619|3470047|P4|NOT COMPLETED|Overall Study||0
1418103|NCT02673619|3470048|P3|NOT COMPLETED|Overall Study||3
1418104|NCT02673619|3470049|P2|NOT COMPLETED|Overall Study||1
1418105|NCT02673619|3470050|P1|NOT COMPLETED|Overall Study||2
1418106|NCT02673619|3470047|P4|COMPLETED|Overall Study||7
1418107|NCT02673619|3470048|P3|COMPLETED|Overall Study||23
1418108|NCT02673619|3470049|P2|COMPLETED|Overall Study||4
1418109|NCT02673619|3470050|P1|COMPLETED|Overall Study||18
1418110|NCT02673619|3470047|P4|STARTED|Overall Study||7
1418111|NCT02673619|3470048|P3|STARTED|Overall Study||26
1418112|NCT02673619|3470049|P2|STARTED|Overall Study||5
1418113|NCT02673619|3470050|P1|STARTED|Overall Study||20
1418114|NCT02673489|3470142|P2|NOT COMPLETED|Follow Up Period||2
1418115|NCT02673489|3470143|P1|NOT COMPLETED|Follow Up Period||0
1418116|NCT02673489|3470142|P2|COMPLETED|Follow Up Period||21
1418117|NCT02673489|3470143|P1|COMPLETED|Follow Up Period||50
1418118|NCT02673489|3470142|P2|STARTED|Follow Up Period||23
1418119|NCT02673489|3470143|P1|STARTED|Follow Up Period||50
1418120|NCT02673489|3470142|P2|NOT COMPLETED|Treatment Period||3
1418121|NCT02673489|3470143|P1|NOT COMPLETED|Treatment Period||5
1418122|NCT02673489|3470142|P2|COMPLETED|Treatment Period||21
1418123|NCT02673489|3470143|P1|COMPLETED|Treatment Period||49
1418124|NCT02673489|3470142|P2|STARTED|Treatment Period||24
1418125|NCT02673489|3470143|P1|STARTED|Treatment Period||54
1418126|NCT02673138|3470156|P1|NOT COMPLETED|Overall Study||0
1418127|NCT02673138|3470156|P1|COMPLETED|Overall Study||10
1418128|NCT02673138|3470156|P1|STARTED|Overall Study||10
1418129|NCT02672514|3470170|P2|NOT COMPLETED|Overall Study||0
1418130|NCT02672514|3470171|P1|NOT COMPLETED|Overall Study||0
1418131|NCT02672514|3470170|P2|COMPLETED|Overall Study||51
1418132|NCT02672514|3470171|P1|COMPLETED|Overall Study||53
1418133|NCT02672514|3470170|P2|STARTED|Overall Study||51
1418134|NCT02672514|3470171|P1|STARTED|Overall Study||53
1418135|NCT02672423|3470180|P10|NOT COMPLETED|Period 3||0
1418136|NCT02672423|3470181|P9|NOT COMPLETED|Period 3||0
1418137|NCT02672423|3470182|P8|NOT COMPLETED|Period 3||1
1418138|NCT02672423|3470183|P7|NOT COMPLETED|Period 3||0
1418139|NCT02672423|3470184|P6|NOT COMPLETED|Period 3||1
1418140|NCT02672423|3470185|P5|NOT COMPLETED|Period 3||0
1418141|NCT02672423|3470186|P4|NOT COMPLETED|Period 3||0
1418142|NCT02672423|3470187|P3|NOT COMPLETED|Period 3||0
1418143|NCT02672423|3470188|P2|NOT COMPLETED|Period 3||0
1418144|NCT02672423|3470189|P1|NOT COMPLETED|Period 3||0
1418145|NCT02672423|3470180|P10|COMPLETED|Period 3||0
1418146|NCT02672423|3470181|P9|COMPLETED|Period 3||0
1418147|NCT02672423|3470182|P8|COMPLETED|Period 3||14
1418148|NCT02672423|3470183|P7|COMPLETED|Period 3||15
1418149|NCT02672423|3470184|P6|COMPLETED|Period 3||14
1418150|NCT02672423|3470185|P5|COMPLETED|Period 3||14
1418151|NCT02672423|3470186|P4|COMPLETED|Period 3||15
1418152|NCT02672423|3470187|P3|COMPLETED|Period 3||13
1418153|NCT02672423|3470188|P2|COMPLETED|Period 3||0
1418154|NCT02672423|3470189|P1|COMPLETED|Period 3||0
1418155|NCT02672423|3470180|P10|STARTED|Period 3|Part C was a 2-period study design.|0
1418156|NCT02672423|3470181|P9|STARTED|Period 3|Part C was a 2-period study design.|0
1418157|NCT02672423|3470182|P8|STARTED|Period 3||15
1418158|NCT02672423|3470183|P7|STARTED|Period 3||15
1418159|NCT02672423|3470184|P6|STARTED|Period 3||15
1418160|NCT02672423|3470185|P5|STARTED|Period 3||14
1418161|NCT02672423|3470186|P4|STARTED|Period 3||15
1418162|NCT02672423|3470187|P3|STARTED|Period 3||13
1418163|NCT02672423|3470188|P2|STARTED|Period 3|Part A was a 2-period study design.|0
1418164|NCT02672423|3470189|P1|STARTED|Period 3|Part A was a 2-period study design.|0
1418165|NCT02672423|3470180|P10|NOT COMPLETED|Washout 2||0
1418166|NCT02672423|3470181|P9|NOT COMPLETED|Washout 2||0
1418167|NCT02672423|3470182|P8|NOT COMPLETED|Washout 2||0
1418168|NCT02672423|3470183|P7|NOT COMPLETED|Washout 2||0
1418169|NCT02672423|3470184|P6|NOT COMPLETED|Washout 2||0
1418170|NCT02672423|3470185|P5|NOT COMPLETED|Washout 2||0
1418171|NCT02672423|3470186|P4|NOT COMPLETED|Washout 2||0
1418172|NCT02672423|3470187|P3|NOT COMPLETED|Washout 2||0
1418173|NCT02672423|3470188|P2|NOT COMPLETED|Washout 2||0
1418174|NCT02672423|3470189|P1|NOT COMPLETED|Washout 2||0
1418175|NCT02672423|3470180|P10|COMPLETED|Washout 2||12
1418176|NCT02672423|3470181|P9|COMPLETED|Washout 2||12
1418177|NCT02672423|3470182|P8|COMPLETED|Washout 2||15
1418178|NCT02672423|3470183|P7|COMPLETED|Washout 2||15
1418179|NCT02672423|3470184|P6|COMPLETED|Washout 2||15
1418180|NCT02672423|3470185|P5|COMPLETED|Washout 2||14
1418181|NCT02672423|3470186|P4|COMPLETED|Washout 2||15
1418182|NCT02672423|3470187|P3|COMPLETED|Washout 2||13
1418183|NCT02672423|3470188|P2|COMPLETED|Washout 2||7
1418184|NCT02672423|3470189|P1|COMPLETED|Washout 2||7
1418185|NCT02672423|3470180|P10|STARTED|Washout 2||12
1418186|NCT02672423|3470181|P9|STARTED|Washout 2||12
1418187|NCT02672423|3470182|P8|STARTED|Washout 2||15
1418188|NCT02672423|3470183|P7|STARTED|Washout 2||15
1418189|NCT02672423|3470184|P6|STARTED|Washout 2||15
1418190|NCT02672423|3470185|P5|STARTED|Washout 2||14
1418191|NCT02672423|3470186|P4|STARTED|Washout 2||15
1418192|NCT02672423|3470187|P3|STARTED|Washout 2||13
1418193|NCT02672423|3470188|P2|STARTED|Washout 2||7
1418194|NCT02672423|3470189|P1|STARTED|Washout 2||7
1418195|NCT02672423|3470180|P10|NOT COMPLETED|Period 2||0
1418196|NCT02672423|3470181|P9|NOT COMPLETED|Period 2||0
1418197|NCT02672423|3470182|P8|NOT COMPLETED|Period 2||0
1418198|NCT02672423|3470183|P7|NOT COMPLETED|Period 2||0
1418199|NCT02672423|3470184|P6|NOT COMPLETED|Period 2||0
1418200|NCT02672423|3470185|P5|NOT COMPLETED|Period 2||0
1418201|NCT02672423|3470186|P4|NOT COMPLETED|Period 2||0
1418202|NCT02672423|3470187|P3|NOT COMPLETED|Period 2||1
1418203|NCT02672423|3470188|P2|NOT COMPLETED|Period 2||0
1418204|NCT02672423|3470189|P1|NOT COMPLETED|Period 2||0
1418205|NCT02672423|3470180|P10|COMPLETED|Period 2||12
1418206|NCT02672423|3470181|P9|COMPLETED|Period 2||12
1418207|NCT02672423|3470182|P8|COMPLETED|Period 2||15
1418208|NCT02672423|3470183|P7|COMPLETED|Period 2||15
1418209|NCT02672423|3470184|P6|COMPLETED|Period 2||15
1418210|NCT02672423|3470185|P5|COMPLETED|Period 2||14
1418211|NCT02672423|3470186|P4|COMPLETED|Period 2||15
1418212|NCT02672423|3470187|P3|COMPLETED|Period 2||13
1418213|NCT02672423|3470188|P2|COMPLETED|Period 2||7
1418214|NCT02672423|3470189|P1|COMPLETED|Period 2||7
1418215|NCT02672423|3470180|P10|STARTED|Period 2||12
1418216|NCT02672423|3470181|P9|STARTED|Period 2||12
1418217|NCT02672423|3470182|P8|STARTED|Period 2||15
1418218|NCT02672423|3470183|P7|STARTED|Period 2||15
1418219|NCT02672423|3470184|P6|STARTED|Period 2||15
1418220|NCT02672423|3470185|P5|STARTED|Period 2||14
1418221|NCT02672423|3470186|P4|STARTED|Period 2||15
1418222|NCT02672423|3470187|P3|STARTED|Period 2||14
1418223|NCT02672423|3470188|P2|STARTED|Period 2||7
1418224|NCT02672423|3470189|P1|STARTED|Period 2||7
1418225|NCT02672423|3470180|P10|NOT COMPLETED|Washout 1||0
1418226|NCT02672423|3470181|P9|NOT COMPLETED|Washout 1||0
1418227|NCT02672423|3470182|P8|NOT COMPLETED|Washout 1||0
1418228|NCT02672423|3470183|P7|NOT COMPLETED|Washout 1||0
1418229|NCT02672423|3470184|P6|NOT COMPLETED|Washout 1||0
1418230|NCT02672423|3470185|P5|NOT COMPLETED|Washout 1||0
1418231|NCT02672423|3470186|P4|NOT COMPLETED|Washout 1||0
1418232|NCT02672423|3470187|P3|NOT COMPLETED|Washout 1||0
1418233|NCT02672423|3470188|P2|NOT COMPLETED|Washout 1||0
1418234|NCT02672423|3470189|P1|NOT COMPLETED|Washout 1||0
1418235|NCT02672423|3470180|P10|COMPLETED|Washout 1||12
1418236|NCT02672423|3470181|P9|COMPLETED|Washout 1||12
1418237|NCT02672423|3470182|P8|COMPLETED|Washout 1||15
1418238|NCT02672423|3470183|P7|COMPLETED|Washout 1||15
1418239|NCT02672423|3470184|P6|COMPLETED|Washout 1||15
1418240|NCT02672423|3470185|P5|COMPLETED|Washout 1||14
1418241|NCT02672423|3470186|P4|COMPLETED|Washout 1||15
1418242|NCT02672423|3470187|P3|COMPLETED|Washout 1||14
1418243|NCT02672423|3470188|P2|COMPLETED|Washout 1||7
1418244|NCT02672423|3470189|P1|COMPLETED|Washout 1||7
1418245|NCT02672423|3470180|P10|STARTED|Washout 1||12
1418246|NCT02672423|3470181|P9|STARTED|Washout 1||12
1418247|NCT02672423|3470182|P8|STARTED|Washout 1||15
1418248|NCT02672423|3470183|P7|STARTED|Washout 1||15
1418249|NCT02672423|3470184|P6|STARTED|Washout 1||15
1418250|NCT02672423|3470185|P5|STARTED|Washout 1||14
1418251|NCT02672423|3470186|P4|STARTED|Washout 1||15
1418252|NCT02672423|3470187|P3|STARTED|Washout 1||14
1418253|NCT02672423|3470188|P2|STARTED|Washout 1||7
1418254|NCT02672423|3470189|P1|STARTED|Washout 1||7
1418255|NCT02672423|3470180|P10|NOT COMPLETED|Period 1||0
1418256|NCT02672423|3470181|P9|NOT COMPLETED|Period 1||0
1418257|NCT02672423|3470182|P8|NOT COMPLETED|Period 1||0
1418258|NCT02672423|3470183|P7|NOT COMPLETED|Period 1||0
1418259|NCT02672423|3470184|P6|NOT COMPLETED|Period 1||0
1418260|NCT02672423|3470185|P5|NOT COMPLETED|Period 1||1
1418261|NCT02672423|3470186|P4|NOT COMPLETED|Period 1||0
1418262|NCT02672423|3470187|P3|NOT COMPLETED|Period 1||0
1418263|NCT02672423|3470188|P2|NOT COMPLETED|Period 1||0
1418264|NCT02672423|3470189|P1|NOT COMPLETED|Period 1||0
1418265|NCT02672423|3470180|P10|COMPLETED|Period 1||12
1418266|NCT02672423|3470181|P9|COMPLETED|Period 1||12
1418267|NCT02672423|3470182|P8|COMPLETED|Period 1||15
1418268|NCT02672423|3470183|P7|COMPLETED|Period 1||15
1418269|NCT02672423|3470184|P6|COMPLETED|Period 1||15
1418270|NCT02672423|3470185|P5|COMPLETED|Period 1||14
1418271|NCT02672423|3470186|P4|COMPLETED|Period 1||15
1418272|NCT02672423|3470187|P3|COMPLETED|Period 1||14
1418273|NCT02672423|3470188|P2|COMPLETED|Period 1||7
1418274|NCT02672423|3470189|P1|COMPLETED|Period 1||7
1418275|NCT02672423|3470180|P10|Received at Least One Dose of Study Drug|Period 1||12
1418276|NCT02672423|3470181|P9|Received at Least One Dose of Study Drug|Period 1||12
1418277|NCT02672423|3470182|P8|Received at Least One Dose of Study Drug|Period 1||15
1418278|NCT02672423|3470183|P7|Received at Least One Dose of Study Drug|Period 1||15
1418279|NCT02672423|3470184|P6|Received at Least One Dose of Study Drug|Period 1||15
1418280|NCT02672423|3470185|P5|Received at Least One Dose of Study Drug|Period 1||15
1418281|NCT02672423|3470186|P4|Received at Least One Dose of Study Drug|Period 1||15
1418282|NCT02672423|3470187|P3|Received at Least One Dose of Study Drug|Period 1||14
1418283|NCT02672423|3470188|P2|Received at Least One Dose of Study Drug|Period 1||7
1418284|NCT02672423|3470189|P1|Received at Least One Dose of Study Drug|Period 1||7
1418285|NCT02672423|3470180|P10|STARTED|Period 1||12
1418286|NCT02672423|3470181|P9|STARTED|Period 1||12
1418287|NCT02672423|3470182|P8|STARTED|Period 1||15
1418288|NCT02672423|3470183|P7|STARTED|Period 1||15
1418289|NCT02672423|3470184|P6|STARTED|Period 1||15
1418290|NCT02672423|3470185|P5|STARTED|Period 1||15
1418291|NCT02672423|3470186|P4|STARTED|Period 1||15
1418292|NCT02672423|3470187|P3|STARTED|Period 1||14
1418293|NCT02672423|3470188|P2|STARTED|Period 1||7
1418294|NCT02672423|3470189|P1|STARTED|Period 1||7
1418295|NCT02671760|3470212|P3|NOT COMPLETED|Overall Study||0
1418296|NCT02671760|3470213|P2|NOT COMPLETED|Overall Study||1
1418297|NCT02671760|3470214|P1|NOT COMPLETED|Overall Study||0
1418298|NCT02671760|3470212|P3|COMPLETED|Overall Study||13
1418299|NCT02671760|3470213|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
1418300|NCT02671760|3470214|P1|COMPLETED|Overall Study||13
1418301|NCT02671760|3470212|P3|STARTED|Overall Study||13
1418302|NCT02671760|3470213|P2|STARTED|Overall Study||13
1418303|NCT02671760|3470214|P1|STARTED|Overall Study||13
1418304|NCT02671461|3470243|P3|NOT COMPLETED|Follow-up||1
1418305|NCT02671461|3470244|P2|NOT COMPLETED|Follow-up||1
1418306|NCT02671461|3470245|P1|NOT COMPLETED|Follow-up||1
1418307|NCT02671461|3470243|P3|COMPLETED|Follow-up||6
1418308|NCT02671461|3470244|P2|COMPLETED|Follow-up||4
1418309|NCT02671461|3470245|P1|COMPLETED|Follow-up||1
1418310|NCT02671461|3470243|P3|STARTED|Follow-up||7
1418311|NCT02671461|3470244|P2|STARTED|Follow-up||5
1418312|NCT02671461|3470245|P1|STARTED|Follow-up||2
1418313|NCT02671461|3470243|P3|NOT COMPLETED|Treatment||5
1418314|NCT02671461|3470244|P2|NOT COMPLETED|Treatment||3
1418315|NCT02671461|3470245|P1|NOT COMPLETED|Treatment||2
1418316|NCT02671461|3470243|P3|COMPLETED|Treatment||2
1418317|NCT02671461|3470244|P2|COMPLETED|Treatment||2
1418318|NCT02671461|3470245|P1|COMPLETED|Treatment||1
1418319|NCT02671461|3470243|P3|STARTED|Treatment||7
1418320|NCT02671461|3470244|P2|STARTED|Treatment||5
1418321|NCT02671461|3470245|P1|STARTED|Treatment||3
1418322|NCT02671266|3470270|P2|NOT COMPLETED|Overall Study||1
1418323|NCT02671266|3470271|P1|NOT COMPLETED|Overall Study||1
1418324|NCT02671266|3470270|P2|COMPLETED|Overall Study||20
1418325|NCT02671266|3470271|P1|COMPLETED|Overall Study||19
1418326|NCT02671266|3470270|P2|Healthy Participants|Overall Study||8
1418327|NCT02671266|3470271|P1|Healthy Participants|Overall Study||8
1418328|NCT02671266|3470270|P2|OCD Participants|Overall Study||3
1418329|NCT02671266|3470271|P1|OCD Participants|Overall Study||2
1418330|NCT02671266|3470270|P2|BDD Participants|Overall Study||9
1418331|NCT02671266|3470271|P1|BDD Participants|Overall Study||9
1418332|NCT02671266|3470270|P2|STARTED|Overall Study||21
1418333|NCT02671266|3470271|P1|STARTED|Overall Study||20
1418334|NCT02670811|3470285|P2|NOT COMPLETED|Overall Study||0
1418335|NCT02670811|3470286|P1|NOT COMPLETED|Overall Study||1
1418336|NCT02670811|3470285|P2|COMPLETED|Overall Study||18
1418337|NCT02670811|3470286|P1|COMPLETED|Overall Study||17
1418338|NCT02670811|3470285|P2|STARTED|Overall Study||18
1418339|NCT02670811|3470286|P1|STARTED|Overall Study||18
1418340|NCT02670473|3470302|P1|NOT COMPLETED|Overall Study||1
1418341|NCT02670473|3470302|P1|COMPLETED|Overall Study||34
1418342|NCT02670473|3470302|P1|STARTED|Overall Study||35
1418343|NCT02670343|3470355|P1|NOT COMPLETED|Overall Study||0
1418344|NCT02670343|3470355|P1|COMPLETED|Overall Study||8
1418345|NCT02670343|3470355|P1|STARTED|Overall Study||8
1418346|NCT02669940|3470361|P2|NOT COMPLETED|Overall Study||3
1418347|NCT02669940|3470362|P1|NOT COMPLETED|Overall Study||1
1418348|NCT02669940|3470361|P2|COMPLETED|Overall Study||92
1418349|NCT02669940|3470362|P1|COMPLETED|Overall Study||62
1418350|NCT02669940|3470361|P2|STARTED|Overall Study||95
1418351|NCT02669940|3470362|P1|STARTED|Overall Study||63
1418352|NCT02669914|3470418|P3|NOT COMPLETED|Overall Study||0
1418353|NCT02669914|3470419|P2|NOT COMPLETED|Overall Study||0
1418354|NCT02669914|3470420|P1|NOT COMPLETED|Overall Study||0
1418355|NCT02669914|3470418|P3|COMPLETED|Overall Study||0
1418356|NCT02669914|3470419|P2|COMPLETED|Overall Study||0
1418357|NCT02669914|3470420|P1|COMPLETED|Overall Study||4
1418358|NCT02669914|3470418|P3|STARTED|Overall Study||0
1418359|NCT02669914|3470419|P2|STARTED|Overall Study||0
1418360|NCT02669914|3470420|P1|STARTED|Overall Study||4
1418361|NCT02669862|3470464|P3|NOT COMPLETED|Overall Study||5
1418362|NCT02669862|3470465|P2|NOT COMPLETED|Overall Study||5
1418363|NCT02669862|3470466|P1|NOT COMPLETED|Overall Study||2
1418364|NCT02669862|3470464|P3|COMPLETED|Overall Study||26
1418365|NCT02669862|3470465|P2|COMPLETED|Overall Study||29
1418366|NCT02669862|3470466|P1|COMPLETED|Overall Study||31
1418367|NCT02669862|3470464|P3|STARTED|Overall Study||31
1418368|NCT02669862|3470465|P2|STARTED|Overall Study||34
1418369|NCT02669862|3470466|P1|STARTED|Overall Study||33
1418370|NCT02669615|3470479|P1|NOT COMPLETED|Overall Study||0
1418371|NCT02669615|3470479|P1|COMPLETED|Overall Study||24
1418372|NCT02669615|3470479|P1|STARTED|Overall Study||24
1418373|NCT02669095|3470487|P2|NOT COMPLETED|Overall Study||3
1418374|NCT02669095|3470488|P1|NOT COMPLETED|Overall Study||1
1418375|NCT02669095|3470487|P2|COMPLETED|Overall Study||72
1418376|NCT02669095|3470488|P1|COMPLETED|Overall Study||74
1418377|NCT02669095|3470487|P2|STARTED|Overall Study||75
1418378|NCT02669095|3470488|P1|STARTED|Overall Study||75
1418379|NCT02669043|3470496|P1|NOT COMPLETED|Overall Study||4
1418380|NCT02669043|3470496|P1|COMPLETED|Overall Study||4
1418381|NCT02669043|3470496|P1|STARTED|Overall Study||8
1418382|NCT02668952|3470502|P2|NOT COMPLETED|Overall Study||0
1418383|NCT02668952|3470503|P1|NOT COMPLETED|Overall Study||0
1418384|NCT02668952|3470502|P2|COMPLETED|Overall Study||14
1418385|NCT02668952|3470503|P1|COMPLETED|Overall Study||16
1418386|NCT02668952|3470502|P2|STARTED|Overall Study||14
1418387|NCT02668952|3470503|P1|STARTED|Overall Study||16
1418388|NCT02668822|3470523|P2|NOT COMPLETED|Overall Study||9
1418389|NCT02668822|3470524|P1|NOT COMPLETED|Overall Study||9
1418390|NCT02668822|3470523|P2|COMPLETED|Overall Study||0
1418391|NCT02668822|3470524|P1|COMPLETED|Overall Study||0
1418392|NCT02668822|3470523|P2|STARTED|Overall Study||9
1418393|NCT02668822|3470524|P1|STARTED|Overall Study||9
1418394|NCT02668783|3470546|P2|NOT COMPLETED|Overall Study||12
1418395|NCT02668783|3470547|P1|NOT COMPLETED|Overall Study||13
1418396|NCT02668783|3470546|P2|COMPLETED|Overall Study||0
1418397|NCT02668783|3470547|P1|COMPLETED|Overall Study||0
1418398|NCT02668783|3470546|P2|Treated|Overall Study||11
1418399|NCT02668783|3470547|P1|Treated|Overall Study||13
1418400|NCT02668783|3470546|P2|STARTED|Overall Study||12
1418401|NCT02668783|3470547|P1|STARTED|Overall Study||13
1418402|NCT02668302|3470569|P2|NOT COMPLETED|Overall Study||0
1418403|NCT02668302|3470570|P1|NOT COMPLETED|Overall Study||1
1418404|NCT02668302|3470569|P2|COMPLETED|Overall Study||20
1418405|NCT02668302|3470570|P1|COMPLETED|Overall Study||19
1418406|NCT02668302|3470569|P2|STARTED|Overall Study||20
1418407|NCT02668302|3470570|P1|STARTED|Overall Study||20
1418408|NCT02667821|3470576|P1|NOT COMPLETED|Overall Study||0
1418409|NCT02667821|3470576|P1|COMPLETED|Overall Study||20
1418410|NCT02667821|3470576|P1|STARTED|Overall Study||20
1418411|NCT02667704|3470582|P1|NOT COMPLETED|Treatment Period 2||0
1418412|NCT02667704|3470582|P1|COMPLETED|Treatment Period 2||13
1418413|NCT02667704|3470582|P1|STARTED|Treatment Period 2||13
1418414|NCT02667704|3470582|P1|NOT COMPLETED|Treatment Period 1||0
1418415|NCT02667704|3470582|P1|COMPLETED|Treatment Period 1||13
1418416|NCT02667704|3470582|P1|STARTED|Treatment Period 1||13
1418417|NCT02667288|3470593|P1|NOT COMPLETED|Overall Study||13
1418418|NCT02667288|3470593|P1|COMPLETED|Overall Study||134
1418419|NCT02667288|3470593|P1|STARTED|Overall Study||147
1418420|NCT02667275|3470600|P2|NOT COMPLETED|Overall Study||15
1418421|NCT02667275|3470601|P1|NOT COMPLETED|Overall Study||11
1418422|NCT02667275|3470600|P2|COMPLETED|Overall Study||228
1418423|NCT02667275|3470601|P1|COMPLETED|Overall Study||233
1418424|NCT02667275|3470600|P2|STARTED|Overall Study||243
1418425|NCT02667275|3470601|P1|STARTED|Overall Study||244
1418426|NCT02667236|3470611|P2|NOT COMPLETED|Overall Study||1
1418427|NCT02667236|3470612|P1|NOT COMPLETED|Overall Study||3
1418428|NCT02667236|3470611|P2|COMPLETED|Overall Study||226
1418429|NCT02667236|3470612|P1|COMPLETED|Overall Study||220
1418430|NCT02667236|3470611|P2|STARTED|Overall Study||227
1418431|NCT02667236|3470612|P1|STARTED|Overall Study||223
1418432|NCT02666560|3470620|P2|NOT COMPLETED|Condition 2 (1 Day)||0
1418433|NCT02666560|3470621|P1|NOT COMPLETED|Condition 2 (1 Day)||0
1418434|NCT02666560|3470620|P2|COMPLETED|Condition 2 (1 Day)||11
1418435|NCT02666560|3470621|P1|COMPLETED|Condition 2 (1 Day)||8
1418436|NCT02666560|3470620|P2|STARTED|Condition 2 (1 Day)||11
1418437|NCT02666560|3470621|P1|STARTED|Condition 2 (1 Day)||8
1418438|NCT02666560|3470620|P2|NOT COMPLETED|Condition 1 (1 Day)||0
1418439|NCT02666560|3470621|P1|NOT COMPLETED|Condition 1 (1 Day)||0
1418440|NCT02666560|3470620|P2|COMPLETED|Condition 1 (1 Day)||11
1418441|NCT02666560|3470621|P1|COMPLETED|Condition 1 (1 Day)||8
1418442|NCT02666560|3470620|P2|STARTED|Condition 1 (1 Day)||11
1418443|NCT02666560|3470621|P1|STARTED|Condition 1 (1 Day)||8
1418444|NCT02666352|3470640|P3|NOT COMPLETED|Overall Study||0
1418445|NCT02666352|3470641|P2|NOT COMPLETED|Overall Study||0
1418446|NCT02666352|3470642|P1|NOT COMPLETED|Overall Study||0
1418447|NCT02666352|3470640|P3|COMPLETED|Overall Study||8
1418448|NCT02666352|3470641|P2|COMPLETED|Overall Study||8
1418449|NCT02666352|3470642|P1|COMPLETED|Overall Study||8
1418450|NCT02666352|3470640|P3|STARTED|Overall Study||8
1418451|NCT02666352|3470641|P2|STARTED|Overall Study||8
1418452|NCT02666352|3470642|P1|STARTED|Overall Study||8
1418453|NCT02666222|3470746|P1|NOT COMPLETED|Overall Study||2
1418454|NCT02666222|3470746|P1|COMPLETED|Overall Study||49
1418455|NCT02666222|3470746|P1|STARTED|Overall Study||51
1418456|NCT02665455|3470754|P1|NOT COMPLETED|Overall Study||9
1418457|NCT02665455|3470754|P1|COMPLETED|Overall Study||74
1418458|NCT02665455|3470754|P1|STARTED|Overall Study||83
1418459|NCT02665286|3470761|P3|NOT COMPLETED|Overall Study||1
1418460|NCT02665286|3470762|P2|NOT COMPLETED|Overall Study||2
1418461|NCT02665286|3470763|P1|NOT COMPLETED|Overall Study||3
1418462|NCT02665286|3470761|P3|COMPLETED|Overall Study||80
1418463|NCT02665286|3470762|P2|COMPLETED|Overall Study||78
1418464|NCT02665286|3470763|P1|COMPLETED|Overall Study||76
1418465|NCT02665286|3470761|P3|STARTED|Overall Study||81
1418466|NCT02665286|3470762|P2|STARTED|Overall Study||80
1418467|NCT02665286|3470763|P1|STARTED|Overall Study||79
1418468|NCT02665260|3470784|P4|NOT COMPLETED|Overall Study||1
1418469|NCT02665260|3470785|P3|NOT COMPLETED|Overall Study||4
1418470|NCT02665260|3470786|P2|NOT COMPLETED|Overall Study||1
1418471|NCT02665260|3470787|P1|NOT COMPLETED|Overall Study||2
1418472|NCT02665260|3470784|P4|COMPLETED|Overall Study||21
1418473|NCT02665260|3470785|P3|COMPLETED|Overall Study||21
1418474|NCT02665260|3470786|P2|COMPLETED|Overall Study||22
1418475|NCT02665260|3470787|P1|COMPLETED|Overall Study||22
1418476|NCT02665260|3470784|P4|STARTED|Overall Study||22
1418477|NCT02665260|3470785|P3|STARTED|Overall Study||25
1418478|NCT02665260|3470786|P2|STARTED|Overall Study||23
1418479|NCT02665260|3470787|P1|STARTED|Overall Study||24
1418480|NCT02665221|3470803|P2|NOT COMPLETED|Overall Study||15
1418481|NCT02665221|3470804|P1|NOT COMPLETED|Overall Study||15
1418482|NCT02665221|3470803|P2|COMPLETED|Overall Study||0
1418483|NCT02665221|3470804|P1|COMPLETED|Overall Study||0
1418484|NCT02665221|3470803|P2|STARTED|Overall Study||15
1418485|NCT02665221|3470804|P1|STARTED|Overall Study||15
1418486|NCT02664987|3470816|P1|NOT COMPLETED|Overall Study||0
1418487|NCT02664987|3470816|P1|COMPLETED|Overall Study||462
1418488|NCT02664987|3470816|P1|STARTED|Overall Study||462
1418489|NCT02664610|3470827|P2|NOT COMPLETED|Overall Study||7
1418490|NCT02664610|3470828|P1|NOT COMPLETED|Overall Study||14
1418491|NCT02664610|3470827|P2|COMPLETED|Overall Study||41
1418492|NCT02664610|3470828|P1|COMPLETED|Overall Study||32
1418493|NCT02664610|3470827|P2|STARTED|Overall Study||48
1418494|NCT02664610|3470828|P1|STARTED|Overall Study||46
1418495|NCT02664532|3470838|P2|NOT COMPLETED|Overall Study||0
1418496|NCT02664532|3470839|P1|NOT COMPLETED|Overall Study||0
1418497|NCT02664532|3470838|P2|COMPLETED|Overall Study||75
1418498|NCT02664532|3470839|P1|COMPLETED|Overall Study||75
1418499|NCT02664532|3470838|P2|STARTED|Overall Study||75
1418500|NCT02664532|3470839|P1|STARTED|Overall Study||75
1418501|NCT02664415|3470853|P2|NOT COMPLETED|Overall Study||0
1418502|NCT02664415|3470854|P1|NOT COMPLETED|Overall Study||1
1418503|NCT02664415|3470853|P2|COMPLETED|Overall Study||5
1418504|NCT02664415|3470854|P1|COMPLETED|Overall Study||13
1418505|NCT02664415|3470853|P2|STARTED|Overall Study||5
1418506|NCT02664415|3470854|P1|STARTED|Overall Study||14
1418507|NCT02664311|3470884|P2|NOT COMPLETED|Overall Study||0
1418508|NCT02664311|3470885|P1|NOT COMPLETED|Overall Study||0
1418509|NCT02664311|3470884|P2|COMPLETED|Overall Study||3
1418510|NCT02664311|3470885|P1|COMPLETED|Overall Study||6
1418511|NCT02664311|3470884|P2|STARTED|Overall Study||3
1418512|NCT02664311|3470885|P1|STARTED|Overall Study||6
1418513|NCT02663752|3470895|P1|NOT COMPLETED|Overall Study||0
1418514|NCT02663752|3470895|P1|COMPLETED|Overall Study||1
1418515|NCT02663752|3470895|P1|STARTED|Overall Study||1
1418516|NCT02663687|3470909|P5|NOT COMPLETED|Overall Study||0
1418517|NCT02663687|3470910|P4|NOT COMPLETED|Overall Study||0
1418518|NCT02663687|3470911|P3|NOT COMPLETED|Overall Study||1
1418519|NCT02663687|3470912|P2|NOT COMPLETED|Overall Study||0
1418520|NCT02663687|3470913|P1|NOT COMPLETED|Overall Study||2
1418521|NCT02663687|3470909|P5|COMPLETED|Overall Study||9
1418522|NCT02663687|3470910|P4|COMPLETED|Overall Study||9
1418523|NCT02663687|3470911|P3|COMPLETED|Overall Study||8
1418524|NCT02663687|3470912|P2|COMPLETED|Overall Study||9
1418525|NCT02663687|3470913|P1|COMPLETED|Overall Study||10
1418526|NCT02663687|3470909|P5|Treatment Period 2 (SC)|Overall Study||9
1418527|NCT02663687|3470910|P4|Treatment Period 2 (SC)|Overall Study||9
1418528|NCT02663687|3470911|P3|Treatment Period 2 (SC)|Overall Study||8
1418529|NCT02663687|3470912|P2|Treatment Period 2 (SC)|Overall Study||9
1418530|NCT02663687|3470913|P1|Treatment Period 2 (SC)|Overall Study||10
1418531|NCT02663687|3470909|P5|Treatment Period 1 (IV)|Overall Study||9
1418532|NCT02663687|3470910|P4|Treatment Period 1 (IV)|Overall Study||9
1418533|NCT02663687|3470911|P3|Treatment Period 1 (IV)|Overall Study||9
1418534|NCT02663687|3470912|P2|Treatment Period 1 (IV)|Overall Study||9
1418535|NCT02663687|3470913|P1|Treatment Period 1 (IV)|Overall Study||12
1418536|NCT02663687|3470909|P5|STARTED|Overall Study||9
1418537|NCT02663687|3470910|P4|STARTED|Overall Study||9
1418538|NCT02663687|3470911|P3|STARTED|Overall Study||9
1418539|NCT02663687|3470912|P2|STARTED|Overall Study||9
1418540|NCT02663687|3470913|P1|STARTED|Overall Study||12
1418541|NCT02663453|3470967|P2|NOT COMPLETED|Overall Study||4
1418542|NCT02663453|3470968|P1|NOT COMPLETED|Overall Study||5
1418543|NCT02663453|3470967|P2|COMPLETED|Overall Study||18
1418544|NCT02663453|3470968|P1|COMPLETED|Overall Study||17
1418545|NCT02663453|3470967|P2|STARTED|Overall Study||22
1418546|NCT02663453|3470968|P1|STARTED|Overall Study||22
1418547|NCT02663232|3470990|P1|NOT COMPLETED|Overall Study||0
1418548|NCT02663232|3470990|P1|COMPLETED|Overall Study||264
1418549|NCT02663232|3470990|P1|STARTED|Overall Study||264
1418550|NCT02662764|3471011|P1|NOT COMPLETED|Overall Study||30
1418551|NCT02662764|3471011|P1|COMPLETED|Overall Study|First 24-hours of study treatment|290
1418552|NCT02662764|3471011|P1|STARTED|Overall Study||320
1418553|NCT02662608|3471071|P1|NOT COMPLETED|Overall Study||0
1418554|NCT02662608|3471071|P1|COMPLETED|Overall Study||1
1418555|NCT02662608|3471071|P1|STARTED|Overall Study||1
1418556|NCT02662556|3471075|P1|NOT COMPLETED|Overall Study||8
1418557|NCT02662556|3471075|P1|COMPLETED|Overall Study||132
1418558|NCT02662556|3471075|P1|STARTED|Overall Study||140
1418559|NCT02662387|3471084|P2|NOT COMPLETED|Overall Study||0
1418560|NCT02662387|3471085|P1|NOT COMPLETED|Overall Study||0
1418561|NCT02662387|3471084|P2|COMPLETED|Overall Study||28
1418562|NCT02662387|3471085|P1|COMPLETED|Overall Study||27
1418563|NCT02662387|3471084|P2|STARTED|Overall Study||28
1418564|NCT02662387|3471085|P1|STARTED|Overall Study||27
1418565|NCT02661828|3471095|P2|NOT COMPLETED|Overall Study||0
1418566|NCT02661828|3471096|P1|NOT COMPLETED|Overall Study||0
1418567|NCT02661828|3471095|P2|COMPLETED|Overall Study||0
1418568|NCT02661828|3471096|P1|COMPLETED|Overall Study||1
1418569|NCT02661828|3471095|P2|STARTED|Overall Study||0
1418570|NCT02661828|3471096|P1|STARTED|Overall Study||1
1418571|NCT02661594|3471107|P4|NOT COMPLETED|Overall Study||0
1418572|NCT02661594|3471108|P3|NOT COMPLETED|Overall Study||1
1418573|NCT02661594|3471109|P2|NOT COMPLETED|Overall Study||0
1418574|NCT02661594|3471110|P1|NOT COMPLETED|Overall Study||1
1418575|NCT02661594|3471107|P4|COMPLETED|Overall Study||9
1418576|NCT02661594|3471108|P3|COMPLETED|Overall Study||9
1418577|NCT02661594|3471109|P2|COMPLETED|Overall Study||11
1418578|NCT02661594|3471110|P1|COMPLETED|Overall Study||9
1418579|NCT02661594|3471107|P4|STARTED|Overall Study||9
1418580|NCT02661594|3471108|P3|STARTED|Overall Study||10
1418581|NCT02661594|3471109|P2|STARTED|Overall Study||11
1418582|NCT02661594|3471110|P1|STARTED|Overall Study||10
1418583|NCT02661126|3471122|P2|NOT COMPLETED|Overall Study||0
1418584|NCT02661126|3471123|P1|NOT COMPLETED|Overall Study||0
1418585|NCT02661126|3471122|P2|COMPLETED|Overall Study||8
1418586|NCT02661126|3471123|P1|COMPLETED|Overall Study||8
1418587|NCT02661126|3471122|P2|STARTED|Overall Study||8
1418588|NCT02661126|3471123|P1|STARTED|Overall Study||8
1418589|NCT02660242|3471211|P1|NOT COMPLETED|Glucagon Injection||1
1418590|NCT02660242|3471211|P1|COMPLETED|Glucagon Injection||15
1418591|NCT02660242|3471211|P1|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
1418592|NCT02660242|3471211|P1|NOT COMPLETED|Glucose Tabs||1
1418593|NCT02660242|3471211|P1|COMPLETED|Glucose Tabs||15
1418594|NCT02660242|3471211|P1|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
1418595|NCT02660242|3471211|P1|NOT COMPLETED|Basal Insulin Reduction||0
1418596|NCT02660242|3471211|P1|COMPLETED|Basal Insulin Reduction||16
1418597|NCT02660242|3471211|P1|STARTED|Basal Insulin Reduction||16
1418598|NCT02660242|3471211|P1|NOT COMPLETED|Control||0
1418599|NCT02660242|3471211|P1|COMPLETED|Control||16
1418600|NCT02660242|3471211|P1|STARTED|Control||16
1418601|NCT02660229|3471267|P2|NOT COMPLETED|Overall Study||1
1418602|NCT02660229|3471268|P1|NOT COMPLETED|Overall Study||2
1418603|NCT02660229|3471267|P2|COMPLETED|Overall Study||31
1418604|NCT02660229|3471268|P1|COMPLETED|Overall Study||32
1418605|NCT02660229|3471267|P2|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
1418606|NCT02660229|3471268|P1|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
1418607|NCT02660229|3471267|P2|FAS Set|Overall Study||32
1418608|NCT02660229|3471268|P1|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
1418609|NCT02660229|3471267|P2|Safety Analysis Set|Overall Study||32
1418610|NCT02660229|3471268|P1|Safety Analysis Set|Overall Study||34
1418611|NCT02660229|3471267|P2|STARTED|Overall Study|Randomization|32
1418612|NCT02660229|3471268|P1|STARTED|Overall Study|Randomization|34
1418613|NCT02658461|3471283|P3|NOT COMPLETED|Overall Study||0
1418614|NCT02658461|3471284|P2|NOT COMPLETED|Overall Study||0
1418615|NCT02658461|3471285|P1|NOT COMPLETED|Overall Study||0
1418616|NCT02658461|3471283|P3|COMPLETED|Overall Study||12
1418617|NCT02658461|3471284|P2|COMPLETED|Overall Study||12
1418618|NCT02658461|3471285|P1|COMPLETED|Overall Study||12
1418619|NCT02658461|3471283|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
1418620|NCT02658461|3471284|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
1418621|NCT02658461|3471285|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
1418622|NCT02658240|3471313|P2|NOT COMPLETED|Overall Study||0
1418623|NCT02658240|3471314|P1|NOT COMPLETED|Overall Study||0
1418624|NCT02658240|3471313|P2|COMPLETED|Overall Study||30
1418625|NCT02658240|3471314|P1|COMPLETED|Overall Study||30
1418626|NCT02658240|3471313|P2|STARTED|Overall Study||30
1418627|NCT02658240|3471314|P1|STARTED|Overall Study||30
1418628|NCT02658149|3471328|P2|NOT COMPLETED|Overall Study||0
1418629|NCT02658149|3471329|P1|NOT COMPLETED|Overall Study||1
1418630|NCT02658149|3471328|P2|COMPLETED|Overall Study||50
1418631|NCT02658149|3471329|P1|COMPLETED|Overall Study||49
1418632|NCT02658149|3471328|P2|STARTED|Overall Study||50
1418633|NCT02658149|3471329|P1|STARTED|Overall Study||50
1418634|NCT02657629|3471345|P2|NOT COMPLETED|Overall Study||0
1418635|NCT02657629|3471346|P1|NOT COMPLETED|Overall Study||2
1418636|NCT02657629|3471345|P2|COMPLETED|Overall Study||14
1418637|NCT02657629|3471346|P1|COMPLETED|Overall Study||12
1418638|NCT02657629|3471345|P2|STARTED|Overall Study||14
1418639|NCT02657629|3471346|P1|STARTED|Overall Study||14
1418640|NCT02657538|3471352|P1|NOT COMPLETED|Overall Study||4
1418641|NCT02657538|3471352|P1|COMPLETED|Overall Study||31
1418642|NCT02657538|3471352|P1|Received Visual Caries Detection + Bite|Overall Study||35
1418643|NCT02657538|3471352|P1|Received Near Infrared Transillumination|Overall Study||35
1418644|NCT02657538|3471352|P1|STARTED|Overall Study||35
1418645|NCT02657252|3471361|P2|NOT COMPLETED|Overall Study||7
1418646|NCT02657252|3471362|P1|NOT COMPLETED|Overall Study||10
1418647|NCT02657252|3471361|P2|COMPLETED|Overall Study||51
1418648|NCT02657252|3471362|P1|COMPLETED|Overall Study||47
1418649|NCT02657252|3471361|P2|STARTED|Overall Study||58
1418650|NCT02657252|3471362|P1|STARTED|Overall Study||57
1418651|NCT02657031|3471374|P2|NOT COMPLETED|Overall Study||2
1418652|NCT02657031|3471375|P1|NOT COMPLETED|Overall Study||1
1418653|NCT02657031|3471374|P2|COMPLETED|Overall Study||23
1418654|NCT02657031|3471375|P1|COMPLETED|Overall Study||28
1418655|NCT02657031|3471374|P2|STARTED|Overall Study||25
1418656|NCT02657031|3471375|P1|STARTED|Overall Study||29
1418657|NCT02656745|3471389|P1|NOT COMPLETED|Overall Study||0
1418658|NCT02656745|3471389|P1|COMPLETED|Overall Study||416
1418659|NCT02656745|3471389|P1|STARTED|Overall Study||416
1418660|NCT02656485|3471400|P4|NOT COMPLETED|Overall Study||2
1418661|NCT02656485|3471401|P3|NOT COMPLETED|Overall Study||2
1418662|NCT02656485|3471402|P2|NOT COMPLETED|Overall Study||3
1418663|NCT02656485|3471403|P1|NOT COMPLETED|Overall Study||2
1418664|NCT02656485|3471400|P4|COMPLETED|Overall Study||7
1418665|NCT02656485|3471401|P3|COMPLETED|Overall Study||7
1418666|NCT02656485|3471402|P2|COMPLETED|Overall Study||6
1418667|NCT02656485|3471403|P1|COMPLETED|Overall Study||7
1418668|NCT02656485|3471400|P4|STARTED|Overall Study||9
1418669|NCT02656485|3471401|P3|STARTED|Overall Study||9
1418670|NCT02656485|3471402|P2|STARTED|Overall Study||9
1418671|NCT02656485|3471403|P1|STARTED|Overall Study||9
1418672|NCT02656173|3471417|P2|NOT COMPLETED|Overall Study||11
1418673|NCT02656173|3471418|P1|NOT COMPLETED|Overall Study||13
1418674|NCT02656173|3471417|P2|COMPLETED|Overall Study||272
1418675|NCT02656173|3471418|P1|COMPLETED|Overall Study||272
1418676|NCT02656173|3471417|P2|Received Treatment|Overall Study||282
1418677|NCT02656173|3471418|P1|Received Treatment|Overall Study||284
1418678|NCT02656173|3471417|P2|STARTED|Overall Study||283
1418679|NCT02656173|3471418|P1|STARTED|Overall Study||285
1418680|NCT02656160|3471454|P2|NOT COMPLETED|Second Study Night||0
1418681|NCT02656160|3471455|P1|NOT COMPLETED|Second Study Night||0
1418682|NCT02656160|3471454|P2|COMPLETED|Second Study Night||6
1418683|NCT02656160|3471455|P1|COMPLETED|Second Study Night||4
1418684|NCT02656160|3471454|P2|STARTED|Second Study Night||6
1418685|NCT02656160|3471455|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
1418686|NCT02656160|3471454|P2|NOT COMPLETED|First Study Night||0
1418687|NCT02656160|3471455|P1|NOT COMPLETED|First Study Night||0
1418688|NCT02656160|3471454|P2|COMPLETED|First Study Night||6
1418689|NCT02656160|3471455|P1|COMPLETED|First Study Night||7
1418690|NCT02656160|3471454|P2|STARTED|First Study Night||6
1418691|NCT02656160|3471455|P1|STARTED|First Study Night||7
1418692|NCT02656069|3471465|P2|NOT COMPLETED|Second Intervention||1
1418693|NCT02656069|3471466|P1|NOT COMPLETED|Second Intervention||1
1418694|NCT02656069|3471465|P2|COMPLETED|Second Intervention||35
1418695|NCT02656069|3471466|P1|COMPLETED|Second Intervention||43
1418696|NCT02656069|3471465|P2|STARTED|Second Intervention||36
1418697|NCT02656069|3471466|P1|STARTED|Second Intervention||44
1418698|NCT02656069|3471465|P2|NOT COMPLETED|First Intervention||0
1418699|NCT02656069|3471466|P1|NOT COMPLETED|First Intervention||0
1418700|NCT02656069|3471465|P2|COMPLETED|First Intervention||36
1418701|NCT02656069|3471466|P1|COMPLETED|First Intervention||44
1418702|NCT02656069|3471465|P2|STARTED|First Intervention||36
1418703|NCT02656069|3471466|P1|STARTED|First Intervention||44
1418704|NCT02655666|3471490|P1|NOT COMPLETED|Overall Study||12
1418705|NCT02655666|3471490|P1|COMPLETED|Overall Study||4
1418706|NCT02655666|3471490|P1|STARTED|Overall Study||16
1418707|NCT02654639|3471503|P1|NOT COMPLETED|Overall Study||0
1418708|NCT02654639|3471503|P1|COMPLETED|Overall Study||4
1418709|NCT02654639|3471503|P1|STARTED|Overall Study||4
1418710|NCT02654145|3471507|P1|NOT COMPLETED|Overall Study||7
1418711|NCT02654145|3471507|P1|COMPLETED|Overall Study||138
1418712|NCT02654145|3471507|P1|STARTED|Overall Study||145
1418713|NCT02653872|3471514|P1|NOT COMPLETED|Overall Study||0
1418714|NCT02653872|3471514|P1|COMPLETED|Overall Study||15
1418715|NCT02653872|3471514|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
1418716|NCT02653872|3471514|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
1418717|NCT02653872|3471514|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
1418718|NCT02653872|3471514|P1|STARTED|Overall Study||15
1418719|NCT02653625|3471549|P1|NOT COMPLETED|Overall Study||4
1418720|NCT02653625|3471549|P1|COMPLETED|Overall Study||20
1418721|NCT02653625|3471549|P1|STARTED|Overall Study||24
1418722|NCT02653560|3471558|P4|NOT COMPLETED|Placebo Phase||0
1418723|NCT02653560|3471559|P3|NOT COMPLETED|Placebo Phase||0
1418724|NCT02653560|3471560|P2|NOT COMPLETED|Placebo Phase||0
1418725|NCT02653560|3471561|P1|NOT COMPLETED|Placebo Phase||0
1418726|NCT02653560|3471558|P4|COMPLETED|Placebo Phase||30
1418727|NCT02653560|3471559|P3|COMPLETED|Placebo Phase||0
1418728|NCT02653560|3471560|P2|COMPLETED|Placebo Phase||0
1418729|NCT02653560|3471561|P1|COMPLETED|Placebo Phase||0
1418730|NCT02653560|3471558|P4|STARTED|Placebo Phase||30
1418731|NCT02653560|3471559|P3|STARTED|Placebo Phase||0
1418732|NCT02653560|3471560|P2|STARTED|Placebo Phase||0
1418733|NCT02653560|3471561|P1|STARTED|Placebo Phase||0
1418734|NCT02653560|3471558|P4|NOT COMPLETED|KCl Phase||0
1418735|NCT02653560|3471559|P3|NOT COMPLETED|KCl Phase||0
1418736|NCT02653560|3471560|P2|NOT COMPLETED|KCl Phase||0
1418737|NCT02653560|3471561|P1|NOT COMPLETED|KCl Phase||0
1418738|NCT02653560|3471558|P4|COMPLETED|KCl Phase||0
1418739|NCT02653560|3471559|P3|COMPLETED|KCl Phase||30
1418740|NCT02653560|3471560|P2|COMPLETED|KCl Phase||0
1418741|NCT02653560|3471561|P1|COMPLETED|KCl Phase||0
1418742|NCT02653560|3471558|P4|STARTED|KCl Phase||0
1418743|NCT02653560|3471559|P3|STARTED|KCl Phase||30
1418744|NCT02653560|3471560|P2|STARTED|KCl Phase||0
1418745|NCT02653560|3471561|P1|STARTED|KCl Phase||0
1418746|NCT02653560|3471558|P4|NOT COMPLETED|K Citrate Phase||0
1418747|NCT02653560|3471559|P3|NOT COMPLETED|K Citrate Phase||0
1418748|NCT02653560|3471560|P2|NOT COMPLETED|K Citrate Phase||0
1418749|NCT02653560|3471561|P1|NOT COMPLETED|K Citrate Phase||0
1418750|NCT02653560|3471558|P4|COMPLETED|K Citrate Phase||0
1418751|NCT02653560|3471559|P3|COMPLETED|K Citrate Phase||0
1418752|NCT02653560|3471560|P2|COMPLETED|K Citrate Phase||30
1418753|NCT02653560|3471561|P1|COMPLETED|K Citrate Phase||0
1418754|NCT02653560|3471558|P4|STARTED|K Citrate Phase||0
1418755|NCT02653560|3471559|P3|STARTED|K Citrate Phase||0
1418756|NCT02653560|3471560|P2|STARTED|K Citrate Phase||30
1418757|NCT02653560|3471561|P1|STARTED|K Citrate Phase||0
1418758|NCT02653560|3471558|P4|NOT COMPLETED|KMgCit Phase||0
1418759|NCT02653560|3471559|P3|NOT COMPLETED|KMgCit Phase||0
1418760|NCT02653560|3471560|P2|NOT COMPLETED|KMgCit Phase||0
1418761|NCT02653560|3471561|P1|NOT COMPLETED|KMgCit Phase||0
1418762|NCT02653560|3471558|P4|COMPLETED|KMgCit Phase||0
1418763|NCT02653560|3471559|P3|COMPLETED|KMgCit Phase||0
1418764|NCT02653560|3471560|P2|COMPLETED|KMgCit Phase||0
1418765|NCT02653560|3471561|P1|COMPLETED|KMgCit Phase||30
1418766|NCT02653560|3471558|P4|STARTED|KMgCit Phase||0
1418767|NCT02653560|3471559|P3|STARTED|KMgCit Phase||0
1418768|NCT02653560|3471560|P2|STARTED|KMgCit Phase||0
1418769|NCT02653560|3471561|P1|STARTED|KMgCit Phase||30
1418770|NCT02653495|3471573|P2|NOT COMPLETED|Overall Study||0
1418771|NCT02653495|3471574|P1|NOT COMPLETED|Overall Study||12
1418772|NCT02653495|3471573|P2|COMPLETED|Overall Study||2
1418773|NCT02653495|3471574|P1|COMPLETED|Overall Study||3
1418774|NCT02653495|3471573|P2|STARTED|Overall Study||2
1418775|NCT02653495|3471574|P1|STARTED|Overall Study||15
1418776|NCT02653456|3471588|P1|NOT COMPLETED|Overall Study||5
1418777|NCT02653456|3471588|P1|COMPLETED|Overall Study||59
1418778|NCT02653456|3471588|P1|STARTED|Overall Study||64
1418779|NCT02652624|3471597|P2|NOT COMPLETED|Extension Phase||228
1418780|NCT02652624|3471598|P1|NOT COMPLETED|Extension Phase||230
1418781|NCT02652624|3471597|P2|COMPLETED|Extension Phase||0
1418782|NCT02652624|3471598|P1|COMPLETED|Extension Phase||0
1418783|NCT02652624|3471597|P2|STARTED|Extension Phase||228
1418784|NCT02652624|3471598|P1|STARTED|Extension Phase||230
1418785|NCT02652624|3471597|P2|NOT COMPLETED|Randomized Phase||9
1418786|NCT02652624|3471598|P1|NOT COMPLETED|Randomized Phase||5
1418787|NCT02652624|3471597|P2|COMPLETED|Randomized Phase||228
1418788|NCT02652624|3471598|P1|COMPLETED|Randomized Phase||230
1418789|NCT02652624|3471597|P2|STARTED|Randomized Phase||237
1418790|NCT02652624|3471598|P1|STARTED|Randomized Phase||235
1418791|NCT02652390|3471611|P3|NOT COMPLETED|Overall Study||0
1418792|NCT02652390|3471612|P2|NOT COMPLETED|Overall Study||0
1418793|NCT02652390|3471613|P1|NOT COMPLETED|Overall Study||0
1418794|NCT02652390|3471611|P3|COMPLETED|Overall Study||37
1418795|NCT02652390|3471612|P2|COMPLETED|Overall Study||37
1418796|NCT02652390|3471613|P1|COMPLETED|Overall Study||37
1418797|NCT02652390|3471611|P3|STARTED|Overall Study||37
1418798|NCT02652390|3471612|P2|STARTED|Overall Study||37
1418799|NCT02652390|3471613|P1|STARTED|Overall Study||37
1418800|NCT02652221|3471635|P1|NOT COMPLETED|Overall Study||0
1418801|NCT02652221|3471635|P1|COMPLETED|Overall Study||55
1418802|NCT02652221|3471635|P1|STARTED|Overall Study||55
1418803|NCT02652208|3471644|P2|NOT COMPLETED|Overall Study||2
1418804|NCT02652208|3471645|P1|NOT COMPLETED|Overall Study||4
1418805|NCT02652208|3471644|P2|COMPLETED|Overall Study||15
1418806|NCT02652208|3471645|P1|COMPLETED|Overall Study||13
1418807|NCT02652208|3471644|P2|STARTED|Overall Study||17
1418808|NCT02652208|3471645|P1|STARTED|Overall Study||17
1418809|NCT02652156|3471658|P3|NOT COMPLETED|Overall Study||0
1418810|NCT02652156|3471659|P2|NOT COMPLETED|Overall Study||0
1418811|NCT02652156|3471660|P1|NOT COMPLETED|Overall Study||1
1418812|NCT02652156|3471658|P3|COMPLETED|Overall Study||4
1418813|NCT02652156|3471659|P2|COMPLETED|Overall Study||6
1418814|NCT02652156|3471660|P1|COMPLETED|Overall Study||3
1418815|NCT02652156|3471658|P3|STARTED|Overall Study||4
1418816|NCT02652156|3471659|P2|STARTED|Overall Study||6
1418817|NCT02652156|3471660|P1|STARTED|Overall Study||4
1418818|NCT02651922|3471686|P1|NOT COMPLETED|Overall Study||2
1418819|NCT02651922|3471686|P1|COMPLETED|Overall Study||154
1418820|NCT02651922|3471686|P1|STARTED|Overall Study||156
1418821|NCT02651467|3471706|P3|NOT COMPLETED|Overall Study||4
1418822|NCT02651467|3471707|P2|NOT COMPLETED|Overall Study||0
1418823|NCT02651467|3471708|P1|NOT COMPLETED|Overall Study||1
1418824|NCT02651467|3471706|P3|COMPLETED|Overall Study||69
1418825|NCT02651467|3471707|P2|COMPLETED|Overall Study||74
1418826|NCT02651467|3471708|P1|COMPLETED|Overall Study||73
1418827|NCT02651467|3471706|P3|STARTED|Overall Study||73
1418828|NCT02651467|3471707|P2|STARTED|Overall Study||74
1418829|NCT02651467|3471708|P1|STARTED|Overall Study||74
1418830|NCT02651194|3471727|P1|NOT COMPLETED|Overall Study||5
1418831|NCT02651194|3471727|P1|COMPLETED|Overall Study||99
1418832|NCT02651194|3471727|P1|STARTED|Overall Study||104
1418833|NCT02651155|3471735|P2|NOT COMPLETED|Overall Study||2
1418834|NCT02651155|3471736|P1|NOT COMPLETED|Overall Study||6
1418835|NCT02651155|3471735|P2|COMPLETED|Overall Study||103
1418836|NCT02651155|3471736|P1|COMPLETED|Overall Study||93
1418837|NCT02651155|3471735|P2|STARTED|Overall Study||105
1418838|NCT02651155|3471736|P1|STARTED|Overall Study||99
1418839|NCT02651103|3471752|P1|NOT COMPLETED|Overall Study||0
1418840|NCT02651103|3471752|P1|COMPLETED|Overall Study||30
1418841|NCT02651103|3471752|P1|STARTED|Overall Study||30
1418842|NCT02650921|3471756|P1|NOT COMPLETED|Overall Study||8
1418843|NCT02650921|3471756|P1|COMPLETED|Overall Study||84
1418844|NCT02650921|3471756|P1|STARTED|Overall Study||92
1418845|NCT02650440|3471806|P2|NOT COMPLETED|Overall Study||2
1418846|NCT02650440|3471807|P1|NOT COMPLETED|Overall Study||0
1418847|NCT02650440|3471806|P2|COMPLETED|Overall Study||8
1418848|NCT02650440|3471807|P1|COMPLETED|Overall Study||10
1418849|NCT02650440|3471806|P2|STARTED|Overall Study||10
1418850|NCT02650440|3471807|P1|STARTED|Overall Study||10
1418851|NCT02650219|3471825|P2|NOT COMPLETED|Overall Study||0
1418852|NCT02650219|3471826|P1|NOT COMPLETED|Overall Study||0
1418853|NCT02650219|3471825|P2|COMPLETED|Overall Study||20
1418854|NCT02650219|3471826|P1|COMPLETED|Overall Study||40
1418855|NCT02650219|3471825|P2|STARTED|Overall Study||20
1418856|NCT02650219|3471826|P1|STARTED|Overall Study||40
1418857|NCT02650193|3471839|P3|NOT COMPLETED|Overall Study||0
1418858|NCT02650193|3471840|P2|NOT COMPLETED|Overall Study||0
1418859|NCT02650193|3471841|P1|NOT COMPLETED|Overall Study||0
1418860|NCT02650193|3471839|P3|COMPLETED|Overall Study||13
1418861|NCT02650193|3471840|P2|COMPLETED|Overall Study||6
1418862|NCT02650193|3471841|P1|COMPLETED|Overall Study||6
1418863|NCT02650193|3471839|P3|STARTED|Overall Study||13
1418864|NCT02650193|3471840|P2|STARTED|Overall Study||6
1418865|NCT02650193|3471841|P1|STARTED|Overall Study||6
1418866|NCT02650128|3471928|P1|NOT COMPLETED|Overall Study||2
1418867|NCT02650128|3471928|P1|COMPLETED|Overall Study||58
1418868|NCT02650128|3471928|P1|30 Day Primary and Safety Endpoint|Overall Study||60
1418869|NCT02650128|3471928|P1|STARTED|Overall Study||60
1418870|NCT02649634|3471937|P2|NOT COMPLETED|Overall Study||6
1418871|NCT02649634|3471938|P1|NOT COMPLETED|Overall Study||3
1418872|NCT02649634|3471937|P2|COMPLETED|Overall Study||60
1418873|NCT02649634|3471938|P1|COMPLETED|Overall Study||66
1418874|NCT02649634|3471937|P2|STARTED|Overall Study||66
1418875|NCT02649634|3471938|P1|STARTED|Overall Study||69
1418876|NCT02648646|3471994|P1|NOT COMPLETED|Overall Study||2
1418877|NCT02648646|3471994|P1|COMPLETED|Overall Study||8
1418878|NCT02648646|3471994|P1|STARTED|Overall Study||10
1418879|NCT02648438|3472045|P3|NOT COMPLETED|Overall Study||0
1418880|NCT02648438|3472046|P2|NOT COMPLETED|Overall Study||3
1418881|NCT02648438|3472047|P1|NOT COMPLETED|Overall Study||3
1418882|NCT02648438|3472045|P3|COMPLETED|Overall Study||6
1418883|NCT02648438|3472046|P2|COMPLETED|Overall Study||9
1418884|NCT02648438|3472047|P1|COMPLETED|Overall Study||9
1418885|NCT02648438|3472045|P3|STARTED|Overall Study||6
1418886|NCT02648438|3472046|P2|STARTED|Overall Study||12
1418887|NCT02648438|3472047|P1|STARTED|Overall Study||12
1418888|NCT02648217|3472089|P2|NOT COMPLETED|Overall Study||5
1418889|NCT02648217|3472090|P1|NOT COMPLETED|Overall Study||10
1418890|NCT02648217|3472089|P2|COMPLETED|Overall Study||127
1418891|NCT02648217|3472090|P1|COMPLETED|Overall Study||121
1418892|NCT02648217|3472089|P2|Exposed|Overall Study||132
1418893|NCT02648217|3472090|P1|Exposed|Overall Study||130
1418894|NCT02648217|3472089|P2|STARTED|Overall Study||132
1418895|NCT02648217|3472090|P1|STARTED|Overall Study||131
1418896|NCT02648204|3472112|P4|NOT COMPLETED|Overall Study||16
1418897|NCT02648204|3472113|P3|NOT COMPLETED|Overall Study||13
1418898|NCT02648204|3472114|P2|NOT COMPLETED|Overall Study||21
1418899|NCT02648204|3472115|P1|NOT COMPLETED|Overall Study||22
1418900|NCT02648204|3472112|P4|COMPLETED|Overall Study||284
1418901|NCT02648204|3472113|P3|COMPLETED|Overall Study||287
1418902|NCT02648204|3472114|P2|COMPLETED|Overall Study||279
1418903|NCT02648204|3472115|P1|COMPLETED|Overall Study||279
1418904|NCT02648204|3472112|P4|Exposed|Overall Study||299
1418905|NCT02648204|3472113|P3|Exposed|Overall Study||299
1418906|NCT02648204|3472114|P2|Exposed|Overall Study||300
1418907|NCT02648204|3472115|P1|Exposed|Overall Study||301
1418908|NCT02648204|3472112|P4|STARTED|Overall Study||300
1418909|NCT02648204|3472113|P3|STARTED|Overall Study||300
1418910|NCT02648204|3472114|P2|STARTED|Overall Study||300
1418911|NCT02648204|3472115|P1|STARTED|Overall Study||301
1418912|NCT02648022|3472235|P2|NOT COMPLETED|Overall Study||0
1418913|NCT02648022|3472236|P1|NOT COMPLETED|Overall Study||0
1418914|NCT02648022|3472235|P2|COMPLETED|Overall Study||39
1418915|NCT02648022|3472236|P1|COMPLETED|Overall Study||40
1418916|NCT02648022|3472235|P2|STARTED|Overall Study||39
1418917|NCT02648022|3472236|P1|STARTED|Overall Study||40
1418918|NCT02647944|3472248|P2|NOT COMPLETED|Overall Study||3
1418919|NCT02647944|3472249|P1|NOT COMPLETED|Overall Study||2
1418920|NCT02647944|3472248|P2|COMPLETED|Overall Study||18
1418921|NCT02647944|3472249|P1|COMPLETED|Overall Study||17
1418922|NCT02647944|3472248|P2|STARTED|Overall Study||21
1418923|NCT02647944|3472249|P1|STARTED|Overall Study||19
1418924|NCT02647905|3472273|P1|NOT COMPLETED|Overall Study||3
1418925|NCT02647905|3472273|P1|COMPLETED|Overall Study||87
1418926|NCT02647905|3472273|P1|STARTED|Overall Study||90
1418927|NCT02647645|3472280|P2|NOT COMPLETED|Overall Study||1
1418928|NCT02647645|3472281|P1|NOT COMPLETED|Overall Study||2
1418929|NCT02647645|3472280|P2|COMPLETED|Overall Study||9
1418930|NCT02647645|3472281|P1|COMPLETED|Overall Study||9
1418931|NCT02647645|3472280|P2|STARTED|Overall Study||10
1418932|NCT02647645|3472281|P1|STARTED|Overall Study||11
1418933|NCT02647320|3472296|P5|NOT COMPLETED|Overall Study||17
1418934|NCT02647320|3472297|P4|NOT COMPLETED|Overall Study||10
1418935|NCT02647320|3472298|P3|NOT COMPLETED|Overall Study||15
1418936|NCT02647320|3472299|P2|NOT COMPLETED|Overall Study||11
1418937|NCT02647320|3472300|P1|NOT COMPLETED|Overall Study||12
1418938|NCT02647320|3472296|P5|COMPLETED|Overall Study||52
1418939|NCT02647320|3472297|P4|COMPLETED|Overall Study||58
1418940|NCT02647320|3472298|P3|COMPLETED|Overall Study||54
1418941|NCT02647320|3472299|P2|COMPLETED|Overall Study||35
1418942|NCT02647320|3472300|P1|COMPLETED|Overall Study||34
1418943|NCT02647320|3472296|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
1418944|NCT02647320|3472297|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
1418945|NCT02647320|3472298|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
1418946|NCT02647320|3472299|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
1418947|NCT02647320|3472300|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
1418948|NCT02647320|3472296|P5|Safety Set|Overall Study||69
1418949|NCT02647320|3472297|P4|Safety Set|Overall Study||68
1418950|NCT02647320|3472298|P3|Safety Set|Overall Study||68
1418951|NCT02647320|3472299|P2|Safety Set|Overall Study||44
1418952|NCT02647320|3472300|P1|Safety Set|Overall Study||43
1418953|NCT02647320|3472296|P5|Inadvertently Randomized|Overall Study||0
1418954|NCT02647320|3472297|P4|Inadvertently Randomized|Overall Study||1
1418955|NCT02647320|3472298|P3|Inadvertently Randomized|Overall Study||0
1418956|NCT02647320|3472299|P2|Inadvertently Randomized|Overall Study||0
1418957|NCT02647320|3472300|P1|Inadvertently Randomized|Overall Study||0
1418958|NCT02647320|3472296|P5|STARTED|Overall Study||69
1418959|NCT02647320|3472297|P4|STARTED|Overall Study||68
1418960|NCT02647320|3472298|P3|STARTED|Overall Study||69
1418961|NCT02647320|3472299|P2|STARTED|Overall Study||46
1418962|NCT02647320|3472300|P1|STARTED|Overall Study||46
1418963|NCT02647281|3472391|P9|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
1418964|NCT02647281|3472392|P8|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418965|NCT02647281|3472393|P7|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418966|NCT02647281|3472394|P6|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418967|NCT02647281|3472395|P5|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418968|NCT02647281|3472396|P4|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418969|NCT02647281|3472397|P3|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418970|NCT02647281|3472398|P2|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418971|NCT02647281|3472399|P1|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418972|NCT02647281|3472391|P9|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
1418973|NCT02647281|3472392|P8|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
1418974|NCT02647281|3472393|P7|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
1418975|NCT02647281|3472394|P6|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
1418976|NCT02647281|3472395|P5|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418977|NCT02647281|3472396|P4|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418978|NCT02647281|3472397|P3|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418979|NCT02647281|3472398|P2|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418980|NCT02647281|3472399|P1|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418981|NCT02647281|3472391|P9|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
1418982|NCT02647281|3472392|P8|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
1418983|NCT02647281|3472393|P7|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
1418984|NCT02647281|3472394|P6|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
1418985|NCT02647281|3472395|P5|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418986|NCT02647281|3472396|P4|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418987|NCT02647281|3472397|P3|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418988|NCT02647281|3472398|P2|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418989|NCT02647281|3472399|P1|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
1418990|NCT02647281|3472391|P9|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1418991|NCT02647281|3472392|P8|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1418992|NCT02647281|3472393|P7|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1418993|NCT02647281|3472394|P6|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1418994|NCT02647281|3472395|P5|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1418995|NCT02647281|3472396|P4|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1418996|NCT02647281|3472397|P3|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1418997|NCT02647281|3472398|P2|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1418998|NCT02647281|3472399|P1|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1418999|NCT02647281|3472391|P9|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1419000|NCT02647281|3472392|P8|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1419001|NCT02647281|3472393|P7|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1419002|NCT02647281|3472394|P6|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
1419003|NCT02647281|3472395|P5|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
1419004|NCT02647281|3472396|P4|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
1419005|NCT02647281|3472397|P3|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
1419006|NCT02647281|3472398|P2|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
1419007|NCT02647281|3472399|P1|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
1419008|NCT02647281|3472391|P9|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
1419009|NCT02647281|3472392|P8|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
1419010|NCT02647281|3472393|P7|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
1419011|NCT02647281|3472394|P6|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
1419012|NCT02647281|3472395|P5|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
1419013|NCT02647281|3472396|P4|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
1419014|NCT02647281|3472397|P3|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
1419015|NCT02647281|3472398|P2|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
1419016|NCT02647281|3472399|P1|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
1419017|NCT02646566|3472580|P3|NOT COMPLETED|Overall Study||5
1419018|NCT02646566|3472581|P2|NOT COMPLETED|Overall Study||4
1419019|NCT02646566|3472582|P1|NOT COMPLETED|Overall Study||6
1419020|NCT02646566|3472580|P3|COMPLETED|Overall Study||230
1419021|NCT02646566|3472581|P2|COMPLETED|Overall Study||226
1419022|NCT02646566|3472582|P1|COMPLETED|Overall Study||231
1419023|NCT02646566|3472580|P3|STARTED|Overall Study||235
1419024|NCT02646566|3472581|P2|STARTED|Overall Study||230
1419025|NCT02646566|3472582|P1|STARTED|Overall Study||237
1419026|NCT02646449|3472622|P2|NOT COMPLETED|Overall Study||0
1419027|NCT02646449|3472623|P1|NOT COMPLETED|Overall Study||0
1419028|NCT02646449|3472622|P2|COMPLETED|Overall Study||3
1419029|NCT02646449|3472623|P1|COMPLETED|Overall Study||4
1419030|NCT02646449|3472622|P2|STARTED|Overall Study||3
1419031|NCT02646449|3472623|P1|STARTED|Overall Study||4
1419032|NCT02646124|3472633|P2|NOT COMPLETED|Overall Study||2
1419033|NCT02646124|3472634|P1|NOT COMPLETED|Overall Study||0
1419034|NCT02646124|3472633|P2|COMPLETED|Overall Study||55
1419035|NCT02646124|3472634|P1|COMPLETED|Overall Study||57
1419036|NCT02646124|3472633|P2|STARTED|Overall Study||57
1419037|NCT02646124|3472634|P1|STARTED|Overall Study||57
1419038|NCT02645760|3472650|P2|NOT COMPLETED|Overall Study||0
1419039|NCT02645760|3472651|P1|NOT COMPLETED|Overall Study||0
1419040|NCT02645760|3472650|P2|COMPLETED|Overall Study||19
1419041|NCT02645760|3472651|P1|COMPLETED|Overall Study||19
1419042|NCT02645760|3472650|P2|STARTED|Overall Study||19
1419043|NCT02645760|3472651|P1|STARTED|Overall Study||19
1419044|NCT02645253|3472667|P4|NOT COMPLETED|Overall Study||0
1419045|NCT02645253|3472668|P3|NOT COMPLETED|Overall Study||0
1419046|NCT02645253|3472669|P2|NOT COMPLETED|Overall Study||0
1419047|NCT02645253|3472670|P1|NOT COMPLETED|Overall Study||0
1419048|NCT02645253|3472667|P4|COMPLETED|Overall Study||6
1419049|NCT02645253|3472668|P3|COMPLETED|Overall Study||7
1419050|NCT02645253|3472669|P2|COMPLETED|Overall Study||7
1419051|NCT02645253|3472670|P1|COMPLETED|Overall Study||7
1419052|NCT02645253|3472667|P4|STARTED|Overall Study||6
1419053|NCT02645253|3472668|P3|STARTED|Overall Study||7
1419054|NCT02645253|3472669|P2|STARTED|Overall Study||7
1419055|NCT02645253|3472670|P1|STARTED|Overall Study||7
1419056|NCT02645123|3472792|P3|NOT COMPLETED|Overall Study||0
1419057|NCT02645123|3472793|P2|NOT COMPLETED|Overall Study||0
1419058|NCT02645123|3472794|P1|NOT COMPLETED|Overall Study||0
1419059|NCT02645123|3472792|P3|COMPLETED|Overall Study||25
1419060|NCT02645123|3472793|P2|COMPLETED|Overall Study||25
1419061|NCT02645123|3472794|P1|COMPLETED|Overall Study||25
1419062|NCT02645123|3472792|P3|STARTED|Overall Study||25
1419063|NCT02645123|3472793|P2|STARTED|Overall Study||25
1419064|NCT02645123|3472794|P1|STARTED|Overall Study||25
1419065|NCT02644356|3472811|P1|NOT COMPLETED|Overall Study||2
1419066|NCT02644356|3472811|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
1419067|NCT02644356|3472811|P1|STARTED|Overall Study||51
1419068|NCT02644122|3472821|P1|NOT COMPLETED|Overall Study||1
1419069|NCT02644122|3472821|P1|COMPLETED|Overall Study||0
1419070|NCT02644122|3472821|P1|STARTED|Overall Study||1
1419071|NCT02644109|3472831|P2|NOT COMPLETED|Overall Study||4
1419072|NCT02644109|3472832|P1|NOT COMPLETED|Overall Study||0
1419073|NCT02644109|3472831|P2|COMPLETED|Overall Study||24
1419074|NCT02644109|3472832|P1|COMPLETED|Overall Study||24
1419075|NCT02644109|3472831|P2|STARTED|Overall Study||28
1419076|NCT02644109|3472832|P1|STARTED|Overall Study||24
1419077|NCT02644096|3472840|P2|NOT COMPLETED|Overall Study||25
1419078|NCT02644096|3472841|P1|NOT COMPLETED|Overall Study||28
1419079|NCT02644096|3472840|P2|COMPLETED|Overall Study||57
1419080|NCT02644096|3472841|P1|COMPLETED|Overall Study||65
1419081|NCT02644096|3472840|P2|9 Month SF-36 Questionnaire|Overall Study||57
1419082|NCT02644096|3472841|P1|9 Month SF-36 Questionnaire|Overall Study||65
1419083|NCT02644096|3472840|P2|12 Week SF-36 Questionnaire|Overall Study||59
1419084|NCT02644096|3472841|P1|12 Week SF-36 Questionnaire|Overall Study||68
1419085|NCT02644096|3472840|P2|10 Week Interview|Overall Study||59
1419086|NCT02644096|3472841|P1|10 Week Interview|Overall Study|Not done in control group|0
1419087|NCT02644096|3472840|P2|2 Week Interview|Overall Study||68
1419088|NCT02644096|3472841|P1|2 Week Interview|Overall Study|Not done in control group|0
1419089|NCT02644096|3472840|P2|STARTED|Overall Study||82
1419090|NCT02644096|3472841|P1|STARTED|Overall Study||93
1419091|NCT02643862|3472849|P2|NOT COMPLETED|Overall Study||0
1419092|NCT02643862|3472850|P1|NOT COMPLETED|Overall Study||0
1419093|NCT02643862|3472849|P2|COMPLETED|Overall Study||12
1419094|NCT02643862|3472850|P1|COMPLETED|Overall Study||36
1419095|NCT02643862|3472849|P2|STARTED|Overall Study||12
1419096|NCT02643862|3472850|P1|STARTED|Overall Study||36
1419097|NCT02643615|3472860|P2|NOT COMPLETED|Overall Study||0
1419098|NCT02643615|3472861|P1|NOT COMPLETED|Overall Study||0
1419099|NCT02643615|3472860|P2|COMPLETED|Overall Study||11
1419100|NCT02643615|3472861|P1|COMPLETED|Overall Study||9
1419101|NCT02643615|3472860|P2|STARTED|Overall Study||11
1419102|NCT02643615|3472861|P1|STARTED|Overall Study||9
1419103|NCT02643394|3472875|P2|NOT COMPLETED|Overall Study||5
1419104|NCT02643394|3472876|P1|NOT COMPLETED|Overall Study||4
1419105|NCT02643394|3472875|P2|COMPLETED|Overall Study||50
1419106|NCT02643394|3472876|P1|COMPLETED|Overall Study||51
1419107|NCT02643394|3472875|P2|STARTED|Overall Study||55
1419108|NCT02643394|3472876|P1|STARTED|Overall Study||55
1419109|NCT02643251|3472886|P2|NOT COMPLETED|Overall Study||2
1419110|NCT02643251|3472887|P1|NOT COMPLETED|Overall Study||11
1419111|NCT02643251|3472886|P2|COMPLETED|Overall Study||67
1419112|NCT02643251|3472887|P1|COMPLETED|Overall Study||58
1419113|NCT02643251|3472886|P2|STARTED|Overall Study||69
1419114|NCT02643251|3472887|P1|STARTED|Overall Study||69
1419115|NCT02643225|3472897|P2|NOT COMPLETED|Overall Study||0
1419116|NCT02643225|3472898|P1|NOT COMPLETED|Overall Study||0
1419117|NCT02643225|3472897|P2|COMPLETED|Overall Study||40
1419118|NCT02643225|3472898|P1|COMPLETED|Overall Study||40
1419119|NCT02643225|3472897|P2|STARTED|Overall Study||40
1419120|NCT02643225|3472898|P1|STARTED|Overall Study||40
1419121|NCT02643199|3472910|P1|NOT COMPLETED|Overall Study||0
1419122|NCT02643199|3472910|P1|COMPLETED|Overall Study||90
1419123|NCT02643199|3472910|P1|STARTED|Overall Study||90
1419124|NCT02643095|3472915|P1|NOT COMPLETED|Overall Study||1
1419125|NCT02643095|3472915|P1|COMPLETED|Overall Study||21
1419126|NCT02643095|3472915|P1|STARTED|Overall Study||22
1419127|NCT02643004|3472919|P2|NOT COMPLETED|Second Intervention (One Week)||0
1419128|NCT02643004|3472920|P1|NOT COMPLETED|Second Intervention (One Week)||0
1419129|NCT02643004|3472919|P2|COMPLETED|Second Intervention (One Week)||35
1419130|NCT02643004|3472920|P1|COMPLETED|Second Intervention (One Week)||35
1419131|NCT02643004|3472919|P2|STARTED|Second Intervention (One Week)||35
1419132|NCT02643004|3472920|P1|STARTED|Second Intervention (One Week)||35
1419133|NCT02643004|3472919|P2|NOT COMPLETED|First Intervention (One Week)||0
1419134|NCT02643004|3472920|P1|NOT COMPLETED|First Intervention (One Week)||0
1419135|NCT02643004|3472919|P2|COMPLETED|First Intervention (One Week)||35
1419136|NCT02643004|3472920|P1|COMPLETED|First Intervention (One Week)||35
1419137|NCT02643004|3472919|P2|STARTED|First Intervention (One Week)||35
1419138|NCT02643004|3472920|P1|STARTED|First Intervention (One Week)||35
1419139|NCT02642835|3472960|P1|NOT COMPLETED|Overall Study||0
1419140|NCT02642835|3472960|P1|COMPLETED|Overall Study||48
1419141|NCT02642835|3472960|P1|STARTED|Overall Study||48
1419142|NCT02642679|3472973|P1|NOT COMPLETED|Overall Study||3
1419143|NCT02642679|3472973|P1|COMPLETED|Overall Study||16
1419144|NCT02642679|3472973|P1|STARTED|Overall Study||19
1419145|NCT02642575|3472979|P1|NOT COMPLETED|Overall Study||0
1419146|NCT02642575|3472979|P1|COMPLETED|Overall Study||67
1419147|NCT02642575|3472979|P1|STARTED|Overall Study||67
1419148|NCT02642536|3472987|P2|NOT COMPLETED|Overall Study||5
1419149|NCT02642536|3472988|P1|NOT COMPLETED|Overall Study||2
1419150|NCT02642536|3472987|P2|COMPLETED|Overall Study||18
1419151|NCT02642536|3472988|P1|COMPLETED|Overall Study||19
1419152|NCT02642536|3472987|P2|STARTED|Overall Study||23
1419153|NCT02642536|3472988|P1|STARTED|Overall Study||21
1419154|NCT02642432|3473014|P1|NOT COMPLETED|Overall Study||8
1419155|NCT02642432|3473014|P1|COMPLETED|Overall Study||138
1419156|NCT02642432|3473014|P1|STARTED|Overall Study||146
1419157|NCT02642159|3473022|P2|NOT COMPLETED|Overall Study||8
1419158|NCT02642159|3473023|P1|NOT COMPLETED|Overall Study||31
1419159|NCT02642159|3473022|P2|COMPLETED|Overall Study||129
1419160|NCT02642159|3473023|P1|COMPLETED|Overall Study||245
1419161|NCT02642159|3473022|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
1419162|NCT02642159|3473023|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|47
1419163|NCT02642159|3473022|P2|ITT Population|Overall Study||136
1419164|NCT02642159|3473023|P1|ITT Population|Overall Study||273
1419165|NCT02642159|3473022|P2|Treated (Safety Population)|Overall Study||137
1419166|NCT02642159|3473023|P1|Treated (Safety Population)|Overall Study||275
1419167|NCT02642159|3473022|P2|STARTED|Overall Study|Randomized|137
1419168|NCT02642159|3473023|P1|STARTED|Overall Study|Randomized|276
1419169|NCT02641912|3473075|P2|NOT COMPLETED|Overall Study||0
1419170|NCT02641912|3473076|P1|NOT COMPLETED|Overall Study||0
1419171|NCT02641912|3473075|P2|COMPLETED|Overall Study||47
1419172|NCT02641912|3473076|P1|COMPLETED|Overall Study||53
1419173|NCT02641912|3473075|P2|STARTED|Overall Study||47
1419174|NCT02641912|3473076|P1|STARTED|Overall Study||53
1419175|NCT02641561|3473148|P4|NOT COMPLETED|Overall Study||0
1419176|NCT02641561|3473149|P3|NOT COMPLETED|Overall Study||0
1419177|NCT02641561|3473150|P2|NOT COMPLETED|Overall Study||0
1419178|NCT02641561|3473151|P1|NOT COMPLETED|Overall Study||0
1419179|NCT02641561|3473148|P4|COMPLETED|Overall Study||48
1419180|NCT02641561|3473149|P3|COMPLETED|Overall Study||48
1419181|NCT02641561|3473150|P2|COMPLETED|Overall Study||48
1419182|NCT02641561|3473151|P1|COMPLETED|Overall Study||48
1419183|NCT02641561|3473148|P4|STARTED|Overall Study||48
1419184|NCT02641561|3473149|P3|STARTED|Overall Study||48
1419185|NCT02641561|3473150|P2|STARTED|Overall Study||48
1419186|NCT02641561|3473151|P1|STARTED|Overall Study||48
1419187|NCT02641522|3473237|P1|NOT COMPLETED|Overall Study||0
1419188|NCT02641522|3473237|P1|COMPLETED|Overall Study||10
1419189|NCT02641522|3473237|P1|STARTED|Overall Study||10
1419190|NCT02641379|3473252|P11|NOT COMPLETED|Overall Study||8
1419191|NCT02641379|3473253|P10|NOT COMPLETED|Overall Study||9
1419192|NCT02641379|3473254|P9|NOT COMPLETED|Overall Study||6
1419193|NCT02641379|3473255|P8|NOT COMPLETED|Overall Study||19
1419194|NCT02641379|3473256|P7|NOT COMPLETED|Overall Study||13
1419195|NCT02641379|3473257|P6|NOT COMPLETED|Overall Study||16
1419196|NCT02641379|3473258|P5|NOT COMPLETED|Overall Study||17
1419197|NCT02641379|3473259|P4|NOT COMPLETED|Overall Study||17
1419198|NCT02641379|3473260|P3|NOT COMPLETED|Overall Study||71
1419199|NCT02641379|3473261|P2|NOT COMPLETED|Overall Study||51
1419200|NCT02641379|3473262|P1|NOT COMPLETED|Overall Study||35
1419201|NCT02641379|3473252|P11|COMPLETED|Overall Study||0
1419202|NCT02641379|3473253|P10|COMPLETED|Overall Study||36
1419203|NCT02641379|3473254|P9|COMPLETED|Overall Study||36
1419204|NCT02641379|3473255|P8|COMPLETED|Overall Study||1
1419205|NCT02641379|3473256|P7|COMPLETED|Overall Study||12
1419206|NCT02641379|3473257|P6|COMPLETED|Overall Study||20
1419207|NCT02641379|3473258|P5|COMPLETED|Overall Study||0
1419208|NCT02641379|3473259|P4|COMPLETED|Overall Study||139
1419209|NCT02641379|3473260|P3|COMPLETED|Overall Study||7
1419210|NCT02641379|3473261|P2|COMPLETED|Overall Study||101
1419211|NCT02641379|3473262|P1|COMPLETED|Overall Study||107
1419212|NCT02641379|3473252|P11|STARTED|Overall Study||8
1419213|NCT02641379|3473253|P10|STARTED|Overall Study||45
1419214|NCT02641379|3473254|P9|STARTED|Overall Study||42
1419215|NCT02641379|3473255|P8|STARTED|Overall Study||20
1419216|NCT02641379|3473256|P7|STARTED|Overall Study||25
1419217|NCT02641379|3473257|P6|STARTED|Overall Study||36
1419218|NCT02641379|3473258|P5|STARTED|Overall Study||17
1419219|NCT02641379|3473259|P4|STARTED|Overall Study||156
1419220|NCT02641379|3473260|P3|STARTED|Overall Study||78
1419221|NCT02641379|3473261|P2|STARTED|Overall Study||152
1419222|NCT02641379|3473262|P1|STARTED|Overall Study||142
1419223|NCT02641249|3473327|P1|NOT COMPLETED|Overall Study||4
1419224|NCT02641249|3473327|P1|COMPLETED|Overall Study||15
1419225|NCT02641249|3473327|P1|STARTED|Overall Study||19
1419226|NCT02640612|3473339|P3|NOT COMPLETED|Overall Study||6
1419227|NCT02640612|3473340|P2|NOT COMPLETED|Overall Study||14
1419228|NCT02640612|3473341|P1|NOT COMPLETED|Overall Study||22
1419229|NCT02640612|3473339|P3|COMPLETED|Overall Study||96
1419230|NCT02640612|3473340|P2|COMPLETED|Overall Study||89
1419231|NCT02640612|3473341|P1|COMPLETED|Overall Study||203
1419232|NCT02640612|3473339|P3|STARTED|Overall Study||102
1419233|NCT02640612|3473340|P2|STARTED|Overall Study||103
1419234|NCT02640612|3473341|P1|STARTED|Overall Study||225
1419235|NCT02640547|3473361|P1|NOT COMPLETED|Overall Study||11
1419236|NCT02640547|3473361|P1|COMPLETED|Overall Study||383
1419237|NCT02640547|3473361|P1|STARTED|Overall Study||394
1419238|NCT02640482|3473438|P2|NOT COMPLETED|Overall Study||0
1419239|NCT02640482|3473439|P1|NOT COMPLETED|Overall Study||3
1419240|NCT02640482|3473438|P2|COMPLETED|Overall Study||100
1419241|NCT02640482|3473439|P1|COMPLETED|Overall Study||199
1419242|NCT02640482|3473438|P2|STARTED|Overall Study||100
1419243|NCT02640482|3473439|P1|STARTED|Overall Study||202
1419244|NCT02640404|3473451|P2|NOT COMPLETED|Overall Study||0
1419245|NCT02640404|3473452|P1|NOT COMPLETED|Overall Study||2
1419246|NCT02640404|3473451|P2|COMPLETED|Overall Study||112
1419247|NCT02640404|3473452|P1|COMPLETED|Overall Study||110
1419248|NCT02640404|3473451|P2|STARTED|Overall Study||112
1419249|NCT02640404|3473452|P1|STARTED|Overall Study||112
1419250|NCT02640157|3473463|P3|NOT COMPLETED|Overall Study||10
1419251|NCT02640157|3473464|P2|NOT COMPLETED|Overall Study||5
1419252|NCT02640157|3473465|P1|NOT COMPLETED|Overall Study||13
1419253|NCT02640157|3473463|P3|COMPLETED|Overall Study||147
1419254|NCT02640157|3473464|P2|COMPLETED|Overall Study||111
1419255|NCT02640157|3473465|P1|COMPLETED|Overall Study||220
1419256|NCT02640157|3473463|P3|Discontinued Study Drug|Overall Study||3
1419257|NCT02640157|3473464|P2|Discontinued Study Drug|Overall Study||3
1419258|NCT02640157|3473465|P1|Discontinued Study Drug|Overall Study||8
1419259|NCT02640157|3473463|P3|Completed Study Drug|Overall Study||154
1419260|NCT02640157|3473464|P2|Completed Study Drug|Overall Study||112
1419261|NCT02640157|3473465|P1|Completed Study Drug|Overall Study||225
1419262|NCT02640157|3473463|P3|Received Study Drug|Overall Study||157
1419263|NCT02640157|3473464|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
1419264|NCT02640157|3473465|P1|Received Study Drug|Overall Study||233
1419265|NCT02640157|3473463|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
1419266|NCT02640157|3473464|P2|STARTED|Overall Study||116
1419267|NCT02640157|3473465|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
1419268|NCT02640053|3473484|P2|NOT COMPLETED|Overall Study||4
1419269|NCT02640053|3473485|P1|NOT COMPLETED|Overall Study||4
1419270|NCT02640053|3473484|P2|COMPLETED|Overall Study||17
1419271|NCT02640053|3473485|P1|COMPLETED|Overall Study||17
1419272|NCT02640053|3473484|P2|STARTED|Overall Study||21
1419273|NCT02640053|3473485|P1|STARTED|Overall Study||21
1419274|NCT02639637|3473508|P4|NOT COMPLETED|Overall Study||0
1419275|NCT02639637|3473509|P3|NOT COMPLETED|Overall Study||0
1419276|NCT02639637|3473510|P2|NOT COMPLETED|Overall Study||0
1419277|NCT02639637|3473511|P1|NOT COMPLETED|Overall Study||0
1419278|NCT02639637|3473508|P4|COMPLETED|Overall Study||3
1419279|NCT02639637|3473509|P3|COMPLETED|Overall Study||2
1419280|NCT02639637|3473510|P2|COMPLETED|Overall Study||6
1419281|NCT02639637|3473511|P1|COMPLETED|Overall Study||7
1419282|NCT02639637|3473508|P4|STARTED|Overall Study||3
1419283|NCT02639637|3473509|P3|STARTED|Overall Study||2
1419284|NCT02639637|3473510|P2|STARTED|Overall Study||6
1419285|NCT02639637|3473511|P1|STARTED|Overall Study||7
1419286|NCT02639494|3473573|P1|NOT COMPLETED|Overall Study||0
1419287|NCT02639494|3473573|P1|COMPLETED|Overall Study||20
1419288|NCT02639494|3473573|P1|STARTED|Overall Study||20
1419289|NCT02639338|3473590|P2|NOT COMPLETED|Overall Study||5
1419290|NCT02639338|3473591|P1|NOT COMPLETED|Overall Study||4
1419291|NCT02639338|3473590|P2|COMPLETED|Overall Study||105
1419292|NCT02639338|3473591|P1|COMPLETED|Overall Study||106
1419293|NCT02639338|3473590|P2|STARTED|Overall Study||110
1419294|NCT02639338|3473591|P1|STARTED|Overall Study||110
1419295|NCT02639247|3473609|P2|NOT COMPLETED|Overall Study||2
1419296|NCT02639247|3473610|P1|NOT COMPLETED|Overall Study||5
1419297|NCT02639247|3473609|P2|COMPLETED|Overall Study||149
1419298|NCT02639247|3473610|P1|COMPLETED|Overall Study||177
1419299|NCT02639247|3473609|P2|STARTED|Overall Study||151
1419300|NCT02639247|3473610|P1|STARTED|Overall Study||182
1419301|NCT02639052|3473626|P1|NOT COMPLETED|Overall Study||1
1419302|NCT02639052|3473626|P1|COMPLETED|Overall Study||34
1419303|NCT02639052|3473626|P1|Visit 4 (3-month Follow-up)|Overall Study||34
1419304|NCT02639052|3473626|P1|Visit 3 (1-month Follow-up)|Overall Study||35
1419305|NCT02639052|3473626|P1|Visit 2 (1-week Follow-up)|Overall Study||35
1419306|NCT02639052|3473626|P1|Visit 1 (Baseline)|Overall Study||35
1419307|NCT02639052|3473626|P1|STARTED|Overall Study||35
1419308|NCT02638493|3473643|P3|NOT COMPLETED|Overall Study||0
1419309|NCT02638493|3473644|P2|NOT COMPLETED|Overall Study||0
1419310|NCT02638493|3473645|P1|NOT COMPLETED|Overall Study||2
1419311|NCT02638493|3473643|P3|COMPLETED|Overall Study||8
1419312|NCT02638493|3473644|P2|COMPLETED|Overall Study||8
1419313|NCT02638493|3473645|P1|COMPLETED|Overall Study||8
1419314|NCT02638493|3473643|P3|STARTED|Overall Study||8
1419315|NCT02638493|3473644|P2|STARTED|Overall Study||8
1419316|NCT02638493|3473645|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
1419317|NCT02638259|3473676|P2|NOT COMPLETED|Treatment Period 2||11
1419318|NCT02638259|3473677|P1|NOT COMPLETED|Treatment Period 2||6
1419319|NCT02638259|3473676|P2|COMPLETED|Treatment Period 2||155
1419320|NCT02638259|3473677|P1|COMPLETED|Treatment Period 2||169
1419321|NCT02638259|3473676|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
1419322|NCT02638259|3473677|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
1419323|NCT02638259|3473676|P2|NOT COMPLETED|Treatment Period 1||18
1419324|NCT02638259|3473677|P1|NOT COMPLETED|Treatment Period 1||5
1419325|NCT02638259|3473676|P2|COMPLETED|Treatment Period 1||172
1419326|NCT02638259|3473677|P1|COMPLETED|Treatment Period 1||181
1419327|NCT02638259|3473676|P2|STARTED|Treatment Period 1||190
1419328|NCT02638259|3473677|P1|STARTED|Treatment Period 1||186
1419329|NCT02638129|3473753|P2|NOT COMPLETED|Overall Study||30
1419330|NCT02638129|3473754|P1|NOT COMPLETED|Overall Study||28
1419331|NCT02638129|3473753|P2|COMPLETED|Overall Study||0
1419332|NCT02638129|3473754|P1|COMPLETED|Overall Study||0
1419333|NCT02638129|3473753|P2|STARTED|Overall Study||30
1419334|NCT02638129|3473754|P1|STARTED|Overall Study||28
1419335|NCT02638051|3473768|P2|NOT COMPLETED|Overall Study||0
1419336|NCT02638051|3473769|P1|NOT COMPLETED|Overall Study||0
1419337|NCT02638051|3473768|P2|COMPLETED|Overall Study||130
1419338|NCT02638051|3473769|P1|COMPLETED|Overall Study||130
1419339|NCT02638051|3473768|P2|STARTED|Overall Study||130
1419340|NCT02638051|3473769|P1|STARTED|Overall Study||130
1419341|NCT02637999|3473782|P3|NOT COMPLETED|Overall Study||2
1419342|NCT02637999|3473783|P2|NOT COMPLETED|Overall Study||2
1419343|NCT02637999|3473784|P1|NOT COMPLETED|Overall Study||1
1419344|NCT02637999|3473782|P3|COMPLETED|Overall Study||6
1419345|NCT02637999|3473783|P2|COMPLETED|Overall Study||6
1419346|NCT02637999|3473784|P1|COMPLETED|Overall Study||7
1419347|NCT02637999|3473782|P3|STARTED|Overall Study||8
1419348|NCT02637999|3473783|P2|STARTED|Overall Study||8
1419349|NCT02637999|3473784|P1|STARTED|Overall Study||8
1419350|NCT02637804|3473818|P4|NOT COMPLETED|Second Intervention (1 Week)||0
1419351|NCT02637804|3473819|P3|NOT COMPLETED|Second Intervention (1 Week)||0
1419352|NCT02637804|3473820|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1419353|NCT02637804|3473821|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1419354|NCT02637804|3473818|P4|COMPLETED|Second Intervention (1 Week)||26
1419355|NCT02637804|3473819|P3|COMPLETED|Second Intervention (1 Week)||25
1419356|NCT02637804|3473820|P2|COMPLETED|Second Intervention (1 Week)||28
1419357|NCT02637804|3473821|P1|COMPLETED|Second Intervention (1 Week)||27
1419358|NCT02637804|3473818|P4|STARTED|Second Intervention (1 Week)||26
1419359|NCT02637804|3473819|P3|STARTED|Second Intervention (1 Week)||25
1419360|NCT02637804|3473820|P2|STARTED|Second Intervention (1 Week)||28
1419361|NCT02637804|3473821|P1|STARTED|Second Intervention (1 Week)||27
1419362|NCT02637804|3473818|P4|NOT COMPLETED|First Intervention (1 Week)||0
1419363|NCT02637804|3473819|P3|NOT COMPLETED|First Intervention (1 Week)||0
1419364|NCT02637804|3473820|P2|NOT COMPLETED|First Intervention (1 Week)||0
1419365|NCT02637804|3473821|P1|NOT COMPLETED|First Intervention (1 Week)||0
1419366|NCT02637804|3473818|P4|COMPLETED|First Intervention (1 Week)||26
1419367|NCT02637804|3473819|P3|COMPLETED|First Intervention (1 Week)||25
1419368|NCT02637804|3473820|P2|COMPLETED|First Intervention (1 Week)||28
1419369|NCT02637804|3473821|P1|COMPLETED|First Intervention (1 Week)||27
1419370|NCT02637804|3473818|P4|STARTED|First Intervention (1 Week)||26
1419371|NCT02637804|3473819|P3|STARTED|First Intervention (1 Week)||25
1419372|NCT02637804|3473820|P2|STARTED|First Intervention (1 Week)||28
1419373|NCT02637804|3473821|P1|STARTED|First Intervention (1 Week)||27
1419374|NCT02637323|3473927|P2|NOT COMPLETED|Overall Study||1
1419375|NCT02637323|3473928|P1|NOT COMPLETED|Overall Study||2
1419376|NCT02637323|3473927|P2|COMPLETED|Overall Study||17
1419377|NCT02637323|3473928|P1|COMPLETED|Overall Study||61
1419378|NCT02637323|3473927|P2|STARTED|Overall Study||18
1419379|NCT02637323|3473928|P1|STARTED|Overall Study||63
1419380|NCT02637063|3473939|P3|NOT COMPLETED|Overall Study||6
1419381|NCT02637063|3473940|P2|NOT COMPLETED|Overall Study||4
1419382|NCT02637063|3473941|P1|NOT COMPLETED|Overall Study||5
1419383|NCT02637063|3473939|P3|COMPLETED|Overall Study||62
1419384|NCT02637063|3473940|P2|COMPLETED|Overall Study||64
1419385|NCT02637063|3473941|P1|COMPLETED|Overall Study||62
1419386|NCT02637063|3473939|P3|STARTED|Overall Study||68
1419387|NCT02637063|3473940|P2|STARTED|Overall Study||68
1419388|NCT02637063|3473941|P1|STARTED|Overall Study||67
1419389|NCT02637037|3473969|P2|NOT COMPLETED|Overall Study||1
1419390|NCT02637037|3473970|P1|NOT COMPLETED|Overall Study||4
1419391|NCT02637037|3473969|P2|COMPLETED|Overall Study||39
1419392|NCT02637037|3473970|P1|COMPLETED|Overall Study||36
1419393|NCT02637037|3473969|P2|STARTED|Overall Study||40
1419394|NCT02637037|3473970|P1|STARTED|Overall Study||40
1419395|NCT02636907|3474036|P1|NOT COMPLETED|Extension Phase||10
1419396|NCT02636907|3474036|P1|COMPLETED|Extension Phase||62
1419397|NCT02636907|3474036|P1|STARTED|Extension Phase||72
1419398|NCT02636907|3474036|P1|NOT COMPLETED|Autoinjector Assessment Period||4
1419399|NCT02636907|3474036|P1|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
1419400|NCT02636907|3474036|P1|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
1419401|NCT02636595|3474045|P1|NOT COMPLETED|Overall Study||2
1419402|NCT02636595|3474045|P1|COMPLETED|Overall Study||119
1419403|NCT02636595|3474045|P1|STARTED|Overall Study||121
1419404|NCT02635984|3474053|P2|NOT COMPLETED|Overall Study||4
1419405|NCT02635984|3474054|P1|NOT COMPLETED|Overall Study||3
1419406|NCT02635984|3474053|P2|COMPLETED|Overall Study||51
1419407|NCT02635984|3474054|P1|COMPLETED|Overall Study||50
1419408|NCT02635984|3474053|P2|STARTED|Overall Study||55
1419409|NCT02635984|3474054|P1|STARTED|Overall Study||53
1419410|NCT02635880|3474074|P1|NOT COMPLETED|Overall Study||0
1419411|NCT02635880|3474074|P1|COMPLETED|Overall Study||32
1419412|NCT02635880|3474074|P1|STARTED|Overall Study||32
1419413|NCT02635828|3474079|P1|NOT COMPLETED|Overall Study||14
1419414|NCT02635828|3474079|P1|COMPLETED|Overall Study||40
1419415|NCT02635828|3474079|P1|STARTED|Overall Study||54
1419416|NCT02635646|3474086|P2|NOT COMPLETED|Overall Study||15
1419417|NCT02635646|3474087|P1|NOT COMPLETED|Overall Study||13
1419418|NCT02635646|3474086|P2|COMPLETED|Overall Study||43
1419419|NCT02635646|3474087|P1|COMPLETED|Overall Study||43
1419420|NCT02635646|3474086|P2|STARTED|Overall Study||58
1419421|NCT02635646|3474087|P1|STARTED|Overall Study||56
1419422|NCT02635542|3474103|P2|NOT COMPLETED|Overall Study||0
1419423|NCT02635542|3474104|P1|NOT COMPLETED|Overall Study||0
1419424|NCT02635542|3474103|P2|COMPLETED|Overall Study||50
1419425|NCT02635542|3474104|P1|COMPLETED|Overall Study||50
1419426|NCT02635542|3474103|P2|STARTED|Overall Study||50
1419427|NCT02635542|3474104|P1|STARTED|Overall Study||50
1419428|NCT02635425|3474114|P2|NOT COMPLETED|Overall Study||0
1419429|NCT02635425|3474115|P1|NOT COMPLETED|Overall Study||0
1419430|NCT02635425|3474114|P2|COMPLETED|Overall Study||15
1419431|NCT02635425|3474115|P1|COMPLETED|Overall Study||15
1419432|NCT02635425|3474114|P2|STARTED|Overall Study||15
1419433|NCT02635425|3474115|P1|STARTED|Overall Study||15
1419434|NCT02635204|3474123|P2|NOT COMPLETED|Overall Study||1
1419435|NCT02635204|3474124|P1|NOT COMPLETED|Overall Study||2
1419436|NCT02635204|3474123|P2|COMPLETED|Overall Study||88
1419437|NCT02635204|3474124|P1|COMPLETED|Overall Study||176
1419438|NCT02635204|3474123|P2|STARTED|Overall Study||89
1419439|NCT02635204|3474124|P1|STARTED|Overall Study||178
1419440|NCT02634801|3474137|P3|NOT COMPLETED|Follow-up Period||8
1419441|NCT02634801|3474138|P2|NOT COMPLETED|Follow-up Period||8
1419442|NCT02634801|3474139|P1|NOT COMPLETED|Follow-up Period||5
1419443|NCT02634801|3474137|P3|COMPLETED|Follow-up Period||38
1419444|NCT02634801|3474138|P2|COMPLETED|Follow-up Period||18
1419445|NCT02634801|3474139|P1|COMPLETED|Follow-up Period||36
1419446|NCT02634801|3474137|P3|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
1419447|NCT02634801|3474138|P2|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
1419448|NCT02634801|3474139|P1|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
1419449|NCT02634801|3474137|P3|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
1419450|NCT02634801|3474138|P2|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
1419451|NCT02634801|3474139|P1|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
1419452|NCT02634801|3474137|P3|COMPLETED|Extension Period (Weeks 24 to 36)||29
1419453|NCT02634801|3474138|P2|COMPLETED|Extension Period (Weeks 24 to 36)||18
1419454|NCT02634801|3474139|P1|COMPLETED|Extension Period (Weeks 24 to 36)||45
1419455|NCT02634801|3474137|P3|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
1419456|NCT02634801|3474138|P2|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
1419457|NCT02634801|3474139|P1|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
1419458|NCT02634801|3474137|P3|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
1419459|NCT02634801|3474138|P2|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
1419460|NCT02634801|3474139|P1|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
1419461|NCT02634801|3474137|P3|COMPLETED|Treatment Period (Weeks 0 to 24)||49
1419462|NCT02634801|3474138|P2|COMPLETED|Treatment Period (Weeks 0 to 24)||23
1419463|NCT02634801|3474139|P1|COMPLETED|Treatment Period (Weeks 0 to 24)||50
1419464|NCT02634801|3474137|P3|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
1419465|NCT02634801|3474138|P2|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
1419466|NCT02634801|3474139|P1|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
1419467|NCT02634801|3474137|P3|STARTED|Treatment Period (Weeks 0 to 24)||54
1419468|NCT02634801|3474138|P2|STARTED|Treatment Period (Weeks 0 to 24)||54
1419469|NCT02634801|3474139|P1|STARTED|Treatment Period (Weeks 0 to 24)||54
1419470|NCT02634788|3474239|P4|NOT COMPLETED|Overall Study||5
1419471|NCT02634788|3474240|P3|NOT COMPLETED|Overall Study||5
1419472|NCT02634788|3474241|P2|NOT COMPLETED|Overall Study||10
1419473|NCT02634788|3474242|P1|NOT COMPLETED|Overall Study||4
1419474|NCT02634788|3474239|P4|COMPLETED|Overall Study||77
1419475|NCT02634788|3474240|P3|COMPLETED|Overall Study||75
1419476|NCT02634788|3474241|P2|COMPLETED|Overall Study||71
1419477|NCT02634788|3474242|P1|COMPLETED|Overall Study||75
1419478|NCT02634788|3474239|P4|STARTED|Overall Study||82
1419479|NCT02634788|3474240|P3|STARTED|Overall Study||80
1419480|NCT02634788|3474241|P2|STARTED|Overall Study||81
1419481|NCT02634788|3474242|P1|STARTED|Overall Study||79
1419482|NCT02634580|3474312|P4|NOT COMPLETED|Overall Study||1
1419483|NCT02634580|3474313|P3|NOT COMPLETED|Overall Study||1
1419484|NCT02634580|3474314|P2|NOT COMPLETED|Overall Study||0
1419485|NCT02634580|3474315|P1|NOT COMPLETED|Overall Study||1
1419486|NCT02634580|3474312|P4|COMPLETED|Overall Study||20
1419487|NCT02634580|3474313|P3|COMPLETED|Overall Study||18
1419488|NCT02634580|3474314|P2|COMPLETED|Overall Study||11
1419489|NCT02634580|3474315|P1|COMPLETED|Overall Study||9
1419490|NCT02634580|3474312|P4|STARTED|Overall Study||21
1419491|NCT02634580|3474313|P3|STARTED|Overall Study||19
1419492|NCT02634580|3474314|P2|STARTED|Overall Study||11
1419493|NCT02634580|3474315|P1|STARTED|Overall Study||10
1419494|NCT02634346|3474372|P3|NOT COMPLETED|Overall Study||23
1419495|NCT02634346|3474373|P2|NOT COMPLETED|Overall Study||14
1419496|NCT02634346|3474374|P1|NOT COMPLETED|Overall Study||12
1419497|NCT02634346|3474372|P3|COMPLETED|Overall Study||111
1419498|NCT02634346|3474373|P2|COMPLETED|Overall Study||119
1419499|NCT02634346|3474374|P1|COMPLETED|Overall Study||122
1419500|NCT02634346|3474372|P3|STARTED|Overall Study||134
1419501|NCT02634346|3474373|P2|STARTED|Overall Study||133
1419502|NCT02634346|3474374|P1|STARTED|Overall Study||134
1419503|NCT02634320|3474388|P1|NOT COMPLETED|Overall Study||16
1419504|NCT02634320|3474388|P1|COMPLETED|Overall Study||35
1419505|NCT02634320|3474388|P1|STARTED|Overall Study||51
1419506|NCT02634073|3474397|P4|NOT COMPLETED|Overall Study||0
1419507|NCT02634073|3474398|P3|NOT COMPLETED|Overall Study||0
1419508|NCT02634073|3474399|P2|NOT COMPLETED|Overall Study||0
1419509|NCT02634073|3474400|P1|NOT COMPLETED|Overall Study||0
1419510|NCT02634073|3474397|P4|COMPLETED|Overall Study||4
1419511|NCT02634073|3474398|P3|COMPLETED|Overall Study||4
1419512|NCT02634073|3474399|P2|COMPLETED|Overall Study||4
1419513|NCT02634073|3474400|P1|COMPLETED|Overall Study||4
1419514|NCT02634073|3474397|P4|STARTED|Overall Study||4
1419515|NCT02634073|3474398|P3|STARTED|Overall Study||4
1419516|NCT02634073|3474399|P2|STARTED|Overall Study||4
1419517|NCT02634073|3474400|P1|STARTED|Overall Study||4
1419518|NCT02633956|3474490|P4|NOT COMPLETED|Overall Study||0
1419519|NCT02633956|3474491|P3|NOT COMPLETED|Overall Study||2
1419520|NCT02633956|3474492|P2|NOT COMPLETED|Overall Study||2
1419521|NCT02633956|3474493|P1|NOT COMPLETED|Overall Study||1
1419522|NCT02633956|3474490|P4|COMPLETED|Overall Study||21
1419523|NCT02633956|3474491|P3|COMPLETED|Overall Study||20
1419524|NCT02633956|3474492|P2|COMPLETED|Overall Study||19
1419525|NCT02633956|3474493|P1|COMPLETED|Overall Study||19
1419526|NCT02633956|3474490|P4|STARTED|Overall Study||21
1419527|NCT02633956|3474491|P3|STARTED|Overall Study||22
1419528|NCT02633956|3474492|P2|STARTED|Overall Study||21
1419529|NCT02633956|3474493|P1|STARTED|Overall Study||20
1419530|NCT02633787|3474511|P1|NOT COMPLETED|Overall Study||1
1419531|NCT02633787|3474511|P1|COMPLETED|Overall Study||109
1419532|NCT02633787|3474511|P1|STARTED|Overall Study||110
1419533|NCT02633371|3474517|P1|NOT COMPLETED|Overall Study||3
1419534|NCT02633371|3474517|P1|COMPLETED|Overall Study||7
1419535|NCT02633371|3474517|P1|STARTED|Overall Study||10
1419536|NCT02633215|3474523|P2|NOT COMPLETED|Overall Study||3
1419537|NCT02633215|3474524|P1|NOT COMPLETED|Overall Study||2
1419538|NCT02633215|3474523|P2|COMPLETED|Overall Study||15
1419539|NCT02633215|3474524|P1|COMPLETED|Overall Study||16
1419540|NCT02633215|3474523|P2|STARTED|Overall Study||18
1419541|NCT02633215|3474524|P1|STARTED|Overall Study||18
1419542|NCT02632838|3474536|P2|NOT COMPLETED|Overall Study||2
1419543|NCT02632838|3474537|P1|NOT COMPLETED|Overall Study||3
1419544|NCT02632838|3474536|P2|COMPLETED|Overall Study||13
1419545|NCT02632838|3474537|P1|COMPLETED|Overall Study||12
1419546|NCT02632838|3474536|P2|STARTED|Overall Study||15
1419547|NCT02632838|3474537|P1|STARTED|Overall Study||15
1419548|NCT02632812|3474553|P2|NOT COMPLETED|Overall Study||0
1419549|NCT02632812|3474554|P1|NOT COMPLETED|Overall Study||0
1419550|NCT02632812|3474553|P2|COMPLETED|Overall Study||12
1419551|NCT02632812|3474554|P1|COMPLETED|Overall Study||12
1419552|NCT02632812|3474553|P2|STARTED|Overall Study||12
1419553|NCT02632812|3474554|P1|STARTED|Overall Study||12
1419554|NCT02632110|3474577|P10|NOT COMPLETED|Overall Study||1
1419555|NCT02632110|3474578|P9|NOT COMPLETED|Overall Study||1
1419556|NCT02632110|3474579|P8|NOT COMPLETED|Overall Study||3
1419557|NCT02632110|3474580|P7|NOT COMPLETED|Overall Study||3
1419558|NCT02632110|3474581|P6|NOT COMPLETED|Overall Study||1
1419559|NCT02632110|3474582|P5|NOT COMPLETED|Overall Study||1
1419560|NCT02632110|3474583|P4|NOT COMPLETED|Overall Study||0
1419561|NCT02632110|3474584|P3|NOT COMPLETED|Overall Study||0
1419562|NCT02632110|3474585|P2|NOT COMPLETED|Overall Study||1
1419563|NCT02632110|3474586|P1|NOT COMPLETED|Overall Study||1
1419564|NCT02632110|3474577|P10|COMPLETED|Overall Study||29
1419565|NCT02632110|3474578|P9|COMPLETED|Overall Study||29
1419566|NCT02632110|3474579|P8|COMPLETED|Overall Study||23
1419567|NCT02632110|3474580|P7|COMPLETED|Overall Study||23
1419568|NCT02632110|3474581|P6|COMPLETED|Overall Study||28
1419569|NCT02632110|3474582|P5|COMPLETED|Overall Study||28
1419570|NCT02632110|3474583|P4|COMPLETED|Overall Study||27
1419571|NCT02632110|3474584|P3|COMPLETED|Overall Study||27
1419572|NCT02632110|3474585|P2|COMPLETED|Overall Study||24
1419573|NCT02632110|3474586|P1|COMPLETED|Overall Study||24
1419574|NCT02632110|3474577|P10|STARTED|Overall Study||30
1419575|NCT02632110|3474578|P9|STARTED|Overall Study||30
1419576|NCT02632110|3474579|P8|STARTED|Overall Study||26
1419577|NCT02632110|3474580|P7|STARTED|Overall Study||26
1419578|NCT02632110|3474581|P6|STARTED|Overall Study||29
1419579|NCT02632110|3474582|P5|STARTED|Overall Study||29
1419580|NCT02632110|3474583|P4|STARTED|Overall Study||27
1419581|NCT02632110|3474584|P3|STARTED|Overall Study||27
1419582|NCT02632110|3474585|P2|STARTED|Overall Study||25
1419583|NCT02632110|3474586|P1|STARTED|Overall Study||25
1419584|NCT02631551|3475057|P4|NOT COMPLETED|Overall Study||11
1419585|NCT02631551|3475058|P3|NOT COMPLETED|Overall Study||11
1419586|NCT02631551|3475059|P2|NOT COMPLETED|Overall Study||19
1419587|NCT02631551|3475060|P1|NOT COMPLETED|Overall Study||13
1419588|NCT02631551|3475057|P4|COMPLETED|Overall Study||276
1419589|NCT02631551|3475058|P3|COMPLETED|Overall Study||283
1419590|NCT02631551|3475059|P2|COMPLETED|Overall Study||278
1419591|NCT02631551|3475060|P1|COMPLETED|Overall Study||289
1419592|NCT02631551|3475057|P4|STARTED|Overall Study||287
1419593|NCT02631551|3475058|P3|STARTED|Overall Study||294
1419594|NCT02631551|3475059|P2|STARTED|Overall Study||297
1419595|NCT02631551|3475060|P1|STARTED|Overall Study||302
1419596|NCT02631057|3475072|P2|NOT COMPLETED|Overall Study||0
1419597|NCT02631057|3475073|P1|NOT COMPLETED|Overall Study||0
1419598|NCT02631057|3475072|P2|COMPLETED|Overall Study||3414
1419599|NCT02631057|3475073|P1|COMPLETED|Overall Study||899
1419600|NCT02631057|3475072|P2|STARTED|Overall Study||3414
1419601|NCT02631057|3475073|P1|STARTED|Overall Study||899
1419602|NCT02630992|3475079|P1|NOT COMPLETED|Overall Study||13
1419603|NCT02630992|3475079|P1|COMPLETED|Overall Study||99
1419604|NCT02630992|3475079|P1|STARTED|Overall Study||112
1419605|NCT02630706|3475099|P3|NOT COMPLETED|Overall Study||10
1419606|NCT02630706|3475100|P2|NOT COMPLETED|Overall Study||9
1419607|NCT02630706|3475101|P1|NOT COMPLETED|Overall Study||7
1419608|NCT02630706|3475099|P3|COMPLETED|Overall Study||157
1419609|NCT02630706|3475100|P2|COMPLETED|Overall Study||160
1419610|NCT02630706|3475101|P1|COMPLETED|Overall Study||163
1419611|NCT02630706|3475099|P3|Treated|Overall Study||167
1419612|NCT02630706|3475100|P2|Treated|Overall Study||169
1419613|NCT02630706|3475101|P1|Treated|Overall Study||170
1419614|NCT02630706|3475099|P3|STARTED|Overall Study||167
1419615|NCT02630706|3475100|P2|STARTED|Overall Study||169
1419616|NCT02630706|3475101|P1|STARTED|Overall Study||170
1419617|NCT02630563|3475208|P1|NOT COMPLETED|Overall Study||1
1419618|NCT02630563|3475208|P1|COMPLETED|Overall Study||8
1419619|NCT02630563|3475208|P1|STARTED|Overall Study||9
1419620|NCT02629861|3475220|P3|NOT COMPLETED|Overall Study||28
1419621|NCT02629861|3475221|P2|NOT COMPLETED|Overall Study||27
1419622|NCT02629861|3475222|P1|NOT COMPLETED|Overall Study||29
1419623|NCT02629861|3475220|P3|COMPLETED|Overall Study||262
1419624|NCT02629861|3475221|P2|COMPLETED|Overall Study||264
1419625|NCT02629861|3475222|P1|COMPLETED|Overall Study||265
1419626|NCT02629861|3475220|P3|Full Analysis Set|Overall Study||287
1419627|NCT02629861|3475221|P2|Full Analysis Set|Overall Study||288
1419628|NCT02629861|3475222|P1|Full Analysis Set|Overall Study||290
1419629|NCT02629861|3475220|P3|Safety Population|Overall Study||289
1419630|NCT02629861|3475221|P2|Safety Population|Overall Study||291
1419631|NCT02629861|3475222|P1|Safety Population|Overall Study||294
1419632|NCT02629861|3475220|P3|Intent to Treat (ITT)|Overall Study||290
1419633|NCT02629861|3475221|P2|Intent to Treat (ITT)|Overall Study||291
1419634|NCT02629861|3475222|P1|Intent to Treat (ITT)|Overall Study||294
1419635|NCT02629861|3475220|P3|STARTED|Overall Study||290
1419636|NCT02629861|3475221|P2|STARTED|Overall Study||291
1419637|NCT02629861|3475222|P1|STARTED|Overall Study||294
1419638|NCT02629354|3475271|P2|NOT COMPLETED|Follow-up||0
1419639|NCT02629354|3475272|P1|NOT COMPLETED|Follow-up||0
1419640|NCT02629354|3475271|P2|COMPLETED|Follow-up||18
1419641|NCT02629354|3475272|P1|COMPLETED|Follow-up||18
1419642|NCT02629354|3475271|P2|STARTED|Follow-up||18
1419643|NCT02629354|3475272|P1|STARTED|Follow-up||18
1419644|NCT02629354|3475271|P2|NOT COMPLETED|Period 2||0
1419645|NCT02629354|3475272|P1|NOT COMPLETED|Period 2||0
1419646|NCT02629354|3475271|P2|COMPLETED|Period 2||18
1419647|NCT02629354|3475272|P1|COMPLETED|Period 2||18
1419648|NCT02629354|3475271|P2|STARTED|Period 2||18
1419649|NCT02629354|3475272|P1|STARTED|Period 2||18
1419650|NCT02629354|3475271|P2|NOT COMPLETED|Washout Period||0
1419651|NCT02629354|3475272|P1|NOT COMPLETED|Washout Period||0
1419652|NCT02629354|3475271|P2|COMPLETED|Washout Period||18
1419653|NCT02629354|3475272|P1|COMPLETED|Washout Period||18
1419654|NCT02629354|3475271|P2|STARTED|Washout Period||18
1419655|NCT02629354|3475272|P1|STARTED|Washout Period||18
1419656|NCT02629354|3475271|P2|NOT COMPLETED|Period 1||0
1419657|NCT02629354|3475272|P1|NOT COMPLETED|Period 1||0
1419658|NCT02629354|3475271|P2|COMPLETED|Period 1||18
1419659|NCT02629354|3475272|P1|COMPLETED|Period 1||18
1419660|NCT02629354|3475271|P2|STARTED|Period 1||18
1419661|NCT02629354|3475272|P1|STARTED|Period 1||18
1419662|NCT02629094|3475294|P1|NOT COMPLETED|Overall Study||0
1419663|NCT02629094|3475294|P1|COMPLETED|Overall Study||5
1419664|NCT02629094|3475294|P1|STARTED|Overall Study||5
1419665|NCT02628938|3475302|P3|NOT COMPLETED|Overall Study||4
1419666|NCT02628938|3475303|P2|NOT COMPLETED|Overall Study||2
1419667|NCT02628938|3475304|P1|NOT COMPLETED|Overall Study||5
1419668|NCT02628938|3475302|P3|COMPLETED|Overall Study||11
1419669|NCT02628938|3475303|P2|COMPLETED|Overall Study||13
1419670|NCT02628938|3475304|P1|COMPLETED|Overall Study||10
1419671|NCT02628938|3475302|P3|STARTED|Overall Study||15
1419672|NCT02628938|3475303|P2|STARTED|Overall Study||15
1419673|NCT02628938|3475304|P1|STARTED|Overall Study||15
1419674|NCT02628418|3475320|P2|NOT COMPLETED|Overall Study||2
1419675|NCT02628418|3475321|P1|NOT COMPLETED|Overall Study||1
1419676|NCT02628418|3475320|P2|COMPLETED|Overall Study||13
1419677|NCT02628418|3475321|P1|COMPLETED|Overall Study||14
1419678|NCT02628418|3475320|P2|STARTED|Overall Study||15
1419679|NCT02628418|3475321|P1|STARTED|Overall Study||15
1419680|NCT02628236|3475342|P1|NOT COMPLETED|Overall Study||0
1419681|NCT02628236|3475342|P1|COMPLETED|Overall Study||14
1419682|NCT02628236|3475342|P1|STARTED|Overall Study||14
1419683|NCT02628106|3475379|P1|NOT COMPLETED|Overall Study||0
1419684|NCT02628106|3475379|P1|COMPLETED|Overall Study||21
1419685|NCT02628106|3475379|P1|STARTED|Overall Study||21
1419686|NCT02627794|3475383|P1|NOT COMPLETED|Overall Study||0
1419687|NCT02627794|3475383|P1|COMPLETED|Overall Study||3
1419688|NCT02627794|3475383|P1|STARTED|Overall Study||3
1419689|NCT02627144|3475396|P1|NOT COMPLETED|Overall Study||365
1419690|NCT02627144|3475396|P1|COMPLETED|Overall Study||0
1419691|NCT02627144|3475396|P1|Treated|Overall Study||359
1419692|NCT02627144|3475396|P1|STARTED|Overall Study||365
1419693|NCT02627118|3475404|P1|NOT COMPLETED|Overall Study||0
1419694|NCT02627118|3475404|P1|COMPLETED|Overall Study||10
1419695|NCT02627118|3475404|P1|STARTED|Overall Study||10
1419696|NCT02627001|3475411|P2|NOT COMPLETED|Overall Study||0
1419697|NCT02627001|3475412|P1|NOT COMPLETED|Overall Study||0
1419698|NCT02627001|3475411|P2|COMPLETED|Overall Study||14
1419699|NCT02627001|3475412|P1|COMPLETED|Overall Study||13
1419700|NCT02627001|3475411|P2|STARTED|Overall Study||14
1419701|NCT02627001|3475412|P1|STARTED|Overall Study||13
1419702|NCT02626910|3475422|P4|NOT COMPLETED|Overall Study||0
1419703|NCT02626910|3475423|P3|NOT COMPLETED|Overall Study||0
1419704|NCT02626910|3475424|P2|NOT COMPLETED|Overall Study||0
1419705|NCT02626910|3475425|P1|NOT COMPLETED|Overall Study||0
1419706|NCT02626910|3475422|P4|COMPLETED|Overall Study||10
1419707|NCT02626910|3475423|P3|COMPLETED|Overall Study||6
1419708|NCT02626910|3475424|P2|COMPLETED|Overall Study||10
1419709|NCT02626910|3475425|P1|COMPLETED|Overall Study||23
1419710|NCT02626910|3475422|P4|STARTED|Overall Study||10
1419711|NCT02626910|3475423|P3|STARTED|Overall Study||6
1419712|NCT02626910|3475424|P2|STARTED|Overall Study||10
1419713|NCT02626910|3475425|P1|STARTED|Overall Study||23
1419714|NCT02626819|3475437|P2|NOT COMPLETED|Overall Study||3
1419715|NCT02626819|3475438|P1|NOT COMPLETED|Overall Study||4
1419716|NCT02626819|3475437|P2|COMPLETED|Overall Study||20
1419717|NCT02626819|3475438|P1|COMPLETED|Overall Study||18
1419718|NCT02626819|3475437|P2|STARTED|Overall Study||23
1419719|NCT02626819|3475438|P1|STARTED|Overall Study||22
1419720|NCT02626611|3475461|P3|NOT COMPLETED|Overall Study||3
1419721|NCT02626611|3475462|P2|NOT COMPLETED|Overall Study||1
1419722|NCT02626611|3475463|P1|NOT COMPLETED|Overall Study||4
1419723|NCT02626611|3475461|P3|COMPLETED|Overall Study||16
1419724|NCT02626611|3475462|P2|COMPLETED|Overall Study||20
1419725|NCT02626611|3475463|P1|COMPLETED|Overall Study||16
1419726|NCT02626611|3475461|P3|STARTED|Overall Study||19
1419727|NCT02626611|3475462|P2|STARTED|Overall Study||21
1419728|NCT02626611|3475463|P1|STARTED|Overall Study||20
1419729|NCT02626520|3475486|P2|NOT COMPLETED|Overall Study||10
1419730|NCT02626520|3475487|P1|NOT COMPLETED|Overall Study||1
1419731|NCT02626520|3475486|P2|COMPLETED|Overall Study||0
1419732|NCT02626520|3475487|P1|COMPLETED|Overall Study||0
1419733|NCT02626520|3475486|P2|STARTED|Overall Study||10
1419734|NCT02626520|3475487|P1|STARTED|Overall Study||1
1419735|NCT02625922|3475499|P2|NOT COMPLETED|Overall Study||2
1419736|NCT02625922|3475500|P1|NOT COMPLETED|Overall Study||2
1419737|NCT02625922|3475499|P2|COMPLETED|Overall Study||10
1419738|NCT02625922|3475500|P1|COMPLETED|Overall Study||12
1419739|NCT02625922|3475499|P2|Completed Treatment Period 2|Overall Study||8
1419740|NCT02625922|3475500|P1|Completed Treatment Period 2|Overall Study||11
1419741|NCT02625922|3475499|P2|Completed Treatment Period 1|Overall Study||10
1419742|NCT02625922|3475500|P1|Completed Treatment Period 1|Overall Study||12
1419743|NCT02625922|3475499|P2|STARTED|Overall Study||12
1419744|NCT02625922|3475500|P1|STARTED|Overall Study||14
1419745|NCT02625844|3475513|P1|NOT COMPLETED|Overall Study||0
1419746|NCT02625844|3475513|P1|COMPLETED|Overall Study||110
1419747|NCT02625844|3475513|P1|STARTED|Overall Study||110
1419748|NCT02625623|3475519|P2|NOT COMPLETED|Overall Study||35
1419749|NCT02625623|3475520|P1|NOT COMPLETED|Overall Study||49
1419750|NCT02625623|3475519|P2|COMPLETED|Overall Study||150
1419751|NCT02625623|3475520|P1|COMPLETED|Overall Study||137
1419752|NCT02625623|3475519|P2|Treated|Overall Study||184
1419753|NCT02625623|3475520|P1|Treated|Overall Study||177
1419754|NCT02625623|3475519|P2|STARTED|Overall Study||185
1419755|NCT02625623|3475520|P1|STARTED|Overall Study||186
1419756|NCT02625402|3475542|P2|NOT COMPLETED|Overall Study||12
1419757|NCT02625402|3475543|P1|NOT COMPLETED|Overall Study||9
1419758|NCT02625402|3475542|P2|COMPLETED|Overall Study||25
1419759|NCT02625402|3475543|P1|COMPLETED|Overall Study||33
1419760|NCT02625402|3475542|P2|STARTED|Overall Study||37
1419761|NCT02625402|3475543|P1|STARTED|Overall Study||42
1419762|NCT02625298|3475555|P2|NOT COMPLETED|Overall Study||0
1419763|NCT02625298|3475556|P1|NOT COMPLETED|Overall Study||1
1419764|NCT02625298|3475555|P2|COMPLETED|Overall Study||13
1419765|NCT02625298|3475556|P1|COMPLETED|Overall Study||10
1419766|NCT02625298|3475555|P2|STARTED|Overall Study||13
1419767|NCT02625298|3475556|P1|STARTED|Overall Study||11
1419768|NCT02625259|3475569|P5|NOT COMPLETED|Second Intervention (Day 15)||0
1419769|NCT02625259|3475570|P4|NOT COMPLETED|Second Intervention (Day 15)||0
1419770|NCT02625259|3475571|P3|NOT COMPLETED|Second Intervention (Day 15)||0
1419771|NCT02625259|3475572|P2|NOT COMPLETED|Second Intervention (Day 15)||0
1419772|NCT02625259|3475573|P1|NOT COMPLETED|Second Intervention (Day 15)||0
1419773|NCT02625259|3475569|P5|COMPLETED|Second Intervention (Day 15)||0
1419774|NCT02625259|3475570|P4|COMPLETED|Second Intervention (Day 15)||9
1419775|NCT02625259|3475571|P3|COMPLETED|Second Intervention (Day 15)||7
1419776|NCT02625259|3475572|P2|COMPLETED|Second Intervention (Day 15)||8
1419777|NCT02625259|3475573|P1|COMPLETED|Second Intervention (Day 15)||9
1419778|NCT02625259|3475569|P5|STARTED|Second Intervention (Day 15)||0
1419779|NCT02625259|3475570|P4|STARTED|Second Intervention (Day 15)||9
1419780|NCT02625259|3475571|P3|STARTED|Second Intervention (Day 15)||7
1419781|NCT02625259|3475572|P2|STARTED|Second Intervention (Day 15)||8
1419782|NCT02625259|3475573|P1|STARTED|Second Intervention (Day 15)||9
1419783|NCT02625259|3475569|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1419784|NCT02625259|3475570|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1419785|NCT02625259|3475571|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1419786|NCT02625259|3475572|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1419787|NCT02625259|3475573|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
1419788|NCT02625259|3475569|P5|COMPLETED|Washout (Day 2 to Day 14)||0
1419789|NCT02625259|3475570|P4|COMPLETED|Washout (Day 2 to Day 14)||9
1419790|NCT02625259|3475571|P3|COMPLETED|Washout (Day 2 to Day 14)||7
1419791|NCT02625259|3475572|P2|COMPLETED|Washout (Day 2 to Day 14)||8
1419792|NCT02625259|3475573|P1|COMPLETED|Washout (Day 2 to Day 14)||9
1419793|NCT02625259|3475569|P5|STARTED|Washout (Day 2 to Day 14)||0
1419794|NCT02625259|3475570|P4|STARTED|Washout (Day 2 to Day 14)||9
1419795|NCT02625259|3475571|P3|STARTED|Washout (Day 2 to Day 14)||7
1419796|NCT02625259|3475572|P2|STARTED|Washout (Day 2 to Day 14)||8
1419797|NCT02625259|3475573|P1|STARTED|Washout (Day 2 to Day 14)||9
1419798|NCT02625259|3475569|P5|NOT COMPLETED|First Intervention (Day 1)||0
1419799|NCT02625259|3475570|P4|NOT COMPLETED|First Intervention (Day 1)||1
1419800|NCT02625259|3475571|P3|NOT COMPLETED|First Intervention (Day 1)||1
1419801|NCT02625259|3475572|P2|NOT COMPLETED|First Intervention (Day 1)||1
1419802|NCT02625259|3475573|P1|NOT COMPLETED|First Intervention (Day 1)||2
1419803|NCT02625259|3475569|P5|COMPLETED|First Intervention (Day 1)||16
1419804|NCT02625259|3475570|P4|COMPLETED|First Intervention (Day 1)||9
1419805|NCT02625259|3475571|P3|COMPLETED|First Intervention (Day 1)||7
1419806|NCT02625259|3475572|P2|COMPLETED|First Intervention (Day 1)||8
1419807|NCT02625259|3475573|P1|COMPLETED|First Intervention (Day 1)||9
1419808|NCT02625259|3475569|P5|STARTED|First Intervention (Day 1)||16
1419809|NCT02625259|3475570|P4|STARTED|First Intervention (Day 1)||10
1419810|NCT02625259|3475571|P3|STARTED|First Intervention (Day 1)||8
1419811|NCT02625259|3475572|P2|STARTED|First Intervention (Day 1)||9
1419812|NCT02625259|3475573|P1|STARTED|First Intervention (Day 1)||11
1419813|NCT02625233|3475610|P2|NOT COMPLETED|Overall Study||0
1419814|NCT02625233|3475611|P1|NOT COMPLETED|Overall Study||2
1419815|NCT02625233|3475610|P2|COMPLETED|Overall Study||56
1419816|NCT02625233|3475611|P1|COMPLETED|Overall Study||47
1419817|NCT02625233|3475610|P2|STARTED|Overall Study||56
1419818|NCT02625233|3475611|P1|STARTED|Overall Study||49
1419819|NCT02625220|3475619|P1|NOT COMPLETED|Overall Study||7
1419820|NCT02625220|3475619|P1|COMPLETED|Overall Study||163
1419821|NCT02625220|3475619|P1|STARTED|Overall Study||170
1419822|NCT02625207|3475630|P4|NOT COMPLETED|Part 2 (11 Days)||0
1419823|NCT02625207|3475631|P3|NOT COMPLETED|Part 2 (11 Days)||0
1419824|NCT02625207|3475632|P2|NOT COMPLETED|Part 2 (11 Days)||0
1419825|NCT02625207|3475633|P1|NOT COMPLETED|Part 2 (11 Days)||0
1419826|NCT02625207|3475630|P4|COMPLETED|Part 2 (11 Days)||0
1419827|NCT02625207|3475631|P3|COMPLETED|Part 2 (11 Days)||12
1419828|NCT02625207|3475632|P2|COMPLETED|Part 2 (11 Days)||0
1419829|NCT02625207|3475633|P1|COMPLETED|Part 2 (11 Days)||11
1419830|NCT02625207|3475630|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
1419831|NCT02625207|3475631|P3|STARTED|Part 2 (11 Days)||12
1419832|NCT02625207|3475632|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
1419833|NCT02625207|3475633|P1|STARTED|Part 2 (11 Days)||11
1419834|NCT02625207|3475630|P4|NOT COMPLETED|Part 1 (6 Days)||0
1419835|NCT02625207|3475631|P3|NOT COMPLETED|Part 1 (6 Days)||0
1419836|NCT02625207|3475632|P2|NOT COMPLETED|Part 1 (6 Days)||0
1419837|NCT02625207|3475633|P1|NOT COMPLETED|Part 1 (6 Days)||0
1419838|NCT02625207|3475630|P4|COMPLETED|Part 1 (6 Days)||12
1419839|NCT02625207|3475631|P3|COMPLETED|Part 1 (6 Days)||12
1419840|NCT02625207|3475632|P2|COMPLETED|Part 1 (6 Days)||12
1419841|NCT02625207|3475633|P1|COMPLETED|Part 1 (6 Days)||11
1419842|NCT02625207|3475630|P4|STARTED|Part 1 (6 Days)||12
1419843|NCT02625207|3475631|P3|STARTED|Part 1 (6 Days)||12
1419844|NCT02625207|3475632|P2|STARTED|Part 1 (6 Days)||12
1419845|NCT02625207|3475633|P1|STARTED|Part 1 (6 Days)||11
1419846|NCT02624791|3475719|P6|NOT COMPLETED|Overall Study||0
1419847|NCT02624791|3475720|P5|NOT COMPLETED|Overall Study||0
1419848|NCT02624791|3475721|P4|NOT COMPLETED|Overall Study||0
1419849|NCT02624791|3475722|P3|NOT COMPLETED|Overall Study||0
1419850|NCT02624791|3475723|P2|NOT COMPLETED|Overall Study||0
1419851|NCT02624791|3475724|P1|NOT COMPLETED|Overall Study||2
1419852|NCT02624791|3475719|P6|COMPLETED|Overall Study||2
1419853|NCT02624791|3475720|P5|COMPLETED|Overall Study||2
1419854|NCT02624791|3475721|P4|COMPLETED|Overall Study||2
1419855|NCT02624791|3475722|P3|COMPLETED|Overall Study||2
1419856|NCT02624791|3475723|P2|COMPLETED|Overall Study||1
1419857|NCT02624791|3475724|P1|COMPLETED|Overall Study||0
1419858|NCT02624791|3475719|P6|STARTED|Overall Study||2
1419859|NCT02624791|3475720|P5|STARTED|Overall Study||2
1419860|NCT02624791|3475721|P4|STARTED|Overall Study||2
1419861|NCT02624791|3475722|P3|STARTED|Overall Study||2
1419862|NCT02624791|3475723|P2|STARTED|Overall Study||1
1419863|NCT02624791|3475724|P1|STARTED|Overall Study||2
1419864|NCT02623361|3475731|P2|NOT COMPLETED|Overall Study||2
1419865|NCT02623361|3475732|P1|NOT COMPLETED|Overall Study||0
1419866|NCT02623361|3475731|P2|COMPLETED|Overall Study||38
1419867|NCT02623361|3475732|P1|COMPLETED|Overall Study||40
1419868|NCT02623361|3475731|P2|STARTED|Overall Study||40
1419869|NCT02623361|3475732|P1|STARTED|Overall Study||40
1419870|NCT02622568|3475744|P2|NOT COMPLETED|Overall Study||5
1419871|NCT02622568|3475745|P1|NOT COMPLETED|Overall Study||5
1419872|NCT02622568|3475744|P2|COMPLETED|Overall Study||9
1419873|NCT02622568|3475745|P1|COMPLETED|Overall Study||9
1419874|NCT02622568|3475744|P2|STARTED|Overall Study||14
1419875|NCT02622568|3475745|P1|STARTED|Overall Study||14
1419876|NCT02622321|3475755|P4|NOT COMPLETED|Overall Study||7
1419877|NCT02622321|3475756|P3|NOT COMPLETED|Overall Study||49
1419878|NCT02622321|3475757|P2|NOT COMPLETED|Overall Study||18
1419879|NCT02622321|3475758|P1|NOT COMPLETED|Overall Study||35
1419880|NCT02622321|3475755|P4|COMPLETED|Overall Study||0
1419881|NCT02622321|3475756|P3|COMPLETED|Overall Study||0
1419882|NCT02622321|3475757|P2|COMPLETED|Overall Study||0
1419883|NCT02622321|3475758|P1|COMPLETED|Overall Study||0
1419884|NCT02622321|3475755|P4|Treated|Overall Study||7
1419885|NCT02622321|3475756|P3|Treated|Overall Study||49
1419886|NCT02622321|3475757|P2|Treated|Overall Study||18
1419887|NCT02622321|3475758|P1|Treated|Overall Study||34
1419888|NCT02622321|3475755|P4|STARTED|Overall Study||7
1419889|NCT02622321|3475756|P3|STARTED|Overall Study||49
1419890|NCT02622321|3475757|P2|STARTED|Overall Study||18
1419891|NCT02622321|3475758|P1|STARTED|Overall Study||35
1419892|NCT02622178|3475804|P3|NOT COMPLETED|Overall Study||0
1419893|NCT02622178|3475805|P2|NOT COMPLETED|Overall Study||0
1419894|NCT02622178|3475806|P1|NOT COMPLETED|Overall Study||0
1419895|NCT02622178|3475804|P3|COMPLETED|Overall Study||49
1419896|NCT02622178|3475805|P2|COMPLETED|Overall Study||45
1419897|NCT02622178|3475806|P1|COMPLETED|Overall Study||42
1419898|NCT02622178|3475804|P3|STARTED|Overall Study||49
1419899|NCT02622178|3475805|P2|STARTED|Overall Study||45
1419900|NCT02622178|3475806|P1|STARTED|Overall Study||42
1419901|NCT02621931|3475820|P3|NOT COMPLETED|Overall Study||36
1419902|NCT02621931|3475821|P2|NOT COMPLETED|Overall Study||27
1419903|NCT02621931|3475822|P1|NOT COMPLETED|Overall Study||33
1419904|NCT02621931|3475820|P3|COMPLETED|Overall Study||343
1419905|NCT02621931|3475821|P2|COMPLETED|Overall Study||349
1419906|NCT02621931|3475822|P1|COMPLETED|Overall Study||342
1419907|NCT02621931|3475820|P3|Full Analysis Set|Overall Study||375
1419908|NCT02621931|3475821|P2|Full Analysis Set|Overall Study||375
1419909|NCT02621931|3475822|P1|Full Analysis Set|Overall Study||371
1419910|NCT02621931|3475820|P3|Safety and ITT Populations|Overall Study||379
1419911|NCT02621931|3475821|P2|Safety and ITT Populations|Overall Study||376
1419912|NCT02621931|3475822|P1|Safety and ITT Populations|Overall Study||375
1419913|NCT02621931|3475820|P3|STARTED|Overall Study||379
1419914|NCT02621931|3475821|P2|STARTED|Overall Study||376
1419915|NCT02621931|3475822|P1|STARTED|Overall Study||375
1419916|NCT02621619|3475873|P2|NOT COMPLETED|Overall Study||0
1419917|NCT02621619|3475874|P1|NOT COMPLETED|Overall Study||0
1419918|NCT02621619|3475873|P2|COMPLETED|Overall Study||79
1419919|NCT02621619|3475874|P1|COMPLETED|Overall Study||80
1419920|NCT02621619|3475873|P2|STARTED|Overall Study||79
1419921|NCT02621619|3475874|P1|STARTED|Overall Study||80
1419922|NCT02621047|3475885|P3|NOT COMPLETED|Overall Study||1
1419923|NCT02621047|3475886|P2|NOT COMPLETED|Overall Study||0
1419924|NCT02621047|3475887|P1|NOT COMPLETED|Overall Study||0
1419925|NCT02621047|3475885|P3|COMPLETED|Overall Study||11
1419926|NCT02621047|3475886|P2|COMPLETED|Overall Study||8
1419927|NCT02621047|3475887|P1|COMPLETED|Overall Study||8
1419928|NCT02621047|3475885|P3|STARTED|Overall Study||12
1419929|NCT02621047|3475886|P2|STARTED|Overall Study||8
1419930|NCT02621047|3475887|P1|STARTED|Overall Study||8
1419931|NCT02621034|3476003|P3|NOT COMPLETED|Overall Study||5
1419932|NCT02621034|3476004|P2|NOT COMPLETED|Overall Study||2
1419933|NCT02621034|3476005|P1|NOT COMPLETED|Overall Study||3
1419934|NCT02621034|3476003|P3|COMPLETED|Overall Study||50
1419935|NCT02621034|3476004|P2|COMPLETED|Overall Study||50
1419936|NCT02621034|3476005|P1|COMPLETED|Overall Study||50
1419937|NCT02621034|3476003|P3|STARTED|Overall Study||55
1419938|NCT02621034|3476004|P2|STARTED|Overall Study||52
1419939|NCT02621034|3476005|P1|STARTED|Overall Study||53
1419940|NCT02620683|3476018|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
1419941|NCT02620683|3476019|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
1419942|NCT02620683|3476018|P2|COMPLETED|Second Intervention (Visit 2)||11
1419943|NCT02620683|3476019|P1|COMPLETED|Second Intervention (Visit 2)||12
1419944|NCT02620683|3476018|P2|STARTED|Second Intervention (Visit 2)||11
1419945|NCT02620683|3476019|P1|STARTED|Second Intervention (Visit 2)||12
1419946|NCT02620683|3476018|P2|NOT COMPLETED|Washout (2 Weeks)||0
1419947|NCT02620683|3476019|P1|NOT COMPLETED|Washout (2 Weeks)||0
1419948|NCT02620683|3476018|P2|COMPLETED|Washout (2 Weeks)||11
1419949|NCT02620683|3476019|P1|COMPLETED|Washout (2 Weeks)||12
1419950|NCT02620683|3476018|P2|STARTED|Washout (2 Weeks)||11
1419951|NCT02620683|3476019|P1|STARTED|Washout (2 Weeks)||12
1419952|NCT02620683|3476018|P2|NOT COMPLETED|First Intervention (Visit 1)||0
1419953|NCT02620683|3476019|P1|NOT COMPLETED|First Intervention (Visit 1)||0
1419954|NCT02620683|3476018|P2|COMPLETED|First Intervention (Visit 1)||11
1419955|NCT02620683|3476019|P1|COMPLETED|First Intervention (Visit 1)||12
1419956|NCT02620683|3476018|P2|STARTED|First Intervention (Visit 1)||11
1419957|NCT02620683|3476019|P1|STARTED|First Intervention (Visit 1)||12
1419958|NCT02619812|3476031|P4|NOT COMPLETED|Overall Study||2
1419959|NCT02619812|3476032|P3|NOT COMPLETED|Overall Study||1
1419960|NCT02619812|3476033|P2|NOT COMPLETED|Overall Study||0
1419961|NCT02619812|3476034|P1|NOT COMPLETED|Overall Study||0
1419962|NCT02619812|3476031|P4|COMPLETED|Overall Study||0
1419963|NCT02619812|3476032|P3|COMPLETED|Overall Study||0
1419964|NCT02619812|3476033|P2|COMPLETED|Overall Study||0
1419965|NCT02619812|3476034|P1|COMPLETED|Overall Study||0
1419966|NCT02619812|3476031|P4|STARTED|Overall Study||2
1419967|NCT02619812|3476032|P3|STARTED|Overall Study||1
1419968|NCT02619812|3476033|P2|STARTED|Overall Study||0
1419969|NCT02619812|3476034|P1|STARTED|Overall Study||0
1419970|NCT02619799|3476050|P2|NOT COMPLETED|Overall Study||0
1419971|NCT02619799|3476051|P1|NOT COMPLETED|Overall Study||0
1419972|NCT02619799|3476050|P2|COMPLETED|Overall Study||25
1419973|NCT02619799|3476051|P1|COMPLETED|Overall Study||25
1419974|NCT02619799|3476050|P2|STARTED|Overall Study||25
1419975|NCT02619799|3476051|P1|STARTED|Overall Study||25
1419976|NCT02619591|3476069|P2|NOT COMPLETED|Overall Study||121
1419977|NCT02619591|3476070|P1|NOT COMPLETED|Overall Study||139
1419978|NCT02619591|3476069|P2|COMPLETED|Overall Study||0
1419979|NCT02619591|3476070|P1|COMPLETED|Overall Study||0
1419980|NCT02619591|3476069|P2|STARTED|Overall Study||121
1419981|NCT02619591|3476070|P1|STARTED|Overall Study||139
1419982|NCT02619409|3476081|P5|NOT COMPLETED|Overall Study||0
1419983|NCT02619409|3476082|P4|NOT COMPLETED|Overall Study||0
1419984|NCT02619409|3476083|P3|NOT COMPLETED|Overall Study||0
1419985|NCT02619409|3476084|P2|NOT COMPLETED|Overall Study||0
1419986|NCT02619409|3476085|P1|NOT COMPLETED|Overall Study||0
1419987|NCT02619409|3476081|P5|COMPLETED|Overall Study||6
1419988|NCT02619409|3476082|P4|COMPLETED|Overall Study||6
1419989|NCT02619409|3476083|P3|COMPLETED|Overall Study||6
1419990|NCT02619409|3476084|P2|COMPLETED|Overall Study||6
1419991|NCT02619409|3476085|P1|COMPLETED|Overall Study||6
1419992|NCT02619409|3476081|P5|STARTED|Overall Study||6
1419993|NCT02619409|3476082|P4|STARTED|Overall Study||6
1419994|NCT02619409|3476083|P3|STARTED|Overall Study||6
1419995|NCT02619409|3476084|P2|STARTED|Overall Study||6
1419996|NCT02619409|3476085|P1|STARTED|Overall Study||6
1419997|NCT02618915|3476104|P2|NOT COMPLETED|Overall Study||0
1419998|NCT02618915|3476105|P1|NOT COMPLETED|Overall Study||0
1419999|NCT02618915|3476104|P2|COMPLETED|Overall Study||3
1420000|NCT02618915|3476105|P1|COMPLETED|Overall Study||3
1420001|NCT02618915|3476104|P2|STARTED|Overall Study||3
1420002|NCT02618915|3476105|P1|STARTED|Overall Study||3
1420003|NCT02618772|3476131|P2|NOT COMPLETED|Overall Study||0
1420004|NCT02618772|3476132|P1|NOT COMPLETED|Overall Study||1
1420005|NCT02618772|3476131|P2|COMPLETED|Overall Study||40
1420006|NCT02618772|3476132|P1|COMPLETED|Overall Study||38
1420007|NCT02618772|3476131|P2|Withdrawal by Subject|Overall Study||0
1420008|NCT02618772|3476132|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
1420009|NCT02618772|3476131|P2|STARTED|Overall Study||40
1420010|NCT02618772|3476132|P1|STARTED|Overall Study||39
1420011|NCT02618759|3476166|P2|NOT COMPLETED|Overall Study||5
1420012|NCT02618759|3476167|P1|NOT COMPLETED|Overall Study||2
1420013|NCT02618759|3476166|P2|COMPLETED|Overall Study||54
1420014|NCT02618759|3476167|P1|COMPLETED|Overall Study||58
1420015|NCT02618759|3476166|P2|STARTED|Overall Study||59
1420016|NCT02618759|3476167|P1|STARTED|Overall Study||60
1420017|NCT02618512|3476183|P1|NOT COMPLETED|Overall Study||0
1420018|NCT02618512|3476183|P1|COMPLETED|Overall Study||3
1420019|NCT02618512|3476183|P1|STARTED|Overall Study||3
1420020|NCT02617901|3476187|P1|NOT COMPLETED|Overall Study||0
1420021|NCT02617901|3476187|P1|COMPLETED|Overall Study||20
1420022|NCT02617901|3476187|P1|STARTED|Overall Study||20
1420023|NCT02617888|3476194|P3|NOT COMPLETED|Overall Study||0
1420024|NCT02617888|3476195|P2|NOT COMPLETED|Overall Study||7
1420025|NCT02617888|3476196|P1|NOT COMPLETED|Overall Study||1
1420026|NCT02617888|3476194|P3|COMPLETED|Overall Study||127
1420027|NCT02617888|3476195|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
1420028|NCT02617888|3476196|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
1420029|NCT02617888|3476194|P3|STARTED|Overall Study||127
1420030|NCT02617888|3476195|P2|STARTED|Overall Study||51
1420031|NCT02617888|3476196|P1|STARTED|Overall Study||50
1420032|NCT02617784|3476205|P2|NOT COMPLETED|Overall Study||0
1420033|NCT02617784|3476206|P1|NOT COMPLETED|Overall Study||0
1420034|NCT02617784|3476205|P2|COMPLETED|Overall Study||12
1420035|NCT02617784|3476206|P1|COMPLETED|Overall Study||12
1420036|NCT02617784|3476205|P2|Second Dose Assessment Period|Overall Study||12
1420037|NCT02617784|3476206|P1|Second Dose Assessment Period|Overall Study||11
1420038|NCT02617784|3476205|P2|First Dose Assessment Period|Overall Study||12
1420039|NCT02617784|3476206|P1|First Dose Assessment Period|Overall Study||12
1420040|NCT02617784|3476205|P2|STARTED|Overall Study||12
1420041|NCT02617784|3476206|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
1420042|NCT02617667|3476257|P4|NOT COMPLETED|Overall Study||1
1420043|NCT02617667|3476258|P3|NOT COMPLETED|Overall Study||4
1420044|NCT02617667|3476259|P2|NOT COMPLETED|Overall Study||1
1420045|NCT02617667|3476260|P1|NOT COMPLETED|Overall Study||1
1420046|NCT02617667|3476257|P4|COMPLETED|Overall Study||52
1420047|NCT02617667|3476258|P3|COMPLETED|Overall Study||48
1420048|NCT02617667|3476259|P2|COMPLETED|Overall Study||50
1420049|NCT02617667|3476260|P1|COMPLETED|Overall Study||50
1420050|NCT02617667|3476257|P4|STARTED|Overall Study||53
1420051|NCT02617667|3476258|P3|STARTED|Overall Study||52
1420052|NCT02617667|3476259|P2|STARTED|Overall Study||51
1420053|NCT02617667|3476260|P1|STARTED|Overall Study||51
1420054|NCT02616523|3476275|P3|NOT COMPLETED|Overall Study||0
1420055|NCT02616523|3476276|P2|NOT COMPLETED|Overall Study||0
1420056|NCT02616523|3476277|P1|NOT COMPLETED|Overall Study||1
1420057|NCT02616523|3476275|P3|COMPLETED|Overall Study|April 2015|20
1420058|NCT02616523|3476276|P2|COMPLETED|Overall Study|April 2015|20
1420059|NCT02616523|3476277|P1|COMPLETED|Overall Study|April 2015|19
1420060|NCT02616523|3476275|P3|STARTED|Overall Study|June 2014|20
1420061|NCT02616523|3476276|P2|STARTED|Overall Study|June 2014|20
1420062|NCT02616523|3476277|P1|STARTED|Overall Study|June 2014|20
1420063|NCT02616250|3476293|P2|NOT COMPLETED|Overall Study||9
1420064|NCT02616250|3476294|P1|NOT COMPLETED|Overall Study||10
1420065|NCT02616250|3476293|P2|COMPLETED|Overall Study||86
1420066|NCT02616250|3476294|P1|COMPLETED|Overall Study||85
1420067|NCT02616250|3476293|P2|STARTED|Overall Study||95
1420068|NCT02616250|3476294|P1|STARTED|Overall Study||95
1420069|NCT02615990|3476302|P2|NOT COMPLETED|Overall Study||1
1420070|NCT02615990|3476303|P1|NOT COMPLETED|Overall Study||1
1420071|NCT02615990|3476302|P2|COMPLETED|Overall Study||0
1420072|NCT02615990|3476303|P1|COMPLETED|Overall Study||0
1420073|NCT02615990|3476302|P2|STARTED|Overall Study||1
1420074|NCT02615990|3476303|P1|STARTED|Overall Study||1
1420075|NCT02615743|3476349|P2|NOT COMPLETED|Overall Study||3
1420076|NCT02615743|3476350|P1|NOT COMPLETED|Overall Study||6
1420077|NCT02615743|3476349|P2|COMPLETED|Overall Study||17
1420078|NCT02615743|3476350|P1|COMPLETED|Overall Study||15
1420079|NCT02615743|3476349|P2|STARTED|Overall Study||20
1420080|NCT02615743|3476350|P1|STARTED|Overall Study||21
1420081|NCT02615717|3476364|P2|NOT COMPLETED|Overall Study||0
1420082|NCT02615717|3476365|P1|NOT COMPLETED|Overall Study||0
1420083|NCT02615717|3476364|P2|COMPLETED|Overall Study||3
1420084|NCT02615717|3476365|P1|COMPLETED|Overall Study||3
1420085|NCT02615717|3476364|P2|STARTED|Overall Study||3
1420086|NCT02615717|3476365|P1|STARTED|Overall Study||3
1420087|NCT02614924|3476379|P2|NOT COMPLETED|Overall Study||0
1420088|NCT02614924|3476380|P1|NOT COMPLETED|Overall Study||0
1420089|NCT02614924|3476379|P2|COMPLETED|Overall Study||20
1420090|NCT02614924|3476380|P1|COMPLETED|Overall Study||20
1420091|NCT02614924|3476379|P2|STARTED|Overall Study||20
1420092|NCT02614924|3476380|P1|STARTED|Overall Study||20
1420093|NCT02614586|3476388|P1|NOT COMPLETED|Overall Study||0
1420094|NCT02614586|3476388|P1|COMPLETED|Overall Study||11
1420095|NCT02614586|3476388|P1|STARTED|Overall Study||11
1420096|NCT02614469|3476395|P2|NOT COMPLETED|Period 2||0
1420097|NCT02614469|3476396|P1|NOT COMPLETED|Period 2||0
1420098|NCT02614469|3476395|P2|COMPLETED|Period 2||9
1420099|NCT02614469|3476396|P1|COMPLETED|Period 2||9
1420100|NCT02614469|3476395|P2|STARTED|Period 2||9
1420101|NCT02614469|3476396|P1|STARTED|Period 2||9
1420102|NCT02614469|3476395|P2|NOT COMPLETED|Period 1||0
1420103|NCT02614469|3476396|P1|NOT COMPLETED|Period 1||0
1420104|NCT02614469|3476395|P2|COMPLETED|Period 1||9
1420105|NCT02614469|3476396|P1|COMPLETED|Period 1||9
1420106|NCT02614469|3476395|P2|STARTED|Period 1||9
1420107|NCT02614469|3476396|P1|STARTED|Period 1||9
1420108|NCT02614274|3476424|P1|NOT COMPLETED|Overall Study||4
1420109|NCT02614274|3476424|P1|COMPLETED|Overall Study||5
1420110|NCT02614274|3476424|P1|STARTED|Overall Study||9
1420111|NCT02614222|3476435|P2|NOT COMPLETED|Overall Study||0
1420112|NCT02614222|3476436|P1|NOT COMPLETED|Overall Study||0
1420113|NCT02614222|3476435|P2|COMPLETED|Overall Study||14
1420114|NCT02614222|3476436|P1|COMPLETED|Overall Study||13
1420115|NCT02614222|3476435|P2|STARTED|Overall Study||14
1420116|NCT02614222|3476436|P1|STARTED|Overall Study||13
1420117|NCT02614183|3476459|P3|NOT COMPLETED|Post Treatment Follow-up Phase||12
1420118|NCT02614183|3476460|P2|NOT COMPLETED|Post Treatment Follow-up Phase||6
1420119|NCT02614183|3476461|P1|NOT COMPLETED|Post Treatment Follow-up Phase||18
1420120|NCT02614183|3476459|P3|COMPLETED|Post Treatment Follow-up Phase||171
1420121|NCT02614183|3476460|P2|COMPLETED|Post Treatment Follow-up Phase||179
1420122|NCT02614183|3476461|P1|COMPLETED|Post Treatment Follow-up Phase||354
1420123|NCT02614183|3476459|P3|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
1420124|NCT02614183|3476460|P2|Safety Population|Post Treatment Follow-up Phase||183
1420125|NCT02614183|3476461|P1|Safety Population|Post Treatment Follow-up Phase||372
1420126|NCT02614183|3476459|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
1420127|NCT02614183|3476460|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
1420128|NCT02614183|3476461|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
1420129|NCT02614183|3476459|P3|NOT COMPLETED|Double Blind Treatment Phase||39
1420130|NCT02614183|3476460|P2|NOT COMPLETED|Double Blind Treatment Phase||37
1420131|NCT02614183|3476461|P1|NOT COMPLETED|Double Blind Treatment Phase||83
1420132|NCT02614183|3476459|P3|COMPLETED|Double Blind Treatment Phase||175
1420133|NCT02614183|3476460|P2|COMPLETED|Double Blind Treatment Phase||177
1420134|NCT02614183|3476461|P1|COMPLETED|Double Blind Treatment Phase||351
1420135|NCT02614183|3476459|P3|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
1420136|NCT02614183|3476460|P2|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
1420137|NCT02614183|3476461|P1|Safety Population|Double Blind Treatment Phase||432
1420138|NCT02614183|3476459|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
1420139|NCT02614183|3476460|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
1420140|NCT02614183|3476461|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
1420141|NCT02614183|3476459|P3|STARTED|Double Blind Treatment Phase||214
1420142|NCT02614183|3476460|P2|STARTED|Double Blind Treatment Phase||214
1420143|NCT02614183|3476461|P1|STARTED|Double Blind Treatment Phase||434
1420144|NCT02614079|3476498|P1|NOT COMPLETED|Overall Study||1
1420145|NCT02614079|3476498|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
1420146|NCT02614079|3476498|P1|STARTED|Overall Study||6
1420147|NCT02613910|3476502|P1|NOT COMPLETED|Overall Study||1
1420148|NCT02613910|3476502|P1|COMPLETED|Overall Study||0
1420149|NCT02613910|3476502|P1|STARTED|Overall Study||1
1420150|NCT02613871|3476551|P1|NOT COMPLETED|Overall Study||111
1420151|NCT02613871|3476551|P1|COMPLETED|Overall Study||0
1420152|NCT02613871|3476551|P1|STARTED|Overall Study||111
1420153|NCT02613403|3476570|P5|NOT COMPLETED|Overall Study||0
1420154|NCT02613403|3476571|P4|NOT COMPLETED|Overall Study||0
1420155|NCT02613403|3476572|P3|NOT COMPLETED|Overall Study||0
1420156|NCT02613403|3476573|P2|NOT COMPLETED|Overall Study||1
1420157|NCT02613403|3476574|P1|NOT COMPLETED|Overall Study||2
1420158|NCT02613403|3476570|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
1420159|NCT02613403|3476571|P4|COMPLETED|Overall Study||13
1420160|NCT02613403|3476572|P3|COMPLETED|Overall Study||9
1420161|NCT02613403|3476573|P2|COMPLETED|Overall Study||35
1420162|NCT02613403|3476574|P1|COMPLETED|Overall Study||34
1420163|NCT02613403|3476570|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
1420164|NCT02613403|3476571|P4|Treated|Overall Study||13
1420165|NCT02613403|3476572|P3|Treated|Overall Study||9
1420166|NCT02613403|3476573|P2|Treated|Overall Study||36
1420167|NCT02613403|3476574|P1|Treated|Overall Study||35
1420168|NCT02613403|3476570|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
1420169|NCT02613403|3476571|P4|STARTED|Overall Study||13
1420170|NCT02613403|3476572|P3|STARTED|Overall Study||9
1420171|NCT02613403|3476573|P2|STARTED|Overall Study||36
1420172|NCT02613403|3476574|P1|STARTED|Overall Study||36
1420173|NCT02612610|3476620|P4|NOT COMPLETED|Overall Study||13
1420174|NCT02612610|3476621|P3|NOT COMPLETED|Overall Study||5
1420175|NCT02612610|3476622|P2|NOT COMPLETED|Overall Study||8
1420176|NCT02612610|3476623|P1|NOT COMPLETED|Overall Study||5
1420177|NCT02612610|3476620|P4|COMPLETED|Overall Study||50
1420178|NCT02612610|3476621|P3|COMPLETED|Overall Study||58
1420179|NCT02612610|3476622|P2|COMPLETED|Overall Study||56
1420180|NCT02612610|3476623|P1|COMPLETED|Overall Study||58
1420181|NCT02612610|3476620|P4|Treated|Overall Study||63
1420182|NCT02612610|3476621|P3|Treated|Overall Study||63
1420183|NCT02612610|3476622|P2|Treated|Overall Study||63
1420184|NCT02612610|3476623|P1|Treated|Overall Study||63
1420185|NCT02612610|3476620|P4|STARTED|Overall Study||63
1420186|NCT02612610|3476621|P3|STARTED|Overall Study||63
1420187|NCT02612610|3476622|P2|STARTED|Overall Study||64
1420188|NCT02612610|3476623|P1|STARTED|Overall Study||63
1420189|NCT02612285|3476865|P1|NOT COMPLETED|Overall Study||1
1420190|NCT02612285|3476865|P1|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
1420191|NCT02612285|3476865|P1|STARTED|Overall Study||1
1420192|NCT02612077|3476869|P1|NOT COMPLETED|Overall Study||466
1420193|NCT02612077|3476869|P1|COMPLETED|Overall Study||299
1420194|NCT02612077|3476869|P1|Efficacy Analysis Set|Overall Study||737
1420195|NCT02612077|3476869|P1|Safety Analysis Set|Overall Study||760
1420196|NCT02612077|3476869|P1|Did Not Receive Study Product|Overall Study||5
1420197|NCT02612077|3476869|P1|STARTED|Overall Study||765
1420198|NCT02612064|3476881|P2|NOT COMPLETED|Overall Study||3
1420199|NCT02612064|3476882|P1|NOT COMPLETED|Overall Study||1
1420200|NCT02612064|3476881|P2|COMPLETED|Overall Study||112
1420201|NCT02612064|3476882|P1|COMPLETED|Overall Study||114
1420202|NCT02612064|3476881|P2|STARTED|Overall Study||115
1420203|NCT02612064|3476882|P1|STARTED|Overall Study||115
1420204|NCT02611765|3476894|P2|NOT COMPLETED|Overall Study||6
1420205|NCT02611765|3476895|P1|NOT COMPLETED|Overall Study||2
1420206|NCT02611765|3476894|P2|COMPLETED|Overall Study||29
1420207|NCT02611765|3476895|P1|COMPLETED|Overall Study||27
1420208|NCT02611765|3476894|P2|STARTED|Overall Study||35
1420209|NCT02611765|3476895|P1|STARTED|Overall Study||29
1420210|NCT02611154|3476901|P1|NOT COMPLETED|Overall Study||0
1420211|NCT02611154|3476901|P1|COMPLETED|Overall Study||5
1420212|NCT02611154|3476901|P1|STARTED|Overall Study||5
1420213|NCT02610842|3476920|P1|NOT COMPLETED|Overall Study||5
1420214|NCT02610842|3476920|P1|COMPLETED|Overall Study||22
1420215|NCT02610842|3476920|P1|STARTED|Overall Study||27
1420216|NCT02610816|3476929|P4|NOT COMPLETED|Phase 2||6
1420217|NCT02610816|3476930|P3|NOT COMPLETED|Phase 2||11
1420218|NCT02610816|3476931|P2|NOT COMPLETED|Phase 2||0
1420219|NCT02610816|3476932|P1|NOT COMPLETED|Phase 2||0
1420220|NCT02610816|3476929|P4|COMPLETED|Phase 2||4
1420221|NCT02610816|3476930|P3|COMPLETED|Phase 2||8
1420222|NCT02610816|3476931|P2|COMPLETED|Phase 2||0
1420223|NCT02610816|3476932|P1|COMPLETED|Phase 2||0
1420224|NCT02610816|3476929|P4|STARTED|Phase 2||10
1420225|NCT02610816|3476930|P3|STARTED|Phase 2||19
1420226|NCT02610816|3476931|P2|STARTED|Phase 2||0
1420227|NCT02610816|3476932|P1|STARTED|Phase 2||0
1420228|NCT02610816|3476929|P4|NOT COMPLETED|Phase 1||0
1420229|NCT02610816|3476930|P3|NOT COMPLETED|Phase 1||0
1420230|NCT02610816|3476931|P2|NOT COMPLETED|Phase 1||8
1420231|NCT02610816|3476932|P1|NOT COMPLETED|Phase 1||4
1420232|NCT02610816|3476929|P4|COMPLETED|Phase 1||0
1420233|NCT02610816|3476930|P3|COMPLETED|Phase 1||0
1420234|NCT02610816|3476931|P2|COMPLETED|Phase 1||17
1420235|NCT02610816|3476932|P1|COMPLETED|Phase 1||34
1420236|NCT02610816|3476929|P4|STARTED|Phase 1||0
1420237|NCT02610816|3476930|P3|STARTED|Phase 1||0
1420238|NCT02610816|3476931|P2|STARTED|Phase 1||25
1420239|NCT02610816|3476932|P1|STARTED|Phase 1||38
1420240|NCT02610634|3476955|P2|NOT COMPLETED|Overall Study||0
1420241|NCT02610634|3476956|P1|NOT COMPLETED|Overall Study||0
1420242|NCT02610634|3476955|P2|COMPLETED|Overall Study||40
1420243|NCT02610634|3476956|P1|COMPLETED|Overall Study||60
1420244|NCT02610634|3476955|P2|STARTED|Overall Study||40
1420245|NCT02610634|3476956|P1|STARTED|Overall Study||60
1420246|NCT02609841|3476964|P1|NOT COMPLETED|Overall Study||28
1420247|NCT02609841|3476964|P1|COMPLETED|Overall Study||212
1420248|NCT02609841|3476964|P1|STARTED|Overall Study||240
1420249|NCT02609672|3476972|P2|NOT COMPLETED|Overall Study||1
1420250|NCT02609672|3476973|P1|NOT COMPLETED|Overall Study||3
1420251|NCT02609672|3476972|P2|COMPLETED|Overall Study||11
1420252|NCT02609672|3476973|P1|COMPLETED|Overall Study||9
1420253|NCT02609672|3476972|P2|STARTED|Overall Study||12
1420254|NCT02609672|3476973|P1|STARTED|Overall Study||12
1420255|NCT02609659|3477007|P1|NOT COMPLETED|Overall Study||8
1420256|NCT02609659|3477007|P1|COMPLETED|Overall Study||97
1420257|NCT02609659|3477007|P1|STARTED|Overall Study||105
1420258|NCT02609633|3477017|P2|NOT COMPLETED|Overall Study||2
1420259|NCT02609633|3477018|P1|NOT COMPLETED|Overall Study||5
1420260|NCT02609633|3477017|P2|COMPLETED|Overall Study||54
1420261|NCT02609633|3477018|P1|COMPLETED|Overall Study||37
1420262|NCT02609633|3477017|P2|Full Analysis Set (FAS)|Overall Study||46
1420263|NCT02609633|3477018|P1|Full Analysis Set (FAS)|Overall Study||32
1420264|NCT02609633|3477017|P2|STARTED|Overall Study||56
1420265|NCT02609633|3477018|P1|STARTED|Overall Study||42
1420266|NCT02609399|3477045|P2|NOT COMPLETED|Influenza Season 2016-2017||5
1420267|NCT02609399|3477046|P1|NOT COMPLETED|Influenza Season 2016-2017||9
1420268|NCT02609399|3477045|P2|COMPLETED|Influenza Season 2016-2017||59
1420269|NCT02609399|3477046|P1|COMPLETED|Influenza Season 2016-2017||49
1420270|NCT02609399|3477045|P2|STARTED|Influenza Season 2016-2017||64
1420271|NCT02609399|3477046|P1|STARTED|Influenza Season 2016-2017||58
1420272|NCT02609399|3477045|P2|NOT COMPLETED|Influenza Season 2015-2016||2
1420273|NCT02609399|3477046|P1|NOT COMPLETED|Influenza Season 2015-2016||3
1420274|NCT02609399|3477045|P2|COMPLETED|Influenza Season 2015-2016||29
1420275|NCT02609399|3477046|P1|COMPLETED|Influenza Season 2015-2016||24
1420276|NCT02609399|3477045|P2|STARTED|Influenza Season 2015-2016||31
1420277|NCT02609399|3477046|P1|STARTED|Influenza Season 2015-2016||27
1420278|NCT02609204|3477058|P1|NOT COMPLETED|Overall Study||0
1420279|NCT02609204|3477058|P1|COMPLETED|Overall Study||51
1420280|NCT02609204|3477058|P1|STARTED|Overall Study||51
1420281|NCT02609178|3477063|P6|NOT COMPLETED|Third Crown||0
1420282|NCT02609178|3477064|P5|NOT COMPLETED|Third Crown||0
1420283|NCT02609178|3477065|P4|NOT COMPLETED|Third Crown||0
1420284|NCT02609178|3477066|P3|NOT COMPLETED|Third Crown||0
1420285|NCT02609178|3477067|P2|NOT COMPLETED|Third Crown||0
1420286|NCT02609178|3477068|P1|NOT COMPLETED|Third Crown||0
1420287|NCT02609178|3477063|P6|COMPLETED|Third Crown||2
1420288|NCT02609178|3477064|P5|COMPLETED|Third Crown||0
1420289|NCT02609178|3477065|P4|COMPLETED|Third Crown||2
1420290|NCT02609178|3477066|P3|COMPLETED|Third Crown||5
1420291|NCT02609178|3477067|P2|COMPLETED|Third Crown||1
1420292|NCT02609178|3477068|P1|COMPLETED|Third Crown||0
1420293|NCT02609178|3477063|P6|STARTED|Third Crown||2
1420294|NCT02609178|3477064|P5|STARTED|Third Crown||0
1420295|NCT02609178|3477065|P4|STARTED|Third Crown||2
1420296|NCT02609178|3477066|P3|STARTED|Third Crown||5
1420297|NCT02609178|3477067|P2|STARTED|Third Crown||1
1420298|NCT02609178|3477068|P1|STARTED|Third Crown||0
1420299|NCT02609178|3477063|P6|NOT COMPLETED|5-minute Washout Time||0
1420300|NCT02609178|3477064|P5|NOT COMPLETED|5-minute Washout Time||0
1420301|NCT02609178|3477065|P4|NOT COMPLETED|5-minute Washout Time||0
1420302|NCT02609178|3477066|P3|NOT COMPLETED|5-minute Washout Time||0
1420303|NCT02609178|3477067|P2|NOT COMPLETED|5-minute Washout Time||0
1420304|NCT02609178|3477068|P1|NOT COMPLETED|5-minute Washout Time||0
1420305|NCT02609178|3477063|P6|COMPLETED|5-minute Washout Time||2
1420306|NCT02609178|3477064|P5|COMPLETED|5-minute Washout Time||0
1420307|NCT02609178|3477065|P4|COMPLETED|5-minute Washout Time||2
1420308|NCT02609178|3477066|P3|COMPLETED|5-minute Washout Time||5
1420309|NCT02609178|3477067|P2|COMPLETED|5-minute Washout Time||1
1420310|NCT02609178|3477068|P1|COMPLETED|5-minute Washout Time||0
1420311|NCT02609178|3477063|P6|STARTED|5-minute Washout Time||2
1420312|NCT02609178|3477064|P5|STARTED|5-minute Washout Time||0
1420313|NCT02609178|3477065|P4|STARTED|5-minute Washout Time||2
1420314|NCT02609178|3477066|P3|STARTED|5-minute Washout Time||5
1420315|NCT02609178|3477067|P2|STARTED|5-minute Washout Time||1
1420316|NCT02609178|3477068|P1|STARTED|5-minute Washout Time||0
1420317|NCT02609178|3477063|P6|NOT COMPLETED|Second Crown||0
1420318|NCT02609178|3477064|P5|NOT COMPLETED|Second Crown||0
1420319|NCT02609178|3477065|P4|NOT COMPLETED|Second Crown||0
1420320|NCT02609178|3477066|P3|NOT COMPLETED|Second Crown||0
1420321|NCT02609178|3477067|P2|NOT COMPLETED|Second Crown||0
1420322|NCT02609178|3477068|P1|NOT COMPLETED|Second Crown||0
1420323|NCT02609178|3477063|P6|COMPLETED|Second Crown||2
1420324|NCT02609178|3477064|P5|COMPLETED|Second Crown||0
1420325|NCT02609178|3477065|P4|COMPLETED|Second Crown||2
1420326|NCT02609178|3477066|P3|COMPLETED|Second Crown||5
1420327|NCT02609178|3477067|P2|COMPLETED|Second Crown||1
1420328|NCT02609178|3477068|P1|COMPLETED|Second Crown||0
1420329|NCT02609178|3477063|P6|STARTED|Second Crown||2
1420330|NCT02609178|3477064|P5|STARTED|Second Crown||0
1420331|NCT02609178|3477065|P4|STARTED|Second Crown||2
1420332|NCT02609178|3477066|P3|STARTED|Second Crown||5
1420333|NCT02609178|3477067|P2|STARTED|Second Crown||1
1420334|NCT02609178|3477068|P1|STARTED|Second Crown||0
1420335|NCT02609178|3477063|P6|NOT COMPLETED|5-minute Washout Time||0
1420336|NCT02609178|3477064|P5|NOT COMPLETED|5-minute Washout Time||0
1420337|NCT02609178|3477065|P4|NOT COMPLETED|5-minute Washout Time||0
1420338|NCT02609178|3477066|P3|NOT COMPLETED|5-minute Washout Time||0
1420339|NCT02609178|3477067|P2|NOT COMPLETED|5-minute Washout Time||0
1420340|NCT02609178|3477068|P1|NOT COMPLETED|5-minute Washout Time||0
1420341|NCT02609178|3477063|P6|COMPLETED|5-minute Washout Time||2
1420342|NCT02609178|3477064|P5|COMPLETED|5-minute Washout Time||0
1420343|NCT02609178|3477065|P4|COMPLETED|5-minute Washout Time||2
1420344|NCT02609178|3477066|P3|COMPLETED|5-minute Washout Time||5
1420345|NCT02609178|3477067|P2|COMPLETED|5-minute Washout Time||1
1420346|NCT02609178|3477068|P1|COMPLETED|5-minute Washout Time||0
1420347|NCT02609178|3477063|P6|STARTED|5-minute Washout Time||2
1420348|NCT02609178|3477064|P5|STARTED|5-minute Washout Time||0
1420349|NCT02609178|3477065|P4|STARTED|5-minute Washout Time||2
1420350|NCT02609178|3477066|P3|STARTED|5-minute Washout Time||5
1420351|NCT02609178|3477067|P2|STARTED|5-minute Washout Time||1
1420352|NCT02609178|3477068|P1|STARTED|5-minute Washout Time||0
1420353|NCT02609178|3477063|P6|NOT COMPLETED|First Crown||0
1420354|NCT02609178|3477064|P5|NOT COMPLETED|First Crown||0
1420355|NCT02609178|3477065|P4|NOT COMPLETED|First Crown||1
1420356|NCT02609178|3477066|P3|NOT COMPLETED|First Crown||1
1420357|NCT02609178|3477067|P2|NOT COMPLETED|First Crown||0
1420358|NCT02609178|3477068|P1|NOT COMPLETED|First Crown||0
1420359|NCT02609178|3477063|P6|COMPLETED|First Crown||2
1420360|NCT02609178|3477064|P5|COMPLETED|First Crown||0
1420361|NCT02609178|3477065|P4|COMPLETED|First Crown||2
1420362|NCT02609178|3477066|P3|COMPLETED|First Crown||5
1420363|NCT02609178|3477067|P2|COMPLETED|First Crown||1
1420364|NCT02609178|3477068|P1|COMPLETED|First Crown||0
1420365|NCT02609178|3477063|P6|STARTED|First Crown||2
1420366|NCT02609178|3477064|P5|STARTED|First Crown||0
1420367|NCT02609178|3477065|P4|STARTED|First Crown||3
1420368|NCT02609178|3477066|P3|STARTED|First Crown||6
1420369|NCT02609178|3477067|P2|STARTED|First Crown||1
1420370|NCT02609178|3477068|P1|STARTED|First Crown||0
1420371|NCT02609113|3477085|P2|NOT COMPLETED|Overall Study||2
1420372|NCT02609113|3477086|P1|NOT COMPLETED|Overall Study||2
1420373|NCT02609113|3477085|P2|COMPLETED|Overall Study||9
1420374|NCT02609113|3477086|P1|COMPLETED|Overall Study||9
1420375|NCT02609113|3477085|P2|STARTED|Overall Study||11
1420376|NCT02609113|3477086|P1|STARTED|Overall Study||11
1420377|NCT02609100|3477100|P2|NOT COMPLETED|Overall Study||0
1420378|NCT02609100|3477101|P1|NOT COMPLETED|Overall Study||0
1420379|NCT02609100|3477100|P2|COMPLETED|Overall Study||2
1420380|NCT02609100|3477101|P1|COMPLETED|Overall Study||2
1420381|NCT02609100|3477100|P2|STARTED|Overall Study||2
1420382|NCT02609100|3477101|P1|STARTED|Overall Study||2
1420383|NCT02608489|3477119|P2|NOT COMPLETED|Overall Study||10
1420384|NCT02608489|3477120|P1|NOT COMPLETED|Overall Study||13
1420385|NCT02608489|3477119|P2|COMPLETED|Overall Study||33
1420386|NCT02608489|3477120|P1|COMPLETED|Overall Study||30
1420387|NCT02608489|3477119|P2|STARTED|Overall Study||43
1420388|NCT02608489|3477120|P1|STARTED|Overall Study||43
1420389|NCT02608177|3477142|P2|NOT COMPLETED|Overall Study||0
1420390|NCT02608177|3477143|P1|NOT COMPLETED|Overall Study||0
1420391|NCT02608177|3477142|P2|COMPLETED|Overall Study||1
1420392|NCT02608177|3477143|P1|COMPLETED|Overall Study||2
1420393|NCT02608177|3477142|P2|STARTED|Overall Study||1
1420394|NCT02608177|3477143|P1|STARTED|Overall Study||2
1420395|NCT02607956|3477165|P2|NOT COMPLETED|Overall Study||330
1420396|NCT02607956|3477166|P1|NOT COMPLETED|Overall Study||327
1420397|NCT02607956|3477165|P2|COMPLETED|Overall Study||0
1420398|NCT02607956|3477166|P1|COMPLETED|Overall Study||0
1420399|NCT02607956|3477165|P2|STARTED|Overall Study||330
1420400|NCT02607956|3477166|P1|STARTED|Overall Study||327
1420401|NCT02607930|3477180|P2|NOT COMPLETED|Overall Study||315
1420402|NCT02607930|3477181|P1|NOT COMPLETED|Overall Study||316
1420403|NCT02607930|3477180|P2|COMPLETED|Overall Study||0
1420404|NCT02607930|3477181|P1|COMPLETED|Overall Study||0
1420405|NCT02607930|3477180|P2|STARTED|Overall Study||315
1420406|NCT02607930|3477181|P1|STARTED|Overall Study||316
1420407|NCT02607800|3477203|P2|NOT COMPLETED|Overall Study||11
1420408|NCT02607800|3477204|P1|NOT COMPLETED|Overall Study||10
1420409|NCT02607800|3477203|P2|COMPLETED|Overall Study||430
1420410|NCT02607800|3477204|P1|COMPLETED|Overall Study||492
1420411|NCT02607800|3477203|P2|STARTED|Overall Study||441
1420412|NCT02607800|3477204|P1|STARTED|Overall Study||502
1420413|NCT02607735|3477222|P3|NOT COMPLETED|Deferred Treatment Substudy||5
1420414|NCT02607735|3477223|P2|NOT COMPLETED|Deferred Treatment Substudy||0
1420415|NCT02607735|3477224|P1|NOT COMPLETED|Deferred Treatment Substudy||0
1420416|NCT02607735|3477222|P3|COMPLETED|Deferred Treatment Substudy||142
1420417|NCT02607735|3477223|P2|COMPLETED|Deferred Treatment Substudy||0
1420418|NCT02607735|3477224|P1|COMPLETED|Deferred Treatment Substudy||0
1420419|NCT02607735|3477222|P3|STARTED|Deferred Treatment Substudy||147
1420420|NCT02607735|3477223|P2|STARTED|Deferred Treatment Substudy||0
1420421|NCT02607735|3477224|P1|STARTED|Deferred Treatment Substudy||0
1420422|NCT02607735|3477222|P3|NOT COMPLETED|Primary Study||0
1420423|NCT02607735|3477223|P2|NOT COMPLETED|Primary Study||0
1420424|NCT02607735|3477224|P1|NOT COMPLETED|Primary Study||7
1420425|NCT02607735|3477222|P3|COMPLETED|Primary Study||0
1420426|NCT02607735|3477223|P2|COMPLETED|Primary Study||152
1420427|NCT02607735|3477224|P1|COMPLETED|Primary Study||257
1420428|NCT02607735|3477222|P3|STARTED|Primary Study||0
1420429|NCT02607735|3477223|P2|STARTED|Primary Study||152
1420430|NCT02607735|3477224|P1|STARTED|Primary Study||264
1420431|NCT02607618|3477246|P2|NOT COMPLETED|Overall Study||2
1420432|NCT02607618|3477247|P1|NOT COMPLETED|Overall Study||11
1420433|NCT02607618|3477246|P2|COMPLETED|Overall Study||305
1420434|NCT02607618|3477247|P1|COMPLETED|Overall Study||295
1420435|NCT02607618|3477246|P2|STARTED|Overall Study||307
1420436|NCT02607618|3477247|P1|STARTED|Overall Study||306
1420437|NCT02607254|3477258|P3|NOT COMPLETED|Overall Study||0
1420438|NCT02607254|3477259|P2|NOT COMPLETED|Overall Study||0
1420439|NCT02607254|3477260|P1|NOT COMPLETED|Overall Study||0
1420440|NCT02607254|3477258|P3|COMPLETED|Overall Study||5
1420441|NCT02607254|3477259|P2|COMPLETED|Overall Study||3
1420442|NCT02607254|3477260|P1|COMPLETED|Overall Study||3
1420443|NCT02607254|3477258|P3|STARTED|Overall Study||5
1420444|NCT02607254|3477259|P2|STARTED|Overall Study||3
1420445|NCT02607254|3477260|P1|STARTED|Overall Study||3
1420446|NCT02606903|3477279|P2|NOT COMPLETED|Overall Study||0
1420447|NCT02606903|3477280|P1|NOT COMPLETED|Overall Study||0
1420448|NCT02606903|3477279|P2|COMPLETED|Overall Study||36
1420449|NCT02606903|3477280|P1|COMPLETED|Overall Study||35
1420450|NCT02606903|3477279|P2|STARTED|Overall Study||36
1420451|NCT02606903|3477280|P1|STARTED|Overall Study||35
1420452|NCT02606838|3477292|P1|NOT COMPLETED|Overall Study||0
1420453|NCT02606838|3477292|P1|COMPLETED|Overall Study||119
1420454|NCT02606838|3477292|P1|STARTED|Overall Study||119
1420455|NCT02606734|3477300|P1|NOT COMPLETED|Overall Study||0
1420456|NCT02606734|3477300|P1|COMPLETED|Overall Study||44
1420457|NCT02606734|3477300|P1|STARTED|Overall Study||44
1420458|NCT02606643|3477306|P2|NOT COMPLETED|Overall Study||3
1420459|NCT02606643|3477307|P1|NOT COMPLETED|Overall Study||1
1420460|NCT02606643|3477306|P2|COMPLETED|Overall Study||73
1420461|NCT02606643|3477307|P1|COMPLETED|Overall Study||67
1420462|NCT02606643|3477306|P2|STARTED|Overall Study||76
1420463|NCT02606643|3477307|P1|STARTED|Overall Study||68
1420464|NCT02606500|3477319|P2|NOT COMPLETED|Overall Study||0
1420465|NCT02606500|3477320|P1|NOT COMPLETED|Overall Study||0
1420466|NCT02606500|3477319|P2|COMPLETED|Overall Study||35
1420467|NCT02606500|3477320|P1|COMPLETED|Overall Study||35
1420468|NCT02606500|3477319|P2|STARTED|Overall Study||35
1420469|NCT02606500|3477320|P1|STARTED|Overall Study||35
1420470|NCT02606279|3477338|P2|NOT COMPLETED|Overall Study||1
1420471|NCT02606279|3477339|P1|NOT COMPLETED|Overall Study||0
1420472|NCT02606279|3477338|P2|COMPLETED|Overall Study||0
1420473|NCT02606279|3477339|P1|COMPLETED|Overall Study||0
1420474|NCT02606279|3477338|P2|STARTED|Overall Study||1
1420475|NCT02606279|3477339|P1|STARTED|Overall Study||0
1420476|NCT02605954|3477353|P2|NOT COMPLETED|Overall Study||4
1420477|NCT02605954|3477354|P1|NOT COMPLETED|Overall Study||12
1420478|NCT02605954|3477353|P2|COMPLETED|Overall Study||88
1420479|NCT02605954|3477354|P1|COMPLETED|Overall Study||171
1420480|NCT02605954|3477353|P2|STARTED|Overall Study||92
1420481|NCT02605954|3477354|P1|STARTED|Overall Study||183
1420482|NCT02605928|3477371|P1|NOT COMPLETED|Overall Study||33
1420483|NCT02605928|3477371|P1|COMPLETED|Overall Study||46
1420484|NCT02605928|3477371|P1|Pivotal Phase, Statistical Phase|Overall Study||51
1420485|NCT02605928|3477371|P1|STARTED|Overall Study||79
1420486|NCT02605863|3477377|P2|NOT COMPLETED|Overall Study||0
1420487|NCT02605863|3477378|P1|NOT COMPLETED|Overall Study||0
1420488|NCT02605863|3477377|P2|COMPLETED|Overall Study||0
1420489|NCT02605863|3477378|P1|COMPLETED|Overall Study||1
1420490|NCT02605863|3477377|P2|STARTED|Overall Study||0
1420491|NCT02605863|3477378|P1|STARTED|Overall Study||1
1420492|NCT02605395|3477384|P2|NOT COMPLETED|Period 2, Day 8||0
1420493|NCT02605395|3477385|P1|NOT COMPLETED|Period 2, Day 8||0
1420494|NCT02605395|3477384|P2|COMPLETED|Period 2, Day 8||35
1420495|NCT02605395|3477385|P1|COMPLETED|Period 2, Day 8||35
1420496|NCT02605395|3477384|P2|STARTED|Period 2, Day 8||35
1420497|NCT02605395|3477385|P1|STARTED|Period 2, Day 8||35
1420498|NCT02605395|3477384|P2|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
1420499|NCT02605395|3477385|P1|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
1420500|NCT02605395|3477384|P2|COMPLETED|Washout Period, Day 2 to Day 7||35
1420501|NCT02605395|3477385|P1|COMPLETED|Washout Period, Day 2 to Day 7||35
1420502|NCT02605395|3477384|P2|STARTED|Washout Period, Day 2 to Day 7||35
1420503|NCT02605395|3477385|P1|STARTED|Washout Period, Day 2 to Day 7||35
1420504|NCT02605395|3477384|P2|NOT COMPLETED|Period 1, Day 1||0
1420505|NCT02605395|3477385|P1|NOT COMPLETED|Period 1, Day 1||0
1420506|NCT02605395|3477384|P2|COMPLETED|Period 1, Day 1||35
1420507|NCT02605395|3477385|P1|COMPLETED|Period 1, Day 1||35
1420508|NCT02605395|3477384|P2|STARTED|Period 1, Day 1||35
1420509|NCT02605395|3477385|P1|STARTED|Period 1, Day 1||35
1420510|NCT02605304|3477403|P2|NOT COMPLETED|Overall Study||0
1420511|NCT02605304|3477404|P1|NOT COMPLETED|Overall Study||0
1420512|NCT02605304|3477403|P2|COMPLETED|Overall Study||3
1420513|NCT02605304|3477404|P1|COMPLETED|Overall Study||4
1420514|NCT02605304|3477403|P2|STARTED|Overall Study||3
1420515|NCT02605304|3477404|P1|STARTED|Overall Study||4
1420516|NCT02605187|3477428|P4|NOT COMPLETED|Overall Study||1
1420517|NCT02605187|3477429|P3|NOT COMPLETED|Overall Study||11
1420518|NCT02605187|3477430|P2|NOT COMPLETED|Overall Study||2
1420519|NCT02605187|3477431|P1|NOT COMPLETED|Overall Study||8
1420520|NCT02605187|3477428|P4|COMPLETED|Overall Study||15
1420521|NCT02605187|3477429|P3|COMPLETED|Overall Study||72
1420522|NCT02605187|3477430|P2|COMPLETED|Overall Study||19
1420523|NCT02605187|3477431|P1|COMPLETED|Overall Study||32
1420524|NCT02605187|3477428|P4|STARTED|Overall Study||16
1420525|NCT02605187|3477429|P3|STARTED|Overall Study||83
1420526|NCT02605187|3477430|P2|STARTED|Overall Study||21
1420527|NCT02605187|3477431|P1|STARTED|Overall Study||40
1420528|NCT02605174|3477489|P7|NOT COMPLETED|Overall Study||89
1420529|NCT02605174|3477490|P6|NOT COMPLETED|Overall Study||32
1420530|NCT02605174|3477491|P5|NOT COMPLETED|Overall Study||53
1420531|NCT02605174|3477492|P4|NOT COMPLETED|Overall Study||36
1420532|NCT02605174|3477493|P3|NOT COMPLETED|Overall Study||76
1420533|NCT02605174|3477494|P2|NOT COMPLETED|Overall Study||23
1420534|NCT02605174|3477495|P1|NOT COMPLETED|Overall Study||64
1420535|NCT02605174|3477489|P7|COMPLETED|Overall Study||662
1420536|NCT02605174|3477490|P6|COMPLETED|Overall Study||217
1420537|NCT02605174|3477491|P5|COMPLETED|Overall Study||448
1420538|NCT02605174|3477492|P4|COMPLETED|Overall Study||216
1420539|NCT02605174|3477493|P3|COMPLETED|Overall Study||426
1420540|NCT02605174|3477494|P2|COMPLETED|Overall Study||226
1420541|NCT02605174|3477495|P1|COMPLETED|Overall Study||437
1420542|NCT02605174|3477489|P7|Received Optional 2nd Dose|Overall Study||361
1420543|NCT02605174|3477490|P6|Received Optional 2nd Dose|Overall Study||74
1420544|NCT02605174|3477491|P5|Received Optional 2nd Dose|Overall Study||144
1420545|NCT02605174|3477492|P4|Received Optional 2nd Dose|Overall Study||83
1420546|NCT02605174|3477493|P3|Received Optional 2nd Dose|Overall Study||177
1420547|NCT02605174|3477494|P2|Received Optional 2nd Dose|Overall Study||96
1420548|NCT02605174|3477495|P1|Received Optional 2nd Dose|Overall Study||206
1420549|NCT02605174|3477489|P7|Received at Least 1 Dose of Study Drug|Overall Study||645
1420550|NCT02605174|3477490|P6|Received at Least 1 Dose of Study Drug|Overall Study||215
1420551|NCT02605174|3477491|P5|Received at Least 1 Dose of Study Drug|Overall Study||434
1420552|NCT02605174|3477492|P4|Received at Least 1 Dose of Study Drug|Overall Study||212
1420553|NCT02605174|3477493|P3|Received at Least 1 Dose of Study Drug|Overall Study||423
1420554|NCT02605174|3477494|P2|Received at Least 1 Dose of Study Drug|Overall Study||225
1420555|NCT02605174|3477495|P1|Received at Least 1 Dose of Study Drug|Overall Study||429
1420556|NCT02605174|3477489|P7|STARTED|Overall Study||751
1420557|NCT02605174|3477490|P6|STARTED|Overall Study||249
1420558|NCT02605174|3477491|P5|STARTED|Overall Study||501
1420559|NCT02605174|3477492|P4|STARTED|Overall Study||252
1420560|NCT02605174|3477493|P3|STARTED|Overall Study||502
1420561|NCT02605174|3477494|P2|STARTED|Overall Study||249
1420562|NCT02605174|3477495|P1|STARTED|Overall Study||501
1420563|NCT02604589|3477558|P3|NOT COMPLETED|Overall Study||1
1420564|NCT02604589|3477559|P2|NOT COMPLETED|Overall Study||0
1420565|NCT02604589|3477560|P1|NOT COMPLETED|Overall Study||0
1420566|NCT02604589|3477558|P3|COMPLETED|Overall Study||1
1420567|NCT02604589|3477559|P2|COMPLETED|Overall Study||5
1420568|NCT02604589|3477560|P1|COMPLETED|Overall Study||3
1420569|NCT02604589|3477558|P3|STARTED|Overall Study||2
1420570|NCT02604589|3477559|P2|STARTED|Overall Study||5
1420571|NCT02604589|3477560|P1|STARTED|Overall Study||3
1420572|NCT02604550|3477588|P2|NOT COMPLETED|Overall Study||26
1420573|NCT02604550|3477589|P1|NOT COMPLETED|Overall Study||25
1420574|NCT02604550|3477588|P2|COMPLETED|Overall Study||33
1420575|NCT02604550|3477589|P1|COMPLETED|Overall Study||31
1420576|NCT02604550|3477588|P2|STARTED|Overall Study||59
1420577|NCT02604550|3477589|P1|STARTED|Overall Study||56
1420578|NCT02604407|3477616|P3|NOT COMPLETED|Overall Study||16
1420579|NCT02604407|3477617|P2|NOT COMPLETED|Overall Study||12
1420580|NCT02604407|3477618|P1|NOT COMPLETED|Overall Study||11
1420581|NCT02604407|3477616|P3|COMPLETED|Overall Study||76
1420582|NCT02604407|3477617|P2|COMPLETED|Overall Study||80
1420583|NCT02604407|3477618|P1|COMPLETED|Overall Study||80
1420584|NCT02604407|3477616|P3|TREATED|Overall Study||90
1420585|NCT02604407|3477617|P2|TREATED|Overall Study||92
1420586|NCT02604407|3477618|P1|TREATED|Overall Study||89
1420587|NCT02604407|3477616|P3|STARTED|Overall Study||92
1420588|NCT02604407|3477617|P2|STARTED|Overall Study||92
1420589|NCT02604407|3477618|P1|STARTED|Overall Study||91
1420590|NCT02604342|3477631|P2|NOT COMPLETED|Overall Study||35
1420591|NCT02604342|3477632|P1|NOT COMPLETED|Overall Study||72
1420592|NCT02604342|3477631|P2|COMPLETED|Overall Study||0
1420593|NCT02604342|3477632|P1|COMPLETED|Overall Study||0
1420594|NCT02604342|3477631|P2|STARTED|Overall Study||35
1420595|NCT02604342|3477632|P1|STARTED|Overall Study||72
1420596|NCT02604264|3477684|P2|NOT COMPLETED|Intervention||242
1420597|NCT02604264|3477685|P1|NOT COMPLETED|Intervention||200
1420598|NCT02604264|3477684|P2|COMPLETED|Intervention||1225
1420599|NCT02604264|3477685|P1|COMPLETED|Intervention||1245
1420600|NCT02604264|3477684|P2|STARTED|Intervention||1467
1420601|NCT02604264|3477685|P1|STARTED|Intervention||1445
1420602|NCT02604264|3477684|P2|NOT COMPLETED|Run-In||0
1420603|NCT02604264|3477685|P1|NOT COMPLETED|Run-In||0
1420604|NCT02604264|3477684|P2|COMPLETED|Run-In||611
1420605|NCT02604264|3477685|P1|COMPLETED|Run-In||618
1420606|NCT02604264|3477684|P2|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
1420607|NCT02604264|3477685|P1|STARTED|Run-In||618
1420608|NCT02604173|3477694|P3|NOT COMPLETED|Overall Study||0
1420609|NCT02604173|3477695|P2|NOT COMPLETED|Overall Study||0
1420610|NCT02604173|3477696|P1|NOT COMPLETED|Overall Study||0
1420611|NCT02604173|3477694|P3|COMPLETED|Overall Study||35
1420612|NCT02604173|3477695|P2|COMPLETED|Overall Study||35
1420613|NCT02604173|3477696|P1|COMPLETED|Overall Study||33
1420614|NCT02604173|3477694|P3|STARTED|Overall Study||35
1420615|NCT02604173|3477695|P2|STARTED|Overall Study||35
1420616|NCT02604173|3477696|P1|STARTED|Overall Study||33
1420617|NCT02604017|3477712|P2|NOT COMPLETED|Overall Study||8
1420618|NCT02604017|3477713|P1|NOT COMPLETED|Overall Study||6
1420619|NCT02604017|3477712|P2|COMPLETED|Overall Study||343
1420620|NCT02604017|3477713|P1|COMPLETED|Overall Study||346
1420621|NCT02604017|3477712|P2|STARTED|Overall Study||351
1420622|NCT02604017|3477713|P1|STARTED|Overall Study||352
1420623|NCT02603952|3477742|P4|NOT COMPLETED|Overall Study||1
1420624|NCT02603952|3477743|P3|NOT COMPLETED|Overall Study||0
1420625|NCT02603952|3477744|P2|NOT COMPLETED|Overall Study||0
1420626|NCT02603952|3477745|P1|NOT COMPLETED|Overall Study||1
1420627|NCT02603952|3477742|P4|COMPLETED|Overall Study||31
1420628|NCT02603952|3477743|P3|COMPLETED|Overall Study||31
1420629|NCT02603952|3477744|P2|COMPLETED|Overall Study||31
1420630|NCT02603952|3477745|P1|COMPLETED|Overall Study||31
1420631|NCT02603952|3477742|P4|Treated|Overall Study||31
1420632|NCT02603952|3477743|P3|Treated|Overall Study||31
1420633|NCT02603952|3477744|P2|Treated|Overall Study||31
1420634|NCT02603952|3477745|P1|Treated|Overall Study||32
1420635|NCT02603952|3477742|P4|STARTED|Overall Study||32
1420636|NCT02603952|3477743|P3|STARTED|Overall Study||31
1420637|NCT02603952|3477744|P2|STARTED|Overall Study||31
1420638|NCT02603952|3477745|P1|STARTED|Overall Study||32
1420639|NCT02603926|3477786|P1|NOT COMPLETED|Overall Study||0
1420640|NCT02603926|3477786|P1|COMPLETED|Overall Study||6
1420641|NCT02603926|3477786|P1|STARTED|Overall Study||6
1420642|NCT02603666|3477793|P1|NOT COMPLETED|Overall Study||0
1420643|NCT02603666|3477793|P1|COMPLETED|Overall Study||130
1420644|NCT02603666|3477793|P1|STARTED|Overall Study||130
1420645|NCT02603120|3477799|P2|NOT COMPLETED|Overall Study||283
1420646|NCT02603120|3477800|P1|NOT COMPLETED|Overall Study||284
1420647|NCT02603120|3477799|P2|COMPLETED|Overall Study||0
1420648|NCT02603120|3477800|P1|COMPLETED|Overall Study||0
1420649|NCT02603120|3477799|P2|STARTED|Overall Study||283
1420650|NCT02603120|3477800|P1|STARTED|Overall Study||284
1420651|NCT02603107|3477820|P2|NOT COMPLETED|Optional Extension Phase||213
1420652|NCT02603107|3477821|P1|NOT COMPLETED|Optional Extension Phase||241
1420653|NCT02603107|3477820|P2|COMPLETED|Optional Extension Phase||0
1420654|NCT02603107|3477821|P1|COMPLETED|Optional Extension Phase||0
1420655|NCT02603107|3477820|P2|STARTED|Optional Extension Phase|27 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|213
1420656|NCT02603107|3477821|P1|STARTED|Optional Extension Phase|4 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|241
1420657|NCT02603107|3477820|P2|NOT COMPLETED|Randomized Phase||48
1420658|NCT02603107|3477821|P1|NOT COMPLETED|Randomized Phase||45
1420659|NCT02603107|3477820|P2|COMPLETED|Randomized Phase||240
1420660|NCT02603107|3477821|P1|COMPLETED|Randomized Phase||245
1420661|NCT02603107|3477820|P2|STARTED|Randomized Phase||288
1420662|NCT02603107|3477821|P1|STARTED|Randomized Phase||290
1420663|NCT02602223|3477831|P1|NOT COMPLETED|Overall Study||0
1420664|NCT02602223|3477831|P1|COMPLETED|Overall Study||9
1420665|NCT02602223|3477831|P1|STARTED|Overall Study||9
1420666|NCT02601976|3477847|P1|NOT COMPLETED|Overall Study||0
1420667|NCT02601976|3477847|P1|COMPLETED|Overall Study||64
1420668|NCT02601976|3477847|P1|STARTED|Overall Study||64
1420669|NCT02601573|3477860|P5|NOT COMPLETED|Overall Study||2
1420670|NCT02601573|3477861|P4|NOT COMPLETED|Overall Study||1
1420671|NCT02601573|3477862|P3|NOT COMPLETED|Overall Study||1
1420672|NCT02601573|3477863|P2|NOT COMPLETED|Overall Study||4
1420673|NCT02601573|3477864|P1|NOT COMPLETED|Overall Study||0
1420674|NCT02601573|3477860|P5|COMPLETED|Overall Study||16
1420675|NCT02601573|3477861|P4|COMPLETED|Overall Study||17
1420676|NCT02601573|3477862|P3|COMPLETED|Overall Study||16
1420677|NCT02601573|3477863|P2|COMPLETED|Overall Study||20
1420678|NCT02601573|3477864|P1|COMPLETED|Overall Study||23
1420679|NCT02601573|3477860|P5|STARTED|Overall Study|Number randomized and treated.|18
1420680|NCT02601573|3477861|P4|STARTED|Overall Study|Number randomized and treated.|18
1420681|NCT02601573|3477862|P3|STARTED|Overall Study|Number randomized and treated.|17
1420682|NCT02601573|3477863|P2|STARTED|Overall Study|Number randomized and treated.|24
1420683|NCT02601573|3477864|P1|STARTED|Overall Study|Number randomized and treated.|23
1420684|NCT02601560|3477899|P8|NOT COMPLETED|Overall Study||0
1420685|NCT02601560|3477900|P7|NOT COMPLETED|Overall Study||1
1420686|NCT02601560|3477901|P6|NOT COMPLETED|Overall Study||0
1420687|NCT02601560|3477902|P5|NOT COMPLETED|Overall Study||0
1420688|NCT02601560|3477903|P4|NOT COMPLETED|Overall Study||0
1420689|NCT02601560|3477904|P3|NOT COMPLETED|Overall Study||0
1420690|NCT02601560|3477905|P2|NOT COMPLETED|Overall Study||0
1420691|NCT02601560|3477906|P1|NOT COMPLETED|Overall Study||0
1420692|NCT02601560|3477899|P8|COMPLETED|Overall Study||6
1420693|NCT02601560|3477900|P7|COMPLETED|Overall Study||5
1420694|NCT02601560|3477901|P6|COMPLETED|Overall Study||4
1420695|NCT02601560|3477902|P5|COMPLETED|Overall Study||6
1420696|NCT02601560|3477903|P4|COMPLETED|Overall Study||6
1420697|NCT02601560|3477904|P3|COMPLETED|Overall Study||6
1420698|NCT02601560|3477905|P2|COMPLETED|Overall Study||6
1420699|NCT02601560|3477906|P1|COMPLETED|Overall Study||8
1420700|NCT02601560|3477899|P8|STARTED|Overall Study||6
1420701|NCT02601560|3477900|P7|STARTED|Overall Study||6
1420702|NCT02601560|3477901|P6|STARTED|Overall Study||4
1420703|NCT02601560|3477902|P5|STARTED|Overall Study||6
1420704|NCT02601560|3477903|P4|STARTED|Overall Study||6
1420705|NCT02601560|3477904|P3|STARTED|Overall Study||6
1420706|NCT02601560|3477905|P2|STARTED|Overall Study||6
1420707|NCT02601560|3477906|P1|STARTED|Overall Study||8
1420708|NCT02601469|3478090|P2|NOT COMPLETED|Overall Study||0
1420709|NCT02601469|3478091|P1|NOT COMPLETED|Overall Study||1
1420710|NCT02601469|3478090|P2|COMPLETED|Overall Study||1
1420711|NCT02601469|3478091|P1|COMPLETED|Overall Study||24
1420712|NCT02601469|3478090|P2|STARTED|Overall Study||1
1420713|NCT02601469|3478091|P1|STARTED|Overall Study||25
1420714|NCT02601300|3478097|P1|NOT COMPLETED|Extension Phase||17
1420715|NCT02601300|3478097|P1|COMPLETED|Extension Phase||18
1420716|NCT02601300|3478097|P1|Treated With IP|Extension Phase||34
1420717|NCT02601300|3478097|P1|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
1420718|NCT02601300|3478097|P1|NOT COMPLETED|Induction Phase||3
1420719|NCT02601300|3478097|P1|COMPLETED|Induction Phase||38
1420720|NCT02601300|3478097|P1|STARTED|Induction Phase||41
1420721|NCT02600871|3478112|P2|NOT COMPLETED|Overall Study||10
1420722|NCT02600871|3478113|P1|NOT COMPLETED|Overall Study||13
1420723|NCT02600871|3478112|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
1420724|NCT02600871|3478113|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
1420725|NCT02600871|3478112|P2|STARTED|Overall Study||49
1420726|NCT02600871|3478113|P1|STARTED|Overall Study||52
1420727|NCT02600845|3478123|P1|NOT COMPLETED|Overall Study||18
1420728|NCT02600845|3478123|P1|COMPLETED|Overall Study||104
1420729|NCT02600845|3478123|P1|STARTED|Overall Study||122
1420730|NCT02600819|3478138|P1|NOT COMPLETED|Overall Study||55
1420731|NCT02600819|3478138|P1|COMPLETED|Overall Study||0
1420732|NCT02600819|3478138|P1|STARTED|Overall Study||55
1420733|NCT02600767|3478148|P1|NOT COMPLETED|Overall Study||5
1420734|NCT02600767|3478148|P1|COMPLETED|Overall Study||74
1420735|NCT02600767|3478148|P1|STARTED|Overall Study||79
1420736|NCT02600715|3478154|P2|NOT COMPLETED|Overall Study||0
1420737|NCT02600715|3478155|P1|NOT COMPLETED|Overall Study||0
1420738|NCT02600715|3478154|P2|COMPLETED|Overall Study||13
1420739|NCT02600715|3478155|P1|COMPLETED|Overall Study||13
1420740|NCT02600715|3478154|P2|Completed 2-week Follow-up Appointment|Overall Study||12
1420741|NCT02600715|3478155|P1|Completed 2-week Follow-up Appointment|Overall Study||13
1420742|NCT02600715|3478154|P2|Received Treatment and Suppository|Overall Study||13
1420743|NCT02600715|3478155|P1|Received Treatment and Suppository|Overall Study||13
1420744|NCT02600715|3478154|P2|Allocated to Randomization|Overall Study||13
1420745|NCT02600715|3478155|P1|Allocated to Randomization|Overall Study||13
1420746|NCT02600715|3478154|P2|STARTED|Overall Study||13
1420747|NCT02600715|3478155|P1|STARTED|Overall Study||13
1420748|NCT02600611|3478186|P2|NOT COMPLETED|Overall Study||0
1420749|NCT02600611|3478187|P1|NOT COMPLETED|Overall Study||2
1420750|NCT02600611|3478186|P2|COMPLETED|Overall Study||300
1420751|NCT02600611|3478187|P1|COMPLETED|Overall Study||298
1420752|NCT02600611|3478186|P2|STARTED|Overall Study||300
1420753|NCT02600611|3478187|P1|STARTED|Overall Study||300
1420754|NCT02600403|3478198|P3|NOT COMPLETED|Overall Study||0
1420755|NCT02600403|3478199|P2|NOT COMPLETED|Overall Study||0
1420756|NCT02600403|3478200|P1|NOT COMPLETED|Overall Study||0
1420757|NCT02600403|3478198|P3|COMPLETED|Overall Study||11
1420758|NCT02600403|3478199|P2|COMPLETED|Overall Study||6
1420759|NCT02600403|3478200|P1|COMPLETED|Overall Study||44
1420760|NCT02600403|3478198|P3|STARTED|Overall Study||11
1420761|NCT02600403|3478199|P2|STARTED|Overall Study||6
1420762|NCT02600403|3478200|P1|STARTED|Overall Study||44
1420763|NCT02600351|3478227|P4|NOT COMPLETED|Overall Study||5
1420764|NCT02600351|3478228|P3|NOT COMPLETED|Overall Study||6
1420765|NCT02600351|3478229|P2|NOT COMPLETED|Overall Study||0
1420766|NCT02600351|3478230|P1|NOT COMPLETED|Overall Study||5
1420767|NCT02600351|3478227|P4|COMPLETED|Overall Study||22
1420768|NCT02600351|3478228|P3|COMPLETED|Overall Study||20
1420769|NCT02600351|3478229|P2|COMPLETED|Overall Study||17
1420770|NCT02600351|3478230|P1|COMPLETED|Overall Study||12
1420771|NCT02600351|3478227|P4|STARTED|Overall Study||27
1420772|NCT02600351|3478228|P3|STARTED|Overall Study||26
1420773|NCT02600351|3478229|P2|STARTED|Overall Study||17
1420774|NCT02600351|3478230|P1|STARTED|Overall Study||17
1420775|NCT02599129|3478262|P2|NOT COMPLETED|Overall Study||3
1420776|NCT02599129|3478263|P1|NOT COMPLETED|Overall Study||5
1420777|NCT02599129|3478262|P2|COMPLETED|Overall Study||1
1420778|NCT02599129|3478263|P1|COMPLETED|Overall Study||2
1420779|NCT02599129|3478262|P2|STARTED|Overall Study||4
1420780|NCT02599129|3478263|P1|STARTED|Overall Study||7
1420781|NCT02598934|3478279|P2|NOT COMPLETED|Overall Study||22
1420782|NCT02598934|3478280|P1|NOT COMPLETED|Overall Study||19
1420783|NCT02598934|3478279|P2|COMPLETED|Overall Study||132
1420784|NCT02598934|3478280|P1|COMPLETED|Overall Study||135
1420785|NCT02598934|3478279|P2|STARTED|Overall Study||154
1420786|NCT02598934|3478280|P1|STARTED|Overall Study||154
1420787|NCT02598622|3478292|P2|NOT COMPLETED|Overall Study||0
1420788|NCT02598622|3478293|P1|NOT COMPLETED|Overall Study||6
1420789|NCT02598622|3478292|P2|COMPLETED|Overall Study||0
1420790|NCT02598622|3478293|P1|COMPLETED|Overall Study||2
1420791|NCT02598622|3478292|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
1420792|NCT02598622|3478293|P1|STARTED|Overall Study||8
1420793|NCT02598583|3478301|P2|NOT COMPLETED|Overall Study||0
1420794|NCT02598583|3478302|P1|NOT COMPLETED|Overall Study||0
1420795|NCT02598583|3478301|P2|COMPLETED|Overall Study||7
1420796|NCT02598583|3478302|P1|COMPLETED|Overall Study||6
1420797|NCT02598583|3478301|P2|STARTED|Overall Study||7
1420798|NCT02598583|3478302|P1|STARTED|Overall Study||6
1420799|NCT02598193|3478320|P1|NOT COMPLETED|Overall Study||16
1420800|NCT02598193|3478320|P1|COMPLETED|Overall Study||73
1420801|NCT02598193|3478320|P1|STARTED|Overall Study||89
1420802|NCT02598128|3478328|P4|NOT COMPLETED|Period C: Days 12 to 20||0
1420803|NCT02598128|3478329|P3|NOT COMPLETED|Period C: Days 12 to 20||0
1420804|NCT02598128|3478330|P2|NOT COMPLETED|Period C: Days 12 to 20||0
1420805|NCT02598128|3478331|P1|NOT COMPLETED|Period C: Days 12 to 20||0
1420806|NCT02598128|3478328|P4|COMPLETED|Period C: Days 12 to 20||33
1420807|NCT02598128|3478329|P3|COMPLETED|Period C: Days 12 to 20||0
1420808|NCT02598128|3478330|P2|COMPLETED|Period C: Days 12 to 20||0
1420809|NCT02598128|3478331|P1|COMPLETED|Period C: Days 12 to 20||0
1420810|NCT02598128|3478328|P4|STARTED|Period C: Days 12 to 20||33
1420811|NCT02598128|3478329|P3|STARTED|Period C: Days 12 to 20||0
1420812|NCT02598128|3478330|P2|STARTED|Period C: Days 12 to 20||0
1420813|NCT02598128|3478331|P1|STARTED|Period C: Days 12 to 20||0
1420814|NCT02598128|3478328|P4|NOT COMPLETED|Period B: Days 1 to 11||0
1420815|NCT02598128|3478329|P3|NOT COMPLETED|Period B: Days 1 to 11||0
1420816|NCT02598128|3478330|P2|NOT COMPLETED|Period B: Days 1 to 11||0
1420817|NCT02598128|3478331|P1|NOT COMPLETED|Period B: Days 1 to 11||0
1420818|NCT02598128|3478328|P4|COMPLETED|Period B: Days 1 to 11||0
1420819|NCT02598128|3478329|P3|COMPLETED|Period B: Days 1 to 11||16
1420820|NCT02598128|3478330|P2|COMPLETED|Period B: Days 1 to 11||17
1420821|NCT02598128|3478331|P1|COMPLETED|Period B: Days 1 to 11||0
1420822|NCT02598128|3478328|P4|STARTED|Period B: Days 1 to 11||0
1420823|NCT02598128|3478329|P3|STARTED|Period B: Days 1 to 11||16
1420824|NCT02598128|3478330|P2|STARTED|Period B: Days 1 to 11||17
1420825|NCT02598128|3478331|P1|STARTED|Period B: Days 1 to 11||0
1420826|NCT02598128|3478328|P4|NOT COMPLETED|Period A: Days -7 to -1||0
1420827|NCT02598128|3478329|P3|NOT COMPLETED|Period A: Days -7 to -1||0
1420828|NCT02598128|3478330|P2|NOT COMPLETED|Period A: Days -7 to -1||0
1420829|NCT02598128|3478331|P1|NOT COMPLETED|Period A: Days -7 to -1||1
1420830|NCT02598128|3478328|P4|COMPLETED|Period A: Days -7 to -1||0
1420831|NCT02598128|3478329|P3|COMPLETED|Period A: Days -7 to -1||0
1420832|NCT02598128|3478330|P2|COMPLETED|Period A: Days -7 to -1||0
1420833|NCT02598128|3478331|P1|COMPLETED|Period A: Days -7 to -1||33
1420834|NCT02598128|3478328|P4|STARTED|Period A: Days -7 to -1||0
1420835|NCT02598128|3478329|P3|STARTED|Period A: Days -7 to -1||0
1420836|NCT02598128|3478330|P2|STARTED|Period A: Days -7 to -1||0
1420837|NCT02598128|3478331|P1|STARTED|Period A: Days -7 to -1||34
1420838|NCT02597907|3478345|P2|NOT COMPLETED|Overall Study||0
1420839|NCT02597907|3478346|P1|NOT COMPLETED|Overall Study||0
1420840|NCT02597907|3478345|P2|COMPLETED|Overall Study||44
1420841|NCT02597907|3478346|P1|COMPLETED|Overall Study||44
1420842|NCT02597907|3478345|P2|STARTED|Overall Study||44
1420843|NCT02597907|3478346|P1|STARTED|Overall Study||44
1420844|NCT02597855|3478354|P2|NOT COMPLETED|Overall Study||1
1420845|NCT02597855|3478355|P1|NOT COMPLETED|Overall Study||2
1420846|NCT02597855|3478354|P2|COMPLETED|Overall Study||13
1420847|NCT02597855|3478355|P1|COMPLETED|Overall Study||16
1420848|NCT02597855|3478354|P2|STARTED|Overall Study||14
1420849|NCT02597855|3478355|P1|STARTED|Overall Study||18
1420850|NCT02597582|3478365|P2|NOT COMPLETED|Overall Study||0
1420851|NCT02597582|3478366|P1|NOT COMPLETED|Overall Study||0
1420852|NCT02597582|3478365|P2|COMPLETED|Overall Study||20
1420853|NCT02597582|3478366|P1|COMPLETED|Overall Study||21
1420854|NCT02597582|3478365|P2|STARTED|Overall Study||20
1420855|NCT02597582|3478366|P1|STARTED|Overall Study||21
1420856|NCT02597543|3478384|P2|NOT COMPLETED|Overall Study||0
1420857|NCT02597543|3478385|P1|NOT COMPLETED|Overall Study||0
1420858|NCT02597543|3478384|P2|COMPLETED|Overall Study||8
1420859|NCT02597543|3478385|P1|COMPLETED|Overall Study||6
1420860|NCT02597543|3478384|P2|STARTED|Overall Study||8
1420861|NCT02597543|3478385|P1|STARTED|Overall Study||6
1420862|NCT02597049|3478404|P3|NOT COMPLETED|Overall Study||3
1420863|NCT02597049|3478405|P2|NOT COMPLETED|Overall Study||5
1420864|NCT02597049|3478406|P1|NOT COMPLETED|Overall Study||7
1420865|NCT02597049|3478404|P3|COMPLETED|Overall Study||137
1420866|NCT02597049|3478405|P2|COMPLETED|Overall Study||137
1420867|NCT02597049|3478406|P1|COMPLETED|Overall Study||135
1420868|NCT02597049|3478404|P3|Received at Least One Dose of Study Drug|Overall Study||140
1420869|NCT02597049|3478405|P2|Received at Least One Dose of Study Drug|Overall Study||141
1420870|NCT02597049|3478406|P1|Received at Least One Dose of Study Drug|Overall Study||142
1420871|NCT02597049|3478404|P3|STARTED|Overall Study||140
1420872|NCT02597049|3478405|P2|STARTED|Overall Study||142
1420873|NCT02597049|3478406|P1|STARTED|Overall Study||142
1420874|NCT02596958|3478444|P1|NOT COMPLETED|Overall Study||996
1420875|NCT02596958|3478444|P1|COMPLETED|Overall Study||0
1420876|NCT02596958|3478444|P1|STARTED|Overall Study||996
1420877|NCT02596945|3478456|P1|NOT COMPLETED|Overall Study||56
1420878|NCT02596945|3478456|P1|COMPLETED|Overall Study||167
1420879|NCT02596945|3478456|P1|Treated|Overall Study||220
1420880|NCT02596945|3478456|P1|STARTED|Overall Study||223
1420881|NCT02596867|3478462|P1|NOT COMPLETED|Overall Study||0
1420882|NCT02596867|3478462|P1|COMPLETED|Overall Study||2
1420883|NCT02596867|3478462|P1|2 Patients Prospectively Recruited|Overall Study||2
1420884|NCT02596867|3478462|P1|STARTED|Overall Study||2
1420885|NCT02596854|3478467|P1|NOT COMPLETED|Overall Study||8
1420886|NCT02596854|3478467|P1|COMPLETED|Overall Study||109
1420887|NCT02596854|3478467|P1|STARTED|Overall Study||117
1420888|NCT02596750|3478473|P2|NOT COMPLETED|30 Minutes||0
1420889|NCT02596750|3478474|P1|NOT COMPLETED|30 Minutes||0
1420890|NCT02596750|3478473|P2|COMPLETED|30 Minutes||21
1420891|NCT02596750|3478474|P1|COMPLETED|30 Minutes||21
1420892|NCT02596750|3478473|P2|STARTED|30 Minutes||21
1420893|NCT02596750|3478474|P1|STARTED|30 Minutes||21
1420894|NCT02596750|3478473|P2|NOT COMPLETED|10 Minutes||0
1420895|NCT02596750|3478474|P1|NOT COMPLETED|10 Minutes||0
1420896|NCT02596750|3478473|P2|COMPLETED|10 Minutes||21
1420897|NCT02596750|3478474|P1|COMPLETED|10 Minutes||21
1420898|NCT02596750|3478473|P2|STARTED|10 Minutes||21
1420899|NCT02596750|3478474|P1|STARTED|10 Minutes||21
1420900|NCT02596750|3478473|P2|NOT COMPLETED|5 Minutes||0
1420901|NCT02596750|3478474|P1|NOT COMPLETED|5 Minutes||0
1420902|NCT02596750|3478473|P2|COMPLETED|5 Minutes||21
1420903|NCT02596750|3478474|P1|COMPLETED|5 Minutes||21
1420904|NCT02596750|3478473|P2|STARTED|5 Minutes||21
1420905|NCT02596750|3478474|P1|STARTED|5 Minutes||21
1420906|NCT02596750|3478473|P2|NOT COMPLETED|2 Minutes||0
1420907|NCT02596750|3478474|P1|NOT COMPLETED|2 Minutes||0
1420908|NCT02596750|3478473|P2|COMPLETED|2 Minutes||21
1420909|NCT02596750|3478474|P1|COMPLETED|2 Minutes||21
1420910|NCT02596750|3478473|P2|STARTED|2 Minutes||21
1420911|NCT02596750|3478474|P1|STARTED|2 Minutes||21
1420912|NCT02596750|3478473|P2|NOT COMPLETED|Baseline||0
1420913|NCT02596750|3478474|P1|NOT COMPLETED|Baseline||0
1420914|NCT02596750|3478473|P2|COMPLETED|Baseline||21
1420915|NCT02596750|3478474|P1|COMPLETED|Baseline||21
1420916|NCT02596750|3478473|P2|STARTED|Baseline||21
1420917|NCT02596750|3478474|P1|STARTED|Baseline||21
1420918|NCT02596620|3478488|P2|NOT COMPLETED|Overall Study||1
1420919|NCT02596620|3478489|P1|NOT COMPLETED|Overall Study||1
1420920|NCT02596620|3478488|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
1420921|NCT02596620|3478489|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
1420922|NCT02596620|3478488|P2|STARTED|Overall Study|Started from 1st October 2013|82
1420923|NCT02596620|3478489|P1|STARTED|Overall Study|Started from 1st October 2013|82
1420924|NCT02596451|3478498|P3|NOT COMPLETED|Overall Study||14
1420925|NCT02596451|3478499|P2|NOT COMPLETED|Overall Study||18
1420926|NCT02596451|3478500|P1|NOT COMPLETED|Overall Study||4
1420927|NCT02596451|3478498|P3|COMPLETED|Overall Study||373
1420928|NCT02596451|3478499|P2|COMPLETED|Overall Study||374
1420929|NCT02596451|3478500|P1|COMPLETED|Overall Study||381
1420930|NCT02596451|3478498|P3|STARTED|Overall Study||387
1420931|NCT02596451|3478499|P2|STARTED|Overall Study||392
1420932|NCT02596451|3478500|P1|STARTED|Overall Study||385
1420933|NCT02596321|3478509|P2|NOT COMPLETED|Overall Study||0
1420934|NCT02596321|3478510|P1|NOT COMPLETED|Overall Study||3
1420935|NCT02596321|3478509|P2|COMPLETED|Overall Study||56
1420936|NCT02596321|3478510|P1|COMPLETED|Overall Study||53
1420937|NCT02596321|3478509|P2|STARTED|Overall Study||56
1420938|NCT02596321|3478510|P1|STARTED|Overall Study||56
1420939|NCT02596022|3478524|P2|NOT COMPLETED|Overall Study||0
1420940|NCT02596022|3478525|P1|NOT COMPLETED|Overall Study||0
1420941|NCT02596022|3478524|P2|COMPLETED|Overall Study||8
1420942|NCT02596022|3478525|P1|COMPLETED|Overall Study||10
1420943|NCT02596022|3478524|P2|STARTED|Overall Study||8
1420944|NCT02596022|3478525|P1|STARTED|Overall Study||10
1420945|NCT02596009|3478531|P6|NOT COMPLETED|Overall Study||0
1420946|NCT02596009|3478532|P5|NOT COMPLETED|Overall Study||0
1420947|NCT02596009|3478533|P4|NOT COMPLETED|Overall Study||0
1420948|NCT02596009|3478534|P3|NOT COMPLETED|Overall Study||0
1420949|NCT02596009|3478535|P2|NOT COMPLETED|Overall Study||1
1420950|NCT02596009|3478536|P1|NOT COMPLETED|Overall Study||0
1420951|NCT02596009|3478531|P6|COMPLETED|Overall Study||17
1420952|NCT02596009|3478532|P5|COMPLETED|Overall Study||18
1420953|NCT02596009|3478533|P4|COMPLETED|Overall Study||16
1420954|NCT02596009|3478534|P3|COMPLETED|Overall Study||16
1420955|NCT02596009|3478535|P2|COMPLETED|Overall Study||15
1420956|NCT02596009|3478536|P1|COMPLETED|Overall Study||14
1420957|NCT02596009|3478531|P6|STARTED|Overall Study||17
1420958|NCT02596009|3478532|P5|STARTED|Overall Study||18
1420959|NCT02596009|3478533|P4|STARTED|Overall Study||16
1420960|NCT02596009|3478534|P3|STARTED|Overall Study||16
1420961|NCT02596009|3478535|P2|STARTED|Overall Study||16
1420962|NCT02596009|3478536|P1|STARTED|Overall Study||14
1420963|NCT02595567|3478545|P1|NOT COMPLETED|Overall Study||0
1420964|NCT02595567|3478545|P1|COMPLETED|Overall Study||25
1420965|NCT02595567|3478545|P1|STARTED|Overall Study||25
1420966|NCT02595502|3478549|P2|NOT COMPLETED|Period 3||2
1420967|NCT02595502|3478550|P1|NOT COMPLETED|Period 3||1
1420968|NCT02595502|3478549|P2|COMPLETED|Period 3||136
1420969|NCT02595502|3478550|P1|COMPLETED|Period 3||140
1420970|NCT02595502|3478549|P2|STARTED|Period 3||138
1420971|NCT02595502|3478550|P1|STARTED|Period 3||141
1420972|NCT02595502|3478549|P2|NOT COMPLETED|Period 2||2
1420973|NCT02595502|3478550|P1|NOT COMPLETED|Period 2||1
1420974|NCT02595502|3478549|P2|COMPLETED|Period 2||138
1420975|NCT02595502|3478550|P1|COMPLETED|Period 2||141
1420976|NCT02595502|3478549|P2|STARTED|Period 2||140
1420977|NCT02595502|3478550|P1|STARTED|Period 2||142
1420978|NCT02595502|3478549|P2|NOT COMPLETED|Period 1||2
1420979|NCT02595502|3478550|P1|NOT COMPLETED|Period 1||1
1420980|NCT02595502|3478549|P2|COMPLETED|Period 1||140
1420981|NCT02595502|3478550|P1|COMPLETED|Period 1||142
1420982|NCT02595502|3478549|P2|STARTED|Period 1||142
1420983|NCT02595502|3478550|P1|STARTED|Period 1||143
1420984|NCT02595450|3478556|P1|NOT COMPLETED|Overall Study||81
1420985|NCT02595450|3478556|P1|COMPLETED|Overall Study||218
1420986|NCT02595450|3478556|P1|Treated|Overall Study||291
1420987|NCT02595450|3478556|P1|STARTED|Overall Study||299
1420988|NCT02595437|3478562|P1|NOT COMPLETED|Triferic Via Hemodialysate||0
1420989|NCT02595437|3478562|P1|COMPLETED|Triferic Via Hemodialysate||21
1420990|NCT02595437|3478562|P1|STARTED|Triferic Via Hemodialysate||21
1420991|NCT02595437|3478562|P1|NOT COMPLETED|Triferic Via IV||1
1420992|NCT02595437|3478562|P1|COMPLETED|Triferic Via IV||21
1420993|NCT02595437|3478562|P1|STARTED|Triferic Via IV||22
1420994|NCT02595073|3478582|P2|NOT COMPLETED|Overall Study||1
1420995|NCT02595073|3478583|P1|NOT COMPLETED|Overall Study||2
1420996|NCT02595073|3478582|P2|COMPLETED|Overall Study||62
1420997|NCT02595073|3478583|P1|COMPLETED|Overall Study||59
1420998|NCT02595073|3478582|P2|STARTED|Overall Study||63
1420999|NCT02595073|3478583|P1|STARTED|Overall Study||61
1421000|NCT02595008|3478593|P2|NOT COMPLETED|Overall Study||0
1421001|NCT02595008|3478594|P1|NOT COMPLETED|Overall Study||1
1421002|NCT02595008|3478593|P2|COMPLETED|Overall Study||4
1421003|NCT02595008|3478594|P1|COMPLETED|Overall Study||19
1421004|NCT02595008|3478593|P2|STARTED|Overall Study||4
1421005|NCT02595008|3478594|P1|STARTED|Overall Study||20
1421006|NCT02594826|3478602|P2|NOT COMPLETED|Overall Study||60
1421007|NCT02594826|3478603|P1|NOT COMPLETED|Overall Study||57
1421008|NCT02594826|3478602|P2|COMPLETED|Overall Study||298
1421009|NCT02594826|3478603|P1|COMPLETED|Overall Study||290
1421010|NCT02594826|3478602|P2|STARTED|Overall Study||358
1421011|NCT02594826|3478603|P1|STARTED|Overall Study||347
1421012|NCT02594644|3478611|P2|NOT COMPLETED|Overall Study||1
1421013|NCT02594644|3478612|P1|NOT COMPLETED|Overall Study||0
1421014|NCT02594644|3478611|P2|COMPLETED|Overall Study||15
1421015|NCT02594644|3478612|P1|COMPLETED|Overall Study||16
1421016|NCT02594644|3478611|P2|STARTED|Overall Study||16
1421017|NCT02594644|3478612|P1|STARTED|Overall Study||16
1421018|NCT02594163|3478630|P2|NOT COMPLETED|Follow-up Period||12
1421019|NCT02594163|3478631|P1|NOT COMPLETED|Follow-up Period||11
1421020|NCT02594163|3478630|P2|COMPLETED|Follow-up Period||1
1421021|NCT02594163|3478631|P1|COMPLETED|Follow-up Period||1
1421022|NCT02594163|3478630|P2|STARTED|Follow-up Period|All participants were to be followed after treatment|13
1421023|NCT02594163|3478631|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|12
1421024|NCT02594163|3478630|P2|NOT COMPLETED|Treatment Period||12
1421025|NCT02594163|3478631|P1|NOT COMPLETED|Treatment Period||7
1421026|NCT02594163|3478630|P2|COMPLETED|Treatment Period||1
1421027|NCT02594163|3478631|P1|COMPLETED|Treatment Period||5
1421028|NCT02594163|3478630|P2|STARTED|Treatment Period||13
1421029|NCT02594163|3478631|P1|STARTED|Treatment Period||12
1421030|NCT02593903|3478649|P2|NOT COMPLETED|Overall Study||1
1421031|NCT02593903|3478650|P1|NOT COMPLETED|Overall Study||0
1421032|NCT02593903|3478649|P2|COMPLETED|Overall Study||31
1421033|NCT02593903|3478650|P1|COMPLETED|Overall Study||35
1421034|NCT02593903|3478649|P2|STARTED|Overall Study||32
1421035|NCT02593903|3478650|P1|STARTED|Overall Study||35
1421036|NCT02593773|3478656|P1|NOT COMPLETED|Overall Study||35
1421037|NCT02593773|3478656|P1|COMPLETED|Overall Study||51
1421038|NCT02593773|3478656|P1|STARTED|Overall Study||86
1421039|NCT02592655|3478668|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
1421040|NCT02592655|3478668|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
1421041|NCT02592655|3478668|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
1421042|NCT02592655|3478668|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
1421043|NCT02592655|3478668|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
1421044|NCT02592655|3478668|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
1421045|NCT02592655|3478668|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
1421046|NCT02592655|3478668|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
1421047|NCT02592655|3478668|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
1421048|NCT02592655|3478668|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
1421049|NCT02592655|3478668|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
1421050|NCT02592655|3478668|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
1421051|NCT02592655|3478668|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
1421052|NCT02592655|3478668|P1|STARTED|Third Tourniquet, Left Thigh.||19
1421053|NCT02592655|3478668|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
1421054|NCT02592655|3478668|P1|COMPLETED|Second Tourniquet Right Thigh.||19
1421055|NCT02592655|3478668|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
1421056|NCT02592655|3478668|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
1421057|NCT02592655|3478668|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
1421058|NCT02592655|3478668|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
1421059|NCT02592655|3478668|P1|STARTED|Second Tourniquet Right Thigh.||19
1421060|NCT02592655|3478668|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
1421061|NCT02592655|3478668|P1|COMPLETED|First Tourniquet, Left Thigh.||19
1421062|NCT02592655|3478668|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
1421063|NCT02592655|3478668|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
1421064|NCT02592655|3478668|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
1421065|NCT02592655|3478668|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
1421066|NCT02592655|3478668|P1|STARTED|First Tourniquet, Left Thigh.||19
1421067|NCT02592629|3478686|P3|NOT COMPLETED|Overall Study||0
1421068|NCT02592629|3478687|P2|NOT COMPLETED|Overall Study||0
1421069|NCT02592629|3478688|P1|NOT COMPLETED|Overall Study||0
1421070|NCT02592629|3478686|P3|COMPLETED|Overall Study||5
1421071|NCT02592629|3478687|P2|COMPLETED|Overall Study||9
1421072|NCT02592629|3478688|P1|COMPLETED|Overall Study||5
1421073|NCT02592629|3478686|P3|STARTED|Overall Study||5
1421074|NCT02592629|3478687|P2|STARTED|Overall Study||9
1421075|NCT02592629|3478688|P1|STARTED|Overall Study||5
1421076|NCT02591537|3478698|P2|NOT COMPLETED|Overall Study||0
1421077|NCT02591537|3478699|P1|NOT COMPLETED|Overall Study||0
1421078|NCT02591537|3478698|P2|COMPLETED|Overall Study||8
1421079|NCT02591537|3478699|P1|COMPLETED|Overall Study||8
1421080|NCT02591537|3478698|P2|STARTED|Overall Study||8
1421081|NCT02591537|3478699|P1|STARTED|Overall Study||8
1421082|NCT02591511|3478721|P2|NOT COMPLETED|Overall Study||0
1421083|NCT02591511|3478722|P1|NOT COMPLETED|Overall Study||0
1421084|NCT02591511|3478721|P2|COMPLETED|Overall Study||33
1421085|NCT02591511|3478722|P1|COMPLETED|Overall Study||30
1421086|NCT02591511|3478721|P2|STARTED|Overall Study||33
1421087|NCT02591511|3478722|P1|STARTED|Overall Study||30
1421088|NCT02591290|3478728|P1|NOT COMPLETED|Overall Study||2
1421089|NCT02591290|3478728|P1|COMPLETED|Overall Study||58
1421090|NCT02591290|3478728|P1|Vaccinated Dose 2|Overall Study||58
1421091|NCT02591290|3478728|P1|Vaccinated Dose 1|Overall Study||60
1421092|NCT02591290|3478728|P1|STARTED|Overall Study||60
1421093|NCT02591238|3478738|P4|NOT COMPLETED|Overall Study||3
1421094|NCT02591238|3478739|P3|NOT COMPLETED|Overall Study||0
1421095|NCT02591238|3478740|P2|NOT COMPLETED|Overall Study||1
1421096|NCT02591238|3478741|P1|NOT COMPLETED|Overall Study||1
1421097|NCT02591238|3478738|P4|COMPLETED|Overall Study||15
1421098|NCT02591238|3478739|P3|COMPLETED|Overall Study||17
1421099|NCT02591238|3478740|P2|COMPLETED|Overall Study||16
1421100|NCT02591238|3478741|P1|COMPLETED|Overall Study||15
1421101|NCT02591238|3478738|P4|STARTED|Overall Study||18
1421102|NCT02591238|3478739|P3|STARTED|Overall Study||17
1421103|NCT02591238|3478740|P2|STARTED|Overall Study||17
1421104|NCT02591238|3478741|P1|STARTED|Overall Study||16
1421105|NCT02591056|3478771|P1|NOT COMPLETED|Overall Study||0
1421106|NCT02591056|3478771|P1|COMPLETED|Overall Study||27
1421107|NCT02591056|3478771|P1|STARTED|Overall Study||27
1421108|NCT02590939|3478777|P2|NOT COMPLETED|Overall Study||2
1421109|NCT02590939|3478778|P1|NOT COMPLETED|Overall Study||5
1421110|NCT02590939|3478777|P2|COMPLETED|Overall Study||52
1421111|NCT02590939|3478778|P1|COMPLETED|Overall Study||47
1421112|NCT02590939|3478777|P2|STARTED|Overall Study||54
1421113|NCT02590939|3478778|P1|STARTED|Overall Study||52
1421114|NCT02590588|3478798|P1|NOT COMPLETED|Overall Study||1
1421115|NCT02590588|3478798|P1|COMPLETED|Overall Study||0
1421116|NCT02590588|3478798|P1|STARTED|Overall Study||1
1421117|NCT02590562|3478806|P1|NOT COMPLETED|Overall Study||6
1421118|NCT02590562|3478806|P1|COMPLETED|Overall Study||802
1421119|NCT02590562|3478806|P1|STARTED|Overall Study||808
1421120|NCT02590003|3478865|P2|NOT COMPLETED|Overall Study||2
1421121|NCT02590003|3478866|P1|NOT COMPLETED|Overall Study||1
1421122|NCT02590003|3478865|P2|COMPLETED|Overall Study||0
1421123|NCT02590003|3478866|P1|COMPLETED|Overall Study||0
1421124|NCT02590003|3478865|P2|STARTED|Overall Study||2
1421125|NCT02590003|3478866|P1|STARTED|Overall Study||1
1421126|NCT02588976|3478886|P1|NOT COMPLETED|Overall Study||0
1421127|NCT02588976|3478886|P1|COMPLETED|Overall Study||30
1421128|NCT02588976|3478886|P1|STARTED|Overall Study||30
1421129|NCT02588872|3478893|P2|NOT COMPLETED|Overall Study||0
1421130|NCT02588872|3478894|P1|NOT COMPLETED|Overall Study||0
1421131|NCT02588872|3478893|P2|COMPLETED|Overall Study||52
1421132|NCT02588872|3478894|P1|COMPLETED|Overall Study||59
1421133|NCT02588872|3478893|P2|STARTED|Overall Study||52
1421134|NCT02588872|3478894|P1|STARTED|Overall Study||59
1421135|NCT02588599|3478908|P1|NOT COMPLETED|Overall Study||0
1421136|NCT02588599|3478908|P1|COMPLETED|Overall Study||54
1421137|NCT02588599|3478908|P1|STARTED|Overall Study||54
1421138|NCT02587819|3478913|P1|NOT COMPLETED|Overall Study||2
1421139|NCT02587819|3478913|P1|COMPLETED|Overall Study||19
1421140|NCT02587819|3478913|P1|Exposed|Overall Study||21
1421141|NCT02587819|3478913|P1|STARTED|Overall Study||21
1421142|NCT02587234|3478922|P2|NOT COMPLETED|Overall Study||3
1421143|NCT02587234|3478923|P1|NOT COMPLETED|Overall Study||1
1421144|NCT02587234|3478922|P2|COMPLETED|Overall Study||7
1421145|NCT02587234|3478923|P1|COMPLETED|Overall Study||10
1421146|NCT02587234|3478922|P2|STARTED|Overall Study||10
1421147|NCT02587234|3478923|P1|STARTED|Overall Study||11
1421148|NCT02587117|3478935|P2|NOT COMPLETED|Overall Study||0
1421149|NCT02587117|3478936|P1|NOT COMPLETED|Overall Study||0
1421150|NCT02587117|3478935|P2|COMPLETED|Overall Study||15
1421151|NCT02587117|3478936|P1|COMPLETED|Overall Study||13
1421152|NCT02587117|3478935|P2|STARTED|Overall Study||15
1421153|NCT02587117|3478936|P1|STARTED|Overall Study||13
1421154|NCT02586805|3478948|P4|NOT COMPLETED|Overall Study||2
1421155|NCT02586805|3478949|P3|NOT COMPLETED|Overall Study||3
1421156|NCT02586805|3478950|P2|NOT COMPLETED|Overall Study||1
1421157|NCT02586805|3478951|P1|NOT COMPLETED|Overall Study||6
1421158|NCT02586805|3478948|P4|COMPLETED|Overall Study||25
1421159|NCT02586805|3478949|P3|COMPLETED|Overall Study||26
1421160|NCT02586805|3478950|P2|COMPLETED|Overall Study||27
1421161|NCT02586805|3478951|P1|COMPLETED|Overall Study||35
1421162|NCT02586805|3478948|P4|STARTED|Overall Study||27
1421163|NCT02586805|3478949|P3|STARTED|Overall Study||29
1421164|NCT02586805|3478950|P2|STARTED|Overall Study||28
1421165|NCT02586805|3478951|P1|STARTED|Overall Study||41
1421166|NCT02586506|3478973|P1|NOT COMPLETED|Overall Study||9
1421167|NCT02586506|3478973|P1|COMPLETED|Overall Study||250
1421168|NCT02586506|3478973|P1|STARTED|Overall Study||259
1421169|NCT02586493|3478979|P1|NOT COMPLETED|Overall Study||12
1421170|NCT02586493|3478979|P1|COMPLETED|Overall Study||266
1421171|NCT02586493|3478979|P1|STARTED|Overall Study||278
1421172|NCT02586415|3478987|P2|NOT COMPLETED|Overall Study||25
1421173|NCT02586415|3478988|P1|NOT COMPLETED|Overall Study||14
1421174|NCT02586415|3478987|P2|COMPLETED|Overall Study||65
1421175|NCT02586415|3478988|P1|COMPLETED|Overall Study||78
1421176|NCT02586415|3478987|P2|Day 90 Assessment|Overall Study||65
1421177|NCT02586415|3478988|P1|Day 90 Assessment|Overall Study||78
1421178|NCT02586415|3478987|P2|Day 30 Assessment|Overall Study||70
1421179|NCT02586415|3478988|P1|Day 30 Assessment|Overall Study||81
1421180|NCT02586415|3478987|P2|24 Hour Assessment|Overall Study||90
1421181|NCT02586415|3478988|P1|24 Hour Assessment|Overall Study||91
1421182|NCT02586415|3478987|P2|STARTED|Overall Study||90
1421183|NCT02586415|3478988|P1|STARTED|Overall Study||92
1421184|NCT02585999|3478996|P1|NOT COMPLETED|Overall Study||2
1421185|NCT02585999|3478996|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
1421186|NCT02585999|3478996|P1|STARTED|Overall Study||28
1421187|NCT02585934|3479003|P2|NOT COMPLETED|Overall Study||73
1421188|NCT02585934|3479004|P1|NOT COMPLETED|Overall Study||69
1421189|NCT02585934|3479003|P2|COMPLETED|Overall Study||581
1421190|NCT02585934|3479004|P1|COMPLETED|Overall Study||592
1421191|NCT02585934|3479003|P2|Per Protocol (PP)|Overall Study||582
1421192|NCT02585934|3479004|P1|Per Protocol (PP)|Overall Study||603
1421193|NCT02585934|3479003|P2|Intent to Treat (ITT)|Overall Study||633
1421194|NCT02585934|3479004|P1|Intent to Treat (ITT)|Overall Study||643
1421195|NCT02585934|3479003|P2|Safety Population|Overall Study||651
1421196|NCT02585934|3479004|P1|Safety Population|Overall Study||656
1421197|NCT02585934|3479003|P2|STARTED|Overall Study||654
1421198|NCT02585934|3479004|P1|STARTED|Overall Study||661
1421199|NCT02585895|3479027|P2|NOT COMPLETED|Post-primary Period||0
1421200|NCT02585895|3479028|P1|NOT COMPLETED|Post-primary Period||0
1421201|NCT02585895|3479027|P2|COMPLETED|Post-primary Period||19
1421202|NCT02585895|3479028|P1|COMPLETED|Post-primary Period||20
1421203|NCT02585895|3479027|P2|STARTED|Post-primary Period||19
1421204|NCT02585895|3479028|P1|STARTED|Post-primary Period||20
1421205|NCT02585895|3479027|P2|NOT COMPLETED|Primary Period||0
1421206|NCT02585895|3479028|P1|NOT COMPLETED|Primary Period||0
1421207|NCT02585895|3479027|P2|COMPLETED|Primary Period||19
1421208|NCT02585895|3479028|P1|COMPLETED|Primary Period||20
1421209|NCT02585895|3479027|P2|STARTED|Primary Period||19
1421210|NCT02585895|3479028|P1|STARTED|Primary Period||20
1421211|NCT02585778|3479047|P2|NOT COMPLETED|Overall Study||15
1421212|NCT02585778|3479048|P1|NOT COMPLETED|Overall Study||33
1421213|NCT02585778|3479047|P2|COMPLETED|Overall Study||157
1421214|NCT02585778|3479048|P1|COMPLETED|Overall Study||312
1421215|NCT02585778|3479047|P2|T2DM Participants|Overall Study||147
1421216|NCT02585778|3479048|P1|T2DM Participants|Overall Study||294
1421217|NCT02585778|3479047|P2|T1DM Participants|Overall Study||25
1421218|NCT02585778|3479048|P1|T1DM Participants|Overall Study||51
1421219|NCT02585778|3479047|P2|mITT Population|Overall Study||164
1421220|NCT02585778|3479048|P1|mITT Population|Overall Study||333
1421221|NCT02585778|3479047|P2|ITT Population|Overall Study||167
1421222|NCT02585778|3479048|P1|ITT Population|Overall Study||336
1421223|NCT02585778|3479047|P2|Treated (Safety Population)|Overall Study||170
1421224|NCT02585778|3479048|P1|Treated (Safety Population)|Overall Study||344
1421225|NCT02585778|3479047|P2|STARTED|Overall Study|Randomized|172
1421226|NCT02585778|3479048|P1|STARTED|Overall Study|Randomized|345
1421227|NCT02585245|3479162|P1|NOT COMPLETED|Overall Study||13
1421228|NCT02585245|3479162|P1|COMPLETED|Overall Study||594
1421229|NCT02585245|3479162|P1|STARTED|Overall Study||607
1421230|NCT02584998|3479170|P3|NOT COMPLETED|Overall Study||0
1421231|NCT02584998|3479171|P2|NOT COMPLETED|Overall Study||0
1421232|NCT02584998|3479172|P1|NOT COMPLETED|Overall Study||0
1421233|NCT02584998|3479170|P3|COMPLETED|Overall Study||261
1421234|NCT02584998|3479171|P2|COMPLETED|Overall Study||261
1421235|NCT02584998|3479172|P1|COMPLETED|Overall Study||260
1421236|NCT02584998|3479170|P3|STARTED|Overall Study||261
1421237|NCT02584998|3479171|P2|STARTED|Overall Study||261
1421238|NCT02584998|3479172|P1|STARTED|Overall Study||260
1421239|NCT02584959|3479186|P3|NOT COMPLETED|Period 2||2
1421240|NCT02584959|3479187|P2|NOT COMPLETED|Period 2||1
1421241|NCT02584959|3479188|P1|NOT COMPLETED|Period 2||6
1421242|NCT02584959|3479186|P3|COMPLETED|Period 2||13
1421243|NCT02584959|3479187|P2|COMPLETED|Period 2||24
1421244|NCT02584959|3479188|P1|COMPLETED|Period 2||22
1421245|NCT02584959|3479186|P3|STARTED|Period 2||15
1421246|NCT02584959|3479187|P2|STARTED|Period 2||25
1421247|NCT02584959|3479188|P1|STARTED|Period 2||28
1421248|NCT02584959|3479186|P3|NOT COMPLETED|Period 1||0
1421249|NCT02584959|3479187|P2|NOT COMPLETED|Period 1||4
1421250|NCT02584959|3479188|P1|NOT COMPLETED|Period 1||3
1421251|NCT02584959|3479186|P3|COMPLETED|Period 1||15
1421252|NCT02584959|3479187|P2|COMPLETED|Period 1||25
1421253|NCT02584959|3479188|P1|COMPLETED|Period 1||28
1421254|NCT02584959|3479186|P3|STARTED|Period 1||15
1421255|NCT02584959|3479187|P2|STARTED|Period 1||29
1421256|NCT02584959|3479188|P1|STARTED|Period 1||31
1421257|NCT02584790|3479243|P1|NOT COMPLETED|Overall Study||15
1421258|NCT02584790|3479243|P1|COMPLETED|Overall Study||40
1421259|NCT02584790|3479243|P1|STARTED|Overall Study||55
1421260|NCT02584686|3479251|P2|NOT COMPLETED|Overall Study||0
1421261|NCT02584686|3479252|P1|NOT COMPLETED|Overall Study||0
1421262|NCT02584686|3479251|P2|COMPLETED|Overall Study||12
1421263|NCT02584686|3479252|P1|COMPLETED|Overall Study||12
1421264|NCT02584686|3479251|P2|STARTED|Overall Study||12
1421265|NCT02584686|3479252|P1|STARTED|Overall Study||12
1421266|NCT02584673|3479280|P2|NOT COMPLETED|Overall Study||0
1421267|NCT02584673|3479281|P1|NOT COMPLETED|Overall Study||0
1421268|NCT02584673|3479280|P2|COMPLETED|Overall Study||15
1421269|NCT02584673|3479281|P1|COMPLETED|Overall Study||15
1421270|NCT02584673|3479280|P2|STARTED|Overall Study||15
1421271|NCT02584673|3479281|P1|STARTED|Overall Study||15
1421272|NCT02584660|3479295|P2|NOT COMPLETED|Overall Study||8
1421273|NCT02584660|3479296|P1|NOT COMPLETED|Overall Study||7
1421274|NCT02584660|3479295|P2|COMPLETED|Overall Study||55
1421275|NCT02584660|3479296|P1|COMPLETED|Overall Study||44
1421276|NCT02584660|3479295|P2|Treated|Overall Study||63
1421277|NCT02584660|3479296|P1|Treated|Overall Study||49
1421278|NCT02584660|3479295|P2|STARTED|Overall Study||63
1421279|NCT02584660|3479296|P1|STARTED|Overall Study||51
1421280|NCT02584504|3479315|P3|NOT COMPLETED|Open-label Treatment||55
1421281|NCT02584504|3479316|P2|NOT COMPLETED|Open-label Treatment||51
1421282|NCT02584504|3479317|P1|NOT COMPLETED|Open-label Treatment||54
1421283|NCT02584504|3479315|P3|COMPLETED|Open-label Treatment||0
1421284|NCT02584504|3479316|P2|COMPLETED|Open-label Treatment||0
1421285|NCT02584504|3479317|P1|COMPLETED|Open-label Treatment||0
1421286|NCT02584504|3479315|P3|Completed 12 Week Treatment|Open-label Treatment||52
1421287|NCT02584504|3479316|P2|Completed 12 Week Treatment|Open-label Treatment||49
1421288|NCT02584504|3479317|P1|Completed 12 Week Treatment|Open-label Treatment||54
1421289|NCT02584504|3479315|P3|Treated|Open-label Treatment||54
1421290|NCT02584504|3479316|P2|Treated|Open-label Treatment||50
1421291|NCT02584504|3479317|P1|Treated|Open-label Treatment||54
1421292|NCT02584504|3479315|P3|STARTED|Open-label Treatment||55
1421293|NCT02584504|3479316|P2|STARTED|Open-label Treatment||51
1421294|NCT02584504|3479317|P1|STARTED|Open-label Treatment||54
1421295|NCT02584504|3479315|P3|NOT COMPLETED|Double-blind Treatment||1
1421296|NCT02584504|3479316|P2|NOT COMPLETED|Double-blind Treatment||2
1421297|NCT02584504|3479317|P1|NOT COMPLETED|Double-blind Treatment||0
1421298|NCT02584504|3479315|P3|COMPLETED|Double-blind Treatment||55
1421299|NCT02584504|3479316|P2|COMPLETED|Double-blind Treatment||51
1421300|NCT02584504|3479317|P1|COMPLETED|Double-blind Treatment||54
1421301|NCT02584504|3479315|P3|Safety Population|Double-blind Treatment||56
1421302|NCT02584504|3479316|P2|Safety Population|Double-blind Treatment||53
1421303|NCT02584504|3479317|P1|Safety Population|Double-blind Treatment||54
1421304|NCT02584504|3479315|P3|mITT Population|Double-blind Treatment||56
1421305|NCT02584504|3479316|P2|mITT Population|Double-blind Treatment||53
1421306|NCT02584504|3479317|P1|mITT Population|Double-blind Treatment||54
1421307|NCT02584504|3479315|P3|ITT Population|Double-blind Treatment||56
1421308|NCT02584504|3479316|P2|ITT Population|Double-blind Treatment||53
1421309|NCT02584504|3479317|P1|ITT Population|Double-blind Treatment||54
1421310|NCT02584504|3479315|P3|STARTED|Double-blind Treatment|Randomized|56
1421311|NCT02584504|3479316|P2|STARTED|Double-blind Treatment|Randomized|53
1421312|NCT02584504|3479317|P1|STARTED|Double-blind Treatment|Randomized|54
1421313|NCT02583425|3479368|P1|NOT COMPLETED|Treatment Period||1
1421314|NCT02583425|3479368|P1|COMPLETED|Treatment Period||9
1421315|NCT02583425|3479368|P1|STARTED|Treatment Period||10
1421316|NCT02583425|3479368|P1|NOT COMPLETED|Baseline||5
1421317|NCT02583425|3479368|P1|COMPLETED|Baseline||10
1421318|NCT02583425|3479368|P1|STARTED|Baseline||15
1421319|NCT02583425|3479368|P1|NOT COMPLETED|Screening||12
1421320|NCT02583425|3479368|P1|COMPLETED|Screening||15
1421321|NCT02583425|3479368|P1|STARTED|Screening||27
1421322|NCT02583230|3479373|P1|NOT COMPLETED|Overall Study||0
1421323|NCT02583230|3479373|P1|COMPLETED|Overall Study||11
1421324|NCT02583230|3479373|P1|STARTED|Overall Study||11
1421325|NCT02582983|3479379|P1|NOT COMPLETED|Overall Study||6
1421326|NCT02582983|3479379|P1|COMPLETED|Overall Study||17
1421327|NCT02582983|3479379|P1|STARTED|Overall Study||23
1421328|NCT02582970|3479384|P1|NOT COMPLETED|Overall Study||0
1421329|NCT02582970|3479384|P1|COMPLETED|Overall Study||40
1421330|NCT02582970|3479384|P1|STARTED|Overall Study||40
1421331|NCT02582684|3479394|P1|NOT COMPLETED|Overall Study||17
1421332|NCT02582684|3479394|P1|COMPLETED|Overall Study||105
1421333|NCT02582684|3479394|P1|STARTED|Overall Study||122
1421334|NCT02582632|3479413|P1|NOT COMPLETED|Overall Study||1
1421335|NCT02582632|3479413|P1|COMPLETED|Overall Study||165
1421336|NCT02582632|3479413|P1|STARTED|Overall Study||166
1421337|NCT02582242|3479428|P2|NOT COMPLETED|Overall Study||17
1421338|NCT02582242|3479429|P1|NOT COMPLETED|Overall Study||20
1421339|NCT02582242|3479428|P2|COMPLETED|Overall Study||200
1421340|NCT02582242|3479429|P1|COMPLETED|Overall Study||200
1421341|NCT02582242|3479428|P2|STARTED|Overall Study||217
1421342|NCT02582242|3479429|P1|STARTED|Overall Study||220
1421343|NCT02581995|3479469|P1|NOT COMPLETED|Overall Study||31
1421344|NCT02581995|3479469|P1|COMPLETED|Overall Study||529
1421345|NCT02581995|3479469|P1|Treated|Overall Study||560
1421346|NCT02581995|3479469|P1|STARTED|Overall Study||560
1421347|NCT02581488|3479485|P2|NOT COMPLETED|Overall Study||11
1421348|NCT02581488|3479486|P1|NOT COMPLETED|Overall Study||9
1421349|NCT02581488|3479485|P2|COMPLETED|Overall Study||40
1421350|NCT02581488|3479486|P1|COMPLETED|Overall Study||42
1421351|NCT02581488|3479485|P2|STARTED|Overall Study||51
1421352|NCT02581488|3479486|P1|STARTED|Overall Study||51
1421353|NCT02581475|3479502|P2|NOT COMPLETED|Overall Study||15
1421354|NCT02581475|3479503|P1|NOT COMPLETED|Overall Study||11
1421355|NCT02581475|3479502|P2|COMPLETED|Overall Study||178
1421356|NCT02581475|3479503|P1|COMPLETED|Overall Study||182
1421357|NCT02581475|3479502|P2|STARTED|Overall Study||193
1421358|NCT02581475|3479503|P1|STARTED|Overall Study||193
1421359|NCT02581410|3479517|P2|NOT COMPLETED|End of Study Phase||11
1421360|NCT02581410|3479518|P1|NOT COMPLETED|End of Study Phase||5
1421361|NCT02581410|3479517|P2|COMPLETED|End of Study Phase||204
1421362|NCT02581410|3479518|P1|COMPLETED|End of Study Phase||210
1421363|NCT02581410|3479517|P2|STARTED|End of Study Phase||215
1421364|NCT02581410|3479518|P1|STARTED|End of Study Phase||215
1421365|NCT02581410|3479517|P2|NOT COMPLETED|Vaccination Phase||3
1421366|NCT02581410|3479518|P1|NOT COMPLETED|Vaccination Phase||2
1421367|NCT02581410|3479517|P2|COMPLETED|Vaccination Phase||212
1421368|NCT02581410|3479518|P1|COMPLETED|Vaccination Phase||213
1421369|NCT02581410|3479517|P2|STARTED|Vaccination Phase||215
1421370|NCT02581410|3479518|P1|STARTED|Vaccination Phase||215
1421371|NCT02581345|3479548|P4|NOT COMPLETED|Part 2: Week 17 to Week 47||12
1421372|NCT02581345|3479549|P3|NOT COMPLETED|Part 2: Week 17 to Week 47||15
1421373|NCT02581345|3479550|P2|NOT COMPLETED|Part 2: Week 17 to Week 47||0
1421374|NCT02581345|3479551|P1|NOT COMPLETED|Part 2: Week 17 to Week 47||29
1421375|NCT02581345|3479548|P4|COMPLETED|Part 2: Week 17 to Week 47||119
1421376|NCT02581345|3479549|P3|COMPLETED|Part 2: Week 17 to Week 47||117
1421377|NCT02581345|3479550|P2|COMPLETED|Part 2: Week 17 to Week 47||0
1421378|NCT02581345|3479551|P1|COMPLETED|Part 2: Week 17 to Week 47||242
1421379|NCT02581345|3479548|P4|STARTED|Part 2: Week 17 to Week 47||131
1421380|NCT02581345|3479549|P3|STARTED|Part 2: Week 17 to Week 47||132
1421381|NCT02581345|3479550|P2|STARTED|Part 2: Week 17 to Week 47||0
1421382|NCT02581345|3479551|P1|STARTED|Part 2: Week 17 to Week 47||271
1421383|NCT02581345|3479548|P4|NOT COMPLETED|Part 1: up to Week 16||0
1421384|NCT02581345|3479549|P3|NOT COMPLETED|Part 1: up to Week 16||0
1421385|NCT02581345|3479550|P2|NOT COMPLETED|Part 1: up to Week 16||23
1421386|NCT02581345|3479551|P1|NOT COMPLETED|Part 1: up to Week 16||15
1421387|NCT02581345|3479548|P4|COMPLETED|Part 1: up to Week 16||0
1421388|NCT02581345|3479549|P3|COMPLETED|Part 1: up to Week 16||0
1421389|NCT02581345|3479550|P2|COMPLETED|Part 1: up to Week 16||263
1421390|NCT02581345|3479551|P1|COMPLETED|Part 1: up to Week 16||271
1421391|NCT02581345|3479548|P4|STARTED|Part 1: up to Week 16||0
1421392|NCT02581345|3479549|P3|STARTED|Part 1: up to Week 16||0
1421393|NCT02581345|3479550|P2|STARTED|Part 1: up to Week 16||286
1421394|NCT02581345|3479551|P1|STARTED|Part 1: up to Week 16||286
1421395|NCT02581111|3479655|P2|NOT COMPLETED|Overall Study||7
1421396|NCT02581111|3479656|P1|NOT COMPLETED|Overall Study||2
1421397|NCT02581111|3479655|P2|COMPLETED|Overall Study||94
1421398|NCT02581111|3479656|P1|COMPLETED|Overall Study||96
1421399|NCT02581111|3479655|P2|STARTED|Overall Study||101
1421400|NCT02581111|3479656|P1|STARTED|Overall Study||98
1421401|NCT02580799|3479666|P1|NOT COMPLETED|Overall Study||0
1421402|NCT02580799|3479666|P1|COMPLETED|Overall Study||30
1421403|NCT02580799|3479666|P1|STARTED|Overall Study||30
1421404|NCT02580591|3479692|P4|NOT COMPLETED|Overall Study||12
1421405|NCT02580591|3479693|P3|NOT COMPLETED|Overall Study||13
1421406|NCT02580591|3479694|P2|NOT COMPLETED|Overall Study||10
1421407|NCT02580591|3479695|P1|NOT COMPLETED|Overall Study||18
1421408|NCT02580591|3479692|P4|COMPLETED|Overall Study||233
1421409|NCT02580591|3479693|P3|COMPLETED|Overall Study||235
1421410|NCT02580591|3479694|P2|COMPLETED|Overall Study||232
1421411|NCT02580591|3479695|P1|COMPLETED|Overall Study||224
1421412|NCT02580591|3479692|P4|Treated|Overall Study||245
1421413|NCT02580591|3479693|P3|Treated|Overall Study||248
1421414|NCT02580591|3479694|P2|Treated|Overall Study||241
1421415|NCT02580591|3479695|P1|Treated|Overall Study||241
1421416|NCT02580591|3479692|P4|STARTED|Overall Study||245
1421417|NCT02580591|3479693|P3|STARTED|Overall Study||248
1421418|NCT02580591|3479694|P2|STARTED|Overall Study||242
1421419|NCT02580591|3479695|P1|STARTED|Overall Study||242
1421420|NCT02580357|3479728|P3|NOT COMPLETED|Overall Study||0
1421421|NCT02580357|3479729|P2|NOT COMPLETED|Overall Study||0
1421422|NCT02580357|3479730|P1|NOT COMPLETED|Overall Study||3
1421423|NCT02580357|3479728|P3|COMPLETED|Overall Study||18
1421424|NCT02580357|3479729|P2|COMPLETED|Overall Study||18
1421425|NCT02580357|3479730|P1|COMPLETED|Overall Study||15
1421426|NCT02580357|3479728|P3|STARTED|Overall Study||18
1421427|NCT02580357|3479729|P2|STARTED|Overall Study||18
1421428|NCT02580357|3479730|P1|STARTED|Overall Study||18
1421429|NCT02580318|3479741|P1|NOT COMPLETED|Overall Study||0
1421430|NCT02580318|3479741|P1|COMPLETED|Overall Study||54
1421431|NCT02580318|3479741|P1|Drinking Water (5 Minutes)|Overall Study||54
1421432|NCT02580318|3479741|P1|Drinking Water (Immediate)|Overall Study||51
1421433|NCT02580318|3479741|P1|Hyperventilation (10 Minutes)|Overall Study||54
1421434|NCT02580318|3479741|P1|Hyperventilation (5 Minutes)|Overall Study||54
1421435|NCT02580318|3479741|P1|Hyperventilation (Immediate)|Overall Study||54
1421436|NCT02580318|3479741|P1|Poor Effort|Overall Study||53
1421437|NCT02580318|3479741|P1|STARTED|Overall Study||54
1421438|NCT02580240|3479747|P2|NOT COMPLETED|Overall Study||0
1421439|NCT02580240|3479748|P1|NOT COMPLETED|Overall Study||2
1421440|NCT02580240|3479747|P2|COMPLETED|Overall Study||58
1421441|NCT02580240|3479748|P1|COMPLETED|Overall Study||60
1421442|NCT02580240|3479747|P2|STARTED|Overall Study||58
1421443|NCT02580240|3479748|P1|STARTED|Overall Study||62
1421444|NCT02580188|3479758|P2|NOT COMPLETED|Overall Study||3
1421445|NCT02580188|3479759|P1|NOT COMPLETED|Overall Study||3
1421446|NCT02580188|3479758|P2|COMPLETED|Overall Study||32
1421447|NCT02580188|3479759|P1|COMPLETED|Overall Study||32
1421448|NCT02580188|3479758|P2|STARTED|Overall Study||35
1421449|NCT02580188|3479759|P1|STARTED|Overall Study||35
1421450|NCT02579772|3479765|P2|NOT COMPLETED|Overall Study||2
1421451|NCT02579772|3479766|P1|NOT COMPLETED|Overall Study||2
1421452|NCT02579772|3479765|P2|COMPLETED|Overall Study||3
1421453|NCT02579772|3479766|P1|COMPLETED|Overall Study||6
1421454|NCT02579772|3479765|P2|STARTED|Overall Study||5
1421455|NCT02579772|3479766|P1|STARTED|Overall Study||8
1421456|NCT02579603|3479786|P2|NOT COMPLETED|Overall Study||2
1421457|NCT02579603|3479787|P1|NOT COMPLETED|Overall Study||4
1421458|NCT02579603|3479786|P2|COMPLETED|Overall Study||51
1421459|NCT02579603|3479787|P1|COMPLETED|Overall Study||48
1421460|NCT02579603|3479786|P2|Number of Patients Treated|Overall Study||53
1421461|NCT02579603|3479787|P1|Number of Patients Treated|Overall Study||51
1421462|NCT02579603|3479786|P2|STARTED|Overall Study|Started are the randomised patients|53
1421463|NCT02579603|3479787|P1|STARTED|Overall Study|Started are the randomised patients|52
1421464|NCT02579135|3479798|P2|NOT COMPLETED|Overall Study||9
1421465|NCT02579135|3479799|P1|NOT COMPLETED|Overall Study||2
1421466|NCT02579135|3479798|P2|COMPLETED|Overall Study||106
1421467|NCT02579135|3479799|P1|COMPLETED|Overall Study||105
1421468|NCT02579135|3479798|P2|STARTED|Overall Study||115
1421469|NCT02579135|3479799|P1|STARTED|Overall Study||107
1421470|NCT02579057|3479810|P2|NOT COMPLETED|Overall Study||0
1421471|NCT02579057|3479811|P1|NOT COMPLETED|Overall Study||0
1421472|NCT02579057|3479810|P2|COMPLETED|Overall Study||21
1421473|NCT02579057|3479811|P1|COMPLETED|Overall Study||19
1421474|NCT02579057|3479810|P2|STARTED|Overall Study||21
1421475|NCT02579057|3479811|P1|STARTED|Overall Study||19
1421476|NCT02578992|3479825|P2|NOT COMPLETED|Overall Study||3
1421477|NCT02578992|3479826|P1|NOT COMPLETED|Overall Study||3
1421478|NCT02578992|3479825|P2|COMPLETED|Overall Study|October 2015|62
1421479|NCT02578992|3479826|P1|COMPLETED|Overall Study|October 2015|62
1421480|NCT02578992|3479825|P2|STARTED|Overall Study|November 2014|65
1421481|NCT02578992|3479826|P1|STARTED|Overall Study|November 2014|65
1421482|NCT02578862|3479840|P2|NOT COMPLETED|Overall Study||2
1421483|NCT02578862|3479841|P1|NOT COMPLETED|Overall Study||0
1421484|NCT02578862|3479840|P2|COMPLETED|Overall Study||33
1421485|NCT02578862|3479841|P1|COMPLETED|Overall Study||37
1421486|NCT02578862|3479840|P2|STARTED|Overall Study||35
1421487|NCT02578862|3479841|P1|STARTED|Overall Study||37
1421488|NCT02578706|3479860|P3|NOT COMPLETED|Overall Study||0
1421489|NCT02578706|3479861|P2|NOT COMPLETED|Overall Study||5
1421490|NCT02578706|3479862|P1|NOT COMPLETED|Overall Study||1
1421491|NCT02578706|3479860|P3|COMPLETED|Overall Study||8
1421492|NCT02578706|3479861|P2|COMPLETED|Overall Study||5
1421493|NCT02578706|3479862|P1|COMPLETED|Overall Study||8
1421494|NCT02578706|3479860|P3|STARTED|Overall Study||8
1421495|NCT02578706|3479861|P2|STARTED|Overall Study||10
1421496|NCT02578706|3479862|P1|STARTED|Overall Study||9
1421497|NCT02578680|3479941|P2|NOT COMPLETED|Overall Study||206
1421498|NCT02578680|3479942|P1|NOT COMPLETED|Overall Study||410
1421499|NCT02578680|3479941|P2|COMPLETED|Overall Study||0
1421500|NCT02578680|3479942|P1|COMPLETED|Overall Study||0
1421501|NCT02578680|3479941|P2|Switched to Pembrolizumab|Overall Study||67
1421502|NCT02578680|3479942|P1|Switched to Pembrolizumab|Overall Study||0
1421503|NCT02578680|3479941|P2|Treated|Overall Study||202
1421504|NCT02578680|3479942|P1|Treated|Overall Study||405
1421505|NCT02578680|3479941|P2|STARTED|Overall Study||206
1421506|NCT02578680|3479942|P1|STARTED|Overall Study||410
1421507|NCT02578316|3479958|P1|NOT COMPLETED|Extension Phase||6
1421508|NCT02578316|3479958|P1|COMPLETED|Extension Phase||0
1421509|NCT02578316|3479958|P1|STARTED|Extension Phase||6
1421510|NCT02578316|3479958|P1|NOT COMPLETED|Study Phase||0
1421511|NCT02578316|3479958|P1|COMPLETED|Study Phase||6
1421512|NCT02578316|3479958|P1|STARTED|Study Phase||6
1421513|NCT02578238|3479982|P1|NOT COMPLETED|Overall Study||0
1421514|NCT02578238|3479982|P1|COMPLETED|Overall Study||143
1421515|NCT02578238|3479982|P1|STARTED|Overall Study||143
1421516|NCT02578199|3479986|P1|NOT COMPLETED|Overall Study||4
1421517|NCT02578199|3479986|P1|COMPLETED|Overall Study||27
1421518|NCT02578199|3479986|P1|STARTED|Overall Study||31
1421519|NCT02578186|3479991|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
1421520|NCT02578186|3479992|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
1421521|NCT02578186|3479991|P2|COMPLETED|Period 2 (Second of Crossover)||13
1421522|NCT02578186|3479992|P1|COMPLETED|Period 2 (Second of Crossover)||12
1421523|NCT02578186|3479991|P2|STARTED|Period 2 (Second of Crossover)||13
1421524|NCT02578186|3479992|P1|STARTED|Period 2 (Second of Crossover)||12
1421525|NCT02578186|3479991|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
1421526|NCT02578186|3479992|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
1421527|NCT02578186|3479991|P2|COMPLETED|Period 1 (First of Crossover)||13
1421528|NCT02578186|3479992|P1|COMPLETED|Period 1 (First of Crossover)||12
1421529|NCT02578186|3479991|P2|STARTED|Period 1 (First of Crossover)||18
1421530|NCT02578186|3479992|P1|STARTED|Period 1 (First of Crossover)||17
1421531|NCT02577718|3479998|P1|NOT COMPLETED|Overall Study||8
1421532|NCT02577718|3479998|P1|COMPLETED|Overall Study||52
1421533|NCT02577718|3479998|P1|STARTED|Overall Study||60
1421534|NCT02577601|3480004|P1|NOT COMPLETED|UPA+COC (1 Month)||0
1421535|NCT02577601|3480004|P1|COMPLETED|UPA+COC (1 Month)||33
1421536|NCT02577601|3480004|P1|STARTED|UPA+COC (1 Month)||33
1421537|NCT02577601|3480004|P1|NOT COMPLETED|Washout (1 Month)||0
1421538|NCT02577601|3480004|P1|COMPLETED|Washout (1 Month)||33
1421539|NCT02577601|3480004|P1|STARTED|Washout (1 Month)||33
1421540|NCT02577601|3480004|P1|NOT COMPLETED|UPA Only (1 Month)||0
1421541|NCT02577601|3480004|P1|COMPLETED|UPA Only (1 Month)||36
1421542|NCT02577601|3480004|P1|STARTED|UPA Only (1 Month)||36
1421543|NCT02577510|3480011|P2|NOT COMPLETED|Overall Study||0
1421544|NCT02577510|3480012|P1|NOT COMPLETED|Overall Study||0
1421545|NCT02577510|3480011|P2|COMPLETED|Overall Study||21
1421546|NCT02577510|3480012|P1|COMPLETED|Overall Study||21
1421547|NCT02577510|3480011|P2|STARTED|Overall Study||21
1421548|NCT02577510|3480012|P1|STARTED|Overall Study||21
1421549|NCT02577445|3480026|P2|NOT COMPLETED|Overall Study||17
1421550|NCT02577445|3480027|P1|NOT COMPLETED|Overall Study||14
1421551|NCT02577445|3480026|P2|COMPLETED|Overall Study|study terminated prematurely|0
1421552|NCT02577445|3480027|P1|COMPLETED|Overall Study|study terminated prematurely|0
1421553|NCT02577445|3480026|P2|STARTED|Overall Study||17
1421554|NCT02577445|3480027|P1|STARTED|Overall Study||14
1421555|NCT02577315|3480040|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1421556|NCT02577315|3480041|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1421557|NCT02577315|3480040|P2|COMPLETED|Treatment Period 2 (4 Days)||12
1421558|NCT02577315|3480041|P1|COMPLETED|Treatment Period 2 (4 Days)||12
1421559|NCT02577315|3480040|P2|STARTED|Treatment Period 2 (4 Days)||12
1421560|NCT02577315|3480041|P1|STARTED|Treatment Period 2 (4 Days)||12
1421561|NCT02577315|3480040|P2|NOT COMPLETED|Washout Period (5 Days)||0
1421562|NCT02577315|3480041|P1|NOT COMPLETED|Washout Period (5 Days)||0
1421563|NCT02577315|3480040|P2|COMPLETED|Washout Period (5 Days)||12
1421564|NCT02577315|3480041|P1|COMPLETED|Washout Period (5 Days)||12
1421565|NCT02577315|3480040|P2|STARTED|Washout Period (5 Days)||12
1421566|NCT02577315|3480041|P1|STARTED|Washout Period (5 Days)||12
1421567|NCT02577315|3480040|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
1421568|NCT02577315|3480041|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1421569|NCT02577315|3480040|P2|COMPLETED|Treatment Period 1 (4 Days)||12
1421570|NCT02577315|3480041|P1|COMPLETED|Treatment Period 1 (4 Days)||12
1421571|NCT02577315|3480040|P2|STARTED|Treatment Period 1 (4 Days)||13
1421572|NCT02577315|3480041|P1|STARTED|Treatment Period 1 (4 Days)||12
1421573|NCT02577107|3480059|P2|NOT COMPLETED|Overall Study||1
1421574|NCT02577107|3480060|P1|NOT COMPLETED|Overall Study||0
1421575|NCT02577107|3480059|P2|COMPLETED|Overall Study||5
1421576|NCT02577107|3480060|P1|COMPLETED|Overall Study||6
1421577|NCT02577107|3480059|P2|STARTED|Overall Study||6
1421578|NCT02577107|3480060|P1|STARTED|Overall Study||6
1421579|NCT02577016|3480074|P2|NOT COMPLETED|Overall Study||2
1421580|NCT02577016|3480075|P1|NOT COMPLETED|Overall Study||2
1421581|NCT02577016|3480074|P2|COMPLETED|Overall Study||69
1421582|NCT02577016|3480075|P1|COMPLETED|Overall Study||68
1421583|NCT02577016|3480074|P2|STARTED|Overall Study||71
1421584|NCT02577016|3480075|P1|STARTED|Overall Study||70
1421585|NCT02577003|3480093|P2|NOT COMPLETED|Overall Study||5
1421586|NCT02577003|3480094|P1|NOT COMPLETED|Overall Study||2
1421587|NCT02577003|3480093|P2|COMPLETED|Overall Study||65
1421588|NCT02577003|3480094|P1|COMPLETED|Overall Study||71
1421589|NCT02577003|3480093|P2|STARTED|Overall Study||70
1421590|NCT02577003|3480094|P1|STARTED|Overall Study||73
1421591|NCT02576938|3480115|P3|NOT COMPLETED|Overall Study||12
1421592|NCT02576938|3480116|P2|NOT COMPLETED|Overall Study||12
1421593|NCT02576938|3480117|P1|NOT COMPLETED|Overall Study||20
1421594|NCT02576938|3480115|P3|COMPLETED|Overall Study||26
1421595|NCT02576938|3480116|P2|COMPLETED|Overall Study||25
1421596|NCT02576938|3480117|P1|COMPLETED|Overall Study||29
1421597|NCT02576938|3480115|P3|Received at Least One Dose of Study Drug|Overall Study||38
1421598|NCT02576938|3480116|P2|Received at Least One Dose of Study Drug|Overall Study||37
1421599|NCT02576938|3480117|P1|Received at Least One Dose of Study Drug|Overall Study||49
1421600|NCT02576938|3480115|P3|STARTED|Overall Study||38
1421601|NCT02576938|3480116|P2|STARTED|Overall Study||37
1421602|NCT02576938|3480117|P1|STARTED|Overall Study||49
1421603|NCT02576678|3480148|P3|NOT COMPLETED|Overall Study||15
1421604|NCT02576678|3480149|P2|NOT COMPLETED|Overall Study||1
1421605|NCT02576678|3480150|P1|NOT COMPLETED|Overall Study||5
1421606|NCT02576678|3480148|P3|COMPLETED|Overall Study||6
1421607|NCT02576678|3480149|P2|COMPLETED|Overall Study||7
1421608|NCT02576678|3480150|P1|COMPLETED|Overall Study||8
1421609|NCT02576678|3480148|P3|Pharmacokinetic (PK) Population|Overall Study||18
1421610|NCT02576678|3480149|P2|Pharmacokinetic (PK) Population|Overall Study||8
1421611|NCT02576678|3480150|P1|Pharmacokinetic (PK) Population|Overall Study||12
1421612|NCT02576678|3480148|P3|STARTED|Overall Study||21
1421613|NCT02576678|3480149|P2|STARTED|Overall Study||8
1421614|NCT02576678|3480150|P1|STARTED|Overall Study||13
1421615|NCT02576639|3480187|P5|NOT COMPLETED|Overall Study||4
1421616|NCT02576639|3480188|P4|NOT COMPLETED|Overall Study||1
1421617|NCT02576639|3480189|P3|NOT COMPLETED|Overall Study||2
1421618|NCT02576639|3480190|P2|NOT COMPLETED|Overall Study||2
1421619|NCT02576639|3480191|P1|NOT COMPLETED|Overall Study||2
1421620|NCT02576639|3480187|P5|COMPLETED|Overall Study||20
1421621|NCT02576639|3480188|P4|COMPLETED|Overall Study||25
1421622|NCT02576639|3480189|P3|COMPLETED|Overall Study||23
1421623|NCT02576639|3480190|P2|COMPLETED|Overall Study||23
1421624|NCT02576639|3480191|P1|COMPLETED|Overall Study||22
1421625|NCT02576639|3480187|P5|Safety Analysis Set|Overall Study||24
1421626|NCT02576639|3480188|P4|Safety Analysis Set|Overall Study||26
1421627|NCT02576639|3480189|P3|Safety Analysis Set|Overall Study||25
1421628|NCT02576639|3480190|P2|Safety Analysis Set|Overall Study||25
1421629|NCT02576639|3480191|P1|Safety Analysis Set|Overall Study||24
1421630|NCT02576639|3480187|P5|Pharmacokinetic Analysis Set|Overall Study||24
1421631|NCT02576639|3480188|P4|Pharmacokinetic Analysis Set|Overall Study||26
1421632|NCT02576639|3480189|P3|Pharmacokinetic Analysis Set|Overall Study||25
1421633|NCT02576639|3480190|P2|Pharmacokinetic Analysis Set|Overall Study||25
1421634|NCT02576639|3480191|P1|Pharmacokinetic Analysis Set|Overall Study||0
1421635|NCT02576639|3480187|P5|Pharmacodynamic Analysis Set|Overall Study||25
1421636|NCT02576639|3480188|P4|Pharmacodynamic Analysis Set|Overall Study||25
1421637|NCT02576639|3480189|P3|Pharmacodynamic Analysis Set|Overall Study||25
1421638|NCT02576639|3480190|P2|Pharmacodynamic Analysis Set|Overall Study||24
1421639|NCT02576639|3480191|P1|Pharmacodynamic Analysis Set|Overall Study||24
1421640|NCT02576639|3480187|P5|STARTED|Overall Study||24
1421641|NCT02576639|3480188|P4|STARTED|Overall Study||26
1421642|NCT02576639|3480189|P3|STARTED|Overall Study||25
1421643|NCT02576639|3480190|P2|STARTED|Overall Study||25
1421644|NCT02576639|3480191|P1|STARTED|Overall Study||24
1421645|NCT02576587|3480250|P2|NOT COMPLETED|Follow up Period (Case Only)||155
1421646|NCT02576587|3480251|P1|NOT COMPLETED|Follow up Period (Case Only)||117
1421647|NCT02576587|3480250|P2|COMPLETED|Follow up Period (Case Only)||0
1421648|NCT02576587|3480251|P1|COMPLETED|Follow up Period (Case Only)||44
1421649|NCT02576587|3480250|P2|Selected for Follow up|Follow up Period (Case Only)||0
1421650|NCT02576587|3480251|P1|Selected for Follow up|Follow up Period (Case Only)||61
1421651|NCT02576587|3480250|P2|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
1421652|NCT02576587|3480251|P1|STARTED|Follow up Period (Case Only)|Completed baseline.|161
1421653|NCT02576587|3480250|P2|NOT COMPLETED|Baseline||1
1421654|NCT02576587|3480251|P1|NOT COMPLETED|Baseline||0
1421655|NCT02576587|3480250|P2|COMPLETED|Baseline|Baseline visit completed|155
1421656|NCT02576587|3480251|P1|COMPLETED|Baseline|Baseline visit completed|161
1421657|NCT02576587|3480250|P2|STARTED|Baseline|Total controls baseline visit|156
1421658|NCT02576587|3480251|P1|STARTED|Baseline|Total cases baseline visit|161
1421659|NCT02576535|3480269|P1|NOT COMPLETED|Overall Study||2
1421660|NCT02576535|3480269|P1|COMPLETED|Overall Study||16
1421661|NCT02576535|3480269|P1|STARTED|Overall Study||18
1421662|NCT02576249|3480280|P2|NOT COMPLETED|Overall Study||0
1421663|NCT02576249|3480281|P1|NOT COMPLETED|Overall Study||0
1421664|NCT02576249|3480280|P2|COMPLETED|Overall Study||14
1421665|NCT02576249|3480281|P1|COMPLETED|Overall Study||15
1421666|NCT02576249|3480280|P2|STARTED|Overall Study||14
1421667|NCT02576249|3480281|P1|STARTED|Overall Study||15
1421668|NCT02576145|3480293|P2|NOT COMPLETED|Overall Study||1
1421669|NCT02576145|3480294|P1|NOT COMPLETED|Overall Study||3
1421670|NCT02576145|3480293|P2|COMPLETED|Overall Study||4
1421671|NCT02576145|3480294|P1|COMPLETED|Overall Study||3
1421672|NCT02576145|3480293|P2|STARTED|Overall Study||5
1421673|NCT02576145|3480294|P1|STARTED|Overall Study||6
1421674|NCT02576041|3480330|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
1421675|NCT02576041|3480330|P1|COMPLETED|Bilastine (Active Treatement)||18
1421676|NCT02576041|3480330|P1|STARTED|Bilastine (Active Treatement)||18
1421677|NCT02576041|3480330|P1|NOT COMPLETED|Placebo (run-in)||0
1421678|NCT02576041|3480330|P1|COMPLETED|Placebo (run-in)||18
1421679|NCT02576041|3480330|P1|STARTED|Placebo (run-in)||18
1421680|NCT02575911|3480336|P1|NOT COMPLETED|Overall Study||1
1421681|NCT02575911|3480336|P1|COMPLETED|Overall Study||29
1421682|NCT02575911|3480336|P1|STARTED|Overall Study||30
1421683|NCT02575833|3480356|P2|NOT COMPLETED|Overall Study||1
1421684|NCT02575833|3480357|P1|NOT COMPLETED|Overall Study||1
1421685|NCT02575833|3480356|P2|COMPLETED|Overall Study||44
1421686|NCT02575833|3480357|P1|COMPLETED|Overall Study||43
1421687|NCT02575833|3480356|P2|Received Study Drug|Overall Study||44
1421688|NCT02575833|3480357|P1|Received Study Drug|Overall Study||44
1421689|NCT02575833|3480356|P2|STARTED|Overall Study||45
1421690|NCT02575833|3480357|P1|STARTED|Overall Study||44
1421691|NCT02574858|3480367|P1|NOT COMPLETED|Overall Study||0
1421692|NCT02574858|3480367|P1|COMPLETED|Overall Study||25
1421693|NCT02574858|3480367|P1|STARTED|Overall Study||25
1421694|NCT02574845|3480378|P6|NOT COMPLETED|Overall Study||1
1421695|NCT02574845|3480379|P5|NOT COMPLETED|Overall Study||1
1421696|NCT02574845|3480380|P4|NOT COMPLETED|Overall Study||0
1421697|NCT02574845|3480381|P3|NOT COMPLETED|Overall Study||0
1421698|NCT02574845|3480382|P2|NOT COMPLETED|Overall Study||1
1421699|NCT02574845|3480383|P1|NOT COMPLETED|Overall Study||0
1421700|NCT02574845|3480378|P6|COMPLETED|Overall Study||2
1421701|NCT02574845|3480379|P5|COMPLETED|Overall Study||2
1421702|NCT02574845|3480380|P4|COMPLETED|Overall Study||3
1421703|NCT02574845|3480381|P3|COMPLETED|Overall Study||3
1421704|NCT02574845|3480382|P2|COMPLETED|Overall Study||2
1421705|NCT02574845|3480383|P1|COMPLETED|Overall Study||3
1421706|NCT02574845|3480378|P6|Received R|Overall Study||3
1421707|NCT02574845|3480379|P5|Received R|Overall Study||2
1421708|NCT02574845|3480380|P4|Received R|Overall Study||3
1421709|NCT02574845|3480381|P3|Received R|Overall Study||3
1421710|NCT02574845|3480382|P2|Received R|Overall Study||2
1421711|NCT02574845|3480383|P1|Received R|Overall Study||3
1421712|NCT02574845|3480378|P6|Received T5|Overall Study||2
1421713|NCT02574845|3480379|P5|Received T5|Overall Study||3
1421714|NCT02574845|3480380|P4|Received T5|Overall Study||3
1421715|NCT02574845|3480381|P3|Received T5|Overall Study||3
1421716|NCT02574845|3480382|P2|Received T5|Overall Study||2
1421717|NCT02574845|3480383|P1|Received T5|Overall Study||3
1421718|NCT02574845|3480378|P6|Received T4|Overall Study||2
1421719|NCT02574845|3480379|P5|Received T4|Overall Study||2
1421720|NCT02574845|3480380|P4|Received T4|Overall Study||3
1421721|NCT02574845|3480381|P3|Received T4|Overall Study||3
1421722|NCT02574845|3480382|P2|Received T4|Overall Study||2
1421723|NCT02574845|3480383|P1|Received T4|Overall Study||3
1421724|NCT02574845|3480378|P6|Received T3|Overall Study||3
1421725|NCT02574845|3480379|P5|Received T3|Overall Study||2
1421726|NCT02574845|3480380|P4|Received T3|Overall Study||3
1421727|NCT02574845|3480381|P3|Received T3|Overall Study||3
1421728|NCT02574845|3480382|P2|Received T3|Overall Study||2
1421729|NCT02574845|3480383|P1|Received T3|Overall Study|one subject missed treatment period 2|2
1421730|NCT02574845|3480378|P6|Received T2|Overall Study||3
1421731|NCT02574845|3480379|P5|Received T2|Overall Study||2
1421732|NCT02574845|3480380|P4|Received T2|Overall Study||3
1421733|NCT02574845|3480381|P3|Received T2|Overall Study||3
1421734|NCT02574845|3480382|P2|Received T2|Overall Study||3
1421735|NCT02574845|3480383|P1|Received T2|Overall Study||3
1421736|NCT02574845|3480378|P6|Received T1|Overall Study|one subject missed treatment period 2|2
1421737|NCT02574845|3480379|P5|Received T1|Overall Study||2
1421738|NCT02574845|3480380|P4|Received T1|Overall Study||3
1421739|NCT02574845|3480381|P3|Received T1|Overall Study||3
1421740|NCT02574845|3480382|P2|Received T1|Overall Study||2
1421741|NCT02574845|3480383|P1|Received T1|Overall Study||3
1421742|NCT02574845|3480378|P6|STARTED|Overall Study||3
1421743|NCT02574845|3480379|P5|STARTED|Overall Study||3
1421744|NCT02574845|3480380|P4|STARTED|Overall Study||3
1421745|NCT02574845|3480381|P3|STARTED|Overall Study||3
1421746|NCT02574845|3480382|P2|STARTED|Overall Study||3
1421747|NCT02574845|3480383|P1|STARTED|Overall Study||3
1421748|NCT02574832|3480409|P1|NOT COMPLETED|Overall Study||0
1421749|NCT02574832|3480409|P1|COMPLETED|Overall Study||2
1421750|NCT02574832|3480409|P1|STARTED|Overall Study||2
1421751|NCT02574260|3480413|P1|NOT COMPLETED|Overall Study||1
1421752|NCT02574260|3480413|P1|COMPLETED|Overall Study||2
1421753|NCT02574260|3480413|P1|STARTED|Overall Study||3
1421754|NCT02574247|3480422|P3|NOT COMPLETED|Overall Study||5
1421755|NCT02574247|3480423|P2|NOT COMPLETED|Overall Study||3
1421756|NCT02574247|3480424|P1|NOT COMPLETED|Overall Study||5
1421757|NCT02574247|3480422|P3|COMPLETED|Overall Study||5
1421758|NCT02574247|3480423|P2|COMPLETED|Overall Study||5
1421759|NCT02574247|3480424|P1|COMPLETED|Overall Study||5
1421760|NCT02574247|3480422|P3|STARTED|Overall Study||10
1421761|NCT02574247|3480423|P2|STARTED|Overall Study||8
1421762|NCT02574247|3480424|P1|STARTED|Overall Study||10
1421763|NCT02573948|3480436|P1|NOT COMPLETED|Longitudinal Cohort||56
1421764|NCT02573948|3480436|P1|COMPLETED|Longitudinal Cohort||194
1421765|NCT02573948|3480436|P1|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
1421766|NCT02573948|3480436|P1|NOT COMPLETED|RDS||0
1421767|NCT02573948|3480436|P1|COMPLETED|RDS||603
1421768|NCT02573948|3480436|P1|STARTED|RDS||603
1421769|NCT02573870|3480446|P2|NOT COMPLETED|Overall Study||7
1421770|NCT02573870|3480447|P1|NOT COMPLETED|Overall Study||0
1421771|NCT02573870|3480446|P2|COMPLETED|Overall Study||35
1421772|NCT02573870|3480447|P1|COMPLETED|Overall Study||20
1421773|NCT02573870|3480446|P2|STARTED|Overall Study||42
1421774|NCT02573870|3480447|P1|STARTED|Overall Study||20
1421775|NCT02573467|3480457|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
1421776|NCT02573467|3480458|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
1421777|NCT02573467|3480459|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
1421778|NCT02573467|3480460|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
1421779|NCT02573467|3480457|P4|COMPLETED|Post-treatment Follow up Epoch||44
1421780|NCT02573467|3480458|P3|COMPLETED|Post-treatment Follow up Epoch||34
1421781|NCT02573467|3480459|P2|COMPLETED|Post-treatment Follow up Epoch||41
1421782|NCT02573467|3480460|P1|COMPLETED|Post-treatment Follow up Epoch||35
1421783|NCT02573467|3480457|P4|STARTED|Post-treatment Follow up Epoch||47
1421784|NCT02573467|3480458|P3|STARTED|Post-treatment Follow up Epoch||44
1421785|NCT02573467|3480459|P2|STARTED|Post-treatment Follow up Epoch||46
1421786|NCT02573467|3480460|P1|STARTED|Post-treatment Follow up Epoch||41
1421787|NCT02573467|3480457|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
1421788|NCT02573467|3480458|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
1421789|NCT02573467|3480459|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
1421790|NCT02573467|3480460|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
1421791|NCT02573467|3480457|P4|COMPLETED|Double-blind Treatment Epoch||0
1421792|NCT02573467|3480458|P3|COMPLETED|Double-blind Treatment Epoch||0
1421793|NCT02573467|3480459|P2|COMPLETED|Double-blind Treatment Epoch||0
1421794|NCT02573467|3480460|P1|COMPLETED|Double-blind Treatment Epoch||0
1421795|NCT02573467|3480457|P4|Full Analysis Set|Double-blind Treatment Epoch||55
1421796|NCT02573467|3480458|P3|Full Analysis Set|Double-blind Treatment Epoch||51
1421797|NCT02573467|3480459|P2|Full Analysis Set|Double-blind Treatment Epoch||52
1421798|NCT02573467|3480460|P1|Full Analysis Set|Double-blind Treatment Epoch||53
1421799|NCT02573467|3480457|P4|STARTED|Double-blind Treatment Epoch||55
1421800|NCT02573467|3480458|P3|STARTED|Double-blind Treatment Epoch||51
1421801|NCT02573467|3480459|P2|STARTED|Double-blind Treatment Epoch||52
1421802|NCT02573467|3480460|P1|STARTED|Double-blind Treatment Epoch||53
1421803|NCT02573402|3480501|P2|NOT COMPLETED|Overall Study||0
1421804|NCT02573402|3480502|P1|NOT COMPLETED|Overall Study||0
1421805|NCT02573402|3480501|P2|COMPLETED|Overall Study||7
1421806|NCT02573402|3480502|P1|COMPLETED|Overall Study||12
1421807|NCT02573402|3480501|P2|STARTED|Overall Study||7
1421808|NCT02573402|3480502|P1|STARTED|Overall Study||12
1421809|NCT02573155|3480524|P2|NOT COMPLETED|Period 5||0
1421810|NCT02573155|3480525|P1|NOT COMPLETED|Period 5||0
1421811|NCT02573155|3480524|P2|COMPLETED|Period 5||28
1421812|NCT02573155|3480525|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
1421813|NCT02573155|3480524|P2|STARTED|Period 5||28
1421814|NCT02573155|3480525|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
1421815|NCT02573155|3480524|P2|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
1421816|NCT02573155|3480525|P1|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
1421817|NCT02573155|3480524|P2|COMPLETED|Washout Between Treatment Period 4 and 5||28
1421818|NCT02573155|3480525|P1|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
1421819|NCT02573155|3480524|P2|STARTED|Washout Between Treatment Period 4 and 5||29
1421820|NCT02573155|3480525|P1|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
1421821|NCT02573155|3480524|P2|NOT COMPLETED|Period 4||0
1421822|NCT02573155|3480525|P1|NOT COMPLETED|Period 4||0
1421823|NCT02573155|3480524|P2|COMPLETED|Period 4||29
1421824|NCT02573155|3480525|P1|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
1421825|NCT02573155|3480524|P2|STARTED|Period 4||29
1421826|NCT02573155|3480525|P1|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
1421827|NCT02573155|3480524|P2|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
1421828|NCT02573155|3480525|P1|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
1421829|NCT02573155|3480524|P2|COMPLETED|Washout Between Treatment Period 3 and 4||29
1421830|NCT02573155|3480525|P1|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
1421831|NCT02573155|3480524|P2|STARTED|Washout Between Treatment Period 3 and 4||31
1421832|NCT02573155|3480525|P1|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
1421833|NCT02573155|3480524|P2|NOT COMPLETED|Period 3||0
1421834|NCT02573155|3480525|P1|NOT COMPLETED|Period 3||0
1421835|NCT02573155|3480524|P2|COMPLETED|Period 3||31
1421836|NCT02573155|3480525|P1|COMPLETED|Period 3||15
1421837|NCT02573155|3480524|P2|STARTED|Period 3||31
1421838|NCT02573155|3480525|P1|STARTED|Period 3||15
1421839|NCT02573155|3480524|P2|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
1421840|NCT02573155|3480525|P1|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
1421841|NCT02573155|3480524|P2|COMPLETED|Washout Between Treatment Period 2 and 3||31
1421842|NCT02573155|3480525|P1|COMPLETED|Washout Between Treatment Period 2 and 3||15
1421843|NCT02573155|3480524|P2|STARTED|Washout Between Treatment Period 2 and 3||33
1421844|NCT02573155|3480525|P1|STARTED|Washout Between Treatment Period 2 and 3||16
1421845|NCT02573155|3480524|P2|NOT COMPLETED|Period 2||0
1421846|NCT02573155|3480525|P1|NOT COMPLETED|Period 2||0
1421847|NCT02573155|3480524|P2|COMPLETED|Period 2||33
1421848|NCT02573155|3480525|P1|COMPLETED|Period 2||16
1421849|NCT02573155|3480524|P2|STARTED|Period 2||33
1421850|NCT02573155|3480525|P1|STARTED|Period 2||16
1421851|NCT02573155|3480524|P2|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
1421852|NCT02573155|3480525|P1|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
1421853|NCT02573155|3480524|P2|COMPLETED|Washout Between Treatment Period 1 and 2||33
1421854|NCT02573155|3480525|P1|COMPLETED|Washout Between Treatment Period 1 and 2||16
1421855|NCT02573155|3480524|P2|STARTED|Washout Between Treatment Period 1 and 2||38
1421856|NCT02573155|3480525|P1|STARTED|Washout Between Treatment Period 1 and 2||16
1421857|NCT02573155|3480524|P2|NOT COMPLETED|Treatment Period 1||0
1421858|NCT02573155|3480525|P1|NOT COMPLETED|Treatment Period 1||0
1421859|NCT02573155|3480524|P2|COMPLETED|Treatment Period 1||38
1421860|NCT02573155|3480525|P1|COMPLETED|Treatment Period 1||16
1421861|NCT02573155|3480524|P2|STARTED|Treatment Period 1||38
1421862|NCT02573155|3480525|P1|STARTED|Treatment Period 1||16
1421863|NCT02572752|3480674|P3|NOT COMPLETED|Period 3 Including Washout||0
1421864|NCT02572752|3480675|P2|NOT COMPLETED|Period 3 Including Washout||0
1421865|NCT02572752|3480676|P1|NOT COMPLETED|Period 3 Including Washout||0
1421866|NCT02572752|3480674|P3|COMPLETED|Period 3 Including Washout||24
1421867|NCT02572752|3480675|P2|COMPLETED|Period 3 Including Washout||23
1421868|NCT02572752|3480676|P1|COMPLETED|Period 3 Including Washout||23
1421869|NCT02572752|3480674|P3|STARTED|Period 3 Including Washout||24
1421870|NCT02572752|3480675|P2|STARTED|Period 3 Including Washout||23
1421871|NCT02572752|3480676|P1|STARTED|Period 3 Including Washout||23
1421872|NCT02572752|3480674|P3|NOT COMPLETED|Period 2 Including Washout||0
1421873|NCT02572752|3480675|P2|NOT COMPLETED|Period 2 Including Washout||0
1421874|NCT02572752|3480676|P1|NOT COMPLETED|Period 2 Including Washout||0
1421875|NCT02572752|3480674|P3|COMPLETED|Period 2 Including Washout||24
1421876|NCT02572752|3480675|P2|COMPLETED|Period 2 Including Washout||23
1421877|NCT02572752|3480676|P1|COMPLETED|Period 2 Including Washout||23
1421878|NCT02572752|3480674|P3|STARTED|Period 2 Including Washout||24
1421879|NCT02572752|3480675|P2|STARTED|Period 2 Including Washout||23
1421880|NCT02572752|3480676|P1|STARTED|Period 2 Including Washout||23
1421881|NCT02572752|3480674|P3|NOT COMPLETED|Period 1 Including Washout||0
1421882|NCT02572752|3480675|P2|NOT COMPLETED|Period 1 Including Washout||0
1421883|NCT02572752|3480676|P1|NOT COMPLETED|Period 1 Including Washout||0
1421884|NCT02572752|3480674|P3|COMPLETED|Period 1 Including Washout||24
1421885|NCT02572752|3480675|P2|COMPLETED|Period 1 Including Washout||23
1421886|NCT02572752|3480676|P1|COMPLETED|Period 1 Including Washout||23
1421887|NCT02572752|3480674|P3|STARTED|Period 1 Including Washout||24
1421888|NCT02572752|3480675|P2|STARTED|Period 1 Including Washout||23
1421889|NCT02572752|3480676|P1|STARTED|Period 1 Including Washout||23
1421890|NCT02572609|3480691|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
1421891|NCT02572609|3480692|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
1421892|NCT02572609|3480691|P2|COMPLETED|Period 2: Treatment Period 2||18
1421893|NCT02572609|3480692|P1|COMPLETED|Period 2: Treatment Period 2||18
1421894|NCT02572609|3480691|P2|STARTED|Period 2: Treatment Period 2||18
1421895|NCT02572609|3480692|P1|STARTED|Period 2: Treatment Period 2||18
1421896|NCT02572609|3480691|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
1421897|NCT02572609|3480692|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
1421898|NCT02572609|3480691|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
1421899|NCT02572609|3480692|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
1421900|NCT02572609|3480691|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
1421901|NCT02572609|3480692|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
1421902|NCT02572427|3480702|P2|NOT COMPLETED|Overall Study||9
1421903|NCT02572427|3480703|P1|NOT COMPLETED|Overall Study||6
1421904|NCT02572427|3480702|P2|COMPLETED|Overall Study||36
1421905|NCT02572427|3480703|P1|COMPLETED|Overall Study||31
1421906|NCT02572427|3480702|P2|STARTED|Overall Study||45
1421907|NCT02572427|3480703|P1|STARTED|Overall Study||37
1421908|NCT02572076|3480711|P1|NOT COMPLETED|Overall Study||1
1421909|NCT02572076|3480711|P1|COMPLETED|Overall Study||9
1421910|NCT02572076|3480711|P1|STARTED|Overall Study||10
1421911|NCT02571634|3480715|P1|NOT COMPLETED|Overall Study||0
1421912|NCT02571634|3480715|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
1421913|NCT02571634|3480715|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
1421914|NCT02571439|3480725|P2|NOT COMPLETED|Overall Study||0
1421915|NCT02571439|3480726|P1|NOT COMPLETED|Overall Study||0
1421916|NCT02571439|3480725|P2|COMPLETED|Overall Study||21
1421917|NCT02571439|3480726|P1|COMPLETED|Overall Study||20
1421918|NCT02571439|3480725|P2|STARTED|Overall Study||21
1421919|NCT02571439|3480726|P1|STARTED|Overall Study||20
1421920|NCT02571244|3480752|P2|NOT COMPLETED|Overall Study||1
1421921|NCT02571244|3480753|P1|NOT COMPLETED|Overall Study||3
1421922|NCT02571244|3480752|P2|COMPLETED|Overall Study||21
1421923|NCT02571244|3480753|P1|COMPLETED|Overall Study||41
1421924|NCT02571244|3480752|P2|STARTED|Overall Study||22
1421925|NCT02571244|3480753|P1|STARTED|Overall Study||44
1421926|NCT02571153|3480770|P3|NOT COMPLETED|Overall Study||2
1421927|NCT02571153|3480771|P2|NOT COMPLETED|Overall Study||8
1421928|NCT02571153|3480772|P1|NOT COMPLETED|Overall Study||6
1421929|NCT02571153|3480770|P3|COMPLETED|Overall Study||43
1421930|NCT02571153|3480771|P2|COMPLETED|Overall Study||37
1421931|NCT02571153|3480772|P1|COMPLETED|Overall Study||39
1421932|NCT02571153|3480770|P3|STARTED|Overall Study||45
1421933|NCT02571153|3480771|P2|STARTED|Overall Study||45
1421934|NCT02571153|3480772|P1|STARTED|Overall Study||45
1421935|NCT02571049|3480798|P2|NOT COMPLETED|Randomization||1
1421936|NCT02571049|3480799|P1|NOT COMPLETED|Randomization||0
1421937|NCT02571049|3480798|P2|COMPLETED|Randomization||11
1421938|NCT02571049|3480799|P1|COMPLETED|Randomization||8
1421939|NCT02571049|3480798|P2|STARTED|Randomization||12
1421940|NCT02571049|3480799|P1|STARTED|Randomization||8
1421941|NCT02571049|3480798|P2|NOT COMPLETED|Screening||2
1421942|NCT02571049|3480799|P1|NOT COMPLETED|Screening||2
1421943|NCT02571049|3480798|P2|COMPLETED|Screening||12
1421944|NCT02571049|3480799|P1|COMPLETED|Screening||8
1421945|NCT02571049|3480798|P2|STARTED|Screening||14
1421946|NCT02571049|3480799|P1|STARTED|Screening||10
1421947|NCT02570750|3480807|P2|NOT COMPLETED|Overall Study||5
1421948|NCT02570750|3480808|P1|NOT COMPLETED|Overall Study||14
1421949|NCT02570750|3480807|P2|COMPLETED|Overall Study||68
1421950|NCT02570750|3480808|P1|COMPLETED|Overall Study||96
1421951|NCT02570750|3480807|P2|STARTED|Overall Study||73
1421952|NCT02570750|3480808|P1|STARTED|Overall Study||110
1421953|NCT02570425|3480826|P2|NOT COMPLETED|Visit 3||0
1421954|NCT02570425|3480827|P1|NOT COMPLETED|Visit 3||0
1421955|NCT02570425|3480826|P2|COMPLETED|Visit 3||231
1421956|NCT02570425|3480827|P1|COMPLETED|Visit 3||229
1421957|NCT02570425|3480826|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
1421958|NCT02570425|3480827|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
1421959|NCT02570425|3480826|P2|NOT COMPLETED|Visit 2||0
1421960|NCT02570425|3480827|P1|NOT COMPLETED|Visit 2||0
1421961|NCT02570425|3480826|P2|COMPLETED|Visit 2||247
1421962|NCT02570425|3480827|P1|COMPLETED|Visit 2||251
1421963|NCT02570425|3480826|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
1421964|NCT02570425|3480827|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
1421965|NCT02570425|3480826|P2|NOT COMPLETED|Visit 1||0
1421966|NCT02570425|3480827|P1|NOT COMPLETED|Visit 1||0
1421967|NCT02570425|3480826|P2|COMPLETED|Visit 1||242
1421968|NCT02570425|3480827|P1|COMPLETED|Visit 1||274
1421969|NCT02570425|3480826|P2|STARTED|Visit 1||242
1421970|NCT02570425|3480827|P1|STARTED|Visit 1||274
1421971|NCT02570295|3480876|P2|NOT COMPLETED|Overall Study||58
1421972|NCT02570295|3480877|P1|NOT COMPLETED|Overall Study||11
1421973|NCT02570295|3480876|P2|COMPLETED|Overall Study||289
1421974|NCT02570295|3480877|P1|COMPLETED|Overall Study||364
1421975|NCT02570295|3480876|P2|STARTED|Overall Study||347
1421976|NCT02570295|3480877|P1|STARTED|Overall Study||375
1421977|NCT02570165|3480906|P7|NOT COMPLETED|Overall Study||0
1421978|NCT02570165|3480907|P6|NOT COMPLETED|Overall Study||2
1421979|NCT02570165|3480908|P5|NOT COMPLETED|Overall Study||6
1421980|NCT02570165|3480909|P4|NOT COMPLETED|Overall Study||5
1421981|NCT02570165|3480910|P3|NOT COMPLETED|Overall Study||5
1421982|NCT02570165|3480911|P2|NOT COMPLETED|Overall Study||3
1421983|NCT02570165|3480912|P1|NOT COMPLETED|Overall Study||2
1421984|NCT02570165|3480906|P7|COMPLETED|Overall Study||47
1421985|NCT02570165|3480907|P6|COMPLETED|Overall Study||44
1421986|NCT02570165|3480908|P5|COMPLETED|Overall Study||41
1421987|NCT02570165|3480909|P4|COMPLETED|Overall Study||40
1421988|NCT02570165|3480910|P3|COMPLETED|Overall Study||41
1421989|NCT02570165|3480911|P2|COMPLETED|Overall Study||43
1421990|NCT02570165|3480912|P1|COMPLETED|Overall Study||44
1421991|NCT02570165|3480906|P7|STARTED|Overall Study||47
1421992|NCT02570165|3480907|P6|STARTED|Overall Study||46
1421993|NCT02570165|3480908|P5|STARTED|Overall Study||47
1421994|NCT02570165|3480909|P4|STARTED|Overall Study||45
1421995|NCT02570165|3480910|P3|STARTED|Overall Study||46
1421996|NCT02570165|3480911|P2|STARTED|Overall Study||46
1421997|NCT02570165|3480912|P1|STARTED|Overall Study||46
1421998|NCT02570139|3480937|P2|NOT COMPLETED|Overall Study||0
1421999|NCT02570139|3480938|P1|NOT COMPLETED|Overall Study||0
1422000|NCT02570139|3480937|P2|COMPLETED|Overall Study||21
1422001|NCT02570139|3480938|P1|COMPLETED|Overall Study||24
1422002|NCT02570139|3480937|P2|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
1422003|NCT02570139|3480938|P1|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
1422004|NCT02570126|3480952|P2|NOT COMPLETED|Overall Study||9
1422005|NCT02570126|3480953|P1|NOT COMPLETED|Overall Study||6
1422006|NCT02570126|3480952|P2|COMPLETED|Overall Study||607
1422007|NCT02570126|3480953|P1|COMPLETED|Overall Study||609
1422008|NCT02570126|3480952|P2|STARTED|Overall Study||616
1422009|NCT02570126|3480953|P1|STARTED|Overall Study||615
1422010|NCT02570022|3480979|P2|NOT COMPLETED|Overall Study||0
1422011|NCT02570022|3480980|P1|NOT COMPLETED|Overall Study||0
1422012|NCT02570022|3480979|P2|COMPLETED|Overall Study||31
1422013|NCT02570022|3480980|P1|COMPLETED|Overall Study||26
1422014|NCT02570022|3480979|P2|STARTED|Overall Study||31
1422015|NCT02570022|3480980|P1|STARTED|Overall Study||26
1422016|NCT02569996|3480988|P1|NOT COMPLETED|Overall Study||55
1422017|NCT02569996|3480988|P1|COMPLETED|Overall Study||69
1422018|NCT02569996|3480988|P1|STARTED|Overall Study||124
1422019|NCT02569957|3481000|P2|NOT COMPLETED|Overall Study||1
1422020|NCT02569957|3481001|P1|NOT COMPLETED|Overall Study||0
1422021|NCT02569957|3481000|P2|COMPLETED|Overall Study||0
1422022|NCT02569957|3481001|P1|COMPLETED|Overall Study||0
1422023|NCT02569957|3481000|P2|STARTED|Overall Study||1
1422024|NCT02569957|3481001|P1|STARTED|Overall Study||0
1422025|NCT02569853|3481033|P2|NOT COMPLETED|Overall Study||14
1422026|NCT02569853|3481034|P1|NOT COMPLETED|Overall Study||20
1422027|NCT02569853|3481033|P2|COMPLETED|Overall Study||123
1422028|NCT02569853|3481034|P1|COMPLETED|Overall Study||111
1422029|NCT02569853|3481033|P2|STARTED|Overall Study||137
1422030|NCT02569853|3481034|P1|STARTED|Overall Study||131
1422031|NCT02569658|3481044|P2|NOT COMPLETED|Overall Study||1
1422032|NCT02569658|3481045|P1|NOT COMPLETED|Overall Study||1
1422033|NCT02569658|3481044|P2|COMPLETED|Overall Study||56
1422034|NCT02569658|3481045|P1|COMPLETED|Overall Study||52
1422035|NCT02569658|3481044|P2|STARTED|Overall Study||57
1422036|NCT02569658|3481045|P1|STARTED|Overall Study||53
1422037|NCT02569437|3481063|P2|NOT COMPLETED|Overall Study||14
1422038|NCT02569437|3481064|P1|NOT COMPLETED|Overall Study||12
1422039|NCT02569437|3481063|P2|COMPLETED|Overall Study||11
1422040|NCT02569437|3481064|P1|COMPLETED|Overall Study||12
1422041|NCT02569437|3481063|P2|STARTED|Overall Study||25
1422042|NCT02569437|3481064|P1|STARTED|Overall Study||24
1422043|NCT02569112|3481078|P2|NOT COMPLETED|Overall Study||0
1422044|NCT02569112|3481079|P1|NOT COMPLETED|Overall Study||0
1422045|NCT02569112|3481078|P2|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
1422046|NCT02569112|3481079|P1|COMPLETED|Overall Study||10
1422047|NCT02569112|3481078|P2|STARTED|Overall Study||10
1422048|NCT02569112|3481079|P1|STARTED|Overall Study||10
1422049|NCT02569086|3481084|P1|NOT COMPLETED|Overall Study||0
1422050|NCT02569086|3481084|P1|COMPLETED|Overall Study||22
1422051|NCT02569086|3481084|P1|STARTED|Overall Study||22
1422052|NCT02568852|3481091|P2|NOT COMPLETED|Overall Study||0
1422053|NCT02568852|3481092|P1|NOT COMPLETED|Overall Study||0
1422054|NCT02568852|3481091|P2|COMPLETED|Overall Study||25
1422055|NCT02568852|3481092|P1|COMPLETED|Overall Study||25
1422056|NCT02568852|3481091|P2|STARTED|Overall Study||25
1422057|NCT02568852|3481092|P1|STARTED|Overall Study||25
1422058|NCT02568384|3481128|P1|NOT COMPLETED|Overall Study||2
1422059|NCT02568384|3481128|P1|COMPLETED|Overall Study||43
1422060|NCT02568384|3481128|P1|STARTED|Overall Study||45
1422061|NCT02568345|3481138|P1|NOT COMPLETED|Overall Study||0
1422062|NCT02568345|3481138|P1|COMPLETED|Overall Study||31
1422063|NCT02568345|3481138|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
1422064|NCT02568345|3481138|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
1422065|NCT02568345|3481138|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
1422066|NCT02568345|3481138|P1|STARTED|Overall Study||31
1422067|NCT02568254|3481142|P6|NOT COMPLETED|Period 3||0
1422068|NCT02568254|3481143|P5|NOT COMPLETED|Period 3||1
1422069|NCT02568254|3481144|P4|NOT COMPLETED|Period 3||0
1422070|NCT02568254|3481145|P3|NOT COMPLETED|Period 3||0
1422071|NCT02568254|3481146|P2|NOT COMPLETED|Period 3||0
1422072|NCT02568254|3481147|P1|NOT COMPLETED|Period 3||0
1422073|NCT02568254|3481142|P6|COMPLETED|Period 3||12
1422074|NCT02568254|3481143|P5|COMPLETED|Period 3||11
1422075|NCT02568254|3481144|P4|COMPLETED|Period 3||12
1422076|NCT02568254|3481145|P3|COMPLETED|Period 3||12
1422077|NCT02568254|3481146|P2|COMPLETED|Period 3||12
1422078|NCT02568254|3481147|P1|COMPLETED|Period 3||13
1422079|NCT02568254|3481142|P6|STARTED|Period 3||12
1422080|NCT02568254|3481143|P5|STARTED|Period 3||12
1422081|NCT02568254|3481144|P4|STARTED|Period 3||12
1422082|NCT02568254|3481145|P3|STARTED|Period 3||12
1422083|NCT02568254|3481146|P2|STARTED|Period 3||12
1422084|NCT02568254|3481147|P1|STARTED|Period 3||13
1422085|NCT02568254|3481142|P6|NOT COMPLETED|Period 2||0
1422086|NCT02568254|3481143|P5|NOT COMPLETED|Period 2||0
1422087|NCT02568254|3481144|P4|NOT COMPLETED|Period 2||0
1422088|NCT02568254|3481145|P3|NOT COMPLETED|Period 2||1
1422089|NCT02568254|3481146|P2|NOT COMPLETED|Period 2||0
1422090|NCT02568254|3481147|P1|NOT COMPLETED|Period 2||0
1422091|NCT02568254|3481142|P6|COMPLETED|Period 2||12
1422092|NCT02568254|3481143|P5|COMPLETED|Period 2||12
1422093|NCT02568254|3481144|P4|COMPLETED|Period 2||12
1422094|NCT02568254|3481145|P3|COMPLETED|Period 2||12
1422095|NCT02568254|3481146|P2|COMPLETED|Period 2||12
1422096|NCT02568254|3481147|P1|COMPLETED|Period 2||13
1422097|NCT02568254|3481142|P6|STARTED|Period 2||12
1422098|NCT02568254|3481143|P5|STARTED|Period 2||12
1422099|NCT02568254|3481144|P4|STARTED|Period 2||12
1422100|NCT02568254|3481145|P3|STARTED|Period 2||13
1422101|NCT02568254|3481146|P2|STARTED|Period 2||12
1422102|NCT02568254|3481147|P1|STARTED|Period 2||13
1422103|NCT02568254|3481142|P6|NOT COMPLETED|Period 1||0
1422104|NCT02568254|3481143|P5|NOT COMPLETED|Period 1||0
1422105|NCT02568254|3481144|P4|NOT COMPLETED|Period 1||0
1422106|NCT02568254|3481145|P3|NOT COMPLETED|Period 1||0
1422107|NCT02568254|3481146|P2|NOT COMPLETED|Period 1||0
1422108|NCT02568254|3481147|P1|NOT COMPLETED|Period 1||0
1422109|NCT02568254|3481142|P6|COMPLETED|Period 1||12
1422110|NCT02568254|3481143|P5|COMPLETED|Period 1||12
1422111|NCT02568254|3481144|P4|COMPLETED|Period 1||12
1422112|NCT02568254|3481145|P3|COMPLETED|Period 1||13
1422113|NCT02568254|3481146|P2|COMPLETED|Period 1||12
1422114|NCT02568254|3481147|P1|COMPLETED|Period 1||13
1422115|NCT02568254|3481142|P6|STARTED|Period 1||12
1422116|NCT02568254|3481143|P5|STARTED|Period 1||12
1422117|NCT02568254|3481144|P4|STARTED|Period 1||12
1422118|NCT02568254|3481145|P3|STARTED|Period 1||13
1422119|NCT02568254|3481146|P2|STARTED|Period 1||12
1422120|NCT02568254|3481147|P1|STARTED|Period 1||13
1422121|NCT02567968|3481155|P2|NOT COMPLETED|Second Intervention||0
1422122|NCT02567968|3481156|P1|NOT COMPLETED|Second Intervention||0
1422123|NCT02567968|3481155|P2|COMPLETED|Second Intervention||4
1422124|NCT02567968|3481156|P1|COMPLETED|Second Intervention||4
1422125|NCT02567968|3481155|P2|STARTED|Second Intervention||4
1422126|NCT02567968|3481156|P1|STARTED|Second Intervention||4
1422127|NCT02567968|3481155|P2|NOT COMPLETED|Washout (2 Weeks)||0
1422128|NCT02567968|3481156|P1|NOT COMPLETED|Washout (2 Weeks)||0
1422129|NCT02567968|3481155|P2|COMPLETED|Washout (2 Weeks)||4
1422130|NCT02567968|3481156|P1|COMPLETED|Washout (2 Weeks)||4
1422131|NCT02567968|3481155|P2|STARTED|Washout (2 Weeks)||4
1422132|NCT02567968|3481156|P1|STARTED|Washout (2 Weeks)||4
1422133|NCT02567968|3481155|P2|NOT COMPLETED|First Intervention||0
1422134|NCT02567968|3481156|P1|NOT COMPLETED|First Intervention||0
1422135|NCT02567968|3481155|P2|COMPLETED|First Intervention||4
1422136|NCT02567968|3481156|P1|COMPLETED|First Intervention||4
1422137|NCT02567968|3481155|P2|STARTED|First Intervention||4
1422138|NCT02567968|3481156|P1|STARTED|First Intervention||4
1422139|NCT02567708|3481178|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
1422140|NCT02567708|3481179|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
1422141|NCT02567708|3481178|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
1422142|NCT02567708|3481179|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
1422143|NCT02567708|3481178|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
1422144|NCT02567708|3481179|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
1422145|NCT02567708|3481178|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
1422146|NCT02567708|3481179|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
1422147|NCT02567708|3481178|P2|COMPLETED|Washout Period (Up to 4 Weeks)||23
1422148|NCT02567708|3481179|P1|COMPLETED|Washout Period (Up to 4 Weeks)||22
1422149|NCT02567708|3481178|P2|STARTED|Washout Period (Up to 4 Weeks)||23
1422150|NCT02567708|3481179|P1|STARTED|Washout Period (Up to 4 Weeks)||22
1422151|NCT02567708|3481178|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
1422152|NCT02567708|3481179|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
1422153|NCT02567708|3481178|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
1422154|NCT02567708|3481179|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
1422155|NCT02567708|3481178|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
1422156|NCT02567708|3481179|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
1422157|NCT02567552|3481220|P2|NOT COMPLETED|Overall Study||1
1422158|NCT02567552|3481221|P1|NOT COMPLETED|Overall Study||0
1422159|NCT02567552|3481220|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
1422160|NCT02567552|3481221|P1|COMPLETED|Overall Study||12
1422161|NCT02567552|3481220|P2|STARTED|Overall Study||12
1422162|NCT02567552|3481221|P1|STARTED|Overall Study||12
1422163|NCT02567188|3481251|P1|NOT COMPLETED|Overall Study||35
1422164|NCT02567188|3481251|P1|COMPLETED|Overall Study||109
1422165|NCT02567188|3481251|P1|STARTED|Overall Study||144
1422166|NCT02566785|3481282|P2|NOT COMPLETED|Overall Study||3
1422167|NCT02566785|3481283|P1|NOT COMPLETED|Overall Study||1
1422168|NCT02566785|3481282|P2|COMPLETED|Overall Study||15
1422169|NCT02566785|3481283|P1|COMPLETED|Overall Study||14
1422170|NCT02566785|3481282|P2|STARTED|Overall Study||18
1422171|NCT02566785|3481283|P1|STARTED|Overall Study||15
1422172|NCT02566759|3481310|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422173|NCT02566759|3481311|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422174|NCT02566759|3481312|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422175|NCT02566759|3481313|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422176|NCT02566759|3481314|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422177|NCT02566759|3481315|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422178|NCT02566759|3481316|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422179|NCT02566759|3481317|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422180|NCT02566759|3481318|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422181|NCT02566759|3481319|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422182|NCT02566759|3481320|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422183|NCT02566759|3481321|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422184|NCT02566759|3481322|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422185|NCT02566759|3481323|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422186|NCT02566759|3481324|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422187|NCT02566759|3481325|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422188|NCT02566759|3481326|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422189|NCT02566759|3481310|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
1422190|NCT02566759|3481311|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
1422191|NCT02566759|3481312|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
1422192|NCT02566759|3481313|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422193|NCT02566759|3481314|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422194|NCT02566759|3481315|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422195|NCT02566759|3481316|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422196|NCT02566759|3481317|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422197|NCT02566759|3481318|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422198|NCT02566759|3481319|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422199|NCT02566759|3481320|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422200|NCT02566759|3481321|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422201|NCT02566759|3481322|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422202|NCT02566759|3481323|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422203|NCT02566759|3481324|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422204|NCT02566759|3481325|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422205|NCT02566759|3481326|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422206|NCT02566759|3481310|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
1422207|NCT02566759|3481311|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1422208|NCT02566759|3481312|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1422209|NCT02566759|3481313|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422210|NCT02566759|3481314|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422211|NCT02566759|3481315|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422212|NCT02566759|3481316|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422213|NCT02566759|3481317|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422214|NCT02566759|3481318|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422215|NCT02566759|3481319|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422216|NCT02566759|3481320|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422217|NCT02566759|3481321|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422218|NCT02566759|3481322|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422219|NCT02566759|3481323|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422220|NCT02566759|3481324|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422221|NCT02566759|3481325|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422222|NCT02566759|3481326|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422223|NCT02566759|3481310|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422224|NCT02566759|3481311|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422225|NCT02566759|3481312|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422226|NCT02566759|3481313|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422227|NCT02566759|3481314|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422228|NCT02566759|3481315|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422229|NCT02566759|3481316|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422230|NCT02566759|3481317|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422231|NCT02566759|3481318|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422232|NCT02566759|3481319|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422233|NCT02566759|3481320|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422234|NCT02566759|3481321|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422235|NCT02566759|3481322|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422236|NCT02566759|3481323|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422237|NCT02566759|3481324|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422238|NCT02566759|3481325|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422239|NCT02566759|3481326|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422240|NCT02566759|3481310|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
1422241|NCT02566759|3481311|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1422242|NCT02566759|3481312|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1422243|NCT02566759|3481313|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422244|NCT02566759|3481314|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422245|NCT02566759|3481315|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422246|NCT02566759|3481316|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422247|NCT02566759|3481317|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422248|NCT02566759|3481318|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422249|NCT02566759|3481319|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422250|NCT02566759|3481320|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422251|NCT02566759|3481321|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422252|NCT02566759|3481322|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422253|NCT02566759|3481323|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422254|NCT02566759|3481324|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422255|NCT02566759|3481325|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422256|NCT02566759|3481326|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422257|NCT02566759|3481310|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
1422258|NCT02566759|3481311|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1422259|NCT02566759|3481312|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1422260|NCT02566759|3481313|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422261|NCT02566759|3481314|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422262|NCT02566759|3481315|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422263|NCT02566759|3481316|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422264|NCT02566759|3481317|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422265|NCT02566759|3481318|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422266|NCT02566759|3481319|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422267|NCT02566759|3481320|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422268|NCT02566759|3481321|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422269|NCT02566759|3481322|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422270|NCT02566759|3481323|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422271|NCT02566759|3481324|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422272|NCT02566759|3481325|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422273|NCT02566759|3481326|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422274|NCT02566759|3481310|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
1422275|NCT02566759|3481311|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422276|NCT02566759|3481312|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422277|NCT02566759|3481313|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422278|NCT02566759|3481314|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422279|NCT02566759|3481315|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422280|NCT02566759|3481316|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422281|NCT02566759|3481317|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422282|NCT02566759|3481318|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422283|NCT02566759|3481319|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422284|NCT02566759|3481320|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422285|NCT02566759|3481321|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422286|NCT02566759|3481322|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422287|NCT02566759|3481323|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422288|NCT02566759|3481324|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422289|NCT02566759|3481325|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422290|NCT02566759|3481326|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422291|NCT02566759|3481310|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
1422292|NCT02566759|3481311|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
1422293|NCT02566759|3481312|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
1422294|NCT02566759|3481313|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422295|NCT02566759|3481314|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422296|NCT02566759|3481315|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422297|NCT02566759|3481316|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422298|NCT02566759|3481317|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422299|NCT02566759|3481318|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422300|NCT02566759|3481319|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422301|NCT02566759|3481320|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422302|NCT02566759|3481321|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422303|NCT02566759|3481322|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422304|NCT02566759|3481323|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422305|NCT02566759|3481324|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422306|NCT02566759|3481325|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422307|NCT02566759|3481326|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
1422308|NCT02566759|3481310|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1422309|NCT02566759|3481311|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1422310|NCT02566759|3481312|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
1422311|NCT02566759|3481313|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422312|NCT02566759|3481314|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422313|NCT02566759|3481315|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422314|NCT02566759|3481316|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422315|NCT02566759|3481317|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422316|NCT02566759|3481318|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422317|NCT02566759|3481319|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422318|NCT02566759|3481320|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422319|NCT02566759|3481321|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422320|NCT02566759|3481322|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422321|NCT02566759|3481323|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422322|NCT02566759|3481324|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422323|NCT02566759|3481325|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422324|NCT02566759|3481326|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
1422325|NCT02566759|3481310|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422326|NCT02566759|3481311|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422327|NCT02566759|3481312|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422328|NCT02566759|3481313|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422329|NCT02566759|3481314|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422330|NCT02566759|3481315|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422331|NCT02566759|3481316|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422332|NCT02566759|3481317|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422333|NCT02566759|3481318|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422334|NCT02566759|3481319|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422335|NCT02566759|3481320|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422336|NCT02566759|3481321|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422337|NCT02566759|3481322|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422338|NCT02566759|3481323|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422339|NCT02566759|3481324|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422340|NCT02566759|3481325|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422341|NCT02566759|3481326|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422342|NCT02566759|3481310|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1422343|NCT02566759|3481311|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1422344|NCT02566759|3481312|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
1422345|NCT02566759|3481313|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422346|NCT02566759|3481314|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422347|NCT02566759|3481315|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422348|NCT02566759|3481316|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422349|NCT02566759|3481317|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422350|NCT02566759|3481318|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422351|NCT02566759|3481319|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422352|NCT02566759|3481320|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422353|NCT02566759|3481321|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422354|NCT02566759|3481322|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422355|NCT02566759|3481323|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422356|NCT02566759|3481324|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422357|NCT02566759|3481325|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422358|NCT02566759|3481326|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
1422359|NCT02566759|3481310|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1422360|NCT02566759|3481311|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1422361|NCT02566759|3481312|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
1422362|NCT02566759|3481313|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422363|NCT02566759|3481314|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422364|NCT02566759|3481315|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422365|NCT02566759|3481316|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422366|NCT02566759|3481317|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422367|NCT02566759|3481318|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422368|NCT02566759|3481319|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422369|NCT02566759|3481320|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422370|NCT02566759|3481321|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422371|NCT02566759|3481322|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422372|NCT02566759|3481323|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422373|NCT02566759|3481324|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422374|NCT02566759|3481325|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422375|NCT02566759|3481326|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
1422376|NCT02566759|3481310|P17|NOT COMPLETED|All Parts||0
1422377|NCT02566759|3481311|P16|NOT COMPLETED|All Parts||0
1422378|NCT02566759|3481312|P15|NOT COMPLETED|All Parts||0
1422379|NCT02566759|3481313|P14|NOT COMPLETED|All Parts||5
1422380|NCT02566759|3481314|P13|NOT COMPLETED|All Parts||1
1422381|NCT02566759|3481315|P12|NOT COMPLETED|All Parts||0
1422382|NCT02566759|3481316|P11|NOT COMPLETED|All Parts||0
1422383|NCT02566759|3481317|P10|NOT COMPLETED|All Parts||0
1422384|NCT02566759|3481318|P9|NOT COMPLETED|All Parts||0
1422385|NCT02566759|3481319|P8|NOT COMPLETED|All Parts||0
1422386|NCT02566759|3481320|P7|NOT COMPLETED|All Parts||0
1422387|NCT02566759|3481321|P6|NOT COMPLETED|All Parts||0
1422388|NCT02566759|3481322|P5|NOT COMPLETED|All Parts||0
1422389|NCT02566759|3481323|P4|NOT COMPLETED|All Parts||0
1422390|NCT02566759|3481324|P3|NOT COMPLETED|All Parts||0
1422391|NCT02566759|3481325|P2|NOT COMPLETED|All Parts||1
1422392|NCT02566759|3481326|P1|NOT COMPLETED|All Parts||0
1422393|NCT02566759|3481310|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
1422394|NCT02566759|3481311|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
1422395|NCT02566759|3481312|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
1422396|NCT02566759|3481313|P14|COMPLETED|All Parts||0
1422397|NCT02566759|3481314|P13|COMPLETED|All Parts||0
1422398|NCT02566759|3481315|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1422399|NCT02566759|3481316|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1422400|NCT02566759|3481317|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1422401|NCT02566759|3481318|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1422402|NCT02566759|3481319|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
1422403|NCT02566759|3481320|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1422404|NCT02566759|3481321|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1422405|NCT02566759|3481322|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1422406|NCT02566759|3481323|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1422407|NCT02566759|3481324|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
1422408|NCT02566759|3481325|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
1422409|NCT02566759|3481326|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
1422410|NCT02566759|3481310|P17|STARTED|All Parts||8
1422411|NCT02566759|3481311|P16|STARTED|All Parts||8
1422412|NCT02566759|3481312|P15|STARTED|All Parts||8
1422413|NCT02566759|3481313|P14|STARTED|All Parts||5
1422414|NCT02566759|3481314|P13|STARTED|All Parts||1
1422415|NCT02566759|3481315|P12|STARTED|All Parts||6
1422416|NCT02566759|3481316|P11|STARTED|All Parts||6
1422417|NCT02566759|3481317|P10|STARTED|All Parts||6
1422418|NCT02566759|3481318|P9|STARTED|All Parts||6
1422419|NCT02566759|3481319|P8|STARTED|All Parts||8
1422420|NCT02566759|3481320|P7|STARTED|All Parts||6
1422421|NCT02566759|3481321|P6|STARTED|All Parts||6
1422422|NCT02566759|3481322|P5|STARTED|All Parts||6
1422423|NCT02566759|3481323|P4|STARTED|All Parts||6
1422424|NCT02566759|3481324|P3|STARTED|All Parts||6
1422425|NCT02566759|3481325|P2|STARTED|All Parts||6
1422426|NCT02566759|3481326|P1|STARTED|All Parts||12
1422427|NCT02566135|3481479|P2|NOT COMPLETED|Overall Study||0
1422428|NCT02566135|3481480|P1|NOT COMPLETED|Overall Study||0
1422429|NCT02566135|3481479|P2|COMPLETED|Overall Study||29
1422430|NCT02566135|3481480|P1|COMPLETED|Overall Study||29
1422431|NCT02566135|3481479|P2|STARTED|Overall Study||29
1422432|NCT02566135|3481480|P1|STARTED|Overall Study||29
1422433|NCT02566005|3481502|P2|NOT COMPLETED|Overall Study||6
1422434|NCT02566005|3481503|P1|NOT COMPLETED|Overall Study||8
1422435|NCT02566005|3481502|P2|COMPLETED|Overall Study||94
1422436|NCT02566005|3481503|P1|COMPLETED|Overall Study||92
1422437|NCT02566005|3481502|P2|STARTED|Overall Study||100
1422438|NCT02566005|3481503|P1|STARTED|Overall Study||100
1422439|NCT02565628|3481533|P2|NOT COMPLETED|Overall Study||0
1422440|NCT02565628|3481534|P1|NOT COMPLETED|Overall Study||0
1422441|NCT02565628|3481533|P2|COMPLETED|Overall Study||9
1422442|NCT02565628|3481534|P1|COMPLETED|Overall Study||10
1422443|NCT02565628|3481533|P2|Received Treatment|Overall Study||9
1422444|NCT02565628|3481534|P1|Received Treatment|Overall Study||10
1422445|NCT02565628|3481533|P2|STARTED|Overall Study||9
1422446|NCT02565628|3481534|P1|STARTED|Overall Study||10
1422447|NCT02565485|3481564|P2|NOT COMPLETED|Overall Study||0
1422448|NCT02565485|3481565|P1|NOT COMPLETED|Overall Study||0
1422449|NCT02565485|3481564|P2|COMPLETED|Overall Study||137
1422450|NCT02565485|3481565|P1|COMPLETED|Overall Study||139
1422451|NCT02565485|3481564|P2|STARTED|Overall Study||137
1422452|NCT02565485|3481565|P1|STARTED|Overall Study||139
1422453|NCT02565381|3481580|P3|NOT COMPLETED|Overall Study||1
1422454|NCT02565381|3481581|P2|NOT COMPLETED|Overall Study||0
1422455|NCT02565381|3481582|P1|NOT COMPLETED|Overall Study||1
1422456|NCT02565381|3481580|P3|COMPLETED|Overall Study||24
1422457|NCT02565381|3481581|P2|COMPLETED|Overall Study||25
1422458|NCT02565381|3481582|P1|COMPLETED|Overall Study||24
1422459|NCT02565381|3481580|P3|STARTED|Overall Study||25
1422460|NCT02565381|3481581|P2|STARTED|Overall Study||25
1422461|NCT02565381|3481582|P1|STARTED|Overall Study||25
1422462|NCT02565147|3481622|P2|NOT COMPLETED|Overall Study||3
1422463|NCT02565147|3481623|P1|NOT COMPLETED|Overall Study||6
1422464|NCT02565147|3481622|P2|COMPLETED|Overall Study||37
1422465|NCT02565147|3481623|P1|COMPLETED|Overall Study||32
1422466|NCT02565147|3481622|P2|Per-Protocol Population|Overall Study||36
1422467|NCT02565147|3481623|P1|Per-Protocol Population|Overall Study||28
1422468|NCT02565147|3481622|P2|Received Study Drug|Overall Study||40
1422469|NCT02565147|3481623|P1|Received Study Drug|Overall Study||38
1422470|NCT02565147|3481622|P2|STARTED|Overall Study||40
1422471|NCT02565147|3481623|P1|STARTED|Overall Study||38
1422472|NCT02565108|3481647|P2|NOT COMPLETED|Overall Study||0
1422473|NCT02565108|3481648|P1|NOT COMPLETED|Overall Study||2
1422474|NCT02565108|3481647|P2|COMPLETED|Overall Study||4
1422475|NCT02565108|3481648|P1|COMPLETED|Overall Study||14
1422476|NCT02565108|3481647|P2|Pharmacokinetic (PK) Set|Overall Study||3
1422477|NCT02565108|3481648|P1|Pharmacokinetic (PK) Set|Overall Study||10
1422478|NCT02565108|3481647|P2|Safety Set|Overall Study||4
1422479|NCT02565108|3481648|P1|Safety Set|Overall Study||16
1422480|NCT02565108|3481647|P2|STARTED|Overall Study||4
1422481|NCT02565108|3481648|P1|STARTED|Overall Study||16
1422482|NCT02564952|3481664|P1|NOT COMPLETED|Overall Study||11
1422483|NCT02564952|3481664|P1|COMPLETED|Overall Study||7
1422484|NCT02564952|3481664|P1|Completed OLE Titration Period|Overall Study||16
1422485|NCT02564952|3481664|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
1422486|NCT02564952|3481664|P1|STARTED|Overall Study||18
1422487|NCT02564718|3481670|P2|NOT COMPLETED|Overall Study||1
1422488|NCT02564718|3481671|P1|NOT COMPLETED|Overall Study||0
1422489|NCT02564718|3481670|P2|COMPLETED|Overall Study||4
1422490|NCT02564718|3481671|P1|COMPLETED|Overall Study||5
1422491|NCT02564718|3481670|P2|STARTED|Overall Study||5
1422492|NCT02564718|3481671|P1|STARTED|Overall Study||5
1422493|NCT02564211|3481699|P1|NOT COMPLETED|Overall Study||4
1422494|NCT02564211|3481699|P1|COMPLETED|Overall Study||73
1422495|NCT02564211|3481699|P1|STARTED|Overall Study||77
1422496|NCT02564055|3481711|P6|NOT COMPLETED|Overall Study||12
1422497|NCT02564055|3481712|P5|NOT COMPLETED|Overall Study||15
1422498|NCT02564055|3481713|P4|NOT COMPLETED|Overall Study||6
1422499|NCT02564055|3481714|P3|NOT COMPLETED|Overall Study||12
1422500|NCT02564055|3481715|P2|NOT COMPLETED|Overall Study||5
1422501|NCT02564055|3481716|P1|NOT COMPLETED|Overall Study||6
1422502|NCT02564055|3481711|P6|COMPLETED|Overall Study||28
1422503|NCT02564055|3481712|P5|COMPLETED|Overall Study||27
1422504|NCT02564055|3481713|P4|COMPLETED|Overall Study||35
1422505|NCT02564055|3481714|P3|COMPLETED|Overall Study||31
1422506|NCT02564055|3481715|P2|COMPLETED|Overall Study||36
1422507|NCT02564055|3481716|P1|COMPLETED|Overall Study||34
1422508|NCT02564055|3481711|P6|STARTED|Overall Study||40
1422509|NCT02564055|3481712|P5|STARTED|Overall Study||42
1422510|NCT02564055|3481713|P4|STARTED|Overall Study||41
1422511|NCT02564055|3481714|P3|STARTED|Overall Study||43
1422512|NCT02564055|3481715|P2|STARTED|Overall Study||41
1422513|NCT02564055|3481716|P1|STARTED|Overall Study||40
1422514|NCT02564042|3481970|P6|NOT COMPLETED|Overall Study||14
1422515|NCT02564042|3481971|P5|NOT COMPLETED|Overall Study||11
1422516|NCT02564042|3481972|P4|NOT COMPLETED|Overall Study||3
1422517|NCT02564042|3481973|P3|NOT COMPLETED|Overall Study||6
1422518|NCT02564042|3481974|P2|NOT COMPLETED|Overall Study||8
1422519|NCT02564042|3481975|P1|NOT COMPLETED|Overall Study||11
1422520|NCT02564042|3481970|P6|COMPLETED|Overall Study||24
1422521|NCT02564042|3481971|P5|COMPLETED|Overall Study||26
1422522|NCT02564042|3481972|P4|COMPLETED|Overall Study||35
1422523|NCT02564042|3481973|P3|COMPLETED|Overall Study||32
1422524|NCT02564042|3481974|P2|COMPLETED|Overall Study||30
1422525|NCT02564042|3481975|P1|COMPLETED|Overall Study||27
1422526|NCT02564042|3481970|P6|STARTED|Overall Study||38
1422527|NCT02564042|3481971|P5|STARTED|Overall Study||37
1422528|NCT02564042|3481972|P4|STARTED|Overall Study||38
1422529|NCT02564042|3481973|P3|STARTED|Overall Study||38
1422530|NCT02564042|3481974|P2|STARTED|Overall Study||38
1422531|NCT02564042|3481975|P1|STARTED|Overall Study||38
1422532|NCT02564029|3482187|P1|NOT COMPLETED|Overall Study||0
1422533|NCT02564029|3482187|P1|COMPLETED|Overall Study||7
1422534|NCT02564029|3482187|P1|STARTED|Overall Study||7
1422535|NCT02564016|3482230|P2|NOT COMPLETED|Overall Study||10
1422536|NCT02564016|3482231|P1|NOT COMPLETED|Overall Study||18
1422537|NCT02564016|3482230|P2|COMPLETED|Overall Study||4
1422538|NCT02564016|3482231|P1|COMPLETED|Overall Study||4
1422539|NCT02564016|3482230|P2|STARTED|Overall Study||14
1422540|NCT02564016|3482231|P1|STARTED|Overall Study||22
1422541|NCT02563899|3482245|P4|NOT COMPLETED|Overall Study||0
1422542|NCT02563899|3482246|P3|NOT COMPLETED|Overall Study||1
1422543|NCT02563899|3482247|P2|NOT COMPLETED|Overall Study||0
1422544|NCT02563899|3482248|P1|NOT COMPLETED|Overall Study||1
1422545|NCT02563899|3482245|P4|COMPLETED|Overall Study||6
1422546|NCT02563899|3482246|P3|COMPLETED|Overall Study||9
1422547|NCT02563899|3482247|P2|COMPLETED|Overall Study||5
1422548|NCT02563899|3482248|P1|COMPLETED|Overall Study||17
1422549|NCT02563899|3482245|P4|STARTED|Overall Study||6
1422550|NCT02563899|3482246|P3|STARTED|Overall Study||10
1422551|NCT02563899|3482247|P2|STARTED|Overall Study||5
1422552|NCT02563899|3482248|P1|STARTED|Overall Study||18
1422553|NCT02563834|3482291|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
1422554|NCT02563834|3482292|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
1422555|NCT02563834|3482291|P2|COMPLETED|Insulin Infusion (*Day 2)||8
1422556|NCT02563834|3482292|P1|COMPLETED|Insulin Infusion (*Day 2)||10
1422557|NCT02563834|3482291|P2|STARTED|Insulin Infusion (*Day 2)||8
1422558|NCT02563834|3482292|P1|STARTED|Insulin Infusion (*Day 2)||10
1422559|NCT02563834|3482291|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
1422560|NCT02563834|3482292|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
1422561|NCT02563834|3482291|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
1422562|NCT02563834|3482292|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
1422563|NCT02563834|3482291|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
1422564|NCT02563834|3482292|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
1422565|NCT02563106|3482310|P2|NOT COMPLETED|Overall Study||29
1422566|NCT02563106|3482311|P1|NOT COMPLETED|Overall Study||34
1422567|NCT02563106|3482310|P2|COMPLETED|Overall Study||178
1422568|NCT02563106|3482311|P1|COMPLETED|Overall Study||172
1422569|NCT02563106|3482310|P2|STARTED|Overall Study||207
1422570|NCT02563106|3482311|P1|STARTED|Overall Study||206
1422571|NCT02563093|3482321|P4|NOT COMPLETED|Overall Study||0
1422572|NCT02563093|3482322|P3|NOT COMPLETED|Overall Study||0
1422573|NCT02563093|3482323|P2|NOT COMPLETED|Overall Study||0
1422574|NCT02563093|3482324|P1|NOT COMPLETED|Overall Study||0
1422575|NCT02563093|3482321|P4|COMPLETED|Overall Study||51
1422576|NCT02563093|3482322|P3|COMPLETED|Overall Study||53
1422577|NCT02563093|3482323|P2|COMPLETED|Overall Study||52
1422578|NCT02563093|3482324|P1|COMPLETED|Overall Study||52
1422579|NCT02563093|3482321|P4|STARTED|Overall Study||51
1422580|NCT02563093|3482322|P3|STARTED|Overall Study||53
1422581|NCT02563093|3482323|P2|STARTED|Overall Study||52
1422582|NCT02563093|3482324|P1|STARTED|Overall Study||52
1422583|NCT02562989|3482353|P3|NOT COMPLETED|Overall Study||0
1422584|NCT02562989|3482354|P2|NOT COMPLETED|Overall Study||0
1422585|NCT02562989|3482355|P1|NOT COMPLETED|Overall Study||0
1422586|NCT02562989|3482353|P3|COMPLETED|Overall Study||6
1422587|NCT02562989|3482354|P2|COMPLETED|Overall Study||4
1422588|NCT02562989|3482355|P1|COMPLETED|Overall Study||3
1422589|NCT02562989|3482353|P3|STARTED|Overall Study||6
1422590|NCT02562989|3482354|P2|STARTED|Overall Study||4
1422591|NCT02562989|3482355|P1|STARTED|Overall Study||3
1422592|NCT02562521|3482380|P2|NOT COMPLETED|Overall Study||0
1422593|NCT02562521|3482381|P1|NOT COMPLETED|Overall Study||0
1422594|NCT02562521|3482380|P2|COMPLETED|Overall Study||7
1422595|NCT02562521|3482381|P1|COMPLETED|Overall Study||18
1422596|NCT02562521|3482380|P2|STARTED|Overall Study||7
1422597|NCT02562521|3482381|P1|STARTED|Overall Study||18
1422598|NCT02561806|3482397|P2|NOT COMPLETED|Post-Treatment Follow-up||1
1422599|NCT02561806|3482398|P1|NOT COMPLETED|Post-Treatment Follow-up||2
1422600|NCT02561806|3482397|P2|COMPLETED|Post-Treatment Follow-up||59
1422601|NCT02561806|3482398|P1|COMPLETED|Post-Treatment Follow-up||155
1422602|NCT02561806|3482397|P2|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
1422603|NCT02561806|3482398|P1|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
1422604|NCT02561806|3482397|P2|NOT COMPLETED|Maintenance Period||8
1422605|NCT02561806|3482398|P1|NOT COMPLETED|Maintenance Period||13
1422606|NCT02561806|3482397|P2|COMPLETED|Maintenance Period||123
1422607|NCT02561806|3482398|P1|COMPLETED|Maintenance Period||151
1422608|NCT02561806|3482397|P2|STARTED|Maintenance Period||131
1422609|NCT02561806|3482398|P1|STARTED|Maintenance Period||164
1422610|NCT02561806|3482397|P2|NOT COMPLETED|Induction Period||5
1422611|NCT02561806|3482398|P1|NOT COMPLETED|Induction Period||2
1422612|NCT02561806|3482397|P2|COMPLETED|Induction Period||131
1422613|NCT02561806|3482398|P1|COMPLETED|Induction Period||164
1422614|NCT02561806|3482397|P2|Received At Least One Dose of Study Drug|Induction Period||135
1422615|NCT02561806|3482398|P1|Received At Least One Dose of Study Drug|Induction Period||166
1422616|NCT02561806|3482397|P2|STARTED|Induction Period||136
1422617|NCT02561806|3482398|P1|STARTED|Induction Period||166
1422618|NCT02561702|3482454|P2|NOT COMPLETED|Second Intervention||0
1422619|NCT02561702|3482455|P1|NOT COMPLETED|Second Intervention||0
1422620|NCT02561702|3482454|P2|COMPLETED|Second Intervention||2
1422621|NCT02561702|3482455|P1|COMPLETED|Second Intervention||2
1422622|NCT02561702|3482454|P2|STARTED|Second Intervention||2
1422623|NCT02561702|3482455|P1|STARTED|Second Intervention||2
1422624|NCT02561702|3482454|P2|NOT COMPLETED|Washout||0
1422625|NCT02561702|3482455|P1|NOT COMPLETED|Washout||0
1422626|NCT02561702|3482454|P2|COMPLETED|Washout||2
1422627|NCT02561702|3482455|P1|COMPLETED|Washout||2
1422628|NCT02561702|3482454|P2|STARTED|Washout||2
1422629|NCT02561702|3482455|P1|STARTED|Washout||2
1422630|NCT02561702|3482454|P2|NOT COMPLETED|First Intervention||0
1422631|NCT02561702|3482455|P1|NOT COMPLETED|First Intervention||0
1422632|NCT02561702|3482454|P2|COMPLETED|First Intervention||2
1422633|NCT02561702|3482455|P1|COMPLETED|First Intervention||2
1422634|NCT02561702|3482454|P2|STARTED|First Intervention||2
1422635|NCT02561702|3482455|P1|STARTED|First Intervention||2
1422636|NCT02561572|3482465|P2|NOT COMPLETED|Overall Study||2
1422637|NCT02561572|3482466|P1|NOT COMPLETED|Overall Study||2
1422638|NCT02561572|3482465|P2|COMPLETED|Overall Study||62
1422639|NCT02561572|3482466|P1|COMPLETED|Overall Study||62
1422640|NCT02561572|3482465|P2|STARTED|Overall Study||64
1422641|NCT02561572|3482466|P1|STARTED|Overall Study||64
1422642|NCT02561195|3482488|P6|NOT COMPLETED|Overall Study||10
1422643|NCT02561195|3482489|P5|NOT COMPLETED|Overall Study||28
1422644|NCT02561195|3482490|P4|NOT COMPLETED|Overall Study||26
1422645|NCT02561195|3482491|P3|NOT COMPLETED|Overall Study||6
1422646|NCT02561195|3482492|P2|NOT COMPLETED|Overall Study||22
1422647|NCT02561195|3482493|P1|NOT COMPLETED|Overall Study||23
1422648|NCT02561195|3482488|P6|COMPLETED|Overall Study||51
1422649|NCT02561195|3482489|P5|COMPLETED|Overall Study||155
1422650|NCT02561195|3482490|P4|COMPLETED|Overall Study||157
1422651|NCT02561195|3482491|P3|COMPLETED|Overall Study||55
1422652|NCT02561195|3482492|P2|COMPLETED|Overall Study||162
1422653|NCT02561195|3482493|P1|COMPLETED|Overall Study||160
1422654|NCT02561195|3482488|P6|Treated|Overall Study||61
1422655|NCT02561195|3482489|P5|Treated|Overall Study||183
1422656|NCT02561195|3482490|P4|Treated|Overall Study||183
1422657|NCT02561195|3482491|P3|Treated|Overall Study||61
1422658|NCT02561195|3482492|P2|Treated|Overall Study||184
1422659|NCT02561195|3482493|P1|Treated|Overall Study||182
1422660|NCT02561195|3482488|P6|STARTED|Overall Study||61
1422661|NCT02561195|3482489|P5|STARTED|Overall Study||183
1422662|NCT02561195|3482490|P4|STARTED|Overall Study||183
1422663|NCT02561195|3482491|P3|STARTED|Overall Study||61
1422664|NCT02561195|3482492|P2|STARTED|Overall Study||184
1422665|NCT02561195|3482493|P1|STARTED|Overall Study||183
1422666|NCT02560753|3482645|P4|NOT COMPLETED|Overall Study||0
1422667|NCT02560753|3482646|P3|NOT COMPLETED|Overall Study||1
1422668|NCT02560753|3482647|P2|NOT COMPLETED|Overall Study||0
1422669|NCT02560753|3482648|P1|NOT COMPLETED|Overall Study||1
1422670|NCT02560753|3482645|P4|COMPLETED|Overall Study||8
1422671|NCT02560753|3482646|P3|COMPLETED|Overall Study||9
1422672|NCT02560753|3482647|P2|COMPLETED|Overall Study||9
1422673|NCT02560753|3482648|P1|COMPLETED|Overall Study||8
1422674|NCT02560753|3482645|P4|STARTED|Overall Study||8
1422675|NCT02560753|3482646|P3|STARTED|Overall Study||10
1422676|NCT02560753|3482647|P2|STARTED|Overall Study||9
1422677|NCT02560753|3482648|P1|STARTED|Overall Study||9
1422678|NCT02560584|3482674|P1|NOT COMPLETED|Overall Study||0
1422679|NCT02560584|3482674|P1|COMPLETED|Overall Study||304
1422680|NCT02560584|3482674|P1|STARTED|Overall Study||304
1422681|NCT02560051|3482684|P3|NOT COMPLETED|Overall Study||1
1422682|NCT02560051|3482685|P2|NOT COMPLETED|Overall Study||4
1422683|NCT02560051|3482686|P1|NOT COMPLETED|Overall Study||3
1422684|NCT02560051|3482684|P3|COMPLETED|Overall Study||4
1422685|NCT02560051|3482685|P2|COMPLETED|Overall Study||4
1422686|NCT02560051|3482686|P1|COMPLETED|Overall Study||3
1422687|NCT02560051|3482684|P3|STARTED|Overall Study||5
1422688|NCT02560051|3482685|P2|STARTED|Overall Study||8
1422689|NCT02560051|3482686|P1|STARTED|Overall Study||6
1422690|NCT02560038|3482742|P1|NOT COMPLETED|Overall Study||2
1422691|NCT02560038|3482742|P1|COMPLETED|Overall Study||1
1422692|NCT02560038|3482742|P1|STARTED|Overall Study||3
1422693|NCT02560025|3482748|P1|NOT COMPLETED|Overall Study||3
1422694|NCT02560025|3482748|P1|COMPLETED|Overall Study||39
1422695|NCT02560025|3482748|P1|STARTED|Overall Study||42
1422696|NCT02560012|3482754|P1|NOT COMPLETED|Overall Study||2
1422697|NCT02560012|3482754|P1|COMPLETED|Overall Study||1
1422698|NCT02560012|3482754|P1|STARTED|Overall Study||3
1422699|NCT02559622|3482762|P4|NOT COMPLETED|Overall Study||3
1422700|NCT02559622|3482763|P3|NOT COMPLETED|Overall Study||2
1422701|NCT02559622|3482764|P2|NOT COMPLETED|Overall Study||5
1422702|NCT02559622|3482765|P1|NOT COMPLETED|Overall Study||1
1422703|NCT02559622|3482762|P4|COMPLETED|Overall Study||20
1422704|NCT02559622|3482763|P3|COMPLETED|Overall Study||24
1422705|NCT02559622|3482764|P2|COMPLETED|Overall Study||49
1422706|NCT02559622|3482765|P1|COMPLETED|Overall Study||47
1422707|NCT02559622|3482762|P4|STARTED|Overall Study||23
1422708|NCT02559622|3482763|P3|STARTED|Overall Study||26
1422709|NCT02559622|3482764|P2|STARTED|Overall Study||54
1422710|NCT02559622|3482765|P1|STARTED|Overall Study||48
1422711|NCT02559414|3482847|P3|NOT COMPLETED|Overall Study||2
1422712|NCT02559414|3482848|P2|NOT COMPLETED|Overall Study||2
1422713|NCT02559414|3482849|P1|NOT COMPLETED|Overall Study||1
1422714|NCT02559414|3482847|P3|COMPLETED|Overall Study||20
1422715|NCT02559414|3482848|P2|COMPLETED|Overall Study||20
1422716|NCT02559414|3482849|P1|COMPLETED|Overall Study||10
1422717|NCT02559414|3482847|P3|STARTED|Overall Study||22
1422718|NCT02559414|3482848|P2|STARTED|Overall Study||22
1422719|NCT02559414|3482849|P1|STARTED|Overall Study||11
1422720|NCT02558894|3482889|P2|NOT COMPLETED|Overall Study||33
1422721|NCT02558894|3482890|P1|NOT COMPLETED|Overall Study||32
1422722|NCT02558894|3482889|P2|COMPLETED|Overall Study||0
1422723|NCT02558894|3482890|P1|COMPLETED|Overall Study||0
1422724|NCT02558894|3482889|P2|Patients Who Received IP|Overall Study||32
1422725|NCT02558894|3482890|P1|Patients Who Received IP|Overall Study||32
1422726|NCT02558894|3482889|P2|STARTED|Overall Study||33
1422727|NCT02558894|3482890|P1|STARTED|Overall Study||32
1422728|NCT02558829|3482918|P8|NOT COMPLETED|Overall Study||3
1422729|NCT02558829|3482919|P7|NOT COMPLETED|Overall Study||1
1422730|NCT02558829|3482920|P6|NOT COMPLETED|Overall Study||2
1422731|NCT02558829|3482921|P5|NOT COMPLETED|Overall Study||2
1422732|NCT02558829|3482922|P4|NOT COMPLETED|Overall Study||2
1422733|NCT02558829|3482923|P3|NOT COMPLETED|Overall Study||3
1422734|NCT02558829|3482924|P2|NOT COMPLETED|Overall Study||3
1422735|NCT02558829|3482925|P1|NOT COMPLETED|Overall Study||1
1422736|NCT02558829|3482918|P8|COMPLETED|Overall Study||8
1422737|NCT02558829|3482919|P7|COMPLETED|Overall Study||17
1422738|NCT02558829|3482920|P6|COMPLETED|Overall Study||24
1422739|NCT02558829|3482921|P5|COMPLETED|Overall Study||16
1422740|NCT02558829|3482922|P4|COMPLETED|Overall Study||16
1422741|NCT02558829|3482923|P3|COMPLETED|Overall Study||21
1422742|NCT02558829|3482924|P2|COMPLETED|Overall Study||18
1422743|NCT02558829|3482925|P1|COMPLETED|Overall Study||20
1422744|NCT02558829|3482918|P8|STARTED|Overall Study||11
1422745|NCT02558829|3482919|P7|STARTED|Overall Study||18
1422746|NCT02558829|3482920|P6|STARTED|Overall Study||26
1422747|NCT02558829|3482921|P5|STARTED|Overall Study||18
1422748|NCT02558829|3482922|P4|STARTED|Overall Study||18
1422749|NCT02558829|3482923|P3|STARTED|Overall Study||24
1422750|NCT02558829|3482924|P2|STARTED|Overall Study||21
1422751|NCT02558829|3482925|P1|STARTED|Overall Study||21
1422752|NCT02558790|3482951|P1|NOT COMPLETED|Overall Study||7
1422753|NCT02558790|3482951|P1|COMPLETED|Overall Study||13
1422754|NCT02558790|3482951|P1|Treated|Overall Study||15
1422755|NCT02558790|3482951|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
1422756|NCT02558374|3482957|P2|NOT COMPLETED|Overall Study||43
1422757|NCT02558374|3482958|P1|NOT COMPLETED|Overall Study||108
1422758|NCT02558374|3482957|P2|COMPLETED|Overall Study||314
1422759|NCT02558374|3482958|P1|COMPLETED|Overall Study||243
1422760|NCT02558374|3482957|P2|STARTED|Overall Study||357
1422761|NCT02558374|3482958|P1|STARTED|Overall Study||351
1422762|NCT02557698|3482968|P2|NOT COMPLETED|Overall Study||0
1422763|NCT02557698|3482969|P1|NOT COMPLETED|Overall Study||0
1422764|NCT02557698|3482968|P2|COMPLETED|Overall Study||30
1422765|NCT02557698|3482969|P1|COMPLETED|Overall Study||30
1422766|NCT02557698|3482968|P2|STARTED|Overall Study||30
1422767|NCT02557698|3482969|P1|STARTED|Overall Study||30
1422768|NCT02557646|3483033|P1|NOT COMPLETED|Overall Study||276
1422769|NCT02557646|3483033|P1|COMPLETED|Overall Study||417
1422770|NCT02557646|3483033|P1|STARTED|Overall Study||693
1422771|NCT02557555|3483051|P1|NOT COMPLETED|Overall Study||0
1422772|NCT02557555|3483051|P1|COMPLETED|Overall Study||100
1422773|NCT02557555|3483051|P1|STARTED|Overall Study||100
1422774|NCT02557399|3483058|P2|NOT COMPLETED|Overall Study||8
1422775|NCT02557399|3483059|P1|NOT COMPLETED|Overall Study||7
1422776|NCT02557399|3483058|P2|COMPLETED|Overall Study||169
1422777|NCT02557399|3483059|P1|COMPLETED|Overall Study||165
1422778|NCT02557399|3483058|P2|STARTED|Overall Study||177
1422779|NCT02557399|3483059|P1|STARTED|Overall Study||172
1422780|NCT02557035|3483093|P2|NOT COMPLETED|Overall Study||9
1422781|NCT02557035|3483094|P1|NOT COMPLETED|Overall Study||7
1422782|NCT02557035|3483093|P2|COMPLETED|Overall Study||206
1422783|NCT02557035|3483094|P1|COMPLETED|Overall Study||218
1422784|NCT02557035|3483093|P2|STARTED|Overall Study||215
1422785|NCT02557035|3483094|P1|STARTED|Overall Study||225
1422786|NCT02556632|3483119|P3|NOT COMPLETED|Overall Study||9
1422787|NCT02556632|3483120|P2|NOT COMPLETED|Overall Study||6
1422788|NCT02556632|3483121|P1|NOT COMPLETED|Overall Study||5
1422789|NCT02556632|3483119|P3|COMPLETED|Overall Study||53
1422790|NCT02556632|3483120|P2|COMPLETED|Overall Study||59
1422791|NCT02556632|3483121|P1|COMPLETED|Overall Study||59
1422792|NCT02556632|3483119|P3|STARTED|Overall Study||62
1422793|NCT02556632|3483120|P2|STARTED|Overall Study||65
1422794|NCT02556632|3483121|P1|STARTED|Overall Study||64
1422795|NCT02556333|3483135|P1|NOT COMPLETED|Overall Study||0
1422796|NCT02556333|3483135|P1|COMPLETED|Overall Study||1
1422797|NCT02556333|3483135|P1|STARTED|Overall Study||1
1422798|NCT02556307|3483139|P1|NOT COMPLETED|Overall Study||53
1422799|NCT02556307|3483139|P1|COMPLETED|Overall Study||217
1422800|NCT02556307|3483139|P1|Treated|Overall Study||268
1422801|NCT02556307|3483139|P1|STARTED|Overall Study||270
1422802|NCT02556138|3483149|P1|NOT COMPLETED|Overall Study||1
1422803|NCT02556138|3483149|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
1422804|NCT02556138|3483149|P1|STARTED|Overall Study||8
1422805|NCT02555722|3483157|P2|NOT COMPLETED|Month 3||0
1422806|NCT02555722|3483158|P1|NOT COMPLETED|Month 3||0
1422807|NCT02555722|3483157|P2|COMPLETED|Month 3||29
1422808|NCT02555722|3483158|P1|COMPLETED|Month 3||53
1422809|NCT02555722|3483157|P2|STARTED|Month 3||29
1422810|NCT02555722|3483158|P1|STARTED|Month 3||53
1422811|NCT02555722|3483157|P2|NOT COMPLETED|Month 2||0
1422812|NCT02555722|3483158|P1|NOT COMPLETED|Month 2||3
1422813|NCT02555722|3483157|P2|COMPLETED|Month 2||29
1422814|NCT02555722|3483158|P1|COMPLETED|Month 2||53
1422815|NCT02555722|3483157|P2|STARTED|Month 2||29
1422816|NCT02555722|3483158|P1|STARTED|Month 2||56
1422817|NCT02555722|3483157|P2|NOT COMPLETED|Month 1||0
1422818|NCT02555722|3483158|P1|NOT COMPLETED|Month 1||2
1422819|NCT02555722|3483157|P2|COMPLETED|Month 1||29
1422820|NCT02555722|3483158|P1|COMPLETED|Month 1||56
1422821|NCT02555722|3483157|P2|STARTED|Month 1||29
1422822|NCT02555722|3483158|P1|STARTED|Month 1||58
1422823|NCT02555722|3483157|P2|NOT COMPLETED|Week 2||1
1422824|NCT02555722|3483158|P1|NOT COMPLETED|Week 2||0
1422825|NCT02555722|3483157|P2|COMPLETED|Week 2||29
1422826|NCT02555722|3483158|P1|COMPLETED|Week 2||58
1422827|NCT02555722|3483157|P2|STARTED|Week 2||30
1422828|NCT02555722|3483158|P1|STARTED|Week 2||58
1422829|NCT02555722|3483157|P2|NOT COMPLETED|Week 1||0
1422830|NCT02555722|3483158|P1|NOT COMPLETED|Week 1||1
1422831|NCT02555722|3483157|P2|COMPLETED|Week 1||30
1422832|NCT02555722|3483158|P1|COMPLETED|Week 1||58
1422833|NCT02555722|3483157|P2|STARTED|Week 1||30
1422834|NCT02555722|3483158|P1|STARTED|Week 1||59
1422835|NCT02555722|3483157|P2|NOT COMPLETED|Lens Dispensed||0
1422836|NCT02555722|3483158|P1|NOT COMPLETED|Lens Dispensed||0
1422837|NCT02555722|3483157|P2|COMPLETED|Lens Dispensed||30
1422838|NCT02555722|3483158|P1|COMPLETED|Lens Dispensed||59
1422839|NCT02555722|3483157|P2|STARTED|Lens Dispensed||30
1422840|NCT02555722|3483158|P1|STARTED|Lens Dispensed||59
1422841|NCT02555631|3483316|P1|NOT COMPLETED|Overall Study||4
1422842|NCT02555631|3483316|P1|COMPLETED|Overall Study||25
1422843|NCT02555631|3483316|P1|STARTED|Overall Study||29
1422844|NCT02555618|3483325|P2|NOT COMPLETED|Overall Study||0
1422845|NCT02555618|3483326|P1|NOT COMPLETED|Overall Study||1
1422846|NCT02555618|3483325|P2|COMPLETED|Overall Study||200
1422847|NCT02555618|3483326|P1|COMPLETED|Overall Study||199
1422848|NCT02555618|3483325|P2|STARTED|Overall Study||200
1422849|NCT02555618|3483326|P1|STARTED|Overall Study||200
1422850|NCT02555228|3483370|P2|NOT COMPLETED|Overall Study||0
1422851|NCT02555228|3483371|P1|NOT COMPLETED|Overall Study||0
1422852|NCT02555228|3483370|P2|COMPLETED|Overall Study|29th October 2015|27
1422853|NCT02555228|3483371|P1|COMPLETED|Overall Study|19th November 2015|27
1422854|NCT02555228|3483370|P2|STARTED|Overall Study|14th August 2015|27
1422855|NCT02555228|3483371|P1|STARTED|Overall Study|20th August 2015|27
1422856|NCT02554981|3483383|P1|NOT COMPLETED|Overall Study||5
1422857|NCT02554981|3483383|P1|COMPLETED|Overall Study||46
1422858|NCT02554981|3483383|P1|STARTED|Overall Study||51
1422859|NCT02554877|3483411|P4|NOT COMPLETED|Overall Study||7
1422860|NCT02554877|3483412|P3|NOT COMPLETED|Overall Study||6
1422861|NCT02554877|3483413|P2|NOT COMPLETED|Overall Study||7
1422862|NCT02554877|3483414|P1|NOT COMPLETED|Overall Study||12
1422863|NCT02554877|3483411|P4|COMPLETED|Overall Study||45
1422864|NCT02554877|3483412|P3|COMPLETED|Overall Study||46
1422865|NCT02554877|3483413|P2|COMPLETED|Overall Study||44
1422866|NCT02554877|3483414|P1|COMPLETED|Overall Study||39
1422867|NCT02554877|3483411|P4|STARTED|Overall Study||52
1422868|NCT02554877|3483412|P3|STARTED|Overall Study||52
1422869|NCT02554877|3483413|P2|STARTED|Overall Study||51
1422870|NCT02554877|3483414|P1|STARTED|Overall Study||51
1422871|NCT02554435|3483478|P2|NOT COMPLETED|Overall Study||1
1422872|NCT02554435|3483479|P1|NOT COMPLETED|Overall Study||6
1422873|NCT02554435|3483478|P2|COMPLETED|Overall Study||19
1422874|NCT02554435|3483479|P1|COMPLETED|Overall Study||14
1422875|NCT02554435|3483478|P2|STARTED|Overall Study||20
1422876|NCT02554435|3483479|P1|STARTED|Overall Study||20
1422877|NCT02554279|3483513|P2|NOT COMPLETED|Overall Study||18
1422878|NCT02554279|3483514|P1|NOT COMPLETED|Overall Study||32
1422879|NCT02554279|3483513|P2|COMPLETED|Overall Study||291
1422880|NCT02554279|3483514|P1|COMPLETED|Overall Study||279
1422881|NCT02554279|3483513|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
1422882|NCT02554279|3483514|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
1422883|NCT02554279|3483513|P2|Completed Oocyte Retrieval|Overall Study||306
1422884|NCT02554279|3483514|P1|Completed Oocyte Retrieval|Overall Study||292
1422885|NCT02554279|3483513|P2|Received Trigger|Overall Study||307
1422886|NCT02554279|3483514|P1|Received Trigger|Overall Study||293
1422887|NCT02554279|3483513|P2|Completed Day 6 of Stimulation|Overall Study||309
1422888|NCT02554279|3483514|P1|Completed Day 6 of Stimulation|Overall Study||308
1422889|NCT02554279|3483513|P2|Treated|Overall Study||309
1422890|NCT02554279|3483514|P1|Treated|Overall Study||310
1422891|NCT02554279|3483513|P2|STARTED|Overall Study||309
1422892|NCT02554279|3483514|P1|STARTED|Overall Study||311
1422893|NCT02553798|3483546|P1|NOT COMPLETED|Overall Study||338
1422894|NCT02553798|3483546|P1|COMPLETED|Overall Study||226
1422895|NCT02553798|3483546|P1|STARTED|Overall Study||564
1422896|NCT02553772|3483555|P2|NOT COMPLETED|Overall Study||6
1422897|NCT02553772|3483556|P1|NOT COMPLETED|Overall Study||6
1422898|NCT02553772|3483555|P2|COMPLETED|Overall Study||116
1422899|NCT02553772|3483556|P1|COMPLETED|Overall Study||114
1422900|NCT02553772|3483555|P2|STARTED|Overall Study||122
1422901|NCT02553772|3483556|P1|STARTED|Overall Study||120
1422902|NCT02553629|3483572|P2|NOT COMPLETED|Overall Study||6
1422903|NCT02553629|3483573|P1|NOT COMPLETED|Overall Study||3
1422904|NCT02553629|3483572|P2|COMPLETED|Overall Study||50
1422905|NCT02553629|3483573|P1|COMPLETED|Overall Study||50
1422906|NCT02553629|3483572|P2|STARTED|Overall Study||56
1422907|NCT02553629|3483573|P1|STARTED|Overall Study||53
1422908|NCT02553538|3483589|P2|NOT COMPLETED|Overall Study||56
1422909|NCT02553538|3483590|P1|NOT COMPLETED|Overall Study||187
1422910|NCT02553538|3483589|P2|COMPLETED|Overall Study||764
1422911|NCT02553538|3483590|P1|COMPLETED|Overall Study||605
1422912|NCT02553538|3483589|P2|STARTED|Overall Study||820
1422913|NCT02553538|3483590|P1|STARTED|Overall Study||792
1422914|NCT02553512|3483602|P1|NOT COMPLETED|Overall Study||23
1422915|NCT02553512|3483602|P1|COMPLETED|Overall Study||144
1422916|NCT02553512|3483602|P1|STARTED|Overall Study||167
1422917|NCT02553421|3483612|P2|NOT COMPLETED|Overall Study||1
1422918|NCT02553421|3483613|P1|NOT COMPLETED|Overall Study||29
1422919|NCT02553421|3483612|P2|COMPLETED|Overall Study||57
1422920|NCT02553421|3483613|P1|COMPLETED|Overall Study||156
1422921|NCT02553421|3483612|P2|STARTED|Overall Study||58
1422922|NCT02553421|3483613|P1|STARTED|Overall Study||185
1422923|NCT02552810|3483623|P2|NOT COMPLETED|Overall Study||0
1422924|NCT02552810|3483624|P1|NOT COMPLETED|Overall Study||0
1422925|NCT02552810|3483623|P2|COMPLETED|Overall Study||15
1422926|NCT02552810|3483624|P1|COMPLETED|Overall Study||15
1422927|NCT02552810|3483623|P2|STARTED|Overall Study||15
1422928|NCT02552810|3483624|P1|STARTED|Overall Study||15
1422929|NCT02552368|3483640|P1|NOT COMPLETED|Overall Study||13
1422930|NCT02552368|3483640|P1|COMPLETED|Overall Study||10
1422931|NCT02552368|3483640|P1|STARTED|Overall Study||23
1422932|NCT02552303|3483649|P4|NOT COMPLETED|Follow-Up||0
1422933|NCT02552303|3483650|P3|NOT COMPLETED|Follow-Up||1
1422934|NCT02552303|3483651|P2|NOT COMPLETED|Follow-Up||2
1422935|NCT02552303|3483652|P1|NOT COMPLETED|Follow-Up||0
1422936|NCT02552303|3483649|P4|COMPLETED|Follow-Up||10
1422937|NCT02552303|3483650|P3|COMPLETED|Follow-Up||6
1422938|NCT02552303|3483651|P2|COMPLETED|Follow-Up||6
1422939|NCT02552303|3483652|P1|COMPLETED|Follow-Up||7
1422940|NCT02552303|3483649|P4|STARTED|Follow-Up||10
1422941|NCT02552303|3483650|P3|STARTED|Follow-Up||7
1422942|NCT02552303|3483651|P2|STARTED|Follow-Up||8
1422943|NCT02552303|3483652|P1|STARTED|Follow-Up||7
1422944|NCT02552303|3483649|P4|NOT COMPLETED|Allocation||1
1422945|NCT02552303|3483650|P3|NOT COMPLETED|Allocation||1
1422946|NCT02552303|3483651|P2|NOT COMPLETED|Allocation||2
1422947|NCT02552303|3483652|P1|NOT COMPLETED|Allocation||3
1422948|NCT02552303|3483649|P4|COMPLETED|Allocation||10
1422949|NCT02552303|3483650|P3|COMPLETED|Allocation||7
1422950|NCT02552303|3483651|P2|COMPLETED|Allocation||8
1422951|NCT02552303|3483652|P1|COMPLETED|Allocation||7
1422952|NCT02552303|3483649|P4|STARTED|Allocation||11
1422953|NCT02552303|3483650|P3|STARTED|Allocation||8
1422954|NCT02552303|3483651|P2|STARTED|Allocation||10
1422955|NCT02552303|3483652|P1|STARTED|Allocation||10
1422956|NCT02551887|3483669|P3|NOT COMPLETED|Overall Study||0
1422957|NCT02551887|3483670|P2|NOT COMPLETED|Overall Study||0
1422958|NCT02551887|3483671|P1|NOT COMPLETED|Overall Study||0
1422959|NCT02551887|3483669|P3|COMPLETED|Overall Study||222
1422960|NCT02551887|3483670|P2|COMPLETED|Overall Study||124
1422961|NCT02551887|3483671|P1|COMPLETED|Overall Study||301
1422962|NCT02551887|3483669|P3|STARTED|Overall Study||222
1422963|NCT02551887|3483670|P2|STARTED|Overall Study||124
1422964|NCT02551887|3483671|P1|STARTED|Overall Study||301
1422965|NCT02551874|3483684|P2|NOT COMPLETED|Overall Study||39
1422966|NCT02551874|3483685|P1|NOT COMPLETED|Overall Study||28
1422967|NCT02551874|3483684|P2|COMPLETED|Overall Study||287
1422968|NCT02551874|3483685|P1|COMPLETED|Overall Study||296
1422969|NCT02551874|3483684|P2|Received Treatment in Long-term Study|Overall Study||284
1422970|NCT02551874|3483685|P1|Received Treatment in Long-term Study|Overall Study||295
1422971|NCT02551874|3483684|P2|Entered Long-term Study|Overall Study||294
1422972|NCT02551874|3483685|P1|Entered Long-term Study|Overall Study||306
1422973|NCT02551874|3483684|P2|Received Treatment in Short-term Study|Overall Study||319
1422974|NCT02551874|3483685|P1|Received Treatment in Short-term Study|Overall Study||324
1422975|NCT02551874|3483684|P2|STARTED|Overall Study||326
1422976|NCT02551874|3483685|P1|STARTED|Overall Study||324
1422977|NCT02551822|3483703|P2|NOT COMPLETED|Overall Study||2
1422978|NCT02551822|3483704|P1|NOT COMPLETED|Overall Study||2
1422979|NCT02551822|3483703|P2|COMPLETED|Overall Study||10
1422980|NCT02551822|3483704|P1|COMPLETED|Overall Study||9
1422981|NCT02551822|3483703|P2|STARTED|Overall Study||12
1422982|NCT02551822|3483704|P1|STARTED|Overall Study||11
1422983|NCT02551731|3483714|P1|NOT COMPLETED|Overall Study||2
1422984|NCT02551731|3483714|P1|COMPLETED|Overall Study||7
1422985|NCT02551731|3483714|P1|STARTED|Overall Study||9
1422986|NCT02551653|3483733|P2|NOT COMPLETED|Overall Study||0
1422987|NCT02551653|3483734|P1|NOT COMPLETED|Overall Study||0
1422988|NCT02551653|3483733|P2|COMPLETED|Overall Study||5
1422989|NCT02551653|3483734|P1|COMPLETED|Overall Study||5
1422990|NCT02551653|3483733|P2|STARTED|Overall Study||5
1422991|NCT02551653|3483734|P1|STARTED|Overall Study||5
1422992|NCT02551224|3483742|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
1422993|NCT02551224|3483743|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
1422994|NCT02551224|3483742|P2|COMPLETED|Second Intervention (5 Min After First )||50
1422995|NCT02551224|3483743|P1|COMPLETED|Second Intervention (5 Min After First )||50
1422996|NCT02551224|3483742|P2|STARTED|Second Intervention (5 Min After First )||50
1422997|NCT02551224|3483743|P1|STARTED|Second Intervention (5 Min After First )||50
1422998|NCT02551224|3483742|P2|NOT COMPLETED|First Intervention||0
1422999|NCT02551224|3483743|P1|NOT COMPLETED|First Intervention||0
1423000|NCT02551224|3483742|P2|COMPLETED|First Intervention||50
1423001|NCT02551224|3483743|P1|COMPLETED|First Intervention||50
1423002|NCT02551224|3483742|P2|STARTED|First Intervention||50
1423003|NCT02551224|3483743|P1|STARTED|First Intervention||50
1423004|NCT02550873|3483753|P3|NOT COMPLETED|Open Label Extension||111
1423005|NCT02550873|3483754|P2|NOT COMPLETED|Open Label Extension||0
1423006|NCT02550873|3483755|P1|NOT COMPLETED|Open Label Extension||0
1423007|NCT02550873|3483753|P3|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
1423008|NCT02550873|3483754|P2|COMPLETED|Open Label Extension||0
1423009|NCT02550873|3483755|P1|COMPLETED|Open Label Extension||0
1423010|NCT02550873|3483753|P3|STARTED|Open Label Extension||111
1423011|NCT02550873|3483754|P2|STARTED|Open Label Extension||0
1423012|NCT02550873|3483755|P1|STARTED|Open Label Extension||0
1423013|NCT02550873|3483753|P3|NOT COMPLETED|Randomized Double Blind||0
1423014|NCT02550873|3483754|P2|NOT COMPLETED|Randomized Double Blind||2
1423015|NCT02550873|3483755|P1|NOT COMPLETED|Randomized Double Blind||4
1423016|NCT02550873|3483753|P3|COMPLETED|Randomized Double Blind||0
1423017|NCT02550873|3483754|P2|COMPLETED|Randomized Double Blind||37
1423018|NCT02550873|3483755|P1|COMPLETED|Randomized Double Blind||74
1423019|NCT02550873|3483753|P3|Continue to Open Label Extension|Randomized Double Blind||0
1423020|NCT02550873|3483754|P2|Continue to Open Label Extension|Randomized Double Blind||37
1423021|NCT02550873|3483755|P1|Continue to Open Label Extension|Randomized Double Blind||74
1423022|NCT02550873|3483753|P3|Received Treatment|Randomized Double Blind||0
1423023|NCT02550873|3483754|P2|Received Treatment|Randomized Double Blind||39
1423024|NCT02550873|3483755|P1|Received Treatment|Randomized Double Blind||77
1423025|NCT02550873|3483753|P3|STARTED|Randomized Double Blind||0
1423026|NCT02550873|3483754|P2|STARTED|Randomized Double Blind||39
1423027|NCT02550873|3483755|P1|STARTED|Randomized Double Blind||78
1423028|NCT02550288|3483838|P5|NOT COMPLETED|Overall Study||3
1423029|NCT02550288|3483839|P4|NOT COMPLETED|Overall Study||3
1423030|NCT02550288|3483840|P3|NOT COMPLETED|Overall Study||1
1423031|NCT02550288|3483841|P2|NOT COMPLETED|Overall Study||3
1423032|NCT02550288|3483842|P1|NOT COMPLETED|Overall Study||2
1423033|NCT02550288|3483838|P5|COMPLETED|Overall Study||66
1423034|NCT02550288|3483839|P4|COMPLETED|Overall Study||65
1423035|NCT02550288|3483840|P3|COMPLETED|Overall Study||68
1423036|NCT02550288|3483841|P2|COMPLETED|Overall Study||65
1423037|NCT02550288|3483842|P1|COMPLETED|Overall Study||33
1423038|NCT02550288|3483838|P5|STARTED|Overall Study||69
1423039|NCT02550288|3483839|P4|STARTED|Overall Study||68
1423040|NCT02550288|3483840|P3|STARTED|Overall Study||69
1423041|NCT02550288|3483841|P2|STARTED|Overall Study||68
1423042|NCT02550288|3483842|P1|STARTED|Overall Study||35
1423043|NCT02550197|3483941|P2|NOT COMPLETED|Overall Study||0
1423044|NCT02550197|3483942|P1|NOT COMPLETED|Overall Study||0
1423045|NCT02550197|3483941|P2|COMPLETED|Overall Study||100
1423046|NCT02550197|3483942|P1|COMPLETED|Overall Study||200
1423047|NCT02550197|3483941|P2|STARTED|Overall Study||100
1423048|NCT02550197|3483942|P1|STARTED|Overall Study||200
1423049|NCT02550132|3483960|P1|NOT COMPLETED|Overall Study||0
1423050|NCT02550132|3483960|P1|COMPLETED|Overall Study||25
1423051|NCT02550132|3483960|P1|STARTED|Overall Study||25
1423052|NCT02549755|3483991|P1|NOT COMPLETED|Overall Study||1
1423053|NCT02549755|3483991|P1|COMPLETED|Overall Study||0
1423054|NCT02549755|3483991|P1|STARTED|Overall Study||1
1423055|NCT02549573|3483997|P2|NOT COMPLETED|Overall Study||3
1423056|NCT02549573|3483998|P1|NOT COMPLETED|Overall Study||0
1423057|NCT02549573|3483997|P2|COMPLETED|Overall Study||4
1423058|NCT02549573|3483998|P1|COMPLETED|Overall Study||6
1423059|NCT02549573|3483997|P2|STARTED|Overall Study||7
1423060|NCT02549573|3483998|P1|STARTED|Overall Study||6
1423061|NCT02549352|3484042|P2|NOT COMPLETED|12-month Follow-up||12
1423062|NCT02549352|3484043|P1|NOT COMPLETED|12-month Follow-up||8
1423063|NCT02549352|3484042|P2|COMPLETED|12-month Follow-up||81
1423064|NCT02549352|3484043|P1|COMPLETED|12-month Follow-up||199
1423065|NCT02549352|3484042|P2|STARTED|12-month Follow-up||93
1423066|NCT02549352|3484043|P1|STARTED|12-month Follow-up||207
1423067|NCT02549352|3484042|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
1423068|NCT02549352|3484043|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
1423069|NCT02549352|3484042|P2|COMPLETED|3-day Treatment and 8-week Follow-up||96
1423070|NCT02549352|3484043|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
1423071|NCT02549352|3484042|P2|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
1423072|NCT02549352|3484043|P1|Treated|3-day Treatment and 8-week Follow-up||209
1423073|NCT02549352|3484042|P2|STARTED|3-day Treatment and 8-week Follow-up||102
1423074|NCT02549352|3484043|P1|STARTED|3-day Treatment and 8-week Follow-up||209
1423075|NCT02549339|3484059|P2|NOT COMPLETED|12-month Follow-up||11
1423076|NCT02549339|3484060|P1|NOT COMPLETED|12-month Follow-up||9
1423077|NCT02549339|3484059|P2|COMPLETED|12-month Follow-up||87
1423078|NCT02549339|3484060|P1|COMPLETED|12-month Follow-up||192
1423079|NCT02549339|3484059|P2|STARTED|12-month Follow-up||98
1423080|NCT02549339|3484060|P1|STARTED|12-month Follow-up||201
1423081|NCT02549339|3484059|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
1423082|NCT02549339|3484060|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
1423083|NCT02549339|3484059|P2|COMPLETED|3-day Treatment and 8-week Follow-up||99
1423084|NCT02549339|3484060|P1|COMPLETED|3-day Treatment and 8-week Follow-up||201
1423085|NCT02549339|3484059|P2|Treated|3-day Treatment and 8-week Follow-up||104
1423086|NCT02549339|3484060|P1|Treated|3-day Treatment and 8-week Follow-up||202
1423087|NCT02549339|3484059|P2|STARTED|3-day Treatment and 8-week Follow-up||104
1423088|NCT02549339|3484060|P1|STARTED|3-day Treatment and 8-week Follow-up||205
1423089|NCT02549027|3484074|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1423090|NCT02549027|3484075|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
1423091|NCT02549027|3484076|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1423092|NCT02549027|3484077|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1423093|NCT02549027|3484078|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1423094|NCT02549027|3484079|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1423095|NCT02549027|3484074|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
1423096|NCT02549027|3484075|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
1423097|NCT02549027|3484076|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
1423098|NCT02549027|3484077|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
1423099|NCT02549027|3484078|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
1423100|NCT02549027|3484079|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
1423101|NCT02549027|3484074|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
1423102|NCT02549027|3484075|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
1423103|NCT02549027|3484076|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
1423104|NCT02549027|3484077|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
1423105|NCT02549027|3484078|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
1423106|NCT02549027|3484079|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
1423107|NCT02549027|3484074|P6|NOT COMPLETED|Washout After Period 4||0
1423108|NCT02549027|3484075|P5|NOT COMPLETED|Washout After Period 4||0
1423109|NCT02549027|3484076|P4|NOT COMPLETED|Washout After Period 4||1
1423110|NCT02549027|3484077|P3|NOT COMPLETED|Washout After Period 4||1
1423111|NCT02549027|3484078|P2|NOT COMPLETED|Washout After Period 4||1
1423112|NCT02549027|3484079|P1|NOT COMPLETED|Washout After Period 4||0
1423113|NCT02549027|3484074|P6|COMPLETED|Washout After Period 4||0
1423114|NCT02549027|3484075|P5|COMPLETED|Washout After Period 4||0
1423115|NCT02549027|3484076|P4|COMPLETED|Washout After Period 4||4
1423116|NCT02549027|3484077|P3|COMPLETED|Washout After Period 4||4
1423117|NCT02549027|3484078|P2|COMPLETED|Washout After Period 4||4
1423118|NCT02549027|3484079|P1|COMPLETED|Washout After Period 4||5
1423119|NCT02549027|3484074|P6|STARTED|Washout After Period 4||0
1423120|NCT02549027|3484075|P5|STARTED|Washout After Period 4||0
1423121|NCT02549027|3484076|P4|STARTED|Washout After Period 4||5
1423122|NCT02549027|3484077|P3|STARTED|Washout After Period 4||5
1423123|NCT02549027|3484078|P2|STARTED|Washout After Period 4||5
1423124|NCT02549027|3484079|P1|STARTED|Washout After Period 4||5
1423125|NCT02549027|3484074|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1423126|NCT02549027|3484075|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1423127|NCT02549027|3484076|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1423128|NCT02549027|3484077|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1423129|NCT02549027|3484078|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1423130|NCT02549027|3484079|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1423131|NCT02549027|3484074|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
1423132|NCT02549027|3484075|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
1423133|NCT02549027|3484076|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
1423134|NCT02549027|3484077|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
1423135|NCT02549027|3484078|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
1423136|NCT02549027|3484079|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
1423137|NCT02549027|3484074|P6|STARTED|Period 4 - MK-1064 or Placebo||0
1423138|NCT02549027|3484075|P5|STARTED|Period 4 - MK-1064 or Placebo||0
1423139|NCT02549027|3484076|P4|STARTED|Period 4 - MK-1064 or Placebo||5
1423140|NCT02549027|3484077|P3|STARTED|Period 4 - MK-1064 or Placebo||5
1423141|NCT02549027|3484078|P2|STARTED|Period 4 - MK-1064 or Placebo||5
1423142|NCT02549027|3484079|P1|STARTED|Period 4 - MK-1064 or Placebo||5
1423143|NCT02549027|3484074|P6|NOT COMPLETED|Washout After Period 3||0
1423144|NCT02549027|3484075|P5|NOT COMPLETED|Washout After Period 3||0
1423145|NCT02549027|3484076|P4|NOT COMPLETED|Washout After Period 3||0
1423146|NCT02549027|3484077|P3|NOT COMPLETED|Washout After Period 3||0
1423147|NCT02549027|3484078|P2|NOT COMPLETED|Washout After Period 3||0
1423148|NCT02549027|3484079|P1|NOT COMPLETED|Washout After Period 3||0
1423149|NCT02549027|3484074|P6|COMPLETED|Washout After Period 3||0
1423150|NCT02549027|3484075|P5|COMPLETED|Washout After Period 3||0
1423151|NCT02549027|3484076|P4|COMPLETED|Washout After Period 3||5
1423152|NCT02549027|3484077|P3|COMPLETED|Washout After Period 3||5
1423153|NCT02549027|3484078|P2|COMPLETED|Washout After Period 3||5
1423154|NCT02549027|3484079|P1|COMPLETED|Washout After Period 3||5
1423155|NCT02549027|3484074|P6|STARTED|Washout After Period 3||0
1423156|NCT02549027|3484075|P5|STARTED|Washout After Period 3||0
1423157|NCT02549027|3484076|P4|STARTED|Washout After Period 3||5
1423158|NCT02549027|3484077|P3|STARTED|Washout After Period 3||5
1423159|NCT02549027|3484078|P2|STARTED|Washout After Period 3||5
1423160|NCT02549027|3484079|P1|STARTED|Washout After Period 3||5
1423161|NCT02549027|3484074|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1423162|NCT02549027|3484075|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1423163|NCT02549027|3484076|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1423164|NCT02549027|3484077|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1423165|NCT02549027|3484078|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1423166|NCT02549027|3484079|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1423167|NCT02549027|3484074|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
1423168|NCT02549027|3484075|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
1423169|NCT02549027|3484076|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
1423170|NCT02549027|3484077|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
1423171|NCT02549027|3484078|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
1423172|NCT02549027|3484079|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
1423173|NCT02549027|3484074|P6|STARTED|Period 3 - MK-1064 or Placebo||0
1423174|NCT02549027|3484075|P5|STARTED|Period 3 - MK-1064 or Placebo||0
1423175|NCT02549027|3484076|P4|STARTED|Period 3 - MK-1064 or Placebo||5
1423176|NCT02549027|3484077|P3|STARTED|Period 3 - MK-1064 or Placebo||5
1423177|NCT02549027|3484078|P2|STARTED|Period 3 - MK-1064 or Placebo||5
1423178|NCT02549027|3484079|P1|STARTED|Period 3 - MK-1064 or Placebo||5
1423179|NCT02549027|3484074|P6|NOT COMPLETED|Washout After Period 2||0
1423180|NCT02549027|3484075|P5|NOT COMPLETED|Washout After Period 2||0
1423181|NCT02549027|3484076|P4|NOT COMPLETED|Washout After Period 2||0
1423182|NCT02549027|3484077|P3|NOT COMPLETED|Washout After Period 2||0
1423183|NCT02549027|3484078|P2|NOT COMPLETED|Washout After Period 2||0
1423184|NCT02549027|3484079|P1|NOT COMPLETED|Washout After Period 2||0
1423185|NCT02549027|3484074|P6|COMPLETED|Washout After Period 2||0
1423186|NCT02549027|3484075|P5|COMPLETED|Washout After Period 2||0
1423187|NCT02549027|3484076|P4|COMPLETED|Washout After Period 2||5
1423188|NCT02549027|3484077|P3|COMPLETED|Washout After Period 2||5
1423189|NCT02549027|3484078|P2|COMPLETED|Washout After Period 2||5
1423190|NCT02549027|3484079|P1|COMPLETED|Washout After Period 2||5
1423191|NCT02549027|3484074|P6|STARTED|Washout After Period 2||0
1423192|NCT02549027|3484075|P5|STARTED|Washout After Period 2||0
1423193|NCT02549027|3484076|P4|STARTED|Washout After Period 2||5
1423194|NCT02549027|3484077|P3|STARTED|Washout After Period 2||5
1423195|NCT02549027|3484078|P2|STARTED|Washout After Period 2||5
1423196|NCT02549027|3484079|P1|STARTED|Washout After Period 2||5
1423197|NCT02549027|3484074|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1423198|NCT02549027|3484075|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1423199|NCT02549027|3484076|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1423200|NCT02549027|3484077|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1423201|NCT02549027|3484078|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1423202|NCT02549027|3484079|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1423203|NCT02549027|3484074|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
1423204|NCT02549027|3484075|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
1423205|NCT02549027|3484076|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
1423206|NCT02549027|3484077|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
1423207|NCT02549027|3484078|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
1423208|NCT02549027|3484079|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
1423209|NCT02549027|3484074|P6|STARTED|Period 2 - MK-1064 or Placebo||0
1423210|NCT02549027|3484075|P5|STARTED|Period 2 - MK-1064 or Placebo||0
1423211|NCT02549027|3484076|P4|STARTED|Period 2 - MK-1064 or Placebo||5
1423212|NCT02549027|3484077|P3|STARTED|Period 2 - MK-1064 or Placebo||5
1423213|NCT02549027|3484078|P2|STARTED|Period 2 - MK-1064 or Placebo||5
1423214|NCT02549027|3484079|P1|STARTED|Period 2 - MK-1064 or Placebo||5
1423215|NCT02549027|3484074|P6|NOT COMPLETED|Washout After Period 1||0
1423216|NCT02549027|3484075|P5|NOT COMPLETED|Washout After Period 1||0
1423217|NCT02549027|3484076|P4|NOT COMPLETED|Washout After Period 1||0
1423218|NCT02549027|3484077|P3|NOT COMPLETED|Washout After Period 1||0
1423219|NCT02549027|3484078|P2|NOT COMPLETED|Washout After Period 1||0
1423220|NCT02549027|3484079|P1|NOT COMPLETED|Washout After Period 1||0
1423221|NCT02549027|3484074|P6|COMPLETED|Washout After Period 1||0
1423222|NCT02549027|3484075|P5|COMPLETED|Washout After Period 1||0
1423223|NCT02549027|3484076|P4|COMPLETED|Washout After Period 1||5
1423224|NCT02549027|3484077|P3|COMPLETED|Washout After Period 1||5
1423225|NCT02549027|3484078|P2|COMPLETED|Washout After Period 1||5
1423226|NCT02549027|3484079|P1|COMPLETED|Washout After Period 1||5
1423227|NCT02549027|3484074|P6|STARTED|Washout After Period 1||0
1423228|NCT02549027|3484075|P5|STARTED|Washout After Period 1||0
1423229|NCT02549027|3484076|P4|STARTED|Washout After Period 1||5
1423230|NCT02549027|3484077|P3|STARTED|Washout After Period 1||5
1423231|NCT02549027|3484078|P2|STARTED|Washout After Period 1||5
1423232|NCT02549027|3484079|P1|STARTED|Washout After Period 1||5
1423233|NCT02549027|3484074|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1423234|NCT02549027|3484075|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1423235|NCT02549027|3484076|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1423236|NCT02549027|3484077|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1423237|NCT02549027|3484078|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1423238|NCT02549027|3484079|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1423239|NCT02549027|3484074|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
1423240|NCT02549027|3484075|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
1423241|NCT02549027|3484076|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
1423242|NCT02549027|3484077|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
1423243|NCT02549027|3484078|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
1423244|NCT02549027|3484079|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
1423245|NCT02549027|3484074|P6|STARTED|Period 1 - MK-1064 or Placebo||0
1423246|NCT02549027|3484075|P5|STARTED|Period 1 - MK-1064 or Placebo||0
1423247|NCT02549027|3484076|P4|STARTED|Period 1 - MK-1064 or Placebo||5
1423248|NCT02549027|3484077|P3|STARTED|Period 1 - MK-1064 or Placebo||5
1423249|NCT02549027|3484078|P2|STARTED|Period 1 - MK-1064 or Placebo||5
1423250|NCT02549027|3484079|P1|STARTED|Period 1 - MK-1064 or Placebo||5
1423251|NCT02549014|3484116|P2|NOT COMPLETED|Overall Study||0
1423252|NCT02549014|3484117|P1|NOT COMPLETED|Overall Study||0
1423253|NCT02549014|3484116|P2|COMPLETED|Overall Study||8
1423254|NCT02549014|3484117|P1|COMPLETED|Overall Study||8
1423255|NCT02549014|3484116|P2|STARTED|Overall Study||8
1423256|NCT02549014|3484117|P1|STARTED|Overall Study||8
1423257|NCT02548845|3484207|P1|NOT COMPLETED|Overall Study||0
1423258|NCT02548845|3484207|P1|COMPLETED|Overall Study||70
1423259|NCT02548845|3484207|P1|STARTED|Overall Study||70
1423260|NCT02548455|3484219|P1|NOT COMPLETED|Overall Study||240
1423261|NCT02548455|3484219|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
1423262|NCT02548455|3484219|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
1423263|NCT02548455|3484219|P1|Completed 6-Month Follow-up|Overall Study||259
1423264|NCT02548455|3484219|P1|Completed Pre-Discharge|Overall Study||484
1423265|NCT02548455|3484219|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
1423266|NCT02548156|3484223|P6|NOT COMPLETED|Period 3||0
1423267|NCT02548156|3484224|P5|NOT COMPLETED|Period 3||0
1423268|NCT02548156|3484225|P4|NOT COMPLETED|Period 3||0
1423269|NCT02548156|3484226|P3|NOT COMPLETED|Period 3||0
1423270|NCT02548156|3484227|P2|NOT COMPLETED|Period 3||0
1423271|NCT02548156|3484228|P1|NOT COMPLETED|Period 3||0
1423272|NCT02548156|3484223|P6|COMPLETED|Period 3||5
1423273|NCT02548156|3484224|P5|COMPLETED|Period 3||4
1423274|NCT02548156|3484225|P4|COMPLETED|Period 3||5
1423275|NCT02548156|3484226|P3|COMPLETED|Period 3||4
1423276|NCT02548156|3484227|P2|COMPLETED|Period 3||5
1423277|NCT02548156|3484228|P1|COMPLETED|Period 3||5
1423278|NCT02548156|3484223|P6|STARTED|Period 3||5
1423279|NCT02548156|3484224|P5|STARTED|Period 3||4
1423280|NCT02548156|3484225|P4|STARTED|Period 3||5
1423281|NCT02548156|3484226|P3|STARTED|Period 3||4
1423282|NCT02548156|3484227|P2|STARTED|Period 3||5
1423283|NCT02548156|3484228|P1|STARTED|Period 3||5
1423284|NCT02548156|3484223|P6|NOT COMPLETED|Washout Period 2||0
1423285|NCT02548156|3484224|P5|NOT COMPLETED|Washout Period 2||0
1423286|NCT02548156|3484225|P4|NOT COMPLETED|Washout Period 2||0
1423287|NCT02548156|3484226|P3|NOT COMPLETED|Washout Period 2||0
1423288|NCT02548156|3484227|P2|NOT COMPLETED|Washout Period 2||0
1423289|NCT02548156|3484228|P1|NOT COMPLETED|Washout Period 2||0
1423290|NCT02548156|3484223|P6|COMPLETED|Washout Period 2||5
1423291|NCT02548156|3484224|P5|COMPLETED|Washout Period 2||4
1423292|NCT02548156|3484225|P4|COMPLETED|Washout Period 2||5
1423293|NCT02548156|3484226|P3|COMPLETED|Washout Period 2||4
1423294|NCT02548156|3484227|P2|COMPLETED|Washout Period 2||5
1423295|NCT02548156|3484228|P1|COMPLETED|Washout Period 2||5
1423296|NCT02548156|3484223|P6|STARTED|Washout Period 2||5
1423297|NCT02548156|3484224|P5|STARTED|Washout Period 2||4
1423298|NCT02548156|3484225|P4|STARTED|Washout Period 2||5
1423299|NCT02548156|3484226|P3|STARTED|Washout Period 2||4
1423300|NCT02548156|3484227|P2|STARTED|Washout Period 2||5
1423301|NCT02548156|3484228|P1|STARTED|Washout Period 2||5
1423302|NCT02548156|3484223|P6|NOT COMPLETED|Period 2||0
1423303|NCT02548156|3484224|P5|NOT COMPLETED|Period 2||0
1423304|NCT02548156|3484225|P4|NOT COMPLETED|Period 2||0
1423305|NCT02548156|3484226|P3|NOT COMPLETED|Period 2||0
1423306|NCT02548156|3484227|P2|NOT COMPLETED|Period 2||0
1423307|NCT02548156|3484228|P1|NOT COMPLETED|Period 2||0
1423308|NCT02548156|3484223|P6|COMPLETED|Period 2||5
1423309|NCT02548156|3484224|P5|COMPLETED|Period 2||4
1423310|NCT02548156|3484225|P4|COMPLETED|Period 2||5
1423311|NCT02548156|3484226|P3|COMPLETED|Period 2||4
1423312|NCT02548156|3484227|P2|COMPLETED|Period 2||5
1423313|NCT02548156|3484228|P1|COMPLETED|Period 2||5
1423314|NCT02548156|3484223|P6|STARTED|Period 2||5
1423315|NCT02548156|3484224|P5|STARTED|Period 2||4
1423316|NCT02548156|3484225|P4|STARTED|Period 2||5
1423317|NCT02548156|3484226|P3|STARTED|Period 2||4
1423318|NCT02548156|3484227|P2|STARTED|Period 2||5
1423319|NCT02548156|3484228|P1|STARTED|Period 2||5
1423320|NCT02548156|3484223|P6|NOT COMPLETED|Washout Period 1||0
1423321|NCT02548156|3484224|P5|NOT COMPLETED|Washout Period 1||1
1423322|NCT02548156|3484225|P4|NOT COMPLETED|Washout Period 1||0
1423323|NCT02548156|3484226|P3|NOT COMPLETED|Washout Period 1||0
1423324|NCT02548156|3484227|P2|NOT COMPLETED|Washout Period 1||0
1423325|NCT02548156|3484228|P1|NOT COMPLETED|Washout Period 1||0
1423326|NCT02548156|3484223|P6|COMPLETED|Washout Period 1||5
1423327|NCT02548156|3484224|P5|COMPLETED|Washout Period 1||4
1423328|NCT02548156|3484225|P4|COMPLETED|Washout Period 1||5
1423329|NCT02548156|3484226|P3|COMPLETED|Washout Period 1||4
1423330|NCT02548156|3484227|P2|COMPLETED|Washout Period 1||5
1423331|NCT02548156|3484228|P1|COMPLETED|Washout Period 1||5
1423332|NCT02548156|3484223|P6|STARTED|Washout Period 1||5
1423333|NCT02548156|3484224|P5|STARTED|Washout Period 1||5
1423334|NCT02548156|3484225|P4|STARTED|Washout Period 1||5
1423335|NCT02548156|3484226|P3|STARTED|Washout Period 1||4
1423336|NCT02548156|3484227|P2|STARTED|Washout Period 1||5
1423337|NCT02548156|3484228|P1|STARTED|Washout Period 1||5
1423338|NCT02548156|3484223|P6|NOT COMPLETED|Period 1||0
1423339|NCT02548156|3484224|P5|NOT COMPLETED|Period 1||0
1423340|NCT02548156|3484225|P4|NOT COMPLETED|Period 1||0
1423341|NCT02548156|3484226|P3|NOT COMPLETED|Period 1||0
1423342|NCT02548156|3484227|P2|NOT COMPLETED|Period 1||0
1423343|NCT02548156|3484228|P1|NOT COMPLETED|Period 1||0
1423344|NCT02548156|3484223|P6|COMPLETED|Period 1||5
1423345|NCT02548156|3484224|P5|COMPLETED|Period 1||5
1423346|NCT02548156|3484225|P4|COMPLETED|Period 1||5
1423347|NCT02548156|3484226|P3|COMPLETED|Period 1||4
1423348|NCT02548156|3484227|P2|COMPLETED|Period 1||5
1423349|NCT02548156|3484228|P1|COMPLETED|Period 1||5
1423350|NCT02548156|3484223|P6|STARTED|Period 1||5
1423351|NCT02548156|3484224|P5|STARTED|Period 1||5
1423352|NCT02548156|3484225|P4|STARTED|Period 1||5
1423353|NCT02548156|3484226|P3|STARTED|Period 1||4
1423354|NCT02548156|3484227|P2|STARTED|Period 1||5
1423355|NCT02548156|3484228|P1|STARTED|Period 1||5
1423356|NCT02548078|3484247|P2|NOT COMPLETED|Overall Study||6
1423357|NCT02548078|3484248|P1|NOT COMPLETED|Overall Study||5
1423358|NCT02548078|3484247|P2|COMPLETED|Overall Study||294
1423359|NCT02548078|3484248|P1|COMPLETED|Overall Study||295
1423360|NCT02548078|3484247|P2|STARTED|Overall Study||300
1423361|NCT02548078|3484248|P1|STARTED|Overall Study||300
1423362|NCT02547974|3484440|P4|NOT COMPLETED|Overall Study||0
1423363|NCT02547974|3484441|P3|NOT COMPLETED|Overall Study||0
1423364|NCT02547974|3484442|P2|NOT COMPLETED|Overall Study||0
1423365|NCT02547974|3484443|P1|NOT COMPLETED|Overall Study||1
1423366|NCT02547974|3484440|P4|COMPLETED|Overall Study||44
1423367|NCT02547974|3484441|P3|COMPLETED|Overall Study||30
1423368|NCT02547974|3484442|P2|COMPLETED|Overall Study||31
1423369|NCT02547974|3484443|P1|COMPLETED|Overall Study||14
1423370|NCT02547974|3484440|P4|STARTED|Overall Study||44
1423371|NCT02547974|3484441|P3|STARTED|Overall Study||30
1423372|NCT02547974|3484442|P2|STARTED|Overall Study||31
1423373|NCT02547974|3484443|P1|STARTED|Overall Study||15
1423374|NCT02547714|3484527|P1|NOT COMPLETED|Overall Study||0
1423375|NCT02547714|3484527|P1|COMPLETED|Overall Study||34
1423376|NCT02547714|3484527|P1|STARTED|Overall Study||34
1423377|NCT02547623|3484539|P2|NOT COMPLETED|Overall Study||3
1423378|NCT02547623|3484540|P1|NOT COMPLETED|Overall Study||4
1423379|NCT02547623|3484539|P2|COMPLETED|Overall Study||52
1423380|NCT02547623|3484540|P1|COMPLETED|Overall Study||122
1423381|NCT02547623|3484539|P2|STARTED|Overall Study||55
1423382|NCT02547623|3484540|P1|STARTED|Overall Study||126
1423383|NCT02547454|3484570|P1|NOT COMPLETED|Overall Study||172
1423384|NCT02547454|3484570|P1|COMPLETED|Overall Study||221
1423385|NCT02547454|3484570|P1|STARTED|Overall Study||393
1423386|NCT02547363|3484600|P2|NOT COMPLETED|12-month Follow-up||5
1423387|NCT02547363|3484601|P1|NOT COMPLETED|12-month Follow-up||10
1423388|NCT02547363|3484600|P2|COMPLETED|12-month Follow-up||81
1423389|NCT02547363|3484601|P1|COMPLETED|12-month Follow-up||194
1423390|NCT02547363|3484600|P2|STARTED|12-month Follow-up||86
1423391|NCT02547363|3484601|P1|STARTED|12-month Follow-up||204
1423392|NCT02547363|3484600|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
1423393|NCT02547363|3484601|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
1423394|NCT02547363|3484600|P2|COMPLETED|3-day Treatment and 8-week Follow-up||94
1423395|NCT02547363|3484601|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
1423396|NCT02547363|3484600|P2|Treated|3-day Treatment and 8-week Follow-up||104
1423397|NCT02547363|3484601|P1|Treated|3-day Treatment and 8-week Follow-up||209
1423398|NCT02547363|3484600|P2|STARTED|3-day Treatment and 8-week Follow-up||105
1423399|NCT02547363|3484601|P1|STARTED|3-day Treatment and 8-week Follow-up||211
1423400|NCT02547233|3484617|P2|NOT COMPLETED|12-month Follow-up||17
1423401|NCT02547233|3484618|P1|NOT COMPLETED|12-month Follow-up||14
1423402|NCT02547233|3484617|P2|COMPLETED|12-month Follow-up||67
1423403|NCT02547233|3484618|P1|COMPLETED|12-month Follow-up||185
1423404|NCT02547233|3484617|P2|STARTED|12-month Follow-up||84
1423405|NCT02547233|3484618|P1|STARTED|12-month Follow-up||199
1423406|NCT02547233|3484617|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
1423407|NCT02547233|3484618|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
1423408|NCT02547233|3484617|P2|COMPLETED|3-day Treatment and 8-week Follow-up||92
1423409|NCT02547233|3484618|P1|COMPLETED|3-day Treatment and 8-week Follow-up||203
1423410|NCT02547233|3484617|P2|Treated|3-day Treatment and 8-week Follow-up||100
1423411|NCT02547233|3484618|P1|Treated|3-day Treatment and 8-week Follow-up||205
1423412|NCT02547233|3484617|P2|STARTED|3-day Treatment and 8-week Follow-up||102
1423413|NCT02547233|3484618|P1|STARTED|3-day Treatment and 8-week Follow-up||205
1423414|NCT02547064|3484634|P2|NOT COMPLETED|Overall Study||2
1423415|NCT02547064|3484635|P1|NOT COMPLETED|Overall Study||3
1423416|NCT02547064|3484634|P2|COMPLETED|Overall Study||79
1423417|NCT02547064|3484635|P1|COMPLETED|Overall Study||78
1423418|NCT02547064|3484634|P2|STARTED|Overall Study||81
1423419|NCT02547064|3484635|P1|STARTED|Overall Study||81
1423420|NCT02546986|3484663|P2|NOT COMPLETED|Survival Follow-Up Phase||35
1423421|NCT02546986|3484664|P1|NOT COMPLETED|Survival Follow-Up Phase||36
1423422|NCT02546986|3484663|P2|COMPLETED|Survival Follow-Up Phase||0
1423423|NCT02546986|3484664|P1|COMPLETED|Survival Follow-Up Phase||0
1423424|NCT02546986|3484663|P2|STARTED|Survival Follow-Up Phase||35
1423425|NCT02546986|3484664|P1|STARTED|Survival Follow-Up Phase||36
1423426|NCT02546986|3484663|P2|NOT COMPLETED|Treatment Period||49
1423427|NCT02546986|3484664|P1|NOT COMPLETED|Treatment Period||51
1423428|NCT02546986|3484663|P2|COMPLETED|Treatment Period||0
1423429|NCT02546986|3484664|P1|COMPLETED|Treatment Period||0
1423430|NCT02546986|3484663|P2|STARTED|Treatment Period||49
1423431|NCT02546986|3484664|P1|STARTED|Treatment Period||51
1423432|NCT02546609|3484690|P3|NOT COMPLETED|Overall Study||7
1423433|NCT02546609|3484691|P2|NOT COMPLETED|Overall Study||11
1423434|NCT02546609|3484692|P1|NOT COMPLETED|Overall Study||2
1423435|NCT02546609|3484690|P3|COMPLETED|Overall Study||25
1423436|NCT02546609|3484691|P2|COMPLETED|Overall Study||24
1423437|NCT02546609|3484692|P1|COMPLETED|Overall Study||22
1423438|NCT02546609|3484690|P3|STARTED|Overall Study||32
1423439|NCT02546609|3484691|P2|STARTED|Overall Study||35
1423440|NCT02546609|3484692|P1|STARTED|Overall Study||24
1423441|NCT02546375|3484733|P1|NOT COMPLETED|Overall Study||0
1423442|NCT02546375|3484733|P1|COMPLETED|Overall Study||87
1423443|NCT02546375|3484733|P1|STARTED|Overall Study||87
1423444|NCT02545868|3484758|P3|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
1423445|NCT02545868|3484759|P2|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
1423446|NCT02545868|3484760|P1|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
1423447|NCT02545868|3484758|P3|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
1423448|NCT02545868|3484759|P2|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
1423449|NCT02545868|3484760|P1|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
1423450|NCT02545868|3484758|P3|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
1423451|NCT02545868|3484759|P2|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
1423452|NCT02545868|3484760|P1|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
1423453|NCT02545868|3484758|P3|NOT COMPLETED|Immunization Study Period (ISP)||0
1423454|NCT02545868|3484759|P2|NOT COMPLETED|Immunization Study Period (ISP)||0
1423455|NCT02545868|3484760|P1|NOT COMPLETED|Immunization Study Period (ISP)||0
1423456|NCT02545868|3484758|P3|COMPLETED|Immunization Study Period (ISP)||34
1423457|NCT02545868|3484759|P2|COMPLETED|Immunization Study Period (ISP)||35
1423458|NCT02545868|3484760|P1|COMPLETED|Immunization Study Period (ISP)||33
1423459|NCT02545868|3484758|P3|STARTED|Immunization Study Period (ISP)||34
1423460|NCT02545868|3484759|P2|STARTED|Immunization Study Period (ISP)||35
1423461|NCT02545868|3484760|P1|STARTED|Immunization Study Period (ISP)||33
1423462|NCT02545543|3484833|P2|NOT COMPLETED|Overall Study||34
1423463|NCT02545543|3484834|P1|NOT COMPLETED|Overall Study||81
1423464|NCT02545543|3484833|P2|COMPLETED|Overall Study||535
1423465|NCT02545543|3484834|P1|COMPLETED|Overall Study||1628
1423466|NCT02545543|3484833|P2|STARTED|Overall Study||569
1423467|NCT02545543|3484834|P1|STARTED|Overall Study||1709
1423468|NCT02545322|3484858|P1|NOT COMPLETED|Overall Study||3
1423469|NCT02545322|3484858|P1|COMPLETED|Overall Study||15
1423470|NCT02545322|3484858|P1|STARTED|Overall Study||18
1423471|NCT02545101|3484863|P1|NOT COMPLETED|Overall Study||0
1423472|NCT02545101|3484863|P1|COMPLETED|Overall Study||100
1423473|NCT02545101|3484863|P1|STARTED|Overall Study||100
1423474|NCT02544984|3484882|P2|NOT COMPLETED|Overall Study||2
1423475|NCT02544984|3484883|P1|NOT COMPLETED|Overall Study||2
1423476|NCT02544984|3484882|P2|COMPLETED|Overall Study||28
1423477|NCT02544984|3484883|P1|COMPLETED|Overall Study||28
1423478|NCT02544984|3484882|P2|STARTED|Overall Study||30
1423479|NCT02544984|3484883|P1|STARTED|Overall Study||30
1423480|NCT02544074|3484914|P21|NOT COMPLETED|Overall Study||0
1423481|NCT02544074|3484915|P20|NOT COMPLETED|Overall Study||0
1423482|NCT02544074|3484916|P19|NOT COMPLETED|Overall Study||0
1423483|NCT02544074|3484917|P18|NOT COMPLETED|Overall Study||0
1423484|NCT02544074|3484918|P17|NOT COMPLETED|Overall Study||0
1423485|NCT02544074|3484919|P16|NOT COMPLETED|Overall Study||0
1423486|NCT02544074|3484920|P15|NOT COMPLETED|Overall Study||0
1423487|NCT02544074|3484921|P14|NOT COMPLETED|Overall Study||0
1423488|NCT02544074|3484922|P13|NOT COMPLETED|Overall Study||0
1423489|NCT02544074|3484923|P12|NOT COMPLETED|Overall Study||0
1423490|NCT02544074|3484924|P11|NOT COMPLETED|Overall Study||0
1423491|NCT02544074|3484925|P10|NOT COMPLETED|Overall Study||1
1423492|NCT02544074|3484926|P9|NOT COMPLETED|Overall Study||0
1423493|NCT02544074|3484927|P8|NOT COMPLETED|Overall Study||0
1423494|NCT02544074|3484928|P7|NOT COMPLETED|Overall Study||0
1423495|NCT02544074|3484929|P6|NOT COMPLETED|Overall Study||1
1423496|NCT02544074|3484930|P5|NOT COMPLETED|Overall Study||0
1423497|NCT02544074|3484931|P4|NOT COMPLETED|Overall Study||0
1423498|NCT02544074|3484932|P3|NOT COMPLETED|Overall Study||0
1423499|NCT02544074|3484933|P2|NOT COMPLETED|Overall Study||1
1423500|NCT02544074|3484934|P1|NOT COMPLETED|Overall Study||0
1423501|NCT02544074|3484914|P21|COMPLETED|Overall Study||3
1423502|NCT02544074|3484915|P20|COMPLETED|Overall Study||3
1423503|NCT02544074|3484916|P19|COMPLETED|Overall Study||4
1423504|NCT02544074|3484917|P18|COMPLETED|Overall Study||3
1423505|NCT02544074|3484918|P17|COMPLETED|Overall Study||6
1423506|NCT02544074|3484919|P16|COMPLETED|Overall Study||8
1423507|NCT02544074|3484920|P15|COMPLETED|Overall Study||5
1423508|NCT02544074|3484921|P14|COMPLETED|Overall Study||5
1423509|NCT02544074|3484922|P13|COMPLETED|Overall Study||4
1423510|NCT02544074|3484923|P12|COMPLETED|Overall Study||3
1423511|NCT02544074|3484924|P11|COMPLETED|Overall Study||2
1423512|NCT02544074|3484925|P10|COMPLETED|Overall Study||1
1423513|NCT02544074|3484926|P9|COMPLETED|Overall Study||6
1423514|NCT02544074|3484927|P8|COMPLETED|Overall Study||4
1423515|NCT02544074|3484928|P7|COMPLETED|Overall Study||2
1423516|NCT02544074|3484929|P6|COMPLETED|Overall Study||0
1423517|NCT02544074|3484930|P5|COMPLETED|Overall Study||4
1423518|NCT02544074|3484931|P4|COMPLETED|Overall Study||1
1423519|NCT02544074|3484932|P3|COMPLETED|Overall Study||1
1423520|NCT02544074|3484933|P2|COMPLETED|Overall Study||0
1423521|NCT02544074|3484934|P1|COMPLETED|Overall Study||1
1423522|NCT02544074|3484914|P21|STARTED|Overall Study||3
1423523|NCT02544074|3484915|P20|STARTED|Overall Study||3
1423524|NCT02544074|3484916|P19|STARTED|Overall Study||4
1423525|NCT02544074|3484917|P18|STARTED|Overall Study||3
1423526|NCT02544074|3484918|P17|STARTED|Overall Study||6
1423527|NCT02544074|3484919|P16|STARTED|Overall Study||8
1423528|NCT02544074|3484920|P15|STARTED|Overall Study||5
1423529|NCT02544074|3484921|P14|STARTED|Overall Study||5
1423530|NCT02544074|3484922|P13|STARTED|Overall Study||4
1423531|NCT02544074|3484923|P12|STARTED|Overall Study||3
1423532|NCT02544074|3484924|P11|STARTED|Overall Study||2
1423533|NCT02544074|3484925|P10|STARTED|Overall Study||2
1423534|NCT02544074|3484926|P9|STARTED|Overall Study||6
1423535|NCT02544074|3484927|P8|STARTED|Overall Study||4
1423536|NCT02544074|3484928|P7|STARTED|Overall Study||2
1423537|NCT02544074|3484929|P6|STARTED|Overall Study||1
1423538|NCT02544074|3484930|P5|STARTED|Overall Study||4
1423539|NCT02544074|3484931|P4|STARTED|Overall Study||1
1423540|NCT02544074|3484932|P3|STARTED|Overall Study||1
1423541|NCT02544074|3484933|P2|STARTED|Overall Study||1
1423542|NCT02544074|3484934|P1|STARTED|Overall Study||1
1423543|NCT02543918|3484970|P2|NOT COMPLETED|Overall Study||4
1423544|NCT02543918|3484971|P1|NOT COMPLETED|Overall Study||3
1423545|NCT02543918|3484970|P2|COMPLETED|Overall Study||39
1423546|NCT02543918|3484971|P1|COMPLETED|Overall Study||38
1423547|NCT02543918|3484970|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
1423548|NCT02543918|3484971|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
1423549|NCT02543918|3484970|P2|STARTED|Overall Study||43
1423550|NCT02543918|3484971|P1|STARTED|Overall Study||41
1423551|NCT02543892|3484985|P8|NOT COMPLETED|Had Immunology Data||0
1423552|NCT02543892|3484986|P7|NOT COMPLETED|Had Immunology Data||1
1423553|NCT02543892|3484987|P6|NOT COMPLETED|Had Immunology Data||0
1423554|NCT02543892|3484988|P5|NOT COMPLETED|Had Immunology Data||0
1423555|NCT02543892|3484989|P4|NOT COMPLETED|Had Immunology Data||0
1423556|NCT02543892|3484990|P3|NOT COMPLETED|Had Immunology Data||0
1423557|NCT02543892|3484991|P2|NOT COMPLETED|Had Immunology Data||0
1423558|NCT02543892|3484992|P1|NOT COMPLETED|Had Immunology Data||0
1423559|NCT02543892|3484985|P8|COMPLETED|Had Immunology Data||49
1423560|NCT02543892|3484986|P7|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
1423561|NCT02543892|3484987|P6|COMPLETED|Had Immunology Data||49
1423562|NCT02543892|3484988|P5|COMPLETED|Had Immunology Data||50
1423563|NCT02543892|3484989|P4|COMPLETED|Had Immunology Data||12
1423564|NCT02543892|3484990|P3|COMPLETED|Had Immunology Data||12
1423565|NCT02543892|3484991|P2|COMPLETED|Had Immunology Data||11
1423566|NCT02543892|3484992|P1|COMPLETED|Had Immunology Data||11
1423567|NCT02543892|3484985|P8|STARTED|Had Immunology Data||49
1423568|NCT02543892|3484986|P7|STARTED|Had Immunology Data||50
1423569|NCT02543892|3484987|P6|STARTED|Had Immunology Data||49
1423570|NCT02543892|3484988|P5|STARTED|Had Immunology Data||50
1423571|NCT02543892|3484989|P4|STARTED|Had Immunology Data||12
1423572|NCT02543892|3484990|P3|STARTED|Had Immunology Data||12
1423573|NCT02543892|3484991|P2|STARTED|Had Immunology Data||11
1423574|NCT02543892|3484992|P1|STARTED|Had Immunology Data||11
1423575|NCT02543892|3484985|P8|NOT COMPLETED|Received Vaccination 2||1
1423576|NCT02543892|3484986|P7|NOT COMPLETED|Received Vaccination 2||0
1423577|NCT02543892|3484987|P6|NOT COMPLETED|Received Vaccination 2||1
1423578|NCT02543892|3484988|P5|NOT COMPLETED|Received Vaccination 2||0
1423579|NCT02543892|3484989|P4|NOT COMPLETED|Received Vaccination 2||0
1423580|NCT02543892|3484990|P3|NOT COMPLETED|Received Vaccination 2||0
1423581|NCT02543892|3484991|P2|NOT COMPLETED|Received Vaccination 2||1
1423582|NCT02543892|3484992|P1|NOT COMPLETED|Received Vaccination 2||1
1423583|NCT02543892|3484985|P8|COMPLETED|Received Vaccination 2||49
1423584|NCT02543892|3484986|P7|COMPLETED|Received Vaccination 2||50
1423585|NCT02543892|3484987|P6|COMPLETED|Received Vaccination 2||49
1423586|NCT02543892|3484988|P5|COMPLETED|Received Vaccination 2||50
1423587|NCT02543892|3484989|P4|COMPLETED|Received Vaccination 2||12
1423588|NCT02543892|3484990|P3|COMPLETED|Received Vaccination 2||12
1423589|NCT02543892|3484991|P2|COMPLETED|Received Vaccination 2||11
1423590|NCT02543892|3484992|P1|COMPLETED|Received Vaccination 2||11
1423591|NCT02543892|3484985|P8|STARTED|Received Vaccination 2||50
1423592|NCT02543892|3484986|P7|STARTED|Received Vaccination 2||50
1423593|NCT02543892|3484987|P6|STARTED|Received Vaccination 2||50
1423594|NCT02543892|3484988|P5|STARTED|Received Vaccination 2||50
1423595|NCT02543892|3484989|P4|STARTED|Received Vaccination 2||12
1423596|NCT02543892|3484990|P3|STARTED|Received Vaccination 2||12
1423597|NCT02543892|3484991|P2|STARTED|Received Vaccination 2||12
1423598|NCT02543892|3484992|P1|STARTED|Received Vaccination 2||12
1423599|NCT02543892|3484985|P8|NOT COMPLETED|Received Vaccination 1||0
1423600|NCT02543892|3484986|P7|NOT COMPLETED|Received Vaccination 1||0
1423601|NCT02543892|3484987|P6|NOT COMPLETED|Received Vaccination 1||0
1423602|NCT02543892|3484988|P5|NOT COMPLETED|Received Vaccination 1||0
1423603|NCT02543892|3484989|P4|NOT COMPLETED|Received Vaccination 1||0
1423604|NCT02543892|3484990|P3|NOT COMPLETED|Received Vaccination 1||0
1423605|NCT02543892|3484991|P2|NOT COMPLETED|Received Vaccination 1||0
1423606|NCT02543892|3484992|P1|NOT COMPLETED|Received Vaccination 1||0
1423607|NCT02543892|3484985|P8|COMPLETED|Received Vaccination 1||50
1423608|NCT02543892|3484986|P7|COMPLETED|Received Vaccination 1||50
1423609|NCT02543892|3484987|P6|COMPLETED|Received Vaccination 1||50
1423610|NCT02543892|3484988|P5|COMPLETED|Received Vaccination 1||50
1423611|NCT02543892|3484989|P4|COMPLETED|Received Vaccination 1||12
1423612|NCT02543892|3484990|P3|COMPLETED|Received Vaccination 1||12
1423613|NCT02543892|3484991|P2|COMPLETED|Received Vaccination 1||12
1423614|NCT02543892|3484992|P1|COMPLETED|Received Vaccination 1||12
1423615|NCT02543892|3484985|P8|STARTED|Received Vaccination 1||50
1423616|NCT02543892|3484986|P7|STARTED|Received Vaccination 1||50
1423617|NCT02543892|3484987|P6|STARTED|Received Vaccination 1||50
1423618|NCT02543892|3484988|P5|STARTED|Received Vaccination 1||50
1423619|NCT02543892|3484989|P4|STARTED|Received Vaccination 1||12
1423620|NCT02543892|3484990|P3|STARTED|Received Vaccination 1||12
1423621|NCT02543892|3484991|P2|STARTED|Received Vaccination 1||12
1423622|NCT02543892|3484992|P1|STARTED|Received Vaccination 1||12
1423623|NCT02543554|3485040|P2|NOT COMPLETED|Overall Study||0
1423624|NCT02543554|3485041|P1|NOT COMPLETED|Overall Study||0
1423625|NCT02543554|3485040|P2|COMPLETED|Overall Study||513
1423626|NCT02543554|3485041|P1|COMPLETED|Overall Study||1192
1423627|NCT02543554|3485040|P2|STARTED|Overall Study||513
1423628|NCT02543554|3485041|P1|STARTED|Overall Study||1192
1423629|NCT02543528|3485049|P5|NOT COMPLETED|Extended Wear Period||0
1423630|NCT02543528|3485050|P4|NOT COMPLETED|Extended Wear Period||12
1423631|NCT02543528|3485051|P3|NOT COMPLETED|Extended Wear Period||28
1423632|NCT02543528|3485052|P2|NOT COMPLETED|Extended Wear Period||21
1423633|NCT02543528|3485053|P1|NOT COMPLETED|Extended Wear Period||23
1423634|NCT02543528|3485049|P5|COMPLETED|Extended Wear Period||0
1423635|NCT02543528|3485050|P4|COMPLETED|Extended Wear Period||23
1423636|NCT02543528|3485051|P3|COMPLETED|Extended Wear Period||8
1423637|NCT02543528|3485052|P2|COMPLETED|Extended Wear Period||14
1423638|NCT02543528|3485053|P1|COMPLETED|Extended Wear Period||13
1423639|NCT02543528|3485049|P5|STARTED|Extended Wear Period||0
1423640|NCT02543528|3485050|P4|STARTED|Extended Wear Period||35
1423641|NCT02543528|3485051|P3|STARTED|Extended Wear Period||36
1423642|NCT02543528|3485052|P2|STARTED|Extended Wear Period||35
1423643|NCT02543528|3485053|P1|STARTED|Extended Wear Period||36
1423644|NCT02543528|3485049|P5|NOT COMPLETED|Adaptation Period||26
1423645|NCT02543528|3485050|P4|NOT COMPLETED|Adaptation Period||0
1423646|NCT02543528|3485051|P3|NOT COMPLETED|Adaptation Period||0
1423647|NCT02543528|3485052|P2|NOT COMPLETED|Adaptation Period||0
1423648|NCT02543528|3485053|P1|NOT COMPLETED|Adaptation Period||0
1423649|NCT02543528|3485049|P5|COMPLETED|Adaptation Period||142
1423650|NCT02543528|3485050|P4|COMPLETED|Adaptation Period||0
1423651|NCT02543528|3485051|P3|COMPLETED|Adaptation Period||0
1423652|NCT02543528|3485052|P2|COMPLETED|Adaptation Period||0
1423653|NCT02543528|3485053|P1|COMPLETED|Adaptation Period||0
1423654|NCT02543528|3485049|P5|STARTED|Adaptation Period||168
1423655|NCT02543528|3485050|P4|STARTED|Adaptation Period||0
1423656|NCT02543528|3485051|P3|STARTED|Adaptation Period||0
1423657|NCT02543528|3485052|P2|STARTED|Adaptation Period||0
1423658|NCT02543528|3485053|P1|STARTED|Adaptation Period||0
1423659|NCT02543437|3485072|P1|NOT COMPLETED|Overall Study||0
1423660|NCT02543437|3485072|P1|COMPLETED|Overall Study||117
1423661|NCT02543437|3485072|P1|STARTED|Overall Study||117
1423662|NCT02543398|3485079|P2|NOT COMPLETED|Overall Study||0
1423663|NCT02543398|3485080|P1|NOT COMPLETED|Overall Study||0
1423664|NCT02543398|3485079|P2|COMPLETED|Overall Study||20
1423665|NCT02543398|3485080|P1|COMPLETED|Overall Study||20
1423666|NCT02543398|3485079|P2|STARTED|Overall Study||20
1423667|NCT02543398|3485080|P1|STARTED|Overall Study||20
1423668|NCT02542943|3485089|P3|NOT COMPLETED|Overall Study||0
1423669|NCT02542943|3485090|P2|NOT COMPLETED|Overall Study||1
1423670|NCT02542943|3485091|P1|NOT COMPLETED|Overall Study||1
1423671|NCT02542943|3485089|P3|COMPLETED|Overall Study||81
1423672|NCT02542943|3485090|P2|COMPLETED|Overall Study||79
1423673|NCT02542943|3485091|P1|COMPLETED|Overall Study||78
1423674|NCT02542943|3485089|P3|STARTED|Overall Study||81
1423675|NCT02542943|3485090|P2|STARTED|Overall Study||80
1423676|NCT02542943|3485091|P1|STARTED|Overall Study||79
1423677|NCT02542761|3485116|P2|NOT COMPLETED|Second Intervention||0
1423678|NCT02542761|3485117|P1|NOT COMPLETED|Second Intervention||0
1423679|NCT02542761|3485116|P2|COMPLETED|Second Intervention||5
1423680|NCT02542761|3485117|P1|COMPLETED|Second Intervention||5
1423681|NCT02542761|3485116|P2|STARTED|Second Intervention||5
1423682|NCT02542761|3485117|P1|STARTED|Second Intervention||5
1423683|NCT02542761|3485116|P2|NOT COMPLETED|Acclimation Period 2||0
1423684|NCT02542761|3485117|P1|NOT COMPLETED|Acclimation Period 2||0
1423685|NCT02542761|3485116|P2|COMPLETED|Acclimation Period 2||5
1423686|NCT02542761|3485117|P1|COMPLETED|Acclimation Period 2||5
1423687|NCT02542761|3485116|P2|STARTED|Acclimation Period 2||5
1423688|NCT02542761|3485117|P1|STARTED|Acclimation Period 2||5
1423689|NCT02542761|3485116|P2|NOT COMPLETED|First Intervention||0
1423690|NCT02542761|3485117|P1|NOT COMPLETED|First Intervention||0
1423691|NCT02542761|3485116|P2|COMPLETED|First Intervention||5
1423692|NCT02542761|3485117|P1|COMPLETED|First Intervention||5
1423693|NCT02542761|3485116|P2|STARTED|First Intervention||5
1423694|NCT02542761|3485117|P1|STARTED|First Intervention||5
1423695|NCT02542761|3485116|P2|NOT COMPLETED|Acclimation Period 1||0
1423696|NCT02542761|3485117|P1|NOT COMPLETED|Acclimation Period 1||0
1423697|NCT02542761|3485116|P2|COMPLETED|Acclimation Period 1||5
1423698|NCT02542761|3485117|P1|COMPLETED|Acclimation Period 1||5
1423699|NCT02542761|3485116|P2|STARTED|Acclimation Period 1||5
1423700|NCT02542761|3485117|P1|STARTED|Acclimation Period 1||5
1423701|NCT02542631|3485135|P2|NOT COMPLETED|Overall Study||31
1423702|NCT02542631|3485136|P1|NOT COMPLETED|Overall Study||31
1423703|NCT02542631|3485135|P2|COMPLETED|Overall Study||108
1423704|NCT02542631|3485136|P1|COMPLETED|Overall Study||108
1423705|NCT02542631|3485135|P2|STARTED|Overall Study||139
1423706|NCT02542631|3485136|P1|STARTED|Overall Study||139
1423707|NCT02542462|3485162|P4|NOT COMPLETED|Overall Study||1
1423708|NCT02542462|3485163|P3|NOT COMPLETED|Overall Study||0
1423709|NCT02542462|3485164|P2|NOT COMPLETED|Overall Study||0
1423710|NCT02542462|3485165|P1|NOT COMPLETED|Overall Study||0
1423711|NCT02542462|3485162|P4|COMPLETED|Overall Study||25
1423712|NCT02542462|3485163|P3|COMPLETED|Overall Study||25
1423713|NCT02542462|3485164|P2|COMPLETED|Overall Study||25
1423714|NCT02542462|3485165|P1|COMPLETED|Overall Study||25
1423715|NCT02542462|3485162|P4|STARTED|Overall Study||26
1423716|NCT02542462|3485163|P3|STARTED|Overall Study||25
1423717|NCT02542462|3485164|P2|STARTED|Overall Study||25
1423718|NCT02542462|3485165|P1|STARTED|Overall Study||25
1423719|NCT02542280|3485179|P2|NOT COMPLETED|Overall Study||8
1423720|NCT02542280|3485180|P1|NOT COMPLETED|Overall Study||12
1423721|NCT02542280|3485179|P2|COMPLETED|Overall Study||167
1423722|NCT02542280|3485180|P1|COMPLETED|Overall Study||162
1423723|NCT02542280|3485179|P2|STARTED|Overall Study||175
1423724|NCT02542280|3485180|P1|STARTED|Overall Study||174
1423725|NCT02542072|3485190|P2|NOT COMPLETED|Second Intervention (1 Month)||0
1423726|NCT02542072|3485191|P1|NOT COMPLETED|Second Intervention (1 Month)||2
1423727|NCT02542072|3485190|P2|COMPLETED|Second Intervention (1 Month)||43
1423728|NCT02542072|3485191|P1|COMPLETED|Second Intervention (1 Month)||37
1423729|NCT02542072|3485190|P2|STARTED|Second Intervention (1 Month)||43
1423730|NCT02542072|3485191|P1|STARTED|Second Intervention (1 Month)||39
1423731|NCT02542072|3485190|P2|NOT COMPLETED|First Intervention (1 Month)||3
1423732|NCT02542072|3485191|P1|NOT COMPLETED|First Intervention (1 Month)||5
1423733|NCT02542072|3485190|P2|COMPLETED|First Intervention (1 Month)||43
1423734|NCT02542072|3485191|P1|COMPLETED|First Intervention (1 Month)||39
1423735|NCT02542072|3485190|P2|STARTED|First Intervention (1 Month)||46
1423736|NCT02542072|3485191|P1|STARTED|First Intervention (1 Month)||44
1423737|NCT02541864|3485293|P2|NOT COMPLETED|Overall Study||0
1423738|NCT02541864|3485294|P1|NOT COMPLETED|Overall Study||0
1423739|NCT02541864|3485293|P2|COMPLETED|Overall Study||166
1423740|NCT02541864|3485294|P1|COMPLETED|Overall Study||164
1423741|NCT02541864|3485293|P2|STARTED|Overall Study||166
1423742|NCT02541864|3485294|P1|STARTED|Overall Study||164
1423743|NCT02541422|3485300|P2|NOT COMPLETED|Second Intervention||0
1423744|NCT02541422|3485301|P1|NOT COMPLETED|Second Intervention||0
1423745|NCT02541422|3485300|P2|COMPLETED|Second Intervention||26
1423746|NCT02541422|3485301|P1|COMPLETED|Second Intervention||23
1423747|NCT02541422|3485300|P2|STARTED|Second Intervention||26
1423748|NCT02541422|3485301|P1|STARTED|Second Intervention||23
1423749|NCT02541422|3485300|P2|NOT COMPLETED|First Intervention||0
1423750|NCT02541422|3485301|P1|NOT COMPLETED|First Intervention||0
1423751|NCT02541422|3485300|P2|COMPLETED|First Intervention||26
1423752|NCT02541422|3485301|P1|COMPLETED|First Intervention||23
1423753|NCT02541422|3485300|P2|STARTED|First Intervention||26
1423754|NCT02541422|3485301|P1|STARTED|First Intervention||23
1423755|NCT02540850|3485310|P3|NOT COMPLETED|Overall Study||34
1423756|NCT02540850|3485311|P2|NOT COMPLETED|Overall Study||66
1423757|NCT02540850|3485312|P1|NOT COMPLETED|Overall Study||69
1423758|NCT02540850|3485310|P3|COMPLETED|Overall Study||410
1423759|NCT02540850|3485311|P2|COMPLETED|Overall Study||330
1423760|NCT02540850|3485312|P1|COMPLETED|Overall Study||291
1423761|NCT02540850|3485310|P3|STARTED|Overall Study||444
1423762|NCT02540850|3485311|P2|STARTED|Overall Study||396
1423763|NCT02540850|3485312|P1|STARTED|Overall Study||360
1423764|NCT02540772|3485340|P2|NOT COMPLETED|Overall Study||0
1423765|NCT02540772|3485341|P1|NOT COMPLETED|Overall Study||0
1423766|NCT02540772|3485340|P2|COMPLETED|Overall Study||10
1423767|NCT02540772|3485341|P1|COMPLETED|Overall Study||10
1423768|NCT02540772|3485340|P2|STARTED|Overall Study||10
1423769|NCT02540772|3485341|P1|STARTED|Overall Study||10
1423770|NCT02540538|3485356|P3|NOT COMPLETED|Overall Study||0
1423771|NCT02540538|3485357|P2|NOT COMPLETED|Overall Study||1
1423772|NCT02540538|3485358|P1|NOT COMPLETED|Overall Study||0
1423773|NCT02540538|3485356|P3|COMPLETED|Overall Study||10
1423774|NCT02540538|3485357|P2|COMPLETED|Overall Study||11
1423775|NCT02540538|3485358|P1|COMPLETED|Overall Study||12
1423776|NCT02540538|3485356|P3|STARTED|Overall Study||10
1423777|NCT02540538|3485357|P2|STARTED|Overall Study||12
1423778|NCT02540538|3485358|P1|STARTED|Overall Study||12
1423779|NCT02540447|3485374|P2|NOT COMPLETED|Overall Study||0
1423780|NCT02540447|3485375|P1|NOT COMPLETED|Overall Study||0
1423781|NCT02540447|3485374|P2|COMPLETED|Overall Study||40
1423782|NCT02540447|3485375|P1|COMPLETED|Overall Study||40
1423783|NCT02540447|3485374|P2|STARTED|Overall Study||40
1423784|NCT02540447|3485375|P1|STARTED|Overall Study||40
1423785|NCT02540434|3485391|P2|NOT COMPLETED|Overall Study||0
1423786|NCT02540434|3485392|P1|NOT COMPLETED|Overall Study||0
1423787|NCT02540434|3485391|P2|COMPLETED|Overall Study||1
1423788|NCT02540434|3485392|P1|COMPLETED|Overall Study||0
1423789|NCT02540434|3485391|P2|STARTED|Overall Study||1
1423790|NCT02540434|3485392|P1|STARTED|Overall Study||0
1423791|NCT02540356|3485402|P2|NOT COMPLETED|Overall Study||0
1423792|NCT02540356|3485403|P1|NOT COMPLETED|Overall Study||1
1423793|NCT02540356|3485402|P2|COMPLETED|Overall Study||0
1423794|NCT02540356|3485403|P1|COMPLETED|Overall Study||0
1423795|NCT02540356|3485402|P2|STARTED|Overall Study||0
1423796|NCT02540356|3485403|P1|STARTED|Overall Study||1
1423797|NCT02540265|3485437|P3|NOT COMPLETED|Overall Study||1
1423798|NCT02540265|3485438|P2|NOT COMPLETED|Overall Study||0
1423799|NCT02540265|3485439|P1|NOT COMPLETED|Overall Study||0
1423800|NCT02540265|3485437|P3|COMPLETED|Overall Study||18
1423801|NCT02540265|3485438|P2|COMPLETED|Overall Study||20
1423802|NCT02540265|3485439|P1|COMPLETED|Overall Study||20
1423803|NCT02540265|3485437|P3|Treatment Completion|Overall Study||18
1423804|NCT02540265|3485438|P2|Treatment Completion|Overall Study||19
1423805|NCT02540265|3485439|P1|Treatment Completion|Overall Study||20
1423806|NCT02540265|3485437|P3|STARTED|Overall Study||19
1423807|NCT02540265|3485438|P2|STARTED|Overall Study||20
1423808|NCT02540265|3485439|P1|STARTED|Overall Study||20
1423809|NCT02540213|3485459|P1|NOT COMPLETED|Overall Study||39
1423810|NCT02540213|3485459|P1|COMPLETED|Overall Study||201
1423811|NCT02540213|3485459|P1|STARTED|Overall Study||240
1423812|NCT02539992|3485483|P3|NOT COMPLETED|Overall Study||4
1423813|NCT02539992|3485484|P2|NOT COMPLETED|Overall Study||4
1423814|NCT02539992|3485485|P1|NOT COMPLETED|Overall Study||0
1423815|NCT02539992|3485483|P3|COMPLETED|Overall Study||14
1423816|NCT02539992|3485484|P2|COMPLETED|Overall Study||7
1423817|NCT02539992|3485485|P1|COMPLETED|Overall Study||15
1423818|NCT02539992|3485483|P3|STARTED|Overall Study||18
1423819|NCT02539992|3485484|P2|STARTED|Overall Study||11
1423820|NCT02539992|3485485|P1|STARTED|Overall Study||15
1423821|NCT02539797|3485511|P3|NOT COMPLETED|Overall Study||0
1423822|NCT02539797|3485512|P2|NOT COMPLETED|Overall Study||1
1423823|NCT02539797|3485513|P1|NOT COMPLETED|Overall Study||0
1423824|NCT02539797|3485511|P3|COMPLETED|Overall Study||13
1423825|NCT02539797|3485512|P2|COMPLETED|Overall Study||12
1423826|NCT02539797|3485513|P1|COMPLETED|Overall Study||12
1423827|NCT02539797|3485511|P3|STARTED|Overall Study||13
1423828|NCT02539797|3485512|P2|STARTED|Overall Study||13
1423829|NCT02539797|3485513|P1|STARTED|Overall Study||12
1423830|NCT02539654|3485524|P1|NOT COMPLETED|Overall Study||0
1423831|NCT02539654|3485524|P1|COMPLETED|Overall Study||14
1423832|NCT02539654|3485524|P1|STARTED|Overall Study||14
1423833|NCT02539134|3485540|P6|NOT COMPLETED|Overall Study||0
1423834|NCT02539134|3485541|P5|NOT COMPLETED|Overall Study||0
1423835|NCT02539134|3485542|P4|NOT COMPLETED|Overall Study||0
1423836|NCT02539134|3485543|P3|NOT COMPLETED|Overall Study||0
1423837|NCT02539134|3485544|P2|NOT COMPLETED|Overall Study||0
1423838|NCT02539134|3485545|P1|NOT COMPLETED|Overall Study||1
1423839|NCT02539134|3485540|P6|COMPLETED|Overall Study||6
1423840|NCT02539134|3485541|P5|COMPLETED|Overall Study||6
1423841|NCT02539134|3485542|P4|COMPLETED|Overall Study||6
1423842|NCT02539134|3485543|P3|COMPLETED|Overall Study||6
1423843|NCT02539134|3485544|P2|COMPLETED|Overall Study||6
1423844|NCT02539134|3485545|P1|COMPLETED|Overall Study||9
1423845|NCT02539134|3485540|P6|STARTED|Overall Study||6
1423846|NCT02539134|3485541|P5|STARTED|Overall Study||6
1423847|NCT02539134|3485542|P4|STARTED|Overall Study||6
1423848|NCT02539134|3485543|P3|STARTED|Overall Study||6
1423849|NCT02539134|3485544|P2|STARTED|Overall Study||6
1423850|NCT02539134|3485545|P1|STARTED|Overall Study||10
1423851|NCT02539108|3485599|P2|NOT COMPLETED|Overall Study||0
1423852|NCT02539108|3485600|P1|NOT COMPLETED|Overall Study||0
1423853|NCT02539108|3485599|P2|COMPLETED|Overall Study||30
1423854|NCT02539108|3485600|P1|COMPLETED|Overall Study||30
1423855|NCT02539108|3485599|P2|STARTED|Overall Study||30
1423856|NCT02539108|3485600|P1|STARTED|Overall Study||30
1423857|NCT02538965|3485614|P1|NOT COMPLETED|Follow-Up Period||15
1423858|NCT02538965|3485614|P1|COMPLETED|Follow-Up Period||2
1423859|NCT02538965|3485614|P1|STARTED|Follow-Up Period||17
1423860|NCT02538965|3485614|P1|NOT COMPLETED|Treatment Period||17
1423861|NCT02538965|3485614|P1|COMPLETED|Treatment Period||0
1423862|NCT02538965|3485614|P1|STARTED|Treatment Period||17
1423863|NCT02538679|3485636|P3|NOT COMPLETED|Overall Study||8
1423864|NCT02538679|3485637|P2|NOT COMPLETED|Overall Study||9
1423865|NCT02538679|3485638|P1|NOT COMPLETED|Overall Study||3
1423866|NCT02538679|3485636|P3|COMPLETED|Overall Study||41
1423867|NCT02538679|3485637|P2|COMPLETED|Overall Study||45
1423868|NCT02538679|3485638|P1|COMPLETED|Overall Study||21
1423869|NCT02538679|3485636|P3|STARTED|Overall Study||49
1423870|NCT02538679|3485637|P2|STARTED|Overall Study||54
1423871|NCT02538679|3485638|P1|STARTED|Overall Study||24
1423872|NCT02538107|3485646|P1|NOT COMPLETED|Overall Study||110
1423873|NCT02538107|3485646|P1|COMPLETED|Overall Study||180
1423874|NCT02538107|3485646|P1|STARTED|Overall Study||290
1423875|NCT02538042|3485668|P2|NOT COMPLETED|Overall Study||11
1423876|NCT02538042|3485669|P1|NOT COMPLETED|Overall Study||11
1423877|NCT02538042|3485668|P2|COMPLETED|Overall Study||6
1423878|NCT02538042|3485669|P1|COMPLETED|Overall Study||6
1423879|NCT02538042|3485668|P2|Completed All Post-Quit Visits|Overall Study||12
1423880|NCT02538042|3485669|P1|Completed All Post-Quit Visits|Overall Study||12
1423881|NCT02538042|3485668|P2|Attended Post-Quit Visit|Overall Study||14
1423882|NCT02538042|3485669|P1|Attended Post-Quit Visit|Overall Study||15
1423883|NCT02538042|3485668|P2|Completed All MCE Sessions|Overall Study||15
1423884|NCT02538042|3485669|P1|Completed All MCE Sessions|Overall Study||15
1423885|NCT02538042|3485668|P2|STARTED|Overall Study||17
1423886|NCT02538042|3485669|P1|STARTED|Overall Study||17
1423887|NCT02537730|3485685|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1423888|NCT02537730|3485686|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1423889|NCT02537730|3485685|P2|COMPLETED|Second Intervention (7 Days)||16
1423890|NCT02537730|3485686|P1|COMPLETED|Second Intervention (7 Days)||17
1423891|NCT02537730|3485685|P2|STARTED|Second Intervention (7 Days)||16
1423892|NCT02537730|3485686|P1|STARTED|Second Intervention (7 Days)||17
1423893|NCT02537730|3485685|P2|NOT COMPLETED|First Intervention (7 Days)||0
1423894|NCT02537730|3485686|P1|NOT COMPLETED|First Intervention (7 Days)||0
1423895|NCT02537730|3485685|P2|COMPLETED|First Intervention (7 Days)||16
1423896|NCT02537730|3485686|P1|COMPLETED|First Intervention (7 Days)||17
1423897|NCT02537730|3485685|P2|STARTED|First Intervention (7 Days)||16
1423898|NCT02537730|3485686|P1|STARTED|First Intervention (7 Days)||17
1423899|NCT02537522|3485698|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
1423900|NCT02537522|3485699|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
1423901|NCT02537522|3485700|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
1423902|NCT02537522|3485701|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
1423903|NCT02537522|3485698|P4|COMPLETED|Phase II - Period 2 Bilateral||22
1423904|NCT02537522|3485699|P3|COMPLETED|Phase II - Period 2 Bilateral||23
1423905|NCT02537522|3485700|P2|COMPLETED|Phase II - Period 2 Bilateral||0
1423906|NCT02537522|3485701|P1|COMPLETED|Phase II - Period 2 Bilateral||0
1423907|NCT02537522|3485698|P4|STARTED|Phase II - Period 2 Bilateral||22
1423908|NCT02537522|3485699|P3|STARTED|Phase II - Period 2 Bilateral||23
1423909|NCT02537522|3485700|P2|STARTED|Phase II - Period 2 Bilateral||0
1423910|NCT02537522|3485701|P1|STARTED|Phase II - Period 2 Bilateral||0
1423911|NCT02537522|3485698|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
1423912|NCT02537522|3485699|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1423913|NCT02537522|3485700|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1423914|NCT02537522|3485701|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1423915|NCT02537522|3485698|P4|COMPLETED|Phase II - Period 1 Bilateral||22
1423916|NCT02537522|3485699|P3|COMPLETED|Phase II - Period 1 Bilateral||23
1423917|NCT02537522|3485700|P2|COMPLETED|Phase II - Period 1 Bilateral||0
1423918|NCT02537522|3485701|P1|COMPLETED|Phase II - Period 1 Bilateral||0
1423919|NCT02537522|3485698|P4|STARTED|Phase II - Period 1 Bilateral||23
1423920|NCT02537522|3485699|P3|STARTED|Phase II - Period 1 Bilateral||23
1423921|NCT02537522|3485700|P2|STARTED|Phase II - Period 1 Bilateral||0
1423922|NCT02537522|3485701|P1|STARTED|Phase II - Period 1 Bilateral||0
1423923|NCT02537522|3485698|P4|NOT COMPLETED|Phase I - Contralateral||0
1423924|NCT02537522|3485699|P3|NOT COMPLETED|Phase I - Contralateral||0
1423925|NCT02537522|3485700|P2|NOT COMPLETED|Phase I - Contralateral||10
1423926|NCT02537522|3485701|P1|NOT COMPLETED|Phase I - Contralateral||15
1423927|NCT02537522|3485698|P4|COMPLETED|Phase I - Contralateral||0
1423928|NCT02537522|3485699|P3|COMPLETED|Phase I - Contralateral||0
1423929|NCT02537522|3485700|P2|COMPLETED|Phase I - Contralateral||27
1423930|NCT02537522|3485701|P1|COMPLETED|Phase I - Contralateral||19
1423931|NCT02537522|3485698|P4|STARTED|Phase I - Contralateral||0
1423932|NCT02537522|3485699|P3|STARTED|Phase I - Contralateral||0
1423933|NCT02537522|3485700|P2|STARTED|Phase I - Contralateral||37
1423934|NCT02537522|3485701|P1|STARTED|Phase I - Contralateral||34
1423935|NCT02537431|3485709|P1|NOT COMPLETED|Overall Study||1
1424030|NCT02534324|3486156|P2|NOT COMPLETED|Overall Study||8
1423936|NCT02537431|3485709|P1|COMPLETED|Overall Study|Completed Open-Label Period (Week 0 - Week 48)|13
1423937|NCT02537431|3485709|P1|STARTED|Overall Study|Screened and received at least 1 dose of study drug.|14
1423938|NCT02536781|3485740|P2|NOT COMPLETED|Overall Study||0
1423939|NCT02536781|3485741|P1|NOT COMPLETED|Overall Study||2
1423940|NCT02536781|3485740|P2|COMPLETED|Overall Study||34
1423941|NCT02536781|3485741|P1|COMPLETED|Overall Study||34
1423942|NCT02536781|3485740|P2|STARTED|Overall Study||34
1423943|NCT02536781|3485741|P1|STARTED|Overall Study||36
1423944|NCT02536664|3485751|P2|NOT COMPLETED|Overall Study||80
1423945|NCT02536664|3485752|P1|NOT COMPLETED|Overall Study||107
1423946|NCT02536664|3485751|P2|COMPLETED|Overall Study||97
1423947|NCT02536664|3485752|P1|COMPLETED|Overall Study||205
1423948|NCT02536664|3485751|P2|STARTED|Overall Study||177
1423949|NCT02536664|3485752|P1|STARTED|Overall Study||312
1423950|NCT02536313|3485772|P2|NOT COMPLETED|Overall Study||1
1423951|NCT02536313|3485773|P1|NOT COMPLETED|Overall Study||0
1423952|NCT02536313|3485772|P2|COMPLETED|Overall Study||24
1423953|NCT02536313|3485773|P1|COMPLETED|Overall Study||24
1423954|NCT02536313|3485772|P2|STARTED|Overall Study||25
1423955|NCT02536313|3485773|P1|STARTED|Overall Study||24
1423956|NCT02535741|3485789|P1|NOT COMPLETED|Overall Study||32
1423957|NCT02535741|3485789|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
1423958|NCT02535741|3485789|P1|STARTED|Overall Study||168
1423959|NCT02535416|3485806|P9|NOT COMPLETED|Overall Study||0
1423960|NCT02535416|3485807|P8|NOT COMPLETED|Overall Study||0
1423961|NCT02535416|3485808|P7|NOT COMPLETED|Overall Study||0
1423962|NCT02535416|3485809|P6|NOT COMPLETED|Overall Study||0
1423963|NCT02535416|3485810|P5|NOT COMPLETED|Overall Study||0
1423964|NCT02535416|3485811|P4|NOT COMPLETED|Overall Study||0
1423965|NCT02535416|3485812|P3|NOT COMPLETED|Overall Study||0
1423966|NCT02535416|3485813|P2|NOT COMPLETED|Overall Study||0
1423967|NCT02535416|3485814|P1|NOT COMPLETED|Overall Study||1
1423968|NCT02535416|3485806|P9|COMPLETED|Overall Study||6
1423969|NCT02535416|3485807|P8|COMPLETED|Overall Study||6
1423970|NCT02535416|3485808|P7|COMPLETED|Overall Study||6
1423971|NCT02535416|3485809|P6|COMPLETED|Overall Study||4
1423972|NCT02535416|3485810|P5|COMPLETED|Overall Study||4
1423973|NCT02535416|3485811|P4|COMPLETED|Overall Study||4
1423974|NCT02535416|3485812|P3|COMPLETED|Overall Study||4
1423975|NCT02535416|3485813|P2|COMPLETED|Overall Study||2
1423976|NCT02535416|3485814|P1|COMPLETED|Overall Study||3
1423977|NCT02535416|3485806|P9|STARTED|Overall Study||6
1423978|NCT02535416|3485807|P8|STARTED|Overall Study||6
1423979|NCT02535416|3485808|P7|STARTED|Overall Study||6
1423980|NCT02535416|3485809|P6|STARTED|Overall Study||4
1423981|NCT02535416|3485810|P5|STARTED|Overall Study||4
1423982|NCT02535416|3485811|P4|STARTED|Overall Study||4
1423983|NCT02535416|3485812|P3|STARTED|Overall Study||4
1423984|NCT02535416|3485813|P2|STARTED|Overall Study||2
1423985|NCT02535416|3485814|P1|STARTED|Overall Study||4
1423986|NCT02535364|3485866|P1|NOT COMPLETED|12-Month Follow-up Period||35
1423987|NCT02535364|3485866|P1|COMPLETED|12-Month Follow-up Period||3
1423988|NCT02535364|3485866|P1|STARTED|12-Month Follow-up Period||38
1423989|NCT02535364|3485866|P1|NOT COMPLETED|Study Treatment||2
1423990|NCT02535364|3485866|P1|COMPLETED|Study Treatment||38
1423991|NCT02535364|3485866|P1|STARTED|Study Treatment||40
1423992|NCT02535364|3485866|P1|NOT COMPLETED|Part B Screening||17
1423993|NCT02535364|3485866|P1|COMPLETED|Part B Screening||40
1423994|NCT02535364|3485866|P1|STARTED|Part B Screening||57
1423995|NCT02535364|3485866|P1|NOT COMPLETED|Part A Screening Through Leukapheresis||25
1423996|NCT02535364|3485866|P1|COMPLETED|Part A Screening Through Leukapheresis||57
1423997|NCT02535364|3485866|P1|STARTED|Part A Screening Through Leukapheresis||82
1423998|NCT02535065|3485891|P1|NOT COMPLETED|Overall Study||62
1423999|NCT02535065|3485891|P1|COMPLETED|Overall Study||0
1424000|NCT02535065|3485891|P1|12-Month Follow-up|Overall Study||61
1424001|NCT02535065|3485891|P1|1-Month Follow-up|Overall Study||62
1424002|NCT02535065|3485891|P1|STARTED|Overall Study||62
1424003|NCT02535026|3485896|P1|NOT COMPLETED|Overall Study||0
1424004|NCT02535026|3485896|P1|COMPLETED|Overall Study||580
1424005|NCT02535026|3485896|P1|STARTED|Overall Study||580
1424006|NCT02534935|3485951|P3|NOT COMPLETED|Overall Study||5
1424007|NCT02534935|3485952|P2|NOT COMPLETED|Overall Study||10
1424008|NCT02534935|3485953|P1|NOT COMPLETED|Overall Study||0
1424009|NCT02534935|3485951|P3|COMPLETED|Overall Study||127
1424010|NCT02534935|3485952|P2|COMPLETED|Overall Study||210
1424011|NCT02534935|3485953|P1|COMPLETED|Overall Study||44
1424012|NCT02534935|3485951|P3|STARTED|Overall Study||132
1424013|NCT02534935|3485952|P2|STARTED|Overall Study||220
1424014|NCT02534935|3485953|P1|STARTED|Overall Study||44
1424015|NCT02534883|3486113|P2|NOT COMPLETED|Overall Study||3
1424016|NCT02534883|3486114|P1|NOT COMPLETED|Overall Study||8
1424017|NCT02534883|3486113|P2|COMPLETED|Overall Study||0
1424018|NCT02534883|3486114|P1|COMPLETED|Overall Study||0
1424019|NCT02534883|3486113|P2|STARTED|Overall Study||3
1424020|NCT02534883|3486114|P1|STARTED|Overall Study||8
1424021|NCT02534493|3486130|P1|NOT COMPLETED|Overall Study||2
1424022|NCT02534493|3486130|P1|COMPLETED|Overall Study||11
1424023|NCT02534493|3486130|P1|STARTED|Overall Study||13
1424024|NCT02534350|3486141|P2|NOT COMPLETED|Overall Study||0
1424025|NCT02534350|3486142|P1|NOT COMPLETED|Overall Study||4
1424026|NCT02534350|3486141|P2|COMPLETED|Overall Study||20
1424027|NCT02534350|3486142|P1|COMPLETED|Overall Study||37
1424028|NCT02534350|3486141|P2|STARTED|Overall Study||20
1424029|NCT02534350|3486142|P1|STARTED|Overall Study||41
1424031|NCT02534324|3486157|P1|NOT COMPLETED|Overall Study||25
1424032|NCT02534324|3486156|P2|COMPLETED|Overall Study||40
1424033|NCT02534324|3486157|P1|COMPLETED|Overall Study||73
1424034|NCT02534324|3486156|P2|STARTED|Overall Study||48
1424035|NCT02534324|3486157|P1|STARTED|Overall Study||98
1424036|NCT02534129|3486167|P2|NOT COMPLETED|Overall Study||0
1424037|NCT02534129|3486168|P1|NOT COMPLETED|Overall Study||0
1424038|NCT02534129|3486167|P2|COMPLETED|Overall Study||13
1424039|NCT02534129|3486168|P1|COMPLETED|Overall Study||13
1424040|NCT02534129|3486167|P2|STARTED|Overall Study||13
1424041|NCT02534129|3486168|P1|STARTED|Overall Study||13
1424042|NCT02533999|3486176|P2|NOT COMPLETED|Overall Study||7
1424043|NCT02533999|3486177|P1|NOT COMPLETED|Overall Study||6
1424044|NCT02533999|3486176|P2|COMPLETED|Overall Study||30
1424045|NCT02533999|3486177|P1|COMPLETED|Overall Study||32
1424046|NCT02533999|3486176|P2|STARTED|Overall Study||37
1424047|NCT02533999|3486177|P1|STARTED|Overall Study||38
1424048|NCT02533726|3486197|P2|NOT COMPLETED|Treatment||0
1424049|NCT02533726|3486198|P1|NOT COMPLETED|Treatment||0
1424050|NCT02533726|3486197|P2|COMPLETED|Treatment||603
1424051|NCT02533726|3486198|P1|COMPLETED|Treatment||709
1424052|NCT02533726|3486197|P2|Per Protocol Population|Treatment||555
1424053|NCT02533726|3486198|P1|Per Protocol Population|Treatment||671
1424054|NCT02533726|3486197|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
1424055|NCT02533726|3486198|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
1424056|NCT02533726|3486197|P2|NOT COMPLETED|Initial Allocation||0
1424057|NCT02533726|3486198|P1|NOT COMPLETED|Initial Allocation||0
1424058|NCT02533726|3486197|P2|COMPLETED|Initial Allocation||653
1424059|NCT02533726|3486198|P1|COMPLETED|Initial Allocation||659
1424060|NCT02533726|3486197|P2|STARTED|Initial Allocation||653
1424061|NCT02533726|3486198|P1|STARTED|Initial Allocation||659
1424062|NCT02533570|3486209|P3|NOT COMPLETED|Overall Study||1
1424063|NCT02533570|3486210|P2|NOT COMPLETED|Overall Study||1
1424064|NCT02533570|3486211|P1|NOT COMPLETED|Overall Study||0
1424065|NCT02533570|3486209|P3|COMPLETED|Overall Study||7
1424066|NCT02533570|3486210|P2|COMPLETED|Overall Study||7
1424067|NCT02533570|3486211|P1|COMPLETED|Overall Study||4
1424068|NCT02533570|3486209|P3|STARTED|Overall Study||8
1424069|NCT02533570|3486210|P2|STARTED|Overall Study||8
1424070|NCT02533570|3486211|P1|STARTED|Overall Study||4
1424071|NCT02533531|3486222|P1|NOT COMPLETED|Overall Study||1
1424072|NCT02533531|3486222|P1|COMPLETED|Overall Study||0
1424073|NCT02533531|3486222|P1|STARTED|Overall Study||1
1424074|NCT02533505|3486227|P2|NOT COMPLETED|Overall Study||1
1424075|NCT02533505|3486228|P1|NOT COMPLETED|Overall Study||3
1424076|NCT02533505|3486227|P2|COMPLETED|Overall Study||24
1424077|NCT02533505|3486228|P1|COMPLETED|Overall Study||23
1424078|NCT02533505|3486227|P2|STARTED|Overall Study||25
1424079|NCT02533505|3486228|P1|STARTED|Overall Study||26
1424080|NCT02533466|3486260|P2|NOT COMPLETED|Overall Study||0
1424081|NCT02533466|3486261|P1|NOT COMPLETED|Overall Study||0
1424082|NCT02533466|3486260|P2|COMPLETED|Overall Study||14
1424083|NCT02533466|3486261|P1|COMPLETED|Overall Study||16
1424084|NCT02533466|3486260|P2|STARTED|Overall Study||14
1424085|NCT02533466|3486261|P1|STARTED|Overall Study||16
1424086|NCT02533401|3486285|P1|NOT COMPLETED|Overall Study||11
1424087|NCT02533401|3486285|P1|COMPLETED|Overall Study||23
1424088|NCT02533401|3486285|P1|STARTED|Overall Study||34
1424089|NCT02533258|3486293|P1|NOT COMPLETED|Overall Study||8
1424090|NCT02533258|3486293|P1|COMPLETED|Overall Study||5
1424091|NCT02533258|3486293|P1|STARTED|Overall Study||13
1424092|NCT02533167|3486305|P1|NOT COMPLETED|Overall Study||15
1424093|NCT02533167|3486305|P1|COMPLETED|Overall Study||55
1424094|NCT02533167|3486305|P1|STARTED|Overall Study||70
1424095|NCT02532998|3486314|P1|NOT COMPLETED|Overall Study||0
1424096|NCT02532998|3486314|P1|COMPLETED|Overall Study||23
1424097|NCT02532998|3486314|P1|STARTED|Overall Study||23
1424098|NCT02532855|3486398|P2|NOT COMPLETED|Overall Study||11
1424099|NCT02532855|3486399|P1|NOT COMPLETED|Overall Study||8
1424100|NCT02532855|3486398|P2|COMPLETED|Overall Study||296
1424101|NCT02532855|3486399|P1|COMPLETED|Overall Study||299
1424102|NCT02532855|3486398|P2|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
1424103|NCT02532855|3486399|P1|Treated|Overall Study||307
1424104|NCT02532855|3486398|P2|STARTED|Overall Study||307
1424105|NCT02532855|3486399|P1|STARTED|Overall Study||307
1424106|NCT02532374|3486423|P1|NOT COMPLETED|Overall Study||2
1424107|NCT02532374|3486423|P1|COMPLETED|Overall Study||14
1424108|NCT02532374|3486423|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
1424109|NCT02532374|3486423|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
1424110|NCT02532374|3486423|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
1424111|NCT02532374|3486423|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
1424112|NCT02532374|3486423|P1|STARTED|Overall Study||16
1424113|NCT02532179|3486447|P1|NOT COMPLETED|Overall Study||3
1424114|NCT02532179|3486447|P1|COMPLETED|Overall Study||9
1424115|NCT02532179|3486447|P1|STARTED|Overall Study||12
1424116|NCT02532010|3486458|P2|NOT COMPLETED|Overall Study||4
1424117|NCT02532010|3486459|P1|NOT COMPLETED|Overall Study||9
1424118|NCT02532010|3486458|P2|COMPLETED|Overall Study||0
1424119|NCT02532010|3486459|P1|COMPLETED|Overall Study||0
1424120|NCT02532010|3486458|P2|STARTED|Overall Study||4
1424121|NCT02532010|3486459|P1|STARTED|Overall Study||9
1424122|NCT02531867|3486477|P1|NOT COMPLETED|Overall Study||0
1424123|NCT02531867|3486477|P1|COMPLETED|Overall Study||13
1424124|NCT02531867|3486477|P1|STARTED|Overall Study||13
1424125|NCT02531802|3486502|P21|NOT COMPLETED|Received Vaccination 2||1
1424126|NCT02531802|3486503|P20|NOT COMPLETED|Received Vaccination 2||1
1424127|NCT02531802|3486504|P19|NOT COMPLETED|Received Vaccination 2||3
1424128|NCT02531802|3486505|P18|NOT COMPLETED|Received Vaccination 2||4
1424129|NCT02531802|3486506|P17|NOT COMPLETED|Received Vaccination 2||0
1424130|NCT02531802|3486507|P16|NOT COMPLETED|Received Vaccination 2||0
1424131|NCT02531802|3486508|P15|NOT COMPLETED|Received Vaccination 2||1
1424132|NCT02531802|3486509|P14|NOT COMPLETED|Received Vaccination 2||2
1424133|NCT02531802|3486510|P13|NOT COMPLETED|Received Vaccination 2||2
1424134|NCT02531802|3486511|P12|NOT COMPLETED|Received Vaccination 2||0
1424135|NCT02531802|3486512|P11|NOT COMPLETED|Received Vaccination 2||2
1424136|NCT02531802|3486513|P10|NOT COMPLETED|Received Vaccination 2||3
1424137|NCT02531802|3486514|P9|NOT COMPLETED|Received Vaccination 2||0
1424138|NCT02531802|3486515|P8|NOT COMPLETED|Received Vaccination 2||0
1424139|NCT02531802|3486516|P7|NOT COMPLETED|Received Vaccination 2||0
1424140|NCT02531802|3486517|P6|NOT COMPLETED|Received Vaccination 2||3
1424141|NCT02531802|3486518|P5|NOT COMPLETED|Received Vaccination 2||0
1424142|NCT02531802|3486519|P4|NOT COMPLETED|Received Vaccination 2||0
1424143|NCT02531802|3486520|P3|NOT COMPLETED|Received Vaccination 2||1
1424144|NCT02531802|3486521|P2|NOT COMPLETED|Received Vaccination 2||0
1424145|NCT02531802|3486522|P1|NOT COMPLETED|Received Vaccination 2||0
1424146|NCT02531802|3486502|P21|COMPLETED|Received Vaccination 2||49
1424147|NCT02531802|3486503|P20|COMPLETED|Received Vaccination 2||29
1424148|NCT02531802|3486504|P19|COMPLETED|Received Vaccination 2||27
1424149|NCT02531802|3486505|P18|COMPLETED|Received Vaccination 2||26
1424150|NCT02531802|3486506|P17|COMPLETED|Received Vaccination 2||30
1424151|NCT02531802|3486507|P16|COMPLETED|Received Vaccination 2||30
1424152|NCT02531802|3486508|P15|COMPLETED|Received Vaccination 2||39
1424153|NCT02531802|3486509|P14|COMPLETED|Received Vaccination 2||13
1424154|NCT02531802|3486510|P13|COMPLETED|Received Vaccination 2||13
1424155|NCT02531802|3486511|P12|COMPLETED|Received Vaccination 2||15
1424156|NCT02531802|3486512|P11|COMPLETED|Received Vaccination 2||13
1424157|NCT02531802|3486513|P10|COMPLETED|Received Vaccination 2||49
1424158|NCT02531802|3486514|P9|COMPLETED|Received Vaccination 2||15
1424159|NCT02531802|3486515|P8|COMPLETED|Received Vaccination 2||15
1424160|NCT02531802|3486516|P7|COMPLETED|Received Vaccination 2||15
1424161|NCT02531802|3486517|P6|COMPLETED|Received Vaccination 2||0
1424162|NCT02531802|3486518|P5|COMPLETED|Received Vaccination 2||15
1424163|NCT02531802|3486519|P4|COMPLETED|Received Vaccination 2||15
1424164|NCT02531802|3486520|P3|COMPLETED|Received Vaccination 2||14
1424165|NCT02531802|3486521|P2|COMPLETED|Received Vaccination 2||15
1424166|NCT02531802|3486522|P1|COMPLETED|Received Vaccination 2||15
1424167|NCT02531802|3486502|P21|STARTED|Received Vaccination 2||50
1424168|NCT02531802|3486503|P20|STARTED|Received Vaccination 2||30
1424169|NCT02531802|3486504|P19|STARTED|Received Vaccination 2||30
1424170|NCT02531802|3486505|P18|STARTED|Received Vaccination 2||30
1424171|NCT02531802|3486506|P17|STARTED|Received Vaccination 2||30
1424172|NCT02531802|3486507|P16|STARTED|Received Vaccination 2||30
1424173|NCT02531802|3486508|P15|STARTED|Received Vaccination 2||40
1424174|NCT02531802|3486509|P14|STARTED|Received Vaccination 2||15
1424175|NCT02531802|3486510|P13|STARTED|Received Vaccination 2||15
1424176|NCT02531802|3486511|P12|STARTED|Received Vaccination 2||15
1424177|NCT02531802|3486512|P11|STARTED|Received Vaccination 2||15
1424178|NCT02531802|3486513|P10|STARTED|Received Vaccination 2||52
1424179|NCT02531802|3486514|P9|STARTED|Received Vaccination 2||15
1424180|NCT02531802|3486515|P8|STARTED|Received Vaccination 2||15
1424181|NCT02531802|3486516|P7|STARTED|Received Vaccination 2||15
1424182|NCT02531802|3486517|P6|STARTED|Received Vaccination 2||3
1424183|NCT02531802|3486518|P5|STARTED|Received Vaccination 2||15
1424184|NCT02531802|3486519|P4|STARTED|Received Vaccination 2||15
1424185|NCT02531802|3486520|P3|STARTED|Received Vaccination 2||15
1424186|NCT02531802|3486521|P2|STARTED|Received Vaccination 2||15
1424187|NCT02531802|3486522|P1|STARTED|Received Vaccination 2||15
1424188|NCT02531802|3486502|P21|NOT COMPLETED|Received Vaccination 1||0
1424189|NCT02531802|3486503|P20|NOT COMPLETED|Received Vaccination 1||0
1424190|NCT02531802|3486504|P19|NOT COMPLETED|Received Vaccination 1||0
1424191|NCT02531802|3486505|P18|NOT COMPLETED|Received Vaccination 1||0
1424192|NCT02531802|3486506|P17|NOT COMPLETED|Received Vaccination 1||0
1424193|NCT02531802|3486507|P16|NOT COMPLETED|Received Vaccination 1||0
1424194|NCT02531802|3486508|P15|NOT COMPLETED|Received Vaccination 1||0
1424195|NCT02531802|3486509|P14|NOT COMPLETED|Received Vaccination 1||0
1424196|NCT02531802|3486510|P13|NOT COMPLETED|Received Vaccination 1||0
1424197|NCT02531802|3486511|P12|NOT COMPLETED|Received Vaccination 1||0
1424198|NCT02531802|3486512|P11|NOT COMPLETED|Received Vaccination 1||0
1424199|NCT02531802|3486513|P10|NOT COMPLETED|Received Vaccination 1||0
1424200|NCT02531802|3486514|P9|NOT COMPLETED|Received Vaccination 1||0
1424201|NCT02531802|3486515|P8|NOT COMPLETED|Received Vaccination 1||0
1424202|NCT02531802|3486516|P7|NOT COMPLETED|Received Vaccination 1||0
1424203|NCT02531802|3486517|P6|NOT COMPLETED|Received Vaccination 1||0
1424204|NCT02531802|3486518|P5|NOT COMPLETED|Received Vaccination 1||0
1424205|NCT02531802|3486519|P4|NOT COMPLETED|Received Vaccination 1||0
1424206|NCT02531802|3486520|P3|NOT COMPLETED|Received Vaccination 1||0
1424207|NCT02531802|3486521|P2|NOT COMPLETED|Received Vaccination 1||0
1424208|NCT02531802|3486522|P1|NOT COMPLETED|Received Vaccination 1||0
1424209|NCT02531802|3486502|P21|COMPLETED|Received Vaccination 1||50
1424210|NCT02531802|3486503|P20|COMPLETED|Received Vaccination 1||30
1424211|NCT02531802|3486504|P19|COMPLETED|Received Vaccination 1||30
1424212|NCT02531802|3486505|P18|COMPLETED|Received Vaccination 1||30
1424213|NCT02531802|3486506|P17|COMPLETED|Received Vaccination 1||30
1424214|NCT02531802|3486507|P16|COMPLETED|Received Vaccination 1||30
1424215|NCT02531802|3486508|P15|COMPLETED|Received Vaccination 1||40
1424216|NCT02531802|3486509|P14|COMPLETED|Received Vaccination 1||15
1424217|NCT02531802|3486510|P13|COMPLETED|Received Vaccination 1||15
1424218|NCT02531802|3486511|P12|COMPLETED|Received Vaccination 1||15
1424219|NCT02531802|3486512|P11|COMPLETED|Received Vaccination 1||15
1424220|NCT02531802|3486513|P10|COMPLETED|Received Vaccination 1||52
1424221|NCT02531802|3486514|P9|COMPLETED|Received Vaccination 1||15
1424222|NCT02531802|3486515|P8|COMPLETED|Received Vaccination 1||15
1424223|NCT02531802|3486516|P7|COMPLETED|Received Vaccination 1||15
1424224|NCT02531802|3486517|P6|COMPLETED|Received Vaccination 1||3
1424225|NCT02531802|3486518|P5|COMPLETED|Received Vaccination 1||15
1424226|NCT02531802|3486519|P4|COMPLETED|Received Vaccination 1||15
1424227|NCT02531802|3486520|P3|COMPLETED|Received Vaccination 1||15
1424228|NCT02531802|3486521|P2|COMPLETED|Received Vaccination 1||15
1424229|NCT02531802|3486522|P1|COMPLETED|Received Vaccination 1||15
1424230|NCT02531802|3486502|P21|STARTED|Received Vaccination 1||50
1424231|NCT02531802|3486503|P20|STARTED|Received Vaccination 1||30
1424232|NCT02531802|3486504|P19|STARTED|Received Vaccination 1||30
1424233|NCT02531802|3486505|P18|STARTED|Received Vaccination 1||30
1424234|NCT02531802|3486506|P17|STARTED|Received Vaccination 1||30
1424235|NCT02531802|3486507|P16|STARTED|Received Vaccination 1||30
1424236|NCT02531802|3486508|P15|STARTED|Received Vaccination 1||40
1424237|NCT02531802|3486509|P14|STARTED|Received Vaccination 1||15
1424238|NCT02531802|3486510|P13|STARTED|Received Vaccination 1||15
1424239|NCT02531802|3486511|P12|STARTED|Received Vaccination 1||15
1424240|NCT02531802|3486512|P11|STARTED|Received Vaccination 1||15
1424241|NCT02531802|3486513|P10|STARTED|Received Vaccination 1||52
1424242|NCT02531802|3486514|P9|STARTED|Received Vaccination 1||15
1424243|NCT02531802|3486515|P8|STARTED|Received Vaccination 1||15
1424244|NCT02531802|3486516|P7|STARTED|Received Vaccination 1||15
1424245|NCT02531802|3486517|P6|STARTED|Received Vaccination 1||3
1424246|NCT02531802|3486518|P5|STARTED|Received Vaccination 1||15
1424247|NCT02531802|3486519|P4|STARTED|Received Vaccination 1||15
1424248|NCT02531802|3486520|P3|STARTED|Received Vaccination 1||15
1424249|NCT02531802|3486521|P2|STARTED|Received Vaccination 1||15
1424250|NCT02531802|3486522|P1|STARTED|Received Vaccination 1||15
1424251|NCT02531698|3486954|P2|NOT COMPLETED|Overall Study||2
1424252|NCT02531698|3486955|P1|NOT COMPLETED|Overall Study||11
1424253|NCT02531698|3486954|P2|COMPLETED|Overall Study||104
1424254|NCT02531698|3486955|P1|COMPLETED|Overall Study||283
1424255|NCT02531698|3486954|P2|STARTED|Overall Study||106
1424256|NCT02531698|3486955|P1|STARTED|Overall Study||294
1424257|NCT02531646|3487202|P3|NOT COMPLETED|Overall Study||0
1424258|NCT02531646|3487203|P2|NOT COMPLETED|Overall Study||1
1424259|NCT02531646|3487204|P1|NOT COMPLETED|Overall Study||5
1424260|NCT02531646|3487202|P3|COMPLETED|Overall Study||11
1424261|NCT02531646|3487203|P2|COMPLETED|Overall Study||17
1424262|NCT02531646|3487204|P1|COMPLETED|Overall Study||32
1424263|NCT02531646|3487202|P3|STARTED|Overall Study||11
1424264|NCT02531646|3487203|P2|STARTED|Overall Study||18
1424265|NCT02531646|3487204|P1|STARTED|Overall Study||37
1424266|NCT02531438|3487220|P2|NOT COMPLETED|Overall Study||26
1424267|NCT02531438|3487221|P1|NOT COMPLETED|Overall Study||30
1424268|NCT02531438|3487220|P2|COMPLETED|Overall Study||362
1424269|NCT02531438|3487221|P1|COMPLETED|Overall Study||356
1424270|NCT02531438|3487220|P2|STARTED|Overall Study||388
1424271|NCT02531438|3487221|P1|STARTED|Overall Study||386
1424272|NCT02531373|3487240|P9|NOT COMPLETED|Overall Study||9
1424273|NCT02531373|3487241|P8|NOT COMPLETED|Overall Study||9
1424274|NCT02531373|3487242|P7|NOT COMPLETED|Overall Study||11
1424275|NCT02531373|3487243|P6|NOT COMPLETED|Overall Study||9
1424276|NCT02531373|3487244|P5|NOT COMPLETED|Overall Study||8
1424277|NCT02531373|3487245|P4|NOT COMPLETED|Overall Study||0
1424278|NCT02531373|3487246|P3|NOT COMPLETED|Overall Study||0
1424279|NCT02531373|3487247|P2|NOT COMPLETED|Overall Study||0
1424280|NCT02531373|3487248|P1|NOT COMPLETED|Overall Study||0
1424281|NCT02531373|3487240|P9|COMPLETED|Overall Study||43
1424282|NCT02531373|3487241|P8|COMPLETED|Overall Study||43
1424283|NCT02531373|3487242|P7|COMPLETED|Overall Study||41
1424284|NCT02531373|3487243|P6|COMPLETED|Overall Study||42
1424285|NCT02531373|3487244|P5|COMPLETED|Overall Study||43
1424286|NCT02531373|3487245|P4|COMPLETED|Overall Study||20
1424287|NCT02531373|3487246|P3|COMPLETED|Overall Study||20
1424288|NCT02531373|3487247|P2|COMPLETED|Overall Study||20
1424289|NCT02531373|3487248|P1|COMPLETED|Overall Study||20
1424290|NCT02531373|3487240|P9|Vaccination 4|Overall Study||43
1424291|NCT02531373|3487241|P8|Vaccination 4|Overall Study||43
1424292|NCT02531373|3487242|P7|Vaccination 4|Overall Study||43
1424293|NCT02531373|3487243|P6|Vaccination 4|Overall Study||43
1424294|NCT02531373|3487244|P5|Vaccination 4|Overall Study||44
1424295|NCT02531373|3487245|P4|Vaccination 4|Overall Study||0
1424296|NCT02531373|3487246|P3|Vaccination 4|Overall Study||0
1424297|NCT02531373|3487247|P2|Vaccination 4|Overall Study||0
1424298|NCT02531373|3487248|P1|Vaccination 4|Overall Study||0
1424299|NCT02531373|3487240|P9|Vaccination 3|Overall Study||49
1424300|NCT02531373|3487241|P8|Vaccination 3|Overall Study||51
1424301|NCT02531373|3487242|P7|Vaccination 3|Overall Study||49
1424302|NCT02531373|3487243|P6|Vaccination 3|Overall Study||47
1424303|NCT02531373|3487244|P5|Vaccination 3|Overall Study||48
1424304|NCT02531373|3487245|P4|Vaccination 3|Overall Study||0
1424305|NCT02531373|3487246|P3|Vaccination 3|Overall Study||0
1424306|NCT02531373|3487247|P2|Vaccination 3|Overall Study||0
1424307|NCT02531373|3487248|P1|Vaccination 3|Overall Study||0
1424308|NCT02531373|3487240|P9|Vaccination 2|Overall Study||51
1424309|NCT02531373|3487241|P8|Vaccination 2|Overall Study||51
1424310|NCT02531373|3487242|P7|Vaccination 2|Overall Study||50
1424311|NCT02531373|3487243|P6|Vaccination 2|Overall Study||48
1424312|NCT02531373|3487244|P5|Vaccination 2|Overall Study||49
1424313|NCT02531373|3487245|P4|Vaccination 2|Overall Study||0
1424314|NCT02531373|3487246|P3|Vaccination 2|Overall Study||0
1424315|NCT02531373|3487247|P2|Vaccination 2|Overall Study||0
1424316|NCT02531373|3487248|P1|Vaccination 2|Overall Study||0
1424317|NCT02531373|3487240|P9|Vaccination 1|Overall Study||52
1424318|NCT02531373|3487241|P8|Vaccination 1|Overall Study||52
1424319|NCT02531373|3487242|P7|Vaccination 1|Overall Study||52
1424320|NCT02531373|3487243|P6|Vaccination 1|Overall Study||50
1424321|NCT02531373|3487244|P5|Vaccination 1|Overall Study||50
1424322|NCT02531373|3487245|P4|Vaccination 1|Overall Study||20
1424323|NCT02531373|3487246|P3|Vaccination 1|Overall Study||20
1424324|NCT02531373|3487247|P2|Vaccination 1|Overall Study||20
1424325|NCT02531373|3487248|P1|Vaccination 1|Overall Study||20
1424326|NCT02531373|3487240|P9|STARTED|Overall Study||52
1424327|NCT02531373|3487241|P8|STARTED|Overall Study||52
1424328|NCT02531373|3487242|P7|STARTED|Overall Study||52
1424329|NCT02531373|3487243|P6|STARTED|Overall Study||51
1424330|NCT02531373|3487244|P5|STARTED|Overall Study||51
1424331|NCT02531373|3487245|P4|STARTED|Overall Study||20
1424332|NCT02531373|3487246|P3|STARTED|Overall Study||20
1424333|NCT02531373|3487247|P2|STARTED|Overall Study||20
1424334|NCT02531373|3487248|P1|STARTED|Overall Study||20
1424335|NCT02531308|3487305|P1|NOT COMPLETED|Overall Study||3
1424336|NCT02531308|3487305|P1|COMPLETED|Overall Study||2
1424337|NCT02531308|3487305|P1|STARTED|Overall Study||5
1424338|NCT02530671|3487311|P2|NOT COMPLETED|Overall Study||0
1424339|NCT02530671|3487312|P1|NOT COMPLETED|Overall Study||3
1424340|NCT02530671|3487311|P2|COMPLETED|Overall Study||55
1424341|NCT02530671|3487312|P1|COMPLETED|Overall Study||52
1424342|NCT02530671|3487311|P2|STARTED|Overall Study||55
1424343|NCT02530671|3487312|P1|STARTED|Overall Study||55
1424344|NCT02530450|3487330|P2|NOT COMPLETED|Overall Study||5
1424345|NCT02530450|3487331|P1|NOT COMPLETED|Overall Study||6
1424346|NCT02530450|3487330|P2|COMPLETED|Overall Study||9
1424347|NCT02530450|3487331|P1|COMPLETED|Overall Study||10
1424348|NCT02530450|3487330|P2|STARTED|Overall Study||14
1424349|NCT02530450|3487331|P1|STARTED|Overall Study||16
1424350|NCT02530294|3487339|P2|NOT COMPLETED|Overall Study||6
1424351|NCT02530294|3487340|P1|NOT COMPLETED|Overall Study||16
1424352|NCT02530294|3487339|P2|COMPLETED|Overall Study||113
1424353|NCT02530294|3487340|P1|COMPLETED|Overall Study||218
1424354|NCT02530294|3487339|P2|STARTED|Overall Study||119
1424355|NCT02530294|3487340|P1|STARTED|Overall Study||234
1424356|NCT02530281|3487356|P2|NOT COMPLETED|Overall Study||3
1424357|NCT02530281|3487357|P1|NOT COMPLETED|Overall Study||21
1424358|NCT02530281|3487356|P2|COMPLETED|Overall Study||112
1424359|NCT02530281|3487357|P1|COMPLETED|Overall Study||208
1424360|NCT02530281|3487356|P2|STARTED|Overall Study||115
1424361|NCT02530281|3487357|P1|STARTED|Overall Study||229
1424362|NCT02530125|3487373|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
1424363|NCT02530125|3487373|P1|COMPLETED|Followed for Survival for 2 Years||0
1424364|NCT02530125|3487373|P1|STARTED|Followed for Survival for 2 Years||3
1424365|NCT02530125|3487373|P1|NOT COMPLETED|Completed Treatment||1
1424366|NCT02530125|3487373|P1|COMPLETED|Completed Treatment||3
1424367|NCT02530125|3487373|P1|STARTED|Completed Treatment||4
1424368|NCT02529995|3487387|P2|NOT COMPLETED|Part B||12
1424369|NCT02529995|3487388|P1|NOT COMPLETED|Part B||6
1424370|NCT02529995|3487387|P2|COMPLETED|Part B||4
1424371|NCT02529995|3487388|P1|COMPLETED|Part B||9
1424372|NCT02529995|3487387|P2|STARTED|Part B||16
1424373|NCT02529995|3487388|P1|STARTED|Part B||15
1424374|NCT02529995|3487387|P2|NOT COMPLETED|Part A||16
1424375|NCT02529995|3487388|P1|NOT COMPLETED|Part A||15
1424376|NCT02529995|3487387|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
1424377|NCT02529995|3487388|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
1424378|NCT02529995|3487387|P2|STARTED|Part A||16
1424379|NCT02529995|3487388|P1|STARTED|Part A||15
1424380|NCT02529488|3487422|P1|NOT COMPLETED|Overall Study||4
1424381|NCT02529488|3487422|P1|COMPLETED|Overall Study||145
1424382|NCT02529488|3487422|P1|STARTED|Overall Study||149
1424383|NCT02528786|3487430|P1|NOT COMPLETED|Overall Study||0
1424384|NCT02528786|3487430|P1|COMPLETED|Overall Study||8
1424385|NCT02528786|3487430|P1|STARTED|Overall Study||8
1424386|NCT02528721|3487436|P2|NOT COMPLETED|Overall Study||3
1424387|NCT02528721|3487437|P1|NOT COMPLETED|Overall Study||7
1424388|NCT02528721|3487436|P2|COMPLETED|Overall Study||76
1424389|NCT02528721|3487437|P1|COMPLETED|Overall Study||196
1424390|NCT02528721|3487436|P2|STARTED|Overall Study||79
1424391|NCT02528721|3487437|P1|STARTED|Overall Study||203
1424392|NCT02528643|3487449|P2|NOT COMPLETED|Overall Study||85
1424393|NCT02528643|3487450|P1|NOT COMPLETED|Overall Study||39
1424394|NCT02528643|3487449|P2|COMPLETED|Overall Study||25
1424395|NCT02528643|3487450|P1|COMPLETED|Overall Study||16
1424396|NCT02528643|3487449|P2|Treated|Overall Study||107
1424397|NCT02528643|3487450|P1|Treated|Overall Study||55
1424398|NCT02528643|3487449|P2|STARTED|Overall Study||110
1424399|NCT02528643|3487450|P1|STARTED|Overall Study||55
1424400|NCT02528500|3487463|P1|NOT COMPLETED|Overall Study||0
1424401|NCT02528500|3487463|P1|COMPLETED|Overall Study||10
1424402|NCT02528500|3487463|P1|STARTED|Overall Study||10
1424403|NCT02528331|3487467|P1|NOT COMPLETED|Overall Study||2
1424404|NCT02528331|3487467|P1|COMPLETED|Overall Study||0
1424405|NCT02528331|3487467|P1|STARTED|Overall Study||2
1424406|NCT02528305|3487474|P1|NOT COMPLETED|Overall Study||3
1424407|NCT02528305|3487474|P1|COMPLETED|Overall Study||9
1424408|NCT02528305|3487474|P1|End of Intervention Period Assessment|Overall Study||9
1424409|NCT02528305|3487474|P1|End of Control Period Assessment|Overall Study||11
1424410|NCT02528305|3487474|P1|STARTED|Overall Study||12
1424411|NCT02528214|3487518|P2|NOT COMPLETED|Overall Study||3
1424412|NCT02528214|3487519|P1|NOT COMPLETED|Overall Study||0
1424413|NCT02528214|3487518|P2|COMPLETED|Overall Study||100
1424414|NCT02528214|3487519|P1|COMPLETED|Overall Study||107
1424415|NCT02528214|3487518|P2|Treated|Overall Study||103
1424416|NCT02528214|3487519|P1|Treated|Overall Study||107
1424417|NCT02528214|3487518|P2|STARTED|Overall Study||103
1424418|NCT02528214|3487519|P1|STARTED|Overall Study||107
1424419|NCT02528097|3487551|P2|NOT COMPLETED|Overall Study||0
1424420|NCT02528097|3487552|P1|NOT COMPLETED|Overall Study||0
1424421|NCT02528097|3487551|P2|COMPLETED|Overall Study||1
1424422|NCT02528097|3487552|P1|COMPLETED|Overall Study||1
1424423|NCT02528097|3487551|P2|STARTED|Overall Study||1
1424424|NCT02528097|3487552|P1|STARTED|Overall Study||1
1424425|NCT02527694|3487562|P2|NOT COMPLETED|Overall Study||8
1424426|NCT02527694|3487563|P1|NOT COMPLETED|Overall Study||10
1424427|NCT02527694|3487562|P2|COMPLETED|Overall Study||21
1424428|NCT02527694|3487563|P1|COMPLETED|Overall Study||10
1424429|NCT02527694|3487562|P2|STARTED|Overall Study||29
1424430|NCT02527694|3487563|P1|STARTED|Overall Study||20
1424431|NCT02527161|3487571|P1|NOT COMPLETED|Overall Study||62
1424432|NCT02527161|3487571|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
1424433|NCT02527161|3487571|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
1424434|NCT02527148|3487590|P2|NOT COMPLETED|Overall Study||0
1424435|NCT02527148|3487591|P1|NOT COMPLETED|Overall Study||1
1424436|NCT02527148|3487590|P2|COMPLETED|Overall Study||50
1424437|NCT02527148|3487591|P1|COMPLETED|Overall Study||49
1424438|NCT02527148|3487590|P2|STARTED|Overall Study||50
1424439|NCT02527148|3487591|P1|STARTED|Overall Study||50
1424440|NCT02526680|3487609|P1|NOT COMPLETED|Overall Study||0
1424441|NCT02526680|3487609|P1|COMPLETED|Overall Study||27
1424442|NCT02526680|3487609|P1|STARTED|Overall Study||27
1424443|NCT02526550|3487616|P1|NOT COMPLETED|Overall Study||1
1424444|NCT02526550|3487616|P1|COMPLETED|Overall Study||49
1424445|NCT02526550|3487616|P1|STARTED|Overall Study||50
1424446|NCT02526524|3487628|P6|NOT COMPLETED|Overall Study||21
1424447|NCT02526524|3487629|P5|NOT COMPLETED|Overall Study||24
1424448|NCT02526524|3487630|P4|NOT COMPLETED|Overall Study||7
1424449|NCT02526524|3487631|P3|NOT COMPLETED|Overall Study||26
1424450|NCT02526524|3487632|P2|NOT COMPLETED|Overall Study||9
1424451|NCT02526524|3487633|P1|NOT COMPLETED|Overall Study||12
1424452|NCT02526524|3487628|P6|COMPLETED|Overall Study||73
1424453|NCT02526524|3487629|P5|COMPLETED|Overall Study||72
1424454|NCT02526524|3487630|P4|COMPLETED|Overall Study||89
1424455|NCT02526524|3487631|P3|COMPLETED|Overall Study||70
1424456|NCT02526524|3487632|P2|COMPLETED|Overall Study||86
1424457|NCT02526524|3487633|P1|COMPLETED|Overall Study||82
1424458|NCT02526524|3487628|P6|STARTED|Overall Study||94
1424459|NCT02526524|3487629|P5|STARTED|Overall Study||96
1424460|NCT02526524|3487630|P4|STARTED|Overall Study||96
1424461|NCT02526524|3487631|P3|STARTED|Overall Study||96
1424462|NCT02526524|3487632|P2|STARTED|Overall Study||95
1424463|NCT02526524|3487633|P1|STARTED|Overall Study||94
1424464|NCT02526290|3487647|P1|NOT COMPLETED|Overall Study||8
1424465|NCT02526290|3487647|P1|COMPLETED|Overall Study||89
1424466|NCT02526290|3487647|P1|STARTED|Overall Study||97
1424467|NCT02525536|3487657|P3|NOT COMPLETED|Overall Study||0
1424468|NCT02525536|3487658|P2|NOT COMPLETED|Overall Study||0
1424469|NCT02525536|3487659|P1|NOT COMPLETED|Overall Study||0
1424470|NCT02525536|3487657|P3|COMPLETED|Overall Study||6
1424471|NCT02525536|3487658|P2|COMPLETED|Overall Study||6
1424472|NCT02525536|3487659|P1|COMPLETED|Overall Study||6
1424473|NCT02525536|3487657|P3|STARTED|Overall Study||6
1424474|NCT02525536|3487658|P2|STARTED|Overall Study||6
1424475|NCT02525536|3487659|P1|STARTED|Overall Study||6
1424476|NCT02525094|3487732|P2|NOT COMPLETED|Overall Study||8
1424477|NCT02525094|3487733|P1|NOT COMPLETED|Overall Study||8
1424478|NCT02525094|3487732|P2|COMPLETED|Overall Study||48
1424479|NCT02525094|3487733|P1|COMPLETED|Overall Study||49
1424480|NCT02525094|3487732|P2|Treated|Overall Study||55
1424481|NCT02525094|3487733|P1|Treated|Overall Study||56
1424482|NCT02525094|3487732|P2|STARTED|Overall Study||56
1424483|NCT02525094|3487733|P1|STARTED|Overall Study||57
1424484|NCT02524977|3487762|P2|NOT COMPLETED|Overall Study||45
1424485|NCT02524977|3487763|P1|NOT COMPLETED|Overall Study||46
1424486|NCT02524977|3487762|P2|COMPLETED|Overall Study||801
1424487|NCT02524977|3487763|P1|COMPLETED|Overall Study||692
1424488|NCT02524977|3487762|P2|STARTED|Overall Study||846
1424489|NCT02524977|3487763|P1|STARTED|Overall Study||738
1424490|NCT02524665|3487771|P1|NOT COMPLETED|Overall Study||1
1424491|NCT02524665|3487771|P1|COMPLETED|Overall Study||19
1424492|NCT02524665|3487771|P1|STARTED|Overall Study||20
1424493|NCT02524561|3487789|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
1424494|NCT02524561|3487790|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
1424495|NCT02524561|3487791|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
1424496|NCT02524561|3487789|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
1424497|NCT02524561|3487790|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
1424498|NCT02524561|3487791|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
1424499|NCT02524561|3487789|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
1424500|NCT02524561|3487790|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
1424501|NCT02524561|3487791|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
1424502|NCT02524561|3487789|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
1424503|NCT02524561|3487790|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
1424504|NCT02524561|3487791|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
1424505|NCT02524561|3487789|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
1424506|NCT02524561|3487790|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
1424507|NCT02524561|3487791|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
1424508|NCT02524561|3487789|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
1424509|NCT02524561|3487790|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
1424510|NCT02524561|3487791|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
1424511|NCT02524561|3487789|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
1424512|NCT02524561|3487790|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
1424513|NCT02524561|3487791|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
1424514|NCT02524561|3487789|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
1424515|NCT02524561|3487790|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
1424516|NCT02524561|3487791|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
1424517|NCT02524561|3487789|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
1424518|NCT02524561|3487790|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
1424519|NCT02524561|3487791|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
1424520|NCT02524561|3487789|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
1424521|NCT02524561|3487790|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
1424522|NCT02524561|3487791|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
1424523|NCT02524561|3487789|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
1424524|NCT02524561|3487790|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
1424525|NCT02524561|3487791|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
1424526|NCT02524561|3487789|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
1424527|NCT02524561|3487790|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
1424528|NCT02524561|3487791|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
1424529|NCT02524418|3487808|P1|NOT COMPLETED|Overall Study||13
1424530|NCT02524418|3487808|P1|COMPLETED|Overall Study||75
1424531|NCT02524418|3487808|P1|STARTED|Overall Study||88
1424532|NCT02524288|3487822|P1|NOT COMPLETED|Overall Study||1941
1424533|NCT02524288|3487822|P1|COMPLETED|Overall Study||0
1424534|NCT02524288|3487822|P1|Treated|Overall Study||1936
1424535|NCT02524288|3487822|P1|STARTED|Overall Study||1941
1424536|NCT02524158|3487832|P2|NOT COMPLETED|6-month Assessment||21
1424537|NCT02524158|3487833|P1|NOT COMPLETED|6-month Assessment||22
1424538|NCT02524158|3487832|P2|COMPLETED|6-month Assessment||55
1424539|NCT02524158|3487833|P1|COMPLETED|6-month Assessment||54
1424540|NCT02524158|3487832|P2|STARTED|6-month Assessment||76
1424541|NCT02524158|3487833|P1|STARTED|6-month Assessment||76
1424542|NCT02524158|3487832|P2|NOT COMPLETED|12-weeks Assessment||13
1424543|NCT02524158|3487833|P1|NOT COMPLETED|12-weeks Assessment||19
1424544|NCT02524158|3487832|P2|COMPLETED|12-weeks Assessment||63
1424545|NCT02524158|3487833|P1|COMPLETED|12-weeks Assessment||57
1424546|NCT02524158|3487832|P2|STARTED|12-weeks Assessment||76
1424547|NCT02524158|3487833|P1|STARTED|12-weeks Assessment||76
1424548|NCT02524054|3487874|P3|NOT COMPLETED|Overall Study||0
1424549|NCT02524054|3487875|P2|NOT COMPLETED|Overall Study||0
1424550|NCT02524054|3487876|P1|NOT COMPLETED|Overall Study||0
1424551|NCT02524054|3487874|P3|COMPLETED|Overall Study||8
1424552|NCT02524054|3487875|P2|COMPLETED|Overall Study||9
1424553|NCT02524054|3487876|P1|COMPLETED|Overall Study||7
1424554|NCT02524054|3487874|P3|STARTED|Overall Study||8
1424555|NCT02524054|3487875|P2|STARTED|Overall Study||9
1424556|NCT02524054|3487876|P1|STARTED|Overall Study||7
1424557|NCT02523586|3487887|P1|NOT COMPLETED|Overall Study||4
1424558|NCT02523586|3487887|P1|COMPLETED|Overall Study||10
1424559|NCT02523586|3487887|P1|STARTED|Overall Study||14
1424560|NCT02522624|3487900|P2|NOT COMPLETED|Overall Study||0
1424561|NCT02522624|3487901|P1|NOT COMPLETED|Overall Study||1
1424562|NCT02522624|3487900|P2|COMPLETED|Overall Study||163
1424563|NCT02522624|3487901|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
1424564|NCT02522624|3487900|P2|STARTED|Overall Study||163
1424565|NCT02522624|3487901|P1|STARTED|Overall Study||165
1424566|NCT02522403|3487919|P2|NOT COMPLETED|Overall Study||6
1424567|NCT02522403|3487920|P1|NOT COMPLETED|Overall Study||4
1424568|NCT02522403|3487919|P2|COMPLETED|Overall Study||13
1424569|NCT02522403|3487920|P1|COMPLETED|Overall Study||13
1424570|NCT02522403|3487919|P2|STARTED|Overall Study||19
1424571|NCT02522403|3487920|P1|STARTED|Overall Study||17
1424572|NCT02522286|3487934|P4|NOT COMPLETED|Overall Study||3
1424573|NCT02522286|3487935|P3|NOT COMPLETED|Overall Study||0
1424574|NCT02522286|3487936|P2|NOT COMPLETED|Overall Study||0
1424575|NCT02522286|3487937|P1|NOT COMPLETED|Overall Study||3
1424576|NCT02522286|3487934|P4|COMPLETED|Overall Study||75
1424577|NCT02522286|3487935|P3|COMPLETED|Overall Study||75
1424578|NCT02522286|3487936|P2|COMPLETED|Overall Study||75
1424579|NCT02522286|3487937|P1|COMPLETED|Overall Study||75
1424580|NCT02522286|3487934|P4|STARTED|Overall Study||78
1424581|NCT02522286|3487935|P3|STARTED|Overall Study||75
1424582|NCT02522286|3487936|P2|STARTED|Overall Study||75
1424583|NCT02522286|3487937|P1|STARTED|Overall Study||78
1424584|NCT02521948|3487963|P1|NOT COMPLETED|Overall Study||13
1424585|NCT02521948|3487963|P1|COMPLETED|Overall Study||37
1424586|NCT02521948|3487963|P1|STARTED|Overall Study||50
1424587|NCT02520726|3487974|P2|NOT COMPLETED|Overall Study||2
1424588|NCT02520726|3487975|P1|NOT COMPLETED|Overall Study||3
1424589|NCT02520726|3487974|P2|COMPLETED|Overall Study||0
1424590|NCT02520726|3487975|P1|COMPLETED|Overall Study||0
1424591|NCT02520726|3487974|P2|STARTED|Overall Study||2
1424592|NCT02520726|3487975|P1|STARTED|Overall Study||3
1424593|NCT02520518|3487987|P4|NOT COMPLETED|Overall Study||1
1424594|NCT02520518|3487988|P3|NOT COMPLETED|Overall Study||2
1424595|NCT02520518|3487989|P2|NOT COMPLETED|Overall Study||0
1424596|NCT02520518|3487990|P1|NOT COMPLETED|Overall Study||0
1424597|NCT02520518|3487987|P4|COMPLETED|Overall Study||1
1424598|NCT02520518|3487988|P3|COMPLETED|Overall Study||1
1424599|NCT02520518|3487989|P2|COMPLETED|Overall Study||1
1424600|NCT02520518|3487990|P1|COMPLETED|Overall Study||3
1424601|NCT02520518|3487987|P4|STARTED|Overall Study||2
1424602|NCT02520518|3487988|P3|STARTED|Overall Study||3
1424603|NCT02520518|3487989|P2|STARTED|Overall Study||1
1424604|NCT02520518|3487990|P1|STARTED|Overall Study||3
1424605|NCT02520414|3488048|P1|NOT COMPLETED|Overall Study||0
1424606|NCT02520414|3488048|P1|COMPLETED|Overall Study||10
1424607|NCT02520414|3488048|P1|STARTED|Overall Study||10
1424608|NCT02520388|3488054|P2|NOT COMPLETED|Overall Study||16
1424609|NCT02520388|3488055|P1|NOT COMPLETED|Overall Study||9
1424610|NCT02520388|3488054|P2|COMPLETED|Overall Study||65
1424611|NCT02520388|3488055|P1|COMPLETED|Overall Study||73
1424612|NCT02520388|3488054|P2|Treated|Overall Study||80
1424613|NCT02520388|3488055|P1|Treated|Overall Study||81
1424614|NCT02520388|3488054|P2|STARTED|Overall Study||81
1424615|NCT02520388|3488055|P1|STARTED|Overall Study||82
1424616|NCT02520089|3488065|P2|NOT COMPLETED|Overall Study||4
1424617|NCT02520089|3488066|P1|NOT COMPLETED|Overall Study||3
1424618|NCT02520089|3488065|P2|COMPLETED|Overall Study||7
1424619|NCT02520089|3488066|P1|COMPLETED|Overall Study||9
1424620|NCT02520089|3488065|P2|STARTED|Overall Study||11
1424621|NCT02520089|3488066|P1|STARTED|Overall Study||12
1424622|NCT02519855|3488076|P2|NOT COMPLETED|Overall Study||4
1424623|NCT02519855|3488077|P1|NOT COMPLETED|Overall Study||3
1424624|NCT02519855|3488076|P2|COMPLETED|Overall Study||437
1424625|NCT02519855|3488077|P1|COMPLETED|Overall Study||438
1424626|NCT02519855|3488076|P2|Vaccinated at Week 4|Overall Study||424
1424627|NCT02519855|3488077|P1|Vaccinated at Week 4|Overall Study||432
1424628|NCT02519855|3488076|P2|Vaccinated on Day 1|Overall Study||441
1424629|NCT02519855|3488077|P1|Vaccinated on Day 1|Overall Study||440
1424630|NCT02519855|3488076|P2|STARTED|Overall Study|Participants are included as treated|441
1424631|NCT02519855|3488077|P1|STARTED|Overall Study|Participants are included as treated|441
1424632|NCT02519842|3488095|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
1424633|NCT02519842|3488096|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
1424634|NCT02519842|3488097|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
1424635|NCT02519842|3488095|P3|COMPLETED|Optional Extension: Cycles 2-6||26
1424636|NCT02519842|3488096|P2|COMPLETED|Optional Extension: Cycles 2-6||0
1424637|NCT02519842|3488097|P1|COMPLETED|Optional Extension: Cycles 2-6||0
1424638|NCT02519842|3488095|P3|Treated|Optional Extension: Cycles 2-6||55
1424639|NCT02519842|3488096|P2|Treated|Optional Extension: Cycles 2-6||0
1424640|NCT02519842|3488097|P1|Treated|Optional Extension: Cycles 2-6||0
1424641|NCT02519842|3488095|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
1424642|NCT02519842|3488096|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
1424643|NCT02519842|3488097|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
1424644|NCT02519842|3488095|P3|NOT COMPLETED|Base Study: Cycle 1||0
1424645|NCT02519842|3488096|P2|NOT COMPLETED|Base Study: Cycle 1||3
1424646|NCT02519842|3488097|P1|NOT COMPLETED|Base Study: Cycle 1||2
1424647|NCT02519842|3488095|P3|COMPLETED|Base Study: Cycle 1||0
1424648|NCT02519842|3488096|P2|COMPLETED|Base Study: Cycle 1||34
1424649|NCT02519842|3488097|P1|COMPLETED|Base Study: Cycle 1||36
1424650|NCT02519842|3488095|P3|Treated|Base Study: Cycle 1||0
1424651|NCT02519842|3488096|P2|Treated|Base Study: Cycle 1||34
1424652|NCT02519842|3488097|P1|Treated|Base Study: Cycle 1||37
1424653|NCT02519842|3488095|P3|STARTED|Base Study: Cycle 1||0
1424654|NCT02519842|3488096|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
1424655|NCT02519842|3488097|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
1424656|NCT02519712|3488116|P1|NOT COMPLETED|Overall Study||4
1424657|NCT02519712|3488116|P1|COMPLETED|Overall Study||0
1424658|NCT02519712|3488116|P1|STARTED|Overall Study||4
1424659|NCT02519595|3488123|P3|NOT COMPLETED|Overall Study||16
1424660|NCT02519595|3488124|P2|NOT COMPLETED|Overall Study||22
1424661|NCT02519595|3488125|P1|NOT COMPLETED|Overall Study||8
1424662|NCT02519595|3488123|P3|COMPLETED|Overall Study||40
1424663|NCT02519595|3488124|P2|COMPLETED|Overall Study||35
1424664|NCT02519595|3488125|P1|COMPLETED|Overall Study||50
1424665|NCT02519595|3488123|P3|STARTED|Overall Study||56
1424666|NCT02519595|3488124|P2|STARTED|Overall Study||57
1424667|NCT02519595|3488125|P1|STARTED|Overall Study||58
1424668|NCT02519387|3488148|P1|NOT COMPLETED|Overall Study||22
1424669|NCT02519387|3488148|P1|COMPLETED|Overall Study||56
1424670|NCT02519387|3488148|P1|STARTED|Overall Study||78
1424671|NCT02519023|3488158|P2|NOT COMPLETED|Overall Study||7
1424672|NCT02519023|3488159|P1|NOT COMPLETED|Overall Study||18
1424673|NCT02519023|3488158|P2|COMPLETED|Overall Study||31
1424674|NCT02519023|3488159|P1|COMPLETED|Overall Study||31
1424675|NCT02519023|3488158|P2|STARTED|Overall Study||38
1424676|NCT02519023|3488159|P1|STARTED|Overall Study||49
1424677|NCT02518919|3488194|P3|NOT COMPLETED|Overall Study||2
1424678|NCT02518919|3488195|P2|NOT COMPLETED|Overall Study||1
1424679|NCT02518919|3488196|P1|NOT COMPLETED|Overall Study||1
1424680|NCT02518919|3488194|P3|COMPLETED|Overall Study||19
1424681|NCT02518919|3488195|P2|COMPLETED|Overall Study||20
1424682|NCT02518919|3488196|P1|COMPLETED|Overall Study||20
1424683|NCT02518919|3488194|P3|STARTED|Overall Study||21
1424684|NCT02518919|3488195|P2|STARTED|Overall Study||21
1424685|NCT02518919|3488196|P1|STARTED|Overall Study||21
1424686|NCT02518139|3488219|P3|NOT COMPLETED|Overall Study||94
1424687|NCT02518139|3488220|P2|NOT COMPLETED|Overall Study||144
1424688|NCT02518139|3488221|P1|NOT COMPLETED|Overall Study||145
1424689|NCT02518139|3488219|P3|COMPLETED|Overall Study||262
1424690|NCT02518139|3488220|P2|COMPLETED|Overall Study||191
1424691|NCT02518139|3488221|P1|COMPLETED|Overall Study||219
1424692|NCT02518139|3488219|P3|STARTED|Overall Study||356
1424693|NCT02518139|3488220|P2|STARTED|Overall Study||335
1424694|NCT02518139|3488221|P1|STARTED|Overall Study||364
1424695|NCT02518048|3488229|P1|NOT COMPLETED|Overall Study||1
1424696|NCT02518048|3488229|P1|COMPLETED|Overall Study||34
1424697|NCT02518048|3488229|P1|STARTED|Overall Study||35
1424698|NCT02517580|3488240|P1|NOT COMPLETED|Overall Study||4
1424699|NCT02517580|3488240|P1|COMPLETED|Overall Study||56
1424700|NCT02517580|3488240|P1|STARTED|Overall Study||60
1424701|NCT02517567|3488244|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
1424702|NCT02517567|3488245|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
1424703|NCT02517567|3488246|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
1424704|NCT02517567|3488247|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
1424705|NCT02517567|3488244|P4|COMPLETED|Fourth Exposure (8 Hours)||8
1424706|NCT02517567|3488245|P3|COMPLETED|Fourth Exposure (8 Hours)||6
1424707|NCT02517567|3488246|P2|COMPLETED|Fourth Exposure (8 Hours)||8
1424708|NCT02517567|3488247|P1|COMPLETED|Fourth Exposure (8 Hours)||6
1424709|NCT02517567|3488244|P4|STARTED|Fourth Exposure (8 Hours)||8
1424710|NCT02517567|3488245|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
1424711|NCT02517567|3488246|P2|STARTED|Fourth Exposure (8 Hours)||8
1424712|NCT02517567|3488247|P1|STARTED|Fourth Exposure (8 Hours)||6
1424713|NCT02517567|3488244|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
1424714|NCT02517567|3488245|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
1424715|NCT02517567|3488246|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
1424716|NCT02517567|3488247|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
1424717|NCT02517567|3488244|P4|COMPLETED|Third Exposure (8 Hours)||8
1424718|NCT02517567|3488245|P3|COMPLETED|Third Exposure (8 Hours)||7
1424719|NCT02517567|3488246|P2|COMPLETED|Third Exposure (8 Hours)||8
1424720|NCT02517567|3488247|P1|COMPLETED|Third Exposure (8 Hours)||6
1424721|NCT02517567|3488244|P4|STARTED|Third Exposure (8 Hours)||8
1424722|NCT02517567|3488245|P3|STARTED|Third Exposure (8 Hours)||7
1424723|NCT02517567|3488246|P2|STARTED|Third Exposure (8 Hours)||8
1424724|NCT02517567|3488247|P1|STARTED|Third Exposure (8 Hours)||6
1424725|NCT02517567|3488244|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
1424726|NCT02517567|3488245|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
1424727|NCT02517567|3488246|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
1424728|NCT02517567|3488247|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
1424729|NCT02517567|3488244|P4|COMPLETED|Second Exposure (8 Hours)||8
1424730|NCT02517567|3488245|P3|COMPLETED|Second Exposure (8 Hours)||7
1424731|NCT02517567|3488246|P2|COMPLETED|Second Exposure (8 Hours)||8
1424732|NCT02517567|3488247|P1|COMPLETED|Second Exposure (8 Hours)||6
1424733|NCT02517567|3488244|P4|STARTED|Second Exposure (8 Hours)||8
1424734|NCT02517567|3488245|P3|STARTED|Second Exposure (8 Hours)||7
1424735|NCT02517567|3488246|P2|STARTED|Second Exposure (8 Hours)||8
1424736|NCT02517567|3488247|P1|STARTED|Second Exposure (8 Hours)||6
1424737|NCT02517567|3488244|P4|NOT COMPLETED|First Exposure (8 Hours)||0
1424738|NCT02517567|3488245|P3|NOT COMPLETED|First Exposure (8 Hours)||0
1424739|NCT02517567|3488246|P2|NOT COMPLETED|First Exposure (8 Hours)||0
1424740|NCT02517567|3488247|P1|NOT COMPLETED|First Exposure (8 Hours)||0
1424741|NCT02517567|3488244|P4|COMPLETED|First Exposure (8 Hours)||8
1424742|NCT02517567|3488245|P3|COMPLETED|First Exposure (8 Hours)||7
1424743|NCT02517567|3488246|P2|COMPLETED|First Exposure (8 Hours)||8
1424744|NCT02517567|3488247|P1|COMPLETED|First Exposure (8 Hours)||6
1424745|NCT02517567|3488244|P4|STARTED|First Exposure (8 Hours)||8
1424746|NCT02517567|3488245|P3|STARTED|First Exposure (8 Hours)||7
1424747|NCT02517567|3488246|P2|STARTED|First Exposure (8 Hours)||8
1424748|NCT02517567|3488247|P1|STARTED|First Exposure (8 Hours)||6
1424749|NCT02517541|3488256|P1|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
1424750|NCT02517541|3488256|P1|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
1424751|NCT02517541|3488256|P1|STARTED|Test Period (SenSura Mio Convex Soft)||73
1424752|NCT02517541|3488256|P1|NOT COMPLETED|Baseline Period (Own Product)||1
1424753|NCT02517541|3488256|P1|COMPLETED|Baseline Period (Own Product)||73
1424754|NCT02517541|3488256|P1|STARTED|Baseline Period (Own Product)||74
1424755|NCT02517528|3488262|P1|NOT COMPLETED|Overall Study||1
1424756|NCT02517528|3488262|P1|COMPLETED|Overall Study||103
1424757|NCT02517528|3488262|P1|STARTED|Overall Study||104
1424758|NCT02517515|3488272|P2|NOT COMPLETED|Overall Study||2
1424759|NCT02517515|3488273|P1|NOT COMPLETED|Overall Study||2
1424760|NCT02517515|3488272|P2|COMPLETED|Overall Study||323
1424761|NCT02517515|3488273|P1|COMPLETED|Overall Study||323
1424762|NCT02517515|3488272|P2|STARTED|Overall Study||325
1424763|NCT02517515|3488273|P1|STARTED|Overall Study||325
1424764|NCT02517463|3488290|P2|NOT COMPLETED|Overall Study||2
1424765|NCT02517463|3488291|P1|NOT COMPLETED|Overall Study||5
1424766|NCT02517463|3488290|P2|COMPLETED|Overall Study||329
1424767|NCT02517463|3488291|P1|COMPLETED|Overall Study||364
1424768|NCT02517463|3488290|P2|STARTED|Overall Study||331
1424769|NCT02517463|3488291|P1|STARTED|Overall Study||369
1424770|NCT02517047|3488301|P1|NOT COMPLETED|Overall Study||2
1424771|NCT02517047|3488301|P1|COMPLETED|Overall Study||24
1424772|NCT02517047|3488301|P1|STARTED|Overall Study||26
1424773|NCT02517021|3488310|P2|NOT COMPLETED|Overall Study||85
1424774|NCT02517021|3488311|P1|NOT COMPLETED|Overall Study||83
1424775|NCT02517021|3488310|P2|COMPLETED|Overall Study||117
1424776|NCT02517021|3488311|P1|COMPLETED|Overall Study||120
1424777|NCT02517021|3488310|P2|STARTED|Overall Study||202
1424778|NCT02517021|3488311|P1|STARTED|Overall Study||203
1424779|NCT02516410|3488337|P2|NOT COMPLETED|Overall Study||2
1424780|NCT02516410|3488338|P1|NOT COMPLETED|Overall Study||0
1424781|NCT02516410|3488337|P2|COMPLETED|Overall Study||81
1424782|NCT02516410|3488338|P1|COMPLETED|Overall Study||85
1424783|NCT02516410|3488337|P2|STARTED|Overall Study||83
1424784|NCT02516410|3488338|P1|STARTED|Overall Study||85
1424785|NCT02516306|3488367|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
1424786|NCT02516306|3488368|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
1424787|NCT02516306|3488367|P2|COMPLETED|Period 2: Day 8 - 91||23
1424788|NCT02516306|3488368|P1|COMPLETED|Period 2: Day 8 - 91||49
1424789|NCT02516306|3488367|P2|STARTED|Period 2: Day 8 - 91||25
1424790|NCT02516306|3488368|P1|STARTED|Period 2: Day 8 - 91||50
1424791|NCT02516306|3488367|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
1424792|NCT02516306|3488368|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
1424793|NCT02516306|3488367|P2|COMPLETED|Period 1: Day 1 - 7||25
1424794|NCT02516306|3488368|P1|COMPLETED|Period 1: Day 1 - 7||50
1424795|NCT02516306|3488367|P2|STARTED|Period 1: Day 1 - 7||25
1424796|NCT02516306|3488368|P1|STARTED|Period 1: Day 1 - 7||50
1424797|NCT02516202|3488377|P3|NOT COMPLETED|Overall Study||3
1424798|NCT02516202|3488378|P2|NOT COMPLETED|Overall Study||1
1424799|NCT02516202|3488379|P1|NOT COMPLETED|Overall Study||2
1424800|NCT02516202|3488377|P3|COMPLETED|Overall Study||97
1424801|NCT02516202|3488378|P2|COMPLETED|Overall Study||99
1424802|NCT02516202|3488379|P1|COMPLETED|Overall Study||100
1424803|NCT02516202|3488377|P3|STARTED|Overall Study||100
1424804|NCT02516202|3488378|P2|STARTED|Overall Study||100
1424805|NCT02516202|3488379|P1|STARTED|Overall Study||102
1424806|NCT02516163|3488405|P1|NOT COMPLETED|Overall Study||28
1424807|NCT02516163|3488405|P1|COMPLETED|Overall Study||24
1424808|NCT02516163|3488405|P1|STARTED|Overall Study||52
1424809|NCT02516150|3488409|P1|NOT COMPLETED|Overall Study||0
1424810|NCT02516150|3488409|P1|COMPLETED|Overall Study||15
1424811|NCT02516150|3488409|P1|STARTED|Overall Study||15
1424812|NCT02516098|3488419|P2|NOT COMPLETED|Washout After Period 2||0
1424813|NCT02516098|3488420|P1|NOT COMPLETED|Washout After Period 2||0
1424814|NCT02516098|3488419|P2|COMPLETED|Washout After Period 2||26
1424815|NCT02516098|3488420|P1|COMPLETED|Washout After Period 2||27
1424816|NCT02516098|3488419|P2|STARTED|Washout After Period 2||26
1424817|NCT02516098|3488420|P1|STARTED|Washout After Period 2||27
1424818|NCT02516098|3488419|P2|NOT COMPLETED|Period 2||1
1424819|NCT02516098|3488420|P1|NOT COMPLETED|Period 2||0
1424820|NCT02516098|3488419|P2|COMPLETED|Period 2||26
1424821|NCT02516098|3488420|P1|COMPLETED|Period 2||27
1424822|NCT02516098|3488419|P2|STARTED|Period 2||27
1424823|NCT02516098|3488420|P1|STARTED|Period 2||27
1424824|NCT02516098|3488419|P2|NOT COMPLETED|Washout After Period 1||1
1424825|NCT02516098|3488420|P1|NOT COMPLETED|Washout After Period 1||0
1424826|NCT02516098|3488419|P2|COMPLETED|Washout After Period 1||27
1424827|NCT02516098|3488420|P1|COMPLETED|Washout After Period 1||27
1424828|NCT02516098|3488419|P2|STARTED|Washout After Period 1||28
1424829|NCT02516098|3488420|P1|STARTED|Washout After Period 1||27
1424830|NCT02516098|3488419|P2|NOT COMPLETED|Period 1||0
1424831|NCT02516098|3488420|P1|NOT COMPLETED|Period 1||1
1424832|NCT02516098|3488419|P2|COMPLETED|Period 1||28
1424833|NCT02516098|3488420|P1|COMPLETED|Period 1||27
1424834|NCT02516098|3488419|P2|STARTED|Period 1||28
1424835|NCT02516098|3488420|P1|STARTED|Period 1||28
1424836|NCT02515994|3488434|P2|NOT COMPLETED|Overall Study||7
1424837|NCT02515994|3488435|P1|NOT COMPLETED|Overall Study||10
1424838|NCT02515994|3488434|P2|COMPLETED|Overall Study||105
1424839|NCT02515994|3488435|P1|COMPLETED|Overall Study||99
1424840|NCT02515994|3488434|P2|STARTED|Overall Study||112
1424841|NCT02515994|3488435|P1|STARTED|Overall Study||109
1424842|NCT02515942|3488450|P3|NOT COMPLETED|Overall Study||4
1424843|NCT02515942|3488451|P2|NOT COMPLETED|Overall Study||3
1424844|NCT02515942|3488452|P1|NOT COMPLETED|Overall Study||7
1424845|NCT02515942|3488450|P3|COMPLETED|Overall Study||35
1424846|NCT02515942|3488451|P2|COMPLETED|Overall Study||36
1424847|NCT02515942|3488452|P1|COMPLETED|Overall Study||29
1424848|NCT02515942|3488450|P3|Completed Day 337|Overall Study||35
1424849|NCT02515942|3488451|P2|Completed Day 337|Overall Study||36
1424850|NCT02515942|3488452|P1|Completed Day 337|Overall Study||30
1424851|NCT02515942|3488450|P3|Completed Day 253|Overall Study||36
1424852|NCT02515942|3488451|P2|Completed Day 253|Overall Study||37
1424853|NCT02515942|3488452|P1|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
1424854|NCT02515942|3488450|P3|Completed Day 169|Overall Study||37
1424855|NCT02515942|3488451|P2|Completed Day 169|Overall Study||37
1424856|NCT02515942|3488452|P1|Completed Day 169|Overall Study||32
1424857|NCT02515942|3488450|P3|Completed Day 85|Overall Study||37
1424858|NCT02515942|3488451|P2|Completed Day 85|Overall Study||38
1424859|NCT02515942|3488452|P1|Completed Day 85|Overall Study||35
1424860|NCT02515942|3488450|P3|Pharmacokinetics (PK) Analysis Set|Overall Study||0
1424861|NCT02515942|3488451|P2|Pharmacokinetics (PK) Analysis Set|Overall Study||39
1424862|NCT02515942|3488452|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||36
1424863|NCT02515942|3488450|P3|Per Protocol Analysis Set (PPS)|Overall Study||34
1424864|NCT02515942|3488451|P2|Per Protocol Analysis Set (PPS)|Overall Study||35
1424865|NCT02515942|3488452|P1|Per Protocol Analysis Set (PPS)|Overall Study||30
1424866|NCT02515942|3488450|P3|Full Analysis Set (FAS)|Overall Study||38
1424867|NCT02515942|3488451|P2|Full Analysis Set (FAS)|Overall Study||37
1424868|NCT02515942|3488452|P1|Full Analysis Set (FAS)|Overall Study||35
1424869|NCT02515942|3488450|P3|Safety Analysis Set|Overall Study||39
1424870|NCT02515942|3488451|P2|Safety Analysis Set|Overall Study||39
1424871|NCT02515942|3488452|P1|Safety Analysis Set|Overall Study||36
1424872|NCT02515942|3488450|P3|STARTED|Overall Study||39
1424873|NCT02515942|3488451|P2|STARTED|Overall Study||39
1424874|NCT02515942|3488452|P1|STARTED|Overall Study||36
1424875|NCT02515851|3488495|P2|NOT COMPLETED|Overall Study||0
1424876|NCT02515851|3488496|P1|NOT COMPLETED|Overall Study||0
1424877|NCT02515851|3488495|P2|COMPLETED|Overall Study||15
1424878|NCT02515851|3488496|P1|COMPLETED|Overall Study||15
1424879|NCT02515851|3488495|P2|STARTED|Overall Study||15
1424880|NCT02515851|3488496|P1|STARTED|Overall Study||15
1424881|NCT02515331|3488511|P3|NOT COMPLETED|Overall Study||4
1424882|NCT02515331|3488512|P2|NOT COMPLETED|Overall Study||0
1424883|NCT02515331|3488513|P1|NOT COMPLETED|Overall Study||2
1424884|NCT02515331|3488511|P3|COMPLETED|Overall Study||28
1424885|NCT02515331|3488512|P2|COMPLETED|Overall Study||15
1424886|NCT02515331|3488513|P1|COMPLETED|Overall Study||15
1424887|NCT02515331|3488511|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1424888|NCT02515331|3488512|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||15
1424889|NCT02515331|3488513|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||17
1424890|NCT02515331|3488511|P3|Primary Pharmacodynamic Analysis Set|Overall Study||29
1424891|NCT02515331|3488512|P2|Primary Pharmacodynamic Analysis Set|Overall Study||14
1424892|NCT02515331|3488513|P1|Primary Pharmacodynamic Analysis Set|Overall Study||15
1424893|NCT02515331|3488511|P3|STARTED|Overall Study||32
1424894|NCT02515331|3488512|P2|STARTED|Overall Study||15
1424895|NCT02515331|3488513|P1|STARTED|Overall Study||17
1424896|NCT02515279|3488534|P1|NOT COMPLETED|Overall Study||104
1424897|NCT02515279|3488534|P1|COMPLETED|Overall Study||359
1424898|NCT02515279|3488534|P1|STARTED|Overall Study||463
1424899|NCT02515058|3488542|P2|NOT COMPLETED|Overall Study||2
1424900|NCT02515058|3488543|P1|NOT COMPLETED|Overall Study||3
1424901|NCT02515058|3488542|P2|COMPLETED|Overall Study||20
1424902|NCT02515058|3488543|P1|COMPLETED|Overall Study||18
1424903|NCT02515058|3488542|P2|STARTED|Overall Study||22
1424904|NCT02515058|3488543|P1|STARTED|Overall Study||21
1424905|NCT02515045|3488553|P3|NOT COMPLETED|Overall Study||4
1424906|NCT02515045|3488554|P2|NOT COMPLETED|Overall Study||4
1424907|NCT02515045|3488555|P1|NOT COMPLETED|Overall Study||0
1424908|NCT02515045|3488553|P3|COMPLETED|Overall Study||55
1424909|NCT02515045|3488554|P2|COMPLETED|Overall Study||26
1424910|NCT02515045|3488555|P1|COMPLETED|Overall Study||29
1424911|NCT02515045|3488553|P3|STARTED|Overall Study||59
1424912|NCT02515045|3488554|P2|STARTED|Overall Study||30
1424913|NCT02515045|3488555|P1|STARTED|Overall Study||29
1424914|NCT02514889|3488571|P2|NOT COMPLETED|Follow-up Assessment Participation||12
1424915|NCT02514889|3488572|P1|NOT COMPLETED|Follow-up Assessment Participation||10
1424916|NCT02514889|3488571|P2|COMPLETED|Follow-up Assessment Participation||86
1424917|NCT02514889|3488572|P1|COMPLETED|Follow-up Assessment Participation||92
1424918|NCT02514889|3488571|P2|STARTED|Follow-up Assessment Participation||98
1424919|NCT02514889|3488572|P1|STARTED|Follow-up Assessment Participation||102
1424920|NCT02514889|3488571|P2|NOT COMPLETED|Intervention Participation||8
1424921|NCT02514889|3488572|P1|NOT COMPLETED|Intervention Participation||9
1424922|NCT02514889|3488571|P2|COMPLETED|Intervention Participation||98
1424923|NCT02514889|3488572|P1|COMPLETED|Intervention Participation||102
1424924|NCT02514889|3488571|P2|STARTED|Intervention Participation||106
1424925|NCT02514889|3488572|P1|STARTED|Intervention Participation||111
1424926|NCT02514889|3488571|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
1424927|NCT02514889|3488572|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
1424928|NCT02514889|3488571|P2|COMPLETED|Randomization/Allocation to Condition||106
1424929|NCT02514889|3488572|P1|COMPLETED|Randomization/Allocation to Condition||111
1424930|NCT02514889|3488571|P2|STARTED|Randomization/Allocation to Condition||130
1424931|NCT02514889|3488572|P1|STARTED|Randomization/Allocation to Condition||131
1424932|NCT02514772|3488592|P2|NOT COMPLETED|Overall Study||2
1424933|NCT02514772|3488593|P1|NOT COMPLETED|Overall Study||3
1424934|NCT02514772|3488592|P2|COMPLETED|Overall Study||52
1424935|NCT02514772|3488593|P1|COMPLETED|Overall Study||50
1424936|NCT02514772|3488592|P2|STARTED|Overall Study||54
1424937|NCT02514772|3488593|P1|STARTED|Overall Study||53
1424938|NCT02514551|3488607|P2|NOT COMPLETED|Overall Study||9
1424939|NCT02514551|3488608|P1|NOT COMPLETED|Overall Study||5
1424940|NCT02514551|3488607|P2|COMPLETED|Overall Study||113
1424941|NCT02514551|3488608|P1|COMPLETED|Overall Study||118
1424942|NCT02514551|3488607|P2|Received at Least One Dose of Study Drug|Overall Study||120
1424943|NCT02514551|3488608|P1|Received at Least One Dose of Study Drug|Overall Study||123
1424944|NCT02514551|3488607|P2|STARTED|Overall Study||122
1424945|NCT02514551|3488608|P1|STARTED|Overall Study||123
1424946|NCT02514473|3488625|P2|NOT COMPLETED|Overall Study||5
1424947|NCT02514473|3488626|P1|NOT COMPLETED|Overall Study||3
1424948|NCT02514473|3488625|P2|COMPLETED|Overall Study||98
1424949|NCT02514473|3488626|P1|COMPLETED|Overall Study||98
1424950|NCT02514473|3488625|P2|STARTED|Overall Study||103
1424951|NCT02514473|3488626|P1|STARTED|Overall Study||101
1424952|NCT02514122|3488669|P2|NOT COMPLETED|Overall Study||0
1424953|NCT02514122|3488670|P1|NOT COMPLETED|Overall Study||2
1424954|NCT02514122|3488669|P2|COMPLETED|Overall Study||29
1424955|NCT02514122|3488670|P1|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
1424956|NCT02514122|3488669|P2|STARTED|Overall Study||29
1424957|NCT02514122|3488670|P1|STARTED|Overall Study||32
1424958|NCT02514044|3488678|P1|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
1424959|NCT02514044|3488678|P1|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
1424960|NCT02514044|3488678|P1|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
1424961|NCT02514044|3488678|P1|NOT COMPLETED|Washout (1 Week)||0
1424962|NCT02514044|3488678|P1|COMPLETED|Washout (1 Week)||10
1424963|NCT02514044|3488678|P1|STARTED|Washout (1 Week)||10
1424964|NCT02514044|3488678|P1|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
1424965|NCT02514044|3488678|P1|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
1424966|NCT02514044|3488678|P1|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
1424967|NCT02513771|3488694|P2|NOT COMPLETED|Overall Study||1
1424968|NCT02513771|3488695|P1|NOT COMPLETED|Overall Study||2
1424969|NCT02513771|3488694|P2|COMPLETED|Overall Study||44
1424970|NCT02513771|3488695|P1|COMPLETED|Overall Study||43
1424971|NCT02513771|3488694|P2|STARTED|Overall Study||45
1424972|NCT02513771|3488695|P1|STARTED|Overall Study||45
1424973|NCT02513550|3488737|P6|NOT COMPLETED|Post-Treatment Follow-up Period||0
1424974|NCT02513550|3488738|P5|NOT COMPLETED|Post-Treatment Follow-up Period||0
1424975|NCT02513550|3488739|P4|NOT COMPLETED|Post-Treatment Follow-up Period||0
1424976|NCT02513550|3488740|P3|NOT COMPLETED|Post-Treatment Follow-up Period||63
1424977|NCT02513550|3488741|P2|NOT COMPLETED|Post-Treatment Follow-up Period||39
1424978|NCT02513550|3488742|P1|NOT COMPLETED|Post-Treatment Follow-up Period||31
1424979|NCT02513550|3488737|P6|COMPLETED|Post-Treatment Follow-up Period||15
1424980|NCT02513550|3488738|P5|COMPLETED|Post-Treatment Follow-up Period||4
1424981|NCT02513550|3488739|P4|COMPLETED|Post-Treatment Follow-up Period||9
1424982|NCT02513550|3488740|P3|COMPLETED|Post-Treatment Follow-up Period||496
1424983|NCT02513550|3488741|P2|COMPLETED|Post-Treatment Follow-up Period||244
1424984|NCT02513550|3488742|P1|COMPLETED|Post-Treatment Follow-up Period||254
1424985|NCT02513550|3488737|P6|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
1424986|NCT02513550|3488738|P5|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
1424987|NCT02513550|3488739|P4|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
1424988|NCT02513550|3488740|P3|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
1424989|NCT02513550|3488741|P2|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
1424990|NCT02513550|3488742|P1|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
1424991|NCT02513550|3488737|P6|NOT COMPLETED|Double Blind Treatment Period||1
1424992|NCT02513550|3488738|P5|NOT COMPLETED|Double Blind Treatment Period||1
1424993|NCT02513550|3488739|P4|NOT COMPLETED|Double Blind Treatment Period||0
1424994|NCT02513550|3488740|P3|NOT COMPLETED|Double Blind Treatment Period||74
1424995|NCT02513550|3488741|P2|NOT COMPLETED|Double Blind Treatment Period||38
1424996|NCT02513550|3488742|P1|NOT COMPLETED|Double Blind Treatment Period||36
1424997|NCT02513550|3488737|P6|COMPLETED|Double Blind Treatment Period||15
1424998|NCT02513550|3488738|P5|COMPLETED|Double Blind Treatment Period||4
1424999|NCT02513550|3488739|P4|COMPLETED|Double Blind Treatment Period||9
1425000|NCT02513550|3488740|P3|COMPLETED|Double Blind Treatment Period||537
1425001|NCT02513550|3488741|P2|COMPLETED|Double Blind Treatment Period||268
1425002|NCT02513550|3488742|P1|COMPLETED|Double Blind Treatment Period||274
1425003|NCT02513550|3488737|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
1425004|NCT02513550|3488738|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
1425005|NCT02513550|3488739|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
1425006|NCT02513550|3488740|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
1425007|NCT02513550|3488741|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
1425008|NCT02513550|3488742|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
1425009|NCT02513550|3488737|P6|STARTED|Double Blind Treatment Period||16
1425010|NCT02513550|3488738|P5|STARTED|Double Blind Treatment Period||5
1425011|NCT02513550|3488739|P4|STARTED|Double Blind Treatment Period||9
1425012|NCT02513550|3488740|P3|STARTED|Double Blind Treatment Period||611
1425013|NCT02513550|3488741|P2|STARTED|Double Blind Treatment Period||306
1425014|NCT02513550|3488742|P1|STARTED|Double Blind Treatment Period||310
1425015|NCT02513160|3488818|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
1425016|NCT02513160|3488819|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
1425017|NCT02513160|3488820|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
1425018|NCT02513160|3488821|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
1425019|NCT02513160|3488818|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
1425020|NCT02513160|3488819|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
1425021|NCT02513160|3488820|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
1425022|NCT02513160|3488821|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
1425023|NCT02513160|3488818|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
1425024|NCT02513160|3488819|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
1425025|NCT02513160|3488820|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
1425026|NCT02513160|3488821|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
1425027|NCT02513160|3488818|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1425028|NCT02513160|3488819|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1425029|NCT02513160|3488820|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1425030|NCT02513160|3488821|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
1425031|NCT02513160|3488818|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1425032|NCT02513160|3488819|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1425033|NCT02513160|3488820|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1425034|NCT02513160|3488821|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
1425035|NCT02513160|3488818|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
1425036|NCT02513160|3488819|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
1425037|NCT02513160|3488820|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
1425038|NCT02513160|3488821|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
1425039|NCT02513095|3488858|P2|NOT COMPLETED|Overall Study||16
1425040|NCT02513095|3488859|P1|NOT COMPLETED|Overall Study||14
1425041|NCT02513095|3488858|P2|COMPLETED|Overall Study||1
1425042|NCT02513095|3488859|P1|COMPLETED|Overall Study||3
1425043|NCT02513095|3488858|P2|STARTED|Overall Study||17
1425044|NCT02513095|3488859|P1|STARTED|Overall Study||17
1425045|NCT02512900|3488867|P2|NOT COMPLETED|Overall Study||0
1425046|NCT02512900|3488868|P1|NOT COMPLETED|Overall Study||0
1425047|NCT02512900|3488867|P2|COMPLETED|Overall Study||10
1425048|NCT02512900|3488868|P1|COMPLETED|Overall Study||11
1425049|NCT02512900|3488867|P2|STARTED|Overall Study||10
1425050|NCT02512900|3488868|P1|STARTED|Overall Study||11
1425051|NCT02512874|3488899|P1|NOT COMPLETED|Overall Study||2
1425052|NCT02512874|3488899|P1|COMPLETED|Overall Study||63
1425053|NCT02512874|3488899|P1|STARTED|Overall Study||65
1425054|NCT02512861|3488905|P2|NOT COMPLETED|Overall Study||9
1425055|NCT02512861|3488906|P1|NOT COMPLETED|Overall Study||6
1425056|NCT02512861|3488905|P2|COMPLETED|Overall Study||40
1425057|NCT02512861|3488906|P1|COMPLETED|Overall Study||38
1425058|NCT02512861|3488905|P2|STARTED|Overall Study||49
1425059|NCT02512861|3488906|P1|STARTED|Overall Study||44
1425060|NCT02512809|3488927|P1|NOT COMPLETED|Overall Study||0
1425061|NCT02512809|3488927|P1|COMPLETED|Overall Study||25
1425062|NCT02512809|3488927|P1|STARTED|Overall Study||25
1425063|NCT02512783|3488933|P2|NOT COMPLETED|Overall Study||0
1425064|NCT02512783|3488934|P1|NOT COMPLETED|Overall Study||0
1425065|NCT02512783|3488933|P2|COMPLETED|Overall Study||75
1425066|NCT02512783|3488934|P1|COMPLETED|Overall Study||96
1425067|NCT02512783|3488933|P2|STARTED|Overall Study||75
1425068|NCT02512783|3488934|P1|STARTED|Overall Study||96
1425069|NCT02512679|3488942|P2|NOT COMPLETED|Overall Study||0
1425070|NCT02512679|3488943|P1|NOT COMPLETED|Overall Study||0
1425071|NCT02512679|3488942|P2|COMPLETED|Overall Study||0
1425072|NCT02512679|3488943|P1|COMPLETED|Overall Study||20
1425073|NCT02512679|3488942|P2|STARTED|Overall Study||0
1425074|NCT02512679|3488943|P1|STARTED|Overall Study||20
1425075|NCT02512575|3488961|P10|NOT COMPLETED|Overall Study||0
1425076|NCT02512575|3488962|P9|NOT COMPLETED|Overall Study||0
1425077|NCT02512575|3488963|P8|NOT COMPLETED|Overall Study||0
1425078|NCT02512575|3488964|P7|NOT COMPLETED|Overall Study||0
1425079|NCT02512575|3488965|P6|NOT COMPLETED|Overall Study||0
1425080|NCT02512575|3488966|P5|NOT COMPLETED|Overall Study||0
1425081|NCT02512575|3488967|P4|NOT COMPLETED|Overall Study||0
1425082|NCT02512575|3488968|P3|NOT COMPLETED|Overall Study||0
1425083|NCT02512575|3488969|P2|NOT COMPLETED|Overall Study||0
1425084|NCT02512575|3488970|P1|NOT COMPLETED|Overall Study||0
1425085|NCT02512575|3488961|P10|COMPLETED|Overall Study||18
1425086|NCT02512575|3488962|P9|COMPLETED|Overall Study||6
1425087|NCT02512575|3488963|P8|COMPLETED|Overall Study||6
1425088|NCT02512575|3488964|P7|COMPLETED|Overall Study||6
1425089|NCT02512575|3488965|P6|COMPLETED|Overall Study||6
1425090|NCT02512575|3488966|P5|COMPLETED|Overall Study||6
1425091|NCT02512575|3488967|P4|COMPLETED|Overall Study||6
1425092|NCT02512575|3488968|P3|COMPLETED|Overall Study||6
1425093|NCT02512575|3488969|P2|COMPLETED|Overall Study||6
1425094|NCT02512575|3488970|P1|COMPLETED|Overall Study||6
1425095|NCT02512575|3488961|P10|STARTED|Overall Study||18
1425096|NCT02512575|3488962|P9|STARTED|Overall Study||6
1425097|NCT02512575|3488963|P8|STARTED|Overall Study||6
1425098|NCT02512575|3488964|P7|STARTED|Overall Study||6
1425099|NCT02512575|3488965|P6|STARTED|Overall Study||6
1425100|NCT02512575|3488966|P5|STARTED|Overall Study||6
1425101|NCT02512575|3488967|P4|STARTED|Overall Study||6
1425102|NCT02512575|3488968|P3|STARTED|Overall Study||6
1425103|NCT02512575|3488969|P2|STARTED|Overall Study||6
1425104|NCT02512575|3488970|P1|STARTED|Overall Study||6
1425105|NCT02512510|3489065|P3|NOT COMPLETED|Overall Study||52
1425106|NCT02512510|3489066|P2|NOT COMPLETED|Overall Study||35
1425107|NCT02512510|3489067|P1|NOT COMPLETED|Overall Study||42
1425108|NCT02512510|3489065|P3|COMPLETED|Overall Study||157
1425109|NCT02512510|3489066|P2|COMPLETED|Overall Study||162
1425110|NCT02512510|3489067|P1|COMPLETED|Overall Study||163
1425111|NCT02512510|3489065|P3|STARTED|Overall Study||209
1425112|NCT02512510|3489066|P2|STARTED|Overall Study||197
1425113|NCT02512510|3489067|P1|STARTED|Overall Study||205
1425114|NCT02512393|3489092|P2|NOT COMPLETED|Overall Study||0
1425115|NCT02512393|3489093|P1|NOT COMPLETED|Overall Study||1
1425116|NCT02512393|3489092|P2|COMPLETED|Overall Study||20
1425117|NCT02512393|3489093|P1|COMPLETED|Overall Study||20
1425118|NCT02512393|3489092|P2|STARTED|Overall Study||20
1425119|NCT02512393|3489093|P1|STARTED|Overall Study||21
1425120|NCT02512302|3489173|P10|NOT COMPLETED|Period 5||0
1425121|NCT02512302|3489174|P9|NOT COMPLETED|Period 5||0
1425122|NCT02512302|3489175|P8|NOT COMPLETED|Period 5||0
1425123|NCT02512302|3489176|P7|NOT COMPLETED|Period 5||0
1425124|NCT02512302|3489177|P6|NOT COMPLETED|Period 5||0
1425125|NCT02512302|3489178|P5|NOT COMPLETED|Period 5||0
1425126|NCT02512302|3489179|P4|NOT COMPLETED|Period 5||0
1425127|NCT02512302|3489180|P3|NOT COMPLETED|Period 5||0
1425128|NCT02512302|3489181|P2|NOT COMPLETED|Period 5||0
1425129|NCT02512302|3489182|P1|NOT COMPLETED|Period 5||0
1425130|NCT02512302|3489173|P10|COMPLETED|Period 5||2
1425131|NCT02512302|3489174|P9|COMPLETED|Period 5||3
1425132|NCT02512302|3489175|P8|COMPLETED|Period 5||3
1425133|NCT02512302|3489176|P7|COMPLETED|Period 5||1
1425134|NCT02512302|3489177|P6|COMPLETED|Period 5||3
1425135|NCT02512302|3489178|P5|COMPLETED|Period 5||3
1425136|NCT02512302|3489179|P4|COMPLETED|Period 5||3
1425137|NCT02512302|3489180|P3|COMPLETED|Period 5||3
1425138|NCT02512302|3489181|P2|COMPLETED|Period 5||2
1425139|NCT02512302|3489182|P1|COMPLETED|Period 5||3
1425140|NCT02512302|3489173|P10|STARTED|Period 5||2
1425141|NCT02512302|3489174|P9|STARTED|Period 5||3
1425142|NCT02512302|3489175|P8|STARTED|Period 5||3
1425143|NCT02512302|3489176|P7|STARTED|Period 5||1
1425144|NCT02512302|3489177|P6|STARTED|Period 5||3
1425145|NCT02512302|3489178|P5|STARTED|Period 5||3
1425146|NCT02512302|3489179|P4|STARTED|Period 5||3
1425147|NCT02512302|3489180|P3|STARTED|Period 5||3
1425148|NCT02512302|3489181|P2|STARTED|Period 5||2
1425149|NCT02512302|3489182|P1|STARTED|Period 5||3
1425150|NCT02512302|3489173|P10|NOT COMPLETED|Period 4||0
1425151|NCT02512302|3489174|P9|NOT COMPLETED|Period 4||0
1425152|NCT02512302|3489175|P8|NOT COMPLETED|Period 4||0
1425153|NCT02512302|3489176|P7|NOT COMPLETED|Period 4||1
1425154|NCT02512302|3489177|P6|NOT COMPLETED|Period 4||0
1425155|NCT02512302|3489178|P5|NOT COMPLETED|Period 4||0
1425156|NCT02512302|3489179|P4|NOT COMPLETED|Period 4||0
1425157|NCT02512302|3489180|P3|NOT COMPLETED|Period 4||0
1425158|NCT02512302|3489181|P2|NOT COMPLETED|Period 4||0
1425159|NCT02512302|3489182|P1|NOT COMPLETED|Period 4||0
1425160|NCT02512302|3489173|P10|COMPLETED|Period 4||2
1425161|NCT02512302|3489174|P9|COMPLETED|Period 4||3
1425162|NCT02512302|3489175|P8|COMPLETED|Period 4||3
1425163|NCT02512302|3489176|P7|COMPLETED|Period 4||1
1425164|NCT02512302|3489177|P6|COMPLETED|Period 4||3
1425165|NCT02512302|3489178|P5|COMPLETED|Period 4||3
1425166|NCT02512302|3489179|P4|COMPLETED|Period 4||3
1425167|NCT02512302|3489180|P3|COMPLETED|Period 4||3
1425168|NCT02512302|3489181|P2|COMPLETED|Period 4||2
1425169|NCT02512302|3489182|P1|COMPLETED|Period 4||3
1425170|NCT02512302|3489173|P10|STARTED|Period 4||2
1425171|NCT02512302|3489174|P9|STARTED|Period 4||3
1425172|NCT02512302|3489175|P8|STARTED|Period 4||3
1425173|NCT02512302|3489176|P7|STARTED|Period 4||2
1425174|NCT02512302|3489177|P6|STARTED|Period 4||3
1425175|NCT02512302|3489178|P5|STARTED|Period 4||3
1425176|NCT02512302|3489179|P4|STARTED|Period 4||3
1425177|NCT02512302|3489180|P3|STARTED|Period 4||3
1425178|NCT02512302|3489181|P2|STARTED|Period 4||2
1425179|NCT02512302|3489182|P1|STARTED|Period 4||3
1425180|NCT02512302|3489173|P10|NOT COMPLETED|Period 3||0
1425181|NCT02512302|3489174|P9|NOT COMPLETED|Period 3||0
1425182|NCT02512302|3489175|P8|NOT COMPLETED|Period 3||0
1425183|NCT02512302|3489176|P7|NOT COMPLETED|Period 3||0
1425184|NCT02512302|3489177|P6|NOT COMPLETED|Period 3||0
1425185|NCT02512302|3489178|P5|NOT COMPLETED|Period 3||0
1425186|NCT02512302|3489179|P4|NOT COMPLETED|Period 3||0
1425187|NCT02512302|3489180|P3|NOT COMPLETED|Period 3||1
1425188|NCT02512302|3489181|P2|NOT COMPLETED|Period 3||0
1425189|NCT02512302|3489182|P1|NOT COMPLETED|Period 3||0
1425190|NCT02512302|3489173|P10|COMPLETED|Period 3||2
1425191|NCT02512302|3489174|P9|COMPLETED|Period 3||3
1425192|NCT02512302|3489175|P8|COMPLETED|Period 3||3
1425193|NCT02512302|3489176|P7|COMPLETED|Period 3||2
1425194|NCT02512302|3489177|P6|COMPLETED|Period 3||3
1425195|NCT02512302|3489178|P5|COMPLETED|Period 3||3
1425196|NCT02512302|3489179|P4|COMPLETED|Period 3||3
1425197|NCT02512302|3489180|P3|COMPLETED|Period 3||3
1425198|NCT02512302|3489181|P2|COMPLETED|Period 3||2
1425199|NCT02512302|3489182|P1|COMPLETED|Period 3||3
1425200|NCT02512302|3489173|P10|STARTED|Period 3||2
1425201|NCT02512302|3489174|P9|STARTED|Period 3||3
1425202|NCT02512302|3489175|P8|STARTED|Period 3||3
1425203|NCT02512302|3489176|P7|STARTED|Period 3||2
1425204|NCT02512302|3489177|P6|STARTED|Period 3||3
1425205|NCT02512302|3489178|P5|STARTED|Period 3||3
1425206|NCT02512302|3489179|P4|STARTED|Period 3||3
1425207|NCT02512302|3489180|P3|STARTED|Period 3||4
1425208|NCT02512302|3489181|P2|STARTED|Period 3||2
1425209|NCT02512302|3489182|P1|STARTED|Period 3||3
1425210|NCT02512302|3489173|P10|NOT COMPLETED|Period 2||1
1425211|NCT02512302|3489174|P9|NOT COMPLETED|Period 2||0
1425212|NCT02512302|3489175|P8|NOT COMPLETED|Period 2||0
1425213|NCT02512302|3489176|P7|NOT COMPLETED|Period 2||0
1425214|NCT02512302|3489177|P6|NOT COMPLETED|Period 2||0
1425215|NCT02512302|3489178|P5|NOT COMPLETED|Period 2||0
1425216|NCT02512302|3489179|P4|NOT COMPLETED|Period 2||0
1425217|NCT02512302|3489180|P3|NOT COMPLETED|Period 2||0
1425218|NCT02512302|3489181|P2|NOT COMPLETED|Period 2||0
1425219|NCT02512302|3489182|P1|NOT COMPLETED|Period 2||0
1425220|NCT02512302|3489173|P10|COMPLETED|Period 2||2
1425221|NCT02512302|3489174|P9|COMPLETED|Period 2||3
1425222|NCT02512302|3489175|P8|COMPLETED|Period 2||3
1425223|NCT02512302|3489176|P7|COMPLETED|Period 2||2
1425224|NCT02512302|3489177|P6|COMPLETED|Period 2||3
1425225|NCT02512302|3489178|P5|COMPLETED|Period 2||3
1425226|NCT02512302|3489179|P4|COMPLETED|Period 2||3
1425227|NCT02512302|3489180|P3|COMPLETED|Period 2||4
1425228|NCT02512302|3489181|P2|COMPLETED|Period 2||2
1425229|NCT02512302|3489182|P1|COMPLETED|Period 2||3
1425230|NCT02512302|3489173|P10|STARTED|Period 2||3
1425231|NCT02512302|3489174|P9|STARTED|Period 2||3
1425232|NCT02512302|3489175|P8|STARTED|Period 2||3
1425233|NCT02512302|3489176|P7|STARTED|Period 2||2
1425234|NCT02512302|3489177|P6|STARTED|Period 2||3
1425235|NCT02512302|3489178|P5|STARTED|Period 2||3
1425236|NCT02512302|3489179|P4|STARTED|Period 2||3
1425237|NCT02512302|3489180|P3|STARTED|Period 2||4
1425238|NCT02512302|3489181|P2|STARTED|Period 2||2
1425239|NCT02512302|3489182|P1|STARTED|Period 2||3
1425240|NCT02512302|3489173|P10|NOT COMPLETED|Period 1||0
1425241|NCT02512302|3489174|P9|NOT COMPLETED|Period 1||0
1425242|NCT02512302|3489175|P8|NOT COMPLETED|Period 1||0
1425243|NCT02512302|3489176|P7|NOT COMPLETED|Period 1||0
1425244|NCT02512302|3489177|P6|NOT COMPLETED|Period 1||0
1425245|NCT02512302|3489178|P5|NOT COMPLETED|Period 1||0
1425246|NCT02512302|3489179|P4|NOT COMPLETED|Period 1||0
1425247|NCT02512302|3489180|P3|NOT COMPLETED|Period 1||0
1425248|NCT02512302|3489181|P2|NOT COMPLETED|Period 1||1
1425249|NCT02512302|3489182|P1|NOT COMPLETED|Period 1||0
1425250|NCT02512302|3489173|P10|COMPLETED|Period 1||3
1425251|NCT02512302|3489174|P9|COMPLETED|Period 1||3
1425252|NCT02512302|3489175|P8|COMPLETED|Period 1||3
1425253|NCT02512302|3489176|P7|COMPLETED|Period 1||2
1425254|NCT02512302|3489177|P6|COMPLETED|Period 1||3
1425255|NCT02512302|3489178|P5|COMPLETED|Period 1||3
1425256|NCT02512302|3489179|P4|COMPLETED|Period 1||3
1425257|NCT02512302|3489180|P3|COMPLETED|Period 1||4
1425258|NCT02512302|3489181|P2|COMPLETED|Period 1||2
1425259|NCT02512302|3489182|P1|COMPLETED|Period 1||3
1425260|NCT02512302|3489173|P10|STARTED|Period 1||3
1425261|NCT02512302|3489174|P9|STARTED|Period 1||3
1425262|NCT02512302|3489175|P8|STARTED|Period 1||3
1425263|NCT02512302|3489176|P7|STARTED|Period 1||2
1425264|NCT02512302|3489177|P6|STARTED|Period 1||3
1425265|NCT02512302|3489178|P5|STARTED|Period 1||3
1425266|NCT02512302|3489179|P4|STARTED|Period 1||3
1425267|NCT02512302|3489180|P3|STARTED|Period 1||4
1425268|NCT02512302|3489181|P2|STARTED|Period 1||3
1425269|NCT02512302|3489182|P1|STARTED|Period 1||3
1425270|NCT02512224|3489256|P2|NOT COMPLETED|Overall Study||0
1425271|NCT02512224|3489257|P1|NOT COMPLETED|Overall Study||0
1425272|NCT02512224|3489256|P2|COMPLETED|Overall Study||2912
1425273|NCT02512224|3489257|P1|COMPLETED|Overall Study||2912
1425274|NCT02512224|3489256|P2|STARTED|Overall Study||2912
1425275|NCT02512224|3489257|P1|STARTED|Overall Study||2912
1425276|NCT02512094|3489273|P1|NOT COMPLETED|Overall Study||0
1425277|NCT02512094|3489273|P1|COMPLETED|Overall Study||53
1425278|NCT02512094|3489273|P1|STARTED|Overall Study||53
1425279|NCT02511782|3489280|P3|NOT COMPLETED|Overall Study||0
1425280|NCT02511782|3489281|P2|NOT COMPLETED|Overall Study||0
1425281|NCT02511782|3489282|P1|NOT COMPLETED|Overall Study||1
1425282|NCT02511782|3489280|P3|COMPLETED|Overall Study||10
1425283|NCT02511782|3489281|P2|COMPLETED|Overall Study||2
1425284|NCT02511782|3489282|P1|COMPLETED|Overall Study||50
1425285|NCT02511782|3489280|P3|STARTED|Overall Study||10
1425286|NCT02511782|3489281|P2|STARTED|Overall Study||2
1425287|NCT02511782|3489282|P1|STARTED|Overall Study||51
1425288|NCT02511587|3489294|P2|NOT COMPLETED|Overall Study||0
1425289|NCT02511587|3489295|P1|NOT COMPLETED|Overall Study||0
1425290|NCT02511587|3489294|P2|COMPLETED|Overall Study||58
1425291|NCT02511587|3489295|P1|COMPLETED|Overall Study||58
1425292|NCT02511587|3489294|P2|STARTED|Overall Study||58
1425293|NCT02511587|3489295|P1|STARTED|Overall Study||58
1425294|NCT02511431|3489311|P6|NOT COMPLETED|Post-treatment Follow-up||0
1425295|NCT02511431|3489312|P5|NOT COMPLETED|Post-treatment Follow-up||0
1425296|NCT02511431|3489313|P4|NOT COMPLETED|Post-treatment Follow-up||0
1425297|NCT02511431|3489314|P3|NOT COMPLETED|Post-treatment Follow-up||0
1425298|NCT02511431|3489315|P2|NOT COMPLETED|Post-treatment Follow-up||0
1425299|NCT02511431|3489316|P1|NOT COMPLETED|Post-treatment Follow-up||0
1425300|NCT02511431|3489311|P6|COMPLETED|Post-treatment Follow-up||2
1425301|NCT02511431|3489312|P5|COMPLETED|Post-treatment Follow-up||3
1425302|NCT02511431|3489313|P4|COMPLETED|Post-treatment Follow-up||3
1425303|NCT02511431|3489314|P3|COMPLETED|Post-treatment Follow-up||3
1425304|NCT02511431|3489315|P2|COMPLETED|Post-treatment Follow-up||4
1425305|NCT02511431|3489316|P1|COMPLETED|Post-treatment Follow-up||4
1425306|NCT02511431|3489311|P6|STARTED|Post-treatment Follow-up||2
1425307|NCT02511431|3489312|P5|STARTED|Post-treatment Follow-up||3
1425308|NCT02511431|3489313|P4|STARTED|Post-treatment Follow-up||3
1425309|NCT02511431|3489314|P3|STARTED|Post-treatment Follow-up||3
1425310|NCT02511431|3489315|P2|STARTED|Post-treatment Follow-up||4
1425311|NCT02511431|3489316|P1|STARTED|Post-treatment Follow-up||4
1425312|NCT02511431|3489311|P6|NOT COMPLETED|Treatment||1
1425313|NCT02511431|3489312|P5|NOT COMPLETED|Treatment||0
1425314|NCT02511431|3489313|P4|NOT COMPLETED|Treatment||0
1425315|NCT02511431|3489314|P3|NOT COMPLETED|Treatment||1
1425316|NCT02511431|3489315|P2|NOT COMPLETED|Treatment||0
1425317|NCT02511431|3489316|P1|NOT COMPLETED|Treatment||0
1425318|NCT02511431|3489311|P6|COMPLETED|Treatment||2
1425319|NCT02511431|3489312|P5|COMPLETED|Treatment||3
1425320|NCT02511431|3489313|P4|COMPLETED|Treatment||3
1425321|NCT02511431|3489314|P3|COMPLETED|Treatment||3
1425322|NCT02511431|3489315|P2|COMPLETED|Treatment||4
1425323|NCT02511431|3489316|P1|COMPLETED|Treatment||4
1425324|NCT02511431|3489311|P6|STARTED|Treatment||3
1425325|NCT02511431|3489312|P5|STARTED|Treatment||3
1425326|NCT02511431|3489313|P4|STARTED|Treatment||3
1425327|NCT02511431|3489314|P3|STARTED|Treatment||4
1425328|NCT02511431|3489315|P2|STARTED|Treatment||4
1425329|NCT02511431|3489316|P1|STARTED|Treatment||4
1425330|NCT02511379|3489337|P1|NOT COMPLETED|Overall Study||0
1425331|NCT02511379|3489337|P1|COMPLETED|Overall Study||14
1425332|NCT02511379|3489337|P1|STARTED|Overall Study||14
1425333|NCT02510820|3489341|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
1425334|NCT02510820|3489342|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
1425335|NCT02510820|3489341|P2|COMPLETED|Second Intervention (4 Weeks)||26
1425336|NCT02510820|3489342|P1|COMPLETED|Second Intervention (4 Weeks)||20
1425337|NCT02510820|3489341|P2|STARTED|Second Intervention (4 Weeks)||26
1425338|NCT02510820|3489342|P1|STARTED|Second Intervention (4 Weeks)||21
1425339|NCT02510820|3489341|P2|NOT COMPLETED|Washout (1 Week)||0
1425340|NCT02510820|3489342|P1|NOT COMPLETED|Washout (1 Week)||0
1425341|NCT02510820|3489341|P2|COMPLETED|Washout (1 Week)||26
1425342|NCT02510820|3489342|P1|COMPLETED|Washout (1 Week)||21
1425343|NCT02510820|3489341|P2|STARTED|Washout (1 Week)||26
1425344|NCT02510820|3489342|P1|STARTED|Washout (1 Week)||21
1425345|NCT02510820|3489341|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
1425346|NCT02510820|3489342|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
1425347|NCT02510820|3489341|P2|COMPLETED|First Intervention (4 Weeks)||26
1425348|NCT02510820|3489342|P1|COMPLETED|First Intervention (4 Weeks)||21
1425349|NCT02510820|3489341|P2|STARTED|First Intervention (4 Weeks)||27
1425350|NCT02510820|3489342|P1|STARTED|First Intervention (4 Weeks)||21
1425351|NCT02510014|3489382|P2|NOT COMPLETED|Treatment Period||57
1425352|NCT02510014|3489383|P1|NOT COMPLETED|Treatment Period||206
1425353|NCT02510014|3489382|P2|COMPLETED|Treatment Period||200
1425354|NCT02510014|3489383|P1|COMPLETED|Treatment Period||206
1425355|NCT02510014|3489382|P2|STARTED|Treatment Period||257
1425356|NCT02510014|3489383|P1|STARTED|Treatment Period||412
1425357|NCT02510014|3489382|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
1425358|NCT02510014|3489383|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
1425359|NCT02510014|3489382|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
1425360|NCT02510014|3489383|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
1425361|NCT02510014|3489382|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
1425362|NCT02510014|3489383|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
1425363|NCT02509117|3489413|P10|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425364|NCT02509117|3489414|P9|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425365|NCT02509117|3489415|P8|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425366|NCT02509117|3489416|P7|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425367|NCT02509117|3489417|P6|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425368|NCT02509117|3489418|P5|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425369|NCT02509117|3489419|P4|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425370|NCT02509117|3489420|P3|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425371|NCT02509117|3489421|P2|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425372|NCT02509117|3489422|P1|NOT COMPLETED|Period 4 -Part A: 4 Days||0
1425373|NCT02509117|3489413|P10|COMPLETED|Period 4 -Part A: 4 Days||0
1425374|NCT02509117|3489414|P9|COMPLETED|Period 4 -Part A: 4 Days||0
1425375|NCT02509117|3489415|P8|COMPLETED|Period 4 -Part A: 4 Days||0
1425376|NCT02509117|3489416|P7|COMPLETED|Period 4 -Part A: 4 Days||0
1425377|NCT02509117|3489417|P6|COMPLETED|Period 4 -Part A: 4 Days||0
1425378|NCT02509117|3489418|P5|COMPLETED|Period 4 -Part A: 4 Days||0
1425379|NCT02509117|3489419|P4|COMPLETED|Period 4 -Part A: 4 Days||2
1425380|NCT02509117|3489420|P3|COMPLETED|Period 4 -Part A: 4 Days||2
1425381|NCT02509117|3489421|P2|COMPLETED|Period 4 -Part A: 4 Days||2
1425382|NCT02509117|3489422|P1|COMPLETED|Period 4 -Part A: 4 Days||2
1425383|NCT02509117|3489413|P10|STARTED|Period 4 -Part A: 4 Days||0
1425384|NCT02509117|3489414|P9|STARTED|Period 4 -Part A: 4 Days||0
1425385|NCT02509117|3489415|P8|STARTED|Period 4 -Part A: 4 Days||0
1425386|NCT02509117|3489416|P7|STARTED|Period 4 -Part A: 4 Days||0
1425387|NCT02509117|3489417|P6|STARTED|Period 4 -Part A: 4 Days||0
1425388|NCT02509117|3489418|P5|STARTED|Period 4 -Part A: 4 Days||0
1425389|NCT02509117|3489419|P4|STARTED|Period 4 -Part A: 4 Days||2
1425390|NCT02509117|3489420|P3|STARTED|Period 4 -Part A: 4 Days||2
1425391|NCT02509117|3489421|P2|STARTED|Period 4 -Part A: 4 Days||2
1425392|NCT02509117|3489422|P1|STARTED|Period 4 -Part A: 4 Days||2
1425393|NCT02509117|3489413|P10|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425394|NCT02509117|3489414|P9|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425395|NCT02509117|3489415|P8|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425396|NCT02509117|3489416|P7|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425397|NCT02509117|3489417|P6|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425398|NCT02509117|3489418|P5|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425399|NCT02509117|3489419|P4|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425400|NCT02509117|3489420|P3|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425401|NCT02509117|3489421|P2|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425402|NCT02509117|3489422|P1|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425403|NCT02509117|3489413|P10|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425404|NCT02509117|3489414|P9|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425405|NCT02509117|3489415|P8|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425406|NCT02509117|3489416|P7|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425407|NCT02509117|3489417|P6|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425408|NCT02509117|3489418|P5|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
1425409|NCT02509117|3489419|P4|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
1425410|NCT02509117|3489420|P3|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
1425411|NCT02509117|3489421|P2|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
1425412|NCT02509117|3489422|P1|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
1425413|NCT02509117|3489413|P10|STARTED|Washout Period 3 (Part A: 7 Days)||0
1425414|NCT02509117|3489414|P9|STARTED|Washout Period 3 (Part A: 7 Days)||0
1425415|NCT02509117|3489415|P8|STARTED|Washout Period 3 (Part A: 7 Days)||0
1425416|NCT02509117|3489416|P7|STARTED|Washout Period 3 (Part A: 7 Days)||0
1425417|NCT02509117|3489417|P6|STARTED|Washout Period 3 (Part A: 7 Days)||0
1425418|NCT02509117|3489418|P5|STARTED|Washout Period 3 (Part A: 7 Days)||0
1425419|NCT02509117|3489419|P4|STARTED|Washout Period 3 (Part A: 7 Days)||2
1425420|NCT02509117|3489420|P3|STARTED|Washout Period 3 (Part A: 7 Days)||2
1425421|NCT02509117|3489421|P2|STARTED|Washout Period 3 (Part A: 7 Days)||2
1425422|NCT02509117|3489422|P1|STARTED|Washout Period 3 (Part A: 7 Days)||2
1425423|NCT02509117|3489413|P10|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425424|NCT02509117|3489414|P9|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425425|NCT02509117|3489415|P8|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425426|NCT02509117|3489416|P7|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425427|NCT02509117|3489417|P6|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425428|NCT02509117|3489418|P5|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425429|NCT02509117|3489419|P4|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425430|NCT02509117|3489420|P3|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425431|NCT02509117|3489421|P2|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425432|NCT02509117|3489422|P1|NOT COMPLETED|Period 3 -Part A: 4 Days||0
1425433|NCT02509117|3489413|P10|COMPLETED|Period 3 -Part A: 4 Days||0
1425434|NCT02509117|3489414|P9|COMPLETED|Period 3 -Part A: 4 Days||0
1425435|NCT02509117|3489415|P8|COMPLETED|Period 3 -Part A: 4 Days||0
1425436|NCT02509117|3489416|P7|COMPLETED|Period 3 -Part A: 4 Days||0
1425437|NCT02509117|3489417|P6|COMPLETED|Period 3 -Part A: 4 Days||0
1425438|NCT02509117|3489418|P5|COMPLETED|Period 3 -Part A: 4 Days||0
1425439|NCT02509117|3489419|P4|COMPLETED|Period 3 -Part A: 4 Days||2
1425440|NCT02509117|3489420|P3|COMPLETED|Period 3 -Part A: 4 Days||2
1425441|NCT02509117|3489421|P2|COMPLETED|Period 3 -Part A: 4 Days||2
1425442|NCT02509117|3489422|P1|COMPLETED|Period 3 -Part A: 4 Days||2
1425443|NCT02509117|3489413|P10|STARTED|Period 3 -Part A: 4 Days||0
1425444|NCT02509117|3489414|P9|STARTED|Period 3 -Part A: 4 Days||0
1425445|NCT02509117|3489415|P8|STARTED|Period 3 -Part A: 4 Days||0
1425446|NCT02509117|3489416|P7|STARTED|Period 3 -Part A: 4 Days||0
1425447|NCT02509117|3489417|P6|STARTED|Period 3 -Part A: 4 Days||0
1425448|NCT02509117|3489418|P5|STARTED|Period 3 -Part A: 4 Days||0
1425449|NCT02509117|3489419|P4|STARTED|Period 3 -Part A: 4 Days||2
1425450|NCT02509117|3489420|P3|STARTED|Period 3 -Part A: 4 Days||2
1425451|NCT02509117|3489421|P2|STARTED|Period 3 -Part A: 4 Days||2
1425452|NCT02509117|3489422|P1|STARTED|Period 3 -Part A: 4 Days||2
1425453|NCT02509117|3489413|P10|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425454|NCT02509117|3489414|P9|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425455|NCT02509117|3489415|P8|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425456|NCT02509117|3489416|P7|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425457|NCT02509117|3489417|P6|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425458|NCT02509117|3489418|P5|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425459|NCT02509117|3489419|P4|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425460|NCT02509117|3489420|P3|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425461|NCT02509117|3489421|P2|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425462|NCT02509117|3489422|P1|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425463|NCT02509117|3489413|P10|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425464|NCT02509117|3489414|P9|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425465|NCT02509117|3489415|P8|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425466|NCT02509117|3489416|P7|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425467|NCT02509117|3489417|P6|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425468|NCT02509117|3489418|P5|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
1425469|NCT02509117|3489419|P4|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
1425470|NCT02509117|3489420|P3|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
1425471|NCT02509117|3489421|P2|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
1425472|NCT02509117|3489422|P1|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
1425473|NCT02509117|3489413|P10|STARTED|Washout Period 2 (Part A: 7 Days)||0
1425474|NCT02509117|3489414|P9|STARTED|Washout Period 2 (Part A: 7 Days)||0
1425475|NCT02509117|3489415|P8|STARTED|Washout Period 2 (Part A: 7 Days)||0
1425476|NCT02509117|3489416|P7|STARTED|Washout Period 2 (Part A: 7 Days)||0
1425477|NCT02509117|3489417|P6|STARTED|Washout Period 2 (Part A: 7 Days)||0
1425478|NCT02509117|3489418|P5|STARTED|Washout Period 2 (Part A: 7 Days)||0
1425479|NCT02509117|3489419|P4|STARTED|Washout Period 2 (Part A: 7 Days)||2
1425480|NCT02509117|3489420|P3|STARTED|Washout Period 2 (Part A: 7 Days)||2
1425481|NCT02509117|3489421|P2|STARTED|Washout Period 2 (Part A: 7 Days)||2
1425482|NCT02509117|3489422|P1|STARTED|Washout Period 2 (Part A: 7 Days)||2
1425483|NCT02509117|3489413|P10|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425484|NCT02509117|3489414|P9|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425485|NCT02509117|3489415|P8|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425486|NCT02509117|3489416|P7|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425487|NCT02509117|3489417|P6|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425488|NCT02509117|3489418|P5|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425489|NCT02509117|3489419|P4|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425490|NCT02509117|3489420|P3|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425491|NCT02509117|3489421|P2|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425492|NCT02509117|3489422|P1|NOT COMPLETED|Period 2 -Part A: 4 Days||0
1425493|NCT02509117|3489413|P10|COMPLETED|Period 2 -Part A: 4 Days||0
1425494|NCT02509117|3489414|P9|COMPLETED|Period 2 -Part A: 4 Days||0
1425495|NCT02509117|3489415|P8|COMPLETED|Period 2 -Part A: 4 Days||0
1425496|NCT02509117|3489416|P7|COMPLETED|Period 2 -Part A: 4 Days||0
1425497|NCT02509117|3489417|P6|COMPLETED|Period 2 -Part A: 4 Days||0
1425498|NCT02509117|3489418|P5|COMPLETED|Period 2 -Part A: 4 Days||0
1425499|NCT02509117|3489419|P4|COMPLETED|Period 2 -Part A: 4 Days||2
1425500|NCT02509117|3489420|P3|COMPLETED|Period 2 -Part A: 4 Days||2
1425501|NCT02509117|3489421|P2|COMPLETED|Period 2 -Part A: 4 Days||2
1425502|NCT02509117|3489422|P1|COMPLETED|Period 2 -Part A: 4 Days||2
1425503|NCT02509117|3489413|P10|Treated|Period 2 -Part A: 4 Days||0
1425504|NCT02509117|3489414|P9|Treated|Period 2 -Part A: 4 Days||0
1425505|NCT02509117|3489415|P8|Treated|Period 2 -Part A: 4 Days||0
1425506|NCT02509117|3489416|P7|Treated|Period 2 -Part A: 4 Days||0
1425507|NCT02509117|3489417|P6|Treated|Period 2 -Part A: 4 Days||0
1425508|NCT02509117|3489418|P5|Treated|Period 2 -Part A: 4 Days||0
1425509|NCT02509117|3489419|P4|Treated|Period 2 -Part A: 4 Days||2
1425510|NCT02509117|3489420|P3|Treated|Period 2 -Part A: 4 Days||2
1425511|NCT02509117|3489421|P2|Treated|Period 2 -Part A: 4 Days||2
1425512|NCT02509117|3489422|P1|Treated|Period 2 -Part A: 4 Days||2
1425513|NCT02509117|3489413|P10|STARTED|Period 2 -Part A: 4 Days||0
1425514|NCT02509117|3489414|P9|STARTED|Period 2 -Part A: 4 Days||0
1425515|NCT02509117|3489415|P8|STARTED|Period 2 -Part A: 4 Days||0
1425516|NCT02509117|3489416|P7|STARTED|Period 2 -Part A: 4 Days||0
1425517|NCT02509117|3489417|P6|STARTED|Period 2 -Part A: 4 Days||0
1425518|NCT02509117|3489418|P5|STARTED|Period 2 -Part A: 4 Days||0
1425519|NCT02509117|3489419|P4|STARTED|Period 2 -Part A: 4 Days||2
1425520|NCT02509117|3489420|P3|STARTED|Period 2 -Part A: 4 Days||2
1425521|NCT02509117|3489421|P2|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
1425522|NCT02509117|3489422|P1|STARTED|Period 2 -Part A: 4 Days||2
1425523|NCT02509117|3489413|P10|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425524|NCT02509117|3489414|P9|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425525|NCT02509117|3489415|P8|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425526|NCT02509117|3489416|P7|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425527|NCT02509117|3489417|P6|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425528|NCT02509117|3489418|P5|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425529|NCT02509117|3489419|P4|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425530|NCT02509117|3489420|P3|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425531|NCT02509117|3489421|P2|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425532|NCT02509117|3489422|P1|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425533|NCT02509117|3489413|P10|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425534|NCT02509117|3489414|P9|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425535|NCT02509117|3489415|P8|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425536|NCT02509117|3489416|P7|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425537|NCT02509117|3489417|P6|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425538|NCT02509117|3489418|P5|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
1425539|NCT02509117|3489419|P4|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
1425540|NCT02509117|3489420|P3|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
1425541|NCT02509117|3489421|P2|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
1425542|NCT02509117|3489422|P1|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
1425543|NCT02509117|3489413|P10|STARTED|Washout Period 1 (Part A: 7 Days)||0
1425544|NCT02509117|3489414|P9|STARTED|Washout Period 1 (Part A: 7 Days)||0
1425545|NCT02509117|3489415|P8|STARTED|Washout Period 1 (Part A: 7 Days)||0
1425546|NCT02509117|3489416|P7|STARTED|Washout Period 1 (Part A: 7 Days)||0
1425547|NCT02509117|3489417|P6|STARTED|Washout Period 1 (Part A: 7 Days)||0
1425548|NCT02509117|3489418|P5|STARTED|Washout Period 1 (Part A: 7 Days)||0
1425549|NCT02509117|3489419|P4|STARTED|Washout Period 1 (Part A: 7 Days)||2
1425550|NCT02509117|3489420|P3|STARTED|Washout Period 1 (Part A: 7 Days)||2
1425551|NCT02509117|3489421|P2|STARTED|Washout Period 1 (Part A: 7 Days)||1
1425552|NCT02509117|3489422|P1|STARTED|Washout Period 1 (Part A: 7 Days)||2
1425553|NCT02509117|3489413|P10|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425554|NCT02509117|3489414|P9|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1425555|NCT02509117|3489415|P8|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1425556|NCT02509117|3489416|P7|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1425557|NCT02509117|3489417|P6|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1425558|NCT02509117|3489418|P5|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1425559|NCT02509117|3489419|P4|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1425560|NCT02509117|3489420|P3|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1425561|NCT02509117|3489421|P2|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
1425562|NCT02509117|3489422|P1|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
1425563|NCT02509117|3489413|P10|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425564|NCT02509117|3489414|P9|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
1425565|NCT02509117|3489415|P8|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425566|NCT02509117|3489416|P7|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425567|NCT02509117|3489417|P6|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425568|NCT02509117|3489418|P5|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425569|NCT02509117|3489419|P4|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425570|NCT02509117|3489420|P3|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425571|NCT02509117|3489421|P2|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
1425572|NCT02509117|3489422|P1|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425573|NCT02509117|3489413|P10|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
1425574|NCT02509117|3489414|P9|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
1425575|NCT02509117|3489415|P8|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425576|NCT02509117|3489416|P7|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425577|NCT02509117|3489417|P6|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425578|NCT02509117|3489418|P5|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425579|NCT02509117|3489419|P4|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425580|NCT02509117|3489420|P3|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425581|NCT02509117|3489421|P2|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
1425582|NCT02509117|3489422|P1|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425583|NCT02509117|3489413|P10|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
1425584|NCT02509117|3489414|P9|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
1425585|NCT02509117|3489415|P8|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425586|NCT02509117|3489416|P7|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425587|NCT02509117|3489417|P6|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425588|NCT02509117|3489418|P5|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
1425589|NCT02509117|3489419|P4|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425590|NCT02509117|3489420|P3|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425591|NCT02509117|3489421|P2|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425592|NCT02509117|3489422|P1|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
1425593|NCT02509065|3489631|P23|NOT COMPLETED|Overall Study||0
1425594|NCT02509065|3489632|P22|NOT COMPLETED|Overall Study||0
1425595|NCT02509065|3489633|P21|NOT COMPLETED|Overall Study||0
1425596|NCT02509065|3489634|P20|NOT COMPLETED|Overall Study||0
1425597|NCT02509065|3489635|P19|NOT COMPLETED|Overall Study||0
1425598|NCT02509065|3489636|P18|NOT COMPLETED|Overall Study||0
1425599|NCT02509065|3489637|P17|NOT COMPLETED|Overall Study||0
1425600|NCT02509065|3489638|P16|NOT COMPLETED|Overall Study||0
1425601|NCT02509065|3489639|P15|NOT COMPLETED|Overall Study||0
1425602|NCT02509065|3489640|P14|NOT COMPLETED|Overall Study||0
1425603|NCT02509065|3489641|P13|NOT COMPLETED|Overall Study||0
1425604|NCT02509065|3489642|P12|NOT COMPLETED|Overall Study||0
1425605|NCT02509065|3489643|P11|NOT COMPLETED|Overall Study||0
1425606|NCT02509065|3489644|P10|NOT COMPLETED|Overall Study||0
1425607|NCT02509065|3489645|P9|NOT COMPLETED|Overall Study||0
1425608|NCT02509065|3489646|P8|NOT COMPLETED|Overall Study||0
1425609|NCT02509065|3489647|P7|NOT COMPLETED|Overall Study||0
1425610|NCT02509065|3489648|P6|NOT COMPLETED|Overall Study||0
1425611|NCT02509065|3489649|P5|NOT COMPLETED|Overall Study||0
1425612|NCT02509065|3489650|P4|NOT COMPLETED|Overall Study||0
1425613|NCT02509065|3489651|P3|NOT COMPLETED|Overall Study||0
1425614|NCT02509065|3489652|P2|NOT COMPLETED|Overall Study||0
1425615|NCT02509065|3489653|P1|NOT COMPLETED|Overall Study||0
1425616|NCT02509065|3489631|P23|COMPLETED|Overall Study||1
1425617|NCT02509065|3489632|P22|COMPLETED|Overall Study||1
1425618|NCT02509065|3489633|P21|COMPLETED|Overall Study||1
1425619|NCT02509065|3489634|P20|COMPLETED|Overall Study||1
1425620|NCT02509065|3489635|P19|COMPLETED|Overall Study||1
1425621|NCT02509065|3489636|P18|COMPLETED|Overall Study||1
1425622|NCT02509065|3489637|P17|COMPLETED|Overall Study||1
1425623|NCT02509065|3489638|P16|COMPLETED|Overall Study||1
1425624|NCT02509065|3489639|P15|COMPLETED|Overall Study||1
1425625|NCT02509065|3489640|P14|COMPLETED|Overall Study||1
1425626|NCT02509065|3489641|P13|COMPLETED|Overall Study||1
1425627|NCT02509065|3489642|P12|COMPLETED|Overall Study||1
1425628|NCT02509065|3489643|P11|COMPLETED|Overall Study||1
1425629|NCT02509065|3489644|P10|COMPLETED|Overall Study||1
1425630|NCT02509065|3489645|P9|COMPLETED|Overall Study||1
1425631|NCT02509065|3489646|P8|COMPLETED|Overall Study||1
1425632|NCT02509065|3489647|P7|COMPLETED|Overall Study||1
1425633|NCT02509065|3489648|P6|COMPLETED|Overall Study||1
1425634|NCT02509065|3489649|P5|COMPLETED|Overall Study||1
1425635|NCT02509065|3489650|P4|COMPLETED|Overall Study||1
1425636|NCT02509065|3489651|P3|COMPLETED|Overall Study||2
1425637|NCT02509065|3489652|P2|COMPLETED|Overall Study||1
1425638|NCT02509065|3489653|P1|COMPLETED|Overall Study||1
1425639|NCT02509065|3489631|P23|STARTED|Overall Study||1
1425640|NCT02509065|3489632|P22|STARTED|Overall Study||1
1425641|NCT02509065|3489633|P21|STARTED|Overall Study||1
1425642|NCT02509065|3489634|P20|STARTED|Overall Study||1
1425643|NCT02509065|3489635|P19|STARTED|Overall Study||1
1425644|NCT02509065|3489636|P18|STARTED|Overall Study||1
1425645|NCT02509065|3489637|P17|STARTED|Overall Study||1
1425646|NCT02509065|3489638|P16|STARTED|Overall Study||1
1425647|NCT02509065|3489639|P15|STARTED|Overall Study||1
1425648|NCT02509065|3489640|P14|STARTED|Overall Study||1
1425649|NCT02509065|3489641|P13|STARTED|Overall Study||1
1425650|NCT02509065|3489642|P12|STARTED|Overall Study||1
1425651|NCT02509065|3489643|P11|STARTED|Overall Study||1
1425652|NCT02509065|3489644|P10|STARTED|Overall Study||1
1425653|NCT02509065|3489645|P9|STARTED|Overall Study||1
1425654|NCT02509065|3489646|P8|STARTED|Overall Study||1
1425655|NCT02509065|3489647|P7|STARTED|Overall Study||1
1425656|NCT02509065|3489648|P6|STARTED|Overall Study||1
1425657|NCT02509065|3489649|P5|STARTED|Overall Study||1
1425658|NCT02509065|3489650|P4|STARTED|Overall Study||1
1425659|NCT02509065|3489651|P3|STARTED|Overall Study||2
1425660|NCT02509065|3489652|P2|STARTED|Overall Study||1
1425661|NCT02509065|3489653|P1|STARTED|Overall Study||1
1425662|NCT02508701|3489742|P4|NOT COMPLETED|Overall Study||3
1425663|NCT02508701|3489743|P3|NOT COMPLETED|Overall Study||5
1425664|NCT02508701|3489744|P2|NOT COMPLETED|Overall Study||5
1425665|NCT02508701|3489745|P1|NOT COMPLETED|Overall Study||9
1425666|NCT02508701|3489742|P4|COMPLETED|Overall Study||1
1425667|NCT02508701|3489743|P3|COMPLETED|Overall Study||0
1425668|NCT02508701|3489744|P2|COMPLETED|Overall Study||1
1425669|NCT02508701|3489745|P1|COMPLETED|Overall Study||0
1425670|NCT02508701|3489742|P4|STARTED|Overall Study||4
1425671|NCT02508701|3489743|P3|STARTED|Overall Study||5
1425672|NCT02508701|3489744|P2|STARTED|Overall Study||6
1425673|NCT02508701|3489745|P1|STARTED|Overall Study||9
1425674|NCT02508207|3489769|P2|NOT COMPLETED|Overall Study||0
1425675|NCT02508207|3489770|P1|NOT COMPLETED|Overall Study||0
1425676|NCT02508207|3489769|P2|COMPLETED|Overall Study||27
1425677|NCT02508207|3489770|P1|COMPLETED|Overall Study||7
1425678|NCT02508207|3489769|P2|STARTED|Overall Study||27
1425679|NCT02508207|3489770|P1|STARTED|Overall Study||7
1425680|NCT02508194|3489786|P2|NOT COMPLETED|Overall Study||44
1425681|NCT02508194|3489787|P1|NOT COMPLETED|Overall Study||52
1425682|NCT02508194|3489786|P2|COMPLETED|Overall Study||907
1425683|NCT02508194|3489787|P1|COMPLETED|Overall Study||897
1425684|NCT02508194|3489786|P2|STARTED|Overall Study||951
1425685|NCT02508194|3489787|P1|STARTED|Overall Study||949
1425686|NCT02508116|3489827|P2|NOT COMPLETED|Overall Study||7
1425687|NCT02508116|3489828|P1|NOT COMPLETED|Overall Study||8
1425688|NCT02508116|3489827|P2|COMPLETED|Overall Study||250
1425689|NCT02508116|3489828|P1|COMPLETED|Overall Study||244
1425690|NCT02508116|3489827|P2|Received Intervention as Randomized|Overall Study||255
1425691|NCT02508116|3489828|P1|Received Intervention as Randomized|Overall Study||249
1425692|NCT02508116|3489827|P2|STARTED|Overall Study||257
1425693|NCT02508116|3489828|P1|STARTED|Overall Study||252
1425694|NCT02508103|3489842|P2|NOT COMPLETED|Overall Study||0
1425695|NCT02508103|3489843|P1|NOT COMPLETED|Overall Study||0
1425696|NCT02508103|3489842|P2|COMPLETED|Overall Study||5
1425697|NCT02508103|3489843|P1|COMPLETED|Overall Study||5
1425698|NCT02508103|3489842|P2|STARTED|Overall Study||5
1425699|NCT02508103|3489843|P1|STARTED|Overall Study||5
1425700|NCT02508077|3489851|P1|NOT COMPLETED|Overall Study||0
1425701|NCT02508077|3489851|P1|COMPLETED|Overall Study||1
1425702|NCT02508077|3489851|P1|STARTED|Overall Study||1
1425703|NCT02507752|3489855|P1|NOT COMPLETED|Overall Study||17
1425704|NCT02507752|3489855|P1|COMPLETED|Overall Study||55
1425705|NCT02507752|3489855|P1|STARTED|Overall Study||72
1425706|NCT02507388|3489875|P2|NOT COMPLETED|Overall Study||0
1425707|NCT02507388|3489876|P1|NOT COMPLETED|Overall Study||0
1425708|NCT02507388|3489875|P2|COMPLETED|Overall Study||25
1425709|NCT02507388|3489876|P1|COMPLETED|Overall Study||25
1425710|NCT02507388|3489875|P2|STARTED|Overall Study||25
1425711|NCT02507388|3489876|P1|STARTED|Overall Study||25
1425712|NCT02507375|3489899|P2|NOT COMPLETED|Overall Study||8
1425713|NCT02507375|3489900|P1|NOT COMPLETED|Overall Study||4
1425714|NCT02507375|3489899|P2|COMPLETED|Overall Study||1
1425715|NCT02507375|3489900|P1|COMPLETED|Overall Study||2
1425716|NCT02507375|3489899|P2|Extension Period|Overall Study||1
1425717|NCT02507375|3489900|P1|Extension Period|Overall Study||2
1425718|NCT02507375|3489899|P2|Cycle 6|Overall Study||1
1425719|NCT02507375|3489900|P1|Cycle 6|Overall Study||3
1425720|NCT02507375|3489899|P2|Cycle 5|Overall Study||1
1425721|NCT02507375|3489900|P1|Cycle 5|Overall Study||3
1425722|NCT02507375|3489899|P2|Cycle 4|Overall Study||2
1425723|NCT02507375|3489900|P1|Cycle 4|Overall Study||4
1425724|NCT02507375|3489899|P2|Cycle 3|Overall Study||5
1425725|NCT02507375|3489900|P1|Cycle 3|Overall Study||4
1425726|NCT02507375|3489899|P2|Cycle 2|Overall Study||5
1425727|NCT02507375|3489900|P1|Cycle 2|Overall Study||5
1425728|NCT02507375|3489899|P2|Received Pertuzumab|Overall Study||6
1425729|NCT02507375|3489900|P1|Received Pertuzumab|Overall Study||6
1425730|NCT02507375|3489899|P2|Cycle 1|Overall Study||9
1425731|NCT02507375|3489900|P1|Cycle 1|Overall Study||6
1425732|NCT02507375|3489899|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
1425733|NCT02507375|3489900|P1|STARTED|Overall Study||6
1425734|NCT02507219|3489917|P6|NOT COMPLETED|Overall Study||0
1425735|NCT02507219|3489918|P5|NOT COMPLETED|Overall Study||1
1425736|NCT02507219|3489919|P4|NOT COMPLETED|Overall Study||0
1425737|NCT02507219|3489920|P3|NOT COMPLETED|Overall Study||0
1425738|NCT02507219|3489921|P2|NOT COMPLETED|Overall Study||0
1425739|NCT02507219|3489922|P1|NOT COMPLETED|Overall Study||1
1425740|NCT02507219|3489917|P6|COMPLETED|Overall Study||3
1425741|NCT02507219|3489918|P5|COMPLETED|Overall Study||3
1425742|NCT02507219|3489919|P4|COMPLETED|Overall Study||3
1425743|NCT02507219|3489920|P3|COMPLETED|Overall Study||3
1425744|NCT02507219|3489921|P2|COMPLETED|Overall Study||4
1425745|NCT02507219|3489922|P1|COMPLETED|Overall Study||4
1425746|NCT02507219|3489917|P6|STARTED|Overall Study||3
1425747|NCT02507219|3489918|P5|STARTED|Overall Study||4
1425748|NCT02507219|3489919|P4|STARTED|Overall Study||3
1425749|NCT02507219|3489920|P3|STARTED|Overall Study||3
1425750|NCT02507219|3489921|P2|STARTED|Overall Study||4
1425751|NCT02507219|3489922|P1|STARTED|Overall Study||5
1425752|NCT02506985|3489932|P2|NOT COMPLETED|Overall Study||0
1425753|NCT02506985|3489933|P1|NOT COMPLETED|Overall Study||0
1425754|NCT02506985|3489932|P2|COMPLETED|Overall Study||6
1425755|NCT02506985|3489933|P1|COMPLETED|Overall Study||4
1425756|NCT02506985|3489932|P2|STARTED|Overall Study||6
1425757|NCT02506985|3489933|P1|STARTED|Overall Study||4
1425758|NCT02506881|3489951|P4|NOT COMPLETED|Second Intervention (Day 1)||0
1425759|NCT02506881|3489952|P3|NOT COMPLETED|Second Intervention (Day 1)||0
1425760|NCT02506881|3489953|P2|NOT COMPLETED|Second Intervention (Day 1)||0
1425761|NCT02506881|3489954|P1|NOT COMPLETED|Second Intervention (Day 1)||0
1425762|NCT02506881|3489951|P4|COMPLETED|Second Intervention (Day 1)||12
1425763|NCT02506881|3489952|P3|COMPLETED|Second Intervention (Day 1)||12
1425764|NCT02506881|3489953|P2|COMPLETED|Second Intervention (Day 1)||12
1425765|NCT02506881|3489954|P1|COMPLETED|Second Intervention (Day 1)||12
1425766|NCT02506881|3489951|P4|STARTED|Second Intervention (Day 1)||12
1425767|NCT02506881|3489952|P3|STARTED|Second Intervention (Day 1)||12
1425768|NCT02506881|3489953|P2|STARTED|Second Intervention (Day 1)||12
1425769|NCT02506881|3489954|P1|STARTED|Second Intervention (Day 1)||12
1425770|NCT02506881|3489951|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
1425771|NCT02506881|3489952|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
1425772|NCT02506881|3489953|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
1425773|NCT02506881|3489954|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
1425774|NCT02506881|3489951|P4|COMPLETED|Washout (at Least 25 Days)||12
1425775|NCT02506881|3489952|P3|COMPLETED|Washout (at Least 25 Days)||12
1425776|NCT02506881|3489953|P2|COMPLETED|Washout (at Least 25 Days)||12
1425777|NCT02506881|3489954|P1|COMPLETED|Washout (at Least 25 Days)||12
1425778|NCT02506881|3489951|P4|STARTED|Washout (at Least 25 Days)||12
1425779|NCT02506881|3489952|P3|STARTED|Washout (at Least 25 Days)||12
1425780|NCT02506881|3489953|P2|STARTED|Washout (at Least 25 Days)||12
1425781|NCT02506881|3489954|P1|STARTED|Washout (at Least 25 Days)||12
1425782|NCT02506881|3489951|P4|NOT COMPLETED|First Intervention (Day 1)||12
1425783|NCT02506881|3489952|P3|NOT COMPLETED|First Intervention (Day 1)||13
1425784|NCT02506881|3489953|P2|NOT COMPLETED|First Intervention (Day 1)||0
1425785|NCT02506881|3489954|P1|NOT COMPLETED|First Intervention (Day 1)||1
1425786|NCT02506881|3489951|P4|COMPLETED|First Intervention (Day 1)||12
1425787|NCT02506881|3489952|P3|COMPLETED|First Intervention (Day 1)||12
1425788|NCT02506881|3489953|P2|COMPLETED|First Intervention (Day 1)||12
1425789|NCT02506881|3489954|P1|COMPLETED|First Intervention (Day 1)||12
1425790|NCT02506881|3489951|P4|STARTED|First Intervention (Day 1)||24
1425791|NCT02506881|3489952|P3|STARTED|First Intervention (Day 1)||25
1425792|NCT02506881|3489953|P2|STARTED|First Intervention (Day 1)||12
1425793|NCT02506881|3489954|P1|STARTED|First Intervention (Day 1)||13
1425794|NCT02506660|3489990|P2|NOT COMPLETED|Overall Study||1
1425795|NCT02506660|3489991|P1|NOT COMPLETED|Overall Study||2
1425796|NCT02506660|3489990|P2|COMPLETED|Overall Study||63
1425797|NCT02506660|3489991|P1|COMPLETED|Overall Study||62
1425798|NCT02506660|3489990|P2|STARTED|Overall Study||64
1425799|NCT02506660|3489991|P1|STARTED|Overall Study||64
1425800|NCT02506309|3490011|P2|NOT COMPLETED|Overall Study||1
1425801|NCT02506309|3490012|P1|NOT COMPLETED|Overall Study||2
1425802|NCT02506309|3490011|P2|COMPLETED|Overall Study||44
1425803|NCT02506309|3490012|P1|COMPLETED|Overall Study||46
1425804|NCT02506309|3490011|P2|STARTED|Overall Study||45
1425805|NCT02506309|3490012|P1|STARTED|Overall Study||48
1425806|NCT02506257|3490028|P4|NOT COMPLETED|Overall Study||0
1425807|NCT02506257|3490029|P3|NOT COMPLETED|Overall Study||4
1425808|NCT02506257|3490030|P2|NOT COMPLETED|Overall Study||2
1425809|NCT02506257|3490031|P1|NOT COMPLETED|Overall Study||0
1425810|NCT02506257|3490028|P4|COMPLETED|Overall Study||9
1425811|NCT02506257|3490029|P3|COMPLETED|Overall Study||23
1425812|NCT02506257|3490030|P2|COMPLETED|Overall Study||26
1425813|NCT02506257|3490031|P1|COMPLETED|Overall Study||26
1425814|NCT02506257|3490028|P4|STARTED|Overall Study||9
1425815|NCT02506257|3490029|P3|STARTED|Overall Study||27
1425816|NCT02506257|3490030|P2|STARTED|Overall Study||28
1425817|NCT02506257|3490031|P1|STARTED|Overall Study||26
1425818|NCT02506101|3490063|P2|NOT COMPLETED|Overall Study||0
1425819|NCT02506101|3490064|P1|NOT COMPLETED|Overall Study||2
1425820|NCT02506101|3490063|P2|COMPLETED|Overall Study||0
1425821|NCT02506101|3490064|P1|COMPLETED|Overall Study||0
1425822|NCT02506101|3490063|P2|STARTED|Overall Study||0
1425823|NCT02506101|3490064|P1|STARTED|Overall Study||2
1425824|NCT02505945|3490080|P2|NOT COMPLETED|Overall Study||4
1425825|NCT02505945|3490081|P1|NOT COMPLETED|Overall Study||22
1425826|NCT02505945|3490080|P2|COMPLETED|Overall Study||46
1425827|NCT02505945|3490081|P1|COMPLETED|Overall Study||80
1425828|NCT02505945|3490080|P2|STARTED|Overall Study||50
1425829|NCT02505945|3490081|P1|STARTED|Overall Study||102
1425830|NCT02505334|3490091|P2|NOT COMPLETED|Extension Treatment Period||0
1425831|NCT02505334|3490092|P1|NOT COMPLETED|Extension Treatment Period||18
1425832|NCT02505334|3490091|P2|COMPLETED|Extension Treatment Period||0
1425833|NCT02505334|3490092|P1|COMPLETED|Extension Treatment Period||194
1425834|NCT02505334|3490091|P2|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
1425835|NCT02505334|3490092|P1|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
1425836|NCT02505334|3490091|P2|NOT COMPLETED|Main Treatment Period||39
1425837|NCT02505334|3490092|P1|NOT COMPLETED|Main Treatment Period||15
1425838|NCT02505334|3490091|P2|COMPLETED|Main Treatment Period||194
1425839|NCT02505334|3490092|P1|COMPLETED|Main Treatment Period||218
1425840|NCT02505334|3490091|P2|STARTED|Main Treatment Period||233
1425841|NCT02505334|3490092|P1|STARTED|Main Treatment Period||233
1425842|NCT02504931|3490219|P2|NOT COMPLETED|Overall Study||10
1425843|NCT02504931|3490220|P1|NOT COMPLETED|Overall Study||12
1425844|NCT02504931|3490219|P2|COMPLETED|Overall Study||13
1425845|NCT02504931|3490220|P1|COMPLETED|Overall Study||14
1425846|NCT02504931|3490219|P2|STARTED|Overall Study||23
1425847|NCT02504931|3490220|P1|STARTED|Overall Study||26
1425848|NCT02504827|3490228|P1|NOT COMPLETED|Overall Study||1
1425849|NCT02504827|3490228|P1|COMPLETED|Overall Study||11
1425850|NCT02504827|3490228|P1|STARTED|Overall Study||12
1425851|NCT02504775|3490233|P2|NOT COMPLETED|Period 2||0
1425852|NCT02504775|3490234|P1|NOT COMPLETED|Period 2||0
1425853|NCT02504775|3490233|P2|COMPLETED|Period 2||14
1425854|NCT02504775|3490234|P1|COMPLETED|Period 2||14
1425855|NCT02504775|3490233|P2|STARTED|Period 2||14
1425856|NCT02504775|3490234|P1|STARTED|Period 2||14
1425857|NCT02504775|3490233|P2|NOT COMPLETED|Washout||0
1425858|NCT02504775|3490234|P1|NOT COMPLETED|Washout||0
1425859|NCT02504775|3490233|P2|COMPLETED|Washout||14
1425860|NCT02504775|3490234|P1|COMPLETED|Washout||14
1425861|NCT02504775|3490233|P2|STARTED|Washout||14
1425862|NCT02504775|3490234|P1|STARTED|Washout||14
1425863|NCT02504775|3490233|P2|NOT COMPLETED|Period 1||0
1425864|NCT02504775|3490234|P1|NOT COMPLETED|Period 1||0
1425865|NCT02504775|3490233|P2|COMPLETED|Period 1||14
1425866|NCT02504775|3490234|P1|COMPLETED|Period 1||14
1425867|NCT02504775|3490233|P2|STARTED|Period 1||14
1425868|NCT02504775|3490234|P1|STARTED|Period 1||14
1425869|NCT02504723|3490248|P2|NOT COMPLETED|Overall Study||0
1425870|NCT02504723|3490249|P1|NOT COMPLETED|Overall Study||0
1425871|NCT02504723|3490248|P2|COMPLETED|Overall Study||61
1425872|NCT02504723|3490249|P1|COMPLETED|Overall Study||60
1425873|NCT02504723|3490248|P2|STARTED|Overall Study||61
1425874|NCT02504723|3490249|P1|STARTED|Overall Study||60
1425875|NCT02504541|3490261|P1|NOT COMPLETED|Overall Study||20
1425876|NCT02504541|3490261|P1|COMPLETED|Overall Study||113
1425877|NCT02504541|3490261|P1|STARTED|Overall Study||133
1425878|NCT02504502|3490267|P2|NOT COMPLETED|Crossover to Enhanced Report||0
1425879|NCT02504502|3490268|P1|NOT COMPLETED|Crossover to Enhanced Report||5
1425880|NCT02504502|3490267|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
1425881|NCT02504502|3490268|P1|COMPLETED|Crossover to Enhanced Report||15
1425882|NCT02504502|3490267|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
1425883|NCT02504502|3490268|P1|STARTED|Crossover to Enhanced Report||20
1425884|NCT02504502|3490267|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
1425885|NCT02504502|3490268|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
1425886|NCT02504502|3490267|P2|COMPLETED|Routine Care vs. Enhanced Report||21
1425887|NCT02504502|3490268|P1|COMPLETED|Routine Care vs. Enhanced Report||20
1425888|NCT02504502|3490267|P2|STARTED|Routine Care vs. Enhanced Report||28
1425889|NCT02504502|3490268|P1|STARTED|Routine Care vs. Enhanced Report||24
1425890|NCT02504424|3490274|P1|NOT COMPLETED|Overall Study||2
1425891|NCT02504424|3490274|P1|COMPLETED|Overall Study|48 subjects completed the study. 2 withdrew prior to study completion.|48
1425892|NCT02504424|3490274|P1|STARTED|Overall Study|54 subjects were consented from 11/12/15-9/29/16. 50 underwent treatment; 4 were not treated.|50
1425893|NCT02504320|3490283|P4|NOT COMPLETED|Treatment Period 4||0
1425894|NCT02504320|3490284|P3|NOT COMPLETED|Treatment Period 4||0
1425895|NCT02504320|3490285|P2|NOT COMPLETED|Treatment Period 4||0
1425896|NCT02504320|3490286|P1|NOT COMPLETED|Treatment Period 4||0
1425897|NCT02504320|3490283|P4|COMPLETED|Treatment Period 4||19
1425898|NCT02504320|3490284|P3|COMPLETED|Treatment Period 4||18
1425899|NCT02504320|3490285|P2|COMPLETED|Treatment Period 4||18
1425900|NCT02504320|3490286|P1|COMPLETED|Treatment Period 4||19
1425901|NCT02504320|3490283|P4|STARTED|Treatment Period 4||19
1425902|NCT02504320|3490284|P3|STARTED|Treatment Period 4||18
1425903|NCT02504320|3490285|P2|STARTED|Treatment Period 4||18
1425904|NCT02504320|3490286|P1|STARTED|Treatment Period 4||19
1425905|NCT02504320|3490283|P4|NOT COMPLETED|Treatment Period 3||1
1425906|NCT02504320|3490284|P3|NOT COMPLETED|Treatment Period 3||1
1425907|NCT02504320|3490285|P2|NOT COMPLETED|Treatment Period 3||0
1425908|NCT02504320|3490286|P1|NOT COMPLETED|Treatment Period 3||0
1425909|NCT02504320|3490283|P4|COMPLETED|Treatment Period 3||19
1425910|NCT02504320|3490284|P3|COMPLETED|Treatment Period 3||18
1425911|NCT02504320|3490285|P2|COMPLETED|Treatment Period 3||18
1425912|NCT02504320|3490286|P1|COMPLETED|Treatment Period 3||19
1425913|NCT02504320|3490283|P4|STARTED|Treatment Period 3||20
1425914|NCT02504320|3490284|P3|STARTED|Treatment Period 3||19
1425915|NCT02504320|3490285|P2|STARTED|Treatment Period 3||18
1425916|NCT02504320|3490286|P1|STARTED|Treatment Period 3||19
1425917|NCT02504320|3490283|P4|NOT COMPLETED|Treatment Period 2||0
1425918|NCT02504320|3490284|P3|NOT COMPLETED|Treatment Period 2||0
1425919|NCT02504320|3490285|P2|NOT COMPLETED|Treatment Period 2||1
1425920|NCT02504320|3490286|P1|NOT COMPLETED|Treatment Period 2||0
1425921|NCT02504320|3490283|P4|COMPLETED|Treatment Period 2||20
1425922|NCT02504320|3490284|P3|COMPLETED|Treatment Period 2||19
1425923|NCT02504320|3490285|P2|COMPLETED|Treatment Period 2||18
1425924|NCT02504320|3490286|P1|COMPLETED|Treatment Period 2||19
1425925|NCT02504320|3490283|P4|STARTED|Treatment Period 2||20
1425926|NCT02504320|3490284|P3|STARTED|Treatment Period 2||19
1425927|NCT02504320|3490285|P2|STARTED|Treatment Period 2||19
1425928|NCT02504320|3490286|P1|STARTED|Treatment Period 2||19
1425929|NCT02504320|3490283|P4|NOT COMPLETED|Treatment Period 1||0
1425930|NCT02504320|3490284|P3|NOT COMPLETED|Treatment Period 1||1
1425931|NCT02504320|3490285|P2|NOT COMPLETED|Treatment Period 1||0
1425932|NCT02504320|3490286|P1|NOT COMPLETED|Treatment Period 1||0
1425933|NCT02504320|3490283|P4|COMPLETED|Treatment Period 1||20
1425934|NCT02504320|3490284|P3|COMPLETED|Treatment Period 1||19
1425935|NCT02504320|3490285|P2|COMPLETED|Treatment Period 1||19
1425936|NCT02504320|3490286|P1|COMPLETED|Treatment Period 1||19
1425937|NCT02504320|3490283|P4|STARTED|Treatment Period 1||20
1425938|NCT02504320|3490284|P3|STARTED|Treatment Period 1||20
1425939|NCT02504320|3490285|P2|STARTED|Treatment Period 1||19
1425940|NCT02504320|3490286|P1|STARTED|Treatment Period 1||19
1425941|NCT02504294|3490306|P2|NOT COMPLETED|Overall Study||48
1425942|NCT02504294|3490307|P1|NOT COMPLETED|Overall Study||56
1425943|NCT02504294|3490306|P2|COMPLETED|Overall Study||158
1425944|NCT02504294|3490307|P1|COMPLETED|Overall Study||156
1425945|NCT02504294|3490306|P2|STARTED|Overall Study||206
1425946|NCT02504294|3490307|P1|STARTED|Overall Study||212
1425947|NCT02504099|3490315|P1|NOT COMPLETED|Overall Study||0
1425948|NCT02504099|3490315|P1|COMPLETED|Overall Study||3
1425949|NCT02504099|3490315|P1|STARTED|Overall Study||3
1425950|NCT02504073|3490323|P1|NOT COMPLETED|Overall Study||0
1425951|NCT02504073|3490323|P1|COMPLETED|Overall Study||54
1425952|NCT02504073|3490323|P1|STARTED|Overall Study||54
1425953|NCT02503982|3490329|P1|NOT COMPLETED|Overall Study||0
1425954|NCT02503982|3490329|P1|COMPLETED|Overall Study||13
1425955|NCT02503982|3490329|P1|STARTED|Overall Study||13
1425956|NCT02503865|3490336|P3|NOT COMPLETED|Overall Study||2
1425957|NCT02503865|3490337|P2|NOT COMPLETED|Overall Study||47
1425958|NCT02503865|3490338|P1|NOT COMPLETED|Overall Study||5
1425959|NCT02503865|3490336|P3|COMPLETED|Overall Study||64
1425960|NCT02503865|3490337|P2|COMPLETED|Overall Study||222
1425961|NCT02503865|3490338|P1|COMPLETED|Overall Study||65
1425962|NCT02503865|3490336|P3|STARTED|Overall Study||66
1425963|NCT02503865|3490337|P2|STARTED|Overall Study||269
1425964|NCT02503865|3490338|P1|STARTED|Overall Study||70
1425965|NCT02503787|3490358|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
1425966|NCT02503787|3490358|P1|COMPLETED|Implant to 3 Month Endpoint||29
1425967|NCT02503787|3490358|P1|STARTED|Implant to 3 Month Endpoint||32
1425968|NCT02503787|3490358|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
1425969|NCT02503787|3490358|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
1425970|NCT02503787|3490358|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
1425971|NCT02503787|3490358|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
1425972|NCT02503787|3490358|P1|COMPLETED|Device Trial (HD Programming Trial)||37
1425973|NCT02503787|3490358|P1|STARTED|Device Trial (HD Programming Trial)||44
1425974|NCT02503787|3490358|P1|NOT COMPLETED|Enrollment||20
1425975|NCT02503787|3490358|P1|COMPLETED|Enrollment||44
1425976|NCT02503787|3490358|P1|STARTED|Enrollment||64
1425977|NCT02503254|3490367|P2|NOT COMPLETED|Overall Study||0
1425978|NCT02503254|3490368|P1|NOT COMPLETED|Overall Study||0
1425979|NCT02503254|3490367|P2|COMPLETED|Overall Study||39
1425980|NCT02503254|3490368|P1|COMPLETED|Overall Study||41
1425981|NCT02503254|3490367|P2|STARTED|Overall Study||39
1425982|NCT02503254|3490368|P1|STARTED|Overall Study||41
1425983|NCT02503215|3490381|P1|NOT COMPLETED|Overall Study||3
1425984|NCT02503215|3490381|P1|COMPLETED|Overall Study||14
1425985|NCT02503215|3490381|P1|STARTED|Overall Study||17
1425986|NCT02503202|3490392|P5|NOT COMPLETED|Extension: Month 6 to 24||1
1425987|NCT02503202|3490393|P4|NOT COMPLETED|Extension: Month 6 to 24||18
1425988|NCT02503202|3490394|P3|NOT COMPLETED|Extension: Month 6 to 24||9
1425989|NCT02503202|3490395|P2|NOT COMPLETED|Extension: Month 6 to 24||16
1425990|NCT02503202|3490396|P1|NOT COMPLETED|Extension: Month 6 to 24||11
1425991|NCT02503202|3490392|P5|COMPLETED|Extension: Month 6 to 24||67
1425992|NCT02503202|3490393|P4|COMPLETED|Extension: Month 6 to 24||119
1425993|NCT02503202|3490394|P3|COMPLETED|Extension: Month 6 to 24||103
1425994|NCT02503202|3490395|P2|COMPLETED|Extension: Month 6 to 24||114
1425995|NCT02503202|3490396|P1|COMPLETED|Extension: Month 6 to 24||108
1425996|NCT02503202|3490392|P5|STARTED|Extension: Month 6 to 24||68
1425997|NCT02503202|3490393|P4|STARTED|Extension: Month 6 to 24||137
1425998|NCT02503202|3490394|P3|STARTED|Extension: Month 6 to 24||112
1425999|NCT02503202|3490395|P2|STARTED|Extension: Month 6 to 24||130
1426000|NCT02503202|3490396|P1|STARTED|Extension: Month 6 to 24||119
1426001|NCT02503202|3490392|P5|NOT COMPLETED|Base Study: Up to Month 6||3
1426002|NCT02503202|3490393|P4|NOT COMPLETED|Base Study: Up to Month 6||11
1426003|NCT02503202|3490394|P3|NOT COMPLETED|Base Study: Up to Month 6||15
1426004|NCT02503202|3490395|P2|NOT COMPLETED|Base Study: Up to Month 6||12
1426005|NCT02503202|3490396|P1|NOT COMPLETED|Base Study: Up to Month 6||18
1426006|NCT02503202|3490392|P5|COMPLETED|Base Study: Up to Month 6||130
1426007|NCT02503202|3490393|P4|COMPLETED|Base Study: Up to Month 6||255
1426008|NCT02503202|3490394|P3|COMPLETED|Base Study: Up to Month 6||252
1426009|NCT02503202|3490395|P2|COMPLETED|Base Study: Up to Month 6||253
1426010|NCT02503202|3490396|P1|COMPLETED|Base Study: Up to Month 6||248
1426011|NCT02503202|3490392|P5|Vaccinated|Base Study: Up to Month 6||133
1426012|NCT02503202|3490393|P4|Vaccinated|Base Study: Up to Month 6||264
1426013|NCT02503202|3490394|P3|Vaccinated|Base Study: Up to Month 6||266
1426014|NCT02503202|3490395|P2|Vaccinated|Base Study: Up to Month 6||265
1426015|NCT02503202|3490396|P1|Vaccinated|Base Study: Up to Month 6||266
1426016|NCT02503202|3490392|P5|STARTED|Base Study: Up to Month 6||133
1426017|NCT02503202|3490393|P4|STARTED|Base Study: Up to Month 6||266
1426018|NCT02503202|3490394|P3|STARTED|Base Study: Up to Month 6||267
1426019|NCT02503202|3490395|P2|STARTED|Base Study: Up to Month 6||265
1426020|NCT02503202|3490396|P1|STARTED|Base Study: Up to Month 6||266
1426021|NCT02503085|3490438|P4|NOT COMPLETED|Period 4||0
1426022|NCT02503085|3490439|P3|NOT COMPLETED|Period 4||0
1426023|NCT02503085|3490440|P2|NOT COMPLETED|Period 4||0
1426024|NCT02503085|3490441|P1|NOT COMPLETED|Period 4||0
1426025|NCT02503085|3490438|P4|COMPLETED|Period 4||7
1426026|NCT02503085|3490439|P3|COMPLETED|Period 4||6
1426027|NCT02503085|3490440|P2|COMPLETED|Period 4||7
1426028|NCT02503085|3490441|P1|COMPLETED|Period 4||6
1426029|NCT02503085|3490438|P4|STARTED|Period 4||7
1426030|NCT02503085|3490439|P3|STARTED|Period 4||6
1426031|NCT02503085|3490440|P2|STARTED|Period 4||7
1426032|NCT02503085|3490441|P1|STARTED|Period 4||6
1426033|NCT02503085|3490438|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1426034|NCT02503085|3490439|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1426035|NCT02503085|3490440|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1426036|NCT02503085|3490441|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
1426037|NCT02503085|3490438|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
1426038|NCT02503085|3490439|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
1426039|NCT02503085|3490440|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
1426040|NCT02503085|3490441|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
1426041|NCT02503085|3490438|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
1426042|NCT02503085|3490439|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
1426043|NCT02503085|3490440|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
1426044|NCT02503085|3490441|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
1426045|NCT02503085|3490438|P4|NOT COMPLETED|Period 3||0
1426046|NCT02503085|3490439|P3|NOT COMPLETED|Period 3||0
1426047|NCT02503085|3490440|P2|NOT COMPLETED|Period 3||0
1426048|NCT02503085|3490441|P1|NOT COMPLETED|Period 3||0
1426049|NCT02503085|3490438|P4|COMPLETED|Period 3||7
1426050|NCT02503085|3490439|P3|COMPLETED|Period 3||6
1426051|NCT02503085|3490440|P2|COMPLETED|Period 3||7
1426052|NCT02503085|3490441|P1|COMPLETED|Period 3||6
1426053|NCT02503085|3490438|P4|STARTED|Period 3||7
1426054|NCT02503085|3490439|P3|STARTED|Period 3||6
1426055|NCT02503085|3490440|P2|STARTED|Period 3||7
1426056|NCT02503085|3490441|P1|STARTED|Period 3||6
1426057|NCT02503085|3490438|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
1426058|NCT02503085|3490439|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
1426059|NCT02503085|3490440|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
1426060|NCT02503085|3490441|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
1426061|NCT02503085|3490438|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
1426062|NCT02503085|3490439|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
1426063|NCT02503085|3490440|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
1426064|NCT02503085|3490441|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
1426065|NCT02503085|3490438|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
1426066|NCT02503085|3490439|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
1426067|NCT02503085|3490440|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
1426068|NCT02503085|3490441|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
1426069|NCT02503085|3490438|P4|NOT COMPLETED|Period 2||0
1426070|NCT02503085|3490439|P3|NOT COMPLETED|Period 2||0
1426071|NCT02503085|3490440|P2|NOT COMPLETED|Period 2||0
1426072|NCT02503085|3490441|P1|NOT COMPLETED|Period 2||0
1426073|NCT02503085|3490438|P4|COMPLETED|Period 2||7
1426074|NCT02503085|3490439|P3|COMPLETED|Period 2||7
1426075|NCT02503085|3490440|P2|COMPLETED|Period 2||7
1426076|NCT02503085|3490441|P1|COMPLETED|Period 2||7
1426077|NCT02503085|3490438|P4|STARTED|Period 2||7
1426078|NCT02503085|3490439|P3|STARTED|Period 2||7
1426079|NCT02503085|3490440|P2|STARTED|Period 2||7
1426080|NCT02503085|3490441|P1|STARTED|Period 2||7
1426081|NCT02503085|3490438|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1426082|NCT02503085|3490439|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1426083|NCT02503085|3490440|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1426084|NCT02503085|3490441|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
1426085|NCT02503085|3490438|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
1426086|NCT02503085|3490439|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
1426087|NCT02503085|3490440|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
1426088|NCT02503085|3490441|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
1426089|NCT02503085|3490438|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
1426090|NCT02503085|3490439|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
1426091|NCT02503085|3490440|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
1426092|NCT02503085|3490441|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
1426093|NCT02503085|3490438|P4|NOT COMPLETED|Period 1||0
1426094|NCT02503085|3490439|P3|NOT COMPLETED|Period 1||0
1426095|NCT02503085|3490440|P2|NOT COMPLETED|Period 1||0
1426096|NCT02503085|3490441|P1|NOT COMPLETED|Period 1||0
1426097|NCT02503085|3490438|P4|COMPLETED|Period 1||7
1426098|NCT02503085|3490439|P3|COMPLETED|Period 1||7
1426099|NCT02503085|3490440|P2|COMPLETED|Period 1||7
1426100|NCT02503085|3490441|P1|COMPLETED|Period 1||7
1426101|NCT02503085|3490438|P4|STARTED|Period 1||7
1426102|NCT02503085|3490439|P3|STARTED|Period 1||7
1426103|NCT02503085|3490440|P2|STARTED|Period 1||7
1426104|NCT02503085|3490441|P1|STARTED|Period 1||7
1426105|NCT02502864|3490480|P1|NOT COMPLETED|Overall Study||1
1426106|NCT02502864|3490480|P1|COMPLETED|Overall Study||8
1426107|NCT02502864|3490480|P1|STARTED|Overall Study||9
1426108|NCT02502734|3490489|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
1426109|NCT02502734|3490490|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
1426110|NCT02502734|3490489|P2|COMPLETED|Double-blind Treatment Period 2||30
1426111|NCT02502734|3490490|P1|COMPLETED|Double-blind Treatment Period 2||28
1426112|NCT02502734|3490489|P2|STARTED|Double-blind Treatment Period 2||30
1426113|NCT02502734|3490490|P1|STARTED|Double-blind Treatment Period 2||28
1426114|NCT02502734|3490489|P2|NOT COMPLETED|Washout Period||0
1426115|NCT02502734|3490490|P1|NOT COMPLETED|Washout Period||1
1426116|NCT02502734|3490489|P2|COMPLETED|Washout Period||30
1426117|NCT02502734|3490490|P1|COMPLETED|Washout Period||28
1426118|NCT02502734|3490489|P2|STARTED|Washout Period||30
1426119|NCT02502734|3490490|P1|STARTED|Washout Period||29
1426120|NCT02502734|3490489|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
1426121|NCT02502734|3490490|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
1426122|NCT02502734|3490489|P2|COMPLETED|Double-blind Treatment Period 1||30
1426123|NCT02502734|3490490|P1|COMPLETED|Double-blind Treatment Period 1||29
1426124|NCT02502734|3490489|P2|STARTED|Double-blind Treatment Period 1||30
1426125|NCT02502734|3490490|P1|STARTED|Double-blind Treatment Period 1||30
1426126|NCT02502526|3490501|P3|NOT COMPLETED|Overall Study||6
1426127|NCT02502526|3490502|P2|NOT COMPLETED|Overall Study||4
1426128|NCT02502526|3490503|P1|NOT COMPLETED|Overall Study||6
1426129|NCT02502526|3490501|P3|COMPLETED|Overall Study||55
1426130|NCT02502526|3490502|P2|COMPLETED|Overall Study||55
1426131|NCT02502526|3490503|P1|COMPLETED|Overall Study||56
1426132|NCT02502526|3490501|P3|Intent-to-Treat (ITT)|Overall Study||59
1426133|NCT02502526|3490502|P2|Intent-to-Treat (ITT)|Overall Study||57
1426134|NCT02502526|3490503|P1|Intent-to-Treat (ITT)|Overall Study||57
1426135|NCT02502526|3490501|P3|STARTED|Overall Study||61
1426136|NCT02502526|3490502|P2|STARTED|Overall Study||59
1426137|NCT02502526|3490503|P1|STARTED|Overall Study||62
1426138|NCT02502487|3490519|P3|NOT COMPLETED|Overall Study||0
1426139|NCT02502487|3490520|P2|NOT COMPLETED|Overall Study||0
1426140|NCT02502487|3490521|P1|NOT COMPLETED|Overall Study||0
1426141|NCT02502487|3490519|P3|COMPLETED|Overall Study||86
1426142|NCT02502487|3490520|P2|COMPLETED|Overall Study||86
1426143|NCT02502487|3490521|P1|COMPLETED|Overall Study||86
1426144|NCT02502487|3490519|P3|STARTED|Overall Study||86
1426145|NCT02502487|3490520|P2|STARTED|Overall Study||86
1426146|NCT02502487|3490521|P1|STARTED|Overall Study||86
1426147|NCT02502149|3490589|P5|NOT COMPLETED|Treatment Period||0
1426148|NCT02502149|3490590|P4|NOT COMPLETED|Treatment Period||0
1426149|NCT02502149|3490591|P3|NOT COMPLETED|Treatment Period||0
1426150|NCT02502149|3490592|P2|NOT COMPLETED|Treatment Period||0
1426151|NCT02502149|3490593|P1|NOT COMPLETED|Treatment Period||0
1426152|NCT02502149|3490589|P5|COMPLETED|Treatment Period||12
1426153|NCT02502149|3490590|P4|COMPLETED|Treatment Period||11
1426154|NCT02502149|3490591|P3|COMPLETED|Treatment Period||0
1426155|NCT02502149|3490592|P2|COMPLETED|Treatment Period||0
1426156|NCT02502149|3490593|P1|COMPLETED|Treatment Period||0
1426157|NCT02502149|3490589|P5|STARTED|Treatment Period||12
1426158|NCT02502149|3490590|P4|STARTED|Treatment Period||11
1426159|NCT02502149|3490591|P3|STARTED|Treatment Period||0
1426160|NCT02502149|3490592|P2|STARTED|Treatment Period||0
1426161|NCT02502149|3490593|P1|STARTED|Treatment Period||0
1426162|NCT02502149|3490589|P5|NOT COMPLETED|PK2 Assessment Period||0
1426163|NCT02502149|3490590|P4|NOT COMPLETED|PK2 Assessment Period||0
1426164|NCT02502149|3490591|P3|NOT COMPLETED|PK2 Assessment Period||0
1426165|NCT02502149|3490592|P2|NOT COMPLETED|PK2 Assessment Period||0
1426166|NCT02502149|3490593|P1|NOT COMPLETED|PK2 Assessment Period||0
1426167|NCT02502149|3490589|P5|COMPLETED|PK2 Assessment Period||0
1426168|NCT02502149|3490590|P4|COMPLETED|PK2 Assessment Period||0
1426169|NCT02502149|3490591|P3|COMPLETED|PK2 Assessment Period||12
1426170|NCT02502149|3490592|P2|COMPLETED|PK2 Assessment Period||11
1426171|NCT02502149|3490593|P1|COMPLETED|PK2 Assessment Period||0
1426172|NCT02502149|3490589|P5|STARTED|PK2 Assessment Period||0
1426173|NCT02502149|3490590|P4|STARTED|PK2 Assessment Period||0
1426174|NCT02502149|3490591|P3|STARTED|PK2 Assessment Period||12
1426175|NCT02502149|3490592|P2|STARTED|PK2 Assessment Period||11
1426176|NCT02502149|3490593|P1|STARTED|PK2 Assessment Period||0
1426177|NCT02502149|3490589|P5|NOT COMPLETED|Intermediate||0
1426178|NCT02502149|3490590|P4|NOT COMPLETED|Intermediate||0
1426179|NCT02502149|3490591|P3|NOT COMPLETED|Intermediate||0
1426180|NCT02502149|3490592|P2|NOT COMPLETED|Intermediate||0
1426181|NCT02502149|3490593|P1|NOT COMPLETED|Intermediate||1
1426182|NCT02502149|3490589|P5|COMPLETED|Intermediate||0
1426183|NCT02502149|3490590|P4|COMPLETED|Intermediate||0
1426184|NCT02502149|3490591|P3|COMPLETED|Intermediate||0
1426185|NCT02502149|3490592|P2|COMPLETED|Intermediate||0
1426186|NCT02502149|3490593|P1|COMPLETED|Intermediate||23
1426187|NCT02502149|3490589|P5|STARTED|Intermediate||0
1426188|NCT02502149|3490590|P4|STARTED|Intermediate||0
1426189|NCT02502149|3490591|P3|STARTED|Intermediate||0
1426190|NCT02502149|3490592|P2|STARTED|Intermediate||0
1426191|NCT02502149|3490593|P1|STARTED|Intermediate||24
1426192|NCT02502149|3490589|P5|NOT COMPLETED|PK1 Assessment Period||0
1426193|NCT02502149|3490590|P4|NOT COMPLETED|PK1 Assessment Period||0
1426194|NCT02502149|3490591|P3|NOT COMPLETED|PK1 Assessment Period||0
1426195|NCT02502149|3490592|P2|NOT COMPLETED|PK1 Assessment Period||0
1426196|NCT02502149|3490593|P1|NOT COMPLETED|PK1 Assessment Period||0
1426197|NCT02502149|3490589|P5|COMPLETED|PK1 Assessment Period||0
1426198|NCT02502149|3490590|P4|COMPLETED|PK1 Assessment Period||0
1426199|NCT02502149|3490591|P3|COMPLETED|PK1 Assessment Period||0
1426200|NCT02502149|3490592|P2|COMPLETED|PK1 Assessment Period||0
1426201|NCT02502149|3490593|P1|COMPLETED|PK1 Assessment Period||24
1426202|NCT02502149|3490589|P5|STARTED|PK1 Assessment Period||0
1426203|NCT02502149|3490590|P4|STARTED|PK1 Assessment Period||0
1426204|NCT02502149|3490591|P3|STARTED|PK1 Assessment Period||0
1426205|NCT02502149|3490592|P2|STARTED|PK1 Assessment Period||0
1426206|NCT02502149|3490593|P1|STARTED|PK1 Assessment Period||24
1426207|NCT02502071|3490712|P1|NOT COMPLETED|Overall Study||0
1426208|NCT02502071|3490712|P1|COMPLETED|Overall Study||45
1426209|NCT02502071|3490712|P1|STARTED|Overall Study||45
1426210|NCT02501629|3490719|P2|NOT COMPLETED|Overall Study||7
1426211|NCT02501629|3490720|P1|NOT COMPLETED|Overall Study||5
1426212|NCT02501629|3490719|P2|COMPLETED|Overall Study||81
1426213|NCT02501629|3490720|P1|COMPLETED|Overall Study||84
1426214|NCT02501629|3490719|P2|STARTED|Overall Study||88
1426215|NCT02501629|3490720|P1|STARTED|Overall Study||89
1426216|NCT02501590|3490744|P2|NOT COMPLETED|Overall Study||0
1426217|NCT02501590|3490745|P1|NOT COMPLETED|Overall Study||0
1426218|NCT02501590|3490744|P2|COMPLETED|Overall Study||35
1426219|NCT02501590|3490745|P1|COMPLETED|Overall Study||13
1426220|NCT02501590|3490744|P2|STARTED|Overall Study||35
1426221|NCT02501590|3490745|P1|STARTED|Overall Study||13
1426222|NCT02500979|3490753|P2|NOT COMPLETED|Period 2||0
1426223|NCT02500979|3490754|P1|NOT COMPLETED|Period 2||1
1426224|NCT02500979|3490753|P2|COMPLETED|Period 2||16
1426225|NCT02500979|3490754|P1|COMPLETED|Period 2||11
1426226|NCT02500979|3490753|P2|STARTED|Period 2||16
1426227|NCT02500979|3490754|P1|STARTED|Period 2||12
1426228|NCT02500979|3490753|P2|NOT COMPLETED|Period 1||1
1426229|NCT02500979|3490754|P1|NOT COMPLETED|Period 1||4
1426230|NCT02500979|3490753|P2|COMPLETED|Period 1||16
1426231|NCT02500979|3490754|P1|COMPLETED|Period 1||12
1426232|NCT02500979|3490753|P2|STARTED|Period 1||17
1426233|NCT02500979|3490754|P1|STARTED|Period 1||16
1426234|NCT02500836|3490791|P3|NOT COMPLETED|Overall Study||1
1426235|NCT02500836|3490792|P2|NOT COMPLETED|Overall Study||5
1426236|NCT02500836|3490793|P1|NOT COMPLETED|Overall Study||3
1426237|NCT02500836|3490791|P3|COMPLETED|Overall Study||127
1426238|NCT02500836|3490792|P2|COMPLETED|Overall Study||254
1426239|NCT02500836|3490793|P1|COMPLETED|Overall Study||256
1426240|NCT02500836|3490791|P3|STARTED|Overall Study||128
1426241|NCT02500836|3490792|P2|STARTED|Overall Study||259
1426242|NCT02500836|3490793|P1|STARTED|Overall Study||259
1426243|NCT02500758|3490804|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
1426244|NCT02500758|3490805|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
1426245|NCT02500758|3490804|P2|COMPLETED|Second Intervention (2 Minutes)||10
1426246|NCT02500758|3490805|P1|COMPLETED|Second Intervention (2 Minutes)||10
1426247|NCT02500758|3490804|P2|STARTED|Second Intervention (2 Minutes)||12
1426248|NCT02500758|3490805|P1|STARTED|Second Intervention (2 Minutes)||13
1426249|NCT02500758|3490804|P2|NOT COMPLETED|Washout (1 Week)||2
1426250|NCT02500758|3490805|P1|NOT COMPLETED|Washout (1 Week)||2
1426251|NCT02500758|3490804|P2|COMPLETED|Washout (1 Week)||12
1426252|NCT02500758|3490805|P1|COMPLETED|Washout (1 Week)||13
1426253|NCT02500758|3490804|P2|STARTED|Washout (1 Week)||14
1426254|NCT02500758|3490805|P1|STARTED|Washout (1 Week)||15
1426255|NCT02500758|3490804|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
1426256|NCT02500758|3490805|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
1426257|NCT02500758|3490804|P2|COMPLETED|First Intervention (2 Minutes)||14
1426258|NCT02500758|3490805|P1|COMPLETED|First Intervention (2 Minutes)||15
1426259|NCT02500758|3490804|P2|STARTED|First Intervention (2 Minutes)||15
1426260|NCT02500758|3490805|P1|STARTED|First Intervention (2 Minutes)||15
1426261|NCT02500706|3490816|P3|NOT COMPLETED|Overall Study||7
1426262|NCT02500706|3490817|P2|NOT COMPLETED|Overall Study||7
1426263|NCT02500706|3490818|P1|NOT COMPLETED|Overall Study||4
1426264|NCT02500706|3490816|P3|COMPLETED|Overall Study||335
1426265|NCT02500706|3490817|P2|COMPLETED|Overall Study||334
1426266|NCT02500706|3490818|P1|COMPLETED|Overall Study||338
1426267|NCT02500706|3490816|P3|Exposed|Overall Study||342
1426268|NCT02500706|3490817|P2|Exposed|Overall Study||341
1426269|NCT02500706|3490818|P1|Exposed|Overall Study||342
1426270|NCT02500706|3490816|P3|STARTED|Overall Study||342
1426271|NCT02500706|3490817|P2|STARTED|Overall Study||341
1426272|NCT02500706|3490818|P1|STARTED|Overall Study||342
1426273|NCT02500628|3490972|P2|NOT COMPLETED|Overall Study||0
1426274|NCT02500628|3490973|P1|NOT COMPLETED|Overall Study||0
1426275|NCT02500628|3490972|P2|COMPLETED|Overall Study||23
1426276|NCT02500628|3490973|P1|COMPLETED|Overall Study||38
1426277|NCT02500628|3490972|P2|STARTED|Overall Study||23
1426278|NCT02500628|3490973|P1|STARTED|Overall Study||38
1426279|NCT02500537|3490985|P2|NOT COMPLETED|Overall Study||1
1426280|NCT02500537|3490986|P1|NOT COMPLETED|Overall Study||3
1426281|NCT02500537|3490985|P2|COMPLETED|Overall Study||39
1426282|NCT02500537|3490986|P1|COMPLETED|Overall Study||57
1426283|NCT02500537|3490985|P2|STARTED|Overall Study||40
1426284|NCT02500537|3490986|P1|STARTED|Overall Study||60
1426285|NCT02500368|3491004|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1426286|NCT02500368|3491005|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1426287|NCT02500368|3491004|P2|COMPLETED|Second Intervention (1 Week)||20
1426288|NCT02500368|3491005|P1|COMPLETED|Second Intervention (1 Week)||20
1426289|NCT02500368|3491004|P2|STARTED|Second Intervention (1 Week)||20
1426290|NCT02500368|3491005|P1|STARTED|Second Intervention (1 Week)||20
1426291|NCT02500368|3491004|P2|NOT COMPLETED|First Intervention (1 Week)||0
1426292|NCT02500368|3491005|P1|NOT COMPLETED|First Intervention (1 Week)||0
1426293|NCT02500368|3491004|P2|COMPLETED|First Intervention (1 Week)||20
1426294|NCT02500368|3491005|P1|COMPLETED|First Intervention (1 Week)||20
1426295|NCT02500368|3491004|P2|STARTED|First Intervention (1 Week)||20
1426296|NCT02500368|3491005|P1|STARTED|First Intervention (1 Week)||20
1426297|NCT02500056|3491055|P2|NOT COMPLETED|Overall Study||8
1426298|NCT02500056|3491056|P1|NOT COMPLETED|Overall Study||7
1426299|NCT02500056|3491055|P2|COMPLETED|Overall Study||65
1426300|NCT02500056|3491056|P1|COMPLETED|Overall Study||63
1426301|NCT02500056|3491055|P2|STARTED|Overall Study||73
1426302|NCT02500056|3491056|P1|STARTED|Overall Study||70
1426303|NCT02499952|3491066|P1|NOT COMPLETED|Overall Study||10
1426304|NCT02499952|3491066|P1|COMPLETED|Overall Study||2
1426305|NCT02499952|3491066|P1|STARTED|Overall Study||12
1426306|NCT02499900|3491075|P2|NOT COMPLETED|Extension Study Period||20
1426307|NCT02499900|3491076|P1|NOT COMPLETED|Extension Study Period||12
1426308|NCT02499900|3491075|P2|COMPLETED|Extension Study Period||377
1426309|NCT02499900|3491076|P1|COMPLETED|Extension Study Period||380
1426310|NCT02499900|3491075|P2|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
1426311|NCT02499900|3491076|P1|Safety Analysis Set|Extension Study Period||392
1426312|NCT02499900|3491075|P2|STARTED|Extension Study Period||397
1426313|NCT02499900|3491076|P1|STARTED|Extension Study Period||392
1426314|NCT02499900|3491075|P2|NOT COMPLETED|Completed Core, Continued Into Extension||2
1426315|NCT02499900|3491076|P1|NOT COMPLETED|Completed Core, Continued Into Extension||3
1426316|NCT02499900|3491075|P2|COMPLETED|Completed Core, Continued Into Extension||397
1426317|NCT02499900|3491076|P1|COMPLETED|Completed Core, Continued Into Extension||392
1426318|NCT02499900|3491075|P2|STARTED|Completed Core, Continued Into Extension||399
1426319|NCT02499900|3491076|P1|STARTED|Completed Core, Continued Into Extension||395
1426320|NCT02499900|3491075|P2|NOT COMPLETED|Core Study Period||32
1426321|NCT02499900|3491076|P1|NOT COMPLETED|Core Study Period||35
1426322|NCT02499900|3491075|P2|COMPLETED|Core Study Period||399
1426323|NCT02499900|3491076|P1|COMPLETED|Core Study Period||395
1426324|NCT02499900|3491075|P2|Safety Analysis Set|Core Study Period||430
1426325|NCT02499900|3491076|P1|Safety Analysis Set|Core Study Period||427
1426326|NCT02499900|3491075|P2|STARTED|Core Study Period||431
1426327|NCT02499900|3491076|P1|STARTED|Core Study Period||430
1426328|NCT02499692|3491096|P1|NOT COMPLETED|Overall Study||0
1426329|NCT02499692|3491096|P1|COMPLETED|Overall Study||103
1426330|NCT02499692|3491096|P1|STARTED|Overall Study||103
1426331|NCT02499575|3491107|P2|NOT COMPLETED|Overall Study||1
1426332|NCT02499575|3491108|P1|NOT COMPLETED|Overall Study||0
1426333|NCT02499575|3491107|P2|COMPLETED|Overall Study||0
1426334|NCT02499575|3491108|P1|COMPLETED|Overall Study||1
1426335|NCT02499575|3491107|P2|STARTED|Overall Study||1
1426336|NCT02499575|3491108|P1|STARTED|Overall Study||1
1426337|NCT02499029|3491120|P2|NOT COMPLETED|Overall Study||3
1426338|NCT02499029|3491121|P1|NOT COMPLETED|Overall Study||5
1426339|NCT02499029|3491120|P2|COMPLETED|Overall Study||14
1426340|NCT02499029|3491121|P1|COMPLETED|Overall Study||13
1426341|NCT02499029|3491120|P2|STARTED|Overall Study||17
1426342|NCT02499029|3491121|P1|STARTED|Overall Study||18
1426343|NCT02498821|3491135|P2|NOT COMPLETED|Overall Study||5
1426344|NCT02498821|3491136|P1|NOT COMPLETED|Overall Study||3
1426345|NCT02498821|3491135|P2|COMPLETED|Overall Study||60
1426346|NCT02498821|3491136|P1|COMPLETED|Overall Study||60
1426347|NCT02498821|3491135|P2|STARTED|Overall Study||65
1426348|NCT02498821|3491136|P1|STARTED|Overall Study||63
1426349|NCT02498769|3491165|P2|NOT COMPLETED|Overall Study||0
1426350|NCT02498769|3491166|P1|NOT COMPLETED|Overall Study||0
1426351|NCT02498769|3491165|P2|COMPLETED|Overall Study||67
1426352|NCT02498769|3491166|P1|COMPLETED|Overall Study||63
1426353|NCT02498769|3491165|P2|STARTED|Overall Study||67
1426354|NCT02498769|3491166|P1|STARTED|Overall Study||63
1426355|NCT02498678|3491180|P2|NOT COMPLETED|Overall Study||2
1426356|NCT02498678|3491181|P1|NOT COMPLETED|Overall Study||0
1426357|NCT02498678|3491180|P2|COMPLETED|Overall Study||23
1426358|NCT02498678|3491181|P1|COMPLETED|Overall Study||25
1426359|NCT02498678|3491180|P2|STARTED|Overall Study||25
1426360|NCT02498678|3491181|P1|STARTED|Overall Study||25
1426361|NCT02498652|3491197|P2|NOT COMPLETED|Overall Study||1
1426362|NCT02498652|3491198|P1|NOT COMPLETED|Overall Study||0
1426363|NCT02498652|3491197|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
1426364|NCT02498652|3491198|P1|COMPLETED|Overall Study||20
1426365|NCT02498652|3491197|P2|STARTED|Overall Study||21
1426366|NCT02498652|3491198|P1|STARTED|Overall Study||20
1426367|NCT02498522|3491299|P2|NOT COMPLETED|Overall Study||2
1426368|NCT02498522|3491300|P1|NOT COMPLETED|Overall Study||2
1426369|NCT02498522|3491299|P2|COMPLETED|Overall Study||83
1426370|NCT02498522|3491300|P1|COMPLETED|Overall Study||83
1426371|NCT02498522|3491299|P2|STARTED|Overall Study||85
1426372|NCT02498522|3491300|P1|STARTED|Overall Study||85
1426373|NCT02497976|3491308|P2|NOT COMPLETED|Overall Study||1
1426374|NCT02497976|3491309|P1|NOT COMPLETED|Overall Study||2
1426375|NCT02497976|3491308|P2|COMPLETED|Overall Study||13
1426376|NCT02497976|3491309|P1|COMPLETED|Overall Study||26
1426377|NCT02497976|3491308|P2|STARTED|Overall Study||14
1426378|NCT02497976|3491309|P1|STARTED|Overall Study||28
1426379|NCT02497937|3491325|P2|NOT COMPLETED|Period 2 (Up to 7 Days)||0
1426380|NCT02497937|3491326|P1|NOT COMPLETED|Period 2 (Up to 7 Days)||0
1426381|NCT02497937|3491325|P2|COMPLETED|Period 2 (Up to 7 Days)||5
1426382|NCT02497937|3491326|P1|COMPLETED|Period 2 (Up to 7 Days)||6
1426383|NCT02497937|3491325|P2|STARTED|Period 2 (Up to 7 Days)||5
1426384|NCT02497937|3491326|P1|STARTED|Period 2 (Up to 7 Days)||6
1426385|NCT02497937|3491325|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
1426386|NCT02497937|3491326|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
1426387|NCT02497937|3491325|P2|COMPLETED|Washout Period (Up to 14 Days)||5
1426388|NCT02497937|3491326|P1|COMPLETED|Washout Period (Up to 14 Days)||6
1426389|NCT02497937|3491325|P2|STARTED|Washout Period (Up to 14 Days)||5
1426390|NCT02497937|3491326|P1|STARTED|Washout Period (Up to 14 Days)||6
1426391|NCT02497937|3491325|P2|NOT COMPLETED|Period 1 (Up to 7 Days)||0
1426392|NCT02497937|3491326|P1|NOT COMPLETED|Period 1 (Up to 7 Days)||0
1426393|NCT02497937|3491325|P2|COMPLETED|Period 1 (Up to 7 Days)||5
1426394|NCT02497937|3491326|P1|COMPLETED|Period 1 (Up to 7 Days)||6
1426395|NCT02497937|3491325|P2|STARTED|Period 1 (Up to 7 Days)||5
1426396|NCT02497937|3491326|P1|STARTED|Period 1 (Up to 7 Days)||6
1426397|NCT02497781|3491404|P2|NOT COMPLETED|Overall Study||3
1426398|NCT02497781|3491405|P1|NOT COMPLETED|Overall Study||4
1426399|NCT02497781|3491404|P2|COMPLETED|Overall Study||26
1426400|NCT02497781|3491405|P1|COMPLETED|Overall Study||64
1426401|NCT02497781|3491404|P2|Treated|Overall Study||28
1426402|NCT02497781|3491405|P1|Treated|Overall Study||67
1426403|NCT02497781|3491404|P2|STARTED|Overall Study||29
1426404|NCT02497781|3491405|P1|STARTED|Overall Study||68
1426405|NCT02497755|3491468|P2|NOT COMPLETED|Overall Study||0
1426406|NCT02497755|3491469|P1|NOT COMPLETED|Overall Study||1
1426407|NCT02497755|3491468|P2|COMPLETED|Overall Study||1
1426408|NCT02497755|3491469|P1|COMPLETED|Overall Study||17
1426409|NCT02497755|3491468|P2|STARTED|Overall Study||1
1426410|NCT02497755|3491469|P1|STARTED|Overall Study||18
1426411|NCT02497391|3491482|P6|NOT COMPLETED|Period 3 (14 Days)||0
1426412|NCT02497391|3491483|P5|NOT COMPLETED|Period 3 (14 Days)||1
1426413|NCT02497391|3491484|P4|NOT COMPLETED|Period 3 (14 Days)||0
1426414|NCT02497391|3491485|P3|NOT COMPLETED|Period 3 (14 Days)||1
1426415|NCT02497391|3491486|P2|NOT COMPLETED|Period 3 (14 Days)||1
1426416|NCT02497391|3491487|P1|NOT COMPLETED|Period 3 (14 Days)||0
1426417|NCT02497391|3491482|P6|COMPLETED|Period 3 (14 Days)||13
1426418|NCT02497391|3491483|P5|COMPLETED|Period 3 (14 Days)||13
1426419|NCT02497391|3491484|P4|COMPLETED|Period 3 (14 Days)||13
1426420|NCT02497391|3491485|P3|COMPLETED|Period 3 (14 Days)||12
1426421|NCT02497391|3491486|P2|COMPLETED|Period 3 (14 Days)||13
1426422|NCT02497391|3491487|P1|COMPLETED|Period 3 (14 Days)||12
1426423|NCT02497391|3491482|P6|STARTED|Period 3 (14 Days)||13
1426424|NCT02497391|3491483|P5|STARTED|Period 3 (14 Days)||14
1426425|NCT02497391|3491484|P4|STARTED|Period 3 (14 Days)||13
1426426|NCT02497391|3491485|P3|STARTED|Period 3 (14 Days)||13
1426427|NCT02497391|3491486|P2|STARTED|Period 3 (14 Days)||14
1426428|NCT02497391|3491487|P1|STARTED|Period 3 (14 Days)||12
1426429|NCT02497391|3491482|P6|NOT COMPLETED|Period 2 (14 Days)||3
1426430|NCT02497391|3491483|P5|NOT COMPLETED|Period 2 (14 Days)||2
1426431|NCT02497391|3491484|P4|NOT COMPLETED|Period 2 (14 Days)||3
1426432|NCT02497391|3491485|P3|NOT COMPLETED|Period 2 (14 Days)||3
1426433|NCT02497391|3491486|P2|NOT COMPLETED|Period 2 (14 Days)||1
1426434|NCT02497391|3491487|P1|NOT COMPLETED|Period 2 (14 Days)||4
1426435|NCT02497391|3491482|P6|COMPLETED|Period 2 (14 Days)||13
1426436|NCT02497391|3491483|P5|COMPLETED|Period 2 (14 Days)||14
1426437|NCT02497391|3491484|P4|COMPLETED|Period 2 (14 Days)||13
1426438|NCT02497391|3491485|P3|COMPLETED|Period 2 (14 Days)||13
1426439|NCT02497391|3491486|P2|COMPLETED|Period 2 (14 Days)||14
1426440|NCT02497391|3491487|P1|COMPLETED|Period 2 (14 Days)||12
1426441|NCT02497391|3491482|P6|STARTED|Period 2 (14 Days)||16
1426442|NCT02497391|3491483|P5|STARTED|Period 2 (14 Days)||16
1426443|NCT02497391|3491484|P4|STARTED|Period 2 (14 Days)||16
1426444|NCT02497391|3491485|P3|STARTED|Period 2 (14 Days)||16
1426445|NCT02497391|3491486|P2|STARTED|Period 2 (14 Days)||15
1426446|NCT02497391|3491487|P1|STARTED|Period 2 (14 Days)||16
1426447|NCT02497391|3491482|P6|NOT COMPLETED|Period 1 (14 Days)||0
1426448|NCT02497391|3491483|P5|NOT COMPLETED|Period 1 (14 Days)||0
1426449|NCT02497391|3491484|P4|NOT COMPLETED|Period 1 (14 Days)||0
1426450|NCT02497391|3491485|P3|NOT COMPLETED|Period 1 (14 Days)||0
1426451|NCT02497391|3491486|P2|NOT COMPLETED|Period 1 (14 Days)||0
1426452|NCT02497391|3491487|P1|NOT COMPLETED|Period 1 (14 Days)||0
1426453|NCT02497391|3491482|P6|COMPLETED|Period 1 (14 Days)||16
1426454|NCT02497391|3491483|P5|COMPLETED|Period 1 (14 Days)||16
1426455|NCT02497391|3491484|P4|COMPLETED|Period 1 (14 Days)||16
1426456|NCT02497391|3491485|P3|COMPLETED|Period 1 (14 Days)||16
1426457|NCT02497391|3491486|P2|COMPLETED|Period 1 (14 Days)||15
1426458|NCT02497391|3491487|P1|COMPLETED|Period 1 (14 Days)||16
1426459|NCT02497391|3491482|P6|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1426460|NCT02497391|3491483|P5|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1426461|NCT02497391|3491484|P4|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1426462|NCT02497391|3491485|P3|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1426463|NCT02497391|3491486|P2|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
1426464|NCT02497391|3491487|P1|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
1426465|NCT02497391|3491482|P6|STARTED|Period 1 (14 Days)||16
1426466|NCT02497391|3491483|P5|STARTED|Period 1 (14 Days)||16
1426467|NCT02497391|3491484|P4|STARTED|Period 1 (14 Days)||16
1426468|NCT02497391|3491485|P3|STARTED|Period 1 (14 Days)||16
1426469|NCT02497391|3491486|P2|STARTED|Period 1 (14 Days)||15
1426470|NCT02497391|3491487|P1|STARTED|Period 1 (14 Days)||16
1426471|NCT02497235|3491503|P5|NOT COMPLETED|Overall Study||0
1426472|NCT02497235|3491504|P4|NOT COMPLETED|Overall Study||0
1426473|NCT02497235|3491505|P3|NOT COMPLETED|Overall Study||0
1426474|NCT02497235|3491506|P2|NOT COMPLETED|Overall Study||0
1426475|NCT02497235|3491507|P1|NOT COMPLETED|Overall Study||0
1426476|NCT02497235|3491503|P5|COMPLETED|Overall Study||3
1426477|NCT02497235|3491504|P4|COMPLETED|Overall Study||2
1426478|NCT02497235|3491505|P3|COMPLETED|Overall Study||2
1426479|NCT02497235|3491506|P2|COMPLETED|Overall Study||2
1426480|NCT02497235|3491507|P1|COMPLETED|Overall Study||2
1426481|NCT02497235|3491503|P5|STARTED|Overall Study||3
1426482|NCT02497235|3491504|P4|STARTED|Overall Study||2
1426483|NCT02497235|3491505|P3|STARTED|Overall Study||2
1426484|NCT02497235|3491506|P2|STARTED|Overall Study||2
1426485|NCT02497235|3491507|P1|STARTED|Overall Study||2
1426486|NCT02497040|3491540|P3|NOT COMPLETED|Overall Study||0
1426487|NCT02497040|3491541|P2|NOT COMPLETED|Overall Study||0
1426488|NCT02497040|3491542|P1|NOT COMPLETED|Overall Study||0
1426489|NCT02497040|3491540|P3|COMPLETED|Overall Study||30
1426490|NCT02497040|3491541|P2|COMPLETED|Overall Study||30
1426491|NCT02497040|3491542|P1|COMPLETED|Overall Study||30
1426492|NCT02497040|3491540|P3|STARTED|Overall Study||30
1426493|NCT02497040|3491541|P2|STARTED|Overall Study||30
1426494|NCT02497040|3491542|P1|STARTED|Overall Study||30
1426495|NCT02496702|3491552|P2|NOT COMPLETED|Overall Study||8
1426496|NCT02496702|3491553|P1|NOT COMPLETED|Overall Study||8
1426497|NCT02496702|3491552|P2|COMPLETED|Overall Study||22
1426498|NCT02496702|3491553|P1|COMPLETED|Overall Study||22
1426499|NCT02496702|3491552|P2|Did Not Receive Allocated Intervention|Overall Study||0
1426500|NCT02496702|3491553|P1|Did Not Receive Allocated Intervention|Overall Study||9
1426501|NCT02496702|3491552|P2|Received Allocated Intervention|Overall Study||0
1426502|NCT02496702|3491553|P1|Received Allocated Intervention|Overall Study||21
1426503|NCT02496702|3491552|P2|STARTED|Overall Study||30
1426504|NCT02496702|3491553|P1|STARTED|Overall Study||30
1426505|NCT02496533|3491575|P2|NOT COMPLETED|Overall Study||6
1426506|NCT02496533|3491576|P1|NOT COMPLETED|Overall Study||3
1426507|NCT02496533|3491575|P2|COMPLETED|Overall Study||106
1426508|NCT02496533|3491576|P1|COMPLETED|Overall Study||102
1426509|NCT02496533|3491575|P2|STARTED|Overall Study||112
1426510|NCT02496533|3491576|P1|STARTED|Overall Study||105
1426511|NCT02496221|3491588|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
1426512|NCT02496221|3491589|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
1426513|NCT02496221|3491588|P2|COMPLETED|Treatment Period 2 - 4 Days||9
1426514|NCT02496221|3491589|P1|COMPLETED|Treatment Period 2 - 4 Days||8
1426515|NCT02496221|3491588|P2|STARTED|Treatment Period 2 - 4 Days||10
1426516|NCT02496221|3491589|P1|STARTED|Treatment Period 2 - 4 Days||10
1426517|NCT02496221|3491588|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
1426518|NCT02496221|3491589|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
1426519|NCT02496221|3491588|P2|COMPLETED|Treatment Period 1 - 4 Days||10
1426520|NCT02496221|3491589|P1|COMPLETED|Treatment Period 1 - 4 Days||10
1426521|NCT02496221|3491588|P2|STARTED|Treatment Period 1 - 4 Days||10
1426522|NCT02496221|3491589|P1|STARTED|Treatment Period 1 - 4 Days||10
1426523|NCT02496039|3491623|P1|NOT COMPLETED|Overall Study||4
1426524|NCT02496039|3491623|P1|COMPLETED|Overall Study||1
1426525|NCT02496039|3491623|P1|STARTED|Overall Study||5
1426526|NCT02496000|3491638|P3|NOT COMPLETED|Overall Study||2
1426527|NCT02496000|3491639|P2|NOT COMPLETED|Overall Study||5
1426528|NCT02496000|3491640|P1|NOT COMPLETED|Overall Study||2
1426529|NCT02496000|3491638|P3|COMPLETED|Overall Study||61
1426530|NCT02496000|3491639|P2|COMPLETED|Overall Study||56
1426531|NCT02496000|3491640|P1|COMPLETED|Overall Study||62
1426532|NCT02496000|3491638|P3|STARTED|Overall Study||63
1426533|NCT02496000|3491639|P2|STARTED|Overall Study||61
1426534|NCT02496000|3491640|P1|STARTED|Overall Study||64
1426535|NCT02495948|3491649|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
1426536|NCT02495948|3491650|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
1426537|NCT02495948|3491649|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
1426538|NCT02495948|3491650|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
1426539|NCT02495948|3491649|P2|STARTED|Period 2, Second 30 Days of Wear||83
1426540|NCT02495948|3491650|P1|STARTED|Period 2, Second 30 Days of Wear||83
1426541|NCT02495948|3491649|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
1426542|NCT02495948|3491650|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
1426543|NCT02495948|3491649|P2|COMPLETED|Period 1, First 30 Days of Wear||83
1426544|NCT02495948|3491650|P1|COMPLETED|Period 1, First 30 Days of Wear||83
1426545|NCT02495948|3491649|P2|STARTED|Period 1, First 30 Days of Wear||84
1426546|NCT02495948|3491650|P1|STARTED|Period 1, First 30 Days of Wear||83
1426547|NCT02495831|3491657|P2|NOT COMPLETED|Second Intervention||0
1426548|NCT02495831|3491658|P1|NOT COMPLETED|Second Intervention||0
1426549|NCT02495831|3491657|P2|COMPLETED|Second Intervention||10
1426550|NCT02495831|3491658|P1|COMPLETED|Second Intervention||12
1426551|NCT02495831|3491657|P2|STARTED|Second Intervention||10
1426552|NCT02495831|3491658|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
1426553|NCT02495831|3491657|P2|NOT COMPLETED|First Intervention||0
1426554|NCT02495831|3491658|P1|NOT COMPLETED|First Intervention||0
1426555|NCT02495831|3491657|P2|COMPLETED|First Intervention||10
1426556|NCT02495831|3491658|P1|COMPLETED|First Intervention||13
1426557|NCT02495831|3491657|P2|STARTED|First Intervention||10
1426558|NCT02495831|3491658|P1|STARTED|First Intervention||13
1426559|NCT02495623|3491675|P3|NOT COMPLETED|Overall Study||8
1426560|NCT02495623|3491676|P2|NOT COMPLETED|Overall Study||9
1426561|NCT02495623|3491677|P1|NOT COMPLETED|Overall Study||5
1426562|NCT02495623|3491675|P3|COMPLETED|Overall Study||20
1426563|NCT02495623|3491676|P2|COMPLETED|Overall Study||17
1426564|NCT02495623|3491677|P1|COMPLETED|Overall Study||20
1426565|NCT02495623|3491675|P3|Dosed|Overall Study||22
1426566|NCT02495623|3491676|P2|Dosed|Overall Study||19
1426567|NCT02495623|3491677|P1|Dosed|Overall Study||22
1426568|NCT02495623|3491675|P3|STARTED|Overall Study||28
1426569|NCT02495623|3491676|P2|STARTED|Overall Study||26
1426570|NCT02495623|3491677|P1|STARTED|Overall Study||25
1426571|NCT02495259|3491688|P3|NOT COMPLETED|Overall Study||0
1426572|NCT02495259|3491689|P2|NOT COMPLETED|Overall Study||1
1426573|NCT02495259|3491690|P1|NOT COMPLETED|Overall Study||0
1426574|NCT02495259|3491688|P3|COMPLETED|Overall Study||8
1426575|NCT02495259|3491689|P2|COMPLETED|Overall Study||3
1426576|NCT02495259|3491690|P1|COMPLETED|Overall Study||7
1426577|NCT02495259|3491688|P3|STARTED|Overall Study||8
1426578|NCT02495259|3491689|P2|STARTED|Overall Study||4
1426579|NCT02495259|3491690|P1|STARTED|Overall Study||7
1426580|NCT02495038|3491716|P3|NOT COMPLETED|Overall Study||0
1426581|NCT02495038|3491717|P2|NOT COMPLETED|Overall Study||0
1426582|NCT02495038|3491718|P1|NOT COMPLETED|Overall Study||0
1426583|NCT02495038|3491716|P3|COMPLETED|Overall Study||27
1426584|NCT02495038|3491717|P2|COMPLETED|Overall Study||27
1426585|NCT02495038|3491718|P1|COMPLETED|Overall Study||27
1426586|NCT02495038|3491716|P3|STARTED|Overall Study||27
1426587|NCT02495038|3491717|P2|STARTED|Overall Study||27
1426588|NCT02495038|3491718|P1|STARTED|Overall Study||27
1426589|NCT02494713|3491753|P1|NOT COMPLETED|Overall Study||0
1426590|NCT02494713|3491753|P1|COMPLETED|Overall Study||4
1426591|NCT02494713|3491753|P1|STARTED|Overall Study||4
1426592|NCT02494596|3491770|P3|NOT COMPLETED|Overall Study||1
1426593|NCT02494596|3491771|P2|NOT COMPLETED|Overall Study||5
1426594|NCT02494596|3491772|P1|NOT COMPLETED|Overall Study||3
1426595|NCT02494596|3491770|P3|COMPLETED|Overall Study||6
1426596|NCT02494596|3491771|P2|COMPLETED|Overall Study||2
1426597|NCT02494596|3491772|P1|COMPLETED|Overall Study||2
1426598|NCT02494596|3491770|P3|STARTED|Overall Study||7
1426599|NCT02494596|3491771|P2|STARTED|Overall Study||7
1426600|NCT02494596|3491772|P1|STARTED|Overall Study||5
1426601|NCT02494440|3491797|P1|NOT COMPLETED|Overall Study||0
1426602|NCT02494440|3491797|P1|COMPLETED|Overall Study||90
1426603|NCT02494440|3491797|P1|STARTED|Overall Study||90
1426604|NCT02494323|3491803|P1|NOT COMPLETED|Overall Study||0
1426605|NCT02494323|3491803|P1|COMPLETED|Overall Study||70
1426606|NCT02494323|3491803|P1|STARTED|Overall Study||70
1426607|NCT02494206|3491808|P1|NOT COMPLETED|Overall Study||2
1426608|NCT02494206|3491808|P1|COMPLETED|Overall Study||7
1426609|NCT02494206|3491808|P1|STARTED|Overall Study||9
1426610|NCT02494076|3491814|P2|NOT COMPLETED|Overall Study||0
1426611|NCT02494076|3491815|P1|NOT COMPLETED|Overall Study||0
1426612|NCT02494076|3491814|P2|COMPLETED|Overall Study||26
1426613|NCT02494076|3491815|P1|COMPLETED|Overall Study||26
1426614|NCT02494076|3491814|P2|STARTED|Overall Study||26
1426615|NCT02494076|3491815|P1|STARTED|Overall Study||26
1426616|NCT02493855|3491828|P3|NOT COMPLETED|Overall Study||0
1426617|NCT02493855|3491829|P2|NOT COMPLETED|Overall Study||1
1426618|NCT02493855|3491830|P1|NOT COMPLETED|Overall Study||2
1426619|NCT02493855|3491828|P3|COMPLETED|Overall Study||6
1426620|NCT02493855|3491829|P2|COMPLETED|Overall Study||18
1426621|NCT02493855|3491830|P1|COMPLETED|Overall Study||19
1426622|NCT02493855|3491828|P3|STARTED|Overall Study||6
1426623|NCT02493855|3491829|P2|STARTED|Overall Study||19
1426624|NCT02493855|3491830|P1|STARTED|Overall Study||21
1426625|NCT02493777|3491840|P2|NOT COMPLETED|Overall Study||1
1426626|NCT02493777|3491841|P1|NOT COMPLETED|Overall Study||0
1426627|NCT02493777|3491840|P2|COMPLETED|Overall Study||53
1426628|NCT02493777|3491841|P1|COMPLETED|Overall Study||65
1426629|NCT02493777|3491840|P2|STARTED|Overall Study||54
1426630|NCT02493777|3491841|P1|STARTED|Overall Study||65
1426631|NCT02493517|3491851|P2|NOT COMPLETED|Overall Study||7
1426632|NCT02493517|3491852|P1|NOT COMPLETED|Overall Study||2
1426633|NCT02493517|3491851|P2|COMPLETED|Overall Study||57
1426634|NCT02493517|3491852|P1|COMPLETED|Overall Study||62
1426635|NCT02493517|3491851|P2|STARTED|Overall Study||64
1426636|NCT02493517|3491852|P1|STARTED|Overall Study||64
1426637|NCT02493127|3491876|P2|NOT COMPLETED|Overall Study||1
1426638|NCT02493127|3491877|P1|NOT COMPLETED|Overall Study||1
1426639|NCT02493127|3491876|P2|COMPLETED|Overall Study||60
1426640|NCT02493127|3491877|P1|COMPLETED|Overall Study||60
1426641|NCT02493127|3491876|P2|STARTED|Overall Study||61
1426642|NCT02493127|3491877|P1|STARTED|Overall Study||61
1426643|NCT02493088|3491889|P1|NOT COMPLETED|Overall Study||0
1426644|NCT02493088|3491889|P1|COMPLETED|Overall Study||11
1426645|NCT02493088|3491889|P1|STARTED|Overall Study||11
1426646|NCT02493036|3491898|P3|NOT COMPLETED|Overall Study||2
1426647|NCT02493036|3491899|P2|NOT COMPLETED|Overall Study||2
1426648|NCT02493036|3491900|P1|NOT COMPLETED|Overall Study||1
1426649|NCT02493036|3491898|P3|COMPLETED|Overall Study||15
1426650|NCT02493036|3491899|P2|COMPLETED|Overall Study||18
1426651|NCT02493036|3491900|P1|COMPLETED|Overall Study||16
1426652|NCT02493036|3491898|P3|STARTED|Overall Study||17
1426653|NCT02493036|3491899|P2|STARTED|Overall Study||20
1426654|NCT02493036|3491900|P1|STARTED|Overall Study||17
1426655|NCT02492984|3491910|P2|NOT COMPLETED|Overall Study||0
1426656|NCT02492984|3491911|P1|NOT COMPLETED|Overall Study||3
1426657|NCT02492984|3491910|P2|COMPLETED|Overall Study||14
1426658|NCT02492984|3491911|P1|COMPLETED|Overall Study||70
1426659|NCT02492984|3491910|P2|STARTED|Overall Study||14
1426660|NCT02492984|3491911|P1|STARTED|Overall Study||73
1426661|NCT02492958|3491935|P4|NOT COMPLETED|Overall Study||0
1426662|NCT02492958|3491936|P3|NOT COMPLETED|Overall Study||2
1426663|NCT02492958|3491937|P2|NOT COMPLETED|Overall Study||0
1426664|NCT02492958|3491938|P1|NOT COMPLETED|Overall Study||1
1426665|NCT02492958|3491935|P4|COMPLETED|Overall Study||34
1426666|NCT02492958|3491936|P3|COMPLETED|Overall Study||32
1426667|NCT02492958|3491937|P2|COMPLETED|Overall Study||34
1426668|NCT02492958|3491938|P1|COMPLETED|Overall Study||33
1426669|NCT02492958|3491935|P4|STARTED|Overall Study||34
1426670|NCT02492958|3491936|P3|STARTED|Overall Study||34
1426671|NCT02492958|3491937|P2|STARTED|Overall Study||34
1426672|NCT02492958|3491938|P1|STARTED|Overall Study||34
1426673|NCT02492880|3492024|P1|NOT COMPLETED|Overall Study||2
1426674|NCT02492880|3492024|P1|COMPLETED|Overall Study||13
1426675|NCT02492880|3492024|P1|STARTED|Overall Study||15
1426676|NCT02492841|3492031|P3|NOT COMPLETED|Overall Study||35
1426677|NCT02492841|3492032|P2|NOT COMPLETED|Overall Study||31
1426678|NCT02492841|3492033|P1|NOT COMPLETED|Overall Study||34
1426679|NCT02492841|3492031|P3|COMPLETED|Overall Study||25
1426680|NCT02492841|3492032|P2|COMPLETED|Overall Study||22
1426681|NCT02492841|3492033|P1|COMPLETED|Overall Study||22
1426682|NCT02492841|3492031|P3|STARTED|Overall Study||60
1426683|NCT02492841|3492032|P2|STARTED|Overall Study||53
1426684|NCT02492841|3492033|P1|STARTED|Overall Study||56
1426685|NCT02492763|3492048|P4|NOT COMPLETED|Overall Study||13
1426686|NCT02492763|3492049|P3|NOT COMPLETED|Overall Study||10
1426687|NCT02492763|3492050|P2|NOT COMPLETED|Overall Study||15
1426688|NCT02492763|3492051|P1|NOT COMPLETED|Overall Study||16
1426689|NCT02492763|3492048|P4|COMPLETED|Overall Study||30
1426690|NCT02492763|3492049|P3|COMPLETED|Overall Study||33
1426691|NCT02492763|3492050|P2|COMPLETED|Overall Study||29
1426692|NCT02492763|3492051|P1|COMPLETED|Overall Study||30
1426693|NCT02492763|3492048|P4|Treated|Overall Study||42
1426694|NCT02492763|3492049|P3|Treated|Overall Study||43
1426695|NCT02492763|3492050|P2|Treated|Overall Study||44
1426696|NCT02492763|3492051|P1|Treated|Overall Study||46
1426697|NCT02492763|3492048|P4|STARTED|Overall Study||43
1426698|NCT02492763|3492049|P3|STARTED|Overall Study||43
1426699|NCT02492763|3492050|P2|STARTED|Overall Study||44
1426700|NCT02492763|3492051|P1|STARTED|Overall Study||46
1426701|NCT02492451|3492108|P3|NOT COMPLETED|Overall Study||0
1426702|NCT02492451|3492109|P2|NOT COMPLETED|Overall Study||0
1426703|NCT02492451|3492110|P1|NOT COMPLETED|Overall Study||0
1426704|NCT02492451|3492108|P3|COMPLETED|Overall Study||39
1426705|NCT02492451|3492109|P2|COMPLETED|Overall Study||39
1426706|NCT02492451|3492110|P1|COMPLETED|Overall Study||40
1426707|NCT02492451|3492108|P3|STARTED|Overall Study||39
1426708|NCT02492451|3492109|P2|STARTED|Overall Study||39
1426709|NCT02492451|3492110|P1|STARTED|Overall Study||40
1426710|NCT02492165|3492122|P4|NOT COMPLETED|Overall Study||0
1426711|NCT02492165|3492123|P3|NOT COMPLETED|Overall Study||0
1426712|NCT02492165|3492124|P2|NOT COMPLETED|Overall Study||1
1426713|NCT02492165|3492125|P1|NOT COMPLETED|Overall Study||0
1426714|NCT02492165|3492122|P4|COMPLETED|Overall Study||30
1426715|NCT02492165|3492123|P3|COMPLETED|Overall Study||60
1426716|NCT02492165|3492124|P2|COMPLETED|Overall Study||59
1426717|NCT02492165|3492125|P1|COMPLETED|Overall Study||100
1426718|NCT02492165|3492122|P4|STARTED|Overall Study||30
1426719|NCT02492165|3492123|P3|STARTED|Overall Study||60
1426720|NCT02492165|3492124|P2|STARTED|Overall Study||60
1426721|NCT02492165|3492125|P1|STARTED|Overall Study||100
1426722|NCT02491944|3492147|P1|NOT COMPLETED|Overall Study||0
1426723|NCT02491944|3492147|P1|COMPLETED|Overall Study||10
1426724|NCT02491944|3492147|P1|STARTED|Overall Study||10
1426725|NCT02491892|3492169|P2|NOT COMPLETED|Overall Study||38
1426726|NCT02491892|3492170|P1|NOT COMPLETED|Overall Study||41
1426727|NCT02491892|3492169|P2|COMPLETED|Overall Study||0
1426728|NCT02491892|3492170|P1|COMPLETED|Overall Study||0
1426729|NCT02491892|3492169|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
1426730|NCT02491892|3492170|P1|Treated|Overall Study||41
1426731|NCT02491892|3492169|P2|STARTED|Overall Study||38
1426732|NCT02491892|3492170|P1|STARTED|Overall Study||41
1426733|NCT02491463|3492218|P4|NOT COMPLETED|Overall Study||1
1426734|NCT02491463|3492219|P3|NOT COMPLETED|Overall Study||4
1426735|NCT02491463|3492220|P2|NOT COMPLETED|Overall Study||10
1426736|NCT02491463|3492221|P1|NOT COMPLETED|Overall Study||2
1426737|NCT02491463|3492218|P4|COMPLETED|Overall Study||14
1426738|NCT02491463|3492219|P3|COMPLETED|Overall Study||15
1426739|NCT02491463|3492220|P2|COMPLETED|Overall Study||21
1426740|NCT02491463|3492221|P1|COMPLETED|Overall Study||5
1426741|NCT02491463|3492218|P4|STARTED|Overall Study||15
1426742|NCT02491463|3492219|P3|STARTED|Overall Study||19
1426743|NCT02491463|3492220|P2|STARTED|Overall Study||31
1426744|NCT02491463|3492221|P1|STARTED|Overall Study||7
1426745|NCT02491411|3492307|P1|NOT COMPLETED|Overall Study||4
1426746|NCT02491411|3492307|P1|COMPLETED|Overall Study||0
1426747|NCT02491411|3492307|P1|STARTED|Overall Study||4
1426748|NCT02491073|3492319|P2|NOT COMPLETED|Overall Study||0
1426749|NCT02491073|3492320|P1|NOT COMPLETED|Overall Study||1
1426750|NCT02491073|3492319|P2|COMPLETED|Overall Study||34
1426751|NCT02491073|3492320|P1|COMPLETED|Overall Study||36
1426752|NCT02491073|3492319|P2|STARTED|Overall Study||34
1426753|NCT02491073|3492320|P1|STARTED|Overall Study||37
1426754|NCT02490670|3492348|P2|NOT COMPLETED|Period 2 (19 Days)||0
1426755|NCT02490670|3492349|P1|NOT COMPLETED|Period 2 (19 Days)||0
1426756|NCT02490670|3492348|P2|COMPLETED|Period 2 (19 Days)||14
1426757|NCT02490670|3492349|P1|COMPLETED|Period 2 (19 Days)||14
1426758|NCT02490670|3492348|P2|STARTED|Period 2 (19 Days)||14
1426759|NCT02490670|3492349|P1|STARTED|Period 2 (19 Days)||14
1426760|NCT02490670|3492348|P2|NOT COMPLETED|Washout Period (7 Days)||0
1426761|NCT02490670|3492349|P1|NOT COMPLETED|Washout Period (7 Days)||0
1426762|NCT02490670|3492348|P2|COMPLETED|Washout Period (7 Days)||14
1426763|NCT02490670|3492349|P1|COMPLETED|Washout Period (7 Days)||14
1426764|NCT02490670|3492348|P2|STARTED|Washout Period (7 Days)||14
1426765|NCT02490670|3492349|P1|STARTED|Washout Period (7 Days)||14
1426766|NCT02490670|3492348|P2|NOT COMPLETED|Period 1 (19 Days)||0
1426767|NCT02490670|3492349|P1|NOT COMPLETED|Period 1 (19 Days)||0
1426768|NCT02490670|3492348|P2|COMPLETED|Period 1 (19 Days)||14
1426769|NCT02490670|3492349|P1|COMPLETED|Period 1 (19 Days)||14
1426770|NCT02490670|3492348|P2|STARTED|Period 1 (19 Days)||14
1426771|NCT02490670|3492349|P1|STARTED|Period 1 (19 Days)||14
1426772|NCT02490475|3492361|P4|NOT COMPLETED|Period 2: Extension Phase||1
1426773|NCT02490475|3492362|P3|NOT COMPLETED|Period 2: Extension Phase||3
1426774|NCT02490475|3492363|P2|NOT COMPLETED|Period 2: Extension Phase||0
1426775|NCT02490475|3492364|P1|NOT COMPLETED|Period 2: Extension Phase||1
1426776|NCT02490475|3492361|P4|COMPLETED|Period 2: Extension Phase||0
1426777|NCT02490475|3492362|P3|COMPLETED|Period 2: Extension Phase||0
1426778|NCT02490475|3492363|P2|COMPLETED|Period 2: Extension Phase||0
1426779|NCT02490475|3492364|P1|COMPLETED|Period 2: Extension Phase||0
1426780|NCT02490475|3492361|P4|STARTED|Period 2: Extension Phase||1
1426781|NCT02490475|3492362|P3|STARTED|Period 2: Extension Phase||3
1426782|NCT02490475|3492363|P2|STARTED|Period 2: Extension Phase||0
1426783|NCT02490475|3492364|P1|STARTED|Period 2: Extension Phase||1
1426784|NCT02490475|3492361|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
1426785|NCT02490475|3492362|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
1426786|NCT02490475|3492363|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
1426787|NCT02490475|3492364|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
1426788|NCT02490475|3492361|P4|COMPLETED|Period 1: First 6 Cycles||0
1426789|NCT02490475|3492362|P3|COMPLETED|Period 1: First 6 Cycles||0
1426790|NCT02490475|3492363|P2|COMPLETED|Period 1: First 6 Cycles||0
1426791|NCT02490475|3492364|P1|COMPLETED|Period 1: First 6 Cycles||0
1426792|NCT02490475|3492361|P4|STARTED|Period 1: First 6 Cycles||5
1426793|NCT02490475|3492362|P3|STARTED|Period 1: First 6 Cycles||6
1426794|NCT02490475|3492363|P2|STARTED|Period 1: First 6 Cycles||2
1426795|NCT02490475|3492364|P1|STARTED|Period 1: First 6 Cycles||6
1426796|NCT02490293|3492442|P2|NOT COMPLETED|Overall Study||3
1426797|NCT02490293|3492443|P1|NOT COMPLETED|Overall Study||2
1426798|NCT02490293|3492442|P2|COMPLETED|Overall Study||99
1426799|NCT02490293|3492443|P1|COMPLETED|Overall Study||94
1426800|NCT02490293|3492442|P2|STARTED|Overall Study||102
1426801|NCT02490293|3492443|P1|STARTED|Overall Study||96
1426802|NCT02489968|3492453|P6|NOT COMPLETED|Double-blind Treatment Period||8
1426803|NCT02489968|3492454|P5|NOT COMPLETED|Double-blind Treatment Period||6
1426804|NCT02489968|3492455|P4|NOT COMPLETED|Double-blind Treatment Period||8
1426805|NCT02489968|3492456|P3|NOT COMPLETED|Double-blind Treatment Period||2
1426806|NCT02489968|3492457|P2|NOT COMPLETED|Double-blind Treatment Period||0
1426807|NCT02489968|3492458|P1|NOT COMPLETED|Double-blind Treatment Period||0
1426808|NCT02489968|3492453|P6|COMPLETED|Double-blind Treatment Period||108
1426809|NCT02489968|3492454|P5|COMPLETED|Double-blind Treatment Period||110
1426810|NCT02489968|3492455|P4|COMPLETED|Double-blind Treatment Period||100
1426811|NCT02489968|3492456|P3|COMPLETED|Double-blind Treatment Period||105
1426812|NCT02489968|3492457|P2|COMPLETED|Double-blind Treatment Period||0
1426813|NCT02489968|3492458|P1|COMPLETED|Double-blind Treatment Period||0
1426814|NCT02489968|3492453|P6|STARTED|Double-blind Treatment Period||116
1426815|NCT02489968|3492454|P5|STARTED|Double-blind Treatment Period||116
1426816|NCT02489968|3492455|P4|STARTED|Double-blind Treatment Period||108
1426817|NCT02489968|3492456|P3|STARTED|Double-blind Treatment Period||107
1426818|NCT02489968|3492457|P2|STARTED|Double-blind Treatment Period||0
1426819|NCT02489968|3492458|P1|STARTED|Double-blind Treatment Period||0
1426820|NCT02489968|3492453|P6|NOT COMPLETED|Open-label Treatment Period||0
1426821|NCT02489968|3492454|P5|NOT COMPLETED|Open-label Treatment Period||0
1426822|NCT02489968|3492455|P4|NOT COMPLETED|Open-label Treatment Period||0
1426823|NCT02489968|3492456|P3|NOT COMPLETED|Open-label Treatment Period||0
1426824|NCT02489968|3492457|P2|NOT COMPLETED|Open-label Treatment Period||208
1426825|NCT02489968|3492458|P1|NOT COMPLETED|Open-label Treatment Period||224
1426826|NCT02489968|3492453|P6|COMPLETED|Open-label Treatment Period||0
1426827|NCT02489968|3492454|P5|COMPLETED|Open-label Treatment Period||0
1426828|NCT02489968|3492455|P4|COMPLETED|Open-label Treatment Period||0
1426829|NCT02489968|3492456|P3|COMPLETED|Open-label Treatment Period||0
1426830|NCT02489968|3492457|P2|COMPLETED|Open-label Treatment Period||232
1426831|NCT02489968|3492458|P1|COMPLETED|Open-label Treatment Period||215
1426832|NCT02489968|3492453|P6|STARTED|Open-label Treatment Period||0
1426833|NCT02489968|3492454|P5|STARTED|Open-label Treatment Period||0
1426834|NCT02489968|3492455|P4|STARTED|Open-label Treatment Period||0
1426835|NCT02489968|3492456|P3|STARTED|Open-label Treatment Period||0
1426836|NCT02489968|3492457|P2|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
1426837|NCT02489968|3492458|P1|STARTED|Open-label Treatment Period||439
1426838|NCT02489799|3492472|P2|NOT COMPLETED|Overall Study||9
1426839|NCT02489799|3492473|P1|NOT COMPLETED|Overall Study||9
1426840|NCT02489799|3492472|P2|COMPLETED|Overall Study||38
1426841|NCT02489799|3492473|P1|COMPLETED|Overall Study||36
1426842|NCT02489799|3492472|P2|Postsurgical One Week Visit (V3)|Overall Study||39
1426843|NCT02489799|3492473|P1|Postsurgical One Week Visit (V3)|Overall Study||40
1426844|NCT02489799|3492472|P2|Presurgical Consent Visit (V2)|Overall Study||39
1426845|NCT02489799|3492473|P1|Presurgical Consent Visit (V2)|Overall Study||40
1426846|NCT02489799|3492472|P2|STARTED|Overall Study||47
1426847|NCT02489799|3492473|P1|STARTED|Overall Study||45
1426848|NCT02489500|3492499|P2|NOT COMPLETED|Overall Study||1
1426849|NCT02489500|3492500|P1|NOT COMPLETED|Overall Study||1
1426850|NCT02489500|3492499|P2|COMPLETED|Overall Study||0
1426851|NCT02489500|3492500|P1|COMPLETED|Overall Study||1
1426852|NCT02489500|3492499|P2|STARTED|Overall Study||1
1426853|NCT02489500|3492500|P1|STARTED|Overall Study||2
1426854|NCT02489110|3492514|P2|NOT COMPLETED|Overall Study||25
1426855|NCT02489110|3492515|P1|NOT COMPLETED|Overall Study||27
1426856|NCT02489110|3492514|P2|COMPLETED|Overall Study||50
1426857|NCT02489110|3492515|P1|COMPLETED|Overall Study||48
1426858|NCT02489110|3492514|P2|STARTED|Overall Study||75
1426859|NCT02489110|3492515|P1|STARTED|Overall Study||75
1426860|NCT02488980|3492526|P3|NOT COMPLETED|Overall Study||2
1426861|NCT02488980|3492527|P2|NOT COMPLETED|Overall Study||2
1426862|NCT02488980|3492528|P1|NOT COMPLETED|Overall Study||2
1426863|NCT02488980|3492526|P3|COMPLETED|Overall Study||99
1426864|NCT02488980|3492527|P2|COMPLETED|Overall Study||99
1426865|NCT02488980|3492528|P1|COMPLETED|Overall Study||102
1426866|NCT02488980|3492526|P3|STARTED|Overall Study||101
1426867|NCT02488980|3492527|P2|STARTED|Overall Study||101
1426868|NCT02488980|3492528|P1|STARTED|Overall Study||104
1426869|NCT02488915|3492545|P1|NOT COMPLETED|Overall Study||26
1426870|NCT02488915|3492545|P1|COMPLETED|Overall Study||202
1426871|NCT02488915|3492545|P1|STARTED|Overall Study||228
1426872|NCT02488681|3492561|P1|NOT COMPLETED|Overall Study||7
1426873|NCT02488681|3492561|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
1426874|NCT02488681|3492561|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
1426875|NCT02488317|3492567|P2|NOT COMPLETED|Overall Study||47
1426876|NCT02488317|3492568|P1|NOT COMPLETED|Overall Study||54
1426877|NCT02488317|3492567|P2|COMPLETED|Overall Study||70
1426878|NCT02488317|3492568|P1|COMPLETED|Overall Study||63
1426879|NCT02488317|3492567|P2|STARTED|Overall Study||117
1426880|NCT02488317|3492568|P1|STARTED|Overall Study||117
1426881|NCT02488070|3492582|P1|NOT COMPLETED|Overall Study||0
1426882|NCT02488070|3492582|P1|COMPLETED|Overall Study||10
1426883|NCT02488070|3492582|P1|STARTED|Overall Study||10
1426884|NCT02488018|3492590|P1|NOT COMPLETED|Overall Study||0
1426885|NCT02488018|3492590|P1|COMPLETED|Overall Study||10
1426886|NCT02488018|3492590|P1|STARTED|Overall Study||10
1426887|NCT02487979|3492594|P1|NOT COMPLETED|Overall Study||21
1426888|NCT02487979|3492594|P1|COMPLETED|Overall Study||1
1426889|NCT02487979|3492594|P1|STARTED|Overall Study||22
1426890|NCT02487771|3492606|P2|NOT COMPLETED|Overall Study||14
1426891|NCT02487771|3492607|P1|NOT COMPLETED|Overall Study||10
1426892|NCT02487771|3492606|P2|COMPLETED|Overall Study||85
1426893|NCT02487771|3492607|P1|COMPLETED|Overall Study||81
1426894|NCT02487771|3492606|P2|STARTED|Overall Study||99
1426895|NCT02487771|3492607|P1|STARTED|Overall Study||91
1426896|NCT02487498|3492757|P2|NOT COMPLETED|Period: Period 2||5
1426897|NCT02487498|3492758|P1|NOT COMPLETED|Period: Period 2||6
1426898|NCT02487498|3492757|P2|COMPLETED|Period: Period 2||154
1426899|NCT02487498|3492758|P1|COMPLETED|Period: Period 2||164
1426900|NCT02487498|3492757|P2|STARTED|Period: Period 2||159
1426901|NCT02487498|3492758|P1|STARTED|Period: Period 2||170
1426902|NCT02487498|3492757|P2|NOT COMPLETED|Period: Washout||7
1426903|NCT02487498|3492758|P1|NOT COMPLETED|Period: Washout||2
1426904|NCT02487498|3492757|P2|COMPLETED|Period: Washout||159
1426905|NCT02487498|3492758|P1|COMPLETED|Period: Washout||170
1426906|NCT02487498|3492757|P2|STARTED|Period: Washout||166
1426907|NCT02487498|3492758|P1|STARTED|Period: Washout||172
1426908|NCT02487498|3492757|P2|NOT COMPLETED|Period: Period 1||11
1426909|NCT02487498|3492758|P1|NOT COMPLETED|Period: Period 1||6
1426910|NCT02487498|3492757|P2|COMPLETED|Period: Period 1||166
1426911|NCT02487498|3492758|P1|COMPLETED|Period: Period 1||172
1426912|NCT02487498|3492757|P2|STARTED|Period: Period 1||177
1426913|NCT02487498|3492758|P1|STARTED|Period: Period 1||178
1426914|NCT02487446|3492781|P2|NOT COMPLETED|Period 2||5
1426915|NCT02487446|3492782|P1|NOT COMPLETED|Period 2||8
1426916|NCT02487446|3492781|P2|COMPLETED|Period 2||158
1426917|NCT02487446|3492782|P1|COMPLETED|Period 2||154
1426918|NCT02487446|3492781|P2|STARTED|Period 2||163
1426919|NCT02487446|3492782|P1|STARTED|Period 2||162
1426920|NCT02487446|3492781|P2|NOT COMPLETED|Washout||8
1426921|NCT02487446|3492782|P1|NOT COMPLETED|Washout||3
1426922|NCT02487446|3492781|P2|COMPLETED|Washout||163
1426923|NCT02487446|3492782|P1|COMPLETED|Washout||162
1426924|NCT02487446|3492781|P2|STARTED|Washout||171
1426925|NCT02487446|3492782|P1|STARTED|Washout||165
1426926|NCT02487446|3492781|P2|NOT COMPLETED|Period 1||8
1426927|NCT02487446|3492782|P1|NOT COMPLETED|Period 1||13
1426928|NCT02487446|3492781|P2|COMPLETED|Period 1||171
1426929|NCT02487446|3492782|P1|COMPLETED|Period 1||165
1426930|NCT02487446|3492781|P2|STARTED|Period 1||179
1426931|NCT02487446|3492782|P1|STARTED|Period 1||178
1426932|NCT02487303|3492808|P3|NOT COMPLETED|Overall Study||1
1426933|NCT02487303|3492809|P2|NOT COMPLETED|Overall Study||4
1426934|NCT02487303|3492810|P1|NOT COMPLETED|Overall Study||2
1426935|NCT02487303|3492808|P3|COMPLETED|Overall Study||47
1426936|NCT02487303|3492809|P2|COMPLETED|Overall Study||47
1426937|NCT02487303|3492810|P1|COMPLETED|Overall Study||47
1426938|NCT02487303|3492808|P3|STARTED|Overall Study||48
1426939|NCT02487303|3492809|P2|STARTED|Overall Study||51
1426940|NCT02487303|3492810|P1|STARTED|Overall Study||49
1426941|NCT02487199|3492829|P2|NOT COMPLETED|Overall Study||1
1426942|NCT02487199|3492830|P1|NOT COMPLETED|Overall Study||0
1426943|NCT02487199|3492829|P2|COMPLETED|Overall Study||4
1426944|NCT02487199|3492830|P1|COMPLETED|Overall Study||13
1426945|NCT02487199|3492829|P2|STARTED|Overall Study||5
1426946|NCT02487199|3492830|P1|STARTED|Overall Study||13
1426947|NCT02487030|3492849|P7|NOT COMPLETED|Overall Study||0
1426948|NCT02487030|3492850|P6|NOT COMPLETED|Overall Study||1
1426949|NCT02487030|3492851|P5|NOT COMPLETED|Overall Study||2
1426950|NCT02487030|3492852|P4|NOT COMPLETED|Overall Study||2
1426951|NCT02487030|3492853|P3|NOT COMPLETED|Overall Study||2
1426952|NCT02487030|3492854|P2|NOT COMPLETED|Overall Study||4
1426953|NCT02487030|3492855|P1|NOT COMPLETED|Overall Study||2
1426954|NCT02487030|3492849|P7|COMPLETED|Overall Study||11
1426955|NCT02487030|3492850|P6|COMPLETED|Overall Study||37
1426956|NCT02487030|3492851|P5|COMPLETED|Overall Study||34
1426957|NCT02487030|3492852|P4|COMPLETED|Overall Study||40
1426958|NCT02487030|3492853|P3|COMPLETED|Overall Study||41
1426959|NCT02487030|3492854|P2|COMPLETED|Overall Study||38
1426960|NCT02487030|3492855|P1|COMPLETED|Overall Study||41
1426961|NCT02487030|3492849|P7|STARTED|Overall Study||11
1426962|NCT02487030|3492850|P6|STARTED|Overall Study||38
1426963|NCT02487030|3492851|P5|STARTED|Overall Study||36
1426964|NCT02487030|3492852|P4|STARTED|Overall Study||42
1426965|NCT02487030|3492853|P3|STARTED|Overall Study||43
1426966|NCT02487030|3492854|P2|STARTED|Overall Study||42
1426967|NCT02487030|3492855|P1|STARTED|Overall Study||43
1426968|NCT02486952|3492886|P1|NOT COMPLETED|Overall Study||50
1426969|NCT02486952|3492886|P1|COMPLETED|Overall Study||104
1426970|NCT02486952|3492886|P1|Started Induction Therapy|Overall Study||151
1426971|NCT02486952|3492886|P1|STARTED|Overall Study||154
1426972|NCT02486939|3492893|P2|NOT COMPLETED|Overall Study||2
1426973|NCT02486939|3492894|P1|NOT COMPLETED|Overall Study||1
1426974|NCT02486939|3492893|P2|COMPLETED|Overall Study||132
1426975|NCT02486939|3492894|P1|COMPLETED|Overall Study||224
1426976|NCT02486939|3492893|P2|STARTED|Overall Study||134
1426977|NCT02486939|3492894|P1|STARTED|Overall Study||225
1426978|NCT02486796|3492904|P2|NOT COMPLETED|Overall Study||1
1426979|NCT02486796|3492905|P1|NOT COMPLETED|Overall Study||2
1426980|NCT02486796|3492904|P2|COMPLETED|Overall Study||1
1426981|NCT02486796|3492905|P1|COMPLETED|Overall Study||1
1426982|NCT02486796|3492904|P2|STARTED|Overall Study||2
1426983|NCT02486796|3492905|P1|STARTED|Overall Study||3
1426984|NCT02486757|3492917|P1|NOT COMPLETED|Overall Study||1
1426985|NCT02486757|3492917|P1|COMPLETED|Overall Study||5
1426986|NCT02486757|3492917|P1|STARTED|Overall Study||6
1426987|NCT02486627|3492923|P2|NOT COMPLETED|Overall Study||9
1426988|NCT02486627|3492924|P1|NOT COMPLETED|Overall Study||7
1426989|NCT02486627|3492923|P2|COMPLETED|Overall Study||294
1426990|NCT02486627|3492924|P1|COMPLETED|Overall Study||299
1426991|NCT02486627|3492923|P2|STARTED|Overall Study||303
1426992|NCT02486627|3492924|P1|STARTED|Overall Study||306
1426993|NCT02485925|3492941|P1|NOT COMPLETED|Overall Study||15
1426994|NCT02485925|3492941|P1|COMPLETED|Overall Study||185
1426995|NCT02485925|3492941|P1|Per-Protocol Population|Overall Study||166
1426996|NCT02485925|3492941|P1|Intent to Treat (ITT) Population|Overall Study||193
1426997|NCT02485925|3492941|P1|Safety Population|Overall Study||200
1426998|NCT02485925|3492941|P1|STARTED|Overall Study||200
1426999|NCT02485561|3492952|P3|NOT COMPLETED|Overall Study||23
1427000|NCT02485561|3492953|P2|NOT COMPLETED|Overall Study||39
1427001|NCT02485561|3492954|P1|NOT COMPLETED|Overall Study||28
1427002|NCT02485561|3492952|P3|COMPLETED|Overall Study||136
1427003|NCT02485561|3492953|P2|COMPLETED|Overall Study||118
1427004|NCT02485561|3492954|P1|COMPLETED|Overall Study||133
1427005|NCT02485561|3492952|P3|Completed 1 mo Survey|Overall Study||144
1427006|NCT02485561|3492953|P2|Completed 1 mo Survey|Overall Study||138
1427007|NCT02485561|3492954|P1|Completed 1 mo Survey|Overall Study||145
1427008|NCT02485561|3492952|P3|STARTED|Overall Study||159
1427009|NCT02485561|3492953|P2|STARTED|Overall Study||157
1427010|NCT02485561|3492954|P1|STARTED|Overall Study||161
1427011|NCT02485483|3492991|P2|NOT COMPLETED|Overall Study||0
1427012|NCT02485483|3492992|P1|NOT COMPLETED|Overall Study||54
1427013|NCT02485483|3492991|P2|COMPLETED|Overall Study||1015
1427014|NCT02485483|3492992|P1|COMPLETED|Overall Study||223
1427015|NCT02485483|3492991|P2|STARTED|Overall Study||1015
1427016|NCT02485483|3492992|P1|STARTED|Overall Study||277
1427017|NCT02485353|3493007|P1|NOT COMPLETED|Overall Study||2
1427018|NCT02485353|3493007|P1|COMPLETED|Overall Study||0
1427019|NCT02485353|3493007|P1|STARTED|Overall Study||2
1427020|NCT02485301|3493014|P2|NOT COMPLETED|Overall Study||49
1427021|NCT02485301|3493015|P1|NOT COMPLETED|Overall Study||38
1427022|NCT02485301|3493014|P2|COMPLETED|Overall Study||1455
1427023|NCT02485301|3493015|P1|COMPLETED|Overall Study||1471
1427024|NCT02485301|3493014|P2|STARTED|Overall Study||1504
1427025|NCT02485301|3493015|P1|STARTED|Overall Study||1509
1427026|NCT02485158|3493065|P1|NOT COMPLETED|Overall Study||4
1427027|NCT02485158|3493065|P1|COMPLETED|Overall Study||24
1427028|NCT02485158|3493065|P1|STARTED|Overall Study||28
1427029|NCT02484911|3493154|P2|NOT COMPLETED|Overall Study||2
1427030|NCT02484911|3493155|P1|NOT COMPLETED|Overall Study||4
1427031|NCT02484911|3493154|P2|COMPLETED|Overall Study||58
1427032|NCT02484911|3493155|P1|COMPLETED|Overall Study||56
1427033|NCT02484911|3493154|P2|STARTED|Overall Study||60
1427034|NCT02484911|3493155|P1|STARTED|Overall Study||60
1427035|NCT02484898|3493183|P1|NOT COMPLETED|Overall Study||18
1427036|NCT02484898|3493183|P1|COMPLETED|Overall Study||182
1427037|NCT02484898|3493183|P1|STARTED|Overall Study||200
1427038|NCT02484729|3493197|P10|NOT COMPLETED|Overall Study||1
1427039|NCT02484729|3493198|P9|NOT COMPLETED|Overall Study||0
1427040|NCT02484729|3493199|P8|NOT COMPLETED|Overall Study||0
1427041|NCT02484729|3493200|P7|NOT COMPLETED|Overall Study||0
1427042|NCT02484729|3493201|P6|NOT COMPLETED|Overall Study||0
1427043|NCT02484729|3493202|P5|NOT COMPLETED|Overall Study||0
1427044|NCT02484729|3493203|P4|NOT COMPLETED|Overall Study||0
1427045|NCT02484729|3493204|P3|NOT COMPLETED|Overall Study||0
1427046|NCT02484729|3493205|P2|NOT COMPLETED|Overall Study||0
1427047|NCT02484729|3493206|P1|NOT COMPLETED|Overall Study||0
1427048|NCT02484729|3493197|P10|COMPLETED|Overall Study||7
1427049|NCT02484729|3493198|P9|COMPLETED|Overall Study||6
1427050|NCT02484729|3493199|P8|COMPLETED|Overall Study||6
1427051|NCT02484729|3493200|P7|COMPLETED|Overall Study||5
1427052|NCT02484729|3493201|P6|COMPLETED|Overall Study||6
1427053|NCT02484729|3493202|P5|COMPLETED|Overall Study||5
1427054|NCT02484729|3493203|P4|COMPLETED|Overall Study||6
1427055|NCT02484729|3493204|P3|COMPLETED|Overall Study||6
1427056|NCT02484729|3493205|P2|COMPLETED|Overall Study||6
1427057|NCT02484729|3493206|P1|COMPLETED|Overall Study||16
1427058|NCT02484729|3493197|P10|STARTED|Overall Study||8
1427059|NCT02484729|3493198|P9|STARTED|Overall Study||6
1427060|NCT02484729|3493199|P8|STARTED|Overall Study||6
1427061|NCT02484729|3493200|P7|STARTED|Overall Study||5
1427062|NCT02484729|3493201|P6|STARTED|Overall Study||6
1427063|NCT02484729|3493202|P5|STARTED|Overall Study||5
1427064|NCT02484729|3493203|P4|STARTED|Overall Study||6
1427065|NCT02484729|3493204|P3|STARTED|Overall Study||6
1427066|NCT02484729|3493205|P2|STARTED|Overall Study||6
1427067|NCT02484729|3493206|P1|STARTED|Overall Study||16
1427068|NCT02483975|3493404|P2|NOT COMPLETED|Overall Study||2
1427069|NCT02483975|3493405|P1|NOT COMPLETED|Overall Study||2
1427070|NCT02483975|3493404|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
1427071|NCT02483975|3493405|P1|COMPLETED|Overall Study||54
1427072|NCT02483975|3493404|P2|STARTED|Overall Study||55
1427073|NCT02483975|3493405|P1|STARTED|Overall Study||56
1427074|NCT02483611|3493422|P3|NOT COMPLETED|Overall Study||1
1427075|NCT02483611|3493423|P2|NOT COMPLETED|Overall Study||0
1427076|NCT02483611|3493424|P1|NOT COMPLETED|Overall Study||0
1427077|NCT02483611|3493422|P3|COMPLETED|Overall Study|One patient required decurarization|15
1427078|NCT02483611|3493423|P2|COMPLETED|Overall Study||16
1427079|NCT02483611|3493424|P1|COMPLETED|Overall Study||16
1427080|NCT02483611|3493422|P3|STARTED|Overall Study||16
1427081|NCT02483611|3493423|P2|STARTED|Overall Study||16
1427082|NCT02483611|3493424|P1|STARTED|Overall Study||16
1427083|NCT02483585|3493521|P2|NOT COMPLETED|Open-label Treatment Phase||25
1427084|NCT02483585|3493522|P1|NOT COMPLETED|Open-label Treatment Phase||27
1427085|NCT02483585|3493521|P2|COMPLETED|Open-label Treatment Phase||243
1427086|NCT02483585|3493522|P1|COMPLETED|Open-label Treatment Phase||243
1427087|NCT02483585|3493521|P2|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
1427088|NCT02483585|3493522|P1|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
1427089|NCT02483585|3493521|P2|NOT COMPLETED|Double-blind Treatment Phase||15
1427090|NCT02483585|3493522|P1|NOT COMPLETED|Double-blind Treatment Phase||16
1427091|NCT02483585|3493521|P2|COMPLETED|Double-blind Treatment Phase||271
1427092|NCT02483585|3493522|P1|COMPLETED|Double-blind Treatment Phase||275
1427093|NCT02483585|3493521|P2|Received Treatment|Double-blind Treatment Phase||283
1427094|NCT02483585|3493522|P1|Received Treatment|Double-blind Treatment Phase||289
1427095|NCT02483585|3493521|P2|STARTED|Double-blind Treatment Phase||286
1427096|NCT02483585|3493522|P1|STARTED|Double-blind Treatment Phase||291
1427097|NCT02482935|3493542|P2|NOT COMPLETED|Period 2||0
1427098|NCT02482935|3493543|P1|NOT COMPLETED|Period 2||0
1427099|NCT02482935|3493542|P2|COMPLETED|Period 2||15
1427100|NCT02482935|3493543|P1|COMPLETED|Period 2||14
1427101|NCT02482935|3493542|P2|Follow-up|Period 2||15
1427102|NCT02482935|3493543|P1|Follow-up|Period 2||14
1427103|NCT02482935|3493542|P2|Received Abemaciclib|Period 2||15
1427104|NCT02482935|3493543|P1|Received Abemaciclib|Period 2||14
1427105|NCT02482935|3493542|P2|STARTED|Period 2||15
1427106|NCT02482935|3493543|P1|STARTED|Period 2||14
1427107|NCT02482935|3493542|P2|NOT COMPLETED|Period 1||0
1427108|NCT02482935|3493543|P1|NOT COMPLETED|Period 1||1
1427109|NCT02482935|3493542|P2|COMPLETED|Period 1||15
1427110|NCT02482935|3493543|P1|COMPLETED|Period 1||14
1427111|NCT02482935|3493542|P2|Washout|Period 1||15
1427112|NCT02482935|3493543|P1|Washout|Period 1||15
1427113|NCT02482935|3493542|P2|Received Abemaciclib|Period 1||15
1427114|NCT02482935|3493543|P1|Received Abemaciclib|Period 1||15
1427115|NCT02482935|3493542|P2|STARTED|Period 1||15
1427116|NCT02482935|3493543|P1|STARTED|Period 1||15
1427117|NCT02482870|3493553|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
1427118|NCT02482870|3493554|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
1427119|NCT02482870|3493553|P2|COMPLETED|Period 2 - Rest of the Study||202
1427120|NCT02482870|3493554|P1|COMPLETED|Period 2 - Rest of the Study||186
1427121|NCT02482870|3493553|P2|STARTED|Period 2 - Rest of the Study||202
1427122|NCT02482870|3493554|P1|STARTED|Period 2 - Rest of the Study||186
1427123|NCT02482870|3493553|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
1427124|NCT02482870|3493554|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
1427125|NCT02482870|3493553|P2|COMPLETED|Period 1 - First 60 Patients||30
1427126|NCT02482870|3493554|P1|COMPLETED|Period 1 - First 60 Patients||30
1427127|NCT02482870|3493553|P2|STARTED|Period 1 - First 60 Patients||30
1427128|NCT02482870|3493554|P1|STARTED|Period 1 - First 60 Patients||30
1427129|NCT02482805|3493571|P3|NOT COMPLETED|Overall Study||0
1427130|NCT02482805|3493572|P2|NOT COMPLETED|Overall Study||4
1427131|NCT02482805|3493573|P1|NOT COMPLETED|Overall Study||4
1427132|NCT02482805|3493571|P3|COMPLETED|Overall Study||20
1427133|NCT02482805|3493572|P2|COMPLETED|Overall Study||23
1427134|NCT02482805|3493573|P1|COMPLETED|Overall Study||22
1427135|NCT02482805|3493571|P3|STARTED|Overall Study||20
1427136|NCT02482805|3493572|P2|STARTED|Overall Study||27
1427137|NCT02482805|3493573|P1|STARTED|Overall Study||26
1427138|NCT02482571|3493587|P1|NOT COMPLETED|Overall Study||8
1427139|NCT02482571|3493587|P1|COMPLETED|Overall Study||17
1427140|NCT02482571|3493587|P1|STARTED|Overall Study||25
1427141|NCT02482428|3493599|P5|NOT COMPLETED|Overall Study||7
1427142|NCT02482428|3493600|P4|NOT COMPLETED|Overall Study||2
1427143|NCT02482428|3493601|P3|NOT COMPLETED|Overall Study||1
1427144|NCT02482428|3493602|P2|NOT COMPLETED|Overall Study||12
1427145|NCT02482428|3493603|P1|NOT COMPLETED|Overall Study||9
1427146|NCT02482428|3493599|P5|COMPLETED|Overall Study||15
1427147|NCT02482428|3493600|P4|COMPLETED|Overall Study||8
1427148|NCT02482428|3493601|P3|COMPLETED|Overall Study||9
1427149|NCT02482428|3493602|P2|COMPLETED|Overall Study||10
1427150|NCT02482428|3493603|P1|COMPLETED|Overall Study||15
1427151|NCT02482428|3493599|P5|STARTED|Overall Study||22
1427152|NCT02482428|3493600|P4|STARTED|Overall Study||10
1427153|NCT02482428|3493601|P3|STARTED|Overall Study||10
1427154|NCT02482428|3493602|P2|STARTED|Overall Study||22
1427155|NCT02482428|3493603|P1|STARTED|Overall Study||24
1427156|NCT02482298|3493626|P3|NOT COMPLETED|Overall Study||3
1427157|NCT02482298|3493627|P2|NOT COMPLETED|Overall Study||3
1427158|NCT02482298|3493628|P1|NOT COMPLETED|Overall Study||2
1427159|NCT02482298|3493626|P3|COMPLETED|Overall Study||27
1427160|NCT02482298|3493627|P2|COMPLETED|Overall Study||24
1427161|NCT02482298|3493628|P1|COMPLETED|Overall Study||28
1427162|NCT02482298|3493626|P3|STARTED|Overall Study||30
1427163|NCT02482298|3493627|P2|STARTED|Overall Study||27
1427164|NCT02482298|3493628|P1|STARTED|Overall Study||30
1427165|NCT02482129|3493650|P2|NOT COMPLETED|Overall Study||2
1427166|NCT02482129|3493651|P1|NOT COMPLETED|Overall Study||6
1427167|NCT02482129|3493650|P2|COMPLETED|Overall Study||9
1427168|NCT02482129|3493651|P1|COMPLETED|Overall Study||26
1427169|NCT02482129|3493650|P2|Treated, as Randomized|Overall Study||9
1427170|NCT02482129|3493651|P1|Treated, as Randomized|Overall Study||30
1427171|NCT02482129|3493650|P2|STARTED|Overall Study||11
1427172|NCT02482129|3493651|P1|STARTED|Overall Study||32
1427173|NCT02481934|3493678|P1|NOT COMPLETED|Overall Study||2
1427174|NCT02481934|3493678|P1|COMPLETED|Overall Study||3
1427175|NCT02481934|3493678|P1|STARTED|Overall Study||5
1427176|NCT02481375|3493687|P4|NOT COMPLETED|Overall Study||14
1427177|NCT02481375|3493688|P3|NOT COMPLETED|Overall Study||10
1427178|NCT02481375|3493689|P2|NOT COMPLETED|Overall Study||11
1427179|NCT02481375|3493690|P1|NOT COMPLETED|Overall Study||14
1427180|NCT02481375|3493687|P4|COMPLETED|Overall Study||186
1427181|NCT02481375|3493688|P3|COMPLETED|Overall Study||191
1427182|NCT02481375|3493689|P2|COMPLETED|Overall Study||191
1427183|NCT02481375|3493690|P1|COMPLETED|Overall Study||192
1427184|NCT02481375|3493687|P4|STARTED|Overall Study||200
1427185|NCT02481375|3493688|P3|STARTED|Overall Study||201
1427186|NCT02481375|3493689|P2|STARTED|Overall Study||202
1427187|NCT02481375|3493690|P1|STARTED|Overall Study||206
1427188|NCT02481219|3493702|P2|NOT COMPLETED|Overall Study||1
1427189|NCT02481219|3493703|P1|NOT COMPLETED|Overall Study||2
1427190|NCT02481219|3493702|P2|COMPLETED|Overall Study||61
1427191|NCT02481219|3493703|P1|COMPLETED|Overall Study||58
1427192|NCT02481219|3493702|P2|STARTED|Overall Study||62
1427193|NCT02481219|3493703|P1|STARTED|Overall Study||60
1427194|NCT02481141|3493721|P2|NOT COMPLETED|Overall Study||5
1427195|NCT02481141|3493722|P1|NOT COMPLETED|Overall Study||9
1427196|NCT02481141|3493721|P2|COMPLETED|Overall Study||13
1427197|NCT02481141|3493722|P1|COMPLETED|Overall Study||26
1427198|NCT02481141|3493721|P2|STARTED|Overall Study||18
1427199|NCT02481141|3493722|P1|STARTED|Overall Study||35
1427200|NCT02481050|3493774|P1|NOT COMPLETED|Overall Study||58
1427201|NCT02481050|3493774|P1|COMPLETED|Overall Study||0
1427202|NCT02481050|3493774|P1|STARTED|Overall Study||58
1427203|NCT02480998|3493785|P2|NOT COMPLETED|Overall Study||0
1427204|NCT02480998|3493786|P1|NOT COMPLETED|Overall Study||0
1427205|NCT02480998|3493785|P2|COMPLETED|Overall Study||28
1427206|NCT02480998|3493786|P1|COMPLETED|Overall Study||56
1427207|NCT02480998|3493785|P2|STARTED|Overall Study||28
1427208|NCT02480998|3493786|P1|STARTED|Overall Study||56
1427209|NCT02480712|3493794|P1|NOT COMPLETED|Overall Study||11
1427210|NCT02480712|3493794|P1|COMPLETED|Overall Study||96
1427211|NCT02480712|3493794|P1|STARTED|Overall Study||107
1427212|NCT02480621|3493813|P2|NOT COMPLETED|Follow Up||2
1427213|NCT02480621|3493814|P1|NOT COMPLETED|Follow Up||4
1427214|NCT02480621|3493813|P2|COMPLETED|Follow Up||37
1427215|NCT02480621|3493814|P1|COMPLETED|Follow Up||39
1427216|NCT02480621|3493813|P2|STARTED|Follow Up||39
1427217|NCT02480621|3493814|P1|STARTED|Follow Up||43
1427218|NCT02480621|3493813|P2|NOT COMPLETED|Randomization||1
1427219|NCT02480621|3493814|P1|NOT COMPLETED|Randomization||1
1427220|NCT02480621|3493813|P2|COMPLETED|Randomization||39
1427221|NCT02480621|3493814|P1|COMPLETED|Randomization||43
1427222|NCT02480621|3493813|P2|STARTED|Randomization||40
1427223|NCT02480621|3493814|P1|STARTED|Randomization||44
1427224|NCT02480582|3493820|P6|NOT COMPLETED|Overall Study||0
1427225|NCT02480582|3493821|P5|NOT COMPLETED|Overall Study||0
1427226|NCT02480582|3493822|P4|NOT COMPLETED|Overall Study||0
1427227|NCT02480582|3493823|P3|NOT COMPLETED|Overall Study||0
1427228|NCT02480582|3493824|P2|NOT COMPLETED|Overall Study||0
1427229|NCT02480582|3493825|P1|NOT COMPLETED|Overall Study||0
1427230|NCT02480582|3493820|P6|COMPLETED|Overall Study||7
1427231|NCT02480582|3493821|P5|COMPLETED|Overall Study||7
1427232|NCT02480582|3493822|P4|COMPLETED|Overall Study||7
1427233|NCT02480582|3493823|P3|COMPLETED|Overall Study||7
1427234|NCT02480582|3493824|P2|COMPLETED|Overall Study||7
1427235|NCT02480582|3493825|P1|COMPLETED|Overall Study||7
1427236|NCT02480582|3493820|P6|STARTED|Overall Study||7
1427237|NCT02480582|3493821|P5|STARTED|Overall Study||7
1427238|NCT02480582|3493822|P4|STARTED|Overall Study||7
1427239|NCT02480582|3493823|P3|STARTED|Overall Study||7
1427240|NCT02480582|3493824|P2|STARTED|Overall Study||7
1427241|NCT02480582|3493825|P1|STARTED|Overall Study||7
1427242|NCT02480439|3493848|P3|NOT COMPLETED|Treatment Period 3||0
1427243|NCT02480439|3493849|P2|NOT COMPLETED|Treatment Period 3||0
1427244|NCT02480439|3493850|P1|NOT COMPLETED|Treatment Period 3||0
1427245|NCT02480439|3493848|P3|COMPLETED|Treatment Period 3||7
1427246|NCT02480439|3493849|P2|COMPLETED|Treatment Period 3||7
1427247|NCT02480439|3493850|P1|COMPLETED|Treatment Period 3||8
1427248|NCT02480439|3493848|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
1427249|NCT02480439|3493849|P2|STARTED|Treatment Period 3||7
1427250|NCT02480439|3493850|P1|STARTED|Treatment Period 3||8
1427251|NCT02480439|3493848|P3|NOT COMPLETED|Treatment Period 2||0
1427252|NCT02480439|3493849|P2|NOT COMPLETED|Treatment Period 2||0
1427253|NCT02480439|3493850|P1|NOT COMPLETED|Treatment Period 2||0
1427254|NCT02480439|3493848|P3|COMPLETED|Treatment Period 2||8
1427255|NCT02480439|3493849|P2|COMPLETED|Treatment Period 2||7
1427256|NCT02480439|3493850|P1|COMPLETED|Treatment Period 2||8
1427257|NCT02480439|3493848|P3|STARTED|Treatment Period 2||8
1427258|NCT02480439|3493849|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
1427259|NCT02480439|3493850|P1|STARTED|Treatment Period 2||8
1427260|NCT02480439|3493848|P3|NOT COMPLETED|Treatment Period 1||0
1427261|NCT02480439|3493849|P2|NOT COMPLETED|Treatment Period 1||0
1427262|NCT02480439|3493850|P1|NOT COMPLETED|Treatment Period 1||0
1427263|NCT02480439|3493848|P3|COMPLETED|Treatment Period 1||8
1427264|NCT02480439|3493849|P2|COMPLETED|Treatment Period 1||8
1427265|NCT02480439|3493850|P1|COMPLETED|Treatment Period 1||8
1427266|NCT02480439|3493848|P3|STARTED|Treatment Period 1||8
1427267|NCT02480439|3493849|P2|STARTED|Treatment Period 1||8
1427268|NCT02480439|3493850|P1|STARTED|Treatment Period 1||8
1427269|NCT02480166|3493876|P3|NOT COMPLETED|Overall Study||0
1427270|NCT02480166|3493877|P2|NOT COMPLETED|Overall Study||0
1427271|NCT02480166|3493878|P1|NOT COMPLETED|Overall Study||0
1427272|NCT02480166|3493876|P3|COMPLETED|Overall Study||4
1427273|NCT02480166|3493877|P2|COMPLETED|Overall Study||36
1427274|NCT02480166|3493878|P1|COMPLETED|Overall Study||20
1427275|NCT02480166|3493876|P3|STARTED|Overall Study||4
1427276|NCT02480166|3493877|P2|STARTED|Overall Study||36
1427277|NCT02480166|3493878|P1|STARTED|Overall Study||20
1427278|NCT02480153|3493891|P2|NOT COMPLETED|Overall Study||27
1427279|NCT02480153|3493892|P1|NOT COMPLETED|Overall Study||11
1427280|NCT02480153|3493891|P2|COMPLETED|Overall Study||273
1427281|NCT02480153|3493892|P1|COMPLETED|Overall Study||286
1427282|NCT02480153|3493891|P2|Received Treatment|Overall Study||299
1427283|NCT02480153|3493892|P1|Received Treatment|Overall Study||297
1427284|NCT02480153|3493891|P2|STARTED|Overall Study||300
1427285|NCT02480153|3493892|P1|STARTED|Overall Study||297
1427286|NCT02480010|3493900|P2|NOT COMPLETED|Overall Study||33
1427287|NCT02480010|3493901|P1|NOT COMPLETED|Overall Study||35
1427288|NCT02480010|3493900|P2|COMPLETED|Overall Study||0
1427289|NCT02480010|3493901|P1|COMPLETED|Overall Study||0
1427290|NCT02480010|3493900|P2|STARTED|Overall Study||33
1427291|NCT02480010|3493901|P1|STARTED|Overall Study||35
1427292|NCT02479763|3493947|P2|NOT COMPLETED|Overall Study||3
1427293|NCT02479763|3493948|P1|NOT COMPLETED|Overall Study||3
1427294|NCT02479763|3493947|P2|COMPLETED|Overall Study||50
1427295|NCT02479763|3493948|P1|COMPLETED|Overall Study||50
1427296|NCT02479763|3493947|P2|STARTED|Overall Study||53
1427297|NCT02479763|3493948|P1|STARTED|Overall Study||53
1427298|NCT02479412|3493963|P9|NOT COMPLETED|Overall Study||1
1427299|NCT02479412|3493964|P8|NOT COMPLETED|Overall Study||1
1427300|NCT02479412|3493965|P7|NOT COMPLETED|Overall Study||0
1427301|NCT02479412|3493966|P6|NOT COMPLETED|Overall Study||0
1427302|NCT02479412|3493967|P5|NOT COMPLETED|Overall Study||1
1427303|NCT02479412|3493968|P4|NOT COMPLETED|Overall Study||1
1427304|NCT02479412|3493969|P3|NOT COMPLETED|Overall Study||2
1427305|NCT02479412|3493970|P2|NOT COMPLETED|Overall Study||0
1427306|NCT02479412|3493971|P1|NOT COMPLETED|Overall Study||0
1427307|NCT02479412|3493963|P9|COMPLETED|Overall Study||6
1427308|NCT02479412|3493964|P8|COMPLETED|Overall Study||4
1427309|NCT02479412|3493965|P7|COMPLETED|Overall Study||6
1427310|NCT02479412|3493966|P6|COMPLETED|Overall Study||5
1427311|NCT02479412|3493967|P5|COMPLETED|Overall Study||5
1427312|NCT02479412|3493968|P4|COMPLETED|Overall Study||6
1427313|NCT02479412|3493969|P3|COMPLETED|Overall Study||4
1427314|NCT02479412|3493970|P2|COMPLETED|Overall Study||6
1427315|NCT02479412|3493971|P1|COMPLETED|Overall Study||6
1427316|NCT02479412|3493963|P9|STARTED|Overall Study||7
1427317|NCT02479412|3493964|P8|STARTED|Overall Study||5
1427318|NCT02479412|3493965|P7|STARTED|Overall Study||6
1427319|NCT02479412|3493966|P6|STARTED|Overall Study||5
1427320|NCT02479412|3493967|P5|STARTED|Overall Study||6
1427321|NCT02479412|3493968|P4|STARTED|Overall Study||7
1427322|NCT02479412|3493969|P3|STARTED|Overall Study||6
1427323|NCT02479412|3493970|P2|STARTED|Overall Study||6
1427324|NCT02479412|3493971|P1|STARTED|Overall Study||6
1427325|NCT02479139|3494048|P6|NOT COMPLETED|Overall Study||6
1427326|NCT02479139|3494049|P5|NOT COMPLETED|Overall Study||5
1427327|NCT02479139|3494050|P4|NOT COMPLETED|Overall Study||7
1427328|NCT02479139|3494051|P3|NOT COMPLETED|Overall Study||7
1427329|NCT02479139|3494052|P2|NOT COMPLETED|Overall Study||10
1427330|NCT02479139|3494053|P1|NOT COMPLETED|Overall Study||8
1427331|NCT02479139|3494048|P6|COMPLETED|Overall Study||19
1427332|NCT02479139|3494049|P5|COMPLETED|Overall Study||17
1427333|NCT02479139|3494050|P4|COMPLETED|Overall Study||14
1427334|NCT02479139|3494051|P3|COMPLETED|Overall Study||21
1427335|NCT02479139|3494052|P2|COMPLETED|Overall Study||12
1427336|NCT02479139|3494053|P1|COMPLETED|Overall Study||19
1427337|NCT02479139|3494048|P6|STARTED|Overall Study||25
1427338|NCT02479139|3494049|P5|STARTED|Overall Study||22
1427339|NCT02479139|3494050|P4|STARTED|Overall Study||21
1427340|NCT02479139|3494051|P3|STARTED|Overall Study||28
1427341|NCT02479139|3494052|P2|STARTED|Overall Study||22
1427342|NCT02479139|3494053|P1|STARTED|Overall Study||27
1427343|NCT02478671|3494079|P1|NOT COMPLETED|Overall Study||0
1427344|NCT02478671|3494079|P1|COMPLETED|Overall Study||4
1427345|NCT02478671|3494079|P1|STARTED|Overall Study||4
1427346|NCT02478632|3494086|P2|NOT COMPLETED|Overall Study||5
1427347|NCT02478632|3494087|P1|NOT COMPLETED|Overall Study||4
1427348|NCT02478632|3494086|P2|COMPLETED|Overall Study||44
1427349|NCT02478632|3494087|P1|COMPLETED|Overall Study||49
1427350|NCT02478632|3494086|P2|STARTED|Overall Study||49
1427351|NCT02478632|3494087|P1|STARTED|Overall Study||53
1427352|NCT02478580|3494103|P2|NOT COMPLETED|Overall Study||0
1427353|NCT02478580|3494104|P1|NOT COMPLETED|Overall Study||0
1427354|NCT02478580|3494103|P2|COMPLETED|Overall Study||33
1427355|NCT02478580|3494104|P1|COMPLETED|Overall Study||34
1427356|NCT02478580|3494103|P2|STARTED|Overall Study||33
1427357|NCT02478580|3494104|P1|STARTED|Overall Study||34
1427358|NCT02478372|3494114|P2|NOT COMPLETED|Overall Study||14
1427359|NCT02478372|3494115|P1|NOT COMPLETED|Overall Study||13
1427360|NCT02478372|3494114|P2|COMPLETED|Overall Study||107
1427361|NCT02478372|3494115|P1|COMPLETED|Overall Study||108
1427362|NCT02478372|3494114|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
1427363|NCT02478372|3494115|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
1427364|NCT02478372|3494114|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
1427365|NCT02478372|3494115|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
1427366|NCT02478372|3494114|P2|Recieved Allocation Intervention|Overall Study||113
1427367|NCT02478372|3494115|P1|Recieved Allocation Intervention|Overall Study||109
1427368|NCT02478372|3494114|P2|STARTED|Overall Study||121
1427369|NCT02478372|3494115|P1|STARTED|Overall Study||121
1427370|NCT02478164|3494137|P1|NOT COMPLETED|Overall Study||15
1427371|NCT02478164|3494137|P1|COMPLETED|Overall Study||0
1427372|NCT02478164|3494137|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
1427373|NCT02477709|3494144|P1|NOT COMPLETED|Overall Study||0
1427374|NCT02477709|3494144|P1|COMPLETED|Overall Study||6
1427375|NCT02477709|3494144|P1|STARTED|Overall Study||6
1427376|NCT02477605|3494150|P2|NOT COMPLETED|Overall Study||4
1427377|NCT02477605|3494151|P1|NOT COMPLETED|Overall Study||1
1427378|NCT02477605|3494150|P2|COMPLETED|Overall Study||64
1427379|NCT02477605|3494151|P1|COMPLETED|Overall Study||67
1427380|NCT02477605|3494150|P2|Randomized and Treated|Overall Study||68
1427381|NCT02477605|3494151|P1|Randomized and Treated|Overall Study||67
1427382|NCT02477605|3494150|P2|STARTED|Overall Study||68
1427383|NCT02477605|3494151|P1|STARTED|Overall Study||68
1427384|NCT02477527|3494165|P1|NOT COMPLETED|Overall Study||6
1427385|NCT02477527|3494165|P1|COMPLETED|Overall Study||21
1427386|NCT02477527|3494165|P1|STARTED|Overall Study||27
1427387|NCT02477332|3494179|P6|NOT COMPLETED|Overall Study||5
1427388|NCT02477332|3494180|P5|NOT COMPLETED|Overall Study||4
1427389|NCT02477332|3494181|P4|NOT COMPLETED|Overall Study||13
1427390|NCT02477332|3494182|P3|NOT COMPLETED|Overall Study||12
1427391|NCT02477332|3494183|P2|NOT COMPLETED|Overall Study||7
1427392|NCT02477332|3494184|P1|NOT COMPLETED|Overall Study||3
1427393|NCT02477332|3494179|P6|COMPLETED|Overall Study||37
1427394|NCT02477332|3494180|P5|COMPLETED|Overall Study||39
1427395|NCT02477332|3494181|P4|COMPLETED|Overall Study||72
1427396|NCT02477332|3494182|P3|COMPLETED|Overall Study||73
1427397|NCT02477332|3494183|P2|COMPLETED|Overall Study||77
1427398|NCT02477332|3494184|P1|COMPLETED|Overall Study||40
1427399|NCT02477332|3494179|P6|STARTED|Overall Study||42
1427400|NCT02477332|3494180|P5|STARTED|Overall Study||43
1427401|NCT02477332|3494181|P4|STARTED|Overall Study||85
1427402|NCT02477332|3494182|P3|STARTED|Overall Study||85
1427403|NCT02477332|3494183|P2|STARTED|Overall Study||84
1427404|NCT02477332|3494184|P1|STARTED|Overall Study||43
1427405|NCT02477020|3494260|P2|NOT COMPLETED|Overall Study||28
1427406|NCT02477020|3494261|P1|NOT COMPLETED|Overall Study||30
1427407|NCT02477020|3494260|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
1427408|NCT02477020|3494261|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
1427409|NCT02477020|3494260|P2|STARTED|Overall Study||83
1427410|NCT02477020|3494261|P1|STARTED|Overall Study||81
1427411|NCT02476994|3494291|P2|NOT COMPLETED|Overall Study||0
1427412|NCT02476994|3494292|P1|NOT COMPLETED|Overall Study||1
1427413|NCT02476994|3494291|P2|COMPLETED|Overall Study||0
1427414|NCT02476994|3494292|P1|COMPLETED|Overall Study||0
1427415|NCT02476994|3494291|P2|STARTED|Overall Study||0
1427416|NCT02476994|3494292|P1|STARTED|Overall Study||1
1427417|NCT02476890|3494322|P4|NOT COMPLETED|Overall Study||0
1427418|NCT02476890|3494323|P3|NOT COMPLETED|Overall Study||0
1427419|NCT02476890|3494324|P2|NOT COMPLETED|Overall Study||0
1427420|NCT02476890|3494325|P1|NOT COMPLETED|Overall Study||0
1427421|NCT02476890|3494322|P4|COMPLETED|Overall Study||12
1427422|NCT02476890|3494323|P3|COMPLETED|Overall Study||12
1427423|NCT02476890|3494324|P2|COMPLETED|Overall Study||6
1427424|NCT02476890|3494325|P1|COMPLETED|Overall Study||6
1427425|NCT02476890|3494322|P4|Washout|Overall Study||12
1427426|NCT02476890|3494323|P3|Washout|Overall Study||12
1427427|NCT02476890|3494324|P2|Washout|Overall Study||6
1427428|NCT02476890|3494325|P1|Washout|Overall Study||6
1427429|NCT02476890|3494322|P4|STARTED|Overall Study|Crossover study|12
1427430|NCT02476890|3494323|P3|STARTED|Overall Study|Crossover study|12
1427431|NCT02476890|3494324|P2|STARTED|Overall Study|Crossover study|6
1427432|NCT02476890|3494325|P1|STARTED|Overall Study|Crossover study|6
1427433|NCT02476617|3494361|P1|NOT COMPLETED|Overall Study||2
1427434|NCT02476617|3494361|P1|COMPLETED|Overall Study||23
1427435|NCT02476617|3494361|P1|STARTED|Overall Study||25
1427436|NCT02476565|3494367|P2|NOT COMPLETED|Overall Study||0
1427437|NCT02476565|3494368|P1|NOT COMPLETED|Overall Study||0
1427438|NCT02476565|3494367|P2|COMPLETED|Overall Study||19
1427439|NCT02476565|3494368|P1|COMPLETED|Overall Study||20
1427440|NCT02476565|3494367|P2|STARTED|Overall Study||19
1427441|NCT02476565|3494368|P1|STARTED|Overall Study||20
1427442|NCT02476422|3494390|P2|NOT COMPLETED|Overall Study||1
1427443|NCT02476422|3494391|P1|NOT COMPLETED|Overall Study||0
1427444|NCT02476422|3494390|P2|COMPLETED|Overall Study||161
1427445|NCT02476422|3494391|P1|COMPLETED|Overall Study||166
1427446|NCT02476422|3494390|P2|STARTED|Overall Study||162
1427447|NCT02476422|3494391|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
1427448|NCT02476175|3494421|P1|NOT COMPLETED|Overall Study||2
1427449|NCT02476175|3494421|P1|COMPLETED|Overall Study||33
1427450|NCT02476175|3494421|P1|STARTED|Overall Study||35
1427451|NCT02476032|3494432|P3|NOT COMPLETED|Overall Study||1
1427452|NCT02476032|3494433|P2|NOT COMPLETED|Overall Study||1
1427453|NCT02476032|3494434|P1|NOT COMPLETED|Overall Study||0
1427454|NCT02476032|3494432|P3|COMPLETED|Overall Study||19
1427455|NCT02476032|3494433|P2|COMPLETED|Overall Study||19
1427456|NCT02476032|3494434|P1|COMPLETED|Overall Study||20
1427457|NCT02476032|3494432|P3|STARTED|Overall Study||20
1427458|NCT02476032|3494433|P2|STARTED|Overall Study||20
1427459|NCT02476032|3494434|P1|STARTED|Overall Study||20
1427460|NCT02475980|3494445|P1|NOT COMPLETED|Overall Study||5
1427461|NCT02475980|3494445|P1|COMPLETED|Overall Study||8
1427462|NCT02475980|3494445|P1|STARTED|Overall Study||13
1427463|NCT02475733|3494456|P2|NOT COMPLETED|Overall Study||0
1427464|NCT02475733|3494457|P1|NOT COMPLETED|Overall Study||2
1427465|NCT02475733|3494456|P2|COMPLETED|Overall Study||22
1427466|NCT02475733|3494457|P1|COMPLETED|Overall Study||59
1427467|NCT02475733|3494456|P2|STARTED|Overall Study||22
1427468|NCT02475733|3494457|P1|STARTED|Overall Study||61
1427469|NCT02475564|3494514|P2|NOT COMPLETED|Overall Study||1
1427470|NCT02475564|3494515|P1|NOT COMPLETED|Overall Study||4
1427471|NCT02475564|3494514|P2|COMPLETED|Overall Study||21
1427472|NCT02475564|3494515|P1|COMPLETED|Overall Study||18
1427473|NCT02475564|3494514|P2|STARTED|Overall Study||22
1427474|NCT02475564|3494515|P1|STARTED|Overall Study||22
1427475|NCT02475395|3494527|P2|NOT COMPLETED|Overall Study||3
1427476|NCT02475395|3494528|P1|NOT COMPLETED|Overall Study||30
1427477|NCT02475395|3494527|P2|COMPLETED|Overall Study||11
1427478|NCT02475395|3494528|P1|COMPLETED|Overall Study||228
1427479|NCT02475395|3494527|P2|STARTED|Overall Study||14
1427480|NCT02475395|3494528|P1|STARTED|Overall Study||258
1427481|NCT02475278|3494538|P1|NOT COMPLETED|Overall Study||2
1427482|NCT02475278|3494538|P1|COMPLETED|Overall Study||48
1427483|NCT02475278|3494538|P1|STARTED|Overall Study||50
1427484|NCT02475031|3494551|P2|NOT COMPLETED|Overall Study||0
1427485|NCT02475031|3494552|P1|NOT COMPLETED|Overall Study||0
1427486|NCT02475031|3494551|P2|COMPLETED|Overall Study||35
1427487|NCT02475031|3494552|P1|COMPLETED|Overall Study||35
1427488|NCT02475031|3494551|P2|STARTED|Overall Study||35
1427489|NCT02475031|3494552|P1|STARTED|Overall Study||35
1427490|NCT02474901|3494568|P2|NOT COMPLETED|Overall Study||0
1427491|NCT02474901|3494569|P1|NOT COMPLETED|Overall Study||1
1427492|NCT02474901|3494568|P2|COMPLETED|Overall Study||56
1427493|NCT02474901|3494569|P1|COMPLETED|Overall Study||44
1427494|NCT02474901|3494568|P2|STARTED|Overall Study||56
1427495|NCT02474901|3494569|P1|STARTED|Overall Study||45
1427496|NCT02474589|3494585|P2|NOT COMPLETED|Overall Study||5
1427497|NCT02474589|3494586|P1|NOT COMPLETED|Overall Study||25
1427498|NCT02474589|3494585|P2|COMPLETED|Overall Study||85
1427499|NCT02474589|3494586|P1|COMPLETED|Overall Study||334
1427500|NCT02474589|3494585|P2|STARTED|Overall Study||90
1427501|NCT02474589|3494586|P1|STARTED|Overall Study||359
1427502|NCT02474498|3494595|P3|NOT COMPLETED|Overall Study||0
1427503|NCT02474498|3494596|P2|NOT COMPLETED|Overall Study||0
1427504|NCT02474498|3494597|P1|NOT COMPLETED|Overall Study||0
1427505|NCT02474498|3494595|P3|COMPLETED|Overall Study||14
1427506|NCT02474498|3494596|P2|COMPLETED|Overall Study||14
1427507|NCT02474498|3494597|P1|COMPLETED|Overall Study||13
1427508|NCT02474498|3494595|P3|STARTED|Overall Study||14
1427509|NCT02474498|3494596|P2|STARTED|Overall Study||14
1427510|NCT02474498|3494597|P1|STARTED|Overall Study||13
1427511|NCT02474407|3494614|P2|NOT COMPLETED|Second Intervention (14 Days)||0
1427512|NCT02474407|3494615|P1|NOT COMPLETED|Second Intervention (14 Days)||0
1427513|NCT02474407|3494614|P2|COMPLETED|Second Intervention (14 Days)||39
1427514|NCT02474407|3494615|P1|COMPLETED|Second Intervention (14 Days)||39
1427515|NCT02474407|3494614|P2|STARTED|Second Intervention (14 Days)||39
1427516|NCT02474407|3494615|P1|STARTED|Second Intervention (14 Days)||39
1427517|NCT02474407|3494614|P2|NOT COMPLETED|Washout (14 Days)||0
1427518|NCT02474407|3494615|P1|NOT COMPLETED|Washout (14 Days)||0
1427519|NCT02474407|3494614|P2|COMPLETED|Washout (14 Days)||39
1427520|NCT02474407|3494615|P1|COMPLETED|Washout (14 Days)||39
1427521|NCT02474407|3494614|P2|STARTED|Washout (14 Days)||39
1427522|NCT02474407|3494615|P1|STARTED|Washout (14 Days)||39
1427523|NCT02474407|3494614|P2|NOT COMPLETED|First Intervention (14 Days)||0
1427524|NCT02474407|3494615|P1|NOT COMPLETED|First Intervention (14 Days)||0
1427525|NCT02474407|3494614|P2|COMPLETED|First Intervention (14 Days)||39
1427526|NCT02474407|3494615|P1|COMPLETED|First Intervention (14 Days)||39
1427527|NCT02474407|3494614|P2|STARTED|First Intervention (14 Days)||39
1427528|NCT02474407|3494615|P1|STARTED|First Intervention (14 Days)||39
1427529|NCT02474082|3494645|P2|NOT COMPLETED|Overall Study||54
1427530|NCT02474082|3494646|P1|NOT COMPLETED|Overall Study||6
1427531|NCT02474082|3494645|P2|COMPLETED|Overall Study||43
1427532|NCT02474082|3494646|P1|COMPLETED|Overall Study||99
1427533|NCT02474082|3494645|P2|Full Analysis Set (FAS)|Overall Study||95
1427534|NCT02474082|3494646|P1|Full Analysis Set (FAS)|Overall Study||105
1427535|NCT02474082|3494645|P2|STARTED|Overall Study||97
1427536|NCT02474082|3494646|P1|STARTED|Overall Study||105
1427537|NCT02473991|3494680|P1|NOT COMPLETED|Overall Study||0
1427538|NCT02473991|3494680|P1|COMPLETED|Overall Study||395
1427539|NCT02473991|3494680|P1|STARTED|Overall Study||395
1427540|NCT02473783|3494688|P2|NOT COMPLETED|Overall Study||0
1427541|NCT02473783|3494689|P1|NOT COMPLETED|Overall Study||0
1427542|NCT02473783|3494688|P2|COMPLETED|Overall Study||17
1427543|NCT02473783|3494689|P1|COMPLETED|Overall Study||20
1427544|NCT02473783|3494688|P2|STARTED|Overall Study||17
1427545|NCT02473783|3494689|P1|STARTED|Overall Study||20
1427546|NCT02473718|3494699|P2|NOT COMPLETED|Overall Study||0
1427547|NCT02473718|3494700|P1|NOT COMPLETED|Overall Study||0
1427548|NCT02473718|3494699|P2|COMPLETED|Overall Study||41
1427549|NCT02473718|3494700|P1|COMPLETED|Overall Study||41
1427550|NCT02473718|3494699|P2|STARTED|Overall Study||41
1427551|NCT02473718|3494700|P1|STARTED|Overall Study||41
1427552|NCT02473640|3494720|P1|NOT COMPLETED|Treatment Period 2||0
1427553|NCT02473640|3494720|P1|COMPLETED|Treatment Period 2||14
1427554|NCT02473640|3494720|P1|STARTED|Treatment Period 2||14
1427555|NCT02473640|3494720|P1|NOT COMPLETED|Run-in Phase||0
1427556|NCT02473640|3494720|P1|COMPLETED|Run-in Phase||14
1427557|NCT02473640|3494720|P1|STARTED|Run-in Phase||14
1427558|NCT02473640|3494720|P1|NOT COMPLETED|Treatment Period 1||1
1427559|NCT02473640|3494720|P1|COMPLETED|Treatment Period 1||14
1427560|NCT02473640|3494720|P1|STARTED|Treatment Period 1||15
1427561|NCT02473523|3494729|P1|NOT COMPLETED|Overall Study||2
1427562|NCT02473523|3494729|P1|COMPLETED|Overall Study||0
1427563|NCT02473523|3494729|P1|STARTED|Overall Study||2
1427564|NCT02473510|3494750|P2|NOT COMPLETED|Overall Study||2
1427565|NCT02473510|3494751|P1|NOT COMPLETED|Overall Study||1
1427566|NCT02473510|3494750|P2|COMPLETED|Overall Study||238
1427567|NCT02473510|3494751|P1|COMPLETED|Overall Study||59
1427568|NCT02473510|3494750|P2|STARTED|Overall Study||240
1427569|NCT02473510|3494751|P1|STARTED|Overall Study||60
1427570|NCT02473471|3494765|P1|NOT COMPLETED|Overall Study||3
1427571|NCT02473471|3494765|P1|COMPLETED|Overall Study||32
1427572|NCT02473471|3494765|P1|Randomized Not Treated|Overall Study||2
1427573|NCT02473471|3494765|P1|Received Allocated Intervention|Overall Study||33
1427574|NCT02473471|3494765|P1|STARTED|Overall Study||35
1427575|NCT02473445|3494796|P1|NOT COMPLETED|Overall Study||22
1427576|NCT02473445|3494796|P1|COMPLETED|Overall Study||0
1427577|NCT02473445|3494796|P1|STARTED|Overall Study||22
1427578|NCT02473367|3494802|P1|NOT COMPLETED|Period 4||1
1427579|NCT02473367|3494802|P1|COMPLETED|Period 4||18
1427580|NCT02473367|3494802|P1|STARTED|Period 4||19
1427581|NCT02473367|3494802|P1|NOT COMPLETED|Wait 3||0
1427582|NCT02473367|3494802|P1|COMPLETED|Wait 3||19
1427583|NCT02473367|3494802|P1|STARTED|Wait 3||19
1427584|NCT02473367|3494802|P1|NOT COMPLETED|Period 3||0
1427585|NCT02473367|3494802|P1|COMPLETED|Period 3||19
1427586|NCT02473367|3494802|P1|STARTED|Period 3||19
1427587|NCT02473367|3494802|P1|NOT COMPLETED|Wait 2||0
1427588|NCT02473367|3494802|P1|COMPLETED|Wait 2||19
1427589|NCT02473367|3494802|P1|STARTED|Wait 2||19
1427590|NCT02473367|3494802|P1|NOT COMPLETED|Period 2||0
1427591|NCT02473367|3494802|P1|COMPLETED|Period 2||19
1427592|NCT02473367|3494802|P1|STARTED|Period 2||19
1427593|NCT02473367|3494802|P1|NOT COMPLETED|Wait 1||1
1427594|NCT02473367|3494802|P1|COMPLETED|Wait 1||19
1427595|NCT02473367|3494802|P1|STARTED|Wait 1||20
1427596|NCT02473367|3494802|P1|NOT COMPLETED|Period 1||0
1427597|NCT02473367|3494802|P1|COMPLETED|Period 1||20
1427598|NCT02473367|3494802|P1|STARTED|Period 1||20
1427599|NCT02472977|3494823|P3|NOT COMPLETED|Overall Study||8
1427600|NCT02472977|3494824|P2|NOT COMPLETED|Overall Study||27
1427601|NCT02472977|3494825|P1|NOT COMPLETED|Overall Study||6
1427602|NCT02472977|3494823|P3|COMPLETED|Overall Study||0
1427603|NCT02472977|3494824|P2|COMPLETED|Overall Study||0
1427604|NCT02472977|3494825|P1|COMPLETED|Overall Study||0
1427605|NCT02472977|3494823|P3|STARTED|Overall Study||8
1427606|NCT02472977|3494824|P2|STARTED|Overall Study||27
1427607|NCT02472977|3494825|P1|STARTED|Overall Study||6
1427608|NCT02472964|3494850|P2|NOT COMPLETED|Part 2 (Week 24-week 48)||63
1427609|NCT02472964|3494851|P1|NOT COMPLETED|Part 2 (Week 24-week 48)||65
1427610|NCT02472964|3494850|P2|COMPLETED|Part 2 (Week 24-week 48)||116
1427611|NCT02472964|3494851|P1|COMPLETED|Part 2 (Week 24-week 48)||98
1427612|NCT02472964|3494850|P2|STARTED|Part 2 (Week 24-week 48)||179
1427613|NCT02472964|3494851|P1|STARTED|Part 2 (Week 24-week 48)||163
1427614|NCT02472964|3494850|P2|NOT COMPLETED|Part 1 (up to Week 24)||62
1427615|NCT02472964|3494851|P1|NOT COMPLETED|Part 1 (up to Week 24)||75
1427616|NCT02472964|3494850|P2|COMPLETED|Part 1 (up to Week 24)||185
1427617|NCT02472964|3494851|P1|COMPLETED|Part 1 (up to Week 24)||171
1427618|NCT02472964|3494850|P2|STARTED|Part 1 (up to Week 24)||247
1427619|NCT02472964|3494851|P1|STARTED|Part 1 (up to Week 24)||246
1427620|NCT02472886|3494860|P3|NOT COMPLETED|Overall Study||1
1427621|NCT02472886|3494861|P2|NOT COMPLETED|Overall Study||2
1427622|NCT02472886|3494862|P1|NOT COMPLETED|Overall Study||0
1427623|NCT02472886|3494860|P3|COMPLETED|Overall Study||26
1427624|NCT02472886|3494861|P2|COMPLETED|Overall Study||57
1427625|NCT02472886|3494862|P1|COMPLETED|Overall Study||67
1427626|NCT02472886|3494860|P3|STARTED|Overall Study||27
1427627|NCT02472886|3494861|P2|STARTED|Overall Study||59
1427628|NCT02472886|3494862|P1|STARTED|Overall Study||67
1427629|NCT02472847|3494890|P2|NOT COMPLETED|Overall Study||5
1427630|NCT02472847|3494891|P1|NOT COMPLETED|Overall Study||1
1427631|NCT02472847|3494890|P2|COMPLETED|Overall Study||21
1427632|NCT02472847|3494891|P1|COMPLETED|Overall Study||23
1427633|NCT02472847|3494890|P2|STARTED|Overall Study||26
1427634|NCT02472847|3494891|P1|STARTED|Overall Study||24
1427635|NCT02472756|3494897|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
1427636|NCT02472756|3494897|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
1427637|NCT02472756|3494897|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
1427638|NCT02472756|3494897|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
1427639|NCT02472756|3494897|P1|COMPLETED|Induction (Approximately 6 Months)||39
1427640|NCT02472756|3494897|P1|Treated|Induction (Approximately 6 Months)||40
1427641|NCT02472756|3494897|P1|STARTED|Induction (Approximately 6 Months)||41
1427642|NCT02472639|3494905|P2|NOT COMPLETED|Overall Study||3
1427643|NCT02472639|3494906|P1|NOT COMPLETED|Overall Study||4
1427644|NCT02472639|3494905|P2|COMPLETED|Overall Study||0
1427645|NCT02472639|3494906|P1|COMPLETED|Overall Study||0
1427646|NCT02472639|3494905|P2|STARTED|Overall Study||3
1427647|NCT02472639|3494906|P1|STARTED|Overall Study||4
1427648|NCT02472522|3494922|P2|NOT COMPLETED|Overall Study||0
1427649|NCT02472522|3494923|P1|NOT COMPLETED|Overall Study||0
1427650|NCT02472522|3494922|P2|COMPLETED|Overall Study||50
1427651|NCT02472522|3494923|P1|COMPLETED|Overall Study||50
1427652|NCT02472522|3494922|P2|STARTED|Overall Study||50
1427653|NCT02472522|3494923|P1|STARTED|Overall Study||50
1427654|NCT02472405|3494953|P1|NOT COMPLETED|Overall Study||10
1427655|NCT02472405|3494953|P1|COMPLETED|Overall Study||8
1427656|NCT02472405|3494953|P1|STARTED|Overall Study||18
1427657|NCT02472366|3494961|P2|NOT COMPLETED|Overall Study||0
1427658|NCT02472366|3494962|P1|NOT COMPLETED|Overall Study||1
1427659|NCT02472366|3494961|P2|COMPLETED|Overall Study||10
1427660|NCT02472366|3494962|P1|COMPLETED|Overall Study||5
1427661|NCT02472366|3494961|P2|STARTED|Overall Study||10
1427662|NCT02472366|3494962|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
1427663|NCT02471755|3494978|P2|NOT COMPLETED|Overall Study||1
1427664|NCT02471755|3494979|P1|NOT COMPLETED|Overall Study||1
1427665|NCT02471755|3494978|P2|COMPLETED|Overall Study||44
1427666|NCT02471755|3494979|P1|COMPLETED|Overall Study||44
1427667|NCT02471755|3494978|P2|STARTED|Overall Study||45
1427668|NCT02471755|3494979|P1|STARTED|Overall Study||45
1427669|NCT02471612|3494995|P1|NOT COMPLETED|Overall Study||2
1427670|NCT02471612|3494995|P1|COMPLETED|Overall Study||157
1427671|NCT02471612|3494995|P1|STARTED|Overall Study||159
1427672|NCT02471326|3495012|P1|NOT COMPLETED|Overall Study||1
1427673|NCT02471326|3495012|P1|COMPLETED|Overall Study||9
1427674|NCT02471326|3495012|P1|STARTED|Overall Study||10
1427675|NCT02471183|3495017|P1|NOT COMPLETED|Extended Treatment Period||1
1427676|NCT02471183|3495017|P1|COMPLETED|Extended Treatment Period||31
1427677|NCT02471183|3495017|P1|STARTED|Extended Treatment Period||32
1427678|NCT02471183|3495017|P1|NOT COMPLETED|Main Treatment Period||2
1427679|NCT02471183|3495017|P1|COMPLETED|Main Treatment Period||32
1427680|NCT02471183|3495017|P1|STARTED|Main Treatment Period||34
1427681|NCT02470949|3495032|P2|NOT COMPLETED|Second Intervention||0
1427682|NCT02470949|3495033|P1|NOT COMPLETED|Second Intervention||0
1427683|NCT02470949|3495032|P2|COMPLETED|Second Intervention||2
1427684|NCT02470949|3495033|P1|COMPLETED|Second Intervention||4
1427685|NCT02470949|3495032|P2|STARTED|Second Intervention||2
1427686|NCT02470949|3495033|P1|STARTED|Second Intervention||4
1427687|NCT02470949|3495032|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
1427688|NCT02470949|3495033|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
1427689|NCT02470949|3495032|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
1427690|NCT02470949|3495033|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
1427691|NCT02470949|3495032|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
1427692|NCT02470949|3495033|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
1427693|NCT02470949|3495032|P2|NOT COMPLETED|First Intervention||0
1427694|NCT02470949|3495033|P1|NOT COMPLETED|First Intervention||0
1427695|NCT02470949|3495032|P2|COMPLETED|First Intervention||5
1427696|NCT02470949|3495033|P1|COMPLETED|First Intervention||4
1427697|NCT02470949|3495032|P2|STARTED|First Intervention||5
1427698|NCT02470949|3495033|P1|STARTED|First Intervention||4
1427699|NCT02470494|3495043|P1|NOT COMPLETED|Overall Study||5
1427700|NCT02470494|3495043|P1|COMPLETED|Overall Study||41
1427701|NCT02470494|3495043|P1|STARTED|Overall Study||46
1427702|NCT02470429|3495053|P2|NOT COMPLETED|Overall Study||0
1427703|NCT02470429|3495054|P1|NOT COMPLETED|Overall Study||2
1427704|NCT02470429|3495053|P2|COMPLETED|Overall Study||49
1427705|NCT02470429|3495054|P1|COMPLETED|Overall Study||48
1427706|NCT02470429|3495053|P2|STARTED|Overall Study||49
1427707|NCT02470429|3495054|P1|STARTED|Overall Study||50
1427708|NCT02470403|3495072|P5|NOT COMPLETED|Overall Study||0
1427709|NCT02470403|3495073|P4|NOT COMPLETED|Overall Study||4
1427710|NCT02470403|3495074|P3|NOT COMPLETED|Overall Study||0
1427711|NCT02470403|3495075|P2|NOT COMPLETED|Overall Study||1
1427712|NCT02470403|3495076|P1|NOT COMPLETED|Overall Study||2
1427713|NCT02470403|3495072|P5|COMPLETED|Overall Study||10
1427714|NCT02470403|3495073|P4|COMPLETED|Overall Study||39
1427715|NCT02470403|3495074|P3|COMPLETED|Overall Study||40
1427716|NCT02470403|3495075|P2|COMPLETED|Overall Study||43
1427717|NCT02470403|3495076|P1|COMPLETED|Overall Study||42
1427718|NCT02470403|3495072|P5|Normoglycemic|Overall Study||5
1427719|NCT02470403|3495073|P4|Normoglycemic|Overall Study||23
1427720|NCT02470403|3495074|P3|Normoglycemic|Overall Study||20
1427721|NCT02470403|3495075|P2|Normoglycemic|Overall Study||20
1427722|NCT02470403|3495076|P1|Normoglycemic|Overall Study||20
1427723|NCT02470403|3495072|P5|Dysglycemic|Overall Study||5
1427724|NCT02470403|3495073|P4|Dysglycemic|Overall Study||20
1427725|NCT02470403|3495074|P3|Dysglycemic|Overall Study||20
1427726|NCT02470403|3495075|P2|Dysglycemic|Overall Study||24
1427727|NCT02470403|3495076|P1|Dysglycemic|Overall Study||24
1427728|NCT02470403|3495072|P5|STARTED|Overall Study||10
1427729|NCT02470403|3495073|P4|STARTED|Overall Study||43
1427730|NCT02470403|3495074|P3|STARTED|Overall Study||40
1427731|NCT02470403|3495075|P2|STARTED|Overall Study||44
1427732|NCT02470403|3495076|P1|STARTED|Overall Study||44
1427733|NCT02470390|3495116|P2|NOT COMPLETED|Overall Study||1
1427734|NCT02470390|3495117|P1|NOT COMPLETED|Overall Study||0
1427735|NCT02470390|3495116|P2|COMPLETED|Overall Study||6
1427736|NCT02470390|3495117|P1|COMPLETED|Overall Study||6
1427737|NCT02470390|3495116|P2|STARTED|Overall Study||7
1427738|NCT02470390|3495117|P1|STARTED|Overall Study||6
1427739|NCT02469961|3495145|P2|NOT COMPLETED|Overall Study||1
1427740|NCT02469961|3495146|P1|NOT COMPLETED|Overall Study||4
1427741|NCT02469961|3495145|P2|COMPLETED|Overall Study||24
1427742|NCT02469961|3495146|P1|COMPLETED|Overall Study||21
1427743|NCT02469961|3495145|P2|STARTED|Overall Study||25
1427744|NCT02469961|3495146|P1|STARTED|Overall Study||25
1427745|NCT02469701|3495158|P1|NOT COMPLETED|Overall Study||0
1427746|NCT02469701|3495158|P1|COMPLETED|Overall Study||10
1427747|NCT02469701|3495158|P1|STARTED|Overall Study||10
1427748|NCT02469597|3495164|P2|NOT COMPLETED|Overall Study||0
1427749|NCT02469597|3495165|P1|NOT COMPLETED|Overall Study||0
1427750|NCT02469597|3495164|P2|COMPLETED|Overall Study||24
1427751|NCT02469597|3495165|P1|COMPLETED|Overall Study||22
1427752|NCT02469597|3495164|P2|STARTED|Overall Study||24
1427753|NCT02469597|3495165|P1|STARTED|Overall Study||22
1427754|NCT02469415|3495181|P1|NOT COMPLETED|Overall Study||3
1427755|NCT02469415|3495181|P1|COMPLETED|Overall Study||0
1427756|NCT02469415|3495181|P1|STARTED|Overall Study||3
1427757|NCT02469298|3495189|P4|NOT COMPLETED|Overall Study||2
1427758|NCT02469298|3495190|P3|NOT COMPLETED|Overall Study||2
1427759|NCT02469298|3495191|P2|NOT COMPLETED|Overall Study||1
1427760|NCT02469298|3495192|P1|NOT COMPLETED|Overall Study||1
1427761|NCT02469298|3495189|P4|COMPLETED|Overall Study||5
1427762|NCT02469298|3495190|P3|COMPLETED|Overall Study||14
1427763|NCT02469298|3495191|P2|COMPLETED|Overall Study||6
1427764|NCT02469298|3495192|P1|COMPLETED|Overall Study||14
1427765|NCT02469298|3495189|P4|STARTED|Overall Study||7
1427766|NCT02469298|3495190|P3|STARTED|Overall Study||16
1427767|NCT02469298|3495191|P2|STARTED|Overall Study||7
1427768|NCT02469298|3495192|P1|STARTED|Overall Study||15
1427769|NCT02469246|3495332|P2|NOT COMPLETED|Overall Study||282
1427770|NCT02469246|3495333|P1|NOT COMPLETED|Overall Study||285
1427771|NCT02469246|3495332|P2|COMPLETED|Overall Study||0
1427772|NCT02469246|3495333|P1|COMPLETED|Overall Study||0
1427773|NCT02469246|3495332|P2|STARTED|Overall Study||282
1427774|NCT02469246|3495333|P1|STARTED|Overall Study||285
1427775|NCT02469168|3495351|P2|NOT COMPLETED|Overall Study||0
1427776|NCT02469168|3495352|P1|NOT COMPLETED|Overall Study||1
1427777|NCT02469168|3495351|P2|COMPLETED|Overall Study||0
1427778|NCT02469168|3495352|P1|COMPLETED|Overall Study||0
1427779|NCT02469168|3495351|P2|STARTED|Overall Study||0
1427780|NCT02469168|3495352|P1|STARTED|Overall Study||1
1427781|NCT02469116|3495360|P1|NOT COMPLETED|Overall Study||0
1427782|NCT02469116|3495360|P1|COMPLETED|Overall Study||18
1427783|NCT02469116|3495360|P1|STARTED|Overall Study||18
1427784|NCT02469064|3495372|P2|NOT COMPLETED|Overall Study||3
1427785|NCT02469064|3495373|P1|NOT COMPLETED|Overall Study||1
1427786|NCT02469064|3495372|P2|COMPLETED|Overall Study||59
1427787|NCT02469064|3495373|P1|COMPLETED|Overall Study||63
1427788|NCT02469064|3495372|P2|STARTED|Overall Study||62
1427789|NCT02469064|3495373|P1|STARTED|Overall Study||64
1427790|NCT02468934|3495381|P1|NOT COMPLETED|Overall Study||7
1427791|NCT02468934|3495381|P1|COMPLETED|Overall Study||20
1427792|NCT02468934|3495381|P1|Underwent Total Knee Arthroplasty|Overall Study||20
1427793|NCT02468934|3495381|P1|Enrolled/Received Leads|Overall Study||24
1427794|NCT02468934|3495381|P1|STARTED|Overall Study||27
1427795|NCT02468830|3495400|P1|NOT COMPLETED|Overall Study||3
1427796|NCT02468830|3495400|P1|COMPLETED|Overall Study||55
1427797|NCT02468830|3495400|P1|STARTED|Overall Study||58
1427798|NCT02468700|3495410|P2|NOT COMPLETED|Overall Study||2
1427799|NCT02468700|3495411|P1|NOT COMPLETED|Overall Study||2
1427800|NCT02468700|3495410|P2|COMPLETED|Overall Study||19
1427801|NCT02468700|3495411|P1|COMPLETED|Overall Study||20
1427802|NCT02468700|3495410|P2|STARTED|Overall Study||21
1427803|NCT02468700|3495411|P1|STARTED|Overall Study||22
1427804|NCT02468583|3495425|P2|NOT COMPLETED|Overall Study||0
1427805|NCT02468583|3495426|P1|NOT COMPLETED|Overall Study||0
1427806|NCT02468583|3495425|P2|COMPLETED|Overall Study||3
1427807|NCT02468583|3495426|P1|COMPLETED|Overall Study||3
1427808|NCT02468583|3495425|P2|STARTED|Overall Study||3
1427809|NCT02468583|3495426|P1|STARTED|Overall Study||3
1427810|NCT02468414|3495464|P2|NOT COMPLETED|Overall Study||0
1427811|NCT02468414|3495465|P1|NOT COMPLETED|Overall Study||3
1427812|NCT02468414|3495464|P2|COMPLETED|Overall Study||0
1427813|NCT02468414|3495465|P1|COMPLETED|Overall Study||0
1427814|NCT02468414|3495464|P2|Safety Follow-up|Overall Study||0
1427815|NCT02468414|3495465|P1|Safety Follow-up|Overall Study||0
1427816|NCT02468414|3495464|P2|Implantation|Overall Study||0
1427817|NCT02468414|3495465|P1|Implantation|Overall Study||1
1427818|NCT02468414|3495464|P2|Harvesting|Overall Study||0
1427819|NCT02468414|3495465|P1|Harvesting|Overall Study||1
1427820|NCT02468414|3495464|P2|Successfully Screened|Overall Study||0
1427821|NCT02468414|3495465|P1|Successfully Screened|Overall Study||2
1427822|NCT02468414|3495464|P2|STARTED|Overall Study||0
1427823|NCT02468414|3495465|P1|STARTED|Overall Study||3
1427824|NCT02468154|3495473|P2|NOT COMPLETED|Overall Study||0
1427825|NCT02468154|3495474|P1|NOT COMPLETED|Overall Study||0
1427826|NCT02468154|3495473|P2|COMPLETED|Overall Study||28
1427827|NCT02468154|3495474|P1|COMPLETED|Overall Study||29
1427828|NCT02468154|3495473|P2|STARTED|Overall Study||28
1427829|NCT02468154|3495474|P1|STARTED|Overall Study||29
1427830|NCT02467777|3495488|P2|NOT COMPLETED|Overall Study||0
1427831|NCT02467777|3495489|P1|NOT COMPLETED|Overall Study||0
1427832|NCT02467777|3495488|P2|COMPLETED|Overall Study||27
1427833|NCT02467777|3495489|P1|COMPLETED|Overall Study||23
1427834|NCT02467777|3495488|P2|STARTED|Overall Study||27
1427835|NCT02467777|3495489|P1|STARTED|Overall Study||23
1427836|NCT02467491|3495495|P1|NOT COMPLETED|Overall Study||0
1427837|NCT02467491|3495495|P1|COMPLETED|Overall Study||12
1427838|NCT02467491|3495495|P1|STARTED|Overall Study||12
1427839|NCT02467075|3495506|P2|NOT COMPLETED|30 Day Follow-up||0
1427840|NCT02467075|3495507|P1|NOT COMPLETED|30 Day Follow-up||0
1427841|NCT02467075|3495506|P2|COMPLETED|30 Day Follow-up||1
1427842|NCT02467075|3495507|P1|COMPLETED|30 Day Follow-up||0
1427843|NCT02467075|3495506|P2|STARTED|30 Day Follow-up||1
1427844|NCT02467075|3495507|P1|STARTED|30 Day Follow-up||0
1427845|NCT02467075|3495506|P2|NOT COMPLETED|72 Hour Follow-up||0
1427846|NCT02467075|3495507|P1|NOT COMPLETED|72 Hour Follow-up||0
1427847|NCT02467075|3495506|P2|COMPLETED|72 Hour Follow-up||1
1427848|NCT02467075|3495507|P1|COMPLETED|72 Hour Follow-up||0
1427849|NCT02467075|3495506|P2|STARTED|72 Hour Follow-up||1
1427850|NCT02467075|3495507|P1|STARTED|72 Hour Follow-up||0
1427851|NCT02467075|3495506|P2|NOT COMPLETED|48 Hour Follow-up||0
1427852|NCT02467075|3495507|P1|NOT COMPLETED|48 Hour Follow-up||0
1427853|NCT02467075|3495506|P2|COMPLETED|48 Hour Follow-up||1
1427854|NCT02467075|3495507|P1|COMPLETED|48 Hour Follow-up||0
1427855|NCT02467075|3495506|P2|STARTED|48 Hour Follow-up||1
1427856|NCT02467075|3495507|P1|STARTED|48 Hour Follow-up||0
1427857|NCT02467075|3495506|P2|NOT COMPLETED|Initial CT Scan||0
1427858|NCT02467075|3495507|P1|NOT COMPLETED|Initial CT Scan||0
1427859|NCT02467075|3495506|P2|COMPLETED|Initial CT Scan||1
1427860|NCT02467075|3495507|P1|COMPLETED|Initial CT Scan||0
1427861|NCT02467075|3495506|P2|STARTED|Initial CT Scan||1
1427862|NCT02467075|3495507|P1|STARTED|Initial CT Scan||0
1427863|NCT02466659|3495525|P2|NOT COMPLETED|Overall Study||2
1427864|NCT02466659|3495526|P1|NOT COMPLETED|Overall Study||5
1427865|NCT02466659|3495525|P2|COMPLETED|Overall Study||1
1427866|NCT02466659|3495526|P1|COMPLETED|Overall Study||0
1427867|NCT02466659|3495525|P2|STARTED|Overall Study||3
1427868|NCT02466659|3495526|P1|STARTED|Overall Study||5
1427869|NCT02466425|3495536|P2|NOT COMPLETED|Overall Study||16
1427870|NCT02466425|3495537|P1|NOT COMPLETED|Overall Study||14
1427871|NCT02466425|3495536|P2|COMPLETED|Overall Study||116
1427872|NCT02466425|3495537|P1|COMPLETED|Overall Study||118
1427873|NCT02466425|3495536|P2|Treated|Overall Study||132
1427874|NCT02466425|3495537|P1|Treated|Overall Study||131
1427875|NCT02466425|3495536|P2|STARTED|Overall Study||132
1427876|NCT02466425|3495537|P1|STARTED|Overall Study||132
1427877|NCT02466412|3495547|P2|NOT COMPLETED|Second Intervention (Day 3)||0
1427878|NCT02466412|3495548|P1|NOT COMPLETED|Second Intervention (Day 3)||0
1427879|NCT02466412|3495547|P2|COMPLETED|Second Intervention (Day 3)||24
1427880|NCT02466412|3495548|P1|COMPLETED|Second Intervention (Day 3)||24
1427881|NCT02466412|3495547|P2|STARTED|Second Intervention (Day 3)||24
1427882|NCT02466412|3495548|P1|STARTED|Second Intervention (Day 3)||24
1427883|NCT02466412|3495547|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1427884|NCT02466412|3495548|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1427885|NCT02466412|3495547|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
1427886|NCT02466412|3495548|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
1427887|NCT02466412|3495547|P2|STARTED|Washout Period of 1 Day (Day 2)||24
1427888|NCT02466412|3495548|P1|STARTED|Washout Period of 1 Day (Day 2)||24
1427889|NCT02466412|3495547|P2|NOT COMPLETED|First Intervention (Day 1)||0
1427890|NCT02466412|3495548|P1|NOT COMPLETED|First Intervention (Day 1)||0
1427891|NCT02466412|3495547|P2|COMPLETED|First Intervention (Day 1)||24
1427892|NCT02466412|3495548|P1|COMPLETED|First Intervention (Day 1)||24
1427893|NCT02466412|3495547|P2|STARTED|First Intervention (Day 1)||24
1427894|NCT02466412|3495548|P1|STARTED|First Intervention (Day 1)||24
1427895|NCT02466412|3495547|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
1427896|NCT02466412|3495548|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
1427897|NCT02466412|3495547|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
1427898|NCT02466412|3495548|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
1427899|NCT02466412|3495547|P2|STARTED|Washout Period of 1 Day (Day -1)||24
1427900|NCT02466412|3495548|P1|STARTED|Washout Period of 1 Day (Day -1)||24
1427901|NCT02466230|3495557|P1|NOT COMPLETED|Overall Study||0
1427902|NCT02466230|3495557|P1|COMPLETED|Overall Study||28
1427903|NCT02466230|3495557|P1|STARTED|Overall Study||28
1427904|NCT02465931|3495564|P2|NOT COMPLETED|Overall Study||11
1427905|NCT02465931|3495565|P1|NOT COMPLETED|Overall Study||11
1427906|NCT02465931|3495564|P2|COMPLETED|Overall Study||45
1427907|NCT02465931|3495565|P1|COMPLETED|Overall Study||44
1427908|NCT02465931|3495564|P2|STARTED|Overall Study||56
1427909|NCT02465931|3495565|P1|STARTED|Overall Study||55
1427910|NCT02465866|3495571|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
1427911|NCT02465866|3495572|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
1427912|NCT02465866|3495573|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
1427913|NCT02465866|3495574|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
1427914|NCT02465866|3495571|P4|COMPLETED|Period 4: Washout (14 Days)||5
1427915|NCT02465866|3495572|P3|COMPLETED|Period 4: Washout (14 Days)||5
1427916|NCT02465866|3495573|P2|COMPLETED|Period 4: Washout (14 Days)||4
1427917|NCT02465866|3495574|P1|COMPLETED|Period 4: Washout (14 Days)||5
1427918|NCT02465866|3495571|P4|STARTED|Period 4: Washout (14 Days)||5
1427919|NCT02465866|3495572|P3|STARTED|Period 4: Washout (14 Days)||5
1427920|NCT02465866|3495573|P2|STARTED|Period 4: Washout (14 Days)||4
1427921|NCT02465866|3495574|P1|STARTED|Period 4: Washout (14 Days)||5
1427922|NCT02465866|3495571|P4|NOT COMPLETED|Period 4||0
1427923|NCT02465866|3495572|P3|NOT COMPLETED|Period 4||0
1427924|NCT02465866|3495573|P2|NOT COMPLETED|Period 4||0
1427925|NCT02465866|3495574|P1|NOT COMPLETED|Period 4||0
1427926|NCT02465866|3495571|P4|COMPLETED|Period 4||5
1427927|NCT02465866|3495572|P3|COMPLETED|Period 4||5
1427928|NCT02465866|3495573|P2|COMPLETED|Period 4||4
1427929|NCT02465866|3495574|P1|COMPLETED|Period 4||5
1427930|NCT02465866|3495571|P4|STARTED|Period 4||5
1427931|NCT02465866|3495572|P3|STARTED|Period 4||5
1427932|NCT02465866|3495573|P2|STARTED|Period 4||4
1427933|NCT02465866|3495574|P1|STARTED|Period 4||5
1427934|NCT02465866|3495571|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
1427935|NCT02465866|3495572|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
1427936|NCT02465866|3495573|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
1427937|NCT02465866|3495574|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
1427938|NCT02465866|3495571|P4|COMPLETED|Period 3: Washout (14 Days)||5
1427939|NCT02465866|3495572|P3|COMPLETED|Period 3: Washout (14 Days)||5
1427940|NCT02465866|3495573|P2|COMPLETED|Period 3: Washout (14 Days)||4
1427941|NCT02465866|3495574|P1|COMPLETED|Period 3: Washout (14 Days)||5
1427942|NCT02465866|3495571|P4|STARTED|Period 3: Washout (14 Days)||5
1427943|NCT02465866|3495572|P3|STARTED|Period 3: Washout (14 Days)||5
1427944|NCT02465866|3495573|P2|STARTED|Period 3: Washout (14 Days)||4
1427945|NCT02465866|3495574|P1|STARTED|Period 3: Washout (14 Days)||5
1427946|NCT02465866|3495571|P4|NOT COMPLETED|Period 3||0
1427947|NCT02465866|3495572|P3|NOT COMPLETED|Period 3||0
1427948|NCT02465866|3495573|P2|NOT COMPLETED|Period 3||1
1427949|NCT02465866|3495574|P1|NOT COMPLETED|Period 3||0
1427950|NCT02465866|3495571|P4|COMPLETED|Period 3||5
1427951|NCT02465866|3495572|P3|COMPLETED|Period 3||5
1427952|NCT02465866|3495573|P2|COMPLETED|Period 3||4
1427953|NCT02465866|3495574|P1|COMPLETED|Period 3||5
1427954|NCT02465866|3495571|P4|STARTED|Period 3||5
1427955|NCT02465866|3495572|P3|STARTED|Period 3||5
1427956|NCT02465866|3495573|P2|STARTED|Period 3||5
1427957|NCT02465866|3495574|P1|STARTED|Period 3||5
1427958|NCT02465866|3495571|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
1427959|NCT02465866|3495572|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
1427960|NCT02465866|3495573|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
1427961|NCT02465866|3495574|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
1427962|NCT02465866|3495571|P4|COMPLETED|Period 2: Washout (14 Days)||5
1427963|NCT02465866|3495572|P3|COMPLETED|Period 2: Washout (14 Days)||5
1427964|NCT02465866|3495573|P2|COMPLETED|Period 2: Washout (14 Days)||5
1427965|NCT02465866|3495574|P1|COMPLETED|Period 2: Washout (14 Days)||5
1427966|NCT02465866|3495571|P4|STARTED|Period 2: Washout (14 Days)||5
1427967|NCT02465866|3495572|P3|STARTED|Period 2: Washout (14 Days)||5
1427968|NCT02465866|3495573|P2|STARTED|Period 2: Washout (14 Days)||5
1427969|NCT02465866|3495574|P1|STARTED|Period 2: Washout (14 Days)||5
1427970|NCT02465866|3495571|P4|NOT COMPLETED|Period 2||0
1427971|NCT02465866|3495572|P3|NOT COMPLETED|Period 2||0
1427972|NCT02465866|3495573|P2|NOT COMPLETED|Period 2||0
1427973|NCT02465866|3495574|P1|NOT COMPLETED|Period 2||0
1427974|NCT02465866|3495571|P4|COMPLETED|Period 2||5
1427975|NCT02465866|3495572|P3|COMPLETED|Period 2||5
1427976|NCT02465866|3495573|P2|COMPLETED|Period 2||5
1427977|NCT02465866|3495574|P1|COMPLETED|Period 2||5
1427978|NCT02465866|3495571|P4|STARTED|Period 2||5
1427979|NCT02465866|3495572|P3|STARTED|Period 2||5
1427980|NCT02465866|3495573|P2|STARTED|Period 2||5
1427981|NCT02465866|3495574|P1|STARTED|Period 2||5
1427982|NCT02465866|3495571|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
1427983|NCT02465866|3495572|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
1427984|NCT02465866|3495573|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
1427985|NCT02465866|3495574|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
1427986|NCT02465866|3495571|P4|COMPLETED|Period 1: Washout (14 Days)||5
1427987|NCT02465866|3495572|P3|COMPLETED|Period 1: Washout (14 Days)||5
1427988|NCT02465866|3495573|P2|COMPLETED|Period 1: Washout (14 Days)||5
1427989|NCT02465866|3495574|P1|COMPLETED|Period 1: Washout (14 Days)||5
1427990|NCT02465866|3495571|P4|STARTED|Period 1: Washout (14 Days)||5
1427991|NCT02465866|3495572|P3|STARTED|Period 1: Washout (14 Days)||5
1427992|NCT02465866|3495573|P2|STARTED|Period 1: Washout (14 Days)||5
1427993|NCT02465866|3495574|P1|STARTED|Period 1: Washout (14 Days)||5
1427994|NCT02465866|3495571|P4|NOT COMPLETED|Period 1||0
1427995|NCT02465866|3495572|P3|NOT COMPLETED|Period 1||0
1427996|NCT02465866|3495573|P2|NOT COMPLETED|Period 1||0
1427997|NCT02465866|3495574|P1|NOT COMPLETED|Period 1||0
1427998|NCT02465866|3495571|P4|COMPLETED|Period 1||5
1427999|NCT02465866|3495572|P3|COMPLETED|Period 1||5
1428000|NCT02465866|3495573|P2|COMPLETED|Period 1||5
1428001|NCT02465866|3495574|P1|COMPLETED|Period 1||5
1428002|NCT02465866|3495571|P4|STARTED|Period 1||5
1428003|NCT02465866|3495572|P3|STARTED|Period 1||5
1428004|NCT02465866|3495573|P2|STARTED|Period 1||5
1428005|NCT02465866|3495574|P1|STARTED|Period 1||5
1428006|NCT02465632|3495647|P3|NOT COMPLETED|Overall Study||17
1428007|NCT02465632|3495648|P2|NOT COMPLETED|Overall Study||23
1428008|NCT02465632|3495649|P1|NOT COMPLETED|Overall Study||31
1428009|NCT02465632|3495647|P3|COMPLETED|Overall Study||203
1428010|NCT02465632|3495648|P2|COMPLETED|Overall Study||417
1428011|NCT02465632|3495649|P1|COMPLETED|Overall Study||409
1428012|NCT02465632|3495647|P3|STARTED|Overall Study||220
1428013|NCT02465632|3495648|P2|STARTED|Overall Study||440
1428014|NCT02465632|3495649|P1|STARTED|Overall Study||440
1428015|NCT02465489|3495660|P1|NOT COMPLETED|Overall Study||5
1428016|NCT02465489|3495660|P1|COMPLETED|Overall Study||15
1428017|NCT02465489|3495660|P1|STARTED|Overall Study||20
1428018|NCT02465463|3495689|P2|NOT COMPLETED|Overall Study||1
1428019|NCT02465463|3495690|P1|NOT COMPLETED|Overall Study||4
1428020|NCT02465463|3495689|P2|COMPLETED|Overall Study||4
1428021|NCT02465463|3495690|P1|COMPLETED|Overall Study||4
1428022|NCT02465463|3495689|P2|STARTED|Overall Study||5
1428023|NCT02465463|3495690|P1|STARTED|Overall Study||8
1428024|NCT02465450|3495709|P6|NOT COMPLETED|Treatment Period 2||0
1428025|NCT02465450|3495710|P5|NOT COMPLETED|Treatment Period 2||4
1428026|NCT02465450|3495711|P4|NOT COMPLETED|Treatment Period 2||3
1428027|NCT02465450|3495712|P3|NOT COMPLETED|Treatment Period 2||0
1428028|NCT02465450|3495713|P2|NOT COMPLETED|Treatment Period 2||0
1428029|NCT02465450|3495714|P1|NOT COMPLETED|Treatment Period 2||0
1428030|NCT02465450|3495709|P6|COMPLETED|Treatment Period 2||23
1428031|NCT02465450|3495710|P5|COMPLETED|Treatment Period 2||24
1428032|NCT02465450|3495711|P4|COMPLETED|Treatment Period 2||27
1428033|NCT02465450|3495712|P3|COMPLETED|Treatment Period 2||0
1428034|NCT02465450|3495713|P2|COMPLETED|Treatment Period 2||0
1428035|NCT02465450|3495714|P1|COMPLETED|Treatment Period 2||0
1428036|NCT02465450|3495709|P6|STARTED|Treatment Period 2||23
1428037|NCT02465450|3495710|P5|STARTED|Treatment Period 2||28
1428038|NCT02465450|3495711|P4|STARTED|Treatment Period 2||30
1428039|NCT02465450|3495712|P3|STARTED|Treatment Period 2||0
1428040|NCT02465450|3495713|P2|STARTED|Treatment Period 2||0
1428041|NCT02465450|3495714|P1|STARTED|Treatment Period 2||0
1428042|NCT02465450|3495709|P6|NOT COMPLETED|Treatment Period 1||0
1428043|NCT02465450|3495710|P5|NOT COMPLETED|Treatment Period 1||0
1428044|NCT02465450|3495711|P4|NOT COMPLETED|Treatment Period 1||0
1428045|NCT02465450|3495712|P3|NOT COMPLETED|Treatment Period 1||1
1428046|NCT02465450|3495713|P2|NOT COMPLETED|Treatment Period 1||1
1428047|NCT02465450|3495714|P1|NOT COMPLETED|Treatment Period 1||2
1428048|NCT02465450|3495709|P6|COMPLETED|Treatment Period 1||0
1428049|NCT02465450|3495710|P5|COMPLETED|Treatment Period 1||0
1428050|NCT02465450|3495711|P4|COMPLETED|Treatment Period 1||0
1428051|NCT02465450|3495712|P3|COMPLETED|Treatment Period 1||34
1428052|NCT02465450|3495713|P2|COMPLETED|Treatment Period 1||23
1428053|NCT02465450|3495714|P1|COMPLETED|Treatment Period 1||24
1428054|NCT02465450|3495709|P6|STARTED|Treatment Period 1||0
1428055|NCT02465450|3495710|P5|STARTED|Treatment Period 1||0
1428056|NCT02465450|3495711|P4|STARTED|Treatment Period 1||0
1428057|NCT02465450|3495712|P3|STARTED|Treatment Period 1||35
1428058|NCT02465450|3495713|P2|STARTED|Treatment Period 1||24
1428059|NCT02465450|3495714|P1|STARTED|Treatment Period 1||26
1428060|NCT02465437|3495738|P4|NOT COMPLETED|Overall Study||1
1428061|NCT02465437|3495739|P3|NOT COMPLETED|Overall Study||1
1428062|NCT02465437|3495740|P2|NOT COMPLETED|Overall Study||1
1428063|NCT02465437|3495741|P1|NOT COMPLETED|Overall Study||1
1428064|NCT02465437|3495738|P4|COMPLETED|Overall Study||14
1428065|NCT02465437|3495739|P3|COMPLETED|Overall Study||8
1428066|NCT02465437|3495740|P2|COMPLETED|Overall Study||8
1428067|NCT02465437|3495741|P1|COMPLETED|Overall Study||8
1428068|NCT02465437|3495738|P4|STARTED|Overall Study||15
1428069|NCT02465437|3495739|P3|STARTED|Overall Study||9
1428070|NCT02465437|3495740|P2|STARTED|Overall Study||9
1428071|NCT02465437|3495741|P1|STARTED|Overall Study||9
1428072|NCT02465372|3495761|P2|NOT COMPLETED|Overall Study||97
1428073|NCT02465372|3495762|P1|NOT COMPLETED|Overall Study||122
1428074|NCT02465372|3495761|P2|COMPLETED|Overall Study||153
1428075|NCT02465372|3495762|P1|COMPLETED|Overall Study||227
1428076|NCT02465372|3495761|P2|STARTED|Overall Study||250
1428077|NCT02465372|3495762|P1|STARTED|Overall Study||349
1428078|NCT02465216|3495777|P5|NOT COMPLETED|Overall Study||3
1428079|NCT02465216|3495778|P4|NOT COMPLETED|Overall Study||2
1428080|NCT02465216|3495779|P3|NOT COMPLETED|Overall Study||1
1428081|NCT02465216|3495780|P2|NOT COMPLETED|Overall Study||0
1428082|NCT02465216|3495781|P1|NOT COMPLETED|Overall Study||3
1428083|NCT02465216|3495777|P5|COMPLETED|Overall Study||9
1428084|NCT02465216|3495778|P4|COMPLETED|Overall Study||12
1428085|NCT02465216|3495779|P3|COMPLETED|Overall Study||13
1428086|NCT02465216|3495780|P2|COMPLETED|Overall Study||5
1428087|NCT02465216|3495781|P1|COMPLETED|Overall Study||12
1428088|NCT02465216|3495777|P5|STARTED|Overall Study||12
1428089|NCT02465216|3495778|P4|STARTED|Overall Study||14
1428090|NCT02465216|3495779|P3|STARTED|Overall Study||14
1428091|NCT02465216|3495780|P2|STARTED|Overall Study||5
1428092|NCT02465216|3495781|P1|STARTED|Overall Study||15
1428093|NCT02465203|3495796|P3|NOT COMPLETED|Overall Study||13
1428094|NCT02465203|3495797|P2|NOT COMPLETED|Overall Study||36
1428095|NCT02465203|3495798|P1|NOT COMPLETED|Overall Study||56
1428096|NCT02465203|3495796|P3|COMPLETED|Overall Study||0
1428097|NCT02465203|3495797|P2|COMPLETED|Overall Study||0
1428098|NCT02465203|3495798|P1|COMPLETED|Overall Study||0
1428099|NCT02465203|3495796|P3|STARTED|Overall Study||13
1428100|NCT02465203|3495797|P2|STARTED|Overall Study||36
1428101|NCT02465203|3495798|P1|STARTED|Overall Study||56
1428102|NCT02465099|3495811|P2|NOT COMPLETED|Overall Study||0
1428103|NCT02465099|3495812|P1|NOT COMPLETED|Overall Study||0
1428104|NCT02465099|3495811|P2|COMPLETED|Overall Study||19
1428105|NCT02465099|3495812|P1|COMPLETED|Overall Study||45
1428106|NCT02465099|3495811|P2|STARTED|Overall Study||19
1428107|NCT02465099|3495812|P1|STARTED|Overall Study||45
1428108|NCT02465073|3495821|P3|NOT COMPLETED|Overall Study||1
1428109|NCT02465073|3495822|P2|NOT COMPLETED|Overall Study||1
1428110|NCT02465073|3495823|P1|NOT COMPLETED|Overall Study||2
1428111|NCT02465073|3495821|P3|COMPLETED|Overall Study||15
1428112|NCT02465073|3495822|P2|COMPLETED|Overall Study||15
1428113|NCT02465073|3495823|P1|COMPLETED|Overall Study||15
1428114|NCT02465073|3495821|P3|STARTED|Overall Study||16
1428115|NCT02465073|3495822|P2|STARTED|Overall Study||16
1428116|NCT02465073|3495823|P1|STARTED|Overall Study||17
1428117|NCT02464176|3495834|P3|NOT COMPLETED|Overall Study||0
1428118|NCT02464176|3495835|P2|NOT COMPLETED|Overall Study||0
1428119|NCT02464176|3495836|P1|NOT COMPLETED|Overall Study||0
1428120|NCT02464176|3495834|P3|COMPLETED|Overall Study||15
1428121|NCT02464176|3495835|P2|COMPLETED|Overall Study||50
1428122|NCT02464176|3495836|P1|COMPLETED|Overall Study||50
1428123|NCT02464176|3495834|P3|STARTED|Overall Study||15
1428124|NCT02464176|3495835|P2|STARTED|Overall Study||50
1428125|NCT02464176|3495836|P1|STARTED|Overall Study||50
1428126|NCT02464163|3495857|P4|NOT COMPLETED|Overall Study||5
1428127|NCT02464163|3495858|P3|NOT COMPLETED|Overall Study||5
1428128|NCT02464163|3495859|P2|NOT COMPLETED|Overall Study||8
1428129|NCT02464163|3495860|P1|NOT COMPLETED|Overall Study||3
1428130|NCT02464163|3495857|P4|COMPLETED|Overall Study||96
1428131|NCT02464163|3495858|P3|COMPLETED|Overall Study||97
1428132|NCT02464163|3495859|P2|COMPLETED|Overall Study||94
1428133|NCT02464163|3495860|P1|COMPLETED|Overall Study||99
1428134|NCT02464163|3495857|P4|STARTED|Overall Study||101
1428135|NCT02464163|3495858|P3|STARTED|Overall Study||102
1428136|NCT02464163|3495859|P2|STARTED|Overall Study||102
1428137|NCT02464163|3495860|P1|STARTED|Overall Study||102
1428138|NCT02463981|3495884|P2|NOT COMPLETED|Overall Study||2
1428139|NCT02463981|3495885|P1|NOT COMPLETED|Overall Study||3
1428140|NCT02463981|3495884|P2|COMPLETED|Overall Study||14
1428141|NCT02463981|3495885|P1|COMPLETED|Overall Study||18
1428142|NCT02463981|3495884|P2|STARTED|Overall Study||16
1428143|NCT02463981|3495885|P1|STARTED|Overall Study||21
1428144|NCT02463409|3495893|P1|NOT COMPLETED|Overall Study||2
1428145|NCT02463409|3495893|P1|COMPLETED|Overall Study||4
1428146|NCT02463409|3495893|P1|STARTED|Overall Study||6
1428147|NCT02463331|3495901|P2|NOT COMPLETED|Overall Study||6
1428148|NCT02463331|3495902|P1|NOT COMPLETED|Overall Study||16
1428149|NCT02463331|3495901|P2|COMPLETED|Overall Study||25
1428150|NCT02463331|3495902|P1|COMPLETED|Overall Study||10
1428151|NCT02463331|3495901|P2|STARTED|Overall Study||31
1428152|NCT02463331|3495902|P1|STARTED|Overall Study||26
1428153|NCT02463227|3495910|P1|NOT COMPLETED|Overall Study||0
1428154|NCT02463227|3495910|P1|COMPLETED|Overall Study||14
1428155|NCT02463227|3495910|P1|STARTED|Overall Study||14
1428156|NCT02463097|3495918|P1|NOT COMPLETED|Overall Study||1
1428157|NCT02463097|3495918|P1|COMPLETED|Overall Study||123
1428158|NCT02463097|3495918|P1|STARTED|Overall Study||124
1428159|NCT02463071|3495927|P3|NOT COMPLETED|Overall Study||6
1428160|NCT02463071|3495928|P2|NOT COMPLETED|Overall Study||16
1428161|NCT02463071|3495929|P1|NOT COMPLETED|Overall Study||12
1428162|NCT02463071|3495927|P3|COMPLETED|Overall Study||71
1428163|NCT02463071|3495928|P2|COMPLETED|Overall Study||138
1428164|NCT02463071|3495929|P1|COMPLETED|Overall Study||140
1428165|NCT02463071|3495927|P3|STARTED|Overall Study||77
1428166|NCT02463071|3495928|P2|STARTED|Overall Study||154
1428167|NCT02463071|3495929|P1|STARTED|Overall Study||152
1428168|NCT02462720|3495955|P2|NOT COMPLETED|Part 2||1
1428169|NCT02462720|3495956|P1|NOT COMPLETED|Part 2||1
1428170|NCT02462720|3495955|P2|COMPLETED|Part 2||16
1428171|NCT02462720|3495956|P1|COMPLETED|Part 2||17
1428172|NCT02462720|3495955|P2|STARTED|Part 2||17
1428173|NCT02462720|3495956|P1|STARTED|Part 2||18
1428174|NCT02462720|3495955|P2|NOT COMPLETED|Part 1||0
1428175|NCT02462720|3495956|P1|NOT COMPLETED|Part 1||0
1428176|NCT02462720|3495955|P2|COMPLETED|Part 1||17
1428177|NCT02462720|3495956|P1|COMPLETED|Part 1||18
1428178|NCT02462720|3495955|P2|STARTED|Part 1||17
1428179|NCT02462720|3495956|P1|STARTED|Part 1||18
1428180|NCT02462473|3495966|P1|NOT COMPLETED|Overall Study||4
1428181|NCT02462473|3495966|P1|COMPLETED|Overall Study||5
1428182|NCT02462473|3495966|P1|STARTED|Overall Study||9
1428183|NCT02462291|3495979|P2|NOT COMPLETED|Overall Study||6
1428184|NCT02462291|3495980|P1|NOT COMPLETED|Overall Study||5
1428185|NCT02462291|3495979|P2|COMPLETED|Overall Study||75
1428186|NCT02462291|3495980|P1|COMPLETED|Overall Study||77
1428187|NCT02462291|3495979|P2|STARTED|Overall Study||81
1428188|NCT02462291|3495980|P1|STARTED|Overall Study||82
1428189|NCT02462148|3496021|P3|NOT COMPLETED|Overall Study||0
1428190|NCT02462148|3496022|P2|NOT COMPLETED|Overall Study||0
1428191|NCT02462148|3496023|P1|NOT COMPLETED|Overall Study||1
1428192|NCT02462148|3496021|P3|COMPLETED|Overall Study||12
1428193|NCT02462148|3496022|P2|COMPLETED|Overall Study||36
1428194|NCT02462148|3496023|P1|COMPLETED|Overall Study||36
1428195|NCT02462148|3496021|P3|STARTED|Overall Study||12
1428196|NCT02462148|3496022|P2|STARTED|Overall Study||36
1428197|NCT02462148|3496023|P1|STARTED|Overall Study||37
1428198|NCT02462057|3496051|P5|NOT COMPLETED|Overall Study||50
1428199|NCT02462057|3496052|P4|NOT COMPLETED|Overall Study||51
1428200|NCT02462057|3496053|P3|NOT COMPLETED|Overall Study||46
1428201|NCT02462057|3496054|P2|NOT COMPLETED|Overall Study||40
1428202|NCT02462057|3496055|P1|NOT COMPLETED|Overall Study||54
1428203|NCT02462057|3496051|P5|COMPLETED|Overall Study||708
1428204|NCT02462057|3496052|P4|COMPLETED|Overall Study||701
1428205|NCT02462057|3496053|P3|COMPLETED|Overall Study||766
1428206|NCT02462057|3496054|P2|COMPLETED|Overall Study||753
1428207|NCT02462057|3496055|P1|COMPLETED|Overall Study||737
1428208|NCT02462057|3496051|P5|STARTED|Overall Study||758
1428209|NCT02462057|3496052|P4|STARTED|Overall Study||752
1428210|NCT02462057|3496053|P3|STARTED|Overall Study||812
1428211|NCT02462057|3496054|P2|STARTED|Overall Study||793
1428212|NCT02462057|3496055|P1|STARTED|Overall Study||791
1428213|NCT02461992|3496067|P1|NOT COMPLETED|Overall Study||0
1428214|NCT02461992|3496067|P1|COMPLETED|Overall Study||13
1428215|NCT02461992|3496067|P1|STARTED|Overall Study||13
1428216|NCT02461966|3496087|P3|NOT COMPLETED|Overall Study||0
1428217|NCT02461966|3496088|P2|NOT COMPLETED|Overall Study||0
1428218|NCT02461966|3496089|P1|NOT COMPLETED|Overall Study||0
1428219|NCT02461966|3496087|P3|COMPLETED|Overall Study||60
1428220|NCT02461966|3496088|P2|COMPLETED|Overall Study||80
1428221|NCT02461966|3496089|P1|COMPLETED|Overall Study||160
1428222|NCT02461966|3496087|P3|STARTED|Overall Study||60
1428223|NCT02461966|3496088|P2|STARTED|Overall Study||80
1428224|NCT02461966|3496089|P1|STARTED|Overall Study||160
1428225|NCT02461693|3496099|P2|NOT COMPLETED|Overall Study||0
1428226|NCT02461693|3496100|P1|NOT COMPLETED|Overall Study||0
1428227|NCT02461693|3496099|P2|COMPLETED|Overall Study||102
1428228|NCT02461693|3496100|P1|COMPLETED|Overall Study||103
1428229|NCT02461693|3496099|P2|STARTED|Overall Study||102
1428230|NCT02461693|3496100|P1|STARTED|Overall Study||103
1428231|NCT02461589|3496122|P10|NOT COMPLETED|Overall Study||5
1428232|NCT02461589|3496123|P9|NOT COMPLETED|Overall Study||6
1428233|NCT02461589|3496124|P8|NOT COMPLETED|Overall Study||5
1428234|NCT02461589|3496125|P7|NOT COMPLETED|Overall Study||6
1428235|NCT02461589|3496126|P6|NOT COMPLETED|Overall Study||3
1428236|NCT02461589|3496127|P5|NOT COMPLETED|Overall Study||2
1428237|NCT02461589|3496128|P4|NOT COMPLETED|Overall Study||5
1428238|NCT02461589|3496129|P3|NOT COMPLETED|Overall Study||5
1428239|NCT02461589|3496130|P2|NOT COMPLETED|Overall Study||2
1428240|NCT02461589|3496131|P1|NOT COMPLETED|Overall Study||6
1428241|NCT02461589|3496122|P10|COMPLETED|Overall Study||60
1428242|NCT02461589|3496123|P9|COMPLETED|Overall Study||123
1428243|NCT02461589|3496124|P8|COMPLETED|Overall Study||60
1428244|NCT02461589|3496125|P7|COMPLETED|Overall Study||58
1428245|NCT02461589|3496126|P6|COMPLETED|Overall Study||61
1428246|NCT02461589|3496127|P5|COMPLETED|Overall Study||62
1428247|NCT02461589|3496128|P4|COMPLETED|Overall Study||58
1428248|NCT02461589|3496129|P3|COMPLETED|Overall Study||60
1428249|NCT02461589|3496130|P2|COMPLETED|Overall Study||61
1428250|NCT02461589|3496131|P1|COMPLETED|Overall Study||58
1428251|NCT02461589|3496122|P10|Exposed|Overall Study||64
1428252|NCT02461589|3496123|P9|Exposed|Overall Study||129
1428253|NCT02461589|3496124|P8|Exposed|Overall Study||65
1428254|NCT02461589|3496125|P7|Exposed|Overall Study||64
1428255|NCT02461589|3496126|P6|Exposed|Overall Study||64
1428256|NCT02461589|3496127|P5|Exposed|Overall Study||64
1428257|NCT02461589|3496128|P4|Exposed|Overall Study||63
1428258|NCT02461589|3496129|P3|Exposed|Overall Study||65
1428259|NCT02461589|3496130|P2|Exposed|Overall Study||63
1428260|NCT02461589|3496131|P1|Exposed|Overall Study||64
1428261|NCT02461589|3496122|P10|STARTED|Overall Study||65
1428262|NCT02461589|3496123|P9|STARTED|Overall Study||129
1428263|NCT02461589|3496124|P8|STARTED|Overall Study||65
1428264|NCT02461589|3496125|P7|STARTED|Overall Study||64
1428265|NCT02461589|3496126|P6|STARTED|Overall Study||64
1428266|NCT02461589|3496127|P5|STARTED|Overall Study||64
1428267|NCT02461589|3496128|P4|STARTED|Overall Study||63
1428268|NCT02461589|3496129|P3|STARTED|Overall Study||65
1428269|NCT02461589|3496130|P2|STARTED|Overall Study||63
1428270|NCT02461589|3496131|P1|STARTED|Overall Study||64
1428271|NCT02461563|3496187|P4|NOT COMPLETED|Overall Study||0
1428272|NCT02461563|3496188|P3|NOT COMPLETED|Overall Study||0
1428273|NCT02461563|3496189|P2|NOT COMPLETED|Overall Study||0
1428274|NCT02461563|3496190|P1|NOT COMPLETED|Overall Study||0
1428275|NCT02461563|3496187|P4|COMPLETED|Overall Study||3
1428276|NCT02461563|3496188|P3|COMPLETED|Overall Study||3
1428277|NCT02461563|3496189|P2|COMPLETED|Overall Study||3
1428278|NCT02461563|3496190|P1|COMPLETED|Overall Study||3
1428279|NCT02461563|3496187|P4|STARTED|Overall Study||3
1428280|NCT02461563|3496188|P3|STARTED|Overall Study||3
1428281|NCT02461563|3496189|P2|STARTED|Overall Study||3
1428282|NCT02461563|3496190|P1|STARTED|Overall Study||3
1428283|NCT02461550|3496224|P1|NOT COMPLETED|Overall Study||0
1428284|NCT02461550|3496224|P1|COMPLETED|Overall Study||2
1428285|NCT02461550|3496224|P1|STARTED|Overall Study||2
1428286|NCT02461433|3496230|P2|NOT COMPLETED|Overall Study||0
1428287|NCT02461433|3496231|P1|NOT COMPLETED|Overall Study||0
1428288|NCT02461433|3496230|P2|COMPLETED|Overall Study||1
1428289|NCT02461433|3496231|P1|COMPLETED|Overall Study||1
1428290|NCT02461433|3496230|P2|STARTED|Overall Study||1
1428291|NCT02461433|3496231|P1|STARTED|Overall Study||1
1428292|NCT02461290|3496257|P1|NOT COMPLETED|Overall Study||10
1428293|NCT02461290|3496257|P1|COMPLETED|Overall Study||89
1428294|NCT02461290|3496257|P1|STARTED|Overall Study||99
1428295|NCT02461134|3496264|P1|NOT COMPLETED|Overall Study||1
1428296|NCT02461134|3496264|P1|COMPLETED|Overall Study||0
1428297|NCT02461134|3496264|P1|STARTED|Overall Study||1
1428298|NCT02460991|3496272|P2|NOT COMPLETED|Overall Study||2
1428299|NCT02460991|3496273|P1|NOT COMPLETED|Overall Study||0
1428300|NCT02460991|3496272|P2|COMPLETED|Overall Study||0
1428301|NCT02460991|3496273|P1|COMPLETED|Overall Study||0
1428302|NCT02460991|3496272|P2|STARTED|Overall Study||2
1428303|NCT02460991|3496273|P1|STARTED|Overall Study||0
1428304|NCT02460978|3496290|P3|NOT COMPLETED|Overall Study||33
1428305|NCT02460978|3496291|P2|NOT COMPLETED|Overall Study||25
1428306|NCT02460978|3496292|P1|NOT COMPLETED|Overall Study||27
1428307|NCT02460978|3496290|P3|COMPLETED|Overall Study||239
1428308|NCT02460978|3496291|P2|COMPLETED|Overall Study||245
1428309|NCT02460978|3496292|P1|COMPLETED|Overall Study||244
1428310|NCT02460978|3496290|P3|STARTED|Overall Study||272
1428311|NCT02460978|3496291|P2|STARTED|Overall Study||270
1428312|NCT02460978|3496292|P1|STARTED|Overall Study||271
1428313|NCT02460822|3496318|P1|NOT COMPLETED|Overall Study||1
1428314|NCT02460822|3496318|P1|COMPLETED|Overall Study||15
1428315|NCT02460822|3496318|P1|STARTED|Overall Study||16
1428316|NCT02460458|3496327|P1|NOT COMPLETED|Prospective Phase||0
1428317|NCT02460458|3496327|P1|COMPLETED|Prospective Phase|Information not yet available.|0
1428318|NCT02460458|3496327|P1|STARTED|Prospective Phase|Information not yet available.|0
1428319|NCT02460458|3496327|P1|NOT COMPLETED|Confirmatory Phase||266
1428320|NCT02460458|3496327|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
1428321|NCT02460458|3496327|P1|STARTED|Confirmatory Phase||266
1428322|NCT02460458|3496327|P1|NOT COMPLETED|Retrospective Phase||0
1428323|NCT02460458|3496327|P1|COMPLETED|Retrospective Phase||266
1428324|NCT02460458|3496327|P1|STARTED|Retrospective Phase||266
1428325|NCT02460380|3496335|P2|NOT COMPLETED|Overall Study||5
1428326|NCT02460380|3496336|P1|NOT COMPLETED|Overall Study||10
1428327|NCT02460380|3496335|P2|COMPLETED|Overall Study||18
1428328|NCT02460380|3496336|P1|COMPLETED|Overall Study||35
1428329|NCT02460380|3496335|P2|STARTED|Overall Study||23
1428330|NCT02460380|3496336|P1|STARTED|Overall Study||45
1428331|NCT02460159|3496358|P2|NOT COMPLETED|Overall Study||1
1428332|NCT02460159|3496359|P1|NOT COMPLETED|Overall Study||6
1428333|NCT02460159|3496358|P2|COMPLETED|Overall Study||17
1428334|NCT02460159|3496359|P1|COMPLETED|Overall Study||111
1428335|NCT02460159|3496358|P2|STARTED|Overall Study||18
1428336|NCT02460159|3496359|P1|STARTED|Overall Study||117
1428337|NCT02459418|3496389|P2|NOT COMPLETED|Overall Study||6
1428338|NCT02459418|3496390|P1|NOT COMPLETED|Overall Study||8
1428339|NCT02459418|3496389|P2|COMPLETED|Overall Study||15
1428340|NCT02459418|3496390|P1|COMPLETED|Overall Study||13
1428341|NCT02459418|3496389|P2|Received Second Treatment|Overall Study||15
1428342|NCT02459418|3496390|P1|Received Second Treatment|Overall Study||13
1428343|NCT02459418|3496389|P2|Received First Treatment|Overall Study||21
1428344|NCT02459418|3496390|P1|Received First Treatment|Overall Study||21
1428345|NCT02459418|3496389|P2|STARTED|Overall Study||21
1428346|NCT02459418|3496390|P1|STARTED|Overall Study||21
1428347|NCT02459093|3496412|P2|NOT COMPLETED|Overall Study||18
1428348|NCT02459093|3496413|P1|NOT COMPLETED|Overall Study||12
1428349|NCT02459093|3496412|P2|COMPLETED|Overall Study||257
1428350|NCT02459093|3496413|P1|COMPLETED|Overall Study||263
1428351|NCT02459093|3496412|P2|STARTED|Overall Study||275
1428352|NCT02459093|3496413|P1|STARTED|Overall Study||275
1428353|NCT02459080|3496424|P3|NOT COMPLETED|Overall Study||58
1428354|NCT02459080|3496425|P2|NOT COMPLETED|Overall Study||40
1428355|NCT02459080|3496426|P1|NOT COMPLETED|Overall Study||44
1428356|NCT02459080|3496424|P3|COMPLETED|Overall Study||151
1428357|NCT02459080|3496425|P2|COMPLETED|Overall Study||158
1428358|NCT02459080|3496426|P1|COMPLETED|Overall Study||168
1428359|NCT02459080|3496424|P3|STARTED|Overall Study||209
1428360|NCT02459080|3496425|P2|STARTED|Overall Study||198
1428361|NCT02459080|3496426|P1|STARTED|Overall Study||212
1428362|NCT02458768|3496451|P2|NOT COMPLETED|Overall Study||5
1428363|NCT02458768|3496452|P1|NOT COMPLETED|Overall Study||7
1428364|NCT02458768|3496451|P2|COMPLETED|Overall Study||50
1428365|NCT02458768|3496452|P1|COMPLETED|Overall Study||50
1428366|NCT02458768|3496451|P2|STARTED|Overall Study||55
1428367|NCT02458768|3496452|P1|STARTED|Overall Study||57
1428368|NCT02458365|3496460|P2|NOT COMPLETED|Overall Study||294
1428369|NCT02458365|3496461|P1|NOT COMPLETED|Overall Study||277
1428370|NCT02458365|3496460|P2|COMPLETED|Overall Study||1607
1428371|NCT02458365|3496461|P1|COMPLETED|Overall Study||1723
1428372|NCT02458365|3496460|P2|STARTED|Overall Study||1901
1428373|NCT02458365|3496461|P1|STARTED|Overall Study||2000
1428374|NCT02458287|3496485|P4|NOT COMPLETED|Overall Study||3
1428375|NCT02458287|3496486|P3|NOT COMPLETED|Overall Study||3
1428376|NCT02458287|3496487|P2|NOT COMPLETED|Overall Study||4
1428377|NCT02458287|3496488|P1|NOT COMPLETED|Overall Study||0
1428378|NCT02458287|3496485|P4|COMPLETED|Overall Study||97
1428379|NCT02458287|3496486|P3|COMPLETED|Overall Study||46
1428380|NCT02458287|3496487|P2|COMPLETED|Overall Study||96
1428381|NCT02458287|3496488|P1|COMPLETED|Overall Study||50
1428382|NCT02458287|3496485|P4|STARTED|Overall Study||100
1428383|NCT02458287|3496486|P3|STARTED|Overall Study||49
1428384|NCT02458287|3496487|P2|STARTED|Overall Study||100
1428385|NCT02458287|3496488|P1|STARTED|Overall Study||50
1428386|NCT02457793|3496539|P6|NOT COMPLETED|Overall Study||6
1428387|NCT02457793|3496540|P5|NOT COMPLETED|Overall Study||4
1428388|NCT02457793|3496541|P4|NOT COMPLETED|Overall Study||5
1428389|NCT02457793|3496542|P3|NOT COMPLETED|Overall Study||3
1428390|NCT02457793|3496543|P2|NOT COMPLETED|Overall Study||4
1428391|NCT02457793|3496544|P1|NOT COMPLETED|Overall Study||1
1428392|NCT02457793|3496539|P6|COMPLETED|Overall Study||0
1428393|NCT02457793|3496540|P5|COMPLETED|Overall Study||0
1428394|NCT02457793|3496541|P4|COMPLETED|Overall Study||0
1428395|NCT02457793|3496542|P3|COMPLETED|Overall Study||0
1428396|NCT02457793|3496543|P2|COMPLETED|Overall Study||1
1428397|NCT02457793|3496544|P1|COMPLETED|Overall Study||0
1428398|NCT02457793|3496539|P6|STARTED|Overall Study||6
1428399|NCT02457793|3496540|P5|STARTED|Overall Study||4
1428400|NCT02457793|3496541|P4|STARTED|Overall Study||5
1428401|NCT02457793|3496542|P3|STARTED|Overall Study||3
1428402|NCT02457793|3496543|P2|STARTED|Overall Study||5
1428403|NCT02457793|3496544|P1|STARTED|Overall Study||1
1428404|NCT02457728|3496684|P1|NOT COMPLETED|Overall Study||0
1428405|NCT02457728|3496684|P1|COMPLETED|Overall Study||34
1428406|NCT02457728|3496684|P1|STARTED|Overall Study||34
1428407|NCT02457611|3496688|P1|NOT COMPLETED|Overall Study||3
1428408|NCT02457611|3496688|P1|COMPLETED|Overall Study||23
1428409|NCT02457611|3496688|P1|STARTED|Overall Study||26
1428410|NCT02457546|3496702|P2|NOT COMPLETED|Overall Study||4
1428411|NCT02457546|3496703|P1|NOT COMPLETED|Overall Study||9
1428412|NCT02457546|3496702|P2|COMPLETED|Overall Study||116
1428413|NCT02457546|3496703|P1|COMPLETED|Overall Study||105
1428414|NCT02457546|3496702|P2|STARTED|Overall Study||120
1428415|NCT02457546|3496703|P1|STARTED|Overall Study||114
1428416|NCT02457260|3496714|P3|NOT COMPLETED|Overall Study||1
1428417|NCT02457260|3496715|P2|NOT COMPLETED|Overall Study||3
1428418|NCT02457260|3496716|P1|NOT COMPLETED|Overall Study||2
1428419|NCT02457260|3496714|P3|COMPLETED|Overall Study||1
1428420|NCT02457260|3496715|P2|COMPLETED|Overall Study||4
1428421|NCT02457260|3496716|P1|COMPLETED|Overall Study||10
1428422|NCT02457260|3496714|P3|STARTED|Overall Study||2
1428423|NCT02457260|3496715|P2|STARTED|Overall Study||7
1428424|NCT02457260|3496716|P1|STARTED|Overall Study||12
1428425|NCT02457247|3496758|P4|NOT COMPLETED|Period 2||0
1428426|NCT02457247|3496759|P3|NOT COMPLETED|Period 2||0
1428427|NCT02457247|3496760|P2|NOT COMPLETED|Period 2||3
1428428|NCT02457247|3496761|P1|NOT COMPLETED|Period 2||2
1428429|NCT02457247|3496758|P4|COMPLETED|Period 2||70
1428430|NCT02457247|3496759|P3|COMPLETED|Period 2||68
1428431|NCT02457247|3496760|P2|COMPLETED|Period 2||65
1428432|NCT02457247|3496761|P1|COMPLETED|Period 2||64
1428433|NCT02457247|3496758|P4|STARTED|Period 2||70
1428434|NCT02457247|3496759|P3|STARTED|Period 2||68
1428435|NCT02457247|3496760|P2|STARTED|Period 2||68
1428436|NCT02457247|3496761|P1|STARTED|Period 2||66
1428437|NCT02457247|3496758|P4|NOT COMPLETED|Period 1||0
1428438|NCT02457247|3496759|P3|NOT COMPLETED|Period 1||0
1428439|NCT02457247|3496760|P2|NOT COMPLETED|Period 1||2
1428440|NCT02457247|3496761|P1|NOT COMPLETED|Period 1||2
1428441|NCT02457247|3496758|P4|COMPLETED|Period 1||70
1428442|NCT02457247|3496759|P3|COMPLETED|Period 1||68
1428443|NCT02457247|3496760|P2|COMPLETED|Period 1||68
1428444|NCT02457247|3496761|P1|COMPLETED|Period 1||66
1428445|NCT02457247|3496758|P4|STARTED|Period 1||70
1428446|NCT02457247|3496759|P3|STARTED|Period 1||68
1428447|NCT02457247|3496760|P2|STARTED|Period 1||70
1428448|NCT02457247|3496761|P1|STARTED|Period 1||68
1428449|NCT02457182|3496783|P2|NOT COMPLETED|Overall Study||0
1428450|NCT02457182|3496784|P1|NOT COMPLETED|Overall Study||1
1428451|NCT02457182|3496783|P2|COMPLETED|Overall Study||11
1428452|NCT02457182|3496784|P1|COMPLETED|Overall Study||8
1428453|NCT02457182|3496783|P2|STARTED|Overall Study||11
1428454|NCT02457182|3496784|P1|STARTED|Overall Study||9
1428455|NCT02457065|3496802|P2|NOT COMPLETED|Overall Study||11
1428456|NCT02457065|3496803|P1|NOT COMPLETED|Overall Study||9
1428457|NCT02457065|3496802|P2|COMPLETED|Overall Study||16
1428458|NCT02457065|3496803|P1|COMPLETED|Overall Study||18
1428459|NCT02457065|3496802|P2|STARTED|Overall Study||27
1428460|NCT02457065|3496803|P1|STARTED|Overall Study||27
1428461|NCT02456740|3496814|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
1428462|NCT02456740|3496815|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
1428463|NCT02456740|3496816|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
1428464|NCT02456740|3496817|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
1428465|NCT02456740|3496818|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
1428466|NCT02456740|3496819|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
1428467|NCT02456740|3496820|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1428468|NCT02456740|3496821|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1428469|NCT02456740|3496822|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1428470|NCT02456740|3496814|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
1428471|NCT02456740|3496815|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
1428472|NCT02456740|3496816|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
1428473|NCT02456740|3496817|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
1428474|NCT02456740|3496818|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
1428475|NCT02456740|3496819|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
1428476|NCT02456740|3496820|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1428477|NCT02456740|3496821|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1428478|NCT02456740|3496822|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1428479|NCT02456740|3496814|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
1428480|NCT02456740|3496815|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
1428481|NCT02456740|3496816|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
1428482|NCT02456740|3496817|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
1428483|NCT02456740|3496818|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
1428484|NCT02456740|3496819|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
1428485|NCT02456740|3496820|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1428486|NCT02456740|3496821|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1428487|NCT02456740|3496822|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1428488|NCT02456740|3496814|P9|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428489|NCT02456740|3496815|P8|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428490|NCT02456740|3496816|P7|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428491|NCT02456740|3496817|P6|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428492|NCT02456740|3496818|P5|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428493|NCT02456740|3496819|P4|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428494|NCT02456740|3496820|P3|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
1428495|NCT02456740|3496821|P2|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
1428496|NCT02456740|3496822|P1|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
1428497|NCT02456740|3496814|P9|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428498|NCT02456740|3496815|P8|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428499|NCT02456740|3496816|P7|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428500|NCT02456740|3496817|P6|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428501|NCT02456740|3496818|P5|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428502|NCT02456740|3496819|P4|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
1428503|NCT02456740|3496820|P3|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
1428504|NCT02456740|3496821|P2|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
1428505|NCT02456740|3496822|P1|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
1428506|NCT02456740|3496814|P9|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1428507|NCT02456740|3496815|P8|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1428508|NCT02456740|3496816|P7|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1428509|NCT02456740|3496817|P6|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1428510|NCT02456740|3496818|P5|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1428511|NCT02456740|3496819|P4|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
1428512|NCT02456740|3496820|P3|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
1428513|NCT02456740|3496821|P2|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
1428514|NCT02456740|3496822|P1|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
1428515|NCT02456740|3496814|P9|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1428516|NCT02456740|3496815|P8|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1428517|NCT02456740|3496816|P7|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1428518|NCT02456740|3496817|P6|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1428519|NCT02456740|3496818|P5|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1428520|NCT02456740|3496819|P4|STARTED|Double-blind Treatment Phase (24 Weeks)||0
1428521|NCT02456740|3496820|P3|STARTED|Double-blind Treatment Phase (24 Weeks)||319
1428522|NCT02456740|3496821|P2|STARTED|Double-blind Treatment Phase (24 Weeks)||317
1428523|NCT02456740|3496822|P1|STARTED|Double-blind Treatment Phase (24 Weeks)||319
1428524|NCT02455518|3496848|P4|NOT COMPLETED|Overall Study||3
1428525|NCT02455518|3496849|P3|NOT COMPLETED|Overall Study||1
1428526|NCT02455518|3496850|P2|NOT COMPLETED|Overall Study||1
1428527|NCT02455518|3496851|P1|NOT COMPLETED|Overall Study||0
1428528|NCT02455518|3496848|P4|COMPLETED|Overall Study||101
1428529|NCT02455518|3496849|P3|COMPLETED|Overall Study||103
1428530|NCT02455518|3496850|P2|COMPLETED|Overall Study||103
1428531|NCT02455518|3496851|P1|COMPLETED|Overall Study||104
1428532|NCT02455518|3496848|P4|STARTED|Overall Study||104
1428533|NCT02455518|3496849|P3|STARTED|Overall Study||104
1428534|NCT02455518|3496850|P2|STARTED|Overall Study||104
1428535|NCT02455518|3496851|P1|STARTED|Overall Study||104
1428536|NCT02455388|3496867|P3|NOT COMPLETED|Overall Study||11
1428537|NCT02455388|3496868|P2|NOT COMPLETED|Overall Study||0
1428538|NCT02455388|3496869|P1|NOT COMPLETED|Overall Study||1
1428539|NCT02455388|3496867|P3|COMPLETED|Overall Study||326
1428540|NCT02455388|3496868|P2|COMPLETED|Overall Study||15
1428541|NCT02455388|3496869|P1|COMPLETED|Overall Study||17
1428542|NCT02455388|3496867|P3|STARTED|Overall Study||337
1428543|NCT02455388|3496868|P2|STARTED|Overall Study||15
1428544|NCT02455388|3496869|P1|STARTED|Overall Study||18
1428545|NCT02455050|3496880|P4|NOT COMPLETED|Treatment Period 2||1
1428546|NCT02455050|3496881|P3|NOT COMPLETED|Treatment Period 2||2
1428547|NCT02455050|3496882|P2|NOT COMPLETED|Treatment Period 2||0
1428548|NCT02455050|3496883|P1|NOT COMPLETED|Treatment Period 2||1
1428549|NCT02455050|3496880|P4|COMPLETED|Treatment Period 2||17
1428550|NCT02455050|3496881|P3|COMPLETED|Treatment Period 2||17
1428551|NCT02455050|3496882|P2|COMPLETED|Treatment Period 2||18
1428552|NCT02455050|3496883|P1|COMPLETED|Treatment Period 2||18
1428553|NCT02455050|3496880|P4|STARTED|Treatment Period 2||18
1428554|NCT02455050|3496881|P3|STARTED|Treatment Period 2||19
1428555|NCT02455050|3496882|P2|STARTED|Treatment Period 2||18
1428556|NCT02455050|3496883|P1|STARTED|Treatment Period 2||19
1428557|NCT02455050|3496880|P4|NOT COMPLETED|Treatment Period 1||2
1428558|NCT02455050|3496881|P3|NOT COMPLETED|Treatment Period 1||1
1428559|NCT02455050|3496882|P2|NOT COMPLETED|Treatment Period 1||1
1428560|NCT02455050|3496883|P1|NOT COMPLETED|Treatment Period 1||1
1428561|NCT02455050|3496880|P4|COMPLETED|Treatment Period 1||18
1428562|NCT02455050|3496881|P3|COMPLETED|Treatment Period 1||19
1428563|NCT02455050|3496882|P2|COMPLETED|Treatment Period 1||18
1428564|NCT02455050|3496883|P1|COMPLETED|Treatment Period 1||19
1428565|NCT02455050|3496880|P4|STARTED|Treatment Period 1||20
1428566|NCT02455050|3496881|P3|STARTED|Treatment Period 1||20
1428567|NCT02455050|3496882|P2|STARTED|Treatment Period 1||19
1428568|NCT02455050|3496883|P1|STARTED|Treatment Period 1||20
1428569|NCT02454959|3496947|P1|NOT COMPLETED|Overall Study||9
1428570|NCT02454959|3496947|P1|COMPLETED|Overall Study||70
1428571|NCT02454959|3496947|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
1428572|NCT02454959|3496947|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
1428573|NCT02454959|3496947|P1|STARTED|Overall Study||79
1428574|NCT02454933|3496967|P2|NOT COMPLETED|Overall Study||8
1428575|NCT02454933|3496968|P1|NOT COMPLETED|Overall Study||8
1428576|NCT02454933|3496967|P2|COMPLETED|Overall Study||4
1428577|NCT02454933|3496968|P1|COMPLETED|Overall Study||9
1428578|NCT02454933|3496967|P2|Treatment Group Randomised to|Overall Study||14
1428579|NCT02454933|3496968|P1|Treatment Group Randomised to|Overall Study||15
1428580|NCT02454933|3496967|P2|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
1428581|NCT02454933|3496968|P1|STARTED|Overall Study||17
1428582|NCT02454608|3496976|P3|NOT COMPLETED|Open Label Period||19
1428583|NCT02454608|3496977|P2|NOT COMPLETED|Open Label Period||0
1428584|NCT02454608|3496978|P1|NOT COMPLETED|Open Label Period||0
1428585|NCT02454608|3496976|P3|COMPLETED|Open Label Period||10
1428586|NCT02454608|3496977|P2|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
1428587|NCT02454608|3496978|P1|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
1428588|NCT02454608|3496976|P3|STARTED|Open Label Period||29
1428589|NCT02454608|3496977|P2|STARTED|Open Label Period|This arm is not part of this period of the study|0
1428590|NCT02454608|3496978|P1|STARTED|Open Label Period|This arm is not part of this period of the study|0
1428591|NCT02454608|3496976|P3|NOT COMPLETED|Double-Blind Period||0
1428592|NCT02454608|3496977|P2|NOT COMPLETED|Double-Blind Period||2
1428593|NCT02454608|3496978|P1|NOT COMPLETED|Double-Blind Period||0
1428594|NCT02454608|3496976|P3|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
1428595|NCT02454608|3496977|P2|COMPLETED|Double-Blind Period||12
1428596|NCT02454608|3496978|P1|COMPLETED|Double-Blind Period||15
1428597|NCT02454608|3496976|P3|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
1428598|NCT02454608|3496977|P2|STARTED|Double-Blind Period||14
1428599|NCT02454608|3496978|P1|STARTED|Double-Blind Period||15
1428600|NCT02454296|3497001|P2|NOT COMPLETED|Overall Study||0
1428601|NCT02454296|3497002|P1|NOT COMPLETED|Overall Study||0
1428602|NCT02454296|3497001|P2|COMPLETED|Overall Study||21
1428603|NCT02454296|3497002|P1|COMPLETED|Overall Study||20
1428604|NCT02454296|3497001|P2|STARTED|Overall Study||21
1428605|NCT02454296|3497002|P1|STARTED|Overall Study||20
1428606|NCT02454283|3497014|P2|NOT COMPLETED|Overall Study||0
1428607|NCT02454283|3497015|P1|NOT COMPLETED|Overall Study||0
1428608|NCT02454283|3497014|P2|COMPLETED|Overall Study||15
1428609|NCT02454283|3497015|P1|COMPLETED|Overall Study||26
1428610|NCT02454283|3497014|P2|STARTED|Overall Study||15
1428611|NCT02454283|3497015|P1|STARTED|Overall Study||26
1428612|NCT02454127|3497027|P4|NOT COMPLETED|Overall Study||20
1428613|NCT02454127|3497028|P3|NOT COMPLETED|Overall Study||14
1428614|NCT02454127|3497029|P2|NOT COMPLETED|Overall Study||14
1428615|NCT02454127|3497030|P1|NOT COMPLETED|Overall Study||19
1428616|NCT02454127|3497027|P4|COMPLETED|Overall Study||20
1428617|NCT02454127|3497028|P3|COMPLETED|Overall Study||26
1428618|NCT02454127|3497029|P2|COMPLETED|Overall Study||26
1428619|NCT02454127|3497030|P1|COMPLETED|Overall Study||21
1428620|NCT02454127|3497027|P4|STARTED|Overall Study||40
1428621|NCT02454127|3497028|P3|STARTED|Overall Study||40
1428622|NCT02454127|3497029|P2|STARTED|Overall Study||40
1428623|NCT02454127|3497030|P1|STARTED|Overall Study||40
1428624|NCT02454101|3497070|P2|NOT COMPLETED|Overall Study||7
1428625|NCT02454101|3497071|P1|NOT COMPLETED|Overall Study||5
1428626|NCT02454101|3497070|P2|COMPLETED|Overall Study||143
1428627|NCT02454101|3497071|P1|COMPLETED|Overall Study||145
1428628|NCT02454101|3497070|P2|STARTED|Overall Study||150
1428629|NCT02454101|3497071|P1|STARTED|Overall Study||150
1428630|NCT02453841|3497093|P1|NOT COMPLETED|Overall Study||3
1428631|NCT02453841|3497093|P1|COMPLETED|Overall Study||27
1428632|NCT02453841|3497093|P1|STARTED|Overall Study||30
1428633|NCT02453581|3497100|P3|NOT COMPLETED|Overall Study||0
1428634|NCT02453581|3497101|P2|NOT COMPLETED|Overall Study||0
1428635|NCT02453581|3497102|P1|NOT COMPLETED|Overall Study||0
1428636|NCT02453581|3497100|P3|COMPLETED|Overall Study||8
1428637|NCT02453581|3497101|P2|COMPLETED|Overall Study||8
1428638|NCT02453581|3497102|P1|COMPLETED|Overall Study||8
1428639|NCT02453581|3497100|P3|STARTED|Overall Study||8
1428640|NCT02453581|3497101|P2|STARTED|Overall Study||8
1428641|NCT02453581|3497102|P1|STARTED|Overall Study||8
1428642|NCT02453347|3497122|P1|NOT COMPLETED|Overall Study||0
1428643|NCT02453347|3497122|P1|COMPLETED|Overall Study||6
1428644|NCT02453347|3497122|P1|STARTED|Overall Study||6
1428645|NCT02453321|3497138|P3|NOT COMPLETED|Overall Study||2
1428646|NCT02453321|3497139|P2|NOT COMPLETED|Overall Study||2
1428647|NCT02453321|3497140|P1|NOT COMPLETED|Overall Study||1
1428648|NCT02453321|3497138|P3|COMPLETED|Overall Study||19
1428649|NCT02453321|3497139|P2|COMPLETED|Overall Study||19
1428650|NCT02453321|3497140|P1|COMPLETED|Overall Study||19
1428651|NCT02453321|3497138|P3|STARTED|Overall Study||21
1428652|NCT02453321|3497139|P2|STARTED|Overall Study||21
1428653|NCT02453321|3497140|P1|STARTED|Overall Study||20
1428654|NCT02452944|3497159|P2|NOT COMPLETED|Overall Study||0
1428655|NCT02452944|3497160|P1|NOT COMPLETED|Overall Study||0
1428656|NCT02452944|3497159|P2|COMPLETED|Overall Study||31
1428657|NCT02452944|3497160|P1|COMPLETED|Overall Study||31
1428658|NCT02452944|3497159|P2|STARTED|Overall Study||31
1428659|NCT02452944|3497160|P1|STARTED|Overall Study||31
1428660|NCT02452892|3497172|P4|NOT COMPLETED|Follow-up||1
1428661|NCT02452892|3497173|P3|NOT COMPLETED|Follow-up||0
1428662|NCT02452892|3497174|P2|NOT COMPLETED|Follow-up||0
1428663|NCT02452892|3497175|P1|NOT COMPLETED|Follow-up||1
1428664|NCT02452892|3497172|P4|COMPLETED|Follow-up||38
1428665|NCT02452892|3497173|P3|COMPLETED|Follow-up||7
1428666|NCT02452892|3497174|P2|COMPLETED|Follow-up||7
1428667|NCT02452892|3497175|P1|COMPLETED|Follow-up||62
1428668|NCT02452892|3497172|P4|STARTED|Follow-up||39
1428669|NCT02452892|3497173|P3|STARTED|Follow-up||7
1428670|NCT02452892|3497174|P2|STARTED|Follow-up||7
1428671|NCT02452892|3497175|P1|STARTED|Follow-up||63
1428672|NCT02452892|3497172|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
1428673|NCT02452892|3497173|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
1428674|NCT02452892|3497174|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
1428675|NCT02452892|3497175|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
1428676|NCT02452892|3497172|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
1428677|NCT02452892|3497173|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
1428678|NCT02452892|3497174|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
1428679|NCT02452892|3497175|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
1428680|NCT02452892|3497172|P4|Responders|Week 2 Stratification & Re-Randomization||0
1428681|NCT02452892|3497173|P3|Responders|Week 2 Stratification & Re-Randomization||7
1428682|NCT02452892|3497174|P2|Responders|Week 2 Stratification & Re-Randomization||7
1428683|NCT02452892|3497175|P1|Responders|Week 2 Stratification & Re-Randomization||27
1428684|NCT02452892|3497172|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
1428685|NCT02452892|3497173|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
1428686|NCT02452892|3497174|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
1428687|NCT02452892|3497175|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
1428688|NCT02452892|3497172|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
1428689|NCT02452892|3497173|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
1428690|NCT02452892|3497174|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
1428691|NCT02452892|3497175|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
1428692|NCT02452892|3497172|P4|NOT COMPLETED|Week 1 Initial Randommization||0
1428693|NCT02452892|3497173|P3|NOT COMPLETED|Week 1 Initial Randommization||1
1428694|NCT02452892|3497174|P2|NOT COMPLETED|Week 1 Initial Randommization||0
1428695|NCT02452892|3497175|P1|NOT COMPLETED|Week 1 Initial Randommization||1
1428696|NCT02452892|3497172|P4|COMPLETED|Week 1 Initial Randommization||0
1428697|NCT02452892|3497173|P3|COMPLETED|Week 1 Initial Randommization||40
1428698|NCT02452892|3497174|P2|COMPLETED|Week 1 Initial Randommization||40
1428699|NCT02452892|3497175|P1|COMPLETED|Week 1 Initial Randommization||40
1428700|NCT02452892|3497172|P4|STARTED|Week 1 Initial Randommization||0
1428701|NCT02452892|3497173|P3|STARTED|Week 1 Initial Randommization||41
1428702|NCT02452892|3497174|P2|STARTED|Week 1 Initial Randommization||40
1428703|NCT02452892|3497175|P1|STARTED|Week 1 Initial Randommization||41
1428704|NCT02452528|3497206|P2|NOT COMPLETED|Overall Study||1
1428705|NCT02452528|3497207|P1|NOT COMPLETED|Overall Study||1
1428706|NCT02452528|3497206|P2|COMPLETED|Overall Study||1
1428707|NCT02452528|3497207|P1|COMPLETED|Overall Study||1
1428708|NCT02452528|3497206|P2|STARTED|Overall Study||2
1428709|NCT02452528|3497207|P1|STARTED|Overall Study||2
1428710|NCT02452346|3497239|P1|NOT COMPLETED|Overall Study||9
1428711|NCT02452346|3497239|P1|COMPLETED|Overall Study||3
1428712|NCT02452346|3497239|P1|STARTED|Overall Study||12
1428713|NCT02452320|3497247|P2|NOT COMPLETED|Overall Study||1
1428714|NCT02452320|3497248|P1|NOT COMPLETED|Overall Study||0
1428715|NCT02452320|3497247|P2|COMPLETED|Overall Study||63
1428716|NCT02452320|3497248|P1|COMPLETED|Overall Study||64
1428717|NCT02452320|3497247|P2|STARTED|Overall Study||64
1428718|NCT02452320|3497248|P1|STARTED|Overall Study||64
1428719|NCT02452047|3497261|P3|NOT COMPLETED|Overall Study||2
1428720|NCT02452047|3497262|P2|NOT COMPLETED|Overall Study||5
1428721|NCT02452047|3497263|P1|NOT COMPLETED|Overall Study||4
1428722|NCT02452047|3497261|P3|COMPLETED|Overall Study||1
1428723|NCT02452047|3497262|P2|COMPLETED|Overall Study||11
1428724|NCT02452047|3497263|P1|COMPLETED|Overall Study||27
1428725|NCT02452047|3497261|P3|STARTED|Overall Study||3
1428726|NCT02452047|3497262|P2|STARTED|Overall Study||16
1428727|NCT02452047|3497263|P1|STARTED|Overall Study||31
1428728|NCT02451917|3497324|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
1428729|NCT02451917|3497325|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
1428730|NCT02451917|3497324|P2|COMPLETED|Second Intervention (24 Weeks)||15
1428731|NCT02451917|3497325|P1|COMPLETED|Second Intervention (24 Weeks)||14
1428732|NCT02451917|3497324|P2|STARTED|Second Intervention (24 Weeks)||15
1428733|NCT02451917|3497325|P1|STARTED|Second Intervention (24 Weeks)||14
1428734|NCT02451917|3497324|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
1428735|NCT02451917|3497325|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
1428736|NCT02451917|3497324|P2|COMPLETED|First Intervention (24 Weeks)||15
1428737|NCT02451917|3497325|P1|COMPLETED|First Intervention (24 Weeks)||14
1428738|NCT02451917|3497324|P2|STARTED|First Intervention (24 Weeks)||18
1428739|NCT02451917|3497325|P1|STARTED|First Intervention (24 Weeks)||16
1428740|NCT02451358|3497347|P4|NOT COMPLETED|Overall Study||0
1428741|NCT02451358|3497348|P3|NOT COMPLETED|Overall Study||1
1428742|NCT02451358|3497349|P2|NOT COMPLETED|Overall Study||2
1428743|NCT02451358|3497350|P1|NOT COMPLETED|Overall Study||1
1428744|NCT02451358|3497347|P4|COMPLETED|Overall Study||100
1428745|NCT02451358|3497348|P3|COMPLETED|Overall Study||99
1428746|NCT02451358|3497349|P2|COMPLETED|Overall Study||98
1428747|NCT02451358|3497350|P1|COMPLETED|Overall Study||99
1428748|NCT02451358|3497347|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
1428749|NCT02451358|3497348|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
1428750|NCT02451358|3497349|P2|Vaccinated at Day 28|Overall Study||98
1428751|NCT02451358|3497350|P1|Vaccinated at Day 28|Overall Study||99
1428752|NCT02451358|3497347|P4|Vaccinated at Day 0|Overall Study||100
1428753|NCT02451358|3497348|P3|Vaccinated at Day 0|Overall Study||100
1428754|NCT02451358|3497349|P2|Vaccinated at Day 0|Overall Study||100
1428755|NCT02451358|3497350|P1|Vaccinated at Day 0|Overall Study||100
1428756|NCT02451358|3497347|P4|STARTED|Overall Study||100
1428757|NCT02451358|3497348|P3|STARTED|Overall Study||100
1428758|NCT02451358|3497349|P2|STARTED|Overall Study||100
1428759|NCT02451358|3497350|P1|STARTED|Overall Study||100
1428760|NCT02451150|3497374|P2|NOT COMPLETED|Overall Study||0
1428761|NCT02451150|3497375|P1|NOT COMPLETED|Overall Study||0
1428762|NCT02451150|3497374|P2|COMPLETED|Overall Study||3
1428763|NCT02451150|3497375|P1|COMPLETED|Overall Study||3
1428764|NCT02451150|3497374|P2|STARTED|Overall Study||3
1428765|NCT02451150|3497375|P1|STARTED|Overall Study||3
1428766|NCT02450799|3497428|P3|NOT COMPLETED|Overall Study||0
1428767|NCT02450799|3497429|P2|NOT COMPLETED|Overall Study||0
1428768|NCT02450799|3497430|P1|NOT COMPLETED|Overall Study||0
1428769|NCT02450799|3497428|P3|COMPLETED|Overall Study||30
1428770|NCT02450799|3497429|P2|COMPLETED|Overall Study||37
1428771|NCT02450799|3497430|P1|COMPLETED|Overall Study||31
1428772|NCT02450799|3497428|P3|STARTED|Overall Study||30
1428773|NCT02450799|3497429|P2|STARTED|Overall Study||37
1428774|NCT02450799|3497430|P1|STARTED|Overall Study||31
1428775|NCT02450747|3497441|P1|NOT COMPLETED|Overall Study||0
1428776|NCT02450747|3497441|P1|COMPLETED|Overall Study||39
1428777|NCT02450747|3497441|P1|STARTED|Overall Study||39
1428778|NCT02450591|3497450|P1|NOT COMPLETED|Overall Study||0
1428779|NCT02450591|3497450|P1|COMPLETED|Overall Study||4
1428780|NCT02450591|3497450|P1|STARTED|Overall Study||4
1428781|NCT02450539|3497456|P2|NOT COMPLETED|Overall Study||33
1428782|NCT02450539|3497457|P1|NOT COMPLETED|Overall Study||50
1428783|NCT02450539|3497456|P2|COMPLETED|Overall Study||20
1428784|NCT02450539|3497457|P1|COMPLETED|Overall Study||56
1428785|NCT02450539|3497456|P2|Death|Overall Study||20
1428786|NCT02450539|3497457|P1|Death|Overall Study||56
1428787|NCT02450539|3497456|P2|Received at Least One Dose of Study Drug|Overall Study||52
1428788|NCT02450539|3497457|P1|Received at Least One Dose of Study Drug|Overall Study||106
1428789|NCT02450539|3497456|P2|STARTED|Overall Study||53
1428790|NCT02450539|3497457|P1|STARTED|Overall Study||106
1428791|NCT02450383|3497479|P2|NOT COMPLETED|Overall Study||0
1428792|NCT02450383|3497480|P1|NOT COMPLETED|Overall Study||0
1428793|NCT02450383|3497479|P2|COMPLETED|Overall Study||10
1428794|NCT02450383|3497480|P1|COMPLETED|Overall Study||10
1428795|NCT02450383|3497479|P2|STARTED|Overall Study||10
1428796|NCT02450383|3497480|P1|STARTED|Overall Study||10
1428797|NCT02449915|3497494|P2|NOT COMPLETED|Overall Study||4
1428798|NCT02449915|3497495|P1|NOT COMPLETED|Overall Study||2
1428799|NCT02449915|3497494|P2|COMPLETED|Overall Study||31
1428800|NCT02449915|3497495|P1|COMPLETED|Overall Study||33
1428801|NCT02449915|3497494|P2|STARTED|Overall Study||35
1428802|NCT02449915|3497495|P1|STARTED|Overall Study||35
1428803|NCT02449902|3497503|P2|NOT COMPLETED|Overall Study||2
1428804|NCT02449902|3497504|P1|NOT COMPLETED|Overall Study||0
1428805|NCT02449902|3497503|P2|COMPLETED|Overall Study||24
1428806|NCT02449902|3497504|P1|COMPLETED|Overall Study||24
1428807|NCT02449902|3497503|P2|STARTED|Overall Study||26
1428808|NCT02449902|3497504|P1|STARTED|Overall Study||24
1428809|NCT02449798|3497528|P1|NOT COMPLETED|Overall Study||0
1428810|NCT02449798|3497528|P1|COMPLETED|Overall Study||120
1428811|NCT02449798|3497528|P1|STARTED|Overall Study||120
1428812|NCT02449356|3497542|P2|NOT COMPLETED|Overall Study||0
1428813|NCT02449356|3497543|P1|NOT COMPLETED|Overall Study||0
1428814|NCT02449356|3497542|P2|COMPLETED|Overall Study||30
1428815|NCT02449356|3497543|P1|COMPLETED|Overall Study||30
1428816|NCT02449356|3497542|P2|STARTED|Overall Study||30
1428817|NCT02449356|3497543|P1|STARTED|Overall Study||30
1428818|NCT02449291|3497562|P3|NOT COMPLETED|Overall Study||1
1428819|NCT02449291|3497563|P2|NOT COMPLETED|Overall Study||2
1428820|NCT02449291|3497564|P1|NOT COMPLETED|Overall Study||5
1428821|NCT02449291|3497562|P3|COMPLETED|Overall Study||180
1428822|NCT02449291|3497563|P2|COMPLETED|Overall Study||186
1428823|NCT02449291|3497564|P1|COMPLETED|Overall Study||186
1428824|NCT02449291|3497562|P3|STARTED|Overall Study||181
1428825|NCT02449291|3497563|P2|STARTED|Overall Study||188
1428826|NCT02449291|3497564|P1|STARTED|Overall Study||191
1428827|NCT02449044|3497599|P1|NOT COMPLETED|Overall Study||64
1428828|NCT02449044|3497599|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
1428829|NCT02449044|3497599|P1|STARTED|Overall Study||111
1428830|NCT02449018|3497620|P2|NOT COMPLETED|Overall Study||2
1428831|NCT02449018|3497621|P1|NOT COMPLETED|Overall Study||12
1428832|NCT02449018|3497620|P2|COMPLETED|Overall Study||26
1428833|NCT02449018|3497621|P1|COMPLETED|Overall Study||52
1428834|NCT02449018|3497620|P2|STARTED|Overall Study||28
1428835|NCT02449018|3497621|P1|STARTED|Overall Study||64
1428836|NCT02448914|3497648|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1428837|NCT02448914|3497649|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1428838|NCT02448914|3497648|P2|COMPLETED|Second Intervention (1 Day)||5
1428839|NCT02448914|3497649|P1|COMPLETED|Second Intervention (1 Day)||6
1428840|NCT02448914|3497648|P2|STARTED|Second Intervention (1 Day)||5
1428841|NCT02448914|3497649|P1|STARTED|Second Intervention (1 Day)||6
1428842|NCT02448914|3497648|P2|NOT COMPLETED|First Intervention (1 Day)||0
1428843|NCT02448914|3497649|P1|NOT COMPLETED|First Intervention (1 Day)||0
1428844|NCT02448914|3497648|P2|COMPLETED|First Intervention (1 Day)||5
1428845|NCT02448914|3497649|P1|COMPLETED|First Intervention (1 Day)||6
1428846|NCT02448914|3497648|P2|STARTED|First Intervention (1 Day)||5
1428847|NCT02448914|3497649|P1|STARTED|First Intervention (1 Day)||6
1428848|NCT02448862|3497667|P2|NOT COMPLETED|Overall Study||0
1428849|NCT02448862|3497668|P1|NOT COMPLETED|Overall Study||0
1428850|NCT02448862|3497667|P2|COMPLETED|Overall Study||6050
1428851|NCT02448862|3497668|P1|COMPLETED|Overall Study||4525
1428852|NCT02448862|3497667|P2|STARTED|Overall Study||6050
1428853|NCT02448862|3497668|P1|STARTED|Overall Study||4525
1428854|NCT02448810|3497690|P8|NOT COMPLETED|Overall Study||8
1428855|NCT02448810|3497691|P7|NOT COMPLETED|Overall Study||18
1428856|NCT02448810|3497692|P6|NOT COMPLETED|Overall Study||16
1428857|NCT02448810|3497693|P5|NOT COMPLETED|Overall Study||31
1428858|NCT02448810|3497694|P4|NOT COMPLETED|Overall Study||3
1428859|NCT02448810|3497695|P3|NOT COMPLETED|Overall Study||3
1428860|NCT02448810|3497696|P2|NOT COMPLETED|Overall Study||3
1428861|NCT02448810|3497697|P1|NOT COMPLETED|Overall Study||3
1428862|NCT02448810|3497690|P8|COMPLETED|Overall Study||0
1428863|NCT02448810|3497691|P7|COMPLETED|Overall Study||0
1428864|NCT02448810|3497692|P6|COMPLETED|Overall Study||0
1428865|NCT02448810|3497693|P5|COMPLETED|Overall Study||0
1428866|NCT02448810|3497694|P4|COMPLETED|Overall Study||0
1428867|NCT02448810|3497695|P3|COMPLETED|Overall Study||0
1428868|NCT02448810|3497696|P2|COMPLETED|Overall Study||0
1428869|NCT02448810|3497697|P1|COMPLETED|Overall Study||0
1428870|NCT02448810|3497690|P8|Treated|Overall Study||7
1428871|NCT02448810|3497691|P7|Treated|Overall Study||18
1428872|NCT02448810|3497692|P6|Treated|Overall Study||13
1428873|NCT02448810|3497693|P5|Treated|Overall Study||29
1428874|NCT02448810|3497694|P4|Treated|Overall Study||3
1428875|NCT02448810|3497695|P3|Treated|Overall Study||3
1428876|NCT02448810|3497696|P2|Treated|Overall Study||3
1428877|NCT02448810|3497697|P1|Treated|Overall Study||3
1428878|NCT02448810|3497690|P8|STARTED|Overall Study||8
1428879|NCT02448810|3497691|P7|STARTED|Overall Study||18
1428880|NCT02448810|3497692|P6|STARTED|Overall Study||16
1428881|NCT02448810|3497693|P5|STARTED|Overall Study||31
1428882|NCT02448810|3497694|P4|STARTED|Overall Study||3
1428883|NCT02448810|3497695|P3|STARTED|Overall Study||3
1428884|NCT02448810|3497696|P2|STARTED|Overall Study||3
1428885|NCT02448810|3497697|P1|STARTED|Overall Study||3
1428886|NCT02448563|3497767|P2|NOT COMPLETED|Overall Study||11
1428887|NCT02448563|3497768|P1|NOT COMPLETED|Overall Study||16
1428888|NCT02448563|3497767|P2|COMPLETED|Overall Study||19
1428889|NCT02448563|3497768|P1|COMPLETED|Overall Study||16
1428890|NCT02448563|3497767|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
1428891|NCT02448563|3497768|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
1428892|NCT02448537|3497790|P3|NOT COMPLETED|Overall Study||1
1428893|NCT02448537|3497791|P2|NOT COMPLETED|Overall Study||1
1428894|NCT02448537|3497792|P1|NOT COMPLETED|Overall Study||1
1428895|NCT02448537|3497790|P3|COMPLETED|Overall Study||11
1428896|NCT02448537|3497791|P2|COMPLETED|Overall Study||9
1428897|NCT02448537|3497792|P1|COMPLETED|Overall Study||19
1428898|NCT02448537|3497790|P3|STARTED|Overall Study||12
1428899|NCT02448537|3497791|P2|STARTED|Overall Study||10
1428900|NCT02448537|3497792|P1|STARTED|Overall Study||20
1428901|NCT02448368|3497808|P13|NOT COMPLETED|Overall Study||0
1428902|NCT02448368|3497809|P12|NOT COMPLETED|Overall Study||0
1428903|NCT02448368|3497810|P11|NOT COMPLETED|Overall Study||0
1428904|NCT02448368|3497811|P10|NOT COMPLETED|Overall Study||0
1428905|NCT02448368|3497812|P9|NOT COMPLETED|Overall Study||0
1428906|NCT02448368|3497813|P8|NOT COMPLETED|Overall Study||0
1428907|NCT02448368|3497814|P7|NOT COMPLETED|Overall Study||0
1428908|NCT02448368|3497815|P6|NOT COMPLETED|Overall Study||0
1428909|NCT02448368|3497816|P5|NOT COMPLETED|Overall Study||0
1428910|NCT02448368|3497817|P4|NOT COMPLETED|Overall Study||0
1428911|NCT02448368|3497818|P3|NOT COMPLETED|Overall Study||0
1428912|NCT02448368|3497819|P2|NOT COMPLETED|Overall Study||0
1428913|NCT02448368|3497820|P1|NOT COMPLETED|Overall Study||0
1428914|NCT02448368|3497808|P13|COMPLETED|Overall Study||5
1428915|NCT02448368|3497809|P12|COMPLETED|Overall Study||5
1428916|NCT02448368|3497810|P11|COMPLETED|Overall Study||5
1428917|NCT02448368|3497811|P10|COMPLETED|Overall Study||2
1428918|NCT02448368|3497812|P9|COMPLETED|Overall Study||2
1428919|NCT02448368|3497813|P8|COMPLETED|Overall Study||2
1428920|NCT02448368|3497814|P7|COMPLETED|Overall Study||2
1428921|NCT02448368|3497815|P6|COMPLETED|Overall Study||2
1428922|NCT02448368|3497816|P5|COMPLETED|Overall Study||2
1428923|NCT02448368|3497817|P4|COMPLETED|Overall Study||2
1428924|NCT02448368|3497818|P3|COMPLETED|Overall Study||2
1428925|NCT02448368|3497819|P2|COMPLETED|Overall Study||2
1428926|NCT02448368|3497820|P1|COMPLETED|Overall Study||2
1428927|NCT02448368|3497808|P13|STARTED|Overall Study||5
1428928|NCT02448368|3497809|P12|STARTED|Overall Study||5
1428929|NCT02448368|3497810|P11|STARTED|Overall Study||5
1428930|NCT02448368|3497811|P10|STARTED|Overall Study||2
1428931|NCT02448368|3497812|P9|STARTED|Overall Study||2
1428932|NCT02448368|3497813|P8|STARTED|Overall Study||2
1428933|NCT02448368|3497814|P7|STARTED|Overall Study||2
1428934|NCT02448368|3497815|P6|STARTED|Overall Study||2
1428935|NCT02448368|3497816|P5|STARTED|Overall Study||2
1428936|NCT02448368|3497817|P4|STARTED|Overall Study||2
1428937|NCT02448368|3497818|P3|STARTED|Overall Study||2
1428938|NCT02448368|3497819|P2|STARTED|Overall Study||2
1428939|NCT02448368|3497820|P1|STARTED|Overall Study||2
1428940|NCT02447952|3497895|P1|NOT COMPLETED|Overall Study||7
1428941|NCT02447952|3497895|P1|COMPLETED|Overall Study||18
1428942|NCT02447952|3497895|P1|STARTED|Overall Study||25
1428943|NCT02447848|3497947|P1|NOT COMPLETED|Overall Study||11
1428944|NCT02447848|3497947|P1|COMPLETED|Overall Study||65
1428945|NCT02447848|3497947|P1|STARTED|Overall Study||76
1428946|NCT02447458|3497959|P6|NOT COMPLETED|Overall Study||0
1428947|NCT02447458|3497960|P5|NOT COMPLETED|Overall Study||0
1428948|NCT02447458|3497961|P4|NOT COMPLETED|Overall Study||0
1428949|NCT02447458|3497962|P3|NOT COMPLETED|Overall Study||1
1428950|NCT02447458|3497963|P2|NOT COMPLETED|Overall Study||0
1428951|NCT02447458|3497964|P1|NOT COMPLETED|Overall Study||0
1428952|NCT02447458|3497959|P6|COMPLETED|Overall Study||10
1428953|NCT02447458|3497960|P5|COMPLETED|Overall Study||6
1428954|NCT02447458|3497961|P4|COMPLETED|Overall Study||6
1428955|NCT02447458|3497962|P3|COMPLETED|Overall Study||5
1428956|NCT02447458|3497963|P2|COMPLETED|Overall Study||6
1428957|NCT02447458|3497964|P1|COMPLETED|Overall Study||5
1428958|NCT02447458|3497959|P6|STARTED|Overall Study||10
1428959|NCT02447458|3497960|P5|STARTED|Overall Study||6
1428960|NCT02447458|3497961|P4|STARTED|Overall Study||6
1428961|NCT02447458|3497962|P3|STARTED|Overall Study||6
1428962|NCT02447458|3497963|P2|STARTED|Overall Study||6
1428963|NCT02447458|3497964|P1|STARTED|Overall Study||5
1428964|NCT02447432|3498062|P2|NOT COMPLETED|Epoch 002||0
1428965|NCT02447432|3498063|P1|NOT COMPLETED|Epoch 002||0
1428966|NCT02447432|3498062|P2|COMPLETED|Epoch 002||145
1428967|NCT02447432|3498063|P1|COMPLETED|Epoch 002||152
1428968|NCT02447432|3498062|P2|STARTED|Epoch 002||145
1428969|NCT02447432|3498063|P1|STARTED|Epoch 002||152
1428970|NCT02447432|3498062|P2|NOT COMPLETED|Epoch 001||13
1428971|NCT02447432|3498063|P1|NOT COMPLETED|Epoch 001||5
1428972|NCT02447432|3498062|P2|COMPLETED|Epoch 001||147
1428973|NCT02447432|3498063|P1|COMPLETED|Epoch 001||155
1428974|NCT02447432|3498062|P2|STARTED|Epoch 001||160
1428975|NCT02447432|3498063|P1|STARTED|Epoch 001||160
1428976|NCT02447328|3498095|P1|NOT COMPLETED|Overall Study||1
1428977|NCT02447328|3498095|P1|COMPLETED|Overall Study||82
1428978|NCT02447328|3498095|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
1428979|NCT02447133|3498099|P1|NOT COMPLETED|Overall Study||0
1428980|NCT02447133|3498099|P1|COMPLETED|Overall Study||12
1428981|NCT02447133|3498099|P1|STARTED|Overall Study||12
1428982|NCT02447029|3498107|P2|NOT COMPLETED|Overall Study||2
1428983|NCT02447029|3498108|P1|NOT COMPLETED|Overall Study||3
1428984|NCT02447029|3498107|P2|COMPLETED|Overall Study||68
1428985|NCT02447029|3498108|P1|COMPLETED|Overall Study||69
1428986|NCT02447029|3498107|P2|Treated|Overall Study||68
1428987|NCT02447029|3498108|P1|Treated|Overall Study||69
1428988|NCT02447029|3498107|P2|STARTED|Overall Study||70
1428989|NCT02447029|3498108|P1|STARTED|Overall Study||72
1428990|NCT02446990|3498128|P2|NOT COMPLETED|Overall Study||658
1428991|NCT02446990|3498129|P1|NOT COMPLETED|Overall Study||720
1428992|NCT02446990|3498128|P2|COMPLETED|Overall Study||8894
1428993|NCT02446990|3498129|P1|COMPLETED|Overall Study||8830
1428994|NCT02446990|3498128|P2|STARTED|Overall Study||9552
1428995|NCT02446990|3498129|P1|STARTED|Overall Study||9550
1428996|NCT02446743|3498163|P2|NOT COMPLETED|Overall Study||5
1428997|NCT02446743|3498164|P1|NOT COMPLETED|Overall Study||5
1428998|NCT02446743|3498163|P2|COMPLETED|Overall Study||250
1428999|NCT02446743|3498164|P1|COMPLETED|Overall Study||271
1429000|NCT02446743|3498163|P2|STARTED|Overall Study||255
1429001|NCT02446743|3498164|P1|STARTED|Overall Study||276
1429002|NCT02446717|3498319|P5|NOT COMPLETED|Overall Study||1
1429003|NCT02446717|3498320|P4|NOT COMPLETED|Overall Study||1
1429004|NCT02446717|3498321|P3|NOT COMPLETED|Overall Study||2
1429005|NCT02446717|3498322|P2|NOT COMPLETED|Overall Study||1
1429006|NCT02446717|3498323|P1|NOT COMPLETED|Overall Study||0
1429007|NCT02446717|3498319|P5|COMPLETED|Overall Study||46
1429008|NCT02446717|3498320|P4|COMPLETED|Overall Study||43
1429009|NCT02446717|3498321|P3|COMPLETED|Overall Study||20
1429010|NCT02446717|3498322|P2|COMPLETED|Overall Study||21
1429011|NCT02446717|3498323|P1|COMPLETED|Overall Study||6
1429012|NCT02446717|3498319|P5|STARTED|Overall Study||47
1429013|NCT02446717|3498320|P4|STARTED|Overall Study||44
1429014|NCT02446717|3498321|P3|STARTED|Overall Study||22
1429015|NCT02446717|3498322|P2|STARTED|Overall Study||22
1429016|NCT02446717|3498323|P1|STARTED|Overall Study||6
1429017|NCT02446613|3498352|P2|NOT COMPLETED|Overall Study||0
1429018|NCT02446613|3498353|P1|NOT COMPLETED|Overall Study||0
1429019|NCT02446613|3498352|P2|COMPLETED|Overall Study||10
1429020|NCT02446613|3498353|P1|COMPLETED|Overall Study||6
1429021|NCT02446613|3498352|P2|STARTED|Overall Study||10
1429022|NCT02446613|3498353|P1|STARTED|Overall Study||6
1429023|NCT02446496|3498375|P1|NOT COMPLETED|Overall Study||0
1429024|NCT02446496|3498375|P1|COMPLETED|Overall Study||24
1429025|NCT02446496|3498375|P1|STARTED|Overall Study||24
1429026|NCT02446483|3498387|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
1429027|NCT02446483|3498388|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
1429028|NCT02446483|3498387|P2|COMPLETED|Period 3: Intervention Period 2||30
1429029|NCT02446483|3498388|P1|COMPLETED|Period 3: Intervention Period 2||30
1429030|NCT02446483|3498387|P2|STARTED|Period 3: Intervention Period 2||30
1429031|NCT02446483|3498388|P1|STARTED|Period 3: Intervention Period 2||30
1429032|NCT02446483|3498387|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1429033|NCT02446483|3498388|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1429034|NCT02446483|3498387|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
1429035|NCT02446483|3498388|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
1429036|NCT02446483|3498387|P2|STARTED|Period 2: Washout Period (7 Days)||30
1429037|NCT02446483|3498388|P1|STARTED|Period 2: Washout Period (7 Days)||30
1429038|NCT02446483|3498387|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
1429039|NCT02446483|3498388|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
1429040|NCT02446483|3498387|P2|COMPLETED|Period 1: Intervention Period 1||30
1429041|NCT02446483|3498388|P1|COMPLETED|Period 1: Intervention Period 1||30
1429042|NCT02446483|3498387|P2|STARTED|Period 1: Intervention Period 1||30
1429043|NCT02446483|3498388|P1|STARTED|Period 1: Intervention Period 1||30
1429044|NCT02446171|3498404|P4|NOT COMPLETED|Overall Study||0
1429045|NCT02446171|3498405|P3|NOT COMPLETED|Overall Study||2
1429046|NCT02446171|3498406|P2|NOT COMPLETED|Overall Study||0
1429047|NCT02446171|3498407|P1|NOT COMPLETED|Overall Study||0
1429048|NCT02446171|3498404|P4|COMPLETED|Overall Study||11
1429049|NCT02446171|3498405|P3|COMPLETED|Overall Study||9
1429050|NCT02446171|3498406|P2|COMPLETED|Overall Study||11
1429051|NCT02446171|3498407|P1|COMPLETED|Overall Study||11
1429052|NCT02446171|3498404|P4|STARTED|Overall Study||11
1429053|NCT02446171|3498405|P3|STARTED|Overall Study||11
1429054|NCT02446171|3498406|P2|STARTED|Overall Study||11
1429055|NCT02446171|3498407|P1|STARTED|Overall Study||11
1429056|NCT02446015|3498478|P2|NOT COMPLETED|Overall Study||1
1429057|NCT02446015|3498479|P1|NOT COMPLETED|Overall Study||1
1429058|NCT02446015|3498478|P2|COMPLETED|Overall Study||62
1429059|NCT02446015|3498479|P1|COMPLETED|Overall Study||33
1429060|NCT02446015|3498478|P2|STARTED|Overall Study||63
1429061|NCT02446015|3498479|P1|STARTED|Overall Study||34
1429062|NCT02445807|3498492|P2|NOT COMPLETED|Overall Study||0
1429063|NCT02445807|3498493|P1|NOT COMPLETED|Overall Study||0
1429064|NCT02445807|3498492|P2|COMPLETED|Overall Study||89
1429065|NCT02445807|3498493|P1|COMPLETED|Overall Study||176
1429066|NCT02445807|3498492|P2|STARTED|Overall Study||89
1429067|NCT02445807|3498493|P1|STARTED|Overall Study||176
1429068|NCT02445755|3498503|P1|NOT COMPLETED|Overall Study||13
1429069|NCT02445755|3498503|P1|COMPLETED|Overall Study||100
1429070|NCT02445755|3498503|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
1429071|NCT02445573|3498512|P2|NOT COMPLETED|Overall Study||2
1429072|NCT02445573|3498513|P1|NOT COMPLETED|Overall Study||1
1429073|NCT02445573|3498512|P2|COMPLETED|Overall Study||38
1429074|NCT02445573|3498513|P1|COMPLETED|Overall Study||39
1429075|NCT02445573|3498512|P2|STARTED|Overall Study||40
1429076|NCT02445573|3498513|P1|STARTED|Overall Study||40
1429077|NCT02445326|3498529|P2|NOT COMPLETED|Overall Study||1
1429078|NCT02445326|3498530|P1|NOT COMPLETED|Overall Study||2
1429079|NCT02445326|3498529|P2|COMPLETED|Overall Study||37
1429080|NCT02445326|3498530|P1|COMPLETED|Overall Study||33
1429081|NCT02445326|3498529|P2|STARTED|Overall Study||38
1429082|NCT02445326|3498530|P1|STARTED|Overall Study||35
1429083|NCT02445287|3498548|P2|NOT COMPLETED|Overall Study||0
1429084|NCT02445287|3498549|P1|NOT COMPLETED|Overall Study||0
1429085|NCT02445287|3498548|P2|COMPLETED|Overall Study||13
1429086|NCT02445287|3498549|P1|COMPLETED|Overall Study||35
1429087|NCT02445287|3498548|P2|STARTED|Overall Study||13
1429088|NCT02445287|3498549|P1|STARTED|Overall Study||35
1429089|NCT02445196|3498564|P2|NOT COMPLETED|Overall Study||6
1429090|NCT02445196|3498565|P1|NOT COMPLETED|Overall Study||11
1429091|NCT02445196|3498564|P2|COMPLETED|Overall Study||52
1429092|NCT02445196|3498565|P1|COMPLETED|Overall Study||51
1429093|NCT02445196|3498564|P2|STARTED|Overall Study||58
1429094|NCT02445196|3498565|P1|STARTED|Overall Study||62
1429095|NCT02444936|3498580|P2|NOT COMPLETED|Overall Study||0
1429096|NCT02444936|3498581|P1|NOT COMPLETED|Overall Study||0
1429097|NCT02444936|3498580|P2|COMPLETED|Overall Study||12
1429098|NCT02444936|3498581|P1|COMPLETED|Overall Study||10
1429099|NCT02444936|3498580|P2|STARTED|Overall Study||12
1429100|NCT02444936|3498581|P1|STARTED|Overall Study||10
1429101|NCT02444715|3498589|P2|NOT COMPLETED|Overall Study||16
1429102|NCT02444715|3498590|P1|NOT COMPLETED|Overall Study||10
1429103|NCT02444715|3498589|P2|COMPLETED|Overall Study||32
1429104|NCT02444715|3498590|P1|COMPLETED|Overall Study||36
1429105|NCT02444715|3498589|P2|STARTED|Overall Study||48
1429106|NCT02444715|3498590|P1|STARTED|Overall Study||46
1429107|NCT02444533|3498621|P2|NOT COMPLETED|Overall Study||4
1429108|NCT02444533|3498622|P1|NOT COMPLETED|Overall Study||2
1429109|NCT02444533|3498621|P2|COMPLETED|Overall Study||18
1429110|NCT02444533|3498622|P1|COMPLETED|Overall Study||15
1429111|NCT02444533|3498621|P2|STARTED|Overall Study||22
1429112|NCT02444533|3498622|P1|STARTED|Overall Study||17
1429113|NCT02444182|3498638|P2|NOT COMPLETED|Overall Study||5
1429114|NCT02444182|3498639|P1|NOT COMPLETED|Overall Study||2
1429115|NCT02444182|3498638|P2|COMPLETED|Overall Study||49
1429116|NCT02444182|3498639|P1|COMPLETED|Overall Study||52
1429117|NCT02444182|3498638|P2|STARTED|Overall Study||54
1429118|NCT02444182|3498639|P1|STARTED|Overall Study||54
1429119|NCT02444143|3498649|P2|NOT COMPLETED|Overall Study||1
1429120|NCT02444143|3498650|P1|NOT COMPLETED|Overall Study||0
1429121|NCT02444143|3498649|P2|COMPLETED|Overall Study|1 patient withdrawal|9
1429122|NCT02444143|3498650|P1|COMPLETED|Overall Study||10
1429123|NCT02444143|3498649|P2|STARTED|Overall Study||10
1429124|NCT02444143|3498650|P1|STARTED|Overall Study||10
1429125|NCT02443883|3498662|P4|NOT COMPLETED|Overall Study||7
1429126|NCT02443883|3498663|P3|NOT COMPLETED|Overall Study||4
1429127|NCT02443883|3498664|P2|NOT COMPLETED|Overall Study||5
1429128|NCT02443883|3498665|P1|NOT COMPLETED|Overall Study||6
1429129|NCT02443883|3498662|P4|COMPLETED|Overall Study||34
1429130|NCT02443883|3498663|P3|COMPLETED|Overall Study||37
1429131|NCT02443883|3498664|P2|COMPLETED|Overall Study||37
1429132|NCT02443883|3498665|P1|COMPLETED|Overall Study||34
1429133|NCT02443883|3498662|P4|Received at Least One Dose of Study Drug|Overall Study||40
1429134|NCT02443883|3498663|P3|Received at Least One Dose of Study Drug|Overall Study||41
1429135|NCT02443883|3498664|P2|Received at Least One Dose of Study Drug|Overall Study||42
1429136|NCT02443883|3498665|P1|Received at Least One Dose of Study Drug|Overall Study||38
1429137|NCT02443883|3498662|P4|STARTED|Overall Study||41
1429138|NCT02443883|3498663|P3|STARTED|Overall Study||41
1429139|NCT02443883|3498664|P2|STARTED|Overall Study||42
1429140|NCT02443883|3498665|P1|STARTED|Overall Study||40
1429141|NCT02443792|3498685|P2|NOT COMPLETED|Overall Study||2
1429142|NCT02443792|3498686|P1|NOT COMPLETED|Overall Study||7
1429143|NCT02443792|3498685|P2|COMPLETED|Overall Study||23
1429144|NCT02443792|3498686|P1|COMPLETED|Overall Study||43
1429145|NCT02443792|3498685|P2|STARTED|Overall Study||25
1429146|NCT02443792|3498686|P1|STARTED|Overall Study||50
1429147|NCT02443740|3498704|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429148|NCT02443740|3498705|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429149|NCT02443740|3498706|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429150|NCT02443740|3498707|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429151|NCT02443740|3498708|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429152|NCT02443740|3498709|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429153|NCT02443740|3498710|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429154|NCT02443740|3498711|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429155|NCT02443740|3498712|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429156|NCT02443740|3498713|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429157|NCT02443740|3498714|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1429158|NCT02443740|3498704|P11|COMPLETED|Intervention Period 4 (3 Days)||0
1429159|NCT02443740|3498705|P10|COMPLETED|Intervention Period 4 (3 Days)||0
1429160|NCT02443740|3498706|P9|COMPLETED|Intervention Period 4 (3 Days)||0
1429161|NCT02443740|3498707|P8|COMPLETED|Intervention Period 4 (3 Days)||2
1429162|NCT02443740|3498708|P7|COMPLETED|Intervention Period 4 (3 Days)||2
1429163|NCT02443740|3498709|P6|COMPLETED|Intervention Period 4 (3 Days)||2
1429164|NCT02443740|3498710|P5|COMPLETED|Intervention Period 4 (3 Days)||2
1429165|NCT02443740|3498711|P4|COMPLETED|Intervention Period 4 (3 Days)||3
1429166|NCT02443740|3498712|P3|COMPLETED|Intervention Period 4 (3 Days)||2
1429167|NCT02443740|3498713|P2|COMPLETED|Intervention Period 4 (3 Days)||2
1429168|NCT02443740|3498714|P1|COMPLETED|Intervention Period 4 (3 Days)||1
1429169|NCT02443740|3498704|P11|STARTED|Intervention Period 4 (3 Days)||0
1429170|NCT02443740|3498705|P10|STARTED|Intervention Period 4 (3 Days)||0
1429171|NCT02443740|3498706|P9|STARTED|Intervention Period 4 (3 Days)||0
1429172|NCT02443740|3498707|P8|STARTED|Intervention Period 4 (3 Days)||2
1429173|NCT02443740|3498708|P7|STARTED|Intervention Period 4 (3 Days)||2
1429174|NCT02443740|3498709|P6|STARTED|Intervention Period 4 (3 Days)||2
1429175|NCT02443740|3498710|P5|STARTED|Intervention Period 4 (3 Days)||2
1429176|NCT02443740|3498711|P4|STARTED|Intervention Period 4 (3 Days)||3
1429177|NCT02443740|3498712|P3|STARTED|Intervention Period 4 (3 Days)||2
1429178|NCT02443740|3498713|P2|STARTED|Intervention Period 4 (3 Days)||2
1429179|NCT02443740|3498714|P1|STARTED|Intervention Period 4 (3 Days)||1
1429180|NCT02443740|3498704|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429181|NCT02443740|3498705|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429182|NCT02443740|3498706|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429183|NCT02443740|3498707|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429184|NCT02443740|3498708|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429185|NCT02443740|3498709|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429186|NCT02443740|3498710|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429187|NCT02443740|3498711|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429188|NCT02443740|3498712|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429189|NCT02443740|3498713|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429190|NCT02443740|3498714|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
1429191|NCT02443740|3498704|P11|COMPLETED|Washout Period 3 (7 Days)||0
1429192|NCT02443740|3498705|P10|COMPLETED|Washout Period 3 (7 Days)||0
1429193|NCT02443740|3498706|P9|COMPLETED|Washout Period 3 (7 Days)||0
1429194|NCT02443740|3498707|P8|COMPLETED|Washout Period 3 (7 Days)||2
1429195|NCT02443740|3498708|P7|COMPLETED|Washout Period 3 (7 Days)||2
1429196|NCT02443740|3498709|P6|COMPLETED|Washout Period 3 (7 Days)||2
1429197|NCT02443740|3498710|P5|COMPLETED|Washout Period 3 (7 Days)||2
1429198|NCT02443740|3498711|P4|COMPLETED|Washout Period 3 (7 Days)||3
1429199|NCT02443740|3498712|P3|COMPLETED|Washout Period 3 (7 Days)||2
1429200|NCT02443740|3498713|P2|COMPLETED|Washout Period 3 (7 Days)||2
1429201|NCT02443740|3498714|P1|COMPLETED|Washout Period 3 (7 Days)||1
1429202|NCT02443740|3498704|P11|STARTED|Washout Period 3 (7 Days)||0
1429203|NCT02443740|3498705|P10|STARTED|Washout Period 3 (7 Days)||0
1429204|NCT02443740|3498706|P9|STARTED|Washout Period 3 (7 Days)||0
1429205|NCT02443740|3498707|P8|STARTED|Washout Period 3 (7 Days)||2
1429206|NCT02443740|3498708|P7|STARTED|Washout Period 3 (7 Days)||2
1429207|NCT02443740|3498709|P6|STARTED|Washout Period 3 (7 Days)||2
1429208|NCT02443740|3498710|P5|STARTED|Washout Period 3 (7 Days)||2
1429209|NCT02443740|3498711|P4|STARTED|Washout Period 3 (7 Days)||3
1429210|NCT02443740|3498712|P3|STARTED|Washout Period 3 (7 Days)||2
1429211|NCT02443740|3498713|P2|STARTED|Washout Period 3 (7 Days)||2
1429212|NCT02443740|3498714|P1|STARTED|Washout Period 3 (7 Days)||1
1429213|NCT02443740|3498704|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429214|NCT02443740|3498705|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429215|NCT02443740|3498706|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429216|NCT02443740|3498707|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429217|NCT02443740|3498708|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429218|NCT02443740|3498709|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429219|NCT02443740|3498710|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429220|NCT02443740|3498711|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429221|NCT02443740|3498712|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429222|NCT02443740|3498713|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429223|NCT02443740|3498714|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1429224|NCT02443740|3498704|P11|COMPLETED|Intervention Period 3 (3 Days)||0
1429225|NCT02443740|3498705|P10|COMPLETED|Intervention Period 3 (3 Days)||0
1429226|NCT02443740|3498706|P9|COMPLETED|Intervention Period 3 (3 Days)||0
1429227|NCT02443740|3498707|P8|COMPLETED|Intervention Period 3 (3 Days)||2
1429228|NCT02443740|3498708|P7|COMPLETED|Intervention Period 3 (3 Days)||2
1429229|NCT02443740|3498709|P6|COMPLETED|Intervention Period 3 (3 Days)||2
1429230|NCT02443740|3498710|P5|COMPLETED|Intervention Period 3 (3 Days)||2
1429231|NCT02443740|3498711|P4|COMPLETED|Intervention Period 3 (3 Days)||3
1429232|NCT02443740|3498712|P3|COMPLETED|Intervention Period 3 (3 Days)||2
1429233|NCT02443740|3498713|P2|COMPLETED|Intervention Period 3 (3 Days)||2
1429234|NCT02443740|3498714|P1|COMPLETED|Intervention Period 3 (3 Days)||1
1429235|NCT02443740|3498704|P11|STARTED|Intervention Period 3 (3 Days)||0
1429236|NCT02443740|3498705|P10|STARTED|Intervention Period 3 (3 Days)||0
1429237|NCT02443740|3498706|P9|STARTED|Intervention Period 3 (3 Days)||0
1429238|NCT02443740|3498707|P8|STARTED|Intervention Period 3 (3 Days)||2
1429239|NCT02443740|3498708|P7|STARTED|Intervention Period 3 (3 Days)||2
1429240|NCT02443740|3498709|P6|STARTED|Intervention Period 3 (3 Days)||2
1429241|NCT02443740|3498710|P5|STARTED|Intervention Period 3 (3 Days)||2
1429242|NCT02443740|3498711|P4|STARTED|Intervention Period 3 (3 Days)||3
1429243|NCT02443740|3498712|P3|STARTED|Intervention Period 3 (3 Days)||2
1429244|NCT02443740|3498713|P2|STARTED|Intervention Period 3 (3 Days)||2
1429245|NCT02443740|3498714|P1|STARTED|Intervention Period 3 (3 Days)||1
1429246|NCT02443740|3498704|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429247|NCT02443740|3498705|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429248|NCT02443740|3498706|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429249|NCT02443740|3498707|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429250|NCT02443740|3498708|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429251|NCT02443740|3498709|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429252|NCT02443740|3498710|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429253|NCT02443740|3498711|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429254|NCT02443740|3498712|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429255|NCT02443740|3498713|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429256|NCT02443740|3498714|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1429257|NCT02443740|3498704|P11|COMPLETED|Washout Period 2 (7 Days)||0
1429258|NCT02443740|3498705|P10|COMPLETED|Washout Period 2 (7 Days)||0
1429259|NCT02443740|3498706|P9|COMPLETED|Washout Period 2 (7 Days)||0
1429260|NCT02443740|3498707|P8|COMPLETED|Washout Period 2 (7 Days)||2
1429261|NCT02443740|3498708|P7|COMPLETED|Washout Period 2 (7 Days)||2
1429262|NCT02443740|3498709|P6|COMPLETED|Washout Period 2 (7 Days)||2
1429263|NCT02443740|3498710|P5|COMPLETED|Washout Period 2 (7 Days)||2
1429264|NCT02443740|3498711|P4|COMPLETED|Washout Period 2 (7 Days)||3
1429265|NCT02443740|3498712|P3|COMPLETED|Washout Period 2 (7 Days)||2
1429266|NCT02443740|3498713|P2|COMPLETED|Washout Period 2 (7 Days)||2
1429267|NCT02443740|3498714|P1|COMPLETED|Washout Period 2 (7 Days)||1
1429268|NCT02443740|3498704|P11|STARTED|Washout Period 2 (7 Days)||0
1429269|NCT02443740|3498705|P10|STARTED|Washout Period 2 (7 Days)||0
1429270|NCT02443740|3498706|P9|STARTED|Washout Period 2 (7 Days)||0
1429271|NCT02443740|3498707|P8|STARTED|Washout Period 2 (7 Days)||2
1429272|NCT02443740|3498708|P7|STARTED|Washout Period 2 (7 Days)||2
1429273|NCT02443740|3498709|P6|STARTED|Washout Period 2 (7 Days)||2
1429274|NCT02443740|3498710|P5|STARTED|Washout Period 2 (7 Days)||2
1429275|NCT02443740|3498711|P4|STARTED|Washout Period 2 (7 Days)||3
1429276|NCT02443740|3498712|P3|STARTED|Washout Period 2 (7 Days)||2
1429277|NCT02443740|3498713|P2|STARTED|Washout Period 2 (7 Days)||2
1429278|NCT02443740|3498714|P1|STARTED|Washout Period 2 (7 Days)||1
1429279|NCT02443740|3498704|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429280|NCT02443740|3498705|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429281|NCT02443740|3498706|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429282|NCT02443740|3498707|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429283|NCT02443740|3498708|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429284|NCT02443740|3498709|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429285|NCT02443740|3498710|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429286|NCT02443740|3498711|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429287|NCT02443740|3498712|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429288|NCT02443740|3498713|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429289|NCT02443740|3498714|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1429290|NCT02443740|3498704|P11|COMPLETED|Intervention Period 2 (3 Days)||3
1429291|NCT02443740|3498705|P10|COMPLETED|Intervention Period 2 (3 Days)||3
1429292|NCT02443740|3498706|P9|COMPLETED|Intervention Period 2 (3 Days)||0
1429293|NCT02443740|3498707|P8|COMPLETED|Intervention Period 2 (3 Days)||2
1429294|NCT02443740|3498708|P7|COMPLETED|Intervention Period 2 (3 Days)||2
1429295|NCT02443740|3498709|P6|COMPLETED|Intervention Period 2 (3 Days)||2
1429296|NCT02443740|3498710|P5|COMPLETED|Intervention Period 2 (3 Days)||2
1429297|NCT02443740|3498711|P4|COMPLETED|Intervention Period 2 (3 Days)||3
1429298|NCT02443740|3498712|P3|COMPLETED|Intervention Period 2 (3 Days)||2
1429299|NCT02443740|3498713|P2|COMPLETED|Intervention Period 2 (3 Days)||2
1429300|NCT02443740|3498714|P1|COMPLETED|Intervention Period 2 (3 Days)||1
1429301|NCT02443740|3498704|P11|STARTED|Intervention Period 2 (3 Days)||3
1429302|NCT02443740|3498705|P10|STARTED|Intervention Period 2 (3 Days)||3
1429303|NCT02443740|3498706|P9|STARTED|Intervention Period 2 (3 Days)||0
1429304|NCT02443740|3498707|P8|STARTED|Intervention Period 2 (3 Days)||2
1429305|NCT02443740|3498708|P7|STARTED|Intervention Period 2 (3 Days)||2
1429306|NCT02443740|3498709|P6|STARTED|Intervention Period 2 (3 Days)||2
1429307|NCT02443740|3498710|P5|STARTED|Intervention Period 2 (3 Days)||2
1429308|NCT02443740|3498711|P4|STARTED|Intervention Period 2 (3 Days)||3
1429309|NCT02443740|3498712|P3|STARTED|Intervention Period 2 (3 Days)||2
1429310|NCT02443740|3498713|P2|STARTED|Intervention Period 2 (3 Days)||2
1429311|NCT02443740|3498714|P1|STARTED|Intervention Period 2 (3 Days)||1
1429312|NCT02443740|3498704|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429313|NCT02443740|3498705|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429314|NCT02443740|3498706|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429315|NCT02443740|3498707|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429316|NCT02443740|3498708|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429317|NCT02443740|3498709|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429318|NCT02443740|3498710|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429319|NCT02443740|3498711|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429320|NCT02443740|3498712|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429321|NCT02443740|3498713|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429322|NCT02443740|3498714|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1429323|NCT02443740|3498704|P11|COMPLETED|Washout Period 1 (7 Days)||3
1429324|NCT02443740|3498705|P10|COMPLETED|Washout Period 1 (7 Days)||3
1429325|NCT02443740|3498706|P9|COMPLETED|Washout Period 1 (7 Days)||0
1429326|NCT02443740|3498707|P8|COMPLETED|Washout Period 1 (7 Days)||2
1429327|NCT02443740|3498708|P7|COMPLETED|Washout Period 1 (7 Days)||2
1429328|NCT02443740|3498709|P6|COMPLETED|Washout Period 1 (7 Days)||2
1429329|NCT02443740|3498710|P5|COMPLETED|Washout Period 1 (7 Days)||2
1429330|NCT02443740|3498711|P4|COMPLETED|Washout Period 1 (7 Days)||3
1429331|NCT02443740|3498712|P3|COMPLETED|Washout Period 1 (7 Days)||2
1429332|NCT02443740|3498713|P2|COMPLETED|Washout Period 1 (7 Days)||2
1429333|NCT02443740|3498714|P1|COMPLETED|Washout Period 1 (7 Days)||1
1429334|NCT02443740|3498704|P11|STARTED|Washout Period 1 (7 Days)||3
1429335|NCT02443740|3498705|P10|STARTED|Washout Period 1 (7 Days)||3
1429336|NCT02443740|3498706|P9|STARTED|Washout Period 1 (7 Days)||0
1429337|NCT02443740|3498707|P8|STARTED|Washout Period 1 (7 Days)||2
1429338|NCT02443740|3498708|P7|STARTED|Washout Period 1 (7 Days)||2
1429339|NCT02443740|3498709|P6|STARTED|Washout Period 1 (7 Days)||2
1429340|NCT02443740|3498710|P5|STARTED|Washout Period 1 (7 Days)||2
1429341|NCT02443740|3498711|P4|STARTED|Washout Period 1 (7 Days)||3
1429342|NCT02443740|3498712|P3|STARTED|Washout Period 1 (7 Days)||2
1429343|NCT02443740|3498713|P2|STARTED|Washout Period 1 (7 Days)||2
1429344|NCT02443740|3498714|P1|STARTED|Washout Period 1 (7 Days)||1
1429345|NCT02443740|3498704|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1429346|NCT02443740|3498705|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1429347|NCT02443740|3498706|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1429348|NCT02443740|3498707|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1429349|NCT02443740|3498708|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
1429350|NCT02443740|3498709|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
1429351|NCT02443740|3498710|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1429352|NCT02443740|3498711|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1429353|NCT02443740|3498712|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1429354|NCT02443740|3498713|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1429355|NCT02443740|3498714|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
1429356|NCT02443740|3498704|P11|COMPLETED|Intervention Period 1 (3 Days)||3
1429357|NCT02443740|3498705|P10|COMPLETED|Intervention Period 1 (3 Days)||3
1429358|NCT02443740|3498706|P9|COMPLETED|Intervention Period 1 (3 Days)||6
1429359|NCT02443740|3498707|P8|COMPLETED|Intervention Period 1 (3 Days)||2
1429360|NCT02443740|3498708|P7|COMPLETED|Intervention Period 1 (3 Days)||2
1429361|NCT02443740|3498709|P6|COMPLETED|Intervention Period 1 (3 Days)||2
1429362|NCT02443740|3498710|P5|COMPLETED|Intervention Period 1 (3 Days)||2
1429363|NCT02443740|3498711|P4|COMPLETED|Intervention Period 1 (3 Days)||3
1429364|NCT02443740|3498712|P3|COMPLETED|Intervention Period 1 (3 Days)||2
1429365|NCT02443740|3498713|P2|COMPLETED|Intervention Period 1 (3 Days)||2
1429366|NCT02443740|3498714|P1|COMPLETED|Intervention Period 1 (3 Days)||1
1429367|NCT02443740|3498704|P11|STARTED|Intervention Period 1 (3 Days)||3
1429368|NCT02443740|3498705|P10|STARTED|Intervention Period 1 (3 Days)||3
1429369|NCT02443740|3498706|P9|STARTED|Intervention Period 1 (3 Days)||6
1429370|NCT02443740|3498707|P8|STARTED|Intervention Period 1 (3 Days)||2
1429371|NCT02443740|3498708|P7|STARTED|Intervention Period 1 (3 Days)||3
1429372|NCT02443740|3498709|P6|STARTED|Intervention Period 1 (3 Days)||4
1429373|NCT02443740|3498710|P5|STARTED|Intervention Period 1 (3 Days)||2
1429374|NCT02443740|3498711|P4|STARTED|Intervention Period 1 (3 Days)||3
1429375|NCT02443740|3498712|P3|STARTED|Intervention Period 1 (3 Days)||2
1429376|NCT02443740|3498713|P2|STARTED|Intervention Period 1 (3 Days)||2
1429377|NCT02443740|3498714|P1|STARTED|Intervention Period 1 (3 Days)||2
1429378|NCT02443571|3498896|P3|NOT COMPLETED|Overall Study||0
1429379|NCT02443571|3498897|P2|NOT COMPLETED|Overall Study||0
1429380|NCT02443571|3498898|P1|NOT COMPLETED|Overall Study||0
1429381|NCT02443571|3498896|P3|COMPLETED|Overall Study||23
1429382|NCT02443571|3498897|P2|COMPLETED|Overall Study||95
1429383|NCT02443571|3498898|P1|COMPLETED|Overall Study||596
1429384|NCT02443571|3498896|P3|STARTED|Overall Study||23
1429385|NCT02443571|3498897|P2|STARTED|Overall Study||95
1429386|NCT02443571|3498898|P1|STARTED|Overall Study||596
1429387|NCT02443402|3498910|P2|NOT COMPLETED|Overall Study||3
1429388|NCT02443402|3498911|P1|NOT COMPLETED|Overall Study||4
1429389|NCT02443402|3498910|P2|COMPLETED|Overall Study||28
1429390|NCT02443402|3498911|P1|COMPLETED|Overall Study||32
1429391|NCT02443402|3498910|P2|STARTED|Overall Study||31
1429392|NCT02443402|3498911|P1|STARTED|Overall Study||36
1429393|NCT02443103|3498971|P1|NOT COMPLETED|Overall Study||3
1429394|NCT02443103|3498971|P1|COMPLETED|Overall Study||1
1429395|NCT02443103|3498971|P1|STARTED|Overall Study||4
1429396|NCT02442830|3498978|P2|NOT COMPLETED|Overall Study||1
1429397|NCT02442830|3498979|P1|NOT COMPLETED|Overall Study||0
1429398|NCT02442830|3498978|P2|COMPLETED|Overall Study||44
1429399|NCT02442830|3498979|P1|COMPLETED|Overall Study||42
1429400|NCT02442830|3498978|P2|STARTED|Overall Study||45
1429401|NCT02442830|3498979|P1|STARTED|Overall Study||42
1429402|NCT02442804|3498989|P2|NOT COMPLETED|Overall Study||1
1429403|NCT02442804|3498990|P1|NOT COMPLETED|Overall Study||1
1429404|NCT02442804|3498989|P2|COMPLETED|Overall Study||7
1429405|NCT02442804|3498990|P1|COMPLETED|Overall Study||7
1429406|NCT02442804|3498989|P2|STARTED|Overall Study||8
1429407|NCT02442804|3498990|P1|STARTED|Overall Study||8
1429408|NCT02442700|3499020|P2|NOT COMPLETED|Later 12 Weeks||0
1429409|NCT02442700|3499021|P1|NOT COMPLETED|Later 12 Weeks||0
1429410|NCT02442700|3499020|P2|COMPLETED|Later 12 Weeks||12
1429411|NCT02442700|3499021|P1|COMPLETED|Later 12 Weeks||12
1429412|NCT02442700|3499020|P2|STARTED|Later 12 Weeks||12
1429413|NCT02442700|3499021|P1|STARTED|Later 12 Weeks||12
1429414|NCT02442700|3499020|P2|NOT COMPLETED|First 12 Weeks||0
1429415|NCT02442700|3499021|P1|NOT COMPLETED|First 12 Weeks||0
1429416|NCT02442700|3499020|P2|COMPLETED|First 12 Weeks||12
1429417|NCT02442700|3499021|P1|COMPLETED|First 12 Weeks||12
1429418|NCT02442700|3499020|P2|STARTED|First 12 Weeks||12
1429419|NCT02442700|3499021|P1|STARTED|First 12 Weeks||12
1429420|NCT02442349|3499029|P1|NOT COMPLETED|Overall Study||171
1429421|NCT02442349|3499029|P1|COMPLETED|Overall Study||0
1429422|NCT02442349|3499029|P1|STARTED|Overall Study||171
1429423|NCT02442310|3499034|P1|NOT COMPLETED|Overall Study||3
1429424|NCT02442310|3499034|P1|COMPLETED|Overall Study||17
1429425|NCT02442310|3499034|P1|STARTED|Overall Study||20
1429426|NCT02442284|3499056|P1|NOT COMPLETED|Overall Study||7
1429427|NCT02442284|3499056|P1|COMPLETED|Overall Study||92
1429428|NCT02442284|3499056|P1|STARTED|Overall Study||99
1429429|NCT02442271|3499063|P1|NOT COMPLETED|Overall Study||4
1429430|NCT02442271|3499063|P1|COMPLETED|Overall Study||218
1429431|NCT02442271|3499063|P1|STARTED|Overall Study||222
1429432|NCT02442206|3499089|P2|NOT COMPLETED|Period 2||0
1429433|NCT02442206|3499090|P1|NOT COMPLETED|Period 2||1
1429434|NCT02442206|3499089|P2|COMPLETED|Period 2||29
1429435|NCT02442206|3499090|P1|COMPLETED|Period 2||28
1429436|NCT02442206|3499089|P2|STARTED|Period 2||29
1429437|NCT02442206|3499090|P1|STARTED|Period 2||29
1429438|NCT02442206|3499089|P2|NOT COMPLETED|Period 1||3
1429439|NCT02442206|3499090|P1|NOT COMPLETED|Period 1||1
1429440|NCT02442206|3499089|P2|COMPLETED|Period 1||29
1429441|NCT02442206|3499090|P1|COMPLETED|Period 1||29
1429442|NCT02442206|3499089|P2|STARTED|Period 1||32
1429443|NCT02442206|3499090|P1|STARTED|Period 1||30
1429444|NCT02441946|3499122|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
1429445|NCT02441946|3499123|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
1429446|NCT02441946|3499124|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
1429447|NCT02441946|3499122|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
1429448|NCT02441946|3499123|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
1429449|NCT02441946|3499124|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
1429450|NCT02441946|3499122|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
1429451|NCT02441946|3499123|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
1429452|NCT02441946|3499124|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||214
1429453|NCT02441946|3499122|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
1429454|NCT02441946|3499123|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
1429455|NCT02441946|3499124|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
1429456|NCT02441946|3499122|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1429457|NCT02441946|3499123|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
1429458|NCT02441946|3499124|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
1429459|NCT02441946|3499122|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
1429460|NCT02441946|3499123|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
1429461|NCT02441946|3499124|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
1429462|NCT02441946|3499122|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
1429463|NCT02441946|3499123|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
1429464|NCT02441946|3499124|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
1429465|NCT02441946|3499122|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
1429466|NCT02441946|3499123|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
1429467|NCT02441946|3499124|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
1429468|NCT02441517|3499136|P1|NOT COMPLETED|Overall Study||4
1429469|NCT02441517|3499136|P1|COMPLETED|Overall Study||0
1429470|NCT02441517|3499136|P1|Received Treatment|Overall Study||4
1429471|NCT02441517|3499136|P1|STARTED|Overall Study||4
1429472|NCT02441218|3499148|P2|NOT COMPLETED|Overall Study||612
1429473|NCT02441218|3499149|P1|NOT COMPLETED|Overall Study||578
1429474|NCT02441218|3499148|P2|COMPLETED|Overall Study||2652
1429475|NCT02441218|3499149|P1|COMPLETED|Overall Study||2663
1429476|NCT02441218|3499148|P2|STARTED|Overall Study||3264
1429477|NCT02441218|3499149|P1|STARTED|Overall Study||3241
1429478|NCT02441179|3499175|P2|NOT COMPLETED|Overall Study||1
1429479|NCT02441179|3499176|P1|NOT COMPLETED|Overall Study||1
1429480|NCT02441179|3499175|P2|COMPLETED|Overall Study||16
1429481|NCT02441179|3499176|P1|COMPLETED|Overall Study||17
1429482|NCT02441179|3499175|P2|STARTED|Overall Study||17
1429483|NCT02441179|3499176|P1|STARTED|Overall Study||18
1429484|NCT02441114|3499194|P1|NOT COMPLETED|Period3||0
1429485|NCT02441114|3499194|P1|COMPLETED|Period3||6
1429486|NCT02441114|3499194|P1|STARTED|Period3||6
1429487|NCT02441114|3499194|P1|NOT COMPLETED|Washout2||4
1429488|NCT02441114|3499194|P1|COMPLETED|Washout2||6
1429489|NCT02441114|3499194|P1|STARTED|Washout2||10
1429490|NCT02441114|3499194|P1|NOT COMPLETED|Period2||0
1429491|NCT02441114|3499194|P1|COMPLETED|Period2||10
1429492|NCT02441114|3499194|P1|STARTED|Period2||10
1429493|NCT02441114|3499194|P1|NOT COMPLETED|Washout1||0
1429494|NCT02441114|3499194|P1|COMPLETED|Washout1||10
1429495|NCT02441114|3499194|P1|STARTED|Washout1||10
1429496|NCT02441114|3499194|P1|NOT COMPLETED|Period1||0
1429497|NCT02441114|3499194|P1|COMPLETED|Period1||10
1429498|NCT02441114|3499194|P1|STARTED|Period1||10
1429499|NCT02440659|3499202|P2|NOT COMPLETED|Overall Study||335
1429500|NCT02440659|3499203|P1|NOT COMPLETED|Overall Study||651
1429501|NCT02440659|3499202|P2|COMPLETED|Overall Study||614
1429502|NCT02440659|3499203|P1|COMPLETED|Overall Study||1346
1429503|NCT02440659|3499202|P2|STARTED|Overall Study||949
1429504|NCT02440659|3499203|P1|STARTED|Overall Study||1997
1429505|NCT02440633|3499209|P1|NOT COMPLETED|Overall Study||0
1429506|NCT02440633|3499209|P1|COMPLETED|Overall Study||8
1429507|NCT02440633|3499209|P1|STARTED|Overall Study||8
1429508|NCT02440451|3499218|P1|NOT COMPLETED|Overall Study||0
1429509|NCT02440451|3499218|P1|COMPLETED|Overall Study||15
1429510|NCT02440451|3499218|P1|STARTED|Overall Study||15
1429511|NCT02440308|3499222|P1|NOT COMPLETED|Overall Study||0
1429512|NCT02440308|3499222|P1|COMPLETED|Overall Study||10
1429513|NCT02440308|3499222|P1|STARTED|Overall Study||10
1429514|NCT02439879|3499229|P2|NOT COMPLETED|Overall Study||0
1429515|NCT02439879|3499230|P1|NOT COMPLETED|Overall Study||0
1429516|NCT02439879|3499229|P2|COMPLETED|Overall Study||17
1429517|NCT02439879|3499230|P1|COMPLETED|Overall Study||16
1429518|NCT02439879|3499229|P2|STARTED|Overall Study||17
1429519|NCT02439879|3499230|P1|STARTED|Overall Study||16
1429520|NCT02439814|3499238|P2|NOT COMPLETED|Overall Study||0
1429521|NCT02439814|3499239|P1|NOT COMPLETED|Overall Study||0
1429522|NCT02439814|3499238|P2|COMPLETED|Overall Study||10
1429523|NCT02439814|3499239|P1|COMPLETED|Overall Study||11
1429524|NCT02439814|3499238|P2|STARTED|Overall Study||10
1429525|NCT02439814|3499239|P1|STARTED|Overall Study||11
1429526|NCT02439164|3499247|P2|NOT COMPLETED|Overall Study||0
1429527|NCT02439164|3499248|P1|NOT COMPLETED|Overall Study||0
1429528|NCT02439164|3499247|P2|COMPLETED|Overall Study||18
1429529|NCT02439164|3499248|P1|COMPLETED|Overall Study||18
1429530|NCT02439164|3499247|P2|STARTED|Overall Study||18
1429531|NCT02439164|3499248|P1|STARTED|Overall Study||18
1429532|NCT02439138|3499261|P1|NOT COMPLETED|Overall Study||3
1429533|NCT02439138|3499261|P1|COMPLETED|Overall Study||2
1429534|NCT02439138|3499261|P1|STARTED|Overall Study||5
1429535|NCT02438813|3499272|P1|NOT COMPLETED|Overall Study||525
1429536|NCT02438813|3499272|P1|COMPLETED|Overall Study||504
1429537|NCT02438813|3499272|P1|Did Not ReceiveTreatment for SMF|Overall Study||353
1429538|NCT02438813|3499272|P1|Received Treatment for SMF|Overall Study||676
1429539|NCT02438813|3499272|P1|STARTED|Overall Study||1029
1429540|NCT02438787|3499324|P3|NOT COMPLETED|Overall Study||83
1429541|NCT02438787|3499325|P2|NOT COMPLETED|Overall Study||83
1429542|NCT02438787|3499326|P1|NOT COMPLETED|Overall Study||81
1429543|NCT02438787|3499324|P3|COMPLETED|Overall Study||22
1429544|NCT02438787|3499325|P2|COMPLETED|Overall Study||23
1429545|NCT02438787|3499326|P1|COMPLETED|Overall Study||23
1429546|NCT02438787|3499324|P3|Cross Over at Week 24|Overall Study||0
1429547|NCT02438787|3499325|P2|Cross Over at Week 24|Overall Study||0
1429548|NCT02438787|3499326|P1|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
1429549|NCT02438787|3499324|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
1429550|NCT02438787|3499325|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
1429551|NCT02438787|3499326|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
1429552|NCT02438787|3499324|P3|STARTED|Overall Study||105
1429553|NCT02438787|3499325|P2|STARTED|Overall Study||106
1429554|NCT02438787|3499326|P1|STARTED|Overall Study||104
1429555|NCT02438540|3499371|P2|NOT COMPLETED|Overall Study||0
1429556|NCT02438540|3499372|P1|NOT COMPLETED|Overall Study||0
1429557|NCT02438540|3499371|P2|COMPLETED|Overall Study||20
1429558|NCT02438540|3499372|P1|COMPLETED|Overall Study||19
1429559|NCT02438540|3499371|P2|STARTED|Overall Study||20
1429560|NCT02438540|3499372|P1|STARTED|Overall Study||19
1429561|NCT02438280|3499414|P2|NOT COMPLETED|Overall Study||0
1429562|NCT02438280|3499415|P1|NOT COMPLETED|Overall Study||1
1429563|NCT02438280|3499414|P2|COMPLETED|Overall Study||13
1429564|NCT02438280|3499415|P1|COMPLETED|Overall Study||13
1429565|NCT02438280|3499414|P2|STARTED|Overall Study||13
1429566|NCT02438280|3499415|P1|STARTED|Overall Study||14
1429567|NCT02438137|3499425|P2|NOT COMPLETED|Overall Study||6
1429568|NCT02438137|3499426|P1|NOT COMPLETED|Overall Study||8
1429569|NCT02438137|3499425|P2|COMPLETED|Overall Study||15
1429570|NCT02438137|3499426|P1|COMPLETED|Overall Study||36
1429571|NCT02438137|3499425|P2|STARTED|Overall Study||21
1429572|NCT02438137|3499426|P1|STARTED|Overall Study||44
1429573|NCT02437903|3499434|P1|NOT COMPLETED|Overall Study||5
1429574|NCT02437903|3499434|P1|COMPLETED|Overall Study||25
1429575|NCT02437903|3499434|P1|STARTED|Overall Study||30
1429576|NCT02437864|3499444|P2|NOT COMPLETED|Overall Study||0
1429577|NCT02437864|3499445|P1|NOT COMPLETED|Overall Study||4
1429578|NCT02437864|3499444|P2|COMPLETED|Overall Study||160
1429579|NCT02437864|3499445|P1|COMPLETED|Overall Study||196
1429580|NCT02437864|3499444|P2|STARTED|Overall Study||160
1429581|NCT02437864|3499445|P1|STARTED|Overall Study||200
1429582|NCT02437513|3499459|P1|NOT COMPLETED|Overall Study||2
1429583|NCT02437513|3499459|P1|COMPLETED|Overall Study||0
1429584|NCT02437513|3499459|P1|STARTED|Overall Study||2
1429585|NCT02437487|3499469|P2|NOT COMPLETED|Overall Study||14
1429586|NCT02437487|3499470|P1|NOT COMPLETED|Overall Study||27
1429587|NCT02437487|3499469|P2|COMPLETED|Overall Study||16
1429588|NCT02437487|3499470|P1|COMPLETED|Overall Study||32
1429589|NCT02437487|3499469|P2|Intention-to-Treat Population|Overall Study||30
1429590|NCT02437487|3499470|P1|Intention-to-Treat Population|Overall Study||59
1429591|NCT02437487|3499469|P2|Actual Treatment Received|Overall Study||29
1429592|NCT02437487|3499470|P1|Actual Treatment Received|Overall Study||60
1429593|NCT02437487|3499469|P2|STARTED|Overall Study||30
1429594|NCT02437487|3499470|P1|STARTED|Overall Study||59
1429595|NCT02437409|3499484|P1|NOT COMPLETED|Overall Study||15
1429596|NCT02437409|3499484|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
1429597|NCT02437409|3499484|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
1429598|NCT02437344|3499493|P1|NOT COMPLETED|Overall Study||1
1429599|NCT02437344|3499493|P1|COMPLETED|Overall Study||15
1429600|NCT02437344|3499493|P1|STARTED|Overall Study||16
1429601|NCT02437305|3499499|P2|NOT COMPLETED|Overall Study||12
1429602|NCT02437305|3499500|P1|NOT COMPLETED|Overall Study||18
1429603|NCT02437305|3499499|P2|COMPLETED|Overall Study||38
1429604|NCT02437305|3499500|P1|COMPLETED|Overall Study||32
1429605|NCT02437305|3499499|P2|STARTED|Overall Study||50
1429606|NCT02437305|3499500|P1|STARTED|Overall Study||50
1429607|NCT02437253|3499510|P2|NOT COMPLETED|Overall Study||0
1429608|NCT02437253|3499511|P1|NOT COMPLETED|Overall Study||0
1429609|NCT02437253|3499510|P2|COMPLETED|Overall Study||1
1429610|NCT02437253|3499511|P1|COMPLETED|Overall Study||1
1429611|NCT02437253|3499510|P2|STARTED|Overall Study||1
1429612|NCT02437253|3499511|P1|STARTED|Overall Study||1
1429613|NCT02437162|3499528|P3|NOT COMPLETED|Overall Study||109
1429614|NCT02437162|3499529|P2|NOT COMPLETED|Overall Study||108
1429615|NCT02437162|3499530|P1|NOT COMPLETED|Overall Study||107
1429616|NCT02437162|3499528|P3|COMPLETED|Overall Study||6
1429617|NCT02437162|3499529|P2|COMPLETED|Overall Study||8
1429618|NCT02437162|3499530|P1|COMPLETED|Overall Study||9
1429619|NCT02437162|3499528|P3|Cross Over at Week 24|Overall Study||0
1429620|NCT02437162|3499529|P2|Cross Over at Week 24|Overall Study||0
1429621|NCT02437162|3499530|P1|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
1429622|NCT02437162|3499528|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
1429623|NCT02437162|3499529|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
1429624|NCT02437162|3499530|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
1429625|NCT02437162|3499528|P3|Treated|Overall Study||114
1429626|NCT02437162|3499529|P2|Treated|Overall Study||116
1429627|NCT02437162|3499530|P1|Treated|Overall Study||116
1429628|NCT02437162|3499528|P3|STARTED|Overall Study||115
1429629|NCT02437162|3499529|P2|STARTED|Overall Study||116
1429630|NCT02437162|3499530|P1|STARTED|Overall Study||116
1429631|NCT02436811|3499651|P3|NOT COMPLETED|Overall Study||7
1429632|NCT02436811|3499652|P2|NOT COMPLETED|Overall Study||9
1429633|NCT02436811|3499653|P1|NOT COMPLETED|Overall Study||2
1429634|NCT02436811|3499651|P3|COMPLETED|Overall Study||53
1429635|NCT02436811|3499652|P2|COMPLETED|Overall Study||51
1429636|NCT02436811|3499653|P1|COMPLETED|Overall Study||58
1429637|NCT02436811|3499651|P3|STARTED|Overall Study||60
1429638|NCT02436811|3499652|P2|STARTED|Overall Study||60
1429639|NCT02436811|3499653|P1|STARTED|Overall Study||60
1429640|NCT02436577|3499667|P6|NOT COMPLETED|Overall Study||0
1429641|NCT02436577|3499668|P5|NOT COMPLETED|Overall Study||0
1429642|NCT02436577|3499669|P4|NOT COMPLETED|Overall Study||0
1429643|NCT02436577|3499670|P3|NOT COMPLETED|Overall Study||0
1429644|NCT02436577|3499671|P2|NOT COMPLETED|Overall Study||1
1429645|NCT02436577|3499672|P1|NOT COMPLETED|Overall Study||0
1429646|NCT02436577|3499667|P6|COMPLETED|Overall Study||7
1429647|NCT02436577|3499668|P5|COMPLETED|Overall Study||7
1429648|NCT02436577|3499669|P4|COMPLETED|Overall Study||7
1429649|NCT02436577|3499670|P3|COMPLETED|Overall Study||7
1429650|NCT02436577|3499671|P2|COMPLETED|Overall Study||6
1429651|NCT02436577|3499672|P1|COMPLETED|Overall Study||7
1429652|NCT02436577|3499667|P6|STARTED|Overall Study||7
1429653|NCT02436577|3499668|P5|STARTED|Overall Study||7
1429654|NCT02436577|3499669|P4|STARTED|Overall Study||7
1429655|NCT02436577|3499670|P3|STARTED|Overall Study||7
1429656|NCT02436577|3499671|P2|STARTED|Overall Study||7
1429657|NCT02436577|3499672|P1|STARTED|Overall Study||7
1429658|NCT02436330|3499727|P2|NOT COMPLETED|Cohort 6||1
1429659|NCT02436330|3499728|P1|NOT COMPLETED|Cohort 6||3
1429660|NCT02436330|3499727|P2|COMPLETED|Cohort 6||4
1429661|NCT02436330|3499728|P1|COMPLETED|Cohort 6||1
1429662|NCT02436330|3499727|P2|STARTED|Cohort 6||5
1429663|NCT02436330|3499728|P1|STARTED|Cohort 6||4
1429664|NCT02436330|3499727|P2|NOT COMPLETED|Cohort 5||4
1429665|NCT02436330|3499728|P1|NOT COMPLETED|Cohort 5||6
1429666|NCT02436330|3499727|P2|COMPLETED|Cohort 5||1
1429667|NCT02436330|3499728|P1|COMPLETED|Cohort 5||4
1429668|NCT02436330|3499727|P2|STARTED|Cohort 5||5
1429669|NCT02436330|3499728|P1|STARTED|Cohort 5||10
1429670|NCT02436330|3499727|P2|NOT COMPLETED|Cohort 4||0
1429671|NCT02436330|3499728|P1|NOT COMPLETED|Cohort 4||2
1429672|NCT02436330|3499727|P2|COMPLETED|Cohort 4||0
1429673|NCT02436330|3499728|P1|COMPLETED|Cohort 4||4
1429674|NCT02436330|3499727|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
1429675|NCT02436330|3499728|P1|STARTED|Cohort 4||6
1429676|NCT02436330|3499727|P2|NOT COMPLETED|Cohort 3||0
1429677|NCT02436330|3499728|P1|NOT COMPLETED|Cohort 3||5
1429678|NCT02436330|3499727|P2|COMPLETED|Cohort 3||0
1429679|NCT02436330|3499728|P1|COMPLETED|Cohort 3||7
1429680|NCT02436330|3499727|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
1429681|NCT02436330|3499728|P1|STARTED|Cohort 3||12
1429682|NCT02436330|3499727|P2|NOT COMPLETED|Cohort 2||3
1429683|NCT02436330|3499728|P1|NOT COMPLETED|Cohort 2||4
1429684|NCT02436330|3499727|P2|COMPLETED|Cohort 2||7
1429685|NCT02436330|3499728|P1|COMPLETED|Cohort 2||10
1429686|NCT02436330|3499727|P2|STARTED|Cohort 2||10
1429687|NCT02436330|3499728|P1|STARTED|Cohort 2||14
1429688|NCT02436330|3499727|P2|NOT COMPLETED|Cohort 1||3
1429689|NCT02436330|3499728|P1|NOT COMPLETED|Cohort 1||5
1429690|NCT02436330|3499727|P2|COMPLETED|Cohort 1||1
1429691|NCT02436330|3499728|P1|COMPLETED|Cohort 1||9
1429692|NCT02436330|3499727|P2|STARTED|Cohort 1||4
1429693|NCT02436330|3499728|P1|STARTED|Cohort 1||14
1429694|NCT02436304|3499773|P3|NOT COMPLETED|Overall Study||1
1429695|NCT02436304|3499774|P2|NOT COMPLETED|Overall Study||2
1429696|NCT02436304|3499775|P1|NOT COMPLETED|Overall Study||0
1429697|NCT02436304|3499773|P3|COMPLETED|Overall Study||100
1429698|NCT02436304|3499774|P2|COMPLETED|Overall Study||100
1429699|NCT02436304|3499775|P1|COMPLETED|Overall Study||153
1429700|NCT02436304|3499773|P3|STARTED|Overall Study||101
1429701|NCT02436304|3499774|P2|STARTED|Overall Study||102
1429702|NCT02436304|3499775|P1|STARTED|Overall Study||153
1429703|NCT02436031|3499790|P2|NOT COMPLETED|Second Study Night||0
1429704|NCT02436031|3499791|P1|NOT COMPLETED|Second Study Night||0
1429705|NCT02436031|3499790|P2|COMPLETED|Second Study Night||8
1429706|NCT02436031|3499791|P1|COMPLETED|Second Study Night||7
1429707|NCT02436031|3499790|P2|STARTED|Second Study Night||8
1429708|NCT02436031|3499791|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
1429709|NCT02436031|3499790|P2|NOT COMPLETED|First Study Night||0
1429710|NCT02436031|3499791|P1|NOT COMPLETED|First Study Night||0
1429711|NCT02436031|3499790|P2|COMPLETED|First Study Night||8
1429712|NCT02436031|3499791|P1|COMPLETED|First Study Night||8
1429713|NCT02436031|3499790|P2|STARTED|First Study Night||8
1429714|NCT02436031|3499791|P1|STARTED|First Study Night||8
1429715|NCT02435966|3499804|P3|NOT COMPLETED|Overall Study||0
1429716|NCT02435966|3499805|P2|NOT COMPLETED|Overall Study||1
1429717|NCT02435966|3499806|P1|NOT COMPLETED|Overall Study||0
1429718|NCT02435966|3499804|P3|COMPLETED|Overall Study||30
1429719|NCT02435966|3499805|P2|COMPLETED|Overall Study||53
1429720|NCT02435966|3499806|P1|COMPLETED|Overall Study||47
1429721|NCT02435966|3499804|P3|Follow-up|Overall Study||30
1429722|NCT02435966|3499805|P2|Follow-up|Overall Study||53
1429723|NCT02435966|3499806|P1|Follow-up|Overall Study||47
1429724|NCT02435966|3499804|P3|Second Intervention|Overall Study||30
1429725|NCT02435966|3499805|P2|Second Intervention|Overall Study||53
1429726|NCT02435966|3499806|P1|Second Intervention|Overall Study||47
1429727|NCT02435966|3499804|P3|First Intervention|Overall Study||30
1429728|NCT02435966|3499805|P2|First Intervention|Overall Study||54
1429729|NCT02435966|3499806|P1|First Intervention|Overall Study||47
1429730|NCT02435966|3499804|P3|STARTED|Overall Study||30
1429731|NCT02435966|3499805|P2|STARTED|Overall Study||54
1429732|NCT02435966|3499806|P1|STARTED|Overall Study||47
1429733|NCT02435836|3499814|P1|NOT COMPLETED|Overall Study||631
1429734|NCT02435836|3499814|P1|COMPLETED|Overall Study||0
1429735|NCT02435836|3499814|P1|STARTED|Overall Study||631
1429736|NCT02435524|3499834|P2|NOT COMPLETED|Endline Survey||0
1429737|NCT02435524|3499835|P1|NOT COMPLETED|Endline Survey||0
1429738|NCT02435524|3499834|P2|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
1429739|NCT02435524|3499835|P1|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
1429740|NCT02435524|3499834|P2|STARTED|Endline Survey||1161
1429741|NCT02435524|3499835|P1|STARTED|Endline Survey||1092
1429742|NCT02435524|3499834|P2|NOT COMPLETED|Baseline Survey||0
1429743|NCT02435524|3499835|P1|NOT COMPLETED|Baseline Survey||0
1429744|NCT02435524|3499834|P2|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
1429745|NCT02435524|3499835|P1|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
1429746|NCT02435524|3499834|P2|STARTED|Baseline Survey||1177
1429747|NCT02435524|3499835|P1|STARTED|Baseline Survey||1111
1429748|NCT02435277|3499845|P4|NOT COMPLETED|Overall Study||0
1429749|NCT02435277|3499846|P3|NOT COMPLETED|Overall Study||0
1429750|NCT02435277|3499847|P2|NOT COMPLETED|Overall Study||1
1429751|NCT02435277|3499848|P1|NOT COMPLETED|Overall Study||2
1429752|NCT02435277|3499845|P4|COMPLETED|Overall Study||11
1429753|NCT02435277|3499846|P3|COMPLETED|Overall Study||11
1429754|NCT02435277|3499847|P2|COMPLETED|Overall Study||15
1429755|NCT02435277|3499848|P1|COMPLETED|Overall Study||10
1429756|NCT02435277|3499845|P4|STARTED|Overall Study||11
1429757|NCT02435277|3499846|P3|STARTED|Overall Study||11
1429758|NCT02435277|3499847|P2|STARTED|Overall Study||16
1429759|NCT02435277|3499848|P1|STARTED|Overall Study||12
1429760|NCT02435147|3499862|P1|NOT COMPLETED|Overall Study||11
1429761|NCT02435147|3499862|P1|COMPLETED|Overall Study||75
1429762|NCT02435147|3499862|P1|STARTED|Overall Study||86
1429763|NCT02434939|3499869|P2|NOT COMPLETED|Overall Study||49
1429764|NCT02434939|3499870|P1|NOT COMPLETED|Overall Study||37
1429765|NCT02434939|3499869|P2|COMPLETED|Overall Study||71
1429766|NCT02434939|3499870|P1|COMPLETED|Overall Study||83
1429767|NCT02434939|3499869|P2|STARTED|Overall Study||120
1429768|NCT02434939|3499870|P1|STARTED|Overall Study||120
1429769|NCT02434523|3499884|P2|NOT COMPLETED|Overall Study||6
1429770|NCT02434523|3499885|P1|NOT COMPLETED|Overall Study||5
1429771|NCT02434523|3499884|P2|COMPLETED|Overall Study||9
1429772|NCT02434523|3499885|P1|COMPLETED|Overall Study||10
1429773|NCT02434523|3499884|P2|STARTED|Overall Study||15
1429774|NCT02434523|3499885|P1|STARTED|Overall Study||15
1429775|NCT02434497|3499897|P1|NOT COMPLETED|Overall Study||5
1429776|NCT02434497|3499897|P1|COMPLETED|Overall Study||4
1429777|NCT02434497|3499897|P1|STARTED|Overall Study||9
1429778|NCT02434471|3499997|P1|NOT COMPLETED|Overall Study||9
1429779|NCT02434471|3499997|P1|COMPLETED|Overall Study||25
1429780|NCT02434471|3499997|P1|STARTED|Overall Study||34
1429781|NCT02434146|3500004|P1|NOT COMPLETED|Overall Study||0
1429782|NCT02434146|3500004|P1|COMPLETED|Overall Study||3
1429783|NCT02434146|3500004|P1|STARTED|Overall Study||3
1429784|NCT02433834|3500016|P1|NOT COMPLETED|Overall Study||37
1429785|NCT02433834|3500016|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
1429786|NCT02433834|3500016|P1|SAL 50 µg|Overall Study||167
1429787|NCT02433834|3500016|P1|Placebo MDI|Overall Study||174
1429788|NCT02433834|3500016|P1|GP MDI 1.9 µg|Overall Study||107
1429789|NCT02433834|3500016|P1|GP MDI 3.6 µg|Overall Study||118
1429790|NCT02433834|3500016|P1|GP MDI 7.2 µg|Overall Study||228
1429791|NCT02433834|3500016|P1|GP MDI 14.4 µg|Overall Study||230
1429792|NCT02433834|3500016|P1|GP MDI 28.8 µg|Overall Study||112
1429793|NCT02433834|3500016|P1|STARTED|Overall Study||248
1429794|NCT02433496|3500077|P3|NOT COMPLETED|Overall Study||0
1429795|NCT02433496|3500078|P2|NOT COMPLETED|Overall Study||0
1429796|NCT02433496|3500079|P1|NOT COMPLETED|Overall Study||0
1429797|NCT02433496|3500077|P3|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
1429798|NCT02433496|3500078|P2|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
1429799|NCT02433496|3500079|P1|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
1429800|NCT02433496|3500077|P3|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
1429801|NCT02433496|3500078|P2|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
1429802|NCT02433496|3500079|P1|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
1429803|NCT02433483|3500109|P1|NOT COMPLETED|Overall Study||2
1429804|NCT02433483|3500109|P1|COMPLETED|Overall Study||0
1429805|NCT02433483|3500109|P1|STARTED|Overall Study||2
1429806|NCT02433366|3500123|P2|NOT COMPLETED|Overall Study||0
1429807|NCT02433366|3500124|P1|NOT COMPLETED|Overall Study||0
1429808|NCT02433366|3500123|P2|COMPLETED|Overall Study||802
1429809|NCT02433366|3500124|P1|COMPLETED|Overall Study||411
1429810|NCT02433366|3500123|P2|STARTED|Overall Study||802
1429811|NCT02433366|3500124|P1|STARTED|Overall Study||411
1429812|NCT02433340|3500136|P4|NOT COMPLETED|Overall Study||2
1429813|NCT02433340|3500137|P3|NOT COMPLETED|Overall Study||2
1429814|NCT02433340|3500138|P2|NOT COMPLETED|Overall Study||2
1429815|NCT02433340|3500139|P1|NOT COMPLETED|Overall Study||2
1429816|NCT02433340|3500136|P4|COMPLETED|Overall Study||38
1429817|NCT02433340|3500137|P3|COMPLETED|Overall Study||37
1429818|NCT02433340|3500138|P2|COMPLETED|Overall Study||35
1429819|NCT02433340|3500139|P1|COMPLETED|Overall Study||40
1429820|NCT02433340|3500136|P4|STARTED|Overall Study||40
1429821|NCT02433340|3500137|P3|STARTED|Overall Study||39
1429822|NCT02433340|3500138|P2|STARTED|Overall Study||37
1429823|NCT02433340|3500139|P1|STARTED|Overall Study||42
1429824|NCT02432300|3501031|P1|NOT COMPLETED|Overall Study||4
1429825|NCT02432300|3501031|P1|COMPLETED|Overall Study||13
1429826|NCT02432300|3501031|P1|STARTED|Overall Study||17
1429827|NCT02432287|3501040|P2|NOT COMPLETED|Second Intervention||0
1429828|NCT02432287|3501041|P1|NOT COMPLETED|Second Intervention||0
1429829|NCT02432287|3501040|P2|COMPLETED|Second Intervention||7
1429830|NCT02432287|3501041|P1|COMPLETED|Second Intervention||7
1429831|NCT02432287|3501040|P2|STARTED|Second Intervention||7
1429832|NCT02432287|3501041|P1|STARTED|Second Intervention||7
1429833|NCT02432287|3501040|P2|NOT COMPLETED|Washout Period||0
1429834|NCT02432287|3501041|P1|NOT COMPLETED|Washout Period||0
1429835|NCT02432287|3501040|P2|COMPLETED|Washout Period||7
1429836|NCT02432287|3501041|P1|COMPLETED|Washout Period||7
1429837|NCT02432287|3501040|P2|STARTED|Washout Period||7
1429838|NCT02432287|3501041|P1|STARTED|Washout Period||7
1429839|NCT02432287|3501040|P2|NOT COMPLETED|First Intervention||1
1429840|NCT02432287|3501041|P1|NOT COMPLETED|First Intervention||0
1429841|NCT02432287|3501040|P2|COMPLETED|First Intervention||7
1429842|NCT02432287|3501041|P1|COMPLETED|First Intervention||8
1429843|NCT02432287|3501040|P2|STARTED|First Intervention||8
1429844|NCT02432287|3501041|P1|STARTED|First Intervention||8
1429845|NCT02432105|3501052|P3|NOT COMPLETED|Overall Study||3
1429846|NCT02432105|3501053|P2|NOT COMPLETED|Overall Study||2
1429847|NCT02432105|3501054|P1|NOT COMPLETED|Overall Study||2
1429848|NCT02432105|3501052|P3|COMPLETED|Overall Study||108
1429849|NCT02432105|3501053|P2|COMPLETED|Overall Study||108
1429850|NCT02432105|3501054|P1|COMPLETED|Overall Study||162
1429851|NCT02432105|3501052|P3|STARTED|Overall Study||111
1429852|NCT02432105|3501053|P2|STARTED|Overall Study||110
1429853|NCT02432105|3501054|P1|STARTED|Overall Study||164
1429854|NCT02432040|3501071|P2|NOT COMPLETED|Overall Study||6
1429855|NCT02432040|3501072|P1|NOT COMPLETED|Overall Study||8
1429856|NCT02432040|3501071|P2|COMPLETED|Overall Study||8
1429857|NCT02432040|3501072|P1|COMPLETED|Overall Study||6
1429858|NCT02432040|3501071|P2|STARTED|Overall Study||14
1429859|NCT02432040|3501072|P1|STARTED|Overall Study||14
1429860|NCT02431754|3501094|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
1429861|NCT02431754|3501095|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
1429862|NCT02431754|3501094|P2|COMPLETED|Period 2 (8 Weeks)||78
1429863|NCT02431754|3501095|P1|COMPLETED|Period 2 (8 Weeks)||74
1429864|NCT02431754|3501094|P2|STARTED|Period 2 (8 Weeks)||82
1429865|NCT02431754|3501095|P1|STARTED|Period 2 (8 Weeks)||75
1429866|NCT02431754|3501094|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
1429867|NCT02431754|3501095|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
1429868|NCT02431754|3501094|P2|COMPLETED|Wash-out Period (4 Weeks)||82
1429869|NCT02431754|3501095|P1|COMPLETED|Wash-out Period (4 Weeks)||75
1429870|NCT02431754|3501094|P2|STARTED|Wash-out Period (4 Weeks)||82
1429871|NCT02431754|3501095|P1|STARTED|Wash-out Period (4 Weeks)||79
1429872|NCT02431754|3501094|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
1429873|NCT02431754|3501095|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
1429874|NCT02431754|3501094|P2|COMPLETED|Period 1 (8 Weeks)||82
1429875|NCT02431754|3501095|P1|COMPLETED|Period 1 (8 Weeks)||79
1429876|NCT02431754|3501094|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
1429877|NCT02431754|3501095|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
1429878|NCT02431754|3501094|P2|STARTED|Period 1 (8 Weeks)||86
1429879|NCT02431754|3501095|P1|STARTED|Period 1 (8 Weeks)||85
1429880|NCT02431741|3501113|P1|NOT COMPLETED|Overall Study||0
1429881|NCT02431741|3501113|P1|COMPLETED|Overall Study||14
1429882|NCT02431741|3501113|P1|STARTED|Overall Study||14
1429883|NCT02431598|3501117|P6|NOT COMPLETED|Overall Study||0
1429884|NCT02431598|3501118|P5|NOT COMPLETED|Overall Study||0
1429885|NCT02431598|3501119|P4|NOT COMPLETED|Overall Study||0
1429886|NCT02431598|3501120|P3|NOT COMPLETED|Overall Study||0
1429887|NCT02431598|3501121|P2|NOT COMPLETED|Overall Study||0
1429888|NCT02431598|3501122|P1|NOT COMPLETED|Overall Study||0
1429889|NCT02431598|3501117|P6|COMPLETED|Overall Study||6
1429890|NCT02431598|3501118|P5|COMPLETED|Overall Study||7
1429891|NCT02431598|3501119|P4|COMPLETED|Overall Study||7
1429892|NCT02431598|3501120|P3|COMPLETED|Overall Study||9
1429893|NCT02431598|3501121|P2|COMPLETED|Overall Study||9
1429894|NCT02431598|3501122|P1|COMPLETED|Overall Study||6
1429895|NCT02431598|3501117|P6|STARTED|Overall Study||6
1429896|NCT02431598|3501118|P5|STARTED|Overall Study||7
1429897|NCT02431598|3501119|P4|STARTED|Overall Study||7
1429898|NCT02431598|3501120|P3|STARTED|Overall Study||9
1429899|NCT02431598|3501121|P2|STARTED|Overall Study||9
1429900|NCT02431598|3501122|P1|STARTED|Overall Study||6
1429901|NCT02431468|3501149|P3|NOT COMPLETED|Overall Study||9
1429902|NCT02431468|3501150|P2|NOT COMPLETED|Overall Study||18
1429903|NCT02431468|3501151|P1|NOT COMPLETED|Overall Study||8
1429904|NCT02431468|3501149|P3|COMPLETED|Overall Study||39
1429905|NCT02431468|3501150|P2|COMPLETED|Overall Study||29
1429906|NCT02431468|3501151|P1|COMPLETED|Overall Study||38
1429907|NCT02431468|3501149|P3|STARTED|Overall Study||48
1429908|NCT02431468|3501150|P2|STARTED|Overall Study||47
1429909|NCT02431468|3501151|P1|STARTED|Overall Study||46
1429910|NCT02431455|3501173|P2|NOT COMPLETED|Overall Study||0
1429911|NCT02431455|3501174|P1|NOT COMPLETED|Overall Study||0
1429912|NCT02431455|3501173|P2|COMPLETED|Overall Study||112
1429913|NCT02431455|3501174|P1|COMPLETED|Overall Study||112
1429914|NCT02431455|3501173|P2|STARTED|Overall Study||112
1429915|NCT02431455|3501174|P1|STARTED|Overall Study||112
1429916|NCT02431299|3501188|P2|NOT COMPLETED|Overall Study||1
1429917|NCT02431299|3501189|P1|NOT COMPLETED|Overall Study||53
1429918|NCT02431299|3501188|P2|COMPLETED|Overall Study||62
1429919|NCT02431299|3501189|P1|COMPLETED|Overall Study||183
1429920|NCT02431299|3501188|P2|STARTED|Overall Study||63
1429921|NCT02431299|3501189|P1|STARTED|Overall Study||236
1429922|NCT02431247|3501204|P2|NOT COMPLETED|Overall Study||363
1429923|NCT02431247|3501205|P1|NOT COMPLETED|Overall Study||362
1429924|NCT02431247|3501204|P2|COMPLETED|Overall Study||0
1429925|NCT02431247|3501205|P1|COMPLETED|Overall Study||0
1429926|NCT02431247|3501204|P2|STARTED|Overall Study||363
1429927|NCT02431247|3501205|P1|STARTED|Overall Study||362
1429928|NCT02430870|3501267|P8|NOT COMPLETED|Part 2||1
1429929|NCT02430870|3501268|P7|NOT COMPLETED|Part 2||1
1429930|NCT02430870|3501269|P6|NOT COMPLETED|Part 2||0
1429931|NCT02430870|3501270|P5|NOT COMPLETED|Part 2||0
1429932|NCT02430870|3501271|P4|NOT COMPLETED|Part 2||0
1429933|NCT02430870|3501272|P3|NOT COMPLETED|Part 2||0
1429934|NCT02430870|3501273|P2|NOT COMPLETED|Part 2||0
1429935|NCT02430870|3501274|P1|NOT COMPLETED|Part 2||0
1429936|NCT02430870|3501267|P8|COMPLETED|Part 2||7
1429937|NCT02430870|3501268|P7|COMPLETED|Part 2||5
1429938|NCT02430870|3501269|P6|COMPLETED|Part 2||6
1429939|NCT02430870|3501270|P5|COMPLETED|Part 2||6
1429940|NCT02430870|3501271|P4|COMPLETED|Part 2||6
1429941|NCT02430870|3501272|P3|COMPLETED|Part 2||0
1429942|NCT02430870|3501273|P2|COMPLETED|Part 2||0
1429943|NCT02430870|3501274|P1|COMPLETED|Part 2||0
1429944|NCT02430870|3501267|P8|STARTED|Part 2||8
1429945|NCT02430870|3501268|P7|STARTED|Part 2||6
1429946|NCT02430870|3501269|P6|STARTED|Part 2||6
1429947|NCT02430870|3501270|P5|STARTED|Part 2||6
1429948|NCT02430870|3501271|P4|STARTED|Part 2||6
1429949|NCT02430870|3501272|P3|STARTED|Part 2||0
1429950|NCT02430870|3501273|P2|STARTED|Part 2||0
1429951|NCT02430870|3501274|P1|STARTED|Part 2||0
1429952|NCT02430870|3501267|P8|NOT COMPLETED|Part 1||0
1429953|NCT02430870|3501268|P7|NOT COMPLETED|Part 1||0
1429954|NCT02430870|3501269|P6|NOT COMPLETED|Part 1||0
1429955|NCT02430870|3501270|P5|NOT COMPLETED|Part 1||0
1429956|NCT02430870|3501271|P4|NOT COMPLETED|Part 1||0
1429957|NCT02430870|3501272|P3|NOT COMPLETED|Part 1||0
1429958|NCT02430870|3501273|P2|NOT COMPLETED|Part 1||0
1429959|NCT02430870|3501274|P1|NOT COMPLETED|Part 1||0
1429960|NCT02430870|3501267|P8|COMPLETED|Part 1||0
1429961|NCT02430870|3501268|P7|COMPLETED|Part 1||0
1429962|NCT02430870|3501269|P6|COMPLETED|Part 1||0
1429963|NCT02430870|3501270|P5|COMPLETED|Part 1||0
1429964|NCT02430870|3501271|P4|COMPLETED|Part 1||0
1429965|NCT02430870|3501272|P3|COMPLETED|Part 1||4
1429966|NCT02430870|3501273|P2|COMPLETED|Part 1||6
1429967|NCT02430870|3501274|P1|COMPLETED|Part 1||6
1429968|NCT02430870|3501267|P8|STARTED|Part 1||0
1429969|NCT02430870|3501268|P7|STARTED|Part 1||0
1429970|NCT02430870|3501269|P6|STARTED|Part 1||0
1429971|NCT02430870|3501270|P5|STARTED|Part 1||0
1429972|NCT02430870|3501271|P4|STARTED|Part 1||0
1429973|NCT02430870|3501272|P3|STARTED|Part 1||4
1429974|NCT02430870|3501273|P2|STARTED|Part 1||6
1429975|NCT02430870|3501274|P1|STARTED|Part 1||6
1429976|NCT02430532|3501348|P2|NOT COMPLETED|Overall Study||28
1429977|NCT02430532|3501349|P1|NOT COMPLETED|Overall Study||30
1429978|NCT02430532|3501348|P2|COMPLETED|Overall Study||0
1429979|NCT02430532|3501349|P1|COMPLETED|Overall Study||0
1429980|NCT02430532|3501348|P2|STARTED|Overall Study||28
1429981|NCT02430532|3501349|P1|STARTED|Overall Study||30
1429982|NCT02430389|3501365|P2|NOT COMPLETED|Overall Study||0
1429983|NCT02430389|3501366|P1|NOT COMPLETED|Overall Study||0
1429984|NCT02430389|3501365|P2|COMPLETED|Overall Study||10
1429985|NCT02430389|3501366|P1|COMPLETED|Overall Study||10
1429986|NCT02430389|3501365|P2|STARTED|Overall Study||10
1429987|NCT02430389|3501366|P1|STARTED|Overall Study||10
1429988|NCT02430311|3501376|P2|NOT COMPLETED|Part B||8
1429989|NCT02430311|3501377|P1|NOT COMPLETED|Part B||10
1429990|NCT02430311|3501376|P2|COMPLETED|Part B||7
1429991|NCT02430311|3501377|P1|COMPLETED|Part B||9
1429992|NCT02430311|3501376|P2|Received Paclitaxel|Part B||14
1429993|NCT02430311|3501377|P1|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
1429994|NCT02430311|3501376|P2|Received Olaparib|Part B||15
1429995|NCT02430311|3501377|P1|Received Olaparib|Part B||19
1429996|NCT02430311|3501376|P2|STARTED|Part B||15
1429997|NCT02430311|3501377|P1|STARTED|Part B||19
1429998|NCT02430311|3501376|P2|NOT COMPLETED|Part A||1
1429999|NCT02430311|3501377|P1|NOT COMPLETED|Part A||1
1430000|NCT02430311|3501376|P2|COMPLETED|Part A||15
1430001|NCT02430311|3501377|P1|COMPLETED|Part A||19
1430002|NCT02430311|3501376|P2|Received Paclitaxel|Part A||16
1430003|NCT02430311|3501377|P1|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
1430004|NCT02430311|3501376|P2|Received Olaparib|Part A||16
1430005|NCT02430311|3501377|P1|Received Olaparib|Part A||20
1430006|NCT02430311|3501376|P2|STARTED|Part A||16
1430007|NCT02430311|3501377|P1|STARTED|Part A||20
1430008|NCT02430090|3501413|P3|NOT COMPLETED|Overall Study||0
1430009|NCT02430090|3501414|P2|NOT COMPLETED|Overall Study||0
1430010|NCT02430090|3501415|P1|NOT COMPLETED|Overall Study||0
1430011|NCT02430090|3501413|P3|COMPLETED|Overall Study||15
1430012|NCT02430090|3501414|P2|COMPLETED|Overall Study||15
1430013|NCT02430090|3501415|P1|COMPLETED|Overall Study||15
1430014|NCT02430090|3501413|P3|STARTED|Overall Study||15
1430015|NCT02430090|3501414|P2|STARTED|Overall Study||15
1430016|NCT02430090|3501415|P1|STARTED|Overall Study||15
1430017|NCT02429791|3501425|P2|NOT COMPLETED|Overall Study||18
1430018|NCT02429791|3501426|P1|NOT COMPLETED|Overall Study||13
1430019|NCT02429791|3501425|P2|COMPLETED|Overall Study||238
1430020|NCT02429791|3501426|P1|COMPLETED|Overall Study||239
1430021|NCT02429791|3501425|P2|STARTED|Overall Study||256
1430022|NCT02429791|3501426|P1|STARTED|Overall Study||252
1430023|NCT02429258|3501498|P2|NOT COMPLETED|Overall Study||1
1430024|NCT02429258|3501499|P1|NOT COMPLETED|Overall Study||2
1430025|NCT02429258|3501498|P2|COMPLETED|Overall Study||49
1430026|NCT02429258|3501499|P1|COMPLETED|Overall Study||48
1430027|NCT02429258|3501498|P2|STARTED|Overall Study||50
1430028|NCT02429258|3501499|P1|STARTED|Overall Study||50
1430029|NCT02428699|3501525|P2|NOT COMPLETED|Period 2||0
1430030|NCT02428699|3501526|P1|NOT COMPLETED|Period 2||0
1430031|NCT02428699|3501525|P2|COMPLETED|Period 2||23
1430032|NCT02428699|3501526|P1|COMPLETED|Period 2||24
1430033|NCT02428699|3501525|P2|STARTED|Period 2||23
1430034|NCT02428699|3501526|P1|STARTED|Period 2||24
1430035|NCT02428699|3501525|P2|NOT COMPLETED|Washout Period 1||2
1430036|NCT02428699|3501526|P1|NOT COMPLETED|Washout Period 1||1
1430037|NCT02428699|3501525|P2|COMPLETED|Washout Period 1||23
1430038|NCT02428699|3501526|P1|COMPLETED|Washout Period 1||24
1430039|NCT02428699|3501525|P2|STARTED|Washout Period 1||25
1430040|NCT02428699|3501526|P1|STARTED|Washout Period 1||25
1430041|NCT02428699|3501525|P2|NOT COMPLETED|Period 1||0
1430042|NCT02428699|3501526|P1|NOT COMPLETED|Period 1||0
1430043|NCT02428699|3501525|P2|COMPLETED|Period 1||25
1430044|NCT02428699|3501526|P1|COMPLETED|Period 1||25
1430045|NCT02428699|3501525|P2|STARTED|Period 1||25
1430046|NCT02428699|3501526|P1|STARTED|Period 1||25
1430047|NCT02428478|3501554|P2|NOT COMPLETED|Second Study Night||0
1430048|NCT02428478|3501555|P1|NOT COMPLETED|Second Study Night||0
1430049|NCT02428478|3501554|P2|COMPLETED|Second Study Night||6
1430050|NCT02428478|3501555|P1|COMPLETED|Second Study Night||8
1430051|NCT02428478|3501554|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
1430052|NCT02428478|3501555|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
1430053|NCT02428478|3501554|P2|NOT COMPLETED|First Study Night||0
1430054|NCT02428478|3501555|P1|NOT COMPLETED|First Study Night||0
1430055|NCT02428478|3501554|P2|COMPLETED|First Study Night||8
1430056|NCT02428478|3501555|P1|COMPLETED|First Study Night||9
1430057|NCT02428478|3501554|P2|STARTED|First Study Night||8
1430058|NCT02428478|3501555|P1|STARTED|First Study Night||9
1430059|NCT02428413|3501565|P2|NOT COMPLETED|Overall Study||9
1430060|NCT02428413|3501566|P1|NOT COMPLETED|Overall Study||8
1430061|NCT02428413|3501565|P2|COMPLETED|Overall Study||52
1430062|NCT02428413|3501566|P1|COMPLETED|Overall Study||56
1430063|NCT02428413|3501565|P2|STARTED|Overall Study||61
1430064|NCT02428413|3501566|P1|STARTED|Overall Study||64
1430065|NCT02428231|3501580|P2|NOT COMPLETED|Overall Study||17
1430066|NCT02428231|3501581|P1|NOT COMPLETED|Overall Study||13
1430067|NCT02428231|3501580|P2|COMPLETED|Overall Study||15
1430068|NCT02428231|3501581|P1|COMPLETED|Overall Study||17
1430069|NCT02428231|3501580|P2|STARTED|Overall Study||32
1430070|NCT02428231|3501581|P1|STARTED|Overall Study||30
1430071|NCT02427984|3501598|P3|NOT COMPLETED|Overall Study||18
1430072|NCT02427984|3501599|P2|NOT COMPLETED|Overall Study||5
1430073|NCT02427984|3501600|P1|NOT COMPLETED|Overall Study||13
1430074|NCT02427984|3501598|P3|COMPLETED|Overall Study||32
1430075|NCT02427984|3501599|P2|COMPLETED|Overall Study||40
1430076|NCT02427984|3501600|P1|COMPLETED|Overall Study||40
1430077|NCT02427984|3501598|P3|STARTED|Overall Study||50
1430078|NCT02427984|3501599|P2|STARTED|Overall Study||45
1430079|NCT02427984|3501600|P1|STARTED|Overall Study||53
1430080|NCT02427750|3501616|P2|NOT COMPLETED|Overall Study||0
1430081|NCT02427750|3501617|P1|NOT COMPLETED|Overall Study||0
1430082|NCT02427750|3501616|P2|COMPLETED|Overall Study||63
1430083|NCT02427750|3501617|P1|COMPLETED|Overall Study||63
1430084|NCT02427750|3501616|P2|STARTED|Overall Study||63
1430085|NCT02427750|3501617|P1|STARTED|Overall Study||63
1430086|NCT02427607|3501640|P1|NOT COMPLETED|Overall Study||1
1430087|NCT02427607|3501640|P1|COMPLETED|Overall Study||6
1430088|NCT02427607|3501640|P1|STARTED|Overall Study||7
1430089|NCT02427477|3501646|P2|NOT COMPLETED|Period 3||0
1430090|NCT02427477|3501647|P1|NOT COMPLETED|Period 3||0
1430091|NCT02427477|3501646|P2|COMPLETED|Period 3||60
1430092|NCT02427477|3501647|P1|COMPLETED|Period 3||59
1430093|NCT02427477|3501646|P2|STARTED|Period 3||60
1430094|NCT02427477|3501647|P1|STARTED|Period 3||59
1430095|NCT02427477|3501646|P2|NOT COMPLETED|Period 2||0
1430096|NCT02427477|3501647|P1|NOT COMPLETED|Period 2||0
1430097|NCT02427477|3501646|P2|COMPLETED|Period 2||60
1430098|NCT02427477|3501647|P1|COMPLETED|Period 2||59
1430099|NCT02427477|3501646|P2|STARTED|Period 2||60
1430100|NCT02427477|3501647|P1|STARTED|Period 2||59
1430101|NCT02427477|3501646|P2|NOT COMPLETED|Period 1||0
1430102|NCT02427477|3501647|P1|NOT COMPLETED|Period 1||1
1430103|NCT02427477|3501646|P2|COMPLETED|Period 1||60
1430104|NCT02427477|3501647|P1|COMPLETED|Period 1||59
1430105|NCT02427477|3501646|P2|STARTED|Period 1||60
1430106|NCT02427477|3501647|P1|STARTED|Period 1||60
1430107|NCT02427399|3501660|P5|NOT COMPLETED|Overall Study||15
1430108|NCT02427399|3501661|P4|NOT COMPLETED|Overall Study||18
1430109|NCT02427399|3501662|P3|NOT COMPLETED|Overall Study||12
1430110|NCT02427399|3501663|P2|NOT COMPLETED|Overall Study||16
1430111|NCT02427399|3501664|P1|NOT COMPLETED|Overall Study||14
1430112|NCT02427399|3501660|P5|COMPLETED|Overall Study||205
1430113|NCT02427399|3501661|P4|COMPLETED|Overall Study||202
1430114|NCT02427399|3501662|P3|COMPLETED|Overall Study||208
1430115|NCT02427399|3501663|P2|COMPLETED|Overall Study||204
1430116|NCT02427399|3501664|P1|COMPLETED|Overall Study||206
1430117|NCT02427399|3501660|P5|STARTED|Overall Study||220
1430118|NCT02427399|3501661|P4|STARTED|Overall Study||220
1430119|NCT02427399|3501662|P3|STARTED|Overall Study||220
1430120|NCT02427399|3501663|P2|STARTED|Overall Study||220
1430121|NCT02427399|3501664|P1|STARTED|Overall Study||220
1430122|NCT02426541|3501688|P2|NOT COMPLETED|Overall Study||0
1430123|NCT02426541|3501689|P1|NOT COMPLETED|Overall Study||1
1430124|NCT02426541|3501688|P2|COMPLETED|Overall Study||16
1430125|NCT02426541|3501689|P1|COMPLETED|Overall Study||15
1430126|NCT02426541|3501688|P2|STARTED|Overall Study||16
1430127|NCT02426541|3501689|P1|STARTED|Overall Study||16
1430128|NCT02425956|3501699|P1|NOT COMPLETED|Overall Study||0
1430129|NCT02425956|3501699|P1|COMPLETED|Overall Study||21
1430130|NCT02425956|3501699|P1|STARTED|Overall Study||21
1430131|NCT02425826|3501706|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
1430132|NCT02425826|3501707|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
1430133|NCT02425826|3501708|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
1430134|NCT02425826|3501706|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
1430135|NCT02425826|3501707|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
1430136|NCT02425826|3501708|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
1430137|NCT02425826|3501706|P3|STARTED|Post-Treatment Observational Follow-Up||49
1430138|NCT02425826|3501707|P2|STARTED|Post-Treatment Observational Follow-Up||0
1430139|NCT02425826|3501708|P1|STARTED|Post-Treatment Observational Follow-Up||81
1430140|NCT02425826|3501706|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
1430141|NCT02425826|3501707|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
1430142|NCT02425826|3501708|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
1430143|NCT02425826|3501706|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
1430144|NCT02425826|3501707|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
1430145|NCT02425826|3501708|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
1430146|NCT02425826|3501706|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
1430147|NCT02425826|3501707|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
1430148|NCT02425826|3501708|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
1430149|NCT02425826|3501706|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
1430150|NCT02425826|3501707|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
1430151|NCT02425826|3501708|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
1430152|NCT02425826|3501706|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
1430153|NCT02425826|3501707|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
1430154|NCT02425826|3501708|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
1430155|NCT02425826|3501706|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
1430156|NCT02425826|3501707|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
1430157|NCT02425826|3501708|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
1430158|NCT02425826|3501706|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
1430159|NCT02425826|3501707|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
1430160|NCT02425826|3501708|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
1430161|NCT02425826|3501706|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
1430162|NCT02425826|3501707|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
1430163|NCT02425826|3501708|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
1430164|NCT02425449|3501746|P5|NOT COMPLETED|Overall Study||0
1430165|NCT02425449|3501747|P4|NOT COMPLETED|Overall Study||0
1430166|NCT02425449|3501748|P3|NOT COMPLETED|Overall Study||0
1430167|NCT02425449|3501749|P2|NOT COMPLETED|Overall Study||0
1430168|NCT02425449|3501750|P1|NOT COMPLETED|Overall Study||0
1430169|NCT02425449|3501746|P5|COMPLETED|Overall Study||5
1430170|NCT02425449|3501747|P4|COMPLETED|Overall Study||5
1430171|NCT02425449|3501748|P3|COMPLETED|Overall Study||5
1430172|NCT02425449|3501749|P2|COMPLETED|Overall Study||4
1430173|NCT02425449|3501750|P1|COMPLETED|Overall Study||0
1430174|NCT02425449|3501746|P5|STARTED|Overall Study||5
1430175|NCT02425449|3501747|P4|STARTED|Overall Study||5
1430176|NCT02425449|3501748|P3|STARTED|Overall Study||5
1430177|NCT02425449|3501749|P2|STARTED|Overall Study||4
1430178|NCT02425449|3501750|P1|STARTED|Overall Study||0
1430179|NCT02425111|3501762|P1|NOT COMPLETED|Part B: Treatment Extension Period||10
1430180|NCT02425111|3501762|P1|COMPLETED|Part B: Treatment Extension Period||46
1430181|NCT02425111|3501762|P1|STARTED|Part B: Treatment Extension Period||56
1430182|NCT02425111|3501762|P1|NOT COMPLETED|Part A: Treatment Period||23
1430183|NCT02425111|3501762|P1|COMPLETED|Part A: Treatment Period||78
1430184|NCT02425111|3501762|P1|STARTED|Part A: Treatment Period||101
1430185|NCT02424734|3501784|P3|NOT COMPLETED|Overall Study||0
1430186|NCT02424734|3501785|P2|NOT COMPLETED|Overall Study||2
1430187|NCT02424734|3501786|P1|NOT COMPLETED|Overall Study||2
1430188|NCT02424734|3501784|P3|COMPLETED|Overall Study||2
1430189|NCT02424734|3501785|P2|COMPLETED|Overall Study||3
1430190|NCT02424734|3501786|P1|COMPLETED|Overall Study||2
1430191|NCT02424734|3501784|P3|Treated|Overall Study||2
1430192|NCT02424734|3501785|P2|Treated|Overall Study||5
1430193|NCT02424734|3501786|P1|Treated|Overall Study||4
1430194|NCT02424734|3501784|P3|STARTED|Overall Study||2
1430195|NCT02424734|3501785|P2|STARTED|Overall Study||5
1430196|NCT02424734|3501786|P1|STARTED|Overall Study||4
1430197|NCT02424591|3501805|P2|NOT COMPLETED|Overall Study||3
1430198|NCT02424591|3501806|P1|NOT COMPLETED|Overall Study||2
1430199|NCT02424591|3501805|P2|COMPLETED|Overall Study||20
1430200|NCT02424591|3501806|P1|COMPLETED|Overall Study||20
1430201|NCT02424591|3501805|P2|STARTED|Overall Study||23
1430202|NCT02424591|3501806|P1|STARTED|Overall Study||22
1430203|NCT02424578|3501818|P2|NOT COMPLETED|Overall Study||1
1430204|NCT02424578|3501819|P1|NOT COMPLETED|Overall Study||0
1430205|NCT02424578|3501818|P2|COMPLETED|Overall Study||14
1430206|NCT02424578|3501819|P1|COMPLETED|Overall Study||15
1430207|NCT02424578|3501818|P2|STARTED|Overall Study||15
1430208|NCT02424578|3501819|P1|STARTED|Overall Study||15
1430209|NCT02424565|3501825|P2|NOT COMPLETED|Period 2 (D3)||0
1430210|NCT02424565|3501826|P1|NOT COMPLETED|Period 2 (D3)||0
1430211|NCT02424565|3501825|P2|COMPLETED|Period 2 (D3)||6
1430212|NCT02424565|3501826|P1|COMPLETED|Period 2 (D3)||8
1430213|NCT02424565|3501825|P2|STARTED|Period 2 (D3)||6
1430214|NCT02424565|3501826|P1|STARTED|Period 2 (D3)||8
1430215|NCT02424565|3501825|P2|NOT COMPLETED|Washout Period||0
1430216|NCT02424565|3501826|P1|NOT COMPLETED|Washout Period||0
1430217|NCT02424565|3501825|P2|COMPLETED|Washout Period||6
1430218|NCT02424565|3501826|P1|COMPLETED|Washout Period||8
1430219|NCT02424565|3501825|P2|STARTED|Washout Period||6
1430220|NCT02424565|3501826|P1|STARTED|Washout Period||8
1430221|NCT02424565|3501825|P2|NOT COMPLETED|Period 1 (D0)||1
1430222|NCT02424565|3501826|P1|NOT COMPLETED|Period 1 (D0)||0
1430223|NCT02424565|3501825|P2|COMPLETED|Period 1 (D0)||6
1430224|NCT02424565|3501826|P1|COMPLETED|Period 1 (D0)||8
1430225|NCT02424565|3501825|P2|STARTED|Period 1 (D0)||7
1430226|NCT02424565|3501826|P1|STARTED|Period 1 (D0)||8
1430227|NCT02424357|3501834|P2|NOT COMPLETED|Overall Study||0
1430228|NCT02424357|3501835|P1|NOT COMPLETED|Overall Study||0
1430229|NCT02424357|3501834|P2|COMPLETED|Overall Study||30
1430230|NCT02424357|3501835|P1|COMPLETED|Overall Study||35
1430231|NCT02424357|3501834|P2|STARTED|Overall Study||30
1430232|NCT02424357|3501835|P1|STARTED|Overall Study||35
1430233|NCT02424344|3501845|P2|NOT COMPLETED|Overall Study||10
1430234|NCT02424344|3501846|P1|NOT COMPLETED|Overall Study||7
1430235|NCT02424344|3501845|P2|COMPLETED|Overall Study||123
1430236|NCT02424344|3501846|P1|COMPLETED|Overall Study||127
1430237|NCT02424344|3501845|P2|STARTED|Overall Study||133
1430238|NCT02424344|3501846|P1|STARTED|Overall Study||134
1430239|NCT02424149|3501858|P2|NOT COMPLETED|Overall Study||1
1430240|NCT02424149|3501859|P1|NOT COMPLETED|Overall Study||2
1430241|NCT02424149|3501858|P2|COMPLETED|Overall Study||52
1430242|NCT02424149|3501859|P1|COMPLETED|Overall Study||52
1430243|NCT02424149|3501858|P2|STARTED|Overall Study||53
1430244|NCT02424149|3501859|P1|STARTED|Overall Study||54
1430245|NCT02424097|3501875|P2|NOT COMPLETED|Overall Study||2
1430246|NCT02424097|3501876|P1|NOT COMPLETED|Overall Study||1
1430247|NCT02424097|3501875|P2|COMPLETED|Overall Study||18
1430248|NCT02424097|3501876|P1|COMPLETED|Overall Study||19
1430249|NCT02424097|3501875|P2|STARTED|Overall Study||20
1430250|NCT02424097|3501876|P1|STARTED|Overall Study||20
1430251|NCT02423993|3501888|P4|NOT COMPLETED|Overall Study||0
1430252|NCT02423993|3501889|P3|NOT COMPLETED|Overall Study||0
1430253|NCT02423993|3501890|P2|NOT COMPLETED|Overall Study||0
1430254|NCT02423993|3501891|P1|NOT COMPLETED|Overall Study||0
1430255|NCT02423993|3501888|P4|COMPLETED|Overall Study||19
1430256|NCT02423993|3501889|P3|COMPLETED|Overall Study||23
1430257|NCT02423993|3501890|P2|COMPLETED|Overall Study||16
1430258|NCT02423993|3501891|P1|COMPLETED|Overall Study||19
1430259|NCT02423993|3501888|P4|STARTED|Overall Study||19
1430260|NCT02423993|3501889|P3|STARTED|Overall Study||23
1430261|NCT02423993|3501890|P2|STARTED|Overall Study||16
1430262|NCT02423993|3501891|P1|STARTED|Overall Study||19
1430263|NCT02423980|3501921|P1|NOT COMPLETED|Overall Study||0
1430264|NCT02423980|3501921|P1|COMPLETED|Overall Study||7
1430265|NCT02423980|3501921|P1|STARTED|Overall Study||7
1430266|NCT02423798|3501931|P1|NOT COMPLETED|Overall Study||3
1430267|NCT02423798|3501931|P1|COMPLETED|Overall Study||21
1430268|NCT02423798|3501931|P1|STARTED|Overall Study||24
1430269|NCT02423577|3501939|P2|NOT COMPLETED|Overall Study||0
1430270|NCT02423577|3501940|P1|NOT COMPLETED|Overall Study||0
1430271|NCT02423577|3501939|P2|COMPLETED|Overall Study||26
1430272|NCT02423577|3501940|P1|COMPLETED|Overall Study||53
1430273|NCT02423577|3501939|P2|STARTED|Overall Study||26
1430274|NCT02423577|3501940|P1|STARTED|Overall Study||53
1430275|NCT02423447|3501946|P2|NOT COMPLETED|Overall Study||0
1430276|NCT02423447|3501947|P1|NOT COMPLETED|Overall Study||0
1430277|NCT02423447|3501946|P2|COMPLETED|Overall Study||12
1430278|NCT02423447|3501947|P1|COMPLETED|Overall Study||13
1430279|NCT02423447|3501946|P2|STARTED|Overall Study||12
1430280|NCT02423447|3501947|P1|STARTED|Overall Study||13
1430281|NCT02423408|3501963|P2|NOT COMPLETED|Overall Study||2
1430282|NCT02423408|3501964|P1|NOT COMPLETED|Overall Study||1
1430283|NCT02423408|3501963|P2|COMPLETED|Overall Study||80
1430284|NCT02423408|3501964|P1|COMPLETED|Overall Study||82
1430285|NCT02423408|3501963|P2|STARTED|Overall Study||82
1430286|NCT02423408|3501964|P1|STARTED|Overall Study||83
1430287|NCT02423317|3501978|P2|NOT COMPLETED|Overall Study||0
1430288|NCT02423317|3501979|P1|NOT COMPLETED|Overall Study||0
1430289|NCT02423317|3501978|P2|COMPLETED|Overall Study||30
1430290|NCT02423317|3501979|P1|COMPLETED|Overall Study||30
1430291|NCT02423317|3501978|P2|STARTED|Overall Study||30
1430292|NCT02423317|3501979|P1|STARTED|Overall Study||30
1430293|NCT02423291|3501997|P1|NOT COMPLETED|Overall Study||15
1430294|NCT02423291|3501997|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
1430295|NCT02423291|3501997|P1|STARTED|Overall Study|Patients enrolled|15
1430296|NCT02423200|3502003|P2|NOT COMPLETED|Overall Study||0
1430297|NCT02423200|3502004|P1|NOT COMPLETED|Overall Study||1
1430298|NCT02423200|3502003|P2|COMPLETED|Overall Study||1
1430299|NCT02423200|3502004|P1|COMPLETED|Overall Study||7
1430300|NCT02423200|3502003|P2|STARTED|Overall Study||1
1430301|NCT02423200|3502004|P1|STARTED|Overall Study||8
1430302|NCT02423109|3502012|P2|NOT COMPLETED|Lens 2||0
1430303|NCT02423109|3502013|P1|NOT COMPLETED|Lens 2||0
1430304|NCT02423109|3502012|P2|COMPLETED|Lens 2||14
1430305|NCT02423109|3502013|P1|COMPLETED|Lens 2||18
1430306|NCT02423109|3502012|P2|STARTED|Lens 2||14
1430307|NCT02423109|3502013|P1|STARTED|Lens 2||18
1430308|NCT02423109|3502012|P2|NOT COMPLETED|Lens 1||0
1430309|NCT02423109|3502013|P1|NOT COMPLETED|Lens 1||1
1430310|NCT02423109|3502012|P2|COMPLETED|Lens 1||14
1430311|NCT02423109|3502013|P1|COMPLETED|Lens 1||18
1430312|NCT02423109|3502012|P2|STARTED|Lens 1||14
1430313|NCT02423109|3502013|P1|STARTED|Lens 1||19
1430314|NCT02422940|3502023|P2|NOT COMPLETED|Overall Study||121
1430315|NCT02422940|3502024|P1|NOT COMPLETED|Overall Study||121
1430316|NCT02422940|3502023|P2|COMPLETED|Overall Study||21
1430317|NCT02422940|3502024|P1|COMPLETED|Overall Study||31
1430318|NCT02422940|3502023|P2|STARTED|Overall Study||142
1430319|NCT02422940|3502024|P1|STARTED|Overall Study||152
1430320|NCT02422797|3502046|P2|NOT COMPLETED|Overall Study||16
1430321|NCT02422797|3502047|P1|NOT COMPLETED|Overall Study||16
1430322|NCT02422797|3502046|P2|COMPLETED|Overall Study||239
1430323|NCT02422797|3502047|P1|COMPLETED|Overall Study||245
1430324|NCT02422797|3502046|P2|STARTED|Overall Study||255
1430325|NCT02422797|3502047|P1|STARTED|Overall Study||261
1430326|NCT02422615|3502119|P2|NOT COMPLETED|Overall Study||166
1430327|NCT02422615|3502120|P1|NOT COMPLETED|Overall Study||280
1430328|NCT02422615|3502119|P2|COMPLETED|Overall Study||76
1430329|NCT02422615|3502120|P1|COMPLETED|Overall Study||204
1430330|NCT02422615|3502119|P2|Untreated|Overall Study||1
1430331|NCT02422615|3502120|P1|Untreated|Overall Study||1
1430332|NCT02422615|3502119|P2|STARTED|Overall Study||242
1430333|NCT02422615|3502120|P1|STARTED|Overall Study||484
1430334|NCT02422446|3502128|P2|NOT COMPLETED|Overall Study||0
1430335|NCT02422446|3502129|P1|NOT COMPLETED|Overall Study||0
1430336|NCT02422446|3502128|P2|COMPLETED|Overall Study||1
1430337|NCT02422446|3502129|P1|COMPLETED|Overall Study||1
1430338|NCT02422446|3502128|P2|STARTED|Overall Study||1
1430339|NCT02422446|3502129|P1|STARTED|Overall Study||1
1430340|NCT02422303|3502137|P2|NOT COMPLETED|Overall Study||1
1430341|NCT02422303|3502138|P1|NOT COMPLETED|Overall Study||1
1430342|NCT02422303|3502137|P2|COMPLETED|Overall Study||5
1430343|NCT02422303|3502138|P1|COMPLETED|Overall Study||5
1430344|NCT02422303|3502137|P2|STARTED|Overall Study||6
1430345|NCT02422303|3502138|P1|STARTED|Overall Study||6
1430346|NCT02421419|3502147|P3|NOT COMPLETED|Overall Study||1
1430347|NCT02421419|3502148|P2|NOT COMPLETED|Overall Study||0
1430348|NCT02421419|3502149|P1|NOT COMPLETED|Overall Study||0
1430349|NCT02421419|3502147|P3|COMPLETED|Overall Study||8
1430350|NCT02421419|3502148|P2|COMPLETED|Overall Study||11
1430351|NCT02421419|3502149|P1|COMPLETED|Overall Study||6
1430352|NCT02421419|3502147|P3|STARTED|Overall Study||9
1430353|NCT02421419|3502148|P2|STARTED|Overall Study||11
1430354|NCT02421419|3502149|P1|STARTED|Overall Study||6
1430355|NCT02421211|3502168|P2|NOT COMPLETED|Overall Study||0
1430356|NCT02421211|3502169|P1|NOT COMPLETED|Overall Study||0
1430357|NCT02421211|3502168|P2|COMPLETED|Overall Study||20
1430358|NCT02421211|3502169|P1|COMPLETED|Overall Study||20
1430359|NCT02421211|3502168|P2|STARTED|Overall Study||20
1430360|NCT02421211|3502169|P1|STARTED|Overall Study||20
1430361|NCT02421146|3502217|P4|NOT COMPLETED|Overall Study||0
1430362|NCT02421146|3502218|P3|NOT COMPLETED|Overall Study||0
1430363|NCT02421146|3502219|P2|NOT COMPLETED|Overall Study||0
1430364|NCT02421146|3502220|P1|NOT COMPLETED|Overall Study||0
1430365|NCT02421146|3502217|P4|COMPLETED|Overall Study||3
1430366|NCT02421146|3502218|P3|COMPLETED|Overall Study||3
1430367|NCT02421146|3502219|P2|COMPLETED|Overall Study||4
1430368|NCT02421146|3502220|P1|COMPLETED|Overall Study||2
1430369|NCT02421146|3502217|P4|STARTED|Overall Study||3
1430370|NCT02421146|3502218|P3|STARTED|Overall Study||3
1430371|NCT02421146|3502219|P2|STARTED|Overall Study||4
1430372|NCT02421146|3502220|P1|STARTED|Overall Study||2
1430373|NCT02421120|3502234|P1|NOT COMPLETED|Overall Study||1
1430374|NCT02421120|3502234|P1|COMPLETED|Overall Study||20
1430375|NCT02421120|3502234|P1|STARTED|Overall Study||21
1430376|NCT02420951|3502244|P2|NOT COMPLETED|Overall Study||0
1430377|NCT02420951|3502245|P1|NOT COMPLETED|Overall Study||0
1430378|NCT02420951|3502244|P2|COMPLETED|Overall Study||25
1430379|NCT02420951|3502245|P1|COMPLETED|Overall Study||25
1430380|NCT02420951|3502244|P2|STARTED|Overall Study||25
1430381|NCT02420951|3502245|P1|STARTED|Overall Study||25
1430382|NCT02420873|3502264|P3|NOT COMPLETED|Overall Study||0
1430383|NCT02420873|3502265|P2|NOT COMPLETED|Overall Study||0
1430384|NCT02420873|3502266|P1|NOT COMPLETED|Overall Study||0
1430385|NCT02420873|3502264|P3|COMPLETED|Overall Study||0
1430386|NCT02420873|3502265|P2|COMPLETED|Overall Study||0
1430387|NCT02420873|3502266|P1|COMPLETED|Overall Study||9
1430388|NCT02420873|3502264|P3|STARTED|Overall Study||0
1430389|NCT02420873|3502265|P2|STARTED|Overall Study||0
1430390|NCT02420873|3502266|P1|STARTED|Overall Study||9
1430391|NCT02420821|3502276|P2|NOT COMPLETED|Overall Study||137
1430392|NCT02420821|3502277|P1|NOT COMPLETED|Overall Study||168
1430393|NCT02420821|3502276|P2|COMPLETED|Overall Study||317
1430394|NCT02420821|3502277|P1|COMPLETED|Overall Study||293
1430395|NCT02420821|3502276|P2|STARTED|Overall Study||454
1430396|NCT02420821|3502277|P1|STARTED|Overall Study||461
1430397|NCT02420327|3502345|P1|NOT COMPLETED|Overall Study||16
1430398|NCT02420327|3502345|P1|COMPLETED|Overall Study||27
1430399|NCT02420327|3502345|P1|STARTED|Overall Study||43
1430400|NCT02420262|3502381|P2|NOT COMPLETED|Overall Study||5
1430401|NCT02420262|3502382|P1|NOT COMPLETED|Overall Study||2
1430402|NCT02420262|3502381|P2|COMPLETED|Overall Study||249
1430403|NCT02420262|3502382|P1|COMPLETED|Overall Study||250
1430404|NCT02420262|3502381|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
1430405|NCT02420262|3502382|P1|Exposed|Overall Study||252
1430406|NCT02420262|3502381|P2|STARTED|Overall Study||254
1430407|NCT02420262|3502382|P1|STARTED|Overall Study||252
1430408|NCT02420210|3502396|P1|NOT COMPLETED|Overall Study||0
1430409|NCT02420210|3502396|P1|COMPLETED|Overall Study||2
1430410|NCT02420210|3502396|P1|STARTED|Overall Study||2
1430411|NCT02420093|3502408|P2|NOT COMPLETED|Overall Study||1
1430412|NCT02420093|3502409|P1|NOT COMPLETED|Overall Study||1
1430413|NCT02420093|3502408|P2|COMPLETED|Overall Study||7
1430414|NCT02420093|3502409|P1|COMPLETED|Overall Study||8
1430415|NCT02420093|3502408|P2|STARTED|Overall Study||8
1430416|NCT02420093|3502409|P1|STARTED|Overall Study||9
1430417|NCT02420041|3502425|P2|NOT COMPLETED|Overall Study||0
1430418|NCT02420041|3502426|P1|NOT COMPLETED|Overall Study||0
1430419|NCT02420041|3502425|P2|COMPLETED|Overall Study||14
1430420|NCT02420041|3502426|P1|COMPLETED|Overall Study||14
1430421|NCT02420041|3502425|P2|STARTED|Overall Study||14
1430422|NCT02420041|3502426|P1|STARTED|Overall Study||14
1430423|NCT02419937|3502452|P2|NOT COMPLETED|Overall Study||0
1430424|NCT02419937|3502453|P1|NOT COMPLETED|Overall Study||1
1430425|NCT02419937|3502452|P2|COMPLETED|Overall Study||16
1430426|NCT02419937|3502453|P1|COMPLETED|Overall Study||11
1430427|NCT02419937|3502452|P2|STARTED|Overall Study||16
1430428|NCT02419937|3502453|P1|STARTED|Overall Study||12
1430429|NCT02419755|3502461|P2|NOT COMPLETED|Overall Study||4
1430430|NCT02419755|3502462|P1|NOT COMPLETED|Overall Study||3
1430431|NCT02419755|3502461|P2|COMPLETED|Overall Study||2
1430432|NCT02419755|3502462|P1|COMPLETED|Overall Study||3
1430433|NCT02419755|3502461|P2|STARTED|Overall Study||6
1430434|NCT02419755|3502462|P1|STARTED|Overall Study||6
1430435|NCT02419612|3502488|P2|NOT COMPLETED|Overall Study||23
1430436|NCT02419612|3502489|P1|NOT COMPLETED|Overall Study||17
1430437|NCT02419612|3502488|P2|COMPLETED|Overall Study||194
1430438|NCT02419612|3502489|P1|COMPLETED|Overall Study||210
1430439|NCT02419612|3502488|P2|STARTED|Overall Study||217
1430440|NCT02419612|3502489|P1|STARTED|Overall Study||227
1430441|NCT02419573|3502505|P2|NOT COMPLETED|Overall Study||0
1430442|NCT02419573|3502506|P1|NOT COMPLETED|Overall Study||4
1430443|NCT02419573|3502505|P2|COMPLETED|Overall Study||1505
1430444|NCT02419573|3502506|P1|COMPLETED|Overall Study||1495
1430445|NCT02419573|3502505|P2|STARTED|Overall Study||1505
1430446|NCT02419573|3502506|P1|STARTED|Overall Study||1499
1430447|NCT02419521|3502518|P1|NOT COMPLETED|Overall Study||1
1430448|NCT02419521|3502518|P1|COMPLETED|Overall Study||74
1430449|NCT02419521|3502518|P1|STARTED|Overall Study||75
1430450|NCT02419508|3502532|P2|NOT COMPLETED|Overall Study||4
1430451|NCT02419508|3502533|P1|NOT COMPLETED|Overall Study||10
1430452|NCT02419508|3502532|P2|COMPLETED|Overall Study||88
1430453|NCT02419508|3502533|P1|COMPLETED|Overall Study||86
1430454|NCT02419508|3502532|P2|Safety Analysis Set|Overall Study||92
1430455|NCT02419508|3502533|P1|Safety Analysis Set|Overall Study||95
1430456|NCT02419508|3502532|P2|Full Analysis Set|Overall Study||92
1430457|NCT02419508|3502533|P1|Full Analysis Set|Overall Study||95
1430458|NCT02419508|3502532|P2|STARTED|Overall Study||92
1430459|NCT02419508|3502533|P1|STARTED|Overall Study||96
1430460|NCT02419469|3502551|P1|NOT COMPLETED|Overall Study||1
1430461|NCT02419469|3502551|P1|COMPLETED|Overall Study||0
1430462|NCT02419469|3502551|P1|STARTED|Overall Study||1
1430463|NCT02419313|3502555|P2|NOT COMPLETED|Second Intervention||0
1430464|NCT02419313|3502556|P1|NOT COMPLETED|Second Intervention||1
1430465|NCT02419313|3502555|P2|COMPLETED|Second Intervention||15
1430466|NCT02419313|3502556|P1|COMPLETED|Second Intervention||15
1430467|NCT02419313|3502555|P2|STARTED|Second Intervention||15
1430468|NCT02419313|3502556|P1|STARTED|Second Intervention||16
1430469|NCT02419313|3502555|P2|NOT COMPLETED|First Intervention||0
1430470|NCT02419313|3502556|P1|NOT COMPLETED|First Intervention||2
1430471|NCT02419313|3502555|P2|COMPLETED|First Intervention||15
1430472|NCT02419313|3502556|P1|COMPLETED|First Intervention||16
1430473|NCT02419313|3502555|P2|STARTED|First Intervention||15
1430474|NCT02419313|3502556|P1|STARTED|First Intervention||18
1430475|NCT02419001|3502568|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
1430476|NCT02419001|3502569|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
1430477|NCT02419001|3502568|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
1430478|NCT02419001|3502569|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
1430479|NCT02419001|3502568|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
1430480|NCT02419001|3502569|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
1430481|NCT02419001|3502568|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
1430482|NCT02419001|3502569|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
1430483|NCT02419001|3502568|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
1430484|NCT02419001|3502569|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
1430485|NCT02419001|3502568|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
1430486|NCT02419001|3502569|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
1430487|NCT02418676|3502582|P3|NOT COMPLETED|Overall Study||0
1430488|NCT02418676|3502583|P2|NOT COMPLETED|Overall Study||0
1430489|NCT02418676|3502584|P1|NOT COMPLETED|Overall Study||0
1430490|NCT02418676|3502582|P3|COMPLETED|Overall Study||5
1430491|NCT02418676|3502583|P2|COMPLETED|Overall Study||5
1430492|NCT02418676|3502584|P1|COMPLETED|Overall Study||5
1430493|NCT02418676|3502582|P3|STARTED|Overall Study||5
1430494|NCT02418676|3502583|P2|STARTED|Overall Study||5
1430495|NCT02418676|3502584|P1|STARTED|Overall Study||5
1430496|NCT02418468|3502597|P2|NOT COMPLETED|Overall Study||1
1430497|NCT02418468|3502598|P1|NOT COMPLETED|Overall Study||2
1430498|NCT02418468|3502597|P2|COMPLETED|Overall Study||10
1430499|NCT02418468|3502598|P1|COMPLETED|Overall Study||11
1430500|NCT02418468|3502597|P2|STARTED|Overall Study||11
1430501|NCT02418468|3502598|P1|STARTED|Overall Study||13
1430502|NCT02418234|3502604|P1|NOT COMPLETED|Overall Study||0
1430503|NCT02418234|3502604|P1|COMPLETED|Overall Study||314
1430504|NCT02418234|3502604|P1|STARTED|Overall Study||314
1430505|NCT02418026|3502617|P2|NOT COMPLETED|Overall Study||0
1430506|NCT02418026|3502618|P1|NOT COMPLETED|Overall Study||0
1430507|NCT02418026|3502617|P2|COMPLETED|Overall Study||35
1430508|NCT02418026|3502618|P1|COMPLETED|Overall Study||44
1430509|NCT02418026|3502617|P2|STARTED|Overall Study||35
1430510|NCT02418026|3502618|P1|STARTED|Overall Study||44
1430511|NCT02417961|3502648|P1|NOT COMPLETED|Overall Study||4
1430512|NCT02417961|3502648|P1|COMPLETED|Overall Study||112
1430513|NCT02417961|3502648|P1|STARTED|Overall Study||116
1430514|NCT02417935|3502660|P2|NOT COMPLETED|Tapering Period||0
1430515|NCT02417935|3502661|P1|NOT COMPLETED|Tapering Period||0
1430516|NCT02417935|3502660|P2|COMPLETED|Tapering Period||142
1430517|NCT02417935|3502661|P1|COMPLETED|Tapering Period||134
1430518|NCT02417935|3502660|P2|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
1430519|NCT02417935|3502661|P1|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
1430520|NCT02417935|3502660|P2|NOT COMPLETED|Treatment Period||16
1430521|NCT02417935|3502661|P1|NOT COMPLETED|Treatment Period||21
1430522|NCT02417935|3502660|P2|COMPLETED|Treatment Period||137
1430523|NCT02417935|3502661|P1|COMPLETED|Treatment Period||130
1430524|NCT02417935|3502660|P2|Received at Least One Dose of Study Drug|Treatment Period||152
1430525|NCT02417935|3502661|P1|Received at Least One Dose of Study Drug|Treatment Period||151
1430526|NCT02417935|3502660|P2|STARTED|Treatment Period||153
1430527|NCT02417935|3502661|P1|STARTED|Treatment Period||151
1430528|NCT02417753|3502685|P1|NOT COMPLETED|Overall Study||1
1430529|NCT02417753|3502685|P1|COMPLETED|Overall Study||0
1430530|NCT02417753|3502685|P1|STARTED|Overall Study||1
1430531|NCT02417532|3502695|P1|NOT COMPLETED|Overall Study||4
1430532|NCT02417532|3502695|P1|COMPLETED|Overall Study||52
1430533|NCT02417532|3502695|P1|STARTED|Overall Study||56
1430534|NCT02417376|3502708|P2|NOT COMPLETED|Overall Study||10
1430535|NCT02417376|3502709|P1|NOT COMPLETED|Overall Study||5
1430536|NCT02417376|3502708|P2|COMPLETED|Overall Study||25
1430537|NCT02417376|3502709|P1|COMPLETED|Overall Study||30
1430538|NCT02417376|3502708|P2|STARTED|Overall Study||35
1430539|NCT02417376|3502709|P1|STARTED|Overall Study||35
1430540|NCT02417233|3502756|P3|NOT COMPLETED|Overall Study||59
1430541|NCT02417233|3502757|P2|NOT COMPLETED|Overall Study||51
1430542|NCT02417233|3502758|P1|NOT COMPLETED|Overall Study||36
1430543|NCT02417233|3502756|P3|COMPLETED|Overall Study||239
1430544|NCT02417233|3502757|P2|COMPLETED|Overall Study||238
1430545|NCT02417233|3502758|P1|COMPLETED|Overall Study||133
1430546|NCT02417233|3502756|P3|STARTED|Overall Study||298
1430547|NCT02417233|3502757|P2|STARTED|Overall Study||289
1430548|NCT02417233|3502758|P1|STARTED|Overall Study||169
1430549|NCT02417129|3502781|P2|NOT COMPLETED|Overall Study||0
1430550|NCT02417129|3502782|P1|NOT COMPLETED|Overall Study||0
1430551|NCT02417129|3502781|P2|COMPLETED|Overall Study||0
1430552|NCT02417129|3502782|P1|COMPLETED|Overall Study||2
1430553|NCT02417129|3502781|P2|STARTED|Overall Study||0
1430554|NCT02417129|3502782|P1|STARTED|Overall Study||2
1430555|NCT02416973|3502795|P3|NOT COMPLETED|Overall Study||1
1430556|NCT02416973|3502796|P2|NOT COMPLETED|Overall Study||3
1430557|NCT02416973|3502797|P1|NOT COMPLETED|Overall Study||1
1430558|NCT02416973|3502795|P3|COMPLETED|Overall Study||13
1430559|NCT02416973|3502796|P2|COMPLETED|Overall Study||10
1430560|NCT02416973|3502797|P1|COMPLETED|Overall Study||13
1430561|NCT02416973|3502795|P3|STARTED|Overall Study||14
1430562|NCT02416973|3502796|P2|STARTED|Overall Study||13
1430563|NCT02416973|3502797|P1|STARTED|Overall Study||14
1430564|NCT02416934|3502807|P2|NOT COMPLETED|Overall Study||7
1430565|NCT02416934|3502808|P1|NOT COMPLETED|Overall Study||3
1430566|NCT02416934|3502807|P2|COMPLETED|Overall Study||31
1430567|NCT02416934|3502808|P1|COMPLETED|Overall Study||33
1430568|NCT02416934|3502807|P2|Last Participant Completed 1 yr|Overall Study||31
1430569|NCT02416934|3502808|P1|Last Participant Completed 1 yr|Overall Study||33
1430570|NCT02416934|3502807|P2|Double Blind (0-52 Weeks)|Overall Study||38
1430571|NCT02416934|3502808|P1|Double Blind (0-52 Weeks)|Overall Study||36
1430572|NCT02416934|3502807|P2|STARTED|Overall Study||38
1430573|NCT02416934|3502808|P1|STARTED|Overall Study||36
1430574|NCT02416180|3502818|P1|NOT COMPLETED|Overall Study||1
1430575|NCT02416180|3502818|P1|COMPLETED|Overall Study||110
1430576|NCT02416180|3502818|P1|STARTED|Overall Study||111
1430577|NCT02415959|3502830|P5|NOT COMPLETED|Overall Study||0
1430578|NCT02415959|3502831|P4|NOT COMPLETED|Overall Study||1
1430579|NCT02415959|3502832|P3|NOT COMPLETED|Overall Study||0
1430580|NCT02415959|3502833|P2|NOT COMPLETED|Overall Study||1
1430581|NCT02415959|3502834|P1|NOT COMPLETED|Overall Study||0
1430582|NCT02415959|3502830|P5|COMPLETED|Overall Study||14
1430583|NCT02415959|3502831|P4|COMPLETED|Overall Study||13
1430584|NCT02415959|3502832|P3|COMPLETED|Overall Study||14
1430585|NCT02415959|3502833|P2|COMPLETED|Overall Study||13
1430586|NCT02415959|3502834|P1|COMPLETED|Overall Study||14
1430587|NCT02415959|3502830|P5|STARTED|Overall Study||14
1430588|NCT02415959|3502831|P4|STARTED|Overall Study||14
1430589|NCT02415959|3502832|P3|STARTED|Overall Study||14
1430590|NCT02415959|3502833|P2|STARTED|Overall Study||14
1430591|NCT02415959|3502834|P1|STARTED|Overall Study||14
1430592|NCT02415608|3502868|P2|NOT COMPLETED|Overall Study||0
1430593|NCT02415608|3502869|P1|NOT COMPLETED|Overall Study||0
1430594|NCT02415608|3502868|P2|COMPLETED|Overall Study||1
1430595|NCT02415608|3502869|P1|COMPLETED|Overall Study||3
1430596|NCT02415608|3502868|P2|STARTED|Overall Study||1
1430597|NCT02415608|3502869|P1|STARTED|Overall Study||3
1430598|NCT02415595|3502899|P4|NOT COMPLETED|Overall Study||53
1430599|NCT02415595|3502900|P3|NOT COMPLETED|Overall Study||51
1430600|NCT02415595|3502901|P2|NOT COMPLETED|Overall Study||52
1430601|NCT02415595|3502902|P1|NOT COMPLETED|Overall Study||50
1430602|NCT02415595|3502899|P4|COMPLETED|Overall Study||0
1430603|NCT02415595|3502900|P3|COMPLETED|Overall Study||0
1430604|NCT02415595|3502901|P2|COMPLETED|Overall Study||0
1430605|NCT02415595|3502902|P1|COMPLETED|Overall Study||0
1430606|NCT02415595|3502899|P4|STARTED|Overall Study||53
1430607|NCT02415595|3502900|P3|STARTED|Overall Study||51
1430608|NCT02415595|3502901|P2|STARTED|Overall Study||52
1430609|NCT02415595|3502902|P1|STARTED|Overall Study||50
1430610|NCT02415439|3502974|P13|NOT COMPLETED|Overall Study||0
1430611|NCT02415439|3502975|P12|NOT COMPLETED|Overall Study||0
1430612|NCT02415439|3502976|P11|NOT COMPLETED|Overall Study||0
1430613|NCT02415439|3502977|P10|NOT COMPLETED|Overall Study||0
1430614|NCT02415439|3502978|P9|NOT COMPLETED|Overall Study||1
1430615|NCT02415439|3502979|P8|NOT COMPLETED|Overall Study||0
1430616|NCT02415439|3502980|P7|NOT COMPLETED|Overall Study||0
1430617|NCT02415439|3502981|P6|NOT COMPLETED|Overall Study||0
1430618|NCT02415439|3502982|P5|NOT COMPLETED|Overall Study||0
1430619|NCT02415439|3502983|P4|NOT COMPLETED|Overall Study||0
1430620|NCT02415439|3502984|P3|NOT COMPLETED|Overall Study||0
1430621|NCT02415439|3502985|P2|NOT COMPLETED|Overall Study||0
1430622|NCT02415439|3502986|P1|NOT COMPLETED|Overall Study||0
1430623|NCT02415439|3502974|P13|COMPLETED|Overall Study||8
1430624|NCT02415439|3502975|P12|COMPLETED|Overall Study||6
1430625|NCT02415439|3502976|P11|COMPLETED|Overall Study||6
1430626|NCT02415439|3502977|P10|COMPLETED|Overall Study||6
1430627|NCT02415439|3502978|P9|COMPLETED|Overall Study||5
1430628|NCT02415439|3502979|P8|COMPLETED|Overall Study||12
1430629|NCT02415439|3502980|P7|COMPLETED|Overall Study||6
1430630|NCT02415439|3502981|P6|COMPLETED|Overall Study||6
1430631|NCT02415439|3502982|P5|COMPLETED|Overall Study||6
1430632|NCT02415439|3502983|P4|COMPLETED|Overall Study||6
1430633|NCT02415439|3502984|P3|COMPLETED|Overall Study||6
1430634|NCT02415439|3502985|P2|COMPLETED|Overall Study||6
1430635|NCT02415439|3502986|P1|COMPLETED|Overall Study||6
1430636|NCT02415439|3502974|P13|STARTED|Overall Study||8
1430637|NCT02415439|3502975|P12|STARTED|Overall Study||6
1430638|NCT02415439|3502976|P11|STARTED|Overall Study||6
1430639|NCT02415439|3502977|P10|STARTED|Overall Study||6
1430640|NCT02415439|3502978|P9|STARTED|Overall Study||6
1430641|NCT02415439|3502979|P8|STARTED|Overall Study||12
1430642|NCT02415439|3502980|P7|STARTED|Overall Study||6
1430643|NCT02415439|3502981|P6|STARTED|Overall Study||6
1430644|NCT02415439|3502982|P5|STARTED|Overall Study||6
1430645|NCT02415439|3502983|P4|STARTED|Overall Study||6
1430646|NCT02415439|3502984|P3|STARTED|Overall Study||6
1430647|NCT02415439|3502985|P2|STARTED|Overall Study||6
1430648|NCT02415439|3502986|P1|STARTED|Overall Study||6
1430649|NCT02415166|3503044|P4|NOT COMPLETED|Overall Study||0
1430650|NCT02415166|3503045|P3|NOT COMPLETED|Overall Study||0
1430651|NCT02415166|3503046|P2|NOT COMPLETED|Overall Study||0
1430652|NCT02415166|3503047|P1|NOT COMPLETED|Overall Study||0
1430653|NCT02415166|3503044|P4|COMPLETED|Overall Study||0
1430654|NCT02415166|3503045|P3|COMPLETED|Overall Study||0
1430655|NCT02415166|3503046|P2|COMPLETED|Overall Study||0
1430656|NCT02415166|3503047|P1|COMPLETED|Overall Study||6
1430657|NCT02415166|3503044|P4|STARTED|Overall Study||0
1430658|NCT02415166|3503045|P3|STARTED|Overall Study||0
1430659|NCT02415166|3503046|P2|STARTED|Overall Study||0
1430660|NCT02415166|3503047|P1|STARTED|Overall Study||6
1430661|NCT02415127|3503075|P2|NOT COMPLETED|Overall Study||0
1430662|NCT02415127|3503076|P1|NOT COMPLETED|Overall Study||1
1430663|NCT02415127|3503075|P2|COMPLETED|Overall Study||45
1430664|NCT02415127|3503076|P1|COMPLETED|Overall Study||46
1430665|NCT02415127|3503075|P2|STARTED|Overall Study||45
1430666|NCT02415127|3503076|P1|STARTED|Overall Study||47
1430667|NCT02414958|3503093|P3|NOT COMPLETED|Overall Study||14
1430668|NCT02414958|3503094|P2|NOT COMPLETED|Overall Study||20
1430669|NCT02414958|3503095|P1|NOT COMPLETED|Overall Study||32
1430670|NCT02414958|3503093|P3|COMPLETED|Overall Study||230
1430671|NCT02414958|3503094|P2|COMPLETED|Overall Study||223
1430672|NCT02414958|3503095|P1|COMPLETED|Overall Study||211
1430673|NCT02414958|3503093|P3|STARTED|Overall Study||244
1430674|NCT02414958|3503094|P2|STARTED|Overall Study||243
1430675|NCT02414958|3503095|P1|STARTED|Overall Study||243
1430676|NCT02414854|3503128|P4|NOT COMPLETED|Overall Study||51
1430677|NCT02414854|3503129|P3|NOT COMPLETED|Overall Study||20
1430678|NCT02414854|3503130|P2|NOT COMPLETED|Overall Study||45
1430679|NCT02414854|3503131|P1|NOT COMPLETED|Overall Study||22
1430680|NCT02414854|3503128|P4|COMPLETED|Overall Study||582
1430681|NCT02414854|3503129|P3|COMPLETED|Overall Study||301
1430682|NCT02414854|3503130|P2|COMPLETED|Overall Study||586
1430683|NCT02414854|3503131|P1|COMPLETED|Overall Study||295
1430684|NCT02414854|3503128|P4|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
1430685|NCT02414854|3503129|P3|Treated|Overall Study||321
1430686|NCT02414854|3503130|P2|Treated|Overall Study||629
1430687|NCT02414854|3503131|P1|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
1430688|NCT02414854|3503128|P4|STARTED|Overall Study||633
1430689|NCT02414854|3503129|P3|STARTED|Overall Study||321
1430690|NCT02414854|3503130|P2|STARTED|Overall Study||631
1430691|NCT02414854|3503131|P1|STARTED|Overall Study||317
1430692|NCT02414828|3503297|P4|NOT COMPLETED|Overall Study||2
1430693|NCT02414828|3503298|P3|NOT COMPLETED|Overall Study||1
1430694|NCT02414828|3503299|P2|NOT COMPLETED|Overall Study||1
1430695|NCT02414828|3503300|P1|NOT COMPLETED|Overall Study||0
1430696|NCT02414828|3503297|P4|COMPLETED|Overall Study||29
1430697|NCT02414828|3503298|P3|COMPLETED|Overall Study||19
1430698|NCT02414828|3503299|P2|COMPLETED|Overall Study||9
1430699|NCT02414828|3503300|P1|COMPLETED|Overall Study||11
1430700|NCT02414828|3503297|P4|STARTED|Overall Study||31
1430701|NCT02414828|3503298|P3|STARTED|Overall Study||20
1430702|NCT02414828|3503299|P2|STARTED|Overall Study||10
1430703|NCT02414828|3503300|P1|STARTED|Overall Study||11
1430704|NCT02414633|3503338|P1|NOT COMPLETED|Overall Study||0
1430705|NCT02414633|3503338|P1|COMPLETED|Overall Study||148
1430706|NCT02414633|3503338|P1|STARTED|Overall Study||148
1430707|NCT02414204|3503361|P2|NOT COMPLETED|Overall Study||0
1430708|NCT02414204|3503362|P1|NOT COMPLETED|Overall Study||0
1430709|NCT02414204|3503361|P2|COMPLETED|Overall Study||2
1430710|NCT02414204|3503362|P1|COMPLETED|Overall Study||2
1430711|NCT02414204|3503361|P2|STARTED|Overall Study||2
1430712|NCT02414204|3503362|P1|STARTED|Overall Study||2
1430713|NCT02414152|3503370|P1|NOT COMPLETED|Overall Study||2
1430714|NCT02414152|3503370|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
1430715|NCT02414152|3503370|P1|STARTED|Overall Study||2
1430716|NCT02413918|3503374|P1|NOT COMPLETED|Overall Study||25
1430717|NCT02413918|3503374|P1|COMPLETED|Overall Study||16
1430718|NCT02413918|3503374|P1|STARTED|Overall Study||41
1430719|NCT02413879|3503381|P1|NOT COMPLETED|Overall Study||0
1430720|NCT02413879|3503381|P1|COMPLETED|Overall Study||86
1430721|NCT02413879|3503381|P1|STARTED|Overall Study||86
1430722|NCT02413684|3503387|P1|NOT COMPLETED|Overall Study||13
1430723|NCT02413684|3503387|P1|COMPLETED|Overall Study||40
1430724|NCT02413684|3503387|P1|STARTED|Overall Study||53
1430725|NCT02413593|3503397|P1|NOT COMPLETED|Overall Study||4
1430726|NCT02413593|3503397|P1|COMPLETED|Overall Study||107
1430727|NCT02413593|3503397|P1|STARTED|Overall Study||111
1430728|NCT02413489|3503409|P3|NOT COMPLETED|Overall Study||5
1430729|NCT02413489|3503410|P2|NOT COMPLETED|Overall Study||16
1430730|NCT02413489|3503411|P1|NOT COMPLETED|Overall Study||15
1430731|NCT02413489|3503409|P3|COMPLETED|Overall Study||0
1430732|NCT02413489|3503410|P2|COMPLETED|Overall Study||0
1430733|NCT02413489|3503411|P1|COMPLETED|Overall Study||0
1430734|NCT02413489|3503409|P3|STARTED|Overall Study||5
1430735|NCT02413489|3503410|P2|STARTED|Overall Study||16
1430736|NCT02413489|3503411|P1|STARTED|Overall Study||15
1430737|NCT02413398|3503433|P2|NOT COMPLETED|Overall Study||7
1430738|NCT02413398|3503434|P1|NOT COMPLETED|Overall Study||4
1430739|NCT02413398|3503433|P2|COMPLETED|Overall Study||154
1430740|NCT02413398|3503434|P1|COMPLETED|Overall Study||156
1430741|NCT02413398|3503433|P2|STARTED|Overall Study||161
1430742|NCT02413398|3503434|P1|STARTED|Overall Study||160
1430743|NCT02413346|3503448|P2|NOT COMPLETED|Overall Study||70
1430744|NCT02413346|3503449|P1|NOT COMPLETED|Overall Study||59
1430745|NCT02413346|3503448|P2|COMPLETED|Overall Study||177
1430746|NCT02413346|3503449|P1|COMPLETED|Overall Study||177
1430747|NCT02413346|3503448|P2|STARTED|Overall Study||247
1430748|NCT02413346|3503449|P1|STARTED|Overall Study||236
1430749|NCT02413333|3503459|P2|NOT COMPLETED|Period 2||0
1430750|NCT02413333|3503460|P1|NOT COMPLETED|Period 2||1
1430751|NCT02413333|3503459|P2|COMPLETED|Period 2||65
1430752|NCT02413333|3503460|P1|COMPLETED|Period 2||64
1430753|NCT02413333|3503459|P2|STARTED|Period 2||65
1430754|NCT02413333|3503460|P1|STARTED|Period 2||65
1430755|NCT02413333|3503459|P2|NOT COMPLETED|Period 1||1
1430756|NCT02413333|3503460|P1|NOT COMPLETED|Period 1||1
1430757|NCT02413333|3503459|P2|COMPLETED|Period 1||65
1430758|NCT02413333|3503460|P1|COMPLETED|Period 1||65
1430759|NCT02413333|3503459|P2|Randomized and Treated|Period 1||66
1430760|NCT02413333|3503460|P1|Randomized and Treated|Period 1||66
1430761|NCT02413333|3503459|P2|STARTED|Period 1||66
1430762|NCT02413333|3503460|P1|STARTED|Period 1||66
1430763|NCT02413294|3503468|P1|NOT COMPLETED|Overall Study||1
1430764|NCT02413294|3503468|P1|COMPLETED|Overall Study||11
1430765|NCT02413294|3503468|P1|STARTED|Overall Study||12
1430766|NCT02413229|3503494|P8|NOT COMPLETED|Overall Study||4
1430767|NCT02413229|3503495|P7|NOT COMPLETED|Overall Study||0
1430768|NCT02413229|3503496|P6|NOT COMPLETED|Overall Study||0
1430769|NCT02413229|3503497|P5|NOT COMPLETED|Overall Study||3
1430770|NCT02413229|3503498|P4|NOT COMPLETED|Overall Study||1
1430771|NCT02413229|3503499|P3|NOT COMPLETED|Overall Study||1
1430772|NCT02413229|3503500|P2|NOT COMPLETED|Overall Study||1
1430773|NCT02413229|3503501|P1|NOT COMPLETED|Overall Study||1
1430774|NCT02413229|3503494|P8|COMPLETED|Overall Study||11
1430775|NCT02413229|3503495|P7|COMPLETED|Overall Study||25
1430776|NCT02413229|3503496|P6|COMPLETED|Overall Study||12
1430777|NCT02413229|3503497|P5|COMPLETED|Overall Study||21
1430778|NCT02413229|3503498|P4|COMPLETED|Overall Study||11
1430779|NCT02413229|3503499|P3|COMPLETED|Overall Study||25
1430780|NCT02413229|3503500|P2|COMPLETED|Overall Study||11
1430781|NCT02413229|3503501|P1|COMPLETED|Overall Study||24
1430782|NCT02413229|3503494|P8|STARTED|Overall Study||15
1430783|NCT02413229|3503495|P7|STARTED|Overall Study||25
1430784|NCT02413229|3503496|P6|STARTED|Overall Study||12
1430785|NCT02413229|3503497|P5|STARTED|Overall Study||24
1430786|NCT02413229|3503498|P4|STARTED|Overall Study||12
1430787|NCT02413229|3503499|P3|STARTED|Overall Study||26
1430788|NCT02413229|3503500|P2|STARTED|Overall Study||12
1430789|NCT02413229|3503501|P1|STARTED|Overall Study||25
1430790|NCT02413203|3503521|P2|NOT COMPLETED|Overall Study||0
1430791|NCT02413203|3503522|P1|NOT COMPLETED|Overall Study||0
1430792|NCT02413203|3503521|P2|COMPLETED|Overall Study||10
1430793|NCT02413203|3503522|P1|COMPLETED|Overall Study||10
1430794|NCT02413203|3503521|P2|STARTED|Overall Study||10
1430795|NCT02413203|3503522|P1|STARTED|Overall Study||10
1430796|NCT02413034|3503544|P2|NOT COMPLETED|Overall Study||0
1430797|NCT02413034|3503545|P1|NOT COMPLETED|Overall Study||0
1430798|NCT02413034|3503544|P2|COMPLETED|Overall Study||14
1430799|NCT02413034|3503545|P1|COMPLETED|Overall Study||14
1430800|NCT02413034|3503544|P2|STARTED|Overall Study||14
1430801|NCT02413034|3503545|P1|STARTED|Overall Study||14
1430802|NCT02412878|3503555|P2|NOT COMPLETED|Overall Study||183
1430803|NCT02412878|3503556|P1|NOT COMPLETED|Overall Study||174
1430804|NCT02412878|3503555|P2|COMPLETED|Overall Study||57
1430805|NCT02412878|3503556|P1|COMPLETED|Overall Study||64
1430806|NCT02412878|3503555|P2|Received Carfilzomib|Overall Study||238
1430807|NCT02412878|3503556|P1|Received Carfilzomib|Overall Study||235
1430808|NCT02412878|3503555|P2|STARTED|Overall Study||240
1430809|NCT02412878|3503556|P1|STARTED|Overall Study||238
1430810|NCT02412761|3503570|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
1430811|NCT02412761|3503571|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
1430812|NCT02412761|3503572|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
1430813|NCT02412761|3503573|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
1430814|NCT02412761|3503574|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
1430815|NCT02412761|3503575|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
1430816|NCT02412761|3503570|P6|COMPLETED|Third Intervention (2 Weeks)||6
1430817|NCT02412761|3503571|P5|COMPLETED|Third Intervention (2 Weeks)||4
1430818|NCT02412761|3503572|P4|COMPLETED|Third Intervention (2 Weeks)||8
1430819|NCT02412761|3503573|P3|COMPLETED|Third Intervention (2 Weeks)||4
1430820|NCT02412761|3503574|P2|COMPLETED|Third Intervention (2 Weeks)||5
1430821|NCT02412761|3503575|P1|COMPLETED|Third Intervention (2 Weeks)||5
1430822|NCT02412761|3503570|P6|STARTED|Third Intervention (2 Weeks)||6
1430823|NCT02412761|3503571|P5|STARTED|Third Intervention (2 Weeks)||4
1430824|NCT02412761|3503572|P4|STARTED|Third Intervention (2 Weeks)||8
1430825|NCT02412761|3503573|P3|STARTED|Third Intervention (2 Weeks)||4
1430826|NCT02412761|3503574|P2|STARTED|Third Intervention (2 Weeks)||5
1430827|NCT02412761|3503575|P1|STARTED|Third Intervention (2 Weeks)||5
1430828|NCT02412761|3503570|P6|NOT COMPLETED|Second Intervention (2 Weeks)||0
1430829|NCT02412761|3503571|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
1430830|NCT02412761|3503572|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
1430831|NCT02412761|3503573|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
1430832|NCT02412761|3503574|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
1430833|NCT02412761|3503575|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
1430834|NCT02412761|3503570|P6|COMPLETED|Second Intervention (2 Weeks)||6
1430835|NCT02412761|3503571|P5|COMPLETED|Second Intervention (2 Weeks)||4
1430836|NCT02412761|3503572|P4|COMPLETED|Second Intervention (2 Weeks)||8
1430837|NCT02412761|3503573|P3|COMPLETED|Second Intervention (2 Weeks)||4
1430838|NCT02412761|3503574|P2|COMPLETED|Second Intervention (2 Weeks)||5
1430839|NCT02412761|3503575|P1|COMPLETED|Second Intervention (2 Weeks)||5
1430840|NCT02412761|3503570|P6|STARTED|Second Intervention (2 Weeks)||6
1430841|NCT02412761|3503571|P5|STARTED|Second Intervention (2 Weeks)||4
1430842|NCT02412761|3503572|P4|STARTED|Second Intervention (2 Weeks)||8
1430843|NCT02412761|3503573|P3|STARTED|Second Intervention (2 Weeks)||4
1430844|NCT02412761|3503574|P2|STARTED|Second Intervention (2 Weeks)||5
1430845|NCT02412761|3503575|P1|STARTED|Second Intervention (2 Weeks)||5
1430846|NCT02412761|3503570|P6|NOT COMPLETED|First Intervention (2 Weeks)||1
1430847|NCT02412761|3503571|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
1430848|NCT02412761|3503572|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
1430849|NCT02412761|3503573|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
1430850|NCT02412761|3503574|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
1430851|NCT02412761|3503575|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
1430852|NCT02412761|3503570|P6|COMPLETED|First Intervention (2 Weeks)||6
1430853|NCT02412761|3503571|P5|COMPLETED|First Intervention (2 Weeks)||4
1430854|NCT02412761|3503572|P4|COMPLETED|First Intervention (2 Weeks)||8
1430855|NCT02412761|3503573|P3|COMPLETED|First Intervention (2 Weeks)||4
1430856|NCT02412761|3503574|P2|COMPLETED|First Intervention (2 Weeks)||5
1430857|NCT02412761|3503575|P1|COMPLETED|First Intervention (2 Weeks)||5
1430858|NCT02412761|3503570|P6|STARTED|First Intervention (2 Weeks)||7
1430859|NCT02412761|3503571|P5|STARTED|First Intervention (2 Weeks)||4
1430860|NCT02412761|3503572|P4|STARTED|First Intervention (2 Weeks)||8
1430861|NCT02412761|3503573|P3|STARTED|First Intervention (2 Weeks)||5
1430862|NCT02412761|3503574|P2|STARTED|First Intervention (2 Weeks)||6
1430863|NCT02412761|3503575|P1|STARTED|First Intervention (2 Weeks)||5
1430864|NCT02412657|3503586|P3|NOT COMPLETED|Overall Study||3
1430865|NCT02412657|3503587|P2|NOT COMPLETED|Overall Study||2
1430866|NCT02412657|3503588|P1|NOT COMPLETED|Overall Study||1
1430867|NCT02412657|3503586|P3|COMPLETED|Overall Study||22
1430868|NCT02412657|3503587|P2|COMPLETED|Overall Study||23
1430869|NCT02412657|3503588|P1|COMPLETED|Overall Study||24
1430870|NCT02412657|3503586|P3|STARTED|Overall Study||25
1430871|NCT02412657|3503587|P2|STARTED|Overall Study||25
1430872|NCT02412657|3503588|P1|STARTED|Overall Study||25
1430873|NCT02412501|3503596|P1|NOT COMPLETED|Overall Study||1
1430874|NCT02412501|3503596|P1|COMPLETED|Overall Study||100
1430875|NCT02412501|3503596|P1|STARTED|Overall Study||101
1430876|NCT02412436|3503605|P1|NOT COMPLETED|Overall Study||18
1430877|NCT02412436|3503605|P1|COMPLETED|Overall Study||44
1430878|NCT02412436|3503605|P1|STARTED|Overall Study||62
1430879|NCT02411929|3503617|P1|NOT COMPLETED|Period 2||0
1430880|NCT02411929|3503617|P1|COMPLETED|Period 2||8
1430881|NCT02411929|3503617|P1|STARTED|Period 2||8
1430882|NCT02411929|3503617|P1|NOT COMPLETED|Washout Period||0
1430883|NCT02411929|3503617|P1|COMPLETED|Washout Period||8
1430884|NCT02411929|3503617|P1|STARTED|Washout Period||8
1430885|NCT02411929|3503617|P1|NOT COMPLETED|Period 1||0
1430886|NCT02411929|3503617|P1|COMPLETED|Period 1||8
1430887|NCT02411929|3503617|P1|STARTED|Period 1||8
1430888|NCT02411747|3503649|P2|NOT COMPLETED|Overall Study||4
1430889|NCT02411747|3503650|P1|NOT COMPLETED|Overall Study||3
1430890|NCT02411747|3503649|P2|COMPLETED|Overall Study||12
1430891|NCT02411747|3503650|P1|COMPLETED|Overall Study||13
1430892|NCT02411747|3503649|P2|Simulation Training Completed|Overall Study||16
1430893|NCT02411747|3503650|P1|Simulation Training Completed|Overall Study||16
1430894|NCT02411747|3503649|P2|STARTED|Overall Study||16
1430895|NCT02411747|3503650|P1|STARTED|Overall Study||16
1430896|NCT02411643|3503656|P1|NOT COMPLETED|Overall Study||0
1430897|NCT02411643|3503656|P1|COMPLETED|Overall Study||2
1430898|NCT02411643|3503656|P1|STARTED|Overall Study||2
1430899|NCT02411578|3503665|P2|NOT COMPLETED|Extension Phase||0
1430900|NCT02411578|3503666|P1|NOT COMPLETED|Extension Phase||0
1430901|NCT02411578|3503665|P2|COMPLETED|Extension Phase||9
1430902|NCT02411578|3503666|P1|COMPLETED|Extension Phase||8
1430903|NCT02411578|3503665|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
1430904|NCT02411578|3503666|P1|STARTED|Extension Phase||8
1430905|NCT02411578|3503665|P2|NOT COMPLETED|Crossover Trial Phase||1
1430906|NCT02411578|3503666|P1|NOT COMPLETED|Crossover Trial Phase||0
1430907|NCT02411578|3503665|P2|COMPLETED|Crossover Trial Phase||11
1430908|NCT02411578|3503666|P1|COMPLETED|Crossover Trial Phase||8
1430909|NCT02411578|3503665|P2|STARTED|Crossover Trial Phase||12
1430910|NCT02411578|3503666|P1|STARTED|Crossover Trial Phase||8
1430911|NCT02411539|3503708|P2|NOT COMPLETED|Overall Study||1
1430912|NCT02411539|3503709|P1|NOT COMPLETED|Overall Study||2
1430913|NCT02411539|3503708|P2|COMPLETED|Overall Study||19
1430914|NCT02411539|3503709|P1|COMPLETED|Overall Study||18
1430915|NCT02411539|3503708|P2|STARTED|Overall Study||20
1430916|NCT02411539|3503709|P1|STARTED|Overall Study||20
1430917|NCT02411461|3503787|P3|NOT COMPLETED|Overall Study||0
1430918|NCT02411461|3503788|P2|NOT COMPLETED|Overall Study||0
1430919|NCT02411461|3503789|P1|NOT COMPLETED|Overall Study||0
1430920|NCT02411461|3503787|P3|COMPLETED|Overall Study||15
1430921|NCT02411461|3503788|P2|COMPLETED|Overall Study||8
1430922|NCT02411461|3503789|P1|COMPLETED|Overall Study||16
1430923|NCT02411461|3503787|P3|STARTED|Overall Study||15
1430924|NCT02411461|3503788|P2|STARTED|Overall Study||8
1430925|NCT02411461|3503789|P1|STARTED|Overall Study||16
1430926|NCT02411292|3503797|P1|NOT COMPLETED|Overall Study||21
1430927|NCT02411292|3503797|P1|COMPLETED|Overall Study||89
1430928|NCT02411292|3503797|P1|STARTED|Overall Study||110
1430929|NCT02411201|3503803|P1|NOT COMPLETED|Overall Study||6
1430930|NCT02411201|3503803|P1|COMPLETED|Overall Study||45
1430931|NCT02411201|3503803|P1|STARTED|Overall Study||51
1430932|NCT02411110|3503816|P2|NOT COMPLETED|Treatment Period 2||4
1430933|NCT02411110|3503817|P1|NOT COMPLETED|Treatment Period 2||1
1430934|NCT02411110|3503816|P2|COMPLETED|Treatment Period 2||44
1430935|NCT02411110|3503817|P1|COMPLETED|Treatment Period 2||49
1430936|NCT02411110|3503816|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
1430937|NCT02411110|3503817|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
1430938|NCT02411110|3503816|P2|NOT COMPLETED|Treatment Period 1||7
1430939|NCT02411110|3503817|P1|NOT COMPLETED|Treatment Period 1||9
1430940|NCT02411110|3503816|P2|COMPLETED|Treatment Period 1||59
1430941|NCT02411110|3503817|P1|COMPLETED|Treatment Period 1||56
1430942|NCT02411110|3503816|P2|STARTED|Treatment Period 1||66
1430943|NCT02411110|3503817|P1|STARTED|Treatment Period 1||65
1430944|NCT02410967|3503827|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
1430945|NCT02410967|3503828|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
1430946|NCT02410967|3503827|P2|COMPLETED|Follow-up Phase (8 Weeks)||16
1430947|NCT02410967|3503828|P1|COMPLETED|Follow-up Phase (8 Weeks)||22
1430948|NCT02410967|3503827|P2|STARTED|Follow-up Phase (8 Weeks)||22
1430949|NCT02410967|3503828|P1|STARTED|Follow-up Phase (8 Weeks)||26
1430950|NCT02410967|3503827|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||4
1430951|NCT02410967|3503828|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||1
1430952|NCT02410967|3503827|P2|COMPLETED|Treatment Phase (4 Weeks)||22
1430953|NCT02410967|3503828|P1|COMPLETED|Treatment Phase (4 Weeks)||26
1430954|NCT02410967|3503827|P2|STARTED|Treatment Phase (4 Weeks)||26
1430955|NCT02410967|3503828|P1|STARTED|Treatment Phase (4 Weeks)||27
1430956|NCT02410824|3503844|P2|NOT COMPLETED|Second Intervention (One Week)||0
1430957|NCT02410824|3503845|P1|NOT COMPLETED|Second Intervention (One Week)||0
1430958|NCT02410824|3503844|P2|COMPLETED|Second Intervention (One Week)||22
1430959|NCT02410824|3503845|P1|COMPLETED|Second Intervention (One Week)||22
1430960|NCT02410824|3503844|P2|STARTED|Second Intervention (One Week)||22
1430961|NCT02410824|3503845|P1|STARTED|Second Intervention (One Week)||22
1430962|NCT02410824|3503844|P2|NOT COMPLETED|First Intervention (One Week)||1
1430963|NCT02410824|3503845|P1|NOT COMPLETED|First Intervention (One Week)||0
1430964|NCT02410824|3503844|P2|COMPLETED|First Intervention (One Week)||22
1430965|NCT02410824|3503845|P1|COMPLETED|First Intervention (One Week)||22
1430966|NCT02410824|3503844|P2|STARTED|First Intervention (One Week)||23
1430967|NCT02410824|3503845|P1|STARTED|First Intervention (One Week)||22
1430968|NCT02410551|3503877|P1|NOT COMPLETED|Overall Study||4
1430969|NCT02410551|3503877|P1|COMPLETED|Overall Study||0
1430970|NCT02410551|3503877|P1|STARTED|Overall Study||4
1430971|NCT02410343|3503884|P2|NOT COMPLETED|Extension Period (12 Months)||1
1430972|NCT02410343|3503885|P1|NOT COMPLETED|Extension Period (12 Months)||1
1430973|NCT02410343|3503884|P2|COMPLETED|Extension Period (12 Months)||0
1430974|NCT02410343|3503885|P1|COMPLETED|Extension Period (12 Months)||0
1430975|NCT02410343|3503884|P2|STARTED|Extension Period (12 Months)||1
1430976|NCT02410343|3503885|P1|STARTED|Extension Period (12 Months)||1
1430977|NCT02410343|3503884|P2|NOT COMPLETED|Core Period (24 Weeks)||7
1430978|NCT02410343|3503885|P1|NOT COMPLETED|Core Period (24 Weeks)||5
1430979|NCT02410343|3503884|P2|COMPLETED|Core Period (24 Weeks)||1
1430980|NCT02410343|3503885|P1|COMPLETED|Core Period (24 Weeks)||1
1430981|NCT02410343|3503884|P2|STARTED|Core Period (24 Weeks)||8
1430982|NCT02410343|3503885|P1|STARTED|Core Period (24 Weeks)||6
1430983|NCT02410291|3503922|P2|NOT COMPLETED|Overall Study||0
1430984|NCT02410291|3503923|P1|NOT COMPLETED|Overall Study||0
1430985|NCT02410291|3503922|P2|COMPLETED|Overall Study||29
1430986|NCT02410291|3503923|P1|COMPLETED|Overall Study||29
1430987|NCT02410291|3503922|P2|STARTED|Overall Study||29
1430988|NCT02410291|3503923|P1|STARTED|Overall Study||29
1430989|NCT02410278|3503931|P3|NOT COMPLETED|Study Treatment Period||4
1430990|NCT02410278|3503932|P2|NOT COMPLETED|Study Treatment Period||11
1430991|NCT02410278|3503933|P1|NOT COMPLETED|Study Treatment Period||0
1430992|NCT02410278|3503931|P3|COMPLETED|Study Treatment Period||29
1430993|NCT02410278|3503932|P2|COMPLETED|Study Treatment Period||20
1430994|NCT02410278|3503933|P1|COMPLETED|Study Treatment Period||0
1430995|NCT02410278|3503931|P3|Completed Randomized Study Treatment|Study Treatment Period||29
1430996|NCT02410278|3503932|P2|Completed Randomized Study Treatment|Study Treatment Period||20
1430997|NCT02410278|3503933|P1|Completed Randomized Study Treatment|Study Treatment Period||0
1430998|NCT02410278|3503931|P3|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
1430999|NCT02410278|3503932|P2|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
1431000|NCT02410278|3503933|P1|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
1431001|NCT02410278|3503931|P3|STARTED|Study Treatment Period||33
1431002|NCT02410278|3503932|P2|STARTED|Study Treatment Period||31
1431003|NCT02410278|3503933|P1|STARTED|Study Treatment Period||0
1431004|NCT02410278|3503931|P3|NOT COMPLETED|Run-in Period||0
1431005|NCT02410278|3503932|P2|NOT COMPLETED|Run-in Period||0
1431006|NCT02410278|3503933|P1|NOT COMPLETED|Run-in Period||38
1431007|NCT02410278|3503931|P3|COMPLETED|Run-in Period||0
1431008|NCT02410278|3503932|P2|COMPLETED|Run-in Period||0
1431009|NCT02410278|3503933|P1|COMPLETED|Run-in Period||64
1431010|NCT02410278|3503931|P3|Received at Least 1 Dose of DMF|Run-in Period||0
1431011|NCT02410278|3503932|P2|Received at Least 1 Dose of DMF|Run-in Period||0
1431012|NCT02410278|3503933|P1|Received at Least 1 Dose of DMF|Run-in Period||98
1431013|NCT02410278|3503931|P3|STARTED|Run-in Period||0
1431014|NCT02410278|3503932|P2|STARTED|Run-in Period||0
1431015|NCT02410278|3503933|P1|STARTED|Run-in Period||102
1431016|NCT02410252|3503958|P1|NOT COMPLETED|Overall Study||6
1431017|NCT02410252|3503958|P1|COMPLETED|Overall Study||19
1431018|NCT02410252|3503958|P1|STARTED|Overall Study||25
1431019|NCT02410213|3503964|P2|NOT COMPLETED|Overall Study||0
1431020|NCT02410213|3503965|P1|NOT COMPLETED|Overall Study||0
1431021|NCT02410213|3503964|P2|COMPLETED|Overall Study||19
1431022|NCT02410213|3503965|P1|COMPLETED|Overall Study||16
1431023|NCT02410213|3503964|P2|STARTED|Overall Study||19
1431024|NCT02410213|3503965|P1|STARTED|Overall Study||16
1431025|NCT02410200|3503971|P1|NOT COMPLETED|Overall Study||2
1431026|NCT02410200|3503971|P1|COMPLETED|Overall Study||20
1431027|NCT02410200|3503971|P1|STARTED|Overall Study||22
1431028|NCT02410018|3503984|P2|NOT COMPLETED|Overall Study||0
1431029|NCT02410018|3503985|P1|NOT COMPLETED|Overall Study||0
1431030|NCT02410018|3503984|P2|COMPLETED|Overall Study||1
1431031|NCT02410018|3503985|P1|COMPLETED|Overall Study||2
1431032|NCT02410018|3503984|P2|STARTED|Overall Study||1
1431033|NCT02410018|3503985|P1|STARTED|Overall Study||2
1431034|NCT02409927|3504005|P1|NOT COMPLETED|Overall Study||0
1431035|NCT02409927|3504005|P1|COMPLETED|Overall Study||10
1431036|NCT02409927|3504005|P1|STARTED|Overall Study||10
1431037|NCT02409784|3504013|P1|NOT COMPLETED|Overall Study||0
1431038|NCT02409784|3504013|P1|COMPLETED|Overall Study||10
1431039|NCT02409784|3504013|P1|STARTED|Overall Study||10
1431040|NCT02409732|3504021|P1|NOT COMPLETED|Overall Study||6
1431041|NCT02409732|3504021|P1|COMPLETED|Overall Study||14
1431042|NCT02409732|3504021|P1|STARTED|Overall Study|First patient consented on 4/23/15|20
1431043|NCT02409459|3504031|P2|NOT COMPLETED|Overall Study||1
1431044|NCT02409459|3504032|P1|NOT COMPLETED|Overall Study||1
1431045|NCT02409459|3504031|P2|COMPLETED|Overall Study||39
1431046|NCT02409459|3504032|P1|COMPLETED|Overall Study||40
1431047|NCT02409459|3504031|P2|STARTED|Overall Study||40
1431048|NCT02409459|3504032|P1|STARTED|Overall Study||41
1431049|NCT02409355|3504052|P2|NOT COMPLETED|Overall Study||4
1431050|NCT02409355|3504053|P1|NOT COMPLETED|Overall Study||4
1431051|NCT02409355|3504052|P2|COMPLETED|Overall Study||0
1431052|NCT02409355|3504053|P1|COMPLETED|Overall Study||0
1431053|NCT02409355|3504052|P2|STARTED|Overall Study||4
1431054|NCT02409355|3504053|P1|STARTED|Overall Study||4
1431055|NCT02408692|3504062|P3|NOT COMPLETED|Overall Study||0
1431056|NCT02408692|3504063|P2|NOT COMPLETED|Overall Study||0
1431057|NCT02408692|3504064|P1|NOT COMPLETED|Overall Study||0
1431058|NCT02408692|3504062|P3|COMPLETED|Overall Study||5
1431059|NCT02408692|3504063|P2|COMPLETED|Overall Study||5
1431060|NCT02408692|3504064|P1|COMPLETED|Overall Study||5
1431061|NCT02408692|3504062|P3|STARTED|Overall Study||5
1431062|NCT02408692|3504063|P2|STARTED|Overall Study||5
1431063|NCT02408692|3504064|P1|STARTED|Overall Study||5
1431064|NCT02408263|3504075|P2|NOT COMPLETED|Overall Study||0
1431065|NCT02408263|3504076|P1|NOT COMPLETED|Overall Study||0
1431066|NCT02408263|3504075|P2|COMPLETED|Overall Study||25
1431067|NCT02408263|3504076|P1|COMPLETED|Overall Study||25
1431068|NCT02408263|3504075|P2|STARTED|Overall Study||25
1431069|NCT02408263|3504076|P1|STARTED|Overall Study||25
1431070|NCT02408068|3504082|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1431071|NCT02408068|3504083|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1431072|NCT02408068|3504084|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1431073|NCT02408068|3504085|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
1431074|NCT02408068|3504086|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1431075|NCT02408068|3504087|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
1431076|NCT02408068|3504082|P6|COMPLETED|Treatment 3 (1.5 Days)||3
1431077|NCT02408068|3504083|P5|COMPLETED|Treatment 3 (1.5 Days)||3
1431078|NCT02408068|3504084|P4|COMPLETED|Treatment 3 (1.5 Days)||3
1431079|NCT02408068|3504085|P3|COMPLETED|Treatment 3 (1.5 Days)||2
1431080|NCT02408068|3504086|P2|COMPLETED|Treatment 3 (1.5 Days)||3
1431081|NCT02408068|3504087|P1|COMPLETED|Treatment 3 (1.5 Days)||3
1431082|NCT02408068|3504082|P6|STARTED|Treatment 3 (1.5 Days)||3
1431083|NCT02408068|3504083|P5|STARTED|Treatment 3 (1.5 Days)||3
1431084|NCT02408068|3504084|P4|STARTED|Treatment 3 (1.5 Days)||3
1431085|NCT02408068|3504085|P3|STARTED|Treatment 3 (1.5 Days)||3
1431086|NCT02408068|3504086|P2|STARTED|Treatment 3 (1.5 Days)||3
1431087|NCT02408068|3504087|P1|STARTED|Treatment 3 (1.5 Days)||3
1431088|NCT02408068|3504082|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1431089|NCT02408068|3504083|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1431090|NCT02408068|3504084|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1431091|NCT02408068|3504085|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1431092|NCT02408068|3504086|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1431093|NCT02408068|3504087|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1431094|NCT02408068|3504082|P6|COMPLETED|Washout Period 2 (7 Days)||3
1431095|NCT02408068|3504083|P5|COMPLETED|Washout Period 2 (7 Days)||3
1431096|NCT02408068|3504084|P4|COMPLETED|Washout Period 2 (7 Days)||3
1431097|NCT02408068|3504085|P3|COMPLETED|Washout Period 2 (7 Days)||3
1431098|NCT02408068|3504086|P2|COMPLETED|Washout Period 2 (7 Days)||3
1431099|NCT02408068|3504087|P1|COMPLETED|Washout Period 2 (7 Days)||3
1431100|NCT02408068|3504082|P6|STARTED|Washout Period 2 (7 Days)||3
1431101|NCT02408068|3504083|P5|STARTED|Washout Period 2 (7 Days)||3
1431102|NCT02408068|3504084|P4|STARTED|Washout Period 2 (7 Days)||3
1431103|NCT02408068|3504085|P3|STARTED|Washout Period 2 (7 Days)||3
1431104|NCT02408068|3504086|P2|STARTED|Washout Period 2 (7 Days)||3
1431105|NCT02408068|3504087|P1|STARTED|Washout Period 2 (7 Days)||3
1431106|NCT02408068|3504082|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1431107|NCT02408068|3504083|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1431108|NCT02408068|3504084|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1431109|NCT02408068|3504085|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1431110|NCT02408068|3504086|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1431111|NCT02408068|3504087|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
1431112|NCT02408068|3504082|P6|COMPLETED|Treatment 2 (1.5 Days)||3
1431113|NCT02408068|3504083|P5|COMPLETED|Treatment 2 (1.5 Days)||3
1431114|NCT02408068|3504084|P4|COMPLETED|Treatment 2 (1.5 Days)||3
1431115|NCT02408068|3504085|P3|COMPLETED|Treatment 2 (1.5 Days)||3
1431116|NCT02408068|3504086|P2|COMPLETED|Treatment 2 (1.5 Days)||3
1431117|NCT02408068|3504087|P1|COMPLETED|Treatment 2 (1.5 Days)||3
1431118|NCT02408068|3504082|P6|STARTED|Treatment 2 (1.5 Days)||3
1431119|NCT02408068|3504083|P5|STARTED|Treatment 2 (1.5 Days)||3
1431120|NCT02408068|3504084|P4|STARTED|Treatment 2 (1.5 Days)||3
1431121|NCT02408068|3504085|P3|STARTED|Treatment 2 (1.5 Days)||3
1431122|NCT02408068|3504086|P2|STARTED|Treatment 2 (1.5 Days)||3
1431123|NCT02408068|3504087|P1|STARTED|Treatment 2 (1.5 Days)||3
1431124|NCT02408068|3504082|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1431125|NCT02408068|3504083|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1431126|NCT02408068|3504084|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1431127|NCT02408068|3504085|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1431128|NCT02408068|3504086|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1431129|NCT02408068|3504087|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1431130|NCT02408068|3504082|P6|COMPLETED|Washout Period 1 (7 Days)||3
1431131|NCT02408068|3504083|P5|COMPLETED|Washout Period 1 (7 Days)||3
1431132|NCT02408068|3504084|P4|COMPLETED|Washout Period 1 (7 Days)||3
1431133|NCT02408068|3504085|P3|COMPLETED|Washout Period 1 (7 Days)||3
1431134|NCT02408068|3504086|P2|COMPLETED|Washout Period 1 (7 Days)||3
1431135|NCT02408068|3504087|P1|COMPLETED|Washout Period 1 (7 Days)||3
1431136|NCT02408068|3504082|P6|STARTED|Washout Period 1 (7 Days)||3
1431137|NCT02408068|3504083|P5|STARTED|Washout Period 1 (7 Days)||3
1431138|NCT02408068|3504084|P4|STARTED|Washout Period 1 (7 Days)||3
1431139|NCT02408068|3504085|P3|STARTED|Washout Period 1 (7 Days)||3
1431140|NCT02408068|3504086|P2|STARTED|Washout Period 1 (7 Days)||3
1431141|NCT02408068|3504087|P1|STARTED|Washout Period 1 (7 Days)||3
1431142|NCT02408068|3504082|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1431143|NCT02408068|3504083|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1431144|NCT02408068|3504084|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1431145|NCT02408068|3504085|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1431146|NCT02408068|3504086|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1431147|NCT02408068|3504087|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
1431148|NCT02408068|3504082|P6|COMPLETED|Treatment 1 (1.5 Days)||3
1431149|NCT02408068|3504083|P5|COMPLETED|Treatment 1 (1.5 Days)||3
1431150|NCT02408068|3504084|P4|COMPLETED|Treatment 1 (1.5 Days)||3
1431151|NCT02408068|3504085|P3|COMPLETED|Treatment 1 (1.5 Days)||3
1431152|NCT02408068|3504086|P2|COMPLETED|Treatment 1 (1.5 Days)||3
1431153|NCT02408068|3504087|P1|COMPLETED|Treatment 1 (1.5 Days)||3
1431154|NCT02408068|3504082|P6|STARTED|Treatment 1 (1.5 Days)||3
1431155|NCT02408068|3504083|P5|STARTED|Treatment 1 (1.5 Days)||3
1431156|NCT02408068|3504084|P4|STARTED|Treatment 1 (1.5 Days)||3
1431157|NCT02408068|3504085|P3|STARTED|Treatment 1 (1.5 Days)||3
1431158|NCT02408068|3504086|P2|STARTED|Treatment 1 (1.5 Days)||3
1431159|NCT02408068|3504087|P1|STARTED|Treatment 1 (1.5 Days)||3
1431160|NCT02407704|3504114|P4|NOT COMPLETED|Overall Study||3
1431161|NCT02407704|3504115|P3|NOT COMPLETED|Overall Study||1
1431162|NCT02407704|3504116|P2|NOT COMPLETED|Overall Study||0
1431163|NCT02407704|3504117|P1|NOT COMPLETED|Overall Study||0
1431164|NCT02407704|3504114|P4|COMPLETED|Overall Study||2
1431165|NCT02407704|3504115|P3|COMPLETED|Overall Study||4
1431166|NCT02407704|3504116|P2|COMPLETED|Overall Study||3
1431167|NCT02407704|3504117|P1|COMPLETED|Overall Study||2
1431168|NCT02407704|3504114|P4|STARTED|Overall Study||5
1431169|NCT02407704|3504115|P3|STARTED|Overall Study||5
1431170|NCT02407704|3504116|P2|STARTED|Overall Study||3
1431171|NCT02407704|3504117|P1|STARTED|Overall Study||2
1431172|NCT02406937|3504154|P3|NOT COMPLETED|Overall Study||2
1431173|NCT02406937|3504155|P2|NOT COMPLETED|Overall Study||1
1431174|NCT02406937|3504156|P1|NOT COMPLETED|Overall Study||1
1431175|NCT02406937|3504154|P3|COMPLETED|Overall Study||58
1431176|NCT02406937|3504155|P2|COMPLETED|Overall Study||59
1431177|NCT02406937|3504156|P1|COMPLETED|Overall Study||59
1431178|NCT02406937|3504154|P3|STARTED|Overall Study||60
1431179|NCT02406937|3504155|P2|STARTED|Overall Study||60
1431180|NCT02406937|3504156|P1|STARTED|Overall Study||60
1431181|NCT02406612|3504214|P2|NOT COMPLETED|Overall Study||4
1431182|NCT02406612|3504215|P1|NOT COMPLETED|Overall Study||4
1431183|NCT02406612|3504214|P2|COMPLETED|Overall Study||17
1431184|NCT02406612|3504215|P1|COMPLETED|Overall Study||22
1431185|NCT02406612|3504214|P2|STARTED|Overall Study||21
1431186|NCT02406612|3504215|P1|STARTED|Overall Study||26
1431187|NCT02406586|3504230|P3|NOT COMPLETED|Overall Study||2
1431188|NCT02406586|3504231|P2|NOT COMPLETED|Overall Study||4
1431189|NCT02406586|3504232|P1|NOT COMPLETED|Overall Study||1
1431190|NCT02406586|3504230|P3|COMPLETED|Overall Study||10
1431191|NCT02406586|3504231|P2|COMPLETED|Overall Study||8
1431192|NCT02406586|3504232|P1|COMPLETED|Overall Study||11
1431193|NCT02406586|3504230|P3|STARTED|Overall Study||12
1431194|NCT02406586|3504231|P2|STARTED|Overall Study||12
1431195|NCT02406586|3504232|P1|STARTED|Overall Study||12
1431196|NCT02406495|3504285|P1|NOT COMPLETED|Overall Study||0
1431197|NCT02406495|3504285|P1|COMPLETED|Overall Study||40
1431198|NCT02406495|3504285|P1|STARTED|Overall Study||40
1431199|NCT02406443|3504326|P2|NOT COMPLETED|Overall Study||2
1431200|NCT02406443|3504327|P1|NOT COMPLETED|Overall Study||2
1431201|NCT02406443|3504326|P2|COMPLETED|Overall Study||16
1431202|NCT02406443|3504327|P1|COMPLETED|Overall Study||16
1431203|NCT02406443|3504326|P2|STARTED|Overall Study||18
1431204|NCT02406443|3504327|P1|STARTED|Overall Study||18
1431205|NCT02406248|3504345|P1|NOT COMPLETED|Overall Study||9
1431206|NCT02406248|3504345|P1|COMPLETED|Overall Study||99
1431207|NCT02406248|3504345|P1|STARTED|Overall Study||108
1431208|NCT02405429|3504353|P1|NOT COMPLETED|Overall Study||0
1431209|NCT02405429|3504353|P1|COMPLETED|Overall Study||49
1431210|NCT02405429|3504353|P1|STARTED|Overall Study||49
1431211|NCT02405390|3504363|P2|NOT COMPLETED|Overall Study||0
1431212|NCT02405390|3504364|P1|NOT COMPLETED|Overall Study||0
1431213|NCT02405390|3504363|P2|COMPLETED|Overall Study||46
1431214|NCT02405390|3504364|P1|COMPLETED|Overall Study||46
1431215|NCT02405390|3504363|P2|STARTED|Overall Study||46
1431216|NCT02405390|3504364|P1|STARTED|Overall Study||46
1431217|NCT02405091|3504375|P3|NOT COMPLETED|Overall Study||2
1431218|NCT02405091|3504376|P2|NOT COMPLETED|Overall Study||33
1431219|NCT02405091|3504377|P1|NOT COMPLETED|Overall Study||29
1431220|NCT02405091|3504375|P3|COMPLETED|Overall Study||9
1431221|NCT02405091|3504376|P2|COMPLETED|Overall Study||74
1431222|NCT02405091|3504377|P1|COMPLETED|Overall Study||20
1431223|NCT02405091|3504375|P3|STARTED|Overall Study||11
1431224|NCT02405091|3504376|P2|STARTED|Overall Study||107
1431225|NCT02405091|3504377|P1|STARTED|Overall Study||49
1431226|NCT02404649|3504400|P2|NOT COMPLETED|Overall Study||2
1431227|NCT02404649|3504401|P1|NOT COMPLETED|Overall Study||1
1431228|NCT02404649|3504400|P2|COMPLETED|Overall Study||14
1431229|NCT02404649|3504401|P1|COMPLETED|Overall Study||16
1431230|NCT02404649|3504400|P2|STARTED|Overall Study||16
1431231|NCT02404649|3504401|P1|STARTED|Overall Study||17
1431232|NCT02404545|3504409|P2|NOT COMPLETED|Overall Study||6
1431233|NCT02404545|3504410|P1|NOT COMPLETED|Overall Study||6
1431234|NCT02404545|3504409|P2|COMPLETED|Overall Study||0
1431235|NCT02404545|3504410|P1|COMPLETED|Overall Study||0
1431236|NCT02404545|3504409|P2|STARTED|Overall Study||6
1431237|NCT02404545|3504410|P1|STARTED|Overall Study||6
1431238|NCT02404532|3504417|P1|NOT COMPLETED|Overall Study||0
1431239|NCT02404532|3504417|P1|COMPLETED|Overall Study||29
1431240|NCT02404532|3504417|P1|STARTED|Overall Study||29
1431241|NCT02404493|3504429|P2|NOT COMPLETED|Overall Study||1
1431242|NCT02404493|3504430|P1|NOT COMPLETED|Overall Study||1
1431243|NCT02404493|3504429|P2|COMPLETED|Overall Study||5
1431244|NCT02404493|3504430|P1|COMPLETED|Overall Study||16
1431245|NCT02404493|3504429|P2|STARTED|Overall Study||6
1431246|NCT02404493|3504430|P1|STARTED|Overall Study||17
1431247|NCT02404389|3504675|P5|NOT COMPLETED|Overall Study||3
1431248|NCT02404389|3504676|P4|NOT COMPLETED|Overall Study||1
1431249|NCT02404389|3504677|P3|NOT COMPLETED|Overall Study||1
1431250|NCT02404389|3504678|P2|NOT COMPLETED|Overall Study||0
1431251|NCT02404389|3504679|P1|NOT COMPLETED|Overall Study||2
1431252|NCT02404389|3504675|P5|COMPLETED|Overall Study||18
1431253|NCT02404389|3504676|P4|COMPLETED|Overall Study||9
1431254|NCT02404389|3504677|P3|COMPLETED|Overall Study||10
1431255|NCT02404389|3504678|P2|COMPLETED|Overall Study||20
1431256|NCT02404389|3504679|P1|COMPLETED|Overall Study||18
1431257|NCT02404389|3504675|P5|STARTED|Overall Study||21
1431258|NCT02404389|3504676|P4|STARTED|Overall Study||10
1431259|NCT02404389|3504677|P3|STARTED|Overall Study||11
1431260|NCT02404389|3504678|P2|STARTED|Overall Study||20
1431261|NCT02404389|3504679|P1|STARTED|Overall Study||20
1431262|NCT02404103|3504717|P2|NOT COMPLETED|Overall Study||3
1431263|NCT02404103|3504718|P1|NOT COMPLETED|Overall Study||4
1431264|NCT02404103|3504717|P2|COMPLETED|Overall Study||9
1431265|NCT02404103|3504718|P1|COMPLETED|Overall Study||10
1431266|NCT02404103|3504717|P2|STARTED|Overall Study||12
1431267|NCT02404103|3504718|P1|STARTED|Overall Study||14
1431268|NCT02403999|3504741|P3|NOT COMPLETED|Overall Study||0
1431269|NCT02403999|3504742|P2|NOT COMPLETED|Overall Study||0
1431270|NCT02403999|3504743|P1|NOT COMPLETED|Overall Study||0
1431271|NCT02403999|3504741|P3|COMPLETED|Overall Study||11
1431272|NCT02403999|3504742|P2|COMPLETED|Overall Study||10
1431273|NCT02403999|3504743|P1|COMPLETED|Overall Study||10
1431274|NCT02403999|3504741|P3|STARTED|Overall Study||11
1431275|NCT02403999|3504742|P2|STARTED|Overall Study||10
1431276|NCT02403999|3504743|P1|STARTED|Overall Study||10
1431277|NCT02403895|3504754|P1|NOT COMPLETED|Overall Study||0
1431278|NCT02403895|3504754|P1|COMPLETED|Overall Study||11
1431279|NCT02403895|3504754|P1|STARTED|Overall Study||11
1431280|NCT02403830|3504767|P2|NOT COMPLETED|Visit 2||0
1431281|NCT02403830|3504768|P1|NOT COMPLETED|Visit 2||0
1431282|NCT02403830|3504767|P2|COMPLETED|Visit 2||15
1431283|NCT02403830|3504768|P1|COMPLETED|Visit 2||14
1431284|NCT02403830|3504767|P2|STARTED|Visit 2||15
1431285|NCT02403830|3504768|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
1431286|NCT02403830|3504767|P2|NOT COMPLETED|Visit 1||0
1431287|NCT02403830|3504768|P1|NOT COMPLETED|Visit 1||0
1431288|NCT02403830|3504767|P2|COMPLETED|Visit 1||15
1431289|NCT02403830|3504768|P1|COMPLETED|Visit 1||15
1431290|NCT02403830|3504767|P2|STARTED|Visit 1||15
1431291|NCT02403830|3504768|P1|STARTED|Visit 1||15
1431292|NCT02403674|3504780|P2|NOT COMPLETED|Overall Study||63
1431293|NCT02403674|3504781|P1|NOT COMPLETED|Overall Study||55
1431294|NCT02403674|3504780|P2|COMPLETED|Overall Study||303
1431295|NCT02403674|3504781|P1|COMPLETED|Overall Study||313
1431296|NCT02403674|3504780|P2|Treated|Overall Study||364
1431297|NCT02403674|3504781|P1|Treated|Overall Study||364
1431298|NCT02403674|3504780|P2|STARTED|Overall Study||366
1431299|NCT02403674|3504781|P1|STARTED|Overall Study||368
1431300|NCT02403206|3504822|P2|NOT COMPLETED|Overall Study||10
1431301|NCT02403206|3504823|P1|NOT COMPLETED|Overall Study||11
1431302|NCT02403206|3504822|P2|COMPLETED|Overall Study||186
1431303|NCT02403206|3504823|P1|COMPLETED|Overall Study||183
1431304|NCT02403206|3504822|P2|Randomized and Treated|Overall Study||190
1431305|NCT02403206|3504823|P1|Randomized and Treated|Overall Study||188
1431306|NCT02403206|3504822|P2|Treated Prior to Randomization|Overall Study||1
1431307|NCT02403206|3504823|P1|Treated Prior to Randomization|Overall Study||0
1431308|NCT02403206|3504822|P2|STARTED|Overall Study||196
1431309|NCT02403206|3504823|P1|STARTED|Overall Study||194
1431310|NCT02403180|3504834|P2|NOT COMPLETED|Period 2 (5 Days)||1
1431311|NCT02403180|3504835|P1|NOT COMPLETED|Period 2 (5 Days)||0
1431312|NCT02403180|3504834|P2|COMPLETED|Period 2 (5 Days)||32
1431313|NCT02403180|3504835|P1|COMPLETED|Period 2 (5 Days)||36
1431314|NCT02403180|3504834|P2|STARTED|Period 2 (5 Days)||33
1431315|NCT02403180|3504835|P1|STARTED|Period 2 (5 Days)||36
1431316|NCT02403180|3504834|P2|NOT COMPLETED|Period 1 (5 Days)||0
1431317|NCT02403180|3504835|P1|NOT COMPLETED|Period 1 (5 Days)||0
1431318|NCT02403180|3504834|P2|COMPLETED|Period 1 (5 Days)||33
1431319|NCT02403180|3504835|P1|COMPLETED|Period 1 (5 Days)||36
1431320|NCT02403180|3504834|P2|Randomized|Period 1 (5 Days)||33
1431321|NCT02403180|3504835|P1|Randomized|Period 1 (5 Days)||36
1431322|NCT02403180|3504834|P2|STARTED|Period 1 (5 Days)||33
1431323|NCT02403180|3504835|P1|STARTED|Period 1 (5 Days)||36
1431324|NCT02403180|3504834|P2|NOT COMPLETED|Pre-Treatment Period||1
1431325|NCT02403180|3504835|P1|NOT COMPLETED|Pre-Treatment Period||0
1431326|NCT02403180|3504834|P2|COMPLETED|Pre-Treatment Period||33
1431327|NCT02403180|3504835|P1|COMPLETED|Pre-Treatment Period||36
1431328|NCT02403180|3504834|P2|STARTED|Pre-Treatment Period||34
1431329|NCT02403180|3504835|P1|STARTED|Pre-Treatment Period||36
1431330|NCT02403154|3504847|P4|NOT COMPLETED|Overall Study||1
1431331|NCT02403154|3504848|P3|NOT COMPLETED|Overall Study||1
1431332|NCT02403154|3504849|P2|NOT COMPLETED|Overall Study||0
1431333|NCT02403154|3504850|P1|NOT COMPLETED|Overall Study||2
1431334|NCT02403154|3504847|P4|COMPLETED|Overall Study||0
1431335|NCT02403154|3504848|P3|COMPLETED|Overall Study||0
1431336|NCT02403154|3504849|P2|COMPLETED|Overall Study||0
1431337|NCT02403154|3504850|P1|COMPLETED|Overall Study||0
1431338|NCT02403154|3504847|P4|STARTED|Overall Study||1
1431339|NCT02403154|3504848|P3|STARTED|Overall Study||1
1431340|NCT02403154|3504849|P2|STARTED|Overall Study||0
1431341|NCT02403154|3504850|P1|STARTED|Overall Study||2
1431342|NCT02402933|3504864|P1|NOT COMPLETED|Overall Study||14
1431343|NCT02402933|3504864|P1|COMPLETED|Overall Study||12
1431344|NCT02402933|3504864|P1|Received at Least One Dose of Study Drug|Overall Study||22
1431345|NCT02402933|3504864|P1|STARTED|Overall Study||26
1431346|NCT02402764|3504871|P1|NOT COMPLETED|Overall Study||0
1431347|NCT02402764|3504871|P1|COMPLETED|Overall Study||10
1431348|NCT02402764|3504871|P1|STARTED|Overall Study||10
1431349|NCT02402322|3504882|P3|NOT COMPLETED|Follow-up||24
1431350|NCT02402322|3504883|P2|NOT COMPLETED|Follow-up||3
1431351|NCT02402322|3504884|P1|NOT COMPLETED|Follow-up||6
1431352|NCT02402322|3504882|P3|COMPLETED|Follow-up||0
1431353|NCT02402322|3504883|P2|COMPLETED|Follow-up||21
1431354|NCT02402322|3504884|P1|COMPLETED|Follow-up||18
1431355|NCT02402322|3504882|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
1431356|NCT02402322|3504883|P2|STARTED|Follow-up||24
1431357|NCT02402322|3504884|P1|STARTED|Follow-up||24
1431358|NCT02402322|3504882|P3|NOT COMPLETED|Pretreatment||1
1431359|NCT02402322|3504883|P2|NOT COMPLETED|Pretreatment||1
1431360|NCT02402322|3504884|P1|NOT COMPLETED|Pretreatment||3
1431361|NCT02402322|3504882|P3|COMPLETED|Pretreatment||24
1431362|NCT02402322|3504883|P2|COMPLETED|Pretreatment||24
1431363|NCT02402322|3504884|P1|COMPLETED|Pretreatment||24
1431364|NCT02402322|3504882|P3|Posttreatment Measures|Pretreatment||24
1431365|NCT02402322|3504883|P2|Posttreatment Measures|Pretreatment||24
1431366|NCT02402322|3504884|P1|Posttreatment Measures|Pretreatment||24
1431367|NCT02402322|3504882|P3|STARTED|Pretreatment||25
1431368|NCT02402322|3504883|P2|STARTED|Pretreatment||25
1431369|NCT02402322|3504884|P1|STARTED|Pretreatment||27
1431370|NCT02402296|3504918|P2|NOT COMPLETED|Overall Study||0
1431371|NCT02402296|3504919|P1|NOT COMPLETED|Overall Study||0
1431372|NCT02402296|3504918|P2|COMPLETED|Overall Study||15
1431373|NCT02402296|3504919|P1|COMPLETED|Overall Study||15
1431374|NCT02402296|3504918|P2|STARTED|Overall Study||15
1431375|NCT02402296|3504919|P1|STARTED|Overall Study||15
1431376|NCT02402166|3504931|P1|NOT COMPLETED|Overall Study||5
1431377|NCT02402166|3504931|P1|COMPLETED|Overall Study||19
1431378|NCT02402166|3504931|P1|STARTED|Overall Study||24
1431379|NCT02402153|3504952|P1|NOT COMPLETED|Overall Study||0
1431380|NCT02402153|3504952|P1|COMPLETED|Overall Study||18
1431381|NCT02402153|3504952|P1|STARTED|Overall Study||18
1431382|NCT02402127|3504968|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
1431383|NCT02402127|3504969|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
1431384|NCT02402127|3504970|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
1431385|NCT02402127|3504971|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
1431386|NCT02402127|3504972|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
1431387|NCT02402127|3504973|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
1431388|NCT02402127|3504968|P6|COMPLETED|Third Wear Period (1 Day)||4
1431389|NCT02402127|3504969|P5|COMPLETED|Third Wear Period (1 Day)||4
1431390|NCT02402127|3504970|P4|COMPLETED|Third Wear Period (1 Day)||4
1431391|NCT02402127|3504971|P3|COMPLETED|Third Wear Period (1 Day)||4
1431392|NCT02402127|3504972|P2|COMPLETED|Third Wear Period (1 Day)||4
1431393|NCT02402127|3504973|P1|COMPLETED|Third Wear Period (1 Day)||4
1431394|NCT02402127|3504968|P6|STARTED|Third Wear Period (1 Day)||4
1431395|NCT02402127|3504969|P5|STARTED|Third Wear Period (1 Day)||4
1431396|NCT02402127|3504970|P4|STARTED|Third Wear Period (1 Day)||4
1431397|NCT02402127|3504971|P3|STARTED|Third Wear Period (1 Day)||4
1431398|NCT02402127|3504972|P2|STARTED|Third Wear Period (1 Day)||4
1431399|NCT02402127|3504973|P1|STARTED|Third Wear Period (1 Day)||4
1431400|NCT02402127|3504968|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
1431401|NCT02402127|3504969|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
1431402|NCT02402127|3504970|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
1431403|NCT02402127|3504971|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
1431404|NCT02402127|3504972|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
1431405|NCT02402127|3504973|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
1431406|NCT02402127|3504968|P6|COMPLETED|Second Wear Period (1 Day)||4
1431407|NCT02402127|3504969|P5|COMPLETED|Second Wear Period (1 Day)||4
1431408|NCT02402127|3504970|P4|COMPLETED|Second Wear Period (1 Day)||4
1431409|NCT02402127|3504971|P3|COMPLETED|Second Wear Period (1 Day)||4
1431410|NCT02402127|3504972|P2|COMPLETED|Second Wear Period (1 Day)||4
1431411|NCT02402127|3504973|P1|COMPLETED|Second Wear Period (1 Day)||4
1431412|NCT02402127|3504968|P6|STARTED|Second Wear Period (1 Day)||4
1431413|NCT02402127|3504969|P5|STARTED|Second Wear Period (1 Day)||4
1431414|NCT02402127|3504970|P4|STARTED|Second Wear Period (1 Day)||4
1431415|NCT02402127|3504971|P3|STARTED|Second Wear Period (1 Day)||4
1431416|NCT02402127|3504972|P2|STARTED|Second Wear Period (1 Day)||4
1431417|NCT02402127|3504973|P1|STARTED|Second Wear Period (1 Day)||4
1431418|NCT02402127|3504968|P6|NOT COMPLETED|First Wear Period (1 Day)||0
1431419|NCT02402127|3504969|P5|NOT COMPLETED|First Wear Period (1 Day)||0
1431420|NCT02402127|3504970|P4|NOT COMPLETED|First Wear Period (1 Day)||0
1431421|NCT02402127|3504971|P3|NOT COMPLETED|First Wear Period (1 Day)||0
1431422|NCT02402127|3504972|P2|NOT COMPLETED|First Wear Period (1 Day)||0
1431423|NCT02402127|3504973|P1|NOT COMPLETED|First Wear Period (1 Day)||0
1431424|NCT02402127|3504968|P6|COMPLETED|First Wear Period (1 Day)||4
1431425|NCT02402127|3504969|P5|COMPLETED|First Wear Period (1 Day)||4
1431426|NCT02402127|3504970|P4|COMPLETED|First Wear Period (1 Day)||4
1431427|NCT02402127|3504971|P3|COMPLETED|First Wear Period (1 Day)||4
1431428|NCT02402127|3504972|P2|COMPLETED|First Wear Period (1 Day)||4
1431429|NCT02402127|3504973|P1|COMPLETED|First Wear Period (1 Day)||4
1431430|NCT02402127|3504968|P6|Randomized and Treated|First Wear Period (1 Day)||4
1431431|NCT02402127|3504969|P5|Randomized and Treated|First Wear Period (1 Day)||4
1431432|NCT02402127|3504970|P4|Randomized and Treated|First Wear Period (1 Day)||4
1431433|NCT02402127|3504971|P3|Randomized and Treated|First Wear Period (1 Day)||4
1431434|NCT02402127|3504972|P2|Randomized and Treated|First Wear Period (1 Day)||4
1431435|NCT02402127|3504973|P1|Randomized and Treated|First Wear Period (1 Day)||4
1431436|NCT02402127|3504968|P6|STARTED|First Wear Period (1 Day)||4
1431437|NCT02402127|3504969|P5|STARTED|First Wear Period (1 Day)||4
1431438|NCT02402127|3504970|P4|STARTED|First Wear Period (1 Day)||4
1431439|NCT02402127|3504971|P3|STARTED|First Wear Period (1 Day)||4
1431440|NCT02402127|3504972|P2|STARTED|First Wear Period (1 Day)||4
1431441|NCT02402127|3504973|P1|STARTED|First Wear Period (1 Day)||4
1431442|NCT02401867|3504984|P1|NOT COMPLETED|Analysis||9
1431443|NCT02401867|3504984|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
1431444|NCT02401867|3504984|P1|STARTED|Analysis||140
1431445|NCT02401867|3504984|P1|NOT COMPLETED|Specimen Collection||10
1431446|NCT02401867|3504984|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
1431447|NCT02401867|3504984|P1|STARTED|Specimen Collection||150
1431448|NCT02401867|3504984|P1|NOT COMPLETED|Enrolled||0
1431449|NCT02401867|3504984|P1|COMPLETED|Enrolled||150
1431450|NCT02401867|3504984|P1|STARTED|Enrolled||150
1431451|NCT02401555|3504992|P3|NOT COMPLETED|Overall Study||0
1431452|NCT02401555|3504993|P2|NOT COMPLETED|Overall Study||0
1431453|NCT02401555|3504994|P1|NOT COMPLETED|Overall Study||0
1431454|NCT02401555|3504992|P3|COMPLETED|Overall Study||120
1431455|NCT02401555|3504993|P2|COMPLETED|Overall Study||212
1431456|NCT02401555|3504994|P1|COMPLETED|Overall Study||87
1431457|NCT02401555|3504992|P3|STARTED|Overall Study||120
1431458|NCT02401555|3504993|P2|STARTED|Overall Study||212
1431459|NCT02401555|3504994|P1|STARTED|Overall Study||87
1431460|NCT02401529|3505004|P2|NOT COMPLETED|Overall Study||7
1431461|NCT02401529|3505005|P1|NOT COMPLETED|Overall Study||9
1431462|NCT02401529|3505004|P2|COMPLETED|Overall Study||50
1431463|NCT02401529|3505005|P1|COMPLETED|Overall Study||50
1431464|NCT02401529|3505004|P2|STARTED|Overall Study||57
1431465|NCT02401529|3505005|P1|STARTED|Overall Study||59
1431466|NCT02401464|3505033|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1431467|NCT02401464|3505034|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1431468|NCT02401464|3505035|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1431469|NCT02401464|3505036|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
1431470|NCT02401464|3505033|P4|COMPLETED|Intervention Period 2 (6 Days)||13
1431471|NCT02401464|3505034|P3|COMPLETED|Intervention Period 2 (6 Days)||13
1431472|NCT02401464|3505035|P2|COMPLETED|Intervention Period 2 (6 Days)||13
1431473|NCT02401464|3505036|P1|COMPLETED|Intervention Period 2 (6 Days)||13
1431474|NCT02401464|3505033|P4|STARTED|Intervention Period 2 (6 Days)||13
1431475|NCT02401464|3505034|P3|STARTED|Intervention Period 2 (6 Days)||13
1431476|NCT02401464|3505035|P2|STARTED|Intervention Period 2 (6 Days)||13
1431477|NCT02401464|3505036|P1|STARTED|Intervention Period 2 (6 Days)||13
1431478|NCT02401464|3505033|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
1431479|NCT02401464|3505034|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
1431480|NCT02401464|3505035|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
1431481|NCT02401464|3505036|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
1431482|NCT02401464|3505033|P4|COMPLETED|Washout Period (At Least 6 Days)||13
1431483|NCT02401464|3505034|P3|COMPLETED|Washout Period (At Least 6 Days)||13
1431484|NCT02401464|3505035|P2|COMPLETED|Washout Period (At Least 6 Days)||13
1431485|NCT02401464|3505036|P1|COMPLETED|Washout Period (At Least 6 Days)||13
1431486|NCT02401464|3505033|P4|STARTED|Washout Period (At Least 6 Days)||13
1431487|NCT02401464|3505034|P3|STARTED|Washout Period (At Least 6 Days)||13
1431488|NCT02401464|3505035|P2|STARTED|Washout Period (At Least 6 Days)||13
1431489|NCT02401464|3505036|P1|STARTED|Washout Period (At Least 6 Days)||13
1431490|NCT02401464|3505033|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1431491|NCT02401464|3505034|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1431492|NCT02401464|3505035|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1431493|NCT02401464|3505036|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
1431494|NCT02401464|3505033|P4|COMPLETED|Intervention Period 1 (6 Days)||13
1431495|NCT02401464|3505034|P3|COMPLETED|Intervention Period 1 (6 Days)||13
1431496|NCT02401464|3505035|P2|COMPLETED|Intervention Period 1 (6 Days)||13
1431497|NCT02401464|3505036|P1|COMPLETED|Intervention Period 1 (6 Days)||13
1431498|NCT02401464|3505033|P4|STARTED|Intervention Period 1 (6 Days)||13
1431499|NCT02401464|3505034|P3|STARTED|Intervention Period 1 (6 Days)||13
1431500|NCT02401464|3505035|P2|STARTED|Intervention Period 1 (6 Days)||13
1431501|NCT02401464|3505036|P1|STARTED|Intervention Period 1 (6 Days)||13
1431502|NCT02401412|3505072|P2|NOT COMPLETED|Overall Study||32
1431503|NCT02401412|3505073|P1|NOT COMPLETED|Overall Study||30
1431504|NCT02401412|3505072|P2|COMPLETED|Overall Study||49
1431505|NCT02401412|3505073|P1|COMPLETED|Overall Study||59
1431506|NCT02401412|3505072|P2|Received Study Device|Overall Study||80
1431507|NCT02401412|3505073|P1|Received Study Device|Overall Study||89
1431508|NCT02401412|3505072|P2|STARTED|Overall Study||81
1431509|NCT02401412|3505073|P1|STARTED|Overall Study||89
1431510|NCT02401256|3505081|P1|NOT COMPLETED|Overall Study||17
1431511|NCT02401256|3505081|P1|COMPLETED|Overall Study||53
1431512|NCT02401256|3505081|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
1431513|NCT02401256|3505081|P1|Finished Phase 3|Overall Study||53
1431514|NCT02401256|3505081|P1|Finished Phase 2|Overall Study||58
1431515|NCT02401256|3505081|P1|Finished Phase 1|Overall Study||64
1431516|NCT02401256|3505081|P1|STARTED|Overall Study||70
1431517|NCT02401230|3505090|P3|NOT COMPLETED|Overall Study||4
1431518|NCT02401230|3505091|P2|NOT COMPLETED|Overall Study||6
1431519|NCT02401230|3505092|P1|NOT COMPLETED|Overall Study||6
1431520|NCT02401230|3505090|P3|COMPLETED|Overall Study||21
1431521|NCT02401230|3505091|P2|COMPLETED|Overall Study||19
1431522|NCT02401230|3505092|P1|COMPLETED|Overall Study||20
1431523|NCT02401230|3505090|P3|STARTED|Overall Study||25
1431524|NCT02401230|3505091|P2|STARTED|Overall Study||25
1431525|NCT02401230|3505092|P1|STARTED|Overall Study||26
1431526|NCT02401022|3505127|P2|NOT COMPLETED|Overall Study||20
1431527|NCT02401022|3505128|P1|NOT COMPLETED|Overall Study||15
1431528|NCT02401022|3505127|P2|COMPLETED|Overall Study||90
1431529|NCT02401022|3505128|P1|COMPLETED|Overall Study||89
1431530|NCT02401022|3505127|P2|STARTED|Overall Study||110
1431531|NCT02401022|3505128|P1|STARTED|Overall Study||104
1431532|NCT02400996|3505134|P1|NOT COMPLETED|Overall Study||0
1431533|NCT02400996|3505134|P1|COMPLETED|Overall Study||40
1431534|NCT02400996|3505134|P1|STARTED|Overall Study||40
1431535|NCT02400749|3505140|P2|NOT COMPLETED|Week 17 - 32||3
1431536|NCT02400749|3505141|P1|NOT COMPLETED|Week 17 - 32||5
1431537|NCT02400749|3505140|P2|COMPLETED|Week 17 - 32||41
1431538|NCT02400749|3505141|P1|COMPLETED|Week 17 - 32||34
1431539|NCT02400749|3505140|P2|STARTED|Week 17 - 32||44
1431540|NCT02400749|3505141|P1|STARTED|Week 17 - 32||39
1431541|NCT02400749|3505140|P2|NOT COMPLETED|Week 0 -16||6
1431542|NCT02400749|3505141|P1|NOT COMPLETED|Week 0 -16||11
1431543|NCT02400749|3505140|P2|COMPLETED|Week 0 -16||44
1431544|NCT02400749|3505141|P1|COMPLETED|Week 0 -16||39
1431545|NCT02400749|3505140|P2|STARTED|Week 0 -16||50
1431546|NCT02400749|3505141|P1|STARTED|Week 0 -16||50
1431547|NCT02400710|3505157|P2|NOT COMPLETED|Overall Study||0
1431548|NCT02400710|3505158|P1|NOT COMPLETED|Overall Study||0
1431549|NCT02400710|3505157|P2|COMPLETED|Overall Study||10
1431550|NCT02400710|3505158|P1|COMPLETED|Overall Study||10
1431551|NCT02400710|3505157|P2|STARTED|Overall Study||10
1431552|NCT02400710|3505158|P1|STARTED|Overall Study||10
1431553|NCT02400580|3505168|P2|NOT COMPLETED|Overall Study||1
1431554|NCT02400580|3505169|P1|NOT COMPLETED|Overall Study||2
1431555|NCT02400580|3505168|P2|COMPLETED|Overall Study||91
1431556|NCT02400580|3505169|P1|COMPLETED|Overall Study||89
1431557|NCT02400580|3505168|P2|STARTED|Overall Study||92
1431558|NCT02400580|3505169|P1|STARTED|Overall Study||91
1431559|NCT02400346|3505185|P1|NOT COMPLETED|Overall Study||44
1431560|NCT02400346|3505185|P1|COMPLETED|Overall Study||88
1431561|NCT02400346|3505185|P1|STARTED|Overall Study||132
1431562|NCT02400333|3505193|P4|NOT COMPLETED|Overall Study||2
1431563|NCT02400333|3505194|P3|NOT COMPLETED|Overall Study||2
1431564|NCT02400333|3505195|P2|NOT COMPLETED|Overall Study||1
1431565|NCT02400333|3505196|P1|NOT COMPLETED|Overall Study||1
1431566|NCT02400333|3505193|P4|COMPLETED|Overall Study||7
1431567|NCT02400333|3505194|P3|COMPLETED|Overall Study||7
1431568|NCT02400333|3505195|P2|COMPLETED|Overall Study||8
1431569|NCT02400333|3505196|P1|COMPLETED|Overall Study||8
1431570|NCT02400333|3505193|P4|STARTED|Overall Study||9
1431571|NCT02400333|3505194|P3|STARTED|Overall Study||9
1431572|NCT02400333|3505195|P2|STARTED|Overall Study||9
1431573|NCT02400333|3505196|P1|STARTED|Overall Study||9
1431574|NCT02399345|3505254|P1|NOT COMPLETED|Overall Study||0
1431575|NCT02399345|3505254|P1|COMPLETED|Overall Study||10
1431576|NCT02399345|3505254|P1|STARTED|Overall Study||10
1431577|NCT02399163|3505260|P1|NOT COMPLETED|Overall Study||9
1431578|NCT02399163|3505260|P1|COMPLETED|Overall Study||53
1431579|NCT02399163|3505260|P1|STARTED|Overall Study||62
1431580|NCT02399111|3505288|P4|NOT COMPLETED|Overall Study||0
1431581|NCT02399111|3505289|P3|NOT COMPLETED|Overall Study||0
1431582|NCT02399111|3505290|P2|NOT COMPLETED|Overall Study||0
1431583|NCT02399111|3505291|P1|NOT COMPLETED|Overall Study||0
1431584|NCT02399111|3505288|P4|COMPLETED|Overall Study||0
1431585|NCT02399111|3505289|P3|COMPLETED|Overall Study||4
1431586|NCT02399111|3505290|P2|COMPLETED|Overall Study||1
1431587|NCT02399111|3505291|P1|COMPLETED|Overall Study||4
1431588|NCT02399111|3505288|P4|STARTED|Overall Study||0
1431589|NCT02399111|3505289|P3|STARTED|Overall Study||4
1431590|NCT02399111|3505290|P2|STARTED|Overall Study||1
1431591|NCT02399111|3505291|P1|STARTED|Overall Study||4
1431592|NCT02398227|3505307|P2|NOT COMPLETED|Overall Study||18
1431593|NCT02398227|3505308|P1|NOT COMPLETED|Overall Study||27
1431594|NCT02398227|3505307|P2|COMPLETED|Overall Study||71
1431595|NCT02398227|3505308|P1|COMPLETED|Overall Study||56
1431596|NCT02398227|3505307|P2|STARTED|Overall Study||89
1431597|NCT02398227|3505308|P1|STARTED|Overall Study||83
1431598|NCT02397915|3505316|P4|NOT COMPLETED|Period 2||0
1431599|NCT02397915|3505317|P3|NOT COMPLETED|Period 2||0
1431600|NCT02397915|3505318|P2|NOT COMPLETED|Period 2||0
1431601|NCT02397915|3505319|P1|NOT COMPLETED|Period 2||0
1431602|NCT02397915|3505316|P4|COMPLETED|Period 2||149
1431603|NCT02397915|3505317|P3|COMPLETED|Period 2||149
1431604|NCT02397915|3505318|P2|COMPLETED|Period 2||0
1431605|NCT02397915|3505319|P1|COMPLETED|Period 2||0
1431606|NCT02397915|3505316|P4|STARTED|Period 2||149
1431607|NCT02397915|3505317|P3|STARTED|Period 2||149
1431608|NCT02397915|3505318|P2|STARTED|Period 2||0
1431609|NCT02397915|3505319|P1|STARTED|Period 2||0
1431610|NCT02397915|3505316|P4|NOT COMPLETED|Period 1||0
1431611|NCT02397915|3505317|P3|NOT COMPLETED|Period 1||0
1431612|NCT02397915|3505318|P2|NOT COMPLETED|Period 1||1
1431613|NCT02397915|3505319|P1|NOT COMPLETED|Period 1||1
1431614|NCT02397915|3505316|P4|COMPLETED|Period 1||0
1431615|NCT02397915|3505317|P3|COMPLETED|Period 1||0
1431616|NCT02397915|3505318|P2|COMPLETED|Period 1||149
1431617|NCT02397915|3505319|P1|COMPLETED|Period 1||149
1431618|NCT02397915|3505316|P4|STARTED|Period 1||0
1431619|NCT02397915|3505317|P3|STARTED|Period 1||0
1431620|NCT02397915|3505318|P2|STARTED|Period 1||150
1431621|NCT02397915|3505319|P1|STARTED|Period 1||150
1431622|NCT02397785|3505371|P2|NOT COMPLETED|Overall Study||9
1431623|NCT02397785|3505372|P1|NOT COMPLETED|Overall Study||2
1431624|NCT02397785|3505371|P2|COMPLETED|Overall Study||25
1431625|NCT02397785|3505372|P1|COMPLETED|Overall Study||22
1431626|NCT02397785|3505371|P2|STARTED|Overall Study||34
1431627|NCT02397785|3505372|P1|STARTED|Overall Study||24
1431628|NCT02397694|3505418|P2|NOT COMPLETED|Open Label Extension Phase||30
1431629|NCT02397694|3505419|P1|NOT COMPLETED|Open Label Extension Phase||62
1431630|NCT02397694|3505418|P2|COMPLETED|Open Label Extension Phase||0
1431631|NCT02397694|3505419|P1|COMPLETED|Open Label Extension Phase||0
1431632|NCT02397694|3505418|P2|STARTED|Open Label Extension Phase||30
1431633|NCT02397694|3505419|P1|STARTED|Open Label Extension Phase||62
1431634|NCT02397694|3505418|P2|NOT COMPLETED|Double-Blinded Phase||3
1431635|NCT02397694|3505419|P1|NOT COMPLETED|Double-Blinded Phase||3
1431636|NCT02397694|3505418|P2|COMPLETED|Double-Blinded Phase||30
1431637|NCT02397694|3505419|P1|COMPLETED|Double-Blinded Phase||62
1431638|NCT02397694|3505418|P2|STARTED|Double-Blinded Phase||33
1431639|NCT02397694|3505419|P1|STARTED|Double-Blinded Phase||65
1431640|NCT02397655|3505457|P1|NOT COMPLETED|Overall Study||1301
1431641|NCT02397655|3505457|P1|COMPLETED|Overall Study||10711
1431642|NCT02397655|3505457|P1|STARTED|Overall Study||12012
1431643|NCT02397564|3505461|P1|NOT COMPLETED|Overall Study||4
1431644|NCT02397564|3505461|P1|COMPLETED|Overall Study||16
1431645|NCT02397564|3505461|P1|STARTED|Overall Study||20
1431646|NCT02397122|3505468|P2|NOT COMPLETED|Overall Study||0
1431647|NCT02397122|3505469|P1|NOT COMPLETED|Overall Study||0
1431648|NCT02397122|3505468|P2|COMPLETED|Overall Study||20
1431649|NCT02397122|3505469|P1|COMPLETED|Overall Study||20
1431650|NCT02397122|3505468|P2|STARTED|Overall Study||20
1431651|NCT02397122|3505469|P1|STARTED|Overall Study||20
1431652|NCT02396537|3505487|P2|NOT COMPLETED|Overall Study||1
1431653|NCT02396537|3505488|P1|NOT COMPLETED|Overall Study||0
1431654|NCT02396537|3505487|P2|COMPLETED|Overall Study||36
1431655|NCT02396537|3505488|P1|COMPLETED|Overall Study||40
1431656|NCT02396537|3505487|P2|STARTED|Overall Study||37
1431657|NCT02396537|3505488|P1|STARTED|Overall Study||40
1431658|NCT02396420|3505494|P1|NOT COMPLETED|Overall Study||1
1431659|NCT02396420|3505494|P1|COMPLETED|Overall Study||1
1431660|NCT02396420|3505494|P1|6 Months Post PAE|Overall Study||2
1431661|NCT02396420|3505494|P1|3 Months Post PAE|Overall Study||2
1431662|NCT02396420|3505494|P1|1 Month Post PAE|Overall Study||2
1431663|NCT02396420|3505494|P1|STARTED|Overall Study||2
1431664|NCT02396316|3505516|P2|NOT COMPLETED|Overall Study||5
1431665|NCT02396316|3505517|P1|NOT COMPLETED|Overall Study||7
1431666|NCT02396316|3505516|P2|COMPLETED|Overall Study||22
1431667|NCT02396316|3505517|P1|COMPLETED|Overall Study||20
1431668|NCT02396316|3505516|P2|Received Active Injection at Week 9|Overall Study||1
1431669|NCT02396316|3505517|P1|Received Active Injection at Week 9|Overall Study||2
1431670|NCT02396316|3505516|P2|Received Active Injection at Week 5|Overall Study||4
1431671|NCT02396316|3505517|P1|Received Active Injection at Week 5|Overall Study||4
1431672|NCT02396316|3505516|P2|Received AFL Injection at Week 1|Overall Study||22
1431673|NCT02396316|3505517|P1|Received AFL Injection at Week 1|Overall Study||0
1431765|NCT02395055|3505790|P2|COMPLETED|Overall Study||44
1431674|NCT02396316|3505516|P2|Received Sham Injection at Week 1|Overall Study||0
1431675|NCT02396316|3505517|P1|Received Sham Injection at Week 1|Overall Study||10
1431676|NCT02396316|3505516|P2|Treated|Overall Study||27
1431677|NCT02396316|3505517|P1|Treated|Overall Study||27
1431678|NCT02396316|3505516|P2|STARTED|Overall Study||27
1431679|NCT02396316|3505517|P1|STARTED|Overall Study||27
1431680|NCT02396160|3505529|P2|NOT COMPLETED|Overall Study||2
1431681|NCT02396160|3505530|P1|NOT COMPLETED|Overall Study||6
1431682|NCT02396160|3505529|P2|COMPLETED|Overall Study||73
1431683|NCT02396160|3505530|P1|COMPLETED|Overall Study||69
1431684|NCT02396160|3505529|P2|STARTED|Overall Study||75
1431685|NCT02396160|3505530|P1|STARTED|Overall Study||75
1431686|NCT02396147|3505546|P2|NOT COMPLETED|Period 3||0
1431687|NCT02396147|3505547|P1|NOT COMPLETED|Period 3||0
1431688|NCT02396147|3505546|P2|COMPLETED|Period 3||27
1431689|NCT02396147|3505547|P1|COMPLETED|Period 3||27
1431690|NCT02396147|3505546|P2|STARTED|Period 3||27
1431691|NCT02396147|3505547|P1|STARTED|Period 3||27
1431692|NCT02396147|3505546|P2|NOT COMPLETED|Period 2||0
1431693|NCT02396147|3505547|P1|NOT COMPLETED|Period 2||0
1431694|NCT02396147|3505546|P2|COMPLETED|Period 2||27
1431695|NCT02396147|3505547|P1|COMPLETED|Period 2||27
1431696|NCT02396147|3505546|P2|STARTED|Period 2||27
1431697|NCT02396147|3505547|P1|STARTED|Period 2||27
1431698|NCT02396147|3505546|P2|NOT COMPLETED|Period 1||0
1431699|NCT02396147|3505547|P1|NOT COMPLETED|Period 1||0
1431700|NCT02396147|3505546|P2|COMPLETED|Period 1||27
1431701|NCT02396147|3505547|P1|COMPLETED|Period 1||27
1431702|NCT02396147|3505546|P2|STARTED|Period 1||27
1431703|NCT02396147|3505547|P1|STARTED|Period 1||27
1431704|NCT02395822|3505615|P1|NOT COMPLETED|Overall Study||2
1431705|NCT02395822|3505615|P1|COMPLETED|Overall Study||15
1431706|NCT02395822|3505615|P1|STARTED|Overall Study||17
1431707|NCT02395653|3505623|P1|NOT COMPLETED|Overall Study||12
1431708|NCT02395653|3505623|P1|COMPLETED|Overall Study||59
1431709|NCT02395653|3505623|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
1431710|NCT02395653|3505623|P1|STARTED|Overall Study||71
1431711|NCT02395536|3505632|P2|NOT COMPLETED|Overall Study||30
1431712|NCT02395536|3505633|P1|NOT COMPLETED|Overall Study||20
1431713|NCT02395536|3505632|P2|COMPLETED|Overall Study||227
1431714|NCT02395536|3505633|P1|COMPLETED|Overall Study||244
1431715|NCT02395536|3505632|P2|REVEAL LINQ Insertion|Overall Study||231
1431716|NCT02395536|3505633|P1|REVEAL LINQ Insertion|Overall Study||251
1431717|NCT02395536|3505632|P2|STARTED|Overall Study||257
1431718|NCT02395536|3505633|P1|STARTED|Overall Study||264
1431719|NCT02395302|3505639|P1|NOT COMPLETED|Overall Study||14
1431720|NCT02395302|3505639|P1|COMPLETED|Overall Study||14
1431721|NCT02395302|3505639|P1|STARTED|Overall Study||28
1431722|NCT02395185|3505643|P1|NOT COMPLETED|Overall Study||0
1431723|NCT02395185|3505643|P1|COMPLETED|Overall Study||33
1431724|NCT02395185|3505643|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
1431725|NCT02395185|3505643|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
1431726|NCT02395185|3505643|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
1431727|NCT02395185|3505643|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
1431728|NCT02395185|3505643|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
1431729|NCT02395185|3505643|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
1431730|NCT02395185|3505643|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
1431731|NCT02395185|3505643|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
1431732|NCT02395185|3505643|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
1431733|NCT02395185|3505643|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
1431734|NCT02395185|3505643|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
1431735|NCT02395185|3505643|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
1431736|NCT02395185|3505643|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
1431737|NCT02395185|3505643|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
1431738|NCT02395185|3505643|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
1431739|NCT02395185|3505643|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
1431740|NCT02395185|3505643|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
1431741|NCT02395185|3505643|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
1431742|NCT02395185|3505643|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
1431743|NCT02395172|3505659|P2|NOT COMPLETED|Overall Study||36
1431744|NCT02395172|3505660|P1|NOT COMPLETED|Overall Study||52
1431745|NCT02395172|3505659|P2|COMPLETED|Overall Study||360
1431746|NCT02395172|3505660|P1|COMPLETED|Overall Study||344
1431747|NCT02395172|3505659|P2|Treated|Overall Study||365
1431748|NCT02395172|3505660|P1|Treated|Overall Study||393
1431749|NCT02395172|3505659|P2|STARTED|Overall Study||396
1431750|NCT02395172|3505660|P1|STARTED|Overall Study||396
1431751|NCT02395133|3505699|P4|NOT COMPLETED|Overall Study||14
1431752|NCT02395133|3505700|P3|NOT COMPLETED|Overall Study||10
1431753|NCT02395133|3505701|P2|NOT COMPLETED|Overall Study||9
1431754|NCT02395133|3505702|P1|NOT COMPLETED|Overall Study||14
1431755|NCT02395133|3505699|P4|COMPLETED|Overall Study||155
1431756|NCT02395133|3505700|P3|COMPLETED|Overall Study||76
1431757|NCT02395133|3505701|P2|COMPLETED|Overall Study||75
1431758|NCT02395133|3505702|P1|COMPLETED|Overall Study||69
1431759|NCT02395133|3505699|P4|STARTED|Overall Study||169
1431760|NCT02395133|3505700|P3|STARTED|Overall Study||86
1431761|NCT02395133|3505701|P2|STARTED|Overall Study||84
1431762|NCT02395133|3505702|P1|STARTED|Overall Study||83
1431763|NCT02395055|3505790|P2|NOT COMPLETED|Overall Study||3
1431764|NCT02395055|3505791|P1|NOT COMPLETED|Overall Study||7
1431766|NCT02395055|3505791|P1|COMPLETED|Overall Study||40
1431767|NCT02395055|3505790|P2|STARTED|Overall Study||47
1431768|NCT02395055|3505791|P1|STARTED|Overall Study||47
1431769|NCT02395042|3505804|P3|NOT COMPLETED|Treatment 2 Period||0
1431770|NCT02395042|3505805|P2|NOT COMPLETED|Treatment 2 Period||1
1431771|NCT02395042|3505806|P1|NOT COMPLETED|Treatment 2 Period||1
1431772|NCT02395042|3505804|P3|COMPLETED|Treatment 2 Period||13
1431773|NCT02395042|3505805|P2|COMPLETED|Treatment 2 Period||23
1431774|NCT02395042|3505806|P1|COMPLETED|Treatment 2 Period||9
1431775|NCT02395042|3505804|P3|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
1431776|NCT02395042|3505805|P2|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
1431777|NCT02395042|3505806|P1|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
1431778|NCT02395042|3505804|P3|NOT COMPLETED|Treatment 1 Period||2
1431779|NCT02395042|3505805|P2|NOT COMPLETED|Treatment 1 Period||6
1431780|NCT02395042|3505806|P1|NOT COMPLETED|Treatment 1 Period||3
1431781|NCT02395042|3505804|P3|COMPLETED|Treatment 1 Period||14
1431782|NCT02395042|3505805|P2|COMPLETED|Treatment 1 Period||25
1431783|NCT02395042|3505806|P1|COMPLETED|Treatment 1 Period||9
1431784|NCT02395042|3505804|P3|STARTED|Treatment 1 Period||16
1431785|NCT02395042|3505805|P2|STARTED|Treatment 1 Period||31
1431786|NCT02395042|3505806|P1|STARTED|Treatment 1 Period||12
1431787|NCT02394925|3505823|P1|NOT COMPLETED|Overall Study||29
1431788|NCT02394925|3505823|P1|COMPLETED|Overall Study||79
1431789|NCT02394925|3505823|P1|STARTED|Overall Study||108
1431790|NCT02394912|3505827|P1|NOT COMPLETED|Overall Study||0
1431791|NCT02394912|3505827|P1|COMPLETED|Overall Study||21
1431792|NCT02394912|3505827|P1|STARTED|Overall Study||21
1431793|NCT02394808|3505831|P2|NOT COMPLETED|Period 2||0
1431794|NCT02394808|3505832|P1|NOT COMPLETED|Period 2||1
1431795|NCT02394808|3505831|P2|COMPLETED|Period 2||28
1431796|NCT02394808|3505832|P1|COMPLETED|Period 2||24
1431797|NCT02394808|3505831|P2|STARTED|Period 2||28
1431798|NCT02394808|3505832|P1|STARTED|Period 2||25
1431799|NCT02394808|3505831|P2|NOT COMPLETED|Period 1||1
1431800|NCT02394808|3505832|P1|NOT COMPLETED|Period 1||0
1431801|NCT02394808|3505831|P2|COMPLETED|Period 1||28
1431802|NCT02394808|3505832|P1|COMPLETED|Period 1||25
1431803|NCT02394808|3505831|P2|STARTED|Period 1||29
1431804|NCT02394808|3505832|P1|STARTED|Period 1||25
1431805|NCT02394756|3505840|P6|NOT COMPLETED|Period 3||0
1431806|NCT02394756|3505841|P5|NOT COMPLETED|Period 3||0
1431807|NCT02394756|3505842|P4|NOT COMPLETED|Period 3||0
1431808|NCT02394756|3505843|P3|NOT COMPLETED|Period 3||0
1431809|NCT02394756|3505844|P2|NOT COMPLETED|Period 3||0
1431810|NCT02394756|3505845|P1|NOT COMPLETED|Period 3||0
1431811|NCT02394756|3505840|P6|COMPLETED|Period 3||6
1431812|NCT02394756|3505841|P5|COMPLETED|Period 3||6
1431813|NCT02394756|3505842|P4|COMPLETED|Period 3||6
1431814|NCT02394756|3505843|P3|COMPLETED|Period 3||6
1431815|NCT02394756|3505844|P2|COMPLETED|Period 3||6
1431816|NCT02394756|3505845|P1|COMPLETED|Period 3||7
1431817|NCT02394756|3505840|P6|STARTED|Period 3||6
1431818|NCT02394756|3505841|P5|STARTED|Period 3||6
1431819|NCT02394756|3505842|P4|STARTED|Period 3||6
1431820|NCT02394756|3505843|P3|STARTED|Period 3||6
1431821|NCT02394756|3505844|P2|STARTED|Period 3||6
1431822|NCT02394756|3505845|P1|STARTED|Period 3||7
1431823|NCT02394756|3505840|P6|NOT COMPLETED|Period 2||0
1431824|NCT02394756|3505841|P5|NOT COMPLETED|Period 2||1
1431825|NCT02394756|3505842|P4|NOT COMPLETED|Period 2||0
1431826|NCT02394756|3505843|P3|NOT COMPLETED|Period 2||0
1431827|NCT02394756|3505844|P2|NOT COMPLETED|Period 2||0
1431828|NCT02394756|3505845|P1|NOT COMPLETED|Period 2||0
1431829|NCT02394756|3505840|P6|COMPLETED|Period 2||6
1431830|NCT02394756|3505841|P5|COMPLETED|Period 2||6
1431831|NCT02394756|3505842|P4|COMPLETED|Period 2||6
1431832|NCT02394756|3505843|P3|COMPLETED|Period 2||6
1431833|NCT02394756|3505844|P2|COMPLETED|Period 2||6
1431834|NCT02394756|3505845|P1|COMPLETED|Period 2||7
1431835|NCT02394756|3505840|P6|STARTED|Period 2||6
1431836|NCT02394756|3505841|P5|STARTED|Period 2||7
1431837|NCT02394756|3505842|P4|STARTED|Period 2||6
1431838|NCT02394756|3505843|P3|STARTED|Period 2||6
1431839|NCT02394756|3505844|P2|STARTED|Period 2||6
1431840|NCT02394756|3505845|P1|STARTED|Period 2||7
1431841|NCT02394756|3505840|P6|NOT COMPLETED|Period 1||1
1431842|NCT02394756|3505841|P5|NOT COMPLETED|Period 1||0
1431843|NCT02394756|3505842|P4|NOT COMPLETED|Period 1||1
1431844|NCT02394756|3505843|P3|NOT COMPLETED|Period 1||1
1431845|NCT02394756|3505844|P2|NOT COMPLETED|Period 1||1
1431846|NCT02394756|3505845|P1|NOT COMPLETED|Period 1||0
1431847|NCT02394756|3505840|P6|COMPLETED|Period 1||6
1431848|NCT02394756|3505841|P5|COMPLETED|Period 1||7
1431849|NCT02394756|3505842|P4|COMPLETED|Period 1||6
1431850|NCT02394756|3505843|P3|COMPLETED|Period 1||6
1431851|NCT02394756|3505844|P2|COMPLETED|Period 1||6
1431852|NCT02394756|3505845|P1|COMPLETED|Period 1||7
1431853|NCT02394756|3505840|P6|STARTED|Period 1||7
1431854|NCT02394756|3505841|P5|STARTED|Period 1||7
1431855|NCT02394756|3505842|P4|STARTED|Period 1||7
1431856|NCT02394756|3505843|P3|STARTED|Period 1||7
1431857|NCT02394756|3505844|P2|STARTED|Period 1||7
1431858|NCT02394756|3505845|P1|STARTED|Period 1||7
1431859|NCT02394665|3505859|P3|NOT COMPLETED|Overall Study||0
1431860|NCT02394665|3505860|P2|NOT COMPLETED|Overall Study||0
1431861|NCT02394665|3505861|P1|NOT COMPLETED|Overall Study||1
1431862|NCT02394665|3505859|P3|COMPLETED|Overall Study||0
1431863|NCT02394665|3505860|P2|COMPLETED|Overall Study||0
1431864|NCT02394665|3505861|P1|COMPLETED|Overall Study||0
1431865|NCT02394665|3505859|P3|STARTED|Overall Study||0
1431866|NCT02394665|3505860|P2|STARTED|Overall Study||0
1431867|NCT02394665|3505861|P1|STARTED|Overall Study||1
1431868|NCT02394600|3505883|P2|NOT COMPLETED|Overall Study||2
1431869|NCT02394600|3505884|P1|NOT COMPLETED|Overall Study||4
1431870|NCT02394600|3505883|P2|COMPLETED|Overall Study||44
1431871|NCT02394600|3505884|P1|COMPLETED|Overall Study||43
1431872|NCT02394600|3505883|P2|STARTED|Overall Study||46
1431873|NCT02394600|3505884|P1|STARTED|Overall Study||47
1431874|NCT02394457|3505894|P2|NOT COMPLETED|Overall Study||0
1431875|NCT02394457|3505895|P1|NOT COMPLETED|Overall Study||0
1431876|NCT02394457|3505894|P2|COMPLETED|Overall Study||13
1431877|NCT02394457|3505895|P1|COMPLETED|Overall Study||15
1431878|NCT02394457|3505894|P2|STARTED|Overall Study||13
1431879|NCT02394457|3505895|P1|STARTED|Overall Study||15
1431880|NCT02393950|3505913|P2|NOT COMPLETED|Overall Study||1
1431881|NCT02393950|3505914|P1|NOT COMPLETED|Overall Study||1
1431882|NCT02393950|3505913|P2|COMPLETED|Overall Study||8
1431883|NCT02393950|3505914|P1|COMPLETED|Overall Study||8
1431884|NCT02393950|3505913|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
1431885|NCT02393950|3505914|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
1431886|NCT02393950|3505913|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
1431887|NCT02393950|3505914|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
1431888|NCT02393950|3505913|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
1431889|NCT02393950|3505914|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
1431890|NCT02393950|3505913|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
1431891|NCT02393950|3505914|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
1431892|NCT02393950|3505913|P2|STARTED|Overall Study||9
1431893|NCT02393950|3505914|P1|STARTED|Overall Study||9
1431894|NCT02393677|3505981|P2|NOT COMPLETED|Overall Study||0
1431895|NCT02393677|3505982|P1|NOT COMPLETED|Overall Study||0
1431896|NCT02393677|3505981|P2|COMPLETED|Overall Study||40
1431897|NCT02393677|3505982|P1|COMPLETED|Overall Study||40
1431898|NCT02393677|3505981|P2|STARTED|Overall Study||40
1431899|NCT02393677|3505982|P1|STARTED|Overall Study||40
1431900|NCT02393547|3505988|P1|NOT COMPLETED|Overall Study||6
1431901|NCT02393547|3505988|P1|COMPLETED|Overall Study||14
1431902|NCT02393547|3505988|P1|STARTED|Overall Study||20
1431903|NCT02393209|3505997|P4|NOT COMPLETED|Overall Study||0
1431904|NCT02393209|3505998|P3|NOT COMPLETED|Overall Study||0
1431905|NCT02393209|3505999|P2|NOT COMPLETED|Overall Study||8
1431906|NCT02393209|3506000|P1|NOT COMPLETED|Overall Study||6
1431907|NCT02393209|3505997|P4|COMPLETED|Overall Study||0
1431908|NCT02393209|3505998|P3|COMPLETED|Overall Study||0
1431909|NCT02393209|3505999|P2|COMPLETED|Overall Study||0
1431910|NCT02393209|3506000|P1|COMPLETED|Overall Study||0
1431911|NCT02393209|3505997|P4|STARTED|Overall Study||0
1431912|NCT02393209|3505998|P3|STARTED|Overall Study||0
1431913|NCT02393209|3505999|P2|STARTED|Overall Study||8
1431914|NCT02393209|3506000|P1|STARTED|Overall Study||6
1431915|NCT02392806|3506058|P2|NOT COMPLETED|Overall Study||0
1431916|NCT02392806|3506059|P1|NOT COMPLETED|Overall Study||0
1431917|NCT02392806|3506058|P2|COMPLETED|Overall Study||21
1431918|NCT02392806|3506059|P1|COMPLETED|Overall Study||22
1431919|NCT02392806|3506058|P2|STARTED|Overall Study||21
1431920|NCT02392806|3506059|P1|STARTED|Overall Study||22
1431921|NCT02392767|3506069|P2|NOT COMPLETED|Overall Study||0
1431922|NCT02392767|3506070|P1|NOT COMPLETED|Overall Study||0
1431923|NCT02392767|3506069|P2|COMPLETED|Overall Study||13
1431924|NCT02392767|3506070|P1|COMPLETED|Overall Study||12
1431925|NCT02392767|3506069|P2|STARTED|Overall Study||13
1431926|NCT02392767|3506070|P1|STARTED|Overall Study||12
1431927|NCT02392624|3506089|P3|NOT COMPLETED|Overall Study||13
1431928|NCT02392624|3506090|P2|NOT COMPLETED|Overall Study||15
1431929|NCT02392624|3506091|P1|NOT COMPLETED|Overall Study||71
1431930|NCT02392624|3506089|P3|COMPLETED|Overall Study||40
1431931|NCT02392624|3506090|P2|COMPLETED|Overall Study||66
1431932|NCT02392624|3506091|P1|COMPLETED|Overall Study||0
1431933|NCT02392624|3506089|P3|STARTED|Overall Study||53
1431934|NCT02392624|3506090|P2|STARTED|Overall Study||81
1431935|NCT02392624|3506091|P1|STARTED|Overall Study||71
1431936|NCT02392494|3506107|P4|NOT COMPLETED|Overall Study||0
1431937|NCT02392494|3506108|P3|NOT COMPLETED|Overall Study||0
1431938|NCT02392494|3506109|P2|NOT COMPLETED|Overall Study||0
1431939|NCT02392494|3506110|P1|NOT COMPLETED|Overall Study||0
1431940|NCT02392494|3506107|P4|COMPLETED|Overall Study||0
1431941|NCT02392494|3506108|P3|COMPLETED|Overall Study||3
1431942|NCT02392494|3506109|P2|COMPLETED|Overall Study||3
1431943|NCT02392494|3506110|P1|COMPLETED|Overall Study||3
1431944|NCT02392494|3506107|P4|STARTED|Overall Study||0
1431945|NCT02392494|3506108|P3|STARTED|Overall Study||3
1431946|NCT02392494|3506109|P2|STARTED|Overall Study||3
1431947|NCT02392494|3506110|P1|STARTED|Overall Study||3
1431948|NCT02392481|3506128|P4|NOT COMPLETED|Overall Study||2
1431949|NCT02392481|3506129|P3|NOT COMPLETED|Overall Study||2
1431950|NCT02392481|3506130|P2|NOT COMPLETED|Overall Study||0
1431951|NCT02392481|3506131|P1|NOT COMPLETED|Overall Study||0
1431952|NCT02392481|3506128|P4|COMPLETED|Overall Study||25
1431953|NCT02392481|3506129|P3|COMPLETED|Overall Study||18
1431954|NCT02392481|3506130|P2|COMPLETED|Overall Study||12
1431955|NCT02392481|3506131|P1|COMPLETED|Overall Study||10
1431956|NCT02392481|3506128|P4|STARTED|Overall Study||27
1431957|NCT02392481|3506129|P3|STARTED|Overall Study||20
1431958|NCT02392481|3506130|P2|STARTED|Overall Study||12
1431959|NCT02392481|3506131|P1|STARTED|Overall Study||10
1431960|NCT02392403|3506153|P1|NOT COMPLETED|Overall Study||3
1431961|NCT02392403|3506153|P1|COMPLETED|Overall Study||42
1431962|NCT02392403|3506153|P1|STARTED|Overall Study||45
1431963|NCT02392377|3506167|P2|NOT COMPLETED|Overall Study||1
1431964|NCT02392377|3506168|P1|NOT COMPLETED|Overall Study||0
1431965|NCT02392377|3506167|P2|COMPLETED|Overall Study||0
1431966|NCT02392377|3506168|P1|COMPLETED|Overall Study||0
1431967|NCT02392377|3506167|P2|STARTED|Overall Study||1
1431968|NCT02392377|3506168|P1|STARTED|Overall Study||0
1431969|NCT02392247|3506192|P1|NOT COMPLETED|Overall Study||2
1431970|NCT02392247|3506192|P1|COMPLETED|Overall Study||50
1431971|NCT02392247|3506192|P1|STARTED|Overall Study||52
1431972|NCT02392234|3506203|P6|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1431973|NCT02392234|3506204|P5|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1431974|NCT02392234|3506205|P4|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1431975|NCT02392234|3506206|P3|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1431976|NCT02392234|3506207|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
1431977|NCT02392234|3506208|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
1431978|NCT02392234|3506203|P6|COMPLETED|Treatment Period 2 (8 Weeks)||38
1431979|NCT02392234|3506204|P5|COMPLETED|Treatment Period 2 (8 Weeks)||37
1431980|NCT02392234|3506205|P4|COMPLETED|Treatment Period 2 (8 Weeks)||41
1431981|NCT02392234|3506206|P3|COMPLETED|Treatment Period 2 (8 Weeks)||38
1431982|NCT02392234|3506207|P2|COMPLETED|Treatment Period 2 (8 Weeks)||43
1431983|NCT02392234|3506208|P1|COMPLETED|Treatment Period 2 (8 Weeks)||37
1431984|NCT02392234|3506203|P6|STARTED|Treatment Period 2 (8 Weeks)||38
1431985|NCT02392234|3506204|P5|STARTED|Treatment Period 2 (8 Weeks)||37
1431986|NCT02392234|3506205|P4|STARTED|Treatment Period 2 (8 Weeks)||41
1431987|NCT02392234|3506206|P3|STARTED|Treatment Period 2 (8 Weeks)||38
1431988|NCT02392234|3506207|P2|STARTED|Treatment Period 2 (8 Weeks)||43
1431989|NCT02392234|3506208|P1|STARTED|Treatment Period 2 (8 Weeks)||38
1431990|NCT02392234|3506203|P6|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
1431991|NCT02392234|3506204|P5|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
1431992|NCT02392234|3506205|P4|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
1431993|NCT02392234|3506206|P3|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
1431994|NCT02392234|3506207|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
1431995|NCT02392234|3506208|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
1431996|NCT02392234|3506203|P6|COMPLETED|Treatment Period 1 (8 Weeks)||38
1431997|NCT02392234|3506204|P5|COMPLETED|Treatment Period 1 (8 Weeks)||37
1431998|NCT02392234|3506205|P4|COMPLETED|Treatment Period 1 (8 Weeks)||41
1431999|NCT02392234|3506206|P3|COMPLETED|Treatment Period 1 (8 Weeks)||38
1432000|NCT02392234|3506207|P2|COMPLETED|Treatment Period 1 (8 Weeks)||43
1432001|NCT02392234|3506208|P1|COMPLETED|Treatment Period 1 (8 Weeks)||38
1432002|NCT02392234|3506203|P6|Treated|Treatment Period 1 (8 Weeks)||41
1432003|NCT02392234|3506204|P5|Treated|Treatment Period 1 (8 Weeks)||40
1432004|NCT02392234|3506205|P4|Treated|Treatment Period 1 (8 Weeks)||42
1432005|NCT02392234|3506206|P3|Treated|Treatment Period 1 (8 Weeks)||39
1432006|NCT02392234|3506207|P2|Treated|Treatment Period 1 (8 Weeks)||43
1432007|NCT02392234|3506208|P1|Treated|Treatment Period 1 (8 Weeks)||41
1432008|NCT02392234|3506203|P6|STARTED|Treatment Period 1 (8 Weeks)||41
1432009|NCT02392234|3506204|P5|STARTED|Treatment Period 1 (8 Weeks)||41
1432010|NCT02392234|3506205|P4|STARTED|Treatment Period 1 (8 Weeks)||42
1432011|NCT02392234|3506206|P3|STARTED|Treatment Period 1 (8 Weeks)||40
1432012|NCT02392234|3506207|P2|STARTED|Treatment Period 1 (8 Weeks)||43
1432013|NCT02392234|3506208|P1|STARTED|Treatment Period 1 (8 Weeks)||41
1432014|NCT02392208|3506230|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
1432015|NCT02392208|3506230|P1|COMPLETED|Telavancin After Hemodialysis||8
1432016|NCT02392208|3506230|P1|STARTED|Telavancin After Hemodialysis||8
1432017|NCT02392208|3506230|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
1432018|NCT02392208|3506230|P1|COMPLETED|Telavancin Before Hemodialysis||8
1432019|NCT02392208|3506230|P1|STARTED|Telavancin Before Hemodialysis||8
1432020|NCT02392000|3506240|P1|NOT COMPLETED|Overall Study||27
1432021|NCT02392000|3506240|P1|COMPLETED|Overall Study||11
1432022|NCT02392000|3506240|P1|STARTED|Overall Study||38
1432023|NCT02391714|3506250|P2|NOT COMPLETED|Overall Study||0
1432024|NCT02391714|3506251|P1|NOT COMPLETED|Overall Study||0
1432025|NCT02391714|3506250|P2|COMPLETED|Overall Study||40
1432026|NCT02391714|3506251|P1|COMPLETED|Overall Study||40
1432027|NCT02391714|3506250|P2|STARTED|Overall Study||40
1432028|NCT02391714|3506251|P1|STARTED|Overall Study||40
1432029|NCT02391584|3506263|P2|NOT COMPLETED|12 Month (End of Study)||0
1432030|NCT02391584|3506264|P1|NOT COMPLETED|12 Month (End of Study)||2
1432031|NCT02391584|3506263|P2|COMPLETED|12 Month (End of Study)||0
1432032|NCT02391584|3506264|P1|COMPLETED|12 Month (End of Study)||49
1432033|NCT02391584|3506263|P2|STARTED|12 Month (End of Study)||0
1432034|NCT02391584|3506264|P1|STARTED|12 Month (End of Study)||51
1432035|NCT02391584|3506263|P2|NOT COMPLETED|6 Month||0
1432036|NCT02391584|3506264|P1|NOT COMPLETED|6 Month||1
1432037|NCT02391584|3506263|P2|COMPLETED|6 Month||0
1432038|NCT02391584|3506264|P1|COMPLETED|6 Month||51
1432039|NCT02391584|3506263|P2|STARTED|6 Month||0
1432040|NCT02391584|3506264|P1|STARTED|6 Month||52
1432041|NCT02391584|3506263|P2|NOT COMPLETED|3 Month||0
1432042|NCT02391584|3506264|P1|NOT COMPLETED|3 Month||1
1432043|NCT02391584|3506263|P2|COMPLETED|3 Month||0
1432044|NCT02391584|3506264|P1|COMPLETED|3 Month||52
1432045|NCT02391584|3506263|P2|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
1432046|NCT02391584|3506264|P1|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
1432047|NCT02391584|3506263|P2|NOT COMPLETED|Primary Endpoint (6-weeks)||2
1432048|NCT02391584|3506264|P1|NOT COMPLETED|Primary Endpoint (6-weeks)||2
1432049|NCT02391584|3506263|P2|COMPLETED|Primary Endpoint (6-weeks)||27
1432050|NCT02391584|3506264|P1|COMPLETED|Primary Endpoint (6-weeks)||29
1432051|NCT02391584|3506263|P2|STARTED|Primary Endpoint (6-weeks)||29
1432052|NCT02391584|3506264|P1|STARTED|Primary Endpoint (6-weeks)||31
1432053|NCT02391311|3506281|P2|NOT COMPLETED|Overall Study||2
1432054|NCT02391311|3506282|P1|NOT COMPLETED|Overall Study||3
1432055|NCT02391311|3506281|P2|COMPLETED|Overall Study||19
1432056|NCT02391311|3506282|P1|COMPLETED|Overall Study||18
1432057|NCT02391311|3506281|P2|STARTED|Overall Study||21
1432058|NCT02391311|3506282|P1|STARTED|Overall Study||21
1432059|NCT02391116|3506290|P1|NOT COMPLETED|Survival Follow-up||14
1432060|NCT02391116|3506290|P1|COMPLETED|Survival Follow-up|Reason for completion in this period was death.|31
1432061|NCT02391116|3506290|P1|STARTED|Survival Follow-up|21 patients discontinued from treatment didn't enter due to withdrawal by subject(3) and death(18)|45
1432062|NCT02391116|3506290|P1|NOT COMPLETED|Active Follow-up||3
1432063|NCT02391116|3506290|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD.|7
1432064|NCT02391116|3506290|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological assessments|10
1432065|NCT02391116|3506290|P1|NOT COMPLETED|Safety Follow-up||13
1432066|NCT02391116|3506290|P1|COMPLETED|Safety Follow-up|14 subjects were considered completed due to death.|41
1432067|NCT02391116|3506290|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 10 subjects entering active follow-up|54
1432068|NCT02391116|3506290|P1|NOT COMPLETED|Treatment||15
1432069|NCT02391116|3506290|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD and lack of efficacy (1).|52
1432070|NCT02391116|3506290|P1|Included in Per Protocol Set|Treatment||40
1432071|NCT02391116|3506290|P1|STARTED|Treatment||67
1432072|NCT02391038|3506343|P3|NOT COMPLETED|Overall Study||6
1432073|NCT02391038|3506344|P2|NOT COMPLETED|Overall Study||3
1432074|NCT02391038|3506345|P1|NOT COMPLETED|Overall Study||3
1432075|NCT02391038|3506343|P3|COMPLETED|Overall Study||0
1432076|NCT02391038|3506344|P2|COMPLETED|Overall Study||0
1432077|NCT02391038|3506345|P1|COMPLETED|Overall Study||0
1432078|NCT02391038|3506343|P3|STARTED|Overall Study||6
1432079|NCT02391038|3506344|P2|STARTED|Overall Study||3
1432080|NCT02391038|3506345|P1|STARTED|Overall Study||3
1432081|NCT02390557|3506462|P3|NOT COMPLETED|Wave 2||23
1432082|NCT02390557|3506463|P2|NOT COMPLETED|Wave 2||41
1432083|NCT02390557|3506464|P1|NOT COMPLETED|Wave 2||72
1432084|NCT02390557|3506462|P3|COMPLETED|Wave 2||112
1432085|NCT02390557|3506463|P2|COMPLETED|Wave 2||115
1432086|NCT02390557|3506464|P1|COMPLETED|Wave 2||88
1432087|NCT02390557|3506462|P3|STARTED|Wave 2||135
1432088|NCT02390557|3506463|P2|STARTED|Wave 2||156
1432089|NCT02390557|3506464|P1|STARTED|Wave 2||160
1432090|NCT02390557|3506462|P3|NOT COMPLETED|Wave 1||0
1432091|NCT02390557|3506463|P2|NOT COMPLETED|Wave 1||0
1432092|NCT02390557|3506464|P1|NOT COMPLETED|Wave 1||0
1432093|NCT02390557|3506462|P3|COMPLETED|Wave 1||135
1432094|NCT02390557|3506463|P2|COMPLETED|Wave 1||156
1432095|NCT02390557|3506464|P1|COMPLETED|Wave 1||160
1432096|NCT02390557|3506462|P3|STARTED|Wave 1||135
1432097|NCT02390557|3506463|P2|STARTED|Wave 1||156
1432098|NCT02390557|3506464|P1|STARTED|Wave 1||160
1432099|NCT02390219|3506472|P1|NOT COMPLETED|Overall Study||13
1432100|NCT02390219|3506472|P1|COMPLETED|Overall Study||33
1432101|NCT02390219|3506472|P1|STARTED|Overall Study||46
1432102|NCT02390167|3506482|P1|NOT COMPLETED|Overall Study||1
1432103|NCT02390167|3506482|P1|COMPLETED|Overall Study||375
1432104|NCT02390167|3506482|P1|Without Diabetes|Overall Study||43
1432105|NCT02390167|3506482|P1|With Diabetes|Overall Study||333
1432106|NCT02390167|3506482|P1|STARTED|Overall Study||376
1432107|NCT02389881|3506508|P7|NOT COMPLETED|Overall Study||0
1432108|NCT02389881|3506509|P6|NOT COMPLETED|Overall Study||0
1432109|NCT02389881|3506510|P5|NOT COMPLETED|Overall Study||0
1432110|NCT02389881|3506511|P4|NOT COMPLETED|Overall Study||0
1432111|NCT02389881|3506512|P3|NOT COMPLETED|Overall Study||0
1432112|NCT02389881|3506513|P2|NOT COMPLETED|Overall Study||0
1432113|NCT02389881|3506514|P1|NOT COMPLETED|Overall Study||0
1432114|NCT02389881|3506508|P7|COMPLETED|Overall Study||2
1432115|NCT02389881|3506509|P6|COMPLETED|Overall Study||8
1432116|NCT02389881|3506510|P5|COMPLETED|Overall Study||6
1432117|NCT02389881|3506511|P4|COMPLETED|Overall Study||6
1432118|NCT02389881|3506512|P3|COMPLETED|Overall Study||6
1432119|NCT02389881|3506513|P2|COMPLETED|Overall Study||6
1432120|NCT02389881|3506514|P1|COMPLETED|Overall Study||6
1432121|NCT02389881|3506508|P7|STARTED|Overall Study||2
1432122|NCT02389881|3506509|P6|STARTED|Overall Study||8
1432123|NCT02389881|3506510|P5|STARTED|Overall Study||6
1432124|NCT02389881|3506511|P4|STARTED|Overall Study||6
1432125|NCT02389881|3506512|P3|STARTED|Overall Study||6
1432126|NCT02389881|3506513|P2|STARTED|Overall Study||6
1432127|NCT02389881|3506514|P1|STARTED|Overall Study||6
1432128|NCT02389829|3506565|P2|NOT COMPLETED|Overall Study||1
1432129|NCT02389829|3506566|P1|NOT COMPLETED|Overall Study||0
1432130|NCT02389829|3506565|P2|COMPLETED|Overall Study||62
1432131|NCT02389829|3506566|P1|COMPLETED|Overall Study||64
1432132|NCT02389829|3506565|P2|STARTED|Overall Study||63
1432133|NCT02389829|3506566|P1|STARTED|Overall Study||64
1432134|NCT02389738|3506578|P1|NOT COMPLETED|Overall Study||1
1432135|NCT02389738|3506578|P1|COMPLETED|Overall Study||5
1432136|NCT02389738|3506578|P1|STARTED|Overall Study||6
1432137|NCT02389621|3506584|P2|NOT COMPLETED|Posttreatment Period||4
1432138|NCT02389621|3506585|P1|NOT COMPLETED|Posttreatment Period||9
1432139|NCT02389621|3506584|P2|COMPLETED|Posttreatment Period||102
1432140|NCT02389621|3506585|P1|COMPLETED|Posttreatment Period||98
1432141|NCT02389621|3506584|P2|STARTED|Posttreatment Period||106
1432142|NCT02389621|3506585|P1|STARTED|Posttreatment Period||107
1432143|NCT02389621|3506584|P2|NOT COMPLETED|Treatment Period||1
1432144|NCT02389621|3506585|P1|NOT COMPLETED|Treatment Period||1
1432145|NCT02389621|3506584|P2|COMPLETED|Treatment Period||106
1432146|NCT02389621|3506585|P1|COMPLETED|Treatment Period||107
1432147|NCT02389621|3506584|P2|Received Study Drug|Treatment Period||107
1432148|NCT02389621|3506585|P1|Received Study Drug|Treatment Period||107
1432149|NCT02389621|3506584|P2|STARTED|Treatment Period||107
1432150|NCT02389621|3506585|P1|STARTED|Treatment Period||108
1432151|NCT02389452|3506615|P1|NOT COMPLETED|Overall Study||25
1432152|NCT02389452|3506615|P1|COMPLETED|Overall Study||369
1432153|NCT02389452|3506615|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
1432154|NCT02389452|3506615|P1|STARTED|Overall Study||394
1432155|NCT02389374|3506636|P3|NOT COMPLETED|Overall Study||1
1432156|NCT02389374|3506637|P2|NOT COMPLETED|Overall Study||28
1432157|NCT02389374|3506638|P1|NOT COMPLETED|Overall Study||9
1432158|NCT02389374|3506636|P3|COMPLETED|Overall Study||10
1432159|NCT02389374|3506637|P2|COMPLETED|Overall Study||87
1432160|NCT02389374|3506638|P1|COMPLETED|Overall Study||46
1432161|NCT02389374|3506636|P3|STARTED|Overall Study||11
1432162|NCT02389374|3506637|P2|STARTED|Overall Study||115
1432163|NCT02389374|3506638|P1|STARTED|Overall Study||55
1432164|NCT02389361|3506670|P2|NOT COMPLETED|Overall Study||0
1432165|NCT02389361|3506671|P1|NOT COMPLETED|Overall Study||0
1432166|NCT02389361|3506670|P2|COMPLETED|Overall Study||27
1432167|NCT02389361|3506671|P1|COMPLETED|Overall Study||24
1432168|NCT02389361|3506670|P2|STARTED|Overall Study||27
1432169|NCT02389361|3506671|P1|STARTED|Overall Study||24
1432170|NCT02389088|3506677|P1|NOT COMPLETED|Phase II - All Study Participants||0
1432171|NCT02389088|3506677|P1|COMPLETED|Phase II - All Study Participants||9
1432172|NCT02389088|3506677|P1|STARTED|Phase II - All Study Participants||9
1432173|NCT02389088|3506677|P1|NOT COMPLETED|Overall Study - Phase I||0
1432174|NCT02389088|3506677|P1|COMPLETED|Overall Study - Phase I||9
1432175|NCT02389088|3506677|P1|STARTED|Overall Study - Phase I||9
1432176|NCT02388997|3506723|P2|NOT COMPLETED|Overall Study||6
1432177|NCT02388997|3506724|P1|NOT COMPLETED|Overall Study||3
1432178|NCT02388997|3506723|P2|COMPLETED|Overall Study||10
1432179|NCT02388997|3506724|P1|COMPLETED|Overall Study||12
1432180|NCT02388997|3506723|P2|STARTED|Overall Study||16
1432181|NCT02388997|3506724|P1|STARTED|Overall Study||15
1432182|NCT02388932|3506742|P1|NOT COMPLETED|Overall Study||1
1432183|NCT02388932|3506742|P1|COMPLETED|Overall Study||2
1432184|NCT02388932|3506742|P1|STARTED|Overall Study||3
1432185|NCT02388815|3506751|P1|NOT COMPLETED|Overall Study||4
1432186|NCT02388815|3506751|P1|COMPLETED|Overall Study||85
1432187|NCT02388815|3506751|P1|STARTED|Overall Study||89
1432188|NCT02388776|3506755|P1|NOT COMPLETED|Overall Study||2
1432189|NCT02388776|3506755|P1|COMPLETED|Overall Study||0
1432190|NCT02388776|3506755|P1|STARTED|Overall Study||2
1432191|NCT02388763|3506760|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
1432192|NCT02388763|3506761|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
1432193|NCT02388763|3506760|P2|COMPLETED|Period 2, 10 Days of Wear||30
1432194|NCT02388763|3506761|P1|COMPLETED|Period 2, 10 Days of Wear||30
1432195|NCT02388763|3506760|P2|STARTED|Period 2, 10 Days of Wear||30
1432196|NCT02388763|3506761|P1|STARTED|Period 2, 10 Days of Wear||30
1432197|NCT02388763|3506760|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
1432198|NCT02388763|3506761|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
1432199|NCT02388763|3506760|P2|COMPLETED|Period 1, 10 Days of Wear||30
1432200|NCT02388763|3506761|P1|COMPLETED|Period 1, 10 Days of Wear||30
1432201|NCT02388763|3506760|P2|STARTED|Period 1, 10 Days of Wear||31
1432202|NCT02388763|3506761|P1|STARTED|Period 1, 10 Days of Wear||31
1432203|NCT02388763|3506760|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
1432204|NCT02388763|3506761|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
1432205|NCT02388763|3506760|P2|COMPLETED|Habitual, 10 Days of Wear||31
1432206|NCT02388763|3506761|P1|COMPLETED|Habitual, 10 Days of Wear||31
1432207|NCT02388763|3506760|P2|STARTED|Habitual, 10 Days of Wear||32
1432208|NCT02388763|3506761|P1|STARTED|Habitual, 10 Days of Wear||32
1432209|NCT02388568|3506774|P2|NOT COMPLETED|Overall Study||15
1432210|NCT02388568|3506775|P1|NOT COMPLETED|Overall Study||10
1432211|NCT02388568|3506774|P2|COMPLETED|Overall Study||53
1432212|NCT02388568|3506775|P1|COMPLETED|Overall Study||59
1432213|NCT02388568|3506774|P2|STARTED|Overall Study||68
1432214|NCT02388568|3506775|P1|STARTED|Overall Study||69
1432215|NCT02388347|3506796|P5|NOT COMPLETED|Overall Study||0
1432216|NCT02388347|3506797|P4|NOT COMPLETED|Overall Study||0
1432217|NCT02388347|3506798|P3|NOT COMPLETED|Overall Study||1
1432218|NCT02388347|3506799|P2|NOT COMPLETED|Overall Study||0
1432219|NCT02388347|3506800|P1|NOT COMPLETED|Overall Study||0
1432220|NCT02388347|3506796|P5|COMPLETED|Overall Study||6
1432221|NCT02388347|3506797|P4|COMPLETED|Overall Study||6
1432222|NCT02388347|3506798|P3|COMPLETED|Overall Study||5
1432223|NCT02388347|3506799|P2|COMPLETED|Overall Study||6
1432224|NCT02388347|3506800|P1|COMPLETED|Overall Study||8
1432225|NCT02388347|3506796|P5|STARTED|Overall Study||6
1432226|NCT02388347|3506797|P4|STARTED|Overall Study||6
1432227|NCT02388347|3506798|P3|STARTED|Overall Study||6
1432228|NCT02388347|3506799|P2|STARTED|Overall Study||6
1432229|NCT02388347|3506800|P1|STARTED|Overall Study||8
1432230|NCT02388321|3506867|P2|NOT COMPLETED|Overall Study||0
1432231|NCT02388321|3506868|P1|NOT COMPLETED|Overall Study||0
1432232|NCT02388321|3506867|P2|COMPLETED|Overall Study||11
1432233|NCT02388321|3506868|P1|COMPLETED|Overall Study||11
1432234|NCT02388321|3506867|P2|STARTED|Overall Study||11
1432235|NCT02388321|3506868|P1|STARTED|Overall Study||11
1432236|NCT02388295|3506879|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
1432237|NCT02388295|3506880|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
1432238|NCT02388295|3506881|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
1432239|NCT02388295|3506879|P3|COMPLETED|Treatment Weeks 3 to 12||17
1432240|NCT02388295|3506880|P2|COMPLETED|Treatment Weeks 3 to 12||13
1432241|NCT02388295|3506881|P1|COMPLETED|Treatment Weeks 3 to 12||15
1432242|NCT02388295|3506879|P3|STARTED|Treatment Weeks 3 to 12||17
1432243|NCT02388295|3506880|P2|STARTED|Treatment Weeks 3 to 12||14
1432244|NCT02388295|3506881|P1|STARTED|Treatment Weeks 3 to 12||16
1432245|NCT02388295|3506879|P3|NOT COMPLETED|Dose Escalation Week 2||1
1432246|NCT02388295|3506880|P2|NOT COMPLETED|Dose Escalation Week 2||2
1432247|NCT02388295|3506881|P1|NOT COMPLETED|Dose Escalation Week 2||1
1432248|NCT02388295|3506879|P3|COMPLETED|Dose Escalation Week 2||17
1432249|NCT02388295|3506880|P2|COMPLETED|Dose Escalation Week 2||14
1432250|NCT02388295|3506881|P1|COMPLETED|Dose Escalation Week 2||16
1432251|NCT02388295|3506879|P3|STARTED|Dose Escalation Week 2||18
1432252|NCT02388295|3506880|P2|STARTED|Dose Escalation Week 2||16
1432253|NCT02388295|3506881|P1|STARTED|Dose Escalation Week 2||17
1432254|NCT02388295|3506879|P3|NOT COMPLETED|Dose Escalation Week 1||2
1432255|NCT02388295|3506880|P2|NOT COMPLETED|Dose Escalation Week 1||3
1432256|NCT02388295|3506881|P1|NOT COMPLETED|Dose Escalation Week 1||2
1432257|NCT02388295|3506879|P3|COMPLETED|Dose Escalation Week 1||18
1432258|NCT02388295|3506880|P2|COMPLETED|Dose Escalation Week 1||16
1432259|NCT02388295|3506881|P1|COMPLETED|Dose Escalation Week 1||17
1432260|NCT02388295|3506879|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
1432261|NCT02388295|3506880|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
1432262|NCT02388295|3506881|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
1432263|NCT02388269|3506899|P3|NOT COMPLETED|Overall Study||10
1432264|NCT02388269|3506900|P2|NOT COMPLETED|Overall Study||2
1432265|NCT02388269|3506901|P1|NOT COMPLETED|Overall Study||9
1432266|NCT02388269|3506899|P3|COMPLETED|Overall Study||0
1432267|NCT02388269|3506900|P2|COMPLETED|Overall Study||38
1432268|NCT02388269|3506901|P1|COMPLETED|Overall Study||32
1432269|NCT02388269|3506899|P3|Open Label|Overall Study||0
1432270|NCT02388269|3506900|P2|Open Label|Overall Study||38
1432271|NCT02388269|3506901|P1|Open Label|Overall Study||37
1432272|NCT02388269|3506899|P3|Randomised Period|Overall Study||0
1432273|NCT02388269|3506900|P2|Randomised Period|Overall Study||40
1432274|NCT02388269|3506901|P1|Randomised Period|Overall Study||41
1432275|NCT02388269|3506899|P3|STARTED|Overall Study||10
1432276|NCT02388269|3506900|P2|STARTED|Overall Study||40
1432277|NCT02388269|3506901|P1|STARTED|Overall Study||41
1432278|NCT02388191|3506933|P2|NOT COMPLETED|Overall Study||0
1432279|NCT02388191|3506934|P1|NOT COMPLETED|Overall Study||1
1432280|NCT02388191|3506933|P2|COMPLETED|Overall Study||60
1432281|NCT02388191|3506934|P1|COMPLETED|Overall Study||58
1432282|NCT02388191|3506933|P2|STARTED|Overall Study||60
1432283|NCT02388191|3506934|P1|STARTED|Overall Study||59
1432284|NCT02388074|3506948|P1|NOT COMPLETED|Overall Study||3
1432285|NCT02388074|3506948|P1|COMPLETED|Overall Study||22
1432286|NCT02388074|3506948|P1|STARTED|Overall Study||25
1432287|NCT02387996|3506952|P1|NOT COMPLETED|Overall Study||204
1432288|NCT02387996|3506952|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
1432289|NCT02387996|3506952|P1|STARTED|Overall Study||270
1432290|NCT02387983|3506963|P1|NOT COMPLETED|Overall Study||7
1432291|NCT02387983|3506963|P1|COMPLETED|Overall Study||58
1432292|NCT02387983|3506963|P1|STARTED|Overall Study||65
1432293|NCT02387801|3506977|P2|NOT COMPLETED|Post-Treatment Follow-up||0
1432294|NCT02387801|3506978|P1|NOT COMPLETED|Post-Treatment Follow-up||0
1432295|NCT02387801|3506977|P2|COMPLETED|Post-Treatment Follow-up||12
1432296|NCT02387801|3506978|P1|COMPLETED|Post-Treatment Follow-up||0
1432297|NCT02387801|3506977|P2|STARTED|Post-Treatment Follow-up||12
1432298|NCT02387801|3506978|P1|STARTED|Post-Treatment Follow-up||0
1432299|NCT02387801|3506977|P2|NOT COMPLETED|Maintenance Dosing Period||0
1432300|NCT02387801|3506978|P1|NOT COMPLETED|Maintenance Dosing Period||0
1432301|NCT02387801|3506977|P2|COMPLETED|Maintenance Dosing Period||12
1432302|NCT02387801|3506978|P1|COMPLETED|Maintenance Dosing Period||0
1432303|NCT02387801|3506977|P2|STARTED|Maintenance Dosing Period||12
1432304|NCT02387801|3506978|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
1432305|NCT02387801|3506977|P2|NOT COMPLETED|Induction Dosing Period||0
1432306|NCT02387801|3506978|P1|NOT COMPLETED|Induction Dosing Period||0
1432307|NCT02387801|3506977|P2|COMPLETED|Induction Dosing Period||6
1432308|NCT02387801|3506978|P1|COMPLETED|Induction Dosing Period||6
1432309|NCT02387801|3506977|P2|STARTED|Induction Dosing Period||6
1432310|NCT02387801|3506978|P1|STARTED|Induction Dosing Period||6
1432311|NCT02387749|3506996|P1|NOT COMPLETED|Overall Study||0
1432312|NCT02387749|3506996|P1|COMPLETED|Overall Study||10
1432313|NCT02387749|3506996|P1|STARTED|Overall Study||10
1432314|NCT02387710|3507005|P2|NOT COMPLETED|Second Study Night||0
1432315|NCT02387710|3507006|P1|NOT COMPLETED|Second Study Night||0
1432316|NCT02387710|3507005|P2|COMPLETED|Second Study Night||7
1432317|NCT02387710|3507006|P1|COMPLETED|Second Study Night||9
1432318|NCT02387710|3507005|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
1432319|NCT02387710|3507006|P1|STARTED|Second Study Night||9
1432320|NCT02387710|3507005|P2|NOT COMPLETED|First Study Night||0
1432321|NCT02387710|3507006|P1|NOT COMPLETED|First Study Night||0
1432322|NCT02387710|3507005|P2|COMPLETED|First Study Night||9
1432323|NCT02387710|3507006|P1|COMPLETED|First Study Night||9
1432324|NCT02387710|3507005|P2|STARTED|First Study Night||9
1432325|NCT02387710|3507006|P1|STARTED|First Study Night||9
1432326|NCT02387580|3507022|P6|NOT COMPLETED|Overall Study||0
1432327|NCT02387580|3507023|P5|NOT COMPLETED|Overall Study||0
1432328|NCT02387580|3507024|P4|NOT COMPLETED|Overall Study||1
1432329|NCT02387580|3507025|P3|NOT COMPLETED|Overall Study||0
1432330|NCT02387580|3507026|P2|NOT COMPLETED|Overall Study||0
1432331|NCT02387580|3507027|P1|NOT COMPLETED|Overall Study||0
1432332|NCT02387580|3507022|P6|COMPLETED|Overall Study||8
1432333|NCT02387580|3507023|P5|COMPLETED|Overall Study||8
1432334|NCT02387580|3507024|P4|COMPLETED|Overall Study||7
1432335|NCT02387580|3507025|P3|COMPLETED|Overall Study||8
1432336|NCT02387580|3507026|P2|COMPLETED|Overall Study||8
1432337|NCT02387580|3507027|P1|COMPLETED|Overall Study||8
1432338|NCT02387580|3507022|P6|STARTED|Overall Study||8
1432339|NCT02387580|3507023|P5|STARTED|Overall Study||8
1432340|NCT02387580|3507024|P4|STARTED|Overall Study||8
1432341|NCT02387580|3507025|P3|STARTED|Overall Study||8
1432342|NCT02387580|3507026|P2|STARTED|Overall Study||8
1432343|NCT02387580|3507027|P1|STARTED|Overall Study||8
1432344|NCT02387554|3507063|P4|NOT COMPLETED|Overall Study||2
1432345|NCT02387554|3507064|P3|NOT COMPLETED|Overall Study||2
1432346|NCT02387554|3507065|P2|NOT COMPLETED|Overall Study||0
1432347|NCT02387554|3507066|P1|NOT COMPLETED|Overall Study||3
1432348|NCT02387554|3507063|P4|COMPLETED|Overall Study||6
1432349|NCT02387554|3507064|P3|COMPLETED|Overall Study||6
1432350|NCT02387554|3507065|P2|COMPLETED|Overall Study||7
1432351|NCT02387554|3507066|P1|COMPLETED|Overall Study||7
1432352|NCT02387554|3507063|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
1432353|NCT02387554|3507064|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
1432354|NCT02387554|3507065|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
1432355|NCT02387554|3507066|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
1432356|NCT02387502|3507079|P3|NOT COMPLETED|Overall Study||0
1432357|NCT02387502|3507080|P2|NOT COMPLETED|Overall Study||0
1432358|NCT02387502|3507081|P1|NOT COMPLETED|Overall Study||0
1432359|NCT02387502|3507079|P3|COMPLETED|Overall Study||40
1432360|NCT02387502|3507080|P2|COMPLETED|Overall Study||40
1432361|NCT02387502|3507081|P1|COMPLETED|Overall Study||40
1432362|NCT02387502|3507079|P3|STARTED|Overall Study||40
1432363|NCT02387502|3507080|P2|STARTED|Overall Study||40
1432364|NCT02387502|3507081|P1|STARTED|Overall Study||40
1432365|NCT02387476|3507091|P2|NOT COMPLETED|Overall Study||5
1432366|NCT02387476|3507092|P1|NOT COMPLETED|Overall Study||6
1432367|NCT02387476|3507091|P2|COMPLETED|Overall Study||17
1432368|NCT02387476|3507092|P1|COMPLETED|Overall Study||19
1432369|NCT02387476|3507091|P2|STARTED|Overall Study||22
1432370|NCT02387476|3507092|P1|STARTED|Overall Study||25
1432371|NCT02387268|3507118|P1|NOT COMPLETED|Overall Study||1
1432372|NCT02387268|3507118|P1|COMPLETED|Overall Study||9
1432373|NCT02387268|3507118|P1|STARTED|Overall Study||10
1432374|NCT02386098|3507128|P5|NOT COMPLETED|Stage 2 (96 Weeks)||0
1432375|NCT02386098|3507129|P4|NOT COMPLETED|Stage 2 (96 Weeks)||0
1432376|NCT02386098|3507130|P3|NOT COMPLETED|Stage 2 (96 Weeks)||0
1432377|NCT02386098|3507131|P2|NOT COMPLETED|Stage 2 (96 Weeks)||0
1432378|NCT02386098|3507132|P1|NOT COMPLETED|Stage 2 (96 Weeks)||0
1432379|NCT02386098|3507128|P5|COMPLETED|Stage 2 (96 Weeks)||0
1432380|NCT02386098|3507129|P4|COMPLETED|Stage 2 (96 Weeks)||0
1432381|NCT02386098|3507130|P3|COMPLETED|Stage 2 (96 Weeks)||0
1432382|NCT02386098|3507131|P2|COMPLETED|Stage 2 (96 Weeks)||0
1432383|NCT02386098|3507132|P1|COMPLETED|Stage 2 (96 Weeks)||0
1432384|NCT02386098|3507128|P5|STARTED|Stage 2 (96 Weeks)||0
1432385|NCT02386098|3507129|P4|STARTED|Stage 2 (96 Weeks)||0
1432386|NCT02386098|3507130|P3|STARTED|Stage 2 (96 Weeks)||0
1432387|NCT02386098|3507131|P2|STARTED|Stage 2 (96 Weeks)||0
1432388|NCT02386098|3507132|P1|STARTED|Stage 2 (96 Weeks)||0
1432389|NCT02386098|3507128|P5|NOT COMPLETED|Stage 1 (96 Weeks)||0
1432390|NCT02386098|3507129|P4|NOT COMPLETED|Stage 1 (96 Weeks)||0
1432391|NCT02386098|3507130|P3|NOT COMPLETED|Stage 1 (96 Weeks)||0
1432392|NCT02386098|3507131|P2|NOT COMPLETED|Stage 1 (96 Weeks)||43
1432393|NCT02386098|3507132|P1|NOT COMPLETED|Stage 1 (96 Weeks)||43
1432394|NCT02386098|3507128|P5|COMPLETED|Stage 1 (96 Weeks)||0
1432395|NCT02386098|3507129|P4|COMPLETED|Stage 1 (96 Weeks)||0
1432396|NCT02386098|3507130|P3|COMPLETED|Stage 1 (96 Weeks)||0
1432397|NCT02386098|3507131|P2|COMPLETED|Stage 1 (96 Weeks)||0
1432398|NCT02386098|3507132|P1|COMPLETED|Stage 1 (96 Weeks)||0
1432399|NCT02386098|3507128|P5|STARTED|Stage 1 (96 Weeks)||0
1432400|NCT02386098|3507129|P4|STARTED|Stage 1 (96 Weeks)||0
1432401|NCT02386098|3507130|P3|STARTED|Stage 1 (96 Weeks)||0
1432402|NCT02386098|3507131|P2|STARTED|Stage 1 (96 Weeks)||43
1432403|NCT02386098|3507132|P1|STARTED|Stage 1 (96 Weeks)||43
1432404|NCT02385526|3507212|P3|NOT COMPLETED|Overall Study||0
1432405|NCT02385526|3507213|P2|NOT COMPLETED|Overall Study||3
1432406|NCT02385526|3507214|P1|NOT COMPLETED|Overall Study||2
1432407|NCT02385526|3507212|P3|COMPLETED|Overall Study||20
1432408|NCT02385526|3507213|P2|COMPLETED|Overall Study||17
1432409|NCT02385526|3507214|P1|COMPLETED|Overall Study||20
1432410|NCT02385526|3507212|P3|STARTED|Overall Study||20
1432411|NCT02385526|3507213|P2|STARTED|Overall Study||20
1432412|NCT02385526|3507214|P1|STARTED|Overall Study||22
1432413|NCT02385084|3507222|P6|NOT COMPLETED|Period 3||0
1432414|NCT02385084|3507223|P5|NOT COMPLETED|Period 3||0
1432415|NCT02385084|3507224|P4|NOT COMPLETED|Period 3||0
1432416|NCT02385084|3507225|P3|NOT COMPLETED|Period 3||0
1432417|NCT02385084|3507226|P2|NOT COMPLETED|Period 3||0
1432418|NCT02385084|3507227|P1|NOT COMPLETED|Period 3||0
1432419|NCT02385084|3507222|P6|COMPLETED|Period 3||3
1432420|NCT02385084|3507223|P5|COMPLETED|Period 3||2
1432421|NCT02385084|3507224|P4|COMPLETED|Period 3||3
1432422|NCT02385084|3507225|P3|COMPLETED|Period 3||1
1432423|NCT02385084|3507226|P2|COMPLETED|Period 3||3
1432424|NCT02385084|3507227|P1|COMPLETED|Period 3||2
1432425|NCT02385084|3507222|P6|Washout|Period 3||3
1432426|NCT02385084|3507223|P5|Washout|Period 3||2
1432427|NCT02385084|3507224|P4|Washout|Period 3||3
1432428|NCT02385084|3507225|P3|Washout|Period 3||1
1432429|NCT02385084|3507226|P2|Washout|Period 3||3
1432430|NCT02385084|3507227|P1|Washout|Period 3||2
1432431|NCT02385084|3507222|P6|Received LY2409021|Period 3||3
1432432|NCT02385084|3507223|P5|Received LY2409021|Period 3||2
1432433|NCT02385084|3507224|P4|Received LY2409021|Period 3||3
1432434|NCT02385084|3507225|P3|Received LY2409021|Period 3||1
1432435|NCT02385084|3507226|P2|Received LY2409021|Period 3||3
1432436|NCT02385084|3507227|P1|Received LY2409021|Period 3||2
1432437|NCT02385084|3507222|P6|STARTED|Period 3||3
1432438|NCT02385084|3507223|P5|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
1432439|NCT02385084|3507224|P4|STARTED|Period 3||3
1432440|NCT02385084|3507225|P3|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
1432441|NCT02385084|3507226|P2|STARTED|Period 3||3
1432442|NCT02385084|3507227|P1|STARTED|Period 3||2
1432443|NCT02385084|3507222|P6|NOT COMPLETED|Period 2||0
1432444|NCT02385084|3507223|P5|NOT COMPLETED|Period 2||0
1432445|NCT02385084|3507224|P4|NOT COMPLETED|Period 2||0
1432446|NCT02385084|3507225|P3|NOT COMPLETED|Period 2||1
1432447|NCT02385084|3507226|P2|NOT COMPLETED|Period 2||0
1432448|NCT02385084|3507227|P1|NOT COMPLETED|Period 2||0
1432449|NCT02385084|3507222|P6|COMPLETED|Period 2||3
1432450|NCT02385084|3507223|P5|COMPLETED|Period 2||3
1432451|NCT02385084|3507224|P4|COMPLETED|Period 2||3
1432452|NCT02385084|3507225|P3|COMPLETED|Period 2||2
1432453|NCT02385084|3507226|P2|COMPLETED|Period 2||3
1432454|NCT02385084|3507227|P1|COMPLETED|Period 2||2
1432455|NCT02385084|3507222|P6|Washout|Period 2||3
1432456|NCT02385084|3507223|P5|Washout|Period 2||3
1432457|NCT02385084|3507224|P4|Washout|Period 2||3
1432458|NCT02385084|3507225|P3|Washout|Period 2||3
1432459|NCT02385084|3507226|P2|Washout|Period 2||3
1432460|NCT02385084|3507227|P1|Washout|Period 2||2
1432461|NCT02385084|3507222|P6|Received LY2409021|Period 2||3
1432462|NCT02385084|3507223|P5|Received LY2409021|Period 2||3
1432463|NCT02385084|3507224|P4|Received LY2409021|Period 2||3
1432464|NCT02385084|3507225|P3|Received LY2409021|Period 2||3
1432465|NCT02385084|3507226|P2|Received LY2409021|Period 2||3
1432466|NCT02385084|3507227|P1|Received LY2409021|Period 2||2
1432467|NCT02385084|3507222|P6|STARTED|Period 2||3
1432468|NCT02385084|3507223|P5|STARTED|Period 2||3
1432469|NCT02385084|3507224|P4|STARTED|Period 2||3
1432470|NCT02385084|3507225|P3|STARTED|Period 2||3
1432471|NCT02385084|3507226|P2|STARTED|Period 2||3
1432472|NCT02385084|3507227|P1|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
1432473|NCT02385084|3507222|P6|NOT COMPLETED|Period 1||0
1432474|NCT02385084|3507223|P5|NOT COMPLETED|Period 1||0
1432475|NCT02385084|3507224|P4|NOT COMPLETED|Period 1||0
1432476|NCT02385084|3507225|P3|NOT COMPLETED|Period 1||0
1432477|NCT02385084|3507226|P2|NOT COMPLETED|Period 1||0
1432478|NCT02385084|3507227|P1|NOT COMPLETED|Period 1||0
1432479|NCT02385084|3507222|P6|COMPLETED|Period 1||3
1432480|NCT02385084|3507223|P5|COMPLETED|Period 1||3
1432481|NCT02385084|3507224|P4|COMPLETED|Period 1||3
1432482|NCT02385084|3507225|P3|COMPLETED|Period 1||3
1432483|NCT02385084|3507226|P2|COMPLETED|Period 1||3
1432484|NCT02385084|3507227|P1|COMPLETED|Period 1||3
1432485|NCT02385084|3507222|P6|Washout|Period 1||3
1432486|NCT02385084|3507223|P5|Washout|Period 1||3
1432487|NCT02385084|3507224|P4|Washout|Period 1||3
1432488|NCT02385084|3507225|P3|Washout|Period 1||3
1432489|NCT02385084|3507226|P2|Washout|Period 1||3
1432490|NCT02385084|3507227|P1|Washout|Period 1||3
1432491|NCT02385084|3507222|P6|Received LY2409021|Period 1||3
1432492|NCT02385084|3507223|P5|Received LY2409021|Period 1||3
1432493|NCT02385084|3507224|P4|Received LY2409021|Period 1||3
1432494|NCT02385084|3507225|P3|Received LY2409021|Period 1||3
1432495|NCT02385084|3507226|P2|Received LY2409021|Period 1||3
1432496|NCT02385084|3507227|P1|Received LY2409021|Period 1||3
1432497|NCT02385084|3507222|P6|STARTED|Period 1||3
1432498|NCT02385084|3507223|P5|STARTED|Period 1||3
1432499|NCT02385084|3507224|P4|STARTED|Period 1||3
1432500|NCT02385084|3507225|P3|STARTED|Period 1||3
1432501|NCT02385084|3507226|P2|STARTED|Period 1||3
1432502|NCT02385084|3507227|P1|STARTED|Period 1||3
1432503|NCT02384538|3507240|P2|NOT COMPLETED|Overall Study||15
1432504|NCT02384538|3507241|P1|NOT COMPLETED|Overall Study||6
1432505|NCT02384538|3507240|P2|COMPLETED|Overall Study||49
1432506|NCT02384538|3507241|P1|COMPLETED|Overall Study||61
1432507|NCT02384538|3507240|P2|STARTED|Overall Study||64
1432508|NCT02384538|3507241|P1|STARTED|Overall Study||67
1432509|NCT02384460|3507261|P2|NOT COMPLETED|Overall Study||7
1432510|NCT02384460|3507262|P1|NOT COMPLETED|Overall Study||7
1432511|NCT02384460|3507261|P2|COMPLETED|Overall Study||80
1432512|NCT02384460|3507262|P1|COMPLETED|Overall Study||75
1432513|NCT02384460|3507261|P2|Received at Least 1 Dose of Study Drug|Overall Study||87
1432514|NCT02384460|3507262|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
1432515|NCT02384460|3507261|P2|STARTED|Overall Study||87
1432516|NCT02384460|3507262|P1|STARTED|Overall Study||82
1432517|NCT02384096|3507282|P2|NOT COMPLETED|Second Intervention (7 Days)||1
1432518|NCT02384096|3507283|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1432519|NCT02384096|3507282|P2|COMPLETED|Second Intervention (7 Days)||6
1432520|NCT02384096|3507283|P1|COMPLETED|Second Intervention (7 Days)||4
1432521|NCT02384096|3507282|P2|STARTED|Second Intervention (7 Days)||7
1432522|NCT02384096|3507283|P1|STARTED|Second Intervention (7 Days)||4
1432523|NCT02384096|3507282|P2|NOT COMPLETED|First Intervention (7 Days)||0
1432524|NCT02384096|3507283|P1|NOT COMPLETED|First Intervention (7 Days)||1
1432525|NCT02384096|3507282|P2|COMPLETED|First Intervention (7 Days)||7
1432526|NCT02384096|3507283|P1|COMPLETED|First Intervention (7 Days)||4
1432527|NCT02384096|3507282|P2|STARTED|First Intervention (7 Days)||7
1432528|NCT02384096|3507283|P1|STARTED|First Intervention (7 Days)||5
1432529|NCT02384070|3507291|P3|NOT COMPLETED|Overall Study||0
1432530|NCT02384070|3507292|P2|NOT COMPLETED|Overall Study||0
1432531|NCT02384070|3507293|P1|NOT COMPLETED|Overall Study||0
1432532|NCT02384070|3507291|P3|COMPLETED|Overall Study||100
1432533|NCT02384070|3507292|P2|COMPLETED|Overall Study||100
1432534|NCT02384070|3507293|P1|COMPLETED|Overall Study||100
1432535|NCT02384070|3507291|P3|STARTED|Overall Study||100
1432536|NCT02384070|3507292|P2|STARTED|Overall Study||100
1432537|NCT02384070|3507293|P1|STARTED|Overall Study||100
1432538|NCT02383862|3507309|P2|NOT COMPLETED|3 Month Follow up||21
1432539|NCT02383862|3507310|P1|NOT COMPLETED|3 Month Follow up||23
1432540|NCT02383862|3507309|P2|COMPLETED|3 Month Follow up||128
1432541|NCT02383862|3507310|P1|COMPLETED|3 Month Follow up||128
1432542|NCT02383862|3507309|P2|STARTED|3 Month Follow up||149
1432543|NCT02383862|3507310|P1|STARTED|3 Month Follow up||151
1432544|NCT02383862|3507309|P2|NOT COMPLETED|Baseline||0
1432545|NCT02383862|3507310|P1|NOT COMPLETED|Baseline||0
1432546|NCT02383862|3507309|P2|COMPLETED|Baseline||149
1432547|NCT02383862|3507310|P1|COMPLETED|Baseline||151
1432548|NCT02383862|3507309|P2|STARTED|Baseline||149
1432549|NCT02383862|3507310|P1|STARTED|Baseline||151
1432550|NCT02383758|3507343|P2|NOT COMPLETED|Overall Study||2
1432551|NCT02383758|3507344|P1|NOT COMPLETED|Overall Study||0
1432552|NCT02383758|3507343|P2|COMPLETED|Overall Study||8
1432553|NCT02383758|3507344|P1|COMPLETED|Overall Study||10
1432554|NCT02383758|3507343|P2|STARTED|Overall Study||10
1432555|NCT02383758|3507344|P1|STARTED|Overall Study||10
1432556|NCT02383719|3507356|P1|NOT COMPLETED|Overall Study||0
1432557|NCT02383719|3507356|P1|COMPLETED|Overall Study||18
1432558|NCT02383719|3507356|P1|STARTED|Overall Study||18
1432559|NCT02383576|3507362|P2|NOT COMPLETED|Overall Study||45
1432560|NCT02383576|3507363|P1|NOT COMPLETED|Overall Study||63
1432561|NCT02383576|3507362|P2|COMPLETED|Overall Study||46
1432562|NCT02383576|3507363|P1|COMPLETED|Overall Study||31
1432563|NCT02383576|3507362|P2|STARTED|Overall Study||91
1432564|NCT02383576|3507363|P1|STARTED|Overall Study||94
1432565|NCT02383472|3507379|P2|NOT COMPLETED|Overall Study||1
1432566|NCT02383472|3507380|P1|NOT COMPLETED|Overall Study||1
1432567|NCT02383472|3507379|P2|COMPLETED|Overall Study||29
1432568|NCT02383472|3507380|P1|COMPLETED|Overall Study||22
1432569|NCT02383472|3507379|P2|STARTED|Overall Study||30
1432570|NCT02383472|3507380|P1|STARTED|Overall Study||23
1432571|NCT02383420|3507397|P3|NOT COMPLETED|Overall Study||0
1432572|NCT02383420|3507398|P2|NOT COMPLETED|Overall Study||0
1432573|NCT02383420|3507399|P1|NOT COMPLETED|Overall Study||2
1432574|NCT02383420|3507397|P3|COMPLETED|Overall Study||3
1432575|NCT02383420|3507398|P2|COMPLETED|Overall Study||10
1432576|NCT02383420|3507399|P1|COMPLETED|Overall Study||8
1432577|NCT02383420|3507397|P3|STARTED|Overall Study||3
1432578|NCT02383420|3507398|P2|STARTED|Overall Study||10
1432579|NCT02383420|3507399|P1|STARTED|Overall Study||10
1432580|NCT02382913|3507417|P10|NOT COMPLETED|Overall Study||0
1432581|NCT02382913|3507418|P9|NOT COMPLETED|Overall Study||0
1432582|NCT02382913|3507419|P8|NOT COMPLETED|Overall Study||0
1432583|NCT02382913|3507420|P7|NOT COMPLETED|Overall Study||0
1432584|NCT02382913|3507421|P6|NOT COMPLETED|Overall Study||0
1432585|NCT02382913|3507422|P5|NOT COMPLETED|Overall Study||0
1432586|NCT02382913|3507423|P4|NOT COMPLETED|Overall Study||0
1432587|NCT02382913|3507424|P3|NOT COMPLETED|Overall Study||0
1432588|NCT02382913|3507425|P2|NOT COMPLETED|Overall Study||0
1432589|NCT02382913|3507426|P1|NOT COMPLETED|Overall Study||0
1432590|NCT02382913|3507417|P10|COMPLETED|Overall Study||33
1432591|NCT02382913|3507418|P9|COMPLETED|Overall Study||30
1432592|NCT02382913|3507419|P8|COMPLETED|Overall Study||30
1432593|NCT02382913|3507420|P7|COMPLETED|Overall Study||37
1432594|NCT02382913|3507421|P6|COMPLETED|Overall Study||30
1432595|NCT02382913|3507422|P5|COMPLETED|Overall Study||33
1432596|NCT02382913|3507423|P4|COMPLETED|Overall Study||27
1432597|NCT02382913|3507424|P3|COMPLETED|Overall Study||32
1432598|NCT02382913|3507425|P2|COMPLETED|Overall Study||36
1432599|NCT02382913|3507426|P1|COMPLETED|Overall Study||27
1432600|NCT02382913|3507417|P10|STARTED|Overall Study||33
1432601|NCT02382913|3507418|P9|STARTED|Overall Study||30
1432602|NCT02382913|3507419|P8|STARTED|Overall Study||30
1432603|NCT02382913|3507420|P7|STARTED|Overall Study||37
1432604|NCT02382913|3507421|P6|STARTED|Overall Study||30
1432605|NCT02382913|3507422|P5|STARTED|Overall Study||33
1432606|NCT02382913|3507423|P4|STARTED|Overall Study||27
1432607|NCT02382913|3507424|P3|STARTED|Overall Study||32
1432608|NCT02382913|3507425|P2|STARTED|Overall Study||36
1432609|NCT02382913|3507426|P1|STARTED|Overall Study||27
1432610|NCT02382744|3507464|P2|NOT COMPLETED|Overall Study||0
1432611|NCT02382744|3507465|P1|NOT COMPLETED|Overall Study||0
1432612|NCT02382744|3507464|P2|COMPLETED|Overall Study||40
1432613|NCT02382744|3507465|P1|COMPLETED|Overall Study||40
1432614|NCT02382744|3507464|P2|Analyzed|Overall Study||40
1432615|NCT02382744|3507465|P1|Analyzed|Overall Study||40
1432616|NCT02382744|3507464|P2|Allocated|Overall Study||40
1432617|NCT02382744|3507465|P1|Allocated|Overall Study||40
1432618|NCT02382744|3507464|P2|STARTED|Overall Study||40
1432619|NCT02382744|3507465|P1|STARTED|Overall Study||40
1432620|NCT02382640|3507500|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1432621|NCT02382640|3507501|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1432622|NCT02382640|3507502|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
1432623|NCT02382640|3507503|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
1432624|NCT02382640|3507500|P4|COMPLETED|Intervention Period 4 (3 Days)||9
1432625|NCT02382640|3507501|P3|COMPLETED|Intervention Period 4 (3 Days)||9
1432626|NCT02382640|3507502|P2|COMPLETED|Intervention Period 4 (3 Days)||9
1432627|NCT02382640|3507503|P1|COMPLETED|Intervention Period 4 (3 Days)||8
1432628|NCT02382640|3507500|P4|STARTED|Intervention Period 4 (3 Days)||9
1432629|NCT02382640|3507501|P3|STARTED|Intervention Period 4 (3 Days)||9
1432630|NCT02382640|3507502|P2|STARTED|Intervention Period 4 (3 Days)||9
1432631|NCT02382640|3507503|P1|STARTED|Intervention Period 4 (3 Days)||9
1432632|NCT02382640|3507500|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
1432633|NCT02382640|3507501|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
1432634|NCT02382640|3507502|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
1432635|NCT02382640|3507503|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
1432636|NCT02382640|3507500|P4|COMPLETED|Washout Period 3 (7 Days)||9
1432637|NCT02382640|3507501|P3|COMPLETED|Washout Period 3 (7 Days)||9
1432638|NCT02382640|3507502|P2|COMPLETED|Washout Period 3 (7 Days)||9
1432639|NCT02382640|3507503|P1|COMPLETED|Washout Period 3 (7 Days)||9
1432640|NCT02382640|3507500|P4|STARTED|Washout Period 3 (7 Days)||9
1432641|NCT02382640|3507501|P3|STARTED|Washout Period 3 (7 Days)||9
1432642|NCT02382640|3507502|P2|STARTED|Washout Period 3 (7 Days)||9
1432643|NCT02382640|3507503|P1|STARTED|Washout Period 3 (7 Days)||9
1432644|NCT02382640|3507500|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1432645|NCT02382640|3507501|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1432646|NCT02382640|3507502|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1432647|NCT02382640|3507503|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
1432648|NCT02382640|3507500|P4|COMPLETED|Intervention Period 3 (3 Days)||9
1432649|NCT02382640|3507501|P3|COMPLETED|Intervention Period 3 (3 Days)||9
1432650|NCT02382640|3507502|P2|COMPLETED|Intervention Period 3 (3 Days)||9
1432651|NCT02382640|3507503|P1|COMPLETED|Intervention Period 3 (3 Days)||9
1432652|NCT02382640|3507500|P4|STARTED|Intervention Period 3 (3 Days)||9
1432653|NCT02382640|3507501|P3|STARTED|Intervention Period 3 (3 Days)||9
1432654|NCT02382640|3507502|P2|STARTED|Intervention Period 3 (3 Days)||9
1432655|NCT02382640|3507503|P1|STARTED|Intervention Period 3 (3 Days)||9
1432656|NCT02382640|3507500|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1432657|NCT02382640|3507501|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1432658|NCT02382640|3507502|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1432659|NCT02382640|3507503|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1432660|NCT02382640|3507500|P4|COMPLETED|Washout Period 2 (7 Days)||9
1432661|NCT02382640|3507501|P3|COMPLETED|Washout Period 2 (7 Days)||9
1432662|NCT02382640|3507502|P2|COMPLETED|Washout Period 2 (7 Days)||9
1432663|NCT02382640|3507503|P1|COMPLETED|Washout Period 2 (7 Days)||9
1432664|NCT02382640|3507500|P4|STARTED|Washout Period 2 (7 Days)||9
1432665|NCT02382640|3507501|P3|STARTED|Washout Period 2 (7 Days)||9
1432666|NCT02382640|3507502|P2|STARTED|Washout Period 2 (7 Days)||9
1432667|NCT02382640|3507503|P1|STARTED|Washout Period 2 (7 Days)||9
1432668|NCT02382640|3507500|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1432669|NCT02382640|3507501|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1432670|NCT02382640|3507502|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1432671|NCT02382640|3507503|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
1432672|NCT02382640|3507500|P4|COMPLETED|Intervention Period 2 (3 Days)||9
1432673|NCT02382640|3507501|P3|COMPLETED|Intervention Period 2 (3 Days)||9
1432674|NCT02382640|3507502|P2|COMPLETED|Intervention Period 2 (3 Days)||9
1432675|NCT02382640|3507503|P1|COMPLETED|Intervention Period 2 (3 Days)||9
1432676|NCT02382640|3507500|P4|STARTED|Intervention Period 2 (3 Days)||9
1432677|NCT02382640|3507501|P3|STARTED|Intervention Period 2 (3 Days)||9
1432678|NCT02382640|3507502|P2|STARTED|Intervention Period 2 (3 Days)||9
1432679|NCT02382640|3507503|P1|STARTED|Intervention Period 2 (3 Days)||9
1432680|NCT02382640|3507500|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1432681|NCT02382640|3507501|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1432682|NCT02382640|3507502|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1432683|NCT02382640|3507503|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1432684|NCT02382640|3507500|P4|COMPLETED|Washout Period 1 (7 Days)||9
1432685|NCT02382640|3507501|P3|COMPLETED|Washout Period 1 (7 Days)||9
1432686|NCT02382640|3507502|P2|COMPLETED|Washout Period 1 (7 Days)||9
1432687|NCT02382640|3507503|P1|COMPLETED|Washout Period 1 (7 Days)||9
1432688|NCT02382640|3507500|P4|STARTED|Washout Period 1 (7 Days)||9
1432689|NCT02382640|3507501|P3|STARTED|Washout Period 1 (7 Days)||9
1432690|NCT02382640|3507502|P2|STARTED|Washout Period 1 (7 Days)||9
1432691|NCT02382640|3507503|P1|STARTED|Washout Period 1 (7 Days)||9
1432692|NCT02382640|3507500|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1432693|NCT02382640|3507501|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1432694|NCT02382640|3507502|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1432695|NCT02382640|3507503|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
1432696|NCT02382640|3507500|P4|COMPLETED|Intervention Period 1 (3 Days)||9
1432697|NCT02382640|3507501|P3|COMPLETED|Intervention Period 1 (3 Days)||9
1432698|NCT02382640|3507502|P2|COMPLETED|Intervention Period 1 (3 Days)||9
1432699|NCT02382640|3507503|P1|COMPLETED|Intervention Period 1 (3 Days)||9
1432700|NCT02382640|3507500|P4|STARTED|Intervention Period 1 (3 Days)||9
1432701|NCT02382640|3507501|P3|STARTED|Intervention Period 1 (3 Days)||9
1432702|NCT02382640|3507502|P2|STARTED|Intervention Period 1 (3 Days)||9
1432703|NCT02382640|3507503|P1|STARTED|Intervention Period 1 (3 Days)||9
1432704|NCT02382133|3507541|P1|NOT COMPLETED|Overall Study||33
1432705|NCT02382133|3507541|P1|COMPLETED|Overall Study||10
1432706|NCT02382133|3507541|P1|STARTED|Overall Study||43
1432707|NCT02382016|3507548|P2|NOT COMPLETED|Overall Study||1
1432708|NCT02382016|3507549|P1|NOT COMPLETED|Overall Study||4
1432709|NCT02382016|3507548|P2|COMPLETED|Overall Study||41
1432710|NCT02382016|3507549|P1|COMPLETED|Overall Study||39
1432711|NCT02382016|3507548|P2|STARTED|Overall Study||42
1432712|NCT02382016|3507549|P1|STARTED|Overall Study||43
1432713|NCT02381795|3507571|P1|NOT COMPLETED|Overall Study||3
1432714|NCT02381795|3507571|P1|COMPLETED|Overall Study||7
1432715|NCT02381795|3507571|P1|STARTED|Overall Study||10
1432716|NCT02381678|3507575|P3|NOT COMPLETED|Overall Study||0
1432717|NCT02381678|3507576|P2|NOT COMPLETED|Overall Study||0
1432718|NCT02381678|3507577|P1|NOT COMPLETED|Overall Study||0
1432719|NCT02381678|3507575|P3|COMPLETED|Overall Study||32
1432720|NCT02381678|3507576|P2|COMPLETED|Overall Study||139
1432721|NCT02381678|3507577|P1|COMPLETED|Overall Study||54
1432722|NCT02381678|3507575|P3|STARTED|Overall Study||32
1432723|NCT02381678|3507576|P2|STARTED|Overall Study||139
1432724|NCT02381678|3507577|P1|STARTED|Overall Study||54
1432725|NCT02381418|3507583|P1|NOT COMPLETED|Overall Study||0
1432726|NCT02381418|3507583|P1|COMPLETED|Overall Study||120
1432727|NCT02381418|3507583|P1|STARTED|Overall Study||120
1432728|NCT02381392|3507591|P2|NOT COMPLETED|Overall Study||0
1432729|NCT02381392|3507592|P1|NOT COMPLETED|Overall Study||0
1432730|NCT02381392|3507591|P2|COMPLETED|Overall Study||12
1432731|NCT02381392|3507592|P1|COMPLETED|Overall Study||11
1432732|NCT02381392|3507591|P2|STARTED|Overall Study||12
1432733|NCT02381392|3507592|P1|STARTED|Overall Study||11
1432734|NCT02381288|3507610|P4|NOT COMPLETED|Overall Study||0
1432735|NCT02381288|3507611|P3|NOT COMPLETED|Overall Study||0
1432736|NCT02381288|3507612|P2|NOT COMPLETED|Overall Study||0
1432737|NCT02381288|3507613|P1|NOT COMPLETED|Overall Study||0
1432738|NCT02381288|3507610|P4|COMPLETED|Overall Study||5
1432739|NCT02381288|3507611|P3|COMPLETED|Overall Study||5
1432740|NCT02381288|3507612|P2|COMPLETED|Overall Study||2
1432741|NCT02381288|3507613|P1|COMPLETED|Overall Study||5
1432742|NCT02381288|3507610|P4|STARTED|Overall Study||5
1432743|NCT02381288|3507611|P3|STARTED|Overall Study||5
1432744|NCT02381288|3507612|P2|STARTED|Overall Study||2
1432745|NCT02381288|3507613|P1|STARTED|Overall Study||5
1432746|NCT02380742|3507642|P2|NOT COMPLETED|Overall Study||0
1432747|NCT02380742|3507643|P1|NOT COMPLETED|Overall Study||1
1432748|NCT02380742|3507642|P2|COMPLETED|Overall Study||26
1432749|NCT02380742|3507643|P1|COMPLETED|Overall Study||27
1432750|NCT02380742|3507642|P2|STARTED|Overall Study||26
1432751|NCT02380742|3507643|P1|STARTED|Overall Study||28
1432752|NCT02380287|3507663|P8|NOT COMPLETED|Overall Study||0
1432753|NCT02380287|3507664|P7|NOT COMPLETED|Overall Study||0
1432754|NCT02380287|3507665|P6|NOT COMPLETED|Overall Study||0
1432755|NCT02380287|3507666|P5|NOT COMPLETED|Overall Study||0
1432756|NCT02380287|3507667|P4|NOT COMPLETED|Overall Study||0
1432757|NCT02380287|3507668|P3|NOT COMPLETED|Overall Study||1
1432758|NCT02380287|3507669|P2|NOT COMPLETED|Overall Study||0
1432759|NCT02380287|3507670|P1|NOT COMPLETED|Overall Study||0
1432760|NCT02380287|3507663|P8|COMPLETED|Overall Study||3
1432761|NCT02380287|3507664|P7|COMPLETED|Overall Study||3
1432762|NCT02380287|3507665|P6|COMPLETED|Overall Study||3
1432763|NCT02380287|3507666|P5|COMPLETED|Overall Study||3
1432764|NCT02380287|3507667|P4|COMPLETED|Overall Study||3
1432765|NCT02380287|3507668|P3|COMPLETED|Overall Study||2
1432766|NCT02380287|3507669|P2|COMPLETED|Overall Study||3
1432767|NCT02380287|3507670|P1|COMPLETED|Overall Study||1
1432768|NCT02380287|3507663|P8|STARTED|Overall Study||3
1432769|NCT02380287|3507664|P7|STARTED|Overall Study||3
1432770|NCT02380287|3507665|P6|STARTED|Overall Study||3
1432771|NCT02380287|3507666|P5|STARTED|Overall Study||3
1432772|NCT02380287|3507667|P4|STARTED|Overall Study||3
1432773|NCT02380287|3507668|P3|STARTED|Overall Study||3
1432774|NCT02380287|3507669|P2|STARTED|Overall Study||3
1432775|NCT02380287|3507670|P1|STARTED|Overall Study||1
1432776|NCT02380261|3507681|P1|NOT COMPLETED|Overall Study||0
1432777|NCT02380261|3507681|P1|COMPLETED|Overall Study||35
1432778|NCT02380261|3507681|P1|STARTED|Overall Study||35
1432779|NCT02380248|3507686|P1|NOT COMPLETED|Overall Study||14
1432780|NCT02380248|3507686|P1|COMPLETED|Overall Study||186
1432781|NCT02380248|3507686|P1|STARTED|Overall Study||200
1432782|NCT02379923|3507691|P1|NOT COMPLETED|Overall Study||5
1432783|NCT02379923|3507691|P1|COMPLETED|Overall Study||158
1432784|NCT02379923|3507691|P1|STARTED|Overall Study||163
1432785|NCT02379637|3507707|P2|NOT COMPLETED|Overall Study||1
1432786|NCT02379637|3507708|P1|NOT COMPLETED|Overall Study||2
1432787|NCT02379637|3507707|P2|COMPLETED|Overall Study||34
1432788|NCT02379637|3507708|P1|COMPLETED|Overall Study||33
1432789|NCT02379637|3507707|P2|STARTED|Overall Study||35
1432790|NCT02379637|3507708|P1|STARTED|Overall Study||35
1432791|NCT02379585|3507718|P2|NOT COMPLETED|Overall Study||5
1432792|NCT02379585|3507719|P1|NOT COMPLETED|Overall Study||3
1432793|NCT02379585|3507718|P2|COMPLETED|Overall Study||0
1432794|NCT02379585|3507719|P1|COMPLETED|Overall Study||0
1432795|NCT02379585|3507718|P2|STARTED|Overall Study||5
1432796|NCT02379585|3507719|P1|STARTED|Overall Study||3
1432797|NCT02379221|3507741|P1|NOT COMPLETED|Overall Study||1
1432798|NCT02379221|3507741|P1|COMPLETED|Overall Study||48
1432799|NCT02379221|3507741|P1|STARTED|Overall Study||49
1432800|NCT02379091|3507760|P4|NOT COMPLETED|Overall Study||14
1432801|NCT02379091|3507761|P3|NOT COMPLETED|Overall Study||7
1432802|NCT02379091|3507762|P2|NOT COMPLETED|Overall Study||10
1432803|NCT02379091|3507763|P1|NOT COMPLETED|Overall Study||12
1432804|NCT02379091|3507760|P4|COMPLETED|Overall Study||14
1432805|NCT02379091|3507761|P3|COMPLETED|Overall Study||18
1432806|NCT02379091|3507762|P2|COMPLETED|Overall Study||18
1432807|NCT02379091|3507763|P1|COMPLETED|Overall Study||15
1432808|NCT02379091|3507760|P4|Full Analysis Set|Overall Study||28
1432809|NCT02379091|3507761|P3|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
1432810|NCT02379091|3507762|P2|Full Analysis Set|Overall Study||28
1432811|NCT02379091|3507763|P1|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
1432812|NCT02379091|3507760|P4|STARTED|Overall Study||28
1432813|NCT02379091|3507761|P3|STARTED|Overall Study||25
1432814|NCT02379091|3507762|P2|STARTED|Overall Study||28
1432815|NCT02379091|3507763|P1|STARTED|Overall Study||27
1432816|NCT02378961|3507803|P4|NOT COMPLETED|Overall Study||1
1432817|NCT02378961|3507804|P3|NOT COMPLETED|Overall Study||1
1432818|NCT02378961|3507805|P2|NOT COMPLETED|Overall Study||2
1432819|NCT02378961|3507806|P1|NOT COMPLETED|Overall Study||4
1432820|NCT02378961|3507803|P4|COMPLETED|Overall Study||28
1432821|NCT02378961|3507804|P3|COMPLETED|Overall Study||35
1432822|NCT02378961|3507805|P2|COMPLETED|Overall Study||28
1432823|NCT02378961|3507806|P1|COMPLETED|Overall Study||29
1432824|NCT02378961|3507803|P4|STARTED|Overall Study||29
1432825|NCT02378961|3507804|P3|STARTED|Overall Study||36
1432826|NCT02378961|3507805|P2|STARTED|Overall Study||30
1432827|NCT02378961|3507806|P1|STARTED|Overall Study||33
1432828|NCT02378935|3507843|P7|NOT COMPLETED|Overall Study||0
1432829|NCT02378935|3507844|P6|NOT COMPLETED|Overall Study||0
1432830|NCT02378935|3507845|P5|NOT COMPLETED|Overall Study||0
1432831|NCT02378935|3507846|P4|NOT COMPLETED|Overall Study||6
1432832|NCT02378935|3507847|P3|NOT COMPLETED|Overall Study||3
1432833|NCT02378935|3507848|P2|NOT COMPLETED|Overall Study||0
1432834|NCT02378935|3507849|P1|NOT COMPLETED|Overall Study||10
1432835|NCT02378935|3507843|P7|COMPLETED|Overall Study||8
1432836|NCT02378935|3507844|P6|COMPLETED|Overall Study||32
1432837|NCT02378935|3507845|P5|COMPLETED|Overall Study||31
1432838|NCT02378935|3507846|P4|COMPLETED|Overall Study||25
1432839|NCT02378935|3507847|P3|COMPLETED|Overall Study||30
1432840|NCT02378935|3507848|P2|COMPLETED|Overall Study||36
1432841|NCT02378935|3507849|P1|COMPLETED|Overall Study||24
1432842|NCT02378935|3507843|P7|STARTED|Overall Study||8
1432843|NCT02378935|3507844|P6|STARTED|Overall Study||32
1432844|NCT02378935|3507845|P5|STARTED|Overall Study||31
1432845|NCT02378935|3507846|P4|STARTED|Overall Study||31
1432846|NCT02378935|3507847|P3|STARTED|Overall Study||33
1432847|NCT02378935|3507848|P2|STARTED|Overall Study||36
1432848|NCT02378935|3507849|P1|STARTED|Overall Study||34
1432849|NCT02378753|3507902|P2|NOT COMPLETED|Overall Study||695
1432850|NCT02378753|3507903|P1|NOT COMPLETED|Overall Study||218
1432851|NCT02378753|3507902|P2|COMPLETED|Overall Study||3637
1432852|NCT02378753|3507903|P1|COMPLETED|Overall Study||4101
1432853|NCT02378753|3507902|P2|STARTED|Overall Study||4332
1432854|NCT02378753|3507903|P1|STARTED|Overall Study||4319
1432855|NCT02378662|3507923|P2|NOT COMPLETED|Overall Study||0
1432856|NCT02378662|3507924|P1|NOT COMPLETED|Overall Study||2
1432857|NCT02378662|3507923|P2|COMPLETED|Overall Study||0
1432858|NCT02378662|3507924|P1|COMPLETED|Overall Study||0
1432859|NCT02378662|3507923|P2|Implantation|Overall Study||0
1432860|NCT02378662|3507924|P1|Implantation|Overall Study||2
1432861|NCT02378662|3507923|P2|Harvesting|Overall Study||0
1432862|NCT02378662|3507924|P1|Harvesting|Overall Study||2
1432863|NCT02378662|3507923|P2|STARTED|Overall Study||0
1432864|NCT02378662|3507924|P1|STARTED|Overall Study||2
1432865|NCT02378506|3507930|P1|NOT COMPLETED|Overall Study||25
1432866|NCT02378506|3507930|P1|COMPLETED|Overall Study||163
1432867|NCT02378506|3507930|P1|Treated|Overall Study||187
1432868|NCT02378506|3507930|P1|STARTED|Overall Study||188
1432869|NCT02378220|3507949|P2|NOT COMPLETED|Overall Study||1
1432870|NCT02378220|3507950|P1|NOT COMPLETED|Overall Study||6
1432871|NCT02378220|3507949|P2|COMPLETED|Overall Study||56
1432872|NCT02378220|3507950|P1|COMPLETED|Overall Study||47
1432873|NCT02378220|3507949|P2|STARTED|Overall Study||57
1432874|NCT02378220|3507950|P1|STARTED|Overall Study||53
1432875|NCT02377921|3507982|P2|NOT COMPLETED|Overall Study||1
1432876|NCT02377921|3507983|P1|NOT COMPLETED|Overall Study||1
1432877|NCT02377921|3507982|P2|COMPLETED|Overall Study||43
1432878|NCT02377921|3507983|P1|COMPLETED|Overall Study||44
1432879|NCT02377921|3507982|P2|STARTED|Overall Study||44
1432880|NCT02377921|3507983|P1|STARTED|Overall Study||45
1432881|NCT02377466|3508007|P2|NOT COMPLETED|Overall Study||2
1432882|NCT02377466|3508008|P1|NOT COMPLETED|Overall Study||0
1432883|NCT02377466|3508007|P2|COMPLETED|Overall Study||10
1432884|NCT02377466|3508008|P1|COMPLETED|Overall Study||13
1432885|NCT02377466|3508007|P2|Treated|Overall Study||10
1432886|NCT02377466|3508008|P1|Treated|Overall Study||13
1432887|NCT02377466|3508007|P2|STARTED|Overall Study||12
1432888|NCT02377466|3508008|P1|STARTED|Overall Study||13
1432889|NCT02377427|3508126|P5|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
1432890|NCT02377427|3508127|P4|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
1432891|NCT02377427|3508128|P3|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
1432892|NCT02377427|3508129|P2|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
1432893|NCT02377427|3508130|P1|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
1432894|NCT02377427|3508126|P5|COMPLETED|Part B (From Week 20 and up to Week 80)||4
1432895|NCT02377427|3508127|P4|COMPLETED|Part B (From Week 20 and up to Week 80)||10
1432896|NCT02377427|3508128|P3|COMPLETED|Part B (From Week 20 and up to Week 80)||15
1432897|NCT02377427|3508129|P2|COMPLETED|Part B (From Week 20 and up to Week 80)||0
1432898|NCT02377427|3508130|P1|COMPLETED|Part B (From Week 20 and up to Week 80)||0
1432899|NCT02377427|3508126|P5|STARTED|Part B (From Week 20 and up to Week 80)||4
1432900|NCT02377427|3508127|P4|STARTED|Part B (From Week 20 and up to Week 80)||10
1432901|NCT02377427|3508128|P3|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
1432902|NCT02377427|3508129|P2|STARTED|Part B (From Week 20 and up to Week 80)||0
1432903|NCT02377427|3508130|P1|STARTED|Part B (From Week 20 and up to Week 80)||0
1432904|NCT02377427|3508126|P5|NOT COMPLETED|Part A (Up to Week 20)||0
1432905|NCT02377427|3508127|P4|NOT COMPLETED|Part A (Up to Week 20)||0
1432906|NCT02377427|3508128|P3|NOT COMPLETED|Part A (Up to Week 20)||0
1432907|NCT02377427|3508129|P2|NOT COMPLETED|Part A (Up to Week 20)||0
1432908|NCT02377427|3508130|P1|NOT COMPLETED|Part A (Up to Week 20)||4
1432909|NCT02377427|3508126|P5|COMPLETED|Part A (Up to Week 20)||0
1432910|NCT02377427|3508127|P4|COMPLETED|Part A (Up to Week 20)||0
1432911|NCT02377427|3508128|P3|COMPLETED|Part A (Up to Week 20)||0
1432912|NCT02377427|3508129|P2|COMPLETED|Part A (Up to Week 20)||10
1432913|NCT02377427|3508130|P1|COMPLETED|Part A (Up to Week 20)||22
1432914|NCT02377427|3508126|P5|STARTED|Part A (Up to Week 20)||0
1432915|NCT02377427|3508127|P4|STARTED|Part A (Up to Week 20)||0
1432916|NCT02377427|3508128|P3|STARTED|Part A (Up to Week 20)||0
1432917|NCT02377427|3508129|P2|STARTED|Part A (Up to Week 20)||10
1432918|NCT02377427|3508130|P1|STARTED|Part A (Up to Week 20)||26
1432919|NCT02376998|3508190|P1|NOT COMPLETED|Overall Study||9
1432920|NCT02376998|3508190|P1|COMPLETED|Overall Study||11
1432921|NCT02376998|3508190|P1|STARTED|Overall Study||20
1432922|NCT02376933|3508194|P1|NOT COMPLETED|Overall Study||2
1432923|NCT02376933|3508194|P1|COMPLETED|Overall Study||8
1432924|NCT02376933|3508194|P1|STARTED|Overall Study||10
1432925|NCT02376530|3508205|P4|NOT COMPLETED|Overall Study||0
1432926|NCT02376530|3508206|P3|NOT COMPLETED|Overall Study||0
1432927|NCT02376530|3508207|P2|NOT COMPLETED|Overall Study||0
1432928|NCT02376530|3508208|P1|NOT COMPLETED|Overall Study||0
1432929|NCT02376530|3508205|P4|COMPLETED|Overall Study||197
1432930|NCT02376530|3508206|P3|COMPLETED|Overall Study||197
1432931|NCT02376530|3508207|P2|COMPLETED|Overall Study||198
1432932|NCT02376530|3508208|P1|COMPLETED|Overall Study||196
1432933|NCT02376530|3508205|P4|STARTED|Overall Study||197
1432934|NCT02376530|3508206|P3|STARTED|Overall Study||197
1432935|NCT02376530|3508207|P2|STARTED|Overall Study||198
1432936|NCT02376530|3508208|P1|STARTED|Overall Study||196
1432937|NCT02376257|3508221|P3|NOT COMPLETED|Overall Study||0
1432938|NCT02376257|3508222|P2|NOT COMPLETED|Overall Study||0
1432939|NCT02376257|3508223|P1|NOT COMPLETED|Overall Study||0
1432940|NCT02376257|3508221|P3|COMPLETED|Overall Study||11
1432941|NCT02376257|3508222|P2|COMPLETED|Overall Study||12
1432942|NCT02376257|3508223|P1|COMPLETED|Overall Study||13
1432943|NCT02376257|3508221|P3|STARTED|Overall Study||11
1432944|NCT02376257|3508222|P2|STARTED|Overall Study||12
1432945|NCT02376257|3508223|P1|STARTED|Overall Study||13
1432946|NCT02376166|3508252|P1|NOT COMPLETED|Overall Study||3
1432947|NCT02376166|3508252|P1|COMPLETED|Overall Study||12
1432948|NCT02376166|3508252|P1|STARTED|Overall Study||15
1432949|NCT02375971|3508280|P3|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
1432950|NCT02375971|3508281|P2|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
1432951|NCT02375971|3508282|P1|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
1432952|NCT02375971|3508280|P3|COMPLETED|Follow-Up Phase (up to Day 169)||64
1432953|NCT02375971|3508281|P2|COMPLETED|Follow-Up Phase (up to Day 169)||71
1432954|NCT02375971|3508282|P1|COMPLETED|Follow-Up Phase (up to Day 169)||66
1432955|NCT02375971|3508280|P3|STARTED|Follow-Up Phase (up to Day 169)||69
1432956|NCT02375971|3508281|P2|STARTED|Follow-Up Phase (up to Day 169)||76
1432957|NCT02375971|3508282|P1|STARTED|Follow-Up Phase (up to Day 169)||73
1432958|NCT02375971|3508280|P3|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
1432959|NCT02375971|3508281|P2|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
1432960|NCT02375971|3508282|P1|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
1432961|NCT02375971|3508280|P3|COMPLETED|Treatment (Day 1 - Baseline)||69
1432962|NCT02375971|3508281|P2|COMPLETED|Treatment (Day 1 - Baseline)||76
1432963|NCT02375971|3508282|P1|COMPLETED|Treatment (Day 1 - Baseline)||73
1432964|NCT02375971|3508280|P3|PK Set|Treatment (Day 1 - Baseline)||0
1432965|NCT02375971|3508281|P2|PK Set|Treatment (Day 1 - Baseline)||46
1432966|NCT02375971|3508282|P1|PK Set|Treatment (Day 1 - Baseline)||49
1432967|NCT02375971|3508280|P3|VEGF Set|Treatment (Day 1 - Baseline)||51
1432968|NCT02375971|3508281|P2|VEGF Set|Treatment (Day 1 - Baseline)||26
1432969|NCT02375971|3508282|P1|VEGF Set|Treatment (Day 1 - Baseline)||19
1432970|NCT02375971|3508280|P3|Safety Set|Treatment (Day 1 - Baseline)||69
1432971|NCT02375971|3508281|P2|Safety Set|Treatment (Day 1 - Baseline)||76
1432972|NCT02375971|3508282|P1|Safety Set|Treatment (Day 1 - Baseline)||73
1432973|NCT02375971|3508280|P3|STARTED|Treatment (Day 1 - Baseline)||74
1432974|NCT02375971|3508281|P2|STARTED|Treatment (Day 1 - Baseline)||77
1432975|NCT02375971|3508282|P1|STARTED|Treatment (Day 1 - Baseline)||74
1432976|NCT02375724|3508324|P2|NOT COMPLETED|Overall Study||6
1432977|NCT02375724|3508325|P1|NOT COMPLETED|Overall Study||6
1432978|NCT02375724|3508324|P2|COMPLETED|Overall Study||128
1432979|NCT02375724|3508325|P1|COMPLETED|Overall Study||129
1432980|NCT02375724|3508324|P2|STARTED|Overall Study||134
1432981|NCT02375724|3508325|P1|STARTED|Overall Study||135
1432982|NCT02375373|3508335|P1|NOT COMPLETED|Overall Study||11
1432983|NCT02375373|3508335|P1|COMPLETED|Overall Study||1
1432984|NCT02375373|3508335|P1|STARTED|Overall Study||12
1432985|NCT02375347|3508339|P1|NOT COMPLETED|Overall Study||1
1432986|NCT02375347|3508339|P1|COMPLETED|Overall Study||12
1432987|NCT02375347|3508339|P1|STARTED|Overall Study||13
1432988|NCT02374957|3508345|P2|NOT COMPLETED|Overall Study||0
1432989|NCT02374957|3508346|P1|NOT COMPLETED|Overall Study||1
1432990|NCT02374957|3508345|P2|COMPLETED|Overall Study||9
1432991|NCT02374957|3508346|P1|COMPLETED|Overall Study||10
1432992|NCT02374957|3508345|P2|STARTED|Overall Study||9
1432993|NCT02374957|3508346|P1|STARTED|Overall Study||11
1432994|NCT02374593|3508374|P2|NOT COMPLETED|Overall Study||0
1432995|NCT02374593|3508375|P1|NOT COMPLETED|Overall Study||2
1432996|NCT02374593|3508374|P2|COMPLETED|Overall Study||44
1432997|NCT02374593|3508375|P1|COMPLETED|Overall Study||22
1432998|NCT02374593|3508374|P2|STARTED|Overall Study||44
1432999|NCT02374593|3508375|P1|STARTED|Overall Study||24
1433000|NCT02374398|3508389|P4|NOT COMPLETED|Overall Study||0
1433001|NCT02374398|3508390|P3|NOT COMPLETED|Overall Study||3
1433002|NCT02374398|3508391|P2|NOT COMPLETED|Overall Study||1
1433003|NCT02374398|3508392|P1|NOT COMPLETED|Overall Study||2
1433004|NCT02374398|3508389|P4|COMPLETED|Overall Study||32
1433005|NCT02374398|3508390|P3|COMPLETED|Overall Study||29
1433006|NCT02374398|3508391|P2|COMPLETED|Overall Study||31
1433007|NCT02374398|3508392|P1|COMPLETED|Overall Study||29
1433008|NCT02374398|3508389|P4|STARTED|Overall Study||32
1433009|NCT02374398|3508390|P3|STARTED|Overall Study||32
1433010|NCT02374398|3508391|P2|STARTED|Overall Study||32
1433011|NCT02374398|3508392|P1|STARTED|Overall Study||31
1433012|NCT02374346|3508418|P1|NOT COMPLETED|Overall Study||48
1433013|NCT02374346|3508418|P1|COMPLETED|Overall Study||446
1433014|NCT02374346|3508418|P1|STARTED|Overall Study||494
1433015|NCT02374164|3508427|P3|NOT COMPLETED|Treatment Period 3||0
1433016|NCT02374164|3508428|P2|NOT COMPLETED|Treatment Period 3||0
1433017|NCT02374164|3508429|P1|NOT COMPLETED|Treatment Period 3||0
1433018|NCT02374164|3508427|P3|COMPLETED|Treatment Period 3||12
1433019|NCT02374164|3508428|P2|COMPLETED|Treatment Period 3||11
1433020|NCT02374164|3508429|P1|COMPLETED|Treatment Period 3||12
1433021|NCT02374164|3508427|P3|STARTED|Treatment Period 3||12
1433022|NCT02374164|3508428|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
1433023|NCT02374164|3508429|P1|STARTED|Treatment Period 3||12
1433024|NCT02374164|3508427|P3|NOT COMPLETED|Treatment Period 2||0
1433025|NCT02374164|3508428|P2|NOT COMPLETED|Treatment Period 2||0
1433026|NCT02374164|3508429|P1|NOT COMPLETED|Treatment Period 2||0
1433027|NCT02374164|3508427|P3|COMPLETED|Treatment Period 2||12
1433028|NCT02374164|3508428|P2|COMPLETED|Treatment Period 2||12
1433029|NCT02374164|3508429|P1|COMPLETED|Treatment Period 2||12
1433030|NCT02374164|3508427|P3|STARTED|Treatment Period 2||12
1433031|NCT02374164|3508428|P2|STARTED|Treatment Period 2||12
1433032|NCT02374164|3508429|P1|STARTED|Treatment Period 2||12
1433033|NCT02374164|3508427|P3|NOT COMPLETED|Treatment Period 1||0
1433034|NCT02374164|3508428|P2|NOT COMPLETED|Treatment Period 1||0
1433035|NCT02374164|3508429|P1|NOT COMPLETED|Treatment Period 1||0
1433036|NCT02374164|3508427|P3|COMPLETED|Treatment Period 1||12
1433037|NCT02374164|3508428|P2|COMPLETED|Treatment Period 1||12
1433038|NCT02374164|3508429|P1|COMPLETED|Treatment Period 1||12
1433039|NCT02374164|3508427|P3|STARTED|Treatment Period 1||12
1433040|NCT02374164|3508428|P2|STARTED|Treatment Period 1||12
1433041|NCT02374164|3508429|P1|STARTED|Treatment Period 1||12
1433042|NCT02374099|3508448|P2|NOT COMPLETED|Overall Study||49
1433043|NCT02374099|3508449|P1|NOT COMPLETED|Overall Study||48
1433044|NCT02374099|3508448|P2|COMPLETED|Overall Study||0
1433045|NCT02374099|3508449|P1|COMPLETED|Overall Study||0
1433046|NCT02374099|3508448|P2|Participants Treated|Overall Study|1 participant randomized, but not treated|48
1433047|NCT02374099|3508449|P1|Participants Treated|Overall Study|2 participants randomized, but not treated|46
1433048|NCT02374099|3508448|P2|STARTED|Overall Study||49
1433049|NCT02374099|3508449|P1|STARTED|Overall Study||48
1433050|NCT02374060|3508468|P3|NOT COMPLETED|Overall Study||3
1433051|NCT02374060|3508469|P2|NOT COMPLETED|Overall Study||1
1433052|NCT02374060|3508470|P1|NOT COMPLETED|Overall Study||2
1433053|NCT02374060|3508468|P3|COMPLETED|Overall Study||61
1433054|NCT02374060|3508469|P2|COMPLETED|Overall Study||62
1433055|NCT02374060|3508470|P1|COMPLETED|Overall Study||63
1433056|NCT02374060|3508468|P3|STARTED|Overall Study||64
1433057|NCT02374060|3508469|P2|STARTED|Overall Study||63
1433058|NCT02374060|3508470|P1|STARTED|Overall Study||65
1433059|NCT02373202|3508524|P4|NOT COMPLETED|Overall Study||1
1433060|NCT02373202|3508525|P3|NOT COMPLETED|Overall Study||3
1433061|NCT02373202|3508526|P2|NOT COMPLETED|Overall Study||6
1433062|NCT02373202|3508527|P1|NOT COMPLETED|Overall Study||2
1433063|NCT02373202|3508524|P4|COMPLETED|Overall Study||30
1433064|NCT02373202|3508525|P3|COMPLETED|Overall Study||27
1433065|NCT02373202|3508526|P2|COMPLETED|Overall Study||9
1433066|NCT02373202|3508527|P1|COMPLETED|Overall Study||13
1433067|NCT02373202|3508524|P4|STARTED|Overall Study||31
1433068|NCT02373202|3508525|P3|STARTED|Overall Study||30
1433069|NCT02373202|3508526|P2|STARTED|Overall Study||15
1433070|NCT02373202|3508527|P1|STARTED|Overall Study||15
1433071|NCT02372396|3508579|P2|NOT COMPLETED|Overall Study||9
1433072|NCT02372396|3508580|P1|NOT COMPLETED|Overall Study||7
1433073|NCT02372396|3508579|P2|COMPLETED|Overall Study||11
1433074|NCT02372396|3508580|P1|COMPLETED|Overall Study||10
1433075|NCT02372396|3508579|P2|Began Intervention|Overall Study||14
1433076|NCT02372396|3508580|P1|Began Intervention|Overall Study||14
1433077|NCT02372396|3508579|P2|STARTED|Overall Study||20
1433078|NCT02372396|3508580|P1|STARTED|Overall Study||17
1433079|NCT02372344|3508586|P3|NOT COMPLETED|Period 3 (Visit 4)||0
1433080|NCT02372344|3508587|P2|NOT COMPLETED|Period 3 (Visit 4)||0
1433081|NCT02372344|3508588|P1|NOT COMPLETED|Period 3 (Visit 4)||0
1433082|NCT02372344|3508586|P3|COMPLETED|Period 3 (Visit 4)||14
1433083|NCT02372344|3508587|P2|COMPLETED|Period 3 (Visit 4)||14
1433084|NCT02372344|3508588|P1|COMPLETED|Period 3 (Visit 4)||14
1433085|NCT02372344|3508586|P3|STARTED|Period 3 (Visit 4)||14
1433086|NCT02372344|3508587|P2|STARTED|Period 3 (Visit 4)||14
1433087|NCT02372344|3508588|P1|STARTED|Period 3 (Visit 4)||14
1433088|NCT02372344|3508586|P3|NOT COMPLETED|Period 2 (Visit 3)||0
1433089|NCT02372344|3508587|P2|NOT COMPLETED|Period 2 (Visit 3)||0
1433090|NCT02372344|3508588|P1|NOT COMPLETED|Period 2 (Visit 3)||0
1433091|NCT02372344|3508586|P3|COMPLETED|Period 2 (Visit 3)||14
1433092|NCT02372344|3508587|P2|COMPLETED|Period 2 (Visit 3)||14
1433093|NCT02372344|3508588|P1|COMPLETED|Period 2 (Visit 3)||14
1433094|NCT02372344|3508586|P3|STARTED|Period 2 (Visit 3)||14
1433095|NCT02372344|3508587|P2|STARTED|Period 2 (Visit 3)||14
1433096|NCT02372344|3508588|P1|STARTED|Period 2 (Visit 3)||14
1433097|NCT02372344|3508586|P3|NOT COMPLETED|Period 1 (Visit 2)||0
1433098|NCT02372344|3508587|P2|NOT COMPLETED|Period 1 (Visit 2)||0
1433099|NCT02372344|3508588|P1|NOT COMPLETED|Period 1 (Visit 2)||0
1433100|NCT02372344|3508586|P3|COMPLETED|Period 1 (Visit 2)||14
1433101|NCT02372344|3508587|P2|COMPLETED|Period 1 (Visit 2)||14
1433102|NCT02372344|3508588|P1|COMPLETED|Period 1 (Visit 2)||14
1433103|NCT02372344|3508586|P3|STARTED|Period 1 (Visit 2)||14
1433104|NCT02372344|3508587|P2|STARTED|Period 1 (Visit 2)||14
1433105|NCT02372344|3508588|P1|STARTED|Period 1 (Visit 2)||14
1433106|NCT02372097|3508604|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
1433107|NCT02372097|3508605|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
1433108|NCT02372097|3508604|P2|COMPLETED|Second Intervention Period (8 Days)||12
1433109|NCT02372097|3508605|P1|COMPLETED|Second Intervention Period (8 Days)||12
1433110|NCT02372097|3508604|P2|STARTED|Second Intervention Period (8 Days)||12
1433111|NCT02372097|3508605|P1|STARTED|Second Intervention Period (8 Days)||12
1433112|NCT02372097|3508604|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
1433113|NCT02372097|3508605|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
1433114|NCT02372097|3508604|P2|COMPLETED|Wash Out Period (13 Days)||12
1433115|NCT02372097|3508605|P1|COMPLETED|Wash Out Period (13 Days)||12
1433116|NCT02372097|3508604|P2|STARTED|Wash Out Period (13 Days)||12
1433117|NCT02372097|3508605|P1|STARTED|Wash Out Period (13 Days)||12
1433118|NCT02372097|3508604|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
1433119|NCT02372097|3508605|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
1433120|NCT02372097|3508604|P2|COMPLETED|First Intervention Period (8 Days)||12
1433121|NCT02372097|3508605|P1|COMPLETED|First Intervention Period (8 Days)||12
1433122|NCT02372097|3508604|P2|STARTED|First Intervention Period (8 Days)||12
1433123|NCT02372097|3508605|P1|STARTED|First Intervention Period (8 Days)||12
1433124|NCT02372071|3508631|P1|NOT COMPLETED|Overall Study||18
1433125|NCT02372071|3508631|P1|COMPLETED|Overall Study||93
1433126|NCT02372071|3508631|P1|STARTED|Overall Study||111
1433127|NCT02372058|3508636|P1|NOT COMPLETED|Overall Study||3
1433128|NCT02372058|3508636|P1|COMPLETED|Overall Study||100
1433129|NCT02372058|3508636|P1|STARTED|Overall Study||103
1433130|NCT02371876|3508642|P1|NOT COMPLETED|Overall Study||0
1433131|NCT02371876|3508642|P1|COMPLETED|Overall Study||134
1433132|NCT02371876|3508642|P1|STARTED|Overall Study||134
1433133|NCT02371850|3508652|P1|NOT COMPLETED|Overall Study||0
1433134|NCT02371850|3508652|P1|COMPLETED|Overall Study||10
1433135|NCT02371850|3508652|P1|STARTED|Overall Study||10
1433136|NCT02371759|3508665|P8|NOT COMPLETED|Overall Study||4
1433137|NCT02371759|3508666|P7|NOT COMPLETED|Overall Study||0
1433138|NCT02371759|3508667|P6|NOT COMPLETED|Overall Study||1
1433139|NCT02371759|3508668|P5|NOT COMPLETED|Overall Study||3
1433140|NCT02371759|3508669|P4|NOT COMPLETED|Overall Study||0
1433141|NCT02371759|3508670|P3|NOT COMPLETED|Overall Study||1
1433142|NCT02371759|3508671|P2|NOT COMPLETED|Overall Study||1
1433143|NCT02371759|3508672|P1|NOT COMPLETED|Overall Study||3
1433144|NCT02371759|3508665|P8|COMPLETED|Overall Study||24
1433145|NCT02371759|3508666|P7|COMPLETED|Overall Study||25
1433146|NCT02371759|3508667|P6|COMPLETED|Overall Study||25
1433147|NCT02371759|3508668|P5|COMPLETED|Overall Study||24
1433148|NCT02371759|3508669|P4|COMPLETED|Overall Study||31
1433149|NCT02371759|3508670|P3|COMPLETED|Overall Study||32
1433150|NCT02371759|3508671|P2|COMPLETED|Overall Study||30
1433151|NCT02371759|3508672|P1|COMPLETED|Overall Study||29
1433152|NCT02371759|3508665|P8|STARTED|Overall Study||28
1433153|NCT02371759|3508666|P7|STARTED|Overall Study||25
1433154|NCT02371759|3508667|P6|STARTED|Overall Study||26
1433155|NCT02371759|3508668|P5|STARTED|Overall Study||27
1433156|NCT02371759|3508669|P4|STARTED|Overall Study||31
1433157|NCT02371759|3508670|P3|STARTED|Overall Study||33
1433158|NCT02371759|3508671|P2|STARTED|Overall Study||31
1433159|NCT02371759|3508672|P1|STARTED|Overall Study||32
1433160|NCT02371616|3508884|P2|NOT COMPLETED|Overall Study||7
1433161|NCT02371616|3508885|P1|NOT COMPLETED|Overall Study||4
1433162|NCT02371616|3508884|P2|COMPLETED|Overall Study||147
1433163|NCT02371616|3508885|P1|COMPLETED|Overall Study||146
1433164|NCT02371616|3508884|P2|STARTED|Overall Study||154
1433165|NCT02371616|3508885|P1|STARTED|Overall Study||150
1433166|NCT02371395|3508897|P1|NOT COMPLETED|Overall Study||0
1433167|NCT02371395|3508897|P1|COMPLETED|Overall Study||1000
1433168|NCT02371395|3508897|P1|STARTED|Overall Study||1000
1433169|NCT02370914|3508901|P1|NOT COMPLETED|Overall Study||2
1433170|NCT02370914|3508901|P1|COMPLETED|Overall Study||82
1433171|NCT02370914|3508901|P1|STARTED|Overall Study||84
1433172|NCT02370667|3508908|P3|NOT COMPLETED|Overall Study||0
1433173|NCT02370667|3508909|P2|NOT COMPLETED|Overall Study||1
1433174|NCT02370667|3508910|P1|NOT COMPLETED|Overall Study||0
1433175|NCT02370667|3508908|P3|COMPLETED|Overall Study||10
1433176|NCT02370667|3508909|P2|COMPLETED|Overall Study||10
1433177|NCT02370667|3508910|P1|COMPLETED|Overall Study||10
1433178|NCT02370667|3508908|P3|STARTED|Overall Study||10
1433179|NCT02370667|3508909|P2|STARTED|Overall Study||11
1433180|NCT02370667|3508910|P1|STARTED|Overall Study||10
1433181|NCT02370615|3508974|P2|NOT COMPLETED|Overall Study||0
1433182|NCT02370615|3508975|P1|NOT COMPLETED|Overall Study||1
1433183|NCT02370615|3508974|P2|COMPLETED|Overall Study||18
1433184|NCT02370615|3508975|P1|COMPLETED|Overall Study||15
1433185|NCT02370615|3508974|P2|STARTED|Overall Study||18
1433186|NCT02370615|3508975|P1|STARTED|Overall Study||16
1433187|NCT02370602|3509018|P6|NOT COMPLETED|Overall Study||0
1433188|NCT02370602|3509019|P5|NOT COMPLETED|Overall Study||0
1433189|NCT02370602|3509020|P4|NOT COMPLETED|Overall Study||0
1433190|NCT02370602|3509021|P3|NOT COMPLETED|Overall Study||0
1433191|NCT02370602|3509022|P2|NOT COMPLETED|Overall Study||0
1433192|NCT02370602|3509023|P1|NOT COMPLETED|Overall Study||1
1433193|NCT02370602|3509018|P6|COMPLETED|Overall Study||2
1433194|NCT02370602|3509019|P5|COMPLETED|Overall Study||3
1433195|NCT02370602|3509020|P4|COMPLETED|Overall Study||3
1433196|NCT02370602|3509021|P3|COMPLETED|Overall Study||2
1433197|NCT02370602|3509022|P2|COMPLETED|Overall Study||2
1433198|NCT02370602|3509023|P1|COMPLETED|Overall Study||0
1433199|NCT02370602|3509018|P6|STARTED|Overall Study||2
1433200|NCT02370602|3509019|P5|STARTED|Overall Study||3
1433201|NCT02370602|3509020|P4|STARTED|Overall Study||3
1433202|NCT02370602|3509021|P3|STARTED|Overall Study||2
1433203|NCT02370602|3509022|P2|STARTED|Overall Study||2
1433204|NCT02370602|3509023|P1|STARTED|Overall Study||1
1433205|NCT02370537|3509117|P3|NOT COMPLETED|Part B||259
1433206|NCT02370537|3509118|P2|NOT COMPLETED|Part B||3
1433207|NCT02370537|3509119|P1|NOT COMPLETED|Part B||1
1433208|NCT02370537|3509117|P3|COMPLETED|Part B||23
1433209|NCT02370537|3509118|P2|COMPLETED|Part B||12
1433210|NCT02370537|3509119|P1|COMPLETED|Part B||15
1433211|NCT02370537|3509117|P3|Period 2 Sequence BA|Part B||12
1433212|NCT02370537|3509118|P2|Period 2 Sequence BA|Part B||7
1433213|NCT02370537|3509119|P1|Period 2 Sequence BA|Part B||7
1433214|NCT02370537|3509117|P3|Period 2 Sequence AB|Part B||11
1433215|NCT02370537|3509118|P2|Period 2 Sequence AB|Part B||5
1433216|NCT02370537|3509119|P1|Period 2 Sequence AB|Part B||8
1433217|NCT02370537|3509117|P3|Period 1 Sequence BA|Part B||12
1433218|NCT02370537|3509118|P2|Period 1 Sequence BA|Part B||7
1433219|NCT02370537|3509119|P1|Period 1 Sequence BA|Part B||7
1433220|NCT02370537|3509117|P3|Period 1 Sequence AB|Part B||11
1433221|NCT02370537|3509118|P2|Period 1 Sequence AB|Part B||6
1433222|NCT02370537|3509119|P1|Period 1 Sequence AB|Part B||8
1433223|NCT02370537|3509117|P3|Eligible for Randomisation|Part B||23
1433224|NCT02370537|3509118|P2|Eligible for Randomisation|Part B||13
1433225|NCT02370537|3509119|P1|Eligible for Randomisation|Part B||15
1433226|NCT02370537|3509117|P3|STARTED|Part B||282
1433227|NCT02370537|3509118|P2|STARTED|Part B||15
1433228|NCT02370537|3509119|P1|STARTED|Part B||16
1433229|NCT02370537|3509117|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
1433230|NCT02370537|3509118|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
1433231|NCT02370537|3509119|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
1433232|NCT02370537|3509117|P3|COMPLETED|Part A (Open-label Recruitment)||282
1433233|NCT02370537|3509118|P2|COMPLETED|Part A (Open-label Recruitment)||15
1433234|NCT02370537|3509119|P1|COMPLETED|Part A (Open-label Recruitment)||16
1433235|NCT02370537|3509117|P3|STARTED|Part A (Open-label Recruitment)||283
1433236|NCT02370537|3509118|P2|STARTED|Part A (Open-label Recruitment)||16
1433237|NCT02370537|3509119|P1|STARTED|Part A (Open-label Recruitment)||16
1433238|NCT02370498|3509168|P2|NOT COMPLETED|Overall Study||296
1433239|NCT02370498|3509169|P1|NOT COMPLETED|Overall Study||296
1433240|NCT02370498|3509168|P2|COMPLETED|Overall Study||0
1433241|NCT02370498|3509169|P1|COMPLETED|Overall Study||0
1433242|NCT02370498|3509168|P2|PD-L1 Positive Participants|Overall Study||199
1433243|NCT02370498|3509169|P1|PD-L1 Positive Participants|Overall Study||196
1433244|NCT02370498|3509168|P2|Treated|Overall Study||276
1433245|NCT02370498|3509169|P1|Treated|Overall Study||294
1433246|NCT02370498|3509168|P2|STARTED|Overall Study||296
1433247|NCT02370498|3509169|P1|STARTED|Overall Study||296
1433248|NCT02370420|3509223|P2|NOT COMPLETED|Overall Study||12
1433249|NCT02370420|3509224|P1|NOT COMPLETED|Overall Study||14
1433250|NCT02370420|3509223|P2|COMPLETED|Overall Study||15
1433251|NCT02370420|3509224|P1|COMPLETED|Overall Study||15
1433252|NCT02370420|3509223|P2|STARTED|Overall Study||27
1433253|NCT02370420|3509224|P1|STARTED|Overall Study||29
1433254|NCT02370407|3509236|P2|NOT COMPLETED|Overall Study||0
1433255|NCT02370407|3509237|P1|NOT COMPLETED|Overall Study||0
1433256|NCT02370407|3509236|P2|COMPLETED|Overall Study||20
1433257|NCT02370407|3509237|P1|COMPLETED|Overall Study||20
1433258|NCT02370407|3509236|P2|STARTED|Overall Study||20
1433259|NCT02370407|3509237|P1|STARTED|Overall Study||20
1433260|NCT02370394|3509261|P2|NOT COMPLETED|Overall Study||2
1433261|NCT02370394|3509262|P1|NOT COMPLETED|Overall Study||2
1433262|NCT02370394|3509261|P2|COMPLETED|Overall Study||23
1433263|NCT02370394|3509262|P1|COMPLETED|Overall Study||26
1433264|NCT02370394|3509261|P2|STARTED|Overall Study||25
1433265|NCT02370394|3509262|P1|STARTED|Overall Study||28
1433266|NCT02370121|3509278|P2|NOT COMPLETED|Overall Study||1
1433267|NCT02370121|3509279|P1|NOT COMPLETED|Overall Study||1
1433268|NCT02370121|3509278|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
1433269|NCT02370121|3509279|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
1433270|NCT02370121|3509278|P2|STARTED|Overall Study||12
1433271|NCT02370121|3509279|P1|STARTED|Overall Study||12
1433272|NCT02369848|3509317|P1|NOT COMPLETED|Overall Study||4
1433273|NCT02369848|3509317|P1|COMPLETED|Overall Study||56
1433274|NCT02369848|3509317|P1|12 Month Primary Endpoint|Overall Study||30
1433275|NCT02369848|3509317|P1|30 Day Primary Safety Endpoint|Overall Study||58
1433276|NCT02369848|3509317|P1|STARTED|Overall Study||60
1433277|NCT02369796|3509336|P5|NOT COMPLETED|Overall Study||0
1433278|NCT02369796|3509337|P4|NOT COMPLETED|Overall Study||0
1433279|NCT02369796|3509338|P3|NOT COMPLETED|Overall Study||0
1433280|NCT02369796|3509339|P2|NOT COMPLETED|Overall Study||0
1433281|NCT02369796|3509340|P1|NOT COMPLETED|Overall Study||0
1433282|NCT02369796|3509336|P5|COMPLETED|Overall Study||3
1433283|NCT02369796|3509337|P4|COMPLETED|Overall Study||3
1433284|NCT02369796|3509338|P3|COMPLETED|Overall Study||3
1433285|NCT02369796|3509339|P2|COMPLETED|Overall Study||3
1433286|NCT02369796|3509340|P1|COMPLETED|Overall Study||3
1433287|NCT02369796|3509336|P5|STARTED|Overall Study||3
1433288|NCT02369796|3509337|P4|STARTED|Overall Study||3
1433289|NCT02369796|3509338|P3|STARTED|Overall Study||3
1433290|NCT02369796|3509339|P2|STARTED|Overall Study||3
1433291|NCT02369796|3509340|P1|STARTED|Overall Study||3
1433292|NCT02369510|3509382|P3|NOT COMPLETED|Overall Study||6
1433293|NCT02369510|3509383|P2|NOT COMPLETED|Overall Study||3
1433294|NCT02369510|3509384|P1|NOT COMPLETED|Overall Study||2
1433295|NCT02369510|3509382|P3|COMPLETED|Overall Study||17
1433296|NCT02369510|3509383|P2|COMPLETED|Overall Study||19
1433297|NCT02369510|3509384|P1|COMPLETED|Overall Study||21
1433298|NCT02369510|3509382|P3|STARTED|Overall Study||23
1433299|NCT02369510|3509383|P2|STARTED|Overall Study||22
1433300|NCT02369510|3509384|P1|STARTED|Overall Study||23
1433301|NCT02369341|3509415|P2|NOT COMPLETED|Overall Study||0
1433302|NCT02369341|3509416|P1|NOT COMPLETED|Overall Study||1
1433303|NCT02369341|3509415|P2|COMPLETED|Overall Study||57
1433304|NCT02369341|3509416|P1|COMPLETED|Overall Study||62
1433305|NCT02369341|3509415|P2|STARTED|Overall Study||57
1433306|NCT02369341|3509416|P1|STARTED|Overall Study||63
1433307|NCT02368457|3509472|P2|NOT COMPLETED|Overall Study||0
1433308|NCT02368457|3509473|P1|NOT COMPLETED|Overall Study||0
1433309|NCT02368457|3509472|P2|COMPLETED|Overall Study||12
1433310|NCT02368457|3509473|P1|COMPLETED|Overall Study||12
1433311|NCT02368457|3509472|P2|STARTED|Overall Study||12
1433312|NCT02368457|3509473|P1|STARTED|Overall Study||12
1433313|NCT02368314|3509483|P2|NOT COMPLETED|Overall Study||3
1433314|NCT02368314|3509484|P1|NOT COMPLETED|Overall Study||3
1433315|NCT02368314|3509483|P2|COMPLETED|Overall Study||57
1433316|NCT02368314|3509484|P1|COMPLETED|Overall Study||61
1433317|NCT02368314|3509483|P2|STARTED|Overall Study||60
1433318|NCT02368314|3509484|P1|STARTED|Overall Study||64
1433319|NCT02368210|3509496|P2|NOT COMPLETED|Overall Study||1
1433320|NCT02368210|3509497|P1|NOT COMPLETED|Overall Study||1
1433321|NCT02368210|3509496|P2|COMPLETED|Overall Study||75
1433322|NCT02368210|3509497|P1|COMPLETED|Overall Study||74
1433323|NCT02368210|3509496|P2|STARTED|Overall Study||76
1433324|NCT02368210|3509497|P1|STARTED|Overall Study||75
1433325|NCT02368093|3509515|P2|NOT COMPLETED|Overall Study||0
1433326|NCT02368093|3509516|P1|NOT COMPLETED|Overall Study||0
1433327|NCT02368093|3509515|P2|COMPLETED|Overall Study||24
1433328|NCT02368093|3509516|P1|COMPLETED|Overall Study||24
1433329|NCT02368093|3509515|P2|STARTED|Overall Study||24
1433330|NCT02368093|3509516|P1|STARTED|Overall Study||24
1433331|NCT02367911|3509524|P2|NOT COMPLETED|Overall Study||4
1433332|NCT02367911|3509525|P1|NOT COMPLETED|Overall Study||5
1433333|NCT02367911|3509524|P2|COMPLETED|Overall Study||69
1433334|NCT02367911|3509525|P1|COMPLETED|Overall Study||66
1433335|NCT02367911|3509524|P2|STARTED|Overall Study||73
1433336|NCT02367911|3509525|P1|STARTED|Overall Study||71
1433337|NCT02367885|3509536|P3|NOT COMPLETED|Overall Study||0
1433338|NCT02367885|3509537|P2|NOT COMPLETED|Overall Study||0
1433339|NCT02367885|3509538|P1|NOT COMPLETED|Overall Study||2
1433340|NCT02367885|3509536|P3|COMPLETED|Overall Study||33
1433341|NCT02367885|3509537|P2|COMPLETED|Overall Study||33
1433342|NCT02367885|3509538|P1|COMPLETED|Overall Study||31
1433343|NCT02367885|3509536|P3|STARTED|Overall Study||33
1433344|NCT02367885|3509537|P2|STARTED|Overall Study||33
1433345|NCT02367885|3509538|P1|STARTED|Overall Study||33
1433346|NCT02367872|3509611|P8|NOT COMPLETED|Overall Study||0
1433347|NCT02367872|3509612|P7|NOT COMPLETED|Overall Study||0
1433348|NCT02367872|3509613|P6|NOT COMPLETED|Overall Study||0
1433349|NCT02367872|3509614|P5|NOT COMPLETED|Overall Study||0
1433350|NCT02367872|3509615|P4|NOT COMPLETED|Overall Study||0
1433351|NCT02367872|3509616|P3|NOT COMPLETED|Overall Study||0
1433352|NCT02367872|3509617|P2|NOT COMPLETED|Overall Study||0
1433353|NCT02367872|3509618|P1|NOT COMPLETED|Overall Study||0
1433354|NCT02367872|3509611|P8|COMPLETED|Overall Study||6
1433355|NCT02367872|3509612|P7|COMPLETED|Overall Study||6
1433356|NCT02367872|3509613|P6|COMPLETED|Overall Study||6
1433357|NCT02367872|3509614|P5|COMPLETED|Overall Study||6
1433358|NCT02367872|3509615|P4|COMPLETED|Overall Study||6
1433359|NCT02367872|3509616|P3|COMPLETED|Overall Study||6
1433360|NCT02367872|3509617|P2|COMPLETED|Overall Study||6
1433361|NCT02367872|3509618|P1|COMPLETED|Overall Study||6
1433362|NCT02367872|3509611|P8|STARTED|Overall Study||6
1433363|NCT02367872|3509612|P7|STARTED|Overall Study||6
1433364|NCT02367872|3509613|P6|STARTED|Overall Study||6
1433365|NCT02367872|3509614|P5|STARTED|Overall Study||6
1433366|NCT02367872|3509615|P4|STARTED|Overall Study||6
1433367|NCT02367872|3509616|P3|STARTED|Overall Study||6
1433368|NCT02367872|3509617|P2|STARTED|Overall Study||6
1433369|NCT02367872|3509618|P1|STARTED|Overall Study||6
1433370|NCT02367729|3509773|P2|NOT COMPLETED|Overall Study||8
1433371|NCT02367729|3509774|P1|NOT COMPLETED|Overall Study||3
1433372|NCT02367729|3509773|P2|COMPLETED|Overall Study||47
1433373|NCT02367729|3509774|P1|COMPLETED|Overall Study||57
1433374|NCT02367729|3509773|P2|STARTED|Overall Study||55
1433375|NCT02367729|3509774|P1|STARTED|Overall Study||60
1433376|NCT02367521|3509792|P2|NOT COMPLETED|Overall Study||0
1433377|NCT02367521|3509793|P1|NOT COMPLETED|Overall Study||4
1433378|NCT02367521|3509792|P2|COMPLETED|Overall Study||17
1433379|NCT02367521|3509793|P1|COMPLETED|Overall Study||13
1433380|NCT02367521|3509792|P2|STARTED|Overall Study||17
1433381|NCT02367521|3509793|P1|STARTED|Overall Study||17
1433382|NCT02367391|3509847|P2|NOT COMPLETED|Overall Study||0
1433383|NCT02367391|3509848|P1|NOT COMPLETED|Overall Study||2
1433384|NCT02367391|3509847|P2|COMPLETED|Overall Study||76
1433385|NCT02367391|3509848|P1|COMPLETED|Overall Study||74
1433386|NCT02367391|3509847|P2|STARTED|Overall Study||76
1433387|NCT02367391|3509848|P1|STARTED|Overall Study||76
1433388|NCT02367170|3509868|P2|NOT COMPLETED|Overall Study||0
1433389|NCT02367170|3509869|P1|NOT COMPLETED|Overall Study||0
1433390|NCT02367170|3509868|P2|COMPLETED|Overall Study||0
1433391|NCT02367170|3509869|P1|COMPLETED|Overall Study||1
1433392|NCT02367170|3509868|P2|STARTED|Overall Study||0
1433393|NCT02367170|3509869|P1|STARTED|Overall Study||1
1433394|NCT02367131|3509879|P1|NOT COMPLETED|Overall Study||222
1433395|NCT02367131|3509879|P1|COMPLETED|Overall Study||201
1433396|NCT02367131|3509879|P1|STARTED|Overall Study|Started are the treated patients|423
1433397|NCT02367066|3509887|P2|NOT COMPLETED|Overall Study||0
1433398|NCT02367066|3509888|P1|NOT COMPLETED|Overall Study||0
1433399|NCT02367066|3509887|P2|COMPLETED|Overall Study||10
1433400|NCT02367066|3509888|P1|COMPLETED|Overall Study||10
1433401|NCT02367066|3509887|P2|STARTED|Overall Study||10
1433402|NCT02367066|3509888|P1|STARTED|Overall Study||10
1433403|NCT02366936|3509946|P1|NOT COMPLETED|Overall Study||8
1433404|NCT02366936|3509946|P1|COMPLETED|Overall Study||24
1433405|NCT02366936|3509946|P1|STARTED|Overall Study||32
1433406|NCT02366923|3509951|P1|NOT COMPLETED|Overall Study||6
1433407|NCT02366923|3509951|P1|COMPLETED|Overall Study||22
1433408|NCT02366923|3509951|P1|STARTED|Overall Study||28
1433409|NCT02366910|3509964|P1|NOT COMPLETED|Overall Study||5
1433410|NCT02366910|3509964|P1|COMPLETED|Overall Study||21
1433411|NCT02366910|3509964|P1|STARTED|Overall Study||26
1433412|NCT02366767|3509978|P2|NOT COMPLETED|Overall Study||0
1433413|NCT02366767|3509979|P1|NOT COMPLETED|Overall Study||1
1433414|NCT02366767|3509978|P2|COMPLETED|Overall Study||10
1433415|NCT02366767|3509979|P1|COMPLETED|Overall Study||10
1433416|NCT02366767|3509978|P2|STARTED|Overall Study||10
1433417|NCT02366767|3509979|P1|STARTED|Overall Study||11
1433418|NCT02366689|3509992|P3|NOT COMPLETED|Overall Study||2
1433419|NCT02366689|3509993|P2|NOT COMPLETED|Overall Study||3
1433420|NCT02366689|3509994|P1|NOT COMPLETED|Overall Study||4
1433421|NCT02366689|3509992|P3|COMPLETED|Overall Study||59
1433422|NCT02366689|3509993|P2|COMPLETED|Overall Study||55
1433423|NCT02366689|3509994|P1|COMPLETED|Overall Study||56
1433424|NCT02366689|3509992|P3|STARTED|Overall Study||61
1433425|NCT02366689|3509993|P2|STARTED|Overall Study||58
1433426|NCT02366689|3509994|P1|STARTED|Overall Study||60
1433427|NCT02366663|3510019|P2|NOT COMPLETED|Overall Study||0
1433428|NCT02366663|3510020|P1|NOT COMPLETED|Overall Study||0
1433429|NCT02366663|3510019|P2|COMPLETED|Overall Study||1
1433430|NCT02366663|3510020|P1|COMPLETED|Overall Study||2
1433431|NCT02366663|3510019|P2|STARTED|Overall Study||1
1433432|NCT02366663|3510020|P1|STARTED|Overall Study||2
1433433|NCT02366637|3510046|P2|NOT COMPLETED|Second Intervention Period||1
1433434|NCT02366637|3510047|P1|NOT COMPLETED|Second Intervention Period||1
1433435|NCT02366637|3510046|P2|COMPLETED|Second Intervention Period||0
1433436|NCT02366637|3510047|P1|COMPLETED|Second Intervention Period||0
1433437|NCT02366637|3510046|P2|STARTED|Second Intervention Period||1
1433438|NCT02366637|3510047|P1|STARTED|Second Intervention Period||1
1433439|NCT02366637|3510046|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
1433440|NCT02366637|3510047|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
1433441|NCT02366637|3510046|P2|COMPLETED|Washout Period 28 to 49 Days||1
1433442|NCT02366637|3510047|P1|COMPLETED|Washout Period 28 to 49 Days||1
1433443|NCT02366637|3510046|P2|STARTED|Washout Period 28 to 49 Days||1
1433444|NCT02366637|3510047|P1|STARTED|Washout Period 28 to 49 Days||1
1433445|NCT02366637|3510046|P2|NOT COMPLETED|First Intervention Period||5
1433446|NCT02366637|3510047|P1|NOT COMPLETED|First Intervention Period||6
1433447|NCT02366637|3510046|P2|COMPLETED|First Intervention Period||1
1433448|NCT02366637|3510047|P1|COMPLETED|First Intervention Period||1
1433449|NCT02366637|3510046|P2|STARTED|First Intervention Period||6
1433450|NCT02366637|3510047|P1|STARTED|First Intervention Period||7
1433451|NCT02366338|3510074|P3|NOT COMPLETED|Overall Study||0
1433452|NCT02366338|3510075|P2|NOT COMPLETED|Overall Study||0
1433453|NCT02366338|3510076|P1|NOT COMPLETED|Overall Study||0
1433454|NCT02366338|3510074|P3|COMPLETED|Overall Study||36
1433455|NCT02366338|3510075|P2|COMPLETED|Overall Study||39
1433456|NCT02366338|3510076|P1|COMPLETED|Overall Study||73
1433457|NCT02366338|3510074|P3|STARTED|Overall Study||36
1433458|NCT02366338|3510075|P2|STARTED|Overall Study||39
1433459|NCT02366338|3510076|P1|STARTED|Overall Study||73
1433460|NCT02366195|3510084|P1|NOT COMPLETED|Overall Study||112
1433461|NCT02366195|3510084|P1|COMPLETED|Overall Study||0
1433462|NCT02366195|3510084|P1|Received Study Drug|Overall Study||111
1433463|NCT02366195|3510084|P1|STARTED|Overall Study||112
1433464|NCT02365714|3510102|P1|NOT COMPLETED|Overall Study||0
1433465|NCT02365714|3510102|P1|COMPLETED|Overall Study||2
1433466|NCT02365714|3510102|P1|STARTED|Overall Study||2
1433467|NCT02365688|3510108|P1|NOT COMPLETED|Overall Study||0
1433468|NCT02365688|3510108|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
1433469|NCT02365688|3510108|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
1433470|NCT02365636|3510115|P3|NOT COMPLETED|Overall Study||3
1433471|NCT02365636|3510116|P2|NOT COMPLETED|Overall Study||7
1433472|NCT02365636|3510117|P1|NOT COMPLETED|Overall Study||6
1433473|NCT02365636|3510115|P3|COMPLETED|Overall Study||97
1433474|NCT02365636|3510116|P2|COMPLETED|Overall Study||93
1433475|NCT02365636|3510117|P1|COMPLETED|Overall Study||94
1433476|NCT02365636|3510115|P3|Full Analysis Set|Overall Study||100
1433477|NCT02365636|3510116|P2|Full Analysis Set|Overall Study||98
1433478|NCT02365636|3510117|P1|Full Analysis Set|Overall Study||100
1433479|NCT02365636|3510115|P3|Safety Population|Overall Study||100
1433480|NCT02365636|3510116|P2|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
1433481|NCT02365636|3510117|P1|Safety Population|Overall Study||100
1433482|NCT02365636|3510115|P3|STARTED|Overall Study||100
1433483|NCT02365636|3510116|P2|STARTED|Overall Study||100
1433484|NCT02365636|3510117|P1|STARTED|Overall Study||100
1433485|NCT02365558|3510161|P2|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
1433486|NCT02365558|3510162|P1|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
1433487|NCT02365558|3510161|P2|COMPLETED|Period 2 (Day 8 Through Day 20)||32
1433488|NCT02365558|3510162|P1|COMPLETED|Period 2 (Day 8 Through Day 20)||0
1433489|NCT02365558|3510161|P2|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
1433490|NCT02365558|3510162|P1|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
1433491|NCT02365558|3510161|P2|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
1433492|NCT02365558|3510162|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
1433493|NCT02365558|3510161|P2|COMPLETED|Period 1 (Day 1 Through Day 7)||0
1433494|NCT02365558|3510162|P1|COMPLETED|Period 1 (Day 1 Through Day 7)||33
1433495|NCT02365558|3510161|P2|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
1433496|NCT02365558|3510162|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
1433497|NCT02365558|3510161|P2|STARTED|Period 1 (Day 1 Through Day 7)||0
1433498|NCT02365558|3510162|P1|STARTED|Period 1 (Day 1 Through Day 7)||34
1433499|NCT02365519|3510175|P3|NOT COMPLETED|Randomized and Treated||1
1433500|NCT02365519|3510176|P2|NOT COMPLETED|Randomized and Treated||2
1433501|NCT02365519|3510177|P1|NOT COMPLETED|Randomized and Treated||0
1433502|NCT02365519|3510175|P3|COMPLETED|Randomized and Treated||64
1433503|NCT02365519|3510176|P2|COMPLETED|Randomized and Treated||67
1433504|NCT02365519|3510177|P1|COMPLETED|Randomized and Treated||0
1433505|NCT02365519|3510175|P3|STARTED|Randomized and Treated||65
1433506|NCT02365519|3510176|P2|STARTED|Randomized and Treated||69
1433507|NCT02365519|3510177|P1|STARTED|Randomized and Treated||0
1433508|NCT02365519|3510175|P3|NOT COMPLETED|Vehicle Run-In||0
1433509|NCT02365519|3510176|P2|NOT COMPLETED|Vehicle Run-In||0
1433510|NCT02365519|3510177|P1|NOT COMPLETED|Vehicle Run-In||79
1433511|NCT02365519|3510175|P3|COMPLETED|Vehicle Run-In||0
1433512|NCT02365519|3510176|P2|COMPLETED|Vehicle Run-In||0
1433513|NCT02365519|3510177|P1|COMPLETED|Vehicle Run-In||134
1433514|NCT02365519|3510175|P3|STARTED|Vehicle Run-In||0
1433515|NCT02365519|3510176|P2|STARTED|Vehicle Run-In||0
1433516|NCT02365519|3510177|P1|STARTED|Vehicle Run-In||213
1433517|NCT02365298|3510198|P2|NOT COMPLETED|Period 2||2
1433518|NCT02365298|3510199|P1|NOT COMPLETED|Period 2||2
1433519|NCT02365298|3510198|P2|COMPLETED|Period 2||12
1433520|NCT02365298|3510199|P1|COMPLETED|Period 2||12
1433521|NCT02365298|3510198|P2|STARTED|Period 2||14
1433522|NCT02365298|3510199|P1|STARTED|Period 2||14
1433523|NCT02365298|3510198|P2|NOT COMPLETED|Period 1||0
1433524|NCT02365298|3510199|P1|NOT COMPLETED|Period 1||0
1433525|NCT02365298|3510198|P2|COMPLETED|Period 1||14
1433526|NCT02365298|3510199|P1|COMPLETED|Period 1||14
1433527|NCT02365298|3510198|P2|STARTED|Period 1||14
1433528|NCT02365298|3510199|P1|STARTED|Period 1||14
1433529|NCT02365233|3510218|P3|NOT COMPLETED|Overall Study||2
1433530|NCT02365233|3510219|P2|NOT COMPLETED|Overall Study||2
1433531|NCT02365233|3510220|P1|NOT COMPLETED|Overall Study||1
1433532|NCT02365233|3510218|P3|COMPLETED|Overall Study||0
1433533|NCT02365233|3510219|P2|COMPLETED|Overall Study||0
1433534|NCT02365233|3510220|P1|COMPLETED|Overall Study||0
1433535|NCT02365233|3510218|P3|STARTED|Overall Study||2
1433536|NCT02365233|3510219|P2|STARTED|Overall Study||2
1433537|NCT02365233|3510220|P1|STARTED|Overall Study||1
1433538|NCT02364999|3510230|P2|NOT COMPLETED|Overall Study||173
1433539|NCT02364999|3510231|P1|NOT COMPLETED|Overall Study||165
1433540|NCT02364999|3510230|P2|COMPLETED|Overall Study||188
1433541|NCT02364999|3510231|P1|COMPLETED|Overall Study||193
1433542|NCT02364999|3510230|P2|Received Treatment|Overall Study||358
1433543|NCT02364999|3510231|P1|Received Treatment|Overall Study||356
1433544|NCT02364999|3510230|P2|STARTED|Overall Study||361
1433545|NCT02364999|3510231|P1|STARTED|Overall Study||358
1433546|NCT02364778|3510256|P1|NOT COMPLETED|Overall Study||0
1433547|NCT02364778|3510256|P1|COMPLETED|Overall Study||30
1433548|NCT02364778|3510256|P1|STARTED|Overall Study||30
1433549|NCT02364700|3510268|P1|NOT COMPLETED|Overall Study||0
1433550|NCT02364700|3510268|P1|COMPLETED|Overall Study||12
1433551|NCT02364700|3510268|P1|STARTED|Overall Study||12
1433552|NCT02364180|3510277|P1|NOT COMPLETED|Overall Study||1
1433553|NCT02364180|3510277|P1|COMPLETED|Overall Study||10
1433554|NCT02364180|3510277|P1|STARTED|Overall Study||11
1433555|NCT02364037|3510283|P2|NOT COMPLETED|Overall Study||53
1433556|NCT02364037|3510284|P1|NOT COMPLETED|Overall Study||44
1433557|NCT02364037|3510283|P2|COMPLETED|Overall Study||453
1433558|NCT02364037|3510284|P1|COMPLETED|Overall Study||458
1433559|NCT02364037|3510283|P2|STARTED|Overall Study||506
1433560|NCT02364037|3510284|P1|STARTED|Overall Study||502
1433561|NCT02363946|3510309|P13|NOT COMPLETED|Overall Study||0
1433562|NCT02363946|3510310|P12|NOT COMPLETED|Overall Study||0
1433563|NCT02363946|3510311|P11|NOT COMPLETED|Overall Study||0
1433564|NCT02363946|3510312|P10|NOT COMPLETED|Overall Study||0
1433565|NCT02363946|3510313|P9|NOT COMPLETED|Overall Study||0
1433566|NCT02363946|3510314|P8|NOT COMPLETED|Overall Study||1
1433567|NCT02363946|3510315|P7|NOT COMPLETED|Overall Study||0
1433568|NCT02363946|3510316|P6|NOT COMPLETED|Overall Study||0
1433569|NCT02363946|3510317|P5|NOT COMPLETED|Overall Study||0
1433570|NCT02363946|3510318|P4|NOT COMPLETED|Overall Study||0
1433571|NCT02363946|3510319|P3|NOT COMPLETED|Overall Study||0
1433572|NCT02363946|3510320|P2|NOT COMPLETED|Overall Study||0
1433573|NCT02363946|3510321|P1|NOT COMPLETED|Overall Study||0
1433574|NCT02363946|3510309|P13|COMPLETED|Overall Study||4
1433575|NCT02363946|3510310|P12|COMPLETED|Overall Study||3
1433576|NCT02363946|3510311|P11|COMPLETED|Overall Study||4
1433577|NCT02363946|3510312|P10|COMPLETED|Overall Study||18
1433578|NCT02363946|3510313|P9|COMPLETED|Overall Study||4
1433579|NCT02363946|3510314|P8|COMPLETED|Overall Study||3
1433580|NCT02363946|3510315|P7|COMPLETED|Overall Study||4
1433581|NCT02363946|3510316|P6|COMPLETED|Overall Study||4
1433582|NCT02363946|3510317|P5|COMPLETED|Overall Study||4
1433583|NCT02363946|3510318|P4|COMPLETED|Overall Study||4
1433584|NCT02363946|3510319|P3|COMPLETED|Overall Study||4
1433585|NCT02363946|3510320|P2|COMPLETED|Overall Study||4
1433586|NCT02363946|3510321|P1|COMPLETED|Overall Study||4
1433587|NCT02363946|3510309|P13|STARTED|Overall Study||4
1433588|NCT02363946|3510310|P12|STARTED|Overall Study||3
1433589|NCT02363946|3510311|P11|STARTED|Overall Study||4
1433590|NCT02363946|3510312|P10|STARTED|Overall Study||18
1433591|NCT02363946|3510313|P9|STARTED|Overall Study||4
1433592|NCT02363946|3510314|P8|STARTED|Overall Study||4
1433593|NCT02363946|3510315|P7|STARTED|Overall Study||4
1433594|NCT02363946|3510316|P6|STARTED|Overall Study||4
1433595|NCT02363946|3510317|P5|STARTED|Overall Study||4
1433596|NCT02363946|3510318|P4|STARTED|Overall Study||4
1433597|NCT02363946|3510319|P3|STARTED|Overall Study||4
1433598|NCT02363946|3510320|P2|STARTED|Overall Study||4
1433599|NCT02363946|3510321|P1|STARTED|Overall Study||4
1433600|NCT02363933|3510507|P1|NOT COMPLETED|Overall Study||6
1433601|NCT02363933|3510507|P1|COMPLETED|Overall Study||2
1433602|NCT02363933|3510507|P1|STARTED|Overall Study||8
1433603|NCT02363907|3510512|P1|NOT COMPLETED|Overall Study||0
1433604|NCT02363907|3510512|P1|COMPLETED|Overall Study||30
1433605|NCT02363907|3510512|P1|STARTED|Overall Study||30
1433606|NCT02363478|3510516|P1|NOT COMPLETED|Overall Study||8
1433607|NCT02363478|3510516|P1|COMPLETED|Overall Study||22
1433608|NCT02363478|3510516|P1|STARTED|Overall Study||30
1433609|NCT02363439|3510523|P1|NOT COMPLETED|Overall Study||4
1433610|NCT02363439|3510523|P1|COMPLETED|Overall Study||1
1433611|NCT02363439|3510523|P1|STARTED|Overall Study||5
1433612|NCT02363270|3510529|P2|NOT COMPLETED|Overall Study||0
1433613|NCT02363270|3510530|P1|NOT COMPLETED|Overall Study||0
1433614|NCT02363270|3510529|P2|COMPLETED|Overall Study||24
1433615|NCT02363270|3510530|P1|COMPLETED|Overall Study||24
1433616|NCT02363270|3510529|P2|STARTED|Overall Study||24
1433617|NCT02363270|3510530|P1|STARTED|Overall Study||24
1433618|NCT02362789|3510538|P3|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
1433619|NCT02362789|3510539|P2|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
1433620|NCT02362789|3510540|P1|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
1433621|NCT02362789|3510538|P3|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
1433622|NCT02362789|3510539|P2|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
1433623|NCT02362789|3510540|P1|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
1433624|NCT02362789|3510538|P3|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
1433625|NCT02362789|3510539|P2|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
1433626|NCT02362789|3510540|P1|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
1433627|NCT02362789|3510538|P3|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
1433628|NCT02362789|3510539|P2|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
1433629|NCT02362789|3510540|P1|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
1433630|NCT02362789|3510538|P3|COMPLETED|Run-in Phase (Week 0 to 16)||0
1433631|NCT02362789|3510539|P2|COMPLETED|Run-in Phase (Week 0 to 16)||0
1433632|NCT02362789|3510540|P1|COMPLETED|Run-in Phase (Week 0 to 16)||128
1433633|NCT02362789|3510538|P3|STARTED|Run-in Phase (Week 0 to 16)||0
1433634|NCT02362789|3510539|P2|STARTED|Run-in Phase (Week 0 to 16)||0
1433635|NCT02362789|3510540|P1|STARTED|Run-in Phase (Week 0 to 16)||130
1433636|NCT02362503|3510550|P3|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||99
1433637|NCT02362503|3510551|P2|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||198
1433638|NCT02362503|3510552|P1|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||68
1433639|NCT02362503|3510550|P3|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
1433640|NCT02362503|3510551|P2|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
1433641|NCT02362503|3510552|P1|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
1433642|NCT02362503|3510550|P3|STARTED|Open Label Period-Up to Atleast 96 Weeks||99
1433643|NCT02362503|3510551|P2|STARTED|Open Label Period-Up to Atleast 96 Weeks|Subject withdrawn due to progression of disease died during study due to squamous cell carcinoma.|198
1433644|NCT02362503|3510552|P1|STARTED|Open Label Period-Up to Atleast 96 Weeks||68
1433645|NCT02362503|3510550|P3|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
1433646|NCT02362503|3510551|P2|NOT COMPLETED|Double-blind Period-Up to 8 Days||5
1433647|NCT02362503|3510552|P1|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
1433648|NCT02362503|3510550|P3|COMPLETED|Double-blind Period-Up to 8 Days||0
1433649|NCT02362503|3510551|P2|COMPLETED|Double-blind Period-Up to 8 Days||198
1433650|NCT02362503|3510552|P1|COMPLETED|Double-blind Period-Up to 8 Days||68
1433651|NCT02362503|3510550|P3|STARTED|Double-blind Period-Up to 8 Days||0
1433652|NCT02362503|3510551|P2|STARTED|Double-blind Period-Up to 8 Days||203
1433653|NCT02362503|3510552|P1|STARTED|Double-blind Period-Up to 8 Days||69
1433654|NCT02362412|3510577|P2|NOT COMPLETED|Treatment Period III||1
1433655|NCT02362412|3510578|P1|NOT COMPLETED|Treatment Period III||0
1433656|NCT02362412|3510577|P2|COMPLETED|Treatment Period III||10
1433657|NCT02362412|3510578|P1|COMPLETED|Treatment Period III||9
1433658|NCT02362412|3510577|P2|TREATED|Treatment Period III||11
1433659|NCT02362412|3510578|P1|TREATED|Treatment Period III||9
1433660|NCT02362412|3510577|P2|STARTED|Treatment Period III||11
1433661|NCT02362412|3510578|P1|STARTED|Treatment Period III||9
1433662|NCT02362412|3510577|P2|NOT COMPLETED|Treatment Period II||0
1433663|NCT02362412|3510578|P1|NOT COMPLETED|Treatment Period II||0
1433664|NCT02362412|3510577|P2|COMPLETED|Treatment Period II||11
1433665|NCT02362412|3510578|P1|COMPLETED|Treatment Period II||9
1433666|NCT02362412|3510577|P2|TREATED|Treatment Period II||11
1433667|NCT02362412|3510578|P1|TREATED|Treatment Period II||9
1433668|NCT02362412|3510577|P2|STARTED|Treatment Period II||11
1433669|NCT02362412|3510578|P1|STARTED|Treatment Period II||9
1433670|NCT02362373|3510604|P1|NOT COMPLETED|Overall Study||0
1433671|NCT02362373|3510604|P1|COMPLETED|Overall Study||20
1433672|NCT02362373|3510604|P1|STARTED|Overall Study||20
1433673|NCT02362360|3510612|P2|NOT COMPLETED|Period 2||0
1433674|NCT02362360|3510613|P1|NOT COMPLETED|Period 2||0
1433675|NCT02362360|3510612|P2|COMPLETED|Period 2||25
1433676|NCT02362360|3510613|P1|COMPLETED|Period 2||23
1433677|NCT02362360|3510612|P2|STARTED|Period 2||25
1433678|NCT02362360|3510613|P1|STARTED|Period 2||23
1433679|NCT02362360|3510612|P2|NOT COMPLETED|Period 1||1
1433680|NCT02362360|3510613|P1|NOT COMPLETED|Period 1||3
1433681|NCT02362360|3510612|P2|COMPLETED|Period 1||25
1433682|NCT02362360|3510613|P1|COMPLETED|Period 1||23
1433683|NCT02362360|3510612|P2|STARTED|Period 1||26
1433684|NCT02362360|3510613|P1|STARTED|Period 1||26
1433685|NCT02362321|3510621|P2|NOT COMPLETED|Overall Study||0
1433686|NCT02362321|3510622|P1|NOT COMPLETED|Overall Study||4
1433687|NCT02362321|3510621|P2|COMPLETED|Overall Study||10
1433688|NCT02362321|3510622|P1|COMPLETED|Overall Study||6
1433689|NCT02362321|3510621|P2|STARTED|Overall Study||10
1433690|NCT02362321|3510622|P1|STARTED|Overall Study||10
1433691|NCT02361736|3510630|P2|NOT COMPLETED|Overall Study||1
1433692|NCT02361736|3510631|P1|NOT COMPLETED|Overall Study||1
1433693|NCT02361736|3510630|P2|COMPLETED|Overall Study||59
1433694|NCT02361736|3510631|P1|COMPLETED|Overall Study||59
1433695|NCT02361736|3510630|P2|STARTED|Overall Study||60
1433696|NCT02361736|3510631|P1|STARTED|Overall Study||60
1433697|NCT02361580|3510651|P2|NOT COMPLETED|Overall Study||3
1433698|NCT02361580|3510652|P1|NOT COMPLETED|Overall Study||6
1433699|NCT02361580|3510651|P2|COMPLETED|Overall Study||0
1433700|NCT02361580|3510652|P1|COMPLETED|Overall Study||0
1433701|NCT02361580|3510651|P2|STARTED|Overall Study||3
1433702|NCT02361580|3510652|P1|STARTED|Overall Study||6
1433703|NCT02361216|3510664|P2|NOT COMPLETED|12-month Follow-up||27
1433704|NCT02361216|3510665|P1|NOT COMPLETED|12-month Follow-up||52
1433705|NCT02361216|3510664|P2|COMPLETED|12-month Follow-up||130
1433706|NCT02361216|3510665|P1|COMPLETED|12-month Follow-up||489
1433707|NCT02361216|3510664|P2|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
1433708|NCT02361216|3510665|P1|STARTED|12-month Follow-up||541
1433709|NCT02361216|3510664|P2|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
1433710|NCT02361216|3510665|P1|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
1433711|NCT02361216|3510664|P2|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
1433712|NCT02361216|3510665|P1|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
1433713|NCT02361216|3510664|P2|STARTED|3 Day Treatment and 8 Week Follow/up||177
1433714|NCT02361216|3510665|P1|STARTED|3 Day Treatment and 8 Week Follow/up||552
1433715|NCT02360995|3510680|P3|NOT COMPLETED|Overall Study||2
1433716|NCT02360995|3510681|P2|NOT COMPLETED|Overall Study||1
1433717|NCT02360995|3510682|P1|NOT COMPLETED|Overall Study||2
1433718|NCT02360995|3510680|P3|COMPLETED|Overall Study||41
1433719|NCT02360995|3510681|P2|COMPLETED|Overall Study||42
1433720|NCT02360995|3510682|P1|COMPLETED|Overall Study||41
1433721|NCT02360995|3510680|P3|STARTED|Overall Study||43
1433722|NCT02360995|3510681|P2|STARTED|Overall Study||43
1433723|NCT02360995|3510682|P1|STARTED|Overall Study||43
1433724|NCT02360774|3510707|P2|NOT COMPLETED|Overall Study||2
1433725|NCT02360774|3510708|P1|NOT COMPLETED|Overall Study||3
1433726|NCT02360774|3510707|P2|COMPLETED|Overall Study||13
1433727|NCT02360774|3510708|P1|COMPLETED|Overall Study||12
1433728|NCT02360774|3510707|P2|STARTED|Overall Study||15
1433729|NCT02360774|3510708|P1|STARTED|Overall Study||15
1433730|NCT02360475|3510724|P4|NOT COMPLETED|Overall Study||5
1433731|NCT02360475|3510725|P3|NOT COMPLETED|Overall Study||8
1433732|NCT02360475|3510726|P2|NOT COMPLETED|Overall Study||13
1433733|NCT02360475|3510727|P1|NOT COMPLETED|Overall Study||4
1433734|NCT02360475|3510724|P4|COMPLETED|Overall Study||120
1433735|NCT02360475|3510725|P3|COMPLETED|Overall Study||117
1433736|NCT02360475|3510726|P2|COMPLETED|Overall Study||111
1433737|NCT02360475|3510727|P1|COMPLETED|Overall Study||122
1433738|NCT02360475|3510724|P4|STARTED|Overall Study||125
1433739|NCT02360475|3510725|P3|STARTED|Overall Study||125
1433740|NCT02360475|3510726|P2|STARTED|Overall Study||124
1433741|NCT02360475|3510727|P1|STARTED|Overall Study||126
1433742|NCT02360228|3510788|P3|NOT COMPLETED|Overall Study||1
1433743|NCT02360228|3510789|P2|NOT COMPLETED|Overall Study||1
1433744|NCT02360228|3510790|P1|NOT COMPLETED|Overall Study||1
1433745|NCT02360228|3510788|P3|COMPLETED|Overall Study||7
1433746|NCT02360228|3510789|P2|COMPLETED|Overall Study||7
1433747|NCT02360228|3510790|P1|COMPLETED|Overall Study||8
1433748|NCT02360228|3510788|P3|STARTED|Overall Study||8
1433749|NCT02360228|3510789|P2|STARTED|Overall Study||8
1433750|NCT02360228|3510790|P1|STARTED|Overall Study||9
1433751|NCT02360124|3510819|P3|NOT COMPLETED|Overall Study||26
1433752|NCT02360124|3510820|P2|NOT COMPLETED|Overall Study||12
1433753|NCT02360124|3510821|P1|NOT COMPLETED|Overall Study||28
1433754|NCT02360124|3510819|P3|COMPLETED|Overall Study||82
1433755|NCT02360124|3510820|P2|COMPLETED|Overall Study||95
1433756|NCT02360124|3510821|P1|COMPLETED|Overall Study||80
1433757|NCT02360124|3510819|P3|STARTED|Overall Study||108
1433758|NCT02360124|3510820|P2|STARTED|Overall Study||107
1433759|NCT02360124|3510821|P1|STARTED|Overall Study||108
1433760|NCT02360111|3510832|P1|NOT COMPLETED|Overall Study||2
1433761|NCT02360111|3510832|P1|COMPLETED|Overall Study||1
1433762|NCT02360111|3510832|P1|STARTED|Overall Study||3
1433763|NCT02360059|3510842|P2|NOT COMPLETED|Overall Study||0
1433764|NCT02360059|3510843|P1|NOT COMPLETED|Overall Study||0
1433765|NCT02360059|3510842|P2|COMPLETED|Overall Study||0
1433766|NCT02360059|3510843|P1|COMPLETED|Overall Study||1
1433767|NCT02360059|3510842|P2|STARTED|Overall Study||0
1433768|NCT02360059|3510843|P1|STARTED|Overall Study||1
1433769|NCT02359955|3510851|P2|NOT COMPLETED|Overall Study||0
1433770|NCT02359955|3510852|P1|NOT COMPLETED|Overall Study||0
1433771|NCT02359955|3510851|P2|COMPLETED|Overall Study||10
1433772|NCT02359955|3510852|P1|COMPLETED|Overall Study||10
1433773|NCT02359955|3510851|P2|STARTED|Overall Study||10
1433774|NCT02359955|3510852|P1|STARTED|Overall Study||10
1433775|NCT02359916|3510875|P7|NOT COMPLETED|Overall Study||0
1433776|NCT02359916|3510876|P6|NOT COMPLETED|Overall Study||0
1433777|NCT02359916|3510877|P5|NOT COMPLETED|Overall Study||0
1433778|NCT02359916|3510878|P4|NOT COMPLETED|Overall Study||0
1433779|NCT02359916|3510879|P3|NOT COMPLETED|Overall Study||0
1433780|NCT02359916|3510880|P2|NOT COMPLETED|Overall Study||0
1433781|NCT02359916|3510881|P1|NOT COMPLETED|Overall Study||0
1433782|NCT02359916|3510875|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
1433783|NCT02359916|3510876|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
1433784|NCT02359916|3510877|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
1433785|NCT02359916|3510878|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
1433786|NCT02359916|3510879|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
1433787|NCT02359916|3510880|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
1433788|NCT02359916|3510881|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
1433789|NCT02359916|3510875|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
1433790|NCT02359916|3510876|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
1433791|NCT02359916|3510877|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
1433792|NCT02359916|3510878|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
1433793|NCT02359916|3510879|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
1433794|NCT02359916|3510880|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
1433795|NCT02359916|3510881|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
1433796|NCT02359903|3510903|P2|NOT COMPLETED|Overall Study||2
1433797|NCT02359903|3510904|P1|NOT COMPLETED|Overall Study||0
1433798|NCT02359903|3510903|P2|COMPLETED|Overall Study||43
1433799|NCT02359903|3510904|P1|COMPLETED|Overall Study||45
1433800|NCT02359903|3510903|P2|STARTED|Overall Study||45
1433801|NCT02359903|3510904|P1|STARTED|Overall Study||45
1433802|NCT02359890|3510912|P1|NOT COMPLETED|Overall Study||10
1433803|NCT02359890|3510912|P1|COMPLETED|Overall Study||155
1433804|NCT02359890|3510912|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
1433805|NCT02359890|3510912|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
1433806|NCT02359890|3510912|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
1433807|NCT02359890|3510912|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
1433808|NCT02359877|3510923|P4|NOT COMPLETED|Overall Study||3
1433809|NCT02359877|3510924|P3|NOT COMPLETED|Overall Study||0
1433810|NCT02359877|3510925|P2|NOT COMPLETED|Overall Study||0
1433811|NCT02359877|3510926|P1|NOT COMPLETED|Overall Study||1
1433812|NCT02359877|3510923|P4|COMPLETED|Overall Study||11
1433813|NCT02359877|3510924|P3|COMPLETED|Overall Study||6
1433814|NCT02359877|3510925|P2|COMPLETED|Overall Study||6
1433815|NCT02359877|3510926|P1|COMPLETED|Overall Study||33
1433816|NCT02359877|3510923|P4|STARTED|Overall Study||14
1433817|NCT02359877|3510924|P3|STARTED|Overall Study||6
1433818|NCT02359877|3510925|P2|STARTED|Overall Study||6
1433819|NCT02359877|3510926|P1|STARTED|Overall Study||34
1433820|NCT02359851|3510976|P1|NOT COMPLETED|Overall Study||2
1433821|NCT02359851|3510976|P1|COMPLETED|Overall Study||3
1433822|NCT02359851|3510976|P1|STARTED|Overall Study||5
1433823|NCT02359435|3510986|P2|NOT COMPLETED|Overall Study||4
1433824|NCT02359435|3510987|P1|NOT COMPLETED|Overall Study||4
1433825|NCT02359435|3510986|P2|COMPLETED|Overall Study||216
1433826|NCT02359435|3510987|P1|COMPLETED|Overall Study||216
1433827|NCT02359435|3510986|P2|STARTED|Overall Study||220
1433828|NCT02359435|3510987|P1|STARTED|Overall Study||220
1433829|NCT02359305|3510995|P2|NOT COMPLETED|Overall Study||0
1433830|NCT02359305|3510996|P1|NOT COMPLETED|Overall Study||0
1433831|NCT02359305|3510995|P2|COMPLETED|Overall Study||34
1433832|NCT02359305|3510996|P1|COMPLETED|Overall Study||34
1433833|NCT02359305|3510995|P2|STARTED|Overall Study||34
1433834|NCT02359305|3510996|P1|STARTED|Overall Study||34
1433835|NCT02359110|3511008|P2|NOT COMPLETED|Overall Study||0
1433836|NCT02359110|3511009|P1|NOT COMPLETED|Overall Study||0
1433837|NCT02359110|3511008|P2|COMPLETED|Overall Study||54
1433838|NCT02359110|3511009|P1|COMPLETED|Overall Study||55
1433839|NCT02359110|3511008|P2|STARTED|Overall Study||54
1433840|NCT02359110|3511009|P1|STARTED|Overall Study||55
1433841|NCT02359058|3511022|P3|NOT COMPLETED|Overall Study||0
1433842|NCT02359058|3511023|P2|NOT COMPLETED|Overall Study||0
1433843|NCT02359058|3511024|P1|NOT COMPLETED|Overall Study||0
1433844|NCT02359058|3511022|P3|COMPLETED|Overall Study||6
1433845|NCT02359058|3511023|P2|COMPLETED|Overall Study||6
1433846|NCT02359058|3511024|P1|COMPLETED|Overall Study||6
1433847|NCT02359058|3511022|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1433848|NCT02359058|3511023|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1433849|NCT02359058|3511024|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
1433850|NCT02359058|3511022|P3|STARTED|Overall Study||6
1433851|NCT02359058|3511023|P2|STARTED|Overall Study||6
1433852|NCT02359058|3511024|P1|STARTED|Overall Study||6
1433853|NCT02359045|3511047|P2|NOT COMPLETED|Overall Study||3
1433854|NCT02359045|3511048|P1|NOT COMPLETED|Overall Study||4
1433855|NCT02359045|3511047|P2|COMPLETED|Overall Study||39
1433856|NCT02359045|3511048|P1|COMPLETED|Overall Study||36
1433857|NCT02359045|3511047|P2|STARTED|Overall Study||42
1433858|NCT02359045|3511048|P1|STARTED|Overall Study||40
1433859|NCT02358876|3511281|P1|NOT COMPLETED|Overall Study||2
1433860|NCT02358876|3511281|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
1433861|NCT02358876|3511281|P1|STARTED|Overall Study||32
1433862|NCT02358863|3511285|P1|NOT COMPLETED|Overall Study||3
1433863|NCT02358863|3511285|P1|COMPLETED|Overall Study||10
1433864|NCT02358863|3511285|P1|STARTED|Overall Study||13
1433865|NCT02358668|3511292|P3|NOT COMPLETED|Overall Study||0
1433866|NCT02358668|3511293|P2|NOT COMPLETED|Overall Study||1
1433867|NCT02358668|3511294|P1|NOT COMPLETED|Overall Study||2
1433868|NCT02358668|3511292|P3|COMPLETED|Overall Study||12
1433869|NCT02358668|3511293|P2|COMPLETED|Overall Study||23
1433870|NCT02358668|3511294|P1|COMPLETED|Overall Study||22
1433871|NCT02358668|3511292|P3|STARTED|Overall Study||12
1433872|NCT02358668|3511293|P2|STARTED|Overall Study||24
1433873|NCT02358668|3511294|P1|STARTED|Overall Study||24
1433874|NCT02358473|3511434|P1|NOT COMPLETED|Overall Study||13
1433875|NCT02358473|3511434|P1|COMPLETED|Overall Study||0
1433876|NCT02358473|3511434|P1|STARTED|Overall Study||13
1433877|NCT02358044|3511445|P2|NOT COMPLETED|Overall Study||7
1433878|NCT02358044|3511446|P1|NOT COMPLETED|Overall Study||2
1433879|NCT02358044|3511445|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
1433880|NCT02358044|3511446|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
1433881|NCT02358044|3511445|P2|Treated|Overall Study||126
1433882|NCT02358044|3511446|P1|Treated|Overall Study||129
1433883|NCT02358044|3511445|P2|STARTED|Overall Study||128
1433884|NCT02358044|3511446|P1|STARTED|Overall Study||129
1433885|NCT02357940|3511464|P2|NOT COMPLETED|Overall Study||2
1433886|NCT02357940|3511465|P1|NOT COMPLETED|Overall Study||0
1433887|NCT02357940|3511464|P2|COMPLETED|Overall Study||30
1433888|NCT02357940|3511465|P1|COMPLETED|Overall Study||9
1433889|NCT02357940|3511464|P2|STARTED|Overall Study||32
1433890|NCT02357940|3511465|P1|STARTED|Overall Study||9
1433891|NCT02357901|3511592|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
1433892|NCT02357901|3511593|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
1433893|NCT02357901|3511594|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
1433894|NCT02357901|3511595|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
1433895|NCT02357901|3511592|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
1433896|NCT02357901|3511593|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
1433897|NCT02357901|3511594|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
1433898|NCT02357901|3511595|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
1433899|NCT02357901|3511592|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
1433900|NCT02357901|3511593|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
1433901|NCT02357901|3511594|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
1433902|NCT02357901|3511595|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
1433903|NCT02357901|3511592|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
1433904|NCT02357901|3511593|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
1433905|NCT02357901|3511594|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
1433906|NCT02357901|3511595|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
1433907|NCT02357901|3511592|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
1433908|NCT02357901|3511593|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
1433909|NCT02357901|3511594|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
1433910|NCT02357901|3511595|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
1433911|NCT02357901|3511592|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1433912|NCT02357901|3511593|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1433913|NCT02357901|3511594|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1433914|NCT02357901|3511595|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
1433915|NCT02357901|3511592|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1433916|NCT02357901|3511593|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1433917|NCT02357901|3511594|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1433918|NCT02357901|3511595|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
1433919|NCT02357901|3511592|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
1433920|NCT02357901|3511593|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
1433921|NCT02357901|3511594|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
1433922|NCT02357901|3511595|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
1433923|NCT02357485|3511645|P1|NOT COMPLETED|Overall Study||0
1433924|NCT02357485|3511645|P1|COMPLETED|Overall Study||6
1433925|NCT02357485|3511645|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
1433926|NCT02357459|3511656|P3|NOT COMPLETED|Overall Study||12
1433927|NCT02357459|3511657|P2|NOT COMPLETED|Overall Study||14
1433928|NCT02357459|3511658|P1|NOT COMPLETED|Overall Study||17
1433929|NCT02357459|3511656|P3|COMPLETED|Overall Study||150
1433930|NCT02357459|3511657|P2|COMPLETED|Overall Study||149
1433931|NCT02357459|3511658|P1|COMPLETED|Overall Study||144
1433932|NCT02357459|3511656|P3|STARTED|Overall Study||162
1433933|NCT02357459|3511657|P2|STARTED|Overall Study||163
1433934|NCT02357459|3511658|P1|STARTED|Overall Study||161
1433935|NCT02357342|3511702|P2|NOT COMPLETED|Extension Study||0
1433936|NCT02357342|3511703|P1|NOT COMPLETED|Extension Study||0
1433937|NCT02357342|3511702|P2|COMPLETED|Extension Study||9
1433938|NCT02357342|3511703|P1|COMPLETED|Extension Study||4
1433939|NCT02357342|3511702|P2|STARTED|Extension Study||9
1433940|NCT02357342|3511703|P1|STARTED|Extension Study||4
1433941|NCT02357342|3511702|P2|NOT COMPLETED|First 6 Months||0
1433942|NCT02357342|3511703|P1|NOT COMPLETED|First 6 Months||2
1433943|NCT02357342|3511702|P2|COMPLETED|First 6 Months||20
1433944|NCT02357342|3511703|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
1433945|NCT02357342|3511702|P2|STARTED|First 6 Months||20
1433946|NCT02357342|3511703|P1|STARTED|First 6 Months||20
1433947|NCT02357264|3511715|P2|NOT COMPLETED|Overall Study||0
1433948|NCT02357264|3511716|P1|NOT COMPLETED|Overall Study||0
1433949|NCT02357264|3511715|P2|COMPLETED|Overall Study||130
1433950|NCT02357264|3511716|P1|COMPLETED|Overall Study||56
1433951|NCT02357264|3511715|P2|STARTED|Overall Study||130
1433952|NCT02357264|3511716|P1|STARTED|Overall Study||56
1433953|NCT02357173|3511725|P3|NOT COMPLETED|Overall Study||6
1433954|NCT02357173|3511726|P2|NOT COMPLETED|Overall Study||6
1433955|NCT02357173|3511727|P1|NOT COMPLETED|Overall Study||6
1433956|NCT02357173|3511725|P3|COMPLETED|Overall Study||16
1433957|NCT02357173|3511726|P2|COMPLETED|Overall Study||15
1433958|NCT02357173|3511727|P1|COMPLETED|Overall Study||19
1433959|NCT02357173|3511725|P3|STARTED|Overall Study||22
1433960|NCT02357173|3511726|P2|STARTED|Overall Study||21
1433961|NCT02357173|3511727|P1|STARTED|Overall Study||25
1433962|NCT02356900|3511746|P2|NOT COMPLETED|Overall Study||0
1433963|NCT02356900|3511747|P1|NOT COMPLETED|Overall Study||0
1433964|NCT02356900|3511746|P2|COMPLETED|Overall Study||10
1433965|NCT02356900|3511747|P1|COMPLETED|Overall Study||11
1433966|NCT02356900|3511746|P2|STARTED|Overall Study||10
1433967|NCT02356900|3511747|P1|STARTED|Overall Study||11
1433968|NCT02356783|3511767|P2|NOT COMPLETED|Overall Study||3
1433969|NCT02356783|3511768|P1|NOT COMPLETED|Overall Study||1
1433970|NCT02356783|3511767|P2|COMPLETED|Overall Study||14
1433971|NCT02356783|3511768|P1|COMPLETED|Overall Study||15
1433972|NCT02356783|3511767|P2|STARTED|Overall Study||17
1433973|NCT02356783|3511768|P1|STARTED|Overall Study||16
1433974|NCT02356588|3511778|P2|NOT COMPLETED|Overall Study||13
1433975|NCT02356588|3511779|P1|NOT COMPLETED|Overall Study||5
1433976|NCT02356588|3511778|P2|COMPLETED|Overall Study||41
1433977|NCT02356588|3511779|P1|COMPLETED|Overall Study||102
1433978|NCT02356588|3511778|P2|STARTED|Overall Study||54
1433979|NCT02356588|3511779|P1|STARTED|Overall Study||107
1433980|NCT02356562|3511813|P2|NOT COMPLETED|Overall Study||1
1433981|NCT02356562|3511814|P1|NOT COMPLETED|Overall Study||2
1433982|NCT02356562|3511813|P2|COMPLETED|Overall Study||6
1433983|NCT02356562|3511814|P1|COMPLETED|Overall Study||20
1433984|NCT02356562|3511813|P2|STARTED|Overall Study||7
1433985|NCT02356562|3511814|P1|STARTED|Overall Study||22
1433986|NCT02356471|3511824|P1|NOT COMPLETED|Overall Study||6
1433987|NCT02356471|3511824|P1|COMPLETED|Overall Study||28
1433988|NCT02356471|3511824|P1|STARTED|Overall Study||34
1433989|NCT02356107|3511837|P1|NOT COMPLETED|Overall Study||3
1433990|NCT02356107|3511837|P1|COMPLETED|Overall Study||12
1433991|NCT02356107|3511837|P1|STARTED|Overall Study||15
1433992|NCT02355977|3511844|P3|NOT COMPLETED|Overall Study||0
1433993|NCT02355977|3511845|P2|NOT COMPLETED|Overall Study||0
1433994|NCT02355977|3511846|P1|NOT COMPLETED|Overall Study||0
1433995|NCT02355977|3511844|P3|COMPLETED|Overall Study||23
1433996|NCT02355977|3511845|P2|COMPLETED|Overall Study||26
1433997|NCT02355977|3511846|P1|COMPLETED|Overall Study||21
1433998|NCT02355977|3511844|P3|STARTED|Overall Study||23
1433999|NCT02355977|3511845|P2|STARTED|Overall Study||26
1434000|NCT02355977|3511846|P1|STARTED|Overall Study||21
1434001|NCT02355743|3511860|P1|NOT COMPLETED|Overall Study||2
1434002|NCT02355743|3511860|P1|COMPLETED|Overall Study||6
1434003|NCT02355743|3511860|P1|STARTED|Overall Study||8
1434004|NCT02355691|3511868|P2|NOT COMPLETED|Overall Study||9
1434005|NCT02355691|3511869|P1|NOT COMPLETED|Overall Study||7
1434006|NCT02355691|3511868|P2|COMPLETED|Overall Study||0
1434007|NCT02355691|3511869|P1|COMPLETED|Overall Study||0
1434008|NCT02355691|3511868|P2|2nd Postop Visit|Overall Study||9
1434009|NCT02355691|3511869|P1|2nd Postop Visit|Overall Study||7
1434010|NCT02355691|3511868|P2|1st Postop Visit|Overall Study||9
1434011|NCT02355691|3511869|P1|1st Postop Visit|Overall Study||7
1434012|NCT02355691|3511868|P2|STARTED|Overall Study||9
1434013|NCT02355691|3511869|P1|STARTED|Overall Study||7
1434014|NCT02355275|3511877|P1|NOT COMPLETED|Overall Study||8
1434015|NCT02355275|3511877|P1|COMPLETED|Overall Study||14
1434016|NCT02355275|3511877|P1|STARTED|Overall Study||22
1434017|NCT02355158|3511882|P1|NOT COMPLETED|Overall Study||150
1434018|NCT02355158|3511882|P1|COMPLETED|Overall Study||47
1434019|NCT02355158|3511882|P1|STARTED|Overall Study||197
1434020|NCT02355028|3511888|P2|NOT COMPLETED|Overall Study||5
1434021|NCT02355028|3511889|P1|NOT COMPLETED|Overall Study||11
1434022|NCT02355028|3511888|P2|COMPLETED|Overall Study||41
1434023|NCT02355028|3511889|P1|COMPLETED|Overall Study||36
1434024|NCT02355028|3511888|P2|Treated|Overall Study||45
1434025|NCT02355028|3511889|P1|Treated|Overall Study||46
1434026|NCT02355028|3511888|P2|STARTED|Overall Study||46
1434027|NCT02355028|3511889|P1|STARTED|Overall Study||47
1434028|NCT02354976|3511925|P3|NOT COMPLETED|Overall Study||3
1434029|NCT02354976|3511926|P2|NOT COMPLETED|Overall Study||1
1434030|NCT02354976|3511927|P1|NOT COMPLETED|Overall Study||2
1434031|NCT02354976|3511925|P3|COMPLETED|Overall Study||23
1434032|NCT02354976|3511926|P2|COMPLETED|Overall Study||26
1434033|NCT02354976|3511927|P1|COMPLETED|Overall Study||23
1434034|NCT02354976|3511925|P3|STARTED|Overall Study||26
1434035|NCT02354976|3511926|P2|STARTED|Overall Study||27
1434036|NCT02354976|3511927|P1|STARTED|Overall Study||25
1434037|NCT02354924|3511938|P2|NOT COMPLETED|Overall Study||0
1434038|NCT02354924|3511939|P1|NOT COMPLETED|Overall Study||0
1434039|NCT02354924|3511938|P2|COMPLETED|Overall Study||20
1434040|NCT02354924|3511939|P1|COMPLETED|Overall Study||40
1434041|NCT02354924|3511938|P2|STARTED|Overall Study||20
1434042|NCT02354924|3511939|P1|STARTED|Overall Study||40
1434043|NCT02354833|3511951|P2|NOT COMPLETED|Overall Study||0
1434044|NCT02354833|3511952|P1|NOT COMPLETED|Overall Study||0
1434045|NCT02354833|3511951|P2|COMPLETED|Overall Study||43
1434046|NCT02354833|3511952|P1|COMPLETED|Overall Study||38
1434047|NCT02354833|3511951|P2|STARTED|Overall Study||43
1434048|NCT02354833|3511952|P1|STARTED|Overall Study||38
1434049|NCT02354599|3511970|P6|NOT COMPLETED|Overall Study||1
1434050|NCT02354599|3511971|P5|NOT COMPLETED|Overall Study||0
1434051|NCT02354599|3511972|P4|NOT COMPLETED|Overall Study||0
1434052|NCT02354599|3511973|P3|NOT COMPLETED|Overall Study||0
1434053|NCT02354599|3511974|P2|NOT COMPLETED|Overall Study||1
1434054|NCT02354599|3511975|P1|NOT COMPLETED|Overall Study||1
1434055|NCT02354599|3511970|P6|COMPLETED|Overall Study||5
1434056|NCT02354599|3511971|P5|COMPLETED|Overall Study||2
1434057|NCT02354599|3511972|P4|COMPLETED|Overall Study||6
1434058|NCT02354599|3511973|P3|COMPLETED|Overall Study||6
1434059|NCT02354599|3511974|P2|COMPLETED|Overall Study||5
1434060|NCT02354599|3511975|P1|COMPLETED|Overall Study||5
1434061|NCT02354599|3511970|P6|STARTED|Overall Study||6
1434062|NCT02354599|3511971|P5|STARTED|Overall Study||2
1434063|NCT02354599|3511972|P4|STARTED|Overall Study||6
1434064|NCT02354599|3511973|P3|STARTED|Overall Study||6
1434065|NCT02354599|3511974|P2|STARTED|Overall Study||6
1434066|NCT02354599|3511975|P1|STARTED|Overall Study||6
1434067|NCT02354443|3512045|P1|NOT COMPLETED|Overall Study||0
1434068|NCT02354443|3512045|P1|COMPLETED|Overall Study||1
1434069|NCT02354443|3512045|P1|STARTED|Overall Study||1
1434070|NCT02354417|3512049|P1|NOT COMPLETED|Overall Study||1
1434071|NCT02354417|3512049|P1|COMPLETED|Overall Study||2
1434072|NCT02354417|3512049|P1|STARTED|Overall Study||3
1434073|NCT02354235|3512055|P2|NOT COMPLETED|Overall Study||7
1434074|NCT02354235|3512056|P1|NOT COMPLETED|Overall Study||3
1434075|NCT02354235|3512055|P2|COMPLETED|Overall Study||61
1434076|NCT02354235|3512056|P1|COMPLETED|Overall Study||67
1434077|NCT02354235|3512055|P2|STARTED|Overall Study||68
1434078|NCT02354235|3512056|P1|STARTED|Overall Study||70
1434079|NCT02354222|3512072|P2|NOT COMPLETED|Overall Study||11
1434080|NCT02354222|3512073|P1|NOT COMPLETED|Overall Study||4
1434081|NCT02354222|3512072|P2|COMPLETED|Overall Study||66
1434082|NCT02354222|3512073|P1|COMPLETED|Overall Study||73
1434083|NCT02354222|3512072|P2|STARTED|Overall Study||77
1434084|NCT02354222|3512073|P1|STARTED|Overall Study||77
1434085|NCT02353871|3512089|P2|NOT COMPLETED|Overall Study||9
1434086|NCT02353871|3512090|P1|NOT COMPLETED|Overall Study||3
1434087|NCT02353871|3512089|P2|COMPLETED|Overall Study||51
1434088|NCT02353871|3512090|P1|COMPLETED|Overall Study||122
1434089|NCT02353871|3512089|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
1434090|NCT02353871|3512090|P1|STARTED|Overall Study|Randomised.|125
1434091|NCT02353754|3512112|P2|NOT COMPLETED|Overall Study||0
1434092|NCT02353754|3512113|P1|NOT COMPLETED|Overall Study||2
1434093|NCT02353754|3512112|P2|COMPLETED|Overall Study||0
1434094|NCT02353754|3512113|P1|COMPLETED|Overall Study||10
1434095|NCT02353754|3512112|P2|STARTED|Overall Study||0
1434096|NCT02353754|3512113|P1|STARTED|Overall Study||12
1434097|NCT02353572|3512123|P1|NOT COMPLETED|Overall Study||3
1434098|NCT02353572|3512123|P1|COMPLETED|Overall Study||0
1434099|NCT02353572|3512123|P1|STARTED|Overall Study||3
1434100|NCT02353468|3512127|P1|NOT COMPLETED|Overall Study||3
1434101|NCT02353468|3512127|P1|COMPLETED|Overall Study||0
1434102|NCT02353468|3512127|P1|STARTED|Overall Study||3
1434103|NCT02353442|3512133|P2|NOT COMPLETED|Overall Study||4
1434104|NCT02353442|3512134|P1|NOT COMPLETED|Overall Study||3
1434105|NCT02353442|3512133|P2|COMPLETED|Overall Study||27
1434106|NCT02353442|3512134|P1|COMPLETED|Overall Study||25
1434107|NCT02353442|3512133|P2|STARTED|Overall Study||31
1434108|NCT02353442|3512134|P1|STARTED|Overall Study||28
1434109|NCT02353299|3512148|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
1434110|NCT02353299|3512149|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
1434111|NCT02353299|3512150|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
1434112|NCT02353299|3512151|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
1434113|NCT02353299|3512148|P4|COMPLETED|Fourth Intervention (1 Night)||13
1434114|NCT02353299|3512149|P3|COMPLETED|Fourth Intervention (1 Night)||13
1434115|NCT02353299|3512150|P2|COMPLETED|Fourth Intervention (1 Night)||12
1434116|NCT02353299|3512151|P1|COMPLETED|Fourth Intervention (1 Night)||13
1434117|NCT02353299|3512148|P4|STARTED|Fourth Intervention (1 Night)||13
1434118|NCT02353299|3512149|P3|STARTED|Fourth Intervention (1 Night)||13
1434119|NCT02353299|3512150|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
1434120|NCT02353299|3512151|P1|STARTED|Fourth Intervention (1 Night)||13
1434121|NCT02353299|3512148|P4|NOT COMPLETED|Third Intervention (1 Night)||0
1434122|NCT02353299|3512149|P3|NOT COMPLETED|Third Intervention (1 Night)||0
1434123|NCT02353299|3512150|P2|NOT COMPLETED|Third Intervention (1 Night)||0
1434124|NCT02353299|3512151|P1|NOT COMPLETED|Third Intervention (1 Night)||0
1434125|NCT02353299|3512148|P4|COMPLETED|Third Intervention (1 Night)||13
1434126|NCT02353299|3512149|P3|COMPLETED|Third Intervention (1 Night)||13
1434127|NCT02353299|3512150|P2|COMPLETED|Third Intervention (1 Night)||13
1434128|NCT02353299|3512151|P1|COMPLETED|Third Intervention (1 Night)||13
1434129|NCT02353299|3512148|P4|STARTED|Third Intervention (1 Night)||13
1434130|NCT02353299|3512149|P3|STARTED|Third Intervention (1 Night)||13
1434131|NCT02353299|3512150|P2|STARTED|Third Intervention (1 Night)||13
1434132|NCT02353299|3512151|P1|STARTED|Third Intervention (1 Night)||13
1434133|NCT02353299|3512148|P4|NOT COMPLETED|Second Intervention (1 Night)||0
1434134|NCT02353299|3512149|P3|NOT COMPLETED|Second Intervention (1 Night)||0
1434135|NCT02353299|3512150|P2|NOT COMPLETED|Second Intervention (1 Night)||0
1434136|NCT02353299|3512151|P1|NOT COMPLETED|Second Intervention (1 Night)||0
1434137|NCT02353299|3512148|P4|COMPLETED|Second Intervention (1 Night)||13
1434138|NCT02353299|3512149|P3|COMPLETED|Second Intervention (1 Night)||13
1434139|NCT02353299|3512150|P2|COMPLETED|Second Intervention (1 Night)||13
1434140|NCT02353299|3512151|P1|COMPLETED|Second Intervention (1 Night)||13
1434141|NCT02353299|3512148|P4|STARTED|Second Intervention (1 Night)||13
1434142|NCT02353299|3512149|P3|STARTED|Second Intervention (1 Night)||13
1434143|NCT02353299|3512150|P2|STARTED|Second Intervention (1 Night)||13
1434144|NCT02353299|3512151|P1|STARTED|Second Intervention (1 Night)||13
1434145|NCT02353299|3512148|P4|NOT COMPLETED|First Intervention (1 Night)||0
1434146|NCT02353299|3512149|P3|NOT COMPLETED|First Intervention (1 Night)||0
1434147|NCT02353299|3512150|P2|NOT COMPLETED|First Intervention (1 Night)||0
1434148|NCT02353299|3512151|P1|NOT COMPLETED|First Intervention (1 Night)||0
1434149|NCT02353299|3512148|P4|COMPLETED|First Intervention (1 Night)||13
1434150|NCT02353299|3512149|P3|COMPLETED|First Intervention (1 Night)||13
1434151|NCT02353299|3512150|P2|COMPLETED|First Intervention (1 Night)||13
1434152|NCT02353299|3512151|P1|COMPLETED|First Intervention (1 Night)||13
1434153|NCT02353299|3512148|P4|STARTED|First Intervention (1 Night)||13
1434154|NCT02353299|3512149|P3|STARTED|First Intervention (1 Night)||13
1434155|NCT02353299|3512150|P2|STARTED|First Intervention (1 Night)||13
1434156|NCT02353299|3512151|P1|STARTED|First Intervention (1 Night)||13
1434157|NCT02352844|3512185|P1|NOT COMPLETED|Overall Study||0
1434158|NCT02352844|3512185|P1|COMPLETED|Overall Study||12
1434159|NCT02352844|3512185|P1|STARTED|Overall Study||12
1434160|NCT02352831|3512193|P2|NOT COMPLETED|Overall Study||0
1434161|NCT02352831|3512194|P1|NOT COMPLETED|Overall Study||0
1434162|NCT02352831|3512193|P2|COMPLETED|Overall Study||10
1434163|NCT02352831|3512194|P1|COMPLETED|Overall Study||6
1434164|NCT02352831|3512193|P2|STARTED|Overall Study||10
1434165|NCT02352831|3512194|P1|STARTED|Overall Study||6
1434166|NCT02352779|3512214|P3|NOT COMPLETED|Overall Study||2
1434167|NCT02352779|3512215|P2|NOT COMPLETED|Overall Study||1
1434168|NCT02352779|3512216|P1|NOT COMPLETED|Overall Study||8
1434169|NCT02352779|3512214|P3|COMPLETED|Overall Study||33
1434170|NCT02352779|3512215|P2|COMPLETED|Overall Study||35
1434171|NCT02352779|3512216|P1|COMPLETED|Overall Study||29
1434172|NCT02352779|3512214|P3|STARTED|Overall Study||35
1434173|NCT02352779|3512215|P2|STARTED|Overall Study||36
1434174|NCT02352779|3512216|P1|STARTED|Overall Study||37
1434175|NCT02352363|3512226|P2|NOT COMPLETED|Overall Study||3
1434176|NCT02352363|3512227|P1|NOT COMPLETED|Overall Study||7
1434177|NCT02352363|3512226|P2|COMPLETED|Overall Study||127
1434178|NCT02352363|3512227|P1|COMPLETED|Overall Study||271
1434179|NCT02352363|3512226|P2|STARTED|Overall Study||130
1434180|NCT02352363|3512227|P1|STARTED|Overall Study||278
1434181|NCT02352298|3512239|P1|NOT COMPLETED|Overall Study||0
1434182|NCT02352298|3512239|P1|COMPLETED|Overall Study||52
1434183|NCT02352298|3512239|P1|STARTED|Overall Study||52
1434184|NCT02351960|3512246|P2|NOT COMPLETED|Overall Study||12
1434185|NCT02351960|3512247|P1|NOT COMPLETED|Overall Study||11
1434186|NCT02351960|3512246|P2|COMPLETED|Overall Study||76
1434187|NCT02351960|3512247|P1|COMPLETED|Overall Study||197
1434188|NCT02351960|3512246|P2|STARTED|Overall Study||88
1434189|NCT02351960|3512247|P1|STARTED|Overall Study||208
1434190|NCT02351934|3512268|P2|NOT COMPLETED|Follow-Up||10
1434191|NCT02351934|3512269|P1|NOT COMPLETED|Follow-Up||12
1434192|NCT02351934|3512268|P2|COMPLETED|Follow-Up||51
1434193|NCT02351934|3512269|P1|COMPLETED|Follow-Up||44
1434194|NCT02351934|3512268|P2|STARTED|Follow-Up||61
1434195|NCT02351934|3512269|P1|STARTED|Follow-Up||56
1434196|NCT02351934|3512268|P2|NOT COMPLETED|Allocation||0
1434197|NCT02351934|3512269|P1|NOT COMPLETED|Allocation||6
1434198|NCT02351934|3512268|P2|COMPLETED|Allocation||61
1434199|NCT02351934|3512269|P1|COMPLETED|Allocation||56
1434200|NCT02351934|3512268|P2|Received Allocation|Allocation||61
1434201|NCT02351934|3512269|P1|Received Allocation|Allocation||56
1434202|NCT02351934|3512268|P2|STARTED|Allocation||61
1434203|NCT02351934|3512269|P1|STARTED|Allocation||62
1434204|NCT02351817|3512285|P2|NOT COMPLETED|Period 2||2
1434205|NCT02351817|3512286|P1|NOT COMPLETED|Period 2||1
1434206|NCT02351817|3512285|P2|COMPLETED|Period 2||3
1434207|NCT02351817|3512286|P1|COMPLETED|Period 2||4
1434208|NCT02351817|3512285|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
1434209|NCT02351817|3512286|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
1434210|NCT02351817|3512285|P2|NOT COMPLETED|Period 1||3
1434211|NCT02351817|3512286|P1|NOT COMPLETED|Period 1||1
1434212|NCT02351817|3512285|P2|COMPLETED|Period 1||2
1434213|NCT02351817|3512286|P1|COMPLETED|Period 1||4
1434214|NCT02351817|3512285|P2|STARTED|Period 1||5
1434215|NCT02351817|3512286|P1|STARTED|Period 1||5
1434216|NCT02351817|3512285|P2|NOT COMPLETED|Baseline Period||0
1434217|NCT02351817|3512286|P1|NOT COMPLETED|Baseline Period||0
1434218|NCT02351817|3512285|P2|COMPLETED|Baseline Period||5
1434219|NCT02351817|3512286|P1|COMPLETED|Baseline Period||5
1434220|NCT02351817|3512285|P2|STARTED|Baseline Period||5
1434221|NCT02351817|3512286|P1|STARTED|Baseline Period||5
1434222|NCT02351505|3512293|P1|NOT COMPLETED|Overall Study||0
1434223|NCT02351505|3512293|P1|COMPLETED|Overall Study||1
1434224|NCT02351505|3512293|P1|STARTED|Overall Study||1
1434225|NCT02351037|3512307|P3|NOT COMPLETED|Overall Study||0
1434226|NCT02351037|3512308|P2|NOT COMPLETED|Overall Study||0
1434227|NCT02351037|3512309|P1|NOT COMPLETED|Overall Study||0
1434228|NCT02351037|3512307|P3|COMPLETED|Overall Study||8
1434229|NCT02351037|3512308|P2|COMPLETED|Overall Study||21
1434230|NCT02351037|3512309|P1|COMPLETED|Overall Study||7
1434231|NCT02351037|3512307|P3|STARTED|Overall Study||8
1434232|NCT02351037|3512308|P2|STARTED|Overall Study||21
1434233|NCT02351037|3512309|P1|STARTED|Overall Study||7
1434234|NCT02350881|3512317|P1|NOT COMPLETED|Overall Study||0
1434235|NCT02350881|3512317|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
1434236|NCT02350881|3512317|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
1434237|NCT02350777|3512347|P2|NOT COMPLETED|Overall Study||0
1434238|NCT02350777|3512348|P1|NOT COMPLETED|Overall Study||0
1434239|NCT02350777|3512347|P2|COMPLETED|Overall Study||2
1434240|NCT02350777|3512348|P1|COMPLETED|Overall Study||2
1434241|NCT02350777|3512347|P2|STARTED|Overall Study||2
1434242|NCT02350777|3512348|P1|STARTED|Overall Study||2
1434243|NCT02350569|3512354|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
1434244|NCT02350569|3512354|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
1434245|NCT02350569|3512354|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
1434246|NCT02350569|3512354|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
1434247|NCT02350569|3512354|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
1434248|NCT02350569|3512354|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
1434249|NCT02349711|3512366|P2|NOT COMPLETED|Overall Study||2
1434250|NCT02349711|3512367|P1|NOT COMPLETED|Overall Study||3
1434251|NCT02349711|3512366|P2|COMPLETED|Overall Study||84
1434252|NCT02349711|3512367|P1|COMPLETED|Overall Study||84
1434253|NCT02349711|3512366|P2|STARTED|Overall Study||86
1434254|NCT02349711|3512367|P1|STARTED|Overall Study||87
1434255|NCT02349685|3512382|P3|NOT COMPLETED|Overall Study||4
1434256|NCT02349685|3512383|P2|NOT COMPLETED|Overall Study||2
1434257|NCT02349685|3512384|P1|NOT COMPLETED|Overall Study||5
1434258|NCT02349685|3512382|P3|COMPLETED|Overall Study||37
1434259|NCT02349685|3512383|P2|COMPLETED|Overall Study||87
1434260|NCT02349685|3512384|P1|COMPLETED|Overall Study||84
1434261|NCT02349685|3512382|P3|STARTED|Overall Study||41
1434262|NCT02349685|3512383|P2|STARTED|Overall Study||89
1434263|NCT02349685|3512384|P1|STARTED|Overall Study||89
1434264|NCT02349646|3512395|P1|NOT COMPLETED|Overall Study||17
1434265|NCT02349646|3512395|P1|COMPLETED|Overall Study||16
1434266|NCT02349646|3512395|P1|Receive Permanent System|Overall Study||27
1434267|NCT02349646|3512395|P1|Received Trial System|Overall Study||24
1434268|NCT02349646|3512395|P1|STARTED|Overall Study||33
1434269|NCT02349542|3512400|P1|NOT COMPLETED|Overall Study||5
1434270|NCT02349542|3512400|P1|COMPLETED|Overall Study||15
1434271|NCT02349542|3512400|P1|STARTED|Overall Study||20
1434272|NCT02349451|3512409|P4|NOT COMPLETED|Overall Study||1
1434273|NCT02349451|3512410|P3|NOT COMPLETED|Overall Study||2
1434274|NCT02349451|3512411|P2|NOT COMPLETED|Overall Study||1
1434275|NCT02349451|3512412|P1|NOT COMPLETED|Overall Study||0
1434276|NCT02349451|3512409|P4|COMPLETED|Overall Study||72
1434277|NCT02349451|3512410|P3|COMPLETED|Overall Study||69
1434278|NCT02349451|3512411|P2|COMPLETED|Overall Study||71
1434279|NCT02349451|3512412|P1|COMPLETED|Overall Study||24
1434280|NCT02349451|3512409|P4|STARTED|Overall Study||73
1434281|NCT02349451|3512410|P3|STARTED|Overall Study||71
1434282|NCT02349451|3512411|P2|STARTED|Overall Study||72
1434283|NCT02349451|3512412|P1|STARTED|Overall Study||24
1434284|NCT02349438|3512448|P2|NOT COMPLETED|Period 2||0
1434285|NCT02349438|3512449|P1|NOT COMPLETED|Period 2||0
1434286|NCT02349438|3512448|P2|COMPLETED|Period 2||10
1434287|NCT02349438|3512449|P1|COMPLETED|Period 2||11
1434288|NCT02349438|3512448|P2|STARTED|Period 2||10
1434289|NCT02349438|3512449|P1|STARTED|Period 2||11
1434290|NCT02349438|3512448|P2|NOT COMPLETED|Period 1||0
1434291|NCT02349438|3512449|P1|NOT COMPLETED|Period 1||0
1434292|NCT02349438|3512448|P2|COMPLETED|Period 1||10
1434293|NCT02349438|3512449|P1|COMPLETED|Period 1||11
1434294|NCT02349438|3512448|P2|STARTED|Period 1||10
1434295|NCT02349438|3512449|P1|STARTED|Period 1||11
1434296|NCT02349360|3512461|P2|NOT COMPLETED|Overall Study||1
1434297|NCT02349360|3512462|P1|NOT COMPLETED|Overall Study||0
1434298|NCT02349360|3512461|P2|COMPLETED|Overall Study||20
1434299|NCT02349360|3512462|P1|COMPLETED|Overall Study||21
1434300|NCT02349360|3512461|P2|STARTED|Overall Study||21
1434301|NCT02349360|3512462|P1|STARTED|Overall Study||21
1434302|NCT02349295|3512473|P5|NOT COMPLETED|IR (Week 16-24)||1
1434303|NCT02349295|3512474|P4|NOT COMPLETED|IR (Week 16-24)||0
1434304|NCT02349295|3512475|P3|NOT COMPLETED|IR (Week 16-24)||0
1434305|NCT02349295|3512476|P2|NOT COMPLETED|IR (Week 16-24)||0
1434306|NCT02349295|3512477|P1|NOT COMPLETED|IR (Week 16-24)||0
1434307|NCT02349295|3512473|P5|COMPLETED|IR (Week 16-24)||32
1434308|NCT02349295|3512474|P4|COMPLETED|IR (Week 16-24)||31
1434309|NCT02349295|3512475|P3|COMPLETED|IR (Week 16-24)||0
1434310|NCT02349295|3512476|P2|COMPLETED|IR (Week 16-24)||0
1434311|NCT02349295|3512477|P1|COMPLETED|IR (Week 16-24)||0
1434312|NCT02349295|3512473|P5|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W and IR from ixekizumab 80 mg Q2W.|33
1434313|NCT02349295|3512474|P4|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W and IR from ixekizumab 80 mg Q4W.|31
1434314|NCT02349295|3512475|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
1434315|NCT02349295|3512476|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
1434316|NCT02349295|3512477|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
1434317|NCT02349295|3512473|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1434318|NCT02349295|3512474|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
1434319|NCT02349295|3512475|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
1434320|NCT02349295|3512476|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
1434321|NCT02349295|3512477|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
1434322|NCT02349295|3512473|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
1434323|NCT02349295|3512474|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
1434324|NCT02349295|3512475|P3|COMPLETED|Double Blind Treatment (Week 0-24)||109
1434325|NCT02349295|3512476|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
1434326|NCT02349295|3512477|P1|COMPLETED|Double Blind Treatment (Week 0-24)||94
1434327|NCT02349295|3512473|P5|STARTED|Double Blind Treatment (Week 0-24)||0
1434328|NCT02349295|3512474|P4|STARTED|Double Blind Treatment (Week 0-24)||0
1434329|NCT02349295|3512475|P3|STARTED|Double Blind Treatment (Week 0-24)||123
1434330|NCT02349295|3512476|P2|STARTED|Double Blind Treatment (Week 0-24)||122
1434331|NCT02349295|3512477|P1|STARTED|Double Blind Treatment (Week 0-24)||118
1434332|NCT02349152|3512553|P2|NOT COMPLETED|Overall Study||4
1434333|NCT02349152|3512554|P1|NOT COMPLETED|Overall Study||6
1434334|NCT02349152|3512553|P2|COMPLETED|Overall Study||52
1434335|NCT02349152|3512554|P1|COMPLETED|Overall Study||54
1434336|NCT02349152|3512553|P2|STARTED|Overall Study||56
1434337|NCT02349152|3512554|P1|STARTED|Overall Study||60
1434338|NCT02349061|3512580|P2|NOT COMPLETED|Overall Study||4
1434339|NCT02349061|3512581|P1|NOT COMPLETED|Overall Study||9
1434340|NCT02349061|3512580|P2|COMPLETED|Overall Study||56
1434341|NCT02349061|3512581|P1|COMPLETED|Overall Study||33
1434342|NCT02349061|3512580|P2|STARTED|Overall Study||60
1434343|NCT02349061|3512581|P1|STARTED|Overall Study||42
1434344|NCT02349048|3512589|P2|NOT COMPLETED|Overall Study||0
1434345|NCT02349048|3512590|P1|NOT COMPLETED|Overall Study||5
1434346|NCT02349048|3512589|P2|COMPLETED|Overall Study||9
1434347|NCT02349048|3512590|P1|COMPLETED|Overall Study||54
1434348|NCT02349048|3512589|P2|STARTED|Overall Study||9
1434349|NCT02349048|3512590|P1|STARTED|Overall Study||59
1434350|NCT02348918|3512619|P9|NOT COMPLETED|Overall Study||0
1434351|NCT02348918|3512620|P8|NOT COMPLETED|Overall Study||0
1434352|NCT02348918|3512621|P7|NOT COMPLETED|Overall Study||0
1434353|NCT02348918|3512622|P6|NOT COMPLETED|Overall Study||0
1434354|NCT02348918|3512623|P5|NOT COMPLETED|Overall Study||0
1434355|NCT02348918|3512624|P4|NOT COMPLETED|Overall Study||0
1434356|NCT02348918|3512625|P3|NOT COMPLETED|Overall Study||0
1434357|NCT02348918|3512626|P2|NOT COMPLETED|Overall Study||0
1434358|NCT02348918|3512627|P1|NOT COMPLETED|Overall Study||0
1434359|NCT02348918|3512619|P9|COMPLETED|Overall Study||15
1434360|NCT02348918|3512620|P8|COMPLETED|Overall Study||16
1434361|NCT02348918|3512621|P7|COMPLETED|Overall Study||13
1434362|NCT02348918|3512622|P6|COMPLETED|Overall Study||17
1434363|NCT02348918|3512623|P5|COMPLETED|Overall Study||19
1434364|NCT02348918|3512624|P4|COMPLETED|Overall Study||24
1434365|NCT02348918|3512625|P3|COMPLETED|Overall Study||42
1434366|NCT02348918|3512626|P2|COMPLETED|Overall Study||33
1434367|NCT02348918|3512627|P1|COMPLETED|Overall Study||39
1434368|NCT02348918|3512619|P9|STARTED|Overall Study||15
1434369|NCT02348918|3512620|P8|STARTED|Overall Study||16
1434370|NCT02348918|3512621|P7|STARTED|Overall Study||13
1434371|NCT02348918|3512622|P6|STARTED|Overall Study||17
1434372|NCT02348918|3512623|P5|STARTED|Overall Study||19
1434373|NCT02348918|3512624|P4|STARTED|Overall Study||24
1434374|NCT02348918|3512625|P3|STARTED|Overall Study||42
1434375|NCT02348918|3512626|P2|STARTED|Overall Study||33
1434376|NCT02348918|3512627|P1|STARTED|Overall Study||39
1434377|NCT02348723|3512649|P2|NOT COMPLETED|Overall Study||26
1434378|NCT02348723|3512650|P1|NOT COMPLETED|Overall Study||28
1434379|NCT02348723|3512649|P2|COMPLETED|Overall Study||312
1434380|NCT02348723|3512650|P1|COMPLETED|Overall Study||310
1434381|NCT02348723|3512649|P2|STARTED|Overall Study||338
1434382|NCT02348723|3512650|P1|STARTED|Overall Study||338
1434383|NCT02348658|3512662|P2|NOT COMPLETED|Period 2 (7 Days)||0
1434384|NCT02348658|3512663|P1|NOT COMPLETED|Period 2 (7 Days)||0
1434385|NCT02348658|3512662|P2|COMPLETED|Period 2 (7 Days)||6
1434386|NCT02348658|3512663|P1|COMPLETED|Period 2 (7 Days)||6
1434387|NCT02348658|3512662|P2|STARTED|Period 2 (7 Days)||6
1434388|NCT02348658|3512663|P1|STARTED|Period 2 (7 Days)||6
1434389|NCT02348658|3512662|P2|NOT COMPLETED|Washout Period (22 Days)||0
1434390|NCT02348658|3512663|P1|NOT COMPLETED|Washout Period (22 Days)||0
1434391|NCT02348658|3512662|P2|COMPLETED|Washout Period (22 Days)||6
1434392|NCT02348658|3512663|P1|COMPLETED|Washout Period (22 Days)||6
1434393|NCT02348658|3512662|P2|STARTED|Washout Period (22 Days)||6
1434394|NCT02348658|3512663|P1|STARTED|Washout Period (22 Days)||6
1434395|NCT02348658|3512662|P2|NOT COMPLETED|Period 1 (7 Days)||0
1434396|NCT02348658|3512663|P1|NOT COMPLETED|Period 1 (7 Days)||0
1434397|NCT02348658|3512662|P2|COMPLETED|Period 1 (7 Days)||6
1434398|NCT02348658|3512663|P1|COMPLETED|Period 1 (7 Days)||6
1434399|NCT02348658|3512662|P2|STARTED|Period 1 (7 Days)||6
1434400|NCT02348658|3512663|P1|STARTED|Period 1 (7 Days)||6
1434401|NCT02348359|3512701|P4|NOT COMPLETED|Overall Study||12
1434402|NCT02348359|3512702|P3|NOT COMPLETED|Overall Study||14
1434403|NCT02348359|3512703|P2|NOT COMPLETED|Overall Study||17
1434404|NCT02348359|3512704|P1|NOT COMPLETED|Overall Study||11
1434405|NCT02348359|3512701|P4|COMPLETED|Overall Study||27
1434406|NCT02348359|3512702|P3|COMPLETED|Overall Study||25
1434407|NCT02348359|3512703|P2|COMPLETED|Overall Study||22
1434408|NCT02348359|3512704|P1|COMPLETED|Overall Study||29
1434409|NCT02348359|3512701|P4|STARTED|Overall Study||39
1434410|NCT02348359|3512702|P3|STARTED|Overall Study||39
1434411|NCT02348359|3512703|P2|STARTED|Overall Study||39
1434412|NCT02348359|3512704|P1|STARTED|Overall Study||40
1434413|NCT02347774|3512717|P3|NOT COMPLETED|On Study Treatment||36
1434414|NCT02347774|3512718|P2|NOT COMPLETED|On Study Treatment||31
1434415|NCT02347774|3512719|P1|NOT COMPLETED|On Study Treatment||24
1434416|NCT02347774|3512717|P3|COMPLETED|On Study Treatment||177
1434417|NCT02347774|3512718|P2|COMPLETED|On Study Treatment||183
1434418|NCT02347774|3512719|P1|COMPLETED|On Study Treatment||190
1434419|NCT02347774|3512717|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
1434420|NCT02347774|3512718|P2|STARTED|On Study Treatment||214
1434421|NCT02347774|3512719|P1|STARTED|On Study Treatment||214
1434422|NCT02347774|3512717|P3|NOT COMPLETED|Study Participation||25
1434423|NCT02347774|3512718|P2|NOT COMPLETED|Study Participation||21
1434424|NCT02347774|3512719|P1|NOT COMPLETED|Study Participation||15
1434425|NCT02347774|3512717|P3|COMPLETED|Study Participation||188
1434426|NCT02347774|3512718|P2|COMPLETED|Study Participation||193
1434427|NCT02347774|3512719|P1|COMPLETED|Study Participation||199
1434428|NCT02347774|3512717|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
1434429|NCT02347774|3512718|P2|STARTED|Study Participation||214
1434430|NCT02347774|3512719|P1|STARTED|Study Participation||214
1434431|NCT02347761|3512775|P3|NOT COMPLETED|On Study Treatment||42
1434432|NCT02347761|3512776|P2|NOT COMPLETED|On Study Treatment||23
1434433|NCT02347761|3512777|P1|NOT COMPLETED|On Study Treatment||27
1434434|NCT02347761|3512775|P3|COMPLETED|On Study Treatment||176
1434435|NCT02347761|3512776|P2|COMPLETED|On Study Treatment||194
1434436|NCT02347761|3512777|P1|COMPLETED|On Study Treatment||191
1434437|NCT02347761|3512775|P3|STARTED|On Study Treatment||218
1434438|NCT02347761|3512776|P2|STARTED|On Study Treatment||217
1434439|NCT02347761|3512777|P1|STARTED|On Study Treatment||218
1434440|NCT02347761|3512775|P3|NOT COMPLETED|All Collected||27
1434441|NCT02347761|3512776|P2|NOT COMPLETED|All Collected||14
1434442|NCT02347761|3512777|P1|NOT COMPLETED|All Collected||17
1434443|NCT02347761|3512775|P3|COMPLETED|All Collected||191
1434444|NCT02347761|3512776|P2|COMPLETED|All Collected||203
1434445|NCT02347761|3512777|P1|COMPLETED|All Collected||201
1434446|NCT02347761|3512775|P3|STARTED|All Collected||218
1434447|NCT02347761|3512776|P2|STARTED|All Collected||217
1434448|NCT02347761|3512777|P1|STARTED|All Collected||218
1434449|NCT02347657|3512838|P2|NOT COMPLETED|Overall Study||15
1434450|NCT02347657|3512839|P1|NOT COMPLETED|Overall Study||18
1434451|NCT02347657|3512838|P2|COMPLETED|Overall Study||236
1434452|NCT02347657|3512839|P1|COMPLETED|Overall Study||241
1434453|NCT02347657|3512838|P2|Treated|Overall Study||251
1434454|NCT02347657|3512839|P1|Treated|Overall Study||258
1434455|NCT02347657|3512838|P2|STARTED|Overall Study||251
1434456|NCT02347657|3512839|P1|STARTED|Overall Study||259
1434457|NCT02347605|3512870|P6|NOT COMPLETED|Overall Study||2
1434458|NCT02347605|3512871|P5|NOT COMPLETED|Overall Study||3
1434459|NCT02347605|3512872|P4|NOT COMPLETED|Overall Study||4
1434460|NCT02347605|3512873|P3|NOT COMPLETED|Overall Study||1
1434461|NCT02347605|3512874|P2|NOT COMPLETED|Overall Study||3
1434462|NCT02347605|3512875|P1|NOT COMPLETED|Overall Study||3
1434463|NCT02347605|3512870|P6|COMPLETED|Overall Study||7
1434464|NCT02347605|3512871|P5|COMPLETED|Overall Study||6
1434465|NCT02347605|3512872|P4|COMPLETED|Overall Study||6
1434466|NCT02347605|3512873|P3|COMPLETED|Overall Study||7
1434467|NCT02347605|3512874|P2|COMPLETED|Overall Study||7
1434468|NCT02347605|3512875|P1|COMPLETED|Overall Study||7
1434469|NCT02347605|3512870|P6|Completed Lab 2|Overall Study||8
1434470|NCT02347605|3512871|P5|Completed Lab 2|Overall Study||6
1434471|NCT02347605|3512872|P4|Completed Lab 2|Overall Study||7
1434472|NCT02347605|3512873|P3|Completed Lab 2|Overall Study||7
1434473|NCT02347605|3512874|P2|Completed Lab 2|Overall Study||7
1434474|NCT02347605|3512875|P1|Completed Lab 2|Overall Study||7
1434475|NCT02347605|3512870|P6|Completed Lab 1|Overall Study||9
1434476|NCT02347605|3512871|P5|Completed Lab 1|Overall Study||8
1434477|NCT02347605|3512872|P4|Completed Lab 1|Overall Study||10
1434478|NCT02347605|3512873|P3|Completed Lab 1|Overall Study||8
1434479|NCT02347605|3512874|P2|Completed Lab 1|Overall Study||10
1434480|NCT02347605|3512875|P1|Completed Lab 1|Overall Study||10
1434481|NCT02347605|3512870|P6|STARTED|Overall Study||9
1434482|NCT02347605|3512871|P5|STARTED|Overall Study||9
1434483|NCT02347605|3512872|P4|STARTED|Overall Study||10
1434484|NCT02347605|3512873|P3|STARTED|Overall Study||8
1434485|NCT02347605|3512874|P2|STARTED|Overall Study||10
1434486|NCT02347605|3512875|P1|STARTED|Overall Study||10
1434487|NCT02347488|3512886|P1|NOT COMPLETED|Overall Study||0
1434488|NCT02347488|3512886|P1|COMPLETED|Overall Study||30
1434489|NCT02347488|3512886|P1|STARTED|Overall Study||30
1434490|NCT02347189|3512896|P1|NOT COMPLETED|Overall Study||11
1434491|NCT02347189|3512896|P1|COMPLETED|Overall Study||28
1434492|NCT02347189|3512896|P1|Implanted > 24 Hours|Overall Study||30
1434493|NCT02347189|3512896|P1|Implanted|Overall Study||30
1434494|NCT02347189|3512896|P1|Catheterized|Overall Study||39
1434495|NCT02347189|3512896|P1|STARTED|Overall Study||39
1434496|NCT02347176|3512904|P4|NOT COMPLETED|Overall Study||4
1434497|NCT02347176|3512905|P3|NOT COMPLETED|Overall Study||8
1434498|NCT02347176|3512906|P2|NOT COMPLETED|Overall Study||10
1434499|NCT02347176|3512907|P1|NOT COMPLETED|Overall Study||12
1434500|NCT02347176|3512904|P4|COMPLETED|Overall Study||48
1434501|NCT02347176|3512905|P3|COMPLETED|Overall Study||43
1434502|NCT02347176|3512906|P2|COMPLETED|Overall Study||40
1434503|NCT02347176|3512907|P1|COMPLETED|Overall Study||39
1434504|NCT02347176|3512904|P4|STARTED|Overall Study||52
1434505|NCT02347176|3512905|P3|STARTED|Overall Study||51
1434506|NCT02347176|3512906|P2|STARTED|Overall Study||50
1434507|NCT02347176|3512907|P1|STARTED|Overall Study||51
1434508|NCT02347124|3512955|P2|NOT COMPLETED|Overall Study||99
1434509|NCT02347124|3512956|P1|NOT COMPLETED|Overall Study||93
1434510|NCT02347124|3512955|P2|COMPLETED|Overall Study||259
1434511|NCT02347124|3512956|P1|COMPLETED|Overall Study||267
1434512|NCT02347124|3512955|P2|2 Month Follow-up|Overall Study||275
1434513|NCT02347124|3512956|P1|2 Month Follow-up|Overall Study||298
1434514|NCT02347124|3512955|P2|STARTED|Overall Study||358
1434515|NCT02347124|3512956|P1|STARTED|Overall Study||360
1434516|NCT02347085|3512990|P1|NOT COMPLETED|Overall Study||10
1434517|NCT02347085|3512990|P1|COMPLETED|Overall Study||33
1434518|NCT02347085|3512990|P1|Placebo MDI|Overall Study||40
1434519|NCT02347085|3512990|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
1434520|NCT02347085|3512990|P1|STARTED|Overall Study||43
1434521|NCT02347072|3513012|P1|NOT COMPLETED|Overall Study||18
1434522|NCT02347072|3513012|P1|COMPLETED|Overall Study||62
1434523|NCT02347072|3513012|P1|Spiriva Respimat 5 µg|Overall Study||73
1434524|NCT02347072|3513012|P1|Placebo MDI|Overall Study||72
1434525|NCT02347072|3513012|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
1434526|NCT02347072|3513012|P1|STARTED|Overall Study||80
1434527|NCT02346877|3513046|P2|NOT COMPLETED|Overall Study||0
1434528|NCT02346877|3513047|P1|NOT COMPLETED|Overall Study||19
1434529|NCT02346877|3513046|P2|COMPLETED|Overall Study||0
1434530|NCT02346877|3513047|P1|COMPLETED|Overall Study||0
1434531|NCT02346877|3513046|P2|STARTED|Overall Study||0
1434532|NCT02346877|3513047|P1|STARTED|Overall Study||19
1434533|NCT02346721|3513057|P1|NOT COMPLETED|Overall Study||4
1434534|NCT02346721|3513057|P1|COMPLETED|Overall Study||107
1434535|NCT02346721|3513057|P1|STARTED|Overall Study||111
1434536|NCT02346643|3513066|P1|NOT COMPLETED|Overall Study||35
1434537|NCT02346643|3513066|P1|COMPLETED|Overall Study||6
1434538|NCT02346643|3513066|P1|Received Permanent System|Overall Study||31
1434539|NCT02346643|3513066|P1|Received Trial System|Overall Study||29
1434540|NCT02346643|3513066|P1|STARTED|Overall Study||41
1434541|NCT02346240|3513075|P17|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||6
1434542|NCT02346240|3513076|P16|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||13
1434543|NCT02346240|3513077|P15|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||14
1434544|NCT02346240|3513078|P14|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||7
1434545|NCT02346240|3513079|P13|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434546|NCT02346240|3513080|P12|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||3
1434547|NCT02346240|3513081|P11|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||2
1434548|NCT02346240|3513082|P10|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||1
1434549|NCT02346240|3513083|P9|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||4
1434550|NCT02346240|3513084|P8|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||2
1434551|NCT02346240|3513085|P7|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||2
1434552|NCT02346240|3513086|P6|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||1
1434553|NCT02346240|3513087|P5|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434554|NCT02346240|3513088|P4|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434555|NCT02346240|3513089|P3|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434556|NCT02346240|3513090|P2|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434557|NCT02346240|3513091|P1|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434558|NCT02346240|3513075|P17|COMPLETED|Finished Wk16 Entered Maintenance Period||30
1434559|NCT02346240|3513076|P16|COMPLETED|Finished Wk16 Entered Maintenance Period||36
1434560|NCT02346240|3513077|P15|COMPLETED|Finished Wk16 Entered Maintenance Period||71
1434561|NCT02346240|3513078|P14|COMPLETED|Finished Wk16 Entered Maintenance Period||46
1434562|NCT02346240|3513079|P13|COMPLETED|Finished Wk16 Entered Maintenance Period||49
1434563|NCT02346240|3513080|P12|COMPLETED|Finished Wk16 Entered Maintenance Period||47
1434564|NCT02346240|3513081|P11|COMPLETED|Finished Wk16 Entered Maintenance Period||23
1434565|NCT02346240|3513082|P10|COMPLETED|Finished Wk16 Entered Maintenance Period||43
1434566|NCT02346240|3513083|P9|COMPLETED|Finished Wk16 Entered Maintenance Period||40
1434567|NCT02346240|3513084|P8|COMPLETED|Finished Wk16 Entered Maintenance Period||20
1434568|NCT02346240|3513085|P7|COMPLETED|Finished Wk16 Entered Maintenance Period||48
1434569|NCT02346240|3513086|P6|COMPLETED|Finished Wk16 Entered Maintenance Period||23
1434570|NCT02346240|3513087|P5|COMPLETED|Finished Wk16 Entered Maintenance Period||2
1434571|NCT02346240|3513088|P4|COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434572|NCT02346240|3513089|P3|COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434573|NCT02346240|3513090|P2|COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434574|NCT02346240|3513091|P1|COMPLETED|Finished Wk16 Entered Maintenance Period||0
1434575|NCT02346240|3513075|P17|STARTED|Finished Wk16 Entered Maintenance Period||36
1434576|NCT02346240|3513076|P16|STARTED|Finished Wk16 Entered Maintenance Period||49
1434577|NCT02346240|3513077|P15|STARTED|Finished Wk16 Entered Maintenance Period||85
1434578|NCT02346240|3513078|P14|STARTED|Finished Wk16 Entered Maintenance Period||53
1434579|NCT02346240|3513079|P13|STARTED|Finished Wk16 Entered Maintenance Period||49
1434580|NCT02346240|3513080|P12|STARTED|Finished Wk16 Entered Maintenance Period||50
1434581|NCT02346240|3513081|P11|STARTED|Finished Wk16 Entered Maintenance Period||25
1434582|NCT02346240|3513082|P10|STARTED|Finished Wk16 Entered Maintenance Period||44
1434583|NCT02346240|3513083|P9|STARTED|Finished Wk16 Entered Maintenance Period||44
1434584|NCT02346240|3513084|P8|STARTED|Finished Wk16 Entered Maintenance Period||22
1434585|NCT02346240|3513085|P7|STARTED|Finished Wk16 Entered Maintenance Period||50
1434586|NCT02346240|3513086|P6|STARTED|Finished Wk16 Entered Maintenance Period||24
1434587|NCT02346240|3513087|P5|STARTED|Finished Wk16 Entered Maintenance Period||2
1434588|NCT02346240|3513088|P4|STARTED|Finished Wk16 Entered Maintenance Period||0
1434589|NCT02346240|3513089|P3|STARTED|Finished Wk16 Entered Maintenance Period||0
1434590|NCT02346240|3513090|P2|STARTED|Finished Wk16 Entered Maintenance Period||0
1434591|NCT02346240|3513091|P1|STARTED|Finished Wk16 Entered Maintenance Period||0
1434592|NCT02346240|3513075|P17|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434593|NCT02346240|3513076|P16|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434594|NCT02346240|3513077|P15|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434595|NCT02346240|3513078|P14|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434596|NCT02346240|3513079|P13|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434597|NCT02346240|3513080|P12|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434598|NCT02346240|3513081|P11|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434599|NCT02346240|3513082|P10|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434600|NCT02346240|3513083|P9|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434601|NCT02346240|3513084|P8|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434602|NCT02346240|3513085|P7|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434603|NCT02346240|3513086|P6|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434604|NCT02346240|3513087|P5|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
1434605|NCT02346240|3513088|P4|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
1434606|NCT02346240|3513089|P3|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
1434607|NCT02346240|3513090|P2|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
1434608|NCT02346240|3513091|P1|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
1434609|NCT02346240|3513075|P17|COMPLETED|Initial Period (Baseline to Week 16)||0
1434610|NCT02346240|3513076|P16|COMPLETED|Initial Period (Baseline to Week 16)||0
1434611|NCT02346240|3513077|P15|COMPLETED|Initial Period (Baseline to Week 16)||0
1434612|NCT02346240|3513078|P14|COMPLETED|Initial Period (Baseline to Week 16)||0
1434613|NCT02346240|3513079|P13|COMPLETED|Initial Period (Baseline to Week 16)||0
1434614|NCT02346240|3513080|P12|COMPLETED|Initial Period (Baseline to Week 16)||0
1434615|NCT02346240|3513081|P11|COMPLETED|Initial Period (Baseline to Week 16)||0
1434616|NCT02346240|3513082|P10|COMPLETED|Initial Period (Baseline to Week 16)||0
1434617|NCT02346240|3513083|P9|COMPLETED|Initial Period (Baseline to Week 16)||0
1434618|NCT02346240|3513084|P8|COMPLETED|Initial Period (Baseline to Week 16)||0
1434619|NCT02346240|3513085|P7|COMPLETED|Initial Period (Baseline to Week 16)||0
1434620|NCT02346240|3513086|P6|COMPLETED|Initial Period (Baseline to Week 16)||0
1434621|NCT02346240|3513087|P5|COMPLETED|Initial Period (Baseline to Week 16)||0
1434622|NCT02346240|3513088|P4|COMPLETED|Initial Period (Baseline to Week 16)||160
1434623|NCT02346240|3513089|P3|COMPLETED|Initial Period (Baseline to Week 16)||159
1434624|NCT02346240|3513090|P2|COMPLETED|Initial Period (Baseline to Week 16)||159
1434625|NCT02346240|3513091|P1|COMPLETED|Initial Period (Baseline to Week 16)||55
1434626|NCT02346240|3513075|P17|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434627|NCT02346240|3513076|P16|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434628|NCT02346240|3513077|P15|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434629|NCT02346240|3513078|P14|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434630|NCT02346240|3513079|P13|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434631|NCT02346240|3513080|P12|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434632|NCT02346240|3513081|P11|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434633|NCT02346240|3513082|P10|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434634|NCT02346240|3513083|P9|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434635|NCT02346240|3513084|P8|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434636|NCT02346240|3513085|P7|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434637|NCT02346240|3513086|P6|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434638|NCT02346240|3513087|P5|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
1434639|NCT02346240|3513088|P4|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
1434640|NCT02346240|3513089|P3|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
1434641|NCT02346240|3513090|P2|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
1434642|NCT02346240|3513091|P1|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
1434643|NCT02346240|3513075|P17|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434644|NCT02346240|3513076|P16|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434645|NCT02346240|3513077|P15|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434646|NCT02346240|3513078|P14|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434647|NCT02346240|3513079|P13|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434648|NCT02346240|3513080|P12|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434649|NCT02346240|3513081|P11|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434650|NCT02346240|3513082|P10|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434651|NCT02346240|3513083|P9|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434652|NCT02346240|3513084|P8|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434653|NCT02346240|3513085|P7|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434654|NCT02346240|3513086|P6|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434655|NCT02346240|3513087|P5|Completed Week 16|Initial Period (Baseline to Week 16)||0
1434656|NCT02346240|3513088|P4|Completed Week 16|Initial Period (Baseline to Week 16)||162
1434657|NCT02346240|3513089|P3|Completed Week 16|Initial Period (Baseline to Week 16)||159
1434658|NCT02346240|3513090|P2|Completed Week 16|Initial Period (Baseline to Week 16)||159
1434659|NCT02346240|3513091|P1|Completed Week 16|Initial Period (Baseline to Week 16)||55
1434660|NCT02346240|3513075|P17|STARTED|Initial Period (Baseline to Week 16)||0
1434661|NCT02346240|3513076|P16|STARTED|Initial Period (Baseline to Week 16)||0
1434662|NCT02346240|3513077|P15|STARTED|Initial Period (Baseline to Week 16)||0
1434663|NCT02346240|3513078|P14|STARTED|Initial Period (Baseline to Week 16)||0
1434664|NCT02346240|3513079|P13|STARTED|Initial Period (Baseline to Week 16)||0
1434665|NCT02346240|3513080|P12|STARTED|Initial Period (Baseline to Week 16)||0
1434666|NCT02346240|3513081|P11|STARTED|Initial Period (Baseline to Week 16)||0
1434667|NCT02346240|3513082|P10|STARTED|Initial Period (Baseline to Week 16)||0
1434668|NCT02346240|3513083|P9|STARTED|Initial Period (Baseline to Week 16)||0
1434669|NCT02346240|3513084|P8|STARTED|Initial Period (Baseline to Week 16)||0
1434670|NCT02346240|3513085|P7|STARTED|Initial Period (Baseline to Week 16)||0
1434671|NCT02346240|3513086|P6|STARTED|Initial Period (Baseline to Week 16)||0
1434672|NCT02346240|3513087|P5|STARTED|Initial Period (Baseline to Week 16)||0
1434673|NCT02346240|3513088|P4|STARTED|Initial Period (Baseline to Week 16)||167
1434674|NCT02346240|3513089|P3|STARTED|Initial Period (Baseline to Week 16)||165
1434675|NCT02346240|3513090|P2|STARTED|Initial Period (Baseline to Week 16)||170
1434676|NCT02346240|3513091|P1|STARTED|Initial Period (Baseline to Week 16)||57
1434677|NCT02345772|3513125|P1|NOT COMPLETED|Overall Study||4
1434678|NCT02345772|3513125|P1|COMPLETED|Overall Study||0
1434679|NCT02345772|3513125|P1|STARTED|Overall Study||4
1434680|NCT02345720|3513131|P1|NOT COMPLETED|Overall Study||0
1434681|NCT02345720|3513131|P1|COMPLETED|Overall Study||20
1434682|NCT02345720|3513131|P1|STARTED|Overall Study||20
1434683|NCT02345642|3513139|P2|NOT COMPLETED|Overall Study||0
1434684|NCT02345642|3513140|P1|NOT COMPLETED|Overall Study||0
1434685|NCT02345642|3513139|P2|COMPLETED|Overall Study||10
1434686|NCT02345642|3513140|P1|COMPLETED|Overall Study||10
1434687|NCT02345642|3513139|P2|STARTED|Overall Study||10
1434688|NCT02345642|3513140|P1|STARTED|Overall Study||10
1434689|NCT02345460|3513146|P1|NOT COMPLETED|Overall Study||0
1434690|NCT02345460|3513146|P1|COMPLETED|Overall Study||1
1434691|NCT02345460|3513146|P1|STARTED|Overall Study||1
1434692|NCT02345369|3513159|P2|NOT COMPLETED|Overall Study||0
1434693|NCT02345369|3513160|P1|NOT COMPLETED|Overall Study||0
1434694|NCT02345369|3513159|P2|COMPLETED|Overall Study||0
1434695|NCT02345369|3513160|P1|COMPLETED|Overall Study||0
1434696|NCT02345369|3513159|P2|STARTED|Overall Study||0
1434697|NCT02345369|3513160|P1|STARTED|Overall Study||0
1434698|NCT02345330|3513170|P1|NOT COMPLETED|Overall Study||3
1434699|NCT02345330|3513170|P1|COMPLETED|Overall Study||1
1434700|NCT02345330|3513170|P1|STARTED|Overall Study||4
1434701|NCT02345252|3513182|P2|NOT COMPLETED|Overall Study||316
1434702|NCT02345252|3513183|P1|NOT COMPLETED|Overall Study||316
1434703|NCT02345252|3513182|P2|COMPLETED|Overall Study||0
1434704|NCT02345252|3513183|P1|COMPLETED|Overall Study||0
1434705|NCT02345252|3513182|P2|STARTED|Overall Study||316
1434706|NCT02345252|3513183|P1|STARTED|Overall Study||316
1434707|NCT02345226|3513199|P2|NOT COMPLETED|Overall Study||441
1434708|NCT02345226|3513200|P1|NOT COMPLETED|Overall Study||440
1434709|NCT02345226|3513199|P2|COMPLETED|Overall Study||0
1434710|NCT02345226|3513200|P1|COMPLETED|Overall Study||0
1434711|NCT02345226|3513199|P2|STARTED|Overall Study||441
1434712|NCT02345226|3513200|P1|STARTED|Overall Study||440
1434713|NCT02345161|3513218|P2|NOT COMPLETED|Overall Study||57
1434714|NCT02345161|3513219|P1|NOT COMPLETED|Overall Study||45
1434715|NCT02345161|3513218|P2|COMPLETED|Overall Study||842
1434716|NCT02345161|3513219|P1|COMPLETED|Overall Study||866
1434717|NCT02345161|3513218|P2|STARTED|Overall Study||899
1434718|NCT02345161|3513219|P1|STARTED|Overall Study||911
1434719|NCT02345031|3513323|P2|NOT COMPLETED|Overall Study||1
1434720|NCT02345031|3513324|P1|NOT COMPLETED|Overall Study||1
1434721|NCT02345031|3513323|P2|COMPLETED|Overall Study||39
1434722|NCT02345031|3513324|P1|COMPLETED|Overall Study||37
1434723|NCT02345031|3513323|P2|STARTED|Overall Study||40
1434724|NCT02345031|3513324|P1|STARTED|Overall Study||38
1434725|NCT02344745|3513340|P2|NOT COMPLETED|Overall Study||0
1434726|NCT02344745|3513341|P1|NOT COMPLETED|Overall Study||2
1434727|NCT02344745|3513340|P2|COMPLETED|Overall Study||40
1434728|NCT02344745|3513341|P1|COMPLETED|Overall Study||38
1434729|NCT02344745|3513340|P2|STARTED|Overall Study||40
1434730|NCT02344745|3513341|P1|STARTED|Overall Study||40
1434731|NCT02344628|3513355|P2|NOT COMPLETED|Overall Study||86
1434732|NCT02344628|3513356|P1|NOT COMPLETED|Overall Study||91
1434733|NCT02344628|3513355|P2|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
1434734|NCT02344628|3513356|P1|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
1434735|NCT02344628|3513355|P2|STARTED|Overall Study||292
1434736|NCT02344628|3513356|P1|STARTED|Overall Study||291
1434737|NCT02344407|3513369|P3|NOT COMPLETED|Overall Study||6
1434738|NCT02344407|3513370|P2|NOT COMPLETED|Overall Study||9
1434739|NCT02344407|3513371|P1|NOT COMPLETED|Overall Study||8
1434740|NCT02344407|3513369|P3|COMPLETED|Overall Study||494
1434741|NCT02344407|3513370|P2|COMPLETED|Overall Study||491
1434742|NCT02344407|3513371|P1|COMPLETED|Overall Study||492
1434743|NCT02344407|3513369|P3|STARTED|Overall Study||500
1434744|NCT02344407|3513370|P2|STARTED|Overall Study||500
1434745|NCT02344407|3513371|P1|STARTED|Overall Study||500
1434746|NCT02344342|3513386|P4|NOT COMPLETED|Overall Study||10
1434747|NCT02344342|3513387|P3|NOT COMPLETED|Overall Study||14
1434748|NCT02344342|3513388|P2|NOT COMPLETED|Overall Study||9
1434749|NCT02344342|3513389|P1|NOT COMPLETED|Overall Study||11
1434750|NCT02344342|3513386|P4|COMPLETED|Overall Study||3
1434751|NCT02344342|3513387|P3|COMPLETED|Overall Study||0
1434752|NCT02344342|3513388|P2|COMPLETED|Overall Study||2
1434753|NCT02344342|3513389|P1|COMPLETED|Overall Study||2
1434754|NCT02344342|3513386|P4|STARTED|Overall Study||13
1434755|NCT02344342|3513387|P3|STARTED|Overall Study||14
1434756|NCT02344342|3513388|P2|STARTED|Overall Study||11
1434757|NCT02344342|3513389|P1|STARTED|Overall Study||13
1434758|NCT02344251|3513413|P2|NOT COMPLETED|Overall Study||0
1434759|NCT02344251|3513414|P1|NOT COMPLETED|Overall Study||0
1434760|NCT02344251|3513413|P2|COMPLETED|Overall Study||20
1434761|NCT02344251|3513414|P1|COMPLETED|Overall Study||20
1434762|NCT02344251|3513413|P2|STARTED|Overall Study||20
1434763|NCT02344251|3513414|P1|STARTED|Overall Study||20
1434764|NCT02344238|3513425|P3|NOT COMPLETED|Overall Study||0
1434765|NCT02344238|3513426|P2|NOT COMPLETED|Overall Study||0
1434766|NCT02344238|3513427|P1|NOT COMPLETED|Overall Study||0
1434767|NCT02344238|3513425|P3|COMPLETED|Overall Study||20
1434768|NCT02344238|3513426|P2|COMPLETED|Overall Study||20
1434769|NCT02344238|3513427|P1|COMPLETED|Overall Study||20
1434770|NCT02344238|3513425|P3|STARTED|Overall Study||20
1434771|NCT02344238|3513426|P2|STARTED|Overall Study||20
1434772|NCT02344238|3513427|P1|STARTED|Overall Study||20
1434773|NCT02344004|3513438|P2|NOT COMPLETED|Overall Study||36
1434774|NCT02344004|3513439|P1|NOT COMPLETED|Overall Study||154
1434775|NCT02344004|3513438|P2|COMPLETED|Overall Study|As of the data cutoff date of 07 July 2017.|76
1434776|NCT02344004|3513439|P1|COMPLETED|Overall Study|As of the data cutoff date of 07 July 2017.|70
1434777|NCT02344004|3513438|P2|Subjects Discontinued the Study|Overall Study||10
1434778|NCT02344004|3513439|P1|Subjects Discontinued the Study|Overall Study||44
1434779|NCT02344004|3513438|P2|STARTED|Overall Study||112
1434780|NCT02344004|3513439|P1|STARTED|Overall Study||224
1434781|NCT02343627|3513453|P2|NOT COMPLETED|Overall Study||1
1434782|NCT02343627|3513454|P1|NOT COMPLETED|Overall Study||12
1434783|NCT02343627|3513453|P2|COMPLETED|Overall Study||11
1434784|NCT02343627|3513454|P1|COMPLETED|Overall Study||23
1434785|NCT02343627|3513453|P2|STARTED|Overall Study||12
1434786|NCT02343627|3513454|P1|STARTED|Overall Study||35
1434787|NCT02343380|3513462|P2|NOT COMPLETED|Overall Study||0
1434788|NCT02343380|3513463|P1|NOT COMPLETED|Overall Study||0
1434789|NCT02343380|3513462|P2|COMPLETED|Overall Study|Morning test (second week)|10
1434790|NCT02343380|3513463|P1|COMPLETED|Overall Study|Evening test (second week)|10
1434791|NCT02343380|3513462|P2|STARTED|Overall Study|Evening test (first week)|10
1434792|NCT02343380|3513463|P1|STARTED|Overall Study|Morning test (first week)|10
1434793|NCT02343263|3513482|P3|NOT COMPLETED|Overall Study||1
1434794|NCT02343263|3513483|P2|NOT COMPLETED|Overall Study||3
1434795|NCT02343263|3513484|P1|NOT COMPLETED|Overall Study||5
1434796|NCT02343263|3513482|P3|COMPLETED|Overall Study||0
1434797|NCT02343263|3513483|P2|COMPLETED|Overall Study||0
1434798|NCT02343263|3513484|P1|COMPLETED|Overall Study|Study closed due for administrative reasons|0
1434799|NCT02343263|3513482|P3|STARTED|Overall Study||1
1434800|NCT02343263|3513483|P2|STARTED|Overall Study||3
1434801|NCT02343263|3513484|P1|STARTED|Overall Study|Study closed due for administrative reasons|5
1434802|NCT02343159|3513513|P3|NOT COMPLETED|Overall Study||30
1434803|NCT02343159|3513514|P2|NOT COMPLETED|Overall Study||26
1434804|NCT02343159|3513515|P1|NOT COMPLETED|Overall Study||26
1434805|NCT02343159|3513513|P3|COMPLETED|Overall Study||0
1434806|NCT02343159|3513514|P2|COMPLETED|Overall Study||1
1434807|NCT02343159|3513515|P1|COMPLETED|Overall Study||1
1434808|NCT02343159|3513513|P3|STARTED|Overall Study||30
1434809|NCT02343159|3513514|P2|STARTED|Overall Study||27
1434810|NCT02343159|3513515|P1|STARTED|Overall Study||27
1434811|NCT02343081|3513542|P2|NOT COMPLETED|Second Intervention (Day 4)||0
1434812|NCT02343081|3513543|P1|NOT COMPLETED|Second Intervention (Day 4)||0
1434813|NCT02343081|3513542|P2|COMPLETED|Second Intervention (Day 4)||8
1434814|NCT02343081|3513543|P1|COMPLETED|Second Intervention (Day 4)||8
1434815|NCT02343081|3513542|P2|Received Intervention|Second Intervention (Day 4)||8
1434816|NCT02343081|3513543|P1|Received Intervention|Second Intervention (Day 4)||8
1434817|NCT02343081|3513542|P2|STARTED|Second Intervention (Day 4)||8
1434818|NCT02343081|3513543|P1|STARTED|Second Intervention (Day 4)||8
1434819|NCT02343081|3513542|P2|NOT COMPLETED|Washout (10 Hours)||0
1434820|NCT02343081|3513543|P1|NOT COMPLETED|Washout (10 Hours)||0
1434821|NCT02343081|3513542|P2|COMPLETED|Washout (10 Hours)||8
1434822|NCT02343081|3513543|P1|COMPLETED|Washout (10 Hours)||8
1434823|NCT02343081|3513542|P2|STARTED|Washout (10 Hours)||8
1434824|NCT02343081|3513543|P1|STARTED|Washout (10 Hours)||8
1434825|NCT02343081|3513542|P2|NOT COMPLETED|First Intervention (Day 3)||0
1434826|NCT02343081|3513543|P1|NOT COMPLETED|First Intervention (Day 3)||0
1434827|NCT02343081|3513542|P2|COMPLETED|First Intervention (Day 3)||8
1434828|NCT02343081|3513543|P1|COMPLETED|First Intervention (Day 3)||8
1434829|NCT02343081|3513542|P2|Received Intervention|First Intervention (Day 3)||8
1434830|NCT02343081|3513543|P1|Received Intervention|First Intervention (Day 3)||8
1434831|NCT02343081|3513542|P2|STARTED|First Intervention (Day 3)||8
1434832|NCT02343081|3513543|P1|STARTED|First Intervention (Day 3)||8
1434833|NCT02343003|3513559|P2|NOT COMPLETED|Overall Study||7
1434834|NCT02343003|3513560|P1|NOT COMPLETED|Overall Study||18
1434835|NCT02343003|3513559|P2|COMPLETED|Overall Study||68
1434836|NCT02343003|3513560|P1|COMPLETED|Overall Study||58
1434837|NCT02343003|3513559|P2|STARTED|Overall Study||75
1434838|NCT02343003|3513560|P1|STARTED|Overall Study||76
1434839|NCT02342743|3513576|P1|NOT COMPLETED|Treatment Period||11
1434840|NCT02342743|3513576|P1|COMPLETED|Treatment Period||47
1434841|NCT02342743|3513576|P1|STARTED|Treatment Period|7 patients did not meet inclusion criteria for treatment period, evaluated at the end of the run-in|58
1434842|NCT02342743|3513576|P1|NOT COMPLETED|Run-in Period||8
1434843|NCT02342743|3513576|P1|COMPLETED|Run-in Period||65
1434844|NCT02342743|3513576|P1|STARTED|Run-in Period||73
1434845|NCT02342704|3513589|P2|NOT COMPLETED|Overall Study||51
1434846|NCT02342704|3513590|P1|NOT COMPLETED|Overall Study||53
1434847|NCT02342704|3513589|P2|COMPLETED|Overall Study||3
1434848|NCT02342704|3513590|P1|COMPLETED|Overall Study||1
1434849|NCT02342704|3513589|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
1434850|NCT02342704|3513590|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
1434851|NCT02342678|3513618|P2|NOT COMPLETED|Overall Study||5
1434852|NCT02342678|3513619|P1|NOT COMPLETED|Overall Study||1
1434853|NCT02342678|3513618|P2|COMPLETED|Overall Study||23
1434854|NCT02342678|3513619|P1|COMPLETED|Overall Study||27
1434855|NCT02342678|3513618|P2|STARTED|Overall Study||28
1434856|NCT02342678|3513619|P1|STARTED|Overall Study||28
1434857|NCT02342561|3513639|P1|NOT COMPLETED|Overall Study||0
1434858|NCT02342561|3513639|P1|COMPLETED|Overall Study||20
1434859|NCT02342561|3513639|P1|STARTED|Overall Study||20
1434860|NCT02342548|3513650|P3|NOT COMPLETED|Overall Study||43
1434861|NCT02342548|3513651|P2|NOT COMPLETED|Overall Study||62
1434862|NCT02342548|3513652|P1|NOT COMPLETED|Overall Study||34
1434863|NCT02342548|3513650|P3|COMPLETED|Overall Study||23
1434864|NCT02342548|3513651|P2|COMPLETED|Overall Study||9
1434865|NCT02342548|3513652|P1|COMPLETED|Overall Study||17
1434866|NCT02342548|3513650|P3|STARTED|Overall Study||66
1434867|NCT02342548|3513651|P2|STARTED|Overall Study||71
1434868|NCT02342548|3513652|P1|STARTED|Overall Study||51
1434869|NCT02342535|3513690|P1|NOT COMPLETED|Overall Study||0
1434870|NCT02342535|3513690|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
1434871|NCT02342535|3513690|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
1434872|NCT02342418|3513696|P2|NOT COMPLETED|Overall Study||1
1434873|NCT02342418|3513697|P1|NOT COMPLETED|Overall Study||0
1434874|NCT02342418|3513696|P2|COMPLETED|Overall Study||9
1434875|NCT02342418|3513697|P1|COMPLETED|Overall Study||9
1434876|NCT02342418|3513696|P2|STARTED|Overall Study||10
1434877|NCT02342418|3513697|P1|STARTED|Overall Study||9
1434878|NCT02342288|3513707|P2|NOT COMPLETED|Overall Study||6
1434879|NCT02342288|3513708|P1|NOT COMPLETED|Overall Study||5
1434880|NCT02342288|3513707|P2|COMPLETED|Overall Study||27
1434881|NCT02342288|3513708|P1|COMPLETED|Overall Study||25
1434882|NCT02342288|3513707|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
1434883|NCT02342288|3513708|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
1434884|NCT02342223|3513714|P1|NOT COMPLETED|Overall Study||1
1434885|NCT02342223|3513714|P1|COMPLETED|Overall Study||19
1434886|NCT02342223|3513714|P1|STARTED|Overall Study||20
1434887|NCT02342197|3513725|P2|NOT COMPLETED|Overall Study||2
1434888|NCT02342197|3513726|P1|NOT COMPLETED|Overall Study||3
1434889|NCT02342197|3513725|P2|COMPLETED|Overall Study||28
1434890|NCT02342197|3513726|P1|COMPLETED|Overall Study||27
1434891|NCT02342197|3513725|P2|STARTED|Overall Study||30
1434892|NCT02342197|3513726|P1|STARTED|Overall Study||30
1434893|NCT02341859|3513732|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1434894|NCT02341859|3513733|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1434895|NCT02341859|3513732|P2|COMPLETED|Second Intervention (1 Day)||9
1434896|NCT02341859|3513733|P1|COMPLETED|Second Intervention (1 Day)||10
1434897|NCT02341859|3513732|P2|STARTED|Second Intervention (1 Day)||9
1434898|NCT02341859|3513733|P1|STARTED|Second Intervention (1 Day)||10
1434899|NCT02341859|3513732|P2|NOT COMPLETED|First Intervention (1 Day)||0
1434900|NCT02341859|3513733|P1|NOT COMPLETED|First Intervention (1 Day)||0
1434901|NCT02341859|3513732|P2|COMPLETED|First Intervention (1 Day)||9
1434902|NCT02341859|3513733|P1|COMPLETED|First Intervention (1 Day)||10
1434903|NCT02341859|3513732|P2|STARTED|First Intervention (1 Day)||9
1434904|NCT02341859|3513733|P1|STARTED|First Intervention (1 Day)||10
1434905|NCT02341482|3513886|P1|NOT COMPLETED|Overall Study||1
1434906|NCT02341482|3513886|P1|COMPLETED|Overall Study||12
1434907|NCT02341482|3513886|P1|STARTED|Overall Study||13
1434908|NCT02341417|3513915|P3|NOT COMPLETED|Overall Study||1
1434909|NCT02341417|3513916|P2|NOT COMPLETED|Overall Study||2
1434910|NCT02341417|3513917|P1|NOT COMPLETED|Overall Study||2
1434911|NCT02341417|3513915|P3|COMPLETED|Overall Study||0
1434912|NCT02341417|3513916|P2|COMPLETED|Overall Study||12
1434913|NCT02341417|3513917|P1|COMPLETED|Overall Study||11
1434914|NCT02341417|3513915|P3|STARTED|Overall Study||1
1434915|NCT02341417|3513916|P2|STARTED|Overall Study||14
1434916|NCT02341417|3513917|P1|STARTED|Overall Study||13
1434917|NCT02341144|3513961|P2|NOT COMPLETED|Overall Study||1
1434918|NCT02341144|3513962|P1|NOT COMPLETED|Overall Study||2
1434919|NCT02341144|3513961|P2|COMPLETED|Overall Study||30
1434920|NCT02341144|3513962|P1|COMPLETED|Overall Study||28
1434921|NCT02341144|3513961|P2|STARTED|Overall Study||31
1434922|NCT02341144|3513962|P1|STARTED|Overall Study||30
1434923|NCT02340962|3513978|P2|NOT COMPLETED|Overall Study||0
1434924|NCT02340962|3513979|P1|NOT COMPLETED|Overall Study||1
1434925|NCT02340962|3513978|P2|COMPLETED|Overall Study||12
1434926|NCT02340962|3513979|P1|COMPLETED|Overall Study||12
1434927|NCT02340962|3513978|P2|STARTED|Overall Study||12
1434928|NCT02340962|3513979|P1|STARTED|Overall Study||13
1434929|NCT02340715|3513999|P1|NOT COMPLETED|Overall Study||0
1434930|NCT02340715|3513999|P1|COMPLETED|Overall Study|158|158
1434931|NCT02340715|3513999|P1|STARTED|Overall Study|158|158
1434932|NCT02340676|3514003|P1|NOT COMPLETED|Overall Study||0
1434933|NCT02340676|3514003|P1|COMPLETED|Overall Study||25
1434934|NCT02340676|3514003|P1|STARTED|Overall Study||25
1434935|NCT02340663|3514016|P2|NOT COMPLETED|Overall Study||1
1434936|NCT02340663|3514017|P1|NOT COMPLETED|Overall Study||5
1434937|NCT02340663|3514016|P2|COMPLETED|Overall Study||31
1434938|NCT02340663|3514017|P1|COMPLETED|Overall Study||30
1434939|NCT02340663|3514016|P2|4 Month Follow-up, Assessments|Overall Study||31
1434940|NCT02340663|3514017|P1|4 Month Follow-up, Assessments|Overall Study||30
1434941|NCT02340663|3514016|P2|1 Week Follow-up, Assessments|Overall Study||31
1434942|NCT02340663|3514017|P1|1 Week Follow-up, Assessments|Overall Study||33
1434943|NCT02340663|3514016|P2|Splint Delivery, Assessments|Overall Study||31
1434944|NCT02340663|3514017|P1|Splint Delivery, Assessments|Overall Study||33
1434945|NCT02340663|3514016|P2|Clinical Exam, Impressions|Overall Study||32
1434946|NCT02340663|3514017|P1|Clinical Exam, Impressions|Overall Study||35
1434947|NCT02340663|3514016|P2|STARTED|Overall Study||32
1434948|NCT02340663|3514017|P1|STARTED|Overall Study||35
1434949|NCT02340520|3514073|P1|NOT COMPLETED|Overall Study||3
1434950|NCT02340520|3514073|P1|COMPLETED|Overall Study||8
1434951|NCT02340520|3514073|P1|STARTED|Overall Study||11
1434952|NCT02340338|3514085|P7|NOT COMPLETED|Overall Study||0
1434953|NCT02340338|3514086|P6|NOT COMPLETED|Overall Study||0
1434954|NCT02340338|3514087|P5|NOT COMPLETED|Overall Study||0
1434955|NCT02340338|3514088|P4|NOT COMPLETED|Overall Study||0
1434956|NCT02340338|3514089|P3|NOT COMPLETED|Overall Study||0
1434957|NCT02340338|3514090|P2|NOT COMPLETED|Overall Study||0
1434958|NCT02340338|3514091|P1|NOT COMPLETED|Overall Study||0
1434959|NCT02340338|3514085|P7|COMPLETED|Overall Study||12
1434960|NCT02340338|3514086|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
1434961|NCT02340338|3514087|P5|COMPLETED|Overall Study||9
1434962|NCT02340338|3514088|P4|COMPLETED|Overall Study||9
1434963|NCT02340338|3514089|P3|COMPLETED|Overall Study||3
1434964|NCT02340338|3514090|P2|COMPLETED|Overall Study||2
1434965|NCT02340338|3514091|P1|COMPLETED|Overall Study||2
1434966|NCT02340338|3514085|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
1434967|NCT02340338|3514086|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
1434968|NCT02340338|3514087|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
1434969|NCT02340338|3514088|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
1434970|NCT02340338|3514089|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
1434971|NCT02340338|3514090|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
1434972|NCT02340338|3514091|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
1434973|NCT02340104|3514114|P1|NOT COMPLETED|Overall Study||0
1434974|NCT02340104|3514114|P1|COMPLETED|Overall Study||8
1434975|NCT02340104|3514114|P1|STARTED|Overall Study||8
1434976|NCT02340000|3514121|P2|NOT COMPLETED|Time Period 2||15
1434977|NCT02340000|3514122|P1|NOT COMPLETED|Time Period 2||19
1434978|NCT02340000|3514121|P2|COMPLETED|Time Period 2||52
1434979|NCT02340000|3514122|P1|COMPLETED|Time Period 2||50
1434980|NCT02340000|3514121|P2|STARTED|Time Period 2||67
1434981|NCT02340000|3514122|P1|STARTED|Time Period 2||69
1434982|NCT02340000|3514121|P2|NOT COMPLETED|Time Period 1||15
1434983|NCT02340000|3514122|P1|NOT COMPLETED|Time Period 1||12
1434984|NCT02340000|3514121|P2|COMPLETED|Time Period 1||74
1434985|NCT02340000|3514122|P1|COMPLETED|Time Period 1||78
1434986|NCT02340000|3514121|P2|STARTED|Time Period 1||89
1434987|NCT02340000|3514122|P1|STARTED|Time Period 1||90
1434988|NCT02339909|3514152|P3|NOT COMPLETED|Overall Study||71
1434989|NCT02339909|3514153|P2|NOT COMPLETED|Overall Study||63
1434990|NCT02339909|3514154|P1|NOT COMPLETED|Overall Study||89
1434991|NCT02339909|3514152|P3|COMPLETED|Overall Study||304
1434992|NCT02339909|3514153|P2|COMPLETED|Overall Study||312
1434993|NCT02339909|3514154|P1|COMPLETED|Overall Study||435
1434994|NCT02339909|3514152|P3|STARTED|Overall Study||375
1434995|NCT02339909|3514153|P2|STARTED|Overall Study||375
1434996|NCT02339909|3514154|P1|STARTED|Overall Study||524
1434997|NCT02339831|3514167|P2|NOT COMPLETED|Overall Study||7
1434998|NCT02339831|3514168|P1|NOT COMPLETED|Overall Study||20
1434999|NCT02339831|3514167|P2|COMPLETED|Overall Study||45
1435000|NCT02339831|3514168|P1|COMPLETED|Overall Study||38
1435001|NCT02339831|3514167|P2|Lost to Follow Up|Overall Study||7
1435002|NCT02339831|3514168|P1|Lost to Follow Up|Overall Study||20
1435003|NCT02339831|3514167|P2|STARTED|Overall Study||52
1435004|NCT02339831|3514168|P1|STARTED|Overall Study||58
1435005|NCT02339584|3514192|P2|NOT COMPLETED|Overall Study||15
1435006|NCT02339584|3514193|P1|NOT COMPLETED|Overall Study||15
1435007|NCT02339584|3514192|P2|COMPLETED|Overall Study||176
1435008|NCT02339584|3514193|P1|COMPLETED|Overall Study||173
1435009|NCT02339584|3514192|P2|STARTED|Overall Study||191
1435010|NCT02339584|3514193|P1|STARTED|Overall Study||188
1435011|NCT02339506|3514199|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
1435012|NCT02339506|3514200|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
1435013|NCT02339506|3514199|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
1435014|NCT02339506|3514200|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
1435015|NCT02339506|3514199|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
1435016|NCT02339506|3514200|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
1435017|NCT02339506|3514199|P2|NOT COMPLETED|Washout (Period 2)||0
1435018|NCT02339506|3514200|P1|NOT COMPLETED|Washout (Period 2)||2
1435019|NCT02339506|3514199|P2|COMPLETED|Washout (Period 2)||10
1435020|NCT02339506|3514200|P1|COMPLETED|Washout (Period 2)||10
1435021|NCT02339506|3514199|P2|STARTED|Washout (Period 2)||10
1435022|NCT02339506|3514200|P1|STARTED|Washout (Period 2)||12
1435023|NCT02339506|3514199|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
1435024|NCT02339506|3514200|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
1435025|NCT02339506|3514199|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
1435026|NCT02339506|3514200|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
1435027|NCT02339506|3514199|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
1435028|NCT02339506|3514200|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
1435029|NCT02339389|3514206|P1|NOT COMPLETED|Overall Study||16
1435030|NCT02339389|3514206|P1|COMPLETED|Overall Study||41
1435031|NCT02339389|3514206|P1|STARTED|Overall Study||57
1435032|NCT02339285|3514214|P3|NOT COMPLETED|Overall Study||2
1435033|NCT02339285|3514215|P2|NOT COMPLETED|Overall Study||3
1435034|NCT02339285|3514216|P1|NOT COMPLETED|Overall Study||1
1435035|NCT02339285|3514214|P3|COMPLETED|Overall Study||9
1435036|NCT02339285|3514215|P2|COMPLETED|Overall Study||8
1435037|NCT02339285|3514216|P1|COMPLETED|Overall Study||9
1435038|NCT02339285|3514214|P3|4 Week Follow-up Visit|Overall Study||9
1435039|NCT02339285|3514215|P2|4 Week Follow-up Visit|Overall Study||8
1435040|NCT02339285|3514216|P1|4 Week Follow-up Visit|Overall Study||9
1435041|NCT02339285|3514214|P3|2 Week Follow-up|Overall Study||10
1435042|NCT02339285|3514215|P2|2 Week Follow-up|Overall Study||10
1435043|NCT02339285|3514216|P1|2 Week Follow-up|Overall Study||9
1435044|NCT02339285|3514214|P3|Completed Intervention|Overall Study||10
1435045|NCT02339285|3514215|P2|Completed Intervention|Overall Study||10
1435046|NCT02339285|3514216|P1|Completed Intervention|Overall Study||10
1435047|NCT02339285|3514214|P3|STARTED|Overall Study||11
1435048|NCT02339285|3514215|P2|STARTED|Overall Study||11
1435049|NCT02339285|3514216|P1|STARTED|Overall Study||10
1435050|NCT02339246|3514244|P3|NOT COMPLETED|Third Period (7 Days)||0
1435051|NCT02339246|3514245|P2|NOT COMPLETED|Third Period (7 Days)||0
1435052|NCT02339246|3514246|P1|NOT COMPLETED|Third Period (7 Days)||0
1435053|NCT02339246|3514244|P3|COMPLETED|Third Period (7 Days)||0
1435054|NCT02339246|3514245|P2|COMPLETED|Third Period (7 Days)||16
1435055|NCT02339246|3514246|P1|COMPLETED|Third Period (7 Days)||15
1435056|NCT02339246|3514244|P3|STARTED|Third Period (7 Days)||0
1435057|NCT02339246|3514245|P2|STARTED|Third Period (7 Days)||16
1435058|NCT02339246|3514246|P1|STARTED|Third Period (7 Days)||15
1435059|NCT02339246|3514244|P3|NOT COMPLETED|Second Intervention (7 Days)||0
1435060|NCT02339246|3514245|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1435061|NCT02339246|3514246|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1435062|NCT02339246|3514244|P3|COMPLETED|Second Intervention (7 Days)||0
1435063|NCT02339246|3514245|P2|COMPLETED|Second Intervention (7 Days)||15
1435064|NCT02339246|3514246|P1|COMPLETED|Second Intervention (7 Days)||16
1435065|NCT02339246|3514244|P3|STARTED|Second Intervention (7 Days)||0
1435066|NCT02339246|3514245|P2|STARTED|Second Intervention (7 Days)||15
1435067|NCT02339246|3514246|P1|STARTED|Second Intervention (7 Days)||16
1435068|NCT02339246|3514244|P3|NOT COMPLETED|First Intervention (7 Days)||0
1435069|NCT02339246|3514245|P2|NOT COMPLETED|First Intervention (7 Days)||0
1435070|NCT02339246|3514246|P1|NOT COMPLETED|First Intervention (7 Days)||0
1435071|NCT02339246|3514244|P3|COMPLETED|First Intervention (7 Days)||31
1435072|NCT02339246|3514245|P2|COMPLETED|First Intervention (7 Days)||0
1435073|NCT02339246|3514246|P1|COMPLETED|First Intervention (7 Days)||0
1435074|NCT02339246|3514244|P3|STARTED|First Intervention (7 Days)||31
1435075|NCT02339246|3514245|P2|STARTED|First Intervention (7 Days)||0
1435076|NCT02339246|3514246|P1|STARTED|First Intervention (7 Days)||0
1435077|NCT02339155|3514262|P2|NOT COMPLETED|Overall Study||21
1435078|NCT02339155|3514263|P1|NOT COMPLETED|Overall Study||15
1435079|NCT02339155|3514262|P2|COMPLETED|Overall Study||266
1435080|NCT02339155|3514263|P1|COMPLETED|Overall Study||271
1435081|NCT02339155|3514262|P2|Received Study Treatment|Overall Study||281
1435082|NCT02339155|3514263|P1|Received Study Treatment|Overall Study||285
1435083|NCT02339155|3514262|P2|STARTED|Overall Study||287
1435084|NCT02339155|3514263|P1|STARTED|Overall Study||286
1435085|NCT02339038|3514289|P1|NOT COMPLETED|Overall Study||600
1435086|NCT02339038|3514289|P1|COMPLETED|Overall Study||0
1435087|NCT02339038|3514289|P1|STARTED|Overall Study||600
1435088|NCT02338843|3514295|P2|NOT COMPLETED|Overall Study||58
1435089|NCT02338843|3514296|P1|NOT COMPLETED|Overall Study||44
1435090|NCT02338843|3514295|P2|COMPLETED|Overall Study||100
1435091|NCT02338843|3514296|P1|COMPLETED|Overall Study||119
1435092|NCT02338843|3514295|P2|STARTED|Overall Study||158
1435093|NCT02338843|3514296|P1|STARTED|Overall Study||163
1435094|NCT02338713|3514302|P1|NOT COMPLETED|Overall Study||0
1435095|NCT02338713|3514302|P1|COMPLETED|Overall Study||27
1435096|NCT02338713|3514302|P1|STARTED|Overall Study||27
1435097|NCT02338492|3514324|P1|NOT COMPLETED|Overall Study||45
1435098|NCT02338492|3514324|P1|COMPLETED|Overall Study||36
1435099|NCT02338492|3514324|P1|Treatment Failure|Overall Study||2
1435100|NCT02338492|3514324|P1|Device Implanted|Overall Study||79
1435101|NCT02338492|3514324|P1|Enrolled|Overall Study||81
1435102|NCT02338492|3514324|P1|STARTED|Overall Study||81
1435103|NCT02338336|3514340|P4|NOT COMPLETED|Overall Study||0
1435104|NCT02338336|3514341|P3|NOT COMPLETED|Overall Study||0
1435105|NCT02338336|3514342|P2|NOT COMPLETED|Overall Study||0
1435106|NCT02338336|3514343|P1|NOT COMPLETED|Overall Study||2
1435107|NCT02338336|3514340|P4|COMPLETED|Overall Study||4
1435108|NCT02338336|3514341|P3|COMPLETED|Overall Study||7
1435109|NCT02338336|3514342|P2|COMPLETED|Overall Study||17
1435110|NCT02338336|3514343|P1|COMPLETED|Overall Study||24
1435111|NCT02338336|3514340|P4|STARTED|Overall Study||4
1435112|NCT02338336|3514341|P3|STARTED|Overall Study||7
1435113|NCT02338336|3514342|P2|STARTED|Overall Study||17
1435114|NCT02338336|3514343|P1|STARTED|Overall Study||26
1435115|NCT02338076|3514351|P1|NOT COMPLETED|Overall Study||0
1435116|NCT02338076|3514351|P1|COMPLETED|Overall Study||20
1435117|NCT02338076|3514351|P1|STARTED|Overall Study||20
1435118|NCT02337959|3514369|P3|NOT COMPLETED|Overall Study||0
1435119|NCT02337959|3514370|P2|NOT COMPLETED|Overall Study||3
1435120|NCT02337959|3514371|P1|NOT COMPLETED|Overall Study||0
1435121|NCT02337959|3514369|P3|COMPLETED|Overall Study||7
1435122|NCT02337959|3514370|P2|COMPLETED|Overall Study||7
1435123|NCT02337959|3514371|P1|COMPLETED|Overall Study||10
1435124|NCT02337959|3514369|P3|STARTED|Overall Study||7
1435125|NCT02337959|3514370|P2|STARTED|Overall Study||10
1435126|NCT02337959|3514371|P1|STARTED|Overall Study||10
1435127|NCT02337907|3514385|P6|NOT COMPLETED|Overall Study||1
1435128|NCT02337907|3514386|P5|NOT COMPLETED|Overall Study||10
1435129|NCT02337907|3514387|P4|NOT COMPLETED|Overall Study||4
1435130|NCT02337907|3514388|P3|NOT COMPLETED|Overall Study||1
1435131|NCT02337907|3514389|P2|NOT COMPLETED|Overall Study||4
1435132|NCT02337907|3514390|P1|NOT COMPLETED|Overall Study||4
1435133|NCT02337907|3514385|P6|COMPLETED|Overall Study||4
1435134|NCT02337907|3514386|P5|COMPLETED|Overall Study||96
1435135|NCT02337907|3514387|P4|COMPLETED|Overall Study||51
1435136|NCT02337907|3514388|P3|COMPLETED|Overall Study||54
1435137|NCT02337907|3514389|P2|COMPLETED|Overall Study||49
1435138|NCT02337907|3514390|P1|COMPLETED|Overall Study||51
1435139|NCT02337907|3514385|P6|STARTED|Overall Study||5
1435140|NCT02337907|3514386|P5|STARTED|Overall Study||106
1435141|NCT02337907|3514387|P4|STARTED|Overall Study||55
1435142|NCT02337907|3514388|P3|STARTED|Overall Study||55
1435143|NCT02337907|3514389|P2|STARTED|Overall Study||53
1435144|NCT02337907|3514390|P1|STARTED|Overall Study||55
1435145|NCT02337725|3514427|P2|NOT COMPLETED|Overall Study||8
1435146|NCT02337725|3514428|P1|NOT COMPLETED|Overall Study||26
1435147|NCT02337725|3514427|P2|COMPLETED|Overall Study||110
1435148|NCT02337725|3514428|P1|COMPLETED|Overall Study||100
1435149|NCT02337725|3514427|P2|STARTED|Overall Study||118
1435150|NCT02337725|3514428|P1|STARTED|Overall Study||126
1435151|NCT02337491|3514452|P2|NOT COMPLETED|Overall Study||30
1435152|NCT02337491|3514453|P1|NOT COMPLETED|Overall Study||50
1435153|NCT02337491|3514452|P2|COMPLETED|Overall Study||0
1435154|NCT02337491|3514453|P1|COMPLETED|Overall Study||0
1435155|NCT02337491|3514452|P2|STARTED|Overall Study||30
1435156|NCT02337491|3514453|P1|STARTED|Overall Study||50
1435157|NCT02337062|3514469|P2|NOT COMPLETED|Overall Study||19
1435158|NCT02337062|3514470|P1|NOT COMPLETED|Overall Study||17
1435159|NCT02337062|3514469|P2|COMPLETED|Overall Study||556
1435160|NCT02337062|3514470|P1|COMPLETED|Overall Study||555
1435161|NCT02337062|3514469|P2|STARTED|Overall Study||575
1435162|NCT02337062|3514470|P1|STARTED|Overall Study||572
1435163|NCT02336958|3514478|P2|NOT COMPLETED|Overall Study||0
1435164|NCT02336958|3514479|P1|NOT COMPLETED|Overall Study||0
1435165|NCT02336958|3514478|P2|COMPLETED|Overall Study||20
1435166|NCT02336958|3514479|P1|COMPLETED|Overall Study||20
1435167|NCT02336958|3514478|P2|STARTED|Overall Study||20
1435168|NCT02336958|3514479|P1|STARTED|Overall Study||20
1435169|NCT02336763|3514487|P1|NOT COMPLETED|Overall Study||0
1435170|NCT02336763|3514487|P1|COMPLETED|Overall Study||2
1435171|NCT02336763|3514487|P1|STARTED|Overall Study||2
1435172|NCT02336607|3514501|P4|NOT COMPLETED|Overall Study||87
1435173|NCT02336607|3514502|P3|NOT COMPLETED|Overall Study||6
1435174|NCT02336607|3514503|P2|NOT COMPLETED|Overall Study||10
1435175|NCT02336607|3514504|P1|NOT COMPLETED|Overall Study||4
1435176|NCT02336607|3514501|P4|COMPLETED|Overall Study||180
1435177|NCT02336607|3514502|P3|COMPLETED|Overall Study||86
1435178|NCT02336607|3514503|P2|COMPLETED|Overall Study||75
1435179|NCT02336607|3514504|P1|COMPLETED|Overall Study||81
1435180|NCT02336607|3514501|P4|Patients Included in Safety Population|Overall Study||260
1435181|NCT02336607|3514502|P3|Patients Included in Safety Population|Overall Study||92
1435182|NCT02336607|3514503|P2|Patients Included in Safety Population|Overall Study||85
1435183|NCT02336607|3514504|P1|Patients Included in Safety Population|Overall Study||85
1435184|NCT02336607|3514501|P4|Patients Included in PP Population|Overall Study||162
1435185|NCT02336607|3514502|P3|Patients Included in PP Population|Overall Study||75
1435186|NCT02336607|3514503|P2|Patients Included in PP Population|Overall Study||75
1435187|NCT02336607|3514504|P1|Patients Included in PP Population|Overall Study||78
1435188|NCT02336607|3514501|P4|Patients Included in ITT Population|Overall Study||222
1435189|NCT02336607|3514502|P3|Patients Included in ITT Population|Overall Study||91
1435190|NCT02336607|3514503|P2|Patients Included in ITT Population|Overall Study||84
1435191|NCT02336607|3514504|P1|Patients Included in ITT Population|Overall Study||84
1435192|NCT02336607|3514501|P4|STARTED|Overall Study||267
1435193|NCT02336607|3514502|P3|STARTED|Overall Study||92
1435194|NCT02336607|3514503|P2|STARTED|Overall Study||85
1435195|NCT02336607|3514504|P1|STARTED|Overall Study||85
1435196|NCT02336594|3514562|P4|NOT COMPLETED|Overall Study||0
1435197|NCT02336594|3514563|P3|NOT COMPLETED|Overall Study||0
1435198|NCT02336594|3514564|P2|NOT COMPLETED|Overall Study||0
1435199|NCT02336594|3514565|P1|NOT COMPLETED|Overall Study||0
1435200|NCT02336594|3514562|P4|COMPLETED|Overall Study||4
1435201|NCT02336594|3514563|P3|COMPLETED|Overall Study||4
1435202|NCT02336594|3514564|P2|COMPLETED|Overall Study||4
1435203|NCT02336594|3514565|P1|COMPLETED|Overall Study||3
1435204|NCT02336594|3514562|P4|STARTED|Overall Study||4
1435205|NCT02336594|3514563|P3|STARTED|Overall Study||4
1435206|NCT02336594|3514564|P2|STARTED|Overall Study||4
1435207|NCT02336594|3514565|P1|STARTED|Overall Study||3
1435208|NCT02336438|3514605|P1|NOT COMPLETED|Overall Study||1
1435209|NCT02336438|3514605|P1|COMPLETED|Overall Study||10
1435210|NCT02336438|3514605|P1|STARTED|Overall Study||11
1435211|NCT02336425|3514618|P4|NOT COMPLETED|Overall Study||3
1435212|NCT02336425|3514619|P3|NOT COMPLETED|Overall Study||3
1435213|NCT02336425|3514620|P2|NOT COMPLETED|Overall Study||2
1435214|NCT02336425|3514621|P1|NOT COMPLETED|Overall Study||2
1435215|NCT02336425|3514618|P4|COMPLETED|Overall Study||0
1435216|NCT02336425|3514619|P3|COMPLETED|Overall Study||0
1435217|NCT02336425|3514620|P2|COMPLETED|Overall Study||0
1435218|NCT02336425|3514621|P1|COMPLETED|Overall Study||0
1435219|NCT02336425|3514618|P4|STARTED|Overall Study||3
1435220|NCT02336425|3514619|P3|STARTED|Overall Study||3
1435221|NCT02336425|3514620|P2|STARTED|Overall Study||2
1435222|NCT02336425|3514621|P1|STARTED|Overall Study||2
1435223|NCT02336282|3514671|P1|NOT COMPLETED|Overall Study||5
1435224|NCT02336282|3514671|P1|COMPLETED|Overall Study||28
1435225|NCT02336282|3514671|P1|STARTED|Overall Study||33
1435226|NCT02336178|3514695|P1|NOT COMPLETED|Overall Study||4
1435227|NCT02336178|3514695|P1|COMPLETED|Overall Study||66
1435228|NCT02336178|3514695|P1|STARTED|Overall Study||70
1435229|NCT02335710|3514783|P2|NOT COMPLETED|Overall Study||0
1435230|NCT02335710|3514784|P1|NOT COMPLETED|Overall Study||0
1435231|NCT02335710|3514783|P2|COMPLETED|Overall Study||10
1435232|NCT02335710|3514784|P1|COMPLETED|Overall Study||40
1435233|NCT02335710|3514783|P2|STARTED|Overall Study||10
1435234|NCT02335710|3514784|P1|STARTED|Overall Study||40
1435235|NCT02335502|3514804|P1|NOT COMPLETED|Overall Study||17
1435236|NCT02335502|3514804|P1|COMPLETED|Overall Study||49
1435237|NCT02335502|3514804|P1|Receiving Permanent System|Overall Study||56
1435238|NCT02335502|3514804|P1|Received Trial System|Overall Study||65
1435239|NCT02335502|3514804|P1|STARTED|Overall Study||66
1435240|NCT02335489|3514809|P1|NOT COMPLETED|Overall Study||10
1435241|NCT02335489|3514809|P1|COMPLETED|Overall Study||0
1435242|NCT02335489|3514809|P1|Receiving Permanent System|Overall Study||8
1435243|NCT02335489|3514809|P1|Received Trial System|Overall Study||9
1435244|NCT02335489|3514809|P1|STARTED|Overall Study||10
1435245|NCT02335346|3514813|P1|NOT COMPLETED|Overall Study||12
1435246|NCT02335346|3514813|P1|COMPLETED|Overall Study||81
1435247|NCT02335346|3514813|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
1435248|NCT02335346|3514813|P1|STARTED|Overall Study||93
1435249|NCT02335216|3514825|P1|NOT COMPLETED|Overall Study||13
1435250|NCT02335216|3514825|P1|COMPLETED|Overall Study||9
1435251|NCT02335216|3514825|P1|Received Permanent System|Overall Study||13
1435252|NCT02335216|3514825|P1|Received Trial System|Overall Study||16
1435253|NCT02335216|3514825|P1|STARTED|Overall Study||22
1435254|NCT02334982|3514837|P7|NOT COMPLETED|Overall Study||0
1435255|NCT02334982|3514838|P6|NOT COMPLETED|Overall Study||0
1435256|NCT02334982|3514839|P5|NOT COMPLETED|Overall Study||0
1435257|NCT02334982|3514840|P4|NOT COMPLETED|Overall Study||0
1435258|NCT02334982|3514841|P3|NOT COMPLETED|Overall Study||0
1435259|NCT02334982|3514842|P2|NOT COMPLETED|Overall Study||0
1435260|NCT02334982|3514843|P1|NOT COMPLETED|Overall Study||0
1435261|NCT02334982|3514837|P7|COMPLETED|Overall Study||12
1435262|NCT02334982|3514838|P6|COMPLETED|Overall Study||6
1435263|NCT02334982|3514839|P5|COMPLETED|Overall Study||6
1435264|NCT02334982|3514840|P4|COMPLETED|Overall Study||6
1435265|NCT02334982|3514841|P3|COMPLETED|Overall Study||6
1435266|NCT02334982|3514842|P2|COMPLETED|Overall Study||5
1435267|NCT02334982|3514843|P1|COMPLETED|Overall Study||6
1435268|NCT02334982|3514837|P7|STARTED|Overall Study||12
1435269|NCT02334982|3514838|P6|STARTED|Overall Study||6
1435270|NCT02334982|3514839|P5|STARTED|Overall Study||6
1435271|NCT02334982|3514840|P4|STARTED|Overall Study||6
1435272|NCT02334982|3514841|P3|STARTED|Overall Study||6
1435273|NCT02334982|3514842|P2|STARTED|Overall Study||5
1435274|NCT02334982|3514843|P1|STARTED|Overall Study||6
1435275|NCT02334813|3514949|P2|NOT COMPLETED|Overall Study||1
1435276|NCT02334813|3514950|P1|NOT COMPLETED|Overall Study||3
1435277|NCT02334813|3514949|P2|COMPLETED|Overall Study||13
1435278|NCT02334813|3514950|P1|COMPLETED|Overall Study||9
1435279|NCT02334813|3514949|P2|STARTED|Overall Study||14
1435280|NCT02334813|3514950|P1|STARTED|Overall Study||12
1435281|NCT02334800|3514960|P4|NOT COMPLETED|Overall Study||0
1435282|NCT02334800|3514961|P3|NOT COMPLETED|Overall Study||0
1435283|NCT02334800|3514962|P2|NOT COMPLETED|Overall Study||0
1435284|NCT02334800|3514963|P1|NOT COMPLETED|Overall Study||0
1435285|NCT02334800|3514960|P4|COMPLETED|Overall Study||7
1435286|NCT02334800|3514961|P3|COMPLETED|Overall Study||7
1435287|NCT02334800|3514962|P2|COMPLETED|Overall Study||7
1435288|NCT02334800|3514963|P1|COMPLETED|Overall Study||7
1435289|NCT02334800|3514960|P4|Received Treatment|Overall Study||7
1435290|NCT02334800|3514961|P3|Received Treatment|Overall Study||7
1435291|NCT02334800|3514962|P2|Received Treatment|Overall Study||7
1435292|NCT02334800|3514963|P1|Received Treatment|Overall Study||7
1435293|NCT02334800|3514960|P4|STARTED|Overall Study||7
1435294|NCT02334800|3514961|P3|STARTED|Overall Study||7
1435295|NCT02334800|3514962|P2|STARTED|Overall Study||7
1435296|NCT02334800|3514963|P1|STARTED|Overall Study||7
1435297|NCT02334787|3515057|P4|NOT COMPLETED|Overall Study||0
1435298|NCT02334787|3515058|P3|NOT COMPLETED|Overall Study||0
1435299|NCT02334787|3515059|P2|NOT COMPLETED|Overall Study||0
1435300|NCT02334787|3515060|P1|NOT COMPLETED|Overall Study||0
1435301|NCT02334787|3515057|P4|COMPLETED|Overall Study||8
1435302|NCT02334787|3515058|P3|COMPLETED|Overall Study||8
1435303|NCT02334787|3515059|P2|COMPLETED|Overall Study||8
1435304|NCT02334787|3515060|P1|COMPLETED|Overall Study||8
1435305|NCT02334787|3515057|P4|STARTED|Overall Study||8
1435306|NCT02334787|3515058|P3|STARTED|Overall Study||8
1435307|NCT02334787|3515059|P2|STARTED|Overall Study||8
1435308|NCT02334787|3515060|P1|STARTED|Overall Study||8
1435309|NCT02334527|3515082|P1|NOT COMPLETED|Overall Study||0
1435310|NCT02334527|3515082|P1|COMPLETED|Overall Study||12
1435311|NCT02334527|3515082|P1|STARTED|Overall Study||12
1435312|NCT02334384|3515093|P2|NOT COMPLETED|Overall Study||1
1435313|NCT02334384|3515094|P1|NOT COMPLETED|Overall Study||1
1435314|NCT02334384|3515093|P2|COMPLETED|Overall Study||1
1435315|NCT02334384|3515094|P1|COMPLETED|Overall Study||3
1435316|NCT02334384|3515093|P2|STARTED|Overall Study||2
1435317|NCT02334384|3515094|P1|STARTED|Overall Study||4
1435318|NCT02334267|3515102|P2|NOT COMPLETED|Overall Study||0
1435319|NCT02334267|3515103|P1|NOT COMPLETED|Overall Study||1
1435320|NCT02334267|3515102|P2|COMPLETED|Overall Study||5
1435321|NCT02334267|3515103|P1|COMPLETED|Overall Study||5
1435322|NCT02334267|3515102|P2|STARTED|Overall Study||5
1435323|NCT02334267|3515103|P1|STARTED|Overall Study||6
1435324|NCT02333045|3515117|P2|NOT COMPLETED|Overall Study||0
1435325|NCT02333045|3515118|P1|NOT COMPLETED|Overall Study||0
1435326|NCT02333045|3515117|P2|COMPLETED|Overall Study||3
1435327|NCT02333045|3515118|P1|COMPLETED|Overall Study||1
1435328|NCT02333045|3515117|P2|STARTED|Overall Study||3
1435329|NCT02333045|3515118|P1|STARTED|Overall Study||1
1435330|NCT02332902|3515128|P1|NOT COMPLETED|Overall Study||7
1435331|NCT02332902|3515128|P1|COMPLETED|Overall Study||17
1435332|NCT02332902|3515128|P1|STARTED|Overall Study||24
1435333|NCT02332889|3515133|P1|NOT COMPLETED|Overall Study||1
1435334|NCT02332889|3515133|P1|COMPLETED|Overall Study||0
1435335|NCT02332889|3515133|P1|STARTED|Overall Study||1
1435336|NCT02332876|3515139|P2|NOT COMPLETED|Overall Study||1
1435337|NCT02332876|3515140|P1|NOT COMPLETED|Overall Study||1
1435338|NCT02332876|3515139|P2|COMPLETED|Overall Study||43
1435339|NCT02332876|3515140|P1|COMPLETED|Overall Study||42
1435340|NCT02332876|3515139|P2|STARTED|Overall Study||44
1435341|NCT02332876|3515140|P1|STARTED|Overall Study||43
1435342|NCT02332824|3515152|P6|NOT COMPLETED|Overall Study||1
1435343|NCT02332824|3515153|P5|NOT COMPLETED|Overall Study||4
1435344|NCT02332824|3515154|P4|NOT COMPLETED|Overall Study||2
1435345|NCT02332824|3515155|P3|NOT COMPLETED|Overall Study||2
1435346|NCT02332824|3515156|P2|NOT COMPLETED|Overall Study||1
1435347|NCT02332824|3515157|P1|NOT COMPLETED|Overall Study||6
1435348|NCT02332824|3515152|P6|COMPLETED|Overall Study||69
1435349|NCT02332824|3515153|P5|COMPLETED|Overall Study||65
1435350|NCT02332824|3515154|P4|COMPLETED|Overall Study||66
1435351|NCT02332824|3515155|P3|COMPLETED|Overall Study||72
1435352|NCT02332824|3515156|P2|COMPLETED|Overall Study||66
1435353|NCT02332824|3515157|P1|COMPLETED|Overall Study||61
1435354|NCT02332824|3515152|P6|STARTED|Overall Study||70
1435355|NCT02332824|3515153|P5|STARTED|Overall Study||69
1435356|NCT02332824|3515154|P4|STARTED|Overall Study||68
1435357|NCT02332824|3515155|P3|STARTED|Overall Study||74
1435358|NCT02332824|3515156|P2|STARTED|Overall Study||67
1435359|NCT02332824|3515157|P1|STARTED|Overall Study||67
1435360|NCT02332798|3515198|P3|NOT COMPLETED|Overall Study||1
1435361|NCT02332798|3515199|P2|NOT COMPLETED|Overall Study||2
1435362|NCT02332798|3515200|P1|NOT COMPLETED|Overall Study||1
1435363|NCT02332798|3515198|P3|COMPLETED|Overall Study||11
1435364|NCT02332798|3515199|P2|COMPLETED|Overall Study||12
1435365|NCT02332798|3515200|P1|COMPLETED|Overall Study||12
1435366|NCT02332798|3515198|P3|STARTED|Overall Study||12
1435367|NCT02332798|3515199|P2|STARTED|Overall Study||14
1435368|NCT02332798|3515200|P1|STARTED|Overall Study||13
1435369|NCT02332720|3515273|P23|NOT COMPLETED|Part C||0
1435370|NCT02332720|3515274|P22|NOT COMPLETED|Part C||0
1435371|NCT02332720|3515275|P21|NOT COMPLETED|Part C||0
1435372|NCT02332720|3515276|P20|NOT COMPLETED|Part C||0
1435373|NCT02332720|3515277|P19|NOT COMPLETED|Part C||0
1435374|NCT02332720|3515278|P18|NOT COMPLETED|Part C||0
1435375|NCT02332720|3515279|P17|NOT COMPLETED|Part C||0
1435376|NCT02332720|3515280|P16|NOT COMPLETED|Part C||0
1435377|NCT02332720|3515281|P15|NOT COMPLETED|Part C||0
1435378|NCT02332720|3515282|P14|NOT COMPLETED|Part C||0
1435379|NCT02332720|3515283|P13|NOT COMPLETED|Part C||0
1435380|NCT02332720|3515284|P12|NOT COMPLETED|Part C||0
1435381|NCT02332720|3515285|P11|NOT COMPLETED|Part C||0
1435382|NCT02332720|3515286|P10|NOT COMPLETED|Part C||0
1435383|NCT02332720|3515287|P9|NOT COMPLETED|Part C||0
1435384|NCT02332720|3515288|P8|NOT COMPLETED|Part C||0
1435385|NCT02332720|3515289|P7|NOT COMPLETED|Part C||0
1435386|NCT02332720|3515290|P6|NOT COMPLETED|Part C||0
1435387|NCT02332720|3515291|P5|NOT COMPLETED|Part C||0
1435388|NCT02332720|3515292|P4|NOT COMPLETED|Part C||0
1435389|NCT02332720|3515293|P3|NOT COMPLETED|Part C||0
1435390|NCT02332720|3515294|P2|NOT COMPLETED|Part C||0
1435391|NCT02332720|3515295|P1|NOT COMPLETED|Part C||0
1435392|NCT02332720|3515273|P23|COMPLETED|Part C||0
1435393|NCT02332720|3515274|P22|COMPLETED|Part C||0
1435394|NCT02332720|3515275|P21|COMPLETED|Part C||0
1435395|NCT02332720|3515276|P20|COMPLETED|Part C||0
1435396|NCT02332720|3515277|P19|COMPLETED|Part C||0
1435397|NCT02332720|3515278|P18|COMPLETED|Part C||0
1435398|NCT02332720|3515279|P17|COMPLETED|Part C||0
1435399|NCT02332720|3515280|P16|COMPLETED|Part C||0
1435400|NCT02332720|3515281|P15|COMPLETED|Part C||0
1435401|NCT02332720|3515282|P14|COMPLETED|Part C||0
1435402|NCT02332720|3515283|P13|COMPLETED|Part C||0
1435403|NCT02332720|3515284|P12|COMPLETED|Part C||0
1435404|NCT02332720|3515285|P11|COMPLETED|Part C||0
1435405|NCT02332720|3515286|P10|COMPLETED|Part C||0
1435406|NCT02332720|3515287|P9|COMPLETED|Part C||0
1435407|NCT02332720|3515288|P8|COMPLETED|Part C||0
1435408|NCT02332720|3515289|P7|COMPLETED|Part C||0
1435409|NCT02332720|3515290|P6|COMPLETED|Part C||0
1435410|NCT02332720|3515291|P5|COMPLETED|Part C||0
1435411|NCT02332720|3515292|P4|COMPLETED|Part C||2
1435412|NCT02332720|3515293|P3|COMPLETED|Part C||3
1435413|NCT02332720|3515294|P2|COMPLETED|Part C||1
1435414|NCT02332720|3515295|P1|COMPLETED|Part C||2
1435415|NCT02332720|3515273|P23|STARTED|Part C|Part B participants were not included in Part C.|0
1435416|NCT02332720|3515274|P22|STARTED|Part C||0
1435417|NCT02332720|3515275|P21|STARTED|Part C|Part B participants were not included in Part C.|0
1435418|NCT02332720|3515276|P20|STARTED|Part C|Part B participants were not included in Part C.|0
1435419|NCT02332720|3515277|P19|STARTED|Part C|Part B participants were not included in Part C.|0
1435420|NCT02332720|3515278|P18|STARTED|Part C|Part B participants were not included in Part C.|0
1435421|NCT02332720|3515279|P17|STARTED|Part C|Part B participants were not included in Part C.|0
1435422|NCT02332720|3515280|P16|STARTED|Part C|Part B participants were not included in Part C.|0
1435423|NCT02332720|3515281|P15|STARTED|Part C|Part B participants were not included in Part C.|0
1435424|NCT02332720|3515282|P14|STARTED|Part C|Part B participants were not included in Part C.|0
1435425|NCT02332720|3515283|P13|STARTED|Part C|Part B participants were not included in Part C.|0
1435426|NCT02332720|3515284|P12|STARTED|Part C|Part B participants were not included in Part C.|0
1435427|NCT02332720|3515285|P11|STARTED|Part C|Part B participants were not included in Part C.|0
1435428|NCT02332720|3515286|P10|STARTED|Part C|Part B participants were not included in Part C.|0
1435429|NCT02332720|3515287|P9|STARTED|Part C|Part B participants were not included in Part C.|0
1435430|NCT02332720|3515288|P8|STARTED|Part C|Part B participants were not included in Part C.|0
1435431|NCT02332720|3515289|P7|STARTED|Part C|Part B participants were not included in Part C.|0
1435432|NCT02332720|3515290|P6|STARTED|Part C|Part B participants were not included in Part C.|0
1435433|NCT02332720|3515291|P5|STARTED|Part C|Part B participants were not included in Part C.|0
1435434|NCT02332720|3515292|P4|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
1435435|NCT02332720|3515293|P3|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
1435436|NCT02332720|3515294|P2|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
1435437|NCT02332720|3515295|P1|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
1435438|NCT02332720|3515273|P23|NOT COMPLETED|Part A and Part B||0
1435439|NCT02332720|3515274|P22|NOT COMPLETED|Part A and Part B||0
1435440|NCT02332720|3515275|P21|NOT COMPLETED|Part A and Part B||0
1435441|NCT02332720|3515276|P20|NOT COMPLETED|Part A and Part B||1
1435442|NCT02332720|3515277|P19|NOT COMPLETED|Part A and Part B||1
1435443|NCT02332720|3515278|P18|NOT COMPLETED|Part A and Part B||1
1435444|NCT02332720|3515279|P17|NOT COMPLETED|Part A and Part B||0
1435445|NCT02332720|3515280|P16|NOT COMPLETED|Part A and Part B||1
1435446|NCT02332720|3515281|P15|NOT COMPLETED|Part A and Part B||0
1435447|NCT02332720|3515282|P14|NOT COMPLETED|Part A and Part B||0
1435448|NCT02332720|3515283|P13|NOT COMPLETED|Part A and Part B||0
1435449|NCT02332720|3515284|P12|NOT COMPLETED|Part A and Part B||0
1435450|NCT02332720|3515285|P11|NOT COMPLETED|Part A and Part B||0
1435451|NCT02332720|3515286|P10|NOT COMPLETED|Part A and Part B||0
1435452|NCT02332720|3515287|P9|NOT COMPLETED|Part A and Part B||0
1435453|NCT02332720|3515288|P8|NOT COMPLETED|Part A and Part B||1
1435454|NCT02332720|3515289|P7|NOT COMPLETED|Part A and Part B||1
1435455|NCT02332720|3515290|P6|NOT COMPLETED|Part A and Part B||3
1435456|NCT02332720|3515291|P5|NOT COMPLETED|Part A and Part B||0
1435457|NCT02332720|3515292|P4|NOT COMPLETED|Part A and Part B||0
1435458|NCT02332720|3515293|P3|NOT COMPLETED|Part A and Part B||0
1435459|NCT02332720|3515294|P2|NOT COMPLETED|Part A and Part B||0
1435460|NCT02332720|3515295|P1|NOT COMPLETED|Part A and Part B||1
1435461|NCT02332720|3515273|P23|COMPLETED|Part A and Part B||4
1435462|NCT02332720|3515274|P22|COMPLETED|Part A and Part B||0
1435463|NCT02332720|3515275|P21|COMPLETED|Part A and Part B||7
1435464|NCT02332720|3515276|P20|COMPLETED|Part A and Part B||24
1435465|NCT02332720|3515277|P19|COMPLETED|Part A and Part B||20
1435466|NCT02332720|3515278|P18|COMPLETED|Part A and Part B||13
1435467|NCT02332720|3515279|P17|COMPLETED|Part A and Part B||15
1435468|NCT02332720|3515280|P16|COMPLETED|Part A and Part B||13
1435469|NCT02332720|3515281|P15|COMPLETED|Part A and Part B||16
1435470|NCT02332720|3515282|P14|COMPLETED|Part A and Part B||13
1435471|NCT02332720|3515283|P13|COMPLETED|Part A and Part B||16
1435472|NCT02332720|3515284|P12|COMPLETED|Part A and Part B||15
1435473|NCT02332720|3515285|P11|COMPLETED|Part A and Part B||14
1435474|NCT02332720|3515286|P10|COMPLETED|Part A and Part B||14
1435475|NCT02332720|3515287|P9|COMPLETED|Part A and Part B||15
1435476|NCT02332720|3515288|P8|COMPLETED|Part A and Part B||34
1435477|NCT02332720|3515289|P7|COMPLETED|Part A and Part B||36
1435478|NCT02332720|3515290|P6|COMPLETED|Part A and Part B||33
1435479|NCT02332720|3515291|P5|COMPLETED|Part A and Part B||16
1435480|NCT02332720|3515292|P4|COMPLETED|Part A and Part B||22
1435481|NCT02332720|3515293|P3|COMPLETED|Part A and Part B||22
1435482|NCT02332720|3515294|P2|COMPLETED|Part A and Part B||21
1435483|NCT02332720|3515295|P1|COMPLETED|Part A and Part B||20
1435484|NCT02332720|3515273|P23|Treated|Part A and Part B||4
1435485|NCT02332720|3515274|P22|Treated|Part A and Part B||0
1435486|NCT02332720|3515275|P21|Treated|Part A and Part B||7
1435487|NCT02332720|3515276|P20|Treated|Part A and Part B||25
1435488|NCT02332720|3515277|P19|Treated|Part A and Part B||20
1435489|NCT02332720|3515278|P18|Treated|Part A and Part B||14
1435490|NCT02332720|3515279|P17|Treated|Part A and Part B||15
1435491|NCT02332720|3515280|P16|Treated|Part A and Part B||14
1435492|NCT02332720|3515281|P15|Treated|Part A and Part B||16
1435493|NCT02332720|3515282|P14|Treated|Part A and Part B||13
1435494|NCT02332720|3515283|P13|Treated|Part A and Part B||16
1435495|NCT02332720|3515284|P12|Treated|Part A and Part B||15
1435496|NCT02332720|3515285|P11|Treated|Part A and Part B||14
1435497|NCT02332720|3515286|P10|Treated|Part A and Part B||14
1435498|NCT02332720|3515287|P9|Treated|Part A and Part B||15
1435499|NCT02332720|3515288|P8|Treated|Part A and Part B||35
1435500|NCT02332720|3515289|P7|Treated|Part A and Part B||37
1435501|NCT02332720|3515290|P6|Treated|Part A and Part B||36
1435502|NCT02332720|3515291|P5|Treated|Part A and Part B||16
1435503|NCT02332720|3515292|P4|Treated|Part A and Part B||22
1435504|NCT02332720|3515293|P3|Treated|Part A and Part B||22
1435505|NCT02332720|3515294|P2|Treated|Part A and Part B||21
1435506|NCT02332720|3515295|P1|Treated|Part A and Part B||21
1435507|NCT02332720|3515273|P23|STARTED|Part A and Part B||4
1435508|NCT02332720|3515274|P22|STARTED|Part A and Part B||0
1435509|NCT02332720|3515275|P21|STARTED|Part A and Part B||7
1435510|NCT02332720|3515276|P20|STARTED|Part A and Part B||25
1435511|NCT02332720|3515277|P19|STARTED|Part A and Part B||21
1435512|NCT02332720|3515278|P18|STARTED|Part A and Part B||14
1435513|NCT02332720|3515279|P17|STARTED|Part A and Part B||15
1435514|NCT02332720|3515280|P16|STARTED|Part A and Part B||14
1435515|NCT02332720|3515281|P15|STARTED|Part A and Part B||16
1435516|NCT02332720|3515282|P14|STARTED|Part A and Part B||13
1435517|NCT02332720|3515283|P13|STARTED|Part A and Part B||16
1435518|NCT02332720|3515284|P12|STARTED|Part A and Part B||15
1435519|NCT02332720|3515285|P11|STARTED|Part A and Part B||14
1435520|NCT02332720|3515286|P10|STARTED|Part A and Part B||14
1435521|NCT02332720|3515287|P9|STARTED|Part A and Part B||15
1435522|NCT02332720|3515288|P8|STARTED|Part A and Part B||35
1435523|NCT02332720|3515289|P7|STARTED|Part A and Part B||37
1435524|NCT02332720|3515290|P6|STARTED|Part A and Part B||36
1435525|NCT02332720|3515291|P5|STARTED|Part A and Part B||16
1435526|NCT02332720|3515292|P4|STARTED|Part A and Part B||22
1435527|NCT02332720|3515293|P3|STARTED|Part A and Part B||22
1435528|NCT02332720|3515294|P2|STARTED|Part A and Part B||21
1435529|NCT02332720|3515295|P1|STARTED|Part A and Part B||21
1435530|NCT02332707|3515431|P18|NOT COMPLETED|Overall Study||0
1435531|NCT02332707|3515432|P17|NOT COMPLETED|Overall Study||0
1435532|NCT02332707|3515433|P16|NOT COMPLETED|Overall Study||0
1435533|NCT02332707|3515434|P15|NOT COMPLETED|Overall Study||0
1435534|NCT02332707|3515435|P14|NOT COMPLETED|Overall Study||0
1435535|NCT02332707|3515436|P13|NOT COMPLETED|Overall Study||5
1435536|NCT02332707|3515437|P12|NOT COMPLETED|Overall Study||0
1435537|NCT02332707|3515438|P11|NOT COMPLETED|Overall Study||2
1435538|NCT02332707|3515439|P10|NOT COMPLETED|Overall Study||3
1435539|NCT02332707|3515440|P9|NOT COMPLETED|Overall Study||0
1435540|NCT02332707|3515441|P8|NOT COMPLETED|Overall Study||0
1435541|NCT02332707|3515442|P7|NOT COMPLETED|Overall Study||0
1435542|NCT02332707|3515443|P6|NOT COMPLETED|Overall Study||1
1435543|NCT02332707|3515444|P5|NOT COMPLETED|Overall Study||0
1435544|NCT02332707|3515445|P4|NOT COMPLETED|Overall Study||1
1435545|NCT02332707|3515446|P3|NOT COMPLETED|Overall Study||1
1435546|NCT02332707|3515447|P2|NOT COMPLETED|Overall Study||0
1435547|NCT02332707|3515448|P1|NOT COMPLETED|Overall Study||0
1435548|NCT02332707|3515431|P18|COMPLETED|Overall Study||16
1435549|NCT02332707|3515432|P17|COMPLETED|Overall Study||30
1435550|NCT02332707|3515433|P16|COMPLETED|Overall Study||26
1435551|NCT02332707|3515434|P15|COMPLETED|Overall Study||16
1435552|NCT02332707|3515435|P14|COMPLETED|Overall Study||15
1435553|NCT02332707|3515436|P13|COMPLETED|Overall Study||35
1435554|NCT02332707|3515437|P12|COMPLETED|Overall Study||35
1435555|NCT02332707|3515438|P11|COMPLETED|Overall Study||29
1435556|NCT02332707|3515439|P10|COMPLETED|Overall Study||28
1435557|NCT02332707|3515440|P9|COMPLETED|Overall Study||48
1435558|NCT02332707|3515441|P8|COMPLETED|Overall Study||16
1435559|NCT02332707|3515442|P7|COMPLETED|Overall Study||15
1435560|NCT02332707|3515443|P6|COMPLETED|Overall Study||22
1435561|NCT02332707|3515444|P5|COMPLETED|Overall Study||23
1435562|NCT02332707|3515445|P4|COMPLETED|Overall Study||13
1435563|NCT02332707|3515446|P3|COMPLETED|Overall Study||15
1435564|NCT02332707|3515447|P2|COMPLETED|Overall Study||24
1435565|NCT02332707|3515448|P1|COMPLETED|Overall Study||23
1435566|NCT02332707|3515431|P18|STARTED|Overall Study||16
1435567|NCT02332707|3515432|P17|STARTED|Overall Study||30
1435568|NCT02332707|3515433|P16|STARTED|Overall Study||26
1435569|NCT02332707|3515434|P15|STARTED|Overall Study||16
1435570|NCT02332707|3515435|P14|STARTED|Overall Study||15
1435571|NCT02332707|3515436|P13|STARTED|Overall Study||40
1435572|NCT02332707|3515437|P12|STARTED|Overall Study||35
1435573|NCT02332707|3515438|P11|STARTED|Overall Study||31
1435574|NCT02332707|3515439|P10|STARTED|Overall Study||31
1435575|NCT02332707|3515440|P9|STARTED|Overall Study||48
1435576|NCT02332707|3515441|P8|STARTED|Overall Study||16
1435577|NCT02332707|3515442|P7|STARTED|Overall Study||15
1435578|NCT02332707|3515443|P6|STARTED|Overall Study||23
1435579|NCT02332707|3515444|P5|STARTED|Overall Study||23
1435580|NCT02332707|3515445|P4|STARTED|Overall Study||14
1435581|NCT02332707|3515446|P3|STARTED|Overall Study||16
1435582|NCT02332707|3515447|P2|STARTED|Overall Study||24
1435583|NCT02332707|3515448|P1|STARTED|Overall Study||23
1435584|NCT02332590|3515542|P2|NOT COMPLETED|Overall Study||19
1435585|NCT02332590|3515543|P1|NOT COMPLETED|Overall Study||29
1435586|NCT02332590|3515542|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
1435587|NCT02332590|3515543|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
1435588|NCT02332590|3515542|P2|Treated|Overall Study||184
1435589|NCT02332590|3515543|P1|Treated|Overall Study||184
1435590|NCT02332590|3515542|P2|STARTED|Overall Study||184
1435591|NCT02332590|3515543|P1|STARTED|Overall Study||185
1435592|NCT02332239|3515607|P2|NOT COMPLETED|Overall Study||6
1435593|NCT02332239|3515608|P1|NOT COMPLETED|Overall Study||4
1435594|NCT02332239|3515607|P2|COMPLETED|Overall Study||52
1435595|NCT02332239|3515608|P1|COMPLETED|Overall Study||54
1435596|NCT02332239|3515607|P2|STARTED|Overall Study||58
1435597|NCT02332239|3515608|P1|STARTED|Overall Study||58
1435598|NCT02331992|3515621|P1|NOT COMPLETED|Overall Study||0
1435599|NCT02331992|3515621|P1|COMPLETED|Overall Study||34
1435600|NCT02331992|3515621|P1|STARTED|Overall Study||34
1435601|NCT02331940|3515628|P2|NOT COMPLETED|Overall Study||5
1435602|NCT02331940|3515629|P1|NOT COMPLETED|Overall Study||7
1435603|NCT02331940|3515628|P2|COMPLETED|Overall Study||95
1435604|NCT02331940|3515629|P1|COMPLETED|Overall Study||93
1435605|NCT02331940|3515628|P2|STARTED|Overall Study||100
1435606|NCT02331940|3515629|P1|STARTED|Overall Study||100
1435607|NCT02331589|3515643|P2|NOT COMPLETED|Overall Study||5
1435608|NCT02331589|3515644|P1|NOT COMPLETED|Overall Study||5
1435609|NCT02331589|3515643|P2|COMPLETED|Overall Study||31
1435610|NCT02331589|3515644|P1|COMPLETED|Overall Study||34
1435611|NCT02331589|3515643|P2|STARTED|Overall Study||36
1435612|NCT02331589|3515644|P1|STARTED|Overall Study||39
1435613|NCT02331446|3515660|P4|NOT COMPLETED|Overall Study||3
1435614|NCT02331446|3515661|P3|NOT COMPLETED|Overall Study||3
1435615|NCT02331446|3515662|P2|NOT COMPLETED|Overall Study||5
1435616|NCT02331446|3515663|P1|NOT COMPLETED|Overall Study||4
1435617|NCT02331446|3515660|P4|COMPLETED|Overall Study||8
1435618|NCT02331446|3515661|P3|COMPLETED|Overall Study||8
1435619|NCT02331446|3515662|P2|COMPLETED|Overall Study||6
1435620|NCT02331446|3515663|P1|COMPLETED|Overall Study||5
1435621|NCT02331446|3515660|P4|STARTED|Overall Study||11
1435622|NCT02331446|3515661|P3|STARTED|Overall Study||11
1435623|NCT02331446|3515662|P2|STARTED|Overall Study||11
1435624|NCT02331446|3515663|P1|STARTED|Overall Study||9
1435625|NCT02331368|3515733|P1|NOT COMPLETED|Overall Study||3
1435626|NCT02331368|3515733|P1|COMPLETED|Overall Study||29
1435627|NCT02331368|3515733|P1|STARTED|Overall Study||32
1435628|NCT02331108|3515745|P6|NOT COMPLETED|Overall Study||2
1435629|NCT02331108|3515746|P5|NOT COMPLETED|Overall Study||2
1435630|NCT02331108|3515747|P4|NOT COMPLETED|Overall Study||1
1435631|NCT02331108|3515748|P3|NOT COMPLETED|Overall Study||1
1435632|NCT02331108|3515749|P2|NOT COMPLETED|Overall Study||2
1435633|NCT02331108|3515750|P1|NOT COMPLETED|Overall Study||1
1435634|NCT02331108|3515745|P6|COMPLETED|Overall Study||50
1435635|NCT02331108|3515746|P5|COMPLETED|Overall Study||50
1435636|NCT02331108|3515747|P4|COMPLETED|Overall Study||50
1435637|NCT02331108|3515748|P3|COMPLETED|Overall Study||50
1435638|NCT02331108|3515749|P2|COMPLETED|Overall Study||50
1435639|NCT02331108|3515750|P1|COMPLETED|Overall Study||50
1435640|NCT02331108|3515745|P6|STARTED|Overall Study||52
1435641|NCT02331108|3515746|P5|STARTED|Overall Study||52
1435642|NCT02331108|3515747|P4|STARTED|Overall Study||51
1435643|NCT02331108|3515748|P3|STARTED|Overall Study||51
1435644|NCT02331108|3515749|P2|STARTED|Overall Study||52
1435645|NCT02331108|3515750|P1|STARTED|Overall Study||51
1435646|NCT02330588|3515777|P5|NOT COMPLETED|Overall Study||19
1435647|NCT02330588|3515778|P4|NOT COMPLETED|Overall Study||22
1435648|NCT02330588|3515779|P3|NOT COMPLETED|Overall Study||15
1435649|NCT02330588|3515780|P2|NOT COMPLETED|Overall Study||18
1435650|NCT02330588|3515781|P1|NOT COMPLETED|Overall Study||16
1435651|NCT02330588|3515777|P5|COMPLETED|Overall Study||28
1435652|NCT02330588|3515778|P4|COMPLETED|Overall Study||24
1435653|NCT02330588|3515779|P3|COMPLETED|Overall Study||31
1435654|NCT02330588|3515780|P2|COMPLETED|Overall Study||25
1435655|NCT02330588|3515781|P1|COMPLETED|Overall Study||28
1435656|NCT02330588|3515777|P5|STARTED|Overall Study||47
1435657|NCT02330588|3515778|P4|STARTED|Overall Study||46
1435658|NCT02330588|3515779|P3|STARTED|Overall Study||46
1435659|NCT02330588|3515780|P2|STARTED|Overall Study||43
1435660|NCT02330588|3515781|P1|STARTED|Overall Study||44
1435661|NCT02330523|3515808|P2|NOT COMPLETED|Overall Study||0
1435662|NCT02330523|3515809|P1|NOT COMPLETED|Overall Study||0
1435663|NCT02330523|3515808|P2|COMPLETED|Overall Study||19
1435664|NCT02330523|3515809|P1|COMPLETED|Overall Study||21
1435665|NCT02330523|3515808|P2|STARTED|Overall Study||19
1435666|NCT02330523|3515809|P1|STARTED|Overall Study||21
1435667|NCT02330276|3515822|P3|NOT COMPLETED|Overall Study||0
1435668|NCT02330276|3515823|P2|NOT COMPLETED|Overall Study||0
1435669|NCT02330276|3515824|P1|NOT COMPLETED|Overall Study||0
1435670|NCT02330276|3515822|P3|COMPLETED|Overall Study||4
1435671|NCT02330276|3515823|P2|COMPLETED|Overall Study||4
1435672|NCT02330276|3515824|P1|COMPLETED|Overall Study||4
1435673|NCT02330276|3515822|P3|STARTED|Overall Study||4
1435674|NCT02330276|3515823|P2|STARTED|Overall Study||4
1435675|NCT02330276|3515824|P1|STARTED|Overall Study||4
1435676|NCT02330172|3515846|P2|NOT COMPLETED|Overall Study||1
1435677|NCT02330172|3515847|P1|NOT COMPLETED|Overall Study||3
1435678|NCT02330172|3515846|P2|COMPLETED|Overall Study||21
1435679|NCT02330172|3515847|P1|COMPLETED|Overall Study||19
1435680|NCT02330172|3515846|P2|STARTED|Overall Study||22
1435681|NCT02330172|3515847|P1|STARTED|Overall Study||22
1435682|NCT02330055|3515857|P2|NOT COMPLETED|Overall Study||9
1435683|NCT02330055|3515858|P1|NOT COMPLETED|Overall Study||10
1435684|NCT02330055|3515857|P2|COMPLETED|Overall Study||40
1435685|NCT02330055|3515858|P1|COMPLETED|Overall Study||40
1435686|NCT02330055|3515857|P2|STARTED|Overall Study||49
1435687|NCT02330055|3515858|P1|STARTED|Overall Study||50
1435688|NCT02329964|3515878|P2|NOT COMPLETED|Overall Study||0
1435689|NCT02329964|3515879|P1|NOT COMPLETED|Overall Study||0
1435690|NCT02329964|3515878|P2|COMPLETED|Overall Study||40
1435691|NCT02329964|3515879|P1|COMPLETED|Overall Study||40
1435692|NCT02329964|3515878|P2|STARTED|Overall Study||40
1435693|NCT02329964|3515879|P1|STARTED|Overall Study||40
1435694|NCT02329730|3515905|P12|NOT COMPLETED|Overall Study||0
1435695|NCT02329730|3515906|P11|NOT COMPLETED|Overall Study||0
1435696|NCT02329730|3515907|P10|NOT COMPLETED|Overall Study||1
1435697|NCT02329730|3515908|P9|NOT COMPLETED|Overall Study||1
1435698|NCT02329730|3515909|P8|NOT COMPLETED|Overall Study||1
1435699|NCT02329730|3515910|P7|NOT COMPLETED|Overall Study||1
1435700|NCT02329730|3515911|P6|NOT COMPLETED|Overall Study||2
1435701|NCT02329730|3515912|P5|NOT COMPLETED|Overall Study||3
1435702|NCT02329730|3515913|P4|NOT COMPLETED|Overall Study||0
1435703|NCT02329730|3515914|P3|NOT COMPLETED|Overall Study||0
1435704|NCT02329730|3515915|P2|NOT COMPLETED|Overall Study||0
1435705|NCT02329730|3515916|P1|NOT COMPLETED|Overall Study||0
1435706|NCT02329730|3515905|P12|COMPLETED|Overall Study||8
1435707|NCT02329730|3515906|P11|COMPLETED|Overall Study||8
1435708|NCT02329730|3515907|P10|COMPLETED|Overall Study||7
1435709|NCT02329730|3515908|P9|COMPLETED|Overall Study||7
1435710|NCT02329730|3515909|P8|COMPLETED|Overall Study||13
1435711|NCT02329730|3515910|P7|COMPLETED|Overall Study||13
1435712|NCT02329730|3515911|P6|COMPLETED|Overall Study||12
1435713|NCT02329730|3515912|P5|COMPLETED|Overall Study||11
1435714|NCT02329730|3515913|P4|COMPLETED|Overall Study||14
1435715|NCT02329730|3515914|P3|COMPLETED|Overall Study||14
1435716|NCT02329730|3515915|P2|COMPLETED|Overall Study||14
1435717|NCT02329730|3515916|P1|COMPLETED|Overall Study||14
1435718|NCT02329730|3515905|P12|STARTED|Overall Study||8
1435719|NCT02329730|3515906|P11|STARTED|Overall Study||8
1435720|NCT02329730|3515907|P10|STARTED|Overall Study||8
1435721|NCT02329730|3515908|P9|STARTED|Overall Study||8
1435722|NCT02329730|3515909|P8|STARTED|Overall Study||14
1435723|NCT02329730|3515910|P7|STARTED|Overall Study||14
1435724|NCT02329730|3515911|P6|STARTED|Overall Study||14
1435725|NCT02329730|3515912|P5|STARTED|Overall Study||14
1435726|NCT02329730|3515913|P4|STARTED|Overall Study||14
1435727|NCT02329730|3515914|P3|STARTED|Overall Study||14
1435728|NCT02329730|3515915|P2|STARTED|Overall Study||14
1435729|NCT02329730|3515916|P1|STARTED|Overall Study||14
1435730|NCT02329600|3515993|P3|NOT COMPLETED|Overall Study||0
1435731|NCT02329600|3515994|P2|NOT COMPLETED|Overall Study||0
1435732|NCT02329600|3515995|P1|NOT COMPLETED|Overall Study||0
1435733|NCT02329600|3515993|P3|COMPLETED|Overall Study||15
1435734|NCT02329600|3515994|P2|COMPLETED|Overall Study||15
1435735|NCT02329600|3515995|P1|COMPLETED|Overall Study||10
1435736|NCT02329600|3515993|P3|STARTED|Overall Study||15
1435737|NCT02329600|3515994|P2|STARTED|Overall Study||15
1435738|NCT02329600|3515995|P1|STARTED|Overall Study||10
1435739|NCT02329587|3516008|P2|NOT COMPLETED|1-month Follow-up||1
1435740|NCT02329587|3516009|P1|NOT COMPLETED|1-month Follow-up||0
1435741|NCT02329587|3516008|P2|COMPLETED|1-month Follow-up||5
1435742|NCT02329587|3516009|P1|COMPLETED|1-month Follow-up||4
1435743|NCT02329587|3516008|P2|STARTED|1-month Follow-up||6
1435744|NCT02329587|3516009|P1|STARTED|1-month Follow-up||4
1435745|NCT02329587|3516008|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
1435746|NCT02329587|3516009|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
1435747|NCT02329587|3516008|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
1435748|NCT02329587|3516009|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
1435749|NCT02329587|3516008|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
1435750|NCT02329587|3516009|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
1435751|NCT02329587|3516008|P2|STARTED|Baseline Thru Post-treatment Assessment||7
1435752|NCT02329587|3516009|P1|STARTED|Baseline Thru Post-treatment Assessment||5
1435753|NCT02329431|3516027|P2|NOT COMPLETED|Overall Study||13
1435754|NCT02329431|3516028|P1|NOT COMPLETED|Overall Study||20
1435755|NCT02329431|3516027|P2|COMPLETED|Overall Study||76
1435756|NCT02329431|3516028|P1|COMPLETED|Overall Study||72
1435757|NCT02329431|3516027|P2|Baseline Interview|Overall Study||85
1435758|NCT02329431|3516028|P1|Baseline Interview|Overall Study||87
1435759|NCT02329431|3516027|P2|STARTED|Overall Study||89
1435760|NCT02329431|3516028|P1|STARTED|Overall Study||92
1435761|NCT02329223|3516047|P3|NOT COMPLETED|Overall Study||6
1435762|NCT02329223|3516048|P2|NOT COMPLETED|Overall Study||3
1435763|NCT02329223|3516049|P1|NOT COMPLETED|Overall Study||1
1435764|NCT02329223|3516047|P3|COMPLETED|Overall Study||68
1435765|NCT02329223|3516048|P2|COMPLETED|Overall Study||68
1435766|NCT02329223|3516049|P1|COMPLETED|Overall Study||72
1435767|NCT02329223|3516047|P3|Safety Set|Overall Study||74
1435768|NCT02329223|3516048|P2|Safety Set|Overall Study||71
1435769|NCT02329223|3516049|P1|Safety Set|Overall Study||73
1435770|NCT02329223|3516047|P3|Full Analysis Set|Overall Study||74
1435771|NCT02329223|3516048|P2|Full Analysis Set|Overall Study||70
1435772|NCT02329223|3516049|P1|Full Analysis Set|Overall Study||73
1435773|NCT02329223|3516047|P3|STARTED|Overall Study||74
1435774|NCT02329223|3516048|P2|STARTED|Overall Study||71
1435775|NCT02329223|3516049|P1|STARTED|Overall Study||73
1435776|NCT02329015|3516082|P2|NOT COMPLETED|Overall Study||0
1435777|NCT02329015|3516083|P1|NOT COMPLETED|Overall Study||0
1435778|NCT02329015|3516082|P2|COMPLETED|Overall Study||64
1435779|NCT02329015|3516083|P1|COMPLETED|Overall Study||48
1435780|NCT02329015|3516082|P2|STARTED|Overall Study||64
1435781|NCT02329015|3516083|P1|STARTED|Overall Study||48
1435782|NCT02328937|3516099|P6|NOT COMPLETED|Period 3||0
1435783|NCT02328937|3516100|P5|NOT COMPLETED|Period 3||0
1435784|NCT02328937|3516101|P4|NOT COMPLETED|Period 3||0
1435785|NCT02328937|3516102|P3|NOT COMPLETED|Period 3||0
1435786|NCT02328937|3516103|P2|NOT COMPLETED|Period 3||0
1435787|NCT02328937|3516104|P1|NOT COMPLETED|Period 3||0
1435788|NCT02328937|3516099|P6|COMPLETED|Period 3||6
1435789|NCT02328937|3516100|P5|COMPLETED|Period 3||6
1435790|NCT02328937|3516101|P4|COMPLETED|Period 3||5
1435791|NCT02328937|3516102|P3|COMPLETED|Period 3||6
1435792|NCT02328937|3516103|P2|COMPLETED|Period 3||6
1435793|NCT02328937|3516104|P1|COMPLETED|Period 3||7
1435794|NCT02328937|3516099|P6|STARTED|Period 3||6
1435795|NCT02328937|3516100|P5|STARTED|Period 3||6
1435796|NCT02328937|3516101|P4|STARTED|Period 3||5
1435797|NCT02328937|3516102|P3|STARTED|Period 3||6
1435798|NCT02328937|3516103|P2|STARTED|Period 3||6
1435799|NCT02328937|3516104|P1|STARTED|Period 3||7
1435800|NCT02328937|3516099|P6|NOT COMPLETED|Period 2||0
1435801|NCT02328937|3516100|P5|NOT COMPLETED|Period 2||0
1435802|NCT02328937|3516101|P4|NOT COMPLETED|Period 2||0
1435803|NCT02328937|3516102|P3|NOT COMPLETED|Period 2||1
1435804|NCT02328937|3516103|P2|NOT COMPLETED|Period 2||0
1435805|NCT02328937|3516104|P1|NOT COMPLETED|Period 2||0
1435806|NCT02328937|3516099|P6|COMPLETED|Period 2||6
1435807|NCT02328937|3516100|P5|COMPLETED|Period 2||6
1435808|NCT02328937|3516101|P4|COMPLETED|Period 2||5
1435809|NCT02328937|3516102|P3|COMPLETED|Period 2||6
1435810|NCT02328937|3516103|P2|COMPLETED|Period 2||6
1435811|NCT02328937|3516104|P1|COMPLETED|Period 2||7
1435812|NCT02328937|3516099|P6|STARTED|Period 2||6
1435813|NCT02328937|3516100|P5|STARTED|Period 2||6
1435814|NCT02328937|3516101|P4|STARTED|Period 2||5
1435815|NCT02328937|3516102|P3|STARTED|Period 2||7
1435816|NCT02328937|3516103|P2|STARTED|Period 2||6
1435817|NCT02328937|3516104|P1|STARTED|Period 2||7
1435818|NCT02328937|3516099|P6|NOT COMPLETED|Period 1||0
1435819|NCT02328937|3516100|P5|NOT COMPLETED|Period 1||0
1435820|NCT02328937|3516101|P4|NOT COMPLETED|Period 1||1
1435821|NCT02328937|3516102|P3|NOT COMPLETED|Period 1||0
1435822|NCT02328937|3516103|P2|NOT COMPLETED|Period 1||0
1435823|NCT02328937|3516104|P1|NOT COMPLETED|Period 1||0
1435824|NCT02328937|3516099|P6|COMPLETED|Period 1||6
1435825|NCT02328937|3516100|P5|COMPLETED|Period 1||6
1435826|NCT02328937|3516101|P4|COMPLETED|Period 1||5
1435827|NCT02328937|3516102|P3|COMPLETED|Period 1||7
1435828|NCT02328937|3516103|P2|COMPLETED|Period 1||6
1435829|NCT02328937|3516104|P1|COMPLETED|Period 1||7
1435830|NCT02328937|3516099|P6|STARTED|Period 1||6
1435831|NCT02328937|3516100|P5|STARTED|Period 1||6
1435832|NCT02328937|3516101|P4|STARTED|Period 1||6
1435833|NCT02328937|3516102|P3|STARTED|Period 1||7
1435834|NCT02328937|3516103|P2|STARTED|Period 1||6
1435835|NCT02328937|3516104|P1|STARTED|Period 1||7
1435836|NCT02328404|3516117|P2|NOT COMPLETED|Overall Study||1
1435837|NCT02328404|3516118|P1|NOT COMPLETED|Overall Study||1
1435838|NCT02328404|3516117|P2|COMPLETED|Overall Study||29
1435839|NCT02328404|3516118|P1|COMPLETED|Overall Study||29
1435840|NCT02328404|3516117|P2|STARTED|Overall Study||30
1435841|NCT02328404|3516118|P1|STARTED|Overall Study||30
1435842|NCT02328105|3516152|P1|NOT COMPLETED|Overall Study||11
1435843|NCT02328105|3516152|P1|COMPLETED|Overall Study||0
1435844|NCT02328105|3516152|P1|STARTED|Overall Study||11
1435845|NCT02328040|3516157|P2|NOT COMPLETED|Second Intervention (2 Days)||0
1435846|NCT02328040|3516158|P1|NOT COMPLETED|Second Intervention (2 Days)||0
1435847|NCT02328040|3516157|P2|COMPLETED|Second Intervention (2 Days)||8
1435848|NCT02328040|3516158|P1|COMPLETED|Second Intervention (2 Days)||7
1435849|NCT02328040|3516157|P2|STARTED|Second Intervention (2 Days)||8
1435850|NCT02328040|3516158|P1|STARTED|Second Intervention (2 Days)||7
1435851|NCT02328040|3516157|P2|NOT COMPLETED|First Intervention (2 Days)||1
1435852|NCT02328040|3516158|P1|NOT COMPLETED|First Intervention (2 Days)||1
1435853|NCT02328040|3516157|P2|COMPLETED|First Intervention (2 Days)||8
1435854|NCT02328040|3516158|P1|COMPLETED|First Intervention (2 Days)||7
1435855|NCT02328040|3516157|P2|STARTED|First Intervention (2 Days)||9
1435856|NCT02328040|3516158|P1|STARTED|First Intervention (2 Days)||8
1435857|NCT02327429|3516166|P1|NOT COMPLETED|Overall Study||2
1435858|NCT02327429|3516166|P1|COMPLETED|Overall Study||17
1435859|NCT02327429|3516166|P1|STARTED|Overall Study||19
1435860|NCT02327325|3516189|P3|NOT COMPLETED|Overall Study||5
1435861|NCT02327325|3516190|P2|NOT COMPLETED|Overall Study||4
1435862|NCT02327325|3516191|P1|NOT COMPLETED|Overall Study||1
1435863|NCT02327325|3516189|P3|COMPLETED|Overall Study||15
1435864|NCT02327325|3516190|P2|COMPLETED|Overall Study||16
1435865|NCT02327325|3516191|P1|COMPLETED|Overall Study||19
1435866|NCT02327325|3516189|P3|STARTED|Overall Study||20
1435867|NCT02327325|3516190|P2|STARTED|Overall Study||20
1435868|NCT02327325|3516191|P1|STARTED|Overall Study||20
1435869|NCT02327143|3516211|P2|NOT COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
1435870|NCT02327143|3516212|P1|NOT COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
1435871|NCT02327143|3516211|P2|COMPLETED|Day 1: Time 6 Hrs – to Day 9||11
1435872|NCT02327143|3516212|P1|COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
1435873|NCT02327143|3516211|P2|STARTED|Day 1: Time 6 Hrs – to Day 9||11
1435874|NCT02327143|3516212|P1|STARTED|Day 1: Time 6 Hrs – to Day 9||0
1435875|NCT02327143|3516211|P2|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
1435876|NCT02327143|3516212|P1|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
1435877|NCT02327143|3516211|P2|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
1435878|NCT02327143|3516212|P1|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
1435879|NCT02327143|3516211|P2|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
1435880|NCT02327143|3516212|P1|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
1435881|NCT02327117|3516222|P2|NOT COMPLETED|Overall Study||0
1435882|NCT02327117|3516223|P1|NOT COMPLETED|Overall Study||0
1435883|NCT02327117|3516222|P2|COMPLETED|Overall Study||45
1435884|NCT02327117|3516223|P1|COMPLETED|Overall Study||45
1435885|NCT02327117|3516222|P2|STARTED|Overall Study||45
1435886|NCT02327117|3516223|P1|STARTED|Overall Study||45
1435887|NCT02327013|3516232|P5|NOT COMPLETED|Overall Study||4
1435888|NCT02327013|3516233|P4|NOT COMPLETED|Overall Study||1
1435889|NCT02327013|3516234|P3|NOT COMPLETED|Overall Study||42
1435890|NCT02327013|3516235|P2|NOT COMPLETED|Overall Study||16
1435891|NCT02327013|3516236|P1|NOT COMPLETED|Overall Study||13
1435892|NCT02327013|3516232|P5|COMPLETED|Overall Study||12
1435893|NCT02327013|3516233|P4|COMPLETED|Overall Study||20
1435894|NCT02327013|3516234|P3|COMPLETED|Overall Study||54
1435895|NCT02327013|3516235|P2|COMPLETED|Overall Study||29
1435896|NCT02327013|3516236|P1|COMPLETED|Overall Study||36
1435897|NCT02327013|3516232|P5|STARTED|Overall Study||16
1435898|NCT02327013|3516233|P4|STARTED|Overall Study||21
1435899|NCT02327013|3516234|P3|STARTED|Overall Study||96
1435900|NCT02327013|3516235|P2|STARTED|Overall Study||45
1435901|NCT02327013|3516236|P1|STARTED|Overall Study||49
1435902|NCT02326844|3516409|P1|NOT COMPLETED|Overall Study||0
1435903|NCT02326844|3516409|P1|COMPLETED|Overall Study||3
1435904|NCT02326844|3516409|P1|STARTED|Overall Study||3
1435905|NCT02326649|3516416|P1|NOT COMPLETED|Overall Study||12
1435906|NCT02326649|3516416|P1|COMPLETED|Overall Study||21
1435907|NCT02326649|3516416|P1|STARTED|Overall Study||33
1435908|NCT02326597|3516422|P2|NOT COMPLETED|Overall Study||32
1435909|NCT02326597|3516423|P1|NOT COMPLETED|Overall Study||42
1435910|NCT02326597|3516422|P2|COMPLETED|Overall Study||28
1435911|NCT02326597|3516423|P1|COMPLETED|Overall Study||18
1435912|NCT02326597|3516422|P2|STARTED|Overall Study||60
1435913|NCT02326597|3516423|P1|STARTED|Overall Study||60
1435914|NCT02326298|3516444|P10|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||1
1435915|NCT02326298|3516445|P9|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||5
1435916|NCT02326298|3516446|P8|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||5
1435917|NCT02326298|3516447|P7|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||7
1435918|NCT02326298|3516448|P6|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||0
1435919|NCT02326298|3516449|P5|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||3
1435920|NCT02326298|3516450|P4|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||0
1435921|NCT02326298|3516451|P3|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||0
1435922|NCT02326298|3516452|P2|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||0
1435923|NCT02326298|3516453|P1|NOT COMPLETED|Maintenance Period (Week 16 - Week 48)||0
1435924|NCT02326298|3516444|P10|COMPLETED|Maintenance Period (Week 16 - Week 48)||7
1435925|NCT02326298|3516445|P9|COMPLETED|Maintenance Period (Week 16 - Week 48)||13
1435926|NCT02326298|3516446|P8|COMPLETED|Maintenance Period (Week 16 - Week 48)||33
1436069|NCT02326272|3516481|P5|STARTED|Initial Period (Week 0 to Week 16)||0
1435927|NCT02326298|3516447|P7|COMPLETED|Maintenance Period (Week 16 - Week 48)||70
1435928|NCT02326298|3516448|P6|COMPLETED|Maintenance Period (Week 16 - Week 48)||5
1435929|NCT02326298|3516449|P5|COMPLETED|Maintenance Period (Week 16 - Week 48)||71
1435930|NCT02326298|3516450|P4|COMPLETED|Maintenance Period (Week 16 - Week 48)||3
1435931|NCT02326298|3516451|P3|COMPLETED|Maintenance Period (Week 16 - Week 48)||0
1435932|NCT02326298|3516452|P2|COMPLETED|Maintenance Period (Week 16 - Week 48)||0
1435933|NCT02326298|3516453|P1|COMPLETED|Maintenance Period (Week 16 - Week 48)||0
1435934|NCT02326298|3516444|P10|STARTED|Maintenance Period (Week 16 - Week 48)||8
1435935|NCT02326298|3516445|P9|STARTED|Maintenance Period (Week 16 - Week 48)||18
1435936|NCT02326298|3516446|P8|STARTED|Maintenance Period (Week 16 - Week 48)||38
1435937|NCT02326298|3516447|P7|STARTED|Maintenance Period (Week 16 - Week 48)||77
1435938|NCT02326298|3516448|P6|STARTED|Maintenance Period (Week 16 - Week 48)||5
1435939|NCT02326298|3516449|P5|STARTED|Maintenance Period (Week 16 - Week 48)||74
1435940|NCT02326298|3516450|P4|STARTED|Maintenance Period (Week 16 - Week 48)||3
1435941|NCT02326298|3516451|P3|STARTED|Maintenance Period (Week 16 - Week 48)||0
1435942|NCT02326298|3516452|P2|STARTED|Maintenance Period (Week 16 - Week 48)||0
1435943|NCT02326298|3516453|P1|STARTED|Maintenance Period (Week 16 - Week 48)||0
1435944|NCT02326298|3516444|P10|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435945|NCT02326298|3516445|P9|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435946|NCT02326298|3516446|P8|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435947|NCT02326298|3516447|P7|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435948|NCT02326298|3516448|P6|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435949|NCT02326298|3516449|P5|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435950|NCT02326298|3516450|P4|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435951|NCT02326298|3516451|P3|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||3
1435952|NCT02326298|3516452|P2|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||3
1435953|NCT02326298|3516453|P1|NOT COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||5
1435954|NCT02326298|3516444|P10|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435955|NCT02326298|3516445|P9|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435956|NCT02326298|3516446|P8|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435957|NCT02326298|3516447|P7|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435958|NCT02326298|3516448|P6|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435959|NCT02326298|3516449|P5|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435960|NCT02326298|3516450|P4|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||0
1435961|NCT02326298|3516451|P3|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||85
1435962|NCT02326298|3516452|P2|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||92
1435963|NCT02326298|3516453|P1|COMPLETED|Initial Period (Week 0/Baseline - Wk 16)||46
1435964|NCT02326298|3516444|P10|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||0
1435965|NCT02326298|3516445|P9|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||0
1435966|NCT02326298|3516446|P8|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||0
1435967|NCT02326298|3516447|P7|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||0
1435968|NCT02326298|3516448|P6|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||0
1435969|NCT02326298|3516449|P5|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||0
1435970|NCT02326298|3516450|P4|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||0
1435971|NCT02326298|3516451|P3|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||85
1435972|NCT02326298|3516452|P2|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||92
1435973|NCT02326298|3516453|P1|Finished Wk16 Started Maintenance Period|Initial Period (Week 0/Baseline - Wk 16)||46
1435974|NCT02326298|3516444|P10|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||0
1435975|NCT02326298|3516445|P9|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||0
1435976|NCT02326298|3516446|P8|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||0
1435977|NCT02326298|3516447|P7|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||0
1435978|NCT02326298|3516448|P6|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||0
1435979|NCT02326298|3516449|P5|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||0
1435980|NCT02326298|3516450|P4|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||0
1435981|NCT02326298|3516451|P3|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||87
1435982|NCT02326298|3516452|P2|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||92
1435983|NCT02326298|3516453|P1|Completed Week 16|Initial Period (Week 0/Baseline - Wk 16)||46
1435984|NCT02326298|3516444|P10|STARTED|Initial Period (Week 0/Baseline - Wk 16)||0
1435985|NCT02326298|3516445|P9|STARTED|Initial Period (Week 0/Baseline - Wk 16)||0
1435986|NCT02326298|3516446|P8|STARTED|Initial Period (Week 0/Baseline - Wk 16)||0
1435987|NCT02326298|3516447|P7|STARTED|Initial Period (Week 0/Baseline - Wk 16)||0
1435988|NCT02326298|3516448|P6|STARTED|Initial Period (Week 0/Baseline - Wk 16)||0
1435989|NCT02326298|3516449|P5|STARTED|Initial Period (Week 0/Baseline - Wk 16)||0
1435990|NCT02326298|3516450|P4|STARTED|Initial Period (Week 0/Baseline - Wk 16)||0
1435991|NCT02326298|3516451|P3|STARTED|Initial Period (Week 0/Baseline - Wk 16)||88
1435992|NCT02326298|3516452|P2|STARTED|Initial Period (Week 0/Baseline - Wk 16)||95
1435993|NCT02326298|3516453|P1|STARTED|Initial Period (Week 0/Baseline - Wk 16)||51
1435994|NCT02326272|3516476|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
1435995|NCT02326272|3516477|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
1435996|NCT02326272|3516478|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
1436070|NCT02326272|3516482|P4|STARTED|Initial Period (Week 0 to Week 16)||0
1435997|NCT02326272|3516479|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
1435998|NCT02326272|3516480|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||12
1435999|NCT02326272|3516481|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
1436000|NCT02326272|3516482|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
1436001|NCT02326272|3516483|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1436002|NCT02326272|3516484|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1436003|NCT02326272|3516485|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1436004|NCT02326272|3516476|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
1436005|NCT02326272|3516477|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
1436006|NCT02326272|3516478|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
1436007|NCT02326272|3516479|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||61
1436008|NCT02326272|3516480|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||64
1436009|NCT02326272|3516481|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
1436010|NCT02326272|3516482|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
1436011|NCT02326272|3516483|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1436012|NCT02326272|3516484|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1436013|NCT02326272|3516485|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
1436014|NCT02326272|3516476|P10|STARTED|Maintenance Period (Week 16 to Week 48)||12
1436015|NCT02326272|3516477|P9|STARTED|Maintenance Period (Week 16 to Week 48)||8
1436016|NCT02326272|3516478|P8|STARTED|Maintenance Period (Week 16 to Week 48)||34
1436017|NCT02326272|3516479|P7|STARTED|Maintenance Period (Week 16 to Week 48)||69
1436018|NCT02326272|3516480|P6|STARTED|Maintenance Period (Week 16 to Week 48)||76
1436019|NCT02326272|3516481|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
1436020|NCT02326272|3516482|P4|STARTED|Maintenance Period (Week 16 to Week 48)||6
1436021|NCT02326272|3516483|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
1436022|NCT02326272|3516484|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
1436023|NCT02326272|3516485|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
1436024|NCT02326272|3516476|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1436025|NCT02326272|3516477|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1436026|NCT02326272|3516478|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1436027|NCT02326272|3516479|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1436028|NCT02326272|3516480|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1436029|NCT02326272|3516481|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1436030|NCT02326272|3516482|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
1436031|NCT02326272|3516483|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
1436032|NCT02326272|3516484|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
1436033|NCT02326272|3516485|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
1436034|NCT02326272|3516476|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
1436035|NCT02326272|3516477|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
1436036|NCT02326272|3516478|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
1436037|NCT02326272|3516479|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
1436038|NCT02326272|3516480|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
1436039|NCT02326272|3516481|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
1436040|NCT02326272|3516482|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
1436041|NCT02326272|3516483|P3|COMPLETED|Initial Period (Week 0 to Week 16)||81
1436042|NCT02326272|3516484|P2|COMPLETED|Initial Period (Week 0 to Week 16)||84
1436043|NCT02326272|3516485|P1|COMPLETED|Initial Period (Week 0 to Week 16)||45
1436044|NCT02326272|3516476|P10|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1436045|NCT02326272|3516477|P9|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1436046|NCT02326272|3516478|P8|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1436047|NCT02326272|3516479|P7|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1436048|NCT02326272|3516480|P6|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1436049|NCT02326272|3516481|P5|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1436050|NCT02326272|3516482|P4|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
1436051|NCT02326272|3516483|P3|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
1436052|NCT02326272|3516484|P2|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
1436053|NCT02326272|3516485|P1|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
1436054|NCT02326272|3516476|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1436055|NCT02326272|3516477|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1436056|NCT02326272|3516478|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1436057|NCT02326272|3516479|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1436058|NCT02326272|3516480|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1436059|NCT02326272|3516481|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1436060|NCT02326272|3516482|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
1436061|NCT02326272|3516483|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||83
1436062|NCT02326272|3516484|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||84
1436063|NCT02326272|3516485|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||45
1436064|NCT02326272|3516476|P10|STARTED|Initial Period (Week 0 to Week 16)||0
1436065|NCT02326272|3516477|P9|STARTED|Initial Period (Week 0 to Week 16)||0
1436066|NCT02326272|3516478|P8|STARTED|Initial Period (Week 0 to Week 16)||0
1436067|NCT02326272|3516479|P7|STARTED|Initial Period (Week 0 to Week 16)||0
1436068|NCT02326272|3516480|P6|STARTED|Initial Period (Week 0 to Week 16)||0
1436071|NCT02326272|3516483|P3|STARTED|Initial Period (Week 0 to Week 16)||87
1436072|NCT02326272|3516484|P2|STARTED|Initial Period (Week 0 to Week 16)||91
1436073|NCT02326272|3516485|P1|STARTED|Initial Period (Week 0 to Week 16)||49
1436074|NCT02325856|3516507|P2|NOT COMPLETED|Overall Study||27
1436075|NCT02325856|3516508|P1|NOT COMPLETED|Overall Study||20
1436076|NCT02325856|3516507|P2|COMPLETED|Overall Study||123
1436077|NCT02325856|3516508|P1|COMPLETED|Overall Study||128
1436078|NCT02325856|3516507|P2|STARTED|Overall Study||150
1436079|NCT02325856|3516508|P1|STARTED|Overall Study||148
1436080|NCT02325791|3516520|P4|NOT COMPLETED|Overall Study||26
1436081|NCT02325791|3516521|P3|NOT COMPLETED|Overall Study||25
1436082|NCT02325791|3516522|P2|NOT COMPLETED|Overall Study||25
1436083|NCT02325791|3516523|P1|NOT COMPLETED|Overall Study||0
1436084|NCT02325791|3516520|P4|COMPLETED|Overall Study||355
1436085|NCT02325791|3516521|P3|COMPLETED|Overall Study||360
1436086|NCT02325791|3516522|P2|COMPLETED|Overall Study||358
1436087|NCT02325791|3516523|P1|COMPLETED|Overall Study||23
1436088|NCT02325791|3516520|P4|STARTED|Overall Study||381
1436089|NCT02325791|3516521|P3|STARTED|Overall Study||385
1436090|NCT02325791|3516522|P2|STARTED|Overall Study||383
1436091|NCT02325791|3516523|P1|STARTED|Overall Study||23
1436092|NCT02325713|3516558|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436093|NCT02325713|3516559|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436094|NCT02325713|3516560|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436095|NCT02325713|3516561|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436096|NCT02325713|3516562|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436097|NCT02325713|3516563|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436098|NCT02325713|3516564|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436099|NCT02325713|3516565|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436100|NCT02325713|3516566|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436101|NCT02325713|3516567|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436102|NCT02325713|3516568|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436103|NCT02325713|3516569|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436104|NCT02325713|3516570|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436105|NCT02325713|3516571|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436106|NCT02325713|3516572|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436107|NCT02325713|3516573|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
1436108|NCT02325713|3516558|P16|COMPLETED|Intervention Period 4 (2 Days)||2
1436109|NCT02325713|3516559|P15|COMPLETED|Intervention Period 4 (2 Days)||2
1436110|NCT02325713|3516560|P14|COMPLETED|Intervention Period 4 (2 Days)||2
1436111|NCT02325713|3516561|P13|COMPLETED|Intervention Period 4 (2 Days)||2
1436112|NCT02325713|3516562|P12|COMPLETED|Intervention Period 4 (2 Days)||2
1436113|NCT02325713|3516563|P11|COMPLETED|Intervention Period 4 (2 Days)||1
1436114|NCT02325713|3516564|P10|COMPLETED|Intervention Period 4 (2 Days)||1
1436115|NCT02325713|3516565|P9|COMPLETED|Intervention Period 4 (2 Days)||2
1436116|NCT02325713|3516566|P8|COMPLETED|Intervention Period 4 (2 Days)||2
1436117|NCT02325713|3516567|P7|COMPLETED|Intervention Period 4 (2 Days)||2
1436118|NCT02325713|3516568|P6|COMPLETED|Intervention Period 4 (2 Days)||2
1436119|NCT02325713|3516569|P5|COMPLETED|Intervention Period 4 (2 Days)||2
1436120|NCT02325713|3516570|P4|COMPLETED|Intervention Period 4 (2 Days)||2
1436121|NCT02325713|3516571|P3|COMPLETED|Intervention Period 4 (2 Days)||2
1436122|NCT02325713|3516572|P2|COMPLETED|Intervention Period 4 (2 Days)||2
1436123|NCT02325713|3516573|P1|COMPLETED|Intervention Period 4 (2 Days)||1
1436124|NCT02325713|3516558|P16|STARTED|Intervention Period 4 (2 Days)||2
1436125|NCT02325713|3516559|P15|STARTED|Intervention Period 4 (2 Days)||2
1436126|NCT02325713|3516560|P14|STARTED|Intervention Period 4 (2 Days)||2
1436127|NCT02325713|3516561|P13|STARTED|Intervention Period 4 (2 Days)||2
1436128|NCT02325713|3516562|P12|STARTED|Intervention Period 4 (2 Days)||2
1436129|NCT02325713|3516563|P11|STARTED|Intervention Period 4 (2 Days)||1
1436130|NCT02325713|3516564|P10|STARTED|Intervention Period 4 (2 Days)||1
1436131|NCT02325713|3516565|P9|STARTED|Intervention Period 4 (2 Days)||2
1436132|NCT02325713|3516566|P8|STARTED|Intervention Period 4 (2 Days)||2
1436133|NCT02325713|3516567|P7|STARTED|Intervention Period 4 (2 Days)||2
1436134|NCT02325713|3516568|P6|STARTED|Intervention Period 4 (2 Days)||2
1436135|NCT02325713|3516569|P5|STARTED|Intervention Period 4 (2 Days)||2
1436136|NCT02325713|3516570|P4|STARTED|Intervention Period 4 (2 Days)||2
1436137|NCT02325713|3516571|P3|STARTED|Intervention Period 4 (2 Days)||2
1436138|NCT02325713|3516572|P2|STARTED|Intervention Period 4 (2 Days)||2
1436139|NCT02325713|3516573|P1|STARTED|Intervention Period 4 (2 Days)||1
1436140|NCT02325713|3516558|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436141|NCT02325713|3516559|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436142|NCT02325713|3516560|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436143|NCT02325713|3516561|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436144|NCT02325713|3516562|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436145|NCT02325713|3516563|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436146|NCT02325713|3516564|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
1436147|NCT02325713|3516565|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436148|NCT02325713|3516566|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436149|NCT02325713|3516567|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436150|NCT02325713|3516568|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436151|NCT02325713|3516569|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436152|NCT02325713|3516570|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436153|NCT02325713|3516571|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436154|NCT02325713|3516572|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436155|NCT02325713|3516573|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
1436156|NCT02325713|3516558|P16|COMPLETED|Intervention Period 3 (2 Days)||2
1436157|NCT02325713|3516559|P15|COMPLETED|Intervention Period 3 (2 Days)||2
1436158|NCT02325713|3516560|P14|COMPLETED|Intervention Period 3 (2 Days)||2
1436159|NCT02325713|3516561|P13|COMPLETED|Intervention Period 3 (2 Days)||2
1436160|NCT02325713|3516562|P12|COMPLETED|Intervention Period 3 (2 Days)||2
1436161|NCT02325713|3516563|P11|COMPLETED|Intervention Period 3 (2 Days)||1
1436162|NCT02325713|3516564|P10|COMPLETED|Intervention Period 3 (2 Days)||1
1436163|NCT02325713|3516565|P9|COMPLETED|Intervention Period 3 (2 Days)||2
1436164|NCT02325713|3516566|P8|COMPLETED|Intervention Period 3 (2 Days)||2
1436165|NCT02325713|3516567|P7|COMPLETED|Intervention Period 3 (2 Days)||2
1436166|NCT02325713|3516568|P6|COMPLETED|Intervention Period 3 (2 Days)||2
1436167|NCT02325713|3516569|P5|COMPLETED|Intervention Period 3 (2 Days)||2
1436168|NCT02325713|3516570|P4|COMPLETED|Intervention Period 3 (2 Days)||2
1436169|NCT02325713|3516571|P3|COMPLETED|Intervention Period 3 (2 Days)||2
1436170|NCT02325713|3516572|P2|COMPLETED|Intervention Period 3 (2 Days)||2
1436171|NCT02325713|3516573|P1|COMPLETED|Intervention Period 3 (2 Days)||1
1436172|NCT02325713|3516558|P16|STARTED|Intervention Period 3 (2 Days)||2
1436173|NCT02325713|3516559|P15|STARTED|Intervention Period 3 (2 Days)||2
1436174|NCT02325713|3516560|P14|STARTED|Intervention Period 3 (2 Days)||2
1436175|NCT02325713|3516561|P13|STARTED|Intervention Period 3 (2 Days)||2
1436176|NCT02325713|3516562|P12|STARTED|Intervention Period 3 (2 Days)||2
1436177|NCT02325713|3516563|P11|STARTED|Intervention Period 3 (2 Days)||1
1436178|NCT02325713|3516564|P10|STARTED|Intervention Period 3 (2 Days)||2
1436179|NCT02325713|3516565|P9|STARTED|Intervention Period 3 (2 Days)||2
1436180|NCT02325713|3516566|P8|STARTED|Intervention Period 3 (2 Days)||2
1436181|NCT02325713|3516567|P7|STARTED|Intervention Period 3 (2 Days)||2
1436182|NCT02325713|3516568|P6|STARTED|Intervention Period 3 (2 Days)||2
1436183|NCT02325713|3516569|P5|STARTED|Intervention Period 3 (2 Days)||2
1436184|NCT02325713|3516570|P4|STARTED|Intervention Period 3 (2 Days)||2
1436185|NCT02325713|3516571|P3|STARTED|Intervention Period 3 (2 Days)||2
1436186|NCT02325713|3516572|P2|STARTED|Intervention Period 3 (2 Days)||2
1436187|NCT02325713|3516573|P1|STARTED|Intervention Period 3 (2 Days)||1
1436188|NCT02325713|3516558|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436189|NCT02325713|3516559|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436190|NCT02325713|3516560|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436191|NCT02325713|3516561|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436192|NCT02325713|3516562|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436193|NCT02325713|3516563|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436194|NCT02325713|3516564|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436195|NCT02325713|3516565|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436196|NCT02325713|3516566|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436197|NCT02325713|3516567|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436198|NCT02325713|3516568|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436199|NCT02325713|3516569|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436200|NCT02325713|3516570|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436201|NCT02325713|3516571|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436202|NCT02325713|3516572|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
1436203|NCT02325713|3516573|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
1436204|NCT02325713|3516558|P16|COMPLETED|Intervention Period 2 (2 Days)||2
1436205|NCT02325713|3516559|P15|COMPLETED|Intervention Period 2 (2 Days)||2
1436206|NCT02325713|3516560|P14|COMPLETED|Intervention Period 2 (2 Days)||2
1436207|NCT02325713|3516561|P13|COMPLETED|Intervention Period 2 (2 Days)||2
1436208|NCT02325713|3516562|P12|COMPLETED|Intervention Period 2 (2 Days)||2
1436209|NCT02325713|3516563|P11|COMPLETED|Intervention Period 2 (2 Days)||1
1436210|NCT02325713|3516564|P10|COMPLETED|Intervention Period 2 (2 Days)||2
1436211|NCT02325713|3516565|P9|COMPLETED|Intervention Period 2 (2 Days)||2
1436212|NCT02325713|3516566|P8|COMPLETED|Intervention Period 2 (2 Days)||2
1436213|NCT02325713|3516567|P7|COMPLETED|Intervention Period 2 (2 Days)||2
1436214|NCT02325713|3516568|P6|COMPLETED|Intervention Period 2 (2 Days)||2
1436215|NCT02325713|3516569|P5|COMPLETED|Intervention Period 2 (2 Days)||2
1436216|NCT02325713|3516570|P4|COMPLETED|Intervention Period 2 (2 Days)||2
1436217|NCT02325713|3516571|P3|COMPLETED|Intervention Period 2 (2 Days)||2
1436218|NCT02325713|3516572|P2|COMPLETED|Intervention Period 2 (2 Days)||2
1436219|NCT02325713|3516573|P1|COMPLETED|Intervention Period 2 (2 Days)||1
1436220|NCT02325713|3516558|P16|STARTED|Intervention Period 2 (2 Days)||2
1436221|NCT02325713|3516559|P15|STARTED|Intervention Period 2 (2 Days)||2
1436222|NCT02325713|3516560|P14|STARTED|Intervention Period 2 (2 Days)||2
1436223|NCT02325713|3516561|P13|STARTED|Intervention Period 2 (2 Days)||2
1436224|NCT02325713|3516562|P12|STARTED|Intervention Period 2 (2 Days)||2
1436225|NCT02325713|3516563|P11|STARTED|Intervention Period 2 (2 Days)||1
1436226|NCT02325713|3516564|P10|STARTED|Intervention Period 2 (2 Days)||2
1436227|NCT02325713|3516565|P9|STARTED|Intervention Period 2 (2 Days)||2
1436228|NCT02325713|3516566|P8|STARTED|Intervention Period 2 (2 Days)||2
1436229|NCT02325713|3516567|P7|STARTED|Intervention Period 2 (2 Days)||2
1436230|NCT02325713|3516568|P6|STARTED|Intervention Period 2 (2 Days)||2
1436231|NCT02325713|3516569|P5|STARTED|Intervention Period 2 (2 Days)||2
1436232|NCT02325713|3516570|P4|STARTED|Intervention Period 2 (2 Days)||2
1436233|NCT02325713|3516571|P3|STARTED|Intervention Period 2 (2 Days)||2
1436234|NCT02325713|3516572|P2|STARTED|Intervention Period 2 (2 Days)||2
1436235|NCT02325713|3516573|P1|STARTED|Intervention Period 2 (2 Days)||2
1436236|NCT02325713|3516558|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436237|NCT02325713|3516559|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436238|NCT02325713|3516560|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436239|NCT02325713|3516561|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436240|NCT02325713|3516562|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436241|NCT02325713|3516563|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
1436242|NCT02325713|3516564|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436243|NCT02325713|3516565|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436244|NCT02325713|3516566|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436245|NCT02325713|3516567|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436246|NCT02325713|3516568|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436247|NCT02325713|3516569|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436248|NCT02325713|3516570|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436249|NCT02325713|3516571|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436250|NCT02325713|3516572|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436251|NCT02325713|3516573|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
1436252|NCT02325713|3516558|P16|COMPLETED|Intervention Period 1 (2 Days)||2
1436253|NCT02325713|3516559|P15|COMPLETED|Intervention Period 1 (2 Days)||2
1436254|NCT02325713|3516560|P14|COMPLETED|Intervention Period 1 (2 Days)||2
1436255|NCT02325713|3516561|P13|COMPLETED|Intervention Period 1 (2 Days)||2
1436256|NCT02325713|3516562|P12|COMPLETED|Intervention Period 1 (2 Days)||2
1436257|NCT02325713|3516563|P11|COMPLETED|Intervention Period 1 (2 Days)||1
1436258|NCT02325713|3516564|P10|COMPLETED|Intervention Period 1 (2 Days)||2
1436259|NCT02325713|3516565|P9|COMPLETED|Intervention Period 1 (2 Days)||2
1436260|NCT02325713|3516566|P8|COMPLETED|Intervention Period 1 (2 Days)||2
1436261|NCT02325713|3516567|P7|COMPLETED|Intervention Period 1 (2 Days)||2
1436262|NCT02325713|3516568|P6|COMPLETED|Intervention Period 1 (2 Days)||2
1436263|NCT02325713|3516569|P5|COMPLETED|Intervention Period 1 (2 Days)||2
1436264|NCT02325713|3516570|P4|COMPLETED|Intervention Period 1 (2 Days)||2
1436265|NCT02325713|3516571|P3|COMPLETED|Intervention Period 1 (2 Days)||2
1436266|NCT02325713|3516572|P2|COMPLETED|Intervention Period 1 (2 Days)||2
1436267|NCT02325713|3516573|P1|COMPLETED|Intervention Period 1 (2 Days)||2
1436268|NCT02325713|3516558|P16|STARTED|Intervention Period 1 (2 Days)||2
1436269|NCT02325713|3516559|P15|STARTED|Intervention Period 1 (2 Days)||2
1436270|NCT02325713|3516560|P14|STARTED|Intervention Period 1 (2 Days)||2
1436271|NCT02325713|3516561|P13|STARTED|Intervention Period 1 (2 Days)||2
1436272|NCT02325713|3516562|P12|STARTED|Intervention Period 1 (2 Days)||2
1436273|NCT02325713|3516563|P11|STARTED|Intervention Period 1 (2 Days)||2
1436274|NCT02325713|3516564|P10|STARTED|Intervention Period 1 (2 Days)||2
1436275|NCT02325713|3516565|P9|STARTED|Intervention Period 1 (2 Days)||2
1436276|NCT02325713|3516566|P8|STARTED|Intervention Period 1 (2 Days)||2
1436277|NCT02325713|3516567|P7|STARTED|Intervention Period 1 (2 Days)||2
1436278|NCT02325713|3516568|P6|STARTED|Intervention Period 1 (2 Days)||2
1436279|NCT02325713|3516569|P5|STARTED|Intervention Period 1 (2 Days)||2
1436280|NCT02325713|3516570|P4|STARTED|Intervention Period 1 (2 Days)||2
1436281|NCT02325713|3516571|P3|STARTED|Intervention Period 1 (2 Days)||2
1436282|NCT02325713|3516572|P2|STARTED|Intervention Period 1 (2 Days)||2
1436283|NCT02325713|3516573|P1|STARTED|Intervention Period 1 (2 Days)||2
1436284|NCT02325518|3516668|P2|NOT COMPLETED|Overall Study||3
1436285|NCT02325518|3516669|P1|NOT COMPLETED|Overall Study||4
1436286|NCT02325518|3516668|P2|COMPLETED|Overall Study||100
1436287|NCT02325518|3516669|P1|COMPLETED|Overall Study||94
1436288|NCT02325518|3516668|P2|Per Protocol Set (PPS)|Overall Study||97
1436289|NCT02325518|3516669|P1|Per Protocol Set (PPS)|Overall Study||92
1436290|NCT02325518|3516668|P2|Full Analysis Set (FAS)|Overall Study||101
1436291|NCT02325518|3516669|P1|Full Analysis Set (FAS)|Overall Study||98
1436292|NCT02325518|3516668|P2|Safety Set|Overall Study||103
1436293|NCT02325518|3516669|P1|Safety Set|Overall Study||98
1436294|NCT02325518|3516668|P2|STARTED|Overall Study||103
1436295|NCT02325518|3516669|P1|STARTED|Overall Study||98
1436296|NCT02324972|3516680|P2|NOT COMPLETED|Overall Study||5
1436297|NCT02324972|3516681|P1|NOT COMPLETED|Overall Study||7
1436298|NCT02324972|3516680|P2|COMPLETED|Overall Study||23
1436299|NCT02324972|3516681|P1|COMPLETED|Overall Study||19
1436300|NCT02324972|3516680|P2|STARTED|Overall Study||28
1436301|NCT02324972|3516681|P1|STARTED|Overall Study||26
1436302|NCT02324673|3516698|P3|NOT COMPLETED|Overall Study||0
1436303|NCT02324673|3516699|P2|NOT COMPLETED|Overall Study||0
1436304|NCT02324673|3516700|P1|NOT COMPLETED|Overall Study||0
1436305|NCT02324673|3516698|P3|COMPLETED|Overall Study||21
1436306|NCT02324673|3516699|P2|COMPLETED|Overall Study||20
1436307|NCT02324673|3516700|P1|COMPLETED|Overall Study||20
1436308|NCT02324673|3516698|P3|STARTED|Overall Study||21
1436309|NCT02324673|3516699|P2|STARTED|Overall Study||20
1436310|NCT02324673|3516700|P1|STARTED|Overall Study||20
1436311|NCT02324660|3516801|P1|NOT COMPLETED|Overall Study||32
1436312|NCT02324660|3516801|P1|COMPLETED|Overall Study||137
1436313|NCT02324660|3516801|P1|STARTED|Overall Study||169
1436314|NCT02324504|3516806|P1|NOT COMPLETED|Overall Study||0
1436315|NCT02324504|3516806|P1|COMPLETED|Overall Study||60
1436316|NCT02324504|3516806|P1|STARTED|Overall Study||60
1436317|NCT02324049|3516813|P1|NOT COMPLETED|Part C||11
1436318|NCT02324049|3516813|P1|COMPLETED|Part C||0
1436319|NCT02324049|3516813|P1|Safety Analysis Set|Part C||11
1436320|NCT02324049|3516813|P1|STARTED|Part C||11
1436321|NCT02324049|3516813|P1|NOT COMPLETED|Part B||0
1436322|NCT02324049|3516813|P1|COMPLETED|Part B||11
1436323|NCT02324049|3516813|P1|Safety Analysis Set|Part B||11
1436324|NCT02324049|3516813|P1|STARTED|Part B||11
1436325|NCT02324049|3516813|P1|NOT COMPLETED|Part A||0
1436326|NCT02324049|3516813|P1|COMPLETED|Part A||11
1436327|NCT02324049|3516813|P1|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
1436328|NCT02324049|3516813|P1|STARTED|Part A||11
1436329|NCT02323854|3516817|P1|NOT COMPLETED|Overall Study||0
1436330|NCT02323854|3516817|P1|COMPLETED|Overall Study||15
1436331|NCT02323854|3516817|P1|STARTED|Overall Study||15
1436332|NCT02323048|3516828|P5|NOT COMPLETED|Overall Study||0
1436333|NCT02323048|3516829|P4|NOT COMPLETED|Overall Study||0
1436334|NCT02323048|3516830|P3|NOT COMPLETED|Overall Study||0
1436335|NCT02323048|3516831|P2|NOT COMPLETED|Overall Study||2
1436336|NCT02323048|3516832|P1|NOT COMPLETED|Overall Study||1
1436337|NCT02323048|3516828|P5|COMPLETED|Overall Study||9
1436338|NCT02323048|3516829|P4|COMPLETED|Overall Study||7
1436339|NCT02323048|3516830|P3|COMPLETED|Overall Study||23
1436340|NCT02323048|3516831|P2|COMPLETED|Overall Study||24
1436341|NCT02323048|3516832|P1|COMPLETED|Overall Study||24
1436342|NCT02323048|3516828|P5|STARTED|Overall Study||9
1436343|NCT02323048|3516829|P4|STARTED|Overall Study||7
1436344|NCT02323048|3516830|P3|STARTED|Overall Study||23
1436345|NCT02323048|3516831|P2|STARTED|Overall Study||26
1436346|NCT02323048|3516832|P1|STARTED|Overall Study||25
1436347|NCT02322892|3516846|P2|NOT COMPLETED|Overall Study||3
1436348|NCT02322892|3516847|P1|NOT COMPLETED|Overall Study||2
1436349|NCT02322892|3516846|P2|COMPLETED|Overall Study|Received thiamine|31
1436350|NCT02322892|3516847|P1|COMPLETED|Overall Study|Received placebo|33
1436351|NCT02322892|3516846|P2|STARTED|Overall Study|Number randomized|34
1436352|NCT02322892|3516847|P1|STARTED|Overall Study|Number randomized|35
1436353|NCT02322879|3516863|P2|NOT COMPLETED|Second Intervention||0
1436354|NCT02322879|3516864|P1|NOT COMPLETED|Second Intervention||0
1436355|NCT02322879|3516863|P2|COMPLETED|Second Intervention||10
1436356|NCT02322879|3516864|P1|COMPLETED|Second Intervention||10
1436357|NCT02322879|3516863|P2|STARTED|Second Intervention||10
1436358|NCT02322879|3516864|P1|STARTED|Second Intervention||10
1436359|NCT02322879|3516863|P2|NOT COMPLETED|Washout||0
1436360|NCT02322879|3516864|P1|NOT COMPLETED|Washout||0
1436361|NCT02322879|3516863|P2|COMPLETED|Washout||10
1436362|NCT02322879|3516864|P1|COMPLETED|Washout||10
1436363|NCT02322879|3516863|P2|STARTED|Washout||10
1436364|NCT02322879|3516864|P1|STARTED|Washout||10
1436365|NCT02322879|3516863|P2|NOT COMPLETED|First Intervention||0
1436366|NCT02322879|3516864|P1|NOT COMPLETED|First Intervention||1
1436367|NCT02322879|3516863|P2|COMPLETED|First Intervention||10
1436368|NCT02322879|3516864|P1|COMPLETED|First Intervention||10
1436369|NCT02322879|3516863|P2|STARTED|First Intervention||10
1436370|NCT02322879|3516864|P1|STARTED|First Intervention||11
1436371|NCT02322866|3516872|P2|NOT COMPLETED|Overall Study||86
1436372|NCT02322866|3516873|P1|NOT COMPLETED|Overall Study||71
1436373|NCT02322866|3516872|P2|COMPLETED|Overall Study||433
1436374|NCT02322866|3516873|P1|COMPLETED|Overall Study||444
1436375|NCT02322866|3516872|P2|STARTED|Overall Study||519
1436376|NCT02322866|3516873|P1|STARTED|Overall Study||515
1436377|NCT02322788|3516895|P4|NOT COMPLETED|Visit 6||0
1436378|NCT02322788|3516896|P3|NOT COMPLETED|Visit 6||0
1436379|NCT02322788|3516897|P2|NOT COMPLETED|Visit 6||0
1436380|NCT02322788|3516898|P1|NOT COMPLETED|Visit 6||0
1436381|NCT02322788|3516895|P4|COMPLETED|Visit 6||15
1436382|NCT02322788|3516896|P3|COMPLETED|Visit 6||15
1436383|NCT02322788|3516897|P2|COMPLETED|Visit 6||16
1436384|NCT02322788|3516898|P1|COMPLETED|Visit 6||14
1436385|NCT02322788|3516895|P4|STARTED|Visit 6||15
1436386|NCT02322788|3516896|P3|STARTED|Visit 6||15
1436387|NCT02322788|3516897|P2|STARTED|Visit 6||16
1436388|NCT02322788|3516898|P1|STARTED|Visit 6||14
1436389|NCT02322788|3516895|P4|NOT COMPLETED|Visit 5||0
1436390|NCT02322788|3516896|P3|NOT COMPLETED|Visit 5||0
1436391|NCT02322788|3516897|P2|NOT COMPLETED|Visit 5||0
1436392|NCT02322788|3516898|P1|NOT COMPLETED|Visit 5||0
1436393|NCT02322788|3516895|P4|COMPLETED|Visit 5||14
1436394|NCT02322788|3516896|P3|COMPLETED|Visit 5||15
1436395|NCT02322788|3516897|P2|COMPLETED|Visit 5||15
1436396|NCT02322788|3516898|P1|COMPLETED|Visit 5||16
1436397|NCT02322788|3516895|P4|STARTED|Visit 5||14
1436398|NCT02322788|3516896|P3|STARTED|Visit 5||15
1436399|NCT02322788|3516897|P2|STARTED|Visit 5||15
1436400|NCT02322788|3516898|P1|STARTED|Visit 5||16
1436401|NCT02322788|3516895|P4|NOT COMPLETED|Visit 4||0
1436402|NCT02322788|3516896|P3|NOT COMPLETED|Visit 4||0
1436403|NCT02322788|3516897|P2|NOT COMPLETED|Visit 4||0
1436404|NCT02322788|3516898|P1|NOT COMPLETED|Visit 4||0
1436405|NCT02322788|3516895|P4|COMPLETED|Visit 4||15
1436406|NCT02322788|3516896|P3|COMPLETED|Visit 4||16
1436407|NCT02322788|3516897|P2|COMPLETED|Visit 4||14
1436408|NCT02322788|3516898|P1|COMPLETED|Visit 4||15
1436409|NCT02322788|3516895|P4|STARTED|Visit 4||15
1436410|NCT02322788|3516896|P3|STARTED|Visit 4||16
1436411|NCT02322788|3516897|P2|STARTED|Visit 4||14
1436412|NCT02322788|3516898|P1|STARTED|Visit 4||15
1436413|NCT02322788|3516895|P4|NOT COMPLETED|Visit 3||0
1436414|NCT02322788|3516896|P3|NOT COMPLETED|Visit 3||0
1436415|NCT02322788|3516897|P2|NOT COMPLETED|Visit 3||0
1436416|NCT02322788|3516898|P1|NOT COMPLETED|Visit 3||0
1436417|NCT02322788|3516895|P4|COMPLETED|Visit 3||16
1436418|NCT02322788|3516896|P3|COMPLETED|Visit 3||14
1436419|NCT02322788|3516897|P2|COMPLETED|Visit 3||15
1436420|NCT02322788|3516898|P1|COMPLETED|Visit 3||15
1436421|NCT02322788|3516895|P4|STARTED|Visit 3||16
1436422|NCT02322788|3516896|P3|STARTED|Visit 3||14
1436423|NCT02322788|3516897|P2|STARTED|Visit 3||15
1436424|NCT02322788|3516898|P1|STARTED|Visit 3||15
1436425|NCT02322775|3516910|P2|NOT COMPLETED|Overall Study||6
1436426|NCT02322775|3516911|P1|NOT COMPLETED|Overall Study||5
1436427|NCT02322775|3516910|P2|COMPLETED|Overall Study||99
1436428|NCT02322775|3516911|P1|COMPLETED|Overall Study||101
1436429|NCT02322775|3516910|P2|STARTED|Overall Study||105
1436430|NCT02322775|3516911|P1|STARTED|Overall Study||106
1436431|NCT02322749|3516937|P6|NOT COMPLETED|Period 3||0
1436432|NCT02322749|3516938|P5|NOT COMPLETED|Period 3||0
1436433|NCT02322749|3516939|P4|NOT COMPLETED|Period 3||0
1436434|NCT02322749|3516940|P3|NOT COMPLETED|Period 3||1
1436435|NCT02322749|3516941|P2|NOT COMPLETED|Period 3||0
1436436|NCT02322749|3516942|P1|NOT COMPLETED|Period 3||0
1436437|NCT02322749|3516937|P6|COMPLETED|Period 3||8
1436438|NCT02322749|3516938|P5|COMPLETED|Period 3||8
1436439|NCT02322749|3516939|P4|COMPLETED|Period 3||6
1436440|NCT02322749|3516940|P3|COMPLETED|Period 3||7
1436441|NCT02322749|3516941|P2|COMPLETED|Period 3||8
1436442|NCT02322749|3516942|P1|COMPLETED|Period 3||8
1436443|NCT02322749|3516937|P6|STARTED|Period 3||8
1436444|NCT02322749|3516938|P5|STARTED|Period 3||8
1436445|NCT02322749|3516939|P4|STARTED|Period 3||6
1436446|NCT02322749|3516940|P3|STARTED|Period 3||8
1436447|NCT02322749|3516941|P2|STARTED|Period 3||8
1436448|NCT02322749|3516942|P1|STARTED|Period 3||8
1436449|NCT02322749|3516937|P6|NOT COMPLETED|Period 2||0
1436450|NCT02322749|3516938|P5|NOT COMPLETED|Period 2||0
1436451|NCT02322749|3516939|P4|NOT COMPLETED|Period 2||2
1436452|NCT02322749|3516940|P3|NOT COMPLETED|Period 2||0
1436453|NCT02322749|3516941|P2|NOT COMPLETED|Period 2||0
1436454|NCT02322749|3516942|P1|NOT COMPLETED|Period 2||0
1436455|NCT02322749|3516937|P6|COMPLETED|Period 2||8
1436456|NCT02322749|3516938|P5|COMPLETED|Period 2||8
1436457|NCT02322749|3516939|P4|COMPLETED|Period 2||6
1436458|NCT02322749|3516940|P3|COMPLETED|Period 2||8
1436459|NCT02322749|3516941|P2|COMPLETED|Period 2||8
1436460|NCT02322749|3516942|P1|COMPLETED|Period 2||8
1436461|NCT02322749|3516937|P6|STARTED|Period 2||8
1436462|NCT02322749|3516938|P5|STARTED|Period 2||8
1436463|NCT02322749|3516939|P4|STARTED|Period 2||8
1436464|NCT02322749|3516940|P3|STARTED|Period 2||8
1436465|NCT02322749|3516941|P2|STARTED|Period 2||8
1436466|NCT02322749|3516942|P1|STARTED|Period 2||8
1436467|NCT02322749|3516937|P6|NOT COMPLETED|Period 1||0
1436468|NCT02322749|3516938|P5|NOT COMPLETED|Period 1||0
1436469|NCT02322749|3516939|P4|NOT COMPLETED|Period 1||0
1436470|NCT02322749|3516940|P3|NOT COMPLETED|Period 1||0
1436471|NCT02322749|3516941|P2|NOT COMPLETED|Period 1||0
1436472|NCT02322749|3516942|P1|NOT COMPLETED|Period 1||0
1436473|NCT02322749|3516937|P6|COMPLETED|Period 1||8
1436474|NCT02322749|3516938|P5|COMPLETED|Period 1||8
1436475|NCT02322749|3516939|P4|COMPLETED|Period 1||8
1436476|NCT02322749|3516940|P3|COMPLETED|Period 1||8
1436477|NCT02322749|3516941|P2|COMPLETED|Period 1||8
1436478|NCT02322749|3516942|P1|COMPLETED|Period 1||8
1436479|NCT02322749|3516937|P6|STARTED|Period 1||8
1436480|NCT02322749|3516938|P5|STARTED|Period 1||8
1436481|NCT02322749|3516939|P4|STARTED|Period 1||8
1436482|NCT02322749|3516940|P3|STARTED|Period 1||8
1436483|NCT02322749|3516941|P2|STARTED|Period 1||8
1436484|NCT02322749|3516942|P1|STARTED|Period 1||8
1436485|NCT02322528|3516965|P1|NOT COMPLETED|Overall Study||0
1436486|NCT02322528|3516965|P1|COMPLETED|Overall Study||10
1436487|NCT02322528|3516965|P1|STARTED|Overall Study||10
1436488|NCT02322229|3516970|P1|NOT COMPLETED|Overall Study||2
1436489|NCT02322229|3516970|P1|COMPLETED|Overall Study||50
1436490|NCT02322229|3516970|P1|STARTED|Overall Study||52
1436491|NCT02322216|3516982|P2|NOT COMPLETED|Overall Study||4
1436492|NCT02322216|3516983|P1|NOT COMPLETED|Overall Study||2
1436493|NCT02322216|3516982|P2|COMPLETED|Overall Study||123
1436494|NCT02322216|3516983|P1|COMPLETED|Overall Study||124
1436495|NCT02322216|3516982|P2|Per Protocol Set (PPS)|Overall Study||122
1436496|NCT02322216|3516983|P1|Per Protocol Set (PPS)|Overall Study||123
1436497|NCT02322216|3516982|P2|Treated (Safety Set)|Overall Study||126
1436498|NCT02322216|3516983|P1|Treated (Safety Set)|Overall Study||126
1436499|NCT02322216|3516982|P2|STARTED|Overall Study||127
1436500|NCT02322216|3516983|P1|STARTED|Overall Study||126
1436501|NCT02321527|3516990|P1|NOT COMPLETED|Overall Study||1
1436502|NCT02321527|3516990|P1|COMPLETED|Overall Study||20
1436503|NCT02321527|3516990|P1|STARTED|Overall Study||21
1436504|NCT02321436|3516996|P2|NOT COMPLETED|Overall Study||1
1436505|NCT02321436|3516997|P1|NOT COMPLETED|Overall Study||1
1436506|NCT02321436|3516996|P2|COMPLETED|Overall Study||13
1436507|NCT02321436|3516997|P1|COMPLETED|Overall Study||27
1436508|NCT02321436|3516996|P2|STARTED|Overall Study||14
1436509|NCT02321436|3516997|P1|STARTED|Overall Study||28
1436510|NCT02321098|3517016|P3|NOT COMPLETED|Additional 15 Months Treatment||8
1436511|NCT02321098|3517017|P2|NOT COMPLETED|Additional 15 Months Treatment||0
1436512|NCT02321098|3517018|P1|NOT COMPLETED|Additional 15 Months Treatment||0
1436513|NCT02321098|3517016|P3|COMPLETED|Additional 15 Months Treatment||21
1436514|NCT02321098|3517017|P2|COMPLETED|Additional 15 Months Treatment||0
1436515|NCT02321098|3517018|P1|COMPLETED|Additional 15 Months Treatment||0
1436516|NCT02321098|3517016|P3|STARTED|Additional 15 Months Treatment||29
1436517|NCT02321098|3517017|P2|STARTED|Additional 15 Months Treatment||0
1436518|NCT02321098|3517018|P1|STARTED|Additional 15 Months Treatment||0
1436519|NCT02321098|3517016|P3|NOT COMPLETED|12 Weeks Treament||0
1436520|NCT02321098|3517017|P2|NOT COMPLETED|12 Weeks Treament||1
1436521|NCT02321098|3517018|P1|NOT COMPLETED|12 Weeks Treament||1
1436522|NCT02321098|3517016|P3|COMPLETED|12 Weeks Treament||0
1436523|NCT02321098|3517017|P2|COMPLETED|12 Weeks Treament||23
1436524|NCT02321098|3517018|P1|COMPLETED|12 Weeks Treament||25
1436525|NCT02321098|3517016|P3|STARTED|12 Weeks Treament||0
1436526|NCT02321098|3517017|P2|STARTED|12 Weeks Treament||24
1436527|NCT02321098|3517018|P1|STARTED|12 Weeks Treament||26
1436528|NCT02320903|3517030|P3|NOT COMPLETED|Overall Study||16
1436529|NCT02320903|3517031|P2|NOT COMPLETED|Overall Study||16
1436530|NCT02320903|3517032|P1|NOT COMPLETED|Overall Study||8
1436531|NCT02320903|3517030|P3|COMPLETED|Overall Study||16
1436532|NCT02320903|3517031|P2|COMPLETED|Overall Study||16
1436533|NCT02320903|3517032|P1|COMPLETED|Overall Study||16
1436534|NCT02320903|3517030|P3|STARTED|Overall Study||32
1436535|NCT02320903|3517031|P2|STARTED|Overall Study||32
1436536|NCT02320903|3517032|P1|STARTED|Overall Study||24
1436537|NCT02320838|3517065|P5|NOT COMPLETED|Third Intervention (1 Day)||0
1436538|NCT02320838|3517066|P4|NOT COMPLETED|Third Intervention (1 Day)||0
1436539|NCT02320838|3517067|P3|NOT COMPLETED|Third Intervention (1 Day)||0
1436540|NCT02320838|3517068|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1436541|NCT02320838|3517069|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1436542|NCT02320838|3517065|P5|COMPLETED|Third Intervention (1 Day)||7
1436543|NCT02320838|3517066|P4|COMPLETED|Third Intervention (1 Day)||7
1436544|NCT02320838|3517067|P3|COMPLETED|Third Intervention (1 Day)||8
1436545|NCT02320838|3517068|P2|COMPLETED|Third Intervention (1 Day)||8
1436546|NCT02320838|3517069|P1|COMPLETED|Third Intervention (1 Day)||8
1436547|NCT02320838|3517065|P5|STARTED|Third Intervention (1 Day)||7
1436548|NCT02320838|3517066|P4|STARTED|Third Intervention (1 Day)||7
1436549|NCT02320838|3517067|P3|STARTED|Third Intervention (1 Day)||8
1436550|NCT02320838|3517068|P2|STARTED|Third Intervention (1 Day)||8
1436551|NCT02320838|3517069|P1|STARTED|Third Intervention (1 Day)||8
1436552|NCT02320838|3517065|P5|NOT COMPLETED|Washout (1 Day)||0
1436553|NCT02320838|3517066|P4|NOT COMPLETED|Washout (1 Day)||0
1436554|NCT02320838|3517067|P3|NOT COMPLETED|Washout (1 Day)||0
1436555|NCT02320838|3517068|P2|NOT COMPLETED|Washout (1 Day)||0
1436556|NCT02320838|3517069|P1|NOT COMPLETED|Washout (1 Day)||0
1436557|NCT02320838|3517065|P5|COMPLETED|Washout (1 Day)||7
1436558|NCT02320838|3517066|P4|COMPLETED|Washout (1 Day)||7
1436559|NCT02320838|3517067|P3|COMPLETED|Washout (1 Day)||8
1436560|NCT02320838|3517068|P2|COMPLETED|Washout (1 Day)||8
1436561|NCT02320838|3517069|P1|COMPLETED|Washout (1 Day)||8
1436562|NCT02320838|3517065|P5|STARTED|Washout (1 Day)||7
1436563|NCT02320838|3517066|P4|STARTED|Washout (1 Day)||7
1436564|NCT02320838|3517067|P3|STARTED|Washout (1 Day)||8
1436565|NCT02320838|3517068|P2|STARTED|Washout (1 Day)||8
1436566|NCT02320838|3517069|P1|STARTED|Washout (1 Day)||8
1436567|NCT02320838|3517065|P5|NOT COMPLETED|Second Intervention (1 Day)||0
1436568|NCT02320838|3517066|P4|NOT COMPLETED|Second Intervention (1 Day)||0
1436569|NCT02320838|3517067|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1436570|NCT02320838|3517068|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1436571|NCT02320838|3517069|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1436572|NCT02320838|3517065|P5|COMPLETED|Second Intervention (1 Day)||7
1436573|NCT02320838|3517066|P4|COMPLETED|Second Intervention (1 Day)||7
1436574|NCT02320838|3517067|P3|COMPLETED|Second Intervention (1 Day)||8
1436575|NCT02320838|3517068|P2|COMPLETED|Second Intervention (1 Day)||8
1436576|NCT02320838|3517069|P1|COMPLETED|Second Intervention (1 Day)||8
1436577|NCT02320838|3517065|P5|STARTED|Second Intervention (1 Day)||7
1436578|NCT02320838|3517066|P4|STARTED|Second Intervention (1 Day)||7
1436579|NCT02320838|3517067|P3|STARTED|Second Intervention (1 Day)||8
1436580|NCT02320838|3517068|P2|STARTED|Second Intervention (1 Day)||8
1436581|NCT02320838|3517069|P1|STARTED|Second Intervention (1 Day)||8
1436582|NCT02320838|3517065|P5|NOT COMPLETED|Washout (1 Day)||0
1436583|NCT02320838|3517066|P4|NOT COMPLETED|Washout (1 Day)||0
1436584|NCT02320838|3517067|P3|NOT COMPLETED|Washout (1 Day)||0
1436585|NCT02320838|3517068|P2|NOT COMPLETED|Washout (1 Day)||0
1436586|NCT02320838|3517069|P1|NOT COMPLETED|Washout (1 Day)||0
1436587|NCT02320838|3517065|P5|COMPLETED|Washout (1 Day)||7
1436588|NCT02320838|3517066|P4|COMPLETED|Washout (1 Day)||7
1436589|NCT02320838|3517067|P3|COMPLETED|Washout (1 Day)||8
1436590|NCT02320838|3517068|P2|COMPLETED|Washout (1 Day)||8
1436591|NCT02320838|3517069|P1|COMPLETED|Washout (1 Day)||8
1436592|NCT02320838|3517065|P5|STARTED|Washout (1 Day)||7
1436593|NCT02320838|3517066|P4|STARTED|Washout (1 Day)||7
1436594|NCT02320838|3517067|P3|STARTED|Washout (1 Day)||8
1436595|NCT02320838|3517068|P2|STARTED|Washout (1 Day)||8
1436596|NCT02320838|3517069|P1|STARTED|Washout (1 Day)||8
1436597|NCT02320838|3517065|P5|NOT COMPLETED|First Intervention (1 Day)||0
1436598|NCT02320838|3517066|P4|NOT COMPLETED|First Intervention (1 Day)||0
1436599|NCT02320838|3517067|P3|NOT COMPLETED|First Intervention (1 Day)||0
1436600|NCT02320838|3517068|P2|NOT COMPLETED|First Intervention (1 Day)||0
1436601|NCT02320838|3517069|P1|NOT COMPLETED|First Intervention (1 Day)||0
1436602|NCT02320838|3517065|P5|COMPLETED|First Intervention (1 Day)||7
1436603|NCT02320838|3517066|P4|COMPLETED|First Intervention (1 Day)||7
1436604|NCT02320838|3517067|P3|COMPLETED|First Intervention (1 Day)||8
1436605|NCT02320838|3517068|P2|COMPLETED|First Intervention (1 Day)||8
1436606|NCT02320838|3517069|P1|COMPLETED|First Intervention (1 Day)||8
1436607|NCT02320838|3517065|P5|STARTED|First Intervention (1 Day)||7
1436608|NCT02320838|3517066|P4|STARTED|First Intervention (1 Day)||7
1436609|NCT02320838|3517067|P3|STARTED|First Intervention (1 Day)||8
1436610|NCT02320838|3517068|P2|STARTED|First Intervention (1 Day)||8
1436611|NCT02320838|3517069|P1|STARTED|First Intervention (1 Day)||8
1436612|NCT02320721|3517136|P2|NOT COMPLETED|Overall Study||34
1436613|NCT02320721|3517137|P1|NOT COMPLETED|Overall Study||27
1436614|NCT02320721|3517136|P2|COMPLETED|Overall Study||472
1436615|NCT02320721|3517137|P1|COMPLETED|Overall Study||481
1436616|NCT02320721|3517136|P2|Treated (Safety Population)|Overall Study||505
1436617|NCT02320721|3517137|P1|Treated (Safety Population)|Overall Study||508
1436618|NCT02320721|3517136|P2|STARTED|Overall Study||506
1436619|NCT02320721|3517137|P1|STARTED|Overall Study||508
1436620|NCT02320695|3517165|P1|NOT COMPLETED|Overall Study||0
1436621|NCT02320695|3517165|P1|COMPLETED|Overall Study||60
1436622|NCT02320695|3517165|P1|Pain Relief Ointment|Overall Study||60
1436623|NCT02320695|3517165|P1|Original Ointment|Overall Study||60
1436624|NCT02320695|3517165|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
1436625|NCT02320695|3517165|P1|Pain Relieving Cream|Overall Study||59
1436626|NCT02320695|3517165|P1|Alcohol|Overall Study||60
1436627|NCT02320695|3517165|P1|Saline|Overall Study||60
1436628|NCT02320695|3517165|P1|STARTED|Overall Study||60
1436629|NCT02320487|3517192|P1|NOT COMPLETED|Overall Study||21
1436630|NCT02320487|3517192|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
1436631|NCT02320487|3517192|P1|STARTED|Overall Study||102
1436632|NCT02320396|3517212|P2|NOT COMPLETED|Overall Study||4
1436633|NCT02320396|3517213|P1|NOT COMPLETED|Overall Study||4
1436634|NCT02320396|3517212|P2|COMPLETED|Overall Study||221
1436635|NCT02320396|3517213|P1|COMPLETED|Overall Study||220
1436636|NCT02320396|3517212|P2|Treated (Full Analysis Set)|Overall Study||225
1436637|NCT02320396|3517213|P1|Treated (Full Analysis Set)|Overall Study||223
1436638|NCT02320396|3517212|P2|STARTED|Overall Study||225
1436639|NCT02320396|3517213|P1|STARTED|Overall Study||224
1436640|NCT02320227|3517243|P1|NOT COMPLETED|Overall Study||0
1436641|NCT02320227|3517243|P1|COMPLETED|Overall Study||30
1436642|NCT02320227|3517243|P1|STARTED|Overall Study||30
1436643|NCT02320214|3517248|P1|NOT COMPLETED|Overall Study||0
1436644|NCT02320214|3517248|P1|COMPLETED|Overall Study||30
1436645|NCT02320214|3517248|P1|STARTED|Overall Study||30
1436646|NCT02320149|3517255|P2|NOT COMPLETED|Overall Study||80
1436647|NCT02320149|3517256|P1|NOT COMPLETED|Overall Study||63
1436648|NCT02320149|3517255|P2|COMPLETED|Overall Study||405
1436649|NCT02320149|3517256|P1|COMPLETED|Overall Study||420
1436650|NCT02320149|3517255|P2|STARTED|Overall Study||485
1436651|NCT02320149|3517256|P1|STARTED|Overall Study||483
1436652|NCT02319824|3517294|P1|NOT COMPLETED|Overall Study||0
1436653|NCT02319824|3517294|P1|COMPLETED|Overall Study||2
1436654|NCT02319824|3517294|P1|STARTED|Overall Study||2
1436655|NCT02319668|3517302|P2|NOT COMPLETED|Overall Study||2
1436656|NCT02319668|3517303|P1|NOT COMPLETED|Overall Study||0
1436657|NCT02319668|3517302|P2|COMPLETED|Overall Study||17
1436658|NCT02319668|3517303|P1|COMPLETED|Overall Study||19
1436659|NCT02319668|3517302|P2|STARTED|Overall Study||19
1436660|NCT02319668|3517303|P1|STARTED|Overall Study||19
1436661|NCT02319642|3517317|P2|NOT COMPLETED|Overall Study||6
1436662|NCT02319642|3517318|P1|NOT COMPLETED|Overall Study||4
1436663|NCT02319642|3517317|P2|COMPLETED|Overall Study||245
1436664|NCT02319642|3517318|P1|COMPLETED|Overall Study||91
1436665|NCT02319642|3517317|P2|STARTED|Overall Study||251
1436666|NCT02319642|3517318|P1|STARTED|Overall Study||95
1436667|NCT02319525|3517338|P2|NOT COMPLETED|Overall Study||1
1436668|NCT02319525|3517339|P1|NOT COMPLETED|Overall Study||2
1436669|NCT02319525|3517338|P2|COMPLETED|Overall Study||147
1436670|NCT02319525|3517339|P1|COMPLETED|Overall Study||151
1436671|NCT02319525|3517338|P2|Primary Research Completion|Overall Study||147
1436672|NCT02319525|3517339|P1|Primary Research Completion|Overall Study||151
1436673|NCT02319525|3517338|P2|STARTED|Overall Study||148
1436674|NCT02319525|3517339|P1|STARTED|Overall Study||153
1436675|NCT02319486|3517357|P1|NOT COMPLETED|Overall Study||0
1436676|NCT02319486|3517357|P1|COMPLETED|Overall Study||26
1436677|NCT02319486|3517357|P1|STARTED|Overall Study||26
1436678|NCT02319317|3517365|P2|NOT COMPLETED|Overall Study||0
1436679|NCT02319317|3517366|P1|NOT COMPLETED|Overall Study||0
1436680|NCT02319317|3517365|P2|COMPLETED|Overall Study||29
1436681|NCT02319317|3517366|P1|COMPLETED|Overall Study||31
1436682|NCT02319317|3517365|P2|STARTED|Overall Study||29
1436683|NCT02319317|3517366|P1|STARTED|Overall Study||31
1436684|NCT02319174|3517372|P1|NOT COMPLETED|Overall Study||1
1436685|NCT02319174|3517372|P1|COMPLETED|Overall Study||42
1436686|NCT02319174|3517372|P1|STARTED|Overall Study||43
1436687|NCT02319148|3517381|P4|NOT COMPLETED|Second Intervention Period||2
1436688|NCT02319148|3517382|P3|NOT COMPLETED|Second Intervention Period||1
1436689|NCT02319148|3517383|P2|NOT COMPLETED|Second Intervention Period||1
1436690|NCT02319148|3517384|P1|NOT COMPLETED|Second Intervention Period||0
1436691|NCT02319148|3517381|P4|COMPLETED|Second Intervention Period||6
1436692|NCT02319148|3517382|P3|COMPLETED|Second Intervention Period||6
1436693|NCT02319148|3517383|P2|COMPLETED|Second Intervention Period||6
1436694|NCT02319148|3517384|P1|COMPLETED|Second Intervention Period||0
1436695|NCT02319148|3517381|P4|STARTED|Second Intervention Period||8
1436696|NCT02319148|3517382|P3|STARTED|Second Intervention Period||7
1436697|NCT02319148|3517383|P2|STARTED|Second Intervention Period||7
1436698|NCT02319148|3517384|P1|STARTED|Second Intervention Period||0
1436699|NCT02319148|3517381|P4|NOT COMPLETED|Washout Period 4 Days||0
1436700|NCT02319148|3517382|P3|NOT COMPLETED|Washout Period 4 Days||0
1436701|NCT02319148|3517383|P2|NOT COMPLETED|Washout Period 4 Days||0
1436702|NCT02319148|3517384|P1|NOT COMPLETED|Washout Period 4 Days||0
1436703|NCT02319148|3517381|P4|COMPLETED|Washout Period 4 Days||0
1436704|NCT02319148|3517382|P3|COMPLETED|Washout Period 4 Days||0
1436705|NCT02319148|3517383|P2|COMPLETED|Washout Period 4 Days||0
1436706|NCT02319148|3517384|P1|COMPLETED|Washout Period 4 Days||22
1436707|NCT02319148|3517381|P4|STARTED|Washout Period 4 Days||0
1436708|NCT02319148|3517382|P3|STARTED|Washout Period 4 Days||0
1436709|NCT02319148|3517383|P2|STARTED|Washout Period 4 Days||0
1436710|NCT02319148|3517384|P1|STARTED|Washout Period 4 Days||22
1436711|NCT02319148|3517381|P4|NOT COMPLETED|First Intervention Period||0
1436712|NCT02319148|3517382|P3|NOT COMPLETED|First Intervention Period||0
1436713|NCT02319148|3517383|P2|NOT COMPLETED|First Intervention Period||0
1436714|NCT02319148|3517384|P1|NOT COMPLETED|First Intervention Period||0
1436715|NCT02319148|3517381|P4|COMPLETED|First Intervention Period||0
1436716|NCT02319148|3517382|P3|COMPLETED|First Intervention Period||0
1436717|NCT02319148|3517383|P2|COMPLETED|First Intervention Period||0
1436718|NCT02319148|3517384|P1|COMPLETED|First Intervention Period||22
1436719|NCT02319148|3517381|P4|STARTED|First Intervention Period||0
1436720|NCT02319148|3517382|P3|STARTED|First Intervention Period||0
1436721|NCT02319148|3517383|P2|STARTED|First Intervention Period||0
1436722|NCT02319148|3517384|P1|STARTED|First Intervention Period||22
1436723|NCT02319044|3517447|P3|NOT COMPLETED|Overall Study||67
1436724|NCT02319044|3517448|P2|NOT COMPLETED|Overall Study||60
1436725|NCT02319044|3517449|P1|NOT COMPLETED|Overall Study||122
1436726|NCT02319044|3517447|P3|COMPLETED|Overall Study||0
1436727|NCT02319044|3517448|P2|COMPLETED|Overall Study||7
1436728|NCT02319044|3517449|P1|COMPLETED|Overall Study||11
1436729|NCT02319044|3517447|P3|STARTED|Overall Study||67
1436730|NCT02319044|3517448|P2|STARTED|Overall Study||67
1436731|NCT02319044|3517449|P1|STARTED|Overall Study||133
1436732|NCT02319031|3517505|P2|NOT COMPLETED|Follow-Up Period||0
1436733|NCT02319031|3517506|P1|NOT COMPLETED|Follow-Up Period||0
1436734|NCT02319031|3517505|P2|COMPLETED|Follow-Up Period||26
1436735|NCT02319031|3517506|P1|COMPLETED|Follow-Up Period||23
1436736|NCT02319031|3517505|P2|STARTED|Follow-Up Period||26
1436737|NCT02319031|3517506|P1|STARTED|Follow-Up Period||23
1436738|NCT02319031|3517505|P2|NOT COMPLETED|Treatment Period||0
1436739|NCT02319031|3517506|P1|NOT COMPLETED|Treatment Period||1
1436740|NCT02319031|3517505|P2|COMPLETED|Treatment Period||26
1436741|NCT02319031|3517506|P1|COMPLETED|Treatment Period||23
1436742|NCT02319031|3517505|P2|STARTED|Treatment Period||26
1436743|NCT02319031|3517506|P1|STARTED|Treatment Period||24
1436744|NCT02319005|3517518|P2|NOT COMPLETED|Overall Study||15
1436745|NCT02319005|3517519|P1|NOT COMPLETED|Overall Study||48
1436746|NCT02319005|3517518|P2|COMPLETED|Overall Study||51
1436747|NCT02319005|3517519|P1|COMPLETED|Overall Study||92
1436748|NCT02319005|3517518|P2|STARTED|Overall Study||66
1436749|NCT02319005|3517519|P1|STARTED|Overall Study||140
1436750|NCT02318940|3517541|P2|NOT COMPLETED|Overall Study||0
1436751|NCT02318940|3517542|P1|NOT COMPLETED|Overall Study||1
1436752|NCT02318940|3517541|P2|COMPLETED|Overall Study||50
1436753|NCT02318940|3517542|P1|COMPLETED|Overall Study||49
1436754|NCT02318940|3517541|P2|STARTED|Overall Study||50
1436755|NCT02318940|3517542|P1|STARTED|Overall Study|in the last patient we lost the record.|50
1436756|NCT02318901|3517557|P3|NOT COMPLETED|Overall Study||10
1436757|NCT02318901|3517558|P2|NOT COMPLETED|Overall Study||1
1436758|NCT02318901|3517559|P1|NOT COMPLETED|Overall Study||5
1436759|NCT02318901|3517557|P3|COMPLETED|Overall Study||0
1436760|NCT02318901|3517558|P2|COMPLETED|Overall Study||0
1436761|NCT02318901|3517559|P1|COMPLETED|Overall Study||0
1436762|NCT02318901|3517557|P3|STARTED|Overall Study||10
1436763|NCT02318901|3517558|P2|STARTED|Overall Study||1
1436764|NCT02318901|3517559|P1|STARTED|Overall Study||5
1436765|NCT02318797|3517569|P2|NOT COMPLETED|Overall Study||102
1436766|NCT02318797|3517570|P1|NOT COMPLETED|Overall Study||88
1436767|NCT02318797|3517569|P2|COMPLETED|Overall Study||611
1436768|NCT02318797|3517570|P1|COMPLETED|Overall Study||428
1436769|NCT02318797|3517569|P2|STARTED|Overall Study||713
1436770|NCT02318797|3517570|P1|STARTED|Overall Study||516
1436771|NCT02318693|3517610|P2|NOT COMPLETED|Overall Study||1
1436772|NCT02318693|3517611|P1|NOT COMPLETED|Overall Study||0
1436773|NCT02318693|3517610|P2|COMPLETED|Overall Study||26
1436774|NCT02318693|3517611|P1|COMPLETED|Overall Study||26
1436775|NCT02318693|3517610|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
1436776|NCT02318693|3517611|P1|Treated|Overall Study||26
1436777|NCT02318693|3517610|P2|STARTED|Overall Study||27
1436778|NCT02318693|3517611|P1|STARTED|Overall Study||26
1436779|NCT02318667|3517625|P1|NOT COMPLETED|Overall Study||9
1436780|NCT02318667|3517625|P1|COMPLETED|Overall Study||29
1436781|NCT02318667|3517625|P1|STARTED|Overall Study||38
1436782|NCT02318602|3517644|P3|NOT COMPLETED|Overall Study||2
1436783|NCT02318602|3517645|P2|NOT COMPLETED|Overall Study||4
1436784|NCT02318602|3517646|P1|NOT COMPLETED|Overall Study||1
1436785|NCT02318602|3517644|P3|COMPLETED|Overall Study||15
1436786|NCT02318602|3517645|P2|COMPLETED|Overall Study||22
1436787|NCT02318602|3517646|P1|COMPLETED|Overall Study||8
1436788|NCT02318602|3517644|P3|STARTED|Overall Study||17
1436789|NCT02318602|3517645|P2|STARTED|Overall Study||26
1436790|NCT02318602|3517646|P1|STARTED|Overall Study||9
1436791|NCT02318303|3517684|P7|NOT COMPLETED|Overall Study||2
1436792|NCT02318303|3517685|P6|NOT COMPLETED|Overall Study||6
1436793|NCT02318303|3517686|P5|NOT COMPLETED|Overall Study||5
1436794|NCT02318303|3517687|P4|NOT COMPLETED|Overall Study||3
1436795|NCT02318303|3517688|P3|NOT COMPLETED|Overall Study||3
1436796|NCT02318303|3517689|P2|NOT COMPLETED|Overall Study||3
1436797|NCT02318303|3517690|P1|NOT COMPLETED|Overall Study||4
1436798|NCT02318303|3517684|P7|COMPLETED|Overall Study||158
1436799|NCT02318303|3517685|P6|COMPLETED|Overall Study||153
1436800|NCT02318303|3517686|P5|COMPLETED|Overall Study||152
1436801|NCT02318303|3517687|P4|COMPLETED|Overall Study||155
1436802|NCT02318303|3517688|P3|COMPLETED|Overall Study||157
1436803|NCT02318303|3517689|P2|COMPLETED|Overall Study||155
1436804|NCT02318303|3517690|P1|COMPLETED|Overall Study||155
1436805|NCT02318303|3517684|P7|STARTED|Overall Study||160
1436806|NCT02318303|3517685|P6|STARTED|Overall Study||159
1436807|NCT02318303|3517686|P5|STARTED|Overall Study||157
1436808|NCT02318303|3517687|P4|STARTED|Overall Study||158
1436809|NCT02318303|3517688|P3|STARTED|Overall Study||160
1436810|NCT02318303|3517689|P2|STARTED|Overall Study||158
1436811|NCT02318303|3517690|P1|STARTED|Overall Study||159
1436812|NCT02317809|3517706|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
1436813|NCT02317809|3517707|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
1436814|NCT02317809|3517706|P2|COMPLETED|Second Intervention Period (8 Days)||17
1436815|NCT02317809|3517707|P1|COMPLETED|Second Intervention Period (8 Days)||14
1436816|NCT02317809|3517706|P2|STARTED|Second Intervention Period (8 Days)||17
1436817|NCT02317809|3517707|P1|STARTED|Second Intervention Period (8 Days)||14
1436818|NCT02317809|3517706|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
1436819|NCT02317809|3517707|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
1436820|NCT02317809|3517706|P2|COMPLETED|First Intervention Period (8 Days)||17
1436821|NCT02317809|3517707|P1|COMPLETED|First Intervention Period (8 Days)||14
1436822|NCT02317809|3517706|P2|STARTED|First Intervention Period (8 Days)||17
1436823|NCT02317809|3517707|P1|STARTED|First Intervention Period (8 Days)||17
1436824|NCT02317744|3517759|P2|NOT COMPLETED|Overall Study||2
1436825|NCT02317744|3517760|P1|NOT COMPLETED|Overall Study||1
1436826|NCT02317744|3517759|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
1436827|NCT02317744|3517760|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
1436828|NCT02317744|3517759|P2|Completed Treatment|Overall Study||7
1436829|NCT02317744|3517760|P1|Completed Treatment|Overall Study||10
1436830|NCT02317744|3517759|P2|STARTED|Overall Study||10
1436831|NCT02317744|3517760|P1|STARTED|Overall Study||12
1436832|NCT02317692|3517774|P2|NOT COMPLETED|Overall Study||0
1436833|NCT02317692|3517775|P1|NOT COMPLETED|Overall Study||6
1436834|NCT02317692|3517774|P2|COMPLETED|Overall Study||77
1436835|NCT02317692|3517775|P1|COMPLETED|Overall Study||63
1436836|NCT02317692|3517774|P2|STARTED|Overall Study||77
1436837|NCT02317692|3517775|P1|STARTED|Overall Study||69
1436838|NCT02317614|3517795|P2|NOT COMPLETED|Overall Study||2
1436839|NCT02317614|3517796|P1|NOT COMPLETED|Overall Study||3
1436840|NCT02317614|3517795|P2|COMPLETED|Overall Study||23
1436841|NCT02317614|3517796|P1|COMPLETED|Overall Study||23
1436842|NCT02317614|3517795|P2|STARTED|Overall Study||25
1436843|NCT02317614|3517796|P1|STARTED|Overall Study||26
1436844|NCT02317549|3517814|P2|NOT COMPLETED|Overall Study||0
1436845|NCT02317549|3517815|P1|NOT COMPLETED|Overall Study||0
1436846|NCT02317549|3517814|P2|COMPLETED|Overall Study||3
1436847|NCT02317549|3517815|P1|COMPLETED|Overall Study||5
1436848|NCT02317549|3517814|P2|STARTED|Overall Study||3
1436849|NCT02317549|3517815|P1|STARTED|Overall Study||5
1436850|NCT02317510|3517823|P2|NOT COMPLETED|Overall Study||1
1436851|NCT02317510|3517824|P1|NOT COMPLETED|Overall Study||0
1436852|NCT02317510|3517823|P2|COMPLETED|Overall Study||24
1436853|NCT02317510|3517824|P1|COMPLETED|Overall Study||25
1436854|NCT02317510|3517823|P2|STARTED|Overall Study||25
1436855|NCT02317510|3517824|P1|STARTED|Overall Study||25
1436856|NCT02317016|3517852|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
1436857|NCT02317016|3517852|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
1436858|NCT02317016|3517852|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
1436859|NCT02317016|3517852|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
1436860|NCT02317016|3517852|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
1436861|NCT02317016|3517852|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
1436862|NCT02317016|3517852|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
1436863|NCT02317016|3517852|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
1436864|NCT02317016|3517852|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
1436865|NCT02317016|3517852|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
1436866|NCT02317016|3517852|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
1436867|NCT02317016|3517852|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
1436868|NCT02316847|3517880|P2|NOT COMPLETED|Overall Study||86
1436869|NCT02316847|3517881|P1|NOT COMPLETED|Overall Study||9
1436870|NCT02316847|3517880|P2|COMPLETED|Overall Study||13
1436871|NCT02316847|3517881|P1|COMPLETED|Overall Study||0
1436872|NCT02316847|3517880|P2|STARTED|Overall Study||99
1436873|NCT02316847|3517881|P1|STARTED|Overall Study||9
1436874|NCT02316769|3517892|P2|NOT COMPLETED|Overall Study||0
1436875|NCT02316769|3517893|P1|NOT COMPLETED|Overall Study||2
1436876|NCT02316769|3517892|P2|COMPLETED|Overall Study||33
1436877|NCT02316769|3517893|P1|COMPLETED|Overall Study||31
1436878|NCT02316769|3517892|P2|STARTED|Overall Study||33
1436879|NCT02316769|3517893|P1|STARTED|Overall Study||33
1436880|NCT02316678|3517903|P2|NOT COMPLETED|Overall Study||0
1436881|NCT02316678|3517904|P1|NOT COMPLETED|Overall Study||0
1436882|NCT02316678|3517903|P2|COMPLETED|Overall Study||7694
1436883|NCT02316678|3517904|P1|COMPLETED|Overall Study||1879
1436884|NCT02316678|3517903|P2|STARTED|Overall Study||7694
1436885|NCT02316678|3517904|P1|STARTED|Overall Study||1879
1436886|NCT02316613|3517910|P1|NOT COMPLETED|Overall Study||104
1436887|NCT02316613|3517910|P1|COMPLETED|Overall Study||156
1436888|NCT02316613|3517910|P1|Overall Population|Overall Study||241
1436889|NCT02316613|3517910|P1|Safety Population|Overall Study||255
1436890|NCT02316613|3517910|P1|STARTED|Overall Study||260
1436891|NCT02316548|3517949|P2|NOT COMPLETED|Overall Study||1
1436892|NCT02316548|3517950|P1|NOT COMPLETED|Overall Study||0
1436893|NCT02316548|3517949|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
1436894|NCT02316548|3517950|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
1436895|NCT02316548|3517949|P2|Eligible With Adverse Event Data|Overall Study||2
1436896|NCT02316548|3517950|P1|Eligible With Adverse Event Data|Overall Study||4
1436897|NCT02316548|3517949|P2|Eligible With Disease Assessment|Overall Study||1
1436898|NCT02316548|3517950|P1|Eligible With Disease Assessment|Overall Study||4
1436899|NCT02316548|3517949|P2|Eligible Population|Overall Study||6
1436900|NCT02316548|3517950|P1|Eligible Population|Overall Study||6
1436901|NCT02316548|3517949|P2|STARTED|Overall Study|Randomized|7
1436902|NCT02316548|3517950|P1|STARTED|Overall Study|Randomized|6
1436903|NCT02316470|3517964|P4|NOT COMPLETED|Overall Study||2
1436904|NCT02316470|3517965|P3|NOT COMPLETED|Overall Study||5
1436905|NCT02316470|3517966|P2|NOT COMPLETED|Overall Study||6
1436906|NCT02316470|3517967|P1|NOT COMPLETED|Overall Study||5
1436907|NCT02316470|3517964|P4|COMPLETED|Overall Study||46
1436908|NCT02316470|3517965|P3|COMPLETED|Overall Study||147
1436909|NCT02316470|3517966|P2|COMPLETED|Overall Study||146
1436910|NCT02316470|3517967|P1|COMPLETED|Overall Study||143
1436911|NCT02316470|3517964|P4|STARTED|Overall Study||48
1436912|NCT02316470|3517965|P3|STARTED|Overall Study||152
1436913|NCT02316470|3517966|P2|STARTED|Overall Study||152
1436914|NCT02316470|3517967|P1|STARTED|Overall Study||148
1436915|NCT02316366|3518063|P2|NOT COMPLETED|Overall Study||0
1436916|NCT02316366|3518064|P1|NOT COMPLETED|Overall Study||0
1436917|NCT02316366|3518063|P2|COMPLETED|Overall Study||40
1436918|NCT02316366|3518064|P1|COMPLETED|Overall Study||40
1436919|NCT02316366|3518063|P2|STARTED|Overall Study||40
1436920|NCT02316366|3518064|P1|STARTED|Overall Study||40
1436921|NCT02316353|3518080|P2|NOT COMPLETED|Overall Study||8
1436922|NCT02316353|3518081|P1|NOT COMPLETED|Overall Study||8
1436923|NCT02316353|3518080|P2|COMPLETED|Overall Study||55
1436924|NCT02316353|3518081|P1|COMPLETED|Overall Study||55
1436925|NCT02316353|3518080|P2|STARTED|Overall Study||63
1436926|NCT02316353|3518081|P1|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
1436927|NCT02315989|3518099|P1|NOT COMPLETED|Overall Study||0
1436928|NCT02315989|3518099|P1|COMPLETED|Overall Study||6
1436929|NCT02315989|3518099|P1|STARTED|Overall Study||6
1436930|NCT02315560|3518107|P1|NOT COMPLETED|Overall Study||3
1436931|NCT02315560|3518107|P1|COMPLETED|Overall Study||22
1436932|NCT02315560|3518107|P1|STARTED|Overall Study||25
1436933|NCT02315352|3518114|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
1436934|NCT02315352|3518115|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
1436935|NCT02315352|3518116|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
1436936|NCT02315352|3518117|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
1436937|NCT02315352|3518118|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
1436938|NCT02315352|3518119|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
1436939|NCT02315352|3518120|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
1436940|NCT02315352|3518121|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
1436941|NCT02315352|3518114|P8|COMPLETED|Fifth Intervention (Day 2)||8
1436942|NCT02315352|3518115|P7|COMPLETED|Fifth Intervention (Day 2)||9
1436943|NCT02315352|3518116|P6|COMPLETED|Fifth Intervention (Day 2)||7
1436944|NCT02315352|3518117|P5|COMPLETED|Fifth Intervention (Day 2)||8
1436945|NCT02315352|3518118|P4|COMPLETED|Fifth Intervention (Day 2)||8
1436946|NCT02315352|3518119|P3|COMPLETED|Fifth Intervention (Day 2)||7
1436947|NCT02315352|3518120|P2|COMPLETED|Fifth Intervention (Day 2)||0
1436948|NCT02315352|3518121|P1|COMPLETED|Fifth Intervention (Day 2)||0
1436949|NCT02315352|3518114|P8|STARTED|Fifth Intervention (Day 2)||8
1436950|NCT02315352|3518115|P7|STARTED|Fifth Intervention (Day 2)||9
1436951|NCT02315352|3518116|P6|STARTED|Fifth Intervention (Day 2)||7
1436952|NCT02315352|3518117|P5|STARTED|Fifth Intervention (Day 2)||8
1436953|NCT02315352|3518118|P4|STARTED|Fifth Intervention (Day 2)||8
1436954|NCT02315352|3518119|P3|STARTED|Fifth Intervention (Day 2)||7
1436955|NCT02315352|3518120|P2|STARTED|Fifth Intervention (Day 2)||0
1436956|NCT02315352|3518121|P1|STARTED|Fifth Intervention (Day 2)||0
1436957|NCT02315352|3518114|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
1436958|NCT02315352|3518115|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
1436959|NCT02315352|3518116|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
1436960|NCT02315352|3518117|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
1436961|NCT02315352|3518118|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
1436962|NCT02315352|3518119|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
1436963|NCT02315352|3518120|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
1436964|NCT02315352|3518121|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
1436965|NCT02315352|3518114|P8|COMPLETED|Fourth Intervention (Day 2)||8
1436966|NCT02315352|3518115|P7|COMPLETED|Fourth Intervention (Day 2)||9
1436967|NCT02315352|3518116|P6|COMPLETED|Fourth Intervention (Day 2)||7
1436968|NCT02315352|3518117|P5|COMPLETED|Fourth Intervention (Day 2)||8
1436969|NCT02315352|3518118|P4|COMPLETED|Fourth Intervention (Day 2)||8
1436970|NCT02315352|3518119|P3|COMPLETED|Fourth Intervention (Day 2)||7
1436971|NCT02315352|3518120|P2|COMPLETED|Fourth Intervention (Day 2)||0
1436972|NCT02315352|3518121|P1|COMPLETED|Fourth Intervention (Day 2)||0
1436973|NCT02315352|3518114|P8|STARTED|Fourth Intervention (Day 2)||8
1436974|NCT02315352|3518115|P7|STARTED|Fourth Intervention (Day 2)||9
1436975|NCT02315352|3518116|P6|STARTED|Fourth Intervention (Day 2)||7
1436976|NCT02315352|3518117|P5|STARTED|Fourth Intervention (Day 2)||8
1436977|NCT02315352|3518118|P4|STARTED|Fourth Intervention (Day 2)||8
1436978|NCT02315352|3518119|P3|STARTED|Fourth Intervention (Day 2)||7
1436979|NCT02315352|3518120|P2|STARTED|Fourth Intervention (Day 2)||0
1436980|NCT02315352|3518121|P1|STARTED|Fourth Intervention (Day 2)||0
1436981|NCT02315352|3518114|P8|NOT COMPLETED|Third Intervention (Day 2)||0
1436982|NCT02315352|3518115|P7|NOT COMPLETED|Third Intervention (Day 2)||0
1436983|NCT02315352|3518116|P6|NOT COMPLETED|Third Intervention (Day 2)||0
1436984|NCT02315352|3518117|P5|NOT COMPLETED|Third Intervention (Day 2)||0
1436985|NCT02315352|3518118|P4|NOT COMPLETED|Third Intervention (Day 2)||0
1436986|NCT02315352|3518119|P3|NOT COMPLETED|Third Intervention (Day 2)||0
1436987|NCT02315352|3518120|P2|NOT COMPLETED|Third Intervention (Day 2)||0
1436988|NCT02315352|3518121|P1|NOT COMPLETED|Third Intervention (Day 2)||0
1436989|NCT02315352|3518114|P8|COMPLETED|Third Intervention (Day 2)||8
1436990|NCT02315352|3518115|P7|COMPLETED|Third Intervention (Day 2)||9
1436991|NCT02315352|3518116|P6|COMPLETED|Third Intervention (Day 2)||7
1436992|NCT02315352|3518117|P5|COMPLETED|Third Intervention (Day 2)||8
1436993|NCT02315352|3518118|P4|COMPLETED|Third Intervention (Day 2)||8
1436994|NCT02315352|3518119|P3|COMPLETED|Third Intervention (Day 2)||7
1436995|NCT02315352|3518120|P2|COMPLETED|Third Intervention (Day 2)||0
1436996|NCT02315352|3518121|P1|COMPLETED|Third Intervention (Day 2)||0
1436997|NCT02315352|3518114|P8|STARTED|Third Intervention (Day 2)||8
1436998|NCT02315352|3518115|P7|STARTED|Third Intervention (Day 2)||9
1436999|NCT02315352|3518116|P6|STARTED|Third Intervention (Day 2)||7
1437000|NCT02315352|3518117|P5|STARTED|Third Intervention (Day 2)||8
1437001|NCT02315352|3518118|P4|STARTED|Third Intervention (Day 2)||8
1437002|NCT02315352|3518119|P3|STARTED|Third Intervention (Day 2)||7
1437003|NCT02315352|3518120|P2|STARTED|Third Intervention (Day 2)||0
1437004|NCT02315352|3518121|P1|STARTED|Third Intervention (Day 2)||0
1437005|NCT02315352|3518114|P8|NOT COMPLETED|Second Intervention (Day 1)||0
1437006|NCT02315352|3518115|P7|NOT COMPLETED|Second Intervention (Day 1)||0
1437007|NCT02315352|3518116|P6|NOT COMPLETED|Second Intervention (Day 1)||0
1437008|NCT02315352|3518117|P5|NOT COMPLETED|Second Intervention (Day 1)||0
1437009|NCT02315352|3518118|P4|NOT COMPLETED|Second Intervention (Day 1)||0
1437010|NCT02315352|3518119|P3|NOT COMPLETED|Second Intervention (Day 1)||0
1437011|NCT02315352|3518120|P2|NOT COMPLETED|Second Intervention (Day 1)||0
1437012|NCT02315352|3518121|P1|NOT COMPLETED|Second Intervention (Day 1)||0
1437013|NCT02315352|3518114|P8|COMPLETED|Second Intervention (Day 1)||0
1437014|NCT02315352|3518115|P7|COMPLETED|Second Intervention (Day 1)||0
1437015|NCT02315352|3518116|P6|COMPLETED|Second Intervention (Day 1)||0
1437016|NCT02315352|3518117|P5|COMPLETED|Second Intervention (Day 1)||0
1437017|NCT02315352|3518118|P4|COMPLETED|Second Intervention (Day 1)||0
1437018|NCT02315352|3518119|P3|COMPLETED|Second Intervention (Day 1)||0
1437019|NCT02315352|3518120|P2|COMPLETED|Second Intervention (Day 1)||24
1437020|NCT02315352|3518121|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
1437021|NCT02315352|3518114|P8|STARTED|Second Intervention (Day 1)||0
1437022|NCT02315352|3518115|P7|STARTED|Second Intervention (Day 1)||0
1437023|NCT02315352|3518116|P6|STARTED|Second Intervention (Day 1)||0
1437024|NCT02315352|3518117|P5|STARTED|Second Intervention (Day 1)||0
1437025|NCT02315352|3518118|P4|STARTED|Second Intervention (Day 1)||0
1437026|NCT02315352|3518119|P3|STARTED|Second Intervention (Day 1)||0
1437027|NCT02315352|3518120|P2|STARTED|Second Intervention (Day 1)||24
1437028|NCT02315352|3518121|P1|STARTED|Second Intervention (Day 1)||24
1437029|NCT02315352|3518114|P8|NOT COMPLETED|First Intervention (Day 1)||0
1437030|NCT02315352|3518115|P7|NOT COMPLETED|First Intervention (Day 1)||0
1437031|NCT02315352|3518116|P6|NOT COMPLETED|First Intervention (Day 1)||0
1437032|NCT02315352|3518117|P5|NOT COMPLETED|First Intervention (Day 1)||0
1437033|NCT02315352|3518118|P4|NOT COMPLETED|First Intervention (Day 1)||0
1437034|NCT02315352|3518119|P3|NOT COMPLETED|First Intervention (Day 1)||0
1437035|NCT02315352|3518120|P2|NOT COMPLETED|First Intervention (Day 1)||0
1437036|NCT02315352|3518121|P1|NOT COMPLETED|First Intervention (Day 1)||0
1437037|NCT02315352|3518114|P8|COMPLETED|First Intervention (Day 1)||0
1437038|NCT02315352|3518115|P7|COMPLETED|First Intervention (Day 1)||0
1437039|NCT02315352|3518116|P6|COMPLETED|First Intervention (Day 1)||0
1437040|NCT02315352|3518117|P5|COMPLETED|First Intervention (Day 1)||0
1437041|NCT02315352|3518118|P4|COMPLETED|First Intervention (Day 1)||0
1437042|NCT02315352|3518119|P3|COMPLETED|First Intervention (Day 1)||0
1437043|NCT02315352|3518120|P2|COMPLETED|First Intervention (Day 1)||24
1437044|NCT02315352|3518121|P1|COMPLETED|First Intervention (Day 1)||24
1437045|NCT02315352|3518114|P8|STARTED|First Intervention (Day 1)||0
1437046|NCT02315352|3518115|P7|STARTED|First Intervention (Day 1)||0
1437047|NCT02315352|3518116|P6|STARTED|First Intervention (Day 1)||0
1437048|NCT02315352|3518117|P5|STARTED|First Intervention (Day 1)||0
1437049|NCT02315352|3518118|P4|STARTED|First Intervention (Day 1)||0
1437050|NCT02315352|3518119|P3|STARTED|First Intervention (Day 1)||0
1437051|NCT02315352|3518120|P2|STARTED|First Intervention (Day 1)||24
1437052|NCT02315352|3518121|P1|STARTED|First Intervention (Day 1)||24
1437053|NCT02315261|3518148|P1|NOT COMPLETED|Overall Study||0
1437054|NCT02315261|3518148|P1|COMPLETED|Overall Study||364
1437055|NCT02315261|3518148|P1|STARTED|Overall Study||364
1437056|NCT02314936|3518159|P4|NOT COMPLETED|Overall Study||0
1437057|NCT02314936|3518160|P3|NOT COMPLETED|Overall Study||2
1437058|NCT02314936|3518161|P2|NOT COMPLETED|Overall Study||0
1437059|NCT02314936|3518162|P1|NOT COMPLETED|Overall Study||0
1437060|NCT02314936|3518159|P4|COMPLETED|Overall Study||48
1437061|NCT02314936|3518160|P3|COMPLETED|Overall Study||46
1437062|NCT02314936|3518161|P2|COMPLETED|Overall Study||48
1437063|NCT02314936|3518162|P1|COMPLETED|Overall Study||48
1437064|NCT02314936|3518159|P4|STARTED|Overall Study||48
1437065|NCT02314936|3518160|P3|STARTED|Overall Study||48
1437066|NCT02314936|3518161|P2|STARTED|Overall Study||48
1437067|NCT02314936|3518162|P1|STARTED|Overall Study||48
1437068|NCT02314689|3518348|P1|NOT COMPLETED|Overall Study||0
1437069|NCT02314689|3518348|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
1437070|NCT02314689|3518348|P1|STARTED|Overall Study||4
1437071|NCT02314637|3518354|P2|NOT COMPLETED|Overall Study||14
1437072|NCT02314637|3518355|P1|NOT COMPLETED|Overall Study||16
1437073|NCT02314637|3518354|P2|COMPLETED|Overall Study||75
1437074|NCT02314637|3518355|P1|COMPLETED|Overall Study||135
1437075|NCT02314637|3518354|P2|STARTED|Overall Study||89
1437076|NCT02314637|3518355|P1|STARTED|Overall Study||151
1437077|NCT02314546|3518368|P3|NOT COMPLETED|Overall Study||0
1437078|NCT02314546|3518369|P2|NOT COMPLETED|Overall Study||0
1437079|NCT02314546|3518370|P1|NOT COMPLETED|Overall Study||0
1437080|NCT02314546|3518368|P3|COMPLETED|Overall Study||5
1437081|NCT02314546|3518369|P2|COMPLETED|Overall Study||5
1437082|NCT02314546|3518370|P1|COMPLETED|Overall Study||5
1437083|NCT02314546|3518368|P3|STARTED|Overall Study||5
1437084|NCT02314546|3518369|P2|STARTED|Overall Study||5
1437085|NCT02314546|3518370|P1|STARTED|Overall Study||5
1437086|NCT02314520|3518398|P2|NOT COMPLETED|Overall Study||0
1437087|NCT02314520|3518399|P1|NOT COMPLETED|Overall Study||0
1437088|NCT02314520|3518398|P2|COMPLETED|Overall Study||80
1437089|NCT02314520|3518399|P1|COMPLETED|Overall Study||72
1437090|NCT02314520|3518398|P2|STARTED|Overall Study||80
1437091|NCT02314520|3518399|P1|STARTED|Overall Study||72
1437092|NCT02314260|3518411|P1|NOT COMPLETED|Overall Study||0
1437093|NCT02314260|3518411|P1|COMPLETED|Overall Study||80
1437094|NCT02314260|3518411|P1|STARTED|Overall Study||80
1437095|NCT02314247|3518420|P3|NOT COMPLETED|Overall Study||1
1437096|NCT02314247|3518421|P2|NOT COMPLETED|Overall Study||6
1437097|NCT02314247|3518422|P1|NOT COMPLETED|Overall Study||9
1437098|NCT02314247|3518420|P3|COMPLETED|Overall Study||0
1437099|NCT02314247|3518421|P2|COMPLETED|Overall Study||0
1437100|NCT02314247|3518422|P1|COMPLETED|Overall Study||0
1437101|NCT02314247|3518420|P3|STARTED|Overall Study||1
1437102|NCT02314247|3518421|P2|STARTED|Overall Study||6
1437103|NCT02314247|3518422|P1|STARTED|Overall Study||9
1437104|NCT02314117|3518446|P2|NOT COMPLETED|Overall Study||38
1437105|NCT02314117|3518447|P1|NOT COMPLETED|Overall Study||41
1437106|NCT02314117|3518446|P2|COMPLETED|Overall Study||281
1437107|NCT02314117|3518447|P1|COMPLETED|Overall Study||285
1437108|NCT02314117|3518446|P2|Alive But Off Treatment|Overall Study||50
1437109|NCT02314117|3518447|P1|Alive But Off Treatment|Overall Study||46
1437110|NCT02314117|3518446|P2|Death|Overall Study||231
1437111|NCT02314117|3518447|P1|Death|Overall Study||239
1437112|NCT02314117|3518446|P2|Received at Least One Dose of Study Drug|Overall Study||315
1437113|NCT02314117|3518447|P1|Received at Least One Dose of Study Drug|Overall Study||323
1437114|NCT02314117|3518446|P2|STARTED|Overall Study||319
1437115|NCT02314117|3518447|P1|STARTED|Overall Study||326
1437116|NCT02314104|3518478|P3|NOT COMPLETED|Overall Study||18
1437117|NCT02314104|3518479|P2|NOT COMPLETED|Overall Study||20
1437118|NCT02314104|3518480|P1|NOT COMPLETED|Overall Study||14
1437119|NCT02314104|3518478|P3|COMPLETED|Overall Study||53
1437120|NCT02314104|3518479|P2|COMPLETED|Overall Study||58
1437121|NCT02314104|3518480|P1|COMPLETED|Overall Study||57
1437122|NCT02314104|3518478|P3|STARTED|Overall Study||71
1437123|NCT02314104|3518479|P2|STARTED|Overall Study||78
1437124|NCT02314104|3518480|P1|STARTED|Overall Study||71
1437125|NCT02314052|3518500|P6|NOT COMPLETED|Cycles 6 -10.5||0
1437126|NCT02314052|3518501|P5|NOT COMPLETED|Cycles 6 -10.5||0
1437127|NCT02314052|3518502|P4|NOT COMPLETED|Cycles 6 -10.5||0
1437128|NCT02314052|3518503|P3|NOT COMPLETED|Cycles 6 -10.5||0
1437129|NCT02314052|3518504|P2|NOT COMPLETED|Cycles 6 -10.5||0
1437130|NCT02314052|3518505|P1|NOT COMPLETED|Cycles 6 -10.5||0
1437131|NCT02314052|3518500|P6|COMPLETED|Cycles 6 -10.5||0
1437132|NCT02314052|3518501|P5|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
1437133|NCT02314052|3518502|P4|COMPLETED|Cycles 6 -10.5||1
1437134|NCT02314052|3518503|P3|COMPLETED|Cycles 6 -10.5||0
1437135|NCT02314052|3518504|P2|COMPLETED|Cycles 6 -10.5||0
1437136|NCT02314052|3518505|P1|COMPLETED|Cycles 6 -10.5||0
1437137|NCT02314052|3518500|P6|STARTED|Cycles 6 -10.5||0
1437138|NCT02314052|3518501|P5|STARTED|Cycles 6 -10.5||2
1437139|NCT02314052|3518502|P4|STARTED|Cycles 6 -10.5||1
1437140|NCT02314052|3518503|P3|STARTED|Cycles 6 -10.5||0
1437141|NCT02314052|3518504|P2|STARTED|Cycles 6 -10.5||0
1437142|NCT02314052|3518505|P1|STARTED|Cycles 6 -10.5||0
1437143|NCT02314052|3518500|P6|NOT COMPLETED|Cycle Five||0
1437144|NCT02314052|3518501|P5|NOT COMPLETED|Cycle Five||0
1437145|NCT02314052|3518502|P4|NOT COMPLETED|Cycle Five||0
1437146|NCT02314052|3518503|P3|NOT COMPLETED|Cycle Five||1
1437147|NCT02314052|3518504|P2|NOT COMPLETED|Cycle Five||2
1437148|NCT02314052|3518505|P1|NOT COMPLETED|Cycle Five||0
1437149|NCT02314052|3518500|P6|COMPLETED|Cycle Five||0
1437150|NCT02314052|3518501|P5|COMPLETED|Cycle Five||2
1437151|NCT02314052|3518502|P4|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
1437152|NCT02314052|3518503|P3|COMPLETED|Cycle Five||0
1437153|NCT02314052|3518504|P2|COMPLETED|Cycle Five||0
1437154|NCT02314052|3518505|P1|COMPLETED|Cycle Five||0
1437155|NCT02314052|3518500|P6|STARTED|Cycle Five||0
1437156|NCT02314052|3518501|P5|STARTED|Cycle Five||2
1437157|NCT02314052|3518502|P4|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
1437158|NCT02314052|3518503|P3|STARTED|Cycle Five||1
1437159|NCT02314052|3518504|P2|STARTED|Cycle Five||2
1437160|NCT02314052|3518505|P1|STARTED|Cycle Five||0
1437161|NCT02314052|3518500|P6|NOT COMPLETED|Cycle Four||3
1437162|NCT02314052|3518501|P5|NOT COMPLETED|Cycle Four||0
1437163|NCT02314052|3518502|P4|NOT COMPLETED|Cycle Four||1
1437164|NCT02314052|3518503|P3|NOT COMPLETED|Cycle Four||1
1437165|NCT02314052|3518504|P2|NOT COMPLETED|Cycle Four||0
1437166|NCT02314052|3518505|P1|NOT COMPLETED|Cycle Four||3
1437167|NCT02314052|3518500|P6|COMPLETED|Cycle Four||0
1437168|NCT02314052|3518501|P5|COMPLETED|Cycle Four||2
1437169|NCT02314052|3518502|P4|COMPLETED|Cycle Four||0
1437170|NCT02314052|3518503|P3|COMPLETED|Cycle Four||1
1437171|NCT02314052|3518504|P2|COMPLETED|Cycle Four||2
1437172|NCT02314052|3518505|P1|COMPLETED|Cycle Four||0
1437173|NCT02314052|3518500|P6|STARTED|Cycle Four||3
1437174|NCT02314052|3518501|P5|STARTED|Cycle Four||2
1437175|NCT02314052|3518502|P4|STARTED|Cycle Four||1
1437176|NCT02314052|3518503|P3|STARTED|Cycle Four||2
1437177|NCT02314052|3518504|P2|STARTED|Cycle Four||2
1437178|NCT02314052|3518505|P1|STARTED|Cycle Four||3
1437179|NCT02314052|3518500|P6|NOT COMPLETED|Cycle Three||0
1437180|NCT02314052|3518501|P5|NOT COMPLETED|Cycle Three||0
1437181|NCT02314052|3518502|P4|NOT COMPLETED|Cycle Three||0
1437182|NCT02314052|3518503|P3|NOT COMPLETED|Cycle Three||0
1437183|NCT02314052|3518504|P2|NOT COMPLETED|Cycle Three||0
1437184|NCT02314052|3518505|P1|NOT COMPLETED|Cycle Three||0
1437185|NCT02314052|3518500|P6|COMPLETED|Cycle Three||3
1437186|NCT02314052|3518501|P5|COMPLETED|Cycle Three||2
1437187|NCT02314052|3518502|P4|COMPLETED|Cycle Three||1
1437188|NCT02314052|3518503|P3|COMPLETED|Cycle Three||2
1437189|NCT02314052|3518504|P2|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
1437190|NCT02314052|3518505|P1|COMPLETED|Cycle Three||3
1437191|NCT02314052|3518500|P6|STARTED|Cycle Three||3
1437192|NCT02314052|3518501|P5|STARTED|Cycle Three||2
1437193|NCT02314052|3518502|P4|STARTED|Cycle Three||1
1437194|NCT02314052|3518503|P3|STARTED|Cycle Three||2
1437195|NCT02314052|3518504|P2|STARTED|Cycle Three||2
1437196|NCT02314052|3518505|P1|STARTED|Cycle Three||3
1437197|NCT02314052|3518500|P6|NOT COMPLETED|Cycle Two||0
1437198|NCT02314052|3518501|P5|NOT COMPLETED|Cycle Two||4
1437199|NCT02314052|3518502|P4|NOT COMPLETED|Cycle Two||1
1437200|NCT02314052|3518503|P3|NOT COMPLETED|Cycle Two||1
1437201|NCT02314052|3518504|P2|NOT COMPLETED|Cycle Two||1
1437202|NCT02314052|3518505|P1|NOT COMPLETED|Cycle Two||0
1437203|NCT02314052|3518500|P6|COMPLETED|Cycle Two||3
1437204|NCT02314052|3518501|P5|COMPLETED|Cycle Two||2
1437205|NCT02314052|3518502|P4|COMPLETED|Cycle Two||1
1437206|NCT02314052|3518503|P3|COMPLETED|Cycle Two||2
1437207|NCT02314052|3518504|P2|COMPLETED|Cycle Two||2
1437208|NCT02314052|3518505|P1|COMPLETED|Cycle Two||3
1437209|NCT02314052|3518500|P6|STARTED|Cycle Two||3
1437210|NCT02314052|3518501|P5|STARTED|Cycle Two||6
1437211|NCT02314052|3518502|P4|STARTED|Cycle Two||2
1437212|NCT02314052|3518503|P3|STARTED|Cycle Two||3
1437213|NCT02314052|3518504|P2|STARTED|Cycle Two||3
1437214|NCT02314052|3518505|P1|STARTED|Cycle Two||3
1437215|NCT02314052|3518500|P6|NOT COMPLETED|Cycle One||0
1437216|NCT02314052|3518501|P5|NOT COMPLETED|Cycle One||0
1437217|NCT02314052|3518502|P4|NOT COMPLETED|Cycle One||1
1437218|NCT02314052|3518503|P3|NOT COMPLETED|Cycle One||0
1437219|NCT02314052|3518504|P2|NOT COMPLETED|Cycle One||0
1437220|NCT02314052|3518505|P1|NOT COMPLETED|Cycle One||0
1437221|NCT02314052|3518500|P6|COMPLETED|Cycle One||3
1437222|NCT02314052|3518501|P5|COMPLETED|Cycle One||6
1437223|NCT02314052|3518502|P4|COMPLETED|Cycle One||2
1437224|NCT02314052|3518503|P3|COMPLETED|Cycle One||3
1437225|NCT02314052|3518504|P2|COMPLETED|Cycle One||3
1437226|NCT02314052|3518505|P1|COMPLETED|Cycle One||3
1437227|NCT02314052|3518500|P6|STARTED|Cycle One||3
1437228|NCT02314052|3518501|P5|STARTED|Cycle One||6
1437229|NCT02314052|3518502|P4|STARTED|Cycle One||3
1437230|NCT02314052|3518503|P3|STARTED|Cycle One||3
1437231|NCT02314052|3518504|P2|STARTED|Cycle One||3
1437232|NCT02314052|3518505|P1|STARTED|Cycle One||3
1437233|NCT02313766|3518576|P3|NOT COMPLETED|Overall Study||0
1437234|NCT02313766|3518577|P2|NOT COMPLETED|Overall Study||3
1437235|NCT02313766|3518578|P1|NOT COMPLETED|Overall Study||1
1437236|NCT02313766|3518576|P3|COMPLETED|Overall Study||50
1437237|NCT02313766|3518577|P2|COMPLETED|Overall Study||47
1437238|NCT02313766|3518578|P1|COMPLETED|Overall Study||49
1437239|NCT02313766|3518576|P3|STARTED|Overall Study||50
1437240|NCT02313766|3518577|P2|STARTED|Overall Study||50
1437241|NCT02313766|3518578|P1|STARTED|Overall Study||50
1437242|NCT02313675|3518596|P4|NOT COMPLETED|Overall Study||0
1437243|NCT02313675|3518597|P3|NOT COMPLETED|Overall Study||0
1437244|NCT02313675|3518598|P2|NOT COMPLETED|Overall Study||0
1437245|NCT02313675|3518599|P1|NOT COMPLETED|Overall Study||0
1437246|NCT02313675|3518596|P4|COMPLETED|Overall Study||11
1437247|NCT02313675|3518597|P3|COMPLETED|Overall Study||11
1437248|NCT02313675|3518598|P2|COMPLETED|Overall Study||11
1437249|NCT02313675|3518599|P1|COMPLETED|Overall Study||11
1437250|NCT02313675|3518596|P4|STARTED|Overall Study||11
1437251|NCT02313675|3518597|P3|STARTED|Overall Study||11
1437252|NCT02313675|3518598|P2|STARTED|Overall Study||11
1437253|NCT02313675|3518599|P1|STARTED|Overall Study||11
1437254|NCT02313558|3518615|P2|NOT COMPLETED|Overall Study||4
1437255|NCT02313558|3518616|P1|NOT COMPLETED|Overall Study||6
1437256|NCT02313558|3518615|P2|COMPLETED|Overall Study||46
1437257|NCT02313558|3518616|P1|COMPLETED|Overall Study||44
1437258|NCT02313558|3518615|P2|STARTED|Overall Study||50
1437259|NCT02313558|3518616|P1|STARTED|Overall Study||50
1437260|NCT02313233|3518630|P2|NOT COMPLETED|Overall Study||3
1437261|NCT02313233|3518631|P1|NOT COMPLETED|Overall Study||2
1437262|NCT02313233|3518630|P2|COMPLETED|Overall Study||18
1437263|NCT02313233|3518631|P1|COMPLETED|Overall Study||18
1437264|NCT02313233|3518630|P2|STARTED|Overall Study||21
1437265|NCT02313233|3518631|P1|STARTED|Overall Study||20
1437266|NCT02313155|3518653|P2|NOT COMPLETED|Overall Study||1
1437267|NCT02313155|3518654|P1|NOT COMPLETED|Overall Study||0
1437268|NCT02313155|3518653|P2|COMPLETED|Overall Study||54
1437269|NCT02313155|3518654|P1|COMPLETED|Overall Study||55
1437270|NCT02313155|3518653|P2|STARTED|Overall Study||55
1437271|NCT02313155|3518654|P1|STARTED|Overall Study||55
1437272|NCT02312882|3518702|P1|NOT COMPLETED|Overall Study||4
1437273|NCT02312882|3518702|P1|COMPLETED|Overall Study||36
1437274|NCT02312882|3518702|P1|STARTED|Overall Study||40
1437275|NCT02312739|3518708|P2|NOT COMPLETED|Overall Study||2
1437276|NCT02312739|3518709|P1|NOT COMPLETED|Overall Study||6
1437277|NCT02312739|3518708|P2|COMPLETED|Overall Study||34
1437278|NCT02312739|3518709|P1|COMPLETED|Overall Study||30
1437279|NCT02312739|3518708|P2|Withdrawn Prior to Procedure|Overall Study||2
1437280|NCT02312739|3518709|P1|Withdrawn Prior to Procedure|Overall Study||6
1437281|NCT02312739|3518708|P2|STARTED|Overall Study||36
1437282|NCT02312739|3518709|P1|STARTED|Overall Study||36
1437283|NCT02312726|3518723|P3|NOT COMPLETED|Overall Study||67
1437284|NCT02312726|3518724|P2|NOT COMPLETED|Overall Study||0
1437285|NCT02312726|3518725|P1|NOT COMPLETED|Overall Study||0
1437286|NCT02312726|3518723|P3|COMPLETED|Overall Study||0
1437287|NCT02312726|3518724|P2|COMPLETED|Overall Study||30
1437288|NCT02312726|3518725|P1|COMPLETED|Overall Study||38
1437289|NCT02312726|3518723|P3|STARTED|Overall Study||67
1437290|NCT02312726|3518724|P2|STARTED|Overall Study||30
1437291|NCT02312726|3518725|P1|STARTED|Overall Study||38
1437292|NCT02312713|3518740|P3|NOT COMPLETED|Overall Study||5
1437293|NCT02312713|3518741|P2|NOT COMPLETED|Overall Study||30
1437294|NCT02312713|3518742|P1|NOT COMPLETED|Overall Study||11
1437295|NCT02312713|3518740|P3|COMPLETED|Overall Study||63
1437296|NCT02312713|3518741|P2|COMPLETED|Overall Study||112
1437297|NCT02312713|3518742|P1|COMPLETED|Overall Study||129
1437298|NCT02312713|3518740|P3|STARTED|Overall Study||68
1437299|NCT02312713|3518741|P2|STARTED|Overall Study||142
1437300|NCT02312713|3518742|P1|STARTED|Overall Study||140
1437301|NCT02312154|3518786|P1|NOT COMPLETED|Overall Study||1
1437302|NCT02312154|3518786|P1|COMPLETED|Overall Study||24
1437303|NCT02312154|3518786|P1|STARTED|Overall Study||25
1437304|NCT02311972|3518803|P2|NOT COMPLETED|Overall Study||0
1437305|NCT02311972|3518804|P1|NOT COMPLETED|Overall Study||0
1437306|NCT02311972|3518803|P2|COMPLETED|Overall Study||8
1437307|NCT02311972|3518804|P1|COMPLETED|Overall Study||12
1437308|NCT02311972|3518803|P2|STARTED|Overall Study||8
1437309|NCT02311972|3518804|P1|STARTED|Overall Study||12
1437310|NCT02311907|3518823|P2|NOT COMPLETED|Overall Study||0
1437311|NCT02311907|3518824|P1|NOT COMPLETED|Overall Study||0
1437312|NCT02311907|3518823|P2|COMPLETED|Overall Study||91
1437313|NCT02311907|3518824|P1|COMPLETED|Overall Study||94
1437314|NCT02311907|3518823|P2|STARTED|Overall Study||91
1437315|NCT02311907|3518824|P1|STARTED|Overall Study||94
1437316|NCT02311894|3518846|P1|NOT COMPLETED|Overall Study||4
1437317|NCT02311894|3518846|P1|COMPLETED|Overall Study||78
1437318|NCT02311894|3518846|P1|STARTED|Overall Study||82
1437319|NCT02311881|3518858|P3|NOT COMPLETED|Overall Study||41
1437320|NCT02311881|3518859|P2|NOT COMPLETED|Overall Study||43
1437321|NCT02311881|3518860|P1|NOT COMPLETED|Overall Study||35
1437322|NCT02311881|3518858|P3|COMPLETED|Overall Study||196
1437323|NCT02311881|3518859|P2|COMPLETED|Overall Study||193
1437324|NCT02311881|3518860|P1|COMPLETED|Overall Study||200
1437325|NCT02311881|3518858|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
1437326|NCT02311881|3518859|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
1437414|NCT02310750|3518964|P2|NOT COMPLETED|HP Washout 2||0
1437327|NCT02311881|3518860|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
1437328|NCT02311881|3518858|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
1437329|NCT02311881|3518859|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
1437330|NCT02311881|3518860|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
1437331|NCT02311309|3518898|P3|NOT COMPLETED|Overall Study||0
1437332|NCT02311309|3518899|P2|NOT COMPLETED|Overall Study||0
1437333|NCT02311309|3518900|P1|NOT COMPLETED|Overall Study||0
1437334|NCT02311309|3518898|P3|COMPLETED|Overall Study||863
1437335|NCT02311309|3518899|P2|COMPLETED|Overall Study||35
1437336|NCT02311309|3518900|P1|COMPLETED|Overall Study||541
1437337|NCT02311309|3518898|P3|STARTED|Overall Study||863
1437338|NCT02311309|3518899|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
1437339|NCT02311309|3518900|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
1437340|NCT02311153|3518913|P2|NOT COMPLETED|Overall Study||7
1437341|NCT02311153|3518914|P1|NOT COMPLETED|Overall Study||5
1437342|NCT02311153|3518913|P2|COMPLETED|Overall Study||42
1437343|NCT02311153|3518914|P1|COMPLETED|Overall Study||48
1437344|NCT02311153|3518913|P2|STARTED|Overall Study||49
1437345|NCT02311153|3518914|P1|STARTED|Overall Study||53
1437346|NCT02310789|3518930|P1|NOT COMPLETED|Overall Study||1
1437347|NCT02310789|3518930|P1|COMPLETED|Overall Study||7
1437348|NCT02310789|3518930|P1|STARTED|Overall Study||8
1437349|NCT02310776|3518935|P1|NOT COMPLETED|Overall Study||0
1437350|NCT02310776|3518935|P1|COMPLETED|Overall Study||501
1437351|NCT02310776|3518935|P1|STARTED|Overall Study||501
1437352|NCT02310750|3518950|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437353|NCT02310750|3518951|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437354|NCT02310750|3518952|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437355|NCT02310750|3518953|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437356|NCT02310750|3518954|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437357|NCT02310750|3518955|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437358|NCT02310750|3518956|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437359|NCT02310750|3518957|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437360|NCT02310750|3518958|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437361|NCT02310750|3518959|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437362|NCT02310750|3518960|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437363|NCT02310750|3518961|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
1437364|NCT02310750|3518962|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437365|NCT02310750|3518963|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437366|NCT02310750|3518964|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437367|NCT02310750|3518965|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
1437368|NCT02310750|3518950|P16|COMPLETED|HP MAD and Fasted/Fed||2
1437369|NCT02310750|3518951|P15|COMPLETED|HP MAD and Fasted/Fed||2
1437370|NCT02310750|3518952|P14|COMPLETED|HP MAD and Fasted/Fed||2
1437371|NCT02310750|3518953|P13|COMPLETED|HP MAD and Fasted/Fed||2
1437372|NCT02310750|3518954|P12|COMPLETED|HP MAD and Fasted/Fed||2
1437373|NCT02310750|3518955|P11|COMPLETED|HP MAD and Fasted/Fed||2
1437374|NCT02310750|3518956|P10|COMPLETED|HP MAD and Fasted/Fed||0
1437375|NCT02310750|3518957|P9|COMPLETED|HP MAD and Fasted/Fed||0
1437376|NCT02310750|3518958|P8|COMPLETED|HP MAD and Fasted/Fed||0
1437377|NCT02310750|3518959|P7|COMPLETED|HP MAD and Fasted/Fed||2
1437378|NCT02310750|3518960|P6|COMPLETED|HP MAD and Fasted/Fed||0
1437379|NCT02310750|3518961|P5|COMPLETED|HP MAD and Fasted/Fed||4
1437380|NCT02310750|3518962|P4|COMPLETED|HP MAD and Fasted/Fed||0
1437381|NCT02310750|3518963|P3|COMPLETED|HP MAD and Fasted/Fed||0
1437382|NCT02310750|3518964|P2|COMPLETED|HP MAD and Fasted/Fed||0
1437383|NCT02310750|3518965|P1|COMPLETED|HP MAD and Fasted/Fed||0
1437384|NCT02310750|3518950|P16|STARTED|HP MAD and Fasted/Fed||2
1437385|NCT02310750|3518951|P15|STARTED|HP MAD and Fasted/Fed||2
1437386|NCT02310750|3518952|P14|STARTED|HP MAD and Fasted/Fed||2
1437387|NCT02310750|3518953|P13|STARTED|HP MAD and Fasted/Fed||2
1437388|NCT02310750|3518954|P12|STARTED|HP MAD and Fasted/Fed||2
1437389|NCT02310750|3518955|P11|STARTED|HP MAD and Fasted/Fed||2
1437390|NCT02310750|3518956|P10|STARTED|HP MAD and Fasted/Fed||0
1437391|NCT02310750|3518957|P9|STARTED|HP MAD and Fasted/Fed||0
1437392|NCT02310750|3518958|P8|STARTED|HP MAD and Fasted/Fed||0
1437393|NCT02310750|3518959|P7|STARTED|HP MAD and Fasted/Fed||2
1437394|NCT02310750|3518960|P6|STARTED|HP MAD and Fasted/Fed||0
1437395|NCT02310750|3518961|P5|STARTED|HP MAD and Fasted/Fed||5
1437396|NCT02310750|3518962|P4|STARTED|HP MAD and Fasted/Fed||0
1437397|NCT02310750|3518963|P3|STARTED|HP MAD and Fasted/Fed||0
1437398|NCT02310750|3518964|P2|STARTED|HP MAD and Fasted/Fed||0
1437399|NCT02310750|3518965|P1|STARTED|HP MAD and Fasted/Fed||0
1437400|NCT02310750|3518950|P16|NOT COMPLETED|HP Washout 2||0
1437401|NCT02310750|3518951|P15|NOT COMPLETED|HP Washout 2||0
1437402|NCT02310750|3518952|P14|NOT COMPLETED|HP Washout 2||0
1437403|NCT02310750|3518953|P13|NOT COMPLETED|HP Washout 2||0
1437404|NCT02310750|3518954|P12|NOT COMPLETED|HP Washout 2||0
1437405|NCT02310750|3518955|P11|NOT COMPLETED|HP Washout 2||0
1437406|NCT02310750|3518956|P10|NOT COMPLETED|HP Washout 2||0
1437407|NCT02310750|3518957|P9|NOT COMPLETED|HP Washout 2||0
1437408|NCT02310750|3518958|P8|NOT COMPLETED|HP Washout 2||0
1437409|NCT02310750|3518959|P7|NOT COMPLETED|HP Washout 2||7
1437410|NCT02310750|3518960|P6|NOT COMPLETED|HP Washout 2||0
1437411|NCT02310750|3518961|P5|NOT COMPLETED|HP Washout 2||1
1437412|NCT02310750|3518962|P4|NOT COMPLETED|HP Washout 2||0
1437413|NCT02310750|3518963|P3|NOT COMPLETED|HP Washout 2||0
1437415|NCT02310750|3518965|P1|NOT COMPLETED|HP Washout 2||0
1437416|NCT02310750|3518950|P16|COMPLETED|HP Washout 2||2
1437417|NCT02310750|3518951|P15|COMPLETED|HP Washout 2||2
1437418|NCT02310750|3518952|P14|COMPLETED|HP Washout 2||2
1437419|NCT02310750|3518953|P13|COMPLETED|HP Washout 2||2
1437420|NCT02310750|3518954|P12|COMPLETED|HP Washout 2||2
1437421|NCT02310750|3518955|P11|COMPLETED|HP Washout 2||2
1437422|NCT02310750|3518956|P10|COMPLETED|HP Washout 2||0
1437423|NCT02310750|3518957|P9|COMPLETED|HP Washout 2||0
1437424|NCT02310750|3518958|P8|COMPLETED|HP Washout 2||0
1437425|NCT02310750|3518959|P7|COMPLETED|HP Washout 2||2
1437426|NCT02310750|3518960|P6|COMPLETED|HP Washout 2||0
1437427|NCT02310750|3518961|P5|COMPLETED|HP Washout 2||5
1437428|NCT02310750|3518962|P4|COMPLETED|HP Washout 2||0
1437429|NCT02310750|3518963|P3|COMPLETED|HP Washout 2||0
1437430|NCT02310750|3518964|P2|COMPLETED|HP Washout 2||0
1437431|NCT02310750|3518965|P1|COMPLETED|HP Washout 2||0
1437432|NCT02310750|3518950|P16|STARTED|HP Washout 2||2
1437433|NCT02310750|3518951|P15|STARTED|HP Washout 2||2
1437434|NCT02310750|3518952|P14|STARTED|HP Washout 2||2
1437435|NCT02310750|3518953|P13|STARTED|HP Washout 2||2
1437436|NCT02310750|3518954|P12|STARTED|HP Washout 2||2
1437437|NCT02310750|3518955|P11|STARTED|HP Washout 2||2
1437438|NCT02310750|3518956|P10|STARTED|HP Washout 2||0
1437439|NCT02310750|3518957|P9|STARTED|HP Washout 2||0
1437440|NCT02310750|3518958|P8|STARTED|HP Washout 2||0
1437441|NCT02310750|3518959|P7|STARTED|HP Washout 2||9
1437442|NCT02310750|3518960|P6|STARTED|HP Washout 2||0
1437443|NCT02310750|3518961|P5|STARTED|HP Washout 2||6
1437444|NCT02310750|3518962|P4|STARTED|HP Washout 2||0
1437445|NCT02310750|3518963|P3|STARTED|HP Washout 2||0
1437446|NCT02310750|3518964|P2|STARTED|HP Washout 2||0
1437447|NCT02310750|3518965|P1|STARTED|HP Washout 2||0
1437448|NCT02310750|3518950|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437449|NCT02310750|3518951|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437450|NCT02310750|3518952|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437451|NCT02310750|3518953|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437452|NCT02310750|3518954|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437453|NCT02310750|3518955|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437454|NCT02310750|3518956|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
1437455|NCT02310750|3518957|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
1437456|NCT02310750|3518958|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437457|NCT02310750|3518959|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437458|NCT02310750|3518960|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437459|NCT02310750|3518961|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437460|NCT02310750|3518962|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
1437461|NCT02310750|3518963|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437462|NCT02310750|3518964|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437463|NCT02310750|3518965|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437464|NCT02310750|3518950|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437465|NCT02310750|3518951|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437466|NCT02310750|3518952|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437467|NCT02310750|3518953|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437468|NCT02310750|3518954|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437469|NCT02310750|3518955|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437470|NCT02310750|3518956|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
1437471|NCT02310750|3518957|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
1437472|NCT02310750|3518958|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
1437473|NCT02310750|3518959|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
1437474|NCT02310750|3518960|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
1437475|NCT02310750|3518961|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
1437476|NCT02310750|3518962|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
1437477|NCT02310750|3518963|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
1437478|NCT02310750|3518964|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437479|NCT02310750|3518965|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437480|NCT02310750|3518950|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437481|NCT02310750|3518951|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437482|NCT02310750|3518952|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437483|NCT02310750|3518953|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437484|NCT02310750|3518954|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437485|NCT02310750|3518955|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
1437486|NCT02310750|3518956|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
1437487|NCT02310750|3518957|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
1437488|NCT02310750|3518958|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
1437489|NCT02310750|3518959|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
1437490|NCT02310750|3518960|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
1437491|NCT02310750|3518961|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
1437492|NCT02310750|3518962|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
1437493|NCT02310750|3518963|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
1437494|NCT02310750|3518964|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437495|NCT02310750|3518965|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
1437496|NCT02310750|3518950|P16|NOT COMPLETED|HP Washout 1||0
1437497|NCT02310750|3518951|P15|NOT COMPLETED|HP Washout 1||0
1437498|NCT02310750|3518952|P14|NOT COMPLETED|HP Washout 1||0
1437499|NCT02310750|3518953|P13|NOT COMPLETED|HP Washout 1||0
1437500|NCT02310750|3518954|P12|NOT COMPLETED|HP Washout 1||0
1437501|NCT02310750|3518955|P11|NOT COMPLETED|HP Washout 1||0
1437502|NCT02310750|3518956|P10|NOT COMPLETED|HP Washout 1||0
1437503|NCT02310750|3518957|P9|NOT COMPLETED|HP Washout 1||0
1437504|NCT02310750|3518958|P8|NOT COMPLETED|HP Washout 1||0
1437505|NCT02310750|3518959|P7|NOT COMPLETED|HP Washout 1||3
1437506|NCT02310750|3518960|P6|NOT COMPLETED|HP Washout 1||2
1437507|NCT02310750|3518961|P5|NOT COMPLETED|HP Washout 1||2
1437508|NCT02310750|3518962|P4|NOT COMPLETED|HP Washout 1||1
1437509|NCT02310750|3518963|P3|NOT COMPLETED|HP Washout 1||1
1437510|NCT02310750|3518964|P2|NOT COMPLETED|HP Washout 1||0
1437511|NCT02310750|3518965|P1|NOT COMPLETED|HP Washout 1||0
1437512|NCT02310750|3518950|P16|COMPLETED|HP Washout 1||2
1437513|NCT02310750|3518951|P15|COMPLETED|HP Washout 1||2
1437514|NCT02310750|3518952|P14|COMPLETED|HP Washout 1||2
1437515|NCT02310750|3518953|P13|COMPLETED|HP Washout 1||2
1437516|NCT02310750|3518954|P12|COMPLETED|HP Washout 1||2
1437517|NCT02310750|3518955|P11|COMPLETED|HP Washout 1||2
1437518|NCT02310750|3518956|P10|COMPLETED|HP Washout 1||0
1437519|NCT02310750|3518957|P9|COMPLETED|HP Washout 1||0
1437520|NCT02310750|3518958|P8|COMPLETED|HP Washout 1||0
1437521|NCT02310750|3518959|P7|COMPLETED|HP Washout 1||9
1437522|NCT02310750|3518960|P6|COMPLETED|HP Washout 1||6
1437523|NCT02310750|3518961|P5|COMPLETED|HP Washout 1||6
1437524|NCT02310750|3518962|P4|COMPLETED|HP Washout 1||4
1437525|NCT02310750|3518963|P3|COMPLETED|HP Washout 1||5
1437526|NCT02310750|3518964|P2|COMPLETED|HP Washout 1||0
1437527|NCT02310750|3518965|P1|COMPLETED|HP Washout 1||0
1437528|NCT02310750|3518950|P16|STARTED|HP Washout 1||2
1437529|NCT02310750|3518951|P15|STARTED|HP Washout 1||2
1437530|NCT02310750|3518952|P14|STARTED|HP Washout 1||2
1437531|NCT02310750|3518953|P13|STARTED|HP Washout 1||2
1437532|NCT02310750|3518954|P12|STARTED|HP Washout 1||2
1437533|NCT02310750|3518955|P11|STARTED|HP Washout 1||2
1437534|NCT02310750|3518956|P10|STARTED|HP Washout 1||0
1437535|NCT02310750|3518957|P9|STARTED|HP Washout 1||0
1437536|NCT02310750|3518958|P8|STARTED|HP Washout 1||0
1437537|NCT02310750|3518959|P7|STARTED|HP Washout 1||12
1437538|NCT02310750|3518960|P6|STARTED|HP Washout 1||8
1437539|NCT02310750|3518961|P5|STARTED|HP Washout 1||8
1437540|NCT02310750|3518962|P4|STARTED|HP Washout 1||5
1437541|NCT02310750|3518963|P3|STARTED|HP Washout 1||6
1437542|NCT02310750|3518964|P2|STARTED|HP Washout 1||0
1437543|NCT02310750|3518965|P1|STARTED|HP Washout 1||0
1437544|NCT02310750|3518950|P16|NOT COMPLETED|HP Period 1||0
1437545|NCT02310750|3518951|P15|NOT COMPLETED|HP Period 1||0
1437546|NCT02310750|3518952|P14|NOT COMPLETED|HP Period 1||0
1437547|NCT02310750|3518953|P13|NOT COMPLETED|HP Period 1||0
1437548|NCT02310750|3518954|P12|NOT COMPLETED|HP Period 1||0
1437549|NCT02310750|3518955|P11|NOT COMPLETED|HP Period 1||0
1437550|NCT02310750|3518956|P10|NOT COMPLETED|HP Period 1||0
1437551|NCT02310750|3518957|P9|NOT COMPLETED|HP Period 1||0
1437552|NCT02310750|3518958|P8|NOT COMPLETED|HP Period 1||0
1437553|NCT02310750|3518959|P7|NOT COMPLETED|HP Period 1||1
1437554|NCT02310750|3518960|P6|NOT COMPLETED|HP Period 1||0
1437555|NCT02310750|3518961|P5|NOT COMPLETED|HP Period 1||0
1437556|NCT02310750|3518962|P4|NOT COMPLETED|HP Period 1||1
1437557|NCT02310750|3518963|P3|NOT COMPLETED|HP Period 1||0
1437558|NCT02310750|3518964|P2|NOT COMPLETED|HP Period 1||0
1437559|NCT02310750|3518965|P1|NOT COMPLETED|HP Period 1||1
1437560|NCT02310750|3518950|P16|COMPLETED|HP Period 1||2
1437561|NCT02310750|3518951|P15|COMPLETED|HP Period 1||2
1437562|NCT02310750|3518952|P14|COMPLETED|HP Period 1||2
1437563|NCT02310750|3518953|P13|COMPLETED|HP Period 1||2
1437564|NCT02310750|3518954|P12|COMPLETED|HP Period 1||2
1437565|NCT02310750|3518955|P11|COMPLETED|HP Period 1||2
1437566|NCT02310750|3518956|P10|COMPLETED|HP Period 1||0
1437567|NCT02310750|3518957|P9|COMPLETED|HP Period 1||0
1437568|NCT02310750|3518958|P8|COMPLETED|HP Period 1||0
1437569|NCT02310750|3518959|P7|COMPLETED|HP Period 1||12
1437570|NCT02310750|3518960|P6|COMPLETED|HP Period 1||8
1437571|NCT02310750|3518961|P5|COMPLETED|HP Period 1||8
1437572|NCT02310750|3518962|P4|COMPLETED|HP Period 1||5
1437573|NCT02310750|3518963|P3|COMPLETED|HP Period 1||6
1437574|NCT02310750|3518964|P2|COMPLETED|HP Period 1||6
1437575|NCT02310750|3518965|P1|COMPLETED|HP Period 1||6
1437576|NCT02310750|3518950|P16|STARTED|HP Period 1||2
1437577|NCT02310750|3518951|P15|STARTED|HP Period 1||2
1437578|NCT02310750|3518952|P14|STARTED|HP Period 1||2
1437579|NCT02310750|3518953|P13|STARTED|HP Period 1||2
1437580|NCT02310750|3518954|P12|STARTED|HP Period 1||2
1437581|NCT02310750|3518955|P11|STARTED|HP Period 1||2
1437582|NCT02310750|3518956|P10|STARTED|HP Period 1||0
1437583|NCT02310750|3518957|P9|STARTED|HP Period 1||0
1437584|NCT02310750|3518958|P8|STARTED|HP Period 1||0
1437585|NCT02310750|3518959|P7|STARTED|HP Period 1||13
1437586|NCT02310750|3518960|P6|STARTED|HP Period 1||8
1437587|NCT02310750|3518961|P5|STARTED|HP Period 1||8
1437588|NCT02310750|3518962|P4|STARTED|HP Period 1||6
1437589|NCT02310750|3518963|P3|STARTED|HP Period 1||6
1437590|NCT02310750|3518964|P2|STARTED|HP Period 1||6
1437591|NCT02310750|3518965|P1|STARTED|HP Period 1||7
1437592|NCT02310646|3519406|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
1437593|NCT02310646|3519407|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
1437594|NCT02310646|3519406|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
1437686|NCT02309294|3519611|P1|STARTED|Overall Study||43
1437595|NCT02310646|3519407|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
1437596|NCT02310646|3519406|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
1437597|NCT02310646|3519407|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
1437598|NCT02310646|3519406|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
1437599|NCT02310646|3519407|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
1437600|NCT02310646|3519406|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
1437601|NCT02310646|3519407|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
1437602|NCT02310646|3519406|P2|STARTED|First Intervention (Day 1 - Day 7)||104
1437603|NCT02310646|3519407|P1|STARTED|First Intervention (Day 1 - Day 7)||109
1437604|NCT02310581|3519435|P4|NOT COMPLETED|Overall Study||1
1437605|NCT02310581|3519436|P3|NOT COMPLETED|Overall Study||1
1437606|NCT02310581|3519437|P2|NOT COMPLETED|Overall Study||2
1437607|NCT02310581|3519438|P1|NOT COMPLETED|Overall Study||3
1437608|NCT02310581|3519435|P4|COMPLETED|Overall Study||9
1437609|NCT02310581|3519436|P3|COMPLETED|Overall Study||9
1437610|NCT02310581|3519437|P2|COMPLETED|Overall Study||9
1437611|NCT02310581|3519438|P1|COMPLETED|Overall Study||6
1437612|NCT02310581|3519435|P4|STARTED|Overall Study||10
1437613|NCT02310581|3519436|P3|STARTED|Overall Study||10
1437614|NCT02310581|3519437|P2|STARTED|Overall Study||11
1437615|NCT02310581|3519438|P1|STARTED|Overall Study||9
1437616|NCT02310568|3519477|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
1437617|NCT02310568|3519478|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
1437618|NCT02310568|3519479|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
1437619|NCT02310568|3519480|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
1437620|NCT02310568|3519481|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
1437621|NCT02310568|3519477|P5|COMPLETED|Stage 2 (4 Weeks)||19
1437622|NCT02310568|3519478|P4|COMPLETED|Stage 2 (4 Weeks)||17
1437623|NCT02310568|3519479|P3|COMPLETED|Stage 2 (4 Weeks)||13
1437624|NCT02310568|3519480|P2|COMPLETED|Stage 2 (4 Weeks)||12
1437625|NCT02310568|3519481|P1|COMPLETED|Stage 2 (4 Weeks)||11
1437626|NCT02310568|3519477|P5|STARTED|Stage 2 (4 Weeks)||20
1437627|NCT02310568|3519478|P4|STARTED|Stage 2 (4 Weeks)||22
1437628|NCT02310568|3519479|P3|STARTED|Stage 2 (4 Weeks)||14
1437629|NCT02310568|3519480|P2|STARTED|Stage 2 (4 Weeks)||13
1437630|NCT02310568|3519481|P1|STARTED|Stage 2 (4 Weeks)||12
1437631|NCT02310568|3519477|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
1437632|NCT02310568|3519478|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
1437633|NCT02310568|3519479|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
1437634|NCT02310568|3519480|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
1437635|NCT02310568|3519481|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
1437636|NCT02310568|3519477|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
1437637|NCT02310568|3519478|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
1437638|NCT02310568|3519479|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
1437639|NCT02310568|3519480|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
1437640|NCT02310568|3519481|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
1437641|NCT02310568|3519477|P5|STARTED|Stage 1 ( 4 Weeks)||21
1437642|NCT02310568|3519478|P4|STARTED|Stage 1 ( 4 Weeks)||24
1437643|NCT02310568|3519479|P3|STARTED|Stage 1 ( 4 Weeks)||15
1437644|NCT02310568|3519480|P2|STARTED|Stage 1 ( 4 Weeks)||15
1437645|NCT02310568|3519481|P1|STARTED|Stage 1 ( 4 Weeks)||15
1437646|NCT02310126|3519561|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
1437647|NCT02310126|3519562|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
1437648|NCT02310126|3519561|P2|COMPLETED|Period 2 (15 Minutes)||95
1437649|NCT02310126|3519562|P1|COMPLETED|Period 2 (15 Minutes)||94
1437650|NCT02310126|3519561|P2|Myopes|Period 2 (15 Minutes)||63
1437651|NCT02310126|3519562|P1|Myopes|Period 2 (15 Minutes)||56
1437652|NCT02310126|3519561|P2|Hyperopes|Period 2 (15 Minutes)||32
1437653|NCT02310126|3519562|P1|Hyperopes|Period 2 (15 Minutes)||38
1437654|NCT02310126|3519561|P2|STARTED|Period 2 (15 Minutes)||95
1437655|NCT02310126|3519562|P1|STARTED|Period 2 (15 Minutes)||94
1437656|NCT02310126|3519561|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
1437657|NCT02310126|3519562|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
1437658|NCT02310126|3519561|P2|COMPLETED|Period 1 (15 Minutes)||95
1437659|NCT02310126|3519562|P1|COMPLETED|Period 1 (15 Minutes)||94
1437660|NCT02310126|3519561|P2|Myopes|Period 1 (15 Minutes)||64
1437661|NCT02310126|3519562|P1|Myopes|Period 1 (15 Minutes)||56
1437662|NCT02310126|3519561|P2|Hyperopes|Period 1 (15 Minutes)||33
1437663|NCT02310126|3519562|P1|Hyperopes|Period 1 (15 Minutes)||38
1437664|NCT02310126|3519561|P2|STARTED|Period 1 (15 Minutes)||97
1437665|NCT02310126|3519562|P1|STARTED|Period 1 (15 Minutes)||94
1437666|NCT02309723|3519571|P3|NOT COMPLETED|Overall Study||24
1437667|NCT02309723|3519572|P2|NOT COMPLETED|Overall Study||23
1437668|NCT02309723|3519573|P1|NOT COMPLETED|Overall Study||24
1437669|NCT02309723|3519571|P3|COMPLETED|Overall Study||105
1437670|NCT02309723|3519572|P2|COMPLETED|Overall Study||105
1437671|NCT02309723|3519573|P1|COMPLETED|Overall Study||105
1437672|NCT02309723|3519571|P3|STARTED|Overall Study||129
1437673|NCT02309723|3519572|P2|STARTED|Overall Study||128
1437674|NCT02309723|3519573|P1|STARTED|Overall Study||129
1437675|NCT02309411|3519590|P3|NOT COMPLETED|Overall Study||0
1437676|NCT02309411|3519591|P2|NOT COMPLETED|Overall Study||1
1437677|NCT02309411|3519592|P1|NOT COMPLETED|Overall Study||2
1437678|NCT02309411|3519590|P3|COMPLETED|Overall Study||6
1437679|NCT02309411|3519591|P2|COMPLETED|Overall Study||14
1437680|NCT02309411|3519592|P1|COMPLETED|Overall Study||23
1437681|NCT02309411|3519590|P3|STARTED|Overall Study||6
1437682|NCT02309411|3519591|P2|STARTED|Overall Study||15
1437683|NCT02309411|3519592|P1|STARTED|Overall Study||25
1437684|NCT02309294|3519611|P1|NOT COMPLETED|Overall Study||2
1437685|NCT02309294|3519611|P1|COMPLETED|Overall Study||41
1437687|NCT02309112|3519618|P3|NOT COMPLETED|Overall Study||1
1437688|NCT02309112|3519619|P2|NOT COMPLETED|Overall Study||1
1437689|NCT02309112|3519620|P1|NOT COMPLETED|Overall Study||1
1437690|NCT02309112|3519618|P3|COMPLETED|Overall Study||4
1437691|NCT02309112|3519619|P2|COMPLETED|Overall Study||4
1437692|NCT02309112|3519620|P1|COMPLETED|Overall Study||4
1437693|NCT02309112|3519618|P3|Completed Yoga Intervention|Overall Study||4
1437694|NCT02309112|3519619|P2|Completed Yoga Intervention|Overall Study||5
1437695|NCT02309112|3519620|P1|Completed Yoga Intervention|Overall Study||4
1437696|NCT02309112|3519618|P3|STARTED|Overall Study||5
1437697|NCT02309112|3519619|P2|STARTED|Overall Study||5
1437698|NCT02309112|3519620|P1|STARTED|Overall Study||5
1437699|NCT02309099|3519643|P2|NOT COMPLETED|Overall Study||0
1437700|NCT02309099|3519644|P1|NOT COMPLETED|Overall Study||2
1437701|NCT02309099|3519643|P2|COMPLETED|Overall Study||3
1437702|NCT02309099|3519644|P1|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
1437703|NCT02309099|3519643|P2|Cochlear Implant Use/Follow-Up|Overall Study||3
1437704|NCT02309099|3519644|P1|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
1437705|NCT02309099|3519643|P2|Initial Activation|Overall Study||3
1437706|NCT02309099|3519644|P1|Initial Activation|Overall Study||7
1437707|NCT02309099|3519643|P2|Cochlear Implantation|Overall Study||3
1437708|NCT02309099|3519644|P1|Cochlear Implantation|Overall Study||7
1437709|NCT02309099|3519643|P2|STARTED|Overall Study||3
1437710|NCT02309099|3519644|P1|STARTED|Overall Study||7
1437711|NCT02308787|3519690|P1|NOT COMPLETED|Overall Study||0
1437712|NCT02308787|3519690|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
1437713|NCT02308787|3519690|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
1437714|NCT02308748|3519705|P10|NOT COMPLETED|Period 5||0
1437715|NCT02308748|3519706|P9|NOT COMPLETED|Period 5||1
1437716|NCT02308748|3519707|P8|NOT COMPLETED|Period 5||0
1437717|NCT02308748|3519708|P7|NOT COMPLETED|Period 5||0
1437718|NCT02308748|3519709|P6|NOT COMPLETED|Period 5||0
1437719|NCT02308748|3519710|P5|NOT COMPLETED|Period 5||0
1437720|NCT02308748|3519711|P4|NOT COMPLETED|Period 5||0
1437721|NCT02308748|3519712|P3|NOT COMPLETED|Period 5||0
1437722|NCT02308748|3519713|P2|NOT COMPLETED|Period 5||0
1437723|NCT02308748|3519714|P1|NOT COMPLETED|Period 5||1
1437724|NCT02308748|3519705|P10|COMPLETED|Period 5||2
1437725|NCT02308748|3519706|P9|COMPLETED|Period 5||1
1437726|NCT02308748|3519707|P8|COMPLETED|Period 5||1
1437727|NCT02308748|3519708|P7|COMPLETED|Period 5||2
1437728|NCT02308748|3519709|P6|COMPLETED|Period 5||3
1437729|NCT02308748|3519710|P5|COMPLETED|Period 5||2
1437730|NCT02308748|3519711|P4|COMPLETED|Period 5||2
1437731|NCT02308748|3519712|P3|COMPLETED|Period 5||1
1437732|NCT02308748|3519713|P2|COMPLETED|Period 5||2
1437733|NCT02308748|3519714|P1|COMPLETED|Period 5||1
1437734|NCT02308748|3519705|P10|STARTED|Period 5||2
1437735|NCT02308748|3519706|P9|STARTED|Period 5||2
1437736|NCT02308748|3519707|P8|STARTED|Period 5||1
1437737|NCT02308748|3519708|P7|STARTED|Period 5||2
1437738|NCT02308748|3519709|P6|STARTED|Period 5||3
1437739|NCT02308748|3519710|P5|STARTED|Period 5||2
1437740|NCT02308748|3519711|P4|STARTED|Period 5||2
1437741|NCT02308748|3519712|P3|STARTED|Period 5||1
1437742|NCT02308748|3519713|P2|STARTED|Period 5||2
1437743|NCT02308748|3519714|P1|STARTED|Period 5||2
1437744|NCT02308748|3519705|P10|NOT COMPLETED|Period 4||0
1437745|NCT02308748|3519706|P9|NOT COMPLETED|Period 4||0
1437746|NCT02308748|3519707|P8|NOT COMPLETED|Period 4||0
1437747|NCT02308748|3519708|P7|NOT COMPLETED|Period 4||0
1437748|NCT02308748|3519709|P6|NOT COMPLETED|Period 4||0
1437749|NCT02308748|3519710|P5|NOT COMPLETED|Period 4||0
1437750|NCT02308748|3519711|P4|NOT COMPLETED|Period 4||0
1437751|NCT02308748|3519712|P3|NOT COMPLETED|Period 4||0
1437752|NCT02308748|3519713|P2|NOT COMPLETED|Period 4||0
1437753|NCT02308748|3519714|P1|NOT COMPLETED|Period 4||0
1437754|NCT02308748|3519705|P10|COMPLETED|Period 4||2
1437755|NCT02308748|3519706|P9|COMPLETED|Period 4||2
1437756|NCT02308748|3519707|P8|COMPLETED|Period 4||1
1437757|NCT02308748|3519708|P7|COMPLETED|Period 4||2
1437758|NCT02308748|3519709|P6|COMPLETED|Period 4||3
1437759|NCT02308748|3519710|P5|COMPLETED|Period 4||2
1437760|NCT02308748|3519711|P4|COMPLETED|Period 4||2
1437761|NCT02308748|3519712|P3|COMPLETED|Period 4||1
1437762|NCT02308748|3519713|P2|COMPLETED|Period 4||2
1437763|NCT02308748|3519714|P1|COMPLETED|Period 4||2
1437764|NCT02308748|3519705|P10|STARTED|Period 4||2
1437765|NCT02308748|3519706|P9|STARTED|Period 4||2
1437766|NCT02308748|3519707|P8|STARTED|Period 4||1
1437767|NCT02308748|3519708|P7|STARTED|Period 4||2
1437768|NCT02308748|3519709|P6|STARTED|Period 4||3
1437769|NCT02308748|3519710|P5|STARTED|Period 4||2
1437770|NCT02308748|3519711|P4|STARTED|Period 4||2
1437771|NCT02308748|3519712|P3|STARTED|Period 4||1
1437772|NCT02308748|3519713|P2|STARTED|Period 4||2
1437773|NCT02308748|3519714|P1|STARTED|Period 4||2
1437774|NCT02308748|3519705|P10|NOT COMPLETED|Period 3||1
1437775|NCT02308748|3519706|P9|NOT COMPLETED|Period 3||0
1437776|NCT02308748|3519707|P8|NOT COMPLETED|Period 3||0
1437777|NCT02308748|3519708|P7|NOT COMPLETED|Period 3||0
1437778|NCT02308748|3519709|P6|NOT COMPLETED|Period 3||0
1437779|NCT02308748|3519710|P5|NOT COMPLETED|Period 3||0
1437780|NCT02308748|3519711|P4|NOT COMPLETED|Period 3||0
1437781|NCT02308748|3519712|P3|NOT COMPLETED|Period 3||0
1437782|NCT02308748|3519713|P2|NOT COMPLETED|Period 3||0
1437783|NCT02308748|3519714|P1|NOT COMPLETED|Period 3||0
1437784|NCT02308748|3519705|P10|COMPLETED|Period 3||2
1437785|NCT02308748|3519706|P9|COMPLETED|Period 3||2
1437786|NCT02308748|3519707|P8|COMPLETED|Period 3||1
1437787|NCT02308748|3519708|P7|COMPLETED|Period 3||2
1437788|NCT02308748|3519709|P6|COMPLETED|Period 3||3
1437789|NCT02308748|3519710|P5|COMPLETED|Period 3||2
1437790|NCT02308748|3519711|P4|COMPLETED|Period 3||2
1437791|NCT02308748|3519712|P3|COMPLETED|Period 3||1
1437792|NCT02308748|3519713|P2|COMPLETED|Period 3||2
1437793|NCT02308748|3519714|P1|COMPLETED|Period 3||2
1437794|NCT02308748|3519705|P10|STARTED|Period 3||3
1437795|NCT02308748|3519706|P9|STARTED|Period 3||2
1437796|NCT02308748|3519707|P8|STARTED|Period 3||1
1437797|NCT02308748|3519708|P7|STARTED|Period 3||2
1437798|NCT02308748|3519709|P6|STARTED|Period 3||3
1437799|NCT02308748|3519710|P5|STARTED|Period 3||2
1437800|NCT02308748|3519711|P4|STARTED|Period 3||2
1437801|NCT02308748|3519712|P3|STARTED|Period 3||1
1437802|NCT02308748|3519713|P2|STARTED|Period 3||2
1437803|NCT02308748|3519714|P1|STARTED|Period 3||2
1437804|NCT02308748|3519705|P10|NOT COMPLETED|Period 2||0
1437805|NCT02308748|3519706|P9|NOT COMPLETED|Period 2||0
1437806|NCT02308748|3519707|P8|NOT COMPLETED|Period 2||1
1437807|NCT02308748|3519708|P7|NOT COMPLETED|Period 2||0
1437808|NCT02308748|3519709|P6|NOT COMPLETED|Period 2||0
1437809|NCT02308748|3519710|P5|NOT COMPLETED|Period 2||0
1437810|NCT02308748|3519711|P4|NOT COMPLETED|Period 2||0
1437811|NCT02308748|3519712|P3|NOT COMPLETED|Period 2||0
1437812|NCT02308748|3519713|P2|NOT COMPLETED|Period 2||0
1437813|NCT02308748|3519714|P1|NOT COMPLETED|Period 2||0
1437814|NCT02308748|3519705|P10|COMPLETED|Period 2||3
1437815|NCT02308748|3519706|P9|COMPLETED|Period 2||2
1437816|NCT02308748|3519707|P8|COMPLETED|Period 2||1
1437817|NCT02308748|3519708|P7|COMPLETED|Period 2||2
1437818|NCT02308748|3519709|P6|COMPLETED|Period 2||3
1437819|NCT02308748|3519710|P5|COMPLETED|Period 2||2
1437820|NCT02308748|3519711|P4|COMPLETED|Period 2||2
1437821|NCT02308748|3519712|P3|COMPLETED|Period 2||1
1437822|NCT02308748|3519713|P2|COMPLETED|Period 2||2
1437823|NCT02308748|3519714|P1|COMPLETED|Period 2||2
1437824|NCT02308748|3519705|P10|STARTED|Period 2||3
1437825|NCT02308748|3519706|P9|STARTED|Period 2||2
1437826|NCT02308748|3519707|P8|STARTED|Period 2||2
1437827|NCT02308748|3519708|P7|STARTED|Period 2||2
1437828|NCT02308748|3519709|P6|STARTED|Period 2||3
1437829|NCT02308748|3519710|P5|STARTED|Period 2||2
1437830|NCT02308748|3519711|P4|STARTED|Period 2||2
1437831|NCT02308748|3519712|P3|STARTED|Period 2||1
1437832|NCT02308748|3519713|P2|STARTED|Period 2||2
1437833|NCT02308748|3519714|P1|STARTED|Period 2||2
1437834|NCT02308748|3519705|P10|NOT COMPLETED|Period 1||0
1437835|NCT02308748|3519706|P9|NOT COMPLETED|Period 1||0
1437836|NCT02308748|3519707|P8|NOT COMPLETED|Period 1||0
1437837|NCT02308748|3519708|P7|NOT COMPLETED|Period 1||0
1437838|NCT02308748|3519709|P6|NOT COMPLETED|Period 1||0
1437839|NCT02308748|3519710|P5|NOT COMPLETED|Period 1||0
1437840|NCT02308748|3519711|P4|NOT COMPLETED|Period 1||0
1437841|NCT02308748|3519712|P3|NOT COMPLETED|Period 1||1
1437842|NCT02308748|3519713|P2|NOT COMPLETED|Period 1||0
1437843|NCT02308748|3519714|P1|NOT COMPLETED|Period 1||0
1437844|NCT02308748|3519705|P10|COMPLETED|Period 1||3
1437845|NCT02308748|3519706|P9|COMPLETED|Period 1||2
1437846|NCT02308748|3519707|P8|COMPLETED|Period 1||2
1437847|NCT02308748|3519708|P7|COMPLETED|Period 1||2
1437848|NCT02308748|3519709|P6|COMPLETED|Period 1||3
1437849|NCT02308748|3519710|P5|COMPLETED|Period 1||2
1437850|NCT02308748|3519711|P4|COMPLETED|Period 1||2
1437851|NCT02308748|3519712|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
1437852|NCT02308748|3519713|P2|COMPLETED|Period 1||2
1437853|NCT02308748|3519714|P1|COMPLETED|Period 1||2
1437854|NCT02308748|3519705|P10|STARTED|Period 1||3
1437855|NCT02308748|3519706|P9|STARTED|Period 1||2
1437856|NCT02308748|3519707|P8|STARTED|Period 1||2
1437857|NCT02308748|3519708|P7|STARTED|Period 1||2
1437858|NCT02308748|3519709|P6|STARTED|Period 1||3
1437859|NCT02308748|3519710|P5|STARTED|Period 1||2
1437860|NCT02308748|3519711|P4|STARTED|Period 1||2
1437861|NCT02308748|3519712|P3|STARTED|Period 1||2
1437862|NCT02308748|3519713|P2|STARTED|Period 1||2
1437863|NCT02308748|3519714|P1|STARTED|Period 1||2
1437864|NCT02308475|3519726|P1|NOT COMPLETED|Overall Study||0
1437865|NCT02308475|3519726|P1|COMPLETED|Overall Study||2
1437866|NCT02308475|3519726|P1|STARTED|Overall Study||2
1437867|NCT02308371|3519734|P2|NOT COMPLETED|Overall Study||0
1437868|NCT02308371|3519735|P1|NOT COMPLETED|Overall Study||0
1437869|NCT02308371|3519734|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
1437870|NCT02308371|3519735|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
1437871|NCT02308371|3519734|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
1437872|NCT02308371|3519735|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
1437873|NCT02308189|3519751|P2|NOT COMPLETED|Overall Study||1
1437874|NCT02308189|3519752|P1|NOT COMPLETED|Overall Study||1
1437875|NCT02308189|3519751|P2|COMPLETED|Overall Study||14
1437876|NCT02308189|3519752|P1|COMPLETED|Overall Study||16
1437877|NCT02308189|3519751|P2|STARTED|Overall Study||15
1437878|NCT02308189|3519752|P1|STARTED|Overall Study||17
1437879|NCT02308124|3519765|P3|NOT COMPLETED|Overall Study||8
1437880|NCT02308124|3519766|P2|NOT COMPLETED|Overall Study||8
1437881|NCT02308124|3519767|P1|NOT COMPLETED|Overall Study||6
1437882|NCT02308124|3519765|P3|COMPLETED|Overall Study||21
1437883|NCT02308124|3519766|P2|COMPLETED|Overall Study||21
1437884|NCT02308124|3519767|P1|COMPLETED|Overall Study||23
1437885|NCT02308124|3519765|P3|STARTED|Overall Study||29
1437886|NCT02308124|3519766|P2|STARTED|Overall Study||29
1437887|NCT02308124|3519767|P1|STARTED|Overall Study||29
1437888|NCT02307838|3519790|P3|NOT COMPLETED|Overall Study||0
1437889|NCT02307838|3519791|P2|NOT COMPLETED|Overall Study||0
1437890|NCT02307838|3519792|P1|NOT COMPLETED|Overall Study||0
1437891|NCT02307838|3519790|P3|COMPLETED|Overall Study||55
1437892|NCT02307838|3519791|P2|COMPLETED|Overall Study||64
1437893|NCT02307838|3519792|P1|COMPLETED|Overall Study||56
1437894|NCT02307838|3519790|P3|STARTED|Overall Study||55
1437895|NCT02307838|3519791|P2|STARTED|Overall Study||64
1437896|NCT02307838|3519792|P1|STARTED|Overall Study||56
1437897|NCT02307552|3519835|P1|NOT COMPLETED|Overall Study||0
1437898|NCT02307552|3519835|P1|COMPLETED|Overall Study||1
1437899|NCT02307552|3519835|P1|STARTED|Overall Study||1
1437900|NCT02307526|3519839|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
1437901|NCT02307526|3519839|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
1437902|NCT02307526|3519839|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
1437903|NCT02307526|3519839|P1|NOT COMPLETED|Day 1 - No Drug||0
1437904|NCT02307526|3519839|P1|COMPLETED|Day 1 - No Drug||10
1437905|NCT02307526|3519839|P1|STARTED|Day 1 - No Drug||10
1437906|NCT02307318|3519849|P1|NOT COMPLETED|Overall Study||0
1437907|NCT02307318|3519849|P1|COMPLETED|Overall Study||51
1437908|NCT02307318|3519849|P1|STARTED|Overall Study||51
1437909|NCT02307266|3519859|P3|NOT COMPLETED|Overall Study||6
1437910|NCT02307266|3519860|P2|NOT COMPLETED|Overall Study||1
1437911|NCT02307266|3519861|P1|NOT COMPLETED|Overall Study||8
1437912|NCT02307266|3519859|P3|COMPLETED|Overall Study||25
1437913|NCT02307266|3519860|P2|COMPLETED|Overall Study||32
1437914|NCT02307266|3519861|P1|COMPLETED|Overall Study||25
1437915|NCT02307266|3519859|P3|STARTED|Overall Study||31
1437916|NCT02307266|3519860|P2|STARTED|Overall Study||33
1437917|NCT02307266|3519861|P1|STARTED|Overall Study||33
1437918|NCT02307188|3519869|P1|NOT COMPLETED|Overall Study||4
1437919|NCT02307188|3519869|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
1437920|NCT02307188|3519869|P1|STARTED|Overall Study||5
1437921|NCT02307123|3519873|P1|NOT COMPLETED|Overall Study||0
1437922|NCT02307123|3519873|P1|COMPLETED|Overall Study||483
1437923|NCT02307123|3519873|P1|STARTED|Overall Study||483
1437924|NCT02306928|3519878|P1|NOT COMPLETED|Overall Study||0
1437925|NCT02306928|3519878|P1|COMPLETED|Overall Study||15
1437926|NCT02306928|3519878|P1|STARTED|Overall Study||15
1437927|NCT02306759|3519888|P2|NOT COMPLETED|Overall Study||0
1437928|NCT02306759|3519889|P1|NOT COMPLETED|Overall Study||0
1437929|NCT02306759|3519888|P2|COMPLETED|Overall Study||30
1437930|NCT02306759|3519889|P1|COMPLETED|Overall Study||30
1437931|NCT02306759|3519888|P2|STARTED|Overall Study||30
1437932|NCT02306759|3519889|P1|STARTED|Overall Study||30
1437933|NCT02305797|3519905|P2|NOT COMPLETED|Overall Study||38
1437934|NCT02305797|3519906|P1|NOT COMPLETED|Overall Study||45
1437935|NCT02305797|3519905|P2|COMPLETED|Overall Study||210
1437936|NCT02305797|3519906|P1|COMPLETED|Overall Study||202
1437937|NCT02305797|3519905|P2|STARTED|Overall Study||248
1437938|NCT02305797|3519906|P1|STARTED|Overall Study||247
1437939|NCT02305758|3519916|P2|NOT COMPLETED|Overall Study||65
1437940|NCT02305758|3519917|P1|NOT COMPLETED|Overall Study||65
1437941|NCT02305758|3519916|P2|COMPLETED|Overall Study||0
1437942|NCT02305758|3519917|P1|COMPLETED|Overall Study||0
1437943|NCT02305758|3519916|P2|STARTED|Overall Study||65
1437944|NCT02305758|3519917|P1|STARTED|Overall Study||65
1437945|NCT02305732|3519927|P1|NOT COMPLETED|Overall Study||18
1437946|NCT02305732|3519927|P1|COMPLETED|Overall Study||72
1437947|NCT02305732|3519927|P1|STARTED|Overall Study||90
1437948|NCT02305446|3519935|P1|NOT COMPLETED|Overall Study||1
1437949|NCT02305446|3519935|P1|COMPLETED|Overall Study||54
1437950|NCT02305446|3519935|P1|STARTED|Overall Study||55
1437951|NCT02305381|3519943|P3|NOT COMPLETED|Overall Study||7
1437952|NCT02305381|3519944|P2|NOT COMPLETED|Overall Study||5
1437953|NCT02305381|3519945|P1|NOT COMPLETED|Overall Study||5
1437954|NCT02305381|3519943|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
1437955|NCT02305381|3519944|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
1437956|NCT02305381|3519945|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
1437957|NCT02305381|3519943|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
1437958|NCT02305381|3519944|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
1437959|NCT02305381|3519945|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
1437960|NCT02305381|3519943|P3|Exposed|Overall Study||133
1437961|NCT02305381|3519944|P2|Exposed|Overall Study||131
1437962|NCT02305381|3519945|P1|Exposed|Overall Study||132
1437963|NCT02305381|3519943|P3|STARTED|Overall Study||133
1437964|NCT02305381|3519944|P2|STARTED|Overall Study||132
1437965|NCT02305381|3519945|P1|STARTED|Overall Study||132
1437966|NCT02305329|3519978|P4|NOT COMPLETED|Overall Study||0
1437967|NCT02305329|3519979|P3|NOT COMPLETED|Overall Study||0
1437968|NCT02305329|3519980|P2|NOT COMPLETED|Overall Study||1
1437969|NCT02305329|3519981|P1|NOT COMPLETED|Overall Study||0
1437970|NCT02305329|3519978|P4|COMPLETED|Overall Study||14
1437971|NCT02305329|3519979|P3|COMPLETED|Overall Study||14
1437972|NCT02305329|3519980|P2|COMPLETED|Overall Study||13
1437973|NCT02305329|3519981|P1|COMPLETED|Overall Study||14
1437974|NCT02305329|3519978|P4|Period 2|Overall Study||14
1437975|NCT02305329|3519979|P3|Period 2|Overall Study||14
1437976|NCT02305329|3519980|P2|Period 2|Overall Study||13
1437977|NCT02305329|3519981|P1|Period 2|Overall Study||14
1437978|NCT02305329|3519978|P4|Period 1|Overall Study||14
1437979|NCT02305329|3519979|P3|Period 1|Overall Study||14
1437980|NCT02305329|3519980|P2|Period 1|Overall Study||14
1437981|NCT02305329|3519981|P1|Period 1|Overall Study||14
1437982|NCT02305329|3519978|P4|STARTED|Overall Study||14
1437983|NCT02305329|3519979|P3|STARTED|Overall Study||14
1437984|NCT02305329|3519980|P2|STARTED|Overall Study||14
1437985|NCT02305329|3519981|P1|STARTED|Overall Study||14
1437986|NCT02305316|3520005|P2|NOT COMPLETED|Overall Study||0
1437987|NCT02305316|3520006|P1|NOT COMPLETED|Overall Study||0
1437988|NCT02305316|3520005|P2|COMPLETED|Overall Study||14
1437989|NCT02305316|3520006|P1|COMPLETED|Overall Study||14
1437990|NCT02305316|3520005|P2|STARTED|Overall Study||14
1437991|NCT02305316|3520006|P1|STARTED|Overall Study||14
1437992|NCT02305277|3520024|P6|NOT COMPLETED|Overall Study||0
1437993|NCT02305277|3520025|P5|NOT COMPLETED|Overall Study||1
1437994|NCT02305277|3520026|P4|NOT COMPLETED|Overall Study||0
1437995|NCT02305277|3520027|P3|NOT COMPLETED|Overall Study||0
1437996|NCT02305277|3520028|P2|NOT COMPLETED|Overall Study||0
1437997|NCT02305277|3520029|P1|NOT COMPLETED|Overall Study||1
1437998|NCT02305277|3520024|P6|COMPLETED|Overall Study||14
1437999|NCT02305277|3520025|P5|COMPLETED|Overall Study||13
1438000|NCT02305277|3520026|P4|COMPLETED|Overall Study||14
1438001|NCT02305277|3520027|P3|COMPLETED|Overall Study||14
1438002|NCT02305277|3520028|P2|COMPLETED|Overall Study||14
1438003|NCT02305277|3520029|P1|COMPLETED|Overall Study||14
1438004|NCT02305277|3520024|P6|Received TBM|Overall Study||14
1438005|NCT02305277|3520025|P5|Received TBM|Overall Study||14
1438006|NCT02305277|3520026|P4|Received TBM|Overall Study||14
1438007|NCT02305277|3520027|P3|Received TBM|Overall Study||14
1438008|NCT02305277|3520028|P2|Received TBM|Overall Study||14
1438009|NCT02305277|3520029|P1|Received TBM|Overall Study||15
1438010|NCT02305277|3520024|P6|Received CM|Overall Study||14
1438011|NCT02305277|3520025|P5|Received CM|Overall Study||14
1438012|NCT02305277|3520026|P4|Received CM|Overall Study||14
1438013|NCT02305277|3520027|P3|Received CM|Overall Study||14
1438014|NCT02305277|3520028|P2|Received CM|Overall Study||14
1438015|NCT02305277|3520029|P1|Received CM|Overall Study||15
1438016|NCT02305277|3520024|P6|STARTED|Overall Study||14
1438017|NCT02305277|3520025|P5|STARTED|Overall Study||14
1438018|NCT02305277|3520026|P4|STARTED|Overall Study||14
1438019|NCT02305277|3520027|P3|STARTED|Overall Study||14
1438020|NCT02305277|3520028|P2|STARTED|Overall Study||14
1438021|NCT02305277|3520029|P1|STARTED|Overall Study||15
1438022|NCT02305238|3520058|P3|NOT COMPLETED|Overall Study||8
1438023|NCT02305238|3520059|P2|NOT COMPLETED|Overall Study||7
1438024|NCT02305238|3520060|P1|NOT COMPLETED|Overall Study||13
1438025|NCT02305238|3520058|P3|COMPLETED|Overall Study||0
1438026|NCT02305238|3520059|P2|COMPLETED|Overall Study||116
1438027|NCT02305238|3520060|P1|COMPLETED|Overall Study||111
1438028|NCT02305238|3520058|P3|BCVA Post-randomization Assessment|Overall Study||0
1438029|NCT02305238|3520059|P2|BCVA Post-randomization Assessment|Overall Study||123
1438030|NCT02305238|3520060|P1|BCVA Post-randomization Assessment|Overall Study||123
1438031|NCT02305238|3520058|P3|Randomized|Overall Study||0
1438032|NCT02305238|3520059|P2|Randomized|Overall Study||123
1438033|NCT02305238|3520060|P1|Randomized|Overall Study||124
1438034|NCT02305238|3520058|P3|Treated|Overall Study||7
1438035|NCT02305238|3520059|P2|Treated|Overall Study||123
1438036|NCT02305238|3520060|P1|Treated|Overall Study||124
1438037|NCT02305238|3520058|P3|STARTED|Overall Study||8
1438038|NCT02305238|3520059|P2|STARTED|Overall Study||123
1438039|NCT02305238|3520060|P1|STARTED|Overall Study||124
1438040|NCT02305017|3520077|P2|NOT COMPLETED|Overall Study||0
1438041|NCT02305017|3520078|P1|NOT COMPLETED|Overall Study||0
1438042|NCT02305017|3520077|P2|COMPLETED|Overall Study||14
1438043|NCT02305017|3520078|P1|COMPLETED|Overall Study||14
1438044|NCT02305017|3520077|P2|STARTED|Overall Study||14
1438045|NCT02305017|3520078|P1|STARTED|Overall Study||14
1438046|NCT02304926|3520092|P2|NOT COMPLETED|Overall Study||1
1438047|NCT02304926|3520093|P1|NOT COMPLETED|Overall Study||2
1438048|NCT02304926|3520092|P2|COMPLETED|Overall Study||19
1438049|NCT02304926|3520093|P1|COMPLETED|Overall Study||20
1438050|NCT02304926|3520092|P2|STARTED|Overall Study||20
1438051|NCT02304926|3520093|P1|STARTED|Overall Study||22
1438052|NCT02304432|3520137|P4|NOT COMPLETED|Second Open Label DCS||0
1438053|NCT02304432|3520138|P3|NOT COMPLETED|Second Open Label DCS||0
1438054|NCT02304432|3520139|P2|NOT COMPLETED|Second Open Label DCS||0
1438055|NCT02304432|3520140|P1|NOT COMPLETED|Second Open Label DCS||0
1438056|NCT02304432|3520137|P4|COMPLETED|Second Open Label DCS||2
1438057|NCT02304432|3520138|P3|COMPLETED|Second Open Label DCS||0
1438058|NCT02304432|3520139|P2|COMPLETED|Second Open Label DCS||0
1438059|NCT02304432|3520140|P1|COMPLETED|Second Open Label DCS||0
1438060|NCT02304432|3520137|P4|STARTED|Second Open Label DCS||2
1438061|NCT02304432|3520138|P3|STARTED|Second Open Label DCS||0
1438062|NCT02304432|3520139|P2|STARTED|Second Open Label DCS||0
1438063|NCT02304432|3520140|P1|STARTED|Second Open Label DCS||0
1438064|NCT02304432|3520137|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
1438065|NCT02304432|3520138|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
1438066|NCT02304432|3520139|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
1438067|NCT02304432|3520140|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
1438068|NCT02304432|3520137|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
1438069|NCT02304432|3520138|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
1438070|NCT02304432|3520139|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
1438071|NCT02304432|3520140|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
1438072|NCT02304432|3520137|P4|STARTED|Double-Blind DCS Placebo Crossover||0
1438073|NCT02304432|3520138|P3|STARTED|Double-Blind DCS Placebo Crossover||1
1438074|NCT02304432|3520139|P2|STARTED|Double-Blind DCS Placebo Crossover||1
1438075|NCT02304432|3520140|P1|STARTED|Double-Blind DCS Placebo Crossover||0
1438076|NCT02304432|3520137|P4|NOT COMPLETED|Open Label DCS||0
1438077|NCT02304432|3520138|P3|NOT COMPLETED|Open Label DCS||0
1438078|NCT02304432|3520139|P2|NOT COMPLETED|Open Label DCS||0
1438079|NCT02304432|3520140|P1|NOT COMPLETED|Open Label DCS||0
1438080|NCT02304432|3520137|P4|COMPLETED|Open Label DCS||0
1438081|NCT02304432|3520138|P3|COMPLETED|Open Label DCS||0
1438082|NCT02304432|3520139|P2|COMPLETED|Open Label DCS||0
1438083|NCT02304432|3520140|P1|COMPLETED|Open Label DCS||2
1438084|NCT02304432|3520137|P4|STARTED|Open Label DCS||0
1438085|NCT02304432|3520138|P3|STARTED|Open Label DCS||0
1438086|NCT02304432|3520139|P2|STARTED|Open Label DCS||0
1438087|NCT02304432|3520140|P1|STARTED|Open Label DCS||2
1438088|NCT02303743|3520174|P2|NOT COMPLETED|Overall Study||0
1438089|NCT02303743|3520175|P1|NOT COMPLETED|Overall Study||0
1438090|NCT02303743|3520174|P2|COMPLETED|Overall Study||152
1438091|NCT02303743|3520175|P1|COMPLETED|Overall Study||108
1438092|NCT02303743|3520174|P2|STARTED|Overall Study||152
1438093|NCT02303743|3520175|P1|STARTED|Overall Study||108
1438094|NCT02303704|3520185|P2|NOT COMPLETED|Overall Study||9
1438095|NCT02303704|3520186|P1|NOT COMPLETED|Overall Study||5
1438096|NCT02303704|3520185|P2|COMPLETED|Overall Study||219
1438097|NCT02303704|3520186|P1|COMPLETED|Overall Study||215
1438098|NCT02303704|3520185|P2|STARTED|Overall Study||228
1438099|NCT02303704|3520186|P1|STARTED|Overall Study||220
1438100|NCT02303574|3520214|P10|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438101|NCT02303574|3520215|P9|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438102|NCT02303574|3520216|P8|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
1438103|NCT02303574|3520217|P7|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438104|NCT02303574|3520218|P6|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438105|NCT02303574|3520219|P5|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438106|NCT02303574|3520220|P4|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438107|NCT02303574|3520221|P3|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438108|NCT02303574|3520222|P2|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438109|NCT02303574|3520223|P1|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438110|NCT02303574|3520214|P10|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
1438111|NCT02303574|3520215|P9|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
1438112|NCT02303574|3520216|P8|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
1438113|NCT02303574|3520217|P7|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
1438114|NCT02303574|3520218|P6|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438115|NCT02303574|3520219|P5|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438116|NCT02303574|3520220|P4|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438117|NCT02303574|3520221|P3|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438118|NCT02303574|3520222|P2|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438119|NCT02303574|3520223|P1|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
1438120|NCT02303574|3520214|P10|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
1438121|NCT02303574|3520215|P9|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
1438122|NCT02303574|3520216|P8|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
1438123|NCT02303574|3520217|P7|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
1438124|NCT02303574|3520218|P6|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1438125|NCT02303574|3520219|P5|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1438126|NCT02303574|3520220|P4|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1438127|NCT02303574|3520221|P3|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1438128|NCT02303574|3520222|P2|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1438129|NCT02303574|3520223|P1|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
1438130|NCT02303574|3520214|P10|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438131|NCT02303574|3520215|P9|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438132|NCT02303574|3520216|P8|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438133|NCT02303574|3520217|P7|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438134|NCT02303574|3520218|P6|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438135|NCT02303574|3520219|P5|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438136|NCT02303574|3520220|P4|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438137|NCT02303574|3520221|P3|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438138|NCT02303574|3520222|P2|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438139|NCT02303574|3520223|P1|NOT COMPLETED|Part 1b (Fed State) - SAD||0
1438140|NCT02303574|3520214|P10|COMPLETED|Part 1b (Fed State) - SAD||3
1438141|NCT02303574|3520215|P9|COMPLETED|Part 1b (Fed State) - SAD||0
1438142|NCT02303574|3520216|P8|COMPLETED|Part 1b (Fed State) - SAD||0
1438143|NCT02303574|3520217|P7|COMPLETED|Part 1b (Fed State) - SAD||0
1438144|NCT02303574|3520218|P6|COMPLETED|Part 1b (Fed State) - SAD||5
1438145|NCT02303574|3520219|P5|COMPLETED|Part 1b (Fed State) - SAD||0
1438146|NCT02303574|3520220|P4|COMPLETED|Part 1b (Fed State) - SAD||0
1438147|NCT02303574|3520221|P3|COMPLETED|Part 1b (Fed State) - SAD||0
1438148|NCT02303574|3520222|P2|COMPLETED|Part 1b (Fed State) - SAD||0
1438149|NCT02303574|3520223|P1|COMPLETED|Part 1b (Fed State) - SAD||0
1438150|NCT02303574|3520214|P10|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
1438151|NCT02303574|3520215|P9|STARTED|Part 1b (Fed State) - SAD||0
1438152|NCT02303574|3520216|P8|STARTED|Part 1b (Fed State) - SAD||0
1438153|NCT02303574|3520217|P7|STARTED|Part 1b (Fed State) - SAD||0
1438154|NCT02303574|3520218|P6|STARTED|Part 1b (Fed State) - SAD||5
1438155|NCT02303574|3520219|P5|STARTED|Part 1b (Fed State) - SAD||0
1438156|NCT02303574|3520220|P4|STARTED|Part 1b (Fed State) - SAD||0
1438157|NCT02303574|3520221|P3|STARTED|Part 1b (Fed State) - SAD||0
1438158|NCT02303574|3520222|P2|STARTED|Part 1b (Fed State) - SAD||0
1438159|NCT02303574|3520223|P1|STARTED|Part 1b (Fed State) - SAD||0
1438160|NCT02303574|3520214|P10|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1438161|NCT02303574|3520215|P9|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1438162|NCT02303574|3520216|P8|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1438163|NCT02303574|3520217|P7|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1438164|NCT02303574|3520218|P6|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1438165|NCT02303574|3520219|P5|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1438166|NCT02303574|3520220|P4|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1438167|NCT02303574|3520221|P3|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
1438168|NCT02303574|3520222|P2|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1438169|NCT02303574|3520223|P1|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
1438170|NCT02303574|3520214|P10|COMPLETED|Part 1a (Fasted State)- SAD||15
1438171|NCT02303574|3520215|P9|COMPLETED|Part 1a (Fasted State)- SAD||0
1438172|NCT02303574|3520216|P8|COMPLETED|Part 1a (Fasted State)- SAD||0
1438173|NCT02303574|3520217|P7|COMPLETED|Part 1a (Fasted State)- SAD||0
1438174|NCT02303574|3520218|P6|COMPLETED|Part 1a (Fasted State)- SAD||0
1438175|NCT02303574|3520219|P5|COMPLETED|Part 1a (Fasted State)- SAD||6
1438176|NCT02303574|3520220|P4|COMPLETED|Part 1a (Fasted State)- SAD||6
1438177|NCT02303574|3520221|P3|COMPLETED|Part 1a (Fasted State)- SAD||5
1438178|NCT02303574|3520222|P2|COMPLETED|Part 1a (Fasted State)- SAD||6
1438179|NCT02303574|3520223|P1|COMPLETED|Part 1a (Fasted State)- SAD||6
1438180|NCT02303574|3520214|P10|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
1438181|NCT02303574|3520215|P9|STARTED|Part 1a (Fasted State)- SAD||0
1438182|NCT02303574|3520216|P8|STARTED|Part 1a (Fasted State)- SAD||0
1438183|NCT02303574|3520217|P7|STARTED|Part 1a (Fasted State)- SAD||0
1438184|NCT02303574|3520218|P6|STARTED|Part 1a (Fasted State)- SAD||0
1438185|NCT02303574|3520219|P5|STARTED|Part 1a (Fasted State)- SAD||6
1438186|NCT02303574|3520220|P4|STARTED|Part 1a (Fasted State)- SAD||6
1438187|NCT02303574|3520221|P3|STARTED|Part 1a (Fasted State)- SAD||6
1438188|NCT02303574|3520222|P2|STARTED|Part 1a (Fasted State)- SAD||6
1438189|NCT02303574|3520223|P1|STARTED|Part 1a (Fasted State)- SAD||6
1438190|NCT02302846|3520435|P1|NOT COMPLETED|Overall Study||1
1438191|NCT02302846|3520435|P1|COMPLETED|Overall Study||4
1438192|NCT02302846|3520435|P1|STARTED|Overall Study||5
1438193|NCT02302807|3520441|P2|NOT COMPLETED|Overall Study||334
1438194|NCT02302807|3520442|P1|NOT COMPLETED|Overall Study||375
1438195|NCT02302807|3520441|P2|COMPLETED|Overall Study||133
1438196|NCT02302807|3520442|P1|COMPLETED|Overall Study||89
1438197|NCT02302807|3520441|P2|Received Treatment|Overall Study||459
1438198|NCT02302807|3520442|P1|Received Treatment|Overall Study||443
1438199|NCT02302807|3520441|P2|STARTED|Overall Study||467
1438200|NCT02302807|3520442|P1|STARTED|Overall Study||464
1438201|NCT02302716|3520489|P2|NOT COMPLETED|Overall Study||19
1438202|NCT02302716|3520490|P1|NOT COMPLETED|Overall Study||19
1438203|NCT02302716|3520489|P2|COMPLETED|Overall Study||225
1438204|NCT02302716|3520490|P1|COMPLETED|Overall Study||230
1438205|NCT02302716|3520489|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
1438206|NCT02302716|3520490|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
1438207|NCT02302716|3520489|P2|STARTED|Overall Study||244
1438208|NCT02302716|3520490|P1|STARTED|Overall Study||249
1438209|NCT02302365|3520516|P1|NOT COMPLETED|0-24 Hour Period||0
1438210|NCT02302365|3520516|P1|COMPLETED|0-24 Hour Period||32
1438211|NCT02302365|3520516|P1|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
1438212|NCT02302365|3520516|P1|NOT COMPLETED|0-2 Hour Period||2
1438213|NCT02302365|3520516|P1|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
1438214|NCT02302365|3520516|P1|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
1438215|NCT02302222|3520536|P2|NOT COMPLETED|Overall Study||6
1438216|NCT02302222|3520537|P1|NOT COMPLETED|Overall Study||1
1438217|NCT02302222|3520536|P2|COMPLETED|Overall Study||31
1438218|NCT02302222|3520537|P1|COMPLETED|Overall Study||33
1438219|NCT02302222|3520536|P2|STARTED|Overall Study||37
1438220|NCT02302222|3520537|P1|STARTED|Overall Study||34
1438221|NCT02302092|3520545|P2|NOT COMPLETED|Overall Study||0
1438222|NCT02302092|3520546|P1|NOT COMPLETED|Overall Study||0
1438223|NCT02302092|3520545|P2|COMPLETED|Overall Study||7
1438224|NCT02302092|3520546|P1|COMPLETED|Overall Study||6
1438225|NCT02302092|3520545|P2|STARTED|Overall Study||7
1438226|NCT02302092|3520546|P1|STARTED|Overall Study||6
1438227|NCT02301988|3520574|P2|NOT COMPLETED|Overall Study||9
1438228|NCT02301988|3520575|P1|NOT COMPLETED|Overall Study||10
1438229|NCT02301988|3520574|P2|COMPLETED|Overall Study||66
1438230|NCT02301988|3520575|P1|COMPLETED|Overall Study||66
1438231|NCT02301988|3520574|P2|STARTED|Overall Study||75
1438232|NCT02301988|3520575|P1|STARTED|Overall Study||76
1438233|NCT02301975|3520608|P3|NOT COMPLETED|Overall Study||22
1438234|NCT02301975|3520609|P2|NOT COMPLETED|Overall Study||25
1438235|NCT02301975|3520610|P1|NOT COMPLETED|Overall Study||31
1438236|NCT02301975|3520608|P3|COMPLETED|Overall Study||477
1438237|NCT02301975|3520609|P2|COMPLETED|Overall Study||476
1438238|NCT02301975|3520610|P1|COMPLETED|Overall Study||473
1438239|NCT02301975|3520608|P3|STARTED|Overall Study||499
1438240|NCT02301975|3520609|P2|STARTED|Overall Study||501
1438241|NCT02301975|3520610|P1|STARTED|Overall Study||504
1438242|NCT02301936|3520638|P2|NOT COMPLETED|Overall Study||0
1438243|NCT02301936|3520639|P1|NOT COMPLETED|Overall Study||1
1438244|NCT02301936|3520638|P2|COMPLETED|Overall Study||1
1438245|NCT02301936|3520639|P1|COMPLETED|Overall Study||8
1438246|NCT02301936|3520638|P2|STARTED|Overall Study||1
1438247|NCT02301936|3520639|P1|STARTED|Overall Study||9
1438248|NCT02301429|3520661|P1|NOT COMPLETED|Overall Study||3
1438249|NCT02301429|3520661|P1|COMPLETED|Overall Study||13
1438250|NCT02301429|3520661|P1|STARTED|Overall Study||16
1438251|NCT02301377|3520667|P2|NOT COMPLETED|Overall Study||0
1438252|NCT02301377|3520668|P1|NOT COMPLETED|Overall Study||0
1438253|NCT02301377|3520667|P2|COMPLETED|Overall Study||2
1438254|NCT02301377|3520668|P1|COMPLETED|Overall Study||3
1438255|NCT02301377|3520667|P2|STARTED|Overall Study||2
1438256|NCT02301377|3520668|P1|STARTED|Overall Study||3
1438257|NCT02301364|3520678|P1|NOT COMPLETED|Overall Study||0
1438258|NCT02301364|3520678|P1|COMPLETED|Overall Study||4
1438259|NCT02301364|3520678|P1|STARTED|Overall Study||4
1438260|NCT02301169|3520687|P2|NOT COMPLETED|Overall Study||0
1438261|NCT02301169|3520688|P1|NOT COMPLETED|Overall Study||1
1438262|NCT02301169|3520687|P2|COMPLETED|Overall Study||21
1438263|NCT02301169|3520688|P1|COMPLETED|Overall Study||20
1438264|NCT02301169|3520687|P2|STARTED|Overall Study||21
1438265|NCT02301169|3520688|P1|STARTED|Overall Study||21
1438266|NCT02300558|3520702|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
1438267|NCT02300558|3520702|P1|COMPLETED|Open-Label (OL) Extension Phase||0
1438268|NCT02300558|3520702|P1|STARTED|Open-Label (OL) Extension Phase||32
1438269|NCT02300558|3520702|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
1438270|NCT02300558|3520702|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
1438271|NCT02300558|3520702|P1|STARTED|Single Blind Phase (24 Weeks)||41
1438272|NCT02300311|3520715|P2|NOT COMPLETED|Overall Study||0
1438273|NCT02300311|3520716|P1|NOT COMPLETED|Overall Study||19
1438274|NCT02300311|3520715|P2|COMPLETED|Overall Study||69
1438275|NCT02300311|3520716|P1|COMPLETED|Overall Study||50
1438276|NCT02300311|3520715|P2|STARTED|Overall Study||69
1438277|NCT02300311|3520716|P1|STARTED|Overall Study||69
1438278|NCT02300298|3520728|P2|NOT COMPLETED|Disposition for Docetaxel||10
1438279|NCT02300298|3520729|P1|NOT COMPLETED|Disposition for Docetaxel||0
1438280|NCT02300298|3520728|P2|COMPLETED|Disposition for Docetaxel||0
1438281|NCT02300298|3520729|P1|COMPLETED|Disposition for Docetaxel||0
1438282|NCT02300298|3520728|P2|STARTED|Disposition for Docetaxel||10
1438283|NCT02300298|3520729|P1|STARTED|Disposition for Docetaxel||0
1438284|NCT02300298|3520728|P2|NOT COMPLETED|Disposition for Nintedanib||0
1438285|NCT02300298|3520729|P1|NOT COMPLETED|Disposition for Nintedanib||10
1438286|NCT02300298|3520728|P2|COMPLETED|Disposition for Nintedanib||0
1438287|NCT02300298|3520729|P1|COMPLETED|Disposition for Nintedanib||0
1438288|NCT02300298|3520728|P2|STARTED|Disposition for Nintedanib||0
1438289|NCT02300298|3520729|P1|STARTED|Disposition for Nintedanib||10
1438290|NCT02300129|3520739|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
1438291|NCT02300129|3520740|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
1438292|NCT02300129|3520741|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
1438293|NCT02300129|3520742|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
1438294|NCT02300129|3520739|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
1438295|NCT02300129|3520740|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
1438296|NCT02300129|3520741|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
1438297|NCT02300129|3520742|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
1438298|NCT02300129|3520739|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
1438299|NCT02300129|3520740|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
1438300|NCT02300129|3520741|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
1438301|NCT02300129|3520742|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
1438302|NCT02300129|3520739|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
1438303|NCT02300129|3520740|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
1438304|NCT02300129|3520741|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
1438305|NCT02300129|3520742|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
1438306|NCT02300129|3520739|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
1438307|NCT02300129|3520740|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
1438308|NCT02300129|3520741|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
1438309|NCT02300129|3520742|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
1438310|NCT02300129|3520739|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
1438311|NCT02300129|3520740|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
1438312|NCT02300129|3520741|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
1438313|NCT02300129|3520742|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
1438314|NCT02300129|3520739|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
1438315|NCT02300129|3520740|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
1438316|NCT02300129|3520741|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
1438317|NCT02300129|3520742|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
1438318|NCT02300129|3520739|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
1438319|NCT02300129|3520740|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
1438320|NCT02300129|3520741|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
1438321|NCT02300129|3520742|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
1438322|NCT02300129|3520739|P4|STARTED|Period 1 Session 3 (Day 5)||11
1438323|NCT02300129|3520740|P3|STARTED|Period 1 Session 3 (Day 5)||7
1438324|NCT02300129|3520741|P2|STARTED|Period 1 Session 3 (Day 5)||4
1438325|NCT02300129|3520742|P1|STARTED|Period 1 Session 3 (Day 5)||11
1438326|NCT02300129|3520739|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
1438327|NCT02300129|3520740|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
1438328|NCT02300129|3520741|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
1438329|NCT02300129|3520742|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
1438330|NCT02300129|3520739|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
1438331|NCT02300129|3520740|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
1438332|NCT02300129|3520741|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
1438333|NCT02300129|3520742|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
1438334|NCT02300129|3520739|P4|STARTED|Period 1 Session 2 (Day 3)||11
1438335|NCT02300129|3520740|P3|STARTED|Period 1 Session 2 (Day 3)||7
1438336|NCT02300129|3520741|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
1438337|NCT02300129|3520742|P1|STARTED|Period 1 Session 2 (Day 3)||11
1438338|NCT02300129|3520739|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
1438339|NCT02300129|3520740|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
1438340|NCT02300129|3520741|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
1438341|NCT02300129|3520742|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
1438342|NCT02300129|3520739|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
1438343|NCT02300129|3520740|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
1438344|NCT02300129|3520741|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
1438345|NCT02300129|3520742|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
1438346|NCT02300129|3520739|P4|STARTED|Period 1 Session 1 (Day 1)||11
1438347|NCT02300129|3520740|P3|STARTED|Period 1 Session 1 (Day 1)||7
1438348|NCT02300129|3520741|P2|STARTED|Period 1 Session 1 (Day 1)||5
1438349|NCT02300129|3520742|P1|STARTED|Period 1 Session 1 (Day 1)||11
1438350|NCT02300103|3520752|P1|NOT COMPLETED|Overall Study||6
1438351|NCT02300103|3520752|P1|COMPLETED|Overall Study||63
1438352|NCT02300103|3520752|P1|STARTED|Overall Study||69
1438353|NCT02300025|3520765|P4|NOT COMPLETED|Overall Study||0
1438354|NCT02300025|3520766|P3|NOT COMPLETED|Overall Study||0
1438355|NCT02300025|3520767|P2|NOT COMPLETED|Overall Study||0
1438356|NCT02300025|3520768|P1|NOT COMPLETED|Overall Study||0
1438357|NCT02300025|3520765|P4|COMPLETED|Overall Study||6
1438358|NCT02300025|3520766|P3|COMPLETED|Overall Study||6
1438359|NCT02300025|3520767|P2|COMPLETED|Overall Study||6
1438360|NCT02300025|3520768|P1|COMPLETED|Overall Study||10
1438361|NCT02300025|3520765|P4|STARTED|Overall Study||6
1438362|NCT02300025|3520766|P3|STARTED|Overall Study||6
1438363|NCT02300025|3520767|P2|STARTED|Overall Study||6
1438364|NCT02300025|3520768|P1|STARTED|Overall Study||10
1438365|NCT02299869|3520814|P4|NOT COMPLETED|Overall Study||0
1438366|NCT02299869|3520815|P3|NOT COMPLETED|Overall Study||0
1438367|NCT02299869|3520816|P2|NOT COMPLETED|Overall Study||0
1438368|NCT02299869|3520817|P1|NOT COMPLETED|Overall Study||0
1438369|NCT02299869|3520814|P4|COMPLETED|Overall Study||10
1438370|NCT02299869|3520815|P3|COMPLETED|Overall Study||10
1438371|NCT02299869|3520816|P2|COMPLETED|Overall Study||10
1438372|NCT02299869|3520817|P1|COMPLETED|Overall Study||10
1438373|NCT02299869|3520814|P4|STARTED|Overall Study||10
1438374|NCT02299869|3520815|P3|STARTED|Overall Study||10
1438375|NCT02299869|3520816|P2|STARTED|Overall Study||10
1438376|NCT02299869|3520817|P1|STARTED|Overall Study||10
1438377|NCT02299791|3520842|P2|NOT COMPLETED|Overall Study||0
1438378|NCT02299791|3520843|P1|NOT COMPLETED|Overall Study||0
1438379|NCT02299791|3520842|P2|COMPLETED|Overall Study||2803
1438380|NCT02299791|3520843|P1|COMPLETED|Overall Study||2053
1438381|NCT02299791|3520842|P2|STARTED|Overall Study||2803
1438382|NCT02299791|3520843|P1|STARTED|Overall Study||2053
1438383|NCT02299635|3520849|P1|NOT COMPLETED|Overall Study||19
1438384|NCT02299635|3520849|P1|COMPLETED|Overall Study||0
1438385|NCT02299635|3520849|P1|STARTED|Overall Study||19
1438386|NCT02299570|3520871|P3|NOT COMPLETED|Overall Study||2
1438387|NCT02299570|3520872|P2|NOT COMPLETED|Overall Study||0
1438388|NCT02299570|3520873|P1|NOT COMPLETED|Overall Study||4
1438389|NCT02299570|3520871|P3|COMPLETED|Overall Study||42
1438390|NCT02299570|3520872|P2|COMPLETED|Overall Study||44
1438391|NCT02299570|3520873|P1|COMPLETED|Overall Study||41
1438392|NCT02299570|3520871|P3|STARTED|Overall Study||44
1438393|NCT02299570|3520872|P2|STARTED|Overall Study||44
1438394|NCT02299570|3520873|P1|STARTED|Overall Study||45
1438395|NCT02299479|3520881|P1|NOT COMPLETED|Overall Study||2
1438396|NCT02299479|3520881|P1|COMPLETED|Overall Study||18
1438397|NCT02299479|3520881|P1|STARTED|Overall Study||20
1438398|NCT02299427|3520889|P2|NOT COMPLETED|Overall Study||3
1438399|NCT02299427|3520890|P1|NOT COMPLETED|Overall Study||23
1438400|NCT02299427|3520889|P2|COMPLETED|Overall Study||31
1438401|NCT02299427|3520890|P1|COMPLETED|Overall Study||12
1438402|NCT02299427|3520889|P2|STARTED|Overall Study||34
1438403|NCT02299427|3520890|P1|STARTED|Overall Study||35
1438404|NCT02299375|3520900|P2|NOT COMPLETED|Overall Study||80
1438405|NCT02299375|3520901|P1|NOT COMPLETED|Overall Study||80
1438406|NCT02299375|3520900|P2|COMPLETED|Overall Study||10
1438407|NCT02299375|3520901|P1|COMPLETED|Overall Study||14
1438408|NCT02299375|3520900|P2|STARTED|Overall Study||90
1438409|NCT02299375|3520901|P1|STARTED|Overall Study||94
1438410|NCT02299349|3520951|P2|NOT COMPLETED|Overall Study||0
1438411|NCT02299349|3520952|P1|NOT COMPLETED|Overall Study||0
1438412|NCT02299349|3520951|P2|COMPLETED|Overall Study||35
1438413|NCT02299349|3520952|P1|COMPLETED|Overall Study||35
1438414|NCT02299349|3520951|P2|STARTED|Overall Study||35
1438415|NCT02299349|3520952|P1|STARTED|Overall Study||35
1438416|NCT02299336|3520960|P1|NOT COMPLETED|Overall Study||14
1438417|NCT02299336|3520960|P1|COMPLETED|Overall Study||46
1438418|NCT02299336|3520960|P1|STARTED|Overall Study||60
1438419|NCT02299258|3520975|P2|NOT COMPLETED|Overall Study||1
1438420|NCT02299258|3520976|P1|NOT COMPLETED|Overall Study||1
1438421|NCT02299258|3520975|P2|COMPLETED|Overall Study||30
1438422|NCT02299258|3520976|P1|COMPLETED|Overall Study||31
1438423|NCT02299258|3520975|P2|STARTED|Overall Study||31
1438424|NCT02299258|3520976|P1|STARTED|Overall Study||32
1438425|NCT02299206|3520984|P1|NOT COMPLETED|Overall Study||2
1438426|NCT02299206|3520984|P1|COMPLETED|Overall Study||2
1438427|NCT02299206|3520984|P1|STARTED|Overall Study||4
1438428|NCT02299089|3520996|P4|NOT COMPLETED|Overall Study||0
1438429|NCT02299089|3520997|P3|NOT COMPLETED|Overall Study||0
1438430|NCT02299089|3520998|P2|NOT COMPLETED|Overall Study||0
1438431|NCT02299089|3520999|P1|NOT COMPLETED|Overall Study||0
1438432|NCT02299089|3520996|P4|COMPLETED|Overall Study||4
1438433|NCT02299089|3520997|P3|COMPLETED|Overall Study||1
1438434|NCT02299089|3520998|P2|COMPLETED|Overall Study||4
1438435|NCT02299089|3520999|P1|COMPLETED|Overall Study||3
1438436|NCT02299089|3520996|P4|STARTED|Overall Study||4
1438437|NCT02299089|3520997|P3|STARTED|Overall Study||1
1438438|NCT02299089|3520998|P2|STARTED|Overall Study||4
1438439|NCT02299089|3520999|P1|STARTED|Overall Study||3
1438440|NCT02299076|3521045|P2|NOT COMPLETED|Overall Study||14
1438441|NCT02299076|3521046|P1|NOT COMPLETED|Overall Study||20
1438442|NCT02299076|3521045|P2|COMPLETED|Overall Study||212
1438443|NCT02299076|3521046|P1|COMPLETED|Overall Study||210
1438444|NCT02299076|3521045|P2|STARTED|Overall Study||226
1438445|NCT02299076|3521046|P1|STARTED|Overall Study||230
1438446|NCT02298868|3521054|P1|NOT COMPLETED|Overall Study||3
1438447|NCT02298868|3521054|P1|COMPLETED|Overall Study||7
1438448|NCT02298868|3521054|P1|STARTED|Overall Study||10
1438449|NCT02298842|3521068|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
1438450|NCT02298842|3521069|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
1438451|NCT02298842|3521068|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
1438452|NCT02298842|3521069|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
1438453|NCT02298842|3521068|P2|STARTED|Second Platelet Donation (Day 6-8)||36
1438454|NCT02298842|3521069|P1|STARTED|Second Platelet Donation (Day 6-8)||38
1438455|NCT02298842|3521068|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
1438456|NCT02298842|3521069|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
1438457|NCT02298842|3521068|P2|COMPLETED|First Platelet Donation (Day 0)||36
1438458|NCT02298842|3521069|P1|COMPLETED|First Platelet Donation (Day 0)||38
1438459|NCT02298842|3521068|P2|STARTED|First Platelet Donation (Day 0)||41
1438460|NCT02298842|3521069|P1|STARTED|First Platelet Donation (Day 0)||44
1438461|NCT02298803|3521095|P1|NOT COMPLETED|Overall Study||0
1438462|NCT02298803|3521095|P1|COMPLETED|Overall Study||30
1438463|NCT02298803|3521095|P1|STARTED|Overall Study||30
1438464|NCT02298361|3521107|P3|NOT COMPLETED|Overall Study||0
1438465|NCT02298361|3521108|P2|NOT COMPLETED|Overall Study||0
1438466|NCT02298361|3521109|P1|NOT COMPLETED|Overall Study||0
1438467|NCT02298361|3521107|P3|COMPLETED|Overall Study||12227
1438468|NCT02298361|3521108|P2|COMPLETED|Overall Study||12784
1438469|NCT02298361|3521109|P1|COMPLETED|Overall Study||2240
1438470|NCT02298361|3521107|P3|STARTED|Overall Study||12227
1438471|NCT02298361|3521108|P2|STARTED|Overall Study||12784
1438472|NCT02298361|3521109|P1|STARTED|Overall Study||2240
1438473|NCT02298192|3521125|P2|NOT COMPLETED|Overall Study||6
1438474|NCT02298192|3521126|P1|NOT COMPLETED|Overall Study||19
1438475|NCT02298192|3521125|P2|COMPLETED|Overall Study||204
1438476|NCT02298192|3521126|P1|COMPLETED|Overall Study||191
1438477|NCT02298192|3521125|P2|STARTED|Overall Study||210
1438478|NCT02298192|3521126|P1|STARTED|Overall Study||210
1438479|NCT02298179|3521150|P12|NOT COMPLETED|Overall Study||0
1438480|NCT02298179|3521151|P11|NOT COMPLETED|Overall Study||0
1438481|NCT02298179|3521152|P10|NOT COMPLETED|Overall Study||0
1438482|NCT02298179|3521153|P9|NOT COMPLETED|Overall Study||0
1438483|NCT02298179|3521154|P8|NOT COMPLETED|Overall Study||1
1438484|NCT02298179|3521155|P7|NOT COMPLETED|Overall Study||0
1438485|NCT02298179|3521156|P6|NOT COMPLETED|Overall Study||0
1438486|NCT02298179|3521157|P5|NOT COMPLETED|Overall Study||0
1438487|NCT02298179|3521158|P4|NOT COMPLETED|Overall Study||0
1438488|NCT02298179|3521159|P3|NOT COMPLETED|Overall Study||1
1438489|NCT02298179|3521160|P2|NOT COMPLETED|Overall Study||0
1438490|NCT02298179|3521161|P1|NOT COMPLETED|Overall Study||0
1438491|NCT02298179|3521150|P12|COMPLETED|Overall Study||24
1438492|NCT02298179|3521151|P11|COMPLETED|Overall Study||24
1438493|NCT02298179|3521152|P10|COMPLETED|Overall Study||24
1438494|NCT02298179|3521153|P9|COMPLETED|Overall Study||24
1438495|NCT02298179|3521154|P8|COMPLETED|Overall Study||23
1438496|NCT02298179|3521155|P7|COMPLETED|Overall Study||24
1438497|NCT02298179|3521156|P6|COMPLETED|Overall Study||24
1438498|NCT02298179|3521157|P5|COMPLETED|Overall Study||24
1438499|NCT02298179|3521158|P4|COMPLETED|Overall Study||24
1438500|NCT02298179|3521159|P3|COMPLETED|Overall Study||23
1438501|NCT02298179|3521160|P2|COMPLETED|Overall Study||24
1438502|NCT02298179|3521161|P1|COMPLETED|Overall Study||24
1438503|NCT02298179|3521150|P12|STARTED|Overall Study||24
1438504|NCT02298179|3521151|P11|STARTED|Overall Study||24
1438505|NCT02298179|3521152|P10|STARTED|Overall Study||24
1438506|NCT02298179|3521153|P9|STARTED|Overall Study||24
1438507|NCT02298179|3521154|P8|STARTED|Overall Study||24
1438508|NCT02298179|3521155|P7|STARTED|Overall Study||24
1438509|NCT02298179|3521156|P6|STARTED|Overall Study||24
1438510|NCT02298179|3521157|P5|STARTED|Overall Study||24
1438511|NCT02298179|3521158|P4|STARTED|Overall Study||24
1438512|NCT02298179|3521159|P3|STARTED|Overall Study||24
1438513|NCT02298179|3521160|P2|STARTED|Overall Study||24
1438514|NCT02298179|3521161|P1|STARTED|Overall Study||24
1438515|NCT02297841|3521403|P1|NOT COMPLETED|Overall Study||8
1438516|NCT02297841|3521403|P1|COMPLETED|Overall Study||201
1438517|NCT02297841|3521403|P1|Challenge Phase|Overall Study||201
1438518|NCT02297841|3521403|P1|Induction Phase|Overall Study||209
1438519|NCT02297841|3521403|P1|STARTED|Overall Study||209
1438520|NCT02297815|3521409|P2|NOT COMPLETED|Overall Study||140
1438521|NCT02297815|3521410|P1|NOT COMPLETED|Overall Study||236
1438522|NCT02297815|3521409|P2|COMPLETED|Overall Study||728
1438523|NCT02297815|3521410|P1|COMPLETED|Overall Study||1368
1438524|NCT02297815|3521409|P2|14-20 Day Interview|Overall Study||728
1438525|NCT02297815|3521410|P1|14-20 Day Interview|Overall Study||1368
1438526|NCT02297815|3521409|P2|5-10 Day Interview|Overall Study||868
1438527|NCT02297815|3521410|P1|5-10 Day Interview|Overall Study||1604
1438528|NCT02297815|3521409|P2|STARTED|Overall Study||868
1438529|NCT02297815|3521410|P1|STARTED|Overall Study||1604
1438530|NCT02297412|3521426|P2|NOT COMPLETED|Overall Study||1
1438531|NCT02297412|3521427|P1|NOT COMPLETED|Overall Study||1
1438532|NCT02297412|3521426|P2|COMPLETED|Overall Study||23
1438533|NCT02297412|3521427|P1|COMPLETED|Overall Study||22
1438534|NCT02297412|3521426|P2|STARTED|Overall Study||24
1438535|NCT02297412|3521427|P1|STARTED|Overall Study||23
1438536|NCT02297308|3521437|P1|NOT COMPLETED|Overall Study||0
1438537|NCT02297308|3521437|P1|COMPLETED|Overall Study||90
1438538|NCT02297308|3521437|P1|STARTED|Overall Study||90
1438539|NCT02297230|3521446|P4|NOT COMPLETED|Overall Study||0
1438540|NCT02297230|3521447|P3|NOT COMPLETED|Overall Study||0
1438541|NCT02297230|3521448|P2|NOT COMPLETED|Overall Study||0
1438542|NCT02297230|3521449|P1|NOT COMPLETED|Overall Study||0
1438543|NCT02297230|3521446|P4|COMPLETED|Overall Study||11
1438544|NCT02297230|3521447|P3|COMPLETED|Overall Study||11
1438545|NCT02297230|3521448|P2|COMPLETED|Overall Study||11
1438546|NCT02297230|3521449|P1|COMPLETED|Overall Study||11
1438547|NCT02297230|3521446|P4|STARTED|Overall Study||11
1438548|NCT02297230|3521447|P3|STARTED|Overall Study||11
1438549|NCT02297230|3521448|P2|STARTED|Overall Study||11
1438550|NCT02297230|3521449|P1|STARTED|Overall Study||11
1438551|NCT02297100|3521473|P2|NOT COMPLETED|Overall Study||0
1438552|NCT02297100|3521474|P1|NOT COMPLETED|Overall Study||0
1438553|NCT02297100|3521473|P2|COMPLETED|Overall Study||14
1438554|NCT02297100|3521474|P1|COMPLETED|Overall Study||13
1438555|NCT02297100|3521473|P2|STARTED|Overall Study||14
1438556|NCT02297100|3521474|P1|STARTED|Overall Study||13
1438557|NCT02296931|3521488|P2|NOT COMPLETED|Overall Study||2
1438558|NCT02296931|3521489|P1|NOT COMPLETED|Overall Study||0
1438559|NCT02296931|3521488|P2|COMPLETED|Overall Study||22
1438560|NCT02296931|3521489|P1|COMPLETED|Overall Study||10
1438561|NCT02296931|3521488|P2|STARTED|Overall Study||24
1438562|NCT02296931|3521489|P1|STARTED|Overall Study||10
1438563|NCT02296840|3521497|P2|NOT COMPLETED|Overall Study||19
1438564|NCT02296840|3521498|P1|NOT COMPLETED|Overall Study||9
1438565|NCT02296840|3521497|P2|COMPLETED|Overall Study||8
1438566|NCT02296840|3521498|P1|COMPLETED|Overall Study||9
1438567|NCT02296840|3521497|P2|STARTED|Overall Study||27
1438568|NCT02296840|3521498|P1|STARTED|Overall Study||18
1438569|NCT02296606|3521506|P1|NOT COMPLETED|Overall Study||0
1438570|NCT02296606|3521506|P1|COMPLETED|Overall Study||127
1438571|NCT02296606|3521506|P1|STARTED|Overall Study||127
1438572|NCT02296476|3521513|P3|NOT COMPLETED|Overall Study||2
1438573|NCT02296476|3521514|P2|NOT COMPLETED|Overall Study||4
1438574|NCT02296476|3521515|P1|NOT COMPLETED|Overall Study||6
1438575|NCT02296476|3521513|P3|COMPLETED|Overall Study||0
1438576|NCT02296476|3521514|P2|COMPLETED|Overall Study||0
1438577|NCT02296476|3521515|P1|COMPLETED|Overall Study||0
1438578|NCT02296476|3521513|P3|STARTED|Overall Study||2
1438579|NCT02296476|3521514|P2|STARTED|Overall Study||4
1438580|NCT02296476|3521515|P1|STARTED|Overall Study||6
1438581|NCT02296242|3521573|P5|NOT COMPLETED|Overall Study||21
1438582|NCT02296242|3521574|P4|NOT COMPLETED|Overall Study||14
1438583|NCT02296242|3521575|P3|NOT COMPLETED|Overall Study||7
1438584|NCT02296242|3521576|P2|NOT COMPLETED|Overall Study||6
1438585|NCT02296242|3521577|P1|NOT COMPLETED|Overall Study||5
1438586|NCT02296242|3521573|P5|COMPLETED|Overall Study||0
1438587|NCT02296242|3521574|P4|COMPLETED|Overall Study||0
1438588|NCT02296242|3521575|P3|COMPLETED|Overall Study||0
1438589|NCT02296242|3521576|P2|COMPLETED|Overall Study||0
1438590|NCT02296242|3521577|P1|COMPLETED|Overall Study||0
1438591|NCT02296242|3521573|P5|STARTED|Overall Study||21
1438592|NCT02296242|3521574|P4|STARTED|Overall Study||14
1438593|NCT02296242|3521575|P3|STARTED|Overall Study||7
1438594|NCT02296242|3521576|P2|STARTED|Overall Study||6
1438595|NCT02296242|3521577|P1|STARTED|Overall Study||5
1438596|NCT02296138|3521601|P2|NOT COMPLETED|Overall Study||500
1438597|NCT02296138|3521602|P1|NOT COMPLETED|Overall Study||661
1438598|NCT02296138|3521601|P2|COMPLETED|Overall Study||3451
1438599|NCT02296138|3521602|P1|COMPLETED|Overall Study||3291
1438600|NCT02296138|3521601|P2|Treated|Overall Study||3939
1438601|NCT02296138|3521602|P1|Treated|Overall Study||3941
1438602|NCT02296138|3521601|P2|STARTED|Overall Study||3951
1438603|NCT02296138|3521602|P1|STARTED|Overall Study||3952
1438604|NCT02296125|3521618|P2|NOT COMPLETED|Overall Study||213
1438605|NCT02296125|3521619|P1|NOT COMPLETED|Overall Study||138
1438606|NCT02296125|3521618|P2|COMPLETED|Overall Study||64
1438607|NCT02296125|3521619|P1|COMPLETED|Overall Study||141
1438608|NCT02296125|3521618|P2|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
1438609|NCT02296125|3521619|P1|STARTED|Overall Study||279
1438610|NCT02296099|3521648|P2|NOT COMPLETED|Overall Study||2
1438611|NCT02296099|3521649|P1|NOT COMPLETED|Overall Study||3
1438612|NCT02296099|3521648|P2|COMPLETED|Overall Study||55
1438613|NCT02296099|3521649|P1|COMPLETED|Overall Study||54
1438614|NCT02296099|3521648|P2|STARTED|Overall Study||57
1438615|NCT02296099|3521649|P1|STARTED|Overall Study||57
1438616|NCT02295774|3521673|P1|NOT COMPLETED|Overall Study||3
1438617|NCT02295774|3521673|P1|COMPLETED|Overall Study||10
1438618|NCT02295774|3521673|P1|STARTED|Overall Study||13
1438619|NCT02295644|3521682|P4|NOT COMPLETED|Overall Study||2
1438620|NCT02295644|3521683|P3|NOT COMPLETED|Overall Study||1
1438621|NCT02295644|3521684|P2|NOT COMPLETED|Overall Study||0
1438622|NCT02295644|3521685|P1|NOT COMPLETED|Overall Study||0
1438623|NCT02295644|3521682|P4|COMPLETED|Overall Study||5
1438624|NCT02295644|3521683|P3|COMPLETED|Overall Study||6
1438625|NCT02295644|3521684|P2|COMPLETED|Overall Study||7
1438626|NCT02295644|3521685|P1|COMPLETED|Overall Study||7
1438627|NCT02295644|3521682|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
1438628|NCT02295644|3521683|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
1438629|NCT02295644|3521684|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
1438630|NCT02295644|3521685|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
1438631|NCT02295280|3521705|P2|NOT COMPLETED|Overall Study||1
1438632|NCT02295280|3521706|P1|NOT COMPLETED|Overall Study||0
1438633|NCT02295280|3521705|P2|COMPLETED|Overall Study||34
1438634|NCT02295280|3521706|P1|COMPLETED|Overall Study||35
1438635|NCT02295280|3521705|P2|STARTED|Overall Study||35
1438636|NCT02295280|3521706|P1|STARTED|Overall Study||35
1438637|NCT02295020|3521714|P2|NOT COMPLETED|Overall Study||3
1438638|NCT02295020|3521715|P1|NOT COMPLETED|Overall Study||3
1438639|NCT02295020|3521714|P2|COMPLETED|Overall Study||17
1438640|NCT02295020|3521715|P1|COMPLETED|Overall Study||17
1438641|NCT02295020|3521714|P2|STARTED|Overall Study||20
1438642|NCT02295020|3521715|P1|STARTED|Overall Study||20
1438643|NCT02294773|3521747|P2|NOT COMPLETED|Overall Study||2
1438644|NCT02294773|3521748|P1|NOT COMPLETED|Overall Study||0
1438645|NCT02294773|3521747|P2|COMPLETED|Overall Study||4
1438646|NCT02294773|3521748|P1|COMPLETED|Overall Study||7
1438647|NCT02294773|3521747|P2|STARTED|Overall Study||6
1438648|NCT02294773|3521748|P1|STARTED|Overall Study||7
1438649|NCT02294734|3521764|P2|NOT COMPLETED|Overall Study||8
1438650|NCT02294734|3521765|P1|NOT COMPLETED|Overall Study||14
1438651|NCT02294734|3521764|P2|COMPLETED|Overall Study||55
1438652|NCT02294734|3521765|P1|COMPLETED|Overall Study||49
1438653|NCT02294734|3521764|P2|STARTED|Overall Study||63
1438654|NCT02294734|3521765|P1|STARTED|Overall Study||63
1438655|NCT02294682|3521817|P2|NOT COMPLETED|Overall Study||0
1438656|NCT02294682|3521818|P1|NOT COMPLETED|Overall Study||1
1438657|NCT02294682|3521817|P2|COMPLETED|Overall Study||53
1438658|NCT02294682|3521818|P1|COMPLETED|Overall Study||52
1438659|NCT02294682|3521817|P2|STARTED|Overall Study||53
1438660|NCT02294682|3521818|P1|STARTED|Overall Study||53
1438661|NCT02294604|3521861|P3|NOT COMPLETED|Overall Study||0
1438662|NCT02294604|3521862|P2|NOT COMPLETED|Overall Study||3
1438663|NCT02294604|3521863|P1|NOT COMPLETED|Overall Study||1
1438664|NCT02294604|3521861|P3|COMPLETED|Overall Study||80
1438665|NCT02294604|3521862|P2|COMPLETED|Overall Study||77
1438666|NCT02294604|3521863|P1|COMPLETED|Overall Study||79
1438667|NCT02294604|3521861|P3|STARTED|Overall Study||80
1438668|NCT02294604|3521862|P2|STARTED|Overall Study||80
1438669|NCT02294604|3521863|P1|STARTED|Overall Study||80
1438670|NCT02294474|3521882|P2|NOT COMPLETED|Overall Study||22
1438671|NCT02294474|3521883|P1|NOT COMPLETED|Overall Study||25
1438672|NCT02294474|3521882|P2|COMPLETED|Overall Study||230
1438673|NCT02294474|3521883|P1|COMPLETED|Overall Study||228
1438674|NCT02294474|3521882|P2|STARTED|Overall Study||252
1438675|NCT02294474|3521883|P1|STARTED|Overall Study||253
1438676|NCT02294461|3521907|P2|NOT COMPLETED|Overall Study||131
1438677|NCT02294461|3521908|P1|NOT COMPLETED|Overall Study||62
1438678|NCT02294461|3521907|P2|COMPLETED|Overall Study||59
1438679|NCT02294461|3521908|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
1438680|NCT02294461|3521907|P2|Treated/Received Study Drug|Overall Study||190
1438681|NCT02294461|3521908|P1|Treated/Received Study Drug|Overall Study||198
1438682|NCT02294461|3521907|P2|STARTED|Overall Study||190
1438683|NCT02294461|3521908|P1|STARTED|Overall Study||198
1438684|NCT02294396|3521964|P4|NOT COMPLETED|Overall Study||37
1438685|NCT02294396|3521965|P3|NOT COMPLETED|Overall Study||35
1438686|NCT02294396|3521966|P2|NOT COMPLETED|Overall Study||33
1438687|NCT02294396|3521967|P1|NOT COMPLETED|Overall Study||40
1438688|NCT02294396|3521964|P4|COMPLETED|Overall Study||123
1438689|NCT02294396|3521965|P3|COMPLETED|Overall Study||126
1438690|NCT02294396|3521966|P2|COMPLETED|Overall Study||128
1438691|NCT02294396|3521967|P1|COMPLETED|Overall Study||127
1438692|NCT02294396|3521964|P4|STARTED|Overall Study||160
1438693|NCT02294396|3521965|P3|STARTED|Overall Study||161
1438694|NCT02294396|3521966|P2|STARTED|Overall Study||161
1438695|NCT02294396|3521967|P1|STARTED|Overall Study||167
1438696|NCT02294019|3522037|P1|NOT COMPLETED|Overall Study||103
1438697|NCT02294019|3522037|P1|COMPLETED|Overall Study||635
1438698|NCT02294019|3522037|P1|STARTED|Overall Study||738
1438699|NCT02293902|3522045|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
1438700|NCT02293902|3522046|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
1438701|NCT02293902|3522047|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
1438702|NCT02293902|3522048|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
1438703|NCT02293902|3522049|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
1438704|NCT02293902|3522045|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
1438705|NCT02293902|3522046|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
1438706|NCT02293902|3522047|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
1438707|NCT02293902|3522048|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
1438708|NCT02293902|3522049|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
1438709|NCT02293902|3522045|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
1438710|NCT02293902|3522046|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
1438711|NCT02293902|3522047|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
1438712|NCT02293902|3522048|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
1438713|NCT02293902|3522049|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
1438714|NCT02293902|3522045|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
1438715|NCT02293902|3522046|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
1438716|NCT02293902|3522047|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
1438717|NCT02293902|3522048|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
1438718|NCT02293902|3522049|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
1438719|NCT02293902|3522045|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
1438720|NCT02293902|3522046|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
1438721|NCT02293902|3522047|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
1438722|NCT02293902|3522048|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
1438723|NCT02293902|3522049|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
1438724|NCT02293902|3522045|P5|Rescued|Double-Blind Period (Up to Week 24)||0
1438725|NCT02293902|3522046|P4|Rescued|Double-Blind Period (Up to Week 24)||0
1438726|NCT02293902|3522047|P3|Rescued|Double-Blind Period (Up to Week 24)||8
1438727|NCT02293902|3522048|P2|Rescued|Double-Blind Period (Up to Week 24)||6
1438728|NCT02293902|3522049|P1|Rescued|Double-Blind Period (Up to Week 24)||44
1438729|NCT02293902|3522045|P5|Treated|Double-Blind Period (Up to Week 24)||0
1438730|NCT02293902|3522046|P4|Treated|Double-Blind Period (Up to Week 24)||0
1438731|NCT02293902|3522047|P3|Treated|Double-Blind Period (Up to Week 24)||80
1438732|NCT02293902|3522048|P2|Treated|Double-Blind Period (Up to Week 24)||81
1438733|NCT02293902|3522049|P1|Treated|Double-Blind Period (Up to Week 24)||81
1438734|NCT02293902|3522045|P5|STARTED|Double-Blind Period (Up to Week 24)||0
1438735|NCT02293902|3522046|P4|STARTED|Double-Blind Period (Up to Week 24)||0
1438736|NCT02293902|3522047|P3|STARTED|Double-Blind Period (Up to Week 24)||80
1438737|NCT02293902|3522048|P2|STARTED|Double-Blind Period (Up to Week 24)||81
1438738|NCT02293902|3522049|P1|STARTED|Double-Blind Period (Up to Week 24)||82
1438739|NCT02293863|3522111|P3|NOT COMPLETED|Overall Study||9
1438740|NCT02293863|3522112|P2|NOT COMPLETED|Overall Study||13
1438741|NCT02293863|3522113|P1|NOT COMPLETED|Overall Study||9
1438742|NCT02293863|3522111|P3|COMPLETED|Overall Study||38
1438743|NCT02293863|3522112|P2|COMPLETED|Overall Study||42
1438744|NCT02293863|3522113|P1|COMPLETED|Overall Study||47
1438745|NCT02293863|3522111|P3|STARTED|Overall Study||47
1438746|NCT02293863|3522112|P2|STARTED|Overall Study||55
1438747|NCT02293863|3522113|P1|STARTED|Overall Study||56
1438748|NCT02293538|3522178|P2|NOT COMPLETED|Overall Study||2
1438749|NCT02293538|3522179|P1|NOT COMPLETED|Overall Study||1
1438750|NCT02293538|3522178|P2|COMPLETED|Overall Study||69
1438751|NCT02293538|3522179|P1|COMPLETED|Overall Study||72
1438752|NCT02293538|3522178|P2|STARTED|Overall Study||71
1438753|NCT02293538|3522179|P1|STARTED|Overall Study||73
1438754|NCT02293512|3522196|P4|NOT COMPLETED|Overall Study||2
1438755|NCT02293512|3522197|P3|NOT COMPLETED|Overall Study||3
1438756|NCT02293512|3522198|P2|NOT COMPLETED|Overall Study||6
1438757|NCT02293512|3522199|P1|NOT COMPLETED|Overall Study||4
1438758|NCT02293512|3522196|P4|COMPLETED|Overall Study||8
1438759|NCT02293512|3522197|P3|COMPLETED|Overall Study||7
1438760|NCT02293512|3522198|P2|COMPLETED|Overall Study||4
1438761|NCT02293512|3522199|P1|COMPLETED|Overall Study||6
1438762|NCT02293512|3522196|P4|STARTED|Overall Study||10
1438763|NCT02293512|3522197|P3|STARTED|Overall Study||10
1438764|NCT02293512|3522198|P2|STARTED|Overall Study||10
1438765|NCT02293512|3522199|P1|STARTED|Overall Study||10
1438766|NCT02293395|3522211|P2|NOT COMPLETED|Overall Study||7
1438767|NCT02293395|3522212|P1|NOT COMPLETED|Overall Study||9
1438768|NCT02293395|3522211|P2|COMPLETED|Overall Study||1511
1438769|NCT02293395|3522212|P1|COMPLETED|Overall Study||1510
1438770|NCT02293395|3522211|P2|Treated|Overall Study||1506
1438771|NCT02293395|3522212|P1|Treated|Overall Study||1510
1438772|NCT02293395|3522211|P2|STARTED|Overall Study||1518
1438773|NCT02293395|3522212|P1|STARTED|Overall Study||1519
1438774|NCT02292849|3522221|P3|NOT COMPLETED|Overall Study||2
1438775|NCT02292849|3522222|P2|NOT COMPLETED|Overall Study||2
1438776|NCT02292849|3522223|P1|NOT COMPLETED|Overall Study||4
1438777|NCT02292849|3522221|P3|COMPLETED|Overall Study||8
1438778|NCT02292849|3522222|P2|COMPLETED|Overall Study||6
1438779|NCT02292849|3522223|P1|COMPLETED|Overall Study||7
1438780|NCT02292849|3522221|P3|STARTED|Overall Study||10
1438781|NCT02292849|3522222|P2|STARTED|Overall Study||8
1438782|NCT02292849|3522223|P1|STARTED|Overall Study||11
1438783|NCT02292771|3522233|P2|NOT COMPLETED|Overall Study||2
1438784|NCT02292771|3522234|P1|NOT COMPLETED|Overall Study||4
1438785|NCT02292771|3522233|P2|COMPLETED|Overall Study||48
1438786|NCT02292771|3522234|P1|COMPLETED|Overall Study||43
1438787|NCT02292771|3522233|P2|STARTED|Overall Study||50
1438788|NCT02292771|3522234|P1|STARTED|Overall Study||47
1438789|NCT02292719|3522330|P6|NOT COMPLETED|Overall Study||0
1438790|NCT02292719|3522331|P5|NOT COMPLETED|Overall Study||1
1438791|NCT02292719|3522332|P4|NOT COMPLETED|Overall Study||1
1438792|NCT02292719|3522333|P3|NOT COMPLETED|Overall Study||1
1438793|NCT02292719|3522334|P2|NOT COMPLETED|Overall Study||0
1438794|NCT02292719|3522335|P1|NOT COMPLETED|Overall Study||0
1438795|NCT02292719|3522330|P6|COMPLETED|Overall Study||10
1438796|NCT02292719|3522331|P5|COMPLETED|Overall Study||20
1438797|NCT02292719|3522332|P4|COMPLETED|Overall Study||8
1438798|NCT02292719|3522333|P3|COMPLETED|Overall Study||9
1438799|NCT02292719|3522334|P2|COMPLETED|Overall Study||11
1438800|NCT02292719|3522335|P1|COMPLETED|Overall Study||9
1438801|NCT02292719|3522330|P6|STARTED|Overall Study||10
1438802|NCT02292719|3522331|P5|STARTED|Overall Study||21
1438803|NCT02292719|3522332|P4|STARTED|Overall Study||9
1438804|NCT02292719|3522333|P3|STARTED|Overall Study||10
1438805|NCT02292719|3522334|P2|STARTED|Overall Study||11
1438806|NCT02292719|3522335|P1|STARTED|Overall Study||9
1438807|NCT02292537|3522363|P2|NOT COMPLETED|Overall Study||0
1438808|NCT02292537|3522364|P1|NOT COMPLETED|Overall Study||0
1438809|NCT02292537|3522363|P2|COMPLETED|Overall Study||84
1438810|NCT02292537|3522364|P1|COMPLETED|Overall Study||42
1438811|NCT02292537|3522363|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
1438812|NCT02292537|3522364|P1|Completed Treatment|Overall Study||42
1438813|NCT02292537|3522363|P2|STARTED|Overall Study||84
1438814|NCT02292537|3522364|P1|STARTED|Overall Study||42
1438815|NCT02292433|3522401|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
1438816|NCT02292433|3522402|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
1438817|NCT02292433|3522403|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
1438818|NCT02292433|3522401|P3|COMPLETED|Third Intervention Period (7 Days)||4
1438819|NCT02292433|3522402|P2|COMPLETED|Third Intervention Period (7 Days)||4
1438820|NCT02292433|3522403|P1|COMPLETED|Third Intervention Period (7 Days)||4
1438821|NCT02292433|3522401|P3|STARTED|Third Intervention Period (7 Days)||4
1438822|NCT02292433|3522402|P2|STARTED|Third Intervention Period (7 Days)||4
1438823|NCT02292433|3522403|P1|STARTED|Third Intervention Period (7 Days)||4
1438824|NCT02292433|3522401|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
1438825|NCT02292433|3522402|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
1438826|NCT02292433|3522403|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
1438827|NCT02292433|3522401|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
1438828|NCT02292433|3522402|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
1438829|NCT02292433|3522403|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
1438830|NCT02292433|3522401|P3|STARTED|Second Washout Period (7 to 14 Days)||4
1438831|NCT02292433|3522402|P2|STARTED|Second Washout Period (7 to 14 Days)||4
1438832|NCT02292433|3522403|P1|STARTED|Second Washout Period (7 to 14 Days)||4
1438833|NCT02292433|3522401|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
1438834|NCT02292433|3522402|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
1438835|NCT02292433|3522403|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
1438836|NCT02292433|3522401|P3|COMPLETED|Second Intervention Period (7 Days)||4
1438837|NCT02292433|3522402|P2|COMPLETED|Second Intervention Period (7 Days)||4
1438838|NCT02292433|3522403|P1|COMPLETED|Second Intervention Period (7 Days)||4
1438839|NCT02292433|3522401|P3|STARTED|Second Intervention Period (7 Days)||4
1438840|NCT02292433|3522402|P2|STARTED|Second Intervention Period (7 Days)||4
1438841|NCT02292433|3522403|P1|STARTED|Second Intervention Period (7 Days)||4
1438842|NCT02292433|3522401|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
1438843|NCT02292433|3522402|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
1438844|NCT02292433|3522403|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
1438845|NCT02292433|3522401|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
1438846|NCT02292433|3522402|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
1438847|NCT02292433|3522403|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
1438848|NCT02292433|3522401|P3|STARTED|First Washout Period (7 to 14 Days)||4
1438849|NCT02292433|3522402|P2|STARTED|First Washout Period (7 to 14 Days)||4
1438850|NCT02292433|3522403|P1|STARTED|First Washout Period (7 to 14 Days)||4
1438851|NCT02292433|3522401|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
1438852|NCT02292433|3522402|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
1438853|NCT02292433|3522403|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
1438854|NCT02292433|3522401|P3|COMPLETED|First Intervention Period (7 Days)||4
1438855|NCT02292433|3522402|P2|COMPLETED|First Intervention Period (7 Days)||4
1438856|NCT02292433|3522403|P1|COMPLETED|First Intervention Period (7 Days)||4
1438857|NCT02292433|3522401|P3|STARTED|First Intervention Period (7 Days)||4
1438858|NCT02292433|3522402|P2|STARTED|First Intervention Period (7 Days)||4
1438859|NCT02292433|3522403|P1|STARTED|First Intervention Period (7 Days)||4
1438860|NCT02292212|3522474|P1|NOT COMPLETED|Post-ViE Phase||0
1438861|NCT02292212|3522474|P1|COMPLETED|Post-ViE Phase||14
1438862|NCT02292212|3522474|P1|STARTED|Post-ViE Phase||14
1438863|NCT02292212|3522474|P1|NOT COMPLETED|ViE Phase||3
1438864|NCT02292212|3522474|P1|COMPLETED|ViE Phase||14
1438865|NCT02292212|3522474|P1|STARTED|ViE Phase||17
1438866|NCT02292212|3522474|P1|NOT COMPLETED|Pre-ViE Phase||0
1438867|NCT02292212|3522474|P1|COMPLETED|Pre-ViE Phase||17
1438868|NCT02292212|3522474|P1|STARTED|Pre-ViE Phase||17
1438869|NCT02292186|3522506|P1|NOT COMPLETED|Overall Study||18
1438870|NCT02292186|3522506|P1|COMPLETED|Overall Study||7
1438871|NCT02292186|3522506|P1|STARTED|Overall Study||25
1438872|NCT02291861|3522518|P4|NOT COMPLETED|Overall Study||10
1438873|NCT02291861|3522519|P3|NOT COMPLETED|Overall Study||9
1438874|NCT02291861|3522520|P2|NOT COMPLETED|Overall Study||8
1438875|NCT02291861|3522521|P1|NOT COMPLETED|Overall Study||7
1438876|NCT02291861|3522518|P4|COMPLETED|Overall Study||65
1438877|NCT02291861|3522519|P3|COMPLETED|Overall Study||65
1438878|NCT02291861|3522520|P2|COMPLETED|Overall Study||67
1438879|NCT02291861|3522521|P1|COMPLETED|Overall Study||67
1438880|NCT02291861|3522518|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
1438881|NCT02291861|3522519|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
1438882|NCT02291861|3522520|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
1438883|NCT02291861|3522521|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
1438884|NCT02291861|3522518|P4|Safety Population|Overall Study||74
1438885|NCT02291861|3522519|P3|Safety Population|Overall Study||73
1438886|NCT02291861|3522520|P2|Safety Population|Overall Study||74
1438887|NCT02291861|3522521|P1|Safety Population|Overall Study||72
1438888|NCT02291861|3522518|P4|STARTED|Overall Study||75
1438889|NCT02291861|3522519|P3|STARTED|Overall Study||74
1438890|NCT02291861|3522520|P2|STARTED|Overall Study||75
1438891|NCT02291861|3522521|P1|STARTED|Overall Study||74
1438892|NCT02291718|3522562|P3|NOT COMPLETED|Overall Study||0
1438893|NCT02291718|3522563|P2|NOT COMPLETED|Overall Study||0
1438894|NCT02291718|3522564|P1|NOT COMPLETED|Overall Study||0
1438895|NCT02291718|3522562|P3|COMPLETED|Overall Study||50
1438896|NCT02291718|3522563|P2|COMPLETED|Overall Study||50
1438897|NCT02291718|3522564|P1|COMPLETED|Overall Study||50
1438898|NCT02291718|3522562|P3|STARTED|Overall Study||50
1438899|NCT02291718|3522563|P2|STARTED|Overall Study||50
1438900|NCT02291718|3522564|P1|STARTED|Overall Study||50
1438901|NCT02291679|3522584|P3|NOT COMPLETED|Overall Study||59
1438902|NCT02291679|3522585|P2|NOT COMPLETED|Overall Study||42
1438903|NCT02291679|3522586|P1|NOT COMPLETED|Overall Study||44
1438904|NCT02291679|3522584|P3|COMPLETED|Overall Study||352
1438905|NCT02291679|3522585|P2|COMPLETED|Overall Study||369
1438906|NCT02291679|3522586|P1|COMPLETED|Overall Study||357
1438907|NCT02291679|3522584|P3|STARTED|Overall Study||411
1438908|NCT02291679|3522585|P2|STARTED|Overall Study||411
1438909|NCT02291679|3522586|P1|STARTED|Overall Study||401
1438910|NCT02291549|3522617|P2|NOT COMPLETED|Overall Study||1
1438911|NCT02291549|3522618|P1|NOT COMPLETED|Overall Study||1
1438912|NCT02291549|3522617|P2|COMPLETED|Overall Study||98
1438913|NCT02291549|3522618|P1|COMPLETED|Overall Study||200
1438914|NCT02291549|3522617|P2|STARTED|Overall Study||99
1438915|NCT02291549|3522618|P1|STARTED|Overall Study||201
1438916|NCT02291510|3522640|P4|NOT COMPLETED|Overall Study||1
1438917|NCT02291510|3522641|P3|NOT COMPLETED|Overall Study||0
1438918|NCT02291510|3522642|P2|NOT COMPLETED|Overall Study||0
1438919|NCT02291510|3522643|P1|NOT COMPLETED|Overall Study||0
1438920|NCT02291510|3522640|P4|COMPLETED|Overall Study||4
1438921|NCT02291510|3522641|P3|COMPLETED|Overall Study||5
1438922|NCT02291510|3522642|P2|COMPLETED|Overall Study||5
1438923|NCT02291510|3522643|P1|COMPLETED|Overall Study||5
1438924|NCT02291510|3522640|P4|Completed Treatment D|Overall Study||5
1438925|NCT02291510|3522641|P3|Completed Treatment D|Overall Study||5
1438926|NCT02291510|3522642|P2|Completed Treatment D|Overall Study||5
1438927|NCT02291510|3522643|P1|Completed Treatment D|Overall Study||5
1438928|NCT02291510|3522640|P4|Completed Treatment C|Overall Study||4
1438929|NCT02291510|3522641|P3|Completed Treatment C|Overall Study||5
1438930|NCT02291510|3522642|P2|Completed Treatment C|Overall Study||5
1438931|NCT02291510|3522643|P1|Completed Treatment C|Overall Study||5
1438932|NCT02291510|3522640|P4|Completed Treatment B|Overall Study||4
1438933|NCT02291510|3522641|P3|Completed Treatment B|Overall Study||5
1438934|NCT02291510|3522642|P2|Completed Treatment B|Overall Study||5
1438935|NCT02291510|3522643|P1|Completed Treatment B|Overall Study||5
1438936|NCT02291510|3522640|P4|Completed Treatment A|Overall Study||5
1438937|NCT02291510|3522641|P3|Completed Treatment A|Overall Study||5
1438938|NCT02291510|3522642|P2|Completed Treatment A|Overall Study||5
1438939|NCT02291510|3522643|P1|Completed Treatment A|Overall Study||5
1438940|NCT02291510|3522640|P4|STARTED|Overall Study||5
1438941|NCT02291510|3522641|P3|STARTED|Overall Study||5
1438942|NCT02291510|3522642|P2|STARTED|Overall Study||5
1438943|NCT02291510|3522643|P1|STARTED|Overall Study||5
1438944|NCT02291419|3522659|P2|NOT COMPLETED|Overall Study||5
1438945|NCT02291419|3522660|P1|NOT COMPLETED|Overall Study||1
1438946|NCT02291419|3522659|P2|COMPLETED|Overall Study||0
1438947|NCT02291419|3522660|P1|COMPLETED|Overall Study||0
1438948|NCT02291419|3522659|P2|STARTED|Overall Study||5
1438949|NCT02291419|3522660|P1|STARTED|Overall Study||1
1438950|NCT02291237|3522678|P2|NOT COMPLETED|Overall Study||86
1438951|NCT02291237|3522679|P1|NOT COMPLETED|Overall Study||86
1438952|NCT02291237|3522678|P2|COMPLETED|Overall Study||0
1438953|NCT02291237|3522679|P1|COMPLETED|Overall Study||0
1438954|NCT02291237|3522678|P2|STARTED|Overall Study||86
1438955|NCT02291237|3522679|P1|STARTED|Overall Study||86
1438956|NCT02290873|3522698|P3|NOT COMPLETED|Overall Study||2
1438957|NCT02290873|3522699|P2|NOT COMPLETED|Overall Study||1
1438958|NCT02290873|3522700|P1|NOT COMPLETED|Overall Study||2
1438959|NCT02290873|3522698|P3|COMPLETED|Overall Study||101
1438960|NCT02290873|3522699|P2|COMPLETED|Overall Study||59
1438961|NCT02290873|3522700|P1|COMPLETED|Overall Study||296
1438962|NCT02290873|3522698|P3|Safety Population|Overall Study||102
1438963|NCT02290873|3522699|P2|Safety Population|Overall Study||60
1438964|NCT02290873|3522700|P1|Safety Population|Overall Study||296
1438965|NCT02290873|3522698|P3|Modified Intention to Treat (mITT)|Overall Study||102
1438966|NCT02290873|3522699|P2|Modified Intention to Treat (mITT)|Overall Study||60
1438967|NCT02290873|3522700|P1|Modified Intention to Treat (mITT)|Overall Study||296
1438968|NCT02290873|3522698|P3|STARTED|Overall Study||103
1438969|NCT02290873|3522699|P2|STARTED|Overall Study||60
1438970|NCT02290873|3522700|P1|STARTED|Overall Study||298
1438971|NCT02290821|3522719|P2|NOT COMPLETED|Overall Study||3
1438972|NCT02290821|3522720|P1|NOT COMPLETED|Overall Study||6
1438973|NCT02290821|3522719|P2|COMPLETED|Overall Study||103
1438974|NCT02290821|3522720|P1|COMPLETED|Overall Study||103
1438975|NCT02290821|3522719|P2|STARTED|Overall Study||106
1438976|NCT02290821|3522720|P1|STARTED|Overall Study||109
1438977|NCT02290691|3522728|P2|NOT COMPLETED|Overall Study||9
1438978|NCT02290691|3522729|P1|NOT COMPLETED|Overall Study||8
1438979|NCT02290691|3522728|P2|COMPLETED|Overall Study||479
1438980|NCT02290691|3522729|P1|COMPLETED|Overall Study||488
1438981|NCT02290691|3522728|P2|STARTED|Overall Study||488
1438982|NCT02290691|3522729|P1|STARTED|Overall Study||496
1438983|NCT02290509|3522745|P2|NOT COMPLETED|Overall Study||14
1438984|NCT02290509|3522746|P1|NOT COMPLETED|Overall Study||49
1438985|NCT02290509|3522745|P2|COMPLETED|Overall Study||325
1438986|NCT02290509|3522746|P1|COMPLETED|Overall Study||962
1438987|NCT02290509|3522745|P2|STARTED|Overall Study||339
1438988|NCT02290509|3522746|P1|STARTED|Overall Study||1011
1438989|NCT02290340|3522762|P4|NOT COMPLETED|Overall Study||2
1438990|NCT02290340|3522763|P3|NOT COMPLETED|Overall Study||0
1438991|NCT02290340|3522764|P2|NOT COMPLETED|Overall Study||0
1438992|NCT02290340|3522765|P1|NOT COMPLETED|Overall Study||2
1438993|NCT02290340|3522762|P4|COMPLETED|Overall Study||30
1438994|NCT02290340|3522763|P3|COMPLETED|Overall Study||31
1438995|NCT02290340|3522764|P2|COMPLETED|Overall Study||8
1438996|NCT02290340|3522765|P1|COMPLETED|Overall Study||16
1438997|NCT02290340|3522762|P4|STARTED|Overall Study||32
1438998|NCT02290340|3522763|P3|STARTED|Overall Study||31
1438999|NCT02290340|3522764|P2|STARTED|Overall Study||8
1439000|NCT02290340|3522765|P1|STARTED|Overall Study||18
1439001|NCT02289989|3522810|P2|NOT COMPLETED|Overall Study||0
1439002|NCT02289989|3522811|P1|NOT COMPLETED|Overall Study||0
1439003|NCT02289989|3522810|P2|COMPLETED|Overall Study||1
1439004|NCT02289989|3522811|P1|COMPLETED|Overall Study||0
1439005|NCT02289989|3522810|P2|STARTED|Overall Study||1
1439006|NCT02289989|3522811|P1|STARTED|Overall Study||0
1439007|NCT02289963|3522829|P2|NOT COMPLETED|Overall Study||10
1439008|NCT02289963|3522830|P1|NOT COMPLETED|Overall Study||5
1439009|NCT02289963|3522829|P2|COMPLETED|Overall Study||87
1439010|NCT02289963|3522830|P1|COMPLETED|Overall Study||97
1439011|NCT02289963|3522829|P2|Treated|Overall Study||97
1439012|NCT02289963|3522830|P1|Treated|Overall Study||102
1439013|NCT02289963|3522829|P2|STARTED|Overall Study|Randomized|97
1439014|NCT02289963|3522830|P1|STARTED|Overall Study|Randomized|102
1439015|NCT02289898|3522881|P3|NOT COMPLETED|Overall Study||56
1439016|NCT02289898|3522882|P2|NOT COMPLETED|Overall Study||53
1439017|NCT02289898|3522883|P1|NOT COMPLETED|Overall Study||52
1439018|NCT02289898|3522881|P3|COMPLETED|Overall Study||9
1439019|NCT02289898|3522882|P2|COMPLETED|Overall Study||18
1439020|NCT02289898|3522883|P1|COMPLETED|Overall Study||16
1439021|NCT02289898|3522881|P3|STARTED|Overall Study||65
1439022|NCT02289898|3522882|P2|STARTED|Overall Study||71
1439023|NCT02289898|3522883|P1|STARTED|Overall Study||68
1439024|NCT02289833|3522892|P2|NOT COMPLETED|Overall Study||20
1439025|NCT02289833|3522893|P1|NOT COMPLETED|Overall Study||29
1439026|NCT02289833|3522892|P2|COMPLETED|Overall Study||0
1439027|NCT02289833|3522893|P1|COMPLETED|Overall Study||0
1439028|NCT02289833|3522892|P2|STARTED|Overall Study||20
1439029|NCT02289833|3522893|P1|STARTED|Overall Study||29
1439030|NCT02289820|3522931|P7|NOT COMPLETED|Overall Study||2
1439031|NCT02289820|3522932|P6|NOT COMPLETED|Overall Study||1
1439032|NCT02289820|3522933|P5|NOT COMPLETED|Overall Study||0
1439033|NCT02289820|3522934|P4|NOT COMPLETED|Overall Study||2
1439034|NCT02289820|3522935|P3|NOT COMPLETED|Overall Study||6
1439035|NCT02289820|3522936|P2|NOT COMPLETED|Overall Study||2
1439036|NCT02289820|3522937|P1|NOT COMPLETED|Overall Study||2
1439037|NCT02289820|3522931|P7|COMPLETED|Overall Study||37
1439038|NCT02289820|3522932|P6|COMPLETED|Overall Study||39
1439039|NCT02289820|3522933|P5|COMPLETED|Overall Study||40
1439040|NCT02289820|3522934|P4|COMPLETED|Overall Study||37
1439041|NCT02289820|3522935|P3|COMPLETED|Overall Study||38
1439042|NCT02289820|3522936|P2|COMPLETED|Overall Study||18
1439043|NCT02289820|3522937|P1|COMPLETED|Overall Study||37
1439044|NCT02289820|3522931|P7|STARTED|Overall Study||39
1439045|NCT02289820|3522932|P6|STARTED|Overall Study||40
1439046|NCT02289820|3522933|P5|STARTED|Overall Study||40
1439047|NCT02289820|3522934|P4|STARTED|Overall Study||39
1439048|NCT02289820|3522935|P3|STARTED|Overall Study||44
1439049|NCT02289820|3522936|P2|STARTED|Overall Study||20
1439050|NCT02289820|3522937|P1|STARTED|Overall Study||39
1439051|NCT02289755|3523048|P1|NOT COMPLETED|Follow up Period [4 Days]||0
1439052|NCT02289755|3523048|P1|COMPLETED|Follow up Period [4 Days]||16
1439053|NCT02289755|3523048|P1|STARTED|Follow up Period [4 Days]||16
1439054|NCT02289755|3523048|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
1439055|NCT02289755|3523048|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
1439056|NCT02289755|3523048|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
1439057|NCT02289755|3523048|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
1439058|NCT02289755|3523048|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
1439059|NCT02289755|3523048|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
1439060|NCT02289742|3523055|P4|NOT COMPLETED|Third Wear Period||1
1439061|NCT02289742|3523056|P3|NOT COMPLETED|Third Wear Period||0
1439062|NCT02289742|3523057|P2|NOT COMPLETED|Third Wear Period||1
1439063|NCT02289742|3523058|P1|NOT COMPLETED|Third Wear Period||0
1439064|NCT02289742|3523055|P4|COMPLETED|Third Wear Period||8
1439065|NCT02289742|3523056|P3|COMPLETED|Third Wear Period||11
1439066|NCT02289742|3523057|P2|COMPLETED|Third Wear Period||10
1439067|NCT02289742|3523058|P1|COMPLETED|Third Wear Period||11
1439068|NCT02289742|3523055|P4|STARTED|Third Wear Period||9
1439069|NCT02289742|3523056|P3|STARTED|Third Wear Period||11
1439070|NCT02289742|3523057|P2|STARTED|Third Wear Period||11
1439071|NCT02289742|3523058|P1|STARTED|Third Wear Period||11
1439072|NCT02289742|3523055|P4|NOT COMPLETED|Second Wear Period||0
1439073|NCT02289742|3523056|P3|NOT COMPLETED|Second Wear Period||0
1439074|NCT02289742|3523057|P2|NOT COMPLETED|Second Wear Period||0
1439075|NCT02289742|3523058|P1|NOT COMPLETED|Second Wear Period||0
1439076|NCT02289742|3523055|P4|COMPLETED|Second Wear Period||9
1439077|NCT02289742|3523056|P3|COMPLETED|Second Wear Period||11
1439078|NCT02289742|3523057|P2|COMPLETED|Second Wear Period||11
1439079|NCT02289742|3523058|P1|COMPLETED|Second Wear Period||11
1439080|NCT02289742|3523055|P4|STARTED|Second Wear Period||9
1439081|NCT02289742|3523056|P3|STARTED|Second Wear Period||11
1439082|NCT02289742|3523057|P2|STARTED|Second Wear Period||11
1439083|NCT02289742|3523058|P1|STARTED|Second Wear Period||11
1439084|NCT02289742|3523055|P4|NOT COMPLETED|First Wear Period||1
1439085|NCT02289742|3523056|P3|NOT COMPLETED|First Wear Period||1
1439086|NCT02289742|3523057|P2|NOT COMPLETED|First Wear Period||1
1439087|NCT02289742|3523058|P1|NOT COMPLETED|First Wear Period||0
1439088|NCT02289742|3523055|P4|COMPLETED|First Wear Period||9
1439089|NCT02289742|3523056|P3|COMPLETED|First Wear Period||11
1439090|NCT02289742|3523057|P2|COMPLETED|First Wear Period||11
1439091|NCT02289742|3523058|P1|COMPLETED|First Wear Period||11
1439092|NCT02289742|3523055|P4|Treated|First Wear Period||9
1439093|NCT02289742|3523056|P3|Treated|First Wear Period||12
1439094|NCT02289742|3523057|P2|Treated|First Wear Period||11
1439095|NCT02289742|3523058|P1|Treated|First Wear Period||11
1439096|NCT02289742|3523055|P4|STARTED|First Wear Period||10
1439097|NCT02289742|3523056|P3|STARTED|First Wear Period||12
1439098|NCT02289742|3523057|P2|STARTED|First Wear Period||12
1439099|NCT02289742|3523058|P1|STARTED|First Wear Period||11
1439100|NCT02289469|3523077|P2|NOT COMPLETED|Overall Study||0
1439101|NCT02289469|3523078|P1|NOT COMPLETED|Overall Study||6
1439102|NCT02289469|3523077|P2|COMPLETED|Overall Study||244
1439103|NCT02289469|3523078|P1|COMPLETED|Overall Study||244
1439104|NCT02289469|3523077|P2|STARTED|Overall Study||244
1439105|NCT02289469|3523078|P1|STARTED|Overall Study||250
1439106|NCT02289456|3523086|P1|NOT COMPLETED|Monotherapy Period||16
1439107|NCT02289456|3523086|P1|COMPLETED|Monotherapy Period||0
1439108|NCT02289456|3523086|P1|STARTED|Monotherapy Period||16
1439109|NCT02289456|3523086|P1|NOT COMPLETED|Induction Period||24
1439110|NCT02289456|3523086|P1|COMPLETED|Induction Period||16
1439111|NCT02289456|3523086|P1|Treated Population|Induction Period||40
1439112|NCT02289456|3523086|P1|STARTED|Induction Period||40
1439113|NCT02289417|3523109|P3|NOT COMPLETED|Overall Study||3
1439114|NCT02289417|3523110|P2|NOT COMPLETED|Overall Study||4
1439115|NCT02289417|3523111|P1|NOT COMPLETED|Overall Study||7
1439116|NCT02289417|3523109|P3|COMPLETED|Overall Study||52
1439117|NCT02289417|3523110|P2|COMPLETED|Overall Study||53
1439118|NCT02289417|3523111|P1|COMPLETED|Overall Study||51
1439119|NCT02289417|3523109|P3|STARTED|Overall Study||55
1439120|NCT02289417|3523110|P2|STARTED|Overall Study||57
1439121|NCT02289417|3523111|P1|STARTED|Overall Study||58
1439122|NCT02289222|3523149|P1|NOT COMPLETED|Overall Study||0
1439123|NCT02289222|3523149|P1|COMPLETED|Overall Study||48
1439124|NCT02289222|3523149|P1|STARTED|Overall Study||48
1439125|NCT02289157|3523157|P2|NOT COMPLETED|Overall Study||0
1439126|NCT02289157|3523158|P1|NOT COMPLETED|Overall Study||0
1439127|NCT02289157|3523157|P2|COMPLETED|Overall Study||219
1439128|NCT02289157|3523158|P1|COMPLETED|Overall Study||222
1439129|NCT02289157|3523157|P2|No Post op Check or Follow up Phone Call|Overall Study||4
1439130|NCT02289157|3523158|P1|No Post op Check or Follow up Phone Call|Overall Study||2
1439131|NCT02289157|3523157|P2|STARTED|Overall Study||219
1439132|NCT02289157|3523158|P1|STARTED|Overall Study||222
1439133|NCT02289105|3523192|P2|NOT COMPLETED|Overall Study||0
1439134|NCT02289105|3523193|P1|NOT COMPLETED|Overall Study||0
1439135|NCT02289105|3523192|P2|COMPLETED|Overall Study||637
1439136|NCT02289105|3523193|P1|COMPLETED|Overall Study||642
1439137|NCT02289105|3523192|P2|STARTED|Overall Study||637
1439138|NCT02289105|3523193|P1|STARTED|Overall Study||642
1439139|NCT02289079|3523205|P2|NOT COMPLETED|Overall Study||1
1439140|NCT02289079|3523206|P1|NOT COMPLETED|Overall Study||2
1439141|NCT02289079|3523205|P2|COMPLETED|Overall Study||29
1439142|NCT02289079|3523206|P1|COMPLETED|Overall Study||28
1439143|NCT02289079|3523205|P2|STARTED|Overall Study||30
1439144|NCT02289079|3523206|P1|STARTED|Overall Study||30
1439145|NCT02288364|3523220|P2|NOT COMPLETED|Overall Study||0
1439146|NCT02288364|3523221|P1|NOT COMPLETED|Overall Study||0
1439147|NCT02288364|3523220|P2|COMPLETED|Overall Study||44
1439148|NCT02288364|3523221|P1|COMPLETED|Overall Study||42
1439149|NCT02288364|3523220|P2|STARTED|Overall Study||44
1439150|NCT02288364|3523221|P1|STARTED|Overall Study||42
1439151|NCT02288325|3523245|P3|NOT COMPLETED|Double-blind Treatment Period||26
1439152|NCT02288325|3523246|P2|NOT COMPLETED|Double-blind Treatment Period||24
1439153|NCT02288325|3523247|P1|NOT COMPLETED|Double-blind Treatment Period||0
1439154|NCT02288325|3523245|P3|COMPLETED|Double-blind Treatment Period||139
1439155|NCT02288325|3523246|P2|COMPLETED|Double-blind Treatment Period||135
1439156|NCT02288325|3523247|P1|COMPLETED|Double-blind Treatment Period||0
1439157|NCT02288325|3523245|P3|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
1439158|NCT02288325|3523246|P2|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
1439159|NCT02288325|3523247|P1|STARTED|Double-blind Treatment Period||0
1439160|NCT02288325|3523245|P3|NOT COMPLETED|Stabilization Period||0
1439161|NCT02288325|3523246|P2|NOT COMPLETED|Stabilization Period||0
1439162|NCT02288325|3523247|P1|NOT COMPLETED|Stabilization Period||98
1439163|NCT02288325|3523245|P3|COMPLETED|Stabilization Period||0
1439164|NCT02288325|3523246|P2|COMPLETED|Stabilization Period||0
1439165|NCT02288325|3523247|P1|COMPLETED|Stabilization Period||331
1439166|NCT02288325|3523245|P3|STARTED|Stabilization Period||0
1439167|NCT02288325|3523246|P2|STARTED|Stabilization Period||0
1439168|NCT02288325|3523247|P1|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
1439169|NCT02288325|3523245|P3|NOT COMPLETED|Run-in Period||0
1439170|NCT02288325|3523246|P2|NOT COMPLETED|Run-in Period||0
1439171|NCT02288325|3523247|P1|NOT COMPLETED|Run-in Period||145
1439172|NCT02288325|3523245|P3|COMPLETED|Run-in Period||0
1439173|NCT02288325|3523246|P2|COMPLETED|Run-in Period||0
1439174|NCT02288325|3523247|P1|COMPLETED|Run-in Period||499
1439175|NCT02288325|3523245|P3|STARTED|Run-in Period||0
1439176|NCT02288325|3523246|P2|STARTED|Run-in Period||0
1439177|NCT02288325|3523247|P1|STARTED|Run-in Period||644
1439178|NCT02288312|3523257|P3|NOT COMPLETED|Overall Study||0
1439179|NCT02288312|3523258|P2|NOT COMPLETED|Overall Study||0
1439180|NCT02288312|3523259|P1|NOT COMPLETED|Overall Study||1
1439181|NCT02288312|3523257|P3|COMPLETED|Overall Study||6
1439182|NCT02288312|3523258|P2|COMPLETED|Overall Study||6
1439183|NCT02288312|3523259|P1|COMPLETED|Overall Study||5
1439184|NCT02288312|3523257|P3|STARTED|Overall Study||6
1439185|NCT02288312|3523258|P2|STARTED|Overall Study||6
1439186|NCT02288312|3523259|P1|STARTED|Overall Study||6
1439187|NCT02288273|3523278|P2|NOT COMPLETED|Overall Study||8
1439188|NCT02288273|3523279|P1|NOT COMPLETED|Overall Study||8
1439189|NCT02288273|3523278|P2|COMPLETED|Overall Study||48
1439190|NCT02288273|3523279|P1|COMPLETED|Overall Study||53
1439191|NCT02288273|3523278|P2|STARTED|Overall Study||56
1439192|NCT02288273|3523279|P1|STARTED|Overall Study||61
1439193|NCT02288091|3523297|P1|NOT COMPLETED|Overall Study||8
1439194|NCT02288091|3523297|P1|COMPLETED|Overall Study||24
1439195|NCT02288091|3523297|P1|Randomized/Treated|Overall Study||25
1439196|NCT02288091|3523297|P1|STARTED|Overall Study||32
1439197|NCT02287883|3523307|P2|NOT COMPLETED|Overall Study||426
1439198|NCT02287883|3523308|P1|NOT COMPLETED|Overall Study||459
1439199|NCT02287883|3523307|P2|COMPLETED|Overall Study||669
1439200|NCT02287883|3523308|P1|COMPLETED|Overall Study||622
1439201|NCT02287883|3523307|P2|One-year Follow-up Survey|Overall Study||669
1439202|NCT02287883|3523308|P1|One-year Follow-up Survey|Overall Study||622
1439203|NCT02287883|3523307|P2|STARTED|Overall Study||1095
1439204|NCT02287883|3523308|P1|STARTED|Overall Study||1081
1439205|NCT02287779|3523326|P8|NOT COMPLETED|Overall Study||0
1439206|NCT02287779|3523327|P7|NOT COMPLETED|Overall Study||0
1439207|NCT02287779|3523328|P6|NOT COMPLETED|Overall Study||0
1439208|NCT02287779|3523329|P5|NOT COMPLETED|Overall Study||0
1439209|NCT02287779|3523330|P4|NOT COMPLETED|Overall Study||0
1439210|NCT02287779|3523331|P3|NOT COMPLETED|Overall Study||0
1439211|NCT02287779|3523332|P2|NOT COMPLETED|Overall Study||0
1439212|NCT02287779|3523333|P1|NOT COMPLETED|Overall Study||0
1439213|NCT02287779|3523326|P8|COMPLETED|Overall Study||9
1439214|NCT02287779|3523327|P7|COMPLETED|Overall Study||9
1439215|NCT02287779|3523328|P6|COMPLETED|Overall Study||9
1439216|NCT02287779|3523329|P5|COMPLETED|Overall Study||9
1439217|NCT02287779|3523330|P4|COMPLETED|Overall Study||9
1439218|NCT02287779|3523331|P3|COMPLETED|Overall Study||9
1439219|NCT02287779|3523332|P2|COMPLETED|Overall Study||9
1439220|NCT02287779|3523333|P1|COMPLETED|Overall Study||21
1439221|NCT02287779|3523326|P8|STARTED|Overall Study||9
1439222|NCT02287779|3523327|P7|STARTED|Overall Study||9
1439223|NCT02287779|3523328|P6|STARTED|Overall Study||9
1439224|NCT02287779|3523329|P5|STARTED|Overall Study||9
1439225|NCT02287779|3523330|P4|STARTED|Overall Study||9
1439226|NCT02287779|3523331|P3|STARTED|Overall Study||9
1439227|NCT02287779|3523332|P2|STARTED|Overall Study||9
1439228|NCT02287779|3523333|P1|STARTED|Overall Study||21
1439229|NCT02287623|3523473|P2|NOT COMPLETED|Overall Study||1
1439230|NCT02287623|3523474|P1|NOT COMPLETED|Overall Study||0
1439231|NCT02287623|3523473|P2|COMPLETED|Overall Study||29
1439232|NCT02287623|3523474|P1|COMPLETED|Overall Study||30
1439233|NCT02287623|3523473|P2|STARTED|Overall Study||30
1439234|NCT02287623|3523474|P1|STARTED|Overall Study||30
1439235|NCT02287610|3523490|P1|NOT COMPLETED|Overall Study||16
1439236|NCT02287610|3523490|P1|COMPLETED|Overall Study||48
1439237|NCT02287610|3523490|P1|Per Protocol Follow-Up|Overall Study||56
1439238|NCT02287610|3523490|P1|STARTED|Overall Study||64
1439239|NCT02287415|3523523|P1|NOT COMPLETED|Overall Study||0
1439240|NCT02287415|3523523|P1|COMPLETED|Overall Study||13
1439241|NCT02287415|3523523|P1|STARTED|Overall Study||13
1439242|NCT02287402|3523529|P1|NOT COMPLETED|Follow-up||3
1439243|NCT02287402|3523529|P1|COMPLETED|Follow-up||103
1439244|NCT02287402|3523529|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
1439245|NCT02287402|3523529|P1|NOT COMPLETED|Treatment Period||27
1439246|NCT02287402|3523529|P1|COMPLETED|Treatment Period||170
1439247|NCT02287402|3523529|P1|STARTED|Treatment Period||197
1439248|NCT02287376|3523544|P1|NOT COMPLETED|Overall Study||0
1439249|NCT02287376|3523544|P1|COMPLETED|Overall Study||25
1439250|NCT02287376|3523544|P1|STARTED|Overall Study||25
1439251|NCT02287350|3523587|P1|NOT COMPLETED|Overall Study||3
1439252|NCT02287350|3523587|P1|COMPLETED|Overall Study||48
1439253|NCT02287350|3523587|P1|STARTED|Overall Study||51
1439254|NCT02287025|3523634|P2|NOT COMPLETED|Overall Study||9
1439255|NCT02287025|3523635|P1|NOT COMPLETED|Overall Study||10
1439256|NCT02287025|3523634|P2|COMPLETED|Overall Study||2
1439257|NCT02287025|3523635|P1|COMPLETED|Overall Study||2
1439258|NCT02287025|3523634|P2|STARTED|Overall Study||11
1439259|NCT02287025|3523635|P1|STARTED|Overall Study||12
1439260|NCT02286895|3523646|P2|NOT COMPLETED|Assessed for Measles Seroconversion||39
1439261|NCT02286895|3523647|P1|NOT COMPLETED|Assessed for Measles Seroconversion||48
1439262|NCT02286895|3523646|P2|COMPLETED|Assessed for Measles Seroconversion||261
1439263|NCT02286895|3523647|P1|COMPLETED|Assessed for Measles Seroconversion||252
1439264|NCT02286895|3523646|P2|STARTED|Assessed for Measles Seroconversion||300
1439265|NCT02286895|3523647|P1|STARTED|Assessed for Measles Seroconversion||300
1439266|NCT02286895|3523646|P2|NOT COMPLETED|Randomized and Vaccinated||0
1439267|NCT02286895|3523647|P1|NOT COMPLETED|Randomized and Vaccinated||0
1439268|NCT02286895|3523646|P2|COMPLETED|Randomized and Vaccinated||300
1439269|NCT02286895|3523647|P1|COMPLETED|Randomized and Vaccinated||300
1439270|NCT02286895|3523646|P2|STARTED|Randomized and Vaccinated||300
1439271|NCT02286895|3523647|P1|STARTED|Randomized and Vaccinated||300
1439272|NCT02286518|3523703|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439273|NCT02286518|3523704|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439274|NCT02286518|3523705|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439275|NCT02286518|3523706|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439276|NCT02286518|3523707|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439277|NCT02286518|3523708|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439278|NCT02286518|3523709|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439279|NCT02286518|3523710|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439280|NCT02286518|3523711|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439281|NCT02286518|3523712|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439282|NCT02286518|3523713|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439283|NCT02286518|3523714|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439284|NCT02286518|3523715|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439285|NCT02286518|3523716|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439286|NCT02286518|3523703|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439287|NCT02286518|3523704|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439288|NCT02286518|3523705|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439289|NCT02286518|3523706|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439290|NCT02286518|3523707|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439291|NCT02286518|3523708|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
1439292|NCT02286518|3523709|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
1439293|NCT02286518|3523710|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439294|NCT02286518|3523711|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439295|NCT02286518|3523712|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439296|NCT02286518|3523713|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439297|NCT02286518|3523714|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439298|NCT02286518|3523715|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439299|NCT02286518|3523716|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
1439300|NCT02286518|3523703|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439301|NCT02286518|3523704|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439302|NCT02286518|3523705|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439303|NCT02286518|3523706|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439304|NCT02286518|3523707|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439305|NCT02286518|3523708|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
1439306|NCT02286518|3523709|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
1439307|NCT02286518|3523710|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439308|NCT02286518|3523711|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439309|NCT02286518|3523712|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439310|NCT02286518|3523713|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439311|NCT02286518|3523714|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439312|NCT02286518|3523715|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439313|NCT02286518|3523716|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
1439314|NCT02286518|3523703|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439315|NCT02286518|3523704|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439316|NCT02286518|3523705|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439317|NCT02286518|3523706|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439318|NCT02286518|3523707|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439319|NCT02286518|3523708|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439320|NCT02286518|3523709|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439321|NCT02286518|3523710|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439322|NCT02286518|3523711|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439323|NCT02286518|3523712|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439324|NCT02286518|3523713|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439325|NCT02286518|3523714|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439326|NCT02286518|3523715|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439327|NCT02286518|3523716|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439328|NCT02286518|3523703|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439329|NCT02286518|3523704|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439330|NCT02286518|3523705|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439331|NCT02286518|3523706|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439332|NCT02286518|3523707|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439333|NCT02286518|3523708|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
1439334|NCT02286518|3523709|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
1439335|NCT02286518|3523710|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439336|NCT02286518|3523711|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439337|NCT02286518|3523712|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439338|NCT02286518|3523713|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439339|NCT02286518|3523714|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439340|NCT02286518|3523715|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439341|NCT02286518|3523716|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
1439342|NCT02286518|3523703|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439343|NCT02286518|3523704|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439344|NCT02286518|3523705|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439345|NCT02286518|3523706|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439346|NCT02286518|3523707|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439347|NCT02286518|3523708|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
1439348|NCT02286518|3523709|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
1439349|NCT02286518|3523710|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439350|NCT02286518|3523711|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439351|NCT02286518|3523712|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439352|NCT02286518|3523713|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439353|NCT02286518|3523714|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439354|NCT02286518|3523715|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439355|NCT02286518|3523716|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
1439356|NCT02286518|3523703|P14|NOT COMPLETED|All Parts (16 Days)||0
1439357|NCT02286518|3523704|P13|NOT COMPLETED|All Parts (16 Days)||0
1439358|NCT02286518|3523705|P12|NOT COMPLETED|All Parts (16 Days)||0
1439359|NCT02286518|3523706|P11|NOT COMPLETED|All Parts (16 Days)||0
1439360|NCT02286518|3523707|P10|NOT COMPLETED|All Parts (16 Days)||0
1439361|NCT02286518|3523708|P9|NOT COMPLETED|All Parts (16 Days)||0
1439362|NCT02286518|3523709|P8|NOT COMPLETED|All Parts (16 Days)||0
1439363|NCT02286518|3523710|P7|NOT COMPLETED|All Parts (16 Days)||0
1439364|NCT02286518|3523711|P6|NOT COMPLETED|All Parts (16 Days)||0
1439365|NCT02286518|3523712|P5|NOT COMPLETED|All Parts (16 Days)||0
1439366|NCT02286518|3523713|P4|NOT COMPLETED|All Parts (16 Days)||0
1439367|NCT02286518|3523714|P3|NOT COMPLETED|All Parts (16 Days)||0
1439368|NCT02286518|3523715|P2|NOT COMPLETED|All Parts (16 Days)||0
1439369|NCT02286518|3523716|P1|NOT COMPLETED|All Parts (16 Days)||0
1439370|NCT02286518|3523703|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439371|NCT02286518|3523704|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439372|NCT02286518|3523705|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439373|NCT02286518|3523706|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439374|NCT02286518|3523707|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
1439375|NCT02286518|3523708|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
1439376|NCT02286518|3523709|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
1439377|NCT02286518|3523710|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439378|NCT02286518|3523711|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439379|NCT02286518|3523712|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439380|NCT02286518|3523713|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439381|NCT02286518|3523714|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439382|NCT02286518|3523715|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439383|NCT02286518|3523716|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
1439384|NCT02286518|3523703|P14|STARTED|All Parts (16 Days)||6
1439385|NCT02286518|3523704|P13|STARTED|All Parts (16 Days)||6
1439386|NCT02286518|3523705|P12|STARTED|All Parts (16 Days)||6
1439387|NCT02286518|3523706|P11|STARTED|All Parts (16 Days)||6
1439388|NCT02286518|3523707|P10|STARTED|All Parts (16 Days)||4
1439389|NCT02286518|3523708|P9|STARTED|All Parts (16 Days)||6
1439390|NCT02286518|3523709|P8|STARTED|All Parts (16 Days)||6
1439391|NCT02286518|3523710|P7|STARTED|All Parts (16 Days)||6
1439392|NCT02286518|3523711|P6|STARTED|All Parts (16 Days)||6
1439393|NCT02286518|3523712|P5|STARTED|All Parts (16 Days)||6
1439394|NCT02286518|3523713|P4|STARTED|All Parts (16 Days)||6
1439395|NCT02286518|3523714|P3|STARTED|All Parts (16 Days)||6
1439396|NCT02286518|3523715|P2|STARTED|All Parts (16 Days)||6
1439397|NCT02286518|3523716|P1|STARTED|All Parts (16 Days)||6
1439398|NCT02286466|3523858|P2|NOT COMPLETED|Overall Study||10
1439399|NCT02286466|3523859|P1|NOT COMPLETED|Overall Study||7
1439400|NCT02286466|3523858|P2|COMPLETED|Overall Study||63
1439401|NCT02286466|3523859|P1|COMPLETED|Overall Study||65
1439402|NCT02286466|3523858|P2|Post Self-report|Overall Study||68
1439403|NCT02286466|3523859|P1|Post Self-report|Overall Study||67
1439404|NCT02286466|3523858|P2|Baseline Clinician Assessment|Overall Study||72
1439405|NCT02286466|3523859|P1|Baseline Clinician Assessment|Overall Study||72
1439406|NCT02286466|3523858|P2|STARTED|Overall Study||73
1439407|NCT02286466|3523859|P1|STARTED|Overall Study||72
1439408|NCT02286193|3523871|P1|NOT COMPLETED|Overall Study||204
1439409|NCT02286193|3523871|P1|COMPLETED|Overall Study||418
1439410|NCT02286193|3523871|P1|STARTED|Overall Study||622
1439411|NCT02286102|3523878|P2|NOT COMPLETED|Overall Study||1
1439412|NCT02286102|3523879|P1|NOT COMPLETED|Overall Study||1
1439413|NCT02286102|3523878|P2|COMPLETED|Overall Study||33
1439414|NCT02286102|3523879|P1|COMPLETED|Overall Study||35
1439415|NCT02286102|3523878|P2|STARTED|Overall Study||34
1439416|NCT02286102|3523879|P1|STARTED|Overall Study||36
1439417|NCT02285998|3523891|P2|NOT COMPLETED|Overall Study||253
1439418|NCT02285998|3523892|P1|NOT COMPLETED|Overall Study||246
1439419|NCT02285998|3523891|P2|COMPLETED|Overall Study||4236
1439420|NCT02285998|3523892|P1|COMPLETED|Overall Study||4228
1439421|NCT02285998|3523891|P2|STARTED|Overall Study||4489
1439422|NCT02285998|3523892|P1|STARTED|Overall Study||4474
1439423|NCT02285907|3523916|P1|NOT COMPLETED|Overall Study||0
1439424|NCT02285907|3523916|P1|COMPLETED|Overall Study||21
1439425|NCT02285907|3523916|P1|Began 4th Intervention|Overall Study||21
1439426|NCT02285907|3523916|P1|Began 3rd Intervention|Overall Study||21
1439427|NCT02285907|3523916|P1|Began 2nd Intervention|Overall Study||21
1439428|NCT02285907|3523916|P1|Began 1st Intervention|Overall Study||21
1439429|NCT02285907|3523916|P1|STARTED|Overall Study||21
1439430|NCT02285777|3523944|P2|NOT COMPLETED|Overall Study||3
1439431|NCT02285777|3523945|P1|NOT COMPLETED|Overall Study||5
1439432|NCT02285777|3523944|P2|COMPLETED|Overall Study||91
1439433|NCT02285777|3523945|P1|COMPLETED|Overall Study||90
1439434|NCT02285777|3523944|P2|STARTED|Overall Study||94
1439435|NCT02285777|3523945|P1|STARTED|Overall Study||95
1439436|NCT02285634|3524001|P4|NOT COMPLETED|Overall Study||1
1439437|NCT02285634|3524002|P3|NOT COMPLETED|Overall Study||4
1439438|NCT02285634|3524003|P2|NOT COMPLETED|Overall Study||0
1439439|NCT02285634|3524004|P1|NOT COMPLETED|Overall Study||0
1439440|NCT02285634|3524001|P4|COMPLETED|Overall Study||17
1439441|NCT02285634|3524002|P3|COMPLETED|Overall Study||11
1439442|NCT02285634|3524003|P2|COMPLETED|Overall Study||20
1439443|NCT02285634|3524004|P1|COMPLETED|Overall Study||15
1439444|NCT02285634|3524001|P4|STARTED|Overall Study||18
1439445|NCT02285634|3524002|P3|STARTED|Overall Study||15
1439446|NCT02285634|3524003|P2|STARTED|Overall Study||20
1439447|NCT02285634|3524004|P1|STARTED|Overall Study||15
1439448|NCT02285270|3524026|P1|NOT COMPLETED|Overall Study||5
1439449|NCT02285270|3524026|P1|COMPLETED|Overall Study||5
1439450|NCT02285270|3524026|P1|STARTED|Overall Study||10
1439451|NCT02284893|3524034|P2|NOT COMPLETED|52 Week (Long Term)||13
1439452|NCT02284893|3524035|P1|NOT COMPLETED|52 Week (Long Term)||11
1439453|NCT02284893|3524034|P2|COMPLETED|52 Week (Long Term)||180
1439454|NCT02284893|3524035|P1|COMPLETED|52 Week (Long Term)||198
1439455|NCT02284893|3524034|P2|STARTED|52 Week (Long Term)||193
1439456|NCT02284893|3524035|P1|STARTED|52 Week (Long Term)||209
1439457|NCT02284893|3524034|P2|NOT COMPLETED|26 Week (Short Term)||31
1439458|NCT02284893|3524035|P1|NOT COMPLETED|26 Week (Short Term)||19
1439459|NCT02284893|3524034|P2|COMPLETED|26 Week (Short Term)||198
1439460|NCT02284893|3524035|P1|COMPLETED|26 Week (Short Term)||213
1439461|NCT02284893|3524034|P2|STARTED|26 Week (Short Term)||229
1439462|NCT02284893|3524035|P1|STARTED|26 Week (Short Term)||232
1439463|NCT02284880|3524049|P4|NOT COMPLETED|Overall Study||0
1439464|NCT02284880|3524050|P3|NOT COMPLETED|Overall Study||2
1439465|NCT02284880|3524051|P2|NOT COMPLETED|Overall Study||0
1439466|NCT02284880|3524052|P1|NOT COMPLETED|Overall Study||0
1439467|NCT02284880|3524049|P4|COMPLETED|Overall Study||10
1439468|NCT02284880|3524050|P3|COMPLETED|Overall Study||8
1439469|NCT02284880|3524051|P2|COMPLETED|Overall Study||9
1439470|NCT02284880|3524052|P1|COMPLETED|Overall Study||11
1439471|NCT02284880|3524049|P4|Second Period (4 Days)|Overall Study||10
1439472|NCT02284880|3524050|P3|Second Period (4 Days)|Overall Study||8
1439473|NCT02284880|3524051|P2|Second Period (4 Days)|Overall Study||9
1439474|NCT02284880|3524052|P1|Second Period (4 Days)|Overall Study||11
1439475|NCT02284880|3524049|P4|Wash-out Period (7 Days)|Overall Study||10
1439476|NCT02284880|3524050|P3|Wash-out Period (7 Days)|Overall Study||10
1439477|NCT02284880|3524051|P2|Wash-out Period (7 Days)|Overall Study||9
1439478|NCT02284880|3524052|P1|Wash-out Period (7 Days)|Overall Study||11
1439479|NCT02284880|3524049|P4|First Period (4 Days)|Overall Study||10
1439480|NCT02284880|3524050|P3|First Period (4 Days)|Overall Study||10
1439481|NCT02284880|3524051|P2|First Period (4 Days)|Overall Study||9
1439482|NCT02284880|3524052|P1|First Period (4 Days)|Overall Study||11
1439483|NCT02284880|3524049|P4|STARTED|Overall Study||10
1439484|NCT02284880|3524050|P3|STARTED|Overall Study||10
1439485|NCT02284880|3524051|P2|STARTED|Overall Study||9
1439486|NCT02284880|3524052|P1|STARTED|Overall Study||11
1439487|NCT02284867|3524068|P2|NOT COMPLETED|Overall Study||0
1439488|NCT02284867|3524069|P1|NOT COMPLETED|Overall Study||0
1439489|NCT02284867|3524068|P2|COMPLETED|Overall Study||30
1439490|NCT02284867|3524069|P1|COMPLETED|Overall Study||30
1439491|NCT02284867|3524068|P2|STARTED|Overall Study||30
1439492|NCT02284867|3524069|P1|STARTED|Overall Study||30
1439493|NCT02284854|3524079|P2|NOT COMPLETED|Overall Study||0
1439494|NCT02284854|3524080|P1|NOT COMPLETED|Overall Study||5
1439495|NCT02284854|3524079|P2|COMPLETED|Overall Study||20
1439496|NCT02284854|3524080|P1|COMPLETED|Overall Study||18
1439497|NCT02284854|3524079|P2|STARTED|Overall Study||20
1439498|NCT02284854|3524080|P1|STARTED|Overall Study||23
1439499|NCT02284828|3524097|P1|NOT COMPLETED|Overall Study||4
1439500|NCT02284828|3524097|P1|COMPLETED|Overall Study||22
1439501|NCT02284828|3524097|P1|STARTED|Overall Study||26
1439502|NCT02284568|3524112|P3|NOT COMPLETED|Overall Study||95
1439503|NCT02284568|3524113|P2|NOT COMPLETED|Overall Study||46
1439504|NCT02284568|3524114|P1|NOT COMPLETED|Overall Study||31
1439505|NCT02284568|3524112|P3|COMPLETED|Overall Study||0
1439506|NCT02284568|3524113|P2|COMPLETED|Overall Study||93
1439507|NCT02284568|3524114|P1|COMPLETED|Overall Study||109
1439508|NCT02284568|3524112|P3|Completed Week 48 MRI - on Treatment|Overall Study||0
1439509|NCT02284568|3524113|P2|Completed Week 48 MRI - on Treatment|Overall Study||107
1439510|NCT02284568|3524114|P1|Completed Week 48 MRI - on Treatment|Overall Study||113
1439511|NCT02284568|3524112|P3|Safety Population|Overall Study||95
1439512|NCT02284568|3524113|P2|Safety Population|Overall Study||138
1439513|NCT02284568|3524114|P1|Safety Population|Overall Study||140
1439514|NCT02284568|3524112|P3|STARTED|Overall Study|Intent to treat (ITT) population|95
1439515|NCT02284568|3524113|P2|STARTED|Overall Study|Intent to treat (ITT) population|139
1439516|NCT02284568|3524114|P1|STARTED|Overall Study|Intent to treat (ITT) population|140
1439517|NCT02284555|3524140|P1|NOT COMPLETED|Overall Study||0
1439518|NCT02284555|3524140|P1|COMPLETED|Overall Study||12
1439519|NCT02284555|3524140|P1|STARTED|Overall Study||12
1439520|NCT02284516|3524147|P2|NOT COMPLETED|Overall Study||36
1439521|NCT02284516|3524148|P1|NOT COMPLETED|Overall Study||38
1439522|NCT02284516|3524147|P2|COMPLETED|Overall Study||319
1439523|NCT02284516|3524148|P1|COMPLETED|Overall Study||318
1439524|NCT02284516|3524147|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
1439525|NCT02284516|3524148|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
1439526|NCT02284516|3524147|P2|STARTED|Overall Study||355
1439527|NCT02284516|3524148|P1|STARTED|Overall Study||356
1439528|NCT02284386|3524156|P1|NOT COMPLETED|Overall Study||0
1439529|NCT02284386|3524156|P1|COMPLETED|Overall Study||15
1439530|NCT02284386|3524156|P1|STARTED|Overall Study||15
1439531|NCT02284347|3524165|P1|NOT COMPLETED|Overall Study||3
1439532|NCT02284347|3524165|P1|COMPLETED|Overall Study||48
1439533|NCT02284347|3524165|P1|STARTED|Overall Study||51
1439534|NCT02284243|3524173|P2|NOT COMPLETED|Overall Study||3
1439535|NCT02284243|3524174|P1|NOT COMPLETED|Overall Study||4
1439536|NCT02284243|3524173|P2|COMPLETED|Overall Study||81
1439537|NCT02284243|3524174|P1|COMPLETED|Overall Study||80
1439538|NCT02284243|3524173|P2|STARTED|Overall Study||84
1439539|NCT02284243|3524174|P1|STARTED|Overall Study||84
1439540|NCT02284165|3524195|P3|NOT COMPLETED|Overall Study||0
1439541|NCT02284165|3524196|P2|NOT COMPLETED|Overall Study||0
1439542|NCT02284165|3524197|P1|NOT COMPLETED|Overall Study||0
1439543|NCT02284165|3524195|P3|COMPLETED|Overall Study||70996
1439544|NCT02284165|3524196|P2|COMPLETED|Overall Study||40272
1439545|NCT02284165|3524197|P1|COMPLETED|Overall Study||36448
1439546|NCT02284165|3524195|P3|STARTED|Overall Study||70996
1439547|NCT02284165|3524196|P2|STARTED|Overall Study||40272
1439548|NCT02284165|3524197|P1|STARTED|Overall Study||36448
1439549|NCT02283840|3524216|P3|NOT COMPLETED|Overall Study||0
1439550|NCT02283840|3524217|P2|NOT COMPLETED|Overall Study||1
1439551|NCT02283840|3524218|P1|NOT COMPLETED|Overall Study||0
1439552|NCT02283840|3524216|P3|COMPLETED|Overall Study||20
1439553|NCT02283840|3524217|P2|COMPLETED|Overall Study||19
1439554|NCT02283840|3524218|P1|COMPLETED|Overall Study||20
1439555|NCT02283840|3524216|P3|STARTED|Overall Study||20
1439556|NCT02283840|3524217|P2|STARTED|Overall Study||20
1439557|NCT02283840|3524218|P1|STARTED|Overall Study||20
1439558|NCT02283827|3524237|P2|NOT COMPLETED|Overall Study||3
1439559|NCT02283827|3524238|P1|NOT COMPLETED|Overall Study||1
1439560|NCT02283827|3524237|P2|COMPLETED|Overall Study||13
1439561|NCT02283827|3524238|P1|COMPLETED|Overall Study||15
1439562|NCT02283827|3524237|P2|STARTED|Overall Study||16
1439563|NCT02283827|3524238|P1|STARTED|Overall Study||16
1439564|NCT02283814|3524255|P2|NOT COMPLETED|Overall Study||2
1439565|NCT02283814|3524256|P1|NOT COMPLETED|Overall Study||3
1439566|NCT02283814|3524255|P2|COMPLETED|Overall Study||14
1439567|NCT02283814|3524256|P1|COMPLETED|Overall Study||13
1439568|NCT02283814|3524255|P2|STARTED|Overall Study||16
1439569|NCT02283814|3524256|P1|STARTED|Overall Study||16
1439570|NCT02283788|3524270|P4|NOT COMPLETED|Overall Study||2
1439571|NCT02283788|3524271|P3|NOT COMPLETED|Overall Study||5
1439572|NCT02283788|3524272|P2|NOT COMPLETED|Overall Study||4
1439573|NCT02283788|3524273|P1|NOT COMPLETED|Overall Study||1
1439574|NCT02283788|3524270|P4|COMPLETED|Overall Study||14
1439575|NCT02283788|3524271|P3|COMPLETED|Overall Study||12
1439576|NCT02283788|3524272|P2|COMPLETED|Overall Study||13
1439577|NCT02283788|3524273|P1|COMPLETED|Overall Study||16
1439578|NCT02283788|3524270|P4|STARTED|Overall Study||16
1439579|NCT02283788|3524271|P3|STARTED|Overall Study||17
1439580|NCT02283788|3524272|P2|STARTED|Overall Study||17
1439581|NCT02283788|3524273|P1|STARTED|Overall Study||17
1439582|NCT02283749|3524283|P1|NOT COMPLETED|Overall Study||0
1439583|NCT02283749|3524283|P1|COMPLETED|Overall Study||5
1439584|NCT02283749|3524283|P1|STARTED|Overall Study||5
1439585|NCT02283411|3524289|P1|NOT COMPLETED|Overall Study||31
1439586|NCT02283411|3524289|P1|COMPLETED|Overall Study||125
1439587|NCT02283411|3524289|P1|STARTED|Overall Study||156
1439588|NCT02283268|3524297|P1|NOT COMPLETED|Overall Study||1
1439589|NCT02283268|3524297|P1|COMPLETED|Overall Study||14
1439590|NCT02283268|3524297|P1|STARTED|Overall Study||15
1439591|NCT02282982|3524358|P1|NOT COMPLETED|Overall Study||206
1439592|NCT02282982|3524358|P1|COMPLETED|Overall Study||153
1439593|NCT02282982|3524358|P1|Attended Follow-up Visit|Overall Study||349
1439594|NCT02282982|3524358|P1|Attended Visit 5|Overall Study||83
1439595|NCT02282982|3524358|P1|Attended Visit 4|Overall Study||194
1439596|NCT02282982|3524358|P1|Attended Visit 3|Overall Study||298
1439597|NCT02282982|3524358|P1|Attended Visit 2|Overall Study||341
1439598|NCT02282982|3524358|P1|Attended Visit 1|Overall Study||359
1439599|NCT02282982|3524358|P1|STARTED|Overall Study||359
1439600|NCT02282813|3524376|P3|NOT COMPLETED|Overall Study||3
1439601|NCT02282813|3524377|P2|NOT COMPLETED|Overall Study||23
1439602|NCT02282813|3524378|P1|NOT COMPLETED|Overall Study||12
1439603|NCT02282813|3524376|P3|COMPLETED|Overall Study||39
1439604|NCT02282813|3524377|P2|COMPLETED|Overall Study||130
1439605|NCT02282813|3524378|P1|COMPLETED|Overall Study||91
1439606|NCT02282813|3524376|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
1439607|NCT02282813|3524377|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
1439608|NCT02282813|3524378|P1|STARTED|Overall Study|ITT Population|103
1439609|NCT02282722|3524397|P2|NOT COMPLETED|Overall Study||19
1439610|NCT02282722|3524398|P1|NOT COMPLETED|Overall Study||23
1439611|NCT02282722|3524397|P2|COMPLETED|Overall Study||73
1439612|NCT02282722|3524398|P1|COMPLETED|Overall Study||71
1439613|NCT02282722|3524397|P2|3-month Assessment|Overall Study||73
1439614|NCT02282722|3524398|P1|3-month Assessment|Overall Study||71
1439615|NCT02282722|3524397|P2|2-week Assessment|Overall Study||75
1439616|NCT02282722|3524398|P1|2-week Assessment|Overall Study||79
1439617|NCT02282722|3524397|P2|STARTED|Overall Study||92
1439618|NCT02282722|3524398|P1|STARTED|Overall Study||94
1439619|NCT02282631|3524424|P2|NOT COMPLETED|Overall Study||0
1439620|NCT02282631|3524425|P1|NOT COMPLETED|Overall Study||2
1439621|NCT02282631|3524424|P2|COMPLETED|Overall Study||15
1439622|NCT02282631|3524425|P1|COMPLETED|Overall Study||12
1439623|NCT02282631|3524424|P2|STARTED|Overall Study||15
1439624|NCT02282631|3524425|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
1439625|NCT02282605|3524466|P3|NOT COMPLETED|Overall Study||0
1439626|NCT02282605|3524467|P2|NOT COMPLETED|Overall Study||0
1439627|NCT02282605|3524468|P1|NOT COMPLETED|Overall Study||3
1439628|NCT02282605|3524466|P3|COMPLETED|Overall Study||24
1439629|NCT02282605|3524467|P2|COMPLETED|Overall Study||12
1439630|NCT02282605|3524468|P1|COMPLETED|Overall Study||24
1439631|NCT02282605|3524466|P3|STARTED|Overall Study||24
1439632|NCT02282605|3524467|P2|STARTED|Overall Study||12
1439633|NCT02282605|3524468|P1|STARTED|Overall Study||27
1439634|NCT02282527|3524490|P2|NOT COMPLETED|Overall Study||1
1439635|NCT02282527|3524491|P1|NOT COMPLETED|Overall Study||1
1439636|NCT02282527|3524490|P2|COMPLETED|Overall Study||15
1439637|NCT02282527|3524491|P1|COMPLETED|Overall Study||15
1439638|NCT02282527|3524490|P2|STARTED|Overall Study||16
1439639|NCT02282527|3524491|P1|STARTED|Overall Study||16
1439640|NCT02282111|3524503|P2|NOT COMPLETED|Overall Study||8
1439641|NCT02282111|3524504|P1|NOT COMPLETED|Overall Study||7
1439642|NCT02282111|3524503|P2|COMPLETED|Overall Study||22
1439643|NCT02282111|3524504|P1|COMPLETED|Overall Study||19
1439644|NCT02282111|3524503|P2|STARTED|Overall Study||30
1439645|NCT02282111|3524504|P1|STARTED|Overall Study||26
1439646|NCT02281773|3524523|P5|NOT COMPLETED|Overall Study||30
1439647|NCT02281773|3524524|P4|NOT COMPLETED|Overall Study||21
1439648|NCT02281773|3524525|P3|NOT COMPLETED|Overall Study||18
1439649|NCT02281773|3524526|P2|NOT COMPLETED|Overall Study||15
1439650|NCT02281773|3524527|P1|NOT COMPLETED|Overall Study||11
1439651|NCT02281773|3524523|P5|COMPLETED|Overall Study||143
1439652|NCT02281773|3524524|P4|COMPLETED|Overall Study||65
1439653|NCT02281773|3524525|P3|COMPLETED|Overall Study||67
1439654|NCT02281773|3524526|P2|COMPLETED|Overall Study||70
1439655|NCT02281773|3524527|P1|COMPLETED|Overall Study||76
1439656|NCT02281773|3524523|P5|STARTED|Overall Study|Started are the treated patients|173
1439657|NCT02281773|3524524|P4|STARTED|Overall Study||86
1439658|NCT02281773|3524525|P3|STARTED|Overall Study||85
1439659|NCT02281773|3524526|P2|STARTED|Overall Study|Started are the treated patients|85
1439660|NCT02281773|3524527|P1|STARTED|Overall Study||87
1439661|NCT02281591|3524588|P4|NOT COMPLETED|Overall Study||0
1439662|NCT02281591|3524589|P3|NOT COMPLETED|Overall Study||0
1439663|NCT02281591|3524590|P2|NOT COMPLETED|Overall Study||0
1439664|NCT02281591|3524591|P1|NOT COMPLETED|Overall Study||0
1439665|NCT02281591|3524588|P4|COMPLETED|Overall Study||8
1439666|NCT02281591|3524589|P3|COMPLETED|Overall Study||8
1439667|NCT02281591|3524590|P2|COMPLETED|Overall Study||8
1439668|NCT02281591|3524591|P1|COMPLETED|Overall Study||8
1439669|NCT02281591|3524588|P4|STARTED|Overall Study||8
1439670|NCT02281591|3524589|P3|STARTED|Overall Study||8
1439671|NCT02281591|3524590|P2|STARTED|Overall Study||8
1439672|NCT02281591|3524591|P1|STARTED|Overall Study||8
1439673|NCT02281552|3524615|P2|NOT COMPLETED|Overall Study||10
1439674|NCT02281552|3524616|P1|NOT COMPLETED|Overall Study||4
1439675|NCT02281552|3524615|P2|COMPLETED|Overall Study||95
1439676|NCT02281552|3524616|P1|COMPLETED|Overall Study||100
1439677|NCT02281552|3524615|P2|STARTED|Overall Study||105
1439678|NCT02281552|3524616|P1|STARTED|Overall Study||104
1439679|NCT02281526|3524656|P2|NOT COMPLETED|Overall Study||0
1439680|NCT02281526|3524657|P1|NOT COMPLETED|Overall Study||1
1439681|NCT02281526|3524656|P2|COMPLETED|Overall Study||8
1439682|NCT02281526|3524657|P1|COMPLETED|Overall Study||8
1439683|NCT02281526|3524656|P2|STARTED|Overall Study||8
1439684|NCT02281526|3524657|P1|STARTED|Overall Study||9
1439685|NCT02281448|3524667|P2|NOT COMPLETED|Overall Study||1
1439686|NCT02281448|3524668|P1|NOT COMPLETED|Overall Study||2
1439687|NCT02281448|3524667|P2|COMPLETED|Overall Study||9
1439688|NCT02281448|3524668|P1|COMPLETED|Overall Study||8
1439689|NCT02281448|3524667|P2|STARTED|Overall Study||10
1439690|NCT02281448|3524668|P1|STARTED|Overall Study||10
1439691|NCT02281422|3524681|P5|NOT COMPLETED|Overall Study||0
1439692|NCT02281422|3524682|P4|NOT COMPLETED|Overall Study||0
1439693|NCT02281422|3524683|P3|NOT COMPLETED|Overall Study||0
1439694|NCT02281422|3524684|P2|NOT COMPLETED|Overall Study||0
1439695|NCT02281422|3524685|P1|NOT COMPLETED|Overall Study||0
1439696|NCT02281422|3524681|P5|COMPLETED|Overall Study||8
1439697|NCT02281422|3524682|P4|COMPLETED|Overall Study||8
1439698|NCT02281422|3524683|P3|COMPLETED|Overall Study||8
1439699|NCT02281422|3524684|P2|COMPLETED|Overall Study||8
1439700|NCT02281422|3524685|P1|COMPLETED|Overall Study||8
1439701|NCT02281422|3524681|P5|STARTED|Overall Study||8
1439702|NCT02281422|3524682|P4|STARTED|Overall Study||8
1439703|NCT02281422|3524683|P3|STARTED|Overall Study||8
1439704|NCT02281422|3524684|P2|STARTED|Overall Study||8
1439705|NCT02281422|3524685|P1|STARTED|Overall Study||8
1439706|NCT02281357|3524709|P2|NOT COMPLETED|Overall Study||4
1439707|NCT02281357|3524710|P1|NOT COMPLETED|Overall Study||7
1439708|NCT02281357|3524709|P2|COMPLETED|Overall Study||66
1439709|NCT02281357|3524710|P1|COMPLETED|Overall Study||63
1439710|NCT02281357|3524709|P2|STARTED|Overall Study||70
1439711|NCT02281357|3524710|P1|STARTED|Overall Study||70
1439712|NCT02281318|3524724|P2|NOT COMPLETED|Overall Study||5
1439713|NCT02281318|3524725|P1|NOT COMPLETED|Overall Study||14
1439714|NCT02281318|3524724|P2|COMPLETED|Overall Study||269
1439715|NCT02281318|3524725|P1|COMPLETED|Overall Study||263
1439716|NCT02281318|3524724|P2|STARTED|Overall Study||274
1439717|NCT02281318|3524725|P1|STARTED|Overall Study||277
1439718|NCT02281136|3524737|P1|NOT COMPLETED|Overall Study||0
1439719|NCT02281136|3524737|P1|COMPLETED|Overall Study||29
1439720|NCT02281136|3524737|P1|STARTED|Overall Study||29
1439721|NCT02280863|3524771|P2|NOT COMPLETED|Integrated Platform||1
1439722|NCT02280863|3524772|P1|NOT COMPLETED|Integrated Platform||0
1439723|NCT02280863|3524771|P2|COMPLETED|Integrated Platform||14
1439724|NCT02280863|3524772|P1|COMPLETED|Integrated Platform||9
1439725|NCT02280863|3524771|P2|STARTED|Integrated Platform||15
1439726|NCT02280863|3524772|P1|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
1439727|NCT02280863|3524771|P2|NOT COMPLETED|Android Platform||0
1439728|NCT02280863|3524772|P1|NOT COMPLETED|Android Platform||0
1439729|NCT02280863|3524771|P2|COMPLETED|Android Platform||0
1439730|NCT02280863|3524772|P1|COMPLETED|Android Platform||8
1439731|NCT02280863|3524771|P2|STARTED|Android Platform||0
1439732|NCT02280863|3524772|P1|STARTED|Android Platform||8
1439733|NCT02280811|3524802|P5|NOT COMPLETED|Retreated at the MTD||0
1439734|NCT02280811|3524803|P4|NOT COMPLETED|Retreated at the MTD||0
1439735|NCT02280811|3524804|P3|NOT COMPLETED|Retreated at the MTD||0
1439736|NCT02280811|3524805|P2|NOT COMPLETED|Retreated at the MTD||0
1439737|NCT02280811|3524806|P1|NOT COMPLETED|Retreated at the MTD||0
1439738|NCT02280811|3524802|P5|COMPLETED|Retreated at the MTD||1
1439739|NCT02280811|3524803|P4|COMPLETED|Retreated at the MTD||0
1439740|NCT02280811|3524804|P3|COMPLETED|Retreated at the MTD||0
1439741|NCT02280811|3524805|P2|COMPLETED|Retreated at the MTD||0
1439742|NCT02280811|3524806|P1|COMPLETED|Retreated at the MTD||0
1439743|NCT02280811|3524802|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
1439744|NCT02280811|3524803|P4|STARTED|Retreated at the MTD||0
1439745|NCT02280811|3524804|P3|STARTED|Retreated at the MTD||0
1439746|NCT02280811|3524805|P2|STARTED|Retreated at the MTD||0
1439747|NCT02280811|3524806|P1|STARTED|Retreated at the MTD||0
1439748|NCT02280811|3524802|P5|NOT COMPLETED|Drug Administration||0
1439749|NCT02280811|3524803|P4|NOT COMPLETED|Drug Administration||0
1439750|NCT02280811|3524804|P3|NOT COMPLETED|Drug Administration||0
1439751|NCT02280811|3524805|P2|NOT COMPLETED|Drug Administration||0
1439752|NCT02280811|3524806|P1|NOT COMPLETED|Drug Administration||0
1439753|NCT02280811|3524802|P5|COMPLETED|Drug Administration||2
1439754|NCT02280811|3524803|P4|COMPLETED|Drug Administration||6
1439755|NCT02280811|3524804|P3|COMPLETED|Drug Administration||1
1439756|NCT02280811|3524805|P2|COMPLETED|Drug Administration||2
1439757|NCT02280811|3524806|P1|COMPLETED|Drug Administration||1
1439758|NCT02280811|3524802|P5|STARTED|Drug Administration||2
1439759|NCT02280811|3524803|P4|STARTED|Drug Administration||6
1439760|NCT02280811|3524804|P3|STARTED|Drug Administration||1
1439761|NCT02280811|3524805|P2|STARTED|Drug Administration||2
1439762|NCT02280811|3524806|P1|STARTED|Drug Administration||1
1439763|NCT02280655|3524847|P2|NOT COMPLETED|Overall Study||0
1439764|NCT02280655|3524848|P1|NOT COMPLETED|Overall Study||0
1439765|NCT02280655|3524847|P2|COMPLETED|Overall Study||18
1439766|NCT02280655|3524848|P1|COMPLETED|Overall Study||25
1439767|NCT02280655|3524847|P2|STARTED|Overall Study||18
1439768|NCT02280655|3524848|P1|STARTED|Overall Study||25
1439769|NCT02280499|3524856|P1|NOT COMPLETED|Overall Study||61
1439770|NCT02280499|3524856|P1|COMPLETED|Overall Study||26
1439771|NCT02280499|3524856|P1|STARTED|Overall Study||87
1439772|NCT02280473|3524864|P2|NOT COMPLETED|Overall Study||3
1439773|NCT02280473|3524865|P1|NOT COMPLETED|Overall Study||1
1439774|NCT02280473|3524864|P2|COMPLETED|Overall Study||91
1439775|NCT02280473|3524865|P1|COMPLETED|Overall Study||93
1439776|NCT02280473|3524864|P2|STARTED|Overall Study||94
1439777|NCT02280473|3524865|P1|STARTED|Overall Study||94
1439778|NCT02280226|3524879|P1|NOT COMPLETED|Overall Study||0
1439779|NCT02280226|3524879|P1|COMPLETED|Overall Study||17
1439780|NCT02280226|3524879|P1|STARTED|Overall Study||17
1439781|NCT02280187|3524884|P1|NOT COMPLETED|Overall Study||218
1439782|NCT02280187|3524884|P1|COMPLETED|Overall Study||182
1439783|NCT02280187|3524884|P1|STARTED|Overall Study||400
1439784|NCT02280122|3524902|P3|NOT COMPLETED|Overall Study||0
1439785|NCT02280122|3524903|P2|NOT COMPLETED|Overall Study||0
1439786|NCT02280122|3524904|P1|NOT COMPLETED|Overall Study||0
1439787|NCT02280122|3524902|P3|COMPLETED|Overall Study||30
1439788|NCT02280122|3524903|P2|COMPLETED|Overall Study||15
1439789|NCT02280122|3524904|P1|COMPLETED|Overall Study||15
1439790|NCT02280122|3524902|P3|STARTED|Overall Study||30
1439791|NCT02280122|3524903|P2|STARTED|Overall Study||15
1439792|NCT02280122|3524904|P1|STARTED|Overall Study||15
1439793|NCT02280044|3524912|P2|NOT COMPLETED|Overall Study||2
1439794|NCT02280044|3524913|P1|NOT COMPLETED|Overall Study||0
1439795|NCT02280044|3524912|P2|COMPLETED|Overall Study||13
1439796|NCT02280044|3524913|P1|COMPLETED|Overall Study||15
1439797|NCT02280044|3524912|P2|STARTED|Overall Study||15
1439798|NCT02280044|3524913|P1|STARTED|Overall Study||15
1439799|NCT02279862|3524923|P2|NOT COMPLETED|Overall Study||25
1439800|NCT02279862|3524924|P1|NOT COMPLETED|Overall Study||26
1439801|NCT02279862|3524923|P2|COMPLETED|Overall Study|Completed treatment in induction period|2
1439802|NCT02279862|3524924|P1|COMPLETED|Overall Study|Completed treatment in induction period|0
1439803|NCT02279862|3524923|P2|Treated|Overall Study||26
1439804|NCT02279862|3524924|P1|Treated|Overall Study||25
1439805|NCT02279862|3524923|P2|STARTED|Overall Study||27
1439806|NCT02279862|3524924|P1|STARTED|Overall Study||26
1439807|NCT02279667|3524943|P3|NOT COMPLETED|Overall Study||0
1439808|NCT02279667|3524944|P2|NOT COMPLETED|Overall Study||0
1439809|NCT02279667|3524945|P1|NOT COMPLETED|Overall Study||0
1439810|NCT02279667|3524943|P3|COMPLETED|Overall Study||6
1439811|NCT02279667|3524944|P2|COMPLETED|Overall Study||6
1439812|NCT02279667|3524945|P1|COMPLETED|Overall Study||6
1439813|NCT02279667|3524943|P3|STARTED|Overall Study||6
1439814|NCT02279667|3524944|P2|STARTED|Overall Study||6
1439815|NCT02279667|3524945|P1|STARTED|Overall Study||6
1439816|NCT02279641|3524965|P2|NOT COMPLETED|Overall Study||0
1439817|NCT02279641|3524966|P1|NOT COMPLETED|Overall Study||0
1439818|NCT02279641|3524965|P2|COMPLETED|Overall Study||6
1439819|NCT02279641|3524966|P1|COMPLETED|Overall Study||6
1439820|NCT02279641|3524965|P2|STARTED|Overall Study||6
1439821|NCT02279641|3524966|P1|STARTED|Overall Study||6
1439822|NCT02279498|3525022|P2|NOT COMPLETED|Overall Study||4
1439823|NCT02279498|3525023|P1|NOT COMPLETED|Overall Study||18
1439824|NCT02279498|3525022|P2|COMPLETED|Overall Study||59
1439825|NCT02279498|3525023|P1|COMPLETED|Overall Study||47
1439826|NCT02279498|3525022|P2|STARTED|Overall Study||63
1439827|NCT02279498|3525023|P1|STARTED|Overall Study||65
1439828|NCT02279420|3525032|P1|NOT COMPLETED|Overall Study||23
1439829|NCT02279420|3525032|P1|COMPLETED|Overall Study||50
1439830|NCT02279420|3525032|P1|STARTED|Overall Study||73
1439831|NCT02279407|3525040|P4|NOT COMPLETED|Overall Study||1
1439832|NCT02279407|3525041|P3|NOT COMPLETED|Overall Study||5
1439833|NCT02279407|3525042|P2|NOT COMPLETED|Overall Study||1
1439834|NCT02279407|3525043|P1|NOT COMPLETED|Overall Study||2
1439835|NCT02279407|3525040|P4|COMPLETED|Overall Study||20
1439836|NCT02279407|3525041|P3|COMPLETED|Overall Study||15
1439837|NCT02279407|3525042|P2|COMPLETED|Overall Study||20
1439838|NCT02279407|3525043|P1|COMPLETED|Overall Study||20
1439839|NCT02279407|3525040|P4|STARTED|Overall Study||21
1439840|NCT02279407|3525041|P3|STARTED|Overall Study||20
1439841|NCT02279407|3525042|P2|STARTED|Overall Study||21
1439842|NCT02279407|3525043|P1|STARTED|Overall Study||22
1439843|NCT02279108|3525056|P2|NOT COMPLETED|Overall Study||1
1439844|NCT02279108|3525057|P1|NOT COMPLETED|Overall Study||0
1439845|NCT02279108|3525056|P2|COMPLETED|Overall Study||49
1439846|NCT02279108|3525057|P1|COMPLETED|Overall Study||50
1439847|NCT02279108|3525056|P2|STARTED|Overall Study||50
1439848|NCT02279108|3525057|P1|STARTED|Overall Study||50
1439849|NCT02279082|3525079|P1|NOT COMPLETED|Overall Study||33
1439850|NCT02279082|3525079|P1|COMPLETED|Overall Study||134
1439851|NCT02279082|3525079|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
1439852|NCT02278939|3525085|P2|NOT COMPLETED|Overall Study||1
1439853|NCT02278939|3525086|P1|NOT COMPLETED|Overall Study||5
1439854|NCT02278939|3525085|P2|COMPLETED|Overall Study||33
1439855|NCT02278939|3525086|P1|COMPLETED|Overall Study||28
1439856|NCT02278939|3525085|P2|STARTED|Overall Study||34
1439857|NCT02278939|3525086|P1|STARTED|Overall Study||33
1439858|NCT02278783|3525098|P1|NOT COMPLETED|Overall Study||0
1439859|NCT02278783|3525098|P1|COMPLETED|Overall Study||1
1439860|NCT02278783|3525098|P1|STARTED|Overall Study||1
1439861|NCT02278640|3525105|P1|NOT COMPLETED|Overall Study||0
1439862|NCT02278640|3525105|P1|COMPLETED|Overall Study||40
1439863|NCT02278640|3525105|P1|STARTED|Overall Study||40
1439864|NCT02278614|3525114|P2|NOT COMPLETED|Overall Study||5
1439865|NCT02278614|3525115|P1|NOT COMPLETED|Overall Study||5
1439866|NCT02278614|3525114|P2|COMPLETED|Overall Study||110
1439867|NCT02278614|3525115|P1|COMPLETED|Overall Study||122
1439868|NCT02278614|3525114|P2|STARTED|Overall Study||115
1439869|NCT02278614|3525115|P1|STARTED|Overall Study||127
1439870|NCT02278562|3525124|P3|NOT COMPLETED|Overall Study||0
1439871|NCT02278562|3525125|P2|NOT COMPLETED|Overall Study||0
1439872|NCT02278562|3525126|P1|NOT COMPLETED|Overall Study||0
1439873|NCT02278562|3525124|P3|COMPLETED|Overall Study||8
1439874|NCT02278562|3525125|P2|COMPLETED|Overall Study||7
1439875|NCT02278562|3525126|P1|COMPLETED|Overall Study||9
1439876|NCT02278562|3525124|P3|STARTED|Overall Study||8
1439877|NCT02278562|3525125|P2|STARTED|Overall Study||7
1439878|NCT02278562|3525126|P1|STARTED|Overall Study||9
1439879|NCT02278484|3525140|P1|NOT COMPLETED|Overall Study||0
1439880|NCT02278484|3525140|P1|COMPLETED|Overall Study||50
1439881|NCT02278484|3525140|P1|STARTED|Overall Study||50
1439882|NCT02278146|3525149|P2|NOT COMPLETED|Overall Study||2
1439883|NCT02278146|3525150|P1|NOT COMPLETED|Overall Study||0
1439884|NCT02278146|3525149|P2|COMPLETED|Overall Study||8
1439885|NCT02278146|3525150|P1|COMPLETED|Overall Study||6
1439886|NCT02278146|3525149|P2|STARTED|Overall Study||10
1439887|NCT02278146|3525150|P1|STARTED|Overall Study||6
1439888|NCT02278003|3525162|P2|NOT COMPLETED|Overall Study||0
1439889|NCT02278003|3525163|P1|NOT COMPLETED|Overall Study||19
1439890|NCT02278003|3525162|P2|COMPLETED|Overall Study||20
1439891|NCT02278003|3525163|P1|COMPLETED|Overall Study||30
1439892|NCT02278003|3525162|P2|STARTED|Overall Study||20
1439893|NCT02278003|3525163|P1|STARTED|Overall Study||49
1439894|NCT02277769|3525174|P3|NOT COMPLETED|Overall Study||18
1439895|NCT02277769|3525175|P2|NOT COMPLETED|Overall Study||13
1439896|NCT02277769|3525176|P1|NOT COMPLETED|Overall Study||46
1439897|NCT02277769|3525174|P3|COMPLETED|Overall Study||221
1439898|NCT02277769|3525175|P2|COMPLETED|Overall Study||220
1439899|NCT02277769|3525176|P1|COMPLETED|Overall Study||190
1439900|NCT02277769|3525174|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
1439901|NCT02277769|3525175|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
1439902|NCT02277769|3525176|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
1439903|NCT02277769|3525174|P3|Treated|Overall Study||239
1439904|NCT02277769|3525175|P2|Treated|Overall Study||233
1439905|NCT02277769|3525176|P1|Treated|Overall Study||235
1439906|NCT02277769|3525174|P3|STARTED|Overall Study||239
1439907|NCT02277769|3525175|P2|STARTED|Overall Study||233
1439908|NCT02277769|3525176|P1|STARTED|Overall Study||236
1439909|NCT02277743|3525247|P3|NOT COMPLETED|Overall Study||26
1439910|NCT02277743|3525248|P2|NOT COMPLETED|Overall Study||16
1439911|NCT02277743|3525249|P1|NOT COMPLETED|Overall Study||40
1439912|NCT02277743|3525247|P3|COMPLETED|Overall Study||197
1439913|NCT02277743|3525248|P2|COMPLETED|Overall Study||208
1439914|NCT02277743|3525249|P1|COMPLETED|Overall Study||184
1439915|NCT02277743|3525247|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
1439916|NCT02277743|3525248|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
1439917|NCT02277743|3525249|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
1439918|NCT02277743|3525247|P3|Treated|Overall Study||223
1439919|NCT02277743|3525248|P2|Treated|Overall Study||223
1439920|NCT02277743|3525249|P1|Treated|Overall Study||223
1439921|NCT02277743|3525247|P3|STARTED|Overall Study||223
1439922|NCT02277743|3525248|P2|STARTED|Overall Study||224
1439923|NCT02277743|3525249|P1|STARTED|Overall Study||224
1439924|NCT02277691|3525317|P1|NOT COMPLETED|Overall Study||46
1439925|NCT02277691|3525317|P1|COMPLETED|Overall Study||295
1439926|NCT02277691|3525317|P1|STARTED|Overall Study||341
1439927|NCT02277639|3525329|P2|NOT COMPLETED|Overall Study||0
1439928|NCT02277639|3525330|P1|NOT COMPLETED|Overall Study||0
1439929|NCT02277639|3525329|P2|COMPLETED|Overall Study||2
1439930|NCT02277639|3525330|P1|COMPLETED|Overall Study||0
1439931|NCT02277639|3525329|P2|STARTED|Overall Study||2
1439932|NCT02277639|3525330|P1|STARTED|Overall Study||0
1439933|NCT02277626|3525336|P2|NOT COMPLETED|Overall Study||0
1439934|NCT02277626|3525337|P1|NOT COMPLETED|Overall Study||0
1439935|NCT02277626|3525336|P2|COMPLETED|Overall Study||9
1439936|NCT02277626|3525337|P1|COMPLETED|Overall Study||6
1439937|NCT02277626|3525336|P2|STARTED|Overall Study||9
1439938|NCT02277626|3525337|P1|STARTED|Overall Study||6
1439939|NCT02277249|3525353|P2|NOT COMPLETED|Overall Study||0
1439940|NCT02277249|3525354|P1|NOT COMPLETED|Overall Study||0
1439941|NCT02277249|3525353|P2|COMPLETED|Overall Study||30
1439942|NCT02277249|3525354|P1|COMPLETED|Overall Study||30
1439943|NCT02277249|3525353|P2|STARTED|Overall Study||30
1439944|NCT02277249|3525354|P1|STARTED|Overall Study||30
1439945|NCT02277119|3525363|P3|NOT COMPLETED|Overall Study||8
1439946|NCT02277119|3525364|P2|NOT COMPLETED|Overall Study||4
1439947|NCT02277119|3525365|P1|NOT COMPLETED|Overall Study||3
1439948|NCT02277119|3525363|P3|COMPLETED|Overall Study||19
1439949|NCT02277119|3525364|P2|COMPLETED|Overall Study||20
1439950|NCT02277119|3525365|P1|COMPLETED|Overall Study||55
1439951|NCT02277119|3525363|P3|STARTED|Overall Study||27
1439952|NCT02277119|3525364|P2|STARTED|Overall Study||24
1439953|NCT02277119|3525365|P1|STARTED|Overall Study||58
1439954|NCT02277093|3525382|P1|NOT COMPLETED|Overall Study||0
1439955|NCT02277093|3525382|P1|COMPLETED|Overall Study||11
1439956|NCT02277093|3525382|P1|STARTED|Overall Study||11
1439957|NCT02277054|3525390|P1|NOT COMPLETED|Overall Study||0
1439958|NCT02277054|3525390|P1|COMPLETED|Overall Study||5
1439959|NCT02277054|3525390|P1|STARTED|Overall Study||5
1439960|NCT02276612|3525398|P2|NOT COMPLETED|Overall Study||0
1439961|NCT02276612|3525399|P1|NOT COMPLETED|Overall Study||4
1439962|NCT02276612|3525398|P2|COMPLETED|Overall Study||10
1439963|NCT02276612|3525399|P1|COMPLETED|Overall Study||46
1439964|NCT02276612|3525398|P2|STARTED|Overall Study||10
1439965|NCT02276612|3525399|P1|STARTED|Overall Study||50
1439966|NCT02276560|3525422|P3|NOT COMPLETED|Overall Study||0
1439967|NCT02276560|3525423|P2|NOT COMPLETED|Overall Study||0
1439968|NCT02276560|3525424|P1|NOT COMPLETED|Overall Study||1
1439969|NCT02276560|3525422|P3|COMPLETED|Overall Study||0
1439970|NCT02276560|3525423|P2|COMPLETED|Overall Study||0
1439971|NCT02276560|3525424|P1|COMPLETED|Overall Study||0
1439972|NCT02276560|3525422|P3|STARTED|Overall Study||0
1439973|NCT02276560|3525423|P2|STARTED|Overall Study||0
1439974|NCT02276560|3525424|P1|STARTED|Overall Study||1
1439975|NCT02276274|3525434|P2|NOT COMPLETED|Second Intervention Period||0
1439976|NCT02276274|3525435|P1|NOT COMPLETED|Second Intervention Period||0
1439977|NCT02276274|3525434|P2|COMPLETED|Second Intervention Period||6
1439978|NCT02276274|3525435|P1|COMPLETED|Second Intervention Period||6
1439979|NCT02276274|3525434|P2|STARTED|Second Intervention Period||6
1439980|NCT02276274|3525435|P1|STARTED|Second Intervention Period||6
1439981|NCT02276274|3525434|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
1439982|NCT02276274|3525435|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
1439983|NCT02276274|3525434|P2|COMPLETED|Washout Period (at Least 15 Days)||6
1439984|NCT02276274|3525435|P1|COMPLETED|Washout Period (at Least 15 Days)||6
1439985|NCT02276274|3525434|P2|STARTED|Washout Period (at Least 15 Days)||6
1439986|NCT02276274|3525435|P1|STARTED|Washout Period (at Least 15 Days)||6
1439987|NCT02276274|3525434|P2|NOT COMPLETED|First Intervention Period||0
1439988|NCT02276274|3525435|P1|NOT COMPLETED|First Intervention Period||0
1439989|NCT02276274|3525434|P2|COMPLETED|First Intervention Period||6
1439990|NCT02276274|3525435|P1|COMPLETED|First Intervention Period||6
1439991|NCT02276274|3525434|P2|STARTED|First Intervention Period||6
1439992|NCT02276274|3525435|P1|STARTED|First Intervention Period||6
1439993|NCT02276222|3525545|P2|NOT COMPLETED|Overall Study||64
1439994|NCT02276222|3525546|P1|NOT COMPLETED|Overall Study||185
1439995|NCT02276222|3525545|P2|COMPLETED|Overall Study||402
1439996|NCT02276222|3525546|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
1439997|NCT02276222|3525545|P2|STARTED|Overall Study||466
1439998|NCT02276222|3525546|P1|STARTED|Overall Study||621
1439999|NCT02276040|3525570|P1|NOT COMPLETED|Overall Study||15
1440000|NCT02276040|3525570|P1|COMPLETED|Overall Study||11
1440001|NCT02276040|3525570|P1|STARTED|Overall Study||26
1440002|NCT02275780|3525576|P2|NOT COMPLETED|Extension Study: up to 192 Weeks||233
1440003|NCT02275780|3525577|P1|NOT COMPLETED|Extension Study: up to 192 Weeks||260
1440004|NCT02275780|3525576|P2|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
1440005|NCT02275780|3525577|P1|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
1440006|NCT02275780|3525576|P2|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
1440007|NCT02275780|3525577|P1|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
1440008|NCT02275780|3525576|P2|NOT COMPLETED|Base Study: 96 Weeks||111
1440009|NCT02275780|3525577|P1|NOT COMPLETED|Base Study: 96 Weeks||93
1440010|NCT02275780|3525576|P2|COMPLETED|Base Study: 96 Weeks||273
1440011|NCT02275780|3525577|P1|COMPLETED|Base Study: 96 Weeks||292
1440012|NCT02275780|3525576|P2|Treated|Base Study: 96 Weeks||383
1440013|NCT02275780|3525577|P1|Treated|Base Study: 96 Weeks||383
1440014|NCT02275780|3525576|P2|STARTED|Base Study: 96 Weeks||384
1440015|NCT02275780|3525577|P1|STARTED|Base Study: 96 Weeks||385
1440016|NCT02275767|3525616|P3|NOT COMPLETED|Overall Study||3
1440017|NCT02275767|3525617|P2|NOT COMPLETED|Overall Study||4
1440018|NCT02275767|3525618|P1|NOT COMPLETED|Overall Study||2
1440019|NCT02275767|3525616|P3|COMPLETED|Overall Study||19
1440020|NCT02275767|3525617|P2|COMPLETED|Overall Study||18
1440021|NCT02275767|3525618|P1|COMPLETED|Overall Study||20
1440022|NCT02275767|3525616|P3|STARTED|Overall Study||22
1440023|NCT02275767|3525617|P2|STARTED|Overall Study||22
1440024|NCT02275767|3525618|P1|STARTED|Overall Study||22
1440025|NCT02275611|3525633|P4|NOT COMPLETED|Outpatient Drinking||0
1440026|NCT02275611|3525634|P3|NOT COMPLETED|Outpatient Drinking||0
1440027|NCT02275611|3525635|P2|NOT COMPLETED|Outpatient Drinking||0
1440028|NCT02275611|3525636|P1|NOT COMPLETED|Outpatient Drinking||0
1440029|NCT02275611|3525633|P4|COMPLETED|Outpatient Drinking||3
1440030|NCT02275611|3525634|P3|COMPLETED|Outpatient Drinking||6
1440031|NCT02275611|3525635|P2|COMPLETED|Outpatient Drinking||0
1440032|NCT02275611|3525636|P1|COMPLETED|Outpatient Drinking||0
1440033|NCT02275611|3525633|P4|STARTED|Outpatient Drinking||3
1440034|NCT02275611|3525634|P3|STARTED|Outpatient Drinking||6
1440035|NCT02275611|3525635|P2|STARTED|Outpatient Drinking||0
1440036|NCT02275611|3525636|P1|STARTED|Outpatient Drinking||0
1440037|NCT02275611|3525633|P4|NOT COMPLETED|Inpatient Withdrawal||0
1440038|NCT02275611|3525634|P3|NOT COMPLETED|Inpatient Withdrawal||0
1440039|NCT02275611|3525635|P2|NOT COMPLETED|Inpatient Withdrawal||0
1440040|NCT02275611|3525636|P1|NOT COMPLETED|Inpatient Withdrawal||1
1440041|NCT02275611|3525633|P4|COMPLETED|Inpatient Withdrawal||0
1440042|NCT02275611|3525634|P3|COMPLETED|Inpatient Withdrawal||0
1440043|NCT02275611|3525635|P2|COMPLETED|Inpatient Withdrawal||4
1440044|NCT02275611|3525636|P1|COMPLETED|Inpatient Withdrawal||4
1440045|NCT02275611|3525633|P4|STARTED|Inpatient Withdrawal||0
1440046|NCT02275611|3525634|P3|STARTED|Inpatient Withdrawal||0
1440047|NCT02275611|3525635|P2|STARTED|Inpatient Withdrawal||4
1440048|NCT02275611|3525636|P1|STARTED|Inpatient Withdrawal||5
1440049|NCT02275546|3525648|P2|NOT COMPLETED|Treatment Period 2||2
1440050|NCT02275546|3525649|P1|NOT COMPLETED|Treatment Period 2||2
1440051|NCT02275546|3525648|P2|COMPLETED|Treatment Period 2||81
1440052|NCT02275546|3525649|P1|COMPLETED|Treatment Period 2||79
1440053|NCT02275546|3525648|P2|STARTED|Treatment Period 2||83
1440054|NCT02275546|3525649|P1|STARTED|Treatment Period 2||81
1440055|NCT02275546|3525648|P2|NOT COMPLETED|Treatment Period 1||0
1440056|NCT02275546|3525649|P1|NOT COMPLETED|Treatment Period 1||0
1440057|NCT02275546|3525648|P2|COMPLETED|Treatment Period 1||83
1440058|NCT02275546|3525649|P1|COMPLETED|Treatment Period 1||81
1440059|NCT02275546|3525648|P2|STARTED|Treatment Period 1||83
1440060|NCT02275546|3525649|P1|STARTED|Treatment Period 1||81
1440061|NCT02275481|3525659|P2|NOT COMPLETED|Overall Study||3
1440062|NCT02275481|3525660|P1|NOT COMPLETED|Overall Study||9
1440063|NCT02275481|3525659|P2|COMPLETED|Overall Study||31
1440064|NCT02275481|3525660|P1|COMPLETED|Overall Study||23
1440065|NCT02275481|3525659|P2|STARTED|Overall Study||34
1440066|NCT02275481|3525660|P1|STARTED|Overall Study||32
1440067|NCT02275364|3525666|P2|NOT COMPLETED|Period 4||0
1440068|NCT02275364|3525667|P1|NOT COMPLETED|Period 4||0
1440069|NCT02275364|3525666|P2|COMPLETED|Period 4||14
1440070|NCT02275364|3525667|P1|COMPLETED|Period 4||12
1440071|NCT02275364|3525666|P2|STARTED|Period 4||14
1440072|NCT02275364|3525667|P1|STARTED|Period 4||12
1440073|NCT02275364|3525666|P2|NOT COMPLETED|Period 3||0
1440074|NCT02275364|3525667|P1|NOT COMPLETED|Period 3||0
1440075|NCT02275364|3525666|P2|COMPLETED|Period 3||14
1440076|NCT02275364|3525667|P1|COMPLETED|Period 3||12
1440077|NCT02275364|3525666|P2|STARTED|Period 3||14
1440078|NCT02275364|3525667|P1|STARTED|Period 3||12
1440079|NCT02275364|3525666|P2|NOT COMPLETED|Washout Period 2||0
1440080|NCT02275364|3525667|P1|NOT COMPLETED|Washout Period 2||0
1440081|NCT02275364|3525666|P2|COMPLETED|Washout Period 2||14
1440082|NCT02275364|3525667|P1|COMPLETED|Washout Period 2||12
1440083|NCT02275364|3525666|P2|STARTED|Washout Period 2||14
1440084|NCT02275364|3525667|P1|STARTED|Washout Period 2||12
1440085|NCT02275364|3525666|P2|NOT COMPLETED|Period 2||0
1440086|NCT02275364|3525667|P1|NOT COMPLETED|Period 2||0
1440087|NCT02275364|3525666|P2|COMPLETED|Period 2||14
1440088|NCT02275364|3525667|P1|COMPLETED|Period 2||12
1440089|NCT02275364|3525666|P2|STARTED|Period 2||14
1440090|NCT02275364|3525667|P1|STARTED|Period 2||12
1440091|NCT02275364|3525666|P2|NOT COMPLETED|Washout Period 1||0
1440092|NCT02275364|3525667|P1|NOT COMPLETED|Washout Period 1||0
1440093|NCT02275364|3525666|P2|COMPLETED|Washout Period 1||14
1440094|NCT02275364|3525667|P1|COMPLETED|Washout Period 1||12
1440095|NCT02275364|3525666|P2|STARTED|Washout Period 1||14
1440096|NCT02275364|3525667|P1|STARTED|Washout Period 1||12
1440097|NCT02275364|3525666|P2|NOT COMPLETED|Period 1||0
1440098|NCT02275364|3525667|P1|NOT COMPLETED|Period 1||2
1440099|NCT02275364|3525666|P2|COMPLETED|Period 1||14
1440100|NCT02275364|3525667|P1|COMPLETED|Period 1||12
1440101|NCT02275364|3525666|P2|STARTED|Period 1||14
1440102|NCT02275364|3525667|P1|STARTED|Period 1||14
1440103|NCT02275156|3525699|P3|NOT COMPLETED|Overall Study||0
1440104|NCT02275156|3525700|P2|NOT COMPLETED|Overall Study||0
1440105|NCT02275156|3525701|P1|NOT COMPLETED|Overall Study||0
1440106|NCT02275156|3525699|P3|COMPLETED|Overall Study||6
1440107|NCT02275156|3525700|P2|COMPLETED|Overall Study||6
1440108|NCT02275156|3525701|P1|COMPLETED|Overall Study||6
1440109|NCT02275156|3525699|P3|STARTED|Overall Study||6
1440110|NCT02275156|3525700|P2|STARTED|Overall Study||6
1440111|NCT02275156|3525701|P1|STARTED|Overall Study||6
1440112|NCT02275052|3525728|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
1440113|NCT02275052|3525729|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
1440114|NCT02275052|3525730|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1440115|NCT02275052|3525731|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1440116|NCT02275052|3525728|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
1440117|NCT02275052|3525729|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
1440118|NCT02275052|3525730|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1440119|NCT02275052|3525731|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1440120|NCT02275052|3525728|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
1440121|NCT02275052|3525729|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
1440122|NCT02275052|3525730|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
1440123|NCT02275052|3525731|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
1440124|NCT02275052|3525728|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
1440125|NCT02275052|3525729|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
1440126|NCT02275052|3525730|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
1440127|NCT02275052|3525731|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
1440128|NCT02275052|3525728|P4|COMPLETED|Washout Period (12-17 Days)||0
1440129|NCT02275052|3525729|P3|COMPLETED|Washout Period (12-17 Days)||0
1440130|NCT02275052|3525730|P2|COMPLETED|Washout Period (12-17 Days)||93
1440131|NCT02275052|3525731|P1|COMPLETED|Washout Period (12-17 Days)||86
1440132|NCT02275052|3525728|P4|STARTED|Washout Period (12-17 Days)||0
1440133|NCT02275052|3525729|P3|STARTED|Washout Period (12-17 Days)||0
1440134|NCT02275052|3525730|P2|STARTED|Washout Period (12-17 Days)||93
1440135|NCT02275052|3525731|P1|STARTED|Washout Period (12-17 Days)||90
1440136|NCT02275052|3525728|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1440137|NCT02275052|3525729|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1440138|NCT02275052|3525730|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
1440139|NCT02275052|3525731|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
1440140|NCT02275052|3525728|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1440141|NCT02275052|3525729|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1440142|NCT02275052|3525730|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
1440143|NCT02275052|3525731|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
1440144|NCT02275052|3525728|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
1440145|NCT02275052|3525729|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
1440146|NCT02275052|3525730|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
1440147|NCT02275052|3525731|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
1440148|NCT02274948|3525745|P2|NOT COMPLETED|Overall Study||91
1440149|NCT02274948|3525746|P1|NOT COMPLETED|Overall Study||98
1440150|NCT02274948|3525745|P2|COMPLETED|Overall Study||82
1440151|NCT02274948|3525746|P1|COMPLETED|Overall Study||68
1440152|NCT02274948|3525745|P2|STARTED|Overall Study||173
1440153|NCT02274948|3525746|P1|STARTED|Overall Study||166
1440154|NCT02274870|3525762|P2|NOT COMPLETED|Overall Study||0
1440155|NCT02274870|3525763|P1|NOT COMPLETED|Overall Study||0
1440156|NCT02274870|3525762|P2|COMPLETED|Overall Study||33
1440157|NCT02274870|3525763|P1|COMPLETED|Overall Study||32
1440158|NCT02274870|3525762|P2|STARTED|Overall Study||33
1440159|NCT02274870|3525763|P1|STARTED|Overall Study||32
1440160|NCT02274792|3525787|P1|NOT COMPLETED|Overall Study||25
1440161|NCT02274792|3525787|P1|COMPLETED|Overall Study||107
1440162|NCT02274792|3525787|P1|Received Treatment|Overall Study||131
1440163|NCT02274792|3525787|P1|STARTED|Overall Study||132
1440164|NCT02274766|3525797|P2|NOT COMPLETED|Overall Study||9
1440165|NCT02274766|3525798|P1|NOT COMPLETED|Overall Study||4
1440166|NCT02274766|3525797|P2|COMPLETED|Overall Study||29
1440167|NCT02274766|3525798|P1|COMPLETED|Overall Study||35
1440168|NCT02274766|3525797|P2|Received Study Drug|Overall Study||37
1440169|NCT02274766|3525798|P1|Received Study Drug|Overall Study||38
1440170|NCT02274766|3525797|P2|STARTED|Overall Study||38
1440171|NCT02274766|3525798|P1|STARTED|Overall Study||39
1440172|NCT02274688|3525808|P2|NOT COMPLETED|Overall Study||13
1440173|NCT02274688|3525809|P1|NOT COMPLETED|Overall Study||14
1440174|NCT02274688|3525808|P2|COMPLETED|Overall Study||72
1440175|NCT02274688|3525809|P1|COMPLETED|Overall Study||72
1440176|NCT02274688|3525808|P2|STARTED|Overall Study||85
1440177|NCT02274688|3525809|P1|STARTED|Overall Study||86
1440178|NCT02274675|3525831|P1|NOT COMPLETED|Overall Study||0
1440179|NCT02274675|3525831|P1|COMPLETED|Overall Study||7
1440180|NCT02274675|3525831|P1|STARTED|Overall Study||7
1440181|NCT02274558|3525844|P3|NOT COMPLETED|Overall Study||9
1440182|NCT02274558|3525845|P2|NOT COMPLETED|Overall Study||13
1440183|NCT02274558|3525846|P1|NOT COMPLETED|Overall Study||7
1440184|NCT02274558|3525844|P3|COMPLETED|Overall Study||71
1440185|NCT02274558|3525845|P2|COMPLETED|Overall Study||63
1440186|NCT02274558|3525846|P1|COMPLETED|Overall Study||71
1440187|NCT02274558|3525844|P3|Included in the Safety Analysis Set|Overall Study||79
1440188|NCT02274558|3525845|P2|Included in the Safety Analysis Set|Overall Study||72
1440189|NCT02274558|3525846|P1|Included in the Safety Analysis Set|Overall Study||76
1440190|NCT02274558|3525844|P3|STARTED|Overall Study||80
1440191|NCT02274558|3525845|P2|STARTED|Overall Study||76
1440192|NCT02274558|3525846|P1|STARTED|Overall Study||78
1440193|NCT02273973|3525862|P2|NOT COMPLETED|Overall Study||8
1440194|NCT02273973|3525863|P1|NOT COMPLETED|Overall Study||9
1440195|NCT02273973|3525862|P2|COMPLETED|Overall Study||160
1440196|NCT02273973|3525863|P1|COMPLETED|Overall Study||157
1440197|NCT02273973|3525862|P2|STARTED|Overall Study||168
1440198|NCT02273973|3525863|P1|STARTED|Overall Study||166
1440199|NCT02273908|3525905|P2|NOT COMPLETED|Overall Study||5
1440200|NCT02273908|3525906|P1|NOT COMPLETED|Overall Study||33
1440201|NCT02273908|3525905|P2|COMPLETED|Overall Study||169
1440202|NCT02273908|3525906|P1|COMPLETED|Overall Study||124
1440203|NCT02273908|3525905|P2|STARTED|Overall Study||174
1440204|NCT02273908|3525906|P1|STARTED|Overall Study||157
1440205|NCT02273752|3525928|P1|NOT COMPLETED|Overall Study||2
1440206|NCT02273752|3525928|P1|COMPLETED|Overall Study||0
1440207|NCT02273752|3525928|P1|STARTED|Overall Study||2
1440208|NCT02273323|3525939|P2|NOT COMPLETED|Overall Study||0
1440209|NCT02273323|3525940|P1|NOT COMPLETED|Overall Study||0
1440210|NCT02273323|3525939|P2|COMPLETED|Overall Study||15
1440211|NCT02273323|3525940|P1|COMPLETED|Overall Study||15
1440212|NCT02273323|3525939|P2|STARTED|Overall Study||15
1440213|NCT02273323|3525940|P1|STARTED|Overall Study||15
1440214|NCT02273310|3525958|P2|NOT COMPLETED|Overall Study||3
1440215|NCT02273310|3525959|P1|NOT COMPLETED|Overall Study||18
1440216|NCT02273310|3525958|P2|COMPLETED|Overall Study||38
1440217|NCT02273310|3525959|P1|COMPLETED|Overall Study||24
1440218|NCT02273310|3525958|P2|STARTED|Overall Study||41
1440219|NCT02273310|3525959|P1|STARTED|Overall Study||42
1440220|NCT02273180|3525972|P2|NOT COMPLETED|Overall Study||19
1440221|NCT02273180|3525973|P1|NOT COMPLETED|Overall Study||27
1440222|NCT02273180|3525972|P2|COMPLETED|Overall Study||235
1440223|NCT02273180|3525973|P1|COMPLETED|Overall Study||226
1440224|NCT02273180|3525972|P2|Treated|Overall Study||254
1440225|NCT02273180|3525973|P1|Treated|Overall Study||252
1440226|NCT02273180|3525972|P2|STARTED|Overall Study||254
1440227|NCT02273180|3525973|P1|STARTED|Overall Study||253
1440228|NCT02273167|3525998|P3|NOT COMPLETED|Overall Study||21
1440229|NCT02273167|3525999|P2|NOT COMPLETED|Overall Study||23
1440230|NCT02273167|3526000|P1|NOT COMPLETED|Overall Study||24
1440231|NCT02273167|3525998|P3|COMPLETED|Overall Study||262
1440232|NCT02273167|3525999|P2|COMPLETED|Overall Study||260
1440233|NCT02273167|3526000|P1|COMPLETED|Overall Study||259
1440234|NCT02273167|3525998|P3|STARTED|Overall Study||283
1440235|NCT02273167|3525999|P2|STARTED|Overall Study||283
1440236|NCT02273167|3526000|P1|STARTED|Overall Study||283
1440237|NCT02273141|3526025|P2|NOT COMPLETED|Overall Study||25
1440238|NCT02273141|3526026|P1|NOT COMPLETED|Overall Study||17
1440239|NCT02273141|3526025|P2|COMPLETED|Overall Study||233
1440240|NCT02273141|3526026|P1|COMPLETED|Overall Study||240
1440241|NCT02273141|3526025|P2|STARTED|Overall Study||258
1440242|NCT02273141|3526026|P1|STARTED|Overall Study||257
1440243|NCT02273115|3526046|P4|NOT COMPLETED|Overall Study||1
1440244|NCT02273115|3526047|P3|NOT COMPLETED|Overall Study||0
1440245|NCT02273115|3526048|P2|NOT COMPLETED|Overall Study||0
1440246|NCT02273115|3526049|P1|NOT COMPLETED|Overall Study||0
1440247|NCT02273115|3526046|P4|COMPLETED|Overall Study||71
1440248|NCT02273115|3526047|P3|COMPLETED|Overall Study||67
1440249|NCT02273115|3526048|P2|COMPLETED|Overall Study||90
1440250|NCT02273115|3526049|P1|COMPLETED|Overall Study||94
1440251|NCT02273115|3526046|P4|STARTED|Overall Study||72
1440252|NCT02273115|3526047|P3|STARTED|Overall Study||67
1440253|NCT02273115|3526048|P2|STARTED|Overall Study||90
1440254|NCT02273115|3526049|P1|STARTED|Overall Study||94
1440255|NCT02273063|3526091|P1|NOT COMPLETED|Overall Study||5
1440256|NCT02273063|3526091|P1|COMPLETED|Overall Study||35
1440257|NCT02273063|3526091|P1|STARTED|Overall Study||40
1440258|NCT02273050|3526099|P3|NOT COMPLETED|Overall Study||29
1440259|NCT02273050|3526100|P2|NOT COMPLETED|Overall Study||22
1440260|NCT02273050|3526101|P1|NOT COMPLETED|Overall Study||24
1440261|NCT02273050|3526099|P3|COMPLETED|Overall Study||185
1440262|NCT02273050|3526100|P2|COMPLETED|Overall Study||194
1440263|NCT02273050|3526101|P1|COMPLETED|Overall Study||186
1440264|NCT02273050|3526099|P3|STARTED|Overall Study||214
1440265|NCT02273050|3526100|P2|STARTED|Overall Study||216
1440266|NCT02273050|3526101|P1|STARTED|Overall Study||210
1440267|NCT02273037|3526129|P2|NOT COMPLETED|Overall Study||8
1440268|NCT02273037|3526130|P1|NOT COMPLETED|Overall Study||8
1440269|NCT02273037|3526129|P2|COMPLETED|Overall Study||992
1440270|NCT02273037|3526130|P1|COMPLETED|Overall Study||979
1440271|NCT02273037|3526129|P2|STARTED|Overall Study||1000
1440272|NCT02273037|3526130|P1|STARTED|Overall Study||987
1440273|NCT02272803|3526142|P2|NOT COMPLETED|Overall Study||17
1440274|NCT02272803|3526143|P1|NOT COMPLETED|Overall Study||9
1440275|NCT02272803|3526142|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
1440276|NCT02272803|3526143|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
1440277|NCT02272803|3526142|P2|STARTED|Overall Study||42
1440278|NCT02272803|3526143|P1|STARTED|Overall Study||40
1440279|NCT02272725|3526156|P2|NOT COMPLETED|Overall Study||0
1440280|NCT02272725|3526157|P1|NOT COMPLETED|Overall Study||2
1440281|NCT02272725|3526156|P2|COMPLETED|Overall Study||42
1440282|NCT02272725|3526157|P1|COMPLETED|Overall Study||47
1440283|NCT02272725|3526156|P2|STARTED|Overall Study||42
1440284|NCT02272725|3526157|P1|STARTED|Overall Study||49
1440285|NCT02272686|3526167|P1|NOT COMPLETED|Overall Study||0
1440286|NCT02272686|3526167|P1|COMPLETED|Overall Study||1
1440287|NCT02272686|3526167|P1|STARTED|Overall Study||1
1440288|NCT02271984|3526172|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440289|NCT02271984|3526173|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440290|NCT02271984|3526174|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440291|NCT02271984|3526175|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440292|NCT02271984|3526176|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440293|NCT02271984|3526177|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440294|NCT02271984|3526178|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440295|NCT02271984|3526179|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440296|NCT02271984|3526180|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440297|NCT02271984|3526181|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440298|NCT02271984|3526182|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440299|NCT02271984|3526183|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
1440300|NCT02271984|3526172|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
1440301|NCT02271984|3526173|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
1440302|NCT02271984|3526174|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
1440303|NCT02271984|3526175|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
1440304|NCT02271984|3526176|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
1440305|NCT02271984|3526177|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
1440306|NCT02271984|3526178|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
1440307|NCT02271984|3526179|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
1440308|NCT02271984|3526180|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
1440309|NCT02271984|3526181|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
1440310|NCT02271984|3526182|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
1440311|NCT02271984|3526183|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
1440312|NCT02271984|3526172|P12|STARTED|Fifth Intervention Period (1 Day)||3
1440313|NCT02271984|3526173|P11|STARTED|Fifth Intervention Period (1 Day)||3
1440314|NCT02271984|3526174|P10|STARTED|Fifth Intervention Period (1 Day)||3
1440315|NCT02271984|3526175|P9|STARTED|Fifth Intervention Period (1 Day)||3
1440316|NCT02271984|3526176|P8|STARTED|Fifth Intervention Period (1 Day)||2
1440317|NCT02271984|3526177|P7|STARTED|Fifth Intervention Period (1 Day)||3
1440318|NCT02271984|3526178|P6|STARTED|Fifth Intervention Period (1 Day)||2
1440319|NCT02271984|3526179|P5|STARTED|Fifth Intervention Period (1 Day)||3
1440320|NCT02271984|3526180|P4|STARTED|Fifth Intervention Period (1 Day)||3
1440321|NCT02271984|3526181|P3|STARTED|Fifth Intervention Period (1 Day)||3
1440322|NCT02271984|3526182|P2|STARTED|Fifth Intervention Period (1 Day)||3
1440323|NCT02271984|3526183|P1|STARTED|Fifth Intervention Period (1 Day)||3
1440324|NCT02271984|3526172|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440325|NCT02271984|3526173|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440326|NCT02271984|3526174|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440327|NCT02271984|3526175|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440328|NCT02271984|3526176|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
1440329|NCT02271984|3526177|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440330|NCT02271984|3526178|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
1440331|NCT02271984|3526179|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440332|NCT02271984|3526180|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440333|NCT02271984|3526181|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440334|NCT02271984|3526182|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440335|NCT02271984|3526183|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
1440336|NCT02271984|3526172|P12|COMPLETED|Washout Period 4 (7 Days)||3
1440337|NCT02271984|3526173|P11|COMPLETED|Washout Period 4 (7 Days)||3
1440338|NCT02271984|3526174|P10|COMPLETED|Washout Period 4 (7 Days)||3
1440339|NCT02271984|3526175|P9|COMPLETED|Washout Period 4 (7 Days)||3
1440340|NCT02271984|3526176|P8|COMPLETED|Washout Period 4 (7 Days)||2
1440341|NCT02271984|3526177|P7|COMPLETED|Washout Period 4 (7 Days)||3
1440342|NCT02271984|3526178|P6|COMPLETED|Washout Period 4 (7 Days)||2
1440343|NCT02271984|3526179|P5|COMPLETED|Washout Period 4 (7 Days)||3
1440344|NCT02271984|3526180|P4|COMPLETED|Washout Period 4 (7 Days)||3
1440345|NCT02271984|3526181|P3|COMPLETED|Washout Period 4 (7 Days)||3
1440346|NCT02271984|3526182|P2|COMPLETED|Washout Period 4 (7 Days)||3
1440347|NCT02271984|3526183|P1|COMPLETED|Washout Period 4 (7 Days)||3
1440348|NCT02271984|3526172|P12|STARTED|Washout Period 4 (7 Days)||3
1440349|NCT02271984|3526173|P11|STARTED|Washout Period 4 (7 Days)||3
1440350|NCT02271984|3526174|P10|STARTED|Washout Period 4 (7 Days)||3
1440351|NCT02271984|3526175|P9|STARTED|Washout Period 4 (7 Days)||3
1440352|NCT02271984|3526176|P8|STARTED|Washout Period 4 (7 Days)||3
1440353|NCT02271984|3526177|P7|STARTED|Washout Period 4 (7 Days)||3
1440354|NCT02271984|3526178|P6|STARTED|Washout Period 4 (7 Days)||3
1440355|NCT02271984|3526179|P5|STARTED|Washout Period 4 (7 Days)||3
1440356|NCT02271984|3526180|P4|STARTED|Washout Period 4 (7 Days)||3
1440357|NCT02271984|3526181|P3|STARTED|Washout Period 4 (7 Days)||3
1440358|NCT02271984|3526182|P2|STARTED|Washout Period 4 (7 Days)||3
1440359|NCT02271984|3526183|P1|STARTED|Washout Period 4 (7 Days)||3
1440360|NCT02271984|3526172|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440361|NCT02271984|3526173|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440362|NCT02271984|3526174|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440363|NCT02271984|3526175|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440364|NCT02271984|3526176|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440365|NCT02271984|3526177|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440366|NCT02271984|3526178|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440367|NCT02271984|3526179|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440368|NCT02271984|3526180|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440369|NCT02271984|3526181|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440370|NCT02271984|3526182|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440371|NCT02271984|3526183|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
1440372|NCT02271984|3526172|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
1440373|NCT02271984|3526173|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
1440374|NCT02271984|3526174|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
1440375|NCT02271984|3526175|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
1440376|NCT02271984|3526176|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
1440377|NCT02271984|3526177|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
1440378|NCT02271984|3526178|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
1440379|NCT02271984|3526179|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
1440380|NCT02271984|3526180|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
1440381|NCT02271984|3526181|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
1440382|NCT02271984|3526182|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
1440383|NCT02271984|3526183|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
1440384|NCT02271984|3526172|P12|STARTED|Fourth Intervention Period (Day 1)||3
1440385|NCT02271984|3526173|P11|STARTED|Fourth Intervention Period (Day 1)||3
1440386|NCT02271984|3526174|P10|STARTED|Fourth Intervention Period (Day 1)||3
1440387|NCT02271984|3526175|P9|STARTED|Fourth Intervention Period (Day 1)||3
1440388|NCT02271984|3526176|P8|STARTED|Fourth Intervention Period (Day 1)||3
1440389|NCT02271984|3526177|P7|STARTED|Fourth Intervention Period (Day 1)||3
1440390|NCT02271984|3526178|P6|STARTED|Fourth Intervention Period (Day 1)||3
1440391|NCT02271984|3526179|P5|STARTED|Fourth Intervention Period (Day 1)||3
1440392|NCT02271984|3526180|P4|STARTED|Fourth Intervention Period (Day 1)||3
1440393|NCT02271984|3526181|P3|STARTED|Fourth Intervention Period (Day 1)||3
1440394|NCT02271984|3526182|P2|STARTED|Fourth Intervention Period (Day 1)||3
1440395|NCT02271984|3526183|P1|STARTED|Fourth Intervention Period (Day 1)||3
1440396|NCT02271984|3526172|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440397|NCT02271984|3526173|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440398|NCT02271984|3526174|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440399|NCT02271984|3526175|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440400|NCT02271984|3526176|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440401|NCT02271984|3526177|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440402|NCT02271984|3526178|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440403|NCT02271984|3526179|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440404|NCT02271984|3526180|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440405|NCT02271984|3526181|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440406|NCT02271984|3526182|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440407|NCT02271984|3526183|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
1440408|NCT02271984|3526172|P12|COMPLETED|Washout Period 3 (7 Days)||3
1440409|NCT02271984|3526173|P11|COMPLETED|Washout Period 3 (7 Days)||3
1440410|NCT02271984|3526174|P10|COMPLETED|Washout Period 3 (7 Days)||3
1440411|NCT02271984|3526175|P9|COMPLETED|Washout Period 3 (7 Days)||3
1440412|NCT02271984|3526176|P8|COMPLETED|Washout Period 3 (7 Days)||3
1440413|NCT02271984|3526177|P7|COMPLETED|Washout Period 3 (7 Days)||3
1440414|NCT02271984|3526178|P6|COMPLETED|Washout Period 3 (7 Days)||3
1440415|NCT02271984|3526179|P5|COMPLETED|Washout Period 3 (7 Days)||3
1440416|NCT02271984|3526180|P4|COMPLETED|Washout Period 3 (7 Days)||3
1440417|NCT02271984|3526181|P3|COMPLETED|Washout Period 3 (7 Days)||3
1440418|NCT02271984|3526182|P2|COMPLETED|Washout Period 3 (7 Days)||3
1440419|NCT02271984|3526183|P1|COMPLETED|Washout Period 3 (7 Days)||3
1440420|NCT02271984|3526172|P12|STARTED|Washout Period 3 (7 Days)||3
1440421|NCT02271984|3526173|P11|STARTED|Washout Period 3 (7 Days)||3
1440422|NCT02271984|3526174|P10|STARTED|Washout Period 3 (7 Days)||3
1440423|NCT02271984|3526175|P9|STARTED|Washout Period 3 (7 Days)||3
1440424|NCT02271984|3526176|P8|STARTED|Washout Period 3 (7 Days)||3
1440425|NCT02271984|3526177|P7|STARTED|Washout Period 3 (7 Days)||3
1440426|NCT02271984|3526178|P6|STARTED|Washout Period 3 (7 Days)||3
1440427|NCT02271984|3526179|P5|STARTED|Washout Period 3 (7 Days)||3
1440428|NCT02271984|3526180|P4|STARTED|Washout Period 3 (7 Days)||3
1440429|NCT02271984|3526181|P3|STARTED|Washout Period 3 (7 Days)||3
1440430|NCT02271984|3526182|P2|STARTED|Washout Period 3 (7 Days)||3
1440431|NCT02271984|3526183|P1|STARTED|Washout Period 3 (7 Days)||3
1440432|NCT02271984|3526172|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440433|NCT02271984|3526173|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440434|NCT02271984|3526174|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440435|NCT02271984|3526175|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440436|NCT02271984|3526176|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440437|NCT02271984|3526177|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440438|NCT02271984|3526178|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440439|NCT02271984|3526179|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440440|NCT02271984|3526180|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440441|NCT02271984|3526181|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440442|NCT02271984|3526182|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440443|NCT02271984|3526183|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
1440444|NCT02271984|3526172|P12|COMPLETED|Third Intervention Period (1 Day)||3
1440445|NCT02271984|3526173|P11|COMPLETED|Third Intervention Period (1 Day)||3
1440446|NCT02271984|3526174|P10|COMPLETED|Third Intervention Period (1 Day)||3
1440447|NCT02271984|3526175|P9|COMPLETED|Third Intervention Period (1 Day)||3
1440448|NCT02271984|3526176|P8|COMPLETED|Third Intervention Period (1 Day)||3
1440449|NCT02271984|3526177|P7|COMPLETED|Third Intervention Period (1 Day)||3
1440450|NCT02271984|3526178|P6|COMPLETED|Third Intervention Period (1 Day)||3
1440451|NCT02271984|3526179|P5|COMPLETED|Third Intervention Period (1 Day)||3
1440452|NCT02271984|3526180|P4|COMPLETED|Third Intervention Period (1 Day)||3
1440453|NCT02271984|3526181|P3|COMPLETED|Third Intervention Period (1 Day)||3
1440454|NCT02271984|3526182|P2|COMPLETED|Third Intervention Period (1 Day)||3
1440455|NCT02271984|3526183|P1|COMPLETED|Third Intervention Period (1 Day)||3
1440456|NCT02271984|3526172|P12|STARTED|Third Intervention Period (1 Day)||3
1440457|NCT02271984|3526173|P11|STARTED|Third Intervention Period (1 Day)||3
1440458|NCT02271984|3526174|P10|STARTED|Third Intervention Period (1 Day)||3
1440459|NCT02271984|3526175|P9|STARTED|Third Intervention Period (1 Day)||3
1440460|NCT02271984|3526176|P8|STARTED|Third Intervention Period (1 Day)||3
1440461|NCT02271984|3526177|P7|STARTED|Third Intervention Period (1 Day)||3
1440462|NCT02271984|3526178|P6|STARTED|Third Intervention Period (1 Day)||3
1440463|NCT02271984|3526179|P5|STARTED|Third Intervention Period (1 Day)||3
1440464|NCT02271984|3526180|P4|STARTED|Third Intervention Period (1 Day)||3
1440465|NCT02271984|3526181|P3|STARTED|Third Intervention Period (1 Day)||3
1440466|NCT02271984|3526182|P2|STARTED|Third Intervention Period (1 Day)||3
1440467|NCT02271984|3526183|P1|STARTED|Third Intervention Period (1 Day)||3
1440468|NCT02271984|3526172|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440469|NCT02271984|3526173|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440470|NCT02271984|3526174|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440471|NCT02271984|3526175|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440472|NCT02271984|3526176|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440473|NCT02271984|3526177|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440474|NCT02271984|3526178|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440475|NCT02271984|3526179|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440476|NCT02271984|3526180|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440477|NCT02271984|3526181|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440478|NCT02271984|3526182|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440479|NCT02271984|3526183|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1440480|NCT02271984|3526172|P12|COMPLETED|Washout Period 2 (7 Days)||3
1440481|NCT02271984|3526173|P11|COMPLETED|Washout Period 2 (7 Days)||3
1440482|NCT02271984|3526174|P10|COMPLETED|Washout Period 2 (7 Days)||3
1440483|NCT02271984|3526175|P9|COMPLETED|Washout Period 2 (7 Days)||3
1440484|NCT02271984|3526176|P8|COMPLETED|Washout Period 2 (7 Days)||3
1440485|NCT02271984|3526177|P7|COMPLETED|Washout Period 2 (7 Days)||3
1440486|NCT02271984|3526178|P6|COMPLETED|Washout Period 2 (7 Days)||3
1440487|NCT02271984|3526179|P5|COMPLETED|Washout Period 2 (7 Days)||3
1440488|NCT02271984|3526180|P4|COMPLETED|Washout Period 2 (7 Days)||3
1440489|NCT02271984|3526181|P3|COMPLETED|Washout Period 2 (7 Days)||3
1440490|NCT02271984|3526182|P2|COMPLETED|Washout Period 2 (7 Days)||3
1440491|NCT02271984|3526183|P1|COMPLETED|Washout Period 2 (7 Days)||3
1440492|NCT02271984|3526172|P12|STARTED|Washout Period 2 (7 Days)||3
1440493|NCT02271984|3526173|P11|STARTED|Washout Period 2 (7 Days)||3
1440494|NCT02271984|3526174|P10|STARTED|Washout Period 2 (7 Days)||3
1440495|NCT02271984|3526175|P9|STARTED|Washout Period 2 (7 Days)||3
1440496|NCT02271984|3526176|P8|STARTED|Washout Period 2 (7 Days)||3
1440497|NCT02271984|3526177|P7|STARTED|Washout Period 2 (7 Days)||3
1440498|NCT02271984|3526178|P6|STARTED|Washout Period 2 (7 Days)||3
1440499|NCT02271984|3526179|P5|STARTED|Washout Period 2 (7 Days)||3
1440500|NCT02271984|3526180|P4|STARTED|Washout Period 2 (7 Days)||3
1440501|NCT02271984|3526181|P3|STARTED|Washout Period 2 (7 Days)||3
1440502|NCT02271984|3526182|P2|STARTED|Washout Period 2 (7 Days)||3
1440503|NCT02271984|3526183|P1|STARTED|Washout Period 2 (7 Days)||3
1440504|NCT02271984|3526172|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440505|NCT02271984|3526173|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440506|NCT02271984|3526174|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440507|NCT02271984|3526175|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440508|NCT02271984|3526176|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440509|NCT02271984|3526177|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440510|NCT02271984|3526178|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440511|NCT02271984|3526179|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440512|NCT02271984|3526180|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440513|NCT02271984|3526181|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440514|NCT02271984|3526182|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440515|NCT02271984|3526183|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
1440516|NCT02271984|3526172|P12|COMPLETED|Second Intervention Period (1 Day)||3
1440517|NCT02271984|3526173|P11|COMPLETED|Second Intervention Period (1 Day)||3
1440518|NCT02271984|3526174|P10|COMPLETED|Second Intervention Period (1 Day)||3
1440519|NCT02271984|3526175|P9|COMPLETED|Second Intervention Period (1 Day)||3
1440520|NCT02271984|3526176|P8|COMPLETED|Second Intervention Period (1 Day)||3
1440521|NCT02271984|3526177|P7|COMPLETED|Second Intervention Period (1 Day)||3
1440522|NCT02271984|3526178|P6|COMPLETED|Second Intervention Period (1 Day)||3
1440523|NCT02271984|3526179|P5|COMPLETED|Second Intervention Period (1 Day)||3
1440524|NCT02271984|3526180|P4|COMPLETED|Second Intervention Period (1 Day)||3
1440525|NCT02271984|3526181|P3|COMPLETED|Second Intervention Period (1 Day)||3
1440526|NCT02271984|3526182|P2|COMPLETED|Second Intervention Period (1 Day)||3
1440527|NCT02271984|3526183|P1|COMPLETED|Second Intervention Period (1 Day)||3
1440528|NCT02271984|3526172|P12|STARTED|Second Intervention Period (1 Day)||3
1440529|NCT02271984|3526173|P11|STARTED|Second Intervention Period (1 Day)||3
1440530|NCT02271984|3526174|P10|STARTED|Second Intervention Period (1 Day)||3
1440531|NCT02271984|3526175|P9|STARTED|Second Intervention Period (1 Day)||3
1440532|NCT02271984|3526176|P8|STARTED|Second Intervention Period (1 Day)||3
1440533|NCT02271984|3526177|P7|STARTED|Second Intervention Period (1 Day)||3
1440534|NCT02271984|3526178|P6|STARTED|Second Intervention Period (1 Day)||3
1440535|NCT02271984|3526179|P5|STARTED|Second Intervention Period (1 Day)||3
1440536|NCT02271984|3526180|P4|STARTED|Second Intervention Period (1 Day)||3
1440537|NCT02271984|3526181|P3|STARTED|Second Intervention Period (1 Day)||3
1440538|NCT02271984|3526182|P2|STARTED|Second Intervention Period (1 Day)||3
1440539|NCT02271984|3526183|P1|STARTED|Second Intervention Period (1 Day)||3
1440540|NCT02271984|3526172|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440541|NCT02271984|3526173|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440542|NCT02271984|3526174|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440543|NCT02271984|3526175|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440544|NCT02271984|3526176|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440545|NCT02271984|3526177|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440546|NCT02271984|3526178|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440547|NCT02271984|3526179|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440548|NCT02271984|3526180|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440549|NCT02271984|3526181|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440550|NCT02271984|3526182|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440551|NCT02271984|3526183|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1440552|NCT02271984|3526172|P12|COMPLETED|Washout Period 1 (7 Days)||3
1440553|NCT02271984|3526173|P11|COMPLETED|Washout Period 1 (7 Days)||3
1440554|NCT02271984|3526174|P10|COMPLETED|Washout Period 1 (7 Days)||3
1440555|NCT02271984|3526175|P9|COMPLETED|Washout Period 1 (7 Days)||3
1440556|NCT02271984|3526176|P8|COMPLETED|Washout Period 1 (7 Days)||3
1440557|NCT02271984|3526177|P7|COMPLETED|Washout Period 1 (7 Days)||3
1440558|NCT02271984|3526178|P6|COMPLETED|Washout Period 1 (7 Days)||3
1440559|NCT02271984|3526179|P5|COMPLETED|Washout Period 1 (7 Days)||3
1440560|NCT02271984|3526180|P4|COMPLETED|Washout Period 1 (7 Days)||3
1440561|NCT02271984|3526181|P3|COMPLETED|Washout Period 1 (7 Days)||3
1440562|NCT02271984|3526182|P2|COMPLETED|Washout Period 1 (7 Days)||3
1440563|NCT02271984|3526183|P1|COMPLETED|Washout Period 1 (7 Days)||3
1440564|NCT02271984|3526172|P12|STARTED|Washout Period 1 (7 Days)||3
1440565|NCT02271984|3526173|P11|STARTED|Washout Period 1 (7 Days)||3
1440566|NCT02271984|3526174|P10|STARTED|Washout Period 1 (7 Days)||3
1440567|NCT02271984|3526175|P9|STARTED|Washout Period 1 (7 Days)||3
1440568|NCT02271984|3526176|P8|STARTED|Washout Period 1 (7 Days)||3
1440569|NCT02271984|3526177|P7|STARTED|Washout Period 1 (7 Days)||3
1440570|NCT02271984|3526178|P6|STARTED|Washout Period 1 (7 Days)||3
1440571|NCT02271984|3526179|P5|STARTED|Washout Period 1 (7 Days)||3
1440572|NCT02271984|3526180|P4|STARTED|Washout Period 1 (7 Days)||3
1440573|NCT02271984|3526181|P3|STARTED|Washout Period 1 (7 Days)||3
1440574|NCT02271984|3526182|P2|STARTED|Washout Period 1 (7 Days)||3
1440575|NCT02271984|3526183|P1|STARTED|Washout Period 1 (7 Days)||3
1440576|NCT02271984|3526172|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
1440577|NCT02271984|3526173|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
1440578|NCT02271984|3526174|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
1440579|NCT02271984|3526175|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
1440580|NCT02271984|3526176|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
1440581|NCT02271984|3526177|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
1440582|NCT02271984|3526178|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
1440583|NCT02271984|3526179|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
1440584|NCT02271984|3526180|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
1440585|NCT02271984|3526181|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
1440586|NCT02271984|3526182|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
1440587|NCT02271984|3526183|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
1440588|NCT02271984|3526172|P12|COMPLETED|First Intervention Period (1 Day)||3
1440589|NCT02271984|3526173|P11|COMPLETED|First Intervention Period (1 Day)||3
1440590|NCT02271984|3526174|P10|COMPLETED|First Intervention Period (1 Day)||3
1440591|NCT02271984|3526175|P9|COMPLETED|First Intervention Period (1 Day)||3
1440592|NCT02271984|3526176|P8|COMPLETED|First Intervention Period (1 Day)||3
1440593|NCT02271984|3526177|P7|COMPLETED|First Intervention Period (1 Day)||3
1440594|NCT02271984|3526178|P6|COMPLETED|First Intervention Period (1 Day)||3
1440595|NCT02271984|3526179|P5|COMPLETED|First Intervention Period (1 Day)||3
1440596|NCT02271984|3526180|P4|COMPLETED|First Intervention Period (1 Day)||3
1440597|NCT02271984|3526181|P3|COMPLETED|First Intervention Period (1 Day)||3
1440598|NCT02271984|3526182|P2|COMPLETED|First Intervention Period (1 Day)||3
1440599|NCT02271984|3526183|P1|COMPLETED|First Intervention Period (1 Day)||3
1440600|NCT02271984|3526172|P12|STARTED|First Intervention Period (1 Day)||3
1440601|NCT02271984|3526173|P11|STARTED|First Intervention Period (1 Day)||3
1440602|NCT02271984|3526174|P10|STARTED|First Intervention Period (1 Day)||3
1440603|NCT02271984|3526175|P9|STARTED|First Intervention Period (1 Day)||3
1440604|NCT02271984|3526176|P8|STARTED|First Intervention Period (1 Day)||3
1440605|NCT02271984|3526177|P7|STARTED|First Intervention Period (1 Day)||3
1440606|NCT02271984|3526178|P6|STARTED|First Intervention Period (1 Day)||3
1440607|NCT02271984|3526179|P5|STARTED|First Intervention Period (1 Day)||3
1440608|NCT02271984|3526180|P4|STARTED|First Intervention Period (1 Day)||3
1440609|NCT02271984|3526181|P3|STARTED|First Intervention Period (1 Day)||3
1440610|NCT02271984|3526182|P2|STARTED|First Intervention Period (1 Day)||3
1440611|NCT02271984|3526183|P1|STARTED|First Intervention Period (1 Day)||3
1440612|NCT02271945|3526272|P2|NOT COMPLETED|Overall Study||5
1440613|NCT02271945|3526273|P1|NOT COMPLETED|Overall Study||5
1440614|NCT02271945|3526272|P2|COMPLETED|Overall Study||0
1440615|NCT02271945|3526273|P1|COMPLETED|Overall Study||0
1440616|NCT02271945|3526272|P2|STARTED|Overall Study||5
1440617|NCT02271945|3526273|P1|STARTED|Overall Study||5
1440618|NCT02271880|3526311|P2|NOT COMPLETED|Overall Study||4
1440619|NCT02271880|3526312|P1|NOT COMPLETED|Overall Study||3
1440620|NCT02271880|3526311|P2|COMPLETED|Overall Study||0
1440621|NCT02271880|3526312|P1|COMPLETED|Overall Study||0
1440622|NCT02271880|3526311|P2|STARTED|Overall Study||4
1440623|NCT02271880|3526312|P1|STARTED|Overall Study||3
1440624|NCT02271854|3526318|P1|NOT COMPLETED|Overall Study||4
1440625|NCT02271854|3526318|P1|COMPLETED|Overall Study||98
1440626|NCT02271854|3526318|P1|STARTED|Overall Study||102
1440627|NCT02271698|3526329|P4|NOT COMPLETED|Overall Study||0
1440628|NCT02271698|3526330|P3|NOT COMPLETED|Overall Study||0
1440629|NCT02271698|3526331|P2|NOT COMPLETED|Overall Study||0
1440630|NCT02271698|3526332|P1|NOT COMPLETED|Overall Study||0
1440631|NCT02271698|3526329|P4|COMPLETED|Overall Study||11
1440632|NCT02271698|3526330|P3|COMPLETED|Overall Study||10
1440633|NCT02271698|3526331|P2|COMPLETED|Overall Study||10
1440634|NCT02271698|3526332|P1|COMPLETED|Overall Study||11
1440635|NCT02271698|3526329|P4|STARTED|Overall Study||11
1440636|NCT02271698|3526330|P3|STARTED|Overall Study||10
1440637|NCT02271698|3526331|P2|STARTED|Overall Study||10
1440638|NCT02271698|3526332|P1|STARTED|Overall Study||11
1440639|NCT02271529|3526358|P1|NOT COMPLETED|Overall Study||1
1440640|NCT02271529|3526358|P1|COMPLETED|Overall Study||39
1440641|NCT02271529|3526358|P1|STARTED|Overall Study||40
1440642|NCT02271477|3526364|P2|NOT COMPLETED|Overall Study||0
1440643|NCT02271477|3526365|P1|NOT COMPLETED|Overall Study||0
1440644|NCT02271477|3526364|P2|COMPLETED|Overall Study||80
1440645|NCT02271477|3526365|P1|COMPLETED|Overall Study||80
1440646|NCT02271477|3526364|P2|STARTED|Overall Study||80
1440647|NCT02271477|3526365|P1|STARTED|Overall Study||80
1440648|NCT02271217|3526380|P3|NOT COMPLETED|Overall Study||12
1440649|NCT02271217|3526381|P2|NOT COMPLETED|Overall Study||13
1440650|NCT02271217|3526382|P1|NOT COMPLETED|Overall Study||11
1440651|NCT02271217|3526380|P3|COMPLETED|Overall Study||113
1440652|NCT02271217|3526381|P2|COMPLETED|Overall Study||113
1440653|NCT02271217|3526382|P1|COMPLETED|Overall Study||115
1440654|NCT02271217|3526380|P3|STARTED|Overall Study||125
1440655|NCT02271217|3526381|P2|STARTED|Overall Study||126
1440656|NCT02271217|3526382|P1|STARTED|Overall Study||126
1440657|NCT02270944|3526395|P2|NOT COMPLETED|Overall Study||5
1440658|NCT02270944|3526396|P1|NOT COMPLETED|Overall Study||11
1440659|NCT02270944|3526395|P2|COMPLETED|Overall Study||516
1440660|NCT02270944|3526396|P1|COMPLETED|Overall Study||518
1440661|NCT02270944|3526395|P2|STARTED|Overall Study||521
1440662|NCT02270944|3526396|P1|STARTED|Overall Study||529
1440663|NCT02270684|3526412|P2|NOT COMPLETED|Overall Study||3
1440664|NCT02270684|3526413|P1|NOT COMPLETED|Overall Study||1
1440665|NCT02270684|3526412|P2|COMPLETED|Overall Study||0
1440666|NCT02270684|3526413|P1|COMPLETED|Overall Study||0
1440667|NCT02270684|3526412|P2|STARTED|Overall Study||3
1440668|NCT02270684|3526413|P1|STARTED|Overall Study||1
1440669|NCT02270671|3526421|P2|NOT COMPLETED|Overall Study||5
1440670|NCT02270671|3526422|P1|NOT COMPLETED|Overall Study||5
1440671|NCT02270671|3526421|P2|COMPLETED|Overall Study||61
1440672|NCT02270671|3526422|P1|COMPLETED|Overall Study||59
1440673|NCT02270671|3526421|P2|STARTED|Overall Study||66
1440674|NCT02270671|3526422|P1|STARTED|Overall Study||64
1440675|NCT02270645|3526438|P2|NOT COMPLETED|Overall Study||0
1440676|NCT02270645|3526439|P1|NOT COMPLETED|Overall Study||2
1440677|NCT02270645|3526438|P2|COMPLETED|Overall Study||4
1440678|NCT02270645|3526439|P1|COMPLETED|Overall Study||6
1440679|NCT02270645|3526438|P2|STARTED|Overall Study||4
1440680|NCT02270645|3526439|P1|STARTED|Overall Study||8
1440681|NCT02270515|3526447|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
1440682|NCT02270515|3526447|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
1440683|NCT02270515|3526447|P1|STARTED|Intervention Period 3: 12-18 Months||127
1440684|NCT02270515|3526447|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
1440685|NCT02270515|3526447|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
1440686|NCT02270515|3526447|P1|STARTED|Intervention Period 2: 6-12 Months||159
1440687|NCT02270515|3526447|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
1440688|NCT02270515|3526447|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
1440689|NCT02270515|3526447|P1|STARTED|Intervention Period 1: 0-6 Months||175
1440690|NCT02269943|3526464|P2|NOT COMPLETED|Follow-Up Survival Period||26
1440691|NCT02269943|3526465|P1|NOT COMPLETED|Follow-Up Survival Period||5
1440692|NCT02269943|3526464|P2|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
1440693|NCT02269943|3526465|P1|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
1440694|NCT02269943|3526464|P2|STARTED|Follow-Up Survival Period||26
1440695|NCT02269943|3526465|P1|STARTED|Follow-Up Survival Period||5
1440696|NCT02269943|3526464|P2|NOT COMPLETED|Treatment Period||30
1440697|NCT02269943|3526465|P1|NOT COMPLETED|Treatment Period||6
1440698|NCT02269943|3526464|P2|COMPLETED|Treatment Period|Not applicable according to the study design|0
1440699|NCT02269943|3526465|P1|COMPLETED|Treatment Period|Not applicable according to the study design|0
1440700|NCT02269943|3526464|P2|Investigational Product (IP) Stopped|Treatment Period||30
1440701|NCT02269943|3526465|P1|Investigational Product (IP) Stopped|Treatment Period||6
1440702|NCT02269943|3526464|P2|STARTED|Treatment Period||30
1440703|NCT02269943|3526465|P1|STARTED|Treatment Period||6
1440704|NCT02269917|3526495|P2|NOT COMPLETED|Overall Study||383
1440705|NCT02269917|3526496|P1|NOT COMPLETED|Overall Study||766
1440706|NCT02269917|3526495|P2|COMPLETED|Overall Study||0
1440707|NCT02269917|3526496|P1|COMPLETED|Overall Study||0
1440708|NCT02269917|3526495|P2|Treated|Overall Study||378
1440709|NCT02269917|3526496|P1|Treated|Overall Study||763
1440710|NCT02269917|3526495|P2|STARTED|Overall Study||383
1440711|NCT02269917|3526496|P1|STARTED|Overall Study||766
1440712|NCT02269709|3526547|P1|NOT COMPLETED|Six Month Follow-up||12
1440713|NCT02269709|3526547|P1|COMPLETED|Six Month Follow-up||5
1440714|NCT02269709|3526547|P1|STARTED|Six Month Follow-up||17
1440715|NCT02269709|3526547|P1|NOT COMPLETED|Prior to Hospital Discharge||0
1440716|NCT02269709|3526547|P1|COMPLETED|Prior to Hospital Discharge||17
1440717|NCT02269709|3526547|P1|STARTED|Prior to Hospital Discharge||17
1440718|NCT02269709|3526547|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
1440719|NCT02269709|3526547|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
1440720|NCT02269709|3526547|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
1440721|NCT02269709|3526547|P1|NOT COMPLETED|Time of Enrollment||3
1440722|NCT02269709|3526547|P1|COMPLETED|Time of Enrollment||18
1440723|NCT02269709|3526547|P1|STARTED|Time of Enrollment||21
1440724|NCT02269657|3526552|P1|NOT COMPLETED|Overall Study||3
1440725|NCT02269657|3526552|P1|COMPLETED|Overall Study||37
1440726|NCT02269657|3526552|P1|STARTED|Overall Study||40
1440727|NCT02269488|3526566|P1|NOT COMPLETED|Overall Study||0
1440728|NCT02269488|3526566|P1|COMPLETED|Overall Study||100
1440729|NCT02269488|3526566|P1|STARTED|Overall Study||100
1440730|NCT02269475|3526572|P2|NOT COMPLETED|Overall Study||1
1440731|NCT02269475|3526573|P1|NOT COMPLETED|Overall Study||3
1440732|NCT02269475|3526572|P2|COMPLETED|Overall Study||432
1440733|NCT02269475|3526573|P1|COMPLETED|Overall Study||865
1440734|NCT02269475|3526572|P2|Per Protocol Population|Overall Study||430
1440735|NCT02269475|3526573|P1|Per Protocol Population|Overall Study||849
1440736|NCT02269475|3526572|P2|Received IP (Safety Population)|Overall Study||433
1440737|NCT02269475|3526573|P1|Received IP (Safety Population)|Overall Study||868
1440738|NCT02269475|3526572|P2|STARTED|Overall Study||433
1440739|NCT02269475|3526573|P1|STARTED|Overall Study||868
1440740|NCT02269098|3526586|P2|NOT COMPLETED|Overall Study||9
1440741|NCT02269098|3526587|P1|NOT COMPLETED|Overall Study||14
1440742|NCT02269098|3526586|P2|COMPLETED|Overall Study||41
1440743|NCT02269098|3526587|P1|COMPLETED|Overall Study||37
1440744|NCT02269098|3526586|P2|STARTED|Overall Study||50
1440745|NCT02269098|3526587|P1|STARTED|Overall Study||51
1440746|NCT02268994|3526603|P2|NOT COMPLETED|Overall Study||35
1440747|NCT02268994|3526604|P1|NOT COMPLETED|Overall Study||31
1440748|NCT02268994|3526603|P2|COMPLETED|Overall Study||81
1440749|NCT02268994|3526604|P1|COMPLETED|Overall Study||86
1440750|NCT02268994|3526603|P2|STARTED|Overall Study||116
1440751|NCT02268994|3526604|P1|STARTED|Overall Study||117
1440752|NCT02268877|3526622|P2|NOT COMPLETED|Overall Study||5
1440753|NCT02268877|3526623|P1|NOT COMPLETED|Overall Study||4
1440754|NCT02268877|3526622|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
1440755|NCT02268877|3526623|P1|COMPLETED|Overall Study||118
1440756|NCT02268877|3526622|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
1440757|NCT02268877|3526623|P1|STARTED|Overall Study||122
1440758|NCT02268864|3526634|P3|NOT COMPLETED|Overall Study||0
1440759|NCT02268864|3526635|P2|NOT COMPLETED|Overall Study||1
1440760|NCT02268864|3526636|P1|NOT COMPLETED|Overall Study||2
1440761|NCT02268864|3526634|P3|COMPLETED|Overall Study||64
1440762|NCT02268864|3526635|P2|COMPLETED|Overall Study||24
1440763|NCT02268864|3526636|P1|COMPLETED|Overall Study||15
1440764|NCT02268864|3526634|P3|STARTED|Overall Study||64
1440765|NCT02268864|3526635|P2|STARTED|Overall Study||25
1440766|NCT02268864|3526636|P1|STARTED|Overall Study||17
1440767|NCT02268812|3526662|P4|NOT COMPLETED|Overall Study||14
1440768|NCT02268812|3526663|P3|NOT COMPLETED|Overall Study||9
1440769|NCT02268812|3526664|P2|NOT COMPLETED|Overall Study||32
1440770|NCT02268812|3526665|P1|NOT COMPLETED|Overall Study||16
1440771|NCT02268812|3526662|P4|COMPLETED|Overall Study||26
1440772|NCT02268812|3526663|P3|COMPLETED|Overall Study||21
1440773|NCT02268812|3526664|P2|COMPLETED|Overall Study||40
1440774|NCT02268812|3526665|P1|COMPLETED|Overall Study||61
1440775|NCT02268812|3526662|P4|STARTED|Overall Study||40
1440776|NCT02268812|3526663|P3|STARTED|Overall Study||30
1440777|NCT02268812|3526664|P2|STARTED|Overall Study||72
1440778|NCT02268812|3526665|P1|STARTED|Overall Study||77
1440779|NCT02268526|3526698|P3|NOT COMPLETED|Overall Study||5
1440780|NCT02268526|3526699|P2|NOT COMPLETED|Overall Study||21
1440781|NCT02268526|3526700|P1|NOT COMPLETED|Overall Study||1
1440782|NCT02268526|3526698|P3|COMPLETED|Overall Study||16
1440783|NCT02268526|3526699|P2|COMPLETED|Overall Study||38
1440784|NCT02268526|3526700|P1|COMPLETED|Overall Study||5
1440785|NCT02268526|3526698|P3|PD Analysis Set (Cohort 2)|Overall Study||17
1440786|NCT02268526|3526699|P2|PD Analysis Set (Cohort 2)|Overall Study||42
1440787|NCT02268526|3526700|P1|PD Analysis Set (Cohort 2)|Overall Study||0
1440788|NCT02268526|3526698|P3|STARTED|Overall Study||21
1440789|NCT02268526|3526699|P2|STARTED|Overall Study||59
1440790|NCT02268526|3526700|P1|STARTED|Overall Study||6
1440791|NCT02268396|3526721|P1|NOT COMPLETED|Overall Study||12
1440792|NCT02268396|3526721|P1|COMPLETED|Overall Study||126
1440793|NCT02268396|3526721|P1|STARTED|Overall Study||138
1440794|NCT02268214|3526733|P3|NOT COMPLETED|Overall Study||42
1440795|NCT02268214|3526734|P2|NOT COMPLETED|Overall Study||41
1440796|NCT02268214|3526735|P1|NOT COMPLETED|Overall Study||42
1440797|NCT02268214|3526733|P3|COMPLETED|Overall Study||218
1440798|NCT02268214|3526734|P2|COMPLETED|Overall Study||255
1440799|NCT02268214|3526735|P1|COMPLETED|Overall Study||235
1440800|NCT02268214|3526733|P3|COMPLETED 24 WEEK PERIOD|Overall Study||232
1440801|NCT02268214|3526734|P2|COMPLETED 24 WEEK PERIOD|Overall Study||273
1440802|NCT02268214|3526735|P1|COMPLETED 24 WEEK PERIOD|Overall Study||252
1440803|NCT02268214|3526733|P3|STARTED|Overall Study||260
1440804|NCT02268214|3526734|P2|STARTED|Overall Study||296
1440805|NCT02268214|3526735|P1|STARTED|Overall Study||277
1440806|NCT02268058|3526765|P4|NOT COMPLETED|Overall Study||0
1440807|NCT02268058|3526766|P3|NOT COMPLETED|Overall Study||0
1440808|NCT02268058|3526767|P2|NOT COMPLETED|Overall Study||0
1440809|NCT02268058|3526768|P1|NOT COMPLETED|Overall Study||1
1440810|NCT02268058|3526765|P4|COMPLETED|Overall Study||20
1440811|NCT02268058|3526766|P3|COMPLETED|Overall Study||20
1440812|NCT02268058|3526767|P2|COMPLETED|Overall Study||20
1440813|NCT02268058|3526768|P1|COMPLETED|Overall Study||19
1440814|NCT02268058|3526765|P4|STARTED|Overall Study||20
1440815|NCT02268058|3526766|P3|STARTED|Overall Study||20
1440816|NCT02268058|3526767|P2|STARTED|Overall Study||20
1440817|NCT02268058|3526768|P1|STARTED|Overall Study||20
1440818|NCT02267850|3526792|P2|NOT COMPLETED|Overall Study||2
1440819|NCT02267850|3526793|P1|NOT COMPLETED|Overall Study||1
1440820|NCT02267850|3526792|P2|COMPLETED|Overall Study||12
1440821|NCT02267850|3526793|P1|COMPLETED|Overall Study||14
1440822|NCT02267850|3526792|P2|STARTED|Overall Study||14
1440823|NCT02267850|3526793|P1|STARTED|Overall Study||15
1440824|NCT02267837|3526801|P2|NOT COMPLETED|Overall Study||0
1440825|NCT02267837|3526802|P1|NOT COMPLETED|Overall Study||0
1440826|NCT02267837|3526801|P2|COMPLETED|Overall Study||9
1440827|NCT02267837|3526802|P1|COMPLETED|Overall Study||11
1440828|NCT02267837|3526801|P2|STARTED|Overall Study||9
1440829|NCT02267837|3526802|P1|STARTED|Overall Study||11
1440830|NCT02267824|3526810|P2|NOT COMPLETED|Overall Study||1
1440831|NCT02267824|3526811|P1|NOT COMPLETED|Overall Study||10
1440832|NCT02267824|3526810|P2|COMPLETED|Overall Study||17
1440833|NCT02267824|3526811|P1|COMPLETED|Overall Study||73
1440834|NCT02267824|3526810|P2|STARTED|Overall Study||18
1440835|NCT02267824|3526811|P1|STARTED|Overall Study||83
1440836|NCT02267629|3526817|P1|NOT COMPLETED|Overall Study||0
1440837|NCT02267629|3526817|P1|COMPLETED|Overall Study||7
1440838|NCT02267629|3526817|P1|STARTED|Overall Study||7
1440839|NCT02267538|3526824|P2|NOT COMPLETED|Overall Study||0
1440840|NCT02267538|3526825|P1|NOT COMPLETED|Overall Study||0
1440841|NCT02267538|3526824|P2|COMPLETED|Overall Study||143
1440842|NCT02267538|3526825|P1|COMPLETED|Overall Study||142
1440843|NCT02267538|3526824|P2|STARTED|Overall Study||143
1440844|NCT02267538|3526825|P1|STARTED|Overall Study||142
1440845|NCT02267447|3526845|P2|NOT COMPLETED|Overall Study||0
1440846|NCT02267447|3526846|P1|NOT COMPLETED|Overall Study||0
1440847|NCT02267447|3526845|P2|COMPLETED|Overall Study||26968
1440848|NCT02267447|3526846|P1|COMPLETED|Overall Study||77251
1440849|NCT02267447|3526845|P2|STARTED|Overall Study||26968
1440850|NCT02267447|3526846|P1|STARTED|Overall Study||77251
1440851|NCT02267187|3526854|P1|NOT COMPLETED|Overall Study||5
1440852|NCT02267187|3526854|P1|COMPLETED|Overall Study||10
1440853|NCT02267187|3526854|P1|STARTED|Overall Study||15
1440854|NCT02267135|3526862|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
1440855|NCT02267135|3526863|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
1440856|NCT02267135|3526862|P2|COMPLETED|Period 2 (Randomized Set)||46
1440857|NCT02267135|3526863|P1|COMPLETED|Period 2 (Randomized Set)||46
1440858|NCT02267135|3526862|P2|STARTED|Period 2 (Randomized Set)||47
1440859|NCT02267135|3526863|P1|STARTED|Period 2 (Randomized Set)||50
1440860|NCT02267135|3526862|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
1440861|NCT02267135|3526863|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
1440862|NCT02267135|3526862|P2|COMPLETED|Period 1 (Randomized Set)||47
1440863|NCT02267135|3526863|P1|COMPLETED|Period 1 (Randomized Set)||50
1440864|NCT02267135|3526862|P2|STARTED|Period 1 (Randomized Set)||51
1440865|NCT02267135|3526863|P1|STARTED|Period 1 (Randomized Set)||51
1440866|NCT02267083|3526894|P1|NOT COMPLETED|Overall Study||19
1440867|NCT02267083|3526894|P1|COMPLETED|Overall Study||3
1440868|NCT02267083|3526894|P1|STARTED|Overall Study||22
1440869|NCT02266875|3526903|P2|NOT COMPLETED|Overall Study||0
1440870|NCT02266875|3526904|P1|NOT COMPLETED|Overall Study||11
1440871|NCT02266875|3526903|P2|COMPLETED|Overall Study||30
1440872|NCT02266875|3526904|P1|COMPLETED|Overall Study||29
1440873|NCT02266875|3526903|P2|STARTED|Overall Study||30
1440874|NCT02266875|3526904|P1|STARTED|Overall Study||40
1440875|NCT02266810|3526916|P2|NOT COMPLETED|Overall Study||1
1440876|NCT02266810|3526917|P1|NOT COMPLETED|Overall Study||1
1440877|NCT02266810|3526916|P2|COMPLETED|Overall Study|sinus sides|79
1440878|NCT02266810|3526917|P1|COMPLETED|Overall Study|sinus sides|79
1440879|NCT02266810|3526916|P2|STARTED|Overall Study|sinus sides|80
1440880|NCT02266810|3526917|P1|STARTED|Overall Study|sinus sides|80
1440881|NCT02266797|3526943|P2|NOT COMPLETED|Overall Study||1
1440882|NCT02266797|3526944|P1|NOT COMPLETED|Overall Study||0
1440883|NCT02266797|3526943|P2|COMPLETED|Overall Study||2
1440884|NCT02266797|3526944|P1|COMPLETED|Overall Study||1
1440885|NCT02266797|3526943|P2|STARTED|Overall Study||3
1440886|NCT02266797|3526944|P1|STARTED|Overall Study||1
1440887|NCT02266472|3526962|P2|NOT COMPLETED|Period 2+ Washout||0
1440888|NCT02266472|3526963|P1|NOT COMPLETED|Period 2+ Washout||0
1440889|NCT02266472|3526962|P2|COMPLETED|Period 2+ Washout||15
1440890|NCT02266472|3526963|P1|COMPLETED|Period 2+ Washout||15
1440891|NCT02266472|3526962|P2|STARTED|Period 2+ Washout||15
1440892|NCT02266472|3526963|P1|STARTED|Period 2+ Washout||15
1440893|NCT02266472|3526962|P2|NOT COMPLETED|Period 1+ Washout||0
1440894|NCT02266472|3526963|P1|NOT COMPLETED|Period 1+ Washout||0
1440895|NCT02266472|3526962|P2|COMPLETED|Period 1+ Washout||15
1440896|NCT02266472|3526963|P1|COMPLETED|Period 1+ Washout||15
1440897|NCT02266472|3526962|P2|STARTED|Period 1+ Washout||15
1440898|NCT02266472|3526963|P1|STARTED|Period 1+ Washout||15
1440899|NCT02266381|3526982|P3|NOT COMPLETED|Overall Study||4
1440900|NCT02266381|3526983|P2|NOT COMPLETED|Overall Study||5
1440901|NCT02266381|3526984|P1|NOT COMPLETED|Overall Study||3
1440902|NCT02266381|3526982|P3|COMPLETED|Overall Study||146
1440903|NCT02266381|3526983|P2|COMPLETED|Overall Study||145
1440904|NCT02266381|3526984|P1|COMPLETED|Overall Study||147
1440905|NCT02266381|3526982|P3|STARTED|Overall Study||150
1440906|NCT02266381|3526983|P2|STARTED|Overall Study||150
1440907|NCT02266381|3526984|P1|STARTED|Overall Study||150
1440908|NCT02266277|3527007|P6|NOT COMPLETED|Overall Study||0
1440909|NCT02266277|3527008|P5|NOT COMPLETED|Overall Study||0
1440910|NCT02266277|3527009|P4|NOT COMPLETED|Overall Study||0
1440911|NCT02266277|3527010|P3|NOT COMPLETED|Overall Study||0
1440912|NCT02266277|3527011|P2|NOT COMPLETED|Overall Study||0
1440913|NCT02266277|3527012|P1|NOT COMPLETED|Overall Study||0
1440914|NCT02266277|3527007|P6|COMPLETED|Overall Study||5000
1440915|NCT02266277|3527008|P5|COMPLETED|Overall Study||5000
1440916|NCT02266277|3527009|P4|COMPLETED|Overall Study||5000
1440917|NCT02266277|3527010|P3|COMPLETED|Overall Study||5000
1440918|NCT02266277|3527011|P2|COMPLETED|Overall Study||5000
1440919|NCT02266277|3527012|P1|COMPLETED|Overall Study||5000
1440920|NCT02266277|3527007|P6|STARTED|Overall Study||5000
1440921|NCT02266277|3527008|P5|STARTED|Overall Study||5000
1440922|NCT02266277|3527009|P4|STARTED|Overall Study||5000
1440923|NCT02266277|3527010|P3|STARTED|Overall Study||5000
1440924|NCT02266277|3527011|P2|STARTED|Overall Study||5000
1440925|NCT02266277|3527012|P1|STARTED|Overall Study||5000
1440926|NCT02265848|3527036|P2|NOT COMPLETED|Overall Study||0
1440927|NCT02265848|3527037|P1|NOT COMPLETED|Overall Study||0
1440928|NCT02265848|3527036|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
1440929|NCT02265848|3527037|P1|COMPLETED|Overall Study||11
1440930|NCT02265848|3527036|P2|STARTED|Overall Study||11
1440931|NCT02265848|3527037|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
1440932|NCT02265796|3527051|P2|NOT COMPLETED|Overall Study||1
1440933|NCT02265796|3527052|P1|NOT COMPLETED|Overall Study||3
1440934|NCT02265796|3527051|P2|COMPLETED|Overall Study||24
1440935|NCT02265796|3527052|P1|COMPLETED|Overall Study||22
1440936|NCT02265796|3527051|P2|STARTED|Overall Study||25
1440937|NCT02265796|3527052|P1|STARTED|Overall Study||25
1440938|NCT02265783|3527062|P1|NOT COMPLETED|Overall Study||0
1440939|NCT02265783|3527062|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
1440940|NCT02265783|3527062|P1|STARTED|Overall Study||20
1440941|NCT02265237|3527070|P4|NOT COMPLETED|As Treated (Overall Study)||1
1440942|NCT02265237|3527071|P3|NOT COMPLETED|As Treated (Overall Study)||10
1440943|NCT02265237|3527072|P2|NOT COMPLETED|As Treated (Overall Study)||3
1440944|NCT02265237|3527073|P1|NOT COMPLETED|As Treated (Overall Study)||5
1440945|NCT02265237|3527070|P4|COMPLETED|As Treated (Overall Study)||2
1440946|NCT02265237|3527071|P3|COMPLETED|As Treated (Overall Study)||51
1440947|NCT02265237|3527072|P2|COMPLETED|As Treated (Overall Study)||57
1440948|NCT02265237|3527073|P1|COMPLETED|As Treated (Overall Study)||55
1440949|NCT02265237|3527070|P4|STARTED|As Treated (Overall Study)||3
1440950|NCT02265237|3527071|P3|STARTED|As Treated (Overall Study)||61
1440951|NCT02265237|3527072|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
1440952|NCT02265237|3527073|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
1440953|NCT02265237|3527070|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
1440954|NCT02265237|3527071|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
1440955|NCT02265237|3527072|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
1440956|NCT02265237|3527073|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
1440957|NCT02265237|3527070|P4|COMPLETED|As Enrolled (Overall Study)||2
1440958|NCT02265237|3527071|P3|COMPLETED|As Enrolled (Overall Study)||51
1440959|NCT02265237|3527072|P2|COMPLETED|As Enrolled (Overall Study)||58
1440960|NCT02265237|3527073|P1|COMPLETED|As Enrolled (Overall Study)||54
1440961|NCT02265237|3527070|P4|STARTED|As Enrolled (Overall Study)||3
1440962|NCT02265237|3527071|P3|STARTED|As Enrolled (Overall Study)||61
1440963|NCT02265237|3527072|P2|STARTED|As Enrolled (Overall Study)||61
1440964|NCT02265237|3527073|P1|STARTED|As Enrolled (Overall Study)||59
1440965|NCT02264977|3527092|P1|NOT COMPLETED|Overall Study||7
1440966|NCT02264977|3527092|P1|COMPLETED|Overall Study||2
1440967|NCT02264977|3527092|P1|STARTED|Overall Study||9
1440968|NCT02264821|3527103|P3|NOT COMPLETED|Overall Study||6
1440969|NCT02264821|3527104|P2|NOT COMPLETED|Overall Study||3
1440970|NCT02264821|3527105|P1|NOT COMPLETED|Overall Study||1
1440971|NCT02264821|3527103|P3|COMPLETED|Overall Study||58
1440972|NCT02264821|3527104|P2|COMPLETED|Overall Study||61
1440973|NCT02264821|3527105|P1|COMPLETED|Overall Study||63
1440974|NCT02264821|3527103|P3|STARTED|Overall Study|Double Blind|64
1440975|NCT02264821|3527104|P2|STARTED|Overall Study|Double Blind|64
1440976|NCT02264821|3527105|P1|STARTED|Overall Study|Double Blind|64
1440977|NCT02264249|3527119|P3|NOT COMPLETED|Overall Study||0
1440978|NCT02264249|3527120|P2|NOT COMPLETED|Overall Study||0
1440979|NCT02264249|3527121|P1|NOT COMPLETED|Overall Study||0
1440980|NCT02264249|3527119|P3|COMPLETED|Overall Study||241
1440981|NCT02264249|3527120|P2|COMPLETED|Overall Study||187
1440982|NCT02264249|3527121|P1|COMPLETED|Overall Study||21
1440983|NCT02264249|3527119|P3|STARTED|Overall Study||241
1440984|NCT02264249|3527120|P2|STARTED|Overall Study||187
1440985|NCT02264249|3527121|P1|STARTED|Overall Study||21
1440986|NCT02263911|3527135|P4|NOT COMPLETED|Period 5||0
1440987|NCT02263911|3527136|P3|NOT COMPLETED|Period 5||0
1440988|NCT02263911|3527137|P2|NOT COMPLETED|Period 5||0
1440989|NCT02263911|3527138|P1|NOT COMPLETED|Period 5||0
1440990|NCT02263911|3527135|P4|COMPLETED|Period 5||4
1440991|NCT02263911|3527136|P3|COMPLETED|Period 5||4
1440992|NCT02263911|3527137|P2|COMPLETED|Period 5||4
1440993|NCT02263911|3527138|P1|COMPLETED|Period 5||4
1440994|NCT02263911|3527135|P4|STARTED|Period 5||4
1440995|NCT02263911|3527136|P3|STARTED|Period 5||4
1440996|NCT02263911|3527137|P2|STARTED|Period 5||4
1440997|NCT02263911|3527138|P1|STARTED|Period 5||4
1440998|NCT02263911|3527135|P4|NOT COMPLETED|Period 4 Washout||0
1440999|NCT02263911|3527136|P3|NOT COMPLETED|Period 4 Washout||0
1441000|NCT02263911|3527137|P2|NOT COMPLETED|Period 4 Washout||0
1441001|NCT02263911|3527138|P1|NOT COMPLETED|Period 4 Washout||0
1441002|NCT02263911|3527135|P4|COMPLETED|Period 4 Washout||4
1441003|NCT02263911|3527136|P3|COMPLETED|Period 4 Washout||4
1441004|NCT02263911|3527137|P2|COMPLETED|Period 4 Washout||4
1441005|NCT02263911|3527138|P1|COMPLETED|Period 4 Washout||4
1441006|NCT02263911|3527135|P4|STARTED|Period 4 Washout||4
1441007|NCT02263911|3527136|P3|STARTED|Period 4 Washout||4
1441008|NCT02263911|3527137|P2|STARTED|Period 4 Washout||4
1441009|NCT02263911|3527138|P1|STARTED|Period 4 Washout||4
1441010|NCT02263911|3527135|P4|NOT COMPLETED|Period 4||0
1441011|NCT02263911|3527136|P3|NOT COMPLETED|Period 4||0
1441012|NCT02263911|3527137|P2|NOT COMPLETED|Period 4||0
1441013|NCT02263911|3527138|P1|NOT COMPLETED|Period 4||0
1441014|NCT02263911|3527135|P4|COMPLETED|Period 4||4
1441015|NCT02263911|3527136|P3|COMPLETED|Period 4||4
1441016|NCT02263911|3527137|P2|COMPLETED|Period 4||4
1441017|NCT02263911|3527138|P1|COMPLETED|Period 4||4
1441018|NCT02263911|3527135|P4|STARTED|Period 4||4
1441019|NCT02263911|3527136|P3|STARTED|Period 4||4
1441020|NCT02263911|3527137|P2|STARTED|Period 4||4
1441021|NCT02263911|3527138|P1|STARTED|Period 4||4
1441022|NCT02263911|3527135|P4|NOT COMPLETED|Period 3 Washout||0
1441023|NCT02263911|3527136|P3|NOT COMPLETED|Period 3 Washout||0
1441024|NCT02263911|3527137|P2|NOT COMPLETED|Period 3 Washout||0
1441025|NCT02263911|3527138|P1|NOT COMPLETED|Period 3 Washout||0
1441026|NCT02263911|3527135|P4|COMPLETED|Period 3 Washout||4
1441027|NCT02263911|3527136|P3|COMPLETED|Period 3 Washout||4
1441028|NCT02263911|3527137|P2|COMPLETED|Period 3 Washout||4
1441029|NCT02263911|3527138|P1|COMPLETED|Period 3 Washout||4
1441030|NCT02263911|3527135|P4|STARTED|Period 3 Washout||4
1441031|NCT02263911|3527136|P3|STARTED|Period 3 Washout||4
1441032|NCT02263911|3527137|P2|STARTED|Period 3 Washout||4
1441033|NCT02263911|3527138|P1|STARTED|Period 3 Washout||4
1441034|NCT02263911|3527135|P4|NOT COMPLETED|Period 3||0
1441035|NCT02263911|3527136|P3|NOT COMPLETED|Period 3||0
1441036|NCT02263911|3527137|P2|NOT COMPLETED|Period 3||0
1441037|NCT02263911|3527138|P1|NOT COMPLETED|Period 3||0
1441038|NCT02263911|3527135|P4|COMPLETED|Period 3||4
1441039|NCT02263911|3527136|P3|COMPLETED|Period 3||4
1441040|NCT02263911|3527137|P2|COMPLETED|Period 3||4
1441041|NCT02263911|3527138|P1|COMPLETED|Period 3||4
1441042|NCT02263911|3527135|P4|STARTED|Period 3||4
1441043|NCT02263911|3527136|P3|STARTED|Period 3||4
1441044|NCT02263911|3527137|P2|STARTED|Period 3||4
1441045|NCT02263911|3527138|P1|STARTED|Period 3||4
1441046|NCT02263911|3527135|P4|NOT COMPLETED|Period 2 Washout||0
1441047|NCT02263911|3527136|P3|NOT COMPLETED|Period 2 Washout||0
1441048|NCT02263911|3527137|P2|NOT COMPLETED|Period 2 Washout||0
1441049|NCT02263911|3527138|P1|NOT COMPLETED|Period 2 Washout||0
1441050|NCT02263911|3527135|P4|COMPLETED|Period 2 Washout||4
1441051|NCT02263911|3527136|P3|COMPLETED|Period 2 Washout||4
1441052|NCT02263911|3527137|P2|COMPLETED|Period 2 Washout||4
1441053|NCT02263911|3527138|P1|COMPLETED|Period 2 Washout||4
1441054|NCT02263911|3527135|P4|STARTED|Period 2 Washout||4
1441055|NCT02263911|3527136|P3|STARTED|Period 2 Washout||4
1441056|NCT02263911|3527137|P2|STARTED|Period 2 Washout||4
1441057|NCT02263911|3527138|P1|STARTED|Period 2 Washout||4
1441058|NCT02263911|3527135|P4|NOT COMPLETED|Period 2||0
1441059|NCT02263911|3527136|P3|NOT COMPLETED|Period 2||0
1441060|NCT02263911|3527137|P2|NOT COMPLETED|Period 2||0
1441061|NCT02263911|3527138|P1|NOT COMPLETED|Period 2||0
1441062|NCT02263911|3527135|P4|COMPLETED|Period 2||4
1441063|NCT02263911|3527136|P3|COMPLETED|Period 2||4
1441064|NCT02263911|3527137|P2|COMPLETED|Period 2||4
1441065|NCT02263911|3527138|P1|COMPLETED|Period 2||4
1441066|NCT02263911|3527135|P4|STARTED|Period 2||4
1441067|NCT02263911|3527136|P3|STARTED|Period 2||4
1441068|NCT02263911|3527137|P2|STARTED|Period 2||4
1441069|NCT02263911|3527138|P1|STARTED|Period 2||4
1441070|NCT02263911|3527135|P4|NOT COMPLETED|Period 1 Washout||0
1441071|NCT02263911|3527136|P3|NOT COMPLETED|Period 1 Washout||0
1441072|NCT02263911|3527137|P2|NOT COMPLETED|Period 1 Washout||0
1441073|NCT02263911|3527138|P1|NOT COMPLETED|Period 1 Washout||0
1441074|NCT02263911|3527135|P4|COMPLETED|Period 1 Washout||4
1441075|NCT02263911|3527136|P3|COMPLETED|Period 1 Washout||4
1441076|NCT02263911|3527137|P2|COMPLETED|Period 1 Washout||4
1441077|NCT02263911|3527138|P1|COMPLETED|Period 1 Washout||4
1441078|NCT02263911|3527135|P4|STARTED|Period 1 Washout||4
1441079|NCT02263911|3527136|P3|STARTED|Period 1 Washout||4
1441080|NCT02263911|3527137|P2|STARTED|Period 1 Washout||4
1441081|NCT02263911|3527138|P1|STARTED|Period 1 Washout||4
1441082|NCT02263911|3527135|P4|NOT COMPLETED|Period 1||0
1441083|NCT02263911|3527136|P3|NOT COMPLETED|Period 1||0
1441084|NCT02263911|3527137|P2|NOT COMPLETED|Period 1||0
1441085|NCT02263911|3527138|P1|NOT COMPLETED|Period 1||0
1441086|NCT02263911|3527135|P4|COMPLETED|Period 1||4
1441087|NCT02263911|3527136|P3|COMPLETED|Period 1||4
1441088|NCT02263911|3527137|P2|COMPLETED|Period 1||4
1441089|NCT02263911|3527138|P1|COMPLETED|Period 1||4
1441090|NCT02263911|3527135|P4|STARTED|Period 1||4
1441091|NCT02263911|3527136|P3|STARTED|Period 1||4
1441092|NCT02263911|3527137|P2|STARTED|Period 1||4
1441093|NCT02263911|3527138|P1|STARTED|Period 1||4
1441094|NCT02263833|3527160|P1|NOT COMPLETED|Overall Study||0
1441095|NCT02263833|3527160|P1|COMPLETED|Overall Study||742
1441096|NCT02263833|3527160|P1|STARTED|Overall Study||742
1441097|NCT02263365|3527167|P2|NOT COMPLETED|Overall Study||18
1441098|NCT02263365|3527168|P1|NOT COMPLETED|Overall Study||22
1441099|NCT02263365|3527167|P2|COMPLETED|Overall Study||0
1441100|NCT02263365|3527168|P1|COMPLETED|Overall Study||0
1441101|NCT02263365|3527167|P2|STARTED|Overall Study||18
1441102|NCT02263365|3527168|P1|STARTED|Overall Study||22
1441103|NCT02263326|3527182|P2|NOT COMPLETED|Overall Study||1
1441104|NCT02263326|3527183|P1|NOT COMPLETED|Overall Study||1
1441105|NCT02263326|3527182|P2|COMPLETED|Overall Study||44
1441106|NCT02263326|3527183|P1|COMPLETED|Overall Study||43
1441107|NCT02263326|3527182|P2|STARTED|Overall Study||45
1441108|NCT02263326|3527183|P1|STARTED|Overall Study||44
1441109|NCT02263131|3527203|P2|NOT COMPLETED|Overall Study||1
1441110|NCT02263131|3527204|P1|NOT COMPLETED|Overall Study||10
1441111|NCT02263131|3527203|P2|COMPLETED|Overall Study||68
1441112|NCT02263131|3527204|P1|COMPLETED|Overall Study||337
1441113|NCT02263131|3527203|P2|STARTED|Overall Study||69
1441114|NCT02263131|3527204|P1|STARTED|Overall Study||347
1441115|NCT02263118|3527216|P4|NOT COMPLETED|Overall Study||2
1441116|NCT02263118|3527217|P3|NOT COMPLETED|Overall Study||8
1441117|NCT02263118|3527218|P2|NOT COMPLETED|Overall Study||8
1441118|NCT02263118|3527219|P1|NOT COMPLETED|Overall Study||4
1441119|NCT02263118|3527216|P4|COMPLETED|Overall Study||12
1441120|NCT02263118|3527217|P3|COMPLETED|Overall Study||22
1441121|NCT02263118|3527218|P2|COMPLETED|Overall Study||24
1441122|NCT02263118|3527219|P1|COMPLETED|Overall Study||20
1441123|NCT02263118|3527216|P4|STARTED|Overall Study||14
1441124|NCT02263118|3527217|P3|STARTED|Overall Study||30
1441125|NCT02263118|3527218|P2|STARTED|Overall Study||32
1441126|NCT02263118|3527219|P1|STARTED|Overall Study||24
1441127|NCT02262754|3527244|P3|NOT COMPLETED|Overall Study||9
1441128|NCT02262754|3527245|P2|NOT COMPLETED|Overall Study||9
1441129|NCT02262754|3527246|P1|NOT COMPLETED|Overall Study||16
1441130|NCT02262754|3527244|P3|COMPLETED|Overall Study||65
1441131|NCT02262754|3527245|P2|COMPLETED|Overall Study||65
1441132|NCT02262754|3527246|P1|COMPLETED|Overall Study||58
1441133|NCT02262754|3527244|P3|STARTED|Overall Study||74
1441134|NCT02262754|3527245|P2|STARTED|Overall Study||74
1441135|NCT02262754|3527246|P1|STARTED|Overall Study||74
1441136|NCT02262728|3527321|P2|NOT COMPLETED|Overall Study||0
1441137|NCT02262728|3527322|P1|NOT COMPLETED|Overall Study||0
1441138|NCT02262728|3527321|P2|COMPLETED|Overall Study||21
1441139|NCT02262728|3527322|P1|COMPLETED|Overall Study||19
1441140|NCT02262728|3527321|P2|STARTED|Overall Study||21
1441141|NCT02262728|3527322|P1|STARTED|Overall Study||19
1441142|NCT02262130|3527350|P1|NOT COMPLETED|Overall Study||0
1441143|NCT02262130|3527350|P1|COMPLETED|Overall Study||10
1441144|NCT02262130|3527350|P1|STARTED|Overall Study||10
1441145|NCT02262078|3527360|P2|NOT COMPLETED|Overall Study||0
1441146|NCT02262078|3527361|P1|NOT COMPLETED|Overall Study||0
1441147|NCT02262078|3527360|P2|COMPLETED|Overall Study||13
1441148|NCT02262078|3527361|P1|COMPLETED|Overall Study||13
1441149|NCT02262078|3527360|P2|STARTED|Overall Study||13
1441150|NCT02262078|3527361|P1|STARTED|Overall Study||13
1441151|NCT02262039|3527369|P2|NOT COMPLETED|Overall Study||0
1441152|NCT02262039|3527370|P1|NOT COMPLETED|Overall Study||0
1441153|NCT02262039|3527369|P2|COMPLETED|Overall Study||27
1441154|NCT02262039|3527370|P1|COMPLETED|Overall Study||14
1441155|NCT02262039|3527369|P2|STARTED|Overall Study||27
1441156|NCT02262039|3527370|P1|STARTED|Overall Study||14
1441157|NCT02261974|3527390|P2|NOT COMPLETED|Overall Study||7
1441158|NCT02261974|3527391|P1|NOT COMPLETED|Overall Study||15
1441159|NCT02261974|3527390|P2|COMPLETED|Overall Study||56
1441160|NCT02261974|3527391|P1|COMPLETED|Overall Study||108
1441161|NCT02261974|3527390|P2|Treated|Overall Study||57
1441162|NCT02261974|3527391|P1|Treated|Overall Study||117
1441163|NCT02261974|3527390|P2|STARTED|Overall Study||63
1441164|NCT02261974|3527391|P1|STARTED|Overall Study||123
1441165|NCT02261948|3527407|P2|NOT COMPLETED|Overall Study||0
1441166|NCT02261948|3527408|P1|NOT COMPLETED|Overall Study||0
1441167|NCT02261948|3527407|P2|COMPLETED|Overall Study||19
1441168|NCT02261948|3527408|P1|COMPLETED|Overall Study||23
1441169|NCT02261948|3527407|P2|STARTED|Overall Study||19
1441170|NCT02261948|3527408|P1|STARTED|Overall Study||23
1441171|NCT02261818|3527418|P1|NOT COMPLETED|Overall Study||3
1441172|NCT02261818|3527418|P1|COMPLETED|Overall Study||27
1441173|NCT02261818|3527418|P1|STARTED|Overall Study||30
1441174|NCT02261805|3527422|P3|NOT COMPLETED|Overall Study||0
1441175|NCT02261805|3527423|P2|NOT COMPLETED|Overall Study||0
1441176|NCT02261805|3527424|P1|NOT COMPLETED|Overall Study||0
1441177|NCT02261805|3527422|P3|COMPLETED|Overall Study||2
1441178|NCT02261805|3527423|P2|COMPLETED|Overall Study||6
1441179|NCT02261805|3527424|P1|COMPLETED|Overall Study||3
1441180|NCT02261805|3527422|P3|STARTED|Overall Study||2
1441181|NCT02261805|3527423|P2|STARTED|Overall Study||6
1441182|NCT02261805|3527424|P1|STARTED|Overall Study||3
1441183|NCT02261493|3527435|P3|NOT COMPLETED|Overall Study||26
1441184|NCT02261493|3527436|P2|NOT COMPLETED|Overall Study||47
1441185|NCT02261493|3527437|P1|NOT COMPLETED|Overall Study||30
1441186|NCT02261493|3527435|P3|COMPLETED|Overall Study||287
1441187|NCT02261493|3527436|P2|COMPLETED|Overall Study||271
1441188|NCT02261493|3527437|P1|COMPLETED|Overall Study||126
1441189|NCT02261493|3527435|P3|STARTED|Overall Study||313
1441190|NCT02261493|3527436|P2|STARTED|Overall Study||318
1441191|NCT02261493|3527437|P1|STARTED|Overall Study||156
1441192|NCT02261467|3527465|P2|NOT COMPLETED|Overall Study||37
1441193|NCT02261467|3527466|P1|NOT COMPLETED|Overall Study||21
1441194|NCT02261467|3527465|P2|COMPLETED|Overall Study||253
1441195|NCT02261467|3527466|P1|COMPLETED|Overall Study||80
1441196|NCT02261467|3527465|P2|STARTED|Overall Study||290
1441197|NCT02261467|3527466|P1|STARTED|Overall Study||101
1441198|NCT02261428|3527486|P2|NOT COMPLETED|Overall Study||0
1441199|NCT02261428|3527487|P1|NOT COMPLETED|Overall Study||0
1441200|NCT02261428|3527486|P2|COMPLETED|Overall Study||10
1441201|NCT02261428|3527487|P1|COMPLETED|Overall Study||10
1441202|NCT02261428|3527486|P2|STARTED|Overall Study|Washout (30 minutes)|10
1441203|NCT02261428|3527487|P1|STARTED|Overall Study|Washout (30 minutes)|10
1441204|NCT02260986|3527508|P3|NOT COMPLETED|Overall Study||41
1441205|NCT02260986|3527509|P2|NOT COMPLETED|Overall Study||13
1441206|NCT02260986|3527510|P1|NOT COMPLETED|Overall Study||90
1441207|NCT02260986|3527508|P3|COMPLETED|Overall Study||278
1441208|NCT02260986|3527509|P2|COMPLETED|Overall Study||93
1441209|NCT02260986|3527510|P1|COMPLETED|Overall Study||225
1441210|NCT02260986|3527508|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
1441211|NCT02260986|3527509|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
1441212|NCT02260986|3527510|P1|Safety Population|Overall Study||315
1441213|NCT02260986|3527508|P3|STARTED|Overall Study||319
1441214|NCT02260986|3527509|P2|STARTED|Overall Study||106
1441215|NCT02260986|3527510|P1|STARTED|Overall Study||315
1441216|NCT02260882|3527628|P2|NOT COMPLETED|Overall Study||1
1441217|NCT02260882|3527629|P1|NOT COMPLETED|Overall Study||0
1441218|NCT02260882|3527628|P2|COMPLETED|Overall Study||81
1441219|NCT02260882|3527629|P1|COMPLETED|Overall Study||161
1441220|NCT02260882|3527628|P2|STARTED|Overall Study||82
1441221|NCT02260882|3527629|P1|STARTED|Overall Study||161
1441222|NCT02260791|3527653|P2|NOT COMPLETED|Overall Study||34
1441223|NCT02260791|3527654|P1|NOT COMPLETED|Overall Study||33
1441224|NCT02260791|3527653|P2|COMPLETED|Overall Study||328
1441225|NCT02260791|3527654|P1|COMPLETED|Overall Study||333
1441226|NCT02260791|3527653|P2|STARTED|Overall Study||362
1441227|NCT02260791|3527654|P1|STARTED|Overall Study||366
1441228|NCT02260648|3527693|P3|NOT COMPLETED|Overall Study||8
1441229|NCT02260648|3527694|P2|NOT COMPLETED|Overall Study||13
1441230|NCT02260648|3527695|P1|NOT COMPLETED|Overall Study||18
1441231|NCT02260648|3527693|P3|COMPLETED|Overall Study||42
1441232|NCT02260648|3527694|P2|COMPLETED|Overall Study||33
1441233|NCT02260648|3527695|P1|COMPLETED|Overall Study||35
1441234|NCT02260648|3527693|P3|Received at Least One Dose of Study Drug|Overall Study||50
1441235|NCT02260648|3527694|P2|Received at Least One Dose of Study Drug|Overall Study||46
1441236|NCT02260648|3527695|P1|Received at Least One Dose of Study Drug|Overall Study||53
1441237|NCT02260648|3527693|P3|STARTED|Overall Study||50
1441238|NCT02260648|3527694|P2|STARTED|Overall Study||46
1441239|NCT02260648|3527695|P1|STARTED|Overall Study||53
1441240|NCT02260635|3527723|P2|NOT COMPLETED|Open-Label Extension||25
1441241|NCT02260635|3527724|P1|NOT COMPLETED|Open-Label Extension||26
1441242|NCT02260635|3527723|P2|COMPLETED|Open-Label Extension||0
1441243|NCT02260635|3527724|P1|COMPLETED|Open-Label Extension||0
1441244|NCT02260635|3527723|P2|Received at Least One Dose of Study Drug|Open-Label Extension||25
1441245|NCT02260635|3527724|P1|Received at Least One Dose of Study Drug|Open-Label Extension||26
1441246|NCT02260635|3527723|P2|STARTED|Open-Label Extension||25
1441247|NCT02260635|3527724|P1|STARTED|Open-Label Extension||26
1441248|NCT02260635|3527723|P2|NOT COMPLETED|Double-Blind Treatment Period||2
1441249|NCT02260635|3527724|P1|NOT COMPLETED|Double-Blind Treatment Period||1
1441250|NCT02260635|3527723|P2|COMPLETED|Double-Blind Treatment Period||25
1441251|NCT02260635|3527724|P1|COMPLETED|Double-Blind Treatment Period||26
1441252|NCT02260635|3527723|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
1441253|NCT02260635|3527724|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
1441254|NCT02260635|3527723|P2|STARTED|Double-Blind Treatment Period||27
1441255|NCT02260635|3527724|P1|STARTED|Double-Blind Treatment Period||27
1441256|NCT02260492|3527747|P3|NOT COMPLETED|Overall Study||5
1441257|NCT02260492|3527748|P2|NOT COMPLETED|Overall Study||13
1441258|NCT02260492|3527749|P1|NOT COMPLETED|Overall Study||23
1441259|NCT02260492|3527747|P3|COMPLETED|Overall Study||37
1441260|NCT02260492|3527748|P2|COMPLETED|Overall Study||406
1441261|NCT02260492|3527749|P1|COMPLETED|Overall Study||395
1441262|NCT02260492|3527747|P3|Completed Day 1|Overall Study||42
1441263|NCT02260492|3527748|P2|Completed Day 1|Overall Study||419
1441264|NCT02260492|3527749|P1|Completed Day 1|Overall Study||418
1441265|NCT02260492|3527747|P3|STARTED|Overall Study||42
1441266|NCT02260492|3527748|P2|STARTED|Overall Study||419
1441267|NCT02260492|3527749|P1|STARTED|Overall Study||418
1441268|NCT02260440|3527763|P1|NOT COMPLETED|Overall Study||0
1441269|NCT02260440|3527763|P1|COMPLETED|Overall Study||31
1441270|NCT02260440|3527763|P1|STARTED|Overall Study||31
1441271|NCT02260401|3527771|P2|NOT COMPLETED|Overall Study||12
1441272|NCT02260401|3527772|P1|NOT COMPLETED|Overall Study||5
1441273|NCT02260401|3527771|P2|COMPLETED|Overall Study||73
1441274|NCT02260401|3527772|P1|COMPLETED|Overall Study||75
1441275|NCT02260401|3527771|P2|STARTED|Overall Study||85
1441276|NCT02260401|3527772|P1|STARTED|Overall Study||80
1441277|NCT02260388|3527782|P4|NOT COMPLETED|Overall Study||4
1441278|NCT02260388|3527783|P3|NOT COMPLETED|Overall Study||3
1441279|NCT02260388|3527784|P2|NOT COMPLETED|Overall Study||8
1441280|NCT02260388|3527785|P1|NOT COMPLETED|Overall Study||2
1441281|NCT02260388|3527782|P4|COMPLETED|Overall Study||65
1441282|NCT02260388|3527783|P3|COMPLETED|Overall Study||70
1441283|NCT02260388|3527784|P2|COMPLETED|Overall Study||118
1441284|NCT02260388|3527785|P1|COMPLETED|Overall Study||132
1441285|NCT02260388|3527782|P4|STARTED|Overall Study||69
1441286|NCT02260388|3527783|P3|STARTED|Overall Study||73
1441287|NCT02260388|3527784|P2|STARTED|Overall Study||126
1441288|NCT02260388|3527785|P1|STARTED|Overall Study||134
1441289|NCT02260180|3527814|P3|NOT COMPLETED|Overall Study||1
1441290|NCT02260180|3527815|P2|NOT COMPLETED|Overall Study||0
1441291|NCT02260180|3527816|P1|NOT COMPLETED|Overall Study||2
1441292|NCT02260180|3527814|P3|COMPLETED|Overall Study||40
1441293|NCT02260180|3527815|P2|COMPLETED|Overall Study||39
1441294|NCT02260180|3527816|P1|COMPLETED|Overall Study||37
1441295|NCT02260180|3527814|P3|STARTED|Overall Study||41
1441296|NCT02260180|3527815|P2|STARTED|Overall Study||39
1441297|NCT02260180|3527816|P1|STARTED|Overall Study||39
1441298|NCT02259608|3527827|P1|NOT COMPLETED|Overall Study||0
1441299|NCT02259608|3527827|P1|COMPLETED|Overall Study||15
1441300|NCT02259608|3527827|P1|STARTED|Overall Study||15
1441301|NCT02259582|3527835|P3|NOT COMPLETED|Overall Study||21
1441302|NCT02259582|3527836|P2|NOT COMPLETED|Overall Study||17
1441303|NCT02259582|3527837|P1|NOT COMPLETED|Overall Study||16
1441304|NCT02259582|3527835|P3|COMPLETED|Overall Study||8
1441305|NCT02259582|3527836|P2|COMPLETED|Overall Study||11
1441306|NCT02259582|3527837|P1|COMPLETED|Overall Study||9
1441307|NCT02259582|3527835|P3|STARTED|Overall Study||29
1441308|NCT02259582|3527836|P2|STARTED|Overall Study||28
1441309|NCT02259582|3527837|P1|STARTED|Overall Study||25
1441310|NCT02259400|3527847|P2|NOT COMPLETED|Overall Study||2
1441311|NCT02259400|3527848|P1|NOT COMPLETED|Overall Study||0
1441312|NCT02259400|3527847|P2|COMPLETED|Overall Study||60
1441313|NCT02259400|3527848|P1|COMPLETED|Overall Study||62
1441314|NCT02259400|3527847|P2|STARTED|Overall Study||62
1441315|NCT02259400|3527848|P1|STARTED|Overall Study||62
1441316|NCT02259348|3527880|P1|NOT COMPLETED|Overall Study||10
1441317|NCT02259348|3527880|P1|COMPLETED|Overall Study||2
1441318|NCT02259348|3527880|P1|One Year Post-transplant|Overall Study||2
1441319|NCT02259348|3527880|P1|STARTED|Overall Study||12
1441320|NCT02259114|3527897|P5|NOT COMPLETED|Overall Study||6
1441321|NCT02259114|3527898|P4|NOT COMPLETED|Overall Study||3
1441322|NCT02259114|3527899|P3|NOT COMPLETED|Overall Study||13
1441323|NCT02259114|3527900|P2|NOT COMPLETED|Overall Study||4
1441324|NCT02259114|3527901|P1|NOT COMPLETED|Overall Study||21
1441325|NCT02259114|3527897|P5|COMPLETED|Overall Study||0
1441326|NCT02259114|3527898|P4|COMPLETED|Overall Study||0
1441327|NCT02259114|3527899|P3|COMPLETED|Overall Study||0
1441328|NCT02259114|3527900|P2|COMPLETED|Overall Study||0
1441329|NCT02259114|3527901|P1|COMPLETED|Overall Study||0
1441330|NCT02259114|3527897|P5|Treated|Overall Study||6
1441331|NCT02259114|3527898|P4|Treated|Overall Study||3
1441332|NCT02259114|3527899|P3|Treated|Overall Study||13
1441333|NCT02259114|3527900|P2|Treated|Overall Study||4
1441334|NCT02259114|3527901|P1|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
1441335|NCT02259114|3527897|P5|STARTED|Overall Study||6
1441336|NCT02259114|3527898|P4|STARTED|Overall Study||3
1441337|NCT02259114|3527899|P3|STARTED|Overall Study||13
1441338|NCT02259114|3527900|P2|STARTED|Overall Study||4
1441339|NCT02259114|3527901|P1|STARTED|Overall Study||21
1441340|NCT02258529|3527958|P1|NOT COMPLETED|Overall Study||10
1441341|NCT02258529|3527958|P1|COMPLETED|Overall Study||0
1441342|NCT02258529|3527958|P1|STARTED|Overall Study||10
1441343|NCT02258477|3527970|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
1441344|NCT02258477|3527971|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
1441345|NCT02258477|3527972|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
1441346|NCT02258477|3527973|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
1441347|NCT02258477|3527970|P4|COMPLETED|Fourth Intervention (1 Week)||8
1441348|NCT02258477|3527971|P3|COMPLETED|Fourth Intervention (1 Week)||8
1441349|NCT02258477|3527972|P2|COMPLETED|Fourth Intervention (1 Week)||8
1441350|NCT02258477|3527973|P1|COMPLETED|Fourth Intervention (1 Week)||9
1441351|NCT02258477|3527970|P4|STARTED|Fourth Intervention (1 Week)||8
1441352|NCT02258477|3527971|P3|STARTED|Fourth Intervention (1 Week)||8
1441353|NCT02258477|3527972|P2|STARTED|Fourth Intervention (1 Week)||8
1441354|NCT02258477|3527973|P1|STARTED|Fourth Intervention (1 Week)||9
1441355|NCT02258477|3527970|P4|NOT COMPLETED|Third Intervention (1 Week)||0
1441356|NCT02258477|3527971|P3|NOT COMPLETED|Third Intervention (1 Week)||0
1441357|NCT02258477|3527972|P2|NOT COMPLETED|Third Intervention (1 Week)||0
1441358|NCT02258477|3527973|P1|NOT COMPLETED|Third Intervention (1 Week)||0
1441359|NCT02258477|3527970|P4|COMPLETED|Third Intervention (1 Week)||8
1441360|NCT02258477|3527971|P3|COMPLETED|Third Intervention (1 Week)||8
1441361|NCT02258477|3527972|P2|COMPLETED|Third Intervention (1 Week)||8
1441362|NCT02258477|3527973|P1|COMPLETED|Third Intervention (1 Week)||9
1441363|NCT02258477|3527970|P4|STARTED|Third Intervention (1 Week)||8
1441364|NCT02258477|3527971|P3|STARTED|Third Intervention (1 Week)||8
1441365|NCT02258477|3527972|P2|STARTED|Third Intervention (1 Week)||8
1441366|NCT02258477|3527973|P1|STARTED|Third Intervention (1 Week)||9
1441367|NCT02258477|3527970|P4|NOT COMPLETED|Second Intervention (1 Week)||1
1441368|NCT02258477|3527971|P3|NOT COMPLETED|Second Intervention (1 Week)||1
1441369|NCT02258477|3527972|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1441370|NCT02258477|3527973|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1441371|NCT02258477|3527970|P4|COMPLETED|Second Intervention (1 Week)||8
1441372|NCT02258477|3527971|P3|COMPLETED|Second Intervention (1 Week)||8
1441373|NCT02258477|3527972|P2|COMPLETED|Second Intervention (1 Week)||8
1441374|NCT02258477|3527973|P1|COMPLETED|Second Intervention (1 Week)||9
1441375|NCT02258477|3527970|P4|STARTED|Second Intervention (1 Week)||9
1441376|NCT02258477|3527971|P3|STARTED|Second Intervention (1 Week)||9
1441377|NCT02258477|3527972|P2|STARTED|Second Intervention (1 Week)||8
1441378|NCT02258477|3527973|P1|STARTED|Second Intervention (1 Week)||9
1441379|NCT02258477|3527970|P4|NOT COMPLETED|First Intervention (1 Week)||0
1441380|NCT02258477|3527971|P3|NOT COMPLETED|First Intervention (1 Week)||0
1441381|NCT02258477|3527972|P2|NOT COMPLETED|First Intervention (1 Week)||1
1441382|NCT02258477|3527973|P1|NOT COMPLETED|First Intervention (1 Week)||1
1441383|NCT02258477|3527970|P4|COMPLETED|First Intervention (1 Week)||9
1441384|NCT02258477|3527971|P3|COMPLETED|First Intervention (1 Week)||9
1441385|NCT02258477|3527972|P2|COMPLETED|First Intervention (1 Week)||8
1441386|NCT02258477|3527973|P1|COMPLETED|First Intervention (1 Week)||9
1441387|NCT02258477|3527970|P4|STARTED|First Intervention (1 Week)||9
1441388|NCT02258477|3527971|P3|STARTED|First Intervention (1 Week)||9
1441389|NCT02258477|3527972|P2|STARTED|First Intervention (1 Week)||9
1441390|NCT02258477|3527973|P1|STARTED|First Intervention (1 Week)||10
1441391|NCT02258412|3527991|P3|NOT COMPLETED|Overall Study||0
1441392|NCT02258412|3527992|P2|NOT COMPLETED|Overall Study||0
1441393|NCT02258412|3527993|P1|NOT COMPLETED|Overall Study||0
1441394|NCT02258412|3527991|P3|COMPLETED|Overall Study||61
1441395|NCT02258412|3527992|P2|COMPLETED|Overall Study||25
1441396|NCT02258412|3527993|P1|COMPLETED|Overall Study||26
1441397|NCT02258412|3527991|P3|STARTED|Overall Study||61
1441398|NCT02258412|3527992|P2|STARTED|Overall Study||25
1441399|NCT02258412|3527993|P1|STARTED|Overall Study||26
1441400|NCT02258373|3528002|P2|NOT COMPLETED|Overall Study||2
1441401|NCT02258373|3528003|P1|NOT COMPLETED|Overall Study||7
1441402|NCT02258373|3528002|P2|COMPLETED|Overall Study||75
1441403|NCT02258373|3528003|P1|COMPLETED|Overall Study||142
1441404|NCT02258373|3528002|P2|STARTED|Overall Study||77
1441405|NCT02258373|3528003|P1|STARTED|Overall Study||149
1441406|NCT02258334|3528047|P4|NOT COMPLETED|Overall Study||0
1441407|NCT02258334|3528048|P3|NOT COMPLETED|Overall Study||0
1441408|NCT02258334|3528049|P2|NOT COMPLETED|Overall Study||0
1441409|NCT02258334|3528050|P1|NOT COMPLETED|Overall Study||1
1441410|NCT02258334|3528047|P4|COMPLETED|Overall Study||52
1441411|NCT02258334|3528048|P3|COMPLETED|Overall Study||52
1441412|NCT02258334|3528049|P2|COMPLETED|Overall Study||54
1441413|NCT02258334|3528050|P1|COMPLETED|Overall Study||49
1441414|NCT02258334|3528047|P4|STARTED|Overall Study||52
1441415|NCT02258334|3528048|P3|STARTED|Overall Study||52
1441416|NCT02258334|3528049|P2|STARTED|Overall Study||54
1441417|NCT02258334|3528050|P1|STARTED|Overall Study||50
1441418|NCT02258256|3528076|P1|NOT COMPLETED|Overall Study||0
1441419|NCT02258256|3528076|P1|COMPLETED|Overall Study||11
1441420|NCT02258256|3528076|P1|STARTED|Overall Study||11
1441421|NCT02257970|3528084|P4|NOT COMPLETED|Part 3||7
1441422|NCT02257970|3528085|P3|NOT COMPLETED|Part 3||7
1441423|NCT02257970|3528086|P2|NOT COMPLETED|Part 3||0
1441424|NCT02257970|3528087|P1|NOT COMPLETED|Part 3||0
1441425|NCT02257970|3528084|P4|COMPLETED|Part 3||14
1441426|NCT02257970|3528085|P3|COMPLETED|Part 3||16
1441427|NCT02257970|3528086|P2|COMPLETED|Part 3||0
1441428|NCT02257970|3528087|P1|COMPLETED|Part 3||0
1441429|NCT02257970|3528084|P4|STARTED|Part 3||21
1441430|NCT02257970|3528085|P3|STARTED|Part 3||23
1441431|NCT02257970|3528086|P2|STARTED|Part 3||0
1441432|NCT02257970|3528087|P1|STARTED|Part 3||0
1441433|NCT02257970|3528084|P4|NOT COMPLETED|Part 2||0
1441434|NCT02257970|3528085|P3|NOT COMPLETED|Part 2||0
1441435|NCT02257970|3528086|P2|NOT COMPLETED|Part 2||7
1441436|NCT02257970|3528087|P1|NOT COMPLETED|Part 2||0
1441437|NCT02257970|3528084|P4|COMPLETED|Part 2||0
1441438|NCT02257970|3528085|P3|COMPLETED|Part 2||0
1441439|NCT02257970|3528086|P2|COMPLETED|Part 2||16
1441440|NCT02257970|3528087|P1|COMPLETED|Part 2||0
1441441|NCT02257970|3528084|P4|STARTED|Part 2||0
1441442|NCT02257970|3528085|P3|STARTED|Part 2||0
1441443|NCT02257970|3528086|P2|STARTED|Part 2||23
1441444|NCT02257970|3528087|P1|STARTED|Part 2||0
1441445|NCT02257970|3528084|P4|NOT COMPLETED|Part 1||0
1441446|NCT02257970|3528085|P3|NOT COMPLETED|Part 1||0
1441447|NCT02257970|3528086|P2|NOT COMPLETED|Part 1||0
1441448|NCT02257970|3528087|P1|NOT COMPLETED|Part 1||0
1441449|NCT02257970|3528084|P4|COMPLETED|Part 1||0
1441450|NCT02257970|3528085|P3|COMPLETED|Part 1||0
1441451|NCT02257970|3528086|P2|COMPLETED|Part 1||0
1441452|NCT02257970|3528087|P1|COMPLETED|Part 1||50
1441453|NCT02257970|3528084|P4|STARTED|Part 1||0
1441454|NCT02257970|3528085|P3|STARTED|Part 1||0
1441455|NCT02257970|3528086|P2|STARTED|Part 1||0
1441456|NCT02257970|3528087|P1|STARTED|Part 1||50
1441457|NCT02257918|3528113|P3|NOT COMPLETED|Overall Study||2
1441458|NCT02257918|3528114|P2|NOT COMPLETED|Overall Study||1
1441459|NCT02257918|3528115|P1|NOT COMPLETED|Overall Study||4
1441460|NCT02257918|3528113|P3|COMPLETED|Overall Study||39
1441461|NCT02257918|3528114|P2|COMPLETED|Overall Study||66
1441462|NCT02257918|3528115|P1|COMPLETED|Overall Study||68
1441463|NCT02257918|3528113|P3|Test of Cure Visit|Overall Study||40
1441464|NCT02257918|3528114|P2|Test of Cure Visit|Overall Study||67
1441465|NCT02257918|3528115|P1|Test of Cure Visit|Overall Study||72
1441466|NCT02257918|3528113|P3|STARTED|Overall Study||41
1441467|NCT02257918|3528114|P2|STARTED|Overall Study||67
1441468|NCT02257918|3528115|P1|STARTED|Overall Study||72
1441469|NCT02257684|3528165|P1|NOT COMPLETED|Overall Study||4
1441470|NCT02257684|3528165|P1|COMPLETED|Overall Study||0
1441471|NCT02257684|3528165|P1|STARTED|Overall Study||4
1441472|NCT02257385|3528175|P2|NOT COMPLETED|Overall Study||22
1441473|NCT02257385|3528176|P1|NOT COMPLETED|Overall Study||22
1441474|NCT02257385|3528175|P2|COMPLETED|Overall Study||457
1441475|NCT02257385|3528176|P1|COMPLETED|Overall Study||460
1441476|NCT02257385|3528175|P2|STARTED|Overall Study||479
1441477|NCT02257385|3528176|P1|STARTED|Overall Study||482
1441478|NCT02257372|3528186|P2|NOT COMPLETED|Overall Study||10
1441479|NCT02257372|3528187|P1|NOT COMPLETED|Overall Study||7
1441480|NCT02257372|3528186|P2|COMPLETED|Overall Study||109
1441481|NCT02257372|3528187|P1|COMPLETED|Overall Study||110
1441482|NCT02257372|3528186|P2|STARTED|Overall Study||119
1441483|NCT02257372|3528187|P1|STARTED|Overall Study||117
1441484|NCT02256982|3528197|P2|NOT COMPLETED|Overall Study||1
1441485|NCT02256982|3528198|P1|NOT COMPLETED|Overall Study||0
1441486|NCT02256982|3528197|P2|COMPLETED|Overall Study||1
1441487|NCT02256982|3528198|P1|COMPLETED|Overall Study||1
1441488|NCT02256982|3528197|P2|STARTED|Overall Study||2
1441489|NCT02256982|3528198|P1|STARTED|Overall Study||1
1441490|NCT02256969|3528207|P3|NOT COMPLETED|Overall Study||1
1441491|NCT02256969|3528208|P2|NOT COMPLETED|Overall Study||1
1441492|NCT02256969|3528209|P1|NOT COMPLETED|Overall Study||2
1441493|NCT02256969|3528207|P3|COMPLETED|Overall Study||14
1441494|NCT02256969|3528208|P2|COMPLETED|Overall Study||14
1441495|NCT02256969|3528209|P1|COMPLETED|Overall Study||13
1441496|NCT02256969|3528207|P3|STARTED|Overall Study||15
1441497|NCT02256969|3528208|P2|STARTED|Overall Study||15
1441498|NCT02256969|3528209|P1|STARTED|Overall Study||15
1441499|NCT02256891|3528228|P2|NOT COMPLETED|Overall Study||13
1441500|NCT02256891|3528229|P1|NOT COMPLETED|Overall Study||12
1441501|NCT02256891|3528228|P2|COMPLETED|Overall Study||29
1441502|NCT02256891|3528229|P1|COMPLETED|Overall Study||43
1441503|NCT02256891|3528228|P2|STARTED|Overall Study||42
1441504|NCT02256891|3528229|P1|STARTED|Overall Study||55
1441505|NCT02256553|3528253|P1|NOT COMPLETED|Period III||3
1441506|NCT02256553|3528253|P1|COMPLETED|Period III||91
1441507|NCT02256553|3528253|P1|STARTED|Period III||94
1441508|NCT02256553|3528253|P1|NOT COMPLETED|Period II||2
1441509|NCT02256553|3528253|P1|COMPLETED|Period II||94
1441510|NCT02256553|3528253|P1|STARTED|Period II||96
1441511|NCT02256553|3528253|P1|NOT COMPLETED|Period I||6
1441512|NCT02256553|3528253|P1|COMPLETED|Period I||96
1441513|NCT02256553|3528253|P1|STARTED|Period I||102
1441514|NCT02256488|3528266|P4|NOT COMPLETED|Overall Study||6
1441515|NCT02256488|3528267|P3|NOT COMPLETED|Overall Study||10
1441516|NCT02256488|3528268|P2|NOT COMPLETED|Overall Study||6
1441517|NCT02256488|3528269|P1|NOT COMPLETED|Overall Study||8
1441518|NCT02256488|3528266|P4|COMPLETED|Overall Study||384
1441519|NCT02256488|3528267|P3|COMPLETED|Overall Study||382
1441520|NCT02256488|3528268|P2|COMPLETED|Overall Study||386
1441521|NCT02256488|3528269|P1|COMPLETED|Overall Study||379
1441522|NCT02256488|3528266|P4|STARTED|Overall Study||390
1441523|NCT02256488|3528267|P3|STARTED|Overall Study||392
1441524|NCT02256488|3528268|P2|STARTED|Overall Study||392
1441525|NCT02256488|3528269|P1|STARTED|Overall Study||387
1441526|NCT02256436|3528285|P2|NOT COMPLETED|Overall Study||272
1441527|NCT02256436|3528286|P1|NOT COMPLETED|Overall Study||270
1441528|NCT02256436|3528285|P2|COMPLETED|Overall Study||0
1441529|NCT02256436|3528286|P1|COMPLETED|Overall Study||0
1441530|NCT02256436|3528285|P2|Treated|Overall Study||255
1441531|NCT02256436|3528286|P1|Treated|Overall Study||266
1441532|NCT02256436|3528285|P2|STARTED|Overall Study||272
1441533|NCT02256436|3528286|P1|STARTED|Overall Study||270
1441534|NCT02256358|3528324|P2|NOT COMPLETED|Overall Study||1
1441535|NCT02256358|3528325|P1|NOT COMPLETED|Overall Study||0
1441536|NCT02256358|3528324|P2|COMPLETED|Overall Study||33
1441537|NCT02256358|3528325|P1|COMPLETED|Overall Study||34
1441538|NCT02256358|3528324|P2|STARTED|Overall Study||34
1441539|NCT02256358|3528325|P1|STARTED|Overall Study||34
1441540|NCT02256345|3528333|P2|NOT COMPLETED|Overall Study||0
1441541|NCT02256345|3528334|P1|NOT COMPLETED|Overall Study||0
1441542|NCT02256345|3528333|P2|COMPLETED|Overall Study||3
1441543|NCT02256345|3528334|P1|COMPLETED|Overall Study||9
1441544|NCT02256345|3528333|P2|STARTED|Overall Study||3
1441545|NCT02256345|3528334|P1|STARTED|Overall Study||9
1441546|NCT02256267|3528346|P1|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
1441547|NCT02256267|3528346|P1|COMPLETED|Period 2 (Day 7 to Day 14)||22
1441548|NCT02256267|3528346|P1|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
1441549|NCT02256267|3528346|P1|STARTED|Period 2 (Day 7 to Day 14)||23
1441550|NCT02256267|3528346|P1|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
1441551|NCT02256267|3528346|P1|COMPLETED|Period 2 (Day 1 to Day 6)||23
1441552|NCT02256267|3528346|P1|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
1441553|NCT02256267|3528346|P1|STARTED|Period 2 (Day 1 to Day 6)||23
1441554|NCT02256267|3528346|P1|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
1441555|NCT02256267|3528346|P1|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
1441556|NCT02256267|3528346|P1|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
1441557|NCT02256267|3528346|P1|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
1441558|NCT02256072|3528357|P2|NOT COMPLETED|Overall Study||29
1441559|NCT02256072|3528358|P1|NOT COMPLETED|Overall Study||42
1441560|NCT02256072|3528357|P2|COMPLETED|Overall Study||162
1441561|NCT02256072|3528358|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
1441562|NCT02256072|3528357|P2|Completed 1 Month Follow-Up|Overall Study||179
1441563|NCT02256072|3528358|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
1441564|NCT02256072|3528357|P2|STARTED|Overall Study||191
1441565|NCT02256072|3528358|P1|STARTED|Overall Study||194
1441566|NCT02255760|3528377|P5|NOT COMPLETED|Overall Study||0
1441567|NCT02255760|3528378|P4|NOT COMPLETED|Overall Study||0
1441568|NCT02255760|3528379|P3|NOT COMPLETED|Overall Study||0
1441569|NCT02255760|3528380|P2|NOT COMPLETED|Overall Study||1
1441570|NCT02255760|3528381|P1|NOT COMPLETED|Overall Study||0
1441571|NCT02255760|3528377|P5|COMPLETED|Overall Study||9
1441572|NCT02255760|3528378|P4|COMPLETED|Overall Study||15
1441573|NCT02255760|3528379|P3|COMPLETED|Overall Study||15
1441574|NCT02255760|3528380|P2|COMPLETED|Overall Study||2
1441575|NCT02255760|3528381|P1|COMPLETED|Overall Study||14
1441576|NCT02255760|3528377|P5|STARTED|Overall Study||9
1441577|NCT02255760|3528378|P4|STARTED|Overall Study||15
1441578|NCT02255760|3528379|P3|STARTED|Overall Study||15
1441579|NCT02255760|3528380|P2|STARTED|Overall Study||3
1441580|NCT02255760|3528381|P1|STARTED|Overall Study||14
1441581|NCT02255565|3528436|P3|NOT COMPLETED|Overall Study||0
1441582|NCT02255565|3528437|P2|NOT COMPLETED|Overall Study||1
1441583|NCT02255565|3528438|P1|NOT COMPLETED|Overall Study||0
1441584|NCT02255565|3528436|P3|COMPLETED|Overall Study||9
1441585|NCT02255565|3528437|P2|COMPLETED|Overall Study||8
1441586|NCT02255565|3528438|P1|COMPLETED|Overall Study||9
1441587|NCT02255565|3528436|P3|STARTED|Overall Study||9
1441588|NCT02255565|3528437|P2|STARTED|Overall Study||9
1441589|NCT02255565|3528438|P1|STARTED|Overall Study||9
1441590|NCT02255279|3528499|P2|NOT COMPLETED|Overall Study||9
1441591|NCT02255279|3528500|P1|NOT COMPLETED|Overall Study||5
1441592|NCT02255279|3528499|P2|COMPLETED|Overall Study||134
1441593|NCT02255279|3528500|P1|COMPLETED|Overall Study||139
1441594|NCT02255279|3528499|P2|STARTED|Overall Study||143
1441595|NCT02255279|3528500|P1|STARTED|Overall Study||144
1441596|NCT02255149|3528526|P1|NOT COMPLETED|Overall Study||5
1441597|NCT02255149|3528526|P1|COMPLETED|Overall Study||5
1441598|NCT02255149|3528526|P1|STARTED|Overall Study||10
1441599|NCT02255110|3528530|P1|NOT COMPLETED|Overall Study||0
1441600|NCT02255110|3528530|P1|COMPLETED|Overall Study||6
1441601|NCT02255110|3528530|P1|STARTED|Overall Study||6
1441602|NCT02255097|3528542|P1|NOT COMPLETED|Overall Study||172
1441603|NCT02255097|3528542|P1|COMPLETED|Overall Study||0
1441604|NCT02255097|3528542|P1|Treated|Overall Study||171
1441605|NCT02255097|3528542|P1|STARTED|Overall Study||172
1441606|NCT02254772|3528563|P1|NOT COMPLETED|Overall Study||2
1441607|NCT02254772|3528563|P1|COMPLETED|Overall Study||7
1441608|NCT02254772|3528563|P1|STARTED|Overall Study||9
1441609|NCT02254681|3528569|P1|NOT COMPLETED|Overall Study||6
1441610|NCT02254681|3528569|P1|COMPLETED|Overall Study||0
1441611|NCT02254681|3528569|P1|STARTED|Overall Study||6
1441612|NCT02254551|3528579|P1|NOT COMPLETED|Maintenance||0
1441613|NCT02254551|3528579|P1|COMPLETED|Maintenance||0
1441614|NCT02254551|3528579|P1|STARTED|Maintenance||0
1441615|NCT02254551|3528579|P1|NOT COMPLETED|Expansion||0
1441616|NCT02254551|3528579|P1|COMPLETED|Expansion||0
1441617|NCT02254551|3528579|P1|STARTED|Expansion||0
1441618|NCT02254551|3528579|P1|NOT COMPLETED|Dose Escalation||3
1441619|NCT02254551|3528579|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
1441620|NCT02254551|3528579|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
1441621|NCT02254551|3528579|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
1441622|NCT02254551|3528579|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
1441623|NCT02254551|3528579|P1|STARTED|Dose Escalation||7
1441624|NCT02254486|3528589|P2|NOT COMPLETED|Overall Study||55
1441625|NCT02254486|3528590|P1|NOT COMPLETED|Overall Study||50
1441626|NCT02254486|3528589|P2|COMPLETED|Overall Study||255
1441627|NCT02254486|3528590|P1|COMPLETED|Overall Study||261
1441628|NCT02254486|3528589|P2|STARTED|Overall Study||310
1441629|NCT02254486|3528590|P1|STARTED|Overall Study||311
1441630|NCT02254460|3528606|P2|NOT COMPLETED|Overall Study||0
1441631|NCT02254460|3528607|P1|NOT COMPLETED|Overall Study||1
1441632|NCT02254460|3528606|P2|COMPLETED|Overall Study||12
1441633|NCT02254460|3528607|P1|COMPLETED|Overall Study||12
1441634|NCT02254460|3528606|P2|STARTED|Overall Study||12
1441635|NCT02254460|3528607|P1|STARTED|Overall Study||13
1441636|NCT02254421|3528615|P2|NOT COMPLETED|Overall Study||3
1441637|NCT02254421|3528616|P1|NOT COMPLETED|Overall Study||2
1441638|NCT02254421|3528615|P2|COMPLETED|Overall Study||26
1441639|NCT02254421|3528616|P1|COMPLETED|Overall Study||29
1441640|NCT02254421|3528615|P2|STARTED|Overall Study||29
1441641|NCT02254421|3528616|P1|STARTED|Overall Study||31
1441642|NCT02254408|3528630|P2|NOT COMPLETED|Overall Study||10
1441643|NCT02254408|3528631|P1|NOT COMPLETED|Overall Study||8
1441644|NCT02254408|3528630|P2|COMPLETED|Overall Study||83
1441645|NCT02254408|3528631|P1|COMPLETED|Overall Study||88
1441646|NCT02254408|3528630|P2|STARTED|Overall Study||93
1441647|NCT02254408|3528631|P1|STARTED|Overall Study||96
1441648|NCT02254304|3528643|P2|NOT COMPLETED|Overall Study||4
1441649|NCT02254304|3528644|P1|NOT COMPLETED|Overall Study||14
1441650|NCT02254304|3528643|P2|COMPLETED|Overall Study||13
1441651|NCT02254304|3528644|P1|COMPLETED|Overall Study||75
1441652|NCT02254304|3528643|P2|STARTED|Overall Study||17
1441653|NCT02254304|3528644|P1|STARTED|Overall Study||89
1441654|NCT02254291|3528704|P3|NOT COMPLETED|Overall Study||2
1441655|NCT02254291|3528705|P2|NOT COMPLETED|Overall Study||3
1441656|NCT02254291|3528706|P1|NOT COMPLETED|Overall Study||0
1441657|NCT02254291|3528704|P3|COMPLETED|Overall Study||101
1441658|NCT02254291|3528705|P2|COMPLETED|Overall Study||99
1441659|NCT02254291|3528706|P1|COMPLETED|Overall Study||103
1441660|NCT02254291|3528704|P3|Exposed|Overall Study||103
1441661|NCT02254291|3528705|P2|Exposed|Overall Study||102
1441662|NCT02254291|3528706|P1|Exposed|Overall Study||103
1441663|NCT02254291|3528704|P3|STARTED|Overall Study||103
1441664|NCT02254291|3528705|P2|STARTED|Overall Study||102
1441665|NCT02254291|3528706|P1|STARTED|Overall Study||103
1441666|NCT02254265|3528723|P3|NOT COMPLETED|Overall Study||8
1441667|NCT02254265|3528724|P2|NOT COMPLETED|Overall Study||12
1441668|NCT02254265|3528725|P1|NOT COMPLETED|Overall Study||9
1441669|NCT02254265|3528723|P3|COMPLETED|Overall Study||144
1441670|NCT02254265|3528724|P2|COMPLETED|Overall Study||140
1441671|NCT02254265|3528725|P1|COMPLETED|Overall Study||142
1441672|NCT02254265|3528723|P3|STARTED|Overall Study||152
1441673|NCT02254265|3528724|P2|STARTED|Overall Study||152
1441674|NCT02254265|3528725|P1|STARTED|Overall Study||151
1441675|NCT02254252|3528750|P2|NOT COMPLETED|Overall Study||2
1441676|NCT02254252|3528751|P1|NOT COMPLETED|Overall Study||3
1441677|NCT02254252|3528750|P2|COMPLETED|Overall Study||25
1441678|NCT02254252|3528751|P1|COMPLETED|Overall Study||24
1441679|NCT02254252|3528750|P2|STARTED|Overall Study||27
1441680|NCT02254252|3528751|P1|STARTED|Overall Study||27
1441681|NCT02253654|3528763|P2|NOT COMPLETED|Overall Study||18
1441682|NCT02253654|3528764|P1|NOT COMPLETED|Overall Study||23
1441683|NCT02253654|3528763|P2|COMPLETED|Overall Study||90
1441684|NCT02253654|3528764|P1|COMPLETED|Overall Study||85
1441685|NCT02253654|3528763|P2|Received Treatment|Overall Study||107
1441686|NCT02253654|3528764|P1|Received Treatment|Overall Study||104
1441687|NCT02253654|3528763|P2|STARTED|Overall Study||108
1441688|NCT02253654|3528764|P1|STARTED|Overall Study||108
1441689|NCT02253433|3528786|P2|NOT COMPLETED|Overall Study||55
1441690|NCT02253433|3528787|P1|NOT COMPLETED|Overall Study||16
1441691|NCT02253433|3528786|P2|COMPLETED|Overall Study||79
1441692|NCT02253433|3528787|P1|COMPLETED|Overall Study||114
1441693|NCT02253433|3528786|P2|STARTED|Overall Study||134
1441694|NCT02253433|3528787|P1|STARTED|Overall Study||130
1441695|NCT02253173|3528801|P4|NOT COMPLETED|Overall Study||14
1441696|NCT02253173|3528802|P3|NOT COMPLETED|Overall Study||13
1441697|NCT02253173|3528803|P2|NOT COMPLETED|Overall Study||17
1441698|NCT02253173|3528804|P1|NOT COMPLETED|Overall Study||16
1441699|NCT02253173|3528801|P4|COMPLETED|Overall Study||178
1441700|NCT02253173|3528802|P3|COMPLETED|Overall Study||177
1441701|NCT02253173|3528803|P2|COMPLETED|Overall Study||174
1441702|NCT02253173|3528804|P1|COMPLETED|Overall Study||175
1441703|NCT02253173|3528801|P4|STARTED|Overall Study||192
1441704|NCT02253173|3528802|P3|STARTED|Overall Study||190
1441705|NCT02253173|3528803|P2|STARTED|Overall Study||191
1441706|NCT02253173|3528804|P1|STARTED|Overall Study||191
1441707|NCT02253160|3529001|P3|NOT COMPLETED|Overall Study||0
1441708|NCT02253160|3529002|P2|NOT COMPLETED|Overall Study||0
1441709|NCT02253160|3529003|P1|NOT COMPLETED|Overall Study||0
1441710|NCT02253160|3529001|P3|COMPLETED|Overall Study||10
1441711|NCT02253160|3529002|P2|COMPLETED|Overall Study||12
1441712|NCT02253160|3529003|P1|COMPLETED|Overall Study||1
1441713|NCT02253160|3529001|P3|STARTED|Overall Study||10
1441714|NCT02253160|3529002|P2|STARTED|Overall Study||12
1441715|NCT02253160|3529003|P1|STARTED|Overall Study||1
1441716|NCT02253147|3529039|P1|NOT COMPLETED|Overall Study||47
1441717|NCT02253147|3529039|P1|COMPLETED|Overall Study||71
1441718|NCT02253147|3529039|P1|N Patients at W52|Overall Study||84
1441719|NCT02253147|3529039|P1|N Patients at W36|Overall Study||86
1441720|NCT02253147|3529039|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
1441721|NCT02253147|3529039|P1|STARTED|Overall Study||118
1441722|NCT02252965|3529073|P2|NOT COMPLETED|Overall Study||43
1441723|NCT02252965|3529074|P1|NOT COMPLETED|Overall Study||40
1441724|NCT02252965|3529073|P2|COMPLETED|Overall Study||222
1441725|NCT02252965|3529074|P1|COMPLETED|Overall Study||227
1441726|NCT02252965|3529073|P2|Safety Population|Overall Study||264
1441811|NCT02251912|3529316|P1|STARTED|Overall Study||12
1441727|NCT02252965|3529074|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
1441728|NCT02252965|3529073|P2|STARTED|Overall Study||265
1441729|NCT02252965|3529074|P1|STARTED|Overall Study||267
1441730|NCT02252939|3529101|P1|NOT COMPLETED|Overall Study||3
1441731|NCT02252939|3529101|P1|COMPLETED|Overall Study||59
1441732|NCT02252939|3529101|P1|STARTED|Overall Study||62
1441733|NCT02252744|3529110|P1|NOT COMPLETED|Overall Study||0
1441734|NCT02252744|3529110|P1|COMPLETED|Overall Study||286
1441735|NCT02252744|3529110|P1|STARTED|Overall Study||286
1441736|NCT02252718|3529114|P1|NOT COMPLETED|Overall Study||0
1441737|NCT02252718|3529114|P1|COMPLETED|Overall Study||100
1441738|NCT02252718|3529114|P1|STARTED|Overall Study||100
1441739|NCT02252536|3529120|P2|NOT COMPLETED|Overall Study||3
1441740|NCT02252536|3529121|P1|NOT COMPLETED|Overall Study||5
1441741|NCT02252536|3529120|P2|COMPLETED|Overall Study||170
1441742|NCT02252536|3529121|P1|COMPLETED|Overall Study||168
1441743|NCT02252536|3529120|P2|STARTED|Overall Study||173
1441744|NCT02252536|3529121|P1|STARTED|Overall Study||173
1441745|NCT02252445|3529155|P2|NOT COMPLETED|Overall Study||0
1441746|NCT02252445|3529156|P1|NOT COMPLETED|Overall Study||0
1441747|NCT02252445|3529155|P2|COMPLETED|Overall Study||41
1441748|NCT02252445|3529156|P1|COMPLETED|Overall Study||41
1441749|NCT02252445|3529155|P2|STARTED|Overall Study||41
1441750|NCT02252445|3529156|P1|STARTED|Overall Study||41
1441751|NCT02252354|3529182|P2|NOT COMPLETED|Overall Study||0
1441752|NCT02252354|3529183|P1|NOT COMPLETED|Overall Study||0
1441753|NCT02252354|3529182|P2|COMPLETED|Overall Study||6
1441754|NCT02252354|3529183|P1|COMPLETED|Overall Study||6
1441755|NCT02252354|3529182|P2|STARTED|Overall Study||6
1441756|NCT02252354|3529183|P1|STARTED|Overall Study||6
1441757|NCT02252146|3529228|P1|NOT COMPLETED|Overall Study||6
1441758|NCT02252146|3529228|P1|COMPLETED|Overall Study||0
1441759|NCT02252146|3529228|P1|STARTED|Overall Study||6
1441760|NCT02252133|3529232|P2|NOT COMPLETED|Period 2||0
1441761|NCT02252133|3529233|P1|NOT COMPLETED|Period 2||0
1441762|NCT02252133|3529232|P2|COMPLETED|Period 2||24
1441763|NCT02252133|3529233|P1|COMPLETED|Period 2||23
1441764|NCT02252133|3529232|P2|STARTED|Period 2||24
1441765|NCT02252133|3529233|P1|STARTED|Period 2||23
1441766|NCT02252133|3529232|P2|NOT COMPLETED|Period 1||0
1441767|NCT02252133|3529233|P1|NOT COMPLETED|Period 1||0
1441768|NCT02252133|3529232|P2|COMPLETED|Period 1||24
1441769|NCT02252133|3529233|P1|COMPLETED|Period 1||23
1441770|NCT02252133|3529232|P2|STARTED|Period 1||24
1441771|NCT02252133|3529233|P1|STARTED|Period 1||23
1441772|NCT02252042|3529241|P2|NOT COMPLETED|Overall Study||248
1441773|NCT02252042|3529242|P1|NOT COMPLETED|Overall Study||247
1441774|NCT02252042|3529241|P2|COMPLETED|Overall Study||0
1441775|NCT02252042|3529242|P1|COMPLETED|Overall Study||0
1441776|NCT02252042|3529241|P2|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
1441777|NCT02252042|3529242|P1|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
1441778|NCT02252042|3529241|P2|STARTED|Overall Study||248
1441779|NCT02252042|3529242|P1|STARTED|Overall Study||247
1441780|NCT02252016|3529282|P2|NOT COMPLETED|Overall Study||3
1441781|NCT02252016|3529283|P1|NOT COMPLETED|Overall Study||3
1441782|NCT02252016|3529282|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
1441783|NCT02252016|3529283|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
1441784|NCT02252016|3529282|P2|STARTED|Overall Study||52
1441785|NCT02252016|3529283|P1|STARTED|Overall Study||107
1441786|NCT02251990|3529297|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
1441787|NCT02251990|3529298|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
1441788|NCT02251990|3529297|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
1441789|NCT02251990|3529298|P1|COMPLETED|Period 3 (DTG Follow-up)||0
1441790|NCT02251990|3529297|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
1441791|NCT02251990|3529298|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
1441792|NCT02251990|3529297|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
1441793|NCT02251990|3529298|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
1441794|NCT02251990|3529297|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
1441795|NCT02251990|3529298|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
1441796|NCT02251990|3529297|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
1441797|NCT02251990|3529298|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
1441798|NCT02251990|3529297|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
1441799|NCT02251990|3529298|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
1441800|NCT02251990|3529297|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
1441801|NCT02251990|3529298|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
1441802|NCT02251990|3529297|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
1441803|NCT02251990|3529298|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
1441804|NCT02251990|3529297|P2|STARTED|Period 1 (Double-blind [DB])||123
1441805|NCT02251990|3529298|P1|STARTED|Period 1 (Double-blind [DB])||366
1441806|NCT02251912|3529315|P2|NOT COMPLETED|Overall Study||5
1441807|NCT02251912|3529316|P1|NOT COMPLETED|Overall Study||2
1441808|NCT02251912|3529315|P2|COMPLETED|Overall Study||5
1441809|NCT02251912|3529316|P1|COMPLETED|Overall Study||10
1441810|NCT02251912|3529315|P2|STARTED|Overall Study||10
1441812|NCT02251886|3529330|P4|NOT COMPLETED|Overall Study||0
1441813|NCT02251886|3529331|P3|NOT COMPLETED|Overall Study||0
1441814|NCT02251886|3529332|P2|NOT COMPLETED|Overall Study||0
1441815|NCT02251886|3529333|P1|NOT COMPLETED|Overall Study||0
1441816|NCT02251886|3529330|P4|COMPLETED|Overall Study||54
1441817|NCT02251886|3529331|P3|COMPLETED|Overall Study||44
1441818|NCT02251886|3529332|P2|COMPLETED|Overall Study||54
1441819|NCT02251886|3529333|P1|COMPLETED|Overall Study||48
1441820|NCT02251886|3529330|P4|STARTED|Overall Study||54
1441821|NCT02251886|3529331|P3|STARTED|Overall Study||44
1441822|NCT02251886|3529332|P2|STARTED|Overall Study||54
1441823|NCT02251886|3529333|P1|STARTED|Overall Study||48
1441824|NCT02251717|3529345|P2|NOT COMPLETED|Overall Study||1
1441825|NCT02251717|3529346|P1|NOT COMPLETED|Overall Study||1
1441826|NCT02251717|3529345|P2|COMPLETED|Overall Study||56
1441827|NCT02251717|3529346|P1|COMPLETED|Overall Study||56
1441828|NCT02251717|3529345|P2|STARTED|Overall Study||57
1441829|NCT02251717|3529346|P1|STARTED|Overall Study||57
1441830|NCT02251652|3529358|P1|NOT COMPLETED|Overall Study||1
1441831|NCT02251652|3529358|P1|COMPLETED|Overall Study||16
1441832|NCT02251652|3529358|P1|STARTED|Overall Study||17
1441833|NCT02251613|3529368|P1|NOT COMPLETED|Overall Study||0
1441834|NCT02251613|3529368|P1|COMPLETED|Overall Study||50
1441835|NCT02251613|3529368|P1|STARTED|Overall Study||50
1441836|NCT02251561|3529376|P1|NOT COMPLETED|Overall Study||0
1441837|NCT02251561|3529376|P1|COMPLETED|Overall Study||28
1441838|NCT02251561|3529376|P1|STARTED|Overall Study||28
1441839|NCT02250807|3529384|P1|NOT COMPLETED|Overall Study||0
1441840|NCT02250807|3529384|P1|COMPLETED|Overall Study||40
1441841|NCT02250807|3529384|P1|STARTED|Overall Study||40
1441842|NCT02250703|3529396|P2|NOT COMPLETED|Overall Study||1
1441843|NCT02250703|3529397|P1|NOT COMPLETED|Overall Study||1
1441844|NCT02250703|3529396|P2|COMPLETED|Overall Study||36
1441845|NCT02250703|3529397|P1|COMPLETED|Overall Study||37
1441846|NCT02250703|3529396|P2|STARTED|Overall Study||37
1441847|NCT02250703|3529397|P1|STARTED|Overall Study||38
1441848|NCT02250521|3529409|P1|NOT COMPLETED|Overall Study||1
1441849|NCT02250521|3529409|P1|COMPLETED|Overall Study||99
1441850|NCT02250521|3529409|P1|STARTED|Overall Study||100
1441851|NCT02250443|3529423|P1|NOT COMPLETED|Overall Study||10
1441852|NCT02250443|3529423|P1|COMPLETED|Overall Study||0
1441853|NCT02250443|3529423|P1|STARTED|Overall Study||10
1441854|NCT02250417|3529436|P2|NOT COMPLETED|Second Intervention (1 Night)||0
1441855|NCT02250417|3529437|P1|NOT COMPLETED|Second Intervention (1 Night)||0
1441856|NCT02250417|3529436|P2|COMPLETED|Second Intervention (1 Night)||6
1441857|NCT02250417|3529437|P1|COMPLETED|Second Intervention (1 Night)||6
1441858|NCT02250417|3529436|P2|STARTED|Second Intervention (1 Night)||6
1441859|NCT02250417|3529437|P1|STARTED|Second Intervention (1 Night)||6
1441860|NCT02250417|3529436|P2|NOT COMPLETED|First Intervention (1 Night)||0
1441861|NCT02250417|3529437|P1|NOT COMPLETED|First Intervention (1 Night)||0
1441862|NCT02250417|3529436|P2|COMPLETED|First Intervention (1 Night)||6
1441863|NCT02250417|3529437|P1|COMPLETED|First Intervention (1 Night)||6
1441864|NCT02250417|3529436|P2|STARTED|First Intervention (1 Night)||6
1441865|NCT02250417|3529437|P1|STARTED|First Intervention (1 Night)||6
1441866|NCT02250326|3529452|P3|NOT COMPLETED|Follow-Up Period||38
1441867|NCT02250326|3529453|P2|NOT COMPLETED|Follow-Up Period||30
1441868|NCT02250326|3529454|P1|NOT COMPLETED|Follow-Up Period||49
1441869|NCT02250326|3529452|P3|COMPLETED|Follow-Up Period||26
1441870|NCT02250326|3529453|P2|COMPLETED|Follow-Up Period||13
1441871|NCT02250326|3529454|P1|COMPLETED|Follow-Up Period||18
1441872|NCT02250326|3529452|P3|STARTED|Follow-Up Period||64
1441873|NCT02250326|3529453|P2|STARTED|Follow-Up Period||43
1441874|NCT02250326|3529454|P1|STARTED|Follow-Up Period||67
1441875|NCT02250326|3529452|P3|NOT COMPLETED|Treatment Period||77
1441876|NCT02250326|3529453|P2|NOT COMPLETED|Treatment Period||64
1441877|NCT02250326|3529454|P1|NOT COMPLETED|Treatment Period||81
1441878|NCT02250326|3529452|P3|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
1441879|NCT02250326|3529453|P2|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
1441880|NCT02250326|3529454|P1|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
1441881|NCT02250326|3529452|P3|Treated Population|Treatment Period||79
1441882|NCT02250326|3529453|P2|Treated Population|Treatment Period||78
1441883|NCT02250326|3529454|P1|Treated Population|Treatment Period||79
1441884|NCT02250326|3529452|P3|STARTED|Treatment Period||80
1441885|NCT02250326|3529453|P2|STARTED|Treatment Period||79
1441886|NCT02250326|3529454|P1|STARTED|Treatment Period||81
1441887|NCT02250274|3529487|P2|NOT COMPLETED|Overall Study||6
1441888|NCT02250274|3529488|P1|NOT COMPLETED|Overall Study||7
1441889|NCT02250274|3529487|P2|COMPLETED|Overall Study||40
1441890|NCT02250274|3529488|P1|COMPLETED|Overall Study||78
1441891|NCT02250274|3529487|P2|STARTED|Overall Study||46
1441892|NCT02250274|3529488|P1|STARTED|Overall Study||85
1441893|NCT02249819|3529504|P2|NOT COMPLETED|Overall Study||0
1441894|NCT02249819|3529505|P1|NOT COMPLETED|Overall Study||0
1441895|NCT02249819|3529504|P2|COMPLETED|Overall Study||7
1441896|NCT02249819|3529505|P1|COMPLETED|Overall Study||8
1441897|NCT02249819|3529504|P2|STARTED|Overall Study||7
1441898|NCT02249819|3529505|P1|STARTED|Overall Study||8
1441899|NCT02249728|3529511|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
1441900|NCT02249728|3529511|P1|COMPLETED|Part Two (up to 6 Days)||6
1441901|NCT02249728|3529511|P1|STARTED|Part Two (up to 6 Days)||6
1441902|NCT02249728|3529511|P1|NOT COMPLETED|Part One (4 Days)||0
1441903|NCT02249728|3529511|P1|COMPLETED|Part One (4 Days)||6
1441904|NCT02249728|3529511|P1|STARTED|Part One (4 Days)||6
1441905|NCT02249585|3529524|P3|NOT COMPLETED|Overall Study||0
1441906|NCT02249585|3529525|P2|NOT COMPLETED|Overall Study||0
1441907|NCT02249585|3529526|P1|NOT COMPLETED|Overall Study||0
1441908|NCT02249585|3529524|P3|COMPLETED|Overall Study||44
1441909|NCT02249585|3529525|P2|COMPLETED|Overall Study||44
1441910|NCT02249585|3529526|P1|COMPLETED|Overall Study||43
1441911|NCT02249585|3529524|P3|STARTED|Overall Study||44
1441912|NCT02249585|3529525|P2|STARTED|Overall Study||44
1441913|NCT02249585|3529526|P1|STARTED|Overall Study||43
1441914|NCT02249143|3529551|P2|NOT COMPLETED|Overall Study||4
1441915|NCT02249143|3529552|P1|NOT COMPLETED|Overall Study||2
1441916|NCT02249143|3529551|P2|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
1441917|NCT02249143|3529552|P1|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
1441918|NCT02249143|3529551|P2|STARTED|Overall Study|randomized|26
1441919|NCT02249143|3529552|P1|STARTED|Overall Study||24
1441920|NCT02249104|3529558|P1|NOT COMPLETED|Overall Study||3
1441921|NCT02249104|3529558|P1|COMPLETED|Overall Study||25
1441922|NCT02249104|3529558|P1|STARTED|Overall Study||28
1441923|NCT02249065|3529567|P1|NOT COMPLETED|Overall Study||29
1441924|NCT02249065|3529567|P1|COMPLETED|Overall Study||176
1441925|NCT02249065|3529567|P1|Treated|Overall Study||181
1441926|NCT02249065|3529567|P1|STARTED|Overall Study||205
1441927|NCT02249052|3529575|P1|NOT COMPLETED|Overall Study||0
1441928|NCT02249052|3529575|P1|COMPLETED|Overall Study||19
1441929|NCT02249052|3529575|P1|STARTED|Overall Study||19
1441930|NCT02248922|3529593|P2|NOT COMPLETED|Overall Study||0
1441931|NCT02248922|3529594|P1|NOT COMPLETED|Overall Study||0
1441932|NCT02248922|3529593|P2|COMPLETED|Overall Study||12
1441933|NCT02248922|3529594|P1|COMPLETED|Overall Study||5
1441934|NCT02248922|3529593|P2|STARTED|Overall Study||12
1441935|NCT02248922|3529594|P1|STARTED|Overall Study||5
1441936|NCT02248818|3529613|P9|NOT COMPLETED|Randomised Study||0
1441937|NCT02248818|3529614|P8|NOT COMPLETED|Randomised Study||0
1441938|NCT02248818|3529615|P7|NOT COMPLETED|Randomised Study||0
1441939|NCT02248818|3529616|P6|NOT COMPLETED|Randomised Study||8
1441940|NCT02248818|3529617|P5|NOT COMPLETED|Randomised Study||0
1441941|NCT02248818|3529618|P4|NOT COMPLETED|Randomised Study||0
1441942|NCT02248818|3529619|P3|NOT COMPLETED|Randomised Study||0
1441943|NCT02248818|3529620|P2|NOT COMPLETED|Randomised Study||0
1441944|NCT02248818|3529621|P1|NOT COMPLETED|Randomised Study||0
1441945|NCT02248818|3529613|P9|COMPLETED|Randomised Study||0
1441946|NCT02248818|3529614|P8|COMPLETED|Randomised Study||4
1441947|NCT02248818|3529615|P7|COMPLETED|Randomised Study||6
1441948|NCT02248818|3529616|P6|COMPLETED|Randomised Study||0
1441949|NCT02248818|3529617|P5|COMPLETED|Randomised Study||6
1441950|NCT02248818|3529618|P4|COMPLETED|Randomised Study||6
1441951|NCT02248818|3529619|P3|COMPLETED|Randomised Study||6
1441952|NCT02248818|3529620|P2|COMPLETED|Randomised Study||6
1441953|NCT02248818|3529621|P1|COMPLETED|Randomised Study||6
1441954|NCT02248818|3529613|P9|STARTED|Randomised Study||0
1441955|NCT02248818|3529614|P8|STARTED|Randomised Study||4
1441956|NCT02248818|3529615|P7|STARTED|Randomised Study||6
1441957|NCT02248818|3529616|P6|STARTED|Randomised Study||8
1441958|NCT02248818|3529617|P5|STARTED|Randomised Study||6
1441959|NCT02248818|3529618|P4|STARTED|Randomised Study||6
1441960|NCT02248818|3529619|P3|STARTED|Randomised Study||6
1441961|NCT02248818|3529620|P2|STARTED|Randomised Study||6
1441962|NCT02248818|3529621|P1|STARTED|Randomised Study||6
1441963|NCT02248818|3529613|P9|NOT COMPLETED|Screening||107
1441964|NCT02248818|3529614|P8|NOT COMPLETED|Screening||0
1441965|NCT02248818|3529615|P7|NOT COMPLETED|Screening||0
1441966|NCT02248818|3529616|P6|NOT COMPLETED|Screening||0
1441967|NCT02248818|3529617|P5|NOT COMPLETED|Screening||0
1441968|NCT02248818|3529618|P4|NOT COMPLETED|Screening||0
1441969|NCT02248818|3529619|P3|NOT COMPLETED|Screening||0
1441970|NCT02248818|3529620|P2|NOT COMPLETED|Screening||0
1441971|NCT02248818|3529621|P1|NOT COMPLETED|Screening||0
1441972|NCT02248818|3529613|P9|COMPLETED|Screening||48
1441973|NCT02248818|3529614|P8|COMPLETED|Screening||0
1441974|NCT02248818|3529615|P7|COMPLETED|Screening||0
1441975|NCT02248818|3529616|P6|COMPLETED|Screening||0
1441976|NCT02248818|3529617|P5|COMPLETED|Screening||0
1441977|NCT02248818|3529618|P4|COMPLETED|Screening||0
1441978|NCT02248818|3529619|P3|COMPLETED|Screening||0
1441979|NCT02248818|3529620|P2|COMPLETED|Screening||0
1441980|NCT02248818|3529621|P1|COMPLETED|Screening||0
1441981|NCT02248818|3529613|P9|STARTED|Screening||155
1441982|NCT02248818|3529614|P8|STARTED|Screening||0
1441983|NCT02248818|3529615|P7|STARTED|Screening||0
1441984|NCT02248818|3529616|P6|STARTED|Screening||0
1441985|NCT02248818|3529617|P5|STARTED|Screening||0
1441986|NCT02248818|3529618|P4|STARTED|Screening||0
1441987|NCT02248818|3529619|P3|STARTED|Screening||0
1441988|NCT02248818|3529620|P2|STARTED|Screening||0
1441989|NCT02248818|3529621|P1|STARTED|Screening||0
1441990|NCT02248766|3529759|P1|NOT COMPLETED|Overall Study||0
1441991|NCT02248766|3529759|P1|COMPLETED|Overall Study||30
1441992|NCT02248766|3529759|P1|STARTED|Overall Study||30
1441993|NCT02248727|3529771|P1|NOT COMPLETED|Overall Study||0
1441994|NCT02248727|3529771|P1|COMPLETED|Overall Study||30
1441995|NCT02248727|3529771|P1|STARTED|Overall Study||30
1441996|NCT02248675|3529784|P2|NOT COMPLETED|Overall Study||1
1441997|NCT02248675|3529785|P1|NOT COMPLETED|Overall Study||3
1441998|NCT02248675|3529784|P2|COMPLETED|Overall Study||27
1441999|NCT02248675|3529785|P1|COMPLETED|Overall Study||23
1442000|NCT02248675|3529784|P2|STARTED|Overall Study||28
1442001|NCT02248675|3529785|P1|STARTED|Overall Study||26
1442002|NCT02248558|3529799|P2|NOT COMPLETED|Overall Study||45
1442003|NCT02248558|3529800|P1|NOT COMPLETED|Overall Study||52
1442004|NCT02248558|3529799|P2|COMPLETED|Overall Study||307
1442005|NCT02248558|3529800|P1|COMPLETED|Overall Study||317
1442006|NCT02248558|3529799|P2|STARTED|Overall Study||352
1442007|NCT02248558|3529800|P1|STARTED|Overall Study||369
1442008|NCT02248480|3529812|P2|NOT COMPLETED|Overall Study||14
1442009|NCT02248480|3529813|P1|NOT COMPLETED|Overall Study||17
1442010|NCT02248480|3529812|P2|COMPLETED|Overall Study||162
1442011|NCT02248480|3529813|P1|COMPLETED|Overall Study||161
1442012|NCT02248480|3529812|P2|Efficacy Population|Overall Study||176
1442013|NCT02248480|3529813|P1|Efficacy Population|Overall Study||177
1442014|NCT02248480|3529812|P2|STARTED|Overall Study||176
1442015|NCT02248480|3529813|P1|STARTED|Overall Study||178
1442016|NCT02248285|3529853|P2|NOT COMPLETED|Overall Study||287
1442017|NCT02248285|3529854|P1|NOT COMPLETED|Overall Study||101
1442018|NCT02248285|3529853|P2|COMPLETED|Overall Study||571
1442019|NCT02248285|3529854|P1|COMPLETED|Overall Study||586
1442020|NCT02248285|3529853|P2|STARTED|Overall Study||858
1442021|NCT02248285|3529854|P1|STARTED|Overall Study||687
1442022|NCT02248246|3529860|P1|NOT COMPLETED|Overall Study||0
1442023|NCT02248246|3529860|P1|COMPLETED|Overall Study||40
1442024|NCT02248246|3529860|P1|STARTED|Overall Study||40
1442025|NCT02248103|3529867|P2|NOT COMPLETED|Overall Study||0
1442026|NCT02248103|3529868|P1|NOT COMPLETED|Overall Study||0
1442027|NCT02248103|3529867|P2|COMPLETED|Overall Study||10
1442028|NCT02248103|3529868|P1|COMPLETED|Overall Study||10
1442029|NCT02248103|3529867|P2|STARTED|Overall Study||10
1442030|NCT02248103|3529868|P1|STARTED|Overall Study||10
1442031|NCT02247960|3529880|P2|NOT COMPLETED|Catheter Removed||10
1442032|NCT02247960|3529881|P1|NOT COMPLETED|Catheter Removed||7
1442033|NCT02247960|3529880|P2|COMPLETED|Catheter Removed||74
1442034|NCT02247960|3529881|P1|COMPLETED|Catheter Removed||76
1442035|NCT02247960|3529880|P2|STARTED|Catheter Removed||84
1442036|NCT02247960|3529881|P1|STARTED|Catheter Removed||83
1442037|NCT02247960|3529880|P2|NOT COMPLETED|Patient Consent and Randomization||6
1442038|NCT02247960|3529881|P1|NOT COMPLETED|Patient Consent and Randomization||2
1442039|NCT02247960|3529880|P2|COMPLETED|Patient Consent and Randomization||84
1442040|NCT02247960|3529881|P1|COMPLETED|Patient Consent and Randomization||83
1442041|NCT02247960|3529880|P2|STARTED|Patient Consent and Randomization||90
1442042|NCT02247960|3529881|P1|STARTED|Patient Consent and Randomization||85
1442043|NCT02247765|3529891|P1|NOT COMPLETED|Overall Study||0
1442044|NCT02247765|3529891|P1|COMPLETED|Overall Study||18
1442045|NCT02247765|3529891|P1|STARTED|Overall Study||18
1442046|NCT02247739|3529896|P6|NOT COMPLETED|Overall Study||1
1442047|NCT02247739|3529897|P5|NOT COMPLETED|Overall Study||1
1442048|NCT02247739|3529898|P4|NOT COMPLETED|Overall Study||0
1442049|NCT02247739|3529899|P3|NOT COMPLETED|Overall Study||1
1442050|NCT02247739|3529900|P2|NOT COMPLETED|Overall Study||3
1442051|NCT02247739|3529901|P1|NOT COMPLETED|Overall Study||0
1442052|NCT02247739|3529896|P6|COMPLETED|Overall Study||4
1442053|NCT02247739|3529897|P5|COMPLETED|Overall Study||5
1442054|NCT02247739|3529898|P4|COMPLETED|Overall Study||5
1442055|NCT02247739|3529899|P3|COMPLETED|Overall Study||4
1442056|NCT02247739|3529900|P2|COMPLETED|Overall Study||3
1442057|NCT02247739|3529901|P1|COMPLETED|Overall Study||5
1442058|NCT02247739|3529896|P6|STARTED|Overall Study||5
1442059|NCT02247739|3529897|P5|STARTED|Overall Study||6
1442060|NCT02247739|3529898|P4|STARTED|Overall Study||5
1442061|NCT02247739|3529899|P3|STARTED|Overall Study||5
1442062|NCT02247739|3529900|P2|STARTED|Overall Study||6
1442063|NCT02247739|3529901|P1|STARTED|Overall Study||5
1442064|NCT02247401|3529920|P3|NOT COMPLETED|Overall Study||2
1442065|NCT02247401|3529921|P2|NOT COMPLETED|Overall Study||2
1442066|NCT02247401|3529922|P1|NOT COMPLETED|Overall Study||6
1442067|NCT02247401|3529920|P3|COMPLETED|Overall Study||27
1442068|NCT02247401|3529921|P2|COMPLETED|Overall Study||29
1442069|NCT02247401|3529922|P1|COMPLETED|Overall Study||94
1442070|NCT02247401|3529920|P3|STARTED|Overall Study||29
1442071|NCT02247401|3529921|P2|STARTED|Overall Study||31
1442072|NCT02247401|3529922|P1|STARTED|Overall Study||100
1442073|NCT02247063|3529941|P2|NOT COMPLETED|Overall Study||0
1442074|NCT02247063|3529942|P1|NOT COMPLETED|Overall Study||0
1442075|NCT02247063|3529941|P2|COMPLETED|Overall Study||12
1442076|NCT02247063|3529942|P1|COMPLETED|Overall Study||12
1442077|NCT02247063|3529941|P2|STARTED|Overall Study||12
1442078|NCT02247063|3529942|P1|STARTED|Overall Study||12
1442079|NCT02247011|3529952|P1|NOT COMPLETED|Overall Study||125
1442080|NCT02247011|3529952|P1|COMPLETED|Overall Study||975
1442081|NCT02247011|3529952|P1|STARTED|Overall Study||1100
1442082|NCT02246998|3529973|P4|NOT COMPLETED|Overall Study||2
1442083|NCT02246998|3529974|P3|NOT COMPLETED|Overall Study||3
1442084|NCT02246998|3529975|P2|NOT COMPLETED|Overall Study||3
1442085|NCT02246998|3529976|P1|NOT COMPLETED|Overall Study||2
1442086|NCT02246998|3529973|P4|COMPLETED|Overall Study||16
1442087|NCT02246998|3529974|P3|COMPLETED|Overall Study||15
1442088|NCT02246998|3529975|P2|COMPLETED|Overall Study||15
1442089|NCT02246998|3529976|P1|COMPLETED|Overall Study||16
1442090|NCT02246998|3529973|P4|STARTED|Overall Study||18
1442091|NCT02246998|3529974|P3|STARTED|Overall Study||18
1442092|NCT02246998|3529975|P2|STARTED|Overall Study||18
1442093|NCT02246998|3529976|P1|STARTED|Overall Study||18
1442094|NCT02246777|3530086|P1|NOT COMPLETED|Overall Study||3
1442095|NCT02246777|3530086|P1|COMPLETED|Overall Study||29
1442096|NCT02246777|3530086|P1|STARTED|Overall Study||32
1442097|NCT02246764|3530102|P3|NOT COMPLETED|Overall Study||4
1442098|NCT02246764|3530103|P2|NOT COMPLETED|Overall Study||32
1442099|NCT02246764|3530104|P1|NOT COMPLETED|Overall Study||18
1442100|NCT02246764|3530102|P3|COMPLETED|Overall Study||19
1442101|NCT02246764|3530103|P2|COMPLETED|Overall Study||4
1442102|NCT02246764|3530104|P1|COMPLETED|Overall Study||16
1442103|NCT02246764|3530102|P3|STARTED|Overall Study||23
1442104|NCT02246764|3530103|P2|STARTED|Overall Study||36
1442105|NCT02246764|3530104|P1|STARTED|Overall Study||34
1442106|NCT02246673|3530117|P5|NOT COMPLETED|Overall Study||1
1442107|NCT02246673|3530118|P4|NOT COMPLETED|Overall Study||2
1442108|NCT02246673|3530119|P3|NOT COMPLETED|Overall Study||0
1442109|NCT02246673|3530120|P2|NOT COMPLETED|Overall Study||0
1442110|NCT02246673|3530121|P1|NOT COMPLETED|Overall Study||1
1442111|NCT02246673|3530117|P5|COMPLETED|Overall Study||11
1442112|NCT02246673|3530118|P4|COMPLETED|Overall Study||12
1442113|NCT02246673|3530119|P3|COMPLETED|Overall Study||12
1442114|NCT02246673|3530120|P2|COMPLETED|Overall Study||12
1442115|NCT02246673|3530121|P1|COMPLETED|Overall Study||13
1442116|NCT02246673|3530117|P5|STARTED|Overall Study||12
1442117|NCT02246673|3530118|P4|STARTED|Overall Study||14
1442118|NCT02246673|3530119|P3|STARTED|Overall Study||12
1442119|NCT02246673|3530120|P2|STARTED|Overall Study||12
1442120|NCT02246673|3530121|P1|STARTED|Overall Study||14
1442121|NCT02246660|3530229|P3|NOT COMPLETED|Overall Study||1
1442122|NCT02246660|3530230|P2|NOT COMPLETED|Overall Study||1
1442123|NCT02246660|3530231|P1|NOT COMPLETED|Overall Study||0
1442124|NCT02246660|3530229|P3|COMPLETED|Overall Study||21
1442125|NCT02246660|3530230|P2|COMPLETED|Overall Study||20
1442126|NCT02246660|3530231|P1|COMPLETED|Overall Study||23
1442127|NCT02246660|3530229|P3|STARTED|Overall Study||22
1442128|NCT02246660|3530230|P2|STARTED|Overall Study||21
1442129|NCT02246660|3530231|P1|STARTED|Overall Study||23
1442130|NCT02246621|3530241|P2|NOT COMPLETED|Overall Study||148
1442131|NCT02246621|3530242|P1|NOT COMPLETED|Overall Study||296
1442132|NCT02246621|3530241|P2|COMPLETED|Overall Study||17
1442133|NCT02246621|3530242|P1|COMPLETED|Overall Study||32
1442134|NCT02246621|3530241|P2|Received At Least One Dose of Study Drug|Overall Study||162
1442135|NCT02246621|3530242|P1|Received At Least One Dose of Study Drug|Overall Study||326
1442136|NCT02246621|3530241|P2|STARTED|Overall Study||165
1442137|NCT02246621|3530242|P1|STARTED|Overall Study||328
1442138|NCT02246608|3530270|P2|NOT COMPLETED|Overall Study||10
1442139|NCT02246608|3530271|P1|NOT COMPLETED|Overall Study||12
1442140|NCT02246608|3530270|P2|COMPLETED|Overall Study||11
1442141|NCT02246608|3530271|P1|COMPLETED|Overall Study||10
1442142|NCT02246608|3530270|P2|STARTED|Overall Study||21
1442143|NCT02246608|3530271|P1|STARTED|Overall Study||22
1442144|NCT02246582|3530279|P2|NOT COMPLETED|Overall Study||4
1442145|NCT02246582|3530280|P1|NOT COMPLETED|Overall Study||3
1442146|NCT02246582|3530279|P2|COMPLETED|Overall Study||41
1442147|NCT02246582|3530280|P1|COMPLETED|Overall Study||41
1442148|NCT02246582|3530279|P2|STARTED|Overall Study||45
1442149|NCT02246582|3530280|P1|STARTED|Overall Study||44
1442150|NCT02246309|3530288|P2|NOT COMPLETED|Overall Study||0
1442151|NCT02246309|3530289|P1|NOT COMPLETED|Overall Study||0
1442152|NCT02246309|3530288|P2|COMPLETED|Overall Study||15
1442153|NCT02246309|3530289|P1|COMPLETED|Overall Study||16
1442154|NCT02246309|3530288|P2|STARTED|Overall Study||15
1442155|NCT02246309|3530289|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
1442156|NCT02246166|3530301|P2|NOT COMPLETED|Overall Study||0
1442157|NCT02246166|3530302|P1|NOT COMPLETED|Overall Study||1
1442158|NCT02246166|3530301|P2|COMPLETED|Overall Study||27
1442159|NCT02246166|3530302|P1|COMPLETED|Overall Study||25
1442160|NCT02246166|3530301|P2|STARTED|Overall Study||27
1442161|NCT02246166|3530302|P1|STARTED|Overall Study||26
1442162|NCT02246114|3530338|P2|NOT COMPLETED|Overall Study||0
1442163|NCT02246114|3530339|P1|NOT COMPLETED|Overall Study||1
1442164|NCT02246114|3530338|P2|COMPLETED|Overall Study||0
1442165|NCT02246114|3530339|P1|COMPLETED|Overall Study||0
1442166|NCT02246114|3530338|P2|STARTED|Overall Study||0
1442167|NCT02246114|3530339|P1|STARTED|Overall Study||1
1442168|NCT02246062|3530349|P4|NOT COMPLETED|Overall Study||0
1442169|NCT02246062|3530350|P3|NOT COMPLETED|Overall Study||0
1442170|NCT02246062|3530351|P2|NOT COMPLETED|Overall Study||0
1442171|NCT02246062|3530352|P1|NOT COMPLETED|Overall Study||0
1442172|NCT02246062|3530349|P4|COMPLETED|Overall Study||21
1442173|NCT02246062|3530350|P3|COMPLETED|Overall Study||21
1442174|NCT02246062|3530351|P2|COMPLETED|Overall Study||21
1442175|NCT02246062|3530352|P1|COMPLETED|Overall Study||21
1442176|NCT02246062|3530349|P4|STARTED|Overall Study||21
1442177|NCT02246062|3530350|P3|STARTED|Overall Study||21
1442178|NCT02246062|3530351|P2|STARTED|Overall Study||21
1442179|NCT02246062|3530352|P1|STARTED|Overall Study||21
1442180|NCT02245412|3530373|P3|NOT COMPLETED|Overall Study||0
1442181|NCT02245412|3530374|P2|NOT COMPLETED|Overall Study||3
1442182|NCT02245412|3530375|P1|NOT COMPLETED|Overall Study||5
1442183|NCT02245412|3530373|P3|COMPLETED|Overall Study||2
1442184|NCT02245412|3530374|P2|COMPLETED|Overall Study||3
1442185|NCT02245412|3530375|P1|COMPLETED|Overall Study||12
1442186|NCT02245412|3530373|P3|STARTED|Overall Study||2
1442187|NCT02245412|3530374|P2|STARTED|Overall Study||6
1442188|NCT02245412|3530375|P1|STARTED|Overall Study||17
1442189|NCT02245360|3530394|P2|NOT COMPLETED|Overall Study||2
1442190|NCT02245360|3530395|P1|NOT COMPLETED|Overall Study||5
1442191|NCT02245360|3530394|P2|COMPLETED|Overall Study||52
1442192|NCT02245360|3530395|P1|COMPLETED|Overall Study||48
1442193|NCT02245360|3530394|P2|STARTED|Overall Study||54
1442194|NCT02245360|3530395|P1|STARTED|Overall Study||53
1442195|NCT02245217|3530403|P1|NOT COMPLETED|Overall Study||2
1442196|NCT02245217|3530403|P1|COMPLETED|Overall Study||7
1442197|NCT02245217|3530403|P1|STARTED|Overall Study||9
1442198|NCT02244944|3530409|P1|NOT COMPLETED|Overall Study||2
1442199|NCT02244944|3530409|P1|COMPLETED|Overall Study||0
1442200|NCT02244944|3530409|P1|STARTED|Overall Study||2
1442201|NCT02244840|3530415|P1|NOT COMPLETED|Overall Study||0
1442202|NCT02244840|3530415|P1|COMPLETED|Overall Study||40
1442203|NCT02244840|3530415|P1|STARTED|Overall Study||40
1442204|NCT02244619|3530421|P2|NOT COMPLETED|Overall Study||21
1442205|NCT02244619|3530422|P1|NOT COMPLETED|Overall Study||8
1442206|NCT02244619|3530421|P2|COMPLETED|Overall Study||245
1442207|NCT02244619|3530422|P1|COMPLETED|Overall Study||241
1442208|NCT02244619|3530421|P2|STARTED|Overall Study||266
1442209|NCT02244619|3530422|P1|STARTED|Overall Study||249
1442210|NCT02244580|3530440|P1|NOT COMPLETED|Overall Study||241
1442211|NCT02244580|3530440|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
1442212|NCT02244580|3530440|P1|STARTED|Overall Study||1010
1442213|NCT02243943|3530450|P2|NOT COMPLETED|Overall Study||0
1442214|NCT02243943|3530451|P1|NOT COMPLETED|Overall Study||0
1442215|NCT02243943|3530450|P2|COMPLETED|Overall Study||50
1442216|NCT02243943|3530451|P1|COMPLETED|Overall Study||50
1442217|NCT02243943|3530450|P2|STARTED|Overall Study||50
1442218|NCT02243943|3530451|P1|STARTED|Overall Study||50
1442219|NCT02243293|3530478|P22|NOT COMPLETED|Overall Study||3
1442220|NCT02243293|3530479|P21|NOT COMPLETED|Overall Study||2
1442221|NCT02243293|3530480|P20|NOT COMPLETED|Overall Study||1
1442222|NCT02243293|3530481|P19|NOT COMPLETED|Overall Study||0
1442223|NCT02243293|3530482|P18|NOT COMPLETED|Overall Study||1
1442224|NCT02243293|3530483|P17|NOT COMPLETED|Overall Study||3
1442225|NCT02243293|3530484|P16|NOT COMPLETED|Overall Study||1
1442226|NCT02243293|3530485|P15|NOT COMPLETED|Overall Study||1
1442227|NCT02243293|3530486|P14|NOT COMPLETED|Overall Study||0
1442228|NCT02243293|3530487|P13|NOT COMPLETED|Overall Study||0
1442229|NCT02243293|3530488|P12|NOT COMPLETED|Overall Study||3
1442230|NCT02243293|3530489|P11|NOT COMPLETED|Overall Study||0
1442231|NCT02243293|3530490|P10|NOT COMPLETED|Overall Study||2
1442232|NCT02243293|3530491|P9|NOT COMPLETED|Overall Study||0
1442233|NCT02243293|3530492|P8|NOT COMPLETED|Overall Study||0
1442234|NCT02243293|3530493|P7|NOT COMPLETED|Overall Study||3
1442235|NCT02243293|3530494|P6|NOT COMPLETED|Overall Study||0
1442236|NCT02243293|3530495|P5|NOT COMPLETED|Overall Study||1
1442237|NCT02243293|3530496|P4|NOT COMPLETED|Overall Study||1
1442238|NCT02243293|3530497|P3|NOT COMPLETED|Overall Study||1
1442239|NCT02243293|3530498|P2|NOT COMPLETED|Overall Study||1
1442240|NCT02243293|3530499|P1|NOT COMPLETED|Overall Study||2
1442241|NCT02243293|3530478|P22|COMPLETED|Overall Study||55
1442242|NCT02243293|3530479|P21|COMPLETED|Overall Study||143
1442243|NCT02243293|3530480|P20|COMPLETED|Overall Study||47
1442244|NCT02243293|3530481|P19|COMPLETED|Overall Study||22
1442245|NCT02243293|3530482|P18|COMPLETED|Overall Study||21
1442246|NCT02243293|3530483|P17|COMPLETED|Overall Study||37
1442247|NCT02243293|3530484|P16|COMPLETED|Overall Study||26
1442248|NCT02243293|3530485|P15|COMPLETED|Overall Study||27
1442249|NCT02243293|3530486|P14|COMPLETED|Overall Study||0
1442250|NCT02243293|3530487|P13|COMPLETED|Overall Study||0
1442251|NCT02243293|3530488|P12|COMPLETED|Overall Study||50
1442252|NCT02243293|3530489|P11|COMPLETED|Overall Study||0
1442253|NCT02243293|3530490|P10|COMPLETED|Overall Study||53
1442254|NCT02243293|3530491|P9|COMPLETED|Overall Study||0
1442255|NCT02243293|3530492|P8|COMPLETED|Overall Study||0
1442256|NCT02243293|3530493|P7|COMPLETED|Overall Study||27
1442257|NCT02243293|3530494|P6|COMPLETED|Overall Study||31
1442258|NCT02243293|3530495|P5|COMPLETED|Overall Study||30
1442259|NCT02243293|3530496|P4|COMPLETED|Overall Study||29
1442260|NCT02243293|3530497|P3|COMPLETED|Overall Study||24
1442261|NCT02243293|3530498|P2|COMPLETED|Overall Study||23
1442262|NCT02243293|3530499|P1|COMPLETED|Overall Study||23
1442263|NCT02243293|3530478|P22|STARTED|Overall Study||58
1442264|NCT02243293|3530479|P21|STARTED|Overall Study||145
1442265|NCT02243293|3530480|P20|STARTED|Overall Study||48
1442266|NCT02243293|3530481|P19|STARTED|Overall Study||22
1442267|NCT02243293|3530482|P18|STARTED|Overall Study||22
1442268|NCT02243293|3530483|P17|STARTED|Overall Study||40
1442269|NCT02243293|3530484|P16|STARTED|Overall Study||27
1442270|NCT02243293|3530485|P15|STARTED|Overall Study||28
1442271|NCT02243293|3530486|P14|STARTED|Overall Study||0
1442272|NCT02243293|3530487|P13|STARTED|Overall Study||0
1442273|NCT02243293|3530488|P12|STARTED|Overall Study||53
1442274|NCT02243293|3530489|P11|STARTED|Overall Study||0
1442275|NCT02243293|3530490|P10|STARTED|Overall Study||55
1442276|NCT02243293|3530491|P9|STARTED|Overall Study||0
1442277|NCT02243293|3530492|P8|STARTED|Overall Study||0
1442278|NCT02243293|3530493|P7|STARTED|Overall Study||30
1442279|NCT02243293|3530494|P6|STARTED|Overall Study||31
1442280|NCT02243293|3530495|P5|STARTED|Overall Study||31
1442281|NCT02243293|3530496|P4|STARTED|Overall Study||30
1442282|NCT02243293|3530497|P3|STARTED|Overall Study||25
1442283|NCT02243293|3530498|P2|STARTED|Overall Study||24
1442284|NCT02243293|3530499|P1|STARTED|Overall Study||25
1442285|NCT02243280|3530598|P11|NOT COMPLETED|Treated||3
1442286|NCT02243280|3530599|P10|NOT COMPLETED|Treated||0
1442287|NCT02243280|3530600|P9|NOT COMPLETED|Treated||1
1442288|NCT02243280|3530601|P8|NOT COMPLETED|Treated||0
1442289|NCT02243280|3530602|P7|NOT COMPLETED|Treated||0
1442290|NCT02243280|3530603|P6|NOT COMPLETED|Treated||0
1442291|NCT02243280|3530604|P5|NOT COMPLETED|Treated||0
1442292|NCT02243280|3530605|P4|NOT COMPLETED|Treated||0
1442293|NCT02243280|3530606|P3|NOT COMPLETED|Treated||0
1442294|NCT02243280|3530607|P2|NOT COMPLETED|Treated||0
1442295|NCT02243280|3530608|P1|NOT COMPLETED|Treated||1
1442296|NCT02243280|3530598|P11|COMPLETED|Treated||31
1442297|NCT02243280|3530599|P10|COMPLETED|Treated||0
1442298|NCT02243280|3530600|P9|COMPLETED|Treated||31
1442299|NCT02243280|3530601|P8|COMPLETED|Treated||0
1442300|NCT02243280|3530602|P7|COMPLETED|Treated||0
1442301|NCT02243280|3530603|P6|COMPLETED|Treated||27
1442302|NCT02243280|3530604|P5|COMPLETED|Treated||0
1442303|NCT02243280|3530605|P4|COMPLETED|Treated||0
1442304|NCT02243280|3530606|P3|COMPLETED|Treated||0
1442305|NCT02243280|3530607|P2|COMPLETED|Treated||39
1442306|NCT02243280|3530608|P1|COMPLETED|Treated||41
1442307|NCT02243280|3530598|P11|Completed Treatment|Treated||33
1442308|NCT02243280|3530599|P10|Completed Treatment|Treated||0
1442309|NCT02243280|3530600|P9|Completed Treatment|Treated||32
1442310|NCT02243280|3530601|P8|Completed Treatment|Treated||0
1442311|NCT02243280|3530602|P7|Completed Treatment|Treated||0
1442312|NCT02243280|3530603|P6|Completed Treatment|Treated||27
1442313|NCT02243280|3530604|P5|Completed Treatment|Treated||0
1442314|NCT02243280|3530605|P4|Completed Treatment|Treated||0
1442315|NCT02243280|3530606|P3|Completed Treatment|Treated||0
1442316|NCT02243280|3530607|P2|Completed Treatment|Treated||38
1442317|NCT02243280|3530608|P1|Completed Treatment|Treated||42
1442318|NCT02243280|3530598|P11|STARTED|Treated||34
1442319|NCT02243280|3530599|P10|STARTED|Treated||0
1442320|NCT02243280|3530600|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
1442321|NCT02243280|3530601|P8|STARTED|Treated||0
1442322|NCT02243280|3530602|P7|STARTED|Treated||0
1442323|NCT02243280|3530603|P6|STARTED|Treated||27
1442324|NCT02243280|3530604|P5|STARTED|Treated||0
1442325|NCT02243280|3530605|P4|STARTED|Treated||0
1442326|NCT02243280|3530606|P3|STARTED|Treated||0
1442327|NCT02243280|3530607|P2|STARTED|Treated||39
1442328|NCT02243280|3530608|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
1442329|NCT02243280|3530598|P11|NOT COMPLETED|Enrolled||0
1442330|NCT02243280|3530599|P10|NOT COMPLETED|Enrolled||0
1442331|NCT02243280|3530600|P9|NOT COMPLETED|Enrolled||0
1442332|NCT02243280|3530601|P8|NOT COMPLETED|Enrolled||0
1442333|NCT02243280|3530602|P7|NOT COMPLETED|Enrolled||0
1442334|NCT02243280|3530603|P6|NOT COMPLETED|Enrolled||0
1442335|NCT02243280|3530604|P5|NOT COMPLETED|Enrolled||0
1442336|NCT02243280|3530605|P4|NOT COMPLETED|Enrolled||0
1442337|NCT02243280|3530606|P3|NOT COMPLETED|Enrolled||0
1442338|NCT02243280|3530607|P2|NOT COMPLETED|Enrolled||0
1442339|NCT02243280|3530608|P1|NOT COMPLETED|Enrolled||0
1442340|NCT02243280|3530598|P11|COMPLETED|Enrolled||34
1442341|NCT02243280|3530599|P10|COMPLETED|Enrolled||0
1442342|NCT02243280|3530600|P9|COMPLETED|Enrolled||34
1442343|NCT02243280|3530601|P8|COMPLETED|Enrolled||0
1442344|NCT02243280|3530602|P7|COMPLETED|Enrolled||0
1442345|NCT02243280|3530603|P6|COMPLETED|Enrolled||27
1442346|NCT02243280|3530604|P5|COMPLETED|Enrolled||0
1442347|NCT02243280|3530605|P4|COMPLETED|Enrolled||0
1442348|NCT02243280|3530606|P3|COMPLETED|Enrolled||0
1442349|NCT02243280|3530607|P2|COMPLETED|Enrolled||39
1442350|NCT02243280|3530608|P1|COMPLETED|Enrolled||40
1442351|NCT02243280|3530598|P11|STARTED|Enrolled||34
1442352|NCT02243280|3530599|P10|STARTED|Enrolled||0
1442353|NCT02243280|3530600|P9|STARTED|Enrolled||34
1442354|NCT02243280|3530601|P8|STARTED|Enrolled||0
1442355|NCT02243280|3530602|P7|STARTED|Enrolled||0
1442356|NCT02243280|3530603|P6|STARTED|Enrolled||27
1442357|NCT02243280|3530604|P5|STARTED|Enrolled||0
1442358|NCT02243280|3530605|P4|STARTED|Enrolled||0
1442359|NCT02243280|3530606|P3|STARTED|Enrolled||0
1442360|NCT02243280|3530607|P2|STARTED|Enrolled||39
1442361|NCT02243280|3530608|P1|STARTED|Enrolled||40
1442362|NCT02243202|3530663|P4|NOT COMPLETED|Overall Study||23
1442363|NCT02243202|3530664|P3|NOT COMPLETED|Overall Study||31
1442364|NCT02243202|3530665|P2|NOT COMPLETED|Overall Study||25
1442365|NCT02243202|3530666|P1|NOT COMPLETED|Overall Study||25
1442366|NCT02243202|3530663|P4|COMPLETED|Overall Study||61
1442367|NCT02243202|3530664|P3|COMPLETED|Overall Study||53
1442368|NCT02243202|3530665|P2|COMPLETED|Overall Study||60
1442369|NCT02243202|3530666|P1|COMPLETED|Overall Study||57
1442370|NCT02243202|3530663|P4|Treated|Overall Study||83
1442371|NCT02243202|3530664|P3|Treated|Overall Study||84
1442372|NCT02243202|3530665|P2|Treated|Overall Study||85
1442373|NCT02243202|3530666|P1|Treated|Overall Study||82
1442374|NCT02243202|3530663|P4|STARTED|Overall Study||84
1442375|NCT02243202|3530664|P3|STARTED|Overall Study||84
1442376|NCT02243202|3530665|P2|STARTED|Overall Study||85
1442377|NCT02243202|3530666|P1|STARTED|Overall Study||82
1442378|NCT02243176|3530702|P2|NOT COMPLETED|Overall Study||15
1442379|NCT02243176|3530703|P1|NOT COMPLETED|Overall Study||14
1442380|NCT02243176|3530702|P2|COMPLETED|Overall Study||229
1442381|NCT02243176|3530703|P1|COMPLETED|Overall Study||230
1442382|NCT02243176|3530702|P2|STARTED|Overall Study||244
1442383|NCT02243176|3530703|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
1442384|NCT02243046|3530728|P3|NOT COMPLETED|Overall Study||4
1442385|NCT02243046|3530729|P2|NOT COMPLETED|Overall Study||1
1442386|NCT02243046|3530730|P1|NOT COMPLETED|Overall Study||1
1442387|NCT02243046|3530728|P3|COMPLETED|Overall Study||49
1442388|NCT02243046|3530729|P2|COMPLETED|Overall Study||53
1442389|NCT02243046|3530730|P1|COMPLETED|Overall Study||54
1442390|NCT02243046|3530728|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
1442391|NCT02243046|3530729|P2|6 Month|Overall Study||53
1442392|NCT02243046|3530730|P1|6 Month|Overall Study||54
1442393|NCT02243046|3530728|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
1442394|NCT02243046|3530729|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
1442395|NCT02243046|3530730|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
1442396|NCT02243046|3530728|P3|STARTED|Overall Study||53
1442397|NCT02243046|3530729|P2|STARTED|Overall Study||54
1442398|NCT02243046|3530730|P1|STARTED|Overall Study||55
1442399|NCT02243007|3530755|P2|NOT COMPLETED|Overall Study||0
1442400|NCT02243007|3530756|P1|NOT COMPLETED|Overall Study||0
1442401|NCT02243007|3530755|P2|COMPLETED|Overall Study||3
1442402|NCT02243007|3530756|P1|COMPLETED|Overall Study||4
1442403|NCT02243007|3530755|P2|STARTED|Overall Study||3
1442404|NCT02243007|3530756|P1|STARTED|Overall Study||4
1442405|NCT02242994|3530778|P1|NOT COMPLETED|Overall Study||0
1442406|NCT02242994|3530778|P1|COMPLETED|Overall Study||5
1442407|NCT02242994|3530778|P1|STARTED|Overall Study||5
1442408|NCT02242903|3530790|P7|NOT COMPLETED|Overall Study||0
1442409|NCT02242903|3530791|P6|NOT COMPLETED|Overall Study||0
1442410|NCT02242903|3530792|P5|NOT COMPLETED|Overall Study||0
1442411|NCT02242903|3530793|P4|NOT COMPLETED|Overall Study||0
1442412|NCT02242903|3530794|P3|NOT COMPLETED|Overall Study||0
1442413|NCT02242903|3530795|P2|NOT COMPLETED|Overall Study||0
1442414|NCT02242903|3530796|P1|NOT COMPLETED|Overall Study||1
1442415|NCT02242903|3530790|P7|COMPLETED|Overall Study||6
1442416|NCT02242903|3530791|P6|COMPLETED|Overall Study||6
1442417|NCT02242903|3530792|P5|COMPLETED|Overall Study||6
1442418|NCT02242903|3530793|P4|COMPLETED|Overall Study||6
1442419|NCT02242903|3530794|P3|COMPLETED|Overall Study||6
1442420|NCT02242903|3530795|P2|COMPLETED|Overall Study||6
1442421|NCT02242903|3530796|P1|COMPLETED|Overall Study||11
1442422|NCT02242903|3530790|P7|Received at Least One Dose of Study Drug|Overall Study||6
1442423|NCT02242903|3530791|P6|Received at Least One Dose of Study Drug|Overall Study||6
1442424|NCT02242903|3530792|P5|Received at Least One Dose of Study Drug|Overall Study||6
1442425|NCT02242903|3530793|P4|Received at Least One Dose of Study Drug|Overall Study||6
1442426|NCT02242903|3530794|P3|Received at Least One Dose of Study Drug|Overall Study||6
1442427|NCT02242903|3530795|P2|Received at Least One Dose of Study Drug|Overall Study||6
1442428|NCT02242903|3530796|P1|Received at Least One Dose of Study Drug|Overall Study||12
1442429|NCT02242903|3530790|P7|STARTED|Overall Study||6
1442430|NCT02242903|3530791|P6|STARTED|Overall Study||6
1442431|NCT02242903|3530792|P5|STARTED|Overall Study||6
1442432|NCT02242903|3530793|P4|STARTED|Overall Study||6
1442433|NCT02242903|3530794|P3|STARTED|Overall Study||6
1442434|NCT02242903|3530795|P2|STARTED|Overall Study||6
1442435|NCT02242903|3530796|P1|STARTED|Overall Study||12
1442436|NCT02242643|3530826|P2|NOT COMPLETED|Overall Study||78
1442437|NCT02242643|3530827|P1|NOT COMPLETED|Overall Study||75
1442438|NCT02242643|3530826|P2|COMPLETED|Overall Study||1139
1442439|NCT02242643|3530827|P1|COMPLETED|Overall Study||1132
1442440|NCT02242643|3530826|P2|STARTED|Overall Study||1217
1442441|NCT02242643|3530827|P1|STARTED|Overall Study||1207
1442442|NCT02242630|3530863|P4|NOT COMPLETED|Overall Study||0
1442443|NCT02242630|3530864|P3|NOT COMPLETED|Overall Study||0
1442444|NCT02242630|3530865|P2|NOT COMPLETED|Overall Study||0
1442445|NCT02242630|3530866|P1|NOT COMPLETED|Overall Study||0
1442446|NCT02242630|3530863|P4|COMPLETED|Overall Study||16
1442447|NCT02242630|3530864|P3|COMPLETED|Overall Study||15
1442448|NCT02242630|3530865|P2|COMPLETED|Overall Study||15
1442449|NCT02242630|3530866|P1|COMPLETED|Overall Study||15
1442450|NCT02242630|3530863|P4|STARTED|Overall Study||16
1442451|NCT02242630|3530864|P3|STARTED|Overall Study||15
1442452|NCT02242630|3530865|P2|STARTED|Overall Study||15
1442453|NCT02242630|3530866|P1|STARTED|Overall Study||15
1442454|NCT02242305|3530882|P2|NOT COMPLETED|Overall Study||10
1442455|NCT02242305|3530883|P1|NOT COMPLETED|Overall Study||6
1442456|NCT02242305|3530882|P2|COMPLETED|Overall Study||141
1442457|NCT02242305|3530883|P1|COMPLETED|Overall Study||145
1442458|NCT02242305|3530882|P2|STARTED|Overall Study||151
1442459|NCT02242305|3530883|P1|STARTED|Overall Study||151
1442460|NCT02242201|3530904|P3|NOT COMPLETED|Overall Study||1
1442461|NCT02242201|3530905|P2|NOT COMPLETED|Overall Study||1
1442462|NCT02242201|3530906|P1|NOT COMPLETED|Overall Study||4
1442463|NCT02242201|3530904|P3|COMPLETED|Overall Study||54
1442464|NCT02242201|3530905|P2|COMPLETED|Overall Study||54
1442465|NCT02242201|3530906|P1|COMPLETED|Overall Study||51
1442466|NCT02242201|3530904|P3|STARTED|Overall Study||55
1442467|NCT02242201|3530905|P2|STARTED|Overall Study||55
1442468|NCT02242201|3530906|P1|STARTED|Overall Study||55
1442469|NCT02242019|3530938|P1|NOT COMPLETED|Overall Study||0
1442470|NCT02242019|3530938|P1|COMPLETED|Overall Study||109
1442471|NCT02242019|3530938|P1|STARTED|Overall Study||109
1442472|NCT02241889|3530944|P6|NOT COMPLETED|Overall Study||1
1442473|NCT02241889|3530945|P5|NOT COMPLETED|Overall Study||0
1442474|NCT02241889|3530946|P4|NOT COMPLETED|Overall Study||0
1442475|NCT02241889|3530947|P3|NOT COMPLETED|Overall Study||1
1442476|NCT02241889|3530948|P2|NOT COMPLETED|Overall Study||0
1442477|NCT02241889|3530949|P1|NOT COMPLETED|Overall Study||0
1442478|NCT02241889|3530944|P6|COMPLETED|Overall Study||3
1442479|NCT02241889|3530945|P5|COMPLETED|Overall Study||5
1442480|NCT02241889|3530946|P4|COMPLETED|Overall Study||3
1442481|NCT02241889|3530947|P3|COMPLETED|Overall Study||2
1442482|NCT02241889|3530948|P2|COMPLETED|Overall Study||4
1442483|NCT02241889|3530949|P1|COMPLETED|Overall Study||4
1442484|NCT02241889|3530944|P6|STARTED|Overall Study||4
1442485|NCT02241889|3530945|P5|STARTED|Overall Study||5
1442486|NCT02241889|3530946|P4|STARTED|Overall Study||3
1442487|NCT02241889|3530947|P3|STARTED|Overall Study||3
1442488|NCT02241889|3530948|P2|STARTED|Overall Study||4
1442489|NCT02241889|3530949|P1|STARTED|Overall Study||4
1442490|NCT02241785|3530984|P1|NOT COMPLETED|Overall Study||47
1442491|NCT02241785|3530984|P1|COMPLETED|Overall Study||0
1442492|NCT02241785|3530984|P1|STARTED|Overall Study||47
1442493|NCT02241720|3530992|P1|NOT COMPLETED|Overall Study||4
1442494|NCT02241720|3530992|P1|COMPLETED|Overall Study||1
1442495|NCT02241720|3530992|P1|STARTED|Overall Study||5
1442496|NCT02241551|3530998|P2|NOT COMPLETED|Overall Study||0
1442497|NCT02241551|3530999|P1|NOT COMPLETED|Overall Study||1
1442498|NCT02241551|3530998|P2|COMPLETED|Overall Study||0
1442499|NCT02241551|3530999|P1|COMPLETED|Overall Study||0
1442500|NCT02241551|3530998|P2|STARTED|Overall Study||0
1442501|NCT02241551|3530999|P1|STARTED|Overall Study||1
1442502|NCT02241486|3531019|P1|NOT COMPLETED|Overall Study||0
1442503|NCT02241486|3531019|P1|COMPLETED|Overall Study||2
1442504|NCT02241486|3531019|P1|STARTED|Overall Study||2
1442505|NCT02241187|3531023|P1|NOT COMPLETED|Overall Study||2
1442506|NCT02241187|3531023|P1|COMPLETED|Overall Study||0
1442507|NCT02241187|3531023|P1|STARTED|Overall Study||2
1442508|NCT02240693|3531033|P5|NOT COMPLETED|Overall Study||1
1442509|NCT02240693|3531034|P4|NOT COMPLETED|Overall Study||1
1442510|NCT02240693|3531035|P3|NOT COMPLETED|Overall Study||4
1442511|NCT02240693|3531036|P2|NOT COMPLETED|Overall Study||0
1442512|NCT02240693|3531037|P1|NOT COMPLETED|Overall Study||0
1442513|NCT02240693|3531033|P5|COMPLETED|Overall Study||42
1442514|NCT02240693|3531034|P4|COMPLETED|Overall Study||20
1442515|NCT02240693|3531035|P3|COMPLETED|Overall Study||17
1442516|NCT02240693|3531036|P2|COMPLETED|Overall Study||21
1442517|NCT02240693|3531037|P1|COMPLETED|Overall Study||22
1442518|NCT02240693|3531033|P5|STARTED|Overall Study||43
1442519|NCT02240693|3531034|P4|STARTED|Overall Study||21
1442520|NCT02240693|3531035|P3|STARTED|Overall Study||21
1442521|NCT02240693|3531036|P2|STARTED|Overall Study||21
1442522|NCT02240693|3531037|P1|STARTED|Overall Study||22
1442523|NCT02240680|3531073|P4|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
1442524|NCT02240680|3531074|P3|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
1442525|NCT02240680|3531075|P2|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
1442526|NCT02240680|3531076|P1|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
1442527|NCT02240680|3531073|P4|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
1442528|NCT02240680|3531074|P3|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
1442529|NCT02240680|3531075|P2|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
1442530|NCT02240680|3531076|P1|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
1442531|NCT02240680|3531073|P4|STARTED|Japanese Patients (Up to 52 Weeks)||52
1442532|NCT02240680|3531074|P3|STARTED|Japanese Patients (Up to 52 Weeks)||50
1442533|NCT02240680|3531075|P2|STARTED|Japanese Patients (Up to 52 Weeks)||0
1442534|NCT02240680|3531076|P1|STARTED|Japanese Patients (Up to 52 Weeks)||0
1442535|NCT02240680|3531073|P4|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
1442536|NCT02240680|3531074|P3|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
1442537|NCT02240680|3531075|P2|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
1442538|NCT02240680|3531076|P1|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
1442539|NCT02240680|3531073|P4|COMPLETED|Overall Study (Up to 24 Weeks)||0
1442540|NCT02240680|3531074|P3|COMPLETED|Overall Study (Up to 24 Weeks)||0
1442541|NCT02240680|3531075|P2|COMPLETED|Overall Study (Up to 24 Weeks)||143
1442542|NCT02240680|3531076|P1|COMPLETED|Overall Study (Up to 24 Weeks)||136
1442543|NCT02240680|3531073|P4|STARTED|Overall Study (Up to 24 Weeks)||0
1442544|NCT02240680|3531074|P3|STARTED|Overall Study (Up to 24 Weeks)||0
1442545|NCT02240680|3531075|P2|STARTED|Overall Study (Up to 24 Weeks)||151
1442546|NCT02240680|3531076|P1|STARTED|Overall Study (Up to 24 Weeks)||151
1442547|NCT02240654|3531099|P5|NOT COMPLETED|Overall Study||0
1442548|NCT02240654|3531100|P4|NOT COMPLETED|Overall Study||0
1442549|NCT02240654|3531101|P3|NOT COMPLETED|Overall Study||0
1442550|NCT02240654|3531102|P2|NOT COMPLETED|Overall Study||0
1442551|NCT02240654|3531103|P1|NOT COMPLETED|Overall Study||0
1442552|NCT02240654|3531099|P5|COMPLETED|Overall Study||1285
1442553|NCT02240654|3531100|P4|COMPLETED|Overall Study||2150
1442554|NCT02240654|3531101|P3|COMPLETED|Overall Study||28619
1442555|NCT02240654|3531102|P2|COMPLETED|Overall Study||2813
1442556|NCT02240654|3531103|P1|COMPLETED|Overall Study||1706
1442557|NCT02240654|3531099|P5|STARTED|Overall Study||1285
1442558|NCT02240654|3531100|P4|STARTED|Overall Study||2150
1442559|NCT02240654|3531101|P3|STARTED|Overall Study||28619
1442560|NCT02240654|3531102|P2|STARTED|Overall Study||2813
1442561|NCT02240654|3531103|P1|STARTED|Overall Study||1706
1442562|NCT02240628|3531117|P2|NOT COMPLETED|Overall Study||5
1442563|NCT02240628|3531118|P1|NOT COMPLETED|Overall Study||6
1442564|NCT02240628|3531117|P2|COMPLETED|Overall Study||33
1442565|NCT02240628|3531118|P1|COMPLETED|Overall Study||32
1442566|NCT02240628|3531117|P2|STARTED|Overall Study||38
1442567|NCT02240628|3531118|P1|STARTED|Overall Study||38
1442568|NCT02240589|3531128|P2|NOT COMPLETED|Overall Study||2
1442569|NCT02240589|3531129|P1|NOT COMPLETED|Overall Study||2
1442570|NCT02240589|3531128|P2|COMPLETED|Overall Study||4
1442571|NCT02240589|3531129|P1|COMPLETED|Overall Study||3
1442572|NCT02240589|3531128|P2|STARTED|Overall Study||6
1442573|NCT02240589|3531129|P1|STARTED|Overall Study||5
1442574|NCT02240368|3531152|P3|NOT COMPLETED|Overall Study||1
1442575|NCT02240368|3531153|P2|NOT COMPLETED|Overall Study||0
1442576|NCT02240368|3531154|P1|NOT COMPLETED|Overall Study||1
1442577|NCT02240368|3531152|P3|COMPLETED|Overall Study||18
1442578|NCT02240368|3531153|P2|COMPLETED|Overall Study||22
1442579|NCT02240368|3531154|P1|COMPLETED|Overall Study||8
1442580|NCT02240368|3531152|P3|STARTED|Overall Study||19
1442581|NCT02240368|3531153|P2|STARTED|Overall Study||22
1442582|NCT02240368|3531154|P1|STARTED|Overall Study||9
1442583|NCT02240329|3531171|P1|NOT COMPLETED|Overall Study||0
1442584|NCT02240329|3531171|P1|COMPLETED|Overall Study||4
1442585|NCT02240329|3531171|P1|Determination of Urge to Cough|Overall Study||4
1442586|NCT02240329|3531171|P1|STARTED|Overall Study||4
1442587|NCT02240186|3531176|P1|NOT COMPLETED|Overall Study||27
1442588|NCT02240186|3531176|P1|COMPLETED|Overall Study||23
1442589|NCT02240186|3531176|P1|STARTED|Overall Study||50
1442590|NCT02240030|3531187|P3|NOT COMPLETED|Overall Study||15
1442591|NCT02240030|3531188|P2|NOT COMPLETED|Overall Study||17
1442592|NCT02240030|3531189|P1|NOT COMPLETED|Overall Study||17
1442593|NCT02240030|3531187|P3|COMPLETED|Overall Study||97
1442594|NCT02240030|3531188|P2|COMPLETED|Overall Study||97
1442595|NCT02240030|3531189|P1|COMPLETED|Overall Study||96
1442596|NCT02240030|3531187|P3|STARTED|Overall Study||112
1442597|NCT02240030|3531188|P2|STARTED|Overall Study||114
1442598|NCT02240030|3531189|P1|STARTED|Overall Study||113
1442599|NCT02239978|3531213|P2|NOT COMPLETED|Overall Study||0
1442600|NCT02239978|3531214|P1|NOT COMPLETED|Overall Study||2
1442601|NCT02239978|3531213|P2|COMPLETED|Overall Study||12
1442602|NCT02239978|3531214|P1|COMPLETED|Overall Study||28
1442603|NCT02239978|3531213|P2|STARTED|Overall Study||12
1442604|NCT02239978|3531214|P1|STARTED|Overall Study||30
1442605|NCT02239939|3531231|P2|NOT COMPLETED|Overall Study||2
1442606|NCT02239939|3531232|P1|NOT COMPLETED|Overall Study||2
1442607|NCT02239939|3531231|P2|COMPLETED|Overall Study||15
1442608|NCT02239939|3531232|P1|COMPLETED|Overall Study||18
1442609|NCT02239939|3531231|P2|STARTED|Overall Study||17
1442610|NCT02239939|3531232|P1|STARTED|Overall Study||20
1442611|NCT02239926|3531248|P2|NOT COMPLETED|Overall Study||1
1442612|NCT02239926|3531249|P1|NOT COMPLETED|Overall Study||0
1442613|NCT02239926|3531248|P2|COMPLETED|Overall Study||1
1442614|NCT02239926|3531249|P1|COMPLETED|Overall Study||0
1442615|NCT02239926|3531248|P2|STARTED|Overall Study||2
1442616|NCT02239926|3531249|P1|STARTED|Overall Study||0
1442617|NCT02239770|3531263|P6|NOT COMPLETED|Part 2||0
1442618|NCT02239770|3531264|P5|NOT COMPLETED|Part 2||0
1442619|NCT02239770|3531265|P4|NOT COMPLETED|Part 2||0
1442620|NCT02239770|3531266|P3|NOT COMPLETED|Part 2||0
1442621|NCT02239770|3531267|P2|NOT COMPLETED|Part 2||0
1442622|NCT02239770|3531268|P1|NOT COMPLETED|Part 2||0
1442623|NCT02239770|3531263|P6|COMPLETED|Part 2||4
1442624|NCT02239770|3531264|P5|COMPLETED|Part 2||4
1442625|NCT02239770|3531265|P4|COMPLETED|Part 2||4
1442626|NCT02239770|3531266|P3|COMPLETED|Part 2||0
1442627|NCT02239770|3531267|P2|COMPLETED|Part 2||0
1442628|NCT02239770|3531268|P1|COMPLETED|Part 2||0
1442629|NCT02239770|3531263|P6|STARTED|Part 2||4
1442630|NCT02239770|3531264|P5|STARTED|Part 2||4
1442631|NCT02239770|3531265|P4|STARTED|Part 2||4
1442632|NCT02239770|3531266|P3|STARTED|Part 2||0
1442633|NCT02239770|3531267|P2|STARTED|Part 2||0
1442634|NCT02239770|3531268|P1|STARTED|Part 2||0
1442635|NCT02239770|3531263|P6|NOT COMPLETED|Part 1||0
1442636|NCT02239770|3531264|P5|NOT COMPLETED|Part 1||0
1442637|NCT02239770|3531265|P4|NOT COMPLETED|Part 1||0
1442638|NCT02239770|3531266|P3|NOT COMPLETED|Part 1||0
1442639|NCT02239770|3531267|P2|NOT COMPLETED|Part 1||0
1442640|NCT02239770|3531268|P1|NOT COMPLETED|Part 1||0
1442641|NCT02239770|3531263|P6|COMPLETED|Part 1||0
1442642|NCT02239770|3531264|P5|COMPLETED|Part 1||0
1442643|NCT02239770|3531265|P4|COMPLETED|Part 1||0
1442644|NCT02239770|3531266|P3|COMPLETED|Part 1||4
1442645|NCT02239770|3531267|P2|COMPLETED|Part 1||4
1442646|NCT02239770|3531268|P1|COMPLETED|Part 1||4
1442647|NCT02239770|3531263|P6|STARTED|Part 1||0
1442648|NCT02239770|3531264|P5|STARTED|Part 1||0
1442649|NCT02239770|3531265|P4|STARTED|Part 1||0
1442650|NCT02239770|3531266|P3|STARTED|Part 1||4
1442651|NCT02239770|3531267|P2|STARTED|Part 1||4
1442652|NCT02239770|3531268|P1|STARTED|Part 1||4
1442653|NCT02239744|3531296|P2|NOT COMPLETED|Period 2||0
1442654|NCT02239744|3531297|P1|NOT COMPLETED|Period 2||0
1442655|NCT02239744|3531296|P2|COMPLETED|Period 2||18
1442656|NCT02239744|3531297|P1|COMPLETED|Period 2||17
1442657|NCT02239744|3531296|P2|STARTED|Period 2||18
1442658|NCT02239744|3531297|P1|STARTED|Period 2||17
1442659|NCT02239744|3531296|P2|NOT COMPLETED|Period 1||0
1442660|NCT02239744|3531297|P1|NOT COMPLETED|Period 1||0
1442661|NCT02239744|3531296|P2|COMPLETED|Period 1||18
1442662|NCT02239744|3531297|P1|COMPLETED|Period 1||17
1442663|NCT02239744|3531296|P2|STARTED|Period 1||18
1442664|NCT02239744|3531297|P1|STARTED|Period 1||17
1442665|NCT02239692|3531311|P2|NOT COMPLETED|Overall Study||13
1442666|NCT02239692|3531312|P1|NOT COMPLETED|Overall Study||6
1442667|NCT02239692|3531311|P2|COMPLETED|Overall Study||118
1442668|NCT02239692|3531312|P1|COMPLETED|Overall Study||67
1442669|NCT02239692|3531311|P2|Safety Analysis Set|Overall Study||125
1442670|NCT02239692|3531312|P1|Safety Analysis Set|Overall Study||70
1442671|NCT02239692|3531311|P2|Per-protocol Analysis Set|Overall Study||120
1442672|NCT02239692|3531312|P1|Per-protocol Analysis Set|Overall Study||66
1442673|NCT02239692|3531311|P2|Intention-to-treat Analysis Set|Overall Study||131
1442674|NCT02239692|3531312|P1|Intention-to-treat Analysis Set|Overall Study||73
1442675|NCT02239692|3531311|P2|STARTED|Overall Study||131
1442676|NCT02239692|3531312|P1|STARTED|Overall Study||73
1442677|NCT02239679|3531331|P3|NOT COMPLETED|Overall Study||1
1442678|NCT02239679|3531332|P2|NOT COMPLETED|Overall Study||3
1442679|NCT02239679|3531333|P1|NOT COMPLETED|Overall Study||3
1442680|NCT02239679|3531331|P3|COMPLETED|Overall Study||53
1442681|NCT02239679|3531332|P2|COMPLETED|Overall Study||56
1442682|NCT02239679|3531333|P1|COMPLETED|Overall Study||50
1442683|NCT02239679|3531331|P3|STARTED|Overall Study||54
1442684|NCT02239679|3531332|P2|STARTED|Overall Study||59
1442685|NCT02239679|3531333|P1|STARTED|Overall Study||53
1442686|NCT02239328|3531545|P1|NOT COMPLETED|Overall Study||8
1442687|NCT02239328|3531545|P1|COMPLETED|Overall Study||174
1442688|NCT02239328|3531545|P1|STARTED|Overall Study||182
1442689|NCT02239289|3531549|P1|NOT COMPLETED|Overall Study||0
1442690|NCT02239289|3531549|P1|COMPLETED|Overall Study||21
1442691|NCT02239289|3531549|P1|STARTED|Overall Study||21
1442692|NCT02239094|3531568|P1|NOT COMPLETED|Overall Study||2
1442693|NCT02239094|3531568|P1|COMPLETED|Overall Study||18
1442694|NCT02239094|3531568|P1|STARTED|Overall Study||20
1442695|NCT02238977|3531575|P2|NOT COMPLETED|Overall Study||0
1442696|NCT02238977|3531576|P1|NOT COMPLETED|Overall Study||0
1442697|NCT02238977|3531575|P2|COMPLETED|Overall Study||1
1442698|NCT02238977|3531576|P1|COMPLETED|Overall Study||0
1442699|NCT02238977|3531575|P2|STARTED|Overall Study||1
1442700|NCT02238977|3531576|P1|STARTED|Overall Study||0
1442701|NCT02238925|3531582|P1|NOT COMPLETED|Overall Study||25
1442702|NCT02238925|3531582|P1|COMPLETED|Overall Study||1
1442703|NCT02238925|3531582|P1|STARTED|Overall Study||26
1442704|NCT02238782|3531590|P1|NOT COMPLETED|Overall Study||0
1442705|NCT02238782|3531590|P1|COMPLETED|Overall Study||12
1442706|NCT02238782|3531590|P1|Subjects Treated|Overall Study||12
1442707|NCT02238782|3531590|P1|STARTED|Overall Study||12
1442708|NCT02238483|3531596|P2|NOT COMPLETED|Overall Study||14
1442709|NCT02238483|3531597|P1|NOT COMPLETED|Overall Study||15
1442710|NCT02238483|3531596|P2|COMPLETED|Overall Study||91
1442711|NCT02238483|3531597|P1|COMPLETED|Overall Study||93
1442712|NCT02238483|3531596|P2|STARTED|Overall Study||105
1442713|NCT02238483|3531597|P1|STARTED|Overall Study||108
1442714|NCT02238379|3531635|P2|NOT COMPLETED|Overall Study||0
1442715|NCT02238379|3531636|P1|NOT COMPLETED|Overall Study||1
1442716|NCT02238379|3531635|P2|COMPLETED|Overall Study||14
1442717|NCT02238379|3531636|P1|COMPLETED|Overall Study||11
1442718|NCT02238379|3531635|P2|STARTED|Overall Study||14
1442719|NCT02238379|3531636|P1|STARTED|Overall Study||12
1442720|NCT02238080|3531662|P1|NOT COMPLETED|Overall Study||25
1442721|NCT02238080|3531662|P1|COMPLETED|Overall Study||172
1442722|NCT02238080|3531662|P1|STARTED|Overall Study||197
1442723|NCT02238067|3531676|P1|NOT COMPLETED|Overall Study||45
1442724|NCT02238067|3531676|P1|COMPLETED|Overall Study||151
1442725|NCT02238067|3531676|P1|STARTED|Overall Study||196
1442726|NCT02238028|3531699|P2|NOT COMPLETED|Overall Study||2
1442727|NCT02238028|3531700|P1|NOT COMPLETED|Overall Study||2
1442728|NCT02238028|3531699|P2|COMPLETED|Overall Study||12
1442729|NCT02238028|3531700|P1|COMPLETED|Overall Study||12
1442730|NCT02238028|3531699|P2|STARTED|Overall Study||14
1442731|NCT02238028|3531700|P1|STARTED|Overall Study||14
1442732|NCT02237118|3531721|P2|NOT COMPLETED|Overall Study||1
1442733|NCT02237118|3531722|P1|NOT COMPLETED|Overall Study||1
1442734|NCT02237118|3531721|P2|COMPLETED|Overall Study||62
1442735|NCT02237118|3531722|P1|COMPLETED|Overall Study||59
1442736|NCT02237118|3531721|P2|STARTED|Overall Study||63
1442737|NCT02237118|3531722|P1|STARTED|Overall Study||60
1442738|NCT02237092|3531736|P1|NOT COMPLETED|Overall Study||0
1442739|NCT02237092|3531736|P1|COMPLETED|Overall Study||196
1442740|NCT02237092|3531736|P1|STARTED|Overall Study||196
1442741|NCT02236767|3531753|P1|NOT COMPLETED|Overall Study||0
1442742|NCT02236767|3531753|P1|COMPLETED|Overall Study||1
1442743|NCT02236767|3531753|P1|STARTED|Overall Study||1
1442744|NCT02236611|3531759|P2|NOT COMPLETED|Overall Study||34
1442745|NCT02236611|3531760|P1|NOT COMPLETED|Overall Study||26
1442746|NCT02236611|3531759|P2|COMPLETED|Overall Study||484
1442747|NCT02236611|3531760|P1|COMPLETED|Overall Study||490
1442748|NCT02236611|3531759|P2|STARTED|Overall Study||518
1442749|NCT02236611|3531760|P1|STARTED|Overall Study||516
1442750|NCT02236598|3531768|P2|NOT COMPLETED|Overall Study||2
1442751|NCT02236598|3531769|P1|NOT COMPLETED|Overall Study||0
1442752|NCT02236598|3531768|P2|COMPLETED|Overall Study||12
1442753|NCT02236598|3531769|P1|COMPLETED|Overall Study||15
1442754|NCT02236598|3531768|P2|STARTED|Overall Study||14
1442755|NCT02236598|3531769|P1|STARTED|Overall Study||15
1442756|NCT02236546|3531781|P1|NOT COMPLETED|Overall Study||0
1442757|NCT02236546|3531781|P1|COMPLETED|Overall Study||3
1442758|NCT02236546|3531781|P1|STARTED|Overall Study||3
1442759|NCT02236338|3531790|P2|NOT COMPLETED|Overall Study||0
1442760|NCT02236338|3531791|P1|NOT COMPLETED|Overall Study||0
1442761|NCT02236338|3531790|P2|COMPLETED|Overall Study||100
1442762|NCT02236338|3531791|P1|COMPLETED|Overall Study||100
1442763|NCT02236338|3531790|P2|STARTED|Overall Study||100
1442764|NCT02236338|3531791|P1|STARTED|Overall Study||100
1442765|NCT02236130|3531805|P2|NOT COMPLETED|Overall Study||12
1442766|NCT02236130|3531806|P1|NOT COMPLETED|Overall Study||7
1442767|NCT02236130|3531805|P2|COMPLETED|Overall Study||15
1442768|NCT02236130|3531806|P1|COMPLETED|Overall Study||15
1442769|NCT02236130|3531805|P2|STARTED|Overall Study||27
1442770|NCT02236130|3531806|P1|STARTED|Overall Study||22
1442771|NCT02235987|3531814|P1|NOT COMPLETED|Overall Study||1
1442772|NCT02235987|3531814|P1|COMPLETED|Overall Study||19
1442773|NCT02235987|3531814|P1|Received 1800 µg DG3173|Overall Study||19
1442774|NCT02235987|3531814|P1|Received 900 µg DG3173|Overall Study||19
1442775|NCT02235987|3531814|P1|Received 300 µg DG3173|Overall Study||20
1442776|NCT02235987|3531814|P1|Received 100 µg DG3173|Overall Study||20
1442777|NCT02235987|3531814|P1|Received Octreotide|Overall Study||20
1442778|NCT02235987|3531814|P1|STARTED|Overall Study||20
1442779|NCT02235870|3531829|P2|NOT COMPLETED|Overall Study||61
1442780|NCT02235870|3531830|P1|NOT COMPLETED|Overall Study||38
1442781|NCT02235870|3531829|P2|COMPLETED|Overall Study||128
1442782|NCT02235870|3531830|P1|COMPLETED|Overall Study||160
1442783|NCT02235870|3531829|P2|Crossover (Week 24)|Overall Study||138
1442784|NCT02235870|3531830|P1|Crossover (Week 24)|Overall Study||170
1442785|NCT02235870|3531829|P2|Completed Phase I (Week 24)|Overall Study||179
1442786|NCT02235870|3531830|P1|Completed Phase I (Week 24)|Overall Study||182
1442787|NCT02235870|3531829|P2|STARTED|Overall Study||189
1442788|NCT02235870|3531830|P1|STARTED|Overall Study||198
1442789|NCT02235831|3531839|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1442790|NCT02235831|3531840|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1442791|NCT02235831|3531841|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1442792|NCT02235831|3531842|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1442793|NCT02235831|3531843|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1442794|NCT02235831|3531844|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
1442795|NCT02235831|3531839|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
1442796|NCT02235831|3531840|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
1442797|NCT02235831|3531841|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
1442798|NCT02235831|3531842|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
1442799|NCT02235831|3531843|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
1442800|NCT02235831|3531844|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
1442801|NCT02235831|3531839|P6|STARTED|Period 3, Third 5 Days of Wear||4
1442802|NCT02235831|3531840|P5|STARTED|Period 3, Third 5 Days of Wear||4
1442803|NCT02235831|3531841|P4|STARTED|Period 3, Third 5 Days of Wear||4
1442804|NCT02235831|3531842|P3|STARTED|Period 3, Third 5 Days of Wear||4
1442805|NCT02235831|3531843|P2|STARTED|Period 3, Third 5 Days of Wear||4
1442806|NCT02235831|3531844|P1|STARTED|Period 3, Third 5 Days of Wear||4
1442807|NCT02235831|3531839|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1442808|NCT02235831|3531840|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1442809|NCT02235831|3531841|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1442810|NCT02235831|3531842|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1442811|NCT02235831|3531843|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1442812|NCT02235831|3531844|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
1442813|NCT02235831|3531839|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
1442814|NCT02235831|3531840|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
1442815|NCT02235831|3531841|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
1442816|NCT02235831|3531842|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
1442817|NCT02235831|3531843|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
1442818|NCT02235831|3531844|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
1442819|NCT02235831|3531839|P6|STARTED|Period 2, Second 5 Days of Wear||4
1442820|NCT02235831|3531840|P5|STARTED|Period 2, Second 5 Days of Wear||4
1442821|NCT02235831|3531841|P4|STARTED|Period 2, Second 5 Days of Wear||4
1442822|NCT02235831|3531842|P3|STARTED|Period 2, Second 5 Days of Wear||4
1442823|NCT02235831|3531843|P2|STARTED|Period 2, Second 5 Days of Wear||4
1442824|NCT02235831|3531844|P1|STARTED|Period 2, Second 5 Days of Wear||4
1442825|NCT02235831|3531839|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1442826|NCT02235831|3531840|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1442827|NCT02235831|3531841|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1442828|NCT02235831|3531842|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1442829|NCT02235831|3531843|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1442830|NCT02235831|3531844|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
1442831|NCT02235831|3531839|P6|COMPLETED|Period 1, First 5 Days of Wear||4
1442832|NCT02235831|3531840|P5|COMPLETED|Period 1, First 5 Days of Wear||4
1442833|NCT02235831|3531841|P4|COMPLETED|Period 1, First 5 Days of Wear||4
1442834|NCT02235831|3531842|P3|COMPLETED|Period 1, First 5 Days of Wear||4
1442835|NCT02235831|3531843|P2|COMPLETED|Period 1, First 5 Days of Wear||4
1442836|NCT02235831|3531844|P1|COMPLETED|Period 1, First 5 Days of Wear||4
1442837|NCT02235831|3531839|P6|STARTED|Period 1, First 5 Days of Wear||4
1442838|NCT02235831|3531840|P5|STARTED|Period 1, First 5 Days of Wear||4
1442839|NCT02235831|3531841|P4|STARTED|Period 1, First 5 Days of Wear||4
1442840|NCT02235831|3531842|P3|STARTED|Period 1, First 5 Days of Wear||4
1442841|NCT02235831|3531843|P2|STARTED|Period 1, First 5 Days of Wear||4
1442842|NCT02235831|3531844|P1|STARTED|Period 1, First 5 Days of Wear||4
1442843|NCT02235493|3531851|P1|NOT COMPLETED|Overall Study||0
1442844|NCT02235493|3531851|P1|COMPLETED|Overall Study||6
1442845|NCT02235493|3531851|P1|STARTED|Overall Study||6
1442846|NCT02235454|3531856|P1|NOT COMPLETED|Overall Study||2
1442847|NCT02235454|3531856|P1|COMPLETED|Overall Study||55
1442848|NCT02235454|3531856|P1|STARTED|Overall Study||57
1442849|NCT02235311|3531862|P2|NOT COMPLETED|Overall Study||2
1442850|NCT02235311|3531863|P1|NOT COMPLETED|Overall Study||0
1442851|NCT02235311|3531862|P2|COMPLETED|Overall Study||0
1442852|NCT02235311|3531863|P1|COMPLETED|Overall Study||1
1442853|NCT02235311|3531862|P2|STARTED|Overall Study||2
1442854|NCT02235311|3531863|P1|STARTED|Overall Study||1
1442855|NCT02235285|3531875|P1|NOT COMPLETED|Overall Study||13
1442856|NCT02235285|3531875|P1|COMPLETED|Overall Study||149
1442857|NCT02235285|3531875|P1|STARTED|Overall Study||162
1442858|NCT02235077|3531881|P2|NOT COMPLETED|Overall Study||19
1442859|NCT02235077|3531882|P1|NOT COMPLETED|Overall Study||18
1442860|NCT02235077|3531881|P2|COMPLETED|Overall Study||159
1442861|NCT02235077|3531882|P1|COMPLETED|Overall Study||164
1442862|NCT02235077|3531881|P2|STARTED|Overall Study||178
1442863|NCT02235077|3531882|P1|STARTED|Overall Study||182
1442864|NCT02235064|3531910|P2|NOT COMPLETED|Overall Study||0
1442865|NCT02235064|3531911|P1|NOT COMPLETED|Overall Study||0
1442866|NCT02235064|3531910|P2|COMPLETED|Overall Study||1
1442867|NCT02235064|3531911|P1|COMPLETED|Overall Study||1
1442868|NCT02235064|3531910|P2|STARTED|Overall Study||1
1442869|NCT02235064|3531911|P1|STARTED|Overall Study||1
1442870|NCT02234752|3531937|P1|NOT COMPLETED|Overall Study||1
1442871|NCT02234752|3531937|P1|COMPLETED|Overall Study||2
1442872|NCT02234752|3531937|P1|STARTED|Overall Study||3
1442873|NCT02234687|3531951|P3|NOT COMPLETED|Overall Study||4
1442874|NCT02234687|3531952|P2|NOT COMPLETED|Overall Study||4
1442875|NCT02234687|3531953|P1|NOT COMPLETED|Overall Study||6
1442876|NCT02234687|3531951|P3|COMPLETED|Overall Study||0
1442877|NCT02234687|3531952|P2|COMPLETED|Overall Study||0
1442878|NCT02234687|3531953|P1|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
1442879|NCT02234687|3531951|P3|STARTED|Overall Study||4
1442880|NCT02234687|3531952|P2|STARTED|Overall Study||4
1442881|NCT02234687|3531953|P1|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
1442882|NCT02234479|3531963|P2|NOT COMPLETED|Overall Study||3
1442883|NCT02234479|3531964|P1|NOT COMPLETED|Overall Study||1
1442884|NCT02234479|3531963|P2|COMPLETED|Overall Study||15
1442885|NCT02234479|3531964|P1|COMPLETED|Overall Study||15
1442886|NCT02234479|3531963|P2|STARTED|Overall Study||18
1442887|NCT02234479|3531964|P1|STARTED|Overall Study||16
1442888|NCT02234427|3531970|P1|NOT COMPLETED|Overall Study||1
1442889|NCT02234427|3531970|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
1442890|NCT02234427|3531970|P1|STARTED|Overall Study||34
1442891|NCT02234362|3531974|P1|NOT COMPLETED|Overall Study||26
1442892|NCT02234362|3531974|P1|COMPLETED|Overall Study||21
1442893|NCT02234362|3531974|P1|Received at Least One Dose of Medication|Overall Study||27
1442894|NCT02234362|3531974|P1|STARTED|Overall Study||47
1442895|NCT02234180|3531991|P2|NOT COMPLETED|Overall Study||0
1442896|NCT02234180|3531992|P1|NOT COMPLETED|Overall Study||0
1442897|NCT02234180|3531991|P2|COMPLETED|Overall Study||1
1442898|NCT02234180|3531992|P1|COMPLETED|Overall Study||2
1442899|NCT02234180|3531991|P2|STARTED|Overall Study||1
1442900|NCT02234180|3531992|P1|STARTED|Overall Study||2
1442901|NCT02234115|3531998|P1|NOT COMPLETED|Overall Study||15
1442902|NCT02234115|3531998|P1|COMPLETED|Overall Study||122
1442903|NCT02234115|3531998|P1|PK Subgroup|Overall Study||31
1442904|NCT02234115|3531998|P1|PP|Overall Study||124
1442905|NCT02234115|3531998|P1|ITT|Overall Study||137
1442906|NCT02234115|3531998|P1|STARTED|Overall Study||137
1442907|NCT02234011|3532003|P1|NOT COMPLETED|Overall Study||0
1442908|NCT02234011|3532003|P1|COMPLETED|Overall Study||0
1442909|NCT02234011|3532003|P1|STARTED|Overall Study||0
1442910|NCT02233998|3532010|P3|NOT COMPLETED|Overall Study||0
1442911|NCT02233998|3532011|P2|NOT COMPLETED|Overall Study||0
1442912|NCT02233998|3532012|P1|NOT COMPLETED|Overall Study||0
1442913|NCT02233998|3532010|P3|COMPLETED|Overall Study||53
1442914|NCT02233998|3532011|P2|COMPLETED|Overall Study||52
1442915|NCT02233998|3532012|P1|COMPLETED|Overall Study||53
1442916|NCT02233998|3532010|P3|STARTED|Overall Study||53
1442917|NCT02233998|3532011|P2|STARTED|Overall Study||52
1442918|NCT02233998|3532012|P1|STARTED|Overall Study||53
1442919|NCT02233985|3532046|P2|NOT COMPLETED|Overall Study||0
1442920|NCT02233985|3532047|P1|NOT COMPLETED|Overall Study||0
1442921|NCT02233985|3532046|P2|COMPLETED|Overall Study||31
1442922|NCT02233985|3532047|P1|COMPLETED|Overall Study||33
1442923|NCT02233985|3532046|P2|STARTED|Overall Study||31
1442924|NCT02233985|3532047|P1|STARTED|Overall Study||33
1442925|NCT02233842|3532055|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
1442926|NCT02233842|3532055|P1|COMPLETED|Questionnaire 3 Version 2||5
1442927|NCT02233842|3532055|P1|STARTED|Questionnaire 3 Version 2||5
1442928|NCT02233842|3532055|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
1442929|NCT02233842|3532055|P1|COMPLETED|Questionnaire 3 Version 1||5
1442930|NCT02233842|3532055|P1|STARTED|Questionnaire 3 Version 1||5
1442931|NCT02233842|3532055|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
1442932|NCT02233842|3532055|P1|COMPLETED|Questionnaire 2 Version 2||5
1442933|NCT02233842|3532055|P1|STARTED|Questionnaire 2 Version 2||5
1442934|NCT02233842|3532055|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
1442935|NCT02233842|3532055|P1|COMPLETED|Questionnaire 2 Version 1||5
1442936|NCT02233842|3532055|P1|STARTED|Questionnaire 2 Version 1||5
1442937|NCT02233842|3532055|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
1442938|NCT02233842|3532055|P1|COMPLETED|Questionnaire 1 Version 2||5
1442939|NCT02233842|3532055|P1|STARTED|Questionnaire 1 Version 2||5
1442940|NCT02233842|3532055|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
1442941|NCT02233842|3532055|P1|COMPLETED|Questionnaire 1 Version 1||5
1442942|NCT02233842|3532055|P1|STARTED|Questionnaire 1 Version 1||5
1442943|NCT02233803|3532062|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
1442944|NCT02233803|3532063|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
1442945|NCT02233803|3532062|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
1442946|NCT02233803|3532063|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
1442947|NCT02233803|3532062|P2|STARTED|Treatment Period 2 (4-Wks)||93
1442948|NCT02233803|3532063|P1|STARTED|Treatment Period 2 (4-Wks)||95
1442949|NCT02233803|3532062|P2|NOT COMPLETED|Washout Period (4-Wks)||2
1442950|NCT02233803|3532063|P1|NOT COMPLETED|Washout Period (4-Wks)||2
1442951|NCT02233803|3532062|P2|COMPLETED|Washout Period (4-Wks)||93
1442952|NCT02233803|3532063|P1|COMPLETED|Washout Period (4-Wks)||95
1442953|NCT02233803|3532062|P2|STARTED|Washout Period (4-Wks)||95
1442954|NCT02233803|3532063|P1|STARTED|Washout Period (4-Wks)||97
1442955|NCT02233803|3532062|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
1442956|NCT02233803|3532063|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
1442957|NCT02233803|3532062|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
1442958|NCT02233803|3532063|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
1442959|NCT02233803|3532062|P2|STARTED|Treatment Period 1 (4-Wks)||99
1442960|NCT02233803|3532063|P1|STARTED|Treatment Period 1 (4-Wks)||100
1442961|NCT02233647|3532073|P1|NOT COMPLETED|Overall Study||1
1442962|NCT02233647|3532073|P1|COMPLETED|Overall Study||10
1442963|NCT02233647|3532073|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
1442964|NCT02233647|3532073|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
1442965|NCT02233647|3532073|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
1442966|NCT02233647|3532073|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
1442967|NCT02233647|3532073|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
1442968|NCT02233647|3532073|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
1442969|NCT02233647|3532073|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
1442970|NCT02233647|3532073|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
1442971|NCT02233647|3532073|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
1442972|NCT02233647|3532073|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
1442973|NCT02233647|3532073|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1442974|NCT02233647|3532073|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1442975|NCT02233647|3532073|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1442976|NCT02233647|3532073|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1442977|NCT02233647|3532073|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
1442978|NCT02233647|3532073|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
1442979|NCT02233647|3532073|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
1442980|NCT02233647|3532073|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
1442981|NCT02233647|3532073|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
1442982|NCT02233647|3532073|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
1442983|NCT02233647|3532073|P1|STARTED|Overall Study||11
1442984|NCT02233543|3532102|P2|NOT COMPLETED|Period 2||1
1442985|NCT02233543|3532103|P1|NOT COMPLETED|Period 2||2
1442986|NCT02233543|3532102|P2|COMPLETED|Period 2||12
1442987|NCT02233543|3532103|P1|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
1442988|NCT02233543|3532102|P2|STARTED|Period 2||13
1442989|NCT02233543|3532103|P1|STARTED|Period 2||19
1442990|NCT02233543|3532102|P2|NOT COMPLETED|Period 1||3
1442991|NCT02233543|3532103|P1|NOT COMPLETED|Period 1||3
1442992|NCT02233543|3532102|P2|COMPLETED|Period 1||13
1442993|NCT02233543|3532103|P1|COMPLETED|Period 1||19
1442994|NCT02233543|3532102|P2|STARTED|Period 1||16
1442995|NCT02233543|3532103|P1|STARTED|Period 1||22
1442996|NCT02233309|3532111|P1|NOT COMPLETED|Overall Study||5
1442997|NCT02233309|3532111|P1|COMPLETED|Overall Study||31
1442998|NCT02233309|3532111|P1|STARTED|Overall Study||36
1442999|NCT02233296|3532117|P2|NOT COMPLETED|Overall Study||0
1443000|NCT02233296|3532118|P1|NOT COMPLETED|Overall Study||0
1443001|NCT02233296|3532117|P2|COMPLETED|Overall Study||14
1443002|NCT02233296|3532118|P1|COMPLETED|Overall Study||16
1443003|NCT02233296|3532117|P2|STARTED|Overall Study||14
1443004|NCT02233296|3532118|P1|STARTED|Overall Study||16
1443005|NCT02233101|3532136|P2|NOT COMPLETED|Overall Study||1
1443006|NCT02233101|3532137|P1|NOT COMPLETED|Overall Study||12
1443007|NCT02233101|3532136|P2|COMPLETED|Overall Study||80
1443008|NCT02233101|3532137|P1|COMPLETED|Overall Study||74
1443009|NCT02233101|3532136|P2|STARTED|Overall Study||81
1443010|NCT02233101|3532137|P1|STARTED|Overall Study||86
1443011|NCT02232880|3532145|P1|NOT COMPLETED|Overall Study||1
1443012|NCT02232880|3532145|P1|COMPLETED|Overall Study||0
1443013|NCT02232880|3532145|P1|STARTED|Overall Study||1
1443014|NCT02232698|3532154|P2|NOT COMPLETED|Overall Study||20
1443015|NCT02232698|3532155|P1|NOT COMPLETED|Overall Study||10
1443016|NCT02232698|3532154|P2|COMPLETED|Overall Study||101
1443017|NCT02232698|3532155|P1|COMPLETED|Overall Study||110
1443018|NCT02232698|3532154|P2|STARTED|Overall Study||121
1443019|NCT02232698|3532155|P1|STARTED|Overall Study||120
1443020|NCT02232178|3532179|P3|NOT COMPLETED|Overall Study||1
1443021|NCT02232178|3532180|P2|NOT COMPLETED|Overall Study||1
1443022|NCT02232178|3532181|P1|NOT COMPLETED|Overall Study||1
1443023|NCT02232178|3532179|P3|COMPLETED|Overall Study||12
1443024|NCT02232178|3532180|P2|COMPLETED|Overall Study||24
1443025|NCT02232178|3532181|P1|COMPLETED|Overall Study||25
1443026|NCT02232178|3532179|P3|Safety Population|Overall Study||12
1443027|NCT02232178|3532180|P2|Safety Population|Overall Study||24
1443028|NCT02232178|3532181|P1|Safety Population|Overall Study||26
1443029|NCT02232178|3532179|P3|Per Protocol PK Population|Overall Study||11
1443030|NCT02232178|3532180|P2|Per Protocol PK Population|Overall Study||24
1443031|NCT02232178|3532181|P1|Per Protocol PK Population|Overall Study||26
1443032|NCT02232178|3532179|P3|STARTED|Overall Study||13
1443033|NCT02232178|3532180|P2|STARTED|Overall Study||25
1443034|NCT02232178|3532181|P1|STARTED|Overall Study||26
1443035|NCT02232126|3532200|P2|NOT COMPLETED|Overall Study||0
1443036|NCT02232126|3532201|P1|NOT COMPLETED|Overall Study||0
1443037|NCT02232126|3532200|P2|COMPLETED|Overall Study||90
1443038|NCT02232126|3532201|P1|COMPLETED|Overall Study||91
1443039|NCT02232126|3532200|P2|STARTED|Overall Study||90
1443040|NCT02232126|3532201|P1|STARTED|Overall Study||91
1443041|NCT02231918|3532212|P3|NOT COMPLETED|Overall Study||1
1443042|NCT02231918|3532213|P2|NOT COMPLETED|Overall Study||1
1443043|NCT02231918|3532214|P1|NOT COMPLETED|Overall Study||0
1443044|NCT02231918|3532212|P3|COMPLETED|Overall Study||1
1443045|NCT02231918|3532213|P2|COMPLETED|Overall Study||14
1443046|NCT02231918|3532214|P1|COMPLETED|Overall Study||9
1443047|NCT02231918|3532212|P3|STARTED|Overall Study||2
1443048|NCT02231918|3532213|P2|STARTED|Overall Study||15
1443049|NCT02231918|3532214|P1|STARTED|Overall Study||9
1443050|NCT02231749|3532278|P2|NOT COMPLETED|Overall Study||449
1443051|NCT02231749|3532279|P1|NOT COMPLETED|Overall Study||422
1443052|NCT02231749|3532278|P2|COMPLETED|Overall Study||97
1443053|NCT02231749|3532279|P1|COMPLETED|Overall Study||128
1443054|NCT02231749|3532278|P2|Received Treatment|Overall Study||535
1443055|NCT02231749|3532279|P1|Received Treatment|Overall Study||547
1443056|NCT02231749|3532278|P2|STARTED|Overall Study||546
1443057|NCT02231749|3532279|P1|STARTED|Overall Study||550
1443058|NCT02231580|3532297|P2|NOT COMPLETED|Overall Study||0
1443059|NCT02231580|3532298|P1|NOT COMPLETED|Overall Study||5
1443060|NCT02231580|3532297|P2|COMPLETED|Overall Study||3
1443061|NCT02231580|3532298|P1|COMPLETED|Overall Study||9
1443062|NCT02231580|3532297|P2|Cohort 2|Overall Study||1
1443063|NCT02231580|3532298|P1|Cohort 2|Overall Study||6
1443064|NCT02231580|3532297|P2|Cohort 1|Overall Study||2
1443065|NCT02231580|3532298|P1|Cohort 1|Overall Study||8
1443066|NCT02231580|3532297|P2|STARTED|Overall Study||3
1443067|NCT02231580|3532298|P1|STARTED|Overall Study||14
1443068|NCT02231177|3532354|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1443069|NCT02231177|3532355|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1443070|NCT02231177|3532356|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1443071|NCT02231177|3532357|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1443072|NCT02231177|3532358|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1443073|NCT02231177|3532359|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
1443074|NCT02231177|3532354|P6|COMPLETED|Treatment Period 3 (21 Days)||9
1443075|NCT02231177|3532355|P5|COMPLETED|Treatment Period 3 (21 Days)||8
1443076|NCT02231177|3532356|P4|COMPLETED|Treatment Period 3 (21 Days)||7
1443077|NCT02231177|3532357|P3|COMPLETED|Treatment Period 3 (21 Days)||8
1443078|NCT02231177|3532358|P2|COMPLETED|Treatment Period 3 (21 Days)||7
1443079|NCT02231177|3532359|P1|COMPLETED|Treatment Period 3 (21 Days)||8
1443080|NCT02231177|3532354|P6|STARTED|Treatment Period 3 (21 Days)||9
1443081|NCT02231177|3532355|P5|STARTED|Treatment Period 3 (21 Days)||8
1443082|NCT02231177|3532356|P4|STARTED|Treatment Period 3 (21 Days)||7
1443083|NCT02231177|3532357|P3|STARTED|Treatment Period 3 (21 Days)||8
1443084|NCT02231177|3532358|P2|STARTED|Treatment Period 3 (21 Days)||7
1443085|NCT02231177|3532359|P1|STARTED|Treatment Period 3 (21 Days)||8
1443086|NCT02231177|3532354|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1443087|NCT02231177|3532355|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1443088|NCT02231177|3532356|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1443089|NCT02231177|3532357|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1443090|NCT02231177|3532358|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1443091|NCT02231177|3532359|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
1443092|NCT02231177|3532354|P6|COMPLETED|Treatment Period 2 (21 Days)||9
1443093|NCT02231177|3532355|P5|COMPLETED|Treatment Period 2 (21 Days)||8
1443094|NCT02231177|3532356|P4|COMPLETED|Treatment Period 2 (21 Days)||7
1443095|NCT02231177|3532357|P3|COMPLETED|Treatment Period 2 (21 Days)||8
1443096|NCT02231177|3532358|P2|COMPLETED|Treatment Period 2 (21 Days)||7
1443097|NCT02231177|3532359|P1|COMPLETED|Treatment Period 2 (21 Days)||8
1443098|NCT02231177|3532354|P6|STARTED|Treatment Period 2 (21 Days)||9
1443099|NCT02231177|3532355|P5|STARTED|Treatment Period 2 (21 Days)||8
1443100|NCT02231177|3532356|P4|STARTED|Treatment Period 2 (21 Days)||7
1443101|NCT02231177|3532357|P3|STARTED|Treatment Period 2 (21 Days)||8
1443102|NCT02231177|3532358|P2|STARTED|Treatment Period 2 (21 Days)||7
1443103|NCT02231177|3532359|P1|STARTED|Treatment Period 2 (21 Days)||8
1443104|NCT02231177|3532354|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1443105|NCT02231177|3532355|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1443106|NCT02231177|3532356|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1443107|NCT02231177|3532357|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1443108|NCT02231177|3532358|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1443109|NCT02231177|3532359|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
1443110|NCT02231177|3532354|P6|COMPLETED|Treatment Period 1 (21 Days)||9
1443111|NCT02231177|3532355|P5|COMPLETED|Treatment Period 1 (21 Days)||8
1443112|NCT02231177|3532356|P4|COMPLETED|Treatment Period 1 (21 Days)||7
1443113|NCT02231177|3532357|P3|COMPLETED|Treatment Period 1 (21 Days)||8
1443114|NCT02231177|3532358|P2|COMPLETED|Treatment Period 1 (21 Days)||7
1443115|NCT02231177|3532359|P1|COMPLETED|Treatment Period 1 (21 Days)||8
1443116|NCT02231177|3532354|P6|STARTED|Treatment Period 1 (21 Days)||9
1443117|NCT02231177|3532355|P5|STARTED|Treatment Period 1 (21 Days)||8
1443118|NCT02231177|3532356|P4|STARTED|Treatment Period 1 (21 Days)||7
1443119|NCT02231177|3532357|P3|STARTED|Treatment Period 1 (21 Days)||8
1443120|NCT02231177|3532358|P2|STARTED|Treatment Period 1 (21 Days)||7
1443121|NCT02231177|3532359|P1|STARTED|Treatment Period 1 (21 Days)||8
1443122|NCT02231164|3532415|P2|NOT COMPLETED|Overall Study||6
1443123|NCT02231164|3532416|P1|NOT COMPLETED|Overall Study||6
1443124|NCT02231164|3532415|P2|COMPLETED|Overall Study||0
1443125|NCT02231164|3532416|P1|COMPLETED|Overall Study||0
1443126|NCT02231164|3532415|P2|STARTED|Overall Study||6
1443127|NCT02231164|3532416|P1|STARTED|Overall Study||6
1443128|NCT02230995|3532424|P2|NOT COMPLETED|Period 2 + Washout||0
1443129|NCT02230995|3532425|P1|NOT COMPLETED|Period 2 + Washout||0
1443130|NCT02230995|3532424|P2|COMPLETED|Period 2 + Washout||15
1443131|NCT02230995|3532425|P1|COMPLETED|Period 2 + Washout||15
1443132|NCT02230995|3532424|P2|STARTED|Period 2 + Washout||15
1443133|NCT02230995|3532425|P1|STARTED|Period 2 + Washout||15
1443134|NCT02230995|3532424|P2|NOT COMPLETED|Period 1 + Washout||0
1443135|NCT02230995|3532425|P1|NOT COMPLETED|Period 1 + Washout||0
1443136|NCT02230995|3532424|P2|COMPLETED|Period 1 + Washout||15
1443137|NCT02230995|3532425|P1|COMPLETED|Period 1 + Washout||15
1443138|NCT02230995|3532424|P2|STARTED|Period 1 + Washout||15
1443139|NCT02230995|3532425|P1|STARTED|Period 1 + Washout||15
1443140|NCT02230956|3532444|P3|NOT COMPLETED|Overall Study||7
1443141|NCT02230956|3532445|P2|NOT COMPLETED|Overall Study||6
1443142|NCT02230956|3532446|P1|NOT COMPLETED|Overall Study||5
1443143|NCT02230956|3532444|P3|COMPLETED|Overall Study||82
1443144|NCT02230956|3532445|P2|COMPLETED|Overall Study||37
1443145|NCT02230956|3532446|P1|COMPLETED|Overall Study||39
1443146|NCT02230956|3532444|P3|STARTED|Overall Study||89
1443147|NCT02230956|3532445|P2|STARTED|Overall Study||43
1443148|NCT02230956|3532446|P1|STARTED|Overall Study||44
1443149|NCT02230904|3532468|P2|NOT COMPLETED|Overall Study||1
1443150|NCT02230904|3532469|P1|NOT COMPLETED|Overall Study||0
1443151|NCT02230904|3532468|P2|COMPLETED|Overall Study||27
1443152|NCT02230904|3532469|P1|COMPLETED|Overall Study||29
1443153|NCT02230904|3532468|P2|STARTED|Overall Study||28
1443154|NCT02230904|3532469|P1|STARTED|Overall Study||29
1443155|NCT02230761|3532491|P2|NOT COMPLETED|Overall Study||1
1443156|NCT02230761|3532492|P1|NOT COMPLETED|Overall Study||0
1443157|NCT02230761|3532491|P2|COMPLETED|Overall Study||29
1443158|NCT02230761|3532492|P1|COMPLETED|Overall Study||60
1443159|NCT02230761|3532491|P2|STARTED|Overall Study||30
1443160|NCT02230761|3532492|P1|STARTED|Overall Study||60
1443161|NCT02230683|3532502|P1|NOT COMPLETED|Overall Study||1
1443162|NCT02230683|3532502|P1|COMPLETED|Overall Study||22
1443163|NCT02230683|3532502|P1|STARTED|Overall Study||23
1443164|NCT02230670|3532519|P2|NOT COMPLETED|Overall Study||8
1443165|NCT02230670|3532520|P1|NOT COMPLETED|Overall Study||4
1443166|NCT02230670|3532519|P2|COMPLETED|Overall Study||34
1443167|NCT02230670|3532520|P1|COMPLETED|Overall Study||40
1443168|NCT02230670|3532519|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
1443169|NCT02230670|3532520|P1|STARTED|Overall Study||44
1443170|NCT02230579|3532537|P7|NOT COMPLETED|Overall Study||0
1443171|NCT02230579|3532538|P6|NOT COMPLETED|Overall Study||0
1443172|NCT02230579|3532539|P5|NOT COMPLETED|Overall Study||0
1443173|NCT02230579|3532540|P4|NOT COMPLETED|Overall Study||0
1443174|NCT02230579|3532541|P3|NOT COMPLETED|Overall Study||0
1443175|NCT02230579|3532542|P2|NOT COMPLETED|Overall Study||0
1443176|NCT02230579|3532543|P1|NOT COMPLETED|Overall Study||0
1443177|NCT02230579|3532537|P7|COMPLETED|Overall Study||12
1443178|NCT02230579|3532538|P6|COMPLETED|Overall Study||6
1443179|NCT02230579|3532539|P5|COMPLETED|Overall Study||6
1443180|NCT02230579|3532540|P4|COMPLETED|Overall Study||6
1443181|NCT02230579|3532541|P3|COMPLETED|Overall Study||6
1443182|NCT02230579|3532542|P2|COMPLETED|Overall Study||6
1443183|NCT02230579|3532543|P1|COMPLETED|Overall Study||6
1443184|NCT02230579|3532537|P7|STARTED|Overall Study||12
1443185|NCT02230579|3532538|P6|STARTED|Overall Study||6
1443186|NCT02230579|3532539|P5|STARTED|Overall Study||6
1443187|NCT02230579|3532540|P4|STARTED|Overall Study||6
1443188|NCT02230579|3532541|P3|STARTED|Overall Study||6
1443189|NCT02230579|3532542|P2|STARTED|Overall Study||6
1443190|NCT02230579|3532543|P1|STARTED|Overall Study||6
1443191|NCT02230566|3532581|P4|NOT COMPLETED|Overall Study||0
1443192|NCT02230566|3532582|P3|NOT COMPLETED|Overall Study||0
1443193|NCT02230566|3532583|P2|NOT COMPLETED|Overall Study||0
1443194|NCT02230566|3532584|P1|NOT COMPLETED|Overall Study||0
1443195|NCT02230566|3532581|P4|COMPLETED|Overall Study||3
1443196|NCT02230566|3532582|P3|COMPLETED|Overall Study||3
1443197|NCT02230566|3532583|P2|COMPLETED|Overall Study||3
1443198|NCT02230566|3532584|P1|COMPLETED|Overall Study||3
1443199|NCT02230566|3532581|P4|STARTED|Overall Study||3
1443200|NCT02230566|3532582|P3|STARTED|Overall Study||3
1443201|NCT02230566|3532583|P2|STARTED|Overall Study||3
1443202|NCT02230566|3532584|P1|STARTED|Overall Study||3
1443203|NCT02230540|3532599|P2|NOT COMPLETED|Overall Study||0
1443204|NCT02230540|3532600|P1|NOT COMPLETED|Overall Study||0
1443205|NCT02230540|3532599|P2|COMPLETED|Overall Study||0
1443206|NCT02230540|3532600|P1|COMPLETED|Overall Study||8
1443207|NCT02230540|3532599|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
1443208|NCT02230540|3532600|P1|STARTED|Overall Study||8
1443209|NCT02230384|3532606|P2|NOT COMPLETED|Phase 2 Wash Out||0
1443210|NCT02230384|3532607|P1|NOT COMPLETED|Phase 2 Wash Out||0
1443211|NCT02230384|3532606|P2|COMPLETED|Phase 2 Wash Out||30
1443212|NCT02230384|3532607|P1|COMPLETED|Phase 2 Wash Out||26
1443213|NCT02230384|3532606|P2|STARTED|Phase 2 Wash Out||30
1443214|NCT02230384|3532607|P1|STARTED|Phase 2 Wash Out||26
1443215|NCT02230384|3532606|P2|NOT COMPLETED|Phase 2 - Switch||1
1443216|NCT02230384|3532607|P1|NOT COMPLETED|Phase 2 - Switch||3
1443217|NCT02230384|3532606|P2|COMPLETED|Phase 2 - Switch||30
1443218|NCT02230384|3532607|P1|COMPLETED|Phase 2 - Switch||26
1443219|NCT02230384|3532606|P2|STARTED|Phase 2 - Switch||31
1443220|NCT02230384|3532607|P1|STARTED|Phase 2 - Switch||29
1443221|NCT02230384|3532606|P2|NOT COMPLETED|Phase 1 Wash Out||0
1443222|NCT02230384|3532607|P1|NOT COMPLETED|Phase 1 Wash Out||0
1443223|NCT02230384|3532606|P2|COMPLETED|Phase 1 Wash Out||31
1443224|NCT02230384|3532607|P1|COMPLETED|Phase 1 Wash Out||29
1443225|NCT02230384|3532606|P2|STARTED|Phase 1 Wash Out|Cross over study|31
1443226|NCT02230384|3532607|P1|STARTED|Phase 1 Wash Out||29
1443227|NCT02230384|3532606|P2|NOT COMPLETED|Phase 1||1
1443228|NCT02230384|3532607|P1|NOT COMPLETED|Phase 1||1
1443229|NCT02230384|3532606|P2|COMPLETED|Phase 1||31
1443230|NCT02230384|3532607|P1|COMPLETED|Phase 1||29
1443231|NCT02230384|3532606|P2|STARTED|Phase 1||32
1443232|NCT02230384|3532607|P1|STARTED|Phase 1||30
1443233|NCT02230332|3532615|P2|NOT COMPLETED|Overall Study||1
1443234|NCT02230332|3532616|P1|NOT COMPLETED|Overall Study||4
1443235|NCT02230332|3532615|P2|COMPLETED|Overall Study||39
1443236|NCT02230332|3532616|P1|COMPLETED|Overall Study||34
1443237|NCT02230332|3532615|P2|STARTED|Overall Study||40
1443238|NCT02230332|3532616|P1|STARTED|Overall Study||38
1443239|NCT02230306|3532632|P1|NOT COMPLETED|Overall Study||1
1443240|NCT02230306|3532632|P1|COMPLETED|Overall Study||4
1443241|NCT02230306|3532632|P1|STARTED|Overall Study||5
1443242|NCT02230085|3532643|P1|NOT COMPLETED|Overall Study||4
1443243|NCT02230085|3532643|P1|COMPLETED|Overall Study||106
1443244|NCT02230085|3532643|P1|STARTED|Overall Study||110
1443245|NCT02229864|3532647|P1|NOT COMPLETED|3 - Year Visit||2
1443246|NCT02229864|3532647|P1|COMPLETED|3 - Year Visit||10
1443247|NCT02229864|3532647|P1|STARTED|3 - Year Visit|The missed visit participant in the 2nd year has joined the study for 3rd year follow-up.|12
1443248|NCT02229864|3532647|P1|NOT COMPLETED|2 - Year Visit||1
1443249|NCT02229864|3532647|P1|COMPLETED|2 - Year Visit||11
1443250|NCT02229864|3532647|P1|STARTED|2 - Year Visit||12
1443251|NCT02229864|3532647|P1|NOT COMPLETED|1 - Year Visit||0
1443252|NCT02229864|3532647|P1|COMPLETED|1 - Year Visit||12
1443253|NCT02229864|3532647|P1|STARTED|1 - Year Visit||12
1443254|NCT02229864|3532647|P1|NOT COMPLETED|6 - Month Visit||0
1443255|NCT02229864|3532647|P1|COMPLETED|6 - Month Visit||12
1443256|NCT02229864|3532647|P1|STARTED|6 - Month Visit||12
1443257|NCT02229864|3532647|P1|NOT COMPLETED|1 - Month Visit||0
1443258|NCT02229864|3532647|P1|COMPLETED|1 - Month Visit||12
1443259|NCT02229864|3532647|P1|STARTED|1 - Month Visit||12
1443260|NCT02229539|3532702|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
1443261|NCT02229539|3532703|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
1443262|NCT02229539|3532704|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
1443263|NCT02229539|3532702|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
1443264|NCT02229539|3532703|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
1443265|NCT02229539|3532704|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
1443266|NCT02229539|3532702|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
1443267|NCT02229539|3532703|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
1443268|NCT02229539|3532704|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
1443269|NCT02229539|3532702|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
1443270|NCT02229539|3532703|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
1443271|NCT02229539|3532704|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
1443272|NCT02229539|3532702|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
1443273|NCT02229539|3532703|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
1443274|NCT02229539|3532704|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
1443275|NCT02229539|3532702|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
1443276|NCT02229539|3532703|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
1443277|NCT02229539|3532704|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
1443278|NCT02229513|3532714|P2|NOT COMPLETED|Overall Study||0
1443279|NCT02229513|3532715|P1|NOT COMPLETED|Overall Study||0
1443280|NCT02229513|3532714|P2|COMPLETED|Overall Study||100
1443281|NCT02229513|3532715|P1|COMPLETED|Overall Study||100
1443282|NCT02229513|3532714|P2|STARTED|Overall Study||100
1443283|NCT02229513|3532715|P1|STARTED|Overall Study||100
1443284|NCT02229487|3532751|P2|NOT COMPLETED|Overall Study||0
1443285|NCT02229487|3532752|P1|NOT COMPLETED|Overall Study||0
1443286|NCT02229487|3532751|P2|COMPLETED|Overall Study||27
1443287|NCT02229487|3532752|P1|COMPLETED|Overall Study||24
1443288|NCT02229487|3532751|P2|STARTED|Overall Study||27
1443289|NCT02229487|3532752|P1|STARTED|Overall Study||24
1443290|NCT02229474|3532760|P2|NOT COMPLETED|Overall Study||3
1443291|NCT02229474|3532761|P1|NOT COMPLETED|Overall Study||0
1443292|NCT02229474|3532760|P2|COMPLETED|Overall Study||15
1443293|NCT02229474|3532761|P1|COMPLETED|Overall Study||16
1443294|NCT02229474|3532760|P2|STARTED|Overall Study||18
1443295|NCT02229474|3532761|P1|STARTED|Overall Study||16
1443296|NCT02229461|3532794|P6|NOT COMPLETED|Overall Study||0
1443297|NCT02229461|3532795|P5|NOT COMPLETED|Overall Study||0
1443298|NCT02229461|3532796|P4|NOT COMPLETED|Overall Study||0
1443299|NCT02229461|3532797|P3|NOT COMPLETED|Overall Study||0
1443300|NCT02229461|3532798|P2|NOT COMPLETED|Overall Study||0
1443301|NCT02229461|3532799|P1|NOT COMPLETED|Overall Study||0
1443302|NCT02229461|3532794|P6|COMPLETED|Overall Study||17
1443303|NCT02229461|3532795|P5|COMPLETED|Overall Study||17
1443304|NCT02229461|3532796|P4|COMPLETED|Overall Study||17
1443305|NCT02229461|3532797|P3|COMPLETED|Overall Study||17
1443306|NCT02229461|3532798|P2|COMPLETED|Overall Study||17
1443307|NCT02229461|3532799|P1|COMPLETED|Overall Study||17
1443308|NCT02229461|3532794|P6|STARTED|Overall Study|Randomized and received treatment|17
1443309|NCT02229461|3532795|P5|STARTED|Overall Study|Randomized and received treatment|17
1443310|NCT02229461|3532796|P4|STARTED|Overall Study|Randomized and received treatment|17
1443311|NCT02229461|3532797|P3|STARTED|Overall Study|Randomized and received treatment|17
1443312|NCT02229461|3532798|P2|STARTED|Overall Study|Randomized and received treatment|17
1443313|NCT02229461|3532799|P1|STARTED|Overall Study|Randomized and received treatment|17
1443314|NCT02229396|3532835|P3|NOT COMPLETED|Overall Study||95
1443315|NCT02229396|3532836|P2|NOT COMPLETED|Overall Study||77
1443316|NCT02229396|3532837|P1|NOT COMPLETED|Overall Study||78
1443317|NCT02229396|3532835|P3|COMPLETED|Overall Study||136
1443318|NCT02229396|3532836|P2|COMPLETED|Overall Study||154
1443319|NCT02229396|3532837|P1|COMPLETED|Overall Study||155
1443320|NCT02229396|3532835|P3|Completed 52-Week Study Period|Overall Study||177
1443321|NCT02229396|3532836|P2|Completed 52-Week Study Period|Overall Study||193
1443322|NCT02229396|3532837|P1|Completed 52-Week Study Period|Overall Study||194
1443323|NCT02229396|3532835|P3|Completed 28-Week Study Period|Overall Study||193
1443324|NCT02229396|3532836|P2|Completed 28-Week Study Period|Overall Study||202
1443325|NCT02229396|3532837|P1|Completed 28-Week Study Period|Overall Study||208
1443326|NCT02229396|3532835|P3|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
1443327|NCT02229396|3532836|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
1443328|NCT02229396|3532837|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
1443329|NCT02229396|3532835|P3|Safety Analysis Set|Overall Study||230
1443330|NCT02229396|3532836|P2|Safety Analysis Set|Overall Study||231
1443331|NCT02229396|3532837|P1|Safety Analysis Set|Overall Study||233
1443332|NCT02229396|3532835|P3|Randomization Code Allocated|Overall Study||231
1443333|NCT02229396|3532836|P2|Randomization Code Allocated|Overall Study||231
1443334|NCT02229396|3532837|P1|Randomization Code Allocated|Overall Study||233
1443335|NCT02229396|3532835|P3|STARTED|Overall Study||231
1443336|NCT02229396|3532836|P2|STARTED|Overall Study||231
1443337|NCT02229396|3532837|P1|STARTED|Overall Study||233
1443338|NCT02229383|3532868|P2|NOT COMPLETED|Overall Study||24
1443339|NCT02229383|3532869|P1|NOT COMPLETED|Overall Study||22
1443340|NCT02229383|3532868|P2|COMPLETED|Overall Study||207
1443341|NCT02229383|3532869|P1|COMPLETED|Overall Study||211
1443342|NCT02229383|3532868|P2|ITT Analysis Set|Overall Study||230
1443343|NCT02229383|3532869|P1|ITT Analysis Set|Overall Study||231
1443344|NCT02229383|3532868|P2|Safety Analysis Set|Overall Study||231
1443345|NCT02229383|3532869|P1|Safety Analysis Set|Overall Study||232
1443346|NCT02229383|3532868|P2|Received Treatment|Overall Study||231
1443347|NCT02229383|3532869|P1|Received Treatment|Overall Study||232
1443348|NCT02229383|3532868|P2|STARTED|Overall Study||231
1443349|NCT02229383|3532869|P1|STARTED|Overall Study||233
1443350|NCT02229318|3532887|P1|NOT COMPLETED|Overall Study||0
1443351|NCT02229318|3532887|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
1443352|NCT02229318|3532887|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
1443353|NCT02229227|3532894|P2|NOT COMPLETED|Overall Study||62
1443354|NCT02229227|3532895|P1|NOT COMPLETED|Overall Study||51
1443355|NCT02229227|3532894|P2|COMPLETED|Overall Study||350
1443356|NCT02229227|3532895|P1|COMPLETED|Overall Study||351
1443357|NCT02229227|3532894|P2|STARTED|Overall Study||412
1443358|NCT02229227|3532895|P1|STARTED|Overall Study||402
1443359|NCT02229214|3532980|P2|NOT COMPLETED|Overall Study||0
1443360|NCT02229214|3532981|P1|NOT COMPLETED|Overall Study||6
1443361|NCT02229214|3532980|P2|COMPLETED|Overall Study||10
1443362|NCT02229214|3532981|P1|COMPLETED|Overall Study||35
1443363|NCT02229214|3532980|P2|STARTED|Overall Study||10
1443364|NCT02229214|3532981|P1|STARTED|Overall Study||41
1443365|NCT02228980|3533005|P4|NOT COMPLETED|Overall Study||3
1443366|NCT02228980|3533006|P3|NOT COMPLETED|Overall Study||2
1443367|NCT02228980|3533007|P2|NOT COMPLETED|Overall Study||3
1443368|NCT02228980|3533008|P1|NOT COMPLETED|Overall Study||24
1443369|NCT02228980|3533005|P4|COMPLETED|Overall Study||148
1443370|NCT02228980|3533006|P3|COMPLETED|Overall Study||149
1443371|NCT02228980|3533007|P2|COMPLETED|Overall Study||147
1443372|NCT02228980|3533008|P1|COMPLETED|Overall Study||126
1443373|NCT02228980|3533005|P4|STARTED|Overall Study||151
1443374|NCT02228980|3533006|P3|STARTED|Overall Study||151
1443375|NCT02228980|3533007|P2|STARTED|Overall Study||150
1443376|NCT02228980|3533008|P1|STARTED|Overall Study||150
1443377|NCT02228824|3533032|P2|NOT COMPLETED|Overall Study||22
1443378|NCT02228824|3533033|P1|NOT COMPLETED|Overall Study||29
1443379|NCT02228824|3533032|P2|COMPLETED|Overall Study||98
1443380|NCT02228824|3533033|P1|COMPLETED|Overall Study||89
1443381|NCT02228824|3533032|P2|STARTED|Overall Study||120
1443382|NCT02228824|3533033|P1|STARTED|Overall Study||118
1443383|NCT02228720|3533047|P1|NOT COMPLETED|Open Label - Day 90||0
1443384|NCT02228720|3533047|P1|COMPLETED|Open Label - Day 90||14
1443385|NCT02228720|3533047|P1|STARTED|Open Label - Day 90||14
1443386|NCT02228720|3533047|P1|NOT COMPLETED|Open Label - Day 30||1
1443387|NCT02228720|3533047|P1|COMPLETED|Open Label - Day 30||14
1443388|NCT02228720|3533047|P1|STARTED|Open Label - Day 30||15
1443389|NCT02228720|3533047|P1|NOT COMPLETED|Open Label - Baseline||0
1443390|NCT02228720|3533047|P1|COMPLETED|Open Label - Baseline||15
1443391|NCT02228720|3533047|P1|STARTED|Open Label - Baseline||15
1443392|NCT02228395|3533055|P3|NOT COMPLETED|Third Intervention Period||0
1443393|NCT02228395|3533056|P2|NOT COMPLETED|Third Intervention Period||0
1443394|NCT02228395|3533057|P1|NOT COMPLETED|Third Intervention Period||0
1443395|NCT02228395|3533055|P3|COMPLETED|Third Intervention Period||3
1443396|NCT02228395|3533056|P2|COMPLETED|Third Intervention Period||3
1443397|NCT02228395|3533057|P1|COMPLETED|Third Intervention Period||3
1443398|NCT02228395|3533055|P3|STARTED|Third Intervention Period||3
1443399|NCT02228395|3533056|P2|STARTED|Third Intervention Period||3
1443400|NCT02228395|3533057|P1|STARTED|Third Intervention Period||3
1443401|NCT02228395|3533055|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1443402|NCT02228395|3533056|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1443403|NCT02228395|3533057|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1443404|NCT02228395|3533055|P3|COMPLETED|Washout Period (at Least 10 Days)||3
1443405|NCT02228395|3533056|P2|COMPLETED|Washout Period (at Least 10 Days)||3
1443406|NCT02228395|3533057|P1|COMPLETED|Washout Period (at Least 10 Days)||3
1443407|NCT02228395|3533055|P3|STARTED|Washout Period (at Least 10 Days)||3
1443408|NCT02228395|3533056|P2|STARTED|Washout Period (at Least 10 Days)||3
1443409|NCT02228395|3533057|P1|STARTED|Washout Period (at Least 10 Days)||3
1443410|NCT02228395|3533055|P3|NOT COMPLETED|Second Intervention Period||0
1443411|NCT02228395|3533056|P2|NOT COMPLETED|Second Intervention Period||0
1443412|NCT02228395|3533057|P1|NOT COMPLETED|Second Intervention Period||0
1443413|NCT02228395|3533055|P3|COMPLETED|Second Intervention Period||3
1443414|NCT02228395|3533056|P2|COMPLETED|Second Intervention Period||3
1443415|NCT02228395|3533057|P1|COMPLETED|Second Intervention Period||3
1443416|NCT02228395|3533055|P3|STARTED|Second Intervention Period||3
1443417|NCT02228395|3533056|P2|STARTED|Second Intervention Period||3
1443418|NCT02228395|3533057|P1|STARTED|Second Intervention Period||3
1443419|NCT02228395|3533055|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1443420|NCT02228395|3533056|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1443421|NCT02228395|3533057|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
1443422|NCT02228395|3533055|P3|COMPLETED|Washout Period (at Least 10 Days)||3
1443423|NCT02228395|3533056|P2|COMPLETED|Washout Period (at Least 10 Days)||3
1443424|NCT02228395|3533057|P1|COMPLETED|Washout Period (at Least 10 Days)||3
1443425|NCT02228395|3533055|P3|STARTED|Washout Period (at Least 10 Days)||3
1443426|NCT02228395|3533056|P2|STARTED|Washout Period (at Least 10 Days)||3
1443427|NCT02228395|3533057|P1|STARTED|Washout Period (at Least 10 Days)||3
1443428|NCT02228395|3533055|P3|NOT COMPLETED|First Intervention Period||1
1443429|NCT02228395|3533056|P2|NOT COMPLETED|First Intervention Period||1
1443430|NCT02228395|3533057|P1|NOT COMPLETED|First Intervention Period||1
1443431|NCT02228395|3533055|P3|COMPLETED|First Intervention Period||2
1443432|NCT02228395|3533056|P2|COMPLETED|First Intervention Period||2
1443433|NCT02228395|3533057|P1|COMPLETED|First Intervention Period||2
1443434|NCT02228395|3533055|P3|STARTED|First Intervention Period||3
1443435|NCT02228395|3533056|P2|STARTED|First Intervention Period||3
1443436|NCT02228395|3533057|P1|STARTED|First Intervention Period||3
1443437|NCT02227810|3533123|P2|NOT COMPLETED|Overall Study||5
1443438|NCT02227810|3533124|P1|NOT COMPLETED|Overall Study||2
1443439|NCT02227810|3533123|P2|COMPLETED|Overall Study||29
1443440|NCT02227810|3533124|P1|COMPLETED|Overall Study||17
1443441|NCT02227810|3533123|P2|STARTED|Overall Study||34
1443442|NCT02227810|3533124|P1|STARTED|Overall Study||19
1443443|NCT02227784|3533140|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
1443444|NCT02227784|3533141|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1443445|NCT02227784|3533142|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1443446|NCT02227784|3533143|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1443447|NCT02227784|3533144|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1443448|NCT02227784|3533140|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
1443449|NCT02227784|3533141|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
1443450|NCT02227784|3533142|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
1443451|NCT02227784|3533143|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
1443452|NCT02227784|3533144|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
1443453|NCT02227784|3533140|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
1443454|NCT02227784|3533141|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
1443455|NCT02227784|3533142|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
1443456|NCT02227784|3533143|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
1443457|NCT02227784|3533144|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
1443458|NCT02227784|3533140|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
1443459|NCT02227784|3533141|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
1443708|NCT02224690|3533575|P2|Safety Analysis Set|Overall Study||85
1443460|NCT02227784|3533142|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
1443461|NCT02227784|3533143|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
1443462|NCT02227784|3533144|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
1443463|NCT02227784|3533140|P5|NOT COMPLETED|Double-Blind Phase||0
1443464|NCT02227784|3533141|P4|NOT COMPLETED|Double-Blind Phase||39
1443465|NCT02227784|3533142|P3|NOT COMPLETED|Double-Blind Phase||21
1443466|NCT02227784|3533143|P2|NOT COMPLETED|Double-Blind Phase||18
1443467|NCT02227784|3533144|P1|NOT COMPLETED|Double-Blind Phase||40
1443468|NCT02227784|3533140|P5|COMPLETED|Double-Blind Phase||0
1443469|NCT02227784|3533141|P4|COMPLETED|Double-Blind Phase||88
1443470|NCT02227784|3533142|P3|COMPLETED|Double-Blind Phase||41
1443471|NCT02227784|3533143|P2|COMPLETED|Double-Blind Phase||36
1443472|NCT02227784|3533144|P1|COMPLETED|Double-Blind Phase||83
1443473|NCT02227784|3533140|P5|STARTED|Double-Blind Phase||0
1443474|NCT02227784|3533141|P4|STARTED|Double-Blind Phase||127
1443475|NCT02227784|3533142|P3|STARTED|Double-Blind Phase||62
1443476|NCT02227784|3533143|P2|STARTED|Double-Blind Phase||54
1443477|NCT02227784|3533144|P1|STARTED|Double-Blind Phase||123
1443478|NCT02227758|3533179|P1|NOT COMPLETED|Overall Study||67
1443479|NCT02227758|3533179|P1|COMPLETED|Overall Study||45
1443480|NCT02227758|3533179|P1|STARTED|Overall Study||112
1443481|NCT02227485|3533193|P2|NOT COMPLETED|Second Follow-up||2
1443482|NCT02227485|3533194|P1|NOT COMPLETED|Second Follow-up||2
1443483|NCT02227485|3533193|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
1443484|NCT02227485|3533194|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
1443485|NCT02227485|3533193|P2|STARTED|Second Follow-up||38
1443486|NCT02227485|3533194|P1|STARTED|Second Follow-up||36
1443487|NCT02227485|3533193|P2|NOT COMPLETED|First Follow-up||2
1443488|NCT02227485|3533194|P1|NOT COMPLETED|First Follow-up||4
1443489|NCT02227485|3533193|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
1443490|NCT02227485|3533194|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
1443491|NCT02227485|3533193|P2|STARTED|First Follow-up||40
1443492|NCT02227485|3533194|P1|STARTED|First Follow-up||40
1443493|NCT02227368|3533212|P2|NOT COMPLETED|Overall Study||4
1443494|NCT02227368|3533213|P1|NOT COMPLETED|Overall Study||2
1443495|NCT02227368|3533212|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
1443496|NCT02227368|3533213|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
1443497|NCT02227368|3533212|P2|Sujects Who Completed Treatment|Overall Study||17
1443498|NCT02227368|3533213|P1|Sujects Who Completed Treatment|Overall Study||10
1443499|NCT02227368|3533212|P2|Sujects Who Received Treatment|Overall Study||24
1443500|NCT02227368|3533213|P1|Sujects Who Received Treatment|Overall Study||16
1443501|NCT02227368|3533212|P2|STARTED|Overall Study||24
1443502|NCT02227368|3533213|P1|STARTED|Overall Study||16
1443503|NCT02227329|3533223|P2|NOT COMPLETED|Overall Study||0
1443504|NCT02227329|3533224|P1|NOT COMPLETED|Overall Study||0
1443505|NCT02227329|3533223|P2|COMPLETED|Overall Study||20
1443506|NCT02227329|3533224|P1|COMPLETED|Overall Study||18
1443507|NCT02227329|3533223|P2|STARTED|Overall Study||20
1443508|NCT02227329|3533224|P1|STARTED|Overall Study||18
1443509|NCT02227316|3533234|P4|NOT COMPLETED|Overall Study||0
1443510|NCT02227316|3533235|P3|NOT COMPLETED|Overall Study||0
1443511|NCT02227316|3533236|P2|NOT COMPLETED|Overall Study||0
1443512|NCT02227316|3533237|P1|NOT COMPLETED|Overall Study||0
1443513|NCT02227316|3533234|P4|COMPLETED|Overall Study||16
1443514|NCT02227316|3533235|P3|COMPLETED|Overall Study||16
1443515|NCT02227316|3533236|P2|COMPLETED|Overall Study||4
1443516|NCT02227316|3533237|P1|COMPLETED|Overall Study||4
1443517|NCT02227316|3533234|P4|STARTED|Overall Study||16
1443518|NCT02227316|3533235|P3|STARTED|Overall Study||16
1443519|NCT02227316|3533236|P2|STARTED|Overall Study||4
1443520|NCT02227316|3533237|P1|STARTED|Overall Study||4
1443521|NCT02227121|3533267|P1|NOT COMPLETED|Overall Study||0
1443522|NCT02227121|3533267|P1|COMPLETED|Overall Study||16
1443523|NCT02227121|3533267|P1|STARTED|Overall Study||16
1443524|NCT02227108|3533271|P1|NOT COMPLETED|Overall Study||31
1443525|NCT02227108|3533271|P1|COMPLETED|Overall Study||1
1443526|NCT02227108|3533271|P1|Treated|Overall Study||30
1443527|NCT02227108|3533271|P1|STARTED|Overall Study||32
1443528|NCT02226653|3533300|P2|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
1443529|NCT02226653|3533301|P1|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
1443530|NCT02226653|3533300|P2|COMPLETED|Washout Period 5 (at Least 21 Days)||23
1443531|NCT02226653|3533301|P1|COMPLETED|Washout Period 5 (at Least 21 Days)||23
1443532|NCT02226653|3533300|P2|STARTED|Washout Period 5 (at Least 21 Days)||23
1443533|NCT02226653|3533301|P1|STARTED|Washout Period 5 (at Least 21 Days)||23
1443534|NCT02226653|3533300|P2|NOT COMPLETED|Treatment Period 5 Fed State||1
1443535|NCT02226653|3533301|P1|NOT COMPLETED|Treatment Period 5 Fed State||0
1443536|NCT02226653|3533300|P2|COMPLETED|Treatment Period 5 Fed State||23
1443537|NCT02226653|3533301|P1|COMPLETED|Treatment Period 5 Fed State||23
1443538|NCT02226653|3533300|P2|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
1443539|NCT02226653|3533301|P1|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
1443540|NCT02226653|3533300|P2|STARTED|Treatment Period 5 Fed State||24
1443541|NCT02226653|3533301|P1|STARTED|Treatment Period 5 Fed State||23
1443542|NCT02226653|3533300|P2|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
1443543|NCT02226653|3533301|P1|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
1443544|NCT02226653|3533300|P2|COMPLETED|Washout Period 4 (at Least 21 Days)||24
1443545|NCT02226653|3533301|P1|COMPLETED|Washout Period 4 (at Least 21 Days)||23
1443546|NCT02226653|3533300|P2|STARTED|Washout Period 4 (at Least 21 Days)||24
1443547|NCT02226653|3533301|P1|STARTED|Washout Period 4 (at Least 21 Days)||23
1443548|NCT02226653|3533300|P2|NOT COMPLETED|Treatment Period 4 Fasted State||0
1443549|NCT02226653|3533301|P1|NOT COMPLETED|Treatment Period 4 Fasted State||0
1443550|NCT02226653|3533300|P2|COMPLETED|Treatment Period 4 Fasted State||24
1443551|NCT02226653|3533301|P1|COMPLETED|Treatment Period 4 Fasted State||23
1443552|NCT02226653|3533300|P2|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
1443553|NCT02226653|3533301|P1|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
1443554|NCT02226653|3533300|P2|STARTED|Treatment Period 4 Fasted State||24
1443555|NCT02226653|3533301|P1|STARTED|Treatment Period 4 Fasted State||23
1443556|NCT02226653|3533300|P2|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
1443557|NCT02226653|3533301|P1|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
1443558|NCT02226653|3533300|P2|COMPLETED|Washout Period 3 (at Least 21 Days)||24
1443559|NCT02226653|3533301|P1|COMPLETED|Washout Period 3 (at Least 21 Days)||23
1443560|NCT02226653|3533300|P2|STARTED|Washout Period 3 (at Least 21 Days)||24
1443561|NCT02226653|3533301|P1|STARTED|Washout Period 3 (at Least 21 Days)||23
1443562|NCT02226653|3533300|P2|NOT COMPLETED|Treatment Period 3 Fasted State||0
1443563|NCT02226653|3533301|P1|NOT COMPLETED|Treatment Period 3 Fasted State||0
1443564|NCT02226653|3533300|P2|COMPLETED|Treatment Period 3 Fasted State||24
1443565|NCT02226653|3533301|P1|COMPLETED|Treatment Period 3 Fasted State||23
1443566|NCT02226653|3533300|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
1443567|NCT02226653|3533301|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
1443568|NCT02226653|3533300|P2|STARTED|Treatment Period 3 Fasted State||24
1443569|NCT02226653|3533301|P1|STARTED|Treatment Period 3 Fasted State||23
1443570|NCT02226653|3533300|P2|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
1443571|NCT02226653|3533301|P1|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
1443572|NCT02226653|3533300|P2|COMPLETED|Washout Period 2 (at Least 21 Days)||24
1443573|NCT02226653|3533301|P1|COMPLETED|Washout Period 2 (at Least 21 Days)||23
1443574|NCT02226653|3533300|P2|STARTED|Washout Period 2 (at Least 21 Days)||24
1443575|NCT02226653|3533301|P1|STARTED|Washout Period 2 (at Least 21 Days)||23
1443576|NCT02226653|3533300|P2|NOT COMPLETED|Treatment Period 2 Fasted State||0
1443577|NCT02226653|3533301|P1|NOT COMPLETED|Treatment Period 2 Fasted State||1
1443578|NCT02226653|3533300|P2|COMPLETED|Treatment Period 2 Fasted State||24
1443579|NCT02226653|3533301|P1|COMPLETED|Treatment Period 2 Fasted State||23
1443580|NCT02226653|3533300|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
1443581|NCT02226653|3533301|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
1443582|NCT02226653|3533300|P2|STARTED|Treatment Period 2 Fasted State||24
1443583|NCT02226653|3533301|P1|STARTED|Treatment Period 2 Fasted State||24
1443584|NCT02226653|3533300|P2|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
1443585|NCT02226653|3533301|P1|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
1443586|NCT02226653|3533300|P2|COMPLETED|Washout Period 1 (at Least 21 Days)||24
1443587|NCT02226653|3533301|P1|COMPLETED|Washout Period 1 (at Least 21 Days)||24
1443588|NCT02226653|3533300|P2|STARTED|Washout Period 1 (at Least 21 Days)||24
1443589|NCT02226653|3533301|P1|STARTED|Washout Period 1 (at Least 21 Days)||24
1443590|NCT02226653|3533300|P2|NOT COMPLETED|Treatment Period 1 Fasted State||0
1443591|NCT02226653|3533301|P1|NOT COMPLETED|Treatment Period 1 Fasted State||0
1443592|NCT02226653|3533300|P2|COMPLETED|Treatment Period 1 Fasted State||24
1443593|NCT02226653|3533301|P1|COMPLETED|Treatment Period 1 Fasted State||24
1443594|NCT02226653|3533300|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
1443595|NCT02226653|3533301|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
1443596|NCT02226653|3533300|P2|STARTED|Treatment Period 1 Fasted State||24
1443597|NCT02226653|3533301|P1|STARTED|Treatment Period 1 Fasted State||24
1443598|NCT02226562|3533325|P2|NOT COMPLETED|Overall Study||1
1443599|NCT02226562|3533326|P1|NOT COMPLETED|Overall Study||0
1443600|NCT02226562|3533325|P2|COMPLETED|Overall Study|Lost to follow up|95
1443601|NCT02226562|3533326|P1|COMPLETED|Overall Study||95
1443602|NCT02226562|3533325|P2|STARTED|Overall Study||96
1443603|NCT02226562|3533326|P1|STARTED|Overall Study||95
1443604|NCT02226549|3533344|P2|NOT COMPLETED|Overall Study||1
1443605|NCT02226549|3533345|P1|NOT COMPLETED|Overall Study||1
1443606|NCT02226549|3533344|P2|COMPLETED|Overall Study||23
1443607|NCT02226549|3533345|P1|COMPLETED|Overall Study||22
1443608|NCT02226549|3533344|P2|STARTED|Overall Study||24
1443609|NCT02226549|3533345|P1|STARTED|Overall Study||23
1443610|NCT02226198|3533355|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
1443611|NCT02226198|3533356|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
1443612|NCT02226198|3533357|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
1443613|NCT02226198|3533355|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
1443614|NCT02226198|3533356|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
1443615|NCT02226198|3533357|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
1443616|NCT02226198|3533355|P3|STARTED|Maintenance Phase (12 Weeks)||0
1443617|NCT02226198|3533356|P2|STARTED|Maintenance Phase (12 Weeks)||0
1443618|NCT02226198|3533357|P1|STARTED|Maintenance Phase (12 Weeks)||13
1443619|NCT02226198|3533355|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
1443620|NCT02226198|3533356|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
1443621|NCT02226198|3533357|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
1443622|NCT02226198|3533355|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
1443623|NCT02226198|3533356|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
1443624|NCT02226198|3533357|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
1443625|NCT02226198|3533355|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
1443626|NCT02226198|3533356|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
1443627|NCT02226198|3533357|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
1443628|NCT02226198|3533355|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
1443629|NCT02226198|3533356|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
1443630|NCT02226198|3533357|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
1443631|NCT02226198|3533355|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
1443632|NCT02226198|3533356|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
1443633|NCT02226198|3533357|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
1443634|NCT02226198|3533355|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
1443635|NCT02226198|3533356|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
1443636|NCT02226198|3533357|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
1443637|NCT02226198|3533355|P3|NOT COMPLETED|Lead-in Phase||0
1443638|NCT02226198|3533356|P2|NOT COMPLETED|Lead-in Phase||0
1443639|NCT02226198|3533357|P1|NOT COMPLETED|Lead-in Phase||1
1443640|NCT02226198|3533355|P3|COMPLETED|Lead-in Phase||0
1443641|NCT02226198|3533356|P2|COMPLETED|Lead-in Phase||0
1443642|NCT02226198|3533357|P1|COMPLETED|Lead-in Phase||10
1443643|NCT02226198|3533355|P3|STARTED|Lead-in Phase||0
1443644|NCT02226198|3533356|P2|STARTED|Lead-in Phase||0
1443645|NCT02226198|3533357|P1|STARTED|Lead-in Phase||11
1443646|NCT02226172|3533430|P1|NOT COMPLETED|Overall Study||13
1443647|NCT02226172|3533430|P1|COMPLETED|Overall Study||8
1443648|NCT02226172|3533430|P1|STARTED|Overall Study||21
1443649|NCT02226003|3533452|P3|NOT COMPLETED|Overall Study||6
1443650|NCT02226003|3533453|P2|NOT COMPLETED|Overall Study||1
1443651|NCT02226003|3533454|P1|NOT COMPLETED|Overall Study||2
1443652|NCT02226003|3533452|P3|COMPLETED|Overall Study||91
1443653|NCT02226003|3533453|P2|COMPLETED|Overall Study||95
1443654|NCT02226003|3533454|P1|COMPLETED|Overall Study||96
1443655|NCT02226003|3533452|P3|STARTED|Overall Study||97
1443656|NCT02226003|3533453|P2|STARTED|Overall Study||96
1443657|NCT02226003|3533454|P1|STARTED|Overall Study||98
1443658|NCT02225860|3533488|P2|NOT COMPLETED|Overall Study||0
1443659|NCT02225860|3533489|P1|NOT COMPLETED|Overall Study||1
1443660|NCT02225860|3533488|P2|COMPLETED|Overall Study||17
1443661|NCT02225860|3533489|P1|COMPLETED|Overall Study||16
1443662|NCT02225860|3533488|P2|STARTED|Overall Study||17
1443663|NCT02225860|3533489|P1|STARTED|Overall Study||17
1443664|NCT02225353|3533502|P3|NOT COMPLETED|Overall Study||15
1443665|NCT02225353|3533503|P2|NOT COMPLETED|Overall Study||6
1443666|NCT02225353|3533504|P1|NOT COMPLETED|Overall Study||4
1443667|NCT02225353|3533502|P3|COMPLETED|Overall Study||75
1443668|NCT02225353|3533503|P2|COMPLETED|Overall Study||84
1443669|NCT02225353|3533504|P1|COMPLETED|Overall Study||87
1443670|NCT02225353|3533502|P3|STARTED|Overall Study||90
1443671|NCT02225353|3533503|P2|STARTED|Overall Study||90
1443672|NCT02225353|3533504|P1|STARTED|Overall Study||91
1443673|NCT02225080|3533527|P1|NOT COMPLETED|Overall Study||0
1443674|NCT02225080|3533527|P1|COMPLETED|Overall Study||100
1443675|NCT02225080|3533527|P1|STARTED|Overall Study||100
1443676|NCT02224846|3533536|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
1443677|NCT02224846|3533537|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
1443678|NCT02224846|3533536|P2|COMPLETED|Period 2 (Month 12 to Month 24)||283
1443679|NCT02224846|3533537|P1|COMPLETED|Period 2 (Month 12 to Month 24)||131
1443680|NCT02224846|3533536|P2|STARTED|Period 2 (Month 12 to Month 24)||357
1443681|NCT02224846|3533537|P1|STARTED|Period 2 (Month 12 to Month 24)||173
1443682|NCT02224846|3533536|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
1443683|NCT02224846|3533537|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
1443684|NCT02224846|3533536|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
1443685|NCT02224846|3533537|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
1443686|NCT02224846|3533536|P2|STARTED|Period 2 (Month 3 to Month 12)||388
1443687|NCT02224846|3533537|P1|STARTED|Period 2 (Month 3 to Month 12)||192
1443688|NCT02224846|3533536|P2|NOT COMPLETED|Period 1 (Month 3)||36
1443689|NCT02224846|3533537|P1|NOT COMPLETED|Period 1 (Month 3)||19
1443690|NCT02224846|3533536|P2|COMPLETED|Period 1 (Month 3)||388
1443691|NCT02224846|3533537|P1|COMPLETED|Period 1 (Month 3)||192
1443692|NCT02224846|3533536|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
1443693|NCT02224846|3533537|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
1443694|NCT02224846|3533536|P2|STARTED|Period 1 (Month 3)||424
1443695|NCT02224846|3533537|P1|STARTED|Period 1 (Month 3)||211
1443696|NCT02224820|3533557|P1|NOT COMPLETED|Overall Study||0
1443697|NCT02224820|3533557|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
1443698|NCT02224820|3533557|P1|STARTED|Overall Study||8
1443699|NCT02224729|3533565|P1|NOT COMPLETED|Overall Study||0
1443700|NCT02224729|3533565|P1|COMPLETED|Overall Study||24
1443701|NCT02224729|3533565|P1|STARTED|Overall Study||24
1443702|NCT02224690|3533575|P2|NOT COMPLETED|Overall Study||1
1443703|NCT02224690|3533576|P1|NOT COMPLETED|Overall Study||14
1443704|NCT02224690|3533575|P2|COMPLETED|Overall Study||84
1443705|NCT02224690|3533576|P1|COMPLETED|Overall Study||72
1443706|NCT02224690|3533575|P2|Intent to Treat (ITT) Analysis Set|Overall Study||85
1443707|NCT02224690|3533576|P1|Intent to Treat (ITT) Analysis Set|Overall Study||86
1443709|NCT02224690|3533576|P1|Safety Analysis Set|Overall Study||86
1443710|NCT02224690|3533575|P2|STARTED|Overall Study||85
1443711|NCT02224690|3533576|P1|STARTED|Overall Study||86
1443712|NCT02224664|3533588|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
1443713|NCT02224664|3533589|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
1443714|NCT02224664|3533590|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
1443715|NCT02224664|3533591|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
1443716|NCT02224664|3533592|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
1443717|NCT02224664|3533588|P5|COMPLETED|Dose Escalation Period (21 Days)||8
1443718|NCT02224664|3533589|P4|COMPLETED|Dose Escalation Period (21 Days)||3
1443719|NCT02224664|3533590|P3|COMPLETED|Dose Escalation Period (21 Days)||9
1443720|NCT02224664|3533591|P2|COMPLETED|Dose Escalation Period (21 Days)||9
1443721|NCT02224664|3533592|P1|COMPLETED|Dose Escalation Period (21 Days)||0
1443722|NCT02224664|3533588|P5|STARTED|Dose Escalation Period (21 Days)||19
1443723|NCT02224664|3533589|P4|STARTED|Dose Escalation Period (21 Days)||6
1443724|NCT02224664|3533590|P3|STARTED|Dose Escalation Period (21 Days)||11
1443725|NCT02224664|3533591|P2|STARTED|Dose Escalation Period (21 Days)||9
1443726|NCT02224664|3533592|P1|STARTED|Dose Escalation Period (21 Days)||0
1443727|NCT02224664|3533588|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
1443728|NCT02224664|3533589|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
1443729|NCT02224664|3533590|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
1443730|NCT02224664|3533591|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
1443731|NCT02224664|3533592|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
1443732|NCT02224664|3533588|P5|COMPLETED|Lead-in Period (3 Days)||0
1443733|NCT02224664|3533589|P4|COMPLETED|Lead-in Period (3 Days)||0
1443734|NCT02224664|3533590|P3|COMPLETED|Lead-in Period (3 Days)||0
1443735|NCT02224664|3533591|P2|COMPLETED|Lead-in Period (3 Days)||0
1443736|NCT02224664|3533592|P1|COMPLETED|Lead-in Period (3 Days)||45
1443737|NCT02224664|3533588|P5|STARTED|Lead-in Period (3 Days)||0
1443738|NCT02224664|3533589|P4|STARTED|Lead-in Period (3 Days)||0
1443739|NCT02224664|3533590|P3|STARTED|Lead-in Period (3 Days)||0
1443740|NCT02224664|3533591|P2|STARTED|Lead-in Period (3 Days)||0
1443741|NCT02224664|3533592|P1|STARTED|Lead-in Period (3 Days)||50
1443742|NCT02224638|3533674|P2|NOT COMPLETED|Overall Study||1
1443743|NCT02224638|3533675|P1|NOT COMPLETED|Overall Study||1
1443744|NCT02224638|3533674|P2|COMPLETED|Overall Study||9
1443745|NCT02224638|3533675|P1|COMPLETED|Overall Study||10
1443746|NCT02224638|3533674|P2|STARTED|Overall Study||10
1443747|NCT02224638|3533675|P1|STARTED|Overall Study||11
1443748|NCT02224625|3533683|P1|NOT COMPLETED|Sensitization||55
1443749|NCT02224625|3533683|P1|COMPLETED|Sensitization||194
1443750|NCT02224625|3533683|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
1443751|NCT02224625|3533683|P1|NOT COMPLETED|Irritation||6
1443752|NCT02224625|3533683|P1|COMPLETED|Irritation||33
1443753|NCT02224625|3533683|P1|STARTED|Irritation||39
1443754|NCT02224560|3533698|P3|NOT COMPLETED|Overall Study||2
1443755|NCT02224560|3533699|P2|NOT COMPLETED|Overall Study||2
1443756|NCT02224560|3533700|P1|NOT COMPLETED|Overall Study||9
1443757|NCT02224560|3533698|P3|COMPLETED|Overall Study||74
1443758|NCT02224560|3533699|P2|COMPLETED|Overall Study||71
1443759|NCT02224560|3533700|P1|COMPLETED|Overall Study||67
1443760|NCT02224560|3533698|P3|Intent to Treat (ITT) Analysis Set|Overall Study||76
1443761|NCT02224560|3533699|P2|Intent to Treat (ITT) Analysis Set|Overall Study||73
1443762|NCT02224560|3533700|P1|Intent to Treat (ITT) Analysis Set|Overall Study||76
1443763|NCT02224560|3533698|P3|Safety Analysis Set|Overall Study||76
1443764|NCT02224560|3533699|P2|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
1443765|NCT02224560|3533700|P1|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
1443766|NCT02224560|3533698|P3|STARTED|Overall Study||76
1443767|NCT02224560|3533699|P2|STARTED|Overall Study||73
1443768|NCT02224560|3533700|P1|STARTED|Overall Study||76
1443769|NCT02224508|3533719|P2|NOT COMPLETED|Overall Study||0
1443770|NCT02224508|3533720|P1|NOT COMPLETED|Overall Study||0
1443771|NCT02224508|3533719|P2|COMPLETED|Overall Study||653
1443772|NCT02224508|3533720|P1|COMPLETED|Overall Study||935
1443773|NCT02224508|3533719|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
1443774|NCT02224508|3533720|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
1443775|NCT02224404|3533730|P1|NOT COMPLETED|Overall Study||0
1443776|NCT02224404|3533730|P1|COMPLETED|Overall Study||21
1443777|NCT02224404|3533730|P1|STARTED|Overall Study||21
1443778|NCT02224053|3533735|P1|NOT COMPLETED|AZD9291 Alone||0
1443779|NCT02224053|3533735|P1|COMPLETED|AZD9291 Alone||47
1443780|NCT02224053|3533735|P1|STARTED|AZD9291 Alone||47
1443781|NCT02224053|3533735|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
1443782|NCT02224053|3533735|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
1443783|NCT02224053|3533735|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
1443784|NCT02223871|3533767|P1|NOT COMPLETED|Overall Study||0
1443785|NCT02223871|3533767|P1|COMPLETED|Overall Study||8
1443786|NCT02223871|3533767|P1|STARTED|Overall Study||8
1443787|NCT02223754|3533781|P2|NOT COMPLETED|Period 2||3
1443788|NCT02223754|3533782|P1|NOT COMPLETED|Period 2||3
1443789|NCT02223754|3533781|P2|COMPLETED|Period 2||141
1443790|NCT02223754|3533782|P1|COMPLETED|Period 2||156
1443791|NCT02223754|3533781|P2|STARTED|Period 2||144
1443792|NCT02223754|3533782|P1|STARTED|Period 2||159
1443793|NCT02223754|3533781|P2|NOT COMPLETED|Period 1||15
1443794|NCT02223754|3533782|P1|NOT COMPLETED|Period 1||4
1443795|NCT02223754|3533781|P2|COMPLETED|Period 1||144
1443796|NCT02223754|3533782|P1|COMPLETED|Period 1||159
1443797|NCT02223754|3533781|P2|STARTED|Period 1||159
1443798|NCT02223754|3533782|P1|STARTED|Period 1||163
1443799|NCT02223715|3533802|P1|NOT COMPLETED|Overall Study||104
1443800|NCT02223715|3533802|P1|COMPLETED|Overall Study||496
1443801|NCT02223715|3533802|P1|STARTED|Overall Study||600
1443802|NCT02223702|3533811|P2|NOT COMPLETED|Overall Study||4
1443803|NCT02223702|3533812|P1|NOT COMPLETED|Overall Study||1
1443804|NCT02223702|3533811|P2|COMPLETED|Overall Study||15
1443805|NCT02223702|3533812|P1|COMPLETED|Overall Study||19
1443806|NCT02223702|3533811|P2|STARTED|Overall Study||19
1443807|NCT02223702|3533812|P1|STARTED|Overall Study||20
1443808|NCT02223650|3533822|P2|NOT COMPLETED|Overall Study||0
1443809|NCT02223650|3533823|P1|NOT COMPLETED|Overall Study||0
1443810|NCT02223650|3533822|P2|COMPLETED|Overall Study||31
1443811|NCT02223650|3533823|P1|COMPLETED|Overall Study||27
1443812|NCT02223650|3533822|P2|STARTED|Overall Study||31
1443813|NCT02223650|3533823|P1|STARTED|Overall Study||27
1443814|NCT02223429|3533857|P4|NOT COMPLETED|Overall Study||0
1443815|NCT02223429|3533858|P3|NOT COMPLETED|Overall Study||0
1443816|NCT02223429|3533859|P2|NOT COMPLETED|Overall Study||0
1443817|NCT02223429|3533860|P1|NOT COMPLETED|Overall Study||1
1443818|NCT02223429|3533857|P4|COMPLETED|Overall Study||8
1443819|NCT02223429|3533858|P3|COMPLETED|Overall Study||8
1443820|NCT02223429|3533859|P2|COMPLETED|Overall Study||8
1443821|NCT02223429|3533860|P1|COMPLETED|Overall Study||7
1443822|NCT02223429|3533857|P4|STARTED|Overall Study||8
1443823|NCT02223429|3533858|P3|STARTED|Overall Study||8
1443824|NCT02223429|3533859|P2|STARTED|Overall Study||8
1443825|NCT02223429|3533860|P1|STARTED|Overall Study||8
1443826|NCT02223390|3533890|P2|NOT COMPLETED|Overall Study||4
1443827|NCT02223390|3533891|P1|NOT COMPLETED|Overall Study||9
1443828|NCT02223390|3533890|P2|COMPLETED|Overall Study||28
1443829|NCT02223390|3533891|P1|COMPLETED|Overall Study||23
1443830|NCT02223390|3533890|P2|STARTED|Overall Study||32
1443831|NCT02223390|3533891|P1|STARTED|Overall Study||32
1443832|NCT02223364|3533902|P3|NOT COMPLETED|Overall Study||3
1443833|NCT02223364|3533903|P2|NOT COMPLETED|Overall Study||0
1443834|NCT02223364|3533904|P1|NOT COMPLETED|Overall Study||5
1443835|NCT02223364|3533902|P3|COMPLETED|Overall Study||52
1443836|NCT02223364|3533903|P2|COMPLETED|Overall Study||55
1443837|NCT02223364|3533904|P1|COMPLETED|Overall Study||50
1443838|NCT02223364|3533902|P3|STARTED|Overall Study||55
1443839|NCT02223364|3533903|P2|STARTED|Overall Study||55
1443840|NCT02223364|3533904|P1|STARTED|Overall Study||55
1443841|NCT02223338|3533956|P2|NOT COMPLETED|Overall Study||0
1443842|NCT02223338|3533957|P1|NOT COMPLETED|Overall Study||0
1443843|NCT02223338|3533956|P2|COMPLETED|Overall Study||60
1443844|NCT02223338|3533957|P1|COMPLETED|Overall Study||60
1443845|NCT02223338|3533956|P2|STARTED|Overall Study||60
1443846|NCT02223338|3533957|P1|STARTED|Overall Study||60
1443847|NCT02223260|3533965|P1|NOT COMPLETED|Overall Study||0
1443848|NCT02223260|3533965|P1|COMPLETED|Overall Study||8
1443849|NCT02223260|3533965|P1|STARTED|Overall Study||8
1443850|NCT02223065|3533983|P2|NOT COMPLETED|Overall Study||0
1443851|NCT02223065|3533984|P1|NOT COMPLETED|Overall Study||0
1443852|NCT02223065|3533983|P2|COMPLETED|Overall Study||18
1443853|NCT02223065|3533984|P1|COMPLETED|Overall Study||18
1443854|NCT02223065|3533983|P2|STARTED|Overall Study||18
1443855|NCT02223065|3533984|P1|STARTED|Overall Study||18
1443856|NCT02222870|3534002|P2|NOT COMPLETED|Overall Study||0
1443857|NCT02222870|3534003|P1|NOT COMPLETED|Overall Study||0
1443858|NCT02222870|3534002|P2|COMPLETED|Overall Study||30
1443859|NCT02222870|3534003|P1|COMPLETED|Overall Study||30
1443860|NCT02222870|3534002|P2|STARTED|Overall Study||30
1443861|NCT02222870|3534003|P1|STARTED|Overall Study||30
1443862|NCT02222818|3534019|P2|NOT COMPLETED|Period 2||0
1443863|NCT02222818|3534020|P1|NOT COMPLETED|Period 2||0
1443864|NCT02222818|3534019|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
1443865|NCT02222818|3534020|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
1443866|NCT02222818|3534019|P2|STARTED|Period 2|Start of CAFR evaluation period|30
1443867|NCT02222818|3534020|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
1443868|NCT02222818|3534019|P2|NOT COMPLETED|Period 1||3
1443869|NCT02222818|3534020|P1|NOT COMPLETED|Period 1||0
1443870|NCT02222818|3534019|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
1443871|NCT02222818|3534020|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
1443872|NCT02222818|3534019|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
1443873|NCT02222818|3534020|P1|STARTED|Period 1|Start of CAFR evaluation period|33
1443874|NCT02222714|3534032|P5|NOT COMPLETED|Overall Study||7
1443875|NCT02222714|3534033|P4|NOT COMPLETED|Overall Study||4
1443876|NCT02222714|3534034|P3|NOT COMPLETED|Overall Study||4
1443877|NCT02222714|3534035|P2|NOT COMPLETED|Overall Study||2
1443878|NCT02222714|3534036|P1|NOT COMPLETED|Overall Study||0
1443879|NCT02222714|3534032|P5|COMPLETED|Overall Study||37
1443880|NCT02222714|3534033|P4|COMPLETED|Overall Study||11
1443881|NCT02222714|3534034|P3|COMPLETED|Overall Study||8
1443882|NCT02222714|3534035|P2|COMPLETED|Overall Study||22
1443883|NCT02222714|3534036|P1|COMPLETED|Overall Study||15
1443884|NCT02222714|3534032|P5|STARTED|Overall Study||44
1443885|NCT02222714|3534033|P4|STARTED|Overall Study||15
1443886|NCT02222714|3534034|P3|STARTED|Overall Study||12
1443887|NCT02222714|3534035|P2|STARTED|Overall Study||24
1443888|NCT02222714|3534036|P1|STARTED|Overall Study||15
1443889|NCT02222558|3534075|P6|NOT COMPLETED|Period 3||1
1443890|NCT02222558|3534076|P5|NOT COMPLETED|Period 3||0
1443891|NCT02222558|3534077|P4|NOT COMPLETED|Period 3||0
1443892|NCT02222558|3534078|P3|NOT COMPLETED|Period 3||0
1443893|NCT02222558|3534079|P2|NOT COMPLETED|Period 3||0
1443894|NCT02222558|3534080|P1|NOT COMPLETED|Period 3||0
1443895|NCT02222558|3534075|P6|COMPLETED|Period 3||7
1443896|NCT02222558|3534076|P5|COMPLETED|Period 3||8
1443897|NCT02222558|3534077|P4|COMPLETED|Period 3||1
1443898|NCT02222558|3534078|P3|COMPLETED|Period 3||4
1443899|NCT02222558|3534079|P2|COMPLETED|Period 3||0
1443900|NCT02222558|3534080|P1|COMPLETED|Period 3||0
1443901|NCT02222558|3534075|P6|STARTED|Period 3||8
1443902|NCT02222558|3534076|P5|STARTED|Period 3||8
1443903|NCT02222558|3534077|P4|STARTED|Period 3||1
1443904|NCT02222558|3534078|P3|STARTED|Period 3||4
1443905|NCT02222558|3534079|P2|STARTED|Period 3||0
1443906|NCT02222558|3534080|P1|STARTED|Period 3||0
1443907|NCT02222558|3534075|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443908|NCT02222558|3534076|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443909|NCT02222558|3534077|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443910|NCT02222558|3534078|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443911|NCT02222558|3534079|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443912|NCT02222558|3534080|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443913|NCT02222558|3534075|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443914|NCT02222558|3534076|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443915|NCT02222558|3534077|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443916|NCT02222558|3534078|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443917|NCT02222558|3534079|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
1443918|NCT02222558|3534080|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
1443919|NCT02222558|3534075|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1443920|NCT02222558|3534076|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1443921|NCT02222558|3534077|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1443922|NCT02222558|3534078|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1443923|NCT02222558|3534079|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
1443924|NCT02222558|3534080|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
1443925|NCT02222558|3534075|P6|NOT COMPLETED|Period 1: Single Dose||0
1443926|NCT02222558|3534076|P5|NOT COMPLETED|Period 1: Single Dose||0
1443927|NCT02222558|3534077|P4|NOT COMPLETED|Period 1: Single Dose||0
1443928|NCT02222558|3534078|P3|NOT COMPLETED|Period 1: Single Dose||0
1443929|NCT02222558|3534079|P2|NOT COMPLETED|Period 1: Single Dose||0
1443930|NCT02222558|3534080|P1|NOT COMPLETED|Period 1: Single Dose||4
1443931|NCT02222558|3534075|P6|COMPLETED|Period 1: Single Dose||0
1443932|NCT02222558|3534076|P5|COMPLETED|Period 1: Single Dose||0
1443933|NCT02222558|3534077|P4|COMPLETED|Period 1: Single Dose||0
1443934|NCT02222558|3534078|P3|COMPLETED|Period 1: Single Dose||0
1443935|NCT02222558|3534079|P2|COMPLETED|Period 1: Single Dose||0
1443936|NCT02222558|3534080|P1|COMPLETED|Period 1: Single Dose||21
1443937|NCT02222558|3534075|P6|STARTED|Period 1: Single Dose||0
1443938|NCT02222558|3534076|P5|STARTED|Period 1: Single Dose||0
1443939|NCT02222558|3534077|P4|STARTED|Period 1: Single Dose||0
1443940|NCT02222558|3534078|P3|STARTED|Period 1: Single Dose||0
1443941|NCT02222558|3534079|P2|STARTED|Period 1: Single Dose||0
1443942|NCT02222558|3534080|P1|STARTED|Period 1: Single Dose||25
1443943|NCT02222493|3534096|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
1443944|NCT02222493|3534097|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
1443945|NCT02222493|3534096|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
1443946|NCT02222493|3534097|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
1443947|NCT02222493|3534096|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
1443948|NCT02222493|3534097|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
1443949|NCT02222493|3534096|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
1443950|NCT02222493|3534097|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
1443951|NCT02222493|3534096|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
1443952|NCT02222493|3534097|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
1443953|NCT02222493|3534096|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
1443954|NCT02222493|3534097|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
1443955|NCT02222493|3534096|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
1443956|NCT02222493|3534097|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
1443957|NCT02222493|3534096|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
1443958|NCT02222493|3534097|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
1443959|NCT02222493|3534096|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
1443960|NCT02222493|3534097|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
1443961|NCT02222493|3534096|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
1443962|NCT02222493|3534097|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
1443963|NCT02222246|3534215|P2|NOT COMPLETED|Overall Study||27
1443964|NCT02222246|3534216|P1|NOT COMPLETED|Overall Study||27
1443965|NCT02222246|3534215|P2|COMPLETED|Overall Study||26
1443966|NCT02222246|3534216|P1|COMPLETED|Overall Study||26
1443967|NCT02222246|3534215|P2|STARTED|Overall Study||53
1443968|NCT02222246|3534216|P1|STARTED|Overall Study||53
1443969|NCT02222207|3534244|P1|NOT COMPLETED|Overall Study||4
1443970|NCT02222207|3534244|P1|COMPLETED|Overall Study||48
1443971|NCT02222207|3534244|P1|Treated and Valid for Full Analysis Set|Overall Study||51
1443972|NCT02222207|3534244|P1|STARTED|Overall Study||52
1443973|NCT02222181|3534251|P1|NOT COMPLETED|Overall Study||108
1443974|NCT02222181|3534251|P1|COMPLETED|Overall Study||55
1443975|NCT02222181|3534251|P1|STARTED|Overall Study||163
1443976|NCT02222129|3534263|P2|NOT COMPLETED|Overall Study||0
1443977|NCT02222129|3534264|P1|NOT COMPLETED|Overall Study||0
1443978|NCT02222129|3534263|P2|COMPLETED|Overall Study||106
1443979|NCT02222129|3534264|P1|COMPLETED|Overall Study||100
1443980|NCT02222129|3534263|P2|STARTED|Overall Study||106
1443981|NCT02222129|3534264|P1|STARTED|Overall Study||100
1443982|NCT02221947|3534272|P2|NOT COMPLETED|Overall Study||0
1443983|NCT02221947|3534273|P1|NOT COMPLETED|Overall Study||0
1443984|NCT02221947|3534272|P2|COMPLETED|Overall Study||3
1443985|NCT02221947|3534273|P1|COMPLETED|Overall Study||6
1443986|NCT02221947|3534272|P2|STARTED|Overall Study||3
1443987|NCT02221947|3534273|P1|STARTED|Overall Study||6
1443988|NCT02221674|3534288|P3|NOT COMPLETED|Overall Study||0
1443989|NCT02221674|3534289|P2|NOT COMPLETED|Overall Study||0
1443990|NCT02221674|3534290|P1|NOT COMPLETED|Overall Study||1
1443991|NCT02221674|3534288|P3|COMPLETED|Overall Study||5
1443992|NCT02221674|3534289|P2|COMPLETED|Overall Study||6
1443993|NCT02221674|3534290|P1|COMPLETED|Overall Study||7
1443994|NCT02221674|3534288|P3|STARTED|Overall Study||5
1443995|NCT02221674|3534289|P2|STARTED|Overall Study||6
1443996|NCT02221674|3534290|P1|STARTED|Overall Study||8
1443997|NCT02221648|3534306|P2|NOT COMPLETED|Overall Study||3
1443998|NCT02221648|3534307|P1|NOT COMPLETED|Overall Study||3
1443999|NCT02221648|3534306|P2|COMPLETED|Overall Study||18
1444000|NCT02221648|3534307|P1|COMPLETED|Overall Study||19
1444001|NCT02221648|3534306|P2|STARTED|Overall Study||21
1444002|NCT02221648|3534307|P1|STARTED|Overall Study||22
1444003|NCT02221557|3534317|P1|NOT COMPLETED|Overall Study||3
1444004|NCT02221557|3534317|P1|COMPLETED|Overall Study||5
1444005|NCT02221557|3534317|P1|STARTED|Overall Study||8
1444006|NCT02220998|3534323|P2|NOT COMPLETED|Overall Study||11
1444007|NCT02220998|3534324|P1|NOT COMPLETED|Overall Study||7
1444008|NCT02220998|3534323|P2|COMPLETED|Overall Study||123
1444009|NCT02220998|3534324|P1|COMPLETED|Overall Study||128
1444010|NCT02220998|3534323|P2|STARTED|Overall Study||134
1444011|NCT02220998|3534324|P1|STARTED|Overall Study||135
1444012|NCT02220920|3534342|P2|NOT COMPLETED|Overall Study||3
1444013|NCT02220920|3534343|P1|NOT COMPLETED|Overall Study||3
1444014|NCT02220920|3534342|P2|COMPLETED|Overall Study||67
1444015|NCT02220920|3534343|P1|COMPLETED|Overall Study||73
1444016|NCT02220920|3534342|P2|STARTED|Overall Study||70
1444017|NCT02220920|3534343|P1|STARTED|Overall Study||76
1444018|NCT02220907|3534357|P1|NOT COMPLETED|Overall Study||11
1444019|NCT02220907|3534357|P1|COMPLETED|Overall Study||142
1444020|NCT02220907|3534357|P1|STARTED|Overall Study||153
1444021|NCT02220855|3534364|P1|NOT COMPLETED|Overall Study||14
1444022|NCT02220855|3534364|P1|COMPLETED|Overall Study||0
1444023|NCT02220855|3534364|P1|STARTED|Overall Study||14
1444024|NCT02220764|3534374|P2|NOT COMPLETED|Overall Study||1
1444025|NCT02220764|3534375|P1|NOT COMPLETED|Overall Study||4
1444026|NCT02220764|3534374|P2|COMPLETED|Overall Study||7
1444027|NCT02220764|3534375|P1|COMPLETED|Overall Study||20
1444028|NCT02220764|3534374|P2|STARTED|Overall Study||8
1444029|NCT02220764|3534375|P1|STARTED|Overall Study||24
1444030|NCT02220725|3534389|P4|NOT COMPLETED|Overall Study||2
1444031|NCT02220725|3534390|P3|NOT COMPLETED|Overall Study||0
1444032|NCT02220725|3534391|P2|NOT COMPLETED|Overall Study||0
1444033|NCT02220725|3534392|P1|NOT COMPLETED|Overall Study||0
1444034|NCT02220725|3534389|P4|COMPLETED|Overall Study||24
1444035|NCT02220725|3534390|P3|COMPLETED|Overall Study||13
1444036|NCT02220725|3534391|P2|COMPLETED|Overall Study||27
1444037|NCT02220725|3534392|P1|COMPLETED|Overall Study||14
1444038|NCT02220725|3534389|P4|STARTED|Overall Study||26
1444039|NCT02220725|3534390|P3|STARTED|Overall Study||13
1444040|NCT02220725|3534391|P2|STARTED|Overall Study||27
1444041|NCT02220725|3534392|P1|STARTED|Overall Study||14
1444042|NCT02220205|3534422|P2|NOT COMPLETED|Overall Study||0
1444043|NCT02220205|3534423|P1|NOT COMPLETED|Overall Study||1
1444044|NCT02220205|3534422|P2|COMPLETED|Overall Study||30
1444045|NCT02220205|3534423|P1|COMPLETED|Overall Study||29
1444046|NCT02220205|3534422|P2|STARTED|Overall Study||30
1444047|NCT02220205|3534423|P1|STARTED|Overall Study||30
1444048|NCT02219997|3534433|P3|NOT COMPLETED|Second Filter||0
1444049|NCT02219997|3534434|P2|NOT COMPLETED|Second Filter||0
1444050|NCT02219997|3534435|P1|NOT COMPLETED|Second Filter||0
1444051|NCT02219997|3534433|P3|COMPLETED|Second Filter||18
1444052|NCT02219997|3534434|P2|COMPLETED|Second Filter||17
1444053|NCT02219997|3534435|P1|COMPLETED|Second Filter||0
1444054|NCT02219997|3534433|P3|STARTED|Second Filter||18
1444055|NCT02219997|3534434|P2|STARTED|Second Filter||17
1444056|NCT02219997|3534435|P1|STARTED|Second Filter||0
1444057|NCT02219997|3534433|P3|NOT COMPLETED|First Filter||0
1444058|NCT02219997|3534434|P2|NOT COMPLETED|First Filter||0
1444059|NCT02219997|3534435|P1|NOT COMPLETED|First Filter||0
1444060|NCT02219997|3534433|P3|COMPLETED|First Filter||18
1444061|NCT02219997|3534434|P2|COMPLETED|First Filter||17
1444062|NCT02219997|3534435|P1|COMPLETED|First Filter||33
1444063|NCT02219997|3534433|P3|STARTED|First Filter||18
1444064|NCT02219997|3534434|P2|STARTED|First Filter||17
1444065|NCT02219997|3534435|P1|STARTED|First Filter||33
1444066|NCT02219932|3534448|P2|NOT COMPLETED|Overall Study||51
1444067|NCT02219932|3534449|P1|NOT COMPLETED|Overall Study||65
1444068|NCT02219932|3534448|P2|COMPLETED|Overall Study||266
1444069|NCT02219932|3534449|P1|COMPLETED|Overall Study||254
1444070|NCT02219932|3534448|P2|Randomized, Not Treated|Overall Study||1
1444071|NCT02219932|3534449|P1|Randomized, Not Treated|Overall Study||0
1444072|NCT02219932|3534448|P2|STARTED|Overall Study||317
1444073|NCT02219932|3534449|P1|STARTED|Overall Study||319
1444074|NCT02219685|3534465|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
1444075|NCT02219685|3534466|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
1444076|NCT02219685|3534465|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
1444077|NCT02219685|3534466|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
1444078|NCT02219685|3534465|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
1444079|NCT02219685|3534466|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
1444080|NCT02219685|3534465|P2|NOT COMPLETED|Blinded Treatment Phase||0
1444081|NCT02219685|3534466|P1|NOT COMPLETED|Blinded Treatment Phase||2
1444082|NCT02219685|3534465|P2|COMPLETED|Blinded Treatment Phase||14
1444083|NCT02219685|3534466|P1|COMPLETED|Blinded Treatment Phase||24
1444084|NCT02219685|3534465|P2|STARTED|Blinded Treatment Phase||14
1444085|NCT02219685|3534466|P1|STARTED|Blinded Treatment Phase||26
1444086|NCT02219516|3534514|P4|NOT COMPLETED|Overall Study||0
1444087|NCT02219516|3534515|P3|NOT COMPLETED|Overall Study||0
1444088|NCT02219516|3534516|P2|NOT COMPLETED|Overall Study||0
1444089|NCT02219516|3534517|P1|NOT COMPLETED|Overall Study||0
1444090|NCT02219516|3534514|P4|COMPLETED|Overall Study||8
1444091|NCT02219516|3534515|P3|COMPLETED|Overall Study||7
1444092|NCT02219516|3534516|P2|COMPLETED|Overall Study||8
1444093|NCT02219516|3534517|P1|COMPLETED|Overall Study||8
1444094|NCT02219516|3534514|P4|STARTED|Overall Study||8
1444095|NCT02219516|3534515|P3|STARTED|Overall Study||7
1444096|NCT02219516|3534516|P2|STARTED|Overall Study||8
1444097|NCT02219516|3534517|P1|STARTED|Overall Study||8
1444098|NCT02219503|3534563|P1|NOT COMPLETED|Overall Study||0
1444099|NCT02219503|3534563|P1|COMPLETED|Overall Study||60
1444100|NCT02219503|3534563|P1|STARTED|Overall Study||60
1444101|NCT02219477|3534572|P3|NOT COMPLETED|Overall Study||1
1444102|NCT02219477|3534573|P2|NOT COMPLETED|Overall Study||2
1444103|NCT02219477|3534574|P1|NOT COMPLETED|Overall Study||0
1444104|NCT02219477|3534572|P3|COMPLETED|Overall Study||2
1444105|NCT02219477|3534573|P2|COMPLETED|Overall Study||22
1444106|NCT02219477|3534574|P1|COMPLETED|Overall Study||9
1444107|NCT02219477|3534572|P3|STARTED|Overall Study||3
1444108|NCT02219477|3534573|P2|STARTED|Overall Study||24
1444109|NCT02219477|3534574|P1|STARTED|Overall Study||9
1444110|NCT02219464|3534602|P2|NOT COMPLETED|Overall Study||0
1444111|NCT02219464|3534603|P1|NOT COMPLETED|Overall Study||3
1444112|NCT02219464|3534602|P2|COMPLETED|Overall Study||30
1444113|NCT02219464|3534603|P1|COMPLETED|Overall Study||27
1444114|NCT02219464|3534602|P2|STARTED|Overall Study||30
1444115|NCT02219464|3534603|P1|STARTED|Overall Study||30
1444116|NCT02219282|3534613|P2|NOT COMPLETED|Overall Study||1
1444117|NCT02219282|3534614|P1|NOT COMPLETED|Overall Study||1
1444118|NCT02219282|3534613|P2|COMPLETED|Overall Study||32
1444119|NCT02219282|3534614|P1|COMPLETED|Overall Study||32
1444120|NCT02219282|3534613|P2|STARTED|Overall Study||33
1444121|NCT02219282|3534614|P1|STARTED|Overall Study||33
1444122|NCT02219256|3534640|P12|NOT COMPLETED|Overall Study||0
1444123|NCT02219256|3534641|P11|NOT COMPLETED|Overall Study||0
1444124|NCT02219256|3534642|P10|NOT COMPLETED|Overall Study||0
1444125|NCT02219256|3534643|P9|NOT COMPLETED|Overall Study||0
1444126|NCT02219256|3534644|P8|NOT COMPLETED|Overall Study||0
1444127|NCT02219256|3534645|P7|NOT COMPLETED|Overall Study||0
1444128|NCT02219256|3534646|P6|NOT COMPLETED|Overall Study||0
1444129|NCT02219256|3534647|P5|NOT COMPLETED|Overall Study||0
1444130|NCT02219256|3534648|P4|NOT COMPLETED|Overall Study||0
1444131|NCT02219256|3534649|P3|NOT COMPLETED|Overall Study||0
1444132|NCT02219256|3534650|P2|NOT COMPLETED|Overall Study||0
1444133|NCT02219256|3534651|P1|NOT COMPLETED|Overall Study||0
1444134|NCT02219256|3534640|P12|COMPLETED|Overall Study||6
1444135|NCT02219256|3534641|P11|COMPLETED|Overall Study||6
1444136|NCT02219256|3534642|P10|COMPLETED|Overall Study||6
1444137|NCT02219256|3534643|P9|COMPLETED|Overall Study||6
1444138|NCT02219256|3534644|P8|COMPLETED|Overall Study||8
1444139|NCT02219256|3534645|P7|COMPLETED|Overall Study||6
1444140|NCT02219256|3534646|P6|COMPLETED|Overall Study||6
1444141|NCT02219256|3534647|P5|COMPLETED|Overall Study||6
1444142|NCT02219256|3534648|P4|COMPLETED|Overall Study||4
1444143|NCT02219256|3534649|P3|COMPLETED|Overall Study||4
1444144|NCT02219256|3534650|P2|COMPLETED|Overall Study||4
1444145|NCT02219256|3534651|P1|COMPLETED|Overall Study||12
1444146|NCT02219256|3534640|P12|STARTED|Overall Study||6
1444147|NCT02219256|3534641|P11|STARTED|Overall Study||6
1444148|NCT02219256|3534642|P10|STARTED|Overall Study||6
1444149|NCT02219256|3534643|P9|STARTED|Overall Study||6
1444150|NCT02219256|3534644|P8|STARTED|Overall Study||8
1444151|NCT02219256|3534645|P7|STARTED|Overall Study||6
1444152|NCT02219256|3534646|P6|STARTED|Overall Study||6
1444153|NCT02219256|3534647|P5|STARTED|Overall Study||6
1444154|NCT02219256|3534648|P4|STARTED|Overall Study||4
1444155|NCT02219256|3534649|P3|STARTED|Overall Study||4
1444156|NCT02219256|3534650|P2|STARTED|Overall Study||4
1444157|NCT02219256|3534651|P1|STARTED|Overall Study||12
1444158|NCT02219087|3534763|P2|NOT COMPLETED|Overall Study||1
1444159|NCT02219087|3534764|P1|NOT COMPLETED|Overall Study||0
1444160|NCT02219087|3534763|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
1444161|NCT02219087|3534764|P1|COMPLETED|Overall Study||30
1444162|NCT02219087|3534763|P2|STARTED|Overall Study||30
1444163|NCT02219087|3534764|P1|STARTED|Overall Study||30
1444164|NCT02219009|3534784|P2|NOT COMPLETED|Overall Study||8
1444165|NCT02219009|3534785|P1|NOT COMPLETED|Overall Study||10
1444166|NCT02219009|3534784|P2|COMPLETED|Overall Study||22
1444167|NCT02219009|3534785|P1|COMPLETED|Overall Study||27
1444168|NCT02219009|3534784|P2|STARTED|Overall Study||30
1444169|NCT02219009|3534785|P1|STARTED|Overall Study||37
1444170|NCT02218697|3534797|P2|NOT COMPLETED|Overall Study||6
1444171|NCT02218697|3534798|P1|NOT COMPLETED|Overall Study||2
1444172|NCT02218697|3534797|P2|COMPLETED|Overall Study||171
1444173|NCT02218697|3534798|P1|COMPLETED|Overall Study||177
1444174|NCT02218697|3534797|P2|STARTED|Overall Study||177
1444175|NCT02218697|3534798|P1|STARTED|Overall Study||179
1444176|NCT02218541|3534838|P2|NOT COMPLETED|Overall Study||2
1444177|NCT02218541|3534839|P1|NOT COMPLETED|Overall Study||6
1444178|NCT02218541|3534838|P2|COMPLETED|Overall Study||9
1444179|NCT02218541|3534839|P1|COMPLETED|Overall Study||5
1444180|NCT02218541|3534838|P2|STARTED|Overall Study||11
1444181|NCT02218541|3534839|P1|STARTED|Overall Study||11
1444182|NCT02218424|3534851|P2|NOT COMPLETED|Overall Study||0
1444183|NCT02218424|3534852|P1|NOT COMPLETED|Overall Study||0
1444184|NCT02218424|3534851|P2|COMPLETED|Overall Study||30
1444185|NCT02218424|3534852|P1|COMPLETED|Overall Study||30
1444186|NCT02218424|3534851|P2|STARTED|Overall Study||30
1444187|NCT02218424|3534852|P1|STARTED|Overall Study||30
1444188|NCT02218372|3534874|P2|NOT COMPLETED|Overall Study||6
1444189|NCT02218372|3534875|P1|NOT COMPLETED|Overall Study||5
1444190|NCT02218372|3534874|P2|COMPLETED|Overall Study||42
1444191|NCT02218372|3534875|P1|COMPLETED|Overall Study||95
1444192|NCT02218372|3534874|P2|Treated|Overall Study||44
1444193|NCT02218372|3534875|P1|Treated|Overall Study||98
1444194|NCT02218372|3534874|P2|STARTED|Overall Study||48
1444195|NCT02218372|3534875|P1|STARTED|Overall Study||100
1444196|NCT02218320|3534933|P2|NOT COMPLETED|Overall Study||0
1444197|NCT02218320|3534934|P1|NOT COMPLETED|Overall Study||0
1444198|NCT02218320|3534933|P2|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
1444199|NCT02218320|3534934|P1|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
1444200|NCT02218320|3534933|P2|STARTED|Overall Study|First participant contact on this arm was December 2014|10
1444201|NCT02218320|3534934|P1|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
1444202|NCT02218307|3534946|P2|NOT COMPLETED|Overall Study||1
1444203|NCT02218307|3534947|P1|NOT COMPLETED|Overall Study||9
1444204|NCT02218307|3534946|P2|COMPLETED|Overall Study||33
1444205|NCT02218307|3534947|P1|COMPLETED|Overall Study||25
1444206|NCT02218307|3534946|P2|STARTED|Overall Study||34
1444207|NCT02218307|3534947|P1|STARTED|Overall Study||34
1444208|NCT02218268|3534955|P2|NOT COMPLETED|Final Phase (2 Hours)||0
1444209|NCT02218268|3534956|P1|NOT COMPLETED|Final Phase (2 Hours)||0
1444210|NCT02218268|3534955|P2|COMPLETED|Final Phase (2 Hours)||21
1444211|NCT02218268|3534956|P1|COMPLETED|Final Phase (2 Hours)||19
1444212|NCT02218268|3534955|P2|STARTED|Final Phase (2 Hours)||21
1444213|NCT02218268|3534956|P1|STARTED|Final Phase (2 Hours)||19
1444214|NCT02218268|3534955|P2|NOT COMPLETED|24 Hour Washout||9
1444215|NCT02218268|3534956|P1|NOT COMPLETED|24 Hour Washout||11
1444216|NCT02218268|3534955|P2|COMPLETED|24 Hour Washout||21
1444217|NCT02218268|3534956|P1|COMPLETED|24 Hour Washout||19
1444218|NCT02218268|3534955|P2|STARTED|24 Hour Washout||30
1444219|NCT02218268|3534956|P1|STARTED|24 Hour Washout||30
1444220|NCT02218268|3534955|P2|NOT COMPLETED|First Phase (2 Hours)||0
1444221|NCT02218268|3534956|P1|NOT COMPLETED|First Phase (2 Hours)||0
1444222|NCT02218268|3534955|P2|COMPLETED|First Phase (2 Hours)||30
1444223|NCT02218268|3534956|P1|COMPLETED|First Phase (2 Hours)||30
1444224|NCT02218268|3534955|P2|STARTED|First Phase (2 Hours)||30
1444225|NCT02218268|3534956|P1|STARTED|First Phase (2 Hours)||30
1444226|NCT02218242|3534962|P1|NOT COMPLETED|Overall Study||0
1444227|NCT02218242|3534962|P1|COMPLETED|Overall Study||9
1444228|NCT02218242|3534962|P1|STARTED|Overall Study||9
1444229|NCT02218216|3534968|P3|NOT COMPLETED|Overall Study||0
1444230|NCT02218216|3534969|P2|NOT COMPLETED|Overall Study||0
1444231|NCT02218216|3534970|P1|NOT COMPLETED|Overall Study||6
1444232|NCT02218216|3534968|P3|COMPLETED|Overall Study||3
1444233|NCT02218216|3534969|P2|COMPLETED|Overall Study||2
1444234|NCT02218216|3534970|P1|COMPLETED|Overall Study||8
1444235|NCT02218216|3534968|P3|STARTED|Overall Study||3
1444236|NCT02218216|3534969|P2|STARTED|Overall Study||2
1444237|NCT02218216|3534970|P1|STARTED|Overall Study||14
1444238|NCT02218203|3534978|P1|NOT COMPLETED|Overall Study||0
1444239|NCT02218203|3534978|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
1444240|NCT02218203|3534978|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
1444241|NCT02218203|3534978|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
1444242|NCT02218203|3534978|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
1444243|NCT02218203|3534978|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
1444244|NCT02218203|3534978|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
1444245|NCT02218203|3534978|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
1444246|NCT02218203|3534978|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
1444247|NCT02218203|3534978|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
1444248|NCT02218203|3534978|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
1444249|NCT02218203|3534978|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
1444250|NCT02218203|3534978|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
1444251|NCT02218203|3534978|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
1444252|NCT02218203|3534978|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
1444253|NCT02218203|3534978|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
1444254|NCT02218203|3534978|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
1444255|NCT02218203|3534978|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
1444256|NCT02218203|3534978|P1|STARTED|Overall Study||26
1444257|NCT02218164|3535000|P1|NOT COMPLETED|Overall Study||0
1444258|NCT02218164|3535000|P1|COMPLETED|Overall Study||8
1444259|NCT02218164|3535000|P1|STARTED|Overall Study||8
1444260|NCT02217982|3535009|P2|NOT COMPLETED|Overall Study||1
1444261|NCT02217982|3535010|P1|NOT COMPLETED|Overall Study||1
1444262|NCT02217982|3535009|P2|COMPLETED|Overall Study||3
1444263|NCT02217982|3535010|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
1444264|NCT02217982|3535009|P2|STARTED|Overall Study||4
1444265|NCT02217982|3535010|P1|STARTED|Overall Study||1
1444266|NCT02217904|3535023|P7|NOT COMPLETED|Overall Study||0
1444267|NCT02217904|3535024|P6|NOT COMPLETED|Overall Study||0
1444268|NCT02217904|3535025|P5|NOT COMPLETED|Overall Study||0
1444269|NCT02217904|3535026|P4|NOT COMPLETED|Overall Study||0
1444270|NCT02217904|3535027|P3|NOT COMPLETED|Overall Study||0
1444271|NCT02217904|3535028|P2|NOT COMPLETED|Overall Study||0
1444272|NCT02217904|3535029|P1|NOT COMPLETED|Overall Study||0
1444273|NCT02217904|3535023|P7|COMPLETED|Overall Study||0
1444274|NCT02217904|3535024|P6|COMPLETED|Overall Study||0
1444275|NCT02217904|3535025|P5|COMPLETED|Overall Study||6
1444276|NCT02217904|3535026|P4|COMPLETED|Overall Study||6
1444277|NCT02217904|3535027|P3|COMPLETED|Overall Study||6
1444278|NCT02217904|3535028|P2|COMPLETED|Overall Study||6
1444279|NCT02217904|3535029|P1|COMPLETED|Overall Study||6
1444280|NCT02217904|3535023|P7|STARTED|Overall Study||0
1444281|NCT02217904|3535024|P6|STARTED|Overall Study||0
1444282|NCT02217904|3535025|P5|STARTED|Overall Study||6
1444283|NCT02217904|3535026|P4|STARTED|Overall Study||6
1444284|NCT02217904|3535027|P3|STARTED|Overall Study||6
1444285|NCT02217904|3535028|P2|STARTED|Overall Study||6
1444286|NCT02217904|3535029|P1|STARTED|Overall Study||6
1444287|NCT02217878|3535093|P2|NOT COMPLETED|Overall Study||2
1444288|NCT02217878|3535094|P1|NOT COMPLETED|Overall Study||2
1444289|NCT02217878|3535093|P2|COMPLETED|Overall Study||35
1444290|NCT02217878|3535094|P1|COMPLETED|Overall Study||35
1444291|NCT02217878|3535093|P2|STARTED|Overall Study||37
1444292|NCT02217878|3535094|P1|STARTED|Overall Study||37
1444293|NCT02217800|3535174|P1|NOT COMPLETED|Overall Study||0
1444294|NCT02217800|3535174|P1|COMPLETED|Overall Study||8
1444295|NCT02217800|3535174|P1|STARTED|Overall Study||8
1444296|NCT02217618|3535186|P1|NOT COMPLETED|Overall Study||0
1444297|NCT02217618|3535186|P1|COMPLETED|Overall Study||16
1444298|NCT02217618|3535186|P1|Received Study Drug|Overall Study||16
1444299|NCT02217618|3535186|P1|STARTED|Overall Study||16
1444300|NCT02217527|3535194|P2|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
1444301|NCT02217527|3535195|P1|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
1444302|NCT02217527|3535194|P2|COMPLETED|Drug Condition 2: Second Study Phase||14
1444303|NCT02217527|3535195|P1|COMPLETED|Drug Condition 2: Second Study Phase||17
1444304|NCT02217527|3535194|P2|STARTED|Drug Condition 2: Second Study Phase||15
1444305|NCT02217527|3535195|P1|STARTED|Drug Condition 2: Second Study Phase||17
1444306|NCT02217527|3535194|P2|NOT COMPLETED|Drug Condition 1: First Study Phase||3
1444307|NCT02217527|3535195|P1|NOT COMPLETED|Drug Condition 1: First Study Phase||1
1444308|NCT02217527|3535194|P2|COMPLETED|Drug Condition 1: First Study Phase||15
1444309|NCT02217527|3535195|P1|COMPLETED|Drug Condition 1: First Study Phase||17
1444310|NCT02217527|3535194|P2|STARTED|Drug Condition 1: First Study Phase||18
1444311|NCT02217527|3535195|P1|STARTED|Drug Condition 1: First Study Phase||18
1444312|NCT02217410|3535208|P3|NOT COMPLETED|Overall Study||5
1444313|NCT02217410|3535209|P2|NOT COMPLETED|Overall Study||4
1444314|NCT02217410|3535210|P1|NOT COMPLETED|Overall Study||1
1444315|NCT02217410|3535208|P3|COMPLETED|Overall Study||13
1444316|NCT02217410|3535209|P2|COMPLETED|Overall Study||30
1444317|NCT02217410|3535210|P1|COMPLETED|Overall Study||6
1444318|NCT02217410|3535208|P3|STARTED|Overall Study||18
1444319|NCT02217410|3535209|P2|STARTED|Overall Study||34
1444320|NCT02217410|3535210|P1|STARTED|Overall Study||7
1444321|NCT02217280|3535233|P1|NOT COMPLETED|Overall Study||4
1444322|NCT02217280|3535233|P1|COMPLETED|Overall Study||16
1444323|NCT02217280|3535233|P1|STARTED|Overall Study||20
1444324|NCT02216812|3535240|P2|NOT COMPLETED|Overall Study||5
1444325|NCT02216812|3535241|P1|NOT COMPLETED|Overall Study||10
1444326|NCT02216812|3535240|P2|COMPLETED|Overall Study||62
1444327|NCT02216812|3535241|P1|COMPLETED|Overall Study||57
1444328|NCT02216812|3535240|P2|STARTED|Overall Study||67
1444329|NCT02216812|3535241|P1|STARTED|Overall Study||67
1444330|NCT02216695|3535255|P1|NOT COMPLETED|Overall Study||0
1444331|NCT02216695|3535255|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
1444332|NCT02216695|3535255|P1|STARTED|Overall Study||64882
1444333|NCT02216591|3535266|P2|NOT COMPLETED|Overall Study||1
1444334|NCT02216591|3535267|P1|NOT COMPLETED|Overall Study||0
1444335|NCT02216591|3535266|P2|COMPLETED|Overall Study||9
1444336|NCT02216591|3535267|P1|COMPLETED|Overall Study||11
1444337|NCT02216591|3535266|P2|STARTED|Overall Study||10
1444338|NCT02216591|3535267|P1|STARTED|Overall Study||11
1444339|NCT02216526|3535280|P3|NOT COMPLETED|Overall Study||8
1444340|NCT02216526|3535281|P2|NOT COMPLETED|Overall Study||3
1444341|NCT02216526|3535282|P1|NOT COMPLETED|Overall Study||5
1444342|NCT02216526|3535280|P3|COMPLETED|Overall Study||36
1444343|NCT02216526|3535281|P2|COMPLETED|Overall Study||41
1444344|NCT02216526|3535282|P1|COMPLETED|Overall Study||40
1444345|NCT02216526|3535280|P3|STARTED|Overall Study||44
1444346|NCT02216526|3535281|P2|STARTED|Overall Study||44
1444347|NCT02216526|3535282|P1|STARTED|Overall Study||45
1444348|NCT02216422|3535392|P1|NOT COMPLETED|Overall Study||0
1444349|NCT02216422|3535392|P1|COMPLETED|Overall Study||36
1444350|NCT02216422|3535392|P1|STARTED|Overall Study||36
1444351|NCT02216357|3535400|P2|NOT COMPLETED|Overall Study||1
1444352|NCT02216357|3535401|P1|NOT COMPLETED|Overall Study||2
1444353|NCT02216357|3535400|P2|COMPLETED|Overall Study||4
1444354|NCT02216357|3535401|P1|COMPLETED|Overall Study||12
1444355|NCT02216357|3535400|P2|STARTED|Overall Study||5
1444356|NCT02216357|3535401|P1|STARTED|Overall Study||14
1444357|NCT02216123|3535427|P2|NOT COMPLETED|Overall Study||2
1444358|NCT02216123|3535428|P1|NOT COMPLETED|Overall Study||6
1444359|NCT02216123|3535427|P2|COMPLETED|Overall Study||83
1444360|NCT02216123|3535428|P1|COMPLETED|Overall Study||160
1444361|NCT02216123|3535427|P2|STARTED|Overall Study||85
1444362|NCT02216123|3535428|P1|STARTED|Overall Study||166
1444363|NCT02216097|3535494|P2|NOT COMPLETED|Overall Study||0
1444364|NCT02216097|3535495|P1|NOT COMPLETED|Overall Study||0
1444365|NCT02216097|3535494|P2|COMPLETED|Overall Study||6
1444366|NCT02216097|3535495|P1|COMPLETED|Overall Study||8
1444367|NCT02216097|3535494|P2|STARTED|Overall Study||6
1444368|NCT02216097|3535495|P1|STARTED|Overall Study||8
1444369|NCT02215954|3535520|P3|NOT COMPLETED|Overall Study||6
1444370|NCT02215954|3535521|P2|NOT COMPLETED|Overall Study||1
1444371|NCT02215954|3535522|P1|NOT COMPLETED|Overall Study||1
1444372|NCT02215954|3535520|P3|COMPLETED|Overall Study||205
1444373|NCT02215954|3535521|P2|COMPLETED|Overall Study||211
1444374|NCT02215954|3535522|P1|COMPLETED|Overall Study||213
1444375|NCT02215954|3535520|P3|Safety Analysis Set|Overall Study||208
1444376|NCT02215954|3535521|P2|Safety Analysis Set|Overall Study||211
1444377|NCT02215954|3535522|P1|Safety Analysis Set|Overall Study||213
1444378|NCT02215954|3535520|P3|Per Protocol (PP) Analysis Set|Overall Study||205
1444379|NCT02215954|3535521|P2|Per Protocol (PP) Analysis Set|Overall Study||208
1444380|NCT02215954|3535522|P1|Per Protocol (PP) Analysis Set|Overall Study||212
1444381|NCT02215954|3535520|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
1444382|NCT02215954|3535521|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
1444383|NCT02215954|3535522|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
1444384|NCT02215954|3535520|P3|STARTED|Overall Study||211
1444385|NCT02215954|3535521|P2|STARTED|Overall Study||212
1444386|NCT02215954|3535522|P1|STARTED|Overall Study||214
1444387|NCT02215252|3535545|P3|NOT COMPLETED|Overall Study||4
1444388|NCT02215252|3535546|P2|NOT COMPLETED|Overall Study||8
1444389|NCT02215252|3535547|P1|NOT COMPLETED|Overall Study||2
1444390|NCT02215252|3535545|P3|COMPLETED|Overall Study||41
1444391|NCT02215252|3535546|P2|COMPLETED|Overall Study||38
1444392|NCT02215252|3535547|P1|COMPLETED|Overall Study||42
1444393|NCT02215252|3535545|P3|STARTED|Overall Study||45
1444394|NCT02215252|3535546|P2|STARTED|Overall Study||46
1444395|NCT02215252|3535547|P1|STARTED|Overall Study||44
1444396|NCT02215161|3535604|P1|NOT COMPLETED|Overall Study||0
1444397|NCT02215161|3535604|P1|COMPLETED|Overall Study||14
1444398|NCT02215161|3535604|P1|STARTED|Overall Study||14
1444399|NCT02214615|3535624|P2|NOT COMPLETED|Second Intervention||0
1444400|NCT02214615|3535625|P1|NOT COMPLETED|Second Intervention||0
1444401|NCT02214615|3535624|P2|COMPLETED|Second Intervention||1
1444402|NCT02214615|3535625|P1|COMPLETED|Second Intervention||1
1444403|NCT02214615|3535624|P2|STARTED|Second Intervention||1
1444404|NCT02214615|3535625|P1|STARTED|Second Intervention||1
1444405|NCT02214615|3535624|P2|NOT COMPLETED|Washout||0
1444406|NCT02214615|3535625|P1|NOT COMPLETED|Washout||0
1444407|NCT02214615|3535624|P2|COMPLETED|Washout||1
1444408|NCT02214615|3535625|P1|COMPLETED|Washout||1
1444409|NCT02214615|3535624|P2|STARTED|Washout||1
1444410|NCT02214615|3535625|P1|STARTED|Washout||1
1444411|NCT02214615|3535624|P2|NOT COMPLETED|First Intervention||0
1444412|NCT02214615|3535625|P1|NOT COMPLETED|First Intervention||0
1444413|NCT02214615|3535624|P2|COMPLETED|First Intervention||1
1444414|NCT02214615|3535625|P1|COMPLETED|First Intervention||1
1444415|NCT02214615|3535624|P2|STARTED|First Intervention||1
1444416|NCT02214615|3535625|P1|STARTED|First Intervention||1
1444417|NCT02214420|3535635|P2|NOT COMPLETED|Overall Study||0
1444418|NCT02214420|3535636|P1|NOT COMPLETED|Overall Study||1
1444419|NCT02214420|3535635|P2|COMPLETED|Overall Study||10
1444420|NCT02214420|3535636|P1|COMPLETED|Overall Study||13
1444421|NCT02214420|3535635|P2|STARTED|Overall Study||10
1444422|NCT02214420|3535636|P1|STARTED|Overall Study||14
1444423|NCT02214277|3535645|P3|NOT COMPLETED|Overall Study||34
1444424|NCT02214277|3535646|P2|NOT COMPLETED|Overall Study||25
1444425|NCT02214277|3535647|P1|NOT COMPLETED|Overall Study||19
1444426|NCT02214277|3535645|P3|COMPLETED|Overall Study||85
1444427|NCT02214277|3535646|P2|COMPLETED|Overall Study||96
1444428|NCT02214277|3535647|P1|COMPLETED|Overall Study||104
1444429|NCT02214277|3535645|P3|STARTED|Overall Study||119
1444430|NCT02214277|3535646|P2|STARTED|Overall Study||121
1444431|NCT02214277|3535647|P1|STARTED|Overall Study||123
1444432|NCT02214238|3535657|P2|NOT COMPLETED|Overall Study||6
1444433|NCT02214238|3535658|P1|NOT COMPLETED|Overall Study||6
1444434|NCT02214238|3535657|P2|COMPLETED|Overall Study||17
1444435|NCT02214238|3535658|P1|COMPLETED|Overall Study||20
1444436|NCT02214238|3535657|P2|STARTED|Overall Study||23
1444437|NCT02214238|3535658|P1|STARTED|Overall Study||26
1444438|NCT02214225|3535671|P3|NOT COMPLETED|Overall Study||22
1444439|NCT02214225|3535672|P2|NOT COMPLETED|Overall Study||19
1444440|NCT02214225|3535673|P1|NOT COMPLETED|Overall Study||55
1444441|NCT02214225|3535671|P3|COMPLETED|Overall Study||850
1444442|NCT02214225|3535672|P2|COMPLETED|Overall Study||852
1444443|NCT02214225|3535673|P1|COMPLETED|Overall Study||1686
1444444|NCT02214225|3535671|P3|STARTED|Overall Study||872
1444445|NCT02214225|3535672|P2|STARTED|Overall Study||871
1444446|NCT02214225|3535673|P1|STARTED|Overall Study||1741
1444447|NCT02214186|3535732|P2|NOT COMPLETED|Overall Study||2
1444448|NCT02214186|3535733|P1|NOT COMPLETED|Overall Study||2
1444449|NCT02214186|3535732|P2|COMPLETED|Overall Study||21
1444450|NCT02214186|3535733|P1|COMPLETED|Overall Study||21
1444451|NCT02214186|3535732|P2|STARTED|Overall Study||23
1444452|NCT02214186|3535733|P1|STARTED|Overall Study||23
1444453|NCT02214147|3535758|P3|NOT COMPLETED|Overall Study||0
1444454|NCT02214147|3535759|P2|NOT COMPLETED|Overall Study||0
1444455|NCT02214147|3535760|P1|NOT COMPLETED|Overall Study||0
1444456|NCT02214147|3535758|P3|COMPLETED|Overall Study||8
1444457|NCT02214147|3535759|P2|COMPLETED|Overall Study||12
1444458|NCT02214147|3535760|P1|COMPLETED|Overall Study||16
1444459|NCT02214147|3535758|P3|STARTED|Overall Study||8
1444460|NCT02214147|3535759|P2|STARTED|Overall Study||12
1444461|NCT02214147|3535760|P1|STARTED|Overall Study||16
1444462|NCT02214121|3535801|P3|NOT COMPLETED|Part B||1
1444463|NCT02214121|3535802|P2|NOT COMPLETED|Part B||3
1444464|NCT02214121|3535803|P1|NOT COMPLETED|Part B||0
1444465|NCT02214121|3535801|P3|COMPLETED|Part B||7
1444466|NCT02214121|3535802|P2|COMPLETED|Part B||14
1444467|NCT02214121|3535803|P1|COMPLETED|Part B||0
1444468|NCT02214121|3535801|P3|STARTED|Part B||8
1444469|NCT02214121|3535802|P2|STARTED|Part B||17
1444470|NCT02214121|3535803|P1|STARTED|Part B||0
1444471|NCT02214121|3535801|P3|NOT COMPLETED|Part A||0
1444472|NCT02214121|3535802|P2|NOT COMPLETED|Part A||0
1444473|NCT02214121|3535803|P1|NOT COMPLETED|Part A||7
1444474|NCT02214121|3535801|P3|COMPLETED|Part A||0
1444475|NCT02214121|3535802|P2|COMPLETED|Part A||0
1444476|NCT02214121|3535803|P1|COMPLETED|Part A||39
1444477|NCT02214121|3535801|P3|STARTED|Part A||0
1444478|NCT02214121|3535802|P2|STARTED|Part A||0
1444479|NCT02214121|3535803|P1|STARTED|Part A||46
1444480|NCT02214017|3535882|P2|NOT COMPLETED|Overall Study||0
1444481|NCT02214017|3535883|P1|NOT COMPLETED|Overall Study||0
1444482|NCT02214017|3535882|P2|COMPLETED|Overall Study||18
1444483|NCT02214017|3535883|P1|COMPLETED|Overall Study||22
1444484|NCT02214017|3535882|P2|STARTED|Overall Study||18
1444485|NCT02214017|3535883|P1|STARTED|Overall Study||22
1444486|NCT02213926|3535893|P1|NOT COMPLETED|Overall Study||70
1444487|NCT02213926|3535893|P1|COMPLETED|Overall Study||54
1444488|NCT02213926|3535893|P1|STARTED|Overall Study||124
1444489|NCT02213900|3535899|P2|NOT COMPLETED|Overall Study||0
1444490|NCT02213900|3535900|P1|NOT COMPLETED|Overall Study||0
1444491|NCT02213900|3535899|P2|COMPLETED|Overall Study||67
1444492|NCT02213900|3535900|P1|COMPLETED|Overall Study||68
1444493|NCT02213900|3535899|P2|STARTED|Overall Study||67
1444494|NCT02213900|3535900|P1|STARTED|Overall Study||68
1444495|NCT02213666|3535912|P1|NOT COMPLETED|Overall Study||1
1444496|NCT02213666|3535912|P1|COMPLETED|Overall Study||71
1444497|NCT02213666|3535912|P1|STARTED|Overall Study||72
1444498|NCT02213510|3535918|P2|NOT COMPLETED|Overall Study||1
1444499|NCT02213510|3535919|P1|NOT COMPLETED|Overall Study||1
1444500|NCT02213510|3535918|P2|COMPLETED|Overall Study||18
1444501|NCT02213510|3535919|P1|COMPLETED|Overall Study||20
1444502|NCT02213510|3535918|P2|STARTED|Overall Study||19
1444503|NCT02213510|3535919|P1|STARTED|Overall Study||21
1444504|NCT02213263|3535947|P2|NOT COMPLETED|Overall Study||65
1444505|NCT02213263|3535948|P1|NOT COMPLETED|Overall Study||66
1444506|NCT02213263|3535947|P2|COMPLETED|Overall Study||131
1444507|NCT02213263|3535948|P1|COMPLETED|Overall Study||132
1444508|NCT02213263|3535947|P2|Treated|Overall Study||196
1444509|NCT02213263|3535948|P1|Treated|Overall Study||197
1444510|NCT02213263|3535947|P2|STARTED|Overall Study||196
1444511|NCT02213263|3535948|P1|STARTED|Overall Study||198
1444512|NCT02213250|3535984|P2|NOT COMPLETED|Overall Study||0
1444513|NCT02213250|3535985|P1|NOT COMPLETED|Overall Study||0
1444514|NCT02213250|3535984|P2|COMPLETED|Overall Study||8
1444515|NCT02213250|3535985|P1|COMPLETED|Overall Study||4
1444516|NCT02213250|3535984|P2|STARTED|Overall Study||8
1444517|NCT02213250|3535985|P1|STARTED|Overall Study||4
1444518|NCT02213198|3536016|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
1444519|NCT02213198|3536017|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
1444520|NCT02213198|3536016|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
1444521|NCT02213198|3536017|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
1444522|NCT02213198|3536016|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
1444523|NCT02213198|3536017|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
1444524|NCT02213198|3536016|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
1444525|NCT02213198|3536017|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
1444526|NCT02213198|3536016|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
1444527|NCT02213198|3536017|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
1444528|NCT02213198|3536016|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
1444529|NCT02213198|3536017|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
1444530|NCT02213198|3536016|P2|NOT COMPLETED|Baseline||51
1444531|NCT02213198|3536017|P1|NOT COMPLETED|Baseline||88
1444532|NCT02213198|3536016|P2|COMPLETED|Baseline||108
1444533|NCT02213198|3536017|P1|COMPLETED|Baseline||218
1444534|NCT02213198|3536016|P2|STARTED|Baseline||159
1444535|NCT02213198|3536017|P1|STARTED|Baseline||306
1444536|NCT02213094|3536027|P2|NOT COMPLETED|Overall Study||0
1444537|NCT02213094|3536028|P1|NOT COMPLETED|Overall Study||1
1444538|NCT02213094|3536027|P2|COMPLETED|Overall Study||5
1444539|NCT02213094|3536028|P1|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
1444540|NCT02213094|3536027|P2|STARTED|Overall Study||5
1444541|NCT02213094|3536028|P1|STARTED|Overall Study||5
1444542|NCT02213055|3536036|P2|NOT COMPLETED|Overall Study||0
1444543|NCT02213055|3536037|P1|NOT COMPLETED|Overall Study||39
1444544|NCT02213055|3536036|P2|COMPLETED|Overall Study||0
1444545|NCT02213055|3536037|P1|COMPLETED|Overall Study||58
1444546|NCT02213055|3536036|P2|STARTED|Overall Study||0
1444547|NCT02213055|3536037|P1|STARTED|Overall Study||97
1444548|NCT02212977|3536045|P2|NOT COMPLETED|Overall Study||6
1444549|NCT02212977|3536046|P1|NOT COMPLETED|Overall Study||5
1444550|NCT02212977|3536045|P2|COMPLETED|Overall Study||48
1444551|NCT02212977|3536046|P1|COMPLETED|Overall Study||50
1444552|NCT02212977|3536045|P2|STARTED|Overall Study||54
1444553|NCT02212977|3536046|P1|STARTED|Overall Study||55
1444554|NCT02212834|3536062|P2|NOT COMPLETED|Overall Study||0
1444555|NCT02212834|3536063|P1|NOT COMPLETED|Overall Study||0
1444556|NCT02212834|3536062|P2|COMPLETED|Overall Study||2506
1444557|NCT02212834|3536063|P1|COMPLETED|Overall Study||33938
1444558|NCT02212834|3536062|P2|STARTED|Overall Study||2506
1444559|NCT02212834|3536063|P1|STARTED|Overall Study||33938
1444560|NCT02212457|3536075|P6|NOT COMPLETED|Overall Study||13
1444561|NCT02212457|3536076|P5|NOT COMPLETED|Overall Study||15
1444562|NCT02212457|3536077|P4|NOT COMPLETED|Overall Study||11
1444563|NCT02212457|3536078|P3|NOT COMPLETED|Overall Study||16
1444564|NCT02212457|3536079|P2|NOT COMPLETED|Overall Study||21
1444565|NCT02212457|3536080|P1|NOT COMPLETED|Overall Study||19
1444566|NCT02212457|3536075|P6|COMPLETED|Overall Study||147
1444567|NCT02212457|3536076|P5|COMPLETED|Overall Study||137
1444568|NCT02212457|3536077|P4|COMPLETED|Overall Study||123
1444569|NCT02212457|3536078|P3|COMPLETED|Overall Study||141
1444570|NCT02212457|3536079|P2|COMPLETED|Overall Study||211
1444571|NCT02212457|3536080|P1|COMPLETED|Overall Study||209
1444572|NCT02212457|3536075|P6|STARTED|Overall Study||160
1444573|NCT02212457|3536076|P5|STARTED|Overall Study||152
1444574|NCT02212457|3536077|P4|STARTED|Overall Study||134
1444575|NCT02212457|3536078|P3|STARTED|Overall Study||157
1444576|NCT02212457|3536079|P2|STARTED|Overall Study||232
1444577|NCT02212457|3536080|P1|STARTED|Overall Study||228
1444578|NCT02212301|3536118|P2|NOT COMPLETED|Period 2||0
1444579|NCT02212301|3536119|P1|NOT COMPLETED|Period 2||0
1444580|NCT02212301|3536118|P2|COMPLETED|Period 2||21
1444581|NCT02212301|3536119|P1|COMPLETED|Period 2||21
1444582|NCT02212301|3536118|P2|STARTED|Period 2||21
1444583|NCT02212301|3536119|P1|STARTED|Period 2||21
1444584|NCT02212301|3536118|P2|NOT COMPLETED|Period 1||1
1444585|NCT02212301|3536119|P1|NOT COMPLETED|Period 1||0
1444586|NCT02212301|3536118|P2|COMPLETED|Period 1||21
1444587|NCT02212301|3536119|P1|COMPLETED|Period 1||21
1444588|NCT02212301|3536118|P2|STARTED|Period 1||22
1444589|NCT02212301|3536119|P1|STARTED|Period 1||21
1444590|NCT02212197|3536130|P3|NOT COMPLETED|Overall Study||0
1444591|NCT02212197|3536131|P2|NOT COMPLETED|Overall Study||0
1444592|NCT02212197|3536132|P1|NOT COMPLETED|Overall Study||1
1444593|NCT02212197|3536130|P3|COMPLETED|Overall Study||17
1444594|NCT02212197|3536131|P2|COMPLETED|Overall Study||15
1444595|NCT02212197|3536132|P1|COMPLETED|Overall Study||18
1444596|NCT02212197|3536130|P3|STARTED|Overall Study||17
1444597|NCT02212197|3536131|P2|STARTED|Overall Study||15
1444598|NCT02212197|3536132|P1|STARTED|Overall Study||19
1444599|NCT02212106|3536157|P2|NOT COMPLETED|Overall Study||4
1444600|NCT02212106|3536158|P1|NOT COMPLETED|Overall Study||10
1444601|NCT02212106|3536157|P2|COMPLETED|Overall Study||96
1444602|NCT02212106|3536158|P1|COMPLETED|Overall Study||292
1444603|NCT02212106|3536157|P2|STARTED|Overall Study||100
1444604|NCT02212106|3536158|P1|STARTED|Overall Study||302
1444605|NCT02212028|3536176|P2|NOT COMPLETED|Overall Study||0
1444606|NCT02212028|3536177|P1|NOT COMPLETED|Overall Study||0
1444607|NCT02212028|3536176|P2|COMPLETED|Overall Study||26
1444608|NCT02212028|3536177|P1|COMPLETED|Overall Study||26
1444609|NCT02212028|3536176|P2|STARTED|Overall Study||26
1444610|NCT02212028|3536177|P1|STARTED|Overall Study||26
1444611|NCT02211638|3536185|P1|NOT COMPLETED|Overall Study||983
1444612|NCT02211638|3536185|P1|COMPLETED|Overall Study||17130
1444613|NCT02211638|3536185|P1|STARTED|Overall Study||18113
1444614|NCT02211534|3536196|P2|NOT COMPLETED|Overall Study||5
1444615|NCT02211534|3536197|P1|NOT COMPLETED|Overall Study||13
1444616|NCT02211534|3536196|P2|COMPLETED|Overall Study||6
1444617|NCT02211534|3536197|P1|COMPLETED|Overall Study||11
1444618|NCT02211534|3536196|P2|STARTED|Overall Study||11
1444619|NCT02211534|3536197|P1|STARTED|Overall Study||24
1444620|NCT02211261|3536228|P11|NOT COMPLETED|Overall Study||0
1444621|NCT02211261|3536229|P10|NOT COMPLETED|Overall Study||2
1444622|NCT02211261|3536230|P9|NOT COMPLETED|Overall Study||0
1444623|NCT02211261|3536231|P8|NOT COMPLETED|Overall Study||1
1444624|NCT02211261|3536232|P7|NOT COMPLETED|Overall Study||0
1444625|NCT02211261|3536233|P6|NOT COMPLETED|Overall Study||1
1444626|NCT02211261|3536234|P5|NOT COMPLETED|Overall Study||2
1444627|NCT02211261|3536235|P4|NOT COMPLETED|Overall Study||0
1444628|NCT02211261|3536236|P3|NOT COMPLETED|Overall Study||1
1444629|NCT02211261|3536237|P2|NOT COMPLETED|Overall Study||0
1444630|NCT02211261|3536238|P1|NOT COMPLETED|Overall Study||0
1444631|NCT02211261|3536228|P11|COMPLETED|Overall Study||8
1444632|NCT02211261|3536229|P10|COMPLETED|Overall Study||14
1444633|NCT02211261|3536230|P9|COMPLETED|Overall Study||8
1444634|NCT02211261|3536231|P8|COMPLETED|Overall Study||7
1444635|NCT02211261|3536232|P7|COMPLETED|Overall Study||6
1444636|NCT02211261|3536233|P6|COMPLETED|Overall Study||1
1444637|NCT02211261|3536234|P5|COMPLETED|Overall Study||7
1444638|NCT02211261|3536235|P4|COMPLETED|Overall Study||6
1444639|NCT02211261|3536236|P3|COMPLETED|Overall Study||5
1444640|NCT02211261|3536237|P2|COMPLETED|Overall Study||6
1444641|NCT02211261|3536238|P1|COMPLETED|Overall Study||9
1444642|NCT02211261|3536228|P11|STARTED|Overall Study||8
1444643|NCT02211261|3536229|P10|STARTED|Overall Study||16
1444644|NCT02211261|3536230|P9|STARTED|Overall Study||8
1444645|NCT02211261|3536231|P8|STARTED|Overall Study||8
1444646|NCT02211261|3536232|P7|STARTED|Overall Study||6
1444647|NCT02211261|3536233|P6|STARTED|Overall Study||2
1444648|NCT02211261|3536234|P5|STARTED|Overall Study||9
1444649|NCT02211261|3536235|P4|STARTED|Overall Study||6
1444650|NCT02211261|3536236|P3|STARTED|Overall Study||6
1444651|NCT02211261|3536237|P2|STARTED|Overall Study||6
1444652|NCT02211261|3536238|P1|STARTED|Overall Study||9
1444653|NCT02210208|3536359|P1|NOT COMPLETED|Period B (Donor Site)||7
1444654|NCT02210208|3536359|P1|COMPLETED|Period B (Donor Site)||12
1444655|NCT02210208|3536359|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
1444656|NCT02210208|3536359|P1|NOT COMPLETED|Period A (Graft Site)||2
1444657|NCT02210208|3536359|P1|COMPLETED|Period A (Graft Site)||23
1444658|NCT02210208|3536359|P1|STARTED|Period A (Graft Site)||25
1444659|NCT02210195|3536368|P2|NOT COMPLETED|Overall Study||0
1444660|NCT02210195|3536369|P1|NOT COMPLETED|Overall Study||4
1444661|NCT02210195|3536368|P2|COMPLETED|Overall Study||10
1444662|NCT02210195|3536369|P1|COMPLETED|Overall Study||6
1444663|NCT02210195|3536368|P2|STARTED|Overall Study||10
1444664|NCT02210195|3536369|P1|STARTED|Overall Study||10
1444665|NCT02210091|3536379|P2|NOT COMPLETED|Overall Study||2
1444666|NCT02210091|3536380|P1|NOT COMPLETED|Overall Study||0
1444667|NCT02210091|3536379|P2|COMPLETED|Overall Study||32
1444668|NCT02210091|3536380|P1|COMPLETED|Overall Study||32
1444669|NCT02210091|3536379|P2|STARTED|Overall Study||34
1444670|NCT02210091|3536380|P1|STARTED|Overall Study||32
1444671|NCT02210052|3536452|P1|NOT COMPLETED|Overall Study||0
1444672|NCT02210052|3536452|P1|COMPLETED|Overall Study||6
1444673|NCT02210052|3536452|P1|STARTED|Overall Study||6
1444674|NCT02210039|3536456|P1|NOT COMPLETED|Overall Study||0
1444675|NCT02210039|3536456|P1|COMPLETED|Overall Study||6
1444676|NCT02210039|3536456|P1|STARTED|Overall Study||6
1444677|NCT02210000|3536462|P2|NOT COMPLETED|Overall Study||21
1444678|NCT02210000|3536463|P1|NOT COMPLETED|Overall Study||19
1444679|NCT02210000|3536462|P2|COMPLETED|Overall Study||36
1444680|NCT02210000|3536463|P1|COMPLETED|Overall Study||38
1444681|NCT02210000|3536462|P2|STARTED|Overall Study||57
1444682|NCT02210000|3536463|P1|STARTED|Overall Study||57
1444683|NCT02209766|3536489|P5|NOT COMPLETED|Overall Study||0
1444684|NCT02209766|3536490|P4|NOT COMPLETED|Overall Study||1
1444685|NCT02209766|3536491|P3|NOT COMPLETED|Overall Study||0
1444686|NCT02209766|3536492|P2|NOT COMPLETED|Overall Study||0
1444687|NCT02209766|3536493|P1|NOT COMPLETED|Overall Study||0
1444688|NCT02209766|3536489|P5|COMPLETED|Overall Study||6
1444689|NCT02209766|3536490|P4|COMPLETED|Overall Study||2
1444690|NCT02209766|3536491|P3|COMPLETED|Overall Study||6
1444691|NCT02209766|3536492|P2|COMPLETED|Overall Study||3
1444692|NCT02209766|3536493|P1|COMPLETED|Overall Study||6
1444693|NCT02209766|3536489|P5|STARTED|Overall Study||6
1444694|NCT02209766|3536490|P4|STARTED|Overall Study||3
1444695|NCT02209766|3536491|P3|STARTED|Overall Study||6
1444696|NCT02209766|3536492|P2|STARTED|Overall Study||3
1444697|NCT02209766|3536493|P1|STARTED|Overall Study||6
1444698|NCT02209506|3536544|P5|NOT COMPLETED|Overall Study||1
1444699|NCT02209506|3536545|P4|NOT COMPLETED|Overall Study||0
1444700|NCT02209506|3536546|P3|NOT COMPLETED|Overall Study||0
1444701|NCT02209506|3536547|P2|NOT COMPLETED|Overall Study||0
1444702|NCT02209506|3536548|P1|NOT COMPLETED|Overall Study||0
1444703|NCT02209506|3536544|P5|COMPLETED|Overall Study||5
1444704|NCT02209506|3536545|P4|COMPLETED|Overall Study||2
1444705|NCT02209506|3536546|P3|COMPLETED|Overall Study||6
1444706|NCT02209506|3536547|P2|COMPLETED|Overall Study||6
1444707|NCT02209506|3536548|P1|COMPLETED|Overall Study||3
1444708|NCT02209506|3536544|P5|STARTED|Overall Study||6
1444709|NCT02209506|3536545|P4|STARTED|Overall Study||2
1444710|NCT02209506|3536546|P3|STARTED|Overall Study||6
1444711|NCT02209506|3536547|P2|STARTED|Overall Study||6
1444712|NCT02209506|3536548|P1|STARTED|Overall Study||3
1444713|NCT02209454|3536623|P2|NOT COMPLETED|Second Period||0
1444714|NCT02209454|3536624|P1|NOT COMPLETED|Second Period||1
1444715|NCT02209454|3536623|P2|COMPLETED|Second Period||13
1444716|NCT02209454|3536624|P1|COMPLETED|Second Period||12
1444717|NCT02209454|3536623|P2|STARTED|Second Period||13
1444718|NCT02209454|3536624|P1|STARTED|Second Period||13
1444719|NCT02209454|3536623|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
1444720|NCT02209454|3536624|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
1444721|NCT02209454|3536623|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
1444722|NCT02209454|3536624|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
1444723|NCT02209454|3536623|P2|STARTED|Washout Period a Minimum of a 7 Day||13
1444724|NCT02209454|3536624|P1|STARTED|Washout Period a Minimum of a 7 Day||13
1444725|NCT02209454|3536623|P2|NOT COMPLETED|First Period||0
1444726|NCT02209454|3536624|P1|NOT COMPLETED|First Period||0
1444727|NCT02209454|3536623|P2|COMPLETED|First Period||13
1444728|NCT02209454|3536624|P1|COMPLETED|First Period||13
1444729|NCT02209454|3536623|P2|STARTED|First Period||13
1444730|NCT02209454|3536624|P1|STARTED|First Period||13
1444731|NCT02209259|3536641|P3|NOT COMPLETED|Overall Study||0
1444732|NCT02209259|3536642|P2|NOT COMPLETED|Overall Study||0
1444733|NCT02209259|3536643|P1|NOT COMPLETED|Overall Study||0
1444734|NCT02209259|3536641|P3|COMPLETED|Overall Study||56
1444735|NCT02209259|3536642|P2|COMPLETED|Overall Study||56
1444736|NCT02209259|3536643|P1|COMPLETED|Overall Study||56
1444737|NCT02209259|3536641|P3|STARTED|Overall Study||56
1444738|NCT02209259|3536642|P2|STARTED|Overall Study||56
1444739|NCT02209259|3536643|P1|STARTED|Overall Study||56
1444740|NCT02209181|3536661|P4|NOT COMPLETED|Overall Study||0
1444741|NCT02209181|3536662|P3|NOT COMPLETED|Overall Study||1
1444742|NCT02209181|3536663|P2|NOT COMPLETED|Overall Study||1
1444743|NCT02209181|3536664|P1|NOT COMPLETED|Overall Study||1
1444744|NCT02209181|3536661|P4|COMPLETED|Overall Study||66
1444745|NCT02209181|3536662|P3|COMPLETED|Overall Study||68
1444746|NCT02209181|3536663|P2|COMPLETED|Overall Study||66
1444747|NCT02209181|3536664|P1|COMPLETED|Overall Study||66
1444748|NCT02209181|3536661|P4|STARTED|Overall Study||66
1444749|NCT02209181|3536662|P3|STARTED|Overall Study||69
1444750|NCT02209181|3536663|P2|STARTED|Overall Study||67
1444751|NCT02209181|3536664|P1|STARTED|Overall Study||67
1444752|NCT02209064|3536826|P1|NOT COMPLETED|Overall Study||0
1444753|NCT02209064|3536826|P1|COMPLETED|Overall Study||25
1444754|NCT02209064|3536826|P1|STARTED|Overall Study||25
1444755|NCT02208843|3536833|P1|NOT COMPLETED|Overall Study||60
1444756|NCT02208843|3536833|P1|COMPLETED|Overall Study||0
1444757|NCT02208843|3536833|P1|STARTED|Overall Study||60
1444758|NCT02208349|3536841|P2|NOT COMPLETED|Sixth 6 Month||0
1444759|NCT02208349|3536842|P1|NOT COMPLETED|Sixth 6 Month||0
1444760|NCT02208349|3536841|P2|COMPLETED|Sixth 6 Month||2
1444761|NCT02208349|3536842|P1|COMPLETED|Sixth 6 Month||3
1444762|NCT02208349|3536841|P2|STARTED|Sixth 6 Month||2
1444763|NCT02208349|3536842|P1|STARTED|Sixth 6 Month||3
1444764|NCT02208349|3536841|P2|NOT COMPLETED|Fifth 6 Month||0
1444765|NCT02208349|3536842|P1|NOT COMPLETED|Fifth 6 Month||0
1444766|NCT02208349|3536841|P2|COMPLETED|Fifth 6 Month||2
1444767|NCT02208349|3536842|P1|COMPLETED|Fifth 6 Month||7
1444768|NCT02208349|3536841|P2|STARTED|Fifth 6 Month||2
1444769|NCT02208349|3536842|P1|STARTED|Fifth 6 Month||7
1444770|NCT02208349|3536841|P2|NOT COMPLETED|Fourth 6 Month||0
1444771|NCT02208349|3536842|P1|NOT COMPLETED|Fourth 6 Month||0
1444772|NCT02208349|3536841|P2|COMPLETED|Fourth 6 Month||2
1444773|NCT02208349|3536842|P1|COMPLETED|Fourth 6 Month||14
1444774|NCT02208349|3536841|P2|STARTED|Fourth 6 Month||2
1444775|NCT02208349|3536842|P1|STARTED|Fourth 6 Month||14
1444776|NCT02208349|3536841|P2|NOT COMPLETED|Third 6 Month||0
1444777|NCT02208349|3536842|P1|NOT COMPLETED|Third 6 Month||0
1444778|NCT02208349|3536841|P2|COMPLETED|Third 6 Month||3
1444779|NCT02208349|3536842|P1|COMPLETED|Third 6 Month||6
1444780|NCT02208349|3536841|P2|STARTED|Third 6 Month||3
1444781|NCT02208349|3536842|P1|STARTED|Third 6 Month||6
1444782|NCT02208349|3536841|P2|NOT COMPLETED|Second 6 Months||0
1444783|NCT02208349|3536842|P1|NOT COMPLETED|Second 6 Months||0
1444784|NCT02208349|3536841|P2|COMPLETED|Second 6 Months||7
1444785|NCT02208349|3536842|P1|COMPLETED|Second 6 Months||11
1444786|NCT02208349|3536841|P2|STARTED|Second 6 Months||7
1444787|NCT02208349|3536842|P1|STARTED|Second 6 Months||11
1444788|NCT02208349|3536841|P2|NOT COMPLETED|Initial 6 Months||0
1444789|NCT02208349|3536842|P1|NOT COMPLETED|Initial 6 Months||0
1444790|NCT02208349|3536841|P2|COMPLETED|Initial 6 Months||9
1444791|NCT02208349|3536842|P1|COMPLETED|Initial 6 Months||16
1444792|NCT02208349|3536841|P2|STARTED|Initial 6 Months||9
1444793|NCT02208349|3536842|P1|STARTED|Initial 6 Months||16
1444794|NCT02208310|3536852|P2|NOT COMPLETED|Overall Study||5
1444795|NCT02208310|3536853|P1|NOT COMPLETED|Overall Study||6
1444796|NCT02208310|3536852|P2|COMPLETED|Overall Study||0
1444797|NCT02208310|3536853|P1|COMPLETED|Overall Study||0
1444798|NCT02208310|3536852|P2|Day 180|Overall Study||1
1444799|NCT02208310|3536853|P1|Day 180|Overall Study||0
1444800|NCT02208310|3536852|P2|STARTED|Overall Study||5
1444801|NCT02208310|3536853|P1|STARTED|Overall Study||6
1444802|NCT02207972|3536885|P2|NOT COMPLETED|Overall Study||0
1444803|NCT02207972|3536886|P1|NOT COMPLETED|Overall Study||0
1444804|NCT02207972|3536885|P2|COMPLETED|Overall Study||24
1444805|NCT02207972|3536886|P1|COMPLETED|Overall Study||22
1444806|NCT02207972|3536885|P2|STARTED|Overall Study||24
1444807|NCT02207972|3536886|P1|STARTED|Overall Study||22
1444808|NCT02207907|3536898|P2|NOT COMPLETED|Overall Study||8
1444809|NCT02207907|3536899|P1|NOT COMPLETED|Overall Study||11
1444810|NCT02207907|3536898|P2|COMPLETED|Overall Study||115
1444811|NCT02207907|3536899|P1|COMPLETED|Overall Study||113
1444812|NCT02207907|3536898|P2|STARTED|Overall Study||123
1444813|NCT02207907|3536899|P1|STARTED|Overall Study||124
1444814|NCT02207829|3536917|P2|NOT COMPLETED|Overall Study||34
1444815|NCT02207829|3536918|P1|NOT COMPLETED|Overall Study||42
1444816|NCT02207829|3536917|P2|COMPLETED|Overall Study||474
1444817|NCT02207829|3536918|P1|COMPLETED|Overall Study||467
1444818|NCT02207829|3536917|P2|STARTED|Overall Study||508
1444819|NCT02207829|3536918|P1|STARTED|Overall Study||509
1444820|NCT02207803|3536926|P2|NOT COMPLETED|Overall Study||17
1444821|NCT02207803|3536927|P1|NOT COMPLETED|Overall Study||15
1444822|NCT02207803|3536926|P2|COMPLETED|Overall Study||108
1444823|NCT02207803|3536927|P1|COMPLETED|Overall Study||110
1444824|NCT02207803|3536926|P2|STARTED|Overall Study||125
1444825|NCT02207803|3536927|P1|STARTED|Overall Study||125
1444826|NCT02207725|3536939|P4|NOT COMPLETED|Overall Study||1
1444827|NCT02207725|3536940|P3|NOT COMPLETED|Overall Study||1
1444828|NCT02207725|3536941|P2|NOT COMPLETED|Overall Study||1
1444829|NCT02207725|3536942|P1|NOT COMPLETED|Overall Study||0
1444830|NCT02207725|3536939|P4|COMPLETED|Overall Study||24
1444831|NCT02207725|3536940|P3|COMPLETED|Overall Study||8
1444832|NCT02207725|3536941|P2|COMPLETED|Overall Study||24
1444833|NCT02207725|3536942|P1|COMPLETED|Overall Study||9
1444834|NCT02207725|3536939|P4|STARTED|Overall Study||25
1444835|NCT02207725|3536940|P3|STARTED|Overall Study||9
1444836|NCT02207725|3536941|P2|STARTED|Overall Study||25
1444837|NCT02207725|3536942|P1|STARTED|Overall Study||9
1444838|NCT02207634|3536972|P2|NOT COMPLETED|Overall Study||31
1444839|NCT02207634|3536973|P1|NOT COMPLETED|Overall Study||22
1444840|NCT02207634|3536972|P2|COMPLETED|Overall Study||953
1444841|NCT02207634|3536973|P1|COMPLETED|Overall Study||968
1444842|NCT02207634|3536972|P2|Received Treatment|Overall Study||983
1444843|NCT02207634|3536973|P1|Received Treatment|Overall Study||990
1444844|NCT02207634|3536972|P2|STARTED|Overall Study||984
1444845|NCT02207634|3536973|P1|STARTED|Overall Study||990
1444846|NCT02207621|3536988|P3|NOT COMPLETED|Overall Study||168
1444847|NCT02207621|3536989|P2|NOT COMPLETED|Overall Study||47
1444848|NCT02207621|3536990|P1|NOT COMPLETED|Overall Study||105
1444849|NCT02207621|3536988|P3|COMPLETED|Overall Study||86
1444850|NCT02207621|3536989|P2|COMPLETED|Overall Study||204
1444851|NCT02207621|3536990|P1|COMPLETED|Overall Study||146
1444852|NCT02207621|3536988|P3|STARTED|Overall Study||254
1444853|NCT02207621|3536989|P2|STARTED|Overall Study||251
1444854|NCT02207621|3536990|P1|STARTED|Overall Study||251
1444855|NCT02207608|3537003|P2|NOT COMPLETED|Overall Study||0
1444856|NCT02207608|3537004|P1|NOT COMPLETED|Overall Study||1
1444857|NCT02207608|3537003|P2|COMPLETED|Overall Study||15
1444858|NCT02207608|3537004|P1|COMPLETED|Overall Study||14
1444859|NCT02207608|3537003|P2|STARTED|Overall Study||15
1444860|NCT02207608|3537004|P1|STARTED|Overall Study||15
1444861|NCT02207569|3537010|P1|NOT COMPLETED|6 Months - 1 Year||9
1444862|NCT02207569|3537010|P1|COMPLETED|6 Months - 1 Year||213
1444863|NCT02207569|3537010|P1|STARTED|6 Months - 1 Year||222
1444864|NCT02207569|3537010|P1|NOT COMPLETED|30 Days to 6 Months||11
1444865|NCT02207569|3537010|P1|COMPLETED|30 Days to 6 Months||222
1444866|NCT02207569|3537010|P1|STARTED|30 Days to 6 Months||233
1444867|NCT02207569|3537010|P1|NOT COMPLETED|Implant to 30 Days||4
1444868|NCT02207569|3537010|P1|COMPLETED|Implant to 30 Days||233
1444869|NCT02207569|3537010|P1|STARTED|Implant to 30 Days||237
1444870|NCT02207569|3537010|P1|NOT COMPLETED|Enrolled to Implant||4
1444871|NCT02207569|3537010|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
1444872|NCT02207569|3537010|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
1444873|NCT02207530|3537028|P1|NOT COMPLETED|Overall Study||91
1444874|NCT02207530|3537028|P1|COMPLETED|Overall Study||21
1444875|NCT02207530|3537028|P1|STARTED|Overall Study||112
1444876|NCT02207491|3537042|P2|NOT COMPLETED|Overall Study||13
1444877|NCT02207491|3537043|P1|NOT COMPLETED|Overall Study||31
1444878|NCT02207491|3537042|P2|COMPLETED|Overall Study||196
1444879|NCT02207491|3537043|P1|COMPLETED|Overall Study||171
1444880|NCT02207491|3537042|P2|STARTED|Overall Study||209
1444881|NCT02207491|3537043|P1|STARTED|Overall Study||202
1444882|NCT02207478|3537053|P2|NOT COMPLETED|Overall Study||0
1444883|NCT02207478|3537054|P1|NOT COMPLETED|Overall Study||0
1444884|NCT02207478|3537053|P2|COMPLETED|Overall Study||46
1444885|NCT02207478|3537054|P1|COMPLETED|Overall Study||40
1444886|NCT02207478|3537053|P2|STARTED|Overall Study||46
1444887|NCT02207478|3537054|P1|STARTED|Overall Study||40
1444888|NCT02207413|3537068|P6|NOT COMPLETED|Overall Study||13
1444889|NCT02207413|3537069|P5|NOT COMPLETED|Overall Study||7
1444890|NCT02207413|3537070|P4|NOT COMPLETED|Overall Study||1
1444891|NCT02207413|3537071|P3|NOT COMPLETED|Overall Study||0
1444892|NCT02207413|3537072|P2|NOT COMPLETED|Overall Study||0
1444893|NCT02207413|3537073|P1|NOT COMPLETED|Overall Study||1
1444894|NCT02207413|3537068|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
1444895|NCT02207413|3537069|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
1444896|NCT02207413|3537070|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
1444897|NCT02207413|3537071|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
1444898|NCT02207413|3537072|P2|COMPLETED|Overall Study||60
1444899|NCT02207413|3537073|P1|COMPLETED|Overall Study||59
1444900|NCT02207413|3537068|P6|STARTED|Overall Study||474
1444901|NCT02207413|3537069|P5|STARTED|Overall Study||466
1444902|NCT02207413|3537070|P4|STARTED|Overall Study||411
1444903|NCT02207413|3537071|P3|STARTED|Overall Study||410
1444904|NCT02207413|3537072|P2|STARTED|Overall Study||60
1444905|NCT02207413|3537073|P1|STARTED|Overall Study||60
1444906|NCT02207400|3537169|P2|NOT COMPLETED|Overall Study||14
1444907|NCT02207400|3537170|P1|NOT COMPLETED|Overall Study||16
1444908|NCT02207400|3537169|P2|COMPLETED|Overall Study||109
1444909|NCT02207400|3537170|P1|COMPLETED|Overall Study||107
1444910|NCT02207400|3537169|P2|STARTED|Overall Study||123
1444911|NCT02207400|3537170|P1|STARTED|Overall Study||123
1444912|NCT02207244|3537191|P9|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
1444913|NCT02207244|3537192|P8|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||13
1444914|NCT02207244|3537193|P7|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
1444915|NCT02207244|3537194|P6|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444916|NCT02207244|3537195|P5|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444917|NCT02207244|3537196|P4|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444918|NCT02207244|3537197|P3|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444919|NCT02207244|3537198|P2|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444920|NCT02207244|3537199|P1|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444921|NCT02207244|3537191|P9|COMPLETED|Withdrawal, Retreatment Period:Week28-48||220
1444922|NCT02207244|3537192|P8|COMPLETED|Withdrawal, Retreatment Period:Week28-48||457
1444923|NCT02207244|3537193|P7|COMPLETED|Withdrawal, Retreatment Period:Week28-48||219
1444924|NCT02207244|3537194|P6|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444925|NCT02207244|3537195|P5|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444926|NCT02207244|3537196|P4|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444927|NCT02207244|3537197|P3|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444928|NCT02207244|3537198|P2|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444929|NCT02207244|3537199|P1|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
1444930|NCT02207244|3537191|P9|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||34
1444931|NCT02207244|3537192|P8|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||16
1444932|NCT02207244|3537193|P7|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||4
1444933|NCT02207244|3537194|P6|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
1444934|NCT02207244|3537195|P5|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
1444935|NCT02207244|3537196|P4|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
1444936|NCT02207244|3537197|P3|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
1444937|NCT02207244|3537198|P2|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
1444938|NCT02207244|3537199|P1|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
1444939|NCT02207244|3537191|P9|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444940|NCT02207244|3537192|P8|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||193
1444941|NCT02207244|3537193|P7|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444942|NCT02207244|3537194|P6|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444943|NCT02207244|3537195|P5|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444944|NCT02207244|3537196|P4|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444945|NCT02207244|3537197|P3|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444946|NCT02207244|3537198|P2|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444947|NCT02207244|3537199|P1|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444948|NCT02207244|3537191|P9|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||82
1444949|NCT02207244|3537192|P8|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||166
1444950|NCT02207244|3537193|P7|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||143
1444951|NCT02207244|3537194|P6|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444952|NCT02207244|3537195|P5|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444953|NCT02207244|3537196|P4|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444954|NCT02207244|3537197|P3|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444955|NCT02207244|3537198|P2|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444956|NCT02207244|3537199|P1|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
1444957|NCT02207244|3537191|P9|Non-Responders|Withdrawal, Retreatment Period:Week28-48||112
1444958|NCT02207244|3537192|P8|Non-Responders|Withdrawal, Retreatment Period:Week28-48||95
1444959|NCT02207244|3537193|P7|Non-Responders|Withdrawal, Retreatment Period:Week28-48||80
1444960|NCT02207244|3537194|P6|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
1444961|NCT02207244|3537195|P5|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
1444962|NCT02207244|3537196|P4|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
1444963|NCT02207244|3537197|P3|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
1444964|NCT02207244|3537198|P2|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
1444965|NCT02207244|3537199|P1|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
1444966|NCT02207244|3537191|P9|STARTED|Withdrawal, Retreatment Period:Week28-48||228
1444967|NCT02207244|3537192|P8|STARTED|Withdrawal, Retreatment Period:Week28-48||470
1444968|NCT02207244|3537193|P7|STARTED|Withdrawal, Retreatment Period:Week28-48||227
1444969|NCT02207244|3537194|P6|STARTED|Withdrawal, Retreatment Period:Week28-48||0
1444970|NCT02207244|3537195|P5|STARTED|Withdrawal, Retreatment Period:Week28-48||0
1444971|NCT02207244|3537196|P4|STARTED|Withdrawal, Retreatment Period:Week28-48||0
1444972|NCT02207244|3537197|P3|STARTED|Withdrawal, Retreatment Period:Week28-48||0
1444973|NCT02207244|3537198|P2|STARTED|Withdrawal, Retreatment Period:Week28-48||0
1444974|NCT02207244|3537199|P1|STARTED|Withdrawal, Retreatment Period:Week28-48||0
1444975|NCT02207244|3537191|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444976|NCT02207244|3537192|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444977|NCT02207244|3537193|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444978|NCT02207244|3537194|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||9
1444979|NCT02207244|3537195|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||8
1444980|NCT02207244|3537196|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||6
1444981|NCT02207244|3537197|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444982|NCT02207244|3537198|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444983|NCT02207244|3537199|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444984|NCT02207244|3537191|P9|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444985|NCT02207244|3537192|P8|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444986|NCT02207244|3537193|P7|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444987|NCT02207244|3537194|P6|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||228
1444988|NCT02207244|3537195|P5|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||470
1444989|NCT02207244|3537196|P4|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||227
1444990|NCT02207244|3537197|P3|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444991|NCT02207244|3537198|P2|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444992|NCT02207244|3537199|P1|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
1444993|NCT02207244|3537191|P9|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
1444994|NCT02207244|3537192|P8|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
1444995|NCT02207244|3537193|P7|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
1444996|NCT02207244|3537194|P6|STARTED|Placebo Crossover and ACP: Week 16 - 28||237
1444997|NCT02207244|3537195|P5|STARTED|Placebo Crossover and ACP: Week 16 - 28||478
1444998|NCT02207244|3537196|P4|STARTED|Placebo Crossover and ACP: Week 16 - 28||233
1444999|NCT02207244|3537197|P3|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
1445000|NCT02207244|3537198|P2|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
1445001|NCT02207244|3537199|P1|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
1445002|NCT02207244|3537191|P9|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445003|NCT02207244|3537192|P8|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445004|NCT02207244|3537193|P7|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445005|NCT02207244|3537194|P6|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445006|NCT02207244|3537195|P5|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445007|NCT02207244|3537196|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445008|NCT02207244|3537197|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||11
1445009|NCT02207244|3537198|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||18
1445010|NCT02207244|3537199|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||15
1445011|NCT02207244|3537191|P9|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445012|NCT02207244|3537192|P8|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445013|NCT02207244|3537193|P7|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445014|NCT02207244|3537194|P6|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445015|NCT02207244|3537195|P5|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445016|NCT02207244|3537196|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
1445017|NCT02207244|3537197|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||237
1445018|NCT02207244|3537198|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||478
1445019|NCT02207244|3537199|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||233
1445020|NCT02207244|3537191|P9|Treated|Placebo Controlled Period: Week 0 - 16||0
1445021|NCT02207244|3537192|P8|Treated|Placebo Controlled Period: Week 0 - 16||0
1445022|NCT02207244|3537193|P7|Treated|Placebo Controlled Period: Week 0 - 16||0
1445023|NCT02207244|3537194|P6|Treated|Placebo Controlled Period: Week 0 - 16||0
1445024|NCT02207244|3537195|P5|Treated|Placebo Controlled Period: Week 0 - 16||0
1445025|NCT02207244|3537196|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
1445026|NCT02207244|3537197|P3|Treated|Placebo Controlled Period: Week 0 - 16||248
1445027|NCT02207244|3537198|P2|Treated|Placebo Controlled Period: Week 0 - 16||494
1445028|NCT02207244|3537199|P1|Treated|Placebo Controlled Period: Week 0 - 16||248
1445029|NCT02207244|3537191|P9|STARTED|Placebo Controlled Period: Week 0 - 16||0
1445030|NCT02207244|3537192|P8|STARTED|Placebo Controlled Period: Week 0 - 16||0
1445031|NCT02207244|3537193|P7|STARTED|Placebo Controlled Period: Week 0 - 16||0
1445032|NCT02207244|3537194|P6|STARTED|Placebo Controlled Period: Week 0 - 16||0
1445033|NCT02207244|3537195|P5|STARTED|Placebo Controlled Period: Week 0 - 16||0
1445034|NCT02207244|3537196|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
1445035|NCT02207244|3537197|P3|STARTED|Placebo Controlled Period: Week 0 - 16||248
1445036|NCT02207244|3537198|P2|STARTED|Placebo Controlled Period: Week 0 - 16||496
1445037|NCT02207244|3537199|P1|STARTED|Placebo Controlled Period: Week 0 - 16||248
1445038|NCT02207231|3537240|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
1445039|NCT02207231|3537241|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
1445040|NCT02207231|3537242|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
1445041|NCT02207231|3537240|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
1445042|NCT02207231|3537241|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
1445043|NCT02207231|3537242|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
1445044|NCT02207231|3537240|P3|STARTED|Active Controlled Period: Week 16 - 48||324
1445045|NCT02207231|3537241|P2|STARTED|Active Controlled Period: Week 16 - 48||322
1445046|NCT02207231|3537242|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
1445047|NCT02207231|3537240|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
1445048|NCT02207231|3537241|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
1445049|NCT02207231|3537242|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
1445050|NCT02207231|3537240|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
1445051|NCT02207231|3537241|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
1445052|NCT02207231|3537242|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
1445053|NCT02207231|3537240|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
1445054|NCT02207231|3537241|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
1445055|NCT02207231|3537242|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
1445056|NCT02207231|3537240|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
1445057|NCT02207231|3537241|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
1445058|NCT02207231|3537242|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
1445059|NCT02207088|3537274|P1|NOT COMPLETED|Overall Study||2
1445060|NCT02207088|3537274|P1|COMPLETED|Overall Study||66
1445061|NCT02207088|3537274|P1|STARTED|Overall Study||68
1445062|NCT02206776|3537282|P2|NOT COMPLETED|Overall Study||0
1445063|NCT02206776|3537283|P1|NOT COMPLETED|Overall Study||0
1445064|NCT02206776|3537282|P2|COMPLETED|Overall Study||1
1445065|NCT02206776|3537283|P1|COMPLETED|Overall Study||1
1445066|NCT02206776|3537282|P2|STARTED|Overall Study||1
1445067|NCT02206776|3537283|P1|STARTED|Overall Study||1
1445068|NCT02206607|3537289|P5|NOT COMPLETED|Fourth Intervention Period||0
1445069|NCT02206607|3537290|P4|NOT COMPLETED|Fourth Intervention Period||0
1445070|NCT02206607|3537291|P3|NOT COMPLETED|Fourth Intervention Period||0
1445071|NCT02206607|3537292|P2|NOT COMPLETED|Fourth Intervention Period||0
1445072|NCT02206607|3537293|P1|NOT COMPLETED|Fourth Intervention Period||0
1445073|NCT02206607|3537289|P5|COMPLETED|Fourth Intervention Period||10
1445074|NCT02206607|3537290|P4|COMPLETED|Fourth Intervention Period||10
1445075|NCT02206607|3537291|P3|COMPLETED|Fourth Intervention Period||9
1445076|NCT02206607|3537292|P2|COMPLETED|Fourth Intervention Period||9
1445077|NCT02206607|3537293|P1|COMPLETED|Fourth Intervention Period||0
1445078|NCT02206607|3537289|P5|STARTED|Fourth Intervention Period||10
1445079|NCT02206607|3537290|P4|STARTED|Fourth Intervention Period||10
1445080|NCT02206607|3537291|P3|STARTED|Fourth Intervention Period||9
1445081|NCT02206607|3537292|P2|STARTED|Fourth Intervention Period||9
1445082|NCT02206607|3537293|P1|STARTED|Fourth Intervention Period||0
1445083|NCT02206607|3537289|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1445084|NCT02206607|3537290|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1445085|NCT02206607|3537291|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1445086|NCT02206607|3537292|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1445087|NCT02206607|3537293|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
1445088|NCT02206607|3537289|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
1445089|NCT02206607|3537290|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
1445090|NCT02206607|3537291|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
1445091|NCT02206607|3537292|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
1445092|NCT02206607|3537293|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
1445093|NCT02206607|3537289|P5|STARTED|Third Washout Period 5 to 10 Days||10
1445094|NCT02206607|3537290|P4|STARTED|Third Washout Period 5 to 10 Days||10
1445095|NCT02206607|3537291|P3|STARTED|Third Washout Period 5 to 10 Days||9
1445096|NCT02206607|3537292|P2|STARTED|Third Washout Period 5 to 10 Days||9
1445097|NCT02206607|3537293|P1|STARTED|Third Washout Period 5 to 10 Days||0
1445098|NCT02206607|3537289|P5|NOT COMPLETED|Third Intervention Period||0
1445099|NCT02206607|3537290|P4|NOT COMPLETED|Third Intervention Period||0
1445100|NCT02206607|3537291|P3|NOT COMPLETED|Third Intervention Period||0
1445101|NCT02206607|3537292|P2|NOT COMPLETED|Third Intervention Period||0
1445102|NCT02206607|3537293|P1|NOT COMPLETED|Third Intervention Period||0
1445103|NCT02206607|3537289|P5|COMPLETED|Third Intervention Period||10
1445104|NCT02206607|3537290|P4|COMPLETED|Third Intervention Period||10
1445105|NCT02206607|3537291|P3|COMPLETED|Third Intervention Period||9
1445106|NCT02206607|3537292|P2|COMPLETED|Third Intervention Period||9
1445107|NCT02206607|3537293|P1|COMPLETED|Third Intervention Period||0
1445108|NCT02206607|3537289|P5|STARTED|Third Intervention Period||10
1445109|NCT02206607|3537290|P4|STARTED|Third Intervention Period||10
1445110|NCT02206607|3537291|P3|STARTED|Third Intervention Period||9
1445111|NCT02206607|3537292|P2|STARTED|Third Intervention Period||9
1445112|NCT02206607|3537293|P1|STARTED|Third Intervention Period||0
1445113|NCT02206607|3537289|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1445114|NCT02206607|3537290|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1445115|NCT02206607|3537291|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1445116|NCT02206607|3537292|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1445117|NCT02206607|3537293|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
1445118|NCT02206607|3537289|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
1445119|NCT02206607|3537290|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
1445120|NCT02206607|3537291|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
1445121|NCT02206607|3537292|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
1445122|NCT02206607|3537293|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
1445123|NCT02206607|3537289|P5|STARTED|Second Washout Period 5 to 10 Days||10
1445124|NCT02206607|3537290|P4|STARTED|Second Washout Period 5 to 10 Days||10
1445125|NCT02206607|3537291|P3|STARTED|Second Washout Period 5 to 10 Days||9
1445126|NCT02206607|3537292|P2|STARTED|Second Washout Period 5 to 10 Days||9
1445127|NCT02206607|3537293|P1|STARTED|Second Washout Period 5 to 10 Days||0
1445128|NCT02206607|3537289|P5|NOT COMPLETED|Second Intervention Period||0
1445129|NCT02206607|3537290|P4|NOT COMPLETED|Second Intervention Period||1
1445130|NCT02206607|3537291|P3|NOT COMPLETED|Second Intervention Period||0
1445131|NCT02206607|3537292|P2|NOT COMPLETED|Second Intervention Period||0
1445132|NCT02206607|3537293|P1|NOT COMPLETED|Second Intervention Period||0
1445133|NCT02206607|3537289|P5|COMPLETED|Second Intervention Period||10
1445134|NCT02206607|3537290|P4|COMPLETED|Second Intervention Period||10
1445135|NCT02206607|3537291|P3|COMPLETED|Second Intervention Period||9
1445136|NCT02206607|3537292|P2|COMPLETED|Second Intervention Period||9
1445137|NCT02206607|3537293|P1|COMPLETED|Second Intervention Period||0
1445138|NCT02206607|3537289|P5|STARTED|Second Intervention Period||10
1445139|NCT02206607|3537290|P4|STARTED|Second Intervention Period||11
1445140|NCT02206607|3537291|P3|STARTED|Second Intervention Period||9
1445141|NCT02206607|3537292|P2|STARTED|Second Intervention Period||9
1445142|NCT02206607|3537293|P1|STARTED|Second Intervention Period||0
1445143|NCT02206607|3537289|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1445144|NCT02206607|3537290|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1445145|NCT02206607|3537291|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1445146|NCT02206607|3537292|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1445147|NCT02206607|3537293|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
1445148|NCT02206607|3537289|P5|COMPLETED|First Washout Period 5 to 10 Days||10
1445149|NCT02206607|3537290|P4|COMPLETED|First Washout Period 5 to 10 Days||11
1445150|NCT02206607|3537291|P3|COMPLETED|First Washout Period 5 to 10 Days||9
1445151|NCT02206607|3537292|P2|COMPLETED|First Washout Period 5 to 10 Days||9
1445152|NCT02206607|3537293|P1|COMPLETED|First Washout Period 5 to 10 Days||0
1445153|NCT02206607|3537289|P5|STARTED|First Washout Period 5 to 10 Days||10
1445154|NCT02206607|3537290|P4|STARTED|First Washout Period 5 to 10 Days||11
1445155|NCT02206607|3537291|P3|STARTED|First Washout Period 5 to 10 Days||9
1445156|NCT02206607|3537292|P2|STARTED|First Washout Period 5 to 10 Days||9
1445157|NCT02206607|3537293|P1|STARTED|First Washout Period 5 to 10 Days||0
1445158|NCT02206607|3537289|P5|NOT COMPLETED|First Intervention Period||0
1445159|NCT02206607|3537290|P4|NOT COMPLETED|First Intervention Period||0
1445160|NCT02206607|3537291|P3|NOT COMPLETED|First Intervention Period||0
1445161|NCT02206607|3537292|P2|NOT COMPLETED|First Intervention Period||0
1445162|NCT02206607|3537293|P1|NOT COMPLETED|First Intervention Period||0
1445163|NCT02206607|3537289|P5|COMPLETED|First Intervention Period||10
1445164|NCT02206607|3537290|P4|COMPLETED|First Intervention Period||11
1445165|NCT02206607|3537291|P3|COMPLETED|First Intervention Period||9
1445166|NCT02206607|3537292|P2|COMPLETED|First Intervention Period||9
1445167|NCT02206607|3537293|P1|COMPLETED|First Intervention Period||0
1445168|NCT02206607|3537289|P5|STARTED|First Intervention Period||10
1445169|NCT02206607|3537290|P4|STARTED|First Intervention Period||11
1445170|NCT02206607|3537291|P3|STARTED|First Intervention Period||9
1445171|NCT02206607|3537292|P2|STARTED|First Intervention Period||9
1445172|NCT02206607|3537293|P1|STARTED|First Intervention Period||0
1445173|NCT02206607|3537289|P5|NOT COMPLETED|Open-Label Run-In||0
1445174|NCT02206607|3537290|P4|NOT COMPLETED|Open-Label Run-In||0
1445175|NCT02206607|3537291|P3|NOT COMPLETED|Open-Label Run-In||0
1445176|NCT02206607|3537292|P2|NOT COMPLETED|Open-Label Run-In||0
1445177|NCT02206607|3537293|P1|NOT COMPLETED|Open-Label Run-In||3
1445178|NCT02206607|3537289|P5|COMPLETED|Open-Label Run-In||0
1445179|NCT02206607|3537290|P4|COMPLETED|Open-Label Run-In||0
1445180|NCT02206607|3537291|P3|COMPLETED|Open-Label Run-In||0
1445181|NCT02206607|3537292|P2|COMPLETED|Open-Label Run-In||0
1445182|NCT02206607|3537293|P1|COMPLETED|Open-Label Run-In||39
1445183|NCT02206607|3537289|P5|STARTED|Open-Label Run-In||0
1445184|NCT02206607|3537290|P4|STARTED|Open-Label Run-In||0
1445185|NCT02206607|3537291|P3|STARTED|Open-Label Run-In||0
1445186|NCT02206607|3537292|P2|STARTED|Open-Label Run-In||0
1445187|NCT02206607|3537293|P1|STARTED|Open-Label Run-In||42
1445188|NCT02205983|3537349|P4|NOT COMPLETED|Overall Study||0
1445189|NCT02205983|3537350|P3|NOT COMPLETED|Overall Study||0
1445190|NCT02205983|3537351|P2|NOT COMPLETED|Overall Study||0
1445191|NCT02205983|3537352|P1|NOT COMPLETED|Overall Study||0
1445192|NCT02205983|3537349|P4|COMPLETED|Overall Study||13
1445193|NCT02205983|3537350|P3|COMPLETED|Overall Study||13
1445194|NCT02205983|3537351|P2|COMPLETED|Overall Study||12
1445195|NCT02205983|3537352|P1|COMPLETED|Overall Study||12
1445196|NCT02205983|3537349|P4|STARTED|Overall Study||13
1445197|NCT02205983|3537350|P3|STARTED|Overall Study||13
1445198|NCT02205983|3537351|P2|STARTED|Overall Study||12
1445199|NCT02205983|3537352|P1|STARTED|Overall Study||12
1445200|NCT02205814|3537366|P4|NOT COMPLETED|Overall Study||4
1445201|NCT02205814|3537367|P3|NOT COMPLETED|Overall Study||5
1445202|NCT02205814|3537368|P2|NOT COMPLETED|Overall Study||1
1445203|NCT02205814|3537369|P1|NOT COMPLETED|Overall Study||2
1445204|NCT02205814|3537366|P4|COMPLETED|Overall Study||104
1445205|NCT02205814|3537367|P3|COMPLETED|Overall Study||103
1445206|NCT02205814|3537368|P2|COMPLETED|Overall Study||109
1445207|NCT02205814|3537369|P1|COMPLETED|Overall Study||108
1445208|NCT02205814|3537366|P4|STARTED|Overall Study||108
1445209|NCT02205814|3537367|P3|STARTED|Overall Study||108
1445210|NCT02205814|3537368|P2|STARTED|Overall Study||110
1445211|NCT02205814|3537369|P1|STARTED|Overall Study||110
1445212|NCT02205801|3537395|P4|NOT COMPLETED|Overall Study||0
1445213|NCT02205801|3537396|P3|NOT COMPLETED|Overall Study||0
1445214|NCT02205801|3537397|P2|NOT COMPLETED|Overall Study||0
1445215|NCT02205801|3537398|P1|NOT COMPLETED|Overall Study||0
1445216|NCT02205801|3537395|P4|COMPLETED|Overall Study||8
1445217|NCT02205801|3537396|P3|COMPLETED|Overall Study||9
1445218|NCT02205801|3537397|P2|COMPLETED|Overall Study||8
1445219|NCT02205801|3537398|P1|COMPLETED|Overall Study||11
1445220|NCT02205801|3537395|P4|STARTED|Overall Study||8
1445221|NCT02205801|3537396|P3|STARTED|Overall Study||9
1445222|NCT02205801|3537397|P2|STARTED|Overall Study||8
1445223|NCT02205801|3537398|P1|STARTED|Overall Study||11
1445224|NCT02205476|3537422|P2|NOT COMPLETED|Overall Study||3
1445225|NCT02205476|3537423|P1|NOT COMPLETED|Overall Study||7
1445226|NCT02205476|3537422|P2|COMPLETED|Overall Study||0
1445227|NCT02205476|3537423|P1|COMPLETED|Overall Study||0
1445228|NCT02205476|3537422|P2|STARTED|Overall Study||3
1445229|NCT02205476|3537423|P1|STARTED|Overall Study||7
1445230|NCT02205333|3537462|P9|NOT COMPLETED|Overall Study||0
1445231|NCT02205333|3537463|P8|NOT COMPLETED|Overall Study||2
1445232|NCT02205333|3537464|P7|NOT COMPLETED|Overall Study||5
1445233|NCT02205333|3537465|P6|NOT COMPLETED|Overall Study||3
1445234|NCT02205333|3537466|P5|NOT COMPLETED|Overall Study||5
1445235|NCT02205333|3537467|P4|NOT COMPLETED|Overall Study||7
1445236|NCT02205333|3537468|P3|NOT COMPLETED|Overall Study||2
1445237|NCT02205333|3537469|P2|NOT COMPLETED|Overall Study||6
1445238|NCT02205333|3537470|P1|NOT COMPLETED|Overall Study||6
1445239|NCT02205333|3537462|P9|COMPLETED|Overall Study||1
1445240|NCT02205333|3537463|P8|COMPLETED|Overall Study||1
1445241|NCT02205333|3537464|P7|COMPLETED|Overall Study||2
1445242|NCT02205333|3537465|P6|COMPLETED|Overall Study||4
1445243|NCT02205333|3537466|P5|COMPLETED|Overall Study||1
1445244|NCT02205333|3537467|P4|COMPLETED|Overall Study||0
1445245|NCT02205333|3537468|P3|COMPLETED|Overall Study||1
1445246|NCT02205333|3537469|P2|COMPLETED|Overall Study||0
1445247|NCT02205333|3537470|P1|COMPLETED|Overall Study||2
1445248|NCT02205333|3537462|P9|STARTED|Overall Study||1
1445249|NCT02205333|3537463|P8|STARTED|Overall Study||3
1445250|NCT02205333|3537464|P7|STARTED|Overall Study||7
1445251|NCT02205333|3537465|P6|STARTED|Overall Study||7
1445252|NCT02205333|3537466|P5|STARTED|Overall Study||6
1445253|NCT02205333|3537467|P4|STARTED|Overall Study||7
1445254|NCT02205333|3537468|P3|STARTED|Overall Study||3
1445255|NCT02205333|3537469|P2|STARTED|Overall Study||6
1445256|NCT02205333|3537470|P1|STARTED|Overall Study||8
1445257|NCT02204917|3537643|P1|NOT COMPLETED|Overall Study||1
1445258|NCT02204917|3537643|P1|COMPLETED|Overall Study||30
1445259|NCT02204917|3537643|P1|STARTED|Overall Study||31
1445260|NCT02204761|3537650|P1|NOT COMPLETED|Overall Study||0
1445261|NCT02204761|3537650|P1|COMPLETED|Overall Study||6
1445262|NCT02204761|3537650|P1|STARTED|Overall Study||6
1445263|NCT02204748|3537657|P1|NOT COMPLETED|Overall Study||0
1445264|NCT02204748|3537657|P1|COMPLETED|Overall Study||5
1445265|NCT02204748|3537657|P1|STARTED|Overall Study||5
1445266|NCT02204657|3537671|P2|NOT COMPLETED|Overall Study||0
1445267|NCT02204657|3537672|P1|NOT COMPLETED|Overall Study||7
1445268|NCT02204657|3537671|P2|COMPLETED|Overall Study||25
1445269|NCT02204657|3537672|P1|COMPLETED|Overall Study||25
1445270|NCT02204657|3537671|P2|STARTED|Overall Study||25
1445271|NCT02204657|3537672|P1|STARTED|Overall Study||32
1445272|NCT02204579|3537680|P1|NOT COMPLETED|Overall Study||2
1445273|NCT02204579|3537680|P1|COMPLETED|Overall Study||5
1445274|NCT02204579|3537680|P1|Treated|Overall Study||5
1445275|NCT02204579|3537680|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
1445276|NCT02204579|3537680|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
1445277|NCT02204579|3537680|P1|STARTED|Overall Study||7
1445278|NCT02204449|3537734|P2|NOT COMPLETED|Overall Study||11
1445279|NCT02204449|3537735|P1|NOT COMPLETED|Overall Study||7
1445280|NCT02204449|3537734|P2|COMPLETED|Overall Study||37
1445281|NCT02204449|3537735|P1|COMPLETED|Overall Study||39
1445282|NCT02204449|3537734|P2|STARTED|Overall Study||48
1445283|NCT02204449|3537735|P1|STARTED|Overall Study||46
1445284|NCT02204410|3537745|P1|NOT COMPLETED|Overall Study||11
1445285|NCT02204410|3537745|P1|COMPLETED|Overall Study||10
1445286|NCT02204410|3537745|P1|STARTED|Overall Study||21
1445287|NCT02204371|3537750|P1|NOT COMPLETED|Overall Study||1
1445288|NCT02204371|3537750|P1|COMPLETED|Overall Study||6
1445289|NCT02204371|3537750|P1|STARTED|Overall Study||7
1445290|NCT02204319|3537773|P1|NOT COMPLETED|Overall Study||3
1445291|NCT02204319|3537773|P1|COMPLETED|Overall Study|3 did not complete study.|7
1445292|NCT02204319|3537773|P1|STARTED|Overall Study||10
1445293|NCT02204124|3537781|P2|NOT COMPLETED|Overall Study||0
1445294|NCT02204124|3537782|P1|NOT COMPLETED|Overall Study||0
1445295|NCT02204124|3537781|P2|COMPLETED|Overall Study||19
1445296|NCT02204124|3537782|P1|COMPLETED|Overall Study||13
1445297|NCT02204124|3537781|P2|STARTED|Overall Study||19
1445298|NCT02204124|3537782|P1|STARTED|Overall Study||13
1445299|NCT02204007|3537802|P2|NOT COMPLETED|Overall Study||1
1445300|NCT02204007|3537803|P1|NOT COMPLETED|Overall Study||1
1445301|NCT02204007|3537802|P2|COMPLETED|Overall Study||17
1445302|NCT02204007|3537803|P1|COMPLETED|Overall Study||17
1445303|NCT02204007|3537802|P2|STARTED|Overall Study||18
1445304|NCT02204007|3537803|P1|STARTED|Overall Study||18
1445305|NCT02203916|3537814|P3|NOT COMPLETED|Overall Study||11
1445306|NCT02203916|3537815|P2|NOT COMPLETED|Overall Study||10
1445307|NCT02203916|3537816|P1|NOT COMPLETED|Overall Study||8
1445308|NCT02203916|3537814|P3|COMPLETED|Overall Study||120
1445309|NCT02203916|3537815|P2|COMPLETED|Overall Study||122
1445310|NCT02203916|3537816|P1|COMPLETED|Overall Study||57
1445311|NCT02203916|3537814|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
1445312|NCT02203916|3537815|P2|Safety Analysis Set (SAS)|Overall Study||132
1445313|NCT02203916|3537816|P1|Safety Analysis Set (SAS)|Overall Study||65
1445314|NCT02203916|3537814|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
1445315|NCT02203916|3537815|P2|Full Analysis Set (FAS)|Overall Study||132
1445316|NCT02203916|3537816|P1|Full Analysis Set (FAS)|Overall Study||65
1445317|NCT02203916|3537814|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
1445318|NCT02203916|3537815|P2|STARTED|Overall Study||132
1445319|NCT02203916|3537816|P1|STARTED|Overall Study||65
1445320|NCT02203838|3537840|P4|NOT COMPLETED|Overall Study||18
1445321|NCT02203838|3537841|P3|NOT COMPLETED|Overall Study||16
1445322|NCT02203838|3537842|P2|NOT COMPLETED|Overall Study||22
1445323|NCT02203838|3537843|P1|NOT COMPLETED|Overall Study||210
1445324|NCT02203838|3537840|P4|COMPLETED|Overall Study||15
1445325|NCT02203838|3537841|P3|COMPLETED|Overall Study||15
1445326|NCT02203838|3537842|P2|COMPLETED|Overall Study||6
1445327|NCT02203838|3537843|P1|COMPLETED|Overall Study||198
1445328|NCT02203838|3537840|P4|STARTED|Overall Study||33
1445329|NCT02203838|3537841|P3|STARTED|Overall Study||31
1445330|NCT02203838|3537842|P2|STARTED|Overall Study||28
1445331|NCT02203838|3537843|P1|STARTED|Overall Study||408
1445332|NCT02203786|3537877|P4|NOT COMPLETED|Overall Study||0
1445333|NCT02203786|3537878|P3|NOT COMPLETED|Overall Study||2
1445334|NCT02203786|3537879|P2|NOT COMPLETED|Overall Study||0
1445335|NCT02203786|3537880|P1|NOT COMPLETED|Overall Study||0
1445336|NCT02203786|3537877|P4|COMPLETED|Overall Study||15
1445337|NCT02203786|3537878|P3|COMPLETED|Overall Study||15
1445338|NCT02203786|3537879|P2|COMPLETED|Overall Study||15
1445339|NCT02203786|3537880|P1|COMPLETED|Overall Study||15
1445340|NCT02203786|3537877|P4|STARTED|Overall Study||15
1445341|NCT02203786|3537878|P3|STARTED|Overall Study||17
1445342|NCT02203786|3537879|P2|STARTED|Overall Study||15
1445343|NCT02203786|3537880|P1|STARTED|Overall Study||15
1445344|NCT02203747|3537912|P2|NOT COMPLETED|Overall Study||0
1445345|NCT02203747|3537913|P1|NOT COMPLETED|Overall Study||0
1445346|NCT02203747|3537912|P2|COMPLETED|Overall Study||34
1445347|NCT02203747|3537913|P1|COMPLETED|Overall Study||45
1445348|NCT02203747|3537912|P2|STARTED|Overall Study||34
1445349|NCT02203747|3537913|P1|STARTED|Overall Study||45
1445350|NCT02203721|3537923|P2|NOT COMPLETED|Overall Study||3
1445351|NCT02203721|3537924|P1|NOT COMPLETED|Overall Study||1
1445352|NCT02203721|3537923|P2|COMPLETED|Overall Study||148
1445353|NCT02203721|3537924|P1|COMPLETED|Overall Study||147
1445354|NCT02203721|3537923|P2|STARTED|Overall Study||151
1445355|NCT02203721|3537924|P1|STARTED|Overall Study||148
1445356|NCT02203630|3537934|P2|NOT COMPLETED|Overall Study||0
1445357|NCT02203630|3537935|P1|NOT COMPLETED|Overall Study||0
1445358|NCT02203630|3537934|P2|COMPLETED|Overall Study||9
1445359|NCT02203630|3537935|P1|COMPLETED|Overall Study||8
1445360|NCT02203630|3537934|P2|STARTED|Overall Study||9
1445361|NCT02203630|3537935|P1|STARTED|Overall Study||8
1445362|NCT02203578|3538005|P1|NOT COMPLETED|Overall Study||0
1445363|NCT02203578|3538005|P1|COMPLETED|Overall Study||1
1445364|NCT02203578|3538005|P1|STARTED|Overall Study||1
1445365|NCT02203565|3538017|P1|NOT COMPLETED|Overall Study||1
1445366|NCT02203565|3538017|P1|COMPLETED|Overall Study||19
1445367|NCT02203565|3538017|P1|STARTED|Overall Study||20
1445368|NCT02203331|3538027|P6|NOT COMPLETED|Overall Study||7
1445369|NCT02203331|3538028|P5|NOT COMPLETED|Overall Study||7
1445370|NCT02203331|3538029|P4|NOT COMPLETED|Overall Study||7
1445371|NCT02203331|3538030|P3|NOT COMPLETED|Overall Study||5
1445372|NCT02203331|3538031|P2|NOT COMPLETED|Overall Study||14
1445373|NCT02203331|3538032|P1|NOT COMPLETED|Overall Study||7
1445374|NCT02203331|3538027|P6|COMPLETED|Overall Study||46
1445375|NCT02203331|3538028|P5|COMPLETED|Overall Study||46
1445376|NCT02203331|3538029|P4|COMPLETED|Overall Study||46
1445377|NCT02203331|3538030|P3|COMPLETED|Overall Study||50
1445378|NCT02203331|3538031|P2|COMPLETED|Overall Study||39
1445379|NCT02203331|3538032|P1|COMPLETED|Overall Study||45
1445380|NCT02203331|3538027|P6|Treated|Overall Study||53
1445381|NCT02203331|3538028|P5|Treated|Overall Study||50
1445382|NCT02203331|3538029|P4|Treated|Overall Study||49
1445383|NCT02203331|3538030|P3|Treated|Overall Study||54
1445384|NCT02203331|3538031|P2|Treated|Overall Study||50
1445385|NCT02203331|3538032|P1|Treated|Overall Study||49
1445386|NCT02203331|3538027|P6|STARTED|Overall Study||53
1445387|NCT02203331|3538028|P5|STARTED|Overall Study||53
1445388|NCT02203331|3538029|P4|STARTED|Overall Study||53
1445389|NCT02203331|3538030|P3|STARTED|Overall Study||55
1445390|NCT02203331|3538031|P2|STARTED|Overall Study||53
1445391|NCT02203331|3538032|P1|STARTED|Overall Study||52
1445392|NCT02203162|3538082|P1|NOT COMPLETED|Overall Study||0
1445393|NCT02203162|3538082|P1|COMPLETED|Overall Study||30
1445394|NCT02203162|3538082|P1|STARTED|Overall Study||30
1445395|NCT02203149|3538091|P5|NOT COMPLETED|Part 2||1
1445396|NCT02203149|3538092|P4|NOT COMPLETED|Part 2||3
1445397|NCT02203149|3538093|P3|NOT COMPLETED|Part 2||1
1445398|NCT02203149|3538094|P2|NOT COMPLETED|Part 2||0
1445399|NCT02203149|3538095|P1|NOT COMPLETED|Part 2||0
1445400|NCT02203149|3538091|P5|COMPLETED|Part 2||34
1445401|NCT02203149|3538092|P4|COMPLETED|Part 2||71
1445402|NCT02203149|3538093|P3|COMPLETED|Part 2||226
1445403|NCT02203149|3538094|P2|COMPLETED|Part 2||0
1445404|NCT02203149|3538095|P1|COMPLETED|Part 2||0
1445405|NCT02203149|3538091|P5|Started Deferred Active Treatment|Part 2||0
1445406|NCT02203149|3538092|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
1445407|NCT02203149|3538093|P3|Started Deferred Active Treatment|Part 2||0
1445408|NCT02203149|3538094|P2|Started Deferred Active Treatment|Part 2||0
1445409|NCT02203149|3538095|P1|Started Deferred Active Treatment|Part 2||0
1445410|NCT02203149|3538091|P5|STARTED|Part 2||35
1445411|NCT02203149|3538092|P4|STARTED|Part 2||74
1445412|NCT02203149|3538093|P3|STARTED|Part 2||227
1445413|NCT02203149|3538094|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
1445414|NCT02203149|3538095|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
1445415|NCT02203149|3538091|P5|NOT COMPLETED|Part 1||0
1445416|NCT02203149|3538092|P4|NOT COMPLETED|Part 1||0
1445417|NCT02203149|3538093|P3|NOT COMPLETED|Part 1||0
1445418|NCT02203149|3538094|P2|NOT COMPLETED|Part 1||1
1445419|NCT02203149|3538095|P1|NOT COMPLETED|Part 1||0
1445420|NCT02203149|3538091|P5|COMPLETED|Part 1||0
1445421|NCT02203149|3538092|P4|COMPLETED|Part 1||0
1445422|NCT02203149|3538093|P3|COMPLETED|Part 1||0
1445423|NCT02203149|3538094|P2|COMPLETED|Part 1||31
1445424|NCT02203149|3538095|P1|COMPLETED|Part 1||31
1445425|NCT02203149|3538091|P5|STARTED|Part 1||0
1445426|NCT02203149|3538092|P4|STARTED|Part 1||0
1445427|NCT02203149|3538093|P3|STARTED|Part 1||0
1445428|NCT02203149|3538094|P2|STARTED|Part 1||32
1445429|NCT02203149|3538095|P1|STARTED|Part 1||31
1445430|NCT02203032|3538128|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
1445431|NCT02203032|3538129|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
1445432|NCT02203032|3538130|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
1445433|NCT02203032|3538131|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
1445434|NCT02203032|3538128|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
1445435|NCT02203032|3538129|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
1445436|NCT02203032|3538130|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
1445437|NCT02203032|3538131|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
1445438|NCT02203032|3538128|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
1445439|NCT02203032|3538129|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
1445440|NCT02203032|3538130|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
1445441|NCT02203032|3538131|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
1445442|NCT02203032|3538128|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1445443|NCT02203032|3538129|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1445444|NCT02203032|3538130|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1445445|NCT02203032|3538131|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
1445446|NCT02203032|3538128|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1445447|NCT02203032|3538129|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1445448|NCT02203032|3538130|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
1445449|NCT02203032|3538131|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
1445450|NCT02203032|3538128|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
1445451|NCT02203032|3538129|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
1445452|NCT02203032|3538130|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
1445453|NCT02203032|3538131|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
1445454|NCT02203032|3538128|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
1445455|NCT02203032|3538129|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
1445456|NCT02203032|3538130|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
1445457|NCT02203032|3538131|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
1445458|NCT02202980|3538159|P14|NOT COMPLETED|Overall Study||0
1445459|NCT02202980|3538160|P13|NOT COMPLETED|Overall Study||11
1445460|NCT02202980|3538161|P12|NOT COMPLETED|Overall Study||3
1445461|NCT02202980|3538162|P11|NOT COMPLETED|Overall Study||0
1445462|NCT02202980|3538163|P10|NOT COMPLETED|Overall Study||0
1445463|NCT02202980|3538164|P9|NOT COMPLETED|Overall Study||4
1445464|NCT02202980|3538165|P8|NOT COMPLETED|Overall Study||3
1445465|NCT02202980|3538166|P7|NOT COMPLETED|Overall Study||11
1445466|NCT02202980|3538167|P6|NOT COMPLETED|Overall Study||1
1445467|NCT02202980|3538168|P5|NOT COMPLETED|Overall Study||6
1445468|NCT02202980|3538169|P4|NOT COMPLETED|Overall Study||4
1445469|NCT02202980|3538170|P3|NOT COMPLETED|Overall Study||10
1445470|NCT02202980|3538171|P2|NOT COMPLETED|Overall Study||2
1445471|NCT02202980|3538172|P1|NOT COMPLETED|Overall Study||1
1445472|NCT02202980|3538159|P14|COMPLETED|Overall Study||4
1445473|NCT02202980|3538160|P13|COMPLETED|Overall Study||19
1445474|NCT02202980|3538161|P12|COMPLETED|Overall Study||25
1445475|NCT02202980|3538162|P11|COMPLETED|Overall Study||19
1445476|NCT02202980|3538163|P10|COMPLETED|Overall Study||17
1445477|NCT02202980|3538164|P9|COMPLETED|Overall Study||14
1445478|NCT02202980|3538165|P8|COMPLETED|Overall Study||12
1445479|NCT02202980|3538166|P7|COMPLETED|Overall Study||4
1445480|NCT02202980|3538167|P6|COMPLETED|Overall Study||14
1445481|NCT02202980|3538168|P5|COMPLETED|Overall Study||7
1445482|NCT02202980|3538169|P4|COMPLETED|Overall Study||28
1445483|NCT02202980|3538170|P3|COMPLETED|Overall Study||17
1445484|NCT02202980|3538171|P2|COMPLETED|Overall Study||24
1445485|NCT02202980|3538172|P1|COMPLETED|Overall Study||13
1445486|NCT02202980|3538159|P14|STARTED|Overall Study||4
1445487|NCT02202980|3538160|P13|STARTED|Overall Study||30
1445488|NCT02202980|3538161|P12|STARTED|Overall Study||28
1445489|NCT02202980|3538162|P11|STARTED|Overall Study||19
1445490|NCT02202980|3538163|P10|STARTED|Overall Study||17
1445491|NCT02202980|3538164|P9|STARTED|Overall Study||18
1445492|NCT02202980|3538165|P8|STARTED|Overall Study||15
1445493|NCT02202980|3538166|P7|STARTED|Overall Study||15
1445494|NCT02202980|3538167|P6|STARTED|Overall Study||15
1445495|NCT02202980|3538168|P5|STARTED|Overall Study||13
1445496|NCT02202980|3538169|P4|STARTED|Overall Study||32
1445497|NCT02202980|3538170|P3|STARTED|Overall Study||27
1445498|NCT02202980|3538171|P2|STARTED|Overall Study||26
1445499|NCT02202980|3538172|P1|STARTED|Overall Study||14
1445500|NCT02202850|3538260|P2|NOT COMPLETED|Overall Study||6
1445501|NCT02202850|3538261|P1|NOT COMPLETED|Overall Study||24
1445502|NCT02202850|3538260|P2|COMPLETED|Overall Study||8
1445503|NCT02202850|3538261|P1|COMPLETED|Overall Study||46
1445504|NCT02202850|3538260|P2|STARTED|Overall Study||14
1445505|NCT02202850|3538261|P1|STARTED|Overall Study||70
1445506|NCT02202837|3538313|P2|NOT COMPLETED|Overall Study||5
1445507|NCT02202837|3538314|P1|NOT COMPLETED|Overall Study||53
1445508|NCT02202837|3538313|P2|COMPLETED|Overall Study||12
1445509|NCT02202837|3538314|P1|COMPLETED|Overall Study||87
1445510|NCT02202837|3538313|P2|STARTED|Overall Study||17
1445511|NCT02202837|3538314|P1|STARTED|Overall Study||140
1445512|NCT02202785|3538365|P3|NOT COMPLETED|Overall Study||17
1445513|NCT02202785|3538366|P2|NOT COMPLETED|Overall Study||15
1445514|NCT02202785|3538367|P1|NOT COMPLETED|Overall Study||11
1445515|NCT02202785|3538365|P3|COMPLETED|Overall Study||0
1445516|NCT02202785|3538366|P2|COMPLETED|Overall Study||0
1445517|NCT02202785|3538367|P1|COMPLETED|Overall Study||0
1445518|NCT02202785|3538365|P3|STARTED|Overall Study||17
1445519|NCT02202785|3538366|P2|STARTED|Overall Study||15
1445520|NCT02202785|3538367|P1|STARTED|Overall Study||11
1445521|NCT02202759|3538404|P3|NOT COMPLETED|Overall Study||14
1445522|NCT02202759|3538405|P2|NOT COMPLETED|Overall Study||15
1445523|NCT02202759|3538406|P1|NOT COMPLETED|Overall Study||9
1445524|NCT02202759|3538404|P3|COMPLETED|Overall Study||0
1445525|NCT02202759|3538405|P2|COMPLETED|Overall Study||0
1445526|NCT02202759|3538406|P1|COMPLETED|Overall Study||0
1445527|NCT02202759|3538404|P3|STARTED|Overall Study||14
1445528|NCT02202759|3538405|P2|STARTED|Overall Study||15
1445529|NCT02202759|3538406|P1|STARTED|Overall Study||9
1445530|NCT02202538|3538440|P1|NOT COMPLETED|Overall Study||8
1445531|NCT02202538|3538440|P1|COMPLETED|Overall Study||45
1445532|NCT02202538|3538440|P1|Screen Failure|Overall Study||2
1445533|NCT02202538|3538440|P1|STARTED|Overall Study||53
1445534|NCT02202317|3538451|P1|NOT COMPLETED|Overall Study||1
1445535|NCT02202317|3538451|P1|COMPLETED|Overall Study||8
1445536|NCT02202317|3538451|P1|STARTED|Overall Study||9
1445537|NCT02202252|3538459|P2|NOT COMPLETED|Overall Study||0
1445538|NCT02202252|3538460|P1|NOT COMPLETED|Overall Study||0
1445539|NCT02202252|3538459|P2|COMPLETED|Overall Study||30
1445540|NCT02202252|3538460|P1|COMPLETED|Overall Study||30
1445541|NCT02202252|3538459|P2|STARTED|Overall Study||30
1445542|NCT02202252|3538460|P1|STARTED|Overall Study||30
1445543|NCT02202161|3538478|P8|NOT COMPLETED|Overall Study||6
1445544|NCT02202161|3538479|P7|NOT COMPLETED|Overall Study||0
1445545|NCT02202161|3538480|P6|NOT COMPLETED|Overall Study||1
1445546|NCT02202161|3538481|P5|NOT COMPLETED|Overall Study||1
1445547|NCT02202161|3538482|P4|NOT COMPLETED|Overall Study||0
1445548|NCT02202161|3538483|P3|NOT COMPLETED|Overall Study||0
1445549|NCT02202161|3538484|P2|NOT COMPLETED|Overall Study||1
1445550|NCT02202161|3538485|P1|NOT COMPLETED|Overall Study||1
1445551|NCT02202161|3538478|P8|COMPLETED|Overall Study||0
1445552|NCT02202161|3538479|P7|COMPLETED|Overall Study||13
1445553|NCT02202161|3538480|P6|COMPLETED|Overall Study||9
1445554|NCT02202161|3538481|P5|COMPLETED|Overall Study||8
1445555|NCT02202161|3538482|P4|COMPLETED|Overall Study||9
1445556|NCT02202161|3538483|P3|COMPLETED|Overall Study||5
1445557|NCT02202161|3538484|P2|COMPLETED|Overall Study||4
1445558|NCT02202161|3538485|P1|COMPLETED|Overall Study||12
1445559|NCT02202161|3538478|P8|STARTED|Overall Study||6
1445560|NCT02202161|3538479|P7|STARTED|Overall Study||13
1445561|NCT02202161|3538480|P6|STARTED|Overall Study||10
1445562|NCT02202161|3538481|P5|STARTED|Overall Study||9
1445563|NCT02202161|3538482|P4|STARTED|Overall Study||9
1445564|NCT02202161|3538483|P3|STARTED|Overall Study||5
1445565|NCT02202161|3538484|P2|STARTED|Overall Study||5
1445566|NCT02202161|3538485|P1|STARTED|Overall Study||13
1445567|NCT02202135|3538639|P1|NOT COMPLETED|Overall Study||0
1445568|NCT02202135|3538639|P1|COMPLETED|Overall Study||4
1445569|NCT02202135|3538639|P1|STARTED|Overall Study||4
1445570|NCT02202109|3538645|P2|NOT COMPLETED|Overall Study||87
1445571|NCT02202109|3538646|P1|NOT COMPLETED|Overall Study||90
1445572|NCT02202109|3538645|P2|COMPLETED|Overall Study||213
1445573|NCT02202109|3538646|P1|COMPLETED|Overall Study||212
1445574|NCT02202109|3538645|P2|STARTED|Overall Study||300
1445575|NCT02202109|3538646|P1|STARTED|Overall Study||302
1445576|NCT02201953|3538658|P2|NOT COMPLETED|Overall Study||56
1445577|NCT02201953|3538659|P1|NOT COMPLETED|Overall Study||20
1445578|NCT02201953|3538658|P2|COMPLETED|Overall Study||224
1445579|NCT02201953|3538659|P1|COMPLETED|Overall Study||258
1445580|NCT02201953|3538658|P2|STARTED|Overall Study||280
1445581|NCT02201953|3538659|P1|STARTED|Overall Study||278
1445582|NCT02201940|3538677|P2|NOT COMPLETED|Overall Study||116
1445583|NCT02201940|3538678|P1|NOT COMPLETED|Overall Study||12
1445584|NCT02201940|3538677|P2|COMPLETED|Overall Study||0
1445585|NCT02201940|3538678|P1|COMPLETED|Overall Study||613
1445586|NCT02201940|3538677|P2|STARTED|Overall Study||116
1445587|NCT02201940|3538678|P1|STARTED|Overall Study||625
1445588|NCT02201901|3538697|P3|NOT COMPLETED|Overall Study||13
1445589|NCT02201901|3538698|P2|NOT COMPLETED|Overall Study||9
1445590|NCT02201901|3538699|P1|NOT COMPLETED|Overall Study||15
1445591|NCT02201901|3538697|P3|COMPLETED|Overall Study||77
1445592|NCT02201901|3538698|P2|COMPLETED|Overall Study||79
1445593|NCT02201901|3538699|P1|COMPLETED|Overall Study||75
1445594|NCT02201901|3538697|P3|STARTED|Overall Study||90
1445595|NCT02201901|3538698|P2|STARTED|Overall Study||88
1445596|NCT02201901|3538699|P1|STARTED|Overall Study||90
1445597|NCT02201784|3538730|P2|NOT COMPLETED|Overall Study||0
1445598|NCT02201784|3538731|P1|NOT COMPLETED|Overall Study||2
1445599|NCT02201784|3538730|P2|COMPLETED|Overall Study||30
1445600|NCT02201784|3538731|P1|COMPLETED|Overall Study||28
1445601|NCT02201784|3538730|P2|STARTED|Overall Study||30
1445602|NCT02201784|3538731|P1|STARTED|Overall Study||30
1445603|NCT02201524|3538749|P4|NOT COMPLETED|Overall Study||4
1445604|NCT02201524|3538750|P3|NOT COMPLETED|Overall Study||4
1445605|NCT02201524|3538751|P2|NOT COMPLETED|Overall Study||3
1445606|NCT02201524|3538752|P1|NOT COMPLETED|Overall Study||2
1445607|NCT02201524|3538749|P4|COMPLETED|Overall Study||10
1445608|NCT02201524|3538750|P3|COMPLETED|Overall Study||12
1445609|NCT02201524|3538751|P2|COMPLETED|Overall Study||12
1445610|NCT02201524|3538752|P1|COMPLETED|Overall Study||12
1445611|NCT02201524|3538749|P4|STARTED|Overall Study||14
1445612|NCT02201524|3538750|P3|STARTED|Overall Study||16
1445613|NCT02201524|3538751|P2|STARTED|Overall Study||15
1445614|NCT02201524|3538752|P1|STARTED|Overall Study||14
1445615|NCT02201446|3538836|P2|NOT COMPLETED|Overall Study||0
1445616|NCT02201446|3538837|P1|NOT COMPLETED|Overall Study||0
1445617|NCT02201446|3538836|P2|COMPLETED|Overall Study||58
1445618|NCT02201446|3538837|P1|COMPLETED|Overall Study||81
1445619|NCT02201446|3538836|P2|STARTED|Overall Study||58
1445620|NCT02201446|3538837|P1|STARTED|Overall Study||81
1445621|NCT02201420|3538865|P1|NOT COMPLETED|Overall Study||0
1445622|NCT02201420|3538865|P1|COMPLETED|Overall Study||5
1445623|NCT02201420|3538865|P1|STARTED|Overall Study||5
1445624|NCT02201394|3538870|P1|NOT COMPLETED|Maintenance Dose||0
1445625|NCT02201394|3538870|P1|COMPLETED|Maintenance Dose||20
1445626|NCT02201394|3538870|P1|STARTED|Maintenance Dose||20
1445627|NCT02201394|3538870|P1|NOT COMPLETED|Loading Dose||0
1445628|NCT02201394|3538870|P1|COMPLETED|Loading Dose||20
1445629|NCT02201394|3538870|P1|STARTED|Loading Dose||20
1445630|NCT02201329|3538877|P1|NOT COMPLETED|Overall Study||5
1445631|NCT02201329|3538877|P1|COMPLETED|Overall Study||0
1445632|NCT02201329|3538877|P1|STARTED|Overall Study||5
1445633|NCT02201056|3538892|P7|NOT COMPLETED|Overall Study||0
1445634|NCT02201056|3538893|P6|NOT COMPLETED|Overall Study||0
1445635|NCT02201056|3538894|P5|NOT COMPLETED|Overall Study||0
1445636|NCT02201056|3538895|P4|NOT COMPLETED|Overall Study||0
1445637|NCT02201056|3538896|P3|NOT COMPLETED|Overall Study||0
1445638|NCT02201056|3538897|P2|NOT COMPLETED|Overall Study||0
1445639|NCT02201056|3538898|P1|NOT COMPLETED|Overall Study||0
1445640|NCT02201056|3538892|P7|COMPLETED|Overall Study||6
1445641|NCT02201056|3538893|P6|COMPLETED|Overall Study||6
1445642|NCT02201056|3538894|P5|COMPLETED|Overall Study||6
1445643|NCT02201056|3538895|P4|COMPLETED|Overall Study||6
1445644|NCT02201056|3538896|P3|COMPLETED|Overall Study||6
1445645|NCT02201056|3538897|P2|COMPLETED|Overall Study||6
1445646|NCT02201056|3538898|P1|COMPLETED|Overall Study||12
1445647|NCT02201056|3538892|P7|STARTED|Overall Study||6
1445648|NCT02201056|3538893|P6|STARTED|Overall Study||6
1445649|NCT02201056|3538894|P5|STARTED|Overall Study||6
1445650|NCT02201056|3538895|P4|STARTED|Overall Study||6
1445651|NCT02201056|3538896|P3|STARTED|Overall Study||6
1445652|NCT02201056|3538897|P2|STARTED|Overall Study||6
1445653|NCT02201056|3538898|P1|STARTED|Overall Study||12
1445654|NCT02200536|3538956|P3|NOT COMPLETED|Overall Study||0
1445655|NCT02200536|3538957|P2|NOT COMPLETED|Overall Study||0
1445656|NCT02200536|3538958|P1|NOT COMPLETED|Overall Study||0
1445657|NCT02200536|3538956|P3|COMPLETED|Overall Study||30
1445658|NCT02200536|3538957|P2|COMPLETED|Overall Study||30
1445659|NCT02200536|3538958|P1|COMPLETED|Overall Study||32
1445660|NCT02200536|3538956|P3|STARTED|Overall Study||30
1445661|NCT02200536|3538957|P2|STARTED|Overall Study||30
1445662|NCT02200536|3538958|P1|STARTED|Overall Study||32
1445663|NCT02200510|3538971|P2|NOT COMPLETED|Overall Study||3
1445664|NCT02200510|3538972|P1|NOT COMPLETED|Overall Study||9
1445665|NCT02200510|3538971|P2|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
1445666|NCT02200510|3538972|P1|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
1445667|NCT02200510|3538971|P2|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
1445668|NCT02200510|3538972|P1|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
1445669|NCT02200458|3538978|P1|NOT COMPLETED|Overall Study||0
1445670|NCT02200458|3538978|P1|COMPLETED|Overall Study||62
1445671|NCT02200458|3538978|P1|STARTED|Overall Study||62
1445672|NCT02200328|3538984|P2|NOT COMPLETED|Overall Study||33
1445673|NCT02200328|3538985|P1|NOT COMPLETED|Overall Study||43
1445674|NCT02200328|3538984|P2|COMPLETED|Overall Study||0
1445675|NCT02200328|3538985|P1|COMPLETED|Overall Study||0
1445676|NCT02200328|3538984|P2|STARTED|Overall Study||33
1445677|NCT02200328|3538985|P1|STARTED|Overall Study||43
1445678|NCT02200211|3538997|P4|NOT COMPLETED|Overall Study||2
1445679|NCT02200211|3538998|P3|NOT COMPLETED|Overall Study||1
1445680|NCT02200211|3538999|P2|NOT COMPLETED|Overall Study||7
1445681|NCT02200211|3539000|P1|NOT COMPLETED|Overall Study||8
1445682|NCT02200211|3538997|P4|COMPLETED|Overall Study||58
1445683|NCT02200211|3538998|P3|COMPLETED|Overall Study||39
1445684|NCT02200211|3538999|P2|COMPLETED|Overall Study||188
1445685|NCT02200211|3539000|P1|COMPLETED|Overall Study||182
1445686|NCT02200211|3538997|P4|Included in 16-week Primary Analysis|Overall Study||56
1445687|NCT02200211|3538998|P3|Included in 16-week Primary Analysis|Overall Study||39
1445688|NCT02200211|3538999|P2|Included in 16-week Primary Analysis|Overall Study||186
1445689|NCT02200211|3539000|P1|Included in 16-week Primary Analysis|Overall Study||177
1445690|NCT02200211|3538997|P4|STARTED|Overall Study||60
1445691|NCT02200211|3538998|P3|STARTED|Overall Study||40
1445692|NCT02200211|3538999|P2|STARTED|Overall Study||195
1445693|NCT02200211|3539000|P1|STARTED|Overall Study||190
1445694|NCT02200055|3539096|P1|NOT COMPLETED|Overall Study||0
1445695|NCT02200055|3539096|P1|COMPLETED|Overall Study||86
1445696|NCT02200055|3539096|P1|STARTED|Overall Study||86
1445697|NCT02199795|3539113|P2|NOT COMPLETED|Overall Study||0
1445698|NCT02199795|3539114|P1|NOT COMPLETED|Overall Study||2
1445699|NCT02199795|3539113|P2|COMPLETED|Overall Study||3
1445700|NCT02199795|3539114|P1|COMPLETED|Overall Study||2
1445701|NCT02199795|3539113|P2|STARTED|Overall Study||3
1445702|NCT02199795|3539114|P1|STARTED|Overall Study||4
1445703|NCT02199717|3539126|P1|NOT COMPLETED|Overall Study||0
1445704|NCT02199717|3539126|P1|COMPLETED|Overall Study||66
1445705|NCT02199717|3539126|P1|STARTED|Overall Study||66
1445706|NCT02199652|3539135|P2|NOT COMPLETED|Overall Study||7
1445707|NCT02199652|3539136|P1|NOT COMPLETED|Overall Study||7
1445708|NCT02199652|3539135|P2|COMPLETED|Overall Study||3
1445709|NCT02199652|3539136|P1|COMPLETED|Overall Study||3
1445710|NCT02199652|3539135|P2|STARTED|Overall Study||10
1445711|NCT02199652|3539136|P1|STARTED|Overall Study||10
1445712|NCT02199574|3539146|P1|NOT COMPLETED|Overall Study||0
1445713|NCT02199574|3539146|P1|COMPLETED|Overall Study||12
1445714|NCT02199574|3539146|P1|STARTED|Overall Study||12
1445715|NCT02199509|3539155|P2|NOT COMPLETED|Overall Study||1
1445716|NCT02199509|3539156|P1|NOT COMPLETED|Overall Study||1
1445717|NCT02199509|3539155|P2|COMPLETED|Overall Study||3
1445718|NCT02199509|3539156|P1|COMPLETED|Overall Study||2
1445719|NCT02199509|3539155|P2|STARTED|Overall Study||4
1445720|NCT02199509|3539156|P1|STARTED|Overall Study||3
1445721|NCT02199041|3539168|P1|NOT COMPLETED|Overall Study||0
1445722|NCT02199041|3539168|P1|COMPLETED|Overall Study||12
1445723|NCT02199041|3539168|P1|STARTED|Overall Study||12
1445724|NCT02198963|3539181|P1|NOT COMPLETED|Overall Study||7
1445725|NCT02198963|3539181|P1|COMPLETED|Overall Study||36
1445726|NCT02198963|3539181|P1|STARTED|Overall Study||43
1445727|NCT02198833|3539192|P2|NOT COMPLETED|Overall Study||0
1445728|NCT02198833|3539193|P1|NOT COMPLETED|Overall Study||0
1445729|NCT02198833|3539192|P2|COMPLETED|Overall Study||1
1445730|NCT02198833|3539193|P1|COMPLETED|Overall Study||1
1445731|NCT02198833|3539192|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
1445732|NCT02198833|3539193|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
1445733|NCT02198430|3539207|P2|NOT COMPLETED|Overall Study||0
1445734|NCT02198430|3539208|P1|NOT COMPLETED|Overall Study||0
1445735|NCT02198430|3539207|P2|COMPLETED|Overall Study||51
1445736|NCT02198430|3539208|P1|COMPLETED|Overall Study||53
1445737|NCT02198430|3539207|P2|STARTED|Overall Study||51
1445738|NCT02198430|3539208|P1|STARTED|Overall Study||53
1445739|NCT02198235|3539223|P3|NOT COMPLETED|Overall Study||2
1445740|NCT02198235|3539224|P2|NOT COMPLETED|Overall Study||2
1445741|NCT02198235|3539225|P1|NOT COMPLETED|Overall Study||3
1445742|NCT02198235|3539223|P3|COMPLETED|Overall Study||28
1445743|NCT02198235|3539224|P2|COMPLETED|Overall Study||28
1445744|NCT02198235|3539225|P1|COMPLETED|Overall Study||27
1445745|NCT02198235|3539223|P3|STARTED|Overall Study||30
1445746|NCT02198235|3539224|P2|STARTED|Overall Study||30
1445747|NCT02198235|3539225|P1|STARTED|Overall Study||30
1445748|NCT02198040|3539245|P3|NOT COMPLETED|Overall Study||1
1445749|NCT02198040|3539246|P2|NOT COMPLETED|Overall Study||1
1445750|NCT02198040|3539247|P1|NOT COMPLETED|Overall Study||0
1445751|NCT02198040|3539245|P3|COMPLETED|Overall Study||8
1445752|NCT02198040|3539246|P2|COMPLETED|Overall Study||8
1445753|NCT02198040|3539247|P1|COMPLETED|Overall Study||9
1445754|NCT02198040|3539245|P3|STARTED|Overall Study||9
1445755|NCT02198040|3539246|P2|STARTED|Overall Study||9
1445756|NCT02198040|3539247|P1|STARTED|Overall Study||9
1445757|NCT02197806|3539277|P4|NOT COMPLETED|Overall Study||1
1445758|NCT02197806|3539278|P3|NOT COMPLETED|Overall Study||0
1445759|NCT02197806|3539279|P2|NOT COMPLETED|Overall Study||1
1445760|NCT02197806|3539280|P1|NOT COMPLETED|Overall Study||0
1445761|NCT02197806|3539277|P4|COMPLETED|Overall Study||16
1445762|NCT02197806|3539278|P3|COMPLETED|Overall Study||16
1445763|NCT02197806|3539279|P2|COMPLETED|Overall Study||16
1445764|NCT02197806|3539280|P1|COMPLETED|Overall Study||15
1445765|NCT02197806|3539277|P4|STARTED|Overall Study||17
1445766|NCT02197806|3539278|P3|STARTED|Overall Study||16
1445767|NCT02197806|3539279|P2|STARTED|Overall Study||17
1445768|NCT02197806|3539280|P1|STARTED|Overall Study||15
1445769|NCT02197520|3539290|P2|NOT COMPLETED|Period 2||2
1445770|NCT02197520|3539291|P1|NOT COMPLETED|Period 2||1
1445771|NCT02197520|3539290|P2|COMPLETED|Period 2||10
1445772|NCT02197520|3539291|P1|COMPLETED|Period 2||10
1445773|NCT02197520|3539290|P2|STARTED|Period 2||12
1445774|NCT02197520|3539291|P1|STARTED|Period 2||11
1445775|NCT02197520|3539290|P2|NOT COMPLETED|Period 1||0
1445776|NCT02197520|3539291|P1|NOT COMPLETED|Period 1||1
1445777|NCT02197520|3539290|P2|COMPLETED|Period 1||12
1445778|NCT02197520|3539291|P1|COMPLETED|Period 1||11
1445779|NCT02197520|3539290|P2|STARTED|Period 1||12
1445780|NCT02197520|3539291|P1|STARTED|Period 1||12
1445781|NCT02197481|3539309|P2|NOT COMPLETED|Overall Study||0
1445782|NCT02197481|3539310|P1|NOT COMPLETED|Overall Study||0
1445783|NCT02197481|3539309|P2|COMPLETED|Overall Study||43
1445784|NCT02197481|3539310|P1|COMPLETED|Overall Study|February 2016|43
1445785|NCT02197481|3539309|P2|STARTED|Overall Study||43
1445786|NCT02197481|3539310|P1|STARTED|Overall Study|October 2014|43
1445787|NCT02197455|3539330|P1|NOT COMPLETED|Overall Study||0
1445788|NCT02197455|3539330|P1|COMPLETED|Overall Study||30
1445789|NCT02197455|3539330|P1|STARTED|Overall Study||30
1445790|NCT02197377|3539337|P2|NOT COMPLETED|Overall Study||3
1445791|NCT02197377|3539338|P1|NOT COMPLETED|Overall Study||0
1445792|NCT02197377|3539337|P2|COMPLETED|Overall Study||27
1445793|NCT02197377|3539338|P1|COMPLETED|Overall Study||30
1445794|NCT02197377|3539337|P2|STARTED|Overall Study||30
1445795|NCT02197377|3539338|P1|STARTED|Overall Study||30
1445796|NCT02197273|3539348|P2|NOT COMPLETED|Overall Study||0
1445797|NCT02197273|3539349|P1|NOT COMPLETED|Overall Study||0
1445798|NCT02197273|3539348|P2|COMPLETED|Overall Study||104
1445799|NCT02197273|3539349|P1|COMPLETED|Overall Study||107
1445800|NCT02197273|3539348|P2|STARTED|Overall Study||104
1445801|NCT02197273|3539349|P1|STARTED|Overall Study||107
1445802|NCT02197247|3539359|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
1445803|NCT02197247|3539359|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
1445804|NCT02197247|3539359|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
1445805|NCT02197247|3539359|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
1445806|NCT02197247|3539359|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
1445807|NCT02197247|3539359|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
1445808|NCT02197247|3539359|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
1445809|NCT02197247|3539359|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
1445810|NCT02197247|3539359|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
1445811|NCT02197247|3539359|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
1445812|NCT02197247|3539359|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
1445813|NCT02197247|3539359|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
1445814|NCT02197234|3539404|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
1445815|NCT02197234|3539404|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
1445816|NCT02197234|3539404|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
1445817|NCT02197234|3539404|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
1445818|NCT02197234|3539404|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
1445819|NCT02197234|3539404|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
1445820|NCT02197234|3539404|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
1445821|NCT02197234|3539404|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
1445822|NCT02197234|3539404|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
1445823|NCT02197234|3539404|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
1445824|NCT02197234|3539404|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
1445825|NCT02197234|3539404|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
1445826|NCT02197130|3539426|P3|NOT COMPLETED|Overall Study||32
1445827|NCT02197130|3539427|P2|NOT COMPLETED|Overall Study||8
1445828|NCT02197130|3539428|P1|NOT COMPLETED|Overall Study||16
1445829|NCT02197130|3539426|P3|COMPLETED|Overall Study||56
1445830|NCT02197130|3539427|P2|COMPLETED|Overall Study||81
1445831|NCT02197130|3539428|P1|COMPLETED|Overall Study||79
1445832|NCT02197130|3539426|P3|Received Treatment|Overall Study||87
1445833|NCT02197130|3539427|P2|Received Treatment|Overall Study||88
1445834|NCT02197130|3539428|P1|Received Treatment|Overall Study||95
1445835|NCT02197130|3539426|P3|STARTED|Overall Study||88
1445836|NCT02197130|3539427|P2|STARTED|Overall Study||89
1445837|NCT02197130|3539428|P1|STARTED|Overall Study||95
1445838|NCT02197065|3539480|P2|NOT COMPLETED|Overall Study||0
1445839|NCT02197065|3539481|P1|NOT COMPLETED|Overall Study||0
1445840|NCT02197065|3539480|P2|COMPLETED|Overall Study||10
1445841|NCT02197065|3539481|P1|COMPLETED|Overall Study||10
1445842|NCT02197065|3539480|P2|STARTED|Overall Study||10
1445843|NCT02197065|3539481|P1|STARTED|Overall Study||10
1445844|NCT02196922|3539492|P2|NOT COMPLETED|Overall Study||0
1445845|NCT02196922|3539493|P1|NOT COMPLETED|Overall Study||0
1445846|NCT02196922|3539492|P2|COMPLETED|Overall Study||46
1445847|NCT02196922|3539493|P1|COMPLETED|Overall Study||58
1445848|NCT02196922|3539492|P2|STARTED|Overall Study||46
1445849|NCT02196922|3539493|P1|STARTED|Overall Study||58
1445850|NCT02196766|3539503|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1445851|NCT02196766|3539504|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1445852|NCT02196766|3539503|P2|COMPLETED|Second Intervention (7 Days)||15
1445853|NCT02196766|3539504|P1|COMPLETED|Second Intervention (7 Days)||15
1445854|NCT02196766|3539503|P2|STARTED|Second Intervention (7 Days)||15
1445855|NCT02196766|3539504|P1|STARTED|Second Intervention (7 Days)||15
1445856|NCT02196766|3539503|P2|NOT COMPLETED|First Intervention (7 Days)||0
1445857|NCT02196766|3539504|P1|NOT COMPLETED|First Intervention (7 Days)||0
1445858|NCT02196766|3539503|P2|COMPLETED|First Intervention (7 Days)||15
1445859|NCT02196766|3539504|P1|COMPLETED|First Intervention (7 Days)||15
1445860|NCT02196766|3539503|P2|STARTED|First Intervention (7 Days)||15
1445861|NCT02196766|3539504|P1|STARTED|First Intervention (7 Days)||15
1445862|NCT02196714|3539520|P4|NOT COMPLETED|Overall Study||0
1445863|NCT02196714|3539521|P3|NOT COMPLETED|Overall Study||1
1445864|NCT02196714|3539522|P2|NOT COMPLETED|Overall Study||0
1445865|NCT02196714|3539523|P1|NOT COMPLETED|Overall Study||0
1445866|NCT02196714|3539520|P4|COMPLETED|Overall Study||24
1445867|NCT02196714|3539521|P3|COMPLETED|Overall Study||23
1445868|NCT02196714|3539522|P2|COMPLETED|Overall Study||23
1445869|NCT02196714|3539523|P1|COMPLETED|Overall Study||24
1445870|NCT02196714|3539520|P4|STARTED|Overall Study||24
1445871|NCT02196714|3539521|P3|STARTED|Overall Study||24
1445872|NCT02196714|3539522|P2|STARTED|Overall Study||23
1445873|NCT02196714|3539523|P1|STARTED|Overall Study||24
1445874|NCT02196701|3539645|P1|NOT COMPLETED|Overall Study||3
1445875|NCT02196701|3539645|P1|COMPLETED|Overall Study||43
1445876|NCT02196701|3539645|P1|STARTED|Overall Study||46
1445877|NCT02196675|3539704|P3|NOT COMPLETED|Overall Study||1
1445878|NCT02196675|3539705|P2|NOT COMPLETED|Overall Study||2
1445879|NCT02196675|3539706|P1|NOT COMPLETED|Overall Study||2
1445880|NCT02196675|3539704|P3|COMPLETED|Overall Study||7
1445881|NCT02196675|3539705|P2|COMPLETED|Overall Study||68
1445882|NCT02196675|3539706|P1|COMPLETED|Overall Study||25
1445883|NCT02196675|3539704|P3|STARTED|Overall Study||8
1445884|NCT02196675|3539705|P2|STARTED|Overall Study||70
1445885|NCT02196675|3539706|P1|STARTED|Overall Study||27
1445886|NCT02196506|3539728|P4|NOT COMPLETED|Phase A+||14
1445887|NCT02196506|3539729|P3|NOT COMPLETED|Phase A+||0
1445888|NCT02196506|3539730|P2|NOT COMPLETED|Phase A+||0
1445889|NCT02196506|3539731|P1|NOT COMPLETED|Phase A+||0
1445890|NCT02196506|3539728|P4|COMPLETED|Phase A+||308
1445891|NCT02196506|3539729|P3|COMPLETED|Phase A+||0
1445892|NCT02196506|3539730|P2|COMPLETED|Phase A+||0
1445893|NCT02196506|3539731|P1|COMPLETED|Phase A+||0
1445894|NCT02196506|3539728|P4|STARTED|Phase A+||322
1445895|NCT02196506|3539729|P3|STARTED|Phase A+||0
1445896|NCT02196506|3539730|P2|STARTED|Phase A+||0
1445897|NCT02196506|3539731|P1|STARTED|Phase A+||0
1445898|NCT02196506|3539728|P4|NOT COMPLETED|Phase B||0
1445899|NCT02196506|3539729|P3|NOT COMPLETED|Phase B||6
1445900|NCT02196506|3539730|P2|NOT COMPLETED|Phase B||15
1445901|NCT02196506|3539731|P1|NOT COMPLETED|Phase B||0
1445902|NCT02196506|3539728|P4|COMPLETED|Phase B||0
1445903|NCT02196506|3539729|P3|COMPLETED|Phase B||196
1445904|NCT02196506|3539730|P2|COMPLETED|Phase B||177
1445905|NCT02196506|3539731|P1|COMPLETED|Phase B||0
1445906|NCT02196506|3539728|P4|STARTED|Phase B||0
1445907|NCT02196506|3539729|P3|STARTED|Phase B||202
1445908|NCT02196506|3539730|P2|STARTED|Phase B||192
1445909|NCT02196506|3539731|P1|STARTED|Phase B||0
1445910|NCT02196506|3539728|P4|NOT COMPLETED|Phase A||0
1445911|NCT02196506|3539729|P3|NOT COMPLETED|Phase A||0
1445912|NCT02196506|3539730|P2|NOT COMPLETED|Phase A||0
1445913|NCT02196506|3539731|P1|NOT COMPLETED|Phase A||121
1445914|NCT02196506|3539728|P4|COMPLETED|Phase A||0
1445915|NCT02196506|3539729|P3|COMPLETED|Phase A||0
1445916|NCT02196506|3539730|P2|COMPLETED|Phase A||0
1445917|NCT02196506|3539731|P1|COMPLETED|Phase A||716
1445918|NCT02196506|3539728|P4|STARTED|Phase A||0
1445919|NCT02196506|3539729|P3|STARTED|Phase A||0
1445920|NCT02196506|3539730|P2|STARTED|Phase A||0
1445921|NCT02196506|3539731|P1|STARTED|Phase A||837
1445922|NCT02196259|3539746|P3|NOT COMPLETED|Overall Study||1
1445923|NCT02196259|3539747|P2|NOT COMPLETED|Overall Study||3
1445924|NCT02196259|3539748|P1|NOT COMPLETED|Overall Study||0
1445925|NCT02196259|3539746|P3|COMPLETED|Overall Study||2
1445926|NCT02196259|3539747|P2|COMPLETED|Overall Study||4
1445927|NCT02196259|3539748|P1|COMPLETED|Overall Study||3
1445928|NCT02196259|3539746|P3|STARTED|Overall Study||3
1445929|NCT02196259|3539747|P2|STARTED|Overall Study||7
1445930|NCT02196259|3539748|P1|STARTED|Overall Study||3
1445931|NCT02196168|3539757|P2|NOT COMPLETED|Overall Study||0
1445932|NCT02196168|3539758|P1|NOT COMPLETED|Overall Study||0
1445933|NCT02196168|3539757|P2|COMPLETED|Overall Study||0
1445934|NCT02196168|3539758|P1|COMPLETED|Overall Study||6
1445935|NCT02196168|3539757|P2|STARTED|Overall Study||0
1445936|NCT02196168|3539758|P1|STARTED|Overall Study||6
1445937|NCT02196077|3539776|P1|NOT COMPLETED|Overall Study||47
1445938|NCT02196077|3539776|P1|COMPLETED|Overall Study||133
1445939|NCT02196077|3539776|P1|FF MDI 9.6 μg|Overall Study||157
1445940|NCT02196077|3539776|P1|BD MDI 320 μg|Overall Study||108
1445941|NCT02196077|3539776|P1|BFF MDI 80/9.6 μg|Overall Study||103
1445942|NCT02196077|3539776|P1|BFF MDI 160/9.6 μg|Overall Study||106
1445943|NCT02196077|3539776|P1|BFF MDI 320/9.6 μg|Overall Study||155
1445944|NCT02196077|3539776|P1|STARTED|Overall Study||180
1445945|NCT02195986|3539826|P3|NOT COMPLETED|Overall Study||2
1445946|NCT02195986|3539827|P2|NOT COMPLETED|Overall Study||5
1445947|NCT02195986|3539828|P1|NOT COMPLETED|Overall Study||3
1445948|NCT02195986|3539826|P3|COMPLETED|Overall Study||71
1445949|NCT02195986|3539827|P2|COMPLETED|Overall Study||142
1445950|NCT02195986|3539828|P1|COMPLETED|Overall Study||143
1445951|NCT02195986|3539826|P3|STARTED|Overall Study||73
1445952|NCT02195986|3539827|P2|STARTED|Overall Study||147
1445953|NCT02195986|3539828|P1|STARTED|Overall Study||146
1445954|NCT02195895|3539843|P1|NOT COMPLETED|Overall Study||0
1445955|NCT02195895|3539843|P1|COMPLETED|Overall Study||17
1445956|NCT02195895|3539843|P1|STARTED|Overall Study||17
1445957|NCT02195713|3539853|P2|NOT COMPLETED|Overall Study||0
1445958|NCT02195713|3539854|P1|NOT COMPLETED|Overall Study||0
1445959|NCT02195713|3539853|P2|COMPLETED|Overall Study||10
1445960|NCT02195713|3539854|P1|COMPLETED|Overall Study||10
1445961|NCT02195713|3539853|P2|STARTED|Overall Study||10
1445962|NCT02195713|3539854|P1|STARTED|Overall Study||10
1445963|NCT02195700|3539862|P2|NOT COMPLETED|Overall Study||7
1445964|NCT02195700|3539863|P1|NOT COMPLETED|Overall Study||6
1445965|NCT02195700|3539862|P2|COMPLETED|Overall Study||52
1445966|NCT02195700|3539863|P1|COMPLETED|Overall Study||52
1445967|NCT02195700|3539862|P2|Maintenance Period|Overall Study||54
1445968|NCT02195700|3539863|P1|Maintenance Period|Overall Study||53
1445969|NCT02195700|3539862|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
1445970|NCT02195700|3539863|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
1445971|NCT02195700|3539862|P2|Safety and ITT Populations|Overall Study||59
1445972|NCT02195700|3539863|P1|Safety and ITT Populations|Overall Study||58
1445973|NCT02195700|3539862|P2|STARTED|Overall Study||59
1445974|NCT02195700|3539863|P1|STARTED|Overall Study||58
1445975|NCT02195687|3539885|P2|NOT COMPLETED|Overall Study||2
1445976|NCT02195687|3539886|P1|NOT COMPLETED|Overall Study||5
1445977|NCT02195687|3539885|P2|COMPLETED|Overall Study||99
1445978|NCT02195687|3539886|P1|COMPLETED|Overall Study||311
1445979|NCT02195687|3539885|P2|STARTED|Overall Study||101
1445980|NCT02195687|3539886|P1|STARTED|Overall Study||316
1445981|NCT02195583|3539902|P1|NOT COMPLETED|Overall Study||9
1445982|NCT02195583|3539902|P1|COMPLETED|Overall Study||53
1445983|NCT02195583|3539902|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
1445984|NCT02195583|3539902|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
1445985|NCT02195583|3539902|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
1445986|NCT02195583|3539902|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
1445987|NCT02195583|3539902|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
1445988|NCT02195583|3539902|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
1445989|NCT02195583|3539902|P1|STARTED|Overall Study||62
1445990|NCT02195479|3539936|P2|NOT COMPLETED|Overall Study||350
1445991|NCT02195479|3539937|P1|NOT COMPLETED|Overall Study||356
1445992|NCT02195479|3539936|P2|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
1445993|NCT02195479|3539937|P1|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
1445994|NCT02195479|3539936|P2|Treated|Overall Study||346
1445995|NCT02195479|3539937|P1|Treated|Overall Study||354
1445996|NCT02195479|3539936|P2|STARTED|Overall Study||350
1445997|NCT02195479|3539937|P1|STARTED|Overall Study||356
1445998|NCT02195427|3539975|P2|NOT COMPLETED|Overall Study||27
1445999|NCT02195427|3539976|P1|NOT COMPLETED|Overall Study||26
1446000|NCT02195427|3539975|P2|COMPLETED|Overall Study||47
1446001|NCT02195427|3539976|P1|COMPLETED|Overall Study||47
1446002|NCT02195427|3539975|P2|N Patients at W52|Overall Study||56
1446003|NCT02195427|3539976|P1|N Patients at W52|Overall Study||63
1446004|NCT02195427|3539975|P2|N Patients at W36|Overall Study||59
1446005|NCT02195427|3539976|P1|N Patients at W36|Overall Study||65
1446006|NCT02195427|3539975|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
1446007|NCT02195427|3539976|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
1446008|NCT02195427|3539975|P2|STARTED|Overall Study||74
1446009|NCT02195427|3539976|P1|STARTED|Overall Study||73
1446010|NCT02195414|3540038|P1|NOT COMPLETED|Overall Study||0
1446011|NCT02195414|3540038|P1|COMPLETED|Overall Study||31
1446012|NCT02195414|3540038|P1|Primary Endpoint|Overall Study||31
1446013|NCT02195414|3540038|P1|STARTED|Overall Study||31
1446014|NCT02195011|3540047|P2|NOT COMPLETED|Overall Study||1
1446015|NCT02195011|3540048|P1|NOT COMPLETED|Overall Study||25
1446016|NCT02195011|3540047|P2|COMPLETED|Overall Study||0
1446017|NCT02195011|3540048|P1|COMPLETED|Overall Study||0
1446018|NCT02195011|3540047|P2|STARTED|Overall Study||1
1446019|NCT02195011|3540048|P1|STARTED|Overall Study||25
1446020|NCT02194933|3540062|P2|NOT COMPLETED|Overall Study||9
1446021|NCT02194933|3540063|P1|NOT COMPLETED|Overall Study||3
1446022|NCT02194933|3540062|P2|COMPLETED|Overall Study||10
1446023|NCT02194933|3540063|P1|COMPLETED|Overall Study||16
1446024|NCT02194933|3540062|P2|STARTED|Overall Study||19
1446025|NCT02194933|3540063|P1|STARTED|Overall Study||19
1446026|NCT02194699|3540117|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
1446027|NCT02194699|3540118|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
1446028|NCT02194699|3540117|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
1446029|NCT02194699|3540118|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
1446030|NCT02194699|3540117|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
1446031|NCT02194699|3540118|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
1446032|NCT02194699|3540117|P2|NOT COMPLETED|Randomised||11
1446033|NCT02194699|3540118|P1|NOT COMPLETED|Randomised||8
1446034|NCT02194699|3540117|P2|COMPLETED|Randomised||417
1446035|NCT02194699|3540118|P1|COMPLETED|Randomised||420
1446036|NCT02194699|3540117|P2|STARTED|Randomised||428
1446037|NCT02194699|3540118|P1|STARTED|Randomised||428
1446038|NCT02194621|3540226|P3|NOT COMPLETED|Overall Study||9
1446039|NCT02194621|3540227|P2|NOT COMPLETED|Overall Study||6
1446040|NCT02194621|3540228|P1|NOT COMPLETED|Overall Study||6
1446041|NCT02194621|3540226|P3|COMPLETED|Overall Study||34
1446042|NCT02194621|3540227|P2|COMPLETED|Overall Study||36
1446043|NCT02194621|3540228|P1|COMPLETED|Overall Study||37
1446044|NCT02194621|3540226|P3|STARTED|Overall Study||43
1446045|NCT02194621|3540227|P2|STARTED|Overall Study||42
1446046|NCT02194621|3540228|P1|STARTED|Overall Study||43
1446047|NCT02194088|3540247|P2|NOT COMPLETED|Overall Study||0
1446048|NCT02194088|3540248|P1|NOT COMPLETED|Overall Study||0
1446049|NCT02194088|3540247|P2|COMPLETED|Overall Study||25
1446050|NCT02194088|3540248|P1|COMPLETED|Overall Study||75
1446051|NCT02194088|3540247|P2|STARTED|Overall Study||25
1446052|NCT02194088|3540248|P1|STARTED|Overall Study||75
1446053|NCT02194062|3540261|P3|NOT COMPLETED|Overall Study||5
1446054|NCT02194062|3540262|P2|NOT COMPLETED|Overall Study||2
1446055|NCT02194062|3540263|P1|NOT COMPLETED|Overall Study||2
1446056|NCT02194062|3540261|P3|COMPLETED|Overall Study||7
1446057|NCT02194062|3540262|P2|COMPLETED|Overall Study||8
1446058|NCT02194062|3540263|P1|COMPLETED|Overall Study||8
1446059|NCT02194062|3540261|P3|STARTED|Overall Study||12
1446060|NCT02194062|3540262|P2|STARTED|Overall Study||10
1446061|NCT02194062|3540263|P1|STARTED|Overall Study||10
1446062|NCT02193828|3540278|P4|NOT COMPLETED|Overall Study||1
1446063|NCT02193828|3540279|P3|NOT COMPLETED|Overall Study||1
1446064|NCT02193828|3540280|P2|NOT COMPLETED|Overall Study||0
1446065|NCT02193828|3540281|P1|NOT COMPLETED|Overall Study||0
1446066|NCT02193828|3540278|P4|COMPLETED|Overall Study||16
1446067|NCT02193828|3540279|P3|COMPLETED|Overall Study||22
1446068|NCT02193828|3540280|P2|COMPLETED|Overall Study||18
1446069|NCT02193828|3540281|P1|COMPLETED|Overall Study||18
1446070|NCT02193828|3540278|P4|STARTED|Overall Study||17
1446071|NCT02193828|3540279|P3|STARTED|Overall Study||23
1446072|NCT02193828|3540280|P2|STARTED|Overall Study||18
1446073|NCT02193828|3540281|P1|STARTED|Overall Study||18
1446074|NCT02193815|3540319|P1|NOT COMPLETED|Overall Study||0
1446075|NCT02193815|3540319|P1|COMPLETED|Overall Study||15
1446076|NCT02193815|3540319|P1|STARTED|Overall Study||15
1446077|NCT02193178|3540354|P1|NOT COMPLETED|Overall Study||2
1446078|NCT02193178|3540354|P1|COMPLETED|Overall Study||13
1446079|NCT02193178|3540354|P1|STARTED|Overall Study||15
1446080|NCT02193165|3540404|P3|NOT COMPLETED|6 Week Product Use||0
1446081|NCT02193165|3540405|P2|NOT COMPLETED|6 Week Product Use||1
1446082|NCT02193165|3540406|P1|NOT COMPLETED|6 Week Product Use||0
1446083|NCT02193165|3540404|P3|COMPLETED|6 Week Product Use||39
1446084|NCT02193165|3540405|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
1446085|NCT02193165|3540406|P1|COMPLETED|6 Week Product Use||39
1446086|NCT02193165|3540404|P3|STARTED|6 Week Product Use||39
1446087|NCT02193165|3540405|P2|STARTED|6 Week Product Use||39
1446088|NCT02193165|3540406|P1|STARTED|6 Week Product Use||39
1446089|NCT02193165|3540404|P3|NOT COMPLETED|4 Week Product Use||1
1446090|NCT02193165|3540405|P2|NOT COMPLETED|4 Week Product Use||1
1446091|NCT02193165|3540406|P1|NOT COMPLETED|4 Week Product Use||1
1446092|NCT02193165|3540404|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
1446093|NCT02193165|3540405|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
1446094|NCT02193165|3540406|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
1446095|NCT02193165|3540404|P3|STARTED|4 Week Product Use||40
1446096|NCT02193165|3540405|P2|STARTED|4 Week Product Use||40
1446097|NCT02193165|3540406|P1|STARTED|4 Week Product Use||40
1446098|NCT02193087|3540433|P4|NOT COMPLETED|Overall Study||79
1446099|NCT02193087|3540434|P3|NOT COMPLETED|Overall Study||7
1446100|NCT02193087|3540435|P2|NOT COMPLETED|Overall Study||14
1446101|NCT02193087|3540436|P1|NOT COMPLETED|Overall Study||37
1446102|NCT02193087|3540433|P4|COMPLETED|Overall Study||524
1446103|NCT02193087|3540434|P3|COMPLETED|Overall Study||93
1446104|NCT02193087|3540435|P2|COMPLETED|Overall Study||86
1446105|NCT02193087|3540436|P1|COMPLETED|Overall Study||162
1446106|NCT02193087|3540433|P4|Received Vaccination|Overall Study||602
1446107|NCT02193087|3540434|P3|Received Vaccination|Overall Study||100
1446108|NCT02193087|3540435|P2|Received Vaccination|Overall Study||97
1446109|NCT02193087|3540436|P1|Received Vaccination|Overall Study||197
1446110|NCT02193087|3540433|P4|STARTED|Overall Study||603
1446111|NCT02193087|3540434|P3|STARTED|Overall Study||100
1446112|NCT02193087|3540435|P2|STARTED|Overall Study||100
1446113|NCT02193087|3540436|P1|STARTED|Overall Study||199
1446114|NCT02193074|3540481|P2|NOT COMPLETED|Overall Study||15
1446115|NCT02193074|3540482|P1|NOT COMPLETED|Overall Study||17
1446116|NCT02193074|3540481|P2|COMPLETED|Overall Study||65
1446117|NCT02193074|3540482|P1|COMPLETED|Overall Study||24
1446118|NCT02193074|3540481|P2|Completed Due to Early Study Termination|Overall Study||39
1446119|NCT02193074|3540482|P1|Completed Due to Early Study Termination|Overall Study||13
1446120|NCT02193074|3540481|P2|Completed During Follow-Up Period|Overall Study||26
1446121|NCT02193074|3540482|P1|Completed During Follow-Up Period|Overall Study||11
1446122|NCT02193074|3540481|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
1446123|NCT02193074|3540482|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
1446124|NCT02192905|3540514|P1|NOT COMPLETED|Overall Study||1
1446125|NCT02192905|3540514|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
1446126|NCT02192905|3540514|P1|STARTED|Overall Study||43
1446127|NCT02192879|3540528|P3|NOT COMPLETED|Overall Study||0
1446128|NCT02192879|3540529|P2|NOT COMPLETED|Overall Study||0
1446129|NCT02192879|3540530|P1|NOT COMPLETED|Overall Study||0
1446130|NCT02192879|3540528|P3|COMPLETED|Overall Study||3
1446131|NCT02192879|3540529|P2|COMPLETED|Overall Study||4
1446132|NCT02192879|3540530|P1|COMPLETED|Overall Study||3
1446133|NCT02192879|3540528|P3|STARTED|Overall Study||3
1446134|NCT02192879|3540529|P2|STARTED|Overall Study||4
1446135|NCT02192879|3540530|P1|STARTED|Overall Study||3
1446136|NCT02192814|3540556|P1|NOT COMPLETED|Overall Study||0
1446137|NCT02192814|3540556|P1|COMPLETED|Overall Study||9
1446138|NCT02192814|3540556|P1|STARTED|Overall Study||9
1446139|NCT02192684|3540569|P2|NOT COMPLETED|Overall Study||0
1446140|NCT02192684|3540570|P1|NOT COMPLETED|Overall Study||0
1446141|NCT02192684|3540569|P2|COMPLETED|Overall Study||15
1446142|NCT02192684|3540570|P1|COMPLETED|Overall Study||30
1446143|NCT02192684|3540569|P2|STARTED|Overall Study||15
1446144|NCT02192684|3540570|P1|STARTED|Overall Study||30
1446145|NCT02192606|3540578|P2|NOT COMPLETED|Overall Study||4
1446146|NCT02192606|3540579|P1|NOT COMPLETED|Overall Study||2
1446147|NCT02192606|3540578|P2|COMPLETED|Overall Study||24
1446148|NCT02192606|3540579|P1|COMPLETED|Overall Study||27
1446149|NCT02192606|3540578|P2|STARTED|Overall Study||28
1446150|NCT02192606|3540579|P1|STARTED|Overall Study||29
1446151|NCT02192541|3540589|P2|NOT COMPLETED|Overall Study||0
1446152|NCT02192541|3540590|P1|NOT COMPLETED|Overall Study||0
1446153|NCT02192541|3540589|P2|COMPLETED|Overall Study||3
1446154|NCT02192541|3540590|P1|COMPLETED|Overall Study||2
1446155|NCT02192541|3540589|P2|Evaluable for Response|Overall Study||3
1446156|NCT02192541|3540590|P1|Evaluable for Response|Overall Study||1
1446157|NCT02192541|3540589|P2|Treated|Overall Study||3
1446158|NCT02192541|3540590|P1|Treated|Overall Study||2
1446159|NCT02192541|3540589|P2|STARTED|Overall Study||3
1446160|NCT02192541|3540590|P1|STARTED|Overall Study||2
1446161|NCT02192190|3540616|P6|NOT COMPLETED|Overall Study||29
1446162|NCT02192190|3540617|P5|NOT COMPLETED|Overall Study||30
1446163|NCT02192190|3540618|P4|NOT COMPLETED|Overall Study||26
1446164|NCT02192190|3540619|P3|NOT COMPLETED|Overall Study||25
1446165|NCT02192190|3540620|P2|NOT COMPLETED|Overall Study||29
1446166|NCT02192190|3540621|P1|NOT COMPLETED|Overall Study||54
1446167|NCT02192190|3540616|P6|COMPLETED|Overall Study||9
1446168|NCT02192190|3540617|P5|COMPLETED|Overall Study||9
1446169|NCT02192190|3540618|P4|COMPLETED|Overall Study||12
1446170|NCT02192190|3540619|P3|COMPLETED|Overall Study||13
1446171|NCT02192190|3540620|P2|COMPLETED|Overall Study||10
1446172|NCT02192190|3540621|P1|COMPLETED|Overall Study||22
1446173|NCT02192190|3540616|P6|Received at Least 1 Dose of Study Drug|Overall Study||37
1446174|NCT02192190|3540617|P5|Received at Least 1 Dose of Study Drug|Overall Study||38
1446175|NCT02192190|3540618|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
1446176|NCT02192190|3540619|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
1446177|NCT02192190|3540620|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
1446178|NCT02192190|3540621|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
1446179|NCT02192190|3540616|P6|STARTED|Overall Study||38
1446180|NCT02192190|3540617|P5|STARTED|Overall Study||39
1446181|NCT02192190|3540618|P4|STARTED|Overall Study||38
1446182|NCT02192190|3540619|P3|STARTED|Overall Study||38
1446183|NCT02192190|3540620|P2|STARTED|Overall Study||39
1446184|NCT02192190|3540621|P1|STARTED|Overall Study||76
1446185|NCT02192164|3540665|P1|NOT COMPLETED|Overall Study||14
1446186|NCT02192164|3540665|P1|COMPLETED|Overall Study||112
1446187|NCT02192164|3540665|P1|Etanercept Treated Population|Overall Study||112
1446188|NCT02192164|3540665|P1|STARTED|Overall Study||126
1446189|NCT02191865|3540684|P3|NOT COMPLETED|Overall Study||0
1446190|NCT02191865|3540685|P2|NOT COMPLETED|Overall Study||0
1446191|NCT02191865|3540686|P1|NOT COMPLETED|Overall Study||0
1446192|NCT02191865|3540684|P3|COMPLETED|Overall Study||17
1446193|NCT02191865|3540685|P2|COMPLETED|Overall Study||8
1446194|NCT02191865|3540686|P1|COMPLETED|Overall Study||8
1446195|NCT02191865|3540684|P3|STARTED|Overall Study||17
1446196|NCT02191865|3540685|P2|STARTED|Overall Study||8
1446197|NCT02191865|3540686|P1|STARTED|Overall Study||8
1446198|NCT02191605|3540711|P5|NOT COMPLETED|Overall Study||4
1446199|NCT02191605|3540712|P4|NOT COMPLETED|Overall Study||3
1446200|NCT02191605|3540713|P3|NOT COMPLETED|Overall Study||7
1446201|NCT02191605|3540714|P2|NOT COMPLETED|Overall Study||4
1446202|NCT02191605|3540715|P1|NOT COMPLETED|Overall Study||9
1446203|NCT02191605|3540711|P5|COMPLETED|Overall Study||3
1446204|NCT02191605|3540712|P4|COMPLETED|Overall Study||5
1446205|NCT02191605|3540713|P3|COMPLETED|Overall Study||8
1446206|NCT02191605|3540714|P2|COMPLETED|Overall Study||11
1446207|NCT02191605|3540715|P1|COMPLETED|Overall Study||6
1446208|NCT02191605|3540711|P5|Completed Intervention Portion|Overall Study||7
1446209|NCT02191605|3540712|P4|Completed Intervention Portion|Overall Study||8
1446210|NCT02191605|3540713|P3|Completed Intervention Portion|Overall Study||15
1446211|NCT02191605|3540714|P2|Completed Intervention Portion|Overall Study||15
1446212|NCT02191605|3540715|P1|Completed Intervention Portion|Overall Study||15
1446213|NCT02191605|3540711|P5|STARTED|Overall Study||7
1446214|NCT02191605|3540712|P4|STARTED|Overall Study||8
1446215|NCT02191605|3540713|P3|STARTED|Overall Study||15
1446216|NCT02191605|3540714|P2|STARTED|Overall Study||15
1446217|NCT02191605|3540715|P1|STARTED|Overall Study||15
1446218|NCT02191579|3540734|P2|NOT COMPLETED|Treatment 2||25
1446219|NCT02191579|3540735|P1|NOT COMPLETED|Treatment 2||0
1446220|NCT02191579|3540734|P2|COMPLETED|Treatment 2||55
1446221|NCT02191579|3540735|P1|COMPLETED|Treatment 2||0
1446222|NCT02191579|3540734|P2|STARTED|Treatment 2||80
1446223|NCT02191579|3540735|P1|STARTED|Treatment 2||0
1446224|NCT02191579|3540734|P2|NOT COMPLETED|Treatment 1||58
1446225|NCT02191579|3540735|P1|NOT COMPLETED|Treatment 1||27
1446226|NCT02191579|3540734|P2|COMPLETED|Treatment 1||84
1446227|NCT02191579|3540735|P1|COMPLETED|Treatment 1||113
1446228|NCT02191579|3540734|P2|STARTED|Treatment 1||142
1446229|NCT02191579|3540735|P1|STARTED|Treatment 1||140
1446230|NCT02191267|3540750|P3|NOT COMPLETED|Overall Study||0
1446231|NCT02191267|3540751|P2|NOT COMPLETED|Overall Study||0
1446232|NCT02191267|3540752|P1|NOT COMPLETED|Overall Study||1
1446233|NCT02191267|3540750|P3|COMPLETED|Overall Study||4
1446234|NCT02191267|3540751|P2|COMPLETED|Overall Study||6
1446235|NCT02191267|3540752|P1|COMPLETED|Overall Study||19
1446236|NCT02191267|3540750|P3|STARTED|Overall Study||4
1446237|NCT02191267|3540751|P2|STARTED|Overall Study||6
1446238|NCT02191267|3540752|P1|STARTED|Overall Study||20
1446239|NCT02191137|3540763|P1|NOT COMPLETED|Follow-up||5
1446240|NCT02191137|3540763|P1|COMPLETED|Follow-up||60
1446241|NCT02191137|3540763|P1|STARTED|Follow-up||65
1446242|NCT02191137|3540763|P1|NOT COMPLETED|Treatment||10
1446243|NCT02191137|3540763|P1|COMPLETED|Treatment||65
1446244|NCT02191137|3540763|P1|STARTED|Treatment||75
1446245|NCT02191046|3540793|P2|NOT COMPLETED|Overall Study||1
1446246|NCT02191046|3540794|P1|NOT COMPLETED|Overall Study||5
1446247|NCT02191046|3540793|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
1446248|NCT02191046|3540794|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
1446249|NCT02191046|3540793|P2|STARTED|Overall Study||39
1446250|NCT02191046|3540794|P1|STARTED|Overall Study||41
1446251|NCT02191033|3540802|P2|NOT COMPLETED|Overall Study||1
1446252|NCT02191033|3540803|P1|NOT COMPLETED|Overall Study||2
1446253|NCT02191033|3540802|P2|COMPLETED|Overall Study||19
1446254|NCT02191033|3540803|P1|COMPLETED|Overall Study||18
1446255|NCT02191033|3540802|P2|STARTED|Overall Study||20
1446256|NCT02191033|3540803|P1|STARTED|Overall Study||20
1446257|NCT02190903|3540815|P2|NOT COMPLETED|Overall Study||0
1446258|NCT02190903|3540816|P1|NOT COMPLETED|Overall Study||0
1446259|NCT02190903|3540815|P2|COMPLETED|Overall Study||6
1446260|NCT02190903|3540816|P1|COMPLETED|Overall Study||6
1446261|NCT02190903|3540815|P2|STARTED|Overall Study||6
1446262|NCT02190903|3540816|P1|STARTED|Overall Study||6
1446263|NCT02190721|3540825|P3|NOT COMPLETED|Overall Study||0
1446264|NCT02190721|3540826|P2|NOT COMPLETED|Overall Study||1
1446265|NCT02190721|3540827|P1|NOT COMPLETED|Overall Study||0
1446266|NCT02190721|3540825|P3|COMPLETED|Overall Study||18
1446267|NCT02190721|3540826|P2|COMPLETED|Overall Study||29
1446268|NCT02190721|3540827|P1|COMPLETED|Overall Study||2
1446269|NCT02190721|3540825|P3|Completed 90 Day Follow-up|Overall Study||18
1446270|NCT02190721|3540826|P2|Completed 90 Day Follow-up|Overall Study||29
1446271|NCT02190721|3540827|P1|Completed 90 Day Follow-up|Overall Study||2
1446272|NCT02190721|3540825|P3|Completed 30 Day Follow-up|Overall Study||18
1446273|NCT02190721|3540826|P2|Completed 30 Day Follow-up|Overall Study||29
1446274|NCT02190721|3540827|P1|Completed 30 Day Follow-up|Overall Study||2
1446275|NCT02190721|3540825|P3|Completed Treatment|Overall Study||18
1446276|NCT02190721|3540826|P2|Completed Treatment|Overall Study||30
1446277|NCT02190721|3540827|P1|Completed Treatment|Overall Study||2
1446278|NCT02190721|3540825|P3|STARTED|Overall Study||18
1446279|NCT02190721|3540826|P2|STARTED|Overall Study||30
1446280|NCT02190721|3540827|P1|STARTED|Overall Study||2
1446281|NCT02190604|3540950|P19|NOT COMPLETED|Part 3 (Patients)||0
1446282|NCT02190604|3540951|P18|NOT COMPLETED|Part 3 (Patients)||0
1446283|NCT02190604|3540952|P17|NOT COMPLETED|Part 3 (Patients)||0
1446284|NCT02190604|3540953|P16|NOT COMPLETED|Part 3 (Patients)||0
1446285|NCT02190604|3540954|P15|NOT COMPLETED|Part 3 (Patients)||0
1446286|NCT02190604|3540955|P14|NOT COMPLETED|Part 3 (Patients)||0
1446287|NCT02190604|3540956|P13|NOT COMPLETED|Part 3 (Patients)||0
1446288|NCT02190604|3540957|P12|NOT COMPLETED|Part 3 (Patients)||0
1446289|NCT02190604|3540958|P11|NOT COMPLETED|Part 3 (Patients)||0
1446290|NCT02190604|3540959|P10|NOT COMPLETED|Part 3 (Patients)||0
1446291|NCT02190604|3540960|P9|NOT COMPLETED|Part 3 (Patients)||0
1446292|NCT02190604|3540961|P8|NOT COMPLETED|Part 3 (Patients)||0
1446293|NCT02190604|3540962|P7|NOT COMPLETED|Part 3 (Patients)||0
1446294|NCT02190604|3540963|P6|NOT COMPLETED|Part 3 (Patients)||0
1446295|NCT02190604|3540964|P5|NOT COMPLETED|Part 3 (Patients)||0
1446296|NCT02190604|3540965|P4|NOT COMPLETED|Part 3 (Patients)||0
1446297|NCT02190604|3540966|P3|NOT COMPLETED|Part 3 (Patients)||0
1446298|NCT02190604|3540967|P2|NOT COMPLETED|Part 3 (Patients)||0
1446299|NCT02190604|3540968|P1|NOT COMPLETED|Part 3 (Patients)||0
1446300|NCT02190604|3540950|P19|COMPLETED|Part 3 (Patients)||12
1446301|NCT02190604|3540951|P18|COMPLETED|Part 3 (Patients)||19
1446302|NCT02190604|3540952|P17|COMPLETED|Part 3 (Patients)||12
1446303|NCT02190604|3540953|P16|COMPLETED|Part 3 (Patients)||6
1446304|NCT02190604|3540954|P15|COMPLETED|Part 3 (Patients)||0
1446305|NCT02190604|3540955|P14|COMPLETED|Part 3 (Patients)||0
1446306|NCT02190604|3540956|P13|COMPLETED|Part 3 (Patients)||0
1446307|NCT02190604|3540957|P12|COMPLETED|Part 3 (Patients)||0
1446308|NCT02190604|3540958|P11|COMPLETED|Part 3 (Patients)||0
1446309|NCT02190604|3540959|P10|COMPLETED|Part 3 (Patients)||0
1446310|NCT02190604|3540960|P9|COMPLETED|Part 3 (Patients)||0
1446311|NCT02190604|3540961|P8|COMPLETED|Part 3 (Patients)||0
1446312|NCT02190604|3540962|P7|COMPLETED|Part 3 (Patients)||0
1446313|NCT02190604|3540963|P6|COMPLETED|Part 3 (Patients)||0
1446314|NCT02190604|3540964|P5|COMPLETED|Part 3 (Patients)||0
1446315|NCT02190604|3540965|P4|COMPLETED|Part 3 (Patients)||0
1446316|NCT02190604|3540966|P3|COMPLETED|Part 3 (Patients)||0
1446317|NCT02190604|3540967|P2|COMPLETED|Part 3 (Patients)||0
1446318|NCT02190604|3540968|P1|COMPLETED|Part 3 (Patients)||0
1446319|NCT02190604|3540950|P19|STARTED|Part 3 (Patients)||12
1446320|NCT02190604|3540951|P18|STARTED|Part 3 (Patients)||19
1446321|NCT02190604|3540952|P17|STARTED|Part 3 (Patients)||12
1446322|NCT02190604|3540953|P16|STARTED|Part 3 (Patients)||6
1446323|NCT02190604|3540954|P15|STARTED|Part 3 (Patients)||0
1446324|NCT02190604|3540955|P14|STARTED|Part 3 (Patients)||0
1446325|NCT02190604|3540956|P13|STARTED|Part 3 (Patients)||0
1446326|NCT02190604|3540957|P12|STARTED|Part 3 (Patients)||0
1446327|NCT02190604|3540958|P11|STARTED|Part 3 (Patients)||0
1446328|NCT02190604|3540959|P10|STARTED|Part 3 (Patients)||0
1446329|NCT02190604|3540960|P9|STARTED|Part 3 (Patients)||0
1446330|NCT02190604|3540961|P8|STARTED|Part 3 (Patients)||0
1446331|NCT02190604|3540962|P7|STARTED|Part 3 (Patients)||0
1446332|NCT02190604|3540963|P6|STARTED|Part 3 (Patients)||0
1446333|NCT02190604|3540964|P5|STARTED|Part 3 (Patients)||0
1446334|NCT02190604|3540965|P4|STARTED|Part 3 (Patients)||0
1446335|NCT02190604|3540966|P3|STARTED|Part 3 (Patients)||0
1446336|NCT02190604|3540967|P2|STARTED|Part 3 (Patients)||0
1446337|NCT02190604|3540968|P1|STARTED|Part 3 (Patients)||0
1446338|NCT02190604|3540950|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446339|NCT02190604|3540951|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446340|NCT02190604|3540952|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446341|NCT02190604|3540953|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446342|NCT02190604|3540954|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
1446343|NCT02190604|3540955|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
1446344|NCT02190604|3540956|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446345|NCT02190604|3540957|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446346|NCT02190604|3540958|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446347|NCT02190604|3540959|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446348|NCT02190604|3540960|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446349|NCT02190604|3540961|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446350|NCT02190604|3540962|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446351|NCT02190604|3540963|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446352|NCT02190604|3540964|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446353|NCT02190604|3540965|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446354|NCT02190604|3540966|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446355|NCT02190604|3540967|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446356|NCT02190604|3540968|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446357|NCT02190604|3540950|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446358|NCT02190604|3540951|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446359|NCT02190604|3540952|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446360|NCT02190604|3540953|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
1446361|NCT02190604|3540954|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
1446362|NCT02190604|3540955|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
1446363|NCT02190604|3540956|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446364|NCT02190604|3540957|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446365|NCT02190604|3540958|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446366|NCT02190604|3540959|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446367|NCT02190604|3540960|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
1446368|NCT02190604|3540961|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446369|NCT02190604|3540962|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446370|NCT02190604|3540963|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446371|NCT02190604|3540964|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446372|NCT02190604|3540965|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446373|NCT02190604|3540966|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446374|NCT02190604|3540967|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446375|NCT02190604|3540968|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
1446376|NCT02190604|3540950|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
1446377|NCT02190604|3540951|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
1446378|NCT02190604|3540952|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
1446379|NCT02190604|3540953|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
1446380|NCT02190604|3540954|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
1446381|NCT02190604|3540955|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446382|NCT02190604|3540956|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446383|NCT02190604|3540957|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446384|NCT02190604|3540958|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446385|NCT02190604|3540959|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446386|NCT02190604|3540960|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
1446387|NCT02190604|3540961|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446388|NCT02190604|3540962|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446389|NCT02190604|3540963|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446390|NCT02190604|3540964|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446391|NCT02190604|3540965|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446392|NCT02190604|3540966|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446393|NCT02190604|3540967|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446394|NCT02190604|3540968|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
1446395|NCT02190591|3541159|P2|NOT COMPLETED|Overall Study||11
1446396|NCT02190591|3541160|P1|NOT COMPLETED|Overall Study||2
1446397|NCT02190591|3541159|P2|COMPLETED|Overall Study||91
1446398|NCT02190591|3541160|P1|COMPLETED|Overall Study||100
1446399|NCT02190591|3541159|P2|STARTED|Overall Study||102
1446400|NCT02190591|3541160|P1|STARTED|Overall Study||102
1446401|NCT02190435|3541172|P2|NOT COMPLETED|Overall Study||0
1446402|NCT02190435|3541173|P1|NOT COMPLETED|Overall Study||15
1446403|NCT02190435|3541172|P2|COMPLETED|Overall Study||24
1446404|NCT02190435|3541173|P1|COMPLETED|Overall Study||26
1446405|NCT02190435|3541172|P2|STARTED|Overall Study||24
1446406|NCT02190435|3541173|P1|STARTED|Overall Study||41
1446407|NCT02190045|3541183|P2|NOT COMPLETED|Overall Study||0
1446408|NCT02190045|3541184|P1|NOT COMPLETED|Overall Study||3
1446409|NCT02190045|3541183|P2|COMPLETED|Overall Study||15
1446410|NCT02190045|3541184|P1|COMPLETED|Overall Study||12
1446411|NCT02190045|3541183|P2|STARTED|Overall Study||15
1446412|NCT02190045|3541184|P1|STARTED|Overall Study||15
1446413|NCT02189954|3541192|P2|NOT COMPLETED|Overall Study||0
1446414|NCT02189954|3541193|P1|NOT COMPLETED|Overall Study||0
1446415|NCT02189954|3541192|P2|COMPLETED|Overall Study||45
1446416|NCT02189954|3541193|P1|COMPLETED|Overall Study||45
1446417|NCT02189954|3541192|P2|STARTED|Overall Study||45
1446418|NCT02189954|3541193|P1|STARTED|Overall Study||45
1446419|NCT02189941|3541201|P3|NOT COMPLETED|Overall Study||1
1446420|NCT02189941|3541202|P2|NOT COMPLETED|Overall Study||0
1446421|NCT02189941|3541203|P1|NOT COMPLETED|Overall Study||0
1446422|NCT02189941|3541201|P3|COMPLETED|Overall Study||2
1446423|NCT02189941|3541202|P2|COMPLETED|Overall Study||4
1446424|NCT02189941|3541203|P1|COMPLETED|Overall Study||4
1446425|NCT02189941|3541201|P3|STARTED|Overall Study||3
1446426|NCT02189941|3541202|P2|STARTED|Overall Study||4
1446427|NCT02189941|3541203|P1|STARTED|Overall Study||4
1446428|NCT02189915|3541226|P1|NOT COMPLETED|Overall Study||3
1446429|NCT02189915|3541226|P1|COMPLETED|Overall Study||11
1446430|NCT02189915|3541226|P1|STARTED|Overall Study||14
1446431|NCT02189863|3541231|P2|NOT COMPLETED|Second 2 Weeks||0
1446432|NCT02189863|3541232|P1|NOT COMPLETED|Second 2 Weeks||0
1446433|NCT02189863|3541231|P2|COMPLETED|Second 2 Weeks||13
1446434|NCT02189863|3541232|P1|COMPLETED|Second 2 Weeks||8
1446435|NCT02189863|3541231|P2|STARTED|Second 2 Weeks||13
1446436|NCT02189863|3541232|P1|STARTED|Second 2 Weeks||8
1446437|NCT02189863|3541231|P2|NOT COMPLETED|First 2 Weeks||2
1446438|NCT02189863|3541232|P1|NOT COMPLETED|First 2 Weeks||4
1446439|NCT02189863|3541231|P2|COMPLETED|First 2 Weeks||13
1446440|NCT02189863|3541232|P1|COMPLETED|First 2 Weeks||8
1446441|NCT02189863|3541231|P2|STARTED|First 2 Weeks||15
1446442|NCT02189863|3541232|P1|STARTED|First 2 Weeks||12
1446443|NCT02189837|3541247|P4|NOT COMPLETED|Overall Study||2
1446444|NCT02189837|3541248|P3|NOT COMPLETED|Overall Study||3
1446445|NCT02189837|3541249|P2|NOT COMPLETED|Overall Study||1
1446446|NCT02189837|3541250|P1|NOT COMPLETED|Overall Study||2
1446447|NCT02189837|3541247|P4|COMPLETED|Overall Study||19
1446448|NCT02189837|3541248|P3|COMPLETED|Overall Study||20
1446449|NCT02189837|3541249|P2|COMPLETED|Overall Study||22
1446450|NCT02189837|3541250|P1|COMPLETED|Overall Study||20
1446451|NCT02189837|3541247|P4|Received Treatment|Overall Study||20
1446452|NCT02189837|3541248|P3|Received Treatment|Overall Study||22
1446453|NCT02189837|3541249|P2|Received Treatment|Overall Study||22
1446454|NCT02189837|3541250|P1|Received Treatment|Overall Study||21
1446455|NCT02189837|3541247|P4|STARTED|Overall Study||21
1446456|NCT02189837|3541248|P3|STARTED|Overall Study||23
1446457|NCT02189837|3541249|P2|STARTED|Overall Study||23
1446458|NCT02189837|3541250|P1|STARTED|Overall Study||22
1446459|NCT02189759|3541280|P4|NOT COMPLETED|Overall Study||5
1446460|NCT02189759|3541281|P3|NOT COMPLETED|Overall Study||2
1446461|NCT02189759|3541282|P2|NOT COMPLETED|Overall Study||0
1446462|NCT02189759|3541283|P1|NOT COMPLETED|Overall Study||0
1446463|NCT02189759|3541280|P4|COMPLETED|Overall Study||84
1446464|NCT02189759|3541281|P3|COMPLETED|Overall Study||81
1446465|NCT02189759|3541282|P2|COMPLETED|Overall Study||101
1446466|NCT02189759|3541283|P1|COMPLETED|Overall Study||102
1446467|NCT02189759|3541280|P4|STARTED|Overall Study||89
1446468|NCT02189759|3541281|P3|STARTED|Overall Study||83
1446469|NCT02189759|3541282|P2|STARTED|Overall Study||101
1446470|NCT02189759|3541283|P1|STARTED|Overall Study||102
1446471|NCT02189668|3541303|P2|NOT COMPLETED|Overall Study||0
1446472|NCT02189668|3541304|P1|NOT COMPLETED|Overall Study||0
1446473|NCT02189668|3541303|P2|COMPLETED|Overall Study||9
1446474|NCT02189668|3541304|P1|COMPLETED|Overall Study||5
1446475|NCT02189668|3541303|P2|STARTED|Overall Study||9
1446476|NCT02189668|3541304|P1|STARTED|Overall Study||5
1446477|NCT02189382|3541314|P2|NOT COMPLETED|Overall Study||0
1446478|NCT02189382|3541315|P1|NOT COMPLETED|Overall Study||0
1446479|NCT02189382|3541314|P2|COMPLETED|Overall Study||35
1446480|NCT02189382|3541315|P1|COMPLETED|Overall Study||35
1446481|NCT02189382|3541314|P2|STARTED|Overall Study||35
1446482|NCT02189382|3541315|P1|STARTED|Overall Study||35
1446483|NCT02189317|3541325|P2|NOT COMPLETED|Overall Study||0
1446484|NCT02189317|3541326|P1|NOT COMPLETED|Overall Study||0
1446485|NCT02189317|3541325|P2|COMPLETED|Overall Study||16
1446486|NCT02189317|3541326|P1|COMPLETED|Overall Study||16
1446487|NCT02189317|3541325|P2|STARTED|Overall Study||16
1446488|NCT02189317|3541326|P1|STARTED|Overall Study||16
1446489|NCT02189252|3541340|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
1446490|NCT02189252|3541341|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
1446491|NCT02189252|3541342|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
1446492|NCT02189252|3541343|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
1446493|NCT02189252|3541340|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
1446494|NCT02189252|3541341|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
1446495|NCT02189252|3541342|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
1446496|NCT02189252|3541343|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
1446497|NCT02189252|3541340|P4|STARTED|Period 2 (Visit6b, Week 12)||4
1446498|NCT02189252|3541341|P3|STARTED|Period 2 (Visit6b, Week 12)||3
1446499|NCT02189252|3541342|P2|STARTED|Period 2 (Visit6b, Week 12)||2
1446500|NCT02189252|3541343|P1|STARTED|Period 2 (Visit6b, Week 12)||4
1446501|NCT02189252|3541340|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
1446502|NCT02189252|3541341|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
1446503|NCT02189252|3541342|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
1446504|NCT02189252|3541343|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
1446505|NCT02189252|3541340|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
1446506|NCT02189252|3541341|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
1446507|NCT02189252|3541342|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
1446508|NCT02189252|3541343|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
1446509|NCT02189252|3541340|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
1446510|NCT02189252|3541341|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
1446511|NCT02189252|3541342|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
1446512|NCT02189252|3541343|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
1446513|NCT02189161|3541375|P1|NOT COMPLETED|Overall Study||0
1446514|NCT02189161|3541375|P1|COMPLETED|Overall Study||10
1446515|NCT02189161|3541375|P1|STARTED|Overall Study||10
1446516|NCT02189122|3541383|P2|NOT COMPLETED|Overall Study||0
1446517|NCT02189122|3541384|P1|NOT COMPLETED|Overall Study||0
1446518|NCT02189122|3541383|P2|COMPLETED|Overall Study||18
1446519|NCT02189122|3541384|P1|COMPLETED|Overall Study||18
1446520|NCT02189122|3541383|P2|STARTED|Overall Study||18
1446521|NCT02189122|3541384|P1|STARTED|Overall Study||18
1446522|NCT02188849|3541402|P2|NOT COMPLETED|Overall Study||8
1446523|NCT02188849|3541403|P1|NOT COMPLETED|Overall Study||3
1446524|NCT02188849|3541402|P2|COMPLETED|Overall Study||17
1446525|NCT02188849|3541403|P1|COMPLETED|Overall Study||22
1446526|NCT02188849|3541402|P2|STARTED|Overall Study||25
1446527|NCT02188849|3541403|P1|STARTED|Overall Study||25
1446528|NCT02188784|3541417|P2|NOT COMPLETED|Overall Study||13
1446529|NCT02188784|3541418|P1|NOT COMPLETED|Overall Study||9
1446530|NCT02188784|3541417|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
1446531|NCT02188784|3541418|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
1446532|NCT02188784|3541417|P2|STARTED|Overall Study||114
1446533|NCT02188784|3541418|P1|STARTED|Overall Study||111
1446534|NCT02188589|3541434|P1|NOT COMPLETED|Overall Study||0
1446535|NCT02188589|3541434|P1|COMPLETED|Overall Study||30
1446536|NCT02188589|3541434|P1|STARTED|Overall Study||30
1446537|NCT02187887|3541441|P2|NOT COMPLETED|Overall Study||4
1446538|NCT02187887|3541442|P1|NOT COMPLETED|Overall Study||5
1446539|NCT02187887|3541441|P2|COMPLETED|Overall Study||396
1446540|NCT02187887|3541442|P1|COMPLETED|Overall Study||388
1446541|NCT02187887|3541441|P2|STARTED|Overall Study||400
1446542|NCT02187887|3541442|P1|STARTED|Overall Study||393
1446543|NCT02187861|3541454|P4|NOT COMPLETED|Overall Study||51
1446544|NCT02187861|3541455|P3|NOT COMPLETED|Overall Study||51
1446545|NCT02187861|3541456|P2|NOT COMPLETED|Overall Study||53
1446546|NCT02187861|3541457|P1|NOT COMPLETED|Overall Study||9
1446547|NCT02187861|3541454|P4|COMPLETED|Overall Study||0
1446548|NCT02187861|3541455|P3|COMPLETED|Overall Study||0
1446549|NCT02187861|3541456|P2|COMPLETED|Overall Study||0
1446550|NCT02187861|3541457|P1|COMPLETED|Overall Study||0
1446551|NCT02187861|3541454|P4|Treated|Overall Study||50
1446552|NCT02187861|3541455|P3|Treated|Overall Study||49
1446553|NCT02187861|3541456|P2|Treated|Overall Study||52
1446554|NCT02187861|3541457|P1|Treated|Overall Study||9
1446555|NCT02187861|3541454|P4|STARTED|Overall Study||51
1446556|NCT02187861|3541455|P3|STARTED|Overall Study||51
1446557|NCT02187861|3541456|P2|STARTED|Overall Study||53
1446558|NCT02187861|3541457|P1|STARTED|Overall Study||9
1446559|NCT02187809|3541553|P1|NOT COMPLETED|Overall Study||3
1446560|NCT02187809|3541553|P1|COMPLETED|Overall Study||0
1446561|NCT02187809|3541553|P1|Treated|Overall Study||1
1446562|NCT02187809|3541553|P1|STARTED|Overall Study||3
1446563|NCT02187744|3541565|P2|NOT COMPLETED|Treatment||5
1446564|NCT02187744|3541566|P1|NOT COMPLETED|Treatment||4
1446565|NCT02187744|3541565|P2|COMPLETED|Treatment||107
1446566|NCT02187744|3541566|P1|COMPLETED|Treatment||109
1446567|NCT02187744|3541565|P2|STARTED|Treatment||112
1446568|NCT02187744|3541566|P1|STARTED|Treatment||113
1446569|NCT02187744|3541565|P2|NOT COMPLETED|Study||6
1446570|NCT02187744|3541566|P1|NOT COMPLETED|Study||4
1446571|NCT02187744|3541565|P2|COMPLETED|Study||106
1446572|NCT02187744|3541566|P1|COMPLETED|Study||109
1446573|NCT02187744|3541565|P2|STARTED|Study|Received treatment|112
1446574|NCT02187744|3541566|P1|STARTED|Study|Received treatment|113
1446575|NCT02187055|3541585|P3|NOT COMPLETED|Overall Study||74
1446576|NCT02187055|3541586|P2|NOT COMPLETED|Overall Study||73
1446577|NCT02187055|3541587|P1|NOT COMPLETED|Overall Study||69
1446578|NCT02187055|3541585|P3|COMPLETED|Overall Study||312
1446579|NCT02187055|3541586|P2|COMPLETED|Overall Study||303
1446580|NCT02187055|3541587|P1|COMPLETED|Overall Study||315
1446581|NCT02187055|3541585|P3|STARTED|Overall Study|Treated|386
1446582|NCT02187055|3541586|P2|STARTED|Overall Study|Treated|376
1446583|NCT02187055|3541587|P1|STARTED|Overall Study|Treated|384
1446584|NCT02187029|3541689|P4|NOT COMPLETED|Overall Study||3
1446585|NCT02187029|3541690|P3|NOT COMPLETED|Overall Study||11
1446586|NCT02187029|3541691|P2|NOT COMPLETED|Overall Study||1
1446587|NCT02187029|3541692|P1|NOT COMPLETED|Overall Study||1
1446588|NCT02187029|3541689|P4|COMPLETED|Overall Study||6
1446589|NCT02187029|3541690|P3|COMPLETED|Overall Study||0
1446590|NCT02187029|3541691|P2|COMPLETED|Overall Study||2
1446591|NCT02187029|3541692|P1|COMPLETED|Overall Study||6
1446592|NCT02187029|3541689|P4|STARTED|Overall Study||9
1446593|NCT02187029|3541690|P3|STARTED|Overall Study||11
1446594|NCT02187029|3541691|P2|STARTED|Overall Study||3
1446595|NCT02187029|3541692|P1|STARTED|Overall Study||7
1446596|NCT02187016|3541768|P4|NOT COMPLETED|Overall Study||0
1446597|NCT02187016|3541769|P3|NOT COMPLETED|Overall Study||1
1446598|NCT02187016|3541770|P2|NOT COMPLETED|Overall Study||2
1446599|NCT02187016|3541771|P1|NOT COMPLETED|Overall Study||1
1446600|NCT02187016|3541768|P4|COMPLETED|Overall Study||51
1446601|NCT02187016|3541769|P3|COMPLETED|Overall Study||78
1446602|NCT02187016|3541770|P2|COMPLETED|Overall Study||78
1446603|NCT02187016|3541771|P1|COMPLETED|Overall Study||79
1446604|NCT02187016|3541768|P4|STARTED|Overall Study||51
1446605|NCT02187016|3541769|P3|STARTED|Overall Study||79
1446606|NCT02187016|3541770|P2|STARTED|Overall Study||80
1446607|NCT02187016|3541771|P1|STARTED|Overall Study||80
1446608|NCT02186938|3541803|P2|NOT COMPLETED|Overall Study||3
1446609|NCT02186938|3541804|P1|NOT COMPLETED|Overall Study||9
1446610|NCT02186938|3541803|P2|COMPLETED|Overall Study||44
1446611|NCT02186938|3541804|P1|COMPLETED|Overall Study||38
1446612|NCT02186938|3541803|P2|STARTED|Overall Study||47
1446613|NCT02186938|3541804|P1|STARTED|Overall Study|2012|47
1446614|NCT02186873|3541814|P2|NOT COMPLETED|Overall Study||8
1446615|NCT02186873|3541815|P1|NOT COMPLETED|Overall Study||9
1446616|NCT02186873|3541814|P2|COMPLETED|Overall Study||97
1446617|NCT02186873|3541815|P1|COMPLETED|Overall Study||94
1446618|NCT02186873|3541814|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
1446619|NCT02186873|3541815|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
1446620|NCT02186873|3541814|P2|STARTED|Overall Study||105
1446621|NCT02186873|3541815|P1|STARTED|Overall Study||103
1446622|NCT02186808|3541838|P1|NOT COMPLETED|Overall Study||13
1446623|NCT02186808|3541838|P1|COMPLETED|Overall Study||67
1446624|NCT02186808|3541838|P1|STARTED|Overall Study||80
1446625|NCT02186665|3541845|P2|NOT COMPLETED|Overall Study||1
1446626|NCT02186665|3541846|P1|NOT COMPLETED|Overall Study||0
1446627|NCT02186665|3541845|P2|COMPLETED|Overall Study||10
1446628|NCT02186665|3541846|P1|COMPLETED|Overall Study||8
1446629|NCT02186665|3541845|P2|STARTED|Overall Study||11
1446630|NCT02186665|3541846|P1|STARTED|Overall Study||8
1446631|NCT02186587|3541854|P2|NOT COMPLETED|Overall Study||0
1446632|NCT02186587|3541855|P1|NOT COMPLETED|Overall Study||5
1446633|NCT02186587|3541854|P2|COMPLETED|Overall Study||0
1446634|NCT02186587|3541855|P1|COMPLETED|Overall Study||23
1446635|NCT02186587|3541854|P2|STARTED|Overall Study||0
1446636|NCT02186587|3541855|P1|STARTED|Overall Study||28
1446637|NCT02186223|3541860|P1|NOT COMPLETED|Overall Study||21
1446638|NCT02186223|3541860|P1|COMPLETED|Overall Study||151
1446639|NCT02186223|3541860|P1|Device Placed|Overall Study||163
1446640|NCT02186223|3541860|P1|STARTED|Overall Study||172
1446641|NCT02186210|3541871|P2|NOT COMPLETED|Overall Study||0
1446642|NCT02186210|3541872|P1|NOT COMPLETED|Overall Study||0
1446643|NCT02186210|3541871|P2|COMPLETED|Overall Study||20
1446644|NCT02186210|3541872|P1|COMPLETED|Overall Study||20
1446645|NCT02186210|3541871|P2|STARTED|Overall Study||20
1446646|NCT02186210|3541872|P1|STARTED|Overall Study||20
1446647|NCT02185729|3541880|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
1446648|NCT02185729|3541880|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
1446649|NCT02185729|3541880|P1|STARTED|24 Hours Into Dextrose Infusion||12
1446650|NCT02185729|3541880|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
1446651|NCT02185729|3541880|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
1446652|NCT02185729|3541880|P1|STARTED|4 Hours Into Dextrose Infusion||12
1446653|NCT02185729|3541880|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
1446654|NCT02185729|3541880|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
1446655|NCT02185729|3541880|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
1446656|NCT02185729|3541880|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
1446657|NCT02185729|3541880|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
1446658|NCT02185729|3541880|P1|STARTED|24 Hours Into ClinOleic Infusion||12
1446659|NCT02185729|3541880|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
1446660|NCT02185729|3541880|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
1446661|NCT02185729|3541880|P1|STARTED|4 Hours Into ClinOleic Infusion||12
1446662|NCT02185729|3541880|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
1446663|NCT02185729|3541880|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
1446664|NCT02185729|3541880|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
1446665|NCT02185729|3541880|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
1446666|NCT02185729|3541880|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
1446667|NCT02185729|3541880|P1|STARTED|24 Hours Into Intralipid Infusion||12
1446668|NCT02185729|3541880|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
1446669|NCT02185729|3541880|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
1446670|NCT02185729|3541880|P1|STARTED|4 Hours Into Intralipid Infusion||12
1446671|NCT02185729|3541880|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
1446672|NCT02185729|3541880|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
1446673|NCT02185729|3541880|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
1446674|NCT02185729|3541880|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
1446675|NCT02185729|3541880|P1|COMPLETED|24 Hours Into Saline Infusion||12
1446676|NCT02185729|3541880|P1|STARTED|24 Hours Into Saline Infusion||12
1446677|NCT02185729|3541880|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
1446678|NCT02185729|3541880|P1|COMPLETED|4 Hours Into Saline Infusion||12
1446679|NCT02185729|3541880|P1|STARTED|4 Hours Into Saline Infusion||12
1446680|NCT02185729|3541880|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
1446681|NCT02185729|3541880|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
1446682|NCT02185729|3541880|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
1446683|NCT02185534|3541901|P6|NOT COMPLETED|Third Period||0
1446684|NCT02185534|3541902|P5|NOT COMPLETED|Third Period||0
1446685|NCT02185534|3541903|P4|NOT COMPLETED|Third Period||0
1446686|NCT02185534|3541904|P3|NOT COMPLETED|Third Period||0
1446687|NCT02185534|3541905|P2|NOT COMPLETED|Third Period||0
1446688|NCT02185534|3541906|P1|NOT COMPLETED|Third Period||0
1446689|NCT02185534|3541901|P6|COMPLETED|Third Period||13
1446690|NCT02185534|3541902|P5|COMPLETED|Third Period||13
1446691|NCT02185534|3541903|P4|COMPLETED|Third Period||13
1446692|NCT02185534|3541904|P3|COMPLETED|Third Period||14
1446693|NCT02185534|3541905|P2|COMPLETED|Third Period||14
1446694|NCT02185534|3541906|P1|COMPLETED|Third Period||13
1446695|NCT02185534|3541901|P6|STARTED|Third Period||13
1446696|NCT02185534|3541902|P5|STARTED|Third Period||13
1446697|NCT02185534|3541903|P4|STARTED|Third Period||13
1446698|NCT02185534|3541904|P3|STARTED|Third Period||14
1446699|NCT02185534|3541905|P2|STARTED|Third Period||14
1446700|NCT02185534|3541906|P1|STARTED|Third Period||13
1446701|NCT02185534|3541901|P6|NOT COMPLETED|Second Washout Period||0
1446702|NCT02185534|3541902|P5|NOT COMPLETED|Second Washout Period||0
1446703|NCT02185534|3541903|P4|NOT COMPLETED|Second Washout Period||0
1446704|NCT02185534|3541904|P3|NOT COMPLETED|Second Washout Period||0
1446705|NCT02185534|3541905|P2|NOT COMPLETED|Second Washout Period||0
1446706|NCT02185534|3541906|P1|NOT COMPLETED|Second Washout Period||0
1446707|NCT02185534|3541901|P6|COMPLETED|Second Washout Period||13
1446708|NCT02185534|3541902|P5|COMPLETED|Second Washout Period||13
1446709|NCT02185534|3541903|P4|COMPLETED|Second Washout Period||13
1446710|NCT02185534|3541904|P3|COMPLETED|Second Washout Period||14
1446711|NCT02185534|3541905|P2|COMPLETED|Second Washout Period||14
1446712|NCT02185534|3541906|P1|COMPLETED|Second Washout Period||13
1446713|NCT02185534|3541901|P6|STARTED|Second Washout Period||13
1446714|NCT02185534|3541902|P5|STARTED|Second Washout Period||13
1446715|NCT02185534|3541903|P4|STARTED|Second Washout Period||13
1446716|NCT02185534|3541904|P3|STARTED|Second Washout Period||14
1446717|NCT02185534|3541905|P2|STARTED|Second Washout Period||14
1446718|NCT02185534|3541906|P1|STARTED|Second Washout Period||13
1446719|NCT02185534|3541901|P6|NOT COMPLETED|Second Period||0
1446720|NCT02185534|3541902|P5|NOT COMPLETED|Second Period||0
1446721|NCT02185534|3541903|P4|NOT COMPLETED|Second Period||0
1446722|NCT02185534|3541904|P3|NOT COMPLETED|Second Period||0
1446723|NCT02185534|3541905|P2|NOT COMPLETED|Second Period||0
1446724|NCT02185534|3541906|P1|NOT COMPLETED|Second Period||0
1446725|NCT02185534|3541901|P6|COMPLETED|Second Period||13
1446726|NCT02185534|3541902|P5|COMPLETED|Second Period||13
1446727|NCT02185534|3541903|P4|COMPLETED|Second Period||13
1446728|NCT02185534|3541904|P3|COMPLETED|Second Period||14
1446729|NCT02185534|3541905|P2|COMPLETED|Second Period||14
1446730|NCT02185534|3541906|P1|COMPLETED|Second Period||13
1446731|NCT02185534|3541901|P6|STARTED|Second Period||13
1446732|NCT02185534|3541902|P5|STARTED|Second Period||13
1446733|NCT02185534|3541903|P4|STARTED|Second Period||13
1446734|NCT02185534|3541904|P3|STARTED|Second Period||14
1446735|NCT02185534|3541905|P2|STARTED|Second Period||14
1446736|NCT02185534|3541906|P1|STARTED|Second Period||13
1446737|NCT02185534|3541901|P6|NOT COMPLETED|First Washout Period||1
1446738|NCT02185534|3541902|P5|NOT COMPLETED|First Washout Period||1
1446739|NCT02185534|3541903|P4|NOT COMPLETED|First Washout Period||0
1446740|NCT02185534|3541904|P3|NOT COMPLETED|First Washout Period||0
1446741|NCT02185534|3541905|P2|NOT COMPLETED|First Washout Period||0
1446742|NCT02185534|3541906|P1|NOT COMPLETED|First Washout Period||1
1446743|NCT02185534|3541901|P6|COMPLETED|First Washout Period||13
1446744|NCT02185534|3541902|P5|COMPLETED|First Washout Period||13
1446745|NCT02185534|3541903|P4|COMPLETED|First Washout Period||13
1446746|NCT02185534|3541904|P3|COMPLETED|First Washout Period||14
1446747|NCT02185534|3541905|P2|COMPLETED|First Washout Period||14
1446748|NCT02185534|3541906|P1|COMPLETED|First Washout Period||13
1446749|NCT02185534|3541901|P6|STARTED|First Washout Period||14
1446750|NCT02185534|3541902|P5|STARTED|First Washout Period||14
1446751|NCT02185534|3541903|P4|STARTED|First Washout Period||13
1446752|NCT02185534|3541904|P3|STARTED|First Washout Period||14
1446753|NCT02185534|3541905|P2|STARTED|First Washout Period||14
1446754|NCT02185534|3541906|P1|STARTED|First Washout Period||14
1446755|NCT02185534|3541901|P6|NOT COMPLETED|First Period||0
1446756|NCT02185534|3541902|P5|NOT COMPLETED|First Period||0
1446757|NCT02185534|3541903|P4|NOT COMPLETED|First Period||1
1446758|NCT02185534|3541904|P3|NOT COMPLETED|First Period||0
1446759|NCT02185534|3541905|P2|NOT COMPLETED|First Period||0
1446760|NCT02185534|3541906|P1|NOT COMPLETED|First Period||0
1446761|NCT02185534|3541901|P6|COMPLETED|First Period||14
1446762|NCT02185534|3541902|P5|COMPLETED|First Period||14
1446763|NCT02185534|3541903|P4|COMPLETED|First Period||13
1446764|NCT02185534|3541904|P3|COMPLETED|First Period||14
1446765|NCT02185534|3541905|P2|COMPLETED|First Period||14
1446766|NCT02185534|3541906|P1|COMPLETED|First Period||14
1446767|NCT02185534|3541901|P6|STARTED|First Period||14
1446768|NCT02185534|3541902|P5|STARTED|First Period||14
1446769|NCT02185534|3541903|P4|STARTED|First Period||14
1446770|NCT02185534|3541904|P3|STARTED|First Period||14
1446771|NCT02185534|3541905|P2|STARTED|First Period||14
1446772|NCT02185534|3541906|P1|STARTED|First Period||14
1446773|NCT02185339|3541923|P2|NOT COMPLETED|Overall Study||1
1446774|NCT02185339|3541924|P1|NOT COMPLETED|Overall Study||0
1446775|NCT02185339|3541923|P2|COMPLETED|Overall Study||30
1446776|NCT02185339|3541924|P1|COMPLETED|Overall Study||30
1446777|NCT02185339|3541923|P2|STARTED|Overall Study||31
1446778|NCT02185339|3541924|P1|STARTED|Overall Study||30
1446779|NCT02185183|3541946|P1|NOT COMPLETED|Overall Study||0
1446780|NCT02185183|3541946|P1|COMPLETED|Overall Study||14
1446781|NCT02185183|3541946|P1|STARTED|Overall Study||14
1446782|NCT02185131|3541952|P2|NOT COMPLETED|Overall Study||1
1446783|NCT02185131|3541953|P1|NOT COMPLETED|Overall Study||1
1446784|NCT02185131|3541952|P2|COMPLETED|Overall Study||8
1446785|NCT02185131|3541953|P1|COMPLETED|Overall Study||6
1446786|NCT02185131|3541952|P2|STARTED|Overall Study||9
1446787|NCT02185131|3541953|P1|STARTED|Overall Study||7
1446788|NCT02185105|3541961|P1|NOT COMPLETED|Overall Study||0
1446789|NCT02185105|3541961|P1|COMPLETED|Overall Study||30
1446790|NCT02185105|3541961|P1|STARTED|Overall Study||30
1446791|NCT02185014|3542004|P1|NOT COMPLETED|Overall Study||54
1446792|NCT02185014|3542004|P1|COMPLETED|Overall Study||198
1446793|NCT02185014|3542004|P1|STARTED|Overall Study||252
1446794|NCT02184624|3542013|P5|NOT COMPLETED|Overall Study||0
1446795|NCT02184624|3542014|P4|NOT COMPLETED|Overall Study||0
1446796|NCT02184624|3542015|P3|NOT COMPLETED|Overall Study||0
1446797|NCT02184624|3542016|P2|NOT COMPLETED|Overall Study||0
1446798|NCT02184624|3542017|P1|NOT COMPLETED|Overall Study||0
1446799|NCT02184624|3542013|P5|COMPLETED|Overall Study||98
1446800|NCT02184624|3542014|P4|COMPLETED|Overall Study||118
1446801|NCT02184624|3542015|P3|COMPLETED|Overall Study||100
1446802|NCT02184624|3542016|P2|COMPLETED|Overall Study||80
1446803|NCT02184624|3542017|P1|COMPLETED|Overall Study||171
1446804|NCT02184624|3542013|P5|STARTED|Overall Study||98
1446805|NCT02184624|3542014|P4|STARTED|Overall Study||118
1446806|NCT02184624|3542015|P3|STARTED|Overall Study||100
1446807|NCT02184624|3542016|P2|STARTED|Overall Study||80
1446808|NCT02184624|3542017|P1|STARTED|Overall Study||171
1446809|NCT02184572|3542061|P2|NOT COMPLETED|Overall Study||30
1446810|NCT02184572|3542062|P1|NOT COMPLETED|Overall Study||47
1446811|NCT02184572|3542061|P2|COMPLETED|Overall Study||542
1446812|NCT02184572|3542062|P1|COMPLETED|Overall Study||1117
1446813|NCT02184572|3542061|P2|STARTED|Overall Study||572
1446814|NCT02184572|3542062|P1|STARTED|Overall Study||1164
1446815|NCT02184494|3542101|P3|NOT COMPLETED|Overall Study||0
1446816|NCT02184494|3542102|P2|NOT COMPLETED|Overall Study||2
1446817|NCT02184494|3542103|P1|NOT COMPLETED|Overall Study||1
1446818|NCT02184494|3542101|P3|COMPLETED|Overall Study||8
1446819|NCT02184494|3542102|P2|COMPLETED|Overall Study||11
1446820|NCT02184494|3542103|P1|COMPLETED|Overall Study||12
1446821|NCT02184494|3542101|P3|STARTED|Overall Study||8
1446822|NCT02184494|3542102|P2|STARTED|Overall Study||13
1446823|NCT02184494|3542103|P1|STARTED|Overall Study||13
1446824|NCT02184442|3542125|P2|NOT COMPLETED|Overall Study||76
1446825|NCT02184442|3542126|P1|NOT COMPLETED|Overall Study||64
1446826|NCT02184442|3542125|P2|COMPLETED|Overall Study||200
1446827|NCT02184442|3542126|P1|COMPLETED|Overall Study||220
1446828|NCT02184442|3542125|P2|Valve-Implant|Overall Study||263
1446829|NCT02184442|3542126|P1|Valve-Implant|Overall Study||280
1446830|NCT02184442|3542125|P2|As-Treated|Overall Study||271
1446831|NCT02184442|3542126|P1|As-Treated|Overall Study||282
1446832|NCT02184442|3542125|P2|STARTED|Overall Study||276
1446833|NCT02184442|3542126|P1|STARTED|Overall Study||284
1446834|NCT02184208|3542138|P1|NOT COMPLETED|Overall Study||56
1446835|NCT02184208|3542138|P1|COMPLETED|Overall Study||222
1446836|NCT02184208|3542138|P1|STARTED|Overall Study||278
1446837|NCT02183675|3542150|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1446838|NCT02183675|3542151|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1446839|NCT02183675|3542152|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1446840|NCT02183675|3542153|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1446841|NCT02183675|3542154|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1446842|NCT02183675|3542155|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
1446843|NCT02183675|3542150|P6|COMPLETED|Treatment Period 3 (10 Days)||4
1446844|NCT02183675|3542151|P5|COMPLETED|Treatment Period 3 (10 Days)||6
1446845|NCT02183675|3542152|P4|COMPLETED|Treatment Period 3 (10 Days)||6
1446846|NCT02183675|3542153|P3|COMPLETED|Treatment Period 3 (10 Days)||6
1446847|NCT02183675|3542154|P2|COMPLETED|Treatment Period 3 (10 Days)||6
1446848|NCT02183675|3542155|P1|COMPLETED|Treatment Period 3 (10 Days)||6
1446849|NCT02183675|3542150|P6|STARTED|Treatment Period 3 (10 Days)||4
1446850|NCT02183675|3542151|P5|STARTED|Treatment Period 3 (10 Days)||6
1446851|NCT02183675|3542152|P4|STARTED|Treatment Period 3 (10 Days)||6
1446852|NCT02183675|3542153|P3|STARTED|Treatment Period 3 (10 Days)||6
1446853|NCT02183675|3542154|P2|STARTED|Treatment Period 3 (10 Days)||6
1446854|NCT02183675|3542155|P1|STARTED|Treatment Period 3 (10 Days)||6
1446855|NCT02183675|3542150|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
1446856|NCT02183675|3542151|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1446857|NCT02183675|3542152|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1446858|NCT02183675|3542153|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1446859|NCT02183675|3542154|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1446860|NCT02183675|3542155|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
1446861|NCT02183675|3542150|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
1446862|NCT02183675|3542151|P5|COMPLETED|Treatment Period 2 (10 Days)||6
1446863|NCT02183675|3542152|P4|COMPLETED|Treatment Period 2 (10 Days)||6
1446864|NCT02183675|3542153|P3|COMPLETED|Treatment Period 2 (10 Days)||6
1446865|NCT02183675|3542154|P2|COMPLETED|Treatment Period 2 (10 Days)||6
1446866|NCT02183675|3542155|P1|COMPLETED|Treatment Period 2 (10 Days)||6
1446867|NCT02183675|3542150|P6|STARTED|Treatment Period 2 (10 Days)||6
1446868|NCT02183675|3542151|P5|STARTED|Treatment Period 2 (10 Days)||6
1446869|NCT02183675|3542152|P4|STARTED|Treatment Period 2 (10 Days)||6
1446870|NCT02183675|3542153|P3|STARTED|Treatment Period 2 (10 Days)||6
1446871|NCT02183675|3542154|P2|STARTED|Treatment Period 2 (10 Days)||6
1446872|NCT02183675|3542155|P1|STARTED|Treatment Period 2 (10 Days)||6
1446873|NCT02183675|3542150|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1446874|NCT02183675|3542151|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1446875|NCT02183675|3542152|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1446876|NCT02183675|3542153|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1446877|NCT02183675|3542154|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1446878|NCT02183675|3542155|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
1446879|NCT02183675|3542150|P6|COMPLETED|Treatment Period 1 (10 Days)||6
1446880|NCT02183675|3542151|P5|COMPLETED|Treatment Period 1 (10 Days)||6
1446881|NCT02183675|3542152|P4|COMPLETED|Treatment Period 1 (10 Days)||6
1446882|NCT02183675|3542153|P3|COMPLETED|Treatment Period 1 (10 Days)||6
1446883|NCT02183675|3542154|P2|COMPLETED|Treatment Period 1 (10 Days)||6
1446884|NCT02183675|3542155|P1|COMPLETED|Treatment Period 1 (10 Days)||6
1446885|NCT02183675|3542150|P6|STARTED|Treatment Period 1 (10 Days)||6
1446886|NCT02183675|3542151|P5|STARTED|Treatment Period 1 (10 Days)||6
1446887|NCT02183675|3542152|P4|STARTED|Treatment Period 1 (10 Days)||6
1446888|NCT02183675|3542153|P3|STARTED|Treatment Period 1 (10 Days)||6
1446889|NCT02183675|3542154|P2|STARTED|Treatment Period 1 (10 Days)||6
1446890|NCT02183675|3542155|P1|STARTED|Treatment Period 1 (10 Days)||6
1446891|NCT02183519|3542179|P2|NOT COMPLETED|Overall Study||3
1446892|NCT02183519|3542180|P1|NOT COMPLETED|Overall Study||3
1446893|NCT02183519|3542179|P2|COMPLETED|Overall Study||13
1446894|NCT02183519|3542180|P1|COMPLETED|Overall Study||25
1446895|NCT02183519|3542179|P2|STARTED|Overall Study||16
1446896|NCT02183519|3542180|P1|STARTED|Overall Study||28
1446897|NCT02182999|3542188|P2|NOT COMPLETED|Overall Study||3
1446898|NCT02182999|3542189|P1|NOT COMPLETED|Overall Study||5
1446899|NCT02182999|3542188|P2|COMPLETED|Overall Study||22
1446900|NCT02182999|3542189|P1|COMPLETED|Overall Study||20
1446901|NCT02182999|3542188|P2|STARTED|Overall Study||25
1446902|NCT02182999|3542189|P1|STARTED|Overall Study||25
1446903|NCT02182895|3542205|P2|NOT COMPLETED|Overall Study||4
1446904|NCT02182895|3542206|P1|NOT COMPLETED|Overall Study||2
1446905|NCT02182895|3542205|P2|COMPLETED|Overall Study||33
1446906|NCT02182895|3542206|P1|COMPLETED|Overall Study||33
1446907|NCT02182895|3542205|P2|STARTED|Overall Study||37
1446908|NCT02182895|3542206|P1|STARTED|Overall Study||35
1446909|NCT02182830|3542228|P2|NOT COMPLETED|Overall Study||15
1446910|NCT02182830|3542229|P1|NOT COMPLETED|Overall Study||15
1446911|NCT02182830|3542228|P2|COMPLETED|Overall Study||68
1446912|NCT02182830|3542229|P1|COMPLETED|Overall Study||68
1446913|NCT02182830|3542228|P2|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
1446914|NCT02182830|3542229|P1|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
1446915|NCT02182830|3542228|P2|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
1446916|NCT02182830|3542229|P1|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
1446917|NCT02182830|3542228|P2|STARTED|Overall Study||83
1446918|NCT02182830|3542229|P1|STARTED|Overall Study||83
1446919|NCT02182492|3542257|P2|NOT COMPLETED|Overall Study||8
1446920|NCT02182492|3542258|P1|NOT COMPLETED|Overall Study||7
1446921|NCT02182492|3542257|P2|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
1446922|NCT02182492|3542258|P1|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
1446923|NCT02182492|3542257|P2|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
1446924|NCT02182492|3542258|P1|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
1446925|NCT02182115|3542268|P2|NOT COMPLETED|Overall Study||0
1446926|NCT02182115|3542269|P1|NOT COMPLETED|Overall Study||0
1446927|NCT02182115|3542268|P2|COMPLETED|Overall Study||57
1446928|NCT02182115|3542269|P1|COMPLETED|Overall Study||53
1446929|NCT02182115|3542268|P2|STARTED|Overall Study||57
1446930|NCT02182115|3542269|P1|STARTED|Overall Study||53
1446931|NCT02181790|3542277|P2|NOT COMPLETED|Overall Study||0
1446932|NCT02181790|3542278|P1|NOT COMPLETED|Overall Study||2
1446933|NCT02181790|3542277|P2|COMPLETED|Overall Study||0
1446934|NCT02181790|3542278|P1|COMPLETED|Overall Study||0
1446935|NCT02181790|3542277|P2|STARTED|Overall Study||0
1446936|NCT02181790|3542278|P1|STARTED|Overall Study||2
1446937|NCT02181738|3542290|P4|NOT COMPLETED|Overall Study||2
1446938|NCT02181738|3542291|P3|NOT COMPLETED|Overall Study||10
1446939|NCT02181738|3542292|P2|NOT COMPLETED|Overall Study||9
1446940|NCT02181738|3542293|P1|NOT COMPLETED|Overall Study||2
1446941|NCT02181738|3542290|P4|COMPLETED|Overall Study||49
1446942|NCT02181738|3542291|P3|COMPLETED|Overall Study||90
1446943|NCT02181738|3542292|P2|COMPLETED|Overall Study||71
1446944|NCT02181738|3542293|P1|COMPLETED|Overall Study||61
1446945|NCT02181738|3542290|P4|STARTED|Overall Study||51
1446946|NCT02181738|3542291|P3|STARTED|Overall Study||100
1446947|NCT02181738|3542292|P2|STARTED|Overall Study||80
1446948|NCT02181738|3542293|P1|STARTED|Overall Study||63
1446949|NCT02181673|3542334|P3|NOT COMPLETED|Week 24-Week 60||17
1446950|NCT02181673|3542335|P2|NOT COMPLETED|Week 24-Week 60||8
1446951|NCT02181673|3542336|P1|NOT COMPLETED|Week 24-Week 60||0
1446952|NCT02181673|3542334|P3|COMPLETED|Week 24-Week 60||213
1446953|NCT02181673|3542335|P2|COMPLETED|Week 24-Week 60||214
1446954|NCT02181673|3542336|P1|COMPLETED|Week 24-Week 60||0
1446955|NCT02181673|3542334|P3|Treated|Week 24-Week 60||230
1446956|NCT02181673|3542335|P2|Treated|Week 24-Week 60||220
1446957|NCT02181673|3542336|P1|Treated|Week 24-Week 60||0
1446958|NCT02181673|3542334|P3|STARTED|Week 24-Week 60||230
1446959|NCT02181673|3542335|P2|STARTED|Week 24-Week 60||222
1446960|NCT02181673|3542336|P1|STARTED|Week 24-Week 60||0
1446961|NCT02181673|3542334|P3|NOT COMPLETED|Up to Week 24||11
1446962|NCT02181673|3542335|P2|NOT COMPLETED|Up to Week 24||0
1446963|NCT02181673|3542336|P1|NOT COMPLETED|Up to Week 24||17
1446964|NCT02181673|3542334|P3|COMPLETED|Up to Week 24||230
1446965|NCT02181673|3542335|P2|COMPLETED|Up to Week 24||0
1446966|NCT02181673|3542336|P1|COMPLETED|Up to Week 24||222
1446967|NCT02181673|3542334|P3|Treated|Up to Week 24||240
1446968|NCT02181673|3542335|P2|Treated|Up to Week 24||0
1446969|NCT02181673|3542336|P1|Treated|Up to Week 24||239
1446970|NCT02181673|3542334|P3|STARTED|Up to Week 24||241
1446971|NCT02181673|3542335|P2|STARTED|Up to Week 24||0
1446972|NCT02181673|3542336|P1|STARTED|Up to Week 24||239
1446973|NCT02181634|3542363|P1|NOT COMPLETED|Overall Study||72
1446974|NCT02181634|3542363|P1|COMPLETED|Overall Study||2
1446975|NCT02181634|3542363|P1|Eligible and Treated|Overall Study||73
1446976|NCT02181634|3542363|P1|STARTED|Overall Study||74
1446977|NCT02181530|3542374|P1|NOT COMPLETED|Overall Study||0
1446978|NCT02181530|3542374|P1|COMPLETED|Overall Study||43
1446979|NCT02181530|3542374|P1|STARTED|Overall Study||43
1446980|NCT02181517|3542387|P3|NOT COMPLETED|Overall Study||0
1446981|NCT02181517|3542388|P2|NOT COMPLETED|Overall Study||0
1446982|NCT02181517|3542389|P1|NOT COMPLETED|Overall Study||0
1446983|NCT02181517|3542387|P3|COMPLETED|Overall Study||5
1446984|NCT02181517|3542388|P2|COMPLETED|Overall Study||10
1446985|NCT02181517|3542389|P1|COMPLETED|Overall Study||10
1446986|NCT02181517|3542387|P3|STARTED|Overall Study||5
1446987|NCT02181517|3542388|P2|STARTED|Overall Study||10
1446988|NCT02181517|3542389|P1|STARTED|Overall Study||10
1446989|NCT02181504|3542412|P3|NOT COMPLETED|Overall Study||1
1446990|NCT02181504|3542413|P2|NOT COMPLETED|Overall Study||1
1446991|NCT02181504|3542414|P1|NOT COMPLETED|Overall Study||1
1446992|NCT02181504|3542412|P3|COMPLETED|Overall Study||4
1446993|NCT02181504|3542413|P2|COMPLETED|Overall Study||9
1446994|NCT02181504|3542414|P1|COMPLETED|Overall Study||9
1446995|NCT02181504|3542412|P3|STARTED|Overall Study||5
1446996|NCT02181504|3542413|P2|STARTED|Overall Study||10
1446997|NCT02181504|3542414|P1|STARTED|Overall Study||10
1446998|NCT02181426|3542438|P4|NOT COMPLETED|Overall Study||0
1446999|NCT02181426|3542439|P3|NOT COMPLETED|Overall Study||0
1447000|NCT02181426|3542440|P2|NOT COMPLETED|Overall Study||0
1447001|NCT02181426|3542441|P1|NOT COMPLETED|Overall Study||0
1447002|NCT02181426|3542438|P4|COMPLETED|Overall Study||28
1447003|NCT02181426|3542439|P3|COMPLETED|Overall Study||28
1447004|NCT02181426|3542440|P2|COMPLETED|Overall Study||28
1447005|NCT02181426|3542441|P1|COMPLETED|Overall Study||28
1447006|NCT02181426|3542438|P4|STARTED|Overall Study||28
1447007|NCT02181426|3542439|P3|STARTED|Overall Study||28
1447008|NCT02181426|3542440|P2|STARTED|Overall Study||28
1447009|NCT02181426|3542441|P1|STARTED|Overall Study||28
1447010|NCT02181387|3542453|P2|NOT COMPLETED|Overall Study||4
1447011|NCT02181387|3542454|P1|NOT COMPLETED|Overall Study||2
1447012|NCT02181387|3542453|P2|COMPLETED|Overall Study||15
1447013|NCT02181387|3542454|P1|COMPLETED|Overall Study||12
1447014|NCT02181387|3542453|P2|STARTED|Overall Study||19
1447015|NCT02181387|3542454|P1|STARTED|Overall Study||14
1447016|NCT02181296|3542462|P2|NOT COMPLETED|Overall Study||6
1447017|NCT02181296|3542463|P1|NOT COMPLETED|Overall Study||7
1447018|NCT02181296|3542462|P2|COMPLETED|Overall Study||19
1447019|NCT02181296|3542463|P1|COMPLETED|Overall Study||18
1447020|NCT02181296|3542462|P2|STARTED|Overall Study||25
1447021|NCT02181296|3542463|P1|STARTED|Overall Study||25
1447022|NCT02181140|3542475|P1|NOT COMPLETED|Overall Study||0
1447023|NCT02181140|3542475|P1|COMPLETED|Overall Study||56
1447024|NCT02181140|3542475|P1|STARTED|Overall Study||56
1447025|NCT02181127|3542481|P1|NOT COMPLETED|Overall Study||0
1447026|NCT02181127|3542481|P1|COMPLETED|Overall Study||22
1447027|NCT02181127|3542481|P1|STARTED|Overall Study||22
1447028|NCT02180893|3542488|P2|NOT COMPLETED|Overall Study||7
1447029|NCT02180893|3542489|P1|NOT COMPLETED|Overall Study||3
1447030|NCT02180893|3542488|P2|COMPLETED|Overall Study||23
1447031|NCT02180893|3542489|P1|COMPLETED|Overall Study||27
1447032|NCT02180893|3542488|P2|STARTED|Overall Study||30
1447033|NCT02180893|3542489|P1|STARTED|Overall Study||30
1447034|NCT02180828|3542503|P2|NOT COMPLETED|Overall Study||7
1447035|NCT02180828|3542504|P1|NOT COMPLETED|Overall Study||5
1447036|NCT02180828|3542503|P2|COMPLETED|Overall Study||113
1447037|NCT02180828|3542504|P1|COMPLETED|Overall Study||115
1447038|NCT02180828|3542503|P2|STARTED|Overall Study||120
1447039|NCT02180828|3542504|P1|STARTED|Overall Study||120
1447040|NCT02180659|3542528|P2|NOT COMPLETED|Overall Study||5
1447041|NCT02180659|3542529|P1|NOT COMPLETED|Overall Study||6
1447042|NCT02180659|3542528|P2|COMPLETED|Overall Study||84
1447043|NCT02180659|3542529|P1|COMPLETED|Overall Study||81
1447044|NCT02180659|3542528|P2|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
1447045|NCT02180659|3542529|P1|STARTED|Overall Study||87
1447046|NCT02180646|3542551|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1447047|NCT02180646|3542552|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1447048|NCT02180646|3542551|P2|COMPLETED|Second Intervention (7 Days)||6
1447049|NCT02180646|3542552|P1|COMPLETED|Second Intervention (7 Days)||6
1447050|NCT02180646|3542551|P2|STARTED|Second Intervention (7 Days)||6
1447051|NCT02180646|3542552|P1|STARTED|Second Intervention (7 Days)||6
1447052|NCT02180646|3542551|P2|NOT COMPLETED|Washout (7 Days)||0
1447053|NCT02180646|3542552|P1|NOT COMPLETED|Washout (7 Days)||0
1447054|NCT02180646|3542551|P2|COMPLETED|Washout (7 Days)||6
1447055|NCT02180646|3542552|P1|COMPLETED|Washout (7 Days)||6
1447056|NCT02180646|3542551|P2|STARTED|Washout (7 Days)||6
1447057|NCT02180646|3542552|P1|STARTED|Washout (7 Days)||6
1447058|NCT02180646|3542551|P2|NOT COMPLETED|First Intervention (7 Days)||0
1447059|NCT02180646|3542552|P1|NOT COMPLETED|First Intervention (7 Days)||0
1447060|NCT02180646|3542551|P2|COMPLETED|First Intervention (7 Days)||6
1447061|NCT02180646|3542552|P1|COMPLETED|First Intervention (7 Days)||6
1447062|NCT02180646|3542551|P2|STARTED|First Intervention (7 Days)||6
1447063|NCT02180646|3542552|P1|STARTED|First Intervention (7 Days)||6
1447064|NCT02180438|3542562|P1|NOT COMPLETED|Overall Study||1
1447065|NCT02180438|3542562|P1|COMPLETED|Overall Study||29
1447066|NCT02180438|3542562|P1|STARTED|Overall Study||30
1447067|NCT02180230|3542577|P1|NOT COMPLETED|Overall Study||7
1447068|NCT02180230|3542577|P1|COMPLETED|Overall Study||31
1447069|NCT02180230|3542577|P1|STARTED|Overall Study||38
1447070|NCT02180061|3542584|P2|NOT COMPLETED|Overall Study||8
1447071|NCT02180061|3542585|P1|NOT COMPLETED|Overall Study||25
1447072|NCT02180061|3542584|P2|COMPLETED|Overall Study||0
1447073|NCT02180061|3542585|P1|COMPLETED|Overall Study||9
1447074|NCT02180061|3542584|P2|STARTED|Overall Study||8
1447075|NCT02180061|3542585|P1|STARTED|Overall Study||34
1447076|NCT02179918|3542604|P5|NOT COMPLETED|Overall Study||8
1447077|NCT02179918|3542605|P4|NOT COMPLETED|Overall Study||3
1447078|NCT02179918|3542606|P3|NOT COMPLETED|Overall Study||2
1447079|NCT02179918|3542607|P2|NOT COMPLETED|Overall Study||3
1447080|NCT02179918|3542608|P1|NOT COMPLETED|Overall Study||4
1447081|NCT02179918|3542604|P5|COMPLETED|Overall Study||1
1447082|NCT02179918|3542605|P4|COMPLETED|Overall Study||0
1447083|NCT02179918|3542606|P3|COMPLETED|Overall Study||1
1447084|NCT02179918|3542607|P2|COMPLETED|Overall Study||0
1447085|NCT02179918|3542608|P1|COMPLETED|Overall Study||1
1447086|NCT02179918|3542604|P5|STARTED|Overall Study||9
1447087|NCT02179918|3542605|P4|STARTED|Overall Study||3
1447088|NCT02179918|3542606|P3|STARTED|Overall Study||3
1447089|NCT02179918|3542607|P2|STARTED|Overall Study||3
1447090|NCT02179918|3542608|P1|STARTED|Overall Study||5
1447091|NCT02179892|3542734|P2|NOT COMPLETED|Overall Study||0
1447092|NCT02179892|3542735|P1|NOT COMPLETED|Overall Study||0
1447093|NCT02179892|3542734|P2|COMPLETED|Overall Study||4
1447094|NCT02179892|3542735|P1|COMPLETED|Overall Study||5
1447095|NCT02179892|3542734|P2|STARTED|Overall Study||4
1447096|NCT02179892|3542735|P1|STARTED|Overall Study||5
1447097|NCT02179424|3542751|P4|NOT COMPLETED|Overall Study||0
1447098|NCT02179424|3542752|P3|NOT COMPLETED|Overall Study||0
1447099|NCT02179424|3542753|P2|NOT COMPLETED|Overall Study||0
1447100|NCT02179424|3542754|P1|NOT COMPLETED|Overall Study||0
1447101|NCT02179424|3542751|P4|COMPLETED|Overall Study||39
1447102|NCT02179424|3542752|P3|COMPLETED|Overall Study||516
1447103|NCT02179424|3542753|P2|COMPLETED|Overall Study||11
1447104|NCT02179424|3542754|P1|COMPLETED|Overall Study||76
1447105|NCT02179424|3542751|P4|STARTED|Overall Study||39
1447106|NCT02179424|3542752|P3|STARTED|Overall Study||516
1447107|NCT02179424|3542753|P2|STARTED|Overall Study||11
1447108|NCT02179424|3542754|P1|STARTED|Overall Study||76
1447109|NCT02179398|3542771|P2|NOT COMPLETED|Overall Study||4
1447110|NCT02179398|3542772|P1|NOT COMPLETED|Overall Study||3
1447111|NCT02179398|3542771|P2|COMPLETED|Overall Study||140
1447112|NCT02179398|3542772|P1|COMPLETED|Overall Study||131
1447113|NCT02179398|3542771|P2|STARTED|Overall Study||144
1447114|NCT02179398|3542772|P1|STARTED|Overall Study||134
1447115|NCT02179190|3542790|P1|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
1447116|NCT02179190|3542790|P1|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
1447117|NCT02179190|3542790|P1|STARTED|Follow-Up Post Barrel VRD Implanted||120
1447118|NCT02179190|3542790|P1|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
1447119|NCT02179190|3542790|P1|COMPLETED|Index Procedure With Barrel VRD Attempt||120
1447120|NCT02179190|3542790|P1|STARTED|Index Procedure With Barrel VRD Attempt||127
1447121|NCT02179190|3542790|P1|NOT COMPLETED|Enrollment||11
1447122|NCT02179190|3542790|P1|COMPLETED|Enrollment||127
1447123|NCT02179190|3542790|P1|STARTED|Enrollment||138
1447124|NCT02178995|3542803|P9|NOT COMPLETED|Open Label||0
1447125|NCT02178995|3542804|P8|NOT COMPLETED|Open Label||0
1447126|NCT02178995|3542805|P7|NOT COMPLETED|Open Label||0
1447127|NCT02178995|3542806|P6|NOT COMPLETED|Open Label||0
1447128|NCT02178995|3542807|P5|NOT COMPLETED|Open Label||0
1447129|NCT02178995|3542808|P4|NOT COMPLETED|Open Label||0
1447130|NCT02178995|3542809|P3|NOT COMPLETED|Open Label||0
1447131|NCT02178995|3542810|P2|NOT COMPLETED|Open Label||0
1447132|NCT02178995|3542811|P1|NOT COMPLETED|Open Label||2
1447133|NCT02178995|3542803|P9|COMPLETED|Open Label||0
1447134|NCT02178995|3542804|P8|COMPLETED|Open Label||0
1447135|NCT02178995|3542805|P7|COMPLETED|Open Label||0
1447136|NCT02178995|3542806|P6|COMPLETED|Open Label||0
1447137|NCT02178995|3542807|P5|COMPLETED|Open Label||0
1447138|NCT02178995|3542808|P4|COMPLETED|Open Label||0
1447139|NCT02178995|3542809|P3|COMPLETED|Open Label||0
1447140|NCT02178995|3542810|P2|COMPLETED|Open Label||14
1447141|NCT02178995|3542811|P1|COMPLETED|Open Label||28
1447142|NCT02178995|3542803|P9|STARTED|Open Label||0
1447143|NCT02178995|3542804|P8|STARTED|Open Label||0
1447144|NCT02178995|3542805|P7|STARTED|Open Label||0
1447145|NCT02178995|3542806|P6|STARTED|Open Label||0
1447146|NCT02178995|3542807|P5|STARTED|Open Label||0
1447147|NCT02178995|3542808|P4|STARTED|Open Label||0
1447148|NCT02178995|3542809|P3|STARTED|Open Label||0
1447149|NCT02178995|3542810|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
1447150|NCT02178995|3542811|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
1447151|NCT02178995|3542803|P9|NOT COMPLETED|Double Blind||1
1447152|NCT02178995|3542804|P8|NOT COMPLETED|Double Blind||2
1447153|NCT02178995|3542805|P7|NOT COMPLETED|Double Blind||0
1447154|NCT02178995|3542806|P6|NOT COMPLETED|Double Blind||1
1447155|NCT02178995|3542807|P5|NOT COMPLETED|Double Blind||0
1447156|NCT02178995|3542808|P4|NOT COMPLETED|Double Blind||0
1447157|NCT02178995|3542809|P3|NOT COMPLETED|Double Blind||0
1447158|NCT02178995|3542810|P2|NOT COMPLETED|Double Blind||1
1447159|NCT02178995|3542811|P1|NOT COMPLETED|Double Blind||0
1447160|NCT02178995|3542803|P9|COMPLETED|Double Blind||0
1447161|NCT02178995|3542804|P8|COMPLETED|Double Blind||4
1447162|NCT02178995|3542805|P7|COMPLETED|Double Blind||5
1447163|NCT02178995|3542806|P6|COMPLETED|Double Blind||5
1447164|NCT02178995|3542807|P5|COMPLETED|Double Blind||6
1447165|NCT02178995|3542808|P4|COMPLETED|Double Blind||6
1447166|NCT02178995|3542809|P3|COMPLETED|Double Blind||5
1447167|NCT02178995|3542810|P2|COMPLETED|Double Blind||15
1447168|NCT02178995|3542811|P1|COMPLETED|Double Blind||0
1447169|NCT02178995|3542803|P9|STARTED|Double Blind||1
1447170|NCT02178995|3542804|P8|STARTED|Double Blind||6
1447171|NCT02178995|3542805|P7|STARTED|Double Blind||5
1447172|NCT02178995|3542806|P6|STARTED|Double Blind||6
1447173|NCT02178995|3542807|P5|STARTED|Double Blind||6
1447174|NCT02178995|3542808|P4|STARTED|Double Blind||6
1447175|NCT02178995|3542809|P3|STARTED|Double Blind||5
1447176|NCT02178995|3542810|P2|STARTED|Double Blind||16
1447177|NCT02178995|3542811|P1|STARTED|Double Blind||0
1447178|NCT02178800|3542884|P2|NOT COMPLETED|Overall Study||6
1447179|NCT02178800|3542885|P1|NOT COMPLETED|Overall Study||20
1447180|NCT02178800|3542884|P2|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
1447181|NCT02178800|3542885|P1|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
1447182|NCT02178800|3542884|P2|STARTED|Overall Study||48
1447183|NCT02178800|3542885|P1|STARTED|Overall Study||151
1447184|NCT02178787|3542893|P2|NOT COMPLETED|Overall Study||9
1447185|NCT02178787|3542894|P1|NOT COMPLETED|Overall Study||5
1447186|NCT02178787|3542893|P2|COMPLETED|Overall Study||30
1447187|NCT02178787|3542894|P1|COMPLETED|Overall Study||30
1447188|NCT02178787|3542893|P2|STARTED|Overall Study||39
1447189|NCT02178787|3542894|P1|STARTED|Overall Study||35
1447190|NCT02178696|3542902|P2|NOT COMPLETED|Open-label Antidepressant||7
1447191|NCT02178696|3542903|P1|NOT COMPLETED|Open-label Antidepressant||6
1447192|NCT02178696|3542902|P2|COMPLETED|Open-label Antidepressant||13
1447193|NCT02178696|3542903|P1|COMPLETED|Open-label Antidepressant||14
1447194|NCT02178696|3542902|P2|STARTED|Open-label Antidepressant||20
1447195|NCT02178696|3542903|P1|STARTED|Open-label Antidepressant||20
1447196|NCT02178696|3542902|P2|NOT COMPLETED|Second Assignment After Crossover||0
1447197|NCT02178696|3542903|P1|NOT COMPLETED|Second Assignment After Crossover||0
1447198|NCT02178696|3542902|P2|COMPLETED|Second Assignment After Crossover||20
1447199|NCT02178696|3542903|P1|COMPLETED|Second Assignment After Crossover||20
1447200|NCT02178696|3542902|P2|STARTED|Second Assignment After Crossover||20
1447201|NCT02178696|3542903|P1|STARTED|Second Assignment After Crossover||20
1447202|NCT02178696|3542902|P2|NOT COMPLETED|First Assignment and Washout||0
1447203|NCT02178696|3542903|P1|NOT COMPLETED|First Assignment and Washout||0
1447204|NCT02178696|3542902|P2|COMPLETED|First Assignment and Washout||20
1447205|NCT02178696|3542903|P1|COMPLETED|First Assignment and Washout||20
1447206|NCT02178696|3542902|P2|STARTED|First Assignment and Washout||20
1447207|NCT02178696|3542903|P1|STARTED|First Assignment and Washout||20
1447208|NCT02178540|3542916|P1|NOT COMPLETED|Overall Study||0
1447209|NCT02178540|3542916|P1|COMPLETED|Overall Study||45
1447210|NCT02178540|3542916|P1|STARTED|Overall Study||45
1447211|NCT02178475|3542923|P1|NOT COMPLETED|Overall Study||129
1447212|NCT02178475|3542923|P1|COMPLETED|Overall Study||814
1447213|NCT02178475|3542923|P1|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
1447214|NCT02178475|3542923|P1|STARTED|Overall Study||943
1447215|NCT02178059|3542943|P2|NOT COMPLETED|Second Intervention||0
1447216|NCT02178059|3542944|P1|NOT COMPLETED|Second Intervention||0
1447217|NCT02178059|3542943|P2|COMPLETED|Second Intervention||17
1447218|NCT02178059|3542944|P1|COMPLETED|Second Intervention||16
1447219|NCT02178059|3542943|P2|STARTED|Second Intervention||17
1447220|NCT02178059|3542944|P1|STARTED|Second Intervention||16
1447221|NCT02178059|3542943|P2|NOT COMPLETED|Washout||0
1447222|NCT02178059|3542944|P1|NOT COMPLETED|Washout||1
1447223|NCT02178059|3542943|P2|COMPLETED|Washout||17
1447224|NCT02178059|3542944|P1|COMPLETED|Washout||16
1447225|NCT02178059|3542943|P2|STARTED|Washout||17
1447226|NCT02178059|3542944|P1|STARTED|Washout||17
1447227|NCT02178059|3542943|P2|NOT COMPLETED|First Intervention||0
1447228|NCT02178059|3542944|P1|NOT COMPLETED|First Intervention||0
1447229|NCT02178059|3542943|P2|COMPLETED|First Intervention||17
1447230|NCT02178059|3542944|P1|COMPLETED|First Intervention||17
1447231|NCT02178059|3542943|P2|STARTED|First Intervention||17
1447232|NCT02178059|3542944|P1|STARTED|First Intervention||17
1447233|NCT02177266|3542962|P2|NOT COMPLETED|Overall Study||1
1447234|NCT02177266|3542963|P1|NOT COMPLETED|Overall Study||1
1447235|NCT02177266|3542962|P2|COMPLETED|Overall Study||0
1447236|NCT02177266|3542963|P1|COMPLETED|Overall Study||0
1447237|NCT02177266|3542962|P2|STARTED|Overall Study||1
1447238|NCT02177266|3542963|P1|STARTED|Overall Study||1
1447239|NCT02177201|3542975|P2|NOT COMPLETED|Overall Study||3
1447240|NCT02177201|3542976|P1|NOT COMPLETED|Overall Study||3
1447241|NCT02177201|3542975|P2|COMPLETED|Overall Study||77
1447242|NCT02177201|3542976|P1|COMPLETED|Overall Study||77
1447243|NCT02177201|3542975|P2|STARTED|Overall Study||80
1447244|NCT02177201|3542976|P1|STARTED|Overall Study||80
1447245|NCT02177136|3542985|P3|NOT COMPLETED|Overall Study||4
1447246|NCT02177136|3542986|P2|NOT COMPLETED|Overall Study||5
1447247|NCT02177136|3542987|P1|NOT COMPLETED|Overall Study||6
1447248|NCT02177136|3542985|P3|COMPLETED|Overall Study||21
1447249|NCT02177136|3542986|P2|COMPLETED|Overall Study||21
1447250|NCT02177136|3542987|P1|COMPLETED|Overall Study||19
1447251|NCT02177136|3542985|P3|STARTED|Overall Study||25
1447252|NCT02177136|3542986|P2|STARTED|Overall Study||26
1447253|NCT02177136|3542987|P1|STARTED|Overall Study||25
1447254|NCT02177032|3543020|P4|NOT COMPLETED|Overall Study||0
1447255|NCT02177032|3543021|P3|NOT COMPLETED|Overall Study||3
1447256|NCT02177032|3543022|P2|NOT COMPLETED|Overall Study||2
1447257|NCT02177032|3543023|P1|NOT COMPLETED|Overall Study||5
1447258|NCT02177032|3543020|P4|COMPLETED|Overall Study||88
1447259|NCT02177032|3543021|P3|COMPLETED|Overall Study||351
1447260|NCT02177032|3543022|P2|COMPLETED|Overall Study||86
1447261|NCT02177032|3543023|P1|COMPLETED|Overall Study||350
1447262|NCT02177032|3543020|P4|STARTED|Overall Study||88
1447263|NCT02177032|3543021|P3|STARTED|Overall Study||354
1447264|NCT02177032|3543022|P2|STARTED|Overall Study||88
1447265|NCT02177032|3543023|P1|STARTED|Overall Study||355
1447266|NCT02176837|3543057|P1|NOT COMPLETED|Overall Study||6
1447267|NCT02176837|3543057|P1|COMPLETED|Overall Study||0
1447268|NCT02176837|3543057|P1|STARTED|Overall Study||6
1447269|NCT02176655|3543061|P1|NOT COMPLETED|Overall Study||6
1447270|NCT02176655|3543061|P1|COMPLETED|Overall Study||25
1447271|NCT02176655|3543061|P1|STARTED|Overall Study||31
1447272|NCT02176642|3543084|P2|NOT COMPLETED|Overall Study||1
1447273|NCT02176642|3543085|P1|NOT COMPLETED|Overall Study||0
1447274|NCT02176642|3543084|P2|COMPLETED|Overall Study||16
1447275|NCT02176642|3543085|P1|COMPLETED|Overall Study||18
1447276|NCT02176642|3543084|P2|STARTED|Overall Study||17
1447277|NCT02176642|3543085|P1|STARTED|Overall Study||18
1447278|NCT02176525|3543115|P8|NOT COMPLETED|Overall Study||0
1447279|NCT02176525|3543116|P7|NOT COMPLETED|Overall Study||1
1447280|NCT02176525|3543117|P6|NOT COMPLETED|Overall Study||1
1447281|NCT02176525|3543118|P5|NOT COMPLETED|Overall Study||1
1447282|NCT02176525|3543119|P4|NOT COMPLETED|Overall Study||1
1447283|NCT02176525|3543120|P3|NOT COMPLETED|Overall Study||0
1447284|NCT02176525|3543121|P2|NOT COMPLETED|Overall Study||0
1447285|NCT02176525|3543122|P1|NOT COMPLETED|Overall Study||1
1447286|NCT02176525|3543115|P8|COMPLETED|Overall Study||10
1447287|NCT02176525|3543116|P7|COMPLETED|Overall Study||8
1447288|NCT02176525|3543117|P6|COMPLETED|Overall Study||5
1447289|NCT02176525|3543118|P5|COMPLETED|Overall Study||7
1447290|NCT02176525|3543119|P4|COMPLETED|Overall Study||8
1447291|NCT02176525|3543120|P3|COMPLETED|Overall Study||9
1447292|NCT02176525|3543121|P2|COMPLETED|Overall Study||9
1447293|NCT02176525|3543122|P1|COMPLETED|Overall Study||14
1447294|NCT02176525|3543115|P8|STARTED|Overall Study||10
1447295|NCT02176525|3543116|P7|STARTED|Overall Study||9
1447296|NCT02176525|3543117|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
1447297|NCT02176525|3543118|P5|STARTED|Overall Study||8
1447298|NCT02176525|3543119|P4|STARTED|Overall Study||9
1447299|NCT02176525|3543120|P3|STARTED|Overall Study||9
1447300|NCT02176525|3543121|P2|STARTED|Overall Study||9
1447301|NCT02176525|3543122|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
1447302|NCT02176421|3543299|P1|NOT COMPLETED|Overall Study||5
1447303|NCT02176421|3543299|P1|COMPLETED|Overall Study||75
1447304|NCT02176421|3543299|P1|STARTED|Overall Study||80
1447305|NCT02176356|3543308|P1|NOT COMPLETED|Overall Study||23
1447306|NCT02176356|3543308|P1|COMPLETED|Overall Study||93
1447307|NCT02176356|3543308|P1|Eligible and Received Treatment|Overall Study||100
1447308|NCT02176356|3543308|P1|STARTED|Overall Study||116
1447309|NCT02176343|3543325|P1|NOT COMPLETED|Overall Study||0
1447310|NCT02176343|3543325|P1|COMPLETED|Overall Study||31
1447311|NCT02176343|3543325|P1|STARTED|Overall Study||31
1447312|NCT02176291|3543338|P2|NOT COMPLETED|Overall Study||0
1447313|NCT02176291|3543339|P1|NOT COMPLETED|Overall Study||5
1447314|NCT02176291|3543338|P2|COMPLETED|Overall Study||11
1447315|NCT02176291|3543339|P1|COMPLETED|Overall Study||15
1447316|NCT02176291|3543338|P2|STARTED|Overall Study||11
1447317|NCT02176291|3543339|P1|STARTED|Overall Study||20
1447318|NCT02176226|3543347|P1|NOT COMPLETED|Overall Study||9
1447319|NCT02176226|3543347|P1|COMPLETED|Overall Study||96
1447320|NCT02176226|3543347|P1|STARTED|Overall Study||105
1447321|NCT02176018|3543355|P2|NOT COMPLETED|Overall Study||6
1447322|NCT02176018|3543356|P1|NOT COMPLETED|Overall Study||5
1447323|NCT02176018|3543355|P2|COMPLETED|Overall Study||17
1447324|NCT02176018|3543356|P1|COMPLETED|Overall Study||17
1447325|NCT02176018|3543355|P2|STARTED|Overall Study||23
1447326|NCT02176018|3543356|P1|STARTED|Overall Study||22
1447327|NCT02175771|3543388|P9|NOT COMPLETED|Treatment Period||6
1447328|NCT02175771|3543389|P8|NOT COMPLETED|Treatment Period||17
1447329|NCT02175771|3543390|P7|NOT COMPLETED|Treatment Period||5
1447330|NCT02175771|3543391|P6|NOT COMPLETED|Treatment Period||10
1447331|NCT02175771|3543392|P5|NOT COMPLETED|Treatment Period||5
1447332|NCT02175771|3543393|P4|NOT COMPLETED|Treatment Period||13
1447333|NCT02175771|3543394|P3|NOT COMPLETED|Treatment Period||7
1447334|NCT02175771|3543395|P2|NOT COMPLETED|Treatment Period||16
1447335|NCT02175771|3543396|P1|NOT COMPLETED|Treatment Period||0
1447336|NCT02175771|3543388|P9|COMPLETED|Treatment Period||38
1447337|NCT02175771|3543389|P8|COMPLETED|Treatment Period||116
1447338|NCT02175771|3543390|P7|COMPLETED|Treatment Period||36
1447339|NCT02175771|3543391|P6|COMPLETED|Treatment Period||110
1447340|NCT02175771|3543392|P5|COMPLETED|Treatment Period||36
1447341|NCT02175771|3543393|P4|COMPLETED|Treatment Period||113
1447342|NCT02175771|3543394|P3|COMPLETED|Treatment Period||35
1447343|NCT02175771|3543395|P2|COMPLETED|Treatment Period||111
1447344|NCT02175771|3543396|P1|COMPLETED|Treatment Period||0
1447345|NCT02175771|3543388|P9|STARTED|Treatment Period||44
1447346|NCT02175771|3543389|P8|STARTED|Treatment Period||133
1447347|NCT02175771|3543390|P7|STARTED|Treatment Period||41
1447348|NCT02175771|3543391|P6|STARTED|Treatment Period||120
1447349|NCT02175771|3543392|P5|STARTED|Treatment Period||41
1447350|NCT02175771|3543393|P4|STARTED|Treatment Period||126
1447351|NCT02175771|3543394|P3|STARTED|Treatment Period||42
1447352|NCT02175771|3543395|P2|STARTED|Treatment Period||127
1447353|NCT02175771|3543396|P1|STARTED|Treatment Period||0
1447354|NCT02175771|3543388|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1447355|NCT02175771|3543389|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1447356|NCT02175771|3543390|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1447357|NCT02175771|3543391|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1447358|NCT02175771|3543392|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1447359|NCT02175771|3543393|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1447360|NCT02175771|3543394|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1447361|NCT02175771|3543395|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1447362|NCT02175771|3543396|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
1447363|NCT02175771|3543388|P9|COMPLETED|Run-In Period (Pre-assignment)||0
1447364|NCT02175771|3543389|P8|COMPLETED|Run-In Period (Pre-assignment)||0
1447365|NCT02175771|3543390|P7|COMPLETED|Run-In Period (Pre-assignment)||0
1447366|NCT02175771|3543391|P6|COMPLETED|Run-In Period (Pre-assignment)||0
1447367|NCT02175771|3543392|P5|COMPLETED|Run-In Period (Pre-assignment)||0
1447368|NCT02175771|3543393|P4|COMPLETED|Run-In Period (Pre-assignment)||0
1447369|NCT02175771|3543394|P3|COMPLETED|Run-In Period (Pre-assignment)||0
1447370|NCT02175771|3543395|P2|COMPLETED|Run-In Period (Pre-assignment)||0
1447371|NCT02175771|3543396|P1|COMPLETED|Run-In Period (Pre-assignment)||674
1447372|NCT02175771|3543388|P9|STARTED|Run-In Period (Pre-assignment)||0
1447373|NCT02175771|3543389|P8|STARTED|Run-In Period (Pre-assignment)||0
1447374|NCT02175771|3543390|P7|STARTED|Run-In Period (Pre-assignment)||0
1447375|NCT02175771|3543391|P6|STARTED|Run-In Period (Pre-assignment)||0
1447376|NCT02175771|3543392|P5|STARTED|Run-In Period (Pre-assignment)||0
1447377|NCT02175771|3543393|P4|STARTED|Run-In Period (Pre-assignment)||0
1447378|NCT02175771|3543394|P3|STARTED|Run-In Period (Pre-assignment)||0
1447379|NCT02175771|3543395|P2|STARTED|Run-In Period (Pre-assignment)||0
1447380|NCT02175771|3543396|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
1447381|NCT02175745|3543454|P1|NOT COMPLETED|Overall Study||1
1447382|NCT02175745|3543454|P1|COMPLETED|Overall Study||1
1447383|NCT02175745|3543454|P1|STARTED|Overall Study||2
1447384|NCT02175472|3543461|P2|NOT COMPLETED|Overall Study||2
1447385|NCT02175472|3543462|P1|NOT COMPLETED|Overall Study||7
1447386|NCT02175472|3543461|P2|COMPLETED|Overall Study||45
1447387|NCT02175472|3543462|P1|COMPLETED|Overall Study||38
1447388|NCT02175472|3543461|P2|STARTED|Overall Study||47
1447389|NCT02175472|3543462|P1|STARTED|Overall Study||45
1447390|NCT02175368|3543476|P1|NOT COMPLETED|Overall Study||1
1447391|NCT02175368|3543476|P1|COMPLETED|Overall Study||27
1447392|NCT02175368|3543476|P1|STARTED|Overall Study||28
1447393|NCT02175277|3543480|P1|NOT COMPLETED|Overall Study||1
1447394|NCT02175277|3543480|P1|COMPLETED|Overall Study||8
1447395|NCT02175277|3543480|P1|STARTED|Overall Study||9
1447396|NCT02175212|3543486|P2|NOT COMPLETED|Overall Study||147
1447397|NCT02175212|3543487|P1|NOT COMPLETED|Overall Study||163
1447398|NCT02175212|3543486|P2|COMPLETED|Overall Study||31
1447399|NCT02175212|3543487|P1|COMPLETED|Overall Study||14
1447400|NCT02175212|3543486|P2|STARTED|Overall Study||178
1447401|NCT02175212|3543487|P1|STARTED|Overall Study||177
1447402|NCT02175199|3543503|P2|NOT COMPLETED|Overall Study||5
1447403|NCT02175199|3543504|P1|NOT COMPLETED|Overall Study||3
1447404|NCT02175199|3543503|P2|COMPLETED|Overall Study||71
1447405|NCT02175199|3543504|P1|COMPLETED|Overall Study||71
1447406|NCT02175199|3543503|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
1447407|NCT02175199|3543504|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
1447408|NCT02175199|3543503|P2|STARTED|Overall Study||76
1447409|NCT02175199|3543504|P1|STARTED|Overall Study||74
1447410|NCT02175121|3543518|P5|NOT COMPLETED|Overall Study||1
1447411|NCT02175121|3543519|P4|NOT COMPLETED|Overall Study||1
1447412|NCT02175121|3543520|P3|NOT COMPLETED|Overall Study||2
1447413|NCT02175121|3543521|P2|NOT COMPLETED|Overall Study||1
1447414|NCT02175121|3543522|P1|NOT COMPLETED|Overall Study||1
1447415|NCT02175121|3543518|P5|COMPLETED|Overall Study||33
1447416|NCT02175121|3543519|P4|COMPLETED|Overall Study||34
1447417|NCT02175121|3543520|P3|COMPLETED|Overall Study||32
1447418|NCT02175121|3543521|P2|COMPLETED|Overall Study||34
1447419|NCT02175121|3543522|P1|COMPLETED|Overall Study||33
1447420|NCT02175121|3543518|P5|STARTED|Overall Study||34
1447421|NCT02175121|3543519|P4|STARTED|Overall Study||35
1447422|NCT02175121|3543520|P3|STARTED|Overall Study||34
1447423|NCT02175121|3543521|P2|STARTED|Overall Study||35
1447424|NCT02175121|3543522|P1|STARTED|Overall Study||34
1447425|NCT02174861|3543649|P1|NOT COMPLETED|Overall Study||158
1447426|NCT02174861|3543649|P1|COMPLETED|Overall Study||451
1447427|NCT02174861|3543649|P1|Enrolled in CHU Substudy|Overall Study||53
1447428|NCT02174861|3543649|P1|STARTED|Overall Study||609
1447429|NCT02173769|3543661|P1|NOT COMPLETED|Overall Study||4
1447430|NCT02173769|3543661|P1|COMPLETED|Overall Study||1854
1447431|NCT02173769|3543661|P1|STARTED|Overall Study||1858
1447432|NCT02173704|3543674|P2|NOT COMPLETED|Overall Study||4
1447433|NCT02173704|3543675|P1|NOT COMPLETED|Overall Study||13
1447434|NCT02173704|3543674|P2|COMPLETED|Overall Study||71
1447435|NCT02173704|3543675|P1|COMPLETED|Overall Study||137
1447436|NCT02173704|3543674|P2|STARTED|Overall Study||75
1447437|NCT02173704|3543675|P1|STARTED|Overall Study||150
1447438|NCT02173548|3543701|P2|NOT COMPLETED|Overall Study||2
1447439|NCT02173548|3543702|P1|NOT COMPLETED|Overall Study||1
1447440|NCT02173548|3543701|P2|COMPLETED|Overall Study||8
1447441|NCT02173548|3543702|P1|COMPLETED|Overall Study||20
1447442|NCT02173548|3543701|P2|STARTED|Overall Study||10
1447443|NCT02173548|3543702|P1|STARTED|Overall Study||21
1447444|NCT02173535|3543742|P20|NOT COMPLETED|Period 5||0
1447445|NCT02173535|3543743|P19|NOT COMPLETED|Period 5||0
1447446|NCT02173535|3543744|P18|NOT COMPLETED|Period 5||0
1447447|NCT02173535|3543745|P17|NOT COMPLETED|Period 5||0
1447448|NCT02173535|3543746|P16|NOT COMPLETED|Period 5||0
1447449|NCT02173535|3543747|P15|NOT COMPLETED|Period 5||0
1447450|NCT02173535|3543748|P14|NOT COMPLETED|Period 5||0
1447451|NCT02173535|3543749|P13|NOT COMPLETED|Period 5||0
1447452|NCT02173535|3543750|P12|NOT COMPLETED|Period 5||0
1447453|NCT02173535|3543751|P11|NOT COMPLETED|Period 5||0
1447454|NCT02173535|3543752|P10|NOT COMPLETED|Period 5||0
1447455|NCT02173535|3543753|P9|NOT COMPLETED|Period 5||0
1447456|NCT02173535|3543754|P8|NOT COMPLETED|Period 5||0
1447457|NCT02173535|3543755|P7|NOT COMPLETED|Period 5||0
1447458|NCT02173535|3543756|P6|NOT COMPLETED|Period 5||0
1447459|NCT02173535|3543757|P5|NOT COMPLETED|Period 5||0
1447460|NCT02173535|3543758|P4|NOT COMPLETED|Period 5||0
1447461|NCT02173535|3543759|P3|NOT COMPLETED|Period 5||0
1447462|NCT02173535|3543760|P2|NOT COMPLETED|Period 5||0
1447463|NCT02173535|3543761|P1|NOT COMPLETED|Period 5||0
1447464|NCT02173535|3543742|P20|COMPLETED|Period 5||12
1447465|NCT02173535|3543743|P19|COMPLETED|Period 5||12
1447466|NCT02173535|3543744|P18|COMPLETED|Period 5||12
1447467|NCT02173535|3543745|P17|COMPLETED|Period 5||12
1447468|NCT02173535|3543746|P16|COMPLETED|Period 5||12
1447469|NCT02173535|3543747|P15|COMPLETED|Period 5||12
1447470|NCT02173535|3543748|P14|COMPLETED|Period 5||12
1447471|NCT02173535|3543749|P13|COMPLETED|Period 5||12
1447472|NCT02173535|3543750|P12|COMPLETED|Period 5||12
1447473|NCT02173535|3543751|P11|COMPLETED|Period 5||12
1447474|NCT02173535|3543752|P10|COMPLETED|Period 5||12
1447475|NCT02173535|3543753|P9|COMPLETED|Period 5||12
1447476|NCT02173535|3543754|P8|COMPLETED|Period 5||12
1447477|NCT02173535|3543755|P7|COMPLETED|Period 5||12
1447478|NCT02173535|3543756|P6|COMPLETED|Period 5||12
1447479|NCT02173535|3543757|P5|COMPLETED|Period 5||12
1447480|NCT02173535|3543758|P4|COMPLETED|Period 5||12
1447481|NCT02173535|3543759|P3|COMPLETED|Period 5||12
1447482|NCT02173535|3543760|P2|COMPLETED|Period 5||12
1447483|NCT02173535|3543761|P1|COMPLETED|Period 5||12
1447484|NCT02173535|3543742|P20|STARTED|Period 5||12
1447485|NCT02173535|3543743|P19|STARTED|Period 5||12
1447486|NCT02173535|3543744|P18|STARTED|Period 5||12
1447487|NCT02173535|3543745|P17|STARTED|Period 5||12
1447488|NCT02173535|3543746|P16|STARTED|Period 5||12
1447489|NCT02173535|3543747|P15|STARTED|Period 5||12
1447490|NCT02173535|3543748|P14|STARTED|Period 5||12
1447491|NCT02173535|3543749|P13|STARTED|Period 5||12
1447492|NCT02173535|3543750|P12|STARTED|Period 5||12
1447493|NCT02173535|3543751|P11|STARTED|Period 5||12
1447494|NCT02173535|3543752|P10|STARTED|Period 5||12
1447495|NCT02173535|3543753|P9|STARTED|Period 5||12
1447496|NCT02173535|3543754|P8|STARTED|Period 5||12
1447497|NCT02173535|3543755|P7|STARTED|Period 5||12
1447498|NCT02173535|3543756|P6|STARTED|Period 5||12
1447499|NCT02173535|3543757|P5|STARTED|Period 5||12
1447500|NCT02173535|3543758|P4|STARTED|Period 5||12
1447501|NCT02173535|3543759|P3|STARTED|Period 5||12
1447502|NCT02173535|3543760|P2|STARTED|Period 5||12
1447503|NCT02173535|3543761|P1|STARTED|Period 5||12
1447504|NCT02173535|3543742|P20|NOT COMPLETED|Period 4||0
1447505|NCT02173535|3543743|P19|NOT COMPLETED|Period 4||0
1447506|NCT02173535|3543744|P18|NOT COMPLETED|Period 4||0
1447507|NCT02173535|3543745|P17|NOT COMPLETED|Period 4||0
1447508|NCT02173535|3543746|P16|NOT COMPLETED|Period 4||0
1447509|NCT02173535|3543747|P15|NOT COMPLETED|Period 4||0
1447510|NCT02173535|3543748|P14|NOT COMPLETED|Period 4||0
1447511|NCT02173535|3543749|P13|NOT COMPLETED|Period 4||0
1447512|NCT02173535|3543750|P12|NOT COMPLETED|Period 4||0
1447513|NCT02173535|3543751|P11|NOT COMPLETED|Period 4||0
1447514|NCT02173535|3543752|P10|NOT COMPLETED|Period 4||0
1447515|NCT02173535|3543753|P9|NOT COMPLETED|Period 4||0
1447516|NCT02173535|3543754|P8|NOT COMPLETED|Period 4||0
1447517|NCT02173535|3543755|P7|NOT COMPLETED|Period 4||0
1447518|NCT02173535|3543756|P6|NOT COMPLETED|Period 4||0
1447519|NCT02173535|3543757|P5|NOT COMPLETED|Period 4||0
1447520|NCT02173535|3543758|P4|NOT COMPLETED|Period 4||0
1447521|NCT02173535|3543759|P3|NOT COMPLETED|Period 4||0
1447522|NCT02173535|3543760|P2|NOT COMPLETED|Period 4||0
1447523|NCT02173535|3543761|P1|NOT COMPLETED|Period 4||0
1447524|NCT02173535|3543742|P20|COMPLETED|Period 4||12
1447525|NCT02173535|3543743|P19|COMPLETED|Period 4||12
1447526|NCT02173535|3543744|P18|COMPLETED|Period 4||12
1447527|NCT02173535|3543745|P17|COMPLETED|Period 4||12
1447528|NCT02173535|3543746|P16|COMPLETED|Period 4||12
1447529|NCT02173535|3543747|P15|COMPLETED|Period 4||12
1447530|NCT02173535|3543748|P14|COMPLETED|Period 4||12
1447531|NCT02173535|3543749|P13|COMPLETED|Period 4||12
1447532|NCT02173535|3543750|P12|COMPLETED|Period 4||12
1447533|NCT02173535|3543751|P11|COMPLETED|Period 4||12
1447534|NCT02173535|3543752|P10|COMPLETED|Period 4||12
1447535|NCT02173535|3543753|P9|COMPLETED|Period 4||12
1447536|NCT02173535|3543754|P8|COMPLETED|Period 4||12
1447537|NCT02173535|3543755|P7|COMPLETED|Period 4||12
1447538|NCT02173535|3543756|P6|COMPLETED|Period 4||12
1447539|NCT02173535|3543757|P5|COMPLETED|Period 4||12
1447540|NCT02173535|3543758|P4|COMPLETED|Period 4||12
1447541|NCT02173535|3543759|P3|COMPLETED|Period 4||12
1447542|NCT02173535|3543760|P2|COMPLETED|Period 4||12
1447543|NCT02173535|3543761|P1|COMPLETED|Period 4||12
1447544|NCT02173535|3543742|P20|STARTED|Period 4||12
1447545|NCT02173535|3543743|P19|STARTED|Period 4||12
1447546|NCT02173535|3543744|P18|STARTED|Period 4||12
1447547|NCT02173535|3543745|P17|STARTED|Period 4||12
1447548|NCT02173535|3543746|P16|STARTED|Period 4||12
1447549|NCT02173535|3543747|P15|STARTED|Period 4||12
1447550|NCT02173535|3543748|P14|STARTED|Period 4||12
1447551|NCT02173535|3543749|P13|STARTED|Period 4||12
1447552|NCT02173535|3543750|P12|STARTED|Period 4||12
1447553|NCT02173535|3543751|P11|STARTED|Period 4||12
1447554|NCT02173535|3543752|P10|STARTED|Period 4||12
1447555|NCT02173535|3543753|P9|STARTED|Period 4||12
1447556|NCT02173535|3543754|P8|STARTED|Period 4||12
1447557|NCT02173535|3543755|P7|STARTED|Period 4||12
1447558|NCT02173535|3543756|P6|STARTED|Period 4||12
1447559|NCT02173535|3543757|P5|STARTED|Period 4||12
1447560|NCT02173535|3543758|P4|STARTED|Period 4||12
1447561|NCT02173535|3543759|P3|STARTED|Period 4||12
1447562|NCT02173535|3543760|P2|STARTED|Period 4||12
1447563|NCT02173535|3543761|P1|STARTED|Period 4||12
1447564|NCT02173535|3543742|P20|NOT COMPLETED|Period 3||0
1447565|NCT02173535|3543743|P19|NOT COMPLETED|Period 3||0
1447566|NCT02173535|3543744|P18|NOT COMPLETED|Period 3||0
1447567|NCT02173535|3543745|P17|NOT COMPLETED|Period 3||0
1447568|NCT02173535|3543746|P16|NOT COMPLETED|Period 3||0
1447569|NCT02173535|3543747|P15|NOT COMPLETED|Period 3||0
1447570|NCT02173535|3543748|P14|NOT COMPLETED|Period 3||0
1447571|NCT02173535|3543749|P13|NOT COMPLETED|Period 3||0
1447572|NCT02173535|3543750|P12|NOT COMPLETED|Period 3||0
1447573|NCT02173535|3543751|P11|NOT COMPLETED|Period 3||0
1447574|NCT02173535|3543752|P10|NOT COMPLETED|Period 3||0
1447575|NCT02173535|3543753|P9|NOT COMPLETED|Period 3||0
1447576|NCT02173535|3543754|P8|NOT COMPLETED|Period 3||0
1447577|NCT02173535|3543755|P7|NOT COMPLETED|Period 3||0
1447578|NCT02173535|3543756|P6|NOT COMPLETED|Period 3||0
1447579|NCT02173535|3543757|P5|NOT COMPLETED|Period 3||0
1447580|NCT02173535|3543758|P4|NOT COMPLETED|Period 3||0
1447581|NCT02173535|3543759|P3|NOT COMPLETED|Period 3||0
1447582|NCT02173535|3543760|P2|NOT COMPLETED|Period 3||0
1447583|NCT02173535|3543761|P1|NOT COMPLETED|Period 3||0
1447584|NCT02173535|3543742|P20|COMPLETED|Period 3||12
1447585|NCT02173535|3543743|P19|COMPLETED|Period 3||12
1447586|NCT02173535|3543744|P18|COMPLETED|Period 3||12
1447587|NCT02173535|3543745|P17|COMPLETED|Period 3||12
1447588|NCT02173535|3543746|P16|COMPLETED|Period 3||12
1447589|NCT02173535|3543747|P15|COMPLETED|Period 3||12
1447590|NCT02173535|3543748|P14|COMPLETED|Period 3||12
1447591|NCT02173535|3543749|P13|COMPLETED|Period 3||12
1447592|NCT02173535|3543750|P12|COMPLETED|Period 3||12
1447593|NCT02173535|3543751|P11|COMPLETED|Period 3||12
1447594|NCT02173535|3543752|P10|COMPLETED|Period 3||12
1447595|NCT02173535|3543753|P9|COMPLETED|Period 3||12
1447596|NCT02173535|3543754|P8|COMPLETED|Period 3||12
1447597|NCT02173535|3543755|P7|COMPLETED|Period 3||12
1447598|NCT02173535|3543756|P6|COMPLETED|Period 3||12
1447599|NCT02173535|3543757|P5|COMPLETED|Period 3||12
1447600|NCT02173535|3543758|P4|COMPLETED|Period 3||12
1447601|NCT02173535|3543759|P3|COMPLETED|Period 3||12
1447602|NCT02173535|3543760|P2|COMPLETED|Period 3||12
1447603|NCT02173535|3543761|P1|COMPLETED|Period 3||12
1447604|NCT02173535|3543742|P20|STARTED|Period 3||12
1447605|NCT02173535|3543743|P19|STARTED|Period 3||12
1447606|NCT02173535|3543744|P18|STARTED|Period 3||12
1447607|NCT02173535|3543745|P17|STARTED|Period 3||12
1447608|NCT02173535|3543746|P16|STARTED|Period 3||12
1447609|NCT02173535|3543747|P15|STARTED|Period 3||12
1447610|NCT02173535|3543748|P14|STARTED|Period 3||12
1447611|NCT02173535|3543749|P13|STARTED|Period 3||12
1447612|NCT02173535|3543750|P12|STARTED|Period 3||12
1447613|NCT02173535|3543751|P11|STARTED|Period 3||12
1447614|NCT02173535|3543752|P10|STARTED|Period 3||12
1447615|NCT02173535|3543753|P9|STARTED|Period 3||12
1447616|NCT02173535|3543754|P8|STARTED|Period 3||12
1447617|NCT02173535|3543755|P7|STARTED|Period 3||12
1447618|NCT02173535|3543756|P6|STARTED|Period 3||12
1447619|NCT02173535|3543757|P5|STARTED|Period 3||12
1447620|NCT02173535|3543758|P4|STARTED|Period 3||12
1447621|NCT02173535|3543759|P3|STARTED|Period 3||12
1447622|NCT02173535|3543760|P2|STARTED|Period 3||12
1447623|NCT02173535|3543761|P1|STARTED|Period 3||12
1447624|NCT02173535|3543742|P20|NOT COMPLETED|Period 2||0
1447625|NCT02173535|3543743|P19|NOT COMPLETED|Period 2||0
1447626|NCT02173535|3543744|P18|NOT COMPLETED|Period 2||0
1447627|NCT02173535|3543745|P17|NOT COMPLETED|Period 2||0
1447628|NCT02173535|3543746|P16|NOT COMPLETED|Period 2||0
1447629|NCT02173535|3543747|P15|NOT COMPLETED|Period 2||0
1447630|NCT02173535|3543748|P14|NOT COMPLETED|Period 2||0
1447631|NCT02173535|3543749|P13|NOT COMPLETED|Period 2||0
1447632|NCT02173535|3543750|P12|NOT COMPLETED|Period 2||0
1447633|NCT02173535|3543751|P11|NOT COMPLETED|Period 2||0
1447634|NCT02173535|3543752|P10|NOT COMPLETED|Period 2||0
1447635|NCT02173535|3543753|P9|NOT COMPLETED|Period 2||0
1447636|NCT02173535|3543754|P8|NOT COMPLETED|Period 2||0
1447637|NCT02173535|3543755|P7|NOT COMPLETED|Period 2||0
1447638|NCT02173535|3543756|P6|NOT COMPLETED|Period 2||0
1447639|NCT02173535|3543757|P5|NOT COMPLETED|Period 2||0
1447640|NCT02173535|3543758|P4|NOT COMPLETED|Period 2||0
1447641|NCT02173535|3543759|P3|NOT COMPLETED|Period 2||0
1447642|NCT02173535|3543760|P2|NOT COMPLETED|Period 2||0
1447643|NCT02173535|3543761|P1|NOT COMPLETED|Period 2||0
1447644|NCT02173535|3543742|P20|COMPLETED|Period 2||12
1447645|NCT02173535|3543743|P19|COMPLETED|Period 2||12
1447646|NCT02173535|3543744|P18|COMPLETED|Period 2||12
1447647|NCT02173535|3543745|P17|COMPLETED|Period 2||12
1447648|NCT02173535|3543746|P16|COMPLETED|Period 2||12
1447649|NCT02173535|3543747|P15|COMPLETED|Period 2||12
1447650|NCT02173535|3543748|P14|COMPLETED|Period 2||12
1447651|NCT02173535|3543749|P13|COMPLETED|Period 2||12
1447652|NCT02173535|3543750|P12|COMPLETED|Period 2||12
1447653|NCT02173535|3543751|P11|COMPLETED|Period 2||12
1447654|NCT02173535|3543752|P10|COMPLETED|Period 2||12
1447655|NCT02173535|3543753|P9|COMPLETED|Period 2||12
1447656|NCT02173535|3543754|P8|COMPLETED|Period 2||12
1447657|NCT02173535|3543755|P7|COMPLETED|Period 2||12
1447658|NCT02173535|3543756|P6|COMPLETED|Period 2||12
1447659|NCT02173535|3543757|P5|COMPLETED|Period 2||12
1447660|NCT02173535|3543758|P4|COMPLETED|Period 2||12
1447661|NCT02173535|3543759|P3|COMPLETED|Period 2||12
1447662|NCT02173535|3543760|P2|COMPLETED|Period 2||12
1447663|NCT02173535|3543761|P1|COMPLETED|Period 2||12
1447664|NCT02173535|3543742|P20|STARTED|Period 2||12
1447665|NCT02173535|3543743|P19|STARTED|Period 2||12
1447666|NCT02173535|3543744|P18|STARTED|Period 2||12
1447667|NCT02173535|3543745|P17|STARTED|Period 2||12
1447668|NCT02173535|3543746|P16|STARTED|Period 2||12
1447669|NCT02173535|3543747|P15|STARTED|Period 2||12
1447670|NCT02173535|3543748|P14|STARTED|Period 2||12
1447671|NCT02173535|3543749|P13|STARTED|Period 2||12
1447672|NCT02173535|3543750|P12|STARTED|Period 2||12
1447673|NCT02173535|3543751|P11|STARTED|Period 2||12
1447674|NCT02173535|3543752|P10|STARTED|Period 2||12
1447675|NCT02173535|3543753|P9|STARTED|Period 2||12
1447676|NCT02173535|3543754|P8|STARTED|Period 2||12
1447677|NCT02173535|3543755|P7|STARTED|Period 2||12
1447678|NCT02173535|3543756|P6|STARTED|Period 2||12
1447679|NCT02173535|3543757|P5|STARTED|Period 2||12
1447680|NCT02173535|3543758|P4|STARTED|Period 2||12
1447681|NCT02173535|3543759|P3|STARTED|Period 2||12
1447682|NCT02173535|3543760|P2|STARTED|Period 2||12
1447683|NCT02173535|3543761|P1|STARTED|Period 2||12
1447684|NCT02173535|3543742|P20|NOT COMPLETED|Period 1||0
1447685|NCT02173535|3543743|P19|NOT COMPLETED|Period 1||0
1447686|NCT02173535|3543744|P18|NOT COMPLETED|Period 1||0
1447687|NCT02173535|3543745|P17|NOT COMPLETED|Period 1||0
1447688|NCT02173535|3543746|P16|NOT COMPLETED|Period 1||0
1447689|NCT02173535|3543747|P15|NOT COMPLETED|Period 1||0
1447690|NCT02173535|3543748|P14|NOT COMPLETED|Period 1||0
1447691|NCT02173535|3543749|P13|NOT COMPLETED|Period 1||0
1447692|NCT02173535|3543750|P12|NOT COMPLETED|Period 1||0
1447693|NCT02173535|3543751|P11|NOT COMPLETED|Period 1||0
1447694|NCT02173535|3543752|P10|NOT COMPLETED|Period 1||0
1447695|NCT02173535|3543753|P9|NOT COMPLETED|Period 1||0
1447696|NCT02173535|3543754|P8|NOT COMPLETED|Period 1||0
1447697|NCT02173535|3543755|P7|NOT COMPLETED|Period 1||0
1447698|NCT02173535|3543756|P6|NOT COMPLETED|Period 1||0
1447699|NCT02173535|3543757|P5|NOT COMPLETED|Period 1||0
1447700|NCT02173535|3543758|P4|NOT COMPLETED|Period 1||0
1447701|NCT02173535|3543759|P3|NOT COMPLETED|Period 1||0
1447702|NCT02173535|3543760|P2|NOT COMPLETED|Period 1||0
1447703|NCT02173535|3543761|P1|NOT COMPLETED|Period 1||0
1447704|NCT02173535|3543742|P20|COMPLETED|Period 1||12
1447705|NCT02173535|3543743|P19|COMPLETED|Period 1||12
1447706|NCT02173535|3543744|P18|COMPLETED|Period 1||12
1447707|NCT02173535|3543745|P17|COMPLETED|Period 1||12
1447708|NCT02173535|3543746|P16|COMPLETED|Period 1||12
1447709|NCT02173535|3543747|P15|COMPLETED|Period 1||12
1447710|NCT02173535|3543748|P14|COMPLETED|Period 1||12
1447711|NCT02173535|3543749|P13|COMPLETED|Period 1||12
1447712|NCT02173535|3543750|P12|COMPLETED|Period 1||12
1447713|NCT02173535|3543751|P11|COMPLETED|Period 1||12
1447714|NCT02173535|3543752|P10|COMPLETED|Period 1||12
1447715|NCT02173535|3543753|P9|COMPLETED|Period 1||12
1447716|NCT02173535|3543754|P8|COMPLETED|Period 1||12
1447717|NCT02173535|3543755|P7|COMPLETED|Period 1||12
1447718|NCT02173535|3543756|P6|COMPLETED|Period 1||12
1447719|NCT02173535|3543757|P5|COMPLETED|Period 1||12
1447720|NCT02173535|3543758|P4|COMPLETED|Period 1||12
1447721|NCT02173535|3543759|P3|COMPLETED|Period 1||12
1447722|NCT02173535|3543760|P2|COMPLETED|Period 1||12
1447723|NCT02173535|3543761|P1|COMPLETED|Period 1||12
1447724|NCT02173535|3543742|P20|STARTED|Period 1||12
1447725|NCT02173535|3543743|P19|STARTED|Period 1||12
1447726|NCT02173535|3543744|P18|STARTED|Period 1||12
1447727|NCT02173535|3543745|P17|STARTED|Period 1||12
1447728|NCT02173535|3543746|P16|STARTED|Period 1||12
1447729|NCT02173535|3543747|P15|STARTED|Period 1||12
1447730|NCT02173535|3543748|P14|STARTED|Period 1||12
1447731|NCT02173535|3543749|P13|STARTED|Period 1||12
1447732|NCT02173535|3543750|P12|STARTED|Period 1||12
1447733|NCT02173535|3543751|P11|STARTED|Period 1||12
1447734|NCT02173535|3543752|P10|STARTED|Period 1||12
1447735|NCT02173535|3543753|P9|STARTED|Period 1||12
1447736|NCT02173535|3543754|P8|STARTED|Period 1||12
1447737|NCT02173535|3543755|P7|STARTED|Period 1||12
1447738|NCT02173535|3543756|P6|STARTED|Period 1||12
1447739|NCT02173535|3543757|P5|STARTED|Period 1||12
1447740|NCT02173535|3543758|P4|STARTED|Period 1||12
1447741|NCT02173535|3543759|P3|STARTED|Period 1||12
1447742|NCT02173535|3543760|P2|STARTED|Period 1||12
1447743|NCT02173535|3543761|P1|STARTED|Period 1||12
1447744|NCT02173392|3543800|P2|NOT COMPLETED|Overall Study||4
1447745|NCT02173392|3543801|P1|NOT COMPLETED|Overall Study||14
1447746|NCT02173392|3543800|P2|COMPLETED|Overall Study||68
1447747|NCT02173392|3543801|P1|COMPLETED|Overall Study||59
1447748|NCT02173392|3543800|P2|STARTED|Overall Study||72
1447749|NCT02173392|3543801|P1|STARTED|Overall Study||73
1447750|NCT02173379|3543813|P2|NOT COMPLETED|Overall Study||7
1447751|NCT02173379|3543814|P1|NOT COMPLETED|Overall Study||9
1447752|NCT02173379|3543813|P2|COMPLETED|Overall Study||1301
1447753|NCT02173379|3543814|P1|COMPLETED|Overall Study||1287
1447754|NCT02173379|3543813|P2|STARTED|Overall Study||1308
1447755|NCT02173379|3543814|P1|STARTED|Overall Study||1296
1447756|NCT02173158|3543880|P1|NOT COMPLETED|Safety Phase||0
1447757|NCT02173158|3543880|P1|COMPLETED|Safety Phase||8
1447758|NCT02173158|3543880|P1|STARTED|Safety Phase||8
1447759|NCT02173158|3543880|P1|NOT COMPLETED|Efficacy Phase||1
1447760|NCT02173158|3543880|P1|COMPLETED|Efficacy Phase||8
1447761|NCT02173158|3543880|P1|STARTED|Efficacy Phase||9
1447762|NCT02173054|3543897|P3|NOT COMPLETED|Overall Study||1
1447763|NCT02173054|3543898|P2|NOT COMPLETED|Overall Study||0
1447764|NCT02173054|3543899|P1|NOT COMPLETED|Overall Study||1
1447765|NCT02173054|3543897|P3|COMPLETED|Overall Study||39
1447766|NCT02173054|3543898|P2|COMPLETED|Overall Study||40
1447767|NCT02173054|3543899|P1|COMPLETED|Overall Study||39
1447768|NCT02173054|3543897|P3|STARTED|Overall Study||40
1447769|NCT02173054|3543898|P2|STARTED|Overall Study||40
1447770|NCT02173054|3543899|P1|STARTED|Overall Study||40
1447771|NCT02172755|3543921|P2|NOT COMPLETED|Overall Study||4
1447772|NCT02172755|3543922|P1|NOT COMPLETED|Overall Study||2
1447773|NCT02172755|3543921|P2|COMPLETED|Overall Study||12
1447774|NCT02172755|3543922|P1|COMPLETED|Overall Study||12
1447775|NCT02172755|3543921|P2|STARTED|Overall Study||16
1447776|NCT02172755|3543922|P1|STARTED|Overall Study||14
1447777|NCT02172742|3543934|P2|NOT COMPLETED|Overall Study||0
1447778|NCT02172742|3543935|P1|NOT COMPLETED|Overall Study||1
1447779|NCT02172742|3543934|P2|COMPLETED|Overall Study||6
1447780|NCT02172742|3543935|P1|COMPLETED|Overall Study||6
1447781|NCT02172742|3543934|P2|STARTED|Overall Study||6
1447782|NCT02172742|3543935|P1|STARTED|Overall Study||7
1447783|NCT02172625|3543944|P2|NOT COMPLETED|Overall Study||3
1447784|NCT02172625|3543945|P1|NOT COMPLETED|Overall Study||0
1447785|NCT02172625|3543944|P2|COMPLETED|Overall Study||16
1447786|NCT02172625|3543945|P1|COMPLETED|Overall Study||19
1447787|NCT02172625|3543944|P2|STARTED|Overall Study||19
1447788|NCT02172625|3543945|P1|STARTED|Overall Study||19
1447789|NCT02172040|3543967|P4|NOT COMPLETED|Overall Study||1
1447790|NCT02172040|3543968|P3|NOT COMPLETED|Overall Study||2
1447791|NCT02172040|3543969|P2|NOT COMPLETED|Overall Study||3
1447792|NCT02172040|3543970|P1|NOT COMPLETED|Overall Study||0
1447793|NCT02172040|3543967|P4|COMPLETED|Overall Study||26
1447794|NCT02172040|3543968|P3|COMPLETED|Overall Study||29
1447795|NCT02172040|3543969|P2|COMPLETED|Overall Study||42
1447796|NCT02172040|3543970|P1|COMPLETED|Overall Study||49
1447797|NCT02172040|3543967|P4|STARTED|Overall Study||27
1447798|NCT02172040|3543968|P3|STARTED|Overall Study||31
1447799|NCT02172040|3543969|P2|STARTED|Overall Study||45
1447800|NCT02172040|3543970|P1|STARTED|Overall Study||49
1447801|NCT02171611|3544016|P6|NOT COMPLETED|Overall Study||0
1447802|NCT02171611|3544017|P5|NOT COMPLETED|Overall Study||0
1447803|NCT02171611|3544018|P4|NOT COMPLETED|Overall Study||0
1447804|NCT02171611|3544019|P3|NOT COMPLETED|Overall Study||0
1447805|NCT02171611|3544020|P2|NOT COMPLETED|Overall Study||0
1447806|NCT02171611|3544021|P1|NOT COMPLETED|Overall Study||0
1447807|NCT02171611|3544016|P6|COMPLETED|Overall Study||5
1447808|NCT02171611|3544017|P5|COMPLETED|Overall Study||5
1447809|NCT02171611|3544018|P4|COMPLETED|Overall Study||5
1447810|NCT02171611|3544019|P3|COMPLETED|Overall Study||5
1447811|NCT02171611|3544020|P2|COMPLETED|Overall Study||5
1447812|NCT02171611|3544021|P1|COMPLETED|Overall Study||5
1447813|NCT02171611|3544016|P6|STARTED|Overall Study||5
1447814|NCT02171611|3544017|P5|STARTED|Overall Study||5
1447815|NCT02171611|3544018|P4|STARTED|Overall Study||5
1447816|NCT02171611|3544019|P3|STARTED|Overall Study||5
1447817|NCT02171611|3544020|P2|STARTED|Overall Study||5
1447818|NCT02171611|3544021|P1|STARTED|Overall Study||5
1447819|NCT02171260|3544093|P4|NOT COMPLETED|Overall Study||5
1447820|NCT02171260|3544094|P3|NOT COMPLETED|Overall Study||5
1447821|NCT02171260|3544095|P2|NOT COMPLETED|Overall Study||6
1447822|NCT02171260|3544096|P1|NOT COMPLETED|Overall Study||6
1447823|NCT02171260|3544093|P4|COMPLETED|Overall Study||0
1447824|NCT02171260|3544094|P3|COMPLETED|Overall Study||0
1447825|NCT02171260|3544095|P2|COMPLETED|Overall Study||0
1447826|NCT02171260|3544096|P1|COMPLETED|Overall Study||0
1447827|NCT02171260|3544093|P4|STARTED|Overall Study||5
1447828|NCT02171260|3544094|P3|STARTED|Overall Study||5
1447829|NCT02171260|3544095|P2|STARTED|Overall Study||6
1447830|NCT02171260|3544096|P1|STARTED|Overall Study||6
1447831|NCT02171247|3544153|P2|NOT COMPLETED|Overall Study||0
1447832|NCT02171247|3544154|P1|NOT COMPLETED|Overall Study||0
1447833|NCT02171247|3544153|P2|COMPLETED|Overall Study||17
1447834|NCT02171247|3544154|P1|COMPLETED|Overall Study||16
1447835|NCT02171247|3544153|P2|STARTED|Overall Study||17
1447836|NCT02171247|3544154|P1|STARTED|Overall Study||16
1447837|NCT02171234|3544171|P5|NOT COMPLETED|Overall Study||0
1447838|NCT02171234|3544172|P4|NOT COMPLETED|Overall Study||0
1447839|NCT02171234|3544173|P3|NOT COMPLETED|Overall Study||0
1447840|NCT02171234|3544174|P2|NOT COMPLETED|Overall Study||0
1447841|NCT02171234|3544175|P1|NOT COMPLETED|Overall Study||0
1447842|NCT02171234|3544171|P5|COMPLETED|Overall Study||6
1447843|NCT02171234|3544172|P4|COMPLETED|Overall Study||6
1447844|NCT02171234|3544173|P3|COMPLETED|Overall Study||6
1447845|NCT02171234|3544174|P2|COMPLETED|Overall Study||6
1447846|NCT02171234|3544175|P1|COMPLETED|Overall Study||8
1447847|NCT02171234|3544171|P5|STARTED|Overall Study||6
1447848|NCT02171234|3544172|P4|STARTED|Overall Study||6
1447849|NCT02171234|3544173|P3|STARTED|Overall Study||6
1447850|NCT02171234|3544174|P2|STARTED|Overall Study||6
1447851|NCT02171234|3544175|P1|STARTED|Overall Study||8
1447852|NCT02171195|3544204|P9|NOT COMPLETED|Overall Study||0
1447853|NCT02171195|3544205|P8|NOT COMPLETED|Overall Study||0
1447854|NCT02171195|3544206|P7|NOT COMPLETED|Overall Study||0
1447855|NCT02171195|3544207|P6|NOT COMPLETED|Overall Study||0
1447856|NCT02171195|3544208|P5|NOT COMPLETED|Overall Study||0
1447857|NCT02171195|3544209|P4|NOT COMPLETED|Overall Study||0
1447858|NCT02171195|3544210|P3|NOT COMPLETED|Overall Study||0
1447859|NCT02171195|3544211|P2|NOT COMPLETED|Overall Study||0
1447860|NCT02171195|3544212|P1|NOT COMPLETED|Overall Study||0
1447861|NCT02171195|3544204|P9|COMPLETED|Overall Study||6
1447862|NCT02171195|3544205|P8|COMPLETED|Overall Study||6
1447863|NCT02171195|3544206|P7|COMPLETED|Overall Study||6
1447864|NCT02171195|3544207|P6|COMPLETED|Overall Study||6
1447865|NCT02171195|3544208|P5|COMPLETED|Overall Study||6
1447866|NCT02171195|3544209|P4|COMPLETED|Overall Study||6
1447867|NCT02171195|3544210|P3|COMPLETED|Overall Study||6
1447868|NCT02171195|3544211|P2|COMPLETED|Overall Study||6
1447869|NCT02171195|3544212|P1|COMPLETED|Overall Study||16
1447870|NCT02171195|3544204|P9|STARTED|Overall Study||6
1447871|NCT02171195|3544205|P8|STARTED|Overall Study||6
1447872|NCT02171195|3544206|P7|STARTED|Overall Study||6
1447873|NCT02171195|3544207|P6|STARTED|Overall Study||6
1447874|NCT02171195|3544208|P5|STARTED|Overall Study||6
1447875|NCT02171195|3544209|P4|STARTED|Overall Study||6
1447876|NCT02171195|3544210|P3|STARTED|Overall Study||6
1447877|NCT02171195|3544211|P2|STARTED|Overall Study||6
1447878|NCT02171195|3544212|P1|STARTED|Overall Study||16
1447879|NCT02170779|3544234|P2|NOT COMPLETED|Overall Study||1
1447880|NCT02170779|3544235|P1|NOT COMPLETED|Overall Study||1
1447881|NCT02170779|3544234|P2|COMPLETED|Overall Study||19
1447882|NCT02170779|3544235|P1|COMPLETED|Overall Study||19
1447883|NCT02170779|3544234|P2|STARTED|Overall Study||20
1447884|NCT02170779|3544235|P1|STARTED|Overall Study||20
1447885|NCT02170688|3544262|P5|NOT COMPLETED|Overall Study||0
1447886|NCT02170688|3544263|P4|NOT COMPLETED|Overall Study||2
1447887|NCT02170688|3544264|P3|NOT COMPLETED|Overall Study||4
1447888|NCT02170688|3544265|P2|NOT COMPLETED|Overall Study||3
1447889|NCT02170688|3544266|P1|NOT COMPLETED|Overall Study||4
1447890|NCT02170688|3544262|P5|COMPLETED|Overall Study||25
1447891|NCT02170688|3544263|P4|COMPLETED|Overall Study||25
1447892|NCT02170688|3544264|P3|COMPLETED|Overall Study||25
1447893|NCT02170688|3544265|P2|COMPLETED|Overall Study||26
1447894|NCT02170688|3544266|P1|COMPLETED|Overall Study||25
1447895|NCT02170688|3544262|P5|STARTED|Overall Study||25
1447896|NCT02170688|3544263|P4|STARTED|Overall Study||27
1447897|NCT02170688|3544264|P3|STARTED|Overall Study||29
1447898|NCT02170688|3544265|P2|STARTED|Overall Study||29
1447899|NCT02170688|3544266|P1|STARTED|Overall Study||29
1447900|NCT02170662|3544285|P2|NOT COMPLETED|Overall Study||0
1447901|NCT02170662|3544286|P1|NOT COMPLETED|Overall Study||0
1447902|NCT02170662|3544285|P2|COMPLETED|Overall Study||6
1447903|NCT02170662|3544286|P1|COMPLETED|Overall Study||3
1447904|NCT02170662|3544285|P2|STARTED|Overall Study||6
1447905|NCT02170662|3544286|P1|STARTED|Overall Study||3
1447906|NCT02170649|3544298|P1|NOT COMPLETED|Fed Period||0
1447907|NCT02170649|3544298|P1|COMPLETED|Fed Period||12
1447908|NCT02170649|3544298|P1|STARTED|Fed Period||12
1447909|NCT02170649|3544298|P1|NOT COMPLETED|Fasting Period||0
1447910|NCT02170649|3544298|P1|COMPLETED|Fasting Period||12
1447911|NCT02170649|3544298|P1|STARTED|Fasting Period||12
1447912|NCT02170532|3544305|P1|NOT COMPLETED|Overall Study||0
1447913|NCT02170532|3544305|P1|COMPLETED|Overall Study||10
1447914|NCT02170532|3544305|P1|STARTED|Overall Study||10
1447915|NCT02170519|3544335|P2|NOT COMPLETED|Overall Study||0
1447916|NCT02170519|3544336|P1|NOT COMPLETED|Overall Study||0
1447917|NCT02170519|3544335|P2|COMPLETED|Overall Study||5
1447918|NCT02170519|3544336|P1|COMPLETED|Overall Study||22
1447919|NCT02170519|3544335|P2|STARTED|Overall Study||5
1447920|NCT02170519|3544336|P1|STARTED|Overall Study||22
1447921|NCT02170376|3544357|P5|NOT COMPLETED|Overall Study||0
1447922|NCT02170376|3544358|P4|NOT COMPLETED|Overall Study||0
1447923|NCT02170376|3544359|P3|NOT COMPLETED|Overall Study||0
1447924|NCT02170376|3544360|P2|NOT COMPLETED|Overall Study||1
1447925|NCT02170376|3544361|P1|NOT COMPLETED|Overall Study||0
1447926|NCT02170376|3544357|P5|COMPLETED|Overall Study||16
1447927|NCT02170376|3544358|P4|COMPLETED|Overall Study||16
1447928|NCT02170376|3544359|P3|COMPLETED|Overall Study||16
1447929|NCT02170376|3544360|P2|COMPLETED|Overall Study||15
1447930|NCT02170376|3544361|P1|COMPLETED|Overall Study||16
1447931|NCT02170376|3544357|P5|Pharmacokinetic Population|Overall Study||16
1447932|NCT02170376|3544358|P4|Pharmacokinetic Population|Overall Study||16
1447933|NCT02170376|3544359|P3|Pharmacokinetic Population|Overall Study||16
1447934|NCT02170376|3544360|P2|Pharmacokinetic Population|Overall Study||15
1447935|NCT02170376|3544361|P1|Pharmacokinetic Population|Overall Study||16
1447936|NCT02170376|3544357|P5|STARTED|Overall Study||16
1447937|NCT02170376|3544358|P4|STARTED|Overall Study||16
1447938|NCT02170376|3544359|P3|STARTED|Overall Study||16
1447939|NCT02170376|3544360|P2|STARTED|Overall Study||16
1447940|NCT02170376|3544361|P1|STARTED|Overall Study||16
1447941|NCT02170363|3544398|P1|NOT COMPLETED|Overall Study||0
1447942|NCT02170363|3544398|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
1447943|NCT02170363|3544398|P1|STARTED|Overall Study||50
1447944|NCT02170220|3544412|P2|NOT COMPLETED|Overall Study||0
1447945|NCT02170220|3544413|P1|NOT COMPLETED|Overall Study||0
1447946|NCT02170220|3544412|P2|COMPLETED|Overall Study||6
1447947|NCT02170220|3544413|P1|COMPLETED|Overall Study||6
1447948|NCT02170220|3544412|P2|STARTED|Overall Study||6
1447949|NCT02170220|3544413|P1|STARTED|Overall Study||6
1447950|NCT02170207|3544439|P1|NOT COMPLETED|Overall Study||5
1447951|NCT02170207|3544439|P1|COMPLETED|Overall Study||58
1447952|NCT02170207|3544439|P1|STARTED|Overall Study||63
1447953|NCT02170077|3544450|P3|NOT COMPLETED|Overall Study||12
1447954|NCT02170077|3544451|P2|NOT COMPLETED|Overall Study||13
1447955|NCT02170077|3544452|P1|NOT COMPLETED|Overall Study||9
1447956|NCT02170077|3544450|P3|COMPLETED|Overall Study||35
1447957|NCT02170077|3544451|P2|COMPLETED|Overall Study||34
1447958|NCT02170077|3544452|P1|COMPLETED|Overall Study||41
1447959|NCT02170077|3544450|P3|Intent to Treat (ITT) Population|Overall Study||47
1447960|NCT02170077|3544451|P2|Intent to Treat (ITT) Population|Overall Study||46
1447961|NCT02170077|3544452|P1|Intent to Treat (ITT) Population|Overall Study||50
1447962|NCT02170077|3544450|P3|STARTED|Overall Study||47
1447963|NCT02170077|3544451|P2|STARTED|Overall Study||47
1447964|NCT02170077|3544452|P1|STARTED|Overall Study||50
1447965|NCT02170064|3544463|P3|NOT COMPLETED|Overall Study||1
1447966|NCT02170064|3544464|P2|NOT COMPLETED|Overall Study||2
1447967|NCT02170064|3544465|P1|NOT COMPLETED|Overall Study||6
1447968|NCT02170064|3544463|P3|COMPLETED|Overall Study||10
1447969|NCT02170064|3544464|P2|COMPLETED|Overall Study||7
1447970|NCT02170064|3544465|P1|COMPLETED|Overall Study||9
1447971|NCT02170064|3544463|P3|Efficacy Population (EP)|Overall Study||10
1447972|NCT02170064|3544464|P2|Efficacy Population (EP)|Overall Study||8
1447973|NCT02170064|3544465|P1|Efficacy Population (EP)|Overall Study||11
1447974|NCT02170064|3544463|P3|Pharmacokinetic Population (PKP)|Overall Study||10
1447975|NCT02170064|3544464|P2|Pharmacokinetic Population (PKP)|Overall Study||8
1447976|NCT02170064|3544465|P1|Pharmacokinetic Population (PKP)|Overall Study||11
1447977|NCT02170064|3544463|P3|Safety Population (SP)|Overall Study||11
1447978|NCT02170064|3544464|P2|Safety Population (SP)|Overall Study||8
1447979|NCT02170064|3544465|P1|Safety Population (SP)|Overall Study||12
1447980|NCT02170064|3544463|P3|STARTED|Overall Study||11
1447981|NCT02170064|3544464|P2|STARTED|Overall Study||9
1447982|NCT02170064|3544465|P1|STARTED|Overall Study||15
1447983|NCT02170025|3544481|P2|NOT COMPLETED|Overall Study||0
1447984|NCT02170025|3544482|P1|NOT COMPLETED|Overall Study||2
1447985|NCT02170025|3544481|P2|COMPLETED|Overall Study||7
1447986|NCT02170025|3544482|P1|COMPLETED|Overall Study||12
1447987|NCT02170025|3544481|P2|STARTED|Overall Study||7
1447988|NCT02170025|3544482|P1|STARTED|Overall Study||14
1447989|NCT02169895|3544494|P4|NOT COMPLETED|Overall Study||2
1447990|NCT02169895|3544495|P3|NOT COMPLETED|Overall Study||0
1447991|NCT02169895|3544496|P2|NOT COMPLETED|Overall Study||0
1447992|NCT02169895|3544497|P1|NOT COMPLETED|Overall Study||0
1447993|NCT02169895|3544494|P4|COMPLETED|Overall Study||2
1447994|NCT02169895|3544495|P3|COMPLETED|Overall Study||4
1447995|NCT02169895|3544496|P2|COMPLETED|Overall Study||4
1447996|NCT02169895|3544497|P1|COMPLETED|Overall Study||4
1447997|NCT02169895|3544494|P4|Placebo|Overall Study||4
1447998|NCT02169895|3544495|P3|Placebo|Overall Study||4
1447999|NCT02169895|3544496|P2|Placebo|Overall Study||4
1448000|NCT02169895|3544497|P1|Placebo|Overall Study||4
1448001|NCT02169895|3544494|P4|100 mg BIA 9-1067|Overall Study||2
1448002|NCT02169895|3544495|P3|100 mg BIA 9-1067|Overall Study||4
1448003|NCT02169895|3544496|P2|100 mg BIA 9-1067|Overall Study||4
1448004|NCT02169895|3544497|P1|100 mg BIA 9-1067|Overall Study||4
1448005|NCT02169895|3544494|P4|50 mg BIA 9-1067|Overall Study||4
1448006|NCT02169895|3544495|P3|50 mg BIA 9-1067|Overall Study||4
1448007|NCT02169895|3544496|P2|50 mg BIA 9-1067|Overall Study||4
1448008|NCT02169895|3544497|P1|50 mg BIA 9-1067|Overall Study||4
1448009|NCT02169895|3544494|P4|25 mg BIA 9-1067|Overall Study||4
1448010|NCT02169895|3544495|P3|25 mg BIA 9-1067|Overall Study||4
1448011|NCT02169895|3544496|P2|25 mg BIA 9-1067|Overall Study||4
1448012|NCT02169895|3544497|P1|25 mg BIA 9-1067|Overall Study||4
1448013|NCT02169895|3544494|P4|STARTED|Overall Study||4
1448014|NCT02169895|3544495|P3|STARTED|Overall Study||4
1448015|NCT02169895|3544496|P2|STARTED|Overall Study||4
1448016|NCT02169895|3544497|P1|STARTED|Overall Study||4
1448017|NCT02169479|3544519|P4|NOT COMPLETED|Overall Study||0
1448018|NCT02169479|3544520|P3|NOT COMPLETED|Overall Study||0
1448019|NCT02169479|3544521|P2|NOT COMPLETED|Overall Study||1
1448020|NCT02169479|3544522|P1|NOT COMPLETED|Overall Study||1
1448021|NCT02169479|3544519|P4|COMPLETED|Overall Study||4
1448022|NCT02169479|3544520|P3|COMPLETED|Overall Study||4
1448023|NCT02169479|3544521|P2|COMPLETED|Overall Study||3
1448024|NCT02169479|3544522|P1|COMPLETED|Overall Study||3
1448025|NCT02169479|3544519|P4|Placebo|Overall Study||4
1448026|NCT02169479|3544520|P3|Placebo|Overall Study||4
1448027|NCT02169479|3544521|P2|Placebo|Overall Study||3
1448028|NCT02169479|3544522|P1|Placebo|Overall Study||3
1448029|NCT02169479|3544519|P4|100 mg BIA 9-1067|Overall Study||4
1448030|NCT02169479|3544520|P3|100 mg BIA 9-1067|Overall Study||4
1448031|NCT02169479|3544521|P2|100 mg BIA 9-1067|Overall Study||4
1448032|NCT02169479|3544522|P1|100 mg BIA 9-1067|Overall Study||3
1448033|NCT02169479|3544519|P4|50 mg BIA 9-1067|Overall Study||4
1448034|NCT02169479|3544520|P3|50 mg BIA 9-1067|Overall Study||4
1448035|NCT02169479|3544521|P2|50 mg BIA 9-1067|Overall Study||4
1448036|NCT02169479|3544522|P1|50 mg BIA 9-1067|Overall Study||4
1448037|NCT02169479|3544519|P4|25 mg BIA 9-1067|Overall Study||4
1448038|NCT02169479|3544520|P3|25 mg BIA 9-1067|Overall Study||4
1448039|NCT02169479|3544521|P2|25 mg BIA 9-1067|Overall Study||3
1448040|NCT02169479|3544522|P1|25 mg BIA 9-1067|Overall Study||4
1448041|NCT02169479|3544519|P4|STARTED|Overall Study||4
1448042|NCT02169479|3544520|P3|STARTED|Overall Study||4
1448043|NCT02169479|3544521|P2|STARTED|Overall Study||4
1448044|NCT02169479|3544522|P1|STARTED|Overall Study||4
1448045|NCT02169466|3544544|P4|NOT COMPLETED|Overall Study||0
1448046|NCT02169466|3544545|P3|NOT COMPLETED|Overall Study||0
1448047|NCT02169466|3544546|P2|NOT COMPLETED|Overall Study||1
1448048|NCT02169466|3544547|P1|NOT COMPLETED|Overall Study||1
1448049|NCT02169466|3544544|P4|COMPLETED|Overall Study||5
1448050|NCT02169466|3544545|P3|COMPLETED|Overall Study||5
1448051|NCT02169466|3544546|P2|COMPLETED|Overall Study||5
1448052|NCT02169466|3544547|P1|COMPLETED|Overall Study||5
1448053|NCT02169466|3544544|P4|Placebo|Overall Study||5
1448054|NCT02169466|3544545|P3|Placebo|Overall Study||5
1448055|NCT02169466|3544546|P2|Placebo|Overall Study||6
1448056|NCT02169466|3544547|P1|Placebo|Overall Study||5
1448057|NCT02169466|3544544|P4|100 mg BIA 9-1067|Overall Study||5
1448058|NCT02169466|3544545|P3|100 mg BIA 9-1067|Overall Study||5
1448059|NCT02169466|3544546|P2|100 mg BIA 9-1067|Overall Study||6
1448060|NCT02169466|3544547|P1|100 mg BIA 9-1067|Overall Study||6
1448061|NCT02169466|3544544|P4|50 mg BIA 9-1067|Overall Study||5
1448062|NCT02169466|3544545|P3|50 mg BIA 9-1067|Overall Study||5
1448063|NCT02169466|3544546|P2|50 mg BIA 9-1067|Overall Study||6
1448064|NCT02169466|3544547|P1|50 mg BIA 9-1067|Overall Study||6
1448065|NCT02169466|3544544|P4|25 mg BIA 9-1067|Overall Study||5
1448066|NCT02169466|3544545|P3|25 mg BIA 9-1067|Overall Study||5
1448067|NCT02169466|3544546|P2|25 mg BIA 9-1067|Overall Study||5
1448068|NCT02169466|3544547|P1|25 mg BIA 9-1067|Overall Study||6
1448069|NCT02169466|3544544|P4|STARTED|Overall Study||5
1448070|NCT02169466|3544545|P3|STARTED|Overall Study||5
1448071|NCT02169466|3544546|P2|STARTED|Overall Study||6
1448072|NCT02169466|3544547|P1|STARTED|Overall Study||6
1448073|NCT02169453|3544573|P4|NOT COMPLETED|Overall Study||0
1448074|NCT02169453|3544574|P3|NOT COMPLETED|Overall Study||1
1448075|NCT02169453|3544575|P2|NOT COMPLETED|Overall Study||0
1448076|NCT02169453|3544576|P1|NOT COMPLETED|Overall Study||0
1448077|NCT02169453|3544573|P4|COMPLETED|Overall Study||3
1448078|NCT02169453|3544574|P3|COMPLETED|Overall Study||2
1448079|NCT02169453|3544575|P2|COMPLETED|Overall Study||3
1448080|NCT02169453|3544576|P1|COMPLETED|Overall Study||3
1448081|NCT02169453|3544573|P4|Placebo|Overall Study||3
1448082|NCT02169453|3544574|P3|Placebo|Overall Study||3
1448083|NCT02169453|3544575|P2|Placebo|Overall Study||3
1448084|NCT02169453|3544576|P1|Placebo|Overall Study||3
1448085|NCT02169453|3544573|P4|100 mg BIA 9-1067|Overall Study||3
1448086|NCT02169453|3544574|P3|100 mg BIA 9-1067|Overall Study||3
1448087|NCT02169453|3544575|P2|100 mg BIA 9-1067|Overall Study||3
1448088|NCT02169453|3544576|P1|100 mg BIA 9-1067|Overall Study||3
1448089|NCT02169453|3544573|P4|50 mg BIA 9-1067|Overall Study||3
1448090|NCT02169453|3544574|P3|50 mg BIA 9-1067|Overall Study||2
1448091|NCT02169453|3544575|P2|50 mg BIA 9-1067|Overall Study||3
1448092|NCT02169453|3544576|P1|50 mg BIA 9-1067|Overall Study||3
1448093|NCT02169453|3544573|P4|25 mg BIA 9-1067|Overall Study||3
1448094|NCT02169453|3544574|P3|25 mg BIA 9-1067|Overall Study||3
1448095|NCT02169453|3544575|P2|25 mg BIA 9-1067|Overall Study||3
1448096|NCT02169453|3544576|P1|25 mg BIA 9-1067|Overall Study||3
1448097|NCT02169453|3544573|P4|STARTED|Overall Study||3
1448098|NCT02169453|3544574|P3|STARTED|Overall Study||3
1448099|NCT02169453|3544575|P2|STARTED|Overall Study||3
1448100|NCT02169453|3544576|P1|STARTED|Overall Study||3
1448101|NCT02169440|3544608|P2|NOT COMPLETED|Overall Study||0
1448102|NCT02169440|3544609|P1|NOT COMPLETED|Overall Study||0
1448103|NCT02169440|3544608|P2|COMPLETED|Overall Study||10
1448104|NCT02169440|3544609|P1|COMPLETED|Overall Study||10
1448105|NCT02169440|3544608|P2|STARTED|Overall Study||10
1448106|NCT02169440|3544609|P1|STARTED|Overall Study||10
1448107|NCT02169427|3544622|P1|NOT COMPLETED|Overall Study||0
1448108|NCT02169427|3544622|P1|COMPLETED|Overall Study||6
1448109|NCT02169427|3544622|P1|STARTED|Overall Study||6
1448110|NCT02169414|3544632|P4|NOT COMPLETED|Overall Study||0
1448111|NCT02169414|3544633|P3|NOT COMPLETED|Overall Study||0
1448112|NCT02169414|3544634|P2|NOT COMPLETED|Overall Study||1
1448113|NCT02169414|3544635|P1|NOT COMPLETED|Overall Study||1
1448114|NCT02169414|3544632|P4|COMPLETED|Overall Study||18
1448115|NCT02169414|3544633|P3|COMPLETED|Overall Study||18
1448116|NCT02169414|3544634|P2|COMPLETED|Overall Study||18
1448117|NCT02169414|3544635|P1|COMPLETED|Overall Study||18
1448118|NCT02169414|3544632|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
1448119|NCT02169414|3544633|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
1448120|NCT02169414|3544634|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
1448121|NCT02169414|3544635|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
1448122|NCT02169414|3544632|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
1448123|NCT02169414|3544633|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
1448124|NCT02169414|3544634|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
1448125|NCT02169414|3544635|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
1448126|NCT02169414|3544632|P4|STARTED|Overall Study||18
1448127|NCT02169414|3544633|P3|STARTED|Overall Study||18
1448128|NCT02169414|3544634|P2|STARTED|Overall Study||19
1448129|NCT02169414|3544635|P1|STARTED|Overall Study||19
1448130|NCT02169336|3544676|P3|NOT COMPLETED|Overall Study||3
1448131|NCT02169336|3544677|P2|NOT COMPLETED|Overall Study||4
1448132|NCT02169336|3544678|P1|NOT COMPLETED|Overall Study||4
1448133|NCT02169336|3544676|P3|COMPLETED|Overall Study||29
1448134|NCT02169336|3544677|P2|COMPLETED|Overall Study||28
1448135|NCT02169336|3544678|P1|COMPLETED|Overall Study||27
1448136|NCT02169336|3544676|P3|STARTED|Overall Study||32
1448137|NCT02169336|3544677|P2|STARTED|Overall Study||32
1448138|NCT02169336|3544678|P1|STARTED|Overall Study||31
1448139|NCT02169219|3544686|P1|NOT COMPLETED|Overall Study||6
1448140|NCT02169219|3544686|P1|COMPLETED|Overall Study||14
1448141|NCT02169219|3544686|P1|STARTED|Overall Study||20
1448142|NCT02169115|3544700|P3|NOT COMPLETED|Overall Study||0
1448143|NCT02169115|3544701|P2|NOT COMPLETED|Overall Study||0
1448144|NCT02169115|3544702|P1|NOT COMPLETED|Overall Study||0
1448145|NCT02169115|3544700|P3|COMPLETED|Overall Study||21
1448146|NCT02169115|3544701|P2|COMPLETED|Overall Study||21
1448147|NCT02169115|3544702|P1|COMPLETED|Overall Study||19
1448148|NCT02169115|3544700|P3|STARTED|Overall Study||21
1448149|NCT02169115|3544701|P2|STARTED|Overall Study||21
1448150|NCT02169115|3544702|P1|STARTED|Overall Study||19
1448151|NCT02168946|3544712|P2|NOT COMPLETED|Overall Study||5
1448152|NCT02168946|3544713|P1|NOT COMPLETED|Overall Study||12
1448153|NCT02168946|3544712|P2|COMPLETED|Overall Study||20
1448154|NCT02168946|3544713|P1|COMPLETED|Overall Study||38
1448155|NCT02168946|3544712|P2|STARTED|Overall Study||25
1448156|NCT02168946|3544713|P1|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
1448157|NCT02168816|3544751|P2|NOT COMPLETED|Overall Study||2
1448158|NCT02168816|3544752|P1|NOT COMPLETED|Overall Study||2
1448159|NCT02168816|3544751|P2|COMPLETED|Overall Study||5
1448160|NCT02168816|3544752|P1|COMPLETED|Overall Study||3
1448161|NCT02168816|3544751|P2|STARTED|Overall Study||7
1448162|NCT02168816|3544752|P1|STARTED|Overall Study||5
1448163|NCT02168803|3544763|P3|NOT COMPLETED|Overall Study||6
1448164|NCT02168803|3544764|P2|NOT COMPLETED|Overall Study||3
1448165|NCT02168803|3544765|P1|NOT COMPLETED|Overall Study||2
1448166|NCT02168803|3544763|P3|COMPLETED|Overall Study||33
1448167|NCT02168803|3544764|P2|COMPLETED|Overall Study||29
1448168|NCT02168803|3544765|P1|COMPLETED|Overall Study||28
1448169|NCT02168803|3544763|P3|Received at Least 1 Dose of Study Drug|Overall Study||39
1448170|NCT02168803|3544764|P2|Received at Least 1 Dose of Study Drug|Overall Study||32
1448171|NCT02168803|3544765|P1|Received at Least 1 Dose of Study Drug|Overall Study||30
1448172|NCT02168803|3544763|P3|STARTED|Overall Study||39
1448173|NCT02168803|3544764|P2|STARTED|Overall Study||32
1448174|NCT02168803|3544765|P1|STARTED|Overall Study||30
1448175|NCT02168777|3544795|P3|NOT COMPLETED|Overall Study||11
1448176|NCT02168777|3544796|P2|NOT COMPLETED|Overall Study||7
1448177|NCT02168777|3544797|P1|NOT COMPLETED|Overall Study||2
1448178|NCT02168777|3544795|P3|COMPLETED|Overall Study||0
1448179|NCT02168777|3544796|P2|COMPLETED|Overall Study||0
1448180|NCT02168777|3544797|P1|COMPLETED|Overall Study||0
1448181|NCT02168777|3544795|P3|STARTED|Overall Study||11
1448182|NCT02168777|3544796|P2|STARTED|Overall Study||7
1448183|NCT02168777|3544797|P1|STARTED|Overall Study||2
1448184|NCT02168491|3544874|P1|NOT COMPLETED|Overall Study||1
1448185|NCT02168491|3544874|P1|COMPLETED|Overall Study||8
1448186|NCT02168491|3544874|P1|STARTED|Overall Study||9
1448187|NCT02168478|3544880|P1|NOT COMPLETED|Overall Study||4
1448188|NCT02168478|3544880|P1|COMPLETED|Overall Study||202
1448189|NCT02168478|3544880|P1|STARTED|Overall Study||206
1448190|NCT02168439|3544886|P2|NOT COMPLETED|Overall Study||2
1448191|NCT02168439|3544887|P1|NOT COMPLETED|Overall Study||0
1448192|NCT02168439|3544886|P2|COMPLETED|Overall Study||18
1448193|NCT02168439|3544887|P1|COMPLETED|Overall Study||20
1448194|NCT02168439|3544886|P2|STARTED|Overall Study||20
1448195|NCT02168439|3544887|P1|STARTED|Overall Study||20
1448196|NCT02168387|3544905|P2|NOT COMPLETED|Overall Study||3
1448197|NCT02168387|3544906|P1|NOT COMPLETED|Overall Study||7
1448198|NCT02168387|3544905|P2|COMPLETED|Overall Study||16
1448199|NCT02168387|3544906|P1|COMPLETED|Overall Study||13
1448200|NCT02168387|3544905|P2|STARTED|Overall Study||19
1448201|NCT02168387|3544906|P1|STARTED|Overall Study||20
1448202|NCT02168361|3544918|P2|NOT COMPLETED|Overall Study||10
1448203|NCT02168361|3544919|P1|NOT COMPLETED|Overall Study||5
1448204|NCT02168361|3544918|P2|COMPLETED|Overall Study||21
1448205|NCT02168361|3544919|P1|COMPLETED|Overall Study||57
1448206|NCT02168361|3544918|P2|STARTED|Overall Study||31
1448207|NCT02168361|3544919|P1|STARTED|Overall Study||62
1448208|NCT02168309|3544929|P2|NOT COMPLETED|Overall Study||0
1448209|NCT02168309|3544930|P1|NOT COMPLETED|Overall Study||0
1448210|NCT02168309|3544929|P2|COMPLETED|Overall Study||25
1448211|NCT02168309|3544930|P1|COMPLETED|Overall Study||25
1448212|NCT02168309|3544929|P2|STARTED|Overall Study||25
1448213|NCT02168309|3544930|P1|STARTED|Overall Study||25
1448214|NCT02168270|3544938|P1|NOT COMPLETED|Overall Study||4
1448215|NCT02168270|3544938|P1|COMPLETED|Overall Study||0
1448216|NCT02168270|3544938|P1|STARTED|Overall Study||4
1448217|NCT02167893|3544945|P1|NOT COMPLETED|Overall Study||163
1448218|NCT02167893|3544945|P1|COMPLETED|Overall Study||11125
1448219|NCT02167893|3544945|P1|STARTED|Overall Study||11288
1448220|NCT02167867|3544956|P2|NOT COMPLETED|Overall Study||0
1448221|NCT02167867|3544957|P1|NOT COMPLETED|Overall Study||0
1448222|NCT02167867|3544956|P2|COMPLETED|Overall Study||22
1448223|NCT02167867|3544957|P1|COMPLETED|Overall Study||22
1448224|NCT02167867|3544956|P2|STARTED|Overall Study||22
1448225|NCT02167867|3544957|P1|STARTED|Overall Study||22
1448226|NCT02167815|3544965|P2|NOT COMPLETED|Overall Study||0
1448227|NCT02167815|3544966|P1|NOT COMPLETED|Overall Study||0
1448228|NCT02167815|3544965|P2|COMPLETED|Overall Study||21
1448229|NCT02167815|3544966|P1|COMPLETED|Overall Study||9
1448230|NCT02167815|3544965|P2|STARTED|Overall Study||21
1448231|NCT02167815|3544966|P1|STARTED|Overall Study||9
1448232|NCT02167217|3544977|P1|NOT COMPLETED|Overall Study||2
1448233|NCT02167217|3544977|P1|COMPLETED|Overall Study||23
1448234|NCT02167217|3544977|P1|STARTED|Overall Study||25
1448235|NCT02167139|3544983|P4|NOT COMPLETED|Transition-extension||5
1448236|NCT02167139|3544984|P3|NOT COMPLETED|Transition-extension||8
1448237|NCT02167139|3544985|P2|NOT COMPLETED|Transition-extension||0
1448238|NCT02167139|3544986|P1|NOT COMPLETED|Transition-extension||6
1448239|NCT02167139|3544983|P4|COMPLETED|Transition-extension||124
1448240|NCT02167139|3544984|P3|COMPLETED|Transition-extension||117
1448241|NCT02167139|3544985|P2|COMPLETED|Transition-extension||0
1448242|NCT02167139|3544986|P1|COMPLETED|Transition-extension||248
1448243|NCT02167139|3544983|P4|STARTED|Transition-extension||129
1448244|NCT02167139|3544984|P3|STARTED|Transition-extension||125
1448245|NCT02167139|3544985|P2|STARTED|Transition-extension||0
1448246|NCT02167139|3544986|P1|STARTED|Transition-extension||254
1448247|NCT02167139|3544983|P4|NOT COMPLETED|Randomised, Double-blind||0
1448248|NCT02167139|3544984|P3|NOT COMPLETED|Randomised, Double-blind||0
1448249|NCT02167139|3544985|P2|NOT COMPLETED|Randomised, Double-blind||19
1448250|NCT02167139|3544986|P1|NOT COMPLETED|Randomised, Double-blind||17
1448251|NCT02167139|3544983|P4|COMPLETED|Randomised, Double-blind||0
1448252|NCT02167139|3544984|P3|COMPLETED|Randomised, Double-blind||0
1448253|NCT02167139|3544985|P2|COMPLETED|Randomised, Double-blind||254
1448254|NCT02167139|3544986|P1|COMPLETED|Randomised, Double-blind||254
1448255|NCT02167139|3544983|P4|STARTED|Randomised, Double-blind||0
1448256|NCT02167139|3544984|P3|STARTED|Randomised, Double-blind||0
1448257|NCT02167139|3544985|P2|STARTED|Randomised, Double-blind||273
1448258|NCT02167139|3544986|P1|STARTED|Randomised, Double-blind||271
1448259|NCT02167035|3545002|P2|NOT COMPLETED|Overall Study||6
1448260|NCT02167035|3545003|P1|NOT COMPLETED|Overall Study||5
1448261|NCT02167035|3545002|P2|COMPLETED|Overall Study||16
1448262|NCT02167035|3545003|P1|COMPLETED|Overall Study||16
1448263|NCT02167035|3545002|P2|STARTED|Overall Study||22
1448264|NCT02167035|3545003|P1|STARTED|Overall Study||21
1448265|NCT02166697|3545011|P1|NOT COMPLETED|Overall Study||347
1448266|NCT02166697|3545011|P1|COMPLETED|Overall Study||13804
1448267|NCT02166697|3545011|P1|STARTED|Overall Study||14151
1448268|NCT02166476|3545022|P2|NOT COMPLETED|Overall Study||23
1448269|NCT02166476|3545023|P1|NOT COMPLETED|Overall Study||14
1448270|NCT02166476|3545022|P2|COMPLETED|Overall Study||250
1448271|NCT02166476|3545023|P1|COMPLETED|Overall Study||258
1448272|NCT02166476|3545022|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
1448273|NCT02166476|3545023|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
1448274|NCT02166476|3545022|P2|STARTED|Overall Study||273
1448275|NCT02166476|3545023|P1|STARTED|Overall Study||272
1448276|NCT02166346|3545056|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
1448277|NCT02166346|3545057|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
1448278|NCT02166346|3545056|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
1448279|NCT02166346|3545057|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
1448280|NCT02166346|3545056|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
1448281|NCT02166346|3545057|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
1448282|NCT02166346|3545056|P2|NOT COMPLETED|Intervention - Phase 1||2
1448283|NCT02166346|3545057|P1|NOT COMPLETED|Intervention - Phase 1||0
1448284|NCT02166346|3545056|P2|COMPLETED|Intervention - Phase 1||6
1448285|NCT02166346|3545057|P1|COMPLETED|Intervention - Phase 1||8
1448286|NCT02166346|3545056|P2|STARTED|Intervention - Phase 1||8
1448287|NCT02166346|3545057|P1|STARTED|Intervention - Phase 1||8
1448288|NCT02166346|3545056|P2|NOT COMPLETED|Screening and Randomization||4
1448289|NCT02166346|3545057|P1|NOT COMPLETED|Screening and Randomization||4
1448290|NCT02166346|3545056|P2|COMPLETED|Screening and Randomization||8
1448291|NCT02166346|3545057|P1|COMPLETED|Screening and Randomization||8
1448292|NCT02166346|3545056|P2|STARTED|Screening and Randomization||12
1448293|NCT02166346|3545057|P1|STARTED|Screening and Randomization||12
1448294|NCT02165826|3545068|P3|NOT COMPLETED|Down-Titration Period||7
1448295|NCT02165826|3545069|P2|NOT COMPLETED|Down-Titration Period||11
1448296|NCT02165826|3545070|P1|NOT COMPLETED|Down-Titration Period||7
1448297|NCT02165826|3545068|P3|COMPLETED|Down-Titration Period||31
1448298|NCT02165826|3545069|P2|COMPLETED|Down-Titration Period||28
1448299|NCT02165826|3545070|P1|COMPLETED|Down-Titration Period||20
1448300|NCT02165826|3545068|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
1448301|NCT02165826|3545069|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
1448302|NCT02165826|3545070|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
1448303|NCT02165826|3545068|P3|STARTED|Down-Titration Period||38
1448304|NCT02165826|3545069|P2|STARTED|Down-Titration Period||39
1448305|NCT02165826|3545070|P1|STARTED|Down-Titration Period||27
1448306|NCT02165826|3545068|P3|NOT COMPLETED|Main Treatment Period||109
1448307|NCT02165826|3545069|P2|NOT COMPLETED|Main Treatment Period||90
1448308|NCT02165826|3545070|P1|NOT COMPLETED|Main Treatment Period||81
1448309|NCT02165826|3545068|P3|COMPLETED|Main Treatment Period||334
1448310|NCT02165826|3545069|P2|COMPLETED|Main Treatment Period||349
1448311|NCT02165826|3545070|P1|COMPLETED|Main Treatment Period||360
1448312|NCT02165826|3545068|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
1448313|NCT02165826|3545069|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
1448314|NCT02165826|3545070|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
1448315|NCT02165826|3545068|P3|STARTED|Main Treatment Period||443
1448316|NCT02165826|3545069|P2|STARTED|Main Treatment Period||439
1448317|NCT02165826|3545070|P1|STARTED|Main Treatment Period||441
1448318|NCT02165761|3545129|P2|NOT COMPLETED|Overall Study||14
1448319|NCT02165761|3545130|P1|NOT COMPLETED|Overall Study||19
1448320|NCT02165761|3545129|P2|COMPLETED|Overall Study||5
1448321|NCT02165761|3545130|P1|COMPLETED|Overall Study||4
1448322|NCT02165761|3545129|P2|STARTED|Overall Study||19
1448323|NCT02165761|3545130|P1|STARTED|Overall Study||23
1448324|NCT02165735|3545138|P2|NOT COMPLETED|Overall Study||14
1448325|NCT02165735|3545139|P1|NOT COMPLETED|Overall Study||16
1448326|NCT02165735|3545138|P2|COMPLETED|Overall Study||166
1448327|NCT02165735|3545139|P1|COMPLETED|Overall Study||164
1448328|NCT02165735|3545138|P2|STARTED|Overall Study||180
1448329|NCT02165735|3545139|P1|STARTED|Overall Study||180
1448330|NCT02165722|3545167|P2|NOT COMPLETED|Overall Study||0
1448331|NCT02165722|3545168|P1|NOT COMPLETED|Overall Study||0
1448332|NCT02165722|3545167|P2|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
1448333|NCT02165722|3545168|P1|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
1448334|NCT02165722|3545167|P2|STARTED|Overall Study||2202
1448335|NCT02165722|3545168|P1|STARTED|Overall Study||1971
1448336|NCT02165462|3545180|P1|NOT COMPLETED|Overall Study||0
1448337|NCT02165462|3545180|P1|COMPLETED|Overall Study||17
1448338|NCT02165462|3545180|P1|STARTED|Overall Study||17
1448339|NCT02165202|3545199|P2|NOT COMPLETED|Injection Phase||6
1448340|NCT02165202|3545200|P1|NOT COMPLETED|Injection Phase||10
1448341|NCT02165202|3545199|P2|COMPLETED|Injection Phase||36
1448342|NCT02165202|3545200|P1|COMPLETED|Injection Phase||70
1448343|NCT02165202|3545199|P2|STARTED|Injection Phase|Participants who received at least one injection.|42
1448344|NCT02165202|3545200|P1|STARTED|Injection Phase|Participants who received at least one injection.|80
1448345|NCT02165202|3545199|P2|NOT COMPLETED|Oral Phase||3
1448346|NCT02165202|3545200|P1|NOT COMPLETED|Oral Phase||11
1448347|NCT02165202|3545199|P2|COMPLETED|Oral Phase||42
1448348|NCT02165202|3545200|P1|COMPLETED|Oral Phase||80
1448349|NCT02165202|3545199|P2|STARTED|Oral Phase|Participants Enrolled in the study|45
1448350|NCT02165202|3545200|P1|STARTED|Oral Phase|Participants Enrolled in the study|91
1448351|NCT02165124|3545206|P1|NOT COMPLETED|Overall Study||5
1448352|NCT02165124|3545206|P1|COMPLETED|Overall Study||15
1448353|NCT02165124|3545206|P1|STARTED|Overall Study||20
1448354|NCT02165111|3545212|P2|NOT COMPLETED|Overall Study||0
1448355|NCT02165111|3545213|P1|NOT COMPLETED|Overall Study||0
1448356|NCT02165111|3545212|P2|COMPLETED|Overall Study||40
1448357|NCT02165111|3545213|P1|COMPLETED|Overall Study||40
1448358|NCT02165111|3545212|P2|STARTED|Overall Study||40
1448359|NCT02165111|3545213|P1|STARTED|Overall Study||40
1448360|NCT02165072|3545229|P1|NOT COMPLETED|Overall Study||0
1448361|NCT02165072|3545229|P1|COMPLETED|Overall Study||30
1448362|NCT02165072|3545229|P1|STARTED|Overall Study||30
1448363|NCT02164981|3545237|P3|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
1448364|NCT02164981|3545238|P2|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
1448365|NCT02164981|3545239|P1|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
1448366|NCT02164981|3545237|P3|COMPLETED|Phase 2 (Day 14 - Day 28)||18
1448367|NCT02164981|3545238|P2|COMPLETED|Phase 2 (Day 14 - Day 28)||12
1448368|NCT02164981|3545239|P1|COMPLETED|Phase 2 (Day 14 - Day 28)||16
1448369|NCT02164981|3545237|P3|STARTED|Phase 2 (Day 14 - Day 28)||18
1448370|NCT02164981|3545238|P2|STARTED|Phase 2 (Day 14 - Day 28)||14
1448371|NCT02164981|3545239|P1|STARTED|Phase 2 (Day 14 - Day 28)||18
1448372|NCT02164981|3545237|P3|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
1448373|NCT02164981|3545238|P2|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
1448374|NCT02164981|3545239|P1|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
1448375|NCT02164981|3545237|P3|COMPLETED|Phase 1 (Day 0 - Day 14)||18
1448376|NCT02164981|3545238|P2|COMPLETED|Phase 1 (Day 0 - Day 14)||14
1448377|NCT02164981|3545239|P1|COMPLETED|Phase 1 (Day 0 - Day 14)||18
1448378|NCT02164981|3545237|P3|STARTED|Phase 1 (Day 0 - Day 14)||18
1448379|NCT02164981|3545238|P2|STARTED|Phase 1 (Day 0 - Day 14)||16
1448380|NCT02164981|3545239|P1|STARTED|Phase 1 (Day 0 - Day 14)||18
1448381|NCT02164981|3545237|P3|NOT COMPLETED|Started||0
1448382|NCT02164981|3545238|P2|NOT COMPLETED|Started||3
1448383|NCT02164981|3545239|P1|NOT COMPLETED|Started||5
1448384|NCT02164981|3545237|P3|COMPLETED|Started||18
1448385|NCT02164981|3545238|P2|COMPLETED|Started||16
1448386|NCT02164981|3545239|P1|COMPLETED|Started||18
1448387|NCT02164981|3545237|P3|STARTED|Started||18
1448388|NCT02164981|3545238|P2|STARTED|Started||19
1448389|NCT02164981|3545239|P1|STARTED|Started||23
1448390|NCT02164929|3545312|P4|NOT COMPLETED|Overall Study||2
1448391|NCT02164929|3545313|P3|NOT COMPLETED|Overall Study||1
1448392|NCT02164929|3545314|P2|NOT COMPLETED|Overall Study||0
1448393|NCT02164929|3545315|P1|NOT COMPLETED|Overall Study||1
1448394|NCT02164929|3545312|P4|COMPLETED|Overall Study||2
1448395|NCT02164929|3545313|P3|COMPLETED|Overall Study||4
1448396|NCT02164929|3545314|P2|COMPLETED|Overall Study||3
1448397|NCT02164929|3545315|P1|COMPLETED|Overall Study||3
1448398|NCT02164929|3545312|P4|STARTED|Overall Study||4
1448399|NCT02164929|3545313|P3|STARTED|Overall Study||5
1448400|NCT02164929|3545314|P2|STARTED|Overall Study||3
1448401|NCT02164929|3545315|P1|STARTED|Overall Study||4
1448402|NCT02164916|3545359|P2|NOT COMPLETED|Overall Study||54
1448403|NCT02164916|3545360|P1|NOT COMPLETED|Overall Study||52
1448404|NCT02164916|3545359|P2|COMPLETED|Overall Study||0
1448405|NCT02164916|3545360|P1|COMPLETED|Overall Study||0
1448406|NCT02164916|3545359|P2|Cross-over to Arm II|Overall Study||0
1448407|NCT02164916|3545360|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
1448408|NCT02164916|3545359|P2|Eligible|Overall Study||49
1448409|NCT02164916|3545360|P1|Eligible|Overall Study||50
1448410|NCT02164916|3545359|P2|STARTED|Overall Study||54
1448411|NCT02164916|3545360|P1|STARTED|Overall Study||52
1448412|NCT02164864|3545380|P3|NOT COMPLETED|Overall Study||132
1448413|NCT02164864|3545381|P2|NOT COMPLETED|Overall Study||60
1448414|NCT02164864|3545382|P1|NOT COMPLETED|Overall Study||95
1448415|NCT02164864|3545380|P3|COMPLETED|Overall Study||849
1448416|NCT02164864|3545381|P2|COMPLETED|Overall Study||703
1448417|NCT02164864|3545382|P1|COMPLETED|Overall Study||886
1448418|NCT02164864|3545380|P3|STARTED|Overall Study|Started are the Randomised/entered patients.|981
1448419|NCT02164864|3545381|P2|STARTED|Overall Study|Started are the Randomised/entered patients.|763
1448420|NCT02164864|3545382|P1|STARTED|Overall Study|Started are the Randomised/entered patients.|981
1448421|NCT02164539|3545447|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
1448422|NCT02164539|3545448|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
1448423|NCT02164539|3545449|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
1448424|NCT02164539|3545450|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
1448425|NCT02164539|3545451|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
1448426|NCT02164539|3545452|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
1448427|NCT02164539|3545453|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
1448428|NCT02164539|3545447|P7|COMPLETED|Treatment Phase C (1 Week)||78
1448429|NCT02164539|3545448|P6|COMPLETED|Treatment Phase C (1 Week)||82
1448430|NCT02164539|3545449|P5|COMPLETED|Treatment Phase C (1 Week)||84
1448431|NCT02164539|3545450|P4|COMPLETED|Treatment Phase C (1 Week)||0
1448432|NCT02164539|3545451|P3|COMPLETED|Treatment Phase C (1 Week)||0
1448433|NCT02164539|3545452|P2|COMPLETED|Treatment Phase C (1 Week)||0
1448434|NCT02164539|3545453|P1|COMPLETED|Treatment Phase C (1 Week)||78
1448435|NCT02164539|3545447|P7|STARTED|Treatment Phase C (1 Week)||80
1448436|NCT02164539|3545448|P6|STARTED|Treatment Phase C (1 Week)||82
1448437|NCT02164539|3545449|P5|STARTED|Treatment Phase C (1 Week)||84
1448438|NCT02164539|3545450|P4|STARTED|Treatment Phase C (1 Week)||0
1448439|NCT02164539|3545451|P3|STARTED|Treatment Phase C (1 Week)||0
1448440|NCT02164539|3545452|P2|STARTED|Treatment Phase C (1 Week)||0
1448441|NCT02164539|3545453|P1|STARTED|Treatment Phase C (1 Week)||79
1448442|NCT02164539|3545447|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
1448443|NCT02164539|3545448|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
1448444|NCT02164539|3545449|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
1448445|NCT02164539|3545450|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
1448446|NCT02164539|3545451|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
1448447|NCT02164539|3545452|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
1448448|NCT02164539|3545453|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
1448449|NCT02164539|3545447|P7|COMPLETED|Treatment Phase B (1 Week)||162
1448450|NCT02164539|3545448|P6|COMPLETED|Treatment Phase B (1 Week)||0
1448451|NCT02164539|3545449|P5|COMPLETED|Treatment Phase B (1 Week)||163
1448452|NCT02164539|3545450|P4|COMPLETED|Treatment Phase B (1 Week)||0
1448453|NCT02164539|3545451|P3|COMPLETED|Treatment Phase B (1 Week)||0
1448454|NCT02164539|3545452|P2|COMPLETED|Treatment Phase B (1 Week)||0
1448455|NCT02164539|3545453|P1|COMPLETED|Treatment Phase B (1 Week)||0
1448456|NCT02164539|3545447|P7|STARTED|Treatment Phase B (1 Week)||163
1448457|NCT02164539|3545448|P6|STARTED|Treatment Phase B (1 Week)||0
1448458|NCT02164539|3545449|P5|STARTED|Treatment Phase B (1 Week)||166
1448459|NCT02164539|3545450|P4|STARTED|Treatment Phase B (1 Week)||0
1448460|NCT02164539|3545451|P3|STARTED|Treatment Phase B (1 Week)||0
1448461|NCT02164539|3545452|P2|STARTED|Treatment Phase B (1 Week)||0
1448462|NCT02164539|3545453|P1|STARTED|Treatment Phase B (1 Week)||0
1448463|NCT02164539|3545447|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
1448464|NCT02164539|3545448|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
1448465|NCT02164539|3545449|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
1448466|NCT02164539|3545450|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
1448467|NCT02164539|3545451|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
1448468|NCT02164539|3545452|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
1448469|NCT02164539|3545453|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
1448470|NCT02164539|3545447|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
1448471|NCT02164539|3545448|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
1448472|NCT02164539|3545449|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
1448473|NCT02164539|3545450|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
1448474|NCT02164539|3545451|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
1448475|NCT02164539|3545452|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
1448476|NCT02164539|3545453|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
1448477|NCT02164539|3545447|P7|STARTED|Treatment Phase A (4 Weeks)||0
1448478|NCT02164539|3545448|P6|STARTED|Treatment Phase A (4 Weeks)||84
1448479|NCT02164539|3545449|P5|STARTED|Treatment Phase A (4 Weeks)||85
1448480|NCT02164539|3545450|P4|STARTED|Treatment Phase A (4 Weeks)||46
1448481|NCT02164539|3545451|P3|STARTED|Treatment Phase A (4 Weeks)||40
1448482|NCT02164539|3545452|P2|STARTED|Treatment Phase A (4 Weeks)||42
1448483|NCT02164539|3545453|P1|STARTED|Treatment Phase A (4 Weeks)||41
1448484|NCT02164513|3545501|P3|NOT COMPLETED|Overall Study||295
1448485|NCT02164513|3545502|P2|NOT COMPLETED|Overall Study||536
1448486|NCT02164513|3545503|P1|NOT COMPLETED|Overall Study||437
1448487|NCT02164513|3545501|P3|COMPLETED|Overall Study||1775
1448488|NCT02164513|3545502|P2|COMPLETED|Overall Study||3598
1448489|NCT02164513|3545503|P1|COMPLETED|Overall Study||3714
1448490|NCT02164513|3545501|P3|WIP :Did Not Complete Study Treatment|Overall Study||0
1448491|NCT02164513|3545502|P2|WIP :Did Not Complete Study Treatment|Overall Study||1
1448492|NCT02164513|3545503|P1|WIP :Did Not Complete Study Treatment|Overall Study||1
1448493|NCT02164513|3545501|P3|WIP: Withdrawal by Participant|Overall Study||153
1448494|NCT02164513|3545502|P2|WIP: Withdrawal by Participant|Overall Study||296
1448495|NCT02164513|3545503|P1|WIP: Withdrawal by Participant|Overall Study||250
1448496|NCT02164513|3545501|P3|WIP: Investigator Discretion|Overall Study||15
1448497|NCT02164513|3545502|P2|WIP: Investigator Discretion|Overall Study||36
1448498|NCT02164513|3545503|P1|WIP: Investigator Discretion|Overall Study||33
1448499|NCT02164513|3545501|P3|WIP: Lost to Follow-up|Overall Study||14
1448500|NCT02164513|3545502|P2|WIP: Lost to Follow-up|Overall Study||25
1448501|NCT02164513|3545503|P1|WIP: Lost to Follow-up|Overall Study||21
1448502|NCT02164513|3545501|P3|WIP: Study Closed/Terminated|Overall Study||5
1448503|NCT02164513|3545502|P2|WIP: Study Closed/Terminated|Overall Study||2
1448504|NCT02164513|3545503|P1|WIP: Study Closed/Terminated|Overall Study||5
1448505|NCT02164513|3545501|P3|WIP (Other): Stopping Criteria Reached|Overall Study||2
1448506|NCT02164513|3545502|P2|WIP (Other): Stopping Criteria Reached|Overall Study||1
1448507|NCT02164513|3545503|P1|WIP (Other): Stopping Criteria Reached|Overall Study||4
1448508|NCT02164513|3545501|P3|Withdrew IP: Protocol Deviation|Overall Study||19
1448509|NCT02164513|3545502|P2|Withdrew IP: Protocol Deviation|Overall Study||41
1448510|NCT02164513|3545503|P1|Withdrew IP: Protocol Deviation|Overall Study||32
1448511|NCT02164513|3545501|P3|WIP: Lack of Efficacy|Overall Study||172
1448512|NCT02164513|3545502|P2|WIP: Lack of Efficacy|Overall Study||313
1448513|NCT02164513|3545503|P1|WIP: Lack of Efficacy|Overall Study||163
1448514|NCT02164513|3545501|P3|Withdrew IP (WIP): Adverse Event|Overall Study||186
1448515|NCT02164513|3545502|P2|Withdrew IP (WIP): Adverse Event|Overall Study||325
1448516|NCT02164513|3545503|P1|Withdrew IP (WIP): Adverse Event|Overall Study||249
1448517|NCT02164513|3545501|P3|Not Completed IP|Overall Study||566
1448518|NCT02164513|3545502|P2|Not Completed IP|Overall Study||1040
1448519|NCT02164513|3545503|P1|Not Completed IP|Overall Study||758
1448520|NCT02164513|3545501|P3|Completed Investigational Product (IP)|Overall Study||1504
1448521|NCT02164513|3545502|P2|Completed Investigational Product (IP)|Overall Study||3094
1448522|NCT02164513|3545503|P1|Completed Investigational Product (IP)|Overall Study||3393
1448523|NCT02164513|3545501|P3|STARTED|Overall Study||2070
1448524|NCT02164513|3545502|P2|STARTED|Overall Study||4134
1448525|NCT02164513|3545503|P1|STARTED|Overall Study||4151
1448526|NCT02164396|3545528|P3|NOT COMPLETED|Overall Study||0
1448527|NCT02164396|3545529|P2|NOT COMPLETED|Overall Study||0
1448528|NCT02164396|3545530|P1|NOT COMPLETED|Overall Study||0
1448529|NCT02164396|3545528|P3|COMPLETED|Overall Study||10
1448530|NCT02164396|3545529|P2|COMPLETED|Overall Study||10
1448531|NCT02164396|3545530|P1|COMPLETED|Overall Study||10
1448532|NCT02164396|3545528|P3|STARTED|Overall Study||10
1448533|NCT02164396|3545529|P2|STARTED|Overall Study||10
1448534|NCT02164396|3545530|P1|STARTED|Overall Study||10
1448535|NCT02164318|3545542|P4|NOT COMPLETED|Overall Study||1
1448536|NCT02164318|3545543|P3|NOT COMPLETED|Overall Study||0
1448537|NCT02164318|3545544|P2|NOT COMPLETED|Overall Study||1
1448538|NCT02164318|3545545|P1|NOT COMPLETED|Overall Study||0
1448539|NCT02164318|3545542|P4|COMPLETED|Overall Study||2
1448540|NCT02164318|3545543|P3|COMPLETED|Overall Study||1
1448541|NCT02164318|3545544|P2|COMPLETED|Overall Study||2
1448542|NCT02164318|3545545|P1|COMPLETED|Overall Study||4
1448543|NCT02164318|3545542|P4|STARTED|Overall Study||3
1448544|NCT02164318|3545543|P3|STARTED|Overall Study||1
1448545|NCT02164318|3545544|P2|STARTED|Overall Study||3
1448546|NCT02164318|3545545|P1|STARTED|Overall Study||4
1448547|NCT02163993|3545568|P5|NOT COMPLETED|Post-treatment Period||3
1448548|NCT02163993|3545569|P4|NOT COMPLETED|Post-treatment Period||2
1448549|NCT02163993|3545570|P3|NOT COMPLETED|Post-treatment Period||4
1448550|NCT02163993|3545571|P2|NOT COMPLETED|Post-treatment Period||6
1448551|NCT02163993|3545572|P1|NOT COMPLETED|Post-treatment Period||4
1448552|NCT02163993|3545568|P5|COMPLETED|Post-treatment Period||62
1448553|NCT02163993|3545569|P4|COMPLETED|Post-treatment Period||61
1448554|NCT02163993|3545570|P3|COMPLETED|Post-treatment Period||62
1448555|NCT02163993|3545571|P2|COMPLETED|Post-treatment Period||55
1448556|NCT02163993|3545572|P1|COMPLETED|Post-treatment Period||121
1448557|NCT02163993|3545568|P5|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
1448558|NCT02163993|3545569|P4|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
1448559|NCT02163993|3545570|P3|STARTED|Post-treatment Period||66
1448560|NCT02163993|3545571|P2|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
1448561|NCT02163993|3545572|P1|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
1448562|NCT02163993|3545568|P5|NOT COMPLETED|Treatment Period||7
1448563|NCT02163993|3545569|P4|NOT COMPLETED|Treatment Period||9
1448564|NCT02163993|3545570|P3|NOT COMPLETED|Treatment Period||2
1448565|NCT02163993|3545571|P2|NOT COMPLETED|Treatment Period||9
1448566|NCT02163993|3545572|P1|NOT COMPLETED|Treatment Period||12
1448567|NCT02163993|3545568|P5|COMPLETED|Treatment Period||62
1448568|NCT02163993|3545569|P4|COMPLETED|Treatment Period||62
1448569|NCT02163993|3545570|P3|COMPLETED|Treatment Period||66
1448570|NCT02163993|3545571|P2|COMPLETED|Treatment Period||59
1448571|NCT02163993|3545572|P1|COMPLETED|Treatment Period||126
1448572|NCT02163993|3545568|P5|Received at Least 1 Dose of Study Drug|Treatment Period||67
1448573|NCT02163993|3545569|P4|Received at Least 1 Dose of Study Drug|Treatment Period||70
1448574|NCT02163993|3545570|P3|Received at Least 1 Dose of Study Drug|Treatment Period||68
1448575|NCT02163993|3545571|P2|Received at Least 1 Dose of Study Drug|Treatment Period||68
1448576|NCT02163993|3545572|P1|Received at Least 1 Dose of Study Drug|Treatment Period||137
1448577|NCT02163993|3545568|P5|STARTED|Treatment Period||69
1448578|NCT02163993|3545569|P4|STARTED|Treatment Period||71
1448579|NCT02163993|3545570|P3|STARTED|Treatment Period||68
1448580|NCT02163993|3545571|P2|STARTED|Treatment Period||68
1448581|NCT02163993|3545572|P1|STARTED|Treatment Period||138
1448582|NCT02163915|3545653|P5|NOT COMPLETED|Overall Study||4
1448583|NCT02163915|3545654|P4|NOT COMPLETED|Overall Study||3
1448584|NCT02163915|3545655|P3|NOT COMPLETED|Overall Study||2
1448585|NCT02163915|3545656|P2|NOT COMPLETED|Overall Study||0
1448586|NCT02163915|3545657|P1|NOT COMPLETED|Overall Study||3
1448587|NCT02163915|3545653|P5|COMPLETED|Overall Study||6
1448588|NCT02163915|3545654|P4|COMPLETED|Overall Study||6
1448589|NCT02163915|3545655|P3|COMPLETED|Overall Study||8
1448590|NCT02163915|3545656|P2|COMPLETED|Overall Study||8
1448591|NCT02163915|3545657|P1|COMPLETED|Overall Study||7
1448592|NCT02163915|3545653|P5|STARTED|Overall Study||10
1448593|NCT02163915|3545654|P4|STARTED|Overall Study||9
1448594|NCT02163915|3545655|P3|STARTED|Overall Study||10
1448595|NCT02163915|3545656|P2|STARTED|Overall Study||8
1448596|NCT02163915|3545657|P1|STARTED|Overall Study||10
1448597|NCT02163733|3545712|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
1448598|NCT02163733|3545713|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
1448599|NCT02163733|3545714|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
1448600|NCT02163733|3545712|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
1448601|NCT02163733|3545713|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
1448602|NCT02163733|3545714|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
1448603|NCT02163733|3545712|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
1448604|NCT02163733|3545713|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
1448605|NCT02163733|3545714|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
1448606|NCT02163733|3545712|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
1448607|NCT02163733|3545713|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
1448608|NCT02163733|3545714|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
1448609|NCT02163733|3545712|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
1448610|NCT02163733|3545713|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
1448611|NCT02163733|3545714|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
1448612|NCT02163733|3545712|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
1448613|NCT02163733|3545713|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
1448614|NCT02163733|3545714|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
1448615|NCT02163733|3545712|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
1448616|NCT02163733|3545713|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
1448617|NCT02163733|3545714|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
1448618|NCT02163733|3545712|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
1448619|NCT02163733|3545713|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
1448620|NCT02163733|3545714|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
1448621|NCT02163733|3545712|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
1448622|NCT02163733|3545713|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
1448623|NCT02163733|3545714|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
1448624|NCT02163538|3545751|P2|NOT COMPLETED|Overall Study||1
1448625|NCT02163538|3545752|P1|NOT COMPLETED|Overall Study||1
1448626|NCT02163538|3545751|P2|COMPLETED|Overall Study||70
1448627|NCT02163538|3545752|P1|COMPLETED|Overall Study||70
1448628|NCT02163538|3545751|P2|STARTED|Overall Study||71
1448629|NCT02163538|3545752|P1|STARTED|Overall Study||71
1448630|NCT02163499|3545768|P1|NOT COMPLETED|Extended Dosing Phase: ZS||280
1448631|NCT02163499|3545768|P1|COMPLETED|Extended Dosing Phase: ZS||466
1448632|NCT02163499|3545768|P1|STARTED|Extended Dosing Phase: ZS||746
1448633|NCT02163499|3545768|P1|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
1448634|NCT02163499|3545768|P1|COMPLETED|Acute Phase: ZS 10 g TID||746
1448635|NCT02163499|3545768|P1|STARTED|Acute Phase: ZS 10 g TID||751
1448636|NCT02163486|3545778|P2|NOT COMPLETED|Overall Study||2
1448637|NCT02163486|3545779|P1|NOT COMPLETED|Overall Study||1
1448638|NCT02163486|3545778|P2|COMPLETED|Overall Study||50
1448639|NCT02163486|3545779|P1|COMPLETED|Overall Study||50
1448640|NCT02163486|3545778|P2|STARTED|Overall Study||52
1448641|NCT02163486|3545779|P1|STARTED|Overall Study||51
1448642|NCT02163447|3545796|P3|NOT COMPLETED|Overall Study||3
1448643|NCT02163447|3545797|P2|NOT COMPLETED|Overall Study||6
1448644|NCT02163447|3545798|P1|NOT COMPLETED|Overall Study||6
1448645|NCT02163447|3545796|P3|COMPLETED|Overall Study||97
1448646|NCT02163447|3545797|P2|COMPLETED|Overall Study||88
1448647|NCT02163447|3545798|P1|COMPLETED|Overall Study||100
1448648|NCT02163447|3545796|P3|STARTED|Overall Study||100
1448649|NCT02163447|3545797|P2|STARTED|Overall Study||94
1448650|NCT02163447|3545798|P1|STARTED|Overall Study||106
1448651|NCT02163421|3545828|P4|NOT COMPLETED|Overall Study||0
1448652|NCT02163421|3545829|P3|NOT COMPLETED|Overall Study||0
1448653|NCT02163421|3545830|P2|NOT COMPLETED|Overall Study||0
1448654|NCT02163421|3545831|P1|NOT COMPLETED|Overall Study||0
1448655|NCT02163421|3545828|P4|COMPLETED|Overall Study||12
1448656|NCT02163421|3545829|P3|COMPLETED|Overall Study||12
1448657|NCT02163421|3545830|P2|COMPLETED|Overall Study||12
1448658|NCT02163421|3545831|P1|COMPLETED|Overall Study||12
1448659|NCT02163421|3545828|P4|STARTED|Overall Study||12
1448660|NCT02163421|3545829|P3|STARTED|Overall Study||12
1448661|NCT02163421|3545830|P2|STARTED|Overall Study||12
1448662|NCT02163421|3545831|P1|STARTED|Overall Study||12
1448663|NCT02163395|3545838|P1|NOT COMPLETED|Overall Study||5
1448664|NCT02163395|3545838|P1|COMPLETED|Overall Study||39
1448665|NCT02163395|3545838|P1|STARTED|Overall Study||44
1448666|NCT02163187|3545847|P2|NOT COMPLETED|Overall Study||0
1448667|NCT02163187|3545848|P1|NOT COMPLETED|Overall Study||2
1448668|NCT02163187|3545847|P2|COMPLETED|Overall Study||0
1448669|NCT02163187|3545848|P1|COMPLETED|Overall Study||2
1448670|NCT02163187|3545847|P2|Treatment|Overall Study||0
1448671|NCT02163187|3545848|P1|Treatment|Overall Study||2
1448672|NCT02163187|3545847|P2|STARTED|Overall Study||0
1448673|NCT02163187|3545848|P1|STARTED|Overall Study||4
1448674|NCT02162979|3545858|P2|NOT COMPLETED|Overall Study||0
1448675|NCT02162979|3545859|P1|NOT COMPLETED|Overall Study||0
1448676|NCT02162979|3545858|P2|COMPLETED|Overall Study||0
1448677|NCT02162979|3545859|P1|COMPLETED|Overall Study||0
1448678|NCT02162979|3545858|P2|STARTED|Overall Study||0
1448679|NCT02162979|3545859|P1|STARTED|Overall Study||0
1448680|NCT02162862|3545872|P3|NOT COMPLETED|Overall Study||4
1448681|NCT02162862|3545873|P2|NOT COMPLETED|Overall Study||11
1448682|NCT02162862|3545874|P1|NOT COMPLETED|Overall Study||0
1448683|NCT02162862|3545872|P3|COMPLETED|Overall Study||29
1448684|NCT02162862|3545873|P2|COMPLETED|Overall Study||24
1448685|NCT02162862|3545874|P1|COMPLETED|Overall Study||31
1448686|NCT02162862|3545872|P3|STARTED|Overall Study||33
1448687|NCT02162862|3545873|P2|STARTED|Overall Study||35
1448688|NCT02162862|3545874|P1|STARTED|Overall Study||31
1448689|NCT02162758|3545887|P2|NOT COMPLETED|Overall Study||1
1448690|NCT02162758|3545888|P1|NOT COMPLETED|Overall Study||0
1448691|NCT02162758|3545887|P2|COMPLETED|Overall Study||2
1448692|NCT02162758|3545888|P1|COMPLETED|Overall Study||3
1448693|NCT02162758|3545887|P2|STARTED|Overall Study||3
1448694|NCT02162758|3545888|P1|STARTED|Overall Study||3
1448695|NCT02162680|3545903|P3|NOT COMPLETED|Overall Study||0
1448696|NCT02162680|3545904|P2|NOT COMPLETED|Overall Study||0
1448697|NCT02162680|3545905|P1|NOT COMPLETED|Overall Study||0
1448698|NCT02162680|3545903|P3|COMPLETED|Overall Study||32
1448699|NCT02162680|3545904|P2|COMPLETED|Overall Study||33
1448700|NCT02162680|3545905|P1|COMPLETED|Overall Study||33
1448701|NCT02162680|3545903|P3|STARTED|Overall Study||32
1448702|NCT02162680|3545904|P2|STARTED|Overall Study||33
1448703|NCT02162680|3545905|P1|STARTED|Overall Study||33
1448704|NCT02162576|3545913|P1|NOT COMPLETED|Overall Study||0
1448705|NCT02162576|3545913|P1|COMPLETED|Overall Study||95
1448706|NCT02162576|3545913|P1|STARTED|Overall Study||95
1448707|NCT02161757|3545922|P3|NOT COMPLETED|Treatment Through Study Completion||39
1448708|NCT02161757|3545923|P2|NOT COMPLETED|Treatment Through Study Completion||43
1448709|NCT02161757|3545924|P1|NOT COMPLETED|Treatment Through Study Completion||57
1448710|NCT02161757|3545922|P3|COMPLETED|Treatment Through Study Completion||361
1448711|NCT02161757|3545923|P2|COMPLETED|Treatment Through Study Completion||361
1448712|NCT02161757|3545924|P1|COMPLETED|Treatment Through Study Completion||341
1448713|NCT02161757|3545922|P3|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
1448714|NCT02161757|3545923|P2|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
1448715|NCT02161757|3545924|P1|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
1448716|NCT02161757|3545922|P3|STARTED|Treatment Through Study Completion||400
1448717|NCT02161757|3545923|P2|STARTED|Treatment Through Study Completion||404
1448718|NCT02161757|3545924|P1|STARTED|Treatment Through Study Completion||398
1448719|NCT02161757|3545922|P3|NOT COMPLETED|Randomised Through Start Treatment||0
1448720|NCT02161757|3545923|P2|NOT COMPLETED|Randomised Through Start Treatment||2
1448721|NCT02161757|3545924|P1|NOT COMPLETED|Randomised Through Start Treatment||3
1448722|NCT02161757|3545922|P3|COMPLETED|Randomised Through Start Treatment||400
1448723|NCT02161757|3545923|P2|COMPLETED|Randomised Through Start Treatment||404
1448724|NCT02161757|3545924|P1|COMPLETED|Randomised Through Start Treatment||398
1448725|NCT02161757|3545922|P3|STARTED|Randomised Through Start Treatment||400
1448726|NCT02161757|3545923|P2|STARTED|Randomised Through Start Treatment||406
1448727|NCT02161757|3545924|P1|STARTED|Randomised Through Start Treatment||401
1448728|NCT02161731|3545982|P2|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
1448729|NCT02161731|3545983|P1|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
1448730|NCT02161731|3545982|P2|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
1448731|NCT02161731|3545983|P1|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
1448732|NCT02161731|3545982|P2|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
1448733|NCT02161731|3545983|P1|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
1448734|NCT02161731|3545982|P2|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
1448735|NCT02161731|3545983|P1|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
1448736|NCT02161731|3545982|P2|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
1448737|NCT02161731|3545983|P1|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
1448738|NCT02161731|3545982|P2|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
1448739|NCT02161731|3545983|P1|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
1448740|NCT02161731|3545982|P2|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
1448741|NCT02161731|3545983|P1|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
1448742|NCT02161731|3545982|P2|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
1448743|NCT02161731|3545983|P1|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
1448744|NCT02161562|3546002|P2|NOT COMPLETED|Overall Study||17
1448745|NCT02161562|3546003|P1|NOT COMPLETED|Overall Study||26
1448746|NCT02161562|3546002|P2|COMPLETED|Overall Study||119
1448747|NCT02161562|3546003|P1|COMPLETED|Overall Study||152
1448748|NCT02161562|3546002|P2|STARTED|Overall Study||136
1448749|NCT02161562|3546003|P1|STARTED|Overall Study||178
1448750|NCT02161549|3546031|P2|NOT COMPLETED|Overall Study||2
1448751|NCT02161549|3546032|P1|NOT COMPLETED|Overall Study||6
1448752|NCT02161549|3546031|P2|COMPLETED|Overall Study||29
1448753|NCT02161549|3546032|P1|COMPLETED|Overall Study||34
1448754|NCT02161549|3546031|P2|STARTED|Overall Study||31
1448755|NCT02161549|3546032|P1|STARTED|Overall Study||40
1448756|NCT02161536|3546041|P3|NOT COMPLETED|Overall Study||0
1448757|NCT02161536|3546042|P2|NOT COMPLETED|Overall Study||0
1448758|NCT02161536|3546043|P1|NOT COMPLETED|Overall Study||0
1448759|NCT02161536|3546041|P3|COMPLETED|Overall Study||20
1448760|NCT02161536|3546042|P2|COMPLETED|Overall Study||21
1448761|NCT02161536|3546043|P1|COMPLETED|Overall Study||6
1448762|NCT02161536|3546041|P3|STARTED|Overall Study||20
1448763|NCT02161536|3546042|P2|STARTED|Overall Study||21
1448764|NCT02161536|3546043|P1|STARTED|Overall Study||6
1448765|NCT02161484|3546053|P2|NOT COMPLETED|Overall Study||3
1448766|NCT02161484|3546054|P1|NOT COMPLETED|Overall Study||4
1448767|NCT02161484|3546053|P2|COMPLETED|Overall Study||2
1448768|NCT02161484|3546054|P1|COMPLETED|Overall Study||1
1448769|NCT02161484|3546053|P2|STARTED|Overall Study||5
1448770|NCT02161484|3546054|P1|STARTED|Overall Study||5
1448771|NCT02161146|3546081|P5|NOT COMPLETED|Overall Study||1
1448772|NCT02161146|3546082|P4|NOT COMPLETED|Overall Study||3
1448773|NCT02161146|3546083|P3|NOT COMPLETED|Overall Study||0
1448774|NCT02161146|3546084|P2|NOT COMPLETED|Overall Study||4
1448775|NCT02161146|3546085|P1|NOT COMPLETED|Overall Study||1
1448776|NCT02161146|3546081|P5|COMPLETED|Overall Study||48
1448777|NCT02161146|3546082|P4|COMPLETED|Overall Study||45
1448778|NCT02161146|3546083|P3|COMPLETED|Overall Study||49
1448779|NCT02161146|3546084|P2|COMPLETED|Overall Study||43
1448780|NCT02161146|3546085|P1|COMPLETED|Overall Study||46
1448781|NCT02161146|3546081|P5|STARTED|Overall Study||49
1448782|NCT02161146|3546082|P4|STARTED|Overall Study||48
1448783|NCT02161146|3546083|P3|STARTED|Overall Study||49
1448784|NCT02161146|3546084|P2|STARTED|Overall Study||47
1448785|NCT02161146|3546085|P1|STARTED|Overall Study||47
1448786|NCT02161016|3546098|P1|NOT COMPLETED|Overall Study||1
1448787|NCT02161016|3546098|P1|COMPLETED|Overall Study||0
1448788|NCT02161016|3546098|P1|STARTED|Overall Study||1
1448789|NCT02160990|3546108|P2|NOT COMPLETED|Overall Study||0
1448790|NCT02160990|3546109|P1|NOT COMPLETED|Overall Study||0
1448791|NCT02160990|3546108|P2|COMPLETED|Overall Study||10
1448792|NCT02160990|3546109|P1|COMPLETED|Overall Study||10
1448793|NCT02160990|3546108|P2|STARTED|Overall Study||10
1448794|NCT02160990|3546109|P1|STARTED|Overall Study||10
1448795|NCT02160977|3546129|P2|NOT COMPLETED|Six Months After Surgery||1
1448796|NCT02160977|3546130|P1|NOT COMPLETED|Six Months After Surgery||2
1448797|NCT02160977|3546129|P2|COMPLETED|Six Months After Surgery||42
1448798|NCT02160977|3546130|P1|COMPLETED|Six Months After Surgery||42
1448799|NCT02160977|3546129|P2|STARTED|Six Months After Surgery||43
1448800|NCT02160977|3546130|P1|STARTED|Six Months After Surgery||44
1448801|NCT02160977|3546129|P2|NOT COMPLETED|Three Months After Surgery||2
1448802|NCT02160977|3546130|P1|NOT COMPLETED|Three Months After Surgery||0
1448803|NCT02160977|3546129|P2|COMPLETED|Three Months After Surgery||43
1448804|NCT02160977|3546130|P1|COMPLETED|Three Months After Surgery||44
1448805|NCT02160977|3546129|P2|STARTED|Three Months After Surgery||45
1448806|NCT02160977|3546130|P1|STARTED|Three Months After Surgery||44
1448807|NCT02160977|3546129|P2|NOT COMPLETED|Six Weeks After Surgery||0
1448808|NCT02160977|3546130|P1|NOT COMPLETED|Six Weeks After Surgery||1
1448809|NCT02160977|3546129|P2|COMPLETED|Six Weeks After Surgery||45
1448810|NCT02160977|3546130|P1|COMPLETED|Six Weeks After Surgery||44
1448811|NCT02160977|3546129|P2|STARTED|Six Weeks After Surgery||45
1448812|NCT02160977|3546130|P1|STARTED|Six Weeks After Surgery||45
1448813|NCT02160977|3546129|P2|NOT COMPLETED|One Week After Surgery||0
1448814|NCT02160977|3546130|P1|NOT COMPLETED|One Week After Surgery||0
1448815|NCT02160977|3546129|P2|COMPLETED|One Week After Surgery||45
1448816|NCT02160977|3546130|P1|COMPLETED|One Week After Surgery||45
1448817|NCT02160977|3546129|P2|STARTED|One Week After Surgery||45
1448818|NCT02160977|3546130|P1|STARTED|One Week After Surgery||45
1448819|NCT02160873|3546142|P2|NOT COMPLETED|Overall Study||0
1448820|NCT02160873|3546143|P1|NOT COMPLETED|Overall Study||0
1448821|NCT02160873|3546142|P2|COMPLETED|Overall Study||6
1448822|NCT02160873|3546143|P1|COMPLETED|Overall Study||6
1448823|NCT02160873|3546142|P2|STARTED|Overall Study||6
1448824|NCT02160873|3546143|P1|STARTED|Overall Study||6
1448825|NCT02160847|3546157|P2|NOT COMPLETED|Overall Study||0
1448826|NCT02160847|3546158|P1|NOT COMPLETED|Overall Study||0
1448827|NCT02160847|3546157|P2|COMPLETED|Overall Study||16
1448828|NCT02160847|3546158|P1|COMPLETED|Overall Study||16
1448829|NCT02160847|3546157|P2|STARTED|Overall Study||16
1448830|NCT02160847|3546158|P1|STARTED|Overall Study||16
1448831|NCT02160626|3546169|P3|NOT COMPLETED|Overall Study||1
1448832|NCT02160626|3546170|P2|NOT COMPLETED|Overall Study||1
1448833|NCT02160626|3546171|P1|NOT COMPLETED|Overall Study||1
1448834|NCT02160626|3546169|P3|COMPLETED|Overall Study||56
1448835|NCT02160626|3546170|P2|COMPLETED|Overall Study||56
1448836|NCT02160626|3546171|P1|COMPLETED|Overall Study||57
1448837|NCT02160626|3546169|P3|STARTED|Overall Study||57
1448838|NCT02160626|3546170|P2|STARTED|Overall Study||57
1448839|NCT02160626|3546171|P1|STARTED|Overall Study||58
1448840|NCT02160535|3546185|P1|NOT COMPLETED|Overall Study||3
1448841|NCT02160535|3546185|P1|COMPLETED|Overall Study||10
1448842|NCT02160535|3546185|P1|STARTED|Overall Study||13
1448843|NCT02160314|3546194|P2|NOT COMPLETED|Overall Study||13
1448844|NCT02160314|3546195|P1|NOT COMPLETED|Overall Study||1
1448845|NCT02160314|3546194|P2|COMPLETED|Overall Study||59
1448846|NCT02160314|3546195|P1|COMPLETED|Overall Study||72
1448847|NCT02160314|3546194|P2|STARTED|Overall Study||72
1448848|NCT02160314|3546195|P1|STARTED|Overall Study||73
1448849|NCT02160145|3546203|P3|NOT COMPLETED|Randomized Double-blind Period||28
1448850|NCT02160145|3546204|P2|NOT COMPLETED|Randomized Double-blind Period||29
1448851|NCT02160145|3546205|P1|NOT COMPLETED|Randomized Double-blind Period||0
1448852|NCT02160145|3546203|P3|COMPLETED|Randomized Double-blind Period||659
1448853|NCT02160145|3546204|P2|COMPLETED|Randomized Double-blind Period||654
1448854|NCT02160145|3546205|P1|COMPLETED|Randomized Double-blind Period||0
1448855|NCT02160145|3546203|P3|Off-treatment Completers|Randomized Double-blind Period||22
1448856|NCT02160145|3546204|P2|Off-treatment Completers|Randomized Double-blind Period||76
1448857|NCT02160145|3546205|P1|Off-treatment Completers|Randomized Double-blind Period||0
1448858|NCT02160145|3546203|P3|On-treatment Completers|Randomized Double-blind Period||637
1448859|NCT02160145|3546204|P2|On-treatment Completers|Randomized Double-blind Period||578
1448860|NCT02160145|3546205|P1|On-treatment Completers|Randomized Double-blind Period||0
1448861|NCT02160145|3546203|P3|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
1448862|NCT02160145|3546204|P2|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
1448863|NCT02160145|3546205|P1|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
1448864|NCT02160145|3546203|P3|NOT COMPLETED|Prerandomization Single-blind Period||0
1448865|NCT02160145|3546204|P2|NOT COMPLETED|Prerandomization Single-blind Period||0
1448866|NCT02160145|3546205|P1|NOT COMPLETED|Prerandomization Single-blind Period||149
1448867|NCT02160145|3546203|P3|COMPLETED|Prerandomization Single-blind Period||0
1448868|NCT02160145|3546204|P2|COMPLETED|Prerandomization Single-blind Period||0
1448869|NCT02160145|3546205|P1|COMPLETED|Prerandomization Single-blind Period||1370
1448870|NCT02160145|3546203|P3|Randomized|Prerandomization Single-blind Period||0
1448871|NCT02160145|3546204|P2|Randomized|Prerandomization Single-blind Period||0
1448872|NCT02160145|3546205|P1|Randomized|Prerandomization Single-blind Period||1370
1448873|NCT02160145|3546203|P3|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
1448874|NCT02160145|3546204|P2|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
1448875|NCT02160145|3546205|P1|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
1448876|NCT02160145|3546203|P3|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
1448877|NCT02160145|3546204|P2|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
1448878|NCT02160145|3546205|P1|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
1448879|NCT02160145|3546203|P3|STARTED|Prerandomization Single-blind Period||0
1448880|NCT02160145|3546204|P2|STARTED|Prerandomization Single-blind Period||0
1448881|NCT02160145|3546205|P1|STARTED|Prerandomization Single-blind Period||1519
1448882|NCT02160002|3546220|P2|NOT COMPLETED|Overall Study||1
1448883|NCT02160002|3546221|P1|NOT COMPLETED|Overall Study||2
1448884|NCT02160002|3546220|P2|COMPLETED|Overall Study||178
1448885|NCT02160002|3546221|P1|COMPLETED|Overall Study||185
1448886|NCT02160002|3546220|P2|Primary Outcome|Overall Study||178
1448887|NCT02160002|3546221|P1|Primary Outcome|Overall Study||185
1448888|NCT02160002|3546220|P2|STARTED|Overall Study||179
1448889|NCT02160002|3546221|P1|STARTED|Overall Study||187
1448890|NCT02159950|3546253|P2|NOT COMPLETED|Overall Study||2
1448891|NCT02159950|3546254|P1|NOT COMPLETED|Overall Study||0
1448892|NCT02159950|3546253|P2|COMPLETED|Overall Study||0
1448893|NCT02159950|3546254|P1|COMPLETED|Overall Study||0
1448894|NCT02159950|3546253|P2|STARTED|Overall Study||2
1448895|NCT02159950|3546254|P1|STARTED|Overall Study||0
1448896|NCT02159898|3546288|P2|NOT COMPLETED|Overall Study||0
1448897|NCT02159898|3546289|P1|NOT COMPLETED|Overall Study||1
1448898|NCT02159898|3546288|P2|COMPLETED|Overall Study||30
1448899|NCT02159898|3546289|P1|COMPLETED|Overall Study||29
1448900|NCT02159898|3546288|P2|STARTED|Overall Study||30
1448901|NCT02159898|3546289|P1|STARTED|Overall Study||30
1448902|NCT02159859|3546297|P1|NOT COMPLETED|Overall Study||0
1448903|NCT02159859|3546297|P1|COMPLETED|Overall Study||7
1448904|NCT02159859|3546297|P1|STARTED|Overall Study||7
1448905|NCT02159768|3546310|P1|NOT COMPLETED|Overall Study||0
1448906|NCT02159768|3546310|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
1448907|NCT02159768|3546310|P1|STARTED|Overall Study|Started 16 July 2014|30
1448908|NCT02159547|3546317|P2|NOT COMPLETED|Overall Study||0
1448909|NCT02159547|3546318|P1|NOT COMPLETED|Overall Study||0
1448910|NCT02159547|3546317|P2|COMPLETED|Overall Study||112
1448911|NCT02159547|3546318|P1|COMPLETED|Overall Study||112
1448912|NCT02159547|3546317|P2|STARTED|Overall Study||112
1448913|NCT02159547|3546318|P1|STARTED|Overall Study||112
1448914|NCT02159482|3546326|P1|NOT COMPLETED|Overall Study||5
1448915|NCT02159482|3546326|P1|COMPLETED|Overall Study||6
1448916|NCT02159482|3546326|P1|STARTED|Overall Study||11
1448917|NCT02159469|3546331|P1|NOT COMPLETED|Overall Study||53
1448918|NCT02159469|3546331|P1|COMPLETED|Overall Study||97
1448919|NCT02159469|3546331|P1|Completed 12 Week|Overall Study||137
1448920|NCT02159469|3546331|P1|STARTED|Overall Study||150
1448921|NCT02159365|3546336|P1|NOT COMPLETED|Overall Study||22
1448922|NCT02159365|3546336|P1|COMPLETED|Overall Study|Completed = Still on Treatment|48
1448923|NCT02159365|3546336|P1|STARTED|Overall Study||70
1448924|NCT02159352|3546342|P2|NOT COMPLETED|Overall Study||2
1448925|NCT02159352|3546343|P1|NOT COMPLETED|Overall Study||3
1448926|NCT02159352|3546342|P2|COMPLETED|Overall Study||12
1448927|NCT02159352|3546343|P1|COMPLETED|Overall Study||11
1448928|NCT02159352|3546342|P2|Phase 2 (Day 5-14)|Overall Study||12
1448929|NCT02159352|3546343|P1|Phase 2 (Day 5-14)|Overall Study||11
1448930|NCT02159352|3546342|P2|Phase 1 (Day 1- 4)|Overall Study||14
1448931|NCT02159352|3546343|P1|Phase 1 (Day 1- 4)|Overall Study||14
1448932|NCT02159352|3546342|P2|STARTED|Overall Study||14
1448933|NCT02159352|3546343|P1|STARTED|Overall Study||14
1448934|NCT02159118|3546395|P2|NOT COMPLETED|Overall Study||0
1448935|NCT02159118|3546396|P1|NOT COMPLETED|Overall Study||0
1448936|NCT02159118|3546395|P2|COMPLETED|Overall Study||22
1448937|NCT02159118|3546396|P1|COMPLETED|Overall Study||22
1448938|NCT02159118|3546395|P2|STARTED|Overall Study||22
1448939|NCT02159118|3546396|P1|STARTED|Overall Study||22
1448940|NCT02159040|3546418|P1|NOT COMPLETED|Overall Study||1
1448941|NCT02159040|3546418|P1|COMPLETED|Overall Study||0
1448942|NCT02159040|3546418|P1|STARTED|Overall Study||1
1448943|NCT02158975|3546431|P1|NOT COMPLETED|Overall Study||1
1448944|NCT02158975|3546431|P1|COMPLETED|Overall Study||12
1448945|NCT02158975|3546431|P1|STARTED|Overall Study||13
1448946|NCT02158936|3546441|P2|NOT COMPLETED|Overall Study||177
1448947|NCT02158936|3546442|P1|NOT COMPLETED|Overall Study||179
1448948|NCT02158936|3546441|P2|COMPLETED|Overall Study||0
1448949|NCT02158936|3546442|P1|COMPLETED|Overall Study||0
1448950|NCT02158936|3546441|P2|Untreated|Overall Study||0
1448951|NCT02158936|3546442|P1|Untreated|Overall Study||2
1448952|NCT02158936|3546441|P2|Treated|Overall Study||177
1448953|NCT02158936|3546442|P1|Treated|Overall Study||177
1448954|NCT02158936|3546441|P2|STARTED|Overall Study||177
1448955|NCT02158936|3546442|P1|STARTED|Overall Study||179
1448956|NCT02158728|3546484|P1|NOT COMPLETED|Overall Study||27
1448957|NCT02158728|3546484|P1|COMPLETED|Overall Study||53
1448958|NCT02158728|3546484|P1|STARTED|Overall Study||80
1448959|NCT02158572|3546488|P1|NOT COMPLETED|Overall Study||1043
1448960|NCT02158572|3546488|P1|COMPLETED|Overall Study||989
1448961|NCT02158572|3546488|P1|STARTED|Overall Study||2032
1448962|NCT02158442|3546501|P2|NOT COMPLETED|Overall Study||0
1448963|NCT02158442|3546502|P1|NOT COMPLETED|Overall Study||2
1448964|NCT02158442|3546501|P2|COMPLETED|Overall Study||7
1448965|NCT02158442|3546502|P1|COMPLETED|Overall Study||6
1448966|NCT02158442|3546501|P2|STARTED|Overall Study||7
1448967|NCT02158442|3546502|P1|STARTED|Overall Study||8
1448968|NCT02158364|3546508|P1|NOT COMPLETED|Overall Study||60
1448969|NCT02158364|3546508|P1|COMPLETED|Overall Study||3271
1448970|NCT02158364|3546508|P1|STARTED|Overall Study||3331
1448971|NCT02158273|3546515|P2|NOT COMPLETED|Overall Study||3
1448972|NCT02158273|3546516|P1|NOT COMPLETED|Overall Study||3
1448973|NCT02158273|3546515|P2|COMPLETED|Overall Study||22
1448974|NCT02158273|3546516|P1|COMPLETED|Overall Study||22
1448975|NCT02158273|3546515|P2|STARTED|Overall Study||25
1448976|NCT02158273|3546516|P1|STARTED|Overall Study||25
1448977|NCT02158247|3546526|P1|NOT COMPLETED|Overall Study||5
1448978|NCT02158247|3546526|P1|COMPLETED|Overall Study||176
1448979|NCT02158247|3546526|P1|STARTED|Overall Study||181
1448980|NCT02158091|3546545|P3|NOT COMPLETED|Overall Study||0
1448981|NCT02158091|3546546|P2|NOT COMPLETED|Overall Study||1
1448982|NCT02158091|3546547|P1|NOT COMPLETED|Overall Study||2
1448983|NCT02158091|3546545|P3|COMPLETED|Overall Study||20
1448984|NCT02158091|3546546|P2|COMPLETED|Overall Study||5
1448985|NCT02158091|3546547|P1|COMPLETED|Overall Study||4
1448986|NCT02158091|3546545|P3|STARTED|Overall Study||20
1448987|NCT02158091|3546546|P2|STARTED|Overall Study||6
1448988|NCT02158091|3546547|P1|STARTED|Overall Study||6
1448989|NCT02158039|3546555|P1|NOT COMPLETED|Overall Study||10
1448990|NCT02158039|3546555|P1|COMPLETED|Overall Study||23
1448991|NCT02158039|3546555|P1|STARTED|Overall Study||33
1448992|NCT02157948|3546562|P2|NOT COMPLETED|Overall Study||9
1448993|NCT02157948|3546563|P1|NOT COMPLETED|Overall Study||9
1448994|NCT02157948|3546562|P2|COMPLETED|Overall Study||188
1448995|NCT02157948|3546563|P1|COMPLETED|Overall Study||188
1448996|NCT02157948|3546562|P2|Received Treatment|Overall Study||196
1448997|NCT02157948|3546563|P1|Received Treatment|Overall Study||196
1448998|NCT02157948|3546562|P2|STARTED|Overall Study||197
1448999|NCT02157948|3546563|P1|STARTED|Overall Study||197
1449000|NCT02157935|3546575|P2|NOT COMPLETED|Overall Study||65
1449001|NCT02157935|3546576|P1|NOT COMPLETED|Overall Study||39
1449002|NCT02157935|3546575|P2|COMPLETED|Overall Study||548
1449003|NCT02157935|3546576|P1|COMPLETED|Overall Study||567
1449004|NCT02157935|3546575|P2|STARTED|Overall Study||613
1449005|NCT02157935|3546576|P1|STARTED|Overall Study||606
1449006|NCT02157909|3546594|P2|NOT COMPLETED|Overall Study||0
1449007|NCT02157909|3546595|P1|NOT COMPLETED|Overall Study||0
1449008|NCT02157909|3546594|P2|COMPLETED|Overall Study||66
1449009|NCT02157909|3546595|P1|COMPLETED|Overall Study||66
1449010|NCT02157909|3546594|P2|STARTED|Overall Study||66
1449011|NCT02157909|3546595|P1|STARTED|Overall Study||66
1449012|NCT02157883|3546602|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
1449013|NCT02157883|3546602|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
1449014|NCT02157883|3546602|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
1449015|NCT02157883|3546602|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
1449016|NCT02157883|3546602|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
1449017|NCT02157883|3546602|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
1449018|NCT02157883|3546602|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
1449019|NCT02157883|3546602|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
1449020|NCT02157883|3546602|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
1449021|NCT02157623|3546633|P2|NOT COMPLETED|Overall Study||3
1449022|NCT02157623|3546634|P1|NOT COMPLETED|Overall Study||4
1449023|NCT02157623|3546633|P2|COMPLETED|Overall Study||0
1449024|NCT02157623|3546634|P1|COMPLETED|Overall Study||0
1449025|NCT02157623|3546633|P2|STARTED|Overall Study||3
1449026|NCT02157623|3546634|P1|STARTED|Overall Study||4
1449027|NCT02157519|3546642|P2|NOT COMPLETED|Overall Study||1
1449028|NCT02157519|3546643|P1|NOT COMPLETED|Overall Study||11
1449029|NCT02157519|3546642|P2|COMPLETED|Overall Study||89
1449030|NCT02157519|3546643|P1|COMPLETED|Overall Study||80
1449031|NCT02157519|3546642|P2|MEMScap Collected|Overall Study||86
1449032|NCT02157519|3546643|P1|MEMScap Collected|Overall Study||84
1449033|NCT02157519|3546642|P2|STARTED|Overall Study||90
1449034|NCT02157519|3546643|P1|STARTED|Overall Study||91
1449035|NCT02157376|3546663|P2|NOT COMPLETED|Overall Study||18
1449036|NCT02157376|3546664|P1|NOT COMPLETED|Overall Study||22
1449037|NCT02157376|3546663|P2|COMPLETED|Overall Study||138
1449038|NCT02157376|3546664|P1|COMPLETED|Overall Study||133
1449039|NCT02157376|3546663|P2|STARTED|Overall Study||156
1449040|NCT02157376|3546664|P1|STARTED|Overall Study||155
1449041|NCT02157298|3546674|P2|NOT COMPLETED|Overall Study||2
1449042|NCT02157298|3546675|P1|NOT COMPLETED|Overall Study||4
1449043|NCT02157298|3546674|P2|COMPLETED|Overall Study||58
1449044|NCT02157298|3546675|P1|COMPLETED|Overall Study||119
1449045|NCT02157298|3546674|P2|STARTED|Overall Study||60
1449046|NCT02157298|3546675|P1|STARTED|Overall Study||123
1449047|NCT02157168|3546692|P3|NOT COMPLETED|Overall Study||0
1449048|NCT02157168|3546693|P2|NOT COMPLETED|Overall Study||0
1449049|NCT02157168|3546694|P1|NOT COMPLETED|Overall Study||0
1449050|NCT02157168|3546692|P3|COMPLETED|Overall Study||1362
1449051|NCT02157168|3546693|P2|COMPLETED|Overall Study||159
1449052|NCT02157168|3546694|P1|COMPLETED|Overall Study||746
1449053|NCT02157168|3546692|P3|STARTED|Overall Study||1362
1449054|NCT02157168|3546693|P2|STARTED|Overall Study||159
1449055|NCT02157168|3546694|P1|STARTED|Overall Study||746
1449056|NCT02157116|3546714|P1|NOT COMPLETED|Overall Study||9
1449057|NCT02157116|3546714|P1|COMPLETED|Overall Study||4
1449058|NCT02157116|3546714|P1|STARTED|Overall Study|signed consent form|13
1449059|NCT02157103|3546723|P1|NOT COMPLETED|Overall Study||0
1449060|NCT02157103|3546723|P1|COMPLETED|Overall Study||3
1449061|NCT02157103|3546723|P1|STARTED|Overall Study||3
1449062|NCT02156492|3546732|P3|NOT COMPLETED|Period 3||0
1449063|NCT02156492|3546733|P2|NOT COMPLETED|Period 3||1
1449064|NCT02156492|3546734|P1|NOT COMPLETED|Period 3||0
1449065|NCT02156492|3546732|P3|COMPLETED|Period 3||22
1449066|NCT02156492|3546733|P2|COMPLETED|Period 3||22
1449067|NCT02156492|3546734|P1|COMPLETED|Period 3||0
1449068|NCT02156492|3546732|P3|STARTED|Period 3||22
1449069|NCT02156492|3546733|P2|STARTED|Period 3||23
1449070|NCT02156492|3546734|P1|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
1449071|NCT02156492|3546732|P3|NOT COMPLETED|Period 2||0
1449072|NCT02156492|3546733|P2|NOT COMPLETED|Period 2||0
1449073|NCT02156492|3546734|P1|NOT COMPLETED|Period 2||0
1449074|NCT02156492|3546732|P3|COMPLETED|Period 2||22
1449075|NCT02156492|3546733|P2|COMPLETED|Period 2||23
1449076|NCT02156492|3546734|P1|COMPLETED|Period 2||16
1449077|NCT02156492|3546732|P3|STARTED|Period 2||22
1449078|NCT02156492|3546733|P2|STARTED|Period 2||23
1449079|NCT02156492|3546734|P1|STARTED|Period 2||16
1449080|NCT02156492|3546732|P3|NOT COMPLETED|Period 1||0
1449081|NCT02156492|3546733|P2|NOT COMPLETED|Period 1||1
1449082|NCT02156492|3546734|P1|NOT COMPLETED|Period 1||0
1449083|NCT02156492|3546732|P3|COMPLETED|Period 1||22
1449084|NCT02156492|3546733|P2|COMPLETED|Period 1||23
1449085|NCT02156492|3546734|P1|COMPLETED|Period 1||16
1449086|NCT02156492|3546732|P3|Received at Least One Dose of Study Drug|Period 1||22
1449087|NCT02156492|3546733|P2|Received at Least One Dose of Study Drug|Period 1||24
1449088|NCT02156492|3546734|P1|Received at Least One Dose of Study Drug|Period 1||16
1449089|NCT02156492|3546732|P3|STARTED|Period 1||22
1449090|NCT02156492|3546733|P2|STARTED|Period 1||24
1449091|NCT02156492|3546734|P1|STARTED|Period 1||16
1449092|NCT02156466|3546760|P5|NOT COMPLETED|Overall Study||0
1449093|NCT02156466|3546761|P4|NOT COMPLETED|Overall Study||2
1449094|NCT02156466|3546762|P3|NOT COMPLETED|Overall Study||1
1449095|NCT02156466|3546763|P2|NOT COMPLETED|Overall Study||0
1449096|NCT02156466|3546764|P1|NOT COMPLETED|Overall Study||0
1449097|NCT02156466|3546760|P5|COMPLETED|Overall Study||8
1449098|NCT02156466|3546761|P4|COMPLETED|Overall Study||7
1449099|NCT02156466|3546762|P3|COMPLETED|Overall Study||7
1449100|NCT02156466|3546763|P2|COMPLETED|Overall Study||8
1449101|NCT02156466|3546764|P1|COMPLETED|Overall Study||8
1449102|NCT02156466|3546760|P5|STARTED|Overall Study||8
1449103|NCT02156466|3546761|P4|STARTED|Overall Study||9
1449104|NCT02156466|3546762|P3|STARTED|Overall Study||8
1449105|NCT02156466|3546763|P2|STARTED|Overall Study||8
1449106|NCT02156466|3546764|P1|STARTED|Overall Study||8
1449107|NCT02156271|3546945|P2|NOT COMPLETED|Overall Study||3
1449108|NCT02156271|3546946|P1|NOT COMPLETED|Overall Study||4
1449109|NCT02156271|3546945|P2|COMPLETED|Overall Study||10
1449110|NCT02156271|3546946|P1|COMPLETED|Overall Study||22
1449111|NCT02156271|3546945|P2|STARTED|Overall Study||13
1449112|NCT02156271|3546946|P1|STARTED|Overall Study||26
1449113|NCT02156167|3546978|P1|NOT COMPLETED|Overall Study||0
1449114|NCT02156167|3546978|P1|COMPLETED|Overall Study||15
1449115|NCT02156167|3546978|P1|STARTED|Overall Study||15
1449116|NCT02155985|3546985|P3|NOT COMPLETED|Overall Study||1
1449117|NCT02155985|3546986|P2|NOT COMPLETED|Overall Study||0
1449118|NCT02155985|3546987|P1|NOT COMPLETED|Overall Study||1
1449119|NCT02155985|3546985|P3|COMPLETED|Overall Study||39
1449120|NCT02155985|3546986|P2|COMPLETED|Overall Study||41
1449121|NCT02155985|3546987|P1|COMPLETED|Overall Study||39
1449122|NCT02155985|3546985|P3|STARTED|Overall Study||40
1449123|NCT02155985|3546986|P2|STARTED|Overall Study||41
1449124|NCT02155985|3546987|P1|STARTED|Overall Study||40
1449125|NCT02155881|3547054|P2|NOT COMPLETED|Overall Study||4
1449126|NCT02155881|3547055|P1|NOT COMPLETED|Overall Study||2
1449127|NCT02155881|3547054|P2|COMPLETED|Overall Study||36
1449128|NCT02155881|3547055|P1|COMPLETED|Overall Study||38
1449129|NCT02155881|3547054|P2|STARTED|Overall Study||40
1449130|NCT02155881|3547055|P1|STARTED|Overall Study||40
1449131|NCT02155738|3547079|P4|NOT COMPLETED|Overall Study||1
1449132|NCT02155738|3547080|P3|NOT COMPLETED|Overall Study||0
1449133|NCT02155738|3547081|P2|NOT COMPLETED|Overall Study||0
1449134|NCT02155738|3547082|P1|NOT COMPLETED|Overall Study||1
1449135|NCT02155738|3547079|P4|COMPLETED|Overall Study||50
1449136|NCT02155738|3547080|P3|COMPLETED|Overall Study||51
1449137|NCT02155738|3547081|P2|COMPLETED|Overall Study||52
1449138|NCT02155738|3547082|P1|COMPLETED|Overall Study||49
1449139|NCT02155738|3547079|P4|STARTED|Overall Study||51
1449140|NCT02155738|3547080|P3|STARTED|Overall Study||51
1449141|NCT02155738|3547081|P2|STARTED|Overall Study||52
1449142|NCT02155738|3547082|P1|STARTED|Overall Study||50
1449143|NCT02155543|3547107|P7|NOT COMPLETED|Overall Study||0
1449144|NCT02155543|3547108|P6|NOT COMPLETED|Overall Study||0
1449145|NCT02155543|3547109|P5|NOT COMPLETED|Overall Study||0
1449146|NCT02155543|3547110|P4|NOT COMPLETED|Overall Study||0
1449147|NCT02155543|3547111|P3|NOT COMPLETED|Overall Study||0
1449148|NCT02155543|3547112|P2|NOT COMPLETED|Overall Study||0
1449149|NCT02155543|3547113|P1|NOT COMPLETED|Overall Study||0
1449150|NCT02155543|3547107|P7|COMPLETED|Overall Study||9
1449151|NCT02155543|3547108|P6|COMPLETED|Overall Study||3
1449152|NCT02155543|3547109|P5|COMPLETED|Overall Study||3
1449153|NCT02155543|3547110|P4|COMPLETED|Overall Study||9
1449154|NCT02155543|3547111|P3|COMPLETED|Overall Study||9
1449155|NCT02155543|3547112|P2|COMPLETED|Overall Study||9
1449156|NCT02155543|3547113|P1|COMPLETED|Overall Study||9
1449157|NCT02155543|3547107|P7|STARTED|Overall Study||9
1449158|NCT02155543|3547108|P6|STARTED|Overall Study||3
1449159|NCT02155543|3547109|P5|STARTED|Overall Study||3
1449160|NCT02155543|3547110|P4|STARTED|Overall Study||9
1449161|NCT02155543|3547111|P3|STARTED|Overall Study||9
1449162|NCT02155543|3547112|P2|STARTED|Overall Study||9
1449163|NCT02155543|3547113|P1|STARTED|Overall Study||9
1449164|NCT02155335|3547126|P2|NOT COMPLETED|Period 2||0
1449165|NCT02155335|3547127|P1|NOT COMPLETED|Period 2||0
1449166|NCT02155335|3547126|P2|COMPLETED|Period 2||49
1449167|NCT02155335|3547127|P1|COMPLETED|Period 2||50
1449168|NCT02155335|3547126|P2|STARTED|Period 2||49
1449169|NCT02155335|3547127|P1|STARTED|Period 2||50
1449170|NCT02155335|3547126|P2|NOT COMPLETED|Period 1||1
1449171|NCT02155335|3547127|P1|NOT COMPLETED|Period 1||0
1449172|NCT02155335|3547126|P2|COMPLETED|Period 1||49
1449173|NCT02155335|3547127|P1|COMPLETED|Period 1||50
1449174|NCT02155335|3547126|P2|Treated|Period 1||49
1449175|NCT02155335|3547127|P1|Treated|Period 1||50
1449176|NCT02155335|3547126|P2|STARTED|Period 1||50
1449177|NCT02155335|3547127|P1|STARTED|Period 1||50
1449178|NCT02155322|3547132|P1|NOT COMPLETED|Overall Study||14
1449179|NCT02155322|3547132|P1|COMPLETED|Overall Study||19
1449180|NCT02155322|3547132|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
1449181|NCT02155322|3547132|P1|STARTED|Overall Study||33
1449182|NCT02155309|3547139|P3|NOT COMPLETED|Overall Study||1
1449183|NCT02155309|3547140|P2|NOT COMPLETED|Overall Study||0
1449184|NCT02155309|3547141|P1|NOT COMPLETED|Overall Study||0
1449185|NCT02155309|3547139|P3|COMPLETED|Overall Study||12
1449186|NCT02155309|3547140|P2|COMPLETED|Overall Study||10
1449187|NCT02155309|3547141|P1|COMPLETED|Overall Study||13
1449188|NCT02155309|3547139|P3|STARTED|Overall Study||13
1449189|NCT02155309|3547140|P2|STARTED|Overall Study||10
1449190|NCT02155309|3547141|P1|STARTED|Overall Study||13
1449191|NCT02155283|3547148|P1|NOT COMPLETED|Overall Study||7
1449192|NCT02155283|3547148|P1|COMPLETED|Overall Study||9
1449193|NCT02155283|3547148|P1|STARTED|Overall Study||16
1449194|NCT02155010|3547155|P2|NOT COMPLETED|Overall Study||6
1449195|NCT02155010|3547156|P1|NOT COMPLETED|Overall Study||6
1449196|NCT02155010|3547155|P2|COMPLETED|Overall Study||31
1449197|NCT02155010|3547156|P1|COMPLETED|Overall Study||31
1449198|NCT02155010|3547155|P2|STARTED|Overall Study||37
1449199|NCT02155010|3547156|P1|STARTED|Overall Study||37
1449200|NCT02154906|3547166|P2|NOT COMPLETED|Overall Study||3
1449201|NCT02154906|3547167|P1|NOT COMPLETED|Overall Study||2
1449202|NCT02154906|3547166|P2|COMPLETED|Overall Study||17
1449203|NCT02154906|3547167|P1|COMPLETED|Overall Study||19
1449204|NCT02154906|3547166|P2|STARTED|Overall Study||20
1449205|NCT02154906|3547167|P1|STARTED|Overall Study||21
1449206|NCT02154425|3547175|P1|NOT COMPLETED|Sampling Period||0
1449207|NCT02154425|3547175|P1|COMPLETED|Sampling Period||17
1449208|NCT02154425|3547175|P1|STARTED|Sampling Period||17
1449209|NCT02154425|3547175|P1|NOT COMPLETED|Screening Period||1
1449210|NCT02154425|3547175|P1|COMPLETED|Screening Period||17
1449211|NCT02154425|3547175|P1|STARTED|Screening Period||18
1449212|NCT02154386|3547207|P2|NOT COMPLETED|Overall Study||2
1449213|NCT02154386|3547208|P1|NOT COMPLETED|Overall Study||1
1449214|NCT02154386|3547207|P2|COMPLETED|Overall Study||21
1449215|NCT02154386|3547208|P1|COMPLETED|Overall Study||22
1449216|NCT02154386|3547207|P2|STARTED|Overall Study||23
1449217|NCT02154386|3547208|P1|STARTED|Overall Study||23
1449218|NCT02154243|3547221|P3|NOT COMPLETED|Overall Study||0
1449219|NCT02154243|3547222|P2|NOT COMPLETED|Overall Study||0
1449220|NCT02154243|3547223|P1|NOT COMPLETED|Overall Study||0
1449221|NCT02154243|3547221|P3|COMPLETED|Overall Study||4
1449222|NCT02154243|3547222|P2|COMPLETED|Overall Study||4
1449223|NCT02154243|3547223|P1|COMPLETED|Overall Study||5
1449224|NCT02154243|3547221|P3|STARTED|Overall Study||4
1449225|NCT02154243|3547222|P2|STARTED|Overall Study||4
1449226|NCT02154243|3547223|P1|STARTED|Overall Study||5
1449227|NCT02154139|3547234|P1|NOT COMPLETED|Overall Study||7
1449228|NCT02154139|3547234|P1|COMPLETED|Overall Study||644
1449229|NCT02154139|3547234|P1|STARTED|Overall Study||651
1449230|NCT02154087|3547242|P1|NOT COMPLETED|Overall Study||1
1449231|NCT02154087|3547242|P1|COMPLETED|Overall Study||0
1449232|NCT02154087|3547242|P1|STARTED|Overall Study||1
1449233|NCT02154061|3547248|P2|NOT COMPLETED|Overall Study||0
1449234|NCT02154061|3547249|P1|NOT COMPLETED|Overall Study||2
1449235|NCT02154061|3547248|P2|COMPLETED|Overall Study||17
1449236|NCT02154061|3547249|P1|COMPLETED|Overall Study||14
1449237|NCT02154061|3547248|P2|STARTED|Overall Study||17
1449238|NCT02154061|3547249|P1|STARTED|Overall Study||16
1449239|NCT02154048|3547258|P3|NOT COMPLETED|Overall Study||0
1449240|NCT02154048|3547259|P2|NOT COMPLETED|Overall Study||0
1449241|NCT02154048|3547260|P1|NOT COMPLETED|Overall Study||0
1449242|NCT02154048|3547258|P3|COMPLETED|Overall Study||1
1449243|NCT02154048|3547259|P2|COMPLETED|Overall Study||2
1449244|NCT02154048|3547260|P1|COMPLETED|Overall Study||2
1449245|NCT02154048|3547258|P3|STARTED|Overall Study||1
1449246|NCT02154048|3547259|P2|STARTED|Overall Study||2
1449247|NCT02154048|3547260|P1|STARTED|Overall Study||2
1449248|NCT02153918|3547268|P1|NOT COMPLETED|Overall Study||1
1449249|NCT02153918|3547268|P1|COMPLETED|Overall Study||26
1449250|NCT02153918|3547268|P1|STARTED|Overall Study||27
1449251|NCT02153827|3547279|P2|NOT COMPLETED|Overall Study||9
1449252|NCT02153827|3547280|P1|NOT COMPLETED|Overall Study||3
1449253|NCT02153827|3547279|P2|COMPLETED|Overall Study||14
1449254|NCT02153827|3547280|P1|COMPLETED|Overall Study||22
1449255|NCT02153827|3547279|P2|STARTED|Overall Study||23
1449256|NCT02153827|3547280|P1|STARTED|Overall Study||25
1449257|NCT02153788|3547296|P2|NOT COMPLETED|Overall Study||1
1449258|NCT02153788|3547297|P1|NOT COMPLETED|Overall Study||2
1449259|NCT02153788|3547296|P2|COMPLETED|Overall Study||18
1449260|NCT02153788|3547297|P1|COMPLETED|Overall Study||23
1449261|NCT02153788|3547296|P2|STARTED|Overall Study||19
1449262|NCT02153788|3547297|P1|STARTED|Overall Study||25
1449263|NCT02153736|3547317|P2|NOT COMPLETED|Overall Study||2
1449264|NCT02153736|3547318|P1|NOT COMPLETED|Overall Study||2
1449265|NCT02153736|3547317|P2|COMPLETED|Overall Study||5
1449266|NCT02153736|3547318|P1|COMPLETED|Overall Study||5
1449267|NCT02153736|3547317|P2|STARTED|Overall Study||7
1449268|NCT02153736|3547318|P1|STARTED|Overall Study||7
1449269|NCT02153723|3547334|P1|NOT COMPLETED|Overall Study||0
1449270|NCT02153723|3547334|P1|COMPLETED|Overall Study||10
1449271|NCT02153723|3547334|P1|STARTED|Overall Study||10
1449272|NCT02153489|3547343|P2|NOT COMPLETED|Period 2||0
1449273|NCT02153489|3547344|P1|NOT COMPLETED|Period 2||0
1449274|NCT02153489|3547343|P2|COMPLETED|Period 2||15
1449275|NCT02153489|3547344|P1|COMPLETED|Period 2||15
1449276|NCT02153489|3547343|P2|STARTED|Period 2||15
1449277|NCT02153489|3547344|P1|STARTED|Period 2||15
1449278|NCT02153489|3547343|P2|NOT COMPLETED|Period 1||0
1449279|NCT02153489|3547344|P1|NOT COMPLETED|Period 1||0
1449280|NCT02153489|3547343|P2|COMPLETED|Period 1||15
1449281|NCT02153489|3547344|P1|COMPLETED|Period 1||15
1449282|NCT02153489|3547343|P2|STARTED|Period 1||15
1449283|NCT02153489|3547344|P1|STARTED|Period 1||15
1449284|NCT02153476|3547384|P2|NOT COMPLETED|Overall Study||0
1449285|NCT02153476|3547385|P1|NOT COMPLETED|Overall Study||1
1449286|NCT02153476|3547384|P2|COMPLETED|Overall Study||22
1449287|NCT02153476|3547385|P1|COMPLETED|Overall Study||22
1449288|NCT02153476|3547384|P2|STARTED|Overall Study||22
1449289|NCT02153476|3547385|P1|STARTED|Overall Study||23
1449290|NCT02153398|3547396|P5|NOT COMPLETED|Overall Study||0
1449291|NCT02153398|3547397|P4|NOT COMPLETED|Overall Study||1
1449292|NCT02153398|3547398|P3|NOT COMPLETED|Overall Study||1
1449293|NCT02153398|3547399|P2|NOT COMPLETED|Overall Study||0
1449294|NCT02153398|3547400|P1|NOT COMPLETED|Overall Study||1
1449295|NCT02153398|3547396|P5|COMPLETED|Overall Study||10
1449296|NCT02153398|3547397|P4|COMPLETED|Overall Study||9
1449297|NCT02153398|3547398|P3|COMPLETED|Overall Study||9
1449298|NCT02153398|3547399|P2|COMPLETED|Overall Study||10
1449299|NCT02153398|3547400|P1|COMPLETED|Overall Study||9
1449300|NCT02153398|3547396|P5|STARTED|Overall Study||10
1449301|NCT02153398|3547397|P4|STARTED|Overall Study||10
1449302|NCT02153398|3547398|P3|STARTED|Overall Study||10
1449303|NCT02153398|3547399|P2|STARTED|Overall Study||10
1449304|NCT02153398|3547400|P1|STARTED|Overall Study||10
1449305|NCT02153346|3547522|P1|NOT COMPLETED|Overall Study||11
1449306|NCT02153346|3547522|P1|COMPLETED|Overall Study||90
1449307|NCT02153346|3547522|P1|STARTED|Overall Study||101
1449308|NCT02153099|3547536|P7|NOT COMPLETED|Overall Study||0
1449309|NCT02153099|3547537|P6|NOT COMPLETED|Overall Study||0
1449310|NCT02153099|3547538|P5|NOT COMPLETED|Overall Study||0
1449311|NCT02153099|3547539|P4|NOT COMPLETED|Overall Study||0
1449312|NCT02153099|3547540|P3|NOT COMPLETED|Overall Study||0
1449313|NCT02153099|3547541|P2|NOT COMPLETED|Overall Study||0
1449314|NCT02153099|3547542|P1|NOT COMPLETED|Overall Study||0
1449315|NCT02153099|3547536|P7|COMPLETED|Overall Study||12
1449316|NCT02153099|3547537|P6|COMPLETED|Overall Study||6
1449317|NCT02153099|3547538|P5|COMPLETED|Overall Study||6
1449318|NCT02153099|3547539|P4|COMPLETED|Overall Study||6
1449319|NCT02153099|3547540|P3|COMPLETED|Overall Study||6
1449320|NCT02153099|3547541|P2|COMPLETED|Overall Study||6
1449321|NCT02153099|3547542|P1|COMPLETED|Overall Study||6
1449322|NCT02153099|3547536|P7|STARTED|Overall Study||12
1449323|NCT02153099|3547537|P6|STARTED|Overall Study||6
1449324|NCT02153099|3547538|P5|STARTED|Overall Study||6
1449325|NCT02153099|3547539|P4|STARTED|Overall Study||6
1449326|NCT02153099|3547540|P3|STARTED|Overall Study||6
1449327|NCT02153099|3547541|P2|STARTED|Overall Study||6
1449328|NCT02153099|3547542|P1|STARTED|Overall Study||6
1449329|NCT02153086|3547596|P1|NOT COMPLETED|Overall Study||4
1449330|NCT02153086|3547596|P1|COMPLETED|Overall Study||232
1449331|NCT02153086|3547596|P1|STARTED|Overall Study||236
1449332|NCT02152631|3547612|P2|NOT COMPLETED|Overall Study||26
1449333|NCT02152631|3547613|P1|NOT COMPLETED|Overall Study||66
1449334|NCT02152631|3547612|P2|COMPLETED|Overall Study||157
1449335|NCT02152631|3547613|P1|COMPLETED|Overall Study||204
1449336|NCT02152631|3547612|P2|Progressive Disease|Overall Study||137
1449337|NCT02152631|3547613|P1|Progressive Disease|Overall Study||174
1449338|NCT02152631|3547612|P2|Death Due to Any Cause|Overall Study||20
1449339|NCT02152631|3547613|P1|Death Due to Any Cause|Overall Study||30
1449340|NCT02152631|3547612|P2|Off Treatment|Overall Study||172
1449341|NCT02152631|3547613|P1|Off Treatment|Overall Study||246
1449342|NCT02152631|3547612|P2|Received at Least One Dose of Study Drug|Overall Study||175
1449343|NCT02152631|3547613|P1|Received at Least One Dose of Study Drug|Overall Study||265
1449344|NCT02152631|3547612|P2|STARTED|Overall Study||183
1449345|NCT02152631|3547613|P1|STARTED|Overall Study||270
1449346|NCT02152605|3547632|P2|NOT COMPLETED|Overall Study||18
1449347|NCT02152605|3547633|P1|NOT COMPLETED|Overall Study||19
1449348|NCT02152605|3547632|P2|COMPLETED|Overall Study||230
1449349|NCT02152605|3547633|P1|COMPLETED|Overall Study||229
1449350|NCT02152605|3547632|P2|STARTED|Overall Study||248
1449351|NCT02152605|3547633|P1|STARTED|Overall Study||248
1449352|NCT02152566|3547643|P1|NOT COMPLETED|Overall Study||3
1449353|NCT02152566|3547643|P1|COMPLETED|Overall Study||3
1449354|NCT02152566|3547643|P1|STARTED|Overall Study||6
1449355|NCT02152371|3547649|P2|NOT COMPLETED|Overall Study||16
1449356|NCT02152371|3547650|P1|NOT COMPLETED|Overall Study||12
1449357|NCT02152371|3547649|P2|COMPLETED|Overall Study||134
1449358|NCT02152371|3547650|P1|COMPLETED|Overall Study||138
1449359|NCT02152371|3547649|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
1449360|NCT02152371|3547650|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
1449361|NCT02152371|3547649|P2|STARTED|Overall Study||150
1449362|NCT02152371|3547650|P1|STARTED|Overall Study||150
1449363|NCT02152007|3547686|P1|NOT COMPLETED|Overall Study||1
1449364|NCT02152007|3547686|P1|COMPLETED|Overall Study||14
1449365|NCT02152007|3547686|P1|STARTED|Overall Study||15
1449366|NCT02151994|3547695|P13|NOT COMPLETED|Food Effect (FE): Fed||0
1449367|NCT02151994|3547696|P12|NOT COMPLETED|Food Effect (FE): Fed||0
1449368|NCT02151994|3547697|P11|NOT COMPLETED|Food Effect (FE): Fed||0
1449369|NCT02151994|3547698|P10|NOT COMPLETED|Food Effect (FE): Fed||0
1449370|NCT02151994|3547699|P9|NOT COMPLETED|Food Effect (FE): Fed||0
1449371|NCT02151994|3547700|P8|NOT COMPLETED|Food Effect (FE): Fed||0
1449372|NCT02151994|3547701|P7|NOT COMPLETED|Food Effect (FE): Fed||0
1449373|NCT02151994|3547702|P6|NOT COMPLETED|Food Effect (FE): Fed||0
1449374|NCT02151994|3547703|P5|NOT COMPLETED|Food Effect (FE): Fed||0
1449375|NCT02151994|3547704|P4|NOT COMPLETED|Food Effect (FE): Fed||0
1449376|NCT02151994|3547705|P3|NOT COMPLETED|Food Effect (FE): Fed||0
1449377|NCT02151994|3547706|P2|NOT COMPLETED|Food Effect (FE): Fed||0
1449378|NCT02151994|3547707|P1|NOT COMPLETED|Food Effect (FE): Fed||0
1449379|NCT02151994|3547695|P13|COMPLETED|Food Effect (FE): Fed||12
1449380|NCT02151994|3547696|P12|COMPLETED|Food Effect (FE): Fed||0
1449381|NCT02151994|3547697|P11|COMPLETED|Food Effect (FE): Fed||0
1449382|NCT02151994|3547698|P10|COMPLETED|Food Effect (FE): Fed||0
1449383|NCT02151994|3547699|P9|COMPLETED|Food Effect (FE): Fed||0
1449384|NCT02151994|3547700|P8|COMPLETED|Food Effect (FE): Fed||0
1449385|NCT02151994|3547701|P7|COMPLETED|Food Effect (FE): Fed||0
1449386|NCT02151994|3547702|P6|COMPLETED|Food Effect (FE): Fed||0
1449387|NCT02151994|3547703|P5|COMPLETED|Food Effect (FE): Fed||0
1449388|NCT02151994|3547704|P4|COMPLETED|Food Effect (FE): Fed||0
1449389|NCT02151994|3547705|P3|COMPLETED|Food Effect (FE): Fed||0
1449390|NCT02151994|3547706|P2|COMPLETED|Food Effect (FE): Fed||0
1449391|NCT02151994|3547707|P1|COMPLETED|Food Effect (FE): Fed||0
1449392|NCT02151994|3547695|P13|STARTED|Food Effect (FE): Fed||12
1449393|NCT02151994|3547696|P12|STARTED|Food Effect (FE): Fed||0
1449394|NCT02151994|3547697|P11|STARTED|Food Effect (FE): Fed||0
1449395|NCT02151994|3547698|P10|STARTED|Food Effect (FE): Fed||0
1449396|NCT02151994|3547699|P9|STARTED|Food Effect (FE): Fed||0
1449397|NCT02151994|3547700|P8|STARTED|Food Effect (FE): Fed||0
1449398|NCT02151994|3547701|P7|STARTED|Food Effect (FE): Fed||0
1449399|NCT02151994|3547702|P6|STARTED|Food Effect (FE): Fed||0
1449400|NCT02151994|3547703|P5|STARTED|Food Effect (FE): Fed||0
1449401|NCT02151994|3547704|P4|STARTED|Food Effect (FE): Fed||0
1449402|NCT02151994|3547705|P3|STARTED|Food Effect (FE): Fed||0
1449403|NCT02151994|3547706|P2|STARTED|Food Effect (FE): Fed||0
1449404|NCT02151994|3547707|P1|STARTED|Food Effect (FE): Fed||0
1449405|NCT02151994|3547695|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
1449406|NCT02151994|3547696|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
1449407|NCT02151994|3547697|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
1449408|NCT02151994|3547698|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
1449409|NCT02151994|3547699|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
1449410|NCT02151994|3547700|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
1449411|NCT02151994|3547701|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
1449412|NCT02151994|3547702|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
1449413|NCT02151994|3547703|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
1449414|NCT02151994|3547704|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
1449415|NCT02151994|3547705|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
1449416|NCT02151994|3547706|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
1449417|NCT02151994|3547707|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
1449418|NCT02151994|3547695|P13|COMPLETED|Food Effect (FE): Fasted||0
1449419|NCT02151994|3547696|P12|COMPLETED|Food Effect (FE): Fasted||12
1449420|NCT02151994|3547697|P11|COMPLETED|Food Effect (FE): Fasted||0
1449421|NCT02151994|3547698|P10|COMPLETED|Food Effect (FE): Fasted||0
1449422|NCT02151994|3547699|P9|COMPLETED|Food Effect (FE): Fasted||0
1449423|NCT02151994|3547700|P8|COMPLETED|Food Effect (FE): Fasted||0
1449424|NCT02151994|3547701|P7|COMPLETED|Food Effect (FE): Fasted||0
1449425|NCT02151994|3547702|P6|COMPLETED|Food Effect (FE): Fasted||0
1449426|NCT02151994|3547703|P5|COMPLETED|Food Effect (FE): Fasted||0
1449427|NCT02151994|3547704|P4|COMPLETED|Food Effect (FE): Fasted||0
1449428|NCT02151994|3547705|P3|COMPLETED|Food Effect (FE): Fasted||0
1449429|NCT02151994|3547706|P2|COMPLETED|Food Effect (FE): Fasted||0
1449430|NCT02151994|3547707|P1|COMPLETED|Food Effect (FE): Fasted||0
1449431|NCT02151994|3547695|P13|STARTED|Food Effect (FE): Fasted||0
1449432|NCT02151994|3547696|P12|STARTED|Food Effect (FE): Fasted||12
1449433|NCT02151994|3547697|P11|STARTED|Food Effect (FE): Fasted||0
1449434|NCT02151994|3547698|P10|STARTED|Food Effect (FE): Fasted||0
1449435|NCT02151994|3547699|P9|STARTED|Food Effect (FE): Fasted||0
1449436|NCT02151994|3547700|P8|STARTED|Food Effect (FE): Fasted||0
1449437|NCT02151994|3547701|P7|STARTED|Food Effect (FE): Fasted||0
1449438|NCT02151994|3547702|P6|STARTED|Food Effect (FE): Fasted||0
1449439|NCT02151994|3547703|P5|STARTED|Food Effect (FE): Fasted||0
1449440|NCT02151994|3547704|P4|STARTED|Food Effect (FE): Fasted||0
1449441|NCT02151994|3547705|P3|STARTED|Food Effect (FE): Fasted||0
1449442|NCT02151994|3547706|P2|STARTED|Food Effect (FE): Fasted||0
1449443|NCT02151994|3547707|P1|STARTED|Food Effect (FE): Fasted||0
1449444|NCT02151994|3547695|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449445|NCT02151994|3547696|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449446|NCT02151994|3547697|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449447|NCT02151994|3547698|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449448|NCT02151994|3547699|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449449|NCT02151994|3547700|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449450|NCT02151994|3547701|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449451|NCT02151994|3547702|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449452|NCT02151994|3547703|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449453|NCT02151994|3547704|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449454|NCT02151994|3547705|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449455|NCT02151994|3547706|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449456|NCT02151994|3547707|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
1449457|NCT02151994|3547695|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
1449458|NCT02151994|3547696|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
1449459|NCT02151994|3547697|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
1449460|NCT02151994|3547698|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
1449461|NCT02151994|3547699|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
1449462|NCT02151994|3547700|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
1449463|NCT02151994|3547701|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
1449464|NCT02151994|3547702|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
1449465|NCT02151994|3547703|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
1449466|NCT02151994|3547704|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
1449467|NCT02151994|3547705|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
1449468|NCT02151994|3547706|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
1449469|NCT02151994|3547707|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
1449470|NCT02151994|3547695|P13|STARTED|Multiple Ascending Dose (MAD)||0
1449471|NCT02151994|3547696|P12|STARTED|Multiple Ascending Dose (MAD)||0
1449472|NCT02151994|3547697|P11|STARTED|Multiple Ascending Dose (MAD)||0
1449473|NCT02151994|3547698|P10|STARTED|Multiple Ascending Dose (MAD)||0
1449474|NCT02151994|3547699|P9|STARTED|Multiple Ascending Dose (MAD)||6
1449475|NCT02151994|3547700|P8|STARTED|Multiple Ascending Dose (MAD)||0
1449476|NCT02151994|3547701|P7|STARTED|Multiple Ascending Dose (MAD)||6
1449477|NCT02151994|3547702|P6|STARTED|Multiple Ascending Dose (MAD)||6
1449478|NCT02151994|3547703|P5|STARTED|Multiple Ascending Dose (MAD)||6
1449479|NCT02151994|3547704|P4|STARTED|Multiple Ascending Dose (MAD)||6
1449480|NCT02151994|3547705|P3|STARTED|Multiple Ascending Dose (MAD)||0
1449481|NCT02151994|3547706|P2|STARTED|Multiple Ascending Dose (MAD)||0
1449482|NCT02151994|3547707|P1|STARTED|Multiple Ascending Dose (MAD)||10
1449483|NCT02151994|3547695|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449484|NCT02151994|3547696|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449485|NCT02151994|3547697|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449486|NCT02151994|3547698|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449487|NCT02151994|3547699|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449488|NCT02151994|3547700|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449489|NCT02151994|3547701|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449490|NCT02151994|3547702|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449491|NCT02151994|3547703|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449492|NCT02151994|3547704|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449493|NCT02151994|3547705|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449494|NCT02151994|3547706|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449495|NCT02151994|3547707|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
1449496|NCT02151994|3547695|P13|COMPLETED|Single Ascending Dose (SAD)||0
1449497|NCT02151994|3547696|P12|COMPLETED|Single Ascending Dose (SAD)||0
1449498|NCT02151994|3547697|P11|COMPLETED|Single Ascending Dose (SAD)||6
1449499|NCT02151994|3547698|P10|COMPLETED|Single Ascending Dose (SAD)||6
1449500|NCT02151994|3547699|P9|COMPLETED|Single Ascending Dose (SAD)||0
1449501|NCT02151994|3547700|P8|COMPLETED|Single Ascending Dose (SAD)||6
1449502|NCT02151994|3547701|P7|COMPLETED|Single Ascending Dose (SAD)||6
1449503|NCT02151994|3547702|P6|COMPLETED|Single Ascending Dose (SAD)||6
1449504|NCT02151994|3547703|P5|COMPLETED|Single Ascending Dose (SAD)||6
1449505|NCT02151994|3547704|P4|COMPLETED|Single Ascending Dose (SAD)||6
1449506|NCT02151994|3547705|P3|COMPLETED|Single Ascending Dose (SAD)||6
1449507|NCT02151994|3547706|P2|COMPLETED|Single Ascending Dose (SAD)||6
1449508|NCT02151994|3547707|P1|COMPLETED|Single Ascending Dose (SAD)||18
1449509|NCT02151994|3547695|P13|STARTED|Single Ascending Dose (SAD)||0
1449510|NCT02151994|3547696|P12|STARTED|Single Ascending Dose (SAD)||0
1449511|NCT02151994|3547697|P11|STARTED|Single Ascending Dose (SAD)||6
1449512|NCT02151994|3547698|P10|STARTED|Single Ascending Dose (SAD)||6
1449513|NCT02151994|3547699|P9|STARTED|Single Ascending Dose (SAD)||0
1449514|NCT02151994|3547700|P8|STARTED|Single Ascending Dose (SAD)||6
1449515|NCT02151994|3547701|P7|STARTED|Single Ascending Dose (SAD)||6
1449516|NCT02151994|3547702|P6|STARTED|Single Ascending Dose (SAD)||6
1449517|NCT02151994|3547703|P5|STARTED|Single Ascending Dose (SAD)||6
1449518|NCT02151994|3547704|P4|STARTED|Single Ascending Dose (SAD)||6
1449519|NCT02151994|3547705|P3|STARTED|Single Ascending Dose (SAD)||6
1449520|NCT02151994|3547706|P2|STARTED|Single Ascending Dose (SAD)||6
1449521|NCT02151994|3547707|P1|STARTED|Single Ascending Dose (SAD)||18
1449522|NCT02151981|3547747|P2|NOT COMPLETED|Overall Study||140
1449523|NCT02151981|3547748|P1|NOT COMPLETED|Overall Study||279
1449524|NCT02151981|3547747|P2|COMPLETED|Overall Study||0
1449525|NCT02151981|3547748|P1|COMPLETED|Overall Study||0
1449526|NCT02151981|3547747|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
1449527|NCT02151981|3547748|P1|Crossed Over AZD9291|Overall Study||0
1449528|NCT02151981|3547747|P2|Did Not Receive Treatment|Overall Study||4
1449529|NCT02151981|3547748|P1|Did Not Receive Treatment|Overall Study||0
1449530|NCT02151981|3547747|P2|Received Randomised Treatment Only|Overall Study||54
1449531|NCT02151981|3547748|P1|Received Randomised Treatment Only|Overall Study||279
1449532|NCT02151981|3547747|P2|STARTED|Overall Study||140
1449533|NCT02151981|3547748|P1|STARTED|Overall Study||279
1449534|NCT02151851|3547766|P2|NOT COMPLETED|Overall Study||130
1449535|NCT02151851|3547767|P1|NOT COMPLETED|Overall Study||76
1449536|NCT02151851|3547766|P2|COMPLETED|Overall Study||186
1449537|NCT02151851|3547767|P1|COMPLETED|Overall Study||38
1449538|NCT02151851|3547766|P2|Included in the Safety Set|Overall Study||316
1449539|NCT02151851|3547767|P1|Included in the Safety Set|Overall Study||113
1449540|NCT02151851|3547766|P2|STARTED|Overall Study||316
1449541|NCT02151851|3547767|P1|STARTED|Overall Study||114
1449542|NCT02151786|3547779|P1|NOT COMPLETED|Overall Study||36
1449543|NCT02151786|3547779|P1|COMPLETED|Overall Study||1084
1449544|NCT02151786|3547779|P1|STARTED|Overall Study||1120
1449545|NCT02151773|3547790|P1|NOT COMPLETED|Overall Study||64
1449546|NCT02151773|3547790|P1|COMPLETED|Overall Study||3429
1449547|NCT02151773|3547790|P1|STARTED|Overall Study||3493
1449548|NCT02151643|3547800|P5|NOT COMPLETED|Overall Study||3
1449549|NCT02151643|3547801|P4|NOT COMPLETED|Overall Study||7
1449550|NCT02151643|3547802|P3|NOT COMPLETED|Overall Study||4
1449551|NCT02151643|3547803|P2|NOT COMPLETED|Overall Study||4
1449552|NCT02151643|3547804|P1|NOT COMPLETED|Overall Study||6
1449553|NCT02151643|3547800|P5|COMPLETED|Overall Study||35
1449554|NCT02151643|3547801|P4|COMPLETED|Overall Study||32
1449555|NCT02151643|3547802|P3|COMPLETED|Overall Study||21
1449556|NCT02151643|3547803|P2|COMPLETED|Overall Study||21
1449557|NCT02151643|3547804|P1|COMPLETED|Overall Study||20
1449558|NCT02151643|3547800|P5|STARTED|Overall Study||38
1449559|NCT02151643|3547801|P4|STARTED|Overall Study||39
1449560|NCT02151643|3547802|P3|STARTED|Overall Study||25
1449561|NCT02151643|3547803|P2|STARTED|Overall Study||25
1449562|NCT02151643|3547804|P1|STARTED|Overall Study||26
1449563|NCT02151461|3547845|P4|NOT COMPLETED|Overall Study||4
1449564|NCT02151461|3547846|P3|NOT COMPLETED|Overall Study||3
1449565|NCT02151461|3547847|P2|NOT COMPLETED|Overall Study||1
1449566|NCT02151461|3547848|P1|NOT COMPLETED|Overall Study||6
1449567|NCT02151461|3547845|P4|COMPLETED|Overall Study||19
1449568|NCT02151461|3547846|P3|COMPLETED|Overall Study||21
1449569|NCT02151461|3547847|P2|COMPLETED|Overall Study||24
1449570|NCT02151461|3547848|P1|COMPLETED|Overall Study||18
1449571|NCT02151461|3547845|P4|STARTED|Overall Study||23
1449572|NCT02151461|3547846|P3|STARTED|Overall Study||24
1449573|NCT02151461|3547847|P2|STARTED|Overall Study||25
1449574|NCT02151461|3547848|P1|STARTED|Overall Study||24
1449575|NCT02151331|3547888|P2|NOT COMPLETED|Overall Study||40
1449576|NCT02151331|3547889|P1|NOT COMPLETED|Overall Study||32
1449577|NCT02151331|3547888|P2|COMPLETED|Overall Study||52
1449578|NCT02151331|3547889|P1|COMPLETED|Overall Study||45
1449579|NCT02151331|3547888|P2|STARTED|Overall Study||92
1449580|NCT02151331|3547889|P1|STARTED|Overall Study||77
1449581|NCT02151253|3547901|P2|NOT COMPLETED|Overall Study||0
1449582|NCT02151253|3547902|P1|NOT COMPLETED|Overall Study||0
1449583|NCT02151253|3547901|P2|COMPLETED|Overall Study||15
1449584|NCT02151253|3547902|P1|COMPLETED|Overall Study||13
1449585|NCT02151253|3547901|P2|STARTED|Overall Study||15
1449586|NCT02151253|3547902|P1|STARTED|Overall Study||13
1449587|NCT02151149|3547918|P2|NOT COMPLETED|Follow-Up Period||37
1449588|NCT02151149|3547919|P1|NOT COMPLETED|Follow-Up Period||39
1449589|NCT02151149|3547918|P2|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
1449590|NCT02151149|3547919|P1|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
1449591|NCT02151149|3547918|P2|STARTED|Follow-Up Period||55
1449592|NCT02151149|3547919|P1|STARTED|Follow-Up Period||58
1449593|NCT02151149|3547918|P2|NOT COMPLETED|Treatment Period||71
1449594|NCT02151149|3547919|P1|NOT COMPLETED|Treatment Period||70
1449595|NCT02151149|3547918|P2|COMPLETED|Treatment Period||1
1449596|NCT02151149|3547919|P1|COMPLETED|Treatment Period||1
1449597|NCT02151149|3547918|P2|Treated Population|Treatment Period||70
1449598|NCT02151149|3547919|P1|Treated Population|Treatment Period||68
1449599|NCT02151149|3547918|P2|STARTED|Treatment Period|2 participants did not receive treatment|72
1449600|NCT02151149|3547919|P1|STARTED|Treatment Period|3 participants did not receive treatment|71
1449601|NCT02151058|3547946|P3|NOT COMPLETED|Overall Study||5
1449602|NCT02151058|3547947|P2|NOT COMPLETED|Overall Study||1
1449603|NCT02151058|3547948|P1|NOT COMPLETED|Overall Study||2
1449604|NCT02151058|3547946|P3|COMPLETED|Overall Study||86
1449605|NCT02151058|3547947|P2|COMPLETED|Overall Study||90
1449606|NCT02151058|3547948|P1|COMPLETED|Overall Study||43
1449607|NCT02151058|3547946|P3|STARTED|Overall Study||91
1449608|NCT02151058|3547947|P2|STARTED|Overall Study||91
1449609|NCT02151058|3547948|P1|STARTED|Overall Study||45
1449610|NCT02150954|3547982|P2|NOT COMPLETED|Overall Study||0
1449611|NCT02150954|3547983|P1|NOT COMPLETED|Overall Study||1
1449612|NCT02150954|3547982|P2|COMPLETED|Overall Study||59
1449613|NCT02150954|3547983|P1|COMPLETED|Overall Study||57
1449614|NCT02150954|3547982|P2|STARTED|Overall Study||59
1449615|NCT02150954|3547983|P1|STARTED|Overall Study||58
1449616|NCT02150499|3548007|P2|NOT COMPLETED|Overall Study||0
1449617|NCT02150499|3548008|P1|NOT COMPLETED|Overall Study||0
1449618|NCT02150499|3548007|P2|COMPLETED|Overall Study||9
1449619|NCT02150499|3548008|P1|COMPLETED|Overall Study||9
1449620|NCT02150499|3548007|P2|STARTED|Overall Study||9
1449621|NCT02150499|3548008|P1|STARTED|Overall Study||9
1449622|NCT02150460|3548030|P2|NOT COMPLETED|Overall Study||0
1449623|NCT02150460|3548031|P1|NOT COMPLETED|Overall Study||0
1449624|NCT02150460|3548030|P2|COMPLETED|Overall Study||50
1449625|NCT02150460|3548031|P1|COMPLETED|Overall Study||50
1449626|NCT02150460|3548030|P2|STARTED|Overall Study||50
1449627|NCT02150460|3548031|P1|STARTED|Overall Study||50
1449628|NCT02150343|3548059|P4|NOT COMPLETED|Overall Study||10
1449629|NCT02150343|3548060|P3|NOT COMPLETED|Overall Study||12
1449630|NCT02150343|3548061|P2|NOT COMPLETED|Overall Study||20
1449631|NCT02150343|3548062|P1|NOT COMPLETED|Overall Study||21
1449632|NCT02150343|3548059|P4|COMPLETED|Overall Study||168
1449633|NCT02150343|3548060|P3|COMPLETED|Overall Study||166
1449634|NCT02150343|3548061|P2|COMPLETED|Overall Study||158
1449635|NCT02150343|3548062|P1|COMPLETED|Overall Study||159
1449636|NCT02150343|3548059|P4|STARTED|Overall Study||178
1449637|NCT02150343|3548060|P3|STARTED|Overall Study||178
1449638|NCT02150343|3548061|P2|STARTED|Overall Study||178
1449639|NCT02150343|3548062|P1|STARTED|Overall Study||180
1449640|NCT02150213|3548100|P1|NOT COMPLETED|Overall Study||2
1449641|NCT02150213|3548100|P1|COMPLETED|Overall Study||57
1449642|NCT02150213|3548100|P1|STARTED|Overall Study||59
1449643|NCT02150109|3548105|P1|NOT COMPLETED|Overall Study||0
1449644|NCT02150109|3548105|P1|COMPLETED|Overall Study||372
1449645|NCT02150109|3548105|P1|STARTED|Overall Study||372
1449646|NCT02150044|3548117|P1|NOT COMPLETED|Overall Study||0
1449647|NCT02150044|3548117|P1|COMPLETED|Overall Study||29
1449648|NCT02150044|3548117|P1|Study Cohort|Overall Study||13
1449649|NCT02150044|3548117|P1|Lead-In Subjects|Overall Study||16
1449650|NCT02150044|3548117|P1|STARTED|Overall Study||29
1449651|NCT02149875|3548126|P3|NOT COMPLETED|Overall Study||9
1449652|NCT02149875|3548127|P2|NOT COMPLETED|Overall Study||8
1449653|NCT02149875|3548128|P1|NOT COMPLETED|Overall Study||7
1449654|NCT02149875|3548126|P3|COMPLETED|Overall Study||20
1449655|NCT02149875|3548127|P2|COMPLETED|Overall Study||20
1449656|NCT02149875|3548128|P1|COMPLETED|Overall Study||20
1449657|NCT02149875|3548126|P3|STARTED|Overall Study||29
1449658|NCT02149875|3548127|P2|STARTED|Overall Study||28
1449659|NCT02149875|3548128|P1|STARTED|Overall Study||27
1449660|NCT02149524|3548141|P2|NOT COMPLETED|Overall Study||57
1449661|NCT02149524|3548142|P1|NOT COMPLETED|Overall Study||54
1449662|NCT02149524|3548141|P2|COMPLETED|Overall Study||380
1449663|NCT02149524|3548142|P1|COMPLETED|Overall Study||384
1449664|NCT02149524|3548141|P2|STARTED|Overall Study||437
1449665|NCT02149524|3548142|P1|STARTED|Overall Study||438
1449666|NCT02149342|3548156|P1|NOT COMPLETED|Overall Study||0
1449667|NCT02149342|3548156|P1|COMPLETED|Overall Study|14 patients|14
1449668|NCT02149342|3548156|P1|STARTED|Overall Study|14 patients|14
1449669|NCT02149303|3548168|P1|NOT COMPLETED|Overall Study||0
1449670|NCT02149303|3548168|P1|COMPLETED|Overall Study||191
1449671|NCT02149303|3548168|P1|STARTED|Overall Study||191
1449672|NCT02149264|3548174|P1|NOT COMPLETED|Overall Study||20
1449673|NCT02149264|3548174|P1|COMPLETED|Overall Study||139
1449674|NCT02149264|3548174|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
1449675|NCT02149108|3548189|P2|NOT COMPLETED|Overall Study||383
1449676|NCT02149108|3548190|P1|NOT COMPLETED|Overall Study||380
1449677|NCT02149108|3548189|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
1449678|NCT02149108|3548190|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
1449679|NCT02149108|3548189|P2|STARTED|Overall Study|Randomised patients.|386
1449680|NCT02149108|3548190|P1|STARTED|Overall Study|Randomised patients.|382
1449681|NCT02148835|3548204|P2|NOT COMPLETED|Overall Study||0
1449682|NCT02148835|3548205|P1|NOT COMPLETED|Overall Study||0
1449683|NCT02148835|3548204|P2|COMPLETED|Overall Study||22
1449684|NCT02148835|3548205|P1|COMPLETED|Overall Study||22
1449685|NCT02148835|3548204|P2|STARTED|Overall Study||22
1449686|NCT02148835|3548205|P1|STARTED|Overall Study||22
1449687|NCT02148809|3548211|P1|NOT COMPLETED|Overall Study||0
1449688|NCT02148809|3548211|P1|COMPLETED|Overall Study||14
1449689|NCT02148809|3548211|P1|STARTED|Overall Study||14
1449690|NCT02148718|3548216|P1|NOT COMPLETED|Overall Study||31
1449691|NCT02148718|3548216|P1|COMPLETED|Overall Study||55
1449692|NCT02148718|3548216|P1|STARTED|Overall Study||86
1449693|NCT02148588|3548237|P1|NOT COMPLETED|Overall Study||0
1449694|NCT02148588|3548237|P1|COMPLETED|Overall Study||8
1449695|NCT02148588|3548237|P1|STARTED|Overall Study||8
1449696|NCT02148523|3548249|P3|NOT COMPLETED|Overall Study||0
1449697|NCT02148523|3548250|P2|NOT COMPLETED|Overall Study||0
1449698|NCT02148523|3548251|P1|NOT COMPLETED|Overall Study||0
1449699|NCT02148523|3548249|P3|COMPLETED|Overall Study||67
1449700|NCT02148523|3548250|P2|COMPLETED|Overall Study||67
1449701|NCT02148523|3548251|P1|COMPLETED|Overall Study||67
1449702|NCT02148523|3548249|P3|STARTED|Overall Study||67
1449703|NCT02148523|3548250|P2|STARTED|Overall Study||67
1449704|NCT02148523|3548251|P1|STARTED|Overall Study||67
1449705|NCT02148445|3548264|P2|NOT COMPLETED|Overall Study||3
1449706|NCT02148445|3548265|P1|NOT COMPLETED|Overall Study||1
1449707|NCT02148445|3548264|P2|COMPLETED|Overall Study||197
1449708|NCT02148445|3548265|P1|COMPLETED|Overall Study||197
1449709|NCT02148445|3548264|P2|STARTED|Overall Study||200
1449710|NCT02148445|3548265|P1|STARTED|Overall Study||198
1449711|NCT02148107|3548304|P3|NOT COMPLETED|Overall Study||0
1449712|NCT02148107|3548305|P2|NOT COMPLETED|Overall Study||0
1449713|NCT02148107|3548306|P1|NOT COMPLETED|Overall Study||0
1449714|NCT02148107|3548304|P3|COMPLETED|Overall Study||3
1449715|NCT02148107|3548305|P2|COMPLETED|Overall Study||7
1449716|NCT02148107|3548306|P1|COMPLETED|Overall Study||8
1449717|NCT02148107|3548304|P3|STARTED|Overall Study||3
1449718|NCT02148107|3548305|P2|STARTED|Overall Study||7
1449719|NCT02148107|3548306|P1|STARTED|Overall Study||8
1449720|NCT02147899|3548325|P3|NOT COMPLETED|Overall Study||0
1449721|NCT02147899|3548326|P2|NOT COMPLETED|Overall Study||0
1449722|NCT02147899|3548327|P1|NOT COMPLETED|Overall Study||0
1449723|NCT02147899|3548325|P3|COMPLETED|Overall Study||72
1449724|NCT02147899|3548326|P2|COMPLETED|Overall Study||72
1449725|NCT02147899|3548327|P1|COMPLETED|Overall Study||71
1449726|NCT02147899|3548325|P3|STARTED|Overall Study||72
1449727|NCT02147899|3548326|P2|STARTED|Overall Study||72
1449728|NCT02147899|3548327|P1|STARTED|Overall Study||71
1449729|NCT02147691|3548340|P2|NOT COMPLETED|Overall Study||1
1449730|NCT02147691|3548341|P1|NOT COMPLETED|Overall Study||4
1449731|NCT02147691|3548340|P2|COMPLETED|Overall Study||11
1449732|NCT02147691|3548341|P1|COMPLETED|Overall Study||6
1449733|NCT02147691|3548340|P2|STARTED|Overall Study||12
1449734|NCT02147691|3548341|P1|STARTED|Overall Study||10
1449735|NCT02147587|3548387|P2|NOT COMPLETED|Overall Study||5
1449736|NCT02147587|3548388|P1|NOT COMPLETED|Overall Study||11
1449737|NCT02147587|3548387|P2|COMPLETED|Overall Study||50
1449738|NCT02147587|3548388|P1|COMPLETED|Overall Study||46
1449739|NCT02147587|3548387|P2|STARTED|Overall Study||55
1449740|NCT02147587|3548388|P1|STARTED|Overall Study||57
1449741|NCT02147561|3548408|P1|NOT COMPLETED|Overall Study||4
1449742|NCT02147561|3548408|P1|COMPLETED|Overall Study||276
1449743|NCT02147561|3548408|P1|STARTED|Overall Study||280
1449744|NCT02147522|3548416|P2|NOT COMPLETED|Overall Study||48
1449745|NCT02147522|3548417|P1|NOT COMPLETED|Overall Study||56
1449746|NCT02147522|3548416|P2|COMPLETED|Overall Study||122
1449747|NCT02147522|3548417|P1|COMPLETED|Overall Study||122
1449748|NCT02147522|3548416|P2|STARTED|Overall Study||170
1449749|NCT02147522|3548417|P1|STARTED|Overall Study||178
1449750|NCT02147288|3548429|P10|NOT COMPLETED|Overall Study||0
1449751|NCT02147288|3548430|P9|NOT COMPLETED|Overall Study||0
1449752|NCT02147288|3548431|P8|NOT COMPLETED|Overall Study||0
1449753|NCT02147288|3548432|P7|NOT COMPLETED|Overall Study||0
1449754|NCT02147288|3548433|P6|NOT COMPLETED|Overall Study||0
1449755|NCT02147288|3548434|P5|NOT COMPLETED|Overall Study||0
1449756|NCT02147288|3548435|P4|NOT COMPLETED|Overall Study||0
1449757|NCT02147288|3548436|P3|NOT COMPLETED|Overall Study||0
1449758|NCT02147288|3548437|P2|NOT COMPLETED|Overall Study||2
1449759|NCT02147288|3548438|P1|NOT COMPLETED|Overall Study||1
1449760|NCT02147288|3548429|P10|COMPLETED|Overall Study||0
1449761|NCT02147288|3548430|P9|COMPLETED|Overall Study||0
1449762|NCT02147288|3548431|P8|COMPLETED|Overall Study||0
1449763|NCT02147288|3548432|P7|COMPLETED|Overall Study||0
1449764|NCT02147288|3548433|P6|COMPLETED|Overall Study||0
1449765|NCT02147288|3548434|P5|COMPLETED|Overall Study||0
1449766|NCT02147288|3548435|P4|COMPLETED|Overall Study||0
1449767|NCT02147288|3548436|P3|COMPLETED|Overall Study||0
1449768|NCT02147288|3548437|P2|COMPLETED|Overall Study||22
1449769|NCT02147288|3548438|P1|COMPLETED|Overall Study||21
1449770|NCT02147288|3548429|P10|STARTED|Overall Study||0
1449771|NCT02147288|3548430|P9|STARTED|Overall Study||0
1449772|NCT02147288|3548431|P8|STARTED|Overall Study||0
1449773|NCT02147288|3548432|P7|STARTED|Overall Study||0
1449774|NCT02147288|3548433|P6|STARTED|Overall Study||0
1449775|NCT02147288|3548434|P5|STARTED|Overall Study||0
1449776|NCT02147288|3548435|P4|STARTED|Overall Study||0
1449777|NCT02147288|3548436|P3|STARTED|Overall Study||0
1449778|NCT02147288|3548437|P2|STARTED|Overall Study||24
1449779|NCT02147288|3548438|P1|STARTED|Overall Study||22
1449780|NCT02147184|3548446|P2|NOT COMPLETED|Overall Study||27
1449781|NCT02147184|3548447|P1|NOT COMPLETED|Overall Study||49
1449782|NCT02147184|3548446|P2|COMPLETED|Overall Study||110
1449783|NCT02147184|3548447|P1|COMPLETED|Overall Study||78
1449784|NCT02147184|3548446|P2|STARTED|Overall Study||137
1449785|NCT02147184|3548447|P1|STARTED|Overall Study||127
1449786|NCT02147132|3548465|P4|NOT COMPLETED|Overall Study||0
1449787|NCT02147132|3548466|P3|NOT COMPLETED|Overall Study||0
1449788|NCT02147132|3548467|P2|NOT COMPLETED|Overall Study||0
1449789|NCT02147132|3548468|P1|NOT COMPLETED|Overall Study||1
1449790|NCT02147132|3548465|P4|COMPLETED|Overall Study||2
1449791|NCT02147132|3548466|P3|COMPLETED|Overall Study||1
1449792|NCT02147132|3548467|P2|COMPLETED|Overall Study||2
1449793|NCT02147132|3548468|P1|COMPLETED|Overall Study||1
1449794|NCT02147132|3548465|P4|STARTED|Overall Study||2
1449795|NCT02147132|3548466|P3|STARTED|Overall Study||1
1449796|NCT02147132|3548467|P2|STARTED|Overall Study||2
1449797|NCT02147132|3548468|P1|STARTED|Overall Study||2
1449798|NCT02147093|3548488|P2|NOT COMPLETED|Period 2||0
1449799|NCT02147093|3548489|P1|NOT COMPLETED|Period 2||2
1449800|NCT02147093|3548488|P2|COMPLETED|Period 2||19
1449801|NCT02147093|3548489|P1|COMPLETED|Period 2||18
1449802|NCT02147093|3548488|P2|STARTED|Period 2||19
1449803|NCT02147093|3548489|P1|STARTED|Period 2||20
1449804|NCT02147093|3548488|P2|NOT COMPLETED|Period 1||1
1449805|NCT02147093|3548489|P1|NOT COMPLETED|Period 1||0
1449806|NCT02147093|3548488|P2|COMPLETED|Period 1||19
1449807|NCT02147093|3548489|P1|COMPLETED|Period 1||20
1449808|NCT02147093|3548488|P2|STARTED|Period 1||20
1449809|NCT02147093|3548489|P1|STARTED|Period 1||20
1449810|NCT02146599|3548497|P1|NOT COMPLETED|Overall Study||5
1449811|NCT02146599|3548497|P1|COMPLETED|Overall Study||296
1449812|NCT02146599|3548497|P1|STARTED|Overall Study||301
1449813|NCT02146482|3548503|P2|NOT COMPLETED|Overall Study||0
1449814|NCT02146482|3548504|P1|NOT COMPLETED|Overall Study||0
1449815|NCT02146482|3548503|P2|COMPLETED|Overall Study||25
1449816|NCT02146482|3548504|P1|COMPLETED|Overall Study||21
1449817|NCT02146482|3548503|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
1449818|NCT02146482|3548504|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
1449819|NCT02146352|3548510|P1|NOT COMPLETED|Overall Study||2
1449820|NCT02146352|3548510|P1|COMPLETED|Overall Study||28
1449821|NCT02146352|3548510|P1|7 Days Post-stent Removal|Overall Study||28
1449822|NCT02146352|3548510|P1|30 or 60 Days Post-procedure|Overall Study||30
1449823|NCT02146352|3548510|P1|STARTED|Overall Study||30
1449824|NCT02146326|3548528|P4|NOT COMPLETED|Overall Study||48
1449825|NCT02146326|3548529|P3|NOT COMPLETED|Overall Study||43
1449826|NCT02146326|3548530|P2|NOT COMPLETED|Overall Study||37
1449827|NCT02146326|3548531|P1|NOT COMPLETED|Overall Study||28
1449828|NCT02146326|3548528|P4|COMPLETED|Overall Study||210
1449829|NCT02146326|3548529|P3|COMPLETED|Overall Study||168
1449830|NCT02146326|3548530|P2|COMPLETED|Overall Study||66
1449831|NCT02146326|3548531|P1|COMPLETED|Overall Study||61
1449832|NCT02146326|3548528|P4|12 Months|Overall Study||210
1449833|NCT02146326|3548529|P3|12 Months|Overall Study||168
1449834|NCT02146326|3548530|P2|12 Months|Overall Study||66
1449835|NCT02146326|3548531|P1|12 Months|Overall Study||61
1449836|NCT02146326|3548528|P4|6 Months|Overall Study||235
1449837|NCT02146326|3548529|P3|6 Months|Overall Study||186
1449838|NCT02146326|3548530|P2|6 Months|Overall Study||71
1449839|NCT02146326|3548531|P1|6 Months|Overall Study||71
1449840|NCT02146326|3548528|P4|3 Months|Overall Study||0
1449841|NCT02146326|3548529|P3|3 Months|Overall Study||0
1449842|NCT02146326|3548530|P2|3 Months|Overall Study||83
1449843|NCT02146326|3548531|P1|3 Months|Overall Study||71
1449844|NCT02146326|3548528|P4|Baseline|Overall Study||258
1449845|NCT02146326|3548529|P3|Baseline|Overall Study||211
1449846|NCT02146326|3548530|P2|Baseline|Overall Study||103
1449847|NCT02146326|3548531|P1|Baseline|Overall Study||89
1449848|NCT02146326|3548528|P4|STARTED|Overall Study||258
1449849|NCT02146326|3548529|P3|STARTED|Overall Study||211
1449850|NCT02146326|3548530|P2|STARTED|Overall Study||103
1449851|NCT02146326|3548531|P1|STARTED|Overall Study||89
1449852|NCT02146248|3548693|P1|NOT COMPLETED|Overall Study||2
1449853|NCT02146248|3548693|P1|COMPLETED|Overall Study||9
1449854|NCT02146248|3548693|P1|HSG 5|Overall Study||1
1449855|NCT02146248|3548693|P1|HSG 4|Overall Study||7
1449856|NCT02146248|3548693|P1|HSG 3|Overall Study||9
1449857|NCT02146248|3548693|P1|HSG 2|Overall Study||10
1449858|NCT02146248|3548693|P1|HSG 1|Overall Study||10
1449859|NCT02146248|3548693|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
1449860|NCT02146248|3548693|P1|Enrolled|Overall Study||11
1449861|NCT02146248|3548693|P1|STARTED|Overall Study||11
1449862|NCT02146131|3548703|P2|NOT COMPLETED|Overall Study||56
1449863|NCT02146131|3548704|P1|NOT COMPLETED|Overall Study||61
1449864|NCT02146131|3548703|P2|COMPLETED|Overall Study||113
1449865|NCT02146131|3548704|P1|COMPLETED|Overall Study||109
1449866|NCT02146131|3548703|P2|STARTED|Overall Study||169
1449867|NCT02146131|3548704|P1|STARTED|Overall Study||170
1449868|NCT02146105|3548710|P1|NOT COMPLETED|Overall Study||6
1449869|NCT02146105|3548710|P1|COMPLETED|Overall Study||39
1449870|NCT02146105|3548710|P1|STARTED|Overall Study||45
1449871|NCT02146001|3548716|P2|NOT COMPLETED|Overall Study||0
1449872|NCT02146001|3548717|P1|NOT COMPLETED|Overall Study||0
1449873|NCT02146001|3548716|P2|COMPLETED|Overall Study||19
1449874|NCT02146001|3548717|P1|COMPLETED|Overall Study||19
1449875|NCT02146001|3548716|P2|STARTED|Overall Study||19
1449876|NCT02146001|3548717|P1|STARTED|Overall Study||19
1449877|NCT02145754|3548727|P1|NOT COMPLETED|Overall Study||0
1449878|NCT02145754|3548727|P1|COMPLETED|Overall Study||235
1449879|NCT02145754|3548727|P1|STARTED|Overall Study||235
1449880|NCT02145676|3548734|P3|NOT COMPLETED|Overall Study||0
1449881|NCT02145676|3548735|P2|NOT COMPLETED|Overall Study||0
1449882|NCT02145676|3548736|P1|NOT COMPLETED|Overall Study||0
1449883|NCT02145676|3548734|P3|COMPLETED|Overall Study||18
1449884|NCT02145676|3548735|P2|COMPLETED|Overall Study||18
1449885|NCT02145676|3548736|P1|COMPLETED|Overall Study||17
1449886|NCT02145676|3548734|P3|STARTED|Overall Study||18
1449887|NCT02145676|3548735|P2|STARTED|Overall Study||18
1449888|NCT02145676|3548736|P1|STARTED|Overall Study||17
1449889|NCT02145468|3548761|P2|NOT COMPLETED|Overall Study||8
1449890|NCT02145468|3548762|P1|NOT COMPLETED|Overall Study||5
1449891|NCT02145468|3548761|P2|COMPLETED|Overall Study||1723
1449892|NCT02145468|3548762|P1|COMPLETED|Overall Study||1753
1449893|NCT02145468|3548761|P2|STARTED|Overall Study||1731
1449894|NCT02145468|3548762|P1|STARTED|Overall Study||1758
1449895|NCT02145390|3548818|P1|NOT COMPLETED|Overall Study||1
1449896|NCT02145390|3548818|P1|COMPLETED|Overall Study||0
1449897|NCT02145390|3548818|P1|STARTED|Overall Study||1
1449898|NCT02145299|3548829|P2|NOT COMPLETED|Overall Study||0
1449899|NCT02145299|3548830|P1|NOT COMPLETED|Overall Study||0
1449900|NCT02145299|3548829|P2|COMPLETED|Overall Study||2
1449901|NCT02145299|3548830|P1|COMPLETED|Overall Study||6
1449902|NCT02145299|3548829|P2|STARTED|Overall Study||2
1449903|NCT02145299|3548830|P1|STARTED|Overall Study||6
1449904|NCT02145182|3548858|P2|NOT COMPLETED|Overall Study||16
1449905|NCT02145182|3548859|P1|NOT COMPLETED|Overall Study||18
1449906|NCT02145182|3548858|P2|COMPLETED|Overall Study||130
1449907|NCT02145182|3548859|P1|COMPLETED|Overall Study||124
1449908|NCT02145182|3548858|P2|Received at Least 1 Dose of Study Drug|Overall Study||146
1449909|NCT02145182|3548859|P1|Received at Least 1 Dose of Study Drug|Overall Study||142
1449910|NCT02145182|3548858|P2|STARTED|Overall Study||146
1449911|NCT02145182|3548859|P1|STARTED|Overall Study||142
1449912|NCT02145156|3548876|P3|NOT COMPLETED|Overall Study||41
1449913|NCT02145156|3548877|P2|NOT COMPLETED|Overall Study||52
1449914|NCT02145156|3548878|P1|NOT COMPLETED|Overall Study||60
1449915|NCT02145156|3548876|P3|COMPLETED|Overall Study||398
1449916|NCT02145156|3548877|P2|COMPLETED|Overall Study||373
1449917|NCT02145156|3548878|P1|COMPLETED|Overall Study||370
1449918|NCT02145156|3548876|P3|STARTED|Overall Study||439
1449919|NCT02145156|3548877|P2|STARTED|Overall Study||425
1449920|NCT02145156|3548878|P1|STARTED|Overall Study||430
1449921|NCT02144714|3548922|P3|NOT COMPLETED|Overall Study||0
1449922|NCT02144714|3548923|P2|NOT COMPLETED|Overall Study||0
1449923|NCT02144714|3548924|P1|NOT COMPLETED|Overall Study||0
1449924|NCT02144714|3548922|P3|COMPLETED|Overall Study||63
1449925|NCT02144714|3548923|P2|COMPLETED|Overall Study||63
1449926|NCT02144714|3548924|P1|COMPLETED|Overall Study||63
1449927|NCT02144714|3548922|P3|STARTED|Overall Study||63
1449928|NCT02144714|3548923|P2|STARTED|Overall Study||63
1449929|NCT02144714|3548924|P1|STARTED|Overall Study||63
1449930|NCT02144701|3548943|P2|NOT COMPLETED|Overall Study||3
1449931|NCT02144701|3548944|P1|NOT COMPLETED|Overall Study||9
1449932|NCT02144701|3548943|P2|COMPLETED|Overall Study||8
1449933|NCT02144701|3548944|P1|COMPLETED|Overall Study||13
1449934|NCT02144701|3548943|P2|STARTED|Overall Study||11
1449935|NCT02144701|3548944|P1|STARTED|Overall Study||22
1449936|NCT02144675|3548962|P2|NOT COMPLETED|Overall Study||0
1449937|NCT02144675|3548963|P1|NOT COMPLETED|Overall Study||0
1449938|NCT02144675|3548962|P2|COMPLETED|Overall Study||14
1449939|NCT02144675|3548963|P1|COMPLETED|Overall Study||13
1449940|NCT02144675|3548962|P2|STARTED|Overall Study||14
1449941|NCT02144675|3548963|P1|STARTED|Overall Study||13
1449942|NCT02144519|3548971|P2|NOT COMPLETED|Year 3||0
1449943|NCT02144519|3548972|P1|NOT COMPLETED|Year 3||0
1449944|NCT02144519|3548971|P2|COMPLETED|Year 3||760
1449945|NCT02144519|3548972|P1|COMPLETED|Year 3||894
1449946|NCT02144519|3548971|P2|STARTED|Year 3||760
1449947|NCT02144519|3548972|P1|STARTED|Year 3||894
1449948|NCT02144519|3548971|P2|NOT COMPLETED|Year 2||0
1449949|NCT02144519|3548972|P1|NOT COMPLETED|Year 2||0
1449950|NCT02144519|3548971|P2|COMPLETED|Year 2||864
1449951|NCT02144519|3548972|P1|COMPLETED|Year 2||763
1449952|NCT02144519|3548971|P2|STARTED|Year 2||864
1449953|NCT02144519|3548972|P1|STARTED|Year 2||763
1449954|NCT02144519|3548971|P2|NOT COMPLETED|Year 1||0
1449955|NCT02144519|3548972|P1|NOT COMPLETED|Year 1||0
1449956|NCT02144519|3548971|P2|COMPLETED|Year 1||870
1449957|NCT02144519|3548972|P1|COMPLETED|Year 1||895
1449958|NCT02144519|3548971|P2|STARTED|Year 1||870
1449959|NCT02144519|3548972|P1|STARTED|Year 1||895
1449960|NCT02144337|3548982|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
1449961|NCT02144337|3548983|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
1449962|NCT02144337|3548982|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
1449963|NCT02144337|3548983|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
1449964|NCT02144337|3548982|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
1449965|NCT02144337|3548983|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
1449966|NCT02144337|3548982|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
1449967|NCT02144337|3548983|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
1449968|NCT02144337|3548982|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
1449969|NCT02144337|3548983|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
1449970|NCT02144337|3548982|P2|STARTED|T2 Follow-up (Post-intervention)||5
1449971|NCT02144337|3548983|P1|STARTED|T2 Follow-up (Post-intervention)||8
1449972|NCT02144337|3548982|P2|NOT COMPLETED|Baseline 0 Months||0
1449973|NCT02144337|3548983|P1|NOT COMPLETED|Baseline 0 Months||0
1449974|NCT02144337|3548982|P2|COMPLETED|Baseline 0 Months||5
1449975|NCT02144337|3548983|P1|COMPLETED|Baseline 0 Months||8
1449976|NCT02144337|3548982|P2|STARTED|Baseline 0 Months||5
1449977|NCT02144337|3548983|P1|STARTED|Baseline 0 Months||8
1449978|NCT02144259|3548996|P3|NOT COMPLETED|Overall Study||18
1449979|NCT02144259|3548997|P2|NOT COMPLETED|Overall Study||5
1449980|NCT02144259|3548998|P1|NOT COMPLETED|Overall Study||10
1449981|NCT02144259|3548996|P3|COMPLETED|Overall Study||16
1449982|NCT02144259|3548997|P2|COMPLETED|Overall Study||28
1449983|NCT02144259|3548998|P1|COMPLETED|Overall Study||23
1449984|NCT02144259|3548996|P3|STARTED|Overall Study||34
1449985|NCT02144259|3548997|P2|STARTED|Overall Study||33
1449986|NCT02144259|3548998|P1|STARTED|Overall Study||33
1449987|NCT02144220|3549012|P1|NOT COMPLETED|Overall Study||19
1449988|NCT02144220|3549012|P1|COMPLETED|Overall Study||258
1449989|NCT02144220|3549012|P1|STARTED|Overall Study||277
1449990|NCT02144012|3549022|P2|NOT COMPLETED|Overall Study||15
1449991|NCT02144012|3549023|P1|NOT COMPLETED|Overall Study||34
1449992|NCT02144012|3549022|P2|COMPLETED|Overall Study||0
1449993|NCT02144012|3549023|P1|COMPLETED|Overall Study||0
1449994|NCT02144012|3549022|P2|STARTED|Overall Study||15
1449995|NCT02144012|3549023|P1|STARTED|Overall Study||34
1449996|NCT02143947|3549060|P2|NOT COMPLETED|Overall Study||2
1449997|NCT02143947|3549061|P1|NOT COMPLETED|Overall Study||4
1449998|NCT02143947|3549060|P2|COMPLETED|Overall Study||42
1449999|NCT02143947|3549061|P1|COMPLETED|Overall Study||32
1450000|NCT02143947|3549060|P2|STARTED|Overall Study||44
1450001|NCT02143947|3549061|P1|STARTED|Overall Study||36
1450002|NCT02143713|3549077|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
1450003|NCT02143713|3549078|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
1450004|NCT02143713|3549079|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
1450005|NCT02143713|3549080|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
1450006|NCT02143713|3549077|P4|COMPLETED|Post-treatment Follow-up (12 Months)||95
1450007|NCT02143713|3549078|P3|COMPLETED|Post-treatment Follow-up (12 Months)||96
1450008|NCT02143713|3549079|P2|COMPLETED|Post-treatment Follow-up (12 Months)||81
1450009|NCT02143713|3549080|P1|COMPLETED|Post-treatment Follow-up (12 Months)||73
1450010|NCT02143713|3549077|P4|STARTED|Post-treatment Follow-up (12 Months)||122
1450011|NCT02143713|3549078|P3|STARTED|Post-treatment Follow-up (12 Months)||125
1450012|NCT02143713|3549079|P2|STARTED|Post-treatment Follow-up (12 Months)||105
1450013|NCT02143713|3549080|P1|STARTED|Post-treatment Follow-up (12 Months)||85
1450014|NCT02143713|3549077|P4|NOT COMPLETED|Treatment Period (6 Months)||28
1450015|NCT02143713|3549078|P3|NOT COMPLETED|Treatment Period (6 Months)||22
1450016|NCT02143713|3549079|P2|NOT COMPLETED|Treatment Period (6 Months)||12
1450017|NCT02143713|3549080|P1|NOT COMPLETED|Treatment Period (6 Months)||20
1450018|NCT02143713|3549077|P4|COMPLETED|Treatment Period (6 Months)||112
1450019|NCT02143713|3549078|P3|COMPLETED|Treatment Period (6 Months)||120
1450020|NCT02143713|3549079|P2|COMPLETED|Treatment Period (6 Months)||99
1450021|NCT02143713|3549080|P1|COMPLETED|Treatment Period (6 Months)||82
1450022|NCT02143713|3549077|P4|Received Elagolix|Treatment Period (6 Months)||140
1450023|NCT02143713|3549078|P3|Received Elagolix|Treatment Period (6 Months)||142
1450024|NCT02143713|3549079|P2|Received Elagolix|Treatment Period (6 Months)||111
1450025|NCT02143713|3549080|P1|Received Elagolix|Treatment Period (6 Months)||102
1450026|NCT02143713|3549077|P4|STARTED|Treatment Period (6 Months)||140
1450027|NCT02143713|3549078|P3|STARTED|Treatment Period (6 Months)||142
1450028|NCT02143713|3549079|P2|STARTED|Treatment Period (6 Months)||111
1450029|NCT02143713|3549080|P1|STARTED|Treatment Period (6 Months)||102
1450030|NCT02143583|3549161|P3|NOT COMPLETED|Overall Study||2
1450031|NCT02143583|3549162|P2|NOT COMPLETED|Overall Study||0
1450032|NCT02143583|3549163|P1|NOT COMPLETED|Overall Study||1
1450033|NCT02143583|3549161|P3|COMPLETED|Overall Study||66
1450034|NCT02143583|3549162|P2|COMPLETED|Overall Study||66
1450035|NCT02143583|3549163|P1|COMPLETED|Overall Study||61
1450036|NCT02143583|3549161|P3|STARTED|Overall Study||68
1450037|NCT02143583|3549162|P2|STARTED|Overall Study||66
1450038|NCT02143583|3549163|P1|STARTED|Overall Study||62
1450039|NCT02143141|3549176|P2|NOT COMPLETED|Overall Study||0
1450040|NCT02143141|3549177|P1|NOT COMPLETED|Overall Study||1
1450041|NCT02143141|3549176|P2|COMPLETED|Overall Study||6
1450042|NCT02143141|3549177|P1|COMPLETED|Overall Study||6
1450043|NCT02143141|3549176|P2|STARTED|Overall Study||6
1450044|NCT02143141|3549177|P1|STARTED|Overall Study||7
1450045|NCT02143102|3549189|P2|NOT COMPLETED|Overall Study||0
1450046|NCT02143102|3549190|P1|NOT COMPLETED|Overall Study||11
1450047|NCT02143102|3549189|P2|COMPLETED|Overall Study||28
1450048|NCT02143102|3549190|P1|COMPLETED|Overall Study||86
1450049|NCT02143102|3549189|P2|STARTED|Overall Study||28
1450050|NCT02143102|3549190|P1|STARTED|Overall Study||97
1450051|NCT02142738|3549200|P2|NOT COMPLETED|Overall Study||151
1450052|NCT02142738|3549201|P1|NOT COMPLETED|Overall Study||154
1450053|NCT02142738|3549200|P2|COMPLETED|Overall Study||0
1450054|NCT02142738|3549201|P1|COMPLETED|Overall Study||0
1450055|NCT02142738|3549200|P2|Treated|Overall Study||150
1450056|NCT02142738|3549201|P1|Treated|Overall Study||154
1450057|NCT02142738|3549200|P2|STARTED|Overall Study||151
1450058|NCT02142738|3549201|P1|STARTED|Overall Study||154
1450059|NCT02142712|3549214|P4|NOT COMPLETED|Overall Study||0
1450060|NCT02142712|3549215|P3|NOT COMPLETED|Overall Study||1
1450061|NCT02142712|3549216|P2|NOT COMPLETED|Overall Study||1
1450062|NCT02142712|3549217|P1|NOT COMPLETED|Overall Study||1
1450063|NCT02142712|3549214|P4|COMPLETED|Overall Study||0
1450064|NCT02142712|3549215|P3|COMPLETED|Overall Study||0
1450065|NCT02142712|3549216|P2|COMPLETED|Overall Study||0
1450066|NCT02142712|3549217|P1|COMPLETED|Overall Study||0
1450067|NCT02142712|3549214|P4|STARTED|Overall Study||0
1450068|NCT02142712|3549215|P3|STARTED|Overall Study||1
1450069|NCT02142712|3549216|P2|STARTED|Overall Study||1
1450070|NCT02142712|3549217|P1|STARTED|Overall Study||1
1450071|NCT02142504|3549240|P3|NOT COMPLETED|Overall Study||43
1450072|NCT02142504|3549241|P2|NOT COMPLETED|Overall Study||42
1450073|NCT02142504|3549242|P1|NOT COMPLETED|Overall Study||31
1450074|NCT02142504|3549240|P3|COMPLETED|Overall Study||111
1450075|NCT02142504|3549241|P2|COMPLETED|Overall Study||105
1450076|NCT02142504|3549242|P1|COMPLETED|Overall Study||122
1450077|NCT02142504|3549240|P3|Received Booster (Second Vaccination)|Overall Study||116
1450078|NCT02142504|3549241|P2|Received Booster (Second Vaccination)|Overall Study||109
1450079|NCT02142504|3549242|P1|Received Booster (Second Vaccination)|Overall Study||126
1450080|NCT02142504|3549240|P3|Randomized and Received Treatment|Overall Study||154
1450081|NCT02142504|3549241|P2|Randomized and Received Treatment|Overall Study||145
1450082|NCT02142504|3549242|P1|Randomized and Received Treatment|Overall Study||153
1450083|NCT02142504|3549240|P3|STARTED|Overall Study||154
1450084|NCT02142504|3549241|P2|STARTED|Overall Study||147
1450085|NCT02142504|3549242|P1|STARTED|Overall Study||153
1450086|NCT02142361|3549328|P3|NOT COMPLETED|Overall Study||0
1450087|NCT02142361|3549329|P2|NOT COMPLETED|Overall Study||0
1450088|NCT02142361|3549330|P1|NOT COMPLETED|Overall Study||0
1450089|NCT02142361|3549328|P3|COMPLETED|Overall Study||20
1450090|NCT02142361|3549329|P2|COMPLETED|Overall Study||20
1450091|NCT02142361|3549330|P1|COMPLETED|Overall Study||20
1450092|NCT02142361|3549328|P3|STARTED|Overall Study||20
1450093|NCT02142361|3549329|P2|STARTED|Overall Study||20
1450094|NCT02142361|3549330|P1|STARTED|Overall Study||20
1450095|NCT02142283|3549431|P2|NOT COMPLETED|Overall Study||21
1450096|NCT02142283|3549432|P1|NOT COMPLETED|Overall Study||21
1450097|NCT02142283|3549431|P2|COMPLETED|Overall Study||78
1450098|NCT02142283|3549432|P1|COMPLETED|Overall Study||86
1450099|NCT02142283|3549431|P2|STARTED|Overall Study||99
1450100|NCT02142283|3549432|P1|STARTED|Overall Study||107
1450101|NCT02142153|3549462|P10|NOT COMPLETED|Overall Study||0
1450102|NCT02142153|3549463|P9|NOT COMPLETED|Overall Study||0
1450103|NCT02142153|3549464|P8|NOT COMPLETED|Overall Study||0
1450104|NCT02142153|3549465|P7|NOT COMPLETED|Overall Study||0
1450105|NCT02142153|3549466|P6|NOT COMPLETED|Overall Study||0
1450106|NCT02142153|3549467|P5|NOT COMPLETED|Overall Study||0
1450107|NCT02142153|3549468|P4|NOT COMPLETED|Overall Study||0
1450108|NCT02142153|3549469|P3|NOT COMPLETED|Overall Study||0
1450109|NCT02142153|3549470|P2|NOT COMPLETED|Overall Study||0
1450110|NCT02142153|3549471|P1|NOT COMPLETED|Overall Study||0
1450111|NCT02142153|3549462|P10|COMPLETED|Overall Study||2
1450112|NCT02142153|3549463|P9|COMPLETED|Overall Study||6
1450113|NCT02142153|3549464|P8|COMPLETED|Overall Study||2
1450114|NCT02142153|3549465|P7|COMPLETED|Overall Study||6
1450115|NCT02142153|3549466|P6|COMPLETED|Overall Study||2
1450116|NCT02142153|3549467|P5|COMPLETED|Overall Study||6
1450117|NCT02142153|3549468|P4|COMPLETED|Overall Study||2
1450118|NCT02142153|3549469|P3|COMPLETED|Overall Study||6
1450119|NCT02142153|3549470|P2|COMPLETED|Overall Study||2
1450120|NCT02142153|3549471|P1|COMPLETED|Overall Study||6
1450121|NCT02142153|3549462|P10|STARTED|Overall Study||2
1450122|NCT02142153|3549463|P9|STARTED|Overall Study||6
1450123|NCT02142153|3549464|P8|STARTED|Overall Study||2
1450124|NCT02142153|3549465|P7|STARTED|Overall Study||6
1450125|NCT02142153|3549466|P6|STARTED|Overall Study||2
1450126|NCT02142153|3549467|P5|STARTED|Overall Study||6
1450127|NCT02142153|3549468|P4|STARTED|Overall Study||2
1450128|NCT02142153|3549469|P3|STARTED|Overall Study||6
1450129|NCT02142153|3549470|P2|STARTED|Overall Study||2
1450130|NCT02142153|3549471|P1|STARTED|Overall Study||6
1450131|NCT02141997|3549507|P4|NOT COMPLETED|Overall Study||1
1450132|NCT02141997|3549508|P3|NOT COMPLETED|Overall Study||3
1450133|NCT02141997|3549509|P2|NOT COMPLETED|Overall Study||6
1450134|NCT02141997|3549510|P1|NOT COMPLETED|Overall Study||3
1450135|NCT02141997|3549507|P4|COMPLETED|Overall Study||54
1450136|NCT02141997|3549508|P3|COMPLETED|Overall Study||53
1450137|NCT02141997|3549509|P2|COMPLETED|Overall Study||49
1450138|NCT02141997|3549510|P1|COMPLETED|Overall Study||53
1450139|NCT02141997|3549507|P4|STARTED|Overall Study||55
1450140|NCT02141997|3549508|P3|STARTED|Overall Study||56
1450141|NCT02141997|3549509|P2|STARTED|Overall Study||55
1450142|NCT02141997|3549510|P1|STARTED|Overall Study||56
1450143|NCT02141984|3549548|P1|NOT COMPLETED|Overall Study||2
1450144|NCT02141984|3549548|P1|COMPLETED|Overall Study||26
1450145|NCT02141984|3549548|P1|STARTED|Overall Study||28
1450146|NCT02141867|3549555|P1|NOT COMPLETED|Overall Study||94
1450147|NCT02141867|3549555|P1|COMPLETED|Overall Study||3927
1450148|NCT02141867|3549555|P1|STARTED|Overall Study||4021
1450149|NCT02141854|3549567|P6|NOT COMPLETED|Treatment Period||38
1450150|NCT02141854|3549568|P5|NOT COMPLETED|Treatment Period||10
1450151|NCT02141854|3549569|P4|NOT COMPLETED|Treatment Period||11
1450152|NCT02141854|3549570|P3|NOT COMPLETED|Treatment Period||9
1450153|NCT02141854|3549571|P2|NOT COMPLETED|Treatment Period||10
1450154|NCT02141854|3549572|P1|NOT COMPLETED|Treatment Period||0
1450155|NCT02141854|3549567|P6|COMPLETED|Treatment Period||107
1450156|NCT02141854|3549568|P5|COMPLETED|Treatment Period||136
1450157|NCT02141854|3549569|P4|COMPLETED|Treatment Period||135
1450158|NCT02141854|3549570|P3|COMPLETED|Treatment Period||136
1450159|NCT02141854|3549571|P2|COMPLETED|Treatment Period||136
1450160|NCT02141854|3549572|P1|COMPLETED|Treatment Period||0
1450161|NCT02141854|3549567|P6|Full Analysis Set|Treatment Period||143
1450162|NCT02141854|3549568|P5|Full Analysis Set|Treatment Period||145
1450163|NCT02141854|3549569|P4|Full Analysis Set|Treatment Period||146
1450164|NCT02141854|3549570|P3|Full Analysis Set|Treatment Period||141
1450165|NCT02141854|3549571|P2|Full Analysis Set|Treatment Period||145
1450166|NCT02141854|3549572|P1|Full Analysis Set|Treatment Period||0
1450167|NCT02141854|3549567|P6|Safety Population|Treatment Period||144
1450168|NCT02141854|3549568|P5|Safety Population|Treatment Period||145
1450169|NCT02141854|3549569|P4|Safety Population|Treatment Period||146
1450170|NCT02141854|3549570|P3|Safety Population|Treatment Period||143
1450171|NCT02141854|3549571|P2|Safety Population|Treatment Period||145
1450172|NCT02141854|3549572|P1|Safety Population|Treatment Period||0
1450173|NCT02141854|3549567|P6|Intent to Treat Population|Treatment Period||145
1450174|NCT02141854|3549568|P5|Intent to Treat Population|Treatment Period||146
1450175|NCT02141854|3549569|P4|Intent to Treat Population|Treatment Period||146
1450176|NCT02141854|3549570|P3|Intent to Treat Population|Treatment Period||145
1450177|NCT02141854|3549571|P2|Intent to Treat Population|Treatment Period||146
1450178|NCT02141854|3549572|P1|Intent to Treat Population|Treatment Period||0
1450179|NCT02141854|3549567|P6|STARTED|Treatment Period||145
1450180|NCT02141854|3549568|P5|STARTED|Treatment Period||146
1450181|NCT02141854|3549569|P4|STARTED|Treatment Period||146
1450182|NCT02141854|3549570|P3|STARTED|Treatment Period||145
1450183|NCT02141854|3549571|P2|STARTED|Treatment Period||146
1450184|NCT02141854|3549572|P1|STARTED|Treatment Period||0
1450185|NCT02141854|3549567|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450186|NCT02141854|3549568|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450187|NCT02141854|3549569|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450188|NCT02141854|3549570|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450189|NCT02141854|3549571|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450190|NCT02141854|3549572|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
1450191|NCT02141854|3549567|P6|COMPLETED|Run-In Period (Pre-assignment)||0
1450192|NCT02141854|3549568|P5|COMPLETED|Run-In Period (Pre-assignment)||0
1450193|NCT02141854|3549569|P4|COMPLETED|Run-In Period (Pre-assignment)||0
1450194|NCT02141854|3549570|P3|COMPLETED|Run-In Period (Pre-assignment)||0
1450195|NCT02141854|3549571|P2|COMPLETED|Run-In Period (Pre-assignment)||0
1450196|NCT02141854|3549572|P1|COMPLETED|Run-In Period (Pre-assignment)||728
1450197|NCT02141854|3549567|P6|STARTED|Run-In Period (Pre-assignment)||0
1450198|NCT02141854|3549568|P5|STARTED|Run-In Period (Pre-assignment)||0
1450199|NCT02141854|3549569|P4|STARTED|Run-In Period (Pre-assignment)||0
1450200|NCT02141854|3549570|P3|STARTED|Run-In Period (Pre-assignment)||0
1450201|NCT02141854|3549571|P2|STARTED|Run-In Period (Pre-assignment)||0
1450202|NCT02141854|3549572|P1|STARTED|Run-In Period (Pre-assignment)||882
1450203|NCT02141659|3549630|P6|NOT COMPLETED|Overall Study||2
1450204|NCT02141659|3549631|P5|NOT COMPLETED|Overall Study||2
1450205|NCT02141659|3549632|P4|NOT COMPLETED|Overall Study||0
1450206|NCT02141659|3549633|P3|NOT COMPLETED|Overall Study||0
1450207|NCT02141659|3549634|P2|NOT COMPLETED|Overall Study||1
1450208|NCT02141659|3549635|P1|NOT COMPLETED|Overall Study||0
1450209|NCT02141659|3549630|P6|COMPLETED|Overall Study||13
1450210|NCT02141659|3549631|P5|COMPLETED|Overall Study||13
1450211|NCT02141659|3549632|P4|COMPLETED|Overall Study||3
1450212|NCT02141659|3549633|P3|COMPLETED|Overall Study||3
1450213|NCT02141659|3549634|P2|COMPLETED|Overall Study||3
1450214|NCT02141659|3549635|P1|COMPLETED|Overall Study||3
1450215|NCT02141659|3549630|P6|STARTED|Overall Study||15
1450216|NCT02141659|3549631|P5|STARTED|Overall Study||15
1450217|NCT02141659|3549632|P4|STARTED|Overall Study||3
1450218|NCT02141659|3549633|P3|STARTED|Overall Study||3
1450219|NCT02141659|3549634|P2|STARTED|Overall Study||4
1450220|NCT02141659|3549635|P1|STARTED|Overall Study||3
1450221|NCT02141633|3549691|P2|NOT COMPLETED|Overall Study||0
1450222|NCT02141633|3549692|P1|NOT COMPLETED|Overall Study||1
1450223|NCT02141633|3549691|P2|COMPLETED|Overall Study||15
1450224|NCT02141633|3549692|P1|COMPLETED|Overall Study||15
1450225|NCT02141633|3549691|P2|STARTED|Overall Study||15
1450226|NCT02141633|3549692|P1|STARTED|Overall Study||16
1450227|NCT02141620|3549700|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
1450228|NCT02141620|3549701|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
1450229|NCT02141620|3549700|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
1450230|NCT02141620|3549701|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
1450231|NCT02141620|3549700|P2|STARTED|Treatment Condition 2 (7 Days)||7
1450232|NCT02141620|3549701|P1|STARTED|Treatment Condition 2 (7 Days)||7
1450233|NCT02141620|3549700|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
1450234|NCT02141620|3549701|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
1450235|NCT02141620|3549700|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
1450236|NCT02141620|3549701|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
1450237|NCT02141620|3549700|P2|STARTED|Treatment Condition 1 (7 Days)||7
1450238|NCT02141620|3549701|P1|STARTED|Treatment Condition 1 (7 Days)||8
1450239|NCT02141581|3549762|P3|NOT COMPLETED|Overall Study||0
1450240|NCT02141581|3549763|P2|NOT COMPLETED|Overall Study||0
1450241|NCT02141581|3549764|P1|NOT COMPLETED|Overall Study||0
1450242|NCT02141581|3549762|P3|COMPLETED|Overall Study||25
1450243|NCT02141581|3549763|P2|COMPLETED|Overall Study||19
1450244|NCT02141581|3549764|P1|COMPLETED|Overall Study||42
1450245|NCT02141581|3549762|P3|STARTED|Overall Study||25
1450246|NCT02141581|3549763|P2|STARTED|Overall Study||19
1450247|NCT02141581|3549764|P1|STARTED|Overall Study||42
1450248|NCT02141516|3549778|P3|NOT COMPLETED|Overall Study||0
1450249|NCT02141516|3549779|P2|NOT COMPLETED|Overall Study||5
1450250|NCT02141516|3549780|P1|NOT COMPLETED|Overall Study||0
1450251|NCT02141516|3549778|P3|COMPLETED|Overall Study||87
1450252|NCT02141516|3549779|P2|COMPLETED|Overall Study||107
1450253|NCT02141516|3549780|P1|COMPLETED|Overall Study||40
1450254|NCT02141516|3549778|P3|STARTED|Overall Study||87
1450255|NCT02141516|3549779|P2|STARTED|Overall Study||112
1450256|NCT02141516|3549780|P1|STARTED|Overall Study||40
1450257|NCT02141399|3549828|P1|NOT COMPLETED|Overall Study||744
1450258|NCT02141399|3549828|P1|COMPLETED|Overall Study||741
1450259|NCT02141399|3549828|P1|STARTED|Overall Study||1485
1450260|NCT02141360|3549834|P3|NOT COMPLETED|Overall Study||0
1450261|NCT02141360|3549835|P2|NOT COMPLETED|Overall Study||0
1450262|NCT02141360|3549836|P1|NOT COMPLETED|Overall Study||7
1450263|NCT02141360|3549834|P3|COMPLETED|Overall Study||6
1450264|NCT02141360|3549835|P2|COMPLETED|Overall Study||6
1450265|NCT02141360|3549836|P1|COMPLETED|Overall Study||4
1450266|NCT02141360|3549834|P3|STARTED|Overall Study||6
1450267|NCT02141360|3549835|P2|STARTED|Overall Study||6
1450268|NCT02141360|3549836|P1|STARTED|Overall Study||11
1450269|NCT02141217|3549846|P2|NOT COMPLETED|Overall Study||8
1450270|NCT02141217|3549847|P1|NOT COMPLETED|Overall Study||11
1450271|NCT02141217|3549846|P2|COMPLETED|Overall Study||229
1450272|NCT02141217|3549847|P1|COMPLETED|Overall Study||223
1450273|NCT02141217|3549846|P2|ITT Population-Actual Treatment Received|Overall Study||235
1450274|NCT02141217|3549847|P1|ITT Population-Actual Treatment Received|Overall Study||236
1450275|NCT02141217|3549846|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
1450276|NCT02141217|3549847|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
1450277|NCT02141217|3549846|P2|STARTED|Overall Study||237
1450278|NCT02141217|3549847|P1|STARTED|Overall Study||234
1450279|NCT02140957|3549867|P2|NOT COMPLETED|Overall Study||23
1450280|NCT02140957|3549868|P1|NOT COMPLETED|Overall Study||27
1450281|NCT02140957|3549867|P2|COMPLETED|Overall Study||99
1450282|NCT02140957|3549868|P1|COMPLETED|Overall Study||102
1450283|NCT02140957|3549867|P2|STARTED|Overall Study||122
1450284|NCT02140957|3549868|P1|STARTED|Overall Study||129
1450285|NCT02140788|3549878|P4|NOT COMPLETED|Overall Study||0
1450286|NCT02140788|3549879|P3|NOT COMPLETED|Overall Study||0
1450287|NCT02140788|3549880|P2|NOT COMPLETED|Overall Study||0
1450288|NCT02140788|3549881|P1|NOT COMPLETED|Overall Study||0
1450289|NCT02140788|3549878|P4|COMPLETED|Overall Study||0
1450290|NCT02140788|3549879|P3|COMPLETED|Overall Study||0
1450291|NCT02140788|3549880|P2|COMPLETED|Overall Study||0
1450292|NCT02140788|3549881|P1|COMPLETED|Overall Study||0
1450293|NCT02140788|3549878|P4|STARTED|Overall Study||0
1450294|NCT02140788|3549879|P3|STARTED|Overall Study||0
1450295|NCT02140788|3549880|P2|STARTED|Overall Study||0
1450296|NCT02140788|3549881|P1|STARTED|Overall Study||0
1450297|NCT02140762|3549909|P2|NOT COMPLETED|Overall Study||12
1450298|NCT02140762|3549910|P1|NOT COMPLETED|Overall Study||17
1450299|NCT02140762|3549909|P2|COMPLETED|Overall Study||139
1450300|NCT02140762|3549910|P1|COMPLETED|Overall Study||137
1450301|NCT02140762|3549909|P2|STARTED|Overall Study||151
1450302|NCT02140762|3549910|P1|STARTED|Overall Study||154
1450303|NCT02140645|3549976|P6|NOT COMPLETED|Overall Study||70896
1450304|NCT02140645|3549977|P5|NOT COMPLETED|Overall Study||3286
1450305|NCT02140645|3549978|P4|NOT COMPLETED|Overall Study||13833
1450306|NCT02140645|3549979|P3|NOT COMPLETED|Overall Study||4236
1450307|NCT02140645|3549980|P2|NOT COMPLETED|Overall Study||61654
1450308|NCT02140645|3549981|P1|NOT COMPLETED|Overall Study||5489
1450309|NCT02140645|3549976|P6|COMPLETED|Overall Study||3050
1450310|NCT02140645|3549977|P5|COMPLETED|Overall Study||150
1450311|NCT02140645|3549978|P4|COMPLETED|Overall Study||530
1450312|NCT02140645|3549979|P3|COMPLETED|Overall Study||205
1450313|NCT02140645|3549980|P2|COMPLETED|Overall Study||3041
1450314|NCT02140645|3549981|P1|COMPLETED|Overall Study||243
1450315|NCT02140645|3549976|P6|STARTED|Overall Study||73946
1450316|NCT02140645|3549977|P5|STARTED|Overall Study||3436
1450317|NCT02140645|3549978|P4|STARTED|Overall Study||14363
1450318|NCT02140645|3549979|P3|STARTED|Overall Study||4441
1450319|NCT02140645|3549980|P2|STARTED|Overall Study||64695
1450320|NCT02140645|3549981|P1|STARTED|Overall Study||5732
1450321|NCT02140593|3550070|P2|NOT COMPLETED|Overall Study||0
1450322|NCT02140593|3550071|P1|NOT COMPLETED|Overall Study||0
1450323|NCT02140593|3550070|P2|COMPLETED|Overall Study||65
1450324|NCT02140593|3550071|P1|COMPLETED|Overall Study||63
1450325|NCT02140593|3550070|P2|STARTED|Overall Study||65
1450326|NCT02140593|3550071|P1|STARTED|Overall Study||63
1450327|NCT02140567|3550079|P1|NOT COMPLETED|Overall Study||6
1450328|NCT02140567|3550079|P1|COMPLETED|Overall Study||134
1450329|NCT02140567|3550079|P1|STARTED|Overall Study||140
1450330|NCT02140372|3550084|P1|NOT COMPLETED|Overall Study||0
1450331|NCT02140372|3550084|P1|COMPLETED|Overall Study||10
1450332|NCT02140372|3550084|P1|STARTED|Overall Study||10
1450333|NCT02140164|3550095|P1|NOT COMPLETED|Overall Study||2
1450334|NCT02140164|3550095|P1|COMPLETED|Overall Study||5
1450335|NCT02140164|3550095|P1|STARTED|Overall Study||7
1450336|NCT02140060|3550116|P6|NOT COMPLETED|Overall Study||1
1450337|NCT02140060|3550117|P5|NOT COMPLETED|Overall Study||1
1450338|NCT02140060|3550118|P4|NOT COMPLETED|Overall Study||2
1450339|NCT02140060|3550119|P3|NOT COMPLETED|Overall Study||0
1450340|NCT02140060|3550120|P2|NOT COMPLETED|Overall Study||0
1450341|NCT02140060|3550121|P1|NOT COMPLETED|Overall Study||0
1450342|NCT02140060|3550116|P6|COMPLETED|Overall Study||43
1450343|NCT02140060|3550117|P5|COMPLETED|Overall Study||44
1450344|NCT02140060|3550118|P4|COMPLETED|Overall Study||43
1450345|NCT02140060|3550119|P3|COMPLETED|Overall Study||44
1450346|NCT02140060|3550120|P2|COMPLETED|Overall Study||44
1450347|NCT02140060|3550121|P1|COMPLETED|Overall Study||44
1450348|NCT02140060|3550116|P6|STARTED|Overall Study||44
1450349|NCT02140060|3550117|P5|STARTED|Overall Study||45
1450350|NCT02140060|3550118|P4|STARTED|Overall Study||45
1450351|NCT02140060|3550119|P3|STARTED|Overall Study||44
1450352|NCT02140060|3550120|P2|STARTED|Overall Study||44
1450353|NCT02140060|3550121|P1|STARTED|Overall Study||44
1450354|NCT02139982|3550146|P10|NOT COMPLETED|Overall Study||0
1450355|NCT02139982|3550147|P9|NOT COMPLETED|Overall Study||0
1450356|NCT02139982|3550148|P8|NOT COMPLETED|Overall Study||0
1450357|NCT02139982|3550149|P7|NOT COMPLETED|Overall Study||0
1450358|NCT02139982|3550150|P6|NOT COMPLETED|Overall Study||0
1450359|NCT02139982|3550151|P5|NOT COMPLETED|Overall Study||0
1450360|NCT02139982|3550152|P4|NOT COMPLETED|Overall Study||1
1450361|NCT02139982|3550153|P3|NOT COMPLETED|Overall Study||0
1450362|NCT02139982|3550154|P2|NOT COMPLETED|Overall Study||1
1450363|NCT02139982|3550155|P1|NOT COMPLETED|Overall Study||0
1450364|NCT02139982|3550146|P10|COMPLETED|Overall Study||13
1450365|NCT02139982|3550147|P9|COMPLETED|Overall Study||13
1450366|NCT02139982|3550148|P8|COMPLETED|Overall Study||13
1450367|NCT02139982|3550149|P7|COMPLETED|Overall Study||13
1450368|NCT02139982|3550150|P6|COMPLETED|Overall Study||13
1450369|NCT02139982|3550151|P5|COMPLETED|Overall Study||13
1450370|NCT02139982|3550152|P4|COMPLETED|Overall Study||7
1450371|NCT02139982|3550153|P3|COMPLETED|Overall Study||8
1450372|NCT02139982|3550154|P2|COMPLETED|Overall Study||7
1450373|NCT02139982|3550155|P1|COMPLETED|Overall Study||8
1450374|NCT02139982|3550146|P10|STARTED|Overall Study||13
1450375|NCT02139982|3550147|P9|STARTED|Overall Study||13
1450376|NCT02139982|3550148|P8|STARTED|Overall Study||13
1450377|NCT02139982|3550149|P7|STARTED|Overall Study||13
1450378|NCT02139982|3550150|P6|STARTED|Overall Study||13
1450379|NCT02139982|3550151|P5|STARTED|Overall Study||13
1450380|NCT02139982|3550152|P4|STARTED|Overall Study||8
1450381|NCT02139982|3550153|P3|STARTED|Overall Study||8
1450382|NCT02139982|3550154|P2|STARTED|Overall Study||8
1450383|NCT02139982|3550155|P1|STARTED|Overall Study||8
1450384|NCT02139943|3550200|P3|NOT COMPLETED|Overall Study||7
1450385|NCT02139943|3550201|P2|NOT COMPLETED|Overall Study||6
1450386|NCT02139943|3550202|P1|NOT COMPLETED|Overall Study||10
1450387|NCT02139943|3550200|P3|COMPLETED|Overall Study||110
1450388|NCT02139943|3550201|P2|COMPLETED|Overall Study||111
1450389|NCT02139943|3550202|P1|COMPLETED|Overall Study||107
1450390|NCT02139943|3550200|P3|STARTED|Overall Study||117
1450391|NCT02139943|3550201|P2|STARTED|Overall Study||117
1450392|NCT02139943|3550202|P1|STARTED|Overall Study||117
1450393|NCT02139878|3550213|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1450394|NCT02139878|3550214|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1450395|NCT02139878|3550213|P2|COMPLETED|Second Intervention (7 Days)||10
1450396|NCT02139878|3550214|P1|COMPLETED|Second Intervention (7 Days)||9
1450397|NCT02139878|3550213|P2|STARTED|Second Intervention (7 Days)||10
1450398|NCT02139878|3550214|P1|STARTED|Second Intervention (7 Days)||9
1450399|NCT02139878|3550213|P2|NOT COMPLETED|Washout Period (8 Days)||0
1450400|NCT02139878|3550214|P1|NOT COMPLETED|Washout Period (8 Days)||0
1450401|NCT02139878|3550213|P2|COMPLETED|Washout Period (8 Days)||10
1450402|NCT02139878|3550214|P1|COMPLETED|Washout Period (8 Days)||9
1450403|NCT02139878|3550213|P2|STARTED|Washout Period (8 Days)||10
1450404|NCT02139878|3550214|P1|STARTED|Washout Period (8 Days)||9
1450405|NCT02139878|3550213|P2|NOT COMPLETED|First Intervention (7 Days)||0
1450406|NCT02139878|3550214|P1|NOT COMPLETED|First Intervention (7 Days)||1
1450407|NCT02139878|3550213|P2|COMPLETED|First Intervention (7 Days)||10
1450408|NCT02139878|3550214|P1|COMPLETED|First Intervention (7 Days)||9
1450409|NCT02139878|3550213|P2|STARTED|First Intervention (7 Days)||10
1450410|NCT02139878|3550214|P1|STARTED|First Intervention (7 Days)||10
1450411|NCT02139644|3550227|P6|NOT COMPLETED|Treatment Period||17
1450412|NCT02139644|3550228|P5|NOT COMPLETED|Treatment Period||8
1450413|NCT02139644|3550229|P4|NOT COMPLETED|Treatment Period||9
1450414|NCT02139644|3550230|P3|NOT COMPLETED|Treatment Period||8
1450415|NCT02139644|3550231|P2|NOT COMPLETED|Treatment Period||3
1450416|NCT02139644|3550232|P1|NOT COMPLETED|Treatment Period||0
1450417|NCT02139644|3550227|P6|COMPLETED|Treatment Period||113
1450418|NCT02139644|3550228|P5|COMPLETED|Treatment Period||121
1450419|NCT02139644|3550229|P4|COMPLETED|Treatment Period||121
1450420|NCT02139644|3550230|P3|COMPLETED|Treatment Period||121
1450421|NCT02139644|3550231|P2|COMPLETED|Treatment Period||126
1450422|NCT02139644|3550232|P1|COMPLETED|Treatment Period||0
1450423|NCT02139644|3550227|P6|STARTED|Treatment Period|Randomized|130
1450424|NCT02139644|3550228|P5|STARTED|Treatment Period|Randomized|129
1450425|NCT02139644|3550229|P4|STARTED|Treatment Period|Randomized|130
1450426|NCT02139644|3550230|P3|STARTED|Treatment Period|Randomized|129
1450427|NCT02139644|3550231|P2|STARTED|Treatment Period|Randomized|129
1450428|NCT02139644|3550232|P1|STARTED|Treatment Period||0
1450429|NCT02139644|3550227|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450430|NCT02139644|3550228|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450431|NCT02139644|3550229|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450432|NCT02139644|3550230|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450433|NCT02139644|3550231|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
1450434|NCT02139644|3550232|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
1450435|NCT02139644|3550227|P6|COMPLETED|Run-In Period (Pre-assignment)||0
1450436|NCT02139644|3550228|P5|COMPLETED|Run-In Period (Pre-assignment)||0
1450437|NCT02139644|3550229|P4|COMPLETED|Run-In Period (Pre-assignment)||0
1450438|NCT02139644|3550230|P3|COMPLETED|Run-In Period (Pre-assignment)||0
1450439|NCT02139644|3550231|P2|COMPLETED|Run-In Period (Pre-assignment)||0
1450440|NCT02139644|3550232|P1|COMPLETED|Run-In Period (Pre-assignment)||647
1450441|NCT02139644|3550227|P6|STARTED|Run-In Period (Pre-assignment)||0
1450442|NCT02139644|3550228|P5|STARTED|Run-In Period (Pre-assignment)||0
1450443|NCT02139644|3550229|P4|STARTED|Run-In Period (Pre-assignment)||0
1450444|NCT02139644|3550230|P3|STARTED|Run-In Period (Pre-assignment)||0
1450445|NCT02139644|3550231|P2|STARTED|Run-In Period (Pre-assignment)||0
1450446|NCT02139644|3550232|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
1450447|NCT02139358|3550284|P1|NOT COMPLETED|Overall Study||0
1450448|NCT02139358|3550284|P1|COMPLETED|Overall Study||15
1450449|NCT02139358|3550284|P1|STARTED|Overall Study||15
1450450|NCT02139228|3550293|P2|NOT COMPLETED|Overall Study||0
1450451|NCT02139228|3550294|P1|NOT COMPLETED|Overall Study||0
1450452|NCT02139228|3550293|P2|COMPLETED|Overall Study||211
1450453|NCT02139228|3550294|P1|COMPLETED|Overall Study||215
1450454|NCT02139228|3550293|P2|STARTED|Overall Study||211
1450455|NCT02139228|3550294|P1|STARTED|Overall Study||215
1450456|NCT02139176|3550304|P2|NOT COMPLETED|Overall Study||0
1450457|NCT02139176|3550305|P1|NOT COMPLETED|Overall Study||0
1450458|NCT02139176|3550304|P2|COMPLETED|Overall Study||100
1450459|NCT02139176|3550305|P1|COMPLETED|Overall Study||100
1450460|NCT02139176|3550304|P2|STARTED|Overall Study||100
1450461|NCT02139176|3550305|P1|STARTED|Overall Study||100
1450462|NCT02139137|3550317|P2|NOT COMPLETED|Overall Study||10
1450463|NCT02139137|3550318|P1|NOT COMPLETED|Overall Study||7
1450464|NCT02139137|3550317|P2|COMPLETED|Overall Study||10
1450465|NCT02139137|3550318|P1|COMPLETED|Overall Study||15
1450466|NCT02139137|3550317|P2|STARTED|Overall Study||20
1450467|NCT02139137|3550318|P1|STARTED|Overall Study||22
1450468|NCT02139046|3550337|P5|NOT COMPLETED|Overall Study||57
1450469|NCT02139046|3550338|P4|NOT COMPLETED|Overall Study||68
1450470|NCT02139046|3550339|P3|NOT COMPLETED|Overall Study||59
1450471|NCT02139046|3550340|P2|NOT COMPLETED|Overall Study||54
1450472|NCT02139046|3550341|P1|NOT COMPLETED|Overall Study||62
1450473|NCT02139046|3550337|P5|COMPLETED|Overall Study||301
1450474|NCT02139046|3550338|P4|COMPLETED|Overall Study||290
1450475|NCT02139046|3550339|P3|COMPLETED|Overall Study||298
1450476|NCT02139046|3550340|P2|COMPLETED|Overall Study||305
1450477|NCT02139046|3550341|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
1450478|NCT02139046|3550337|P5|Full Analysis Set|Overall Study||357
1450479|NCT02139046|3550338|P4|Full Analysis Set|Overall Study||357
1450480|NCT02139046|3550339|P3|Full Analysis Set|Overall Study||355
1450481|NCT02139046|3550340|P2|Full Analysis Set|Overall Study||357
1450482|NCT02139046|3550341|P1|Full Analysis Set|Overall Study||357
1450483|NCT02139046|3550337|P5|Safety Analysis Set|Overall Study||357
1450484|NCT02139046|3550338|P4|Safety Analysis Set|Overall Study||357
1450485|NCT02139046|3550339|P3|Safety Analysis Set|Overall Study||355
1450486|NCT02139046|3550340|P2|Safety Analysis Set|Overall Study||358
1450487|NCT02139046|3550341|P1|Safety Analysis Set|Overall Study||356
1450488|NCT02139046|3550337|P5|STARTED|Overall Study||358
1450489|NCT02139046|3550338|P4|STARTED|Overall Study||358
1450490|NCT02139046|3550339|P3|STARTED|Overall Study||357
1450491|NCT02139046|3550340|P2|STARTED|Overall Study||359
1450492|NCT02139046|3550341|P1|STARTED|Overall Study||358
1450493|NCT02139007|3550365|P2|NOT COMPLETED|Patient Participant Recruitment||1
1450494|NCT02139007|3550366|P1|NOT COMPLETED|Patient Participant Recruitment||2
1450495|NCT02139007|3550365|P2|COMPLETED|Patient Participant Recruitment||13
1450496|NCT02139007|3550366|P1|COMPLETED|Patient Participant Recruitment||11
1450497|NCT02139007|3550365|P2|STARTED|Patient Participant Recruitment||14
1450498|NCT02139007|3550366|P1|STARTED|Patient Participant Recruitment||13
1450499|NCT02139007|3550365|P2|NOT COMPLETED|Study Site Recruitment||4
1450500|NCT02139007|3550366|P1|NOT COMPLETED|Study Site Recruitment||3
1450501|NCT02139007|3550365|P2|COMPLETED|Study Site Recruitment||1
1450502|NCT02139007|3550366|P1|COMPLETED|Study Site Recruitment||1
1450503|NCT02139007|3550365|P2|STARTED|Study Site Recruitment||5
1450504|NCT02139007|3550366|P1|STARTED|Study Site Recruitment||4
1450505|NCT02138838|3550381|P2|NOT COMPLETED|Overall Study||11
1450506|NCT02138838|3550382|P1|NOT COMPLETED|Overall Study||8
1450507|NCT02138838|3550381|P2|COMPLETED|Overall Study||16
1450508|NCT02138838|3550382|P1|COMPLETED|Overall Study||20
1450509|NCT02138838|3550381|P2|Received Study Drug|Overall Study||25
1450510|NCT02138838|3550382|P1|Received Study Drug|Overall Study||28
1450511|NCT02138838|3550381|P2|STARTED|Overall Study||27
1450512|NCT02138838|3550382|P1|STARTED|Overall Study||28
1450513|NCT02138825|3550400|P2|NOT COMPLETED|Safety Follow-up||17
1450514|NCT02138825|3550401|P1|NOT COMPLETED|Safety Follow-up||22
1450515|NCT02138825|3550400|P2|COMPLETED|Safety Follow-up||47
1450516|NCT02138825|3550401|P1|COMPLETED|Safety Follow-up||50
1450517|NCT02138825|3550400|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
1450518|NCT02138825|3550401|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
1450519|NCT02138825|3550400|P2|NOT COMPLETED|Long-term Extension||38
1450520|NCT02138825|3550401|P1|NOT COMPLETED|Long-term Extension||32
1450521|NCT02138825|3550400|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
1450522|NCT02138825|3550401|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
1450523|NCT02138825|3550400|P2|STARTED|Long-term Extension||38
1450524|NCT02138825|3550401|P1|STARTED|Long-term Extension||32
1450525|NCT02138825|3550400|P2|NOT COMPLETED|Main Study Treatment||35
1450526|NCT02138825|3550401|P1|NOT COMPLETED|Main Study Treatment||40
1450527|NCT02138825|3550400|P2|COMPLETED|Main Study Treatment||39
1450528|NCT02138825|3550401|P1|COMPLETED|Main Study Treatment||33
1450529|NCT02138825|3550400|P2|STARTED|Main Study Treatment|safety population|74
1450530|NCT02138825|3550401|P1|STARTED|Main Study Treatment|safety population|73
1450531|NCT02138747|3550419|P4|NOT COMPLETED|Treatment Period 2||3
1450532|NCT02138747|3550420|P3|NOT COMPLETED|Treatment Period 2||2
1450533|NCT02138747|3550421|P2|NOT COMPLETED|Treatment Period 2||7
1450534|NCT02138747|3550422|P1|NOT COMPLETED|Treatment Period 2||17
1450535|NCT02138747|3550419|P4|COMPLETED|Treatment Period 2||24
1450536|NCT02138747|3550420|P3|COMPLETED|Treatment Period 2||24
1450537|NCT02138747|3550421|P2|COMPLETED|Treatment Period 2||125
1450538|NCT02138747|3550422|P1|COMPLETED|Treatment Period 2||121
1450539|NCT02138747|3550419|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
1450540|NCT02138747|3550420|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
1450541|NCT02138747|3550421|P2|STARTED|Treatment Period 2||132
1450542|NCT02138747|3550422|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
1450543|NCT02138747|3550419|P4|NOT COMPLETED|Treatment Period 1||4
1450544|NCT02138747|3550420|P3|NOT COMPLETED|Treatment Period 1||4
1450545|NCT02138747|3550421|P2|NOT COMPLETED|Treatment Period 1||25
1450546|NCT02138747|3550422|P1|NOT COMPLETED|Treatment Period 1||20
1450547|NCT02138747|3550419|P4|COMPLETED|Treatment Period 1||28
1450548|NCT02138747|3550420|P3|COMPLETED|Treatment Period 1||27
1450549|NCT02138747|3550421|P2|COMPLETED|Treatment Period 1||132
1450550|NCT02138747|3550422|P1|COMPLETED|Treatment Period 1||136
1450551|NCT02138747|3550419|P4|STARTED|Treatment Period 1||32
1450552|NCT02138747|3550420|P3|STARTED|Treatment Period 1||31
1450553|NCT02138747|3550421|P2|STARTED|Treatment Period 1||157
1450554|NCT02138747|3550422|P1|STARTED|Treatment Period 1||156
1450555|NCT02138578|3550457|P3|NOT COMPLETED|Overall Study||0
1450556|NCT02138578|3550458|P2|NOT COMPLETED|Overall Study||0
1450557|NCT02138578|3550459|P1|NOT COMPLETED|Overall Study||0
1450558|NCT02138578|3550457|P3|COMPLETED|Overall Study||3
1450559|NCT02138578|3550458|P2|COMPLETED|Overall Study||0
1450560|NCT02138578|3550459|P1|COMPLETED|Overall Study||1
1450561|NCT02138578|3550457|P3|STARTED|Overall Study||3
1450562|NCT02138578|3550458|P2|STARTED|Overall Study||0
1450563|NCT02138578|3550459|P1|STARTED|Overall Study||1
1450564|NCT02138461|3550487|P2|NOT COMPLETED|Overall Study||0
1450565|NCT02138461|3550488|P1|NOT COMPLETED|Overall Study||0
1450566|NCT02138461|3550487|P2|COMPLETED|Overall Study||110
1450567|NCT02138461|3550488|P1|COMPLETED|Overall Study||101
1450568|NCT02138461|3550487|P2|STARTED|Overall Study||110
1450569|NCT02138461|3550488|P1|STARTED|Overall Study||101
1450570|NCT02138227|3550496|P2|NOT COMPLETED|Overall Study||0
1450571|NCT02138227|3550497|P1|NOT COMPLETED|Overall Study||0
1450572|NCT02138227|3550496|P2|COMPLETED|Overall Study||218
1450573|NCT02138227|3550497|P1|COMPLETED|Overall Study||55
1450574|NCT02138227|3550496|P2|STARTED|Overall Study||218
1450575|NCT02138227|3550497|P1|STARTED|Overall Study||55
1450576|NCT02138110|3550528|P1|NOT COMPLETED|6-month Post-implantation Follow-up||3
1450577|NCT02138110|3550528|P1|COMPLETED|6-month Post-implantation Follow-up||16
1450578|NCT02138110|3550528|P1|STARTED|6-month Post-implantation Follow-up||19
1450579|NCT02138110|3550528|P1|NOT COMPLETED|Enrolled for Scaffold Implantation||1
1450580|NCT02138110|3550528|P1|COMPLETED|Enrolled for Scaffold Implantation||19
1450581|NCT02138110|3550528|P1|STARTED|Enrolled for Scaffold Implantation||20
1450582|NCT02138110|3550528|P1|NOT COMPLETED|Enrolled in Study||5
1450583|NCT02138110|3550528|P1|COMPLETED|Enrolled in Study||20
1450584|NCT02138110|3550528|P1|STARTED|Enrolled in Study||25
1450585|NCT02138097|3550556|P2|NOT COMPLETED|Overall Study||0
1450586|NCT02138097|3550557|P1|NOT COMPLETED|Overall Study||0
1450587|NCT02138097|3550556|P2|COMPLETED|Overall Study||459722
1450588|NCT02138097|3550557|P1|COMPLETED|Overall Study||155345
1450589|NCT02138097|3550556|P2|STARTED|Overall Study||459722
1450590|NCT02138097|3550557|P1|STARTED|Overall Study||155345
1450591|NCT02138006|3550749|P2|NOT COMPLETED|Overall Study||0
1450592|NCT02138006|3550750|P1|NOT COMPLETED|Overall Study||0
1450593|NCT02138006|3550749|P2|COMPLETED|Overall Study||54
1450594|NCT02138006|3550750|P1|COMPLETED|Overall Study||48
1450595|NCT02138006|3550749|P2|STARTED|Overall Study||54
1450596|NCT02138006|3550750|P1|STARTED|Overall Study||48
1450597|NCT02137785|3550760|P2|NOT COMPLETED|Overall Study||4
1450598|NCT02137785|3550761|P1|NOT COMPLETED|Overall Study||3
1450599|NCT02137785|3550760|P2|COMPLETED|Overall Study||130
1450600|NCT02137785|3550761|P1|COMPLETED|Overall Study||132
1450601|NCT02137785|3550760|P2|STARTED|Overall Study||134
1450602|NCT02137785|3550761|P1|STARTED|Overall Study||135
1450603|NCT02137772|3550869|P2|NOT COMPLETED|Overall Study||75
1450604|NCT02137772|3550870|P1|NOT COMPLETED|Overall Study||132
1450605|NCT02137772|3550869|P2|COMPLETED|Overall Study||119
1450606|NCT02137772|3550870|P1|COMPLETED|Overall Study||244
1450607|NCT02137772|3550869|P2|Treated Participants|Overall Study||192
1450608|NCT02137772|3550870|P1|Treated Participants|Overall Study||373
1450609|NCT02137772|3550869|P2|STARTED|Overall Study|Randomized participants|194
1450610|NCT02137772|3550870|P1|STARTED|Overall Study|Randomized participants|376
1450611|NCT02137603|3550896|P2|NOT COMPLETED|Overall Study||0
1450612|NCT02137603|3550897|P1|NOT COMPLETED|Overall Study||2
1450613|NCT02137603|3550896|P2|COMPLETED|Overall Study||18
1450614|NCT02137603|3550897|P1|COMPLETED|Overall Study||16
1450615|NCT02137603|3550896|P2|STARTED|Overall Study||18
1450616|NCT02137603|3550897|P1|STARTED|Overall Study||18
1450617|NCT02137512|3550905|P1|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
1450618|NCT02137512|3550905|P1|COMPLETED|5-Month 24/7 Closed-Loop||14
1450619|NCT02137512|3550905|P1|STARTED|5-Month 24/7 Closed-Loop||14
1450620|NCT02137512|3550905|P1|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
1450621|NCT02137512|3550905|P1|COMPLETED|2-Week 24/7 Closed-Loop||30
1450622|NCT02137512|3550905|P1|STARTED|2-Week 24/7 Closed-Loop||30
1450623|NCT02137512|3550905|P1|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
1450624|NCT02137512|3550905|P1|COMPLETED|2-Week Overnight-Only Closed-Loop||30
1450625|NCT02137512|3550905|P1|STARTED|2-Week Overnight-Only Closed-Loop||30
1450626|NCT02137512|3550905|P1|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
1450627|NCT02137512|3550905|P1|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
1450628|NCT02137512|3550905|P1|STARTED|2-Week Baseline Sensor-Augmented Pump||30
1450629|NCT02137447|3551058|P1|NOT COMPLETED|Overall Study||0
1450630|NCT02137447|3551058|P1|COMPLETED|Overall Study||10
1450631|NCT02137447|3551058|P1|STARTED|Overall Study||10
1450632|NCT02137382|3551063|P2|NOT COMPLETED|Cross-over Period 2||0
1450633|NCT02137382|3551064|P1|NOT COMPLETED|Cross-over Period 2||0
1450634|NCT02137382|3551063|P2|COMPLETED|Cross-over Period 2||21
1450635|NCT02137382|3551064|P1|COMPLETED|Cross-over Period 2||18
1450636|NCT02137382|3551063|P2|STARTED|Cross-over Period 2||21
1450637|NCT02137382|3551064|P1|STARTED|Cross-over Period 2||18
1450638|NCT02137382|3551063|P2|NOT COMPLETED|Wash Out||0
1450639|NCT02137382|3551064|P1|NOT COMPLETED|Wash Out||0
1450640|NCT02137382|3551063|P2|COMPLETED|Wash Out||21
1450641|NCT02137382|3551064|P1|COMPLETED|Wash Out||18
1450642|NCT02137382|3551063|P2|STARTED|Wash Out||21
1450643|NCT02137382|3551064|P1|STARTED|Wash Out||18
1450644|NCT02137382|3551063|P2|NOT COMPLETED|Cross-over Period 1||0
1450645|NCT02137382|3551064|P1|NOT COMPLETED|Cross-over Period 1||2
1450646|NCT02137382|3551063|P2|COMPLETED|Cross-over Period 1||21
1450647|NCT02137382|3551064|P1|COMPLETED|Cross-over Period 1||18
1450648|NCT02137382|3551063|P2|STARTED|Cross-over Period 1||21
1450649|NCT02137382|3551064|P1|STARTED|Cross-over Period 1||20
1450650|NCT02137226|3551084|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
1450651|NCT02137226|3551085|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
1450652|NCT02137226|3551086|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
1450653|NCT02137226|3551087|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
1450654|NCT02137226|3551088|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
1450655|NCT02137226|3551084|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
1450656|NCT02137226|3551085|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
1450657|NCT02137226|3551086|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
1450658|NCT02137226|3551087|P2|COMPLETED|Period 2 (Re - Randomization)||0
1450659|NCT02137226|3551088|P1|COMPLETED|Period 2 (Re - Randomization)||0
1450660|NCT02137226|3551084|P5|STARTED|Period 2 (Re - Randomization)||147
1450661|NCT02137226|3551085|P4|STARTED|Period 2 (Re - Randomization)||148
1450662|NCT02137226|3551086|P3|STARTED|Period 2 (Re - Randomization)||298
1450663|NCT02137226|3551087|P2|STARTED|Period 2 (Re - Randomization)||0
1450664|NCT02137226|3551088|P1|STARTED|Period 2 (Re - Randomization)||0
1450665|NCT02137226|3551084|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
1450666|NCT02137226|3551085|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
1450667|NCT02137226|3551086|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
1450668|NCT02137226|3551087|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
1450669|NCT02137226|3551088|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
1450670|NCT02137226|3551084|P5|COMPLETED|Period 1 (Initial Randomization)||0
1450671|NCT02137226|3551085|P4|COMPLETED|Period 1 (Initial Randomization)||0
1450672|NCT02137226|3551086|P3|COMPLETED|Period 1 (Initial Randomization)||0
1450673|NCT02137226|3551087|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
1450674|NCT02137226|3551088|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
1450675|NCT02137226|3551084|P5|STARTED|Period 1 (Initial Randomization)||0
1450676|NCT02137226|3551085|P4|STARTED|Period 1 (Initial Randomization)||0
1450677|NCT02137226|3551086|P3|STARTED|Period 1 (Initial Randomization)||0
1450678|NCT02137226|3551087|P2|STARTED|Period 1 (Initial Randomization)||321
1450679|NCT02137226|3551088|P1|STARTED|Period 1 (Initial Randomization)||324
1450680|NCT02136914|3551102|P2|NOT COMPLETED|Overall Study||21
1450681|NCT02136914|3551103|P1|NOT COMPLETED|Overall Study||21
1450682|NCT02136914|3551102|P2|COMPLETED|Overall Study||42
1450683|NCT02136914|3551103|P1|COMPLETED|Overall Study||42
1450684|NCT02136914|3551102|P2|Received Study Drug|Overall Study||63
1450685|NCT02136914|3551103|P1|Received Study Drug|Overall Study||60
1450686|NCT02136914|3551102|P2|STARTED|Overall Study||63
1450687|NCT02136914|3551103|P1|STARTED|Overall Study||63
1450688|NCT02136810|3551117|P1|NOT COMPLETED|Overall Study||0
1450689|NCT02136810|3551117|P1|COMPLETED|Overall Study||200
1450690|NCT02136810|3551117|P1|STARTED|Overall Study||200
1450691|NCT02136498|3551123|P2|NOT COMPLETED|Overall Study||0
1450692|NCT02136498|3551124|P1|NOT COMPLETED|Overall Study||0
1450693|NCT02136498|3551123|P2|COMPLETED|Overall Study||33
1450694|NCT02136498|3551124|P1|COMPLETED|Overall Study||33
1450695|NCT02136498|3551123|P2|STARTED|Overall Study||33
1450696|NCT02136498|3551124|P1|STARTED|Overall Study||33
1450697|NCT02136420|3551136|P10|NOT COMPLETED|Overall Study||0
1450698|NCT02136420|3551137|P9|NOT COMPLETED|Overall Study||0
1450699|NCT02136420|3551138|P8|NOT COMPLETED|Overall Study||0
1450700|NCT02136420|3551139|P7|NOT COMPLETED|Overall Study||0
1450701|NCT02136420|3551140|P6|NOT COMPLETED|Overall Study||0
1450702|NCT02136420|3551141|P5|NOT COMPLETED|Overall Study||0
1450703|NCT02136420|3551142|P4|NOT COMPLETED|Overall Study||0
1450704|NCT02136420|3551143|P3|NOT COMPLETED|Overall Study||0
1450705|NCT02136420|3551144|P2|NOT COMPLETED|Overall Study||0
1450706|NCT02136420|3551145|P1|NOT COMPLETED|Overall Study||1
1450707|NCT02136420|3551136|P10|COMPLETED|Overall Study||5
1450708|NCT02136420|3551137|P9|COMPLETED|Overall Study||5
1450709|NCT02136420|3551138|P8|COMPLETED|Overall Study||0
1450710|NCT02136420|3551139|P7|COMPLETED|Overall Study||0
1450711|NCT02136420|3551140|P6|COMPLETED|Overall Study||0
1450712|NCT02136420|3551141|P5|COMPLETED|Overall Study||10
1450713|NCT02136420|3551142|P4|COMPLETED|Overall Study||0
1450714|NCT02136420|3551143|P3|COMPLETED|Overall Study||0
1450715|NCT02136420|3551144|P2|COMPLETED|Overall Study||0
1450716|NCT02136420|3551145|P1|COMPLETED|Overall Study||9
1450717|NCT02136420|3551136|P10|STARTED|Overall Study||5
1450718|NCT02136420|3551137|P9|STARTED|Overall Study||5
1450719|NCT02136420|3551138|P8|STARTED|Overall Study||0
1450720|NCT02136420|3551139|P7|STARTED|Overall Study||0
1450721|NCT02136420|3551140|P6|STARTED|Overall Study||0
1450722|NCT02136420|3551141|P5|STARTED|Overall Study||10
1450723|NCT02136420|3551142|P4|STARTED|Overall Study||0
1450724|NCT02136420|3551143|P3|STARTED|Overall Study||0
1450725|NCT02136420|3551144|P2|STARTED|Overall Study||0
1450726|NCT02136420|3551145|P1|STARTED|Overall Study||10
1450727|NCT02136238|3551167|P3|NOT COMPLETED|Overall Study||0
1450728|NCT02136238|3551168|P2|NOT COMPLETED|Overall Study||0
1450729|NCT02136238|3551169|P1|NOT COMPLETED|Overall Study||0
1450730|NCT02136238|3551167|P3|COMPLETED|Overall Study||10
1450731|NCT02136238|3551168|P2|COMPLETED|Overall Study||4
1450732|NCT02136238|3551169|P1|COMPLETED|Overall Study||4
1450733|NCT02136238|3551167|P3|STARTED|Overall Study||10
1450734|NCT02136238|3551168|P2|STARTED|Overall Study||4
1450735|NCT02136238|3551169|P1|STARTED|Overall Study||4
1450736|NCT02136134|3551182|P2|NOT COMPLETED|Overall Study||251
1450737|NCT02136134|3551183|P1|NOT COMPLETED|Overall Study||247
1450738|NCT02136134|3551182|P2|COMPLETED|Overall Study||0
1450739|NCT02136134|3551183|P1|COMPLETED|Overall Study||0
1450740|NCT02136134|3551182|P2|Treated|Overall Study||243
1450741|NCT02136134|3551183|P1|Treated|Overall Study||237
1450742|NCT02136134|3551182|P2|STARTED|Overall Study||251
1450743|NCT02136134|3551183|P1|STARTED|Overall Study||247
1450744|NCT02136004|3551201|P1|NOT COMPLETED|Overall Study||1
1450745|NCT02136004|3551201|P1|COMPLETED|Overall Study||219
1450746|NCT02136004|3551201|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
1450747|NCT02135900|3551212|P1|NOT COMPLETED|Overall Study||0
1450748|NCT02135900|3551212|P1|COMPLETED|Overall Study||32
1450749|NCT02135900|3551212|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
1450750|NCT02135848|3551221|P2|NOT COMPLETED|Overall Study||1
1450751|NCT02135848|3551222|P1|NOT COMPLETED|Overall Study||3
1450752|NCT02135848|3551221|P2|COMPLETED|Overall Study||19
1450753|NCT02135848|3551222|P1|COMPLETED|Overall Study||23
1450754|NCT02135848|3551221|P2|STARTED|Overall Study||20
1450755|NCT02135848|3551222|P1|STARTED|Overall Study||26
1450756|NCT02135692|3551280|P1|NOT COMPLETED|Overall Study||339
1450757|NCT02135692|3551280|P1|COMPLETED|Overall Study||0
1450758|NCT02135692|3551280|P1|STARTED|Overall Study||339
1450759|NCT02135614|3551299|P2|NOT COMPLETED|Overall Study||5
1450760|NCT02135614|3551300|P1|NOT COMPLETED|Overall Study||8
1450761|NCT02135614|3551299|P2|COMPLETED|Overall Study||90
1450762|NCT02135614|3551300|P1|COMPLETED|Overall Study||86
1450763|NCT02135614|3551299|P2|STARTED|Overall Study||95
1450764|NCT02135614|3551300|P1|STARTED|Overall Study||94
1450765|NCT02135445|3551314|P2|NOT COMPLETED|Overall Study||0
1450766|NCT02135445|3551315|P1|NOT COMPLETED|Overall Study||2
1450767|NCT02135445|3551314|P2|COMPLETED|Overall Study||38
1450768|NCT02135445|3551315|P1|COMPLETED|Overall Study||63
1450769|NCT02135445|3551314|P2|STARTED|Overall Study||38
1450770|NCT02135445|3551315|P1|STARTED|Overall Study||65
1450771|NCT02135432|3551366|P2|NOT COMPLETED|Overall Study||0
1450772|NCT02135432|3551367|P1|NOT COMPLETED|Overall Study||0
1450773|NCT02135432|3551366|P2|COMPLETED|Overall Study||4
1450774|NCT02135432|3551367|P1|COMPLETED|Overall Study||8
1450775|NCT02135432|3551366|P2|STARTED|Overall Study||4
1450776|NCT02135432|3551367|P1|STARTED|Overall Study||8
1450777|NCT02135107|3551381|P4|NOT COMPLETED|Maintenance Therapy Period||20
1450778|NCT02135107|3551382|P3|NOT COMPLETED|Maintenance Therapy Period||15
1450779|NCT02135107|3551383|P2|NOT COMPLETED|Maintenance Therapy Period||0
1450780|NCT02135107|3551384|P1|NOT COMPLETED|Maintenance Therapy Period||0
1450781|NCT02135107|3551381|P4|COMPLETED|Maintenance Therapy Period||161
1450782|NCT02135107|3551382|P3|COMPLETED|Maintenance Therapy Period||163
1450783|NCT02135107|3551383|P2|COMPLETED|Maintenance Therapy Period||0
1450784|NCT02135107|3551384|P1|COMPLETED|Maintenance Therapy Period||0
1450785|NCT02135107|3551381|P4|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
1450786|NCT02135107|3551382|P3|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
1450787|NCT02135107|3551383|P2|STARTED|Maintenance Therapy Period|Treatment Phase only|0
1450788|NCT02135107|3551384|P1|STARTED|Maintenance Therapy Period|Treatment Phase only|0
1450789|NCT02135107|3551381|P4|NOT COMPLETED|Treatment Period||0
1450790|NCT02135107|3551382|P3|NOT COMPLETED|Treatment Period||0
1450791|NCT02135107|3551383|P2|NOT COMPLETED|Treatment Period||26
1450792|NCT02135107|3551384|P1|NOT COMPLETED|Treatment Period||132
1450793|NCT02135107|3551381|P4|COMPLETED|Treatment Period||0
1450794|NCT02135107|3551382|P3|COMPLETED|Treatment Period||0
1450795|NCT02135107|3551383|P2|COMPLETED|Treatment Period||54
1450796|NCT02135107|3551384|P1|COMPLETED|Treatment Period||305
1450797|NCT02135107|3551381|P4|STARTED|Treatment Period||0
1450798|NCT02135107|3551382|P3|STARTED|Treatment Period||0
1450799|NCT02135107|3551383|P2|STARTED|Treatment Period||80
1450800|NCT02135107|3551384|P1|STARTED|Treatment Period||437
1450801|NCT02135094|3551412|P2|NOT COMPLETED|Overall Study||0
1450802|NCT02135094|3551413|P1|NOT COMPLETED|Overall Study||0
1450803|NCT02135094|3551412|P2|COMPLETED|Overall Study||8
1450804|NCT02135094|3551413|P1|COMPLETED|Overall Study||25
1450805|NCT02135094|3551412|P2|Week 4|Overall Study||8
1450806|NCT02135094|3551413|P1|Week 4|Overall Study||25
1450807|NCT02135094|3551412|P2|Week 3|Overall Study||8
1450808|NCT02135094|3551413|P1|Week 3|Overall Study||25
1450809|NCT02135094|3551412|P2|Week 2|Overall Study||8
1450810|NCT02135094|3551413|P1|Week 2|Overall Study||25
1450811|NCT02135094|3551412|P2|STARTED|Overall Study||8
1450812|NCT02135094|3551413|P1|STARTED|Overall Study||25
1450813|NCT02135029|3551430|P3|NOT COMPLETED|Overall Study||3
1450814|NCT02135029|3551431|P2|NOT COMPLETED|Overall Study||5
1450815|NCT02135029|3551432|P1|NOT COMPLETED|Overall Study||4
1450816|NCT02135029|3551430|P3|COMPLETED|Overall Study||34
1450817|NCT02135029|3551431|P2|COMPLETED|Overall Study||69
1450818|NCT02135029|3551432|P1|COMPLETED|Overall Study||69
1450819|NCT02135029|3551430|P3|Treated|Overall Study||36
1450820|NCT02135029|3551431|P2|Treated|Overall Study||74
1450821|NCT02135029|3551432|P1|Treated|Overall Study||73
1450822|NCT02135029|3551430|P3|STARTED|Overall Study||37
1450823|NCT02135029|3551431|P2|STARTED|Overall Study||74
1450824|NCT02135029|3551432|P1|STARTED|Overall Study||73
1450825|NCT02135016|3551515|P3|NOT COMPLETED|Overall Study||0
1450826|NCT02135016|3551516|P2|NOT COMPLETED|Overall Study||0
1450827|NCT02135016|3551517|P1|NOT COMPLETED|Overall Study||0
1450828|NCT02135016|3551515|P3|COMPLETED|Overall Study||15
1450829|NCT02135016|3551516|P2|COMPLETED|Overall Study||15
1450830|NCT02135016|3551517|P1|COMPLETED|Overall Study||15
1450831|NCT02135016|3551515|P3|STARTED|Overall Study||15
1450832|NCT02135016|3551516|P2|STARTED|Overall Study||15
1450833|NCT02135016|3551517|P1|STARTED|Overall Study||15
1450834|NCT02134977|3551537|P1|NOT COMPLETED|Overall Study||102
1450835|NCT02134977|3551537|P1|COMPLETED|Overall Study||2714
1450836|NCT02134977|3551537|P1|STARTED|Overall Study||2816
1450837|NCT02134951|3551560|P2|NOT COMPLETED|Overall Study||0
1450838|NCT02134951|3551561|P1|NOT COMPLETED|Overall Study||0
1450839|NCT02134951|3551560|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
1450840|NCT02134951|3551561|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
1450841|NCT02134951|3551560|P2|STARTED|Overall Study||20
1450842|NCT02134951|3551561|P1|STARTED|Overall Study||39
1450843|NCT02134925|3551571|P2|NOT COMPLETED|Overall Study||6
1450844|NCT02134925|3551572|P1|NOT COMPLETED|Overall Study||2
1450845|NCT02134925|3551571|P2|COMPLETED|Overall Study||50
1450846|NCT02134925|3551572|P1|COMPLETED|Overall Study||52
1450847|NCT02134925|3551571|P2|STARTED|Overall Study||56
1450848|NCT02134925|3551572|P1|STARTED|Overall Study||54
1450849|NCT02134717|3551580|P1|NOT COMPLETED|Overall Study||0
1450850|NCT02134717|3551580|P1|COMPLETED|Overall Study||3
1450851|NCT02134717|3551580|P1|STARTED|Overall Study||3
1450852|NCT02134587|3551586|P1|NOT COMPLETED|Overall Study||30
1450853|NCT02134587|3551586|P1|COMPLETED|Overall Study||173
1450854|NCT02134587|3551586|P1|STARTED|Overall Study||203
1450855|NCT02134522|3551595|P1|NOT COMPLETED|Overall Study||0
1450856|NCT02134522|3551595|P1|COMPLETED|Overall Study||1
1450857|NCT02134522|3551595|P1|STARTED|Overall Study||1
1450858|NCT02134314|3551602|P2|NOT COMPLETED|Overall Study||1
1450859|NCT02134314|3551603|P1|NOT COMPLETED|Overall Study||1
1450860|NCT02134314|3551602|P2|COMPLETED|Overall Study||34
1450861|NCT02134314|3551603|P1|COMPLETED|Overall Study||34
1450862|NCT02134314|3551602|P2|STARTED|Overall Study||35
1450863|NCT02134314|3551603|P1|STARTED|Overall Study||35
1450864|NCT02134184|3551636|P3|NOT COMPLETED|Overall Study||0
1450865|NCT02134184|3551637|P2|NOT COMPLETED|Overall Study||0
1450866|NCT02134184|3551638|P1|NOT COMPLETED|Overall Study||0
1450867|NCT02134184|3551636|P3|COMPLETED|Overall Study||8
1450868|NCT02134184|3551637|P2|COMPLETED|Overall Study||37
1450869|NCT02134184|3551638|P1|COMPLETED|Overall Study||33
1450870|NCT02134184|3551636|P3|STARTED|Overall Study||8
1450871|NCT02134184|3551637|P2|STARTED|Overall Study||37
1450872|NCT02134184|3551638|P1|STARTED|Overall Study||33
1450873|NCT02134119|3551651|P2|NOT COMPLETED|Overall Study||0
1450874|NCT02134119|3551652|P1|NOT COMPLETED|Overall Study||0
1450875|NCT02134119|3551651|P2|COMPLETED|Overall Study||15
1450876|NCT02134119|3551652|P1|COMPLETED|Overall Study||30
1450877|NCT02134119|3551651|P2|STARTED|Overall Study||15
1450878|NCT02134119|3551652|P1|STARTED|Overall Study||30
1450879|NCT02134015|3551692|P2|NOT COMPLETED|Overall Study||74
1450880|NCT02134015|3551693|P1|NOT COMPLETED|Overall Study||71
1450881|NCT02134015|3551692|P2|COMPLETED|Overall Study||0
1450882|NCT02134015|3551693|P1|COMPLETED|Overall Study||0
1450883|NCT02134015|3551692|P2|STARTED|Overall Study||74
1450884|NCT02134015|3551693|P1|STARTED|Overall Study||71
1450885|NCT02133781|3551716|P3|NOT COMPLETED|Overall Study||0
1450886|NCT02133781|3551717|P2|NOT COMPLETED|Overall Study||0
1450887|NCT02133781|3551718|P1|NOT COMPLETED|Overall Study||0
1450888|NCT02133781|3551716|P3|COMPLETED|Overall Study||21
1450889|NCT02133781|3551717|P2|COMPLETED|Overall Study||24
1450890|NCT02133781|3551718|P1|COMPLETED|Overall Study||6
1450891|NCT02133781|3551716|P3|STARTED|Overall Study||21
1450892|NCT02133781|3551717|P2|STARTED|Overall Study||24
1450893|NCT02133781|3551718|P1|STARTED|Overall Study||6
1450894|NCT02133664|3551731|P2|NOT COMPLETED|Overall Study||7
1450895|NCT02133664|3551732|P1|NOT COMPLETED|Overall Study||5
1450896|NCT02133664|3551731|P2|COMPLETED|Overall Study||21
1450897|NCT02133664|3551732|P1|COMPLETED|Overall Study||21
1450898|NCT02133664|3551731|P2|STARTED|Overall Study||28
1450899|NCT02133664|3551732|P1|STARTED|Overall Study||26
1450900|NCT02133534|3551744|P1|NOT COMPLETED|Overall Study||0
1450901|NCT02133534|3551744|P1|COMPLETED|Overall Study||1
1450902|NCT02133534|3551744|P1|STARTED|Overall Study||1
1450903|NCT02133508|3551748|P1|NOT COMPLETED|Overall Study||15
1450904|NCT02133508|3551748|P1|COMPLETED|Overall Study||141
1450905|NCT02133508|3551748|P1|STARTED|Overall Study||156
1450906|NCT02133352|3551756|P1|NOT COMPLETED|Longer Term Extension||6
1450907|NCT02133352|3551756|P1|COMPLETED|Longer Term Extension||4
1450908|NCT02133352|3551756|P1|STARTED|Longer Term Extension||10
1450909|NCT02133352|3551756|P1|NOT COMPLETED|Main Study (180 Day)||0
1450910|NCT02133352|3551756|P1|COMPLETED|Main Study (180 Day)||10
1450911|NCT02133352|3551756|P1|STARTED|Main Study (180 Day)||10
1450912|NCT02133235|3551767|P2|NOT COMPLETED|Overall Study||0
1450913|NCT02133235|3551768|P1|NOT COMPLETED|Overall Study||0
1450914|NCT02133235|3551767|P2|COMPLETED|Overall Study||57
1450915|NCT02133235|3551768|P1|COMPLETED|Overall Study||55
1450916|NCT02133235|3551767|P2|STARTED|Overall Study||57
1450917|NCT02133235|3551768|P1|STARTED|Overall Study||55
1450918|NCT02133131|3551787|P7|NOT COMPLETED|Overall Study||12
1450919|NCT02133131|3551788|P6|NOT COMPLETED|Overall Study||14
1450920|NCT02133131|3551789|P5|NOT COMPLETED|Overall Study||15
1450921|NCT02133131|3551790|P4|NOT COMPLETED|Overall Study||6
1450922|NCT02133131|3551791|P3|NOT COMPLETED|Overall Study||1
1450923|NCT02133131|3551792|P2|NOT COMPLETED|Overall Study||5
1450924|NCT02133131|3551793|P1|NOT COMPLETED|Overall Study||5
1450925|NCT02133131|3551787|P7|COMPLETED|Overall Study||0
1450926|NCT02133131|3551788|P6|COMPLETED|Overall Study||0
1450927|NCT02133131|3551789|P5|COMPLETED|Overall Study||0
1450928|NCT02133131|3551790|P4|COMPLETED|Overall Study||15
1450929|NCT02133131|3551791|P3|COMPLETED|Overall Study||19
1450930|NCT02133131|3551792|P2|COMPLETED|Overall Study||25
1450931|NCT02133131|3551793|P1|COMPLETED|Overall Study||26
1450932|NCT02133131|3551787|P7|STARTED|Overall Study||12
1450933|NCT02133131|3551788|P6|STARTED|Overall Study||14
1450934|NCT02133131|3551789|P5|STARTED|Overall Study||15
1450935|NCT02133131|3551790|P4|STARTED|Overall Study||21
1450936|NCT02133131|3551791|P3|STARTED|Overall Study||20
1450937|NCT02133131|3551792|P2|STARTED|Overall Study||30
1450938|NCT02133131|3551793|P1|STARTED|Overall Study||31
1450939|NCT02133066|3551832|P2|NOT COMPLETED|Overall Study||0
1450940|NCT02133066|3551833|P1|NOT COMPLETED|Overall Study||0
1450941|NCT02133066|3551832|P2|COMPLETED|Overall Study||64
1450942|NCT02133066|3551833|P1|COMPLETED|Overall Study||64
1450943|NCT02133066|3551832|P2|STARTED|Overall Study||64
1450944|NCT02133066|3551833|P1|STARTED|Overall Study||64
1450945|NCT02132949|3551847|P2|NOT COMPLETED|Adjuvant Treatment Period||167
1450946|NCT02132949|3551848|P1|NOT COMPLETED|Adjuvant Treatment Period||149
1450947|NCT02132949|3551847|P2|COMPLETED|Adjuvant Treatment Period||23
1450948|NCT02132949|3551848|P1|COMPLETED|Adjuvant Treatment Period||29
1450949|NCT02132949|3551847|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
1450950|NCT02132949|3551848|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
1450951|NCT02132949|3551847|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
1450952|NCT02132949|3551848|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
1450953|NCT02132949|3551847|P2|COMPLETED|Neoadjuvant Treatment Period||189
1450954|NCT02132949|3551848|P1|COMPLETED|Neoadjuvant Treatment Period||182
1450955|NCT02132949|3551847|P2|No Treatment|Neoadjuvant Treatment Period||3
1450956|NCT02132949|3551848|P1|No Treatment|Neoadjuvant Treatment Period||1
1450957|NCT02132949|3551847|P2|STARTED|Neoadjuvant Treatment Period||201
1450958|NCT02132949|3551848|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
1450959|NCT02132936|3551880|P4|NOT COMPLETED|Overall Study||14
1450960|NCT02132936|3551881|P3|NOT COMPLETED|Overall Study||14
1450961|NCT02132936|3551882|P2|NOT COMPLETED|Overall Study||9
1450962|NCT02132936|3551883|P1|NOT COMPLETED|Overall Study||10
1450963|NCT02132936|3551880|P4|COMPLETED|Overall Study||29
1450964|NCT02132936|3551881|P3|COMPLETED|Overall Study||174
1450965|NCT02132936|3551882|P2|COMPLETED|Overall Study||38
1450966|NCT02132936|3551883|P1|COMPLETED|Overall Study||175
1450967|NCT02132936|3551880|P4|STARTED|Overall Study||43
1450968|NCT02132936|3551881|P3|STARTED|Overall Study||188
1450969|NCT02132936|3551882|P2|STARTED|Overall Study||47
1450970|NCT02132936|3551883|P1|STARTED|Overall Study||185
1450971|NCT02132884|3551901|P2|NOT COMPLETED|Overall Study||0
1450972|NCT02132884|3551902|P1|NOT COMPLETED|Overall Study||0
1450973|NCT02132884|3551901|P2|COMPLETED|Overall Study||0
1450974|NCT02132884|3551902|P1|COMPLETED|Overall Study||0
1450975|NCT02132884|3551901|P2|STARTED|Overall Study||0
1450976|NCT02132884|3551902|P1|STARTED|Overall Study||0
1450977|NCT02132832|3551910|P2|NOT COMPLETED|Overall Study||7
1450978|NCT02132832|3551911|P1|NOT COMPLETED|Overall Study||3
1450979|NCT02132832|3551910|P2|COMPLETED|Overall Study||16
1450980|NCT02132832|3551911|P1|COMPLETED|Overall Study||16
1450981|NCT02132832|3551910|P2|STARTED|Overall Study||23
1450982|NCT02132832|3551911|P1|STARTED|Overall Study||19
1450983|NCT02132767|3551941|P2|NOT COMPLETED|Overall Study||15
1450984|NCT02132767|3551942|P1|NOT COMPLETED|Overall Study||17
1450985|NCT02132767|3551941|P2|COMPLETED|Overall Study||246
1450986|NCT02132767|3551942|P1|COMPLETED|Overall Study||245
1450987|NCT02132767|3551941|P2|STARTED|Overall Study||261
1450988|NCT02132767|3551942|P1|STARTED|Overall Study||262
1450989|NCT02132637|3551964|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
1450990|NCT02132637|3551965|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
1450991|NCT02132637|3551964|P2|COMPLETED|Study Period 2 (Crossover)||29
1450992|NCT02132637|3551965|P1|COMPLETED|Study Period 2 (Crossover)||31
1450993|NCT02132637|3551964|P2|STARTED|Study Period 2 (Crossover)||30
1450994|NCT02132637|3551965|P1|STARTED|Study Period 2 (Crossover)||33
1450995|NCT02132637|3551964|P2|NOT COMPLETED|Study Period 1||4
1450996|NCT02132637|3551965|P1|NOT COMPLETED|Study Period 1||1
1450997|NCT02132637|3551964|P2|COMPLETED|Study Period 1||30
1450998|NCT02132637|3551965|P1|COMPLETED|Study Period 1||33
1450999|NCT02132637|3551964|P2|Received at Least One Dose of Study Drug|Study Period 1||34
1451000|NCT02132637|3551965|P1|Received at Least One Dose of Study Drug|Study Period 1||34
1451001|NCT02132637|3551964|P2|STARTED|Study Period 1||34
1451002|NCT02132637|3551965|P1|STARTED|Study Period 1||34
1451003|NCT02132611|3551989|P1|NOT COMPLETED|Overall Study||2
1451004|NCT02132611|3551989|P1|COMPLETED|Overall Study||98
1451005|NCT02132611|3551989|P1|STARTED|Overall Study||100
1451006|NCT02132572|3551994|P1|NOT COMPLETED|Overall Study||0
1451007|NCT02132572|3551994|P1|COMPLETED|Overall Study||201
1451008|NCT02132572|3551994|P1|STARTED|Overall Study||201
1451009|NCT02132468|3551998|P1|NOT COMPLETED|Overall Study||7
1451010|NCT02132468|3551998|P1|COMPLETED|Overall Study||11
1451011|NCT02132468|3551998|P1|STARTED|Overall Study||18
1451012|NCT02132247|3552007|P2|NOT COMPLETED|Overall Study||0
1451013|NCT02132247|3552008|P1|NOT COMPLETED|Overall Study||1
1451014|NCT02132247|3552007|P2|COMPLETED|Overall Study||52
1451015|NCT02132247|3552008|P1|COMPLETED|Overall Study||51
1451016|NCT02132247|3552007|P2|STARTED|Overall Study||52
1451017|NCT02132247|3552008|P1|STARTED|Overall Study||52
1451018|NCT02132169|3552022|P2|NOT COMPLETED|Overall Study||9
1451019|NCT02132169|3552023|P1|NOT COMPLETED|Overall Study||15
1451020|NCT02132169|3552022|P2|COMPLETED|Overall Study||162
1451021|NCT02132169|3552023|P1|COMPLETED|Overall Study||326
1451022|NCT02132169|3552022|P2|STARTED|Overall Study||171
1451023|NCT02132169|3552023|P1|STARTED|Overall Study||341
1451024|NCT02132117|3552037|P2|NOT COMPLETED|Overall Study||5
1451025|NCT02132117|3552038|P1|NOT COMPLETED|Overall Study||11
1451026|NCT02132117|3552037|P2|COMPLETED|Overall Study||216
1451027|NCT02132117|3552038|P1|COMPLETED|Overall Study||213
1451028|NCT02132117|3552037|P2|STARTED|Overall Study||221
1451029|NCT02132117|3552038|P1|STARTED|Overall Study||224
1451030|NCT02131662|3552059|P5|NOT COMPLETED|Overall Study||18
1451031|NCT02131662|3552060|P4|NOT COMPLETED|Overall Study||21
1451032|NCT02131662|3552061|P3|NOT COMPLETED|Overall Study||7
1451033|NCT02131662|3552062|P2|NOT COMPLETED|Overall Study||14
1451034|NCT02131662|3552063|P1|NOT COMPLETED|Overall Study||8
1451035|NCT02131662|3552059|P5|COMPLETED|Overall Study||43
1451036|NCT02131662|3552060|P4|COMPLETED|Overall Study||41
1451037|NCT02131662|3552061|P3|COMPLETED|Overall Study||56
1451038|NCT02131662|3552062|P2|COMPLETED|Overall Study||47
1451039|NCT02131662|3552063|P1|COMPLETED|Overall Study||54
1451040|NCT02131662|3552059|P5|Completed Follow-up|Overall Study||44
1451041|NCT02131662|3552060|P4|Completed Follow-up|Overall Study||42
1451042|NCT02131662|3552061|P3|Completed Follow-up|Overall Study||56
1451043|NCT02131662|3552062|P2|Completed Follow-up|Overall Study||47
1451044|NCT02131662|3552063|P1|Completed Follow-up|Overall Study||54
1451045|NCT02131662|3552059|P5|Completed Treatment|Overall Study||52
1451046|NCT02131662|3552060|P4|Completed Treatment|Overall Study||56
1451047|NCT02131662|3552061|P3|Completed Treatment|Overall Study||61
1451048|NCT02131662|3552062|P2|Completed Treatment|Overall Study||60
1451049|NCT02131662|3552063|P1|Completed Treatment|Overall Study||57
1451050|NCT02131662|3552059|P5|Treated|Overall Study||58
1451051|NCT02131662|3552060|P4|Treated|Overall Study||60
1451052|NCT02131662|3552061|P3|Treated|Overall Study||61
1451053|NCT02131662|3552062|P2|Treated|Overall Study||61
1451054|NCT02131662|3552063|P1|Treated|Overall Study||60
1451055|NCT02131662|3552059|P5|STARTED|Overall Study||61
1451056|NCT02131662|3552060|P4|STARTED|Overall Study||62
1451057|NCT02131662|3552061|P3|STARTED|Overall Study||63
1451058|NCT02131662|3552062|P2|STARTED|Overall Study||61
1451059|NCT02131662|3552063|P1|STARTED|Overall Study||62
1451060|NCT02131636|3552109|P2|NOT COMPLETED|Overall Study||5
1451061|NCT02131636|3552110|P1|NOT COMPLETED|Overall Study||12
1451062|NCT02131636|3552109|P2|COMPLETED|Overall Study||213
1451063|NCT02131636|3552110|P1|COMPLETED|Overall Study||210
1451064|NCT02131636|3552109|P2|STARTED|Overall Study||218
1451065|NCT02131636|3552110|P1|STARTED|Overall Study||222
1451066|NCT02131532|3552126|P1|NOT COMPLETED|Overall Study||4
1451067|NCT02131532|3552126|P1|COMPLETED|Overall Study||8
1451068|NCT02131532|3552126|P1|STARTED|Overall Study||12
1451069|NCT02131402|3552145|P1|NOT COMPLETED|Overall Study||0
1451070|NCT02131402|3552145|P1|COMPLETED|Overall Study||60
1451071|NCT02131402|3552145|P1|STARTED|Overall Study||60
1451072|NCT02131324|3552218|P2|NOT COMPLETED|Overall Study||3
1451073|NCT02131324|3552219|P1|NOT COMPLETED|Overall Study||2
1451074|NCT02131324|3552218|P2|COMPLETED|Overall Study||23
1451075|NCT02131324|3552219|P1|COMPLETED|Overall Study||22
1451076|NCT02131324|3552218|P2|Analyzed|Overall Study||24
1451077|NCT02131324|3552219|P1|Analyzed|Overall Study||22
1451078|NCT02131324|3552218|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
1451079|NCT02131324|3552219|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
1451080|NCT02131311|3552225|P1|NOT COMPLETED|Overall Study||4
1451081|NCT02131311|3552225|P1|COMPLETED|Overall Study||86
1451082|NCT02131311|3552225|P1|STARTED|Overall Study||90
1451083|NCT02131272|3552237|P2|NOT COMPLETED|Overall Study||2
1451084|NCT02131272|3552238|P1|NOT COMPLETED|Overall Study||1
1451085|NCT02131272|3552237|P2|COMPLETED|Overall Study||20
1451086|NCT02131272|3552238|P1|COMPLETED|Overall Study||19
1451087|NCT02131272|3552237|P2|STARTED|Overall Study||22
1451088|NCT02131272|3552238|P1|STARTED|Overall Study||20
1451089|NCT02131259|3552256|P1|NOT COMPLETED|Overall Study||1225
1451090|NCT02131259|3552256|P1|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
1451091|NCT02131259|3552256|P1|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
1451092|NCT02131233|3552263|P2|NOT COMPLETED|Overall Study||42
1451093|NCT02131233|3552264|P1|NOT COMPLETED|Overall Study||66
1451094|NCT02131233|3552263|P2|COMPLETED|Overall Study|Completed to Week 96|227
1451095|NCT02131233|3552264|P1|COMPLETED|Overall Study|Completed to Week 96|467
1451096|NCT02131233|3552263|P2|Treated|Overall Study||266
1451097|NCT02131233|3552264|P1|Treated|Overall Study||531
1451098|NCT02131233|3552263|P2|STARTED|Overall Study|Enrolled participants|269
1451099|NCT02131233|3552264|P1|STARTED|Overall Study|Enrolled participants|533
1451100|NCT02131064|3552298|P2|NOT COMPLETED|Overall Study||223
1451101|NCT02131064|3552299|P1|NOT COMPLETED|Overall Study||221
1451102|NCT02131064|3552298|P2|COMPLETED|Overall Study||0
1451103|NCT02131064|3552299|P1|COMPLETED|Overall Study||0
1451104|NCT02131064|3552298|P2|STARTED|Overall Study||223
1451105|NCT02131064|3552299|P1|STARTED|Overall Study||221
1451106|NCT02130999|3552331|P2|NOT COMPLETED|Overall Study||0
1451107|NCT02130999|3552332|P1|NOT COMPLETED|Overall Study||0
1451108|NCT02130999|3552331|P2|COMPLETED|Overall Study||8
1451109|NCT02130999|3552332|P1|COMPLETED|Overall Study||6
1451110|NCT02130999|3552331|P2|STARTED|Overall Study||8
1451111|NCT02130999|3552332|P1|STARTED|Overall Study||6
1451112|NCT02130765|3552362|P4|NOT COMPLETED|Overall Study||0
1451113|NCT02130765|3552363|P3|NOT COMPLETED|Overall Study||0
1451114|NCT02130765|3552364|P2|NOT COMPLETED|Overall Study||0
1451115|NCT02130765|3552365|P1|NOT COMPLETED|Overall Study||4
1451116|NCT02130765|3552362|P4|COMPLETED|Overall Study||19
1451117|NCT02130765|3552363|P3|COMPLETED|Overall Study||26
1451118|NCT02130765|3552364|P2|COMPLETED|Overall Study||8
1451119|NCT02130765|3552365|P1|COMPLETED|Overall Study||7
1451120|NCT02130765|3552362|P4|STARTED|Overall Study||19
1451121|NCT02130765|3552363|P3|STARTED|Overall Study||26
1451122|NCT02130765|3552364|P2|STARTED|Overall Study||8
1451123|NCT02130765|3552365|P1|STARTED|Overall Study||11
1451124|NCT02130635|3552393|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
1451125|NCT02130635|3552394|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
1451126|NCT02130635|3552395|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
1451127|NCT02130635|3552396|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
1451128|NCT02130635|3552397|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
1451129|NCT02130635|3552398|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
1451130|NCT02130635|3552399|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
1451131|NCT02130635|3552400|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
1451132|NCT02130635|3552401|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
1451133|NCT02130635|3552393|P9|COMPLETED|Part B-Dose-Response Relationship||5
1451134|NCT02130635|3552394|P8|COMPLETED|Part B-Dose-Response Relationship||5
1451135|NCT02130635|3552395|P7|COMPLETED|Part B-Dose-Response Relationship||6
1451136|NCT02130635|3552396|P6|COMPLETED|Part B-Dose-Response Relationship||5
1451137|NCT02130635|3552397|P5|COMPLETED|Part B-Dose-Response Relationship||5
1451138|NCT02130635|3552398|P4|COMPLETED|Part B-Dose-Response Relationship||5
1451139|NCT02130635|3552399|P3|COMPLETED|Part B-Dose-Response Relationship||5
1451140|NCT02130635|3552400|P2|COMPLETED|Part B-Dose-Response Relationship||0
1451141|NCT02130635|3552401|P1|COMPLETED|Part B-Dose-Response Relationship||0
1451142|NCT02130635|3552393|P9|STARTED|Part B-Dose-Response Relationship||5
1451143|NCT02130635|3552394|P8|STARTED|Part B-Dose-Response Relationship||5
1451144|NCT02130635|3552395|P7|STARTED|Part B-Dose-Response Relationship||6
1451145|NCT02130635|3552396|P6|STARTED|Part B-Dose-Response Relationship||5
1451146|NCT02130635|3552397|P5|STARTED|Part B-Dose-Response Relationship||5
1451147|NCT02130635|3552398|P4|STARTED|Part B-Dose-Response Relationship||5
1451148|NCT02130635|3552399|P3|STARTED|Part B-Dose-Response Relationship||5
1451149|NCT02130635|3552400|P2|STARTED|Part B-Dose-Response Relationship||0
1451150|NCT02130635|3552401|P1|STARTED|Part B-Dose-Response Relationship||0
1451151|NCT02130635|3552393|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
1451152|NCT02130635|3552394|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
1451153|NCT02130635|3552395|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
1451154|NCT02130635|3552396|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
1451155|NCT02130635|3552397|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
1451156|NCT02130635|3552398|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
1451157|NCT02130635|3552399|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
1451158|NCT02130635|3552400|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
1451159|NCT02130635|3552401|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
1451160|NCT02130635|3552393|P9|COMPLETED|Part A-Safety and Tolerability||0
1451161|NCT02130635|3552394|P8|COMPLETED|Part A-Safety and Tolerability||0
1451162|NCT02130635|3552395|P7|COMPLETED|Part A-Safety and Tolerability||0
1451163|NCT02130635|3552396|P6|COMPLETED|Part A-Safety and Tolerability||0
1451164|NCT02130635|3552397|P5|COMPLETED|Part A-Safety and Tolerability||0
1451165|NCT02130635|3552398|P4|COMPLETED|Part A-Safety and Tolerability||0
1451166|NCT02130635|3552399|P3|COMPLETED|Part A-Safety and Tolerability||0
1451167|NCT02130635|3552400|P2|COMPLETED|Part A-Safety and Tolerability||21
1451168|NCT02130635|3552401|P1|COMPLETED|Part A-Safety and Tolerability||7
1451169|NCT02130635|3552393|P9|STARTED|Part A-Safety and Tolerability||0
1451170|NCT02130635|3552394|P8|STARTED|Part A-Safety and Tolerability||0
1451171|NCT02130635|3552395|P7|STARTED|Part A-Safety and Tolerability||0
1451172|NCT02130635|3552396|P6|STARTED|Part A-Safety and Tolerability||0
1451173|NCT02130635|3552397|P5|STARTED|Part A-Safety and Tolerability||0
1451174|NCT02130635|3552398|P4|STARTED|Part A-Safety and Tolerability||0
1451175|NCT02130635|3552399|P3|STARTED|Part A-Safety and Tolerability||0
1451176|NCT02130635|3552400|P2|STARTED|Part A-Safety and Tolerability||21
1451177|NCT02130635|3552401|P1|STARTED|Part A-Safety and Tolerability||7
1451178|NCT02130622|3552575|P2|NOT COMPLETED|Overall Study||0
1451179|NCT02130622|3552576|P1|NOT COMPLETED|Overall Study||0
1451180|NCT02130622|3552575|P2|COMPLETED|Overall Study||1
1451181|NCT02130622|3552576|P1|COMPLETED|Overall Study||2
1451182|NCT02130622|3552575|P2|STARTED|Overall Study||1
1451183|NCT02130622|3552576|P1|STARTED|Overall Study||2
1451184|NCT02130557|3552590|P2|NOT COMPLETED|Overall Study||268
1451185|NCT02130557|3552591|P1|NOT COMPLETED|Overall Study||268
1451186|NCT02130557|3552590|P2|COMPLETED|Overall Study||0
1451187|NCT02130557|3552591|P1|COMPLETED|Overall Study||0
1451188|NCT02130557|3552590|P2|mITT Population|Overall Study||241
1451189|NCT02130557|3552591|P1|mITT Population|Overall Study||246
1451190|NCT02130557|3552590|P2|Treated|Overall Study||265
1451191|NCT02130557|3552591|P1|Treated|Overall Study||268
1451192|NCT02130557|3552590|P2|STARTED|Overall Study||268
1451193|NCT02130557|3552591|P1|STARTED|Overall Study||268
1451194|NCT02130284|3552623|P1|NOT COMPLETED|Overall Study||9
1451195|NCT02130284|3552623|P1|COMPLETED|Overall Study||71
1451196|NCT02130284|3552623|P1|STARTED|Overall Study||80
1451197|NCT02130258|3552636|P2|NOT COMPLETED|Overall Study||0
1451198|NCT02130258|3552637|P1|NOT COMPLETED|Overall Study||0
1451199|NCT02130258|3552636|P2|COMPLETED|Overall Study||11
1451200|NCT02130258|3552637|P1|COMPLETED|Overall Study||9
1451201|NCT02130258|3552636|P2|STARTED|Overall Study||11
1451202|NCT02130258|3552637|P1|STARTED|Overall Study||9
1451203|NCT02130193|3552649|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
1451204|NCT02130193|3552650|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
1451205|NCT02130193|3552651|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
1451206|NCT02130193|3552649|P3|COMPLETED|Part B: 52-week Double-blind Period||37
1451207|NCT02130193|3552650|P2|COMPLETED|Part B: 52-week Double-blind Period||38
1451208|NCT02130193|3552651|P1|COMPLETED|Part B: 52-week Double-blind Period||0
1451209|NCT02130193|3552649|P3|STARTED|Part B: 52-week Double-blind Period||45
1451210|NCT02130193|3552650|P2|STARTED|Part B: 52-week Double-blind Period||48
1451211|NCT02130193|3552651|P1|STARTED|Part B: 52-week Double-blind Period||0
1451212|NCT02130193|3552649|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
1451213|NCT02130193|3552650|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
1451214|NCT02130193|3552651|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
1451215|NCT02130193|3552649|P3|COMPLETED|Part A: 4-week Open-label Period||0
1451216|NCT02130193|3552650|P2|COMPLETED|Part A: 4-week Open-label Period||0
1451217|NCT02130193|3552651|P1|COMPLETED|Part A: 4-week Open-label Period||9
1451218|NCT02130193|3552649|P3|STARTED|Part A: 4-week Open-label Period||0
1451219|NCT02130193|3552650|P2|STARTED|Part A: 4-week Open-label Period||0
1451220|NCT02130193|3552651|P1|STARTED|Part A: 4-week Open-label Period||9
1451221|NCT02130063|3552717|P2|NOT COMPLETED|Overall Study||17
1451222|NCT02130063|3552718|P1|NOT COMPLETED|Overall Study||25
1451223|NCT02130063|3552717|P2|COMPLETED|Overall Study||152
1451224|NCT02130063|3552718|P1|COMPLETED|Overall Study||317
1451225|NCT02130063|3552717|P2|STARTED|Overall Study||169
1451226|NCT02130063|3552718|P1|STARTED|Overall Study||342
1451227|NCT02129777|3552735|P7|NOT COMPLETED|Open-Label Period||48
1451228|NCT02129777|3552736|P6|NOT COMPLETED|Open-Label Period||12
1451229|NCT02129777|3552737|P5|NOT COMPLETED|Open-Label Period||0
1451230|NCT02129777|3552738|P4|NOT COMPLETED|Open-Label Period||0
1451231|NCT02129777|3552739|P3|NOT COMPLETED|Open-Label Period||0
1451232|NCT02129777|3552740|P2|NOT COMPLETED|Open-Label Period||0
1451233|NCT02129777|3552741|P1|NOT COMPLETED|Open-Label Period||0
1451234|NCT02129777|3552735|P7|COMPLETED|Open-Label Period||0
1451235|NCT02129777|3552736|P6|COMPLETED|Open-Label Period||0
1451236|NCT02129777|3552737|P5|COMPLETED|Open-Label Period||0
1451237|NCT02129777|3552738|P4|COMPLETED|Open-Label Period||0
1451238|NCT02129777|3552739|P3|COMPLETED|Open-Label Period||0
1451239|NCT02129777|3552740|P2|COMPLETED|Open-Label Period||0
1451240|NCT02129777|3552741|P1|COMPLETED|Open-Label Period||0
1451241|NCT02129777|3552735|P7|STARTED|Open-Label Period||48
1451242|NCT02129777|3552736|P6|STARTED|Open-Label Period||12
1451243|NCT02129777|3552737|P5|STARTED|Open-Label Period||0
1451244|NCT02129777|3552738|P4|STARTED|Open-Label Period||0
1451245|NCT02129777|3552739|P3|STARTED|Open-Label Period||0
1451246|NCT02129777|3552740|P2|STARTED|Open-Label Period||0
1451247|NCT02129777|3552741|P1|STARTED|Open-Label Period||0
1451248|NCT02129777|3552735|P7|NOT COMPLETED|Double-Blind Period||0
1451249|NCT02129777|3552736|P6|NOT COMPLETED|Double-Blind Period||0
1451250|NCT02129777|3552737|P5|NOT COMPLETED|Double-Blind Period||7
1451251|NCT02129777|3552738|P4|NOT COMPLETED|Double-Blind Period||7
1451252|NCT02129777|3552739|P3|NOT COMPLETED|Double-Blind Period||4
1451253|NCT02129777|3552740|P2|NOT COMPLETED|Double-Blind Period||8
1451254|NCT02129777|3552741|P1|NOT COMPLETED|Double-Blind Period||7
1451255|NCT02129777|3552735|P7|COMPLETED|Double-Blind Period||0
1451256|NCT02129777|3552736|P6|COMPLETED|Double-Blind Period||0
1451257|NCT02129777|3552737|P5|COMPLETED|Double-Blind Period||18
1451258|NCT02129777|3552738|P4|COMPLETED|Double-Blind Period||18
1451259|NCT02129777|3552739|P3|COMPLETED|Double-Blind Period||20
1451260|NCT02129777|3552740|P2|COMPLETED|Double-Blind Period||16
1451261|NCT02129777|3552741|P1|COMPLETED|Double-Blind Period||17
1451262|NCT02129777|3552735|P7|STARTED|Double-Blind Period||0
1451263|NCT02129777|3552736|P6|STARTED|Double-Blind Period||0
1451264|NCT02129777|3552737|P5|STARTED|Double-Blind Period||25
1451265|NCT02129777|3552738|P4|STARTED|Double-Blind Period||25
1451266|NCT02129777|3552739|P3|STARTED|Double-Blind Period||24
1451267|NCT02129777|3552740|P2|STARTED|Double-Blind Period||24
1451268|NCT02129777|3552741|P1|STARTED|Double-Blind Period||24
1451269|NCT02129725|3552847|P2|NOT COMPLETED|Overall Study||3
1451270|NCT02129725|3552848|P1|NOT COMPLETED|Overall Study||2
1451271|NCT02129725|3552847|P2|COMPLETED|Overall Study||4
1451272|NCT02129725|3552848|P1|COMPLETED|Overall Study||6
1451273|NCT02129725|3552847|P2|STARTED|Overall Study||7
1451274|NCT02129725|3552848|P1|STARTED|Overall Study||8
1451275|NCT02129660|3552859|P5|NOT COMPLETED|Overall Study||2
1451276|NCT02129660|3552860|P4|NOT COMPLETED|Overall Study||0
1451277|NCT02129660|3552861|P3|NOT COMPLETED|Overall Study||1
1451278|NCT02129660|3552862|P2|NOT COMPLETED|Overall Study||0
1451279|NCT02129660|3552863|P1|NOT COMPLETED|Overall Study||2
1451280|NCT02129660|3552859|P5|COMPLETED|Overall Study||20
1451281|NCT02129660|3552860|P4|COMPLETED|Overall Study||20
1451282|NCT02129660|3552861|P3|COMPLETED|Overall Study||21
1451283|NCT02129660|3552862|P2|COMPLETED|Overall Study||20
1451284|NCT02129660|3552863|P1|COMPLETED|Overall Study||19
1451285|NCT02129660|3552859|P5|STARTED|Overall Study||22
1451286|NCT02129660|3552860|P4|STARTED|Overall Study||20
1451287|NCT02129660|3552861|P3|STARTED|Overall Study||22
1451288|NCT02129660|3552862|P2|STARTED|Overall Study||20
1451289|NCT02129660|3552863|P1|STARTED|Overall Study||21
1451290|NCT02129608|3552908|P3|NOT COMPLETED|Overall Study||3
1451291|NCT02129608|3552909|P2|NOT COMPLETED|Overall Study||1
1451292|NCT02129608|3552910|P1|NOT COMPLETED|Overall Study||0
1451293|NCT02129608|3552908|P3|COMPLETED|Overall Study||12
1451294|NCT02129608|3552909|P2|COMPLETED|Overall Study||13
1451295|NCT02129608|3552910|P1|COMPLETED|Overall Study||15
1451296|NCT02129608|3552908|P3|End of Treatment|Overall Study||12
1451297|NCT02129608|3552909|P2|End of Treatment|Overall Study||13
1451298|NCT02129608|3552910|P1|End of Treatment|Overall Study||15
1451299|NCT02129608|3552908|P3|STARTED|Overall Study||15
1451300|NCT02129608|3552909|P2|STARTED|Overall Study||14
1451301|NCT02129608|3552910|P1|STARTED|Overall Study||15
1451302|NCT02129192|3552923|P2|NOT COMPLETED|Period 5||0
1451303|NCT02129192|3552924|P1|NOT COMPLETED|Period 5||0
1451304|NCT02129192|3552923|P2|COMPLETED|Period 5||0
1451305|NCT02129192|3552924|P1|COMPLETED|Period 5||36
1451306|NCT02129192|3552923|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
1451307|NCT02129192|3552924|P1|STARTED|Period 5||36
1451308|NCT02129192|3552923|P2|NOT COMPLETED|Period 4 Including Washout Period||0
1451309|NCT02129192|3552924|P1|NOT COMPLETED|Period 4 Including Washout Period||0
1451310|NCT02129192|3552923|P2|COMPLETED|Period 4 Including Washout Period||35
1451311|NCT02129192|3552924|P1|COMPLETED|Period 4 Including Washout Period||36
1451312|NCT02129192|3552923|P2|STARTED|Period 4 Including Washout Period||35
1451313|NCT02129192|3552924|P1|STARTED|Period 4 Including Washout Period||36
1451314|NCT02129192|3552923|P2|NOT COMPLETED|Period 3 Including Washout Period||0
1451315|NCT02129192|3552924|P1|NOT COMPLETED|Period 3 Including Washout Period||0
1451316|NCT02129192|3552923|P2|COMPLETED|Period 3 Including Washout Period||35
1451317|NCT02129192|3552924|P1|COMPLETED|Period 3 Including Washout Period||36
1451318|NCT02129192|3552923|P2|STARTED|Period 3 Including Washout Period||35
1451319|NCT02129192|3552924|P1|STARTED|Period 3 Including Washout Period||36
1451320|NCT02129192|3552923|P2|NOT COMPLETED|Period 2 Including Washout Period||0
1451321|NCT02129192|3552924|P1|NOT COMPLETED|Period 2 Including Washout Period||0
1451322|NCT02129192|3552923|P2|COMPLETED|Period 2 Including Washout Period||35
1451323|NCT02129192|3552924|P1|COMPLETED|Period 2 Including Washout Period||36
1451324|NCT02129192|3552923|P2|STARTED|Period 2 Including Washout Period||35
1451325|NCT02129192|3552924|P1|STARTED|Period 2 Including Washout Period||36
1451326|NCT02129192|3552923|P2|NOT COMPLETED|Period 1 Including Washout Period||1
1451327|NCT02129192|3552924|P1|NOT COMPLETED|Period 1 Including Washout Period||0
1451328|NCT02129192|3552923|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
1451329|NCT02129192|3552924|P1|COMPLETED|Period 1 Including Washout Period||36
1451330|NCT02129192|3552923|P2|STARTED|Period 1 Including Washout Period||36
1451331|NCT02129192|3552924|P1|STARTED|Period 1 Including Washout Period||36
1451332|NCT02129062|3552941|P1|NOT COMPLETED|Overall Study||3
1451333|NCT02129062|3552941|P1|COMPLETED|Overall Study||0
1451334|NCT02129062|3552941|P1|STARTED|Overall Study||3
1451335|NCT02128997|3552948|P2|NOT COMPLETED|Overall Study||11
1451336|NCT02128997|3552949|P1|NOT COMPLETED|Overall Study||6
1451337|NCT02128997|3552948|P2|COMPLETED|Overall Study||58
1451338|NCT02128997|3552949|P1|COMPLETED|Overall Study||61
1451339|NCT02128997|3552948|P2|STARTED|Overall Study||69
1451340|NCT02128997|3552949|P1|STARTED|Overall Study||67
1451341|NCT02128932|3552964|P3|NOT COMPLETED|Overall Study||18
1451342|NCT02128932|3552965|P2|NOT COMPLETED|Overall Study||19
1451343|NCT02128932|3552966|P1|NOT COMPLETED|Overall Study||27
1451344|NCT02128932|3552964|P3|COMPLETED|Overall Study||342
1451345|NCT02128932|3552965|P2|COMPLETED|Overall Study||341
1451346|NCT02128932|3552966|P1|COMPLETED|Overall Study||335
1451347|NCT02128932|3552964|P3|STARTED|Overall Study||360
1451348|NCT02128932|3552965|P2|STARTED|Overall Study||360
1451349|NCT02128932|3552966|P1|STARTED|Overall Study||362
1451350|NCT02128919|3552997|P2|NOT COMPLETED|Overall Study||1
1451351|NCT02128919|3552998|P1|NOT COMPLETED|Overall Study||3
1451352|NCT02128919|3552997|P2|COMPLETED|Overall Study||15
1451353|NCT02128919|3552998|P1|COMPLETED|Overall Study||14
1451354|NCT02128919|3552997|P2|STARTED|Overall Study||16
1451355|NCT02128919|3552998|P1|STARTED|Overall Study||17
1451356|NCT02128867|3553011|P3|NOT COMPLETED|Overall Study||4
1451357|NCT02128867|3553012|P2|NOT COMPLETED|Overall Study||2
1451358|NCT02128867|3553013|P1|NOT COMPLETED|Overall Study||3
1451359|NCT02128867|3553011|P3|COMPLETED|Overall Study||50
1451360|NCT02128867|3553012|P2|COMPLETED|Overall Study||50
1451361|NCT02128867|3553013|P1|COMPLETED|Overall Study||50
1451362|NCT02128867|3553011|P3|STARTED|Overall Study||54
1451363|NCT02128867|3553012|P2|STARTED|Overall Study||52
1451364|NCT02128867|3553013|P1|STARTED|Overall Study||53
1451365|NCT02128542|3553023|P2|NOT COMPLETED|Overall Study||0
1451366|NCT02128542|3553024|P1|NOT COMPLETED|Overall Study||4
1451367|NCT02128542|3553023|P2|COMPLETED|Overall Study||19
1451368|NCT02128542|3553024|P1|COMPLETED|Overall Study||43
1451369|NCT02128542|3553023|P2|STARTED|Overall Study||19
1451370|NCT02128542|3553024|P1|STARTED|Overall Study||47
1451371|NCT02128490|3553042|P5|NOT COMPLETED|Overall Study||7
1451372|NCT02128490|3553043|P4|NOT COMPLETED|Overall Study||6
1451373|NCT02128490|3553044|P3|NOT COMPLETED|Overall Study||5
1451374|NCT02128490|3553045|P2|NOT COMPLETED|Overall Study||6
1451375|NCT02128490|3553046|P1|NOT COMPLETED|Overall Study||5
1451376|NCT02128490|3553042|P5|COMPLETED|Overall Study||31
1451377|NCT02128490|3553043|P4|COMPLETED|Overall Study||31
1451378|NCT02128490|3553044|P3|COMPLETED|Overall Study||34
1451379|NCT02128490|3553045|P2|COMPLETED|Overall Study||31
1451380|NCT02128490|3553046|P1|COMPLETED|Overall Study||33
1451381|NCT02128490|3553042|P5|STARTED|Overall Study||38
1451382|NCT02128490|3553043|P4|STARTED|Overall Study||37
1451383|NCT02128490|3553044|P3|STARTED|Overall Study||39
1451384|NCT02128490|3553045|P2|STARTED|Overall Study||37
1451385|NCT02128490|3553046|P1|STARTED|Overall Study||38
1451386|NCT02128269|3553068|P1|NOT COMPLETED|Follow-up||0
1451387|NCT02128269|3553068|P1|COMPLETED|Follow-up||9
1451388|NCT02128269|3553068|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
1451389|NCT02128269|3553068|P1|NOT COMPLETED|Treatment Period||2
1451390|NCT02128269|3553068|P1|COMPLETED|Treatment Period||7
1451391|NCT02128269|3553068|P1|STARTED|Treatment Period||9
1451392|NCT02128217|3553074|P2|NOT COMPLETED|Overall Study||1
1451393|NCT02128217|3553075|P1|NOT COMPLETED|Overall Study||0
1451394|NCT02128217|3553074|P2|COMPLETED|Overall Study||26
1451395|NCT02128217|3553075|P1|COMPLETED|Overall Study||17
1451396|NCT02128217|3553074|P2|STARTED|Overall Study||27
1451397|NCT02128217|3553075|P1|STARTED|Overall Study||17
1451398|NCT02128074|3553117|P1|NOT COMPLETED|Overall Study||6
1451399|NCT02128074|3553117|P1|COMPLETED|Overall Study||26
1451400|NCT02128074|3553117|P1|STARTED|Overall Study||32
1451401|NCT02127970|3553123|P2|NOT COMPLETED|Overall Study||27
1451402|NCT02127970|3553124|P1|NOT COMPLETED|Overall Study||26
1451403|NCT02127970|3553123|P2|COMPLETED|Overall Study||322
1451404|NCT02127970|3553124|P1|COMPLETED|Overall Study||323
1451405|NCT02127970|3553123|P2|STARTED|Overall Study||349
1451406|NCT02127970|3553124|P1|STARTED|Overall Study||349
1451407|NCT02127892|3553150|P4|NOT COMPLETED|Overall Study||0
1451408|NCT02127892|3553151|P3|NOT COMPLETED|Overall Study||0
1451409|NCT02127892|3553152|P2|NOT COMPLETED|Overall Study||1
1451410|NCT02127892|3553153|P1|NOT COMPLETED|Overall Study||1
1451411|NCT02127892|3553150|P4|COMPLETED|Overall Study||0
1451412|NCT02127892|3553151|P3|COMPLETED|Overall Study||0
1451413|NCT02127892|3553152|P2|COMPLETED|Overall Study||1
1451414|NCT02127892|3553153|P1|COMPLETED|Overall Study||6
1451415|NCT02127892|3553150|P4|STARTED|Overall Study||0
1451416|NCT02127892|3553151|P3|STARTED|Overall Study||0
1451417|NCT02127892|3553152|P2|STARTED|Overall Study||2
1451418|NCT02127892|3553153|P1|STARTED|Overall Study||7
1451419|NCT02127710|3553182|P3|NOT COMPLETED|Overall Study||0
1451420|NCT02127710|3553183|P2|NOT COMPLETED|Overall Study||0
1451421|NCT02127710|3553184|P1|NOT COMPLETED|Overall Study||0
1451422|NCT02127710|3553182|P3|COMPLETED|Overall Study||19
1451423|NCT02127710|3553183|P2|COMPLETED|Overall Study||46
1451424|NCT02127710|3553184|P1|COMPLETED|Overall Study||44
1451425|NCT02127710|3553182|P3|STARTED|Overall Study||19
1451426|NCT02127710|3553183|P2|STARTED|Overall Study||46
1451427|NCT02127710|3553184|P1|STARTED|Overall Study||44
1451428|NCT02127632|3553226|P2|NOT COMPLETED|Overall Study||0
1451429|NCT02127632|3553227|P1|NOT COMPLETED|Overall Study||0
1451430|NCT02127632|3553226|P2|COMPLETED|Overall Study||50
1451431|NCT02127632|3553227|P1|COMPLETED|Overall Study||50
1451432|NCT02127632|3553226|P2|STARTED|Overall Study||50
1451433|NCT02127632|3553227|P1|STARTED|Overall Study||50
1451434|NCT02127567|3553237|P1|NOT COMPLETED|Overall Study||0
1451435|NCT02127567|3553237|P1|COMPLETED|Overall Study||41
1451436|NCT02127567|3553237|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
1451437|NCT02127372|3553259|P2|NOT COMPLETED|Overall Study||0
1451438|NCT02127372|3553260|P1|NOT COMPLETED|Overall Study||1
1451439|NCT02127372|3553259|P2|COMPLETED|Overall Study||28
1451440|NCT02127372|3553260|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
1451441|NCT02127372|3553259|P2|Started Study Treatment|Overall Study||28
1451442|NCT02127372|3553260|P1|Started Study Treatment|Overall Study||15
1451443|NCT02127372|3553259|P2|STARTED|Overall Study|Signed Consent|28
1451444|NCT02127372|3553260|P1|STARTED|Overall Study|Signed Consent|15
1451445|NCT02127307|3553270|P1|NOT COMPLETED|Overall Study||308
1451446|NCT02127307|3553270|P1|COMPLETED|Overall Study||656
1451447|NCT02127307|3553270|P1|STARTED|Overall Study||964
1451448|NCT02127281|3553276|P2|NOT COMPLETED|Overall Study||0
1451449|NCT02127281|3553277|P1|NOT COMPLETED|Overall Study||1
1451450|NCT02127281|3553276|P2|COMPLETED|Overall Study||80
1451451|NCT02127281|3553277|P1|COMPLETED|Overall Study||79
1451452|NCT02127281|3553276|P2|STARTED|Overall Study||80
1451453|NCT02127281|3553277|P1|STARTED|Overall Study||80
1451454|NCT02126839|3553305|P2|NOT COMPLETED|Overall Study||14
1451455|NCT02126839|3553306|P1|NOT COMPLETED|Overall Study||10
1451456|NCT02126839|3553305|P2|COMPLETED|Overall Study||80
1451457|NCT02126839|3553306|P1|COMPLETED|Overall Study||82
1451458|NCT02126839|3553305|P2|Full Analysis Set|Overall Study||92
1451459|NCT02126839|3553306|P1|Full Analysis Set|Overall Study||92
1451460|NCT02126839|3553305|P2|Safety Population|Overall Study||93
1451461|NCT02126839|3553306|P1|Safety Population|Overall Study||92
1451462|NCT02126839|3553305|P2|STARTED|Overall Study||94
1451463|NCT02126839|3553306|P1|STARTED|Overall Study||92
1451464|NCT02126748|3553319|P3|NOT COMPLETED|Overall Study||5
1451465|NCT02126748|3553320|P2|NOT COMPLETED|Overall Study||3
1451466|NCT02126748|3553321|P1|NOT COMPLETED|Overall Study||2
1451467|NCT02126748|3553319|P3|COMPLETED|Overall Study||31
1451468|NCT02126748|3553320|P2|COMPLETED|Overall Study||31
1451469|NCT02126748|3553321|P1|COMPLETED|Overall Study||31
1451470|NCT02126748|3553319|P3|STARTED|Overall Study||36
1451471|NCT02126748|3553320|P2|STARTED|Overall Study||34
1451472|NCT02126748|3553321|P1|STARTED|Overall Study||33
1451473|NCT02126670|3553333|P4|NOT COMPLETED|Overall Study||1
1451474|NCT02126670|3553334|P3|NOT COMPLETED|Overall Study||0
1451475|NCT02126670|3553335|P2|NOT COMPLETED|Overall Study||0
1451476|NCT02126670|3553336|P1|NOT COMPLETED|Overall Study||1
1451477|NCT02126670|3553333|P4|COMPLETED|Overall Study||24
1451478|NCT02126670|3553334|P3|COMPLETED|Overall Study||25
1451479|NCT02126670|3553335|P2|COMPLETED|Overall Study||24
1451480|NCT02126670|3553336|P1|COMPLETED|Overall Study||25
1451481|NCT02126670|3553333|P4|STARTED|Overall Study||25
1451482|NCT02126670|3553334|P3|STARTED|Overall Study||25
1451483|NCT02126670|3553335|P2|STARTED|Overall Study||24
1451484|NCT02126670|3553336|P1|STARTED|Overall Study||26
1451485|NCT02126319|3553352|P2|NOT COMPLETED|Overall Study||24
1451486|NCT02126319|3553353|P1|NOT COMPLETED|Overall Study||21
1451487|NCT02126319|3553352|P2|COMPLETED|Overall Study||43
1451488|NCT02126319|3553353|P1|COMPLETED|Overall Study||40
1451489|NCT02126319|3553352|P2|STARTED|Overall Study||67
1451490|NCT02126319|3553353|P1|STARTED|Overall Study||61
1451491|NCT02126306|3553379|P2|NOT COMPLETED|Overall Study||0
1451492|NCT02126306|3553380|P1|NOT COMPLETED|Overall Study||0
1451493|NCT02126306|3553379|P2|COMPLETED|Overall Study||13
1451494|NCT02126306|3553380|P1|COMPLETED|Overall Study||10
1451495|NCT02126306|3553379|P2|STARTED|Overall Study||13
1451496|NCT02126306|3553380|P1|STARTED|Overall Study||10
1451497|NCT02125877|3553388|P2|NOT COMPLETED|Overall Study||10
1451498|NCT02125877|3553389|P1|NOT COMPLETED|Overall Study||13
1451499|NCT02125877|3553388|P2|COMPLETED|Overall Study||77
1451500|NCT02125877|3553389|P1|COMPLETED|Overall Study||73
1451501|NCT02125877|3553388|P2|Safety Set|Overall Study||87
1451502|NCT02125877|3553389|P1|Safety Set|Overall Study||86
1451503|NCT02125877|3553388|P2|Pharmacokinetic Subset A|Overall Study||15
1451504|NCT02125877|3553389|P1|Pharmacokinetic Subset A|Overall Study||16
1451505|NCT02125877|3553388|P2|Pharmacokinetic Analysis Set|Overall Study||83
1451506|NCT02125877|3553389|P1|Pharmacokinetic Analysis Set|Overall Study||83
1451507|NCT02125877|3553388|P2|STARTED|Overall Study||87
1451508|NCT02125877|3553389|P1|STARTED|Overall Study||86
1451509|NCT02125838|3553419|P2|NOT COMPLETED|Overall Study||4
1451510|NCT02125838|3553420|P1|NOT COMPLETED|Overall Study||4
1451511|NCT02125838|3553419|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
1451512|NCT02125838|3553420|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
1451513|NCT02125838|3553419|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
1451514|NCT02125838|3553420|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
1451515|NCT02125734|3553438|P2|NOT COMPLETED|Period 2||1
1451516|NCT02125734|3553439|P1|NOT COMPLETED|Period 2||0
1451517|NCT02125734|3553438|P2|COMPLETED|Period 2||47
1451518|NCT02125734|3553439|P1|COMPLETED|Period 2||40
1451519|NCT02125734|3553438|P2|STARTED|Period 2||48
1451520|NCT02125734|3553439|P1|STARTED|Period 2||40
1451521|NCT02125734|3553438|P2|NOT COMPLETED|Period 1||0
1451522|NCT02125734|3553439|P1|NOT COMPLETED|Period 1||0
1451523|NCT02125734|3553438|P2|COMPLETED|Period 1||48
1451524|NCT02125734|3553439|P1|COMPLETED|Period 1||40
1451525|NCT02125734|3553438|P2|STARTED|Period 1||48
1451526|NCT02125734|3553439|P1|STARTED|Period 1||40
1451527|NCT02125604|3553449|P1|NOT COMPLETED|Overall Study||31
1451528|NCT02125604|3553449|P1|COMPLETED|Overall Study||180
1451529|NCT02125604|3553449|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
1451530|NCT02125292|3553463|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
1451531|NCT02125292|3553464|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
1451532|NCT02125292|3553465|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
1451533|NCT02125292|3553466|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
1451534|NCT02125292|3553467|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
1451535|NCT02125292|3553468|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
1451536|NCT02125292|3553463|P6|COMPLETED|Third Intervention (1 Hour)||3
1451537|NCT02125292|3553464|P5|COMPLETED|Third Intervention (1 Hour)||3
1451538|NCT02125292|3553465|P4|COMPLETED|Third Intervention (1 Hour)||3
1451539|NCT02125292|3553466|P3|COMPLETED|Third Intervention (1 Hour)||3
1451540|NCT02125292|3553467|P2|COMPLETED|Third Intervention (1 Hour)||3
1451541|NCT02125292|3553468|P1|COMPLETED|Third Intervention (1 Hour)||3
1451542|NCT02125292|3553463|P6|STARTED|Third Intervention (1 Hour)||3
1451543|NCT02125292|3553464|P5|STARTED|Third Intervention (1 Hour)||3
1451544|NCT02125292|3553465|P4|STARTED|Third Intervention (1 Hour)||3
1451545|NCT02125292|3553466|P3|STARTED|Third Intervention (1 Hour)||3
1451546|NCT02125292|3553467|P2|STARTED|Third Intervention (1 Hour)||3
1451547|NCT02125292|3553468|P1|STARTED|Third Intervention (1 Hour)||3
1451548|NCT02125292|3553463|P6|NOT COMPLETED|Washout (2 Hours)||0
1451549|NCT02125292|3553464|P5|NOT COMPLETED|Washout (2 Hours)||0
1451550|NCT02125292|3553465|P4|NOT COMPLETED|Washout (2 Hours)||0
1451551|NCT02125292|3553466|P3|NOT COMPLETED|Washout (2 Hours)||0
1451552|NCT02125292|3553467|P2|NOT COMPLETED|Washout (2 Hours)||0
1451553|NCT02125292|3553468|P1|NOT COMPLETED|Washout (2 Hours)||0
1451554|NCT02125292|3553463|P6|COMPLETED|Washout (2 Hours)||3
1451555|NCT02125292|3553464|P5|COMPLETED|Washout (2 Hours)||3
1451556|NCT02125292|3553465|P4|COMPLETED|Washout (2 Hours)||3
1451557|NCT02125292|3553466|P3|COMPLETED|Washout (2 Hours)||3
1451558|NCT02125292|3553467|P2|COMPLETED|Washout (2 Hours)||3
1451559|NCT02125292|3553468|P1|COMPLETED|Washout (2 Hours)||3
1451560|NCT02125292|3553463|P6|STARTED|Washout (2 Hours)||3
1451561|NCT02125292|3553464|P5|STARTED|Washout (2 Hours)||3
1451562|NCT02125292|3553465|P4|STARTED|Washout (2 Hours)||3
1451563|NCT02125292|3553466|P3|STARTED|Washout (2 Hours)||3
1451564|NCT02125292|3553467|P2|STARTED|Washout (2 Hours)||3
1451565|NCT02125292|3553468|P1|STARTED|Washout (2 Hours)||3
1451566|NCT02125292|3553463|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
1451567|NCT02125292|3553464|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
1451568|NCT02125292|3553465|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
1451569|NCT02125292|3553466|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
1451570|NCT02125292|3553467|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
1451571|NCT02125292|3553468|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
1451572|NCT02125292|3553463|P6|COMPLETED|Second Intervention (1 Hour)||3
1451573|NCT02125292|3553464|P5|COMPLETED|Second Intervention (1 Hour)||3
1451574|NCT02125292|3553465|P4|COMPLETED|Second Intervention (1 Hour)||3
1451575|NCT02125292|3553466|P3|COMPLETED|Second Intervention (1 Hour)||3
1451576|NCT02125292|3553467|P2|COMPLETED|Second Intervention (1 Hour)||3
1451577|NCT02125292|3553468|P1|COMPLETED|Second Intervention (1 Hour)||3
1451578|NCT02125292|3553463|P6|STARTED|Second Intervention (1 Hour)||3
1451579|NCT02125292|3553464|P5|STARTED|Second Intervention (1 Hour)||3
1451580|NCT02125292|3553465|P4|STARTED|Second Intervention (1 Hour)||3
1451581|NCT02125292|3553466|P3|STARTED|Second Intervention (1 Hour)||3
1451582|NCT02125292|3553467|P2|STARTED|Second Intervention (1 Hour)||3
1451583|NCT02125292|3553468|P1|STARTED|Second Intervention (1 Hour)||3
1451584|NCT02125292|3553463|P6|NOT COMPLETED|Washout (2 Hours)||0
1451585|NCT02125292|3553464|P5|NOT COMPLETED|Washout (2 Hours)||0
1451586|NCT02125292|3553465|P4|NOT COMPLETED|Washout (2 Hours)||0
1451587|NCT02125292|3553466|P3|NOT COMPLETED|Washout (2 Hours)||0
1451588|NCT02125292|3553467|P2|NOT COMPLETED|Washout (2 Hours)||0
1451589|NCT02125292|3553468|P1|NOT COMPLETED|Washout (2 Hours)||0
1451590|NCT02125292|3553463|P6|COMPLETED|Washout (2 Hours)||3
1451591|NCT02125292|3553464|P5|COMPLETED|Washout (2 Hours)||3
1451592|NCT02125292|3553465|P4|COMPLETED|Washout (2 Hours)||3
1451593|NCT02125292|3553466|P3|COMPLETED|Washout (2 Hours)||3
1451594|NCT02125292|3553467|P2|COMPLETED|Washout (2 Hours)||3
1451595|NCT02125292|3553468|P1|COMPLETED|Washout (2 Hours)||3
1451596|NCT02125292|3553463|P6|STARTED|Washout (2 Hours)||3
1451597|NCT02125292|3553464|P5|STARTED|Washout (2 Hours)||3
1451598|NCT02125292|3553465|P4|STARTED|Washout (2 Hours)||3
1451599|NCT02125292|3553466|P3|STARTED|Washout (2 Hours)||3
1451600|NCT02125292|3553467|P2|STARTED|Washout (2 Hours)||3
1451601|NCT02125292|3553468|P1|STARTED|Washout (2 Hours)||3
1451602|NCT02125292|3553463|P6|NOT COMPLETED|First Intervention (1 Hour)||0
1451603|NCT02125292|3553464|P5|NOT COMPLETED|First Intervention (1 Hour)||0
1451604|NCT02125292|3553465|P4|NOT COMPLETED|First Intervention (1 Hour)||0
1451605|NCT02125292|3553466|P3|NOT COMPLETED|First Intervention (1 Hour)||0
1451606|NCT02125292|3553467|P2|NOT COMPLETED|First Intervention (1 Hour)||0
1451607|NCT02125292|3553468|P1|NOT COMPLETED|First Intervention (1 Hour)||0
1451608|NCT02125292|3553463|P6|COMPLETED|First Intervention (1 Hour)||3
1451609|NCT02125292|3553464|P5|COMPLETED|First Intervention (1 Hour)||3
1451610|NCT02125292|3553465|P4|COMPLETED|First Intervention (1 Hour)||3
1451611|NCT02125292|3553466|P3|COMPLETED|First Intervention (1 Hour)||3
1451612|NCT02125292|3553467|P2|COMPLETED|First Intervention (1 Hour)||3
1451613|NCT02125292|3553468|P1|COMPLETED|First Intervention (1 Hour)||3
1451614|NCT02125292|3553463|P6|STARTED|First Intervention (1 Hour)||3
1451615|NCT02125292|3553464|P5|STARTED|First Intervention (1 Hour)||3
1451616|NCT02125292|3553465|P4|STARTED|First Intervention (1 Hour)||3
1451617|NCT02125292|3553466|P3|STARTED|First Intervention (1 Hour)||3
1451618|NCT02125292|3553467|P2|STARTED|First Intervention (1 Hour)||3
1451619|NCT02125292|3553468|P1|STARTED|First Intervention (1 Hour)||3
1451620|NCT02124863|3553489|P1|NOT COMPLETED|Overall Study||17
1451621|NCT02124863|3553489|P1|COMPLETED|Overall Study||50
1451622|NCT02124863|3553489|P1|STARTED|Overall Study||67
1451623|NCT02124811|3553497|P2|NOT COMPLETED|Overall Study||2
1451624|NCT02124811|3553498|P1|NOT COMPLETED|Overall Study||3
1451625|NCT02124811|3553497|P2|COMPLETED|Overall Study||3
1451626|NCT02124811|3553498|P1|COMPLETED|Overall Study||2
1451627|NCT02124811|3553497|P2|STARTED|Overall Study||5
1451628|NCT02124811|3553498|P1|STARTED|Overall Study||5
1451629|NCT02124798|3553514|P1|NOT COMPLETED|Overall Study||4
1451630|NCT02124798|3553514|P1|COMPLETED|Overall Study||91
1451631|NCT02124798|3553514|P1|STARTED|Overall Study||95
1451632|NCT02124603|3553520|P1|NOT COMPLETED|Overall Study||0
1451633|NCT02124603|3553520|P1|COMPLETED|Overall Study||120
1451634|NCT02124603|3553520|P1|STARTED|Overall Study||120
1451635|NCT02124460|3553528|P2|NOT COMPLETED|Overall Study||24
1451636|NCT02124460|3553529|P1|NOT COMPLETED|Overall Study||33
1451637|NCT02124460|3553528|P2|COMPLETED|Overall Study||336
1451638|NCT02124460|3553529|P1|COMPLETED|Overall Study||328
1451639|NCT02124460|3553528|P2|STARTED|Overall Study||360
1451640|NCT02124460|3553529|P1|STARTED|Overall Study||361
1451641|NCT02124304|3553561|P2|NOT COMPLETED|Overall Study||0
1451642|NCT02124304|3553562|P1|NOT COMPLETED|Overall Study||0
1451643|NCT02124304|3553561|P2|COMPLETED|Overall Study||15
1451644|NCT02124304|3553562|P1|COMPLETED|Overall Study||15
1451645|NCT02124304|3553561|P2|STARTED|Overall Study||15
1451646|NCT02124304|3553562|P1|STARTED|Overall Study||15
1451647|NCT02124161|3553572|P2|NOT COMPLETED|Overall Study||15
1451648|NCT02124161|3553573|P1|NOT COMPLETED|Overall Study||16
1451649|NCT02124161|3553572|P2|COMPLETED|Overall Study||426
1451650|NCT02124161|3553573|P1|COMPLETED|Overall Study||425
1451651|NCT02124161|3553572|P2|Vaccination 2|Overall Study||432
1451652|NCT02124161|3553573|P1|Vaccination 2|Overall Study||431
1451653|NCT02124161|3553572|P2|Vaccination 1|Overall Study||437
1451654|NCT02124161|3553573|P1|Vaccination 1|Overall Study||439
1451655|NCT02124161|3553572|P2|STARTED|Overall Study||441
1451656|NCT02124161|3553573|P1|STARTED|Overall Study||441
1451657|NCT02124122|3553605|P2|NOT COMPLETED|Overall Study||0
1451658|NCT02124122|3553606|P1|NOT COMPLETED|Overall Study||0
1451659|NCT02124122|3553605|P2|COMPLETED|Overall Study||19
1451660|NCT02124122|3553606|P1|COMPLETED|Overall Study||41
1451661|NCT02124122|3553605|P2|STARTED|Overall Study||19
1451662|NCT02124122|3553606|P1|STARTED|Overall Study||41
1451663|NCT02124083|3553614|P1|NOT COMPLETED|Overall Study||1
1451664|NCT02124083|3553614|P1|COMPLETED|Overall Study||11
1451665|NCT02124083|3553614|P1|STARTED|Overall Study||12
1451666|NCT02124044|3553625|P2|NOT COMPLETED|Overall Study||1
1451667|NCT02124044|3553626|P1|NOT COMPLETED|Overall Study||0
1451668|NCT02124044|3553625|P2|COMPLETED|Overall Study||9
1451669|NCT02124044|3553626|P1|COMPLETED|Overall Study||20
1451670|NCT02124044|3553625|P2|STARTED|Overall Study||10
1451671|NCT02124044|3553626|P1|STARTED|Overall Study||20
1451672|NCT02123966|3553632|P1|NOT COMPLETED|Overall Study||1
1451673|NCT02123966|3553632|P1|COMPLETED|Overall Study||9
1451674|NCT02123966|3553632|P1|STARTED|Overall Study||10
1451675|NCT02123849|3553639|P2|NOT COMPLETED|Overall Study||9
1451676|NCT02123849|3553640|P1|NOT COMPLETED|Overall Study||4
1451677|NCT02123849|3553639|P2|COMPLETED|Overall Study||18
1451678|NCT02123849|3553640|P1|COMPLETED|Overall Study||23
1451679|NCT02123849|3553639|P2|STARTED|Overall Study||27
1451680|NCT02123849|3553640|P1|STARTED|Overall Study||27
1451681|NCT02123745|3553664|P1|NOT COMPLETED|Overall Study||0
1451682|NCT02123745|3553664|P1|COMPLETED|Overall Study||71
1451683|NCT02123745|3553664|P1|STARTED|Overall Study||71
1451684|NCT02123472|3553672|P2|NOT COMPLETED|Period 2 (7 Days)||1
1451685|NCT02123472|3553673|P1|NOT COMPLETED|Period 2 (7 Days)||0
1451686|NCT02123472|3553672|P2|COMPLETED|Period 2 (7 Days)||13
1451687|NCT02123472|3553673|P1|COMPLETED|Period 2 (7 Days)||14
1451688|NCT02123472|3553672|P2|STARTED|Period 2 (7 Days)||14
1451689|NCT02123472|3553673|P1|STARTED|Period 2 (7 Days)||14
1451690|NCT02123472|3553672|P2|NOT COMPLETED|Washout Period (1 Day)||0
1451691|NCT02123472|3553673|P1|NOT COMPLETED|Washout Period (1 Day)||0
1451692|NCT02123472|3553672|P2|COMPLETED|Washout Period (1 Day)||14
1451693|NCT02123472|3553673|P1|COMPLETED|Washout Period (1 Day)||14
1451694|NCT02123472|3553672|P2|STARTED|Washout Period (1 Day)||14
1451695|NCT02123472|3553673|P1|STARTED|Washout Period (1 Day)||14
1451696|NCT02123472|3553672|P2|NOT COMPLETED|Period 1 (7 Days)||0
1451697|NCT02123472|3553673|P1|NOT COMPLETED|Period 1 (7 Days)||0
1451698|NCT02123472|3553672|P2|COMPLETED|Period 1 (7 Days)||14
1451699|NCT02123472|3553673|P1|COMPLETED|Period 1 (7 Days)||14
1451700|NCT02123472|3553672|P2|STARTED|Period 1 (7 Days)||14
1451701|NCT02123472|3553673|P1|STARTED|Period 1 (7 Days)||14
1451702|NCT02123459|3553683|P2|NOT COMPLETED|Period 2 (7 Days)||0
1451703|NCT02123459|3553684|P1|NOT COMPLETED|Period 2 (7 Days)||0
1451704|NCT02123459|3553683|P2|COMPLETED|Period 2 (7 Days)||14
1451705|NCT02123459|3553684|P1|COMPLETED|Period 2 (7 Days)||13
1451706|NCT02123459|3553683|P2|STARTED|Period 2 (7 Days)||14
1451707|NCT02123459|3553684|P1|STARTED|Period 2 (7 Days)||13
1451708|NCT02123459|3553683|P2|NOT COMPLETED|Washout Period (1 Day)||0
1451709|NCT02123459|3553684|P1|NOT COMPLETED|Washout Period (1 Day)||1
1451710|NCT02123459|3553683|P2|COMPLETED|Washout Period (1 Day)||14
1451711|NCT02123459|3553684|P1|COMPLETED|Washout Period (1 Day)||13
1451712|NCT02123459|3553683|P2|STARTED|Washout Period (1 Day)||14
1451713|NCT02123459|3553684|P1|STARTED|Washout Period (1 Day)||14
1451714|NCT02123459|3553683|P2|NOT COMPLETED|Period 1 (7 Days)||0
1451715|NCT02123459|3553684|P1|NOT COMPLETED|Period 1 (7 Days)||0
1451716|NCT02123459|3553683|P2|COMPLETED|Period 1 (7 Days)||14
1451717|NCT02123459|3553684|P1|COMPLETED|Period 1 (7 Days)||14
1451718|NCT02123459|3553683|P2|STARTED|Period 1 (7 Days)||14
1451719|NCT02123459|3553684|P1|STARTED|Period 1 (7 Days)||14
1451720|NCT02123446|3553694|P2|NOT COMPLETED|Period 2 (7 Days)||0
1451721|NCT02123446|3553695|P1|NOT COMPLETED|Period 2 (7 Days)||0
1451722|NCT02123446|3553694|P2|COMPLETED|Period 2 (7 Days)||14
1451723|NCT02123446|3553695|P1|COMPLETED|Period 2 (7 Days)||13
1451724|NCT02123446|3553694|P2|STARTED|Period 2 (7 Days)||14
1451725|NCT02123446|3553695|P1|STARTED|Period 2 (7 Days)||13
1451726|NCT02123446|3553694|P2|NOT COMPLETED|Washout Period (1 Day)||0
1451727|NCT02123446|3553695|P1|NOT COMPLETED|Washout Period (1 Day)||1
1451728|NCT02123446|3553694|P2|COMPLETED|Washout Period (1 Day)||14
1451729|NCT02123446|3553695|P1|COMPLETED|Washout Period (1 Day)||13
1451730|NCT02123446|3553694|P2|STARTED|Washout Period (1 Day)||14
1451731|NCT02123446|3553695|P1|STARTED|Washout Period (1 Day)||14
1451732|NCT02123446|3553694|P2|NOT COMPLETED|Period 1 (7 Days)||0
1451733|NCT02123446|3553695|P1|NOT COMPLETED|Period 1 (7 Days)||0
1451734|NCT02123446|3553694|P2|COMPLETED|Period 1 (7 Days)||14
1451735|NCT02123446|3553695|P1|COMPLETED|Period 1 (7 Days)||14
1451736|NCT02123446|3553694|P2|STARTED|Period 1 (7 Days)||14
1451737|NCT02123446|3553695|P1|STARTED|Period 1 (7 Days)||14
1451738|NCT02123329|3553707|P2|NOT COMPLETED|12 Month Outcome Measure||79
1451739|NCT02123329|3553708|P1|NOT COMPLETED|12 Month Outcome Measure||64
1451740|NCT02123329|3553707|P2|COMPLETED|12 Month Outcome Measure||88
1451741|NCT02123329|3553708|P1|COMPLETED|12 Month Outcome Measure||83
1451742|NCT02123329|3553707|P2|STARTED|12 Month Outcome Measure||167
1451743|NCT02123329|3553708|P1|STARTED|12 Month Outcome Measure||147
1451744|NCT02123329|3553707|P2|NOT COMPLETED|6 Month Outcome Measure||67
1451745|NCT02123329|3553708|P1|NOT COMPLETED|6 Month Outcome Measure||48
1451746|NCT02123329|3553707|P2|COMPLETED|6 Month Outcome Measure||100
1451747|NCT02123329|3553708|P1|COMPLETED|6 Month Outcome Measure||99
1451748|NCT02123329|3553707|P2|STARTED|6 Month Outcome Measure||167
1451749|NCT02123329|3553708|P1|STARTED|6 Month Outcome Measure||147
1451750|NCT02123329|3553707|P2|NOT COMPLETED|3 Month Outcome Measure||66
1451751|NCT02123329|3553708|P1|NOT COMPLETED|3 Month Outcome Measure||49
1451752|NCT02123329|3553707|P2|COMPLETED|3 Month Outcome Measure||101
1451753|NCT02123329|3553708|P1|COMPLETED|3 Month Outcome Measure||98
1451754|NCT02123329|3553707|P2|STARTED|3 Month Outcome Measure||167
1451755|NCT02123329|3553708|P1|STARTED|3 Month Outcome Measure||147
1451756|NCT02123017|3553737|P3|NOT COMPLETED|Overall Study||0
1451757|NCT02123017|3553738|P2|NOT COMPLETED|Overall Study||0
1451758|NCT02123017|3553739|P1|NOT COMPLETED|Overall Study||0
1451759|NCT02123017|3553737|P3|COMPLETED|Overall Study||12
1451760|NCT02123017|3553738|P2|COMPLETED|Overall Study||12
1451761|NCT02123017|3553739|P1|COMPLETED|Overall Study||8
1451762|NCT02123017|3553737|P3|STARTED|Overall Study||12
1451763|NCT02123017|3553738|P2|STARTED|Overall Study||12
1451764|NCT02123017|3553739|P1|STARTED|Overall Study||8
1451765|NCT02122796|3553758|P2|NOT COMPLETED|Visit 2||1
1451766|NCT02122796|3553759|P1|NOT COMPLETED|Visit 2||3
1451767|NCT02122796|3553758|P2|COMPLETED|Visit 2||14
1451768|NCT02122796|3553759|P1|COMPLETED|Visit 2||12
1451769|NCT02122796|3553758|P2|STARTED|Visit 2||15
1451770|NCT02122796|3553759|P1|STARTED|Visit 2||15
1451771|NCT02122796|3553758|P2|NOT COMPLETED|Visit 1||0
1451772|NCT02122796|3553759|P1|NOT COMPLETED|Visit 1||0
1451773|NCT02122796|3553758|P2|COMPLETED|Visit 1||15
1451774|NCT02122796|3553759|P1|COMPLETED|Visit 1||15
1451775|NCT02122796|3553758|P2|STARTED|Visit 1||15
1451776|NCT02122796|3553759|P1|STARTED|Visit 1||15
1451777|NCT02122549|3553772|P1|NOT COMPLETED|Overall Study||0
1451778|NCT02122549|3553772|P1|COMPLETED|Overall Study||59
1451779|NCT02122549|3553772|P1|STARTED|Overall Study||59
1451780|NCT02122445|3553776|P1|NOT COMPLETED|Overall Study||0
1451781|NCT02122445|3553776|P1|COMPLETED|Overall Study||20
1451782|NCT02122445|3553776|P1|STARTED|Overall Study||20
1451783|NCT02122406|3553781|P1|NOT COMPLETED|Overall Study||0
1451784|NCT02122406|3553781|P1|COMPLETED|Overall Study||200
1451785|NCT02122406|3553781|P1|STARTED|Overall Study||200
1451786|NCT02122146|3553793|P8|NOT COMPLETED|Part 3: Expansion||0
1451787|NCT02122146|3553794|P7|NOT COMPLETED|Part 3: Expansion||0
1451788|NCT02122146|3553795|P6|NOT COMPLETED|Part 3: Expansion||0
1451789|NCT02122146|3553796|P5|NOT COMPLETED|Part 3: Expansion||0
1451790|NCT02122146|3553797|P4|NOT COMPLETED|Part 3: Expansion||0
1451791|NCT02122146|3553798|P3|NOT COMPLETED|Part 3: Expansion||0
1451792|NCT02122146|3553799|P2|NOT COMPLETED|Part 3: Expansion||0
1451793|NCT02122146|3553800|P1|NOT COMPLETED|Part 3: Expansion||0
1451794|NCT02122146|3553793|P8|COMPLETED|Part 3: Expansion||0
1451795|NCT02122146|3553794|P7|COMPLETED|Part 3: Expansion||0
1451796|NCT02122146|3553795|P6|COMPLETED|Part 3: Expansion||0
1451797|NCT02122146|3553796|P5|COMPLETED|Part 3: Expansion||0
1451798|NCT02122146|3553797|P4|COMPLETED|Part 3: Expansion||0
1451799|NCT02122146|3553798|P3|COMPLETED|Part 3: Expansion||0
1451800|NCT02122146|3553799|P2|COMPLETED|Part 3: Expansion||0
1451801|NCT02122146|3553800|P1|COMPLETED|Part 3: Expansion||0
1451802|NCT02122146|3553793|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1451803|NCT02122146|3553794|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1451804|NCT02122146|3553795|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1451805|NCT02122146|3553796|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1451806|NCT02122146|3553797|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1451807|NCT02122146|3553798|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1451808|NCT02122146|3553799|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1451809|NCT02122146|3553800|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
1451810|NCT02122146|3553793|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1451811|NCT02122146|3553794|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1451812|NCT02122146|3553795|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1451813|NCT02122146|3553796|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1451814|NCT02122146|3553797|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1451815|NCT02122146|3553798|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1451816|NCT02122146|3553799|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1451817|NCT02122146|3553800|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
1451818|NCT02122146|3553793|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
1451819|NCT02122146|3553794|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
1451820|NCT02122146|3553795|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
1451821|NCT02122146|3553796|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
1451822|NCT02122146|3553797|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
1451823|NCT02122146|3553798|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
1451824|NCT02122146|3553799|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
1451825|NCT02122146|3553800|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
1451826|NCT02122146|3553793|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1451827|NCT02122146|3553794|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1451828|NCT02122146|3553795|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1451829|NCT02122146|3553796|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1451830|NCT02122146|3553797|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1451831|NCT02122146|3553798|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1451832|NCT02122146|3553799|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1451833|NCT02122146|3553800|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
1451834|NCT02122146|3553793|P8|NOT COMPLETED|Part 1: Dose Escalation||2
1451835|NCT02122146|3553794|P7|NOT COMPLETED|Part 1: Dose Escalation||1
1451836|NCT02122146|3553795|P6|NOT COMPLETED|Part 1: Dose Escalation||1
1451837|NCT02122146|3553796|P5|NOT COMPLETED|Part 1: Dose Escalation||1
1451838|NCT02122146|3553797|P4|NOT COMPLETED|Part 1: Dose Escalation||1
1451839|NCT02122146|3553798|P3|NOT COMPLETED|Part 1: Dose Escalation||2
1451840|NCT02122146|3553799|P2|NOT COMPLETED|Part 1: Dose Escalation||1
1451841|NCT02122146|3553800|P1|NOT COMPLETED|Part 1: Dose Escalation||1
1451842|NCT02122146|3553793|P8|COMPLETED|Part 1: Dose Escalation||6
1451843|NCT02122146|3553794|P7|COMPLETED|Part 1: Dose Escalation||0
1451844|NCT02122146|3553795|P6|COMPLETED|Part 1: Dose Escalation||5
1451845|NCT02122146|3553796|P5|COMPLETED|Part 1: Dose Escalation||3
1451846|NCT02122146|3553797|P4|COMPLETED|Part 1: Dose Escalation||3
1451847|NCT02122146|3553798|P3|COMPLETED|Part 1: Dose Escalation||2
1451848|NCT02122146|3553799|P2|COMPLETED|Part 1: Dose Escalation||1
1451849|NCT02122146|3553800|P1|COMPLETED|Part 1: Dose Escalation||1
1451850|NCT02122146|3553793|P8|STARTED|Part 1: Dose Escalation||8
1451851|NCT02122146|3553794|P7|STARTED|Part 1: Dose Escalation||1
1451852|NCT02122146|3553795|P6|STARTED|Part 1: Dose Escalation||6
1451853|NCT02122146|3553796|P5|STARTED|Part 1: Dose Escalation||4
1451854|NCT02122146|3553797|P4|STARTED|Part 1: Dose Escalation||4
1451855|NCT02122146|3553798|P3|STARTED|Part 1: Dose Escalation||4
1451856|NCT02122146|3553799|P2|STARTED|Part 1: Dose Escalation||2
1451857|NCT02122146|3553800|P1|STARTED|Part 1: Dose Escalation||2
1451858|NCT02121860|3554039|P4|NOT COMPLETED|Overall Study||0
1451859|NCT02121860|3554040|P3|NOT COMPLETED|Overall Study||0
1451860|NCT02121860|3554041|P2|NOT COMPLETED|Overall Study||0
1451861|NCT02121860|3554042|P1|NOT COMPLETED|Overall Study||0
1451862|NCT02121860|3554039|P4|COMPLETED|Overall Study||8
1451863|NCT02121860|3554040|P3|COMPLETED|Overall Study||8
1451864|NCT02121860|3554041|P2|COMPLETED|Overall Study||12
1451865|NCT02121860|3554042|P1|COMPLETED|Overall Study||8
1451866|NCT02121860|3554039|P4|STARTED|Overall Study||8
1451867|NCT02121860|3554040|P3|STARTED|Overall Study||8
1451868|NCT02121860|3554041|P2|STARTED|Overall Study||12
1451869|NCT02121860|3554042|P1|STARTED|Overall Study||8
1451870|NCT02121847|3554061|P1|NOT COMPLETED|Overall Study||3
1451871|NCT02121847|3554061|P1|COMPLETED|Overall Study||37
1451872|NCT02121847|3554061|P1|STARTED|Overall Study||40
1451873|NCT02121834|3554087|P7|NOT COMPLETED|Overall Study||0
1451874|NCT02121834|3554088|P6|NOT COMPLETED|Overall Study||0
1451875|NCT02121834|3554089|P5|NOT COMPLETED|Overall Study||0
1451876|NCT02121834|3554090|P4|NOT COMPLETED|Overall Study||0
1451877|NCT02121834|3554091|P3|NOT COMPLETED|Overall Study||2
1451878|NCT02121834|3554092|P2|NOT COMPLETED|Overall Study||2
1451879|NCT02121834|3554093|P1|NOT COMPLETED|Overall Study||0
1451880|NCT02121834|3554087|P7|COMPLETED|Overall Study||3
1451881|NCT02121834|3554088|P6|COMPLETED|Overall Study||9
1451882|NCT02121834|3554089|P5|COMPLETED|Overall Study||9
1451883|NCT02121834|3554090|P4|COMPLETED|Overall Study||10
1451884|NCT02121834|3554091|P3|COMPLETED|Overall Study||7
1451885|NCT02121834|3554092|P2|COMPLETED|Overall Study||9
1451886|NCT02121834|3554093|P1|COMPLETED|Overall Study||12
1451887|NCT02121834|3554087|P7|Received at Least One Dose of Study Drug|Overall Study||3
1451888|NCT02121834|3554088|P6|Received at Least One Dose of Study Drug|Overall Study||9
1451889|NCT02121834|3554089|P5|Received at Least One Dose of Study Drug|Overall Study||9
1451890|NCT02121834|3554090|P4|Received at Least One Dose of Study Drug|Overall Study||10
1451891|NCT02121834|3554091|P3|Received at Least One Dose of Study Drug|Overall Study||9
1451892|NCT02121834|3554092|P2|Received at Least One Dose of Study Drug|Overall Study||11
1451893|NCT02121834|3554093|P1|Received at Least One Dose of Study Drug|Overall Study||12
1451894|NCT02121834|3554087|P7|STARTED|Overall Study||3
1451895|NCT02121834|3554088|P6|STARTED|Overall Study||9
1451896|NCT02121834|3554089|P5|STARTED|Overall Study||9
1451897|NCT02121834|3554090|P4|STARTED|Overall Study||10
1451898|NCT02121834|3554091|P3|STARTED|Overall Study||9
1451899|NCT02121834|3554092|P2|STARTED|Overall Study||11
1451900|NCT02121834|3554093|P1|STARTED|Overall Study||12
1451901|NCT02121808|3554119|P1|NOT COMPLETED|Overall Study||3
1451902|NCT02121808|3554119|P1|COMPLETED|Overall Study||17
1451903|NCT02121808|3554119|P1|STARTED|Overall Study||20
1451904|NCT02121795|3554130|P2|NOT COMPLETED|Overall Study||334
1451905|NCT02121795|3554131|P1|NOT COMPLETED|Overall Study||334
1451906|NCT02121795|3554130|P2|COMPLETED|Overall Study||0
1451907|NCT02121795|3554131|P1|COMPLETED|Overall Study||0
1451908|NCT02121795|3554130|P2|STARTED|Overall Study||334
1451909|NCT02121795|3554131|P1|STARTED|Overall Study||334
1451910|NCT02121535|3554147|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
1451911|NCT02121535|3554148|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
1451912|NCT02121535|3554147|P2|COMPLETED|Period 4 (8 Trial Days)||35
1451913|NCT02121535|3554148|P1|COMPLETED|Period 4 (8 Trial Days)||35
1451914|NCT02121535|3554147|P2|STARTED|Period 4 (8 Trial Days)||35
1451915|NCT02121535|3554148|P1|STARTED|Period 4 (8 Trial Days)||35
1451916|NCT02121535|3554147|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
1451917|NCT02121535|3554148|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
1451918|NCT02121535|3554147|P2|COMPLETED|Period 3 (8 Trial Days)||35
1451919|NCT02121535|3554148|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
1451920|NCT02121535|3554147|P2|STARTED|Period 3 (8 Trial Days)||35
1451921|NCT02121535|3554148|P1|STARTED|Period 3 (8 Trial Days)||36
1451922|NCT02121535|3554147|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
1451923|NCT02121535|3554148|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
1451924|NCT02121535|3554147|P2|COMPLETED|Period 2 (8 Trial Days)||35
1451925|NCT02121535|3554148|P1|COMPLETED|Period 2 (8 Trial Days)||36
1451926|NCT02121535|3554147|P2|STARTED|Period 2 (8 Trial Days)||35
1451927|NCT02121535|3554148|P1|STARTED|Period 2 (8 Trial Days)||36
1451928|NCT02121535|3554147|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
1451929|NCT02121535|3554148|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
1451930|NCT02121535|3554147|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
1451931|NCT02121535|3554148|P1|COMPLETED|Period 1 (8 Trial Days)||36
1451932|NCT02121535|3554147|P2|STARTED|Period 1 (8 Trial Days)||36
1451933|NCT02121535|3554148|P1|STARTED|Period 1 (8 Trial Days)||36
1451934|NCT02121522|3554171|P1|NOT COMPLETED|Overall Study||1
1451935|NCT02121522|3554171|P1|COMPLETED|Overall Study||13
1451936|NCT02121522|3554171|P1|STARTED|Overall Study||14
1451937|NCT02121509|3554178|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
1451938|NCT02121509|3554179|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
1451939|NCT02121509|3554180|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
1451940|NCT02121509|3554181|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
1451941|NCT02121509|3554178|P4|COMPLETED|Treatment Period-2 (4 Days)||8
1451942|NCT02121509|3554179|P3|COMPLETED|Treatment Period-2 (4 Days)||8
1451943|NCT02121509|3554180|P2|COMPLETED|Treatment Period-2 (4 Days)||24
1451944|NCT02121509|3554181|P1|COMPLETED|Treatment Period-2 (4 Days)||28
1451945|NCT02121509|3554178|P4|STARTED|Treatment Period-2 (4 Days)||8
1451946|NCT02121509|3554179|P3|STARTED|Treatment Period-2 (4 Days)||8
1451947|NCT02121509|3554180|P2|STARTED|Treatment Period-2 (4 Days)||24
1451948|NCT02121509|3554181|P1|STARTED|Treatment Period-2 (4 Days)||28
1451949|NCT02121509|3554178|P4|NOT COMPLETED|Washout Period (35 Days)||0
1451950|NCT02121509|3554179|P3|NOT COMPLETED|Washout Period (35 Days)||0
1451951|NCT02121509|3554180|P2|NOT COMPLETED|Washout Period (35 Days)||4
1451952|NCT02121509|3554181|P1|NOT COMPLETED|Washout Period (35 Days)||2
1451953|NCT02121509|3554178|P4|COMPLETED|Washout Period (35 Days)||8
1451954|NCT02121509|3554179|P3|COMPLETED|Washout Period (35 Days)||8
1451955|NCT02121509|3554180|P2|COMPLETED|Washout Period (35 Days)||24
1451956|NCT02121509|3554181|P1|COMPLETED|Washout Period (35 Days)||28
1451957|NCT02121509|3554178|P4|STARTED|Washout Period (35 Days)||8
1451958|NCT02121509|3554179|P3|STARTED|Washout Period (35 Days)||8
1451959|NCT02121509|3554180|P2|STARTED|Washout Period (35 Days)||28
1451960|NCT02121509|3554181|P1|STARTED|Washout Period (35 Days)||30
1451961|NCT02121509|3554178|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
1451962|NCT02121509|3554179|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
1451963|NCT02121509|3554180|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
1451964|NCT02121509|3554181|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
1451965|NCT02121509|3554178|P4|COMPLETED|Treatment Period-1 (4 Days)||8
1451966|NCT02121509|3554179|P3|COMPLETED|Treatment Period-1 (4 Days)||8
1451967|NCT02121509|3554180|P2|COMPLETED|Treatment Period-1 (4 Days)||28
1451968|NCT02121509|3554181|P1|COMPLETED|Treatment Period-1 (4 Days)||30
1451969|NCT02121509|3554178|P4|STARTED|Treatment Period-1 (4 Days)||8
1451970|NCT02121509|3554179|P3|STARTED|Treatment Period-1 (4 Days)||8
1451971|NCT02121509|3554180|P2|STARTED|Treatment Period-1 (4 Days)||28
1451972|NCT02121509|3554181|P1|STARTED|Treatment Period-1 (4 Days)||30
1451973|NCT02121483|3554214|P3|NOT COMPLETED|Overall Study||0
1451974|NCT02121483|3554215|P2|NOT COMPLETED|Overall Study||0
1451975|NCT02121483|3554216|P1|NOT COMPLETED|Overall Study||0
1451976|NCT02121483|3554214|P3|COMPLETED|Overall Study||10
1451977|NCT02121483|3554215|P2|COMPLETED|Overall Study||8
1451978|NCT02121483|3554216|P1|COMPLETED|Overall Study||9
1451979|NCT02121483|3554214|P3|STARTED|Overall Study||10
1451980|NCT02121483|3554215|P2|STARTED|Overall Study||8
1451981|NCT02121483|3554216|P1|STARTED|Overall Study||9
1451982|NCT02121418|3554245|P1|NOT COMPLETED|Overall Study||0
1451983|NCT02121418|3554245|P1|COMPLETED|Overall Study||12
1451984|NCT02121418|3554245|P1|STARTED|Overall Study||12
1451985|NCT02121210|3554252|P2|NOT COMPLETED|Overall Study||9
1451986|NCT02121210|3554253|P1|NOT COMPLETED|Overall Study||7
1451987|NCT02121210|3554252|P2|COMPLETED|Overall Study||58
1451988|NCT02121210|3554253|P1|COMPLETED|Overall Study||58
1451989|NCT02121210|3554252|P2|STARTED|Overall Study||67
1451990|NCT02121210|3554253|P1|STARTED|Overall Study||65
1451991|NCT02121067|3554261|P1|NOT COMPLETED|Overall Study||0
1451992|NCT02121067|3554261|P1|COMPLETED|Overall Study||50
1451993|NCT02121067|3554261|P1|STARTED|Overall Study||50
1451994|NCT02121041|3554269|P2|NOT COMPLETED|Overall Study||6
1451995|NCT02121041|3554270|P1|NOT COMPLETED|Overall Study||1
1451996|NCT02121041|3554269|P2|COMPLETED|Overall Study||8
1451997|NCT02121041|3554270|P1|COMPLETED|Overall Study||13
1451998|NCT02121041|3554269|P2|STARTED|Overall Study||14
1451999|NCT02121041|3554270|P1|STARTED|Overall Study||14
1452000|NCT02120833|3554278|P2|NOT COMPLETED|Overall Study||1
1452001|NCT02120833|3554279|P1|NOT COMPLETED|Overall Study||4
1452002|NCT02120833|3554278|P2|COMPLETED|Overall Study||11
1452003|NCT02120833|3554279|P1|COMPLETED|Overall Study||35
1452004|NCT02120833|3554278|P2|STARTED|Overall Study||12
1452005|NCT02120833|3554279|P1|STARTED|Overall Study||39
1452006|NCT02120794|3554433|P1|NOT COMPLETED|Overall Study||58
1452007|NCT02120794|3554433|P1|COMPLETED|Overall Study||136
1452008|NCT02120794|3554433|P1|STARTED|Overall Study||194
1452009|NCT02120716|3554442|P2|NOT COMPLETED|Overall Study||0
1452010|NCT02120716|3554443|P1|NOT COMPLETED|Overall Study||1
1452011|NCT02120716|3554442|P2|COMPLETED|Overall Study||19
1452012|NCT02120716|3554443|P1|COMPLETED|Overall Study||30
1452013|NCT02120716|3554442|P2|STARTED|Overall Study||19
1452014|NCT02120716|3554443|P1|STARTED|Overall Study||31
1452015|NCT02120664|3554457|P5|NOT COMPLETED|Overall Study||0
1452016|NCT02120664|3554458|P4|NOT COMPLETED|Overall Study||1
1452017|NCT02120664|3554459|P3|NOT COMPLETED|Overall Study||0
1452018|NCT02120664|3554460|P2|NOT COMPLETED|Overall Study||0
1452019|NCT02120664|3554461|P1|NOT COMPLETED|Overall Study||0
1452020|NCT02120664|3554457|P5|COMPLETED|Overall Study||10
1452021|NCT02120664|3554458|P4|COMPLETED|Overall Study||3
1452022|NCT02120664|3554459|P3|COMPLETED|Overall Study||7
1452023|NCT02120664|3554460|P2|COMPLETED|Overall Study||4
1452024|NCT02120664|3554461|P1|COMPLETED|Overall Study||10
1452025|NCT02120664|3554457|P5|STARTED|Overall Study||10
1452026|NCT02120664|3554458|P4|STARTED|Overall Study||4
1452027|NCT02120664|3554459|P3|STARTED|Overall Study||7
1452028|NCT02120664|3554460|P2|STARTED|Overall Study||4
1452029|NCT02120664|3554461|P1|STARTED|Overall Study||10
1452030|NCT02120625|3554479|P1|NOT COMPLETED|Overall Study||2
1452031|NCT02120625|3554479|P1|COMPLETED|Overall Study||6
1452032|NCT02120625|3554479|P1|STARTED|Overall Study||8
1452033|NCT02120443|3554486|P1|NOT COMPLETED|Overall Study||0
1452034|NCT02120443|3554486|P1|COMPLETED|Overall Study||43
1452035|NCT02120443|3554486|P1|STARTED|Overall Study||43
1452036|NCT02120417|3554494|P2|NOT COMPLETED|Overall Study||68
1452037|NCT02120417|3554495|P1|NOT COMPLETED|Overall Study||60
1452038|NCT02120417|3554494|P2|COMPLETED|Overall Study||5
1452039|NCT02120417|3554495|P1|COMPLETED|Overall Study||16
1452040|NCT02120417|3554494|P2|STARTED|Overall Study||73
1452041|NCT02120417|3554495|P1|STARTED|Overall Study||76
1452042|NCT02120300|3554517|P4|NOT COMPLETED|Overall Study||1
1452043|NCT02120300|3554518|P3|NOT COMPLETED|Overall Study||0
1452044|NCT02120300|3554519|P2|NOT COMPLETED|Overall Study||0
1452045|NCT02120300|3554520|P1|NOT COMPLETED|Overall Study||3
1452046|NCT02120300|3554517|P4|COMPLETED|Overall Study||5
1452047|NCT02120300|3554518|P3|COMPLETED|Overall Study||10
1452048|NCT02120300|3554519|P2|COMPLETED|Overall Study||5
1452049|NCT02120300|3554520|P1|COMPLETED|Overall Study||98
1452050|NCT02120300|3554517|P4|STARTED|Overall Study||6
1452051|NCT02120300|3554518|P3|STARTED|Overall Study||10
1452052|NCT02120300|3554519|P2|STARTED|Overall Study||5
1452053|NCT02120300|3554520|P1|STARTED|Overall Study||101
1452054|NCT02120027|3554558|P2|NOT COMPLETED|Overall Study||119
1452055|NCT02120027|3554559|P1|NOT COMPLETED|Overall Study||116
1452056|NCT02120027|3554558|P2|COMPLETED|Overall Study||160
1452057|NCT02120027|3554559|P1|COMPLETED|Overall Study||161
1452058|NCT02120027|3554558|P2|STARTED|Overall Study||279
1452059|NCT02120027|3554559|P1|STARTED|Overall Study||277
1452060|NCT02120001|3554575|P2|NOT COMPLETED|Overall Study||0
1452061|NCT02120001|3554576|P1|NOT COMPLETED|Overall Study||0
1452062|NCT02120001|3554575|P2|COMPLETED|Overall Study||19
1452063|NCT02120001|3554576|P1|COMPLETED|Overall Study||17
1452064|NCT02120001|3554575|P2|STARTED|Overall Study||19
1452065|NCT02120001|3554576|P1|STARTED|Overall Study||17
1452066|NCT02119936|3554584|P1|NOT COMPLETED|Overall Study||10
1452067|NCT02119936|3554584|P1|COMPLETED|Overall Study||0
1452068|NCT02119936|3554584|P1|STARTED|Overall Study||10
1452069|NCT02119871|3554595|P2|NOT COMPLETED|Overall Study||0
1452070|NCT02119871|3554596|P1|NOT COMPLETED|Overall Study||0
1452071|NCT02119871|3554595|P2|COMPLETED|Overall Study||10
1452072|NCT02119871|3554596|P1|COMPLETED|Overall Study||10
1452073|NCT02119871|3554595|P2|STARTED|Overall Study||10
1452074|NCT02119871|3554596|P1|STARTED|Overall Study||10
1452075|NCT02119676|3554618|P4|NOT COMPLETED|Overall Study||101
1452076|NCT02119676|3554619|P3|NOT COMPLETED|Overall Study||97
1452077|NCT02119676|3554620|P2|NOT COMPLETED|Overall Study||86
1452078|NCT02119676|3554621|P1|NOT COMPLETED|Overall Study||83
1452079|NCT02119676|3554618|P4|COMPLETED|Overall Study||10
1452080|NCT02119676|3554619|P3|COMPLETED|Overall Study||13
1452081|NCT02119676|3554620|P2|COMPLETED|Overall Study||2
1452082|NCT02119676|3554621|P1|COMPLETED|Overall Study||4
1452083|NCT02119676|3554618|P4|Treated Patients|Overall Study||106
1452084|NCT02119676|3554619|P3|Treated Patients|Overall Study||106
1452085|NCT02119676|3554620|P2|Treated Patients|Overall Study||86
1452086|NCT02119676|3554621|P1|Treated Patients|Overall Study||85
1452087|NCT02119676|3554618|P4|STARTED|Overall Study||111
1452088|NCT02119676|3554619|P3|STARTED|Overall Study||110
1452089|NCT02119676|3554620|P2|STARTED|Overall Study||88
1452090|NCT02119676|3554621|P1|STARTED|Overall Study||87
1452091|NCT02119663|3554653|P2|NOT COMPLETED|Overall Study||41
1452092|NCT02119663|3554654|P1|NOT COMPLETED|Overall Study||40
1452093|NCT02119663|3554653|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
1452094|NCT02119663|3554654|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
1452095|NCT02119663|3554653|P2|STARTED|Overall Study||43
1452096|NCT02119663|3554654|P1|STARTED|Overall Study||43
1452097|NCT02119650|3554672|P2|NOT COMPLETED|Overall Study||26
1452098|NCT02119650|3554673|P1|NOT COMPLETED|Overall Study||25
1452099|NCT02119650|3554672|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
1452100|NCT02119650|3554673|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
1452101|NCT02119650|3554672|P2|STARTED|Overall Study||37
1452102|NCT02119650|3554673|P1|STARTED|Overall Study||39
1452103|NCT02119325|3554687|P2|NOT COMPLETED|Period 2||0
1452104|NCT02119325|3554688|P1|NOT COMPLETED|Period 2||0
1452105|NCT02119325|3554687|P2|COMPLETED|Period 2||47
1452106|NCT02119325|3554688|P1|COMPLETED|Period 2||48
1452107|NCT02119325|3554687|P2|STARTED|Period 2||47
1452108|NCT02119325|3554688|P1|STARTED|Period 2||48
1452109|NCT02119325|3554687|P2|NOT COMPLETED|Washout Period 1||1
1452110|NCT02119325|3554688|P1|NOT COMPLETED|Washout Period 1||0
1452111|NCT02119325|3554687|P2|COMPLETED|Washout Period 1||47
1452112|NCT02119325|3554688|P1|COMPLETED|Washout Period 1||48
1452113|NCT02119325|3554687|P2|STARTED|Washout Period 1||48
1452114|NCT02119325|3554688|P1|STARTED|Washout Period 1||48
1452115|NCT02119325|3554687|P2|NOT COMPLETED|Period 1||0
1452116|NCT02119325|3554688|P1|NOT COMPLETED|Period 1||0
1452117|NCT02119325|3554687|P2|COMPLETED|Period 1||48
1452118|NCT02119325|3554688|P1|COMPLETED|Period 1||48
1452119|NCT02119325|3554687|P2|STARTED|Period 1||48
1452120|NCT02119325|3554688|P1|STARTED|Period 1||48
1452121|NCT02119299|3554732|P1|NOT COMPLETED|Overall Study||9
1452122|NCT02119299|3554732|P1|COMPLETED|Overall Study||67
1452123|NCT02119299|3554732|P1|STARTED|Overall Study||76
1452124|NCT02119286|3554746|P3|NOT COMPLETED|Overall Study||7
1452125|NCT02119286|3554747|P2|NOT COMPLETED|Overall Study||11
1452126|NCT02119286|3554748|P1|NOT COMPLETED|Overall Study||26
1452127|NCT02119286|3554746|P3|COMPLETED|Overall Study||200
1452128|NCT02119286|3554747|P2|COMPLETED|Overall Study||195
1452129|NCT02119286|3554748|P1|COMPLETED|Overall Study||180
1452130|NCT02119286|3554746|P3|STARTED|Overall Study||207
1452131|NCT02119286|3554747|P2|STARTED|Overall Study||206
1452132|NCT02119286|3554748|P1|STARTED|Overall Study||206
1452133|NCT02119260|3554766|P7|NOT COMPLETED|Overall Study||0
1452134|NCT02119260|3554767|P6|NOT COMPLETED|Overall Study||0
1452135|NCT02119260|3554768|P5|NOT COMPLETED|Overall Study||0
1452136|NCT02119260|3554769|P4|NOT COMPLETED|Overall Study||0
1452137|NCT02119260|3554770|P3|NOT COMPLETED|Overall Study||1
1452138|NCT02119260|3554771|P2|NOT COMPLETED|Overall Study||1
1452139|NCT02119260|3554772|P1|NOT COMPLETED|Overall Study||1
1452140|NCT02119260|3554766|P7|COMPLETED|Overall Study||2
1452141|NCT02119260|3554767|P6|COMPLETED|Overall Study||6
1452142|NCT02119260|3554768|P5|COMPLETED|Overall Study||13
1452143|NCT02119260|3554769|P4|COMPLETED|Overall Study||10
1452144|NCT02119260|3554770|P3|COMPLETED|Overall Study||7
1452145|NCT02119260|3554771|P2|COMPLETED|Overall Study||11
1452146|NCT02119260|3554772|P1|COMPLETED|Overall Study||8
1452147|NCT02119260|3554766|P7|STARTED|Overall Study||2
1452148|NCT02119260|3554767|P6|STARTED|Overall Study||6
1452149|NCT02119260|3554768|P5|STARTED|Overall Study||13
1452150|NCT02119260|3554769|P4|STARTED|Overall Study||10
1452151|NCT02119260|3554770|P3|STARTED|Overall Study||8
1452152|NCT02119260|3554771|P2|STARTED|Overall Study||12
1452153|NCT02119260|3554772|P1|STARTED|Overall Study||9
1452154|NCT02119104|3554842|P1|NOT COMPLETED|Overall Study||16
1452155|NCT02119104|3554842|P1|COMPLETED|Overall Study||1071
1452156|NCT02119104|3554842|P1|STARTED|Overall Study||1087
1452157|NCT02118961|3554848|P2|NOT COMPLETED|Overall Study||0
1452158|NCT02118961|3554849|P1|NOT COMPLETED|Overall Study||1
1452159|NCT02118961|3554848|P2|COMPLETED|Overall Study||222
1452160|NCT02118961|3554849|P1|COMPLETED|Overall Study||223
1452161|NCT02118961|3554848|P2|STARTED|Overall Study||222
1452162|NCT02118961|3554849|P1|STARTED|Overall Study||224
1452163|NCT02118896|3554877|P10|NOT COMPLETED|Overall Study||2
1452164|NCT02118896|3554878|P9|NOT COMPLETED|Overall Study||4
1452165|NCT02118896|3554879|P8|NOT COMPLETED|Overall Study||2
1452166|NCT02118896|3554880|P7|NOT COMPLETED|Overall Study||2
1452167|NCT02118896|3554881|P6|NOT COMPLETED|Overall Study||28
1452168|NCT02118896|3554882|P5|NOT COMPLETED|Overall Study||17
1452169|NCT02118896|3554883|P4|NOT COMPLETED|Overall Study||24
1452170|NCT02118896|3554884|P3|NOT COMPLETED|Overall Study||14
1452171|NCT02118896|3554885|P2|NOT COMPLETED|Overall Study||15
1452172|NCT02118896|3554886|P1|NOT COMPLETED|Overall Study||17
1452173|NCT02118896|3554877|P10|COMPLETED|Overall Study||7
1452174|NCT02118896|3554878|P9|COMPLETED|Overall Study||84
1452175|NCT02118896|3554879|P8|COMPLETED|Overall Study||105
1452176|NCT02118896|3554880|P7|COMPLETED|Overall Study||83
1452177|NCT02118896|3554881|P6|COMPLETED|Overall Study||163
1452178|NCT02118896|3554882|P5|COMPLETED|Overall Study||113
1452179|NCT02118896|3554883|P4|COMPLETED|Overall Study||55
1452180|NCT02118896|3554884|P3|COMPLETED|Overall Study||53
1452181|NCT02118896|3554885|P2|COMPLETED|Overall Study||32
1452182|NCT02118896|3554886|P1|COMPLETED|Overall Study||30
1452183|NCT02118896|3554877|P10|STARTED|Overall Study||9
1452184|NCT02118896|3554878|P9|STARTED|Overall Study||88
1452185|NCT02118896|3554879|P8|STARTED|Overall Study||107
1452186|NCT02118896|3554880|P7|STARTED|Overall Study||85
1452187|NCT02118896|3554881|P6|STARTED|Overall Study||191
1452188|NCT02118896|3554882|P5|STARTED|Overall Study||130
1452189|NCT02118896|3554883|P4|STARTED|Overall Study||79
1452190|NCT02118896|3554884|P3|STARTED|Overall Study||67
1452191|NCT02118896|3554885|P2|STARTED|Overall Study||47
1452192|NCT02118896|3554886|P1|STARTED|Overall Study||47
1452193|NCT02118831|3554961|P3|NOT COMPLETED|Overall Study||0
1452194|NCT02118831|3554962|P2|NOT COMPLETED|Overall Study||0
1452195|NCT02118831|3554963|P1|NOT COMPLETED|Overall Study||0
1452196|NCT02118831|3554961|P3|COMPLETED|Overall Study||20
1452197|NCT02118831|3554962|P2|COMPLETED|Overall Study||15
1452198|NCT02118831|3554963|P1|COMPLETED|Overall Study||21
1452199|NCT02118831|3554961|P3|STARTED|Overall Study||20
1452200|NCT02118831|3554962|P2|STARTED|Overall Study||15
1452201|NCT02118831|3554963|P1|STARTED|Overall Study||21
1452202|NCT02118792|3554976|P2|NOT COMPLETED|Overall Study||37
1452203|NCT02118792|3554977|P1|NOT COMPLETED|Overall Study||31
1452204|NCT02118792|3554976|P2|COMPLETED|Overall Study||213
1452205|NCT02118792|3554977|P1|COMPLETED|Overall Study||483
1452206|NCT02118792|3554976|P2|Treated|Overall Study||250
1452207|NCT02118792|3554977|P1|Treated|Overall Study||513
1452208|NCT02118792|3554976|P2|STARTED|Overall Study||250
1452209|NCT02118792|3554977|P1|STARTED|Overall Study||514
1452210|NCT02118766|3555019|P2|NOT COMPLETED|Overall Study||31
1452211|NCT02118766|3555020|P1|NOT COMPLETED|Overall Study||30
1452212|NCT02118766|3555019|P2|COMPLETED|Overall Study||225
1452213|NCT02118766|3555020|P1|COMPLETED|Overall Study||477
1452214|NCT02118766|3555019|P2|Treated|Overall Study||256
1452215|NCT02118766|3555020|P1|Treated|Overall Study||503
1452216|NCT02118766|3555019|P2|STARTED|Overall Study||256
1452217|NCT02118766|3555020|P1|STARTED|Overall Study||507
1452218|NCT02118597|3555042|P1|NOT COMPLETED|Overall Study||16
1452219|NCT02118597|3555042|P1|COMPLETED|Overall Study||3
1452220|NCT02118597|3555042|P1|STARTED|Overall Study||19
1452221|NCT02118441|3555058|P2|NOT COMPLETED|Overall Study||1
1452222|NCT02118441|3555059|P1|NOT COMPLETED|Overall Study||3
1452223|NCT02118441|3555058|P2|COMPLETED|Overall Study||63
1452224|NCT02118441|3555059|P1|COMPLETED|Overall Study||62
1452225|NCT02118441|3555058|P2|STARTED|Overall Study||64
1452226|NCT02118441|3555059|P1|STARTED|Overall Study||65
1452227|NCT02117934|3555073|P2|NOT COMPLETED|Overall Study||215
1452228|NCT02117934|3555074|P1|NOT COMPLETED|Overall Study||500
1452229|NCT02117934|3555073|P2|COMPLETED|Overall Study||2567
1452230|NCT02117934|3555074|P1|COMPLETED|Overall Study||5092
1452231|NCT02117934|3555073|P2|STARTED|Overall Study||2782
1452232|NCT02117934|3555074|P1|STARTED|Overall Study||5592
1452233|NCT02117687|3555084|P2|NOT COMPLETED|Overall Study||4
1452234|NCT02117687|3555085|P1|NOT COMPLETED|Overall Study||1
1452235|NCT02117687|3555084|P2|COMPLETED|Overall Study||36
1452236|NCT02117687|3555085|P1|COMPLETED|Overall Study||39
1452237|NCT02117687|3555084|P2|STARTED|Overall Study||40
1452238|NCT02117687|3555085|P1|STARTED|Overall Study||40
1452239|NCT02117648|3555117|P1|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
1452240|NCT02117648|3555117|P1|COMPLETED|Abemaciclib Safety-Extension Phase||0
1452241|NCT02117648|3555117|P1|STARTED|Abemaciclib Safety-Extension Phase||20
1452242|NCT02117648|3555117|P1|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
1452243|NCT02117648|3555117|P1|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
1452244|NCT02117648|3555117|P1|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
1452245|NCT02117648|3555117|P1|STARTED|Abemaciclib + Clarithromycin Period 2||24
1452246|NCT02117648|3555117|P1|NOT COMPLETED|Abemaciclib Alone Period 1||2
1452247|NCT02117648|3555117|P1|COMPLETED|Abemaciclib Alone Period 1||24
1452248|NCT02117648|3555117|P1|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
1452249|NCT02117648|3555117|P1|STARTED|Abemaciclib Alone Period 1||26
1452250|NCT02117570|3555130|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
1452251|NCT02117570|3555131|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
1452252|NCT02117570|3555132|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
1452253|NCT02117570|3555130|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
1452254|NCT02117570|3555131|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
1452255|NCT02117570|3555132|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
1452256|NCT02117570|3555130|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
1452257|NCT02117570|3555131|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
1452258|NCT02117570|3555132|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
1452259|NCT02117570|3555130|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
1452260|NCT02117570|3555131|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
1452261|NCT02117570|3555132|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
1452262|NCT02117570|3555130|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
1452263|NCT02117570|3555131|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
1452264|NCT02117570|3555132|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
1452265|NCT02117570|3555130|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
1452266|NCT02117570|3555131|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
1452267|NCT02117570|3555132|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
1452268|NCT02117570|3555130|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
1452269|NCT02117570|3555131|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
1452270|NCT02117570|3555132|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
1452271|NCT02117570|3555130|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
1452272|NCT02117570|3555131|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
1452273|NCT02117570|3555132|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
1452274|NCT02117570|3555130|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
1452275|NCT02117570|3555131|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
1452276|NCT02117570|3555132|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
1452277|NCT02117570|3555130|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
1452278|NCT02117570|3555131|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
1452279|NCT02117570|3555132|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
1452280|NCT02117570|3555130|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
1452281|NCT02117570|3555131|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
1452282|NCT02117570|3555132|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
1452283|NCT02117570|3555130|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
1452284|NCT02117570|3555131|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
1452285|NCT02117570|3555132|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
1452286|NCT02117544|3555182|P2|NOT COMPLETED|Period 2||0
1452287|NCT02117544|3555183|P1|NOT COMPLETED|Period 2||0
1452288|NCT02117544|3555182|P2|COMPLETED|Period 2||55
1452289|NCT02117544|3555183|P1|COMPLETED|Period 2||52
1452290|NCT02117544|3555182|P2|STARTED|Period 2||55
1452291|NCT02117544|3555183|P1|STARTED|Period 2||52
1452292|NCT02117544|3555182|P2|NOT COMPLETED|Period 1||0
1452293|NCT02117544|3555183|P1|NOT COMPLETED|Period 1||2
1452294|NCT02117544|3555182|P2|COMPLETED|Period 1||55
1452295|NCT02117544|3555183|P1|COMPLETED|Period 1||52
1452296|NCT02117544|3555182|P2|Treated|Period 1||55
1452297|NCT02117544|3555183|P1|Treated|Period 1||52
1452298|NCT02117544|3555182|P2|STARTED|Period 1||55
1452299|NCT02117544|3555183|P1|STARTED|Period 1||54
1452300|NCT02117479|3555198|P2|NOT COMPLETED|Overall Study||156
1452301|NCT02117479|3555199|P1|NOT COMPLETED|Overall Study||156
1452302|NCT02117479|3555198|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
1452303|NCT02117479|3555199|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
1452304|NCT02117479|3555198|P2|STARTED|Overall Study||160
1452305|NCT02117479|3555199|P1|STARTED|Overall Study||161
1452306|NCT02117427|3555218|P3|NOT COMPLETED|Overall Study||0
1452307|NCT02117427|3555219|P2|NOT COMPLETED|Overall Study||5
1452308|NCT02117427|3555220|P1|NOT COMPLETED|Overall Study||5
1452309|NCT02117427|3555218|P3|COMPLETED|Overall Study||0
1452310|NCT02117427|3555219|P2|COMPLETED|Overall Study||0
1452311|NCT02117427|3555220|P1|COMPLETED|Overall Study||1
1452312|NCT02117427|3555218|P3|Long Term Safety Follow-up|Overall Study||0
1452313|NCT02117427|3555219|P2|Long Term Safety Follow-up|Overall Study||0
1452314|NCT02117427|3555220|P1|Long Term Safety Follow-up|Overall Study||1
1452315|NCT02117427|3555218|P3|Safety Follow-up|Overall Study||0
1452316|NCT02117427|3555219|P2|Safety Follow-up|Overall Study||0
1452317|NCT02117427|3555220|P1|Safety Follow-up|Overall Study||1
1452318|NCT02117427|3555218|P3|Implantation & Efficacy|Overall Study||0
1452319|NCT02117427|3555219|P2|Implantation & Efficacy|Overall Study||4
1452320|NCT02117427|3555220|P1|Implantation & Efficacy|Overall Study||6
1452321|NCT02117427|3555218|P3|Run in Phase & Harvest|Overall Study||0
1452322|NCT02117427|3555219|P2|Run in Phase & Harvest|Overall Study||4
1452323|NCT02117427|3555220|P1|Run in Phase & Harvest|Overall Study||6
1452324|NCT02117427|3555218|P3|STARTED|Overall Study||0
1452325|NCT02117427|3555219|P2|STARTED|Overall Study||5
1452326|NCT02117427|3555220|P1|STARTED|Overall Study||6
1452327|NCT02117414|3555230|P2|NOT COMPLETED|Overall Study||6
1452328|NCT02117414|3555231|P1|NOT COMPLETED|Overall Study||15
1452329|NCT02117414|3555230|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
1452330|NCT02117414|3555231|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
1452331|NCT02117414|3555230|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
1452332|NCT02117414|3555231|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
1452333|NCT02117310|3555249|P1|NOT COMPLETED|Overall Study||0
1452334|NCT02117310|3555249|P1|COMPLETED|Overall Study||5
1452335|NCT02117310|3555249|P1|STARTED|Overall Study||5
1452336|NCT02117193|3555253|P1|NOT COMPLETED|Overall Study||0
1452337|NCT02117193|3555253|P1|COMPLETED|Overall Study||10
1452338|NCT02117193|3555253|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
1452339|NCT02117193|3555253|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
1452340|NCT02117193|3555253|P1|Placebo Intake + Normal Sleep|Overall Study||10
1452341|NCT02117193|3555253|P1|Alcohol Intake + Normal Sleep|Overall Study||10
1452342|NCT02117193|3555253|P1|STARTED|Overall Study||10
1452343|NCT02117050|3555275|P1|NOT COMPLETED|Overall Study||1
1452344|NCT02117050|3555275|P1|COMPLETED|Overall Study||0
1452345|NCT02117050|3555275|P1|STARTED|Overall Study||1
1452346|NCT02116972|3555290|P3|NOT COMPLETED|Overall Study||19
1452347|NCT02116972|3555291|P2|NOT COMPLETED|Overall Study||17
1452348|NCT02116972|3555292|P1|NOT COMPLETED|Overall Study||19
1452349|NCT02116972|3555290|P3|COMPLETED|Overall Study||85
1452350|NCT02116972|3555291|P2|COMPLETED|Overall Study||87
1452351|NCT02116972|3555292|P1|COMPLETED|Overall Study||83
1452352|NCT02116972|3555290|P3|STARTED|Overall Study||104
1452353|NCT02116972|3555291|P2|STARTED|Overall Study||104
1452354|NCT02116972|3555292|P1|STARTED|Overall Study||102
1452355|NCT02116803|3555324|P2|NOT COMPLETED|Overall Study||2
1452356|NCT02116803|3555325|P1|NOT COMPLETED|Overall Study||10
1452357|NCT02116803|3555324|P2|COMPLETED|Overall Study||0
1452358|NCT02116803|3555325|P1|COMPLETED|Overall Study||0
1452359|NCT02116803|3555324|P2|STARTED|Overall Study||2
1452360|NCT02116803|3555325|P1|STARTED|Overall Study||10
1452361|NCT02116621|3555333|P2|NOT COMPLETED|Twelve Month Follow-up||12
1452362|NCT02116621|3555334|P1|NOT COMPLETED|Twelve Month Follow-up||16
1452363|NCT02116621|3555333|P2|COMPLETED|Twelve Month Follow-up||86
1452364|NCT02116621|3555334|P1|COMPLETED|Twelve Month Follow-up||84
1452365|NCT02116621|3555333|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
1452366|NCT02116621|3555334|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
1452367|NCT02116621|3555333|P2|NOT COMPLETED|Six Month Follow-up||3
1452368|NCT02116621|3555334|P1|NOT COMPLETED|Six Month Follow-up||4
1452369|NCT02116621|3555333|P2|COMPLETED|Six Month Follow-up||97
1452370|NCT02116621|3555334|P1|COMPLETED|Six Month Follow-up||99
1452371|NCT02116621|3555333|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
1452372|NCT02116621|3555334|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
1452373|NCT02116621|3555333|P2|NOT COMPLETED|Three Month Follow-up||7
1452374|NCT02116621|3555334|P1|NOT COMPLETED|Three Month Follow-up||19
1452375|NCT02116621|3555333|P2|COMPLETED|Three Month Follow-up||96
1452376|NCT02116621|3555334|P1|COMPLETED|Three Month Follow-up||89
1452377|NCT02116621|3555333|P2|STARTED|Three Month Follow-up||103
1452378|NCT02116621|3555334|P1|STARTED|Three Month Follow-up||108
1452379|NCT02116621|3555333|P2|NOT COMPLETED|Baseline||4
1452380|NCT02116621|3555334|P1|NOT COMPLETED|Baseline||0
1452381|NCT02116621|3555333|P2|COMPLETED|Baseline||103
1452382|NCT02116621|3555334|P1|COMPLETED|Baseline||108
1452383|NCT02116621|3555333|P2|Completed Intervention Period|Baseline||103
1452384|NCT02116621|3555334|P1|Completed Intervention Period|Baseline||95
1452385|NCT02116621|3555333|P2|Completed Baseline Visit|Baseline||103
1452386|NCT02116621|3555334|P1|Completed Baseline Visit|Baseline||108
1452387|NCT02116621|3555333|P2|STARTED|Baseline||107
1452388|NCT02116621|3555334|P1|STARTED|Baseline||108
1452389|NCT02116582|3555422|P1|NOT COMPLETED|Overall Study||215
1452390|NCT02116582|3555422|P1|COMPLETED|Overall Study||0
1452391|NCT02116582|3555422|P1|Treated|Overall Study||214
1452392|NCT02116582|3555422|P1|STARTED|Overall Study||215
1452393|NCT02116530|3555432|P2|NOT COMPLETED|Overall Study||4
1452394|NCT02116530|3555433|P1|NOT COMPLETED|Overall Study||9
1452395|NCT02116530|3555432|P2|COMPLETED|Overall Study||184
1452396|NCT02116530|3555433|P1|COMPLETED|Overall Study||183
1452397|NCT02116530|3555432|P2|STARTED|Overall Study||188
1452398|NCT02116530|3555433|P1|STARTED|Overall Study||192
1452399|NCT02116361|3555451|P4|NOT COMPLETED|Overall Study||31
1452400|NCT02116361|3555452|P3|NOT COMPLETED|Overall Study||26
1452401|NCT02116361|3555453|P2|NOT COMPLETED|Overall Study||31
1452402|NCT02116361|3555454|P1|NOT COMPLETED|Overall Study||31
1452403|NCT02116361|3555451|P4|COMPLETED|Overall Study||34
1452404|NCT02116361|3555452|P3|COMPLETED|Overall Study||33
1452405|NCT02116361|3555453|P2|COMPLETED|Overall Study||34
1452406|NCT02116361|3555454|P1|COMPLETED|Overall Study||38
1452407|NCT02116361|3555451|P4|STARTED|Overall Study||65
1452408|NCT02116361|3555452|P3|STARTED|Overall Study||59
1452409|NCT02116361|3555453|P2|STARTED|Overall Study||65
1452410|NCT02116361|3555454|P1|STARTED|Overall Study||69
1452411|NCT02116322|3555484|P1|NOT COMPLETED|Overall Study||0
1452412|NCT02116322|3555484|P1|COMPLETED|Overall Study||1
1452413|NCT02116322|3555484|P1|STARTED|Overall Study||1
1452414|NCT02116309|3555491|P2|NOT COMPLETED|Overall Study||1
1452415|NCT02116309|3555492|P1|NOT COMPLETED|Overall Study||0
1452416|NCT02116309|3555491|P2|COMPLETED|Overall Study||477
1452417|NCT02116309|3555492|P1|COMPLETED|Overall Study||482
1452418|NCT02116309|3555491|P2|STARTED|Overall Study||478
1452419|NCT02116309|3555492|P1|STARTED|Overall Study||482
1452420|NCT02115984|3555502|P2|NOT COMPLETED|Overall Study||7
1452421|NCT02115984|3555503|P1|NOT COMPLETED|Overall Study||6
1452422|NCT02115984|3555502|P2|COMPLETED|Overall Study||16
1452423|NCT02115984|3555503|P1|COMPLETED|Overall Study||51
1452424|NCT02115984|3555502|P2|STARTED|Overall Study||23
1452425|NCT02115984|3555503|P1|STARTED|Overall Study||57
1452426|NCT02115828|3555509|P1|NOT COMPLETED|Overall Study||0
1452427|NCT02115828|3555509|P1|COMPLETED|Overall Study||9
1452428|NCT02115828|3555509|P1|STARTED|Overall Study||9
1452429|NCT02115815|3555524|P7|NOT COMPLETED|Overall Study||0
1452430|NCT02115815|3555525|P6|NOT COMPLETED|Overall Study||2
1452431|NCT02115815|3555526|P5|NOT COMPLETED|Overall Study||0
1452432|NCT02115815|3555527|P4|NOT COMPLETED|Overall Study||0
1452433|NCT02115815|3555528|P3|NOT COMPLETED|Overall Study||0
1452434|NCT02115815|3555529|P2|NOT COMPLETED|Overall Study||0
1452435|NCT02115815|3555530|P1|NOT COMPLETED|Overall Study||2
1452436|NCT02115815|3555524|P7|COMPLETED|Overall Study||20
1452437|NCT02115815|3555525|P6|COMPLETED|Overall Study||20
1452438|NCT02115815|3555526|P5|COMPLETED|Overall Study||20
1452439|NCT02115815|3555527|P4|COMPLETED|Overall Study||20
1452440|NCT02115815|3555528|P3|COMPLETED|Overall Study||20
1452441|NCT02115815|3555529|P2|COMPLETED|Overall Study||20
1452442|NCT02115815|3555530|P1|COMPLETED|Overall Study||22
1452443|NCT02115815|3555524|P7|STARTED|Overall Study||20
1452444|NCT02115815|3555525|P6|STARTED|Overall Study||22
1452445|NCT02115815|3555526|P5|STARTED|Overall Study||20
1452446|NCT02115815|3555527|P4|STARTED|Overall Study||20
1452447|NCT02115815|3555528|P3|STARTED|Overall Study||20
1452448|NCT02115815|3555529|P2|STARTED|Overall Study||20
1452449|NCT02115815|3555530|P1|STARTED|Overall Study||24
1452450|NCT02115646|3555623|P1|NOT COMPLETED|Overall Study||7
1452451|NCT02115646|3555623|P1|COMPLETED|Overall Study||22
1452452|NCT02115646|3555623|P1|STARTED|Overall Study||29
1452453|NCT02115633|3555638|P2|NOT COMPLETED|Overall Study||0
1452454|NCT02115633|3555639|P1|NOT COMPLETED|Overall Study||0
1452455|NCT02115633|3555638|P2|COMPLETED|Overall Study||16
1452456|NCT02115633|3555639|P1|COMPLETED|Overall Study||15
1452457|NCT02115633|3555638|P2|STARTED|Overall Study||16
1452458|NCT02115633|3555639|P1|STARTED|Overall Study||15
1452459|NCT02115581|3555653|P2|NOT COMPLETED|Overall Study||0
1452460|NCT02115581|3555654|P1|NOT COMPLETED|Overall Study||0
1452461|NCT02115581|3555653|P2|COMPLETED|Overall Study||21
1452462|NCT02115581|3555654|P1|COMPLETED|Overall Study||17
1452463|NCT02115581|3555653|P2|STARTED|Overall Study||21
1452464|NCT02115581|3555654|P1|STARTED|Overall Study||17
1452465|NCT02115347|3555666|P3|NOT COMPLETED|Overall Study||0
1452466|NCT02115347|3555667|P2|NOT COMPLETED|Overall Study||0
1452467|NCT02115347|3555668|P1|NOT COMPLETED|Overall Study||0
1452468|NCT02115347|3555666|P3|COMPLETED|Overall Study||0
1452469|NCT02115347|3555667|P2|COMPLETED|Overall Study||8
1452470|NCT02115347|3555668|P1|COMPLETED|Overall Study||8
1452471|NCT02115347|3555666|P3|STARTED|Overall Study||0
1452472|NCT02115347|3555667|P2|STARTED|Overall Study||8
1452473|NCT02115347|3555668|P1|STARTED|Overall Study||8
1452474|NCT02115321|3555688|P2|NOT COMPLETED|Overall Study||0
1452475|NCT02115321|3555689|P1|NOT COMPLETED|Overall Study||1
1452476|NCT02115321|3555688|P2|COMPLETED|Overall Study||10
1452477|NCT02115321|3555689|P1|COMPLETED|Overall Study||29
1452478|NCT02115321|3555688|P2|STARTED|Overall Study||10
1452479|NCT02115321|3555689|P1|STARTED|Overall Study||30
1452480|NCT02115308|3555711|P2|NOT COMPLETED|Overall Study||2
1452481|NCT02115308|3555712|P1|NOT COMPLETED|Overall Study||2
1452482|NCT02115308|3555711|P2|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
1452483|NCT02115308|3555712|P1|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
1452484|NCT02115308|3555711|P2|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
1452485|NCT02115308|3555712|P1|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
1452486|NCT02115269|3555728|P1|NOT COMPLETED|Overall Study||57
1452487|NCT02115269|3555728|P1|COMPLETED|Overall Study||702
1452488|NCT02115269|3555728|P1|STARTED|Overall Study||759
1452489|NCT02115256|3555748|P2|NOT COMPLETED|Overall Study||1
1452490|NCT02115256|3555749|P1|NOT COMPLETED|Overall Study||0
1452491|NCT02115256|3555748|P2|COMPLETED|Overall Study||2
1452492|NCT02115256|3555749|P1|COMPLETED|Overall Study||3
1452493|NCT02115256|3555748|P2|STARTED|Overall Study||3
1452494|NCT02115256|3555749|P1|STARTED|Overall Study||3
1452495|NCT02114931|3555763|P2|NOT COMPLETED|Overall Study||30
1452496|NCT02114931|3555764|P1|NOT COMPLETED|Overall Study||25
1452497|NCT02114931|3555763|P2|COMPLETED|Overall Study||207
1452498|NCT02114931|3555764|P1|COMPLETED|Overall Study||205
1452499|NCT02114931|3555763|P2|Received Treatment|Overall Study||237
1452590|NCT02113436|3556051|P1|STARTED|Period 2: 16 Weeks||0
1452591|NCT02113436|3556048|P4|NOT COMPLETED|Period 1: 8 Weeks||0
1452500|NCT02114931|3555764|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
1452501|NCT02114931|3555763|P2|STARTED|Overall Study||237
1452502|NCT02114931|3555764|P1|STARTED|Overall Study||230
1452503|NCT02114892|3555780|P2|NOT COMPLETED|Overall Study||2
1452504|NCT02114892|3555781|P1|NOT COMPLETED|Overall Study||1
1452505|NCT02114892|3555780|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
1452506|NCT02114892|3555781|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
1452507|NCT02114892|3555780|P2|STARTED|Overall Study||12
1452508|NCT02114892|3555781|P1|STARTED|Overall Study||12
1452509|NCT02114697|3555817|P2|NOT COMPLETED|Overall Study||4
1452510|NCT02114697|3555818|P1|NOT COMPLETED|Overall Study||5
1452511|NCT02114697|3555817|P2|COMPLETED|Overall Study||0
1452512|NCT02114697|3555818|P1|COMPLETED|Overall Study||0
1452513|NCT02114697|3555817|P2|Completed Month 18 Visit|Overall Study||1
1452514|NCT02114697|3555818|P1|Completed Month 18 Visit|Overall Study||0
1452515|NCT02114697|3555817|P2|STARTED|Overall Study||4
1452516|NCT02114697|3555818|P1|STARTED|Overall Study||5
1452517|NCT02114385|3555826|P2|NOT COMPLETED|Overall Study||8
1452518|NCT02114385|3555827|P1|NOT COMPLETED|Overall Study||3
1452519|NCT02114385|3555826|P2|COMPLETED|Overall Study||243
1452520|NCT02114385|3555827|P1|COMPLETED|Overall Study||246
1452521|NCT02114385|3555826|P2|Vaccinated|Overall Study||251
1452522|NCT02114385|3555827|P1|Vaccinated|Overall Study||249
1452523|NCT02114385|3555826|P2|STARTED|Overall Study||251
1452524|NCT02114385|3555827|P1|STARTED|Overall Study||249
1452525|NCT02114268|3555855|P6|NOT COMPLETED|Overall Study||3
1452526|NCT02114268|3555856|P5|NOT COMPLETED|Overall Study||0
1452527|NCT02114268|3555857|P4|NOT COMPLETED|Overall Study||0
1452528|NCT02114268|3555858|P3|NOT COMPLETED|Overall Study||1
1452529|NCT02114268|3555859|P2|NOT COMPLETED|Overall Study||1
1452530|NCT02114268|3555860|P1|NOT COMPLETED|Overall Study||6
1452531|NCT02114268|3555855|P6|COMPLETED|Overall Study||75
1452532|NCT02114268|3555856|P5|COMPLETED|Overall Study||6
1452533|NCT02114268|3555857|P4|COMPLETED|Overall Study||6
1452534|NCT02114268|3555858|P3|COMPLETED|Overall Study||5
1452535|NCT02114268|3555859|P2|COMPLETED|Overall Study||5
1452536|NCT02114268|3555860|P1|COMPLETED|Overall Study||28
1452537|NCT02114268|3555855|P6|STARTED|Overall Study||78
1452538|NCT02114268|3555856|P5|STARTED|Overall Study||6
1452539|NCT02114268|3555857|P4|STARTED|Overall Study||6
1452540|NCT02114268|3555858|P3|STARTED|Overall Study||6
1452541|NCT02114268|3555859|P2|STARTED|Overall Study||6
1452542|NCT02114268|3555860|P1|STARTED|Overall Study||34
1452543|NCT02114216|3555913|P3|NOT COMPLETED|Overall Study||0
1452544|NCT02114216|3555914|P2|NOT COMPLETED|Overall Study||0
1452545|NCT02114216|3555915|P1|NOT COMPLETED|Overall Study||0
1452546|NCT02114216|3555913|P3|COMPLETED|Overall Study||14
1452547|NCT02114216|3555914|P2|COMPLETED|Overall Study||45
1452548|NCT02114216|3555915|P1|COMPLETED|Overall Study||16
1452549|NCT02114216|3555913|P3|STARTED|Overall Study||14
1452550|NCT02114216|3555914|P2|STARTED|Overall Study||45
1452551|NCT02114216|3555915|P1|STARTED|Overall Study||16
1452552|NCT02114203|3555929|P3|NOT COMPLETED|Overall Study||0
1452553|NCT02114203|3555930|P2|NOT COMPLETED|Overall Study||2
1452554|NCT02114203|3555931|P1|NOT COMPLETED|Overall Study||0
1452555|NCT02114203|3555929|P3|COMPLETED|Overall Study||7
1452556|NCT02114203|3555930|P2|COMPLETED|Overall Study||14
1452557|NCT02114203|3555931|P1|COMPLETED|Overall Study||7
1452558|NCT02114203|3555929|P3|STARTED|Overall Study||7
1452559|NCT02114203|3555930|P2|STARTED|Overall Study||16
1452560|NCT02114203|3555931|P1|STARTED|Overall Study||7
1452561|NCT02114177|3555965|P2|NOT COMPLETED|Overall Study||4
1452562|NCT02114177|3555966|P1|NOT COMPLETED|Overall Study||9
1452563|NCT02114177|3555965|P2|COMPLETED|Overall Study||151
1452564|NCT02114177|3555966|P1|COMPLETED|Overall Study||146
1452565|NCT02114177|3555965|P2|STARTED|Overall Study||155
1452566|NCT02114177|3555966|P1|STARTED|Overall Study||155
1452567|NCT02114151|3555990|P1|NOT COMPLETED|Overall Study||7
1452568|NCT02114151|3555990|P1|COMPLETED|Overall Study||96
1452569|NCT02114151|3555990|P1|STARTED|Overall Study||103
1452570|NCT02113579|3556007|P2|NOT COMPLETED|Overall Study||4
1452571|NCT02113579|3556008|P1|NOT COMPLETED|Overall Study||10
1452572|NCT02113579|3556007|P2|COMPLETED|Overall Study||185
1452573|NCT02113579|3556008|P1|COMPLETED|Overall Study||176
1452574|NCT02113579|3556007|P2|STARTED|Overall Study||189
1452575|NCT02113579|3556008|P1|STARTED|Overall Study||186
1452576|NCT02113449|3556032|P1|NOT COMPLETED|Overall Study||4
1452577|NCT02113449|3556032|P1|COMPLETED|Overall Study||143
1452578|NCT02113449|3556032|P1|STARTED|Overall Study||147
1452579|NCT02113436|3556048|P4|NOT COMPLETED|Period 2: 16 Weeks||11
1452580|NCT02113436|3556049|P3|NOT COMPLETED|Period 2: 16 Weeks||9
1452581|NCT02113436|3556050|P2|NOT COMPLETED|Period 2: 16 Weeks||0
1452582|NCT02113436|3556051|P1|NOT COMPLETED|Period 2: 16 Weeks||0
1452583|NCT02113436|3556048|P4|COMPLETED|Period 2: 16 Weeks||136
1452584|NCT02113436|3556049|P3|COMPLETED|Period 2: 16 Weeks||132
1452585|NCT02113436|3556050|P2|COMPLETED|Period 2: 16 Weeks||0
1452586|NCT02113436|3556051|P1|COMPLETED|Period 2: 16 Weeks||0
1452587|NCT02113436|3556048|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|147
1452588|NCT02113436|3556049|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|141
1452589|NCT02113436|3556050|P2|STARTED|Period 2: 16 Weeks||0
1452592|NCT02113436|3556049|P3|NOT COMPLETED|Period 1: 8 Weeks||0
1452593|NCT02113436|3556050|P2|NOT COMPLETED|Period 1: 8 Weeks||2
1452594|NCT02113436|3556051|P1|NOT COMPLETED|Period 1: 8 Weeks||8
1452595|NCT02113436|3556048|P4|COMPLETED|Period 1: 8 Weeks||0
1452596|NCT02113436|3556049|P3|COMPLETED|Period 1: 8 Weeks||0
1452597|NCT02113436|3556050|P2|COMPLETED|Period 1: 8 Weeks||148
1452598|NCT02113436|3556051|P1|COMPLETED|Period 1: 8 Weeks||142
1452599|NCT02113436|3556048|P4|STARTED|Period 1: 8 Weeks||0
1452600|NCT02113436|3556049|P3|STARTED|Period 1: 8 Weeks||0
1452601|NCT02113436|3556050|P2|STARTED|Period 1: 8 Weeks||150
1452602|NCT02113436|3556051|P1|STARTED|Period 1: 8 Weeks||150
1452603|NCT02113124|3556074|P2|NOT COMPLETED|Overall Study||1
1452604|NCT02113124|3556075|P1|NOT COMPLETED|Overall Study||1
1452605|NCT02113124|3556074|P2|COMPLETED|Overall Study||24
1452606|NCT02113124|3556075|P1|COMPLETED|Overall Study||17
1452607|NCT02113124|3556074|P2|STARTED|Overall Study||25
1452608|NCT02113124|3556075|P1|STARTED|Overall Study||18
1452609|NCT02113007|3556081|P1|NOT COMPLETED|Overall Study||2
1452610|NCT02113007|3556081|P1|COMPLETED|Overall Study||0
1452611|NCT02113007|3556081|P1|STARTED|Overall Study||2
1452612|NCT02112448|3556089|P2|NOT COMPLETED|Overall Study||10
1452613|NCT02112448|3556090|P1|NOT COMPLETED|Overall Study||8
1452614|NCT02112448|3556089|P2|COMPLETED|Overall Study||30
1452615|NCT02112448|3556090|P1|COMPLETED|Overall Study||30
1452616|NCT02112448|3556089|P2|STARTED|Overall Study||40
1452617|NCT02112448|3556090|P1|STARTED|Overall Study||38
1452618|NCT02112370|3556100|P2|NOT COMPLETED|Overall Study||0
1452619|NCT02112370|3556101|P1|NOT COMPLETED|Overall Study||0
1452620|NCT02112370|3556100|P2|COMPLETED|Overall Study||74
1452621|NCT02112370|3556101|P1|COMPLETED|Overall Study||74
1452622|NCT02112370|3556100|P2|STARTED|Overall Study||74
1452623|NCT02112370|3556101|P1|STARTED|Overall Study||74
1452624|NCT02111863|3556121|P1|NOT COMPLETED|Overall Study||0
1452625|NCT02111863|3556121|P1|COMPLETED|Overall Study||6
1452626|NCT02111863|3556121|P1|STARTED|Overall Study||6
1452627|NCT02111785|3556131|P4|NOT COMPLETED|Overall Study||0
1452628|NCT02111785|3556132|P3|NOT COMPLETED|Overall Study||0
1452629|NCT02111785|3556133|P2|NOT COMPLETED|Overall Study||1
1452630|NCT02111785|3556134|P1|NOT COMPLETED|Overall Study||0
1452631|NCT02111785|3556131|P4|COMPLETED|Overall Study||1
1452632|NCT02111785|3556132|P3|COMPLETED|Overall Study||1
1452633|NCT02111785|3556133|P2|COMPLETED|Overall Study||4
1452634|NCT02111785|3556134|P1|COMPLETED|Overall Study||3
1452635|NCT02111785|3556131|P4|STARTED|Overall Study||1
1452636|NCT02111785|3556132|P3|STARTED|Overall Study||1
1452637|NCT02111785|3556133|P2|STARTED|Overall Study||5
1452638|NCT02111785|3556134|P1|STARTED|Overall Study||3
1452639|NCT02111772|3556162|P2|NOT COMPLETED|Overall Study||0
1452640|NCT02111772|3556163|P1|NOT COMPLETED|Overall Study||0
1452641|NCT02111772|3556162|P2|COMPLETED|Overall Study||14
1452642|NCT02111772|3556163|P1|COMPLETED|Overall Study||12
1452643|NCT02111772|3556162|P2|STARTED|Overall Study||14
1452644|NCT02111772|3556163|P1|STARTED|Overall Study||12
1452645|NCT02111746|3556173|P2|NOT COMPLETED|Overall Study||2
1452646|NCT02111746|3556174|P1|NOT COMPLETED|Overall Study||3
1452647|NCT02111746|3556173|P2|COMPLETED|Overall Study||169
1452648|NCT02111746|3556174|P1|COMPLETED|Overall Study||169
1452649|NCT02111746|3556173|P2|STARTED|Overall Study||171
1452650|NCT02111746|3556174|P1|STARTED|Overall Study||172
1452651|NCT02111603|3556196|P1|NOT COMPLETED|Overall Study||1
1452652|NCT02111603|3556196|P1|COMPLETED|Overall Study||12
1452653|NCT02111603|3556196|P1|STARTED|Overall Study||13
1452654|NCT02111369|3556205|P1|NOT COMPLETED|Overall Study||3
1452655|NCT02111369|3556205|P1|COMPLETED|Overall Study||15
1452656|NCT02111369|3556205|P1|STARTED|Overall Study||18
1452657|NCT02111252|3556213|P1|NOT COMPLETED|Overall Study||0
1452658|NCT02111252|3556213|P1|COMPLETED|Overall Study||55
1452659|NCT02111252|3556213|P1|STARTED|Overall Study||55
1452660|NCT02111200|3556231|P4|NOT COMPLETED|Overall Study||0
1452661|NCT02111200|3556232|P3|NOT COMPLETED|Overall Study||0
1452662|NCT02111200|3556233|P2|NOT COMPLETED|Overall Study||0
1452663|NCT02111200|3556234|P1|NOT COMPLETED|Overall Study||0
1452664|NCT02111200|3556231|P4|COMPLETED|Overall Study||1
1452665|NCT02111200|3556232|P3|COMPLETED|Overall Study||1
1452666|NCT02111200|3556233|P2|COMPLETED|Overall Study||2
1452667|NCT02111200|3556234|P1|COMPLETED|Overall Study||3
1452668|NCT02111200|3556231|P4|STARTED|Overall Study||1
1452669|NCT02111200|3556232|P3|STARTED|Overall Study||1
1452670|NCT02111200|3556233|P2|STARTED|Overall Study||2
1452671|NCT02111200|3556234|P1|STARTED|Overall Study||3
1452672|NCT02111174|3556250|P2|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
1452673|NCT02111174|3556251|P1|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
1452674|NCT02111174|3556250|P2|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
1452675|NCT02111174|3556251|P1|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
1452676|NCT02111174|3556250|P2|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
1452677|NCT02111174|3556251|P1|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
1452678|NCT02111174|3556250|P2|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
1452679|NCT02111174|3556251|P1|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
1452680|NCT02111174|3556250|P2|NOT COMPLETED|Treatment and Primary Outcome||2
1452681|NCT02111174|3556251|P1|NOT COMPLETED|Treatment and Primary Outcome||3
1452682|NCT02111174|3556250|P2|COMPLETED|Treatment and Primary Outcome||16
1452683|NCT02111174|3556251|P1|COMPLETED|Treatment and Primary Outcome||15
1452684|NCT02111174|3556250|P2|STARTED|Treatment and Primary Outcome||18
1452685|NCT02111174|3556251|P1|STARTED|Treatment and Primary Outcome||18
1452686|NCT02111096|3556280|P3|NOT COMPLETED|Overall Study||66
1452687|NCT02111096|3556281|P2|NOT COMPLETED|Overall Study||41
1452688|NCT02111096|3556282|P1|NOT COMPLETED|Overall Study||64
1452689|NCT02111096|3556280|P3|COMPLETED|Overall Study||2
1452690|NCT02111096|3556281|P2|COMPLETED|Overall Study||0
1452691|NCT02111096|3556282|P1|COMPLETED|Overall Study||1
1452692|NCT02111096|3556280|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
1452693|NCT02111096|3556281|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
1452694|NCT02111096|3556282|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
1452695|NCT02111096|3556280|P3|STARTED|Overall Study||68
1452696|NCT02111096|3556281|P2|STARTED|Overall Study||41
1452697|NCT02111096|3556282|P1|STARTED|Overall Study||65
1452698|NCT02111083|3556330|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
1452699|NCT02111083|3556331|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
1452700|NCT02111083|3556330|P2|COMPLETED|Fourth Intervention (1 Day)||18
1452701|NCT02111083|3556331|P1|COMPLETED|Fourth Intervention (1 Day)||18
1452702|NCT02111083|3556330|P2|STARTED|Fourth Intervention (1 Day)||18
1452703|NCT02111083|3556331|P1|STARTED|Fourth Intervention (1 Day)||18
1452704|NCT02111083|3556330|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
1452705|NCT02111083|3556331|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
1452706|NCT02111083|3556330|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
1452707|NCT02111083|3556331|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
1452708|NCT02111083|3556330|P2|STARTED|Interval Between Dosing (7-8 Days)||19
1452709|NCT02111083|3556331|P1|STARTED|Interval Between Dosing (7-8 Days)||19
1452710|NCT02111083|3556330|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1452711|NCT02111083|3556331|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1452712|NCT02111083|3556330|P2|COMPLETED|Third Intervention (1 Day)||19
1452713|NCT02111083|3556331|P1|COMPLETED|Third Intervention (1 Day)||19
1452714|NCT02111083|3556330|P2|STARTED|Third Intervention (1 Day)||19
1452715|NCT02111083|3556331|P1|STARTED|Third Intervention (1 Day)||19
1452716|NCT02111083|3556330|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
1452717|NCT02111083|3556331|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
1452718|NCT02111083|3556330|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
1452719|NCT02111083|3556331|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
1452720|NCT02111083|3556330|P2|STARTED|Interval Between Dosing (7-8 Days)||19
1452721|NCT02111083|3556331|P1|STARTED|Interval Between Dosing (7-8 Days)||19
1452722|NCT02111083|3556330|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1452723|NCT02111083|3556331|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1452724|NCT02111083|3556330|P2|COMPLETED|Second Intervention (1 Day)||19
1452725|NCT02111083|3556331|P1|COMPLETED|Second Intervention (1 Day)||19
1452726|NCT02111083|3556330|P2|STARTED|Second Intervention (1 Day)||19
1452727|NCT02111083|3556331|P1|STARTED|Second Intervention (1 Day)||19
1452728|NCT02111083|3556330|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
1452729|NCT02111083|3556331|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
1452730|NCT02111083|3556330|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
1452731|NCT02111083|3556331|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
1452732|NCT02111083|3556330|P2|STARTED|Interval Between Dosing (7-8 Days)||19
1452733|NCT02111083|3556331|P1|STARTED|Interval Between Dosing (7-8 Days)||19
1452734|NCT02111083|3556330|P2|NOT COMPLETED|First Intervention (1 Day)||0
1452735|NCT02111083|3556331|P1|NOT COMPLETED|First Intervention (1 Day)||0
1452736|NCT02111083|3556330|P2|COMPLETED|First Intervention (1 Day)||19
1452737|NCT02111083|3556331|P1|COMPLETED|First Intervention (1 Day)||19
1452738|NCT02111083|3556330|P2|STARTED|First Intervention (1 Day)||19
1452739|NCT02111083|3556331|P1|STARTED|First Intervention (1 Day)||19
1452740|NCT02110706|3556351|P2|NOT COMPLETED|Overall Study||4
1452741|NCT02110706|3556352|P1|NOT COMPLETED|Overall Study||5
1452742|NCT02110706|3556351|P2|COMPLETED|Overall Study||23
1452743|NCT02110706|3556352|P1|COMPLETED|Overall Study||20
1452744|NCT02110706|3556351|P2|No. Completing Study Through Week 52|Overall Study||24
1452745|NCT02110706|3556352|P1|No. Completing Study Through Week 52|Overall Study||23
1452746|NCT02110706|3556351|P2|STARTED|Overall Study||27
1452747|NCT02110706|3556352|P1|STARTED|Overall Study||25
1452748|NCT02110693|3556364|P2|NOT COMPLETED|Overall Study||29
1452749|NCT02110693|3556365|P1|NOT COMPLETED|Overall Study||28
1452750|NCT02110693|3556364|P2|COMPLETED|Overall Study||1002
1452751|NCT02110693|3556365|P1|COMPLETED|Overall Study||998
1452752|NCT02110693|3556364|P2|STARTED|Overall Study||1031
1452753|NCT02110693|3556365|P1|STARTED|Overall Study||1026
1452754|NCT02110381|3556392|P2|NOT COMPLETED|Dual Modality||1
1452755|NCT02110381|3556393|P1|NOT COMPLETED|Dual Modality||2
1452756|NCT02110381|3556392|P2|COMPLETED|Dual Modality||7
1452757|NCT02110381|3556393|P1|COMPLETED|Dual Modality||5
1452758|NCT02110381|3556392|P2|Began Active Treatment|Dual Modality||7
1452759|NCT02110381|3556393|P1|Began Active Treatment|Dual Modality||7
1452760|NCT02110381|3556392|P2|STARTED|Dual Modality||8
1452761|NCT02110381|3556393|P1|STARTED|Dual Modality||7
1452762|NCT02110381|3556392|P2|NOT COMPLETED|Single Modality||1
1452763|NCT02110381|3556393|P1|NOT COMPLETED|Single Modality||2
1452764|NCT02110381|3556392|P2|COMPLETED|Single Modality||8
1452765|NCT02110381|3556393|P1|COMPLETED|Single Modality||7
1452766|NCT02110381|3556392|P2|STARTED|Single Modality||9
1452767|NCT02110381|3556393|P1|STARTED|Single Modality||9
1452768|NCT02110277|3556404|P1|NOT COMPLETED|Overall Study||2
1452769|NCT02110277|3556404|P1|COMPLETED|Overall Study||0
1452770|NCT02110277|3556404|P1|STARTED|Overall Study||2
1452771|NCT02110238|3556411|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
1452772|NCT02110238|3556412|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
1452773|NCT02110238|3556411|P2|COMPLETED|14 Week Blinded Extension Phase||188
1452774|NCT02110238|3556412|P1|COMPLETED|14 Week Blinded Extension Phase||190
1452775|NCT02110238|3556411|P2|STARTED|14 Week Blinded Extension Phase||200
1452776|NCT02110238|3556412|P1|STARTED|14 Week Blinded Extension Phase||202
1452777|NCT02110238|3556411|P2|NOT COMPLETED|12 Week Pivotal Phase||9
1452778|NCT02110238|3556412|P1|NOT COMPLETED|12 Week Pivotal Phase||10
1452779|NCT02110238|3556411|P2|COMPLETED|12 Week Pivotal Phase||200
1452780|NCT02110238|3556412|P1|COMPLETED|12 Week Pivotal Phase||202
1452781|NCT02110238|3556411|P2|STARTED|12 Week Pivotal Phase||209
1452782|NCT02110238|3556412|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
1452783|NCT02110147|3556418|P1|NOT COMPLETED|Overall Study||0
1452784|NCT02110147|3556418|P1|COMPLETED|Overall Study||4
1452785|NCT02110147|3556418|P1|STARTED|Overall Study||4
1452786|NCT02109809|3556424|P1|NOT COMPLETED|Overall Study||3
1452787|NCT02109809|3556424|P1|COMPLETED|Overall Study||1
1452788|NCT02109809|3556424|P1|STARTED|Overall Study||4
1452789|NCT02109731|3556430|P1|NOT COMPLETED|Overall Study||0
1452790|NCT02109731|3556430|P1|COMPLETED|Overall Study||15
1452791|NCT02109731|3556430|P1|STARTED|Overall Study||15
1452792|NCT02109640|3556436|P2|NOT COMPLETED|Overall Study||0
1452793|NCT02109640|3556437|P1|NOT COMPLETED|Overall Study||0
1452794|NCT02109640|3556436|P2|COMPLETED|Overall Study||23
1452795|NCT02109640|3556437|P1|COMPLETED|Overall Study||27
1452796|NCT02109640|3556436|P2|STARTED|Overall Study||23
1452797|NCT02109640|3556437|P1|STARTED|Overall Study||27
1452798|NCT02109562|3556450|P3|NOT COMPLETED|Overall Study||35
1452799|NCT02109562|3556451|P2|NOT COMPLETED|Overall Study||34
1452800|NCT02109562|3556452|P1|NOT COMPLETED|Overall Study||26
1452801|NCT02109562|3556450|P3|COMPLETED|Overall Study||84
1452802|NCT02109562|3556451|P2|COMPLETED|Overall Study||85
1452803|NCT02109562|3556452|P1|COMPLETED|Overall Study||90
1452804|NCT02109562|3556450|P3|Intent to Treat (ITT)|Overall Study||112
1452805|NCT02109562|3556451|P2|Intent to Treat (ITT)|Overall Study||114
1452806|NCT02109562|3556452|P1|Intent to Treat (ITT)|Overall Study||111
1452807|NCT02109562|3556450|P3|Safety|Overall Study||118
1452808|NCT02109562|3556451|P2|Safety|Overall Study||117
1452809|NCT02109562|3556452|P1|Safety|Overall Study||115
1452810|NCT02109562|3556450|P3|STARTED|Overall Study||119
1452811|NCT02109562|3556451|P2|STARTED|Overall Study||119
1452812|NCT02109562|3556452|P1|STARTED|Overall Study||116
1452813|NCT02109497|3556466|P1|NOT COMPLETED|Overall Study||1
1452814|NCT02109497|3556466|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
1452815|NCT02109497|3556466|P1|STARTED|Overall Study||18
1452816|NCT02109484|3556479|P8|NOT COMPLETED|Overall Study||3
1452817|NCT02109484|3556480|P7|NOT COMPLETED|Overall Study||3
1452818|NCT02109484|3556481|P6|NOT COMPLETED|Overall Study||1
1452819|NCT02109484|3556482|P5|NOT COMPLETED|Overall Study||4
1452820|NCT02109484|3556483|P4|NOT COMPLETED|Overall Study||1
1452821|NCT02109484|3556484|P3|NOT COMPLETED|Overall Study||0
1452822|NCT02109484|3556485|P2|NOT COMPLETED|Overall Study||0
1452823|NCT02109484|3556486|P1|NOT COMPLETED|Overall Study||0
1452824|NCT02109484|3556479|P8|COMPLETED|Overall Study||47
1452825|NCT02109484|3556480|P7|COMPLETED|Overall Study||47
1452826|NCT02109484|3556481|P6|COMPLETED|Overall Study||11
1452827|NCT02109484|3556482|P5|COMPLETED|Overall Study||46
1452828|NCT02109484|3556483|P4|COMPLETED|Overall Study||11
1452829|NCT02109484|3556484|P3|COMPLETED|Overall Study||12
1452830|NCT02109484|3556485|P2|COMPLETED|Overall Study||13
1452831|NCT02109484|3556486|P1|COMPLETED|Overall Study||5
1452832|NCT02109484|3556479|P8|STARTED|Overall Study||50
1452833|NCT02109484|3556480|P7|STARTED|Overall Study||50
1452834|NCT02109484|3556481|P6|STARTED|Overall Study||12
1452835|NCT02109484|3556482|P5|STARTED|Overall Study||50
1452836|NCT02109484|3556483|P4|STARTED|Overall Study||12
1452837|NCT02109484|3556484|P3|STARTED|Overall Study||12
1452838|NCT02109484|3556485|P2|STARTED|Overall Study||13
1452839|NCT02109484|3556486|P1|STARTED|Overall Study||5
1452840|NCT02109458|3556535|P1|NOT COMPLETED|Overall Study||0
1452841|NCT02109458|3556535|P1|COMPLETED|Overall Study||24
1452842|NCT02109458|3556535|P1|STARTED|Overall Study||24
1452843|NCT02109445|3556542|P1|NOT COMPLETED|Overall Study||3
1452844|NCT02109445|3556542|P1|COMPLETED|Overall Study||0
1452845|NCT02109445|3556542|P1|STARTED|Overall Study||3
1452846|NCT02109172|3556575|P6|NOT COMPLETED|Overall Study||1
1452847|NCT02109172|3556576|P5|NOT COMPLETED|Overall Study||1
1452848|NCT02109172|3556577|P4|NOT COMPLETED|Overall Study||1
1452849|NCT02109172|3556578|P3|NOT COMPLETED|Overall Study||1
1452850|NCT02109172|3556579|P2|NOT COMPLETED|Overall Study||0
1452851|NCT02109172|3556580|P1|NOT COMPLETED|Overall Study||1
1452852|NCT02109172|3556575|P6|COMPLETED|Overall Study||10
1452853|NCT02109172|3556576|P5|COMPLETED|Overall Study||9
1452854|NCT02109172|3556577|P4|COMPLETED|Overall Study||10
1452855|NCT02109172|3556578|P3|COMPLETED|Overall Study||9
1452856|NCT02109172|3556579|P2|COMPLETED|Overall Study||11
1452857|NCT02109172|3556580|P1|COMPLETED|Overall Study||10
1452858|NCT02109172|3556575|P6|STARTED|Overall Study||11
1452859|NCT02109172|3556576|P5|STARTED|Overall Study||10
1452860|NCT02109172|3556577|P4|STARTED|Overall Study||11
1452861|NCT02109172|3556578|P3|STARTED|Overall Study||10
1452862|NCT02109172|3556579|P2|STARTED|Overall Study||11
1452863|NCT02109172|3556580|P1|STARTED|Overall Study||11
1452864|NCT02109159|3556590|P2|NOT COMPLETED|Overall Study||0
1452865|NCT02109159|3556591|P1|NOT COMPLETED|Overall Study||0
1452866|NCT02109159|3556590|P2|COMPLETED|Overall Study||4175
1452867|NCT02109159|3556591|P1|COMPLETED|Overall Study||4178
1452868|NCT02109159|3556590|P2|STARTED|Overall Study||4175
1452869|NCT02109159|3556591|P1|STARTED|Overall Study||4178
1452870|NCT02109133|3556601|P2|NOT COMPLETED|Overall Study||0
1452871|NCT02109133|3556602|P1|NOT COMPLETED|Overall Study||1
1452872|NCT02109133|3556601|P2|COMPLETED|Overall Study||34
1452873|NCT02109133|3556602|P1|COMPLETED|Overall Study||32
1452874|NCT02109133|3556601|P2|STARTED|Overall Study||34
1452875|NCT02109133|3556602|P1|STARTED|Overall Study||33
1452876|NCT02109107|3556614|P1|NOT COMPLETED|Overall Study||2
1452877|NCT02109107|3556614|P1|COMPLETED|Overall Study||52
1452878|NCT02109107|3556614|P1|STARTED|Overall Study||54
1452879|NCT02109042|3556621|P1|NOT COMPLETED|Overall Study||15
1452880|NCT02109042|3556621|P1|COMPLETED|Overall Study||0
1452881|NCT02109042|3556621|P1|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
1452882|NCT02109042|3556621|P1|Received 180 mg Loading Dose|Overall Study||15
1452883|NCT02109042|3556621|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
1452884|NCT02109042|3556621|P1|STARTED|Overall Study||15
1452885|NCT02108977|3556629|P2|NOT COMPLETED|Overall Study||1
1452886|NCT02108977|3556630|P1|NOT COMPLETED|Overall Study||10
1452887|NCT02108977|3556629|P2|COMPLETED|Overall Study||19
1452888|NCT02108977|3556630|P1|COMPLETED|Overall Study||8
1452889|NCT02108977|3556629|P2|STARTED|Overall Study||20
1452890|NCT02108977|3556630|P1|STARTED|Overall Study||18
1452891|NCT02108951|3556642|P1|NOT COMPLETED|Overall Study||16
1452892|NCT02108951|3556642|P1|COMPLETED|Overall Study||4
1452893|NCT02108951|3556642|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
1452894|NCT02108691|3556661|P2|NOT COMPLETED|Overall Study||9
1452895|NCT02108691|3556662|P1|NOT COMPLETED|Overall Study||8
1452896|NCT02108691|3556661|P2|COMPLETED|Overall Study||31
1452897|NCT02108691|3556662|P1|COMPLETED|Overall Study||32
1452898|NCT02108691|3556661|P2|STARTED|Overall Study||40
1452899|NCT02108691|3556662|P1|STARTED|Overall Study||40
1452900|NCT02108652|3556680|P1|NOT COMPLETED|Overall Study||310
1452901|NCT02108652|3556680|P1|COMPLETED|Overall Study||0
1452902|NCT02108652|3556680|P1|STARTED|Overall Study||310
1452903|NCT02108288|3556704|P3|NOT COMPLETED|Overall Study||0
1452904|NCT02108288|3556705|P2|NOT COMPLETED|Overall Study||0
1452905|NCT02108288|3556706|P1|NOT COMPLETED|Overall Study||0
1452906|NCT02108288|3556704|P3|COMPLETED|Overall Study||10
1452907|NCT02108288|3556705|P2|COMPLETED|Overall Study||10
1452908|NCT02108288|3556706|P1|COMPLETED|Overall Study||10
1452909|NCT02108288|3556704|P3|STARTED|Overall Study||10
1452910|NCT02108288|3556705|P2|STARTED|Overall Study||10
1452911|NCT02108288|3556706|P1|STARTED|Overall Study||10
1452912|NCT02108223|3556722|P3|NOT COMPLETED|Overall Study||0
1452913|NCT02108223|3556723|P2|NOT COMPLETED|Overall Study||0
1452914|NCT02108223|3556724|P1|NOT COMPLETED|Overall Study||0
1452915|NCT02108223|3556722|P3|COMPLETED|Overall Study||35
1452916|NCT02108223|3556723|P2|COMPLETED|Overall Study||50
1452917|NCT02108223|3556724|P1|COMPLETED|Overall Study||52
1452918|NCT02108223|3556722|P3|STARTED|Overall Study||35
1452919|NCT02108223|3556723|P2|STARTED|Overall Study||50
1452920|NCT02108223|3556724|P1|STARTED|Overall Study||52
1452921|NCT02108171|3556746|P2|NOT COMPLETED|Overall Study||0
1452922|NCT02108171|3556747|P1|NOT COMPLETED|Overall Study||0
1452923|NCT02108171|3556746|P2|COMPLETED|Overall Study||41
1452924|NCT02108171|3556747|P1|COMPLETED|Overall Study||40
1452925|NCT02108171|3556746|P2|STARTED|Overall Study||41
1452926|NCT02108171|3556747|P1|STARTED|Overall Study||40
1452927|NCT02107898|3556849|P2|NOT COMPLETED|Overall Study||12
1452928|NCT02107898|3556850|P1|NOT COMPLETED|Overall Study||6
1452929|NCT02107898|3556849|P2|COMPLETED|Overall Study||132
1452930|NCT02107898|3556850|P1|COMPLETED|Overall Study||66
1452931|NCT02107898|3556849|P2|Treated|Overall Study||143
1452932|NCT02107898|3556850|P1|Treated|Overall Study||72
1452933|NCT02107898|3556849|P2|STARTED|Overall Study|Randomized|144
1452934|NCT02107898|3556850|P1|STARTED|Overall Study|Randomized|72
1452935|NCT02107703|3556904|P2|NOT COMPLETED|Overall Study||175
1452936|NCT02107703|3556905|P1|NOT COMPLETED|Overall Study||361
1452937|NCT02107703|3556904|P2|COMPLETED|Overall Study||48
1452938|NCT02107703|3556905|P1|COMPLETED|Overall Study||85
1452939|NCT02107703|3556904|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
1452940|NCT02107703|3556905|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
1452941|NCT02107703|3556904|P2|STARTED|Overall Study||223
1452942|NCT02107703|3556905|P1|STARTED|Overall Study||446
1452943|NCT02107599|3556930|P1|NOT COMPLETED|Overall Study||0
1452944|NCT02107599|3556930|P1|COMPLETED|Overall Study||96
1452945|NCT02107599|3556930|P1|STARTED|Overall Study||96
1452946|NCT02107482|3556937|P1|NOT COMPLETED|Overall Study||4
1452947|NCT02107482|3556937|P1|COMPLETED|Overall Study||17
1452948|NCT02107482|3556937|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
1452949|NCT02107443|3556945|P2|NOT COMPLETED|Overall Study||83
1452950|NCT02107443|3556946|P1|NOT COMPLETED|Overall Study||98
1452951|NCT02107443|3556945|P2|COMPLETED|Overall Study||167
1452952|NCT02107443|3556946|P1|COMPLETED|Overall Study||198
1452953|NCT02107443|3556945|P2|STARTED|Overall Study||250
1452954|NCT02107443|3556946|P1|STARTED|Overall Study||296
1452955|NCT02107339|3556956|P2|NOT COMPLETED|Overall Study||4
1452956|NCT02107339|3556957|P1|NOT COMPLETED|Overall Study||1
1452957|NCT02107339|3556956|P2|COMPLETED|Overall Study||53
1452958|NCT02107339|3556957|P1|COMPLETED|Overall Study||62
1452959|NCT02107339|3556956|P2|STARTED|Overall Study||57
1452960|NCT02107339|3556957|P1|STARTED|Overall Study||63
1452961|NCT02107313|3556985|P2|NOT COMPLETED|Overall Study||1
1452962|NCT02107313|3556986|P1|NOT COMPLETED|Overall Study||0
1452963|NCT02107313|3556985|P2|COMPLETED|Overall Study||8
1452964|NCT02107313|3556986|P1|COMPLETED|Overall Study||9
1452965|NCT02107313|3556985|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
1452966|NCT02107313|3556986|P1|STARTED|Overall Study||9
1452967|NCT02107300|3556996|P2|NOT COMPLETED|Overall Study||0
1452968|NCT02107300|3556997|P1|NOT COMPLETED|Overall Study||0
1452969|NCT02107300|3556996|P2|COMPLETED|Overall Study||15
1452970|NCT02107300|3556997|P1|COMPLETED|Overall Study||16
1452971|NCT02107300|3556996|P2|STARTED|Overall Study||15
1452972|NCT02107300|3556997|P1|STARTED|Overall Study||16
1452973|NCT02107274|3557007|P2|NOT COMPLETED|Control Phase||2
1452974|NCT02107274|3557008|P1|NOT COMPLETED|Control Phase||3
1452975|NCT02107274|3557007|P2|COMPLETED|Control Phase||35
1452976|NCT02107274|3557008|P1|COMPLETED|Control Phase||33
1452977|NCT02107274|3557007|P2|STARTED|Control Phase||37
1452978|NCT02107274|3557008|P1|STARTED|Control Phase||36
1452979|NCT02107274|3557007|P2|NOT COMPLETED|Treatment vs. Placebo||2
1452980|NCT02107274|3557008|P1|NOT COMPLETED|Treatment vs. Placebo||3
1452981|NCT02107274|3557007|P2|COMPLETED|Treatment vs. Placebo||37
1452982|NCT02107274|3557008|P1|COMPLETED|Treatment vs. Placebo||36
1452983|NCT02107274|3557007|P2|STARTED|Treatment vs. Placebo||39
1452984|NCT02107274|3557008|P1|STARTED|Treatment vs. Placebo||39
1452985|NCT02107196|3557022|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
1452986|NCT02107196|3557023|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
1452987|NCT02107196|3557022|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
1452988|NCT02107196|3557023|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
1452989|NCT02107196|3557022|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
1452990|NCT02107196|3557023|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
1452991|NCT02107196|3557022|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
1452992|NCT02107196|3557023|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
1452993|NCT02107196|3557022|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
1452994|NCT02107196|3557023|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
1452995|NCT02107196|3557022|P2|NOT COMPLETED|12-week Treatment Period||39
1452996|NCT02107196|3557023|P1|NOT COMPLETED|12-week Treatment Period||44
1452997|NCT02107196|3557022|P2|COMPLETED|12-week Treatment Period||225
1452998|NCT02107196|3557023|P1|COMPLETED|12-week Treatment Period||227
1452999|NCT02107196|3557022|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
1453000|NCT02107196|3557023|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
1453001|NCT02107196|3557022|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
1453002|NCT02107196|3557023|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
1453003|NCT02107196|3557022|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
1453004|NCT02107196|3557023|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
1453005|NCT02107131|3557038|P2|NOT COMPLETED|Overall Study||9
1453006|NCT02107131|3557039|P1|NOT COMPLETED|Overall Study||8
1453007|NCT02107131|3557038|P2|COMPLETED|Overall Study||11
1453008|NCT02107131|3557039|P1|COMPLETED|Overall Study||12
1453009|NCT02107131|3557038|P2|STARTED|Overall Study||20
1453010|NCT02107131|3557039|P1|STARTED|Overall Study||20
1453011|NCT02107092|3557051|P1|NOT COMPLETED|Overall Study||44
1453012|NCT02107092|3557051|P1|COMPLETED|Overall Study||79
1453013|NCT02107092|3557051|P1|STARTED|Overall Study||123
1453014|NCT02107014|3557056|P1|NOT COMPLETED|Overall Study||1
1453015|NCT02107014|3557056|P1|COMPLETED|Overall Study||8
1453016|NCT02107014|3557056|P1|STARTED|Overall Study||9
1453017|NCT02106962|3557126|P2|NOT COMPLETED|Overall Study||0
1453018|NCT02106962|3557127|P1|NOT COMPLETED|Overall Study||0
1453019|NCT02106962|3557126|P2|COMPLETED|Overall Study||9
1453020|NCT02106962|3557127|P1|COMPLETED|Overall Study||8
1453021|NCT02106962|3557126|P2|STARTED|Overall Study||9
1453022|NCT02106962|3557127|P1|STARTED|Overall Study||8
1453023|NCT02106923|3557138|P6|NOT COMPLETED|Overall Study||1
1453024|NCT02106923|3557139|P5|NOT COMPLETED|Overall Study||0
1453025|NCT02106923|3557140|P4|NOT COMPLETED|Overall Study||0
1453026|NCT02106923|3557141|P3|NOT COMPLETED|Overall Study||0
1453027|NCT02106923|3557142|P2|NOT COMPLETED|Overall Study||0
1453028|NCT02106923|3557143|P1|NOT COMPLETED|Overall Study||0
1453029|NCT02106923|3557138|P6|COMPLETED|Overall Study||11
1453030|NCT02106923|3557139|P5|COMPLETED|Overall Study||12
1453031|NCT02106923|3557140|P4|COMPLETED|Overall Study||12
1453032|NCT02106923|3557141|P3|COMPLETED|Overall Study||12
1453033|NCT02106923|3557142|P2|COMPLETED|Overall Study||12
1453034|NCT02106923|3557143|P1|COMPLETED|Overall Study||12
1453035|NCT02106923|3557138|P6|STARTED|Overall Study||12
1453036|NCT02106923|3557139|P5|STARTED|Overall Study||12
1453037|NCT02106923|3557140|P4|STARTED|Overall Study||12
1453038|NCT02106923|3557141|P3|STARTED|Overall Study||12
1453039|NCT02106923|3557142|P2|STARTED|Overall Study||12
1453040|NCT02106923|3557143|P1|STARTED|Overall Study||12
1453041|NCT02106832|3557191|P4|NOT COMPLETED|Overall Study||15
1453042|NCT02106832|3557192|P3|NOT COMPLETED|Overall Study||16
1453043|NCT02106832|3557193|P2|NOT COMPLETED|Overall Study||25
1453044|NCT02106832|3557194|P1|NOT COMPLETED|Overall Study||23
1453045|NCT02106832|3557191|P4|COMPLETED|Overall Study||73
1453046|NCT02106832|3557192|P3|COMPLETED|Overall Study||70
1453047|NCT02106832|3557193|P2|COMPLETED|Overall Study||151
1453048|NCT02106832|3557194|P1|COMPLETED|Overall Study||148
1453049|NCT02106832|3557191|P4|Participants Received Treatment|Overall Study||88
1453050|NCT02106832|3557192|P3|Participants Received Treatment|Overall Study||86
1453051|NCT02106832|3557193|P2|Participants Received Treatment|Overall Study||174
1453052|NCT02106832|3557194|P1|Participants Received Treatment|Overall Study||171
1453053|NCT02106832|3557191|P4|STARTED|Overall Study||88
1453054|NCT02106832|3557192|P3|STARTED|Overall Study||86
1453055|NCT02106832|3557193|P2|STARTED|Overall Study||176
1453056|NCT02106832|3557194|P1|STARTED|Overall Study||171
1453057|NCT02106728|3557229|P2|NOT COMPLETED|Overall Study||0
1453058|NCT02106728|3557230|P1|NOT COMPLETED|Overall Study||0
1453059|NCT02106728|3557229|P2|COMPLETED|Overall Study||47
1453060|NCT02106728|3557230|P1|COMPLETED|Overall Study||70
1453061|NCT02106728|3557229|P2|STARTED|Overall Study||47
1453062|NCT02106728|3557230|P1|STARTED|Overall Study||70
1453063|NCT02106494|3557246|P2|NOT COMPLETED|Overall Study||25
1453064|NCT02106494|3557247|P1|NOT COMPLETED|Overall Study||26
1453065|NCT02106494|3557246|P2|COMPLETED|Overall Study||446
1453066|NCT02106494|3557247|P1|COMPLETED|Overall Study||445
1453067|NCT02106494|3557246|P2|Efficacy Population|Overall Study||452
1453068|NCT02106494|3557247|P1|Efficacy Population|Overall Study||450
1453069|NCT02106494|3557246|P2|Safety Population|Overall Study||459
1453070|NCT02106494|3557247|P1|Safety Population|Overall Study||456
1453071|NCT02106494|3557246|P2|STARTED|Overall Study||471
1453072|NCT02106494|3557247|P1|STARTED|Overall Study||471
1453073|NCT02106403|3557261|P6|NOT COMPLETED|Follow-Up Visit 3||1
1453074|NCT02106403|3557262|P5|NOT COMPLETED|Follow-Up Visit 3||0
1453075|NCT02106403|3557263|P4|NOT COMPLETED|Follow-Up Visit 3||0
1453076|NCT02106403|3557264|P3|NOT COMPLETED|Follow-Up Visit 3||0
1453077|NCT02106403|3557265|P2|NOT COMPLETED|Follow-Up Visit 3||0
1453078|NCT02106403|3557266|P1|NOT COMPLETED|Follow-Up Visit 3||0
1453079|NCT02106403|3557261|P6|COMPLETED|Follow-Up Visit 3||8
1453080|NCT02106403|3557262|P5|COMPLETED|Follow-Up Visit 3||8
1453081|NCT02106403|3557263|P4|COMPLETED|Follow-Up Visit 3||8
1453082|NCT02106403|3557264|P3|COMPLETED|Follow-Up Visit 3||9
1453083|NCT02106403|3557265|P2|COMPLETED|Follow-Up Visit 3||8
1453084|NCT02106403|3557266|P1|COMPLETED|Follow-Up Visit 3||8
1453085|NCT02106403|3557261|P6|STARTED|Follow-Up Visit 3||9
1453086|NCT02106403|3557262|P5|STARTED|Follow-Up Visit 3||8
1453087|NCT02106403|3557263|P4|STARTED|Follow-Up Visit 3||8
1453088|NCT02106403|3557264|P3|STARTED|Follow-Up Visit 3||9
1453089|NCT02106403|3557265|P2|STARTED|Follow-Up Visit 3||8
1453090|NCT02106403|3557266|P1|STARTED|Follow-Up Visit 3||8
1453091|NCT02106403|3557261|P6|NOT COMPLETED|Follow-Up Visit 2||0
1453092|NCT02106403|3557262|P5|NOT COMPLETED|Follow-Up Visit 2||0
1453093|NCT02106403|3557263|P4|NOT COMPLETED|Follow-Up Visit 2||0
1453094|NCT02106403|3557264|P3|NOT COMPLETED|Follow-Up Visit 2||0
1453095|NCT02106403|3557265|P2|NOT COMPLETED|Follow-Up Visit 2||0
1453096|NCT02106403|3557266|P1|NOT COMPLETED|Follow-Up Visit 2||0
1453097|NCT02106403|3557261|P6|COMPLETED|Follow-Up Visit 2||9
1453098|NCT02106403|3557262|P5|COMPLETED|Follow-Up Visit 2||8
1453099|NCT02106403|3557263|P4|COMPLETED|Follow-Up Visit 2||8
1453100|NCT02106403|3557264|P3|COMPLETED|Follow-Up Visit 2||9
1453101|NCT02106403|3557265|P2|COMPLETED|Follow-Up Visit 2||8
1453102|NCT02106403|3557266|P1|COMPLETED|Follow-Up Visit 2||8
1453103|NCT02106403|3557261|P6|STARTED|Follow-Up Visit 2||9
1453104|NCT02106403|3557262|P5|STARTED|Follow-Up Visit 2||8
1453105|NCT02106403|3557263|P4|STARTED|Follow-Up Visit 2||8
1453106|NCT02106403|3557264|P3|STARTED|Follow-Up Visit 2||9
1453107|NCT02106403|3557265|P2|STARTED|Follow-Up Visit 2||8
1453108|NCT02106403|3557266|P1|STARTED|Follow-Up Visit 2||8
1453109|NCT02106403|3557261|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
1453110|NCT02106403|3557262|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
1453111|NCT02106403|3557263|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
1453112|NCT02106403|3557264|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
1453113|NCT02106403|3557265|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
1453114|NCT02106403|3557266|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
1453115|NCT02106403|3557261|P6|COMPLETED|Visit 1, Treatment Period 3||9
1453116|NCT02106403|3557262|P5|COMPLETED|Visit 1, Treatment Period 3||8
1453117|NCT02106403|3557263|P4|COMPLETED|Visit 1, Treatment Period 3||8
1453118|NCT02106403|3557264|P3|COMPLETED|Visit 1, Treatment Period 3||9
1453119|NCT02106403|3557265|P2|COMPLETED|Visit 1, Treatment Period 3||8
1453120|NCT02106403|3557266|P1|COMPLETED|Visit 1, Treatment Period 3||8
1453121|NCT02106403|3557261|P6|STARTED|Visit 1, Treatment Period 3||9
1453122|NCT02106403|3557262|P5|STARTED|Visit 1, Treatment Period 3||8
1453123|NCT02106403|3557263|P4|STARTED|Visit 1, Treatment Period 3||8
1453124|NCT02106403|3557264|P3|STARTED|Visit 1, Treatment Period 3||9
1453125|NCT02106403|3557265|P2|STARTED|Visit 1, Treatment Period 3||8
1453126|NCT02106403|3557266|P1|STARTED|Visit 1, Treatment Period 3||8
1453127|NCT02106403|3557261|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
1453128|NCT02106403|3557262|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
1453129|NCT02106403|3557263|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
1453130|NCT02106403|3557264|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
1453131|NCT02106403|3557265|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
1453132|NCT02106403|3557266|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
1453133|NCT02106403|3557261|P6|COMPLETED|Visit 1, Treatment Period 2||9
1453134|NCT02106403|3557262|P5|COMPLETED|Visit 1, Treatment Period 2||8
1453135|NCT02106403|3557263|P4|COMPLETED|Visit 1, Treatment Period 2||8
1453136|NCT02106403|3557264|P3|COMPLETED|Visit 1, Treatment Period 2||9
1453137|NCT02106403|3557265|P2|COMPLETED|Visit 1, Treatment Period 2||8
1453138|NCT02106403|3557266|P1|COMPLETED|Visit 1, Treatment Period 2||8
1453139|NCT02106403|3557261|P6|STARTED|Visit 1, Treatment Period 2||9
1453140|NCT02106403|3557262|P5|STARTED|Visit 1, Treatment Period 2||8
1453141|NCT02106403|3557263|P4|STARTED|Visit 1, Treatment Period 2||8
1453142|NCT02106403|3557264|P3|STARTED|Visit 1, Treatment Period 2||9
1453143|NCT02106403|3557265|P2|STARTED|Visit 1, Treatment Period 2||8
1453144|NCT02106403|3557266|P1|STARTED|Visit 1, Treatment Period 2||8
1453145|NCT02106403|3557261|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
1453146|NCT02106403|3557262|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
1453147|NCT02106403|3557263|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
1453148|NCT02106403|3557264|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
1453149|NCT02106403|3557265|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
1453150|NCT02106403|3557266|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
1453151|NCT02106403|3557261|P6|COMPLETED|Visit 1, Treatment Period 1||9
1453152|NCT02106403|3557262|P5|COMPLETED|Visit 1, Treatment Period 1||8
1453153|NCT02106403|3557263|P4|COMPLETED|Visit 1, Treatment Period 1||8
1453154|NCT02106403|3557264|P3|COMPLETED|Visit 1, Treatment Period 1||9
1453155|NCT02106403|3557265|P2|COMPLETED|Visit 1, Treatment Period 1||8
1453156|NCT02106403|3557266|P1|COMPLETED|Visit 1, Treatment Period 1||8
1453157|NCT02106403|3557261|P6|STARTED|Visit 1, Treatment Period 1||9
1453158|NCT02106403|3557262|P5|STARTED|Visit 1, Treatment Period 1||8
1453159|NCT02106403|3557263|P4|STARTED|Visit 1, Treatment Period 1||8
1453160|NCT02106403|3557264|P3|STARTED|Visit 1, Treatment Period 1||9
1453161|NCT02106403|3557265|P2|STARTED|Visit 1, Treatment Period 1||8
1453162|NCT02106403|3557266|P1|STARTED|Visit 1, Treatment Period 1||8
1453163|NCT02106390|3557289|P3|NOT COMPLETED|Overall Study||43
1453164|NCT02106390|3557290|P2|NOT COMPLETED|Overall Study||48
1453165|NCT02106390|3557291|P1|NOT COMPLETED|Overall Study||49
1453166|NCT02106390|3557289|P3|COMPLETED|Overall Study||205
1453167|NCT02106390|3557290|P2|COMPLETED|Overall Study||202
1453168|NCT02106390|3557291|P1|COMPLETED|Overall Study||203
1453169|NCT02106390|3557289|P3|STARTED|Overall Study||248
1453170|NCT02106390|3557290|P2|STARTED|Overall Study||250
1453171|NCT02106390|3557291|P1|STARTED|Overall Study||252
1453172|NCT02106325|3557367|P2|NOT COMPLETED|Phase 3||1
1453173|NCT02106325|3557368|P1|NOT COMPLETED|Phase 3||2
1453174|NCT02106325|3557367|P2|COMPLETED|Phase 3||2
1453175|NCT02106325|3557368|P1|COMPLETED|Phase 3||0
1453176|NCT02106325|3557367|P2|STARTED|Phase 3||3
1453177|NCT02106325|3557368|P1|STARTED|Phase 3||2
1453178|NCT02106325|3557367|P2|NOT COMPLETED|Phase 2||3
1453179|NCT02106325|3557368|P1|NOT COMPLETED|Phase 2||2
1453180|NCT02106325|3557367|P2|COMPLETED|Phase 2||1
1453181|NCT02106325|3557368|P1|COMPLETED|Phase 2||2
1453182|NCT02106325|3557367|P2|STARTED|Phase 2||4
1453183|NCT02106325|3557368|P1|STARTED|Phase 2||4
1453184|NCT02106325|3557367|P2|NOT COMPLETED|Phase 1||2
1453185|NCT02106325|3557368|P1|NOT COMPLETED|Phase 1||2
1453186|NCT02106325|3557367|P2|COMPLETED|Phase 1||1
1453187|NCT02106325|3557368|P1|COMPLETED|Phase 1||3
1453188|NCT02106325|3557367|P2|STARTED|Phase 1||3
1453189|NCT02106325|3557368|P1|STARTED|Phase 1||5
1453190|NCT02106156|3557393|P3|NOT COMPLETED|Overall Study||0
1453191|NCT02106156|3557394|P2|NOT COMPLETED|Overall Study||40
1453192|NCT02106156|3557395|P1|NOT COMPLETED|Overall Study||2549
1453193|NCT02106156|3557393|P3|COMPLETED|Overall Study||518
1453194|NCT02106156|3557394|P2|COMPLETED|Overall Study||50
1453195|NCT02106156|3557395|P1|COMPLETED|Overall Study||7071
1453196|NCT02106156|3557393|P3|STARTED|Overall Study||518
1453197|NCT02106156|3557394|P2|STARTED|Overall Study||90
1453198|NCT02106156|3557395|P1|STARTED|Overall Study||9620
1453199|NCT02105987|3557419|P6|NOT COMPLETED|Continuation Phase||0
1453200|NCT02105987|3557420|P5|NOT COMPLETED|Continuation Phase||1
1453201|NCT02105987|3557421|P4|NOT COMPLETED|Continuation Phase||0
1453202|NCT02105987|3557422|P3|NOT COMPLETED|Continuation Phase||0
1453203|NCT02105987|3557423|P2|NOT COMPLETED|Continuation Phase||0
1453204|NCT02105987|3557424|P1|NOT COMPLETED|Continuation Phase||0
1453205|NCT02105987|3557419|P6|COMPLETED|Continuation Phase||23
1453206|NCT02105987|3557420|P5|COMPLETED|Continuation Phase||13
1453207|NCT02105987|3557421|P4|COMPLETED|Continuation Phase||0
1453208|NCT02105987|3557422|P3|COMPLETED|Continuation Phase||0
1453209|NCT02105987|3557423|P2|COMPLETED|Continuation Phase||0
1453210|NCT02105987|3557424|P1|COMPLETED|Continuation Phase||0
1453211|NCT02105987|3557419|P6|STARTED|Continuation Phase||23
1453212|NCT02105987|3557420|P5|STARTED|Continuation Phase||14
1453213|NCT02105987|3557421|P4|STARTED|Continuation Phase||0
1453214|NCT02105987|3557422|P3|STARTED|Continuation Phase||0
1453215|NCT02105987|3557423|P2|STARTED|Continuation Phase||0
1453216|NCT02105987|3557424|P1|STARTED|Continuation Phase||0
1453217|NCT02105987|3557419|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
1453218|NCT02105987|3557420|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
1453219|NCT02105987|3557421|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
1453220|NCT02105987|3557422|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
1453221|NCT02105987|3557423|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
1453222|NCT02105987|3557424|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
1453223|NCT02105987|3557419|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
1453224|NCT02105987|3557420|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
1453225|NCT02105987|3557421|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
1453226|NCT02105987|3557422|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
1453227|NCT02105987|3557423|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
1453228|NCT02105987|3557424|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
1453229|NCT02105987|3557419|P6|STARTED|Late Switch Phase (24 Weeks)||0
1453230|NCT02105987|3557420|P5|STARTED|Late Switch Phase (24 Weeks)||0
1453231|NCT02105987|3557421|P4|STARTED|Late Switch Phase (24 Weeks)||244
1453232|NCT02105987|3557422|P3|STARTED|Late Switch Phase (24 Weeks)||275
1453233|NCT02105987|3557423|P2|STARTED|Late Switch Phase (24 Weeks)||0
1453234|NCT02105987|3557424|P1|STARTED|Late Switch Phase (24 Weeks)||0
1453235|NCT02105987|3557419|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
1453236|NCT02105987|3557420|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
1453237|NCT02105987|3557421|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
1453238|NCT02105987|3557422|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
1453239|NCT02105987|3557423|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
1453240|NCT02105987|3557424|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
1453241|NCT02105987|3557419|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
1453242|NCT02105987|3557420|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
1453243|NCT02105987|3557421|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
1453244|NCT02105987|3557422|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
1453245|NCT02105987|3557423|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
1453246|NCT02105987|3557424|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
1453247|NCT02105987|3557419|P6|STARTED|Early Switch Phase (24 Weeks)||0
1453248|NCT02105987|3557420|P5|STARTED|Early Switch Phase (24 Weeks)||0
1453249|NCT02105987|3557421|P4|STARTED|Early Switch Phase (24 Weeks)||0
1453250|NCT02105987|3557422|P3|STARTED|Early Switch Phase (24 Weeks)||0
1453251|NCT02105987|3557423|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
1453252|NCT02105987|3557424|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
1453253|NCT02105974|3557478|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
1453254|NCT02105974|3557479|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
1453255|NCT02105974|3557480|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
1453256|NCT02105974|3557478|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
1453257|NCT02105974|3557479|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
1453258|NCT02105974|3557480|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
1453259|NCT02105974|3557478|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
1453260|NCT02105974|3557479|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
1453261|NCT02105974|3557480|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
1453262|NCT02105974|3557478|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
1453263|NCT02105974|3557479|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
1453264|NCT02105974|3557480|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
1453265|NCT02105974|3557478|P3|NOT COMPLETED|2 Week Run-in Period||0
1453266|NCT02105974|3557479|P2|NOT COMPLETED|2 Week Run-in Period||0
1453267|NCT02105974|3557480|P1|NOT COMPLETED|2 Week Run-in Period||801
1453268|NCT02105974|3557478|P3|COMPLETED|2 Week Run-in Period||0
1453269|NCT02105974|3557479|P2|COMPLETED|2 Week Run-in Period||0
1453270|NCT02105974|3557480|P1|COMPLETED|2 Week Run-in Period||1622
1453271|NCT02105974|3557478|P3|STARTED|2 Week Run-in Period||0
1453272|NCT02105974|3557479|P2|STARTED|2 Week Run-in Period||0
1453273|NCT02105974|3557480|P1|STARTED|2 Week Run-in Period||2423
1453274|NCT02105961|3557493|P3|NOT COMPLETED|Overall Study||30
1453275|NCT02105961|3557494|P2|NOT COMPLETED|Overall Study||17
1453276|NCT02105961|3557495|P1|NOT COMPLETED|Overall Study||41
1453277|NCT02105961|3557493|P3|COMPLETED|Overall Study||195
1453278|NCT02105961|3557494|P2|COMPLETED|Overall Study||206
1453279|NCT02105961|3557495|P1|COMPLETED|Overall Study||185
1453280|NCT02105961|3557493|P3|Withdrew IP Due to: Site Closed|Overall Study||1
1453281|NCT02105961|3557494|P2|Withdrew IP Due to: Site Closed|Overall Study||0
1453282|NCT02105961|3557495|P1|Withdrew IP Due to: Site Closed|Overall Study||1
1453283|NCT02105961|3557493|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
1453284|NCT02105961|3557494|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
1453285|NCT02105961|3557495|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
1453286|NCT02105961|3557493|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
1453287|NCT02105961|3557494|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
1453288|NCT02105961|3557495|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
1453289|NCT02105961|3557493|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
1453290|NCT02105961|3557494|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
1453291|NCT02105961|3557495|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
1453292|NCT02105961|3557493|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
1453293|NCT02105961|3557494|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
1453294|NCT02105961|3557495|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
1453295|NCT02105961|3557493|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
1453296|NCT02105961|3557494|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
1453297|NCT02105961|3557495|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
1453298|NCT02105961|3557493|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
1453299|NCT02105961|3557494|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
1453300|NCT02105961|3557495|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
1453301|NCT02105961|3557493|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
1453302|NCT02105961|3557494|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
1453303|NCT02105961|3557495|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
1453304|NCT02105961|3557493|P3|Not Completed IP|Overall Study||42
1453305|NCT02105961|3557494|P2|Not Completed IP|Overall Study||27
1453306|NCT02105961|3557495|P1|Not Completed IP|Overall Study||56
1453307|NCT02105961|3557493|P3|Completed Investigational Product (IP)|Overall Study||183
1453308|NCT02105961|3557494|P2|Completed Investigational Product (IP)|Overall Study||196
1453309|NCT02105961|3557495|P1|Completed Investigational Product (IP)|Overall Study||170
1453310|NCT02105961|3557493|P3|STARTED|Overall Study||225
1453311|NCT02105961|3557494|P2|STARTED|Overall Study||223
1453312|NCT02105961|3557495|P1|STARTED|Overall Study||226
1453313|NCT02105948|3557519|P4|NOT COMPLETED|Overall Study||27
1453314|NCT02105948|3557520|P3|NOT COMPLETED|Overall Study||28
1453315|NCT02105948|3557521|P2|NOT COMPLETED|Overall Study||20
1453316|NCT02105948|3557522|P1|NOT COMPLETED|Overall Study||27
1453317|NCT02105948|3557519|P4|COMPLETED|Overall Study||157
1453318|NCT02105948|3557520|P3|COMPLETED|Overall Study||162
1453319|NCT02105948|3557521|P2|COMPLETED|Overall Study||213
1453320|NCT02105948|3557522|P1|COMPLETED|Overall Study||202
1453321|NCT02105948|3557519|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
1453322|NCT02105948|3557520|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
1453323|NCT02105948|3557521|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
1453324|NCT02105948|3557522|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
1453325|NCT02105948|3557519|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
1453326|NCT02105948|3557520|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
1453327|NCT02105948|3557521|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
1453328|NCT02105948|3557522|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
1453329|NCT02105948|3557519|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
1453330|NCT02105948|3557520|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
1453331|NCT02105948|3557521|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
1453332|NCT02105948|3557522|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
1453333|NCT02105948|3557519|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
1453334|NCT02105948|3557520|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
1453335|NCT02105948|3557521|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
1453336|NCT02105948|3557522|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
1453337|NCT02105948|3557519|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
1453338|NCT02105948|3557520|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
1453339|NCT02105948|3557521|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
1453340|NCT02105948|3557522|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
1453341|NCT02105948|3557519|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
1453342|NCT02105948|3557520|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
1453343|NCT02105948|3557521|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
1453344|NCT02105948|3557522|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
1453345|NCT02105948|3557519|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
1453346|NCT02105948|3557520|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
1453347|NCT02105948|3557521|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
1453348|NCT02105948|3557522|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
1453349|NCT02105948|3557519|P4|Not Completed IP|Overall Study||35
1453350|NCT02105948|3557520|P3|Not Completed IP|Overall Study||42
1453351|NCT02105948|3557521|P2|Not Completed IP|Overall Study||30
1453352|NCT02105948|3557522|P1|Not Completed IP|Overall Study||44
1453353|NCT02105948|3557519|P4|Completed Investigational Product (IP)|Overall Study||149
1453354|NCT02105948|3557520|P3|Completed Investigational Product (IP)|Overall Study||148
1453355|NCT02105948|3557521|P2|Completed Investigational Product (IP)|Overall Study||203
1453356|NCT02105948|3557522|P1|Completed Investigational Product (IP)|Overall Study||185
1453357|NCT02105948|3557519|P4|STARTED|Overall Study||184
1453358|NCT02105948|3557520|P3|STARTED|Overall Study||190
1453359|NCT02105948|3557521|P2|STARTED|Overall Study||233
1453360|NCT02105948|3557522|P1|STARTED|Overall Study||229
1453361|NCT02105740|3557550|P2|NOT COMPLETED|Overall Study||1
1453362|NCT02105740|3557551|P1|NOT COMPLETED|Overall Study||0
1453363|NCT02105740|3557550|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
1453364|NCT02105740|3557551|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
1453365|NCT02105740|3557550|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
1453366|NCT02105740|3557551|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
1453367|NCT02105740|3557550|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
1453368|NCT02105740|3557551|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
1453369|NCT02105701|3557563|P4|NOT COMPLETED|Overall Study||2
1453370|NCT02105701|3557564|P3|NOT COMPLETED|Overall Study||3
1453371|NCT02105701|3557565|P2|NOT COMPLETED|Overall Study||1
1453372|NCT02105701|3557566|P1|NOT COMPLETED|Overall Study||4
1453373|NCT02105701|3557563|P4|COMPLETED|Overall Study||104
1453374|NCT02105701|3557564|P3|COMPLETED|Overall Study||102
1453375|NCT02105701|3557565|P2|COMPLETED|Overall Study||103
1453376|NCT02105701|3557566|P1|COMPLETED|Overall Study||101
1453377|NCT02105701|3557563|P4|STARTED|Overall Study||106
1453378|NCT02105701|3557564|P3|STARTED|Overall Study||105
1453379|NCT02105701|3557565|P2|STARTED|Overall Study||104
1453380|NCT02105701|3557566|P1|STARTED|Overall Study||105
1453381|NCT02105688|3557590|P2|NOT COMPLETED|Overall Study||99
1453382|NCT02105688|3557591|P1|NOT COMPLETED|Overall Study||26
1453383|NCT02105688|3557590|P2|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|1
1453384|NCT02105688|3557591|P1|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|175
1453385|NCT02105688|3557590|P2|Not Reached FU Week 12 Visit|Overall Study||15
1453386|NCT02105688|3557591|P1|Not Reached FU Week 12 Visit|Overall Study||2
1453387|NCT02105688|3557590|P2|Completed FU Week 12 Visit, Still in FU|Overall Study||75
1453388|NCT02105688|3557591|P1|Completed FU Week 12 Visit, Still in FU|Overall Study||10
1453389|NCT02105688|3557590|P2|STARTED|Overall Study||100
1453390|NCT02105688|3557591|P1|STARTED|Overall Study||201
1453391|NCT02105662|3557601|P1|NOT COMPLETED|Overall Study||6
1453392|NCT02105662|3557601|P1|COMPLETED|Overall Study||212
1453393|NCT02105662|3557601|P1|STARTED|Overall Study||218
1453394|NCT02105636|3557610|P2|NOT COMPLETED|Overall Study||108
1453395|NCT02105636|3557611|P1|NOT COMPLETED|Overall Study||195
1453396|NCT02105636|3557610|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
1453397|NCT02105636|3557611|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
1453398|NCT02105636|3557610|P2|STARTED|Overall Study||111
1453399|NCT02105636|3557611|P1|STARTED|Overall Study||236
1453400|NCT02105558|3557623|P2|NOT COMPLETED|Overall Study||0
1453401|NCT02105558|3557624|P1|NOT COMPLETED|Overall Study||0
1453402|NCT02105558|3557623|P2|COMPLETED|Overall Study||28
1453403|NCT02105558|3557624|P1|COMPLETED|Overall Study||15
1453404|NCT02105558|3557623|P2|STARTED|Overall Study||28
1453405|NCT02105558|3557624|P1|STARTED|Overall Study||15
1453406|NCT02105467|3557654|P2|NOT COMPLETED|Period 3||1
1453407|NCT02105467|3557655|P1|NOT COMPLETED|Period 3||0
1453408|NCT02105467|3557654|P2|COMPLETED|Period 3||102
1453409|NCT02105467|3557655|P1|COMPLETED|Period 3||0
1453410|NCT02105467|3557654|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
1453411|NCT02105467|3557655|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
1453412|NCT02105467|3557654|P2|NOT COMPLETED|Period 2||2
1453413|NCT02105467|3557655|P1|NOT COMPLETED|Period 2||2
1453414|NCT02105467|3557654|P2|COMPLETED|Period 2||102
1453415|NCT02105467|3557655|P1|COMPLETED|Period 2||312
1453416|NCT02105467|3557654|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
1453417|NCT02105467|3557655|P1|STARTED|Period 2||314
1453418|NCT02105467|3557654|P2|NOT COMPLETED|Period 1||0
1453419|NCT02105467|3557655|P1|NOT COMPLETED|Period 1||2
1453420|NCT02105467|3557654|P2|COMPLETED|Period 1||105
1453421|NCT02105467|3557655|P1|COMPLETED|Period 1||314
1453422|NCT02105467|3557654|P2|STARTED|Period 1||105
1453423|NCT02105467|3557655|P1|STARTED|Period 1||316
1453424|NCT02105454|3557667|P1|NOT COMPLETED|Overall Study||1
1453425|NCT02105454|3557667|P1|COMPLETED|Overall Study||78
1453426|NCT02105454|3557667|P1|STARTED|Overall Study||79
1453427|NCT02105324|3557674|P2|NOT COMPLETED|Period 2||0
1453428|NCT02105324|3557675|P1|NOT COMPLETED|Period 2||0
1453429|NCT02105324|3557674|P2|COMPLETED|Period 2||10
1453430|NCT02105324|3557675|P1|COMPLETED|Period 2||9
1453431|NCT02105324|3557674|P2|STARTED|Period 2||10
1453432|NCT02105324|3557675|P1|STARTED|Period 2||9
1453433|NCT02105324|3557674|P2|NOT COMPLETED|Period 1||0
1453434|NCT02105324|3557675|P1|NOT COMPLETED|Period 1||0
1453435|NCT02105324|3557674|P2|COMPLETED|Period 1||10
1453436|NCT02105324|3557675|P1|COMPLETED|Period 1||9
1453437|NCT02105324|3557674|P2|STARTED|Period 1||10
1453438|NCT02105324|3557675|P1|STARTED|Period 1||9
1453439|NCT02105285|3557754|P3|NOT COMPLETED|Overall Study||0
1453440|NCT02105285|3557755|P2|NOT COMPLETED|Overall Study||2
1453441|NCT02105285|3557756|P1|NOT COMPLETED|Overall Study||2
1453442|NCT02105285|3557754|P3|COMPLETED|Overall Study||37
1453443|NCT02105285|3557755|P2|COMPLETED|Overall Study||76
1453444|NCT02105285|3557756|P1|COMPLETED|Overall Study||76
1453445|NCT02105285|3557754|P3|STARTED|Overall Study||37
1453446|NCT02105285|3557755|P2|STARTED|Overall Study||78
1453447|NCT02105285|3557756|P1|STARTED|Overall Study||78
1453448|NCT02105272|3557775|P2|NOT COMPLETED|Overall Study||3
1453449|NCT02105272|3557776|P1|NOT COMPLETED|Overall Study||5
1453450|NCT02105272|3557775|P2|COMPLETED|Overall Study||116
1453451|NCT02105272|3557776|P1|COMPLETED|Overall Study||113
1453452|NCT02105272|3557775|P2|STARTED|Overall Study||119
1453453|NCT02105272|3557776|P1|STARTED|Overall Study||118
1453454|NCT02105116|3557792|P1|NOT COMPLETED|Overall Study||6
1453455|NCT02105116|3557792|P1|COMPLETED|Overall Study||0
1453456|NCT02105116|3557792|P1|STARTED|Overall Study||6
1453457|NCT02105012|3557799|P1|NOT COMPLETED|Overall Study||33
1453458|NCT02105012|3557799|P1|COMPLETED|Overall Study||114
1453459|NCT02105012|3557799|P1|Placebo MDI|Overall Study||127
1453460|NCT02105012|3557799|P1|BD MDI 40 µg|Overall Study||63
1453461|NCT02105012|3557799|P1|BD MDI 80 µg|Overall Study||64
1453462|NCT02105012|3557799|P1|BD MDI 160 µg|Overall Study||132
1453463|NCT02105012|3557799|P1|BD MDI 320 µg|Overall Study||124
1453464|NCT02105012|3557799|P1|STARTED|Overall Study||147
1453465|NCT02104947|3557833|P2|NOT COMPLETED|Overall Study||56
1453466|NCT02104947|3557834|P1|NOT COMPLETED|Overall Study||79
1453467|NCT02104947|3557833|P2|COMPLETED|Overall Study||146
1453468|NCT02104947|3557834|P1|COMPLETED|Overall Study||222
1453469|NCT02104947|3557833|P2|STARTED|Overall Study||202
1453470|NCT02104947|3557834|P1|STARTED|Overall Study||301
1453471|NCT02104895|3557852|P2|NOT COMPLETED|Overall Study||14
1453472|NCT02104895|3557853|P1|NOT COMPLETED|Overall Study||0
1453473|NCT02104895|3557852|P2|COMPLETED|Overall Study||246
1453474|NCT02104895|3557853|P1|COMPLETED|Overall Study||260
1453475|NCT02104895|3557852|P2|STARTED|Overall Study||260
1453476|NCT02104895|3557853|P1|STARTED|Overall Study||260
1453477|NCT02104830|3557866|P3|NOT COMPLETED|Overall Study||7
1453478|NCT02104830|3557867|P2|NOT COMPLETED|Overall Study||7
1453479|NCT02104830|3557868|P1|NOT COMPLETED|Overall Study||4
1453480|NCT02104830|3557866|P3|COMPLETED|Overall Study||36
1453481|NCT02104830|3557867|P2|COMPLETED|Overall Study||36
1453482|NCT02104830|3557868|P1|COMPLETED|Overall Study||38
1453483|NCT02104830|3557866|P3|STARTED|Overall Study||43
1453484|NCT02104830|3557867|P2|STARTED|Overall Study||43
1453485|NCT02104830|3557868|P1|STARTED|Overall Study||42
1453486|NCT02104804|3557893|P2|NOT COMPLETED|Overall Study||19
1453487|NCT02104804|3557894|P1|NOT COMPLETED|Overall Study||16
1453488|NCT02104804|3557893|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
1453489|NCT02104804|3557894|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
1453490|NCT02104804|3557893|P2|STARTED|Overall Study|Number of patients who were randomized|232
1453491|NCT02104804|3557894|P1|STARTED|Overall Study|Number of patients who were randomized|234
1453492|NCT02104739|3557910|P7|NOT COMPLETED|Extension Phase (6 Weeks)||1
1453493|NCT02104739|3557911|P6|NOT COMPLETED|Extension Phase (6 Weeks)||0
1453494|NCT02104739|3557912|P5|NOT COMPLETED|Extension Phase (6 Weeks)||0
1453495|NCT02104739|3557913|P4|NOT COMPLETED|Extension Phase (6 Weeks)||0
1453496|NCT02104739|3557914|P3|NOT COMPLETED|Extension Phase (6 Weeks)||0
1453497|NCT02104739|3557915|P2|NOT COMPLETED|Extension Phase (6 Weeks)||0
1453498|NCT02104739|3557916|P1|NOT COMPLETED|Extension Phase (6 Weeks)||0
1453499|NCT02104739|3557910|P7|COMPLETED|Extension Phase (6 Weeks)||7
1453500|NCT02104739|3557911|P6|COMPLETED|Extension Phase (6 Weeks)||0
1453501|NCT02104739|3557912|P5|COMPLETED|Extension Phase (6 Weeks)||0
1453502|NCT02104739|3557913|P4|COMPLETED|Extension Phase (6 Weeks)||0
1453503|NCT02104739|3557914|P3|COMPLETED|Extension Phase (6 Weeks)||0
1453504|NCT02104739|3557915|P2|COMPLETED|Extension Phase (6 Weeks)||0
1453505|NCT02104739|3557916|P1|COMPLETED|Extension Phase (6 Weeks)||0
1453506|NCT02104739|3557910|P7|STARTED|Extension Phase (6 Weeks)||8
1453507|NCT02104739|3557911|P6|STARTED|Extension Phase (6 Weeks)||0
1453508|NCT02104739|3557912|P5|STARTED|Extension Phase (6 Weeks)||0
1453509|NCT02104739|3557913|P4|STARTED|Extension Phase (6 Weeks)||0
1453510|NCT02104739|3557914|P3|STARTED|Extension Phase (6 Weeks)||0
1453511|NCT02104739|3557915|P2|STARTED|Extension Phase (6 Weeks)||0
1453512|NCT02104739|3557916|P1|STARTED|Extension Phase (6 Weeks)||0
1453513|NCT02104739|3557910|P7|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
1453514|NCT02104739|3557911|P6|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453515|NCT02104739|3557912|P5|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453516|NCT02104739|3557913|P4|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453517|NCT02104739|3557914|P3|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453518|NCT02104739|3557915|P2|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453519|NCT02104739|3557916|P1|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453520|NCT02104739|3557910|P7|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
1453521|NCT02104739|3557911|P6|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453522|NCT02104739|3557912|P5|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453523|NCT02104739|3557913|P4|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453524|NCT02104739|3557914|P3|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453525|NCT02104739|3557915|P2|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453526|NCT02104739|3557916|P1|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
1453527|NCT02104739|3557910|P7|STARTED|Washout (Min of 10 and Max of 323 Days)||8
1453528|NCT02104739|3557911|P6|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1453529|NCT02104739|3557912|P5|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1453530|NCT02104739|3557913|P4|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1453531|NCT02104739|3557914|P3|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1453532|NCT02104739|3557915|P2|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1453533|NCT02104739|3557916|P1|STARTED|Washout (Min of 10 and Max of 323 Days)||0
1453534|NCT02104739|3557910|P7|NOT COMPLETED|Third Intervention (1 Day)||0
1453535|NCT02104739|3557911|P6|NOT COMPLETED|Third Intervention (1 Day)||0
1453536|NCT02104739|3557912|P5|NOT COMPLETED|Third Intervention (1 Day)||0
1453537|NCT02104739|3557913|P4|NOT COMPLETED|Third Intervention (1 Day)||0
1453538|NCT02104739|3557914|P3|NOT COMPLETED|Third Intervention (1 Day)||0
1453539|NCT02104739|3557915|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1453540|NCT02104739|3557916|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1453541|NCT02104739|3557910|P7|COMPLETED|Third Intervention (1 Day)||0
1453542|NCT02104739|3557911|P6|COMPLETED|Third Intervention (1 Day)||2
1453543|NCT02104739|3557912|P5|COMPLETED|Third Intervention (1 Day)||0
1453544|NCT02104739|3557913|P4|COMPLETED|Third Intervention (1 Day)||7
1453545|NCT02104739|3557914|P3|COMPLETED|Third Intervention (1 Day)||2
1453546|NCT02104739|3557915|P2|COMPLETED|Third Intervention (1 Day)||4
1453547|NCT02104739|3557916|P1|COMPLETED|Third Intervention (1 Day)||1
1453548|NCT02104739|3557910|P7|STARTED|Third Intervention (1 Day)||0
1453549|NCT02104739|3557911|P6|STARTED|Third Intervention (1 Day)||2
1453550|NCT02104739|3557912|P5|STARTED|Third Intervention (1 Day)||0
1453551|NCT02104739|3557913|P4|STARTED|Third Intervention (1 Day)||7
1453552|NCT02104739|3557914|P3|STARTED|Third Intervention (1 Day)||2
1453553|NCT02104739|3557915|P2|STARTED|Third Intervention (1 Day)||4
1453554|NCT02104739|3557916|P1|STARTED|Third Intervention (1 Day)||1
1453555|NCT02104739|3557910|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453556|NCT02104739|3557911|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453557|NCT02104739|3557912|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453558|NCT02104739|3557913|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453559|NCT02104739|3557914|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453560|NCT02104739|3557915|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453561|NCT02104739|3557916|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453562|NCT02104739|3557910|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453563|NCT02104739|3557911|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
1453564|NCT02104739|3557912|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453565|NCT02104739|3557913|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
1453566|NCT02104739|3557914|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
1453567|NCT02104739|3557915|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
1453568|NCT02104739|3557916|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
1453569|NCT02104739|3557910|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
1453570|NCT02104739|3557911|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
1453571|NCT02104739|3557912|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
1453572|NCT02104739|3557913|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
1453573|NCT02104739|3557914|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
1453574|NCT02104739|3557915|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
1453575|NCT02104739|3557916|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
1453576|NCT02104739|3557910|P7|NOT COMPLETED|Second Intervention (1 Day)||0
1453577|NCT02104739|3557911|P6|NOT COMPLETED|Second Intervention (1 Day)||0
1453578|NCT02104739|3557912|P5|NOT COMPLETED|Second Intervention (1 Day)||0
1453579|NCT02104739|3557913|P4|NOT COMPLETED|Second Intervention (1 Day)||0
1453580|NCT02104739|3557914|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1453581|NCT02104739|3557915|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1453582|NCT02104739|3557916|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1453583|NCT02104739|3557910|P7|COMPLETED|Second Intervention (1 Day)||0
1453584|NCT02104739|3557911|P6|COMPLETED|Second Intervention (1 Day)||2
1453585|NCT02104739|3557912|P5|COMPLETED|Second Intervention (1 Day)||0
1453586|NCT02104739|3557913|P4|COMPLETED|Second Intervention (1 Day)||7
1453587|NCT02104739|3557914|P3|COMPLETED|Second Intervention (1 Day)||2
1453588|NCT02104739|3557915|P2|COMPLETED|Second Intervention (1 Day)||4
1453589|NCT02104739|3557916|P1|COMPLETED|Second Intervention (1 Day)||1
1453590|NCT02104739|3557910|P7|STARTED|Second Intervention (1 Day)||0
1453591|NCT02104739|3557911|P6|STARTED|Second Intervention (1 Day)||2
1453592|NCT02104739|3557912|P5|STARTED|Second Intervention (1 Day)||0
1453593|NCT02104739|3557913|P4|STARTED|Second Intervention (1 Day)||7
1453594|NCT02104739|3557914|P3|STARTED|Second Intervention (1 Day)||2
1453595|NCT02104739|3557915|P2|STARTED|Second Intervention (1 Day)||4
1453596|NCT02104739|3557916|P1|STARTED|Second Intervention (1 Day)||1
1453597|NCT02104739|3557910|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453598|NCT02104739|3557911|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453599|NCT02104739|3557912|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453600|NCT02104739|3557913|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453601|NCT02104739|3557914|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453602|NCT02104739|3557915|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453603|NCT02104739|3557916|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453604|NCT02104739|3557910|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453605|NCT02104739|3557911|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
1453606|NCT02104739|3557912|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
1453607|NCT02104739|3557913|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
1453608|NCT02104739|3557914|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
1453609|NCT02104739|3557915|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
1453610|NCT02104739|3557916|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
1453611|NCT02104739|3557910|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
1453612|NCT02104739|3557911|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
1453613|NCT02104739|3557912|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
1453614|NCT02104739|3557913|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
1453615|NCT02104739|3557914|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
1453616|NCT02104739|3557915|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
1453617|NCT02104739|3557916|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
1453618|NCT02104739|3557910|P7|NOT COMPLETED|First Intervention (1 Day)||0
1453619|NCT02104739|3557911|P6|NOT COMPLETED|First Intervention (1 Day)||0
1453620|NCT02104739|3557912|P5|NOT COMPLETED|First Intervention (1 Day)||0
1453621|NCT02104739|3557913|P4|NOT COMPLETED|First Intervention (1 Day)||1
1453622|NCT02104739|3557914|P3|NOT COMPLETED|First Intervention (1 Day)||0
1453623|NCT02104739|3557915|P2|NOT COMPLETED|First Intervention (1 Day)||1
1453624|NCT02104739|3557916|P1|NOT COMPLETED|First Intervention (1 Day)||0
1453625|NCT02104739|3557910|P7|COMPLETED|First Intervention (1 Day)||0
1453626|NCT02104739|3557911|P6|COMPLETED|First Intervention (1 Day)||3
1453627|NCT02104739|3557912|P5|COMPLETED|First Intervention (1 Day)||0
1453628|NCT02104739|3557913|P4|COMPLETED|First Intervention (1 Day)||7
1453629|NCT02104739|3557914|P3|COMPLETED|First Intervention (1 Day)||2
1453630|NCT02104739|3557915|P2|COMPLETED|First Intervention (1 Day)||4
1453631|NCT02104739|3557916|P1|COMPLETED|First Intervention (1 Day)||2
1453632|NCT02104739|3557910|P7|STARTED|First Intervention (1 Day)||0
1453633|NCT02104739|3557911|P6|STARTED|First Intervention (1 Day)||3
1453634|NCT02104739|3557912|P5|STARTED|First Intervention (1 Day)||0
1453635|NCT02104739|3557913|P4|STARTED|First Intervention (1 Day)||8
1453636|NCT02104739|3557914|P3|STARTED|First Intervention (1 Day)||2
1453637|NCT02104739|3557915|P2|STARTED|First Intervention (1 Day)||5
1453638|NCT02104739|3557916|P1|STARTED|First Intervention (1 Day)||2
1453639|NCT02104505|3557976|P2|NOT COMPLETED|Second Intervention (14 Days)||1
1453640|NCT02104505|3557977|P1|NOT COMPLETED|Second Intervention (14 Days)||2
1453641|NCT02104505|3557976|P2|COMPLETED|Second Intervention (14 Days)||7
1453642|NCT02104505|3557977|P1|COMPLETED|Second Intervention (14 Days)||8
1453643|NCT02104505|3557976|P2|STARTED|Second Intervention (14 Days)||8
1453644|NCT02104505|3557977|P1|STARTED|Second Intervention (14 Days)||10
1453645|NCT02104505|3557976|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
1453646|NCT02104505|3557977|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
1453647|NCT02104505|3557976|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
1453648|NCT02104505|3557977|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
1453649|NCT02104505|3557976|P2|STARTED|Washout (Minimum 3 Weeks)||8
1453650|NCT02104505|3557977|P1|STARTED|Washout (Minimum 3 Weeks)||10
1453651|NCT02104505|3557976|P2|NOT COMPLETED|First Intervention (14 Days)||3
1453652|NCT02104505|3557977|P1|NOT COMPLETED|First Intervention (14 Days)||2
1453653|NCT02104505|3557976|P2|COMPLETED|First Intervention (14 Days)||8
1453654|NCT02104505|3557977|P1|COMPLETED|First Intervention (14 Days)||10
1453655|NCT02104505|3557976|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
1453656|NCT02104505|3557977|P1|STARTED|First Intervention (14 Days)||12
1453657|NCT02104427|3557989|P1|NOT COMPLETED|Overall Study||0
1453658|NCT02104427|3557989|P1|COMPLETED|Overall Study||12
1453659|NCT02104427|3557989|P1|STARTED|Overall Study||12
1453660|NCT02104414|3558015|P3|NOT COMPLETED|Overall Study||0
1453661|NCT02104414|3558016|P2|NOT COMPLETED|Overall Study||0
1453662|NCT02104414|3558017|P1|NOT COMPLETED|Overall Study||0
1453663|NCT02104414|3558015|P3|COMPLETED|Overall Study||2
1453664|NCT02104414|3558016|P2|COMPLETED|Overall Study||4
1453665|NCT02104414|3558017|P1|COMPLETED|Overall Study||5
1453666|NCT02104414|3558015|P3|STARTED|Overall Study||2
1453667|NCT02104414|3558016|P2|STARTED|Overall Study||4
1453668|NCT02104414|3558017|P1|STARTED|Overall Study||5
1453669|NCT02104219|3558040|P1|NOT COMPLETED|Overall Study||0
1453670|NCT02104219|3558040|P1|COMPLETED|Overall Study||32
1453671|NCT02104219|3558040|P1|STARTED|Overall Study||32
1453672|NCT02103855|3558047|P1|NOT COMPLETED|Overall Study||2
1453673|NCT02103855|3558047|P1|COMPLETED|Overall Study||4
1453674|NCT02103855|3558047|P1|STARTED|Overall Study||6
1453675|NCT02103608|3558055|P1|NOT COMPLETED|Overall Study||2
1453676|NCT02103608|3558055|P1|COMPLETED|Overall Study||15
1453677|NCT02103608|3558055|P1|STARTED|Overall Study||17
1453678|NCT02103439|3558061|P2|NOT COMPLETED|Overall Study||3
1453679|NCT02103439|3558062|P1|NOT COMPLETED|Overall Study||3
1453680|NCT02103439|3558061|P2|COMPLETED|Overall Study||67
1453681|NCT02103439|3558062|P1|COMPLETED|Overall Study||67
1453682|NCT02103439|3558061|P2|STARTED|Overall Study||70
1453683|NCT02103439|3558062|P1|STARTED|Overall Study||70
1453684|NCT02103309|3558082|P2|NOT COMPLETED|Overall Study||0
1453685|NCT02103309|3558083|P1|NOT COMPLETED|Overall Study||0
1453686|NCT02103309|3558082|P2|COMPLETED|Overall Study||22
1453687|NCT02103309|3558083|P1|COMPLETED|Overall Study||20
1453688|NCT02103309|3558082|P2|STARTED|Overall Study||22
1453689|NCT02103309|3558083|P1|STARTED|Overall Study||20
1453690|NCT02103114|3558097|P2|NOT COMPLETED|Overall Study||1
1453691|NCT02103114|3558098|P1|NOT COMPLETED|Overall Study||0
1453692|NCT02103114|3558097|P2|COMPLETED|Overall Study||19
1453693|NCT02103114|3558098|P1|COMPLETED|Overall Study||20
1453694|NCT02103114|3558097|P2|STARTED|Overall Study||20
1453695|NCT02103114|3558098|P1|STARTED|Overall Study||20
1453696|NCT02103062|3558154|P2|NOT COMPLETED|Overall Study||23
1453697|NCT02103062|3558155|P1|NOT COMPLETED|Overall Study||18
1453698|NCT02103062|3558154|P2|COMPLETED|Overall Study||0
1453699|NCT02103062|3558155|P1|COMPLETED|Overall Study||0
1453700|NCT02103062|3558154|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
1453701|NCT02103062|3558155|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
1453702|NCT02103062|3558154|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
1453703|NCT02103062|3558155|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
1453704|NCT02103062|3558154|P2|STARTED|Overall Study||23
1453705|NCT02103062|3558155|P1|STARTED|Overall Study||18
1453706|NCT02102932|3558181|P8|NOT COMPLETED|Overall Study||0
1453707|NCT02102932|3558182|P7|NOT COMPLETED|Overall Study||0
1453708|NCT02102932|3558183|P6|NOT COMPLETED|Overall Study||0
1453709|NCT02102932|3558184|P5|NOT COMPLETED|Overall Study||0
1453710|NCT02102932|3558185|P4|NOT COMPLETED|Overall Study||0
1453711|NCT02102932|3558186|P3|NOT COMPLETED|Overall Study||0
1453712|NCT02102932|3558187|P2|NOT COMPLETED|Overall Study||0
1453713|NCT02102932|3558188|P1|NOT COMPLETED|Overall Study||0
1453714|NCT02102932|3558181|P8|COMPLETED|Overall Study||12
1453715|NCT02102932|3558182|P7|COMPLETED|Overall Study||12
1453716|NCT02102932|3558183|P6|COMPLETED|Overall Study||12
1453717|NCT02102932|3558184|P5|COMPLETED|Overall Study||12
1453718|NCT02102932|3558185|P4|COMPLETED|Overall Study||12
1453719|NCT02102932|3558186|P3|COMPLETED|Overall Study||12
1453720|NCT02102932|3558187|P2|COMPLETED|Overall Study||12
1453721|NCT02102932|3558188|P1|COMPLETED|Overall Study||12
1453722|NCT02102932|3558181|P8|STARTED|Overall Study||12
1453723|NCT02102932|3558182|P7|STARTED|Overall Study||12
1453724|NCT02102932|3558183|P6|STARTED|Overall Study||12
1453725|NCT02102932|3558184|P5|STARTED|Overall Study||12
1453726|NCT02102932|3558185|P4|STARTED|Overall Study||12
1453727|NCT02102932|3558186|P3|STARTED|Overall Study||12
1453728|NCT02102932|3558187|P2|STARTED|Overall Study||12
1453729|NCT02102932|3558188|P1|STARTED|Overall Study||12
1453730|NCT02102490|3558246|P1|NOT COMPLETED|Overall Study||9
1453731|NCT02102490|3558246|P1|COMPLETED|Overall Study||123
1453732|NCT02102490|3558246|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
1453733|NCT02102490|3558246|P1|STARTED|Overall Study||132
1453734|NCT02102464|3558260|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
1453735|NCT02102464|3558261|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
1453736|NCT02102464|3558262|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
1453737|NCT02102464|3558260|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
1453738|NCT02102464|3558261|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
1453739|NCT02102464|3558262|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
1453740|NCT02102464|3558260|P3|STARTED|Crossover LipiFlow Treatment of Control||25
1453741|NCT02102464|3558261|P2|STARTED|Crossover LipiFlow Treatment of Control||0
1453742|NCT02102464|3558262|P1|STARTED|Crossover LipiFlow Treatment of Control||0
1453743|NCT02102464|3558260|P3|NOT COMPLETED|Randomized Study||0
1453744|NCT02102464|3558261|P2|NOT COMPLETED|Randomized Study||1
1453745|NCT02102464|3558262|P1|NOT COMPLETED|Randomized Study||0
1453746|NCT02102464|3558260|P3|COMPLETED|Randomized Study||0
1453747|NCT02102464|3558261|P2|COMPLETED|Randomized Study||25
1453748|NCT02102464|3558262|P1|COMPLETED|Randomized Study||29
1453749|NCT02102464|3558260|P3|STARTED|Randomized Study||0
1453750|NCT02102464|3558261|P2|STARTED|Randomized Study||26
1453751|NCT02102464|3558262|P1|STARTED|Randomized Study||29
1453752|NCT02102399|3558281|P2|NOT COMPLETED|Overall Study||4
1453753|NCT02102399|3558282|P1|NOT COMPLETED|Overall Study||6
1453754|NCT02102399|3558281|P2|COMPLETED|Overall Study||17
1453755|NCT02102399|3558282|P1|COMPLETED|Overall Study||14
1453756|NCT02102399|3558281|P2|STARTED|Overall Study||21
1453757|NCT02102399|3558282|P1|STARTED|Overall Study||20
1453758|NCT02102204|3558330|P1|NOT COMPLETED|Overall Study||304
1453759|NCT02102204|3558330|P1|COMPLETED|Overall Study||598
1453760|NCT02102204|3558330|P1|Received Etelcalcetide|Overall Study||884
1453761|NCT02102204|3558330|P1|STARTED|Overall Study||902
1453762|NCT02101983|3558341|P2|NOT COMPLETED|Overall Study||0
1453763|NCT02101983|3558342|P1|NOT COMPLETED|Overall Study||1
1453764|NCT02101983|3558341|P2|COMPLETED|Overall Study||6
1453765|NCT02101983|3558342|P1|COMPLETED|Overall Study||4
1453766|NCT02101983|3558341|P2|STARTED|Overall Study||6
1453767|NCT02101983|3558342|P1|STARTED|Overall Study||5
1453768|NCT02101515|3558354|P2|NOT COMPLETED|Overall Study||0
1453769|NCT02101515|3558355|P1|NOT COMPLETED|Overall Study||0
1453770|NCT02101515|3558354|P2|COMPLETED|Overall Study||41
1453771|NCT02101515|3558355|P1|COMPLETED|Overall Study||37
1453772|NCT02101515|3558354|P2|STARTED|Overall Study||41
1453773|NCT02101515|3558355|P1|STARTED|Overall Study||37
1453774|NCT02101359|3558395|P2|NOT COMPLETED|Overall Study||19
1453775|NCT02101359|3558396|P1|NOT COMPLETED|Overall Study||29
1453776|NCT02101359|3558395|P2|COMPLETED|Overall Study||277
1453777|NCT02101359|3558396|P1|COMPLETED|Overall Study||266
1453778|NCT02101359|3558395|P2|STARTED|Overall Study||296
1453779|NCT02101359|3558396|P1|STARTED|Overall Study||295
1453780|NCT02101294|3558402|P1|NOT COMPLETED|Overall Study||11
1453781|NCT02101294|3558402|P1|COMPLETED|Overall Study||20
1453782|NCT02101294|3558402|P1|STARTED|Overall Study||31
1453783|NCT02101190|3558411|P2|NOT COMPLETED|Overall Study||0
1453784|NCT02101190|3558412|P1|NOT COMPLETED|Overall Study||0
1453785|NCT02101190|3558411|P2|COMPLETED|Overall Study||8
1453786|NCT02101190|3558412|P1|COMPLETED|Overall Study||8
1453787|NCT02101190|3558411|P2|STARTED|Overall Study||8
1453788|NCT02101190|3558412|P1|STARTED|Overall Study||8
1453789|NCT02101112|3558422|P6|NOT COMPLETED|Overall Study||0
1453790|NCT02101112|3558423|P5|NOT COMPLETED|Overall Study||1
1453791|NCT02101112|3558424|P4|NOT COMPLETED|Overall Study||0
1453792|NCT02101112|3558425|P3|NOT COMPLETED|Overall Study||1
1453793|NCT02101112|3558426|P2|NOT COMPLETED|Overall Study||0
1453794|NCT02101112|3558427|P1|NOT COMPLETED|Overall Study||0
1453795|NCT02101112|3558422|P6|COMPLETED|Overall Study||5
1453796|NCT02101112|3558423|P5|COMPLETED|Overall Study||5
1453797|NCT02101112|3558424|P4|COMPLETED|Overall Study||5
1453798|NCT02101112|3558425|P3|COMPLETED|Overall Study||5
1453799|NCT02101112|3558426|P2|COMPLETED|Overall Study||5
1453800|NCT02101112|3558427|P1|COMPLETED|Overall Study||6
1453801|NCT02101112|3558422|P6|STARTED|Overall Study||5
1453802|NCT02101112|3558423|P5|STARTED|Overall Study||6
1453803|NCT02101112|3558424|P4|STARTED|Overall Study||5
1453804|NCT02101112|3558425|P3|STARTED|Overall Study||6
1453805|NCT02101112|3558426|P2|STARTED|Overall Study||5
1453806|NCT02101112|3558427|P1|STARTED|Overall Study||6
1453807|NCT02101021|3558457|P5|NOT COMPLETED|Overall Study||4
1453808|NCT02101021|3558458|P4|NOT COMPLETED|Overall Study||3
1453809|NCT02101021|3558459|P3|NOT COMPLETED|Overall Study||7
1453810|NCT02101021|3558460|P2|NOT COMPLETED|Overall Study||4
1453811|NCT02101021|3558461|P1|NOT COMPLETED|Overall Study||7
1453812|NCT02101021|3558457|P5|COMPLETED|Overall Study||0
1453813|NCT02101021|3558458|P4|COMPLETED|Overall Study||0
1453814|NCT02101021|3558459|P3|COMPLETED|Overall Study||0
1453815|NCT02101021|3558460|P2|COMPLETED|Overall Study||0
1453816|NCT02101021|3558461|P1|COMPLETED|Overall Study||0
1453817|NCT02101021|3558457|P5|STARTED|Overall Study||4
1453818|NCT02101021|3558458|P4|STARTED|Overall Study||3
1453819|NCT02101021|3558459|P3|STARTED|Overall Study||7
1453820|NCT02101021|3558460|P2|STARTED|Overall Study||4
1453821|NCT02101021|3558461|P1|STARTED|Overall Study||7
1453822|NCT02101008|3558503|P1|NOT COMPLETED|Overall Study||0
1453823|NCT02101008|3558503|P1|COMPLETED|Overall Study||12
1453824|NCT02101008|3558503|P1|STARTED|Overall Study||12
1453825|NCT02100839|3558510|P2|NOT COMPLETED|Multiple Ascending Dose||0
1453826|NCT02100839|3558511|P1|NOT COMPLETED|Multiple Ascending Dose||4
1453827|NCT02100839|3558510|P2|COMPLETED|Multiple Ascending Dose||3
1453828|NCT02100839|3558511|P1|COMPLETED|Multiple Ascending Dose||9
1453829|NCT02100839|3558510|P2|STARTED|Multiple Ascending Dose||3
1453830|NCT02100839|3558511|P1|STARTED|Multiple Ascending Dose||13
1453831|NCT02100839|3558510|P2|NOT COMPLETED|Single Ascending Dose||0
1453832|NCT02100839|3558511|P1|NOT COMPLETED|Single Ascending Dose||0
1453833|NCT02100839|3558510|P2|COMPLETED|Single Ascending Dose||12
1453834|NCT02100839|3558511|P1|COMPLETED|Single Ascending Dose||24
1453835|NCT02100839|3558510|P2|STARTED|Single Ascending Dose||12
1453836|NCT02100839|3558511|P1|STARTED|Single Ascending Dose||24
1453837|NCT02100826|3558523|P2|NOT COMPLETED|Period 2 (7 Days)||0
1453838|NCT02100826|3558524|P1|NOT COMPLETED|Period 2 (7 Days)||0
1453839|NCT02100826|3558523|P2|COMPLETED|Period 2 (7 Days)||14
1453840|NCT02100826|3558524|P1|COMPLETED|Period 2 (7 Days)||14
1453841|NCT02100826|3558523|P2|STARTED|Period 2 (7 Days)||14
1453842|NCT02100826|3558524|P1|STARTED|Period 2 (7 Days)||14
1453843|NCT02100826|3558523|P2|NOT COMPLETED|Washout Period (1 Day)||0
1453844|NCT02100826|3558524|P1|NOT COMPLETED|Washout Period (1 Day)||0
1453845|NCT02100826|3558523|P2|COMPLETED|Washout Period (1 Day)||14
1453846|NCT02100826|3558524|P1|COMPLETED|Washout Period (1 Day)||14
1453847|NCT02100826|3558523|P2|STARTED|Washout Period (1 Day)||14
1453848|NCT02100826|3558524|P1|STARTED|Washout Period (1 Day)||14
1453849|NCT02100826|3558523|P2|NOT COMPLETED|Period 1 (7 Days)||0
1453850|NCT02100826|3558524|P1|NOT COMPLETED|Period 1 (7 Days)||0
1453851|NCT02100826|3558523|P2|COMPLETED|Period 1 (7 Days)||14
1453852|NCT02100826|3558524|P1|COMPLETED|Period 1 (7 Days)||14
1453853|NCT02100826|3558523|P2|STARTED|Period 1 (7 Days)||14
1453854|NCT02100826|3558524|P1|STARTED|Period 1 (7 Days)||14
1453855|NCT02100670|3558538|P4|NOT COMPLETED|Overall Study||1
1453856|NCT02100670|3558539|P3|NOT COMPLETED|Overall Study||4
1453857|NCT02100670|3558540|P2|NOT COMPLETED|Overall Study||7
1453858|NCT02100670|3558541|P1|NOT COMPLETED|Overall Study||13
1453859|NCT02100670|3558538|P4|COMPLETED|Overall Study||75
1453860|NCT02100670|3558539|P3|COMPLETED|Overall Study||74
1453861|NCT02100670|3558540|P2|COMPLETED|Overall Study||106
1453862|NCT02100670|3558541|P1|COMPLETED|Overall Study||105
1453863|NCT02100670|3558538|P4|STARTED|Overall Study||76
1453864|NCT02100670|3558539|P3|STARTED|Overall Study||78
1453865|NCT02100670|3558540|P2|STARTED|Overall Study||113
1453866|NCT02100670|3558541|P1|STARTED|Overall Study||118
1453867|NCT02100644|3558601|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
1453868|NCT02100644|3558602|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
1453869|NCT02100644|3558603|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
1453870|NCT02100644|3558601|P3|COMPLETED|LTG and VPA Maintenance Phase||20
1453871|NCT02100644|3558602|P2|COMPLETED|LTG and VPA Maintenance Phase||0
1453872|NCT02100644|3558603|P1|COMPLETED|LTG and VPA Maintenance Phase||0
1453873|NCT02100644|3558601|P3|STARTED|LTG and VPA Maintenance Phase||20
1453874|NCT02100644|3558602|P2|STARTED|LTG and VPA Maintenance Phase||0
1453875|NCT02100644|3558603|P1|STARTED|LTG and VPA Maintenance Phase||0
1453876|NCT02100644|3558601|P3|NOT COMPLETED|VPA Reduction Phase||0
1453877|NCT02100644|3558602|P2|NOT COMPLETED|VPA Reduction Phase||0
1453878|NCT02100644|3558603|P1|NOT COMPLETED|VPA Reduction Phase||0
1453879|NCT02100644|3558601|P3|COMPLETED|VPA Reduction Phase||0
1453880|NCT02100644|3558602|P2|COMPLETED|VPA Reduction Phase||20
1453881|NCT02100644|3558603|P1|COMPLETED|VPA Reduction Phase||0
1453882|NCT02100644|3558601|P3|STARTED|VPA Reduction Phase||0
1453883|NCT02100644|3558602|P2|STARTED|VPA Reduction Phase||20
1453884|NCT02100644|3558603|P1|STARTED|VPA Reduction Phase||0
1453885|NCT02100644|3558601|P3|NOT COMPLETED|LTG Escalation Phase||0
1453886|NCT02100644|3558602|P2|NOT COMPLETED|LTG Escalation Phase||0
1453887|NCT02100644|3558603|P1|NOT COMPLETED|LTG Escalation Phase||13
1453888|NCT02100644|3558601|P3|COMPLETED|LTG Escalation Phase||0
1453889|NCT02100644|3558602|P2|COMPLETED|LTG Escalation Phase||0
1453890|NCT02100644|3558603|P1|COMPLETED|LTG Escalation Phase||20
1453891|NCT02100644|3558601|P3|STARTED|LTG Escalation Phase||0
1453892|NCT02100644|3558602|P2|STARTED|LTG Escalation Phase||0
1453893|NCT02100644|3558603|P1|STARTED|LTG Escalation Phase||33
1453894|NCT02100579|3558615|P2|NOT COMPLETED|Overall Study||0
1453895|NCT02100579|3558616|P1|NOT COMPLETED|Overall Study||0
1453896|NCT02100579|3558615|P2|COMPLETED|Overall Study||20
1453897|NCT02100579|3558616|P1|COMPLETED|Overall Study||20
1453898|NCT02100579|3558615|P2|STARTED|Overall Study||20
1453899|NCT02100579|3558616|P1|STARTED|Overall Study||20
1453900|NCT02100514|3558628|P5|NOT COMPLETED|Extension Period||0
1453901|NCT02100514|3558629|P4|NOT COMPLETED|Extension Period||0
1453902|NCT02100514|3558630|P3|NOT COMPLETED|Extension Period||2
1453903|NCT02100514|3558631|P2|NOT COMPLETED|Extension Period||0
1453904|NCT02100514|3558632|P1|NOT COMPLETED|Extension Period||0
1453905|NCT02100514|3558628|P5|COMPLETED|Extension Period||56
1453906|NCT02100514|3558629|P4|COMPLETED|Extension Period||33
1453907|NCT02100514|3558630|P3|COMPLETED|Extension Period||42
1453908|NCT02100514|3558631|P2|COMPLETED|Extension Period||0
1453909|NCT02100514|3558632|P1|COMPLETED|Extension Period||0
1453910|NCT02100514|3558628|P5|STARTED|Extension Period||56
1453911|NCT02100514|3558629|P4|STARTED|Extension Period||33
1453912|NCT02100514|3558630|P3|STARTED|Extension Period||44
1453913|NCT02100514|3558631|P2|STARTED|Extension Period||0
1453914|NCT02100514|3558632|P1|STARTED|Extension Period||0
1453915|NCT02100514|3558628|P5|NOT COMPLETED|Treatment Period||0
1453916|NCT02100514|3558629|P4|NOT COMPLETED|Treatment Period||0
1453917|NCT02100514|3558630|P3|NOT COMPLETED|Treatment Period||0
1453918|NCT02100514|3558631|P2|NOT COMPLETED|Treatment Period||74
1453919|NCT02100514|3558632|P1|NOT COMPLETED|Treatment Period||29
1453920|NCT02100514|3558628|P5|COMPLETED|Treatment Period||0
1453921|NCT02100514|3558629|P4|COMPLETED|Treatment Period||0
1453922|NCT02100514|3558630|P3|COMPLETED|Treatment Period||0
1453923|NCT02100514|3558631|P2|COMPLETED|Treatment Period||425
1453924|NCT02100514|3558632|P1|COMPLETED|Treatment Period||218
1453925|NCT02100514|3558628|P5|STARTED|Treatment Period||0
1453926|NCT02100514|3558629|P4|STARTED|Treatment Period||0
1453927|NCT02100514|3558630|P3|STARTED|Treatment Period||0
1453928|NCT02100514|3558631|P2|STARTED|Treatment Period||499
1453929|NCT02100514|3558632|P1|STARTED|Treatment Period||247
1453930|NCT02100475|3558700|P2|NOT COMPLETED|Overall Study||2
1453931|NCT02100475|3558701|P1|NOT COMPLETED|Overall Study||2
1453932|NCT02100475|3558700|P2|COMPLETED|Overall Study||13
1453933|NCT02100475|3558701|P1|COMPLETED|Overall Study||14
1453934|NCT02100475|3558700|P2|STARTED|Overall Study||15
1453935|NCT02100475|3558701|P1|STARTED|Overall Study||16
1453936|NCT02100410|3558711|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1453937|NCT02100410|3558712|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1453938|NCT02100410|3558713|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1453939|NCT02100410|3558714|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1453940|NCT02100410|3558715|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1453941|NCT02100410|3558716|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
1453942|NCT02100410|3558711|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
1453943|NCT02100410|3558712|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
1453944|NCT02100410|3558713|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
1453945|NCT02100410|3558714|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
1453946|NCT02100410|3558715|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
1453947|NCT02100410|3558716|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
1453948|NCT02100410|3558711|P6|STARTED|Exposure Pair 3, 30 Minutes||9
1453949|NCT02100410|3558712|P5|STARTED|Exposure Pair 3, 30 Minutes||8
1453950|NCT02100410|3558713|P4|STARTED|Exposure Pair 3, 30 Minutes||8
1453951|NCT02100410|3558714|P3|STARTED|Exposure Pair 3, 30 Minutes||8
1453952|NCT02100410|3558715|P2|STARTED|Exposure Pair 3, 30 Minutes||8
1453953|NCT02100410|3558716|P1|STARTED|Exposure Pair 3, 30 Minutes||8
1453954|NCT02100410|3558711|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1453955|NCT02100410|3558712|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1453956|NCT02100410|3558713|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1453957|NCT02100410|3558714|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1453958|NCT02100410|3558715|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1453959|NCT02100410|3558716|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
1453960|NCT02100410|3558711|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
1453961|NCT02100410|3558712|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
1453962|NCT02100410|3558713|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
1453963|NCT02100410|3558714|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
1453964|NCT02100410|3558715|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
1453965|NCT02100410|3558716|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
1453966|NCT02100410|3558711|P6|STARTED|Exposure Pair 2, 30 Minutes||9
1453967|NCT02100410|3558712|P5|STARTED|Exposure Pair 2, 30 Minutes||8
1453968|NCT02100410|3558713|P4|STARTED|Exposure Pair 2, 30 Minutes||8
1453969|NCT02100410|3558714|P3|STARTED|Exposure Pair 2, 30 Minutes||8
1453970|NCT02100410|3558715|P2|STARTED|Exposure Pair 2, 30 Minutes||8
1453971|NCT02100410|3558716|P1|STARTED|Exposure Pair 2, 30 Minutes||8
1453972|NCT02100410|3558711|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1453973|NCT02100410|3558712|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1453974|NCT02100410|3558713|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1453975|NCT02100410|3558714|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1453976|NCT02100410|3558715|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1453977|NCT02100410|3558716|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
1453978|NCT02100410|3558711|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
1453979|NCT02100410|3558712|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
1453980|NCT02100410|3558713|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
1453981|NCT02100410|3558714|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
1453982|NCT02100410|3558715|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
1453983|NCT02100410|3558716|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
1453984|NCT02100410|3558711|P6|STARTED|Exposure Pair 1, 30 Minutes||9
1453985|NCT02100410|3558712|P5|STARTED|Exposure Pair 1, 30 Minutes||8
1453986|NCT02100410|3558713|P4|STARTED|Exposure Pair 1, 30 Minutes||8
1453987|NCT02100410|3558714|P3|STARTED|Exposure Pair 1, 30 Minutes||8
1453988|NCT02100410|3558715|P2|STARTED|Exposure Pair 1, 30 Minutes||8
1453989|NCT02100410|3558716|P1|STARTED|Exposure Pair 1, 30 Minutes||8
1453990|NCT02100280|3558734|P2|NOT COMPLETED|Overall Study||4
1453991|NCT02100280|3558735|P1|NOT COMPLETED|Overall Study||4
1453992|NCT02100280|3558734|P2|COMPLETED|Overall Study||44
1453993|NCT02100280|3558735|P1|COMPLETED|Overall Study||44
1453994|NCT02100280|3558734|P2|STARTED|Overall Study||48
1453995|NCT02100280|3558735|P1|STARTED|Overall Study||48
1453996|NCT02100228|3558751|P2|NOT COMPLETED|Overall Study||90
1453997|NCT02100228|3558752|P1|NOT COMPLETED|Overall Study||75
1453998|NCT02100228|3558751|P2|COMPLETED|Overall Study||657
1453999|NCT02100228|3558752|P1|COMPLETED|Overall Study||678
1454000|NCT02100228|3558751|P2|STARTED|Overall Study|721 treated with Usual Care|747
1454001|NCT02100228|3558752|P1|STARTED|Overall Study|735 treated with Apixaban|753
1454002|NCT02100189|3558778|P1|NOT COMPLETED|Overall Study||0
1454003|NCT02100189|3558778|P1|COMPLETED|Overall Study||50
1454004|NCT02100189|3558778|P1|STARTED|Overall Study||50
1454005|NCT02100124|3558788|P3|NOT COMPLETED|Overall Study||3
1454006|NCT02100124|3558789|P2|NOT COMPLETED|Overall Study||11
1454007|NCT02100124|3558790|P1|NOT COMPLETED|Overall Study||6
1454008|NCT02100124|3558788|P3|COMPLETED|Overall Study||323
1454009|NCT02100124|3558789|P2|COMPLETED|Overall Study||318
1454010|NCT02100124|3558790|P1|COMPLETED|Overall Study||323
1454011|NCT02100124|3558788|P3|STARTED|Overall Study||326
1454012|NCT02100124|3558789|P2|STARTED|Overall Study||329
1454013|NCT02100124|3558790|P1|STARTED|Overall Study||329
1454014|NCT02100007|3558807|P1|NOT COMPLETED|Overall Study||0
1454015|NCT02100007|3558807|P1|COMPLETED|Overall Study||46
1454016|NCT02100007|3558807|P1|STARTED|Overall Study||46
1454017|NCT02099838|3558820|P2|NOT COMPLETED|Overall Study||2
1454018|NCT02099838|3558821|P1|NOT COMPLETED|Overall Study||4
1454019|NCT02099838|3558820|P2|COMPLETED|Overall Study||49
1454020|NCT02099838|3558821|P1|COMPLETED|Overall Study||43
1454021|NCT02099838|3558820|P2|STARTED|Overall Study||51
1454022|NCT02099838|3558821|P1|STARTED|Overall Study||47
1454023|NCT02099708|3558851|P1|NOT COMPLETED|Overall Study||200
1454024|NCT02099708|3558851|P1|COMPLETED|Overall Study||3302
1454025|NCT02099708|3558851|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
1454026|NCT02099708|3558851|P1|STARTED|Overall Study|Number of cases.|3502
1454027|NCT02099682|3558862|P1|NOT COMPLETED|Overall Study||111
1454028|NCT02099682|3558862|P1|COMPLETED|Overall Study||3255
1454029|NCT02099682|3558862|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
1454030|NCT02099682|3558862|P1|STARTED|Overall Study|Number of cases.|3366
1454031|NCT02099461|3558876|P3|NOT COMPLETED|Overall Study||0
1454032|NCT02099461|3558877|P2|NOT COMPLETED|Overall Study||0
1454033|NCT02099461|3558878|P1|NOT COMPLETED|Overall Study||0
1454034|NCT02099461|3558876|P3|COMPLETED|Overall Study||28
1454035|NCT02099461|3558877|P2|COMPLETED|Overall Study||27
1454036|NCT02099461|3558878|P1|COMPLETED|Overall Study||27
1454037|NCT02099461|3558876|P3|STARTED|Overall Study||28
1454038|NCT02099461|3558877|P2|STARTED|Overall Study||27
1454039|NCT02099461|3558878|P1|STARTED|Overall Study||27
1454040|NCT02099344|3558888|P2|NOT COMPLETED|Overall Study||0
1454041|NCT02099344|3558889|P1|NOT COMPLETED|Overall Study||1
1454042|NCT02099344|3558888|P2|COMPLETED|Overall Study||0
1454043|NCT02099344|3558889|P1|COMPLETED|Overall Study||0
1454044|NCT02099344|3558888|P2|STARTED|Overall Study||0
1454045|NCT02099344|3558889|P1|STARTED|Overall Study||1
1454046|NCT02099318|3558899|P2|NOT COMPLETED|Overall Study||0
1454047|NCT02099318|3558900|P1|NOT COMPLETED|Overall Study||0
1454048|NCT02099318|3558899|P2|COMPLETED|Overall Study||20
1454049|NCT02099318|3558900|P1|COMPLETED|Overall Study||20
1454050|NCT02099318|3558899|P2|STARTED|Overall Study||20
1454051|NCT02099318|3558900|P1|STARTED|Overall Study||20
1454052|NCT02099266|3558914|P1|NOT COMPLETED|Overall Study||0
1454053|NCT02099266|3558914|P1|COMPLETED|Overall Study||15
1454054|NCT02099266|3558914|P1|STARTED|Overall Study||15
1454055|NCT02099110|3558926|P5|NOT COMPLETED|Overall Study||27
1454056|NCT02099110|3558927|P4|NOT COMPLETED|Overall Study||22
1454057|NCT02099110|3558928|P3|NOT COMPLETED|Overall Study||28
1454058|NCT02099110|3558929|P2|NOT COMPLETED|Overall Study||31
1454059|NCT02099110|3558930|P1|NOT COMPLETED|Overall Study||24
1454060|NCT02099110|3558926|P5|COMPLETED|Overall Study||218
1454061|NCT02099110|3558927|P4|COMPLETED|Overall Study||221
1454062|NCT02099110|3558928|P3|COMPLETED|Overall Study||219
1454063|NCT02099110|3558929|P2|COMPLETED|Overall Study||217
1454064|NCT02099110|3558930|P1|COMPLETED|Overall Study||226
1454065|NCT02099110|3558926|P5|Treated|Overall Study||244
1454066|NCT02099110|3558927|P4|Treated|Overall Study||243
1454067|NCT02099110|3558928|P3|Treated|Overall Study||247
1454068|NCT02099110|3558929|P2|Treated|Overall Study||248
1454069|NCT02099110|3558930|P1|Treated|Overall Study||250
1454070|NCT02099110|3558926|P5|STARTED|Overall Study||245
1454071|NCT02099110|3558927|P4|STARTED|Overall Study||243
1454072|NCT02099110|3558928|P3|STARTED|Overall Study||247
1454073|NCT02099110|3558929|P2|STARTED|Overall Study||248
1454074|NCT02099110|3558930|P1|STARTED|Overall Study||250
1454075|NCT02099084|3558977|P2|NOT COMPLETED|Second Intervention||0
1454076|NCT02099084|3558978|P1|NOT COMPLETED|Second Intervention||0
1454077|NCT02099084|3558977|P2|COMPLETED|Second Intervention||4
1454078|NCT02099084|3558978|P1|COMPLETED|Second Intervention||4
1454079|NCT02099084|3558977|P2|STARTED|Second Intervention||4
1454080|NCT02099084|3558978|P1|STARTED|Second Intervention||4
1454081|NCT02099084|3558977|P2|NOT COMPLETED|Washout Period of 14 Days||0
1454082|NCT02099084|3558978|P1|NOT COMPLETED|Washout Period of 14 Days||0
1454083|NCT02099084|3558977|P2|COMPLETED|Washout Period of 14 Days||4
1454084|NCT02099084|3558978|P1|COMPLETED|Washout Period of 14 Days||4
1454085|NCT02099084|3558977|P2|STARTED|Washout Period of 14 Days||4
1454086|NCT02099084|3558978|P1|STARTED|Washout Period of 14 Days||4
1454087|NCT02099084|3558977|P2|NOT COMPLETED|First Intervention||0
1454088|NCT02099084|3558978|P1|NOT COMPLETED|First Intervention||0
1454089|NCT02099084|3558977|P2|COMPLETED|First Intervention||4
1454090|NCT02099084|3558978|P1|COMPLETED|First Intervention||4
1454091|NCT02099084|3558977|P2|STARTED|First Intervention||4
1454092|NCT02099084|3558978|P1|STARTED|First Intervention||4
1454093|NCT02099006|3558996|P1|NOT COMPLETED|Overall Study||1
1454094|NCT02099006|3558996|P1|COMPLETED|Overall Study||8
1454095|NCT02099006|3558996|P1|Received Gabapentin|Overall Study||8
1454096|NCT02099006|3558996|P1|Received Ketamine|Overall Study||6
1454097|NCT02099006|3558996|P1|Received Loperamide|Overall Study||7
1454098|NCT02099006|3558996|P1|Received Ketoprofen|Overall Study||3
1454099|NCT02099006|3558996|P1|Received Amitriptyline/ Baclofen|Overall Study||7
1454100|NCT02099006|3558996|P1|Received Placebo|Overall Study||9
1454101|NCT02099006|3558996|P1|STARTED|Overall Study||9
1454102|NCT02098746|3559004|P1|NOT COMPLETED|Overall Study||5
1454103|NCT02098746|3559004|P1|COMPLETED|Overall Study||289
1454104|NCT02098746|3559004|P1|STARTED|Overall Study||294
1454105|NCT02098733|3559012|P1|NOT COMPLETED|Overall Study||10
1454106|NCT02098733|3559012|P1|COMPLETED|Overall Study||1158
1454107|NCT02098733|3559012|P1|STARTED|Overall Study||1168
1454108|NCT02098395|3559026|P4|NOT COMPLETED|Overall Study||27
1454109|NCT02098395|3559027|P3|NOT COMPLETED|Overall Study||42
1454110|NCT02098395|3559028|P2|NOT COMPLETED|Overall Study||32
1454111|NCT02098395|3559029|P1|NOT COMPLETED|Overall Study||26
1454112|NCT02098395|3559026|P4|COMPLETED|Overall Study||180
1454113|NCT02098395|3559027|P3|COMPLETED|Overall Study||165
1454114|NCT02098395|3559028|P2|COMPLETED|Overall Study||177
1454115|NCT02098395|3559029|P1|COMPLETED|Overall Study||186
1454116|NCT02098395|3559026|P4|Exposed|Overall Study||206
1454117|NCT02098395|3559027|P3|Exposed|Overall Study||206
1454118|NCT02098395|3559028|P2|Exposed|Overall Study||209
1454119|NCT02098395|3559029|P1|Exposed|Overall Study||211
1454120|NCT02098395|3559026|P4|STARTED|Overall Study||207
1454121|NCT02098395|3559027|P3|STARTED|Overall Study||207
1454122|NCT02098395|3559028|P2|STARTED|Overall Study||209
1454123|NCT02098395|3559029|P1|STARTED|Overall Study||212
1454124|NCT02098369|3559050|P3|NOT COMPLETED|Overall Study||5
1454125|NCT02098369|3559051|P2|NOT COMPLETED|Overall Study||9
1454126|NCT02098369|3559052|P1|NOT COMPLETED|Overall Study||7
1454127|NCT02098369|3559050|P3|COMPLETED|Overall Study||143
1454128|NCT02098369|3559051|P2|COMPLETED|Overall Study||145
1454129|NCT02098369|3559052|P1|COMPLETED|Overall Study||135
1454130|NCT02098369|3559050|P3|STARTED|Overall Study||148
1454131|NCT02098369|3559051|P2|STARTED|Overall Study||154
1454132|NCT02098369|3559052|P1|STARTED|Overall Study||142
1454133|NCT02098304|3559081|P1|NOT COMPLETED|Overall Study||0
1454134|NCT02098304|3559081|P1|COMPLETED|Overall Study||42
1454135|NCT02098304|3559081|P1|STARTED|Overall Study||42
1454136|NCT02098109|3559090|P2|NOT COMPLETED|Overall Study||0
1454137|NCT02098109|3559091|P1|NOT COMPLETED|Overall Study||3
1454138|NCT02098109|3559090|P2|COMPLETED|Overall Study||51
1454139|NCT02098109|3559091|P1|COMPLETED|Overall Study||46
1454140|NCT02098109|3559090|P2|STARTED|Overall Study||51
1454141|NCT02098109|3559091|P1|STARTED|Overall Study||49
1454142|NCT02097992|3559117|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
1454143|NCT02097992|3559118|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
1454144|NCT02097992|3559119|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
1454145|NCT02097992|3559120|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
1454146|NCT02097992|3559117|P4|COMPLETED|Treatment 3 (4 Weeks)||2
1454147|NCT02097992|3559118|P3|COMPLETED|Treatment 3 (4 Weeks)||4
1454148|NCT02097992|3559119|P2|COMPLETED|Treatment 3 (4 Weeks)||3
1454149|NCT02097992|3559120|P1|COMPLETED|Treatment 3 (4 Weeks)||2
1454150|NCT02097992|3559117|P4|STARTED|Treatment 3 (4 Weeks)||2
1454151|NCT02097992|3559118|P3|STARTED|Treatment 3 (4 Weeks)||4
1454152|NCT02097992|3559119|P2|STARTED|Treatment 3 (4 Weeks)||3
1454153|NCT02097992|3559120|P1|STARTED|Treatment 3 (4 Weeks)||2
1454154|NCT02097992|3559117|P4|NOT COMPLETED|Washout (4 Weeks)||0
1454155|NCT02097992|3559118|P3|NOT COMPLETED|Washout (4 Weeks)||0
1454156|NCT02097992|3559119|P2|NOT COMPLETED|Washout (4 Weeks)||0
1454157|NCT02097992|3559120|P1|NOT COMPLETED|Washout (4 Weeks)||0
1454158|NCT02097992|3559117|P4|COMPLETED|Washout (4 Weeks)||2
1454159|NCT02097992|3559118|P3|COMPLETED|Washout (4 Weeks)||4
1454160|NCT02097992|3559119|P2|COMPLETED|Washout (4 Weeks)||3
1454161|NCT02097992|3559120|P1|COMPLETED|Washout (4 Weeks)||2
1454162|NCT02097992|3559117|P4|STARTED|Washout (4 Weeks)||2
1454163|NCT02097992|3559118|P3|STARTED|Washout (4 Weeks)||4
1454164|NCT02097992|3559119|P2|STARTED|Washout (4 Weeks)||3
1454165|NCT02097992|3559120|P1|STARTED|Washout (4 Weeks)||2
1454166|NCT02097992|3559117|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
1454167|NCT02097992|3559118|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
1454168|NCT02097992|3559119|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
1454169|NCT02097992|3559120|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
1454170|NCT02097992|3559117|P4|COMPLETED|Treatment 2 (4 Weeks)||2
1454171|NCT02097992|3559118|P3|COMPLETED|Treatment 2 (4 Weeks)||4
1454172|NCT02097992|3559119|P2|COMPLETED|Treatment 2 (4 Weeks)||3
1454173|NCT02097992|3559120|P1|COMPLETED|Treatment 2 (4 Weeks)||2
1454174|NCT02097992|3559117|P4|STARTED|Treatment 2 (4 Weeks)||2
1454175|NCT02097992|3559118|P3|STARTED|Treatment 2 (4 Weeks)||4
1454176|NCT02097992|3559119|P2|STARTED|Treatment 2 (4 Weeks)||3
1454177|NCT02097992|3559120|P1|STARTED|Treatment 2 (4 Weeks)||2
1454178|NCT02097992|3559117|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
1454179|NCT02097992|3559118|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
1454180|NCT02097992|3559119|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
1454181|NCT02097992|3559120|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
1454182|NCT02097992|3559117|P4|COMPLETED|Treatment 1 (1 Day)||2
1454183|NCT02097992|3559118|P3|COMPLETED|Treatment 1 (1 Day)||4
1454184|NCT02097992|3559119|P2|COMPLETED|Treatment 1 (1 Day)||3
1454185|NCT02097992|3559120|P1|COMPLETED|Treatment 1 (1 Day)||2
1454186|NCT02097992|3559117|P4|STARTED|Treatment 1 (1 Day)||2
1454187|NCT02097992|3559118|P3|STARTED|Treatment 1 (1 Day)||4
1454188|NCT02097992|3559119|P2|STARTED|Treatment 1 (1 Day)||3
1454189|NCT02097992|3559120|P1|STARTED|Treatment 1 (1 Day)||2
1454190|NCT02097849|3559130|P2|NOT COMPLETED|Overall Study||0
1454191|NCT02097849|3559131|P1|NOT COMPLETED|Overall Study||0
1454192|NCT02097849|3559130|P2|COMPLETED|Overall Study||38
1454193|NCT02097849|3559131|P1|COMPLETED|Overall Study||33
1454194|NCT02097849|3559130|P2|STARTED|Overall Study||38
1454195|NCT02097849|3559131|P1|STARTED|Overall Study||33
1454196|NCT02097823|3559169|P2|NOT COMPLETED|Overall Study||1
1454197|NCT02097823|3559170|P1|NOT COMPLETED|Overall Study||1
1454198|NCT02097823|3559169|P2|COMPLETED|Overall Study||3
1454199|NCT02097823|3559170|P1|COMPLETED|Overall Study||10
1454200|NCT02097823|3559169|P2|STARTED|Overall Study||4
1454201|NCT02097823|3559170|P1|STARTED|Overall Study||11
1454202|NCT02097745|3559185|P1|NOT COMPLETED|Overall Study||178
1454203|NCT02097745|3559185|P1|COMPLETED|Overall Study||157
1454204|NCT02097745|3559185|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
1454205|NCT02097732|3559209|P2|NOT COMPLETED|Overall Study||0
1454206|NCT02097732|3559210|P1|NOT COMPLETED|Overall Study||0
1454207|NCT02097732|3559209|P2|COMPLETED|Overall Study||3
1454208|NCT02097732|3559210|P1|COMPLETED|Overall Study||1
1454209|NCT02097732|3559209|P2|STARTED|Overall Study||3
1454210|NCT02097732|3559210|P1|STARTED|Overall Study||1
1454211|NCT02097719|3559221|P2|NOT COMPLETED|Overall Study||1
1454212|NCT02097719|3559222|P1|NOT COMPLETED|Overall Study||3
1454213|NCT02097719|3559221|P2|COMPLETED|Overall Study||50
1454214|NCT02097719|3559222|P1|COMPLETED|Overall Study||46
1454215|NCT02097719|3559221|P2|STARTED|Overall Study||51
1454216|NCT02097719|3559222|P1|STARTED|Overall Study||49
1454217|NCT02097537|3559228|P1|NOT COMPLETED|Overall Study||0
1454218|NCT02097537|3559228|P1|COMPLETED|Overall Study||10
1454219|NCT02097537|3559228|P1|Follow-Up|Overall Study||10
1454220|NCT02097537|3559228|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
1454221|NCT02097537|3559228|P1|STARTED|Overall Study||10
1454222|NCT02097472|3559242|P8|NOT COMPLETED|Assessed for Immunogenicity||1
1454223|NCT02097472|3559243|P7|NOT COMPLETED|Assessed for Immunogenicity||2
1454224|NCT02097472|3559244|P6|NOT COMPLETED|Assessed for Immunogenicity||2
1454225|NCT02097472|3559245|P5|NOT COMPLETED|Assessed for Immunogenicity||0
1454226|NCT02097472|3559246|P4|NOT COMPLETED|Assessed for Immunogenicity||2
1454227|NCT02097472|3559247|P3|NOT COMPLETED|Assessed for Immunogenicity||1
1454228|NCT02097472|3559248|P2|NOT COMPLETED|Assessed for Immunogenicity||0
1454229|NCT02097472|3559249|P1|NOT COMPLETED|Assessed for Immunogenicity||0
1454230|NCT02097472|3559242|P8|COMPLETED|Assessed for Immunogenicity||49
1454231|NCT02097472|3559243|P7|COMPLETED|Assessed for Immunogenicity||47
1454232|NCT02097472|3559244|P6|COMPLETED|Assessed for Immunogenicity||48
1454233|NCT02097472|3559245|P5|COMPLETED|Assessed for Immunogenicity||50
1454234|NCT02097472|3559246|P4|COMPLETED|Assessed for Immunogenicity||48
1454235|NCT02097472|3559247|P3|COMPLETED|Assessed for Immunogenicity||17
1454236|NCT02097472|3559248|P2|COMPLETED|Assessed for Immunogenicity||18
1454237|NCT02097472|3559249|P1|COMPLETED|Assessed for Immunogenicity||18
1454238|NCT02097472|3559242|P8|STARTED|Assessed for Immunogenicity||50
1454239|NCT02097472|3559243|P7|STARTED|Assessed for Immunogenicity||49
1454240|NCT02097472|3559244|P6|STARTED|Assessed for Immunogenicity||50
1454241|NCT02097472|3559245|P5|STARTED|Assessed for Immunogenicity||50
1454242|NCT02097472|3559246|P4|STARTED|Assessed for Immunogenicity||50
1454243|NCT02097472|3559247|P3|STARTED|Assessed for Immunogenicity||18
1454244|NCT02097472|3559248|P2|STARTED|Assessed for Immunogenicity||18
1454245|NCT02097472|3559249|P1|STARTED|Assessed for Immunogenicity||18
1454246|NCT02097472|3559242|P8|NOT COMPLETED|Received Vaccination 2||0
1454247|NCT02097472|3559243|P7|NOT COMPLETED|Received Vaccination 2||1
1454248|NCT02097472|3559244|P6|NOT COMPLETED|Received Vaccination 2||0
1454249|NCT02097472|3559245|P5|NOT COMPLETED|Received Vaccination 2||0
1454250|NCT02097472|3559246|P4|NOT COMPLETED|Received Vaccination 2||0
1454251|NCT02097472|3559247|P3|NOT COMPLETED|Received Vaccination 2||0
1454252|NCT02097472|3559248|P2|NOT COMPLETED|Received Vaccination 2||0
1454253|NCT02097472|3559249|P1|NOT COMPLETED|Received Vaccination 2||0
1454254|NCT02097472|3559242|P8|COMPLETED|Received Vaccination 2||50
1454255|NCT02097472|3559243|P7|COMPLETED|Received Vaccination 2||49
1454256|NCT02097472|3559244|P6|COMPLETED|Received Vaccination 2||50
1454257|NCT02097472|3559245|P5|COMPLETED|Received Vaccination 2||50
1454258|NCT02097472|3559246|P4|COMPLETED|Received Vaccination 2||50
1454259|NCT02097472|3559247|P3|COMPLETED|Received Vaccination 2||18
1454260|NCT02097472|3559248|P2|COMPLETED|Received Vaccination 2||18
1454261|NCT02097472|3559249|P1|COMPLETED|Received Vaccination 2||18
1454262|NCT02097472|3559242|P8|STARTED|Received Vaccination 2||50
1454263|NCT02097472|3559243|P7|STARTED|Received Vaccination 2||50
1454264|NCT02097472|3559244|P6|STARTED|Received Vaccination 2||50
1454265|NCT02097472|3559245|P5|STARTED|Received Vaccination 2||50
1454266|NCT02097472|3559246|P4|STARTED|Received Vaccination 2||50
1454267|NCT02097472|3559247|P3|STARTED|Received Vaccination 2||18
1454268|NCT02097472|3559248|P2|STARTED|Received Vaccination 2||18
1454269|NCT02097472|3559249|P1|STARTED|Received Vaccination 2||18
1454270|NCT02097472|3559242|P8|NOT COMPLETED|Received Vaccination 1||0
1454271|NCT02097472|3559243|P7|NOT COMPLETED|Received Vaccination 1||0
1454272|NCT02097472|3559244|P6|NOT COMPLETED|Received Vaccination 1||0
1454273|NCT02097472|3559245|P5|NOT COMPLETED|Received Vaccination 1||0
1454274|NCT02097472|3559246|P4|NOT COMPLETED|Received Vaccination 1||0
1454275|NCT02097472|3559247|P3|NOT COMPLETED|Received Vaccination 1||0
1454276|NCT02097472|3559248|P2|NOT COMPLETED|Received Vaccination 1||0
1454277|NCT02097472|3559249|P1|NOT COMPLETED|Received Vaccination 1||0
1454278|NCT02097472|3559242|P8|COMPLETED|Received Vaccination 1||50
1454279|NCT02097472|3559243|P7|COMPLETED|Received Vaccination 1||50
1454280|NCT02097472|3559244|P6|COMPLETED|Received Vaccination 1||50
1454281|NCT02097472|3559245|P5|COMPLETED|Received Vaccination 1||50
1454282|NCT02097472|3559246|P4|COMPLETED|Received Vaccination 1||50
1454283|NCT02097472|3559247|P3|COMPLETED|Received Vaccination 1||18
1454284|NCT02097472|3559248|P2|COMPLETED|Received Vaccination 1||18
1454285|NCT02097472|3559249|P1|COMPLETED|Received Vaccination 1||18
1454286|NCT02097472|3559242|P8|STARTED|Received Vaccination 1||50
1454287|NCT02097472|3559243|P7|STARTED|Received Vaccination 1||50
1454288|NCT02097472|3559244|P6|STARTED|Received Vaccination 1||50
1454289|NCT02097472|3559245|P5|STARTED|Received Vaccination 1||50
1454290|NCT02097472|3559246|P4|STARTED|Received Vaccination 1||50
1454291|NCT02097472|3559247|P3|STARTED|Received Vaccination 1||18
1454292|NCT02097472|3559248|P2|STARTED|Received Vaccination 1||18
1454293|NCT02097472|3559249|P1|STARTED|Received Vaccination 1||18
1454294|NCT02097303|3559670|P1|NOT COMPLETED|Overall Study||5
1454295|NCT02097303|3559670|P1|COMPLETED|Overall Study||31
1454296|NCT02097303|3559670|P1|STARTED|Overall Study||36
1454297|NCT02097290|3559680|P1|NOT COMPLETED|Overall Study||17
1454298|NCT02097290|3559680|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
1454299|NCT02097290|3559680|P1|STARTED|Overall Study||210
1454300|NCT02097238|3559690|P1|NOT COMPLETED|Overall Study||19
1454301|NCT02097238|3559690|P1|COMPLETED|Overall Study||0
1454302|NCT02097238|3559690|P1|STARTED|Overall Study||19
1454303|NCT02097134|3559696|P1|NOT COMPLETED|Overall Study||9
1454304|NCT02097134|3559696|P1|COMPLETED|Overall Study||5
1454305|NCT02097134|3559696|P1|STARTED|Overall Study||14
1454306|NCT02097108|3559700|P1|NOT COMPLETED|Overall Study||2
1454307|NCT02097108|3559700|P1|COMPLETED|Overall Study||9
1454308|NCT02097108|3559700|P1|STARTED|Overall Study||11
1454309|NCT02097056|3559707|P1|NOT COMPLETED|Overall Study||58
1454310|NCT02097056|3559707|P1|COMPLETED|Overall Study||113
1454311|NCT02097056|3559707|P1|ParticipantsTreated|Overall Study||170
1454312|NCT02097056|3559707|P1|STARTED|Overall Study||171
1454313|NCT02097030|3559715|P2|NOT COMPLETED|Second Intervention (3 Days)||0
1454314|NCT02097030|3559716|P1|NOT COMPLETED|Second Intervention (3 Days)||0
1454315|NCT02097030|3559715|P2|COMPLETED|Second Intervention (3 Days)||16
1454316|NCT02097030|3559716|P1|COMPLETED|Second Intervention (3 Days)||14
1454317|NCT02097030|3559715|P2|STARTED|Second Intervention (3 Days)||16
1454318|NCT02097030|3559716|P1|STARTED|Second Intervention (3 Days)||14
1454319|NCT02097030|3559715|P2|NOT COMPLETED|First Intervention (3 Days)||1
1454320|NCT02097030|3559716|P1|NOT COMPLETED|First Intervention (3 Days)||1
1454321|NCT02097030|3559715|P2|COMPLETED|First Intervention (3 Days)||16
1454322|NCT02097030|3559716|P1|COMPLETED|First Intervention (3 Days)||14
1454323|NCT02097030|3559715|P2|STARTED|First Intervention (3 Days)||17
1454324|NCT02097030|3559716|P1|STARTED|First Intervention (3 Days)||15
1454325|NCT02096952|3559777|P1|NOT COMPLETED|Overall Study||1
1454326|NCT02096952|3559777|P1|COMPLETED|Overall Study||14
1454327|NCT02096952|3559777|P1|STARTED|Overall Study||15
1454328|NCT02096900|3559783|P2|NOT COMPLETED|Overall Study||2
1454329|NCT02096900|3559784|P1|NOT COMPLETED|Overall Study||4
1454330|NCT02096900|3559783|P2|COMPLETED|Overall Study||42
1454331|NCT02096900|3559784|P1|COMPLETED|Overall Study||38
1454332|NCT02096900|3559783|P2|STARTED|Overall Study|Allocated to Zolpidem|44
1454333|NCT02096900|3559784|P1|STARTED|Overall Study|Allocated to Midazolam|42
1454334|NCT02096861|3559802|P4|NOT COMPLETED|Overall Study||10
1454335|NCT02096861|3559803|P3|NOT COMPLETED|Overall Study||17
1454336|NCT02096861|3559804|P2|NOT COMPLETED|Overall Study||15
1454337|NCT02096861|3559805|P1|NOT COMPLETED|Overall Study||12
1454338|NCT02096861|3559802|P4|COMPLETED|Overall Study||45
1454339|NCT02096861|3559803|P3|COMPLETED|Overall Study||37
1454340|NCT02096861|3559804|P2|COMPLETED|Overall Study||40
1454341|NCT02096861|3559805|P1|COMPLETED|Overall Study||44
1454342|NCT02096861|3559802|P4|Drug Switching at Week 30|Overall Study||47
1454343|NCT02096861|3559803|P3|Drug Switching at Week 30|Overall Study||41
1454344|NCT02096861|3559804|P2|Drug Switching at Week 30|Overall Study||44
1454345|NCT02096861|3559805|P1|Drug Switching at Week 30|Overall Study||48
1454346|NCT02096861|3559802|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
1454347|NCT02096861|3559803|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
1454348|NCT02096861|3559804|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
1454349|NCT02096861|3559805|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
1454350|NCT02096835|3559836|P3|NOT COMPLETED|Overall Study||1
1454351|NCT02096835|3559837|P2|NOT COMPLETED|Overall Study||0
1454352|NCT02096835|3559838|P1|NOT COMPLETED|Overall Study||3
1454353|NCT02096835|3559836|P3|COMPLETED|Overall Study||50
1454354|NCT02096835|3559837|P2|COMPLETED|Overall Study||53
1454355|NCT02096835|3559838|P1|COMPLETED|Overall Study||50
1454356|NCT02096835|3559836|P3|STARTED|Overall Study||51
1454357|NCT02096835|3559837|P2|STARTED|Overall Study||53
1454358|NCT02096835|3559838|P1|STARTED|Overall Study||53
1454359|NCT02096744|3559855|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
1454360|NCT02096744|3559856|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1454361|NCT02096744|3559855|P2|COMPLETED|Treatment Period 3 (7 Days)||27
1454362|NCT02096744|3559856|P1|COMPLETED|Treatment Period 3 (7 Days)||28
1454363|NCT02096744|3559855|P2|STARTED|Treatment Period 3 (7 Days)||28
1454364|NCT02096744|3559856|P1|STARTED|Treatment Period 3 (7 Days)||28
1454365|NCT02096744|3559855|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
1454366|NCT02096744|3559856|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
1454367|NCT02096744|3559855|P2|COMPLETED|Washout Period 2 (3 Days)||28
1454368|NCT02096744|3559856|P1|COMPLETED|Washout Period 2 (3 Days)||28
1454369|NCT02096744|3559855|P2|STARTED|Washout Period 2 (3 Days)||28
1454370|NCT02096744|3559856|P1|STARTED|Washout Period 2 (3 Days)||28
1454371|NCT02096744|3559855|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1454372|NCT02096744|3559856|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1454373|NCT02096744|3559855|P2|COMPLETED|Treatment Period 2 (7 Days)||28
1454374|NCT02096744|3559856|P1|COMPLETED|Treatment Period 2 (7 Days)||28
1454375|NCT02096744|3559855|P2|STARTED|Treatment Period 2 (7 Days)||28
1454376|NCT02096744|3559856|P1|STARTED|Treatment Period 2 (7 Days)||28
1454377|NCT02096744|3559855|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
1454378|NCT02096744|3559856|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
1454379|NCT02096744|3559855|P2|COMPLETED|Washout Period 1(7 Days)||28
1454380|NCT02096744|3559856|P1|COMPLETED|Washout Period 1(7 Days)||28
1454381|NCT02096744|3559855|P2|STARTED|Washout Period 1(7 Days)||28
1454382|NCT02096744|3559856|P1|STARTED|Washout Period 1(7 Days)||28
1454383|NCT02096744|3559855|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
1454384|NCT02096744|3559856|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
1454385|NCT02096744|3559855|P2|COMPLETED|Treatment Period 1(7 Days)||28
1454386|NCT02096744|3559856|P1|COMPLETED|Treatment Period 1(7 Days)||28
1454387|NCT02096744|3559855|P2|STARTED|Treatment Period 1(7 Days)||29
1454388|NCT02096744|3559856|P1|STARTED|Treatment Period 1(7 Days)||29
1454389|NCT02096731|3559871|P2|NOT COMPLETED|Overall Study||0
1454390|NCT02096731|3559872|P1|NOT COMPLETED|Overall Study||0
1454391|NCT02096731|3559871|P2|COMPLETED|Overall Study||88955
1454392|NCT02096731|3559872|P1|COMPLETED|Overall Study||26442
1454393|NCT02096731|3559871|P2|STARTED|Overall Study||88955
1454394|NCT02096731|3559872|P1|STARTED|Overall Study||26442
1454395|NCT02096718|3559889|P3|NOT COMPLETED|Overall Study||0
1454396|NCT02096718|3559890|P2|NOT COMPLETED|Overall Study||0
1454397|NCT02096718|3559891|P1|NOT COMPLETED|Overall Study||0
1454398|NCT02096718|3559889|P3|COMPLETED|Overall Study||14
1454399|NCT02096718|3559890|P2|COMPLETED|Overall Study||8
1454400|NCT02096718|3559891|P1|COMPLETED|Overall Study||8
1454401|NCT02096718|3559889|P3|STARTED|Overall Study||14
1454402|NCT02096718|3559890|P2|STARTED|Overall Study||8
1454403|NCT02096718|3559891|P1|STARTED|Overall Study||8
1454404|NCT02096705|3559910|P2|NOT COMPLETED|Follow-up||4
1454405|NCT02096705|3559911|P1|NOT COMPLETED|Follow-up||4
1454406|NCT02096705|3559910|P2|COMPLETED|Follow-up||135
1454407|NCT02096705|3559911|P1|COMPLETED|Follow-up||125
1454408|NCT02096705|3559910|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
1454409|NCT02096705|3559911|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
1454410|NCT02096705|3559910|P2|NOT COMPLETED|Treatment||5
1454411|NCT02096705|3559911|P1|NOT COMPLETED|Treatment||9
1454412|NCT02096705|3559910|P2|COMPLETED|Treatment||134
1454413|NCT02096705|3559911|P1|COMPLETED|Treatment||124
1454414|NCT02096705|3559910|P2|STARTED|Treatment||139
1454415|NCT02096705|3559911|P1|STARTED|Treatment||133
1454416|NCT02096692|3559923|P1|NOT COMPLETED|Overall Study||4
1454417|NCT02096692|3559923|P1|COMPLETED|Overall Study||150
1454418|NCT02096692|3559923|P1|STARTED|Overall Study||154
1454419|NCT02096679|3559929|P1|NOT COMPLETED|Overall Study||0
1454420|NCT02096679|3559929|P1|COMPLETED|Overall Study||8
1454421|NCT02096679|3559929|P1|STARTED|Overall Study||8
1454422|NCT02096575|3559954|P3|NOT COMPLETED|Overall Study||5
1454423|NCT02096575|3559955|P2|NOT COMPLETED|Overall Study||0
1454424|NCT02096575|3559956|P1|NOT COMPLETED|Overall Study||0
1454425|NCT02096575|3559954|P3|COMPLETED|Overall Study||0
1454426|NCT02096575|3559955|P2|COMPLETED|Overall Study||67
1454427|NCT02096575|3559956|P1|COMPLETED|Overall Study||68
1454428|NCT02096575|3559954|P3|STARTED|Overall Study||5
1454429|NCT02096575|3559955|P2|STARTED|Overall Study||67
1454430|NCT02096575|3559956|P1|STARTED|Overall Study||68
1454431|NCT02096458|3559970|P1|NOT COMPLETED|Overall Study||0
1454432|NCT02096458|3559970|P1|COMPLETED|Overall Study||8
1454433|NCT02096458|3559970|P1|STARTED|Overall Study||8
1454434|NCT02096263|3559977|P3|NOT COMPLETED|Overall Study||39
1454435|NCT02096263|3559978|P2|NOT COMPLETED|Overall Study||36
1454436|NCT02096263|3559979|P1|NOT COMPLETED|Overall Study||34
1454437|NCT02096263|3559977|P3|COMPLETED|Overall Study||157
1454438|NCT02096263|3559978|P2|COMPLETED|Overall Study||158
1454439|NCT02096263|3559979|P1|COMPLETED|Overall Study||161
1454440|NCT02096263|3559977|P3|STARTED|Overall Study||196
1454441|NCT02096263|3559978|P2|STARTED|Overall Study||194
1454442|NCT02096263|3559979|P1|STARTED|Overall Study||195
1454443|NCT02096107|3560115|P2|NOT COMPLETED|Overall Study||0
1454444|NCT02096107|3560116|P1|NOT COMPLETED|Overall Study||0
1454445|NCT02096107|3560115|P2|COMPLETED|Overall Study||30
1454446|NCT02096107|3560116|P1|COMPLETED|Overall Study||30
1454447|NCT02096107|3560115|P2|STARTED|Overall Study||30
1454448|NCT02096107|3560116|P1|STARTED|Overall Study||30
1454449|NCT02096081|3560134|P2|NOT COMPLETED|Overall Study||4
1454450|NCT02096081|3560135|P1|NOT COMPLETED|Overall Study||3
1454451|NCT02096081|3560134|P2|COMPLETED|Overall Study||124
1454452|NCT02096081|3560135|P1|COMPLETED|Overall Study||119
1454453|NCT02096081|3560134|P2|STARTED|Overall Study||128
1454454|NCT02096081|3560135|P1|STARTED|Overall Study||122
1454455|NCT02096042|3560167|P3|NOT COMPLETED|Overall Study||0
1454456|NCT02096042|3560168|P2|NOT COMPLETED|Overall Study||0
1454457|NCT02096042|3560169|P1|NOT COMPLETED|Overall Study||1
1454458|NCT02096042|3560167|P3|COMPLETED|Overall Study||0
1454459|NCT02096042|3560168|P2|COMPLETED|Overall Study||0
1454460|NCT02096042|3560169|P1|COMPLETED|Overall Study||0
1454461|NCT02096042|3560167|P3|STARTED|Overall Study||0
1454462|NCT02096042|3560168|P2|STARTED|Overall Study||0
1454463|NCT02096042|3560169|P1|STARTED|Overall Study||1
1454464|NCT02095951|3560178|P2|NOT COMPLETED|Overall Study||6
1454465|NCT02095951|3560179|P1|NOT COMPLETED|Overall Study||9
1454466|NCT02095951|3560178|P2|COMPLETED|Overall Study||8
1454467|NCT02095951|3560179|P1|COMPLETED|Overall Study||4
1454468|NCT02095951|3560178|P2|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
1454469|NCT02095951|3560179|P1|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
1454470|NCT02095873|3560199|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
1454471|NCT02095873|3560200|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
1454472|NCT02095873|3560199|P2|COMPLETED|Second Intervention (8 Weeks)||16
1454473|NCT02095873|3560200|P1|COMPLETED|Second Intervention (8 Weeks)||13
1454474|NCT02095873|3560199|P2|STARTED|Second Intervention (8 Weeks)||16
1454475|NCT02095873|3560200|P1|STARTED|Second Intervention (8 Weeks)||15
1454476|NCT02095873|3560199|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
1454477|NCT02095873|3560200|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
1454478|NCT02095873|3560199|P2|COMPLETED|First Intervention (8 Weeks)||16
1454479|NCT02095873|3560200|P1|COMPLETED|First Intervention (8 Weeks)||15
1454480|NCT02095873|3560199|P2|STARTED|First Intervention (8 Weeks)||16
1454481|NCT02095873|3560200|P1|STARTED|First Intervention (8 Weeks)||16
1454482|NCT02095691|3560212|P1|NOT COMPLETED|Overall Study||1
1454483|NCT02095691|3560212|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
1454484|NCT02095691|3560212|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
1454485|NCT02095561|3560231|P2|NOT COMPLETED|Overall Study||0
1454486|NCT02095561|3560232|P1|NOT COMPLETED|Overall Study||0
1454487|NCT02095561|3560231|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
1454488|NCT02095561|3560232|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
1454489|NCT02095561|3560231|P2|HPV Tested at Health Centers|Overall Study||599
1454490|NCT02095561|3560232|P1|HPV Tested at Health Centers|Overall Study||99
1454491|NCT02095561|3560231|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
1454492|NCT02095561|3560232|P1|HPV Self-tested Women|Overall Study||2519
1454493|NCT02095561|3560231|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
1454494|NCT02095561|3560232|P1|Self-testing Acceptability|Overall Study||2616
1454495|NCT02095561|3560231|P2|STARTED|Overall Study||2964
1454496|NCT02095561|3560232|P1|STARTED|Overall Study||3049
1454497|NCT02095535|3560244|P1|NOT COMPLETED|Analysis||0
1454498|NCT02095535|3560244|P1|COMPLETED|Analysis||18
1454499|NCT02095535|3560244|P1|STARTED|Analysis||18
1454500|NCT02095535|3560244|P1|NOT COMPLETED|Recruitment||2
1454501|NCT02095535|3560244|P1|COMPLETED|Recruitment||18
1454502|NCT02095535|3560244|P1|STARTED|Recruitment||20
1454503|NCT02095223|3560250|P2|NOT COMPLETED|Overall Study||0
1454504|NCT02095223|3560251|P1|NOT COMPLETED|Overall Study||1
1454505|NCT02095223|3560250|P2|COMPLETED|Overall Study||2
1454506|NCT02095223|3560251|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
1454507|NCT02095223|3560250|P2|STARTED|Overall Study||2
1454508|NCT02095223|3560251|P1|STARTED|Overall Study||2
1454509|NCT02095197|3560261|P2|NOT COMPLETED|Overall Study||3
1454510|NCT02095197|3560262|P1|NOT COMPLETED|Overall Study||0
1454511|NCT02095197|3560261|P2|COMPLETED|Overall Study||36
1454512|NCT02095197|3560262|P1|COMPLETED|Overall Study||40
1454513|NCT02095197|3560261|P2|STARTED|Overall Study||39
1454514|NCT02095197|3560262|P1|STARTED|Overall Study||40
1454515|NCT02095158|3560274|P1|NOT COMPLETED|Overall Study||75
1454516|NCT02095158|3560274|P1|COMPLETED|Overall Study||365
1454517|NCT02095158|3560274|P1|STARTED|Overall Study||440
1454518|NCT02095106|3560281|P2|NOT COMPLETED|Second Intervention (14 Days)||1
1454519|NCT02095106|3560282|P1|NOT COMPLETED|Second Intervention (14 Days)||0
1454520|NCT02095106|3560281|P2|COMPLETED|Second Intervention (14 Days)||12
1454521|NCT02095106|3560282|P1|COMPLETED|Second Intervention (14 Days)||14
1454522|NCT02095106|3560281|P2|STARTED|Second Intervention (14 Days)||13
1454523|NCT02095106|3560282|P1|STARTED|Second Intervention (14 Days)||14
1454524|NCT02095106|3560281|P2|NOT COMPLETED|First Intervention (14 Days)||0
1454525|NCT02095106|3560282|P1|NOT COMPLETED|First Intervention (14 Days)||0
1454526|NCT02095106|3560281|P2|COMPLETED|First Intervention (14 Days)||13
1454527|NCT02095106|3560282|P1|COMPLETED|First Intervention (14 Days)||14
1454528|NCT02095106|3560281|P2|STARTED|First Intervention (14 Days)||13
1454529|NCT02095106|3560282|P1|STARTED|First Intervention (14 Days)||14
1454530|NCT02094937|3560298|P4|NOT COMPLETED|12 Weeks in Period 2||12
1454531|NCT02094937|3560299|P3|NOT COMPLETED|12 Weeks in Period 2||12
1454532|NCT02094937|3560300|P2|NOT COMPLETED|12 Weeks in Period 2||11
1454533|NCT02094937|3560301|P1|NOT COMPLETED|12 Weeks in Period 2||0
1454534|NCT02094937|3560298|P4|COMPLETED|12 Weeks in Period 2||112
1454535|NCT02094937|3560299|P3|COMPLETED|12 Weeks in Period 2||112
1454536|NCT02094937|3560300|P2|COMPLETED|12 Weeks in Period 2||112
1454537|NCT02094937|3560301|P1|COMPLETED|12 Weeks in Period 2||0
1454538|NCT02094937|3560298|P4|STARTED|12 Weeks in Period 2||124
1454539|NCT02094937|3560299|P3|STARTED|12 Weeks in Period 2||124
1454540|NCT02094937|3560300|P2|STARTED|12 Weeks in Period 2||123
1454541|NCT02094937|3560301|P1|STARTED|12 Weeks in Period 2||0
1454542|NCT02094937|3560298|P4|NOT COMPLETED|8 Weeks in Period 1||0
1454543|NCT02094937|3560299|P3|NOT COMPLETED|8 Weeks in Period 1||0
1454544|NCT02094937|3560300|P2|NOT COMPLETED|8 Weeks in Period 1||0
1454545|NCT02094937|3560301|P1|NOT COMPLETED|8 Weeks in Period 1||60
1454546|NCT02094937|3560298|P4|COMPLETED|8 Weeks in Period 1||0
1454547|NCT02094937|3560299|P3|COMPLETED|8 Weeks in Period 1||0
1454548|NCT02094937|3560300|P2|COMPLETED|8 Weeks in Period 1||0
1454549|NCT02094937|3560301|P1|COMPLETED|8 Weeks in Period 1||370
1454550|NCT02094937|3560298|P4|STARTED|8 Weeks in Period 1||0
1454551|NCT02094937|3560299|P3|STARTED|8 Weeks in Period 1||0
1454552|NCT02094937|3560300|P2|STARTED|8 Weeks in Period 1||0
1454553|NCT02094937|3560301|P1|STARTED|8 Weeks in Period 1||430
1454554|NCT02094898|3560331|P1|NOT COMPLETED|Overall Study||5
1454555|NCT02094898|3560331|P1|COMPLETED|Overall Study||7
1454556|NCT02094898|3560331|P1|STARTED|Overall Study||12
1454557|NCT02094885|3560378|P2|NOT COMPLETED|Overall Study||5
1454558|NCT02094885|3560379|P1|NOT COMPLETED|Overall Study||2
1454559|NCT02094885|3560378|P2|COMPLETED|Overall Study||122
1454560|NCT02094885|3560379|P1|COMPLETED|Overall Study||123
1454561|NCT02094885|3560378|P2|STARTED|Overall Study||127
1454562|NCT02094885|3560379|P1|STARTED|Overall Study||125
1454563|NCT02094677|3560393|P2|NOT COMPLETED|Overall Study||1
1454564|NCT02094677|3560394|P1|NOT COMPLETED|Overall Study||3
1454565|NCT02094677|3560393|P2|COMPLETED|Overall Study||30
1454566|NCT02094677|3560394|P1|COMPLETED|Overall Study||40
1454567|NCT02094677|3560393|P2|STARTED|Overall Study||31
1454568|NCT02094677|3560394|P1|STARTED|Overall Study||43
1454569|NCT02094664|3560458|P2|NOT COMPLETED|Overall Study||0
1454570|NCT02094664|3560459|P1|NOT COMPLETED|Overall Study||0
1454571|NCT02094664|3560458|P2|COMPLETED|Overall Study||16
1454572|NCT02094664|3560459|P1|COMPLETED|Overall Study||16
1454573|NCT02094664|3560458|P2|STARTED|Overall Study||16
1454574|NCT02094664|3560459|P1|STARTED|Overall Study||16
1454575|NCT02094612|3560473|P2|NOT COMPLETED|Overall Study||70
1454576|NCT02094612|3560474|P1|NOT COMPLETED|Overall Study||79
1454577|NCT02094612|3560473|P2|COMPLETED|Overall Study||25
1454578|NCT02094612|3560474|P1|COMPLETED|Overall Study||33
1454579|NCT02094612|3560473|P2|6 Month Follow up|Overall Study||25
1454580|NCT02094612|3560474|P1|6 Month Follow up|Overall Study||33
1454581|NCT02094612|3560473|P2|3 Month Follow up|Overall Study||43
1454582|NCT02094612|3560474|P1|3 Month Follow up|Overall Study||50
1454583|NCT02094612|3560473|P2|1 Month Follow up|Overall Study||50
1454584|NCT02094612|3560474|P1|1 Month Follow up|Overall Study||67
1454585|NCT02094612|3560473|P2|STARTED|Overall Study||95
1454586|NCT02094612|3560474|P1|STARTED|Overall Study||112
1454587|NCT02094573|3560494|P2|NOT COMPLETED|Overall Study||110
1454588|NCT02094573|3560495|P1|NOT COMPLETED|Overall Study||112
1454589|NCT02094573|3560494|P2|COMPLETED|Overall Study||0
1454590|NCT02094573|3560495|P1|COMPLETED|Overall Study||0
1454591|NCT02094573|3560494|P2|Treated|Overall Study||110
1454592|NCT02094573|3560495|P1|Treated|Overall Study||109
1454593|NCT02094573|3560494|P2|STARTED|Overall Study||110
1454594|NCT02094573|3560495|P1|STARTED|Overall Study||112
1454595|NCT02094534|3560529|P2|NOT COMPLETED|Overall Study||0
1454596|NCT02094534|3560530|P1|NOT COMPLETED|Overall Study||0
1454597|NCT02094534|3560529|P2|COMPLETED|Overall Study||10
1454598|NCT02094534|3560530|P1|COMPLETED|Overall Study||15
1454599|NCT02094534|3560529|P2|STARTED|Overall Study||10
1454600|NCT02094534|3560530|P1|STARTED|Overall Study||15
1454601|NCT02094443|3560540|P2|NOT COMPLETED|Overall Study||17
1454602|NCT02094443|3560541|P1|NOT COMPLETED|Overall Study||15
1454603|NCT02094443|3560540|P2|COMPLETED|Overall Study||9
1454604|NCT02094443|3560541|P1|COMPLETED|Overall Study||11
1454605|NCT02094443|3560540|P2|Completed at Week 24|Overall Study||8
1454606|NCT02094443|3560541|P1|Completed at Week 24|Overall Study||11
1454607|NCT02094443|3560540|P2|Completed at Week 12|Overall Study||1
1454608|NCT02094443|3560541|P1|Completed at Week 12|Overall Study||0
1454609|NCT02094443|3560540|P2|STARTED|Overall Study||26
1454610|NCT02094443|3560541|P1|STARTED|Overall Study||26
1454611|NCT02094352|3560561|P2|NOT COMPLETED|Overall Study||0
1454612|NCT02094352|3560562|P1|NOT COMPLETED|Overall Study||0
1454613|NCT02094352|3560561|P2|COMPLETED|Overall Study||1
1454614|NCT02094352|3560562|P1|COMPLETED|Overall Study||2
1454615|NCT02094352|3560561|P2|STARTED|Overall Study||1
1454616|NCT02094352|3560562|P1|STARTED|Overall Study||2
1454617|NCT02094326|3560568|P1|NOT COMPLETED|Overall Study||0
1454618|NCT02094326|3560568|P1|COMPLETED|Overall Study||301
1454619|NCT02094326|3560568|P1|STARTED|Overall Study||301
1454620|NCT02094300|3560577|P1|NOT COMPLETED|Overall Study||20
1454621|NCT02094300|3560577|P1|COMPLETED|Overall Study||6
1454622|NCT02094300|3560577|P1|30 Days|Overall Study||24
1454623|NCT02094300|3560577|P1|STARTED|Overall Study||26
1454624|NCT02094261|3560581|P1|NOT COMPLETED|Overall Study||210
1454625|NCT02094261|3560581|P1|COMPLETED|Overall Study||0
1454626|NCT02094261|3560581|P1|STARTED|Overall Study||210
1454627|NCT02093962|3560590|P2|NOT COMPLETED|Overall Study||131
1454628|NCT02093962|3560591|P1|NOT COMPLETED|Overall Study||134
1454629|NCT02093962|3560590|P2|COMPLETED|Overall Study||0
1454630|NCT02093962|3560591|P1|COMPLETED|Overall Study||0
1454631|NCT02093962|3560590|P2|Received Treatment|Overall Study||130
1454632|NCT02093962|3560591|P1|Received Treatment|Overall Study||130
1454633|NCT02093962|3560590|P2|STARTED|Overall Study||131
1454634|NCT02093962|3560591|P1|STARTED|Overall Study||134
1454635|NCT02093949|3560599|P2|NOT COMPLETED|Overall Study||0
1454636|NCT02093949|3560600|P1|NOT COMPLETED|Overall Study||0
1454637|NCT02093949|3560599|P2|COMPLETED|Overall Study||47
1454638|NCT02093949|3560600|P1|COMPLETED|Overall Study||105
1454639|NCT02093949|3560599|P2|STARTED|Overall Study||47
1454640|NCT02093949|3560600|P1|STARTED|Overall Study||105
1454641|NCT02093923|3560623|P5|NOT COMPLETED|Overall Study||0
1454642|NCT02093923|3560624|P4|NOT COMPLETED|Overall Study||2
1454643|NCT02093923|3560625|P3|NOT COMPLETED|Overall Study||0
1454644|NCT02093923|3560626|P2|NOT COMPLETED|Overall Study||0
1454645|NCT02093923|3560627|P1|NOT COMPLETED|Overall Study||0
1454646|NCT02093923|3560623|P5|COMPLETED|Overall Study||13
1454647|NCT02093923|3560624|P4|COMPLETED|Overall Study||10
1454648|NCT02093923|3560625|P3|COMPLETED|Overall Study||5
1454649|NCT02093923|3560626|P2|COMPLETED|Overall Study||4
1454650|NCT02093923|3560627|P1|COMPLETED|Overall Study||4
1454651|NCT02093923|3560623|P5|Treated - 2 Doses:|Overall Study||13
1454652|NCT02093923|3560624|P4|Treated - 2 Doses:|Overall Study||10
1454653|NCT02093923|3560625|P3|Treated - 2 Doses:|Overall Study||5
1454654|NCT02093923|3560626|P2|Treated - 2 Doses:|Overall Study||4
1454655|NCT02093923|3560627|P1|Treated - 2 Doses:|Overall Study||4
1454656|NCT02093923|3560623|P5|Treated - 1 Dose Only:|Overall Study||0
1454657|NCT02093923|3560624|P4|Treated - 1 Dose Only:|Overall Study||1
1454658|NCT02093923|3560625|P3|Treated - 1 Dose Only:|Overall Study||0
1454659|NCT02093923|3560626|P2|Treated - 1 Dose Only:|Overall Study||0
1454660|NCT02093923|3560627|P1|Treated - 1 Dose Only:|Overall Study||0
1454661|NCT02093923|3560623|P5|Total Treated|Overall Study||13
1454662|NCT02093923|3560624|P4|Total Treated|Overall Study||11
1454663|NCT02093923|3560625|P3|Total Treated|Overall Study||5
1454664|NCT02093923|3560626|P2|Total Treated|Overall Study||4
1454665|NCT02093923|3560627|P1|Total Treated|Overall Study||4
1454666|NCT02093923|3560623|P5|STARTED|Overall Study||13
1454667|NCT02093923|3560624|P4|STARTED|Overall Study||12
1454668|NCT02093923|3560625|P3|STARTED|Overall Study||5
1454669|NCT02093923|3560626|P2|STARTED|Overall Study||4
1454670|NCT02093923|3560627|P1|STARTED|Overall Study||4
1454671|NCT02093897|3560682|P1|NOT COMPLETED|Overall Study||19
1454672|NCT02093897|3560682|P1|COMPLETED|Overall Study||65
1454673|NCT02093897|3560682|P1|STARTED|Overall Study||84
1454674|NCT02093819|3560710|P8|NOT COMPLETED|Overall Study||0
1454675|NCT02093819|3560711|P7|NOT COMPLETED|Overall Study||0
1454676|NCT02093819|3560712|P6|NOT COMPLETED|Overall Study||0
1454677|NCT02093819|3560713|P5|NOT COMPLETED|Overall Study||0
1454678|NCT02093819|3560714|P4|NOT COMPLETED|Overall Study||0
1454679|NCT02093819|3560715|P3|NOT COMPLETED|Overall Study||0
1454680|NCT02093819|3560716|P2|NOT COMPLETED|Overall Study||0
1454681|NCT02093819|3560717|P1|NOT COMPLETED|Overall Study||0
1454682|NCT02093819|3560710|P8|COMPLETED|Overall Study||6
1454683|NCT02093819|3560711|P7|COMPLETED|Overall Study||5
1454684|NCT02093819|3560712|P6|COMPLETED|Overall Study||6
1454685|NCT02093819|3560713|P5|COMPLETED|Overall Study||6
1454686|NCT02093819|3560714|P4|COMPLETED|Overall Study||6
1454687|NCT02093819|3560715|P3|COMPLETED|Overall Study||10
1454688|NCT02093819|3560716|P2|COMPLETED|Overall Study||6
1454689|NCT02093819|3560717|P1|COMPLETED|Overall Study||15
1454690|NCT02093819|3560710|P8|STARTED|Overall Study||6
1454691|NCT02093819|3560711|P7|STARTED|Overall Study||5
1454692|NCT02093819|3560712|P6|STARTED|Overall Study||6
1454693|NCT02093819|3560713|P5|STARTED|Overall Study||6
1454694|NCT02093819|3560714|P4|STARTED|Overall Study||6
1454695|NCT02093819|3560715|P3|STARTED|Overall Study||10
1454696|NCT02093819|3560716|P2|STARTED|Overall Study||6
1454697|NCT02093819|3560717|P1|STARTED|Overall Study||15
1454698|NCT02093702|3560753|P2|NOT COMPLETED|Overall Study||0
1454699|NCT02093702|3560754|P1|NOT COMPLETED|Overall Study||0
1454700|NCT02093702|3560753|P2|COMPLETED|Overall Study||3
1454701|NCT02093702|3560754|P1|COMPLETED|Overall Study||2
1454702|NCT02093702|3560753|P2|STARTED|Overall Study||3
1454703|NCT02093702|3560754|P1|STARTED|Overall Study||2
1454704|NCT02093689|3560785|P3|NOT COMPLETED|Overall Study||0
1454705|NCT02093689|3560786|P2|NOT COMPLETED|Overall Study||0
1454706|NCT02093689|3560787|P1|NOT COMPLETED|Overall Study||4
1454707|NCT02093689|3560785|P3|COMPLETED|Overall Study||0
1454708|NCT02093689|3560786|P2|COMPLETED|Overall Study||0
1454709|NCT02093689|3560787|P1|COMPLETED|Overall Study||14
1454710|NCT02093689|3560785|P3|STARTED|Overall Study||0
1454711|NCT02093689|3560786|P2|STARTED|Overall Study||0
1454712|NCT02093689|3560787|P1|STARTED|Overall Study||18
1454713|NCT02093520|3560795|P2|NOT COMPLETED|Overall Study||22
1454714|NCT02093520|3560796|P1|NOT COMPLETED|Overall Study||6
1454715|NCT02093520|3560795|P2|COMPLETED|Overall Study||131
1454716|NCT02093520|3560796|P1|COMPLETED|Overall Study||143
1454717|NCT02093520|3560795|P2|STARTED|Overall Study||153
1454718|NCT02093520|3560796|P1|STARTED|Overall Study||149
1454719|NCT02093390|3560808|P2|NOT COMPLETED|Overall Study||1
1454720|NCT02093390|3560809|P1|NOT COMPLETED|Overall Study||0
1454721|NCT02093390|3560808|P2|COMPLETED|Overall Study||19
1454722|NCT02093390|3560809|P1|COMPLETED|Overall Study||20
1454723|NCT02093390|3560808|P2|STARTED|Overall Study||20
1454724|NCT02093390|3560809|P1|STARTED|Overall Study||20
1454725|NCT02093351|3560848|P3|NOT COMPLETED|Overall Study||3
1454726|NCT02093351|3560849|P2|NOT COMPLETED|Overall Study||2
1454727|NCT02093351|3560850|P1|NOT COMPLETED|Overall Study||2
1454728|NCT02093351|3560848|P3|COMPLETED|Overall Study||23
1454729|NCT02093351|3560849|P2|COMPLETED|Overall Study||21
1454730|NCT02093351|3560850|P1|COMPLETED|Overall Study||28
1454731|NCT02093351|3560848|P3|Completing Treatment Period 3|Overall Study||23
1454732|NCT02093351|3560849|P2|Completing Treatment Period 3|Overall Study||21
1454733|NCT02093351|3560850|P1|Completing Treatment Period 3|Overall Study||28
1454734|NCT02093351|3560848|P3|Completing Treatment Period 2|Overall Study||23
1454735|NCT02093351|3560849|P2|Completing Treatment Period 2|Overall Study||21
1454736|NCT02093351|3560850|P1|Completing Treatment Period 2|Overall Study||29
1454737|NCT02093351|3560848|P3|Completing Treatment Period 1|Overall Study||23
1454738|NCT02093351|3560849|P2|Completing Treatment Period 1|Overall Study||22
1454739|NCT02093351|3560850|P1|Completing Treatment Period 1|Overall Study||29
1454740|NCT02093351|3560848|P3|STARTED|Overall Study||26
1454741|NCT02093351|3560849|P2|STARTED|Overall Study||23
1454742|NCT02093351|3560850|P1|STARTED|Overall Study||30
1454743|NCT02093234|3560882|P3|NOT COMPLETED|Overall Study||4
1454744|NCT02093234|3560883|P2|NOT COMPLETED|Overall Study||4
1454745|NCT02093234|3560884|P1|NOT COMPLETED|Overall Study||3
1454746|NCT02093234|3560882|P3|COMPLETED|Overall Study||50
1454747|NCT02093234|3560883|P2|COMPLETED|Overall Study||52
1454748|NCT02093234|3560884|P1|COMPLETED|Overall Study||53
1454749|NCT02093234|3560882|P3|STARTED|Overall Study||54
1454750|NCT02093234|3560883|P2|STARTED|Overall Study||56
1454751|NCT02093234|3560884|P1|STARTED|Overall Study||56
1454752|NCT02093221|3560906|P5|NOT COMPLETED|Overall Study||8
1454753|NCT02093221|3560907|P4|NOT COMPLETED|Overall Study||8
1454754|NCT02093221|3560908|P3|NOT COMPLETED|Overall Study||9
1454755|NCT02093221|3560909|P2|NOT COMPLETED|Overall Study||8
1454756|NCT02093221|3560910|P1|NOT COMPLETED|Overall Study||10
1454757|NCT02093221|3560906|P5|COMPLETED|Overall Study||7
1454758|NCT02093221|3560907|P4|COMPLETED|Overall Study||7
1454759|NCT02093221|3560908|P3|COMPLETED|Overall Study||6
1454760|NCT02093221|3560909|P2|COMPLETED|Overall Study||8
1454761|NCT02093221|3560910|P1|COMPLETED|Overall Study||5
1454762|NCT02093221|3560906|P5|STARTED|Overall Study||15
1454763|NCT02093221|3560907|P4|STARTED|Overall Study||15
1454764|NCT02093221|3560908|P3|STARTED|Overall Study||15
1454765|NCT02093221|3560909|P2|STARTED|Overall Study||16
1454766|NCT02093221|3560910|P1|STARTED|Overall Study||15
1454767|NCT02093026|3560947|P1|NOT COMPLETED|Overall Study||193
1454768|NCT02093026|3560947|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
1454769|NCT02093026|3560947|P1|STARTED|Overall Study||465
1454770|NCT02092961|3560969|P3|NOT COMPLETED|Overall Study||16
1454771|NCT02092961|3560970|P2|NOT COMPLETED|Overall Study||14
1454772|NCT02092961|3560971|P1|NOT COMPLETED|Overall Study||21
1454773|NCT02092961|3560969|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
1454774|NCT02092961|3560970|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
1454775|NCT02092961|3560971|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
1454776|NCT02092961|3560969|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
1454777|NCT02092961|3560970|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
1454778|NCT02092961|3560971|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
1454779|NCT02092961|3560969|P3|STARTED|Overall Study|Patients who received treatment|29
1454780|NCT02092961|3560970|P2|STARTED|Overall Study|Patients who received treatment|28
1454781|NCT02092961|3560971|P1|STARTED|Overall Study|Patients who received treatment|33
1454782|NCT02092857|3560995|P3|NOT COMPLETED|Overall Study||13
1454783|NCT02092857|3560996|P2|NOT COMPLETED|Overall Study||12
1454784|NCT02092857|3560997|P1|NOT COMPLETED|Overall Study||10
1454785|NCT02092857|3560995|P3|COMPLETED|Overall Study||16
1454786|NCT02092857|3560996|P2|COMPLETED|Overall Study||18
1454787|NCT02092857|3560997|P1|COMPLETED|Overall Study||20
1454788|NCT02092857|3560995|P3|STARTED|Overall Study||29
1454789|NCT02092857|3560996|P2|STARTED|Overall Study||30
1454790|NCT02092857|3560997|P1|STARTED|Overall Study||30
1454791|NCT02092662|3561007|P2|NOT COMPLETED|Overall Study||0
1454792|NCT02092662|3561008|P1|NOT COMPLETED|Overall Study||13
1454793|NCT02092662|3561007|P2|COMPLETED|Overall Study||19
1454794|NCT02092662|3561008|P1|COMPLETED|Overall Study||25
1454795|NCT02092662|3561007|P2|Recruited|Overall Study||19
1454796|NCT02092662|3561008|P1|Recruited|Overall Study||38
1454797|NCT02092662|3561007|P2|STARTED|Overall Study||19
1454798|NCT02092662|3561008|P1|STARTED|Overall Study||38
1454799|NCT02092649|3561017|P2|NOT COMPLETED|Overall Study||0
1454800|NCT02092649|3561018|P1|NOT COMPLETED|Overall Study||0
1454801|NCT02092649|3561017|P2|COMPLETED|Overall Study|13 participants finished study|13
1454802|NCT02092649|3561018|P1|COMPLETED|Overall Study|13 participants finished study|13
1454803|NCT02092649|3561017|P2|STARTED|Overall Study|13 participants recruited|13
1454804|NCT02092649|3561018|P1|STARTED|Overall Study|13 participants recruited|13
1454805|NCT02092610|3561036|P2|NOT COMPLETED|Overall Study||12
1454806|NCT02092610|3561037|P1|NOT COMPLETED|Overall Study||8
1454807|NCT02092610|3561036|P2|COMPLETED|Overall Study||40
1454808|NCT02092610|3561037|P1|COMPLETED|Overall Study||17
1454809|NCT02092610|3561036|P2|STARTED|Overall Study||52
1454810|NCT02092610|3561037|P1|STARTED|Overall Study||25
1454811|NCT02092441|3561051|P2|NOT COMPLETED|Overall Study||0
1454812|NCT02092441|3561052|P1|NOT COMPLETED|Overall Study||0
1454813|NCT02092441|3561051|P2|COMPLETED|Overall Study||43
1454814|NCT02092441|3561052|P1|COMPLETED|Overall Study||37
1454815|NCT02092441|3561051|P2|STARTED|Overall Study||43
1454816|NCT02092441|3561052|P1|STARTED|Overall Study||37
1454817|NCT02092415|3561062|P1|NOT COMPLETED|Overall Study||0
1454818|NCT02092415|3561062|P1|COMPLETED|Overall Study||10
1454819|NCT02092415|3561062|P1|STARTED|Overall Study||10
1454820|NCT02092389|3561067|P1|NOT COMPLETED|Overall Study||6
1454821|NCT02092389|3561067|P1|COMPLETED|Overall Study||4
1454822|NCT02092389|3561067|P1|STARTED|Overall Study||10
1454823|NCT02092350|3561079|P2|NOT COMPLETED|Overall Study||12
1454824|NCT02092350|3561080|P1|NOT COMPLETED|Overall Study||10
1454825|NCT02092350|3561079|P2|COMPLETED|Overall Study||102
1454826|NCT02092350|3561080|P1|COMPLETED|Overall Study||113
1454827|NCT02092350|3561079|P2|STARTED|Overall Study||114
1454828|NCT02092350|3561080|P1|STARTED|Overall Study||123
1454829|NCT02092311|3561097|P2|NOT COMPLETED|Overall Study||0
1454830|NCT02092311|3561098|P1|NOT COMPLETED|Overall Study||0
1454831|NCT02092311|3561097|P2|COMPLETED|Overall Study||285
1454832|NCT02092311|3561098|P1|COMPLETED|Overall Study||285
1454833|NCT02092311|3561097|P2|STARTED|Overall Study||285
1454834|NCT02092311|3561098|P1|STARTED|Overall Study||285
1454835|NCT02092285|3561108|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
1454836|NCT02092285|3561108|P1|COMPLETED|Maintenance Phase & Follow-up||60
1454837|NCT02092285|3561108|P1|STARTED|Maintenance Phase & Follow-up||170
1454838|NCT02092285|3561108|P1|NOT COMPLETED|Induction Phase||35
1454839|NCT02092285|3561108|P1|COMPLETED|Induction Phase||170
1454840|NCT02092285|3561108|P1|STARTED|Induction Phase||205
1454841|NCT02092220|3561112|P2|NOT COMPLETED|Period 2||1
1454842|NCT02092220|3561113|P1|NOT COMPLETED|Period 2||1
1454843|NCT02092220|3561112|P2|COMPLETED|Period 2||19
1454844|NCT02092220|3561113|P1|COMPLETED|Period 2||20
1454845|NCT02092220|3561112|P2|STARTED|Period 2||20
1454846|NCT02092220|3561113|P1|STARTED|Period 2||21
1454847|NCT02092220|3561112|P2|NOT COMPLETED|Period 1||2
1454848|NCT02092220|3561113|P1|NOT COMPLETED|Period 1||0
1454849|NCT02092220|3561112|P2|COMPLETED|Period 1||20
1454850|NCT02092220|3561113|P1|COMPLETED|Period 1||21
1454851|NCT02092220|3561112|P2|STARTED|Period 1||22
1454852|NCT02092220|3561113|P1|STARTED|Period 1||21
1454853|NCT02092168|3561173|P2|NOT COMPLETED|Overall Study||0
1454854|NCT02092168|3561174|P1|NOT COMPLETED|Overall Study||0
1454855|NCT02092168|3561173|P2|COMPLETED|Overall Study||12
1454856|NCT02092168|3561174|P1|COMPLETED|Overall Study||12
1454857|NCT02092168|3561173|P2|STARTED|Overall Study||12
1454858|NCT02092168|3561174|P1|STARTED|Overall Study||12
1454859|NCT02092116|3561186|P2|NOT COMPLETED|Overall Study||4
1454860|NCT02092116|3561187|P1|NOT COMPLETED|Overall Study||0
1454861|NCT02092116|3561186|P2|COMPLETED|Overall Study||16
1454862|NCT02092116|3561187|P1|COMPLETED|Overall Study||6
1454863|NCT02092116|3561186|P2|STARTED|Overall Study||20
1454864|NCT02092116|3561187|P1|STARTED|Overall Study||6
1454865|NCT02091986|3561199|P3|NOT COMPLETED|Overall Study||8
1454866|NCT02091986|3561200|P2|NOT COMPLETED|Overall Study||11
1454867|NCT02091986|3561201|P1|NOT COMPLETED|Overall Study||7
1454868|NCT02091986|3561199|P3|COMPLETED|Overall Study||84
1454869|NCT02091986|3561200|P2|COMPLETED|Overall Study||84
1454870|NCT02091986|3561201|P1|COMPLETED|Overall Study||85
1454871|NCT02091986|3561199|P3|STARTED|Overall Study||92
1454872|NCT02091986|3561200|P2|STARTED|Overall Study||95
1454873|NCT02091986|3561201|P1|STARTED|Overall Study||92
1454874|NCT02091960|3561248|P1|NOT COMPLETED|Overall Study||51
1454875|NCT02091960|3561248|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
1454876|NCT02091960|3561248|P1|Received Treatment|Overall Study||103
1454877|NCT02091960|3561248|P1|STARTED|Overall Study||103
1454878|NCT02091869|3561261|P2|NOT COMPLETED|Overall Study||3
1454879|NCT02091869|3561262|P1|NOT COMPLETED|Overall Study||0
1454880|NCT02091869|3561261|P2|COMPLETED|Overall Study||14
1454881|NCT02091869|3561262|P1|COMPLETED|Overall Study||17
1454882|NCT02091869|3561261|P2|STARTED|Overall Study||17
1454883|NCT02091869|3561262|P1|STARTED|Overall Study||17
1454884|NCT02091856|3561277|P3|NOT COMPLETED|Follow-up Assessment||0
1454885|NCT02091856|3561278|P2|NOT COMPLETED|Follow-up Assessment||3
1454886|NCT02091856|3561279|P1|NOT COMPLETED|Follow-up Assessment||5
1454887|NCT02091856|3561277|P3|COMPLETED|Follow-up Assessment||0
1454888|NCT02091856|3561278|P2|COMPLETED|Follow-up Assessment||9
1454889|NCT02091856|3561279|P1|COMPLETED|Follow-up Assessment||10
1454890|NCT02091856|3561277|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
1454891|NCT02091856|3561278|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
1454892|NCT02091856|3561279|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
1454893|NCT02091856|3561277|P3|NOT COMPLETED|Active Intervention Interval||7
1454894|NCT02091856|3561278|P2|NOT COMPLETED|Active Intervention Interval||7
1454895|NCT02091856|3561279|P1|NOT COMPLETED|Active Intervention Interval||19
1454896|NCT02091856|3561277|P3|COMPLETED|Active Intervention Interval||19
1454897|NCT02091856|3561278|P2|COMPLETED|Active Intervention Interval||12
1454898|NCT02091856|3561279|P1|COMPLETED|Active Intervention Interval||15
1454899|NCT02091856|3561277|P3|STARTED|Active Intervention Interval||26
1454900|NCT02091856|3561278|P2|STARTED|Active Intervention Interval||19
1454901|NCT02091856|3561279|P1|STARTED|Active Intervention Interval||34
1454902|NCT02091778|3561299|P1|NOT COMPLETED|Overall Study||1
1454903|NCT02091778|3561299|P1|COMPLETED|Overall Study||20
1454904|NCT02091778|3561299|P1|STARTED|Overall Study||21
1454905|NCT02091752|3561303|P1|NOT COMPLETED|Overall Study||3
1454906|NCT02091752|3561303|P1|COMPLETED|Overall Study||0
1454907|NCT02091752|3561303|P1|STARTED|Overall Study||3
1454908|NCT02091739|3561317|P5|NOT COMPLETED|EP: 48 Weeks||14
1454909|NCT02091739|3561318|P4|NOT COMPLETED|EP: 48 Weeks||8
1454910|NCT02091739|3561319|P3|NOT COMPLETED|EP: 48 Weeks||0
1454911|NCT02091739|3561320|P2|NOT COMPLETED|EP: 48 Weeks||0
1454912|NCT02091739|3561321|P1|NOT COMPLETED|EP: 48 Weeks||0
1454913|NCT02091739|3561317|P5|COMPLETED|EP: 48 Weeks||75
1454914|NCT02091739|3561318|P4|COMPLETED|EP: 48 Weeks||76
1454915|NCT02091739|3561319|P3|COMPLETED|EP: 48 Weeks||0
1454916|NCT02091739|3561320|P2|COMPLETED|EP: 48 Weeks||0
1454917|NCT02091739|3561321|P1|COMPLETED|EP: 48 Weeks||0
1454918|NCT02091739|3561317|P5|STARTED|EP: 48 Weeks||89
1454919|NCT02091739|3561318|P4|STARTED|EP: 48 Weeks||84
1454920|NCT02091739|3561319|P3|STARTED|EP: 48 Weeks||0
1454921|NCT02091739|3561320|P2|STARTED|EP: 48 Weeks||0
1454922|NCT02091739|3561321|P1|STARTED|EP: 48 Weeks||0
1454923|NCT02091739|3561317|P5|NOT COMPLETED|MP: 16 Weeks||0
1454924|NCT02091739|3561318|P4|NOT COMPLETED|MP: 16 Weeks||0
1454925|NCT02091739|3561319|P3|NOT COMPLETED|MP: 16 Weeks||2
1454926|NCT02091739|3561320|P2|NOT COMPLETED|MP: 16 Weeks||5
1454927|NCT02091739|3561321|P1|NOT COMPLETED|MP: 16 Weeks||4
1454928|NCT02091739|3561317|P5|COMPLETED|MP: 16 Weeks||0
1454929|NCT02091739|3561318|P4|COMPLETED|MP: 16 Weeks||0
1454930|NCT02091739|3561319|P3|COMPLETED|MP: 16 Weeks||72
1454931|NCT02091739|3561320|P2|COMPLETED|MP: 16 Weeks||69
1454932|NCT02091739|3561321|P1|COMPLETED|MP: 16 Weeks||32
1454933|NCT02091739|3561317|P5|STARTED|MP: 16 Weeks||0
1454934|NCT02091739|3561318|P4|STARTED|MP: 16 Weeks||0
1454935|NCT02091739|3561319|P3|STARTED|MP: 16 Weeks||74
1454936|NCT02091739|3561320|P2|STARTED|MP: 16 Weeks||74
1454937|NCT02091739|3561321|P1|STARTED|MP: 16 Weeks||36
1454938|NCT02091726|3561340|P1|NOT COMPLETED|Overall Study||6
1454939|NCT02091726|3561340|P1|COMPLETED|Overall Study||104
1454940|NCT02091726|3561340|P1|4 Week Followup|Overall Study||104
1454941|NCT02091726|3561340|P1|1 Week Followup|Overall Study||110
1454942|NCT02091726|3561340|P1|STARTED|Overall Study||110
1454943|NCT02091466|3561350|P2|NOT COMPLETED|Overall Study||0
1454944|NCT02091466|3561351|P1|NOT COMPLETED|Overall Study||0
1454945|NCT02091466|3561350|P2|COMPLETED|Overall Study||20
1454946|NCT02091466|3561351|P1|COMPLETED|Overall Study||20
1454947|NCT02091466|3561350|P2|STARTED|Overall Study||20
1454948|NCT02091466|3561351|P1|STARTED|Overall Study||20
1454949|NCT02091414|3561357|P1|NOT COMPLETED|Overall Study||4
1454950|NCT02091414|3561357|P1|COMPLETED|Overall Study||32
1454951|NCT02091414|3561357|P1|STARTED|Overall Study||36
1454952|NCT02091375|3561371|P2|NOT COMPLETED|Overall Study||3
1454953|NCT02091375|3561372|P1|NOT COMPLETED|Overall Study||9
1454954|NCT02091375|3561371|P2|COMPLETED|Overall Study||56
1454955|NCT02091375|3561372|P1|COMPLETED|Overall Study||52
1454956|NCT02091375|3561371|P2|Intention to Treat (ITT) Analysis Set|Overall Study||59
1454957|NCT02091375|3561372|P1|Intention to Treat (ITT) Analysis Set|Overall Study||61
1454958|NCT02091375|3561371|P2|Safety Analysis Set|Overall Study||59
1454959|NCT02091375|3561372|P1|Safety Analysis Set|Overall Study||61
1454960|NCT02091375|3561371|P2|STARTED|Overall Study||59
1454961|NCT02091375|3561372|P1|STARTED|Overall Study||61
1454962|NCT02091362|3561402|P2|NOT COMPLETED|Period 2||2
1454963|NCT02091362|3561403|P1|NOT COMPLETED|Period 2||2
1454964|NCT02091362|3561402|P2|COMPLETED|Period 2||128
1454965|NCT02091362|3561403|P1|COMPLETED|Period 2||125
1454966|NCT02091362|3561402|P2|STARTED|Period 2||130
1454967|NCT02091362|3561403|P1|STARTED|Period 2||127
1454968|NCT02091362|3561402|P2|NOT COMPLETED|Wash-out||3
1454969|NCT02091362|3561403|P1|NOT COMPLETED|Wash-out||1
1454970|NCT02091362|3561402|P2|COMPLETED|Wash-out||130
1454971|NCT02091362|3561403|P1|COMPLETED|Wash-out||127
1454972|NCT02091362|3561402|P2|STARTED|Wash-out||133
1454973|NCT02091362|3561403|P1|STARTED|Wash-out||128
1454974|NCT02091362|3561402|P2|NOT COMPLETED|Period 1||4
1454975|NCT02091362|3561403|P1|NOT COMPLETED|Period 1||5
1454976|NCT02091362|3561402|P2|COMPLETED|Period 1||133
1454977|NCT02091362|3561403|P1|COMPLETED|Period 1||128
1454978|NCT02091362|3561402|P2|STARTED|Period 1||137
1454979|NCT02091362|3561403|P1|STARTED|Period 1||133
1454980|NCT02091206|3561427|P4|NOT COMPLETED|Taper Period||2
1454981|NCT02091206|3561428|P3|NOT COMPLETED|Taper Period||0
1454982|NCT02091206|3561429|P2|NOT COMPLETED|Taper Period||0
1454983|NCT02091206|3561430|P1|NOT COMPLETED|Taper Period||1
1454984|NCT02091206|3561427|P4|COMPLETED|Taper Period||5
1454985|NCT02091206|3561428|P3|COMPLETED|Taper Period||8
1454986|NCT02091206|3561429|P2|COMPLETED|Taper Period||7
1454987|NCT02091206|3561430|P1|COMPLETED|Taper Period||9
1454988|NCT02091206|3561427|P4|STARTED|Taper Period||7
1454989|NCT02091206|3561428|P3|STARTED|Taper Period||8
1454990|NCT02091206|3561429|P2|STARTED|Taper Period||7
1454991|NCT02091206|3561430|P1|STARTED|Taper Period||10
1454992|NCT02091206|3561427|P4|NOT COMPLETED|Treatment Period||0
1454993|NCT02091206|3561428|P3|NOT COMPLETED|Treatment Period||1
1454994|NCT02091206|3561429|P2|NOT COMPLETED|Treatment Period||1
1454995|NCT02091206|3561430|P1|NOT COMPLETED|Treatment Period||0
1454996|NCT02091206|3561427|P4|COMPLETED|Treatment Period||7
1454997|NCT02091206|3561428|P3|COMPLETED|Treatment Period||8
1454998|NCT02091206|3561429|P2|COMPLETED|Treatment Period||7
1454999|NCT02091206|3561430|P1|COMPLETED|Treatment Period||10
1455000|NCT02091206|3561427|P4|Safety Analysis Set|Treatment Period||7
1455001|NCT02091206|3561428|P3|Safety Analysis Set|Treatment Period||9
1455002|NCT02091206|3561429|P2|Safety Analysis Set|Treatment Period||8
1455003|NCT02091206|3561430|P1|Safety Analysis Set|Treatment Period||10
1455004|NCT02091206|3561427|P4|STARTED|Treatment Period||7
1455005|NCT02091206|3561428|P3|STARTED|Treatment Period||9
1455006|NCT02091206|3561429|P2|STARTED|Treatment Period||8
1455007|NCT02091206|3561430|P1|STARTED|Treatment Period||10
1455008|NCT02090894|3561447|P1|NOT COMPLETED|Overall Study||0
1455009|NCT02090894|3561447|P1|COMPLETED|Overall Study||11
1455010|NCT02090894|3561447|P1|STARTED|Overall Study||11
1455011|NCT02090855|3561452|P1|NOT COMPLETED|Overall Study||2
1455012|NCT02090855|3561452|P1|COMPLETED|Overall Study||106
1455013|NCT02090855|3561452|P1|STARTED|Overall Study||108
1455014|NCT02090777|3561459|P1|NOT COMPLETED|Overall Study||0
1455015|NCT02090777|3561459|P1|COMPLETED|Overall Study||4
1455016|NCT02090777|3561459|P1|STARTED|Overall Study||4
1455017|NCT02090764|3561465|P2|NOT COMPLETED|Overall Study||20
1455018|NCT02090764|3561466|P1|NOT COMPLETED|Overall Study||6
1455019|NCT02090764|3561465|P2|COMPLETED|Overall Study||186
1455020|NCT02090764|3561466|P1|COMPLETED|Overall Study||200
1455021|NCT02090764|3561465|P2|STARTED|Overall Study||206
1455022|NCT02090764|3561466|P1|STARTED|Overall Study||206
1455023|NCT02090413|3561475|P3|NOT COMPLETED|Overall Study||23
1455024|NCT02090413|3561476|P2|NOT COMPLETED|Overall Study||20
1455025|NCT02090413|3561477|P1|NOT COMPLETED|Overall Study||19
1455026|NCT02090413|3561475|P3|COMPLETED|Overall Study||57
1455027|NCT02090413|3561476|P2|COMPLETED|Overall Study||60
1455028|NCT02090413|3561477|P1|COMPLETED|Overall Study||62
1455029|NCT02090413|3561475|P3|STARTED|Overall Study||80
1455030|NCT02090413|3561476|P2|STARTED|Overall Study||80
1455031|NCT02090413|3561477|P1|STARTED|Overall Study||81
1455032|NCT02090088|3561551|P1|NOT COMPLETED|Overall Study||0
1455033|NCT02090088|3561551|P1|COMPLETED|Overall Study||4
1455034|NCT02090088|3561551|P1|Gave Birth|Overall Study||4
1455035|NCT02090088|3561551|P1|STARTED|Overall Study||4
1455036|NCT02089997|3561563|P1|NOT COMPLETED|Overall Study||246
1455037|NCT02089997|3561563|P1|COMPLETED|Overall Study||3058
1455038|NCT02089997|3561563|P1|STARTED|Overall Study||3304
1455039|NCT02089737|3561578|P1|NOT COMPLETED|Overall Study||6
1455040|NCT02089737|3561578|P1|COMPLETED|Overall Study||3085
1455041|NCT02089737|3561578|P1|STARTED|Overall Study||3091
1455042|NCT02089659|3561587|P3|NOT COMPLETED|Overall Study||0
1455043|NCT02089659|3561588|P2|NOT COMPLETED|Overall Study||0
1455044|NCT02089659|3561589|P1|NOT COMPLETED|Overall Study||0
1455045|NCT02089659|3561587|P3|COMPLETED|Overall Study||0
1455046|NCT02089659|3561588|P2|COMPLETED|Overall Study||8
1455047|NCT02089659|3561589|P1|COMPLETED|Overall Study||8
1455048|NCT02089659|3561587|P3|STARTED|Overall Study||0
1455049|NCT02089659|3561588|P2|STARTED|Overall Study||8
1455050|NCT02089659|3561589|P1|STARTED|Overall Study||8
1455051|NCT02089347|3561603|P2|NOT COMPLETED|Overall Study||0
1455052|NCT02089347|3561604|P1|NOT COMPLETED|Overall Study||1
1455053|NCT02089347|3561603|P2|COMPLETED|Overall Study||178
1455054|NCT02089347|3561604|P1|COMPLETED|Overall Study||355
1455055|NCT02089347|3561603|P2|STARTED|Overall Study||178
1455056|NCT02089347|3561604|P1|STARTED|Overall Study||356
1455057|NCT02089191|3561626|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
1455058|NCT02089191|3561627|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
1455059|NCT02089191|3561626|P2|COMPLETED|Period 2, Second 12 Hours||15
1455060|NCT02089191|3561627|P1|COMPLETED|Period 2, Second 12 Hours||15
1455061|NCT02089191|3561626|P2|STARTED|Period 2, Second 12 Hours||15
1455062|NCT02089191|3561627|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
1455063|NCT02089191|3561626|P2|NOT COMPLETED|Period 1, First 12 Hours||0
1455064|NCT02089191|3561627|P1|NOT COMPLETED|Period 1, First 12 Hours||0
1455065|NCT02089191|3561626|P2|COMPLETED|Period 1, First 12 Hours||15
1455066|NCT02089191|3561627|P1|COMPLETED|Period 1, First 12 Hours||16
1455067|NCT02089191|3561626|P2|STARTED|Period 1, First 12 Hours||15
1455068|NCT02089191|3561627|P1|STARTED|Period 1, First 12 Hours||16
1455069|NCT02089113|3561637|P2|NOT COMPLETED|Overall Study||0
1455070|NCT02089113|3561638|P1|NOT COMPLETED|Overall Study||1
1455071|NCT02089113|3561637|P2|COMPLETED|Overall Study||80
1455072|NCT02089113|3561638|P1|COMPLETED|Overall Study||160
1455073|NCT02089113|3561637|P2|STARTED|Overall Study||80
1455074|NCT02089113|3561638|P1|STARTED|Overall Study||161
1455075|NCT02088957|3561644|P2|NOT COMPLETED|Overall Study||0
1455076|NCT02088957|3561645|P1|NOT COMPLETED|Overall Study||1
1455077|NCT02088957|3561644|P2|COMPLETED|Overall Study||0
1455078|NCT02088957|3561645|P1|COMPLETED|Overall Study||0
1455079|NCT02088957|3561644|P2|STARTED|Overall Study||0
1455080|NCT02088957|3561645|P1|STARTED|Overall Study||1
1455081|NCT02088788|3561663|P2|NOT COMPLETED|Overall Study||41
1455082|NCT02088788|3561664|P1|NOT COMPLETED|Overall Study||30
1455083|NCT02088788|3561663|P2|COMPLETED|Overall Study||89
1455084|NCT02088788|3561664|P1|COMPLETED|Overall Study||105
1455085|NCT02088788|3561663|P2|STARTED|Overall Study||130
1455086|NCT02088788|3561664|P1|STARTED|Overall Study||135
1455087|NCT02088177|3561672|P1|NOT COMPLETED|Overall Study||3
1455088|NCT02088177|3561672|P1|COMPLETED|Overall Study||9
1455089|NCT02088177|3561672|P1|STARTED|Overall Study||12
1455090|NCT02088073|3561682|P5|NOT COMPLETED|Maintanance Phase||7
1455091|NCT02088073|3561683|P4|NOT COMPLETED|Maintanance Phase||7
1455092|NCT02088073|3561684|P3|NOT COMPLETED|Maintanance Phase||5
1455093|NCT02088073|3561685|P2|NOT COMPLETED|Maintanance Phase||10
1455094|NCT02088073|3561686|P1|NOT COMPLETED|Maintanance Phase||0
1455095|NCT02088073|3561682|P5|COMPLETED|Maintanance Phase||49
1455096|NCT02088073|3561683|P4|COMPLETED|Maintanance Phase||44
1455097|NCT02088073|3561684|P3|COMPLETED|Maintanance Phase||40
1455098|NCT02088073|3561685|P2|COMPLETED|Maintanance Phase||75
1455099|NCT02088073|3561686|P1|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
1455100|NCT02088073|3561682|P5|STARTED|Maintanance Phase||56
1455101|NCT02088073|3561683|P4|STARTED|Maintanance Phase||51
1455102|NCT02088073|3561684|P3|STARTED|Maintanance Phase||45
1455103|NCT02088073|3561685|P2|STARTED|Maintanance Phase||85
1455104|NCT02088073|3561686|P1|STARTED|Maintanance Phase||0
1455105|NCT02088073|3561682|P5|NOT COMPLETED|Acute Phase||0
1455106|NCT02088073|3561683|P4|NOT COMPLETED|Acute Phase||0
1455107|NCT02088073|3561684|P3|NOT COMPLETED|Acute Phase||0
1455108|NCT02088073|3561685|P2|NOT COMPLETED|Acute Phase||0
1455109|NCT02088073|3561686|P1|NOT COMPLETED|Acute Phase||7
1455110|NCT02088073|3561682|P5|COMPLETED|Acute Phase||0
1455111|NCT02088073|3561683|P4|COMPLETED|Acute Phase||0
1455112|NCT02088073|3561684|P3|COMPLETED|Acute Phase||0
1455113|NCT02088073|3561685|P2|COMPLETED|Acute Phase||0
1455114|NCT02088073|3561686|P1|COMPLETED|Acute Phase||251
1455115|NCT02088073|3561682|P5|STARTED|Acute Phase||0
1455116|NCT02088073|3561683|P4|STARTED|Acute Phase||0
1455117|NCT02088073|3561684|P3|STARTED|Acute Phase||0
1455118|NCT02088073|3561685|P2|STARTED|Acute Phase||0
1455119|NCT02088073|3561686|P1|STARTED|Acute Phase||258
1455120|NCT02087995|3561738|P1|NOT COMPLETED|Overall Study||0
1455121|NCT02087995|3561738|P1|COMPLETED|Overall Study||51
1455122|NCT02087995|3561738|P1|STARTED|Overall Study||51
1455123|NCT02087943|3561745|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
1455124|NCT02087943|3561746|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
1455125|NCT02087943|3561747|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
1455126|NCT02087943|3561748|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
1455127|NCT02087943|3561749|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
1455128|NCT02087943|3561745|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
1455129|NCT02087943|3561746|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
1455130|NCT02087943|3561747|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
1455131|NCT02087943|3561748|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
1455132|NCT02087943|3561749|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
1455133|NCT02087943|3561745|P5|STARTED|Observational Follow-up Phase Week 24-30||23
1455134|NCT02087943|3561746|P4|STARTED|Observational Follow-up Phase Week 24-30||24
1455135|NCT02087943|3561747|P3|STARTED|Observational Follow-up Phase Week 24-30||48
1455136|NCT02087943|3561748|P2|STARTED|Observational Follow-up Phase Week 24-30||46
1455137|NCT02087943|3561749|P1|STARTED|Observational Follow-up Phase Week 24-30||0
1455138|NCT02087943|3561745|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
1455139|NCT02087943|3561746|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
1455140|NCT02087943|3561747|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
1455141|NCT02087943|3561748|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
1455142|NCT02087943|3561749|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
1455143|NCT02087943|3561745|P5|COMPLETED|Active Treatment Phase Week 12-24||21
1455144|NCT02087943|3561746|P4|COMPLETED|Active Treatment Phase Week 12-24||22
1455145|NCT02087943|3561747|P3|COMPLETED|Active Treatment Phase Week 12-24||44
1455146|NCT02087943|3561748|P2|COMPLETED|Active Treatment Phase Week 12-24||42
1455147|NCT02087943|3561749|P1|COMPLETED|Active Treatment Phase Week 12-24||0
1455148|NCT02087943|3561745|P5|STARTED|Active Treatment Phase Week 12-24||23
1455149|NCT02087943|3561746|P4|STARTED|Active Treatment Phase Week 12-24||24
1455150|NCT02087943|3561747|P3|STARTED|Active Treatment Phase Week 12-24||49
1455151|NCT02087943|3561748|P2|STARTED|Active Treatment Phase Week 12-24||46
1455152|NCT02087943|3561749|P1|STARTED|Active Treatment Phase Week 12-24||0
1455153|NCT02087943|3561745|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
1455154|NCT02087943|3561746|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
1455155|NCT02087943|3561747|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
1455156|NCT02087943|3561748|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
1455157|NCT02087943|3561749|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
1455158|NCT02087943|3561745|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
1455159|NCT02087943|3561746|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
1455160|NCT02087943|3561747|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
1455161|NCT02087943|3561748|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
1455162|NCT02087943|3561749|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
1455163|NCT02087943|3561745|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
1455164|NCT02087943|3561746|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
1455165|NCT02087943|3561747|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
1455166|NCT02087943|3561748|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
1455167|NCT02087943|3561749|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
1455168|NCT02087943|3561745|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
1455169|NCT02087943|3561746|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
1455170|NCT02087943|3561747|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
1455171|NCT02087943|3561748|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
1455172|NCT02087943|3561749|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
1455173|NCT02087774|3561775|P2|NOT COMPLETED|Overall Study||20
1455174|NCT02087774|3561776|P1|NOT COMPLETED|Overall Study||8
1455175|NCT02087774|3561775|P2|COMPLETED|Overall Study||130
1455176|NCT02087774|3561776|P1|COMPLETED|Overall Study||142
1455177|NCT02087774|3561775|P2|STARTED|Overall Study||150
1455178|NCT02087774|3561776|P1|STARTED|Overall Study||150
1455179|NCT02087748|3561784|P1|NOT COMPLETED|Overall Study||0
1455180|NCT02087748|3561784|P1|COMPLETED|Overall Study||24
1455181|NCT02087748|3561784|P1|STARTED|Overall Study||24
1455182|NCT02087670|3561796|P2|NOT COMPLETED|Overall Study||2
1455183|NCT02087670|3561797|P1|NOT COMPLETED|Overall Study||3
1455184|NCT02087670|3561796|P2|COMPLETED|Overall Study||20
1455185|NCT02087670|3561797|P1|COMPLETED|Overall Study||17
1455186|NCT02087670|3561796|P2|STARTED|Overall Study||22
1455187|NCT02087670|3561797|P1|STARTED|Overall Study||20
1455188|NCT02087514|3561811|P6|NOT COMPLETED|Overall Study||1
1455189|NCT02087514|3561812|P5|NOT COMPLETED|Overall Study||0
1455190|NCT02087514|3561813|P4|NOT COMPLETED|Overall Study||2
1455191|NCT02087514|3561814|P3|NOT COMPLETED|Overall Study||3
1455192|NCT02087514|3561815|P2|NOT COMPLETED|Overall Study||0
1455193|NCT02087514|3561816|P1|NOT COMPLETED|Overall Study||2
1455194|NCT02087514|3561811|P6|COMPLETED|Overall Study||9
1455195|NCT02087514|3561812|P5|COMPLETED|Overall Study||10
1455196|NCT02087514|3561813|P4|COMPLETED|Overall Study||8
1455197|NCT02087514|3561814|P3|COMPLETED|Overall Study||7
1455198|NCT02087514|3561815|P2|COMPLETED|Overall Study||10
1455199|NCT02087514|3561816|P1|COMPLETED|Overall Study||8
1455200|NCT02087514|3561811|P6|STARTED|Overall Study||10
1455201|NCT02087514|3561812|P5|STARTED|Overall Study||10
1455202|NCT02087514|3561813|P4|STARTED|Overall Study||10
1455203|NCT02087514|3561814|P3|STARTED|Overall Study||10
1455204|NCT02087514|3561815|P2|STARTED|Overall Study||10
1455205|NCT02087514|3561816|P1|STARTED|Overall Study||10
1455206|NCT02087423|3561833|P3|NOT COMPLETED|Overall Study||68
1455207|NCT02087423|3561834|P2|NOT COMPLETED|Overall Study||265
1455208|NCT02087423|3561835|P1|NOT COMPLETED|Overall Study||111
1455209|NCT02087423|3561833|P3|COMPLETED|Overall Study||0
1455210|NCT02087423|3561834|P2|COMPLETED|Overall Study||0
1455211|NCT02087423|3561835|P1|COMPLETED|Overall Study||0
1455212|NCT02087423|3561833|P3|Completed 12 Months of Treatment|Overall Study||26
1455213|NCT02087423|3561834|P2|Completed 12 Months of Treatment|Overall Study||60
1455214|NCT02087423|3561835|P1|Completed 12 Months of Treatment|Overall Study||18
1455215|NCT02087423|3561833|P3|STARTED|Overall Study|Treated|68
1455216|NCT02087423|3561834|P2|STARTED|Overall Study|Treated|265
1455217|NCT02087423|3561835|P1|STARTED|Overall Study|Treated|111
1455218|NCT02087241|3561864|P4|NOT COMPLETED|Overall Study||7
1455219|NCT02087241|3561865|P3|NOT COMPLETED|Overall Study||1
1455220|NCT02087241|3561866|P2|NOT COMPLETED|Overall Study||3
1455221|NCT02087241|3561867|P1|NOT COMPLETED|Overall Study||3
1455222|NCT02087241|3561864|P4|COMPLETED|Overall Study||0
1455223|NCT02087241|3561865|P3|COMPLETED|Overall Study||0
1455224|NCT02087241|3561866|P2|COMPLETED|Overall Study||0
1455225|NCT02087241|3561867|P1|COMPLETED|Overall Study||0
1455226|NCT02087241|3561864|P4|STARTED|Overall Study||7
1455227|NCT02087241|3561865|P3|STARTED|Overall Study||1
1455228|NCT02087241|3561866|P2|STARTED|Overall Study||3
1455229|NCT02087241|3561867|P1|STARTED|Overall Study||3
1455230|NCT02087176|3561893|P1|NOT COMPLETED|Overall Study||32
1455231|NCT02087176|3561893|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
1455232|NCT02087176|3561893|P1|STARTED|Overall Study||32
1455233|NCT02087059|3561898|P1|NOT COMPLETED|Overall Study||7
1455234|NCT02087059|3561898|P1|COMPLETED|Overall Study||44
1455235|NCT02087059|3561898|P1|STARTED|Overall Study||51
1455236|NCT02086786|3561908|P2|NOT COMPLETED|Overall Study||16
1455237|NCT02086786|3561909|P1|NOT COMPLETED|Overall Study||18
1455238|NCT02086786|3561908|P2|COMPLETED|Overall Study||19
1455239|NCT02086786|3561909|P1|COMPLETED|Overall Study||17
1455240|NCT02086786|3561908|P2|STARTED|Overall Study||35
1455241|NCT02086786|3561909|P1|STARTED|Overall Study||35
1455242|NCT02086708|3561933|P1|NOT COMPLETED|Overall Study||0
1455243|NCT02086708|3561933|P1|COMPLETED|Overall Study||24
1455244|NCT02086708|3561933|P1|STARTED|Overall Study||24
1455245|NCT02086591|3561945|P1|NOT COMPLETED|Overall Study||5
1455246|NCT02086591|3561945|P1|COMPLETED|Overall Study||2
1455247|NCT02086591|3561945|P1|STARTED|Overall Study||7
1455248|NCT02086162|3561953|P2|NOT COMPLETED|Overall Study||7
1455249|NCT02086162|3561954|P1|NOT COMPLETED|Overall Study||10
1455250|NCT02086162|3561953|P2|COMPLETED|Overall Study||77
1455251|NCT02086162|3561954|P1|COMPLETED|Overall Study||68
1455252|NCT02086162|3561953|P2|STARTED|Overall Study||84
1455253|NCT02086162|3561954|P1|STARTED|Overall Study||78
1455254|NCT02085785|3561966|P2|NOT COMPLETED|Overall Study||2
1455255|NCT02085785|3561967|P1|NOT COMPLETED|Overall Study||2
1455256|NCT02085785|3561966|P2|COMPLETED|Overall Study||6
1455257|NCT02085785|3561967|P1|COMPLETED|Overall Study||5
1455258|NCT02085785|3561966|P2|STARTED|Overall Study||8
1455259|NCT02085785|3561967|P1|STARTED|Overall Study||7
1455260|NCT02085720|3561979|P1|NOT COMPLETED|Overall Study||0
1455261|NCT02085720|3561979|P1|COMPLETED|Overall Study||819
1455262|NCT02085720|3561979|P1|STARTED|Overall Study||819
1455263|NCT02085473|3561991|P4|NOT COMPLETED|Overall Study||0
1455264|NCT02085473|3561992|P3|NOT COMPLETED|Overall Study||0
1455265|NCT02085473|3561993|P2|NOT COMPLETED|Overall Study||0
1455266|NCT02085473|3561994|P1|NOT COMPLETED|Overall Study||0
1455267|NCT02085473|3561991|P4|COMPLETED|Overall Study||15
1455268|NCT02085473|3561992|P3|COMPLETED|Overall Study||15
1455269|NCT02085473|3561993|P2|COMPLETED|Overall Study||15
1455270|NCT02085473|3561994|P1|COMPLETED|Overall Study||15
1455271|NCT02085473|3561991|P4|STARTED|Overall Study||15
1455272|NCT02085473|3561992|P3|STARTED|Overall Study||15
1455273|NCT02085473|3561993|P2|STARTED|Overall Study||15
1455274|NCT02085473|3561994|P1|STARTED|Overall Study||15
1455275|NCT02085161|3562060|P4|NOT COMPLETED|Overall Study||10
1455276|NCT02085161|3562061|P3|NOT COMPLETED|Overall Study||5
1455277|NCT02085161|3562062|P2|NOT COMPLETED|Overall Study||10
1455278|NCT02085161|3562063|P1|NOT COMPLETED|Overall Study||12
1455279|NCT02085161|3562060|P4|COMPLETED|Overall Study||66
1455280|NCT02085161|3562061|P3|COMPLETED|Overall Study||71
1455281|NCT02085161|3562062|P2|COMPLETED|Overall Study||66
1455282|NCT02085161|3562063|P1|COMPLETED|Overall Study||64
1455283|NCT02085161|3562060|P4|STARTED|Overall Study||76
1455284|NCT02085161|3562061|P3|STARTED|Overall Study||76
1455285|NCT02085161|3562062|P2|STARTED|Overall Study||76
1455286|NCT02085161|3562063|P1|STARTED|Overall Study||76
1455287|NCT02084797|3562102|P1|NOT COMPLETED|Overall Study||0
1455288|NCT02084797|3562102|P1|COMPLETED|Overall Study||10
1455289|NCT02084797|3562102|P1|STARTED|Overall Study||10
1455290|NCT02084706|3562111|P2|NOT COMPLETED|Overall Study||0
1455291|NCT02084706|3562112|P1|NOT COMPLETED|Overall Study||0
1455292|NCT02084706|3562111|P2|COMPLETED|Overall Study||31
1455293|NCT02084706|3562112|P1|COMPLETED|Overall Study||29
1455294|NCT02084706|3562111|P2|STARTED|Overall Study||31
1455295|NCT02084706|3562112|P1|STARTED|Overall Study||29
1455296|NCT02084628|3562118|P1|NOT COMPLETED|Overall Study||0
1455297|NCT02084628|3562118|P1|COMPLETED|Overall Study||1
1455298|NCT02084628|3562118|P1|STARTED|Overall Study||1
1455299|NCT02084238|3562131|P1|NOT COMPLETED|Overall Study||2
1455300|NCT02084238|3562131|P1|COMPLETED|Overall Study||38
1455301|NCT02084238|3562131|P1|STARTED|Overall Study||40
1455302|NCT02084134|3562144|P2|NOT COMPLETED|Overall Study||3
1455303|NCT02084134|3562145|P1|NOT COMPLETED|Overall Study||4
1455304|NCT02084134|3562144|P2|COMPLETED|Overall Study||17
1455305|NCT02084134|3562145|P1|COMPLETED|Overall Study||19
1455306|NCT02084134|3562144|P2|STARTED|Overall Study||20
1455307|NCT02084134|3562145|P1|STARTED|Overall Study||23
1455308|NCT02084082|3562155|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1455309|NCT02084082|3562156|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1455310|NCT02084082|3562157|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1455311|NCT02084082|3562158|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1455312|NCT02084082|3562155|P4|COMPLETED|Treatment Period 2 (4 Days)||6
1455313|NCT02084082|3562156|P3|COMPLETED|Treatment Period 2 (4 Days)||7
1455314|NCT02084082|3562157|P2|COMPLETED|Treatment Period 2 (4 Days)||26
1455315|NCT02084082|3562158|P1|COMPLETED|Treatment Period 2 (4 Days)||26
1455316|NCT02084082|3562155|P4|STARTED|Treatment Period 2 (4 Days)||6
1455317|NCT02084082|3562156|P3|STARTED|Treatment Period 2 (4 Days)||7
1455318|NCT02084082|3562157|P2|STARTED|Treatment Period 2 (4 Days)||26
1455319|NCT02084082|3562158|P1|STARTED|Treatment Period 2 (4 Days)||26
1455320|NCT02084082|3562155|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
1455321|NCT02084082|3562156|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
1455322|NCT02084082|3562157|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
1455323|NCT02084082|3562158|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
1455324|NCT02084082|3562155|P4|COMPLETED|Washout Period 1 (35 Days)||6
1455325|NCT02084082|3562156|P3|COMPLETED|Washout Period 1 (35 Days)||7
1455326|NCT02084082|3562157|P2|COMPLETED|Washout Period 1 (35 Days)||26
1455327|NCT02084082|3562158|P1|COMPLETED|Washout Period 1 (35 Days)||26
1455328|NCT02084082|3562155|P4|STARTED|Washout Period 1 (35 Days)||8
1455329|NCT02084082|3562156|P3|STARTED|Washout Period 1 (35 Days)||8
1455330|NCT02084082|3562157|P2|STARTED|Washout Period 1 (35 Days)||26
1455331|NCT02084082|3562158|P1|STARTED|Washout Period 1 (35 Days)||26
1455332|NCT02084082|3562155|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1455333|NCT02084082|3562156|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1455334|NCT02084082|3562157|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1455335|NCT02084082|3562158|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1455336|NCT02084082|3562155|P4|COMPLETED|Treatment Period 1 (4 Days)||8
1455337|NCT02084082|3562156|P3|COMPLETED|Treatment Period 1 (4 Days)||8
1455338|NCT02084082|3562157|P2|COMPLETED|Treatment Period 1 (4 Days)||26
1455339|NCT02084082|3562158|P1|COMPLETED|Treatment Period 1 (4 Days)||26
1455340|NCT02084082|3562155|P4|STARTED|Treatment Period 1 (4 Days)||8
1455341|NCT02084082|3562156|P3|STARTED|Treatment Period 1 (4 Days)||8
1455342|NCT02084082|3562157|P2|STARTED|Treatment Period 1 (4 Days)||26
1455343|NCT02084082|3562158|P1|STARTED|Treatment Period 1 (4 Days)||26
1455344|NCT02084069|3562190|P2|NOT COMPLETED|Overall Study||0
1455345|NCT02084069|3562191|P1|NOT COMPLETED|Overall Study||0
1455346|NCT02084069|3562190|P2|COMPLETED|Overall Study||29
1455347|NCT02084069|3562191|P1|COMPLETED|Overall Study||29
1455348|NCT02084069|3562190|P2|STARTED|Overall Study||29
1455349|NCT02084069|3562191|P1|STARTED|Overall Study||29
1455350|NCT02084056|3562199|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1455351|NCT02084056|3562200|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1455352|NCT02084056|3562201|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1455353|NCT02084056|3562202|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1455354|NCT02084056|3562199|P4|COMPLETED|Treatment Period 2 (4 Days)||8
1455355|NCT02084056|3562200|P3|COMPLETED|Treatment Period 2 (4 Days)||8
1455356|NCT02084056|3562201|P2|COMPLETED|Treatment Period 2 (4 Days)||30
1455357|NCT02084056|3562202|P1|COMPLETED|Treatment Period 2 (4 Days)||26
1455358|NCT02084056|3562199|P4|STARTED|Treatment Period 2 (4 Days)||8
1455359|NCT02084056|3562200|P3|STARTED|Treatment Period 2 (4 Days)||8
1455360|NCT02084056|3562201|P2|STARTED|Treatment Period 2 (4 Days)||30
1455361|NCT02084056|3562202|P1|STARTED|Treatment Period 2 (4 Days)||26
1455362|NCT02084056|3562199|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
1455363|NCT02084056|3562200|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
1455364|NCT02084056|3562201|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
1455365|NCT02084056|3562202|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
1455366|NCT02084056|3562199|P4|COMPLETED|Washout Period 1 (35 Days)||8
1455367|NCT02084056|3562200|P3|COMPLETED|Washout Period 1 (35 Days)||8
1455368|NCT02084056|3562201|P2|COMPLETED|Washout Period 1 (35 Days)||30
1455369|NCT02084056|3562202|P1|COMPLETED|Washout Period 1 (35 Days)||26
1455370|NCT02084056|3562199|P4|STARTED|Washout Period 1 (35 Days)||8
1455371|NCT02084056|3562200|P3|STARTED|Washout Period 1 (35 Days)||8
1455372|NCT02084056|3562201|P2|STARTED|Washout Period 1 (35 Days)||30
1455373|NCT02084056|3562202|P1|STARTED|Washout Period 1 (35 Days)||27
1455374|NCT02084056|3562199|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1455375|NCT02084056|3562200|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1455376|NCT02084056|3562201|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1455377|NCT02084056|3562202|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
1455378|NCT02084056|3562199|P4|COMPLETED|Treatment Period 1 (4 Days)||8
1455379|NCT02084056|3562200|P3|COMPLETED|Treatment Period 1 (4 Days)||8
1455380|NCT02084056|3562201|P2|COMPLETED|Treatment Period 1 (4 Days)||30
1455381|NCT02084056|3562202|P1|COMPLETED|Treatment Period 1 (4 Days)||27
1455382|NCT02084056|3562199|P4|STARTED|Treatment Period 1 (4 Days)||8
1455383|NCT02084056|3562200|P3|STARTED|Treatment Period 1 (4 Days)||8
1455384|NCT02084056|3562201|P2|STARTED|Treatment Period 1 (4 Days)||30
1455385|NCT02084056|3562202|P1|STARTED|Treatment Period 1 (4 Days)||28
1455386|NCT02083965|3562234|P2|NOT COMPLETED|Treatment Period||0
1455387|NCT02083965|3562235|P1|NOT COMPLETED|Treatment Period||1
1455388|NCT02083965|3562234|P2|COMPLETED|Treatment Period||8
1455389|NCT02083965|3562235|P1|COMPLETED|Treatment Period||9
1455390|NCT02083965|3562234|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
1455391|NCT02083965|3562235|P1|STARTED|Treatment Period||10
1455392|NCT02083965|3562234|P2|NOT COMPLETED|PK Period 2||0
1455393|NCT02083965|3562235|P1|NOT COMPLETED|PK Period 2||0
1455394|NCT02083965|3562234|P2|COMPLETED|PK Period 2||9
1455395|NCT02083965|3562235|P1|COMPLETED|PK Period 2||10
1455396|NCT02083965|3562234|P2|STARTED|PK Period 2||9
1455397|NCT02083965|3562235|P1|STARTED|PK Period 2||10
1455398|NCT02083965|3562234|P2|NOT COMPLETED|Washout Period||0
1455399|NCT02083965|3562235|P1|NOT COMPLETED|Washout Period||0
1455400|NCT02083965|3562234|P2|COMPLETED|Washout Period||9
1455401|NCT02083965|3562235|P1|COMPLETED|Washout Period||10
1455402|NCT02083965|3562234|P2|STARTED|Washout Period||9
1455403|NCT02083965|3562235|P1|STARTED|Washout Period||10
1455404|NCT02083965|3562234|P2|NOT COMPLETED|PK Period 1||0
1455405|NCT02083965|3562235|P1|NOT COMPLETED|PK Period 1||0
1455406|NCT02083965|3562234|P2|COMPLETED|PK Period 1||9
1455407|NCT02083965|3562235|P1|COMPLETED|PK Period 1||10
1455408|NCT02083965|3562234|P2|STARTED|PK Period 1||9
1455409|NCT02083965|3562235|P1|STARTED|PK Period 1||10
1455410|NCT02083861|3562293|P2|NOT COMPLETED|Overall Study||3
1455411|NCT02083861|3562294|P1|NOT COMPLETED|Overall Study||6
1455412|NCT02083861|3562293|P2|COMPLETED|Overall Study||33
1455413|NCT02083861|3562294|P1|COMPLETED|Overall Study||51
1455414|NCT02083861|3562293|P2|Treated|Overall Study||35
1455415|NCT02083861|3562294|P1|Treated|Overall Study||55
1455416|NCT02083861|3562293|P2|STARTED|Overall Study||36
1455417|NCT02083861|3562294|P1|STARTED|Overall Study||57
1455418|NCT02083679|3562310|P4|NOT COMPLETED|Overall Study||0
1455419|NCT02083679|3562311|P3|NOT COMPLETED|Overall Study||0
1455420|NCT02083679|3562312|P2|NOT COMPLETED|Overall Study||0
1455421|NCT02083679|3562313|P1|NOT COMPLETED|Overall Study||0
1455422|NCT02083679|3562310|P4|COMPLETED|Overall Study||3
1455423|NCT02083679|3562311|P3|COMPLETED|Overall Study||3
1455424|NCT02083679|3562312|P2|COMPLETED|Overall Study||6
1455425|NCT02083679|3562313|P1|COMPLETED|Overall Study||3
1455426|NCT02083679|3562310|P4|STARTED|Overall Study||3
1455427|NCT02083679|3562311|P3|STARTED|Overall Study||3
1455428|NCT02083679|3562312|P2|STARTED|Overall Study||6
1455429|NCT02083679|3562313|P1|STARTED|Overall Study||3
1455430|NCT02083653|3562330|P3|NOT COMPLETED|Overall Study||84
1455431|NCT02083653|3562331|P2|NOT COMPLETED|Overall Study||85
1455432|NCT02083653|3562332|P1|NOT COMPLETED|Overall Study||82
1455433|NCT02083653|3562330|P3|COMPLETED|Overall Study||1
1455434|NCT02083653|3562331|P2|COMPLETED|Overall Study||1
1455435|NCT02083653|3562332|P1|COMPLETED|Overall Study||1
1455436|NCT02083653|3562330|P3|STARTED|Overall Study||85
1455437|NCT02083653|3562331|P2|STARTED|Overall Study||86
1455438|NCT02083653|3562332|P1|STARTED|Overall Study||83
1455439|NCT02083406|3562378|P3|NOT COMPLETED|Overall Study||0
1455440|NCT02083406|3562379|P2|NOT COMPLETED|Overall Study||0
1455441|NCT02083406|3562380|P1|NOT COMPLETED|Overall Study||0
1455442|NCT02083406|3562378|P3|COMPLETED|Overall Study||7
1455443|NCT02083406|3562379|P2|COMPLETED|Overall Study||8
1455444|NCT02083406|3562380|P1|COMPLETED|Overall Study||7
1455445|NCT02083406|3562378|P3|STARTED|Overall Study||7
1455446|NCT02083406|3562379|P2|STARTED|Overall Study||8
1455447|NCT02083406|3562380|P1|STARTED|Overall Study||7
1455448|NCT02083380|3562400|P3|NOT COMPLETED|Overall Study||84
1455449|NCT02083380|3562401|P2|NOT COMPLETED|Overall Study||95
1455450|NCT02083380|3562402|P1|NOT COMPLETED|Overall Study||91
1455451|NCT02083380|3562400|P3|COMPLETED|Overall Study||65
1455452|NCT02083380|3562401|P2|COMPLETED|Overall Study||56
1455453|NCT02083380|3562402|P1|COMPLETED|Overall Study||57
1455454|NCT02083380|3562400|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
1455455|NCT02083380|3562401|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
1455456|NCT02083380|3562402|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
1455457|NCT02083263|3562497|P2|NOT COMPLETED|Overall Study||0
1455458|NCT02083263|3562498|P1|NOT COMPLETED|Overall Study||0
1455459|NCT02083263|3562497|P2|COMPLETED|Overall Study||16
1455460|NCT02083263|3562498|P1|COMPLETED|Overall Study||16
1455461|NCT02083263|3562497|P2|STARTED|Overall Study||16
1455462|NCT02083263|3562498|P1|STARTED|Overall Study||16
1455463|NCT02083185|3562507|P3|NOT COMPLETED|Overall Study||7
1455464|NCT02083185|3562508|P2|NOT COMPLETED|Overall Study||29
1455465|NCT02083185|3562509|P1|NOT COMPLETED|Overall Study||20
1455466|NCT02083185|3562507|P3|COMPLETED|Overall Study||17
1455467|NCT02083185|3562508|P2|COMPLETED|Overall Study||27
1455468|NCT02083185|3562509|P1|COMPLETED|Overall Study||36
1455469|NCT02083185|3562507|P3|Safety Population|Overall Study||24
1455470|NCT02083185|3562508|P2|Safety Population|Overall Study||54
1455471|NCT02083185|3562509|P1|Safety Population|Overall Study||56
1455472|NCT02083185|3562507|P3|STARTED|Overall Study||24
1455473|NCT02083185|3562508|P2|STARTED|Overall Study||56
1455474|NCT02083185|3562509|P1|STARTED|Overall Study||56
1455475|NCT02083107|3562567|P3|NOT COMPLETED|Overall Study||0
1455476|NCT02083107|3562568|P2|NOT COMPLETED|Overall Study||0
1455477|NCT02083107|3562569|P1|NOT COMPLETED|Overall Study||0
1455478|NCT02083107|3562567|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
1455479|NCT02083107|3562568|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
1455480|NCT02083107|3562569|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
1455481|NCT02083107|3562567|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
1455482|NCT02083107|3562568|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
1455483|NCT02083107|3562569|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
1455484|NCT02082912|3562606|P2|NOT COMPLETED|Overall Study||1
1455485|NCT02082912|3562607|P1|NOT COMPLETED|Overall Study||0
1455486|NCT02082912|3562606|P2|COMPLETED|Overall Study||6
1455487|NCT02082912|3562607|P1|COMPLETED|Overall Study||7
1455488|NCT02082912|3562606|P2|STARTED|Overall Study||7
1455489|NCT02082912|3562607|P1|STARTED|Overall Study||7
1455490|NCT02082769|3562624|P3|NOT COMPLETED|Overall Study||36
1455491|NCT02082769|3562625|P2|NOT COMPLETED|Overall Study||27
1455492|NCT02082769|3562626|P1|NOT COMPLETED|Overall Study||24
1455493|NCT02082769|3562624|P3|COMPLETED|Overall Study||132
1455494|NCT02082769|3562625|P2|COMPLETED|Overall Study||141
1455495|NCT02082769|3562626|P1|COMPLETED|Overall Study||144
1455496|NCT02082769|3562624|P3|STARTED|Overall Study||168
1455497|NCT02082769|3562625|P2|STARTED|Overall Study||168
1455498|NCT02082769|3562626|P1|STARTED|Overall Study||168
1455499|NCT02082392|3562642|P2|NOT COMPLETED|Overall Study||0
1455500|NCT02082392|3562643|P1|NOT COMPLETED|Overall Study||0
1455501|NCT02082392|3562642|P2|COMPLETED|Overall Study||1
1455502|NCT02082392|3562643|P1|COMPLETED|Overall Study||2
1455503|NCT02082392|3562642|P2|STARTED|Overall Study||1
1455504|NCT02082392|3562643|P1|STARTED|Overall Study||2
1455505|NCT02082288|3562675|P1|NOT COMPLETED|Overall Study||0
1455506|NCT02082288|3562675|P1|COMPLETED|Overall Study||243
1455507|NCT02082288|3562675|P1|STARTED|Overall Study||243
1455508|NCT02082262|3562679|P1|NOT COMPLETED|Overall Study||51
1455509|NCT02082262|3562679|P1|COMPLETED|Overall Study||89
1455510|NCT02082262|3562679|P1|STARTED|Overall Study||140
1455511|NCT02082184|3562685|P2|NOT COMPLETED|Overall Study||13
1455512|NCT02082184|3562686|P1|NOT COMPLETED|Overall Study||10
1455513|NCT02082184|3562685|P2|COMPLETED|Overall Study||62
1455514|NCT02082184|3562686|P1|COMPLETED|Overall Study||139
1455515|NCT02082184|3562685|P2|STARTED|Overall Study||75
1455516|NCT02082184|3562686|P1|STARTED|Overall Study||149
1455517|NCT02082158|3562711|P6|NOT COMPLETED|Overall Study||7
1455518|NCT02082158|3562712|P5|NOT COMPLETED|Overall Study||4
1455519|NCT02082158|3562713|P4|NOT COMPLETED|Overall Study||4
1455520|NCT02082158|3562714|P3|NOT COMPLETED|Overall Study||14
1455521|NCT02082158|3562715|P2|NOT COMPLETED|Overall Study||8
1455522|NCT02082158|3562716|P1|NOT COMPLETED|Overall Study||8
1455523|NCT02082158|3562711|P6|COMPLETED|Overall Study||56
1455524|NCT02082158|3562712|P5|COMPLETED|Overall Study||64
1455525|NCT02082158|3562713|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
1455526|NCT02082158|3562714|P3|COMPLETED|Overall Study||38
1455527|NCT02082158|3562715|P2|COMPLETED|Overall Study||53
1455528|NCT02082158|3562716|P1|COMPLETED|Overall Study||58
1455529|NCT02082158|3562711|P6|STARTED|Overall Study||63
1455530|NCT02082158|3562712|P5|STARTED|Overall Study||68
1455531|NCT02082158|3562713|P4|STARTED|Overall Study||72
1455532|NCT02082158|3562714|P3|STARTED|Overall Study||52
1455533|NCT02082158|3562715|P2|STARTED|Overall Study||61
1455534|NCT02082158|3562716|P1|STARTED|Overall Study||66
1455535|NCT02081859|3562738|P2|NOT COMPLETED|Overall Study||31
1455536|NCT02081859|3562739|P1|NOT COMPLETED|Overall Study||34
1455537|NCT02081859|3562738|P2|COMPLETED|Overall Study||119
1455538|NCT02081859|3562739|P1|COMPLETED|Overall Study||116
1455539|NCT02081859|3562738|P2|STARTED|Overall Study||150
1455540|NCT02081859|3562739|P1|STARTED|Overall Study||150
1455541|NCT02081690|3562747|P1|NOT COMPLETED|Overall Study||7
1455542|NCT02081690|3562747|P1|COMPLETED|Overall Study||81
1455543|NCT02081690|3562747|P1|STARTED|Overall Study||88
1455544|NCT02081677|3562758|P4|NOT COMPLETED|Overall Study||0
1455545|NCT02081677|3562759|P3|NOT COMPLETED|Overall Study||2
1455546|NCT02081677|3562760|P2|NOT COMPLETED|Overall Study||1
1455547|NCT02081677|3562761|P1|NOT COMPLETED|Overall Study||1
1455548|NCT02081677|3562758|P4|COMPLETED|Overall Study||19
1455549|NCT02081677|3562759|P3|COMPLETED|Overall Study||17
1455550|NCT02081677|3562760|P2|COMPLETED|Overall Study||18
1455551|NCT02081677|3562761|P1|COMPLETED|Overall Study||18
1455552|NCT02081677|3562758|P4|STARTED|Overall Study||19
1455553|NCT02081677|3562759|P3|STARTED|Overall Study||19
1455554|NCT02081677|3562760|P2|STARTED|Overall Study||19
1455555|NCT02081677|3562761|P1|STARTED|Overall Study||19
1455556|NCT02081599|3562853|P2|NOT COMPLETED|Period 2：Open-label Period||4
1455557|NCT02081599|3562854|P1|NOT COMPLETED|Period 2：Open-label Period||6
1455558|NCT02081599|3562853|P2|COMPLETED|Period 2：Open-label Period||71
1455559|NCT02081599|3562854|P1|COMPLETED|Period 2：Open-label Period||57
1455560|NCT02081599|3562853|P2|STARTED|Period 2：Open-label Period||75
1455561|NCT02081599|3562854|P1|STARTED|Period 2：Open-label Period||63
1455562|NCT02081599|3562853|P2|NOT COMPLETED|Period 1：Double-blind Period||2
1455563|NCT02081599|3562854|P1|NOT COMPLETED|Period 1：Double-blind Period||8
1455564|NCT02081599|3562853|P2|COMPLETED|Period 1：Double-blind Period||75
1455565|NCT02081599|3562854|P1|COMPLETED|Period 1：Double-blind Period||63
1455566|NCT02081599|3562853|P2|STARTED|Period 1：Double-blind Period||77
1455567|NCT02081599|3562854|P1|STARTED|Period 1：Double-blind Period||71
1455568|NCT02081586|3562872|P4|NOT COMPLETED|Overall Study||1
1455569|NCT02081586|3562873|P3|NOT COMPLETED|Overall Study||1
1455570|NCT02081586|3562874|P2|NOT COMPLETED|Overall Study||1
1455571|NCT02081586|3562875|P1|NOT COMPLETED|Overall Study||0
1455572|NCT02081586|3562872|P4|COMPLETED|Overall Study||2
1455573|NCT02081586|3562873|P3|COMPLETED|Overall Study||3
1455574|NCT02081586|3562874|P2|COMPLETED|Overall Study||2
1455575|NCT02081586|3562875|P1|COMPLETED|Overall Study||3
1455576|NCT02081586|3562872|P4|STARTED|Overall Study||3
1455577|NCT02081586|3562873|P3|STARTED|Overall Study||4
1455578|NCT02081586|3562874|P2|STARTED|Overall Study||3
1455579|NCT02081586|3562875|P1|STARTED|Overall Study||3
1455580|NCT02081573|3562902|P1|NOT COMPLETED|Overall Study||0
1455581|NCT02081573|3562902|P1|COMPLETED|Overall Study||10
1455582|NCT02081573|3562902|P1|STARTED|Overall Study||10
1455583|NCT02081456|3562913|P2|NOT COMPLETED|Overall Study||0
1455584|NCT02081456|3562914|P1|NOT COMPLETED|Overall Study||0
1455585|NCT02081456|3562913|P2|COMPLETED|Overall Study||12
1455586|NCT02081456|3562914|P1|COMPLETED|Overall Study||11
1455587|NCT02081456|3562913|P2|STARTED|Overall Study||12
1455588|NCT02081456|3562914|P1|STARTED|Overall Study||11
1455589|NCT02081443|3562928|P2|NOT COMPLETED|Overall Study||0
1455590|NCT02081443|3562929|P1|NOT COMPLETED|Overall Study||0
1455591|NCT02081443|3562928|P2|COMPLETED|Overall Study||30
1455592|NCT02081443|3562929|P1|COMPLETED|Overall Study||30
1455593|NCT02081443|3562928|P2|STARTED|Overall Study||30
1455594|NCT02081443|3562929|P1|STARTED|Overall Study||30
1455595|NCT02081365|3562941|P2|NOT COMPLETED|Overall Study||23
1455596|NCT02081365|3562942|P1|NOT COMPLETED|Overall Study||30
1455597|NCT02081365|3562941|P2|COMPLETED|Overall Study||54
1455598|NCT02081365|3562942|P1|COMPLETED|Overall Study||44
1455599|NCT02081365|3562941|P2|Received Allocated Intervention|Overall Study||59
1455600|NCT02081365|3562942|P1|Received Allocated Intervention|Overall Study||46
1455601|NCT02081365|3562941|P2|STARTED|Overall Study||77
1455602|NCT02081365|3562942|P1|STARTED|Overall Study||74
1455603|NCT02081248|3562956|P2|NOT COMPLETED|Overall Study||13
1455604|NCT02081248|3562957|P1|NOT COMPLETED|Overall Study||22
1455605|NCT02081248|3562956|P2|COMPLETED|Overall Study||87
1455606|NCT02081248|3562957|P1|COMPLETED|Overall Study||76
1455607|NCT02081248|3562956|P2|STARTED|Overall Study||100
1455608|NCT02081248|3562957|P1|STARTED|Overall Study||98
1455609|NCT02081183|3562981|P2|NOT COMPLETED|Overall Study||4
1455610|NCT02081183|3562982|P1|NOT COMPLETED|Overall Study||4
1455611|NCT02081183|3562981|P2|COMPLETED|Overall Study||2
1455612|NCT02081183|3562982|P1|COMPLETED|Overall Study||1
1455613|NCT02081183|3562981|P2|STARTED|Overall Study||6
1455614|NCT02081183|3562982|P1|STARTED|Overall Study||5
1455615|NCT02081079|3562998|P2|NOT COMPLETED|Overall Study||2
1455616|NCT02081079|3562999|P1|NOT COMPLETED|Overall Study||4
1455617|NCT02081079|3562998|P2|COMPLETED|Overall Study||39
1455618|NCT02081079|3562999|P1|COMPLETED|Overall Study||40
1455619|NCT02081079|3562998|P2|STARTED|Overall Study||41
1455620|NCT02081079|3562999|P1|STARTED|Overall Study||44
1455621|NCT02081014|3563021|P6|NOT COMPLETED|Overall Study||0
1455622|NCT02081014|3563022|P5|NOT COMPLETED|Overall Study||0
1455623|NCT02081014|3563023|P4|NOT COMPLETED|Overall Study||0
1455624|NCT02081014|3563024|P3|NOT COMPLETED|Overall Study||0
1455625|NCT02081014|3563025|P2|NOT COMPLETED|Overall Study||0
1455626|NCT02081014|3563026|P1|NOT COMPLETED|Overall Study||0
1455627|NCT02081014|3563021|P6|COMPLETED|Overall Study||2
1455628|NCT02081014|3563022|P5|COMPLETED|Overall Study||2
1455629|NCT02081014|3563023|P4|COMPLETED|Overall Study||2
1455630|NCT02081014|3563024|P3|COMPLETED|Overall Study||2
1455631|NCT02081014|3563025|P2|COMPLETED|Overall Study||2
1455632|NCT02081014|3563026|P1|COMPLETED|Overall Study||2
1455633|NCT02081014|3563021|P6|STARTED|Overall Study||2
1455634|NCT02081014|3563022|P5|STARTED|Overall Study||2
1455635|NCT02081014|3563023|P4|STARTED|Overall Study||2
1455636|NCT02081014|3563024|P3|STARTED|Overall Study||2
1455637|NCT02081014|3563025|P2|STARTED|Overall Study||2
1455638|NCT02081014|3563026|P1|STARTED|Overall Study||2
1455639|NCT02081001|3563072|P12|NOT COMPLETED|Overall Study||0
1455640|NCT02081001|3563073|P11|NOT COMPLETED|Overall Study||0
1455641|NCT02081001|3563074|P10|NOT COMPLETED|Overall Study||0
1455642|NCT02081001|3563075|P9|NOT COMPLETED|Overall Study||0
1455643|NCT02081001|3563076|P8|NOT COMPLETED|Overall Study||0
1455644|NCT02081001|3563077|P7|NOT COMPLETED|Overall Study||0
1455645|NCT02081001|3563078|P6|NOT COMPLETED|Overall Study||0
1455646|NCT02081001|3563079|P5|NOT COMPLETED|Overall Study||1
1455647|NCT02081001|3563080|P4|NOT COMPLETED|Overall Study||0
1455648|NCT02081001|3563081|P3|NOT COMPLETED|Overall Study||0
1455649|NCT02081001|3563082|P2|NOT COMPLETED|Overall Study||0
1455650|NCT02081001|3563083|P1|NOT COMPLETED|Overall Study||0
1455651|NCT02081001|3563072|P12|COMPLETED|Overall Study||1
1455652|NCT02081001|3563073|P11|COMPLETED|Overall Study||2
1455653|NCT02081001|3563074|P10|COMPLETED|Overall Study||1
1455654|NCT02081001|3563075|P9|COMPLETED|Overall Study||2
1455655|NCT02081001|3563076|P8|COMPLETED|Overall Study||1
1455656|NCT02081001|3563077|P7|COMPLETED|Overall Study||2
1455657|NCT02081001|3563078|P6|COMPLETED|Overall Study||1
1455658|NCT02081001|3563079|P5|COMPLETED|Overall Study||2
1455659|NCT02081001|3563080|P4|COMPLETED|Overall Study||1
1455660|NCT02081001|3563081|P3|COMPLETED|Overall Study||2
1455661|NCT02081001|3563082|P2|COMPLETED|Overall Study||1
1455662|NCT02081001|3563083|P1|COMPLETED|Overall Study||2
1455663|NCT02081001|3563072|P12|STARTED|Overall Study||1
1455664|NCT02081001|3563073|P11|STARTED|Overall Study||2
1455665|NCT02081001|3563074|P10|STARTED|Overall Study||1
1455666|NCT02081001|3563075|P9|STARTED|Overall Study||2
1455667|NCT02081001|3563076|P8|STARTED|Overall Study||1
1455668|NCT02081001|3563077|P7|STARTED|Overall Study||2
1455669|NCT02081001|3563078|P6|STARTED|Overall Study||1
1455670|NCT02081001|3563079|P5|STARTED|Overall Study||3
1455671|NCT02081001|3563080|P4|STARTED|Overall Study||1
1455672|NCT02081001|3563081|P3|STARTED|Overall Study||2
1455673|NCT02081001|3563082|P2|STARTED|Overall Study||1
1455674|NCT02081001|3563083|P1|STARTED|Overall Study||2
1455675|NCT02080871|3563147|P1|NOT COMPLETED|Overall Study||2
1455676|NCT02080871|3563147|P1|COMPLETED|Overall Study||132
1455677|NCT02080871|3563147|P1|STARTED|Overall Study||134
1455678|NCT02080832|3563192|P3|NOT COMPLETED|Overall Study||16
1455679|NCT02080832|3563193|P2|NOT COMPLETED|Overall Study||12
1455680|NCT02080832|3563194|P1|NOT COMPLETED|Overall Study||9
1455681|NCT02080832|3563192|P3|COMPLETED|Overall Study||6
1455682|NCT02080832|3563193|P2|COMPLETED|Overall Study||5
1455683|NCT02080832|3563194|P1|COMPLETED|Overall Study||6
1455684|NCT02080832|3563192|P3|STARTED|Overall Study||22
1455685|NCT02080832|3563193|P2|STARTED|Overall Study||17
1455686|NCT02080832|3563194|P1|STARTED|Overall Study||15
1455687|NCT02080819|3563211|P3|NOT COMPLETED|Overall Study||22
1455688|NCT02080819|3563212|P2|NOT COMPLETED|Overall Study||26
1455689|NCT02080819|3563213|P1|NOT COMPLETED|Overall Study||25
1455690|NCT02080819|3563211|P3|COMPLETED|Overall Study||11
1455691|NCT02080819|3563212|P2|COMPLETED|Overall Study||9
1455692|NCT02080819|3563213|P1|COMPLETED|Overall Study||38
1455693|NCT02080819|3563211|P3|STARTED|Overall Study||33
1455694|NCT02080819|3563212|P2|STARTED|Overall Study||35
1455695|NCT02080819|3563213|P1|STARTED|Overall Study||63
1455696|NCT02080780|3563221|P1|NOT COMPLETED|Overall Study||0
1455697|NCT02080780|3563221|P1|COMPLETED|Overall Study||24
1455698|NCT02080780|3563221|P1|STARTED|Overall Study||24
1455699|NCT02080546|3563230|P2|NOT COMPLETED|Overall Study||11
1455700|NCT02080546|3563231|P1|NOT COMPLETED|Overall Study||8
1455701|NCT02080546|3563230|P2|COMPLETED|Overall Study||52
1455702|NCT02080546|3563231|P1|COMPLETED|Overall Study||49
1455703|NCT02080546|3563230|P2|STARTED|Overall Study||63
1455704|NCT02080546|3563231|P1|STARTED|Overall Study||57
1455705|NCT02080507|3563241|P2|NOT COMPLETED|Overall Study||0
1455706|NCT02080507|3563242|P1|NOT COMPLETED|Overall Study||0
1455707|NCT02080507|3563241|P2|COMPLETED|Overall Study||7
1455708|NCT02080507|3563242|P1|COMPLETED|Overall Study||5
1455709|NCT02080507|3563241|P2|STARTED|Overall Study||7
1455710|NCT02080507|3563242|P1|STARTED|Overall Study||5
1455711|NCT02080481|3563252|P2|NOT COMPLETED|Overall Study||0
1455712|NCT02080481|3563253|P1|NOT COMPLETED|Overall Study||1
1455713|NCT02080481|3563252|P2|COMPLETED|Overall Study||67
1455714|NCT02080481|3563253|P1|COMPLETED|Overall Study||67
1455715|NCT02080481|3563252|P2|STARTED|Overall Study||67
1455716|NCT02080481|3563253|P1|STARTED|Overall Study||68
1455717|NCT02080312|3563265|P1|NOT COMPLETED|Overall Study||0
1455718|NCT02080312|3563265|P1|COMPLETED|Overall Study||6
1455719|NCT02080312|3563265|P1|STARTED|Overall Study||6
1455720|NCT02080195|3563271|P1|NOT COMPLETED|Overall Study||0
1455721|NCT02080195|3563271|P1|COMPLETED|Overall Study||1
1455722|NCT02080195|3563271|P1|STARTED|Overall Study||1
1455723|NCT02080091|3563280|P1|NOT COMPLETED|Overall Study||25
1455724|NCT02080091|3563280|P1|COMPLETED|Overall Study||0
1455725|NCT02080091|3563280|P1|STARTED|Overall Study||25
1455726|NCT02079909|3563289|P3|NOT COMPLETED|Overall Study||18
1455727|NCT02079909|3563290|P2|NOT COMPLETED|Overall Study||49
1455728|NCT02079909|3563291|P1|NOT COMPLETED|Overall Study||38
1455729|NCT02079909|3563289|P3|COMPLETED|Overall Study||140
1455730|NCT02079909|3563290|P2|COMPLETED|Overall Study||117
1455731|NCT02079909|3563291|P1|COMPLETED|Overall Study||120
1455732|NCT02079909|3563289|P3|STARTED|Overall Study||158
1455733|NCT02079909|3563290|P2|STARTED|Overall Study||166
1455734|NCT02079909|3563291|P1|STARTED|Overall Study||158
1455735|NCT02079844|3563308|P3|NOT COMPLETED|Treatment Period 3||0
1455736|NCT02079844|3563309|P2|NOT COMPLETED|Treatment Period 3||0
1455737|NCT02079844|3563310|P1|NOT COMPLETED|Treatment Period 3||0
1455738|NCT02079844|3563308|P3|COMPLETED|Treatment Period 3||5
1455739|NCT02079844|3563309|P2|COMPLETED|Treatment Period 3||5
1455740|NCT02079844|3563310|P1|COMPLETED|Treatment Period 3||5
1455741|NCT02079844|3563308|P3|STARTED|Treatment Period 3||5
1455742|NCT02079844|3563309|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
1455743|NCT02079844|3563310|P1|STARTED|Treatment Period 3||5
1455744|NCT02079844|3563308|P3|NOT COMPLETED|Treatment Period 2||0
1455745|NCT02079844|3563309|P2|NOT COMPLETED|Treatment Period 2||1
1455746|NCT02079844|3563310|P1|NOT COMPLETED|Treatment Period 2||0
1455747|NCT02079844|3563308|P3|COMPLETED|Treatment Period 2||5
1455748|NCT02079844|3563309|P2|COMPLETED|Treatment Period 2||6
1455749|NCT02079844|3563310|P1|COMPLETED|Treatment Period 2||5
1455750|NCT02079844|3563308|P3|STARTED|Treatment Period 2||5
1455751|NCT02079844|3563309|P2|STARTED|Treatment Period 2||7
1455752|NCT02079844|3563310|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
1455753|NCT02079844|3563308|P3|NOT COMPLETED|Treatment Period 1||2
1455754|NCT02079844|3563309|P2|NOT COMPLETED|Treatment Period 1||0
1455755|NCT02079844|3563310|P1|NOT COMPLETED|Treatment Period 1||0
1455756|NCT02079844|3563308|P3|COMPLETED|Treatment Period 1||5
1455757|NCT02079844|3563309|P2|COMPLETED|Treatment Period 1||7
1455758|NCT02079844|3563310|P1|COMPLETED|Treatment Period 1||6
1455759|NCT02079844|3563308|P3|STARTED|Treatment Period 1||7
1455760|NCT02079844|3563309|P2|STARTED|Treatment Period 1||7
1455761|NCT02079844|3563310|P1|STARTED|Treatment Period 1||6
1455762|NCT02079805|3563368|P2|NOT COMPLETED|Overall Study||2
1455763|NCT02079805|3563369|P1|NOT COMPLETED|Overall Study||0
1455764|NCT02079805|3563368|P2|COMPLETED|Overall Study||15
1455765|NCT02079805|3563369|P1|COMPLETED|Overall Study||16
1455766|NCT02079805|3563368|P2|STARTED|Overall Study||17
1455767|NCT02079805|3563369|P1|STARTED|Overall Study||16
1455768|NCT02079649|3563391|P4|NOT COMPLETED|Overall Study||2
1455769|NCT02079649|3563392|P3|NOT COMPLETED|Overall Study||1
1455770|NCT02079649|3563393|P2|NOT COMPLETED|Overall Study||0
1455771|NCT02079649|3563394|P1|NOT COMPLETED|Overall Study||1
1455772|NCT02079649|3563391|P4|COMPLETED|Overall Study||38
1455773|NCT02079649|3563392|P3|COMPLETED|Overall Study||40
1455774|NCT02079649|3563393|P2|COMPLETED|Overall Study||41
1455775|NCT02079649|3563394|P1|COMPLETED|Overall Study||41
1455776|NCT02079649|3563391|P4|Treated|Overall Study||40
1455777|NCT02079649|3563392|P3|Treated|Overall Study||40
1455778|NCT02079649|3563393|P2|Treated|Overall Study||41
1455779|NCT02079649|3563394|P1|Treated|Overall Study||41
1455780|NCT02079649|3563391|P4|STARTED|Overall Study||40
1455781|NCT02079649|3563392|P3|STARTED|Overall Study||41
1455782|NCT02079649|3563393|P2|STARTED|Overall Study||41
1455783|NCT02079649|3563394|P1|STARTED|Overall Study||42
1455784|NCT02079610|3563411|P2|NOT COMPLETED|Overall Study||1
1455785|NCT02079610|3563412|P1|NOT COMPLETED|Overall Study||1
1455786|NCT02079610|3563411|P2|COMPLETED|Overall Study||16
1455787|NCT02079610|3563412|P1|COMPLETED|Overall Study||18
1455788|NCT02079610|3563411|P2|STARTED|Overall Study||17
1455789|NCT02079610|3563412|P1|STARTED|Overall Study||19
1455790|NCT02079532|3563422|P1|NOT COMPLETED|Overall Study||29
1455791|NCT02079532|3563422|P1|COMPLETED|Overall Study||273
1455792|NCT02079532|3563422|P1|STARTED|Overall Study||302
1455793|NCT02079519|3563444|P1|NOT COMPLETED|Overall Study||10
1455794|NCT02079519|3563444|P1|COMPLETED|Overall Study||0
1455795|NCT02079519|3563444|P1|STARTED|Overall Study||10
1455796|NCT02079311|3563450|P2|NOT COMPLETED|Overall Study||1
1455797|NCT02079311|3563451|P1|NOT COMPLETED|Overall Study||0
1455798|NCT02079311|3563450|P2|COMPLETED|Overall Study||26
1455799|NCT02079311|3563451|P1|COMPLETED|Overall Study||28
1455800|NCT02079311|3563450|P2|STARTED|Overall Study||27
1455801|NCT02079311|3563451|P1|STARTED|Overall Study||28
1455802|NCT02079246|3563457|P2|NOT COMPLETED|OLEX-MEM||19
1455803|NCT02079246|3563458|P1|NOT COMPLETED|OLEX-MEM||0
1455804|NCT02079246|3563457|P2|COMPLETED|OLEX-MEM||82
1455805|NCT02079246|3563458|P1|COMPLETED|OLEX-MEM||0
1455806|NCT02079246|3563457|P2|STARTED|OLEX-MEM||101
1455807|NCT02079246|3563458|P1|STARTED|OLEX-MEM||0
1455808|NCT02079246|3563457|P2|NOT COMPLETED|OLEX||0
1455809|NCT02079246|3563458|P1|NOT COMPLETED|OLEX||228
1455810|NCT02079246|3563457|P2|COMPLETED|OLEX||0
1455811|NCT02079246|3563458|P1|COMPLETED|OLEX||1235
1455812|NCT02079246|3563457|P2|STARTED|OLEX||0
1455813|NCT02079246|3563458|P1|STARTED|OLEX||1463
1455814|NCT02078713|3563479|P4|NOT COMPLETED|Overall Study||0
1455815|NCT02078713|3563480|P3|NOT COMPLETED|Overall Study||0
1455816|NCT02078713|3563481|P2|NOT COMPLETED|Overall Study||61
1455817|NCT02078713|3563482|P1|NOT COMPLETED|Overall Study||52
1455818|NCT02078713|3563479|P4|COMPLETED|Overall Study||13
1455819|NCT02078713|3563480|P3|COMPLETED|Overall Study||15
1455820|NCT02078713|3563481|P2|COMPLETED|Overall Study||290
1455821|NCT02078713|3563482|P1|COMPLETED|Overall Study||355
1455822|NCT02078713|3563479|P4|STARTED|Overall Study||13
1455823|NCT02078713|3563480|P3|STARTED|Overall Study||15
1455824|NCT02078713|3563481|P2|STARTED|Overall Study||351
1455825|NCT02078713|3563482|P1|STARTED|Overall Study||407
1455826|NCT02078557|3563534|P1|NOT COMPLETED|Overall Study||0
1455827|NCT02078557|3563534|P1|COMPLETED|Overall Study||4
1455828|NCT02078557|3563534|P1|STARTED|Overall Study||4
1455829|NCT02078492|3563543|P3|NOT COMPLETED|Overall Study||0
1455830|NCT02078492|3563544|P2|NOT COMPLETED|Overall Study||0
1455831|NCT02078492|3563545|P1|NOT COMPLETED|Overall Study||0
1455832|NCT02078492|3563543|P3|COMPLETED|Overall Study||80
1455833|NCT02078492|3563544|P2|COMPLETED|Overall Study||80
1455834|NCT02078492|3563545|P1|COMPLETED|Overall Study||80
1455835|NCT02078492|3563543|P3|STARTED|Overall Study||80
1455836|NCT02078492|3563544|P2|STARTED|Overall Study||80
1455837|NCT02078492|3563545|P1|STARTED|Overall Study||80
1455838|NCT02078193|3563562|P1|NOT COMPLETED|Overall Study||0
1455839|NCT02078193|3563562|P1|COMPLETED|Overall Study||3
1455840|NCT02078193|3563562|P1|STARTED|Overall Study||3
1455841|NCT02078180|3563568|P1|NOT COMPLETED|Overall Study||5
1455842|NCT02078180|3563568|P1|COMPLETED|Overall Study||29
1455843|NCT02078180|3563568|P1|XL 300|Overall Study||32
1455844|NCT02078180|3563568|P1|XL 150|Overall Study||31
1455845|NCT02078180|3563568|P1|SR150|Overall Study||32
1455846|NCT02078180|3563568|P1|SR100|Overall Study||31
1455847|NCT02078180|3563568|P1|IR100|Overall Study||31
1455848|NCT02078180|3563568|P1|IR75|Overall Study||30
1455849|NCT02078180|3563568|P1|STARTED|Overall Study||34
1455850|NCT02077374|3563585|P2|NOT COMPLETED|Overall Study||2
1455851|NCT02077374|3563586|P1|NOT COMPLETED|Overall Study||0
1455852|NCT02077374|3563585|P2|COMPLETED|Overall Study||17
1455853|NCT02077374|3563586|P1|COMPLETED|Overall Study||19
1455854|NCT02077374|3563585|P2|STARTED|Overall Study||19
1455855|NCT02077374|3563586|P1|STARTED|Overall Study||19
1455856|NCT02077140|3563607|P5|NOT COMPLETED|Overall Study||5
1455857|NCT02077140|3563608|P4|NOT COMPLETED|Overall Study||4
1455858|NCT02077140|3563609|P3|NOT COMPLETED|Overall Study||2
1455859|NCT02077140|3563610|P2|NOT COMPLETED|Overall Study||2
1455860|NCT02077140|3563611|P1|NOT COMPLETED|Overall Study||4
1455861|NCT02077140|3563607|P5|COMPLETED|Overall Study||43
1455862|NCT02077140|3563608|P4|COMPLETED|Overall Study||32
1455863|NCT02077140|3563609|P3|COMPLETED|Overall Study||34
1455864|NCT02077140|3563610|P2|COMPLETED|Overall Study||34
1455865|NCT02077140|3563611|P1|COMPLETED|Overall Study||32
1455866|NCT02077140|3563607|P5|STARTED|Overall Study||48
1455867|NCT02077140|3563608|P4|STARTED|Overall Study||36
1455868|NCT02077140|3563609|P3|STARTED|Overall Study||36
1455869|NCT02077140|3563610|P2|STARTED|Overall Study||36
1455870|NCT02077140|3563611|P1|STARTED|Overall Study||36
1455871|NCT02076919|3563710|P4|NOT COMPLETED|Overall Study||0
1455872|NCT02076919|3563711|P3|NOT COMPLETED|Overall Study||0
1455873|NCT02076919|3563712|P2|NOT COMPLETED|Overall Study||0
1455874|NCT02076919|3563713|P1|NOT COMPLETED|Overall Study||0
1455875|NCT02076919|3563710|P4|COMPLETED|Overall Study||12
1455876|NCT02076919|3563711|P3|COMPLETED|Overall Study||36
1455877|NCT02076919|3563712|P2|COMPLETED|Overall Study||8
1455878|NCT02076919|3563713|P1|COMPLETED|Overall Study||24
1455879|NCT02076919|3563710|P4|STARTED|Overall Study||12
1455880|NCT02076919|3563711|P3|STARTED|Overall Study||36
1455881|NCT02076919|3563712|P2|STARTED|Overall Study||8
1455882|NCT02076919|3563713|P1|STARTED|Overall Study||24
1455883|NCT02076776|3563814|P3|NOT COMPLETED|Overall Study||0
1455884|NCT02076776|3563815|P2|NOT COMPLETED|Overall Study||2
1455885|NCT02076776|3563816|P1|NOT COMPLETED|Overall Study||1
1455886|NCT02076776|3563814|P3|COMPLETED|Overall Study||6
1455887|NCT02076776|3563815|P2|COMPLETED|Overall Study||6
1455888|NCT02076776|3563816|P1|COMPLETED|Overall Study||5
1455889|NCT02076776|3563814|P3|STARTED|Overall Study||6
1455890|NCT02076776|3563815|P2|STARTED|Overall Study||8
1455891|NCT02076776|3563816|P1|STARTED|Overall Study||6
1455892|NCT02076334|3563834|P4|NOT COMPLETED|Overall Study||1
1455893|NCT02076334|3563835|P3|NOT COMPLETED|Overall Study||1
1455894|NCT02076334|3563836|P2|NOT COMPLETED|Overall Study||1
1455895|NCT02076334|3563837|P1|NOT COMPLETED|Overall Study||1
1455896|NCT02076334|3563834|P4|COMPLETED|Overall Study||20
1455897|NCT02076334|3563835|P3|COMPLETED|Overall Study||20
1455898|NCT02076334|3563836|P2|COMPLETED|Overall Study||20
1455899|NCT02076334|3563837|P1|COMPLETED|Overall Study||20
1455900|NCT02076334|3563834|P4|STARTED|Overall Study||21
1455901|NCT02076334|3563835|P3|STARTED|Overall Study||21
1455902|NCT02076334|3563836|P2|STARTED|Overall Study||21
1455903|NCT02076334|3563837|P1|STARTED|Overall Study||21
1455904|NCT02076321|3563853|P2|NOT COMPLETED|Overall Study||2
1455905|NCT02076321|3563854|P1|NOT COMPLETED|Overall Study||5
1455906|NCT02076321|3563853|P2|COMPLETED|Overall Study||49
1455907|NCT02076321|3563854|P1|COMPLETED|Overall Study||46
1455908|NCT02076321|3563853|P2|STARTED|Overall Study||51
1455909|NCT02076321|3563854|P1|STARTED|Overall Study||51
1455910|NCT02076243|3563860|P1|NOT COMPLETED|Overall Study||2
1455911|NCT02076243|3563860|P1|COMPLETED|Overall Study||0
1455912|NCT02076243|3563860|P1|STARTED|Overall Study||2
1455913|NCT02076178|3563870|P2|NOT COMPLETED|Injection Phase||7
1455914|NCT02076178|3563871|P1|NOT COMPLETED|Injection Phase||1
1455915|NCT02076178|3563870|P2|COMPLETED|Injection Phase||87
1455916|NCT02076178|3563871|P1|COMPLETED|Injection Phase||20
1455917|NCT02076178|3563870|P2|STARTED|Injection Phase||94
1455918|NCT02076178|3563871|P1|STARTED|Injection Phase||21
1455919|NCT02076178|3563870|P2|NOT COMPLETED|Oral Phase||12
1455920|NCT02076178|3563871|P1|NOT COMPLETED|Oral Phase||0
1455921|NCT02076178|3563870|P2|COMPLETED|Oral Phase||94
1455922|NCT02076178|3563871|P1|COMPLETED|Oral Phase||21
1455923|NCT02076178|3563870|P2|STARTED|Oral Phase||106
1455924|NCT02076178|3563871|P1|STARTED|Oral Phase||21
1455925|NCT02076100|3563910|P7|NOT COMPLETED|Overall Study||0
1455926|NCT02076100|3563911|P6|NOT COMPLETED|Overall Study||0
1455927|NCT02076100|3563912|P5|NOT COMPLETED|Overall Study||0
1455928|NCT02076100|3563913|P4|NOT COMPLETED|Overall Study||0
1455929|NCT02076100|3563914|P3|NOT COMPLETED|Overall Study||0
1455930|NCT02076100|3563915|P2|NOT COMPLETED|Overall Study||0
1455931|NCT02076100|3563916|P1|NOT COMPLETED|Overall Study||0
1455932|NCT02076100|3563910|P7|COMPLETED|Overall Study||4
1455933|NCT02076100|3563911|P6|COMPLETED|Overall Study||3
1455934|NCT02076100|3563912|P5|COMPLETED|Overall Study||3
1455935|NCT02076100|3563913|P4|COMPLETED|Overall Study||3
1455936|NCT02076100|3563914|P3|COMPLETED|Overall Study||3
1455937|NCT02076100|3563915|P2|COMPLETED|Overall Study||3
1455938|NCT02076100|3563916|P1|COMPLETED|Overall Study||3
1455939|NCT02076100|3563910|P7|STARTED|Overall Study||4
1455940|NCT02076100|3563911|P6|STARTED|Overall Study||3
1455941|NCT02076100|3563912|P5|STARTED|Overall Study||3
1455942|NCT02076100|3563913|P4|STARTED|Overall Study||3
1455943|NCT02076100|3563914|P3|STARTED|Overall Study||3
1455944|NCT02076100|3563915|P2|STARTED|Overall Study||3
1455945|NCT02076100|3563916|P1|STARTED|Overall Study||3
1455946|NCT02076009|3563949|P2|NOT COMPLETED|Overall Study||286
1455947|NCT02076009|3563950|P1|NOT COMPLETED|Overall Study||283
1455948|NCT02076009|3563949|P2|COMPLETED|Overall Study||0
1455949|NCT02076009|3563950|P1|COMPLETED|Overall Study||0
1455950|NCT02076009|3563949|P2|Treated|Overall Study||283
1455951|NCT02076009|3563950|P1|Treated|Overall Study||281
1455952|NCT02076009|3563949|P2|STARTED|Overall Study||286
1455953|NCT02076009|3563950|P1|STARTED|Overall Study||283
1455954|NCT02075840|3563972|P2|NOT COMPLETED|Overall Study||151
1455955|NCT02075840|3563973|P1|NOT COMPLETED|Overall Study||152
1455956|NCT02075840|3563972|P2|COMPLETED|Overall Study||0
1455957|NCT02075840|3563973|P1|COMPLETED|Overall Study||0
1455958|NCT02075840|3563972|P2|STARTED|Overall Study||151
1455959|NCT02075840|3563973|P1|STARTED|Overall Study||152
1455960|NCT02075658|3564029|P2|NOT COMPLETED|Overall Study||2
1455961|NCT02075658|3564030|P1|NOT COMPLETED|Overall Study||2
1455962|NCT02075658|3564029|P2|COMPLETED|Overall Study||28
1455963|NCT02075658|3564030|P1|COMPLETED|Overall Study||28
1455964|NCT02075658|3564029|P2|STARTED|Overall Study||30
1455965|NCT02075658|3564030|P1|STARTED|Overall Study||30
1455966|NCT02075632|3564040|P2|NOT COMPLETED|Overall Study||5
1455967|NCT02075632|3564041|P1|NOT COMPLETED|Overall Study||1
1455968|NCT02075632|3564040|P2|COMPLETED|Overall Study||143
1455969|NCT02075632|3564041|P1|COMPLETED|Overall Study||161
1455970|NCT02075632|3564040|P2|STARTED|Overall Study||148
1455971|NCT02075632|3564041|P1|STARTED|Overall Study||162
1455972|NCT02075541|3564053|P2|NOT COMPLETED|Overall Study||8
1455973|NCT02075541|3564054|P1|NOT COMPLETED|Overall Study||4
1455974|NCT02075541|3564053|P2|COMPLETED|Overall Study||64
1455975|NCT02075541|3564054|P1|COMPLETED|Overall Study||69
1455976|NCT02075541|3564053|P2|STARTED|Overall Study||72
1455977|NCT02075541|3564054|P1|STARTED|Overall Study||73
1455978|NCT02075515|3564103|P3|NOT COMPLETED|Overall Study||8
1455979|NCT02075515|3564104|P2|NOT COMPLETED|Overall Study||5
1455980|NCT02075515|3564105|P1|NOT COMPLETED|Overall Study||4
1455981|NCT02075515|3564103|P3|COMPLETED|Overall Study||208
1455982|NCT02075515|3564104|P2|COMPLETED|Overall Study||212
1455983|NCT02075515|3564105|P1|COMPLETED|Overall Study||214
1455984|NCT02075515|3564103|P3|STARTED|Overall Study||216
1455985|NCT02075515|3564104|P2|STARTED|Overall Study||217
1455986|NCT02075515|3564105|P1|STARTED|Overall Study||218
1455987|NCT02075463|3564140|P1|NOT COMPLETED|Overall Study||8
1455988|NCT02075463|3564140|P1|COMPLETED|Overall Study||7
1455989|NCT02075463|3564140|P1|STARTED|Overall Study||15
1455990|NCT02075411|3564169|P4|NOT COMPLETED|Overall Study||0
1455991|NCT02075411|3564170|P3|NOT COMPLETED|Overall Study||0
1455992|NCT02075411|3564171|P2|NOT COMPLETED|Overall Study||0
1455993|NCT02075411|3564172|P1|NOT COMPLETED|Overall Study||0
1455994|NCT02075411|3564169|P4|COMPLETED|Overall Study||1
1455995|NCT02075411|3564170|P3|COMPLETED|Overall Study||0
1455996|NCT02075411|3564171|P2|COMPLETED|Overall Study||0
1455997|NCT02075411|3564172|P1|COMPLETED|Overall Study||0
1455998|NCT02075411|3564169|P4|STARTED|Overall Study||1
1455999|NCT02075411|3564170|P3|STARTED|Overall Study||0
1456000|NCT02075411|3564171|P2|STARTED|Overall Study||0
1456001|NCT02075411|3564172|P1|STARTED|Overall Study||0
1456002|NCT02075320|3564190|P1|NOT COMPLETED|Overall Study||2
1456003|NCT02075320|3564190|P1|COMPLETED|Overall Study||48
1456004|NCT02075320|3564190|P1|STARTED|Overall Study||50
1456005|NCT02075255|3564200|P3|NOT COMPLETED|Overall Study||3
1456006|NCT02075255|3564201|P2|NOT COMPLETED|Overall Study||4
1456007|NCT02075255|3564202|P1|NOT COMPLETED|Overall Study||4
1456008|NCT02075255|3564200|P3|COMPLETED|Overall Study||72
1456009|NCT02075255|3564201|P2|COMPLETED|Overall Study||69
1456010|NCT02075255|3564202|P1|COMPLETED|Overall Study||68
1456011|NCT02075255|3564200|P3|STARTED|Overall Study||75
1456012|NCT02075255|3564201|P2|STARTED|Overall Study||73
1456013|NCT02075255|3564202|P1|STARTED|Overall Study||72
1456014|NCT02075125|3564311|P2|NOT COMPLETED|Overall Study||1
1456015|NCT02075125|3564312|P1|NOT COMPLETED|Overall Study||0
1456016|NCT02075125|3564311|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
1456017|NCT02075125|3564312|P1|COMPLETED|Overall Study||19
1456018|NCT02075125|3564311|P2|STARTED|Overall Study||20
1456019|NCT02075125|3564312|P1|STARTED|Overall Study||19
1456020|NCT02075073|3564333|P3|NOT COMPLETED|Overall Study||0
1456021|NCT02075073|3564334|P2|NOT COMPLETED|Overall Study||1
1456022|NCT02075073|3564335|P1|NOT COMPLETED|Overall Study||0
1456023|NCT02075073|3564333|P3|COMPLETED|Overall Study||36
1456024|NCT02075073|3564334|P2|COMPLETED|Overall Study||36
1456025|NCT02075073|3564335|P1|COMPLETED|Overall Study||36
1456026|NCT02075073|3564333|P3|STARTED|Overall Study||36
1456027|NCT02075073|3564334|P2|STARTED|Overall Study||37
1456028|NCT02075073|3564335|P1|STARTED|Overall Study||36
1456029|NCT02075021|3564352|P1|NOT COMPLETED|Overall Study||0
1456030|NCT02075021|3564352|P1|COMPLETED|Overall Study||3
1456031|NCT02075021|3564352|P1|STARTED|Overall Study||3
1456032|NCT02075008|3564357|P1|NOT COMPLETED|Overall Study||176
1456033|NCT02075008|3564357|P1|COMPLETED|Overall Study||94
1456034|NCT02075008|3564357|P1|STARTED|Overall Study||270
1456035|NCT02074995|3564361|P3|NOT COMPLETED|Overall Study||0
1456036|NCT02074995|3564362|P2|NOT COMPLETED|Overall Study||0
1456037|NCT02074995|3564363|P1|NOT COMPLETED|Overall Study||0
1456038|NCT02074995|3564361|P3|COMPLETED|Overall Study||0
1456039|NCT02074995|3564362|P2|COMPLETED|Overall Study||0
1456040|NCT02074995|3564363|P1|COMPLETED|Overall Study||1
1456041|NCT02074995|3564361|P3|STARTED|Overall Study||0
1456042|NCT02074995|3564362|P2|STARTED|Overall Study||0
1456043|NCT02074995|3564363|P1|STARTED|Overall Study||1
1456044|NCT02074982|3564380|P2|NOT COMPLETED|Overall Study||54
1456045|NCT02074982|3564381|P1|NOT COMPLETED|Overall Study||51
1456046|NCT02074982|3564380|P2|COMPLETED|Overall Study||285
1456047|NCT02074982|3564381|P1|COMPLETED|Overall Study||286
1456048|NCT02074982|3564380|P2|Safety Set (SF)|Overall Study||336
1456049|NCT02074982|3564381|P1|Safety Set (SF)|Overall Study||335
1456050|NCT02074982|3564380|P2|Full Analysis Set (FAS)|Overall Study||339
1456051|NCT02074982|3564381|P1|Full Analysis Set (FAS)|Overall Study||336
1456052|NCT02074982|3564380|P2|STARTED|Overall Study||339
1456053|NCT02074982|3564381|P1|STARTED|Overall Study||337
1456054|NCT02074904|3564393|P2|NOT COMPLETED|Overall Study||0
1456055|NCT02074904|3564394|P1|NOT COMPLETED|Overall Study||0
1456056|NCT02074904|3564393|P2|COMPLETED|Overall Study||0
1456057|NCT02074904|3564394|P1|COMPLETED|Overall Study||1
1456058|NCT02074904|3564393|P2|STARTED|Overall Study||0
1456059|NCT02074904|3564394|P1|STARTED|Overall Study||1
1456060|NCT02074735|3564410|P2|NOT COMPLETED|Overall Study||4
1456061|NCT02074735|3564411|P1|NOT COMPLETED|Overall Study||3
1456062|NCT02074735|3564410|P2|COMPLETED|Overall Study||29
1456063|NCT02074735|3564411|P1|COMPLETED|Overall Study||26
1456064|NCT02074735|3564410|P2|STARTED|Overall Study||33
1456065|NCT02074735|3564411|P1|STARTED|Overall Study||29
1456066|NCT02074709|3564419|P2|NOT COMPLETED|Overall Study||1
1456067|NCT02074709|3564420|P1|NOT COMPLETED|Overall Study||1
1456068|NCT02074709|3564419|P2|COMPLETED|Overall Study||29
1456069|NCT02074709|3564420|P1|COMPLETED|Overall Study||29
1456070|NCT02074709|3564419|P2|STARTED|Overall Study||30
1456071|NCT02074709|3564420|P1|STARTED|Overall Study||30
1456072|NCT02074553|3564428|P8|NOT COMPLETED|Intervention Period 4||0
1456073|NCT02074553|3564429|P7|NOT COMPLETED|Intervention Period 4||0
1456074|NCT02074553|3564430|P6|NOT COMPLETED|Intervention Period 4||0
1456075|NCT02074553|3564431|P5|NOT COMPLETED|Intervention Period 4||0
1456076|NCT02074553|3564432|P4|NOT COMPLETED|Intervention Period 4||0
1456077|NCT02074553|3564433|P3|NOT COMPLETED|Intervention Period 4||0
1456078|NCT02074553|3564434|P2|NOT COMPLETED|Intervention Period 4||0
1456079|NCT02074553|3564435|P1|NOT COMPLETED|Intervention Period 4||0
1456080|NCT02074553|3564428|P8|COMPLETED|Intervention Period 4||11
1456081|NCT02074553|3564429|P7|COMPLETED|Intervention Period 4||11
1456082|NCT02074553|3564430|P6|COMPLETED|Intervention Period 4||10
1456083|NCT02074553|3564431|P5|COMPLETED|Intervention Period 4||12
1456084|NCT02074553|3564432|P4|COMPLETED|Intervention Period 4||11
1456085|NCT02074553|3564433|P3|COMPLETED|Intervention Period 4||11
1456086|NCT02074553|3564434|P2|COMPLETED|Intervention Period 4||12
1456087|NCT02074553|3564435|P1|COMPLETED|Intervention Period 4||11
1456088|NCT02074553|3564428|P8|STARTED|Intervention Period 4||11
1456089|NCT02074553|3564429|P7|STARTED|Intervention Period 4||11
1456090|NCT02074553|3564430|P6|STARTED|Intervention Period 4||10
1456091|NCT02074553|3564431|P5|STARTED|Intervention Period 4||12
1456092|NCT02074553|3564432|P4|STARTED|Intervention Period 4||11
1456093|NCT02074553|3564433|P3|STARTED|Intervention Period 4||11
1456094|NCT02074553|3564434|P2|STARTED|Intervention Period 4||12
1456095|NCT02074553|3564435|P1|STARTED|Intervention Period 4||11
1456096|NCT02074553|3564428|P8|NOT COMPLETED|Washout Period 3||1
1456097|NCT02074553|3564429|P7|NOT COMPLETED|Washout Period 3||0
1456098|NCT02074553|3564430|P6|NOT COMPLETED|Washout Period 3||0
1456099|NCT02074553|3564431|P5|NOT COMPLETED|Washout Period 3||0
1456100|NCT02074553|3564432|P4|NOT COMPLETED|Washout Period 3||0
1456101|NCT02074553|3564433|P3|NOT COMPLETED|Washout Period 3||0
1456102|NCT02074553|3564434|P2|NOT COMPLETED|Washout Period 3||0
1456103|NCT02074553|3564435|P1|NOT COMPLETED|Washout Period 3||0
1456104|NCT02074553|3564428|P8|COMPLETED|Washout Period 3||11
1456105|NCT02074553|3564429|P7|COMPLETED|Washout Period 3||11
1456106|NCT02074553|3564430|P6|COMPLETED|Washout Period 3||10
1456107|NCT02074553|3564431|P5|COMPLETED|Washout Period 3||12
1456108|NCT02074553|3564432|P4|COMPLETED|Washout Period 3||11
1456109|NCT02074553|3564433|P3|COMPLETED|Washout Period 3||11
1456110|NCT02074553|3564434|P2|COMPLETED|Washout Period 3||12
1456111|NCT02074553|3564435|P1|COMPLETED|Washout Period 3||11
1456112|NCT02074553|3564428|P8|STARTED|Washout Period 3||12
1456113|NCT02074553|3564429|P7|STARTED|Washout Period 3||11
1456114|NCT02074553|3564430|P6|STARTED|Washout Period 3||10
1456115|NCT02074553|3564431|P5|STARTED|Washout Period 3||12
1456116|NCT02074553|3564432|P4|STARTED|Washout Period 3||11
1456117|NCT02074553|3564433|P3|STARTED|Washout Period 3||11
1456118|NCT02074553|3564434|P2|STARTED|Washout Period 3||12
1456119|NCT02074553|3564435|P1|STARTED|Washout Period 3||11
1456120|NCT02074553|3564428|P8|NOT COMPLETED|Intervention Period 3||0
1456121|NCT02074553|3564429|P7|NOT COMPLETED|Intervention Period 3||0
1456122|NCT02074553|3564430|P6|NOT COMPLETED|Intervention Period 3||0
1456123|NCT02074553|3564431|P5|NOT COMPLETED|Intervention Period 3||0
1456124|NCT02074553|3564432|P4|NOT COMPLETED|Intervention Period 3||0
1456125|NCT02074553|3564433|P3|NOT COMPLETED|Intervention Period 3||0
1456126|NCT02074553|3564434|P2|NOT COMPLETED|Intervention Period 3||0
1456127|NCT02074553|3564435|P1|NOT COMPLETED|Intervention Period 3||0
1456128|NCT02074553|3564428|P8|COMPLETED|Intervention Period 3||12
1456129|NCT02074553|3564429|P7|COMPLETED|Intervention Period 3||11
1456130|NCT02074553|3564430|P6|COMPLETED|Intervention Period 3||10
1456131|NCT02074553|3564431|P5|COMPLETED|Intervention Period 3||12
1456132|NCT02074553|3564432|P4|COMPLETED|Intervention Period 3||11
1456133|NCT02074553|3564433|P3|COMPLETED|Intervention Period 3||11
1456134|NCT02074553|3564434|P2|COMPLETED|Intervention Period 3||12
1456135|NCT02074553|3564435|P1|COMPLETED|Intervention Period 3||11
1456136|NCT02074553|3564428|P8|STARTED|Intervention Period 3||12
1456137|NCT02074553|3564429|P7|STARTED|Intervention Period 3||11
1456138|NCT02074553|3564430|P6|STARTED|Intervention Period 3||10
1456139|NCT02074553|3564431|P5|STARTED|Intervention Period 3||12
1456140|NCT02074553|3564432|P4|STARTED|Intervention Period 3||11
1456141|NCT02074553|3564433|P3|STARTED|Intervention Period 3||11
1456142|NCT02074553|3564434|P2|STARTED|Intervention Period 3||12
1456143|NCT02074553|3564435|P1|STARTED|Intervention Period 3||11
1456144|NCT02074553|3564428|P8|NOT COMPLETED|Washout Period 2||0
1456145|NCT02074553|3564429|P7|NOT COMPLETED|Washout Period 2||1
1456146|NCT02074553|3564430|P6|NOT COMPLETED|Washout Period 2||1
1456147|NCT02074553|3564431|P5|NOT COMPLETED|Washout Period 2||0
1456148|NCT02074553|3564432|P4|NOT COMPLETED|Washout Period 2||0
1456149|NCT02074553|3564433|P3|NOT COMPLETED|Washout Period 2||1
1456150|NCT02074553|3564434|P2|NOT COMPLETED|Washout Period 2||0
1456151|NCT02074553|3564435|P1|NOT COMPLETED|Washout Period 2||0
1456152|NCT02074553|3564428|P8|COMPLETED|Washout Period 2||12
1456153|NCT02074553|3564429|P7|COMPLETED|Washout Period 2||11
1456154|NCT02074553|3564430|P6|COMPLETED|Washout Period 2||10
1456155|NCT02074553|3564431|P5|COMPLETED|Washout Period 2||12
1456156|NCT02074553|3564432|P4|COMPLETED|Washout Period 2||11
1456157|NCT02074553|3564433|P3|COMPLETED|Washout Period 2||11
1456158|NCT02074553|3564434|P2|COMPLETED|Washout Period 2||12
1456159|NCT02074553|3564435|P1|COMPLETED|Washout Period 2||11
1456160|NCT02074553|3564428|P8|STARTED|Washout Period 2||12
1456161|NCT02074553|3564429|P7|STARTED|Washout Period 2||12
1456162|NCT02074553|3564430|P6|STARTED|Washout Period 2||11
1456163|NCT02074553|3564431|P5|STARTED|Washout Period 2||12
1456164|NCT02074553|3564432|P4|STARTED|Washout Period 2||11
1456165|NCT02074553|3564433|P3|STARTED|Washout Period 2||12
1456166|NCT02074553|3564434|P2|STARTED|Washout Period 2||12
1456167|NCT02074553|3564435|P1|STARTED|Washout Period 2||11
1456168|NCT02074553|3564428|P8|NOT COMPLETED|Intervention Period 2||0
1456169|NCT02074553|3564429|P7|NOT COMPLETED|Intervention Period 2||0
1456170|NCT02074553|3564430|P6|NOT COMPLETED|Intervention Period 2||0
1456171|NCT02074553|3564431|P5|NOT COMPLETED|Intervention Period 2||0
1456172|NCT02074553|3564432|P4|NOT COMPLETED|Intervention Period 2||0
1456173|NCT02074553|3564433|P3|NOT COMPLETED|Intervention Period 2||0
1456174|NCT02074553|3564434|P2|NOT COMPLETED|Intervention Period 2||0
1456175|NCT02074553|3564435|P1|NOT COMPLETED|Intervention Period 2||0
1456176|NCT02074553|3564428|P8|COMPLETED|Intervention Period 2||12
1456177|NCT02074553|3564429|P7|COMPLETED|Intervention Period 2||12
1456178|NCT02074553|3564430|P6|COMPLETED|Intervention Period 2||11
1456179|NCT02074553|3564431|P5|COMPLETED|Intervention Period 2||12
1456180|NCT02074553|3564432|P4|COMPLETED|Intervention Period 2||11
1456181|NCT02074553|3564433|P3|COMPLETED|Intervention Period 2||12
1456182|NCT02074553|3564434|P2|COMPLETED|Intervention Period 2||12
1456183|NCT02074553|3564435|P1|COMPLETED|Intervention Period 2||11
1456184|NCT02074553|3564428|P8|STARTED|Intervention Period 2||12
1456185|NCT02074553|3564429|P7|STARTED|Intervention Period 2||12
1456186|NCT02074553|3564430|P6|STARTED|Intervention Period 2||11
1456187|NCT02074553|3564431|P5|STARTED|Intervention Period 2||12
1456188|NCT02074553|3564432|P4|STARTED|Intervention Period 2||11
1456189|NCT02074553|3564433|P3|STARTED|Intervention Period 2||12
1456190|NCT02074553|3564434|P2|STARTED|Intervention Period 2||12
1456191|NCT02074553|3564435|P1|STARTED|Intervention Period 2||11
1456192|NCT02074553|3564428|P8|NOT COMPLETED|Washout Period 1||0
1456193|NCT02074553|3564429|P7|NOT COMPLETED|Washout Period 1||0
1456194|NCT02074553|3564430|P6|NOT COMPLETED|Washout Period 1||1
1456195|NCT02074553|3564431|P5|NOT COMPLETED|Washout Period 1||0
1456196|NCT02074553|3564432|P4|NOT COMPLETED|Washout Period 1||1
1456197|NCT02074553|3564433|P3|NOT COMPLETED|Washout Period 1||0
1456198|NCT02074553|3564434|P2|NOT COMPLETED|Washout Period 1||0
1456199|NCT02074553|3564435|P1|NOT COMPLETED|Washout Period 1||1
1456200|NCT02074553|3564428|P8|COMPLETED|Washout Period 1||12
1456201|NCT02074553|3564429|P7|COMPLETED|Washout Period 1||12
1456202|NCT02074553|3564430|P6|COMPLETED|Washout Period 1||11
1456203|NCT02074553|3564431|P5|COMPLETED|Washout Period 1||12
1456204|NCT02074553|3564432|P4|COMPLETED|Washout Period 1||11
1456205|NCT02074553|3564433|P3|COMPLETED|Washout Period 1||12
1456206|NCT02074553|3564434|P2|COMPLETED|Washout Period 1||12
1456207|NCT02074553|3564435|P1|COMPLETED|Washout Period 1||11
1456208|NCT02074553|3564428|P8|STARTED|Washout Period 1||12
1456209|NCT02074553|3564429|P7|STARTED|Washout Period 1||12
1456210|NCT02074553|3564430|P6|STARTED|Washout Period 1||12
1456211|NCT02074553|3564431|P5|STARTED|Washout Period 1||12
1456212|NCT02074553|3564432|P4|STARTED|Washout Period 1||12
1456213|NCT02074553|3564433|P3|STARTED|Washout Period 1||12
1456214|NCT02074553|3564434|P2|STARTED|Washout Period 1||12
1456215|NCT02074553|3564435|P1|STARTED|Washout Period 1||12
1456216|NCT02074553|3564428|P8|NOT COMPLETED|Intervention Period 1||0
1456217|NCT02074553|3564429|P7|NOT COMPLETED|Intervention Period 1||0
1456218|NCT02074553|3564430|P6|NOT COMPLETED|Intervention Period 1||0
1456219|NCT02074553|3564431|P5|NOT COMPLETED|Intervention Period 1||0
1456220|NCT02074553|3564432|P4|NOT COMPLETED|Intervention Period 1||1
1456221|NCT02074553|3564433|P3|NOT COMPLETED|Intervention Period 1||0
1456222|NCT02074553|3564434|P2|NOT COMPLETED|Intervention Period 1||0
1456223|NCT02074553|3564435|P1|NOT COMPLETED|Intervention Period 1||0
1456224|NCT02074553|3564428|P8|COMPLETED|Intervention Period 1||12
1456225|NCT02074553|3564429|P7|COMPLETED|Intervention Period 1||12
1456226|NCT02074553|3564430|P6|COMPLETED|Intervention Period 1||12
1456227|NCT02074553|3564431|P5|COMPLETED|Intervention Period 1||12
1456228|NCT02074553|3564432|P4|COMPLETED|Intervention Period 1||12
1456229|NCT02074553|3564433|P3|COMPLETED|Intervention Period 1||12
1456230|NCT02074553|3564434|P2|COMPLETED|Intervention Period 1||12
1456231|NCT02074553|3564435|P1|COMPLETED|Intervention Period 1||12
1456232|NCT02074553|3564428|P8|STARTED|Intervention Period 1||12
1456233|NCT02074553|3564429|P7|STARTED|Intervention Period 1||12
1456234|NCT02074553|3564430|P6|STARTED|Intervention Period 1||12
1456235|NCT02074553|3564431|P5|STARTED|Intervention Period 1||12
1456236|NCT02074553|3564432|P4|STARTED|Intervention Period 1||13
1456237|NCT02074553|3564433|P3|STARTED|Intervention Period 1||12
1456238|NCT02074553|3564434|P2|STARTED|Intervention Period 1||12
1456239|NCT02074553|3564435|P1|STARTED|Intervention Period 1||12
1456240|NCT02074514|3564617|P2|NOT COMPLETED|Overall Study||4
1456241|NCT02074514|3564618|P1|NOT COMPLETED|Overall Study||3
1456242|NCT02074514|3564617|P2|COMPLETED|Overall Study||54
1456243|NCT02074514|3564618|P1|COMPLETED|Overall Study||56
1456244|NCT02074514|3564617|P2|STARTED|Overall Study||58
1456245|NCT02074514|3564618|P1|STARTED|Overall Study||59
1456246|NCT02074384|3564639|P3|NOT COMPLETED|Overall Study||0
1456247|NCT02074384|3564640|P2|NOT COMPLETED|Overall Study||0
1456248|NCT02074384|3564641|P1|NOT COMPLETED|Overall Study||0
1456249|NCT02074384|3564639|P3|COMPLETED|Overall Study||17
1456250|NCT02074384|3564640|P2|COMPLETED|Overall Study||70
1456251|NCT02074384|3564641|P1|COMPLETED|Overall Study||74
1456252|NCT02074384|3564639|P3|STARTED|Overall Study||17
1456253|NCT02074384|3564640|P2|STARTED|Overall Study||70
1456254|NCT02074384|3564641|P1|STARTED|Overall Study||74
1456255|NCT02074358|3564649|P6|NOT COMPLETED|Overall Study||0
1456256|NCT02074358|3564650|P5|NOT COMPLETED|Overall Study||0
1456257|NCT02074358|3564651|P4|NOT COMPLETED|Overall Study||0
1456258|NCT02074358|3564652|P3|NOT COMPLETED|Overall Study||0
1456259|NCT02074358|3564653|P2|NOT COMPLETED|Overall Study||0
1456260|NCT02074358|3564654|P1|NOT COMPLETED|Overall Study||0
1456261|NCT02074358|3564649|P6|COMPLETED|Overall Study||2
1456262|NCT02074358|3564650|P5|COMPLETED|Overall Study||3
1456263|NCT02074358|3564651|P4|COMPLETED|Overall Study||2
1456264|NCT02074358|3564652|P3|COMPLETED|Overall Study||2
1456265|NCT02074358|3564653|P2|COMPLETED|Overall Study||3
1456266|NCT02074358|3564654|P1|COMPLETED|Overall Study||3
1456267|NCT02074358|3564649|P6|STARTED|Overall Study||2
1456268|NCT02074358|3564650|P5|STARTED|Overall Study||3
1456269|NCT02074358|3564651|P4|STARTED|Overall Study||2
1456270|NCT02074358|3564652|P3|STARTED|Overall Study||2
1456271|NCT02074358|3564653|P2|STARTED|Overall Study||3
1456272|NCT02074358|3564654|P1|STARTED|Overall Study||3
1456273|NCT02074345|3564743|P1|NOT COMPLETED|Overall Study||0
1456274|NCT02074345|3564743|P1|COMPLETED|Overall Study||31
1456275|NCT02074345|3564743|P1|STARTED|Overall Study||31
1456276|NCT02074059|3564759|P6|NOT COMPLETED|Overall Study||1
1456277|NCT02074059|3564760|P5|NOT COMPLETED|Overall Study||1
1456278|NCT02074059|3564761|P4|NOT COMPLETED|Overall Study||0
1456279|NCT02074059|3564762|P3|NOT COMPLETED|Overall Study||0
1456280|NCT02074059|3564763|P2|NOT COMPLETED|Overall Study||0
1456281|NCT02074059|3564764|P1|NOT COMPLETED|Overall Study||0
1456282|NCT02074059|3564759|P6|COMPLETED|Overall Study||39
1456283|NCT02074059|3564760|P5|COMPLETED|Overall Study||7
1456284|NCT02074059|3564761|P4|COMPLETED|Overall Study||8
1456285|NCT02074059|3564762|P3|COMPLETED|Overall Study||8
1456286|NCT02074059|3564763|P2|COMPLETED|Overall Study||8
1456287|NCT02074059|3564764|P1|COMPLETED|Overall Study||8
1456288|NCT02074059|3564759|P6|STARTED|Overall Study||40
1456289|NCT02074059|3564760|P5|STARTED|Overall Study||8
1456290|NCT02074059|3564761|P4|STARTED|Overall Study||8
1456291|NCT02074059|3564762|P3|STARTED|Overall Study||8
1456292|NCT02074059|3564763|P2|STARTED|Overall Study||8
1456293|NCT02074059|3564764|P1|STARTED|Overall Study||8
1456294|NCT02073747|3564804|P2|NOT COMPLETED|Overall Study||1
1456295|NCT02073747|3564805|P1|NOT COMPLETED|Overall Study||1
1456296|NCT02073747|3564804|P2|COMPLETED|Overall Study||14
1456297|NCT02073747|3564805|P1|COMPLETED|Overall Study||14
1456298|NCT02073747|3564804|P2|STARTED|Overall Study||15
1456299|NCT02073747|3564805|P1|STARTED|Overall Study||15
1456300|NCT02073682|3564813|P2|NOT COMPLETED|Overall Study||370
1456301|NCT02073682|3564814|P1|NOT COMPLETED|Overall Study||322
1456302|NCT02073682|3564813|P2|COMPLETED|Overall Study||154
1456303|NCT02073682|3564814|P1|COMPLETED|Overall Study||200
1456304|NCT02073682|3564813|P2|STARTED|Overall Study||524
1456305|NCT02073682|3564814|P1|STARTED|Overall Study||522
1456306|NCT02073656|3564832|P1|NOT COMPLETED|Retreatment Substudy||0
1456307|NCT02073656|3564832|P1|COMPLETED|Retreatment Substudy||9
1456308|NCT02073656|3564832|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
1456309|NCT02073656|3564832|P1|NOT COMPLETED|Primary Study||8
1456310|NCT02073656|3564832|P1|COMPLETED|Primary Study||327
1456311|NCT02073656|3564832|P1|STARTED|Primary Study||335
1456312|NCT02073565|3564850|P2|NOT COMPLETED|Cohort C||4
1456313|NCT02073565|3564851|P1|NOT COMPLETED|Cohort C||0
1456314|NCT02073565|3564850|P2|COMPLETED|Cohort C||211
1456315|NCT02073565|3564851|P1|COMPLETED|Cohort C||217
1456316|NCT02073565|3564850|P2|STARTED|Cohort C||215
1456317|NCT02073565|3564851|P1|STARTED|Cohort C||217
1456318|NCT02073565|3564850|P2|NOT COMPLETED|Cohort B||2
1456319|NCT02073565|3564851|P1|NOT COMPLETED|Cohort B||1
1456320|NCT02073565|3564850|P2|COMPLETED|Cohort B||54
1456321|NCT02073565|3564851|P1|COMPLETED|Cohort B||53
1456322|NCT02073565|3564850|P2|STARTED|Cohort B||56
1456323|NCT02073565|3564851|P1|STARTED|Cohort B||54
1456324|NCT02073565|3564850|P2|NOT COMPLETED|Cohort A||0
1456325|NCT02073565|3564851|P1|NOT COMPLETED|Cohort A||1
1456326|NCT02073565|3564850|P2|COMPLETED|Cohort A||14
1456327|NCT02073565|3564851|P1|COMPLETED|Cohort A||15
1456328|NCT02073565|3564850|P2|STARTED|Cohort A||14
1456329|NCT02073565|3564851|P1|STARTED|Cohort A||16
1456330|NCT02073565|3564850|P2|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
1456331|NCT02073565|3564851|P1|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
1456332|NCT02073565|3564850|P2|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
1456333|NCT02073565|3564851|P1|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
1456334|NCT02073565|3564850|P2|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
1456335|NCT02073565|3564851|P1|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
1456336|NCT02073461|3564866|P3|NOT COMPLETED|Overall Study||1
1456337|NCT02073461|3564867|P2|NOT COMPLETED|Overall Study||1
1456338|NCT02073461|3564868|P1|NOT COMPLETED|Overall Study||4
1456339|NCT02073461|3564866|P3|COMPLETED|Overall Study||78
1456340|NCT02073461|3564867|P2|COMPLETED|Overall Study||77
1456341|NCT02073461|3564868|P1|COMPLETED|Overall Study||75
1456342|NCT02073461|3564866|P3|STARTED|Overall Study||79
1456343|NCT02073461|3564867|P2|STARTED|Overall Study||78
1456344|NCT02073461|3564868|P1|STARTED|Overall Study||79
1456345|NCT02073448|3564897|P3|NOT COMPLETED|Overall Study||5
1456346|NCT02073448|3564898|P2|NOT COMPLETED|Overall Study||12
1456347|NCT02073448|3564899|P1|NOT COMPLETED|Overall Study||2
1456348|NCT02073448|3564897|P3|COMPLETED|Overall Study||99
1456349|NCT02073448|3564898|P2|COMPLETED|Overall Study||200
1456350|NCT02073448|3564899|P1|COMPLETED|Overall Study||99
1456351|NCT02073448|3564897|P3|STARTED|Overall Study||104
1456352|NCT02073448|3564898|P2|STARTED|Overall Study||212
1456353|NCT02073448|3564899|P1|STARTED|Overall Study||101
1456354|NCT02073435|3564927|P2|NOT COMPLETED|Overall Study||0
1456355|NCT02073435|3564928|P1|NOT COMPLETED|Overall Study||0
1456356|NCT02073435|3564927|P2|COMPLETED|Overall Study||96
1456357|NCT02073435|3564928|P1|COMPLETED|Overall Study||81
1456358|NCT02073435|3564927|P2|STARTED|Overall Study||96
1456359|NCT02073435|3564928|P1|STARTED|Overall Study||81
1456360|NCT02072980|3564936|P2|NOT COMPLETED|Period 2, Second Wear||1
1456361|NCT02072980|3564937|P1|NOT COMPLETED|Period 2, Second Wear||0
1456362|NCT02072980|3564936|P2|COMPLETED|Period 2, Second Wear||7
1456363|NCT02072980|3564937|P1|COMPLETED|Period 2, Second Wear||7
1456364|NCT02072980|3564936|P2|STARTED|Period 2, Second Wear||8
1456365|NCT02072980|3564937|P1|STARTED|Period 2, Second Wear||7
1456366|NCT02072980|3564936|P2|NOT COMPLETED|Period 1, First Wear||0
1456367|NCT02072980|3564937|P1|NOT COMPLETED|Period 1, First Wear||0
1456368|NCT02072980|3564936|P2|COMPLETED|Period 1, First Wear||8
1456369|NCT02072980|3564937|P1|COMPLETED|Period 1, First Wear||7
1456370|NCT02072980|3564936|P2|STARTED|Period 1, First Wear||8
1456371|NCT02072980|3564937|P1|STARTED|Period 1, First Wear||7
1456372|NCT02072928|3564943|P1|NOT COMPLETED|Overall Study||0
1456373|NCT02072928|3564943|P1|COMPLETED|Overall Study||55
1456374|NCT02072928|3564943|P1|STARTED|Overall Study||55
1456375|NCT02072824|3564950|P3|NOT COMPLETED|Overall Study||3
1456376|NCT02072824|3564951|P2|NOT COMPLETED|Overall Study||1
1456377|NCT02072824|3564952|P1|NOT COMPLETED|Overall Study||2
1456378|NCT02072824|3564950|P3|COMPLETED|Overall Study||67
1456379|NCT02072824|3564951|P2|COMPLETED|Overall Study||33
1456380|NCT02072824|3564952|P1|COMPLETED|Overall Study||69
1456381|NCT02072824|3564950|P3|STARTED|Overall Study||70
1456382|NCT02072824|3564951|P2|STARTED|Overall Study||34
1456383|NCT02072824|3564952|P1|STARTED|Overall Study||71
1456384|NCT02072421|3564987|P1|NOT COMPLETED|Overall Study||390
1456385|NCT02072421|3564987|P1|COMPLETED|Overall Study||2489
1456386|NCT02072421|3564987|P1|STARTED|Overall Study||2879
1456387|NCT02072226|3564997|P2|NOT COMPLETED|Overall Study||10
1456388|NCT02072226|3564998|P1|NOT COMPLETED|Overall Study||15
1456389|NCT02072226|3564997|P2|COMPLETED|Overall Study||147
1456390|NCT02072226|3564998|P1|COMPLETED|Overall Study||141
1456391|NCT02072226|3564997|P2|STARTED|Overall Study||157
1456392|NCT02072226|3564998|P1|STARTED|Overall Study||156
1456393|NCT02072200|3565020|P1|NOT COMPLETED|Overall Study||2
1456394|NCT02072200|3565020|P1|COMPLETED|Overall Study||145
1456395|NCT02072200|3565020|P1|STARTED|Overall Study||147
1456396|NCT02072096|3565028|P2|NOT COMPLETED|Overall Study||78
1456397|NCT02072096|3565029|P1|NOT COMPLETED|Overall Study||85
1456398|NCT02072096|3565028|P2|COMPLETED|Overall Study||15
1456399|NCT02072096|3565029|P1|COMPLETED|Overall Study||14
1456400|NCT02072096|3565028|P2|Received at Least One Dose of Study Drug|Overall Study||93
1456401|NCT02072096|3565029|P1|Received at Least One Dose of Study Drug|Overall Study||98
1456402|NCT02072096|3565028|P2|STARTED|Overall Study||93
1456403|NCT02072096|3565029|P1|STARTED|Overall Study||99
1456404|NCT02071849|3565051|P1|NOT COMPLETED|2-year Extended Follow-up||1
1456405|NCT02071849|3565051|P1|COMPLETED|2-year Extended Follow-up||14
1456406|NCT02071849|3565051|P1|STARTED|2-year Extended Follow-up||15
1456407|NCT02071849|3565051|P1|NOT COMPLETED|6-month Primary Endpoint||5
1456408|NCT02071849|3565051|P1|COMPLETED|6-month Primary Endpoint||15
1456409|NCT02071849|3565051|P1|STARTED|6-month Primary Endpoint||20
1456410|NCT02071823|3565085|P2|NOT COMPLETED|Overall Study||0
1456411|NCT02071823|3565086|P1|NOT COMPLETED|Overall Study||1
1456412|NCT02071823|3565085|P2|COMPLETED|Overall Study||6
1456413|NCT02071823|3565086|P1|COMPLETED|Overall Study||5
1456414|NCT02071823|3565085|P2|STARTED|Overall Study||6
1456415|NCT02071823|3565086|P1|STARTED|Overall Study||6
1456416|NCT02071810|3565101|P5|NOT COMPLETED|Overall Study||1
1456417|NCT02071810|3565102|P4|NOT COMPLETED|Overall Study||1
1456418|NCT02071810|3565103|P3|NOT COMPLETED|Overall Study||0
1456419|NCT02071810|3565104|P2|NOT COMPLETED|Overall Study||0
1456420|NCT02071810|3565105|P1|NOT COMPLETED|Overall Study||0
1456421|NCT02071810|3565101|P5|COMPLETED|Overall Study||8
1456422|NCT02071810|3565102|P4|COMPLETED|Overall Study||6
1456423|NCT02071810|3565103|P3|COMPLETED|Overall Study||6
1456424|NCT02071810|3565104|P2|COMPLETED|Overall Study||6
1456425|NCT02071810|3565105|P1|COMPLETED|Overall Study||6
1456426|NCT02071810|3565101|P5|STARTED|Overall Study||9
1456427|NCT02071810|3565102|P4|STARTED|Overall Study||7
1456428|NCT02071810|3565103|P3|STARTED|Overall Study||6
1456429|NCT02071810|3565104|P2|STARTED|Overall Study||6
1456430|NCT02071810|3565105|P1|STARTED|Overall Study||6
1456431|NCT02071771|3565117|P2|NOT COMPLETED|Period 2: Second 10 Days||0
1456432|NCT02071771|3565118|P1|NOT COMPLETED|Period 2: Second 10 Days||0
1456433|NCT02071771|3565117|P2|COMPLETED|Period 2: Second 10 Days||38
1456434|NCT02071771|3565118|P1|COMPLETED|Period 2: Second 10 Days||39
1456435|NCT02071771|3565117|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
1456436|NCT02071771|3565118|P1|STARTED|Period 2: Second 10 Days||39
1456437|NCT02071771|3565117|P2|NOT COMPLETED|Period 1: First 10 Days||0
1456438|NCT02071771|3565118|P1|NOT COMPLETED|Period 1: First 10 Days||2
1456439|NCT02071771|3565117|P2|COMPLETED|Period 1: First 10 Days||39
1456440|NCT02071771|3565118|P1|COMPLETED|Period 1: First 10 Days||39
1456441|NCT02071771|3565117|P2|Dispensed|Period 1: First 10 Days||39
1456442|NCT02071771|3565118|P1|Dispensed|Period 1: First 10 Days||39
1456443|NCT02071771|3565117|P2|STARTED|Period 1: First 10 Days||39
1456444|NCT02071771|3565118|P1|STARTED|Period 1: First 10 Days||41
1456445|NCT02071420|3565128|P2|NOT COMPLETED|Overall Study||3
1456446|NCT02071420|3565129|P1|NOT COMPLETED|Overall Study||3
1456447|NCT02071420|3565128|P2|COMPLETED|Overall Study||27
1456448|NCT02071420|3565129|P1|COMPLETED|Overall Study||27
1456449|NCT02071420|3565128|P2|STARTED|Overall Study||30
1456450|NCT02071420|3565129|P1|STARTED|Overall Study||30
1456451|NCT02071108|3565135|P1|NOT COMPLETED|Overall Study||0
1456452|NCT02071108|3565135|P1|COMPLETED|Overall Study||35
1456453|NCT02071108|3565135|P1|STARTED|Overall Study||35
1456454|NCT02071095|3565156|P2|NOT COMPLETED|Overall Study||0
1456455|NCT02071095|3565157|P1|NOT COMPLETED|Overall Study||0
1456456|NCT02071095|3565156|P2|COMPLETED|Overall Study||3
1456457|NCT02071095|3565157|P1|COMPLETED|Overall Study||12
1456458|NCT02071095|3565156|P2|STARTED|Overall Study||3
1456459|NCT02071095|3565157|P1|STARTED|Overall Study||12
1456460|NCT02071082|3565173|P2|NOT COMPLETED|Overall Study||7
1456461|NCT02071082|3565174|P1|NOT COMPLETED|Overall Study||2
1456462|NCT02071082|3565173|P2|COMPLETED|Overall Study||68
1456463|NCT02071082|3565174|P1|COMPLETED|Overall Study||2
1456464|NCT02071082|3565173|P2|STARTED|Overall Study||75
1456465|NCT02071082|3565174|P1|STARTED|Overall Study||4
1456466|NCT02070965|3565205|P3|NOT COMPLETED|Overall Study||1
1456467|NCT02070965|3565206|P2|NOT COMPLETED|Overall Study||2
1456468|NCT02070965|3565207|P1|NOT COMPLETED|Overall Study||2
1456469|NCT02070965|3565205|P3|COMPLETED|Overall Study||24
1456470|NCT02070965|3565206|P2|COMPLETED|Overall Study||21
1456471|NCT02070965|3565207|P1|COMPLETED|Overall Study||25
1456472|NCT02070965|3565205|P3|STARTED|Overall Study||25
1456473|NCT02070965|3565206|P2|STARTED|Overall Study||23
1456474|NCT02070965|3565207|P1|STARTED|Overall Study||27
1456475|NCT02070744|3565219|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
1456476|NCT02070744|3565220|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
1456477|NCT02070744|3565221|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
1456478|NCT02070744|3565222|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
1456479|NCT02070744|3565223|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
1456480|NCT02070744|3565219|P5|COMPLETED|OLE Phase (48 Weeks)||24
1456481|NCT02070744|3565220|P4|COMPLETED|OLE Phase (48 Weeks)||0
1456482|NCT02070744|3565221|P3|COMPLETED|OLE Phase (48 Weeks)||0
1456483|NCT02070744|3565222|P2|COMPLETED|OLE Phase (48 Weeks)||0
1456484|NCT02070744|3565223|P1|COMPLETED|OLE Phase (48 Weeks)||0
1456485|NCT02070744|3565219|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
1456486|NCT02070744|3565220|P4|STARTED|OLE Phase (48 Weeks)||0
1456487|NCT02070744|3565221|P3|STARTED|OLE Phase (48 Weeks)||0
1456488|NCT02070744|3565222|P2|STARTED|OLE Phase (48 Weeks)||0
1456489|NCT02070744|3565223|P1|STARTED|OLE Phase (48 Weeks)||0
1456490|NCT02070744|3565219|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
1456491|NCT02070744|3565220|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
1456492|NCT02070744|3565221|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
1456493|NCT02070744|3565222|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
1456494|NCT02070744|3565223|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
1456495|NCT02070744|3565219|P5|COMPLETED|PC Phase (12 Weeks)||0
1456496|NCT02070744|3565220|P4|COMPLETED|PC Phase (12 Weeks)||13
1456497|NCT02070744|3565221|P3|COMPLETED|PC Phase (12 Weeks)||15
1456498|NCT02070744|3565222|P2|COMPLETED|PC Phase (12 Weeks)||5
1456499|NCT02070744|3565223|P1|COMPLETED|PC Phase (12 Weeks)||6
1456500|NCT02070744|3565219|P5|Treated|PC Phase (12 Weeks)||0
1456501|NCT02070744|3565220|P4|Treated|PC Phase (12 Weeks)||13
1456502|NCT02070744|3565221|P3|Treated|PC Phase (12 Weeks)||15
1456503|NCT02070744|3565222|P2|Treated|PC Phase (12 Weeks)||5
1456504|NCT02070744|3565223|P1|Treated|PC Phase (12 Weeks)||6
1456505|NCT02070744|3565219|P5|STARTED|PC Phase (12 Weeks)||0
1456506|NCT02070744|3565220|P4|STARTED|PC Phase (12 Weeks)||14
1456507|NCT02070744|3565221|P3|STARTED|PC Phase (12 Weeks)||15
1456508|NCT02070744|3565222|P2|STARTED|PC Phase (12 Weeks)||5
1456509|NCT02070744|3565223|P1|STARTED|PC Phase (12 Weeks)||6
1456510|NCT02070692|3565275|P2|NOT COMPLETED|Overall Study||12
1456511|NCT02070692|3565276|P1|NOT COMPLETED|Overall Study||10
1456512|NCT02070692|3565275|P2|COMPLETED|Overall Study||16
1456513|NCT02070692|3565276|P1|COMPLETED|Overall Study||18
1456514|NCT02070692|3565275|P2|STARTED|Overall Study||28
1456515|NCT02070692|3565276|P1|STARTED|Overall Study||28
1456516|NCT02070640|3565292|P2|NOT COMPLETED|Overall Study||0
1456517|NCT02070640|3565293|P1|NOT COMPLETED|Overall Study||11
1456518|NCT02070640|3565292|P2|COMPLETED|Overall Study||6
1456519|NCT02070640|3565293|P1|COMPLETED|Overall Study||82
1456520|NCT02070640|3565292|P2|STARTED|Overall Study||6
1456521|NCT02070640|3565293|P1|STARTED|Overall Study||93
1456522|NCT02070588|3565306|P3|NOT COMPLETED|Overall Study||0
1456523|NCT02070588|3565307|P2|NOT COMPLETED|Overall Study||1
1456524|NCT02070588|3565308|P1|NOT COMPLETED|Overall Study||39
1456525|NCT02070588|3565306|P3|COMPLETED|Overall Study||0
1456526|NCT02070588|3565307|P2|COMPLETED|Overall Study||25
1456527|NCT02070588|3565308|P1|COMPLETED|Overall Study||47
1456528|NCT02070588|3565306|P3|STARTED|Overall Study||0
1456529|NCT02070588|3565307|P2|STARTED|Overall Study||26
1456530|NCT02070588|3565308|P1|STARTED|Overall Study||86
1456531|NCT02070484|3565324|P2|NOT COMPLETED|Overall Study||0
1456532|NCT02070484|3565325|P1|NOT COMPLETED|Overall Study||1
1456533|NCT02070484|3565324|P2|COMPLETED|Overall Study||3
1456534|NCT02070484|3565325|P1|COMPLETED|Overall Study||2
1456535|NCT02070484|3565324|P2|STARTED|Overall Study||3
1456536|NCT02070484|3565325|P1|STARTED|Overall Study||3
1456537|NCT02070380|3565347|P4|NOT COMPLETED|Second Injection||5
1456538|NCT02070380|3565348|P3|NOT COMPLETED|Second Injection||1
1456539|NCT02070380|3565349|P2|NOT COMPLETED|Second Injection||2
1456540|NCT02070380|3565350|P1|NOT COMPLETED|Second Injection||0
1456541|NCT02070380|3565347|P4|COMPLETED|Second Injection||46
1456542|NCT02070380|3565348|P3|COMPLETED|Second Injection||50
1456543|NCT02070380|3565349|P2|COMPLETED|Second Injection||32
1456544|NCT02070380|3565350|P1|COMPLETED|Second Injection||31
1456545|NCT02070380|3565347|P4|STARTED|Second Injection||51
1456546|NCT02070380|3565348|P3|STARTED|Second Injection||51
1456547|NCT02070380|3565349|P2|STARTED|Second Injection||34
1456548|NCT02070380|3565350|P1|STARTED|Second Injection||31
1456549|NCT02070380|3565347|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
1456550|NCT02070380|3565348|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
1456551|NCT02070380|3565349|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
1456552|NCT02070380|3565350|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
1456553|NCT02070380|3565347|P4|COMPLETED|Washout (no Second Injection/MRI)||51
1456554|NCT02070380|3565348|P3|COMPLETED|Washout (no Second Injection/MRI)||51
1456555|NCT02070380|3565349|P2|COMPLETED|Washout (no Second Injection/MRI)||34
1456556|NCT02070380|3565350|P1|COMPLETED|Washout (no Second Injection/MRI)||31
1456557|NCT02070380|3565347|P4|STARTED|Washout (no Second Injection/MRI)||54
1456558|NCT02070380|3565348|P3|STARTED|Washout (no Second Injection/MRI)||53
1456559|NCT02070380|3565349|P2|STARTED|Washout (no Second Injection/MRI)||39
1456560|NCT02070380|3565350|P1|STARTED|Washout (no Second Injection/MRI)||31
1456561|NCT02070380|3565347|P4|NOT COMPLETED|First Injection||0
1456562|NCT02070380|3565348|P3|NOT COMPLETED|First Injection||0
1456563|NCT02070380|3565349|P2|NOT COMPLETED|First Injection||0
1456564|NCT02070380|3565350|P1|NOT COMPLETED|First Injection||0
1456565|NCT02070380|3565347|P4|COMPLETED|First Injection||54
1456566|NCT02070380|3565348|P3|COMPLETED|First Injection||53
1456567|NCT02070380|3565349|P2|COMPLETED|First Injection||39
1456568|NCT02070380|3565350|P1|COMPLETED|First Injection||31
1456569|NCT02070380|3565347|P4|STARTED|First Injection||54
1456570|NCT02070380|3565348|P3|STARTED|First Injection||53
1456571|NCT02070380|3565349|P2|STARTED|First Injection||39
1456572|NCT02070380|3565350|P1|STARTED|First Injection||31
1456573|NCT02070302|3565400|P2|NOT COMPLETED|Overall Study||0
1456574|NCT02070302|3565401|P1|NOT COMPLETED|Overall Study||0
1456575|NCT02070302|3565400|P2|COMPLETED|Overall Study||5
1456576|NCT02070302|3565401|P1|COMPLETED|Overall Study||5
1456577|NCT02070302|3565400|P2|STARTED|Overall Study||5
1456578|NCT02070302|3565401|P1|STARTED|Overall Study||5
1456579|NCT02070237|3565419|P2|NOT COMPLETED|Overall Study||3
1456580|NCT02070237|3565420|P1|NOT COMPLETED|Overall Study||3
1456581|NCT02070237|3565419|P2|COMPLETED|Overall Study||42
1456582|NCT02070237|3565420|P1|COMPLETED|Overall Study||42
1456583|NCT02070237|3565419|P2|STARTED|Overall Study||45
1456584|NCT02070237|3565420|P1|STARTED|Overall Study||45
1456585|NCT02069379|3565430|P4|NOT COMPLETED|Second Treatment Arm||0
1456586|NCT02069379|3565431|P3|NOT COMPLETED|Second Treatment Arm||1
1456587|NCT02069379|3565432|P2|NOT COMPLETED|Second Treatment Arm||0
1456588|NCT02069379|3565433|P1|NOT COMPLETED|Second Treatment Arm||0
1456589|NCT02069379|3565430|P4|COMPLETED|Second Treatment Arm||0
1456590|NCT02069379|3565431|P3|COMPLETED|Second Treatment Arm||0
1456591|NCT02069379|3565432|P2|COMPLETED|Second Treatment Arm||1
1456592|NCT02069379|3565433|P1|COMPLETED|Second Treatment Arm||0
1456593|NCT02069379|3565430|P4|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
1456594|NCT02069379|3565431|P3|STARTED|Second Treatment Arm||1
1456595|NCT02069379|3565432|P2|STARTED|Second Treatment Arm||1
1456596|NCT02069379|3565433|P1|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
1456597|NCT02069379|3565430|P4|NOT COMPLETED|Washout Period (4 Weeks)||0
1456598|NCT02069379|3565431|P3|NOT COMPLETED|Washout Period (4 Weeks)||0
1456599|NCT02069379|3565432|P2|NOT COMPLETED|Washout Period (4 Weeks)||2
1456600|NCT02069379|3565433|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
1456601|NCT02069379|3565430|P4|COMPLETED|Washout Period (4 Weeks)||0
1456602|NCT02069379|3565431|P3|COMPLETED|Washout Period (4 Weeks)||1
1456603|NCT02069379|3565432|P2|COMPLETED|Washout Period (4 Weeks)||1
1456604|NCT02069379|3565433|P1|COMPLETED|Washout Period (4 Weeks)||0
1456605|NCT02069379|3565430|P4|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
1456606|NCT02069379|3565431|P3|STARTED|Washout Period (4 Weeks)||1
1456607|NCT02069379|3565432|P2|STARTED|Washout Period (4 Weeks)||3
1456608|NCT02069379|3565433|P1|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
1456609|NCT02069379|3565430|P4|NOT COMPLETED|First Treatment Arm||0
1456610|NCT02069379|3565431|P3|NOT COMPLETED|First Treatment Arm||1
1456611|NCT02069379|3565432|P2|NOT COMPLETED|First Treatment Arm||1
1456612|NCT02069379|3565433|P1|NOT COMPLETED|First Treatment Arm||0
1456613|NCT02069379|3565430|P4|COMPLETED|First Treatment Arm||0
1456614|NCT02069379|3565431|P3|COMPLETED|First Treatment Arm||1
1456615|NCT02069379|3565432|P2|COMPLETED|First Treatment Arm||3
1456616|NCT02069379|3565433|P1|COMPLETED|First Treatment Arm||0
1456617|NCT02069379|3565430|P4|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
1456618|NCT02069379|3565431|P3|STARTED|First Treatment Arm||2
1456619|NCT02069379|3565432|P2|STARTED|First Treatment Arm||4
1456620|NCT02069379|3565433|P1|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
1456621|NCT02069379|3565430|P4|NOT COMPLETED|Baseline Measurements||2
1456622|NCT02069379|3565431|P3|NOT COMPLETED|Baseline Measurements||0
1456623|NCT02069379|3565432|P2|NOT COMPLETED|Baseline Measurements||0
1456624|NCT02069379|3565433|P1|NOT COMPLETED|Baseline Measurements||3
1456625|NCT02069379|3565430|P4|COMPLETED|Baseline Measurements||4
1456626|NCT02069379|3565431|P3|COMPLETED|Baseline Measurements||2
1456627|NCT02069379|3565432|P2|COMPLETED|Baseline Measurements||4
1456628|NCT02069379|3565433|P1|COMPLETED|Baseline Measurements||27
1456629|NCT02069379|3565430|P4|Baseline Measurements Taken|Baseline Measurements||6
1456630|NCT02069379|3565431|P3|Baseline Measurements Taken|Baseline Measurements||2
1456631|NCT02069379|3565432|P2|Baseline Measurements Taken|Baseline Measurements||4
1456632|NCT02069379|3565433|P1|Baseline Measurements Taken|Baseline Measurements||30
1456633|NCT02069379|3565430|P4|STARTED|Baseline Measurements||6
1456634|NCT02069379|3565431|P3|STARTED|Baseline Measurements||2
1456635|NCT02069379|3565432|P2|STARTED|Baseline Measurements||4
1456636|NCT02069379|3565433|P1|STARTED|Baseline Measurements||30
1456637|NCT02069119|3565463|P4|NOT COMPLETED|Overall Study||0
1456638|NCT02069119|3565464|P3|NOT COMPLETED|Overall Study||0
1456639|NCT02069119|3565465|P2|NOT COMPLETED|Overall Study||0
1456640|NCT02069119|3565466|P1|NOT COMPLETED|Overall Study||0
1456641|NCT02069119|3565463|P4|COMPLETED|Overall Study||4
1456642|NCT02069119|3565464|P3|COMPLETED|Overall Study||20
1456643|NCT02069119|3565465|P2|COMPLETED|Overall Study||4
1456644|NCT02069119|3565466|P1|COMPLETED|Overall Study||20
1456645|NCT02069119|3565463|P4|STARTED|Overall Study||4
1456646|NCT02069119|3565464|P3|STARTED|Overall Study||20
1456647|NCT02069119|3565465|P2|STARTED|Overall Study||4
1456648|NCT02069119|3565466|P1|STARTED|Overall Study||20
1456649|NCT02069093|3565490|P1|NOT COMPLETED|Overall Study||30
1456650|NCT02069093|3565490|P1|COMPLETED|Overall Study||56
1456651|NCT02069093|3565490|P1|Pharmacokinetic Analysis Set|Overall Study||50
1456652|NCT02069093|3565490|P1|STARTED|Overall Study||86
1456653|NCT02069041|3565499|P1|NOT COMPLETED|Overall Study||0
1456654|NCT02069041|3565499|P1|COMPLETED|Overall Study||8
1456655|NCT02069041|3565499|P1|Received at Least One Dose of Study Drug|Overall Study||8
1456656|NCT02069041|3565499|P1|STARTED|Overall Study||8
1456657|NCT02068599|3565510|P3|NOT COMPLETED|Overall Study||13
1456658|NCT02068599|3565511|P2|NOT COMPLETED|Overall Study||10
1456659|NCT02068599|3565512|P1|NOT COMPLETED|Overall Study||11
1456660|NCT02068599|3565510|P3|COMPLETED|Overall Study||117
1456661|NCT02068599|3565511|P2|COMPLETED|Overall Study||119
1456662|NCT02068599|3565512|P1|COMPLETED|Overall Study||119
1456663|NCT02068599|3565510|P3|Full Analysis Set|Overall Study||130
1456664|NCT02068599|3565511|P2|Full Analysis Set|Overall Study||128
1456665|NCT02068599|3565512|P1|Full Analysis Set|Overall Study||129
1456666|NCT02068599|3565510|P3|Safety Analysis Set|Overall Study||130
1456667|NCT02068599|3565511|P2|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
1456668|NCT02068599|3565512|P1|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
1456669|NCT02068599|3565510|P3|STARTED|Overall Study||130
1456670|NCT02068599|3565511|P2|STARTED|Overall Study||129
1456671|NCT02068599|3565512|P1|STARTED|Overall Study||130
1456672|NCT02068547|3565552|P2|NOT COMPLETED|Overall Study||3
1456673|NCT02068547|3565553|P1|NOT COMPLETED|Overall Study||4
1456674|NCT02068547|3565552|P2|COMPLETED|Overall Study||1
1456675|NCT02068547|3565553|P1|COMPLETED|Overall Study||0
1456676|NCT02068547|3565552|P2|STARTED|Overall Study||4
1456677|NCT02068547|3565553|P1|STARTED|Overall Study||4
1456678|NCT02068495|3565563|P1|NOT COMPLETED|Overall Study||109
1456679|NCT02068495|3565563|P1|COMPLETED|Overall Study||3300
1456680|NCT02068495|3565563|P1|STARTED|Overall Study||3409
1456681|NCT02068443|3565575|P3|NOT COMPLETED|Overall Study||3
1456682|NCT02068443|3565576|P2|NOT COMPLETED|Overall Study||6
1456683|NCT02068443|3565577|P1|NOT COMPLETED|Overall Study||7
1456684|NCT02068443|3565575|P3|COMPLETED|Overall Study||148
1456685|NCT02068443|3565576|P2|COMPLETED|Overall Study||146
1456686|NCT02068443|3565577|P1|COMPLETED|Overall Study||64
1456687|NCT02068443|3565575|P3|STARTED|Overall Study||151
1456688|NCT02068443|3565576|P2|STARTED|Overall Study||152
1456689|NCT02068443|3565577|P1|STARTED|Overall Study||71
1456690|NCT02068222|3565612|P1|NOT COMPLETED|Overall Study||1
1456691|NCT02068222|3565612|P1|COMPLETED|Overall Study||9
1456692|NCT02068222|3565612|P1|STARTED|Overall Study||10
1456693|NCT02068157|3565619|P1|NOT COMPLETED|Overall Study||0
1456694|NCT02068157|3565619|P1|COMPLETED|Overall Study||3
1456695|NCT02068157|3565619|P1|STARTED|Overall Study||3
1456696|NCT02068027|3565626|P2|NOT COMPLETED|Overall Study||16
1456697|NCT02068027|3565627|P1|NOT COMPLETED|Overall Study||13
1456698|NCT02068027|3565626|P2|COMPLETED|Overall Study||114
1456699|NCT02068027|3565627|P1|COMPLETED|Overall Study||117
1456700|NCT02068027|3565626|P2|STARTED|Overall Study||130
1456701|NCT02068027|3565627|P1|STARTED|Overall Study||130
1456702|NCT02067858|3565635|P1|NOT COMPLETED|Overall Study||0
1456703|NCT02067858|3565635|P1|COMPLETED|Overall Study||6
1456704|NCT02067858|3565635|P1|STARTED|Overall Study||6
1456705|NCT02067728|3565643|P2|NOT COMPLETED|6 Month Measurements||97
1456706|NCT02067728|3565644|P1|NOT COMPLETED|6 Month Measurements||114
1456707|NCT02067728|3565643|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
1456708|NCT02067728|3565644|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
1456709|NCT02067728|3565643|P2|STARTED|6 Month Measurements||210
1456710|NCT02067728|3565644|P1|STARTED|6 Month Measurements||220
1456711|NCT02067728|3565643|P2|NOT COMPLETED|6 Month Follow up Survey||60
1456712|NCT02067728|3565644|P1|NOT COMPLETED|6 Month Follow up Survey||48
1456713|NCT02067728|3565643|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
1456804|NCT02066415|3565871|P3|STARTED|Overall Study||190
1456714|NCT02067728|3565644|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
1456715|NCT02067728|3565643|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
1456716|NCT02067728|3565644|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
1456717|NCT02067728|3565643|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
1456718|NCT02067728|3565644|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
1456719|NCT02067728|3565643|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
1456720|NCT02067728|3565644|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
1456721|NCT02067728|3565643|P2|STARTED|Baseline - 1 Month Follow up Survey||210
1456722|NCT02067728|3565644|P1|STARTED|Baseline - 1 Month Follow up Survey||220
1456723|NCT02067676|3565678|P6|NOT COMPLETED|Overall Study||0
1456724|NCT02067676|3565679|P5|NOT COMPLETED|Overall Study||0
1456725|NCT02067676|3565680|P4|NOT COMPLETED|Overall Study||0
1456726|NCT02067676|3565681|P3|NOT COMPLETED|Overall Study||0
1456727|NCT02067676|3565682|P2|NOT COMPLETED|Overall Study||0
1456728|NCT02067676|3565683|P1|NOT COMPLETED|Overall Study||1
1456729|NCT02067676|3565678|P6|COMPLETED|Overall Study||8
1456730|NCT02067676|3565679|P5|COMPLETED|Overall Study||8
1456731|NCT02067676|3565680|P4|COMPLETED|Overall Study||8
1456732|NCT02067676|3565681|P3|COMPLETED|Overall Study||8
1456733|NCT02067676|3565682|P2|COMPLETED|Overall Study||8
1456734|NCT02067676|3565683|P1|COMPLETED|Overall Study||7
1456735|NCT02067676|3565678|P6|STARTED|Overall Study||8
1456736|NCT02067676|3565679|P5|STARTED|Overall Study||8
1456737|NCT02067676|3565680|P4|STARTED|Overall Study||8
1456738|NCT02067676|3565681|P3|STARTED|Overall Study||8
1456739|NCT02067676|3565682|P2|STARTED|Overall Study||8
1456740|NCT02067676|3565683|P1|STARTED|Overall Study||8
1456741|NCT02067611|3565721|P3|NOT COMPLETED|Overall Study||4
1456742|NCT02067611|3565722|P2|NOT COMPLETED|Overall Study||6
1456743|NCT02067611|3565723|P1|NOT COMPLETED|Overall Study||6
1456744|NCT02067611|3565721|P3|COMPLETED|Overall Study||68
1456745|NCT02067611|3565722|P2|COMPLETED|Overall Study||66
1456746|NCT02067611|3565723|P1|COMPLETED|Overall Study||66
1456747|NCT02067611|3565721|P3|STARTED|Overall Study||72
1456748|NCT02067611|3565722|P2|STARTED|Overall Study||72
1456749|NCT02067611|3565723|P1|STARTED|Overall Study||72
1456750|NCT02067585|3565761|P3|NOT COMPLETED|Overall Study||0
1456751|NCT02067585|3565762|P2|NOT COMPLETED|Overall Study||0
1456752|NCT02067585|3565763|P1|NOT COMPLETED|Overall Study||0
1456753|NCT02067585|3565761|P3|COMPLETED|Overall Study||16
1456754|NCT02067585|3565762|P2|COMPLETED|Overall Study||16
1456755|NCT02067585|3565763|P1|COMPLETED|Overall Study||16
1456756|NCT02067585|3565761|P3|STARTED|Overall Study||16
1456757|NCT02067585|3565762|P2|STARTED|Overall Study||16
1456758|NCT02067585|3565763|P1|STARTED|Overall Study||16
1456759|NCT02067533|3565800|P2|NOT COMPLETED|Overall Study||2
1456760|NCT02067533|3565801|P1|NOT COMPLETED|Overall Study||4
1456761|NCT02067533|3565800|P2|COMPLETED|Overall Study||44
1456762|NCT02067533|3565801|P1|COMPLETED|Overall Study||41
1456763|NCT02067533|3565800|P2|STARTED|Overall Study||46
1456764|NCT02067533|3565801|P1|STARTED|Overall Study||45
1456765|NCT02067273|3565809|P2|NOT COMPLETED|Overall Study||3
1456766|NCT02067273|3565810|P1|NOT COMPLETED|Overall Study||0
1456767|NCT02067273|3565809|P2|COMPLETED|Overall Study||12
1456768|NCT02067273|3565810|P1|COMPLETED|Overall Study||5
1456769|NCT02067273|3565809|P2|STARTED|Overall Study||15
1456770|NCT02067273|3565810|P1|STARTED|Overall Study||5
1456771|NCT02066922|3565816|P1|NOT COMPLETED|Overall Study||1
1456772|NCT02066922|3565816|P1|COMPLETED|Overall Study||14
1456773|NCT02066922|3565816|P1|STARTED|Overall Study||15
1456774|NCT02066896|3565826|P2|NOT COMPLETED|Overall Study||0
1456775|NCT02066896|3565827|P1|NOT COMPLETED|Overall Study||0
1456776|NCT02066896|3565826|P2|COMPLETED|Overall Study||33
1456777|NCT02066896|3565827|P1|COMPLETED|Overall Study||33
1456778|NCT02066896|3565826|P2|STARTED|Overall Study||33
1456779|NCT02066896|3565827|P1|STARTED|Overall Study||33
1456780|NCT02066857|3565839|P2|NOT COMPLETED|Overall Study||1
1456781|NCT02066857|3565840|P1|NOT COMPLETED|Overall Study||1
1456782|NCT02066857|3565839|P2|COMPLETED|Overall Study||3
1456783|NCT02066857|3565840|P1|COMPLETED|Overall Study||0
1456784|NCT02066857|3565839|P2|STARTED|Overall Study||4
1456785|NCT02066857|3565840|P1|STARTED|Overall Study||1
1456786|NCT02066740|3565854|P1|NOT COMPLETED|Overall Study||2
1456787|NCT02066740|3565854|P1|COMPLETED|Overall Study||32
1456788|NCT02066740|3565854|P1|STARTED|Overall Study||34
1456789|NCT02066727|3565861|P2|NOT COMPLETED|Overall Study||0
1456790|NCT02066727|3565862|P1|NOT COMPLETED|Overall Study||0
1456791|NCT02066727|3565861|P2|COMPLETED|Overall Study||30
1456792|NCT02066727|3565862|P1|COMPLETED|Overall Study||30
1456793|NCT02066727|3565861|P2|STARTED|Overall Study||30
1456794|NCT02066727|3565862|P1|STARTED|Overall Study||30
1456795|NCT02066415|3565871|P3|NOT COMPLETED|Overall Study||8
1456796|NCT02066415|3565872|P2|NOT COMPLETED|Overall Study||7
1456797|NCT02066415|3565873|P1|NOT COMPLETED|Overall Study||21
1456798|NCT02066415|3565871|P3|COMPLETED|Overall Study||182
1456799|NCT02066415|3565872|P2|COMPLETED|Overall Study||184
1456800|NCT02066415|3565873|P1|COMPLETED|Overall Study||265
1456801|NCT02066415|3565871|P3|Received Study Drug|Overall Study||188
1456802|NCT02066415|3565872|P2|Received Study Drug|Overall Study||190
1456803|NCT02066415|3565873|P1|Received Study Drug|Overall Study||282
1456805|NCT02066415|3565872|P2|STARTED|Overall Study||191
1456806|NCT02066415|3565873|P1|STARTED|Overall Study||286
1456807|NCT02066402|3565898|P2|NOT COMPLETED|Overall Study||23
1456808|NCT02066402|3565899|P1|NOT COMPLETED|Overall Study||26
1456809|NCT02066402|3565898|P2|COMPLETED|Overall Study||275
1456810|NCT02066402|3565899|P1|COMPLETED|Overall Study||274
1456811|NCT02066402|3565898|P2|Completed Study Treatment Period|Overall Study||256
1456812|NCT02066402|3565899|P1|Completed Study Treatment Period|Overall Study||261
1456813|NCT02066402|3565898|P2|Participants Received Treatment|Overall Study||297
1456814|NCT02066402|3565899|P1|Participants Received Treatment|Overall Study||292
1456815|NCT02066402|3565898|P2|STARTED|Overall Study||298
1456816|NCT02066402|3565899|P1|STARTED|Overall Study||300
1456817|NCT02066233|3565927|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
1456818|NCT02066233|3565928|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
1456819|NCT02066233|3565927|P2|COMPLETED|Standard Endoscopy (Day 2)||44
1456820|NCT02066233|3565928|P1|COMPLETED|Standard Endoscopy (Day 2)||44
1456821|NCT02066233|3565927|P2|STARTED|Standard Endoscopy (Day 2)||44
1456822|NCT02066233|3565928|P1|STARTED|Standard Endoscopy (Day 2)||44
1456823|NCT02066233|3565927|P2|NOT COMPLETED|EG Scan II (Day 1)||6
1456824|NCT02066233|3565928|P1|NOT COMPLETED|EG Scan II (Day 1)||6
1456825|NCT02066233|3565927|P2|COMPLETED|EG Scan II (Day 1)||44
1456826|NCT02066233|3565928|P1|COMPLETED|EG Scan II (Day 1)||44
1456827|NCT02066233|3565927|P2|STARTED|EG Scan II (Day 1)||50
1456828|NCT02066233|3565928|P1|STARTED|EG Scan II (Day 1)||50
1456829|NCT02066129|3565938|P2|NOT COMPLETED|Overall Study||33
1456830|NCT02066129|3565939|P1|NOT COMPLETED|Overall Study||29
1456831|NCT02066129|3565938|P2|COMPLETED|Overall Study||94
1456832|NCT02066129|3565939|P1|COMPLETED|Overall Study||98
1456833|NCT02066129|3565938|P2|STARTED|Overall Study||127
1456834|NCT02066129|3565939|P1|STARTED|Overall Study||127
1456835|NCT02066051|3565953|P1|NOT COMPLETED|Overall Study||1
1456836|NCT02066051|3565953|P1|COMPLETED|Overall Study||7
1456837|NCT02066051|3565953|P1|STARTED|Overall Study||8
1456838|NCT02065895|3565958|P6|NOT COMPLETED|Overall Study||0
1456839|NCT02065895|3565959|P5|NOT COMPLETED|Overall Study||0
1456840|NCT02065895|3565960|P4|NOT COMPLETED|Overall Study||1
1456841|NCT02065895|3565961|P3|NOT COMPLETED|Overall Study||0
1456842|NCT02065895|3565962|P2|NOT COMPLETED|Overall Study||1
1456843|NCT02065895|3565963|P1|NOT COMPLETED|Overall Study||1
1456844|NCT02065895|3565958|P6|COMPLETED|Overall Study||1
1456845|NCT02065895|3565959|P5|COMPLETED|Overall Study||1
1456846|NCT02065895|3565960|P4|COMPLETED|Overall Study||0
1456847|NCT02065895|3565961|P3|COMPLETED|Overall Study||1
1456848|NCT02065895|3565962|P2|COMPLETED|Overall Study||2
1456849|NCT02065895|3565963|P1|COMPLETED|Overall Study||0
1456850|NCT02065895|3565958|P6|STARTED|Overall Study||1
1456851|NCT02065895|3565959|P5|STARTED|Overall Study||1
1456852|NCT02065895|3565960|P4|STARTED|Overall Study||1
1456853|NCT02065895|3565961|P3|STARTED|Overall Study||1
1456854|NCT02065895|3565962|P2|STARTED|Overall Study||3
1456855|NCT02065895|3565963|P1|STARTED|Overall Study||1
1456856|NCT02065453|3565982|P2|NOT COMPLETED|Overall Study||4
1456857|NCT02065453|3565983|P1|NOT COMPLETED|Overall Study||3
1456858|NCT02065453|3565982|P2|COMPLETED|Overall Study||21
1456859|NCT02065453|3565983|P1|COMPLETED|Overall Study||24
1456860|NCT02065453|3565982|P2|STARTED|Overall Study||25
1456861|NCT02065453|3565983|P1|STARTED|Overall Study||27
1456862|NCT02064985|3565991|P3|NOT COMPLETED|Overall Study||0
1456863|NCT02064985|3565992|P2|NOT COMPLETED|Overall Study||0
1456864|NCT02064985|3565993|P1|NOT COMPLETED|Overall Study||0
1456865|NCT02064985|3565991|P3|COMPLETED|Overall Study||12
1456866|NCT02064985|3565992|P2|COMPLETED|Overall Study||12
1456867|NCT02064985|3565993|P1|COMPLETED|Overall Study||12
1456868|NCT02064985|3565991|P3|STARTED|Overall Study||12
1456869|NCT02064985|3565992|P2|STARTED|Overall Study||12
1456870|NCT02064985|3565993|P1|STARTED|Overall Study||12
1456871|NCT02064920|3566156|P2|NOT COMPLETED|Overall Study||9
1456872|NCT02064920|3566157|P1|NOT COMPLETED|Overall Study||1
1456873|NCT02064920|3566156|P2|COMPLETED|Overall Study||21
1456874|NCT02064920|3566157|P1|COMPLETED|Overall Study||5
1456875|NCT02064920|3566156|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
1456876|NCT02064920|3566157|P1|Treated|Overall Study||6
1456877|NCT02064920|3566156|P2|STARTED|Overall Study||30
1456878|NCT02064920|3566157|P1|STARTED|Overall Study||6
1456879|NCT02064907|3566167|P2|NOT COMPLETED|Period 2||0
1456880|NCT02064907|3566168|P1|NOT COMPLETED|Period 2||0
1456881|NCT02064907|3566167|P2|COMPLETED|Period 2||26
1456882|NCT02064907|3566168|P1|COMPLETED|Period 2||26
1456883|NCT02064907|3566167|P2|STARTED|Period 2||26
1456884|NCT02064907|3566168|P1|STARTED|Period 2||26
1456885|NCT02064907|3566167|P2|NOT COMPLETED|Period 1||0
1456886|NCT02064907|3566168|P1|NOT COMPLETED|Period 1||0
1456887|NCT02064907|3566167|P2|COMPLETED|Period 1||26
1456888|NCT02064907|3566168|P1|COMPLETED|Period 1||26
1456889|NCT02064907|3566167|P2|STARTED|Period 1||26
1456890|NCT02064907|3566168|P1|STARTED|Period 1||26
1456891|NCT02064894|3566187|P3|NOT COMPLETED|Overall Study||115
1456892|NCT02064894|3566188|P2|NOT COMPLETED|Overall Study||102
1456893|NCT02064894|3566189|P1|NOT COMPLETED|Overall Study||43
1456894|NCT02064894|3566187|P3|COMPLETED|Overall Study||86
1456895|NCT02064894|3566188|P2|COMPLETED|Overall Study||99
1456896|NCT02064894|3566189|P1|COMPLETED|Overall Study||56
1456897|NCT02064894|3566187|P3|Avalaible at T-90|Overall Study||129
1456898|NCT02064894|3566188|P2|Avalaible at T-90|Overall Study||134
1456899|NCT02064894|3566189|P1|Avalaible at T-90|Overall Study||74
1456900|NCT02064894|3566187|P3|Available at T-60|Overall Study||177
1456901|NCT02064894|3566188|P2|Available at T-60|Overall Study||188
1456902|NCT02064894|3566189|P1|Available at T-60|Overall Study||91
1456903|NCT02064894|3566187|P3|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
1456904|NCT02064894|3566188|P2|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
1456905|NCT02064894|3566189|P1|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
1456906|NCT02064816|3566202|P2|NOT COMPLETED|Overall Study||8
1456907|NCT02064816|3566203|P1|NOT COMPLETED|Overall Study||8
1456908|NCT02064816|3566202|P2|COMPLETED|Overall Study||88
1456909|NCT02064816|3566203|P1|COMPLETED|Overall Study||96
1456910|NCT02064816|3566202|P2|STARTED|Overall Study||96
1456911|NCT02064816|3566203|P1|STARTED|Overall Study||104
1456912|NCT02064439|3566244|P3|NOT COMPLETED|Overall Study||182
1456913|NCT02064439|3566245|P2|NOT COMPLETED|Overall Study||138
1456914|NCT02064439|3566246|P1|NOT COMPLETED|Overall Study||143
1456915|NCT02064439|3566244|P3|COMPLETED|Overall Study||949
1456916|NCT02064439|3566245|P2|COMPLETED|Overall Study||969
1456917|NCT02064439|3566246|P1|COMPLETED|Overall Study||984
1456918|NCT02064439|3566244|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
1456919|NCT02064439|3566245|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
1456920|NCT02064439|3566246|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
1456921|NCT02064270|3566265|P2|NOT COMPLETED|Overall Study||32
1456922|NCT02064270|3566266|P1|NOT COMPLETED|Overall Study||62
1456923|NCT02064270|3566265|P2|COMPLETED|Overall Study||231
1456924|NCT02064270|3566266|P1|COMPLETED|Overall Study||201
1456925|NCT02064270|3566265|P2|STARTED|Overall Study||263
1456926|NCT02064270|3566266|P1|STARTED|Overall Study||263
1456927|NCT02064231|3566281|P4|NOT COMPLETED|Third Test Period (Own Product)||0
1456928|NCT02064231|3566282|P3|NOT COMPLETED|Third Test Period (Own Product)||0
1456929|NCT02064231|3566283|P2|NOT COMPLETED|Third Test Period (Own Product)||0
1456930|NCT02064231|3566284|P1|NOT COMPLETED|Third Test Period (Own Product)||0
1456931|NCT02064231|3566281|P4|COMPLETED|Third Test Period (Own Product)||1
1456932|NCT02064231|3566282|P3|COMPLETED|Third Test Period (Own Product)||0
1456933|NCT02064231|3566283|P2|COMPLETED|Third Test Period (Own Product)||8
1456934|NCT02064231|3566284|P1|COMPLETED|Third Test Period (Own Product)||8
1456935|NCT02064231|3566281|P4|STARTED|Third Test Period (Own Product)||1
1456936|NCT02064231|3566282|P3|STARTED|Third Test Period (Own Product)||0
1456937|NCT02064231|3566283|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
1456938|NCT02064231|3566284|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
1456939|NCT02064231|3566281|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
1456940|NCT02064231|3566282|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
1456941|NCT02064231|3566283|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
1456942|NCT02064231|3566284|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
1456943|NCT02064231|3566281|P4|COMPLETED|Second Test Period (Test B or Test D)||1
1456944|NCT02064231|3566282|P3|COMPLETED|Second Test Period (Test B or Test D)||0
1456945|NCT02064231|3566283|P2|COMPLETED|Second Test Period (Test B or Test D)||7
1456946|NCT02064231|3566284|P1|COMPLETED|Second Test Period (Test B or Test D)||6
1456947|NCT02064231|3566281|P4|STARTED|Second Test Period (Test B or Test D)||1
1456948|NCT02064231|3566282|P3|STARTED|Second Test Period (Test B or Test D)||0
1456949|NCT02064231|3566283|P2|STARTED|Second Test Period (Test B or Test D)||8
1456950|NCT02064231|3566284|P1|STARTED|Second Test Period (Test B or Test D)||7
1456951|NCT02064231|3566281|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
1456952|NCT02064231|3566282|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
1456953|NCT02064231|3566283|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
1456954|NCT02064231|3566284|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
1456955|NCT02064231|3566281|P4|COMPLETED|First Test Period (Test A or Test C)||1
1456956|NCT02064231|3566282|P3|COMPLETED|First Test Period (Test A or Test C)||0
1456957|NCT02064231|3566283|P2|COMPLETED|First Test Period (Test A or Test C)||8
1456958|NCT02064231|3566284|P1|COMPLETED|First Test Period (Test A or Test C)||7
1456959|NCT02064231|3566281|P4|STARTED|First Test Period (Test A or Test C)||1
1456960|NCT02064231|3566282|P3|STARTED|First Test Period (Test A or Test C)||1
1456961|NCT02064231|3566283|P2|STARTED|First Test Period (Test A or Test C)||12
1456962|NCT02064231|3566284|P1|STARTED|First Test Period (Test A or Test C)||14
1456963|NCT02064205|3566296|P1|NOT COMPLETED|Overall Study||1
1456964|NCT02064205|3566296|P1|COMPLETED|Overall Study||31
1456965|NCT02064205|3566296|P1|Condition D|Overall Study||32
1456966|NCT02064205|3566296|P1|Condition C|Overall Study||31
1456967|NCT02064205|3566296|P1|Condition B|Overall Study||32
1456968|NCT02064205|3566296|P1|Condition A|Overall Study||32
1456969|NCT02064205|3566296|P1|STARTED|Overall Study||32
1456970|NCT02064166|3566314|P2|NOT COMPLETED|Overall Study||0
1456971|NCT02064166|3566315|P1|NOT COMPLETED|Overall Study||1
1456972|NCT02064166|3566314|P2|COMPLETED|Overall Study||6
1456973|NCT02064166|3566315|P1|COMPLETED|Overall Study||8
1456974|NCT02064166|3566314|P2|STARTED|Overall Study||6
1456975|NCT02064166|3566315|P1|STARTED|Overall Study||9
1456976|NCT02063880|3566345|P2|NOT COMPLETED|Overall Study||27
1456977|NCT02063880|3566346|P1|NOT COMPLETED|Overall Study||28
1456978|NCT02063880|3566345|P2|COMPLETED|Overall Study||66
1456979|NCT02063880|3566346|P1|COMPLETED|Overall Study||62
1456980|NCT02063880|3566345|P2|STARTED|Overall Study||93
1456981|NCT02063880|3566346|P1|STARTED|Overall Study||90
1456982|NCT02063854|3566363|P7|NOT COMPLETED|Overall Study||6
1456983|NCT02063854|3566364|P6|NOT COMPLETED|Overall Study||31
1456984|NCT02063854|3566365|P5|NOT COMPLETED|Overall Study||11
1456985|NCT02063854|3566366|P4|NOT COMPLETED|Overall Study||10
1456986|NCT02063854|3566367|P3|NOT COMPLETED|Overall Study||30
1456987|NCT02063854|3566368|P2|NOT COMPLETED|Overall Study||12
1456988|NCT02063854|3566369|P1|NOT COMPLETED|Overall Study||21
1456989|NCT02063854|3566363|P7|COMPLETED|Overall Study||60
1456990|NCT02063854|3566364|P6|COMPLETED|Overall Study||170
1456991|NCT02063854|3566365|P5|COMPLETED|Overall Study||54
1456992|NCT02063854|3566366|P4|COMPLETED|Overall Study||58
1456993|NCT02063854|3566367|P3|COMPLETED|Overall Study||176
1456994|NCT02063854|3566368|P2|COMPLETED|Overall Study||54
1456995|NCT02063854|3566369|P1|COMPLETED|Overall Study||178
1456996|NCT02063854|3566363|P7|Full Analysis Set: Received Study Drug|Overall Study||66
1456997|NCT02063854|3566364|P6|Full Analysis Set: Received Study Drug|Overall Study||200
1456998|NCT02063854|3566365|P5|Full Analysis Set: Received Study Drug|Overall Study||65
1456999|NCT02063854|3566366|P4|Full Analysis Set: Received Study Drug|Overall Study||68
1457000|NCT02063854|3566367|P3|Full Analysis Set: Received Study Drug|Overall Study||206
1457001|NCT02063854|3566368|P2|Full Analysis Set: Received Study Drug|Overall Study||66
1457002|NCT02063854|3566369|P1|Full Analysis Set: Received Study Drug|Overall Study||199
1457003|NCT02063854|3566363|P7|STARTED|Overall Study||66
1457004|NCT02063854|3566364|P6|STARTED|Overall Study||201
1457005|NCT02063854|3566365|P5|STARTED|Overall Study||65
1457006|NCT02063854|3566366|P4|STARTED|Overall Study||68
1457007|NCT02063854|3566367|P3|STARTED|Overall Study||206
1457008|NCT02063854|3566368|P2|STARTED|Overall Study||66
1457009|NCT02063854|3566369|P1|STARTED|Overall Study||199
1457010|NCT02063737|3566453|P2|NOT COMPLETED|Overall Study||4
1457011|NCT02063737|3566454|P1|NOT COMPLETED|Overall Study||11
1457012|NCT02063737|3566453|P2|COMPLETED|Overall Study||44
1457013|NCT02063737|3566454|P1|COMPLETED|Overall Study||41
1457014|NCT02063737|3566453|P2|STARTED|Overall Study||48
1457015|NCT02063737|3566454|P1|STARTED|Overall Study||52
1457016|NCT02063672|3566488|P2|NOT COMPLETED|Overall Study||22
1457017|NCT02063672|3566489|P1|NOT COMPLETED|Overall Study||35
1457018|NCT02063672|3566488|P2|COMPLETED|Overall Study||7
1457019|NCT02063672|3566489|P1|COMPLETED|Overall Study||18
1457020|NCT02063672|3566488|P2|STARTED|Overall Study||29
1457021|NCT02063672|3566489|P1|STARTED|Overall Study||53
1457022|NCT02063659|3566536|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
1457023|NCT02063659|3566537|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1457024|NCT02063659|3566538|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1457025|NCT02063659|3566539|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1457026|NCT02063659|3566536|P4|COMPLETED|Open-Label Extension Period (OLE)||47
1457027|NCT02063659|3566537|P3|COMPLETED|Open-Label Extension Period (OLE)||0
1457028|NCT02063659|3566538|P2|COMPLETED|Open-Label Extension Period (OLE)||0
1457029|NCT02063659|3566539|P1|COMPLETED|Open-Label Extension Period (OLE)||0
1457030|NCT02063659|3566536|P4|STARTED|Open-Label Extension Period (OLE)||67
1457031|NCT02063659|3566537|P3|STARTED|Open-Label Extension Period (OLE)||0
1457032|NCT02063659|3566538|P2|STARTED|Open-Label Extension Period (OLE)||0
1457033|NCT02063659|3566539|P1|STARTED|Open-Label Extension Period (OLE)||0
1457034|NCT02063659|3566536|P4|NOT COMPLETED|Double-Blind Treatment Period||0
1457035|NCT02063659|3566537|P3|NOT COMPLETED|Double-Blind Treatment Period||3
1457036|NCT02063659|3566538|P2|NOT COMPLETED|Double-Blind Treatment Period||3
1457037|NCT02063659|3566539|P1|NOT COMPLETED|Double-Blind Treatment Period||2
1457038|NCT02063659|3566536|P4|COMPLETED|Double-Blind Treatment Period||0
1457039|NCT02063659|3566537|P3|COMPLETED|Double-Blind Treatment Period||22
1457040|NCT02063659|3566538|P2|COMPLETED|Double-Blind Treatment Period||22
1457041|NCT02063659|3566539|P1|COMPLETED|Double-Blind Treatment Period||24
1457042|NCT02063659|3566536|P4|STARTED|Double-Blind Treatment Period||0
1457043|NCT02063659|3566537|P3|STARTED|Double-Blind Treatment Period||25
1457044|NCT02063659|3566538|P2|STARTED|Double-Blind Treatment Period||25
1457045|NCT02063659|3566539|P1|STARTED|Double-Blind Treatment Period||26
1457046|NCT02063516|3566571|P2|NOT COMPLETED|Overall Study||0
1457047|NCT02063516|3566572|P1|NOT COMPLETED|Overall Study||0
1457048|NCT02063516|3566571|P2|COMPLETED|Overall Study||40
1457049|NCT02063516|3566572|P1|COMPLETED|Overall Study||40
1457050|NCT02063516|3566571|P2|STARTED|Overall Study||40
1457051|NCT02063516|3566572|P1|STARTED|Overall Study||40
1457052|NCT02063230|3566586|P4|NOT COMPLETED|Overall Study||0
1457053|NCT02063230|3566587|P3|NOT COMPLETED|Overall Study||0
1457054|NCT02063230|3566588|P2|NOT COMPLETED|Overall Study||0
1457055|NCT02063230|3566589|P1|NOT COMPLETED|Overall Study||0
1457056|NCT02063230|3566586|P4|COMPLETED|Overall Study||8
1457057|NCT02063230|3566587|P3|COMPLETED|Overall Study||8
1457058|NCT02063230|3566588|P2|COMPLETED|Overall Study||8
1457059|NCT02063230|3566589|P1|COMPLETED|Overall Study||8
1457060|NCT02063230|3566586|P4|Received Treatment|Overall Study||8
1457061|NCT02063230|3566587|P3|Received Treatment|Overall Study||8
1457062|NCT02063230|3566588|P2|Received Treatment|Overall Study||8
1457063|NCT02063230|3566589|P1|Received Treatment|Overall Study||8
1457064|NCT02063230|3566586|P4|STARTED|Overall Study||8
1457065|NCT02063230|3566587|P3|STARTED|Overall Study||8
1457066|NCT02063230|3566588|P2|STARTED|Overall Study||8
1457067|NCT02063230|3566589|P1|STARTED|Overall Study||8
1457068|NCT02063217|3566622|P3|NOT COMPLETED|Overall Study||0
1457069|NCT02063217|3566623|P2|NOT COMPLETED|Overall Study||0
1457070|NCT02063217|3566624|P1|NOT COMPLETED|Overall Study||1
1457071|NCT02063217|3566622|P3|COMPLETED|Overall Study||12
1457072|NCT02063217|3566623|P2|COMPLETED|Overall Study||12
1457073|NCT02063217|3566624|P1|COMPLETED|Overall Study||11
1457074|NCT02063217|3566622|P3|STARTED|Overall Study||12
1457075|NCT02063217|3566623|P2|STARTED|Overall Study||12
1457076|NCT02063217|3566624|P1|STARTED|Overall Study||12
1457077|NCT02063035|3566634|P2|NOT COMPLETED|Overall Study||0
1457078|NCT02063035|3566635|P1|NOT COMPLETED|Overall Study||0
1457079|NCT02063035|3566634|P2|COMPLETED|Overall Study||17
1457080|NCT02063035|3566635|P1|COMPLETED|Overall Study||12
1457081|NCT02063035|3566634|P2|STARTED|Overall Study||17
1457082|NCT02063035|3566635|P1|STARTED|Overall Study||12
1457083|NCT02062905|3566649|P2|NOT COMPLETED|Overall Study||2
1457084|NCT02062905|3566650|P1|NOT COMPLETED|Overall Study||7
1457085|NCT02062905|3566649|P2|COMPLETED|Overall Study||31
1457086|NCT02062905|3566650|P1|COMPLETED|Overall Study||28
1457087|NCT02062905|3566649|P2|STARTED|Overall Study||33
1457088|NCT02062905|3566650|P1|STARTED|Overall Study||35
1457089|NCT02062879|3566660|P2|NOT COMPLETED|Overall Study||1
1457090|NCT02062879|3566661|P1|NOT COMPLETED|Overall Study||4
1457091|NCT02062879|3566660|P2|COMPLETED|Overall Study||9
1457092|NCT02062879|3566661|P1|COMPLETED|Overall Study||6
1457093|NCT02062879|3566660|P2|STARTED|Overall Study||10
1457094|NCT02062879|3566661|P1|STARTED|Overall Study||10
1457095|NCT02062801|3566673|P2|NOT COMPLETED|Overall Study||4
1457096|NCT02062801|3566674|P1|NOT COMPLETED|Overall Study||2
1457097|NCT02062801|3566673|P2|COMPLETED|Overall Study||297
1457098|NCT02062801|3566674|P1|COMPLETED|Overall Study||299
1457099|NCT02062801|3566673|P2|STARTED|Overall Study||301
1457100|NCT02062801|3566674|P1|STARTED|Overall Study||301
1457101|NCT02062710|3566684|P6|NOT COMPLETED|Overall Study||0
1457102|NCT02062710|3566685|P5|NOT COMPLETED|Overall Study||0
1457103|NCT02062710|3566686|P4|NOT COMPLETED|Overall Study||0
1457104|NCT02062710|3566687|P3|NOT COMPLETED|Overall Study||0
1457105|NCT02062710|3566688|P2|NOT COMPLETED|Overall Study||0
1457106|NCT02062710|3566689|P1|NOT COMPLETED|Overall Study||0
1457107|NCT02062710|3566684|P6|COMPLETED|Overall Study||4
1457108|NCT02062710|3566685|P5|COMPLETED|Overall Study||3
1457109|NCT02062710|3566686|P4|COMPLETED|Overall Study||3
1457110|NCT02062710|3566687|P3|COMPLETED|Overall Study||5
1457111|NCT02062710|3566688|P2|COMPLETED|Overall Study||4
1457112|NCT02062710|3566689|P1|COMPLETED|Overall Study||3
1457113|NCT02062710|3566684|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
1457114|NCT02062710|3566685|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
1457115|NCT02062710|3566686|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
1457116|NCT02062710|3566687|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
1457117|NCT02062710|3566688|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
1457118|NCT02062710|3566689|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
1457119|NCT02062658|3566697|P1|NOT COMPLETED|Overall Study||2
1457120|NCT02062658|3566697|P1|COMPLETED|Overall Study||8
1457121|NCT02062658|3566697|P1|STARTED|Overall Study||10
1457122|NCT02062645|3566701|P1|NOT COMPLETED|Overall Study||15
1457123|NCT02062645|3566701|P1|COMPLETED|Overall Study||100
1457124|NCT02062645|3566701|P1|STARTED|Overall Study||115
1457125|NCT02062580|3566711|P2|NOT COMPLETED|Overall Study||13
1457126|NCT02062580|3566712|P1|NOT COMPLETED|Overall Study||12
1457127|NCT02062580|3566711|P2|COMPLETED|Overall Study||65
1457128|NCT02062580|3566712|P1|COMPLETED|Overall Study||59
1457129|NCT02062580|3566711|P2|STARTED|Overall Study||78
1457130|NCT02062580|3566712|P1|STARTED|Overall Study||71
1457131|NCT02062502|3566722|P2|NOT COMPLETED|Overall Study||35
1457132|NCT02062502|3566723|P1|NOT COMPLETED|Overall Study||43
1457133|NCT02062502|3566722|P2|COMPLETED|Overall Study||270
1457134|NCT02062502|3566723|P1|COMPLETED|Overall Study||263
1457135|NCT02062502|3566722|P2|Vaccinated Dose 1|Overall Study||305
1457136|NCT02062502|3566723|P1|Vaccinated Dose 1|Overall Study||306
1457137|NCT02062502|3566722|P2|STARTED|Overall Study||305
1457138|NCT02062502|3566723|P1|STARTED|Overall Study||306
1457139|NCT02062450|3566743|P1|NOT COMPLETED|Overall Study||124
1457140|NCT02062450|3566743|P1|COMPLETED|Overall Study||255
1457141|NCT02062450|3566743|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
1457142|NCT02062450|3566743|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
1457143|NCT02062437|3566757|P1|NOT COMPLETED|Overall Study||52
1457144|NCT02062437|3566757|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
1457145|NCT02062437|3566757|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
1457146|NCT02062385|3566770|P4|NOT COMPLETED|Overall Study||9
1457147|NCT02062385|3566771|P3|NOT COMPLETED|Overall Study||12
1457148|NCT02062385|3566772|P2|NOT COMPLETED|Overall Study||65
1457149|NCT02062385|3566773|P1|NOT COMPLETED|Overall Study||78
1457150|NCT02062385|3566770|P4|COMPLETED|Overall Study||391
1457151|NCT02062385|3566771|P3|COMPLETED|Overall Study||388
1457152|NCT02062385|3566772|P2|COMPLETED|Overall Study||1555
1457153|NCT02062385|3566773|P1|COMPLETED|Overall Study||1542
1457154|NCT02062385|3566770|P4|Received Vaccination 3|Overall Study||392
1457155|NCT02062385|3566771|P3|Received Vaccination 3|Overall Study||389
1457156|NCT02062385|3566772|P2|Received Vaccination 3|Overall Study||1554
1457157|NCT02062385|3566773|P1|Received Vaccination 3|Overall Study||1543
1457158|NCT02062385|3566770|P4|Received Vaccination 2|Overall Study||393
1457159|NCT02062385|3566771|P3|Received Vaccination 2|Overall Study||392
1457160|NCT02062385|3566772|P2|Received Vaccination 2|Overall Study||1566
1457161|NCT02062385|3566773|P1|Received Vaccination 2|Overall Study||1554
1457162|NCT02062385|3566770|P4|Received Vaccination 1|Overall Study||400
1457163|NCT02062385|3566771|P3|Received Vaccination 1|Overall Study||400
1457164|NCT02062385|3566772|P2|Received Vaccination 1|Overall Study||1619
1457165|NCT02062385|3566773|P1|Received Vaccination 1|Overall Study||1618
1457166|NCT02062385|3566770|P4|STARTED|Overall Study||400
1457167|NCT02062385|3566771|P3|STARTED|Overall Study||400
1457168|NCT02062385|3566772|P2|STARTED|Overall Study||1620
1457169|NCT02062385|3566773|P1|STARTED|Overall Study||1620
1457170|NCT02062359|3566793|P1|NOT COMPLETED|Overall Study||0
1457171|NCT02062359|3566793|P1|COMPLETED|Overall Study||2
1457172|NCT02062359|3566793|P1|STARTED|Overall Study||2
1457173|NCT02062294|3566799|P1|NOT COMPLETED|Overall Study||0
1457174|NCT02062294|3566799|P1|COMPLETED|Overall Study||14
1457175|NCT02062294|3566799|P1|STARTED|Overall Study||14
1457176|NCT02062177|3566806|P2|NOT COMPLETED|Overall Study||0
1457177|NCT02062177|3566807|P1|NOT COMPLETED|Overall Study||0
1457178|NCT02062177|3566806|P2|COMPLETED|Overall Study||70
1457179|NCT02062177|3566807|P1|COMPLETED|Overall Study||70
1457180|NCT02062177|3566806|P2|STARTED|Overall Study||70
1457181|NCT02062177|3566807|P1|STARTED|Overall Study||70
1457182|NCT02061969|3566819|P2|NOT COMPLETED|Overall Study||0
1457183|NCT02061969|3566820|P1|NOT COMPLETED|Overall Study||0
1457184|NCT02061969|3566819|P2|COMPLETED|Overall Study||67
1457185|NCT02061969|3566820|P1|COMPLETED|Overall Study||73
1457186|NCT02061969|3566819|P2|STARTED|Overall Study||67
1457187|NCT02061969|3566820|P1|STARTED|Overall Study||73
1457188|NCT02061748|3566850|P2|NOT COMPLETED|Overall Study||0
1457189|NCT02061748|3566851|P1|NOT COMPLETED|Overall Study||0
1457190|NCT02061748|3566850|P2|COMPLETED|Overall Study||30853
1457191|NCT02061748|3566851|P1|COMPLETED|Overall Study||7646
1457192|NCT02061748|3566850|P2|STARTED|Overall Study||30853
1457193|NCT02061748|3566851|P1|STARTED|Overall Study||7646
1457194|NCT02061696|3566925|P2|NOT COMPLETED|Overall Study||0
1457195|NCT02061696|3566926|P1|NOT COMPLETED|Overall Study||0
1457196|NCT02061696|3566925|P2|COMPLETED|Overall Study||22
1457197|NCT02061696|3566926|P1|COMPLETED|Overall Study||17
1457198|NCT02061696|3566925|P2|STARTED|Overall Study||22
1457199|NCT02061696|3566926|P1|STARTED|Overall Study||17
1457200|NCT02061683|3566950|P1|NOT COMPLETED|Overall Study||60
1457201|NCT02061683|3566950|P1|COMPLETED|Overall Study||203
1457202|NCT02061683|3566950|P1|STARTED|Overall Study||263
1457203|NCT02061592|3566957|P2|NOT COMPLETED|Period 2||1
1457204|NCT02061592|3566958|P1|NOT COMPLETED|Period 2||0
1457205|NCT02061592|3566957|P2|COMPLETED|Period 2||61
1457206|NCT02061592|3566958|P1|COMPLETED|Period 2||64
1457207|NCT02061592|3566957|P2|STARTED|Period 2||62
1457208|NCT02061592|3566958|P1|STARTED|Period 2||64
1457209|NCT02061592|3566957|P2|NOT COMPLETED|Period 1||0
1457210|NCT02061592|3566958|P1|NOT COMPLETED|Period 1||2
1457211|NCT02061592|3566957|P2|COMPLETED|Period 1||62
1457212|NCT02061592|3566958|P1|COMPLETED|Period 1||64
1457213|NCT02061592|3566957|P2|STARTED|Period 1||62
1457214|NCT02061592|3566958|P1|STARTED|Period 1||66
1457215|NCT02061540|3566970|P1|NOT COMPLETED|Overall Study||4
1457216|NCT02061540|3566970|P1|COMPLETED|Overall Study||23
1457217|NCT02061540|3566970|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
1457218|NCT02061540|3566970|P1|STARTED|Overall Study||27
1457219|NCT02061358|3566992|P9|NOT COMPLETED|Overall Study||0
1457220|NCT02061358|3566993|P8|NOT COMPLETED|Overall Study||0
1457221|NCT02061358|3566994|P7|NOT COMPLETED|Overall Study||0
1457222|NCT02061358|3566995|P6|NOT COMPLETED|Overall Study||0
1457223|NCT02061358|3566996|P5|NOT COMPLETED|Overall Study||0
1457224|NCT02061358|3566997|P4|NOT COMPLETED|Overall Study||0
1457225|NCT02061358|3566998|P3|NOT COMPLETED|Overall Study||0
1457226|NCT02061358|3566999|P2|NOT COMPLETED|Overall Study||0
1457227|NCT02061358|3567000|P1|NOT COMPLETED|Overall Study||0
1457228|NCT02061358|3566992|P9|COMPLETED|Overall Study||16
1457229|NCT02061358|3566993|P8|COMPLETED|Overall Study||6
1457230|NCT02061358|3566994|P7|COMPLETED|Overall Study||6
1457231|NCT02061358|3566995|P6|COMPLETED|Overall Study||6
1457232|NCT02061358|3566996|P5|COMPLETED|Overall Study||6
1457233|NCT02061358|3566997|P4|COMPLETED|Overall Study||6
1457234|NCT02061358|3566998|P3|COMPLETED|Overall Study||6
1457235|NCT02061358|3566999|P2|COMPLETED|Overall Study||6
1457236|NCT02061358|3567000|P1|COMPLETED|Overall Study||6
1457237|NCT02061358|3566992|P9|STARTED|Overall Study||16
1457238|NCT02061358|3566993|P8|STARTED|Overall Study||6
1457239|NCT02061358|3566994|P7|STARTED|Overall Study||6
1457240|NCT02061358|3566995|P6|STARTED|Overall Study||6
1457241|NCT02061358|3566996|P5|STARTED|Overall Study||6
1457242|NCT02061358|3566997|P4|STARTED|Overall Study||6
1457243|NCT02061358|3566998|P3|STARTED|Overall Study||6
1457244|NCT02061358|3566999|P2|STARTED|Overall Study||6
1457245|NCT02061358|3567000|P1|STARTED|Overall Study||6
1457246|NCT02061280|3567138|P2|NOT COMPLETED|Overall Study||12
1457247|NCT02061280|3567139|P1|NOT COMPLETED|Overall Study||18
1457248|NCT02061280|3567138|P2|COMPLETED|Overall Study||25
1457249|NCT02061280|3567139|P1|COMPLETED|Overall Study||53
1457250|NCT02061280|3567138|P2|Randomized to Treatment|Overall Study||25
1457251|NCT02061280|3567139|P1|Randomized to Treatment|Overall Study||54
1457252|NCT02061280|3567138|P2|STARTED|Overall Study||37
1457253|NCT02061280|3567139|P1|STARTED|Overall Study||71
1457254|NCT02060890|3567169|P1|NOT COMPLETED|Overall Study||4
1457255|NCT02060890|3567169|P1|COMPLETED|Overall Study||16
1457256|NCT02060890|3567169|P1|STARTED|Overall Study||20
1457257|NCT02060838|3567178|P2|NOT COMPLETED|Overall Study||0
1457258|NCT02060838|3567179|P1|NOT COMPLETED|Overall Study||0
1457259|NCT02060838|3567178|P2|COMPLETED|Overall Study||22
1457260|NCT02060838|3567179|P1|COMPLETED|Overall Study||28
1457261|NCT02060838|3567178|P2|STARTED|Overall Study||22
1457262|NCT02060838|3567179|P1|STARTED|Overall Study||28
1457263|NCT02060539|3567187|P1|NOT COMPLETED|Overall Study||0
1457264|NCT02060539|3567187|P1|COMPLETED|Overall Study||19
1457265|NCT02060539|3567187|P1|STARTED|Overall Study||19
1457266|NCT02060526|3567235|P3|NOT COMPLETED|Overall Study||0
1457267|NCT02060526|3567236|P2|NOT COMPLETED|Overall Study||0
1457268|NCT02060526|3567237|P1|NOT COMPLETED|Overall Study||0
1457269|NCT02060526|3567235|P3|COMPLETED|Overall Study||7
1457270|NCT02060526|3567236|P2|COMPLETED|Overall Study||7
1457271|NCT02060526|3567237|P1|COMPLETED|Overall Study||7
1457272|NCT02060526|3567235|P3|STARTED|Overall Study||7
1457273|NCT02060526|3567236|P2|STARTED|Overall Study||7
1457274|NCT02060526|3567237|P1|STARTED|Overall Study||7
1457275|NCT02060461|3567273|P1|NOT COMPLETED|Overall Study||0
1457276|NCT02060461|3567273|P1|COMPLETED|Overall Study||33
1457277|NCT02060461|3567273|P1|STARTED|Overall Study||33
1457278|NCT02060058|3567282|P3|NOT COMPLETED|Overall Study||0
1457279|NCT02060058|3567283|P2|NOT COMPLETED|Overall Study||0
1457280|NCT02060058|3567284|P1|NOT COMPLETED|Overall Study||0
1457281|NCT02060058|3567282|P3|COMPLETED|Overall Study||8
1457282|NCT02060058|3567283|P2|COMPLETED|Overall Study||0
1457283|NCT02060058|3567284|P1|COMPLETED|Overall Study||4
1457284|NCT02060058|3567282|P3|STARTED|Overall Study||8
1457285|NCT02060058|3567283|P2|STARTED|Overall Study||0
1457286|NCT02060058|3567284|P1|STARTED|Overall Study||4
1457287|NCT02059993|3567300|P2|NOT COMPLETED|Overall Study||4
1457288|NCT02059993|3567301|P1|NOT COMPLETED|Overall Study||2
1457289|NCT02059993|3567300|P2|COMPLETED|Overall Study||37
1457290|NCT02059993|3567301|P1|COMPLETED|Overall Study||40
1457291|NCT02059993|3567300|P2|STARTED|Overall Study||41
1457292|NCT02059993|3567301|P1|STARTED|Overall Study||42
1457293|NCT02059980|3567309|P2|NOT COMPLETED|Overall Study||1
1457294|NCT02059980|3567310|P1|NOT COMPLETED|Overall Study||2
1457295|NCT02059980|3567309|P2|COMPLETED|Overall Study||14
1457296|NCT02059980|3567310|P1|COMPLETED|Overall Study||16
1457297|NCT02059980|3567309|P2|STARTED|Overall Study||15
1457298|NCT02059980|3567310|P1|STARTED|Overall Study||18
1457299|NCT02059928|3567322|P1|NOT COMPLETED|Overall Study||0
1457300|NCT02059928|3567322|P1|COMPLETED|Overall Study||20
1457301|NCT02059928|3567322|P1|STARTED|Overall Study||20
1457302|NCT02059902|3567328|P2|NOT COMPLETED|Overall Study||4
1457303|NCT02059902|3567329|P1|NOT COMPLETED|Overall Study||4
1457304|NCT02059902|3567328|P2|COMPLETED|Overall Study||14
1457305|NCT02059902|3567329|P1|COMPLETED|Overall Study||14
1457306|NCT02059902|3567328|P2|STARTED|Overall Study||18
1457307|NCT02059902|3567329|P1|STARTED|Overall Study||18
1457308|NCT02059642|3567337|P2|NOT COMPLETED|Overall Study||24
1457309|NCT02059642|3567338|P1|NOT COMPLETED|Overall Study||27
1457310|NCT02059642|3567337|P2|COMPLETED|Overall Study||128
1457311|NCT02059642|3567338|P1|COMPLETED|Overall Study||121
1457312|NCT02059642|3567337|P2|STARTED|Overall Study||152
1457313|NCT02059642|3567338|P1|STARTED|Overall Study||148
1457314|NCT02059395|3567348|P2|NOT COMPLETED|Overall Study||4
1457315|NCT02059395|3567349|P1|NOT COMPLETED|Overall Study||2
1457316|NCT02059395|3567348|P2|COMPLETED|Overall Study||23
1457317|NCT02059395|3567349|P1|COMPLETED|Overall Study||20
1457318|NCT02059395|3567348|P2|STARTED|Overall Study||27
1457319|NCT02059395|3567349|P1|STARTED|Overall Study||22
1457320|NCT02059291|3567364|P25|NOT COMPLETED|Epoch 4||0
1457321|NCT02059291|3567365|P24|NOT COMPLETED|Epoch 4||1
1457322|NCT02059291|3567366|P23|NOT COMPLETED|Epoch 4||1
1457323|NCT02059291|3567367|P22|NOT COMPLETED|Epoch 4||0
1457324|NCT02059291|3567368|P21|NOT COMPLETED|Epoch 4||1
1457325|NCT02059291|3567369|P20|NOT COMPLETED|Epoch 4||0
1457326|NCT02059291|3567370|P19|NOT COMPLETED|Epoch 4||0
1457327|NCT02059291|3567371|P18|NOT COMPLETED|Epoch 4||0
1457328|NCT02059291|3567372|P17|NOT COMPLETED|Epoch 4||2
1457329|NCT02059291|3567373|P16|NOT COMPLETED|Epoch 4||0
1457330|NCT02059291|3567374|P15|NOT COMPLETED|Epoch 4||0
1457331|NCT02059291|3567375|P14|NOT COMPLETED|Epoch 4||0
1457332|NCT02059291|3567376|P13|NOT COMPLETED|Epoch 4||0
1457333|NCT02059291|3567377|P12|NOT COMPLETED|Epoch 4||0
1457334|NCT02059291|3567378|P11|NOT COMPLETED|Epoch 4||0
1457335|NCT02059291|3567379|P10|NOT COMPLETED|Epoch 4||0
1457336|NCT02059291|3567380|P9|NOT COMPLETED|Epoch 4||0
1457337|NCT02059291|3567381|P8|NOT COMPLETED|Epoch 4||0
1457338|NCT02059291|3567382|P7|NOT COMPLETED|Epoch 4||0
1457339|NCT02059291|3567383|P6|NOT COMPLETED|Epoch 4||0
1457340|NCT02059291|3567384|P5|NOT COMPLETED|Epoch 4||0
1457341|NCT02059291|3567385|P4|NOT COMPLETED|Epoch 4||0
1457342|NCT02059291|3567386|P3|NOT COMPLETED|Epoch 4||0
1457343|NCT02059291|3567387|P2|NOT COMPLETED|Epoch 4||0
1457344|NCT02059291|3567388|P1|NOT COMPLETED|Epoch 4||0
1457345|NCT02059291|3567364|P25|COMPLETED|Epoch 4||0
1457346|NCT02059291|3567365|P24|COMPLETED|Epoch 4||21
1457347|NCT02059291|3567366|P23|COMPLETED|Epoch 4||30
1457348|NCT02059291|3567367|P22|COMPLETED|Epoch 4||14
1457349|NCT02059291|3567368|P21|COMPLETED|Epoch 4||33
1457350|NCT02059291|3567369|P20|COMPLETED|Epoch 4||18
1457351|NCT02059291|3567370|P19|COMPLETED|Epoch 4||2
1457352|NCT02059291|3567371|P18|COMPLETED|Epoch 4||14
1457353|NCT02059291|3567372|P17|COMPLETED|Epoch 4||41
1457354|NCT02059291|3567373|P16|COMPLETED|Epoch 4||0
1457355|NCT02059291|3567374|P15|COMPLETED|Epoch 4||0
1457356|NCT02059291|3567375|P14|COMPLETED|Epoch 4||0
1457357|NCT02059291|3567376|P13|COMPLETED|Epoch 4||0
1457358|NCT02059291|3567377|P12|COMPLETED|Epoch 4||0
1457359|NCT02059291|3567378|P11|COMPLETED|Epoch 4||0
1457360|NCT02059291|3567379|P10|COMPLETED|Epoch 4||0
1457361|NCT02059291|3567380|P9|COMPLETED|Epoch 4||0
1457362|NCT02059291|3567381|P8|COMPLETED|Epoch 4||0
1457363|NCT02059291|3567382|P7|COMPLETED|Epoch 4||0
1457364|NCT02059291|3567383|P6|COMPLETED|Epoch 4||0
1457365|NCT02059291|3567384|P5|COMPLETED|Epoch 4||0
1457366|NCT02059291|3567385|P4|COMPLETED|Epoch 4||0
1457367|NCT02059291|3567386|P3|COMPLETED|Epoch 4||0
1457368|NCT02059291|3567387|P2|COMPLETED|Epoch 4||0
1457369|NCT02059291|3567388|P1|COMPLETED|Epoch 4||0
1457370|NCT02059291|3567364|P25|STARTED|Epoch 4||0
1457371|NCT02059291|3567365|P24|STARTED|Epoch 4||22
1457372|NCT02059291|3567366|P23|STARTED|Epoch 4||31
1457373|NCT02059291|3567367|P22|STARTED|Epoch 4||14
1457374|NCT02059291|3567368|P21|STARTED|Epoch 4||34
1457375|NCT02059291|3567369|P20|STARTED|Epoch 4||18
1457376|NCT02059291|3567370|P19|STARTED|Epoch 4||2
1457377|NCT02059291|3567371|P18|STARTED|Epoch 4||14
1457378|NCT02059291|3567372|P17|STARTED|Epoch 4||43
1457379|NCT02059291|3567373|P16|STARTED|Epoch 4||0
1457380|NCT02059291|3567374|P15|STARTED|Epoch 4||0
1457381|NCT02059291|3567375|P14|STARTED|Epoch 4||0
1457382|NCT02059291|3567376|P13|STARTED|Epoch 4||0
1457383|NCT02059291|3567377|P12|STARTED|Epoch 4||0
1457384|NCT02059291|3567378|P11|STARTED|Epoch 4||0
1457385|NCT02059291|3567379|P10|STARTED|Epoch 4||0
1457386|NCT02059291|3567380|P9|STARTED|Epoch 4||0
1457387|NCT02059291|3567381|P8|STARTED|Epoch 4||0
1457388|NCT02059291|3567382|P7|STARTED|Epoch 4||0
1457389|NCT02059291|3567383|P6|STARTED|Epoch 4||0
1457390|NCT02059291|3567384|P5|STARTED|Epoch 4||0
1457391|NCT02059291|3567385|P4|STARTED|Epoch 4||0
1457392|NCT02059291|3567386|P3|STARTED|Epoch 4||0
1457393|NCT02059291|3567387|P2|STARTED|Epoch 4||0
1457394|NCT02059291|3567388|P1|STARTED|Epoch 4||0
1457395|NCT02059291|3567364|P25|NOT COMPLETED|Epoch 3||0
1457396|NCT02059291|3567365|P24|NOT COMPLETED|Epoch 3||0
1457397|NCT02059291|3567366|P23|NOT COMPLETED|Epoch 3||0
1457398|NCT02059291|3567367|P22|NOT COMPLETED|Epoch 3||0
1457399|NCT02059291|3567368|P21|NOT COMPLETED|Epoch 3||0
1457400|NCT02059291|3567369|P20|NOT COMPLETED|Epoch 3||0
1457401|NCT02059291|3567370|P19|NOT COMPLETED|Epoch 3||0
1457402|NCT02059291|3567371|P18|NOT COMPLETED|Epoch 3||0
1457403|NCT02059291|3567372|P17|NOT COMPLETED|Epoch 3||0
1457404|NCT02059291|3567373|P16|NOT COMPLETED|Epoch 3||6
1457405|NCT02059291|3567374|P15|NOT COMPLETED|Epoch 3||0
1457406|NCT02059291|3567375|P14|NOT COMPLETED|Epoch 3||1
1457407|NCT02059291|3567376|P13|NOT COMPLETED|Epoch 3||0
1457408|NCT02059291|3567377|P12|NOT COMPLETED|Epoch 3||0
1457409|NCT02059291|3567378|P11|NOT COMPLETED|Epoch 3||0
1457410|NCT02059291|3567379|P10|NOT COMPLETED|Epoch 3||0
1457411|NCT02059291|3567380|P9|NOT COMPLETED|Epoch 3||0
1457412|NCT02059291|3567381|P8|NOT COMPLETED|Epoch 3||0
1457413|NCT02059291|3567382|P7|NOT COMPLETED|Epoch 3||0
1457414|NCT02059291|3567383|P6|NOT COMPLETED|Epoch 3||0
1457415|NCT02059291|3567384|P5|NOT COMPLETED|Epoch 3||0
1457416|NCT02059291|3567385|P4|NOT COMPLETED|Epoch 3||0
1457417|NCT02059291|3567386|P3|NOT COMPLETED|Epoch 3||0
1457418|NCT02059291|3567387|P2|NOT COMPLETED|Epoch 3||0
1457419|NCT02059291|3567388|P1|NOT COMPLETED|Epoch 3||0
1457420|NCT02059291|3567364|P25|COMPLETED|Epoch 3||0
1457421|NCT02059291|3567365|P24|COMPLETED|Epoch 3||0
1457422|NCT02059291|3567366|P23|COMPLETED|Epoch 3||0
1457423|NCT02059291|3567367|P22|COMPLETED|Epoch 3||0
1457424|NCT02059291|3567368|P21|COMPLETED|Epoch 3||0
1457425|NCT02059291|3567369|P20|COMPLETED|Epoch 3||0
1457426|NCT02059291|3567370|P19|COMPLETED|Epoch 3||0
1457427|NCT02059291|3567371|P18|COMPLETED|Epoch 3||0
1457428|NCT02059291|3567372|P17|COMPLETED|Epoch 3||0
1457429|NCT02059291|3567373|P16|COMPLETED|Epoch 3||120
1457430|NCT02059291|3567374|P15|COMPLETED|Epoch 3||5
1457431|NCT02059291|3567375|P14|COMPLETED|Epoch 3||3
1457432|NCT02059291|3567376|P13|COMPLETED|Epoch 3||7
1457433|NCT02059291|3567377|P12|COMPLETED|Epoch 3||6
1457434|NCT02059291|3567378|P11|COMPLETED|Epoch 3||10
1457435|NCT02059291|3567379|P10|COMPLETED|Epoch 3||9
1457436|NCT02059291|3567380|P9|COMPLETED|Epoch 3||0
1457437|NCT02059291|3567381|P8|COMPLETED|Epoch 3||1
1457438|NCT02059291|3567382|P7|COMPLETED|Epoch 3||2
1457439|NCT02059291|3567383|P6|COMPLETED|Epoch 3||0
1457440|NCT02059291|3567384|P5|COMPLETED|Epoch 3||0
1457441|NCT02059291|3567385|P4|COMPLETED|Epoch 3||0
1457442|NCT02059291|3567386|P3|COMPLETED|Epoch 3||0
1457443|NCT02059291|3567387|P2|COMPLETED|Epoch 3||0
1457444|NCT02059291|3567388|P1|COMPLETED|Epoch 3||0
1457445|NCT02059291|3567364|P25|STARTED|Epoch 3||0
1457446|NCT02059291|3567365|P24|STARTED|Epoch 3||0
1457447|NCT02059291|3567366|P23|STARTED|Epoch 3||0
1457448|NCT02059291|3567367|P22|STARTED|Epoch 3||0
1457449|NCT02059291|3567368|P21|STARTED|Epoch 3||0
1457450|NCT02059291|3567369|P20|STARTED|Epoch 3||0
1457451|NCT02059291|3567370|P19|STARTED|Epoch 3||0
1457452|NCT02059291|3567371|P18|STARTED|Epoch 3||0
1457453|NCT02059291|3567372|P17|STARTED|Epoch 3||0
1457454|NCT02059291|3567373|P16|STARTED|Epoch 3||126
1457455|NCT02059291|3567374|P15|STARTED|Epoch 3||5
1457456|NCT02059291|3567375|P14|STARTED|Epoch 3||4
1457457|NCT02059291|3567376|P13|STARTED|Epoch 3||7
1457458|NCT02059291|3567377|P12|STARTED|Epoch 3||6
1457459|NCT02059291|3567378|P11|STARTED|Epoch 3||10
1457460|NCT02059291|3567379|P10|STARTED|Epoch 3||9
1457461|NCT02059291|3567380|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
1457462|NCT02059291|3567381|P8|STARTED|Epoch 3||1
1457463|NCT02059291|3567382|P7|STARTED|Epoch 3||2
1457464|NCT02059291|3567383|P6|STARTED|Epoch 3||0
1457465|NCT02059291|3567384|P5|STARTED|Epoch 3||0
1457466|NCT02059291|3567385|P4|STARTED|Epoch 3||0
1457467|NCT02059291|3567386|P3|STARTED|Epoch 3||0
1457468|NCT02059291|3567387|P2|STARTED|Epoch 3||0
1457469|NCT02059291|3567388|P1|STARTED|Epoch 3||0
1457470|NCT02059291|3567364|P25|NOT COMPLETED|Epoch 2||0
1457471|NCT02059291|3567365|P24|NOT COMPLETED|Epoch 2||0
1457472|NCT02059291|3567366|P23|NOT COMPLETED|Epoch 2||0
1457473|NCT02059291|3567367|P22|NOT COMPLETED|Epoch 2||0
1457474|NCT02059291|3567368|P21|NOT COMPLETED|Epoch 2||0
1457475|NCT02059291|3567369|P20|NOT COMPLETED|Epoch 2||0
1457476|NCT02059291|3567370|P19|NOT COMPLETED|Epoch 2||0
1457477|NCT02059291|3567371|P18|NOT COMPLETED|Epoch 2||0
1457478|NCT02059291|3567372|P17|NOT COMPLETED|Epoch 2||0
1457479|NCT02059291|3567373|P16|NOT COMPLETED|Epoch 2||0
1457480|NCT02059291|3567374|P15|NOT COMPLETED|Epoch 2||0
1457481|NCT02059291|3567375|P14|NOT COMPLETED|Epoch 2||0
1457482|NCT02059291|3567376|P13|NOT COMPLETED|Epoch 2||0
1457483|NCT02059291|3567377|P12|NOT COMPLETED|Epoch 2||0
1457484|NCT02059291|3567378|P11|NOT COMPLETED|Epoch 2||0
1457485|NCT02059291|3567379|P10|NOT COMPLETED|Epoch 2||0
1457486|NCT02059291|3567380|P9|NOT COMPLETED|Epoch 2||2
1457487|NCT02059291|3567381|P8|NOT COMPLETED|Epoch 2||1
1457488|NCT02059291|3567382|P7|NOT COMPLETED|Epoch 2||0
1457489|NCT02059291|3567383|P6|NOT COMPLETED|Epoch 2||2
1457490|NCT02059291|3567384|P5|NOT COMPLETED|Epoch 2||0
1457491|NCT02059291|3567385|P4|NOT COMPLETED|Epoch 2||2
1457492|NCT02059291|3567386|P3|NOT COMPLETED|Epoch 2||1
1457493|NCT02059291|3567387|P2|NOT COMPLETED|Epoch 2||1
1457494|NCT02059291|3567388|P1|NOT COMPLETED|Epoch 2||0
1457495|NCT02059291|3567364|P25|COMPLETED|Epoch 2||0
1457496|NCT02059291|3567365|P24|COMPLETED|Epoch 2||0
1457497|NCT02059291|3567366|P23|COMPLETED|Epoch 2||0
1457498|NCT02059291|3567367|P22|COMPLETED|Epoch 2||0
1457499|NCT02059291|3567368|P21|COMPLETED|Epoch 2||0
1457500|NCT02059291|3567369|P20|COMPLETED|Epoch 2||0
1457501|NCT02059291|3567370|P19|COMPLETED|Epoch 2||0
1457502|NCT02059291|3567371|P18|COMPLETED|Epoch 2||0
1457503|NCT02059291|3567372|P17|COMPLETED|Epoch 2||0
1457504|NCT02059291|3567373|P16|COMPLETED|Epoch 2||0
1457505|NCT02059291|3567374|P15|COMPLETED|Epoch 2||0
1457506|NCT02059291|3567375|P14|COMPLETED|Epoch 2||0
1457507|NCT02059291|3567376|P13|COMPLETED|Epoch 2||0
1457508|NCT02059291|3567377|P12|COMPLETED|Epoch 2||0
1457509|NCT02059291|3567378|P11|COMPLETED|Epoch 2||0
1457510|NCT02059291|3567379|P10|COMPLETED|Epoch 2||0
1457511|NCT02059291|3567380|P9|COMPLETED|Epoch 2||16
1457512|NCT02059291|3567381|P8|COMPLETED|Epoch 2||1
1457513|NCT02059291|3567382|P7|COMPLETED|Epoch 2||2
1457514|NCT02059291|3567383|P6|COMPLETED|Epoch 2||22
1457515|NCT02059291|3567384|P5|COMPLETED|Epoch 2||22
1457516|NCT02059291|3567385|P4|COMPLETED|Epoch 2||33
1457517|NCT02059291|3567386|P3|COMPLETED|Epoch 2||36
1457518|NCT02059291|3567387|P2|COMPLETED|Epoch 2||31
1457519|NCT02059291|3567388|P1|COMPLETED|Epoch 2||31
1457520|NCT02059291|3567364|P25|STARTED|Epoch 2||0
1457521|NCT02059291|3567365|P24|STARTED|Epoch 2||0
1457522|NCT02059291|3567366|P23|STARTED|Epoch 2||0
1457523|NCT02059291|3567367|P22|STARTED|Epoch 2||0
1457524|NCT02059291|3567368|P21|STARTED|Epoch 2||0
1457525|NCT02059291|3567369|P20|STARTED|Epoch 2||0
1457526|NCT02059291|3567370|P19|STARTED|Epoch 2||0
1457527|NCT02059291|3567371|P18|STARTED|Epoch 2||0
1457528|NCT02059291|3567372|P17|STARTED|Epoch 2||0
1457529|NCT02059291|3567373|P16|STARTED|Epoch 2||0
1457530|NCT02059291|3567374|P15|STARTED|Epoch 2||0
1457531|NCT02059291|3567375|P14|STARTED|Epoch 2||0
1457532|NCT02059291|3567376|P13|STARTED|Epoch 2||0
1457533|NCT02059291|3567377|P12|STARTED|Epoch 2||0
1457534|NCT02059291|3567378|P11|STARTED|Epoch 2||0
1457535|NCT02059291|3567379|P10|STARTED|Epoch 2||0
1457536|NCT02059291|3567380|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
1457537|NCT02059291|3567381|P8|STARTED|Epoch 2||2
1457538|NCT02059291|3567382|P7|STARTED|Epoch 2||2
1457539|NCT02059291|3567383|P6|STARTED|Epoch 2||24
1457540|NCT02059291|3567384|P5|STARTED|Epoch 2||22
1457541|NCT02059291|3567385|P4|STARTED|Epoch 2||35
1457542|NCT02059291|3567386|P3|STARTED|Epoch 2||37
1457543|NCT02059291|3567387|P2|STARTED|Epoch 2||32
1457544|NCT02059291|3567388|P1|STARTED|Epoch 2||31
1457545|NCT02059278|3567442|P2|NOT COMPLETED|Overall Study||4
1457546|NCT02059278|3567443|P1|NOT COMPLETED|Overall Study||3
1457547|NCT02059278|3567442|P2|COMPLETED|Overall Study||166
1457548|NCT02059278|3567443|P1|COMPLETED|Overall Study||162
1457549|NCT02059278|3567442|P2|STARTED|Overall Study||170
1457550|NCT02059278|3567443|P1|STARTED|Overall Study||165
1457551|NCT02059187|3567459|P2|NOT COMPLETED|Overall Study||22
1457552|NCT02059187|3567460|P1|NOT COMPLETED|Overall Study||25
1457553|NCT02059187|3567459|P2|COMPLETED|Overall Study||244
1457554|NCT02059187|3567460|P1|COMPLETED|Overall Study||240
1457555|NCT02059187|3567459|P2|STARTED|Overall Study||266
1457556|NCT02059187|3567460|P1|STARTED|Overall Study||265
1457557|NCT02059174|3567486|P2|NOT COMPLETED|Period 4||0
1457558|NCT02059174|3567487|P1|NOT COMPLETED|Period 4||0
1457559|NCT02059174|3567486|P2|COMPLETED|Period 4||35
1457560|NCT02059174|3567487|P1|COMPLETED|Period 4||35
1457561|NCT02059174|3567486|P2|STARTED|Period 4||35
1457562|NCT02059174|3567487|P1|STARTED|Period 4||35
1457563|NCT02059174|3567486|P2|NOT COMPLETED|Period 3||0
1457564|NCT02059174|3567487|P1|NOT COMPLETED|Period 3||1
1457565|NCT02059174|3567486|P2|COMPLETED|Period 3||35
1457566|NCT02059174|3567487|P1|COMPLETED|Period 3||35
1457567|NCT02059174|3567486|P2|STARTED|Period 3||35
1457568|NCT02059174|3567487|P1|STARTED|Period 3||36
1457569|NCT02059174|3567486|P2|NOT COMPLETED|Period 2||2
1457570|NCT02059174|3567487|P1|NOT COMPLETED|Period 2||1
1457571|NCT02059174|3567486|P2|COMPLETED|Period 2||35
1457572|NCT02059174|3567487|P1|COMPLETED|Period 2||36
1457573|NCT02059174|3567486|P2|STARTED|Period 2||37
1457574|NCT02059174|3567487|P1|STARTED|Period 2||37
1457575|NCT02059174|3567486|P2|NOT COMPLETED|Period 1||2
1457576|NCT02059174|3567487|P1|NOT COMPLETED|Period 1||0
1457577|NCT02059174|3567486|P2|COMPLETED|Period 1||37
1457578|NCT02059174|3567487|P1|COMPLETED|Period 1||37
1457579|NCT02059174|3567486|P2|STARTED|Period 1||39
1457580|NCT02059174|3567487|P1|STARTED|Period 1||37
1457581|NCT02059161|3567511|P2|NOT COMPLETED|Overall Study||41
1457582|NCT02059161|3567512|P1|NOT COMPLETED|Overall Study||49
1457583|NCT02059161|3567511|P2|COMPLETED|Overall Study||222
1457584|NCT02059161|3567512|P1|COMPLETED|Overall Study||196
1457585|NCT02059161|3567511|P2|Treated|Overall Study||258
1457586|NCT02059161|3567512|P1|Treated|Overall Study||241
1457587|NCT02059161|3567511|P2|STARTED|Overall Study||263
1457588|NCT02059161|3567512|P1|STARTED|Overall Study||245
1457589|NCT02059148|3567572|P6|NOT COMPLETED|Treatment 3||0
1457590|NCT02059148|3567573|P5|NOT COMPLETED|Treatment 3||0
1457591|NCT02059148|3567574|P4|NOT COMPLETED|Treatment 3||0
1457592|NCT02059148|3567575|P3|NOT COMPLETED|Treatment 3||0
1457593|NCT02059148|3567576|P2|NOT COMPLETED|Treatment 3||0
1457594|NCT02059148|3567577|P1|NOT COMPLETED|Treatment 3||0
1457595|NCT02059148|3567572|P6|COMPLETED|Treatment 3||3
1457596|NCT02059148|3567573|P5|COMPLETED|Treatment 3||4
1457597|NCT02059148|3567574|P4|COMPLETED|Treatment 3||4
1457598|NCT02059148|3567575|P3|COMPLETED|Treatment 3||4
1457599|NCT02059148|3567576|P2|COMPLETED|Treatment 3||4
1457600|NCT02059148|3567577|P1|COMPLETED|Treatment 3||4
1457601|NCT02059148|3567572|P6|STARTED|Treatment 3||3
1457602|NCT02059148|3567573|P5|STARTED|Treatment 3||4
1457603|NCT02059148|3567574|P4|STARTED|Treatment 3||4
1457604|NCT02059148|3567575|P3|STARTED|Treatment 3||4
1457605|NCT02059148|3567576|P2|STARTED|Treatment 3||4
1457606|NCT02059148|3567577|P1|STARTED|Treatment 3||4
1457607|NCT02059148|3567572|P6|NOT COMPLETED|Treatment 2||0
1457608|NCT02059148|3567573|P5|NOT COMPLETED|Treatment 2||0
1457609|NCT02059148|3567574|P4|NOT COMPLETED|Treatment 2||0
1457610|NCT02059148|3567575|P3|NOT COMPLETED|Treatment 2||0
1457611|NCT02059148|3567576|P2|NOT COMPLETED|Treatment 2||0
1457612|NCT02059148|3567577|P1|NOT COMPLETED|Treatment 2||0
1457613|NCT02059148|3567572|P6|COMPLETED|Treatment 2||3
1457614|NCT02059148|3567573|P5|COMPLETED|Treatment 2||4
1457615|NCT02059148|3567574|P4|COMPLETED|Treatment 2||4
1457616|NCT02059148|3567575|P3|COMPLETED|Treatment 2||4
1457617|NCT02059148|3567576|P2|COMPLETED|Treatment 2||4
1457618|NCT02059148|3567577|P1|COMPLETED|Treatment 2||4
1457619|NCT02059148|3567572|P6|STARTED|Treatment 2||3
1457620|NCT02059148|3567573|P5|STARTED|Treatment 2||4
1457621|NCT02059148|3567574|P4|STARTED|Treatment 2||4
1457622|NCT02059148|3567575|P3|STARTED|Treatment 2||4
1457623|NCT02059148|3567576|P2|STARTED|Treatment 2||4
1457624|NCT02059148|3567577|P1|STARTED|Treatment 2||4
1457625|NCT02059148|3567572|P6|NOT COMPLETED|Treatment 1||1
1457626|NCT02059148|3567573|P5|NOT COMPLETED|Treatment 1||0
1457627|NCT02059148|3567574|P4|NOT COMPLETED|Treatment 1||0
1457628|NCT02059148|3567575|P3|NOT COMPLETED|Treatment 1||0
1457629|NCT02059148|3567576|P2|NOT COMPLETED|Treatment 1||0
1457630|NCT02059148|3567577|P1|NOT COMPLETED|Treatment 1||0
1457631|NCT02059148|3567572|P6|COMPLETED|Treatment 1||3
1457632|NCT02059148|3567573|P5|COMPLETED|Treatment 1||4
1457633|NCT02059148|3567574|P4|COMPLETED|Treatment 1||4
1457634|NCT02059148|3567575|P3|COMPLETED|Treatment 1||4
1457635|NCT02059148|3567576|P2|COMPLETED|Treatment 1||4
1457636|NCT02059148|3567577|P1|COMPLETED|Treatment 1||4
1457637|NCT02059148|3567572|P6|STARTED|Treatment 1||4
1457638|NCT02059148|3567573|P5|STARTED|Treatment 1||4
1457639|NCT02059148|3567574|P4|STARTED|Treatment 1||4
1457640|NCT02059148|3567575|P3|STARTED|Treatment 1||4
1457641|NCT02059148|3567576|P2|STARTED|Treatment 1||4
1457642|NCT02059148|3567577|P1|STARTED|Treatment 1||4
1457643|NCT02059135|3567596|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
1457644|NCT02059135|3567597|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
1457645|NCT02059135|3567596|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
1457646|NCT02059135|3567597|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
1457647|NCT02059135|3567596|P2|STARTED|Neonatal Follow-up (Safety Population)||54
1457648|NCT02059135|3567597|P1|STARTED|Neonatal Follow-up (Safety Population)||60
1457649|NCT02059135|3567596|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
1457650|NCT02059135|3567597|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
1457651|NCT02059135|3567596|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
1457652|NCT02059135|3567597|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
1457653|NCT02059135|3567596|P2|STARTED|Maternal Follow-up (ITT Population)||58
1457654|NCT02059135|3567597|P1|STARTED|Maternal Follow-up (ITT Population)||62
1457655|NCT02059070|3567611|P2|NOT COMPLETED|Overall Study||4
1457656|NCT02059070|3567612|P1|NOT COMPLETED|Overall Study||5
1457657|NCT02059070|3567611|P2|COMPLETED|Overall Study||16
1457658|NCT02059070|3567612|P1|COMPLETED|Overall Study||14
1457659|NCT02059070|3567611|P2|STARTED|Overall Study||20
1457660|NCT02059070|3567612|P1|STARTED|Overall Study||19
1457661|NCT02059057|3567624|P1|NOT COMPLETED|Overall Study||15
1457662|NCT02059057|3567624|P1|COMPLETED|Overall Study||87
1457663|NCT02059057|3567624|P1|STARTED|Overall Study||102
1457664|NCT02059005|3567633|P2|NOT COMPLETED|Overall Study||24
1457665|NCT02059005|3567634|P1|NOT COMPLETED|Overall Study||20
1457666|NCT02059005|3567633|P2|COMPLETED|Overall Study||24
1457667|NCT02059005|3567634|P1|COMPLETED|Overall Study||29
1457668|NCT02059005|3567633|P2|6 Month Assessment|Overall Study||24
1457669|NCT02059005|3567634|P1|6 Month Assessment|Overall Study||29
1457670|NCT02059005|3567633|P2|3 Month Assessment|Overall Study||33
1457671|NCT02059005|3567634|P1|3 Month Assessment|Overall Study||37
1457672|NCT02059005|3567633|P2|STARTED|Overall Study||48
1457673|NCT02059005|3567634|P1|STARTED|Overall Study||49
1457674|NCT02058992|3567644|P1|NOT COMPLETED|Overall Study||116
1457675|NCT02058992|3567644|P1|COMPLETED|Overall Study||3223
1457676|NCT02058992|3567644|P1|STARTED|Overall Study||3339
1457677|NCT02058940|3567653|P1|NOT COMPLETED|Overall Study||1
1457678|NCT02058940|3567653|P1|COMPLETED|Overall Study||7
1457679|NCT02058940|3567653|P1|STARTED|Overall Study||8
1457680|NCT02058836|3567677|P2|NOT COMPLETED|Overall Study||1
1457681|NCT02058836|3567678|P1|NOT COMPLETED|Overall Study||1
1457682|NCT02058836|3567677|P2|COMPLETED|Overall Study||3
1457683|NCT02058836|3567678|P1|COMPLETED|Overall Study||3
1457684|NCT02058836|3567677|P2|STARTED|Overall Study||4
1457685|NCT02058836|3567678|P1|STARTED|Overall Study||4
1457686|NCT02058628|3567708|P2|NOT COMPLETED|Overall Study||8
1457687|NCT02058628|3567709|P1|NOT COMPLETED|Overall Study||7
1457688|NCT02058628|3567708|P2|COMPLETED|Overall Study||102
1457689|NCT02058628|3567709|P1|COMPLETED|Overall Study||104
1457690|NCT02058628|3567708|P2|STARTED|Overall Study||110
1457691|NCT02058628|3567709|P1|STARTED|Overall Study||111
1457692|NCT02058589|3567741|P2|NOT COMPLETED|Overall Study||2
1457693|NCT02058589|3567742|P1|NOT COMPLETED|Overall Study||2
1457694|NCT02058589|3567741|P2|COMPLETED|Overall Study||130
1457695|NCT02058589|3567742|P1|COMPLETED|Overall Study||130
1457696|NCT02058589|3567741|P2|STARTED|Overall Study||132
1457697|NCT02058589|3567742|P1|STARTED|Overall Study||132
1457698|NCT02058563|3567784|P2|NOT COMPLETED|Overall Study||24
1457699|NCT02058563|3567785|P1|NOT COMPLETED|Overall Study||28
1457700|NCT02058563|3567784|P2|COMPLETED|Overall Study||433
1457701|NCT02058563|3567785|P1|COMPLETED|Overall Study||426
1457702|NCT02058563|3567784|P2|STARTED|Overall Study||457
1457703|NCT02058563|3567785|P1|STARTED|Overall Study||454
1457704|NCT02058537|3567821|P1|NOT COMPLETED|Overall Study||1
1457705|NCT02058537|3567821|P1|COMPLETED|Overall Study||2
1457706|NCT02058537|3567821|P1|STARTED|Overall Study||3
1457707|NCT02058498|3567827|P1|NOT COMPLETED|Overall Study||4
1457708|NCT02058498|3567827|P1|COMPLETED|Overall Study||8
1457709|NCT02058498|3567827|P1|6 Weeks|Overall Study||8
1457710|NCT02058498|3567827|P1|STARTED|Overall Study||12
1457711|NCT02058290|3567835|P2|NOT COMPLETED|Overall Study||9
1457712|NCT02058290|3567836|P1|NOT COMPLETED|Overall Study||11
1457713|NCT02058290|3567835|P2|COMPLETED|Overall Study||36
1457714|NCT02058290|3567836|P1|COMPLETED|Overall Study||66
1457715|NCT02058290|3567835|P2|STARTED|Overall Study||45
1457716|NCT02058290|3567836|P1|STARTED|Overall Study||77
1457717|NCT02058160|3567852|P2|NOT COMPLETED|Overall Study||14
1457718|NCT02058160|3567853|P1|NOT COMPLETED|Overall Study||31
1457719|NCT02058160|3567852|P2|COMPLETED|Overall Study||355
1457720|NCT02058160|3567853|P1|COMPLETED|Overall Study||336
1457721|NCT02058160|3567852|P2|Treated|Overall Study||365
1457722|NCT02058160|3567853|P1|Treated|Overall Study||365
1457723|NCT02058160|3567852|P2|STARTED|Overall Study||369
1457724|NCT02058160|3567853|P1|STARTED|Overall Study||367
1457725|NCT02058147|3567890|P3|NOT COMPLETED|Overall Study||29
1457726|NCT02058147|3567891|P2|NOT COMPLETED|Overall Study||27
1457727|NCT02058147|3567892|P1|NOT COMPLETED|Overall Study||29
1457728|NCT02058147|3567890|P3|COMPLETED|Overall Study||205
1457729|NCT02058147|3567891|P2|COMPLETED|Overall Study||440
1457730|NCT02058147|3567892|P1|COMPLETED|Overall Study||440
1457731|NCT02058147|3567890|P3|Treated|Overall Study||233
1457732|NCT02058147|3567891|P2|Treated|Overall Study||467
1457733|NCT02058147|3567892|P1|Treated|Overall Study||469
1457734|NCT02058147|3567890|P3|STARTED|Overall Study||234
1457735|NCT02058147|3567891|P2|STARTED|Overall Study||467
1457736|NCT02058147|3567892|P1|STARTED|Overall Study||469
1457737|NCT02058069|3567941|P1|NOT COMPLETED|Overall Study||11
1457738|NCT02058069|3567941|P1|COMPLETED|Overall Study||89
1457739|NCT02058069|3567941|P1|STARTED|Overall Study||100
1457740|NCT02057952|3567953|P3|NOT COMPLETED|Overall Study||22
1457741|NCT02057952|3567954|P2|NOT COMPLETED|Overall Study||10
1457742|NCT02057952|3567955|P1|NOT COMPLETED|Overall Study||8
1457743|NCT02057952|3567953|P3|COMPLETED|Overall Study||28
1457744|NCT02057952|3567954|P2|COMPLETED|Overall Study||39
1457745|NCT02057952|3567955|P1|COMPLETED|Overall Study||43
1457746|NCT02057952|3567953|P3|STARTED|Overall Study||50
1457747|NCT02057952|3567954|P2|STARTED|Overall Study||49
1457748|NCT02057952|3567955|P1|STARTED|Overall Study||51
1457749|NCT02057874|3567990|P1|NOT COMPLETED|Overall Study||1
1457750|NCT02057874|3567990|P1|COMPLETED|Overall Study||1
1457751|NCT02057874|3567990|P1|STARTED|Overall Study||2
1457752|NCT02057835|3568008|P10|NOT COMPLETED|Overall Study||0
1457753|NCT02057835|3568009|P9|NOT COMPLETED|Overall Study||0
1457754|NCT02057835|3568010|P8|NOT COMPLETED|Overall Study||0
1457755|NCT02057835|3568011|P7|NOT COMPLETED|Overall Study||0
1457756|NCT02057835|3568012|P6|NOT COMPLETED|Overall Study||0
1457757|NCT02057835|3568013|P5|NOT COMPLETED|Overall Study||0
1457758|NCT02057835|3568014|P4|NOT COMPLETED|Overall Study||0
1457759|NCT02057835|3568015|P3|NOT COMPLETED|Overall Study||0
1457760|NCT02057835|3568016|P2|NOT COMPLETED|Overall Study||2
1457761|NCT02057835|3568017|P1|NOT COMPLETED|Overall Study||0
1457762|NCT02057835|3568008|P10|COMPLETED|Overall Study||6
1457763|NCT02057835|3568009|P9|COMPLETED|Overall Study||6
1457764|NCT02057835|3568010|P8|COMPLETED|Overall Study||6
1457765|NCT02057835|3568011|P7|COMPLETED|Overall Study||6
1457766|NCT02057835|3568012|P6|COMPLETED|Overall Study||8
1457767|NCT02057835|3568013|P5|COMPLETED|Overall Study||6
1457768|NCT02057835|3568014|P4|COMPLETED|Overall Study||6
1457769|NCT02057835|3568015|P3|COMPLETED|Overall Study||6
1457770|NCT02057835|3568016|P2|COMPLETED|Overall Study||4
1457771|NCT02057835|3568017|P1|COMPLETED|Overall Study||8
1457772|NCT02057835|3568008|P10|STARTED|Overall Study||6
1457773|NCT02057835|3568009|P9|STARTED|Overall Study||6
1457774|NCT02057835|3568010|P8|STARTED|Overall Study||6
1457775|NCT02057835|3568011|P7|STARTED|Overall Study||6
1457776|NCT02057835|3568012|P6|STARTED|Overall Study||8
1457777|NCT02057835|3568013|P5|STARTED|Overall Study||6
1457778|NCT02057835|3568014|P4|STARTED|Overall Study||6
1457779|NCT02057835|3568015|P3|STARTED|Overall Study||6
1457780|NCT02057835|3568016|P2|STARTED|Overall Study||6
1457781|NCT02057835|3568017|P1|STARTED|Overall Study||8
1457782|NCT02057757|3568096|P2|NOT COMPLETED|Overall Study||8
1457783|NCT02057757|3568097|P1|NOT COMPLETED|Overall Study||14
1457784|NCT02057757|3568096|P2|COMPLETED|Overall Study||121
1457785|NCT02057757|3568097|P1|COMPLETED|Overall Study||117
1457786|NCT02057757|3568096|P2|Intent to Treat|Overall Study||127
1457787|NCT02057757|3568097|P1|Intent to Treat|Overall Study||130
1457788|NCT02057757|3568096|P2|STARTED|Overall Study||129
1457789|NCT02057757|3568097|P1|STARTED|Overall Study||131
1457790|NCT02057692|3568151|P4|NOT COMPLETED|Overall Study||1
1457791|NCT02057692|3568152|P3|NOT COMPLETED|Overall Study||0
1457792|NCT02057692|3568153|P2|NOT COMPLETED|Overall Study||0
1457793|NCT02057692|3568154|P1|NOT COMPLETED|Overall Study||1
1457794|NCT02057692|3568151|P4|COMPLETED|Overall Study||11
1457795|NCT02057692|3568152|P3|COMPLETED|Overall Study||6
1457796|NCT02057692|3568153|P2|COMPLETED|Overall Study||11
1457797|NCT02057692|3568154|P1|COMPLETED|Overall Study||7
1457798|NCT02057692|3568151|P4|STARTED|Overall Study||12
1457799|NCT02057692|3568152|P3|STARTED|Overall Study||6
1457800|NCT02057692|3568153|P2|STARTED|Overall Study||11
1457801|NCT02057692|3568154|P1|STARTED|Overall Study||8
1457802|NCT02057549|3568184|P2|NOT COMPLETED|Overall Study||0
1457803|NCT02057549|3568185|P1|NOT COMPLETED|Overall Study||3
1457804|NCT02057549|3568184|P2|COMPLETED|Overall Study||18
1457805|NCT02057549|3568185|P1|COMPLETED|Overall Study||15
1457806|NCT02057549|3568184|P2|STARTED|Overall Study||18
1457807|NCT02057549|3568185|P1|STARTED|Overall Study||18
1457808|NCT02057406|3568208|P3|NOT COMPLETED|Overall Study||4
1457809|NCT02057406|3568209|P2|NOT COMPLETED|Overall Study||3
1457810|NCT02057406|3568210|P1|NOT COMPLETED|Overall Study||1
1457811|NCT02057406|3568208|P3|COMPLETED|Overall Study||32
1457812|NCT02057406|3568209|P2|COMPLETED|Overall Study||33
1457813|NCT02057406|3568210|P1|COMPLETED|Overall Study||35
1457814|NCT02057406|3568208|P3|STARTED|Overall Study||36
1457815|NCT02057406|3568209|P2|STARTED|Overall Study||36
1457816|NCT02057406|3568210|P1|STARTED|Overall Study||36
1457817|NCT02057393|3568221|P1|NOT COMPLETED|Overall Study||2
1457818|NCT02057393|3568221|P1|COMPLETED|Overall Study||87
1457819|NCT02057393|3568221|P1|STARTED|Overall Study||89
1457820|NCT02057276|3568227|P2|NOT COMPLETED|Overall Study||0
1457821|NCT02057276|3568228|P1|NOT COMPLETED|Overall Study||0
1457822|NCT02057276|3568227|P2|COMPLETED|Overall Study||0
1457823|NCT02057276|3568228|P1|COMPLETED|Overall Study||0
1457824|NCT02057276|3568227|P2|STARTED|Overall Study||0
1457825|NCT02057276|3568228|P1|STARTED|Overall Study||0
1457826|NCT02057250|3568242|P5|NOT COMPLETED|Extension Phase||36
1457827|NCT02057250|3568243|P4|NOT COMPLETED|Extension Phase||0
1457828|NCT02057250|3568244|P3|NOT COMPLETED|Extension Phase||0
1457829|NCT02057250|3568245|P2|NOT COMPLETED|Extension Phase||0
1457830|NCT02057250|3568246|P1|NOT COMPLETED|Extension Phase||0
1457831|NCT02057250|3568242|P5|COMPLETED|Extension Phase||156
1457832|NCT02057250|3568243|P4|COMPLETED|Extension Phase||0
1457833|NCT02057250|3568244|P3|COMPLETED|Extension Phase||0
1457834|NCT02057250|3568245|P2|COMPLETED|Extension Phase||0
1457835|NCT02057250|3568246|P1|COMPLETED|Extension Phase||0
1457836|NCT02057250|3568242|P5|Treated|Extension Phase||188
1457837|NCT02057250|3568243|P4|Treated|Extension Phase||0
1457838|NCT02057250|3568244|P3|Treated|Extension Phase||0
1457839|NCT02057250|3568245|P2|Treated|Extension Phase||0
1457840|NCT02057250|3568246|P1|Treated|Extension Phase||0
1457841|NCT02057250|3568242|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
1457842|NCT02057250|3568243|P4|STARTED|Extension Phase||0
1457843|NCT02057250|3568244|P3|STARTED|Extension Phase||0
1457844|NCT02057250|3568245|P2|STARTED|Extension Phase||0
1457845|NCT02057250|3568246|P1|STARTED|Extension Phase||0
1457846|NCT02057250|3568242|P5|NOT COMPLETED|AID Assessment Phase||0
1457847|NCT02057250|3568243|P4|NOT COMPLETED|AID Assessment Phase||2
1457848|NCT02057250|3568244|P3|NOT COMPLETED|AID Assessment Phase||7
1457849|NCT02057250|3568245|P2|NOT COMPLETED|AID Assessment Phase||3
1457850|NCT02057250|3568246|P1|NOT COMPLETED|AID Assessment Phase||4
1457851|NCT02057250|3568242|P5|COMPLETED|AID Assessment Phase||0
1457852|NCT02057250|3568243|P4|COMPLETED|AID Assessment Phase||54
1457853|NCT02057250|3568244|P3|COMPLETED|AID Assessment Phase||45
1457854|NCT02057250|3568245|P2|COMPLETED|AID Assessment Phase||50
1457855|NCT02057250|3568246|P1|COMPLETED|AID Assessment Phase||52
1457856|NCT02057250|3568242|P5|STARTED|AID Assessment Phase||0
1457857|NCT02057250|3568243|P4|STARTED|AID Assessment Phase||56
1457858|NCT02057250|3568244|P3|STARTED|AID Assessment Phase||52
1457859|NCT02057250|3568245|P2|STARTED|AID Assessment Phase||53
1457860|NCT02057250|3568246|P1|STARTED|AID Assessment Phase||56
1457861|NCT02057237|3568259|P1|NOT COMPLETED|Overall Study||0
1457862|NCT02057237|3568259|P1|COMPLETED|Overall Study||1
1457863|NCT02057237|3568259|P1|STARTED|Overall Study||1
1457864|NCT02057068|3568266|P2|NOT COMPLETED|Overall Study||8
1457865|NCT02057068|3568267|P1|NOT COMPLETED|Overall Study||8
1457866|NCT02057068|3568266|P2|COMPLETED|Overall Study||28
1457867|NCT02057068|3568267|P1|COMPLETED|Overall Study||52
1457868|NCT02057068|3568266|P2|STARTED|Overall Study||36
1457869|NCT02057068|3568267|P1|STARTED|Overall Study||60
1457870|NCT02056834|3568277|P1|NOT COMPLETED|Overall Study||7
1457871|NCT02056834|3568277|P1|COMPLETED|Overall Study||29
1457872|NCT02056834|3568277|P1|6 Months|Overall Study||31
1457873|NCT02056834|3568277|P1|6 Weeks|Overall Study||34
1457874|NCT02056834|3568277|P1|STARTED|Overall Study||36
1457875|NCT02056652|3568298|P2|NOT COMPLETED|Overall Study||3
1457876|NCT02056652|3568299|P1|NOT COMPLETED|Overall Study||1
1457877|NCT02056652|3568298|P2|COMPLETED|Overall Study||58
1457878|NCT02056652|3568299|P1|COMPLETED|Overall Study||60
1457879|NCT02056652|3568298|P2|STARTED|Overall Study||61
1457880|NCT02056652|3568299|P1|STARTED|Overall Study||61
1457881|NCT02056639|3568317|P2|NOT COMPLETED|Overall Study||0
1457882|NCT02056639|3568318|P1|NOT COMPLETED|Overall Study||0
1457883|NCT02056639|3568317|P2|COMPLETED|Overall Study||23
1457884|NCT02056639|3568318|P1|COMPLETED|Overall Study||23
1457885|NCT02056639|3568317|P2|STARTED|Overall Study||23
1457886|NCT02056639|3568318|P1|STARTED|Overall Study||23
1457887|NCT02056431|3568334|P2|NOT COMPLETED|Overall Study||47
1457888|NCT02056431|3568335|P1|NOT COMPLETED|Overall Study||44
1457889|NCT02056431|3568334|P2|COMPLETED|Overall Study||619
1457890|NCT02056431|3568335|P1|COMPLETED|Overall Study||560
1457891|NCT02056431|3568334|P2|STARTED|Overall Study||666
1457892|NCT02056431|3568335|P1|STARTED|Overall Study||604
1457893|NCT02056392|3568349|P6|NOT COMPLETED|Overall Study||0
1457894|NCT02056392|3568350|P5|NOT COMPLETED|Overall Study||1
1457895|NCT02056392|3568351|P4|NOT COMPLETED|Overall Study||0
1457896|NCT02056392|3568352|P3|NOT COMPLETED|Overall Study||3
1457897|NCT02056392|3568353|P2|NOT COMPLETED|Overall Study||1
1457898|NCT02056392|3568354|P1|NOT COMPLETED|Overall Study||2
1457899|NCT02056392|3568349|P6|COMPLETED|Overall Study||9
1457900|NCT02056392|3568350|P5|COMPLETED|Overall Study||7
1457901|NCT02056392|3568351|P4|COMPLETED|Overall Study||9
1457902|NCT02056392|3568352|P3|COMPLETED|Overall Study||6
1457903|NCT02056392|3568353|P2|COMPLETED|Overall Study||8
1457904|NCT02056392|3568354|P1|COMPLETED|Overall Study||8
1457905|NCT02056392|3568349|P6|STARTED|Overall Study||9
1457906|NCT02056392|3568350|P5|STARTED|Overall Study||8
1457907|NCT02056392|3568351|P4|STARTED|Overall Study||9
1457908|NCT02056392|3568352|P3|STARTED|Overall Study||9
1457909|NCT02056392|3568353|P2|STARTED|Overall Study||9
1457910|NCT02056392|3568354|P1|STARTED|Overall Study||10
1457911|NCT02056171|3568391|P2|NOT COMPLETED|Overall Study||0
1457912|NCT02056171|3568392|P1|NOT COMPLETED|Overall Study||0
1457913|NCT02056171|3568391|P2|COMPLETED|Overall Study||3
1457914|NCT02056171|3568392|P1|COMPLETED|Overall Study||3
1457915|NCT02056171|3568391|P2|STARTED|Overall Study||3
1457916|NCT02056171|3568392|P1|STARTED|Overall Study||3
1457917|NCT02055820|3568412|P10|NOT COMPLETED|Phase II: Expansion||0
1457918|NCT02055820|3568413|P9|NOT COMPLETED|Phase II: Expansion||0
1457919|NCT02055820|3568414|P8|NOT COMPLETED|Phase II: Expansion||0
1457920|NCT02055820|3568415|P7|NOT COMPLETED|Phase II: Expansion||0
1457921|NCT02055820|3568416|P6|NOT COMPLETED|Phase II: Expansion||0
1457922|NCT02055820|3568417|P5|NOT COMPLETED|Phase II: Expansion||208
1457923|NCT02055820|3568418|P4|NOT COMPLETED|Phase II: Expansion||0
1457924|NCT02055820|3568419|P3|NOT COMPLETED|Phase II: Expansion||0
1457925|NCT02055820|3568420|P2|NOT COMPLETED|Phase II: Expansion||0
1457926|NCT02055820|3568421|P1|NOT COMPLETED|Phase II: Expansion||0
1457927|NCT02055820|3568412|P10|COMPLETED|Phase II: Expansion||0
1457928|NCT02055820|3568413|P9|COMPLETED|Phase II: Expansion||0
1457929|NCT02055820|3568414|P8|COMPLETED|Phase II: Expansion||0
1457930|NCT02055820|3568415|P7|COMPLETED|Phase II: Expansion||0
1457931|NCT02055820|3568416|P6|COMPLETED|Phase II: Expansion||0
1457932|NCT02055820|3568417|P5|COMPLETED|Phase II: Expansion|Study is still on-going|0
1457933|NCT02055820|3568418|P4|COMPLETED|Phase II: Expansion||0
1457934|NCT02055820|3568419|P3|COMPLETED|Phase II: Expansion||0
1457935|NCT02055820|3568420|P2|COMPLETED|Phase II: Expansion||0
1457936|NCT02055820|3568421|P1|COMPLETED|Phase II: Expansion||0
1457937|NCT02055820|3568412|P10|STARTED|Phase II: Expansion||0
1457938|NCT02055820|3568413|P9|STARTED|Phase II: Expansion||0
1457939|NCT02055820|3568414|P8|STARTED|Phase II: Expansion||0
1457940|NCT02055820|3568415|P7|STARTED|Phase II: Expansion||0
1457941|NCT02055820|3568416|P6|STARTED|Phase II: Expansion||0
1457942|NCT02055820|3568417|P5|STARTED|Phase II: Expansion||208
1457943|NCT02055820|3568418|P4|STARTED|Phase II: Expansion||0
1457944|NCT02055820|3568419|P3|STARTED|Phase II: Expansion||0
1457945|NCT02055820|3568420|P2|STARTED|Phase II: Expansion||0
1457946|NCT02055820|3568421|P1|STARTED|Phase II: Expansion||0
1457947|NCT02055820|3568412|P10|NOT COMPLETED|Phase I: Dose-Finding||6
1457948|NCT02055820|3568413|P9|NOT COMPLETED|Phase I: Dose-Finding||6
1457949|NCT02055820|3568414|P8|NOT COMPLETED|Phase I: Dose-Finding||6
1457950|NCT02055820|3568415|P7|NOT COMPLETED|Phase I: Dose-Finding||7
1457951|NCT02055820|3568416|P6|NOT COMPLETED|Phase I: Dose-Finding||7
1457952|NCT02055820|3568417|P5|NOT COMPLETED|Phase I: Dose-Finding||0
1457953|NCT02055820|3568418|P4|NOT COMPLETED|Phase I: Dose-Finding||6
1457954|NCT02055820|3568419|P3|NOT COMPLETED|Phase I: Dose-Finding||8
1457955|NCT02055820|3568420|P2|NOT COMPLETED|Phase I: Dose-Finding||3
1457956|NCT02055820|3568421|P1|NOT COMPLETED|Phase I: Dose-Finding||7
1457957|NCT02055820|3568412|P10|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
1457958|NCT02055820|3568413|P9|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
1457959|NCT02055820|3568414|P8|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
1457960|NCT02055820|3568415|P7|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
1457961|NCT02055820|3568416|P6|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
1457962|NCT02055820|3568417|P5|COMPLETED|Phase I: Dose-Finding||0
1457963|NCT02055820|3568418|P4|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
1457964|NCT02055820|3568419|P3|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
1457965|NCT02055820|3568420|P2|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
1457966|NCT02055820|3568421|P1|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
1457967|NCT02055820|3568412|P10|STARTED|Phase I: Dose-Finding||6
1457968|NCT02055820|3568413|P9|STARTED|Phase I: Dose-Finding||6
1457969|NCT02055820|3568414|P8|STARTED|Phase I: Dose-Finding||6
1457970|NCT02055820|3568415|P7|STARTED|Phase I: Dose-Finding||7
1457971|NCT02055820|3568416|P6|STARTED|Phase I: Dose-Finding||7
1457972|NCT02055820|3568417|P5|STARTED|Phase I: Dose-Finding||0
1457973|NCT02055820|3568418|P4|STARTED|Phase I: Dose-Finding||6
1457974|NCT02055820|3568419|P3|STARTED|Phase I: Dose-Finding||8
1457975|NCT02055820|3568420|P2|STARTED|Phase I: Dose-Finding||3
1457976|NCT02055820|3568421|P1|STARTED|Phase I: Dose-Finding||7
1457977|NCT02055430|3568525|P2|NOT COMPLETED|Overall Study||0
1457978|NCT02055430|3568526|P1|NOT COMPLETED|Overall Study||0
1457979|NCT02055430|3568525|P2|COMPLETED|Overall Study||45
1457980|NCT02055430|3568526|P1|COMPLETED|Overall Study||45
1457981|NCT02055430|3568525|P2|STARTED|Overall Study||45
1457982|NCT02055430|3568526|P1|STARTED|Overall Study||45
1457983|NCT02055404|3568532|P1|NOT COMPLETED|Overall Study||0
1457984|NCT02055404|3568532|P1|COMPLETED|Overall Study||3
1457985|NCT02055404|3568532|P1|STARTED|Overall Study||3
1457986|NCT02055365|3568545|P1|NOT COMPLETED|Overall Study||1
1457987|NCT02055365|3568545|P1|COMPLETED|Overall Study||9
1457988|NCT02055365|3568545|P1|STARTED|Overall Study||10
1457989|NCT02055352|3568558|P2|NOT COMPLETED|Overall Study||17
1457990|NCT02055352|3568559|P1|NOT COMPLETED|Overall Study||6
1457991|NCT02055352|3568558|P2|COMPLETED|Overall Study||96
1457992|NCT02055352|3568559|P1|COMPLETED|Overall Study||103
1457993|NCT02055352|3568558|P2|Per-Protocol Set (PPS)|Overall Study||111
1457994|NCT02055352|3568559|P1|Per-Protocol Set (PPS)|Overall Study||108
1457995|NCT02055352|3568558|P2|STARTED|Overall Study||113
1457996|NCT02055352|3568559|P1|STARTED|Overall Study||109
1457997|NCT02055118|3568576|P3|NOT COMPLETED|Overall Study||0
1457998|NCT02055118|3568577|P2|NOT COMPLETED|Overall Study||2
1457999|NCT02055118|3568578|P1|NOT COMPLETED|Overall Study||0
1458000|NCT02055118|3568576|P3|COMPLETED|Overall Study||9
1458001|NCT02055118|3568577|P2|COMPLETED|Overall Study||32
1458002|NCT02055118|3568578|P1|COMPLETED|Overall Study||15
1458003|NCT02055118|3568576|P3|STARTED|Overall Study||9
1458004|NCT02055118|3568577|P2|STARTED|Overall Study||34
1458005|NCT02055118|3568578|P1|STARTED|Overall Study||15
1458006|NCT02054910|3568637|P2|NOT COMPLETED|Overall Study||1
1458007|NCT02054910|3568638|P1|NOT COMPLETED|Overall Study||4
1458008|NCT02054910|3568637|P2|COMPLETED|Overall Study||0
1458009|NCT02054910|3568638|P1|COMPLETED|Overall Study||0
1458010|NCT02054910|3568637|P2|STARTED|Overall Study||1
1458011|NCT02054910|3568638|P1|STARTED|Overall Study||4
1458012|NCT02054897|3568657|P3|NOT COMPLETED|Overall Study||12
1458013|NCT02054897|3568658|P2|NOT COMPLETED|Overall Study||7
1458014|NCT02054897|3568659|P1|NOT COMPLETED|Overall Study||10
1458015|NCT02054897|3568657|P3|COMPLETED|Overall Study||117
1458016|NCT02054897|3568658|P2|COMPLETED|Overall Study||123
1458017|NCT02054897|3568659|P1|COMPLETED|Overall Study||119
1458018|NCT02054897|3568657|P3|Exposed|Overall Study||129
1458019|NCT02054897|3568658|P2|Exposed|Overall Study||130
1458020|NCT02054897|3568659|P1|Exposed|Overall Study||128
1458021|NCT02054897|3568657|P3|STARTED|Overall Study||129
1458022|NCT02054897|3568658|P2|STARTED|Overall Study||130
1458023|NCT02054897|3568659|P1|STARTED|Overall Study||129
1458024|NCT02054754|3568684|P6|NOT COMPLETED|Overall Study||0
1458025|NCT02054754|3568685|P5|NOT COMPLETED|Overall Study||0
1458026|NCT02054754|3568686|P4|NOT COMPLETED|Overall Study||0
1458027|NCT02054754|3568687|P3|NOT COMPLETED|Overall Study||0
1458028|NCT02054754|3568688|P2|NOT COMPLETED|Overall Study||0
1458029|NCT02054754|3568689|P1|NOT COMPLETED|Overall Study||0
1458030|NCT02054754|3568684|P6|COMPLETED|Overall Study||10
1458031|NCT02054754|3568685|P5|COMPLETED|Overall Study||6
1458032|NCT02054754|3568686|P4|COMPLETED|Overall Study||6
1458033|NCT02054754|3568687|P3|COMPLETED|Overall Study||6
1458034|NCT02054754|3568688|P2|COMPLETED|Overall Study||6
1458035|NCT02054754|3568689|P1|COMPLETED|Overall Study||6
1458036|NCT02054754|3568684|P6|STARTED|Overall Study||10
1458037|NCT02054754|3568685|P5|STARTED|Overall Study||6
1458038|NCT02054754|3568686|P4|STARTED|Overall Study||6
1458039|NCT02054754|3568687|P3|STARTED|Overall Study||6
1458040|NCT02054754|3568688|P2|STARTED|Overall Study||6
1458041|NCT02054754|3568689|P1|STARTED|Overall Study||6
1458042|NCT02054715|3568706|P2|NOT COMPLETED|Follow-up 2||19
1458043|NCT02054715|3568707|P1|NOT COMPLETED|Follow-up 2||19
1458044|NCT02054715|3568706|P2|COMPLETED|Follow-up 2||173
1458045|NCT02054715|3568707|P1|COMPLETED|Follow-up 2||192
1458046|NCT02054715|3568706|P2|STARTED|Follow-up 2||192
1458047|NCT02054715|3568707|P1|STARTED|Follow-up 2||211
1458048|NCT02054715|3568706|P2|NOT COMPLETED|Baseline/Follow-up 1||7
1458049|NCT02054715|3568707|P1|NOT COMPLETED|Baseline/Follow-up 1||8
1458050|NCT02054715|3568706|P2|COMPLETED|Baseline/Follow-up 1||192
1458051|NCT02054715|3568707|P1|COMPLETED|Baseline/Follow-up 1||211
1458052|NCT02054715|3568706|P2|STARTED|Baseline/Follow-up 1||199
1458053|NCT02054715|3568707|P1|STARTED|Baseline/Follow-up 1||219
1458054|NCT02054702|3568721|P2|NOT COMPLETED|Overall Study||12
1458055|NCT02054702|3568722|P1|NOT COMPLETED|Overall Study||24
1458056|NCT02054702|3568721|P2|COMPLETED|Overall Study||21
1458057|NCT02054702|3568722|P1|COMPLETED|Overall Study||40
1458058|NCT02054702|3568721|P2|STARTED|Overall Study||33
1458059|NCT02054702|3568722|P1|STARTED|Overall Study||64
1458060|NCT02054572|3568750|P1|NOT COMPLETED|Overall Study||0
1458061|NCT02054572|3568750|P1|COMPLETED|Overall Study||6
1458062|NCT02054572|3568750|P1|STARTED|Overall Study||6
1458063|NCT02054481|3568777|P4|NOT COMPLETED|Overall Study||1
1458064|NCT02054481|3568778|P3|NOT COMPLETED|Overall Study||2
1458065|NCT02054481|3568779|P2|NOT COMPLETED|Overall Study||2
1458066|NCT02054481|3568780|P1|NOT COMPLETED|Overall Study||4
1458067|NCT02054481|3568777|P4|COMPLETED|Overall Study||39
1458068|NCT02054481|3568778|P3|COMPLETED|Overall Study||40
1458069|NCT02054481|3568779|P2|COMPLETED|Overall Study||39
1458070|NCT02054481|3568780|P1|COMPLETED|Overall Study||39
1458071|NCT02054481|3568777|P4|STARTED|Overall Study||40
1458072|NCT02054481|3568778|P3|STARTED|Overall Study||42
1458073|NCT02054481|3568779|P2|STARTED|Overall Study||41
1458074|NCT02054481|3568780|P1|STARTED|Overall Study||43
1458075|NCT02054325|3568828|P2|NOT COMPLETED|Overall Study||5
1458076|NCT02054325|3568829|P1|NOT COMPLETED|Overall Study||8
1458077|NCT02054325|3568828|P2|COMPLETED|Overall Study||50
1458078|NCT02054325|3568829|P1|COMPLETED|Overall Study||43
1458079|NCT02054325|3568828|P2|STARTED|Overall Study||55
1458080|NCT02054325|3568829|P1|STARTED|Overall Study||51
1458081|NCT02054130|3568841|P4|NOT COMPLETED|Overall Study||22
1458082|NCT02054130|3568842|P3|NOT COMPLETED|Overall Study||15
1458083|NCT02054130|3568843|P2|NOT COMPLETED|Overall Study||11
1458084|NCT02054130|3568844|P1|NOT COMPLETED|Overall Study||8
1458085|NCT02054130|3568841|P4|COMPLETED|Overall Study||115
1458086|NCT02054130|3568842|P3|COMPLETED|Overall Study||122
1458087|NCT02054130|3568843|P2|COMPLETED|Overall Study||127
1458088|NCT02054130|3568844|P1|COMPLETED|Overall Study||130
1458089|NCT02054130|3568841|P4|STARTED|Overall Study||137
1458090|NCT02054130|3568842|P3|STARTED|Overall Study||137
1458091|NCT02054130|3568843|P2|STARTED|Overall Study||138
1458092|NCT02054130|3568844|P1|STARTED|Overall Study||138
1458093|NCT02053753|3568938|P2|NOT COMPLETED|Overall Study||8
1458094|NCT02053753|3568939|P1|NOT COMPLETED|Overall Study||7
1458095|NCT02053753|3568938|P2|COMPLETED|Overall Study||66
1458096|NCT02053753|3568939|P1|COMPLETED|Overall Study||65
1458097|NCT02053753|3568938|P2|Received Treatment|Overall Study||71
1458098|NCT02053753|3568939|P1|Received Treatment|Overall Study||71
1458099|NCT02053753|3568938|P2|STARTED|Overall Study||74
1458100|NCT02053753|3568939|P1|STARTED|Overall Study||72
1458101|NCT02053610|3568963|P2|NOT COMPLETED|Overall Study||67
1458102|NCT02053610|3568964|P1|NOT COMPLETED|Overall Study||42
1458103|NCT02053610|3568963|P2|COMPLETED|Overall Study|Completed=Completed Treatment|266
1458104|NCT02053610|3568964|P1|COMPLETED|Overall Study|Completed=Completed Treatment|288
1458105|NCT02053610|3568963|P2|Received Study Drug|Overall Study||331
1458106|NCT02053610|3568964|P1|Received Study Drug|Overall Study||326
1458107|NCT02053610|3568963|P2|STARTED|Overall Study||333
1458108|NCT02053610|3568964|P1|STARTED|Overall Study||330
1458109|NCT02053493|3568996|P2|NOT COMPLETED|Overall Study||1
1458110|NCT02053493|3568997|P1|NOT COMPLETED|Overall Study||1
1458111|NCT02053493|3568996|P2|COMPLETED|Overall Study||58
1458112|NCT02053493|3568997|P1|COMPLETED|Overall Study||50
1458113|NCT02053493|3568996|P2|STARTED|Overall Study||59
1458114|NCT02053493|3568997|P1|STARTED|Overall Study||51
1458115|NCT02053168|3569035|P1|NOT COMPLETED|Overall Study||3
1458116|NCT02053168|3569035|P1|COMPLETED|Overall Study||22
1458117|NCT02053168|3569035|P1|STARTED|Overall Study||25
1458118|NCT02052895|3569052|P3|NOT COMPLETED|Overall Study||0
1458119|NCT02052895|3569053|P2|NOT COMPLETED|Overall Study||0
1458120|NCT02052895|3569054|P1|NOT COMPLETED|Overall Study||0
1458121|NCT02052895|3569052|P3|COMPLETED|Overall Study||15
1458122|NCT02052895|3569053|P2|COMPLETED|Overall Study||15
1458123|NCT02052895|3569054|P1|COMPLETED|Overall Study||196
1458124|NCT02052895|3569052|P3|STARTED|Overall Study||15
1458125|NCT02052895|3569053|P2|STARTED|Overall Study||15
1458126|NCT02052895|3569054|P1|STARTED|Overall Study||196
1458127|NCT02052752|3569064|P3|NOT COMPLETED|Overall Study||0
1458128|NCT02052752|3569065|P2|NOT COMPLETED|Overall Study||0
1458129|NCT02052752|3569066|P1|NOT COMPLETED|Overall Study||0
1458130|NCT02052752|3569064|P3|COMPLETED|Overall Study||30
1458131|NCT02052752|3569065|P2|COMPLETED|Overall Study||30
1458132|NCT02052752|3569066|P1|COMPLETED|Overall Study||30
1458133|NCT02052752|3569064|P3|STARTED|Overall Study||30
1458134|NCT02052752|3569065|P2|STARTED|Overall Study||30
1458135|NCT02052752|3569066|P1|STARTED|Overall Study||30
1458136|NCT02052661|3569089|P1|NOT COMPLETED|Overall Study||0
1458137|NCT02052661|3569089|P1|COMPLETED|Overall Study||300
1458138|NCT02052661|3569089|P1|STARTED|Overall Study||300
1458139|NCT02052635|3569103|P2|NOT COMPLETED|Overall Study||0
1458140|NCT02052635|3569104|P1|NOT COMPLETED|Overall Study||0
1458141|NCT02052635|3569103|P2|COMPLETED|Overall Study||6
1458142|NCT02052635|3569104|P1|COMPLETED|Overall Study||7
1458143|NCT02052635|3569103|P2|STARTED|Overall Study||6
1458144|NCT02052635|3569104|P1|STARTED|Overall Study||7
1458145|NCT02052596|3569114|P2|NOT COMPLETED|Safety Phase||35
1458146|NCT02052596|3569115|P1|NOT COMPLETED|Safety Phase||27
1458147|NCT02052596|3569114|P2|COMPLETED|Safety Phase||383
1458148|NCT02052596|3569115|P1|COMPLETED|Safety Phase||385
1458149|NCT02052596|3569114|P2|STARTED|Safety Phase||418
1458150|NCT02052596|3569115|P1|STARTED|Safety Phase||412
1458151|NCT02052596|3569114|P2|NOT COMPLETED|Active Phase||20
1458152|NCT02052596|3569115|P1|NOT COMPLETED|Active Phase||16
1458153|NCT02052596|3569114|P2|COMPLETED|Active Phase||398
1458154|NCT02052596|3569115|P1|COMPLETED|Active Phase||396
1458155|NCT02052596|3569114|P2|STARTED|Active Phase||418
1458156|NCT02052596|3569115|P1|STARTED|Active Phase||412
1458157|NCT02052544|3569140|P1|NOT COMPLETED|Overall Study||0
1458158|NCT02052544|3569140|P1|COMPLETED|Overall Study|Last Subject Out|123
1458159|NCT02052544|3569140|P1|STARTED|Overall Study|First Subject In|123
1458160|NCT02052466|3569145|P1|NOT COMPLETED|Overall Study||2
1458161|NCT02052466|3569145|P1|COMPLETED|Overall Study||30
1458162|NCT02052466|3569145|P1|STARTED|Overall Study||32
1458163|NCT02052440|3569162|P2|NOT COMPLETED|Overall Study||1
1458164|NCT02052440|3569163|P1|NOT COMPLETED|Overall Study||0
1458165|NCT02052440|3569162|P2|COMPLETED|Overall Study||51
1458166|NCT02052440|3569163|P1|COMPLETED|Overall Study||50
1458167|NCT02052440|3569162|P2|STARTED|Overall Study||52
1458168|NCT02052440|3569163|P1|STARTED|Overall Study||50
1458169|NCT02052414|3569175|P1|NOT COMPLETED|Overall Study||17
1458170|NCT02052414|3569175|P1|COMPLETED|Overall Study||17
1458171|NCT02052414|3569175|P1|STARTED|Overall Study||34
1458172|NCT02052141|3569185|P2|NOT COMPLETED|Intervention Period 2||0
1458173|NCT02052141|3569186|P1|NOT COMPLETED|Intervention Period 2||0
1458174|NCT02052141|3569185|P2|COMPLETED|Intervention Period 2||7
1458175|NCT02052141|3569186|P1|COMPLETED|Intervention Period 2||5
1458176|NCT02052141|3569185|P2|STARTED|Intervention Period 2||7
1458177|NCT02052141|3569186|P1|STARTED|Intervention Period 2||5
1458178|NCT02052141|3569185|P2|NOT COMPLETED|Intervention Period 1||0
1458179|NCT02052141|3569186|P1|NOT COMPLETED|Intervention Period 1||0
1458180|NCT02052141|3569185|P2|COMPLETED|Intervention Period 1||7
1458181|NCT02052141|3569186|P1|COMPLETED|Intervention Period 1||5
1458182|NCT02052141|3569185|P2|STARTED|Intervention Period 1||7
1458183|NCT02052141|3569186|P1|STARTED|Intervention Period 1||5
1458184|NCT02052011|3569210|P2|NOT COMPLETED|Overall Study||2
1458185|NCT02052011|3569211|P1|NOT COMPLETED|Overall Study||4
1458186|NCT02052011|3569210|P2|COMPLETED|Overall Study||8
1458187|NCT02052011|3569211|P1|COMPLETED|Overall Study||17
1458188|NCT02052011|3569210|P2|STARTED|Overall Study||10
1458189|NCT02052011|3569211|P1|STARTED|Overall Study||21
1458190|NCT02051816|3569221|P4|NOT COMPLETED|Overall Study||0
1458191|NCT02051816|3569222|P3|NOT COMPLETED|Overall Study||0
1458192|NCT02051816|3569223|P2|NOT COMPLETED|Overall Study||0
1458193|NCT02051816|3569224|P1|NOT COMPLETED|Overall Study||0
1458194|NCT02051816|3569221|P4|COMPLETED|Overall Study||36
1458195|NCT02051816|3569222|P3|COMPLETED|Overall Study||37
1458196|NCT02051816|3569223|P2|COMPLETED|Overall Study||40
1458197|NCT02051816|3569224|P1|COMPLETED|Overall Study||37
1458198|NCT02051816|3569221|P4|STARTED|Overall Study||36
1458199|NCT02051816|3569222|P3|STARTED|Overall Study||37
1458200|NCT02051816|3569223|P2|STARTED|Overall Study||40
1458201|NCT02051816|3569224|P1|STARTED|Overall Study||37
1458202|NCT02051790|3569262|P1|NOT COMPLETED|Overall Study||0
1458203|NCT02051790|3569262|P1|COMPLETED|Overall Study||241
1458204|NCT02051790|3569262|P1|STARTED|Overall Study||241
1458205|NCT02051686|3569268|P2|NOT COMPLETED|Overall Study||0
1458206|NCT02051686|3569269|P1|NOT COMPLETED|Overall Study||0
1458207|NCT02051686|3569268|P2|COMPLETED|Overall Study||46
1458208|NCT02051686|3569269|P1|COMPLETED|Overall Study||42
1458209|NCT02051686|3569268|P2|STARTED|Overall Study||46
1458210|NCT02051686|3569269|P1|STARTED|Overall Study||42
1458211|NCT02051595|3569277|P1|NOT COMPLETED|Overall Study||0
1458212|NCT02051595|3569277|P1|COMPLETED|Overall Study||25
1458213|NCT02051595|3569277|P1|STARTED|Overall Study||25
1458214|NCT02051426|3569283|P2|NOT COMPLETED|Second Intervention||0
1458215|NCT02051426|3569284|P1|NOT COMPLETED|Second Intervention||0
1458216|NCT02051426|3569283|P2|COMPLETED|Second Intervention||19
1458217|NCT02051426|3569284|P1|COMPLETED|Second Intervention||16
1458218|NCT02051426|3569283|P2|STARTED|Second Intervention||19
1458219|NCT02051426|3569284|P1|STARTED|Second Intervention||16
1458220|NCT02051426|3569283|P2|NOT COMPLETED|Washout Period of 1 Month||0
1458221|NCT02051426|3569284|P1|NOT COMPLETED|Washout Period of 1 Month||0
1458222|NCT02051426|3569283|P2|COMPLETED|Washout Period of 1 Month||19
1458223|NCT02051426|3569284|P1|COMPLETED|Washout Period of 1 Month||16
1458224|NCT02051426|3569283|P2|STARTED|Washout Period of 1 Month||19
1458225|NCT02051426|3569284|P1|STARTED|Washout Period of 1 Month||16
1458226|NCT02051426|3569283|P2|NOT COMPLETED|First Intervention||0
1458227|NCT02051426|3569284|P1|NOT COMPLETED|First Intervention||0
1458228|NCT02051426|3569283|P2|COMPLETED|First Intervention||19
1458229|NCT02051426|3569284|P1|COMPLETED|First Intervention||16
1458230|NCT02051426|3569283|P2|STARTED|First Intervention||19
1458231|NCT02051426|3569284|P1|STARTED|First Intervention||16
1458232|NCT02051335|3569298|P4|NOT COMPLETED|Period 4||0
1458233|NCT02051335|3569299|P3|NOT COMPLETED|Period 4||0
1458234|NCT02051335|3569300|P2|NOT COMPLETED|Period 4||0
1458235|NCT02051335|3569301|P1|NOT COMPLETED|Period 4||0
1458236|NCT02051335|3569298|P4|COMPLETED|Period 4||4
1458237|NCT02051335|3569299|P3|COMPLETED|Period 4||5
1458238|NCT02051335|3569300|P2|COMPLETED|Period 4||7
1458239|NCT02051335|3569301|P1|COMPLETED|Period 4||7
1458240|NCT02051335|3569298|P4|STARTED|Period 4||4
1458241|NCT02051335|3569299|P3|STARTED|Period 4||5
1458242|NCT02051335|3569300|P2|STARTED|Period 4||7
1458243|NCT02051335|3569301|P1|STARTED|Period 4||7
1458244|NCT02051335|3569298|P4|NOT COMPLETED|Period 3||0
1458245|NCT02051335|3569299|P3|NOT COMPLETED|Period 3||0
1458246|NCT02051335|3569300|P2|NOT COMPLETED|Period 3||0
1458247|NCT02051335|3569301|P1|NOT COMPLETED|Period 3||0
1458248|NCT02051335|3569298|P4|COMPLETED|Period 3||4
1458249|NCT02051335|3569299|P3|COMPLETED|Period 3||5
1458250|NCT02051335|3569300|P2|COMPLETED|Period 3||7
1458251|NCT02051335|3569301|P1|COMPLETED|Period 3||7
1458252|NCT02051335|3569298|P4|STARTED|Period 3||4
1458253|NCT02051335|3569299|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
1458254|NCT02051335|3569300|P2|STARTED|Period 3||7
1458255|NCT02051335|3569301|P1|STARTED|Period 3||7
1458256|NCT02051335|3569298|P4|NOT COMPLETED|Period 2||0
1458257|NCT02051335|3569299|P3|NOT COMPLETED|Period 2||0
1458258|NCT02051335|3569300|P2|NOT COMPLETED|Period 2||0
1458259|NCT02051335|3569301|P1|NOT COMPLETED|Period 2||0
1458260|NCT02051335|3569298|P4|COMPLETED|Period 2||4
1458261|NCT02051335|3569299|P3|COMPLETED|Period 2||7
1458262|NCT02051335|3569300|P2|COMPLETED|Period 2||7
1458263|NCT02051335|3569301|P1|COMPLETED|Period 2||7
1458264|NCT02051335|3569298|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
1458265|NCT02051335|3569299|P3|STARTED|Period 2||7
1458266|NCT02051335|3569300|P2|STARTED|Period 2||7
1458267|NCT02051335|3569301|P1|STARTED|Period 2||7
1458268|NCT02051335|3569298|P4|NOT COMPLETED|Period 1||0
1458269|NCT02051335|3569299|P3|NOT COMPLETED|Period 1||0
1458270|NCT02051335|3569300|P2|NOT COMPLETED|Period 1||0
1458271|NCT02051335|3569301|P1|NOT COMPLETED|Period 1||0
1458272|NCT02051335|3569298|P4|COMPLETED|Period 1||6
1458273|NCT02051335|3569299|P3|COMPLETED|Period 1||7
1458274|NCT02051335|3569300|P2|COMPLETED|Period 1||7
1458275|NCT02051335|3569301|P1|COMPLETED|Period 1||7
1458276|NCT02051335|3569298|P4|STARTED|Period 1||6
1458277|NCT02051335|3569299|P3|STARTED|Period 1||7
1458278|NCT02051335|3569300|P2|STARTED|Period 1||7
1458279|NCT02051335|3569301|P1|STARTED|Period 1||7
1458280|NCT02051296|3569353|P2|NOT COMPLETED|Overall Study||9
1458281|NCT02051296|3569354|P1|NOT COMPLETED|Overall Study||8
1458282|NCT02051296|3569353|P2|COMPLETED|Overall Study||56
1458283|NCT02051296|3569354|P1|COMPLETED|Overall Study||58
1458284|NCT02051296|3569353|P2|Received Allocated Intervention|Overall Study||58
1458285|NCT02051296|3569354|P1|Received Allocated Intervention|Overall Study||59
1458286|NCT02051296|3569353|P2|STARTED|Overall Study||65
1458287|NCT02051296|3569354|P1|STARTED|Overall Study||66
1458288|NCT02050334|3569362|P2|NOT COMPLETED|Overall Study||0
1458289|NCT02050334|3569363|P1|NOT COMPLETED|Overall Study||0
1458290|NCT02050334|3569362|P2|COMPLETED|Overall Study||9
1458291|NCT02050334|3569363|P1|COMPLETED|Overall Study||9
1458292|NCT02050334|3569362|P2|STARTED|Overall Study||9
1458293|NCT02050334|3569363|P1|STARTED|Overall Study||9
1458294|NCT02050321|3569371|P1|NOT COMPLETED|Overall Study||2
1458295|NCT02050321|3569371|P1|COMPLETED|Overall Study||0
1458296|NCT02050321|3569371|P1|STARTED|Overall Study||2
1458297|NCT02050048|3569378|P2|NOT COMPLETED|Overall Study||2
1458298|NCT02050048|3569379|P1|NOT COMPLETED|Overall Study||5
1458299|NCT02050048|3569378|P2|COMPLETED|Overall Study||10
1458300|NCT02050048|3569379|P1|COMPLETED|Overall Study||9
1458301|NCT02050048|3569378|P2|STARTED|Overall Study||12
1458302|NCT02050048|3569379|P1|STARTED|Overall Study||14
1458303|NCT02049931|3569388|P3|NOT COMPLETED|Overall Study||3
1458304|NCT02049931|3569389|P2|NOT COMPLETED|Overall Study||5
1458305|NCT02049931|3569390|P1|NOT COMPLETED|Overall Study||3
1458306|NCT02049931|3569388|P3|COMPLETED|Overall Study||17
1458307|NCT02049931|3569389|P2|COMPLETED|Overall Study||15
1458308|NCT02049931|3569390|P1|COMPLETED|Overall Study||17
1458309|NCT02049931|3569388|P3|STARTED|Overall Study||20
1458310|NCT02049931|3569389|P2|STARTED|Overall Study||20
1458311|NCT02049931|3569390|P1|STARTED|Overall Study||20
1458312|NCT02049450|3569410|P1|NOT COMPLETED|Overall Study||4
1458313|NCT02049450|3569410|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
1458314|NCT02049450|3569410|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
1458315|NCT02049450|3569410|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
1458316|NCT02049450|3569410|P1|STARTED|Overall Study||30
1458317|NCT02049385|3569424|P2|NOT COMPLETED|Second Intervention||2
1458318|NCT02049385|3569425|P1|NOT COMPLETED|Second Intervention||0
1458319|NCT02049385|3569424|P2|COMPLETED|Second Intervention||0
1458320|NCT02049385|3569425|P1|COMPLETED|Second Intervention||1
1458321|NCT02049385|3569424|P2|STARTED|Second Intervention||2
1458322|NCT02049385|3569425|P1|STARTED|Second Intervention||1
1458323|NCT02049385|3569424|P2|NOT COMPLETED|First Intervention||0
1458324|NCT02049385|3569425|P1|NOT COMPLETED|First Intervention||3
1458325|NCT02049385|3569424|P2|COMPLETED|First Intervention||2
1458326|NCT02049385|3569425|P1|COMPLETED|First Intervention||1
1458327|NCT02049385|3569424|P2|STARTED|First Intervention||2
1458328|NCT02049385|3569425|P1|STARTED|First Intervention||4
1458329|NCT02049151|3569433|P2|NOT COMPLETED|Overall Study||0
1458330|NCT02049151|3569434|P1|NOT COMPLETED|Overall Study||0
1458331|NCT02049151|3569433|P2|COMPLETED|Overall Study||17
1458332|NCT02049151|3569434|P1|COMPLETED|Overall Study||15
1458333|NCT02049151|3569433|P2|STARTED|Overall Study|1 subject did not receive treatment|17
1458334|NCT02049151|3569434|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
1458335|NCT02048904|3569448|P1|NOT COMPLETED|Overall Study||77
1458336|NCT02048904|3569448|P1|COMPLETED|Overall Study||65
1458337|NCT02048904|3569448|P1|STARTED|Overall Study||142
1458338|NCT02048891|3569454|P2|NOT COMPLETED|Overall Study||0
1458339|NCT02048891|3569455|P1|NOT COMPLETED|Overall Study||0
1458340|NCT02048891|3569454|P2|COMPLETED|Overall Study||1
1458341|NCT02048891|3569455|P1|COMPLETED|Overall Study||2
1458342|NCT02048891|3569454|P2|STARTED|Overall Study||1
1458343|NCT02048891|3569455|P1|STARTED|Overall Study||2
1458344|NCT02048241|3569463|P2|NOT COMPLETED|Overall Study||1
1458345|NCT02048241|3569464|P1|NOT COMPLETED|Overall Study||0
1458346|NCT02048241|3569463|P2|COMPLETED|Overall Study||5
1458347|NCT02048241|3569464|P1|COMPLETED|Overall Study||5
1458348|NCT02048241|3569463|P2|STARTED|Overall Study||6
1458349|NCT02048241|3569464|P1|STARTED|Overall Study||5
1458350|NCT02048072|3569470|P1|NOT COMPLETED|Overall Study||4
1458351|NCT02048072|3569470|P1|COMPLETED|Overall Study||29
1458352|NCT02048072|3569470|P1|STARTED|Overall Study||33
1458353|NCT02047747|3569474|P1|NOT COMPLETED|Overall Study||3
1458354|NCT02047747|3569474|P1|COMPLETED|Overall Study||1
1458355|NCT02047747|3569474|P1|STARTED|Overall Study||4
1458356|NCT02047500|3569479|P1|NOT COMPLETED|Overall Study||19
1458357|NCT02047500|3569479|P1|COMPLETED|Overall Study||0
1458358|NCT02047500|3569479|P1|STARTED|Overall Study||19
1458359|NCT02047253|3569483|P1|NOT COMPLETED|Overall Study||8
1458360|NCT02047253|3569483|P1|COMPLETED|Overall Study||20
1458361|NCT02047253|3569483|P1|STARTED|Overall Study||28
1458362|NCT02047227|3569493|P2|NOT COMPLETED|Overall Study||130
1458363|NCT02047227|3569494|P1|NOT COMPLETED|Overall Study||144
1458364|NCT02047227|3569493|P2|COMPLETED|Overall Study||347
1458365|NCT02047227|3569494|P1|COMPLETED|Overall Study||318
1458366|NCT02047227|3569493|P2|Completed Ovarian Stimulation Phase|Overall Study||440
1458367|NCT02047227|3569494|P1|Completed Ovarian Stimulation Phase|Overall Study||424
1458368|NCT02047227|3569493|P2|STARTED|Overall Study||477
1458369|NCT02047227|3569494|P1|STARTED|Overall Study||462
1458370|NCT02046993|3569512|P2|NOT COMPLETED|Overall Study||11
1458371|NCT02046993|3569513|P1|NOT COMPLETED|Overall Study||3
1458372|NCT02046993|3569512|P2|COMPLETED|Overall Study||94
1458373|NCT02046993|3569513|P1|COMPLETED|Overall Study||102
1458374|NCT02046993|3569512|P2|6th Month|Overall Study||94
1458375|NCT02046993|3569513|P1|6th Month|Overall Study||102
1458376|NCT02046993|3569512|P2|3rd Month|Overall Study||97
1458377|NCT02046993|3569513|P1|3rd Month|Overall Study||104
1458378|NCT02046993|3569512|P2|STARTED|Overall Study||105
1458379|NCT02046993|3569513|P1|STARTED|Overall Study||105
1458380|NCT02046980|3569532|P3|NOT COMPLETED|Overall Study||1
1458381|NCT02046980|3569533|P2|NOT COMPLETED|Overall Study||5
1458382|NCT02046980|3569534|P1|NOT COMPLETED|Overall Study||2
1458383|NCT02046980|3569532|P3|COMPLETED|Overall Study||72
1458384|NCT02046980|3569533|P2|COMPLETED|Overall Study||67
1458385|NCT02046980|3569534|P1|COMPLETED|Overall Study||70
1458386|NCT02046980|3569532|P3|STARTED|Overall Study||73
1458387|NCT02046980|3569533|P2|STARTED|Overall Study||72
1458388|NCT02046980|3569534|P1|STARTED|Overall Study||72
1458389|NCT02046863|3569542|P1|NOT COMPLETED|Overall Study||0
1458390|NCT02046863|3569542|P1|COMPLETED|Overall Study||7
1458391|NCT02046863|3569542|P1|STARTED|Overall Study||7
1458392|NCT02046772|3569548|P2|NOT COMPLETED|Overall Study||0
1458393|NCT02046772|3569549|P1|NOT COMPLETED|Overall Study||0
1458394|NCT02046772|3569548|P2|COMPLETED|Overall Study||33
1458395|NCT02046772|3569549|P1|COMPLETED|Overall Study||30
1458396|NCT02046772|3569548|P2|STARTED|Overall Study||33
1458397|NCT02046772|3569549|P1|STARTED|Overall Study||30
1458398|NCT02046616|3569563|P1|NOT COMPLETED|8-Week FU Period||1
1458399|NCT02046616|3569563|P1|COMPLETED|8-Week FU Period||113
1458400|NCT02046616|3569563|P1|STARTED|8-Week FU Period||114
1458401|NCT02046616|3569563|P1|NOT COMPLETED|24-Week Treatment Period||19
1458402|NCT02046616|3569563|P1|COMPLETED|24-Week Treatment Period||114
1458403|NCT02046616|3569563|P1|STARTED|24-Week Treatment Period||133
1458404|NCT02046603|3569585|P2|NOT COMPLETED|Overall Study||75
1458405|NCT02046603|3569586|P1|NOT COMPLETED|Overall Study||15
1458406|NCT02046603|3569585|P2|COMPLETED|Overall Study||65
1458407|NCT02046603|3569586|P1|COMPLETED|Overall Study||7
1458408|NCT02046603|3569585|P2|Received at Least 1 Dose of Tocilizumab|Overall Study||140
1458409|NCT02046603|3569586|P1|Received at Least 1 Dose of Tocilizumab|Overall Study||21
1458410|NCT02046603|3569585|P2|STARTED|Overall Study||140
1458411|NCT02046603|3569586|P1|STARTED|Overall Study||22
1458412|NCT02046564|3569665|P2|NOT COMPLETED|Overall Study||20
1458413|NCT02046564|3569666|P1|NOT COMPLETED|Overall Study||15
1458414|NCT02046564|3569665|P2|COMPLETED|Overall Study||183
1458415|NCT02046564|3569666|P1|COMPLETED|Overall Study||194
1458416|NCT02046564|3569665|P2|STARTED|Overall Study||203
1458417|NCT02046564|3569666|P1|STARTED|Overall Study||209
1458418|NCT02046382|3569690|P2|NOT COMPLETED|Overall Study||20
1458419|NCT02046382|3569691|P1|NOT COMPLETED|Overall Study||8
1458420|NCT02046382|3569690|P2|COMPLETED|Overall Study||47
1458421|NCT02046382|3569691|P1|COMPLETED|Overall Study||57
1458422|NCT02046382|3569690|P2|STARTED|Overall Study||67
1458423|NCT02046382|3569691|P1|STARTED|Overall Study||65
1458424|NCT02046369|3569705|P2|NOT COMPLETED|Overall Study||18
1458425|NCT02046369|3569706|P1|NOT COMPLETED|Overall Study||14
1458426|NCT02046369|3569705|P2|COMPLETED|Overall Study||156
1458427|NCT02046369|3569706|P1|COMPLETED|Overall Study||162
1458428|NCT02046369|3569705|P2|STARTED|Overall Study||174
1458429|NCT02046369|3569706|P1|STARTED|Overall Study||176
1458430|NCT02046317|3569724|P2|NOT COMPLETED|Overall Study||0
1458431|NCT02046317|3569725|P1|NOT COMPLETED|Overall Study||0
1458432|NCT02046317|3569724|P2|COMPLETED|Overall Study||8
1458433|NCT02046317|3569725|P1|COMPLETED|Overall Study||4
1458434|NCT02046317|3569724|P2|STARTED|Overall Study||8
1458435|NCT02046317|3569725|P1|STARTED|Overall Study||4
1458436|NCT02046265|3569737|P4|NOT COMPLETED|Overall Study||2
1458437|NCT02046265|3569738|P3|NOT COMPLETED|Overall Study||2
1458438|NCT02046265|3569739|P2|NOT COMPLETED|Overall Study||2
1458439|NCT02046265|3569740|P1|NOT COMPLETED|Overall Study||1
1458440|NCT02046265|3569737|P4|COMPLETED|Overall Study||12
1458441|NCT02046265|3569738|P3|COMPLETED|Overall Study||10
1458442|NCT02046265|3569739|P2|COMPLETED|Overall Study||15
1458443|NCT02046265|3569740|P1|COMPLETED|Overall Study||16
1458444|NCT02046265|3569737|P4|STARTED|Overall Study||14
1458445|NCT02046265|3569738|P3|STARTED|Overall Study||12
1458446|NCT02046265|3569739|P2|STARTED|Overall Study||17
1458447|NCT02046265|3569740|P1|STARTED|Overall Study||17
1458448|NCT02046226|3569750|P1|NOT COMPLETED|Overall Study||7
1458449|NCT02046226|3569750|P1|COMPLETED|Overall Study||0
1458450|NCT02046226|3569750|P1|STARTED|Overall Study||7
1458451|NCT02046200|3569757|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1458452|NCT02046200|3569758|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1458453|NCT02046200|3569757|P2|COMPLETED|Second Intervention (1 Day)||6
1458454|NCT02046200|3569758|P1|COMPLETED|Second Intervention (1 Day)||5
1458455|NCT02046200|3569757|P2|STARTED|Second Intervention (1 Day)||6
1458456|NCT02046200|3569758|P1|STARTED|Second Intervention (1 Day)||5
1458457|NCT02046200|3569757|P2|NOT COMPLETED|First Intervention (1 Day)||0
1458458|NCT02046200|3569758|P1|NOT COMPLETED|First Intervention (1 Day)||0
1458459|NCT02046200|3569757|P2|COMPLETED|First Intervention (1 Day)||6
1458460|NCT02046200|3569758|P1|COMPLETED|First Intervention (1 Day)||5
1458461|NCT02046200|3569757|P2|STARTED|First Intervention (1 Day)||6
1458462|NCT02046200|3569758|P1|STARTED|First Intervention (1 Day)||5
1458463|NCT02046148|3569798|P2|NOT COMPLETED|Overall Study||3
1458464|NCT02046148|3569799|P1|NOT COMPLETED|Overall Study||1
1458465|NCT02046148|3569798|P2|COMPLETED|Overall Study||23
1458466|NCT02046148|3569799|P1|COMPLETED|Overall Study||48
1458467|NCT02046148|3569798|P2|STARTED|Overall Study||26
1458468|NCT02046148|3569799|P1|STARTED|Overall Study||49
1458469|NCT02046122|3569843|P1|NOT COMPLETED|Overall Study||9
1458470|NCT02046122|3569843|P1|COMPLETED|Overall Study||8
1458471|NCT02046122|3569843|P1|STARTED|Overall Study||17
1458472|NCT02046005|3569852|P3|NOT COMPLETED|Overall Study||10
1458473|NCT02046005|3569853|P2|NOT COMPLETED|Overall Study||7
1458474|NCT02046005|3569854|P1|NOT COMPLETED|Overall Study||8
1458475|NCT02046005|3569852|P3|COMPLETED|Overall Study||70
1458476|NCT02046005|3569853|P2|COMPLETED|Overall Study||71
1458477|NCT02046005|3569854|P1|COMPLETED|Overall Study||72
1458478|NCT02046005|3569852|P3|STARTED|Overall Study||80
1458479|NCT02046005|3569853|P2|STARTED|Overall Study||78
1458480|NCT02046005|3569854|P1|STARTED|Overall Study||80
1458481|NCT02045979|3569865|P3|NOT COMPLETED|Overall Study||1
1458482|NCT02045979|3569866|P2|NOT COMPLETED|Overall Study||1
1458483|NCT02045979|3569867|P1|NOT COMPLETED|Overall Study||2
1458484|NCT02045979|3569865|P3|COMPLETED|Overall Study||107
1458485|NCT02045979|3569866|P2|COMPLETED|Overall Study||107
1458486|NCT02045979|3569867|P1|COMPLETED|Overall Study||106
1458487|NCT02045979|3569865|P3|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
1458488|NCT02045979|3569866|P2|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
1458489|NCT02045979|3569867|P1|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
1458490|NCT02045875|3569904|P2|NOT COMPLETED|Overall Study||3
1458491|NCT02045875|3569905|P1|NOT COMPLETED|Overall Study||7
1458492|NCT02045875|3569904|P2|COMPLETED|Overall Study||20
1458493|NCT02045875|3569905|P1|COMPLETED|Overall Study||20
1458494|NCT02045875|3569904|P2|STARTED|Overall Study||23
1458495|NCT02045875|3569905|P1|STARTED|Overall Study||27
1458496|NCT02045862|3569916|P3|NOT COMPLETED|Overall Study||126
1458497|NCT02045862|3569917|P2|NOT COMPLETED|Overall Study||40
1458498|NCT02045862|3569918|P1|NOT COMPLETED|Overall Study||39
1458499|NCT02045862|3569916|P3|COMPLETED|Overall Study||1092
1458500|NCT02045862|3569917|P2|COMPLETED|Overall Study||265
1458501|NCT02045862|3569918|P1|COMPLETED|Overall Study||267
1458502|NCT02045862|3569916|P3|Treated|Overall Study||1210
1458503|NCT02045862|3569917|P2|Treated|Overall Study||303
1458504|NCT02045862|3569918|P1|Treated|Overall Study||306
1458505|NCT02045862|3569916|P3|STARTED|Overall Study||1218
1458506|NCT02045862|3569917|P2|STARTED|Overall Study||305
1458507|NCT02045862|3569918|P1|STARTED|Overall Study||306
1458508|NCT02045836|3570099|P2|NOT COMPLETED|Overall Study||14
1458509|NCT02045836|3570100|P1|NOT COMPLETED|Overall Study||9
1458510|NCT02045836|3570099|P2|COMPLETED|Overall Study||419
1458511|NCT02045836|3570100|P1|COMPLETED|Overall Study||423
1458512|NCT02045836|3570099|P2|STARTED|Overall Study||433
1458513|NCT02045836|3570100|P1|STARTED|Overall Study||432
1458514|NCT02045797|3570132|P3|NOT COMPLETED|Overall Study||1
1458515|NCT02045797|3570133|P2|NOT COMPLETED|Overall Study||7
1458516|NCT02045797|3570134|P1|NOT COMPLETED|Overall Study||7
1458517|NCT02045797|3570132|P3|COMPLETED|Overall Study||24
1458518|NCT02045797|3570133|P2|COMPLETED|Overall Study||32
1458519|NCT02045797|3570134|P1|COMPLETED|Overall Study||51
1458520|NCT02045797|3570132|P3|STARTED|Overall Study||25
1458521|NCT02045797|3570133|P2|STARTED|Overall Study||39
1458522|NCT02045797|3570134|P1|STARTED|Overall Study||58
1458523|NCT02045732|3570279|P2|NOT COMPLETED|Overall Study||1
1458524|NCT02045732|3570280|P1|NOT COMPLETED|Overall Study||1
1458525|NCT02045732|3570279|P2|COMPLETED|Overall Study||2
1458526|NCT02045732|3570280|P1|COMPLETED|Overall Study||0
1458527|NCT02045732|3570279|P2|STARTED|Overall Study||3
1458528|NCT02045732|3570280|P1|STARTED|Overall Study||1
1458529|NCT02045511|3570300|P2|NOT COMPLETED|Overall Study||0
1458530|NCT02045511|3570301|P1|NOT COMPLETED|Overall Study||0
1458531|NCT02045511|3570300|P2|COMPLETED|Overall Study||7
1458532|NCT02045511|3570301|P1|COMPLETED|Overall Study||8
1458533|NCT02045511|3570300|P2|STARTED|Overall Study||7
1458534|NCT02045511|3570301|P1|STARTED|Overall Study||8
1458535|NCT02045264|3570317|P1|NOT COMPLETED|Overall Study||0
1458536|NCT02045264|3570317|P1|COMPLETED|Overall Study||12
1458537|NCT02045264|3570317|P1|STARTED|Overall Study||12
1458538|NCT02045238|3570334|P2|NOT COMPLETED|Overall Study||1
1458539|NCT02045238|3570335|P1|NOT COMPLETED|Overall Study||7
1458540|NCT02045238|3570334|P2|COMPLETED|Overall Study||14
1458541|NCT02045238|3570335|P1|COMPLETED|Overall Study||9
1458542|NCT02045238|3570334|P2|STARTED|Overall Study||15
1458543|NCT02045238|3570335|P1|STARTED|Overall Study||16
1458544|NCT02045108|3570347|P4|NOT COMPLETED|Overall Study||1
1458545|NCT02045108|3570348|P3|NOT COMPLETED|Overall Study||2
1458546|NCT02045108|3570349|P2|NOT COMPLETED|Overall Study||3
1458547|NCT02045108|3570350|P1|NOT COMPLETED|Overall Study||1
1458548|NCT02045108|3570347|P4|COMPLETED|Overall Study||19
1458549|NCT02045108|3570348|P3|COMPLETED|Overall Study||18
1458550|NCT02045108|3570349|P2|COMPLETED|Overall Study||12
1458551|NCT02045108|3570350|P1|COMPLETED|Overall Study||21
1458552|NCT02045108|3570347|P4|STARTED|Overall Study||20
1458553|NCT02045108|3570348|P3|STARTED|Overall Study||20
1458554|NCT02045108|3570349|P2|STARTED|Overall Study||15
1458555|NCT02045108|3570350|P1|STARTED|Overall Study||22
1458556|NCT02044991|3570398|P2|NOT COMPLETED|Overall Study||0
1458557|NCT02044991|3570399|P1|NOT COMPLETED|Overall Study||0
1458558|NCT02044991|3570398|P2|COMPLETED|Overall Study||0
1458559|NCT02044991|3570399|P1|COMPLETED|Overall Study||2
1458560|NCT02044991|3570398|P2|STARTED|Overall Study||0
1458561|NCT02044991|3570399|P1|STARTED|Overall Study||2
1458562|NCT02044848|3570411|P2|NOT COMPLETED|Overall Study||3
1458563|NCT02044848|3570412|P1|NOT COMPLETED|Overall Study||2
1458564|NCT02044848|3570411|P2|COMPLETED|Overall Study||0
1458565|NCT02044848|3570412|P1|COMPLETED|Overall Study||0
1458566|NCT02044848|3570411|P2|STARTED|Overall Study||3
1458567|NCT02044848|3570412|P1|STARTED|Overall Study||2
1458568|NCT02044822|3570418|P1|NOT COMPLETED|Overall Study||93
1458569|NCT02044822|3570418|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
1458570|NCT02044822|3570418|P1|STARTED|Overall Study||102
1458571|NCT02044458|3570430|P2|NOT COMPLETED|Overall Study||8
1458572|NCT02044458|3570431|P1|NOT COMPLETED|Overall Study||3
1458573|NCT02044458|3570430|P2|COMPLETED|Overall Study||61
1458574|NCT02044458|3570431|P1|COMPLETED|Overall Study||62
1458575|NCT02044458|3570430|P2|STARTED|Overall Study||69
1458576|NCT02044458|3570431|P1|STARTED|Overall Study||65
1458577|NCT02044419|3570444|P3|NOT COMPLETED|Third Intervention||0
1458578|NCT02044419|3570445|P2|NOT COMPLETED|Third Intervention||0
1458579|NCT02044419|3570446|P1|NOT COMPLETED|Third Intervention||0
1458580|NCT02044419|3570444|P3|COMPLETED|Third Intervention||10
1458581|NCT02044419|3570445|P2|COMPLETED|Third Intervention||9
1458582|NCT02044419|3570446|P1|COMPLETED|Third Intervention||11
1458583|NCT02044419|3570444|P3|STARTED|Third Intervention||10
1458584|NCT02044419|3570445|P2|STARTED|Third Intervention||9
1458585|NCT02044419|3570446|P1|STARTED|Third Intervention||11
1458586|NCT02044419|3570444|P3|NOT COMPLETED|Second Intervention||0
1458587|NCT02044419|3570445|P2|NOT COMPLETED|Second Intervention||0
1458588|NCT02044419|3570446|P1|NOT COMPLETED|Second Intervention||0
1458589|NCT02044419|3570444|P3|COMPLETED|Second Intervention||10
1458590|NCT02044419|3570445|P2|COMPLETED|Second Intervention||9
1458591|NCT02044419|3570446|P1|COMPLETED|Second Intervention||11
1458592|NCT02044419|3570444|P3|STARTED|Second Intervention||10
1458593|NCT02044419|3570445|P2|STARTED|Second Intervention||9
1458594|NCT02044419|3570446|P1|STARTED|Second Intervention||11
1458595|NCT02044419|3570444|P3|NOT COMPLETED|First Intervention||1
1458596|NCT02044419|3570445|P2|NOT COMPLETED|First Intervention||1
1458597|NCT02044419|3570446|P1|NOT COMPLETED|First Intervention||0
1458598|NCT02044419|3570444|P3|COMPLETED|First Intervention||10
1458599|NCT02044419|3570445|P2|COMPLETED|First Intervention||9
1458600|NCT02044419|3570446|P1|COMPLETED|First Intervention||11
1458601|NCT02044419|3570444|P3|STARTED|First Intervention||11
1458602|NCT02044419|3570445|P2|STARTED|First Intervention||10
1458603|NCT02044419|3570446|P1|STARTED|First Intervention||11
1458604|NCT02044393|3570471|P2|NOT COMPLETED|Period 2||0
1458605|NCT02044393|3570472|P1|NOT COMPLETED|Period 2||0
1458606|NCT02044393|3570471|P2|COMPLETED|Period 2||10
1458607|NCT02044393|3570472|P1|COMPLETED|Period 2||10
1458608|NCT02044393|3570471|P2|STARTED|Period 2||10
1458609|NCT02044393|3570472|P1|STARTED|Period 2||10
1458610|NCT02044393|3570471|P2|NOT COMPLETED|Period 1||0
1458611|NCT02044393|3570472|P1|NOT COMPLETED|Period 1||0
1458612|NCT02044393|3570471|P2|COMPLETED|Period 1||10
1458613|NCT02044393|3570472|P1|COMPLETED|Period 1||10
1458614|NCT02044393|3570471|P2|STARTED|Period 1||10
1458615|NCT02044393|3570472|P1|STARTED|Period 1||10
1458616|NCT02044380|3570485|P1|NOT COMPLETED|Overall Study||0
1458617|NCT02044380|3570485|P1|COMPLETED|Overall Study||14
1458618|NCT02044380|3570485|P1|STARTED|Overall Study|Started are the treated patients|14
1458619|NCT02044367|3570489|P6|NOT COMPLETED|Overall Study||0
1458620|NCT02044367|3570490|P5|NOT COMPLETED|Overall Study||0
1458621|NCT02044367|3570491|P4|NOT COMPLETED|Overall Study||0
1458622|NCT02044367|3570492|P3|NOT COMPLETED|Overall Study||0
1458623|NCT02044367|3570493|P2|NOT COMPLETED|Overall Study||0
1458624|NCT02044367|3570494|P1|NOT COMPLETED|Overall Study||0
1458625|NCT02044367|3570489|P6|COMPLETED|Overall Study||9
1458626|NCT02044367|3570490|P5|COMPLETED|Overall Study||9
1458627|NCT02044367|3570491|P4|COMPLETED|Overall Study||9
1458628|NCT02044367|3570492|P3|COMPLETED|Overall Study||9
1458629|NCT02044367|3570493|P2|COMPLETED|Overall Study||9
1458630|NCT02044367|3570494|P1|COMPLETED|Overall Study||9
1458631|NCT02044367|3570489|P6|STARTED|Overall Study||9
1458632|NCT02044367|3570490|P5|STARTED|Overall Study||9
1458633|NCT02044367|3570491|P4|STARTED|Overall Study||9
1458634|NCT02044367|3570492|P3|STARTED|Overall Study||9
1458635|NCT02044367|3570493|P2|STARTED|Overall Study||9
1458636|NCT02044367|3570494|P1|STARTED|Overall Study||9
1458637|NCT02044302|3570517|P2|NOT COMPLETED|Overall Study||0
1458638|NCT02044302|3570518|P1|NOT COMPLETED|Overall Study||2
1458639|NCT02044302|3570517|P2|COMPLETED|Overall Study||0
1458640|NCT02044302|3570518|P1|COMPLETED|Overall Study||0
1458641|NCT02044302|3570517|P2|STARTED|Overall Study||0
1458642|NCT02044302|3570518|P1|STARTED|Overall Study||2
1458643|NCT02044094|3570524|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
1458644|NCT02044094|3570524|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
1458645|NCT02044094|3570524|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
1458646|NCT02044094|3570524|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
1458647|NCT02044094|3570524|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
1458648|NCT02044094|3570524|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
1458649|NCT02044094|3570524|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
1458650|NCT02044094|3570524|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
1458651|NCT02043938|3570581|P1|NOT COMPLETED|Overall Study||10
1458652|NCT02043938|3570581|P1|COMPLETED|Overall Study||36
1458653|NCT02043938|3570581|P1|STARTED|Overall Study||46
1458654|NCT02043808|3570593|P2|NOT COMPLETED|Overall Study||0
1458655|NCT02043808|3570594|P1|NOT COMPLETED|Overall Study||0
1458656|NCT02043808|3570593|P2|COMPLETED|Overall Study||12793
1458657|NCT02043808|3570594|P1|COMPLETED|Overall Study||12793
1458658|NCT02043808|3570593|P2|STARTED|Overall Study||12793
1458659|NCT02043808|3570594|P1|STARTED|Overall Study||12793
1458660|NCT02043782|3570632|P6|NOT COMPLETED|Period 3||0
1458661|NCT02043782|3570633|P5|NOT COMPLETED|Period 3||0
1458662|NCT02043782|3570634|P4|NOT COMPLETED|Period 3||0
1458663|NCT02043782|3570635|P3|NOT COMPLETED|Period 3||0
1458664|NCT02043782|3570636|P2|NOT COMPLETED|Period 3||0
1458665|NCT02043782|3570637|P1|NOT COMPLETED|Period 3||0
1458666|NCT02043782|3570632|P6|COMPLETED|Period 3||6
1458667|NCT02043782|3570633|P5|COMPLETED|Period 3||6
1458668|NCT02043782|3570634|P4|COMPLETED|Period 3||6
1458669|NCT02043782|3570635|P3|COMPLETED|Period 3||6
1458670|NCT02043782|3570636|P2|COMPLETED|Period 3||6
1458671|NCT02043782|3570637|P1|COMPLETED|Period 3||7
1458672|NCT02043782|3570632|P6|STARTED|Period 3||6
1458673|NCT02043782|3570633|P5|STARTED|Period 3||6
1458674|NCT02043782|3570634|P4|STARTED|Period 3||6
1458675|NCT02043782|3570635|P3|STARTED|Period 3||6
1458676|NCT02043782|3570636|P2|STARTED|Period 3||6
1458677|NCT02043782|3570637|P1|STARTED|Period 3||7
1458678|NCT02043782|3570632|P6|NOT COMPLETED|Period 2||0
1458679|NCT02043782|3570633|P5|NOT COMPLETED|Period 2||0
1458680|NCT02043782|3570634|P4|NOT COMPLETED|Period 2||0
1458681|NCT02043782|3570635|P3|NOT COMPLETED|Period 2||0
1458682|NCT02043782|3570636|P2|NOT COMPLETED|Period 2||0
1458683|NCT02043782|3570637|P1|NOT COMPLETED|Period 2||0
1458684|NCT02043782|3570632|P6|COMPLETED|Period 2||6
1458685|NCT02043782|3570633|P5|COMPLETED|Period 2||6
1458686|NCT02043782|3570634|P4|COMPLETED|Period 2||6
1458687|NCT02043782|3570635|P3|COMPLETED|Period 2||6
1458688|NCT02043782|3570636|P2|COMPLETED|Period 2||6
1458689|NCT02043782|3570637|P1|COMPLETED|Period 2||7
1458690|NCT02043782|3570632|P6|STARTED|Period 2||6
1458691|NCT02043782|3570633|P5|STARTED|Period 2||6
1458692|NCT02043782|3570634|P4|STARTED|Period 2||6
1458693|NCT02043782|3570635|P3|STARTED|Period 2||6
1458694|NCT02043782|3570636|P2|STARTED|Period 2||6
1458695|NCT02043782|3570637|P1|STARTED|Period 2||7
1458696|NCT02043782|3570632|P6|NOT COMPLETED|Period 1||0
1458697|NCT02043782|3570633|P5|NOT COMPLETED|Period 1||0
1458698|NCT02043782|3570634|P4|NOT COMPLETED|Period 1||0
1458699|NCT02043782|3570635|P3|NOT COMPLETED|Period 1||1
1458700|NCT02043782|3570636|P2|NOT COMPLETED|Period 1||0
1458701|NCT02043782|3570637|P1|NOT COMPLETED|Period 1||0
1458702|NCT02043782|3570632|P6|COMPLETED|Period 1||6
1458703|NCT02043782|3570633|P5|COMPLETED|Period 1||6
1458704|NCT02043782|3570634|P4|COMPLETED|Period 1||6
1458705|NCT02043782|3570635|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
1458706|NCT02043782|3570636|P2|COMPLETED|Period 1||6
1458707|NCT02043782|3570637|P1|COMPLETED|Period 1||7
1458708|NCT02043782|3570632|P6|STARTED|Period 1||6
1458709|NCT02043782|3570633|P5|STARTED|Period 1||6
1458710|NCT02043782|3570634|P4|STARTED|Period 1||6
1458711|NCT02043782|3570635|P3|STARTED|Period 1||7
1458712|NCT02043782|3570636|P2|STARTED|Period 1||6
1458713|NCT02043782|3570637|P1|STARTED|Period 1||7
1458714|NCT02043704|3570647|P2|NOT COMPLETED|Overall Study||7
1458715|NCT02043704|3570648|P1|NOT COMPLETED|Overall Study||3
1458716|NCT02043704|3570647|P2|COMPLETED|Overall Study||43
1458717|NCT02043704|3570648|P1|COMPLETED|Overall Study||47
1458718|NCT02043704|3570647|P2|STARTED|Overall Study||50
1458719|NCT02043704|3570648|P1|STARTED|Overall Study||50
1458720|NCT02043652|3570678|P1|NOT COMPLETED|Overall Study||26
1458721|NCT02043652|3570678|P1|COMPLETED|Overall Study||93
1458722|NCT02043652|3570678|P1|STARTED|Overall Study||119
1458723|NCT02043379|3570685|P2|NOT COMPLETED|Overall Study||0
1458724|NCT02043379|3570686|P1|NOT COMPLETED|Overall Study||0
1458725|NCT02043379|3570685|P2|COMPLETED|Overall Study||20
1458726|NCT02043379|3570686|P1|COMPLETED|Overall Study||30
1458727|NCT02043379|3570685|P2|STARTED|Overall Study||20
1458728|NCT02043379|3570686|P1|STARTED|Overall Study||30
1458729|NCT02043366|3570748|P6|NOT COMPLETED|Overall Study||2
1458730|NCT02043366|3570749|P5|NOT COMPLETED|Overall Study||2
1458731|NCT02043366|3570750|P4|NOT COMPLETED|Overall Study||2
1458732|NCT02043366|3570751|P3|NOT COMPLETED|Overall Study||2
1458733|NCT02043366|3570752|P2|NOT COMPLETED|Overall Study||2
1458734|NCT02043366|3570753|P1|NOT COMPLETED|Overall Study||2
1458735|NCT02043366|3570748|P6|COMPLETED|Overall Study||28
1458736|NCT02043366|3570749|P5|COMPLETED|Overall Study||28
1458737|NCT02043366|3570750|P4|COMPLETED|Overall Study||28
1458738|NCT02043366|3570751|P3|COMPLETED|Overall Study||28
1458739|NCT02043366|3570752|P2|COMPLETED|Overall Study||28
1458740|NCT02043366|3570753|P1|COMPLETED|Overall Study||28
1458741|NCT02043366|3570748|P6|STARTED|Overall Study||30
1458742|NCT02043366|3570749|P5|STARTED|Overall Study||30
1458743|NCT02043366|3570750|P4|STARTED|Overall Study||30
1458744|NCT02043366|3570751|P3|STARTED|Overall Study||30
1458745|NCT02043366|3570752|P2|STARTED|Overall Study||30
1458746|NCT02043366|3570753|P1|STARTED|Overall Study||30
1458747|NCT02043197|3570773|P1|NOT COMPLETED|Overall Study||8
1458748|NCT02043197|3570773|P1|COMPLETED|Overall Study||292
1458749|NCT02043197|3570773|P1|STARTED|Overall Study||300
1458750|NCT02043145|3570797|P3|NOT COMPLETED|Overall Study||0
1458751|NCT02043145|3570798|P2|NOT COMPLETED|Overall Study||0
1458752|NCT02043145|3570799|P1|NOT COMPLETED|Overall Study||0
1458753|NCT02043145|3570797|P3|COMPLETED|Overall Study||425
1458754|NCT02043145|3570798|P2|COMPLETED|Overall Study||247
1458755|NCT02043145|3570799|P1|COMPLETED|Overall Study||55
1458756|NCT02043145|3570797|P3|STARTED|Overall Study||425
1458757|NCT02043145|3570798|P2|STARTED|Overall Study||247
1458758|NCT02043145|3570799|P1|STARTED|Overall Study||55
1458759|NCT02043132|3570812|P2|NOT COMPLETED|Overall Study||9
1458760|NCT02043132|3570813|P1|NOT COMPLETED|Overall Study||5
1458761|NCT02043132|3570812|P2|COMPLETED|Overall Study||49
1458762|NCT02043132|3570813|P1|COMPLETED|Overall Study||53
1458763|NCT02043132|3570812|P2|STARTED|Overall Study||58
1458764|NCT02043132|3570813|P1|STARTED|Overall Study||58
1458765|NCT02043015|3570833|P1|NOT COMPLETED|Overall Study||28
1458766|NCT02043015|3570833|P1|COMPLETED|Overall Study||87
1458767|NCT02043015|3570833|P1|STARTED|Overall Study||115
1458768|NCT02042924|3570846|P1|NOT COMPLETED|Overall Study||1
1458769|NCT02042924|3570846|P1|COMPLETED|Overall Study||1
1458770|NCT02042924|3570846|P1|STARTED|Overall Study||2
1458771|NCT02042911|3570852|P1|NOT COMPLETED|Overall Study||1
1458772|NCT02042911|3570852|P1|COMPLETED|Overall Study||9
1458773|NCT02042911|3570852|P1|STARTED|Overall Study||10
1458774|NCT02042872|3570866|P2|NOT COMPLETED|Overall Study||5
1458775|NCT02042872|3570867|P1|NOT COMPLETED|Overall Study||0
1458776|NCT02042872|3570866|P2|COMPLETED|Overall Study||8
1458777|NCT02042872|3570867|P1|COMPLETED|Overall Study||8
1458778|NCT02042872|3570866|P2|STARTED|Overall Study||13
1458779|NCT02042872|3570867|P1|STARTED|Overall Study||8
1458780|NCT02042534|3570877|P2|NOT COMPLETED|Overall Study||0
1458781|NCT02042534|3570878|P1|NOT COMPLETED|Overall Study||0
1458782|NCT02042534|3570877|P2|COMPLETED|Overall Study||94
1458783|NCT02042534|3570878|P1|COMPLETED|Overall Study||101
1458784|NCT02042534|3570877|P2|STARTED|Overall Study||94
1458785|NCT02042534|3570878|P1|STARTED|Overall Study||101
1458786|NCT02042443|3570894|P2|NOT COMPLETED|Overall Study||26
1458787|NCT02042443|3570895|P1|NOT COMPLETED|Overall Study||27
1458788|NCT02042443|3570894|P2|COMPLETED|Overall Study||0
1458789|NCT02042443|3570895|P1|COMPLETED|Overall Study||0
1458790|NCT02042443|3570894|P2|Eligible and Analyzable|Overall Study||20
1458791|NCT02042443|3570895|P1|Eligible and Analyzable|Overall Study||24
1458792|NCT02042443|3570894|P2|STARTED|Overall Study||26
1458793|NCT02042443|3570895|P1|STARTED|Overall Study||27
1458794|NCT02042404|3570907|P2|NOT COMPLETED|Overall Study||0
1458795|NCT02042404|3570908|P1|NOT COMPLETED|Overall Study||5
1458796|NCT02042404|3570907|P2|COMPLETED|Overall Study||5
1458797|NCT02042404|3570908|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
1458798|NCT02042404|3570907|P2|STARTED|Overall Study||5
1458799|NCT02042404|3570908|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
1458800|NCT02042274|3570919|P1|NOT COMPLETED|Overall Study||0
1458801|NCT02042274|3570919|P1|COMPLETED|Overall Study||12
1458802|NCT02042274|3570919|P1|STARTED|Overall Study||12
1458803|NCT02042131|3570927|P3|NOT COMPLETED|Overall Study||0
1458804|NCT02042131|3570928|P2|NOT COMPLETED|Overall Study||0
1458805|NCT02042131|3570929|P1|NOT COMPLETED|Overall Study||0
1458806|NCT02042131|3570927|P3|COMPLETED|Overall Study||33
1458807|NCT02042131|3570928|P2|COMPLETED|Overall Study||32
1458808|NCT02042131|3570929|P1|COMPLETED|Overall Study||32
1458809|NCT02042131|3570927|P3|STARTED|Overall Study||33
1458810|NCT02042131|3570928|P2|STARTED|Overall Study||32
1458811|NCT02042131|3570929|P1|STARTED|Overall Study||32
1458812|NCT02041533|3570948|P2|NOT COMPLETED|Overall Study||258
1458813|NCT02041533|3570949|P1|NOT COMPLETED|Overall Study||228
1458814|NCT02041533|3570948|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
1458815|NCT02041533|3570949|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
1458816|NCT02041533|3570948|P2|Began Treatment|Overall Study||263
1458817|NCT02041533|3570949|P1|Began Treatment|Overall Study||267
1458818|NCT02041533|3570948|P2|STARTED|Overall Study||270
1458819|NCT02041533|3570949|P1|STARTED|Overall Study||271
1458820|NCT02041520|3570971|P2|NOT COMPLETED|Overall Study||7
1458821|NCT02041520|3570972|P1|NOT COMPLETED|Overall Study||6
1458822|NCT02041520|3570971|P2|COMPLETED|Overall Study||28
1458823|NCT02041520|3570972|P1|COMPLETED|Overall Study||29
1458824|NCT02041520|3570971|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
1458825|NCT02041520|3570972|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
1458826|NCT02041377|3570992|P1|NOT COMPLETED|Overall Study||0
1458827|NCT02041377|3570992|P1|COMPLETED|Overall Study||134
1458828|NCT02041377|3570992|P1|STARTED|Overall Study||134
1458829|NCT02041325|3571002|P2|NOT COMPLETED|Overall Study||3
1458830|NCT02041325|3571003|P1|NOT COMPLETED|Overall Study||3
1458831|NCT02041325|3571002|P2|COMPLETED|Overall Study||13
1458832|NCT02041325|3571003|P1|COMPLETED|Overall Study||19
1458833|NCT02041325|3571002|P2|STARTED|Overall Study||16
1458834|NCT02041325|3571003|P1|STARTED|Overall Study||22
1458835|NCT02041286|3571015|P1|NOT COMPLETED|Overall Study||1
1458836|NCT02041286|3571015|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
1458837|NCT02041286|3571015|P1|STARTED|Overall Study||136
1458838|NCT02041221|3571029|P6|NOT COMPLETED|Part 2||0
1458839|NCT02041221|3571030|P5|NOT COMPLETED|Part 2||0
1458840|NCT02041221|3571031|P4|NOT COMPLETED|Part 2||0
1458841|NCT02041221|3571032|P3|NOT COMPLETED|Part 2||1
1458842|NCT02041221|3571033|P2|NOT COMPLETED|Part 2||0
1458843|NCT02041221|3571034|P1|NOT COMPLETED|Part 2||0
1458844|NCT02041221|3571029|P6|COMPLETED|Part 2||6
1458845|NCT02041221|3571030|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
1458846|NCT02041221|3571031|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
1458847|NCT02041221|3571032|P3|COMPLETED|Part 2||5
1458848|NCT02041221|3571033|P2|COMPLETED|Part 2||6
1458849|NCT02041221|3571034|P1|COMPLETED|Part 2||6
1458850|NCT02041221|3571029|P6|STARTED|Part 2||6
1458851|NCT02041221|3571030|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
1458852|NCT02041221|3571031|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
1458853|NCT02041221|3571032|P3|STARTED|Part 2||6
1458854|NCT02041221|3571033|P2|STARTED|Part 2||6
1458855|NCT02041221|3571034|P1|STARTED|Part 2||6
1458856|NCT02041221|3571029|P6|NOT COMPLETED|Part 1||0
1458857|NCT02041221|3571030|P5|NOT COMPLETED|Part 1||0
1458858|NCT02041221|3571031|P4|NOT COMPLETED|Part 1||0
1458859|NCT02041221|3571032|P3|NOT COMPLETED|Part 1||0
1458860|NCT02041221|3571033|P2|NOT COMPLETED|Part 1||0
1458861|NCT02041221|3571034|P1|NOT COMPLETED|Part 1||0
1458862|NCT02041221|3571029|P6|COMPLETED|Part 1||10
1458863|NCT02041221|3571030|P5|COMPLETED|Part 1||6
1458864|NCT02041221|3571031|P4|COMPLETED|Part 1||6
1458865|NCT02041221|3571032|P3|COMPLETED|Part 1||6
1458866|NCT02041221|3571033|P2|COMPLETED|Part 1||6
1458867|NCT02041221|3571034|P1|COMPLETED|Part 1||6
1458868|NCT02041221|3571029|P6|STARTED|Part 1||10
1458869|NCT02041221|3571030|P5|STARTED|Part 1||6
1458870|NCT02041221|3571031|P4|STARTED|Part 1||6
1458871|NCT02041221|3571032|P3|STARTED|Part 1||6
1458872|NCT02041221|3571033|P2|STARTED|Part 1||6
1458873|NCT02041221|3571034|P1|STARTED|Part 1||6
1458874|NCT02041091|3571050|P2|NOT COMPLETED|Optional Safety Extension Period||82
1458875|NCT02041091|3571051|P1|NOT COMPLETED|Optional Safety Extension Period||85
1458876|NCT02041091|3571050|P2|COMPLETED|Optional Safety Extension Period||0
1458877|NCT02041091|3571051|P1|COMPLETED|Optional Safety Extension Period||0
1458878|NCT02041091|3571050|P2|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
1458879|NCT02041091|3571051|P1|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
1458880|NCT02041091|3571050|P2|NOT COMPLETED|Treatment||23
1458881|NCT02041091|3571051|P1|NOT COMPLETED|Treatment||22
1458882|NCT02041091|3571050|P2|COMPLETED|Treatment||91
1458883|NCT02041091|3571051|P1|COMPLETED|Treatment||90
1458884|NCT02041091|3571050|P2|Participated in Follow Up|Treatment||96
1458885|NCT02041091|3571051|P1|Participated in Follow Up|Treatment||106
1458886|NCT02041091|3571050|P2|Received At Least One Dose of Study Drug|Treatment||114
1458887|NCT02041091|3571051|P1|Received At Least One Dose of Study Drug|Treatment||112
1458888|NCT02041091|3571050|P2|STARTED|Treatment||114
1458889|NCT02041091|3571051|P1|STARTED|Treatment||112
1458890|NCT02040844|3571076|P3|NOT COMPLETED|Overall Study||47
1458891|NCT02040844|3571077|P2|NOT COMPLETED|Overall Study||39
1458892|NCT02040844|3571078|P1|NOT COMPLETED|Overall Study||50
1458893|NCT02040844|3571076|P3|COMPLETED|Overall Study||97
1458894|NCT02040844|3571077|P2|COMPLETED|Overall Study||109
1458895|NCT02040844|3571078|P1|COMPLETED|Overall Study||88
1458896|NCT02040844|3571076|P3|STARTED|Overall Study||144
1458897|NCT02040844|3571077|P2|STARTED|Overall Study||148
1458898|NCT02040844|3571078|P1|STARTED|Overall Study||138
1458899|NCT02040792|3571106|P5|NOT COMPLETED|Overall Study||7
1458900|NCT02040792|3571107|P4|NOT COMPLETED|Overall Study||7
1458901|NCT02040792|3571108|P3|NOT COMPLETED|Overall Study||3
1458902|NCT02040792|3571109|P2|NOT COMPLETED|Overall Study||3
1458903|NCT02040792|3571110|P1|NOT COMPLETED|Overall Study||6
1458904|NCT02040792|3571106|P5|COMPLETED|Overall Study||67
1458905|NCT02040792|3571107|P4|COMPLETED|Overall Study||64
1458906|NCT02040792|3571108|P3|COMPLETED|Overall Study||68
1458907|NCT02040792|3571109|P2|COMPLETED|Overall Study||65
1458908|NCT02040792|3571110|P1|COMPLETED|Overall Study||64
1458909|NCT02040792|3571106|P5|STARTED|Overall Study||74
1458910|NCT02040792|3571107|P4|STARTED|Overall Study||71
1458911|NCT02040792|3571108|P3|STARTED|Overall Study||71
1458912|NCT02040792|3571109|P2|STARTED|Overall Study||68
1458913|NCT02040792|3571110|P1|STARTED|Overall Study||70
1458914|NCT02040779|3571125|P3|NOT COMPLETED|Overall Study||4
1458915|NCT02040779|3571126|P2|NOT COMPLETED|Overall Study||7
1458916|NCT02040779|3571127|P1|NOT COMPLETED|Overall Study||12
1458917|NCT02040779|3571125|P3|COMPLETED|Overall Study||88
1458918|NCT02040779|3571126|P2|COMPLETED|Overall Study||83
1458919|NCT02040779|3571127|P1|COMPLETED|Overall Study||79
1458920|NCT02040779|3571125|P3|Full Analysis Set (FAS)|Overall Study||92
1458921|NCT02040779|3571126|P2|Full Analysis Set (FAS)|Overall Study||88
1458922|NCT02040779|3571127|P1|Full Analysis Set (FAS)|Overall Study||90
1458923|NCT02040779|3571125|P3|STARTED|Overall Study||92
1458924|NCT02040779|3571126|P2|STARTED|Overall Study||90
1458925|NCT02040779|3571127|P1|STARTED|Overall Study||91
1458926|NCT02040766|3571167|P5|NOT COMPLETED|Overall Study||13
1458927|NCT02040766|3571168|P4|NOT COMPLETED|Overall Study||13
1458928|NCT02040766|3571169|P3|NOT COMPLETED|Overall Study||12
1458929|NCT02040766|3571170|P2|NOT COMPLETED|Overall Study||10
1458930|NCT02040766|3571171|P1|NOT COMPLETED|Overall Study||18
1458931|NCT02040766|3571167|P5|COMPLETED|Overall Study||112
1458932|NCT02040766|3571168|P4|COMPLETED|Overall Study||112
1458933|NCT02040766|3571169|P3|COMPLETED|Overall Study||113
1458934|NCT02040766|3571170|P2|COMPLETED|Overall Study||116
1458935|NCT02040766|3571171|P1|COMPLETED|Overall Study||109
1458936|NCT02040766|3571167|P5|STARTED|Overall Study||125
1458937|NCT02040766|3571168|P4|STARTED|Overall Study||125
1458938|NCT02040766|3571169|P3|STARTED|Overall Study||125
1458939|NCT02040766|3571170|P2|STARTED|Overall Study||126
1458940|NCT02040766|3571171|P1|STARTED|Overall Study||127
1458941|NCT02040623|3571212|P3|NOT COMPLETED|Overall Study||2
1458942|NCT02040623|3571213|P2|NOT COMPLETED|Overall Study||6
1458943|NCT02040623|3571214|P1|NOT COMPLETED|Overall Study||4
1458944|NCT02040623|3571212|P3|COMPLETED|Overall Study||10
1458945|NCT02040623|3571213|P2|COMPLETED|Overall Study||6
1458946|NCT02040623|3571214|P1|COMPLETED|Overall Study||7
1458947|NCT02040623|3571212|P3|STARTED|Overall Study||12
1458948|NCT02040623|3571213|P2|STARTED|Overall Study||12
1458949|NCT02040623|3571214|P1|STARTED|Overall Study||11
1458950|NCT02040532|3571222|P1|NOT COMPLETED|Overall Study||12
1458951|NCT02040532|3571222|P1|COMPLETED|Overall Study||20
1458952|NCT02040532|3571222|P1|Received at Least One Dose of Medication|Overall Study||26
1458953|NCT02040532|3571222|P1|STARTED|Overall Study||32
1458954|NCT02040428|3571235|P2|NOT COMPLETED|Overall Study||4
1458955|NCT02040428|3571236|P1|NOT COMPLETED|Overall Study||5
1458956|NCT02040428|3571235|P2|COMPLETED|Overall Study||77
1458957|NCT02040428|3571236|P1|COMPLETED|Overall Study||70
1458958|NCT02040428|3571235|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
1458959|NCT02040428|3571236|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
1458960|NCT02040428|3571235|P2|STARTED|Overall Study||81
1458961|NCT02040428|3571236|P1|STARTED|Overall Study||75
1458962|NCT02040116|3571248|P1|NOT COMPLETED|Overall Study||0
1458963|NCT02040116|3571248|P1|COMPLETED|Overall Study||19
1458964|NCT02040116|3571248|P1|STARTED|Overall Study||19
1458965|NCT02040077|3571259|P3|NOT COMPLETED|Overall Study||0
1458966|NCT02040077|3571260|P2|NOT COMPLETED|Overall Study||0
1458967|NCT02040077|3571261|P1|NOT COMPLETED|Overall Study||0
1458968|NCT02040077|3571259|P3|COMPLETED|Overall Study||25
1458969|NCT02040077|3571260|P2|COMPLETED|Overall Study||24
1458970|NCT02040077|3571261|P1|COMPLETED|Overall Study||27
1458971|NCT02040077|3571259|P3|STARTED|Overall Study||25
1458972|NCT02040077|3571260|P2|STARTED|Overall Study||24
1458973|NCT02040077|3571261|P1|STARTED|Overall Study||27
1458974|NCT02039817|3571274|P2|NOT COMPLETED|Overall Study||0
1458975|NCT02039817|3571275|P1|NOT COMPLETED|Overall Study||0
1458976|NCT02039817|3571274|P2|COMPLETED|Overall Study||8
1458977|NCT02039817|3571275|P1|COMPLETED|Overall Study||8
1458978|NCT02039817|3571274|P2|STARTED|Overall Study||8
1458979|NCT02039817|3571275|P1|STARTED|Overall Study||8
1458980|NCT02039778|3571284|P1|NOT COMPLETED|Overall Study||4
1458981|NCT02039778|3571284|P1|COMPLETED|Overall Study||0
1458982|NCT02039778|3571284|P1|STARTED|Overall Study||4
1458983|NCT02039687|3571296|P4|NOT COMPLETED|Overall Study||0
1458984|NCT02039687|3571297|P3|NOT COMPLETED|Overall Study||3
1458985|NCT02039687|3571298|P2|NOT COMPLETED|Overall Study||1
1458986|NCT02039687|3571299|P1|NOT COMPLETED|Overall Study||0
1458987|NCT02039687|3571296|P4|COMPLETED|Overall Study||16
1458988|NCT02039687|3571297|P3|COMPLETED|Overall Study||13
1458989|NCT02039687|3571298|P2|COMPLETED|Overall Study||15
1458990|NCT02039687|3571299|P1|COMPLETED|Overall Study||16
1458991|NCT02039687|3571296|P4|STARTED|Overall Study||16
1458992|NCT02039687|3571297|P3|STARTED|Overall Study||16
1458993|NCT02039687|3571298|P2|STARTED|Overall Study||16
1458994|NCT02039687|3571299|P1|STARTED|Overall Study||16
1458995|NCT02039674|3571334|P9|NOT COMPLETED|Overall Study||45
1458996|NCT02039674|3571335|P8|NOT COMPLETED|Overall Study||63
1458997|NCT02039674|3571336|P7|NOT COMPLETED|Overall Study||60
1458998|NCT02039674|3571337|P6|NOT COMPLETED|Overall Study||7
1458999|NCT02039674|3571338|P5|NOT COMPLETED|Overall Study||12
1459000|NCT02039674|3571339|P4|NOT COMPLETED|Overall Study||6
1459001|NCT02039674|3571340|P3|NOT COMPLETED|Overall Study||24
1459002|NCT02039674|3571341|P2|NOT COMPLETED|Overall Study||25
1459003|NCT02039674|3571342|P1|NOT COMPLETED|Overall Study||24
1459004|NCT02039674|3571334|P9|COMPLETED|Overall Study||0
1459005|NCT02039674|3571335|P8|COMPLETED|Overall Study||0
1459006|NCT02039674|3571336|P7|COMPLETED|Overall Study||0
1459007|NCT02039674|3571337|P6|COMPLETED|Overall Study||0
1459008|NCT02039674|3571338|P5|COMPLETED|Overall Study||0
1459009|NCT02039674|3571339|P4|COMPLETED|Overall Study||0
1459010|NCT02039674|3571340|P3|COMPLETED|Overall Study||0
1459011|NCT02039674|3571341|P2|COMPLETED|Overall Study||0
1459012|NCT02039674|3571342|P1|COMPLETED|Overall Study||1
1459013|NCT02039674|3571334|P9|Treated|Overall Study||45
1459014|NCT02039674|3571335|P8|Treated|Overall Study|One participant was randomized but did not receive study treatment|62
1459015|NCT02039674|3571336|P7|Treated|Overall Study|One participant was randomized but did not receive study treatment.|59
1459016|NCT02039674|3571337|P6|Treated|Overall Study||7
1459017|NCT02039674|3571338|P5|Treated|Overall Study||12
1459018|NCT02039674|3571339|P4|Treated|Overall Study||6
1459019|NCT02039674|3571340|P3|Treated|Overall Study||24
1459020|NCT02039674|3571341|P2|Treated|Overall Study|One participant was randomized but did not receive study treatment.|24
1459021|NCT02039674|3571342|P1|Treated|Overall Study||25
1459022|NCT02039674|3571334|P9|STARTED|Overall Study||45
1459023|NCT02039674|3571335|P8|STARTED|Overall Study||63
1459024|NCT02039674|3571336|P7|STARTED|Overall Study||60
1459025|NCT02039674|3571337|P6|STARTED|Overall Study||7
1459026|NCT02039674|3571338|P5|STARTED|Overall Study||12
1459027|NCT02039674|3571339|P4|STARTED|Overall Study||6
1459028|NCT02039674|3571340|P3|STARTED|Overall Study||24
1459029|NCT02039674|3571341|P2|STARTED|Overall Study||25
1459030|NCT02039674|3571342|P1|STARTED|Overall Study||25
1459031|NCT02039427|3571378|P4|NOT COMPLETED|Overall Study||5
1459032|NCT02039427|3571379|P3|NOT COMPLETED|Overall Study||3
1459033|NCT02039427|3571380|P2|NOT COMPLETED|Overall Study||1
1459034|NCT02039427|3571381|P1|NOT COMPLETED|Overall Study||3
1459035|NCT02039427|3571378|P4|COMPLETED|Overall Study||43
1459036|NCT02039427|3571379|P3|COMPLETED|Overall Study||45
1459037|NCT02039427|3571380|P2|COMPLETED|Overall Study||47
1459038|NCT02039427|3571381|P1|COMPLETED|Overall Study||45
1459039|NCT02039427|3571378|P4|STARTED|Overall Study||48
1459040|NCT02039427|3571379|P3|STARTED|Overall Study||48
1459041|NCT02039427|3571380|P2|STARTED|Overall Study||48
1459042|NCT02039427|3571381|P1|STARTED|Overall Study||48
1459043|NCT02039414|3571401|P2|NOT COMPLETED|Overall Study||2
1459044|NCT02039414|3571402|P1|NOT COMPLETED|Overall Study||6
1459045|NCT02039414|3571401|P2|COMPLETED|Overall Study||16
1459046|NCT02039414|3571402|P1|COMPLETED|Overall Study||16
1459047|NCT02039414|3571401|P2|STARTED|Overall Study||18
1459048|NCT02039414|3571402|P1|STARTED|Overall Study||22
1459049|NCT02039115|3571416|P2|NOT COMPLETED|Overall Study||0
1459050|NCT02039115|3571417|P1|NOT COMPLETED|Overall Study||0
1459051|NCT02039115|3571416|P2|COMPLETED|Overall Study||0
1459052|NCT02039115|3571417|P1|COMPLETED|Overall Study||1
1459053|NCT02039115|3571416|P2|STARTED|Overall Study||0
1459054|NCT02039115|3571417|P1|STARTED|Overall Study||1
1459055|NCT02038959|3571425|P2|NOT COMPLETED|Overall Study||8
1459056|NCT02038959|3571426|P1|NOT COMPLETED|Overall Study||6
1459057|NCT02038959|3571425|P2|COMPLETED|Overall Study||89
1459058|NCT02038959|3571426|P1|COMPLETED|Overall Study||92
1459059|NCT02038959|3571425|P2|STARTED|Overall Study||97
1459060|NCT02038959|3571426|P1|STARTED|Overall Study||98
1459061|NCT02038946|3571452|P1|NOT COMPLETED|Overall Study||11
1459062|NCT02038946|3571452|P1|COMPLETED|Overall Study||81
1459063|NCT02038946|3571452|P1|STARTED|Overall Study||92
1459064|NCT02038933|3571463|P1|NOT COMPLETED|Follow-up||19
1459065|NCT02038933|3571463|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
1459066|NCT02038933|3571463|P1|STARTED|Follow-up||121
1459067|NCT02038933|3571463|P1|NOT COMPLETED|Treatment||114
1459068|NCT02038933|3571463|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
1459069|NCT02038933|3571463|P1|STARTED|Treatment||121
1459070|NCT02038907|3571496|P14|NOT COMPLETED|Overall Study||0
1459071|NCT02038907|3571497|P13|NOT COMPLETED|Overall Study||0
1459072|NCT02038907|3571498|P12|NOT COMPLETED|Overall Study||0
1459073|NCT02038907|3571499|P11|NOT COMPLETED|Overall Study||2
1459074|NCT02038907|3571500|P10|NOT COMPLETED|Overall Study||0
1459075|NCT02038907|3571501|P9|NOT COMPLETED|Overall Study||0
1459076|NCT02038907|3571502|P8|NOT COMPLETED|Overall Study||0
1459077|NCT02038907|3571503|P7|NOT COMPLETED|Overall Study||0
1459078|NCT02038907|3571504|P6|NOT COMPLETED|Overall Study||0
1459079|NCT02038907|3571505|P5|NOT COMPLETED|Overall Study||0
1459080|NCT02038907|3571506|P4|NOT COMPLETED|Overall Study||0
1459081|NCT02038907|3571507|P3|NOT COMPLETED|Overall Study||0
1459082|NCT02038907|3571508|P2|NOT COMPLETED|Overall Study||0
1459083|NCT02038907|3571509|P1|NOT COMPLETED|Overall Study||0
1459084|NCT02038907|3571496|P14|COMPLETED|Overall Study||31
1459085|NCT02038907|3571497|P13|COMPLETED|Overall Study||29
1459086|NCT02038907|3571498|P12|COMPLETED|Overall Study||28
1459087|NCT02038907|3571499|P11|COMPLETED|Overall Study||27
1459088|NCT02038907|3571500|P10|COMPLETED|Overall Study||30
1459089|NCT02038907|3571501|P9|COMPLETED|Overall Study||29
1459090|NCT02038907|3571502|P8|COMPLETED|Overall Study||32
1459091|NCT02038907|3571503|P7|COMPLETED|Overall Study||30
1459092|NCT02038907|3571504|P6|COMPLETED|Overall Study||31
1459093|NCT02038907|3571505|P5|COMPLETED|Overall Study||30
1459094|NCT02038907|3571506|P4|COMPLETED|Overall Study||31
1459095|NCT02038907|3571507|P3|COMPLETED|Overall Study||30
1459096|NCT02038907|3571508|P2|COMPLETED|Overall Study||30
1459097|NCT02038907|3571509|P1|COMPLETED|Overall Study||30
1459098|NCT02038907|3571496|P14|STARTED|Overall Study||31
1459099|NCT02038907|3571497|P13|STARTED|Overall Study||29
1459100|NCT02038907|3571498|P12|STARTED|Overall Study||28
1459101|NCT02038907|3571499|P11|STARTED|Overall Study||29
1459102|NCT02038907|3571500|P10|STARTED|Overall Study||30
1459103|NCT02038907|3571501|P9|STARTED|Overall Study||29
1459104|NCT02038907|3571502|P8|STARTED|Overall Study||32
1459105|NCT02038907|3571503|P7|STARTED|Overall Study||30
1459106|NCT02038907|3571504|P6|STARTED|Overall Study||31
1459107|NCT02038907|3571505|P5|STARTED|Overall Study||30
1459108|NCT02038907|3571506|P4|STARTED|Overall Study||31
1459109|NCT02038907|3571507|P3|STARTED|Overall Study||30
1459110|NCT02038907|3571508|P2|STARTED|Overall Study||30
1459111|NCT02038907|3571509|P1|STARTED|Overall Study||30
1459112|NCT02038829|3572037|P12|NOT COMPLETED|Treatment Period 6||0
1459113|NCT02038829|3572038|P11|NOT COMPLETED|Treatment Period 6||0
1459114|NCT02038829|3572039|P10|NOT COMPLETED|Treatment Period 6||0
1459115|NCT02038829|3572040|P9|NOT COMPLETED|Treatment Period 6||0
1459116|NCT02038829|3572041|P8|NOT COMPLETED|Treatment Period 6||0
1459117|NCT02038829|3572042|P7|NOT COMPLETED|Treatment Period 6||0
1459118|NCT02038829|3572043|P6|NOT COMPLETED|Treatment Period 6||0
1459119|NCT02038829|3572044|P5|NOT COMPLETED|Treatment Period 6||0
1459120|NCT02038829|3572045|P4|NOT COMPLETED|Treatment Period 6||0
1459121|NCT02038829|3572046|P3|NOT COMPLETED|Treatment Period 6||1
1459122|NCT02038829|3572047|P2|NOT COMPLETED|Treatment Period 6||0
1459123|NCT02038829|3572048|P1|NOT COMPLETED|Treatment Period 6||0
1459124|NCT02038829|3572037|P12|COMPLETED|Treatment Period 6||8
1459125|NCT02038829|3572038|P11|COMPLETED|Treatment Period 6||7
1459126|NCT02038829|3572039|P10|COMPLETED|Treatment Period 6||8
1459127|NCT02038829|3572040|P9|COMPLETED|Treatment Period 6||7
1459128|NCT02038829|3572041|P8|COMPLETED|Treatment Period 6||8
1459129|NCT02038829|3572042|P7|COMPLETED|Treatment Period 6||7
1459130|NCT02038829|3572043|P6|COMPLETED|Treatment Period 6||7
1459131|NCT02038829|3572044|P5|COMPLETED|Treatment Period 6||7
1459132|NCT02038829|3572045|P4|COMPLETED|Treatment Period 6||8
1459133|NCT02038829|3572046|P3|COMPLETED|Treatment Period 6||7
1459134|NCT02038829|3572047|P2|COMPLETED|Treatment Period 6||7
1459135|NCT02038829|3572048|P1|COMPLETED|Treatment Period 6||7
1459136|NCT02038829|3572037|P12|STARTED|Treatment Period 6||8
1459137|NCT02038829|3572038|P11|STARTED|Treatment Period 6||7
1459138|NCT02038829|3572039|P10|STARTED|Treatment Period 6||8
1459139|NCT02038829|3572040|P9|STARTED|Treatment Period 6||7
1459140|NCT02038829|3572041|P8|STARTED|Treatment Period 6||8
1459141|NCT02038829|3572042|P7|STARTED|Treatment Period 6||7
1459142|NCT02038829|3572043|P6|STARTED|Treatment Period 6||7
1459143|NCT02038829|3572044|P5|STARTED|Treatment Period 6||7
1459144|NCT02038829|3572045|P4|STARTED|Treatment Period 6||8
1459145|NCT02038829|3572046|P3|STARTED|Treatment Period 6||8
1459146|NCT02038829|3572047|P2|STARTED|Treatment Period 6||7
1459147|NCT02038829|3572048|P1|STARTED|Treatment Period 6||7
1459148|NCT02038829|3572037|P12|NOT COMPLETED|Washout Period 5||0
1459149|NCT02038829|3572038|P11|NOT COMPLETED|Washout Period 5||0
1459150|NCT02038829|3572039|P10|NOT COMPLETED|Washout Period 5||0
1459151|NCT02038829|3572040|P9|NOT COMPLETED|Washout Period 5||0
1459152|NCT02038829|3572041|P8|NOT COMPLETED|Washout Period 5||0
1459153|NCT02038829|3572042|P7|NOT COMPLETED|Washout Period 5||0
1459154|NCT02038829|3572043|P6|NOT COMPLETED|Washout Period 5||0
1459155|NCT02038829|3572044|P5|NOT COMPLETED|Washout Period 5||0
1459156|NCT02038829|3572045|P4|NOT COMPLETED|Washout Period 5||0
1459157|NCT02038829|3572046|P3|NOT COMPLETED|Washout Period 5||0
1459158|NCT02038829|3572047|P2|NOT COMPLETED|Washout Period 5||0
1459159|NCT02038829|3572048|P1|NOT COMPLETED|Washout Period 5||0
1459160|NCT02038829|3572037|P12|COMPLETED|Washout Period 5||8
1459161|NCT02038829|3572038|P11|COMPLETED|Washout Period 5||7
1459162|NCT02038829|3572039|P10|COMPLETED|Washout Period 5||8
1459163|NCT02038829|3572040|P9|COMPLETED|Washout Period 5||7
1459164|NCT02038829|3572041|P8|COMPLETED|Washout Period 5||8
1459165|NCT02038829|3572042|P7|COMPLETED|Washout Period 5||7
1459166|NCT02038829|3572043|P6|COMPLETED|Washout Period 5||7
1459167|NCT02038829|3572044|P5|COMPLETED|Washout Period 5||7
1459168|NCT02038829|3572045|P4|COMPLETED|Washout Period 5||8
1459169|NCT02038829|3572046|P3|COMPLETED|Washout Period 5||8
1459170|NCT02038829|3572047|P2|COMPLETED|Washout Period 5||7
1459171|NCT02038829|3572048|P1|COMPLETED|Washout Period 5||7
1459172|NCT02038829|3572037|P12|STARTED|Washout Period 5||8
1459173|NCT02038829|3572038|P11|STARTED|Washout Period 5||7
1459174|NCT02038829|3572039|P10|STARTED|Washout Period 5||8
1459175|NCT02038829|3572040|P9|STARTED|Washout Period 5||7
1459176|NCT02038829|3572041|P8|STARTED|Washout Period 5||8
1459177|NCT02038829|3572042|P7|STARTED|Washout Period 5||7
1459178|NCT02038829|3572043|P6|STARTED|Washout Period 5||7
1459179|NCT02038829|3572044|P5|STARTED|Washout Period 5||7
1459180|NCT02038829|3572045|P4|STARTED|Washout Period 5||8
1459181|NCT02038829|3572046|P3|STARTED|Washout Period 5||8
1459182|NCT02038829|3572047|P2|STARTED|Washout Period 5||7
1459183|NCT02038829|3572048|P1|STARTED|Washout Period 5||7
1459184|NCT02038829|3572037|P12|NOT COMPLETED|Treatment Period 5||0
1459185|NCT02038829|3572038|P11|NOT COMPLETED|Treatment Period 5||0
1459186|NCT02038829|3572039|P10|NOT COMPLETED|Treatment Period 5||0
1459187|NCT02038829|3572040|P9|NOT COMPLETED|Treatment Period 5||0
1459188|NCT02038829|3572041|P8|NOT COMPLETED|Treatment Period 5||0
1459189|NCT02038829|3572042|P7|NOT COMPLETED|Treatment Period 5||0
1459190|NCT02038829|3572043|P6|NOT COMPLETED|Treatment Period 5||0
1459191|NCT02038829|3572044|P5|NOT COMPLETED|Treatment Period 5||0
1459192|NCT02038829|3572045|P4|NOT COMPLETED|Treatment Period 5||0
1459193|NCT02038829|3572046|P3|NOT COMPLETED|Treatment Period 5||0
1459194|NCT02038829|3572047|P2|NOT COMPLETED|Treatment Period 5||0
1459195|NCT02038829|3572048|P1|NOT COMPLETED|Treatment Period 5||0
1459196|NCT02038829|3572037|P12|COMPLETED|Treatment Period 5||8
1459197|NCT02038829|3572038|P11|COMPLETED|Treatment Period 5||7
1459198|NCT02038829|3572039|P10|COMPLETED|Treatment Period 5||8
1459199|NCT02038829|3572040|P9|COMPLETED|Treatment Period 5||7
1459200|NCT02038829|3572041|P8|COMPLETED|Treatment Period 5||8
1459201|NCT02038829|3572042|P7|COMPLETED|Treatment Period 5||7
1459202|NCT02038829|3572043|P6|COMPLETED|Treatment Period 5||7
1459203|NCT02038829|3572044|P5|COMPLETED|Treatment Period 5||7
1459204|NCT02038829|3572045|P4|COMPLETED|Treatment Period 5||8
1459205|NCT02038829|3572046|P3|COMPLETED|Treatment Period 5||8
1459206|NCT02038829|3572047|P2|COMPLETED|Treatment Period 5||7
1459207|NCT02038829|3572048|P1|COMPLETED|Treatment Period 5||7
1459208|NCT02038829|3572037|P12|STARTED|Treatment Period 5||8
1459209|NCT02038829|3572038|P11|STARTED|Treatment Period 5||7
1459210|NCT02038829|3572039|P10|STARTED|Treatment Period 5||8
1459211|NCT02038829|3572040|P9|STARTED|Treatment Period 5||7
1459212|NCT02038829|3572041|P8|STARTED|Treatment Period 5||8
1459213|NCT02038829|3572042|P7|STARTED|Treatment Period 5||7
1459214|NCT02038829|3572043|P6|STARTED|Treatment Period 5||7
1459215|NCT02038829|3572044|P5|STARTED|Treatment Period 5||7
1459216|NCT02038829|3572045|P4|STARTED|Treatment Period 5||8
1459217|NCT02038829|3572046|P3|STARTED|Treatment Period 5||8
1459218|NCT02038829|3572047|P2|STARTED|Treatment Period 5||7
1459219|NCT02038829|3572048|P1|STARTED|Treatment Period 5||7
1459220|NCT02038829|3572037|P12|NOT COMPLETED|Washout Period 4||0
1459221|NCT02038829|3572038|P11|NOT COMPLETED|Washout Period 4||0
1459222|NCT02038829|3572039|P10|NOT COMPLETED|Washout Period 4||0
1459223|NCT02038829|3572040|P9|NOT COMPLETED|Washout Period 4||0
1459224|NCT02038829|3572041|P8|NOT COMPLETED|Washout Period 4||0
1459225|NCT02038829|3572042|P7|NOT COMPLETED|Washout Period 4||1
1459226|NCT02038829|3572043|P6|NOT COMPLETED|Washout Period 4||0
1459227|NCT02038829|3572044|P5|NOT COMPLETED|Washout Period 4||0
1459228|NCT02038829|3572045|P4|NOT COMPLETED|Washout Period 4||0
1459229|NCT02038829|3572046|P3|NOT COMPLETED|Washout Period 4||0
1459230|NCT02038829|3572047|P2|NOT COMPLETED|Washout Period 4||0
1459231|NCT02038829|3572048|P1|NOT COMPLETED|Washout Period 4||0
1459232|NCT02038829|3572037|P12|COMPLETED|Washout Period 4||8
1459233|NCT02038829|3572038|P11|COMPLETED|Washout Period 4||7
1459234|NCT02038829|3572039|P10|COMPLETED|Washout Period 4||8
1459235|NCT02038829|3572040|P9|COMPLETED|Washout Period 4||7
1459236|NCT02038829|3572041|P8|COMPLETED|Washout Period 4||8
1459237|NCT02038829|3572042|P7|COMPLETED|Washout Period 4||7
1459238|NCT02038829|3572043|P6|COMPLETED|Washout Period 4||7
1459239|NCT02038829|3572044|P5|COMPLETED|Washout Period 4||7
1459240|NCT02038829|3572045|P4|COMPLETED|Washout Period 4||8
1459241|NCT02038829|3572046|P3|COMPLETED|Washout Period 4||8
1459242|NCT02038829|3572047|P2|COMPLETED|Washout Period 4||7
1459243|NCT02038829|3572048|P1|COMPLETED|Washout Period 4||7
1459244|NCT02038829|3572037|P12|STARTED|Washout Period 4||8
1459245|NCT02038829|3572038|P11|STARTED|Washout Period 4||7
1459246|NCT02038829|3572039|P10|STARTED|Washout Period 4||8
1459247|NCT02038829|3572040|P9|STARTED|Washout Period 4||7
1459248|NCT02038829|3572041|P8|STARTED|Washout Period 4||8
1459249|NCT02038829|3572042|P7|STARTED|Washout Period 4||8
1459250|NCT02038829|3572043|P6|STARTED|Washout Period 4||7
1459251|NCT02038829|3572044|P5|STARTED|Washout Period 4||7
1459252|NCT02038829|3572045|P4|STARTED|Washout Period 4||8
1459253|NCT02038829|3572046|P3|STARTED|Washout Period 4||8
1459254|NCT02038829|3572047|P2|STARTED|Washout Period 4||7
1459255|NCT02038829|3572048|P1|STARTED|Washout Period 4||7
1459256|NCT02038829|3572037|P12|NOT COMPLETED|Treatment Period 4||0
1459257|NCT02038829|3572038|P11|NOT COMPLETED|Treatment Period 4||0
1459258|NCT02038829|3572039|P10|NOT COMPLETED|Treatment Period 4||0
1459259|NCT02038829|3572040|P9|NOT COMPLETED|Treatment Period 4||0
1459260|NCT02038829|3572041|P8|NOT COMPLETED|Treatment Period 4||0
1459261|NCT02038829|3572042|P7|NOT COMPLETED|Treatment Period 4||0
1459262|NCT02038829|3572043|P6|NOT COMPLETED|Treatment Period 4||0
1459263|NCT02038829|3572044|P5|NOT COMPLETED|Treatment Period 4||0
1459264|NCT02038829|3572045|P4|NOT COMPLETED|Treatment Period 4||0
1459265|NCT02038829|3572046|P3|NOT COMPLETED|Treatment Period 4||0
1459266|NCT02038829|3572047|P2|NOT COMPLETED|Treatment Period 4||1
1459267|NCT02038829|3572048|P1|NOT COMPLETED|Treatment Period 4||0
1459268|NCT02038829|3572037|P12|COMPLETED|Treatment Period 4||8
1459269|NCT02038829|3572038|P11|COMPLETED|Treatment Period 4||7
1459270|NCT02038829|3572039|P10|COMPLETED|Treatment Period 4||8
1459271|NCT02038829|3572040|P9|COMPLETED|Treatment Period 4||7
1459272|NCT02038829|3572041|P8|COMPLETED|Treatment Period 4||8
1459273|NCT02038829|3572042|P7|COMPLETED|Treatment Period 4||8
1459274|NCT02038829|3572043|P6|COMPLETED|Treatment Period 4||7
1459275|NCT02038829|3572044|P5|COMPLETED|Treatment Period 4||7
1459276|NCT02038829|3572045|P4|COMPLETED|Treatment Period 4||8
1459277|NCT02038829|3572046|P3|COMPLETED|Treatment Period 4||8
1459278|NCT02038829|3572047|P2|COMPLETED|Treatment Period 4||7
1459279|NCT02038829|3572048|P1|COMPLETED|Treatment Period 4||7
1459280|NCT02038829|3572037|P12|STARTED|Treatment Period 4||8
1459281|NCT02038829|3572038|P11|STARTED|Treatment Period 4||7
1459282|NCT02038829|3572039|P10|STARTED|Treatment Period 4||8
1459283|NCT02038829|3572040|P9|STARTED|Treatment Period 4||7
1459284|NCT02038829|3572041|P8|STARTED|Treatment Period 4||8
1459285|NCT02038829|3572042|P7|STARTED|Treatment Period 4||8
1459286|NCT02038829|3572043|P6|STARTED|Treatment Period 4||7
1459287|NCT02038829|3572044|P5|STARTED|Treatment Period 4||7
1459288|NCT02038829|3572045|P4|STARTED|Treatment Period 4||8
1459289|NCT02038829|3572046|P3|STARTED|Treatment Period 4||8
1459290|NCT02038829|3572047|P2|STARTED|Treatment Period 4||8
1459291|NCT02038829|3572048|P1|STARTED|Treatment Period 4||7
1459292|NCT02038829|3572037|P12|NOT COMPLETED|Washout Period 3||0
1459293|NCT02038829|3572038|P11|NOT COMPLETED|Washout Period 3||0
1459294|NCT02038829|3572039|P10|NOT COMPLETED|Washout Period 3||0
1459295|NCT02038829|3572040|P9|NOT COMPLETED|Washout Period 3||0
1459296|NCT02038829|3572041|P8|NOT COMPLETED|Washout Period 3||0
1459297|NCT02038829|3572042|P7|NOT COMPLETED|Washout Period 3||0
1459298|NCT02038829|3572043|P6|NOT COMPLETED|Washout Period 3||0
1459299|NCT02038829|3572044|P5|NOT COMPLETED|Washout Period 3||0
1459300|NCT02038829|3572045|P4|NOT COMPLETED|Washout Period 3||0
1459301|NCT02038829|3572046|P3|NOT COMPLETED|Washout Period 3||0
1459302|NCT02038829|3572047|P2|NOT COMPLETED|Washout Period 3||0
1459303|NCT02038829|3572048|P1|NOT COMPLETED|Washout Period 3||0
1459304|NCT02038829|3572037|P12|COMPLETED|Washout Period 3||8
1459305|NCT02038829|3572038|P11|COMPLETED|Washout Period 3||7
1459306|NCT02038829|3572039|P10|COMPLETED|Washout Period 3||8
1459307|NCT02038829|3572040|P9|COMPLETED|Washout Period 3||7
1459308|NCT02038829|3572041|P8|COMPLETED|Washout Period 3||8
1459309|NCT02038829|3572042|P7|COMPLETED|Washout Period 3||8
1459310|NCT02038829|3572043|P6|COMPLETED|Washout Period 3||7
1459311|NCT02038829|3572044|P5|COMPLETED|Washout Period 3||7
1459312|NCT02038829|3572045|P4|COMPLETED|Washout Period 3||8
1459313|NCT02038829|3572046|P3|COMPLETED|Washout Period 3||8
1459314|NCT02038829|3572047|P2|COMPLETED|Washout Period 3||8
1459315|NCT02038829|3572048|P1|COMPLETED|Washout Period 3||7
1459316|NCT02038829|3572037|P12|STARTED|Washout Period 3||8
1459317|NCT02038829|3572038|P11|STARTED|Washout Period 3||7
1459318|NCT02038829|3572039|P10|STARTED|Washout Period 3||8
1459319|NCT02038829|3572040|P9|STARTED|Washout Period 3||7
1459320|NCT02038829|3572041|P8|STARTED|Washout Period 3||8
1459321|NCT02038829|3572042|P7|STARTED|Washout Period 3||8
1459322|NCT02038829|3572043|P6|STARTED|Washout Period 3||7
1459323|NCT02038829|3572044|P5|STARTED|Washout Period 3||7
1459324|NCT02038829|3572045|P4|STARTED|Washout Period 3||8
1459325|NCT02038829|3572046|P3|STARTED|Washout Period 3||8
1459326|NCT02038829|3572047|P2|STARTED|Washout Period 3||8
1459327|NCT02038829|3572048|P1|STARTED|Washout Period 3||7
1459328|NCT02038829|3572037|P12|NOT COMPLETED|Treatment Period 3||0
1459329|NCT02038829|3572038|P11|NOT COMPLETED|Treatment Period 3||0
1459330|NCT02038829|3572039|P10|NOT COMPLETED|Treatment Period 3||0
1459331|NCT02038829|3572040|P9|NOT COMPLETED|Treatment Period 3||0
1459332|NCT02038829|3572041|P8|NOT COMPLETED|Treatment Period 3||0
1459333|NCT02038829|3572042|P7|NOT COMPLETED|Treatment Period 3||0
1459334|NCT02038829|3572043|P6|NOT COMPLETED|Treatment Period 3||0
1459335|NCT02038829|3572044|P5|NOT COMPLETED|Treatment Period 3||0
1459336|NCT02038829|3572045|P4|NOT COMPLETED|Treatment Period 3||0
1459337|NCT02038829|3572046|P3|NOT COMPLETED|Treatment Period 3||0
1459338|NCT02038829|3572047|P2|NOT COMPLETED|Treatment Period 3||0
1459339|NCT02038829|3572048|P1|NOT COMPLETED|Treatment Period 3||0
1459340|NCT02038829|3572037|P12|COMPLETED|Treatment Period 3||8
1459341|NCT02038829|3572038|P11|COMPLETED|Treatment Period 3||7
1459342|NCT02038829|3572039|P10|COMPLETED|Treatment Period 3||8
1459343|NCT02038829|3572040|P9|COMPLETED|Treatment Period 3||7
1459344|NCT02038829|3572041|P8|COMPLETED|Treatment Period 3||8
1459345|NCT02038829|3572042|P7|COMPLETED|Treatment Period 3||8
1459346|NCT02038829|3572043|P6|COMPLETED|Treatment Period 3||7
1459347|NCT02038829|3572044|P5|COMPLETED|Treatment Period 3||7
1459348|NCT02038829|3572045|P4|COMPLETED|Treatment Period 3||8
1459349|NCT02038829|3572046|P3|COMPLETED|Treatment Period 3||8
1459350|NCT02038829|3572047|P2|COMPLETED|Treatment Period 3||8
1459351|NCT02038829|3572048|P1|COMPLETED|Treatment Period 3||7
1459352|NCT02038829|3572037|P12|STARTED|Treatment Period 3||8
1459353|NCT02038829|3572038|P11|STARTED|Treatment Period 3||7
1459354|NCT02038829|3572039|P10|STARTED|Treatment Period 3||8
1459355|NCT02038829|3572040|P9|STARTED|Treatment Period 3||7
1459356|NCT02038829|3572041|P8|STARTED|Treatment Period 3||8
1459357|NCT02038829|3572042|P7|STARTED|Treatment Period 3||8
1459358|NCT02038829|3572043|P6|STARTED|Treatment Period 3||7
1459359|NCT02038829|3572044|P5|STARTED|Treatment Period 3||7
1459360|NCT02038829|3572045|P4|STARTED|Treatment Period 3||8
1459361|NCT02038829|3572046|P3|STARTED|Treatment Period 3||8
1459362|NCT02038829|3572047|P2|STARTED|Treatment Period 3||8
1459363|NCT02038829|3572048|P1|STARTED|Treatment Period 3||7
1459364|NCT02038829|3572037|P12|NOT COMPLETED|Washout Period 2||0
1459365|NCT02038829|3572038|P11|NOT COMPLETED|Washout Period 2||0
1459366|NCT02038829|3572039|P10|NOT COMPLETED|Washout Period 2||0
1459367|NCT02038829|3572040|P9|NOT COMPLETED|Washout Period 2||1
1459368|NCT02038829|3572041|P8|NOT COMPLETED|Washout Period 2||0
1459369|NCT02038829|3572042|P7|NOT COMPLETED|Washout Period 2||0
1459370|NCT02038829|3572043|P6|NOT COMPLETED|Washout Period 2||1
1459371|NCT02038829|3572044|P5|NOT COMPLETED|Washout Period 2||0
1459372|NCT02038829|3572045|P4|NOT COMPLETED|Washout Period 2||0
1459373|NCT02038829|3572046|P3|NOT COMPLETED|Washout Period 2||0
1459374|NCT02038829|3572047|P2|NOT COMPLETED|Washout Period 2||0
1459375|NCT02038829|3572048|P1|NOT COMPLETED|Washout Period 2||0
1459376|NCT02038829|3572037|P12|COMPLETED|Washout Period 2||8
1459377|NCT02038829|3572038|P11|COMPLETED|Washout Period 2||7
1459378|NCT02038829|3572039|P10|COMPLETED|Washout Period 2||8
1459379|NCT02038829|3572040|P9|COMPLETED|Washout Period 2||7
1459380|NCT02038829|3572041|P8|COMPLETED|Washout Period 2||8
1459381|NCT02038829|3572042|P7|COMPLETED|Washout Period 2||8
1459382|NCT02038829|3572043|P6|COMPLETED|Washout Period 2||7
1459383|NCT02038829|3572044|P5|COMPLETED|Washout Period 2||7
1459384|NCT02038829|3572045|P4|COMPLETED|Washout Period 2||8
1459385|NCT02038829|3572046|P3|COMPLETED|Washout Period 2||8
1459386|NCT02038829|3572047|P2|COMPLETED|Washout Period 2||8
1459387|NCT02038829|3572048|P1|COMPLETED|Washout Period 2||7
1459388|NCT02038829|3572037|P12|STARTED|Washout Period 2||8
1459389|NCT02038829|3572038|P11|STARTED|Washout Period 2||7
1459390|NCT02038829|3572039|P10|STARTED|Washout Period 2||8
1459391|NCT02038829|3572040|P9|STARTED|Washout Period 2||8
1459392|NCT02038829|3572041|P8|STARTED|Washout Period 2||8
1459393|NCT02038829|3572042|P7|STARTED|Washout Period 2||8
1459394|NCT02038829|3572043|P6|STARTED|Washout Period 2||8
1459395|NCT02038829|3572044|P5|STARTED|Washout Period 2||7
1459396|NCT02038829|3572045|P4|STARTED|Washout Period 2||8
1459397|NCT02038829|3572046|P3|STARTED|Washout Period 2||8
1459398|NCT02038829|3572047|P2|STARTED|Washout Period 2||8
1459399|NCT02038829|3572048|P1|STARTED|Washout Period 2||7
1459400|NCT02038829|3572037|P12|NOT COMPLETED|Treatment Period 2||0
1459401|NCT02038829|3572038|P11|NOT COMPLETED|Treatment Period 2||1
1459402|NCT02038829|3572039|P10|NOT COMPLETED|Treatment Period 2||0
1459403|NCT02038829|3572040|P9|NOT COMPLETED|Treatment Period 2||0
1459404|NCT02038829|3572041|P8|NOT COMPLETED|Treatment Period 2||0
1459405|NCT02038829|3572042|P7|NOT COMPLETED|Treatment Period 2||0
1459406|NCT02038829|3572043|P6|NOT COMPLETED|Treatment Period 2||0
1459407|NCT02038829|3572044|P5|NOT COMPLETED|Treatment Period 2||0
1459408|NCT02038829|3572045|P4|NOT COMPLETED|Treatment Period 2||0
1459409|NCT02038829|3572046|P3|NOT COMPLETED|Treatment Period 2||0
1459410|NCT02038829|3572047|P2|NOT COMPLETED|Treatment Period 2||0
1459411|NCT02038829|3572048|P1|NOT COMPLETED|Treatment Period 2||1
1459412|NCT02038829|3572037|P12|COMPLETED|Treatment Period 2||8
1459413|NCT02038829|3572038|P11|COMPLETED|Treatment Period 2||7
1459414|NCT02038829|3572039|P10|COMPLETED|Treatment Period 2||8
1459415|NCT02038829|3572040|P9|COMPLETED|Treatment Period 2||8
1459416|NCT02038829|3572041|P8|COMPLETED|Treatment Period 2||8
1459417|NCT02038829|3572042|P7|COMPLETED|Treatment Period 2||8
1459418|NCT02038829|3572043|P6|COMPLETED|Treatment Period 2||8
1459419|NCT02038829|3572044|P5|COMPLETED|Treatment Period 2||7
1459420|NCT02038829|3572045|P4|COMPLETED|Treatment Period 2||8
1459421|NCT02038829|3572046|P3|COMPLETED|Treatment Period 2||8
1459422|NCT02038829|3572047|P2|COMPLETED|Treatment Period 2||8
1459423|NCT02038829|3572048|P1|COMPLETED|Treatment Period 2||7
1459424|NCT02038829|3572037|P12|STARTED|Treatment Period 2||8
1459425|NCT02038829|3572038|P11|STARTED|Treatment Period 2||8
1459426|NCT02038829|3572039|P10|STARTED|Treatment Period 2||8
1459427|NCT02038829|3572040|P9|STARTED|Treatment Period 2||8
1459428|NCT02038829|3572041|P8|STARTED|Treatment Period 2||8
1459429|NCT02038829|3572042|P7|STARTED|Treatment Period 2||8
1459430|NCT02038829|3572043|P6|STARTED|Treatment Period 2||8
1459431|NCT02038829|3572044|P5|STARTED|Treatment Period 2||7
1459432|NCT02038829|3572045|P4|STARTED|Treatment Period 2||8
1459433|NCT02038829|3572046|P3|STARTED|Treatment Period 2||8
1459434|NCT02038829|3572047|P2|STARTED|Treatment Period 2||8
1459435|NCT02038829|3572048|P1|STARTED|Treatment Period 2||8
1459436|NCT02038829|3572037|P12|NOT COMPLETED|Washout Period 1||0
1459437|NCT02038829|3572038|P11|NOT COMPLETED|Washout Period 1||0
1459438|NCT02038829|3572039|P10|NOT COMPLETED|Washout Period 1||0
1459439|NCT02038829|3572040|P9|NOT COMPLETED|Washout Period 1||0
1459440|NCT02038829|3572041|P8|NOT COMPLETED|Washout Period 1||0
1459441|NCT02038829|3572042|P7|NOT COMPLETED|Washout Period 1||0
1459442|NCT02038829|3572043|P6|NOT COMPLETED|Washout Period 1||0
1459443|NCT02038829|3572044|P5|NOT COMPLETED|Washout Period 1||1
1459444|NCT02038829|3572045|P4|NOT COMPLETED|Washout Period 1||0
1459445|NCT02038829|3572046|P3|NOT COMPLETED|Washout Period 1||0
1459446|NCT02038829|3572047|P2|NOT COMPLETED|Washout Period 1||0
1459447|NCT02038829|3572048|P1|NOT COMPLETED|Washout Period 1||0
1459448|NCT02038829|3572037|P12|COMPLETED|Washout Period 1||8
1459449|NCT02038829|3572038|P11|COMPLETED|Washout Period 1||8
1459450|NCT02038829|3572039|P10|COMPLETED|Washout Period 1||8
1459451|NCT02038829|3572040|P9|COMPLETED|Washout Period 1||8
1459452|NCT02038829|3572041|P8|COMPLETED|Washout Period 1||8
1459453|NCT02038829|3572042|P7|COMPLETED|Washout Period 1||8
1459454|NCT02038829|3572043|P6|COMPLETED|Washout Period 1||8
1459455|NCT02038829|3572044|P5|COMPLETED|Washout Period 1||7
1459456|NCT02038829|3572045|P4|COMPLETED|Washout Period 1||8
1459457|NCT02038829|3572046|P3|COMPLETED|Washout Period 1||8
1459458|NCT02038829|3572047|P2|COMPLETED|Washout Period 1||8
1459459|NCT02038829|3572048|P1|COMPLETED|Washout Period 1||8
1459460|NCT02038829|3572037|P12|STARTED|Washout Period 1||8
1459461|NCT02038829|3572038|P11|STARTED|Washout Period 1||8
1459462|NCT02038829|3572039|P10|STARTED|Washout Period 1||8
1459463|NCT02038829|3572040|P9|STARTED|Washout Period 1||8
1459464|NCT02038829|3572041|P8|STARTED|Washout Period 1||8
1459465|NCT02038829|3572042|P7|STARTED|Washout Period 1||8
1459466|NCT02038829|3572043|P6|STARTED|Washout Period 1||8
1459467|NCT02038829|3572044|P5|STARTED|Washout Period 1||8
1459468|NCT02038829|3572045|P4|STARTED|Washout Period 1||8
1459469|NCT02038829|3572046|P3|STARTED|Washout Period 1||8
1459470|NCT02038829|3572047|P2|STARTED|Washout Period 1||8
1459471|NCT02038829|3572048|P1|STARTED|Washout Period 1||8
1459472|NCT02038829|3572037|P12|NOT COMPLETED|Treatment Period 1||0
1459473|NCT02038829|3572038|P11|NOT COMPLETED|Treatment Period 1||0
1459474|NCT02038829|3572039|P10|NOT COMPLETED|Treatment Period 1||0
1459475|NCT02038829|3572040|P9|NOT COMPLETED|Treatment Period 1||0
1459476|NCT02038829|3572041|P8|NOT COMPLETED|Treatment Period 1||0
1459477|NCT02038829|3572042|P7|NOT COMPLETED|Treatment Period 1||0
1459478|NCT02038829|3572043|P6|NOT COMPLETED|Treatment Period 1||0
1459479|NCT02038829|3572044|P5|NOT COMPLETED|Treatment Period 1||0
1459480|NCT02038829|3572045|P4|NOT COMPLETED|Treatment Period 1||0
1459481|NCT02038829|3572046|P3|NOT COMPLETED|Treatment Period 1||0
1459482|NCT02038829|3572047|P2|NOT COMPLETED|Treatment Period 1||0
1459483|NCT02038829|3572048|P1|NOT COMPLETED|Treatment Period 1||0
1459484|NCT02038829|3572037|P12|COMPLETED|Treatment Period 1||8
1459485|NCT02038829|3572038|P11|COMPLETED|Treatment Period 1||8
1459486|NCT02038829|3572039|P10|COMPLETED|Treatment Period 1||8
1459487|NCT02038829|3572040|P9|COMPLETED|Treatment Period 1||8
1459488|NCT02038829|3572041|P8|COMPLETED|Treatment Period 1||8
1459489|NCT02038829|3572042|P7|COMPLETED|Treatment Period 1||8
1459490|NCT02038829|3572043|P6|COMPLETED|Treatment Period 1||8
1459491|NCT02038829|3572044|P5|COMPLETED|Treatment Period 1||8
1459492|NCT02038829|3572045|P4|COMPLETED|Treatment Period 1||8
1459493|NCT02038829|3572046|P3|COMPLETED|Treatment Period 1||8
1459494|NCT02038829|3572047|P2|COMPLETED|Treatment Period 1||8
1459495|NCT02038829|3572048|P1|COMPLETED|Treatment Period 1||8
1459496|NCT02038829|3572037|P12|STARTED|Treatment Period 1||8
1459497|NCT02038829|3572038|P11|STARTED|Treatment Period 1||8
1459498|NCT02038829|3572039|P10|STARTED|Treatment Period 1||8
1459499|NCT02038829|3572040|P9|STARTED|Treatment Period 1||8
1459500|NCT02038829|3572041|P8|STARTED|Treatment Period 1||8
1459501|NCT02038829|3572042|P7|STARTED|Treatment Period 1||8
1459502|NCT02038829|3572043|P6|STARTED|Treatment Period 1||8
1459503|NCT02038829|3572044|P5|STARTED|Treatment Period 1||8
1459504|NCT02038829|3572045|P4|STARTED|Treatment Period 1||8
1459505|NCT02038829|3572046|P3|STARTED|Treatment Period 1||8
1459506|NCT02038829|3572047|P2|STARTED|Treatment Period 1||8
1459507|NCT02038829|3572048|P1|STARTED|Treatment Period 1||8
1459508|NCT02038790|3572082|P2|NOT COMPLETED|Day 1 - Second Treatment||0
1459509|NCT02038790|3572083|P1|NOT COMPLETED|Day 1 - Second Treatment||0
1459510|NCT02038790|3572082|P2|COMPLETED|Day 1 - Second Treatment||16
1459511|NCT02038790|3572083|P1|COMPLETED|Day 1 - Second Treatment||15
1459512|NCT02038790|3572082|P2|STARTED|Day 1 - Second Treatment||16
1459513|NCT02038790|3572083|P1|STARTED|Day 1 - Second Treatment||15
1459514|NCT02038790|3572082|P2|NOT COMPLETED|Day 0 - First Treatment||1
1459515|NCT02038790|3572083|P1|NOT COMPLETED|Day 0 - First Treatment||1
1459516|NCT02038790|3572082|P2|COMPLETED|Day 0 - First Treatment||16
1459517|NCT02038790|3572083|P1|COMPLETED|Day 0 - First Treatment||15
1459518|NCT02038790|3572082|P2|STARTED|Day 0 - First Treatment||17
1459519|NCT02038790|3572083|P1|STARTED|Day 0 - First Treatment||16
1459520|NCT02038764|3572119|P5|NOT COMPLETED|Overall Study||1
1459521|NCT02038764|3572120|P4|NOT COMPLETED|Overall Study||0
1459522|NCT02038764|3572121|P3|NOT COMPLETED|Overall Study||2
1459523|NCT02038764|3572122|P2|NOT COMPLETED|Overall Study||1
1459524|NCT02038764|3572123|P1|NOT COMPLETED|Overall Study||1
1459525|NCT02038764|3572119|P5|COMPLETED|Overall Study||7
1459526|NCT02038764|3572120|P4|COMPLETED|Overall Study||5
1459527|NCT02038764|3572121|P3|COMPLETED|Overall Study||7
1459528|NCT02038764|3572122|P2|COMPLETED|Overall Study||7
1459529|NCT02038764|3572123|P1|COMPLETED|Overall Study||6
1459530|NCT02038764|3572119|P5|STARTED|Overall Study||8
1459531|NCT02038764|3572120|P4|STARTED|Overall Study||5
1459532|NCT02038764|3572121|P3|STARTED|Overall Study||9
1459533|NCT02038764|3572122|P2|STARTED|Overall Study||8
1459534|NCT02038764|3572123|P1|STARTED|Overall Study||7
1459535|NCT02038647|3572225|P2|NOT COMPLETED|Overall Study||89
1459536|NCT02038647|3572226|P1|NOT COMPLETED|Overall Study||89
1459537|NCT02038647|3572225|P2|COMPLETED|Overall Study||0
1459538|NCT02038647|3572226|P1|COMPLETED|Overall Study||0
1459539|NCT02038647|3572225|P2|STARTED|Overall Study||89
1459540|NCT02038647|3572226|P1|STARTED|Overall Study||89
1459541|NCT02038569|3572258|P1|NOT COMPLETED|Overall Study||5
1459542|NCT02038569|3572258|P1|COMPLETED|Overall Study||102
1459543|NCT02038569|3572258|P1|STARTED|Overall Study||107
1459544|NCT02038543|3572289|P4|NOT COMPLETED|Overall Study||2
1459545|NCT02038543|3572290|P3|NOT COMPLETED|Overall Study||0
1459546|NCT02038543|3572291|P2|NOT COMPLETED|Overall Study||0
1459547|NCT02038543|3572292|P1|NOT COMPLETED|Overall Study||0
1459548|NCT02038543|3572289|P4|COMPLETED|Overall Study||1
1459549|NCT02038543|3572290|P3|COMPLETED|Overall Study||8
1459550|NCT02038543|3572291|P2|COMPLETED|Overall Study||4
1459551|NCT02038543|3572292|P1|COMPLETED|Overall Study||7
1459552|NCT02038543|3572289|P4|STARTED|Overall Study||3
1459553|NCT02038543|3572290|P3|STARTED|Overall Study||8
1459554|NCT02038543|3572291|P2|STARTED|Overall Study||4
1459555|NCT02038543|3572292|P1|STARTED|Overall Study||7
1459556|NCT02038075|3572308|P2|NOT COMPLETED|Overall Study||0
1459557|NCT02038075|3572309|P1|NOT COMPLETED|Overall Study||3
1459558|NCT02038075|3572308|P2|COMPLETED|Overall Study||76
1459559|NCT02038075|3572309|P1|COMPLETED|Overall Study||73
1459560|NCT02038075|3572308|P2|STARTED|Overall Study||76
1459561|NCT02038075|3572309|P1|STARTED|Overall Study||76
1459562|NCT02038023|3572315|P1|NOT COMPLETED|Overall Study||1
1459563|NCT02038023|3572315|P1|COMPLETED|Overall Study||73
1459564|NCT02038023|3572315|P1|STARTED|Overall Study||74
1459565|NCT02037893|3572326|P4|NOT COMPLETED|Overall Study||0
1459566|NCT02037893|3572327|P3|NOT COMPLETED|Overall Study||1
1459567|NCT02037893|3572328|P2|NOT COMPLETED|Overall Study||0
1459568|NCT02037893|3572329|P1|NOT COMPLETED|Overall Study||0
1459569|NCT02037893|3572326|P4|COMPLETED|Overall Study||28
1459570|NCT02037893|3572327|P3|COMPLETED|Overall Study||26
1459571|NCT02037893|3572328|P2|COMPLETED|Overall Study||25
1459572|NCT02037893|3572329|P1|COMPLETED|Overall Study||32
1459573|NCT02037893|3572326|P4|STARTED|Overall Study||28
1459574|NCT02037893|3572327|P3|STARTED|Overall Study||27
1459575|NCT02037893|3572328|P2|STARTED|Overall Study||25
1459576|NCT02037893|3572329|P1|STARTED|Overall Study||32
1459577|NCT02037776|3572381|P2|NOT COMPLETED|Overall Study||4
1459578|NCT02037776|3572382|P1|NOT COMPLETED|Overall Study||5
1459579|NCT02037776|3572381|P2|COMPLETED|Overall Study||60
1459580|NCT02037776|3572382|P1|COMPLETED|Overall Study||56
1459581|NCT02037776|3572381|P2|STARTED|Overall Study||64
1459582|NCT02037776|3572382|P1|STARTED|Overall Study||61
1459583|NCT02037607|3572398|P1|NOT COMPLETED|Overall Study||9
1459584|NCT02037607|3572398|P1|COMPLETED|Overall Study||91
1459585|NCT02037607|3572398|P1|STARTED|Overall Study||100
1459586|NCT02037568|3572404|P2|NOT COMPLETED|Overall Study||39
1459587|NCT02037568|3572405|P1|NOT COMPLETED|Overall Study||36
1459588|NCT02037568|3572404|P2|COMPLETED|Overall Study||37
1459589|NCT02037568|3572405|P1|COMPLETED|Overall Study||47
1459590|NCT02037568|3572404|P2|Month 6 (Post Transplantation)|Overall Study||52
1459591|NCT02037568|3572405|P1|Month 6 (Post Transplantation)|Overall Study||63
1459592|NCT02037568|3572404|P2|Month 3 (Post Transplantation)|Overall Study||62
1459593|NCT02037568|3572405|P1|Month 3 (Post Transplantation)|Overall Study||66
1459594|NCT02037568|3572404|P2|Month 1.5 (Post Transplantation)|Overall Study||76
1459595|NCT02037568|3572405|P1|Month 1.5 (Post Transplantation)|Overall Study||79
1459596|NCT02037568|3572404|P2|STARTED|Overall Study||76
1459597|NCT02037568|3572405|P1|STARTED|Overall Study||83
1459598|NCT02037477|3572431|P4|NOT COMPLETED|Treatment Period 2||0
1459599|NCT02037477|3572432|P3|NOT COMPLETED|Treatment Period 2||0
1459600|NCT02037477|3572433|P2|NOT COMPLETED|Treatment Period 2||0
1459601|NCT02037477|3572434|P1|NOT COMPLETED|Treatment Period 2||0
1459602|NCT02037477|3572431|P4|COMPLETED|Treatment Period 2||5
1459603|NCT02037477|3572432|P3|COMPLETED|Treatment Period 2||4
1459604|NCT02037477|3572433|P2|COMPLETED|Treatment Period 2||5
1459605|NCT02037477|3572434|P1|COMPLETED|Treatment Period 2||5
1459606|NCT02037477|3572431|P4|STARTED|Treatment Period 2||5
1459607|NCT02037477|3572432|P3|STARTED|Treatment Period 2||4
1459608|NCT02037477|3572433|P2|STARTED|Treatment Period 2||5
1459609|NCT02037477|3572434|P1|STARTED|Treatment Period 2||5
1459610|NCT02037477|3572431|P4|NOT COMPLETED|Treatment Period 1||0
1459611|NCT02037477|3572432|P3|NOT COMPLETED|Treatment Period 1||1
1459612|NCT02037477|3572433|P2|NOT COMPLETED|Treatment Period 1||0
1459613|NCT02037477|3572434|P1|NOT COMPLETED|Treatment Period 1||0
1459614|NCT02037477|3572431|P4|COMPLETED|Treatment Period 1||5
1459615|NCT02037477|3572432|P3|COMPLETED|Treatment Period 1||4
1459616|NCT02037477|3572433|P2|COMPLETED|Treatment Period 1||5
1459617|NCT02037477|3572434|P1|COMPLETED|Treatment Period 1||5
1459618|NCT02037477|3572431|P4|STARTED|Treatment Period 1||5
1459619|NCT02037477|3572432|P3|STARTED|Treatment Period 1||5
1459620|NCT02037477|3572433|P2|STARTED|Treatment Period 1||5
1459621|NCT02037477|3572434|P1|STARTED|Treatment Period 1||5
1459622|NCT02037425|3572460|P1|NOT COMPLETED|Overall Study||26
1459623|NCT02037425|3572460|P1|COMPLETED|Overall Study||18
1459624|NCT02037425|3572460|P1|Randomized to Treatment|Overall Study||32
1459625|NCT02037425|3572460|P1|STARTED|Overall Study||44
1459626|NCT02037347|3572502|P1|NOT COMPLETED|Overall Study||0
1459627|NCT02037347|3572502|P1|COMPLETED|Overall Study||1
1459628|NCT02037347|3572502|P1|STARTED|Overall Study||1
1459629|NCT02036840|3572508|P1|NOT COMPLETED|Overall Study||0
1459630|NCT02036840|3572508|P1|COMPLETED|Overall Study||513
1459631|NCT02036840|3572508|P1|STARTED|Overall Study||513
1459632|NCT02036775|3572512|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1459633|NCT02036775|3572513|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1459634|NCT02036775|3572514|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1459635|NCT02036775|3572515|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1459636|NCT02036775|3572516|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1459637|NCT02036775|3572517|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
1459638|NCT02036775|3572512|P6|COMPLETED|Treatment Period 3 (6 Days)||3
1459639|NCT02036775|3572513|P5|COMPLETED|Treatment Period 3 (6 Days)||4
1459640|NCT02036775|3572514|P4|COMPLETED|Treatment Period 3 (6 Days)||4
1459641|NCT02036775|3572515|P3|COMPLETED|Treatment Period 3 (6 Days)||4
1459642|NCT02036775|3572516|P2|COMPLETED|Treatment Period 3 (6 Days)||4
1459643|NCT02036775|3572517|P1|COMPLETED|Treatment Period 3 (6 Days)||4
1459644|NCT02036775|3572512|P6|STARTED|Treatment Period 3 (6 Days)||3
1459645|NCT02036775|3572513|P5|STARTED|Treatment Period 3 (6 Days)||4
1459646|NCT02036775|3572514|P4|STARTED|Treatment Period 3 (6 Days)||4
1459647|NCT02036775|3572515|P3|STARTED|Treatment Period 3 (6 Days)||4
1459648|NCT02036775|3572516|P2|STARTED|Treatment Period 3 (6 Days)||4
1459649|NCT02036775|3572517|P1|STARTED|Treatment Period 3 (6 Days)||4
1459650|NCT02036775|3572512|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
1459651|NCT02036775|3572513|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1459652|NCT02036775|3572514|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1459653|NCT02036775|3572515|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1459654|NCT02036775|3572516|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1459655|NCT02036775|3572517|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
1459656|NCT02036775|3572512|P6|COMPLETED|Treatment Period 2 (6 Days)||3
1459657|NCT02036775|3572513|P5|COMPLETED|Treatment Period 2 (6 Days)||4
1459658|NCT02036775|3572514|P4|COMPLETED|Treatment Period 2 (6 Days)||4
1459659|NCT02036775|3572515|P3|COMPLETED|Treatment Period 2 (6 Days)||4
1459660|NCT02036775|3572516|P2|COMPLETED|Treatment Period 2 (6 Days)||4
1459661|NCT02036775|3572517|P1|COMPLETED|Treatment Period 2 (6 Days)||4
1459662|NCT02036775|3572512|P6|STARTED|Treatment Period 2 (6 Days)||4
1459663|NCT02036775|3572513|P5|STARTED|Treatment Period 2 (6 Days)||4
1459664|NCT02036775|3572514|P4|STARTED|Treatment Period 2 (6 Days)||4
1459665|NCT02036775|3572515|P3|STARTED|Treatment Period 2 (6 Days)||4
1459666|NCT02036775|3572516|P2|STARTED|Treatment Period 2 (6 Days)||4
1459667|NCT02036775|3572517|P1|STARTED|Treatment Period 2 (6 Days)||4
1459668|NCT02036775|3572512|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1459669|NCT02036775|3572513|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1459670|NCT02036775|3572514|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1459671|NCT02036775|3572515|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1459672|NCT02036775|3572516|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1459673|NCT02036775|3572517|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
1459674|NCT02036775|3572512|P6|COMPLETED|Treatment Period 1 (6 Days)||4
1459675|NCT02036775|3572513|P5|COMPLETED|Treatment Period 1 (6 Days)||4
1459676|NCT02036775|3572514|P4|COMPLETED|Treatment Period 1 (6 Days)||4
1459677|NCT02036775|3572515|P3|COMPLETED|Treatment Period 1 (6 Days)||4
1459678|NCT02036775|3572516|P2|COMPLETED|Treatment Period 1 (6 Days)||4
1459679|NCT02036775|3572517|P1|COMPLETED|Treatment Period 1 (6 Days)||4
1459680|NCT02036775|3572512|P6|STARTED|Treatment Period 1 (6 Days)||4
1459681|NCT02036775|3572513|P5|STARTED|Treatment Period 1 (6 Days)||4
1459682|NCT02036775|3572514|P4|STARTED|Treatment Period 1 (6 Days)||4
1459683|NCT02036775|3572515|P3|STARTED|Treatment Period 1 (6 Days)||4
1459684|NCT02036775|3572516|P2|STARTED|Treatment Period 1 (6 Days)||4
1459685|NCT02036775|3572517|P1|STARTED|Treatment Period 1 (6 Days)||4
1459686|NCT02036580|3572558|P3|NOT COMPLETED|Overall Study||0
1459687|NCT02036580|3572559|P2|NOT COMPLETED|Overall Study||1
1459688|NCT02036580|3572560|P1|NOT COMPLETED|Overall Study||1
1459689|NCT02036580|3572558|P3|COMPLETED|Overall Study||4
1459690|NCT02036580|3572559|P2|COMPLETED|Overall Study||7
1459691|NCT02036580|3572560|P1|COMPLETED|Overall Study||7
1459692|NCT02036580|3572558|P3|STARTED|Overall Study||4
1459693|NCT02036580|3572559|P2|STARTED|Overall Study||8
1459694|NCT02036580|3572560|P1|STARTED|Overall Study||8
1459695|NCT02036541|3572573|P1|NOT COMPLETED|Overall Study||16
1459696|NCT02036541|3572573|P1|COMPLETED|Overall Study||49
1459697|NCT02036541|3572573|P1|Completed Endpoint Visit|Overall Study||54
1459698|NCT02036541|3572573|P1|STARTED|Overall Study||65
1459699|NCT02036515|3572581|P3|NOT COMPLETED|Overall Study||14
1459700|NCT02036515|3572582|P2|NOT COMPLETED|Overall Study||12
1459701|NCT02036515|3572583|P1|NOT COMPLETED|Overall Study||5
1459702|NCT02036515|3572581|P3|COMPLETED|Overall Study||139
1459703|NCT02036515|3572582|P2|COMPLETED|Overall Study||143
1459704|NCT02036515|3572583|P1|COMPLETED|Overall Study||151
1459705|NCT02036515|3572581|P3|Treated|Overall Study||153
1459706|NCT02036515|3572582|P2|Treated|Overall Study||153
1459707|NCT02036515|3572583|P1|Treated|Overall Study||156
1459708|NCT02036515|3572581|P3|STARTED|Overall Study||153
1459709|NCT02036515|3572582|P2|STARTED|Overall Study||155
1459710|NCT02036515|3572583|P1|STARTED|Overall Study||156
1459711|NCT02036424|3572662|P2|NOT COMPLETED|Overall Study||0
1459712|NCT02036424|3572663|P1|NOT COMPLETED|Overall Study||0
1459713|NCT02036424|3572662|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
1459714|NCT02036424|3572663|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
1459715|NCT02036424|3572662|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
1459716|NCT02036424|3572663|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
1459717|NCT02036320|3572671|P2|NOT COMPLETED|Period 2||0
1459718|NCT02036320|3572672|P1|NOT COMPLETED|Period 2||0
1459719|NCT02036320|3572671|P2|COMPLETED|Period 2||95
1459720|NCT02036320|3572672|P1|COMPLETED|Period 2||95
1459721|NCT02036320|3572671|P2|STARTED|Period 2||95
1459722|NCT02036320|3572672|P1|STARTED|Period 2||95
1459723|NCT02036320|3572671|P2|NOT COMPLETED|Period 1||0
1459724|NCT02036320|3572672|P1|NOT COMPLETED|Period 1||0
1459725|NCT02036320|3572671|P2|COMPLETED|Period 1||95
1459726|NCT02036320|3572672|P1|COMPLETED|Period 1||95
1459727|NCT02036320|3572671|P2|STARTED|Period 1||95
1459728|NCT02036320|3572672|P1|STARTED|Period 1||95
1459729|NCT02035748|3572682|P1|NOT COMPLETED|Overall Study||20
1459730|NCT02035748|3572682|P1|COMPLETED|Overall Study||448
1459731|NCT02035748|3572682|P1|STARTED|Overall Study||468
1459732|NCT02035696|3572696|P4|NOT COMPLETED|Overall Study||3
1459733|NCT02035696|3572697|P3|NOT COMPLETED|Overall Study||3
1459734|NCT02035696|3572698|P2|NOT COMPLETED|Overall Study||3
1459735|NCT02035696|3572699|P1|NOT COMPLETED|Overall Study||3
1459736|NCT02035696|3572696|P4|COMPLETED|Overall Study||161
1459737|NCT02035696|3572697|P3|COMPLETED|Overall Study||164
1459738|NCT02035696|3572698|P2|COMPLETED|Overall Study||163
1459739|NCT02035696|3572699|P1|COMPLETED|Overall Study||171
1459740|NCT02035696|3572696|P4|STARTED|Overall Study||164
1459741|NCT02035696|3572697|P3|STARTED|Overall Study||167
1459742|NCT02035696|3572698|P2|STARTED|Overall Study||166
1459743|NCT02035696|3572699|P1|STARTED|Overall Study||174
1459744|NCT02035553|3572755|P2|NOT COMPLETED|Overall Study||23
1459745|NCT02035553|3572756|P1|NOT COMPLETED|Overall Study||18
1459746|NCT02035553|3572755|P2|COMPLETED|Overall Study||67
1459747|NCT02035553|3572756|P1|COMPLETED|Overall Study||73
1459748|NCT02035553|3572755|P2|STARTED|Overall Study||90
1459749|NCT02035553|3572756|P1|STARTED|Overall Study||91
1459750|NCT02035475|3572762|P1|NOT COMPLETED|Overall Study||6
1459751|NCT02035475|3572762|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
1459752|NCT02035475|3572762|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
1459753|NCT02035345|3572768|P1|NOT COMPLETED|Overall Study||0
1459754|NCT02035345|3572768|P1|COMPLETED|Overall Study||15
1459755|NCT02035345|3572768|P1|STARTED|Overall Study||15
1459756|NCT02035332|3572773|P1|NOT COMPLETED|Overall Study||1
1459757|NCT02035332|3572773|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
1459758|NCT02035332|3572773|P1|Treated|Overall Study|Treatment Completed|20
1459759|NCT02035332|3572773|P1|STARTED|Overall Study|Treatment Attempted|21
1459760|NCT02034916|3572781|P2|NOT COMPLETED|Overall Study||35
1459761|NCT02034916|3572782|P1|NOT COMPLETED|Overall Study||49
1459762|NCT02034916|3572781|P2|COMPLETED|Overall Study||0
1459763|NCT02034916|3572782|P1|COMPLETED|Overall Study||0
1459764|NCT02034916|3572781|P2|Treated|Overall Study||35
1459765|NCT02034916|3572782|P1|Treated|Overall Study||48
1459766|NCT02034916|3572781|P2|STARTED|Overall Study||35
1459767|NCT02034916|3572782|P1|STARTED|Overall Study||49
1459768|NCT02034877|3572817|P2|NOT COMPLETED|Overall Study||6
1459769|NCT02034877|3572818|P1|NOT COMPLETED|Overall Study||0
1459770|NCT02034877|3572817|P2|COMPLETED|Overall Study||993
1459771|NCT02034877|3572818|P1|COMPLETED|Overall Study||200
1459772|NCT02034877|3572817|P2|STARTED|Overall Study||999
1459773|NCT02034877|3572818|P1|STARTED|Overall Study||200
1459774|NCT02034799|3572836|P2|NOT COMPLETED|Overall Study||4
1459775|NCT02034799|3572837|P1|NOT COMPLETED|Overall Study||2
1459776|NCT02034799|3572836|P2|COMPLETED|Overall Study||123
1459777|NCT02034799|3572837|P1|COMPLETED|Overall Study||127
1459778|NCT02034799|3572836|P2|STARTED|Overall Study||127
1459779|NCT02034799|3572837|P1|STARTED|Overall Study||129
1459780|NCT02034708|3572851|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
1459781|NCT02034708|3572852|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
1459782|NCT02034708|3572851|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
1459783|NCT02034708|3572852|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
1459784|NCT02034708|3572851|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
1459785|NCT02034708|3572852|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
1459786|NCT02034708|3572851|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
1459787|NCT02034708|3572852|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
1459788|NCT02034708|3572851|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
1459789|NCT02034708|3572852|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
1459790|NCT02034708|3572851|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
1459791|NCT02034708|3572852|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
1459792|NCT02034708|3572851|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
1459793|NCT02034708|3572852|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
1459794|NCT02034708|3572851|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
1459795|NCT02034708|3572852|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
1459796|NCT02034708|3572851|P2|STARTED|First Contrast Agent Injection (1 Day)||130
1459797|NCT02034708|3572852|P1|STARTED|First Contrast Agent Injection (1 Day)||138
1459798|NCT02034591|3572863|P6|NOT COMPLETED|Overall Study||0
1459799|NCT02034591|3572864|P5|NOT COMPLETED|Overall Study||1
1459800|NCT02034591|3572865|P4|NOT COMPLETED|Overall Study||0
1459801|NCT02034591|3572866|P3|NOT COMPLETED|Overall Study||0
1459802|NCT02034591|3572867|P2|NOT COMPLETED|Overall Study||0
1459803|NCT02034591|3572868|P1|NOT COMPLETED|Overall Study||0
1459804|NCT02034591|3572863|P6|COMPLETED|Overall Study||3
1459805|NCT02034591|3572864|P5|COMPLETED|Overall Study||3
1459806|NCT02034591|3572865|P4|COMPLETED|Overall Study||3
1459807|NCT02034591|3572866|P3|COMPLETED|Overall Study||4
1459808|NCT02034591|3572867|P2|COMPLETED|Overall Study||3
1459809|NCT02034591|3572868|P1|COMPLETED|Overall Study||4
1459810|NCT02034591|3572863|P6|STARTED|Overall Study||3
1459811|NCT02034591|3572864|P5|STARTED|Overall Study||4
1459812|NCT02034591|3572865|P4|STARTED|Overall Study||3
1459813|NCT02034591|3572866|P3|STARTED|Overall Study||4
1459814|NCT02034591|3572867|P2|STARTED|Overall Study||3
1459815|NCT02034591|3572868|P1|STARTED|Overall Study||4
1459816|NCT02034578|3572891|P6|NOT COMPLETED|Overall Study||0
1459817|NCT02034578|3572892|P5|NOT COMPLETED|Overall Study||0
1459818|NCT02034578|3572893|P4|NOT COMPLETED|Overall Study||0
1459819|NCT02034578|3572894|P3|NOT COMPLETED|Overall Study||0
1459820|NCT02034578|3572895|P2|NOT COMPLETED|Overall Study||0
1459821|NCT02034578|3572896|P1|NOT COMPLETED|Overall Study||0
1459822|NCT02034578|3572891|P6|COMPLETED|Overall Study||3
1459823|NCT02034578|3572892|P5|COMPLETED|Overall Study||4
1459824|NCT02034578|3572893|P4|COMPLETED|Overall Study||3
1459825|NCT02034578|3572894|P3|COMPLETED|Overall Study||4
1459826|NCT02034578|3572895|P2|COMPLETED|Overall Study||3
1459827|NCT02034578|3572896|P1|COMPLETED|Overall Study||4
1459828|NCT02034578|3572891|P6|STARTED|Overall Study||3
1459829|NCT02034578|3572892|P5|STARTED|Overall Study||4
1459830|NCT02034578|3572893|P4|STARTED|Overall Study||3
1459831|NCT02034578|3572894|P3|STARTED|Overall Study||4
1459832|NCT02034578|3572895|P2|STARTED|Overall Study||3
1459833|NCT02034578|3572896|P1|STARTED|Overall Study||4
1459834|NCT02034565|3572923|P2|NOT COMPLETED|Overall Study||0
1459835|NCT02034565|3572924|P1|NOT COMPLETED|Overall Study||1
1459836|NCT02034565|3572923|P2|COMPLETED|Overall Study||7
1459837|NCT02034565|3572924|P1|COMPLETED|Overall Study||6
1459838|NCT02034565|3572923|P2|STARTED|Overall Study||7
1459839|NCT02034565|3572924|P1|STARTED|Overall Study||7
1459840|NCT02034552|3572941|P3|NOT COMPLETED|Overall Study||15
1459841|NCT02034552|3572942|P2|NOT COMPLETED|Overall Study||17
1459842|NCT02034552|3572943|P1|NOT COMPLETED|Overall Study||6
1459843|NCT02034552|3572941|P3|COMPLETED|Overall Study||7
1459844|NCT02034552|3572942|P2|COMPLETED|Overall Study||7
1459845|NCT02034552|3572943|P1|COMPLETED|Overall Study||16
1459846|NCT02034552|3572941|P3|Received Treatment|Overall Study||22
1459847|NCT02034552|3572942|P2|Received Treatment|Overall Study||22
1459848|NCT02034552|3572943|P1|Received Treatment|Overall Study||19
1459849|NCT02034552|3572941|P3|STARTED|Overall Study||22
1459850|NCT02034552|3572942|P2|STARTED|Overall Study||24
1459851|NCT02034552|3572943|P1|STARTED|Overall Study||22
1459852|NCT02034513|3572968|P2|NOT COMPLETED|Overall Study||57
1459853|NCT02034513|3572969|P1|NOT COMPLETED|Overall Study||49
1459854|NCT02034513|3572968|P2|COMPLETED|Overall Study||195
1459855|NCT02034513|3572969|P1|COMPLETED|Overall Study||200
1459856|NCT02034513|3572968|P2|Exposed|Overall Study||251
1459857|NCT02034513|3572969|P1|Exposed|Overall Study||249
1459858|NCT02034513|3572968|P2|STARTED|Overall Study||252
1459859|NCT02034513|3572969|P1|STARTED|Overall Study||249
1459860|NCT02034474|3572987|P2|NOT COMPLETED|Overall Study||4
1459861|NCT02034474|3572988|P1|NOT COMPLETED|Overall Study||4
1459862|NCT02034474|3572987|P2|COMPLETED|Overall Study||13
1459863|NCT02034474|3572988|P1|COMPLETED|Overall Study||15
1459864|NCT02034474|3572987|P2|3 Doses|Overall Study||13
1459865|NCT02034474|3572988|P1|3 Doses|Overall Study||15
1459866|NCT02034474|3572987|P2|2 Doses|Overall Study||0
1459867|NCT02034474|3572988|P1|2 Doses|Overall Study||2
1459868|NCT02034474|3572987|P2|1 Dose|Overall Study||4
1459869|NCT02034474|3572988|P1|1 Dose|Overall Study||2
1459870|NCT02034474|3572987|P2|STARTED|Overall Study||17
1459871|NCT02034474|3572988|P1|STARTED|Overall Study||19
1459872|NCT02034162|3573000|P3|NOT COMPLETED|Open-label||0
1459873|NCT02034162|3573001|P2|NOT COMPLETED|Open-label||0
1459874|NCT02034162|3573002|P1|NOT COMPLETED|Open-label||0
1459875|NCT02034162|3573000|P3|COMPLETED|Open-label||278
1459876|NCT02034162|3573001|P2|COMPLETED|Open-label||0
1459877|NCT02034162|3573002|P1|COMPLETED|Open-label||0
1459878|NCT02034162|3573000|P3|STARTED|Open-label||278
1459879|NCT02034162|3573001|P2|STARTED|Open-label||0
1459880|NCT02034162|3573002|P1|STARTED|Open-label||0
1459881|NCT02034162|3573000|P3|NOT COMPLETED|Double-blind||0
1459882|NCT02034162|3573001|P2|NOT COMPLETED|Double-blind||8
1459883|NCT02034162|3573002|P1|NOT COMPLETED|Double-blind||9
1459884|NCT02034162|3573000|P3|COMPLETED|Double-blind||0
1459885|NCT02034162|3573001|P2|COMPLETED|Double-blind||141
1459886|NCT02034162|3573002|P1|COMPLETED|Double-blind||137
1459887|NCT02034162|3573000|P3|STARTED|Double-blind||0
1459888|NCT02034162|3573001|P2|STARTED|Double-blind||149
1459889|NCT02034162|3573002|P1|STARTED|Double-blind||146
1459890|NCT02033889|3573033|P3|NOT COMPLETED|Overall Study||25
1459891|NCT02033889|3573034|P2|NOT COMPLETED|Overall Study||20
1459892|NCT02033889|3573035|P1|NOT COMPLETED|Overall Study||34
1459893|NCT02033889|3573033|P3|COMPLETED|Overall Study||180
1459894|NCT02033889|3573034|P2|COMPLETED|Overall Study||187
1459895|NCT02033889|3573035|P1|COMPLETED|Overall Study||175
1459896|NCT02033889|3573033|P3|STARTED|Overall Study||205
1459897|NCT02033889|3573034|P2|STARTED|Overall Study||207
1459898|NCT02033889|3573035|P1|STARTED|Overall Study||209
1459899|NCT02033499|3573190|P3|NOT COMPLETED|Overall Study||9
1459900|NCT02033499|3573191|P2|NOT COMPLETED|Overall Study||8
1459901|NCT02033499|3573192|P1|NOT COMPLETED|Overall Study||5
1459902|NCT02033499|3573190|P3|COMPLETED|Overall Study||139
1459903|NCT02033499|3573191|P2|COMPLETED|Overall Study||142
1459904|NCT02033499|3573192|P1|COMPLETED|Overall Study||147
1459905|NCT02033499|3573190|P3|STARTED|Overall Study||148
1459906|NCT02033499|3573191|P2|STARTED|Overall Study||150
1459907|NCT02033499|3573192|P1|STARTED|Overall Study||152
1459908|NCT02033369|3573232|P2|NOT COMPLETED|Overall Study||5
1459909|NCT02033369|3573233|P1|NOT COMPLETED|Overall Study||5
1459910|NCT02033369|3573232|P2|COMPLETED|Overall Study||21
1459911|NCT02033369|3573233|P1|COMPLETED|Overall Study||21
1459912|NCT02033369|3573232|P2|STARTED|Overall Study||26
1459913|NCT02033369|3573233|P1|STARTED|Overall Study||26
1459914|NCT02033317|3573243|P1|NOT COMPLETED|Overall Study||0
1459915|NCT02033317|3573243|P1|COMPLETED|Overall Study||6
1459916|NCT02033317|3573243|P1|STARTED|Overall Study||6
1459917|NCT02033213|3573250|P2|NOT COMPLETED|Overall Study||0
1459918|NCT02033213|3573251|P1|NOT COMPLETED|Overall Study||0
1459919|NCT02033213|3573250|P2|COMPLETED|Overall Study||8
1459920|NCT02033213|3573251|P1|COMPLETED|Overall Study||8
1459921|NCT02033213|3573250|P2|STARTED|Overall Study||8
1459922|NCT02033213|3573251|P1|STARTED|Overall Study||8
1459923|NCT02033200|3573269|P2|NOT COMPLETED|Overall Study||0
1459924|NCT02033200|3573270|P1|NOT COMPLETED|Overall Study||0
1459925|NCT02033200|3573269|P2|COMPLETED|Overall Study||40
1459926|NCT02033200|3573270|P1|COMPLETED|Overall Study||40
1459927|NCT02033200|3573269|P2|STARTED|Overall Study||40
1459928|NCT02033200|3573270|P1|STARTED|Overall Study||40
1459929|NCT02033174|3573290|P2|NOT COMPLETED|Second Intervention||0
1459930|NCT02033174|3573291|P1|NOT COMPLETED|Second Intervention||0
1459931|NCT02033174|3573290|P2|COMPLETED|Second Intervention||8
1459932|NCT02033174|3573291|P1|COMPLETED|Second Intervention||8
1459933|NCT02033174|3573290|P2|STARTED|Second Intervention||8
1459934|NCT02033174|3573291|P1|STARTED|Second Intervention||8
1459935|NCT02033174|3573290|P2|NOT COMPLETED|Washout (1 Week)||0
1459936|NCT02033174|3573291|P1|NOT COMPLETED|Washout (1 Week)||0
1459937|NCT02033174|3573290|P2|COMPLETED|Washout (1 Week)||8
1459938|NCT02033174|3573291|P1|COMPLETED|Washout (1 Week)||8
1459939|NCT02033174|3573290|P2|STARTED|Washout (1 Week)||8
1459940|NCT02033174|3573291|P1|STARTED|Washout (1 Week)||8
1459941|NCT02033174|3573290|P2|NOT COMPLETED|First Intervention||0
1459942|NCT02033174|3573291|P1|NOT COMPLETED|First Intervention||0
1459943|NCT02033174|3573290|P2|COMPLETED|First Intervention||8
1459944|NCT02033174|3573291|P1|COMPLETED|First Intervention||8
1459945|NCT02033174|3573290|P2|STARTED|First Intervention||8
1459946|NCT02033174|3573291|P1|STARTED|First Intervention||8
1459947|NCT02033083|3573299|P2|NOT COMPLETED|Overall Study||1
1459948|NCT02033083|3573300|P1|NOT COMPLETED|Overall Study||1
1459949|NCT02033083|3573299|P2|COMPLETED|Overall Study||88
1459950|NCT02033083|3573300|P1|COMPLETED|Overall Study||88
1459951|NCT02033083|3573299|P2|STARTED|Overall Study||89
1459952|NCT02033083|3573300|P1|STARTED|Overall Study||89
1459953|NCT02032901|3573308|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
1459954|NCT02032901|3573309|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
1459955|NCT02032901|3573308|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
1459956|NCT02032901|3573309|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
1459957|NCT02032901|3573308|P2|STARTED|Follow-Up Period (24 Weeks)||51
1459958|NCT02032901|3573309|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
1459959|NCT02032901|3573308|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
1459960|NCT02032901|3573309|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
1459961|NCT02032901|3573308|P2|COMPLETED|Treatment Period (12 Weeks)||51
1459962|NCT02032901|3573309|P1|COMPLETED|Treatment Period (12 Weeks)||100
1459963|NCT02032901|3573308|P2|STARTED|Treatment Period (12 Weeks)||51
1459964|NCT02032901|3573309|P1|STARTED|Treatment Period (12 Weeks)||101
1459965|NCT02032888|3573333|P3|NOT COMPLETED|Follow-up Period||0
1459966|NCT02032888|3573334|P2|NOT COMPLETED|Follow-up Period||2
1459967|NCT02032888|3573335|P1|NOT COMPLETED|Follow-up Period||3
1459968|NCT02032888|3573333|P3|COMPLETED|Follow-up Period||52
1459969|NCT02032888|3573334|P2|COMPLETED|Follow-up Period||47
1459970|NCT02032888|3573335|P1|COMPLETED|Follow-up Period||97
1459971|NCT02032888|3573333|P3|STARTED|Follow-up Period||52
1459972|NCT02032888|3573334|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
1459973|NCT02032888|3573335|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
1459974|NCT02032888|3573333|P3|NOT COMPLETED|Treatment Period||0
1459975|NCT02032888|3573334|P2|NOT COMPLETED|Treatment Period||2
1459976|NCT02032888|3573335|P1|NOT COMPLETED|Treatment Period||2
1459977|NCT02032888|3573333|P3|COMPLETED|Treatment Period||52
1459978|NCT02032888|3573334|P2|COMPLETED|Treatment Period||48
1459979|NCT02032888|3573335|P1|COMPLETED|Treatment Period||99
1459980|NCT02032888|3573333|P3|STARTED|Treatment Period||52
1459981|NCT02032888|3573334|P2|STARTED|Treatment Period||50
1459982|NCT02032888|3573335|P1|STARTED|Treatment Period||101
1459983|NCT02032875|3573366|P2|NOT COMPLETED|Follow-up Period||11
1459984|NCT02032875|3573367|P1|NOT COMPLETED|Follow-up Period||3
1459985|NCT02032875|3573366|P2|COMPLETED|Follow-up Period||46
1459986|NCT02032875|3573367|P1|COMPLETED|Follow-up Period||50
1459987|NCT02032875|3573366|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
1459988|NCT02032875|3573367|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
1459989|NCT02032875|3573366|P2|NOT COMPLETED|Treatment Period||4
1459990|NCT02032875|3573367|P1|NOT COMPLETED|Treatment Period||1
1459991|NCT02032875|3573366|P2|COMPLETED|Treatment Period||56
1459992|NCT02032875|3573367|P1|COMPLETED|Treatment Period||52
1459993|NCT02032875|3573366|P2|STARTED|Treatment Period||60
1459994|NCT02032875|3573367|P1|STARTED|Treatment Period||53
1459995|NCT02032758|3573387|P2|NOT COMPLETED|Overall Study||0
1459996|NCT02032758|3573388|P1|NOT COMPLETED|Overall Study||0
1459997|NCT02032758|3573387|P2|COMPLETED|Overall Study||11
1459998|NCT02032758|3573388|P1|COMPLETED|Overall Study||27
1459999|NCT02032758|3573387|P2|STARTED|Overall Study||11
1460000|NCT02032758|3573388|P1|STARTED|Overall Study||27
1460001|NCT02032706|3573396|P1|NOT COMPLETED|Overall Study||6
1460002|NCT02032706|3573396|P1|COMPLETED|Overall Study||30
1460003|NCT02032706|3573396|P1|STARTED|Overall Study||36
1460004|NCT02032641|3573409|P1|NOT COMPLETED|Overall Study||1
1460005|NCT02032641|3573409|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
1460006|NCT02032641|3573409|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
1460007|NCT02032433|3573421|P2|NOT COMPLETED|Overall Study||62
1460008|NCT02032433|3573422|P1|NOT COMPLETED|Overall Study||78
1460009|NCT02032433|3573421|P2|COMPLETED|Overall Study||225
1460010|NCT02032433|3573422|P1|COMPLETED|Overall Study||205
1460011|NCT02032433|3573421|P2|STARTED|Overall Study||287
1460012|NCT02032433|3573422|P1|STARTED|Overall Study||283
1460013|NCT02032420|3573440|P2|NOT COMPLETED|Overall Study||0
1460014|NCT02032420|3573441|P1|NOT COMPLETED|Overall Study||0
1460015|NCT02032420|3573440|P2|COMPLETED|Overall Study||17
1460016|NCT02032420|3573441|P1|COMPLETED|Overall Study||18
1460017|NCT02032420|3573440|P2|STARTED|Overall Study||17
1460018|NCT02032420|3573441|P1|STARTED|Overall Study||18
1460019|NCT02032407|3573453|P1|NOT COMPLETED|Overall Study||5
1460020|NCT02032407|3573453|P1|COMPLETED|Overall Study||63
1460021|NCT02032407|3573453|P1|STARTED|Overall Study||68
1460022|NCT02032238|3573466|P2|NOT COMPLETED|Overall Study||0
1460023|NCT02032238|3573467|P1|NOT COMPLETED|Overall Study||2
1460024|NCT02032238|3573466|P2|COMPLETED|Overall Study||0
1460025|NCT02032238|3573467|P1|COMPLETED|Overall Study||10
1460026|NCT02032238|3573466|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
1460027|NCT02032238|3573467|P1|STARTED|Overall Study||12
1460028|NCT02032212|3573477|P4|NOT COMPLETED|Overall Study||0
1460029|NCT02032212|3573478|P3|NOT COMPLETED|Overall Study||0
1460030|NCT02032212|3573479|P2|NOT COMPLETED|Overall Study||0
1460031|NCT02032212|3573480|P1|NOT COMPLETED|Overall Study||0
1460032|NCT02032212|3573477|P4|COMPLETED|Overall Study||3
1460033|NCT02032212|3573478|P3|COMPLETED|Overall Study||3
1460034|NCT02032212|3573479|P2|COMPLETED|Overall Study||3
1460035|NCT02032212|3573480|P1|COMPLETED|Overall Study||3
1460036|NCT02032212|3573477|P4|STARTED|Overall Study||3
1460037|NCT02032212|3573478|P3|STARTED|Overall Study||3
1460038|NCT02032212|3573479|P2|STARTED|Overall Study||3
1460039|NCT02032212|3573480|P1|STARTED|Overall Study||3
1460040|NCT02031679|3573508|P2|NOT COMPLETED|Overall Study||2
1460041|NCT02031679|3573509|P1|NOT COMPLETED|Overall Study||0
1460042|NCT02031679|3573508|P2|COMPLETED|Overall Study||12
1460043|NCT02031679|3573509|P1|COMPLETED|Overall Study||14
1460044|NCT02031679|3573508|P2|STARTED|Overall Study||14
1460045|NCT02031679|3573509|P1|STARTED|Overall Study||14
1460046|NCT02031640|3573524|P6|NOT COMPLETED|Double-blind Treatment Period||3
1460047|NCT02031640|3573525|P5|NOT COMPLETED|Double-blind Treatment Period||11
1460048|NCT02031640|3573526|P4|NOT COMPLETED|Double-blind Treatment Period||7
1460049|NCT02031640|3573527|P3|NOT COMPLETED|Double-blind Treatment Period||6
1460050|NCT02031640|3573528|P2|NOT COMPLETED|Double-blind Treatment Period||22
1460051|NCT02031640|3573529|P1|NOT COMPLETED|Double-blind Treatment Period||0
1460052|NCT02031640|3573524|P6|COMPLETED|Double-blind Treatment Period||104
1460053|NCT02031640|3573525|P5|COMPLETED|Double-blind Treatment Period||96
1460054|NCT02031640|3573526|P4|COMPLETED|Double-blind Treatment Period||99
1460055|NCT02031640|3573527|P3|COMPLETED|Double-blind Treatment Period||100
1460056|NCT02031640|3573528|P2|COMPLETED|Double-blind Treatment Period||84
1460057|NCT02031640|3573529|P1|COMPLETED|Double-blind Treatment Period||0
1460058|NCT02031640|3573524|P6|Full Analysis Set|Double-blind Treatment Period||107
1460059|NCT02031640|3573525|P5|Full Analysis Set|Double-blind Treatment Period||106
1460060|NCT02031640|3573526|P4|Full Analysis Set|Double-blind Treatment Period||106
1460061|NCT02031640|3573527|P3|Full Analysis Set|Double-blind Treatment Period||104
1460062|NCT02031640|3573528|P2|Full Analysis Set|Double-blind Treatment Period||106
1460063|NCT02031640|3573529|P1|Full Analysis Set|Double-blind Treatment Period||0
1460064|NCT02031640|3573524|P6|STARTED|Double-blind Treatment Period||107
1460065|NCT02031640|3573525|P5|STARTED|Double-blind Treatment Period||107
1460066|NCT02031640|3573526|P4|STARTED|Double-blind Treatment Period||106
1460067|NCT02031640|3573527|P3|STARTED|Double-blind Treatment Period||106
1460068|NCT02031640|3573528|P2|STARTED|Double-blind Treatment Period||106
1460069|NCT02031640|3573529|P1|STARTED|Double-blind Treatment Period||0
1460070|NCT02031640|3573524|P6|NOT COMPLETED|Run-In Period||0
1460071|NCT02031640|3573525|P5|NOT COMPLETED|Run-In Period||0
1460072|NCT02031640|3573526|P4|NOT COMPLETED|Run-In Period||0
1460073|NCT02031640|3573527|P3|NOT COMPLETED|Run-In Period||0
1460074|NCT02031640|3573528|P2|NOT COMPLETED|Run-In Period||0
1460075|NCT02031640|3573529|P1|NOT COMPLETED|Run-In Period||169
1460076|NCT02031640|3573524|P6|COMPLETED|Run-In Period||0
1460077|NCT02031640|3573525|P5|COMPLETED|Run-In Period||0
1460078|NCT02031640|3573526|P4|COMPLETED|Run-In Period||0
1460079|NCT02031640|3573527|P3|COMPLETED|Run-In Period||0
1460080|NCT02031640|3573528|P2|COMPLETED|Run-In Period||0
1460081|NCT02031640|3573529|P1|COMPLETED|Run-In Period||532
1460082|NCT02031640|3573524|P6|STARTED|Run-In Period||0
1460083|NCT02031640|3573525|P5|STARTED|Run-In Period||0
1460084|NCT02031640|3573526|P4|STARTED|Run-In Period||0
1460085|NCT02031640|3573527|P3|STARTED|Run-In Period||0
1460086|NCT02031640|3573528|P2|STARTED|Run-In Period||0
1460087|NCT02031640|3573529|P1|STARTED|Run-In Period||701
1460088|NCT02031640|3573524|P6|NOT COMPLETED|Screening Period||0
1460089|NCT02031640|3573525|P5|NOT COMPLETED|Screening Period||0
1460090|NCT02031640|3573526|P4|NOT COMPLETED|Screening Period||0
1460091|NCT02031640|3573527|P3|NOT COMPLETED|Screening Period||0
1460092|NCT02031640|3573528|P2|NOT COMPLETED|Screening Period||0
1460093|NCT02031640|3573529|P1|NOT COMPLETED|Screening Period||412
1460094|NCT02031640|3573524|P6|COMPLETED|Screening Period||0
1460095|NCT02031640|3573525|P5|COMPLETED|Screening Period||0
1460096|NCT02031640|3573526|P4|COMPLETED|Screening Period||0
1460097|NCT02031640|3573527|P3|COMPLETED|Screening Period||0
1460098|NCT02031640|3573528|P2|COMPLETED|Screening Period||0
1460099|NCT02031640|3573529|P1|COMPLETED|Screening Period||701
1460100|NCT02031640|3573524|P6|STARTED|Screening Period||0
1460101|NCT02031640|3573525|P5|STARTED|Screening Period||0
1460102|NCT02031640|3573526|P4|STARTED|Screening Period||0
1460103|NCT02031640|3573527|P3|STARTED|Screening Period||0
1460104|NCT02031640|3573528|P2|STARTED|Screening Period||0
1460105|NCT02031640|3573529|P1|STARTED|Screening Period|Consented|1113
1460106|NCT02031471|3573572|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
1460107|NCT02031471|3573572|P1|COMPLETED|Long Term Extension (LTE) Period||37
1460108|NCT02031471|3573572|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
1460109|NCT02031471|3573572|P1|NOT COMPLETED|24 Week Treatment Period||11
1460110|NCT02031471|3573572|P1|COMPLETED|24 Week Treatment Period||46
1460111|NCT02031471|3573572|P1|STARTED|24 Week Treatment Period||57
1460112|NCT02031458|3573605|P3|NOT COMPLETED|Overall Study||253
1460113|NCT02031458|3573606|P2|NOT COMPLETED|Overall Study||267
1460114|NCT02031458|3573607|P1|NOT COMPLETED|Overall Study||139
1460115|NCT02031458|3573605|P3|COMPLETED|Overall Study||0
1460116|NCT02031458|3573606|P2|COMPLETED|Overall Study||0
1460117|NCT02031458|3573607|P1|COMPLETED|Overall Study||0
1460118|NCT02031458|3573605|P3|STARTED|Overall Study||253
1460119|NCT02031458|3573606|P2|STARTED|Overall Study||267
1460120|NCT02031458|3573607|P1|STARTED|Overall Study||139
1460121|NCT02031276|3573704|P3|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
1460122|NCT02031276|3573705|P2|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
1460123|NCT02031276|3573706|P1|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
1460124|NCT02031276|3573704|P3|COMPLETED|Period 3 Open-label Risankizumab SC||19
1460125|NCT02031276|3573705|P2|COMPLETED|Period 3 Open-label Risankizumab SC||19
1460126|NCT02031276|3573706|P1|COMPLETED|Period 3 Open-label Risankizumab SC||16
1460127|NCT02031276|3573704|P3|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
1460128|NCT02031276|3573705|P2|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
1460129|NCT02031276|3573706|P1|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
1460130|NCT02031276|3573704|P3|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
1460131|NCT02031276|3573705|P2|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
1460132|NCT02031276|3573706|P1|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
1460133|NCT02031276|3573704|P3|COMPLETED|Period 2 Open-label Risankizumab IV||38
1460134|NCT02031276|3573705|P2|COMPLETED|Period 2 Open-label Risankizumab IV||33
1460135|NCT02031276|3573706|P1|COMPLETED|Period 2 Open-label Risankizumab IV||29
1460136|NCT02031276|3573704|P3|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
1460137|NCT02031276|3573705|P2|STARTED|Period 2 Open-label Risankizumab IV||35
1460138|NCT02031276|3573706|P1|STARTED|Period 2 Open-label Risankizumab IV||33
1460139|NCT02031276|3573704|P3|NOT COMPLETED|Period 1 Double-blind IV||1
1460140|NCT02031276|3573705|P2|NOT COMPLETED|Period 1 Double-blind IV||6
1460141|NCT02031276|3573706|P1|NOT COMPLETED|Period 1 Double-blind IV||6
1460142|NCT02031276|3573704|P3|COMPLETED|Period 1 Double-blind IV||40
1460143|NCT02031276|3573705|P2|COMPLETED|Period 1 Double-blind IV||35
1460144|NCT02031276|3573706|P1|COMPLETED|Period 1 Double-blind IV||33
1460145|NCT02031276|3573704|P3|STARTED|Period 1 Double-blind IV||41
1460146|NCT02031276|3573705|P2|STARTED|Period 1 Double-blind IV||41
1460147|NCT02031276|3573706|P1|STARTED|Period 1 Double-blind IV||39
1460148|NCT02030821|3573742|P4|NOT COMPLETED|Overall Study||2
1460149|NCT02030821|3573743|P3|NOT COMPLETED|Overall Study||5
1460150|NCT02030821|3573744|P2|NOT COMPLETED|Overall Study||2
1460151|NCT02030821|3573745|P1|NOT COMPLETED|Overall Study||2
1460152|NCT02030821|3573742|P4|COMPLETED|Overall Study||72
1460153|NCT02030821|3573743|P3|COMPLETED|Overall Study||73
1460154|NCT02030821|3573744|P2|COMPLETED|Overall Study||44
1460155|NCT02030821|3573745|P1|COMPLETED|Overall Study||46
1460156|NCT02030821|3573742|P4|STARTED|Overall Study||74
1460157|NCT02030821|3573743|P3|STARTED|Overall Study||78
1460158|NCT02030821|3573744|P2|STARTED|Overall Study||46
1460159|NCT02030821|3573745|P1|STARTED|Overall Study||48
1460160|NCT02030600|3573773|P2|NOT COMPLETED|Treatment Period 2||18
1460161|NCT02030600|3573774|P1|NOT COMPLETED|Treatment Period 2||25
1460162|NCT02030600|3573773|P2|COMPLETED|Treatment Period 2||297
1460163|NCT02030600|3573774|P1|COMPLETED|Treatment Period 2||283
1460164|NCT02030600|3573773|P2|STARTED|Treatment Period 2||315
1460165|NCT02030600|3573774|P1|STARTED|Treatment Period 2||308
1460166|NCT02030600|3573773|P2|NOT COMPLETED|Treatment Period 1||45
1460167|NCT02030600|3573774|P1|NOT COMPLETED|Treatment Period 1||53
1460168|NCT02030600|3573773|P2|COMPLETED|Treatment Period 1||315
1460169|NCT02030600|3573774|P1|COMPLETED|Treatment Period 1||308
1460170|NCT02030600|3573773|P2|Exposed|Treatment Period 1||357
1460171|NCT02030600|3573774|P1|Exposed|Treatment Period 1||356
1460172|NCT02030600|3573773|P2|STARTED|Treatment Period 1||360
1460173|NCT02030600|3573774|P1|STARTED|Treatment Period 1||361
1460174|NCT02030574|3573790|P1|NOT COMPLETED|Overall Study||0
1460175|NCT02030574|3573790|P1|COMPLETED|Overall Study||2
1460176|NCT02030574|3573790|P1|STARTED|Overall Study||2
1460177|NCT02030535|3573795|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1460178|NCT02030535|3573795|P1|COMPLETED|Treatment Period 3 (1 Day)||52
1460179|NCT02030535|3573795|P1|STARTED|Treatment Period 3 (1 Day)||52
1460180|NCT02030535|3573795|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
1460181|NCT02030535|3573795|P1|COMPLETED|Washout Period 2 (21 Days)||52
1460182|NCT02030535|3573795|P1|STARTED|Washout Period 2 (21 Days)||52
1460183|NCT02030535|3573795|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1460184|NCT02030535|3573795|P1|COMPLETED|Treatment Period 2 (1 Day)||52
1460185|NCT02030535|3573795|P1|STARTED|Treatment Period 2 (1 Day)||52
1460186|NCT02030535|3573795|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
1460187|NCT02030535|3573795|P1|COMPLETED|Washout Period 1 (21 Days)||52
1460188|NCT02030535|3573795|P1|STARTED|Washout Period 1 (21 Days)||53
1460189|NCT02030535|3573795|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1460190|NCT02030535|3573795|P1|COMPLETED|Treatment Period 1 (1 Day)||53
1460191|NCT02030535|3573795|P1|STARTED|Treatment Period 1 (1 Day)||53
1460192|NCT02030405|3573863|P1|NOT COMPLETED|Overall Study||2
1460193|NCT02030405|3573863|P1|COMPLETED|Overall Study||2
1460194|NCT02030405|3573863|P1|STARTED|Overall Study||4
1460195|NCT02030119|3573872|P4|NOT COMPLETED|Overall Study||3
1460196|NCT02030119|3573873|P3|NOT COMPLETED|Overall Study||6
1460197|NCT02030119|3573874|P2|NOT COMPLETED|Overall Study||2
1460198|NCT02030119|3573875|P1|NOT COMPLETED|Overall Study||3
1460199|NCT02030119|3573872|P4|COMPLETED|Overall Study||67
1460200|NCT02030119|3573873|P3|COMPLETED|Overall Study||65
1460201|NCT02030119|3573874|P2|COMPLETED|Overall Study||68
1460202|NCT02030119|3573875|P1|COMPLETED|Overall Study||67
1460203|NCT02030119|3573872|P4|STARTED|Overall Study||70
1460204|NCT02030119|3573873|P3|STARTED|Overall Study||71
1460205|NCT02030119|3573874|P2|STARTED|Overall Study||70
1460206|NCT02030119|3573875|P1|STARTED|Overall Study||70
1460207|NCT02030080|3573893|P4|NOT COMPLETED|Overall Study||2
1460208|NCT02030080|3573894|P3|NOT COMPLETED|Overall Study||0
1460209|NCT02030080|3573895|P2|NOT COMPLETED|Overall Study||0
1460210|NCT02030080|3573896|P1|NOT COMPLETED|Overall Study||0
1460211|NCT02030080|3573893|P4|COMPLETED|Overall Study||42
1460212|NCT02030080|3573894|P3|COMPLETED|Overall Study||80
1460213|NCT02030080|3573895|P2|COMPLETED|Overall Study||64
1460214|NCT02030080|3573896|P1|COMPLETED|Overall Study||100
1460215|NCT02030080|3573893|P4|STARTED|Overall Study|11 teams|44
1460216|NCT02030080|3573894|P3|STARTED|Overall Study|20 teams|80
1460217|NCT02030080|3573895|P2|STARTED|Overall Study|16 teams|64
1460218|NCT02030080|3573896|P1|STARTED|Overall Study|25 teams|100
1460219|NCT02030041|3573913|P3|NOT COMPLETED|Overall Study||1
1460220|NCT02030041|3573914|P2|NOT COMPLETED|Overall Study||2
1460221|NCT02030041|3573915|P1|NOT COMPLETED|Overall Study||2
1460222|NCT02030041|3573913|P3|COMPLETED|Overall Study||10
1460223|NCT02030041|3573914|P2|COMPLETED|Overall Study||9
1460224|NCT02030041|3573915|P1|COMPLETED|Overall Study||9
1460225|NCT02030041|3573913|P3|STARTED|Overall Study||11
1460226|NCT02030041|3573914|P2|STARTED|Overall Study||11
1460227|NCT02030041|3573915|P1|STARTED|Overall Study||11
1460228|NCT02029989|3573928|P2|NOT COMPLETED|Overall Study||11
1460229|NCT02029989|3573929|P1|NOT COMPLETED|Overall Study||16
1460230|NCT02029989|3573928|P2|COMPLETED|Overall Study||49
1460231|NCT02029989|3573929|P1|COMPLETED|Overall Study||45
1460232|NCT02029989|3573928|P2|STARTED|Overall Study||60
1460233|NCT02029989|3573929|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
1460234|NCT02029911|3573935|P1|NOT COMPLETED|Overall Study||0
1460235|NCT02029911|3573935|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
1460236|NCT02029911|3573935|P1|Treated|Overall Study|Treatment Completed|60
1460237|NCT02029911|3573935|P1|STARTED|Overall Study|Treatment Attempted|60
1460238|NCT02029872|3573943|P2|NOT COMPLETED|Overall Study||3
1460239|NCT02029872|3573944|P1|NOT COMPLETED|Overall Study||2
1460240|NCT02029872|3573943|P2|COMPLETED|Overall Study||6
1460241|NCT02029872|3573944|P1|COMPLETED|Overall Study||7
1460242|NCT02029872|3573943|P2|STARTED|Overall Study||9
1460243|NCT02029872|3573944|P1|STARTED|Overall Study||9
1460244|NCT02029846|3573952|P2|NOT COMPLETED|Overall Study||1
1460245|NCT02029846|3573953|P1|NOT COMPLETED|Overall Study||1
1460246|NCT02029846|3573952|P2|COMPLETED|Overall Study||0
1460247|NCT02029846|3573953|P1|COMPLETED|Overall Study||0
1460248|NCT02029846|3573952|P2|STARTED|Overall Study||1
1460249|NCT02029846|3573953|P1|STARTED|Overall Study||1
1460250|NCT02029755|3573966|P3|NOT COMPLETED|Overall Study||0
1460251|NCT02029755|3573967|P2|NOT COMPLETED|Overall Study||0
1460252|NCT02029755|3573968|P1|NOT COMPLETED|Overall Study||0
1460253|NCT02029755|3573966|P3|COMPLETED|Overall Study||36
1460254|NCT02029755|3573967|P2|COMPLETED|Overall Study||36
1460255|NCT02029755|3573968|P1|COMPLETED|Overall Study||36
1460256|NCT02029755|3573966|P3|STARTED|Overall Study||36
1460257|NCT02029755|3573967|P2|STARTED|Overall Study||36
1460258|NCT02029755|3573968|P1|STARTED|Overall Study||36
1460259|NCT02029703|3573981|P2|NOT COMPLETED|Overall Study||0
1460260|NCT02029703|3573982|P1|NOT COMPLETED|Overall Study||0
1460261|NCT02029703|3573981|P2|COMPLETED|Overall Study||22
1460262|NCT02029703|3573982|P1|COMPLETED|Overall Study||20
1460263|NCT02029703|3573981|P2|STARTED|Overall Study||22
1460264|NCT02029703|3573982|P1|STARTED|Overall Study||20
1460265|NCT02029638|3573991|P3|NOT COMPLETED|Overall Study||1
1460266|NCT02029638|3573992|P2|NOT COMPLETED|Overall Study||0
1460267|NCT02029638|3573993|P1|NOT COMPLETED|Overall Study||2
1460268|NCT02029638|3573991|P3|COMPLETED|Overall Study||0
1460269|NCT02029638|3573992|P2|COMPLETED|Overall Study||1
1460270|NCT02029638|3573993|P1|COMPLETED|Overall Study||0
1460271|NCT02029638|3573991|P3|STARTED|Overall Study||1
1460272|NCT02029638|3573992|P2|STARTED|Overall Study||1
1460273|NCT02029638|3573993|P1|STARTED|Overall Study||2
1460274|NCT02029521|3574022|P2|NOT COMPLETED|Overall Study||1
1460275|NCT02029521|3574023|P1|NOT COMPLETED|Overall Study||2
1460276|NCT02029521|3574022|P2|COMPLETED|Overall Study||22
1460277|NCT02029521|3574023|P1|COMPLETED|Overall Study||22
1460278|NCT02029521|3574022|P2|STARTED|Overall Study||23
1460279|NCT02029521|3574023|P1|STARTED|Overall Study||24
1460280|NCT02029495|3574108|P3|NOT COMPLETED|Overall Study||2
1460281|NCT02029495|3574109|P2|NOT COMPLETED|Overall Study||0
1460282|NCT02029495|3574110|P1|NOT COMPLETED|Overall Study||1
1460283|NCT02029495|3574108|P3|COMPLETED|Overall Study||159
1460284|NCT02029495|3574109|P2|COMPLETED|Overall Study||158
1460285|NCT02029495|3574110|P1|COMPLETED|Overall Study||158
1460286|NCT02029495|3574108|P3|STARTED|Overall Study||161
1460287|NCT02029495|3574109|P2|STARTED|Overall Study||158
1460288|NCT02029495|3574110|P1|STARTED|Overall Study||159
1460289|NCT02029417|3574121|P1|NOT COMPLETED|Overall Study||2
1460290|NCT02029417|3574121|P1|COMPLETED|Overall Study||0
1460291|NCT02029417|3574121|P1|STARTED|Overall Study||2
1460292|NCT02029235|3574128|P2|NOT COMPLETED|Overall Study||1
1460293|NCT02029235|3574129|P1|NOT COMPLETED|Overall Study||4
1460294|NCT02029235|3574128|P2|COMPLETED|Overall Study||30
1460295|NCT02029235|3574129|P1|COMPLETED|Overall Study||30
1460296|NCT02029235|3574128|P2|STARTED|Overall Study||31
1460297|NCT02029235|3574129|P1|STARTED|Overall Study||34
1460298|NCT02029196|3574139|P2|NOT COMPLETED|Overall Study||1
1460299|NCT02029196|3574140|P1|NOT COMPLETED|Overall Study||20
1460300|NCT02029196|3574139|P2|COMPLETED|Overall Study||101
1460301|NCT02029196|3574140|P1|COMPLETED|Overall Study||286
1460302|NCT02029196|3574139|P2|STARTED|Overall Study||102
1460303|NCT02029196|3574140|P1|STARTED|Overall Study||306
1460304|NCT02028871|3574150|P2|NOT COMPLETED|Overall Study||3
1460305|NCT02028871|3574151|P1|NOT COMPLETED|Overall Study||4
1460306|NCT02028871|3574150|P2|COMPLETED|Overall Study||9
1460307|NCT02028871|3574151|P1|COMPLETED|Overall Study||10
1460308|NCT02028871|3574150|P2|STARTED|Overall Study||12
1460309|NCT02028871|3574151|P1|STARTED|Overall Study||14
1460310|NCT02028780|3574172|P12|NOT COMPLETED|Follow up Phase||0
1460311|NCT02028780|3574173|P11|NOT COMPLETED|Follow up Phase||0
1460312|NCT02028780|3574174|P10|NOT COMPLETED|Follow up Phase||0
1460313|NCT02028780|3574175|P9|NOT COMPLETED|Follow up Phase||0
1460314|NCT02028780|3574176|P8|NOT COMPLETED|Follow up Phase||0
1460315|NCT02028780|3574177|P7|NOT COMPLETED|Follow up Phase||0
1460316|NCT02028780|3574178|P6|NOT COMPLETED|Follow up Phase||0
1460317|NCT02028780|3574179|P5|NOT COMPLETED|Follow up Phase||0
1460318|NCT02028780|3574180|P4|NOT COMPLETED|Follow up Phase||0
1460319|NCT02028780|3574181|P3|NOT COMPLETED|Follow up Phase||0
1460320|NCT02028780|3574182|P2|NOT COMPLETED|Follow up Phase||0
1460321|NCT02028780|3574183|P1|NOT COMPLETED|Follow up Phase||0
1460322|NCT02028780|3574172|P12|COMPLETED|Follow up Phase||9
1460323|NCT02028780|3574173|P11|COMPLETED|Follow up Phase||9
1460324|NCT02028780|3574174|P10|COMPLETED|Follow up Phase||9
1460325|NCT02028780|3574175|P9|COMPLETED|Follow up Phase||9
1460326|NCT02028780|3574176|P8|COMPLETED|Follow up Phase||3
1460327|NCT02028780|3574177|P7|COMPLETED|Follow up Phase||9
1460328|NCT02028780|3574178|P6|COMPLETED|Follow up Phase||6
1460329|NCT02028780|3574179|P5|COMPLETED|Follow up Phase||6
1460330|NCT02028780|3574180|P4|COMPLETED|Follow up Phase||6
1460331|NCT02028780|3574181|P3|COMPLETED|Follow up Phase||6
1460332|NCT02028780|3574182|P2|COMPLETED|Follow up Phase||2
1460333|NCT02028780|3574183|P1|COMPLETED|Follow up Phase||6
1460334|NCT02028780|3574172|P12|STARTED|Follow up Phase||9
1460335|NCT02028780|3574173|P11|STARTED|Follow up Phase||9
1460336|NCT02028780|3574174|P10|STARTED|Follow up Phase||9
1460337|NCT02028780|3574175|P9|STARTED|Follow up Phase||9
1460338|NCT02028780|3574176|P8|STARTED|Follow up Phase||3
1460339|NCT02028780|3574177|P7|STARTED|Follow up Phase||9
1460340|NCT02028780|3574178|P6|STARTED|Follow up Phase||6
1460341|NCT02028780|3574179|P5|STARTED|Follow up Phase||6
1460342|NCT02028780|3574180|P4|STARTED|Follow up Phase||6
1460343|NCT02028780|3574181|P3|STARTED|Follow up Phase||6
1460344|NCT02028780|3574182|P2|STARTED|Follow up Phase||2
1460345|NCT02028780|3574183|P1|STARTED|Follow up Phase||6
1460346|NCT02028780|3574172|P12|NOT COMPLETED|Observation Phase||0
1460347|NCT02028780|3574173|P11|NOT COMPLETED|Observation Phase||0
1460348|NCT02028780|3574174|P10|NOT COMPLETED|Observation Phase||0
1460349|NCT02028780|3574175|P9|NOT COMPLETED|Observation Phase||0
1460350|NCT02028780|3574176|P8|NOT COMPLETED|Observation Phase||0
1460351|NCT02028780|3574177|P7|NOT COMPLETED|Observation Phase||0
1460352|NCT02028780|3574178|P6|NOT COMPLETED|Observation Phase||0
1460353|NCT02028780|3574179|P5|NOT COMPLETED|Observation Phase||0
1460354|NCT02028780|3574180|P4|NOT COMPLETED|Observation Phase||0
1460355|NCT02028780|3574181|P3|NOT COMPLETED|Observation Phase||0
1460356|NCT02028780|3574182|P2|NOT COMPLETED|Observation Phase||0
1460357|NCT02028780|3574183|P1|NOT COMPLETED|Observation Phase||0
1460358|NCT02028780|3574172|P12|COMPLETED|Observation Phase||9
1460359|NCT02028780|3574173|P11|COMPLETED|Observation Phase||9
1460360|NCT02028780|3574174|P10|COMPLETED|Observation Phase||9
1460361|NCT02028780|3574175|P9|COMPLETED|Observation Phase||9
1460362|NCT02028780|3574176|P8|COMPLETED|Observation Phase||3
1460363|NCT02028780|3574177|P7|COMPLETED|Observation Phase||9
1460364|NCT02028780|3574178|P6|COMPLETED|Observation Phase||6
1460365|NCT02028780|3574179|P5|COMPLETED|Observation Phase||6
1460366|NCT02028780|3574180|P4|COMPLETED|Observation Phase||6
1460367|NCT02028780|3574181|P3|COMPLETED|Observation Phase||6
1460368|NCT02028780|3574182|P2|COMPLETED|Observation Phase||2
1460369|NCT02028780|3574183|P1|COMPLETED|Observation Phase||6
1460370|NCT02028780|3574172|P12|STARTED|Observation Phase||9
1460371|NCT02028780|3574173|P11|STARTED|Observation Phase||9
1460372|NCT02028780|3574174|P10|STARTED|Observation Phase||9
1460373|NCT02028780|3574175|P9|STARTED|Observation Phase||9
1460374|NCT02028780|3574176|P8|STARTED|Observation Phase||3
1460375|NCT02028780|3574177|P7|STARTED|Observation Phase||9
1460376|NCT02028780|3574178|P6|STARTED|Observation Phase||6
1460377|NCT02028780|3574179|P5|STARTED|Observation Phase||6
1460378|NCT02028780|3574180|P4|STARTED|Observation Phase||6
1460379|NCT02028780|3574181|P3|STARTED|Observation Phase||6
1460380|NCT02028780|3574182|P2|STARTED|Observation Phase||2
1460381|NCT02028780|3574183|P1|STARTED|Observation Phase||6
1460382|NCT02028767|3574248|P2|NOT COMPLETED|Treatment Period 2||0
1460383|NCT02028767|3574249|P1|NOT COMPLETED|Treatment Period 2||2
1460384|NCT02028767|3574248|P2|COMPLETED|Treatment Period 2||16
1460385|NCT02028767|3574249|P1|COMPLETED|Treatment Period 2||14
1460386|NCT02028767|3574248|P2|STARTED|Treatment Period 2||16
1460387|NCT02028767|3574249|P1|STARTED|Treatment Period 2||16
1460388|NCT02028767|3574248|P2|NOT COMPLETED|Treatment Period 1||0
1460389|NCT02028767|3574249|P1|NOT COMPLETED|Treatment Period 1||0
1460390|NCT02028767|3574248|P2|COMPLETED|Treatment Period 1||16
1460391|NCT02028767|3574249|P1|COMPLETED|Treatment Period 1||16
1460392|NCT02028767|3574248|P2|STARTED|Treatment Period 1||16
1460393|NCT02028767|3574249|P1|STARTED|Treatment Period 1||16
1460394|NCT02028754|3574261|P2|NOT COMPLETED|Overall Study||8
1460395|NCT02028754|3574262|P1|NOT COMPLETED|Overall Study||7
1460396|NCT02028754|3574261|P2|COMPLETED|Overall Study||82
1460397|NCT02028754|3574262|P1|COMPLETED|Overall Study||83
1460398|NCT02028754|3574261|P2|STARTED|Overall Study||90
1460399|NCT02028754|3574262|P1|STARTED|Overall Study||90
1460400|NCT02028715|3574282|P2|NOT COMPLETED|Overall Study||4
1460401|NCT02028715|3574283|P1|NOT COMPLETED|Overall Study||5
1460402|NCT02028715|3574282|P2|COMPLETED|Overall Study||30
1460403|NCT02028715|3574283|P1|COMPLETED|Overall Study||29
1460404|NCT02028715|3574282|P2|STARTED|Overall Study||34
1460405|NCT02028715|3574283|P1|STARTED|Overall Study||34
1460406|NCT02028676|3574310|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460407|NCT02028676|3574311|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460408|NCT02028676|3574312|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460409|NCT02028676|3574313|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460410|NCT02028676|3574314|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460411|NCT02028676|3574315|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460412|NCT02028676|3574316|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460413|NCT02028676|3574317|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460414|NCT02028676|3574318|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460415|NCT02028676|3574310|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
1460416|NCT02028676|3574311|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
1460417|NCT02028676|3574312|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460418|NCT02028676|3574313|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460419|NCT02028676|3574314|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460420|NCT02028676|3574315|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460421|NCT02028676|3574316|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460422|NCT02028676|3574317|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460423|NCT02028676|3574318|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
1460424|NCT02028676|3574310|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
1460425|NCT02028676|3574311|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
1460426|NCT02028676|3574312|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
1460427|NCT02028676|3574313|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
1460428|NCT02028676|3574314|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
1460429|NCT02028676|3574315|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
1460430|NCT02028676|3574316|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
1460431|NCT02028676|3574317|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
1460432|NCT02028676|3574318|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
1460433|NCT02028676|3574310|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460434|NCT02028676|3574311|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460435|NCT02028676|3574312|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460436|NCT02028676|3574313|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460437|NCT02028676|3574314|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460438|NCT02028676|3574315|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460439|NCT02028676|3574316|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460440|NCT02028676|3574317|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460441|NCT02028676|3574318|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460442|NCT02028676|3574310|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460443|NCT02028676|3574311|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460444|NCT02028676|3574312|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
1460445|NCT02028676|3574313|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
1460446|NCT02028676|3574314|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460447|NCT02028676|3574315|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460448|NCT02028676|3574316|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460449|NCT02028676|3574317|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460450|NCT02028676|3574318|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
1460451|NCT02028676|3574310|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1460452|NCT02028676|3574311|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1460453|NCT02028676|3574312|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
1460454|NCT02028676|3574313|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
1460455|NCT02028676|3574314|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1460456|NCT02028676|3574315|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1460457|NCT02028676|3574316|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1460458|NCT02028676|3574317|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1460459|NCT02028676|3574318|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
1460460|NCT02028676|3574310|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
1460461|NCT02028676|3574311|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
1460462|NCT02028676|3574312|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
1460463|NCT02028676|3574313|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
1460464|NCT02028676|3574314|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
1460465|NCT02028676|3574315|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
1460466|NCT02028676|3574316|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
1460467|NCT02028676|3574317|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
1460468|NCT02028676|3574318|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
1460469|NCT02028676|3574310|P9|COMPLETED|Initial Enrolment: Induction ART||0
1460470|NCT02028676|3574311|P8|COMPLETED|Initial Enrolment: Induction ART||0
1460471|NCT02028676|3574312|P7|COMPLETED|Initial Enrolment: Induction ART||0
1460472|NCT02028676|3574313|P6|COMPLETED|Initial Enrolment: Induction ART||0
1460473|NCT02028676|3574314|P5|COMPLETED|Initial Enrolment: Induction ART||405
1460474|NCT02028676|3574315|P4|COMPLETED|Initial Enrolment: Induction ART||404
1460475|NCT02028676|3574316|P3|COMPLETED|Initial Enrolment: Induction ART||397
1460476|NCT02028676|3574317|P2|COMPLETED|Initial Enrolment: Induction ART||0
1460477|NCT02028676|3574318|P1|COMPLETED|Initial Enrolment: Induction ART||0
1460478|NCT02028676|3574310|P9|STARTED|Initial Enrolment: Induction ART||0
1460479|NCT02028676|3574311|P8|STARTED|Initial Enrolment: Induction ART||0
1460480|NCT02028676|3574312|P7|STARTED|Initial Enrolment: Induction ART||0
1460481|NCT02028676|3574313|P6|STARTED|Initial Enrolment: Induction ART||0
1460482|NCT02028676|3574314|P5|STARTED|Initial Enrolment: Induction ART||405
1460483|NCT02028676|3574315|P4|STARTED|Initial Enrolment: Induction ART||404
1460484|NCT02028676|3574316|P3|STARTED|Initial Enrolment: Induction ART||397
1460485|NCT02028676|3574317|P2|STARTED|Initial Enrolment: Induction ART||0
1460486|NCT02028676|3574318|P1|STARTED|Initial Enrolment: Induction ART||0
1460487|NCT02028676|3574310|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1460488|NCT02028676|3574311|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1460489|NCT02028676|3574312|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1460490|NCT02028676|3574313|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1460491|NCT02028676|3574314|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1460492|NCT02028676|3574315|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1460493|NCT02028676|3574316|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1460494|NCT02028676|3574317|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1460495|NCT02028676|3574318|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
1460496|NCT02028676|3574310|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
1460497|NCT02028676|3574311|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
1460498|NCT02028676|3574312|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
1460499|NCT02028676|3574313|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
1460500|NCT02028676|3574314|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
1460501|NCT02028676|3574315|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
1460502|NCT02028676|3574316|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
1460503|NCT02028676|3574317|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
1460504|NCT02028676|3574318|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
1460505|NCT02028676|3574310|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
1460506|NCT02028676|3574311|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
1460507|NCT02028676|3574312|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
1460508|NCT02028676|3574313|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
1460509|NCT02028676|3574314|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
1460510|NCT02028676|3574315|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
1460511|NCT02028676|3574316|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
1460512|NCT02028676|3574317|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
1460513|NCT02028676|3574318|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
1460514|NCT02028325|3574491|P1|NOT COMPLETED|Overall Study||10
1460515|NCT02028325|3574491|P1|COMPLETED|Overall Study||126
1460516|NCT02028325|3574491|P1|STARTED|Overall Study||136
1460517|NCT02028169|3574495|P1|NOT COMPLETED|Overall Study||28
1460518|NCT02028169|3574495|P1|COMPLETED|Overall Study||92
1460519|NCT02028169|3574495|P1|STARTED|Overall Study||120
1460520|NCT02028065|3574521|P3|NOT COMPLETED|Treatment Through Study Completion||14
1460521|NCT02028065|3574522|P2|NOT COMPLETED|Treatment Through Study Completion||15
1460522|NCT02028065|3574523|P1|NOT COMPLETED|Treatment Through Study Completion||12
1460523|NCT02028065|3574521|P3|COMPLETED|Treatment Through Study Completion||134
1460524|NCT02028065|3574522|P2|COMPLETED|Treatment Through Study Completion||136
1460525|NCT02028065|3574523|P1|COMPLETED|Treatment Through Study Completion||64
1460526|NCT02028065|3574521|P3|Received Third Dose|Treatment Through Study Completion||134
1460527|NCT02028065|3574522|P2|Received Third Dose|Treatment Through Study Completion||136
1460528|NCT02028065|3574523|P1|Received Third Dose|Treatment Through Study Completion||64
1460529|NCT02028065|3574521|P3|Received Second Dose|Treatment Through Study Completion||138
1460530|NCT02028065|3574522|P2|Received Second Dose|Treatment Through Study Completion||140
1460531|NCT02028065|3574523|P1|Received Second Dose|Treatment Through Study Completion||69
1460532|NCT02028065|3574521|P3|Received First Dose|Treatment Through Study Completion||148
1460533|NCT02028065|3574522|P2|Received First Dose|Treatment Through Study Completion||151
1460534|NCT02028065|3574523|P1|Received First Dose|Treatment Through Study Completion||76
1460535|NCT02028065|3574521|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
1460536|NCT02028065|3574522|P2|STARTED|Treatment Through Study Completion||151
1460537|NCT02028065|3574523|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
1460538|NCT02028065|3574521|P3|NOT COMPLETED|Randomization Through Start Treatment||3
1460539|NCT02028065|3574522|P2|NOT COMPLETED|Randomization Through Start Treatment||3
1460540|NCT02028065|3574523|P1|NOT COMPLETED|Randomization Through Start Treatment||1
1460541|NCT02028065|3574521|P3|COMPLETED|Randomization Through Start Treatment||149
1460542|NCT02028065|3574522|P2|COMPLETED|Randomization Through Start Treatment||151
1460543|NCT02028065|3574523|P1|COMPLETED|Randomization Through Start Treatment||75
1460544|NCT02028065|3574521|P3|STARTED|Randomization Through Start Treatment|Randomized|152
1460545|NCT02028065|3574522|P2|STARTED|Randomization Through Start Treatment|Randomized|154
1460546|NCT02028065|3574523|P1|STARTED|Randomization Through Start Treatment|Randomized|76
1460547|NCT02027883|3574536|P2|NOT COMPLETED|Overall Study||0
1460548|NCT02027883|3574537|P1|NOT COMPLETED|Overall Study||0
1460549|NCT02027883|3574536|P2|COMPLETED|Overall Study||50
1460550|NCT02027883|3574537|P1|COMPLETED|Overall Study||50
1460551|NCT02027883|3574536|P2|STARTED|Overall Study||50
1460552|NCT02027883|3574537|P1|STARTED|Overall Study||50
1460553|NCT02027844|3574550|P3|NOT COMPLETED|Overall Study||2
1460554|NCT02027844|3574551|P2|NOT COMPLETED|Overall Study||6
1460555|NCT02027844|3574552|P1|NOT COMPLETED|Overall Study||5
1460556|NCT02027844|3574550|P3|COMPLETED|Overall Study||37
1460557|NCT02027844|3574551|P2|COMPLETED|Overall Study||33
1460558|NCT02027844|3574552|P1|COMPLETED|Overall Study||34
1460559|NCT02027844|3574550|P3|STARTED|Overall Study||39
1460560|NCT02027844|3574551|P2|STARTED|Overall Study||39
1460561|NCT02027844|3574552|P1|STARTED|Overall Study||39
1460562|NCT02027701|3574569|P1|NOT COMPLETED|Overall Study||16
1460563|NCT02027701|3574569|P1|COMPLETED|Overall Study||66
1460564|NCT02027701|3574569|P1|STARTED|Overall Study||82
1460565|NCT02027428|3574587|P3|NOT COMPLETED|Survival Follow-up||30
1460566|NCT02027428|3574588|P2|NOT COMPLETED|Survival Follow-up||48
1460567|NCT02027428|3574589|P1|NOT COMPLETED|Survival Follow-up||0
1460568|NCT02027428|3574587|P3|COMPLETED|Survival Follow-up||19
1460569|NCT02027428|3574588|P2|COMPLETED|Survival Follow-up||43
1460570|NCT02027428|3574589|P1|COMPLETED|Survival Follow-up||0
1460571|NCT02027428|3574587|P3|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|49
1460572|NCT02027428|3574588|P2|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|91
1460573|NCT02027428|3574589|P1|STARTED|Survival Follow-up||0
1460574|NCT02027428|3574587|P3|NOT COMPLETED|Maintenance||60
1460575|NCT02027428|3574588|P2|NOT COMPLETED|Maintenance||124
1460576|NCT02027428|3574589|P1|NOT COMPLETED|Maintenance||0
1460577|NCT02027428|3574587|P3|COMPLETED|Maintenance||6
1460578|NCT02027428|3574588|P2|COMPLETED|Maintenance||12
1460579|NCT02027428|3574589|P1|COMPLETED|Maintenance||0
1460580|NCT02027428|3574587|P3|STARTED|Maintenance||66
1460581|NCT02027428|3574588|P2|STARTED|Maintenance||136
1460582|NCT02027428|3574589|P1|STARTED|Maintenance||0
1460583|NCT02027428|3574587|P3|NOT COMPLETED|Induction||0
1460584|NCT02027428|3574588|P2|NOT COMPLETED|Induction||0
1460585|NCT02027428|3574589|P1|NOT COMPLETED|Induction||225
1460586|NCT02027428|3574587|P3|COMPLETED|Induction||0
1460587|NCT02027428|3574588|P2|COMPLETED|Induction||0
1460588|NCT02027428|3574589|P1|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
1460589|NCT02027428|3574587|P3|STARTED|Induction||0
1460590|NCT02027428|3574588|P2|STARTED|Induction||0
1460591|NCT02027428|3574589|P1|STARTED|Induction||427
1460592|NCT02027402|3574627|P2|NOT COMPLETED|Overall Study||1
1460593|NCT02027402|3574628|P1|NOT COMPLETED|Overall Study||4
1460594|NCT02027402|3574627|P2|COMPLETED|Overall Study||99
1460595|NCT02027402|3574628|P1|COMPLETED|Overall Study||94
1460596|NCT02027402|3574627|P2|STARTED|Overall Study||100
1460597|NCT02027402|3574628|P1|STARTED|Overall Study||98
1460598|NCT02027376|3574640|P3|NOT COMPLETED|Overall Study||0
1460599|NCT02027376|3574641|P2|NOT COMPLETED|Overall Study||0
1460600|NCT02027376|3574642|P1|NOT COMPLETED|Overall Study||1
1460601|NCT02027376|3574640|P3|COMPLETED|Overall Study||3
1460602|NCT02027376|3574641|P2|COMPLETED|Overall Study||4
1460603|NCT02027376|3574642|P1|COMPLETED|Overall Study||4
1460604|NCT02027376|3574640|P3|STARTED|Overall Study||3
1460605|NCT02027376|3574641|P2|STARTED|Overall Study||4
1460606|NCT02027376|3574642|P1|STARTED|Overall Study||5
1460607|NCT02027311|3574668|P2|NOT COMPLETED|Overall Study||2
1460608|NCT02027311|3574669|P1|NOT COMPLETED|Overall Study||3
1460609|NCT02027311|3574668|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
1460610|NCT02027311|3574669|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
1460611|NCT02027311|3574668|P2|STARTED|Overall Study||35
1460612|NCT02027311|3574669|P1|STARTED|Overall Study||33
1460613|NCT02027272|3574679|P2|NOT COMPLETED|Overall Study||1
1460614|NCT02027272|3574680|P1|NOT COMPLETED|Overall Study||0
1460615|NCT02027272|3574679|P2|COMPLETED|Overall Study||0
1460616|NCT02027272|3574680|P1|COMPLETED|Overall Study||0
1460617|NCT02027272|3574679|P2|STARTED|Overall Study||1
1460618|NCT02027272|3574680|P1|STARTED|Overall Study||0
1460619|NCT02026453|3574689|P3|NOT COMPLETED|Overall Study||13
1460620|NCT02026453|3574690|P2|NOT COMPLETED|Overall Study||9
1460621|NCT02026453|3574691|P1|NOT COMPLETED|Overall Study||6
1460622|NCT02026453|3574689|P3|COMPLETED|Overall Study||89
1460623|NCT02026453|3574690|P2|COMPLETED|Overall Study||94
1460624|NCT02026453|3574691|P1|COMPLETED|Overall Study||95
1460625|NCT02026453|3574689|P3|STARTED|Overall Study||102
1460626|NCT02026453|3574690|P2|STARTED|Overall Study||103
1460627|NCT02026453|3574691|P1|STARTED|Overall Study||101
1460628|NCT02026258|3574704|P2|NOT COMPLETED|Recieved Allocated Intervention||2
1460629|NCT02026258|3574705|P1|NOT COMPLETED|Recieved Allocated Intervention||1
1460630|NCT02026258|3574704|P2|COMPLETED|Recieved Allocated Intervention||17
1460631|NCT02026258|3574705|P1|COMPLETED|Recieved Allocated Intervention||15
1460632|NCT02026258|3574704|P2|STARTED|Recieved Allocated Intervention||19
1460633|NCT02026258|3574705|P1|STARTED|Recieved Allocated Intervention||16
1460634|NCT02026258|3574704|P2|NOT COMPLETED|Randomized||2
1460635|NCT02026258|3574705|P1|NOT COMPLETED|Randomized||4
1460636|NCT02026258|3574704|P2|COMPLETED|Randomized||19
1460637|NCT02026258|3574705|P1|COMPLETED|Randomized||16
1460638|NCT02026258|3574704|P2|STARTED|Randomized||21
1460639|NCT02026258|3574705|P1|STARTED|Randomized||20
1460640|NCT02026206|3574719|P2|NOT COMPLETED|Overall Study||8
1460641|NCT02026206|3574720|P1|NOT COMPLETED|Overall Study||4
1460642|NCT02026206|3574719|P2|COMPLETED|Overall Study||36
1460643|NCT02026206|3574720|P1|COMPLETED|Overall Study||40
1460644|NCT02026206|3574719|P2|STARTED|Overall Study||44
1460645|NCT02026206|3574720|P1|STARTED|Overall Study||44
1460646|NCT02026193|3574730|P2|NOT COMPLETED|Overall Study||0
1460647|NCT02026193|3574731|P1|NOT COMPLETED|Overall Study||0
1460648|NCT02026193|3574730|P2|COMPLETED|Overall Study||8
1460649|NCT02026193|3574731|P1|COMPLETED|Overall Study||3
1460650|NCT02026193|3574730|P2|STARTED|Overall Study||8
1460651|NCT02026193|3574731|P1|STARTED|Overall Study||3
1460652|NCT02026141|3574739|P2|NOT COMPLETED|Overall Study||1
1460653|NCT02026141|3574740|P1|NOT COMPLETED|Overall Study||0
1460654|NCT02026141|3574739|P2|COMPLETED|Overall Study||19
1460655|NCT02026141|3574740|P1|COMPLETED|Overall Study||20
1460656|NCT02026141|3574739|P2|STARTED|Overall Study||20
1460657|NCT02026141|3574740|P1|STARTED|Overall Study||20
1460658|NCT02025907|3574748|P2|NOT COMPLETED|Overall Study||12
1460659|NCT02025907|3574749|P1|NOT COMPLETED|Overall Study||27
1460660|NCT02025907|3574748|P2|COMPLETED|Overall Study||96
1460661|NCT02025907|3574749|P1|COMPLETED|Overall Study||81
1460662|NCT02025907|3574748|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
1460663|NCT02025907|3574749|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
1460664|NCT02025829|3574765|P2|NOT COMPLETED|Overall Study||0
1460665|NCT02025829|3574766|P1|NOT COMPLETED|Overall Study||0
1460666|NCT02025829|3574765|P2|COMPLETED|Overall Study||11
1460667|NCT02025829|3574766|P1|COMPLETED|Overall Study||3
1460668|NCT02025829|3574765|P2|STARTED|Overall Study||11
1460669|NCT02025829|3574766|P1|STARTED|Overall Study||3
1460670|NCT02025647|3574775|P1|NOT COMPLETED|Overall Study||0
1460671|NCT02025647|3574775|P1|COMPLETED|Overall Study||139
1460672|NCT02025647|3574775|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
1460673|NCT02025647|3574775|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
1460674|NCT02025647|3574775|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
1460675|NCT02025647|3574775|P1|Session 1 (Narrative Module)|Overall Study||139
1460676|NCT02025647|3574775|P1|STARTED|Overall Study||139
1460677|NCT02025621|3574806|P2|NOT COMPLETED|Overall Study||19
1460678|NCT02025621|3574807|P1|NOT COMPLETED|Overall Study||14
1460679|NCT02025621|3574806|P2|COMPLETED|Overall Study||421
1460680|NCT02025621|3574807|P1|COMPLETED|Overall Study||428
1460681|NCT02025621|3574806|P2|STARTED|Overall Study||440
1460682|NCT02025621|3574807|P1|STARTED|Overall Study||442
1460683|NCT02025179|3574828|P3|NOT COMPLETED|Overall Study||1
1460684|NCT02025179|3574829|P2|NOT COMPLETED|Overall Study||0
1460685|NCT02025179|3574830|P1|NOT COMPLETED|Overall Study||0
1460686|NCT02025179|3574828|P3|COMPLETED|Overall Study||7
1460687|NCT02025179|3574829|P2|COMPLETED|Overall Study||9
1460688|NCT02025179|3574830|P1|COMPLETED|Overall Study||8
1460689|NCT02025179|3574828|P3|STARTED|Overall Study||8
1460690|NCT02025179|3574829|P2|STARTED|Overall Study||9
1460691|NCT02025179|3574830|P1|STARTED|Overall Study||8
1460692|NCT02025075|3574855|P2|NOT COMPLETED|Overall Study||2
1460693|NCT02025075|3574856|P1|NOT COMPLETED|Overall Study||0
1460694|NCT02025075|3574855|P2|COMPLETED|Overall Study||19
1460695|NCT02025075|3574856|P1|COMPLETED|Overall Study||16
1460696|NCT02025075|3574855|P2|STARTED|Overall Study||21
1460697|NCT02025075|3574856|P1|STARTED|Overall Study||16
1460698|NCT02024971|3574880|P1|NOT COMPLETED|Overall Study||36
1460699|NCT02024971|3574880|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
1460700|NCT02024971|3574880|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
1460701|NCT02024971|3574880|P1|STARTED|Overall Study||1103
1460702|NCT02024932|3574893|P6|NOT COMPLETED|Overall Study||0
1460703|NCT02024932|3574894|P5|NOT COMPLETED|Overall Study||2
1460704|NCT02024932|3574895|P4|NOT COMPLETED|Overall Study||2
1460705|NCT02024932|3574896|P3|NOT COMPLETED|Overall Study||0
1460706|NCT02024932|3574897|P2|NOT COMPLETED|Overall Study||3
1460707|NCT02024932|3574898|P1|NOT COMPLETED|Overall Study||2
1460708|NCT02024932|3574893|P6|COMPLETED|Overall Study||9
1460709|NCT02024932|3574894|P5|COMPLETED|Overall Study||16
1460710|NCT02024932|3574895|P4|COMPLETED|Overall Study||0
1460711|NCT02024932|3574896|P3|COMPLETED|Overall Study||2
1460712|NCT02024932|3574897|P2|COMPLETED|Overall Study||1
1460713|NCT02024932|3574898|P1|COMPLETED|Overall Study||0
1460714|NCT02024932|3574893|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
1460715|NCT02024932|3574894|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
1460716|NCT02024932|3574895|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
1460717|NCT02024932|3574896|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
1460718|NCT02024932|3574897|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
1460719|NCT02024932|3574898|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
1460720|NCT02024932|3574893|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1460721|NCT02024932|3574894|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
1460722|NCT02024932|3574895|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
1460723|NCT02024932|3574896|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1460724|NCT02024932|3574897|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
1460725|NCT02024932|3574898|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
1460726|NCT02024932|3574893|P6|Safety Analysis Set|Overall Study||9
1460727|NCT02024932|3574894|P5|Safety Analysis Set|Overall Study||18
1460728|NCT02024932|3574895|P4|Safety Analysis Set|Overall Study||2
1460729|NCT02024932|3574896|P3|Safety Analysis Set|Overall Study||2
1460730|NCT02024932|3574897|P2|Safety Analysis Set|Overall Study||4
1460731|NCT02024932|3574898|P1|Safety Analysis Set|Overall Study||2
1460732|NCT02024932|3574893|P6|STARTED|Overall Study||9
1460733|NCT02024932|3574894|P5|STARTED|Overall Study||18
1460734|NCT02024932|3574895|P4|STARTED|Overall Study||2
1460735|NCT02024932|3574896|P3|STARTED|Overall Study||2
1460736|NCT02024932|3574897|P2|STARTED|Overall Study||4
1460737|NCT02024932|3574898|P1|STARTED|Overall Study||2
1460738|NCT02024867|3574957|P2|NOT COMPLETED|Overall Study||7
1460739|NCT02024867|3574958|P1|NOT COMPLETED|Overall Study||9
1460740|NCT02024867|3574957|P2|COMPLETED|Overall Study||124
1460741|NCT02024867|3574958|P1|COMPLETED|Overall Study||125
1460742|NCT02024867|3574957|P2|STARTED|Overall Study||131
1460743|NCT02024867|3574958|P1|STARTED|Overall Study||134
1460744|NCT02024724|3574976|P2|NOT COMPLETED|Overall Study||0
1460745|NCT02024724|3574977|P1|NOT COMPLETED|Overall Study||1
1460746|NCT02024724|3574976|P2|COMPLETED|Overall Study||30
1460747|NCT02024724|3574977|P1|COMPLETED|Overall Study||29
1460748|NCT02024724|3574976|P2|STARTED|Overall Study||30
1460749|NCT02024724|3574977|P1|STARTED|Overall Study||30
1460750|NCT02024698|3574983|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1460751|NCT02024698|3574984|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1460752|NCT02024698|3574983|P2|COMPLETED|Second Intervention (7 Days)||26
1460753|NCT02024698|3574984|P1|COMPLETED|Second Intervention (7 Days)||16
1460754|NCT02024698|3574983|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
1460755|NCT02024698|3574984|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
1460756|NCT02024698|3574983|P2|STARTED|Second Intervention (7 Days)||26
1460757|NCT02024698|3574984|P1|STARTED|Second Intervention (7 Days)||16
1460758|NCT02024698|3574983|P2|NOT COMPLETED|First Intervention (7 Days)||1
1460759|NCT02024698|3574984|P1|NOT COMPLETED|First Intervention (7 Days)||0
1460760|NCT02024698|3574983|P2|COMPLETED|First Intervention (7 Days)||26
1460761|NCT02024698|3574984|P1|COMPLETED|First Intervention (7 Days)||16
1460762|NCT02024698|3574983|P2|STARTED|First Intervention (7 Days)||27
1460763|NCT02024698|3574984|P1|STARTED|First Intervention (7 Days)||16
1460764|NCT02024386|3575013|P3|NOT COMPLETED|Overall Study||0
1460765|NCT02024386|3575014|P2|NOT COMPLETED|Overall Study||0
1460766|NCT02024386|3575015|P1|NOT COMPLETED|Overall Study||0
1460767|NCT02024386|3575013|P3|COMPLETED|Overall Study||5
1460768|NCT02024386|3575014|P2|COMPLETED|Overall Study||11
1460769|NCT02024386|3575015|P1|COMPLETED|Overall Study||6
1460770|NCT02024386|3575013|P3|STARTED|Overall Study||5
1460771|NCT02024386|3575014|P2|STARTED|Overall Study||11
1460772|NCT02024386|3575015|P1|STARTED|Overall Study||6
1460773|NCT02024165|3575038|P1|NOT COMPLETED|Overall Study||0
1460774|NCT02024165|3575038|P1|COMPLETED|Overall Study||71
1460775|NCT02024165|3575038|P1|STARTED|Overall Study||71
1460776|NCT02023983|3575045|P2|NOT COMPLETED|Overall Study||0
1460777|NCT02023983|3575046|P1|NOT COMPLETED|Overall Study||0
1460778|NCT02023983|3575045|P2|COMPLETED|Overall Study||75
1460779|NCT02023983|3575046|P1|COMPLETED|Overall Study||76
1460780|NCT02023983|3575045|P2|STARTED|Overall Study||75
1460781|NCT02023983|3575046|P1|STARTED|Overall Study||76
1460782|NCT02023918|3575054|P1|NOT COMPLETED|Overall Study||0
1460783|NCT02023918|3575054|P1|COMPLETED|Overall Study||6
1460784|NCT02023918|3575054|P1|STARTED|Overall Study||6
1460785|NCT02023879|3575062|P3|NOT COMPLETED|Extension Open Label Treatment||5
1460786|NCT02023879|3575063|P2|NOT COMPLETED|Extension Open Label Treatment||17
1460787|NCT02023879|3575064|P1|NOT COMPLETED|Extension Open Label Treatment||5
1460788|NCT02023879|3575062|P3|COMPLETED|Extension Open Label Treatment||43
1460789|NCT02023879|3575063|P2|COMPLETED|Extension Open Label Treatment||89
1460790|NCT02023879|3575064|P1|COMPLETED|Extension Open Label Treatment||46
1460791|NCT02023879|3575062|P3|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
1460792|NCT02023879|3575063|P2|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
1460793|NCT02023879|3575064|P1|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
1460794|NCT02023879|3575062|P3|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
1460795|NCT02023879|3575063|P2|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
1460796|NCT02023879|3575064|P1|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
1460797|NCT02023879|3575062|P3|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
1460798|NCT02023879|3575063|P2|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
1460799|NCT02023879|3575064|P1|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
1460800|NCT02023879|3575062|P3|Treated|Period 1: 24-Week Double-blind Treatment||58
1460801|NCT02023879|3575063|P2|Treated|Period 1: 24-Week Double-blind Treatment||115
1460802|NCT02023879|3575064|P1|Treated|Period 1: 24-Week Double-blind Treatment||58
1460803|NCT02023879|3575062|P3|STARTED|Period 1: 24-Week Double-blind Treatment||59
1460804|NCT02023879|3575063|P2|STARTED|Period 1: 24-Week Double-blind Treatment||116
1460805|NCT02023879|3575064|P1|STARTED|Period 1: 24-Week Double-blind Treatment||58
1460806|NCT02023866|3575153|P1|NOT COMPLETED|Overall Study||6
1460807|NCT02023866|3575153|P1|COMPLETED|Overall Study||30
1460808|NCT02023866|3575153|P1|STARTED|Overall Study||36
1460809|NCT02023801|3575166|P1|NOT COMPLETED|Overall Study||0
1460810|NCT02023801|3575166|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
1460811|NCT02023801|3575166|P1|Treated|Overall Study|Treatment Completed|24
1460812|NCT02023801|3575166|P1|STARTED|Overall Study|Treatment Attempted|24
1460813|NCT02023697|3575175|P3|NOT COMPLETED|Active Follow-up Period||116
1460814|NCT02023697|3575176|P2|NOT COMPLETED|Active Follow-up Period||119
1460815|NCT02023697|3575177|P1|NOT COMPLETED|Active Follow-up Period||117
1460816|NCT02023697|3575175|P3|COMPLETED|Active Follow-up Period||0
1460817|NCT02023697|3575176|P2|COMPLETED|Active Follow-up Period||1
1460818|NCT02023697|3575177|P1|COMPLETED|Active Follow-up Period||3
1460819|NCT02023697|3575175|P3|Ongoing Active Follow-up|Active Follow-up Period||31
1460820|NCT02023697|3575176|P2|Ongoing Active Follow-up|Active Follow-up Period||31
1460821|NCT02023697|3575177|P1|Ongoing Active Follow-up|Active Follow-up Period||35
1460822|NCT02023697|3575175|P3|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
1460823|NCT02023697|3575176|P2|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
1460824|NCT02023697|3575177|P1|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
1460825|NCT02023697|3575175|P3|NOT COMPLETED|Treatment Period||102
1460826|NCT02023697|3575176|P2|NOT COMPLETED|Treatment Period||63
1460827|NCT02023697|3575177|P1|NOT COMPLETED|Treatment Period||46
1460828|NCT02023697|3575175|P3|COMPLETED|Treatment Period||29
1460829|NCT02023697|3575176|P2|COMPLETED|Treatment Period||67
1460830|NCT02023697|3575177|P1|COMPLETED|Treatment Period||84
1460831|NCT02023697|3575175|P3|Received Treatment|Treatment Period||121
1460832|NCT02023697|3575176|P2|Received Treatment|Treatment Period||124
1460833|NCT02023697|3575177|P1|Received Treatment|Treatment Period||125
1460834|NCT02023697|3575175|P3|STARTED|Treatment Period||131
1460835|NCT02023697|3575176|P2|STARTED|Treatment Period||130
1460836|NCT02023697|3575177|P1|STARTED|Treatment Period||130
1460837|NCT02023515|3575279|P2|NOT COMPLETED|Overall Study||3
1460838|NCT02023515|3575280|P1|NOT COMPLETED|Overall Study||1
1460839|NCT02023515|3575279|P2|COMPLETED|Overall Study||22
1460840|NCT02023515|3575280|P1|COMPLETED|Overall Study||23
1460841|NCT02023515|3575279|P2|STARTED|Overall Study||25
1460842|NCT02023515|3575280|P1|STARTED|Overall Study||24
1460843|NCT02023268|3575290|P2|NOT COMPLETED|Overall Study||4
1460844|NCT02023268|3575291|P1|NOT COMPLETED|Overall Study||0
1460845|NCT02023268|3575290|P2|COMPLETED|Overall Study||49
1460846|NCT02023268|3575291|P1|COMPLETED|Overall Study||52
1460847|NCT02023268|3575290|P2|STARTED|Overall Study||53
1460848|NCT02023268|3575291|P1|STARTED|Overall Study||52
1460849|NCT02023151|3575297|P1|NOT COMPLETED|Overall Study||4
1460850|NCT02023151|3575297|P1|COMPLETED|Overall Study||13
1460851|NCT02023151|3575297|P1|STARTED|Overall Study||17
1460852|NCT02023125|3575304|P3|NOT COMPLETED|Period 2||0
1460853|NCT02023125|3575305|P2|NOT COMPLETED|Period 2||0
1460854|NCT02023125|3575306|P1|NOT COMPLETED|Period 2||0
1460855|NCT02023125|3575304|P3|COMPLETED|Period 2||24
1460856|NCT02023125|3575305|P2|COMPLETED|Period 2||9
1460857|NCT02023125|3575306|P1|COMPLETED|Period 2||9
1460858|NCT02023125|3575304|P3|STARTED|Period 2||24
1460859|NCT02023125|3575305|P2|STARTED|Period 2||9
1460860|NCT02023125|3575306|P1|STARTED|Period 2||9
1460861|NCT02023125|3575304|P3|NOT COMPLETED|Washout Period||0
1460862|NCT02023125|3575305|P2|NOT COMPLETED|Washout Period||0
1460863|NCT02023125|3575306|P1|NOT COMPLETED|Washout Period||0
1460864|NCT02023125|3575304|P3|COMPLETED|Washout Period||24
1460865|NCT02023125|3575305|P2|COMPLETED|Washout Period||9
1460866|NCT02023125|3575306|P1|COMPLETED|Washout Period||9
1460867|NCT02023125|3575304|P3|STARTED|Washout Period||24
1460868|NCT02023125|3575305|P2|STARTED|Washout Period||9
1460869|NCT02023125|3575306|P1|STARTED|Washout Period||9
1460870|NCT02023125|3575304|P3|NOT COMPLETED|Period 1||0
1460871|NCT02023125|3575305|P2|NOT COMPLETED|Period 1||0
1460872|NCT02023125|3575306|P1|NOT COMPLETED|Period 1||0
1460873|NCT02023125|3575304|P3|COMPLETED|Period 1||24
1460874|NCT02023125|3575305|P2|COMPLETED|Period 1||9
1460875|NCT02023125|3575306|P1|COMPLETED|Period 1||9
1460876|NCT02023125|3575304|P3|STARTED|Period 1||24
1460877|NCT02023125|3575305|P2|STARTED|Period 1||9
1460878|NCT02023125|3575306|P1|STARTED|Period 1||9
1460879|NCT02023112|3575367|P2|NOT COMPLETED|Overall Study||1
1460880|NCT02023112|3575368|P1|NOT COMPLETED|Overall Study||2
1460881|NCT02023112|3575367|P2|COMPLETED|Overall Study||85
1460882|NCT02023112|3575368|P1|COMPLETED|Overall Study||83
1460883|NCT02023112|3575367|P2|STARTED|Overall Study||86
1460884|NCT02023112|3575368|P1|STARTED|Overall Study||85
1460885|NCT02023099|3575389|P3|NOT COMPLETED|Overall Study||3
1460886|NCT02023099|3575390|P2|NOT COMPLETED|Overall Study||0
1460887|NCT02023099|3575391|P1|NOT COMPLETED|Overall Study||3
1460888|NCT02023099|3575389|P3|COMPLETED|Overall Study||39
1460889|NCT02023099|3575390|P2|COMPLETED|Overall Study||106
1460890|NCT02023099|3575391|P1|COMPLETED|Overall Study||212
1460891|NCT02023099|3575389|P3|STARTED|Overall Study||42
1460892|NCT02023099|3575390|P2|STARTED|Overall Study||106
1460893|NCT02023099|3575391|P1|STARTED|Overall Study||215
1460894|NCT02022826|3575407|P1|NOT COMPLETED|Overall Study||28
1460895|NCT02022826|3575407|P1|COMPLETED|Overall Study||139
1460896|NCT02022826|3575407|P1|STARTED|Overall Study||167
1460897|NCT02022748|3575414|P3|NOT COMPLETED|Overall Study||0
1460898|NCT02022748|3575415|P2|NOT COMPLETED|Overall Study||2
1460899|NCT02022748|3575416|P1|NOT COMPLETED|Overall Study||1
1460900|NCT02022748|3575414|P3|COMPLETED|Overall Study||13
1460901|NCT02022748|3575415|P2|COMPLETED|Overall Study||4
1460902|NCT02022748|3575416|P1|COMPLETED|Overall Study||7
1460903|NCT02022748|3575414|P3|Subjects Who Completed Treatment|Overall Study||13
1460904|NCT02022748|3575415|P2|Subjects Who Completed Treatment|Overall Study||4
1460905|NCT02022748|3575416|P1|Subjects Who Completed Treatment|Overall Study||7
1460906|NCT02022748|3575414|P3|Subject Who Started Treatment|Overall Study||13
1460907|NCT02022748|3575415|P2|Subject Who Started Treatment|Overall Study||6
1460908|NCT02022748|3575416|P1|Subject Who Started Treatment|Overall Study||8
1460909|NCT02022748|3575414|P3|STARTED|Overall Study||13
1460910|NCT02022748|3575415|P2|STARTED|Overall Study||6
1460911|NCT02022748|3575416|P1|STARTED|Overall Study||8
1460912|NCT02022670|3575442|P3|NOT COMPLETED|Overall Study||1
1460913|NCT02022670|3575443|P2|NOT COMPLETED|Overall Study||0
1460914|NCT02022670|3575444|P1|NOT COMPLETED|Overall Study||1
1460915|NCT02022670|3575442|P3|COMPLETED|Overall Study||11
1460916|NCT02022670|3575443|P2|COMPLETED|Overall Study||10
1460917|NCT02022670|3575444|P1|COMPLETED|Overall Study||10
1460918|NCT02022670|3575442|P3|STARTED|Overall Study||12
1460919|NCT02022670|3575443|P2|STARTED|Overall Study||10
1460920|NCT02022670|3575444|P1|STARTED|Overall Study||11
1460921|NCT02022085|3575458|P1|NOT COMPLETED|Overall Study||1
1460922|NCT02022085|3575458|P1|COMPLETED|Overall Study||53
1460923|NCT02022085|3575458|P1|STARTED|Overall Study||54
1460924|NCT02022020|3575484|P1|NOT COMPLETED|Overall Study||0
1460925|NCT02022020|3575484|P1|COMPLETED|Overall Study||220
1460926|NCT02022020|3575484|P1|STARTED|Overall Study||220
1460927|NCT02022007|3575493|P3|NOT COMPLETED|Overall Study||2
1460928|NCT02022007|3575494|P2|NOT COMPLETED|Overall Study||1
1460929|NCT02022007|3575495|P1|NOT COMPLETED|Overall Study||1
1460930|NCT02022007|3575493|P3|COMPLETED|Overall Study||11
1460931|NCT02022007|3575494|P2|COMPLETED|Overall Study||11
1460932|NCT02022007|3575495|P1|COMPLETED|Overall Study||12
1460933|NCT02022007|3575493|P3|STARTED|Overall Study||13
1460934|NCT02022007|3575494|P2|STARTED|Overall Study||12
1460935|NCT02022007|3575495|P1|STARTED|Overall Study||13
1460936|NCT02021942|3575536|P1|NOT COMPLETED|Overall Study||0
1460937|NCT02021942|3575536|P1|COMPLETED|Overall Study||16
1460938|NCT02021942|3575536|P1|STARTED|Overall Study||16
1460939|NCT02021812|3575546|P1|NOT COMPLETED|Overall Study||24
1460940|NCT02021812|3575546|P1|COMPLETED|Overall Study||7
1460941|NCT02021812|3575546|P1|STARTED|Overall Study||31
1460942|NCT02021656|3575554|P1|NOT COMPLETED|Overall Study||6
1460943|NCT02021656|3575554|P1|COMPLETED|Overall Study||378
1460944|NCT02021656|3575554|P1|STARTED|Overall Study||384
1460945|NCT02021643|3575574|P4|NOT COMPLETED|Overall Study||12
1460946|NCT02021643|3575575|P3|NOT COMPLETED|Overall Study||0
1460947|NCT02021643|3575576|P2|NOT COMPLETED|Overall Study||10
1460948|NCT02021643|3575577|P1|NOT COMPLETED|Overall Study||9
1460949|NCT02021643|3575574|P4|COMPLETED|Overall Study||218
1460950|NCT02021643|3575575|P3|COMPLETED|Overall Study||11
1460951|NCT02021643|3575576|P2|COMPLETED|Overall Study||280
1460952|NCT02021643|3575577|P1|COMPLETED|Overall Study||147
1460953|NCT02021643|3575574|P4|STARTED|Overall Study||230
1460954|NCT02021643|3575575|P3|STARTED|Overall Study||11
1460955|NCT02021643|3575576|P2|STARTED|Overall Study||290
1460956|NCT02021643|3575577|P1|STARTED|Overall Study||156
1460957|NCT02021565|3575619|P2|NOT COMPLETED|3-month Follow-up||2
1460958|NCT02021565|3575620|P1|NOT COMPLETED|3-month Follow-up||10
1460959|NCT02021565|3575619|P2|COMPLETED|3-month Follow-up||34
1460960|NCT02021565|3575620|P1|COMPLETED|3-month Follow-up||50
1460961|NCT02021565|3575619|P2|Care Recipients|3-month Follow-up||18
1460962|NCT02021565|3575620|P1|Care Recipients|3-month Follow-up||30
1460963|NCT02021565|3575619|P2|Caregivers|3-month Follow-up||18
1460964|NCT02021565|3575620|P1|Caregivers|3-month Follow-up||30
1460965|NCT02021565|3575619|P2|STARTED|3-month Follow-up||36
1460966|NCT02021565|3575620|P1|STARTED|3-month Follow-up||60
1460967|NCT02021565|3575619|P2|NOT COMPLETED|Baseline Through Intervention||18
1460968|NCT02021565|3575620|P1|NOT COMPLETED|Baseline Through Intervention||12
1460969|NCT02021565|3575619|P2|COMPLETED|Baseline Through Intervention||36
1460970|NCT02021565|3575620|P1|COMPLETED|Baseline Through Intervention||60
1460971|NCT02021565|3575619|P2|Care Recipients|Baseline Through Intervention||27
1460972|NCT02021565|3575620|P1|Care Recipients|Baseline Through Intervention||36
1460973|NCT02021565|3575619|P2|Caregivers|Baseline Through Intervention||27
1460974|NCT02021565|3575620|P1|Caregivers|Baseline Through Intervention||36
1460975|NCT02021565|3575619|P2|STARTED|Baseline Through Intervention||54
1460976|NCT02021565|3575620|P1|STARTED|Baseline Through Intervention||72
1460977|NCT02021461|3575632|P1|NOT COMPLETED|Overall Study||0
1460978|NCT02021461|3575632|P1|COMPLETED|Overall Study||38
1460979|NCT02021461|3575632|P1|STARTED|Overall Study||38
1460980|NCT02021331|3575640|P2|NOT COMPLETED|Overall Study||2
1460981|NCT02021331|3575641|P1|NOT COMPLETED|Overall Study||0
1460982|NCT02021331|3575640|P2|COMPLETED|Overall Study||1
1460983|NCT02021331|3575641|P1|COMPLETED|Overall Study||2
1460984|NCT02021331|3575640|P2|STARTED|Overall Study||3
1460985|NCT02021331|3575641|P1|STARTED|Overall Study||2
1460986|NCT02021292|3575653|P2|NOT COMPLETED|Overall Study||3
1460987|NCT02021292|3575654|P1|NOT COMPLETED|Overall Study||0
1460988|NCT02021292|3575653|P2|COMPLETED|Overall Study||37
1460989|NCT02021292|3575654|P1|COMPLETED|Overall Study||40
1460990|NCT02021292|3575653|P2|STARTED|Overall Study||40
1460991|NCT02021292|3575654|P1|STARTED|Overall Study||40
1460992|NCT02021071|3575672|P2|NOT COMPLETED|Overall Study||0
1460993|NCT02021071|3575673|P1|NOT COMPLETED|Overall Study||0
1460994|NCT02021071|3575672|P2|COMPLETED|Overall Study||12
1460995|NCT02021071|3575673|P1|COMPLETED|Overall Study||12
1460996|NCT02021071|3575672|P2|STARTED|Overall Study||12
1460997|NCT02021071|3575673|P1|STARTED|Overall Study||12
1460998|NCT02020941|3575680|P1|NOT COMPLETED|Overall Study||8
1460999|NCT02020941|3575680|P1|COMPLETED|Overall Study||2
1461000|NCT02020941|3575680|P1|STARTED|Overall Study||10
1461001|NCT02020889|3575691|P2|NOT COMPLETED|Overall Study||3
1461002|NCT02020889|3575692|P1|NOT COMPLETED|Overall Study||7
1461003|NCT02020889|3575691|P2|COMPLETED|Overall Study||65
1461004|NCT02020889|3575692|P1|COMPLETED|Overall Study||61
1461005|NCT02020889|3575691|P2|STARTED|Overall Study||68
1461006|NCT02020889|3575692|P1|STARTED|Overall Study||68
1461007|NCT02020863|3575746|P1|NOT COMPLETED|Overall Study||5
1461008|NCT02020863|3575746|P1|COMPLETED|Overall Study||35
1461009|NCT02020863|3575746|P1|STARTED|Overall Study||40
1461010|NCT02020837|3575750|P1|NOT COMPLETED|Overall Study||0
1461011|NCT02020837|3575750|P1|COMPLETED|Overall Study||2
1461012|NCT02020837|3575750|P1|STARTED|Overall Study||2
1461013|NCT02020616|3575761|P7|NOT COMPLETED|Overall Study||4
1461014|NCT02020616|3575762|P6|NOT COMPLETED|Overall Study||5
1461015|NCT02020616|3575763|P5|NOT COMPLETED|Overall Study||2
1461016|NCT02020616|3575764|P4|NOT COMPLETED|Overall Study||2
1461017|NCT02020616|3575765|P3|NOT COMPLETED|Overall Study||2
1461018|NCT02020616|3575766|P2|NOT COMPLETED|Overall Study||1
1461019|NCT02020616|3575767|P1|NOT COMPLETED|Overall Study||0
1461020|NCT02020616|3575761|P7|COMPLETED|Overall Study||6
1461021|NCT02020616|3575762|P6|COMPLETED|Overall Study||3
1461022|NCT02020616|3575763|P5|COMPLETED|Overall Study||6
1461023|NCT02020616|3575764|P4|COMPLETED|Overall Study||6
1461024|NCT02020616|3575765|P3|COMPLETED|Overall Study||6
1461025|NCT02020616|3575766|P2|COMPLETED|Overall Study||7
1461026|NCT02020616|3575767|P1|COMPLETED|Overall Study||10
1461027|NCT02020616|3575761|P7|Received at Least One Dose of Study Drug|Overall Study||10
1461028|NCT02020616|3575762|P6|Received at Least One Dose of Study Drug|Overall Study||8
1461029|NCT02020616|3575763|P5|Received at Least One Dose of Study Drug|Overall Study||8
1461030|NCT02020616|3575764|P4|Received at Least One Dose of Study Drug|Overall Study||7
1461031|NCT02020616|3575765|P3|Received at Least One Dose of Study Drug|Overall Study||8
1461032|NCT02020616|3575766|P2|Received at Least One Dose of Study Drug|Overall Study||8
1461033|NCT02020616|3575767|P1|Received at Least One Dose of Study Drug|Overall Study||10
1461034|NCT02020616|3575761|P7|STARTED|Overall Study||10
1461035|NCT02020616|3575762|P6|STARTED|Overall Study||8
1461036|NCT02020616|3575763|P5|STARTED|Overall Study||8
1461037|NCT02020616|3575764|P4|STARTED|Overall Study||8
1461038|NCT02020616|3575765|P3|STARTED|Overall Study||8
1461039|NCT02020616|3575766|P2|STARTED|Overall Study||8
1461040|NCT02020616|3575767|P1|STARTED|Overall Study||10
1461041|NCT02020577|3575860|P2|NOT COMPLETED|Overall Study||55
1461042|NCT02020577|3575861|P1|NOT COMPLETED|Overall Study||3
1461043|NCT02020577|3575860|P2|COMPLETED|Overall Study||0
1461044|NCT02020577|3575861|P1|COMPLETED|Overall Study||0
1461045|NCT02020577|3575860|P2|STARTED|Overall Study||55
1461046|NCT02020577|3575861|P1|STARTED|Overall Study||3
1461047|NCT02020512|3575888|P1|NOT COMPLETED|Overall Study||8
1461048|NCT02020512|3575888|P1|COMPLETED|Overall Study||79
1461049|NCT02020512|3575888|P1|STARTED|Overall Study||87
1461050|NCT02020369|3575894|P2|NOT COMPLETED|Overall Study||2
1461051|NCT02020369|3575895|P1|NOT COMPLETED|Overall Study||3
1461052|NCT02020369|3575894|P2|COMPLETED|Overall Study||11
1461053|NCT02020369|3575895|P1|COMPLETED|Overall Study||11
1461054|NCT02020369|3575894|P2|STARTED|Overall Study||13
1461055|NCT02020369|3575895|P1|STARTED|Overall Study||14
1461056|NCT02020304|3575911|P2|NOT COMPLETED|Overall Study||2
1461057|NCT02020304|3575912|P1|NOT COMPLETED|Overall Study||3
1461058|NCT02020304|3575911|P2|COMPLETED|Overall Study||26
1461059|NCT02020304|3575912|P1|COMPLETED|Overall Study||27
1461060|NCT02020304|3575911|P2|STARTED|Overall Study||28
1461061|NCT02020304|3575912|P1|STARTED|Overall Study||30
1461062|NCT02020135|3575928|P1|NOT COMPLETED|Overall Study||9
1461063|NCT02020135|3575928|P1|COMPLETED|Overall Study||0
1461064|NCT02020135|3575928|P1|STARTED|Overall Study||9
1461065|NCT02020031|3575940|P2|NOT COMPLETED|Overall Study||1
1461066|NCT02020031|3575941|P1|NOT COMPLETED|Overall Study||1
1461067|NCT02020031|3575940|P2|COMPLETED|Overall Study||10
1461068|NCT02020031|3575941|P1|COMPLETED|Overall Study||10
1461069|NCT02020031|3575940|P2|STARTED|Overall Study||11
1461070|NCT02020031|3575941|P1|STARTED|Overall Study||11
1461071|NCT02019979|3575949|P1|NOT COMPLETED|Overall Study||14
1461072|NCT02019979|3575949|P1|COMPLETED|Overall Study||0
1461073|NCT02019979|3575949|P1|STARTED|Overall Study||14
1461074|NCT02019719|3575960|P5|NOT COMPLETED|Overall Study||2
1461075|NCT02019719|3575961|P4|NOT COMPLETED|Overall Study||2
1461076|NCT02019719|3575962|P3|NOT COMPLETED|Overall Study||0
1461077|NCT02019719|3575963|P2|NOT COMPLETED|Overall Study||1
1461078|NCT02019719|3575964|P1|NOT COMPLETED|Overall Study||6
1461079|NCT02019719|3575960|P5|COMPLETED|Overall Study||18
1461080|NCT02019719|3575961|P4|COMPLETED|Overall Study||17
1461081|NCT02019719|3575962|P3|COMPLETED|Overall Study||20
1461082|NCT02019719|3575963|P2|COMPLETED|Overall Study||18
1461083|NCT02019719|3575964|P1|COMPLETED|Overall Study||13
1461084|NCT02019719|3575960|P5|STARTED|Overall Study||20
1461085|NCT02019719|3575961|P4|STARTED|Overall Study||19
1461086|NCT02019719|3575962|P3|STARTED|Overall Study||20
1461087|NCT02019719|3575963|P2|STARTED|Overall Study||19
1461088|NCT02019719|3575964|P1|STARTED|Overall Study||19
1461089|NCT02019563|3576063|P2|NOT COMPLETED|Overall Study||0
1461090|NCT02019563|3576064|P1|NOT COMPLETED|Overall Study||0
1461091|NCT02019563|3576063|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
1461092|NCT02019563|3576064|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
1461093|NCT02019563|3576063|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
1461094|NCT02019563|3576064|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
1461095|NCT02019550|3576080|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1461096|NCT02019550|3576081|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1461097|NCT02019550|3576080|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
1461098|NCT02019550|3576081|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
1461099|NCT02019550|3576080|P2|STARTED|Treatment Period 2 (4 Weeks)||50
1461100|NCT02019550|3576081|P1|STARTED|Treatment Period 2 (4 Weeks)||46
1461101|NCT02019550|3576080|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
1461102|NCT02019550|3576081|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1461103|NCT02019550|3576080|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
1461104|NCT02019550|3576081|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
1461105|NCT02019550|3576080|P2|STARTED|Treatment Period 1 (4 Weeks)||51
1461106|NCT02019550|3576081|P1|STARTED|Treatment Period 1 (4 Weeks)||46
1461107|NCT02019472|3576122|P3|NOT COMPLETED|Overall Study||42
1461108|NCT02019472|3576123|P2|NOT COMPLETED|Overall Study||52
1461109|NCT02019472|3576124|P1|NOT COMPLETED|Overall Study||37
1461110|NCT02019472|3576122|P3|COMPLETED|Overall Study||145
1461111|NCT02019472|3576123|P2|COMPLETED|Overall Study||134
1461112|NCT02019472|3576124|P1|COMPLETED|Overall Study||149
1461113|NCT02019472|3576122|P3|STARTED|Overall Study||187
1461114|NCT02019472|3576123|P2|STARTED|Overall Study||186
1461115|NCT02019472|3576124|P1|STARTED|Overall Study||186
1461116|NCT02019277|3576145|P1|NOT COMPLETED|Overall Study||12
1461117|NCT02019277|3576145|P1|COMPLETED|Overall Study||38
1461118|NCT02019277|3576145|P1|STARTED|Overall Study||50
1461119|NCT02018822|3576164|P3|NOT COMPLETED|Overall Study||6
1461120|NCT02018822|3576165|P2|NOT COMPLETED|Overall Study||8
1461121|NCT02018822|3576166|P1|NOT COMPLETED|Overall Study||6
1461122|NCT02018822|3576164|P3|COMPLETED|Overall Study||29
1461123|NCT02018822|3576165|P2|COMPLETED|Overall Study||42
1461124|NCT02018822|3576166|P1|COMPLETED|Overall Study||44
1461125|NCT02018822|3576164|P3|STARTED|Overall Study||35
1461126|NCT02018822|3576165|P2|STARTED|Overall Study||50
1461127|NCT02018822|3576166|P1|STARTED|Overall Study||50
1461128|NCT02018809|3576193|P4|NOT COMPLETED|Overall Study||0
1461129|NCT02018809|3576194|P3|NOT COMPLETED|Overall Study||0
1461130|NCT02018809|3576195|P2|NOT COMPLETED|Overall Study||0
1461131|NCT02018809|3576196|P1|NOT COMPLETED|Overall Study||0
1461132|NCT02018809|3576193|P4|COMPLETED|Overall Study||50
1461133|NCT02018809|3576194|P3|COMPLETED|Overall Study||50
1461134|NCT02018809|3576195|P2|COMPLETED|Overall Study||50
1461135|NCT02018809|3576196|P1|COMPLETED|Overall Study||50
1461136|NCT02018809|3576193|P4|STARTED|Overall Study||50
1461137|NCT02018809|3576194|P3|STARTED|Overall Study||50
1461138|NCT02018809|3576195|P2|STARTED|Overall Study||50
1461139|NCT02018809|3576196|P1|STARTED|Overall Study||50
1461140|NCT02018653|3576212|P2|NOT COMPLETED|Overall Study||1
1461141|NCT02018653|3576213|P1|NOT COMPLETED|Overall Study||0
1461142|NCT02018653|3576212|P2|COMPLETED|Overall Study||0
1461143|NCT02018653|3576213|P1|COMPLETED|Overall Study||1
1461144|NCT02018653|3576212|P2|STARTED|Overall Study||1
1461145|NCT02018653|3576213|P1|STARTED|Overall Study||1
1461146|NCT02018562|3576221|P2|NOT COMPLETED|Overall Study||0
1461147|NCT02018562|3576222|P1|NOT COMPLETED|Overall Study||3
1461148|NCT02018562|3576221|P2|COMPLETED|Overall Study||25
1461149|NCT02018562|3576222|P1|COMPLETED|Overall Study||22
1461150|NCT02018562|3576221|P2|STARTED|Overall Study||25
1461151|NCT02018562|3576222|P1|STARTED|Overall Study||25
1461152|NCT02017574|3576242|P2|NOT COMPLETED|Overall Study||0
1461153|NCT02017574|3576243|P1|NOT COMPLETED|Overall Study||0
1461154|NCT02017574|3576242|P2|COMPLETED|Overall Study||12
1461155|NCT02017574|3576243|P1|COMPLETED|Overall Study||12
1461156|NCT02017574|3576242|P2|STARTED|Overall Study||12
1461157|NCT02017574|3576243|P1|STARTED|Overall Study||12
1461158|NCT02017522|3576251|P1|NOT COMPLETED|Overall Study||1
1461159|NCT02017522|3576251|P1|COMPLETED|Overall Study||2
1461160|NCT02017522|3576251|P1|Scan|Overall Study||2
1461161|NCT02017522|3576251|P1|STARTED|Overall Study||3
1461162|NCT02017093|3576258|P2|NOT COMPLETED|Overall Study||0
1461163|NCT02017093|3576259|P1|NOT COMPLETED|Overall Study||0
1461164|NCT02017093|3576258|P2|COMPLETED|Overall Study||3
1461165|NCT02017093|3576259|P1|COMPLETED|Overall Study||4
1461166|NCT02017093|3576258|P2|STARTED|Overall Study||3
1461167|NCT02017093|3576259|P1|STARTED|Overall Study||4
1461168|NCT02017015|3576267|P1|NOT COMPLETED|Overall Study||69
1461169|NCT02017015|3576267|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
1461170|NCT02017015|3576267|P1|Safety Population|Overall Study||83
1461171|NCT02017015|3576267|P1|STARTED|Overall Study||83
1461172|NCT02016963|3576274|P1|NOT COMPLETED|Overall Study||0
1461173|NCT02016963|3576274|P1|COMPLETED|Overall Study||20
1461174|NCT02016963|3576274|P1|STARTED|Overall Study||20
1461175|NCT02016898|3576292|P2|NOT COMPLETED|Overall Study||5
1461176|NCT02016898|3576293|P1|NOT COMPLETED|Overall Study||5
1461177|NCT02016898|3576292|P2|COMPLETED|Overall Study||40
1461178|NCT02016898|3576293|P1|COMPLETED|Overall Study||45
1461179|NCT02016898|3576292|P2|STARTED|Overall Study||45
1461180|NCT02016898|3576293|P1|STARTED|Overall Study||50
1461181|NCT02016885|3576306|P5|NOT COMPLETED|Overall Study||1
1461182|NCT02016885|3576307|P4|NOT COMPLETED|Overall Study||10
1461183|NCT02016885|3576308|P3|NOT COMPLETED|Overall Study||1
1461184|NCT02016885|3576309|P2|NOT COMPLETED|Overall Study||4
1461185|NCT02016885|3576310|P1|NOT COMPLETED|Overall Study||4
1461186|NCT02016885|3576306|P5|COMPLETED|Overall Study||39
1461187|NCT02016885|3576307|P4|COMPLETED|Overall Study||30
1461188|NCT02016885|3576308|P3|COMPLETED|Overall Study||39
1461189|NCT02016885|3576309|P2|COMPLETED|Overall Study||36
1461190|NCT02016885|3576310|P1|COMPLETED|Overall Study||34
1461191|NCT02016885|3576306|P5|STARTED|Overall Study||40
1461192|NCT02016885|3576307|P4|STARTED|Overall Study||40
1461193|NCT02016885|3576308|P3|STARTED|Overall Study||40
1461194|NCT02016885|3576309|P2|STARTED|Overall Study||40
1461195|NCT02016885|3576310|P1|STARTED|Overall Study||38
1461196|NCT02016716|3576350|P3|NOT COMPLETED|Overall Study||6
1461197|NCT02016716|3576351|P2|NOT COMPLETED|Overall Study||8
1461198|NCT02016716|3576352|P1|NOT COMPLETED|Overall Study||6
1461199|NCT02016716|3576350|P3|COMPLETED|Overall Study||117
1461200|NCT02016716|3576351|P2|COMPLETED|Overall Study||110
1461201|NCT02016716|3576352|P1|COMPLETED|Overall Study||47
1461202|NCT02016716|3576350|P3|Received Study Treatment|Overall Study||123
1461203|NCT02016716|3576351|P2|Received Study Treatment|Overall Study||118
1461204|NCT02016716|3576352|P1|Received Study Treatment|Overall Study||53
1461205|NCT02016716|3576350|P3|STARTED|Overall Study||123
1461206|NCT02016716|3576351|P2|STARTED|Overall Study||118
1461207|NCT02016716|3576352|P1|STARTED|Overall Study||53
1461208|NCT02016690|3576373|P1|NOT COMPLETED|Overall Study||24
1461209|NCT02016690|3576373|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
1461210|NCT02016690|3576373|P1|Safety Analysis Set (SAS)|Overall Study||304
1461211|NCT02016690|3576373|P1|Treated|Overall Study||312
1461212|NCT02016690|3576373|P1|STARTED|Overall Study||312
1461213|NCT02016625|3576386|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
1461214|NCT02016625|3576387|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
1461215|NCT02016625|3576386|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
1461216|NCT02016625|3576387|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
1461217|NCT02016625|3576386|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
1461218|NCT02016625|3576387|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
1461219|NCT02016625|3576386|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
1461220|NCT02016625|3576387|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
1461221|NCT02016625|3576386|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
1461222|NCT02016625|3576387|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
1461223|NCT02016625|3576386|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
1461224|NCT02016625|3576387|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
1461225|NCT02016612|3576423|P4|NOT COMPLETED|Overall Study||0
1461226|NCT02016612|3576424|P3|NOT COMPLETED|Overall Study||0
1461227|NCT02016612|3576425|P2|NOT COMPLETED|Overall Study||0
1461228|NCT02016612|3576426|P1|NOT COMPLETED|Overall Study||0
1461229|NCT02016612|3576423|P4|COMPLETED|Overall Study||61
1461230|NCT02016612|3576424|P3|COMPLETED|Overall Study||26
1461231|NCT02016612|3576425|P2|COMPLETED|Overall Study||25
1461232|NCT02016612|3576426|P1|COMPLETED|Overall Study||25
1461233|NCT02016612|3576423|P4|STARTED|Overall Study||61
1461234|NCT02016612|3576424|P3|STARTED|Overall Study||26
1461235|NCT02016612|3576425|P2|STARTED|Overall Study||25
1461236|NCT02016612|3576426|P1|STARTED|Overall Study||25
1461237|NCT02016482|3576442|P2|NOT COMPLETED|Period B||7
1461238|NCT02016482|3576443|P1|NOT COMPLETED|Period B||13
1461239|NCT02016482|3576442|P2|COMPLETED|Period B||87
1461240|NCT02016482|3576443|P1|COMPLETED|Period B||81
1461241|NCT02016482|3576442|P2|STARTED|Period B||94
1461242|NCT02016482|3576443|P1|STARTED|Period B||94
1461243|NCT02016482|3576442|P2|NOT COMPLETED|Period A||15
1461244|NCT02016482|3576443|P1|NOT COMPLETED|Period A||14
1461245|NCT02016482|3576442|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
1461246|NCT02016482|3576443|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
1461247|NCT02016482|3576442|P2|STARTED|Period A||109
1461248|NCT02016482|3576443|P1|STARTED|Period A||108
1461249|NCT02016183|3576531|P1|NOT COMPLETED|Overall Study||65
1461250|NCT02016183|3576531|P1|COMPLETED|Overall Study||3157
1461251|NCT02016183|3576531|P1|STARTED|Overall Study||3222
1461252|NCT02016170|3576541|P3|NOT COMPLETED|Overall Study||0
1461253|NCT02016170|3576542|P2|NOT COMPLETED|Overall Study||1
1461254|NCT02016170|3576543|P1|NOT COMPLETED|Overall Study||2
1461255|NCT02016170|3576541|P3|COMPLETED|Overall Study||27
1461256|NCT02016170|3576542|P2|COMPLETED|Overall Study||27
1461257|NCT02016170|3576543|P1|COMPLETED|Overall Study||25
1461258|NCT02016170|3576541|P3|STARTED|Overall Study||27
1461259|NCT02016170|3576542|P2|STARTED|Overall Study||28
1461260|NCT02016170|3576543|P1|STARTED|Overall Study||27
1461261|NCT02016105|3576554|P6|NOT COMPLETED|EXTENSION PERIOD||6
1461262|NCT02016105|3576555|P5|NOT COMPLETED|EXTENSION PERIOD||6
1461263|NCT02016105|3576556|P4|NOT COMPLETED|EXTENSION PERIOD||5
1461264|NCT02016105|3576557|P3|NOT COMPLETED|EXTENSION PERIOD||5
1461265|NCT02016105|3576558|P2|NOT COMPLETED|EXTENSION PERIOD||0
1461266|NCT02016105|3576559|P1|NOT COMPLETED|EXTENSION PERIOD||0
1461267|NCT02016105|3576554|P6|COMPLETED|EXTENSION PERIOD||100
1461268|NCT02016105|3576555|P5|COMPLETED|EXTENSION PERIOD||50
1461269|NCT02016105|3576556|P4|COMPLETED|EXTENSION PERIOD||104
1461270|NCT02016105|3576557|P3|COMPLETED|EXTENSION PERIOD||47
1461271|NCT02016105|3576558|P2|COMPLETED|EXTENSION PERIOD||0
1461272|NCT02016105|3576559|P1|COMPLETED|EXTENSION PERIOD||0
1461273|NCT02016105|3576554|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
1461274|NCT02016105|3576555|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
1461275|NCT02016105|3576556|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
1461276|NCT02016105|3576557|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
1461277|NCT02016105|3576558|P2|STARTED|EXTENSION PERIOD||0
1461278|NCT02016105|3576559|P1|STARTED|EXTENSION PERIOD||0
1461279|NCT02016105|3576554|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
1461280|NCT02016105|3576555|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
1461281|NCT02016105|3576556|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
1461282|NCT02016105|3576557|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
1461283|NCT02016105|3576558|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
1461284|NCT02016105|3576559|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
1461285|NCT02016105|3576554|P6|COMPLETED|TREATMENT PERIOD 2||112
1461286|NCT02016105|3576555|P5|COMPLETED|TREATMENT PERIOD 2||59
1461287|NCT02016105|3576556|P4|COMPLETED|TREATMENT PERIOD 2||116
1461288|NCT02016105|3576557|P3|COMPLETED|TREATMENT PERIOD 2||57
1461289|NCT02016105|3576558|P2|COMPLETED|TREATMENT PERIOD 2||0
1461290|NCT02016105|3576559|P1|COMPLETED|TREATMENT PERIOD 2||0
1461291|NCT02016105|3576554|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
1461292|NCT02016105|3576555|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
1461293|NCT02016105|3576556|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
1461294|NCT02016105|3576557|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
1461295|NCT02016105|3576558|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
1461296|NCT02016105|3576559|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
1461297|NCT02016105|3576554|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
1461298|NCT02016105|3576555|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
1461299|NCT02016105|3576556|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
1461300|NCT02016105|3576557|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
1461301|NCT02016105|3576558|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
1461302|NCT02016105|3576559|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
1461303|NCT02016105|3576554|P6|COMPLETED|TREATMENT PERIOD 1||0
1461304|NCT02016105|3576555|P5|COMPLETED|TREATMENT PERIOD 1||0
1461305|NCT02016105|3576556|P4|COMPLETED|TREATMENT PERIOD 1||0
1461306|NCT02016105|3576557|P3|COMPLETED|TREATMENT PERIOD 1||0
1461307|NCT02016105|3576558|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
1461308|NCT02016105|3576559|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
1461309|NCT02016105|3576554|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1461310|NCT02016105|3576555|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1461311|NCT02016105|3576556|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1461312|NCT02016105|3576557|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1461313|NCT02016105|3576558|P2|STARTED|TREATMENT PERIOD 1||234
1461314|NCT02016105|3576559|P1|STARTED|TREATMENT PERIOD 1||231
1461315|NCT02015910|3576609|P2|NOT COMPLETED|Overall Study||0
1461316|NCT02015910|3576610|P1|NOT COMPLETED|Overall Study||0
1461317|NCT02015910|3576609|P2|COMPLETED|Overall Study||1
1461318|NCT02015910|3576610|P1|COMPLETED|Overall Study||0
1461319|NCT02015910|3576609|P2|STARTED|Overall Study||1
1461320|NCT02015910|3576610|P1|STARTED|Overall Study||0
1461321|NCT02015793|3576618|P2|NOT COMPLETED|Overall Study||4
1461322|NCT02015793|3576619|P1|NOT COMPLETED|Overall Study||4
1461323|NCT02015793|3576618|P2|COMPLETED|Overall Study||11
1461324|NCT02015793|3576619|P1|COMPLETED|Overall Study||11
1461325|NCT02015793|3576618|P2|Entered Open-label Extension Period|Overall Study||14
1461326|NCT02015793|3576619|P1|Entered Open-label Extension Period|Overall Study||13
1461327|NCT02015793|3576618|P2|Completed Double-Blind Period|Overall Study||14
1461328|NCT02015793|3576619|P1|Completed Double-Blind Period|Overall Study||14
1461329|NCT02015793|3576618|P2|STARTED|Overall Study||15
1461330|NCT02015793|3576619|P1|STARTED|Overall Study||15
1461331|NCT02015754|3576649|P1|NOT COMPLETED|Overall Study||11
1461332|NCT02015754|3576649|P1|COMPLETED|Overall Study||3
1461333|NCT02015754|3576649|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
1461334|NCT02015754|3576649|P1|Completed First TACE|Overall Study||14
1461335|NCT02015754|3576649|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
1461336|NCT02015676|3576669|P3|NOT COMPLETED|Overall Study||3
1461337|NCT02015676|3576670|P2|NOT COMPLETED|Overall Study||34
1461338|NCT02015676|3576671|P1|NOT COMPLETED|Overall Study||9
1461339|NCT02015676|3576669|P3|COMPLETED|Overall Study||3
1461340|NCT02015676|3576670|P2|COMPLETED|Overall Study||14
1461341|NCT02015676|3576671|P1|COMPLETED|Overall Study||6
1461342|NCT02015676|3576669|P3|STARTED|Overall Study||6
1461343|NCT02015676|3576670|P2|STARTED|Overall Study||48
1461344|NCT02015676|3576671|P1|STARTED|Overall Study||15
1461345|NCT02015663|3576687|P2|NOT COMPLETED|Overall Study||12
1461346|NCT02015663|3576688|P1|NOT COMPLETED|Overall Study||15
1461347|NCT02015663|3576687|P2|COMPLETED|Overall Study||4
1461348|NCT02015663|3576688|P1|COMPLETED|Overall Study||1
1461349|NCT02015663|3576687|P2|STARTED|Overall Study||16
1461350|NCT02015663|3576688|P1|STARTED|Overall Study||16
1461351|NCT02015637|3576719|P2|NOT COMPLETED|Overall Study||5
1461352|NCT02015637|3576720|P1|NOT COMPLETED|Overall Study||8
1461353|NCT02015637|3576719|P2|COMPLETED|Overall Study||149
1461354|NCT02015637|3576720|P1|COMPLETED|Overall Study||298
1461355|NCT02015637|3576719|P2|STARTED|Overall Study||154
1461356|NCT02015637|3576720|P1|STARTED|Overall Study||306
1461357|NCT02015546|3576731|P3|NOT COMPLETED|Overall Study||4
1461358|NCT02015546|3576732|P2|NOT COMPLETED|Overall Study||2
1461359|NCT02015546|3576733|P1|NOT COMPLETED|Overall Study||3
1461360|NCT02015546|3576731|P3|COMPLETED|Overall Study||22
1461361|NCT02015546|3576732|P2|COMPLETED|Overall Study||19
1461362|NCT02015546|3576733|P1|COMPLETED|Overall Study||20
1461363|NCT02015546|3576731|P3|STARTED|Overall Study||26
1461364|NCT02015546|3576732|P2|STARTED|Overall Study||21
1461365|NCT02015546|3576733|P1|STARTED|Overall Study||23
1461366|NCT02015481|3576765|P1|NOT COMPLETED|Overall Study||1
1461367|NCT02015481|3576765|P1|COMPLETED|Overall Study||24
1461368|NCT02015481|3576765|P1|STARTED|Overall Study||25
1461369|NCT02015234|3576774|P2|NOT COMPLETED|Overall Study||25
1461370|NCT02015234|3576775|P1|NOT COMPLETED|Overall Study||36
1461371|NCT02015234|3576774|P2|COMPLETED|Overall Study||54
1461372|NCT02015234|3576775|P1|COMPLETED|Overall Study||43
1461373|NCT02015234|3576774|P2|STARTED|Overall Study||79
1461374|NCT02015234|3576775|P1|STARTED|Overall Study||79
1461375|NCT02015221|3576789|P2|NOT COMPLETED|Overall Study||6
1461376|NCT02015221|3576790|P1|NOT COMPLETED|Overall Study||9
1461377|NCT02015221|3576789|P2|COMPLETED|Overall Study||34
1461378|NCT02015221|3576790|P1|COMPLETED|Overall Study||32
1461379|NCT02015221|3576789|P2|STARTED|Overall Study||40
1461380|NCT02015221|3576790|P1|STARTED|Overall Study||41
1461381|NCT02015195|3576803|P7|NOT COMPLETED|Overall Study||0
1461382|NCT02015195|3576804|P6|NOT COMPLETED|Overall Study||0
1461383|NCT02015195|3576805|P5|NOT COMPLETED|Overall Study||0
1461384|NCT02015195|3576806|P4|NOT COMPLETED|Overall Study||1
1461385|NCT02015195|3576807|P3|NOT COMPLETED|Overall Study||0
1461386|NCT02015195|3576808|P2|NOT COMPLETED|Overall Study||0
1461387|NCT02015195|3576809|P1|NOT COMPLETED|Overall Study||0
1461388|NCT02015195|3576803|P7|COMPLETED|Overall Study||16
1461389|NCT02015195|3576804|P6|COMPLETED|Overall Study||16
1461390|NCT02015195|3576805|P5|COMPLETED|Overall Study||16
1461391|NCT02015195|3576806|P4|COMPLETED|Overall Study||0
1461392|NCT02015195|3576807|P3|COMPLETED|Overall Study||16
1461393|NCT02015195|3576808|P2|COMPLETED|Overall Study||16
1461394|NCT02015195|3576809|P1|COMPLETED|Overall Study||16
1461395|NCT02015195|3576803|P7|STARTED|Overall Study||16
1461396|NCT02015195|3576804|P6|STARTED|Overall Study||16
1461397|NCT02015195|3576805|P5|STARTED|Overall Study||16
1461398|NCT02015195|3576806|P4|STARTED|Overall Study||1
1461399|NCT02015195|3576807|P3|STARTED|Overall Study||16
1461400|NCT02015195|3576808|P2|STARTED|Overall Study||16
1461401|NCT02015195|3576809|P1|STARTED|Overall Study||16
1461402|NCT02015039|3576832|P2|NOT COMPLETED|Overall Study||1
1461403|NCT02015039|3576833|P1|NOT COMPLETED|Overall Study||0
1461404|NCT02015039|3576832|P2|COMPLETED|Overall Study||6
1461405|NCT02015039|3576833|P1|COMPLETED|Overall Study||6
1461406|NCT02015039|3576832|P2|STARTED|Overall Study||7
1461407|NCT02015039|3576833|P1|STARTED|Overall Study||6
1461408|NCT02014740|3576853|P2|NOT COMPLETED|Overall Study||5
1461409|NCT02014740|3576854|P1|NOT COMPLETED|Overall Study||6
1461410|NCT02014740|3576853|P2|COMPLETED|Overall Study||40
1461411|NCT02014740|3576854|P1|COMPLETED|Overall Study||49
1461412|NCT02014740|3576853|P2|STARTED|Overall Study||45
1461413|NCT02014740|3576854|P1|STARTED|Overall Study||55
1461414|NCT02014584|3576862|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1461415|NCT02014584|3576863|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
1461416|NCT02014584|3576864|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1461417|NCT02014584|3576865|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1461418|NCT02014584|3576866|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1461419|NCT02014584|3576867|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1461420|NCT02014584|3576862|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
1461421|NCT02014584|3576863|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
1461422|NCT02014584|3576864|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1461423|NCT02014584|3576865|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1461424|NCT02014584|3576866|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1461425|NCT02014584|3576867|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
1461426|NCT02014584|3576862|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
1461427|NCT02014584|3576863|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
1461428|NCT02014584|3576864|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
1461429|NCT02014584|3576865|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
1461430|NCT02014584|3576866|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
1461431|NCT02014584|3576867|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
1461432|NCT02014584|3576862|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
1461433|NCT02014584|3576863|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
1461434|NCT02014584|3576864|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
1461435|NCT02014584|3576865|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
1461436|NCT02014584|3576866|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
1461437|NCT02014584|3576867|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
1461438|NCT02014584|3576862|P6|COMPLETED|Open-Label Period (24 Weeks)||0
1461439|NCT02014584|3576863|P5|COMPLETED|Open-Label Period (24 Weeks)||0
1461440|NCT02014584|3576864|P4|COMPLETED|Open-Label Period (24 Weeks)||47
1461441|NCT02014584|3576865|P3|COMPLETED|Open-Label Period (24 Weeks)||44
1461442|NCT02014584|3576866|P2|COMPLETED|Open-Label Period (24 Weeks)||0
1461443|NCT02014584|3576867|P1|COMPLETED|Open-Label Period (24 Weeks)||0
1461444|NCT02014584|3576862|P6|STARTED|Open-Label Period (24 Weeks)||0
1461445|NCT02014584|3576863|P5|STARTED|Open-Label Period (24 Weeks)||0
1461446|NCT02014584|3576864|P4|STARTED|Open-Label Period (24 Weeks)||48
1461447|NCT02014584|3576865|P3|STARTED|Open-Label Period (24 Weeks)||49
1461448|NCT02014584|3576866|P2|STARTED|Open-Label Period (24 Weeks)||0
1461449|NCT02014584|3576867|P1|STARTED|Open-Label Period (24 Weeks)||0
1461450|NCT02014584|3576862|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
1461451|NCT02014584|3576863|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
1461452|NCT02014584|3576864|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
1461453|NCT02014584|3576865|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
1461454|NCT02014584|3576866|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
1461455|NCT02014584|3576867|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
1461456|NCT02014584|3576862|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
1461457|NCT02014584|3576863|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
1461458|NCT02014584|3576864|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
1461459|NCT02014584|3576865|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
1461460|NCT02014584|3576866|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
1461461|NCT02014584|3576867|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
1461462|NCT02014584|3576862|P6|STARTED|Double-Blind Period (24 Weeks)||0
1461463|NCT02014584|3576863|P5|STARTED|Double-Blind Period (24 Weeks)||0
1461464|NCT02014584|3576864|P4|STARTED|Double-Blind Period (24 Weeks)||0
1461465|NCT02014584|3576865|P3|STARTED|Double-Blind Period (24 Weeks)||0
1461466|NCT02014584|3576866|P2|STARTED|Double-Blind Period (24 Weeks)||58
1461467|NCT02014584|3576867|P1|STARTED|Double-Blind Period (24 Weeks)||59
1461468|NCT02014519|3576984|P1|NOT COMPLETED|Overall Study||0
1461469|NCT02014519|3576984|P1|COMPLETED|Overall Study||2000
1461470|NCT02014519|3576984|P1|STARTED|Overall Study||2000
1461471|NCT02014480|3577041|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
1461472|NCT02014480|3577042|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1461473|NCT02014480|3577043|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1461474|NCT02014480|3577044|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1461475|NCT02014480|3577045|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1461476|NCT02014480|3577046|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1461477|NCT02014480|3577041|P6|COMPLETED|Treatment Period 3 (14 Days)||32
1461478|NCT02014480|3577042|P5|COMPLETED|Treatment Period 3 (14 Days)||34
1461479|NCT02014480|3577043|P4|COMPLETED|Treatment Period 3 (14 Days)||31
1461480|NCT02014480|3577044|P3|COMPLETED|Treatment Period 3 (14 Days)||29
1461481|NCT02014480|3577045|P2|COMPLETED|Treatment Period 3 (14 Days)||32
1461482|NCT02014480|3577046|P1|COMPLETED|Treatment Period 3 (14 Days)||34
1461483|NCT02014480|3577041|P6|STARTED|Treatment Period 3 (14 Days)||34
1461484|NCT02014480|3577042|P5|STARTED|Treatment Period 3 (14 Days)||34
1461485|NCT02014480|3577043|P4|STARTED|Treatment Period 3 (14 Days)||31
1461486|NCT02014480|3577044|P3|STARTED|Treatment Period 3 (14 Days)||30
1461487|NCT02014480|3577045|P2|STARTED|Treatment Period 3 (14 Days)||33
1461488|NCT02014480|3577046|P1|STARTED|Treatment Period 3 (14 Days)||34
1461489|NCT02014480|3577041|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1461490|NCT02014480|3577042|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1461491|NCT02014480|3577043|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1461492|NCT02014480|3577044|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1461493|NCT02014480|3577045|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1461494|NCT02014480|3577046|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1461495|NCT02014480|3577041|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
1461496|NCT02014480|3577042|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
1461497|NCT02014480|3577043|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
1461498|NCT02014480|3577044|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
1461499|NCT02014480|3577045|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
1461500|NCT02014480|3577046|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
1461501|NCT02014480|3577041|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
1461502|NCT02014480|3577042|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
1461503|NCT02014480|3577043|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
1461504|NCT02014480|3577044|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
1461505|NCT02014480|3577045|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
1461506|NCT02014480|3577046|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
1461507|NCT02014480|3577041|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1461508|NCT02014480|3577042|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1461509|NCT02014480|3577043|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1461510|NCT02014480|3577044|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
1461511|NCT02014480|3577045|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1461512|NCT02014480|3577046|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1461513|NCT02014480|3577041|P6|COMPLETED|Treatment Period 2 (14 Days)||34
1461514|NCT02014480|3577042|P5|COMPLETED|Treatment Period 2 (14 Days)||34
1461515|NCT02014480|3577043|P4|COMPLETED|Treatment Period 2 (14 Days)||31
1461516|NCT02014480|3577044|P3|COMPLETED|Treatment Period 2 (14 Days)||30
1461517|NCT02014480|3577045|P2|COMPLETED|Treatment Period 2 (14 Days)||33
1461518|NCT02014480|3577046|P1|COMPLETED|Treatment Period 2 (14 Days)||34
1461519|NCT02014480|3577041|P6|STARTED|Treatment Period 2 (14 Days)||34
1461520|NCT02014480|3577042|P5|STARTED|Treatment Period 2 (14 Days)||34
1461521|NCT02014480|3577043|P4|STARTED|Treatment Period 2 (14 Days)||32
1461522|NCT02014480|3577044|P3|STARTED|Treatment Period 2 (14 Days)||32
1461523|NCT02014480|3577045|P2|STARTED|Treatment Period 2 (14 Days)||34
1461524|NCT02014480|3577046|P1|STARTED|Treatment Period 2 (14 Days)||35
1461525|NCT02014480|3577041|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1461526|NCT02014480|3577042|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1461527|NCT02014480|3577043|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1461528|NCT02014480|3577044|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
1461529|NCT02014480|3577045|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1461530|NCT02014480|3577046|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1461531|NCT02014480|3577041|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
1461532|NCT02014480|3577042|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
1461533|NCT02014480|3577043|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
1461534|NCT02014480|3577044|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
1461535|NCT02014480|3577045|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
1461536|NCT02014480|3577046|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
1461537|NCT02014480|3577041|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
1461538|NCT02014480|3577042|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
1461539|NCT02014480|3577043|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
1461540|NCT02014480|3577044|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
1461541|NCT02014480|3577045|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
1461542|NCT02014480|3577046|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
1461543|NCT02014480|3577041|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1461544|NCT02014480|3577042|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1461545|NCT02014480|3577043|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1461546|NCT02014480|3577044|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1461547|NCT02014480|3577045|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1461548|NCT02014480|3577046|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1461549|NCT02014480|3577041|P6|COMPLETED|Treatment Period 1 (14 Days)||34
1461550|NCT02014480|3577042|P5|COMPLETED|Treatment Period 1 (14 Days)||34
1461551|NCT02014480|3577043|P4|COMPLETED|Treatment Period 1 (14 Days)||32
1461552|NCT02014480|3577044|P3|COMPLETED|Treatment Period 1 (14 Days)||33
1461553|NCT02014480|3577045|P2|COMPLETED|Treatment Period 1 (14 Days)||34
1461554|NCT02014480|3577046|P1|COMPLETED|Treatment Period 1 (14 Days)||35
1461555|NCT02014480|3577041|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
1461556|NCT02014480|3577042|P5|STARTED|Treatment Period 1 (14 Days)||35
1461557|NCT02014480|3577043|P4|STARTED|Treatment Period 1 (14 Days)||34
1461558|NCT02014480|3577044|P3|STARTED|Treatment Period 1 (14 Days)||34
1461559|NCT02014480|3577045|P2|STARTED|Treatment Period 1 (14 Days)||35
1461560|NCT02014480|3577046|P1|STARTED|Treatment Period 1 (14 Days)||35
1461561|NCT02014467|3577065|P2|NOT COMPLETED|Overall Study||7
1461562|NCT02014467|3577066|P1|NOT COMPLETED|Overall Study||25
1461563|NCT02014467|3577065|P2|COMPLETED|Overall Study||112
1461564|NCT02014467|3577066|P1|COMPLETED|Overall Study||340
1461565|NCT02014467|3577065|P2|STARTED|Overall Study||119
1461566|NCT02014467|3577066|P1|STARTED|Overall Study||365
1461567|NCT02014441|3577126|P1|NOT COMPLETED|Overall Study||30
1461568|NCT02014441|3577126|P1|COMPLETED|Overall Study||31
1461569|NCT02014441|3577126|P1|Received Treatment|Overall Study||60
1461570|NCT02014441|3577126|P1|STARTED|Overall Study||61
1461571|NCT02014402|3577222|P4|NOT COMPLETED|Overall Study||3
1461572|NCT02014402|3577223|P3|NOT COMPLETED|Overall Study||3
1461573|NCT02014402|3577224|P2|NOT COMPLETED|Overall Study||3
1461574|NCT02014402|3577225|P1|NOT COMPLETED|Overall Study||2
1461575|NCT02014402|3577222|P4|COMPLETED|Overall Study||82
1461576|NCT02014402|3577223|P3|COMPLETED|Overall Study||32
1461577|NCT02014402|3577224|P2|COMPLETED|Overall Study||27
1461578|NCT02014402|3577225|P1|COMPLETED|Overall Study||29
1461579|NCT02014402|3577222|P4|Bovine Thrombin|Overall Study||28
1461580|NCT02014402|3577223|P3|Bovine Thrombin|Overall Study||12
1461581|NCT02014402|3577224|P2|Bovine Thrombin|Overall Study||10
1461582|NCT02014402|3577225|P1|Bovine Thrombin|Overall Study||11
1461583|NCT02014402|3577222|P4|Human Thrombin|Overall Study||57
1461584|NCT02014402|3577223|P3|Human Thrombin|Overall Study||23
1461585|NCT02014402|3577224|P2|Human Thrombin|Overall Study||20
1461586|NCT02014402|3577225|P1|Human Thrombin|Overall Study||20
1461587|NCT02014402|3577222|P4|STARTED|Overall Study||85
1461588|NCT02014402|3577223|P3|STARTED|Overall Study||35
1461589|NCT02014402|3577224|P2|STARTED|Overall Study||30
1461590|NCT02014402|3577225|P1|STARTED|Overall Study||31
1461591|NCT02014363|3577255|P3|NOT COMPLETED|Overall Study||24
1461592|NCT02014363|3577256|P2|NOT COMPLETED|Overall Study||19
1461593|NCT02014363|3577257|P1|NOT COMPLETED|Overall Study||17
1461594|NCT02014363|3577255|P3|COMPLETED|Overall Study||31
1461595|NCT02014363|3577256|P2|COMPLETED|Overall Study||35
1461596|NCT02014363|3577257|P1|COMPLETED|Overall Study||38
1461597|NCT02014363|3577255|P3|STARTED|Overall Study||55
1461598|NCT02014363|3577256|P2|STARTED|Overall Study||54
1461599|NCT02014363|3577257|P1|STARTED|Overall Study||55
1461600|NCT02014272|3577265|P2|NOT COMPLETED|Intervention Period 2||0
1461601|NCT02014272|3577266|P1|NOT COMPLETED|Intervention Period 2||0
1461602|NCT02014272|3577265|P2|COMPLETED|Intervention Period 2||13
1461603|NCT02014272|3577266|P1|COMPLETED|Intervention Period 2||13
1461604|NCT02014272|3577265|P2|STARTED|Intervention Period 2||13
1461605|NCT02014272|3577266|P1|STARTED|Intervention Period 2||13
1461606|NCT02014272|3577265|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1461607|NCT02014272|3577266|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1461608|NCT02014272|3577265|P2|COMPLETED|Washout Period 1 (7 Days)||13
1461609|NCT02014272|3577266|P1|COMPLETED|Washout Period 1 (7 Days)||13
1461610|NCT02014272|3577265|P2|STARTED|Washout Period 1 (7 Days)||13
1461611|NCT02014272|3577266|P1|STARTED|Washout Period 1 (7 Days)||13
1461612|NCT02014272|3577265|P2|NOT COMPLETED|Intervention Period 1||1
1461613|NCT02014272|3577266|P1|NOT COMPLETED|Intervention Period 1||1
1461614|NCT02014272|3577265|P2|COMPLETED|Intervention Period 1||13
1461615|NCT02014272|3577266|P1|COMPLETED|Intervention Period 1||13
1461616|NCT02014272|3577265|P2|STARTED|Intervention Period 1||14
1461617|NCT02014272|3577266|P1|STARTED|Intervention Period 1||14
1461618|NCT02014051|3577284|P2|NOT COMPLETED|Overall Study||1
1461619|NCT02014051|3577285|P1|NOT COMPLETED|Overall Study||1
1461620|NCT02014051|3577284|P2|COMPLETED|Overall Study||5
1461621|NCT02014051|3577285|P1|COMPLETED|Overall Study||2
1461622|NCT02014051|3577284|P2|STARTED|Overall Study||6
1461623|NCT02014051|3577285|P1|STARTED|Overall Study||3
1461624|NCT02013830|3577298|P1|NOT COMPLETED|Overall Study||30
1461625|NCT02013830|3577298|P1|COMPLETED|Overall Study||15
1461626|NCT02013830|3577298|P1|STARTED|Overall Study||45
1461627|NCT02013817|3577309|P1|NOT COMPLETED|Overall Study||27
1461628|NCT02013817|3577309|P1|COMPLETED|Overall Study||16
1461629|NCT02013817|3577309|P1|STARTED|Overall Study||43
1461630|NCT02013791|3577327|P9|NOT COMPLETED|Period 2||0
1461631|NCT02013791|3577328|P8|NOT COMPLETED|Period 2||0
1461632|NCT02013791|3577329|P7|NOT COMPLETED|Period 2||0
1461633|NCT02013791|3577330|P6|NOT COMPLETED|Period 2||0
1461634|NCT02013791|3577331|P5|NOT COMPLETED|Period 2||0
1461635|NCT02013791|3577332|P4|NOT COMPLETED|Period 2||0
1461636|NCT02013791|3577333|P3|NOT COMPLETED|Period 2||0
1461637|NCT02013791|3577334|P2|NOT COMPLETED|Period 2||0
1461638|NCT02013791|3577335|P1|NOT COMPLETED|Period 2||0
1461639|NCT02013791|3577327|P9|COMPLETED|Period 2||0
1461640|NCT02013791|3577328|P8|COMPLETED|Period 2||0
1461641|NCT02013791|3577329|P7|COMPLETED|Period 2||3
1461642|NCT02013791|3577330|P6|COMPLETED|Period 2||0
1461643|NCT02013791|3577331|P5|COMPLETED|Period 2||0
1461644|NCT02013791|3577332|P4|COMPLETED|Period 2||0
1461645|NCT02013791|3577333|P3|COMPLETED|Period 2||2
1461646|NCT02013791|3577334|P2|COMPLETED|Period 2||0
1461647|NCT02013791|3577335|P1|COMPLETED|Period 2||0
1461648|NCT02013791|3577327|P9|STARTED|Period 2||0
1461649|NCT02013791|3577328|P8|STARTED|Period 2||0
1461650|NCT02013791|3577329|P7|STARTED|Period 2||3
1461651|NCT02013791|3577330|P6|STARTED|Period 2||0
1461652|NCT02013791|3577331|P5|STARTED|Period 2||0
1461653|NCT02013791|3577332|P4|STARTED|Period 2||0
1461654|NCT02013791|3577333|P3|STARTED|Period 2||2
1461655|NCT02013791|3577334|P2|STARTED|Period 2||0
1461656|NCT02013791|3577335|P1|STARTED|Period 2||0
1461657|NCT02013791|3577327|P9|NOT COMPLETED|Period 1||0
1461658|NCT02013791|3577328|P8|NOT COMPLETED|Period 1||1
1461659|NCT02013791|3577329|P7|NOT COMPLETED|Period 1||1
1461660|NCT02013791|3577330|P6|NOT COMPLETED|Period 1||0
1461661|NCT02013791|3577331|P5|NOT COMPLETED|Period 1||0
1461662|NCT02013791|3577332|P4|NOT COMPLETED|Period 1||1
1461663|NCT02013791|3577333|P3|NOT COMPLETED|Period 1||0
1461664|NCT02013791|3577334|P2|NOT COMPLETED|Period 1||2
1461665|NCT02013791|3577335|P1|NOT COMPLETED|Period 1||0
1461666|NCT02013791|3577327|P9|COMPLETED|Period 1||3
1461667|NCT02013791|3577328|P8|COMPLETED|Period 1||7
1461668|NCT02013791|3577329|P7|COMPLETED|Period 1||3
1461669|NCT02013791|3577330|P6|COMPLETED|Period 1||8
1461670|NCT02013791|3577331|P5|COMPLETED|Period 1||4
1461671|NCT02013791|3577332|P4|COMPLETED|Period 1||7
1461672|NCT02013791|3577333|P3|COMPLETED|Period 1||4
1461673|NCT02013791|3577334|P2|COMPLETED|Period 1||6
1461674|NCT02013791|3577335|P1|COMPLETED|Period 1||8
1461675|NCT02013791|3577327|P9|STARTED|Period 1||3
1461676|NCT02013791|3577328|P8|STARTED|Period 1||8
1461677|NCT02013791|3577329|P7|STARTED|Period 1||4
1461678|NCT02013791|3577330|P6|STARTED|Period 1||8
1461679|NCT02013791|3577331|P5|STARTED|Period 1||4
1461680|NCT02013791|3577332|P4|STARTED|Period 1||8
1461681|NCT02013791|3577333|P3|STARTED|Period 1||4
1461682|NCT02013791|3577334|P2|STARTED|Period 1||8
1461683|NCT02013791|3577335|P1|STARTED|Period 1||8
1461684|NCT02013765|3577356|P1|NOT COMPLETED|Overall Study||1
1461685|NCT02013765|3577356|P1|COMPLETED|Overall Study||4
1461686|NCT02013765|3577356|P1|STARTED|Overall Study||5
1461687|NCT02013687|3577370|P4|NOT COMPLETED|Overall Study||2
1461688|NCT02013687|3577371|P3|NOT COMPLETED|Overall Study||2
1461689|NCT02013687|3577372|P2|NOT COMPLETED|Overall Study||0
1461690|NCT02013687|3577373|P1|NOT COMPLETED|Overall Study||0
1461691|NCT02013687|3577370|P4|COMPLETED|Overall Study||14
1461692|NCT02013687|3577371|P3|COMPLETED|Overall Study||14
1461693|NCT02013687|3577372|P2|COMPLETED|Overall Study||6
1461694|NCT02013687|3577373|P1|COMPLETED|Overall Study||6
1461695|NCT02013687|3577370|P4|STARTED|Overall Study||16
1461696|NCT02013687|3577371|P3|STARTED|Overall Study||16
1461697|NCT02013687|3577372|P2|STARTED|Overall Study||6
1461698|NCT02013687|3577373|P1|STARTED|Overall Study||6
1461699|NCT02013622|3577403|P1|NOT COMPLETED|Overall Study||24
1461700|NCT02013622|3577403|P1|COMPLETED|Overall Study||25
1461701|NCT02013622|3577403|P1|STARTED|Overall Study||49
1461702|NCT02013609|3577423|P1|NOT COMPLETED|Overall Study||18
1461703|NCT02013609|3577423|P1|COMPLETED|Overall Study||29
1461704|NCT02013609|3577423|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
1461705|NCT02013544|3577448|P2|NOT COMPLETED|Overall Study||20
1461706|NCT02013544|3577449|P1|NOT COMPLETED|Overall Study||11
1461707|NCT02013544|3577448|P2|COMPLETED|Overall Study||356
1461708|NCT02013544|3577449|P1|COMPLETED|Overall Study||171
1461709|NCT02013544|3577448|P2|ITT Population|Overall Study||325
1461710|NCT02013544|3577449|P1|ITT Population|Overall Study||157
1461711|NCT02013544|3577448|P2|Safety Population|Overall Study||374
1461712|NCT02013544|3577449|P1|Safety Population|Overall Study||180
1461713|NCT02013544|3577448|P2|STARTED|Overall Study||376
1461714|NCT02013544|3577449|P1|STARTED|Overall Study||182
1461715|NCT02013531|3577471|P1|NOT COMPLETED|Overall Study||5
1461716|NCT02013531|3577471|P1|COMPLETED|Overall Study||32
1461717|NCT02013531|3577471|P1|STARTED|Overall Study||37
1461718|NCT02013388|3577501|P8|NOT COMPLETED|Overall Study||0
1461719|NCT02013388|3577502|P7|NOT COMPLETED|Overall Study||0
1461720|NCT02013388|3577503|P6|NOT COMPLETED|Overall Study||0
1461721|NCT02013388|3577504|P5|NOT COMPLETED|Overall Study||1
1461722|NCT02013388|3577505|P4|NOT COMPLETED|Overall Study||0
1461723|NCT02013388|3577506|P3|NOT COMPLETED|Overall Study||0
1461724|NCT02013388|3577507|P2|NOT COMPLETED|Overall Study||0
1461725|NCT02013388|3577508|P1|NOT COMPLETED|Overall Study||1
1461726|NCT02013388|3577501|P8|COMPLETED|Overall Study||4
1461727|NCT02013388|3577502|P7|COMPLETED|Overall Study||6
1461728|NCT02013388|3577503|P6|COMPLETED|Overall Study||6
1461729|NCT02013388|3577504|P5|COMPLETED|Overall Study||5
1461730|NCT02013388|3577505|P4|COMPLETED|Overall Study||6
1461731|NCT02013388|3577506|P3|COMPLETED|Overall Study||6
1461732|NCT02013388|3577507|P2|COMPLETED|Overall Study||6
1461733|NCT02013388|3577508|P1|COMPLETED|Overall Study||8
1461734|NCT02013388|3577501|P8|STARTED|Overall Study||4
1461735|NCT02013388|3577502|P7|STARTED|Overall Study||6
1461736|NCT02013388|3577503|P6|STARTED|Overall Study||6
1461737|NCT02013388|3577504|P5|STARTED|Overall Study||6
1461738|NCT02013388|3577505|P4|STARTED|Overall Study||6
1461739|NCT02013388|3577506|P3|STARTED|Overall Study||6
1461740|NCT02013388|3577507|P2|STARTED|Overall Study||6
1461741|NCT02013388|3577508|P1|STARTED|Overall Study||9
1461742|NCT02013245|3577546|P4|NOT COMPLETED|Overall Study||0
1461743|NCT02013245|3577547|P3|NOT COMPLETED|Overall Study||0
1461744|NCT02013245|3577548|P2|NOT COMPLETED|Overall Study||1
1461745|NCT02013245|3577549|P1|NOT COMPLETED|Overall Study||0
1461746|NCT02013245|3577546|P4|COMPLETED|Overall Study||9
1461747|NCT02013245|3577547|P3|COMPLETED|Overall Study||9
1461748|NCT02013245|3577548|P2|COMPLETED|Overall Study||8
1461749|NCT02013245|3577549|P1|COMPLETED|Overall Study||9
1461750|NCT02013245|3577546|P4|STARTED|Overall Study||9
1461751|NCT02013245|3577547|P3|STARTED|Overall Study||9
1461752|NCT02013245|3577548|P2|STARTED|Overall Study||9
1461753|NCT02013245|3577549|P1|STARTED|Overall Study||9
1461754|NCT02013206|3577565|P2|NOT COMPLETED|Overall Study||22
1461755|NCT02013206|3577566|P1|NOT COMPLETED|Overall Study||27
1461756|NCT02013206|3577565|P2|COMPLETED|Overall Study||1
1461757|NCT02013206|3577566|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
1461758|NCT02013206|3577565|P2|Received Study Drug|Overall Study||23
1461759|NCT02013206|3577566|P1|Received Study Drug|Overall Study||26
1461760|NCT02013206|3577565|P2|STARTED|Overall Study||23
1461761|NCT02013206|3577566|P1|STARTED|Overall Study||29
1461762|NCT02013167|3577588|P2|NOT COMPLETED|Overall Study||178
1461763|NCT02013167|3577589|P1|NOT COMPLETED|Overall Study||101
1461764|NCT02013167|3577588|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
1461765|NCT02013167|3577589|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
1461766|NCT02013167|3577588|P2|Received Treatment|Overall Study||267
1461767|NCT02013167|3577589|P1|Received Treatment|Overall Study||109
1461768|NCT02013167|3577588|P2|STARTED|Overall Study||271
1461769|NCT02013167|3577589|P1|STARTED|Overall Study||134
1461770|NCT02013050|3577620|P4|NOT COMPLETED|Overall Study||4
1461771|NCT02013050|3577621|P3|NOT COMPLETED|Overall Study||0
1461772|NCT02013050|3577622|P2|NOT COMPLETED|Overall Study||5
1461773|NCT02013050|3577623|P1|NOT COMPLETED|Overall Study||4
1461774|NCT02013050|3577620|P4|COMPLETED|Overall Study||19
1461775|NCT02013050|3577621|P3|COMPLETED|Overall Study||3
1461776|NCT02013050|3577622|P2|COMPLETED|Overall Study||36
1461777|NCT02013050|3577623|P1|COMPLETED|Overall Study||38
1461778|NCT02013050|3577620|P4|STARTED|Overall Study||23
1461779|NCT02013050|3577621|P3|STARTED|Overall Study||3
1461780|NCT02013050|3577622|P2|STARTED|Overall Study||41
1461781|NCT02013050|3577623|P1|STARTED|Overall Study||42
1461782|NCT02012959|3577665|P5|NOT COMPLETED|Treatment Phase B||0
1461783|NCT02012959|3577666|P4|NOT COMPLETED|Treatment Phase B||0
1461784|NCT02012959|3577667|P3|NOT COMPLETED|Treatment Phase B||0
1461785|NCT02012959|3577668|P2|NOT COMPLETED|Treatment Phase B||0
1461786|NCT02012959|3577669|P1|NOT COMPLETED|Treatment Phase B||0
1461787|NCT02012959|3577665|P5|COMPLETED|Treatment Phase B||1
1461788|NCT02012959|3577666|P4|COMPLETED|Treatment Phase B||1
1461789|NCT02012959|3577667|P3|COMPLETED|Treatment Phase B||3
1461790|NCT02012959|3577668|P2|COMPLETED|Treatment Phase B||2
1461791|NCT02012959|3577669|P1|COMPLETED|Treatment Phase B||0
1461792|NCT02012959|3577665|P5|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
1461793|NCT02012959|3577666|P4|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
1461794|NCT02012959|3577667|P3|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
1461795|NCT02012959|3577668|P2|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
1461796|NCT02012959|3577669|P1|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
1461797|NCT02012959|3577665|P5|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
1461798|NCT02012959|3577666|P4|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator’s discretion|1
1461799|NCT02012959|3577667|P3|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
1461800|NCT02012959|3577668|P2|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
1461801|NCT02012959|3577669|P1|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
1461802|NCT02012959|3577665|P5|NOT COMPLETED|Treatment Phase A||0
1461803|NCT02012959|3577666|P4|NOT COMPLETED|Treatment Phase A||0
1461804|NCT02012959|3577667|P3|NOT COMPLETED|Treatment Phase A||0
1461805|NCT02012959|3577668|P2|NOT COMPLETED|Treatment Phase A||0
1461806|NCT02012959|3577669|P1|NOT COMPLETED|Treatment Phase A||2
1461807|NCT02012959|3577665|P5|COMPLETED|Treatment Phase A||0
1461808|NCT02012959|3577666|P4|COMPLETED|Treatment Phase A||0
1461809|NCT02012959|3577667|P3|COMPLETED|Treatment Phase A||0
1461810|NCT02012959|3577668|P2|COMPLETED|Treatment Phase A||0
1461811|NCT02012959|3577669|P1|COMPLETED|Treatment Phase A||7
1461812|NCT02012959|3577665|P5|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
1461813|NCT02012959|3577666|P4|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
1461814|NCT02012959|3577667|P3|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
1461815|NCT02012959|3577668|P2|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
1461816|NCT02012959|3577669|P1|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
1461817|NCT02012959|3577665|P5|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
1461818|NCT02012959|3577666|P4|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
1461819|NCT02012959|3577667|P3|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
1461820|NCT02012959|3577668|P2|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
1461821|NCT02012959|3577669|P1|STARTED|Treatment Phase A||9
1461822|NCT02012686|3577682|P2|NOT COMPLETED|Overall Study||2
1461823|NCT02012686|3577683|P1|NOT COMPLETED|Overall Study||0
1461824|NCT02012686|3577682|P2|COMPLETED|Overall Study||48
1461825|NCT02012686|3577683|P1|COMPLETED|Overall Study||50
1461826|NCT02012686|3577682|P2|STARTED|Overall Study||50
1461827|NCT02012686|3577683|P1|STARTED|Overall Study||50
1461828|NCT02012582|3577699|P4|NOT COMPLETED|Overall Study||1
1461829|NCT02012582|3577700|P3|NOT COMPLETED|Overall Study||0
1461830|NCT02012582|3577701|P2|NOT COMPLETED|Overall Study||0
1461831|NCT02012582|3577702|P1|NOT COMPLETED|Overall Study||0
1461832|NCT02012582|3577699|P4|COMPLETED|Overall Study||7
1461833|NCT02012582|3577700|P3|COMPLETED|Overall Study||8
1461834|NCT02012582|3577701|P2|COMPLETED|Overall Study||8
1461835|NCT02012582|3577702|P1|COMPLETED|Overall Study||8
1461836|NCT02012582|3577699|P4|STARTED|Overall Study||8
1461837|NCT02012582|3577700|P3|STARTED|Overall Study||8
1461838|NCT02012582|3577701|P2|STARTED|Overall Study||8
1461839|NCT02012582|3577702|P1|STARTED|Overall Study||8
1461840|NCT02012491|3577730|P2|NOT COMPLETED|Overall Study||1
1461841|NCT02012491|3577731|P1|NOT COMPLETED|Overall Study||2
1461842|NCT02012491|3577730|P2|COMPLETED|Overall Study||148
1461843|NCT02012491|3577731|P1|COMPLETED|Overall Study||149
1461844|NCT02012491|3577730|P2|STARTED|Overall Study||149
1461845|NCT02012491|3577731|P1|STARTED|Overall Study||151
1461846|NCT02012452|3577749|P2|NOT COMPLETED|Overall Study||1
1461847|NCT02012452|3577750|P1|NOT COMPLETED|Overall Study||6
1461848|NCT02012452|3577749|P2|COMPLETED|Overall Study||1
1461849|NCT02012452|3577750|P1|COMPLETED|Overall Study||1
1461850|NCT02012452|3577749|P2|STARTED|Overall Study||2
1461851|NCT02012452|3577750|P1|STARTED|Overall Study||7
1461852|NCT02012218|3577763|P5|NOT COMPLETED|Overall Study||1
1461853|NCT02012218|3577764|P4|NOT COMPLETED|Overall Study||2
1461854|NCT02012218|3577765|P3|NOT COMPLETED|Overall Study||2
1461855|NCT02012218|3577766|P2|NOT COMPLETED|Overall Study||1
1461856|NCT02012218|3577767|P1|NOT COMPLETED|Overall Study||4
1461857|NCT02012218|3577763|P5|COMPLETED|Overall Study||5
1461858|NCT02012218|3577764|P4|COMPLETED|Overall Study||17
1461859|NCT02012218|3577765|P3|COMPLETED|Overall Study||11
1461860|NCT02012218|3577766|P2|COMPLETED|Overall Study||10
1461861|NCT02012218|3577767|P1|COMPLETED|Overall Study||8
1461862|NCT02012218|3577763|P5|STARTED|Overall Study||6
1461863|NCT02012218|3577764|P4|STARTED|Overall Study||19
1461864|NCT02012218|3577765|P3|STARTED|Overall Study||13
1461865|NCT02012218|3577766|P2|STARTED|Overall Study||11
1461866|NCT02012218|3577767|P1|STARTED|Overall Study||12
1461867|NCT02011893|3577779|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
1461868|NCT02011893|3577780|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
1461869|NCT02011893|3577781|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
1461870|NCT02011893|3577779|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
1461871|NCT02011893|3577780|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
1461872|NCT02011893|3577781|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
1461873|NCT02011893|3577779|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
1461874|NCT02011893|3577780|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
1461875|NCT02011893|3577781|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
1461876|NCT02011893|3577779|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
1461877|NCT02011893|3577780|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
1461878|NCT02011893|3577781|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
1461879|NCT02011893|3577779|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
1461880|NCT02011893|3577780|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
1461881|NCT02011893|3577781|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
1461882|NCT02011893|3577779|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
1461883|NCT02011893|3577780|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
1461884|NCT02011893|3577781|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
1461885|NCT02011893|3577779|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
1461886|NCT02011893|3577780|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
1461887|NCT02011893|3577781|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
1461888|NCT02011893|3577779|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
1461889|NCT02011893|3577780|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
1461890|NCT02011893|3577781|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
1461891|NCT02011893|3577779|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
1461892|NCT02011893|3577780|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
1461893|NCT02011893|3577781|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
1461894|NCT02011893|3577779|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
1461895|NCT02011893|3577780|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
1461896|NCT02011893|3577781|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
1461897|NCT02011893|3577779|P3|NOT COMPLETED|Enrollment to Randomization||0
1461898|NCT02011893|3577780|P2|NOT COMPLETED|Enrollment to Randomization||0
1461899|NCT02011893|3577781|P1|NOT COMPLETED|Enrollment to Randomization||73
1461900|NCT02011893|3577779|P3|COMPLETED|Enrollment to Randomization||0
1461901|NCT02011893|3577780|P2|COMPLETED|Enrollment to Randomization||0
1461902|NCT02011893|3577781|P1|COMPLETED|Enrollment to Randomization||100
1461903|NCT02011893|3577779|P3|Randomization|Enrollment to Randomization||0
1461904|NCT02011893|3577780|P2|Randomization|Enrollment to Randomization||0
1461905|NCT02011893|3577781|P1|Randomization|Enrollment to Randomization||100
1461906|NCT02011893|3577779|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
1461907|NCT02011893|3577780|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
1461908|NCT02011893|3577781|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
1461909|NCT02011893|3577779|P3|Trial Stimulation Implant|Enrollment to Randomization||0
1461910|NCT02011893|3577780|P2|Trial Stimulation Implant|Enrollment to Randomization||0
1461911|NCT02011893|3577781|P1|Trial Stimulation Implant|Enrollment to Randomization||121
1461912|NCT02011893|3577779|P3|Baseline|Enrollment to Randomization||0
1461913|NCT02011893|3577780|P2|Baseline|Enrollment to Randomization||0
1461914|NCT02011893|3577781|P1|Baseline|Enrollment to Randomization||141
1461915|NCT02011893|3577779|P3|STARTED|Enrollment to Randomization||0
1461916|NCT02011893|3577780|P2|STARTED|Enrollment to Randomization||0
1461917|NCT02011893|3577781|P1|STARTED|Enrollment to Randomization||173
1461918|NCT02011542|3577792|P1|NOT COMPLETED|Overall Study||1
1461919|NCT02011542|3577792|P1|COMPLETED|Overall Study||29
1461920|NCT02011542|3577792|P1|STARTED|Overall Study||30
1461921|NCT02011516|3577799|P2|NOT COMPLETED|Overall Study||2
1461922|NCT02011516|3577800|P1|NOT COMPLETED|Overall Study||4
1461923|NCT02011516|3577799|P2|COMPLETED|Overall Study||6
1461924|NCT02011516|3577800|P1|COMPLETED|Overall Study||4
1461925|NCT02011516|3577799|P2|STARTED|Overall Study||8
1461926|NCT02011516|3577800|P1|STARTED|Overall Study||8
1461927|NCT02011490|3577809|P6|NOT COMPLETED|Part 2||0
1461928|NCT02011490|3577810|P5|NOT COMPLETED|Part 2||0
1461929|NCT02011490|3577811|P4|NOT COMPLETED|Part 2||0
1461930|NCT02011490|3577812|P3|NOT COMPLETED|Part 2||0
1461931|NCT02011490|3577813|P2|NOT COMPLETED|Part 2||0
1461932|NCT02011490|3577814|P1|NOT COMPLETED|Part 2||0
1461933|NCT02011490|3577809|P6|COMPLETED|Part 2||6
1461934|NCT02011490|3577810|P5|COMPLETED|Part 2||6
1461935|NCT02011490|3577811|P4|COMPLETED|Part 2||6
1461936|NCT02011490|3577812|P3|COMPLETED|Part 2||0
1461937|NCT02011490|3577813|P2|COMPLETED|Part 2||0
1461938|NCT02011490|3577814|P1|COMPLETED|Part 2||0
1461939|NCT02011490|3577809|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
1461940|NCT02011490|3577810|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
1461941|NCT02011490|3577811|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
1461942|NCT02011490|3577812|P3|STARTED|Part 2||0
1461943|NCT02011490|3577813|P2|STARTED|Part 2||0
1461944|NCT02011490|3577814|P1|STARTED|Part 2||0
1461945|NCT02011490|3577809|P6|NOT COMPLETED|Part 1||0
1461946|NCT02011490|3577810|P5|NOT COMPLETED|Part 1||0
1461947|NCT02011490|3577811|P4|NOT COMPLETED|Part 1||0
1461948|NCT02011490|3577812|P3|NOT COMPLETED|Part 1||0
1461949|NCT02011490|3577813|P2|NOT COMPLETED|Part 1||0
1461950|NCT02011490|3577814|P1|NOT COMPLETED|Part 1||0
1461951|NCT02011490|3577809|P6|COMPLETED|Part 1||0
1461952|NCT02011490|3577810|P5|COMPLETED|Part 1||0
1461953|NCT02011490|3577811|P4|COMPLETED|Part 1||0
1461954|NCT02011490|3577812|P3|COMPLETED|Part 1||8
1461955|NCT02011490|3577813|P2|COMPLETED|Part 1||8
1461956|NCT02011490|3577814|P1|COMPLETED|Part 1||8
1461957|NCT02011490|3577809|P6|STARTED|Part 1||0
1461958|NCT02011490|3577810|P5|STARTED|Part 1||0
1461959|NCT02011490|3577811|P4|STARTED|Part 1||0
1461960|NCT02011490|3577812|P3|STARTED|Part 1||8
1461961|NCT02011490|3577813|P2|STARTED|Part 1||8
1461962|NCT02011490|3577814|P1|STARTED|Part 1||8
1461963|NCT02011464|3577902|P2|NOT COMPLETED|Overall Study||0
1461964|NCT02011464|3577903|P1|NOT COMPLETED|Overall Study||0
1461965|NCT02011464|3577902|P2|COMPLETED|Overall Study||10
1461966|NCT02011464|3577903|P1|COMPLETED|Overall Study||10
1461967|NCT02011464|3577902|P2|STARTED|Overall Study||10
1461968|NCT02011464|3577903|P1|STARTED|Overall Study||10
1461969|NCT02011113|3577923|P1|NOT COMPLETED|Overall Study||36
1461970|NCT02011113|3577923|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
1461971|NCT02011113|3577923|P1|STARTED|Overall Study||36
1461972|NCT02010996|3577939|P2|NOT COMPLETED|Overall Study||0
1461973|NCT02010996|3577940|P1|NOT COMPLETED|Overall Study||0
1461974|NCT02010996|3577939|P2|COMPLETED|Overall Study||36
1461975|NCT02010996|3577940|P1|COMPLETED|Overall Study||36
1461976|NCT02010996|3577939|P2|STARTED|Overall Study||36
1461977|NCT02010996|3577940|P1|STARTED|Overall Study||36
1461978|NCT02010684|3577952|P2|NOT COMPLETED|Overall Study||23
1461979|NCT02010684|3577953|P1|NOT COMPLETED|Overall Study||12
1461980|NCT02010684|3577952|P2|COMPLETED|Overall Study||59
1461981|NCT02010684|3577953|P1|COMPLETED|Overall Study||27
1461982|NCT02010684|3577952|P2|STARTED|Overall Study||82
1461983|NCT02010684|3577953|P1|STARTED|Overall Study||39
1461984|NCT02010632|3577971|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1461985|NCT02010632|3577972|P1|NOT COMPLETED|Second Intervention (7 Days)||1
1461986|NCT02010632|3577971|P2|COMPLETED|Second Intervention (7 Days)||16
1461987|NCT02010632|3577972|P1|COMPLETED|Second Intervention (7 Days)||15
1461988|NCT02010632|3577971|P2|STARTED|Second Intervention (7 Days)||16
1461989|NCT02010632|3577972|P1|STARTED|Second Intervention (7 Days)||16
1461990|NCT02010632|3577971|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
1461991|NCT02010632|3577972|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
1461992|NCT02010632|3577971|P2|COMPLETED|Wash Out Period (14 Days)||16
1461993|NCT02010632|3577972|P1|COMPLETED|Wash Out Period (14 Days)||16
1461994|NCT02010632|3577971|P2|STARTED|Wash Out Period (14 Days)||16
1461995|NCT02010632|3577972|P1|STARTED|Wash Out Period (14 Days)||16
1461996|NCT02010632|3577971|P2|NOT COMPLETED|First Intervention (7 Days)||0
1461997|NCT02010632|3577972|P1|NOT COMPLETED|First Intervention (7 Days)||0
1461998|NCT02010632|3577971|P2|COMPLETED|First Intervention (7 Days)||16
1461999|NCT02010632|3577972|P1|COMPLETED|First Intervention (7 Days)||16
1462000|NCT02010632|3577971|P2|STARTED|First Intervention (7 Days)||16
1462001|NCT02010632|3577972|P1|STARTED|First Intervention (7 Days)||16
1462002|NCT02010567|3577983|P5|NOT COMPLETED|Overall Study||1
1462003|NCT02010567|3577984|P4|NOT COMPLETED|Overall Study||0
1462004|NCT02010567|3577985|P3|NOT COMPLETED|Overall Study||1
1462005|NCT02010567|3577986|P2|NOT COMPLETED|Overall Study||0
1462006|NCT02010567|3577987|P1|NOT COMPLETED|Overall Study||0
1462007|NCT02010567|3577983|P5|COMPLETED|Overall Study||5
1462008|NCT02010567|3577984|P4|COMPLETED|Overall Study||3
1462009|NCT02010567|3577985|P3|COMPLETED|Overall Study||13
1462010|NCT02010567|3577986|P2|COMPLETED|Overall Study||6
1462011|NCT02010567|3577987|P1|COMPLETED|Overall Study||3
1462012|NCT02010567|3577983|P5|STARTED|Overall Study||6
1462013|NCT02010567|3577984|P4|STARTED|Overall Study||3
1462014|NCT02010567|3577985|P3|STARTED|Overall Study||14
1462015|NCT02010567|3577986|P2|STARTED|Overall Study||6
1462016|NCT02010567|3577987|P1|STARTED|Overall Study||3
1462017|NCT02010255|3578012|P14|NOT COMPLETED|Overall Study||1
1462018|NCT02010255|3578013|P13|NOT COMPLETED|Overall Study||0
1462019|NCT02010255|3578014|P12|NOT COMPLETED|Overall Study||1
1462020|NCT02010255|3578015|P11|NOT COMPLETED|Overall Study||2
1462021|NCT02010255|3578016|P10|NOT COMPLETED|Overall Study||0
1462022|NCT02010255|3578017|P9|NOT COMPLETED|Overall Study||1
1462023|NCT02010255|3578018|P8|NOT COMPLETED|Overall Study||1
1462024|NCT02010255|3578019|P7|NOT COMPLETED|Overall Study||1
1462025|NCT02010255|3578020|P6|NOT COMPLETED|Overall Study||0
1462026|NCT02010255|3578021|P5|NOT COMPLETED|Overall Study||4
1462027|NCT02010255|3578022|P4|NOT COMPLETED|Overall Study||6
1462028|NCT02010255|3578023|P3|NOT COMPLETED|Overall Study||7
1462029|NCT02010255|3578024|P2|NOT COMPLETED|Overall Study||2
1462030|NCT02010255|3578025|P1|NOT COMPLETED|Overall Study||6
1462031|NCT02010255|3578012|P14|COMPLETED|Overall Study||2
1462032|NCT02010255|3578013|P13|COMPLETED|Overall Study||3
1462033|NCT02010255|3578014|P12|COMPLETED|Overall Study||4
1462034|NCT02010255|3578015|P11|COMPLETED|Overall Study||1
1462035|NCT02010255|3578016|P10|COMPLETED|Overall Study||23
1462036|NCT02010255|3578017|P9|COMPLETED|Overall Study||21
1462037|NCT02010255|3578018|P8|COMPLETED|Overall Study||32
1462038|NCT02010255|3578019|P7|COMPLETED|Overall Study||33
1462039|NCT02010255|3578020|P6|COMPLETED|Overall Study||49
1462040|NCT02010255|3578021|P5|COMPLETED|Overall Study||48
1462041|NCT02010255|3578022|P4|COMPLETED|Overall Study||20
1462042|NCT02010255|3578023|P3|COMPLETED|Overall Study||18
1462043|NCT02010255|3578024|P2|COMPLETED|Overall Study||26
1462044|NCT02010255|3578025|P1|COMPLETED|Overall Study||22
1462045|NCT02010255|3578012|P14|STARTED|Overall Study||3
1462046|NCT02010255|3578013|P13|STARTED|Overall Study||3
1462047|NCT02010255|3578014|P12|STARTED|Overall Study||5
1462048|NCT02010255|3578015|P11|STARTED|Overall Study||3
1462049|NCT02010255|3578016|P10|STARTED|Overall Study||23
1462050|NCT02010255|3578017|P9|STARTED|Overall Study||22
1462051|NCT02010255|3578018|P8|STARTED|Overall Study||33
1462052|NCT02010255|3578019|P7|STARTED|Overall Study||34
1462053|NCT02010255|3578020|P6|STARTED|Overall Study||49
1462054|NCT02010255|3578021|P5|STARTED|Overall Study||52
1462055|NCT02010255|3578022|P4|STARTED|Overall Study||26
1462056|NCT02010255|3578023|P3|STARTED|Overall Study||25
1462057|NCT02010255|3578024|P2|STARTED|Overall Study||28
1462058|NCT02010255|3578025|P1|STARTED|Overall Study||28
1462059|NCT02010216|3578349|P1|NOT COMPLETED|Overall Study||0
1462060|NCT02010216|3578349|P1|COMPLETED|Overall Study||23
1462061|NCT02010216|3578349|P1|STARTED|Overall Study||23
1462062|NCT02010021|3578357|P2|NOT COMPLETED|Overall Study||0
1462063|NCT02010021|3578358|P1|NOT COMPLETED|Overall Study||0
1462064|NCT02010021|3578357|P2|COMPLETED|Overall Study||7
1462065|NCT02010021|3578358|P1|COMPLETED|Overall Study||10
1462066|NCT02010021|3578357|P2|STARTED|Overall Study||7
1462067|NCT02010021|3578358|P1|STARTED|Overall Study||10
1462068|NCT02009982|3578368|P2|NOT COMPLETED|Overall Study||0
1462069|NCT02009982|3578369|P1|NOT COMPLETED|Overall Study||0
1462070|NCT02009982|3578368|P2|COMPLETED|Overall Study||2
1462071|NCT02009982|3578369|P1|COMPLETED|Overall Study||1
1462072|NCT02009982|3578368|P2|STARTED|Overall Study||2
1462073|NCT02009982|3578369|P1|STARTED|Overall Study||1
1462074|NCT02009878|3578380|P3|NOT COMPLETED|Overall Study||0
1462075|NCT02009878|3578381|P2|NOT COMPLETED|Overall Study||1
1462076|NCT02009878|3578382|P1|NOT COMPLETED|Overall Study||0
1462077|NCT02009878|3578380|P3|COMPLETED|Overall Study||9
1462078|NCT02009878|3578381|P2|COMPLETED|Overall Study||10
1462079|NCT02009878|3578382|P1|COMPLETED|Overall Study||10
1462080|NCT02009878|3578380|P3|STARTED|Overall Study||9
1462081|NCT02009878|3578381|P2|STARTED|Overall Study||11
1462082|NCT02009878|3578382|P1|STARTED|Overall Study||10
1462083|NCT02009865|3578416|P2|NOT COMPLETED|Overall Study||5
1462084|NCT02009865|3578417|P1|NOT COMPLETED|Overall Study||1
1462085|NCT02009865|3578416|P2|COMPLETED|Overall Study||76
1462086|NCT02009865|3578417|P1|COMPLETED|Overall Study||80
1462087|NCT02009865|3578416|P2|STARTED|Overall Study||81
1462088|NCT02009865|3578417|P1|STARTED|Overall Study||81
1462089|NCT02009722|3578433|P2|NOT COMPLETED|Overall Study||3
1462090|NCT02009722|3578434|P1|NOT COMPLETED|Overall Study||1
1462091|NCT02009722|3578433|P2|COMPLETED|Overall Study||40
1462092|NCT02009722|3578434|P1|COMPLETED|Overall Study||40
1462093|NCT02009722|3578433|P2|Received Intervention|Overall Study||42
1462094|NCT02009722|3578434|P1|Received Intervention|Overall Study||41
1462095|NCT02009722|3578433|P2|STARTED|Overall Study||43
1462096|NCT02009722|3578434|P1|STARTED|Overall Study||41
1462097|NCT02009696|3578458|P1|NOT COMPLETED|Overall Study||2
1462098|NCT02009696|3578458|P1|COMPLETED|Overall Study||219
1462099|NCT02009696|3578458|P1|STARTED|Overall Study||221
1462100|NCT02009501|3578468|P2|NOT COMPLETED|Overall Study||0
1462101|NCT02009501|3578469|P1|NOT COMPLETED|Overall Study||0
1462102|NCT02009501|3578468|P2|COMPLETED|Overall Study||11
1462103|NCT02009501|3578469|P1|COMPLETED|Overall Study||9
1462104|NCT02009501|3578468|P2|STARTED|Overall Study||11
1462105|NCT02009501|3578469|P1|STARTED|Overall Study||9
1462106|NCT02009163|3578475|P3|NOT COMPLETED|Randomized-withdrawal Period||35
1462107|NCT02009163|3578476|P2|NOT COMPLETED|Randomized-withdrawal Period||88
1462108|NCT02009163|3578477|P1|NOT COMPLETED|Randomized-withdrawal Period||0
1462109|NCT02009163|3578475|P3|COMPLETED|Randomized-withdrawal Period||102
1462110|NCT02009163|3578476|P2|COMPLETED|Randomized-withdrawal Period||50
1462111|NCT02009163|3578477|P1|COMPLETED|Randomized-withdrawal Period||0
1462112|NCT02009163|3578475|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
1462113|NCT02009163|3578476|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
1462114|NCT02009163|3578477|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
1462115|NCT02009163|3578475|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
1462116|NCT02009163|3578476|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
1462117|NCT02009163|3578477|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
1462118|NCT02009163|3578475|P3|COMPLETED|Open-label Period (Non-randomized)||0
1462119|NCT02009163|3578476|P2|COMPLETED|Open-label Period (Non-randomized)||0
1462120|NCT02009163|3578477|P1|COMPLETED|Open-label Period (Non-randomized)||275
1462121|NCT02009163|3578475|P3|STARTED|Open-label Period (Non-randomized)||0
1462122|NCT02009163|3578476|P2|STARTED|Open-label Period (Non-randomized)||0
1462123|NCT02009163|3578477|P1|STARTED|Open-label Period (Non-randomized)||418
1462124|NCT02009046|3578512|P2|NOT COMPLETED|Overall Study||206
1462125|NCT02009046|3578513|P1|NOT COMPLETED|Overall Study||256
1462126|NCT02009046|3578512|P2|COMPLETED|Overall Study||678
1462127|NCT02009046|3578513|P1|COMPLETED|Overall Study||769
1462128|NCT02009046|3578512|P2|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
1462129|NCT02009046|3578513|P1|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
1462130|NCT02009046|3578512|P2|Ctrl Curriculum Only|Overall Study||456
1462131|NCT02009046|3578513|P1|Ctrl Curriculum Only|Overall Study||0
1462132|NCT02009046|3578512|P2|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
1462133|NCT02009046|3578513|P1|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
1462134|NCT02009046|3578512|P2|SEI Curriculum Only|Overall Study||0
1462135|NCT02009046|3578513|P1|SEI Curriculum Only|Overall Study||461
1462136|NCT02009046|3578512|P2|STARTED|Overall Study||884
1462137|NCT02009046|3578513|P1|STARTED|Overall Study||1025
1462138|NCT02008942|3578563|P2|NOT COMPLETED|Second Intervention||0
1462139|NCT02008942|3578564|P1|NOT COMPLETED|Second Intervention||1
1462140|NCT02008942|3578563|P2|COMPLETED|Second Intervention||30
1462141|NCT02008942|3578564|P1|COMPLETED|Second Intervention||25
1462142|NCT02008942|3578563|P2|STARTED|Second Intervention||30
1462143|NCT02008942|3578564|P1|STARTED|Second Intervention||26
1462144|NCT02008942|3578563|P2|NOT COMPLETED|First Intervention||0
1462145|NCT02008942|3578564|P1|NOT COMPLETED|First Intervention||0
1462146|NCT02008942|3578563|P2|COMPLETED|First Intervention||30
1462147|NCT02008942|3578564|P1|COMPLETED|First Intervention||27
1462148|NCT02008942|3578563|P2|STARTED|First Intervention||30
1462149|NCT02008942|3578564|P1|STARTED|First Intervention||27
1462150|NCT02008916|3578573|P3|NOT COMPLETED|Week 16 - 156||10
1462151|NCT02008916|3578574|P2|NOT COMPLETED|Week 16 - 156||13
1462152|NCT02008916|3578575|P1|NOT COMPLETED|Week 16 - 156||19
1462153|NCT02008916|3578573|P3|COMPLETED|Week 16 - 156||63
1462154|NCT02008916|3578574|P2|COMPLETED|Week 16 - 156||62
1462155|NCT02008916|3578575|P1|COMPLETED|Week 16 - 156||55
1462156|NCT02008916|3578573|P3|STARTED|Week 16 - 156||73
1462157|NCT02008916|3578574|P2|STARTED|Week 16 - 156||75
1462158|NCT02008916|3578575|P1|STARTED|Week 16 - 156||74
1462159|NCT02008916|3578573|P3|NOT COMPLETED|Primary Assessment (up to Week 16)||3
1462160|NCT02008916|3578574|P2|NOT COMPLETED|Primary Assessment (up to Week 16)||1
1462161|NCT02008916|3578575|P1|NOT COMPLETED|Primary Assessment (up to Week 16)||0
1462162|NCT02008916|3578573|P3|COMPLETED|Primary Assessment (up to Week 16)||73
1462163|NCT02008916|3578574|P2|COMPLETED|Primary Assessment (up to Week 16)||75
1462164|NCT02008916|3578575|P1|COMPLETED|Primary Assessment (up to Week 16)||74
1462165|NCT02008916|3578573|P3|Safety Set|Primary Assessment (up to Week 16)||75
1462166|NCT02008916|3578574|P2|Safety Set|Primary Assessment (up to Week 16)||76
1462167|NCT02008916|3578575|P1|Safety Set|Primary Assessment (up to Week 16)||74
1462168|NCT02008916|3578573|P3|FAS|Primary Assessment (up to Week 16)||76
1462169|NCT02008916|3578574|P2|FAS|Primary Assessment (up to Week 16)||76
1462170|NCT02008916|3578575|P1|FAS|Primary Assessment (up to Week 16)||74
1462171|NCT02008916|3578573|P3|STARTED|Primary Assessment (up to Week 16)||76
1462172|NCT02008916|3578574|P2|STARTED|Primary Assessment (up to Week 16)||76
1462173|NCT02008916|3578575|P1|STARTED|Primary Assessment (up to Week 16)||74
1462174|NCT02008682|3578610|P2|NOT COMPLETED|Overall Study||14
1462175|NCT02008682|3578611|P1|NOT COMPLETED|Overall Study||27
1462176|NCT02008682|3578610|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
1462177|NCT02008682|3578611|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
1462178|NCT02008682|3578610|P2|Exposed|Overall Study||184
1462179|NCT02008682|3578611|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
1462180|NCT02008682|3578610|P2|STARTED|Overall Study||184
1462181|NCT02008682|3578611|P1|STARTED|Overall Study||184
1462182|NCT02008617|3578629|P2|NOT COMPLETED|Overall Study||0
1462183|NCT02008617|3578630|P1|NOT COMPLETED|Overall Study||0
1462184|NCT02008617|3578629|P2|COMPLETED|Overall Study||10
1462185|NCT02008617|3578630|P1|COMPLETED|Overall Study||8
1462186|NCT02008617|3578629|P2|STARTED|Overall Study||10
1462187|NCT02008617|3578630|P1|STARTED|Overall Study||8
1462188|NCT02008565|3578646|P4|NOT COMPLETED|Overall Study||0
1462189|NCT02008565|3578647|P3|NOT COMPLETED|Overall Study||2
1462190|NCT02008565|3578648|P2|NOT COMPLETED|Overall Study||1
1462191|NCT02008565|3578649|P1|NOT COMPLETED|Overall Study||1
1462192|NCT02008565|3578646|P4|COMPLETED|Overall Study||42
1462193|NCT02008565|3578647|P3|COMPLETED|Overall Study||86
1462194|NCT02008565|3578648|P2|COMPLETED|Overall Study||83
1462195|NCT02008565|3578649|P1|COMPLETED|Overall Study||85
1462196|NCT02008565|3578646|P4|STARTED|Overall Study||42
1462197|NCT02008565|3578647|P3|STARTED|Overall Study||88
1462198|NCT02008565|3578648|P2|STARTED|Overall Study||84
1462199|NCT02008565|3578649|P1|STARTED|Overall Study||86
1462200|NCT02008526|3578710|P3|NOT COMPLETED|Overall Study||9
1462201|NCT02008526|3578711|P2|NOT COMPLETED|Overall Study||14
1462202|NCT02008526|3578712|P1|NOT COMPLETED|Overall Study||8
1462203|NCT02008526|3578710|P3|COMPLETED|Overall Study||84
1462204|NCT02008526|3578711|P2|COMPLETED|Overall Study||85
1462205|NCT02008526|3578712|P1|COMPLETED|Overall Study||86
1462206|NCT02008526|3578710|P3|STARTED|Overall Study||93
1462207|NCT02008526|3578711|P2|STARTED|Overall Study||99
1462208|NCT02008526|3578712|P1|STARTED|Overall Study||94
1462209|NCT02008227|3578725|P2|NOT COMPLETED|Overall Study||613
1462210|NCT02008227|3578726|P1|NOT COMPLETED|Overall Study||612
1462211|NCT02008227|3578725|P2|COMPLETED|Overall Study||0
1462212|NCT02008227|3578726|P1|COMPLETED|Overall Study||0
1462213|NCT02008227|3578725|P2|Treated|Overall Study||608
1462214|NCT02008227|3578726|P1|Treated|Overall Study||579
1462215|NCT02008227|3578725|P2|STARTED|Overall Study||613
1462216|NCT02008227|3578726|P1|STARTED|Overall Study||612
1462217|NCT02007954|3578787|P1|NOT COMPLETED|Overall Study||7
1462218|NCT02007954|3578787|P1|COMPLETED|Overall Study||17
1462219|NCT02007954|3578787|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
1462220|NCT02007954|3578787|P1|Completed First TACE|Overall Study||24
1462221|NCT02007954|3578787|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
1462222|NCT02007863|3578800|P1|NOT COMPLETED|Overall Study||0
1462223|NCT02007863|3578800|P1|COMPLETED|Overall Study||2
1462224|NCT02007863|3578800|P1|STARTED|Overall Study||2
1462225|NCT02007577|3578806|P2|NOT COMPLETED|Overall Study||1
1462226|NCT02007577|3578807|P1|NOT COMPLETED|Overall Study||1
1462227|NCT02007577|3578806|P2|COMPLETED|Overall Study||13
1462228|NCT02007577|3578807|P1|COMPLETED|Overall Study||26
1462229|NCT02007577|3578806|P2|STARTED|Overall Study||14
1462230|NCT02007577|3578807|P1|STARTED|Overall Study||27
1462231|NCT02007512|3578819|P4|NOT COMPLETED|Open Label Treatment Period||12
1462232|NCT02007512|3578820|P3|NOT COMPLETED|Open Label Treatment Period||0
1462233|NCT02007512|3578821|P2|NOT COMPLETED|Open Label Treatment Period||21
1462234|NCT02007512|3578822|P1|NOT COMPLETED|Open Label Treatment Period||0
1462235|NCT02007512|3578819|P4|COMPLETED|Open Label Treatment Period||0
1462236|NCT02007512|3578820|P3|COMPLETED|Open Label Treatment Period||0
1462237|NCT02007512|3578821|P2|COMPLETED|Open Label Treatment Period||0
1462238|NCT02007512|3578822|P1|COMPLETED|Open Label Treatment Period||0
1462239|NCT02007512|3578819|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
1462240|NCT02007512|3578820|P3|STARTED|Open Label Treatment Period||0
1462423|NCT02006108|3579352|P1|STARTED|Overall Study||21
1462241|NCT02007512|3578821|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
1462242|NCT02007512|3578822|P1|STARTED|Open Label Treatment Period||0
1462243|NCT02007512|3578819|P4|NOT COMPLETED|Double Blind Treatment Period||60
1462244|NCT02007512|3578820|P3|NOT COMPLETED|Double Blind Treatment Period||60
1462245|NCT02007512|3578821|P2|NOT COMPLETED|Double Blind Treatment Period||64
1462246|NCT02007512|3578822|P1|NOT COMPLETED|Double Blind Treatment Period||63
1462247|NCT02007512|3578819|P4|COMPLETED|Double Blind Treatment Period||0
1462248|NCT02007512|3578820|P3|COMPLETED|Double Blind Treatment Period||0
1462249|NCT02007512|3578821|P2|COMPLETED|Double Blind Treatment Period||0
1462250|NCT02007512|3578822|P1|COMPLETED|Double Blind Treatment Period||0
1462251|NCT02007512|3578819|P4|Treated|Double Blind Treatment Period||60
1462252|NCT02007512|3578820|P3|Treated|Double Blind Treatment Period||60
1462253|NCT02007512|3578821|P2|Treated|Double Blind Treatment Period||63
1462254|NCT02007512|3578822|P1|Treated|Double Blind Treatment Period||62
1462255|NCT02007512|3578819|P4|STARTED|Double Blind Treatment Period||60
1462256|NCT02007512|3578820|P3|STARTED|Double Blind Treatment Period||60
1462257|NCT02007512|3578821|P2|STARTED|Double Blind Treatment Period||64
1462258|NCT02007512|3578822|P1|STARTED|Double Blind Treatment Period||63
1462259|NCT02007434|3578900|P8|NOT COMPLETED|Overall Study||0
1462260|NCT02007434|3578901|P7|NOT COMPLETED|Overall Study||0
1462261|NCT02007434|3578902|P6|NOT COMPLETED|Overall Study||0
1462262|NCT02007434|3578903|P5|NOT COMPLETED|Overall Study||0
1462263|NCT02007434|3578904|P4|NOT COMPLETED|Overall Study||0
1462264|NCT02007434|3578905|P3|NOT COMPLETED|Overall Study||1
1462265|NCT02007434|3578906|P2|NOT COMPLETED|Overall Study||1
1462266|NCT02007434|3578907|P1|NOT COMPLETED|Overall Study||1
1462267|NCT02007434|3578900|P8|COMPLETED|Overall Study||4
1462268|NCT02007434|3578901|P7|COMPLETED|Overall Study||18
1462269|NCT02007434|3578902|P6|COMPLETED|Overall Study||4
1462270|NCT02007434|3578903|P5|COMPLETED|Overall Study||16
1462271|NCT02007434|3578904|P4|COMPLETED|Overall Study||4
1462272|NCT02007434|3578905|P3|COMPLETED|Overall Study||16
1462273|NCT02007434|3578906|P2|COMPLETED|Overall Study||3
1462274|NCT02007434|3578907|P1|COMPLETED|Overall Study||16
1462275|NCT02007434|3578900|P8|Received Treatment|Overall Study||4
1462276|NCT02007434|3578901|P7|Received Treatment|Overall Study||18
1462277|NCT02007434|3578902|P6|Received Treatment|Overall Study||4
1462278|NCT02007434|3578903|P5|Received Treatment|Overall Study||16
1462279|NCT02007434|3578904|P4|Received Treatment|Overall Study||4
1462280|NCT02007434|3578905|P3|Received Treatment|Overall Study||17
1462281|NCT02007434|3578906|P2|Received Treatment|Overall Study||3
1462282|NCT02007434|3578907|P1|Received Treatment|Overall Study||17
1462283|NCT02007434|3578900|P8|STARTED|Overall Study||4
1462284|NCT02007434|3578901|P7|STARTED|Overall Study||18
1462285|NCT02007434|3578902|P6|STARTED|Overall Study||4
1462286|NCT02007434|3578903|P5|STARTED|Overall Study||16
1462287|NCT02007434|3578904|P4|STARTED|Overall Study||4
1462288|NCT02007434|3578905|P3|STARTED|Overall Study||17
1462289|NCT02007434|3578906|P2|STARTED|Overall Study||4
1462290|NCT02007434|3578907|P1|STARTED|Overall Study||17
1462291|NCT02007369|3579008|P3|NOT COMPLETED|Overall Study||0
1462292|NCT02007369|3579009|P2|NOT COMPLETED|Overall Study||0
1462293|NCT02007369|3579010|P1|NOT COMPLETED|Overall Study||0
1462294|NCT02007369|3579008|P3|COMPLETED|Overall Study||54
1462295|NCT02007369|3579009|P2|COMPLETED|Overall Study||40
1462296|NCT02007369|3579010|P1|COMPLETED|Overall Study||42
1462297|NCT02007369|3579008|P3|STARTED|Overall Study||54
1462298|NCT02007369|3579009|P2|STARTED|Overall Study||40
1462299|NCT02007369|3579010|P1|STARTED|Overall Study||42
1462300|NCT02007291|3579027|P2|NOT COMPLETED|Overall Study||0
1462301|NCT02007291|3579028|P1|NOT COMPLETED|Overall Study||0
1462302|NCT02007291|3579027|P2|COMPLETED|Overall Study||23
1462303|NCT02007291|3579028|P1|COMPLETED|Overall Study||48
1462304|NCT02007291|3579027|P2|STARTED|Overall Study||23
1462305|NCT02007291|3579028|P1|STARTED|Overall Study||48
1462306|NCT02007278|3579038|P2|NOT COMPLETED|Overall Study||3
1462307|NCT02007278|3579039|P1|NOT COMPLETED|Overall Study||2
1462308|NCT02007278|3579038|P2|COMPLETED|Overall Study||17
1462309|NCT02007278|3579039|P1|COMPLETED|Overall Study||18
1462310|NCT02007278|3579038|P2|STARTED|Overall Study||20
1462311|NCT02007278|3579039|P1|STARTED|Overall Study||20
1462312|NCT02007252|3579061|P2|NOT COMPLETED|Overall Study||11
1462313|NCT02007252|3579062|P1|NOT COMPLETED|Overall Study||11
1462314|NCT02007252|3579061|P2|COMPLETED|Overall Study||22
1462315|NCT02007252|3579062|P1|COMPLETED|Overall Study||20
1462316|NCT02007252|3579061|P2|Pharmacodynamic Analysis Set|Overall Study||33
1462317|NCT02007252|3579062|P1|Pharmacodynamic Analysis Set|Overall Study||31
1462318|NCT02007252|3579061|P2|Safety Analysis Set|Overall Study||33
1462319|NCT02007252|3579062|P1|Safety Analysis Set|Overall Study||31
1462320|NCT02007252|3579061|P2|STARTED|Overall Study||33
1462321|NCT02007252|3579062|P1|STARTED|Overall Study||31
1462322|NCT02007200|3579068|P1|NOT COMPLETED|Overall Study||0
1462323|NCT02007200|3579068|P1|COMPLETED|Overall Study||55
1462324|NCT02007200|3579068|P1|STARTED|Overall Study||55
1462325|NCT02007096|3579077|P2|NOT COMPLETED|Overall Study||16
1462326|NCT02007096|3579078|P1|NOT COMPLETED|Overall Study||11
1462327|NCT02007096|3579077|P2|COMPLETED|Overall Study||48
1462328|NCT02007096|3579078|P1|COMPLETED|Overall Study||52
1462329|NCT02007096|3579077|P2|STARTED|Overall Study||64
1462330|NCT02007096|3579078|P1|STARTED|Overall Study||63
1462331|NCT02007070|3579090|P1|NOT COMPLETED|Overall Study||33
1462332|NCT02007070|3579090|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
1462333|NCT02007070|3579090|P1|STARTED|Overall Study||38
1462334|NCT02006888|3579112|P3|NOT COMPLETED|Overall Study||22
1462335|NCT02006888|3579113|P2|NOT COMPLETED|Overall Study||34
1462336|NCT02006888|3579114|P1|NOT COMPLETED|Overall Study||36
1462337|NCT02006888|3579112|P3|COMPLETED|Overall Study||58
1462338|NCT02006888|3579113|P2|COMPLETED|Overall Study||122
1462339|NCT02006888|3579114|P1|COMPLETED|Overall Study||122
1462340|NCT02006888|3579112|P3|STARTED|Overall Study||80
1462341|NCT02006888|3579113|P2|STARTED|Overall Study||156
1462342|NCT02006888|3579114|P1|STARTED|Overall Study||158
1462343|NCT02006836|3579125|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
1462344|NCT02006836|3579126|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
1462345|NCT02006836|3579127|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
1462346|NCT02006836|3579125|P3|COMPLETED|Self-control Period: Month 7-month 12||19
1462347|NCT02006836|3579126|P2|COMPLETED|Self-control Period: Month 7-month 12||0
1462348|NCT02006836|3579127|P1|COMPLETED|Self-control Period: Month 7-month 12||0
1462349|NCT02006836|3579125|P3|STARTED|Self-control Period: Month 7-month 12||19
1462350|NCT02006836|3579126|P2|STARTED|Self-control Period: Month 7-month 12||0
1462351|NCT02006836|3579127|P1|STARTED|Self-control Period: Month 7-month 12||0
1462352|NCT02006836|3579125|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
1462353|NCT02006836|3579126|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
1462354|NCT02006836|3579127|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
1462355|NCT02006836|3579125|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
1462356|NCT02006836|3579126|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
1462357|NCT02006836|3579127|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
1462358|NCT02006836|3579125|P3|STARTED|Case-control Period: Month 1- Month 6||0
1462359|NCT02006836|3579126|P2|STARTED|Case-control Period: Month 1- Month 6||20
1462360|NCT02006836|3579127|P1|STARTED|Case-control Period: Month 1- Month 6||20
1462361|NCT02006732|3579147|P4|NOT COMPLETED|Overall Study||4
1462362|NCT02006732|3579148|P3|NOT COMPLETED|Overall Study||9
1462363|NCT02006732|3579149|P2|NOT COMPLETED|Overall Study||12
1462364|NCT02006732|3579150|P1|NOT COMPLETED|Overall Study||20
1462365|NCT02006732|3579147|P4|COMPLETED|Overall Study||198
1462366|NCT02006732|3579148|P3|COMPLETED|Overall Study||193
1462367|NCT02006732|3579149|P2|COMPLETED|Overall Study||191
1462368|NCT02006732|3579150|P1|COMPLETED|Overall Study||182
1462369|NCT02006732|3579147|P4|STARTED|Overall Study||202
1462370|NCT02006732|3579148|P3|STARTED|Overall Study||202
1462371|NCT02006732|3579149|P2|STARTED|Overall Study||203
1462372|NCT02006732|3579150|P1|STARTED|Overall Study||202
1462373|NCT02006719|3579190|P2|NOT COMPLETED|Overall Study||5
1462374|NCT02006719|3579191|P1|NOT COMPLETED|Overall Study||18
1462375|NCT02006719|3579190|P2|COMPLETED|Overall Study||80
1462376|NCT02006719|3579191|P1|COMPLETED|Overall Study||219
1462377|NCT02006719|3579190|P2|STARTED|Overall Study||85
1462378|NCT02006719|3579191|P1|STARTED|Overall Study||237
1462379|NCT02006706|3579221|P1|NOT COMPLETED|Overall Study||1
1462380|NCT02006706|3579221|P1|COMPLETED|Overall Study||14
1462381|NCT02006706|3579221|P1|STARTED|Overall Study||15
1462382|NCT02006667|3579226|P1|NOT COMPLETED|Overall Study||6
1462383|NCT02006667|3579226|P1|COMPLETED|Overall Study||7
1462384|NCT02006667|3579226|P1|STARTED|Overall Study||13
1462385|NCT02006654|3579238|P2|NOT COMPLETED|Overall Study||44
1462386|NCT02006654|3579239|P1|NOT COMPLETED|Overall Study||45
1462387|NCT02006654|3579238|P2|COMPLETED|Overall Study||321
1462388|NCT02006654|3579239|P1|COMPLETED|Overall Study||324
1462389|NCT02006654|3579238|P2|Treated|Overall Study||363
1462390|NCT02006654|3579239|P1|Treated|Overall Study||365
1462391|NCT02006654|3579238|P2|STARTED|Overall Study||365
1462392|NCT02006654|3579239|P1|STARTED|Overall Study||369
1462393|NCT02006641|3579268|P3|NOT COMPLETED|Overall Study||36
1462394|NCT02006641|3579269|P2|NOT COMPLETED|Overall Study||33
1462395|NCT02006641|3579270|P1|NOT COMPLETED|Overall Study||26
1462396|NCT02006641|3579268|P3|COMPLETED|Overall Study||248
1462397|NCT02006641|3579269|P2|COMPLETED|Overall Study||257
1462398|NCT02006641|3579270|P1|COMPLETED|Overall Study||258
1462399|NCT02006641|3579268|P3|Treated|Overall Study||281
1462400|NCT02006641|3579269|P2|Treated|Overall Study||285
1462401|NCT02006641|3579270|P1|Treated|Overall Study||282
1462402|NCT02006641|3579268|P3|STARTED|Overall Study||284
1462403|NCT02006641|3579269|P2|STARTED|Overall Study||290
1462404|NCT02006641|3579270|P1|STARTED|Overall Study||284
1462405|NCT02006407|3579308|P1|NOT COMPLETED|Overall Study||0
1462406|NCT02006407|3579308|P1|COMPLETED|Overall Study||5
1462407|NCT02006407|3579308|P1|STARTED|Overall Study||5
1462408|NCT02006342|3579316|P2|NOT COMPLETED|Overall Study||0
1462409|NCT02006342|3579317|P1|NOT COMPLETED|Overall Study||1
1462410|NCT02006342|3579316|P2|COMPLETED|Overall Study||20
1462411|NCT02006342|3579317|P1|COMPLETED|Overall Study||19
1462412|NCT02006342|3579316|P2|STARTED|Overall Study||20
1462413|NCT02006342|3579317|P1|STARTED|Overall Study||20
1462414|NCT02006264|3579333|P2|NOT COMPLETED|Overall Study||0
1462415|NCT02006264|3579334|P1|NOT COMPLETED|Overall Study||1
1462416|NCT02006264|3579333|P2|COMPLETED|Overall Study||15
1462417|NCT02006264|3579334|P1|COMPLETED|Overall Study||14
1462418|NCT02006264|3579333|P2|STARTED|Overall Study||15
1462419|NCT02006264|3579334|P1|STARTED|Overall Study||15
1462420|NCT02006108|3579352|P1|NOT COMPLETED|Overall Study||2
1462421|NCT02006108|3579352|P1|COMPLETED|Overall Study||19
1462422|NCT02006108|3579352|P1|MR Imaging|Overall Study||19
1462424|NCT02006056|3579359|P2|NOT COMPLETED|Overall Study||0
1462425|NCT02006056|3579360|P1|NOT COMPLETED|Overall Study||0
1462426|NCT02006056|3579359|P2|COMPLETED|Overall Study||4
1462427|NCT02006056|3579360|P1|COMPLETED|Overall Study||26
1462428|NCT02006056|3579359|P2|STARTED|Overall Study||4
1462429|NCT02006056|3579360|P1|STARTED|Overall Study||26
1462430|NCT02005692|3579369|P1|NOT COMPLETED|Overall Study||7
1462431|NCT02005692|3579369|P1|COMPLETED|Overall Study||63
1462432|NCT02005692|3579369|P1|STARTED|Overall Study||70
1462433|NCT02005601|3579376|P2|NOT COMPLETED|Overall Study||0
1462434|NCT02005601|3579377|P1|NOT COMPLETED|Overall Study||0
1462435|NCT02005601|3579376|P2|COMPLETED|Overall Study||53
1462436|NCT02005601|3579377|P1|COMPLETED|Overall Study||53
1462437|NCT02005601|3579376|P2|STARTED|Overall Study||53
1462438|NCT02005601|3579377|P1|STARTED|Overall Study||53
1462439|NCT02005562|3579389|P2|NOT COMPLETED|Overall Study||15
1462440|NCT02005562|3579390|P1|NOT COMPLETED|Overall Study||12
1462441|NCT02005562|3579389|P2|COMPLETED|Overall Study||110
1462442|NCT02005562|3579390|P1|COMPLETED|Overall Study||115
1462443|NCT02005562|3579389|P2|Transplanted|Overall Study||121
1462444|NCT02005562|3579390|P1|Transplanted|Overall Study||126
1462445|NCT02005562|3579389|P2|STARTED|Overall Study||125
1462446|NCT02005562|3579390|P1|STARTED|Overall Study||127
1462447|NCT02005549|3579418|P1|NOT COMPLETED|Overall Study||0
1462448|NCT02005549|3579418|P1|COMPLETED|Overall Study||18
1462449|NCT02005549|3579418|P1|STARTED|Overall Study||18
1462450|NCT02005536|3579424|P1|NOT COMPLETED|Overall Study||0
1462451|NCT02005536|3579424|P1|COMPLETED|Overall Study||60
1462452|NCT02005536|3579424|P1|STARTED|Overall Study||60
1462453|NCT02005484|3579432|P1|NOT COMPLETED|Overall Study||4
1462454|NCT02005484|3579432|P1|COMPLETED|Overall Study||2
1462455|NCT02005484|3579432|P1|STARTED|Overall Study||6
1462456|NCT02005471|3579444|P2|NOT COMPLETED|Overall Study||194
1462457|NCT02005471|3579445|P1|NOT COMPLETED|Overall Study||195
1462458|NCT02005471|3579444|P2|COMPLETED|Overall Study||0
1462459|NCT02005471|3579445|P1|COMPLETED|Overall Study||0
1462460|NCT02005471|3579444|P2|Treated|Overall Study||194
1462461|NCT02005471|3579445|P1|Treated|Overall Study||188
1462462|NCT02005471|3579444|P2|STARTED|Overall Study||194
1462463|NCT02005471|3579445|P1|STARTED|Overall Study||195
1462464|NCT02005393|3579498|P1|NOT COMPLETED|Overall Study||0
1462465|NCT02005393|3579498|P1|COMPLETED|Overall Study||20
1462466|NCT02005393|3579498|P1|STARTED|Overall Study||20
1462467|NCT02005211|3579509|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462468|NCT02005211|3579510|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462469|NCT02005211|3579511|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
1462470|NCT02005211|3579512|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462471|NCT02005211|3579513|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462472|NCT02005211|3579514|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462473|NCT02005211|3579515|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462474|NCT02005211|3579509|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
1462475|NCT02005211|3579510|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
1462476|NCT02005211|3579511|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
1462477|NCT02005211|3579512|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462478|NCT02005211|3579513|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462479|NCT02005211|3579514|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462480|NCT02005211|3579515|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462481|NCT02005211|3579509|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
1462482|NCT02005211|3579510|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
1462483|NCT02005211|3579511|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
1462484|NCT02005211|3579512|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462485|NCT02005211|3579513|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462486|NCT02005211|3579514|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462487|NCT02005211|3579515|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
1462488|NCT02005211|3579509|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462489|NCT02005211|3579510|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462490|NCT02005211|3579511|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462491|NCT02005211|3579512|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462492|NCT02005211|3579513|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462493|NCT02005211|3579514|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462494|NCT02005211|3579515|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462495|NCT02005211|3579509|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462496|NCT02005211|3579510|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462497|NCT02005211|3579511|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462498|NCT02005211|3579512|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
1462499|NCT02005211|3579513|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
1462500|NCT02005211|3579514|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
1462501|NCT02005211|3579515|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
1462502|NCT02005211|3579509|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462503|NCT02005211|3579510|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462504|NCT02005211|3579511|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
1462505|NCT02005211|3579512|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
1462506|NCT02005211|3579513|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
1462507|NCT02005211|3579514|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
1462508|NCT02005211|3579515|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
1462509|NCT02005029|3579550|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1462510|NCT02005029|3579551|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1462511|NCT02005029|3579550|P2|COMPLETED|Second Intervention (1 Day)||5
1462512|NCT02005029|3579551|P1|COMPLETED|Second Intervention (1 Day)||4
1462513|NCT02005029|3579550|P2|STARTED|Second Intervention (1 Day)||5
1462514|NCT02005029|3579551|P1|STARTED|Second Intervention (1 Day)||4
1462515|NCT02005029|3579550|P2|NOT COMPLETED|Washout (2 Weeks)||0
1462516|NCT02005029|3579551|P1|NOT COMPLETED|Washout (2 Weeks)||0
1462517|NCT02005029|3579550|P2|COMPLETED|Washout (2 Weeks)||5
1462518|NCT02005029|3579551|P1|COMPLETED|Washout (2 Weeks)||4
1462519|NCT02005029|3579550|P2|STARTED|Washout (2 Weeks)||5
1462520|NCT02005029|3579551|P1|STARTED|Washout (2 Weeks)||4
1462521|NCT02005029|3579550|P2|NOT COMPLETED|First Intervention (1 Day)||0
1462522|NCT02005029|3579551|P1|NOT COMPLETED|First Intervention (1 Day)||1
1462523|NCT02005029|3579550|P2|COMPLETED|First Intervention (1 Day)||5
1462524|NCT02005029|3579551|P1|COMPLETED|First Intervention (1 Day)||4
1462525|NCT02005029|3579550|P2|STARTED|First Intervention (1 Day)||5
1462526|NCT02005029|3579551|P1|STARTED|First Intervention (1 Day)||5
1462527|NCT02004990|3579577|P1|NOT COMPLETED|Overall Study||0
1462528|NCT02004990|3579577|P1|COMPLETED|Overall Study||12
1462529|NCT02004990|3579577|P1|STARTED|Overall Study||12
1462530|NCT02004977|3579584|P2|NOT COMPLETED|Overall Study||5
1462531|NCT02004977|3579585|P1|NOT COMPLETED|Overall Study||54
1462532|NCT02004977|3579584|P2|COMPLETED|Overall Study||436
1462533|NCT02004977|3579585|P1|COMPLETED|Overall Study||409
1462534|NCT02004977|3579584|P2|STARTED|Overall Study||441
1462535|NCT02004977|3579585|P1|STARTED|Overall Study||463
1462536|NCT02004886|3579603|P4|NOT COMPLETED|Overall Study||0
1462537|NCT02004886|3579604|P3|NOT COMPLETED|Overall Study||0
1462538|NCT02004886|3579605|P2|NOT COMPLETED|Overall Study||1
1462539|NCT02004886|3579606|P1|NOT COMPLETED|Overall Study||1
1462540|NCT02004886|3579603|P4|COMPLETED|Overall Study||19
1462541|NCT02004886|3579604|P3|COMPLETED|Overall Study||18
1462542|NCT02004886|3579605|P2|COMPLETED|Overall Study||17
1462543|NCT02004886|3579606|P1|COMPLETED|Overall Study||18
1462544|NCT02004886|3579603|P4|STARTED|Overall Study||19
1462545|NCT02004886|3579604|P3|STARTED|Overall Study||18
1462546|NCT02004886|3579605|P2|STARTED|Overall Study||18
1462547|NCT02004886|3579606|P1|STARTED|Overall Study||19
1462548|NCT02004873|3579656|P1|NOT COMPLETED|Overall Study||424
1462549|NCT02004873|3579656|P1|COMPLETED|Overall Study|6-Month Follow-up|301
1462550|NCT02004873|3579656|P1|Micra Implant Success|Overall Study||719
1462551|NCT02004873|3579656|P1|STARTED|Overall Study|Micra Implant Attempt|725
1462552|NCT02004847|3579665|P2|NOT COMPLETED|Overall Study||1
1462553|NCT02004847|3579666|P1|NOT COMPLETED|Overall Study||1
1462554|NCT02004847|3579665|P2|COMPLETED|Overall Study||22
1462555|NCT02004847|3579666|P1|COMPLETED|Overall Study||23
1462556|NCT02004847|3579665|P2|STARTED|Overall Study||23
1462557|NCT02004847|3579666|P1|STARTED|Overall Study||24
1462558|NCT02004366|3579715|P5|NOT COMPLETED|On Discharge||0
1462559|NCT02004366|3579716|P4|NOT COMPLETED|On Discharge||0
1462560|NCT02004366|3579717|P3|NOT COMPLETED|On Discharge||0
1462561|NCT02004366|3579718|P2|NOT COMPLETED|On Discharge||0
1462562|NCT02004366|3579719|P1|NOT COMPLETED|On Discharge||0
1462563|NCT02004366|3579715|P5|COMPLETED|On Discharge||39
1462564|NCT02004366|3579716|P4|COMPLETED|On Discharge||93
1462565|NCT02004366|3579717|P3|COMPLETED|On Discharge||92
1462566|NCT02004366|3579718|P2|COMPLETED|On Discharge||0
1462567|NCT02004366|3579719|P1|COMPLETED|On Discharge||0
1462568|NCT02004366|3579715|P5|STARTED|On Discharge||39
1462569|NCT02004366|3579716|P4|STARTED|On Discharge||93
1462570|NCT02004366|3579717|P3|STARTED|On Discharge||92
1462571|NCT02004366|3579718|P2|STARTED|On Discharge||0
1462572|NCT02004366|3579719|P1|STARTED|On Discharge||0
1462573|NCT02004366|3579715|P5|NOT COMPLETED|In-hospital||0
1462574|NCT02004366|3579716|P4|NOT COMPLETED|In-hospital||0
1462575|NCT02004366|3579717|P3|NOT COMPLETED|In-hospital||0
1462576|NCT02004366|3579718|P2|NOT COMPLETED|In-hospital||0
1462577|NCT02004366|3579719|P1|NOT COMPLETED|In-hospital||0
1462578|NCT02004366|3579715|P5|COMPLETED|In-hospital||0
1462579|NCT02004366|3579716|P4|COMPLETED|In-hospital||0
1462580|NCT02004366|3579717|P3|COMPLETED|In-hospital||0
1462581|NCT02004366|3579718|P2|COMPLETED|In-hospital||122
1462582|NCT02004366|3579719|P1|COMPLETED|In-hospital||128
1462583|NCT02004366|3579715|P5|STARTED|In-hospital||0
1462584|NCT02004366|3579716|P4|STARTED|In-hospital||0
1462585|NCT02004366|3579717|P3|STARTED|In-hospital||0
1462586|NCT02004366|3579718|P2|STARTED|In-hospital||122
1462587|NCT02004366|3579719|P1|STARTED|In-hospital||128
1462588|NCT02004262|3579812|P6|NOT COMPLETED|Overall Study||30
1462589|NCT02004262|3579813|P5|NOT COMPLETED|Overall Study||31
1462590|NCT02004262|3579814|P4|NOT COMPLETED|Overall Study||29
1462591|NCT02004262|3579815|P3|NOT COMPLETED|Overall Study||72
1462592|NCT02004262|3579816|P2|NOT COMPLETED|Overall Study||68
1462593|NCT02004262|3579817|P1|NOT COMPLETED|Overall Study||73
1462594|NCT02004262|3579812|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1462595|NCT02004262|3579813|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1462596|NCT02004262|3579814|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1462597|NCT02004262|3579815|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1462687|NCT02003053|3580109|P1|STARTED|Overall Study||4
1462598|NCT02004262|3579816|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1462599|NCT02004262|3579817|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
1462600|NCT02004262|3579812|P6|Treated|Overall Study||11
1462601|NCT02004262|3579813|P5|Treated|Overall Study||29
1462602|NCT02004262|3579814|P4|Treated|Overall Study||26
1462603|NCT02004262|3579815|P3|Treated|Overall Study||43
1462604|NCT02004262|3579816|P2|Treated|Overall Study||58
1462605|NCT02004262|3579817|P1|Treated|Overall Study||68
1462606|NCT02004262|3579812|P6|STARTED|Overall Study||30
1462607|NCT02004262|3579813|P5|STARTED|Overall Study||31
1462608|NCT02004262|3579814|P4|STARTED|Overall Study||29
1462609|NCT02004262|3579815|P3|STARTED|Overall Study||72
1462610|NCT02004262|3579816|P2|STARTED|Overall Study||68
1462611|NCT02004262|3579817|P1|STARTED|Overall Study||73
1462612|NCT02004236|3579837|P3|NOT COMPLETED|Overall Study||16
1462613|NCT02004236|3579838|P2|NOT COMPLETED|Overall Study||0
1462614|NCT02004236|3579839|P1|NOT COMPLETED|Overall Study||0
1462615|NCT02004236|3579837|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
1462616|NCT02004236|3579838|P2|COMPLETED|Overall Study||75
1462617|NCT02004236|3579839|P1|COMPLETED|Overall Study||75
1462618|NCT02004236|3579837|P3|STARTED|Overall Study||75
1462619|NCT02004236|3579838|P2|STARTED|Overall Study||75
1462620|NCT02004236|3579839|P1|STARTED|Overall Study||75
1462621|NCT02004158|3579883|P1|NOT COMPLETED|Overall Study||3
1462622|NCT02004158|3579883|P1|COMPLETED|Overall Study||20
1462623|NCT02004158|3579883|P1|STARTED|Overall Study||23
1462624|NCT02004132|3579891|P1|NOT COMPLETED|Overall Study||0
1462625|NCT02004132|3579891|P1|COMPLETED|Overall Study||12
1462626|NCT02004132|3579891|P1|Received Study Drug|Overall Study||12
1462627|NCT02004132|3579891|P1|STARTED|Overall Study||12
1462628|NCT02004093|3579899|P2|NOT COMPLETED|Overall Study||73
1462629|NCT02004093|3579900|P1|NOT COMPLETED|Overall Study||74
1462630|NCT02004093|3579899|P2|COMPLETED|Overall Study||1
1462631|NCT02004093|3579900|P1|COMPLETED|Overall Study||1
1462632|NCT02004093|3579899|P2|STARTED|Overall Study||74
1462633|NCT02004093|3579900|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
1462634|NCT02003963|3579932|P2|NOT COMPLETED|Overall Study||1
1462635|NCT02003963|3579933|P1|NOT COMPLETED|Overall Study||2
1462636|NCT02003963|3579932|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
1462637|NCT02003963|3579933|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
1462638|NCT02003963|3579932|P2|STARTED|Overall Study||19
1462639|NCT02003963|3579933|P1|STARTED|Overall Study||22
1462640|NCT02003924|3579955|P2|NOT COMPLETED|Overall Study||468
1462641|NCT02003924|3579956|P1|NOT COMPLETED|Overall Study||933
1462642|NCT02003924|3579955|P2|COMPLETED|Overall Study||0
1462643|NCT02003924|3579956|P1|COMPLETED|Overall Study||0
1462644|NCT02003924|3579955|P2|Treated|Overall Study||465
1462645|NCT02003924|3579956|P1|Treated|Overall Study||930
1462646|NCT02003924|3579955|P2|STARTED|Overall Study||468
1462647|NCT02003924|3579956|P1|STARTED|Overall Study||933
1462648|NCT02003638|3580056|P2|NOT COMPLETED|Overall Study||0
1462649|NCT02003638|3580057|P1|NOT COMPLETED|Overall Study||1
1462650|NCT02003638|3580056|P2|COMPLETED|Overall Study||3
1462651|NCT02003638|3580057|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
1462652|NCT02003638|3580056|P2|STARTED|Overall Study||3
1462653|NCT02003638|3580057|P1|STARTED|Overall Study||6
1462654|NCT02003534|3580063|P1|NOT COMPLETED|Overall Study||47
1462655|NCT02003534|3580063|P1|COMPLETED|Overall Study||329
1462656|NCT02003534|3580063|P1|STARTED|Overall Study||376
1462657|NCT02003404|3580067|P1|NOT COMPLETED|Overall Study||0
1462658|NCT02003404|3580067|P1|COMPLETED|Overall Study||17
1462659|NCT02003404|3580067|P1|STARTED|Overall Study||17
1462660|NCT02003391|3580075|P2|NOT COMPLETED|Overall Study||2
1462661|NCT02003391|3580076|P1|NOT COMPLETED|Overall Study||3
1462662|NCT02003391|3580075|P2|COMPLETED|Overall Study||73
1462663|NCT02003391|3580076|P1|COMPLETED|Overall Study||78
1462664|NCT02003391|3580075|P2|Intent to Treat Population|Overall Study||73
1462665|NCT02003391|3580076|P1|Intent to Treat Population|Overall Study||78
1462666|NCT02003391|3580075|P2|Safety Population|Overall Study||75
1462667|NCT02003391|3580076|P1|Safety Population|Overall Study||81
1462668|NCT02003391|3580075|P2|STARTED|Overall Study||75
1462669|NCT02003391|3580076|P1|STARTED|Overall Study||81
1462670|NCT02003365|3580089|P3|NOT COMPLETED|Overall Study||1
1462671|NCT02003365|3580090|P2|NOT COMPLETED|Overall Study||0
1462672|NCT02003365|3580091|P1|NOT COMPLETED|Overall Study||0
1462673|NCT02003365|3580089|P3|COMPLETED|Overall Study||9
1462674|NCT02003365|3580090|P2|COMPLETED|Overall Study||30
1462675|NCT02003365|3580091|P1|COMPLETED|Overall Study||10
1462676|NCT02003365|3580089|P3|STARTED|Overall Study||10
1462677|NCT02003365|3580090|P2|STARTED|Overall Study||30
1462678|NCT02003365|3580091|P1|STARTED|Overall Study||10
1462679|NCT02003352|3580102|P1|NOT COMPLETED|Overall Study||0
1462680|NCT02003352|3580102|P1|COMPLETED|Overall Study||98
1462681|NCT02003352|3580102|P1|STARTED|Overall Study||98
1462682|NCT02003053|3580108|P2|NOT COMPLETED|Overall Study||0
1462683|NCT02003053|3580109|P1|NOT COMPLETED|Overall Study||0
1462684|NCT02003053|3580108|P2|COMPLETED|Overall Study||3
1462685|NCT02003053|3580109|P1|COMPLETED|Overall Study||4
1462686|NCT02003053|3580108|P2|STARTED|Overall Study||3
1462688|NCT02003014|3580115|P1|NOT COMPLETED|Overall Study||19
1462689|NCT02003014|3580115|P1|COMPLETED|Overall Study||880
1462690|NCT02003014|3580115|P1|STARTED|Overall Study||899
1462691|NCT02002936|3580125|P1|NOT COMPLETED|Overall Study||0
1462692|NCT02002936|3580125|P1|COMPLETED|Overall Study||1
1462693|NCT02002936|3580125|P1|STARTED|Overall Study||1
1462694|NCT02002871|3580134|P1|NOT COMPLETED|Overall Study||1
1462695|NCT02002871|3580134|P1|COMPLETED|Overall Study||20
1462696|NCT02002871|3580134|P1|STARTED|Overall Study||21
1462697|NCT02002702|3580163|P3|NOT COMPLETED|Overall Study||0
1462698|NCT02002702|3580164|P2|NOT COMPLETED|Overall Study||0
1462699|NCT02002702|3580165|P1|NOT COMPLETED|Overall Study||0
1462700|NCT02002702|3580163|P3|COMPLETED|Overall Study||15
1462701|NCT02002702|3580164|P2|COMPLETED|Overall Study||15
1462702|NCT02002702|3580165|P1|COMPLETED|Overall Study||16
1462703|NCT02002702|3580163|P3|STARTED|Overall Study||15
1462704|NCT02002702|3580164|P2|STARTED|Overall Study||15
1462705|NCT02002702|3580165|P1|STARTED|Overall Study||16
1462706|NCT02002689|3580197|P1|NOT COMPLETED|Overall Study||10
1462707|NCT02002689|3580197|P1|COMPLETED|Overall Study||0
1462708|NCT02002689|3580197|P1|STARTED|Overall Study||10
1462709|NCT02002650|3580205|P2|NOT COMPLETED|Overall Study||0
1462710|NCT02002650|3580206|P1|NOT COMPLETED|Overall Study||0
1462711|NCT02002650|3580205|P2|COMPLETED|Overall Study||1303
1462712|NCT02002650|3580206|P1|COMPLETED|Overall Study||1297
1462713|NCT02002650|3580205|P2|STARTED|Overall Study||1303
1462714|NCT02002650|3580206|P1|STARTED|Overall Study||1297
1462715|NCT02002533|3580216|P2|NOT COMPLETED|Overall Study||18
1462716|NCT02002533|3580217|P1|NOT COMPLETED|Overall Study||6
1462717|NCT02002533|3580216|P2|COMPLETED|Overall Study||19
1462718|NCT02002533|3580217|P1|COMPLETED|Overall Study||28
1462719|NCT02002533|3580216|P2|STARTED|Overall Study||37
1462720|NCT02002533|3580217|P1|STARTED|Overall Study||34
1462721|NCT02002221|3580242|P2|NOT COMPLETED|Overall Study||3
1462722|NCT02002221|3580243|P1|NOT COMPLETED|Overall Study||2
1462723|NCT02002221|3580242|P2|COMPLETED|Overall Study||75
1462724|NCT02002221|3580243|P1|COMPLETED|Overall Study||76
1462725|NCT02002221|3580242|P2|STARTED|Overall Study||78
1462726|NCT02002221|3580243|P1|STARTED|Overall Study||78
1462727|NCT02002208|3580259|P2|NOT COMPLETED|Overall Study||40
1462728|NCT02002208|3580260|P1|NOT COMPLETED|Overall Study||37
1462729|NCT02002208|3580259|P2|COMPLETED|Overall Study||30
1462730|NCT02002208|3580260|P1|COMPLETED|Overall Study||32
1462731|NCT02002208|3580259|P2|STARTED|Overall Study||70
1462732|NCT02002208|3580260|P1|STARTED|Overall Study||69
1462733|NCT02002091|3580270|P2|NOT COMPLETED|One Year Follow up||0
1462734|NCT02002091|3580271|P1|NOT COMPLETED|One Year Follow up||0
1462735|NCT02002091|3580270|P2|COMPLETED|One Year Follow up||191
1462736|NCT02002091|3580271|P1|COMPLETED|One Year Follow up||109
1462737|NCT02002091|3580270|P2|STARTED|One Year Follow up||191
1462738|NCT02002091|3580271|P1|STARTED|One Year Follow up||109
1462739|NCT02002091|3580270|P2|NOT COMPLETED|Screening||14
1462740|NCT02002091|3580271|P1|NOT COMPLETED|Screening||13
1462741|NCT02002091|3580270|P2|COMPLETED|Screening||191
1462742|NCT02002091|3580271|P1|COMPLETED|Screening||109
1462743|NCT02002091|3580270|P2|STARTED|Screening||205
1462744|NCT02002091|3580271|P1|STARTED|Screening||122
1462745|NCT02001987|3580306|P1|NOT COMPLETED|LTE Period (52 Weeks)||9
1462746|NCT02001987|3580306|P1|COMPLETED|LTE Period (52 Weeks)||107
1462747|NCT02001987|3580306|P1|STARTED|LTE Period (52 Weeks)||116
1462748|NCT02001987|3580306|P1|NOT COMPLETED|Core Study Period (24 Weeks)||23
1462749|NCT02001987|3580306|P1|COMPLETED|Core Study Period (24 Weeks)||116
1462750|NCT02001987|3580306|P1|STARTED|Core Study Period (24 Weeks)||139
1462751|NCT02001714|3580382|P2|NOT COMPLETED|Overall Study||12
1462752|NCT02001714|3580383|P1|NOT COMPLETED|Overall Study||22
1462753|NCT02001714|3580382|P2|COMPLETED|Overall Study||219
1462754|NCT02001714|3580383|P1|COMPLETED|Overall Study||210
1462755|NCT02001714|3580382|P2|STARTED|Overall Study||231
1462756|NCT02001714|3580383|P1|STARTED|Overall Study||232
1462757|NCT02001558|3580391|P2|NOT COMPLETED|Overall Study||14
1462758|NCT02001558|3580392|P1|NOT COMPLETED|Overall Study||8
1462759|NCT02001558|3580391|P2|COMPLETED|Overall Study||19
1462760|NCT02001558|3580392|P1|COMPLETED|Overall Study||24
1462761|NCT02001558|3580391|P2|STARTED|Overall Study||33
1462762|NCT02001558|3580392|P1|STARTED|Overall Study||32
1462763|NCT02001181|3580426|P2|NOT COMPLETED|Overall Study||3
1462764|NCT02001181|3580427|P1|NOT COMPLETED|Overall Study||1
1462765|NCT02001181|3580426|P2|COMPLETED|Overall Study||31
1462766|NCT02001181|3580427|P1|COMPLETED|Overall Study||34
1462767|NCT02001181|3580426|P2|STARTED|Overall Study||34
1462768|NCT02001181|3580427|P1|STARTED|Overall Study||35
1462769|NCT02001051|3580443|P2|NOT COMPLETED|Overall Study||1
1462770|NCT02001051|3580444|P1|NOT COMPLETED|Overall Study||0
1462771|NCT02001051|3580443|P2|COMPLETED|Overall Study||1
1462772|NCT02001051|3580444|P1|COMPLETED|Overall Study||2
1462773|NCT02001051|3580443|P2|STARTED|Overall Study||2
1462774|NCT02001051|3580444|P1|STARTED|Overall Study||2
1462775|NCT02000973|3580468|P4|NOT COMPLETED|Overall Study||0
1462776|NCT02000973|3580469|P3|NOT COMPLETED|Overall Study||0
1462777|NCT02000973|3580470|P2|NOT COMPLETED|Overall Study||0
1462778|NCT02000973|3580471|P1|NOT COMPLETED|Overall Study||0
1462779|NCT02000973|3580468|P4|COMPLETED|Overall Study||20
1462780|NCT02000973|3580469|P3|COMPLETED|Overall Study||20
1462781|NCT02000973|3580470|P2|COMPLETED|Overall Study||20
1462782|NCT02000973|3580471|P1|COMPLETED|Overall Study||20
1462783|NCT02000973|3580468|P4|STARTED|Overall Study||20
1462784|NCT02000973|3580469|P3|STARTED|Overall Study||20
1462785|NCT02000973|3580470|P2|STARTED|Overall Study||20
1462786|NCT02000973|3580471|P1|STARTED|Overall Study||20
1462787|NCT02000921|3580496|P3|NOT COMPLETED|Overall Study||10
1462788|NCT02000921|3580497|P2|NOT COMPLETED|Overall Study||16
1462789|NCT02000921|3580498|P1|NOT COMPLETED|Overall Study||5
1462790|NCT02000921|3580496|P3|COMPLETED|Overall Study||46
1462791|NCT02000921|3580497|P2|COMPLETED|Overall Study||37
1462792|NCT02000921|3580498|P1|COMPLETED|Overall Study||22
1462793|NCT02000921|3580496|P3|STARTED|Overall Study||56
1462794|NCT02000921|3580497|P2|STARTED|Overall Study||53
1462795|NCT02000921|3580498|P1|STARTED|Overall Study||27
1462796|NCT02000752|3580517|P2|NOT COMPLETED|Overall Study||13
1462797|NCT02000752|3580518|P1|NOT COMPLETED|Overall Study||31
1462798|NCT02000752|3580517|P2|COMPLETED|Overall Study||47
1462799|NCT02000752|3580518|P1|COMPLETED|Overall Study||29
1462800|NCT02000752|3580517|P2|STARTED|Overall Study||60
1462801|NCT02000752|3580518|P1|STARTED|Overall Study||60
1462802|NCT02000622|3580532|P2|NOT COMPLETED|Overall Study||53
1462803|NCT02000622|3580533|P1|NOT COMPLETED|Overall Study||101
1462804|NCT02000622|3580532|P2|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|44
1462805|NCT02000622|3580533|P1|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|104
1462806|NCT02000622|3580532|P2|STARTED|Overall Study||97
1462807|NCT02000622|3580533|P1|STARTED|Overall Study||205
1462808|NCT02000531|3580555|P2|NOT COMPLETED|Overall Study||8
1462809|NCT02000531|3580556|P1|NOT COMPLETED|Overall Study||4
1462810|NCT02000531|3580555|P2|COMPLETED|Overall Study||16
1462811|NCT02000531|3580556|P1|COMPLETED|Overall Study||17
1462812|NCT02000531|3580555|P2|Safety Population|Overall Study||24
1462813|NCT02000531|3580556|P1|Safety Population|Overall Study||21
1462814|NCT02000531|3580555|P2|STARTED|Overall Study||24
1462815|NCT02000531|3580556|P1|STARTED|Overall Study||21
1462816|NCT02000440|3580564|P1|NOT COMPLETED|Overall Study||4
1462817|NCT02000440|3580564|P1|COMPLETED|Overall Study||13
1462818|NCT02000440|3580564|P1|STARTED|Overall Study||17
1462819|NCT02000427|3580584|P1|NOT COMPLETED|Overall Study||22
1462820|NCT02000427|3580584|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
1462821|NCT02000427|3580584|P1|STARTED|Overall Study||45
1462822|NCT02000180|3580601|P2|NOT COMPLETED|Overall Study||0
1462823|NCT02000180|3580602|P1|NOT COMPLETED|Overall Study||0
1462824|NCT02000180|3580601|P2|COMPLETED|Overall Study||19
1462825|NCT02000180|3580602|P1|COMPLETED|Overall Study||18
1462826|NCT02000180|3580601|P2|STARTED|Overall Study||19
1462827|NCT02000180|3580602|P1|STARTED|Overall Study||18
1462828|NCT02000154|3580614|P1|NOT COMPLETED|Overall Study||0
1462829|NCT02000154|3580614|P1|COMPLETED|Overall Study||1
1462830|NCT02000154|3580614|P1|STARTED|Overall Study||1
1462831|NCT01999920|3580624|P2|NOT COMPLETED|Overall Study||2
1462832|NCT01999920|3580625|P1|NOT COMPLETED|Overall Study||6
1462833|NCT01999920|3580624|P2|COMPLETED|Overall Study||9
1462834|NCT01999920|3580625|P1|COMPLETED|Overall Study||7
1462835|NCT01999920|3580624|P2|STARTED|Overall Study||11
1462836|NCT01999920|3580625|P1|STARTED|Overall Study||13
1462837|NCT01999894|3580641|P1|NOT COMPLETED|Overall Study||36
1462838|NCT01999894|3580641|P1|COMPLETED|Overall Study||66
1462839|NCT01999894|3580641|P1|STARTED|Overall Study||102
1462840|NCT01999868|3580649|P3|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||0
1462841|NCT01999868|3580650|P2|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||29
1462842|NCT01999868|3580651|P1|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||23
1462843|NCT01999868|3580649|P3|COMPLETED|Blinded Observation Phase (Week 40 – 88)||0
1462844|NCT01999868|3580650|P2|COMPLETED|Blinded Observation Phase (Week 40 – 88)||6
1462845|NCT01999868|3580651|P1|COMPLETED|Blinded Observation Phase (Week 40 – 88)||4
1462846|NCT01999868|3580649|P3|STARTED|Blinded Observation Phase (Week 40 – 88)||0
1462847|NCT01999868|3580650|P2|STARTED|Blinded Observation Phase (Week 40 – 88)||35
1462848|NCT01999868|3580651|P1|STARTED|Blinded Observation Phase (Week 40 – 88)||27
1462849|NCT01999868|3580649|P3|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||0
1462850|NCT01999868|3580650|P2|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||11
1462851|NCT01999868|3580651|P1|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||18
1462852|NCT01999868|3580649|P3|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||0
1462853|NCT01999868|3580650|P2|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||35
1462854|NCT01999868|3580651|P1|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||27
1462855|NCT01999868|3580649|P3|STARTED|Blinded Treatment Phase (Week 12 – 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
1462856|NCT01999868|3580650|P2|STARTED|Blinded Treatment Phase (Week 12 – 40)||46
1462857|NCT01999868|3580651|P1|STARTED|Blinded Treatment Phase (Week 12 – 40)||45
1462858|NCT01999868|3580649|P3|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||5
1462859|NCT01999868|3580650|P2|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||0
1462860|NCT01999868|3580651|P1|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||0
1462861|NCT01999868|3580649|P3|COMPLETED|Lead-in Phase (Week 0 – 12)||12
1462862|NCT01999868|3580650|P2|COMPLETED|Lead-in Phase (Week 0 – 12)||46
1462863|NCT01999868|3580651|P1|COMPLETED|Lead-in Phase (Week 0 – 12)||45
1462864|NCT01999868|3580649|P3|STARTED|Lead-in Phase (Week 0 – 12)||17
1462865|NCT01999868|3580650|P2|STARTED|Lead-in Phase (Week 0 – 12)||46
1462866|NCT01999868|3580651|P1|STARTED|Lead-in Phase (Week 0 – 12)||45
1462867|NCT01999777|3580678|P2|NOT COMPLETED|Overall Study||0
1462868|NCT01999777|3580679|P1|NOT COMPLETED|Overall Study||0
1462869|NCT01999777|3580678|P2|COMPLETED|Overall Study||31
1462870|NCT01999777|3580679|P1|COMPLETED|Overall Study||31
1462871|NCT01999777|3580678|P2|STARTED|Overall Study||31
1462872|NCT01999777|3580679|P1|STARTED|Overall Study||31
1462873|NCT01999465|3580689|P2|NOT COMPLETED|Overall Study||3
1462874|NCT01999465|3580690|P1|NOT COMPLETED|Overall Study||0
1462875|NCT01999465|3580689|P2|COMPLETED|Overall Study||7
1462876|NCT01999465|3580690|P1|COMPLETED|Overall Study||10
1462877|NCT01999465|3580689|P2|STARTED|Overall Study||10
1462878|NCT01999465|3580690|P1|STARTED|Overall Study||10
1462879|NCT01999400|3580698|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
1462880|NCT01999400|3580699|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
1462881|NCT01999400|3580700|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
1462882|NCT01999400|3580701|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
1462883|NCT01999400|3580702|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
1462884|NCT01999400|3580703|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
1462885|NCT01999400|3580698|P6|COMPLETED|Fourth Intervention (1 Day)||0
1462886|NCT01999400|3580699|P5|COMPLETED|Fourth Intervention (1 Day)||0
1462887|NCT01999400|3580700|P4|COMPLETED|Fourth Intervention (1 Day)||0
1462888|NCT01999400|3580701|P3|COMPLETED|Fourth Intervention (1 Day)||1
1462889|NCT01999400|3580702|P2|COMPLETED|Fourth Intervention (1 Day)||0
1462890|NCT01999400|3580703|P1|COMPLETED|Fourth Intervention (1 Day)||1
1462891|NCT01999400|3580698|P6|STARTED|Fourth Intervention (1 Day)||0
1462892|NCT01999400|3580699|P5|STARTED|Fourth Intervention (1 Day)||0
1462893|NCT01999400|3580700|P4|STARTED|Fourth Intervention (1 Day)||0
1462894|NCT01999400|3580701|P3|STARTED|Fourth Intervention (1 Day)||1
1462895|NCT01999400|3580702|P2|STARTED|Fourth Intervention (1 Day)||0
1462896|NCT01999400|3580703|P1|STARTED|Fourth Intervention (1 Day)||1
1462897|NCT01999400|3580698|P6|NOT COMPLETED|Washout (10 Days)||0
1462898|NCT01999400|3580699|P5|NOT COMPLETED|Washout (10 Days)||0
1462899|NCT01999400|3580700|P4|NOT COMPLETED|Washout (10 Days)||0
1462900|NCT01999400|3580701|P3|NOT COMPLETED|Washout (10 Days)||0
1462901|NCT01999400|3580702|P2|NOT COMPLETED|Washout (10 Days)||0
1462902|NCT01999400|3580703|P1|NOT COMPLETED|Washout (10 Days)||0
1462903|NCT01999400|3580698|P6|COMPLETED|Washout (10 Days)||0
1462904|NCT01999400|3580699|P5|COMPLETED|Washout (10 Days)||0
1462905|NCT01999400|3580700|P4|COMPLETED|Washout (10 Days)||0
1462906|NCT01999400|3580701|P3|COMPLETED|Washout (10 Days)||1
1462907|NCT01999400|3580702|P2|COMPLETED|Washout (10 Days)||0
1462908|NCT01999400|3580703|P1|COMPLETED|Washout (10 Days)||1
1462909|NCT01999400|3580698|P6|STARTED|Washout (10 Days)||0
1462910|NCT01999400|3580699|P5|STARTED|Washout (10 Days)||0
1462911|NCT01999400|3580700|P4|STARTED|Washout (10 Days)||0
1462912|NCT01999400|3580701|P3|STARTED|Washout (10 Days)||1
1462913|NCT01999400|3580702|P2|STARTED|Washout (10 Days)||0
1462914|NCT01999400|3580703|P1|STARTED|Washout (10 Days)||1
1462915|NCT01999400|3580698|P6|NOT COMPLETED|Third Intervention (1 Day)||1
1462916|NCT01999400|3580699|P5|NOT COMPLETED|Third Intervention (1 Day)||0
1462917|NCT01999400|3580700|P4|NOT COMPLETED|Third Intervention (1 Day)||0
1462918|NCT01999400|3580701|P3|NOT COMPLETED|Third Intervention (1 Day)||0
1462919|NCT01999400|3580702|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1462920|NCT01999400|3580703|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1462921|NCT01999400|3580698|P6|COMPLETED|Third Intervention (1 Day)||0
1462922|NCT01999400|3580699|P5|COMPLETED|Third Intervention (1 Day)||1
1462923|NCT01999400|3580700|P4|COMPLETED|Third Intervention (1 Day)||1
1462924|NCT01999400|3580701|P3|COMPLETED|Third Intervention (1 Day)||1
1462925|NCT01999400|3580702|P2|COMPLETED|Third Intervention (1 Day)||0
1462926|NCT01999400|3580703|P1|COMPLETED|Third Intervention (1 Day)||2
1462927|NCT01999400|3580698|P6|STARTED|Third Intervention (1 Day)||1
1462928|NCT01999400|3580699|P5|STARTED|Third Intervention (1 Day)||1
1462929|NCT01999400|3580700|P4|STARTED|Third Intervention (1 Day)||1
1462930|NCT01999400|3580701|P3|STARTED|Third Intervention (1 Day)||1
1462931|NCT01999400|3580702|P2|STARTED|Third Intervention (1 Day)||0
1462932|NCT01999400|3580703|P1|STARTED|Third Intervention (1 Day)||2
1462933|NCT01999400|3580698|P6|NOT COMPLETED|Washout (10 Days)||0
1462934|NCT01999400|3580699|P5|NOT COMPLETED|Washout (10 Days)||0
1462935|NCT01999400|3580700|P4|NOT COMPLETED|Washout (10 Days)||0
1462936|NCT01999400|3580701|P3|NOT COMPLETED|Washout (10 Days)||0
1462937|NCT01999400|3580702|P2|NOT COMPLETED|Washout (10 Days)||0
1462938|NCT01999400|3580703|P1|NOT COMPLETED|Washout (10 Days)||0
1462939|NCT01999400|3580698|P6|COMPLETED|Washout (10 Days)||1
1462940|NCT01999400|3580699|P5|COMPLETED|Washout (10 Days)||1
1462941|NCT01999400|3580700|P4|COMPLETED|Washout (10 Days)||1
1462942|NCT01999400|3580701|P3|COMPLETED|Washout (10 Days)||1
1462943|NCT01999400|3580702|P2|COMPLETED|Washout (10 Days)||0
1462944|NCT01999400|3580703|P1|COMPLETED|Washout (10 Days)||2
1462945|NCT01999400|3580698|P6|STARTED|Washout (10 Days)||1
1462946|NCT01999400|3580699|P5|STARTED|Washout (10 Days)||1
1462947|NCT01999400|3580700|P4|STARTED|Washout (10 Days)||1
1462948|NCT01999400|3580701|P3|STARTED|Washout (10 Days)||1
1462949|NCT01999400|3580702|P2|STARTED|Washout (10 Days)||0
1462950|NCT01999400|3580703|P1|STARTED|Washout (10 Days)||2
1462951|NCT01999400|3580698|P6|NOT COMPLETED|Second Intervention (1 Day)||0
1462952|NCT01999400|3580699|P5|NOT COMPLETED|Second Intervention (1 Day)||0
1462953|NCT01999400|3580700|P4|NOT COMPLETED|Second Intervention (1 Day)||0
1462954|NCT01999400|3580701|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1462955|NCT01999400|3580702|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1462956|NCT01999400|3580703|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1462957|NCT01999400|3580698|P6|COMPLETED|Second Intervention (1 Day)||3
1462958|NCT01999400|3580699|P5|COMPLETED|Second Intervention (1 Day)||3
1462959|NCT01999400|3580700|P4|COMPLETED|Second Intervention (1 Day)||2
1462960|NCT01999400|3580701|P3|COMPLETED|Second Intervention (1 Day)||3
1462961|NCT01999400|3580702|P2|COMPLETED|Second Intervention (1 Day)||4
1462962|NCT01999400|3580703|P1|COMPLETED|Second Intervention (1 Day)||5
1462963|NCT01999400|3580698|P6|STARTED|Second Intervention (1 Day)||3
1462964|NCT01999400|3580699|P5|STARTED|Second Intervention (1 Day)||3
1462965|NCT01999400|3580700|P4|STARTED|Second Intervention (1 Day)||2
1462966|NCT01999400|3580701|P3|STARTED|Second Intervention (1 Day)||3
1462967|NCT01999400|3580702|P2|STARTED|Second Intervention (1 Day)||4
1462968|NCT01999400|3580703|P1|STARTED|Second Intervention (1 Day)||5
1462969|NCT01999400|3580698|P6|NOT COMPLETED|Washout (10 Days)||0
1462970|NCT01999400|3580699|P5|NOT COMPLETED|Washout (10 Days)||0
1462971|NCT01999400|3580700|P4|NOT COMPLETED|Washout (10 Days)||0
1462972|NCT01999400|3580701|P3|NOT COMPLETED|Washout (10 Days)||0
1462973|NCT01999400|3580702|P2|NOT COMPLETED|Washout (10 Days)||0
1462974|NCT01999400|3580703|P1|NOT COMPLETED|Washout (10 Days)||0
1462975|NCT01999400|3580698|P6|COMPLETED|Washout (10 Days)||3
1462976|NCT01999400|3580699|P5|COMPLETED|Washout (10 Days)||3
1462977|NCT01999400|3580700|P4|COMPLETED|Washout (10 Days)||2
1462978|NCT01999400|3580701|P3|COMPLETED|Washout (10 Days)||3
1462979|NCT01999400|3580702|P2|COMPLETED|Washout (10 Days)||4
1462980|NCT01999400|3580703|P1|COMPLETED|Washout (10 Days)||5
1462981|NCT01999400|3580698|P6|STARTED|Washout (10 Days)||3
1462982|NCT01999400|3580699|P5|STARTED|Washout (10 Days)||3
1462983|NCT01999400|3580700|P4|STARTED|Washout (10 Days)||2
1462984|NCT01999400|3580701|P3|STARTED|Washout (10 Days)||3
1462985|NCT01999400|3580702|P2|STARTED|Washout (10 Days)||4
1462986|NCT01999400|3580703|P1|STARTED|Washout (10 Days)||5
1462987|NCT01999400|3580698|P6|NOT COMPLETED|First Intervention (1 Day)||1
1462988|NCT01999400|3580699|P5|NOT COMPLETED|First Intervention (1 Day)||0
1462989|NCT01999400|3580700|P4|NOT COMPLETED|First Intervention (1 Day)||3
1462990|NCT01999400|3580701|P3|NOT COMPLETED|First Intervention (1 Day)||2
1462991|NCT01999400|3580702|P2|NOT COMPLETED|First Intervention (1 Day)||2
1462992|NCT01999400|3580703|P1|NOT COMPLETED|First Intervention (1 Day)||2
1462993|NCT01999400|3580698|P6|COMPLETED|First Intervention (1 Day)||3
1462994|NCT01999400|3580699|P5|COMPLETED|First Intervention (1 Day)||4
1462995|NCT01999400|3580700|P4|COMPLETED|First Intervention (1 Day)||2
1462996|NCT01999400|3580701|P3|COMPLETED|First Intervention (1 Day)||3
1462997|NCT01999400|3580702|P2|COMPLETED|First Intervention (1 Day)||4
1462998|NCT01999400|3580703|P1|COMPLETED|First Intervention (1 Day)||4
1462999|NCT01999400|3580698|P6|STARTED|First Intervention (1 Day)||4
1463000|NCT01999400|3580699|P5|STARTED|First Intervention (1 Day)||4
1463001|NCT01999400|3580700|P4|STARTED|First Intervention (1 Day)||5
1463002|NCT01999400|3580701|P3|STARTED|First Intervention (1 Day)||5
1463003|NCT01999400|3580702|P2|STARTED|First Intervention (1 Day)||6
1463004|NCT01999400|3580703|P1|STARTED|First Intervention (1 Day)||6
1463005|NCT01999348|3580723|P1|NOT COMPLETED|Overall Study||120
1463006|NCT01999348|3580723|P1|COMPLETED|Overall Study||1433
1463007|NCT01999348|3580723|P1|STARTED|Overall Study||1553
1463008|NCT01999322|3580735|P2|NOT COMPLETED|Overall Study||0
1463009|NCT01999322|3580736|P1|NOT COMPLETED|Overall Study||1
1463010|NCT01999322|3580735|P2|COMPLETED|Overall Study||12
1463011|NCT01999322|3580736|P1|COMPLETED|Overall Study||24
1463012|NCT01999322|3580735|P2|STARTED|Overall Study||12
1463013|NCT01999322|3580736|P1|STARTED|Overall Study||25
1463014|NCT01999231|3580752|P4|NOT COMPLETED|Overall Study||0
1463015|NCT01999231|3580753|P3|NOT COMPLETED|Overall Study||0
1463016|NCT01999231|3580754|P2|NOT COMPLETED|Overall Study||0
1463017|NCT01999231|3580755|P1|NOT COMPLETED|Overall Study||0
1463018|NCT01999231|3580752|P4|COMPLETED|Overall Study||6
1463019|NCT01999231|3580753|P3|COMPLETED|Overall Study||6
1463020|NCT01999231|3580754|P2|COMPLETED|Overall Study||6
1463021|NCT01999231|3580755|P1|COMPLETED|Overall Study||6
1463022|NCT01999231|3580752|P4|STARTED|Overall Study||6
1463023|NCT01999231|3580753|P3|STARTED|Overall Study||6
1463024|NCT01999231|3580754|P2|STARTED|Overall Study||6
1463025|NCT01999231|3580755|P1|STARTED|Overall Study||6
1463026|NCT01999218|3580788|P3|NOT COMPLETED|Overall Study||110
1463027|NCT01999218|3580789|P2|NOT COMPLETED|Overall Study||101
1463028|NCT01999218|3580790|P1|NOT COMPLETED|Overall Study||109
1463029|NCT01999218|3580788|P3|COMPLETED|Overall Study||327
1463030|NCT01999218|3580789|P2|COMPLETED|Overall Study||340
1463031|NCT01999218|3580790|P1|COMPLETED|Overall Study||339
1463032|NCT01999218|3580788|P3|Site Issue|Overall Study||435
1463033|NCT01999218|3580789|P2|Site Issue|Overall Study||435
1463034|NCT01999218|3580790|P1|Site Issue|Overall Study||445
1463035|NCT01999218|3580788|P3|Treated|Overall Study||437
1463036|NCT01999218|3580789|P2|Treated|Overall Study||440
1463037|NCT01999218|3580790|P1|Treated|Overall Study||448
1463038|NCT01999218|3580788|P3|STARTED|Overall Study||437
1463039|NCT01999218|3580789|P2|STARTED|Overall Study||441
1463040|NCT01999218|3580790|P1|STARTED|Overall Study||448
1463041|NCT01999192|3580817|P4|NOT COMPLETED|Extension Phase||0
1463042|NCT01999192|3580818|P3|NOT COMPLETED|Extension Phase||24
1463043|NCT01999192|3580819|P2|NOT COMPLETED|Extension Phase||18
1463044|NCT01999192|3580820|P1|NOT COMPLETED|Extension Phase||13
1463045|NCT01999192|3580817|P4|COMPLETED|Extension Phase||0
1463046|NCT01999192|3580818|P3|COMPLETED|Extension Phase||44
1463047|NCT01999192|3580819|P2|COMPLETED|Extension Phase||38
1463048|NCT01999192|3580820|P1|COMPLETED|Extension Phase||41
1463049|NCT01999192|3580817|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
1463050|NCT01999192|3580818|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
1463051|NCT01999192|3580819|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
1463052|NCT01999192|3580820|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
1463053|NCT01999192|3580817|P4|NOT COMPLETED|Main Phase II||1
1463054|NCT01999192|3580818|P3|NOT COMPLETED|Main Phase II||22
1463055|NCT01999192|3580819|P2|NOT COMPLETED|Main Phase II||9
1463056|NCT01999192|3580820|P1|NOT COMPLETED|Main Phase II||9
1463057|NCT01999192|3580817|P4|COMPLETED|Main Phase II||43
1463058|NCT01999192|3580818|P3|COMPLETED|Main Phase II||76
1463059|NCT01999192|3580819|P2|COMPLETED|Main Phase II||66
1463060|NCT01999192|3580820|P1|COMPLETED|Main Phase II||55
1463061|NCT01999192|3580817|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
1463062|NCT01999192|3580818|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
1463063|NCT01999192|3580819|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
1463064|NCT01999192|3580820|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
1463065|NCT01999192|3580817|P4|NOT COMPLETED|Main Phase I||8
1463066|NCT01999192|3580818|P3|NOT COMPLETED|Main Phase I||8
1463067|NCT01999192|3580819|P2|NOT COMPLETED|Main Phase I||10
1463068|NCT01999192|3580820|P1|NOT COMPLETED|Main Phase I||11
1463069|NCT01999192|3580817|P4|COMPLETED|Main Phase I||72
1463070|NCT01999192|3580818|P3|COMPLETED|Main Phase I||70
1463071|NCT01999192|3580819|P2|COMPLETED|Main Phase I||70
1463072|NCT01999192|3580820|P1|COMPLETED|Main Phase I||72
1463073|NCT01999192|3580817|P4|STARTED|Main Phase I||80
1463074|NCT01999192|3580818|P3|STARTED|Main Phase I||78
1463075|NCT01999192|3580819|P2|STARTED|Main Phase I||80
1463076|NCT01999192|3580820|P1|STARTED|Main Phase I||83
1463077|NCT01999114|3580835|P5|NOT COMPLETED|Overall Study||4
1463078|NCT01999114|3580836|P4|NOT COMPLETED|Overall Study||3
1463079|NCT01999114|3580837|P3|NOT COMPLETED|Overall Study||5
1463080|NCT01999114|3580838|P2|NOT COMPLETED|Overall Study||7
1463081|NCT01999114|3580839|P1|NOT COMPLETED|Overall Study||8
1463082|NCT01999114|3580835|P5|COMPLETED|Overall Study||61
1463083|NCT01999114|3580836|P4|COMPLETED|Overall Study||62
1463084|NCT01999114|3580837|P3|COMPLETED|Overall Study||61
1463085|NCT01999114|3580838|P2|COMPLETED|Overall Study||59
1463086|NCT01999114|3580839|P1|COMPLETED|Overall Study||58
1463087|NCT01999114|3580835|P5|STARTED|Overall Study||65
1463088|NCT01999114|3580836|P4|STARTED|Overall Study||65
1463089|NCT01999114|3580837|P3|STARTED|Overall Study||66
1463090|NCT01999114|3580838|P2|STARTED|Overall Study||66
1463091|NCT01999114|3580839|P1|STARTED|Overall Study||66
1463092|NCT01998984|3580907|P4|NOT COMPLETED|Overall Study||3
1463093|NCT01998984|3580908|P3|NOT COMPLETED|Overall Study||1
1463094|NCT01998984|3580909|P2|NOT COMPLETED|Overall Study||1
1463095|NCT01998984|3580910|P1|NOT COMPLETED|Overall Study||0
1463096|NCT01998984|3580907|P4|COMPLETED|Overall Study||58
1463097|NCT01998984|3580908|P3|COMPLETED|Overall Study||48
1463098|NCT01998984|3580909|P2|COMPLETED|Overall Study||58
1463099|NCT01998984|3580910|P1|COMPLETED|Overall Study||55
1463100|NCT01998984|3580907|P4|STARTED|Overall Study||61
1463101|NCT01998984|3580908|P3|STARTED|Overall Study||49
1463102|NCT01998984|3580909|P2|STARTED|Overall Study||59
1463103|NCT01998984|3580910|P1|STARTED|Overall Study||55
1463104|NCT01998919|3580930|P2|NOT COMPLETED|Overall Study||35
1463105|NCT01998919|3580931|P1|NOT COMPLETED|Overall Study||42
1463106|NCT01998919|3580930|P2|COMPLETED|Overall Study||39
1463107|NCT01998919|3580931|P1|COMPLETED|Overall Study||37
1463108|NCT01998919|3580930|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
1463109|NCT01998919|3580931|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
1463110|NCT01998919|3580930|P2|STARTED|Overall Study||74
1463111|NCT01998919|3580931|P1|STARTED|Overall Study||79
1463112|NCT01998906|3580952|P3|NOT COMPLETED|Overall Study||98
1463113|NCT01998906|3580953|P2|NOT COMPLETED|Overall Study||114
1463114|NCT01998906|3580954|P1|NOT COMPLETED|Overall Study||114
1463115|NCT01998906|3580952|P3|COMPLETED|Overall Study||1
1463116|NCT01998906|3580953|P2|COMPLETED|Overall Study||2
1463117|NCT01998906|3580954|P1|COMPLETED|Overall Study||1
1463118|NCT01998906|3580952|P3|STARTED|Overall Study||99
1463119|NCT01998906|3580953|P2|STARTED|Overall Study||116
1463120|NCT01998906|3580954|P1|STARTED|Overall Study||115
1463121|NCT01998893|3580998|P1|NOT COMPLETED|Overall Study||17
1463122|NCT01998893|3580998|P1|COMPLETED|Overall Study||21
1463123|NCT01998893|3580998|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
1463124|NCT01998893|3580998|P1|2nd Treatment Cycle Started|Overall Study||5
1463125|NCT01998893|3580998|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
1463126|NCT01998893|3580998|P1|STARTED|Overall Study||38
1463127|NCT01998880|3581010|P2|NOT COMPLETED|Overall Study||40
1463128|NCT01998880|3581011|P1|NOT COMPLETED|Overall Study||28
1463129|NCT01998880|3581010|P2|COMPLETED|Overall Study||78
1463130|NCT01998880|3581011|P1|COMPLETED|Overall Study|Completed=Completed treatment.|205
1463131|NCT01998880|3581010|P2|Received Study Drug|Overall Study||116
1463132|NCT01998880|3581011|P1|Received Study Drug|Overall Study||230
1463133|NCT01998880|3581010|P2|STARTED|Overall Study||118
1463134|NCT01998880|3581011|P1|STARTED|Overall Study||233
1463135|NCT01998737|3581043|P2|NOT COMPLETED|Overall Study||0
1463136|NCT01998737|3581044|P1|NOT COMPLETED|Overall Study||23
1463137|NCT01998737|3581043|P2|COMPLETED|Overall Study||100
1463138|NCT01998737|3581044|P1|COMPLETED|Overall Study||888
1463139|NCT01998737|3581043|P2|STARTED|Overall Study||100
1463140|NCT01998737|3581044|P1|STARTED|Overall Study||911
1463141|NCT01998633|3581056|P1|NOT COMPLETED|Overall Study||1
1463142|NCT01998633|3581056|P1|COMPLETED|Overall Study||46
1463143|NCT01998633|3581056|P1|STARTED|Overall Study||47
1463144|NCT01998581|3581074|P2|NOT COMPLETED|Overall Study||12
1463145|NCT01998581|3581075|P1|NOT COMPLETED|Overall Study||46
1463146|NCT01998581|3581074|P2|COMPLETED|Overall Study||44
1463147|NCT01998581|3581075|P1|COMPLETED|Overall Study||123
1463148|NCT01998581|3581074|P2|STARTED|Overall Study||56
1463149|NCT01998581|3581075|P1|STARTED|Overall Study||169
1463150|NCT01998477|3581087|P2|NOT COMPLETED|Overall Study||5
1463151|NCT01998477|3581088|P1|NOT COMPLETED|Overall Study||10
1463152|NCT01998477|3581087|P2|COMPLETED|Overall Study||143
1463153|NCT01998477|3581088|P1|COMPLETED|Overall Study||272
1463154|NCT01998477|3581087|P2|STARTED|Overall Study||148
1463155|NCT01998477|3581088|P1|STARTED|Overall Study||282
1463156|NCT01998438|3581122|P3|NOT COMPLETED|Overall Study||0
1463157|NCT01998438|3581123|P2|NOT COMPLETED|Overall Study||0
1463158|NCT01998438|3581124|P1|NOT COMPLETED|Overall Study||0
1463159|NCT01998438|3581122|P3|COMPLETED|Overall Study||318
1463160|NCT01998438|3581123|P2|COMPLETED|Overall Study||318
1463161|NCT01998438|3581124|P1|COMPLETED|Overall Study||319
1463162|NCT01998438|3581122|P3|STARTED|Overall Study||318
1463163|NCT01998438|3581123|P2|STARTED|Overall Study||318
1463164|NCT01998438|3581124|P1|STARTED|Overall Study||319
1463165|NCT01998399|3581134|P2|NOT COMPLETED|Overall Study||9
1463166|NCT01998399|3581135|P1|NOT COMPLETED|Overall Study||8
1463167|NCT01998399|3581134|P2|COMPLETED|Overall Study||4
1463168|NCT01998399|3581135|P1|COMPLETED|Overall Study||4
1463169|NCT01998399|3581134|P2|STARTED|Overall Study||13
1463170|NCT01998399|3581135|P1|STARTED|Overall Study||12
1463171|NCT01998360|3581169|P2|NOT COMPLETED|Overall Study||0
1463172|NCT01998360|3581170|P1|NOT COMPLETED|Overall Study||0
1463173|NCT01998360|3581169|P2|COMPLETED|Overall Study||50
1463174|NCT01998360|3581170|P1|COMPLETED|Overall Study||50
1463175|NCT01998360|3581169|P2|STARTED|Overall Study||50
1463176|NCT01998360|3581170|P1|STARTED|Overall Study||50
1463177|NCT01998269|3581184|P1|NOT COMPLETED|Overall Study||0
1463178|NCT01998269|3581184|P1|COMPLETED|Overall Study||193
1463179|NCT01998269|3581184|P1|STARTED|Overall Study||193
1463180|NCT01997905|3581188|P1|NOT COMPLETED|Overall Study||3
1463181|NCT01997905|3581188|P1|COMPLETED|Overall Study||10
1463182|NCT01997905|3581188|P1|Baseline Completed|Overall Study||11
1463183|NCT01997905|3581188|P1|STARTED|Overall Study||13
1463184|NCT01997892|3581197|P1|NOT COMPLETED|Overall Study||68
1463185|NCT01997892|3581197|P1|COMPLETED|Overall Study||959
1463186|NCT01997892|3581197|P1|Received Darbepoetin Alfa|Overall Study||987
1463187|NCT01997892|3581197|P1|STARTED|Overall Study||1027
1463188|NCT01997723|3581209|P1|NOT COMPLETED|Overall Study||0
1463189|NCT01997723|3581209|P1|COMPLETED|Overall Study||75
1463190|NCT01997723|3581209|P1|STARTED|Overall Study||75
1463191|NCT01997567|3581217|P2|NOT COMPLETED|Overall Study||0
1463192|NCT01997567|3581218|P1|NOT COMPLETED|Overall Study||0
1463193|NCT01997567|3581217|P2|COMPLETED|Overall Study||0
1463194|NCT01997567|3581218|P1|COMPLETED|Overall Study||0
1463195|NCT01997567|3581217|P2|STARTED|Overall Study||0
1463196|NCT01997567|3581218|P1|STARTED|Overall Study||0
1463197|NCT01997437|3581236|P1|NOT COMPLETED|Overall Study||0
1463198|NCT01997437|3581236|P1|COMPLETED|Overall Study||6
1463199|NCT01997437|3581236|P1|STARTED|Overall Study||6
1463200|NCT01997411|3581248|P8|NOT COMPLETED|Overall Study||0
1463201|NCT01997411|3581249|P7|NOT COMPLETED|Overall Study||0
1463202|NCT01997411|3581250|P6|NOT COMPLETED|Overall Study||1
1463203|NCT01997411|3581251|P5|NOT COMPLETED|Overall Study||0
1463204|NCT01997411|3581252|P4|NOT COMPLETED|Overall Study||0
1463205|NCT01997411|3581253|P3|NOT COMPLETED|Overall Study||0
1463206|NCT01997411|3581254|P2|NOT COMPLETED|Overall Study||0
1463207|NCT01997411|3581255|P1|NOT COMPLETED|Overall Study||0
1463208|NCT01997411|3581248|P8|COMPLETED|Overall Study||6
1463209|NCT01997411|3581249|P7|COMPLETED|Overall Study||6
1463210|NCT01997411|3581250|P6|COMPLETED|Overall Study||5
1463211|NCT01997411|3581251|P5|COMPLETED|Overall Study||6
1463212|NCT01997411|3581252|P4|COMPLETED|Overall Study||6
1463213|NCT01997411|3581253|P3|COMPLETED|Overall Study||6
1463214|NCT01997411|3581254|P2|COMPLETED|Overall Study||6
1463215|NCT01997411|3581255|P1|COMPLETED|Overall Study||6
1463216|NCT01997411|3581248|P8|STARTED|Overall Study||6
1463217|NCT01997411|3581249|P7|STARTED|Overall Study||6
1463218|NCT01997411|3581250|P6|STARTED|Overall Study||6
1463219|NCT01997411|3581251|P5|STARTED|Overall Study||6
1463220|NCT01997411|3581252|P4|STARTED|Overall Study||6
1463221|NCT01997411|3581253|P3|STARTED|Overall Study||6
1463222|NCT01997411|3581254|P2|STARTED|Overall Study||6
1463223|NCT01997411|3581255|P1|STARTED|Overall Study||6
1463224|NCT01997398|3581345|P1|NOT COMPLETED|Overall Study||1
1463225|NCT01997398|3581345|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
1463226|NCT01997398|3581345|P1|STARTED|Overall Study||35
1463227|NCT01997229|3581356|P2|NOT COMPLETED|Overall Study||2
1463228|NCT01997229|3581357|P1|NOT COMPLETED|Overall Study||5
1463229|NCT01997229|3581356|P2|COMPLETED|Overall Study||61
1463230|NCT01997229|3581357|P1|COMPLETED|Overall Study||57
1463231|NCT01997229|3581356|P2|STARTED|Overall Study||63
1463232|NCT01997229|3581357|P1|STARTED|Overall Study||62
1463233|NCT01997216|3581363|P2|NOT COMPLETED|Second 9 Hours||0
1463234|NCT01997216|3581364|P1|NOT COMPLETED|Second 9 Hours||0
1463235|NCT01997216|3581363|P2|COMPLETED|Second 9 Hours||21
1463236|NCT01997216|3581364|P1|COMPLETED|Second 9 Hours||19
1463237|NCT01997216|3581363|P2|STARTED|Second 9 Hours||21
1463238|NCT01997216|3581364|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
1463239|NCT01997216|3581363|P2|NOT COMPLETED|First 9 Hours||0
1463240|NCT01997216|3581364|P1|NOT COMPLETED|First 9 Hours||0
1463241|NCT01997216|3581363|P2|COMPLETED|First 9 Hours||21
1463242|NCT01997216|3581364|P1|COMPLETED|First 9 Hours||18
1463243|NCT01997216|3581363|P2|STARTED|First 9 Hours||21
1463244|NCT01997216|3581364|P1|STARTED|First 9 Hours||18
1463245|NCT01996904|3581376|P2|NOT COMPLETED|Overall Study||27
1463246|NCT01996904|3581377|P1|NOT COMPLETED|Overall Study||38
1463247|NCT01996904|3581376|P2|COMPLETED|Overall Study||90
1463248|NCT01996904|3581377|P1|COMPLETED|Overall Study||101
1463249|NCT01996904|3581376|P2|STARTED|Overall Study||117
1463250|NCT01996904|3581377|P1|STARTED|Overall Study||139
1463251|NCT01996813|3581385|P2|NOT COMPLETED|Overall Study||0
1463252|NCT01996813|3581386|P1|NOT COMPLETED|Overall Study||0
1463253|NCT01996813|3581385|P2|COMPLETED|Overall Study||24
1463254|NCT01996813|3581386|P1|COMPLETED|Overall Study||23
1463255|NCT01996813|3581385|P2|STARTED|Overall Study||24
1463256|NCT01996813|3581386|P1|STARTED|Overall Study||23
1463257|NCT01996748|3581396|P2|NOT COMPLETED|Overall Study||6
1463258|NCT01996748|3581397|P1|NOT COMPLETED|Overall Study||8
1463259|NCT01996748|3581396|P2|COMPLETED|Overall Study||63
1463260|NCT01996748|3581397|P1|COMPLETED|Overall Study||58
1463261|NCT01996748|3581396|P2|STARTED|Overall Study||69
1463262|NCT01996748|3581397|P1|STARTED|Overall Study||66
1463263|NCT01996709|3581411|P2|NOT COMPLETED|Overall Study||1
1463264|NCT01996709|3581412|P1|NOT COMPLETED|Overall Study||5
1463265|NCT01996709|3581411|P2|COMPLETED|Overall Study||67
1463266|NCT01996709|3581412|P1|COMPLETED|Overall Study||61
1463267|NCT01996709|3581411|P2|STARTED|Overall Study||68
1463268|NCT01996709|3581412|P1|STARTED|Overall Study||66
1463269|NCT01996657|3581429|P3|NOT COMPLETED|Overall Study||14
1463270|NCT01996657|3581430|P2|NOT COMPLETED|Overall Study||11
1463271|NCT01996657|3581431|P1|NOT COMPLETED|Overall Study||13
1463272|NCT01996657|3581429|P3|COMPLETED|Overall Study||234
1463273|NCT01996657|3581430|P2|COMPLETED|Overall Study||239
1463274|NCT01996657|3581431|P1|COMPLETED|Overall Study||237
1463275|NCT01996657|3581429|P3|STARTED|Overall Study||248
1463276|NCT01996657|3581430|P2|STARTED|Overall Study||250
1463277|NCT01996657|3581431|P1|STARTED|Overall Study||250
1463278|NCT01996644|3581447|P2|NOT COMPLETED|Overall Study||0
1463279|NCT01996644|3581448|P1|NOT COMPLETED|Overall Study||0
1463280|NCT01996644|3581447|P2|COMPLETED|Overall Study||16
1463281|NCT01996644|3581448|P1|COMPLETED|Overall Study||20
1463282|NCT01996644|3581447|P2|STARTED|Overall Study||16
1463283|NCT01996644|3581448|P1|STARTED|Overall Study||20
1463284|NCT01996592|3581459|P1|NOT COMPLETED|Overall Study||45
1463285|NCT01996592|3581459|P1|COMPLETED|Overall Study||530
1463286|NCT01996592|3581459|P1|STARTED|Overall Study||575
1463287|NCT01996410|3581476|P8|NOT COMPLETED|Overall Study||0
1463288|NCT01996410|3581477|P7|NOT COMPLETED|Overall Study||0
1463289|NCT01996410|3581478|P6|NOT COMPLETED|Overall Study||0
1463290|NCT01996410|3581479|P5|NOT COMPLETED|Overall Study||0
1463291|NCT01996410|3581480|P4|NOT COMPLETED|Overall Study||0
1463292|NCT01996410|3581481|P3|NOT COMPLETED|Overall Study||0
1463293|NCT01996410|3581482|P2|NOT COMPLETED|Overall Study||0
1463294|NCT01996410|3581483|P1|NOT COMPLETED|Overall Study||0
1463295|NCT01996410|3581476|P8|COMPLETED|Overall Study||0
1463296|NCT01996410|3581477|P7|COMPLETED|Overall Study||0
1463297|NCT01996410|3581478|P6|COMPLETED|Overall Study||2
1463298|NCT01996410|3581479|P5|COMPLETED|Overall Study||2
1463299|NCT01996410|3581480|P4|COMPLETED|Overall Study||0
1463300|NCT01996410|3581481|P3|COMPLETED|Overall Study||0
1463301|NCT01996410|3581482|P2|COMPLETED|Overall Study||3
1463302|NCT01996410|3581483|P1|COMPLETED|Overall Study||3
1463303|NCT01996410|3581476|P8|STARTED|Overall Study||0
1463304|NCT01996410|3581477|P7|STARTED|Overall Study||0
1463305|NCT01996410|3581478|P6|STARTED|Overall Study||2
1463306|NCT01996410|3581479|P5|STARTED|Overall Study||2
1463307|NCT01996410|3581480|P4|STARTED|Overall Study||0
1463308|NCT01996410|3581481|P3|STARTED|Overall Study||0
1463309|NCT01996410|3581482|P2|STARTED|Overall Study||3
1463310|NCT01996410|3581483|P1|STARTED|Overall Study||3
1463311|NCT01996332|3581495|P1|NOT COMPLETED|Overall Study||1805
1463312|NCT01996332|3581495|P1|COMPLETED|Overall Study||0
1463313|NCT01996332|3581495|P1|STARTED|Overall Study||1805
1463314|NCT01996319|3581503|P2|NOT COMPLETED|Overall Study||3
1463315|NCT01996319|3581504|P1|NOT COMPLETED|Overall Study||8
1463316|NCT01996319|3581503|P2|COMPLETED|Overall Study||95
1463317|NCT01996319|3581504|P1|COMPLETED|Overall Study||88
1463318|NCT01996319|3581503|P2|STARTED|Overall Study||98
1463319|NCT01996319|3581504|P1|STARTED|Overall Study||96
1463320|NCT01996033|3581524|P1|NOT COMPLETED|Overall Study||9
1463321|NCT01996033|3581524|P1|COMPLETED|Overall Study||16
1463322|NCT01996033|3581524|P1|STARTED|Overall Study||25
1463323|NCT01995539|3581537|P1|NOT COMPLETED|Overall Study||33
1463324|NCT01995539|3581537|P1|COMPLETED|Overall Study||148
1463325|NCT01995539|3581537|P1|STARTED|Overall Study||181
1463326|NCT01995526|3581542|P1|NOT COMPLETED|Overall Study||1
1463327|NCT01995526|3581542|P1|COMPLETED|Overall Study||10
1463328|NCT01995526|3581542|P1|Received One Dose of Study Drug|Overall Study||11
1463329|NCT01995526|3581542|P1|STARTED|Overall Study||11
1463330|NCT01995513|3581550|P3|NOT COMPLETED|Double Blind Treatment Period||125
1463331|NCT01995513|3581551|P2|NOT COMPLETED|Double Blind Treatment Period||126
1463332|NCT01995513|3581552|P1|NOT COMPLETED|Double Blind Treatment Period||0
1463333|NCT01995513|3581550|P3|COMPLETED|Double Blind Treatment Period||0
1463334|NCT01995513|3581551|P2|COMPLETED|Double Blind Treatment Period||0
1463335|NCT01995513|3581552|P1|COMPLETED|Double Blind Treatment Period||0
1463336|NCT01995513|3581550|P3|Treated|Double Blind Treatment Period||124
1463337|NCT01995513|3581551|P2|Treated|Double Blind Treatment Period||125
1463338|NCT01995513|3581552|P1|Treated|Double Blind Treatment Period||0
1463339|NCT01995513|3581550|P3|STARTED|Double Blind Treatment Period||125
1463340|NCT01995513|3581551|P2|STARTED|Double Blind Treatment Period||126
1463341|NCT01995513|3581552|P1|STARTED|Double Blind Treatment Period||0
1463342|NCT01995513|3581550|P3|NOT COMPLETED|Open Label Treatment Period||0
1463343|NCT01995513|3581551|P2|NOT COMPLETED|Open Label Treatment Period||0
1463344|NCT01995513|3581552|P1|NOT COMPLETED|Open Label Treatment Period||258
1463345|NCT01995513|3581550|P3|COMPLETED|Open Label Treatment Period||0
1463346|NCT01995513|3581551|P2|COMPLETED|Open Label Treatment Period||0
1463347|NCT01995513|3581552|P1|COMPLETED|Open Label Treatment Period||251
1463348|NCT01995513|3581550|P3|STARTED|Open Label Treatment Period||0
1463349|NCT01995513|3581551|P2|STARTED|Open Label Treatment Period||0
1463350|NCT01995513|3581552|P1|STARTED|Open Label Treatment Period||509
1463351|NCT01995461|3581595|P1|NOT COMPLETED|Overall Study||5
1463352|NCT01995461|3581595|P1|COMPLETED|Overall Study||21
1463353|NCT01995461|3581595|P1|STARTED|Overall Study||26
1463354|NCT01995357|3581601|P6|NOT COMPLETED|Period 5||0
1463355|NCT01995357|3581602|P5|NOT COMPLETED|Period 5||0
1463356|NCT01995357|3581603|P4|NOT COMPLETED|Period 5||0
1463357|NCT01995357|3581604|P3|NOT COMPLETED|Period 5||1
1463358|NCT01995357|3581605|P2|NOT COMPLETED|Period 5||0
1463359|NCT01995357|3581606|P1|NOT COMPLETED|Period 5||2
1463360|NCT01995357|3581601|P6|COMPLETED|Period 5||4
1463361|NCT01995357|3581602|P5|COMPLETED|Period 5||4
1463362|NCT01995357|3581603|P4|COMPLETED|Period 5||3
1463363|NCT01995357|3581604|P3|COMPLETED|Period 5||3
1463364|NCT01995357|3581605|P2|COMPLETED|Period 5||3
1463365|NCT01995357|3581606|P1|COMPLETED|Period 5||2
1463366|NCT01995357|3581601|P6|STARTED|Period 5||4
1463367|NCT01995357|3581602|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
1463368|NCT01995357|3581603|P4|STARTED|Period 5||3
1463369|NCT01995357|3581604|P3|STARTED|Period 5||4
1463370|NCT01995357|3581605|P2|STARTED|Period 5||3
1463371|NCT01995357|3581606|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
1463372|NCT01995357|3581601|P6|NOT COMPLETED|Period 4||0
1463373|NCT01995357|3581602|P5|NOT COMPLETED|Period 4||0
1463374|NCT01995357|3581603|P4|NOT COMPLETED|Period 4||0
1463375|NCT01995357|3581604|P3|NOT COMPLETED|Period 4||0
1463376|NCT01995357|3581605|P2|NOT COMPLETED|Period 4||0
1463377|NCT01995357|3581606|P1|NOT COMPLETED|Period 4||0
1463378|NCT01995357|3581601|P6|COMPLETED|Period 4||4
1463379|NCT01995357|3581602|P5|COMPLETED|Period 4||4
1463380|NCT01995357|3581603|P4|COMPLETED|Period 4||3
1463381|NCT01995357|3581604|P3|COMPLETED|Period 4||4
1463382|NCT01995357|3581605|P2|COMPLETED|Period 4||3
1463383|NCT01995357|3581606|P1|COMPLETED|Period 4||4
1463384|NCT01995357|3581601|P6|STARTED|Period 4||4
1463385|NCT01995357|3581602|P5|STARTED|Period 4||4
1463386|NCT01995357|3581603|P4|STARTED|Period 4||3
1463387|NCT01995357|3581604|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
1463388|NCT01995357|3581605|P2|STARTED|Period 4||3
1463389|NCT01995357|3581606|P1|STARTED|Period 4||4
1463390|NCT01995357|3581601|P6|NOT COMPLETED|Period 3||0
1463391|NCT01995357|3581602|P5|NOT COMPLETED|Period 3||0
1463392|NCT01995357|3581603|P4|NOT COMPLETED|Period 3||0
1463393|NCT01995357|3581604|P3|NOT COMPLETED|Period 3||0
1463394|NCT01995357|3581605|P2|NOT COMPLETED|Period 3||0
1463395|NCT01995357|3581606|P1|NOT COMPLETED|Period 3||0
1463396|NCT01995357|3581601|P6|COMPLETED|Period 3||4
1463397|NCT01995357|3581602|P5|COMPLETED|Period 3||4
1463398|NCT01995357|3581603|P4|COMPLETED|Period 3||3
1463399|NCT01995357|3581604|P3|COMPLETED|Period 3||4
1463400|NCT01995357|3581605|P2|COMPLETED|Period 3||3
1463401|NCT01995357|3581606|P1|COMPLETED|Period 3||4
1463402|NCT01995357|3581601|P6|STARTED|Period 3||4
1463403|NCT01995357|3581602|P5|STARTED|Period 3||4
1463404|NCT01995357|3581603|P4|STARTED|Period 3||3
1463405|NCT01995357|3581604|P3|STARTED|Period 3||4
1463406|NCT01995357|3581605|P2|STARTED|Period 3||3
1463407|NCT01995357|3581606|P1|STARTED|Period 3||4
1463408|NCT01995357|3581601|P6|NOT COMPLETED|Period 2||0
1463409|NCT01995357|3581602|P5|NOT COMPLETED|Period 2||0
1463410|NCT01995357|3581603|P4|NOT COMPLETED|Period 2||0
1463411|NCT01995357|3581604|P3|NOT COMPLETED|Period 2||0
1463412|NCT01995357|3581605|P2|NOT COMPLETED|Period 2||0
1463413|NCT01995357|3581606|P1|NOT COMPLETED|Period 2||0
1463414|NCT01995357|3581601|P6|COMPLETED|Period 2||4
1463415|NCT01995357|3581602|P5|COMPLETED|Period 2||4
1463416|NCT01995357|3581603|P4|COMPLETED|Period 2||3
1463417|NCT01995357|3581604|P3|COMPLETED|Period 2||4
1463418|NCT01995357|3581605|P2|COMPLETED|Period 2||3
1463419|NCT01995357|3581606|P1|COMPLETED|Period 2||4
1463420|NCT01995357|3581601|P6|STARTED|Period 2||4
1463421|NCT01995357|3581602|P5|STARTED|Period 2||4
1463422|NCT01995357|3581603|P4|STARTED|Period 2||3
1463423|NCT01995357|3581604|P3|STARTED|Period 2||4
1463424|NCT01995357|3581605|P2|STARTED|Period 2||3
1463425|NCT01995357|3581606|P1|STARTED|Period 2||4
1463426|NCT01995357|3581601|P6|NOT COMPLETED|Period 1||0
1463427|NCT01995357|3581602|P5|NOT COMPLETED|Period 1||0
1463428|NCT01995357|3581603|P4|NOT COMPLETED|Period 1||0
1463429|NCT01995357|3581604|P3|NOT COMPLETED|Period 1||0
1463430|NCT01995357|3581605|P2|NOT COMPLETED|Period 1||0
1463431|NCT01995357|3581606|P1|NOT COMPLETED|Period 1||0
1463432|NCT01995357|3581601|P6|COMPLETED|Period 1||4
1463433|NCT01995357|3581602|P5|COMPLETED|Period 1||4
1463434|NCT01995357|3581603|P4|COMPLETED|Period 1||3
1463435|NCT01995357|3581604|P3|COMPLETED|Period 1||4
1463436|NCT01995357|3581605|P2|COMPLETED|Period 1||3
1463437|NCT01995357|3581606|P1|COMPLETED|Period 1||4
1463438|NCT01995357|3581601|P6|STARTED|Period 1||4
1463439|NCT01995357|3581602|P5|STARTED|Period 1||4
1463440|NCT01995357|3581603|P4|STARTED|Period 1||3
1463441|NCT01995357|3581604|P3|STARTED|Period 1||4
1463442|NCT01995357|3581605|P2|STARTED|Period 1||3
1463443|NCT01995357|3581606|P1|STARTED|Period 1||4
1463444|NCT01995201|3581624|P7|NOT COMPLETED|From Week 24 Until Week 48||2
1463445|NCT01995201|3581625|P6|NOT COMPLETED|From Week 24 Until Week 48||8
1463446|NCT01995201|3581626|P5|NOT COMPLETED|From Week 24 Until Week 48||6
1463447|NCT01995201|3581627|P4|NOT COMPLETED|From Week 24 Until Week 48||1
1463448|NCT01995201|3581628|P3|NOT COMPLETED|From Week 24 Until Week 48||5
1463449|NCT01995201|3581629|P2|NOT COMPLETED|From Week 24 Until Week 48||0
1463450|NCT01995201|3581630|P1|NOT COMPLETED|From Week 24 Until Week 48||0
1463451|NCT01995201|3581624|P7|COMPLETED|From Week 24 Until Week 48||0
1463452|NCT01995201|3581625|P6|COMPLETED|From Week 24 Until Week 48||59
1463453|NCT01995201|3581626|P5|COMPLETED|From Week 24 Until Week 48||89
1463454|NCT01995201|3581627|P4|COMPLETED|From Week 24 Until Week 48||89
1463455|NCT01995201|3581628|P3|COMPLETED|From Week 24 Until Week 48||84
1463456|NCT01995201|3581629|P2|COMPLETED|From Week 24 Until Week 48||0
1463457|NCT01995201|3581630|P1|COMPLETED|From Week 24 Until Week 48||0
1463458|NCT01995201|3581624|P7|STARTED|From Week 24 Until Week 48||2
1463459|NCT01995201|3581625|P6|STARTED|From Week 24 Until Week 48||67
1463460|NCT01995201|3581626|P5|STARTED|From Week 24 Until Week 48||95
1463461|NCT01995201|3581627|P4|STARTED|From Week 24 Until Week 48||90
1463462|NCT01995201|3581628|P3|STARTED|From Week 24 Until Week 48||89
1463463|NCT01995201|3581629|P2|STARTED|From Week 24 Until Week 48||0
1463464|NCT01995201|3581630|P1|STARTED|From Week 24 Until Week 48||0
1463465|NCT01995201|3581624|P7|NOT COMPLETED|From Baseline Until Week 24||0
1463466|NCT01995201|3581625|P6|NOT COMPLETED|From Baseline Until Week 24||0
1463467|NCT01995201|3581626|P5|NOT COMPLETED|From Baseline Until Week 24||0
1463468|NCT01995201|3581627|P4|NOT COMPLETED|From Baseline Until Week 24||0
1463469|NCT01995201|3581628|P3|NOT COMPLETED|From Baseline Until Week 24||0
1463470|NCT01995201|3581629|P2|NOT COMPLETED|From Baseline Until Week 24||46
1463471|NCT01995201|3581630|P1|NOT COMPLETED|From Baseline Until Week 24||10
1463472|NCT01995201|3581624|P7|COMPLETED|From Baseline Until Week 24||0
1463473|NCT01995201|3581625|P6|COMPLETED|From Baseline Until Week 24||0
1463474|NCT01995201|3581626|P5|COMPLETED|From Baseline Until Week 24||0
1463475|NCT01995201|3581627|P4|COMPLETED|From Baseline Until Week 24||0
1463476|NCT01995201|3581628|P3|COMPLETED|From Baseline Until Week 24||0
1463477|NCT01995201|3581629|P2|COMPLETED|From Baseline Until Week 24||281
1463478|NCT01995201|3581630|P1|COMPLETED|From Baseline Until Week 24||64
1463479|NCT01995201|3581624|P7|STARTED|From Baseline Until Week 24||0
1463480|NCT01995201|3581625|P6|STARTED|From Baseline Until Week 24||0
1463481|NCT01995201|3581626|P5|STARTED|From Baseline Until Week 24||0
1463482|NCT01995201|3581627|P4|STARTED|From Baseline Until Week 24||0
1463483|NCT01995201|3581628|P3|STARTED|From Baseline Until Week 24||0
1463484|NCT01995201|3581629|P2|STARTED|From Baseline Until Week 24||327
1463485|NCT01995201|3581630|P1|STARTED|From Baseline Until Week 24||74
1463486|NCT01995136|3581739|P1|NOT COMPLETED|Overall Study||1
1463487|NCT01995136|3581739|P1|COMPLETED|Overall Study||31
1463488|NCT01995136|3581739|P1|STARTED|Overall Study||32
1463489|NCT01995071|3581755|P12|NOT COMPLETED|Overall Study||0
1463490|NCT01995071|3581756|P11|NOT COMPLETED|Overall Study||1
1463491|NCT01995071|3581757|P10|NOT COMPLETED|Overall Study||0
1463492|NCT01995071|3581758|P9|NOT COMPLETED|Overall Study||1
1463493|NCT01995071|3581759|P8|NOT COMPLETED|Overall Study||2
1463494|NCT01995071|3581760|P7|NOT COMPLETED|Overall Study||1
1463495|NCT01995071|3581761|P6|NOT COMPLETED|Overall Study||0
1463496|NCT01995071|3581762|P5|NOT COMPLETED|Overall Study||1
1463497|NCT01995071|3581763|P4|NOT COMPLETED|Overall Study||0
1463498|NCT01995071|3581764|P3|NOT COMPLETED|Overall Study||1
1463499|NCT01995071|3581765|P2|NOT COMPLETED|Overall Study||0
1463500|NCT01995071|3581766|P1|NOT COMPLETED|Overall Study||1
1463501|NCT01995071|3581755|P12|COMPLETED|Overall Study||0
1463502|NCT01995071|3581756|P11|COMPLETED|Overall Study||7
1463503|NCT01995071|3581757|P10|COMPLETED|Overall Study||8
1463504|NCT01995071|3581758|P9|COMPLETED|Overall Study||7
1463505|NCT01995071|3581759|P8|COMPLETED|Overall Study||6
1463506|NCT01995071|3581760|P7|COMPLETED|Overall Study||7
1463507|NCT01995071|3581761|P6|COMPLETED|Overall Study||8
1463508|NCT01995071|3581762|P5|COMPLETED|Overall Study||7
1463509|NCT01995071|3581763|P4|COMPLETED|Overall Study||8
1463510|NCT01995071|3581764|P3|COMPLETED|Overall Study||8
1463511|NCT01995071|3581765|P2|COMPLETED|Overall Study||8
1463512|NCT01995071|3581766|P1|COMPLETED|Overall Study||7
1463513|NCT01995071|3581755|P12|STARTED|Overall Study||0
1463514|NCT01995071|3581756|P11|STARTED|Overall Study||8
1463515|NCT01995071|3581757|P10|STARTED|Overall Study||8
1463516|NCT01995071|3581758|P9|STARTED|Overall Study||8
1463517|NCT01995071|3581759|P8|STARTED|Overall Study||8
1463518|NCT01995071|3581760|P7|STARTED|Overall Study||8
1463519|NCT01995071|3581761|P6|STARTED|Overall Study||8
1463520|NCT01995071|3581762|P5|STARTED|Overall Study||8
1463521|NCT01995071|3581763|P4|STARTED|Overall Study||8
1463522|NCT01995071|3581764|P3|STARTED|Overall Study||9
1463523|NCT01995071|3581765|P2|STARTED|Overall Study||8
1463524|NCT01995071|3581766|P1|STARTED|Overall Study||8
1463525|NCT01995045|3581827|P2|NOT COMPLETED|Overall Study||0
1463526|NCT01995045|3581828|P1|NOT COMPLETED|Overall Study||0
1463527|NCT01995045|3581827|P2|COMPLETED|Overall Study||28
1463528|NCT01995045|3581828|P1|COMPLETED|Overall Study||29
1463529|NCT01995045|3581827|P2|STARTED|Overall Study||28
1463530|NCT01995045|3581828|P1|STARTED|Overall Study||29
1463531|NCT01994993|3581845|P5|NOT COMPLETED|Overall Study||2
1463532|NCT01994993|3581846|P4|NOT COMPLETED|Overall Study||46
1463533|NCT01994993|3581847|P3|NOT COMPLETED|Overall Study||47
1463534|NCT01994993|3581848|P2|NOT COMPLETED|Overall Study||35
1463535|NCT01994993|3581849|P1|NOT COMPLETED|Overall Study||35
1463536|NCT01994993|3581845|P5|COMPLETED|Overall Study||22
1463537|NCT01994993|3581846|P4|COMPLETED|Overall Study||9
1463538|NCT01994993|3581847|P3|COMPLETED|Overall Study||23
1463539|NCT01994993|3581848|P2|COMPLETED|Overall Study||12
1463540|NCT01994993|3581849|P1|COMPLETED|Overall Study||28
1463541|NCT01994993|3581845|P5|STARTED|Overall Study||24
1463542|NCT01994993|3581846|P4|STARTED|Overall Study||55
1463543|NCT01994993|3581847|P3|STARTED|Overall Study||70
1463544|NCT01994993|3581848|P2|STARTED|Overall Study||47
1463545|NCT01994993|3581849|P1|STARTED|Overall Study||63
1463546|NCT01994902|3581901|P2|NOT COMPLETED|Test Period 2||6
1463547|NCT01994902|3581902|P1|NOT COMPLETED|Test Period 2||0
1463548|NCT01994902|3581901|P2|COMPLETED|Test Period 2||55
1463549|NCT01994902|3581902|P1|COMPLETED|Test Period 2||57
1463550|NCT01994902|3581901|P2|STARTED|Test Period 2||61
1463551|NCT01994902|3581902|P1|STARTED|Test Period 2||57
1463552|NCT01994902|3581901|P2|NOT COMPLETED|Test Period 1||3
1463553|NCT01994902|3581902|P1|NOT COMPLETED|Test Period 1||6
1463554|NCT01994902|3581901|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
1463555|NCT01994902|3581902|P1|COMPLETED|Test Period 1||57
1463556|NCT01994902|3581901|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
1463557|NCT01994902|3581902|P1|STARTED|Test Period 1||63
1463558|NCT01994876|3581908|P2|NOT COMPLETED|Test Period 2||1
1463559|NCT01994876|3581909|P1|NOT COMPLETED|Test Period 2||1
1463560|NCT01994876|3581908|P2|COMPLETED|Test Period 2||6
1463561|NCT01994876|3581909|P1|COMPLETED|Test Period 2||8
1463562|NCT01994876|3581908|P2|STARTED|Test Period 2||7
1463563|NCT01994876|3581909|P1|STARTED|Test Period 2||9
1463564|NCT01994876|3581908|P2|NOT COMPLETED|Test Period 1||2
1463565|NCT01994876|3581909|P1|NOT COMPLETED|Test Period 1||0
1463566|NCT01994876|3581908|P2|COMPLETED|Test Period 1||7
1463567|NCT01994876|3581909|P1|COMPLETED|Test Period 1||9
1463568|NCT01994876|3581908|P2|STARTED|Test Period 1||9
1463569|NCT01994876|3581909|P1|STARTED|Test Period 1||9
1463570|NCT01994876|3581908|P2|NOT COMPLETED|Baseline - Own Product||0
1463571|NCT01994876|3581909|P1|NOT COMPLETED|Baseline - Own Product||0
1463572|NCT01994876|3581908|P2|COMPLETED|Baseline - Own Product||9
1463573|NCT01994876|3581909|P1|COMPLETED|Baseline - Own Product||9
1463574|NCT01994876|3581908|P2|STARTED|Baseline - Own Product||9
1463575|NCT01994876|3581909|P1|STARTED|Baseline - Own Product||9
1463576|NCT01994863|3581917|P2|NOT COMPLETED|Period 2||4
1463577|NCT01994863|3581918|P1|NOT COMPLETED|Period 2||1
1463578|NCT01994863|3581917|P2|COMPLETED|Period 2||5
1463579|NCT01994863|3581918|P1|COMPLETED|Period 2||7
1463580|NCT01994863|3581917|P2|STARTED|Period 2||9
1463581|NCT01994863|3581918|P1|STARTED|Period 2||8
1463582|NCT01994863|3581917|P2|NOT COMPLETED|Period 1||3
1463583|NCT01994863|3581918|P1|NOT COMPLETED|Period 1||7
1463584|NCT01994863|3581917|P2|COMPLETED|Period 1||9
1463585|NCT01994863|3581918|P1|COMPLETED|Period 1||4
1463586|NCT01994863|3581917|P2|STARTED|Period 1||12
1463587|NCT01994863|3581918|P1|STARTED|Period 1||11
1463588|NCT01994837|3581924|P1|NOT COMPLETED|Overall Study||32
1463589|NCT01994837|3581924|P1|COMPLETED|Overall Study||0
1463590|NCT01994837|3581924|P1|Treated|Overall Study||32
1463591|NCT01994837|3581924|P1|STARTED|Overall Study||32
1463592|NCT01994785|3581941|P4|NOT COMPLETED|Overall Study||3
1463593|NCT01994785|3581942|P3|NOT COMPLETED|Overall Study||0
1463594|NCT01994785|3581943|P2|NOT COMPLETED|Overall Study||1
1463595|NCT01994785|3581944|P1|NOT COMPLETED|Overall Study||8
1463596|NCT01994785|3581941|P4|COMPLETED|Overall Study||114
1463597|NCT01994785|3581942|P3|COMPLETED|Overall Study||117
1463598|NCT01994785|3581943|P2|COMPLETED|Overall Study||108
1463599|NCT01994785|3581944|P1|COMPLETED|Overall Study||101
1463600|NCT01994785|3581941|P4|STARTED|Overall Study||117
1463601|NCT01994785|3581942|P3|STARTED|Overall Study||117
1463602|NCT01994785|3581943|P2|STARTED|Overall Study||109
1463603|NCT01994785|3581944|P1|STARTED|Overall Study||109
1463604|NCT01994746|3581954|P2|NOT COMPLETED|Second Visit||0
1463605|NCT01994746|3581955|P1|NOT COMPLETED|Second Visit||0
1463606|NCT01994746|3581954|P2|COMPLETED|Second Visit||38
1463607|NCT01994746|3581955|P1|COMPLETED|Second Visit||38
1463608|NCT01994746|3581954|P2|Completed Both Dosing Visits|Second Visit||38
1463609|NCT01994746|3581955|P1|Completed Both Dosing Visits|Second Visit||38
1463610|NCT01994746|3581954|P2|STARTED|Second Visit||38
1463611|NCT01994746|3581955|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
1463612|NCT01994746|3581954|P2|NOT COMPLETED|First Visit||0
1463613|NCT01994746|3581955|P1|NOT COMPLETED|First Visit||0
1463614|NCT01994746|3581954|P2|COMPLETED|First Visit||38
1463615|NCT01994746|3581955|P1|COMPLETED|First Visit||39
1463616|NCT01994746|3581954|P2|Received At Least 1 Dose|First Visit||38
1463617|NCT01994746|3581955|P1|Received At Least 1 Dose|First Visit||39
1463618|NCT01994746|3581954|P2|STARTED|First Visit||38
1463619|NCT01994746|3581955|P1|STARTED|First Visit||39
1463620|NCT01994720|3581981|P2|NOT COMPLETED|Overall Study||56
1463621|NCT01994720|3581982|P1|NOT COMPLETED|Overall Study||46
1463622|NCT01994720|3581981|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
1463623|NCT01994720|3581982|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
1463624|NCT01994720|3581981|P2|STARTED|Overall Study||6610
1463625|NCT01994720|3581982|P1|STARTED|Overall Study||6589
1463626|NCT01994629|3582024|P2|NOT COMPLETED|Overall Study||3
1463627|NCT01994629|3582025|P1|NOT COMPLETED|Overall Study||1
1463628|NCT01994629|3582024|P2|COMPLETED|Overall Study||99
1463629|NCT01994629|3582025|P1|COMPLETED|Overall Study||99
1463630|NCT01994629|3582024|P2|STARTED|Overall Study||102
1463631|NCT01994629|3582025|P1|STARTED|Overall Study||100
1463632|NCT01994486|3582049|P1|NOT COMPLETED|Overall Study||0
1463633|NCT01994486|3582049|P1|COMPLETED|Overall Study||20
1463634|NCT01994486|3582049|P1|STARTED|Overall Study||20
1463635|NCT01994395|3582060|P2|NOT COMPLETED|Overall Study||2
1463636|NCT01994395|3582061|P1|NOT COMPLETED|Overall Study||1
1463637|NCT01994395|3582060|P2|COMPLETED|Overall Study||25
1463638|NCT01994395|3582061|P1|COMPLETED|Overall Study||25
1463639|NCT01994395|3582060|P2|STARTED|Overall Study||27
1463640|NCT01994395|3582061|P1|STARTED|Overall Study||26
1463641|NCT01994291|3582086|P3|NOT COMPLETED|Overall Study||9
1463642|NCT01994291|3582087|P2|NOT COMPLETED|Overall Study||7
1463643|NCT01994291|3582088|P1|NOT COMPLETED|Overall Study||15
1463644|NCT01994291|3582086|P3|COMPLETED|Overall Study||47
1463645|NCT01994291|3582087|P2|COMPLETED|Overall Study||36
1463646|NCT01994291|3582088|P1|COMPLETED|Overall Study||84
1463647|NCT01994291|3582086|P3|Received Treatment|Overall Study||56
1463648|NCT01994291|3582087|P2|Received Treatment|Overall Study||43
1463649|NCT01994291|3582088|P1|Received Treatment|Overall Study||99
1463650|NCT01994291|3582086|P3|STARTED|Overall Study||56
1463651|NCT01994291|3582087|P2|STARTED|Overall Study||43
1463652|NCT01994291|3582088|P1|STARTED|Overall Study||99
1463653|NCT01994226|3582144|P2|NOT COMPLETED|Overall Study||21
1463654|NCT01994226|3582145|P1|NOT COMPLETED|Overall Study||19
1463655|NCT01994226|3582144|P2|COMPLETED|Overall Study||179
1463656|NCT01994226|3582145|P1|COMPLETED|Overall Study||180
1463657|NCT01994226|3582144|P2|STARTED|Overall Study||200
1463658|NCT01994226|3582145|P1|STARTED|Overall Study||199
1463659|NCT01993940|3582153|P2|NOT COMPLETED|Overall Study||44
1463660|NCT01993940|3582154|P1|NOT COMPLETED|Overall Study||40
1463661|NCT01993940|3582153|P2|COMPLETED|Overall Study||232
1463662|NCT01993940|3582154|P1|COMPLETED|Overall Study||237
1463663|NCT01993940|3582153|P2|Received Treatment|Overall Study||276
1463664|NCT01993940|3582154|P1|Received Treatment|Overall Study||272
1463665|NCT01993940|3582153|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
1463666|NCT01993940|3582154|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
1463667|NCT01993927|3582168|P1|NOT COMPLETED|Overall Study||29
1463668|NCT01993927|3582168|P1|COMPLETED|Overall Study||713
1463669|NCT01993927|3582168|P1|STARTED|Overall Study||742
1463670|NCT01993888|3582176|P2|NOT COMPLETED|Overall Study||3
1463671|NCT01993888|3582177|P1|NOT COMPLETED|Overall Study||2
1463672|NCT01993888|3582176|P2|COMPLETED|Overall Study||49
1463673|NCT01993888|3582177|P1|COMPLETED|Overall Study||48
1463674|NCT01993888|3582176|P2|STARTED|Overall Study||52
1463675|NCT01993888|3582177|P1|STARTED|Overall Study||50
1463676|NCT01993849|3582195|P2|NOT COMPLETED|Overall Study||2
1463677|NCT01993849|3582196|P1|NOT COMPLETED|Overall Study||3
1463678|NCT01993849|3582195|P2|COMPLETED|Overall Study||9
1463679|NCT01993849|3582196|P1|COMPLETED|Overall Study||9
1463680|NCT01993849|3582195|P2|STARTED|Overall Study||11
1463681|NCT01993849|3582196|P1|STARTED|Overall Study||12
1463682|NCT01993823|3582206|P2|NOT COMPLETED|Overall Study||16
1463683|NCT01993823|3582207|P1|NOT COMPLETED|Overall Study||7
1463684|NCT01993823|3582206|P2|COMPLETED|Overall Study||79
1463685|NCT01993823|3582207|P1|COMPLETED|Overall Study||88
1463686|NCT01993823|3582206|P2|STARTED|Overall Study||95
1463687|NCT01993823|3582207|P1|STARTED|Overall Study||95
1463688|NCT01993238|3582215|P1|NOT COMPLETED|Overall Study||0
1463689|NCT01993238|3582215|P1|COMPLETED|Overall Study||11
1463690|NCT01993238|3582215|P1|STARTED|Overall Study||11
1463691|NCT01993108|3582222|P2|NOT COMPLETED|Overall Study||0
1463692|NCT01993108|3582223|P1|NOT COMPLETED|Overall Study||0
1463693|NCT01993108|3582222|P2|COMPLETED|Overall Study||12
1463694|NCT01993108|3582223|P1|COMPLETED|Overall Study||11
1463695|NCT01993108|3582222|P2|STARTED|Overall Study||12
1463696|NCT01993108|3582223|P1|STARTED|Overall Study||11
1463697|NCT01993030|3582254|P2|NOT COMPLETED|Overall Study||4
1463698|NCT01993030|3582255|P1|NOT COMPLETED|Overall Study||0
1463699|NCT01993030|3582254|P2|COMPLETED|Overall Study||31
1463700|NCT01993030|3582255|P1|COMPLETED|Overall Study||36
1463701|NCT01993030|3582254|P2|STARTED|Overall Study||35
1463702|NCT01993030|3582255|P1|STARTED|Overall Study||36
1463703|NCT01992874|3582269|P3|NOT COMPLETED|Part B||0
1463704|NCT01992874|3582270|P2|NOT COMPLETED|Part B||0
1463705|NCT01992874|3582271|P1|NOT COMPLETED|Part B||0
1463706|NCT01992874|3582269|P3|COMPLETED|Part B||38
1463707|NCT01992874|3582270|P2|COMPLETED|Part B||0
1463708|NCT01992874|3582271|P1|COMPLETED|Part B||0
1463709|NCT01992874|3582269|P3|STARTED|Part B||38
1463710|NCT01992874|3582270|P2|STARTED|Part B||0
1463711|NCT01992874|3582271|P1|STARTED|Part B||0
1463712|NCT01992874|3582269|P3|NOT COMPLETED|Part A||0
1463713|NCT01992874|3582270|P2|NOT COMPLETED|Part A||0
1463714|NCT01992874|3582271|P1|NOT COMPLETED|Part A||0
1463715|NCT01992874|3582269|P3|COMPLETED|Part A||0
1463716|NCT01992874|3582270|P2|COMPLETED|Part A||17
1463717|NCT01992874|3582271|P1|COMPLETED|Part A||21
1463718|NCT01992874|3582269|P3|STARTED|Part A||0
1463719|NCT01992874|3582270|P2|STARTED|Part A||17
1463720|NCT01992874|3582271|P1|STARTED|Part A||21
1463721|NCT01992757|3582299|P1|NOT COMPLETED|Overall Study||2
1463722|NCT01992757|3582299|P1|COMPLETED|Overall Study||49
1463723|NCT01992757|3582299|P1|STARTED|Overall Study||51
1463724|NCT01992536|3582314|P10|NOT COMPLETED|Overall Study||1
1463725|NCT01992536|3582315|P9|NOT COMPLETED|Overall Study||1
1463726|NCT01992536|3582316|P8|NOT COMPLETED|Overall Study||0
1463727|NCT01992536|3582317|P7|NOT COMPLETED|Overall Study||7
1463728|NCT01992536|3582318|P6|NOT COMPLETED|Overall Study||1
1463729|NCT01992536|3582319|P5|NOT COMPLETED|Overall Study||0
1463730|NCT01992536|3582320|P4|NOT COMPLETED|Overall Study||2
1463731|NCT01992536|3582321|P3|NOT COMPLETED|Overall Study||1
1463732|NCT01992536|3582322|P2|NOT COMPLETED|Overall Study||3
1463733|NCT01992536|3582323|P1|NOT COMPLETED|Overall Study||4
1463734|NCT01992536|3582314|P10|COMPLETED|Overall Study||18
1463735|NCT01992536|3582315|P9|COMPLETED|Overall Study||18
1463736|NCT01992536|3582316|P8|COMPLETED|Overall Study||21
1463737|NCT01992536|3582317|P7|COMPLETED|Overall Study||0
1463738|NCT01992536|3582318|P6|COMPLETED|Overall Study||20
1463739|NCT01992536|3582319|P5|COMPLETED|Overall Study||11
1463740|NCT01992536|3582320|P4|COMPLETED|Overall Study||22
1463741|NCT01992536|3582321|P3|COMPLETED|Overall Study||16
1463742|NCT01992536|3582322|P2|COMPLETED|Overall Study||22
1463743|NCT01992536|3582323|P1|COMPLETED|Overall Study||22
1463744|NCT01992536|3582314|P10|STARTED|Overall Study||19
1463745|NCT01992536|3582315|P9|STARTED|Overall Study||19
1463746|NCT01992536|3582316|P8|STARTED|Overall Study||21
1463747|NCT01992536|3582317|P7|STARTED|Overall Study||7
1463748|NCT01992536|3582318|P6|STARTED|Overall Study||21
1463749|NCT01992536|3582319|P5|STARTED|Overall Study||11
1463750|NCT01992536|3582320|P4|STARTED|Overall Study||24
1463751|NCT01992536|3582321|P3|STARTED|Overall Study||17
1463752|NCT01992536|3582322|P2|STARTED|Overall Study||25
1463753|NCT01992536|3582323|P1|STARTED|Overall Study||26
1463754|NCT01992523|3582540|P2|NOT COMPLETED|Overall Study||0
1463755|NCT01992523|3582541|P1|NOT COMPLETED|Overall Study||0
1463756|NCT01992523|3582540|P2|COMPLETED|Overall Study||41
1463757|NCT01992523|3582541|P1|COMPLETED|Overall Study||41
1463758|NCT01992523|3582540|P2|STARTED|Overall Study||41
1463759|NCT01992523|3582541|P1|STARTED|Overall Study||41
1463760|NCT01992185|3582555|P2|NOT COMPLETED|Overall Study||0
1463761|NCT01992185|3582556|P1|NOT COMPLETED|Overall Study||0
1463762|NCT01992185|3582555|P2|COMPLETED|Overall Study||8
1463763|NCT01992185|3582556|P1|COMPLETED|Overall Study||7
1463764|NCT01992185|3582555|P2|STARTED|Overall Study||8
1463765|NCT01992185|3582556|P1|STARTED|Overall Study||7
1463766|NCT01992172|3582564|P2|NOT COMPLETED|Overall Study||0
1463767|NCT01992172|3582565|P1|NOT COMPLETED|Overall Study||0
1463768|NCT01992172|3582564|P2|COMPLETED|Overall Study||0
1463769|NCT01992172|3582565|P1|COMPLETED|Overall Study||7
1463770|NCT01992172|3582564|P2|STARTED|Overall Study||0
1463771|NCT01992172|3582565|P1|STARTED|Overall Study||7
1463772|NCT01992107|3582574|P3|NOT COMPLETED|Overall Study||36
1463773|NCT01992107|3582575|P2|NOT COMPLETED|Overall Study||33
1463774|NCT01992107|3582576|P1|NOT COMPLETED|Overall Study||68
1463775|NCT01992107|3582574|P3|COMPLETED|Overall Study||545
1463776|NCT01992107|3582575|P2|COMPLETED|Overall Study||560
1463777|NCT01992107|3582576|P1|COMPLETED|Overall Study||1091
1463778|NCT01992107|3582574|P3|STARTED|Overall Study||581
1463779|NCT01992107|3582575|P2|STARTED|Overall Study||593
1463780|NCT01992107|3582576|P1|STARTED|Overall Study||1159
1463781|NCT01992094|3582632|P3|NOT COMPLETED|Overall Study||21
1463782|NCT01992094|3582633|P2|NOT COMPLETED|Overall Study||24
1463783|NCT01992094|3582634|P1|NOT COMPLETED|Overall Study||50
1463784|NCT01992094|3582632|P3|COMPLETED|Overall Study||648
1463785|NCT01992094|3582633|P2|COMPLETED|Overall Study||652
1463786|NCT01992094|3582634|P1|COMPLETED|Overall Study||1285
1463787|NCT01992094|3582632|P3|STARTED|Overall Study||669
1463788|NCT01992094|3582633|P2|STARTED|Overall Study||676
1463789|NCT01992094|3582634|P1|STARTED|Overall Study||1335
1463790|NCT01992016|3582692|P2|NOT COMPLETED|Overall Study||0
1463791|NCT01992016|3582693|P1|NOT COMPLETED|Overall Study||0
1463792|NCT01992016|3582692|P2|COMPLETED|Overall Study||7
1463793|NCT01992016|3582693|P1|COMPLETED|Overall Study||4
1463794|NCT01992016|3582692|P2|STARTED|Overall Study||7
1463795|NCT01992016|3582693|P1|STARTED|Overall Study||4
1463796|NCT01991990|3582701|P2|NOT COMPLETED|Overall Study||0
1463797|NCT01991990|3582702|P1|NOT COMPLETED|Overall Study||0
1463798|NCT01991990|3582701|P2|COMPLETED|Overall Study||12
1463799|NCT01991990|3582702|P1|COMPLETED|Overall Study||6
1463800|NCT01991990|3582701|P2|STARTED|Overall Study||12
1463801|NCT01991990|3582702|P1|STARTED|Overall Study||6
1463802|NCT01991860|3582744|P2|NOT COMPLETED|Overall Study||2
1463803|NCT01991860|3582745|P1|NOT COMPLETED|Overall Study||4
1463804|NCT01991860|3582744|P2|COMPLETED|Overall Study||164
1463805|NCT01991860|3582745|P1|COMPLETED|Overall Study||172
1463806|NCT01991860|3582744|P2|STARTED|Overall Study||166
1463807|NCT01991860|3582745|P1|STARTED|Overall Study||176
1463808|NCT01991548|3582751|P1|NOT COMPLETED|Overall Study||1
1463809|NCT01991548|3582751|P1|COMPLETED|Overall Study||39
1463810|NCT01991548|3582751|P1|STARTED|Overall Study||40
1463811|NCT01991522|3582757|P2|NOT COMPLETED|Overall Study||0
1463812|NCT01991522|3582758|P1|NOT COMPLETED|Overall Study||0
1463813|NCT01991522|3582757|P2|COMPLETED|Overall Study||17
1463814|NCT01991522|3582758|P1|COMPLETED|Overall Study||16
1463815|NCT01991522|3582757|P2|STARTED|Overall Study||17
1463816|NCT01991522|3582758|P1|STARTED|Overall Study||16
1463817|NCT01991470|3582766|P1|NOT COMPLETED|Enlite 3 Period||12
1463818|NCT01991470|3582766|P1|COMPLETED|Enlite 3 Period||146
1463819|NCT01991470|3582766|P1|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
1463820|NCT01991470|3582766|P1|NOT COMPLETED|Enlite 1 Period||20
1463821|NCT01991470|3582766|P1|COMPLETED|Enlite 1 Period||141
1463822|NCT01991470|3582766|P1|STARTED|Enlite 1 Period||161
1463823|NCT01991314|3582780|P2|NOT COMPLETED|Overall Study||11
1463824|NCT01991314|3582781|P1|NOT COMPLETED|Overall Study||11
1463825|NCT01991314|3582780|P2|COMPLETED|Overall Study||32
1463826|NCT01991314|3582781|P1|COMPLETED|Overall Study||34
1463827|NCT01991314|3582780|P2|STARTED|Overall Study||43
1463828|NCT01991314|3582781|P1|STARTED|Overall Study||45
1463829|NCT01990898|3582799|P1|NOT COMPLETED|Overall Study||4
1463830|NCT01990898|3582799|P1|COMPLETED|Overall Study||22
1463831|NCT01990898|3582799|P1|3 Months|Overall Study||22
1463832|NCT01990898|3582799|P1|STARTED|Overall Study||26
1463833|NCT01990859|3582803|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
1463834|NCT01990859|3582803|P1|COMPLETED|90 Day Follow Up for All Participants||20
1463835|NCT01990859|3582803|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
1463836|NCT01990859|3582803|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
1463837|NCT01990859|3582803|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
1463838|NCT01990859|3582803|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
1463839|NCT01990859|3582803|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
1463840|NCT01990859|3582803|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
1463841|NCT01990859|3582803|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
1463842|NCT01990794|3582814|P1|NOT COMPLETED|Overall Study||3
1463843|NCT01990794|3582814|P1|COMPLETED|Overall Study||10
1463844|NCT01990794|3582814|P1|One Month Into Study|Overall Study||10
1463845|NCT01990794|3582814|P1|STARTED|Overall Study||13
1463846|NCT01990742|3582928|P2|NOT COMPLETED|Overall Study||1353
1463847|NCT01990742|3582929|P1|NOT COMPLETED|Overall Study||407
1463848|NCT01990742|3582928|P2|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
1463849|NCT01990742|3582929|P1|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
1463850|NCT01990742|3582928|P2|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
1463851|NCT01990742|3582929|P1|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
1463852|NCT01990703|3582941|P2|NOT COMPLETED|Overall Study||45
1463853|NCT01990703|3582942|P1|NOT COMPLETED|Overall Study||39
1463854|NCT01990703|3582941|P2|COMPLETED|Overall Study||93
1463855|NCT01990703|3582942|P1|COMPLETED|Overall Study||108
1463856|NCT01990703|3582941|P2|STARTED|Overall Study||138
1463857|NCT01990703|3582942|P1|STARTED|Overall Study||147
1463858|NCT01990677|3582952|P2|NOT COMPLETED|Overall Study||1
1463859|NCT01990677|3582953|P1|NOT COMPLETED|Overall Study||2
1463860|NCT01990677|3582952|P2|COMPLETED|Overall Study||5
1463861|NCT01990677|3582953|P1|COMPLETED|Overall Study||10
1463862|NCT01990677|3582952|P2|STARTED|Overall Study||6
1463863|NCT01990677|3582953|P1|STARTED|Overall Study||12
1463864|NCT01990664|3582965|P2|NOT COMPLETED|Overall Study||11
1463865|NCT01990664|3582966|P1|NOT COMPLETED|Overall Study||7
1463866|NCT01990664|3582965|P2|COMPLETED|Overall Study||79
1463867|NCT01990664|3582966|P1|COMPLETED|Overall Study||95
1463868|NCT01990664|3582965|P2|STARTED|Overall Study||90
1463869|NCT01990664|3582966|P1|STARTED|Overall Study||102
1463870|NCT01990560|3582972|P1|NOT COMPLETED|Overall Study||1
1463871|NCT01990560|3582972|P1|COMPLETED|Overall Study||7
1463872|NCT01990560|3582972|P1|STARTED|Overall Study||8
1463873|NCT01990534|3582986|P1|NOT COMPLETED|Overall Study||60
1463874|NCT01990534|3582986|P1|COMPLETED|Overall Study||0
1463875|NCT01990534|3582986|P1|Ongoing|Overall Study||36
1463876|NCT01990534|3582986|P1|STARTED|Overall Study||60
1463877|NCT01990339|3583002|P1|NOT COMPLETED|Overall Study||2312
1463878|NCT01990339|3583002|P1|COMPLETED|Overall Study||12653
1463879|NCT01990339|3583002|P1|STARTED|Overall Study||14965
1463880|NCT01990313|3583007|P1|NOT COMPLETED|Overall Study||1
1463881|NCT01990313|3583007|P1|COMPLETED|Overall Study||14
1463882|NCT01990313|3583007|P1|STARTED|Overall Study||15
1463883|NCT01990261|3583012|P1|NOT COMPLETED|Overall Study||25
1463884|NCT01990261|3583012|P1|COMPLETED|Overall Study||8
1463885|NCT01990261|3583012|P1|Treated|Overall Study||29
1463886|NCT01990261|3583012|P1|STARTED|Overall Study||33
1463887|NCT01989793|3583024|P2|NOT COMPLETED|Overall Study||4
1463888|NCT01989793|3583025|P1|NOT COMPLETED|Overall Study||8
1463889|NCT01989793|3583024|P2|COMPLETED|Overall Study||15
1463890|NCT01989793|3583025|P1|COMPLETED|Overall Study||10
1463891|NCT01989793|3583024|P2|STARTED|Overall Study||19
1463892|NCT01989793|3583025|P1|STARTED|Overall Study||18
1463893|NCT01989754|3583049|P2|NOT COMPLETED|Overall Study||35
1463894|NCT01989754|3583050|P1|NOT COMPLETED|Overall Study||39
1463895|NCT01989754|3583049|P2|COMPLETED|Overall Study|Participants who died are included in this category.|2872
1463896|NCT01989754|3583050|P1|COMPLETED|Overall Study|Participants who died are included in this category.|2866
1463897|NCT01989754|3583049|P2|Treated|Overall Study||2904
1463898|NCT01989754|3583050|P1|Treated|Overall Study||2903
1463899|NCT01989754|3583049|P2|STARTED|Overall Study||2907
1463900|NCT01989754|3583050|P1|STARTED|Overall Study||2905
1463901|NCT01989689|3583062|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
1463902|NCT01989689|3583063|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
1463903|NCT01989689|3583062|P2|COMPLETED|Treatment Period ( 3 Months)||10
1463904|NCT01989689|3583063|P1|COMPLETED|Treatment Period ( 3 Months)||11
1463905|NCT01989689|3583062|P2|STARTED|Treatment Period ( 3 Months)||10
1463906|NCT01989689|3583063|P1|STARTED|Treatment Period ( 3 Months)||11
1463907|NCT01989689|3583062|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
1463908|NCT01989689|3583063|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
1463909|NCT01989689|3583062|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
1463910|NCT01989689|3583063|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
1463911|NCT01989689|3583062|P2|STARTED|Treatment Period 1 ( 3 Months)||13
1463912|NCT01989689|3583063|P1|STARTED|Treatment Period 1 ( 3 Months)||11
1463913|NCT01989689|3583062|P2|NOT COMPLETED|Baseline||0
1463914|NCT01989689|3583063|P1|NOT COMPLETED|Baseline||0
1463915|NCT01989689|3583062|P2|COMPLETED|Baseline||13
1463916|NCT01989689|3583063|P1|COMPLETED|Baseline||11
1463917|NCT01989689|3583062|P2|STARTED|Baseline||13
1463918|NCT01989689|3583063|P1|STARTED|Baseline||11
1463919|NCT01989676|3583075|P2|NOT COMPLETED|Overall Study||347
1463920|NCT01989676|3583076|P1|NOT COMPLETED|Overall Study||338
1463921|NCT01989676|3583075|P2|COMPLETED|Overall Study||6
1463922|NCT01989676|3583076|P1|COMPLETED|Overall Study||11
1463923|NCT01989676|3583075|P2|STARTED|Overall Study|Treated (355 randomized)|353
1463924|NCT01989676|3583076|P1|STARTED|Overall Study|Treated (352 randomized)|349
1463925|NCT01989572|3583102|P6|NOT COMPLETED|Overall Study||110
1463926|NCT01989572|3583103|P5|NOT COMPLETED|Overall Study||98
1463927|NCT01989572|3583104|P4|NOT COMPLETED|Overall Study||51
1463928|NCT01989572|3583105|P3|NOT COMPLETED|Overall Study||62
1463929|NCT01989572|3583106|P2|NOT COMPLETED|Overall Study||58
1463930|NCT01989572|3583107|P1|NOT COMPLETED|Overall Study||55
1463931|NCT01989572|3583102|P6|COMPLETED|Overall Study||79
1463932|NCT01989572|3583103|P5|COMPLETED|Overall Study||92
1463933|NCT01989572|3583104|P4|COMPLETED|Overall Study||56
1463934|NCT01989572|3583105|P3|COMPLETED|Overall Study||47
1463935|NCT01989572|3583106|P2|COMPLETED|Overall Study||53
1463936|NCT01989572|3583107|P1|COMPLETED|Overall Study||54
1463937|NCT01989572|3583102|P6|Treated|Overall Study||171
1463938|NCT01989572|3583103|P5|Treated|Overall Study||186
1463939|NCT01989572|3583104|P4|Treated|Overall Study||104
1463940|NCT01989572|3583105|P3|Treated|Overall Study||107
1463941|NCT01989572|3583106|P2|Treated|Overall Study||110
1463942|NCT01989572|3583107|P1|Treated|Overall Study||104
1463943|NCT01989572|3583102|P6|STARTED|Overall Study||189
1463944|NCT01989572|3583103|P5|STARTED|Overall Study||190
1463945|NCT01989572|3583104|P4|STARTED|Overall Study||107
1463946|NCT01989572|3583105|P3|STARTED|Overall Study||109
1463947|NCT01989572|3583106|P2|STARTED|Overall Study||111
1463948|NCT01989572|3583107|P1|STARTED|Overall Study||109
1463949|NCT01989455|3583140|P5|NOT COMPLETED|Overall Study||1
1463950|NCT01989455|3583141|P4|NOT COMPLETED|Overall Study||0
1463951|NCT01989455|3583142|P3|NOT COMPLETED|Overall Study||1
1463952|NCT01989455|3583143|P2|NOT COMPLETED|Overall Study||2
1463953|NCT01989455|3583144|P1|NOT COMPLETED|Overall Study||0
1463954|NCT01989455|3583140|P5|COMPLETED|Overall Study||7
1463955|NCT01989455|3583141|P4|COMPLETED|Overall Study||14
1463956|NCT01989455|3583142|P3|COMPLETED|Overall Study||13
1463957|NCT01989455|3583143|P2|COMPLETED|Overall Study||12
1463958|NCT01989455|3583144|P1|COMPLETED|Overall Study||14
1463959|NCT01989455|3583140|P5|STARTED|Overall Study||8
1463960|NCT01989455|3583141|P4|STARTED|Overall Study||14
1463961|NCT01989455|3583142|P3|STARTED|Overall Study||14
1463962|NCT01989455|3583143|P2|STARTED|Overall Study||14
1463963|NCT01989455|3583144|P1|STARTED|Overall Study||14
1463964|NCT01989195|3583178|P1|NOT COMPLETED|Overall Study||0
1463965|NCT01989195|3583178|P1|COMPLETED|Overall Study||6
1463966|NCT01989195|3583178|P1|STARTED|Overall Study||6
1463967|NCT01989169|3583188|P2|NOT COMPLETED|Period 2||1
1463968|NCT01989169|3583189|P1|NOT COMPLETED|Period 2||0
1463969|NCT01989169|3583188|P2|COMPLETED|Period 2||14
1463970|NCT01989169|3583189|P1|COMPLETED|Period 2||15
1463971|NCT01989169|3583188|P2|STARTED|Period 2||15
1463972|NCT01989169|3583189|P1|STARTED|Period 2||15
1463973|NCT01989169|3583188|P2|NOT COMPLETED|Period 1||0
1463974|NCT01989169|3583189|P1|NOT COMPLETED|Period 1||0
1463975|NCT01989169|3583188|P2|COMPLETED|Period 1||15
1463976|NCT01989169|3583189|P1|COMPLETED|Period 1||15
1463977|NCT01989169|3583188|P2|STARTED|Period 1||15
1463978|NCT01989169|3583189|P1|STARTED|Period 1||15
1463979|NCT01989156|3583202|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
1463980|NCT01989156|3583203|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
1463981|NCT01989156|3583204|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
1463982|NCT01989156|3583202|P3|COMPLETED|End of Study (Population at Day 90)||31
1463983|NCT01989156|3583203|P2|COMPLETED|End of Study (Population at Day 90)||35
1463984|NCT01989156|3583204|P1|COMPLETED|End of Study (Population at Day 90)||73
1463985|NCT01989156|3583202|P3|STARTED|End of Study (Population at Day 90)||34
1463986|NCT01989156|3583203|P2|STARTED|End of Study (Population at Day 90)||40
1463987|NCT01989156|3583204|P1|STARTED|End of Study (Population at Day 90)||80
1463988|NCT01989156|3583202|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
1463989|NCT01989156|3583203|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
1463990|NCT01989156|3583204|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
1463991|NCT01989156|3583202|P3|COMPLETED|Confinement Period (Population at Day 5)||34
1463992|NCT01989156|3583203|P2|COMPLETED|Confinement Period (Population at Day 5)||40
1463993|NCT01989156|3583204|P1|COMPLETED|Confinement Period (Population at Day 5)||80
1463994|NCT01989156|3583202|P3|STARTED|Confinement Period (Population at Day 5)||39
1463995|NCT01989156|3583203|P2|STARTED|Confinement Period (Population at Day 5)||41
1463996|NCT01989156|3583204|P1|STARTED|Confinement Period (Population at Day 5)||80
1463997|NCT01989130|3583226|P2|NOT COMPLETED|Overall Study||0
1463998|NCT01989130|3583227|P1|NOT COMPLETED|Overall Study||0
1463999|NCT01989130|3583226|P2|COMPLETED|Overall Study||27
1464000|NCT01989130|3583227|P1|COMPLETED|Overall Study||43
1464001|NCT01989130|3583226|P2|STARTED|Overall Study||27
1464002|NCT01989130|3583227|P1|STARTED|Overall Study||43
1464003|NCT01988922|3583242|P3|NOT COMPLETED|Overall Study||0
1464004|NCT01988922|3583243|P2|NOT COMPLETED|Overall Study||0
1464005|NCT01988922|3583244|P1|NOT COMPLETED|Overall Study||0
1464006|NCT01988922|3583242|P3|COMPLETED|Overall Study||10
1464007|NCT01988922|3583243|P2|COMPLETED|Overall Study||10
1464008|NCT01988922|3583244|P1|COMPLETED|Overall Study||10
1464009|NCT01988922|3583242|P3|STARTED|Overall Study||10
1464010|NCT01988922|3583243|P2|STARTED|Overall Study||10
1464011|NCT01988922|3583244|P1|STARTED|Overall Study||10
1464012|NCT01988857|3583255|P1|NOT COMPLETED|Overall Study||0
1464013|NCT01988857|3583255|P1|COMPLETED|Overall Study||300
1464014|NCT01988857|3583255|P1|STARTED|Overall Study||300
1464015|NCT01988662|3583264|P2|NOT COMPLETED|Overall Study||2
1464016|NCT01988662|3583265|P1|NOT COMPLETED|Overall Study||4
1464017|NCT01988662|3583264|P2|COMPLETED|Overall Study||99
1464018|NCT01988662|3583265|P1|COMPLETED|Overall Study||100
1464019|NCT01988662|3583264|P2|STARTED|Overall Study||101
1464020|NCT01988662|3583265|P1|STARTED|Overall Study||104
1464021|NCT01988415|3583282|P1|NOT COMPLETED|Overall Study||0
1464022|NCT01988415|3583282|P1|COMPLETED|Overall Study||26
1464023|NCT01988415|3583282|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
1464024|NCT01988402|3583292|P2|NOT COMPLETED|Overall Study||2
1464025|NCT01988402|3583293|P1|NOT COMPLETED|Overall Study||2
1464026|NCT01988402|3583292|P2|COMPLETED|Overall Study||17
1464027|NCT01988402|3583293|P1|COMPLETED|Overall Study||14
1464028|NCT01988402|3583292|P2|STARTED|Overall Study||19
1464029|NCT01988402|3583293|P1|STARTED|Overall Study||16
1464030|NCT01988376|3583307|P2|NOT COMPLETED|Overall Study||0
1464031|NCT01988376|3583308|P1|NOT COMPLETED|Overall Study||0
1464032|NCT01988376|3583307|P2|COMPLETED|Overall Study||129
1464033|NCT01988376|3583308|P1|COMPLETED|Overall Study||129
1464034|NCT01988376|3583307|P2|STARTED|Overall Study||129
1464035|NCT01988376|3583308|P1|STARTED|Overall Study||129
1464036|NCT01988129|3583316|P2|NOT COMPLETED|Overall Study||0
1464037|NCT01988129|3583317|P1|NOT COMPLETED|Overall Study||0
1464038|NCT01988129|3583316|P2|COMPLETED|Overall Study||588
1464039|NCT01988129|3583317|P1|COMPLETED|Overall Study||601
1464040|NCT01988129|3583316|P2|Completed 1-year Follow-up Survey|Overall Study||4
1464041|NCT01988129|3583317|P1|Completed 1-year Follow-up Survey|Overall Study||100
1464042|NCT01988129|3583316|P2|Screened for Sleep Disorders|Overall Study||15
1464043|NCT01988129|3583317|P1|Screened for Sleep Disorders|Overall Study||416
1464044|NCT01988129|3583316|P2|Attended Education Session|Overall Study||18
1464045|NCT01988129|3583317|P1|Attended Education Session|Overall Study||542
1464046|NCT01988129|3583316|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
1464047|NCT01988129|3583317|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
1464048|NCT01988012|3583344|P1|NOT COMPLETED|Overall Study||15
1464049|NCT01988012|3583344|P1|COMPLETED|Overall Study||85
1464050|NCT01988012|3583344|P1|STARTED|Overall Study||100
1464051|NCT01987986|3583370|P4|NOT COMPLETED|Overall Study||0
1464052|NCT01987986|3583371|P3|NOT COMPLETED|Overall Study||2
1464053|NCT01987986|3583372|P2|NOT COMPLETED|Overall Study||0
1464054|NCT01987986|3583373|P1|NOT COMPLETED|Overall Study||2
1464055|NCT01987986|3583370|P4|COMPLETED|Overall Study||24
1464056|NCT01987986|3583371|P3|COMPLETED|Overall Study||38
1464057|NCT01987986|3583372|P2|COMPLETED|Overall Study||43
1464058|NCT01987986|3583373|P1|COMPLETED|Overall Study||41
1464059|NCT01987986|3583370|P4|STARTED|Overall Study||24
1464060|NCT01987986|3583371|P3|STARTED|Overall Study||40
1464061|NCT01987986|3583372|P2|STARTED|Overall Study||43
1464062|NCT01987986|3583373|P1|STARTED|Overall Study||43
1464063|NCT01987960|3583413|P4|NOT COMPLETED|Period 3||71
1464064|NCT01987960|3583414|P3|NOT COMPLETED|Period 3||0
1464065|NCT01987960|3583415|P2|NOT COMPLETED|Period 3||0
1464066|NCT01987960|3583416|P1|NOT COMPLETED|Period 3||0
1464067|NCT01987960|3583413|P4|COMPLETED|Period 3||119
1464068|NCT01987960|3583414|P3|COMPLETED|Period 3||0
1464069|NCT01987960|3583415|P2|COMPLETED|Period 3||0
1464070|NCT01987960|3583416|P1|COMPLETED|Period 3||0
1464071|NCT01987960|3583413|P4|STARTED|Period 3||190
1464072|NCT01987960|3583414|P3|STARTED|Period 3||0
1464073|NCT01987960|3583415|P2|STARTED|Period 3||0
1464074|NCT01987960|3583416|P1|STARTED|Period 3||0
1464075|NCT01987960|3583413|P4|NOT COMPLETED|Period 2||0
1464076|NCT01987960|3583414|P3|NOT COMPLETED|Period 2||9
1464077|NCT01987960|3583415|P2|NOT COMPLETED|Period 2||5
1464078|NCT01987960|3583416|P1|NOT COMPLETED|Period 2||0
1464079|NCT01987960|3583413|P4|COMPLETED|Period 2||0
1464080|NCT01987960|3583414|P3|COMPLETED|Period 2||14
1464081|NCT01987960|3583415|P2|COMPLETED|Period 2||12
1464082|NCT01987960|3583416|P1|COMPLETED|Period 2||0
1464083|NCT01987960|3583413|P4|STARTED|Period 2||0
1464084|NCT01987960|3583414|P3|STARTED|Period 2||23
1464085|NCT01987960|3583415|P2|STARTED|Period 2||17
1464086|NCT01987960|3583416|P1|STARTED|Period 2||0
1464087|NCT01987960|3583413|P4|NOT COMPLETED|Period 1||0
1464088|NCT01987960|3583414|P3|NOT COMPLETED|Period 1||0
1464089|NCT01987960|3583415|P2|NOT COMPLETED|Period 1||0
1464090|NCT01987960|3583416|P1|NOT COMPLETED|Period 1||186
1464091|NCT01987960|3583413|P4|COMPLETED|Period 1||0
1464092|NCT01987960|3583414|P3|COMPLETED|Period 1||0
1464093|NCT01987960|3583415|P2|COMPLETED|Period 1||0
1464094|NCT01987960|3583416|P1|COMPLETED|Period 1||231
1464095|NCT01987960|3583413|P4|STARTED|Period 1||0
1464096|NCT01987960|3583414|P3|STARTED|Period 1||0
1464097|NCT01987960|3583415|P2|STARTED|Period 1||0
1464098|NCT01987960|3583416|P1|STARTED|Period 1||417
1464099|NCT01987908|3583428|P3|NOT COMPLETED|Post-Treatment Observation Period||0
1464100|NCT01987908|3583429|P2|NOT COMPLETED|Post-Treatment Observation Period||3
1464101|NCT01987908|3583430|P1|NOT COMPLETED|Post-Treatment Observation Period||0
1464102|NCT01987908|3583428|P3|COMPLETED|Post-Treatment Observation Period||2
1464103|NCT01987908|3583429|P2|COMPLETED|Post-Treatment Observation Period||7
1464104|NCT01987908|3583430|P1|COMPLETED|Post-Treatment Observation Period||0
1464105|NCT01987908|3583428|P3|STARTED|Post-Treatment Observation Period||2
1464106|NCT01987908|3583429|P2|STARTED|Post-Treatment Observation Period||10
1464107|NCT01987908|3583430|P1|STARTED|Post-Treatment Observation Period||0
1464108|NCT01987908|3583428|P3|NOT COMPLETED|Treatment Period||1
1464109|NCT01987908|3583429|P2|NOT COMPLETED|Treatment Period||1
1464110|NCT01987908|3583430|P1|NOT COMPLETED|Treatment Period||0
1464111|NCT01987908|3583428|P3|COMPLETED|Treatment Period||2
1464112|NCT01987908|3583429|P2|COMPLETED|Treatment Period||10
1464113|NCT01987908|3583430|P1|COMPLETED|Treatment Period||0
1464114|NCT01987908|3583428|P3|STARTED|Treatment Period||3
1464115|NCT01987908|3583429|P2|STARTED|Treatment Period||11
1464116|NCT01987908|3583430|P1|STARTED|Treatment Period||0
1464117|NCT01987908|3583428|P3|NOT COMPLETED|Placebo Lead-in Period||0
1464118|NCT01987908|3583429|P2|NOT COMPLETED|Placebo Lead-in Period||0
1464119|NCT01987908|3583430|P1|NOT COMPLETED|Placebo Lead-in Period||9
1464120|NCT01987908|3583428|P3|COMPLETED|Placebo Lead-in Period||0
1464121|NCT01987908|3583429|P2|COMPLETED|Placebo Lead-in Period||0
1464122|NCT01987908|3583430|P1|COMPLETED|Placebo Lead-in Period||14
1464123|NCT01987908|3583428|P3|STARTED|Placebo Lead-in Period||0
1464124|NCT01987908|3583429|P2|STARTED|Placebo Lead-in Period||0
1464125|NCT01987908|3583430|P1|STARTED|Placebo Lead-in Period||23
1464126|NCT01987895|3583513|P2|NOT COMPLETED|Overall Study||30
1464127|NCT01987895|3583514|P1|NOT COMPLETED|Overall Study||30
1464128|NCT01987895|3583513|P2|COMPLETED|Overall Study||296
1464129|NCT01987895|3583514|P1|COMPLETED|Overall Study||276
1464130|NCT01987895|3583513|P2|STARTED|Overall Study||326
1464131|NCT01987895|3583514|P1|STARTED|Overall Study||306
1464132|NCT01987765|3583538|P1|NOT COMPLETED|Overall Study||102
1464133|NCT01987765|3583538|P1|COMPLETED|Overall Study||745
1464134|NCT01987765|3583538|P1|STARTED|Overall Study||847
1464135|NCT01987752|3583543|P1|NOT COMPLETED|Overall Study||0
1464136|NCT01987752|3583543|P1|COMPLETED|Overall Study||732
1464137|NCT01987752|3583543|P1|STARTED|Overall Study||732
1464138|NCT01987583|3583550|P2|NOT COMPLETED|Overall Study||2
1464139|NCT01987583|3583551|P1|NOT COMPLETED|Overall Study||3
1464140|NCT01987583|3583550|P2|COMPLETED|Overall Study||38
1464141|NCT01987583|3583551|P1|COMPLETED|Overall Study||37
1464142|NCT01987583|3583550|P2|STARTED|Overall Study||40
1464143|NCT01987583|3583551|P1|STARTED|Overall Study||40
1464144|NCT01987557|3583562|P3|NOT COMPLETED|Overall Study||3
1464145|NCT01987557|3583563|P2|NOT COMPLETED|Overall Study||3
1464146|NCT01987557|3583564|P1|NOT COMPLETED|Overall Study||3
1464147|NCT01987557|3583562|P3|COMPLETED|Overall Study||13
1464148|NCT01987557|3583563|P2|COMPLETED|Overall Study||13
1464149|NCT01987557|3583564|P1|COMPLETED|Overall Study||13
1464150|NCT01987557|3583562|P3|STARTED|Overall Study||16
1464151|NCT01987557|3583563|P2|STARTED|Overall Study||16
1464152|NCT01987557|3583564|P1|STARTED|Overall Study||16
1464153|NCT01987505|3583574|P1|NOT COMPLETED|Overall Study||34
1464154|NCT01987505|3583574|P1|COMPLETED|Overall Study||106
1464155|NCT01987505|3583574|P1|STARTED|Overall Study||140
1464156|NCT01987479|3583604|P1|NOT COMPLETED|Overall Study||17
1464157|NCT01987479|3583604|P1|COMPLETED|Overall Study||133
1464158|NCT01987479|3583604|P1|STARTED|Overall Study||150
1464159|NCT01987453|3583632|P3|NOT COMPLETED|Overall Study||1
1464160|NCT01987453|3583633|P2|NOT COMPLETED|Overall Study||12
1464161|NCT01987453|3583634|P1|NOT COMPLETED|Overall Study||1
1464162|NCT01987453|3583632|P3|COMPLETED|Overall Study||7
1464163|NCT01987453|3583633|P2|COMPLETED|Overall Study||29
1464164|NCT01987453|3583634|P1|COMPLETED|Overall Study||50
1464165|NCT01987453|3583632|P3|STARTED|Overall Study||8
1464166|NCT01987453|3583633|P2|STARTED|Overall Study||41
1464167|NCT01987453|3583634|P1|STARTED|Overall Study||51
1464168|NCT01987401|3583660|P3|NOT COMPLETED|Overall Study||44
1464169|NCT01987401|3583661|P2|NOT COMPLETED|Overall Study||470
1464170|NCT01987401|3583662|P1|NOT COMPLETED|Overall Study||454
1464171|NCT01987401|3583660|P3|COMPLETED|Overall Study||16
1464172|NCT01987401|3583661|P2|COMPLETED|Overall Study||121
1464173|NCT01987401|3583662|P1|COMPLETED|Overall Study||137
1464174|NCT01987401|3583660|P3|STARTED|Overall Study||60
1464175|NCT01987401|3583661|P2|STARTED|Overall Study||591
1464176|NCT01987401|3583662|P1|STARTED|Overall Study||591
1464177|NCT01987349|3583678|P8|NOT COMPLETED|Overall Study||1
1464178|NCT01987349|3583679|P7|NOT COMPLETED|Overall Study||0
1464179|NCT01987349|3583680|P6|NOT COMPLETED|Overall Study||0
1464180|NCT01987349|3583681|P5|NOT COMPLETED|Overall Study||0
1464181|NCT01987349|3583682|P4|NOT COMPLETED|Overall Study||0
1464182|NCT01987349|3583683|P3|NOT COMPLETED|Overall Study||0
1464183|NCT01987349|3583684|P2|NOT COMPLETED|Overall Study||0
1464184|NCT01987349|3583685|P1|NOT COMPLETED|Overall Study||0
1464185|NCT01987349|3583678|P8|COMPLETED|Overall Study||24
1464186|NCT01987349|3583679|P7|COMPLETED|Overall Study||10
1464187|NCT01987349|3583680|P6|COMPLETED|Overall Study||6
1464188|NCT01987349|3583681|P5|COMPLETED|Overall Study||6
1464189|NCT01987349|3583682|P4|COMPLETED|Overall Study||6
1464190|NCT01987349|3583683|P3|COMPLETED|Overall Study||8
1464191|NCT01987349|3583684|P2|COMPLETED|Overall Study||6
1464192|NCT01987349|3583685|P1|COMPLETED|Overall Study||6
1464193|NCT01987349|3583678|P8|STARTED|Overall Study||25
1464194|NCT01987349|3583679|P7|STARTED|Overall Study||10
1464195|NCT01987349|3583680|P6|STARTED|Overall Study||6
1464196|NCT01987349|3583681|P5|STARTED|Overall Study||6
1464197|NCT01987349|3583682|P4|STARTED|Overall Study||6
1464198|NCT01987349|3583683|P3|STARTED|Overall Study||8
1464199|NCT01987349|3583684|P2|STARTED|Overall Study||6
1464200|NCT01987349|3583685|P1|STARTED|Overall Study||6
1464201|NCT01987232|3583716|P5|NOT COMPLETED|Overall Study||0
1464202|NCT01987232|3583717|P4|NOT COMPLETED|Overall Study||1
1464203|NCT01987232|3583718|P3|NOT COMPLETED|Overall Study||0
1464204|NCT01987232|3583719|P2|NOT COMPLETED|Overall Study||0
1464205|NCT01987232|3583720|P1|NOT COMPLETED|Overall Study||0
1464206|NCT01987232|3583716|P5|COMPLETED|Overall Study||6
1464207|NCT01987232|3583717|P4|COMPLETED|Overall Study||14
1464208|NCT01987232|3583718|P3|COMPLETED|Overall Study||3
1464209|NCT01987232|3583719|P2|COMPLETED|Overall Study||3
1464210|NCT01987232|3583720|P1|COMPLETED|Overall Study||5
1464211|NCT01987232|3583716|P5|STARTED|Overall Study||6
1464212|NCT01987232|3583717|P4|STARTED|Overall Study||15
1464213|NCT01987232|3583718|P3|STARTED|Overall Study||3
1464214|NCT01987232|3583719|P2|STARTED|Overall Study||3
1464215|NCT01987232|3583720|P1|STARTED|Overall Study||5
1464216|NCT01987219|3583785|P6|NOT COMPLETED|Overall Study||0
1464217|NCT01987219|3583786|P5|NOT COMPLETED|Overall Study||0
1464218|NCT01987219|3583787|P4|NOT COMPLETED|Overall Study||0
1464219|NCT01987219|3583788|P3|NOT COMPLETED|Overall Study||1
1464220|NCT01987219|3583789|P2|NOT COMPLETED|Overall Study||0
1464221|NCT01987219|3583790|P1|NOT COMPLETED|Overall Study||0
1464222|NCT01987219|3583785|P6|COMPLETED|Overall Study||1
1464223|NCT01987219|3583786|P5|COMPLETED|Overall Study||1
1464224|NCT01987219|3583787|P4|COMPLETED|Overall Study||2
1464225|NCT01987219|3583788|P3|COMPLETED|Overall Study||6
1464226|NCT01987219|3583789|P2|COMPLETED|Overall Study||2
1464227|NCT01987219|3583790|P1|COMPLETED|Overall Study||2
1464228|NCT01987219|3583785|P6|STARTED|Overall Study||1
1464229|NCT01987219|3583786|P5|STARTED|Overall Study||1
1464230|NCT01987219|3583787|P4|STARTED|Overall Study||2
1464231|NCT01987219|3583788|P3|STARTED|Overall Study||7
1464232|NCT01987219|3583789|P2|STARTED|Overall Study||2
1464233|NCT01987219|3583790|P1|STARTED|Overall Study||2
1464234|NCT01986985|3583807|P1|NOT COMPLETED|Overall Study||7
1464235|NCT01986985|3583807|P1|COMPLETED|Overall Study||51
1464236|NCT01986985|3583807|P1|STARTED|Overall Study||58
1464237|NCT01986946|3583813|P2|NOT COMPLETED|Overall Study||0
1464238|NCT01986946|3583814|P1|NOT COMPLETED|Overall Study||0
1464239|NCT01986946|3583813|P2|COMPLETED|Overall Study||9
1464240|NCT01986946|3583814|P1|COMPLETED|Overall Study||5
1464241|NCT01986946|3583813|P2|STARTED|Overall Study||9
1464242|NCT01986946|3583814|P1|STARTED|Overall Study||5
1464243|NCT01986920|3583844|P4|NOT COMPLETED|Placebo||1
1464244|NCT01986920|3583845|P3|NOT COMPLETED|Placebo||0
1464245|NCT01986920|3583846|P2|NOT COMPLETED|Placebo||0
1464246|NCT01986920|3583847|P1|NOT COMPLETED|Placebo||0
1464247|NCT01986920|3583844|P4|COMPLETED|Placebo||34
1464248|NCT01986920|3583845|P3|COMPLETED|Placebo||0
1464249|NCT01986920|3583846|P2|COMPLETED|Placebo||0
1464250|NCT01986920|3583847|P1|COMPLETED|Placebo||0
1464251|NCT01986920|3583844|P4|STARTED|Placebo||35
1464252|NCT01986920|3583845|P3|STARTED|Placebo||0
1464253|NCT01986920|3583846|P2|STARTED|Placebo||0
1464254|NCT01986920|3583847|P1|STARTED|Placebo||0
1464255|NCT01986920|3583844|P4|NOT COMPLETED|A-101 40%||0
1464256|NCT01986920|3583845|P3|NOT COMPLETED|A-101 40%||1
1464257|NCT01986920|3583846|P2|NOT COMPLETED|A-101 40%||0
1464258|NCT01986920|3583847|P1|NOT COMPLETED|A-101 40%||0
1464259|NCT01986920|3583844|P4|COMPLETED|A-101 40%||0
1464260|NCT01986920|3583845|P3|COMPLETED|A-101 40%||34
1464261|NCT01986920|3583846|P2|COMPLETED|A-101 40%||0
1464262|NCT01986920|3583847|P1|COMPLETED|A-101 40%||0
1464263|NCT01986920|3583844|P4|STARTED|A-101 40%||0
1464264|NCT01986920|3583845|P3|STARTED|A-101 40%||35
1464265|NCT01986920|3583846|P2|STARTED|A-101 40%||0
1464266|NCT01986920|3583847|P1|STARTED|A-101 40%||0
1464267|NCT01986920|3583844|P4|NOT COMPLETED|A-101 32.5%||0
1464268|NCT01986920|3583845|P3|NOT COMPLETED|A-101 32.5%||0
1464269|NCT01986920|3583846|P2|NOT COMPLETED|A-101 32.5%||1
1464270|NCT01986920|3583847|P1|NOT COMPLETED|A-101 32.5%||0
1464271|NCT01986920|3583844|P4|COMPLETED|A-101 32.5%||0
1464272|NCT01986920|3583845|P3|COMPLETED|A-101 32.5%||0
1464273|NCT01986920|3583846|P2|COMPLETED|A-101 32.5%||34
1464274|NCT01986920|3583847|P1|COMPLETED|A-101 32.5%||0
1464275|NCT01986920|3583844|P4|STARTED|A-101 32.5%||0
1464276|NCT01986920|3583845|P3|STARTED|A-101 32.5%||0
1464277|NCT01986920|3583846|P2|STARTED|A-101 32.5%||35
1464278|NCT01986920|3583847|P1|STARTED|A-101 32.5%||0
1464279|NCT01986920|3583844|P4|NOT COMPLETED|A- 101 25%||0
1464280|NCT01986920|3583845|P3|NOT COMPLETED|A- 101 25%||0
1464281|NCT01986920|3583846|P2|NOT COMPLETED|A- 101 25%||0
1464282|NCT01986920|3583847|P1|NOT COMPLETED|A- 101 25%||1
1464283|NCT01986920|3583844|P4|COMPLETED|A- 101 25%||0
1464284|NCT01986920|3583845|P3|COMPLETED|A- 101 25%||0
1464285|NCT01986920|3583846|P2|COMPLETED|A- 101 25%||0
1464286|NCT01986920|3583847|P1|COMPLETED|A- 101 25%||34
1464287|NCT01986920|3583844|P4|STARTED|A- 101 25%||0
1464288|NCT01986920|3583845|P3|STARTED|A- 101 25%||0
1464289|NCT01986920|3583846|P2|STARTED|A- 101 25%||0
1464290|NCT01986920|3583847|P1|STARTED|A- 101 25%||35
1464291|NCT01986855|3583864|P3|NOT COMPLETED|Overall Study||11
1464292|NCT01986855|3583865|P2|NOT COMPLETED|Overall Study||14
1464293|NCT01986855|3583866|P1|NOT COMPLETED|Overall Study||13
1464294|NCT01986855|3583864|P3|COMPLETED|Overall Study||143
1464295|NCT01986855|3583865|P2|COMPLETED|Overall Study||142
1464296|NCT01986855|3583866|P1|COMPLETED|Overall Study||145
1464297|NCT01986855|3583864|P3|Treated|Overall Study||154
1464298|NCT01986855|3583865|P2|Treated|Overall Study||155
1464299|NCT01986855|3583866|P1|Treated|Overall Study||158
1464300|NCT01986855|3583864|P3|STARTED|Overall Study||154
1464301|NCT01986855|3583865|P2|STARTED|Overall Study||156
1464302|NCT01986855|3583866|P1|STARTED|Overall Study||158
1464303|NCT01986829|3583895|P1|NOT COMPLETED|Overall Study||1
1464304|NCT01986829|3583895|P1|COMPLETED|Overall Study||8
1464305|NCT01986829|3583895|P1|STARTED|Overall Study||9
1464306|NCT01986790|3583925|P3|NOT COMPLETED|Overall Study||0
1464307|NCT01986790|3583926|P2|NOT COMPLETED|Overall Study||0
1464308|NCT01986790|3583927|P1|NOT COMPLETED|Overall Study||0
1464309|NCT01986790|3583925|P3|COMPLETED|Overall Study||98
1464310|NCT01986790|3583926|P2|COMPLETED|Overall Study||154
1464311|NCT01986790|3583927|P1|COMPLETED|Overall Study||91
1464312|NCT01986790|3583925|P3|STARTED|Overall Study||98
1464313|NCT01986790|3583926|P2|STARTED|Overall Study||154
1464314|NCT01986790|3583927|P1|STARTED|Overall Study||91
1464315|NCT01986751|3583943|P2|NOT COMPLETED|Overall Study||2
1464316|NCT01986751|3583944|P1|NOT COMPLETED|Overall Study||10
1464317|NCT01986751|3583943|P2|COMPLETED|Overall Study||2
1464318|NCT01986751|3583944|P1|COMPLETED|Overall Study||0
1464319|NCT01986751|3583943|P2|STARTED|Overall Study||4
1464320|NCT01986751|3583944|P1|STARTED|Overall Study||10
1464321|NCT01986686|3583966|P2|NOT COMPLETED|Overall Study||0
1464322|NCT01986686|3583967|P1|NOT COMPLETED|Overall Study||0
1464323|NCT01986686|3583966|P2|COMPLETED|Overall Study||26
1464324|NCT01986686|3583967|P1|COMPLETED|Overall Study||81
1464325|NCT01986686|3583966|P2|STARTED|Overall Study||26
1464326|NCT01986686|3583967|P1|STARTED|Overall Study||81
1464327|NCT01986361|3583975|P2|NOT COMPLETED|Overall Study||0
1464328|NCT01986361|3583976|P1|NOT COMPLETED|Overall Study||0
1464329|NCT01986361|3583975|P2|COMPLETED|Overall Study||21
1464330|NCT01986361|3583976|P1|COMPLETED|Overall Study||101
1464331|NCT01986361|3583975|P2|STARTED|Overall Study||21
1464332|NCT01986361|3583976|P1|STARTED|Overall Study||101
1464333|NCT01986231|3583998|P1|NOT COMPLETED|Overall Study||1
1464334|NCT01986231|3583998|P1|COMPLETED|Overall Study||11
1464335|NCT01986231|3583998|P1|STARTED|Overall Study||12
1464336|NCT01986140|3584005|P2|NOT COMPLETED|Overall Study||28
1464337|NCT01986140|3584006|P1|NOT COMPLETED|Overall Study||35
1464338|NCT01986140|3584005|P2|COMPLETED|Overall Study||51
1464339|NCT01986140|3584006|P1|COMPLETED|Overall Study||122
1464340|NCT01986140|3584005|P2|STARTED|Overall Study||79
1464341|NCT01986140|3584006|P1|STARTED|Overall Study||157
1464342|NCT01986062|3584014|P2|NOT COMPLETED|Overall Study||1
1464343|NCT01986062|3584015|P1|NOT COMPLETED|Overall Study||1
1464344|NCT01986062|3584014|P2|COMPLETED|Overall Study||49
1464345|NCT01986062|3584015|P1|COMPLETED|Overall Study||46
1464346|NCT01986062|3584014|P2|STARTED|Overall Study||50
1464347|NCT01986062|3584015|P1|STARTED|Overall Study||47
1464348|NCT01985685|3584033|P2|NOT COMPLETED|Overall Study||0
1464349|NCT01985685|3584034|P1|NOT COMPLETED|Overall Study||0
1464350|NCT01985685|3584033|P2|COMPLETED|Overall Study||29
1464351|NCT01985685|3584034|P1|COMPLETED|Overall Study||27
1464352|NCT01985685|3584033|P2|STARTED|Overall Study||29
1464353|NCT01985685|3584034|P1|STARTED|Overall Study||27
1464354|NCT01985581|3584046|P2|NOT COMPLETED|Second Intervention||4
1464355|NCT01985581|3584047|P1|NOT COMPLETED|Second Intervention||2
1464356|NCT01985581|3584046|P2|COMPLETED|Second Intervention||19
1464357|NCT01985581|3584047|P1|COMPLETED|Second Intervention||20
1464358|NCT01985581|3584046|P2|STARTED|Second Intervention||23
1464359|NCT01985581|3584047|P1|STARTED|Second Intervention||22
1464360|NCT01985581|3584046|P2|NOT COMPLETED|First Intervention||2
1464361|NCT01985581|3584047|P1|NOT COMPLETED|First Intervention||3
1464362|NCT01985581|3584046|P2|COMPLETED|First Intervention||23
1464363|NCT01985581|3584047|P1|COMPLETED|First Intervention||22
1464364|NCT01985581|3584046|P2|STARTED|First Intervention||25
1464365|NCT01985581|3584047|P1|STARTED|First Intervention||25
1464366|NCT01985425|3584067|P2|NOT COMPLETED|Overall Study||0
1464367|NCT01985425|3584068|P1|NOT COMPLETED|Overall Study||0
1464368|NCT01985425|3584067|P2|COMPLETED|Overall Study||51
1464369|NCT01985425|3584068|P1|COMPLETED|Overall Study||49
1464370|NCT01985425|3584067|P2|STARTED|Overall Study||51
1464371|NCT01985425|3584068|P1|STARTED|Overall Study||49
1464372|NCT01985321|3584088|P2|NOT COMPLETED|Overall Study||5
1464373|NCT01985321|3584089|P1|NOT COMPLETED|Overall Study||11
1464374|NCT01985321|3584088|P2|COMPLETED|Overall Study||78
1464375|NCT01985321|3584089|P1|COMPLETED|Overall Study||79
1464376|NCT01985321|3584088|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
1464377|NCT01985321|3584089|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
1464378|NCT01985126|3584099|P2|NOT COMPLETED|Overall Study||106
1464379|NCT01985126|3584100|P1|NOT COMPLETED|Overall Study||18
1464380|NCT01985126|3584099|P2|COMPLETED|Overall Study||0
1464381|NCT01985126|3584100|P1|COMPLETED|Overall Study||0
1464382|NCT01985126|3584099|P2|STARTED|Overall Study||106
1464383|NCT01985126|3584100|P1|STARTED|Overall Study||18
1464384|NCT01984892|3584118|P1|NOT COMPLETED|Overall Study||7
1464385|NCT01984892|3584118|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
1464386|NCT01984892|3584118|P1|STARTED|Overall Study||8
1464387|NCT01984697|3584129|P5|NOT COMPLETED|Overall Study||35
1464388|NCT01984697|3584130|P4|NOT COMPLETED|Overall Study||21
1464389|NCT01984697|3584131|P3|NOT COMPLETED|Overall Study||29
1464390|NCT01984697|3584132|P2|NOT COMPLETED|Overall Study||31
1464391|NCT01984697|3584133|P1|NOT COMPLETED|Overall Study||43
1464392|NCT01984697|3584129|P5|COMPLETED|Overall Study||279
1464393|NCT01984697|3584130|P4|COMPLETED|Overall Study||280
1464394|NCT01984697|3584131|P3|COMPLETED|Overall Study||272
1464395|NCT01984697|3584132|P2|COMPLETED|Overall Study||270
1464396|NCT01984697|3584133|P1|COMPLETED|Overall Study||258
1464397|NCT01984697|3584129|P5|Month 36 Vaccination|Overall Study||31
1464398|NCT01984697|3584130|P4|Month 36 Vaccination|Overall Study||9
1464399|NCT01984697|3584131|P3|Month 36 Vaccination|Overall Study||280
1464400|NCT01984697|3584132|P2|Month 36 Vaccination|Overall Study||281
1464401|NCT01984697|3584133|P1|Month 36 Vaccination|Overall Study||270
1464402|NCT01984697|3584129|P5|Vaccination 3|Overall Study||311
1464403|NCT01984697|3584130|P4|Vaccination 3|Overall Study||293
1464404|NCT01984697|3584131|P3|Vaccination 3|Overall Study||0
1464405|NCT01984697|3584132|P2|Vaccination 3|Overall Study||0
1464406|NCT01984697|3584133|P1|Vaccination 3|Overall Study||0
1464407|NCT01984697|3584129|P5|Vaccination 2|Overall Study||313
1464408|NCT01984697|3584130|P4|Vaccination 2|Overall Study||298
1464409|NCT01984697|3584131|P3|Vaccination 2|Overall Study||291
1464410|NCT01984697|3584132|P2|Vaccination 2|Overall Study||296
1464411|NCT01984697|3584133|P1|Vaccination 2|Overall Study||293
1464412|NCT01984697|3584129|P5|Vaccination 1|Overall Study||314
1464413|NCT01984697|3584130|P4|Vaccination 1|Overall Study||300
1464414|NCT01984697|3584131|P3|Vaccination 1|Overall Study||300
1464415|NCT01984697|3584132|P2|Vaccination 1|Overall Study||301
1464416|NCT01984697|3584133|P1|Vaccination 1|Overall Study||301
1464417|NCT01984697|3584129|P5|STARTED|Overall Study||314
1464418|NCT01984697|3584130|P4|STARTED|Overall Study||301
1464419|NCT01984697|3584131|P3|STARTED|Overall Study||301
1464420|NCT01984697|3584132|P2|STARTED|Overall Study||301
1464421|NCT01984697|3584133|P1|STARTED|Overall Study||301
1464422|NCT01984684|3584252|P2|NOT COMPLETED|Overall Study||59
1464423|NCT01984684|3584253|P1|NOT COMPLETED|Overall Study||57
1464424|NCT01984684|3584252|P2|COMPLETED|Overall Study||368
1464425|NCT01984684|3584253|P1|COMPLETED|Overall Study||366
1464426|NCT01984684|3584252|P2|STARTED|Overall Study||427
1464427|NCT01984684|3584253|P1|STARTED|Overall Study||423
1464428|NCT01984515|3584263|P1|NOT COMPLETED|Overall Study||19
1464429|NCT01984515|3584263|P1|COMPLETED|Overall Study||40
1464430|NCT01984515|3584263|P1|Received CBT Session|Overall Study||40
1464431|NCT01984515|3584263|P1|STARTED|Overall Study||59
1464432|NCT01984424|3584271|P2|NOT COMPLETED|Overall Study||7
1464433|NCT01984424|3584272|P1|NOT COMPLETED|Overall Study||3
1464434|NCT01984424|3584271|P2|COMPLETED|Overall Study||138
1464435|NCT01984424|3584272|P1|COMPLETED|Overall Study||70
1464436|NCT01984424|3584271|P2|STARTED|Overall Study||145
1464437|NCT01984424|3584272|P1|STARTED|Overall Study||73
1464438|NCT01984294|3584327|P3|NOT COMPLETED|Overall Study||7
1464439|NCT01984294|3584328|P2|NOT COMPLETED|Overall Study||3
1464440|NCT01984294|3584329|P1|NOT COMPLETED|Overall Study||4
1464441|NCT01984294|3584327|P3|COMPLETED|Overall Study||27
1464442|NCT01984294|3584328|P2|COMPLETED|Overall Study||29
1464443|NCT01984294|3584329|P1|COMPLETED|Overall Study||31
1464444|NCT01984294|3584327|P3|STARTED|Overall Study||34
1464445|NCT01984294|3584328|P2|STARTED|Overall Study||32
1464446|NCT01984294|3584329|P1|STARTED|Overall Study||35
1464447|NCT01984242|3584352|P3|NOT COMPLETED|Overall Study||101
1464448|NCT01984242|3584353|P2|NOT COMPLETED|Overall Study||103
1464449|NCT01984242|3584354|P1|NOT COMPLETED|Overall Study||101
1464450|NCT01984242|3584352|P3|COMPLETED|Overall Study||0
1464451|NCT01984242|3584353|P2|COMPLETED|Overall Study||0
1464452|NCT01984242|3584354|P1|COMPLETED|Overall Study||0
1464453|NCT01984242|3584352|P3|Crossover Population|Overall Study||57
1464454|NCT01984242|3584353|P2|Crossover Population|Overall Study||44
1464455|NCT01984242|3584354|P1|Crossover Population|Overall Study||0
1464456|NCT01984242|3584352|P3|Treated|Overall Study||100
1464457|NCT01984242|3584353|P2|Treated|Overall Study||103
1464458|NCT01984242|3584354|P1|Treated|Overall Study||101
1464459|NCT01984242|3584352|P3|STARTED|Overall Study||101
1464460|NCT01984242|3584353|P2|STARTED|Overall Study||103
1464461|NCT01984242|3584354|P1|STARTED|Overall Study||101
1464462|NCT01984229|3584504|P2|NOT COMPLETED|Safety Follow-up Period||1
1464463|NCT01984229|3584505|P1|NOT COMPLETED|Safety Follow-up Period||2
1464464|NCT01984229|3584504|P2|COMPLETED|Safety Follow-up Period||16
1464465|NCT01984229|3584505|P1|COMPLETED|Safety Follow-up Period||4
1464466|NCT01984229|3584504|P2|STARTED|Safety Follow-up Period||17
1464467|NCT01984229|3584505|P1|STARTED|Safety Follow-up Period||6
1464468|NCT01984229|3584504|P2|NOT COMPLETED|Period 3||0
1464469|NCT01984229|3584505|P1|NOT COMPLETED|Period 3||0
1464470|NCT01984229|3584504|P2|COMPLETED|Period 3||17
1464471|NCT01984229|3584505|P1|COMPLETED|Period 3||6
1464472|NCT01984229|3584504|P2|STARTED|Period 3||17
1464473|NCT01984229|3584505|P1|STARTED|Period 3||6
1464474|NCT01984229|3584504|P2|NOT COMPLETED|Period 2||0
1464475|NCT01984229|3584505|P1|NOT COMPLETED|Period 2||0
1464476|NCT01984229|3584504|P2|COMPLETED|Period 2||17
1464477|NCT01984229|3584505|P1|COMPLETED|Period 2||6
1464478|NCT01984229|3584504|P2|STARTED|Period 2||17
1464479|NCT01984229|3584505|P1|STARTED|Period 2||6
1464480|NCT01984229|3584504|P2|NOT COMPLETED|Period 1||0
1464481|NCT01984229|3584505|P1|NOT COMPLETED|Period 1||0
1464482|NCT01984229|3584504|P2|COMPLETED|Period 1||17
1464483|NCT01984229|3584505|P1|COMPLETED|Period 1||6
1464484|NCT01984229|3584504|P2|STARTED|Period 1||17
1464485|NCT01984229|3584505|P1|STARTED|Period 1||6
1464486|NCT01983930|3584557|P2|NOT COMPLETED|Overall Study||9
1464487|NCT01983930|3584558|P1|NOT COMPLETED|Overall Study||9
1464488|NCT01983930|3584557|P2|COMPLETED|Overall Study||29
1464489|NCT01983930|3584558|P1|COMPLETED|Overall Study||32
1464490|NCT01983930|3584557|P2|STARTED|Overall Study||38
1464491|NCT01983930|3584558|P1|STARTED|Overall Study||41
1464492|NCT01983878|3584570|P1|NOT COMPLETED|Overall Study||0
1464493|NCT01983878|3584570|P1|COMPLETED|Overall Study||36
1464494|NCT01983878|3584570|P1|Received At Least One Dose of Study Drug|Overall Study||36
1464495|NCT01983878|3584570|P1|STARTED|Overall Study||36
1464496|NCT01983839|3584581|P1|NOT COMPLETED|Overall Study||0
1464497|NCT01983839|3584581|P1|COMPLETED|Overall Study||18
1464498|NCT01983839|3584581|P1|STARTED|Overall Study||18
1464499|NCT01983787|3584586|P1|NOT COMPLETED|Overall Study||0
1464500|NCT01983787|3584586|P1|COMPLETED|Overall Study||10
1464501|NCT01983787|3584586|P1|STARTED|Overall Study||10
1464502|NCT01983683|3584611|P2|NOT COMPLETED|Overall Study||51
1464503|NCT01983683|3584612|P1|NOT COMPLETED|Overall Study||38
1464504|NCT01983683|3584611|P2|COMPLETED|Overall Study||260
1464505|NCT01983683|3584612|P1|COMPLETED|Overall Study||260
1464506|NCT01983683|3584611|P2|STARTED|Overall Study||311
1464507|NCT01983683|3584612|P1|STARTED|Overall Study||298
1464508|NCT01983566|3584640|P4|NOT COMPLETED|Test Period 4||0
1464509|NCT01983566|3584641|P3|NOT COMPLETED|Test Period 4||0
1464510|NCT01983566|3584642|P2|NOT COMPLETED|Test Period 4||0
1464511|NCT01983566|3584643|P1|NOT COMPLETED|Test Period 4||0
1464512|NCT01983566|3584640|P4|COMPLETED|Test Period 4||0
1464513|NCT01983566|3584641|P3|COMPLETED|Test Period 4||0
1464514|NCT01983566|3584642|P2|COMPLETED|Test Period 4||0
1464515|NCT01983566|3584643|P1|COMPLETED|Test Period 4||0
1464516|NCT01983566|3584640|P4|STARTED|Test Period 4||0
1464517|NCT01983566|3584641|P3|STARTED|Test Period 4||0
1464518|NCT01983566|3584642|P2|STARTED|Test Period 4||0
1464519|NCT01983566|3584643|P1|STARTED|Test Period 4||0
1464520|NCT01983566|3584640|P4|NOT COMPLETED|Wash-Out 3||0
1464521|NCT01983566|3584641|P3|NOT COMPLETED|Wash-Out 3||0
1464522|NCT01983566|3584642|P2|NOT COMPLETED|Wash-Out 3||0
1464523|NCT01983566|3584643|P1|NOT COMPLETED|Wash-Out 3||0
1464524|NCT01983566|3584640|P4|COMPLETED|Wash-Out 3||0
1464525|NCT01983566|3584641|P3|COMPLETED|Wash-Out 3||0
1464526|NCT01983566|3584642|P2|COMPLETED|Wash-Out 3||0
1464527|NCT01983566|3584643|P1|COMPLETED|Wash-Out 3||0
1464528|NCT01983566|3584640|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
1464529|NCT01983566|3584641|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
1464530|NCT01983566|3584642|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
1464531|NCT01983566|3584643|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
1464532|NCT01983566|3584640|P4|NOT COMPLETED|Test Period 3||0
1464533|NCT01983566|3584641|P3|NOT COMPLETED|Test Period 3||0
1464534|NCT01983566|3584642|P2|NOT COMPLETED|Test Period 3||0
1464535|NCT01983566|3584643|P1|NOT COMPLETED|Test Period 3||0
1464536|NCT01983566|3584640|P4|COMPLETED|Test Period 3||4
1464537|NCT01983566|3584641|P3|COMPLETED|Test Period 3||2
1464538|NCT01983566|3584642|P2|COMPLETED|Test Period 3||3
1464539|NCT01983566|3584643|P1|COMPLETED|Test Period 3||2
1464540|NCT01983566|3584640|P4|STARTED|Test Period 3||4
1464541|NCT01983566|3584641|P3|STARTED|Test Period 3||2
1464542|NCT01983566|3584642|P2|STARTED|Test Period 3||3
1464543|NCT01983566|3584643|P1|STARTED|Test Period 3||2
1464544|NCT01983566|3584640|P4|NOT COMPLETED|Wash-Out 2||0
1464545|NCT01983566|3584641|P3|NOT COMPLETED|Wash-Out 2||0
1464546|NCT01983566|3584642|P2|NOT COMPLETED|Wash-Out 2||0
1464547|NCT01983566|3584643|P1|NOT COMPLETED|Wash-Out 2||0
1464548|NCT01983566|3584640|P4|COMPLETED|Wash-Out 2||4
1464549|NCT01983566|3584641|P3|COMPLETED|Wash-Out 2||2
1464550|NCT01983566|3584642|P2|COMPLETED|Wash-Out 2||3
1464551|NCT01983566|3584643|P1|COMPLETED|Wash-Out 2||2
1464552|NCT01983566|3584640|P4|STARTED|Wash-Out 2||4
1464553|NCT01983566|3584641|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
1464554|NCT01983566|3584642|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
1464555|NCT01983566|3584643|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
1464556|NCT01983566|3584640|P4|NOT COMPLETED|Test Period 2||0
1464557|NCT01983566|3584641|P3|NOT COMPLETED|Test Period 2||0
1464558|NCT01983566|3584642|P2|NOT COMPLETED|Test Period 2||0
1464559|NCT01983566|3584643|P1|NOT COMPLETED|Test Period 2||0
1464560|NCT01983566|3584640|P4|COMPLETED|Test Period 2||4
1464561|NCT01983566|3584641|P3|COMPLETED|Test Period 2||4
1464562|NCT01983566|3584642|P2|COMPLETED|Test Period 2||4
1464563|NCT01983566|3584643|P1|COMPLETED|Test Period 2||4
1464564|NCT01983566|3584640|P4|STARTED|Test Period 2||4
1464565|NCT01983566|3584641|P3|STARTED|Test Period 2||4
1464566|NCT01983566|3584642|P2|STARTED|Test Period 2||4
1464567|NCT01983566|3584643|P1|STARTED|Test Period 2||4
1464568|NCT01983566|3584640|P4|NOT COMPLETED|Wash-Out 1||0
1464569|NCT01983566|3584641|P3|NOT COMPLETED|Wash-Out 1||0
1464570|NCT01983566|3584642|P2|NOT COMPLETED|Wash-Out 1||0
1464571|NCT01983566|3584643|P1|NOT COMPLETED|Wash-Out 1||0
1464572|NCT01983566|3584640|P4|COMPLETED|Wash-Out 1||4
1464573|NCT01983566|3584641|P3|COMPLETED|Wash-Out 1||4
1464574|NCT01983566|3584642|P2|COMPLETED|Wash-Out 1||4
1464575|NCT01983566|3584643|P1|COMPLETED|Wash-Out 1||4
1464576|NCT01983566|3584640|P4|STARTED|Wash-Out 1||4
1464577|NCT01983566|3584641|P3|STARTED|Wash-Out 1||4
1464578|NCT01983566|3584642|P2|STARTED|Wash-Out 1||4
1464579|NCT01983566|3584643|P1|STARTED|Wash-Out 1||4
1464580|NCT01983566|3584640|P4|NOT COMPLETED|Test Period 1||0
1464581|NCT01983566|3584641|P3|NOT COMPLETED|Test Period 1||0
1464582|NCT01983566|3584642|P2|NOT COMPLETED|Test Period 1||0
1464583|NCT01983566|3584643|P1|NOT COMPLETED|Test Period 1||0
1464584|NCT01983566|3584640|P4|COMPLETED|Test Period 1||4
1464585|NCT01983566|3584641|P3|COMPLETED|Test Period 1||4
1464586|NCT01983566|3584642|P2|COMPLETED|Test Period 1||4
1464587|NCT01983566|3584643|P1|COMPLETED|Test Period 1||4
1464588|NCT01983566|3584640|P4|STARTED|Test Period 1||4
1464589|NCT01983566|3584641|P3|STARTED|Test Period 1||4
1464590|NCT01983566|3584642|P2|STARTED|Test Period 1||4
1464591|NCT01983566|3584643|P1|STARTED|Test Period 1||4
1464592|NCT01983254|3584664|P2|NOT COMPLETED|Overall Study||30
1464593|NCT01983254|3584665|P1|NOT COMPLETED|Overall Study||34
1464594|NCT01983254|3584664|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
1464595|NCT01983254|3584665|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
1464596|NCT01983254|3584664|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
1464597|NCT01983254|3584665|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
1464598|NCT01983254|3584664|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
1464599|NCT01983254|3584665|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
1464600|NCT01983254|3584664|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
1464601|NCT01983254|3584665|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
1464602|NCT01983254|3584664|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
1464603|NCT01983254|3584665|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
1464604|NCT01983111|3584677|P2|NOT COMPLETED|Overall Study||7
1464605|NCT01983111|3584678|P1|NOT COMPLETED|Overall Study||12
1464606|NCT01983111|3584677|P2|COMPLETED|Overall Study||59
1464607|NCT01983111|3584678|P1|COMPLETED|Overall Study||58
1464608|NCT01983111|3584677|P2|STARTED|Overall Study||66
1464609|NCT01983111|3584678|P1|STARTED|Overall Study||70
1464610|NCT01983020|3584698|P4|NOT COMPLETED|Overall Study||0
1464611|NCT01983020|3584699|P3|NOT COMPLETED|Overall Study||0
1464612|NCT01983020|3584700|P2|NOT COMPLETED|Overall Study||0
1464613|NCT01983020|3584701|P1|NOT COMPLETED|Overall Study||0
1464614|NCT01983020|3584698|P4|COMPLETED|Overall Study||11
1464615|NCT01983020|3584699|P3|COMPLETED|Overall Study||12
1464616|NCT01983020|3584700|P2|COMPLETED|Overall Study||11
1464617|NCT01983020|3584701|P1|COMPLETED|Overall Study||12
1464618|NCT01983020|3584698|P4|STARTED|Overall Study||11
1464619|NCT01983020|3584699|P3|STARTED|Overall Study||12
1464620|NCT01983020|3584700|P2|STARTED|Overall Study||11
1464621|NCT01983020|3584701|P1|STARTED|Overall Study||12
1464622|NCT01982812|3584713|P2|NOT COMPLETED|Overall Study||10
1464623|NCT01982812|3584714|P1|NOT COMPLETED|Overall Study||1
1464624|NCT01982812|3584713|P2|COMPLETED|Overall Study||11
1464625|NCT01982812|3584714|P1|COMPLETED|Overall Study||22
1464626|NCT01982812|3584713|P2|STARTED|Overall Study||21
1464627|NCT01982812|3584714|P1|STARTED|Overall Study||23
1464628|NCT01982773|3584728|P2|NOT COMPLETED|Overall Study||4
1464629|NCT01982773|3584729|P1|NOT COMPLETED|Overall Study||8
1464630|NCT01982773|3584728|P2|COMPLETED|Overall Study||56
1464631|NCT01982773|3584729|P1|COMPLETED|Overall Study||50
1464632|NCT01982773|3584728|P2|STARTED|Overall Study||60
1464633|NCT01982773|3584729|P1|STARTED|Overall Study||58
1464634|NCT01982695|3584743|P2|NOT COMPLETED|Overall Study||1
1464635|NCT01982695|3584744|P1|NOT COMPLETED|Overall Study||0
1464636|NCT01982695|3584743|P2|COMPLETED|Overall Study||10
1464637|NCT01982695|3584744|P1|COMPLETED|Overall Study||12
1464638|NCT01982695|3584743|P2|STARTED|Overall Study||11
1464639|NCT01982695|3584744|P1|STARTED|Overall Study||12
1464640|NCT01982682|3584750|P1|NOT COMPLETED|Overall Study||1
1464641|NCT01982682|3584750|P1|COMPLETED|Overall Study||40
1464642|NCT01982682|3584750|P1|STARTED|Overall Study||41
1464643|NCT01982539|3584758|P1|NOT COMPLETED|Overall Study||0
1464644|NCT01982539|3584758|P1|COMPLETED|Overall Study||25
1464645|NCT01982539|3584758|P1|STARTED|Overall Study||25
1464646|NCT01982435|3584764|P2|NOT COMPLETED|Overall Study||0
1464647|NCT01982435|3584765|P1|NOT COMPLETED|Overall Study||1
1464648|NCT01982435|3584764|P2|COMPLETED|Overall Study||12
1464649|NCT01982435|3584765|P1|COMPLETED|Overall Study||14
1464650|NCT01982435|3584764|P2|STARTED|Overall Study||12
1464651|NCT01982435|3584765|P1|STARTED|Overall Study||15
1464652|NCT01982383|3584795|P2|NOT COMPLETED|Overall Study||0
1464653|NCT01982383|3584796|P1|NOT COMPLETED|Overall Study||0
1464654|NCT01982383|3584795|P2|COMPLETED|Overall Study||0
1464655|NCT01982383|3584796|P1|COMPLETED|Overall Study||2
1464656|NCT01982383|3584795|P2|STARTED|Overall Study||0
1464657|NCT01982383|3584796|P1|STARTED|Overall Study||2
1464658|NCT01982292|3584804|P2|NOT COMPLETED|Overall Study||1
1464659|NCT01982292|3584805|P1|NOT COMPLETED|Overall Study||12
1464660|NCT01982292|3584804|P2|COMPLETED|Overall Study||107
1464661|NCT01982292|3584805|P1|COMPLETED|Overall Study||203
1464662|NCT01982292|3584804|P2|Safety Set|Overall Study||108
1464663|NCT01982292|3584805|P1|Safety Set|Overall Study||212
1464664|NCT01982292|3584804|P2|Full Analaysis Set (FAS)|Overall Study||108
1464665|NCT01982292|3584805|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
1464666|NCT01982292|3584804|P2|STARTED|Overall Study||108
1464667|NCT01982292|3584805|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
1464668|NCT01982253|3584826|P3|NOT COMPLETED|Overall Study||4
1464669|NCT01982253|3584827|P2|NOT COMPLETED|Overall Study||4
1464670|NCT01982253|3584828|P1|NOT COMPLETED|Overall Study||2
1464671|NCT01982253|3584826|P3|COMPLETED|Overall Study||0
1464672|NCT01982253|3584827|P2|COMPLETED|Overall Study||0
1464673|NCT01982253|3584828|P1|COMPLETED|Overall Study||0
1464674|NCT01982253|3584826|P3|STARTED|Overall Study||4
1464675|NCT01982253|3584827|P2|STARTED|Overall Study||4
1464676|NCT01982253|3584828|P1|STARTED|Overall Study||2
1464677|NCT01982123|3584839|P1|NOT COMPLETED|Overall Study||0
1464678|NCT01982123|3584839|P1|COMPLETED|Overall Study||12
1464679|NCT01982123|3584839|P1|STARTED|Overall Study||12
1464680|NCT01981967|3584846|P2|NOT COMPLETED|Overall Study||0
1464681|NCT01981967|3584847|P1|NOT COMPLETED|Overall Study||0
1464682|NCT01981967|3584846|P2|COMPLETED|Overall Study||3149
1464683|NCT01981967|3584847|P1|COMPLETED|Overall Study||6851
1464684|NCT01981967|3584846|P2|STARTED|Overall Study||3149
1464685|NCT01981967|3584847|P1|STARTED|Overall Study||6851
1464686|NCT01981954|3584857|P1|NOT COMPLETED|Fixed-Dose Assessment Period||1
1464687|NCT01981954|3584857|P1|COMPLETED|Fixed-Dose Assessment Period||21
1464688|NCT01981954|3584857|P1|Treated|Fixed-Dose Assessment Period||22
1464689|NCT01981954|3584857|P1|STARTED|Fixed-Dose Assessment Period||22
1464690|NCT01981954|3584857|P1|NOT COMPLETED|Titration Period||1
1464691|NCT01981954|3584857|P1|COMPLETED|Titration Period||22
1464692|NCT01981954|3584857|P1|Treated|Titration Period||23
1464693|NCT01981954|3584857|P1|STARTED|Titration Period||23
1464694|NCT01981863|3584904|P2|NOT COMPLETED|Overall Study||0
1464695|NCT01981863|3584905|P1|NOT COMPLETED|Overall Study||0
1464696|NCT01981863|3584904|P2|COMPLETED|Overall Study||20
1464697|NCT01981863|3584905|P1|COMPLETED|Overall Study||20
1464698|NCT01981863|3584904|P2|STARTED|Overall Study||20
1464699|NCT01981863|3584905|P1|STARTED|Overall Study||20
1464700|NCT01981759|3584917|P2|NOT COMPLETED|Overall Study||11
1464701|NCT01981759|3584918|P1|NOT COMPLETED|Overall Study||7
1464702|NCT01981759|3584917|P2|COMPLETED|Overall Study||19
1464703|NCT01981759|3584918|P1|COMPLETED|Overall Study||21
1464704|NCT01981759|3584917|P2|Completed Week 12|Overall Study||22
1464705|NCT01981759|3584918|P1|Completed Week 12|Overall Study||22
1464706|NCT01981759|3584917|P2|Randomization (Week 3)|Overall Study||30
1464707|NCT01981759|3584918|P1|Randomization (Week 3)|Overall Study||28
1464708|NCT01981759|3584917|P2|Baseline (Week 1)|Overall Study||30
1464709|NCT01981759|3584918|P1|Baseline (Week 1)|Overall Study||28
1464710|NCT01981759|3584917|P2|STARTED|Overall Study||30
1464711|NCT01981759|3584918|P1|STARTED|Overall Study||28
1464712|NCT01981616|3584926|P2|NOT COMPLETED|Overall Study||1
1464713|NCT01981616|3584927|P1|NOT COMPLETED|Overall Study||1
1464714|NCT01981616|3584926|P2|COMPLETED|Overall Study||62
1464715|NCT01981616|3584927|P1|COMPLETED|Overall Study||63
1464716|NCT01981616|3584926|P2|STARTED|Overall Study||63
1464717|NCT01981616|3584927|P1|STARTED|Overall Study||64
1464718|NCT01981564|3584941|P2|NOT COMPLETED|Overall Study||9
1464719|NCT01981564|3584942|P1|NOT COMPLETED|Overall Study||9
1464720|NCT01981564|3584941|P2|COMPLETED|Overall Study||106
1464721|NCT01981564|3584942|P1|COMPLETED|Overall Study||98
1464722|NCT01981564|3584941|P2|STARTED|Overall Study||115
1464723|NCT01981564|3584942|P1|STARTED|Overall Study||107
1464724|NCT01981473|3584953|P3|NOT COMPLETED|Overall Study||8
1464725|NCT01981473|3584954|P2|NOT COMPLETED|Overall Study||0
1464726|NCT01981473|3584955|P1|NOT COMPLETED|Overall Study||2
1464727|NCT01981473|3584953|P3|COMPLETED|Overall Study||196
1464728|NCT01981473|3584954|P2|COMPLETED|Overall Study||199
1464729|NCT01981473|3584955|P1|COMPLETED|Overall Study||200
1464730|NCT01981473|3584953|P3|STARTED|Overall Study||204
1464731|NCT01981473|3584954|P2|STARTED|Overall Study||199
1464732|NCT01981473|3584955|P1|STARTED|Overall Study||202
1464733|NCT01981356|3584996|P2|NOT COMPLETED|Overall Study||2
1464734|NCT01981356|3584997|P1|NOT COMPLETED|Overall Study||7
1464735|NCT01981356|3584996|P2|COMPLETED|Overall Study||4
1464736|NCT01981356|3584997|P1|COMPLETED|Overall Study||5
1464737|NCT01981356|3584996|P2|STARTED|Overall Study||6
1464738|NCT01981356|3584997|P1|STARTED|Overall Study||12
1464739|NCT01981122|3585024|P2|NOT COMPLETED|Overall Study||20
1464740|NCT01981122|3585025|P1|NOT COMPLETED|Overall Study||14
1464741|NCT01981122|3585024|P2|COMPLETED|Overall Study||7
1464742|NCT01981122|3585025|P1|COMPLETED|Overall Study||11
1464743|NCT01981122|3585024|P2|STARTED|Overall Study||27
1464744|NCT01981122|3585025|P1|STARTED|Overall Study||25
1464745|NCT01981096|3585033|P2|NOT COMPLETED|Overall Study||1
1464746|NCT01981096|3585034|P1|NOT COMPLETED|Overall Study||3
1464747|NCT01981096|3585033|P2|COMPLETED|Overall Study||19
1464748|NCT01981096|3585034|P1|COMPLETED|Overall Study||17
1464749|NCT01981096|3585033|P2|Post-treatment|Overall Study||19
1464750|NCT01981096|3585034|P1|Post-treatment|Overall Study||17
1464751|NCT01981096|3585033|P2|STARTED|Overall Study||20
1464752|NCT01981096|3585034|P1|STARTED|Overall Study||20
1464753|NCT01981057|3585046|P2|NOT COMPLETED|Overall Study||0
1464754|NCT01981057|3585047|P1|NOT COMPLETED|Overall Study||0
1464755|NCT01981057|3585046|P2|COMPLETED|Overall Study||50
1464756|NCT01981057|3585047|P1|COMPLETED|Overall Study||50
1464757|NCT01981057|3585046|P2|STARTED|Overall Study||50
1464758|NCT01981057|3585047|P1|STARTED|Overall Study||50
1464759|NCT01980992|3585055|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
1464760|NCT01980992|3585056|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
1464761|NCT01980992|3585055|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
1464762|NCT01980992|3585056|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
1464763|NCT01980992|3585055|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
1464764|NCT01980992|3585056|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
1464765|NCT01980992|3585055|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
1464766|NCT01980992|3585056|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
1464767|NCT01980992|3585055|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
1464768|NCT01980992|3585056|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
1464769|NCT01980992|3585055|P2|STARTED|52 Weeks Blinded Study Treatment||23
1464770|NCT01980992|3585056|P1|STARTED|52 Weeks Blinded Study Treatment||23
1464771|NCT01980940|3585081|P8|NOT COMPLETED|Overall Study||0
1464772|NCT01980940|3585082|P7|NOT COMPLETED|Overall Study||0
1464773|NCT01980940|3585083|P6|NOT COMPLETED|Overall Study||2
1464774|NCT01980940|3585084|P5|NOT COMPLETED|Overall Study||0
1464775|NCT01980940|3585085|P4|NOT COMPLETED|Overall Study||0
1464776|NCT01980940|3585086|P3|NOT COMPLETED|Overall Study||0
1464777|NCT01980940|3585087|P2|NOT COMPLETED|Overall Study||0
1464778|NCT01980940|3585088|P1|NOT COMPLETED|Overall Study||0
1464779|NCT01980940|3585081|P8|COMPLETED|Overall Study||24
1464780|NCT01980940|3585082|P7|COMPLETED|Overall Study||24
1464781|NCT01980940|3585083|P6|COMPLETED|Overall Study||0
1464782|NCT01980940|3585084|P5|COMPLETED|Overall Study||2
1464783|NCT01980940|3585085|P4|COMPLETED|Overall Study||3
1464784|NCT01980940|3585086|P3|COMPLETED|Overall Study||5
1464785|NCT01980940|3585087|P2|COMPLETED|Overall Study||5
1464786|NCT01980940|3585088|P1|COMPLETED|Overall Study||5
1464787|NCT01980940|3585081|P8|Treated|Overall Study||24
1464788|NCT01980940|3585082|P7|Treated|Overall Study||24
1464789|NCT01980940|3585083|P6|Treated|Overall Study||2
1464790|NCT01980940|3585084|P5|Treated|Overall Study||2
1464791|NCT01980940|3585085|P4|Treated|Overall Study||3
1464792|NCT01980940|3585086|P3|Treated|Overall Study||5
1464793|NCT01980940|3585087|P2|Treated|Overall Study||5
1464794|NCT01980940|3585088|P1|Treated|Overall Study||5
1464795|NCT01980940|3585081|P8|STARTED|Overall Study||24
1464796|NCT01980940|3585082|P7|STARTED|Overall Study||24
1464797|NCT01980940|3585083|P6|STARTED|Overall Study||2
1464798|NCT01980940|3585084|P5|STARTED|Overall Study||2
1464799|NCT01980940|3585085|P4|STARTED|Overall Study||3
1464800|NCT01980940|3585086|P3|STARTED|Overall Study||5
1464801|NCT01980940|3585087|P2|STARTED|Overall Study||5
1464802|NCT01980940|3585088|P1|STARTED|Overall Study||5
1464803|NCT01980888|3585142|P2|NOT COMPLETED|Overall Study||133
1464804|NCT01980888|3585143|P1|NOT COMPLETED|Overall Study||144
1464805|NCT01980888|3585142|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
1464806|NCT01980888|3585143|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
1464807|NCT01980888|3585142|P2|STARTED|Overall Study||154
1464808|NCT01980888|3585143|P1|STARTED|Overall Study||157
1464809|NCT01980875|3585162|P3|NOT COMPLETED|Overall Study||24
1464810|NCT01980875|3585163|P2|NOT COMPLETED|Overall Study||25
1464811|NCT01980875|3585164|P1|NOT COMPLETED|Overall Study||8
1464812|NCT01980875|3585162|P3|COMPLETED|Overall Study||0
1464813|NCT01980875|3585163|P2|COMPLETED|Overall Study||0
1464814|NCT01980875|3585164|P1|COMPLETED|Overall Study||0
1464815|NCT01980875|3585162|P3|STARTED|Overall Study||24
1464816|NCT01980875|3585163|P2|STARTED|Overall Study||25
1464817|NCT01980875|3585164|P1|STARTED|Overall Study||8
1464818|NCT01980771|3585189|P2|NOT COMPLETED|Overall Study||119
1464819|NCT01980771|3585190|P1|NOT COMPLETED|Overall Study||84
1464820|NCT01980771|3585189|P2|COMPLETED|Overall Study||305
1464821|NCT01980771|3585190|P1|COMPLETED|Overall Study||352
1464822|NCT01980771|3585189|P2|STARTED|Overall Study||424
1464823|NCT01980771|3585190|P1|STARTED|Overall Study||436
1464824|NCT01980628|3585196|P1|NOT COMPLETED|Overall Study||63
1464825|NCT01980628|3585196|P1|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
1464826|NCT01980628|3585196|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
1464827|NCT01980589|3585204|P3|NOT COMPLETED|Overall Study||0
1464828|NCT01980589|3585205|P2|NOT COMPLETED|Overall Study||0
1464829|NCT01980589|3585206|P1|NOT COMPLETED|Overall Study||0
1464830|NCT01980589|3585204|P3|COMPLETED|Overall Study||16
1464831|NCT01980589|3585205|P2|COMPLETED|Overall Study||3
1464832|NCT01980589|3585206|P1|COMPLETED|Overall Study||3
1464833|NCT01980589|3585204|P3|STARTED|Overall Study||16
1464834|NCT01980589|3585205|P2|STARTED|Overall Study||3
1464835|NCT01980589|3585206|P1|STARTED|Overall Study||3
1464836|NCT01980524|3585223|P2|NOT COMPLETED|Study Day 2||0
1464837|NCT01980524|3585224|P1|NOT COMPLETED|Study Day 2||0
1464838|NCT01980524|3585223|P2|COMPLETED|Study Day 2||4
1464839|NCT01980524|3585224|P1|COMPLETED|Study Day 2||4
1464840|NCT01980524|3585223|P2|STARTED|Study Day 2||4
1464841|NCT01980524|3585224|P1|STARTED|Study Day 2||4
1464842|NCT01980524|3585223|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
1464843|NCT01980524|3585224|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
1464844|NCT01980524|3585223|P2|COMPLETED|Washout (at Least 2 Weeks)||4
1464845|NCT01980524|3585224|P1|COMPLETED|Washout (at Least 2 Weeks)||4
1464846|NCT01980524|3585223|P2|STARTED|Washout (at Least 2 Weeks)||4
1464847|NCT01980524|3585224|P1|STARTED|Washout (at Least 2 Weeks)||4
1464848|NCT01980524|3585223|P2|NOT COMPLETED|Study Day 1||0
1464849|NCT01980524|3585224|P1|NOT COMPLETED|Study Day 1||0
1464850|NCT01980524|3585223|P2|COMPLETED|Study Day 1||4
1464851|NCT01980524|3585224|P1|COMPLETED|Study Day 1||4
1464852|NCT01980524|3585223|P2|STARTED|Study Day 1||4
1464853|NCT01980524|3585224|P1|STARTED|Study Day 1||4
1464854|NCT01980342|3585234|P1|NOT COMPLETED|Overall Study||1
1464855|NCT01980342|3585234|P1|COMPLETED|Overall Study||0
1464856|NCT01980342|3585234|P1|STARTED|Overall Study||1
1464857|NCT01980095|3585244|P2|NOT COMPLETED|Overall Study||11
1464858|NCT01980095|3585245|P1|NOT COMPLETED|Overall Study||14
1464859|NCT01980095|3585244|P2|COMPLETED|Overall Study||30
1464860|NCT01980095|3585245|P1|COMPLETED|Overall Study||63
1464861|NCT01980095|3585244|P2|Treated|Overall Study||41
1464862|NCT01980095|3585245|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
1464863|NCT01980095|3585244|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
1464864|NCT01980095|3585245|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|77
1464865|NCT01980056|3585256|P3|NOT COMPLETED|Overall Study||0
1464866|NCT01980056|3585257|P2|NOT COMPLETED|Overall Study||1
1464867|NCT01980056|3585258|P1|NOT COMPLETED|Overall Study||1
1464868|NCT01980056|3585256|P3|COMPLETED|Overall Study||2
1464869|NCT01980056|3585257|P2|COMPLETED|Overall Study||3
1464870|NCT01980056|3585258|P1|COMPLETED|Overall Study||3
1464871|NCT01980056|3585256|P3|STARTED|Overall Study||2
1464872|NCT01980056|3585257|P2|STARTED|Overall Study||4
1464873|NCT01980056|3585258|P1|STARTED|Overall Study||4
1464874|NCT01979952|3585272|P2|NOT COMPLETED|Overall Study||6
1464875|NCT01979952|3585273|P1|NOT COMPLETED|Overall Study||8
1464876|NCT01979952|3585272|P2|COMPLETED|Overall Study||51
1464877|NCT01979952|3585273|P1|COMPLETED|Overall Study||48
1464878|NCT01979952|3585272|P2|STARTED|Overall Study||57
1464879|NCT01979952|3585273|P1|STARTED|Overall Study||56
1464880|NCT01979445|3585303|P4|NOT COMPLETED|Overall Study||0
1464881|NCT01979445|3585304|P3|NOT COMPLETED|Overall Study||0
1464882|NCT01979445|3585305|P2|NOT COMPLETED|Overall Study||0
1464883|NCT01979445|3585306|P1|NOT COMPLETED|Overall Study||0
1464884|NCT01979445|3585303|P4|COMPLETED|Overall Study||3
1464885|NCT01979445|3585304|P3|COMPLETED|Overall Study||6
1464886|NCT01979445|3585305|P2|COMPLETED|Overall Study||3
1464887|NCT01979445|3585306|P1|COMPLETED|Overall Study||3
1464888|NCT01979445|3585303|P4|ITT Population|Overall Study||3
1464889|NCT01979445|3585304|P3|ITT Population|Overall Study||6
1464890|NCT01979445|3585305|P2|ITT Population|Overall Study||3
1464891|NCT01979445|3585306|P1|ITT Population|Overall Study||3
1464892|NCT01979445|3585303|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
1464893|NCT01979445|3585304|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1464894|NCT01979445|3585305|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
1464895|NCT01979445|3585306|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1464896|NCT01979445|3585303|P4|STARTED|Overall Study||3
1464897|NCT01979445|3585304|P3|STARTED|Overall Study||6
1464898|NCT01979445|3585305|P2|STARTED|Overall Study||3
1464899|NCT01979445|3585306|P1|STARTED|Overall Study||3
1464900|NCT01979276|3585332|P1|NOT COMPLETED|Overall Study||0
1464901|NCT01979276|3585332|P1|COMPLETED|Overall Study||2
1464902|NCT01979276|3585332|P1|STARTED|Overall Study||2
1464903|NCT01979185|3585340|P2|NOT COMPLETED|Period 2||1
1464904|NCT01979185|3585341|P1|NOT COMPLETED|Period 2||0
1464905|NCT01979185|3585340|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
1464906|NCT01979185|3585341|P1|COMPLETED|Period 2||15
1464907|NCT01979185|3585340|P2|STARTED|Period 2||15
1464908|NCT01979185|3585341|P1|STARTED|Period 2||15
1464909|NCT01979185|3585340|P2|NOT COMPLETED|Period 1||0
1464910|NCT01979185|3585341|P1|NOT COMPLETED|Period 1||0
1464911|NCT01979185|3585340|P2|COMPLETED|Period 1||15
1464912|NCT01979185|3585341|P1|COMPLETED|Period 1||15
1464913|NCT01979185|3585340|P2|STARTED|Period 1||15
1464914|NCT01979185|3585341|P1|STARTED|Period 1||15
1464915|NCT01979133|3585351|P1|NOT COMPLETED|Overall Study||3
1464916|NCT01979133|3585351|P1|COMPLETED|Overall Study||7
1464917|NCT01979133|3585351|P1|STARTED|Overall Study||10
1464918|NCT01979029|3585370|P2|NOT COMPLETED|Overall Study||0
1464919|NCT01979029|3585371|P1|NOT COMPLETED|Overall Study||0
1464920|NCT01979029|3585370|P2|COMPLETED|Overall Study||28
1464921|NCT01979029|3585371|P1|COMPLETED|Overall Study||29
1464922|NCT01979029|3585370|P2|STARTED|Overall Study||28
1464923|NCT01979029|3585371|P1|STARTED|Overall Study||29
1464924|NCT01978938|3585383|P2|NOT COMPLETED|Overall Study||14
1464925|NCT01978938|3585384|P1|NOT COMPLETED|Overall Study||23
1464926|NCT01978938|3585383|P2|COMPLETED|Overall Study||439
1464927|NCT01978938|3585384|P1|COMPLETED|Overall Study||432
1464928|NCT01978938|3585383|P2|Received at Least 1 Dose of Study Drug|Overall Study||451
1464929|NCT01978938|3585384|P1|Received at Least 1 Dose of Study Drug|Overall Study||454
1464930|NCT01978938|3585383|P2|STARTED|Overall Study||453
1464931|NCT01978938|3585384|P1|STARTED|Overall Study||455
1464932|NCT01978743|3585394|P1|NOT COMPLETED|Overall Study||0
1464933|NCT01978743|3585394|P1|COMPLETED|Overall Study||10
1464934|NCT01978743|3585394|P1|STARTED|Overall Study||10
1464935|NCT01978600|3585408|P2|NOT COMPLETED|Overall Study||0
1464936|NCT01978600|3585409|P1|NOT COMPLETED|Overall Study||0
1464937|NCT01978600|3585408|P2|COMPLETED|Overall Study||42
1464938|NCT01978600|3585409|P1|COMPLETED|Overall Study||44
1464939|NCT01978600|3585408|P2|STARTED|Overall Study||42
1464940|NCT01978600|3585409|P1|STARTED|Overall Study||44
1464941|NCT01978535|3585421|P2|NOT COMPLETED|Overall Study||0
1464942|NCT01978535|3585422|P1|NOT COMPLETED|Overall Study||0
1464943|NCT01978535|3585421|P2|COMPLETED|Overall Study||2
1464944|NCT01978535|3585422|P1|COMPLETED|Overall Study||1
1464945|NCT01978535|3585421|P2|STARTED|Overall Study||2
1464946|NCT01978535|3585422|P1|STARTED|Overall Study||1
1464947|NCT01978314|3585433|P5|NOT COMPLETED|Overall Study||0
1464948|NCT01978314|3585434|P4|NOT COMPLETED|Overall Study||0
1464949|NCT01978314|3585435|P3|NOT COMPLETED|Overall Study||0
1464950|NCT01978314|3585436|P2|NOT COMPLETED|Overall Study||0
1464951|NCT01978314|3585437|P1|NOT COMPLETED|Overall Study||0
1464952|NCT01978314|3585433|P5|COMPLETED|Overall Study||8
1464953|NCT01978314|3585434|P4|COMPLETED|Overall Study||1
1464954|NCT01978314|3585435|P3|COMPLETED|Overall Study||8
1464955|NCT01978314|3585436|P2|COMPLETED|Overall Study||8
1464956|NCT01978314|3585437|P1|COMPLETED|Overall Study||8
1464957|NCT01978314|3585433|P5|STARTED|Overall Study||8
1464958|NCT01978314|3585434|P4|STARTED|Overall Study||1
1464959|NCT01978314|3585435|P3|STARTED|Overall Study||8
1464960|NCT01978314|3585436|P2|STARTED|Overall Study||8
1464961|NCT01978314|3585437|P1|STARTED|Overall Study||8
1464962|NCT01978262|3585519|P1|NOT COMPLETED|Overall Study||11
1464963|NCT01978262|3585519|P1|COMPLETED|Overall Study||92
1464964|NCT01978262|3585519|P1|STARTED|Overall Study||103
1464965|NCT01978236|3585524|P1|NOT COMPLETED|Overall Study||2
1464966|NCT01978236|3585524|P1|COMPLETED|Overall Study||4
1464967|NCT01978236|3585524|P1|STARTED|Overall Study||6
1464968|NCT01978145|3585543|P2|NOT COMPLETED|Treatment Period 2||14
1464969|NCT01978145|3585544|P1|NOT COMPLETED|Treatment Period 2||19
1464970|NCT01978145|3585543|P2|COMPLETED|Treatment Period 2||179
1464971|NCT01978145|3585544|P1|COMPLETED|Treatment Period 2||185
1464972|NCT01978145|3585543|P2|STARTED|Treatment Period 2||193
1464973|NCT01978145|3585544|P1|STARTED|Treatment Period 2||204
1464974|NCT01978145|3585543|P2|NOT COMPLETED|Washout Period 1||3
1464975|NCT01978145|3585544|P1|NOT COMPLETED|Washout Period 1||1
1464976|NCT01978145|3585543|P2|COMPLETED|Washout Period 1||193
1464977|NCT01978145|3585544|P1|COMPLETED|Washout Period 1||204
1464978|NCT01978145|3585543|P2|STARTED|Washout Period 1||196
1464979|NCT01978145|3585544|P1|STARTED|Washout Period 1||205
1464980|NCT01978145|3585543|P2|NOT COMPLETED|Treatment Period 1||16
1464981|NCT01978145|3585544|P1|NOT COMPLETED|Treatment Period 1||9
1464982|NCT01978145|3585543|P2|COMPLETED|Treatment Period 1||196
1464983|NCT01978145|3585544|P1|COMPLETED|Treatment Period 1||205
1464984|NCT01978145|3585543|P2|STARTED|Treatment Period 1||212
1464985|NCT01978145|3585544|P1|STARTED|Treatment Period 1||214
1464986|NCT01978119|3585560|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
1464987|NCT01978119|3585561|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
1464988|NCT01978119|3585560|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
1464989|NCT01978119|3585561|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
1464990|NCT01978119|3585560|P2|STARTED|Treatment Period 2 (12 Weeks)||42
1464991|NCT01978119|3585561|P1|STARTED|Treatment Period 2 (12 Weeks)||38
1464992|NCT01978119|3585560|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
1464993|NCT01978119|3585561|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
1464994|NCT01978119|3585560|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
1464995|NCT01978119|3585561|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
1464996|NCT01978119|3585560|P2|STARTED|Washout Period 1 (3 Weeks)||42
1464997|NCT01978119|3585561|P1|STARTED|Washout Period 1 (3 Weeks)||38
1464998|NCT01978119|3585560|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
1464999|NCT01978119|3585561|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
1465000|NCT01978119|3585560|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
1465001|NCT01978119|3585561|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
1465002|NCT01978119|3585560|P2|STARTED|Treatment Period 1 (12 Weeks)||42
1465003|NCT01978119|3585561|P1|STARTED|Treatment Period 1 (12 Weeks)||40
1465004|NCT01978093|3585587|P2|NOT COMPLETED|Overall Study||73
1465005|NCT01978093|3585588|P1|NOT COMPLETED|Overall Study||65
1465006|NCT01978093|3585587|P2|COMPLETED|Overall Study||230
1465007|NCT01978093|3585588|P1|COMPLETED|Overall Study||232
1465008|NCT01978093|3585587|P2|STARTED|Overall Study||303
1465009|NCT01978093|3585588|P1|STARTED|Overall Study||297
1465010|NCT01977820|3585632|P2|NOT COMPLETED|Overall Study||1
1465011|NCT01977820|3585633|P1|NOT COMPLETED|Overall Study||1
1465012|NCT01977820|3585632|P2|COMPLETED|Overall Study||0
1465013|NCT01977820|3585633|P1|COMPLETED|Overall Study||0
1465014|NCT01977820|3585632|P2|STARTED|Overall Study||1
1465015|NCT01977820|3585633|P1|STARTED|Overall Study||1
1465016|NCT01977794|3585641|P2|NOT COMPLETED|Overall Study||6
1465017|NCT01977794|3585642|P1|NOT COMPLETED|Overall Study||8
1465018|NCT01977794|3585641|P2|COMPLETED|Overall Study||94
1465019|NCT01977794|3585642|P1|COMPLETED|Overall Study||92
1465020|NCT01977794|3585641|P2|STARTED|Overall Study||100
1465021|NCT01977794|3585642|P1|STARTED|Overall Study||100
1465022|NCT01977781|3585658|P2|NOT COMPLETED|Overall Study||1
1465023|NCT01977781|3585659|P1|NOT COMPLETED|Overall Study||6
1465024|NCT01977781|3585658|P2|COMPLETED|Overall Study||15
1465025|NCT01977781|3585659|P1|COMPLETED|Overall Study||18
1465026|NCT01977781|3585658|P2|STARTED|Overall Study||16
1465027|NCT01977781|3585659|P1|STARTED|Overall Study||24
1465028|NCT01977729|3585677|P1|NOT COMPLETED|Overall Study||1
1465029|NCT01977729|3585677|P1|COMPLETED|Overall Study||0
1465030|NCT01977729|3585677|P1|STARTED|Overall Study||1
1465031|NCT01977690|3585689|P2|NOT COMPLETED|Overall Study||4
1465032|NCT01977690|3585690|P1|NOT COMPLETED|Overall Study||0
1465033|NCT01977690|3585689|P2|COMPLETED|Overall Study||11
1465034|NCT01977690|3585690|P1|COMPLETED|Overall Study||15
1465035|NCT01977690|3585689|P2|STARTED|Overall Study||15
1465036|NCT01977690|3585690|P1|STARTED|Overall Study||15
1465037|NCT01977677|3585699|P3|NOT COMPLETED|Overall Study||1
1465038|NCT01977677|3585700|P2|NOT COMPLETED|Overall Study||0
1465039|NCT01977677|3585701|P1|NOT COMPLETED|Overall Study||0
1465040|NCT01977677|3585699|P3|COMPLETED|Overall Study||20
1465041|NCT01977677|3585700|P2|COMPLETED|Overall Study||6
1465042|NCT01977677|3585701|P1|COMPLETED|Overall Study||3
1465043|NCT01977677|3585699|P3|STARTED|Overall Study||21
1465044|NCT01977677|3585700|P2|STARTED|Overall Study||6
1465045|NCT01977677|3585701|P1|STARTED|Overall Study||3
1465046|NCT01977625|3585712|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
1465047|NCT01977625|3585713|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
1465048|NCT01977625|3585712|P2|COMPLETED|Second Intervention (4 Weeks)||7
1465049|NCT01977625|3585713|P1|COMPLETED|Second Intervention (4 Weeks)||7
1465050|NCT01977625|3585712|P2|STARTED|Second Intervention (4 Weeks)||7
1465051|NCT01977625|3585713|P1|STARTED|Second Intervention (4 Weeks)||8
1465052|NCT01977625|3585712|P2|NOT COMPLETED|Washout (2 Weeks)||0
1465053|NCT01977625|3585713|P1|NOT COMPLETED|Washout (2 Weeks)||0
1465054|NCT01977625|3585712|P2|COMPLETED|Washout (2 Weeks)||7
1465055|NCT01977625|3585713|P1|COMPLETED|Washout (2 Weeks)||8
1465056|NCT01977625|3585712|P2|STARTED|Washout (2 Weeks)||7
1465057|NCT01977625|3585713|P1|STARTED|Washout (2 Weeks)||8
1465058|NCT01977625|3585712|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
1465059|NCT01977625|3585713|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
1465060|NCT01977625|3585712|P2|COMPLETED|First Intervention (4 Weeks)||7
1465061|NCT01977625|3585713|P1|COMPLETED|First Intervention (4 Weeks)||8
1465062|NCT01977625|3585712|P2|STARTED|First Intervention (4 Weeks)||7
1465063|NCT01977625|3585713|P1|STARTED|First Intervention (4 Weeks)||11
1465064|NCT01977612|3585723|P2|NOT COMPLETED|Overall Study||1
1465065|NCT01977612|3585724|P1|NOT COMPLETED|Overall Study||1
1465066|NCT01977612|3585723|P2|COMPLETED|Overall Study||79
1465067|NCT01977612|3585724|P1|COMPLETED|Overall Study||84
1465068|NCT01977612|3585723|P2|STARTED|Overall Study||80
1465069|NCT01977612|3585724|P1|STARTED|Overall Study||85
1465070|NCT01977573|3585746|P4|NOT COMPLETED|Overall Study||3
1465071|NCT01977573|3585747|P3|NOT COMPLETED|Overall Study||4
1465072|NCT01977573|3585748|P2|NOT COMPLETED|Overall Study||3
1465073|NCT01977573|3585749|P1|NOT COMPLETED|Overall Study||20
1465074|NCT01977573|3585746|P4|COMPLETED|Overall Study||33
1465075|NCT01977573|3585747|P3|COMPLETED|Overall Study||32
1465076|NCT01977573|3585748|P2|COMPLETED|Overall Study||41
1465077|NCT01977573|3585749|P1|COMPLETED|Overall Study||116
1465078|NCT01977573|3585746|P4|STARTED|Overall Study||36
1465079|NCT01977573|3585747|P3|STARTED|Overall Study||36
1465080|NCT01977573|3585748|P2|STARTED|Overall Study||44
1465081|NCT01977573|3585749|P1|STARTED|Overall Study||136
1465082|NCT01977482|3585863|P6|NOT COMPLETED|Overall Study||5
1465083|NCT01977482|3585864|P5|NOT COMPLETED|Overall Study||3
1465084|NCT01977482|3585865|P4|NOT COMPLETED|Overall Study||4
1465085|NCT01977482|3585866|P3|NOT COMPLETED|Overall Study||5
1465086|NCT01977482|3585867|P2|NOT COMPLETED|Overall Study||9
1465087|NCT01977482|3585868|P1|NOT COMPLETED|Overall Study||3
1465088|NCT01977482|3585863|P6|COMPLETED|Overall Study||14
1465089|NCT01977482|3585864|P5|COMPLETED|Overall Study||37
1465090|NCT01977482|3585865|P4|COMPLETED|Overall Study||35
1465091|NCT01977482|3585866|P3|COMPLETED|Overall Study||35
1465092|NCT01977482|3585867|P2|COMPLETED|Overall Study||30
1465093|NCT01977482|3585868|P1|COMPLETED|Overall Study||36
1465094|NCT01977482|3585863|P6|STARTED|Overall Study||19
1465095|NCT01977482|3585864|P5|STARTED|Overall Study||40
1465096|NCT01977482|3585865|P4|STARTED|Overall Study||39
1465097|NCT01977482|3585866|P3|STARTED|Overall Study||40
1465098|NCT01977482|3585867|P2|STARTED|Overall Study||39
1465099|NCT01977482|3585868|P1|STARTED|Overall Study||39
1465100|NCT01977456|3585983|P1|NOT COMPLETED|Overall Study||5
1465101|NCT01977456|3585983|P1|COMPLETED|Overall Study||22
1465102|NCT01977456|3585983|P1|STARTED|Overall Study||27
1465103|NCT01977352|3585992|P2|NOT COMPLETED|Overall Study||2
1465104|NCT01977352|3585993|P1|NOT COMPLETED|Overall Study||1
1465105|NCT01977352|3585992|P2|COMPLETED|Overall Study||19
1465106|NCT01977352|3585993|P1|COMPLETED|Overall Study||20
1465107|NCT01977352|3585992|P2|STARTED|Overall Study||21
1465108|NCT01977352|3585993|P1|STARTED|Overall Study||21
1465109|NCT01977222|3586011|P1|NOT COMPLETED|Overall Study||1
1465110|NCT01977222|3586011|P1|COMPLETED|Overall Study||11
1465111|NCT01977222|3586011|P1|STARTED|Overall Study||12
1465112|NCT01977092|3586024|P2|NOT COMPLETED|Overall Study||30
1465113|NCT01977092|3586025|P1|NOT COMPLETED|Overall Study||31
1465114|NCT01977092|3586024|P2|COMPLETED|Overall Study||151
1465115|NCT01977092|3586025|P1|COMPLETED|Overall Study||118
1465116|NCT01977092|3586024|P2|STARTED|Overall Study||181
1465117|NCT01977092|3586025|P1|STARTED|Overall Study||149
1465118|NCT01976988|3586037|P2|NOT COMPLETED|Overall Study||18
1465119|NCT01976988|3586038|P1|NOT COMPLETED|Overall Study||16
1465120|NCT01976988|3586037|P2|COMPLETED|Overall Study||184
1465121|NCT01976988|3586038|P1|COMPLETED|Overall Study||192
1465122|NCT01976988|3586037|P2|STARTED|Overall Study||202
1465123|NCT01976988|3586038|P1|STARTED|Overall Study||208
1465124|NCT01976871|3586054|P1|NOT COMPLETED|Overall Study||1
1465125|NCT01976871|3586054|P1|COMPLETED|Overall Study||20
1465126|NCT01976871|3586054|P1|STARTED|Overall Study||21
1465127|NCT01976845|3586066|P3|NOT COMPLETED|Overall Study||3
1465128|NCT01976845|3586067|P2|NOT COMPLETED|Overall Study||8
1465129|NCT01976845|3586068|P1|NOT COMPLETED|Overall Study||8
1465130|NCT01976845|3586066|P3|COMPLETED|Overall Study||40
1465131|NCT01976845|3586067|P2|COMPLETED|Overall Study||40
1465132|NCT01976845|3586068|P1|COMPLETED|Overall Study||40
1465133|NCT01976845|3586066|P3|STARTED|Overall Study||43
1465134|NCT01976845|3586067|P2|STARTED|Overall Study||48
1465135|NCT01976845|3586068|P1|STARTED|Overall Study||48
1465136|NCT01976819|3586082|P1|NOT COMPLETED|Overall Study||5
1465137|NCT01976819|3586082|P1|COMPLETED|Overall Study||11
1465138|NCT01976819|3586082|P1|STARTED|Overall Study||16
1465139|NCT01976806|3586093|P2|NOT COMPLETED|Overall Study||6
1465140|NCT01976806|3586094|P1|NOT COMPLETED|Overall Study||3
1465141|NCT01976806|3586093|P2|COMPLETED|Overall Study||22
1465142|NCT01976806|3586094|P1|COMPLETED|Overall Study||24
1465143|NCT01976806|3586093|P2|STARTED|Overall Study||28
1465144|NCT01976806|3586094|P1|STARTED|Overall Study||27
1465145|NCT01976663|3586122|P1|NOT COMPLETED|Overall Study||42
1465146|NCT01976663|3586122|P1|COMPLETED|Overall Study||84
1465147|NCT01976663|3586122|P1|STARTED|Overall Study||126
1465148|NCT01976650|3586136|P1|NOT COMPLETED|Overall Study||6
1465149|NCT01976650|3586136|P1|COMPLETED|Overall Study||718
1465150|NCT01976650|3586136|P1|STARTED|Overall Study||724
1465151|NCT01976624|3586141|P1|NOT COMPLETED|Overall Study||14
1465152|NCT01976624|3586141|P1|COMPLETED|Overall Study||742
1465153|NCT01976624|3586141|P1|STARTED|Overall Study||756
1465154|NCT01976572|3586146|P3|NOT COMPLETED|Overall Study||0
1465155|NCT01976572|3586147|P2|NOT COMPLETED|Overall Study||0
1465156|NCT01976572|3586148|P1|NOT COMPLETED|Overall Study||0
1465157|NCT01976572|3586146|P3|COMPLETED|Overall Study||6
1465158|NCT01976572|3586147|P2|COMPLETED|Overall Study||6
1465159|NCT01976572|3586148|P1|COMPLETED|Overall Study||6
1465160|NCT01976572|3586146|P3|STARTED|Overall Study||6
1465161|NCT01976572|3586147|P2|STARTED|Overall Study||6
1465162|NCT01976572|3586148|P1|STARTED|Overall Study||6
1465163|NCT01976507|3586169|P1|NOT COMPLETED|Overall Study||7
1465164|NCT01976507|3586169|P1|COMPLETED|Overall Study||94
1465165|NCT01976507|3586169|P1|Received Initial Dose of Dabigatran|Overall Study||100
1465166|NCT01976507|3586169|P1|STARTED|Overall Study||101
1465167|NCT01976442|3586178|P2|NOT COMPLETED|Overall Study||0
1465168|NCT01976442|3586179|P1|NOT COMPLETED|Overall Study||0
1465169|NCT01976442|3586178|P2|COMPLETED|Overall Study||31
1465170|NCT01976442|3586179|P1|COMPLETED|Overall Study||69
1465171|NCT01976442|3586178|P2|STARTED|Overall Study||31
1465172|NCT01976442|3586179|P1|STARTED|Overall Study||69
1465173|NCT01976416|3586193|P2|NOT COMPLETED|Overall Study||2
1465174|NCT01976416|3586194|P1|NOT COMPLETED|Overall Study||2
1465175|NCT01976416|3586193|P2|COMPLETED|Overall Study||102
1465176|NCT01976416|3586194|P1|COMPLETED|Overall Study||102
1465177|NCT01976416|3586193|P2|STARTED|Overall Study||104
1465178|NCT01976416|3586194|P1|STARTED|Overall Study||104
1465179|NCT01976338|3586202|P2|NOT COMPLETED|Overall Study||4
1465180|NCT01976338|3586203|P1|NOT COMPLETED|Overall Study||13
1465181|NCT01976338|3586202|P2|COMPLETED|Overall Study|12 months|89
1465182|NCT01976338|3586203|P1|COMPLETED|Overall Study|12 months|177
1465183|NCT01976338|3586202|P2|Discontinued Study Prior to 6 Months|Overall Study||2
1465184|NCT01976338|3586203|P1|Discontinued Study Prior to 6 Months|Overall Study||5
1465185|NCT01976338|3586202|P2|Completed 6 Months|Overall Study||91
1465186|NCT01976338|3586203|P1|Completed 6 Months|Overall Study||185
1465187|NCT01976338|3586202|P2|STARTED|Overall Study||93
1465188|NCT01976338|3586203|P1|STARTED|Overall Study||190
1465189|NCT01976312|3586230|P2|NOT COMPLETED|Overall Study||9
1465190|NCT01976312|3586231|P1|NOT COMPLETED|Overall Study||17
1465191|NCT01976312|3586230|P2|COMPLETED|Overall Study|Completed study at 12 months|53
1465192|NCT01976312|3586231|P1|COMPLETED|Overall Study|Completed study at 12 months|173
1465193|NCT01976312|3586230|P2|Discontinued Study Prior to 3 Months|Overall Study||2
1465194|NCT01976312|3586231|P1|Discontinued Study Prior to 3 Months|Overall Study||4
1465195|NCT01976312|3586230|P2|Completed 3 Months|Overall Study||60
1465196|NCT01976312|3586231|P1|Completed 3 Months|Overall Study||186
1465197|NCT01976312|3586230|P2|STARTED|Overall Study||62
1465198|NCT01976312|3586231|P1|STARTED|Overall Study||190
1465199|NCT01976299|3586252|P2|NOT COMPLETED|Overall Study||6
1465200|NCT01976299|3586253|P1|NOT COMPLETED|Overall Study||23
1465201|NCT01976299|3586252|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
1465202|NCT01976299|3586253|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
1465203|NCT01976299|3586252|P2|Completed Procedure|Overall Study||284
1465204|NCT01976299|3586253|P1|Completed Procedure|Overall Study||283
1465205|NCT01976299|3586252|P2|STARTED|Overall Study||286
1465206|NCT01976299|3586253|P1|STARTED|Overall Study||292
1465207|NCT01976273|3586269|P2|NOT COMPLETED|Overall Study||1
1465208|NCT01976273|3586270|P1|NOT COMPLETED|Overall Study||1
1465209|NCT01976273|3586269|P2|COMPLETED|Overall Study||9
1465210|NCT01976273|3586270|P1|COMPLETED|Overall Study||9
1465211|NCT01976273|3586269|P2|STARTED|Overall Study||10
1465212|NCT01976273|3586270|P1|STARTED|Overall Study||10
1465213|NCT01976104|3586280|P4|NOT COMPLETED|Overall Study||3
1465214|NCT01976104|3586281|P3|NOT COMPLETED|Overall Study||2
1465215|NCT01976104|3586282|P2|NOT COMPLETED|Overall Study||2
1465216|NCT01976104|3586283|P1|NOT COMPLETED|Overall Study||6
1465217|NCT01976104|3586280|P4|COMPLETED|Overall Study||55
1465218|NCT01976104|3586281|P3|COMPLETED|Overall Study||31
1465219|NCT01976104|3586282|P2|COMPLETED|Overall Study||68
1465220|NCT01976104|3586283|P1|COMPLETED|Overall Study||37
1465221|NCT01976104|3586280|P4|STARTED|Overall Study||58
1465222|NCT01976104|3586281|P3|STARTED|Overall Study||33
1465223|NCT01976104|3586282|P2|STARTED|Overall Study||70
1465224|NCT01976104|3586283|P1|STARTED|Overall Study||43
1465225|NCT01975974|3586309|P1|NOT COMPLETED|Overall Study||0
1465226|NCT01975974|3586309|P1|COMPLETED|Overall Study||100
1465227|NCT01975974|3586309|P1|STARTED|Overall Study||100
1465228|NCT01975948|3586317|P4|NOT COMPLETED|Overall Study||6
1465229|NCT01975948|3586318|P3|NOT COMPLETED|Overall Study||7
1465230|NCT01975948|3586319|P2|NOT COMPLETED|Overall Study||21
1465231|NCT01975948|3586320|P1|NOT COMPLETED|Overall Study||17
1465232|NCT01975948|3586317|P4|COMPLETED|Overall Study||51
1465233|NCT01975948|3586318|P3|COMPLETED|Overall Study||65
1465234|NCT01975948|3586319|P2|COMPLETED|Overall Study||34
1465235|NCT01975948|3586320|P1|COMPLETED|Overall Study||39
1465236|NCT01975948|3586317|P4|STARTED|Overall Study||57
1465237|NCT01975948|3586318|P3|STARTED|Overall Study||72
1465238|NCT01975948|3586319|P2|STARTED|Overall Study||55
1465239|NCT01975948|3586320|P1|STARTED|Overall Study||56
1465240|NCT01975935|3586346|P2|NOT COMPLETED|Overall Study||1
1465241|NCT01975935|3586347|P1|NOT COMPLETED|Overall Study||3
1465242|NCT01975935|3586346|P2|COMPLETED|Overall Study||20
1465243|NCT01975935|3586347|P1|COMPLETED|Overall Study||18
1465244|NCT01975935|3586346|P2|STARTED|Overall Study||21
1465245|NCT01975935|3586347|P1|STARTED|Overall Study||21
1465246|NCT01975922|3586359|P2|NOT COMPLETED|Overall Study||9
1465247|NCT01975922|3586360|P1|NOT COMPLETED|Overall Study||0
1465248|NCT01975922|3586359|P2|COMPLETED|Overall Study||43
1465249|NCT01975922|3586360|P1|COMPLETED|Overall Study||45
1465250|NCT01975922|3586359|P2|STARTED|Overall Study||52
1465251|NCT01975922|3586360|P1|STARTED|Overall Study||45
1465252|NCT01975909|3586370|P2|NOT COMPLETED|Overall Study||0
1465253|NCT01975909|3586371|P1|NOT COMPLETED|Overall Study||0
1465254|NCT01975909|3586370|P2|COMPLETED|Overall Study||10
1465255|NCT01975909|3586371|P1|COMPLETED|Overall Study||10
1465256|NCT01975909|3586370|P2|STARTED|Overall Study||10
1465257|NCT01975909|3586371|P1|STARTED|Overall Study||10
1465258|NCT01975675|3586391|P4|NOT COMPLETED|Overall Study||0
1465259|NCT01975675|3586392|P3|NOT COMPLETED|Overall Study||0
1465260|NCT01975675|3586393|P2|NOT COMPLETED|Overall Study||1
1465261|NCT01975675|3586394|P1|NOT COMPLETED|Overall Study||0
1465262|NCT01975675|3586391|P4|COMPLETED|Overall Study||87
1465263|NCT01975675|3586392|P3|COMPLETED|Overall Study||88
1465264|NCT01975675|3586393|P2|COMPLETED|Overall Study||82
1465265|NCT01975675|3586394|P1|COMPLETED|Overall Study||83
1465266|NCT01975675|3586391|P4|STARTED|Overall Study||87
1465267|NCT01975675|3586392|P3|STARTED|Overall Study||88
1465268|NCT01975675|3586393|P2|STARTED|Overall Study||83
1465269|NCT01975675|3586394|P1|STARTED|Overall Study||83
1465270|NCT01975467|3586416|P2|NOT COMPLETED|Overall Study||0
1465271|NCT01975467|3586417|P1|NOT COMPLETED|Overall Study||0
1465272|NCT01975467|3586416|P2|COMPLETED|Overall Study||0
1465273|NCT01975467|3586417|P1|COMPLETED|Overall Study||0
1465274|NCT01975467|3586416|P2|STARTED|Overall Study|Study terminated before enrollment|0
1465275|NCT01975467|3586417|P1|STARTED|Overall Study|Study terminated before enrollment|0
1465276|NCT01975389|3586427|P2|NOT COMPLETED|Overall Study||236
1465277|NCT01975389|3586428|P1|NOT COMPLETED|Overall Study||252
1465278|NCT01975389|3586427|P2|COMPLETED|Overall Study||5045
1465279|NCT01975389|3586428|P1|COMPLETED|Overall Study||5031
1465280|NCT01975389|3586427|P2|Treated|Overall Study||5276
1465281|NCT01975389|3586428|P1|Treated|Overall Study||5279
1465282|NCT01975389|3586427|P2|STARTED|Overall Study||5281
1465283|NCT01975389|3586428|P1|STARTED|Overall Study||5283
1465284|NCT01975376|3586488|P2|NOT COMPLETED|Overall Study||217
1465285|NCT01975376|3586489|P1|NOT COMPLETED|Overall Study||226
1465286|NCT01975376|3586488|P2|COMPLETED|Overall Study||8177
1465287|NCT01975376|3586489|P1|COMPLETED|Overall Study||8164
1465288|NCT01975376|3586488|P2|Treated|Overall Study||8386
1465289|NCT01975376|3586489|P1|Treated|Overall Study||8374
1465290|NCT01975376|3586488|P2|STARTED|Overall Study||8394
1465291|NCT01975376|3586489|P1|STARTED|Overall Study||8390
1465292|NCT01975285|3586549|P2|NOT COMPLETED|Overall Study||2
1465293|NCT01975285|3586550|P1|NOT COMPLETED|Overall Study||2
1465294|NCT01975285|3586549|P2|COMPLETED|Overall Study||28
1465295|NCT01975285|3586550|P1|COMPLETED|Overall Study||28
1465296|NCT01975285|3586549|P2|STARTED|Overall Study||30
1465297|NCT01975285|3586550|P1|STARTED|Overall Study||30
1465298|NCT01975246|3586566|P2|NOT COMPLETED|Overall Study||2
1465299|NCT01975246|3586567|P1|NOT COMPLETED|Overall Study||4
1465300|NCT01975246|3586566|P2|COMPLETED|Overall Study||158
1465301|NCT01975246|3586567|P1|COMPLETED|Overall Study||145
1465302|NCT01975246|3586566|P2|STARTED|Overall Study||160
1465303|NCT01975246|3586567|P1|STARTED|Overall Study||149
1465304|NCT01975220|3586580|P6|NOT COMPLETED|Test Period 2||0
1465305|NCT01975220|3586581|P5|NOT COMPLETED|Test Period 2||0
1465306|NCT01975220|3586582|P4|NOT COMPLETED|Test Period 2||0
1465307|NCT01975220|3586583|P3|NOT COMPLETED|Test Period 2||0
1465308|NCT01975220|3586584|P2|NOT COMPLETED|Test Period 2||0
1465309|NCT01975220|3586585|P1|NOT COMPLETED|Test Period 2||0
1465310|NCT01975220|3586580|P6|COMPLETED|Test Period 2||12
1465311|NCT01975220|3586581|P5|COMPLETED|Test Period 2||12
1465312|NCT01975220|3586582|P4|COMPLETED|Test Period 2||12
1465313|NCT01975220|3586583|P3|COMPLETED|Test Period 2||12
1465314|NCT01975220|3586584|P2|COMPLETED|Test Period 2||11
1465315|NCT01975220|3586585|P1|COMPLETED|Test Period 2||12
1465316|NCT01975220|3586580|P6|STARTED|Test Period 2||12
1465317|NCT01975220|3586581|P5|STARTED|Test Period 2||12
1465318|NCT01975220|3586582|P4|STARTED|Test Period 2||12
1465319|NCT01975220|3586583|P3|STARTED|Test Period 2||12
1465320|NCT01975220|3586584|P2|STARTED|Test Period 2||11
1465321|NCT01975220|3586585|P1|STARTED|Test Period 2||12
1465322|NCT01975220|3586580|P6|NOT COMPLETED|Test Period 1||0
1465323|NCT01975220|3586581|P5|NOT COMPLETED|Test Period 1||0
1465324|NCT01975220|3586582|P4|NOT COMPLETED|Test Period 1||0
1465325|NCT01975220|3586583|P3|NOT COMPLETED|Test Period 1||0
1465326|NCT01975220|3586584|P2|NOT COMPLETED|Test Period 1||1
1465327|NCT01975220|3586585|P1|NOT COMPLETED|Test Period 1||0
1465328|NCT01975220|3586580|P6|COMPLETED|Test Period 1||12
1465329|NCT01975220|3586581|P5|COMPLETED|Test Period 1||12
1465330|NCT01975220|3586582|P4|COMPLETED|Test Period 1||12
1465331|NCT01975220|3586583|P3|COMPLETED|Test Period 1||12
1465332|NCT01975220|3586584|P2|COMPLETED|Test Period 1||11
1465333|NCT01975220|3586585|P1|COMPLETED|Test Period 1||12
1465334|NCT01975220|3586580|P6|STARTED|Test Period 1||12
1465335|NCT01975220|3586581|P5|STARTED|Test Period 1||12
1465336|NCT01975220|3586582|P4|STARTED|Test Period 1||12
1465337|NCT01975220|3586583|P3|STARTED|Test Period 1||12
1465338|NCT01975220|3586584|P2|STARTED|Test Period 1||12
1465339|NCT01975220|3586585|P1|STARTED|Test Period 1||12
1465340|NCT01975090|3586629|P1|NOT COMPLETED|Overall Study||12
1465341|NCT01975090|3586629|P1|COMPLETED|Overall Study||117
1465342|NCT01975090|3586629|P1|6-month Follow-up|Overall Study||117
1465343|NCT01975090|3586629|P1|STARTED|Overall Study||129
1465344|NCT01974895|3586641|P2|NOT COMPLETED|Overall Study||15
1465345|NCT01974895|3586642|P1|NOT COMPLETED|Overall Study||15
1465346|NCT01974895|3586641|P2|COMPLETED|Overall Study||141
1465347|NCT01974895|3586642|P1|COMPLETED|Overall Study||143
1465348|NCT01974895|3586641|P2|STARTED|Overall Study||156
1465349|NCT01974895|3586642|P1|STARTED|Overall Study||158
1465350|NCT01974817|3586672|P1|NOT COMPLETED|Overall Study||8
1465351|NCT01974817|3586672|P1|COMPLETED|Overall Study||17
1465352|NCT01974817|3586672|P1|STARTED|Overall Study||25
1465353|NCT01974752|3586678|P2|NOT COMPLETED|Overall Study||15
1465354|NCT01974752|3586679|P1|NOT COMPLETED|Overall Study||37
1465355|NCT01974752|3586678|P2|COMPLETED|Overall Study||17
1465356|NCT01974752|3586679|P1|COMPLETED|Overall Study||60
1465357|NCT01974752|3586678|P2|STARTED|Overall Study||32
1465358|NCT01974752|3586679|P1|STARTED|Overall Study||97
1465359|NCT01974700|3586693|P2|NOT COMPLETED|Overall Study||0
1465360|NCT01974700|3586694|P1|NOT COMPLETED|Overall Study||0
1465361|NCT01974700|3586693|P2|COMPLETED|Overall Study||3
1465362|NCT01974700|3586694|P1|COMPLETED|Overall Study||5
1465363|NCT01974700|3586693|P2|STARTED|Overall Study||3
1465364|NCT01974700|3586694|P1|STARTED|Overall Study||5
1465365|NCT01974687|3586729|P25|NOT COMPLETED|Overall Study||0
1465366|NCT01974687|3586730|P24|NOT COMPLETED|Overall Study||0
1465367|NCT01974687|3586731|P23|NOT COMPLETED|Overall Study||0
1465368|NCT01974687|3586732|P22|NOT COMPLETED|Overall Study||0
1465369|NCT01974687|3586733|P21|NOT COMPLETED|Overall Study||0
1465370|NCT01974687|3586734|P20|NOT COMPLETED|Overall Study||0
1465371|NCT01974687|3586735|P19|NOT COMPLETED|Overall Study||0
1465372|NCT01974687|3586736|P18|NOT COMPLETED|Overall Study||3
1465373|NCT01974687|3586737|P17|NOT COMPLETED|Overall Study||1
1465374|NCT01974687|3586738|P16|NOT COMPLETED|Overall Study||1
1465375|NCT01974687|3586739|P15|NOT COMPLETED|Overall Study||1
1465376|NCT01974687|3586740|P14|NOT COMPLETED|Overall Study||2
1465377|NCT01974687|3586741|P13|NOT COMPLETED|Overall Study||3
1465378|NCT01974687|3586742|P12|NOT COMPLETED|Overall Study||2
1465379|NCT01974687|3586743|P11|NOT COMPLETED|Overall Study||0
1465380|NCT01974687|3586744|P10|NOT COMPLETED|Overall Study||0
1465381|NCT01974687|3586745|P9|NOT COMPLETED|Overall Study||0
1465382|NCT01974687|3586746|P8|NOT COMPLETED|Overall Study||0
1465383|NCT01974687|3586747|P7|NOT COMPLETED|Overall Study||0
1465384|NCT01974687|3586748|P6|NOT COMPLETED|Overall Study||0
1465385|NCT01974687|3586749|P5|NOT COMPLETED|Overall Study||0
1465386|NCT01974687|3586750|P4|NOT COMPLETED|Overall Study||0
1465387|NCT01974687|3586751|P3|NOT COMPLETED|Overall Study||0
1465388|NCT01974687|3586752|P2|NOT COMPLETED|Overall Study||0
1465389|NCT01974687|3586753|P1|NOT COMPLETED|Overall Study||0
1465390|NCT01974687|3586729|P25|COMPLETED|Overall Study||10
1465391|NCT01974687|3586730|P24|COMPLETED|Overall Study||6
1465392|NCT01974687|3586731|P23|COMPLETED|Overall Study||8
1465393|NCT01974687|3586732|P22|COMPLETED|Overall Study||8
1465394|NCT01974687|3586733|P21|COMPLETED|Overall Study||3
1465395|NCT01974687|3586734|P20|COMPLETED|Overall Study||3
1465396|NCT01974687|3586735|P19|COMPLETED|Overall Study||9
1465397|NCT01974687|3586736|P18|COMPLETED|Overall Study||8
1465398|NCT01974687|3586737|P17|COMPLETED|Overall Study||8
1465399|NCT01974687|3586738|P16|COMPLETED|Overall Study||8
1465400|NCT01974687|3586739|P15|COMPLETED|Overall Study||18
1465401|NCT01974687|3586740|P14|COMPLETED|Overall Study||8
1465402|NCT01974687|3586741|P13|COMPLETED|Overall Study||10
1465403|NCT01974687|3586742|P12|COMPLETED|Overall Study||11
1465404|NCT01974687|3586743|P11|COMPLETED|Overall Study||3
1465405|NCT01974687|3586744|P10|COMPLETED|Overall Study||3
1465406|NCT01974687|3586745|P9|COMPLETED|Overall Study||3
1465407|NCT01974687|3586746|P8|COMPLETED|Overall Study||3
1465408|NCT01974687|3586747|P7|COMPLETED|Overall Study||3
1465409|NCT01974687|3586748|P6|COMPLETED|Overall Study||6
1465410|NCT01974687|3586749|P5|COMPLETED|Overall Study||2
1465411|NCT01974687|3586750|P4|COMPLETED|Overall Study||6
1465412|NCT01974687|3586751|P3|COMPLETED|Overall Study||6
1465413|NCT01974687|3586752|P2|COMPLETED|Overall Study||6
1465414|NCT01974687|3586753|P1|COMPLETED|Overall Study||6
1465415|NCT01974687|3586729|P25|Treated|Overall Study||10
1465416|NCT01974687|3586730|P24|Treated|Overall Study||6
1465417|NCT01974687|3586731|P23|Treated|Overall Study||8
1465418|NCT01974687|3586732|P22|Treated|Overall Study||8
1465419|NCT01974687|3586733|P21|Treated|Overall Study||3
1465420|NCT01974687|3586734|P20|Treated|Overall Study||3
1465421|NCT01974687|3586735|P19|Treated|Overall Study||9
1465422|NCT01974687|3586736|P18|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
1465423|NCT01974687|3586737|P17|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
1465424|NCT01974687|3586738|P16|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
1465425|NCT01974687|3586739|P15|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
1465426|NCT01974687|3586740|P14|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
1465427|NCT01974687|3586741|P13|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
1465428|NCT01974687|3586742|P12|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
1465429|NCT01974687|3586743|P11|Treated|Overall Study||3
1465430|NCT01974687|3586744|P10|Treated|Overall Study||3
1465431|NCT01974687|3586745|P9|Treated|Overall Study||3
1465432|NCT01974687|3586746|P8|Treated|Overall Study||3
1465433|NCT01974687|3586747|P7|Treated|Overall Study||3
1465434|NCT01974687|3586748|P6|Treated|Overall Study||6
1465435|NCT01974687|3586749|P5|Treated|Overall Study||2
1465436|NCT01974687|3586750|P4|Treated|Overall Study||6
1465437|NCT01974687|3586751|P3|Treated|Overall Study||6
1465438|NCT01974687|3586752|P2|Treated|Overall Study||6
1465439|NCT01974687|3586753|P1|Treated|Overall Study||6
1465440|NCT01974687|3586729|P25|STARTED|Overall Study||10
1465441|NCT01974687|3586730|P24|STARTED|Overall Study||6
1465442|NCT01974687|3586731|P23|STARTED|Overall Study||8
1465443|NCT01974687|3586732|P22|STARTED|Overall Study||8
1465444|NCT01974687|3586733|P21|STARTED|Overall Study||3
1465445|NCT01974687|3586734|P20|STARTED|Overall Study||3
1465446|NCT01974687|3586735|P19|STARTED|Overall Study||9
1465447|NCT01974687|3586736|P18|STARTED|Overall Study||11
1465448|NCT01974687|3586737|P17|STARTED|Overall Study||9
1465449|NCT01974687|3586738|P16|STARTED|Overall Study||9
1465450|NCT01974687|3586739|P15|STARTED|Overall Study||19
1465451|NCT01974687|3586740|P14|STARTED|Overall Study||10
1465452|NCT01974687|3586741|P13|STARTED|Overall Study||13
1465453|NCT01974687|3586742|P12|STARTED|Overall Study||13
1465454|NCT01974687|3586743|P11|STARTED|Overall Study||3
1465455|NCT01974687|3586744|P10|STARTED|Overall Study||3
1465456|NCT01974687|3586745|P9|STARTED|Overall Study||3
1465457|NCT01974687|3586746|P8|STARTED|Overall Study||3
1465458|NCT01974687|3586747|P7|STARTED|Overall Study||3
1465459|NCT01974687|3586748|P6|STARTED|Overall Study||6
1465460|NCT01974687|3586749|P5|STARTED|Overall Study||2
1465461|NCT01974687|3586750|P4|STARTED|Overall Study||6
1465462|NCT01974687|3586751|P3|STARTED|Overall Study||6
1465463|NCT01974687|3586752|P2|STARTED|Overall Study||6
1465464|NCT01974687|3586753|P1|STARTED|Overall Study||6
1465465|NCT01974323|3587102|P2|NOT COMPLETED|Overall Study||93
1465466|NCT01974323|3587103|P1|NOT COMPLETED|Overall Study||92
1465467|NCT01974323|3587102|P2|COMPLETED|Overall Study||1027
1465468|NCT01974323|3587103|P1|COMPLETED|Overall Study||1026
1465469|NCT01974323|3587102|P2|STARTED|Overall Study||1120
1465470|NCT01974323|3587103|P1|STARTED|Overall Study||1118
1465471|NCT01974245|3587127|P2|NOT COMPLETED|Overall Study||8
1465472|NCT01974245|3587128|P1|NOT COMPLETED|Overall Study||9
1465473|NCT01974245|3587127|P2|COMPLETED|Overall Study||20
1465474|NCT01974245|3587128|P1|COMPLETED|Overall Study||18
1465475|NCT01974245|3587127|P2|STARTED|Overall Study||28
1465476|NCT01974245|3587128|P1|STARTED|Overall Study||27
1465477|NCT01974141|3587136|P2|NOT COMPLETED|Overall Study||82
1465478|NCT01974141|3587137|P1|NOT COMPLETED|Overall Study||96
1465479|NCT01974141|3587136|P2|COMPLETED|Overall Study||976
1465480|NCT01974141|3587137|P1|COMPLETED|Overall Study||948
1465481|NCT01974141|3587136|P2|STARTED|Overall Study||1058
1465482|NCT01974141|3587137|P1|STARTED|Overall Study||1044
1465483|NCT01974089|3587161|P2|NOT COMPLETED|Overall Study||0
1465484|NCT01974089|3587162|P1|NOT COMPLETED|Overall Study||0
1465485|NCT01974089|3587161|P2|COMPLETED|Overall Study||101
1465486|NCT01974089|3587162|P1|COMPLETED|Overall Study||53
1465487|NCT01974089|3587161|P2|STARTED|Overall Study||101
1465488|NCT01974089|3587162|P1|STARTED|Overall Study||53
1465489|NCT01974050|3587172|P1|NOT COMPLETED|Overall Study||25
1465490|NCT01974050|3587172|P1|COMPLETED|Overall Study||141
1465491|NCT01974050|3587172|P1|STARTED|Overall Study||166
1465492|NCT01973777|3587179|P1|NOT COMPLETED|Overall Study||7
1465493|NCT01973777|3587179|P1|COMPLETED|Overall Study||44
1465494|NCT01973777|3587179|P1|One Year Follow-up|Overall Study||44
1465495|NCT01973777|3587179|P1|STARTED|Overall Study|January 2014|51
1465496|NCT01973608|3587189|P4|NOT COMPLETED|Overall Study||0
1465497|NCT01973608|3587190|P3|NOT COMPLETED|Overall Study||0
1465498|NCT01973608|3587191|P2|NOT COMPLETED|Overall Study||0
1465499|NCT01973608|3587192|P1|NOT COMPLETED|Overall Study||0
1465500|NCT01973608|3587189|P4|COMPLETED|Overall Study||2
1465501|NCT01973608|3587190|P3|COMPLETED|Overall Study||6
1465502|NCT01973608|3587191|P2|COMPLETED|Overall Study||2
1465503|NCT01973608|3587192|P1|COMPLETED|Overall Study||2
1465504|NCT01973608|3587189|P4|STARTED|Overall Study||2
1465505|NCT01973608|3587190|P3|STARTED|Overall Study||6
1465506|NCT01973608|3587191|P2|STARTED|Overall Study||2
1465507|NCT01973608|3587192|P1|STARTED|Overall Study||2
1465508|NCT01973595|3587214|P4|NOT COMPLETED|Intervention Phase 2||0
1465509|NCT01973595|3587215|P3|NOT COMPLETED|Intervention Phase 2||0
1465510|NCT01973595|3587216|P2|NOT COMPLETED|Intervention Phase 2||0
1465511|NCT01973595|3587217|P1|NOT COMPLETED|Intervention Phase 2||0
1465512|NCT01973595|3587214|P4|COMPLETED|Intervention Phase 2||14
1465513|NCT01973595|3587215|P3|COMPLETED|Intervention Phase 2||14
1465514|NCT01973595|3587216|P2|COMPLETED|Intervention Phase 2||14
1465515|NCT01973595|3587217|P1|COMPLETED|Intervention Phase 2||14
1465516|NCT01973595|3587214|P4|STARTED|Intervention Phase 2||14
1465517|NCT01973595|3587215|P3|STARTED|Intervention Phase 2||14
1465518|NCT01973595|3587216|P2|STARTED|Intervention Phase 2||14
1465519|NCT01973595|3587217|P1|STARTED|Intervention Phase 2||14
1465520|NCT01973595|3587214|P4|NOT COMPLETED|Washout||0
1465521|NCT01973595|3587215|P3|NOT COMPLETED|Washout||1
1465522|NCT01973595|3587216|P2|NOT COMPLETED|Washout||0
1465523|NCT01973595|3587217|P1|NOT COMPLETED|Washout||1
1465524|NCT01973595|3587214|P4|COMPLETED|Washout||14
1465525|NCT01973595|3587215|P3|COMPLETED|Washout||14
1465526|NCT01973595|3587216|P2|COMPLETED|Washout||14
1465527|NCT01973595|3587217|P1|COMPLETED|Washout||14
1465528|NCT01973595|3587214|P4|STARTED|Washout||14
1465529|NCT01973595|3587215|P3|STARTED|Washout||15
1465530|NCT01973595|3587216|P2|STARTED|Washout||14
1465531|NCT01973595|3587217|P1|STARTED|Washout||15
1465532|NCT01973595|3587214|P4|NOT COMPLETED|Intervention Phase 1||0
1465533|NCT01973595|3587215|P3|NOT COMPLETED|Intervention Phase 1||0
1465534|NCT01973595|3587216|P2|NOT COMPLETED|Intervention Phase 1||0
1465535|NCT01973595|3587217|P1|NOT COMPLETED|Intervention Phase 1||0
1465536|NCT01973595|3587214|P4|COMPLETED|Intervention Phase 1||14
1465537|NCT01973595|3587215|P3|COMPLETED|Intervention Phase 1||15
1465538|NCT01973595|3587216|P2|COMPLETED|Intervention Phase 1||14
1465539|NCT01973595|3587217|P1|COMPLETED|Intervention Phase 1||15
1465540|NCT01973595|3587214|P4|STARTED|Intervention Phase 1||14
1465541|NCT01973595|3587215|P3|STARTED|Intervention Phase 1||15
1465542|NCT01973595|3587216|P2|STARTED|Intervention Phase 1||14
1465543|NCT01973595|3587217|P1|STARTED|Intervention Phase 1||15
1465544|NCT01973491|3587231|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
1465545|NCT01973491|3587231|P1|COMPLETED|Treatment Period (16 Weeks)||18
1465546|NCT01973491|3587231|P1|STARTED|Treatment Period (16 Weeks)||19
1465547|NCT01973491|3587231|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
1465548|NCT01973491|3587231|P1|COMPLETED|Titration Period(4 Weeks)||19
1465549|NCT01973491|3587231|P1|STARTED|Titration Period(4 Weeks)||19
1465550|NCT01973491|3587231|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
1465551|NCT01973491|3587231|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
1465552|NCT01973491|3587231|P1|STARTED|Baseline Control Period (8 Weeks)||37
1465553|NCT01973439|3587247|P1|NOT COMPLETED|Overall Study||5
1465554|NCT01973439|3587247|P1|COMPLETED|Overall Study||18
1465555|NCT01973439|3587247|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
1465556|NCT01973439|3587247|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
1465557|NCT01973439|3587247|P1|STARTED|Overall Study||23
1465558|NCT01973413|3587256|P2|NOT COMPLETED|Overall Study||0
1465559|NCT01973413|3587257|P1|NOT COMPLETED|Overall Study||1
1465560|NCT01973413|3587256|P2|COMPLETED|Overall Study||20
1465561|NCT01973413|3587257|P1|COMPLETED|Overall Study||11
1465562|NCT01973413|3587256|P2|STARTED|Overall Study||20
1465563|NCT01973413|3587257|P1|STARTED|Overall Study||12
1465564|NCT01973387|3587269|P2|NOT COMPLETED|Overall Study||18
1465565|NCT01973387|3587270|P1|NOT COMPLETED|Overall Study||106
1465566|NCT01973387|3587269|P2|COMPLETED|Overall Study||36
1465567|NCT01973387|3587270|P1|COMPLETED|Overall Study||0
1465568|NCT01973387|3587269|P2|Treated|Overall Study||52
1465569|NCT01973387|3587270|P1|Treated|Overall Study||104
1465570|NCT01973387|3587269|P2|STARTED|Overall Study||54
1465571|NCT01973387|3587270|P1|STARTED|Overall Study||106
1465572|NCT01973348|3587288|P4|NOT COMPLETED|Overall Study||0
1465573|NCT01973348|3587289|P3|NOT COMPLETED|Overall Study||0
1465574|NCT01973348|3587290|P2|NOT COMPLETED|Overall Study||3
1465575|NCT01973348|3587291|P1|NOT COMPLETED|Overall Study||8
1465576|NCT01973348|3587288|P4|COMPLETED|Overall Study||0
1465577|NCT01973348|3587289|P3|COMPLETED|Overall Study||0
1465578|NCT01973348|3587290|P2|COMPLETED|Overall Study||15
1465579|NCT01973348|3587291|P1|COMPLETED|Overall Study||19
1465580|NCT01973348|3587288|P4|STARTED|Overall Study||0
1465581|NCT01973348|3587289|P3|STARTED|Overall Study||0
1465582|NCT01973348|3587290|P2|STARTED|Overall Study||18
1465583|NCT01973348|3587291|P1|STARTED|Overall Study||27
1465584|NCT01973231|3587311|P2|NOT COMPLETED|Overall Study||12
1465585|NCT01973231|3587312|P1|NOT COMPLETED|Overall Study||11
1465586|NCT01973231|3587311|P2|COMPLETED|Overall Study||190
1465587|NCT01973231|3587312|P1|COMPLETED|Overall Study||191
1465588|NCT01973231|3587311|P2|STARTED|Overall Study||202
1465589|NCT01973231|3587312|P1|STARTED|Overall Study||202
1465590|NCT01973218|3587332|P2|NOT COMPLETED|Overall Study||0
1465591|NCT01973218|3587333|P1|NOT COMPLETED|Overall Study||2
1465592|NCT01973218|3587332|P2|COMPLETED|Overall Study||88
1465593|NCT01973218|3587333|P1|COMPLETED|Overall Study||174
1465594|NCT01973218|3587332|P2|STARTED|Overall Study||88
1465595|NCT01973218|3587333|P1|STARTED|Overall Study||176
1465596|NCT01973205|3587356|P2|NOT COMPLETED|Overall Study||22
1465597|NCT01973205|3587357|P1|NOT COMPLETED|Overall Study||30
1465598|NCT01973205|3587356|P2|COMPLETED|Overall Study||425
1465599|NCT01973205|3587357|P1|COMPLETED|Overall Study||423
1465600|NCT01973205|3587356|P2|STARTED|Overall Study||447
1465601|NCT01973205|3587357|P1|STARTED|Overall Study||453
1465602|NCT01973062|3587369|P1|NOT COMPLETED|Overall Study||0
1465603|NCT01973062|3587369|P1|COMPLETED|Overall Study||1
1465604|NCT01973062|3587369|P1|STARTED|Overall Study||1
1465605|NCT01973036|3587379|P2|NOT COMPLETED|Overall Study||0
1465606|NCT01973036|3587380|P1|NOT COMPLETED|Overall Study||0
1465607|NCT01973036|3587379|P2|COMPLETED|Overall Study||93
1465608|NCT01973036|3587380|P1|COMPLETED|Overall Study||108
1465609|NCT01973036|3587379|P2|Received Assigned Intervention|Overall Study||88
1465610|NCT01973036|3587380|P1|Received Assigned Intervention|Overall Study||113
1465611|NCT01973036|3587379|P2|STARTED|Overall Study||93
1465612|NCT01973036|3587380|P1|STARTED|Overall Study||108
1465613|NCT01972841|3587426|P6|NOT COMPLETED|Overall Study||85
1465614|NCT01972841|3587427|P5|NOT COMPLETED|Overall Study||83
1465615|NCT01972841|3587428|P4|NOT COMPLETED|Overall Study||37
1465616|NCT01972841|3587429|P3|NOT COMPLETED|Overall Study||50
1465617|NCT01972841|3587430|P2|NOT COMPLETED|Overall Study||44
1465618|NCT01972841|3587431|P1|NOT COMPLETED|Overall Study||43
1465619|NCT01972841|3587426|P6|COMPLETED|Overall Study||798
1465620|NCT01972841|3587427|P5|COMPLETED|Overall Study||802
1465621|NCT01972841|3587428|P4|COMPLETED|Overall Study||397
1465622|NCT01972841|3587429|P3|COMPLETED|Overall Study||387
1465623|NCT01972841|3587430|P2|COMPLETED|Overall Study||397
1465624|NCT01972841|3587431|P1|COMPLETED|Overall Study||404
1465625|NCT01972841|3587426|P6|STARTED|Overall Study||883
1465626|NCT01972841|3587427|P5|STARTED|Overall Study||885
1465627|NCT01972841|3587428|P4|STARTED|Overall Study||434
1465628|NCT01972841|3587429|P3|STARTED|Overall Study||437
1465629|NCT01972841|3587430|P2|STARTED|Overall Study||441
1465630|NCT01972841|3587431|P1|STARTED|Overall Study||447
1465631|NCT01972776|3587865|P6|NOT COMPLETED|Part 2||7
1465632|NCT01972776|3587866|P5|NOT COMPLETED|Part 2||13
1465633|NCT01972776|3587867|P4|NOT COMPLETED|Part 2||0
1465634|NCT01972776|3587868|P3|NOT COMPLETED|Part 2||0
1465635|NCT01972776|3587869|P2|NOT COMPLETED|Part 2||0
1465636|NCT01972776|3587870|P1|NOT COMPLETED|Part 2||0
1465637|NCT01972776|3587865|P6|COMPLETED|Part 2||0
1465638|NCT01972776|3587866|P5|COMPLETED|Part 2||1
1465639|NCT01972776|3587867|P4|COMPLETED|Part 2||0
1465640|NCT01972776|3587868|P3|COMPLETED|Part 2||0
1465641|NCT01972776|3587869|P2|COMPLETED|Part 2||0
1465642|NCT01972776|3587870|P1|COMPLETED|Part 2||0
1465643|NCT01972776|3587865|P6|STARTED|Part 2||7
1465644|NCT01972776|3587866|P5|STARTED|Part 2||14
1465645|NCT01972776|3587867|P4|STARTED|Part 2||0
1465646|NCT01972776|3587868|P3|STARTED|Part 2||0
1465647|NCT01972776|3587869|P2|STARTED|Part 2||0
1465648|NCT01972776|3587870|P1|STARTED|Part 2||0
1465649|NCT01972776|3587865|P6|NOT COMPLETED|Part 1||0
1465650|NCT01972776|3587866|P5|NOT COMPLETED|Part 1||0
1465651|NCT01972776|3587867|P4|NOT COMPLETED|Part 1||1
1465652|NCT01972776|3587868|P3|NOT COMPLETED|Part 1||2
1465653|NCT01972776|3587869|P2|NOT COMPLETED|Part 1||0
1465654|NCT01972776|3587870|P1|NOT COMPLETED|Part 1||0
1465655|NCT01972776|3587865|P6|COMPLETED|Part 1||0
1465656|NCT01972776|3587866|P5|COMPLETED|Part 1||0
1465657|NCT01972776|3587867|P4|COMPLETED|Part 1||6
1465658|NCT01972776|3587868|P3|COMPLETED|Part 1||6
1465659|NCT01972776|3587869|P2|COMPLETED|Part 1||6
1465660|NCT01972776|3587870|P1|COMPLETED|Part 1||6
1465661|NCT01972776|3587865|P6|STARTED|Part 1||0
1465662|NCT01972776|3587866|P5|STARTED|Part 1||0
1465663|NCT01972776|3587867|P4|STARTED|Part 1||7
1465664|NCT01972776|3587868|P3|STARTED|Part 1||8
1465665|NCT01972776|3587869|P2|STARTED|Part 1||6
1465666|NCT01972776|3587870|P1|STARTED|Part 1||6
1465667|NCT01972724|3587941|P3|NOT COMPLETED|Open-Label||5
1465668|NCT01972724|3587942|P2|NOT COMPLETED|Open-Label||0
1465669|NCT01972724|3587943|P1|NOT COMPLETED|Open-Label||0
1465670|NCT01972724|3587941|P3|COMPLETED|Open-Label||72
1465671|NCT01972724|3587942|P2|COMPLETED|Open-Label||0
1465672|NCT01972724|3587943|P1|COMPLETED|Open-Label||0
1465673|NCT01972724|3587941|P3|STARTED|Open-Label||77
1465674|NCT01972724|3587942|P2|STARTED|Open-Label||0
1465675|NCT01972724|3587943|P1|STARTED|Open-Label||0
1465676|NCT01972724|3587941|P3|NOT COMPLETED|Double-Blind||0
1465677|NCT01972724|3587942|P2|NOT COMPLETED|Double-Blind||9
1465678|NCT01972724|3587943|P1|NOT COMPLETED|Double-Blind||9
1465679|NCT01972724|3587941|P3|COMPLETED|Double-Blind||0
1465680|NCT01972724|3587942|P2|COMPLETED|Double-Blind||9
1465681|NCT01972724|3587943|P1|COMPLETED|Double-Blind||10
1465682|NCT01972724|3587941|P3|Intent-to-treat:Received Study Drug|Double-Blind||0
1465683|NCT01972724|3587942|P2|Intent-to-treat:Received Study Drug|Double-Blind||17
1465684|NCT01972724|3587943|P1|Intent-to-treat:Received Study Drug|Double-Blind||17
1465685|NCT01972724|3587941|P3|STARTED|Double-Blind||0
1465686|NCT01972724|3587942|P2|STARTED|Double-Blind||18
1465687|NCT01972724|3587943|P1|STARTED|Double-Blind||19
1465688|NCT01972659|3587956|P2|NOT COMPLETED|Overall Study||3
1465689|NCT01972659|3587957|P1|NOT COMPLETED|Overall Study||4
1465690|NCT01972659|3587956|P2|COMPLETED|Overall Study||37
1465691|NCT01972659|3587957|P1|COMPLETED|Overall Study||36
1465692|NCT01972659|3587956|P2|STARTED|Overall Study||40
1465693|NCT01972659|3587957|P1|STARTED|Overall Study||40
1465694|NCT01972568|3587966|P3|NOT COMPLETED|Overall Study||16
1465695|NCT01972568|3587967|P2|NOT COMPLETED|Overall Study||12
1465696|NCT01972568|3587968|P1|NOT COMPLETED|Overall Study||16
1465697|NCT01972568|3587966|P3|COMPLETED|Overall Study||84
1465698|NCT01972568|3587967|P2|COMPLETED|Overall Study||92
1465699|NCT01972568|3587968|P1|COMPLETED|Overall Study||86
1465700|NCT01972568|3587966|P3|STARTED|Overall Study||100
1465701|NCT01972568|3587967|P2|STARTED|Overall Study||104
1465702|NCT01972568|3587968|P1|STARTED|Overall Study||102
1465703|NCT01972529|3588007|P4|NOT COMPLETED|Overall Study||4
1465704|NCT01972529|3588008|P3|NOT COMPLETED|Overall Study||2
1465705|NCT01972529|3588009|P2|NOT COMPLETED|Overall Study||5
1465706|NCT01972529|3588010|P1|NOT COMPLETED|Overall Study||2
1465707|NCT01972529|3588007|P4|COMPLETED|Overall Study||55
1465708|NCT01972529|3588008|P3|COMPLETED|Overall Study||32
1465709|NCT01972529|3588009|P2|COMPLETED|Overall Study||85
1465710|NCT01972529|3588010|P1|COMPLETED|Overall Study||46
1465711|NCT01972529|3588007|P4|STARTED|Overall Study||59
1465712|NCT01972529|3588008|P3|STARTED|Overall Study||34
1465713|NCT01972529|3588009|P2|STARTED|Overall Study||90
1465714|NCT01972529|3588010|P1|STARTED|Overall Study||48
1465715|NCT01972516|3588038|P2|NOT COMPLETED|Overall Study||0
1465716|NCT01972516|3588039|P1|NOT COMPLETED|Overall Study||0
1465717|NCT01972516|3588038|P2|COMPLETED|Overall Study||1
1465718|NCT01972516|3588039|P1|COMPLETED|Overall Study||3
1465719|NCT01972516|3588038|P2|STARTED|Overall Study||1
1465720|NCT01972516|3588039|P1|STARTED|Overall Study||3
1465721|NCT01972464|3588055|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
1465722|NCT01972464|3588056|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
1465723|NCT01972464|3588055|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
1465724|NCT01972464|3588056|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
1465725|NCT01972464|3588055|P2|STARTED|3-Month Follow-Up (Week 20)||18
1465726|NCT01972464|3588056|P1|STARTED|3-Month Follow-Up (Week 20)||16
1465727|NCT01972464|3588055|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
1465728|NCT01972464|3588056|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
1465729|NCT01972464|3588055|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
1465730|NCT01972464|3588056|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
1465731|NCT01972464|3588055|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
1465732|NCT01972464|3588056|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
1465733|NCT01972438|3588072|P2|NOT COMPLETED|Post Month 12 Study Period||4
1465734|NCT01972438|3588073|P1|NOT COMPLETED|Post Month 12 Study Period||3
1465735|NCT01972438|3588072|P2|COMPLETED|Post Month 12 Study Period||0
1465736|NCT01972438|3588073|P1|COMPLETED|Post Month 12 Study Period||0
1465737|NCT01972438|3588072|P2|STARTED|Post Month 12 Study Period||4
1465738|NCT01972438|3588073|P1|STARTED|Post Month 12 Study Period||3
1465739|NCT01972438|3588072|P2|NOT COMPLETED|Months 6-12 Study Period||2
1465740|NCT01972438|3588073|P1|NOT COMPLETED|Months 6-12 Study Period||3
1465741|NCT01972438|3588072|P2|COMPLETED|Months 6-12 Study Period||4
1465742|NCT01972438|3588073|P1|COMPLETED|Months 6-12 Study Period||3
1465743|NCT01972438|3588072|P2|STARTED|Months 6-12 Study Period||6
1465744|NCT01972438|3588073|P1|STARTED|Months 6-12 Study Period||6
1465745|NCT01972438|3588072|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
1465746|NCT01972438|3588073|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
1465747|NCT01972438|3588072|P2|COMPLETED|Months 3-6 Crossover Period||6
1465748|NCT01972438|3588073|P1|COMPLETED|Months 3-6 Crossover Period||6
1465749|NCT01972438|3588072|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
1465750|NCT01972438|3588073|P1|STARTED|Months 3-6 Crossover Period||6
1465751|NCT01972438|3588072|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
1465752|NCT01972438|3588073|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
1465753|NCT01972438|3588072|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
1465754|NCT01972438|3588073|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
1465755|NCT01972438|3588072|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
1465756|NCT01972438|3588073|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
1465757|NCT01972308|3588127|P2|NOT COMPLETED|Overall Study||8
1465758|NCT01972308|3588128|P1|NOT COMPLETED|Overall Study||8
1465759|NCT01972308|3588127|P2|COMPLETED|Overall Study||148
1465760|NCT01972308|3588128|P1|COMPLETED|Overall Study||148
1465761|NCT01972308|3588127|P2|STARTED|Overall Study||156
1465762|NCT01972308|3588128|P1|STARTED|Overall Study||156
1465763|NCT01972217|3588148|P4|NOT COMPLETED|Part B Double-blind, Randomised Period||47
1465764|NCT01972217|3588149|P3|NOT COMPLETED|Part B Double-blind, Randomised Period||46
1465765|NCT01972217|3588150|P2|NOT COMPLETED|Part B Double-blind, Randomised Period||0
1465766|NCT01972217|3588151|P1|NOT COMPLETED|Part B Double-blind, Randomised Period||0
1465767|NCT01972217|3588148|P4|COMPLETED|Part B Double-blind, Randomised Period||24
1465768|NCT01972217|3588149|P3|COMPLETED|Part B Double-blind, Randomised Period||25
1465769|NCT01972217|3588150|P2|COMPLETED|Part B Double-blind, Randomised Period||0
1465770|NCT01972217|3588151|P1|COMPLETED|Part B Double-blind, Randomised Period||0
1465771|NCT01972217|3588148|P4|Received Abiraterone|Part B Double-blind, Randomised Period||71
1465772|NCT01972217|3588149|P3|Received Abiraterone|Part B Double-blind, Randomised Period||71
1465773|NCT01972217|3588150|P2|Received Abiraterone|Part B Double-blind, Randomised Period||0
1465774|NCT01972217|3588151|P1|Received Abiraterone|Part B Double-blind, Randomised Period||0
1465775|NCT01972217|3588148|P4|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
1465776|NCT01972217|3588149|P3|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
1465777|NCT01972217|3588150|P2|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
1465778|NCT01972217|3588151|P1|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
1465779|NCT01972217|3588148|P4|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
1465780|NCT01972217|3588149|P3|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
1465781|NCT01972217|3588150|P2|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
1465782|NCT01972217|3588151|P1|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
1465783|NCT01972217|3588148|P4|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
1465784|NCT01972217|3588149|P3|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
1465785|NCT01972217|3588150|P2|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
1465786|NCT01972217|3588151|P1|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
1465787|NCT01972217|3588148|P4|COMPLETED|Part A: Open-label Safety Run-in Period||0
1465788|NCT01972217|3588149|P3|COMPLETED|Part A: Open-label Safety Run-in Period||0
1465789|NCT01972217|3588150|P2|COMPLETED|Part A: Open-label Safety Run-in Period||1
1465790|NCT01972217|3588151|P1|COMPLETED|Part A: Open-label Safety Run-in Period||2
1465791|NCT01972217|3588148|P4|STARTED|Part A: Open-label Safety Run-in Period||0
1465792|NCT01972217|3588149|P3|STARTED|Part A: Open-label Safety Run-in Period||0
1465793|NCT01972217|3588150|P2|STARTED|Part A: Open-label Safety Run-in Period||13
1465794|NCT01972217|3588151|P1|STARTED|Part A: Open-label Safety Run-in Period||3
1465795|NCT01972152|3588197|P6|NOT COMPLETED|Third Treatment Visit||0
1465796|NCT01972152|3588198|P5|NOT COMPLETED|Third Treatment Visit||0
1465797|NCT01972152|3588199|P4|NOT COMPLETED|Third Treatment Visit||0
1465798|NCT01972152|3588200|P3|NOT COMPLETED|Third Treatment Visit||0
1465799|NCT01972152|3588201|P2|NOT COMPLETED|Third Treatment Visit||0
1465800|NCT01972152|3588202|P1|NOT COMPLETED|Third Treatment Visit||0
1465801|NCT01972152|3588197|P6|COMPLETED|Third Treatment Visit||5
1465802|NCT01972152|3588198|P5|COMPLETED|Third Treatment Visit||5
1465803|NCT01972152|3588199|P4|COMPLETED|Third Treatment Visit||5
1465804|NCT01972152|3588200|P3|COMPLETED|Third Treatment Visit||5
1465805|NCT01972152|3588201|P2|COMPLETED|Third Treatment Visit||3
1465806|NCT01972152|3588202|P1|COMPLETED|Third Treatment Visit||5
1465807|NCT01972152|3588197|P6|STARTED|Third Treatment Visit||5
1465808|NCT01972152|3588198|P5|STARTED|Third Treatment Visit||5
1465809|NCT01972152|3588199|P4|STARTED|Third Treatment Visit||5
1465810|NCT01972152|3588200|P3|STARTED|Third Treatment Visit||5
1465811|NCT01972152|3588201|P2|STARTED|Third Treatment Visit||3
1465812|NCT01972152|3588202|P1|STARTED|Third Treatment Visit||5
1465813|NCT01972152|3588197|P6|NOT COMPLETED|Second Treatment Visit||0
1465814|NCT01972152|3588198|P5|NOT COMPLETED|Second Treatment Visit||0
1465815|NCT01972152|3588199|P4|NOT COMPLETED|Second Treatment Visit||0
1465816|NCT01972152|3588200|P3|NOT COMPLETED|Second Treatment Visit||0
1465817|NCT01972152|3588201|P2|NOT COMPLETED|Second Treatment Visit||1
1465818|NCT01972152|3588202|P1|NOT COMPLETED|Second Treatment Visit||0
1465819|NCT01972152|3588197|P6|COMPLETED|Second Treatment Visit||5
1465820|NCT01972152|3588198|P5|COMPLETED|Second Treatment Visit||5
1465821|NCT01972152|3588199|P4|COMPLETED|Second Treatment Visit||5
1465822|NCT01972152|3588200|P3|COMPLETED|Second Treatment Visit||5
1465823|NCT01972152|3588201|P2|COMPLETED|Second Treatment Visit||3
1465824|NCT01972152|3588202|P1|COMPLETED|Second Treatment Visit||5
1465825|NCT01972152|3588197|P6|STARTED|Second Treatment Visit||5
1465826|NCT01972152|3588198|P5|STARTED|Second Treatment Visit||5
1465827|NCT01972152|3588199|P4|STARTED|Second Treatment Visit||5
1465828|NCT01972152|3588200|P3|STARTED|Second Treatment Visit||5
1465829|NCT01972152|3588201|P2|STARTED|Second Treatment Visit||4
1465830|NCT01972152|3588202|P1|STARTED|Second Treatment Visit||5
1465831|NCT01972152|3588197|P6|NOT COMPLETED|First Treatment Visit||0
1465832|NCT01972152|3588198|P5|NOT COMPLETED|First Treatment Visit||0
1465833|NCT01972152|3588199|P4|NOT COMPLETED|First Treatment Visit||0
1465834|NCT01972152|3588200|P3|NOT COMPLETED|First Treatment Visit||0
1465835|NCT01972152|3588201|P2|NOT COMPLETED|First Treatment Visit||1
1465836|NCT01972152|3588202|P1|NOT COMPLETED|First Treatment Visit||0
1465837|NCT01972152|3588197|P6|COMPLETED|First Treatment Visit||5
1465838|NCT01972152|3588198|P5|COMPLETED|First Treatment Visit||5
1465839|NCT01972152|3588199|P4|COMPLETED|First Treatment Visit||5
1465840|NCT01972152|3588200|P3|COMPLETED|First Treatment Visit||5
1465841|NCT01972152|3588201|P2|COMPLETED|First Treatment Visit||4
1465842|NCT01972152|3588202|P1|COMPLETED|First Treatment Visit||5
1465843|NCT01972152|3588197|P6|STARTED|First Treatment Visit||5
1465844|NCT01972152|3588198|P5|STARTED|First Treatment Visit||5
1465845|NCT01972152|3588199|P4|STARTED|First Treatment Visit||5
1465846|NCT01972152|3588200|P3|STARTED|First Treatment Visit||5
1465847|NCT01972152|3588201|P2|STARTED|First Treatment Visit||5
1465848|NCT01972152|3588202|P1|STARTED|First Treatment Visit||5
1465849|NCT01971723|3588239|P2|NOT COMPLETED|Overall Study||3
1465850|NCT01971723|3588240|P1|NOT COMPLETED|Overall Study||2
1465851|NCT01971723|3588239|P2|COMPLETED|Overall Study||13
1465852|NCT01971723|3588240|P1|COMPLETED|Overall Study||14
1465853|NCT01971723|3588239|P2|STARTED|Overall Study||16
1465854|NCT01971723|3588240|P1|STARTED|Overall Study||16
1465855|NCT01971645|3588273|P3|NOT COMPLETED|Overall Study||2
1465856|NCT01971645|3588274|P2|NOT COMPLETED|Overall Study||0
1465857|NCT01971645|3588275|P1|NOT COMPLETED|Overall Study||2
1465858|NCT01971645|3588273|P3|COMPLETED|Overall Study||23
1465859|NCT01971645|3588274|P2|COMPLETED|Overall Study||27
1465860|NCT01971645|3588275|P1|COMPLETED|Overall Study||23
1465861|NCT01971645|3588273|P3|STARTED|Overall Study||25
1465862|NCT01971645|3588274|P2|STARTED|Overall Study||27
1465863|NCT01971645|3588275|P1|STARTED|Overall Study||25
1465864|NCT01971593|3588286|P2|NOT COMPLETED|Overall Study||4
1465865|NCT01971593|3588287|P1|NOT COMPLETED|Overall Study||5
1465866|NCT01971593|3588286|P2|COMPLETED|Overall Study||8
1465867|NCT01971593|3588287|P1|COMPLETED|Overall Study||9
1465868|NCT01971593|3588286|P2|STARTED|Overall Study||12
1465869|NCT01971593|3588287|P1|STARTED|Overall Study||14
1465870|NCT01971580|3588298|P2|NOT COMPLETED|Overall Study||5
1465871|NCT01971580|3588299|P1|NOT COMPLETED|Overall Study||4
1465872|NCT01971580|3588298|P2|COMPLETED|Overall Study||9
1465873|NCT01971580|3588299|P1|COMPLETED|Overall Study||10
1465874|NCT01971580|3588298|P2|STARTED|Overall Study||14
1465875|NCT01971580|3588299|P1|STARTED|Overall Study||14
1465876|NCT01971567|3588309|P2|NOT COMPLETED|Overall Study||2
1465877|NCT01971567|3588310|P1|NOT COMPLETED|Overall Study||4
1465878|NCT01971567|3588309|P2|COMPLETED|Overall Study||49
1465879|NCT01971567|3588310|P1|COMPLETED|Overall Study||52
1465880|NCT01971567|3588309|P2|STARTED|Overall Study||51
1465881|NCT01971567|3588310|P1|STARTED|Overall Study||56
1465882|NCT01971554|3588336|P4|NOT COMPLETED|Overall Study||0
1465883|NCT01971554|3588337|P3|NOT COMPLETED|Overall Study||0
1465884|NCT01971554|3588338|P2|NOT COMPLETED|Overall Study||0
1465885|NCT01971554|3588339|P1|NOT COMPLETED|Overall Study||1
1465886|NCT01971554|3588336|P4|COMPLETED|Overall Study||18
1465887|NCT01971554|3588337|P3|COMPLETED|Overall Study||18
1465888|NCT01971554|3588338|P2|COMPLETED|Overall Study||18
1465889|NCT01971554|3588339|P1|COMPLETED|Overall Study||8
1465890|NCT01971554|3588336|P4|STARTED|Overall Study||18
1465891|NCT01971554|3588337|P3|STARTED|Overall Study||18
1465892|NCT01971554|3588338|P2|STARTED|Overall Study||18
1465893|NCT01971554|3588339|P1|STARTED|Overall Study||9
1465894|NCT01971476|3588376|P3|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
1465895|NCT01971476|3588377|P2|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
1465896|NCT01971476|3588378|P1|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
1465897|NCT01971476|3588376|P3|COMPLETED|Cohort 2: 12 to <18 Years||0
1465898|NCT01971476|3588377|P2|COMPLETED|Cohort 2: 12 to <18 Years||0
1465899|NCT01971476|3588378|P1|COMPLETED|Cohort 2: 12 to <18 Years||0
1465900|NCT01971476|3588376|P3|STARTED|Cohort 2: 12 to <18 Years||0
1465901|NCT01971476|3588377|P2|STARTED|Cohort 2: 12 to <18 Years||4
1465902|NCT01971476|3588378|P1|STARTED|Cohort 2: 12 to <18 Years||6
1465903|NCT01971476|3588376|P3|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
1465904|NCT01971476|3588377|P2|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
1465905|NCT01971476|3588378|P1|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
1465906|NCT01971476|3588376|P3|COMPLETED|Cohort 1: 2 to <12 Years||0
1465907|NCT01971476|3588377|P2|COMPLETED|Cohort 1: 2 to <12 Years||0
1465908|NCT01971476|3588378|P1|COMPLETED|Cohort 1: 2 to <12 Years||0
1465909|NCT01971476|3588376|P3|STARTED|Cohort 1: 2 to <12 Years||6
1465910|NCT01971476|3588377|P2|STARTED|Cohort 1: 2 to <12 Years||3
1465911|NCT01971476|3588378|P1|STARTED|Cohort 1: 2 to <12 Years||3
1465912|NCT01971385|3588458|P3|NOT COMPLETED|Overall Study||4
1465913|NCT01971385|3588459|P2|NOT COMPLETED|Overall Study||5
1465914|NCT01971385|3588460|P1|NOT COMPLETED|Overall Study||3
1465915|NCT01971385|3588458|P3|COMPLETED|Overall Study||15
1465916|NCT01971385|3588459|P2|COMPLETED|Overall Study||13
1465917|NCT01971385|3588460|P1|COMPLETED|Overall Study||14
1465918|NCT01971385|3588458|P3|STARTED|Overall Study||19
1465919|NCT01971385|3588459|P2|STARTED|Overall Study||18
1465920|NCT01971385|3588460|P1|STARTED|Overall Study||17
1465921|NCT01971255|3588469|P2|NOT COMPLETED|Overall Study||2
1465922|NCT01971255|3588470|P1|NOT COMPLETED|Overall Study||1
1465923|NCT01971255|3588469|P2|COMPLETED|Overall Study||40
1465924|NCT01971255|3588470|P1|COMPLETED|Overall Study||31
1465925|NCT01971255|3588469|P2|STARTED|Overall Study||42
1465926|NCT01971255|3588470|P1|STARTED|Overall Study||32
1465927|NCT01971203|3588488|P2|NOT COMPLETED|Overall Study||8
1465928|NCT01971203|3588489|P1|NOT COMPLETED|Overall Study||9
1465929|NCT01971203|3588488|P2|COMPLETED|Overall Study||21
1465930|NCT01971203|3588489|P1|COMPLETED|Overall Study||17
1465931|NCT01971203|3588488|P2|STARTED|Overall Study||29
1465932|NCT01971203|3588489|P1|STARTED|Overall Study||26
1465933|NCT01971086|3588501|P1|NOT COMPLETED|Overall Study||0
1465934|NCT01971086|3588501|P1|COMPLETED|Overall Study||300
1465935|NCT01971086|3588501|P1|STARTED|Overall Study||300
1465936|NCT01970995|3588516|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
1465937|NCT01970995|3588517|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
1465938|NCT01970995|3588518|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
1465939|NCT01970995|3588516|P3|COMPLETED|End of Study (Population at Day 90)||38
1465940|NCT01970995|3588517|P2|COMPLETED|End of Study (Population at Day 90)||41
1465941|NCT01970995|3588518|P1|COMPLETED|End of Study (Population at Day 90)||76
1465942|NCT01970995|3588516|P3|STARTED|End of Study (Population at Day 90)||39
1465943|NCT01970995|3588517|P2|STARTED|End of Study (Population at Day 90)||41
1465944|NCT01970995|3588518|P1|STARTED|End of Study (Population at Day 90)||77
1465945|NCT01970995|3588516|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
1465946|NCT01970995|3588517|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
1465947|NCT01970995|3588518|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
1465948|NCT01970995|3588516|P3|COMPLETED|Confinement Period (Population at Day 5)||39
1465949|NCT01970995|3588517|P2|COMPLETED|Confinement Period (Population at Day 5)||41
1465950|NCT01970995|3588518|P1|COMPLETED|Confinement Period (Population at Day 5)||77
1465951|NCT01970995|3588516|P3|STARTED|Confinement Period (Population at Day 5)||40
1465952|NCT01970995|3588517|P2|STARTED|Confinement Period (Population at Day 5)||42
1465953|NCT01970995|3588518|P1|STARTED|Confinement Period (Population at Day 5)||78
1465954|NCT01970982|3588541|P3|NOT COMPLETED|Overall Study||2
1465955|NCT01970982|3588542|P2|NOT COMPLETED|Overall Study||0
1465956|NCT01970982|3588543|P1|NOT COMPLETED|Overall Study||0
1465957|NCT01970982|3588541|P3|COMPLETED|Overall Study||38
1465958|NCT01970982|3588542|P2|COMPLETED|Overall Study||40
1465959|NCT01970982|3588543|P1|COMPLETED|Overall Study||80
1465960|NCT01970982|3588541|P3|STARTED|Overall Study||40
1465961|NCT01970982|3588542|P2|STARTED|Overall Study||40
1465962|NCT01970982|3588543|P1|STARTED|Overall Study||80
1465963|NCT01970878|3588565|P4|NOT COMPLETED|Overall Study||24
1465964|NCT01970878|3588566|P3|NOT COMPLETED|Overall Study||26
1465965|NCT01970878|3588567|P2|NOT COMPLETED|Overall Study||27
1465966|NCT01970878|3588568|P1|NOT COMPLETED|Overall Study||37
1465967|NCT01970878|3588565|P4|COMPLETED|Overall Study||147
1465968|NCT01970878|3588566|P3|COMPLETED|Overall Study||187
1465969|NCT01970878|3588567|P2|COMPLETED|Overall Study||191
1465970|NCT01970878|3588568|P1|COMPLETED|Overall Study||253
1465971|NCT01970878|3588565|P4|STARTED|Overall Study||171
1465972|NCT01970878|3588566|P3|STARTED|Overall Study||213
1465973|NCT01970878|3588567|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
1465974|NCT01970878|3588568|P1|STARTED|Overall Study||290
1465975|NCT01970865|3588611|P17|NOT COMPLETED|Overall Study||3
1465976|NCT01970865|3588612|P16|NOT COMPLETED|Overall Study||47
1465977|NCT01970865|3588613|P15|NOT COMPLETED|Overall Study||46
1465978|NCT01970865|3588614|P14|NOT COMPLETED|Overall Study||66
1465979|NCT01970865|3588615|P13|NOT COMPLETED|Overall Study||60
1465980|NCT01970865|3588616|P12|NOT COMPLETED|Overall Study||27
1465981|NCT01970865|3588617|P11|NOT COMPLETED|Overall Study||30
1465982|NCT01970865|3588618|P10|NOT COMPLETED|Overall Study||4
1465983|NCT01970865|3588619|P9|NOT COMPLETED|Overall Study||3
1465984|NCT01970865|3588620|P8|NOT COMPLETED|Overall Study||3
1465985|NCT01970865|3588621|P7|NOT COMPLETED|Overall Study||3
1465986|NCT01970865|3588622|P6|NOT COMPLETED|Overall Study||3
1465987|NCT01970865|3588623|P5|NOT COMPLETED|Overall Study||17
1465988|NCT01970865|3588624|P4|NOT COMPLETED|Overall Study||13
1465989|NCT01970865|3588625|P3|NOT COMPLETED|Overall Study||3
1465990|NCT01970865|3588626|P2|NOT COMPLETED|Overall Study||3
1465991|NCT01970865|3588627|P1|NOT COMPLETED|Overall Study||3
1465992|NCT01970865|3588611|P17|COMPLETED|Overall Study||0
1465993|NCT01970865|3588612|P16|COMPLETED|Overall Study||0
1465994|NCT01970865|3588613|P15|COMPLETED|Overall Study||0
1465995|NCT01970865|3588614|P14|COMPLETED|Overall Study||0
1465996|NCT01970865|3588615|P13|COMPLETED|Overall Study||0
1465997|NCT01970865|3588616|P12|COMPLETED|Overall Study||0
1465998|NCT01970865|3588617|P11|COMPLETED|Overall Study||0
1465999|NCT01970865|3588618|P10|COMPLETED|Overall Study||0
1466000|NCT01970865|3588619|P9|COMPLETED|Overall Study||0
1466001|NCT01970865|3588620|P8|COMPLETED|Overall Study||0
1466002|NCT01970865|3588621|P7|COMPLETED|Overall Study||0
1466003|NCT01970865|3588622|P6|COMPLETED|Overall Study||0
1466004|NCT01970865|3588623|P5|COMPLETED|Overall Study||0
1466005|NCT01970865|3588624|P4|COMPLETED|Overall Study||0
1466006|NCT01970865|3588625|P3|COMPLETED|Overall Study||0
1466007|NCT01970865|3588626|P2|COMPLETED|Overall Study||0
1466008|NCT01970865|3588627|P1|COMPLETED|Overall Study||0
1466009|NCT01970865|3588611|P17|Received Treatment|Overall Study||3
1466010|NCT01970865|3588612|P16|Received Treatment|Overall Study||47
1466011|NCT01970865|3588613|P15|Received Treatment|Overall Study||46
1466012|NCT01970865|3588614|P14|Received Treatment|Overall Study||65
1466013|NCT01970865|3588615|P13|Received Treatment|Overall Study||60
1466014|NCT01970865|3588616|P12|Received Treatment|Overall Study||27
1466015|NCT01970865|3588617|P11|Received Treatment|Overall Study||30
1466016|NCT01970865|3588618|P10|Received Treatment|Overall Study||4
1466017|NCT01970865|3588619|P9|Received Treatment|Overall Study||3
1466018|NCT01970865|3588620|P8|Received Treatment|Overall Study||3
1466019|NCT01970865|3588621|P7|Received Treatment|Overall Study||3
1466020|NCT01970865|3588622|P6|Received Treatment|Overall Study||3
1466021|NCT01970865|3588623|P5|Received Treatment|Overall Study||17
1466022|NCT01970865|3588624|P4|Received Treatment|Overall Study||12
1466023|NCT01970865|3588625|P3|Received Treatment|Overall Study||3
1466024|NCT01970865|3588626|P2|Received Treatment|Overall Study||3
1466025|NCT01970865|3588627|P1|Received Treatment|Overall Study||3
1466026|NCT01970865|3588611|P17|STARTED|Overall Study||3
1466027|NCT01970865|3588612|P16|STARTED|Overall Study||47
1466028|NCT01970865|3588613|P15|STARTED|Overall Study||46
1466029|NCT01970865|3588614|P14|STARTED|Overall Study||66
1466030|NCT01970865|3588615|P13|STARTED|Overall Study||60
1466031|NCT01970865|3588616|P12|STARTED|Overall Study||27
1466032|NCT01970865|3588617|P11|STARTED|Overall Study||30
1466033|NCT01970865|3588618|P10|STARTED|Overall Study||4
1466034|NCT01970865|3588619|P9|STARTED|Overall Study||3
1466035|NCT01970865|3588620|P8|STARTED|Overall Study||3
1466036|NCT01970865|3588621|P7|STARTED|Overall Study||3
1466037|NCT01970865|3588622|P6|STARTED|Overall Study||3
1466038|NCT01970865|3588623|P5|STARTED|Overall Study||17
1466039|NCT01970865|3588624|P4|STARTED|Overall Study||13
1466040|NCT01970865|3588625|P3|STARTED|Overall Study||3
1466041|NCT01970865|3588626|P2|STARTED|Overall Study||3
1466042|NCT01970865|3588627|P1|STARTED|Overall Study||3
1466043|NCT01970787|3589051|P1|NOT COMPLETED|Overall Study||1
1466044|NCT01970787|3589051|P1|COMPLETED|Overall Study||21
1466045|NCT01970787|3589051|P1|STARTED|Overall Study||22
1466046|NCT01970488|3589061|P5|NOT COMPLETED|Part 2: Post Week 16||8
1466047|NCT01970488|3589062|P4|NOT COMPLETED|Part 2: Post Week 16||8
1466048|NCT01970488|3589063|P3|NOT COMPLETED|Part 2: Post Week 16||17
1466049|NCT01970488|3589064|P2|NOT COMPLETED|Part 2: Post Week 16||0
1466050|NCT01970488|3589065|P1|NOT COMPLETED|Part 2: Post Week 16||0
1466051|NCT01970488|3589061|P5|COMPLETED|Part 2: Post Week 16||69
1466052|NCT01970488|3589062|P4|COMPLETED|Part 2: Post Week 16||71
1466053|NCT01970488|3589063|P3|COMPLETED|Part 2: Post Week 16||135
1466054|NCT01970488|3589064|P2|COMPLETED|Part 2: Post Week 16||0
1466055|NCT01970488|3589065|P1|COMPLETED|Part 2: Post Week 16||0
1466056|NCT01970488|3589061|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
1466057|NCT01970488|3589062|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
1466058|NCT01970488|3589063|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
1466059|NCT01970488|3589064|P2|STARTED|Part 2: Post Week 16||0
1466060|NCT01970488|3589065|P1|STARTED|Part 2: Post Week 16||0
1466061|NCT01970488|3589061|P5|NOT COMPLETED|Part 1: Through Week 16||0
1466062|NCT01970488|3589062|P4|NOT COMPLETED|Part 1: Through Week 16||0
1466063|NCT01970488|3589063|P3|NOT COMPLETED|Part 1: Through Week 16||0
1466064|NCT01970488|3589064|P2|NOT COMPLETED|Part 1: Through Week 16||13
1466065|NCT01970488|3589065|P1|NOT COMPLETED|Part 1: Through Week 16||11
1466066|NCT01970488|3589061|P5|COMPLETED|Part 1: Through Week 16||0
1466067|NCT01970488|3589062|P4|COMPLETED|Part 1: Through Week 16||0
1466068|NCT01970488|3589063|P3|COMPLETED|Part 1: Through Week 16||0
1466069|NCT01970488|3589064|P2|COMPLETED|Part 1: Through Week 16||162
1466070|NCT01970488|3589065|P1|COMPLETED|Part 1: Through Week 16||164
1466071|NCT01970488|3589061|P5|Received Treatment|Part 1: Through Week 16||0
1466072|NCT01970488|3589062|P4|Received Treatment|Part 1: Through Week 16||0
1466073|NCT01970488|3589063|P3|Received Treatment|Part 1: Through Week 16||0
1466074|NCT01970488|3589064|P2|Received Treatment|Part 1: Through Week 16||173
1466075|NCT01970488|3589065|P1|Received Treatment|Part 1: Through Week 16||174
1466076|NCT01970488|3589061|P5|STARTED|Part 1: Through Week 16||0
1466077|NCT01970488|3589062|P4|STARTED|Part 1: Through Week 16||0
1466078|NCT01970488|3589063|P3|STARTED|Part 1: Through Week 16||0
1466079|NCT01970488|3589064|P2|STARTED|Part 1: Through Week 16||175
1466080|NCT01970488|3589065|P1|STARTED|Part 1: Through Week 16||175
1466081|NCT01970475|3589132|P2|NOT COMPLETED|Overall Study||11
1466082|NCT01970475|3589133|P1|NOT COMPLETED|Overall Study||21
1466083|NCT01970475|3589132|P2|COMPLETED|Overall Study||251
1466084|NCT01970475|3589133|P1|COMPLETED|Overall Study||243
1466085|NCT01970475|3589132|P2|STARTED|Overall Study||262
1466086|NCT01970475|3589133|P1|STARTED|Overall Study||264
1466087|NCT01970462|3589153|P2|NOT COMPLETED|Overall Study||2
1466088|NCT01970462|3589154|P1|NOT COMPLETED|Overall Study||0
1466089|NCT01970462|3589153|P2|COMPLETED|Overall Study||2
1466090|NCT01970462|3589154|P1|COMPLETED|Overall Study||1
1466091|NCT01970462|3589153|P2|STARTED|Overall Study||4
1466092|NCT01970462|3589154|P1|STARTED|Overall Study||1
1466093|NCT01970397|3589168|P2|NOT COMPLETED|Overall Study||5
1466094|NCT01970397|3589169|P1|NOT COMPLETED|Overall Study||2
1466095|NCT01970397|3589168|P2|COMPLETED|Overall Study||64
1466096|NCT01970397|3589169|P1|COMPLETED|Overall Study||67
1466097|NCT01970397|3589168|P2|STARTED|Overall Study||69
1466098|NCT01970397|3589169|P1|STARTED|Overall Study||69
1466099|NCT01970371|3589182|P3|NOT COMPLETED|Overall Study||13
1466100|NCT01970371|3589183|P2|NOT COMPLETED|Overall Study||13
1466101|NCT01970371|3589184|P1|NOT COMPLETED|Overall Study||8
1466102|NCT01970371|3589182|P3|COMPLETED|Overall Study||17
1466103|NCT01970371|3589183|P2|COMPLETED|Overall Study||8
1466104|NCT01970371|3589184|P1|COMPLETED|Overall Study||10
1466105|NCT01970371|3589182|P3|STARTED|Overall Study||30
1466106|NCT01970371|3589183|P2|STARTED|Overall Study||21
1466107|NCT01970371|3589184|P1|STARTED|Overall Study||18
1466108|NCT01969799|3589209|P2|NOT COMPLETED|Overall Study||14
1466109|NCT01969799|3589210|P1|NOT COMPLETED|Overall Study||17
1466110|NCT01969799|3589209|P2|COMPLETED|Overall Study||58
1466111|NCT01969799|3589210|P1|COMPLETED|Overall Study||54
1466112|NCT01969799|3589209|P2|STARTED|Overall Study||72
1466113|NCT01969799|3589210|P1|STARTED|Overall Study||71
1466114|NCT01969747|3589234|P4|NOT COMPLETED|Overall Study||0
1466115|NCT01969747|3589235|P3|NOT COMPLETED|Overall Study||0
1466116|NCT01969747|3589236|P2|NOT COMPLETED|Overall Study||0
1466117|NCT01969747|3589237|P1|NOT COMPLETED|Overall Study||0
1466118|NCT01969747|3589234|P4|COMPLETED|Overall Study||18
1466119|NCT01969747|3589235|P3|COMPLETED|Overall Study||19
1466120|NCT01969747|3589236|P2|COMPLETED|Overall Study||19
1466121|NCT01969747|3589237|P1|COMPLETED|Overall Study||19
1466122|NCT01969747|3589234|P4|STARTED|Overall Study||18
1466123|NCT01969747|3589235|P3|STARTED|Overall Study||19
1466124|NCT01969747|3589236|P2|STARTED|Overall Study||19
1466125|NCT01969747|3589237|P1|STARTED|Overall Study||19
1466126|NCT01969721|3589247|P4|NOT COMPLETED|Overall Study||6
1466127|NCT01969721|3589248|P3|NOT COMPLETED|Overall Study||5
1466128|NCT01969721|3589249|P2|NOT COMPLETED|Overall Study||12
1466129|NCT01969721|3589250|P1|NOT COMPLETED|Overall Study||4
1466130|NCT01969721|3589247|P4|COMPLETED|Overall Study||46
1466131|NCT01969721|3589248|P3|COMPLETED|Overall Study||45
1466132|NCT01969721|3589249|P2|COMPLETED|Overall Study||57
1466133|NCT01969721|3589250|P1|COMPLETED|Overall Study||54
1466134|NCT01969721|3589247|P4|STARTED|Overall Study||52
1466135|NCT01969721|3589248|P3|STARTED|Overall Study||50
1466136|NCT01969721|3589249|P2|STARTED|Overall Study||69
1466137|NCT01969721|3589250|P1|STARTED|Overall Study||58
1466138|NCT01969708|3589278|P2|NOT COMPLETED|Overall Study||9
1466139|NCT01969708|3589279|P1|NOT COMPLETED|Overall Study||5
1466140|NCT01969708|3589278|P2|COMPLETED|Overall Study||173
1466141|NCT01969708|3589279|P1|COMPLETED|Overall Study||175
1466142|NCT01969708|3589278|P2|STARTED|Overall Study||182
1466143|NCT01969708|3589279|P1|STARTED|Overall Study||180
1466144|NCT01969565|3589295|P1|NOT COMPLETED|Overall Study||1
1466145|NCT01969565|3589295|P1|COMPLETED|Overall Study||0
1466146|NCT01969565|3589295|P1|STARTED|Overall Study||1
1466147|NCT01969539|3589301|P1|NOT COMPLETED|Overall Study||0
1466148|NCT01969539|3589301|P1|COMPLETED|Overall Study||11
1466149|NCT01969539|3589301|P1|STARTED|Overall Study||11
1466150|NCT01969448|3589310|P3|NOT COMPLETED|Overall Study||0
1466151|NCT01969448|3589311|P2|NOT COMPLETED|Overall Study||0
1466152|NCT01969448|3589312|P1|NOT COMPLETED|Overall Study||0
1466153|NCT01969448|3589310|P3|COMPLETED|Overall Study||0
1466154|NCT01969448|3589311|P2|COMPLETED|Overall Study||24
1466155|NCT01969448|3589312|P1|COMPLETED|Overall Study||55
1466156|NCT01969448|3589310|P3|STARTED|Overall Study||0
1466157|NCT01969448|3589311|P2|STARTED|Overall Study||24
1466158|NCT01969448|3589312|P1|STARTED|Overall Study||55
1466159|NCT01969435|3589335|P1|NOT COMPLETED|Overall Study||0
1466160|NCT01969435|3589335|P1|COMPLETED|Overall Study||50
1466161|NCT01969435|3589335|P1|STARTED|Overall Study||50
1466162|NCT01969240|3589351|P2|NOT COMPLETED|Overall Study||0
1466163|NCT01969240|3589352|P1|NOT COMPLETED|Overall Study||0
1466164|NCT01969240|3589351|P2|COMPLETED|Overall Study||447
1466165|NCT01969240|3589352|P1|COMPLETED|Overall Study||451
1466166|NCT01969240|3589351|P2|STARTED|Overall Study||447
1466167|NCT01969240|3589352|P1|STARTED|Overall Study||451
1466168|NCT01969162|3589370|P1|NOT COMPLETED|Overall Study||0
1466169|NCT01969162|3589370|P1|COMPLETED|Overall Study||35
1466170|NCT01969162|3589370|P1|STARTED|Overall Study||35
1466171|NCT01969084|3589376|P2|NOT COMPLETED|Overall Study||1
1466172|NCT01969084|3589377|P1|NOT COMPLETED|Overall Study||0
1466173|NCT01969084|3589376|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
1466174|NCT01969084|3589377|P1|COMPLETED|Overall Study||19
1466175|NCT01969084|3589376|P2|STARTED|Overall Study||22
1466176|NCT01969084|3589377|P1|STARTED|Overall Study||19
1466177|NCT01969058|3589393|P2|NOT COMPLETED|Overall Study||0
1466178|NCT01969058|3589394|P1|NOT COMPLETED|Overall Study||3
1466179|NCT01969058|3589393|P2|COMPLETED|Overall Study||26
1466180|NCT01969058|3589394|P1|COMPLETED|Overall Study||47
1466181|NCT01969058|3589393|P2|STARTED|Overall Study||26
1466182|NCT01969058|3589394|P1|STARTED|Overall Study||50
1466183|NCT01968980|3589430|P2|NOT COMPLETED|Overall Study||14
1466184|NCT01968980|3589431|P1|NOT COMPLETED|Overall Study||16
1466185|NCT01968980|3589430|P2|COMPLETED|Overall Study||171
1466186|NCT01968980|3589431|P1|COMPLETED|Overall Study||169
1466187|NCT01968980|3589430|P2|STARTED|Overall Study||185
1466188|NCT01968980|3589431|P1|STARTED|Overall Study||185
1466189|NCT01968967|3589493|P5|NOT COMPLETED|Extension Period||5
1466190|NCT01968967|3589494|P4|NOT COMPLETED|Extension Period||0
1466191|NCT01968967|3589495|P3|NOT COMPLETED|Extension Period||2
1466192|NCT01968967|3589496|P2|NOT COMPLETED|Extension Period||0
1466193|NCT01968967|3589497|P1|NOT COMPLETED|Extension Period||0
1466194|NCT01968967|3589493|P5|COMPLETED|Extension Period||34
1466195|NCT01968967|3589494|P4|COMPLETED|Extension Period||19
1466196|NCT01968967|3589495|P3|COMPLETED|Extension Period||45
1466197|NCT01968967|3589496|P2|COMPLETED|Extension Period||0
1466198|NCT01968967|3589497|P1|COMPLETED|Extension Period||0
1466199|NCT01968967|3589493|P5|STARTED|Extension Period||39
1466200|NCT01968967|3589494|P4|STARTED|Extension Period||19
1466201|NCT01968967|3589495|P3|STARTED|Extension Period||47
1466202|NCT01968967|3589496|P2|STARTED|Extension Period||0
1466203|NCT01968967|3589497|P1|STARTED|Extension Period||0
1466204|NCT01968967|3589493|P5|NOT COMPLETED|Treatment Period||0
1466205|NCT01968967|3589494|P4|NOT COMPLETED|Treatment Period||0
1466206|NCT01968967|3589495|P3|NOT COMPLETED|Treatment Period||0
1466207|NCT01968967|3589496|P2|NOT COMPLETED|Treatment Period||134
1466208|NCT01968967|3589497|P1|NOT COMPLETED|Treatment Period||146
1466209|NCT01968967|3589493|P5|COMPLETED|Treatment Period||0
1466210|NCT01968967|3589494|P4|COMPLETED|Treatment Period||0
1466211|NCT01968967|3589495|P3|COMPLETED|Treatment Period||0
1466212|NCT01968967|3589496|P2|COMPLETED|Treatment Period||934
1466213|NCT01968967|3589497|P1|COMPLETED|Treatment Period||925
1466214|NCT01968967|3589493|P5|Treated|Treatment Period||0
1466215|NCT01968967|3589494|P4|Treated|Treatment Period||0
1466216|NCT01968967|3589495|P3|Treated|Treatment Period||0
1466217|NCT01968967|3589496|P2|Treated|Treatment Period||1063
1466218|NCT01968967|3589497|P1|Treated|Treatment Period||1065
1466219|NCT01968967|3589493|P5|STARTED|Treatment Period||0
1466220|NCT01968967|3589494|P4|STARTED|Treatment Period||0
1466221|NCT01968967|3589495|P3|STARTED|Treatment Period||0
1466222|NCT01968967|3589496|P2|STARTED|Treatment Period||1068
1466223|NCT01968967|3589497|P1|STARTED|Treatment Period||1071
1466224|NCT01968954|3589566|P2|NOT COMPLETED|Overall Study||43
1466225|NCT01968954|3589567|P1|NOT COMPLETED|Overall Study||40
1466226|NCT01968954|3589566|P2|COMPLETED|Overall Study||314
1466227|NCT01968954|3589567|P1|COMPLETED|Overall Study||314
1466228|NCT01968954|3589566|P2|Treated|Overall Study||356
1466229|NCT01968954|3589567|P1|Treated|Overall Study||353
1466230|NCT01968954|3589566|P2|STARTED|Overall Study||357
1466231|NCT01968954|3589567|P1|STARTED|Overall Study||354
1466232|NCT01968811|3589631|P1|NOT COMPLETED|Overall Study||5
1466233|NCT01968811|3589631|P1|COMPLETED|Overall Study||5
1466234|NCT01968811|3589631|P1|STARTED|Overall Study||10
1466235|NCT01968694|3589638|P2|NOT COMPLETED|Visit 2 (1 Day)||0
1466236|NCT01968694|3589639|P1|NOT COMPLETED|Visit 2 (1 Day)||0
1466237|NCT01968694|3589638|P2|COMPLETED|Visit 2 (1 Day)||8
1466238|NCT01968694|3589639|P1|COMPLETED|Visit 2 (1 Day)||10
1466239|NCT01968694|3589638|P2|STARTED|Visit 2 (1 Day)||8
1466240|NCT01968694|3589639|P1|STARTED|Visit 2 (1 Day)||10
1466241|NCT01968694|3589638|P2|NOT COMPLETED|Washout (1 Month)||1
1466242|NCT01968694|3589639|P1|NOT COMPLETED|Washout (1 Month)||0
1466243|NCT01968694|3589638|P2|COMPLETED|Washout (1 Month)||8
1466244|NCT01968694|3589639|P1|COMPLETED|Washout (1 Month)||10
1466245|NCT01968694|3589638|P2|STARTED|Washout (1 Month)||9
1466246|NCT01968694|3589639|P1|STARTED|Washout (1 Month)||10
1466247|NCT01968694|3589638|P2|NOT COMPLETED|Visit 1 (1 Day)||0
1466248|NCT01968694|3589639|P1|NOT COMPLETED|Visit 1 (1 Day)||0
1466249|NCT01968694|3589638|P2|COMPLETED|Visit 1 (1 Day)||9
1466250|NCT01968694|3589639|P1|COMPLETED|Visit 1 (1 Day)||10
1466251|NCT01968694|3589638|P2|STARTED|Visit 1 (1 Day)||9
1466252|NCT01968694|3589639|P1|STARTED|Visit 1 (1 Day)||10
1466253|NCT01968551|3589656|P3|NOT COMPLETED|Extension Phase||4
1466254|NCT01968551|3589657|P2|NOT COMPLETED|Extension Phase||1
1466255|NCT01968551|3589658|P1|NOT COMPLETED|Extension Phase||1
1466256|NCT01968551|3589656|P3|COMPLETED|Extension Phase||30
1466257|NCT01968551|3589657|P2|COMPLETED|Extension Phase||86
1466258|NCT01968551|3589658|P1|COMPLETED|Extension Phase||19
1466259|NCT01968551|3589656|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
1466260|NCT01968551|3589657|P2|STARTED|Extension Phase||87
1466261|NCT01968551|3589658|P1|STARTED|Extension Phase||20
1466262|NCT01968551|3589656|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
1466263|NCT01968551|3589657|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
1466264|NCT01968551|3589658|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
1466265|NCT01968551|3589656|P3|COMPLETED|Open Label Phase (48 Weeks)||41
1466266|NCT01968551|3589657|P2|COMPLETED|Open Label Phase (48 Weeks)||87
1466267|NCT01968551|3589658|P1|COMPLETED|Open Label Phase (48 Weeks)||20
1466268|NCT01968551|3589656|P3|STARTED|Open Label Phase (48 Weeks)||46
1466269|NCT01968551|3589657|P2|STARTED|Open Label Phase (48 Weeks)||90
1466270|NCT01968551|3589658|P1|STARTED|Open Label Phase (48 Weeks)||22
1466271|NCT01968434|3589674|P2|NOT COMPLETED|Overall Study||6
1466272|NCT01968434|3589675|P1|NOT COMPLETED|Overall Study||3
1466273|NCT01968434|3589674|P2|COMPLETED|Overall Study||66
1466274|NCT01968434|3589675|P1|COMPLETED|Overall Study||75
1466275|NCT01968434|3589674|P2|STARTED|Overall Study||72
1466276|NCT01968434|3589675|P1|STARTED|Overall Study||78
1466277|NCT01968226|3589685|P1|NOT COMPLETED|Overall Study||2
1466278|NCT01968226|3589685|P1|COMPLETED|Overall Study||1
1466279|NCT01968226|3589685|P1|STARTED|Overall Study||3
1466280|NCT01968213|3589691|P2|NOT COMPLETED|Overall Study||9
1466281|NCT01968213|3589692|P1|NOT COMPLETED|Overall Study||90
1466282|NCT01968213|3589691|P2|COMPLETED|Overall Study||180
1466283|NCT01968213|3589692|P1|COMPLETED|Overall Study||285
1466284|NCT01968213|3589691|P2|STARTED|Overall Study||189
1466285|NCT01968213|3589692|P1|STARTED|Overall Study||375
1466286|NCT01968135|3589703|P2|NOT COMPLETED|Overall Study||0
1466287|NCT01968135|3589704|P1|NOT COMPLETED|Overall Study||0
1466288|NCT01968135|3589703|P2|COMPLETED|Overall Study||16
1466289|NCT01968135|3589704|P1|COMPLETED|Overall Study||16
1466290|NCT01968135|3589703|P2|STARTED|Overall Study||16
1466291|NCT01968135|3589704|P1|STARTED|Overall Study||16
1466292|NCT01968057|3589716|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
1466293|NCT01968057|3589716|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
1466294|NCT01968057|3589716|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
1466295|NCT01968057|3589716|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
1466296|NCT01968057|3589716|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
1466297|NCT01968057|3589716|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
1466298|NCT01968057|3589716|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
1466299|NCT01968057|3589716|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
1466300|NCT01967940|3589729|P4|NOT COMPLETED|Part 2||3
1466301|NCT01967940|3589730|P3|NOT COMPLETED|Part 2||0
1466302|NCT01967940|3589731|P2|NOT COMPLETED|Part 2||0
1466303|NCT01967940|3589732|P1|NOT COMPLETED|Part 2||0
1466304|NCT01967940|3589729|P4|COMPLETED|Part 2||35
1466305|NCT01967940|3589730|P3|COMPLETED|Part 2||0
1466306|NCT01967940|3589731|P2|COMPLETED|Part 2||0
1466307|NCT01967940|3589732|P1|COMPLETED|Part 2||0
1466308|NCT01967940|3589729|P4|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
1466309|NCT01967940|3589730|P3|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
1466310|NCT01967940|3589731|P2|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
1466311|NCT01967940|3589732|P1|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
1466312|NCT01967940|3589729|P4|NOT COMPLETED|Part 1||0
1466313|NCT01967940|3589730|P3|NOT COMPLETED|Part 1||0
1466314|NCT01967940|3589731|P2|NOT COMPLETED|Part 1||0
1466315|NCT01967940|3589732|P1|NOT COMPLETED|Part 1||0
1466316|NCT01967940|3589729|P4|COMPLETED|Part 1||0
1466317|NCT01967940|3589730|P3|COMPLETED|Part 1||15
1466318|NCT01967940|3589731|P2|COMPLETED|Part 1||28
1466319|NCT01967940|3589732|P1|COMPLETED|Part 1||12
1466320|NCT01967940|3589729|P4|STARTED|Part 1||0
1466321|NCT01967940|3589730|P3|STARTED|Part 1||15
1466322|NCT01967940|3589731|P2|STARTED|Part 1||28
1466323|NCT01967940|3589732|P1|STARTED|Part 1||12
1466324|NCT01967836|3589758|P1|NOT COMPLETED|Overall Study||9
1466325|NCT01967836|3589758|P1|COMPLETED|Overall Study||11
1466326|NCT01967836|3589758|P1|STARTED|Overall Study||20
1466327|NCT01967784|3589764|P1|NOT COMPLETED|Overall Study||0
1466328|NCT01967784|3589764|P1|COMPLETED|Overall Study||100
1466329|NCT01967784|3589764|P1|STARTED|Overall Study||100
1466330|NCT01967732|3589774|P4|NOT COMPLETED|Second Intervention (Day 3)||0
1466331|NCT01967732|3589775|P3|NOT COMPLETED|Second Intervention (Day 3)||0
1466332|NCT01967732|3589776|P2|NOT COMPLETED|Second Intervention (Day 3)||0
1466333|NCT01967732|3589777|P1|NOT COMPLETED|Second Intervention (Day 3)||0
1466334|NCT01967732|3589774|P4|COMPLETED|Second Intervention (Day 3)||9
1466335|NCT01967732|3589775|P3|COMPLETED|Second Intervention (Day 3)||9
1466336|NCT01967732|3589776|P2|COMPLETED|Second Intervention (Day 3)||20
1466337|NCT01967732|3589777|P1|COMPLETED|Second Intervention (Day 3)||22
1466338|NCT01967732|3589774|P4|STARTED|Second Intervention (Day 3)||9
1466339|NCT01967732|3589775|P3|STARTED|Second Intervention (Day 3)||9
1466340|NCT01967732|3589776|P2|STARTED|Second Intervention (Day 3)||20
1466341|NCT01967732|3589777|P1|STARTED|Second Intervention (Day 3)||22
1466342|NCT01967732|3589774|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466343|NCT01967732|3589775|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466344|NCT01967732|3589776|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466345|NCT01967732|3589777|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466346|NCT01967732|3589774|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
1466347|NCT01967732|3589775|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
1466348|NCT01967732|3589776|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
1466349|NCT01967732|3589777|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
1466350|NCT01967732|3589774|P4|STARTED|Washout Period of 1 Day (Day 2)||9
1466351|NCT01967732|3589775|P3|STARTED|Washout Period of 1 Day (Day 2)||9
1466352|NCT01967732|3589776|P2|STARTED|Washout Period of 1 Day (Day 2)||20
1466353|NCT01967732|3589777|P1|STARTED|Washout Period of 1 Day (Day 2)||22
1466354|NCT01967732|3589774|P4|NOT COMPLETED|First Intervention (Day 1)||0
1466355|NCT01967732|3589775|P3|NOT COMPLETED|First Intervention (Day 1)||0
1466356|NCT01967732|3589776|P2|NOT COMPLETED|First Intervention (Day 1)||1
1466357|NCT01967732|3589777|P1|NOT COMPLETED|First Intervention (Day 1)||0
1466358|NCT01967732|3589774|P4|COMPLETED|First Intervention (Day 1)||9
1466359|NCT01967732|3589775|P3|COMPLETED|First Intervention (Day 1)||9
1466360|NCT01967732|3589776|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
1466361|NCT01967732|3589777|P1|COMPLETED|First Intervention (Day 1)||22
1466362|NCT01967732|3589774|P4|STARTED|First Intervention (Day 1)||9
1466363|NCT01967732|3589775|P3|STARTED|First Intervention (Day 1)||9
1466364|NCT01967732|3589776|P2|STARTED|First Intervention (Day 1)||21
1466365|NCT01967732|3589777|P1|STARTED|First Intervention (Day 1)||22
1466366|NCT01967732|3589774|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466367|NCT01967732|3589775|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466368|NCT01967732|3589776|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
1466369|NCT01967732|3589777|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466370|NCT01967732|3589774|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
1466371|NCT01967732|3589775|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
1466372|NCT01967732|3589776|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
1466373|NCT01967732|3589777|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
1466374|NCT01967732|3589774|P4|STARTED|Washout Period of 1 Day (Day 0)||9
1466375|NCT01967732|3589775|P3|STARTED|Washout Period of 1 Day (Day 0)||9
1466376|NCT01967732|3589776|P2|STARTED|Washout Period of 1 Day (Day 0)||22
1466377|NCT01967732|3589777|P1|STARTED|Washout Period of 1 Day (Day 0)||22
1466378|NCT01967719|3589791|P4|NOT COMPLETED|Second Intervention (Day 3)||0
1466379|NCT01967719|3589792|P3|NOT COMPLETED|Second Intervention (Day 3)||0
1466380|NCT01967719|3589793|P2|NOT COMPLETED|Second Intervention (Day 3)||1
1466381|NCT01967719|3589794|P1|NOT COMPLETED|Second Intervention (Day 3)||0
1466382|NCT01967719|3589791|P4|COMPLETED|Second Intervention (Day 3)||8
1466383|NCT01967719|3589792|P3|COMPLETED|Second Intervention (Day 3)||9
1466384|NCT01967719|3589793|P2|COMPLETED|Second Intervention (Day 3)||20
1466385|NCT01967719|3589794|P1|COMPLETED|Second Intervention (Day 3)||22
1466386|NCT01967719|3589791|P4|STARTED|Second Intervention (Day 3)||8
1466387|NCT01967719|3589792|P3|STARTED|Second Intervention (Day 3)||9
1466388|NCT01967719|3589793|P2|STARTED|Second Intervention (Day 3)||21
1466389|NCT01967719|3589794|P1|STARTED|Second Intervention (Day 3)||22
1466390|NCT01967719|3589791|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466391|NCT01967719|3589792|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466392|NCT01967719|3589793|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466393|NCT01967719|3589794|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466394|NCT01967719|3589791|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
1466395|NCT01967719|3589792|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
1466396|NCT01967719|3589793|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
1466397|NCT01967719|3589794|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
1466398|NCT01967719|3589791|P4|STARTED|Washout Period of 1 Day (Day 2)||8
1466399|NCT01967719|3589792|P3|STARTED|Washout Period of 1 Day (Day 2)||9
1466400|NCT01967719|3589793|P2|STARTED|Washout Period of 1 Day (Day 2)||21
1466401|NCT01967719|3589794|P1|STARTED|Washout Period of 1 Day (Day 2)||22
1466402|NCT01967719|3589791|P4|NOT COMPLETED|First Intervention (Day 1)||1
1466403|NCT01967719|3589792|P3|NOT COMPLETED|First Intervention (Day 1)||0
1466404|NCT01967719|3589793|P2|NOT COMPLETED|First Intervention (Day 1)||1
1466405|NCT01967719|3589794|P1|NOT COMPLETED|First Intervention (Day 1)||0
1466406|NCT01967719|3589791|P4|COMPLETED|First Intervention (Day 1)||8
1466407|NCT01967719|3589792|P3|COMPLETED|First Intervention (Day 1)||9
1466408|NCT01967719|3589793|P2|COMPLETED|First Intervention (Day 1)||21
1466409|NCT01967719|3589794|P1|COMPLETED|First Intervention (Day 1)||22
1466410|NCT01967719|3589791|P4|STARTED|First Intervention (Day 1)||9
1466411|NCT01967719|3589792|P3|STARTED|First Intervention (Day 1)||9
1466412|NCT01967719|3589793|P2|STARTED|First Intervention (Day 1)||22
1466413|NCT01967719|3589794|P1|STARTED|First Intervention (Day 1)||22
1466414|NCT01967719|3589791|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466415|NCT01967719|3589792|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466416|NCT01967719|3589793|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466417|NCT01967719|3589794|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466418|NCT01967719|3589791|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
1466419|NCT01967719|3589792|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
1466420|NCT01967719|3589793|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
1466421|NCT01967719|3589794|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
1466422|NCT01967719|3589791|P4|STARTED|Washout Period of 1 Day (Day 0)||9
1466423|NCT01967719|3589792|P3|STARTED|Washout Period of 1 Day (Day 0)||9
1466424|NCT01967719|3589793|P2|STARTED|Washout Period of 1 Day (Day 0)||22
1466425|NCT01967719|3589794|P1|STARTED|Washout Period of 1 Day (Day 0)||22
1466426|NCT01967706|3589809|P4|NOT COMPLETED|Second Intervention (Day 3)||0
1466427|NCT01967706|3589810|P3|NOT COMPLETED|Second Intervention (Day 3)||0
1466428|NCT01967706|3589811|P2|NOT COMPLETED|Second Intervention (Day 3)||0
1466429|NCT01967706|3589812|P1|NOT COMPLETED|Second Intervention (Day 3)||0
1466430|NCT01967706|3589809|P4|COMPLETED|Second Intervention (Day 3)||9
1466431|NCT01967706|3589810|P3|COMPLETED|Second Intervention (Day 3)||9
1466432|NCT01967706|3589811|P2|COMPLETED|Second Intervention (Day 3)||22
1466433|NCT01967706|3589812|P1|COMPLETED|Second Intervention (Day 3)||21
1466434|NCT01967706|3589809|P4|STARTED|Second Intervention (Day 3)||9
1466435|NCT01967706|3589810|P3|STARTED|Second Intervention (Day 3)||9
1466436|NCT01967706|3589811|P2|STARTED|Second Intervention (Day 3)||22
1466437|NCT01967706|3589812|P1|STARTED|Second Intervention (Day 3)||21
1466438|NCT01967706|3589809|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466439|NCT01967706|3589810|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466440|NCT01967706|3589811|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466441|NCT01967706|3589812|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1466442|NCT01967706|3589809|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
1466443|NCT01967706|3589810|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
1466444|NCT01967706|3589811|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
1466445|NCT01967706|3589812|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
1466446|NCT01967706|3589809|P4|STARTED|Washout Period of 1 Day (Day 2)||9
1466447|NCT01967706|3589810|P3|STARTED|Washout Period of 1 Day (Day 2)||9
1466448|NCT01967706|3589811|P2|STARTED|Washout Period of 1 Day (Day 2)||22
1466449|NCT01967706|3589812|P1|STARTED|Washout Period of 1 Day (Day 2)||21
1466450|NCT01967706|3589809|P4|NOT COMPLETED|First Intervention (Day 1)||0
1466451|NCT01967706|3589810|P3|NOT COMPLETED|First Intervention (Day 1)||0
1466452|NCT01967706|3589811|P2|NOT COMPLETED|First Intervention (Day 1)||0
1466453|NCT01967706|3589812|P1|NOT COMPLETED|First Intervention (Day 1)||1
1466454|NCT01967706|3589809|P4|COMPLETED|First Intervention (Day 1)||9
1466455|NCT01967706|3589810|P3|COMPLETED|First Intervention (Day 1)||9
1466456|NCT01967706|3589811|P2|COMPLETED|First Intervention (Day 1)||22
1466457|NCT01967706|3589812|P1|COMPLETED|First Intervention (Day 1)||21
1466458|NCT01967706|3589809|P4|STARTED|First Intervention (Day 1)||9
1466459|NCT01967706|3589810|P3|STARTED|First Intervention (Day 1)||9
1466460|NCT01967706|3589811|P2|STARTED|First Intervention (Day 1)||22
1466461|NCT01967706|3589812|P1|STARTED|First Intervention (Day 1)||22
1466462|NCT01967706|3589809|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466463|NCT01967706|3589810|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466464|NCT01967706|3589811|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466465|NCT01967706|3589812|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1466466|NCT01967706|3589809|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
1466467|NCT01967706|3589810|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
1466468|NCT01967706|3589811|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
1466469|NCT01967706|3589812|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
1466470|NCT01967706|3589809|P4|STARTED|Washout Period of 1 Day (Day 0)||9
1466471|NCT01967706|3589810|P3|STARTED|Washout Period of 1 Day (Day 0)||9
1466472|NCT01967706|3589811|P2|STARTED|Washout Period of 1 Day (Day 0)||22
1466473|NCT01967706|3589812|P1|STARTED|Washout Period of 1 Day (Day 0)||22
1466474|NCT01967641|3589825|P1|NOT COMPLETED|12-week Outpatient Phase||13
1466475|NCT01967641|3589825|P1|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
1466476|NCT01967641|3589825|P1|STARTED|12-week Outpatient Phase||31
1466477|NCT01967641|3589825|P1|NOT COMPLETED|Admission to Inpatient Phase||12
1466478|NCT01967641|3589825|P1|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
1466479|NCT01967641|3589825|P1|STARTED|Admission to Inpatient Phase||43
1466480|NCT01967641|3589825|P1|NOT COMPLETED|Randomized||8
1466481|NCT01967641|3589825|P1|COMPLETED|Randomized|Completed week 12|43
1466482|NCT01967641|3589825|P1|STARTED|Randomized||51
1466483|NCT01967628|3589833|P2|NOT COMPLETED|Overall Study||31
1466484|NCT01967628|3589834|P1|NOT COMPLETED|Overall Study||27
1466485|NCT01967628|3589833|P2|COMPLETED|Overall Study||19
1466486|NCT01967628|3589834|P1|COMPLETED|Overall Study||21
1466487|NCT01967628|3589833|P2|STARTED|Overall Study||50
1466488|NCT01967628|3589834|P1|STARTED|Overall Study||48
1466489|NCT01967550|3589842|P2|NOT COMPLETED|Overall Study||2
1466490|NCT01967550|3589843|P1|NOT COMPLETED|Overall Study||5
1466491|NCT01967550|3589842|P2|COMPLETED|Overall Study||149
1466492|NCT01967550|3589843|P1|COMPLETED|Overall Study||148
1466493|NCT01967550|3589842|P2|STARTED|Overall Study||151
1466494|NCT01967550|3589843|P1|STARTED|Overall Study||153
1466495|NCT01967342|3589852|P3|NOT COMPLETED|Overall Study||29
1466496|NCT01967342|3589853|P2|NOT COMPLETED|Overall Study||25
1466497|NCT01967342|3589854|P1|NOT COMPLETED|Overall Study||27
1466498|NCT01967342|3589852|P3|COMPLETED|Overall Study||68
1466499|NCT01967342|3589853|P2|COMPLETED|Overall Study||70
1466500|NCT01967342|3589854|P1|COMPLETED|Overall Study||71
1466501|NCT01967342|3589852|P3|10-week Follow-up|Overall Study||80
1466502|NCT01967342|3589853|P2|10-week Follow-up|Overall Study||83
1466503|NCT01967342|3589854|P1|10-week Follow-up|Overall Study||78
1466504|NCT01967342|3589852|P3|5-week Follow-up|Overall Study||76
1466505|NCT01967342|3589853|P2|5-week Follow-up|Overall Study||78
1466506|NCT01967342|3589854|P1|5-week Follow-up|Overall Study||83
1466507|NCT01967342|3589852|P3|STARTED|Overall Study||97
1466508|NCT01967342|3589853|P2|STARTED|Overall Study||95
1466509|NCT01967342|3589854|P1|STARTED|Overall Study||98
1466510|NCT01967277|3589873|P2|NOT COMPLETED|Overall Study||3
1466511|NCT01967277|3589874|P1|NOT COMPLETED|Overall Study||1
1466512|NCT01967277|3589873|P2|COMPLETED|Overall Study||19
1466513|NCT01967277|3589874|P1|COMPLETED|Overall Study||21
1466514|NCT01967277|3589873|P2|STARTED|Overall Study||22
1466515|NCT01967277|3589874|P1|STARTED|Overall Study||22
1466516|NCT01967225|3589886|P2|NOT COMPLETED|Overall Study||3
1466517|NCT01967225|3589887|P1|NOT COMPLETED|Overall Study||12
1466518|NCT01967225|3589886|P2|COMPLETED|Overall Study||38
1466519|NCT01967225|3589887|P1|COMPLETED|Overall Study||72
1466520|NCT01967225|3589886|P2|Participants Received Treatment|Overall Study||41
1466521|NCT01967225|3589887|P1|Participants Received Treatment|Overall Study||83
1466522|NCT01967225|3589886|P2|STARTED|Overall Study||41
1466523|NCT01967225|3589887|P1|STARTED|Overall Study||84
1466524|NCT01967173|3589919|P8|NOT COMPLETED|Overall Study||24
1466525|NCT01967173|3589920|P7|NOT COMPLETED|Overall Study||18
1466526|NCT01967173|3589921|P6|NOT COMPLETED|Overall Study||23
1466527|NCT01967173|3589922|P5|NOT COMPLETED|Overall Study||17
1466528|NCT01967173|3589923|P4|NOT COMPLETED|Overall Study||14
1466529|NCT01967173|3589924|P3|NOT COMPLETED|Overall Study||16
1466530|NCT01967173|3589925|P2|NOT COMPLETED|Overall Study||17
1466531|NCT01967173|3589926|P1|NOT COMPLETED|Overall Study||24
1466532|NCT01967173|3589919|P8|COMPLETED|Overall Study||50
1466533|NCT01967173|3589920|P7|COMPLETED|Overall Study||57
1466534|NCT01967173|3589921|P6|COMPLETED|Overall Study||49
1466535|NCT01967173|3589922|P5|COMPLETED|Overall Study||56
1466536|NCT01967173|3589923|P4|COMPLETED|Overall Study||57
1466537|NCT01967173|3589924|P3|COMPLETED|Overall Study||55
1466538|NCT01967173|3589925|P2|COMPLETED|Overall Study||52
1466539|NCT01967173|3589926|P1|COMPLETED|Overall Study||45
1466540|NCT01967173|3589919|P8|Completed 4th Period|Overall Study||50
1466541|NCT01967173|3589920|P7|Completed 4th Period|Overall Study||57
1466542|NCT01967173|3589921|P6|Completed 4th Period|Overall Study||49
1466543|NCT01967173|3589922|P5|Completed 4th Period|Overall Study||56
1466544|NCT01967173|3589923|P4|Completed 4th Period|Overall Study||57
1466545|NCT01967173|3589924|P3|Completed 4th Period|Overall Study||55
1466546|NCT01967173|3589925|P2|Completed 4th Period|Overall Study||52
1466547|NCT01967173|3589926|P1|Completed 4th Period|Overall Study||45
1466548|NCT01967173|3589919|P8|Completed 3rd Period|Overall Study||56
1466549|NCT01967173|3589920|P7|Completed 3rd Period|Overall Study||59
1466550|NCT01967173|3589921|P6|Completed 3rd Period|Overall Study||56
1466551|NCT01967173|3589922|P5|Completed 3rd Period|Overall Study||59
1466552|NCT01967173|3589923|P4|Completed 3rd Period|Overall Study||61
1466553|NCT01967173|3589924|P3|Completed 3rd Period|Overall Study||60
1466554|NCT01967173|3589925|P2|Completed 3rd Period|Overall Study||54
1466555|NCT01967173|3589926|P1|Completed 3rd Period|Overall Study||48
1466556|NCT01967173|3589919|P8|Completed 2nd Period|Overall Study||61
1466557|NCT01967173|3589920|P7|Completed 2nd Period|Overall Study||63
1466558|NCT01967173|3589921|P6|Completed 2nd Period|Overall Study||57
1466559|NCT01967173|3589922|P5|Completed 2nd Period|Overall Study||63
1466560|NCT01967173|3589923|P4|Completed 2nd Period|Overall Study||62
1466561|NCT01967173|3589924|P3|Completed 2nd Period|Overall Study||63
1466562|NCT01967173|3589925|P2|Completed 2nd Period|Overall Study||58
1466563|NCT01967173|3589926|P1|Completed 2nd Period|Overall Study||52
1466564|NCT01967173|3589919|P8|Completed 1st Period|Overall Study||69
1466565|NCT01967173|3589920|P7|Completed 1st Period|Overall Study||67
1466566|NCT01967173|3589921|P6|Completed 1st Period|Overall Study||62
1466567|NCT01967173|3589922|P5|Completed 1st Period|Overall Study||64
1466568|NCT01967173|3589923|P4|Completed 1st Period|Overall Study||65
1466569|NCT01967173|3589924|P3|Completed 1st Period|Overall Study||67
1466570|NCT01967173|3589925|P2|Completed 1st Period|Overall Study||60
1466571|NCT01967173|3589926|P1|Completed 1st Period|Overall Study||58
1466572|NCT01967173|3589919|P8|STARTED|Overall Study||74
1466573|NCT01967173|3589920|P7|STARTED|Overall Study||75
1466574|NCT01967173|3589921|P6|STARTED|Overall Study||72
1466575|NCT01967173|3589922|P5|STARTED|Overall Study||73
1466576|NCT01967173|3589923|P4|STARTED|Overall Study||71
1466577|NCT01967173|3589924|P3|STARTED|Overall Study||71
1466578|NCT01967173|3589925|P2|STARTED|Overall Study||69
1466579|NCT01967173|3589926|P1|STARTED|Overall Study||69
1466580|NCT01967147|3589940|P2|NOT COMPLETED|Overall Study||20
1466581|NCT01967147|3589941|P1|NOT COMPLETED|Overall Study||13
1466582|NCT01967147|3589940|P2|COMPLETED|Overall Study||82
1466583|NCT01967147|3589941|P1|COMPLETED|Overall Study||99
1466584|NCT01967147|3589940|P2|STARTED|Overall Study||102
1466585|NCT01967147|3589941|P1|STARTED|Overall Study||112
1466586|NCT01967121|3589959|P3|NOT COMPLETED|Overall Study||0
1466587|NCT01967121|3589960|P2|NOT COMPLETED|Overall Study||0
1466588|NCT01967121|3589961|P1|NOT COMPLETED|Overall Study||0
1466589|NCT01967121|3589959|P3|COMPLETED|Overall Study||25
1466590|NCT01967121|3589960|P2|COMPLETED|Overall Study||25
1466591|NCT01967121|3589961|P1|COMPLETED|Overall Study||25
1466592|NCT01967121|3589959|P3|STARTED|Overall Study||25
1466593|NCT01967121|3589960|P2|STARTED|Overall Study||25
1466594|NCT01967121|3589961|P1|STARTED|Overall Study||25
1466595|NCT01967069|3589971|P2|NOT COMPLETED|Overall Study||8
1466596|NCT01967069|3589972|P1|NOT COMPLETED|Overall Study||8
1466597|NCT01967069|3589971|P2|COMPLETED|Overall Study||87
1466598|NCT01967069|3589972|P1|COMPLETED|Overall Study||174
1466599|NCT01967069|3589971|P2|STARTED|Overall Study||95
1466600|NCT01967069|3589972|P1|STARTED|Overall Study||182
1466601|NCT01966926|3589980|P2|NOT COMPLETED|Overall Study||0
1466602|NCT01966926|3589981|P1|NOT COMPLETED|Overall Study||0
1466603|NCT01966926|3589980|P2|COMPLETED|Overall Study||15
1466604|NCT01966926|3589981|P1|COMPLETED|Overall Study||15
1466605|NCT01966926|3589980|P2|STARTED|Overall Study||15
1466606|NCT01966926|3589981|P1|STARTED|Overall Study||15
1466607|NCT01966770|3589997|P1|NOT COMPLETED|Overall Study||0
1466608|NCT01966770|3589997|P1|COMPLETED|Overall Study||20
1466609|NCT01966770|3589997|P1|STARTED|Overall Study||20
1466610|NCT01966718|3590106|P1|NOT COMPLETED|Overall Study||0
1466611|NCT01966718|3590106|P1|COMPLETED|Overall Study||8
1466612|NCT01966718|3590106|P1|STARTED|Overall Study||8
1466613|NCT01966458|3590116|P2|NOT COMPLETED|Overall Study||2
1466614|NCT01966458|3590117|P1|NOT COMPLETED|Overall Study||4
1466615|NCT01966458|3590116|P2|COMPLETED|Overall Study||155
1466616|NCT01966458|3590117|P1|COMPLETED|Overall Study||304
1466617|NCT01966458|3590116|P2|STARTED|Overall Study||157
1466618|NCT01966458|3590117|P1|STARTED|Overall Study||308
1466619|NCT01966432|3590129|P3|NOT COMPLETED|Overall Study||26
1466620|NCT01966432|3590130|P2|NOT COMPLETED|Overall Study||13
1466621|NCT01966432|3590131|P1|NOT COMPLETED|Overall Study||5
1466622|NCT01966432|3590129|P3|COMPLETED|Overall Study||28
1466623|NCT01966432|3590130|P2|COMPLETED|Overall Study||21
1466624|NCT01966432|3590131|P1|COMPLETED|Overall Study||5
1466625|NCT01966432|3590129|P3|STARTED|Overall Study||54
1466626|NCT01966432|3590130|P2|STARTED|Overall Study||34
1466627|NCT01966432|3590131|P1|STARTED|Overall Study||10
1466628|NCT01966380|3590151|P2|NOT COMPLETED|Overall Study||1
1466629|NCT01966380|3590152|P1|NOT COMPLETED|Overall Study||0
1466630|NCT01966380|3590151|P2|COMPLETED|Overall Study||2
1466631|NCT01966380|3590152|P1|COMPLETED|Overall Study||3
1466632|NCT01966380|3590151|P2|STARTED|Overall Study||3
1466633|NCT01966380|3590152|P1|STARTED|Overall Study||3
1466634|NCT01966354|3590161|P3|NOT COMPLETED|Overall Study||0
1466635|NCT01966354|3590162|P2|NOT COMPLETED|Overall Study||0
1466636|NCT01966354|3590163|P1|NOT COMPLETED|Overall Study||0
1466637|NCT01966354|3590161|P3|COMPLETED|Overall Study||72
1466638|NCT01966354|3590162|P2|COMPLETED|Overall Study||73
1466639|NCT01966354|3590163|P1|COMPLETED|Overall Study||75
1466640|NCT01966354|3590161|P3|STARTED|Overall Study||72
1466641|NCT01966354|3590162|P2|STARTED|Overall Study||73
1466642|NCT01966354|3590163|P1|STARTED|Overall Study||75
1466643|NCT01966159|3590188|P2|NOT COMPLETED|Overall Study||0
1466644|NCT01966159|3590189|P1|NOT COMPLETED|Overall Study||0
1466645|NCT01966159|3590188|P2|COMPLETED|Overall Study||207
1466646|NCT01966159|3590189|P1|COMPLETED|Overall Study||205
1466647|NCT01966159|3590188|P2|STARTED|Overall Study||207
1466648|NCT01966159|3590189|P1|STARTED|Overall Study||205
1466649|NCT01966120|3590201|P2|NOT COMPLETED|Overall Study||6
1466650|NCT01966120|3590202|P1|NOT COMPLETED|Overall Study||1
1466651|NCT01966120|3590201|P2|COMPLETED|Overall Study||26
1466652|NCT01966120|3590202|P1|COMPLETED|Overall Study||54
1466653|NCT01966120|3590201|P2|STARTED|Overall Study||32
1466654|NCT01966120|3590202|P1|STARTED|Overall Study||55
1466655|NCT01966107|3590226|P2|NOT COMPLETED|Overall Study||881
1466656|NCT01966107|3590227|P1|NOT COMPLETED|Overall Study||802
1466657|NCT01966107|3590226|P2|COMPLETED|Overall Study||937
1466658|NCT01966107|3590227|P1|COMPLETED|Overall Study||1010
1466659|NCT01966107|3590226|P2|Full Analysis Set|Overall Study||1798
1466660|NCT01966107|3590227|P1|Full Analysis Set|Overall Study||1791
1466661|NCT01966107|3590226|P2|STARTED|Overall Study||1818
1466662|NCT01966107|3590227|P1|STARTED|Overall Study||1812
1466663|NCT01966068|3590241|P1|NOT COMPLETED|Overall Study||138
1466664|NCT01966068|3590241|P1|COMPLETED|Overall Study||156
1466665|NCT01966068|3590241|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
1466666|NCT01966068|3590241|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
1466667|NCT01966068|3590241|P1|STARTED|Overall Study||294
1466668|NCT01966042|3590246|P1|NOT COMPLETED|Overall Study||2
1466669|NCT01966042|3590246|P1|COMPLETED|Overall Study||11
1466670|NCT01966042|3590246|P1|STARTED|Overall Study||13
1466671|NCT01966003|3590255|P2|NOT COMPLETED|Overall Study||270
1466672|NCT01966003|3590256|P1|NOT COMPLETED|Overall Study||270
1466673|NCT01966003|3590255|P2|COMPLETED|Overall Study||44
1466674|NCT01966003|3590256|P1|COMPLETED|Overall Study||58
1466675|NCT01966003|3590255|P2|Received Study Drug|Overall Study||309
1466676|NCT01966003|3590256|P1|Received Study Drug|Overall Study||324
1466677|NCT01966003|3590255|P2|STARTED|Overall Study||314
1466678|NCT01966003|3590256|P1|STARTED|Overall Study||328
1466679|NCT01965938|3590274|P2|NOT COMPLETED|Overall Study||0
1466680|NCT01965938|3590275|P1|NOT COMPLETED|Overall Study||1
1466681|NCT01965938|3590274|P2|COMPLETED|Overall Study||20
1466682|NCT01965938|3590275|P1|COMPLETED|Overall Study||20
1466683|NCT01965938|3590274|P2|STARTED|Overall Study||20
1466684|NCT01965938|3590275|P1|STARTED|Overall Study||21
1466685|NCT01965899|3590295|P1|NOT COMPLETED|Overall Study||6
1466686|NCT01965899|3590295|P1|COMPLETED|Overall Study||145
1466687|NCT01965899|3590295|P1|STARTED|Overall Study||151
1466688|NCT01965834|3590306|P1|NOT COMPLETED|Overall Study||4
1466689|NCT01965834|3590306|P1|COMPLETED|Overall Study||2
1466690|NCT01965834|3590306|P1|STARTED|Overall Study||6
1466691|NCT01965782|3590312|P1|NOT COMPLETED|Overall Study||0
1466692|NCT01965782|3590312|P1|COMPLETED|Overall Study||0
1466693|NCT01965782|3590312|P1|STARTED|Overall Study||0
1466694|NCT01965756|3590324|P2|NOT COMPLETED|Overall Study||0
1466695|NCT01965756|3590325|P1|NOT COMPLETED|Overall Study||0
1466696|NCT01965756|3590324|P2|COMPLETED|Overall Study||10
1466697|NCT01965756|3590325|P1|COMPLETED|Overall Study||10
1466698|NCT01965756|3590324|P2|STARTED|Overall Study||10
1466699|NCT01965756|3590325|P1|STARTED|Overall Study||10
1466700|NCT01965665|3590339|P1|NOT COMPLETED|Overall Study||1
1466701|NCT01965665|3590339|P1|COMPLETED|Overall Study||19
1466702|NCT01965665|3590339|P1|STARTED|Overall Study||20
1466703|NCT01965652|3590347|P2|NOT COMPLETED|Overall Study||210
1466704|NCT01965652|3590348|P1|NOT COMPLETED|Overall Study||210
1466705|NCT01965652|3590347|P2|COMPLETED|Overall Study||413
1466706|NCT01965652|3590348|P1|COMPLETED|Overall Study||413
1466707|NCT01965652|3590347|P2|Received Treatment|Overall Study||623
1466708|NCT01965652|3590348|P1|Received Treatment|Overall Study||622
1466709|NCT01965652|3590347|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
1466710|NCT01965652|3590348|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
1466711|NCT01965600|3590378|P4|NOT COMPLETED|Second Intervention||2
1466712|NCT01965600|3590379|P3|NOT COMPLETED|Second Intervention||2
1466713|NCT01965600|3590380|P2|NOT COMPLETED|Second Intervention||0
1466714|NCT01965600|3590381|P1|NOT COMPLETED|Second Intervention||0
1466715|NCT01965600|3590378|P4|COMPLETED|Second Intervention||0
1466716|NCT01965600|3590379|P3|COMPLETED|Second Intervention||1
1466717|NCT01965600|3590380|P2|COMPLETED|Second Intervention||4
1466718|NCT01965600|3590381|P1|COMPLETED|Second Intervention||4
1466719|NCT01965600|3590378|P4|STARTED|Second Intervention||2
1466720|NCT01965600|3590379|P3|STARTED|Second Intervention||3
1466721|NCT01965600|3590380|P2|STARTED|Second Intervention||4
1466722|NCT01965600|3590381|P1|STARTED|Second Intervention||4
1466723|NCT01965600|3590378|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
1466724|NCT01965600|3590379|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
1466725|NCT01965600|3590380|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
1466726|NCT01965600|3590381|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
1466727|NCT01965600|3590378|P4|COMPLETED|Washout Period of Approximately 15 Days||2
1466728|NCT01965600|3590379|P3|COMPLETED|Washout Period of Approximately 15 Days||3
1466729|NCT01965600|3590380|P2|COMPLETED|Washout Period of Approximately 15 Days||4
1466730|NCT01965600|3590381|P1|COMPLETED|Washout Period of Approximately 15 Days||4
1466731|NCT01965600|3590378|P4|STARTED|Washout Period of Approximately 15 Days||4
1466732|NCT01965600|3590379|P3|STARTED|Washout Period of Approximately 15 Days||5
1466733|NCT01965600|3590380|P2|STARTED|Washout Period of Approximately 15 Days||8
1466734|NCT01965600|3590381|P1|STARTED|Washout Period of Approximately 15 Days||6
1466735|NCT01965600|3590378|P4|NOT COMPLETED|First Intervention||0
1466736|NCT01965600|3590379|P3|NOT COMPLETED|First Intervention||0
1466737|NCT01965600|3590380|P2|NOT COMPLETED|First Intervention||0
1466738|NCT01965600|3590381|P1|NOT COMPLETED|First Intervention||0
1466739|NCT01965600|3590378|P4|COMPLETED|First Intervention||4
1466740|NCT01965600|3590379|P3|COMPLETED|First Intervention||5
1466741|NCT01965600|3590380|P2|COMPLETED|First Intervention||8
1466742|NCT01965600|3590381|P1|COMPLETED|First Intervention||6
1466743|NCT01965600|3590378|P4|Received at Least One Dose of Drug|First Intervention||4
1466744|NCT01965600|3590379|P3|Received at Least One Dose of Drug|First Intervention||5
1466745|NCT01965600|3590380|P2|Received at Least One Dose of Drug|First Intervention||8
1466746|NCT01965600|3590381|P1|Received at Least One Dose of Drug|First Intervention||6
1466747|NCT01965600|3590378|P4|STARTED|First Intervention||4
1466748|NCT01965600|3590379|P3|STARTED|First Intervention||5
1466749|NCT01965600|3590380|P2|STARTED|First Intervention||8
1466750|NCT01965600|3590381|P1|STARTED|First Intervention||6
1466751|NCT01965561|3590425|P1|NOT COMPLETED|Overall Study||0
1466752|NCT01965561|3590425|P1|COMPLETED|Overall Study||10
1466753|NCT01965561|3590425|P1|STARTED|Overall Study||10
1466754|NCT01965535|3590438|P2|NOT COMPLETED|Overall Study||1
1466755|NCT01965535|3590439|P1|NOT COMPLETED|Overall Study||2
1466756|NCT01965535|3590438|P2|COMPLETED|Overall Study||76
1466757|NCT01965535|3590439|P1|COMPLETED|Overall Study||76
1466758|NCT01965535|3590438|P2|STARTED|Overall Study||77
1466759|NCT01965535|3590439|P1|STARTED|Overall Study||78
1466760|NCT01965431|3590453|P6|NOT COMPLETED|Overall Study||6
1466761|NCT01965431|3590454|P5|NOT COMPLETED|Overall Study||6
1466762|NCT01965431|3590455|P4|NOT COMPLETED|Overall Study||6
1466763|NCT01965431|3590456|P3|NOT COMPLETED|Overall Study||6
1466764|NCT01965431|3590457|P2|NOT COMPLETED|Overall Study||6
1466765|NCT01965431|3590458|P1|NOT COMPLETED|Overall Study||6
1466766|NCT01965431|3590453|P6|COMPLETED|Overall Study||2
1466767|NCT01965431|3590454|P5|COMPLETED|Overall Study||2
1466768|NCT01965431|3590455|P4|COMPLETED|Overall Study||2
1466769|NCT01965431|3590456|P3|COMPLETED|Overall Study||2
1466770|NCT01965431|3590457|P2|COMPLETED|Overall Study||2
1466771|NCT01965431|3590458|P1|COMPLETED|Overall Study||2
1466772|NCT01965431|3590453|P6|STARTED|Overall Study||8
1466773|NCT01965431|3590454|P5|STARTED|Overall Study||8
1466774|NCT01965431|3590455|P4|STARTED|Overall Study||8
1466775|NCT01965431|3590456|P3|STARTED|Overall Study||8
1466776|NCT01965431|3590457|P2|STARTED|Overall Study||8
1466777|NCT01965431|3590458|P1|STARTED|Overall Study|Started are actually Treated subjects|8
1466778|NCT01965366|3590473|P2|NOT COMPLETED|Overall Study||5
1466779|NCT01965366|3590474|P1|NOT COMPLETED|Overall Study||10
1466780|NCT01965366|3590473|P2|COMPLETED|Overall Study||9
1466781|NCT01965366|3590474|P1|COMPLETED|Overall Study||3
1466782|NCT01965366|3590473|P2|STARTED|Overall Study||14
1466783|NCT01965366|3590474|P1|STARTED|Overall Study||13
1466784|NCT01965327|3590482|P1|NOT COMPLETED|Overall Study||2
1466785|NCT01965327|3590482|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
1466786|NCT01965327|3590482|P1|STARTED|Overall Study||12
1466787|NCT01965288|3590489|P2|NOT COMPLETED|Overall Study||0
1466788|NCT01965288|3590490|P1|NOT COMPLETED|Overall Study||0
1466789|NCT01965288|3590489|P2|COMPLETED|Overall Study||30
1466790|NCT01965288|3590490|P1|COMPLETED|Overall Study||30
1466791|NCT01965288|3590489|P2|STARTED|Overall Study||30
1466792|NCT01965288|3590490|P1|STARTED|Overall Study||30
1466793|NCT01965262|3590696|P2|NOT COMPLETED|Second Intervention (7 Days)||10
1466794|NCT01965262|3590697|P1|NOT COMPLETED|Second Intervention (7 Days)||1
1466795|NCT01965262|3590696|P2|COMPLETED|Second Intervention (7 Days)||5
1466796|NCT01965262|3590697|P1|COMPLETED|Second Intervention (7 Days)||14
1466797|NCT01965262|3590696|P2|STARTED|Second Intervention (7 Days)||15
1466798|NCT01965262|3590697|P1|STARTED|Second Intervention (7 Days)||15
1466799|NCT01965262|3590696|P2|NOT COMPLETED|First Intervention (7 Days)||0
1466800|NCT01965262|3590697|P1|NOT COMPLETED|First Intervention (7 Days)||0
1466801|NCT01965262|3590696|P2|COMPLETED|First Intervention (7 Days)||15
1466802|NCT01965262|3590697|P1|COMPLETED|First Intervention (7 Days)||15
1466803|NCT01965262|3590696|P2|STARTED|First Intervention (7 Days)||15
1466804|NCT01965262|3590697|P1|STARTED|First Intervention (7 Days)||15
1466805|NCT01965158|3590761|P2|NOT COMPLETED|Overall Study||35
1466806|NCT01965158|3590762|P1|NOT COMPLETED|Overall Study||41
1466807|NCT01965158|3590761|P2|COMPLETED|Overall Study||238
1466808|NCT01965158|3590762|P1|COMPLETED|Overall Study||233
1466809|NCT01965158|3590761|P2|Received Treatment|Overall Study||273
1466810|NCT01965158|3590762|P1|Received Treatment|Overall Study||272
1466811|NCT01965158|3590761|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
1466812|NCT01965158|3590762|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
1466813|NCT01965067|3590778|P2|NOT COMPLETED|Overall Study||0
1466814|NCT01965067|3590779|P1|NOT COMPLETED|Overall Study||0
1466815|NCT01965067|3590778|P2|COMPLETED|Overall Study||30
1466816|NCT01965067|3590779|P1|COMPLETED|Overall Study||30
1466817|NCT01965067|3590778|P2|STARTED|Overall Study||30
1466818|NCT01965067|3590779|P1|STARTED|Overall Study||30
1466819|NCT01965002|3590795|P1|NOT COMPLETED|Overall Study||0
1466820|NCT01965002|3590795|P1|COMPLETED|Overall Study||5
1466821|NCT01965002|3590795|P1|STARTED|Overall Study||5
1466822|NCT01964976|3590803|P1|NOT COMPLETED|Overall Study||31
1466823|NCT01964976|3590803|P1|COMPLETED|Overall Study||1065
1466824|NCT01964976|3590803|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
1466825|NCT01964950|3590817|P1|NOT COMPLETED|Overall Study||25
1466826|NCT01964950|3590817|P1|COMPLETED|Overall Study||1076
1466827|NCT01964950|3590817|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
1466828|NCT01964898|3590831|P2|NOT COMPLETED|Overall Study||7
1466829|NCT01964898|3590832|P1|NOT COMPLETED|Overall Study||7
1466830|NCT01964898|3590831|P2|COMPLETED|Overall Study||26
1466831|NCT01964898|3590832|P1|COMPLETED|Overall Study||24
1466832|NCT01964898|3590831|P2|12 Week Assessment|Overall Study||30
1466833|NCT01964898|3590832|P1|12 Week Assessment|Overall Study||25
1466834|NCT01964898|3590831|P2|STARTED|Overall Study||33
1466835|NCT01964898|3590832|P1|STARTED|Overall Study||31
1466836|NCT01964716|3590854|P2|NOT COMPLETED|Overall Study||6
1466837|NCT01964716|3590855|P1|NOT COMPLETED|Overall Study||5
1466838|NCT01964716|3590854|P2|COMPLETED|Overall Study||244
1466839|NCT01964716|3590855|P1|COMPLETED|Overall Study||245
1466840|NCT01964716|3590854|P2|Vaccinated Dose 3|Overall Study||244
1466841|NCT01964716|3590855|P1|Vaccinated Dose 3|Overall Study||247
1466842|NCT01964716|3590854|P2|Vaccinated Dose 2|Overall Study||248
1466843|NCT01964716|3590855|P1|Vaccinated Dose 2|Overall Study||249
1466844|NCT01964716|3590854|P2|Vaccinated Dose 1|Overall Study||250
1466845|NCT01964716|3590855|P1|Vaccinated Dose 1|Overall Study||250
1466846|NCT01964716|3590854|P2|STARTED|Overall Study||250
1466847|NCT01964716|3590855|P1|STARTED|Overall Study||250
1466848|NCT01964547|3590893|P2|NOT COMPLETED|Overall Study||11
1466849|NCT01964547|3590894|P1|NOT COMPLETED|Overall Study||12
1466850|NCT01964547|3590893|P2|COMPLETED|Overall Study||48
1466851|NCT01964547|3590894|P1|COMPLETED|Overall Study||50
1466852|NCT01964547|3590893|P2|STARTED|Overall Study||59
1466853|NCT01964547|3590894|P1|STARTED|Overall Study||62
1466854|NCT01964521|3590918|P1|NOT COMPLETED|Overall Study||4
1466855|NCT01964521|3590918|P1|COMPLETED|Overall Study||20
1466856|NCT01964521|3590918|P1|STARTED|Overall Study||24
1466857|NCT01964352|3590927|P4|NOT COMPLETED|Overall Study||8
1466858|NCT01964352|3590928|P3|NOT COMPLETED|Overall Study||6
1466859|NCT01964352|3590929|P2|NOT COMPLETED|Overall Study||11
1466860|NCT01964352|3590930|P1|NOT COMPLETED|Overall Study||26
1466861|NCT01964352|3590927|P4|COMPLETED|Overall Study||195
1466862|NCT01964352|3590928|P3|COMPLETED|Overall Study||196
1466863|NCT01964352|3590929|P2|COMPLETED|Overall Study||192
1466864|NCT01964352|3590930|P1|COMPLETED|Overall Study||178
1466865|NCT01964352|3590927|P4|STARTED|Overall Study||203
1466866|NCT01964352|3590928|P3|STARTED|Overall Study||202
1466867|NCT01964352|3590929|P2|STARTED|Overall Study||203
1466868|NCT01964352|3590930|P1|STARTED|Overall Study||204
1466869|NCT01964326|3590960|P1|NOT COMPLETED|Overall Study||297
1466870|NCT01964326|3590960|P1|COMPLETED|Overall Study||1014
1466871|NCT01964326|3590960|P1|STARTED|Overall Study||1311
1466872|NCT01964222|3590969|P2|NOT COMPLETED|Overall Study||11
1466873|NCT01964222|3590970|P1|NOT COMPLETED|Overall Study||15
1466874|NCT01964222|3590969|P2|COMPLETED|Overall Study||89
1466875|NCT01964222|3590970|P1|COMPLETED|Overall Study||86
1466876|NCT01964222|3590969|P2|STARTED|Overall Study||100
1466877|NCT01964222|3590970|P1|STARTED|Overall Study||101
1466878|NCT01964105|3590987|P3|NOT COMPLETED|Overall Study||0
1466879|NCT01964105|3590988|P2|NOT COMPLETED|Overall Study||13
1466880|NCT01964105|3590989|P1|NOT COMPLETED|Overall Study||2
1466881|NCT01964105|3590987|P3|COMPLETED|Overall Study||10
1466882|NCT01964105|3590988|P2|COMPLETED|Overall Study||62
1466883|NCT01964105|3590989|P1|COMPLETED|Overall Study||13
1466884|NCT01964105|3590987|P3|STARTED|Overall Study||10
1466885|NCT01964105|3590988|P2|STARTED|Overall Study||75
1466886|NCT01964105|3590989|P1|STARTED|Overall Study||15
1466887|NCT01963845|3590999|P2|NOT COMPLETED|Overall Study||0
1466888|NCT01963845|3591000|P1|NOT COMPLETED|Overall Study||0
1466889|NCT01963845|3590999|P2|COMPLETED|Overall Study||25
1466890|NCT01963845|3591000|P1|COMPLETED|Overall Study||25
1466891|NCT01963845|3590999|P2|STARTED|Overall Study||25
1466892|NCT01963845|3591000|P1|STARTED|Overall Study||25
1466893|NCT01963767|3591016|P2|NOT COMPLETED|Overall Study||2
1466894|NCT01963767|3591017|P1|NOT COMPLETED|Overall Study||6
1466895|NCT01963767|3591016|P2|COMPLETED|Overall Study||53
1466896|NCT01963767|3591017|P1|COMPLETED|Overall Study||52
1466897|NCT01963767|3591016|P2|STARTED|Overall Study||55
1466898|NCT01963767|3591017|P1|STARTED|Overall Study||58
1466899|NCT01963676|3591027|P2|NOT COMPLETED|Overall Study||0
1466900|NCT01963676|3591028|P1|NOT COMPLETED|Overall Study||1
1466901|NCT01963676|3591027|P2|COMPLETED|Overall Study||13
1466902|NCT01963676|3591028|P1|COMPLETED|Overall Study||13
1466903|NCT01963676|3591027|P2|STARTED|Overall Study||13
1466904|NCT01963676|3591028|P1|STARTED|Overall Study||14
1466905|NCT01963611|3591041|P5|NOT COMPLETED|Overall Study||51
1466906|NCT01963611|3591042|P4|NOT COMPLETED|Overall Study||52
1466907|NCT01963611|3591043|P3|NOT COMPLETED|Overall Study||52
1466908|NCT01963611|3591044|P2|NOT COMPLETED|Overall Study||49
1466909|NCT01963611|3591045|P1|NOT COMPLETED|Overall Study||51
1466910|NCT01963611|3591041|P5|COMPLETED|Overall Study||0
1466911|NCT01963611|3591042|P4|COMPLETED|Overall Study||0
1466912|NCT01963611|3591043|P3|COMPLETED|Overall Study||0
1466913|NCT01963611|3591044|P2|COMPLETED|Overall Study||0
1466914|NCT01963611|3591045|P1|COMPLETED|Overall Study||0
1466915|NCT01963611|3591041|P5|Safety Analysis Set|Overall Study||50
1466916|NCT01963611|3591042|P4|Safety Analysis Set|Overall Study||52
1466917|NCT01963611|3591043|P3|Safety Analysis Set|Overall Study||52
1466918|NCT01963611|3591044|P2|Safety Analysis Set|Overall Study||49
1466919|NCT01963611|3591045|P1|Safety Analysis Set|Overall Study||51
1466920|NCT01963611|3591041|P5|STARTED|Overall Study||51
1466921|NCT01963611|3591042|P4|STARTED|Overall Study||52
1466922|NCT01963611|3591043|P3|STARTED|Overall Study||52
1466923|NCT01963611|3591044|P2|STARTED|Overall Study||49
1466924|NCT01963611|3591045|P1|STARTED|Overall Study||51
1466925|NCT01963403|3591104|P2|NOT COMPLETED|Overall Study||4
1466926|NCT01963403|3591105|P1|NOT COMPLETED|Overall Study||2
1466927|NCT01963403|3591104|P2|COMPLETED|Overall Study|Follow-up over three months|9
1466928|NCT01963403|3591105|P1|COMPLETED|Overall Study|Follow-up over three months|11
1466929|NCT01963403|3591104|P2|STARTED|Overall Study||13
1466930|NCT01963403|3591105|P1|STARTED|Overall Study||13
1466931|NCT01963260|3591127|P10|NOT COMPLETED|Overall Study||0
1466932|NCT01963260|3591128|P9|NOT COMPLETED|Overall Study||0
1466933|NCT01963260|3591129|P8|NOT COMPLETED|Overall Study||0
1466934|NCT01963260|3591130|P7|NOT COMPLETED|Overall Study||0
1466935|NCT01963260|3591131|P6|NOT COMPLETED|Overall Study||0
1466936|NCT01963260|3591132|P5|NOT COMPLETED|Overall Study||2
1466937|NCT01963260|3591133|P4|NOT COMPLETED|Overall Study||1
1466938|NCT01963260|3591134|P3|NOT COMPLETED|Overall Study||0
1466939|NCT01963260|3591135|P2|NOT COMPLETED|Overall Study||0
1466940|NCT01963260|3591136|P1|NOT COMPLETED|Overall Study||2
1466941|NCT01963260|3591127|P10|COMPLETED|Overall Study||4
1466942|NCT01963260|3591128|P9|COMPLETED|Overall Study||1
1466943|NCT01963260|3591129|P8|COMPLETED|Overall Study||2
1466944|NCT01963260|3591130|P7|COMPLETED|Overall Study||3
1466945|NCT01963260|3591131|P6|COMPLETED|Overall Study||10
1466946|NCT01963260|3591132|P5|COMPLETED|Overall Study||4
1466947|NCT01963260|3591133|P4|COMPLETED|Overall Study||5
1466948|NCT01963260|3591134|P3|COMPLETED|Overall Study||6
1466949|NCT01963260|3591135|P2|COMPLETED|Overall Study||6
1466950|NCT01963260|3591136|P1|COMPLETED|Overall Study||4
1466951|NCT01963260|3591127|P10|Treated|Overall Study||4
1466952|NCT01963260|3591128|P9|Treated|Overall Study||1
1466953|NCT01963260|3591129|P8|Treated|Overall Study||2
1466954|NCT01963260|3591130|P7|Treated|Overall Study||3
1466955|NCT01963260|3591131|P6|Treated|Overall Study||10
1466956|NCT01963260|3591132|P5|Treated|Overall Study||6
1466957|NCT01963260|3591133|P4|Treated|Overall Study||6
1466958|NCT01963260|3591134|P3|Treated|Overall Study||6
1466959|NCT01963260|3591135|P2|Treated|Overall Study||6
1466960|NCT01963260|3591136|P1|Treated|Overall Study||6
1466961|NCT01963260|3591127|P10|STARTED|Overall Study||4
1466962|NCT01963260|3591128|P9|STARTED|Overall Study||1
1466963|NCT01963260|3591129|P8|STARTED|Overall Study||2
1466964|NCT01963260|3591130|P7|STARTED|Overall Study||3
1466965|NCT01963260|3591131|P6|STARTED|Overall Study||10
1466966|NCT01963260|3591132|P5|STARTED|Overall Study||6
1466967|NCT01963260|3591133|P4|STARTED|Overall Study||6
1466968|NCT01963260|3591134|P3|STARTED|Overall Study||6
1466969|NCT01963260|3591135|P2|STARTED|Overall Study||6
1466970|NCT01963260|3591136|P1|STARTED|Overall Study||6
1466971|NCT01963234|3591191|P2|NOT COMPLETED|Overall Study||0
1466972|NCT01963234|3591192|P1|NOT COMPLETED|Overall Study||61
1466973|NCT01963234|3591191|P2|COMPLETED|Overall Study||171
1466974|NCT01963234|3591192|P1|COMPLETED|Overall Study||207
1466975|NCT01963234|3591191|P2|STARTED|Overall Study||171
1466976|NCT01963234|3591192|P1|STARTED|Overall Study||268
1466977|NCT01963143|3591219|P3|NOT COMPLETED|Overall Study||1
1466978|NCT01963143|3591220|P2|NOT COMPLETED|Overall Study||1
1466979|NCT01963143|3591221|P1|NOT COMPLETED|Overall Study||0
1466980|NCT01963143|3591219|P3|COMPLETED|Overall Study||14
1466981|NCT01963143|3591220|P2|COMPLETED|Overall Study||18
1466982|NCT01963143|3591221|P1|COMPLETED|Overall Study||14
1466983|NCT01963143|3591219|P3|STARTED|Overall Study||15
1466984|NCT01963143|3591220|P2|STARTED|Overall Study||19
1466985|NCT01963143|3591221|P1|STARTED|Overall Study||14
1466986|NCT01963091|3591233|P2|NOT COMPLETED|Overall Study||0
1466987|NCT01963091|3591234|P1|NOT COMPLETED|Overall Study||0
1466988|NCT01963091|3591233|P2|COMPLETED|Overall Study||16
1466989|NCT01963091|3591234|P1|COMPLETED|Overall Study||17
1466990|NCT01963091|3591233|P2|STARTED|Overall Study||16
1466991|NCT01963091|3591234|P1|STARTED|Overall Study||17
1466992|NCT01963078|3591248|P4|NOT COMPLETED|Overall Study||2
1466993|NCT01963078|3591249|P3|NOT COMPLETED|Overall Study||1
1466994|NCT01963078|3591250|P2|NOT COMPLETED|Overall Study||1
1466995|NCT01963078|3591251|P1|NOT COMPLETED|Overall Study||1
1466996|NCT01963078|3591248|P4|COMPLETED|Overall Study||7
1466997|NCT01963078|3591249|P3|COMPLETED|Overall Study||9
1466998|NCT01963078|3591250|P2|COMPLETED|Overall Study||9
1466999|NCT01963078|3591251|P1|COMPLETED|Overall Study||8
1467000|NCT01963078|3591248|P4|STARTED|Overall Study||9
1467001|NCT01963078|3591249|P3|STARTED|Overall Study||10
1467002|NCT01963078|3591250|P2|STARTED|Overall Study||10
1467003|NCT01963078|3591251|P1|STARTED|Overall Study||9
1467004|NCT01962974|3591261|P1|NOT COMPLETED|Overall Study||7
1467005|NCT01962974|3591261|P1|COMPLETED|Overall Study||0
1467006|NCT01962974|3591261|P1|STARTED|Overall Study||7
1467007|NCT01962961|3591270|P3|NOT COMPLETED|Overall Study||1
1467008|NCT01962961|3591271|P2|NOT COMPLETED|Overall Study||1
1467009|NCT01962961|3591272|P1|NOT COMPLETED|Overall Study||0
1467010|NCT01962961|3591270|P3|COMPLETED|Overall Study||6
1467011|NCT01962961|3591271|P2|COMPLETED|Overall Study||7
1467012|NCT01962961|3591272|P1|COMPLETED|Overall Study||9
1467013|NCT01962961|3591270|P3|STARTED|Overall Study||7
1467014|NCT01962961|3591271|P2|STARTED|Overall Study||8
1467015|NCT01962961|3591272|P1|STARTED|Overall Study||9
1467016|NCT01962922|3591288|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
1467017|NCT01962922|3591289|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
1467018|NCT01962922|3591288|P2|COMPLETED|Extendion Portion (up to Month 6)||20
1467019|NCT01962922|3591289|P1|COMPLETED|Extendion Portion (up to Month 6)||18
1467020|NCT01962922|3591288|P2|STARTED|Extendion Portion (up to Month 6)||23
1467021|NCT01962922|3591289|P1|STARTED|Extendion Portion (up to Month 6)||23
1467022|NCT01962922|3591288|P2|NOT COMPLETED|PK Portion Day 21||0
1467023|NCT01962922|3591289|P1|NOT COMPLETED|PK Portion Day 21||0
1467024|NCT01962922|3591288|P2|COMPLETED|PK Portion Day 21||23
1467025|NCT01962922|3591289|P1|COMPLETED|PK Portion Day 21||23
1467026|NCT01962922|3591288|P2|STARTED|PK Portion Day 21||23
1467027|NCT01962922|3591289|P1|STARTED|PK Portion Day 21||23
1467028|NCT01962922|3591288|P2|NOT COMPLETED|PK Portion Day 14||0
1467029|NCT01962922|3591289|P1|NOT COMPLETED|PK Portion Day 14||0
1467030|NCT01962922|3591288|P2|COMPLETED|PK Portion Day 14||23
1467031|NCT01962922|3591289|P1|COMPLETED|PK Portion Day 14||23
1467032|NCT01962922|3591288|P2|STARTED|PK Portion Day 14||23
1467033|NCT01962922|3591289|P1|STARTED|PK Portion Day 14||23
1467034|NCT01962922|3591288|P2|NOT COMPLETED|PK Portion Day 7||0
1467035|NCT01962922|3591289|P1|NOT COMPLETED|PK Portion Day 7||4
1467036|NCT01962922|3591288|P2|COMPLETED|PK Portion Day 7||23
1467037|NCT01962922|3591289|P1|COMPLETED|PK Portion Day 7||23
1467038|NCT01962922|3591288|P2|STARTED|PK Portion Day 7||23
1467039|NCT01962922|3591289|P1|STARTED|PK Portion Day 7||27
1467040|NCT01962688|3591313|P2|NOT COMPLETED|Overall Study||0
1467041|NCT01962688|3591314|P1|NOT COMPLETED|Overall Study||0
1467042|NCT01962688|3591313|P2|COMPLETED|Overall Study||18
1467043|NCT01962688|3591314|P1|COMPLETED|Overall Study||19
1467044|NCT01962688|3591313|P2|STARTED|Overall Study||18
1467045|NCT01962688|3591314|P1|STARTED|Overall Study||19
1467046|NCT01962675|3591332|P2|NOT COMPLETED|Overall Study||0
1467047|NCT01962675|3591333|P1|NOT COMPLETED|Overall Study||0
1467048|NCT01962675|3591332|P2|COMPLETED|Overall Study||7
1467049|NCT01962675|3591333|P1|COMPLETED|Overall Study||7
1467050|NCT01962675|3591332|P2|STARTED|Overall Study||7
1467051|NCT01962675|3591333|P1|STARTED|Overall Study||7
1467052|NCT01962558|3591347|P2|NOT COMPLETED|Overall Study||0
1467053|NCT01962558|3591348|P1|NOT COMPLETED|Overall Study||0
1467054|NCT01962558|3591347|P2|COMPLETED|Overall Study||14
1467055|NCT01962558|3591348|P1|COMPLETED|Overall Study||16
1467056|NCT01962558|3591347|P2|12-Weeks|Overall Study||14
1467057|NCT01962558|3591348|P1|12-Weeks|Overall Study||16
1467058|NCT01962558|3591347|P2|Acute Study|Overall Study||14
1467059|NCT01962558|3591348|P1|Acute Study|Overall Study||16
1467060|NCT01962558|3591347|P2|STARTED|Overall Study||14
1467061|NCT01962558|3591348|P1|STARTED|Overall Study||16
1467062|NCT01962493|3591366|P2|NOT COMPLETED|Overall Study||5
1467063|NCT01962493|3591367|P1|NOT COMPLETED|Overall Study||5
1467064|NCT01962493|3591366|P2|COMPLETED|Overall Study||77
1467065|NCT01962493|3591367|P1|COMPLETED|Overall Study||73
1467066|NCT01962493|3591366|P2|STARTED|Overall Study||82
1467067|NCT01962493|3591367|P1|STARTED|Overall Study||78
1467068|NCT01962441|3591390|P3|NOT COMPLETED|Retreatment Substudy||0
1467069|NCT01962441|3591391|P2|NOT COMPLETED|Retreatment Substudy||0
1467070|NCT01962441|3591392|P1|NOT COMPLETED|Retreatment Substudy||2
1467071|NCT01962441|3591390|P3|COMPLETED|Retreatment Substudy||0
1467072|NCT01962441|3591391|P2|COMPLETED|Retreatment Substudy||10
1467073|NCT01962441|3591392|P1|COMPLETED|Retreatment Substudy||18
1467074|NCT01962441|3591390|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
1467075|NCT01962441|3591391|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
1467076|NCT01962441|3591392|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
1467077|NCT01962441|3591390|P3|NOT COMPLETED|Randomized Period||11
1467078|NCT01962441|3591391|P2|NOT COMPLETED|Randomized Period||11
1467079|NCT01962441|3591392|P1|NOT COMPLETED|Randomized Period||10
1467080|NCT01962441|3591390|P3|COMPLETED|Randomized Period||189
1467081|NCT01962441|3591391|P2|COMPLETED|Randomized Period||190
1467082|NCT01962441|3591392|P1|COMPLETED|Randomized Period||190
1467083|NCT01962441|3591390|P3|STARTED|Randomized Period||200
1467084|NCT01962441|3591391|P2|STARTED|Randomized Period||201
1467085|NCT01962441|3591392|P1|STARTED|Randomized Period||200
1467086|NCT01962428|3591424|P2|NOT COMPLETED|Overall Study||6
1467087|NCT01962428|3591425|P1|NOT COMPLETED|Overall Study||10
1467088|NCT01962428|3591424|P2|COMPLETED|Overall Study||133
1467089|NCT01962428|3591425|P1|COMPLETED|Overall Study||129
1467090|NCT01962428|3591424|P2|STARTED|Overall Study||139
1467091|NCT01962428|3591425|P1|STARTED|Overall Study||139
1467092|NCT01962298|3591436|P5|NOT COMPLETED|Overall Study||6
1467093|NCT01962298|3591437|P4|NOT COMPLETED|Overall Study||2
1467094|NCT01962298|3591438|P3|NOT COMPLETED|Overall Study||5
1467095|NCT01962298|3591439|P2|NOT COMPLETED|Overall Study||4
1467096|NCT01962298|3591440|P1|NOT COMPLETED|Overall Study||3
1467097|NCT01962298|3591436|P5|COMPLETED|Overall Study||9
1467098|NCT01962298|3591437|P4|COMPLETED|Overall Study||13
1467099|NCT01962298|3591438|P3|COMPLETED|Overall Study||10
1467100|NCT01962298|3591439|P2|COMPLETED|Overall Study||11
1467101|NCT01962298|3591440|P1|COMPLETED|Overall Study||12
1467102|NCT01962298|3591436|P5|Received Intervention|Overall Study||15
1467103|NCT01962298|3591437|P4|Received Intervention|Overall Study||15
1467104|NCT01962298|3591438|P3|Received Intervention|Overall Study||15
1467105|NCT01962298|3591439|P2|Received Intervention|Overall Study||15
1467106|NCT01962298|3591440|P1|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
1467107|NCT01962298|3591436|P5|STARTED|Overall Study||15
1467108|NCT01962298|3591437|P4|STARTED|Overall Study||15
1467109|NCT01962298|3591438|P3|STARTED|Overall Study||15
1467110|NCT01962298|3591439|P2|STARTED|Overall Study||15
1467111|NCT01962298|3591440|P1|STARTED|Overall Study||15
1467112|NCT01962103|3591466|P9|NOT COMPLETED|Phase 2||14
1467113|NCT01962103|3591467|P8|NOT COMPLETED|Phase 2||14
1467114|NCT01962103|3591468|P7|NOT COMPLETED|Phase 2||14
1467115|NCT01962103|3591469|P6|NOT COMPLETED|Phase 2||0
1467116|NCT01962103|3591470|P5|NOT COMPLETED|Phase 2||0
1467117|NCT01962103|3591471|P4|NOT COMPLETED|Phase 2||0
1467118|NCT01962103|3591472|P3|NOT COMPLETED|Phase 2||0
1467119|NCT01962103|3591473|P2|NOT COMPLETED|Phase 2||0
1467120|NCT01962103|3591474|P1|NOT COMPLETED|Phase 2||0
1467121|NCT01962103|3591466|P9|COMPLETED|Phase 2|completed treatment|0
1467122|NCT01962103|3591467|P8|COMPLETED|Phase 2|completed treatment|0
1467123|NCT01962103|3591468|P7|COMPLETED|Phase 2|completed treatment|0
1467124|NCT01962103|3591469|P6|COMPLETED|Phase 2||0
1467125|NCT01962103|3591470|P5|COMPLETED|Phase 2||0
1467126|NCT01962103|3591471|P4|COMPLETED|Phase 2||0
1467127|NCT01962103|3591472|P3|COMPLETED|Phase 2||0
1467128|NCT01962103|3591473|P2|COMPLETED|Phase 2||0
1467129|NCT01962103|3591474|P1|COMPLETED|Phase 2||0
1467130|NCT01962103|3591466|P9|STARTED|Phase 2||14
1467131|NCT01962103|3591467|P8|STARTED|Phase 2||14
1467132|NCT01962103|3591468|P7|STARTED|Phase 2||14
1467133|NCT01962103|3591469|P6|STARTED|Phase 2||0
1467134|NCT01962103|3591470|P5|STARTED|Phase 2||0
1467135|NCT01962103|3591471|P4|STARTED|Phase 2||0
1467136|NCT01962103|3591472|P3|STARTED|Phase 2||0
1467137|NCT01962103|3591473|P2|STARTED|Phase 2||0
1467138|NCT01962103|3591474|P1|STARTED|Phase 2||0
1467139|NCT01962103|3591466|P9|NOT COMPLETED|Phase 1||0
1467140|NCT01962103|3591467|P8|NOT COMPLETED|Phase 1||0
1467141|NCT01962103|3591468|P7|NOT COMPLETED|Phase 1||0
1467142|NCT01962103|3591469|P6|NOT COMPLETED|Phase 1||7
1467143|NCT01962103|3591470|P5|NOT COMPLETED|Phase 1||8
1467144|NCT01962103|3591471|P4|NOT COMPLETED|Phase 1||11
1467145|NCT01962103|3591472|P3|NOT COMPLETED|Phase 1||14
1467146|NCT01962103|3591473|P2|NOT COMPLETED|Phase 1||8
1467147|NCT01962103|3591474|P1|NOT COMPLETED|Phase 1||16
1467148|NCT01962103|3591466|P9|COMPLETED|Phase 1||0
1467149|NCT01962103|3591467|P8|COMPLETED|Phase 1||0
1467150|NCT01962103|3591468|P7|COMPLETED|Phase 1||0
1467151|NCT01962103|3591469|P6|COMPLETED|Phase 1||0
1467152|NCT01962103|3591470|P5|COMPLETED|Phase 1||0
1467153|NCT01962103|3591471|P4|COMPLETED|Phase 1||0
1467154|NCT01962103|3591472|P3|COMPLETED|Phase 1||0
1467155|NCT01962103|3591473|P2|COMPLETED|Phase 1||0
1467156|NCT01962103|3591474|P1|COMPLETED|Phase 1||0
1467157|NCT01962103|3591466|P9|STARTED|Phase 1||0
1467158|NCT01962103|3591467|P8|STARTED|Phase 1||0
1467159|NCT01962103|3591468|P7|STARTED|Phase 1||0
1467160|NCT01962103|3591469|P6|STARTED|Phase 1||7
1467161|NCT01962103|3591470|P5|STARTED|Phase 1||8
1467162|NCT01962103|3591471|P4|STARTED|Phase 1||11
1467163|NCT01962103|3591472|P3|STARTED|Phase 1||14
1467164|NCT01962103|3591473|P2|STARTED|Phase 1||8
1467165|NCT01962103|3591474|P1|STARTED|Phase 1||16
1467166|NCT01961921|3591574|P1|NOT COMPLETED|Overall Study||2
1467167|NCT01961921|3591574|P1|COMPLETED|Overall Study||25
1467168|NCT01961921|3591574|P1|STARTED|Overall Study||27
1467169|NCT01961544|3591584|P1|NOT COMPLETED|Overall Study||13
1467170|NCT01961544|3591584|P1|COMPLETED|Overall Study||88
1467171|NCT01961544|3591584|P1|STARTED|Overall Study||101
1467172|NCT01961349|3591592|P3|NOT COMPLETED|Overall Study||2
1467173|NCT01961349|3591593|P2|NOT COMPLETED|Overall Study||6
1467174|NCT01961349|3591594|P1|NOT COMPLETED|Overall Study||3
1467175|NCT01961349|3591592|P3|COMPLETED|Overall Study||109
1467176|NCT01961349|3591593|P2|COMPLETED|Overall Study||101
1467177|NCT01961349|3591594|P1|COMPLETED|Overall Study||51
1467178|NCT01961349|3591592|P3|STARTED|Overall Study||111
1467179|NCT01961349|3591593|P2|STARTED|Overall Study||107
1467180|NCT01961349|3591594|P1|STARTED|Overall Study||54
1467181|NCT01961323|3591605|P1|NOT COMPLETED|Overall Study||49
1467182|NCT01961323|3591605|P1|COMPLETED|Overall Study||21
1467183|NCT01961323|3591605|P1|STARTED|Overall Study||70
1467184|NCT01961297|3591613|P2|NOT COMPLETED|Overall Study||1
1467185|NCT01961297|3591614|P1|NOT COMPLETED|Overall Study||2
1467186|NCT01961297|3591613|P2|COMPLETED|Overall Study||22
1467187|NCT01961297|3591614|P1|COMPLETED|Overall Study||28
1467188|NCT01961297|3591613|P2|STARTED|Overall Study||23
1467189|NCT01961297|3591614|P1|STARTED|Overall Study||30
1467190|NCT01961271|3591628|P1|NOT COMPLETED|Overall Study||50
1467191|NCT01961271|3591628|P1|COMPLETED|Overall Study||64
1467192|NCT01961271|3591628|P1|STARTED|Overall Study||114
1467193|NCT01961115|3591640|P3|NOT COMPLETED|Overall Study||4
1467194|NCT01961115|3591641|P2|NOT COMPLETED|Overall Study||0
1467195|NCT01961115|3591642|P1|NOT COMPLETED|Overall Study||2
1467196|NCT01961115|3591640|P3|COMPLETED|Overall Study||5
1467197|NCT01961115|3591641|P2|COMPLETED|Overall Study||0
1467198|NCT01961115|3591642|P1|COMPLETED|Overall Study||0
1467199|NCT01961115|3591640|P3|STARTED|Overall Study||9
1467200|NCT01961115|3591641|P2|STARTED|Overall Study||0
1467201|NCT01961115|3591642|P1|STARTED|Overall Study||2
1467202|NCT01961089|3591677|P1|NOT COMPLETED|Overall Study||0
1467203|NCT01961089|3591677|P1|COMPLETED|Overall Study||40
1467204|NCT01961089|3591677|P1|STARTED|Overall Study||40
1467205|NCT01960907|3591685|P2|NOT COMPLETED|Overall Study||45
1467206|NCT01960907|3591686|P1|NOT COMPLETED|Overall Study||36
1467207|NCT01960907|3591685|P2|COMPLETED|Overall Study||109
1467208|NCT01960907|3591686|P1|COMPLETED|Overall Study||122
1467209|NCT01960907|3591685|P2|STARTED|Overall Study||154
1467210|NCT01960907|3591686|P1|STARTED|Overall Study||158
1467211|NCT01960855|3591701|P5|NOT COMPLETED|Overall Study||5
1467212|NCT01960855|3591702|P4|NOT COMPLETED|Overall Study||4
1467213|NCT01960855|3591703|P3|NOT COMPLETED|Overall Study||9
1467214|NCT01960855|3591704|P2|NOT COMPLETED|Overall Study||4
1467215|NCT01960855|3591705|P1|NOT COMPLETED|Overall Study||11
1467216|NCT01960855|3591701|P5|COMPLETED|Overall Study||50
1467217|NCT01960855|3591702|P4|COMPLETED|Overall Study||51
1467218|NCT01960855|3591703|P3|COMPLETED|Overall Study||46
1467219|NCT01960855|3591704|P2|COMPLETED|Overall Study||51
1467220|NCT01960855|3591705|P1|COMPLETED|Overall Study||45
1467221|NCT01960855|3591701|P5|STARTED|Overall Study||55
1467222|NCT01960855|3591702|P4|STARTED|Overall Study||55
1467223|NCT01960855|3591703|P3|STARTED|Overall Study||55
1467224|NCT01960855|3591704|P2|STARTED|Overall Study||55
1467225|NCT01960855|3591705|P1|STARTED|Overall Study||56
1467226|NCT01960842|3591737|P1|NOT COMPLETED|Overall Study||3
1467227|NCT01960842|3591737|P1|COMPLETED|Overall Study||28
1467228|NCT01960842|3591737|P1|STARTED|Overall Study||31
1467229|NCT01960816|3591760|P1|NOT COMPLETED|Overall Study||1
1467230|NCT01960816|3591760|P1|COMPLETED|Overall Study||32
1467231|NCT01960816|3591760|P1|STARTED|Overall Study||33
1467232|NCT01960725|3591768|P2|NOT COMPLETED|Overall Study||5
1467233|NCT01960725|3591769|P1|NOT COMPLETED|Overall Study||6
1467234|NCT01960725|3591768|P2|COMPLETED|Overall Study||28
1467235|NCT01960725|3591769|P1|COMPLETED|Overall Study||27
1467236|NCT01960725|3591768|P2|Received Third Vaccine|Overall Study||32
1467237|NCT01960725|3591769|P1|Received Third Vaccine|Overall Study||32
1467238|NCT01960725|3591768|P2|Recieved Second Vaccine|Overall Study||33
1467239|NCT01960725|3591769|P1|Recieved Second Vaccine|Overall Study||33
1467240|NCT01960725|3591768|P2|Received First Vaccine|Overall Study||33
1467241|NCT01960725|3591769|P1|Received First Vaccine|Overall Study||33
1467242|NCT01960725|3591768|P2|STARTED|Overall Study||33
1467243|NCT01960725|3591769|P1|STARTED|Overall Study||33
1467244|NCT01960530|3591791|P1|NOT COMPLETED|Overall Study||0
1467245|NCT01960530|3591791|P1|COMPLETED|Overall Study||14
1467246|NCT01960530|3591791|P1|STARTED|Overall Study||14
1467247|NCT01960400|3591826|P2|NOT COMPLETED|Overall Study||0
1467248|NCT01960400|3591827|P1|NOT COMPLETED|Overall Study||0
1467249|NCT01960400|3591826|P2|COMPLETED|Overall Study||11
1467250|NCT01960400|3591827|P1|COMPLETED|Overall Study||11
1467251|NCT01960400|3591826|P2|STARTED|Overall Study||11
1467252|NCT01960400|3591827|P1|STARTED|Overall Study||11
1467253|NCT01960387|3591839|P1|NOT COMPLETED|Overall Study||0
1467254|NCT01960387|3591839|P1|COMPLETED|Overall Study||2
1467255|NCT01960387|3591839|P1|STARTED|Overall Study||2
1467256|NCT01960348|3591848|P2|NOT COMPLETED|Overall Study||22
1467257|NCT01960348|3591849|P1|NOT COMPLETED|Overall Study||10
1467258|NCT01960348|3591848|P2|COMPLETED|Overall Study||55
1467259|NCT01960348|3591849|P1|COMPLETED|Overall Study||138
1467260|NCT01960348|3591848|P2|STARTED|Overall Study||77
1467261|NCT01960348|3591849|P1|STARTED|Overall Study||148
1467262|NCT01960296|3591869|P2|NOT COMPLETED|Overall Study||3
1467263|NCT01960296|3591870|P1|NOT COMPLETED|Overall Study||2
1467264|NCT01960296|3591869|P2|COMPLETED|Overall Study||22
1467265|NCT01960296|3591870|P1|COMPLETED|Overall Study||21
1467266|NCT01960296|3591869|P2|STARTED|Overall Study||25
1467267|NCT01960296|3591870|P1|STARTED|Overall Study||23
1467268|NCT01960140|3591890|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
1467269|NCT01960140|3591890|P1|COMPLETED|Period 2 (Days 3-18)||38
1467270|NCT01960140|3591890|P1|Received Simvastatin|Period 2 (Days 3-18)||38
1467271|NCT01960140|3591890|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
1467272|NCT01960140|3591890|P1|STARTED|Period 2 (Days 3-18)||40
1467273|NCT01960140|3591890|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
1467274|NCT01960140|3591890|P1|COMPLETED|Period 1 (Days 1-2)||40
1467275|NCT01960140|3591890|P1|Received Simvastatin|Period 1 (Days 1-2)||40
1467276|NCT01960140|3591890|P1|STARTED|Period 1 (Days 1-2)||40
1467277|NCT01960114|3591901|P2|NOT COMPLETED|Overall Study||1
1467278|NCT01960114|3591902|P1|NOT COMPLETED|Overall Study||1
1467279|NCT01960114|3591901|P2|COMPLETED|Overall Study||268
1467280|NCT01960114|3591902|P1|COMPLETED|Overall Study||133
1467281|NCT01960114|3591901|P2|STARTED|Overall Study||269
1467282|NCT01960114|3591902|P1|STARTED|Overall Study||134
1467283|NCT01959945|3591920|P4|NOT COMPLETED|Overall Study||16
1467284|NCT01959945|3591921|P3|NOT COMPLETED|Overall Study||19
1467285|NCT01959945|3591922|P2|NOT COMPLETED|Overall Study||3
1467286|NCT01959945|3591923|P1|NOT COMPLETED|Overall Study||4
1467287|NCT01959945|3591920|P4|COMPLETED|Overall Study||15
1467288|NCT01959945|3591921|P3|COMPLETED|Overall Study||9
1467289|NCT01959945|3591922|P2|COMPLETED|Overall Study||75
1467290|NCT01959945|3591923|P1|COMPLETED|Overall Study||76
1467291|NCT01959945|3591920|P4|STARTED|Overall Study||31
1467292|NCT01959945|3591921|P3|STARTED|Overall Study||28
1467293|NCT01959945|3591922|P2|STARTED|Overall Study||78
1467294|NCT01959945|3591923|P1|STARTED|Overall Study||80
1467295|NCT01959932|3591948|P3|NOT COMPLETED|Overall Study||0
1467296|NCT01959932|3591949|P2|NOT COMPLETED|Overall Study||0
1467297|NCT01959932|3591950|P1|NOT COMPLETED|Overall Study||1
1467298|NCT01959932|3591948|P3|COMPLETED|Overall Study||39
1467299|NCT01959932|3591949|P2|COMPLETED|Overall Study||41
1467300|NCT01959932|3591950|P1|COMPLETED|Overall Study||79
1467301|NCT01959932|3591948|P3|STARTED|Overall Study||39
1467302|NCT01959932|3591949|P2|STARTED|Overall Study||41
1467303|NCT01959932|3591950|P1|STARTED|Overall Study||80
1467304|NCT01959919|3591968|P1|NOT COMPLETED|Overall Study||2
1467305|NCT01959919|3591968|P1|COMPLETED|Overall Study||84
1467306|NCT01959919|3591968|P1|STARTED|Overall Study||86
1467307|NCT01959880|3591982|P4|NOT COMPLETED|Overall Study||181
1467308|NCT01959880|3591983|P3|NOT COMPLETED|Overall Study||208
1467309|NCT01959880|3591984|P2|NOT COMPLETED|Overall Study||369
1467310|NCT01959880|3591985|P1|NOT COMPLETED|Overall Study||1132
1467311|NCT01959880|3591982|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
1467312|NCT01959880|3591983|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
1467313|NCT01959880|3591984|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
1467314|NCT01959880|3591985|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
1467315|NCT01959880|3591982|P4|STARTED|Overall Study||181
1467316|NCT01959880|3591983|P3|STARTED|Overall Study||209
1467317|NCT01959880|3591984|P2|STARTED|Overall Study||369
1467318|NCT01959880|3591985|P1|STARTED|Overall Study||1132
1467319|NCT01959841|3592010|P3|NOT COMPLETED|Overall Study||43
1467320|NCT01959841|3592011|P2|NOT COMPLETED|Overall Study||57
1467321|NCT01959841|3592012|P1|NOT COMPLETED|Overall Study||43
1467322|NCT01959841|3592010|P3|COMPLETED|Overall Study||206
1467323|NCT01959841|3592011|P2|COMPLETED|Overall Study||193
1467324|NCT01959841|3592012|P1|COMPLETED|Overall Study||209
1467325|NCT01959841|3592010|P3|Reason FAS Excluding 3|Overall Study||0
1467326|NCT01959841|3592011|P2|Reason FAS Excluding 3|Overall Study||1
1467327|NCT01959841|3592012|P1|Reason FAS Excluding 3|Overall Study||0
1467328|NCT01959841|3592010|P3|Reason FAS Excluding 2|Overall Study||0
1467329|NCT01959841|3592011|P2|Reason FAS Excluding 2|Overall Study||1
1467330|NCT01959841|3592012|P1|Reason FAS Excluding 2|Overall Study||0
1467331|NCT01959841|3592010|P3|Reason FAS Excluding 1|Overall Study||4
1467332|NCT01959841|3592011|P2|Reason FAS Excluding 1|Overall Study||5
1467333|NCT01959841|3592012|P1|Reason FAS Excluding 1|Overall Study||5
1467334|NCT01959841|3592010|P3|Full Analysis Set Excluded|Overall Study||4
1467335|NCT01959841|3592011|P2|Full Analysis Set Excluded|Overall Study||7
1467336|NCT01959841|3592012|P1|Full Analysis Set Excluded|Overall Study||5
1467337|NCT01959841|3592010|P3|Full Analysis Set Included|Overall Study||245
1467338|NCT01959841|3592011|P2|Full Analysis Set Included|Overall Study||243
1467339|NCT01959841|3592012|P1|Full Analysis Set Included|Overall Study||247
1467340|NCT01959841|3592010|P3|STARTED|Overall Study||249
1467341|NCT01959841|3592011|P2|STARTED|Overall Study||250
1467342|NCT01959841|3592012|P1|STARTED|Overall Study||252
1467343|NCT01959685|3592035|P1|NOT COMPLETED|Overall Study||0
1467344|NCT01959685|3592035|P1|COMPLETED|Overall Study||9
1467345|NCT01959685|3592035|P1|STARTED|Overall Study||9
1467346|NCT01959607|3592042|P4|NOT COMPLETED|Second Intervention (Day 3)||0
1467347|NCT01959607|3592043|P3|NOT COMPLETED|Second Intervention (Day 3)||0
1467348|NCT01959607|3592044|P2|NOT COMPLETED|Second Intervention (Day 3)||0
1467349|NCT01959607|3592045|P1|NOT COMPLETED|Second Intervention (Day 3)||0
1467350|NCT01959607|3592042|P4|COMPLETED|Second Intervention (Day 3)||9
1467351|NCT01959607|3592043|P3|COMPLETED|Second Intervention (Day 3)||9
1467352|NCT01959607|3592044|P2|COMPLETED|Second Intervention (Day 3)||21
1467353|NCT01959607|3592045|P1|COMPLETED|Second Intervention (Day 3)||21
1467354|NCT01959607|3592042|P4|STARTED|Second Intervention (Day 3)||9
1467355|NCT01959607|3592043|P3|STARTED|Second Intervention (Day 3)||9
1467356|NCT01959607|3592044|P2|STARTED|Second Intervention (Day 3)||21
1467357|NCT01959607|3592045|P1|STARTED|Second Intervention (Day 3)||21
1467358|NCT01959607|3592042|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1467359|NCT01959607|3592043|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1467360|NCT01959607|3592044|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1467361|NCT01959607|3592045|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
1467362|NCT01959607|3592042|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
1467363|NCT01959607|3592043|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
1467364|NCT01959607|3592044|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
1467365|NCT01959607|3592045|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
1467366|NCT01959607|3592042|P4|STARTED|Washout Period of 1 Day (Day 2)||9
1467367|NCT01959607|3592043|P3|STARTED|Washout Period of 1 Day (Day 2)||9
1467368|NCT01959607|3592044|P2|STARTED|Washout Period of 1 Day (Day 2)||21
1467369|NCT01959607|3592045|P1|STARTED|Washout Period of 1 Day (Day 2)||21
1467370|NCT01959607|3592042|P4|NOT COMPLETED|First Intervention (Day 1)||0
1467371|NCT01959607|3592043|P3|NOT COMPLETED|First Intervention (Day 1)||0
1467372|NCT01959607|3592044|P2|NOT COMPLETED|First Intervention (Day 1)||1
1467373|NCT01959607|3592045|P1|NOT COMPLETED|First Intervention (Day 1)||1
1467374|NCT01959607|3592042|P4|COMPLETED|First Intervention (Day 1)||9
1467375|NCT01959607|3592043|P3|COMPLETED|First Intervention (Day 1)||9
1467376|NCT01959607|3592044|P2|COMPLETED|First Intervention (Day 1)||21
1467377|NCT01959607|3592045|P1|COMPLETED|First Intervention (Day 1)||21
1467378|NCT01959607|3592042|P4|STARTED|First Intervention (Day 1)||9
1467379|NCT01959607|3592043|P3|STARTED|First Intervention (Day 1)||9
1467380|NCT01959607|3592044|P2|STARTED|First Intervention (Day 1)||22
1467381|NCT01959607|3592045|P1|STARTED|First Intervention (Day 1)||22
1467382|NCT01959607|3592042|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1467383|NCT01959607|3592043|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1467384|NCT01959607|3592044|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1467385|NCT01959607|3592045|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
1467386|NCT01959607|3592042|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
1467387|NCT01959607|3592043|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
1467388|NCT01959607|3592044|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
1467389|NCT01959607|3592045|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
1467390|NCT01959607|3592042|P4|STARTED|Washout Period of 1 Day (Day 0)||9
1467391|NCT01959607|3592043|P3|STARTED|Washout Period of 1 Day (Day 0)||9
1467392|NCT01959607|3592044|P2|STARTED|Washout Period of 1 Day (Day 0)||22
1467393|NCT01959607|3592045|P1|STARTED|Washout Period of 1 Day (Day 0)||22
1467394|NCT01959581|3592058|P1|NOT COMPLETED|Overall Study||5
1467395|NCT01959581|3592058|P1|COMPLETED|Overall Study||25
1467396|NCT01959581|3592058|P1|STARTED|Overall Study||30
1467397|NCT01959529|3592064|P2|NOT COMPLETED|Overall Study||72
1467398|NCT01959529|3592065|P1|NOT COMPLETED|Overall Study||76
1467399|NCT01959529|3592064|P2|COMPLETED|Overall Study||3747
1467400|NCT01959529|3592065|P1|COMPLETED|Overall Study||3742
1467401|NCT01959529|3592064|P2|Exposed|Overall Study||3806
1467402|NCT01959529|3592065|P1|Exposed|Overall Study||3809
1467403|NCT01959529|3592064|P2|STARTED|Overall Study||3819
1467404|NCT01959529|3592065|P1|STARTED|Overall Study||3818
1467405|NCT01959516|3592077|P2|NOT COMPLETED|Epoch 2||1
1467406|NCT01959516|3592078|P1|NOT COMPLETED|Epoch 2||2
1467407|NCT01959516|3592077|P2|COMPLETED|Epoch 2||62
1467408|NCT01959516|3592078|P1|COMPLETED|Epoch 2||61
1467409|NCT01959516|3592077|P2|STARTED|Epoch 2||63
1467410|NCT01959516|3592078|P1|STARTED|Epoch 2||63
1467411|NCT01959516|3592077|P2|NOT COMPLETED|Epoch 1||5
1467412|NCT01959516|3592078|P1|NOT COMPLETED|Epoch 1||10
1467413|NCT01959516|3592077|P2|COMPLETED|Epoch 1||58
1467414|NCT01959516|3592078|P1|COMPLETED|Epoch 1||53
1467415|NCT01959516|3592077|P2|ITT Population|Epoch 1||62
1467416|NCT01959516|3592078|P1|ITT Population|Epoch 1||62
1467417|NCT01959516|3592077|P2|Safety Population|Epoch 1||62
1467418|NCT01959516|3592078|P1|Safety Population|Epoch 1||62
1467419|NCT01959516|3592077|P2|STARTED|Epoch 1||63
1467420|NCT01959516|3592078|P1|STARTED|Epoch 1||63
1467421|NCT01959503|3592088|P2|NOT COMPLETED|Overall Study||2
1467422|NCT01959503|3592089|P1|NOT COMPLETED|Overall Study||3
1467423|NCT01959503|3592088|P2|COMPLETED|Overall Study||49
1467424|NCT01959503|3592089|P1|COMPLETED|Overall Study||104
1467425|NCT01959503|3592088|P2|STARTED|Overall Study||51
1467426|NCT01959503|3592089|P1|STARTED|Overall Study||107
1467427|NCT01959412|3592109|P6|NOT COMPLETED|Overall Study||0
1467428|NCT01959412|3592110|P5|NOT COMPLETED|Overall Study||3
1467429|NCT01959412|3592111|P4|NOT COMPLETED|Overall Study||2
1467430|NCT01959412|3592112|P3|NOT COMPLETED|Overall Study||0
1467431|NCT01959412|3592113|P2|NOT COMPLETED|Overall Study||1
1467432|NCT01959412|3592114|P1|NOT COMPLETED|Overall Study||1
1467433|NCT01959412|3592109|P6|COMPLETED|Overall Study||15
1467434|NCT01959412|3592110|P5|COMPLETED|Overall Study||13
1467435|NCT01959412|3592111|P4|COMPLETED|Overall Study||13
1467436|NCT01959412|3592112|P3|COMPLETED|Overall Study||15
1467437|NCT01959412|3592113|P2|COMPLETED|Overall Study||14
1467438|NCT01959412|3592114|P1|COMPLETED|Overall Study||14
1467439|NCT01959412|3592109|P6|STARTED|Overall Study||15
1467440|NCT01959412|3592110|P5|STARTED|Overall Study||16
1467441|NCT01959412|3592111|P4|STARTED|Overall Study||15
1467442|NCT01959412|3592112|P3|STARTED|Overall Study||15
1467443|NCT01959412|3592113|P2|STARTED|Overall Study||15
1467444|NCT01959412|3592114|P1|STARTED|Overall Study||15
1467445|NCT01959035|3592152|P1|NOT COMPLETED|Overall Study||11
1467446|NCT01959035|3592152|P1|COMPLETED|Overall Study||77
1467447|NCT01959035|3592152|P1|STARTED|Overall Study||88
1467448|NCT01958827|3592178|P1|NOT COMPLETED|Overall Study||10
1467449|NCT01958827|3592178|P1|COMPLETED|Overall Study||18
1467450|NCT01958827|3592178|P1|STARTED|Overall Study||28
1467451|NCT01958788|3592196|P1|NOT COMPLETED|Overall Study||0
1467452|NCT01958788|3592196|P1|COMPLETED|Overall Study||7
1467453|NCT01958788|3592196|P1|STARTED|Overall Study||7
1467454|NCT01958671|3592209|P3|NOT COMPLETED|Overall Study||32
1467455|NCT01958671|3592210|P2|NOT COMPLETED|Overall Study||24
1467456|NCT01958671|3592211|P1|NOT COMPLETED|Overall Study||19
1467457|NCT01958671|3592209|P3|COMPLETED|Overall Study||121
1467458|NCT01958671|3592210|P2|COMPLETED|Overall Study||128
1467459|NCT01958671|3592211|P1|COMPLETED|Overall Study||137
1467460|NCT01958671|3592209|P3|STARTED|Overall Study||153
1467461|NCT01958671|3592210|P2|STARTED|Overall Study||152
1467462|NCT01958671|3592211|P1|STARTED|Overall Study||156
1467463|NCT01958645|3592255|P3|NOT COMPLETED|Overall Study||0
1467464|NCT01958645|3592256|P2|NOT COMPLETED|Overall Study||0
1467465|NCT01958645|3592257|P1|NOT COMPLETED|Overall Study||0
1467466|NCT01958645|3592255|P3|COMPLETED|Overall Study||4
1467467|NCT01958645|3592256|P2|COMPLETED|Overall Study||4
1467468|NCT01958645|3592257|P1|COMPLETED|Overall Study||4
1467469|NCT01958645|3592255|P3|STARTED|Overall Study||4
1467470|NCT01958645|3592256|P2|STARTED|Overall Study||4
1467471|NCT01958645|3592257|P1|STARTED|Overall Study||4
1467472|NCT01958619|3592285|P4|NOT COMPLETED|Overall Study||0
1467473|NCT01958619|3592286|P3|NOT COMPLETED|Overall Study||1
1467474|NCT01958619|3592287|P2|NOT COMPLETED|Overall Study||0
1467475|NCT01958619|3592288|P1|NOT COMPLETED|Overall Study||2
1467476|NCT01958619|3592285|P4|COMPLETED|Overall Study||12
1467477|NCT01958619|3592286|P3|COMPLETED|Overall Study||13
1467478|NCT01958619|3592287|P2|COMPLETED|Overall Study||14
1467479|NCT01958619|3592288|P1|COMPLETED|Overall Study||13
1467480|NCT01958619|3592285|P4|STARTED|Overall Study||12
1467481|NCT01958619|3592286|P3|STARTED|Overall Study||14
1467482|NCT01958619|3592287|P2|STARTED|Overall Study||14
1467483|NCT01958619|3592288|P1|STARTED|Overall Study||15
1467484|NCT01958606|3592310|P2|NOT COMPLETED|Overall Study||0
1467485|NCT01958606|3592311|P1|NOT COMPLETED|Overall Study||2
1467486|NCT01958606|3592310|P2|COMPLETED|Overall Study||5
1467487|NCT01958606|3592311|P1|COMPLETED|Overall Study||11
1467488|NCT01958606|3592310|P2|STARTED|Overall Study||5
1467489|NCT01958606|3592311|P1|STARTED|Overall Study||13
1467490|NCT01958489|3592349|P2|NOT COMPLETED|Period 2||1
1467491|NCT01958489|3592350|P1|NOT COMPLETED|Period 2||0
1467492|NCT01958489|3592349|P2|COMPLETED|Period 2||23
1467493|NCT01958489|3592350|P1|COMPLETED|Period 2||0
1467494|NCT01958489|3592349|P2|Received at Least 1 Dose of Study Drug|Period 2||24
1467495|NCT01958489|3592350|P1|Received at Least 1 Dose of Study Drug|Period 2||0
1467496|NCT01958489|3592349|P2|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
1467497|NCT01958489|3592350|P1|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
1467498|NCT01958489|3592349|P2|NOT COMPLETED|Period 1||0
1467499|NCT01958489|3592350|P1|NOT COMPLETED|Period 1||0
1467500|NCT01958489|3592349|P2|COMPLETED|Period 1||0
1467501|NCT01958489|3592350|P1|COMPLETED|Period 1||24
1467502|NCT01958489|3592349|P2|Received at Least 1 Dose of Study Drug|Period 1||0
1467503|NCT01958489|3592350|P1|Received at Least 1 Dose of Study Drug|Period 1||24
1467504|NCT01958489|3592349|P2|STARTED|Period 1||0
1467505|NCT01958489|3592350|P1|STARTED|Period 1||24
1467506|NCT01958437|3592366|P4|NOT COMPLETED|Overall Study||1
1467507|NCT01958437|3592367|P3|NOT COMPLETED|Overall Study||1
1467508|NCT01958437|3592368|P2|NOT COMPLETED|Overall Study||0
1467509|NCT01958437|3592369|P1|NOT COMPLETED|Overall Study||0
1467510|NCT01958437|3592366|P4|COMPLETED|Overall Study||10
1467511|NCT01958437|3592367|P3|COMPLETED|Overall Study||10
1467512|NCT01958437|3592368|P2|COMPLETED|Overall Study||11
1467513|NCT01958437|3592369|P1|COMPLETED|Overall Study||11
1467514|NCT01958437|3592366|P4|STARTED|Overall Study||11
1467515|NCT01958437|3592367|P3|STARTED|Overall Study||11
1467516|NCT01958437|3592368|P2|STARTED|Overall Study||11
1467517|NCT01958437|3592369|P1|STARTED|Overall Study||11
1467518|NCT01958346|3592393|P2|NOT COMPLETED|Overall Study||0
1467519|NCT01958346|3592394|P1|NOT COMPLETED|Overall Study||0
1467520|NCT01958346|3592393|P2|COMPLETED|Overall Study||39
1467521|NCT01958346|3592394|P1|COMPLETED|Overall Study||39
1467522|NCT01958346|3592393|P2|STARTED|Overall Study||39
1467523|NCT01958346|3592394|P1|STARTED|Overall Study||39
1467524|NCT01958320|3592404|P2|NOT COMPLETED|Overall Study||0
1467525|NCT01958320|3592405|P1|NOT COMPLETED|Overall Study||0
1467526|NCT01958320|3592404|P2|COMPLETED|Overall Study||98
1467527|NCT01958320|3592405|P1|COMPLETED|Overall Study||104
1467528|NCT01958320|3592404|P2|STARTED|Overall Study||98
1467529|NCT01958320|3592405|P1|STARTED|Overall Study||104
1467530|NCT01958281|3592436|P3|NOT COMPLETED|Overall Study||0
1467531|NCT01958281|3592437|P2|NOT COMPLETED|Overall Study||4
1467532|NCT01958281|3592438|P1|NOT COMPLETED|Overall Study||6
1467533|NCT01958281|3592436|P3|COMPLETED|Overall Study||18
1467534|NCT01958281|3592437|P2|COMPLETED|Overall Study||6
1467535|NCT01958281|3592438|P1|COMPLETED|Overall Study||4
1467536|NCT01958281|3592436|P3|STARTED|Overall Study||18
1467537|NCT01958281|3592437|P2|STARTED|Overall Study||10
1467538|NCT01958281|3592438|P1|STARTED|Overall Study||10
1467539|NCT01958164|3592514|P2|NOT COMPLETED|Overall Study||5
1467540|NCT01958164|3592515|P1|NOT COMPLETED|Overall Study||2
1467541|NCT01958164|3592514|P2|COMPLETED|Overall Study||5
1467542|NCT01958164|3592515|P1|COMPLETED|Overall Study||4
1467543|NCT01958164|3592514|P2|STARTED|Overall Study|Randomised and treated|10
1467544|NCT01958164|3592515|P1|STARTED|Overall Study|Randomised and treated|6
1467545|NCT01958060|3592534|P6|NOT COMPLETED|Overall Study||0
1467546|NCT01958060|3592535|P5|NOT COMPLETED|Overall Study||1
1467547|NCT01958060|3592536|P4|NOT COMPLETED|Overall Study||0
1467548|NCT01958060|3592537|P3|NOT COMPLETED|Overall Study||0
1467549|NCT01958060|3592538|P2|NOT COMPLETED|Overall Study||0
1467550|NCT01958060|3592539|P1|NOT COMPLETED|Overall Study||2
1467642|NCT01957488|3592732|P6|STARTED|Test Period 3||23
1467551|NCT01958060|3592534|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
1467552|NCT01958060|3592535|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
1467553|NCT01958060|3592536|P4|COMPLETED|Overall Study||5
1467554|NCT01958060|3592537|P3|COMPLETED|Overall Study||6
1467555|NCT01958060|3592538|P2|COMPLETED|Overall Study||6
1467556|NCT01958060|3592539|P1|COMPLETED|Overall Study||8
1467557|NCT01958060|3592534|P6|STARTED|Overall Study||1
1467558|NCT01958060|3592535|P5|STARTED|Overall Study||7
1467559|NCT01958060|3592536|P4|STARTED|Overall Study||5
1467560|NCT01958060|3592537|P3|STARTED|Overall Study||6
1467561|NCT01958060|3592538|P2|STARTED|Overall Study||6
1467562|NCT01958060|3592539|P1|STARTED|Overall Study||10
1467563|NCT01958021|3592564|P2|NOT COMPLETED|Overall Study||180
1467564|NCT01958021|3592565|P1|NOT COMPLETED|Overall Study||139
1467565|NCT01958021|3592564|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
1467566|NCT01958021|3592565|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
1467567|NCT01958021|3592564|P2|Patients Treated|Overall Study||330
1467568|NCT01958021|3592565|P1|Patients Treated|Overall Study||334
1467569|NCT01958021|3592564|P2|Patients Untreated|Overall Study||4
1467570|NCT01958021|3592565|P1|Patients Untreated|Overall Study||0
1467571|NCT01958021|3592564|P2|STARTED|Overall Study||334
1467572|NCT01958021|3592565|P1|STARTED|Overall Study||334
1467573|NCT01958008|3592577|P4|NOT COMPLETED|Overall Study||0
1467574|NCT01958008|3592578|P3|NOT COMPLETED|Overall Study||1
1467575|NCT01958008|3592579|P2|NOT COMPLETED|Overall Study||0
1467576|NCT01958008|3592580|P1|NOT COMPLETED|Overall Study||1
1467577|NCT01958008|3592577|P4|COMPLETED|Overall Study||21
1467578|NCT01958008|3592578|P3|COMPLETED|Overall Study||20
1467579|NCT01958008|3592579|P2|COMPLETED|Overall Study||21
1467580|NCT01958008|3592580|P1|COMPLETED|Overall Study||20
1467581|NCT01958008|3592577|P4|STARTED|Overall Study||21
1467582|NCT01958008|3592578|P3|STARTED|Overall Study||21
1467583|NCT01958008|3592579|P2|STARTED|Overall Study||21
1467584|NCT01958008|3592580|P1|STARTED|Overall Study||21
1467585|NCT01957930|3592610|P2|NOT COMPLETED|Overall Study||0
1467586|NCT01957930|3592611|P1|NOT COMPLETED|Overall Study||0
1467587|NCT01957930|3592610|P2|COMPLETED|Overall Study||37
1467588|NCT01957930|3592611|P1|COMPLETED|Overall Study||35
1467589|NCT01957930|3592610|P2|STARTED|Overall Study||37
1467590|NCT01957930|3592611|P1|STARTED|Overall Study||35
1467591|NCT01957865|3592620|P3|NOT COMPLETED|Overall Study||3
1467592|NCT01957865|3592621|P2|NOT COMPLETED|Overall Study||2
1467593|NCT01957865|3592622|P1|NOT COMPLETED|Overall Study||0
1467594|NCT01957865|3592620|P3|COMPLETED|Overall Study||19
1467595|NCT01957865|3592621|P2|COMPLETED|Overall Study||18
1467596|NCT01957865|3592622|P1|COMPLETED|Overall Study||21
1467597|NCT01957865|3592620|P3|STARTED|Overall Study||22
1467598|NCT01957865|3592621|P2|STARTED|Overall Study||20
1467599|NCT01957865|3592622|P1|STARTED|Overall Study||21
1467600|NCT01957761|3592633|P1|NOT COMPLETED|Overall Study||0
1467601|NCT01957761|3592633|P1|COMPLETED|Overall Study||189
1467602|NCT01957761|3592633|P1|STARTED|Overall Study||189
1467603|NCT01957657|3592637|P1|NOT COMPLETED|Overall Study||0
1467604|NCT01957657|3592637|P1|COMPLETED|Overall Study||4
1467605|NCT01957657|3592637|P1|STARTED|Overall Study||4
1467606|NCT01957579|3592655|P4|NOT COMPLETED|Overall Study||0
1467607|NCT01957579|3592656|P3|NOT COMPLETED|Overall Study||2
1467608|NCT01957579|3592657|P2|NOT COMPLETED|Overall Study||1
1467609|NCT01957579|3592658|P1|NOT COMPLETED|Overall Study||0
1467610|NCT01957579|3592655|P4|COMPLETED|Overall Study||6
1467611|NCT01957579|3592656|P3|COMPLETED|Overall Study||2
1467612|NCT01957579|3592657|P2|COMPLETED|Overall Study||6
1467613|NCT01957579|3592658|P1|COMPLETED|Overall Study||3
1467614|NCT01957579|3592655|P4|STARTED|Overall Study||6
1467615|NCT01957579|3592656|P3|STARTED|Overall Study||4
1467616|NCT01957579|3592657|P2|STARTED|Overall Study||7
1467617|NCT01957579|3592658|P1|STARTED|Overall Study||3
1467618|NCT01957553|3592725|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
1467619|NCT01957553|3592726|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
1467620|NCT01957553|3592725|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
1467621|NCT01957553|3592726|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
1467622|NCT01957553|3592725|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
1467623|NCT01957553|3592726|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
1467624|NCT01957553|3592725|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
1467625|NCT01957553|3592726|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
1467626|NCT01957553|3592725|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
1467627|NCT01957553|3592726|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
1467628|NCT01957553|3592725|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
1467629|NCT01957553|3592726|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
1467630|NCT01957488|3592732|P6|NOT COMPLETED|Test Period 3||0
1467631|NCT01957488|3592733|P5|NOT COMPLETED|Test Period 3||0
1467632|NCT01957488|3592734|P4|NOT COMPLETED|Test Period 3||0
1467633|NCT01957488|3592735|P3|NOT COMPLETED|Test Period 3||0
1467634|NCT01957488|3592736|P2|NOT COMPLETED|Test Period 3||1
1467635|NCT01957488|3592737|P1|NOT COMPLETED|Test Period 3||1
1467636|NCT01957488|3592732|P6|COMPLETED|Test Period 3||23
1467637|NCT01957488|3592733|P5|COMPLETED|Test Period 3||25
1467638|NCT01957488|3592734|P4|COMPLETED|Test Period 3||28
1467639|NCT01957488|3592735|P3|COMPLETED|Test Period 3||25
1467640|NCT01957488|3592736|P2|COMPLETED|Test Period 3||26
1467641|NCT01957488|3592737|P1|COMPLETED|Test Period 3||23
1467643|NCT01957488|3592733|P5|STARTED|Test Period 3||25
1467644|NCT01957488|3592734|P4|STARTED|Test Period 3||28
1467645|NCT01957488|3592735|P3|STARTED|Test Period 3||25
1467646|NCT01957488|3592736|P2|STARTED|Test Period 3||27
1467647|NCT01957488|3592737|P1|STARTED|Test Period 3||24
1467648|NCT01957488|3592732|P6|NOT COMPLETED|Test Period 2||1
1467649|NCT01957488|3592733|P5|NOT COMPLETED|Test Period 2||2
1467650|NCT01957488|3592734|P4|NOT COMPLETED|Test Period 2||1
1467651|NCT01957488|3592735|P3|NOT COMPLETED|Test Period 2||1
1467652|NCT01957488|3592736|P2|NOT COMPLETED|Test Period 2||1
1467653|NCT01957488|3592737|P1|NOT COMPLETED|Test Period 2||3
1467654|NCT01957488|3592732|P6|COMPLETED|Test Period 2||23
1467655|NCT01957488|3592733|P5|COMPLETED|Test Period 2||25
1467656|NCT01957488|3592734|P4|COMPLETED|Test Period 2||28
1467657|NCT01957488|3592735|P3|COMPLETED|Test Period 2||25
1467658|NCT01957488|3592736|P2|COMPLETED|Test Period 2||27
1467659|NCT01957488|3592737|P1|COMPLETED|Test Period 2||24
1467660|NCT01957488|3592732|P6|STARTED|Test Period 2||24
1467661|NCT01957488|3592733|P5|STARTED|Test Period 2||27
1467662|NCT01957488|3592734|P4|STARTED|Test Period 2||29
1467663|NCT01957488|3592735|P3|STARTED|Test Period 2||26
1467664|NCT01957488|3592736|P2|STARTED|Test Period 2||28
1467665|NCT01957488|3592737|P1|STARTED|Test Period 2||27
1467666|NCT01957488|3592732|P6|NOT COMPLETED|Test Period 1||6
1467667|NCT01957488|3592733|P5|NOT COMPLETED|Test Period 1||3
1467668|NCT01957488|3592734|P4|NOT COMPLETED|Test Period 1||3
1467669|NCT01957488|3592735|P3|NOT COMPLETED|Test Period 1||4
1467670|NCT01957488|3592736|P2|NOT COMPLETED|Test Period 1||3
1467671|NCT01957488|3592737|P1|NOT COMPLETED|Test Period 1||3
1467672|NCT01957488|3592732|P6|COMPLETED|Test Period 1||24
1467673|NCT01957488|3592733|P5|COMPLETED|Test Period 1||27
1467674|NCT01957488|3592734|P4|COMPLETED|Test Period 1||29
1467675|NCT01957488|3592735|P3|COMPLETED|Test Period 1||26
1467676|NCT01957488|3592736|P2|COMPLETED|Test Period 1||28
1467677|NCT01957488|3592737|P1|COMPLETED|Test Period 1||27
1467678|NCT01957488|3592732|P6|STARTED|Test Period 1||30
1467679|NCT01957488|3592733|P5|STARTED|Test Period 1||30
1467680|NCT01957488|3592734|P4|STARTED|Test Period 1||32
1467681|NCT01957488|3592735|P3|STARTED|Test Period 1||30
1467682|NCT01957488|3592736|P2|STARTED|Test Period 1||31
1467683|NCT01957488|3592737|P1|STARTED|Test Period 1||30
1467684|NCT01957475|3592745|P2|NOT COMPLETED|Test Period 2||0
1467685|NCT01957475|3592746|P1|NOT COMPLETED|Test Period 2||1
1467686|NCT01957475|3592745|P2|COMPLETED|Test Period 2||8
1467687|NCT01957475|3592746|P1|COMPLETED|Test Period 2||8
1467688|NCT01957475|3592745|P2|STARTED|Test Period 2||8
1467689|NCT01957475|3592746|P1|STARTED|Test Period 2||9
1467690|NCT01957475|3592745|P2|NOT COMPLETED|Test Period 1||1
1467691|NCT01957475|3592746|P1|NOT COMPLETED|Test Period 1||2
1467692|NCT01957475|3592745|P2|COMPLETED|Test Period 1||9
1467693|NCT01957475|3592746|P1|COMPLETED|Test Period 1||8
1467694|NCT01957475|3592745|P2|STARTED|Test Period 1||10
1467695|NCT01957475|3592746|P1|STARTED|Test Period 1||10
1467696|NCT01957462|3592752|P2|NOT COMPLETED|Test Period 2||0
1467697|NCT01957462|3592753|P1|NOT COMPLETED|Test Period 2||0
1467698|NCT01957462|3592752|P2|COMPLETED|Test Period 2||15
1467699|NCT01957462|3592753|P1|COMPLETED|Test Period 2||14
1467700|NCT01957462|3592752|P2|STARTED|Test Period 2||15
1467701|NCT01957462|3592753|P1|STARTED|Test Period 2||14
1467702|NCT01957462|3592752|P2|NOT COMPLETED|Test Period 1||0
1467703|NCT01957462|3592753|P1|NOT COMPLETED|Test Period 1||2
1467704|NCT01957462|3592752|P2|COMPLETED|Test Period 1||15
1467705|NCT01957462|3592753|P1|COMPLETED|Test Period 1||14
1467706|NCT01957462|3592752|P2|STARTED|Test Period 1||15
1467707|NCT01957462|3592753|P1|STARTED|Test Period 1||16
1467708|NCT01957410|3592759|P1|NOT COMPLETED|Optional Open Label||0
1467709|NCT01957410|3592759|P1|COMPLETED|Optional Open Label||13
1467710|NCT01957410|3592759|P1|STARTED|Optional Open Label||13
1467711|NCT01957410|3592759|P1|NOT COMPLETED|Open Label||0
1467712|NCT01957410|3592759|P1|COMPLETED|Open Label||13
1467713|NCT01957410|3592759|P1|STARTED|Open Label||13
1467714|NCT01957397|3592764|P2|NOT COMPLETED|Test Period 3||2
1467715|NCT01957397|3592765|P1|NOT COMPLETED|Test Period 3||2
1467716|NCT01957397|3592764|P2|COMPLETED|Test Period 3||9
1467717|NCT01957397|3592765|P1|COMPLETED|Test Period 3||9
1467718|NCT01957397|3592764|P2|STARTED|Test Period 3||11
1467719|NCT01957397|3592765|P1|STARTED|Test Period 3||11
1467720|NCT01957397|3592764|P2|NOT COMPLETED|Test Period 2||1
1467721|NCT01957397|3592765|P1|NOT COMPLETED|Test Period 2||0
1467722|NCT01957397|3592764|P2|COMPLETED|Test Period 2||11
1467723|NCT01957397|3592765|P1|COMPLETED|Test Period 2||11
1467724|NCT01957397|3592764|P2|STARTED|Test Period 2||12
1467725|NCT01957397|3592765|P1|STARTED|Test Period 2||11
1467726|NCT01957397|3592764|P2|NOT COMPLETED|Test Period 1||1
1467727|NCT01957397|3592765|P1|NOT COMPLETED|Test Period 1||2
1467728|NCT01957397|3592764|P2|COMPLETED|Test Period 1||12
1467729|NCT01957397|3592765|P1|COMPLETED|Test Period 1||11
1467730|NCT01957397|3592764|P2|STARTED|Test Period 1||13
1467731|NCT01957397|3592765|P1|STARTED|Test Period 1||13
1467732|NCT01957397|3592764|P2|NOT COMPLETED|Baseline Own Product||0
1467733|NCT01957397|3592765|P1|NOT COMPLETED|Baseline Own Product||0
1467734|NCT01957397|3592764|P2|COMPLETED|Baseline Own Product||13
1467735|NCT01957397|3592765|P1|COMPLETED|Baseline Own Product||13
1467736|NCT01957397|3592764|P2|STARTED|Baseline Own Product||13
1467737|NCT01957397|3592765|P1|STARTED|Baseline Own Product||13
1467738|NCT01957384|3592775|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
1467739|NCT01957384|3592776|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
1467740|NCT01957384|3592777|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
1467741|NCT01957384|3592778|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
1467742|NCT01957384|3592779|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
1467743|NCT01957384|3592780|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
1467744|NCT01957384|3592775|P6|COMPLETED|Test Period 3 (14 Days)||3
1467745|NCT01957384|3592776|P5|COMPLETED|Test Period 3 (14 Days)||3
1467746|NCT01957384|3592777|P4|COMPLETED|Test Period 3 (14 Days)||4
1467747|NCT01957384|3592778|P3|COMPLETED|Test Period 3 (14 Days)||4
1467748|NCT01957384|3592779|P2|COMPLETED|Test Period 3 (14 Days)||4
1467749|NCT01957384|3592780|P1|COMPLETED|Test Period 3 (14 Days)||4
1467750|NCT01957384|3592775|P6|STARTED|Test Period 3 (14 Days)||3
1467751|NCT01957384|3592776|P5|STARTED|Test Period 3 (14 Days)||3
1467752|NCT01957384|3592777|P4|STARTED|Test Period 3 (14 Days)||4
1467753|NCT01957384|3592778|P3|STARTED|Test Period 3 (14 Days)||4
1467754|NCT01957384|3592779|P2|STARTED|Test Period 3 (14 Days)||4
1467755|NCT01957384|3592780|P1|STARTED|Test Period 3 (14 Days)||4
1467756|NCT01957384|3592775|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
1467757|NCT01957384|3592776|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
1467758|NCT01957384|3592777|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
1467759|NCT01957384|3592778|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
1467760|NCT01957384|3592779|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
1467761|NCT01957384|3592780|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
1467762|NCT01957384|3592775|P6|COMPLETED|Test Period 2 (14 Days)||3
1467763|NCT01957384|3592776|P5|COMPLETED|Test Period 2 (14 Days)||3
1467764|NCT01957384|3592777|P4|COMPLETED|Test Period 2 (14 Days)||4
1467765|NCT01957384|3592778|P3|COMPLETED|Test Period 2 (14 Days)||4
1467766|NCT01957384|3592779|P2|COMPLETED|Test Period 2 (14 Days)||4
1467767|NCT01957384|3592780|P1|COMPLETED|Test Period 2 (14 Days)||4
1467768|NCT01957384|3592775|P6|STARTED|Test Period 2 (14 Days)||3
1467769|NCT01957384|3592776|P5|STARTED|Test Period 2 (14 Days)||3
1467770|NCT01957384|3592777|P4|STARTED|Test Period 2 (14 Days)||4
1467771|NCT01957384|3592778|P3|STARTED|Test Period 2 (14 Days)||4
1467772|NCT01957384|3592779|P2|STARTED|Test Period 2 (14 Days)||4
1467773|NCT01957384|3592780|P1|STARTED|Test Period 2 (14 Days)||4
1467774|NCT01957384|3592775|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
1467775|NCT01957384|3592776|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
1467776|NCT01957384|3592777|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
1467777|NCT01957384|3592778|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
1467778|NCT01957384|3592779|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
1467779|NCT01957384|3592780|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
1467780|NCT01957384|3592775|P6|COMPLETED|Test Period 1 (14 Days)||3
1467781|NCT01957384|3592776|P5|COMPLETED|Test Period 1 (14 Days)||3
1467782|NCT01957384|3592777|P4|COMPLETED|Test Period 1 (14 Days)||4
1467783|NCT01957384|3592778|P3|COMPLETED|Test Period 1 (14 Days)||4
1467784|NCT01957384|3592779|P2|COMPLETED|Test Period 1 (14 Days)||4
1467785|NCT01957384|3592780|P1|COMPLETED|Test Period 1 (14 Days)||4
1467786|NCT01957384|3592775|P6|STARTED|Test Period 1 (14 Days)||3
1467787|NCT01957384|3592776|P5|STARTED|Test Period 1 (14 Days)||3
1467788|NCT01957384|3592777|P4|STARTED|Test Period 1 (14 Days)||4
1467789|NCT01957384|3592778|P3|STARTED|Test Period 1 (14 Days)||4
1467790|NCT01957384|3592779|P2|STARTED|Test Period 1 (14 Days)||4
1467791|NCT01957384|3592780|P1|STARTED|Test Period 1 (14 Days)||4
1467792|NCT01957215|3592790|P2|NOT COMPLETED|Overall Study||12
1467793|NCT01957215|3592791|P1|NOT COMPLETED|Overall Study||13
1467794|NCT01957215|3592790|P2|COMPLETED|Overall Study||123
1467795|NCT01957215|3592791|P1|COMPLETED|Overall Study||122
1467796|NCT01957215|3592790|P2|STARTED|Overall Study||135
1467797|NCT01957215|3592791|P1|STARTED|Overall Study||135
1467798|NCT01957202|3592819|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467799|NCT01957202|3592820|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
1467800|NCT01957202|3592821|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467801|NCT01957202|3592822|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467802|NCT01957202|3592823|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467803|NCT01957202|3592824|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467804|NCT01957202|3592825|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467805|NCT01957202|3592826|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467806|NCT01957202|3592827|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467807|NCT01957202|3592828|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467808|NCT01957202|3592829|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467809|NCT01957202|3592830|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467810|NCT01957202|3592831|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467811|NCT01957202|3592832|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467812|NCT01957202|3592833|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467813|NCT01957202|3592834|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467814|NCT01957202|3592835|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467815|NCT01957202|3592836|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
1467816|NCT01957202|3592819|P18|COMPLETED|Treatment Period 3 (8 Days)||3
1467817|NCT01957202|3592820|P17|COMPLETED|Treatment Period 3 (8 Days)||4
1467818|NCT01957202|3592821|P16|COMPLETED|Treatment Period 3 (8 Days)||3
1467819|NCT01957202|3592822|P15|COMPLETED|Treatment Period 3 (8 Days)||6
1467820|NCT01957202|3592823|P14|COMPLETED|Treatment Period 3 (8 Days)||3
1467821|NCT01957202|3592824|P13|COMPLETED|Treatment Period 3 (8 Days)||3
1467822|NCT01957202|3592825|P12|COMPLETED|Treatment Period 3 (8 Days)||6
1467823|NCT01957202|3592826|P11|COMPLETED|Treatment Period 3 (8 Days)||3
1467824|NCT01957202|3592827|P10|COMPLETED|Treatment Period 3 (8 Days)||6
1467825|NCT01957202|3592828|P9|COMPLETED|Treatment Period 3 (8 Days)||3
1467826|NCT01957202|3592829|P8|COMPLETED|Treatment Period 3 (8 Days)||3
1467827|NCT01957202|3592830|P7|COMPLETED|Treatment Period 3 (8 Days)||3
1467828|NCT01957202|3592831|P6|COMPLETED|Treatment Period 3 (8 Days)||2
1467829|NCT01957202|3592832|P5|COMPLETED|Treatment Period 3 (8 Days)||3
1467830|NCT01957202|3592833|P4|COMPLETED|Treatment Period 3 (8 Days)||3
1467831|NCT01957202|3592834|P3|COMPLETED|Treatment Period 3 (8 Days)||6
1467832|NCT01957202|3592835|P2|COMPLETED|Treatment Period 3 (8 Days)||5
1467833|NCT01957202|3592836|P1|COMPLETED|Treatment Period 3 (8 Days)||3
1467834|NCT01957202|3592819|P18|STARTED|Treatment Period 3 (8 Days)||3
1467835|NCT01957202|3592820|P17|STARTED|Treatment Period 3 (8 Days)||5
1467836|NCT01957202|3592821|P16|STARTED|Treatment Period 3 (8 Days)||3
1467837|NCT01957202|3592822|P15|STARTED|Treatment Period 3 (8 Days)||6
1467838|NCT01957202|3592823|P14|STARTED|Treatment Period 3 (8 Days)||3
1467839|NCT01957202|3592824|P13|STARTED|Treatment Period 3 (8 Days)||3
1467840|NCT01957202|3592825|P12|STARTED|Treatment Period 3 (8 Days)||6
1467841|NCT01957202|3592826|P11|STARTED|Treatment Period 3 (8 Days)||3
1467842|NCT01957202|3592827|P10|STARTED|Treatment Period 3 (8 Days)||6
1467843|NCT01957202|3592828|P9|STARTED|Treatment Period 3 (8 Days)||3
1467844|NCT01957202|3592829|P8|STARTED|Treatment Period 3 (8 Days)||3
1467845|NCT01957202|3592830|P7|STARTED|Treatment Period 3 (8 Days)||3
1467846|NCT01957202|3592831|P6|STARTED|Treatment Period 3 (8 Days)||2
1467847|NCT01957202|3592832|P5|STARTED|Treatment Period 3 (8 Days)||3
1467848|NCT01957202|3592833|P4|STARTED|Treatment Period 3 (8 Days)||3
1467849|NCT01957202|3592834|P3|STARTED|Treatment Period 3 (8 Days)||6
1467850|NCT01957202|3592835|P2|STARTED|Treatment Period 3 (8 Days)||5
1467851|NCT01957202|3592836|P1|STARTED|Treatment Period 3 (8 Days)||3
1467852|NCT01957202|3592819|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467853|NCT01957202|3592820|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467854|NCT01957202|3592821|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467855|NCT01957202|3592822|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467856|NCT01957202|3592823|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467857|NCT01957202|3592824|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467858|NCT01957202|3592825|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467859|NCT01957202|3592826|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467860|NCT01957202|3592827|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467861|NCT01957202|3592828|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467862|NCT01957202|3592829|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467863|NCT01957202|3592830|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467864|NCT01957202|3592831|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467865|NCT01957202|3592832|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467866|NCT01957202|3592833|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467867|NCT01957202|3592834|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467868|NCT01957202|3592835|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467869|NCT01957202|3592836|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
1467870|NCT01957202|3592819|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467871|NCT01957202|3592820|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
1467872|NCT01957202|3592821|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467873|NCT01957202|3592822|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
1467874|NCT01957202|3592823|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467875|NCT01957202|3592824|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467876|NCT01957202|3592825|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
1467877|NCT01957202|3592826|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467878|NCT01957202|3592827|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
1467879|NCT01957202|3592828|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467880|NCT01957202|3592829|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467881|NCT01957202|3592830|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467882|NCT01957202|3592831|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
1467883|NCT01957202|3592832|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467884|NCT01957202|3592833|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467885|NCT01957202|3592834|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
1467886|NCT01957202|3592835|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
1467887|NCT01957202|3592836|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
1467888|NCT01957202|3592819|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
1467889|NCT01957202|3592820|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
1467890|NCT01957202|3592821|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
1467891|NCT01957202|3592822|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
1467892|NCT01957202|3592823|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
1467893|NCT01957202|3592824|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
1467894|NCT01957202|3592825|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
1467895|NCT01957202|3592826|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
1467896|NCT01957202|3592827|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
1467897|NCT01957202|3592828|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
1467898|NCT01957202|3592829|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
1467899|NCT01957202|3592830|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
1467900|NCT01957202|3592831|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
1467901|NCT01957202|3592832|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
1467902|NCT01957202|3592833|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
1467903|NCT01957202|3592834|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
1467904|NCT01957202|3592835|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
1467905|NCT01957202|3592836|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
1467906|NCT01957202|3592819|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467907|NCT01957202|3592820|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
1467908|NCT01957202|3592821|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467909|NCT01957202|3592822|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467910|NCT01957202|3592823|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467911|NCT01957202|3592824|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467912|NCT01957202|3592825|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467913|NCT01957202|3592826|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467914|NCT01957202|3592827|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467915|NCT01957202|3592828|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467916|NCT01957202|3592829|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467917|NCT01957202|3592830|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467918|NCT01957202|3592831|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467919|NCT01957202|3592832|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467920|NCT01957202|3592833|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467921|NCT01957202|3592834|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467922|NCT01957202|3592835|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
1467923|NCT01957202|3592836|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
1467924|NCT01957202|3592819|P18|COMPLETED|Treatment Period 2 (8 Days)||3
1467925|NCT01957202|3592820|P17|COMPLETED|Treatment Period 2 (8 Days)||5
1467926|NCT01957202|3592821|P16|COMPLETED|Treatment Period 2 (8 Days)||3
1467927|NCT01957202|3592822|P15|COMPLETED|Treatment Period 2 (8 Days)||6
1467928|NCT01957202|3592823|P14|COMPLETED|Treatment Period 2 (8 Days)||3
1467929|NCT01957202|3592824|P13|COMPLETED|Treatment Period 2 (8 Days)||3
1467930|NCT01957202|3592825|P12|COMPLETED|Treatment Period 2 (8 Days)||6
1467931|NCT01957202|3592826|P11|COMPLETED|Treatment Period 2 (8 Days)||3
1467932|NCT01957202|3592827|P10|COMPLETED|Treatment Period 2 (8 Days)||6
1467933|NCT01957202|3592828|P9|COMPLETED|Treatment Period 2 (8 Days)||3
1467934|NCT01957202|3592829|P8|COMPLETED|Treatment Period 2 (8 Days)||3
1467935|NCT01957202|3592830|P7|COMPLETED|Treatment Period 2 (8 Days)||3
1467936|NCT01957202|3592831|P6|COMPLETED|Treatment Period 2 (8 Days)||2
1467937|NCT01957202|3592832|P5|COMPLETED|Treatment Period 2 (8 Days)||3
1467938|NCT01957202|3592833|P4|COMPLETED|Treatment Period 2 (8 Days)||3
1467939|NCT01957202|3592834|P3|COMPLETED|Treatment Period 2 (8 Days)||6
1467940|NCT01957202|3592835|P2|COMPLETED|Treatment Period 2 (8 Days)||5
1467941|NCT01957202|3592836|P1|COMPLETED|Treatment Period 2 (8 Days)||3
1467942|NCT01957202|3592819|P18|STARTED|Treatment Period 2 (8 Days)||3
1467943|NCT01957202|3592820|P17|STARTED|Treatment Period 2 (8 Days)||6
1467944|NCT01957202|3592821|P16|STARTED|Treatment Period 2 (8 Days)||3
1467945|NCT01957202|3592822|P15|STARTED|Treatment Period 2 (8 Days)||6
1467946|NCT01957202|3592823|P14|STARTED|Treatment Period 2 (8 Days)||3
1467947|NCT01957202|3592824|P13|STARTED|Treatment Period 2 (8 Days)||3
1467948|NCT01957202|3592825|P12|STARTED|Treatment Period 2 (8 Days)||6
1467949|NCT01957202|3592826|P11|STARTED|Treatment Period 2 (8 Days)||3
1467950|NCT01957202|3592827|P10|STARTED|Treatment Period 2 (8 Days)||6
1467951|NCT01957202|3592828|P9|STARTED|Treatment Period 2 (8 Days)||3
1467952|NCT01957202|3592829|P8|STARTED|Treatment Period 2 (8 Days)||3
1467953|NCT01957202|3592830|P7|STARTED|Treatment Period 2 (8 Days)||3
1467954|NCT01957202|3592831|P6|STARTED|Treatment Period 2 (8 Days)||2
1467955|NCT01957202|3592832|P5|STARTED|Treatment Period 2 (8 Days)||3
1467956|NCT01957202|3592833|P4|STARTED|Treatment Period 2 (8 Days)||3
1467957|NCT01957202|3592834|P3|STARTED|Treatment Period 2 (8 Days)||6
1467958|NCT01957202|3592835|P2|STARTED|Treatment Period 2 (8 Days)||6
1467959|NCT01957202|3592836|P1|STARTED|Treatment Period 2 (8 Days)||3
1467960|NCT01957202|3592819|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467961|NCT01957202|3592820|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467962|NCT01957202|3592821|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467963|NCT01957202|3592822|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467964|NCT01957202|3592823|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467965|NCT01957202|3592824|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467966|NCT01957202|3592825|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467967|NCT01957202|3592826|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467968|NCT01957202|3592827|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467969|NCT01957202|3592828|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467970|NCT01957202|3592829|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467971|NCT01957202|3592830|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467972|NCT01957202|3592831|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467973|NCT01957202|3592832|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467974|NCT01957202|3592833|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467975|NCT01957202|3592834|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467976|NCT01957202|3592835|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467977|NCT01957202|3592836|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
1467978|NCT01957202|3592819|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467979|NCT01957202|3592820|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1467980|NCT01957202|3592821|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467981|NCT01957202|3592822|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1467982|NCT01957202|3592823|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467983|NCT01957202|3592824|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467984|NCT01957202|3592825|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1467985|NCT01957202|3592826|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467986|NCT01957202|3592827|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1467987|NCT01957202|3592828|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467988|NCT01957202|3592829|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467989|NCT01957202|3592830|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467990|NCT01957202|3592831|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
1467991|NCT01957202|3592832|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467992|NCT01957202|3592833|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467993|NCT01957202|3592834|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1467994|NCT01957202|3592835|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
1467995|NCT01957202|3592836|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
1467996|NCT01957202|3592819|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
1467997|NCT01957202|3592820|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
1467998|NCT01957202|3592821|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
1467999|NCT01957202|3592822|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
1468000|NCT01957202|3592823|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
1468001|NCT01957202|3592824|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
1468002|NCT01957202|3592825|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
1468003|NCT01957202|3592826|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
1468004|NCT01957202|3592827|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
1468005|NCT01957202|3592828|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
1468006|NCT01957202|3592829|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
1468007|NCT01957202|3592830|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
1468008|NCT01957202|3592831|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
1468009|NCT01957202|3592832|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
1468010|NCT01957202|3592833|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
1468011|NCT01957202|3592834|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
1468012|NCT01957202|3592835|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
1468013|NCT01957202|3592836|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
1468014|NCT01957202|3592819|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468015|NCT01957202|3592820|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468016|NCT01957202|3592821|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468017|NCT01957202|3592822|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468018|NCT01957202|3592823|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468019|NCT01957202|3592824|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468020|NCT01957202|3592825|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468021|NCT01957202|3592826|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468022|NCT01957202|3592827|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468023|NCT01957202|3592828|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468024|NCT01957202|3592829|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468025|NCT01957202|3592830|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468026|NCT01957202|3592831|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468027|NCT01957202|3592832|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468028|NCT01957202|3592833|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468029|NCT01957202|3592834|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468030|NCT01957202|3592835|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468031|NCT01957202|3592836|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
1468032|NCT01957202|3592819|P18|COMPLETED|Treatment Period 1 (8 Days)||3
1468033|NCT01957202|3592820|P17|COMPLETED|Treatment Period 1 (8 Days)||6
1468034|NCT01957202|3592821|P16|COMPLETED|Treatment Period 1 (8 Days)||3
1468035|NCT01957202|3592822|P15|COMPLETED|Treatment Period 1 (8 Days)||6
1468036|NCT01957202|3592823|P14|COMPLETED|Treatment Period 1 (8 Days)||3
1468037|NCT01957202|3592824|P13|COMPLETED|Treatment Period 1 (8 Days)||3
1468038|NCT01957202|3592825|P12|COMPLETED|Treatment Period 1 (8 Days)||6
1468039|NCT01957202|3592826|P11|COMPLETED|Treatment Period 1 (8 Days)||3
1468040|NCT01957202|3592827|P10|COMPLETED|Treatment Period 1 (8 Days)||6
1468041|NCT01957202|3592828|P9|COMPLETED|Treatment Period 1 (8 Days)||3
1468042|NCT01957202|3592829|P8|COMPLETED|Treatment Period 1 (8 Days)||3
1468043|NCT01957202|3592830|P7|COMPLETED|Treatment Period 1 (8 Days)||3
1468044|NCT01957202|3592831|P6|COMPLETED|Treatment Period 1 (8 Days)||2
1468045|NCT01957202|3592832|P5|COMPLETED|Treatment Period 1 (8 Days)||3
1468046|NCT01957202|3592833|P4|COMPLETED|Treatment Period 1 (8 Days)||3
1468047|NCT01957202|3592834|P3|COMPLETED|Treatment Period 1 (8 Days)||6
1468048|NCT01957202|3592835|P2|COMPLETED|Treatment Period 1 (8 Days)||6
1468049|NCT01957202|3592836|P1|COMPLETED|Treatment Period 1 (8 Days)||3
1468050|NCT01957202|3592819|P18|STARTED|Treatment Period 1 (8 Days)||3
1468051|NCT01957202|3592820|P17|STARTED|Treatment Period 1 (8 Days)||6
1468052|NCT01957202|3592821|P16|STARTED|Treatment Period 1 (8 Days)||3
1468053|NCT01957202|3592822|P15|STARTED|Treatment Period 1 (8 Days)||6
1468054|NCT01957202|3592823|P14|STARTED|Treatment Period 1 (8 Days)||3
1468055|NCT01957202|3592824|P13|STARTED|Treatment Period 1 (8 Days)||3
1468056|NCT01957202|3592825|P12|STARTED|Treatment Period 1 (8 Days)||6
1468057|NCT01957202|3592826|P11|STARTED|Treatment Period 1 (8 Days)||3
1468058|NCT01957202|3592827|P10|STARTED|Treatment Period 1 (8 Days)||6
1468059|NCT01957202|3592828|P9|STARTED|Treatment Period 1 (8 Days)||3
1468060|NCT01957202|3592829|P8|STARTED|Treatment Period 1 (8 Days)||3
1468061|NCT01957202|3592830|P7|STARTED|Treatment Period 1 (8 Days)||3
1468062|NCT01957202|3592831|P6|STARTED|Treatment Period 1 (8 Days)||2
1468063|NCT01957202|3592832|P5|STARTED|Treatment Period 1 (8 Days)||3
1468064|NCT01957202|3592833|P4|STARTED|Treatment Period 1 (8 Days)||3
1468065|NCT01957202|3592834|P3|STARTED|Treatment Period 1 (8 Days)||6
1468066|NCT01957202|3592835|P2|STARTED|Treatment Period 1 (8 Days)||6
1468067|NCT01957202|3592836|P1|STARTED|Treatment Period 1 (8 Days)||3
1468068|NCT01957163|3592861|P3|NOT COMPLETED|Overall Study||18
1468069|NCT01957163|3592862|P2|NOT COMPLETED|Overall Study||11
1468070|NCT01957163|3592863|P1|NOT COMPLETED|Overall Study||15
1468071|NCT01957163|3592861|P3|COMPLETED|Overall Study||189
1468072|NCT01957163|3592862|P2|COMPLETED|Overall Study||195
1468073|NCT01957163|3592863|P1|COMPLETED|Overall Study||191
1468074|NCT01957163|3592861|P3|STARTED|Overall Study||207
1468075|NCT01957163|3592862|P2|STARTED|Overall Study||206
1468076|NCT01957163|3592863|P1|STARTED|Overall Study||206
1468077|NCT01957137|3592874|P1|NOT COMPLETED|No Stimulation||0
1468078|NCT01957137|3592874|P1|COMPLETED|No Stimulation||28
1468079|NCT01957137|3592874|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
1468080|NCT01957137|3592874|P1|NOT COMPLETED|Randomized Portion||2
1468081|NCT01957137|3592874|P1|COMPLETED|Randomized Portion||28
1468082|NCT01957137|3592874|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
1468083|NCT01957137|3592874|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
1468084|NCT01957137|3592874|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
1468085|NCT01957137|3592874|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
1468086|NCT01957137|3592874|P1|STARTED|Randomized Portion||30
1468087|NCT01957111|3592904|P2|NOT COMPLETED|Overall Study||1
1468088|NCT01957111|3592905|P1|NOT COMPLETED|Overall Study||1
1468089|NCT01957111|3592904|P2|COMPLETED|Overall Study||15
1468090|NCT01957111|3592905|P1|COMPLETED|Overall Study||15
1468091|NCT01957111|3592904|P2|STARTED|Overall Study||16
1468092|NCT01957111|3592905|P1|STARTED|Overall Study||16
1468093|NCT01956435|3592913|P2|NOT COMPLETED|Overall Study||0
1468094|NCT01956435|3592914|P1|NOT COMPLETED|Overall Study||0
1468095|NCT01956435|3592913|P2|COMPLETED|Overall Study||3
1468096|NCT01956435|3592914|P1|COMPLETED|Overall Study||3
1468097|NCT01956435|3592913|P2|STARTED|Overall Study||3
1468098|NCT01956435|3592914|P1|STARTED|Overall Study||3
1468099|NCT01956240|3592923|P2|NOT COMPLETED|Overall Study||24
1468100|NCT01956240|3592924|P1|NOT COMPLETED|Overall Study||23
1468101|NCT01956240|3592923|P2|COMPLETED|Overall Study||25
1468102|NCT01956240|3592924|P1|COMPLETED|Overall Study||25
1468103|NCT01956240|3592923|P2|STARTED|Overall Study||49
1468104|NCT01956240|3592924|P1|STARTED|Overall Study||48
1468105|NCT01956123|3592934|P4|NOT COMPLETED|COS Cycle 3||2
1468106|NCT01956123|3592935|P3|NOT COMPLETED|COS Cycle 3||6
1468107|NCT01956123|3592936|P2|NOT COMPLETED|COS Cycle 3||0
1468108|NCT01956123|3592937|P1|NOT COMPLETED|COS Cycle 3||0
1468109|NCT01956123|3592934|P4|COMPLETED|COS Cycle 3||91
1468110|NCT01956123|3592935|P3|COMPLETED|COS Cycle 3||89
1468111|NCT01956123|3592936|P2|COMPLETED|COS Cycle 3||0
1468112|NCT01956123|3592937|P1|COMPLETED|COS Cycle 3||0
1468113|NCT01956123|3592934|P4|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
1468114|NCT01956123|3592935|P3|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
1468115|NCT01956123|3592936|P2|STARTED|COS Cycle 3||0
1468116|NCT01956123|3592937|P1|STARTED|COS Cycle 3||0
1468117|NCT01956123|3592934|P4|NOT COMPLETED|COS Cycle 2||0
1468118|NCT01956123|3592935|P3|NOT COMPLETED|COS Cycle 2||0
1468119|NCT01956123|3592936|P2|NOT COMPLETED|COS Cycle 2||7
1468120|NCT01956123|3592937|P1|NOT COMPLETED|COS Cycle 2||14
1468121|NCT01956123|3592934|P4|COMPLETED|COS Cycle 2||0
1468122|NCT01956123|3592935|P3|COMPLETED|COS Cycle 2||0
1468123|NCT01956123|3592936|P2|COMPLETED|COS Cycle 2||254
1468124|NCT01956123|3592937|P1|COMPLETED|COS Cycle 2||238
1468125|NCT01956123|3592934|P4|STARTED|COS Cycle 2||0
1468126|NCT01956123|3592935|P3|STARTED|COS Cycle 2||0
1468127|NCT01956123|3592936|P2|STARTED|COS Cycle 2||261
1468128|NCT01956123|3592937|P1|STARTED|COS Cycle 2||252
1468129|NCT01956110|3592989|P2|NOT COMPLETED|Overall Study||22
1468130|NCT01956110|3592990|P1|NOT COMPLETED|Overall Study||35
1468131|NCT01956110|3592989|P2|COMPLETED|Overall Study||639
1468132|NCT01956110|3592990|P1|COMPLETED|Overall Study||630
1468133|NCT01956110|3592989|P2|STARTED|Overall Study||661
1468134|NCT01956110|3592990|P1|STARTED|Overall Study||665
1468135|NCT01956097|3593043|P3|NOT COMPLETED|Overall Study||0
1468136|NCT01956097|3593044|P2|NOT COMPLETED|Overall Study||2
1468137|NCT01956097|3593045|P1|NOT COMPLETED|Overall Study||6
1468138|NCT01956097|3593043|P3|COMPLETED|Overall Study||15
1468139|NCT01956097|3593044|P2|COMPLETED|Overall Study||28
1468140|NCT01956097|3593045|P1|COMPLETED|Overall Study||24
1468141|NCT01956097|3593043|P3|STARTED|Overall Study||15
1468142|NCT01956097|3593044|P2|STARTED|Overall Study||30
1468143|NCT01956097|3593045|P1|STARTED|Overall Study||30
1468144|NCT01956032|3593062|P1|NOT COMPLETED|Overall Study||0
1468145|NCT01956032|3593062|P1|COMPLETED|Overall Study||15
1468146|NCT01956032|3593062|P1|STARTED|Overall Study||15
1468147|NCT01955954|3593109|P1|NOT COMPLETED|Overall Study||36
1468148|NCT01955954|3593109|P1|COMPLETED|Overall Study|12-months|33
1468149|NCT01955954|3593109|P1|Completed 6-month Assessement|Overall Study||42
1468150|NCT01955954|3593109|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
1468151|NCT01955954|3593109|P1|Completed Post-treatment Assessement|Overall Study||48
1468152|NCT01955954|3593109|P1|Completed Treatment|Overall Study||53
1468153|NCT01955954|3593109|P1|Received Treatment|Overall Study||66
1468154|NCT01955954|3593109|P1|STARTED|Overall Study||69
1468155|NCT01955733|3593121|P3|NOT COMPLETED|Period 2||21
1468156|NCT01955733|3593122|P2|NOT COMPLETED|Period 2||19
1468157|NCT01955733|3593123|P1|NOT COMPLETED|Period 2||12
1468158|NCT01955733|3593121|P3|COMPLETED|Period 2||8
1468159|NCT01955733|3593122|P2|COMPLETED|Period 2||10
1468160|NCT01955733|3593123|P1|COMPLETED|Period 2||20
1468161|NCT01955733|3593121|P3|STARTED|Period 2||29
1468162|NCT01955733|3593122|P2|STARTED|Period 2||29
1468163|NCT01955733|3593123|P1|STARTED|Period 2||32
1468164|NCT01955733|3593121|P3|NOT COMPLETED|Period 1||0
1468165|NCT01955733|3593122|P2|NOT COMPLETED|Period 1||0
1468166|NCT01955733|3593123|P1|NOT COMPLETED|Period 1||1
1468167|NCT01955733|3593121|P3|COMPLETED|Period 1||29
1468168|NCT01955733|3593122|P2|COMPLETED|Period 1||29
1468169|NCT01955733|3593123|P1|COMPLETED|Period 1||32
1468170|NCT01955733|3593121|P3|STARTED|Period 1||29
1468171|NCT01955733|3593122|P2|STARTED|Period 1||29
1468172|NCT01955733|3593123|P1|STARTED|Period 1||33
1468173|NCT01955720|3593143|P6|NOT COMPLETED|Overall Study||0
1468174|NCT01955720|3593144|P5|NOT COMPLETED|Overall Study||0
1468175|NCT01955720|3593145|P4|NOT COMPLETED|Overall Study||0
1468176|NCT01955720|3593146|P3|NOT COMPLETED|Overall Study||0
1468177|NCT01955720|3593147|P2|NOT COMPLETED|Overall Study||0
1468178|NCT01955720|3593148|P1|NOT COMPLETED|Overall Study||0
1468179|NCT01955720|3593143|P6|COMPLETED|Overall Study||7
1468180|NCT01955720|3593144|P5|COMPLETED|Overall Study||7
1468181|NCT01955720|3593145|P4|COMPLETED|Overall Study||3
1468182|NCT01955720|3593146|P3|COMPLETED|Overall Study||3
1468183|NCT01955720|3593147|P2|COMPLETED|Overall Study||13
1468184|NCT01955720|3593148|P1|COMPLETED|Overall Study||13
1468185|NCT01955720|3593143|P6|Subjects With Moderate Renal Impairment|Overall Study||0
1468186|NCT01955720|3593144|P5|Subjects With Moderate Renal Impairment|Overall Study||0
1468187|NCT01955720|3593145|P4|Subjects With Moderate Renal Impairment|Overall Study||0
1468188|NCT01955720|3593146|P3|Subjects With Moderate Renal Impairment|Overall Study||0
1468189|NCT01955720|3593147|P2|Subjects With Moderate Renal Impairment|Overall Study||3
1468190|NCT01955720|3593148|P1|Subjects With Moderate Renal Impairment|Overall Study||3
1468191|NCT01955720|3593143|P6|Subjects With Mild Renal Impairment|Overall Study||3
1468192|NCT01955720|3593144|P5|Subjects With Mild Renal Impairment|Overall Study||3
1468193|NCT01955720|3593145|P4|Subjects With Mild Renal Impairment|Overall Study||0
1468194|NCT01955720|3593146|P3|Subjects With Mild Renal Impairment|Overall Study||0
1468195|NCT01955720|3593147|P2|Subjects With Mild Renal Impairment|Overall Study||3
1468196|NCT01955720|3593148|P1|Subjects With Mild Renal Impairment|Overall Study||3
1468197|NCT01955720|3593143|P6|Healthy Subjects Aged 65-80|Overall Study||4
1468198|NCT01955720|3593144|P5|Healthy Subjects Aged 65-80|Overall Study||4
1468199|NCT01955720|3593145|P4|Healthy Subjects Aged 65-80|Overall Study||0
1468200|NCT01955720|3593146|P3|Healthy Subjects Aged 65-80|Overall Study||0
1468201|NCT01955720|3593147|P2|Healthy Subjects Aged 65-80|Overall Study||4
1468202|NCT01955720|3593148|P1|Healthy Subjects Aged 65-80|Overall Study||4
1468203|NCT01955720|3593143|P6|Healthy Subjects Aged 45-64|Overall Study||0
1468204|NCT01955720|3593144|P5|Healthy Subjects Aged 45-64|Overall Study||0
1468205|NCT01955720|3593145|P4|Healthy Subjects Aged 45-64|Overall Study||3
1468206|NCT01955720|3593146|P3|Healthy Subjects Aged 45-64|Overall Study||3
1468207|NCT01955720|3593147|P2|Healthy Subjects Aged 45-64|Overall Study||3
1468208|NCT01955720|3593148|P1|Healthy Subjects Aged 45-64|Overall Study||3
1468209|NCT01955720|3593143|P6|STARTED|Overall Study||7
1468210|NCT01955720|3593144|P5|STARTED|Overall Study||7
1468211|NCT01955720|3593145|P4|STARTED|Overall Study||3
1468212|NCT01955720|3593146|P3|STARTED|Overall Study||3
1468213|NCT01955720|3593147|P2|STARTED|Overall Study||13
1468214|NCT01955720|3593148|P1|STARTED|Overall Study||13
1468215|NCT01955707|3593216|P2|NOT COMPLETED|Overall Study||22
1468216|NCT01955707|3593217|P1|NOT COMPLETED|Overall Study||20
1468217|NCT01955707|3593216|P2|COMPLETED|Overall Study||57
1468218|NCT01955707|3593217|P1|COMPLETED|Overall Study||62
1468219|NCT01955707|3593216|P2|Received Total Volume of Study Drug|Overall Study||77
1468220|NCT01955707|3593217|P1|Received Total Volume of Study Drug|Overall Study||82
1468221|NCT01955707|3593216|P2|Dosed|Overall Study||78
1468222|NCT01955707|3593217|P1|Dosed|Overall Study||82
1468223|NCT01955707|3593216|P2|Withdrew Prior to Dosing|Overall Study||1
1468224|NCT01955707|3593217|P1|Withdrew Prior to Dosing|Overall Study||0
1468225|NCT01955707|3593216|P2|STARTED|Overall Study||79
1468226|NCT01955707|3593217|P1|STARTED|Overall Study||82
1468227|NCT01955629|3593241|P1|NOT COMPLETED|Overall Study||0
1468228|NCT01955629|3593241|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
1468229|NCT01955629|3593241|P1|STARTED|Overall Study||4
1468230|NCT01955564|3593260|P7|NOT COMPLETED|Overall Study||0
1468231|NCT01955564|3593261|P6|NOT COMPLETED|Overall Study||0
1468232|NCT01955564|3593262|P5|NOT COMPLETED|Overall Study||0
1468233|NCT01955564|3593263|P4|NOT COMPLETED|Overall Study||0
1468234|NCT01955564|3593264|P3|NOT COMPLETED|Overall Study||0
1468235|NCT01955564|3593265|P2|NOT COMPLETED|Overall Study||0
1468236|NCT01955564|3593266|P1|NOT COMPLETED|Overall Study||0
1468237|NCT01955564|3593260|P7|COMPLETED|Overall Study||6
1468238|NCT01955564|3593261|P6|COMPLETED|Overall Study||6
1468239|NCT01955564|3593262|P5|COMPLETED|Overall Study||6
1468240|NCT01955564|3593263|P4|COMPLETED|Overall Study||6
1468241|NCT01955564|3593264|P3|COMPLETED|Overall Study||6
1468242|NCT01955564|3593265|P2|COMPLETED|Overall Study||6
1468243|NCT01955564|3593266|P1|COMPLETED|Overall Study||18
1468244|NCT01955564|3593260|P7|STARTED|Overall Study||6
1468245|NCT01955564|3593261|P6|STARTED|Overall Study||6
1468246|NCT01955564|3593262|P5|STARTED|Overall Study||6
1468247|NCT01955564|3593263|P4|STARTED|Overall Study||6
1468248|NCT01955564|3593264|P3|STARTED|Overall Study||6
1468249|NCT01955564|3593265|P2|STARTED|Overall Study||6
1468250|NCT01955564|3593266|P1|STARTED|Overall Study||18
1468251|NCT01955473|3593299|P5|NOT COMPLETED|Overall Study||0
1468252|NCT01955473|3593300|P4|NOT COMPLETED|Overall Study||0
1468253|NCT01955473|3593301|P3|NOT COMPLETED|Overall Study||0
1468254|NCT01955473|3593302|P2|NOT COMPLETED|Overall Study||0
1468255|NCT01955473|3593303|P1|NOT COMPLETED|Overall Study||0
1468256|NCT01955473|3593299|P5|COMPLETED|Overall Study||30
1468257|NCT01955473|3593300|P4|COMPLETED|Overall Study||6
1468258|NCT01955473|3593301|P3|COMPLETED|Overall Study||6
1468259|NCT01955473|3593302|P2|COMPLETED|Overall Study||6
1468260|NCT01955473|3593303|P1|COMPLETED|Overall Study||3
1468261|NCT01955473|3593299|P5|STARTED|Overall Study||30
1468262|NCT01955473|3593300|P4|STARTED|Overall Study||6
1468263|NCT01955473|3593301|P3|STARTED|Overall Study||6
1468264|NCT01955473|3593302|P2|STARTED|Overall Study||6
1468265|NCT01955473|3593303|P1|STARTED|Overall Study||3
1468266|NCT01955434|3593457|P1|NOT COMPLETED|Overall Study||0
1468267|NCT01955434|3593457|P1|COMPLETED|Overall Study||25
1468268|NCT01955434|3593457|P1|STARTED|Overall Study||25
1468269|NCT01955382|3593467|P2|NOT COMPLETED|Overall Study||0
1468270|NCT01955382|3593468|P1|NOT COMPLETED|Overall Study||0
1468271|NCT01955382|3593467|P2|COMPLETED|Overall Study||35
1468272|NCT01955382|3593468|P1|COMPLETED|Overall Study||35
1468273|NCT01955382|3593467|P2|STARTED|Overall Study||35
1468274|NCT01955382|3593468|P1|STARTED|Overall Study||35
1468275|NCT01955369|3593476|P1|NOT COMPLETED|Overall Study||0
1468276|NCT01955369|3593476|P1|COMPLETED|Overall Study||200
1468277|NCT01955369|3593476|P1|STARTED|Overall Study||200
1468278|NCT01955161|3593485|P3|NOT COMPLETED|Overall Study||35
1468279|NCT01955161|3593486|P2|NOT COMPLETED|Overall Study||25
1468280|NCT01955161|3593487|P1|NOT COMPLETED|Overall Study||27
1468281|NCT01955161|3593485|P3|COMPLETED|Overall Study||275
1468282|NCT01955161|3593486|P2|COMPLETED|Overall Study||288
1468283|NCT01955161|3593487|P1|COMPLETED|Overall Study||283
1468284|NCT01955161|3593485|P3|Treated|Overall Study||309
1468285|NCT01955161|3593486|P2|Treated|Overall Study||313
1468286|NCT01955161|3593487|P1|Treated|Overall Study||308
1468287|NCT01955161|3593485|P3|STARTED|Overall Study||310
1468288|NCT01955161|3593486|P2|STARTED|Overall Study||313
1468289|NCT01955161|3593487|P1|STARTED|Overall Study||310
1468290|NCT01955122|3593527|P2|NOT COMPLETED|Overall Study||5
1468291|NCT01955122|3593528|P1|NOT COMPLETED|Overall Study||5
1468292|NCT01955122|3593527|P2|COMPLETED|Overall Study||57
1468293|NCT01955122|3593528|P1|COMPLETED|Overall Study||59
1468294|NCT01955122|3593527|P2|No. Patients Completed Double Procedure|Overall Study||57
1468295|NCT01955122|3593528|P1|No. Patients Completed Double Procedure|Overall Study||59
1468296|NCT01955122|3593527|P2|No.Patients Enrolled|Overall Study||62
1468297|NCT01955122|3593528|P1|No.Patients Enrolled|Overall Study||64
1468298|NCT01955122|3593527|P2|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
1468299|NCT01955122|3593528|P1|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
1468300|NCT01955083|3593548|P2|NOT COMPLETED|Overall Study||1
1468301|NCT01955083|3593549|P1|NOT COMPLETED|Overall Study||1
1468302|NCT01955083|3593548|P2|COMPLETED|Overall Study||14
1468303|NCT01955083|3593549|P1|COMPLETED|Overall Study||14
1468304|NCT01955083|3593548|P2|STARTED|Overall Study||15
1468305|NCT01955083|3593549|P1|STARTED|Overall Study||15
1468306|NCT01955044|3593582|P3|NOT COMPLETED|Overall Study||0
1468307|NCT01955044|3593583|P2|NOT COMPLETED|Overall Study||1
1468308|NCT01955044|3593584|P1|NOT COMPLETED|Overall Study||1
1468309|NCT01955044|3593582|P3|COMPLETED|Overall Study||10
1468310|NCT01955044|3593583|P2|COMPLETED|Overall Study||9
1468311|NCT01955044|3593584|P1|COMPLETED|Overall Study||9
1468312|NCT01955044|3593582|P3|STARTED|Overall Study||10
1468313|NCT01955044|3593583|P2|STARTED|Overall Study||10
1468314|NCT01955044|3593584|P1|STARTED|Overall Study||10
1468315|NCT01955005|3593597|P2|NOT COMPLETED|Overall Study||5
1468316|NCT01955005|3593598|P1|NOT COMPLETED|Overall Study||3
1468317|NCT01955005|3593597|P2|COMPLETED|Overall Study||25
1468318|NCT01955005|3593598|P1|COMPLETED|Overall Study||27
1468319|NCT01955005|3593597|P2|STARTED|Overall Study||30
1468320|NCT01955005|3593598|P1|STARTED|Overall Study||30
1468321|NCT01954771|3593611|P3|NOT COMPLETED|Overall Study||3
1468322|NCT01954771|3593612|P2|NOT COMPLETED|Overall Study||3
1468323|NCT01954771|3593613|P1|NOT COMPLETED|Overall Study||7
1468324|NCT01954771|3593611|P3|COMPLETED|Overall Study||25
1468325|NCT01954771|3593612|P2|COMPLETED|Overall Study||29
1468326|NCT01954771|3593613|P1|COMPLETED|Overall Study||22
1468327|NCT01954771|3593611|P3|STARTED|Overall Study||28
1468328|NCT01954771|3593612|P2|STARTED|Overall Study||32
1468329|NCT01954771|3593613|P1|STARTED|Overall Study||29
1468330|NCT01954745|3593630|P1|NOT COMPLETED|Overall Study||19
1468331|NCT01954745|3593630|P1|COMPLETED|Overall Study||0
1468332|NCT01954745|3593630|P1|STARTED|Overall Study||19
1468333|NCT01954628|3593639|P2|NOT COMPLETED|Overall Study||27
1468334|NCT01954628|3593640|P1|NOT COMPLETED|Overall Study||31
1468335|NCT01954628|3593639|P2|COMPLETED|Overall Study||173
1468336|NCT01954628|3593640|P1|COMPLETED|Overall Study||169
1468337|NCT01954628|3593639|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
1468338|NCT01954628|3593640|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
1468339|NCT01954628|3593639|P2|Pharmacokinetic Population|Overall Study||0
1468340|NCT01954628|3593640|P1|Pharmacokinetic Population|Overall Study||181
1468341|NCT01954628|3593639|P2|Safety Set|Overall Study||200
1468342|NCT01954628|3593640|P1|Safety Set|Overall Study||200
1468343|NCT01954628|3593639|P2|Full Analysis Set (FAS)|Overall Study||198
1468344|NCT01954628|3593640|P1|Full Analysis Set (FAS)|Overall Study||200
1468345|NCT01954628|3593639|P2|STARTED|Overall Study||200
1468346|NCT01954628|3593640|P1|STARTED|Overall Study||200
1468347|NCT01954394|3593661|P2|NOT COMPLETED|Overall Study||57
1468348|NCT01954394|3593662|P1|NOT COMPLETED|Overall Study||30
1468349|NCT01954394|3593661|P2|COMPLETED|Overall Study||598
1468350|NCT01954394|3593662|P1|COMPLETED|Overall Study||301
1468351|NCT01954394|3593661|P2|Treated|Overall Study|Safety population|655
1468352|NCT01954394|3593662|P1|Treated|Overall Study|Safety population|330
1468353|NCT01954394|3593661|P2|STARTED|Overall Study|Enrolled|655
1468354|NCT01954394|3593662|P1|STARTED|Overall Study|Enrolled|331
1468355|NCT01954264|3593712|P1|NOT COMPLETED|Overall Study||0
1468356|NCT01954264|3593712|P1|COMPLETED|Overall Study||2421
1468357|NCT01954264|3593712|P1|STARTED|Overall Study||2421
1468358|NCT01954251|3593764|P2|NOT COMPLETED|Overall Study||19
1468359|NCT01954251|3593765|P1|NOT COMPLETED|Overall Study||13
1468360|NCT01954251|3593764|P2|COMPLETED|Overall Study||396
1468361|NCT01954251|3593765|P1|COMPLETED|Overall Study||400
1468362|NCT01954251|3593764|P2|STARTED|Overall Study||415
1468363|NCT01954251|3593765|P1|STARTED|Overall Study||413
1468364|NCT01954160|3593801|P2|NOT COMPLETED|Overall Study||0
1468365|NCT01954160|3593802|P1|NOT COMPLETED|Overall Study||5
1468366|NCT01954160|3593801|P2|COMPLETED|Overall Study||0
1468367|NCT01954160|3593802|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
1468368|NCT01954160|3593801|P2|STARTED|Overall Study|Not started|0
1468369|NCT01954160|3593802|P1|STARTED|Overall Study||5
1468370|NCT01954121|3593862|P2|NOT COMPLETED|Overall Study||91
1468371|NCT01954121|3593863|P1|NOT COMPLETED|Overall Study||127
1468372|NCT01954121|3593862|P2|COMPLETED|Overall Study||125
1468373|NCT01954121|3593863|P1|COMPLETED|Overall Study||93
1468374|NCT01954121|3593862|P2|STARTED|Overall Study||216
1468375|NCT01954121|3593863|P1|STARTED|Overall Study||220
1468376|NCT01954082|3593879|P2|NOT COMPLETED|Overall Study||57
1468377|NCT01954082|3593880|P1|NOT COMPLETED|Overall Study||68
1468378|NCT01954082|3593879|P2|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
1468379|NCT01954082|3593880|P1|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
1468380|NCT01954082|3593879|P2|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
1468381|NCT01954082|3593880|P1|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
1468382|NCT01954082|3593879|P2|STARTED|Overall Study||321
1468383|NCT01954082|3593880|P1|STARTED|Overall Study||317
1468384|NCT01953874|3593900|P2|NOT COMPLETED|Overall Study||0
1468385|NCT01953874|3593901|P1|NOT COMPLETED|Overall Study||0
1468386|NCT01953874|3593900|P2|COMPLETED|Overall Study||61
1468387|NCT01953874|3593901|P1|COMPLETED|Overall Study||65
1468388|NCT01953874|3593900|P2|STARTED|Overall Study||61
1468389|NCT01953874|3593901|P1|STARTED|Overall Study||65
1468390|NCT01953354|3593946|P2|NOT COMPLETED|Overall Study||2
1468391|NCT01953354|3593947|P1|NOT COMPLETED|Overall Study||1
1468392|NCT01953354|3593946|P2|COMPLETED|Overall Study||5
1468393|NCT01953354|3593947|P1|COMPLETED|Overall Study||8
1468394|NCT01953354|3593946|P2|STARTED|Overall Study||7
1468395|NCT01953354|3593947|P1|STARTED|Overall Study||9
1468396|NCT01953328|3593975|P8|NOT COMPLETED|Overall Study||0
1468397|NCT01953328|3593976|P7|NOT COMPLETED|Overall Study||0
1468398|NCT01953328|3593977|P6|NOT COMPLETED|Overall Study||0
1468399|NCT01953328|3593978|P5|NOT COMPLETED|Overall Study||2
1468400|NCT01953328|3593979|P4|NOT COMPLETED|Overall Study||0
1468401|NCT01953328|3593980|P3|NOT COMPLETED|Overall Study||0
1468402|NCT01953328|3593981|P2|NOT COMPLETED|Overall Study||0
1468403|NCT01953328|3593982|P1|NOT COMPLETED|Overall Study||0
1468404|NCT01953328|3593975|P8|COMPLETED|Overall Study||51
1468405|NCT01953328|3593976|P7|COMPLETED|Overall Study||51
1468406|NCT01953328|3593977|P6|COMPLETED|Overall Study||51
1468407|NCT01953328|3593978|P5|COMPLETED|Overall Study||50
1468408|NCT01953328|3593979|P4|COMPLETED|Overall Study||50
1468409|NCT01953328|3593980|P3|COMPLETED|Overall Study||50
1468410|NCT01953328|3593981|P2|COMPLETED|Overall Study||50
1468411|NCT01953328|3593982|P1|COMPLETED|Overall Study||49
1468412|NCT01953328|3593975|P8|Received Treatment|Overall Study||51
1468413|NCT01953328|3593976|P7|Received Treatment|Overall Study||51
1468414|NCT01953328|3593977|P6|Received Treatment|Overall Study||51
1468415|NCT01953328|3593978|P5|Received Treatment|Overall Study||52
1468416|NCT01953328|3593979|P4|Received Treatment|Overall Study||50
1468417|NCT01953328|3593980|P3|Received Treatment|Overall Study||50
1468418|NCT01953328|3593981|P2|Received Treatment|Overall Study||50
1468419|NCT01953328|3593982|P1|Received Treatment|Overall Study||49
1468420|NCT01953328|3593975|P8|STARTED|Overall Study||51
1468421|NCT01953328|3593976|P7|STARTED|Overall Study||51
1468422|NCT01953328|3593977|P6|STARTED|Overall Study||51
1468423|NCT01953328|3593978|P5|STARTED|Overall Study||52
1468424|NCT01953328|3593979|P4|STARTED|Overall Study||50
1468425|NCT01953328|3593980|P3|STARTED|Overall Study||50
1468426|NCT01953328|3593981|P2|STARTED|Overall Study||50
1468427|NCT01953328|3593982|P1|STARTED|Overall Study||49
1468428|NCT01953237|3594186|P2|NOT COMPLETED|Overall Study||0
1468429|NCT01953237|3594187|P1|NOT COMPLETED|Overall Study||0
1468430|NCT01953237|3594186|P2|COMPLETED|Overall Study||21
1468431|NCT01953237|3594187|P1|COMPLETED|Overall Study||10
1468432|NCT01953237|3594186|P2|STARTED|Overall Study||21
1468433|NCT01953237|3594187|P1|STARTED|Overall Study||10
1468434|NCT01953224|3594195|P2|NOT COMPLETED|Overall Study||3
1468435|NCT01953224|3594196|P1|NOT COMPLETED|Overall Study||2
1468436|NCT01953224|3594195|P2|COMPLETED|Overall Study||17
1468437|NCT01953224|3594196|P1|COMPLETED|Overall Study||18
1468438|NCT01953224|3594195|P2|STARTED|Overall Study||20
1468439|NCT01953224|3594196|P1|STARTED|Overall Study||20
1468440|NCT01953081|3594214|P2|NOT COMPLETED|Overall Study||3
1468441|NCT01953081|3594215|P1|NOT COMPLETED|Overall Study||2
1468442|NCT01953081|3594214|P2|COMPLETED|Overall Study||3
1468443|NCT01953081|3594215|P1|COMPLETED|Overall Study||5
1468444|NCT01953081|3594214|P2|STARTED|Overall Study||6
1468445|NCT01953081|3594215|P1|STARTED|Overall Study||7
1468446|NCT01952834|3594231|P1|NOT COMPLETED|Overall Study||1
1468447|NCT01952834|3594231|P1|COMPLETED|Overall Study||20
1468448|NCT01952834|3594231|P1|STARTED|Overall Study||21
1468449|NCT01952691|3594238|P1|NOT COMPLETED|Overall Study||2
1468450|NCT01952691|3594238|P1|COMPLETED|Overall Study||20
1468451|NCT01952691|3594238|P1|STARTED|Overall Study||22
1468452|NCT01952678|3594246|P2|NOT COMPLETED|Overall Study||0
1468453|NCT01952678|3594247|P1|NOT COMPLETED|Overall Study||0
1468454|NCT01952678|3594246|P2|COMPLETED|Overall Study||102
1468455|NCT01952678|3594247|P1|COMPLETED|Overall Study||102
1468456|NCT01952678|3594246|P2|STARTED|Overall Study||102
1468457|NCT01952678|3594247|P1|STARTED|Overall Study||102
1468458|NCT01952665|3594265|P2|NOT COMPLETED|Overall Study||6
1468459|NCT01952665|3594266|P1|NOT COMPLETED|Overall Study||6
1468460|NCT01952665|3594265|P2|COMPLETED|Overall Study||20
1468461|NCT01952665|3594266|P1|COMPLETED|Overall Study||31
1468462|NCT01952665|3594265|P2|STARTED|Overall Study||26
1468463|NCT01952665|3594266|P1|STARTED|Overall Study||37
1468464|NCT01952600|3594407|P3|NOT COMPLETED|Overall Study||7
1468465|NCT01952600|3594408|P2|NOT COMPLETED|Overall Study||13
1468466|NCT01952600|3594409|P1|NOT COMPLETED|Overall Study||15
1468467|NCT01952600|3594407|P3|COMPLETED|Overall Study||38
1468468|NCT01952600|3594408|P2|COMPLETED|Overall Study||77
1468469|NCT01952600|3594409|P1|COMPLETED|Overall Study||65
1468470|NCT01952600|3594407|P3|STARTED|Overall Study||45
1468471|NCT01952600|3594408|P2|STARTED|Overall Study||90
1468472|NCT01952600|3594409|P1|STARTED|Overall Study||80
1468473|NCT01952574|3594421|P4|NOT COMPLETED|Overall Study||6
1468474|NCT01952574|3594422|P3|NOT COMPLETED|Overall Study||9
1468475|NCT01952574|3594423|P2|NOT COMPLETED|Overall Study||3
1468476|NCT01952574|3594424|P1|NOT COMPLETED|Overall Study||17
1468477|NCT01952574|3594421|P4|COMPLETED|Overall Study||101
1468478|NCT01952574|3594422|P3|COMPLETED|Overall Study||99
1468479|NCT01952574|3594423|P2|COMPLETED|Overall Study||105
1468480|NCT01952574|3594424|P1|COMPLETED|Overall Study||143
1468481|NCT01952574|3594421|P4|Received Study Drug|Overall Study||106
1468482|NCT01952574|3594422|P3|Received Study Drug|Overall Study||105
1468483|NCT01952574|3594423|P2|Received Study Drug|Overall Study||108
1468484|NCT01952574|3594424|P1|Received Study Drug|Overall Study||153
1468485|NCT01952574|3594421|P4|STARTED|Overall Study||107
1468486|NCT01952574|3594422|P3|STARTED|Overall Study||108
1468487|NCT01952574|3594423|P2|STARTED|Overall Study||108
1468488|NCT01952574|3594424|P1|STARTED|Overall Study||160
1468489|NCT01952418|3594444|P2|NOT COMPLETED|Overall Study||0
1468490|NCT01952418|3594445|P1|NOT COMPLETED|Overall Study||0
1468491|NCT01952418|3594444|P2|COMPLETED|Overall Study||895
1468492|NCT01952418|3594445|P1|COMPLETED|Overall Study||910
1468493|NCT01952418|3594444|P2|STARTED|Overall Study||895
1468494|NCT01952418|3594445|P1|STARTED|Overall Study||910
1468495|NCT01952366|3594457|P1|NOT COMPLETED|Overall Study||31
1468496|NCT01952366|3594457|P1|COMPLETED|Overall Study||138
1468497|NCT01952366|3594457|P1|STARTED|Overall Study||169
1468498|NCT01952301|3594464|P1|NOT COMPLETED|Overall Study||0
1468499|NCT01952301|3594464|P1|COMPLETED|Overall Study||30
1468500|NCT01952301|3594464|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
1468501|NCT01952145|3594472|P2|NOT COMPLETED|Overall Study||14
1468502|NCT01952145|3594473|P1|NOT COMPLETED|Overall Study||28
1468503|NCT01952145|3594472|P2|COMPLETED|Overall Study||265
1468504|NCT01952145|3594473|P1|COMPLETED|Overall Study||250
1468505|NCT01952145|3594472|P2|STARTED|Overall Study||279
1468506|NCT01952145|3594473|P1|STARTED|Overall Study||278
1468507|NCT01952080|3594487|P4|NOT COMPLETED|Overall Study||1
1468508|NCT01952080|3594488|P3|NOT COMPLETED|Overall Study||0
1468509|NCT01952080|3594489|P2|NOT COMPLETED|Overall Study||1
1468510|NCT01952080|3594490|P1|NOT COMPLETED|Overall Study||0
1468511|NCT01952080|3594487|P4|COMPLETED|Overall Study||14
1468512|NCT01952080|3594488|P3|COMPLETED|Overall Study||14
1468513|NCT01952080|3594489|P2|COMPLETED|Overall Study||7
1468514|NCT01952080|3594490|P1|COMPLETED|Overall Study||5
1468515|NCT01952080|3594487|P4|Treated|Overall Study||15
1468516|NCT01952080|3594488|P3|Treated|Overall Study||14
1468517|NCT01952080|3594489|P2|Treated|Overall Study||8
1468518|NCT01952080|3594490|P1|Treated|Overall Study||5
1468519|NCT01952080|3594487|P4|STARTED|Overall Study||15
1468520|NCT01952080|3594488|P3|STARTED|Overall Study||14
1468521|NCT01952080|3594489|P2|STARTED|Overall Study||8
1468522|NCT01952080|3594490|P1|STARTED|Overall Study||5
1468523|NCT01951963|3594538|P2|NOT COMPLETED|Overall Study||0
1468524|NCT01951963|3594539|P1|NOT COMPLETED|Overall Study||0
1468525|NCT01951963|3594538|P2|COMPLETED|Overall Study||32
1468526|NCT01951963|3594539|P1|COMPLETED|Overall Study||31
1468527|NCT01951963|3594538|P2|STARTED|Overall Study||32
1468528|NCT01951963|3594539|P1|STARTED|Overall Study||31
1468529|NCT01951950|3594551|P2|NOT COMPLETED|Overall Study||6
1468530|NCT01951950|3594552|P1|NOT COMPLETED|Overall Study||6
1468531|NCT01951950|3594551|P2|COMPLETED|Overall Study||20
1468532|NCT01951950|3594552|P1|COMPLETED|Overall Study||20
1468533|NCT01951950|3594551|P2|STARTED|Overall Study||26
1468534|NCT01951950|3594552|P1|STARTED|Overall Study||26
1468535|NCT01951820|3594560|P2|NOT COMPLETED|Overall Study||0
1468536|NCT01951820|3594561|P1|NOT COMPLETED|Overall Study||0
1468537|NCT01951820|3594560|P2|COMPLETED|Overall Study||30
1468538|NCT01951820|3594561|P1|COMPLETED|Overall Study||34
1468539|NCT01951820|3594560|P2|STARTED|Overall Study||30
1468540|NCT01951820|3594561|P1|STARTED|Overall Study||34
1468541|NCT01951703|3594569|P2|NOT COMPLETED|Second Intervention||2
1468542|NCT01951703|3594570|P1|NOT COMPLETED|Second Intervention||0
1468543|NCT01951703|3594569|P2|COMPLETED|Second Intervention||60
1468544|NCT01951703|3594570|P1|COMPLETED|Second Intervention||61
1468545|NCT01951703|3594569|P2|STARTED|Second Intervention||62
1468546|NCT01951703|3594570|P1|STARTED|Second Intervention||61
1468547|NCT01951703|3594569|P2|NOT COMPLETED|First Intervention||1
1468548|NCT01951703|3594570|P1|NOT COMPLETED|First Intervention||3
1468549|NCT01951703|3594569|P2|COMPLETED|First Intervention||62
1468550|NCT01951703|3594570|P1|COMPLETED|First Intervention||61
1468551|NCT01951703|3594569|P2|STARTED|First Intervention||63
1468552|NCT01951703|3594570|P1|STARTED|First Intervention||64
1468553|NCT01951651|3594580|P2|NOT COMPLETED|Overall Study||2
1468554|NCT01951651|3594581|P1|NOT COMPLETED|Overall Study||4
1468555|NCT01951651|3594580|P2|COMPLETED|Overall Study||10
1468556|NCT01951651|3594581|P1|COMPLETED|Overall Study||8
1468557|NCT01951651|3594580|P2|STARTED|Overall Study||12
1468558|NCT01951651|3594581|P1|STARTED|Overall Study||12
1468559|NCT01951586|3594595|P2|NOT COMPLETED|Overall Study||113
1468560|NCT01951586|3594596|P1|NOT COMPLETED|Overall Study||59
1468561|NCT01951586|3594595|P2|COMPLETED|Overall Study||35
1468562|NCT01951586|3594596|P1|COMPLETED|Overall Study||19
1468563|NCT01951586|3594595|P2|Received Study Drug|Overall Study||145
1468564|NCT01951586|3594596|P1|Received Study Drug|Overall Study||76
1468565|NCT01951586|3594595|P2|STARTED|Overall Study||148
1468566|NCT01951586|3594596|P1|STARTED|Overall Study||78
1468567|NCT01951573|3594620|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
1468568|NCT01951573|3594621|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
1468569|NCT01951573|3594620|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
1468570|NCT01951573|3594621|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
1468571|NCT01951573|3594620|P2|STARTED|Period 2, Second 9 Hours of Wear||16
1468572|NCT01951573|3594621|P1|STARTED|Period 2, Second 9 Hours of Wear||17
1468573|NCT01951573|3594620|P2|NOT COMPLETED|Washout Period||1
1468574|NCT01951573|3594621|P1|NOT COMPLETED|Washout Period||0
1468575|NCT01951573|3594620|P2|COMPLETED|Washout Period||16
1468576|NCT01951573|3594621|P1|COMPLETED|Washout Period||17
1468577|NCT01951573|3594620|P2|STARTED|Washout Period||17
1468578|NCT01951573|3594621|P1|STARTED|Washout Period||17
1468579|NCT01951573|3594620|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
1468580|NCT01951573|3594621|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
1468581|NCT01951573|3594620|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
1468582|NCT01951573|3594621|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
1468583|NCT01951573|3594620|P2|STARTED|Period 1, First 9 Hours of Wear||17
1468584|NCT01951573|3594621|P1|STARTED|Period 1, First 9 Hours of Wear||17
1468585|NCT01951417|3594631|P1|NOT COMPLETED|Overall Study||9
1468586|NCT01951417|3594631|P1|COMPLETED|Overall Study||72
1468587|NCT01951417|3594631|P1|STARTED|Overall Study||81
1468588|NCT01951170|3594654|P1|NOT COMPLETED|Overall Study||1
1468589|NCT01951170|3594654|P1|COMPLETED|Overall Study||51
1468590|NCT01951170|3594654|P1|STARTED|Overall Study||52
1468591|NCT01951092|3594677|P1|NOT COMPLETED|Overall Study||12
1468592|NCT01951092|3594677|P1|COMPLETED|Overall Study||20
1468593|NCT01951092|3594677|P1|STARTED|Overall Study||32
1468594|NCT01951066|3594682|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
1468595|NCT01951066|3594683|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
1468596|NCT01951066|3594682|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
1468597|NCT01951066|3594683|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
1468598|NCT01951066|3594682|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
1468599|NCT01951066|3594683|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
1468600|NCT01951066|3594682|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
1468601|NCT01951066|3594683|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
1468602|NCT01951066|3594682|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
1468603|NCT01951066|3594683|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
1468604|NCT01951066|3594682|P2|STARTED|First Intervention (Baseline to Week 16)||10
1468605|NCT01951066|3594683|P1|STARTED|First Intervention (Baseline to Week 16)||10
1468606|NCT01950741|3594688|P1|NOT COMPLETED|Overall Study||3
1468607|NCT01950741|3594688|P1|COMPLETED|Overall Study||45
1468608|NCT01950741|3594688|P1|STARTED|Overall Study||48
1468609|NCT01950663|3594697|P1|NOT COMPLETED|Overall Study||1
1468610|NCT01950663|3594697|P1|COMPLETED|Overall Study||467
1468611|NCT01950663|3594697|P1|STARTED|Overall Study||468
1468612|NCT01950364|3594703|P2|NOT COMPLETED|Overall Study||10
1468613|NCT01950364|3594704|P1|NOT COMPLETED|Overall Study||10
1468614|NCT01950364|3594703|P2|COMPLETED|Overall Study||0
1468615|NCT01950364|3594704|P1|COMPLETED|Overall Study||0
1468616|NCT01950364|3594703|P2|STARTED|Overall Study||10
1468617|NCT01950364|3594704|P1|STARTED|Overall Study||10
1468618|NCT01950273|3594804|P2|NOT COMPLETED|Overall Study||0
1468619|NCT01950273|3594805|P1|NOT COMPLETED|Overall Study||4
1468620|NCT01950273|3594804|P2|COMPLETED|Overall Study||46
1468621|NCT01950273|3594805|P1|COMPLETED|Overall Study||45
1468622|NCT01950273|3594804|P2|STARTED|Overall Study||46
1468623|NCT01950273|3594805|P1|STARTED|Overall Study||49
1468624|NCT01950078|3594827|P2|NOT COMPLETED|Overall Study||12
1468625|NCT01950078|3594828|P1|NOT COMPLETED|Overall Study||20
1468626|NCT01950078|3594827|P2|COMPLETED|Overall Study||496
1468627|NCT01950078|3594828|P1|COMPLETED|Overall Study||1005
1468628|NCT01950078|3594827|P2|STARTED|Overall Study||508
1468629|NCT01950078|3594828|P1|STARTED|Overall Study||1025
1468630|NCT01949870|3594836|P1|NOT COMPLETED|Overall Study||6
1468631|NCT01949870|3594836|P1|COMPLETED|Overall Study||0
1468632|NCT01949870|3594836|P1|Received Treatment|Overall Study||4
1468633|NCT01949870|3594836|P1|STARTED|Overall Study||6
1468634|NCT01949844|3594840|P1|NOT COMPLETED|Overall Study||0
1468635|NCT01949844|3594840|P1|COMPLETED|Overall Study||44
1468636|NCT01949844|3594840|P1|STARTED|Overall Study||44
1468637|NCT01949545|3594848|P4|NOT COMPLETED|Overall Study||0
1468638|NCT01949545|3594849|P3|NOT COMPLETED|Overall Study||0
1468639|NCT01949545|3594850|P2|NOT COMPLETED|Overall Study||0
1468640|NCT01949545|3594851|P1|NOT COMPLETED|Overall Study||0
1468641|NCT01949545|3594848|P4|COMPLETED|Overall Study||4
1468642|NCT01949545|3594849|P3|COMPLETED|Overall Study||14
1468643|NCT01949545|3594850|P2|COMPLETED|Overall Study||17
1468644|NCT01949545|3594851|P1|COMPLETED|Overall Study||11
1468645|NCT01949545|3594848|P4|STARTED|Overall Study||4
1468646|NCT01949545|3594849|P3|STARTED|Overall Study||14
1468647|NCT01949545|3594850|P2|STARTED|Overall Study||17
1468648|NCT01949545|3594851|P1|STARTED|Overall Study||11
1468649|NCT01949532|3594999|P2|NOT COMPLETED|Overall Study||3
1468650|NCT01949532|3595000|P1|NOT COMPLETED|Overall Study||3
1468651|NCT01949532|3594999|P2|COMPLETED|Overall Study||8
1468652|NCT01949532|3595000|P1|COMPLETED|Overall Study||12
1468653|NCT01949532|3594999|P2|STARTED|Overall Study||11
1468654|NCT01949532|3595000|P1|STARTED|Overall Study||15
1468655|NCT01949389|3595068|P1|NOT COMPLETED|Overall Study||0
1468656|NCT01949389|3595068|P1|COMPLETED|Overall Study||51
1468657|NCT01949389|3595068|P1|STARTED|Overall Study||51
1468658|NCT01949155|3595075|P2|NOT COMPLETED|Overall Study||0
1468659|NCT01949155|3595076|P1|NOT COMPLETED|Overall Study||2
1468660|NCT01949155|3595075|P2|COMPLETED|Overall Study||88
1468661|NCT01949155|3595076|P1|COMPLETED|Overall Study||176
1468662|NCT01949155|3595075|P2|STARTED|Overall Study||88
1468663|NCT01949155|3595076|P1|STARTED|Overall Study||178
1468664|NCT01949142|3595088|P2|NOT COMPLETED|Overall Study||1
1468665|NCT01949142|3595089|P1|NOT COMPLETED|Overall Study||3
1468666|NCT01949142|3595088|P2|COMPLETED|Overall Study||86
1468667|NCT01949142|3595089|P1|COMPLETED|Overall Study||176
1468668|NCT01949142|3595088|P2|STARTED|Overall Study||87
1468669|NCT01949142|3595089|P1|STARTED|Overall Study||179
1468670|NCT01949116|3595101|P2|NOT COMPLETED|Overall Study||6
1468671|NCT01949116|3595102|P1|NOT COMPLETED|Overall Study||8
1468672|NCT01949116|3595101|P2|COMPLETED|Overall Study||84
1468673|NCT01949116|3595102|P1|COMPLETED|Overall Study||78
1468674|NCT01949116|3595101|P2|STARTED|Overall Study||90
1468675|NCT01949116|3595102|P1|STARTED|Overall Study||86
1468676|NCT01949090|3595139|P5|NOT COMPLETED|Overall Study||4
1468677|NCT01949090|3595140|P4|NOT COMPLETED|Overall Study||1
1468678|NCT01949090|3595141|P3|NOT COMPLETED|Overall Study||2
1468679|NCT01949090|3595142|P2|NOT COMPLETED|Overall Study||2
1468680|NCT01949090|3595143|P1|NOT COMPLETED|Overall Study||4
1468681|NCT01949090|3595139|P5|COMPLETED|Overall Study||116
1468682|NCT01949090|3595140|P4|COMPLETED|Overall Study||59
1468683|NCT01949090|3595141|P3|COMPLETED|Overall Study||58
1468684|NCT01949090|3595142|P2|COMPLETED|Overall Study||58
1468685|NCT01949090|3595143|P1|COMPLETED|Overall Study||56
1468686|NCT01949090|3595139|P5|STARTED|Overall Study||120
1468687|NCT01949090|3595140|P4|STARTED|Overall Study||60
1468688|NCT01949090|3595141|P3|STARTED|Overall Study||60
1468689|NCT01949090|3595142|P2|STARTED|Overall Study||60
1468690|NCT01949090|3595143|P1|STARTED|Overall Study||60
1468691|NCT01949051|3595320|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1468692|NCT01949051|3595321|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1468693|NCT01949051|3595322|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1468694|NCT01949051|3595323|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1468695|NCT01949051|3595324|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1468696|NCT01949051|3595325|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1468697|NCT01949051|3595320|P6|COMPLETED|Treatment Period 3 (7 Days)||12
1468698|NCT01949051|3595321|P5|COMPLETED|Treatment Period 3 (7 Days)||13
1468699|NCT01949051|3595322|P4|COMPLETED|Treatment Period 3 (7 Days)||12
1468700|NCT01949051|3595323|P3|COMPLETED|Treatment Period 3 (7 Days)||12
1468701|NCT01949051|3595324|P2|COMPLETED|Treatment Period 3 (7 Days)||12
1468702|NCT01949051|3595325|P1|COMPLETED|Treatment Period 3 (7 Days)||11
1468703|NCT01949051|3595320|P6|STARTED|Treatment Period 3 (7 Days)||12
1468704|NCT01949051|3595321|P5|STARTED|Treatment Period 3 (7 Days)||13
1468705|NCT01949051|3595322|P4|STARTED|Treatment Period 3 (7 Days)||12
1468706|NCT01949051|3595323|P3|STARTED|Treatment Period 3 (7 Days)||12
1468707|NCT01949051|3595324|P2|STARTED|Treatment Period 3 (7 Days)||12
1468708|NCT01949051|3595325|P1|STARTED|Treatment Period 3 (7 Days)||11
1468709|NCT01949051|3595320|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1468710|NCT01949051|3595321|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1468711|NCT01949051|3595322|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1468712|NCT01949051|3595323|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1468713|NCT01949051|3595324|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1468714|NCT01949051|3595325|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
1468715|NCT01949051|3595320|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
1468716|NCT01949051|3595321|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
1468717|NCT01949051|3595322|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
1468718|NCT01949051|3595323|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
1468719|NCT01949051|3595324|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
1468720|NCT01949051|3595325|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
1468721|NCT01949051|3595320|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
1468722|NCT01949051|3595321|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
1468723|NCT01949051|3595322|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
1468724|NCT01949051|3595323|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
1468725|NCT01949051|3595324|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
1468726|NCT01949051|3595325|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
1468727|NCT01949051|3595320|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
1468728|NCT01949051|3595321|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1468729|NCT01949051|3595322|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1468730|NCT01949051|3595323|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
1468731|NCT01949051|3595324|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
1468732|NCT01949051|3595325|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1468733|NCT01949051|3595320|P6|COMPLETED|Treatment Period 2 (7 Days)||12
1468734|NCT01949051|3595321|P5|COMPLETED|Treatment Period 2 (7 Days)||13
1468735|NCT01949051|3595322|P4|COMPLETED|Treatment Period 2 (7 Days)||12
1468736|NCT01949051|3595323|P3|COMPLETED|Treatment Period 2 (7 Days)||12
1468737|NCT01949051|3595324|P2|COMPLETED|Treatment Period 2 (7 Days)||12
1468738|NCT01949051|3595325|P1|COMPLETED|Treatment Period 2 (7 Days)||11
1468739|NCT01949051|3595320|P6|STARTED|Treatment Period 2 (7 Days)||13
1468740|NCT01949051|3595321|P5|STARTED|Treatment Period 2 (7 Days)||13
1468741|NCT01949051|3595322|P4|STARTED|Treatment Period 2 (7 Days)||12
1468742|NCT01949051|3595323|P3|STARTED|Treatment Period 2 (7 Days)||13
1468743|NCT01949051|3595324|P2|STARTED|Treatment Period 2 (7 Days)||13
1468744|NCT01949051|3595325|P1|STARTED|Treatment Period 2 (7 Days)||11
1468745|NCT01949051|3595320|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1468746|NCT01949051|3595321|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1468747|NCT01949051|3595322|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1468748|NCT01949051|3595323|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1468749|NCT01949051|3595324|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1468750|NCT01949051|3595325|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
1468751|NCT01949051|3595320|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
1468752|NCT01949051|3595321|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
1468753|NCT01949051|3595322|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
1468754|NCT01949051|3595323|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
1468755|NCT01949051|3595324|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
1468756|NCT01949051|3595325|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
1468757|NCT01949051|3595320|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
1468758|NCT01949051|3595321|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
1468759|NCT01949051|3595322|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
1468760|NCT01949051|3595323|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
1468761|NCT01949051|3595324|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
1468762|NCT01949051|3595325|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
1468763|NCT01949051|3595320|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1468764|NCT01949051|3595321|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1468765|NCT01949051|3595322|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
1468766|NCT01949051|3595323|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1468767|NCT01949051|3595324|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1468768|NCT01949051|3595325|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
1468769|NCT01949051|3595320|P6|COMPLETED|Treatment Period 1 (7 Days)||13
1468770|NCT01949051|3595321|P5|COMPLETED|Treatment Period 1 (7 Days)||13
1468771|NCT01949051|3595322|P4|COMPLETED|Treatment Period 1 (7 Days)||12
1468772|NCT01949051|3595323|P3|COMPLETED|Treatment Period 1 (7 Days)||13
1468773|NCT01949051|3595324|P2|COMPLETED|Treatment Period 1 (7 Days)||13
1468774|NCT01949051|3595325|P1|COMPLETED|Treatment Period 1 (7 Days)||11
1468775|NCT01949051|3595320|P6|STARTED|Treatment Period 1 (7 Days)||13
1468776|NCT01949051|3595321|P5|STARTED|Treatment Period 1 (7 Days)||13
1468777|NCT01949051|3595322|P4|STARTED|Treatment Period 1 (7 Days)||13
1468778|NCT01949051|3595323|P3|STARTED|Treatment Period 1 (7 Days)||13
1468779|NCT01949051|3595324|P2|STARTED|Treatment Period 1 (7 Days)||13
1468780|NCT01949051|3595325|P1|STARTED|Treatment Period 1 (7 Days)||13
1468781|NCT01948947|3595338|P2|NOT COMPLETED|Overall Study||0
1468782|NCT01948947|3595339|P1|NOT COMPLETED|Overall Study||0
1468783|NCT01948947|3595338|P2|COMPLETED|Overall Study||15
1468784|NCT01948947|3595339|P1|COMPLETED|Overall Study||14
1468785|NCT01948947|3595338|P2|STARTED|Overall Study||15
1468786|NCT01948947|3595339|P1|STARTED|Overall Study||14
1468787|NCT01948908|3595354|P3|NOT COMPLETED|Overall Study||2
1468788|NCT01948908|3595355|P2|NOT COMPLETED|Overall Study||0
1468789|NCT01948908|3595356|P1|NOT COMPLETED|Overall Study||1
1468790|NCT01948908|3595354|P3|COMPLETED|Overall Study||31
1468791|NCT01948908|3595355|P2|COMPLETED|Overall Study||33
1468792|NCT01948908|3595356|P1|COMPLETED|Overall Study||32
1468793|NCT01948908|3595354|P3|STARTED|Overall Study||33
1468794|NCT01948908|3595355|P2|STARTED|Overall Study||33
1468795|NCT01948908|3595356|P1|STARTED|Overall Study||33
1468796|NCT01948830|3595372|P2|NOT COMPLETED|Overall Study||32
1468797|NCT01948830|3595373|P1|NOT COMPLETED|Overall Study||33
1468798|NCT01948830|3595372|P2|COMPLETED|Overall Study||295
1468799|NCT01948830|3595373|P1|COMPLETED|Overall Study||290
1468800|NCT01948830|3595372|P2|Safety Set|Overall Study||326
1468801|NCT01948830|3595373|P1|Safety Set|Overall Study||323
1468802|NCT01948830|3595372|P2|STARTED|Overall Study||327
1468803|NCT01948830|3595373|P1|STARTED|Overall Study||323
1468804|NCT01948791|3595405|P1|NOT COMPLETED|Overall Study||71
1468805|NCT01948791|3595405|P1|COMPLETED|Overall Study||151
1468806|NCT01948791|3595405|P1|STARTED|Overall Study||222
1468807|NCT01948518|3595413|P1|NOT COMPLETED|Overall Study||0
1468808|NCT01948518|3595413|P1|COMPLETED|Overall Study||15
1468809|NCT01948518|3595413|P1|STARTED|Overall Study||15
1468810|NCT01948375|3595420|P2|NOT COMPLETED|Overall Study||0
1468811|NCT01948375|3595421|P1|NOT COMPLETED|Overall Study||0
1468812|NCT01948375|3595420|P2|COMPLETED|Overall Study||30
1468813|NCT01948375|3595421|P1|COMPLETED|Overall Study||30
1468814|NCT01948375|3595420|P2|STARTED|Overall Study||30
1468815|NCT01948375|3595421|P1|STARTED|Overall Study||30
1468816|NCT01948310|3595437|P2|NOT COMPLETED|Overall Study||5
1468817|NCT01948310|3595438|P1|NOT COMPLETED|Overall Study||3
1468818|NCT01948310|3595437|P2|COMPLETED|Overall Study||13
1468819|NCT01948310|3595438|P1|COMPLETED|Overall Study||16
1468820|NCT01948310|3595437|P2|STARTED|Overall Study||18
1468821|NCT01948310|3595438|P1|STARTED|Overall Study||19
1468822|NCT01948258|3595448|P1|NOT COMPLETED|Overall Study||162
1468823|NCT01948258|3595448|P1|COMPLETED|Overall Study||233
1468824|NCT01948258|3595448|P1|STARTED|Overall Study||395
1468825|NCT01948193|3595454|P1|NOT COMPLETED|Overall Study||9
1468826|NCT01948193|3595454|P1|COMPLETED|Overall Study||168
1468827|NCT01948193|3595454|P1|STARTED|Overall Study||177
1468828|NCT01948141|3595463|P1|NOT COMPLETED|Overall Study||0
1468829|NCT01948141|3595463|P1|COMPLETED|Overall Study||6
1468830|NCT01948141|3595463|P1|STARTED|Overall Study||6
1468831|NCT01948076|3595476|P2|NOT COMPLETED|Overall Study||1
1468832|NCT01948076|3595477|P1|NOT COMPLETED|Overall Study||0
1468833|NCT01948076|3595476|P2|COMPLETED|Overall Study||19
1468834|NCT01948076|3595477|P1|COMPLETED|Overall Study||20
1468835|NCT01948076|3595476|P2|STARTED|Overall Study||20
1468836|NCT01948076|3595477|P1|STARTED|Overall Study||20
1468837|NCT01948063|3595487|P2|NOT COMPLETED|Overall Study||2
1468838|NCT01948063|3595488|P1|NOT COMPLETED|Overall Study||1
1468839|NCT01948063|3595487|P2|COMPLETED|Overall Study||19
1468840|NCT01948063|3595488|P1|COMPLETED|Overall Study||19
1468841|NCT01948063|3595487|P2|STARTED|Overall Study||21
1468842|NCT01948063|3595488|P1|STARTED|Overall Study||20
1468843|NCT01948050|3595496|P2|NOT COMPLETED|Overall Study||1
1468844|NCT01948050|3595497|P1|NOT COMPLETED|Overall Study||0
1468845|NCT01948050|3595496|P2|COMPLETED|Overall Study||7
1468846|NCT01948050|3595497|P1|COMPLETED|Overall Study||16
1468847|NCT01948050|3595496|P2|STARTED|Overall Study||8
1468848|NCT01948050|3595497|P1|STARTED|Overall Study||16
1468849|NCT01947946|3595506|P3|NOT COMPLETED|Overall Study||5
1468850|NCT01947946|3595507|P2|NOT COMPLETED|Overall Study||5
1468851|NCT01947946|3595508|P1|NOT COMPLETED|Overall Study||3
1468852|NCT01947946|3595506|P3|COMPLETED|Overall Study||0
1468853|NCT01947946|3595507|P2|COMPLETED|Overall Study||0
1468854|NCT01947946|3595508|P1|COMPLETED|Overall Study|Study Stopped|0
1468855|NCT01947946|3595506|P3|STARTED|Overall Study||5
1468856|NCT01947946|3595507|P2|STARTED|Overall Study||5
1468857|NCT01947946|3595508|P1|STARTED|Overall Study||3
1468858|NCT01947907|3595520|P4|NOT COMPLETED|Overall Study||0
1468859|NCT01947907|3595521|P3|NOT COMPLETED|Overall Study||0
1468860|NCT01947907|3595522|P2|NOT COMPLETED|Overall Study||0
1468861|NCT01947907|3595523|P1|NOT COMPLETED|Overall Study||0
1468862|NCT01947907|3595520|P4|COMPLETED|Overall Study||13
1468863|NCT01947907|3595521|P3|COMPLETED|Overall Study||14
1468864|NCT01947907|3595522|P2|COMPLETED|Overall Study||14
1468865|NCT01947907|3595523|P1|COMPLETED|Overall Study||12
1468866|NCT01947907|3595520|P4|STARTED|Overall Study||13
1468867|NCT01947907|3595521|P3|STARTED|Overall Study||14
1468868|NCT01947907|3595522|P2|STARTED|Overall Study||14
1468869|NCT01947907|3595523|P1|STARTED|Overall Study||12
1468870|NCT01947855|3595565|P3|NOT COMPLETED|Overall Study||0
1468871|NCT01947855|3595566|P2|NOT COMPLETED|Overall Study||0
1468872|NCT01947855|3595567|P1|NOT COMPLETED|Overall Study||1
1468873|NCT01947855|3595565|P3|COMPLETED|Overall Study||19
1468874|NCT01947855|3595566|P2|COMPLETED|Overall Study||20
1468875|NCT01947855|3595567|P1|COMPLETED|Overall Study||20
1468876|NCT01947855|3595565|P3|STARTED|Overall Study||19
1468877|NCT01947855|3595566|P2|STARTED|Overall Study||20
1468878|NCT01947855|3595567|P1|STARTED|Overall Study||21
1468879|NCT01947582|3595575|P1|NOT COMPLETED|Overall Study||1
1468880|NCT01947582|3595575|P1|COMPLETED|Overall Study||1
1468881|NCT01947582|3595575|P1|STARTED|Overall Study||2
1468882|NCT01947517|3595584|P2|NOT COMPLETED|Overall Study||1
1468883|NCT01947517|3595585|P1|NOT COMPLETED|Overall Study||1
1468884|NCT01947517|3595584|P2|COMPLETED|Overall Study||25
1468885|NCT01947517|3595585|P1|COMPLETED|Overall Study||25
1468886|NCT01947517|3595584|P2|STARTED|Overall Study||26
1468887|NCT01947517|3595585|P1|STARTED|Overall Study||26
1468888|NCT01947491|3595603|P4|NOT COMPLETED|Overall Study||5
1468889|NCT01947491|3595604|P3|NOT COMPLETED|Overall Study||2
1468890|NCT01947491|3595605|P2|NOT COMPLETED|Overall Study||6
1468891|NCT01947491|3595606|P1|NOT COMPLETED|Overall Study||8
1468892|NCT01947491|3595603|P4|COMPLETED|Overall Study||38
1468893|NCT01947491|3595604|P3|COMPLETED|Overall Study||88
1468894|NCT01947491|3595605|P2|COMPLETED|Overall Study||81
1468895|NCT01947491|3595606|P1|COMPLETED|Overall Study||166
1468896|NCT01947491|3595603|P4|STARTED|Overall Study||43
1468897|NCT01947491|3595604|P3|STARTED|Overall Study||90
1468898|NCT01947491|3595605|P2|STARTED|Overall Study||87
1468899|NCT01947491|3595606|P1|STARTED|Overall Study||174
1468900|NCT01947335|3595618|P2|NOT COMPLETED|Overall Study||0
1468901|NCT01947335|3595619|P1|NOT COMPLETED|Overall Study||0
1468902|NCT01947335|3595618|P2|COMPLETED|Overall Study||41
1468903|NCT01947335|3595619|P1|COMPLETED|Overall Study||42
1468904|NCT01947335|3595618|P2|STARTED|Overall Study||41
1468905|NCT01947335|3595619|P1|STARTED|Overall Study||42
1468906|NCT01947153|3595629|P2|NOT COMPLETED|Test Period 2||0
1468907|NCT01947153|3595630|P1|NOT COMPLETED|Test Period 2||0
1468908|NCT01947153|3595629|P2|COMPLETED|Test Period 2||18
1468909|NCT01947153|3595630|P1|COMPLETED|Test Period 2||18
1468910|NCT01947153|3595629|P2|STARTED|Test Period 2||18
1468911|NCT01947153|3595630|P1|STARTED|Test Period 2||18
1468912|NCT01947153|3595629|P2|NOT COMPLETED|Test Period 1||0
1468913|NCT01947153|3595630|P1|NOT COMPLETED|Test Period 1||0
1468914|NCT01947153|3595629|P2|COMPLETED|Test Period 1||18
1468915|NCT01947153|3595630|P1|COMPLETED|Test Period 1||18
1468916|NCT01947153|3595629|P2|STARTED|Test Period 1||18
1468917|NCT01947153|3595630|P1|STARTED|Test Period 1||18
1468918|NCT01947127|3595650|P2|NOT COMPLETED|Overall Study||43
1468919|NCT01947127|3595651|P1|NOT COMPLETED|Overall Study||23
1468920|NCT01947127|3595650|P2|COMPLETED|Overall Study||249
1468921|NCT01947127|3595651|P1|COMPLETED|Overall Study||143
1468922|NCT01947127|3595650|P2|STARTED|Overall Study||292
1468923|NCT01947127|3595651|P1|STARTED|Overall Study||166
1468924|NCT01946542|3595663|P2|NOT COMPLETED|Testing Visit 2||0
1468925|NCT01946542|3595664|P1|NOT COMPLETED|Testing Visit 2||0
1468926|NCT01946542|3595663|P2|COMPLETED|Testing Visit 2||1
1468927|NCT01946542|3595664|P1|COMPLETED|Testing Visit 2||1
1468928|NCT01946542|3595663|P2|STARTED|Testing Visit 2||1
1468929|NCT01946542|3595664|P1|STARTED|Testing Visit 2||1
1468930|NCT01946542|3595663|P2|NOT COMPLETED|Testing Visit 1||0
1468931|NCT01946542|3595664|P1|NOT COMPLETED|Testing Visit 1||0
1468932|NCT01946542|3595663|P2|COMPLETED|Testing Visit 1||1
1468933|NCT01946542|3595664|P1|COMPLETED|Testing Visit 1||1
1468934|NCT01946542|3595663|P2|STARTED|Testing Visit 1||1
1468935|NCT01946542|3595664|P1|STARTED|Testing Visit 1||1
1468936|NCT01946529|3595675|P3|NOT COMPLETED|Completion of All Therapy||6
1468937|NCT01946529|3595676|P2|NOT COMPLETED|Completion of All Therapy||16
1468938|NCT01946529|3595677|P1|NOT COMPLETED|Completion of All Therapy||1
1468939|NCT01946529|3595675|P3|COMPLETED|Completion of All Therapy||0
1468940|NCT01946529|3595676|P2|COMPLETED|Completion of All Therapy||0
1468941|NCT01946529|3595677|P1|COMPLETED|Completion of All Therapy||0
1468942|NCT01946529|3595675|P3|STARTED|Completion of All Therapy||6
1468943|NCT01946529|3595676|P2|STARTED|Completion of All Therapy||16
1468944|NCT01946529|3595677|P1|STARTED|Completion of All Therapy||1
1468945|NCT01946529|3595675|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
1468946|NCT01946529|3595676|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
1468947|NCT01946529|3595677|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
1468948|NCT01946529|3595675|P3|COMPLETED|End of Window Therapy (2 Courses)||6
1468949|NCT01946529|3595676|P2|COMPLETED|End of Window Therapy (2 Courses)||16
1468950|NCT01946529|3595677|P1|COMPLETED|End of Window Therapy (2 Courses)||1
1468951|NCT01946529|3595675|P3|STARTED|End of Window Therapy (2 Courses)||6
1468952|NCT01946529|3595676|P2|STARTED|End of Window Therapy (2 Courses)||17
1468953|NCT01946529|3595677|P1|STARTED|End of Window Therapy (2 Courses)||1
1468954|NCT01946438|3595688|P4|NOT COMPLETED|Overall Study||1
1468955|NCT01946438|3595689|P3|NOT COMPLETED|Overall Study||1
1468956|NCT01946438|3595690|P2|NOT COMPLETED|Overall Study||0
1468957|NCT01946438|3595691|P1|NOT COMPLETED|Overall Study||2
1468958|NCT01946438|3595688|P4|COMPLETED|Overall Study||51
1468959|NCT01946438|3595689|P3|COMPLETED|Overall Study||51
1468960|NCT01946438|3595690|P2|COMPLETED|Overall Study||52
1468961|NCT01946438|3595691|P1|COMPLETED|Overall Study||50
1468962|NCT01946438|3595688|P4|STARTED|Overall Study||52
1468963|NCT01946438|3595689|P3|STARTED|Overall Study||52
1468964|NCT01946438|3595690|P2|STARTED|Overall Study||52
1468965|NCT01946438|3595691|P1|STARTED|Overall Study||52
1468966|NCT01946425|3595719|P2|NOT COMPLETED|Overall Study||0
1468967|NCT01946425|3595720|P1|NOT COMPLETED|Overall Study||2
1468968|NCT01946425|3595719|P2|COMPLETED|Overall Study||30
1468969|NCT01946425|3595720|P1|COMPLETED|Overall Study||28
1468970|NCT01946425|3595719|P2|STARTED|Overall Study||30
1468971|NCT01946425|3595720|P1|STARTED|Overall Study||30
1468972|NCT01946412|3595734|P1|NOT COMPLETED|Overall Study||5
1468973|NCT01946412|3595734|P1|COMPLETED|Overall Study||28
1468974|NCT01946412|3595734|P1|STARTED|Overall Study||33
1468975|NCT01946243|3595756|P1|NOT COMPLETED|Overall Study||0
1468976|NCT01946243|3595756|P1|COMPLETED|Overall Study||96
1468977|NCT01946243|3595756|P1|STARTED|Overall Study||96
1468978|NCT01946204|3595779|P2|NOT COMPLETED|Overall Study||806
1468979|NCT01946204|3595780|P1|NOT COMPLETED|Overall Study||401
1468980|NCT01946204|3595779|P2|COMPLETED|Overall Study||0
1468981|NCT01946204|3595780|P1|COMPLETED|Overall Study||0
1468982|NCT01946204|3595779|P2|Treated|Overall Study||803
1468983|NCT01946204|3595780|P1|Treated|Overall Study||398
1468984|NCT01946204|3595779|P2|STARTED|Overall Study||806
1468985|NCT01946204|3595780|P1|STARTED|Overall Study||401
1468986|NCT01946178|3595796|P1|NOT COMPLETED|Overall Study||2
1468987|NCT01946178|3595796|P1|COMPLETED|Overall Study||71
1468988|NCT01946178|3595796|P1|STARTED|Overall Study||73
1468989|NCT01946126|3595806|P2|NOT COMPLETED|Overall Study||0
1468990|NCT01946126|3595807|P1|NOT COMPLETED|Overall Study||0
1468991|NCT01946126|3595806|P2|COMPLETED|Overall Study||275
1468992|NCT01946126|3595807|P1|COMPLETED|Overall Study||184
1468993|NCT01946126|3595806|P2|STARTED|Overall Study||275
1468994|NCT01946126|3595807|P1|STARTED|Overall Study||184
1468995|NCT01945996|3595823|P2|NOT COMPLETED|Overall Study||5
1468996|NCT01945996|3595824|P1|NOT COMPLETED|Overall Study||3
1468997|NCT01945996|3595823|P2|COMPLETED|Overall Study||17
1468998|NCT01945996|3595824|P1|COMPLETED|Overall Study||19
1468999|NCT01945996|3595823|P2|STARTED|Overall Study||22
1469000|NCT01945996|3595824|P1|STARTED|Overall Study||22
1469001|NCT01945970|3595856|P6|NOT COMPLETED|Overall Study||0
1469002|NCT01945970|3595857|P5|NOT COMPLETED|Overall Study||0
1469003|NCT01945970|3595858|P4|NOT COMPLETED|Overall Study||0
1469004|NCT01945970|3595859|P3|NOT COMPLETED|Overall Study||0
1469005|NCT01945970|3595860|P2|NOT COMPLETED|Overall Study||0
1469006|NCT01945970|3595861|P1|NOT COMPLETED|Overall Study||0
1469007|NCT01945970|3595856|P6|COMPLETED|Overall Study||5
1469008|NCT01945970|3595857|P5|COMPLETED|Overall Study||5
1469009|NCT01945970|3595858|P4|COMPLETED|Overall Study||5
1469010|NCT01945970|3595859|P3|COMPLETED|Overall Study||5
1469011|NCT01945970|3595860|P2|COMPLETED|Overall Study||5
1469012|NCT01945970|3595861|P1|COMPLETED|Overall Study||5
1469013|NCT01945970|3595856|P6|STARTED|Overall Study||5
1469014|NCT01945970|3595857|P5|STARTED|Overall Study||5
1469015|NCT01945970|3595858|P4|STARTED|Overall Study||5
1469016|NCT01945970|3595859|P3|STARTED|Overall Study||5
1469017|NCT01945970|3595860|P2|STARTED|Overall Study||5
1469018|NCT01945970|3595861|P1|STARTED|Overall Study||5
1469019|NCT01945944|3595900|P2|NOT COMPLETED|Overall Study||3
1469020|NCT01945944|3595901|P1|NOT COMPLETED|Overall Study||1
1469021|NCT01945944|3595900|P2|COMPLETED|Overall Study||6
1469022|NCT01945944|3595901|P1|COMPLETED|Overall Study||8
1469023|NCT01945944|3595900|P2|STARTED|Overall Study||9
1469024|NCT01945944|3595901|P1|STARTED|Overall Study||9
1469025|NCT01945866|3595925|P2|NOT COMPLETED|Overall Study||0
1469026|NCT01945866|3595926|P1|NOT COMPLETED|Overall Study||2
1469027|NCT01945866|3595925|P2|COMPLETED|Overall Study||64
1469028|NCT01945866|3595926|P1|COMPLETED|Overall Study||63
1469029|NCT01945866|3595925|P2|STARTED|Overall Study||64
1469030|NCT01945866|3595926|P1|STARTED|Overall Study||65
1469031|NCT01945775|3595947|P2|NOT COMPLETED|Overall Study||144
1469032|NCT01945775|3595948|P1|NOT COMPLETED|Overall Study||287
1469033|NCT01945775|3595947|P2|COMPLETED|Overall Study||0
1469034|NCT01945775|3595948|P1|COMPLETED|Overall Study||0
1469035|NCT01945775|3595947|P2|Treated|Overall Study||126
1469036|NCT01945775|3595948|P1|Treated|Overall Study||286
1469037|NCT01945775|3595947|P2|STARTED|Overall Study||144
1469038|NCT01945775|3595948|P1|STARTED|Overall Study||287
1469039|NCT01945489|3595979|P2|NOT COMPLETED|Cycle 2||1
1469040|NCT01945489|3595980|P1|NOT COMPLETED|Cycle 2||1
1469041|NCT01945489|3595979|P2|COMPLETED|Cycle 2||106
1469042|NCT01945489|3595980|P1|COMPLETED|Cycle 2||87
1469043|NCT01945489|3595979|P2|STARTED|Cycle 2||107
1469044|NCT01945489|3595980|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
1469045|NCT01945489|3595979|P2|NOT COMPLETED|Cycle 1||4
1469046|NCT01945489|3595980|P1|NOT COMPLETED|Cycle 1||13
1469047|NCT01945489|3595979|P2|COMPLETED|Cycle 1||121
1469048|NCT01945489|3595980|P1|COMPLETED|Cycle 1||116
1469049|NCT01945489|3595979|P2|STARTED|Cycle 1||125
1469050|NCT01945489|3595980|P1|STARTED|Cycle 1||129
1469051|NCT01945294|3596000|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
1469052|NCT01945294|3596001|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
1469053|NCT01945294|3596002|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
1469054|NCT01945294|3596003|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
1469055|NCT01945294|3596000|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
1469056|NCT01945294|3596001|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
1469057|NCT01945294|3596002|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
1469058|NCT01945294|3596003|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
1469059|NCT01945294|3596000|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
1469060|NCT01945294|3596001|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
1469061|NCT01945294|3596002|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
1469062|NCT01945294|3596003|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
1469063|NCT01945294|3596000|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1469064|NCT01945294|3596001|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1469065|NCT01945294|3596002|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1469066|NCT01945294|3596003|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
1469067|NCT01945294|3596000|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1469068|NCT01945294|3596001|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1469069|NCT01945294|3596002|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
1469070|NCT01945294|3596003|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
1469071|NCT01945294|3596000|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
1469072|NCT01945294|3596001|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
1469073|NCT01945294|3596002|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
1469074|NCT01945294|3596003|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
1469075|NCT01945281|3596034|P2|NOT COMPLETED|Overall Study||4
1469076|NCT01945281|3596035|P1|NOT COMPLETED|Overall Study||6
1469077|NCT01945281|3596034|P2|COMPLETED|Overall Study||13
1469078|NCT01945281|3596035|P1|COMPLETED|Overall Study||28
1469079|NCT01945281|3596034|P2|Treated|Overall Study||16
1469080|NCT01945281|3596035|P1|Treated|Overall Study||33
1469081|NCT01945281|3596034|P2|STARTED|Overall Study||17
1469082|NCT01945281|3596035|P1|STARTED|Overall Study||34
1469083|NCT01945242|3596047|P2|NOT COMPLETED|Overall Study||3
1469084|NCT01945242|3596048|P1|NOT COMPLETED|Overall Study||3
1469085|NCT01945242|3596047|P2|COMPLETED|Overall Study||120
1469086|NCT01945242|3596048|P1|COMPLETED|Overall Study||1248
1469087|NCT01945242|3596047|P2|STARTED|Overall Study||123
1469088|NCT01945242|3596048|P1|STARTED|Overall Study||1251
1469089|NCT01945216|3596063|P1|NOT COMPLETED|Overall Study||94
1469090|NCT01945216|3596063|P1|COMPLETED|Overall Study||3223
1469091|NCT01945216|3596063|P1|STARTED|Overall Study||3317
1469092|NCT01945138|3596077|P2|NOT COMPLETED|Overall Study||0
1469093|NCT01945138|3596078|P1|NOT COMPLETED|Overall Study||0
1469094|NCT01945138|3596077|P2|COMPLETED|Overall Study||7
1469095|NCT01945138|3596078|P1|COMPLETED|Overall Study||7
1469096|NCT01945138|3596077|P2|STARTED|Overall Study||7
1469097|NCT01945138|3596078|P1|STARTED|Overall Study||7
1469098|NCT01945112|3596112|P2|NOT COMPLETED|Overall Study||0
1469099|NCT01945112|3596113|P1|NOT COMPLETED|Overall Study||0
1469100|NCT01945112|3596112|P2|COMPLETED|Overall Study||51
1469101|NCT01945112|3596113|P1|COMPLETED|Overall Study||77
1469102|NCT01945112|3596112|P2|STARTED|Overall Study|total number of sites where tape was applied|51
1469103|NCT01945112|3596113|P1|STARTED|Overall Study|total number of sites where tape was applied|77
1469104|NCT01945086|3596121|P3|NOT COMPLETED|Overall Study||2
1469105|NCT01945086|3596122|P2|NOT COMPLETED|Overall Study||0
1469106|NCT01945086|3596123|P1|NOT COMPLETED|Overall Study||1
1469107|NCT01945086|3596121|P3|COMPLETED|Overall Study||26
1469108|NCT01945086|3596122|P2|COMPLETED|Overall Study||24
1469109|NCT01945086|3596123|P1|COMPLETED|Overall Study||26
1469110|NCT01945086|3596121|P3|STARTED|Overall Study||28
1469111|NCT01945086|3596122|P2|STARTED|Overall Study||24
1469112|NCT01945086|3596123|P1|STARTED|Overall Study||27
1469113|NCT01945034|3596167|P3|NOT COMPLETED|Overall Study||7
1469114|NCT01945034|3596168|P2|NOT COMPLETED|Overall Study||5
1469115|NCT01945034|3596169|P1|NOT COMPLETED|Overall Study||1
1469116|NCT01945034|3596167|P3|COMPLETED|Overall Study||145
1469117|NCT01945034|3596168|P2|COMPLETED|Overall Study||80
1469118|NCT01945034|3596169|P1|COMPLETED|Overall Study||66
1469119|NCT01945034|3596167|P3|STARTED|Overall Study||152
1469120|NCT01945034|3596168|P2|STARTED|Overall Study||85
1469121|NCT01945034|3596169|P1|STARTED|Overall Study||67
1469122|NCT01945021|3596219|P1|NOT COMPLETED|Overall Study||47
1469123|NCT01945021|3596219|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
1469124|NCT01945021|3596219|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
1469125|NCT01945021|3596219|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
1469126|NCT01945021|3596219|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
1469127|NCT01945021|3596219|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
1469128|NCT01944969|3596233|P1|NOT COMPLETED|Overall Study||26
1469129|NCT01944969|3596233|P1|COMPLETED|Overall Study||0
1469130|NCT01944969|3596233|P1|STARTED|Overall Study||26
1469131|NCT01944878|3596246|P2|NOT COMPLETED|Overall Study||0
1469132|NCT01944878|3596247|P1|NOT COMPLETED|Overall Study||0
1469133|NCT01944878|3596246|P2|COMPLETED|Overall Study||328
1469134|NCT01944878|3596247|P1|COMPLETED|Overall Study||127
1469135|NCT01944878|3596246|P2|STARTED|Overall Study||328
1469136|NCT01944878|3596247|P1|STARTED|Overall Study||127
1469137|NCT01944839|3596257|P2|NOT COMPLETED|Overall Study||28
1469138|NCT01944839|3596258|P1|NOT COMPLETED|Overall Study||22
1469139|NCT01944839|3596257|P2|COMPLETED|Overall Study||282
1469140|NCT01944839|3596258|P1|COMPLETED|Overall Study||287
1469141|NCT01944839|3596257|P2|STARTED|Overall Study||310
1469142|NCT01944839|3596258|P1|STARTED|Overall Study||309
1469143|NCT01944774|3596267|P3|NOT COMPLETED|Overall Study||8
1469144|NCT01944774|3596268|P2|NOT COMPLETED|Overall Study||8
1469145|NCT01944774|3596269|P1|NOT COMPLETED|Overall Study||6
1469146|NCT01944774|3596267|P3|COMPLETED|Overall Study||62
1469147|NCT01944774|3596268|P2|COMPLETED|Overall Study||60
1469148|NCT01944774|3596269|P1|COMPLETED|Overall Study||63
1469149|NCT01944774|3596267|P3|Received Treatment|Overall Study||70
1469150|NCT01944774|3596268|P2|Received Treatment|Overall Study||67
1469151|NCT01944774|3596269|P1|Received Treatment|Overall Study||68
1469152|NCT01944774|3596267|P3|STARTED|Overall Study||70
1469153|NCT01944774|3596268|P2|STARTED|Overall Study||68
1469154|NCT01944774|3596269|P1|STARTED|Overall Study||69
1469155|NCT01944722|3596312|P1|NOT COMPLETED|Overall Study||9515
1469156|NCT01944722|3596312|P1|COMPLETED|Overall Study||24343
1469157|NCT01944722|3596312|P1|STARTED|Overall Study||33858
1469158|NCT01944670|3596346|P1|NOT COMPLETED|Overall Study||2
1469159|NCT01944670|3596346|P1|COMPLETED|Overall Study||24
1469160|NCT01944670|3596346|P1|STARTED|Overall Study||26
1469161|NCT01944644|3596353|P2|NOT COMPLETED|Overall Study||0
1469162|NCT01944644|3596354|P1|NOT COMPLETED|Overall Study||0
1469163|NCT01944644|3596353|P2|COMPLETED|Overall Study||32
1469164|NCT01944644|3596354|P1|COMPLETED|Overall Study||34
1469165|NCT01944644|3596353|P2|STARTED|Overall Study||32
1469166|NCT01944644|3596354|P1|STARTED|Overall Study||34
1469167|NCT01944631|3596368|P2|NOT COMPLETED|Overall Study||2
1469168|NCT01944631|3596369|P1|NOT COMPLETED|Overall Study||4
1469169|NCT01944631|3596368|P2|COMPLETED|Overall Study||98
1469170|NCT01944631|3596369|P1|COMPLETED|Overall Study||96
1469171|NCT01944631|3596368|P2|STARTED|Overall Study||100
1469172|NCT01944631|3596369|P1|STARTED|Overall Study||100
1469173|NCT01944462|3596385|P1|NOT COMPLETED|Optional Vaccination||0
1469174|NCT01944462|3596385|P1|COMPLETED|Optional Vaccination||20
1469175|NCT01944462|3596385|P1|STARTED|Optional Vaccination||20
1469176|NCT01944462|3596385|P1|NOT COMPLETED|PPPP Educational Program||60
1469177|NCT01944462|3596385|P1|COMPLETED|PPPP Educational Program||143
1469178|NCT01944462|3596385|P1|3 Month Follow-Up|PPPP Educational Program||143
1469179|NCT01944462|3596385|P1|Post-Test|PPPP Educational Program||187
1469180|NCT01944462|3596385|P1|Baseline|PPPP Educational Program||203
1469181|NCT01944462|3596385|P1|STARTED|PPPP Educational Program||203
1469182|NCT01944345|3596394|P1|NOT COMPLETED|Overall Study||0
1469183|NCT01944345|3596394|P1|COMPLETED|Overall Study||69
1469184|NCT01944345|3596394|P1|STARTED|Overall Study||69
1469185|NCT01944319|3596402|P2|NOT COMPLETED|Overall Study||0
1469186|NCT01944319|3596403|P1|NOT COMPLETED|Overall Study||0
1469187|NCT01944319|3596402|P2|COMPLETED|Overall Study||39
1469188|NCT01944319|3596403|P1|COMPLETED|Overall Study||40
1469189|NCT01944319|3596402|P2|STARTED|Overall Study||39
1469190|NCT01944319|3596403|P1|STARTED|Overall Study||40
1469191|NCT01944098|3596415|P2|NOT COMPLETED|Overall Study||0
1469192|NCT01944098|3596416|P1|NOT COMPLETED|Overall Study||1
1469193|NCT01944098|3596415|P2|COMPLETED|Overall Study||10
1469194|NCT01944098|3596416|P1|COMPLETED|Overall Study||9
1469195|NCT01944098|3596415|P2|STARTED|Overall Study||10
1469196|NCT01944098|3596416|P1|STARTED|Overall Study||10
1469197|NCT01944059|3596428|P1|NOT COMPLETED|Overall Study||7
1469198|NCT01944059|3596428|P1|COMPLETED|Overall Study||24
1469199|NCT01944059|3596428|P1|STARTED|Overall Study||31
1469200|NCT01943864|3596437|P1|NOT COMPLETED|Overall Study||0
1469201|NCT01943864|3596437|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
1469202|NCT01943864|3596437|P1|STARTED|Overall Study||20
1469203|NCT01943565|3596468|P3|NOT COMPLETED|Overall Study||0
1469204|NCT01943565|3596469|P2|NOT COMPLETED|Overall Study||0
1469205|NCT01943565|3596470|P1|NOT COMPLETED|Overall Study||0
1469206|NCT01943565|3596468|P3|COMPLETED|Overall Study||9
1469207|NCT01943565|3596469|P2|COMPLETED|Overall Study||9
1469208|NCT01943565|3596470|P1|COMPLETED|Overall Study||11
1469209|NCT01943565|3596468|P3|STARTED|Overall Study||9
1469210|NCT01943565|3596469|P2|STARTED|Overall Study||9
1469211|NCT01943565|3596470|P1|STARTED|Overall Study||11
1469212|NCT01943552|3596501|P2|NOT COMPLETED|Overall Study||25
1469213|NCT01943552|3596502|P1|NOT COMPLETED|Overall Study||25
1469214|NCT01943552|3596501|P2|COMPLETED|Overall Study||69
1469215|NCT01943552|3596502|P1|COMPLETED|Overall Study||71
1469216|NCT01943552|3596501|P2|STARTED|Overall Study||94
1469217|NCT01943552|3596502|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
1469218|NCT01943539|3596518|P2|NOT COMPLETED|Overall Study||0
1469219|NCT01943539|3596519|P1|NOT COMPLETED|Overall Study||4
1469220|NCT01943539|3596518|P2|COMPLETED|Overall Study||40
1469221|NCT01943539|3596519|P1|COMPLETED|Overall Study||40
1469222|NCT01943539|3596518|P2|STARTED|Overall Study||40
1469223|NCT01943539|3596519|P1|STARTED|Overall Study||44
1469224|NCT01943474|3596530|P2|NOT COMPLETED|Overall Study||0
1469225|NCT01943474|3596531|P1|NOT COMPLETED|Overall Study||0
1469226|NCT01943474|3596530|P2|COMPLETED|Overall Study||125
1469227|NCT01943474|3596531|P1|COMPLETED|Overall Study||123
1469228|NCT01943474|3596530|P2|STARTED|Overall Study||125
1469229|NCT01943474|3596531|P1|STARTED|Overall Study||123
1469230|NCT01943435|3596555|P3|NOT COMPLETED|6 Month Follow up||15
1469231|NCT01943435|3596556|P2|NOT COMPLETED|6 Month Follow up||7
1469232|NCT01943435|3596557|P1|NOT COMPLETED|6 Month Follow up||12
1469233|NCT01943435|3596555|P3|COMPLETED|6 Month Follow up||65
1469234|NCT01943435|3596556|P2|COMPLETED|6 Month Follow up||59
1469235|NCT01943435|3596557|P1|COMPLETED|6 Month Follow up||67
1469236|NCT01943435|3596555|P3|STARTED|6 Month Follow up||80
1469237|NCT01943435|3596556|P2|STARTED|6 Month Follow up||66
1469238|NCT01943435|3596557|P1|STARTED|6 Month Follow up||79
1469239|NCT01943435|3596555|P3|NOT COMPLETED|2 Month Follow up||0
1469240|NCT01943435|3596556|P2|NOT COMPLETED|2 Month Follow up||3
1469241|NCT01943435|3596557|P1|NOT COMPLETED|2 Month Follow up||2
1469242|NCT01943435|3596555|P3|COMPLETED|2 Month Follow up||80
1469243|NCT01943435|3596556|P2|COMPLETED|2 Month Follow up||66
1469244|NCT01943435|3596557|P1|COMPLETED|2 Month Follow up||79
1469245|NCT01943435|3596555|P3|STARTED|2 Month Follow up||80
1469246|NCT01943435|3596556|P2|STARTED|2 Month Follow up||69
1469247|NCT01943435|3596557|P1|STARTED|2 Month Follow up||81
1469248|NCT01943435|3596555|P3|NOT COMPLETED|Intervention Period||4
1469249|NCT01943435|3596556|P2|NOT COMPLETED|Intervention Period||3
1469250|NCT01943435|3596557|P1|NOT COMPLETED|Intervention Period||3
1469251|NCT01943435|3596555|P3|COMPLETED|Intervention Period||80
1469252|NCT01943435|3596556|P2|COMPLETED|Intervention Period||69
1469253|NCT01943435|3596557|P1|COMPLETED|Intervention Period||81
1469254|NCT01943435|3596555|P3|STARTED|Intervention Period||84
1469255|NCT01943435|3596556|P2|STARTED|Intervention Period||72
1469256|NCT01943435|3596557|P1|STARTED|Intervention Period||84
1469257|NCT01943435|3596555|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
1469258|NCT01943435|3596556|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
1469259|NCT01943435|3596557|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
1469260|NCT01943435|3596555|P3|COMPLETED|Baseline Eligibility and Randomization||84
1469261|NCT01943435|3596556|P2|COMPLETED|Baseline Eligibility and Randomization||72
1469262|NCT01943435|3596557|P1|COMPLETED|Baseline Eligibility and Randomization||84
1469263|NCT01943435|3596555|P3|STARTED|Baseline Eligibility and Randomization||87
1469264|NCT01943435|3596556|P2|STARTED|Baseline Eligibility and Randomization||84
1469265|NCT01943435|3596557|P1|STARTED|Baseline Eligibility and Randomization||88
1469266|NCT01943344|3596571|P1|NOT COMPLETED|Overall Study||3
1469267|NCT01943344|3596571|P1|COMPLETED|Overall Study||9
1469268|NCT01943344|3596571|P1|STARTED|Overall Study||12
1469269|NCT01943292|3596580|P3|NOT COMPLETED|Overall Study||0
1469270|NCT01943292|3596581|P2|NOT COMPLETED|Overall Study||0
1469271|NCT01943292|3596582|P1|NOT COMPLETED|Overall Study||1
1469272|NCT01943292|3596580|P3|COMPLETED|Overall Study||3
1469273|NCT01943292|3596581|P2|COMPLETED|Overall Study||3
1469274|NCT01943292|3596582|P1|COMPLETED|Overall Study||2
1469275|NCT01943292|3596580|P3|Completed Follow-Up|Overall Study||3
1469276|NCT01943292|3596581|P2|Completed Follow-Up|Overall Study||3
1469277|NCT01943292|3596582|P1|Completed Follow-Up|Overall Study||2
1469278|NCT01943292|3596580|P3|Completed Treatment|Overall Study||3
1469279|NCT01943292|3596581|P2|Completed Treatment|Overall Study||3
1469280|NCT01943292|3596582|P1|Completed Treatment|Overall Study||3
1469281|NCT01943292|3596580|P3|Completed Cycle 1|Overall Study||3
1469282|NCT01943292|3596581|P2|Completed Cycle 1|Overall Study||3
1469283|NCT01943292|3596582|P1|Completed Cycle 1|Overall Study||3
1469284|NCT01943292|3596580|P3|STARTED|Overall Study||3
1469285|NCT01943292|3596581|P2|STARTED|Overall Study||3
1469286|NCT01943292|3596582|P1|STARTED|Overall Study||3
1469287|NCT01943110|3596593|P1|NOT COMPLETED|Overall Study||0
1469288|NCT01943110|3596593|P1|COMPLETED|Overall Study||30
1469289|NCT01943110|3596593|P1|STARTED|Overall Study||30
1469290|NCT01942785|3596609|P1|NOT COMPLETED|Overall Study||4
1469291|NCT01942785|3596609|P1|COMPLETED|Overall Study||50
1469292|NCT01942785|3596609|P1|STARTED|Overall Study||54
1469293|NCT01942733|3596638|P1|NOT COMPLETED|Overall Study||3
1469294|NCT01942733|3596638|P1|COMPLETED|Overall Study||41
1469295|NCT01942733|3596638|P1|STARTED|Overall Study||44
1469296|NCT01942720|3596667|P1|NOT COMPLETED|Overall Study||21
1469297|NCT01942720|3596667|P1|COMPLETED|Overall Study||53
1469298|NCT01942720|3596667|P1|STARTED|Overall Study||74
1469299|NCT01942707|3596677|P2|NOT COMPLETED|Overall Study||0
1469300|NCT01942707|3596678|P1|NOT COMPLETED|Overall Study||0
1469301|NCT01942707|3596677|P2|COMPLETED|Overall Study||23
1469302|NCT01942707|3596678|P1|COMPLETED|Overall Study||23
1469303|NCT01942707|3596677|P2|STARTED|Overall Study||23
1469304|NCT01942707|3596678|P1|STARTED|Overall Study||23
1469305|NCT01942590|3596690|P2|NOT COMPLETED|Overall Study||1
1469306|NCT01942590|3596691|P1|NOT COMPLETED|Overall Study||1
1469307|NCT01942590|3596690|P2|COMPLETED|Overall Study||4
1469308|NCT01942590|3596691|P1|COMPLETED|Overall Study||7
1469309|NCT01942590|3596690|P2|STARTED|Overall Study||5
1469310|NCT01942590|3596691|P1|STARTED|Overall Study||8
1469311|NCT01942161|3596724|P3|NOT COMPLETED|Overall Study||6
1469312|NCT01942161|3596725|P2|NOT COMPLETED|Overall Study||6
1469313|NCT01942161|3596726|P1|NOT COMPLETED|Overall Study||8
1469314|NCT01942161|3596724|P3|COMPLETED|Overall Study||35
1469315|NCT01942161|3596725|P2|COMPLETED|Overall Study||24
1469316|NCT01942161|3596726|P1|COMPLETED|Overall Study||27
1469317|NCT01942161|3596724|P3|STARTED|Overall Study||41
1469318|NCT01942161|3596725|P2|STARTED|Overall Study||30
1469319|NCT01942161|3596726|P1|STARTED|Overall Study||35
1469320|NCT01942148|3596746|P1|NOT COMPLETED|Overall Study||27
1469321|NCT01942148|3596746|P1|COMPLETED|Overall Study||41
1469322|NCT01942148|3596746|P1|STARTED|Overall Study||68
1469323|NCT01942135|3596754|P2|NOT COMPLETED|Overall Study||174
1469324|NCT01942135|3596755|P1|NOT COMPLETED|Overall Study||347
1469325|NCT01942135|3596754|P2|COMPLETED|Overall Study||0
1469326|NCT01942135|3596755|P1|COMPLETED|Overall Study||0
1469327|NCT01942135|3596754|P2|STARTED|Overall Study||174
1469328|NCT01942135|3596755|P1|STARTED|Overall Study||347
1469329|NCT01941940|3596792|P1|NOT COMPLETED|Overall Study||33
1469330|NCT01941940|3596792|P1|COMPLETED|Overall Study||194
1469331|NCT01941940|3596792|P1|STARTED|Overall Study||227
1469332|NCT01941615|3596832|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
1469333|NCT01941615|3596832|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
1469334|NCT01941615|3596832|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
1469335|NCT01941615|3596832|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
1469336|NCT01941615|3596832|P1|COMPLETED|Reference Treatment: Microgynon®||0
1469337|NCT01941615|3596832|P1|STARTED|Reference Treatment: Microgynon®||0
1469338|NCT01941615|3596832|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
1469339|NCT01941615|3596832|P1|COMPLETED|Run in Treatment: Microgynon®||16
1469340|NCT01941615|3596832|P1|STARTED|Run in Treatment: Microgynon®||16
1469341|NCT01941498|3596841|P1|NOT COMPLETED|Overall Study||1
1469342|NCT01941498|3596841|P1|COMPLETED|Overall Study||96
1469343|NCT01941498|3596841|P1|STARTED|Overall Study||97
1469344|NCT01941485|3596887|P1|NOT COMPLETED|Overall Study||0
1469345|NCT01941485|3596887|P1|COMPLETED|Overall Study||59
1469346|NCT01941485|3596887|P1|STARTED|Overall Study||59
1469347|NCT01941472|3596953|P1|NOT COMPLETED|Overall Study||0
1469348|NCT01941472|3596953|P1|COMPLETED|Overall Study||40
1469349|NCT01941472|3596953|P1|STARTED|Overall Study||40
1469350|NCT01941186|3596959|P2|NOT COMPLETED|Follow-up||0
1469351|NCT01941186|3596960|P1|NOT COMPLETED|Follow-up||1
1469352|NCT01941186|3596959|P2|COMPLETED|Follow-up||33
1469353|NCT01941186|3596960|P1|COMPLETED|Follow-up||30
1469354|NCT01941186|3596959|P2|STARTED|Follow-up||33
1469355|NCT01941186|3596960|P1|STARTED|Follow-up||31
1469356|NCT01941186|3596959|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
1469357|NCT01941186|3596960|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
1469358|NCT01941186|3596959|P2|COMPLETED|Randomization/Allocation to Study Group||33
1469359|NCT01941186|3596960|P1|COMPLETED|Randomization/Allocation to Study Group||31
1469360|NCT01941186|3596959|P2|STARTED|Randomization/Allocation to Study Group||33
1469361|NCT01941186|3596960|P1|STARTED|Randomization/Allocation to Study Group||31
1469362|NCT01941095|3596986|P1|NOT COMPLETED|Overall Study||56
1469363|NCT01941095|3596986|P1|COMPLETED|Overall Study||41
1469364|NCT01941095|3596986|P1|STARTED|Overall Study||97
1469365|NCT01940939|3597011|P2|NOT COMPLETED|Overall Study||8
1469366|NCT01940939|3597012|P1|NOT COMPLETED|Overall Study||2
1469367|NCT01940939|3597011|P2|COMPLETED|Overall Study||27
1469368|NCT01940939|3597012|P1|COMPLETED|Overall Study||33
1469369|NCT01940939|3597011|P2|STARTED|Overall Study||35
1469370|NCT01940939|3597012|P1|STARTED|Overall Study||35
1469371|NCT01940900|3597024|P2|NOT COMPLETED|Overall Study||31
1469372|NCT01940900|3597025|P1|NOT COMPLETED|Overall Study||29
1469373|NCT01940900|3597024|P2|COMPLETED|Overall Study||284
1469374|NCT01940900|3597025|P1|COMPLETED|Overall Study||282
1469375|NCT01940900|3597024|P2|STARTED|Overall Study||315
1469376|NCT01940900|3597025|P1|STARTED|Overall Study||311
1469377|NCT01940523|3597033|P2|NOT COMPLETED|Overall Study||0
1469378|NCT01940523|3597034|P1|NOT COMPLETED|Overall Study||0
1469379|NCT01940523|3597033|P2|COMPLETED|Overall Study||320
1469380|NCT01940523|3597034|P1|COMPLETED|Overall Study||320
1469381|NCT01940523|3597033|P2|STARTED|Overall Study||320
1469382|NCT01940523|3597034|P1|STARTED|Overall Study||320
1469383|NCT01940510|3597042|P1|NOT COMPLETED|Overall Study||0
1469384|NCT01940510|3597042|P1|COMPLETED|Overall Study||24
1469385|NCT01940510|3597042|P1|STARTED|Overall Study||24
1469386|NCT01940497|3597075|P2|NOT COMPLETED|Overall Study||118
1469387|NCT01940497|3597076|P1|NOT COMPLETED|Overall Study||120
1469388|NCT01940497|3597075|P2|COMPLETED|Overall Study||1
1469389|NCT01940497|3597076|P1|COMPLETED|Overall Study||1
1469390|NCT01940497|3597075|P2|Treated: Neoadjuvant|Overall Study||21
1469391|NCT01940497|3597076|P1|Treated: Neoadjuvant|Overall Study||20
1469392|NCT01940497|3597075|P2|Treated: Adjuvant|Overall Study||92
1469393|NCT01940497|3597076|P1|Treated: Adjuvant|Overall Study||95
1469394|NCT01940497|3597075|P2|Treated|Overall Study||113
1469395|NCT01940497|3597076|P1|Treated|Overall Study||115
1469396|NCT01940497|3597075|P2|STARTED|Overall Study||119
1469397|NCT01940497|3597076|P1|STARTED|Overall Study||121
1469398|NCT01940484|3597115|P1|NOT COMPLETED|Overall Study||10
1469399|NCT01940484|3597115|P1|COMPLETED|Overall Study||88
1469400|NCT01940484|3597115|P1|STARTED|Overall Study||98
1469401|NCT01940471|3597135|P2|NOT COMPLETED|Open-Label Extension||8
1469402|NCT01940471|3597136|P1|NOT COMPLETED|Open-Label Extension||14
1469403|NCT01940471|3597135|P2|COMPLETED|Open-Label Extension||0
1469404|NCT01940471|3597136|P1|COMPLETED|Open-Label Extension||0
1469405|NCT01940471|3597135|P2|STARTED|Open-Label Extension||8
1469406|NCT01940471|3597136|P1|STARTED|Open-Label Extension||14
1469407|NCT01940471|3597135|P2|NOT COMPLETED|Double-Blind Phase||285
1469408|NCT01940471|3597136|P1|NOT COMPLETED|Double-Blind Phase||568
1469409|NCT01940471|3597135|P2|COMPLETED|Double-Blind Phase||8
1469410|NCT01940471|3597136|P1|COMPLETED|Double-Blind Phase||14
1469411|NCT01940471|3597135|P2|STARTED|Double-Blind Phase||293
1469412|NCT01940471|3597136|P1|STARTED|Double-Blind Phase||582
1469413|NCT01940354|3597154|P2|NOT COMPLETED|Overall Study||2
1469414|NCT01940354|3597155|P1|NOT COMPLETED|Overall Study||4
1469415|NCT01940354|3597154|P2|COMPLETED|Overall Study||108
1469416|NCT01940354|3597155|P1|COMPLETED|Overall Study||106
1469417|NCT01940354|3597154|P2|STARTED|Overall Study||110
1469418|NCT01940354|3597155|P1|STARTED|Overall Study||110
1469419|NCT01940341|3597167|P2|NOT COMPLETED|Open-label Extension Phase||1
1469420|NCT01940341|3597168|P1|NOT COMPLETED|Open-label Extension Phase||4
1469421|NCT01940341|3597167|P2|COMPLETED|Open-label Extension Phase||0
1469422|NCT01940341|3597168|P1|COMPLETED|Open-label Extension Phase||0
1469423|NCT01940341|3597167|P2|STARTED|Open-label Extension Phase||1
1469424|NCT01940341|3597168|P1|STARTED|Open-label Extension Phase||4
1469425|NCT01940341|3597167|P2|NOT COMPLETED|Double-Blind Phase||140
1469426|NCT01940341|3597168|P1|NOT COMPLETED|Double-Blind Phase||281
1469427|NCT01940341|3597167|P2|COMPLETED|Double-Blind Phase||1
1469428|NCT01940341|3597168|P1|COMPLETED|Double-Blind Phase||4
1469429|NCT01940341|3597167|P2|STARTED|Double-Blind Phase||141
1469430|NCT01940341|3597168|P1|STARTED|Double-Blind Phase||285
1469431|NCT01940146|3597186|P4|NOT COMPLETED|Overall Study||2
1469432|NCT01940146|3597187|P3|NOT COMPLETED|Overall Study||1
1469433|NCT01940146|3597188|P2|NOT COMPLETED|Overall Study||0
1469434|NCT01940146|3597189|P1|NOT COMPLETED|Overall Study||1
1469435|NCT01940146|3597186|P4|COMPLETED|Overall Study||53
1469436|NCT01940146|3597187|P3|COMPLETED|Overall Study||55
1469437|NCT01940146|3597188|P2|COMPLETED|Overall Study||55
1469438|NCT01940146|3597189|P1|COMPLETED|Overall Study||55
1469439|NCT01940146|3597186|P4|STARTED|Overall Study||55
1469440|NCT01940146|3597187|P3|STARTED|Overall Study||56
1469441|NCT01940146|3597188|P2|STARTED|Overall Study||55
1469442|NCT01940146|3597189|P1|STARTED|Overall Study||56
1469443|NCT01940120|3597199|P1|NOT COMPLETED|Overall Study||48
1469444|NCT01940120|3597199|P1|COMPLETED|Overall Study||30
1469445|NCT01940120|3597199|P1|STARTED|Overall Study||78
1469446|NCT01939977|3597355|P2|NOT COMPLETED|Overall Study||7
1469447|NCT01939977|3597356|P1|NOT COMPLETED|Overall Study||9
1469448|NCT01939977|3597355|P2|COMPLETED|Overall Study||41
1469449|NCT01939977|3597356|P1|COMPLETED|Overall Study||37
1469450|NCT01939977|3597355|P2|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
1469451|NCT01939977|3597356|P1|STARTED|Overall Study||46
1469452|NCT01939938|3597392|P1|NOT COMPLETED|Overall Study||0
1469453|NCT01939938|3597392|P1|COMPLETED|Overall Study||10
1469454|NCT01939938|3597392|P1|STARTED|Overall Study||10
1469455|NCT01939548|3597401|P3|NOT COMPLETED|Overall Study||30
1469456|NCT01939548|3597402|P2|NOT COMPLETED|Overall Study||49
1469457|NCT01939548|3597403|P1|NOT COMPLETED|Overall Study||37
1469458|NCT01939548|3597401|P3|COMPLETED|Overall Study||50
1469459|NCT01939548|3597402|P2|COMPLETED|Overall Study||33
1469460|NCT01939548|3597403|P1|COMPLETED|Overall Study||41
1469461|NCT01939548|3597401|P3|STARTED|Overall Study||80
1469462|NCT01939548|3597402|P2|STARTED|Overall Study||82
1469463|NCT01939548|3597403|P1|STARTED|Overall Study||78
1469464|NCT01939496|3597477|P3|NOT COMPLETED|Overall Study||2
1469465|NCT01939496|3597478|P2|NOT COMPLETED|Overall Study||3
1469466|NCT01939496|3597479|P1|NOT COMPLETED|Overall Study||9
1469467|NCT01939496|3597477|P3|COMPLETED|Overall Study||54
1469468|NCT01939496|3597478|P2|COMPLETED|Overall Study||54
1469469|NCT01939496|3597479|P1|COMPLETED|Overall Study||47
1469470|NCT01939496|3597477|P3|STARTED|Overall Study||56
1469471|NCT01939496|3597478|P2|STARTED|Overall Study||57
1469472|NCT01939496|3597479|P1|STARTED|Overall Study||56
1469473|NCT01939405|3597531|P2|NOT COMPLETED|Overall Study||2
1469474|NCT01939405|3597532|P1|NOT COMPLETED|Overall Study||3
1469475|NCT01939405|3597531|P2|COMPLETED|Overall Study||28
1469476|NCT01939405|3597532|P1|COMPLETED|Overall Study||27
1469477|NCT01939405|3597531|P2|STARTED|Overall Study||30
1469478|NCT01939405|3597532|P1|STARTED|Overall Study||30
1469479|NCT01939314|3597546|P2|NOT COMPLETED|Overall Study||8
1469480|NCT01939314|3597547|P1|NOT COMPLETED|Overall Study||9
1469481|NCT01939314|3597546|P2|COMPLETED|Overall Study||40
1469482|NCT01939314|3597547|P1|COMPLETED|Overall Study||36
1469483|NCT01939314|3597546|P2|24 Hour Endpoint|Overall Study||40
1469484|NCT01939314|3597547|P1|24 Hour Endpoint|Overall Study||36
1469485|NCT01939314|3597546|P2|15 Minute Endpoint|Overall Study||46
1469486|NCT01939314|3597547|P1|15 Minute Endpoint|Overall Study||41
1469487|NCT01939314|3597546|P2|STARTED|Overall Study||48
1469488|NCT01939314|3597547|P1|STARTED|Overall Study||45
1469489|NCT01939301|3597559|P2|NOT COMPLETED|Overall Study||1
1469490|NCT01939301|3597560|P1|NOT COMPLETED|Overall Study||1
1469491|NCT01939301|3597559|P2|COMPLETED|Overall Study||38
1469492|NCT01939301|3597560|P1|COMPLETED|Overall Study||38
1469493|NCT01939301|3597559|P2|STARTED|Overall Study||39
1469494|NCT01939301|3597560|P1|STARTED|Overall Study||39
1469495|NCT01939223|3597568|P2|NOT COMPLETED|Overall Study||11
1469496|NCT01939223|3597569|P1|NOT COMPLETED|Overall Study||13
1469497|NCT01939223|3597568|P2|COMPLETED|Overall Study||0
1469498|NCT01939223|3597569|P1|COMPLETED|Overall Study||1
1469499|NCT01939223|3597568|P2|Participants Received Treatment|Overall Study||11
1469500|NCT01939223|3597569|P1|Participants Received Treatment|Overall Study||14
1469501|NCT01939223|3597568|P2|STARTED|Overall Study||11
1469502|NCT01939223|3597569|P1|STARTED|Overall Study||14
1469503|NCT01939197|3597584|P7|NOT COMPLETED|Overall Study||2
1469504|NCT01939197|3597585|P6|NOT COMPLETED|Overall Study||1
1469505|NCT01939197|3597586|P5|NOT COMPLETED|Overall Study||4
1469506|NCT01939197|3597587|P4|NOT COMPLETED|Overall Study||1
1469507|NCT01939197|3597588|P3|NOT COMPLETED|Overall Study||0
1469508|NCT01939197|3597589|P2|NOT COMPLETED|Overall Study||1
1469509|NCT01939197|3597590|P1|NOT COMPLETED|Overall Study||1
1469510|NCT01939197|3597584|P7|COMPLETED|Overall Study||26
1469511|NCT01939197|3597585|P6|COMPLETED|Overall Study||4
1469512|NCT01939197|3597586|P5|COMPLETED|Overall Study||196
1469513|NCT01939197|3597587|P4|COMPLETED|Overall Study||11
1469514|NCT01939197|3597588|P3|COMPLETED|Overall Study||10
1469515|NCT01939197|3597589|P2|COMPLETED|Overall Study||31
1469516|NCT01939197|3597590|P1|COMPLETED|Overall Study||30
1469517|NCT01939197|3597584|P7|STARTED|Overall Study||28
1469518|NCT01939197|3597585|P6|STARTED|Overall Study||5
1469519|NCT01939197|3597586|P5|STARTED|Overall Study||200
1469520|NCT01939197|3597587|P4|STARTED|Overall Study||12
1469521|NCT01939197|3597588|P3|STARTED|Overall Study||10
1469522|NCT01939197|3597589|P2|STARTED|Overall Study||32
1469523|NCT01939197|3597590|P1|STARTED|Overall Study||31
1469524|NCT01939145|3597650|P2|NOT COMPLETED|Overall Study||7
1469525|NCT01939145|3597651|P1|NOT COMPLETED|Overall Study||2
1469526|NCT01939145|3597650|P2|COMPLETED|Overall Study||44
1469527|NCT01939145|3597651|P1|COMPLETED|Overall Study||47
1469528|NCT01939145|3597650|P2|STARTED|Overall Study||51
1469529|NCT01939145|3597651|P1|STARTED|Overall Study||49
1469530|NCT01939002|3597661|P2|NOT COMPLETED|Overall Study||18
1469531|NCT01939002|3597662|P1|NOT COMPLETED|Overall Study||19
1469532|NCT01939002|3597661|P2|COMPLETED|Overall Study||80
1469533|NCT01939002|3597662|P1|COMPLETED|Overall Study||84
1469534|NCT01939002|3597661|P2|STARTED|Overall Study||98
1469535|NCT01939002|3597662|P1|STARTED|Overall Study||103
1469536|NCT01938989|3597728|P2|NOT COMPLETED|Overall Study||0
1469537|NCT01938989|3597729|P1|NOT COMPLETED|Overall Study||0
1469538|NCT01938989|3597728|P2|COMPLETED|Overall Study||77
1469539|NCT01938989|3597729|P1|COMPLETED|Overall Study||77
1469540|NCT01938989|3597728|P2|STARTED|Overall Study||77
1469541|NCT01938989|3597729|P1|STARTED|Overall Study||77
1469542|NCT01938833|3597735|P1|NOT COMPLETED|Overall Study||0
1469543|NCT01938833|3597735|P1|COMPLETED|Overall Study||9
1469544|NCT01938833|3597735|P1|STARTED|Overall Study||9
1469545|NCT01938625|3597745|P2|NOT COMPLETED|Overall Study||2
1469546|NCT01938625|3597746|P1|NOT COMPLETED|Overall Study||0
1469547|NCT01938625|3597745|P2|COMPLETED|Overall Study||23
1469548|NCT01938625|3597746|P1|COMPLETED|Overall Study||10
1469549|NCT01938625|3597745|P2|STARTED|Overall Study||25
1469550|NCT01938625|3597746|P1|STARTED|Overall Study||10
1469551|NCT01938573|3597766|P2|NOT COMPLETED|Overall Study||0
1469552|NCT01938573|3597767|P1|NOT COMPLETED|Overall Study||2
1469553|NCT01938573|3597766|P2|COMPLETED|Overall Study||6
1469554|NCT01938573|3597767|P1|COMPLETED|Overall Study||13
1469555|NCT01938573|3597766|P2|STARTED|Overall Study||6
1469556|NCT01938573|3597767|P1|STARTED|Overall Study||15
1469557|NCT01938430|3597787|P14|NOT COMPLETED|Overall Study||1
1469558|NCT01938430|3597788|P13|NOT COMPLETED|Overall Study||0
1469559|NCT01938430|3597789|P12|NOT COMPLETED|Overall Study||1
1469560|NCT01938430|3597790|P11|NOT COMPLETED|Overall Study||3
1469561|NCT01938430|3597791|P10|NOT COMPLETED|Overall Study||3
1469562|NCT01938430|3597792|P9|NOT COMPLETED|Overall Study||4
1469563|NCT01938430|3597793|P8|NOT COMPLETED|Overall Study||1
1469564|NCT01938430|3597794|P7|NOT COMPLETED|Overall Study||2
1469565|NCT01938430|3597795|P6|NOT COMPLETED|Overall Study||1
1469566|NCT01938430|3597796|P5|NOT COMPLETED|Overall Study||0
1469567|NCT01938430|3597797|P4|NOT COMPLETED|Overall Study||2
1469568|NCT01938430|3597798|P3|NOT COMPLETED|Overall Study||5
1469569|NCT01938430|3597799|P2|NOT COMPLETED|Overall Study||3
1469570|NCT01938430|3597800|P1|NOT COMPLETED|Overall Study||4
1469571|NCT01938430|3597787|P14|COMPLETED|Overall Study||2
1469572|NCT01938430|3597788|P13|COMPLETED|Overall Study||4
1469573|NCT01938430|3597789|P12|COMPLETED|Overall Study||3
1469574|NCT01938430|3597790|P11|COMPLETED|Overall Study||3
1469575|NCT01938430|3597791|P10|COMPLETED|Overall Study||23
1469576|NCT01938430|3597792|P9|COMPLETED|Overall Study||22
1469577|NCT01938430|3597793|P8|COMPLETED|Overall Study||24
1469578|NCT01938430|3597794|P7|COMPLETED|Overall Study||24
1469579|NCT01938430|3597795|P6|COMPLETED|Overall Study||55
1469580|NCT01938430|3597796|P5|COMPLETED|Overall Study||55
1469581|NCT01938430|3597797|P4|COMPLETED|Overall Study||24
1469582|NCT01938430|3597798|P3|COMPLETED|Overall Study||18
1469583|NCT01938430|3597799|P2|COMPLETED|Overall Study||26
1469584|NCT01938430|3597800|P1|COMPLETED|Overall Study||26
1469585|NCT01938430|3597787|P14|STARTED|Overall Study||3
1469586|NCT01938430|3597788|P13|STARTED|Overall Study||4
1469587|NCT01938430|3597789|P12|STARTED|Overall Study||4
1469588|NCT01938430|3597790|P11|STARTED|Overall Study||6
1469589|NCT01938430|3597791|P10|STARTED|Overall Study||26
1469590|NCT01938430|3597792|P9|STARTED|Overall Study||26
1469591|NCT01938430|3597793|P8|STARTED|Overall Study||25
1469592|NCT01938430|3597794|P7|STARTED|Overall Study||26
1469593|NCT01938430|3597795|P6|STARTED|Overall Study||56
1469594|NCT01938430|3597796|P5|STARTED|Overall Study||55
1469595|NCT01938430|3597797|P4|STARTED|Overall Study||26
1469596|NCT01938430|3597798|P3|STARTED|Overall Study||23
1469597|NCT01938430|3597799|P2|STARTED|Overall Study||29
1469598|NCT01938430|3597800|P1|STARTED|Overall Study||30
1469599|NCT01938391|3598125|P1|NOT COMPLETED|12 Month Follow up||2
1469600|NCT01938391|3598125|P1|COMPLETED|12 Month Follow up||22
1469601|NCT01938391|3598125|P1|STARTED|12 Month Follow up||24
1469602|NCT01938391|3598125|P1|NOT COMPLETED|6 Month Follow up||1
1469603|NCT01938391|3598125|P1|COMPLETED|6 Month Follow up||24
1469604|NCT01938391|3598125|P1|STARTED|6 Month Follow up||25
1469605|NCT01938391|3598125|P1|NOT COMPLETED|2 Week Follow up||0
1469606|NCT01938391|3598125|P1|COMPLETED|2 Week Follow up||25
1469607|NCT01938391|3598125|P1|STARTED|2 Week Follow up||25
1469608|NCT01938391|3598125|P1|NOT COMPLETED|Baseline||0
1469609|NCT01938391|3598125|P1|COMPLETED|Baseline||25
1469610|NCT01938391|3598125|P1|STARTED|Baseline||25
1469611|NCT01938170|3598135|P1|NOT COMPLETED|Overall Study||0
1469612|NCT01938170|3598135|P1|COMPLETED|Overall Study||41
1469613|NCT01938170|3598135|P1|STARTED|Overall Study||41
1469614|NCT01938079|3598142|P2|NOT COMPLETED|Overall Study||0
1469615|NCT01938079|3598143|P1|NOT COMPLETED|Overall Study||0
1469616|NCT01938079|3598142|P2|COMPLETED|Overall Study||10
1469617|NCT01938079|3598143|P1|COMPLETED|Overall Study||10
1469618|NCT01938079|3598142|P2|STARTED|Overall Study||10
1469619|NCT01938079|3598143|P1|STARTED|Overall Study||10
1469620|NCT01938066|3598151|P2|NOT COMPLETED|Overall Study||2
1469621|NCT01938066|3598152|P1|NOT COMPLETED|Overall Study||1
1469622|NCT01938066|3598151|P2|COMPLETED|Overall Study||13
1469623|NCT01938066|3598152|P1|COMPLETED|Overall Study||14
1469624|NCT01938066|3598151|P2|STARTED|Overall Study||15
1469625|NCT01938066|3598152|P1|STARTED|Overall Study||15
1469626|NCT01938040|3598162|P2|NOT COMPLETED|Overall Study||0
1469627|NCT01938040|3598163|P1|NOT COMPLETED|Overall Study||0
1469628|NCT01938040|3598162|P2|COMPLETED|Overall Study||27
1469629|NCT01938040|3598163|P1|COMPLETED|Overall Study||28
1469630|NCT01938040|3598162|P2|Behavior Metrics|Overall Study||27
1469631|NCT01938040|3598163|P1|Behavior Metrics|Overall Study||28
1469632|NCT01938040|3598162|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
1469633|NCT01938040|3598163|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
1469634|NCT01938040|3598162|P2|STARTED|Overall Study||27
1469635|NCT01938040|3598163|P1|STARTED|Overall Study||28
1469636|NCT01937975|3598192|P3|NOT COMPLETED|Overall Study||0
1469637|NCT01937975|3598193|P2|NOT COMPLETED|Overall Study||0
1469638|NCT01937975|3598194|P1|NOT COMPLETED|Overall Study||0
1469639|NCT01937975|3598192|P3|COMPLETED|Overall Study||8
1469640|NCT01937975|3598193|P2|COMPLETED|Overall Study||8
1469641|NCT01937975|3598194|P1|COMPLETED|Overall Study||8
1469642|NCT01937975|3598192|P3|STARTED|Overall Study||8
1469643|NCT01937975|3598193|P2|STARTED|Overall Study||8
1469644|NCT01937975|3598194|P1|STARTED|Overall Study||8
1469645|NCT01937871|3598244|P3|NOT COMPLETED|Overall Study||11
1469646|NCT01937871|3598245|P2|NOT COMPLETED|Overall Study||17
1469647|NCT01937871|3598246|P1|NOT COMPLETED|Overall Study||24
1469648|NCT01937871|3598244|P3|COMPLETED|Overall Study||174
1469649|NCT01937871|3598245|P2|COMPLETED|Overall Study||346
1469650|NCT01937871|3598246|P1|COMPLETED|Overall Study||337
1469651|NCT01937871|3598244|P3|Received at Least One Dose of Study Drug|Overall Study||185
1469652|NCT01937871|3598245|P2|Received at Least One Dose of Study Drug|Overall Study||362
1469653|NCT01937871|3598246|P1|Received at Least One Dose of Study Drug|Overall Study||361
1469654|NCT01937871|3598244|P3|STARTED|Overall Study||185
1469655|NCT01937871|3598245|P2|STARTED|Overall Study||363
1469656|NCT01937871|3598246|P1|STARTED|Overall Study||361
1469657|NCT01937715|3598322|P5|NOT COMPLETED|Overall Study||2
1469658|NCT01937715|3598323|P4|NOT COMPLETED|Overall Study||4
1469659|NCT01937715|3598324|P3|NOT COMPLETED|Overall Study||0
1469660|NCT01937715|3598325|P2|NOT COMPLETED|Overall Study||1
1469661|NCT01937715|3598326|P1|NOT COMPLETED|Overall Study||0
1469662|NCT01937715|3598322|P5|COMPLETED|Overall Study||1
1469663|NCT01937715|3598323|P4|COMPLETED|Overall Study||1
1469664|NCT01937715|3598324|P3|COMPLETED|Overall Study||3
1469665|NCT01937715|3598325|P2|COMPLETED|Overall Study||3
1469666|NCT01937715|3598326|P1|COMPLETED|Overall Study||3
1469667|NCT01937715|3598322|P5|STARTED|Overall Study||3
1469668|NCT01937715|3598323|P4|STARTED|Overall Study||5
1469669|NCT01937715|3598324|P3|STARTED|Overall Study||3
1469670|NCT01937715|3598325|P2|STARTED|Overall Study||4
1469671|NCT01937715|3598326|P1|STARTED|Overall Study||3
1469672|NCT01937598|3598448|P2|NOT COMPLETED|Overall Study||0
1469673|NCT01937598|3598449|P1|NOT COMPLETED|Overall Study||0
1469674|NCT01937598|3598448|P2|COMPLETED|Overall Study||8
1469675|NCT01937598|3598449|P1|COMPLETED|Overall Study||8
1469676|NCT01937598|3598448|P2|STARTED|Overall Study||8
1469677|NCT01937598|3598449|P1|STARTED|Overall Study||8
1469678|NCT01937520|3598473|P2|NOT COMPLETED|Overall Study||0
1469679|NCT01937520|3598474|P1|NOT COMPLETED|Overall Study||0
1469680|NCT01937520|3598473|P2|COMPLETED|Overall Study||9
1469681|NCT01937520|3598474|P1|COMPLETED|Overall Study||11
1469682|NCT01937520|3598473|P2|STARTED|Overall Study||9
1469683|NCT01937520|3598474|P1|STARTED|Overall Study||11
1469684|NCT01937507|3598510|P1|NOT COMPLETED|Overall Study||2
1469685|NCT01937507|3598510|P1|COMPLETED|Overall Study||0
1469686|NCT01937507|3598510|P1|STARTED|Overall Study||2
1469687|NCT01937390|3598517|P1|NOT COMPLETED|Overall Study||35
1469688|NCT01937390|3598517|P1|COMPLETED|Overall Study||550
1469689|NCT01937390|3598517|P1|STARTED|Overall Study||585
1469690|NCT01937364|3598527|P2|NOT COMPLETED|Overall Study||1
1469691|NCT01937364|3598528|P1|NOT COMPLETED|Overall Study||2
1469692|NCT01937364|3598527|P2|COMPLETED|Overall Study||7
1469693|NCT01937364|3598528|P1|COMPLETED|Overall Study||7
1469694|NCT01937364|3598527|P2|STARTED|Overall Study||8
1469695|NCT01937364|3598528|P1|STARTED|Overall Study||9
1469696|NCT01937351|3598540|P2|NOT COMPLETED|Overall Study||2
1469697|NCT01937351|3598541|P1|NOT COMPLETED|Overall Study||9
1469698|NCT01937351|3598540|P2|COMPLETED|Overall Study||26
1469699|NCT01937351|3598541|P1|COMPLETED|Overall Study||125
1469700|NCT01937351|3598540|P2|6-Month Follow-up|Overall Study||26
1469701|NCT01937351|3598541|P1|6-Month Follow-up|Overall Study||125
1469702|NCT01937351|3598540|P2|30-Day Follow-up|Overall Study||27
1469703|NCT01937351|3598541|P1|30-Day Follow-up|Overall Study||128
1469704|NCT01937351|3598540|P2|Treated w Study Device|Overall Study||28
1469705|NCT01937351|3598541|P1|Treated w Study Device|Overall Study||130
1469706|NCT01937351|3598540|P2|STARTED|Overall Study||28
1469707|NCT01937351|3598541|P1|STARTED|Overall Study||134
1469708|NCT01937312|3598549|P2|NOT COMPLETED|Overall Study||3
1469709|NCT01937312|3598550|P1|NOT COMPLETED|Overall Study||11
1469710|NCT01937312|3598549|P2|COMPLETED|Overall Study||92
1469711|NCT01937312|3598550|P1|COMPLETED|Overall Study||83
1469712|NCT01937312|3598549|P2|Treated|Overall Study||95
1469713|NCT01937312|3598550|P1|Treated|Overall Study||93
1469714|NCT01937312|3598549|P2|STARTED|Overall Study||95
1469715|NCT01937312|3598550|P1|STARTED|Overall Study||94
1469716|NCT01937299|3598565|P2|NOT COMPLETED|Overall Study||4
1469717|NCT01937299|3598566|P1|NOT COMPLETED|Overall Study||14
1469718|NCT01937299|3598565|P2|COMPLETED|Overall Study||112
1469719|NCT01937299|3598566|P1|COMPLETED|Overall Study||103
1469720|NCT01937299|3598565|P2|STARTED|Overall Study||116
1469721|NCT01937299|3598566|P1|STARTED|Overall Study||117
1469722|NCT01937260|3598579|P2|NOT COMPLETED|Overall Study||0
1469723|NCT01937260|3598580|P1|NOT COMPLETED|Overall Study||1
1469724|NCT01937260|3598579|P2|COMPLETED|Overall Study||10
1469725|NCT01937260|3598580|P1|COMPLETED|Overall Study||20
1469726|NCT01937260|3598579|P2|STARTED|Overall Study||10
1469727|NCT01937260|3598580|P1|STARTED|Overall Study||21
1469728|NCT01937195|3598587|P1|NOT COMPLETED|Overall Study||0
1469729|NCT01937195|3598587|P1|COMPLETED|Overall Study||95
1469730|NCT01937195|3598587|P1|STARTED|Overall Study||95
1469731|NCT01937130|3598601|P4|NOT COMPLETED|Overall Study||2
1469732|NCT01937130|3598602|P3|NOT COMPLETED|Overall Study||3
1469733|NCT01937130|3598603|P2|NOT COMPLETED|Overall Study||4
1469734|NCT01937130|3598604|P1|NOT COMPLETED|Overall Study||5
1469735|NCT01937130|3598601|P4|COMPLETED|Overall Study||2
1469736|NCT01937130|3598602|P3|COMPLETED|Overall Study||2
1469737|NCT01937130|3598603|P2|COMPLETED|Overall Study||3
1469738|NCT01937130|3598604|P1|COMPLETED|Overall Study||0
1469739|NCT01937130|3598601|P4|STARTED|Overall Study||4
1469740|NCT01937130|3598602|P3|STARTED|Overall Study||5
1469741|NCT01937130|3598603|P2|STARTED|Overall Study||7
1469742|NCT01937130|3598604|P1|STARTED|Overall Study||5
1469743|NCT01937026|3598631|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
1469744|NCT01937026|3598631|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
1469745|NCT01937026|3598631|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
1469746|NCT01937026|3598631|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
1469747|NCT01937026|3598631|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
1469748|NCT01937026|3598631|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
1469749|NCT01937026|3598631|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
1469750|NCT01937026|3598631|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
1469751|NCT01937026|3598631|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
1469752|NCT01936974|3598642|P2|NOT COMPLETED|Overall Study||5
1469753|NCT01936974|3598643|P1|NOT COMPLETED|Overall Study||2
1469754|NCT01936974|3598642|P2|COMPLETED|Overall Study||0
1469755|NCT01936974|3598643|P1|COMPLETED|Overall Study||0
1469756|NCT01936974|3598642|P2|STARTED|Overall Study||5
1469757|NCT01936974|3598643|P1|STARTED|Overall Study||2
1469758|NCT01936909|3598652|P3|NOT COMPLETED|Overall Study||6
1469759|NCT01936909|3598653|P2|NOT COMPLETED|Overall Study||8
1469760|NCT01936909|3598654|P1|NOT COMPLETED|Overall Study||10
1469761|NCT01936909|3598652|P3|COMPLETED|Overall Study||14
1469762|NCT01936909|3598653|P2|COMPLETED|Overall Study||12
1469763|NCT01936909|3598654|P1|COMPLETED|Overall Study||10
1469764|NCT01936909|3598652|P3|STARTED|Overall Study||20
1469765|NCT01936909|3598653|P2|STARTED|Overall Study||20
1469766|NCT01936909|3598654|P1|STARTED|Overall Study||20
1469767|NCT01936896|3598668|P1|NOT COMPLETED|Overall Study||0
1469768|NCT01936896|3598668|P1|COMPLETED|Overall Study||10
1469769|NCT01936896|3598668|P1|STARTED|Overall Study||10
1469770|NCT01936870|3598673|P1|NOT COMPLETED|Overall Study||189
1469771|NCT01936870|3598673|P1|COMPLETED|Overall Study||2303
1469772|NCT01936870|3598673|P1|STARTED|Overall Study||2492
1469773|NCT01936844|3598688|P2|NOT COMPLETED|Overall Study||7
1469774|NCT01936844|3598689|P1|NOT COMPLETED|Overall Study||6
1469775|NCT01936844|3598688|P2|COMPLETED|Overall Study||8
1469776|NCT01936844|3598689|P1|COMPLETED|Overall Study||9
1469777|NCT01936844|3598688|P2|STARTED|Overall Study||15
1469778|NCT01936844|3598689|P1|STARTED|Overall Study||15
1469779|NCT01936662|3598701|P2|NOT COMPLETED|Overall Study||0
1469780|NCT01936662|3598702|P1|NOT COMPLETED|Overall Study||0
1469781|NCT01936662|3598701|P2|COMPLETED|Overall Study||42
1469782|NCT01936662|3598702|P1|COMPLETED|Overall Study||42
1469783|NCT01936662|3598701|P2|STARTED|Overall Study||42
1469784|NCT01936662|3598702|P1|STARTED|Overall Study||42
1469785|NCT01936649|3598710|P1|NOT COMPLETED|Overall Study||13
1469786|NCT01936649|3598710|P1|COMPLETED|Overall Study||50
1469787|NCT01936649|3598710|P1|Treated|Overall Study||51
1469788|NCT01936649|3598710|P1|STARTED|Overall Study||63
1469789|NCT01936623|3598717|P2|NOT COMPLETED|Overall Study||5
1469790|NCT01936623|3598718|P1|NOT COMPLETED|Overall Study||0
1469791|NCT01936623|3598717|P2|COMPLETED|Overall Study||35
1469792|NCT01936623|3598718|P1|COMPLETED|Overall Study||40
1469793|NCT01936623|3598717|P2|STARTED|Overall Study||40
1469794|NCT01936623|3598718|P1|STARTED|Overall Study||40
1469795|NCT01936467|3598732|P2|NOT COMPLETED|Overall Study||0
1469796|NCT01936467|3598733|P1|NOT COMPLETED|Overall Study||0
1469797|NCT01936467|3598732|P2|COMPLETED|Overall Study||61
1469798|NCT01936467|3598733|P1|COMPLETED|Overall Study||60
1469799|NCT01936467|3598732|P2|STARTED|Overall Study||61
1469800|NCT01936467|3598733|P1|STARTED|Overall Study||60
1469801|NCT01936389|3598753|P2|NOT COMPLETED|Overall Study||0
1469802|NCT01936389|3598754|P1|NOT COMPLETED|Overall Study||1
1469803|NCT01936389|3598753|P2|COMPLETED|Overall Study||5
1469804|NCT01936389|3598754|P1|COMPLETED|Overall Study||4
1469805|NCT01936389|3598753|P2|STARTED|Overall Study||5
1469806|NCT01936389|3598754|P1|STARTED|Overall Study||5
1469807|NCT01936363|3598762|P2|NOT COMPLETED|Overall Study||0
1469808|NCT01936363|3598763|P1|NOT COMPLETED|Overall Study||0
1469809|NCT01936363|3598762|P2|COMPLETED|Overall Study||33
1469810|NCT01936363|3598763|P1|COMPLETED|Overall Study||32
1469811|NCT01936363|3598762|P2|STARTED|Overall Study||33
1469812|NCT01936363|3598763|P1|STARTED|Overall Study||32
1469813|NCT01936181|3598789|P4|NOT COMPLETED|Transition-extension||5
1469814|NCT01936181|3598790|P3|NOT COMPLETED|Transition-extension||6
1469815|NCT01936181|3598791|P2|NOT COMPLETED|Transition-extension||0
1469816|NCT01936181|3598792|P1|NOT COMPLETED|Transition-extension||15
1469817|NCT01936181|3598789|P4|COMPLETED|Transition-extension||96
1469818|NCT01936181|3598790|P3|COMPLETED|Transition-extension||88
1469819|NCT01936181|3598791|P2|COMPLETED|Transition-extension||0
1469820|NCT01936181|3598792|P1|COMPLETED|Transition-extension||186
1469821|NCT01936181|3598789|P4|STARTED|Transition-extension||101
1469822|NCT01936181|3598790|P3|STARTED|Transition-extension||94
1469823|NCT01936181|3598791|P2|STARTED|Transition-extension||0
1469824|NCT01936181|3598792|P1|STARTED|Transition-extension||201
1469825|NCT01936181|3598789|P4|NOT COMPLETED|Randomised, Double-blind||0
1469826|NCT01936181|3598790|P3|NOT COMPLETED|Randomised, Double-blind||0
1469827|NCT01936181|3598791|P2|NOT COMPLETED|Randomised, Double-blind||68
1469828|NCT01936181|3598792|P1|NOT COMPLETED|Randomised, Double-blind||64
1469829|NCT01936181|3598789|P4|COMPLETED|Randomised, Double-blind||0
1469830|NCT01936181|3598790|P3|COMPLETED|Randomised, Double-blind||0
1469831|NCT01936181|3598791|P2|COMPLETED|Randomised, Double-blind||225
1469832|NCT01936181|3598792|P1|COMPLETED|Randomised, Double-blind||227
1469833|NCT01936181|3598789|P4|STARTED|Randomised, Double-blind||0
1469834|NCT01936181|3598790|P3|STARTED|Randomised, Double-blind||0
1469835|NCT01936181|3598791|P2|STARTED|Randomised, Double-blind||293
1469836|NCT01936181|3598792|P1|STARTED|Randomised, Double-blind||291
1469837|NCT01935947|3598806|P3|NOT COMPLETED|Overall Study||2
1469838|NCT01935947|3598807|P2|NOT COMPLETED|Overall Study||4
1469839|NCT01935947|3598808|P1|NOT COMPLETED|Overall Study||3
1469840|NCT01935947|3598806|P3|COMPLETED|Overall Study||0
1469841|NCT01935947|3598807|P2|COMPLETED|Overall Study||0
1469842|NCT01935947|3598808|P1|COMPLETED|Overall Study||1
1469843|NCT01935947|3598806|P3|Cytotoxic Therapy|Overall Study||2
1469844|NCT01935947|3598807|P2|Cytotoxic Therapy|Overall Study||3
1469845|NCT01935947|3598808|P1|Cytotoxic Therapy|Overall Study||3
1469846|NCT01935947|3598806|P3|Epigenetic Therapy|Overall Study||0
1469847|NCT01935947|3598807|P2|Epigenetic Therapy|Overall Study||4
1469848|NCT01935947|3598808|P1|Epigenetic Therapy|Overall Study||4
1469849|NCT01935947|3598806|P3|STARTED|Overall Study||2
1469850|NCT01935947|3598807|P2|STARTED|Overall Study||4
1469851|NCT01935947|3598808|P1|STARTED|Overall Study||4
1469852|NCT01935622|3598834|P3|NOT COMPLETED|Overall Study||0
1469853|NCT01935622|3598835|P2|NOT COMPLETED|Overall Study||2
1469854|NCT01935622|3598836|P1|NOT COMPLETED|Overall Study||2
1469855|NCT01935622|3598834|P3|COMPLETED|Overall Study||4
1469856|NCT01935622|3598835|P2|COMPLETED|Overall Study||1
1469857|NCT01935622|3598836|P1|COMPLETED|Overall Study||1
1469858|NCT01935622|3598834|P3|STARTED|Overall Study||4
1469859|NCT01935622|3598835|P2|STARTED|Overall Study||3
1469860|NCT01935622|3598836|P1|STARTED|Overall Study||3
1469861|NCT01935180|3598846|P2|NOT COMPLETED|Overall Study||14
1469862|NCT01935180|3598847|P1|NOT COMPLETED|Overall Study||21
1469863|NCT01935180|3598846|P2|COMPLETED|Overall Study||561
1469864|NCT01935180|3598847|P1|COMPLETED|Overall Study||552
1469865|NCT01935180|3598846|P2|STARTED|Overall Study||575
1469866|NCT01935180|3598847|P1|STARTED|Overall Study||573
1469867|NCT01934894|3598867|P2|NOT COMPLETED|Overall Study||5
1469868|NCT01934894|3598868|P1|NOT COMPLETED|Overall Study||6
1469869|NCT01934894|3598867|P2|COMPLETED|Overall Study||0
1469870|NCT01934894|3598868|P1|COMPLETED|Overall Study||0
1469871|NCT01934894|3598867|P2|STARTED|Overall Study||5
1469872|NCT01934894|3598868|P1|STARTED|Overall Study||6
1469873|NCT01934790|3598883|P1|NOT COMPLETED|Long Term Follow up||0
1469874|NCT01934790|3598883|P1|COMPLETED|Long Term Follow up||12
1469875|NCT01934790|3598883|P1|STARTED|Long Term Follow up||12
1469876|NCT01934790|3598883|P1|NOT COMPLETED|Active Follow up||24
1469877|NCT01934790|3598883|P1|COMPLETED|Active Follow up||10
1469878|NCT01934790|3598883|P1|STARTED|Active Follow up||34
1469879|NCT01934790|3598883|P1|NOT COMPLETED|Treatment||16
1469880|NCT01934790|3598883|P1|COMPLETED|Treatment||29
1469881|NCT01934790|3598883|P1|Participants Received Study Treatment|Treatment||44
1469882|NCT01934790|3598883|P1|STARTED|Treatment|Eligible for treatment|45
1469883|NCT01934647|3598914|P3|NOT COMPLETED|Overall Study||0
1469884|NCT01934647|3598915|P2|NOT COMPLETED|Overall Study||0
1469885|NCT01934647|3598916|P1|NOT COMPLETED|Overall Study||0
1469886|NCT01934647|3598914|P3|COMPLETED|Overall Study||3
1469887|NCT01934647|3598915|P2|COMPLETED|Overall Study||2
1469888|NCT01934647|3598916|P1|COMPLETED|Overall Study||2
1469889|NCT01934647|3598914|P3|STARTED|Overall Study||3
1469890|NCT01934647|3598915|P2|STARTED|Overall Study||2
1469891|NCT01934647|3598916|P1|STARTED|Overall Study||2
1469892|NCT01934582|3598924|P1|NOT COMPLETED|Overall Study||0
1469893|NCT01934582|3598924|P1|COMPLETED|Overall Study||13
1469894|NCT01934582|3598924|P1|STARTED|Overall Study||13
1469895|NCT01934517|3598938|P1|NOT COMPLETED|Overall Study||0
1469896|NCT01934517|3598938|P1|COMPLETED|Overall Study||25
1469897|NCT01934517|3598938|P1|STARTED|Overall Study||25
1469898|NCT01934504|3598950|P4|NOT COMPLETED|Overall Study||7
1469899|NCT01934504|3598951|P3|NOT COMPLETED|Overall Study||5
1469900|NCT01934504|3598952|P2|NOT COMPLETED|Overall Study||0
1469901|NCT01934504|3598953|P1|NOT COMPLETED|Overall Study||1
1469902|NCT01934504|3598950|P4|COMPLETED|Overall Study||1
1469903|NCT01934504|3598951|P3|COMPLETED|Overall Study||11
1469904|NCT01934504|3598952|P2|COMPLETED|Overall Study||3
1469905|NCT01934504|3598953|P1|COMPLETED|Overall Study||5
1469906|NCT01934504|3598950|P4|STARTED|Overall Study||8
1469907|NCT01934504|3598951|P3|STARTED|Overall Study||16
1469908|NCT01934504|3598952|P2|STARTED|Overall Study||3
1469909|NCT01934504|3598953|P1|STARTED|Overall Study||6
1469910|NCT01934231|3598975|P1|NOT COMPLETED|Overall Study||0
1469911|NCT01934231|3598975|P1|COMPLETED|Overall Study||27
1469912|NCT01934231|3598975|P1|STARTED|Overall Study||27
1469913|NCT01934218|3598986|P2|NOT COMPLETED|Open-Label Phase||24
1469914|NCT01934218|3598987|P1|NOT COMPLETED|Open-Label Phase||26
1469915|NCT01934218|3598986|P2|COMPLETED|Open-Label Phase||304
1469916|NCT01934218|3598987|P1|COMPLETED|Open-Label Phase||290
1469917|NCT01934218|3598986|P2|STARTED|Open-Label Phase||328
1469918|NCT01934218|3598987|P1|STARTED|Open-Label Phase||316
1469919|NCT01934218|3598986|P2|NOT COMPLETED|Double-blind Phase||54
1469920|NCT01934218|3598987|P1|NOT COMPLETED|Double-blind Phase||48
1469921|NCT01934218|3598986|P2|COMPLETED|Double-blind Phase||356
1469922|NCT01934218|3598987|P1|COMPLETED|Double-blind Phase||356
1469923|NCT01934218|3598986|P2|Analyzed Participants|Double-blind Phase||407
1469924|NCT01934218|3598987|P1|Analyzed Participants|Double-blind Phase||402
1469925|NCT01934218|3598986|P2|STARTED|Double-blind Phase||410
1469926|NCT01934218|3598987|P1|STARTED|Double-blind Phase||404
1469927|NCT01934192|3598998|P4|NOT COMPLETED|Overall Study||1
1469928|NCT01934192|3598999|P3|NOT COMPLETED|Overall Study||1
1469929|NCT01934192|3599000|P2|NOT COMPLETED|Overall Study||7
1469930|NCT01934192|3599001|P1|NOT COMPLETED|Overall Study||9
1469931|NCT01934192|3598998|P4|COMPLETED|Overall Study||3
1469932|NCT01934192|3598999|P3|COMPLETED|Overall Study||3
1469933|NCT01934192|3599000|P2|COMPLETED|Overall Study||37
1469934|NCT01934192|3599001|P1|COMPLETED|Overall Study||31
1469935|NCT01934192|3598998|P4|STARTED|Overall Study||4
1469936|NCT01934192|3598999|P3|STARTED|Overall Study||4
1469937|NCT01934192|3599000|P2|STARTED|Overall Study||44
1469938|NCT01934192|3599001|P1|STARTED|Overall Study||40
1469939|NCT01934010|3599138|P3|NOT COMPLETED|Overall Study||2
1469940|NCT01934010|3599139|P2|NOT COMPLETED|Overall Study||11
1469941|NCT01934010|3599140|P1|NOT COMPLETED|Overall Study||23
1469942|NCT01934010|3599138|P3|COMPLETED|Overall Study||74
1469943|NCT01934010|3599139|P2|COMPLETED|Overall Study||56
1469944|NCT01934010|3599140|P1|COMPLETED|Overall Study||91
1469945|NCT01934010|3599138|P3|STARTED|Overall Study||76
1469946|NCT01934010|3599139|P2|STARTED|Overall Study||67
1469947|NCT01934010|3599140|P1|STARTED|Overall Study||114
1469948|NCT01933932|3599159|P2|NOT COMPLETED|Overall Study||178
1469949|NCT01933932|3599160|P1|NOT COMPLETED|Overall Study||184
1469950|NCT01933932|3599159|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
1469951|NCT01933932|3599160|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
1469952|NCT01933932|3599159|P2|STARTED|Overall Study||256
1469953|NCT01933932|3599160|P1|STARTED|Overall Study||254
1469954|NCT01933919|3599178|P2|NOT COMPLETED|Open-label Long-term Phase||6
1469955|NCT01933919|3599179|P1|NOT COMPLETED|Open-label Long-term Phase||7
1469956|NCT01933919|3599178|P2|COMPLETED|Open-label Long-term Phase||9
1469957|NCT01933919|3599179|P1|COMPLETED|Open-label Long-term Phase||12
1469958|NCT01933919|3599178|P2|STARTED|Open-label Long-term Phase||15
1469959|NCT01933919|3599179|P1|STARTED|Open-label Long-term Phase||19
1469960|NCT01933919|3599178|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
1469961|NCT01933919|3599179|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
1469962|NCT01933919|3599178|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
1469963|NCT01933919|3599179|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
1469964|NCT01933919|3599178|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
1469965|NCT01933919|3599179|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
1469966|NCT01933919|3599178|P2|STARTED|Double-blind Placebo-controlled Phase||19
1469967|NCT01933919|3599179|P1|STARTED|Double-blind Placebo-controlled Phase||19
1469968|NCT01933880|3599215|P2|NOT COMPLETED|Overall Study||1
1469969|NCT01933880|3599216|P1|NOT COMPLETED|Overall Study||30
1469970|NCT01933880|3599215|P2|COMPLETED|Overall Study||40
1469971|NCT01933880|3599216|P1|COMPLETED|Overall Study||123
1469972|NCT01933880|3599215|P2|STARTED|Overall Study||41
1469973|NCT01933880|3599216|P1|STARTED|Overall Study||153
1469974|NCT01933776|3599283|P2|NOT COMPLETED|Overall Study||0
1469975|NCT01933776|3599284|P1|NOT COMPLETED|Overall Study||0
1469976|NCT01933776|3599283|P2|COMPLETED|Overall Study||20
1469977|NCT01933776|3599284|P1|COMPLETED|Overall Study||20
1469978|NCT01933776|3599283|P2|STARTED|Overall Study||20
1469979|NCT01933776|3599284|P1|STARTED|Overall Study||20
1469980|NCT01933672|3599292|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1469981|NCT01933672|3599293|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1469982|NCT01933672|3599294|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1469983|NCT01933672|3599295|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
1469984|NCT01933672|3599296|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1469985|NCT01933672|3599297|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
1469986|NCT01933672|3599298|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
1469987|NCT01933672|3599292|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
1469988|NCT01933672|3599293|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
1469989|NCT01933672|3599294|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
1469990|NCT01933672|3599295|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
1469991|NCT01933672|3599296|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
1469992|NCT01933672|3599297|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
1469993|NCT01933672|3599298|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
1469994|NCT01933672|3599292|P7|STARTED|Third Intervention Period (12-16 Days)||6
1469995|NCT01933672|3599293|P6|STARTED|Third Intervention Period (12-16 Days)||4
1469996|NCT01933672|3599294|P5|STARTED|Third Intervention Period (12-16 Days)||6
1469997|NCT01933672|3599295|P4|STARTED|Third Intervention Period (12-16 Days)||5
1469998|NCT01933672|3599296|P3|STARTED|Third Intervention Period (12-16 Days)||1
1469999|NCT01933672|3599297|P2|STARTED|Third Intervention Period (12-16 Days)||6
1470000|NCT01933672|3599298|P1|STARTED|Third Intervention Period (12-16 Days)||0
1470001|NCT01933672|3599292|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1470002|NCT01933672|3599293|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1470003|NCT01933672|3599294|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1470004|NCT01933672|3599295|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1470005|NCT01933672|3599296|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1470006|NCT01933672|3599297|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1470007|NCT01933672|3599298|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
1470008|NCT01933672|3599292|P7|COMPLETED|Second Washout Period (7-14 Days)||6
1470009|NCT01933672|3599293|P6|COMPLETED|Second Washout Period (7-14 Days)||4
1470010|NCT01933672|3599294|P5|COMPLETED|Second Washout Period (7-14 Days)||6
1470011|NCT01933672|3599295|P4|COMPLETED|Second Washout Period (7-14 Days)||5
1470012|NCT01933672|3599296|P3|COMPLETED|Second Washout Period (7-14 Days)||1
1470013|NCT01933672|3599297|P2|COMPLETED|Second Washout Period (7-14 Days)||6
1470014|NCT01933672|3599298|P1|COMPLETED|Second Washout Period (7-14 Days)||0
1470015|NCT01933672|3599292|P7|STARTED|Second Washout Period (7-14 Days)||6
1470016|NCT01933672|3599293|P6|STARTED|Second Washout Period (7-14 Days)||4
1470017|NCT01933672|3599294|P5|STARTED|Second Washout Period (7-14 Days)||6
1470018|NCT01933672|3599295|P4|STARTED|Second Washout Period (7-14 Days)||5
1470019|NCT01933672|3599296|P3|STARTED|Second Washout Period (7-14 Days)||1
1470020|NCT01933672|3599297|P2|STARTED|Second Washout Period (7-14 Days)||6
1470021|NCT01933672|3599298|P1|STARTED|Second Washout Period (7-14 Days)||0
1470022|NCT01933672|3599292|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1470023|NCT01933672|3599293|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1470024|NCT01933672|3599294|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1470025|NCT01933672|3599295|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1470026|NCT01933672|3599296|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
1470027|NCT01933672|3599297|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
1470028|NCT01933672|3599298|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
1470029|NCT01933672|3599292|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
1470030|NCT01933672|3599293|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
1470031|NCT01933672|3599294|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
1470032|NCT01933672|3599295|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
1470033|NCT01933672|3599296|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
1470034|NCT01933672|3599297|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
1470035|NCT01933672|3599298|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
1470036|NCT01933672|3599292|P7|STARTED|Second Intervention Period (12-16 Days)||6
1470037|NCT01933672|3599293|P6|STARTED|Second Intervention Period (12-16 Days)||4
1470038|NCT01933672|3599294|P5|STARTED|Second Intervention Period (12-16 Days)||6
1470039|NCT01933672|3599295|P4|STARTED|Second Intervention Period (12-16 Days)||5
1470040|NCT01933672|3599296|P3|STARTED|Second Intervention Period (12-16 Days)||2
1470041|NCT01933672|3599297|P2|STARTED|Second Intervention Period (12-16 Days)||7
1470042|NCT01933672|3599298|P1|STARTED|Second Intervention Period (12-16 Days)||0
1470043|NCT01933672|3599292|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
1470044|NCT01933672|3599293|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
1470045|NCT01933672|3599294|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
1470046|NCT01933672|3599295|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
1470047|NCT01933672|3599296|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
1470048|NCT01933672|3599297|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
1470049|NCT01933672|3599298|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
1470050|NCT01933672|3599292|P7|COMPLETED|First Washout Period (7-14 Days)||6
1470051|NCT01933672|3599293|P6|COMPLETED|First Washout Period (7-14 Days)||4
1470052|NCT01933672|3599294|P5|COMPLETED|First Washout Period (7-14 Days)||6
1470053|NCT01933672|3599295|P4|COMPLETED|First Washout Period (7-14 Days)||5
1470054|NCT01933672|3599296|P3|COMPLETED|First Washout Period (7-14 Days)||2
1470055|NCT01933672|3599297|P2|COMPLETED|First Washout Period (7-14 Days)||7
1470056|NCT01933672|3599298|P1|COMPLETED|First Washout Period (7-14 Days)||0
1470057|NCT01933672|3599292|P7|STARTED|First Washout Period (7-14 Days)||6
1470058|NCT01933672|3599293|P6|STARTED|First Washout Period (7-14 Days)||4
1470059|NCT01933672|3599294|P5|STARTED|First Washout Period (7-14 Days)||6
1470060|NCT01933672|3599295|P4|STARTED|First Washout Period (7-14 Days)||5
1470061|NCT01933672|3599296|P3|STARTED|First Washout Period (7-14 Days)||2
1470062|NCT01933672|3599297|P2|STARTED|First Washout Period (7-14 Days)||7
1470063|NCT01933672|3599298|P1|STARTED|First Washout Period (7-14 Days)||0
1470064|NCT01933672|3599292|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
1470065|NCT01933672|3599293|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
1470066|NCT01933672|3599294|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
1470411|NCT01930045|3600432|P5|NOT COMPLETED|Part 2 - Period 5||0
1470067|NCT01933672|3599295|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
1470068|NCT01933672|3599296|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
1470069|NCT01933672|3599297|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
1470070|NCT01933672|3599298|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
1470071|NCT01933672|3599292|P7|COMPLETED|First Intervention Period (12-16 Days)||6
1470072|NCT01933672|3599293|P6|COMPLETED|First Intervention Period (12-16 Days)||4
1470073|NCT01933672|3599294|P5|COMPLETED|First Intervention Period (12-16 Days)||6
1470074|NCT01933672|3599295|P4|COMPLETED|First Intervention Period (12-16 Days)||5
1470075|NCT01933672|3599296|P3|COMPLETED|First Intervention Period (12-16 Days)||2
1470076|NCT01933672|3599297|P2|COMPLETED|First Intervention Period (12-16 Days)||7
1470077|NCT01933672|3599298|P1|COMPLETED|First Intervention Period (12-16 Days)||0
1470078|NCT01933672|3599292|P7|STARTED|First Intervention Period (12-16 Days)||6
1470079|NCT01933672|3599293|P6|STARTED|First Intervention Period (12-16 Days)||5
1470080|NCT01933672|3599294|P5|STARTED|First Intervention Period (12-16 Days)||7
1470081|NCT01933672|3599295|P4|STARTED|First Intervention Period (12-16 Days)||5
1470082|NCT01933672|3599296|P3|STARTED|First Intervention Period (12-16 Days)||3
1470083|NCT01933672|3599297|P2|STARTED|First Intervention Period (12-16 Days)||7
1470084|NCT01933672|3599298|P1|STARTED|First Intervention Period (12-16 Days)||0
1470085|NCT01933672|3599292|P7|NOT COMPLETED|Metformin Run-in Period||0
1470086|NCT01933672|3599293|P6|NOT COMPLETED|Metformin Run-in Period||0
1470087|NCT01933672|3599294|P5|NOT COMPLETED|Metformin Run-in Period||0
1470088|NCT01933672|3599295|P4|NOT COMPLETED|Metformin Run-in Period||0
1470089|NCT01933672|3599296|P3|NOT COMPLETED|Metformin Run-in Period||0
1470090|NCT01933672|3599297|P2|NOT COMPLETED|Metformin Run-in Period||0
1470091|NCT01933672|3599298|P1|NOT COMPLETED|Metformin Run-in Period||10
1470092|NCT01933672|3599292|P7|COMPLETED|Metformin Run-in Period||0
1470093|NCT01933672|3599293|P6|COMPLETED|Metformin Run-in Period||0
1470094|NCT01933672|3599294|P5|COMPLETED|Metformin Run-in Period||0
1470095|NCT01933672|3599295|P4|COMPLETED|Metformin Run-in Period||0
1470096|NCT01933672|3599296|P3|COMPLETED|Metformin Run-in Period||0
1470097|NCT01933672|3599297|P2|COMPLETED|Metformin Run-in Period||0
1470098|NCT01933672|3599298|P1|COMPLETED|Metformin Run-in Period||33
1470099|NCT01933672|3599292|P7|Received Treatment|Metformin Run-in Period||0
1470100|NCT01933672|3599293|P6|Received Treatment|Metformin Run-in Period||0
1470101|NCT01933672|3599294|P5|Received Treatment|Metformin Run-in Period||0
1470102|NCT01933672|3599295|P4|Received Treatment|Metformin Run-in Period||0
1470103|NCT01933672|3599296|P3|Received Treatment|Metformin Run-in Period||0
1470104|NCT01933672|3599297|P2|Received Treatment|Metformin Run-in Period||0
1470105|NCT01933672|3599298|P1|Received Treatment|Metformin Run-in Period||43
1470106|NCT01933672|3599292|P7|STARTED|Metformin Run-in Period||0
1470107|NCT01933672|3599293|P6|STARTED|Metformin Run-in Period||0
1470108|NCT01933672|3599294|P5|STARTED|Metformin Run-in Period||0
1470109|NCT01933672|3599295|P4|STARTED|Metformin Run-in Period||0
1470110|NCT01933672|3599296|P3|STARTED|Metformin Run-in Period||0
1470111|NCT01933672|3599297|P2|STARTED|Metformin Run-in Period||0
1470112|NCT01933672|3599298|P1|STARTED|Metformin Run-in Period||43
1470113|NCT01933425|3599344|P2|NOT COMPLETED|Overall Study||0
1470114|NCT01933425|3599345|P1|NOT COMPLETED|Overall Study||0
1470115|NCT01933425|3599344|P2|COMPLETED|Overall Study||7
1470116|NCT01933425|3599345|P1|COMPLETED|Overall Study||7
1470117|NCT01933425|3599344|P2|STARTED|Overall Study||7
1470118|NCT01933425|3599345|P1|STARTED|Overall Study||7
1470119|NCT01933399|3599358|P3|NOT COMPLETED|Overall Study||0
1470120|NCT01933399|3599359|P2|NOT COMPLETED|Overall Study||0
1470121|NCT01933399|3599360|P1|NOT COMPLETED|Overall Study||0
1470122|NCT01933399|3599358|P3|COMPLETED|Overall Study||37
1470123|NCT01933399|3599359|P2|COMPLETED|Overall Study||32
1470124|NCT01933399|3599360|P1|COMPLETED|Overall Study||29
1470125|NCT01933399|3599358|P3|STARTED|Overall Study||37
1470126|NCT01933399|3599359|P2|STARTED|Overall Study||32
1470127|NCT01933399|3599360|P1|STARTED|Overall Study||29
1470128|NCT01933334|3599373|P2|NOT COMPLETED|Overall Study||2
1470129|NCT01933334|3599374|P1|NOT COMPLETED|Overall Study||5
1470130|NCT01933334|3599373|P2|COMPLETED|Overall Study||29
1470131|NCT01933334|3599374|P1|COMPLETED|Overall Study||27
1470132|NCT01933334|3599373|P2|STARTED|Overall Study||31
1470133|NCT01933334|3599374|P1|STARTED|Overall Study||32
1470134|NCT01933243|3599386|P2|NOT COMPLETED|Overall Study||4
1470135|NCT01933243|3599387|P1|NOT COMPLETED|Overall Study||2
1470136|NCT01933243|3599386|P2|COMPLETED|Overall Study||8
1470137|NCT01933243|3599387|P1|COMPLETED|Overall Study||10
1470138|NCT01933243|3599386|P2|STARTED|Overall Study||12
1470139|NCT01933243|3599387|P1|STARTED|Overall Study||12
1470140|NCT01933230|3599397|P1|NOT COMPLETED|Overall Study||0
1470141|NCT01933230|3599397|P1|COMPLETED|Overall Study||2
1470142|NCT01933230|3599397|P1|STARTED|Overall Study||2
1470143|NCT01933048|3599403|P2|NOT COMPLETED|Overall Study||28
1470144|NCT01933048|3599404|P1|NOT COMPLETED|Overall Study||25
1470145|NCT01933048|3599403|P2|COMPLETED|Overall Study||501
1470146|NCT01933048|3599404|P1|COMPLETED|Overall Study||523
1470147|NCT01933048|3599403|P2|STARTED|Overall Study||529
1470148|NCT01933048|3599404|P1|STARTED|Overall Study||548
1470149|NCT01932970|3599417|P1|NOT COMPLETED|Overall Study||18
1470150|NCT01932970|3599417|P1|COMPLETED|Overall Study||140
1470151|NCT01932970|3599417|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
1470238|NCT01931839|3599941|P7|Safety Analysis Set (As Dosed)|Overall Study||60
1470152|NCT01932970|3599417|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
1470153|NCT01932788|3599427|P2|NOT COMPLETED|Overall Study||51
1470154|NCT01932788|3599428|P1|NOT COMPLETED|Overall Study||38
1470155|NCT01932788|3599427|P2|COMPLETED|Overall Study||118
1470156|NCT01932788|3599428|P1|COMPLETED|Overall Study||135
1470157|NCT01932788|3599427|P2|STARTED|Overall Study||169
1470158|NCT01932788|3599428|P1|STARTED|Overall Study||173
1470159|NCT01932762|3599438|P4|NOT COMPLETED|Overall Study||1
1470160|NCT01932762|3599439|P3|NOT COMPLETED|Overall Study||0
1470161|NCT01932762|3599440|P2|NOT COMPLETED|Overall Study||2
1470162|NCT01932762|3599441|P1|NOT COMPLETED|Overall Study||6
1470163|NCT01932762|3599438|P4|COMPLETED|Overall Study||18
1470164|NCT01932762|3599439|P3|COMPLETED|Overall Study||19
1470165|NCT01932762|3599440|P2|COMPLETED|Overall Study||28
1470166|NCT01932762|3599441|P1|COMPLETED|Overall Study||24
1470167|NCT01932762|3599438|P4|STARTED|Overall Study||19
1470168|NCT01932762|3599439|P3|STARTED|Overall Study||19
1470169|NCT01932762|3599440|P2|STARTED|Overall Study||30
1470170|NCT01932762|3599441|P1|STARTED|Overall Study||30
1470171|NCT01932606|3599477|P2|NOT COMPLETED|Overall Study||0
1470172|NCT01932606|3599478|P1|NOT COMPLETED|Overall Study||0
1470173|NCT01932606|3599477|P2|COMPLETED|Overall Study||14
1470174|NCT01932606|3599478|P1|COMPLETED|Overall Study||14
1470175|NCT01932606|3599477|P2|STARTED|Overall Study||14
1470176|NCT01932606|3599478|P1|STARTED|Overall Study||14
1470177|NCT01932294|3599528|P1|NOT COMPLETED|Overall Study||99
1470178|NCT01932294|3599528|P1|COMPLETED|Overall Study||72
1470179|NCT01932294|3599528|P1|STARTED|Overall Study||171
1470180|NCT01932164|3599534|P1|NOT COMPLETED|Overall Study||0
1470181|NCT01932164|3599534|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
1470182|NCT01932164|3599534|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
1470183|NCT01932164|3599534|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
1470184|NCT01932164|3599534|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
1470185|NCT01932164|3599534|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
1470186|NCT01932164|3599534|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
1470187|NCT01932164|3599534|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
1470188|NCT01932112|3599539|P1|NOT COMPLETED|Overall Study||0
1470189|NCT01932112|3599539|P1|COMPLETED|Overall Study||378
1470190|NCT01932112|3599539|P1|STARTED|Overall Study||378
1470191|NCT01932060|3599545|P2|NOT COMPLETED|Overall Study||0
1470192|NCT01932060|3599546|P1|NOT COMPLETED|Overall Study||0
1470193|NCT01932060|3599545|P2|COMPLETED|Overall Study||24
1470194|NCT01932060|3599546|P1|COMPLETED|Overall Study||27
1470195|NCT01932060|3599545|P2|STARTED|Overall Study||24
1470196|NCT01932060|3599546|P1|STARTED|Overall Study||27
1470197|NCT01931956|3599558|P4|NOT COMPLETED|Overall Study||133
1470198|NCT01931956|3599559|P3|NOT COMPLETED|Overall Study||487
1470199|NCT01931956|3599560|P2|NOT COMPLETED|Overall Study||7
1470200|NCT01931956|3599561|P1|NOT COMPLETED|Overall Study||51
1470201|NCT01931956|3599558|P4|COMPLETED|Overall Study||138
1470202|NCT01931956|3599559|P3|COMPLETED|Overall Study||141
1470203|NCT01931956|3599560|P2|COMPLETED|Overall Study||0
1470204|NCT01931956|3599561|P1|COMPLETED|Overall Study||8
1470205|NCT01931956|3599558|P4|STARTED|Overall Study||271
1470206|NCT01931956|3599559|P3|STARTED|Overall Study||628
1470207|NCT01931956|3599560|P2|STARTED|Overall Study||7
1470208|NCT01931956|3599561|P1|STARTED|Overall Study||59
1470209|NCT01931878|3599917|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
1470210|NCT01931878|3599918|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
1470211|NCT01931878|3599917|P2|COMPLETED|Second Intervention (After 3 Months)||12
1470212|NCT01931878|3599918|P1|COMPLETED|Second Intervention (After 3 Months)||9
1470213|NCT01931878|3599917|P2|STARTED|Second Intervention (After 3 Months)||14
1470214|NCT01931878|3599918|P1|STARTED|Second Intervention (After 3 Months)||9
1470215|NCT01931878|3599917|P2|NOT COMPLETED|First Intervention||0
1470216|NCT01931878|3599918|P1|NOT COMPLETED|First Intervention||1
1470217|NCT01931878|3599917|P2|COMPLETED|First Intervention||14
1470218|NCT01931878|3599918|P1|COMPLETED|First Intervention||9
1470219|NCT01931878|3599917|P2|STARTED|First Intervention||14
1470220|NCT01931878|3599918|P1|STARTED|First Intervention||10
1470221|NCT01931865|3599928|P1|NOT COMPLETED|Overall Study||4
1470222|NCT01931865|3599928|P1|COMPLETED|Overall Study||8
1470223|NCT01931865|3599928|P1|STARTED|Overall Study||12
1470224|NCT01931839|3599941|P7|NOT COMPLETED|Overall Study||4
1470225|NCT01931839|3599942|P6|NOT COMPLETED|Overall Study||5
1470226|NCT01931839|3599943|P5|NOT COMPLETED|Overall Study||1
1470227|NCT01931839|3599944|P4|NOT COMPLETED|Overall Study||14
1470228|NCT01931839|3599945|P3|NOT COMPLETED|Overall Study||39
1470229|NCT01931839|3599946|P2|NOT COMPLETED|Overall Study||26
1470230|NCT01931839|3599947|P1|NOT COMPLETED|Overall Study||41
1470231|NCT01931839|3599941|P7|COMPLETED|Overall Study||56
1470232|NCT01931839|3599942|P6|COMPLETED|Overall Study||50
1470233|NCT01931839|3599943|P5|COMPLETED|Overall Study||18
1470234|NCT01931839|3599944|P4|COMPLETED|Overall Study||162
1470235|NCT01931839|3599945|P3|COMPLETED|Overall Study||301
1470236|NCT01931839|3599946|P2|COMPLETED|Overall Study||152
1470237|NCT01931839|3599947|P1|COMPLETED|Overall Study||294
1470239|NCT01931839|3599942|P6|Safety Analysis Set (As Dosed)|Overall Study||55
1470240|NCT01931839|3599943|P5|Safety Analysis Set (As Dosed)|Overall Study||19
1470241|NCT01931839|3599944|P4|Safety Analysis Set (As Dosed)|Overall Study||176
1470242|NCT01931839|3599945|P3|Safety Analysis Set (As Dosed)|Overall Study||340
1470243|NCT01931839|3599946|P2|Safety Analysis Set (As Dosed)|Overall Study||178
1470244|NCT01931839|3599947|P1|Safety Analysis Set (As Dosed)|Overall Study||335
1470245|NCT01931839|3599941|P7|Full Analysis Set (As Randomized)|Overall Study||60
1470246|NCT01931839|3599942|P6|Full Analysis Set (As Randomized)|Overall Study||55
1470247|NCT01931839|3599943|P5|Full Analysis Set (As Randomized)|Overall Study||19
1470248|NCT01931839|3599944|P4|Full Analysis Set (As Randomized)|Overall Study||176
1470249|NCT01931839|3599945|P3|Full Analysis Set (As Randomized)|Overall Study||340
1470250|NCT01931839|3599946|P2|Full Analysis Set (As Randomized)|Overall Study||179
1470251|NCT01931839|3599947|P1|Full Analysis Set (As Randomized)|Overall Study||334
1470252|NCT01931839|3599941|P7|STARTED|Overall Study||60
1470253|NCT01931839|3599942|P6|STARTED|Overall Study||55
1470254|NCT01931839|3599943|P5|STARTED|Overall Study||19
1470255|NCT01931839|3599944|P4|STARTED|Overall Study||176
1470256|NCT01931839|3599945|P3|STARTED|Overall Study||340
1470257|NCT01931839|3599946|P2|STARTED|Overall Study||178
1470258|NCT01931839|3599947|P1|STARTED|Overall Study||335
1470259|NCT01931735|3600019|P4|NOT COMPLETED|Observational Non-Randomized Phase||2
1470260|NCT01931735|3600020|P3|NOT COMPLETED|Observational Non-Randomized Phase||0
1470261|NCT01931735|3600021|P2|NOT COMPLETED|Observational Non-Randomized Phase||0
1470262|NCT01931735|3600022|P1|NOT COMPLETED|Observational Non-Randomized Phase||0
1470263|NCT01931735|3600019|P4|COMPLETED|Observational Non-Randomized Phase||9
1470264|NCT01931735|3600020|P3|COMPLETED|Observational Non-Randomized Phase||0
1470265|NCT01931735|3600021|P2|COMPLETED|Observational Non-Randomized Phase||1
1470266|NCT01931735|3600022|P1|COMPLETED|Observational Non-Randomized Phase||2
1470267|NCT01931735|3600019|P4|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
1470268|NCT01931735|3600020|P3|STARTED|Observational Non-Randomized Phase||0
1470269|NCT01931735|3600021|P2|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
1470270|NCT01931735|3600022|P1|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
1470271|NCT01931735|3600019|P4|NOT COMPLETED|Randomized Phase||0
1470272|NCT01931735|3600020|P3|NOT COMPLETED|Randomized Phase||5
1470273|NCT01931735|3600021|P2|NOT COMPLETED|Randomized Phase||2
1470274|NCT01931735|3600022|P1|NOT COMPLETED|Randomized Phase||2
1470275|NCT01931735|3600019|P4|COMPLETED|Randomized Phase||0
1470276|NCT01931735|3600020|P3|COMPLETED|Randomized Phase||4
1470277|NCT01931735|3600021|P2|COMPLETED|Randomized Phase||1
1470278|NCT01931735|3600022|P1|COMPLETED|Randomized Phase||2
1470279|NCT01931735|3600019|P4|STARTED|Randomized Phase||0
1470280|NCT01931735|3600020|P3|STARTED|Randomized Phase||9
1470281|NCT01931735|3600021|P2|STARTED|Randomized Phase||3
1470282|NCT01931735|3600022|P1|STARTED|Randomized Phase||4
1470283|NCT01931709|3600056|P1|NOT COMPLETED|Overall Study||0
1470284|NCT01931709|3600056|P1|COMPLETED|Overall Study||35
1470285|NCT01931709|3600056|P1|STARTED|Overall Study||35
1470286|NCT01931670|3600069|P3|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
1470287|NCT01931670|3600070|P2|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
1470288|NCT01931670|3600071|P1|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
1470289|NCT01931670|3600069|P3|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
1470290|NCT01931670|3600070|P2|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
1470291|NCT01931670|3600071|P1|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
1470292|NCT01931670|3600069|P3|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
1470293|NCT01931670|3600070|P2|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
1470294|NCT01931670|3600071|P1|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
1470295|NCT01931670|3600069|P3|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
1470296|NCT01931670|3600070|P2|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
1470297|NCT01931670|3600071|P1|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
1470298|NCT01931670|3600069|P3|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
1470299|NCT01931670|3600070|P2|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
1470300|NCT01931670|3600071|P1|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
1470301|NCT01931670|3600069|P3|NOT COMPLETED|Treatment Period||45
1470302|NCT01931670|3600070|P2|NOT COMPLETED|Treatment Period||48
1470303|NCT01931670|3600071|P1|NOT COMPLETED|Treatment Period||90
1470304|NCT01931670|3600069|P3|COMPLETED|Treatment Period||184
1470305|NCT01931670|3600070|P2|COMPLETED|Treatment Period||178
1470306|NCT01931670|3600071|P1|COMPLETED|Treatment Period||270
1470307|NCT01931670|3600069|P3|STARTED|Treatment Period||229
1470308|NCT01931670|3600070|P2|STARTED|Treatment Period||226
1470309|NCT01931670|3600071|P1|STARTED|Treatment Period||360
1470310|NCT01931527|3600171|P2|NOT COMPLETED|Overall Study||0
1470311|NCT01931527|3600172|P1|NOT COMPLETED|Overall Study||0
1470312|NCT01931527|3600171|P2|COMPLETED|Overall Study||15
1470313|NCT01931527|3600172|P1|COMPLETED|Overall Study||16
1470314|NCT01931527|3600171|P2|STARTED|Overall Study||15
1470315|NCT01931527|3600172|P1|STARTED|Overall Study||16
1470316|NCT01931475|3600194|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
1470317|NCT01931475|3600195|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
1470318|NCT01931475|3600194|P2|COMPLETED|Period 2: Extension Treatment Phase||157
1470319|NCT01931475|3600195|P1|COMPLETED|Period 2: Extension Treatment Phase||162
1470320|NCT01931475|3600194|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
1470321|NCT01931475|3600195|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
1470322|NCT01931475|3600194|P2|STARTED|Period 2: Extension Treatment Phase||176
1470323|NCT01931475|3600195|P1|STARTED|Period 2: Extension Treatment Phase||166
1470324|NCT01931475|3600194|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
1470325|NCT01931475|3600195|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
1470326|NCT01931475|3600194|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
1470327|NCT01931475|3600195|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
1470328|NCT01931475|3600194|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
1470329|NCT01931475|3600195|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
1470330|NCT01931475|3600194|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
1470331|NCT01931475|3600195|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
1470332|NCT01931462|3600222|P1|NOT COMPLETED|Overall Study||1
1470333|NCT01931462|3600222|P1|COMPLETED|Overall Study||1
1470334|NCT01931462|3600222|P1|STARTED|Overall Study||2
1470335|NCT01931397|3600233|P1|NOT COMPLETED|Overall Study||11
1470336|NCT01931397|3600233|P1|COMPLETED|Overall Study||19
1470337|NCT01931397|3600233|P1|STARTED|Overall Study||30
1470338|NCT01931150|3600244|P2|NOT COMPLETED|Overall Study||2
1470339|NCT01931150|3600245|P1|NOT COMPLETED|Overall Study||1
1470340|NCT01931150|3600244|P2|COMPLETED|Overall Study||4
1470341|NCT01931150|3600245|P1|COMPLETED|Overall Study||4
1470342|NCT01931150|3600244|P2|STARTED|Overall Study||6
1470343|NCT01931150|3600245|P1|STARTED|Overall Study||5
1470344|NCT01931059|3600253|P2|NOT COMPLETED|Day3||0
1470345|NCT01931059|3600254|P1|NOT COMPLETED|Day3||1
1470346|NCT01931059|3600253|P2|COMPLETED|Day3||4
1470347|NCT01931059|3600254|P1|COMPLETED|Day3||5
1470348|NCT01931059|3600253|P2|STARTED|Day3||4
1470349|NCT01931059|3600254|P1|STARTED|Day3||6
1470350|NCT01931059|3600253|P2|NOT COMPLETED|Day2||0
1470351|NCT01931059|3600254|P1|NOT COMPLETED|Day2||0
1470352|NCT01931059|3600253|P2|COMPLETED|Day2||4
1470353|NCT01931059|3600254|P1|COMPLETED|Day2||6
1470354|NCT01931059|3600253|P2|STARTED|Day2||4
1470355|NCT01931059|3600254|P1|STARTED|Day2||6
1470356|NCT01931059|3600253|P2|NOT COMPLETED|Day 1||1
1470357|NCT01931059|3600254|P1|NOT COMPLETED|Day 1||0
1470358|NCT01931059|3600253|P2|COMPLETED|Day 1||4
1470359|NCT01931059|3600254|P1|COMPLETED|Day 1||6
1470360|NCT01931059|3600253|P2|STARTED|Day 1||5
1470361|NCT01931059|3600254|P1|STARTED|Day 1||6
1470362|NCT01930890|3600270|P4|NOT COMPLETED|Overall Study||27
1470363|NCT01930890|3600271|P3|NOT COMPLETED|Overall Study||13
1470364|NCT01930890|3600272|P2|NOT COMPLETED|Overall Study||33
1470365|NCT01930890|3600273|P1|NOT COMPLETED|Overall Study||14
1470366|NCT01930890|3600270|P4|COMPLETED|Overall Study||0
1470367|NCT01930890|3600271|P3|COMPLETED|Overall Study||0
1470368|NCT01930890|3600272|P2|COMPLETED|Overall Study||0
1470369|NCT01930890|3600273|P1|COMPLETED|Overall Study||0
1470370|NCT01930890|3600270|P4|STARTED|Overall Study||27
1470371|NCT01930890|3600271|P3|STARTED|Overall Study||13
1470372|NCT01930890|3600272|P2|STARTED|Overall Study||33
1470373|NCT01930890|3600273|P1|STARTED|Overall Study||14
1470374|NCT01930799|3600287|P1|NOT COMPLETED|Overall Study||8
1470375|NCT01930799|3600287|P1|COMPLETED|Overall Study||112
1470376|NCT01930799|3600287|P1|STARTED|Overall Study||120
1470377|NCT01930487|3600292|P2|NOT COMPLETED|Second Intervention (30 Days)||0
1470378|NCT01930487|3600293|P1|NOT COMPLETED|Second Intervention (30 Days)||0
1470379|NCT01930487|3600292|P2|COMPLETED|Second Intervention (30 Days)||23
1470380|NCT01930487|3600293|P1|COMPLETED|Second Intervention (30 Days)||19
1470381|NCT01930487|3600292|P2|STARTED|Second Intervention (30 Days)||23
1470382|NCT01930487|3600293|P1|STARTED|Second Intervention (30 Days)||19
1470383|NCT01930487|3600292|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
1470384|NCT01930487|3600293|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
1470385|NCT01930487|3600292|P2|COMPLETED|Washout Period (3 Weeks)||23
1470386|NCT01930487|3600293|P1|COMPLETED|Washout Period (3 Weeks)||19
1470387|NCT01930487|3600292|P2|STARTED|Washout Period (3 Weeks)||23
1470388|NCT01930487|3600293|P1|STARTED|Washout Period (3 Weeks)||19
1470389|NCT01930487|3600292|P2|NOT COMPLETED|First Intervention (30 Days)||2
1470390|NCT01930487|3600293|P1|NOT COMPLETED|First Intervention (30 Days)||2
1470391|NCT01930487|3600292|P2|COMPLETED|First Intervention (30 Days)||23
1470392|NCT01930487|3600293|P1|COMPLETED|First Intervention (30 Days)||19
1470393|NCT01930487|3600292|P2|STARTED|First Intervention (30 Days)||25
1470394|NCT01930487|3600293|P1|STARTED|First Intervention (30 Days)||21
1470395|NCT01930435|3600387|P1|NOT COMPLETED|Overall Study||0
1470396|NCT01930435|3600387|P1|COMPLETED|Overall Study||20
1470397|NCT01930435|3600387|P1|STARTED|Overall Study||20
1470398|NCT01930162|3600395|P1|NOT COMPLETED|Overall Study||5
1470399|NCT01930162|3600395|P1|COMPLETED|Overall Study||4
1470400|NCT01930162|3600395|P1|STARTED|Overall Study||9
1470401|NCT01930058|3600407|P3|NOT COMPLETED|Overall Study||0
1470402|NCT01930058|3600408|P2|NOT COMPLETED|Overall Study||0
1470403|NCT01930058|3600409|P1|NOT COMPLETED|Overall Study||0
1470404|NCT01930058|3600407|P3|COMPLETED|Overall Study||3
1470405|NCT01930058|3600408|P2|COMPLETED|Overall Study||3
1470406|NCT01930058|3600409|P1|COMPLETED|Overall Study||3
1470407|NCT01930058|3600407|P3|STARTED|Overall Study||3
1470408|NCT01930058|3600408|P2|STARTED|Overall Study||3
1470409|NCT01930058|3600409|P1|STARTED|Overall Study||3
1470410|NCT01930045|3600431|P6|NOT COMPLETED|Part 2 - Period 5||0
1470412|NCT01930045|3600433|P4|NOT COMPLETED|Part 2 - Period 5||0
1470413|NCT01930045|3600434|P3|NOT COMPLETED|Part 2 - Period 5||0
1470414|NCT01930045|3600435|P2|NOT COMPLETED|Part 2 - Period 5||0
1470415|NCT01930045|3600436|P1|NOT COMPLETED|Part 2 - Period 5||0
1470416|NCT01930045|3600431|P6|COMPLETED|Part 2 - Period 5||1
1470417|NCT01930045|3600432|P5|COMPLETED|Part 2 - Period 5||3
1470418|NCT01930045|3600433|P4|COMPLETED|Part 2 - Period 5||3
1470419|NCT01930045|3600434|P3|COMPLETED|Part 2 - Period 5||3
1470420|NCT01930045|3600435|P2|COMPLETED|Part 2 - Period 5||3
1470421|NCT01930045|3600436|P1|COMPLETED|Part 2 - Period 5||3
1470422|NCT01930045|3600431|P6|STARTED|Part 2 - Period 5||1
1470423|NCT01930045|3600432|P5|STARTED|Part 2 - Period 5||3
1470424|NCT01930045|3600433|P4|STARTED|Part 2 - Period 5||3
1470425|NCT01930045|3600434|P3|STARTED|Part 2 - Period 5||3
1470426|NCT01930045|3600435|P2|STARTED|Part 2 - Period 5||3
1470427|NCT01930045|3600436|P1|STARTED|Part 2 - Period 5||3
1470428|NCT01930045|3600431|P6|NOT COMPLETED|Part 2 - Period 4||0
1470429|NCT01930045|3600432|P5|NOT COMPLETED|Part 2 - Period 4||0
1470430|NCT01930045|3600433|P4|NOT COMPLETED|Part 2 - Period 4||0
1470431|NCT01930045|3600434|P3|NOT COMPLETED|Part 2 - Period 4||0
1470432|NCT01930045|3600435|P2|NOT COMPLETED|Part 2 - Period 4||0
1470433|NCT01930045|3600436|P1|NOT COMPLETED|Part 2 - Period 4||0
1470434|NCT01930045|3600431|P6|COMPLETED|Part 2 - Period 4||1
1470435|NCT01930045|3600432|P5|COMPLETED|Part 2 - Period 4||3
1470436|NCT01930045|3600433|P4|COMPLETED|Part 2 - Period 4||3
1470437|NCT01930045|3600434|P3|COMPLETED|Part 2 - Period 4||3
1470438|NCT01930045|3600435|P2|COMPLETED|Part 2 - Period 4||3
1470439|NCT01930045|3600436|P1|COMPLETED|Part 2 - Period 4||3
1470440|NCT01930045|3600431|P6|STARTED|Part 2 - Period 4||1
1470441|NCT01930045|3600432|P5|STARTED|Part 2 - Period 4||3
1470442|NCT01930045|3600433|P4|STARTED|Part 2 - Period 4||3
1470443|NCT01930045|3600434|P3|STARTED|Part 2 - Period 4||3
1470444|NCT01930045|3600435|P2|STARTED|Part 2 - Period 4||3
1470445|NCT01930045|3600436|P1|STARTED|Part 2 - Period 4||3
1470446|NCT01930045|3600431|P6|NOT COMPLETED|Pause (up to 37 Days)||2
1470447|NCT01930045|3600432|P5|NOT COMPLETED|Pause (up to 37 Days)||0
1470448|NCT01930045|3600433|P4|NOT COMPLETED|Pause (up to 37 Days)||0
1470449|NCT01930045|3600434|P3|NOT COMPLETED|Pause (up to 37 Days)||0
1470450|NCT01930045|3600435|P2|NOT COMPLETED|Pause (up to 37 Days)||0
1470451|NCT01930045|3600436|P1|NOT COMPLETED|Pause (up to 37 Days)||0
1470452|NCT01930045|3600431|P6|COMPLETED|Pause (up to 37 Days)||1
1470453|NCT01930045|3600432|P5|COMPLETED|Pause (up to 37 Days)||3
1470454|NCT01930045|3600433|P4|COMPLETED|Pause (up to 37 Days)||3
1470455|NCT01930045|3600434|P3|COMPLETED|Pause (up to 37 Days)||3
1470456|NCT01930045|3600435|P2|COMPLETED|Pause (up to 37 Days)||3
1470457|NCT01930045|3600436|P1|COMPLETED|Pause (up to 37 Days)||3
1470458|NCT01930045|3600431|P6|STARTED|Pause (up to 37 Days)||3
1470459|NCT01930045|3600432|P5|STARTED|Pause (up to 37 Days)||3
1470460|NCT01930045|3600433|P4|STARTED|Pause (up to 37 Days)||3
1470461|NCT01930045|3600434|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
1470462|NCT01930045|3600435|P2|STARTED|Pause (up to 37 Days)||3
1470463|NCT01930045|3600436|P1|STARTED|Pause (up to 37 Days)||3
1470464|NCT01930045|3600431|P6|NOT COMPLETED|Part 1 - Period 3||0
1470465|NCT01930045|3600432|P5|NOT COMPLETED|Part 1 - Period 3||0
1470466|NCT01930045|3600433|P4|NOT COMPLETED|Part 1 - Period 3||0
1470467|NCT01930045|3600434|P3|NOT COMPLETED|Part 1 - Period 3||0
1470468|NCT01930045|3600435|P2|NOT COMPLETED|Part 1 - Period 3||0
1470469|NCT01930045|3600436|P1|NOT COMPLETED|Part 1 - Period 3||0
1470470|NCT01930045|3600431|P6|COMPLETED|Part 1 - Period 3||3
1470471|NCT01930045|3600432|P5|COMPLETED|Part 1 - Period 3||3
1470472|NCT01930045|3600433|P4|COMPLETED|Part 1 - Period 3||3
1470473|NCT01930045|3600434|P3|COMPLETED|Part 1 - Period 3||2
1470474|NCT01930045|3600435|P2|COMPLETED|Part 1 - Period 3||3
1470475|NCT01930045|3600436|P1|COMPLETED|Part 1 - Period 3||3
1470476|NCT01930045|3600431|P6|STARTED|Part 1 - Period 3||3
1470477|NCT01930045|3600432|P5|STARTED|Part 1 - Period 3||3
1470478|NCT01930045|3600433|P4|STARTED|Part 1 - Period 3||3
1470479|NCT01930045|3600434|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
1470480|NCT01930045|3600435|P2|STARTED|Part 1 - Period 3||3
1470481|NCT01930045|3600436|P1|STARTED|Part 1 - Period 3||3
1470482|NCT01930045|3600431|P6|NOT COMPLETED|Part 1 - Period 2||0
1470483|NCT01930045|3600432|P5|NOT COMPLETED|Part 1 - Period 2||0
1470484|NCT01930045|3600433|P4|NOT COMPLETED|Part 1 - Period 2||0
1470485|NCT01930045|3600434|P3|NOT COMPLETED|Part 1 - Period 2||0
1470486|NCT01930045|3600435|P2|NOT COMPLETED|Part 1 - Period 2||0
1470487|NCT01930045|3600436|P1|NOT COMPLETED|Part 1 - Period 2||0
1470488|NCT01930045|3600431|P6|COMPLETED|Part 1 - Period 2||3
1470489|NCT01930045|3600432|P5|COMPLETED|Part 1 - Period 2||3
1470490|NCT01930045|3600433|P4|COMPLETED|Part 1 - Period 2||3
1470491|NCT01930045|3600434|P3|COMPLETED|Part 1 - Period 2||3
1470492|NCT01930045|3600435|P2|COMPLETED|Part 1 - Period 2||3
1470493|NCT01930045|3600436|P1|COMPLETED|Part 1 - Period 2||3
1470494|NCT01930045|3600431|P6|STARTED|Part 1 - Period 2||3
1470495|NCT01930045|3600432|P5|STARTED|Part 1 - Period 2||3
1470496|NCT01930045|3600433|P4|STARTED|Part 1 - Period 2||3
1470497|NCT01930045|3600434|P3|STARTED|Part 1 - Period 2||3
1470498|NCT01930045|3600435|P2|STARTED|Part 1 - Period 2||3
1470499|NCT01930045|3600436|P1|STARTED|Part 1 - Period 2||3
1470500|NCT01930045|3600431|P6|NOT COMPLETED|Part 1 - Period 1||0
1470501|NCT01930045|3600432|P5|NOT COMPLETED|Part 1 - Period 1||0
1470502|NCT01930045|3600433|P4|NOT COMPLETED|Part 1 - Period 1||0
1470503|NCT01930045|3600434|P3|NOT COMPLETED|Part 1 - Period 1||0
1470504|NCT01930045|3600435|P2|NOT COMPLETED|Part 1 - Period 1||0
1470505|NCT01930045|3600436|P1|NOT COMPLETED|Part 1 - Period 1||0
1470506|NCT01930045|3600431|P6|COMPLETED|Part 1 - Period 1||3
1470507|NCT01930045|3600432|P5|COMPLETED|Part 1 - Period 1||3
1470508|NCT01930045|3600433|P4|COMPLETED|Part 1 - Period 1||3
1470509|NCT01930045|3600434|P3|COMPLETED|Part 1 - Period 1||3
1470510|NCT01930045|3600435|P2|COMPLETED|Part 1 - Period 1||3
1470511|NCT01930045|3600436|P1|COMPLETED|Part 1 - Period 1||3
1470512|NCT01930045|3600431|P6|STARTED|Part 1 - Period 1||3
1470513|NCT01930045|3600432|P5|STARTED|Part 1 - Period 1||3
1470514|NCT01930045|3600433|P4|STARTED|Part 1 - Period 1||3
1470515|NCT01930045|3600434|P3|STARTED|Part 1 - Period 1||3
1470516|NCT01930045|3600435|P2|STARTED|Part 1 - Period 1||3
1470517|NCT01930045|3600436|P1|STARTED|Part 1 - Period 1||3
1470518|NCT01929993|3600463|P2|NOT COMPLETED|Overall Study||28
1470519|NCT01929993|3600464|P1|NOT COMPLETED|Overall Study||30
1470520|NCT01929993|3600463|P2|COMPLETED|Overall Study||54
1470521|NCT01929993|3600464|P1|COMPLETED|Overall Study||52
1470522|NCT01929993|3600463|P2|STARTED|Overall Study||82
1470523|NCT01929993|3600464|P1|STARTED|Overall Study||82
1470524|NCT01929980|3600470|P1|NOT COMPLETED|Overall Study||1
1470525|NCT01929980|3600470|P1|COMPLETED|Overall Study||3
1470526|NCT01929980|3600470|P1|STARTED|Overall Study||4
1470527|NCT01929889|3600474|P1|NOT COMPLETED|Overall Study||5
1470528|NCT01929889|3600474|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
1470529|NCT01929889|3600474|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
1470530|NCT01929876|3600478|P1|NOT COMPLETED|Period 2||1
1470531|NCT01929876|3600478|P1|COMPLETED|Period 2||15
1470532|NCT01929876|3600478|P1|STARTED|Period 2||16
1470533|NCT01929876|3600478|P1|NOT COMPLETED|Period 1||0
1470534|NCT01929876|3600478|P1|COMPLETED|Period 1||16
1470535|NCT01929876|3600478|P1|STARTED|Period 1||16
1470536|NCT01929863|3600491|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
1470537|NCT01929863|3600492|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
1470538|NCT01929863|3600491|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
1470539|NCT01929863|3600492|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
1470540|NCT01929863|3600491|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
1470541|NCT01929863|3600492|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
1470542|NCT01929863|3600491|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
1470543|NCT01929863|3600492|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
1470544|NCT01929863|3600491|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
1470545|NCT01929863|3600492|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
1470546|NCT01929863|3600491|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
1470547|NCT01929863|3600492|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
1470548|NCT01929863|3600491|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
1470549|NCT01929863|3600492|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
1470550|NCT01929863|3600491|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
1470551|NCT01929863|3600492|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
1470552|NCT01929863|3600491|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
1470553|NCT01929863|3600492|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
1470554|NCT01929863|3600491|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
1470555|NCT01929863|3600492|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
1470556|NCT01929863|3600491|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
1470557|NCT01929863|3600492|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
1470558|NCT01929863|3600491|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
1470559|NCT01929863|3600492|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
1470560|NCT01929759|3600535|P1|NOT COMPLETED|Overall Study||0
1470561|NCT01929759|3600535|P1|COMPLETED|Overall Study||10
1470562|NCT01929759|3600535|P1|STARTED|Overall Study||10
1470563|NCT01929707|3600547|P8|NOT COMPLETED|Intervention Period 2||0
1470564|NCT01929707|3600548|P7|NOT COMPLETED|Intervention Period 2||0
1470565|NCT01929707|3600549|P6|NOT COMPLETED|Intervention Period 2||2
1470566|NCT01929707|3600550|P5|NOT COMPLETED|Intervention Period 2||0
1470567|NCT01929707|3600551|P4|NOT COMPLETED|Intervention Period 2||0
1470568|NCT01929707|3600552|P3|NOT COMPLETED|Intervention Period 2||0
1470569|NCT01929707|3600553|P2|NOT COMPLETED|Intervention Period 2||0
1470570|NCT01929707|3600554|P1|NOT COMPLETED|Intervention Period 2||0
1470571|NCT01929707|3600547|P8|COMPLETED|Intervention Period 2||4
1470572|NCT01929707|3600548|P7|COMPLETED|Intervention Period 2||12
1470573|NCT01929707|3600549|P6|COMPLETED|Intervention Period 2||6
1470574|NCT01929707|3600550|P5|COMPLETED|Intervention Period 2||6
1470575|NCT01929707|3600551|P4|COMPLETED|Intervention Period 2||5
1470576|NCT01929707|3600552|P3|COMPLETED|Intervention Period 2||0
1470577|NCT01929707|3600553|P2|COMPLETED|Intervention Period 2||0
1470578|NCT01929707|3600554|P1|COMPLETED|Intervention Period 2||0
1470579|NCT01929707|3600547|P8|STARTED|Intervention Period 2|Incomplete-crossover design|4
1470580|NCT01929707|3600548|P7|STARTED|Intervention Period 2|Incomplete-crossover design|12
1470581|NCT01929707|3600549|P6|STARTED|Intervention Period 2|Incomplete-crossover design|8
1470582|NCT01929707|3600550|P5|STARTED|Intervention Period 2|Incomplete-crossover design|6
1470583|NCT01929707|3600551|P4|STARTED|Intervention Period 2|Incomplete-crossover design|5
1470584|NCT01929707|3600552|P3|STARTED|Intervention Period 2|Incomplete-crossover design|0
1470585|NCT01929707|3600553|P2|STARTED|Intervention Period 2|Incomplete-crossover design|0
1470586|NCT01929707|3600554|P1|STARTED|Intervention Period 2|Incomplete-crossover design|0
1470587|NCT01929707|3600547|P8|NOT COMPLETED|Washout Period ≥7 Days||0
1470588|NCT01929707|3600548|P7|NOT COMPLETED|Washout Period ≥7 Days||0
1470589|NCT01929707|3600549|P6|NOT COMPLETED|Washout Period ≥7 Days||0
1470590|NCT01929707|3600550|P5|NOT COMPLETED|Washout Period ≥7 Days||0
1470591|NCT01929707|3600551|P4|NOT COMPLETED|Washout Period ≥7 Days||0
1470592|NCT01929707|3600552|P3|NOT COMPLETED|Washout Period ≥7 Days||0
1470593|NCT01929707|3600553|P2|NOT COMPLETED|Washout Period ≥7 Days||0
1470594|NCT01929707|3600554|P1|NOT COMPLETED|Washout Period ≥7 Days||0
1470595|NCT01929707|3600547|P8|COMPLETED|Washout Period ≥7 Days||0
1470596|NCT01929707|3600548|P7|COMPLETED|Washout Period ≥7 Days||0
1470597|NCT01929707|3600549|P6|COMPLETED|Washout Period ≥7 Days||0
1470598|NCT01929707|3600550|P5|COMPLETED|Washout Period ≥7 Days||0
1470599|NCT01929707|3600551|P4|COMPLETED|Washout Period ≥7 Days||7
1470600|NCT01929707|3600552|P3|COMPLETED|Washout Period ≥7 Days||12
1470601|NCT01929707|3600553|P2|COMPLETED|Washout Period ≥7 Days||8
1470602|NCT01929707|3600554|P1|COMPLETED|Washout Period ≥7 Days||6
1470603|NCT01929707|3600547|P8|STARTED|Washout Period ≥7 Days||0
1470604|NCT01929707|3600548|P7|STARTED|Washout Period ≥7 Days||0
1470605|NCT01929707|3600549|P6|STARTED|Washout Period ≥7 Days||0
1470606|NCT01929707|3600550|P5|STARTED|Washout Period ≥7 Days||0
1470607|NCT01929707|3600551|P4|STARTED|Washout Period ≥7 Days||7
1470608|NCT01929707|3600552|P3|STARTED|Washout Period ≥7 Days||12
1470609|NCT01929707|3600553|P2|STARTED|Washout Period ≥7 Days||8
1470610|NCT01929707|3600554|P1|STARTED|Washout Period ≥7 Days||6
1470611|NCT01929707|3600547|P8|NOT COMPLETED|Intervention Period 1||0
1470612|NCT01929707|3600548|P7|NOT COMPLETED|Intervention Period 1||0
1470613|NCT01929707|3600549|P6|NOT COMPLETED|Intervention Period 1||0
1470614|NCT01929707|3600550|P5|NOT COMPLETED|Intervention Period 1||0
1470615|NCT01929707|3600551|P4|NOT COMPLETED|Intervention Period 1||3
1470616|NCT01929707|3600552|P3|NOT COMPLETED|Intervention Period 1||0
1470617|NCT01929707|3600553|P2|NOT COMPLETED|Intervention Period 1||0
1470618|NCT01929707|3600554|P1|NOT COMPLETED|Intervention Period 1||0
1470619|NCT01929707|3600547|P8|COMPLETED|Intervention Period 1||0
1470620|NCT01929707|3600548|P7|COMPLETED|Intervention Period 1||0
1470621|NCT01929707|3600549|P6|COMPLETED|Intervention Period 1||0
1470622|NCT01929707|3600550|P5|COMPLETED|Intervention Period 1||0
1470623|NCT01929707|3600551|P4|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
1470624|NCT01929707|3600552|P3|COMPLETED|Intervention Period 1||12
1470625|NCT01929707|3600553|P2|COMPLETED|Intervention Period 1||8
1470626|NCT01929707|3600554|P1|COMPLETED|Intervention Period 1||6
1470627|NCT01929707|3600547|P8|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
1470628|NCT01929707|3600548|P7|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
1470629|NCT01929707|3600549|P6|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
1470630|NCT01929707|3600550|P5|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
1470631|NCT01929707|3600551|P4|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
1470632|NCT01929707|3600552|P3|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
1470633|NCT01929707|3600553|P2|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
1470634|NCT01929707|3600554|P1|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
1470635|NCT01929707|3600547|P8|STARTED|Intervention Period 1||0
1470636|NCT01929707|3600548|P7|STARTED|Intervention Period 1||0
1470637|NCT01929707|3600549|P6|STARTED|Intervention Period 1||0
1470638|NCT01929707|3600550|P5|STARTED|Intervention Period 1||0
1470639|NCT01929707|3600551|P4|STARTED|Intervention Period 1||10
1470640|NCT01929707|3600552|P3|STARTED|Intervention Period 1||12
1470641|NCT01929707|3600553|P2|STARTED|Intervention Period 1||8
1470642|NCT01929707|3600554|P1|STARTED|Intervention Period 1||6
1470643|NCT01929681|3600586|P2|NOT COMPLETED|Overall Study||1
1470644|NCT01929681|3600587|P1|NOT COMPLETED|Overall Study||2
1470645|NCT01929681|3600586|P2|COMPLETED|Overall Study||24
1470646|NCT01929681|3600587|P1|COMPLETED|Overall Study||26
1470647|NCT01929681|3600586|P2|STARTED|Overall Study||25
1470648|NCT01929681|3600587|P1|STARTED|Overall Study||28
1470649|NCT01929473|3600601|P1|NOT COMPLETED|Overall Study||587
1470650|NCT01929473|3600601|P1|COMPLETED|Overall Study||3243
1470651|NCT01929473|3600601|P1|365 Day|Overall Study||3589
1470652|NCT01929473|3600601|P1|STARTED|Overall Study|0 day|3830
1470653|NCT01929460|3600607|P2|NOT COMPLETED|Overall Study||0
1470654|NCT01929460|3600608|P1|NOT COMPLETED|Overall Study||0
1470655|NCT01929460|3600607|P2|COMPLETED|Overall Study||13
1470656|NCT01929460|3600608|P1|COMPLETED|Overall Study||13
1470657|NCT01929460|3600607|P2|STARTED|Overall Study||13
1470658|NCT01929460|3600608|P1|STARTED|Overall Study||13
1470659|NCT01929317|3600632|P2|NOT COMPLETED|Long-term Phase||4
1470660|NCT01929317|3600633|P1|NOT COMPLETED|Long-term Phase||19
1470661|NCT01929317|3600632|P2|COMPLETED|Long-term Phase||14
1470662|NCT01929317|3600633|P1|COMPLETED|Long-term Phase||25
1470663|NCT01929317|3600632|P2|STARTED|Long-term Phase||18
1470664|NCT01929317|3600633|P1|STARTED|Long-term Phase||44
1470665|NCT01929317|3600632|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
1470666|NCT01929317|3600633|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
1470667|NCT01929317|3600632|P2|COMPLETED|Dose Increase Effect Verification Phase||19
1470668|NCT01929317|3600633|P1|COMPLETED|Dose Increase Effect Verification Phase||52
1470669|NCT01929317|3600632|P2|STARTED|Dose Increase Effect Verification Phase||20
1470670|NCT01929317|3600633|P1|STARTED|Dose Increase Effect Verification Phase||61
1470671|NCT01929135|3600702|P2|NOT COMPLETED|Overall Study||1
1470672|NCT01929135|3600703|P1|NOT COMPLETED|Overall Study||1
1470673|NCT01929135|3600702|P2|COMPLETED|Overall Study||18
1470674|NCT01929135|3600703|P1|COMPLETED|Overall Study||18
1470675|NCT01929135|3600702|P2|STARTED|Overall Study||19
1470676|NCT01929135|3600703|P1|STARTED|Overall Study||19
1470677|NCT01929109|3600722|P5|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1470678|NCT01929109|3600723|P4|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1470679|NCT01929109|3600724|P3|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1470680|NCT01929109|3600725|P2|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1470681|NCT01929109|3600726|P1|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1470682|NCT01929109|3600722|P5|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
1470683|NCT01929109|3600723|P4|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1470684|NCT01929109|3600724|P3|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1470685|NCT01929109|3600725|P2|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1470686|NCT01929109|3600726|P1|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
1470687|NCT01929109|3600722|P5|STARTED|Period 2 (End Stage Renal Disease Only)||8
1470688|NCT01929109|3600723|P4|STARTED|Period 2 (End Stage Renal Disease Only)||0
1470689|NCT01929109|3600724|P3|STARTED|Period 2 (End Stage Renal Disease Only)||0
1470690|NCT01929109|3600725|P2|STARTED|Period 2 (End Stage Renal Disease Only)||0
1470691|NCT01929109|3600726|P1|STARTED|Period 2 (End Stage Renal Disease Only)||0
1470692|NCT01929109|3600722|P5|NOT COMPLETED|Period 1 (All Groups)||0
1470693|NCT01929109|3600723|P4|NOT COMPLETED|Period 1 (All Groups)||0
1470694|NCT01929109|3600724|P3|NOT COMPLETED|Period 1 (All Groups)||1
1470695|NCT01929109|3600725|P2|NOT COMPLETED|Period 1 (All Groups)||0
1470696|NCT01929109|3600726|P1|NOT COMPLETED|Period 1 (All Groups)||0
1470697|NCT01929109|3600722|P5|COMPLETED|Period 1 (All Groups)||8
1470698|NCT01929109|3600723|P4|COMPLETED|Period 1 (All Groups)||8
1470699|NCT01929109|3600724|P3|COMPLETED|Period 1 (All Groups)||8
1470700|NCT01929109|3600725|P2|COMPLETED|Period 1 (All Groups)||8
1470701|NCT01929109|3600726|P1|COMPLETED|Period 1 (All Groups)||14
1470702|NCT01929109|3600722|P5|STARTED|Period 1 (All Groups)||8
1470703|NCT01929109|3600723|P4|STARTED|Period 1 (All Groups)||8
1470704|NCT01929109|3600724|P3|STARTED|Period 1 (All Groups)||9
1470705|NCT01929109|3600725|P2|STARTED|Period 1 (All Groups)||8
1470706|NCT01929109|3600726|P1|STARTED|Period 1 (All Groups)||14
1470707|NCT01929083|3600745|P2|NOT COMPLETED|Intervention 2||1
1470708|NCT01929083|3600746|P1|NOT COMPLETED|Intervention 2||0
1470709|NCT01929083|3600745|P2|COMPLETED|Intervention 2||8
1470710|NCT01929083|3600746|P1|COMPLETED|Intervention 2||7
1470711|NCT01929083|3600745|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
1470712|NCT01929083|3600746|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
1470713|NCT01929083|3600745|P2|STARTED|Intervention 2||9
1470714|NCT01929083|3600746|P1|STARTED|Intervention 2||7
1470715|NCT01929083|3600745|P2|NOT COMPLETED|Intervention 1||0
1470716|NCT01929083|3600746|P1|NOT COMPLETED|Intervention 1||3
1470717|NCT01929083|3600745|P2|COMPLETED|Intervention 1||9
1470718|NCT01929083|3600746|P1|COMPLETED|Intervention 1||7
1470719|NCT01929083|3600745|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
1470720|NCT01929083|3600746|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
1470721|NCT01929083|3600745|P2|STARTED|Intervention 1||9
1470722|NCT01929083|3600746|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
1470723|NCT01929044|3600772|P2|NOT COMPLETED|Overall Study||17
1470724|NCT01929044|3600773|P1|NOT COMPLETED|Overall Study||11
1470725|NCT01929044|3600772|P2|COMPLETED|Overall Study||129
1470726|NCT01929044|3600773|P1|COMPLETED|Overall Study||142
1470727|NCT01929044|3600772|P2|STARTED|Overall Study||146
1470728|NCT01929044|3600773|P1|STARTED|Overall Study||153
1470729|NCT01929031|3600795|P6|NOT COMPLETED|Overall Study||1
1470730|NCT01929031|3600796|P5|NOT COMPLETED|Overall Study||1
1470731|NCT01929031|3600797|P4|NOT COMPLETED|Overall Study||0
1470732|NCT01929031|3600798|P3|NOT COMPLETED|Overall Study||1
1470733|NCT01929031|3600799|P2|NOT COMPLETED|Overall Study||2
1470734|NCT01929031|3600800|P1|NOT COMPLETED|Overall Study||4
1470735|NCT01929031|3600795|P6|COMPLETED|Overall Study||35
1470736|NCT01929031|3600796|P5|COMPLETED|Overall Study||33
1470737|NCT01929031|3600797|P4|COMPLETED|Overall Study||35
1470738|NCT01929031|3600798|P3|COMPLETED|Overall Study||34
1470739|NCT01929031|3600799|P2|COMPLETED|Overall Study||207
1470740|NCT01929031|3600800|P1|COMPLETED|Overall Study||209
1470741|NCT01929031|3600795|P6|STARTED|Overall Study||36
1470742|NCT01929031|3600796|P5|STARTED|Overall Study||34
1470743|NCT01929031|3600797|P4|STARTED|Overall Study||35
1470744|NCT01929031|3600798|P3|STARTED|Overall Study||35
1470745|NCT01929031|3600799|P2|STARTED|Overall Study||209
1470746|NCT01929031|3600800|P1|STARTED|Overall Study||213
1470747|NCT01928940|3600824|P2|NOT COMPLETED|Overall Study||1
1470748|NCT01928940|3600825|P1|NOT COMPLETED|Overall Study||0
1470749|NCT01928940|3600824|P2|COMPLETED|Overall Study||5
1470750|NCT01928940|3600825|P1|COMPLETED|Overall Study||6
1470751|NCT01928940|3600824|P2|STARTED|Overall Study||6
1470752|NCT01928940|3600825|P1|STARTED|Overall Study||6
1470753|NCT01928927|3600868|P2|NOT COMPLETED|Overall Study||1
1470754|NCT01928927|3600869|P1|NOT COMPLETED|Overall Study||2
1470755|NCT01928927|3600868|P2|COMPLETED|Overall Study||14
1470756|NCT01928927|3600869|P1|COMPLETED|Overall Study||27
1470757|NCT01928927|3600868|P2|STARTED|Overall Study||15
1470758|NCT01928927|3600869|P1|STARTED|Overall Study||29
1470759|NCT01928862|3600996|P5|NOT COMPLETED|Overall Study||1
1470760|NCT01928862|3600997|P4|NOT COMPLETED|Overall Study||0
1470761|NCT01928862|3600998|P3|NOT COMPLETED|Overall Study||0
1470762|NCT01928862|3600999|P2|NOT COMPLETED|Overall Study||0
1470763|NCT01928862|3601000|P1|NOT COMPLETED|Overall Study||1
1470764|NCT01928862|3600996|P5|COMPLETED|Overall Study||13
1470765|NCT01928862|3600997|P4|COMPLETED|Overall Study||16
1470766|NCT01928862|3600998|P3|COMPLETED|Overall Study||16
1470767|NCT01928862|3600999|P2|COMPLETED|Overall Study||16
1470768|NCT01928862|3601000|P1|COMPLETED|Overall Study||15
1470769|NCT01928862|3600996|P5|STARTED|Overall Study||14
1470770|NCT01928862|3600997|P4|STARTED|Overall Study||16
1470771|NCT01928862|3600998|P3|STARTED|Overall Study||16
1470772|NCT01928862|3600999|P2|STARTED|Overall Study||16
1470773|NCT01928862|3601000|P1|STARTED|Overall Study||16
1470774|NCT01928849|3601039|P2|NOT COMPLETED|Overall Study||7
1470775|NCT01928849|3601040|P1|NOT COMPLETED|Overall Study||14
1470776|NCT01928849|3601039|P2|COMPLETED|Overall Study||55
1470777|NCT01928849|3601040|P1|COMPLETED|Overall Study||52
1470778|NCT01928849|3601039|P2|STARTED|Overall Study||62
1470779|NCT01928849|3601040|P1|STARTED|Overall Study||66
1470780|NCT01928797|3601060|P2|NOT COMPLETED|Overall Study||0
1470781|NCT01928797|3601061|P1|NOT COMPLETED|Overall Study||0
1470782|NCT01928797|3601060|P2|COMPLETED|Overall Study||30
1470783|NCT01928797|3601061|P1|COMPLETED|Overall Study||30
1470784|NCT01928797|3601060|P2|STARTED|Overall Study||30
1470785|NCT01928797|3601061|P1|STARTED|Overall Study||30
1470786|NCT01928771|3601074|P3|NOT COMPLETED|Overall Study||40
1470787|NCT01928771|3601075|P2|NOT COMPLETED|Overall Study||40
1470788|NCT01928771|3601076|P1|NOT COMPLETED|Overall Study||46
1470789|NCT01928771|3601074|P3|COMPLETED|Overall Study||367
1470790|NCT01928771|3601075|P2|COMPLETED|Overall Study||358
1470791|NCT01928771|3601076|P1|COMPLETED|Overall Study||354
1470792|NCT01928771|3601074|P3|Received Treatment|Overall Study||407
1470793|NCT01928771|3601075|P2|Received Treatment|Overall Study||398
1470794|NCT01928771|3601076|P1|Received Treatment|Overall Study||399
1470795|NCT01928771|3601074|P3|STARTED|Overall Study||407
1470796|NCT01928771|3601075|P2|STARTED|Overall Study||398
1470797|NCT01928771|3601076|P1|STARTED|Overall Study||400
1470798|NCT01928693|3601156|P3|NOT COMPLETED|Overall Study||0
1470799|NCT01928693|3601157|P2|NOT COMPLETED|Overall Study||0
1470800|NCT01928693|3601158|P1|NOT COMPLETED|Overall Study||0
1470801|NCT01928693|3601156|P3|COMPLETED|Overall Study||1
1470802|NCT01928693|3601157|P2|COMPLETED|Overall Study||1
1470803|NCT01928693|3601158|P1|COMPLETED|Overall Study||0
1470804|NCT01928693|3601156|P3|STARTED|Overall Study||1
1470805|NCT01928693|3601157|P2|STARTED|Overall Study||1
1470806|NCT01928693|3601158|P1|STARTED|Overall Study||0
1470807|NCT01928680|3601184|P1|NOT COMPLETED|Overall Study||0
1470808|NCT01928680|3601184|P1|COMPLETED|Overall Study||33
1470809|NCT01928680|3601184|P1|STARTED|Overall Study||33
1470810|NCT01928615|3601188|P1|NOT COMPLETED|Overall Study||2
1470811|NCT01928615|3601188|P1|COMPLETED|Overall Study||0
1470812|NCT01928615|3601188|P1|STARTED|Overall Study||2
1470813|NCT01928472|3601207|P4|NOT COMPLETED|Overall Study||2
1470814|NCT01928472|3601208|P3|NOT COMPLETED|Overall Study||7
1470815|NCT01928472|3601209|P2|NOT COMPLETED|Overall Study||8
1470816|NCT01928472|3601210|P1|NOT COMPLETED|Overall Study||8
1470817|NCT01928472|3601207|P4|COMPLETED|Overall Study||100
1470818|NCT01928472|3601208|P3|COMPLETED|Overall Study||91
1470819|NCT01928472|3601209|P2|COMPLETED|Overall Study||96
1470820|NCT01928472|3601210|P1|COMPLETED|Overall Study||90
1470821|NCT01928472|3601207|P4|STARTED|Overall Study||102
1470822|NCT01928472|3601208|P3|STARTED|Overall Study||98
1470823|NCT01928472|3601209|P2|STARTED|Overall Study||104
1470824|NCT01928472|3601210|P1|STARTED|Overall Study||98
1470825|NCT01928433|3601280|P3|NOT COMPLETED|Overall Study||28
1470826|NCT01928433|3601281|P2|NOT COMPLETED|Overall Study||21
1470827|NCT01928433|3601282|P1|NOT COMPLETED|Overall Study||20
1470828|NCT01928433|3601280|P3|COMPLETED|Overall Study||46
1470829|NCT01928433|3601281|P2|COMPLETED|Overall Study||54
1470830|NCT01928433|3601282|P1|COMPLETED|Overall Study||56
1470831|NCT01928433|3601280|P3|STARTED|Overall Study||74
1470832|NCT01928433|3601281|P2|STARTED|Overall Study||75
1470833|NCT01928433|3601282|P1|STARTED|Overall Study||76
1470834|NCT01928381|3601305|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
1470835|NCT01928381|3601306|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
1470836|NCT01928381|3601307|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
1470837|NCT01928381|3601308|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
1470838|NCT01928381|3601309|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
1470839|NCT01928381|3601310|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
1470840|NCT01928381|3601311|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
1470841|NCT01928381|3601305|P7|COMPLETED|Part 2 - Post Third Intervention||5
1470842|NCT01928381|3601306|P6|COMPLETED|Part 2 - Post Third Intervention||5
1470843|NCT01928381|3601307|P5|COMPLETED|Part 2 - Post Third Intervention||3
1470844|NCT01928381|3601308|P4|COMPLETED|Part 2 - Post Third Intervention||4
1470845|NCT01928381|3601309|P3|COMPLETED|Part 2 - Post Third Intervention||3
1470846|NCT01928381|3601310|P2|COMPLETED|Part 2 - Post Third Intervention||5
1470847|NCT01928381|3601311|P1|COMPLETED|Part 2 - Post Third Intervention||0
1470848|NCT01928381|3601305|P7|STARTED|Part 2 - Post Third Intervention||5
1470849|NCT01928381|3601306|P6|STARTED|Part 2 - Post Third Intervention||5
1470850|NCT01928381|3601307|P5|STARTED|Part 2 - Post Third Intervention||3
1470851|NCT01928381|3601308|P4|STARTED|Part 2 - Post Third Intervention||4
1470852|NCT01928381|3601309|P3|STARTED|Part 2 - Post Third Intervention||4
1470853|NCT01928381|3601310|P2|STARTED|Part 2 - Post Third Intervention||5
1470854|NCT01928381|3601311|P1|STARTED|Part 2 - Post Third Intervention||0
1470855|NCT01928381|3601305|P7|NOT COMPLETED|Part 2 - Third Intervention||0
1470856|NCT01928381|3601306|P6|NOT COMPLETED|Part 2 - Third Intervention||0
1470857|NCT01928381|3601307|P5|NOT COMPLETED|Part 2 - Third Intervention||0
1470858|NCT01928381|3601308|P4|NOT COMPLETED|Part 2 - Third Intervention||0
1470859|NCT01928381|3601309|P3|NOT COMPLETED|Part 2 - Third Intervention||0
1470860|NCT01928381|3601310|P2|NOT COMPLETED|Part 2 - Third Intervention||0
1470861|NCT01928381|3601311|P1|NOT COMPLETED|Part 2 - Third Intervention||0
1470862|NCT01928381|3601305|P7|COMPLETED|Part 2 - Third Intervention||5
1470863|NCT01928381|3601306|P6|COMPLETED|Part 2 - Third Intervention||5
1470864|NCT01928381|3601307|P5|COMPLETED|Part 2 - Third Intervention||3
1470865|NCT01928381|3601308|P4|COMPLETED|Part 2 - Third Intervention||4
1470866|NCT01928381|3601309|P3|COMPLETED|Part 2 - Third Intervention||4
1470867|NCT01928381|3601310|P2|COMPLETED|Part 2 - Third Intervention||5
1470868|NCT01928381|3601311|P1|COMPLETED|Part 2 - Third Intervention||0
1470869|NCT01928381|3601305|P7|STARTED|Part 2 - Third Intervention||5
1470870|NCT01928381|3601306|P6|STARTED|Part 2 - Third Intervention||5
1470871|NCT01928381|3601307|P5|STARTED|Part 2 - Third Intervention||3
1470872|NCT01928381|3601308|P4|STARTED|Part 2 - Third Intervention||4
1470873|NCT01928381|3601309|P3|STARTED|Part 2 - Third Intervention||4
1470874|NCT01928381|3601310|P2|STARTED|Part 2 - Third Intervention||5
1470875|NCT01928381|3601311|P1|STARTED|Part 2 - Third Intervention||0
1470876|NCT01928381|3601305|P7|NOT COMPLETED|Washout Second Intervention||0
1470877|NCT01928381|3601306|P6|NOT COMPLETED|Washout Second Intervention||0
1470878|NCT01928381|3601307|P5|NOT COMPLETED|Washout Second Intervention||0
1470879|NCT01928381|3601308|P4|NOT COMPLETED|Washout Second Intervention||0
1470880|NCT01928381|3601309|P3|NOT COMPLETED|Washout Second Intervention||0
1470881|NCT01928381|3601310|P2|NOT COMPLETED|Washout Second Intervention||0
1470882|NCT01928381|3601311|P1|NOT COMPLETED|Washout Second Intervention||0
1470883|NCT01928381|3601305|P7|COMPLETED|Washout Second Intervention||5
1470884|NCT01928381|3601306|P6|COMPLETED|Washout Second Intervention||5
1470885|NCT01928381|3601307|P5|COMPLETED|Washout Second Intervention||3
1470886|NCT01928381|3601308|P4|COMPLETED|Washout Second Intervention||4
1470887|NCT01928381|3601309|P3|COMPLETED|Washout Second Intervention||4
1470888|NCT01928381|3601310|P2|COMPLETED|Washout Second Intervention||5
1470889|NCT01928381|3601311|P1|COMPLETED|Washout Second Intervention||0
1470890|NCT01928381|3601305|P7|STARTED|Washout Second Intervention||5
1470891|NCT01928381|3601306|P6|STARTED|Washout Second Intervention||5
1470892|NCT01928381|3601307|P5|STARTED|Washout Second Intervention||3
1470893|NCT01928381|3601308|P4|STARTED|Washout Second Intervention||4
1470894|NCT01928381|3601309|P3|STARTED|Washout Second Intervention||4
1470895|NCT01928381|3601310|P2|STARTED|Washout Second Intervention||5
1470896|NCT01928381|3601311|P1|STARTED|Washout Second Intervention||0
1470897|NCT01928381|3601305|P7|NOT COMPLETED|Part 2 - Second Intervention||0
1470898|NCT01928381|3601306|P6|NOT COMPLETED|Part 2 - Second Intervention||0
1470899|NCT01928381|3601307|P5|NOT COMPLETED|Part 2 - Second Intervention||0
1470900|NCT01928381|3601308|P4|NOT COMPLETED|Part 2 - Second Intervention||1
1470901|NCT01928381|3601309|P3|NOT COMPLETED|Part 2 - Second Intervention||0
1470902|NCT01928381|3601310|P2|NOT COMPLETED|Part 2 - Second Intervention||1
1470903|NCT01928381|3601311|P1|NOT COMPLETED|Part 2 - Second Intervention||0
1470904|NCT01928381|3601305|P7|COMPLETED|Part 2 - Second Intervention||5
1470905|NCT01928381|3601306|P6|COMPLETED|Part 2 - Second Intervention||5
1470906|NCT01928381|3601307|P5|COMPLETED|Part 2 - Second Intervention||3
1470907|NCT01928381|3601308|P4|COMPLETED|Part 2 - Second Intervention||4
1470908|NCT01928381|3601309|P3|COMPLETED|Part 2 - Second Intervention||4
1470909|NCT01928381|3601310|P2|COMPLETED|Part 2 - Second Intervention||5
1470910|NCT01928381|3601311|P1|COMPLETED|Part 2 - Second Intervention||0
1470911|NCT01928381|3601305|P7|STARTED|Part 2 - Second Intervention||5
1470912|NCT01928381|3601306|P6|STARTED|Part 2 - Second Intervention||5
1470913|NCT01928381|3601307|P5|STARTED|Part 2 - Second Intervention||3
1470914|NCT01928381|3601308|P4|STARTED|Part 2 - Second Intervention||5
1470915|NCT01928381|3601309|P3|STARTED|Part 2 - Second Intervention||4
1470916|NCT01928381|3601310|P2|STARTED|Part 2 - Second Intervention||6
1470917|NCT01928381|3601311|P1|STARTED|Part 2 - Second Intervention||0
1470918|NCT01928381|3601305|P7|NOT COMPLETED|Washout First Intervention||0
1470919|NCT01928381|3601306|P6|NOT COMPLETED|Washout First Intervention||0
1470920|NCT01928381|3601307|P5|NOT COMPLETED|Washout First Intervention||1
1470921|NCT01928381|3601308|P4|NOT COMPLETED|Washout First Intervention||0
1470922|NCT01928381|3601309|P3|NOT COMPLETED|Washout First Intervention||0
1470923|NCT01928381|3601310|P2|NOT COMPLETED|Washout First Intervention||0
1470924|NCT01928381|3601311|P1|NOT COMPLETED|Washout First Intervention||0
1470925|NCT01928381|3601305|P7|COMPLETED|Washout First Intervention||5
1470926|NCT01928381|3601306|P6|COMPLETED|Washout First Intervention||5
1470927|NCT01928381|3601307|P5|COMPLETED|Washout First Intervention||3
1470928|NCT01928381|3601308|P4|COMPLETED|Washout First Intervention||5
1470929|NCT01928381|3601309|P3|COMPLETED|Washout First Intervention||4
1470930|NCT01928381|3601310|P2|COMPLETED|Washout First Intervention||6
1470931|NCT01928381|3601311|P1|COMPLETED|Washout First Intervention||0
1470932|NCT01928381|3601305|P7|STARTED|Washout First Intervention||5
1470933|NCT01928381|3601306|P6|STARTED|Washout First Intervention||5
1470934|NCT01928381|3601307|P5|STARTED|Washout First Intervention||4
1470935|NCT01928381|3601308|P4|STARTED|Washout First Intervention||5
1470936|NCT01928381|3601309|P3|STARTED|Washout First Intervention||4
1470937|NCT01928381|3601310|P2|STARTED|Washout First Intervention||6
1470938|NCT01928381|3601311|P1|STARTED|Washout First Intervention||0
1470939|NCT01928381|3601305|P7|NOT COMPLETED|Part 2 - First Intervention||1
1470940|NCT01928381|3601306|P6|NOT COMPLETED|Part 2 - First Intervention||1
1470941|NCT01928381|3601307|P5|NOT COMPLETED|Part 2 - First Intervention||0
1470942|NCT01928381|3601308|P4|NOT COMPLETED|Part 2 - First Intervention||1
1470943|NCT01928381|3601309|P3|NOT COMPLETED|Part 2 - First Intervention||2
1470944|NCT01928381|3601310|P2|NOT COMPLETED|Part 2 - First Intervention||0
1470945|NCT01928381|3601311|P1|NOT COMPLETED|Part 2 - First Intervention||0
1470946|NCT01928381|3601305|P7|COMPLETED|Part 2 - First Intervention||5
1470947|NCT01928381|3601306|P6|COMPLETED|Part 2 - First Intervention||5
1470948|NCT01928381|3601307|P5|COMPLETED|Part 2 - First Intervention||4
1470949|NCT01928381|3601308|P4|COMPLETED|Part 2 - First Intervention||5
1470950|NCT01928381|3601309|P3|COMPLETED|Part 2 - First Intervention||4
1470951|NCT01928381|3601310|P2|COMPLETED|Part 2 - First Intervention||6
1470952|NCT01928381|3601311|P1|COMPLETED|Part 2 - First Intervention||0
1470953|NCT01928381|3601305|P7|STARTED|Part 2 - First Intervention||6
1470954|NCT01928381|3601306|P6|STARTED|Part 2 - First Intervention||6
1470955|NCT01928381|3601307|P5|STARTED|Part 2 - First Intervention||4
1470956|NCT01928381|3601308|P4|STARTED|Part 2 - First Intervention||6
1470957|NCT01928381|3601309|P3|STARTED|Part 2 - First Intervention||6
1470958|NCT01928381|3601310|P2|STARTED|Part 2 - First Intervention||6
1470959|NCT01928381|3601311|P1|STARTED|Part 2 - First Intervention||0
1470960|NCT01928381|3601305|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470961|NCT01928381|3601306|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470962|NCT01928381|3601307|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470963|NCT01928381|3601308|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470964|NCT01928381|3601309|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470965|NCT01928381|3601310|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470966|NCT01928381|3601311|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
1470967|NCT01928381|3601305|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470968|NCT01928381|3601306|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470969|NCT01928381|3601307|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470970|NCT01928381|3601308|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470971|NCT01928381|3601309|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470972|NCT01928381|3601310|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
1470973|NCT01928381|3601311|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
1470974|NCT01928381|3601305|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
1470975|NCT01928381|3601306|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
1470976|NCT01928381|3601307|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
1470977|NCT01928381|3601308|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
1470978|NCT01928381|3601309|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
1470979|NCT01928381|3601310|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
1470980|NCT01928381|3601311|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
1470981|NCT01928381|3601305|P7|NOT COMPLETED|Part 1 - Pain Training||0
1470982|NCT01928381|3601306|P6|NOT COMPLETED|Part 1 - Pain Training||0
1470983|NCT01928381|3601307|P5|NOT COMPLETED|Part 1 - Pain Training||0
1470984|NCT01928381|3601308|P4|NOT COMPLETED|Part 1 - Pain Training||0
1470985|NCT01928381|3601309|P3|NOT COMPLETED|Part 1 - Pain Training||0
1470986|NCT01928381|3601310|P2|NOT COMPLETED|Part 1 - Pain Training||0
1470987|NCT01928381|3601311|P1|NOT COMPLETED|Part 1 - Pain Training||35
1470988|NCT01928381|3601305|P7|COMPLETED|Part 1 - Pain Training||0
1470989|NCT01928381|3601306|P6|COMPLETED|Part 1 - Pain Training||0
1470990|NCT01928381|3601307|P5|COMPLETED|Part 1 - Pain Training||0
1470991|NCT01928381|3601308|P4|COMPLETED|Part 1 - Pain Training||0
1470992|NCT01928381|3601309|P3|COMPLETED|Part 1 - Pain Training||0
1470993|NCT01928381|3601310|P2|COMPLETED|Part 1 - Pain Training||0
1470994|NCT01928381|3601311|P1|COMPLETED|Part 1 - Pain Training||48
1470995|NCT01928381|3601305|P7|STARTED|Part 1 - Pain Training||0
1470996|NCT01928381|3601306|P6|STARTED|Part 1 - Pain Training||0
1470997|NCT01928381|3601307|P5|STARTED|Part 1 - Pain Training||0
1470998|NCT01928381|3601308|P4|STARTED|Part 1 - Pain Training||0
1470999|NCT01928381|3601309|P3|STARTED|Part 1 - Pain Training||0
1471000|NCT01928381|3601310|P2|STARTED|Part 1 - Pain Training||0
1471001|NCT01928381|3601311|P1|STARTED|Part 1 - Pain Training||83
1471002|NCT01928381|3601305|P7|NOT COMPLETED|Screening for Pain Training||0
1471003|NCT01928381|3601306|P6|NOT COMPLETED|Screening for Pain Training||0
1471004|NCT01928381|3601307|P5|NOT COMPLETED|Screening for Pain Training||0
1471005|NCT01928381|3601308|P4|NOT COMPLETED|Screening for Pain Training||0
1471006|NCT01928381|3601309|P3|NOT COMPLETED|Screening for Pain Training||0
1471007|NCT01928381|3601310|P2|NOT COMPLETED|Screening for Pain Training||0
1471008|NCT01928381|3601311|P1|NOT COMPLETED|Screening for Pain Training||60
1471009|NCT01928381|3601305|P7|COMPLETED|Screening for Pain Training||0
1471010|NCT01928381|3601306|P6|COMPLETED|Screening for Pain Training||0
1471011|NCT01928381|3601307|P5|COMPLETED|Screening for Pain Training||0
1471012|NCT01928381|3601308|P4|COMPLETED|Screening for Pain Training||0
1471013|NCT01928381|3601309|P3|COMPLETED|Screening for Pain Training||0
1471014|NCT01928381|3601310|P2|COMPLETED|Screening for Pain Training||0
1471015|NCT01928381|3601311|P1|COMPLETED|Screening for Pain Training||83
1471016|NCT01928381|3601305|P7|STARTED|Screening for Pain Training||0
1471017|NCT01928381|3601306|P6|STARTED|Screening for Pain Training||0
1471018|NCT01928381|3601307|P5|STARTED|Screening for Pain Training||0
1471019|NCT01928381|3601308|P4|STARTED|Screening for Pain Training||0
1471020|NCT01928381|3601309|P3|STARTED|Screening for Pain Training||0
1471021|NCT01928381|3601310|P2|STARTED|Screening for Pain Training||0
1471022|NCT01928381|3601311|P1|STARTED|Screening for Pain Training||143
1471023|NCT01928186|3601324|P1|NOT COMPLETED|Overall Study||0
1471024|NCT01928186|3601324|P1|COMPLETED|Overall Study||28
1471025|NCT01928186|3601324|P1|STARTED|Overall Study||28
1471026|NCT01928082|3601338|P1|NOT COMPLETED|Overall Study||1
1471027|NCT01928082|3601338|P1|COMPLETED|Overall Study||0
1471028|NCT01928082|3601338|P1|STARTED|Overall Study||1
1471029|NCT01928030|3601356|P3|NOT COMPLETED|Overall Study||0
1471030|NCT01928030|3601357|P2|NOT COMPLETED|Overall Study||0
1471031|NCT01928030|3601358|P1|NOT COMPLETED|Overall Study||0
1471032|NCT01928030|3601356|P3|COMPLETED|Overall Study||0
1471033|NCT01928030|3601357|P2|COMPLETED|Overall Study||0
1471034|NCT01928030|3601358|P1|COMPLETED|Overall Study||3
1471035|NCT01928030|3601356|P3|STARTED|Overall Study||0
1471036|NCT01928030|3601357|P2|STARTED|Overall Study||0
1471037|NCT01928030|3601358|P1|STARTED|Overall Study||3
1471038|NCT01927887|3601365|P1|NOT COMPLETED|Overall Study||0
1471039|NCT01927887|3601365|P1|COMPLETED|Overall Study||12
1471040|NCT01927887|3601365|P1|STARTED|Overall Study||12
1471041|NCT01927757|3601370|P1|NOT COMPLETED|Overall Study||23
1471042|NCT01927757|3601370|P1|COMPLETED|Overall Study||67
1471043|NCT01927757|3601370|P1|Received Etanercept|Overall Study||88
1471044|NCT01927757|3601370|P1|STARTED|Overall Study||90
1471045|NCT01927575|3601388|P1|NOT COMPLETED|Overall Study||0
1471046|NCT01927575|3601388|P1|COMPLETED|Overall Study||1
1471047|NCT01927575|3601388|P1|STARTED|Overall Study||1
1471048|NCT01927419|3601398|P2|NOT COMPLETED|Overall Study||28
1471049|NCT01927419|3601399|P1|NOT COMPLETED|Overall Study||70
1471050|NCT01927419|3601398|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
1471051|NCT01927419|3601399|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
1471052|NCT01927419|3601398|P2|Received Treatment|Overall Study||46
1471053|NCT01927419|3601399|P1|Received Treatment|Overall Study||94
1471054|NCT01927419|3601398|P2|STARTED|Overall Study||47
1471055|NCT01927419|3601399|P1|STARTED|Overall Study||95
1471056|NCT01927120|3601415|P1|NOT COMPLETED|Overall Study||10
1471057|NCT01927120|3601415|P1|COMPLETED|Overall Study||10
1471058|NCT01927120|3601415|P1|STARTED|Overall Study||20
1471059|NCT01927055|3601433|P3|NOT COMPLETED|Double-Blind||13
1471060|NCT01927055|3601434|P2|NOT COMPLETED|Double-Blind||11
1471061|NCT01927055|3601435|P1|NOT COMPLETED|Double-Blind||0
1471062|NCT01927055|3601433|P3|COMPLETED|Double-Blind||10
1471063|NCT01927055|3601434|P2|COMPLETED|Double-Blind||11
1471064|NCT01927055|3601435|P1|COMPLETED|Double-Blind||0
1471065|NCT01927055|3601433|P3|STARTED|Double-Blind||23
1471066|NCT01927055|3601434|P2|STARTED|Double-Blind||22
1471067|NCT01927055|3601435|P1|STARTED|Double-Blind||0
1471068|NCT01927055|3601433|P3|NOT COMPLETED|Open-label||0
1471069|NCT01927055|3601434|P2|NOT COMPLETED|Open-label||0
1471070|NCT01927055|3601435|P1|NOT COMPLETED|Open-label||16
1471071|NCT01927055|3601433|P3|COMPLETED|Open-label||0
1471072|NCT01927055|3601434|P2|COMPLETED|Open-label||0
1471073|NCT01927055|3601435|P1|COMPLETED|Open-label||45
1471074|NCT01927055|3601433|P3|STARTED|Open-label||0
1471075|NCT01927055|3601434|P2|STARTED|Open-label||0
1471076|NCT01927055|3601435|P1|STARTED|Open-label||61
1471077|NCT01926977|3601444|P2|NOT COMPLETED|Overall Study||0
1471078|NCT01926977|3601445|P1|NOT COMPLETED|Overall Study||0
1471079|NCT01926977|3601444|P2|COMPLETED|Overall Study||53
1471080|NCT01926977|3601445|P1|COMPLETED|Overall Study||47
1471081|NCT01926977|3601444|P2|STARTED|Overall Study||53
1471082|NCT01926977|3601445|P1|STARTED|Overall Study||47
1471083|NCT01926782|3601459|P6|NOT COMPLETED|Overall Study||41
1471084|NCT01926782|3601460|P5|NOT COMPLETED|Overall Study||8
1471085|NCT01926782|3601461|P4|NOT COMPLETED|Overall Study||20
1471086|NCT01926782|3601462|P3|NOT COMPLETED|Overall Study||40
1471087|NCT01926782|3601463|P2|NOT COMPLETED|Overall Study||13
1471088|NCT01926782|3601464|P1|NOT COMPLETED|Overall Study||28
1471089|NCT01926782|3601459|P6|COMPLETED|Overall Study||105
1471090|NCT01926782|3601460|P5|COMPLETED|Overall Study||29
1471091|NCT01926782|3601461|P4|COMPLETED|Overall Study||53
1471092|NCT01926782|3601462|P3|COMPLETED|Overall Study||272
1471093|NCT01926782|3601463|P2|COMPLETED|Overall Study||65
1471094|NCT01926782|3601464|P1|COMPLETED|Overall Study||129
1471095|NCT01926782|3601459|P6|Completed 24 Weeks Treatment Period|Overall Study||120
1471096|NCT01926782|3601460|P5|Completed 24 Weeks Treatment Period|Overall Study||31
1471097|NCT01926782|3601461|P4|Completed 24 Weeks Treatment Period|Overall Study||58
1471098|NCT01926782|3601462|P3|Completed 24 Weeks Treatment Period|Overall Study||285
1471099|NCT01926782|3601463|P2|Completed 24 Weeks Treatment Period|Overall Study||68
1471100|NCT01926782|3601464|P1|Completed 24 Weeks Treatment Period|Overall Study||137
1471101|NCT01926782|3601459|P6|Treated|Overall Study||146
1471102|NCT01926782|3601460|P5|Treated|Overall Study||37
1471103|NCT01926782|3601461|P4|Treated|Overall Study||72
1471104|NCT01926782|3601462|P3|Treated|Overall Study||312
1471105|NCT01926782|3601463|P2|Treated|Overall Study||78
1471106|NCT01926782|3601464|P1|Treated|Overall Study||157
1471107|NCT01926782|3601459|P6|STARTED|Overall Study||146
1471108|NCT01926782|3601460|P5|STARTED|Overall Study||37
1471109|NCT01926782|3601461|P4|STARTED|Overall Study||73
1471110|NCT01926782|3601462|P3|STARTED|Overall Study||312
1471111|NCT01926782|3601463|P2|STARTED|Overall Study||78
1471112|NCT01926782|3601464|P1|STARTED|Overall Study||157
1471113|NCT01926626|3601613|P1|NOT COMPLETED|Overall Study||22
1471114|NCT01926626|3601613|P1|COMPLETED|Overall Study||16
1471115|NCT01926626|3601613|P1|Received Moclobemide|Overall Study||37
1471116|NCT01926626|3601613|P1|STARTED|Overall Study||38
1471117|NCT01926509|3601627|P4|NOT COMPLETED|Overall Study||0
1471118|NCT01926509|3601628|P3|NOT COMPLETED|Overall Study||0
1471119|NCT01926509|3601629|P2|NOT COMPLETED|Overall Study||0
1471120|NCT01926509|3601630|P1|NOT COMPLETED|Overall Study||1
1471121|NCT01926509|3601627|P4|COMPLETED|Overall Study||6
1471122|NCT01926509|3601628|P3|COMPLETED|Overall Study||5
1471123|NCT01926509|3601629|P2|COMPLETED|Overall Study||6
1471124|NCT01926509|3601630|P1|COMPLETED|Overall Study||5
1471125|NCT01926509|3601627|P4|STARTED|Overall Study||6
1471126|NCT01926509|3601628|P3|STARTED|Overall Study||5
1471127|NCT01926509|3601629|P2|STARTED|Overall Study||6
1471128|NCT01926509|3601630|P1|STARTED|Overall Study||6
1471129|NCT01926119|3601647|P1|NOT COMPLETED|Overall Study||1
1471130|NCT01926119|3601647|P1|COMPLETED|Overall Study||3
1471131|NCT01926119|3601647|P1|STARTED|Overall Study||4
1471132|NCT01926028|3601660|P3|NOT COMPLETED|Overall Study||2
1471133|NCT01926028|3601661|P2|NOT COMPLETED|Overall Study||22
1471134|NCT01926028|3601662|P1|NOT COMPLETED|Overall Study||21
1471135|NCT01926028|3601660|P3|COMPLETED|Overall Study||12
1471136|NCT01926028|3601661|P2|COMPLETED|Overall Study||67
1471137|NCT01926028|3601662|P1|COMPLETED|Overall Study||64
1471138|NCT01926028|3601660|P3|STARTED|Overall Study||14
1471139|NCT01926028|3601661|P2|STARTED|Overall Study||89
1471140|NCT01926028|3601662|P1|STARTED|Overall Study||85
1471141|NCT01926015|3601698|P2|NOT COMPLETED|Overall Study||1
1471142|NCT01926015|3601699|P1|NOT COMPLETED|Overall Study||2
1471143|NCT01926015|3601698|P2|COMPLETED|Overall Study||95
1471144|NCT01926015|3601699|P1|COMPLETED|Overall Study||94
1471145|NCT01926015|3601698|P2|Received >=1 Vaccination|Overall Study||96
1471146|NCT01926015|3601699|P1|Received >=1 Vaccination|Overall Study||94
1471147|NCT01926015|3601698|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
1471148|NCT01926015|3601699|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
1471149|NCT01925950|3601731|P2|NOT COMPLETED|Part 2||0
1471150|NCT01925950|3601732|P1|NOT COMPLETED|Part 2||1
1471151|NCT01925950|3601731|P2|COMPLETED|Part 2||0
1471152|NCT01925950|3601732|P1|COMPLETED|Part 2||0
1471153|NCT01925950|3601731|P2|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
1471154|NCT01925950|3601732|P1|STARTED|Part 2||1
1471155|NCT01925950|3601731|P2|NOT COMPLETED|Part 1||0
1471156|NCT01925950|3601732|P1|NOT COMPLETED|Part 1||0
1471157|NCT01925950|3601731|P2|COMPLETED|Part 1||1
1471158|NCT01925950|3601732|P1|COMPLETED|Part 1||1
1471159|NCT01925950|3601731|P2|STARTED|Part 1||1
1471160|NCT01925950|3601732|P1|STARTED|Part 1||1
1471161|NCT01925781|3601740|P2|NOT COMPLETED|Overall Study||4
1471162|NCT01925781|3601741|P1|NOT COMPLETED|Overall Study||2
1471163|NCT01925781|3601740|P2|COMPLETED|Overall Study||1
1471164|NCT01925781|3601741|P1|COMPLETED|Overall Study||3
1471165|NCT01925781|3601740|P2|STARTED|Overall Study||5
1471166|NCT01925781|3601741|P1|STARTED|Overall Study||5
1471167|NCT01925768|3601751|P2|NOT COMPLETED|Overall Study||23
1471168|NCT01925768|3601752|P1|NOT COMPLETED|Overall Study||11
1471169|NCT01925768|3601751|P2|COMPLETED|Overall Study|Completed = participants who completed week 24|87
1471170|NCT01925768|3601752|P1|COMPLETED|Overall Study|Completed = participants who completed week 24|98
1471171|NCT01925768|3601751|P2|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|13
1471172|NCT01925768|3601752|P1|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|35
1471173|NCT01925768|3601751|P2|Completed Week 16|Overall Study||91
1471174|NCT01925768|3601752|P1|Completed Week 16|Overall Study||101
1471175|NCT01925768|3601751|P2|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
1471176|NCT01925768|3601752|P1|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
1471177|NCT01925768|3601751|P2|Received Treatment|Overall Study||109
1471178|NCT01925768|3601752|P1|Received Treatment|Overall Study||109
1471179|NCT01925768|3601751|P2|STARTED|Overall Study||110
1471180|NCT01925768|3601752|P1|STARTED|Overall Study||109
1471181|NCT01925703|3601760|P1|NOT COMPLETED|Overall Study||4
1471182|NCT01925703|3601760|P1|COMPLETED|Overall Study||9
1471183|NCT01925703|3601760|P1|Follow-up Completed|Overall Study||9
1471184|NCT01925703|3601760|P1|Full Iron Repletion Achieved|Overall Study||11
1471185|NCT01925703|3601760|P1|Dosing Regimen Completed|Overall Study||12
1471186|NCT01925703|3601760|P1|STARTED|Overall Study||13
1471187|NCT01925612|3601771|P5|NOT COMPLETED|Overall Study||2
1471188|NCT01925612|3601772|P4|NOT COMPLETED|Overall Study||1
1471189|NCT01925612|3601773|P3|NOT COMPLETED|Overall Study||1
1471190|NCT01925612|3601774|P2|NOT COMPLETED|Overall Study||4
1471191|NCT01925612|3601775|P1|NOT COMPLETED|Overall Study||4
1471192|NCT01925612|3601771|P5|COMPLETED|Overall Study||10
1471193|NCT01925612|3601772|P4|COMPLETED|Overall Study||10
1471194|NCT01925612|3601773|P3|COMPLETED|Overall Study||10
1471195|NCT01925612|3601774|P2|COMPLETED|Overall Study||18
1471196|NCT01925612|3601775|P1|COMPLETED|Overall Study||25
1471197|NCT01925612|3601771|P5|STARTED|Overall Study||12
1471198|NCT01925612|3601772|P4|STARTED|Overall Study||11
1471199|NCT01925612|3601773|P3|STARTED|Overall Study||11
1471200|NCT01925612|3601774|P2|STARTED|Overall Study||22
1471201|NCT01925612|3601775|P1|STARTED|Overall Study||29
1471202|NCT01925469|3601814|P2|NOT COMPLETED|Overall Study||0
1471203|NCT01925469|3601815|P1|NOT COMPLETED|Overall Study||1
1471204|NCT01925469|3601814|P2|COMPLETED|Overall Study||15
1471205|NCT01925469|3601815|P1|COMPLETED|Overall Study||14
1471206|NCT01925469|3601814|P2|STARTED|Overall Study||15
1471207|NCT01925469|3601815|P1|STARTED|Overall Study||15
1471208|NCT01925417|3601825|P1|NOT COMPLETED|Overall Study||3
1471209|NCT01925417|3601825|P1|COMPLETED|Overall Study||31
1471210|NCT01925417|3601825|P1|STARTED|Overall Study||34
1471211|NCT01925404|3601837|P4|NOT COMPLETED|Overall Study||0
1471212|NCT01925404|3601838|P3|NOT COMPLETED|Overall Study||0
1471213|NCT01925404|3601839|P2|NOT COMPLETED|Overall Study||0
1471214|NCT01925404|3601840|P1|NOT COMPLETED|Overall Study||0
1471215|NCT01925404|3601837|P4|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
1471216|NCT01925404|3601838|P3|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
1471217|NCT01925404|3601839|P2|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
1471218|NCT01925404|3601840|P1|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
1471219|NCT01925404|3601837|P4|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
1471220|NCT01925404|3601838|P3|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
1471221|NCT01925404|3601839|P2|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
1471222|NCT01925404|3601840|P1|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|0
1471223|NCT01925274|3601857|P3|NOT COMPLETED|Overall Study||6
1471224|NCT01925274|3601858|P2|NOT COMPLETED|Overall Study||6
1471225|NCT01925274|3601859|P1|NOT COMPLETED|Overall Study||7
1471226|NCT01925274|3601857|P3|COMPLETED|Overall Study||0
1471227|NCT01925274|3601858|P2|COMPLETED|Overall Study||0
1471228|NCT01925274|3601859|P1|COMPLETED|Overall Study||0
1471229|NCT01925274|3601857|P3|STARTED|Overall Study||6
1471230|NCT01925274|3601858|P2|STARTED|Overall Study||6
1471231|NCT01925274|3601859|P1|STARTED|Overall Study||7
1471232|NCT01925209|3601940|P4|NOT COMPLETED|Follow-up||4
1471233|NCT01925209|3601941|P3|NOT COMPLETED|Follow-up||1
1471234|NCT01925209|3601942|P2|NOT COMPLETED|Follow-up||6
1471235|NCT01925209|3601943|P1|NOT COMPLETED|Follow-up||1
1471236|NCT01925209|3601940|P4|COMPLETED|Follow-up||54
1471237|NCT01925209|3601941|P3|COMPLETED|Follow-up||55
1471238|NCT01925209|3601942|P2|COMPLETED|Follow-up||55
1471239|NCT01925209|3601943|P1|COMPLETED|Follow-up||56
1471240|NCT01925209|3601940|P4|STARTED|Follow-up||58
1471241|NCT01925209|3601941|P3|STARTED|Follow-up||56
1471242|NCT01925209|3601942|P2|STARTED|Follow-up||61
1471243|NCT01925209|3601943|P1|STARTED|Follow-up||57
1471244|NCT01925209|3601940|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
1471245|NCT01925209|3601941|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
1471246|NCT01925209|3601942|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
1471247|NCT01925209|3601943|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
1471248|NCT01925209|3601940|P4|COMPLETED|Maintenance Treatment Epoch||48
1471249|NCT01925209|3601941|P3|COMPLETED|Maintenance Treatment Epoch||50
1471250|NCT01925209|3601942|P2|COMPLETED|Maintenance Treatment Epoch||45
1471251|NCT01925209|3601943|P1|COMPLETED|Maintenance Treatment Epoch||49
1471252|NCT01925209|3601940|P4|STARTED|Maintenance Treatment Epoch||50
1471253|NCT01925209|3601941|P3|STARTED|Maintenance Treatment Epoch||52
1471254|NCT01925209|3601942|P2|STARTED|Maintenance Treatment Epoch||46
1471255|NCT01925209|3601943|P1|STARTED|Maintenance Treatment Epoch||49
1471256|NCT01925209|3601940|P4|NOT COMPLETED|Treatment Epoch||5
1471257|NCT01925209|3601941|P3|NOT COMPLETED|Treatment Epoch||7
1471258|NCT01925209|3601942|P2|NOT COMPLETED|Treatment Epoch||8
1471259|NCT01925209|3601943|P1|NOT COMPLETED|Treatment Epoch||9
1471260|NCT01925209|3601940|P4|COMPLETED|Treatment Epoch||57
1471261|NCT01925209|3601941|P3|COMPLETED|Treatment Epoch||56
1471262|NCT01925209|3601942|P2|COMPLETED|Treatment Epoch||55
1471263|NCT01925209|3601943|P1|COMPLETED|Treatment Epoch||54
1471264|NCT01925209|3601940|P4|Full Analysis Set|Treatment Epoch||62
1471265|NCT01925209|3601941|P3|Full Analysis Set|Treatment Epoch||63
1471266|NCT01925209|3601942|P2|Full Analysis Set|Treatment Epoch||63
1471267|NCT01925209|3601943|P1|Full Analysis Set|Treatment Epoch||63
1471268|NCT01925209|3601940|P4|STARTED|Treatment Epoch||62
1471269|NCT01925209|3601941|P3|STARTED|Treatment Epoch||63
1471270|NCT01925209|3601942|P2|STARTED|Treatment Epoch||63
1471271|NCT01925209|3601943|P1|STARTED|Treatment Epoch||63
1471272|NCT01925183|3601975|P2|NOT COMPLETED|Overall Study||0
1471273|NCT01925183|3601976|P1|NOT COMPLETED|Overall Study||1
1471274|NCT01925183|3601975|P2|COMPLETED|Overall Study||3
1471275|NCT01925183|3601976|P1|COMPLETED|Overall Study||2
1471276|NCT01925183|3601975|P2|STARTED|Overall Study||3
1471277|NCT01925183|3601976|P1|STARTED|Overall Study||3
1471278|NCT01925170|3601984|P1|NOT COMPLETED|Overall Study||53
1471279|NCT01925170|3601984|P1|COMPLETED|Overall Study||1585
1471280|NCT01925170|3601984|P1|STARTED|Overall Study||1638
1471281|NCT01925144|3602002|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
1471282|NCT01925144|3602002|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
1471283|NCT01925144|3602002|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
1471284|NCT01925144|3602002|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
1471285|NCT01925144|3602002|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
1471286|NCT01925144|3602002|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
1471287|NCT01925144|3602002|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
1471288|NCT01925144|3602002|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
1471289|NCT01925144|3602002|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
1471290|NCT01924975|3602015|P2|NOT COMPLETED|Overall Study||0
1471291|NCT01924975|3602016|P1|NOT COMPLETED|Overall Study||0
1471292|NCT01924975|3602015|P2|COMPLETED|Overall Study||51
1471293|NCT01924975|3602016|P1|COMPLETED|Overall Study||51
1471294|NCT01924975|3602015|P2|STARTED|Overall Study||51
1471295|NCT01924975|3602016|P1|STARTED|Overall Study||51
1471296|NCT01924949|3602026|P1|NOT COMPLETED|Overall Study||0
1471297|NCT01924949|3602026|P1|COMPLETED|Overall Study||5
1471298|NCT01924949|3602026|P1|STARTED|Overall Study||5
1471299|NCT01924871|3602037|P2|NOT COMPLETED|Overall Study||2
1471300|NCT01924871|3602038|P1|NOT COMPLETED|Overall Study||6
1471301|NCT01924871|3602037|P2|COMPLETED|Overall Study||29
1471302|NCT01924871|3602038|P1|COMPLETED|Overall Study||25
1471303|NCT01924871|3602037|P2|STARTED|Overall Study||31
1471304|NCT01924871|3602038|P1|STARTED|Overall Study||31
1471305|NCT01924845|3602044|P1|NOT COMPLETED|Overall Study||6
1471306|NCT01924845|3602044|P1|COMPLETED|Overall Study||18
1471307|NCT01924845|3602044|P1|STARTED|Overall Study||24
1471308|NCT01924767|3602057|P5|NOT COMPLETED|Overall Study||0
1471309|NCT01924767|3602058|P4|NOT COMPLETED|Overall Study||0
1471310|NCT01924767|3602059|P3|NOT COMPLETED|Overall Study||1
1471311|NCT01924767|3602060|P2|NOT COMPLETED|Overall Study||0
1471312|NCT01924767|3602061|P1|NOT COMPLETED|Overall Study||1
1471313|NCT01924767|3602057|P5|COMPLETED|Overall Study||9
1471314|NCT01924767|3602058|P4|COMPLETED|Overall Study||9
1471315|NCT01924767|3602059|P3|COMPLETED|Overall Study||8
1471316|NCT01924767|3602060|P2|COMPLETED|Overall Study||9
1471317|NCT01924767|3602061|P1|COMPLETED|Overall Study||11
1471318|NCT01924767|3602057|P5|STARTED|Overall Study||9
1471319|NCT01924767|3602058|P4|STARTED|Overall Study||9
1471320|NCT01924767|3602059|P3|STARTED|Overall Study||9
1471321|NCT01924767|3602060|P2|STARTED|Overall Study||9
1471322|NCT01924767|3602061|P1|STARTED|Overall Study||12
1471323|NCT01924559|3602161|P1|NOT COMPLETED|Overall Study||0
1471324|NCT01924559|3602161|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
1471325|NCT01924559|3602161|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
1471326|NCT01924533|3602177|P2|NOT COMPLETED|Overall Study||205
1471327|NCT01924533|3602178|P1|NOT COMPLETED|Overall Study||189
1471328|NCT01924533|3602177|P2|COMPLETED|Overall Study||57
1471329|NCT01924533|3602178|P1|COMPLETED|Overall Study||74
1471330|NCT01924533|3602177|P2|STARTED|Overall Study||262
1471331|NCT01924533|3602178|P1|STARTED|Overall Study||263
1471332|NCT01924429|3602208|P2|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
1471333|NCT01924429|3602209|P1|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
1471334|NCT01924429|3602208|P2|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
1471335|NCT01924429|3602209|P1|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
1471336|NCT01924429|3602208|P2|STARTED|Period 2 - Second Intervention (4 Weeks)||11
1471337|NCT01924429|3602209|P1|STARTED|Period 2 - Second Intervention (4 Weeks)||14
1471338|NCT01924429|3602208|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
1471339|NCT01924429|3602209|P1|NOT COMPLETED|Washout Period (2 Weeks)||3
1471340|NCT01924429|3602208|P2|COMPLETED|Washout Period (2 Weeks)||11
1471341|NCT01924429|3602209|P1|COMPLETED|Washout Period (2 Weeks)||14
1471342|NCT01924429|3602208|P2|STARTED|Washout Period (2 Weeks)||13
1471343|NCT01924429|3602209|P1|STARTED|Washout Period (2 Weeks)||17
1471344|NCT01924429|3602208|P2|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
1471345|NCT01924429|3602209|P1|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
1471346|NCT01924429|3602208|P2|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
1471347|NCT01924429|3602209|P1|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
1471348|NCT01924429|3602208|P2|STARTED|Period 1 - First Intervention (4 Weeks)||13
1471349|NCT01924429|3602209|P1|STARTED|Period 1 - First Intervention (4 Weeks)||17
1471350|NCT01924390|3602241|P2|NOT COMPLETED|Overall Study||1
1471351|NCT01924390|3602242|P1|NOT COMPLETED|Overall Study||1
1471352|NCT01924390|3602241|P2|COMPLETED|Overall Study||21
1471353|NCT01924390|3602242|P1|COMPLETED|Overall Study||21
1471354|NCT01924390|3602241|P2|STARTED|Overall Study||22
1471355|NCT01924390|3602242|P1|STARTED|Overall Study||22
1471356|NCT01924364|3602252|P1|NOT COMPLETED|Overall Study||3
1471357|NCT01924364|3602252|P1|COMPLETED|Overall Study||4
1471358|NCT01924364|3602252|P1|STARTED|Overall Study||7
1471359|NCT01924299|3602269|P2|NOT COMPLETED|Period 2||1
1471360|NCT01924299|3602270|P1|NOT COMPLETED|Period 2||1
1471361|NCT01924299|3602269|P2|COMPLETED|Period 2||17
1471362|NCT01924299|3602270|P1|COMPLETED|Period 2||17
1471363|NCT01924299|3602269|P2|Received Baricitinib|Period 2||17
1471364|NCT01924299|3602270|P1|Received Baricitinib|Period 2||17
1471365|NCT01924299|3602269|P2|Received at Least 1 Dose of Study Drug|Period 2||18
1471366|NCT01924299|3602270|P1|Received at Least 1 Dose of Study Drug|Period 2||18
1471367|NCT01924299|3602269|P2|STARTED|Period 2||18
1471368|NCT01924299|3602270|P1|STARTED|Period 2||18
1471369|NCT01924299|3602269|P2|NOT COMPLETED|Period 1||0
1471370|NCT01924299|3602270|P1|NOT COMPLETED|Period 1||0
1471371|NCT01924299|3602269|P2|COMPLETED|Period 1||18
1471372|NCT01924299|3602270|P1|COMPLETED|Period 1||18
1471373|NCT01924299|3602269|P2|Received Baricitinib|Period 1||18
1471374|NCT01924299|3602270|P1|Received Baricitinib|Period 1||18
1471375|NCT01924299|3602269|P2|STARTED|Period 1||18
1471376|NCT01924299|3602270|P1|STARTED|Period 1||18
1471377|NCT01924182|3602292|P2|NOT COMPLETED|Overall Study||0
1471378|NCT01924182|3602293|P1|NOT COMPLETED|Overall Study||1
1471379|NCT01924182|3602292|P2|COMPLETED|Overall Study||0
1471380|NCT01924182|3602293|P1|COMPLETED|Overall Study||2
1471381|NCT01924182|3602292|P2|STARTED|Overall Study||0
1471382|NCT01924182|3602293|P1|STARTED|Overall Study||3
1471383|NCT01924169|3602305|P1|NOT COMPLETED|Overall Study||0
1471384|NCT01924169|3602305|P1|COMPLETED|Overall Study||3
1471385|NCT01924169|3602305|P1|STARTED|Overall Study||3
1471386|NCT01923896|3602312|P2|NOT COMPLETED|Overall Study||0
1471387|NCT01923896|3602313|P1|NOT COMPLETED|Overall Study||1
1471388|NCT01923896|3602312|P2|COMPLETED|Overall Study||8
1471389|NCT01923896|3602313|P1|COMPLETED|Overall Study||7
1471390|NCT01923896|3602312|P2|STARTED|Overall Study||8
1471391|NCT01923896|3602313|P1|STARTED|Overall Study||8
1471392|NCT01923805|3602327|P2|NOT COMPLETED|Overall Study||5
1471393|NCT01923805|3602328|P1|NOT COMPLETED|Overall Study||3
1471394|NCT01923805|3602327|P2|COMPLETED|Overall Study||0
1471395|NCT01923805|3602328|P1|COMPLETED|Overall Study||0
1471396|NCT01923805|3602327|P2|STARTED|Overall Study|early termination|5
1471397|NCT01923805|3602328|P1|STARTED|Overall Study|early termination|3
1471398|NCT01923740|3602336|P2|NOT COMPLETED|3 Year Clinical Follow-up||0
1471399|NCT01923740|3602337|P1|NOT COMPLETED|3 Year Clinical Follow-up||1
1471400|NCT01923740|3602336|P2|COMPLETED|3 Year Clinical Follow-up||225
1471401|NCT01923740|3602337|P1|COMPLETED|3 Year Clinical Follow-up||223
1471402|NCT01923740|3602336|P2|STARTED|3 Year Clinical Follow-up||225
1471403|NCT01923740|3602337|P1|STARTED|3 Year Clinical Follow-up||224
1471404|NCT01923740|3602336|P2|NOT COMPLETED|2 Year Clinical Follow-up||3
1471405|NCT01923740|3602337|P1|NOT COMPLETED|2 Year Clinical Follow-up||2
1471406|NCT01923740|3602336|P2|COMPLETED|2 Year Clinical Follow-up||225
1471407|NCT01923740|3602337|P1|COMPLETED|2 Year Clinical Follow-up||224
1471408|NCT01923740|3602336|P2|STARTED|2 Year Clinical Follow-up||228
1471409|NCT01923740|3602337|P1|STARTED|2 Year Clinical Follow-up||226
1471410|NCT01923740|3602336|P2|NOT COMPLETED|1 Year Clinical Follow-up||0
1471411|NCT01923740|3602337|P1|NOT COMPLETED|1 Year Clinical Follow-up||1
1471412|NCT01923740|3602336|P2|COMPLETED|1 Year Clinical Follow-up||228
1471413|NCT01923740|3602337|P1|COMPLETED|1 Year Clinical Follow-up||226
1471414|NCT01923740|3602336|P2|STARTED|1 Year Clinical Follow-up||228
1471415|NCT01923740|3602337|P1|STARTED|1 Year Clinical Follow-up||227
1471416|NCT01923740|3602336|P2|NOT COMPLETED|270-day Clinical Follow-up||4
1471417|NCT01923740|3602337|P1|NOT COMPLETED|270-day Clinical Follow-up||0
1471418|NCT01923740|3602336|P2|COMPLETED|270-day Clinical Follow-up||228
1471419|NCT01923740|3602337|P1|COMPLETED|270-day Clinical Follow-up||227
1471420|NCT01923740|3602336|P2|STARTED|270-day Clinical Follow-up||232
1471421|NCT01923740|3602337|P1|STARTED|270-day Clinical Follow-up||227
1471422|NCT01923740|3602336|P2|NOT COMPLETED|180-day Clinical Follow-up||0
1471423|NCT01923740|3602337|P1|NOT COMPLETED|180-day Clinical Follow-up||0
1471424|NCT01923740|3602336|P2|COMPLETED|180-day Clinical Follow-up||232
1471425|NCT01923740|3602337|P1|COMPLETED|180-day Clinical Follow-up||227
1471426|NCT01923740|3602336|P2|STARTED|180-day Clinical Follow-up||232
1471427|NCT01923740|3602337|P1|STARTED|180-day Clinical Follow-up||227
1471428|NCT01923740|3602336|P2|NOT COMPLETED|30-day Clinical Follow-up||0
1471429|NCT01923740|3602337|P1|NOT COMPLETED|30-day Clinical Follow-up||0
1471430|NCT01923740|3602336|P2|COMPLETED|30-day Clinical Follow-up||232
1471431|NCT01923740|3602337|P1|COMPLETED|30-day Clinical Follow-up||227
1471432|NCT01923740|3602336|P2|STARTED|30-day Clinical Follow-up|Per-treatment-evaluable (PTE) population|232
1471433|NCT01923740|3602337|P1|STARTED|30-day Clinical Follow-up|Per-treatment-evaluable (PTE) population|227
1471434|NCT01923480|3602554|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
1471435|NCT01923480|3602555|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
1471436|NCT01923480|3602556|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
1471437|NCT01923480|3602557|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
1471438|NCT01923480|3602558|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
1471439|NCT01923480|3602559|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
1471440|NCT01923480|3602554|P6|COMPLETED|Period 2 (Hours 1-7)||2
1471441|NCT01923480|3602555|P5|COMPLETED|Period 2 (Hours 1-7)||2
1471442|NCT01923480|3602556|P4|COMPLETED|Period 2 (Hours 1-7)||2
1471443|NCT01923480|3602557|P3|COMPLETED|Period 2 (Hours 1-7)||2
1471444|NCT01923480|3602558|P2|COMPLETED|Period 2 (Hours 1-7)||1
1471445|NCT01923480|3602559|P1|COMPLETED|Period 2 (Hours 1-7)||1
1471446|NCT01923480|3602554|P6|STARTED|Period 2 (Hours 1-7)||2
1471447|NCT01923480|3602555|P5|STARTED|Period 2 (Hours 1-7)||2
1471448|NCT01923480|3602556|P4|STARTED|Period 2 (Hours 1-7)||2
1471449|NCT01923480|3602557|P3|STARTED|Period 2 (Hours 1-7)||2
1471529|NCT01922739|3602886|P1|COMPLETED|Open-label Treatment Period||136
1471450|NCT01923480|3602558|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
1471451|NCT01923480|3602559|P1|STARTED|Period 2 (Hours 1-7)||1
1471452|NCT01923480|3602554|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
1471453|NCT01923480|3602555|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
1471454|NCT01923480|3602556|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
1471455|NCT01923480|3602557|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
1471456|NCT01923480|3602558|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
1471457|NCT01923480|3602559|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
1471458|NCT01923480|3602554|P6|COMPLETED|Period 1 (Hours 1-7)||2
1471459|NCT01923480|3602555|P5|COMPLETED|Period 1 (Hours 1-7)||2
1471460|NCT01923480|3602556|P4|COMPLETED|Period 1 (Hours 1-7)||2
1471461|NCT01923480|3602557|P3|COMPLETED|Period 1 (Hours 1-7)||2
1471462|NCT01923480|3602558|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
1471463|NCT01923480|3602559|P1|COMPLETED|Period 1 (Hours 1-7)||1
1471464|NCT01923480|3602554|P6|STARTED|Period 1 (Hours 1-7)||2
1471465|NCT01923480|3602555|P5|STARTED|Period 1 (Hours 1-7)||2
1471466|NCT01923480|3602556|P4|STARTED|Period 1 (Hours 1-7)||2
1471467|NCT01923480|3602557|P3|STARTED|Period 1 (Hours 1-7)||2
1471468|NCT01923480|3602558|P2|STARTED|Period 1 (Hours 1-7)||2
1471469|NCT01923480|3602559|P1|STARTED|Period 1 (Hours 1-7)||1
1471470|NCT01923467|3602714|P1|NOT COMPLETED|Overall Study||541
1471471|NCT01923467|3602714|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
1471472|NCT01923467|3602714|P1|Baseline Completed, Enrolled|Overall Study||288
1471473|NCT01923467|3602714|P1|STARTED|Overall Study|Offered stop smoking program|767
1471474|NCT01923389|3602720|P2|NOT COMPLETED|Overall Study||0
1471475|NCT01923389|3602721|P1|NOT COMPLETED|Overall Study||1
1471476|NCT01923389|3602720|P2|COMPLETED|Overall Study||2
1471477|NCT01923389|3602721|P1|COMPLETED|Overall Study||1
1471478|NCT01923389|3602720|P2|STARTED|Overall Study||2
1471479|NCT01923389|3602721|P1|STARTED|Overall Study||2
1471480|NCT01923363|3602743|P1|NOT COMPLETED|Overall Study||1
1471481|NCT01923363|3602743|P1|COMPLETED|Overall Study||28
1471482|NCT01923363|3602743|P1|STARTED|Overall Study||29
1471483|NCT01923311|3602752|P2|NOT COMPLETED|Overall Study||1
1471484|NCT01923311|3602753|P1|NOT COMPLETED|Overall Study||17
1471485|NCT01923311|3602752|P2|COMPLETED|Overall Study||13
1471486|NCT01923311|3602753|P1|COMPLETED|Overall Study||0
1471487|NCT01923311|3602752|P2|STARTED|Overall Study||14
1471488|NCT01923311|3602753|P1|STARTED|Overall Study||17
1471489|NCT01923168|3602799|P3|NOT COMPLETED|Overall Study||17
1471490|NCT01923168|3602800|P2|NOT COMPLETED|Overall Study||39
1471491|NCT01923168|3602801|P1|NOT COMPLETED|Overall Study||37
1471492|NCT01923168|3602799|P3|COMPLETED|Overall Study||109
1471493|NCT01923168|3602800|P2|COMPLETED|Overall Study||44
1471494|NCT01923168|3602801|P1|COMPLETED|Overall Study||94
1471495|NCT01923168|3602799|P3|STARTED|Overall Study||126
1471496|NCT01923168|3602800|P2|STARTED|Overall Study||83
1471497|NCT01923168|3602801|P1|STARTED|Overall Study||131
1471498|NCT01922986|3602860|P2|NOT COMPLETED|Overall Study||0
1471499|NCT01922986|3602861|P1|NOT COMPLETED|Overall Study||0
1471500|NCT01922986|3602860|P2|COMPLETED|Overall Study||2
1471501|NCT01922986|3602861|P1|COMPLETED|Overall Study||2
1471502|NCT01922986|3602860|P2|STARTED|Overall Study||2
1471503|NCT01922986|3602861|P1|STARTED|Overall Study||2
1471504|NCT01922934|3602873|P2|NOT COMPLETED|Visit 12 / Final Visits||290
1471505|NCT01922934|3602874|P1|NOT COMPLETED|Visit 12 / Final Visits||6
1471506|NCT01922934|3602873|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
1471507|NCT01922934|3602874|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
1471508|NCT01922934|3602873|P2|STARTED|Visit 12 / Final Visits||2930
1471509|NCT01922934|3602874|P1|STARTED|Visit 12 / Final Visits||119
1471510|NCT01922934|3602873|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
1471511|NCT01922934|3602874|P1|NOT COMPLETED|Visit 1- Weight Measured||21
1471512|NCT01922934|3602873|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
1471513|NCT01922934|3602874|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
1471514|NCT01922934|3602873|P2|STARTED|Visit 1- Weight Measured||4214
1471515|NCT01922934|3602874|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
1471516|NCT01922934|3602873|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
1471517|NCT01922934|3602874|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
1471518|NCT01922934|3602873|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
1471519|NCT01922934|3602874|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
1471520|NCT01922934|3602873|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
1471521|NCT01922934|3602874|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
1471522|NCT01922934|3602873|P2|NOT COMPLETED|Eligible Patients||88
1471523|NCT01922934|3602874|P1|NOT COMPLETED|Eligible Patients||53
1471524|NCT01922934|3602873|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
1471525|NCT01922934|3602874|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
1471526|NCT01922934|3602873|P2|STARTED|Eligible Patients||4302
1471527|NCT01922934|3602874|P1|STARTED|Eligible Patients||428
1471528|NCT01922739|3602886|P1|NOT COMPLETED|Open-label Treatment Period||34
1471530|NCT01922739|3602886|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
1471531|NCT01922739|3602886|P1|STARTED|Open-label Treatment Period||170
1471532|NCT01922739|3602886|P1|NOT COMPLETED|Titration/Adjustment Period||12
1471533|NCT01922739|3602886|P1|COMPLETED|Titration/Adjustment Period||170
1471534|NCT01922739|3602886|P1|Safety Analysis Set|Titration/Adjustment Period||182
1471535|NCT01922739|3602886|P1|STARTED|Titration/Adjustment Period||182
1471536|NCT01922349|3602915|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
1471537|NCT01922349|3602916|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
1471538|NCT01922349|3602917|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
1471539|NCT01922349|3602918|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
1471540|NCT01922349|3602915|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
1471541|NCT01922349|3602916|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
1471542|NCT01922349|3602917|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
1471543|NCT01922349|3602918|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
1471544|NCT01922349|3602915|P4|STARTED|Multiple Rising Dose (MRD) Period||27
1471545|NCT01922349|3602916|P3|STARTED|Multiple Rising Dose (MRD) Period||18
1471546|NCT01922349|3602917|P2|STARTED|Multiple Rising Dose (MRD) Period||27
1471547|NCT01922349|3602918|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
1471548|NCT01922349|3602915|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
1471549|NCT01922349|3602916|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
1471550|NCT01922349|3602917|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
1471551|NCT01922349|3602918|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
1471552|NCT01922349|3602915|P4|COMPLETED|Single Rising Dose (SRD) Period||27
1471553|NCT01922349|3602916|P3|COMPLETED|Single Rising Dose (SRD) Period||18
1471554|NCT01922349|3602917|P2|COMPLETED|Single Rising Dose (SRD) Period||27
1471555|NCT01922349|3602918|P1|COMPLETED|Single Rising Dose (SRD) Period||25
1471556|NCT01922349|3602915|P4|STARTED|Single Rising Dose (SRD) Period||27
1471557|NCT01922349|3602916|P3|STARTED|Single Rising Dose (SRD) Period||18
1471558|NCT01922349|3602917|P2|STARTED|Single Rising Dose (SRD) Period||27
1471559|NCT01922349|3602918|P1|STARTED|Single Rising Dose (SRD) Period||25
1471560|NCT01922271|3603025|P2|NOT COMPLETED|PERIOD 2||0
1471561|NCT01922271|3603026|P1|NOT COMPLETED|PERIOD 2||0
1471562|NCT01922271|3603025|P2|COMPLETED|PERIOD 2||76
1471563|NCT01922271|3603026|P1|COMPLETED|PERIOD 2||75
1471564|NCT01922271|3603025|P2|STARTED|PERIOD 2||76
1471565|NCT01922271|3603026|P1|STARTED|PERIOD 2||75
1471566|NCT01922271|3603025|P2|NOT COMPLETED|WASHOUT Period||0
1471567|NCT01922271|3603026|P1|NOT COMPLETED|WASHOUT Period||1
1471568|NCT01922271|3603025|P2|COMPLETED|WASHOUT Period||76
1471569|NCT01922271|3603026|P1|COMPLETED|WASHOUT Period||75
1471570|NCT01922271|3603025|P2|STARTED|WASHOUT Period||76
1471571|NCT01922271|3603026|P1|STARTED|WASHOUT Period||76
1471572|NCT01922271|3603025|P2|NOT COMPLETED|PERIOD 1||0
1471573|NCT01922271|3603026|P1|NOT COMPLETED|PERIOD 1||0
1471574|NCT01922271|3603025|P2|COMPLETED|PERIOD 1||76
1471575|NCT01922271|3603026|P1|COMPLETED|PERIOD 1||76
1471576|NCT01922271|3603025|P2|STARTED|PERIOD 1||76
1471577|NCT01922271|3603026|P1|STARTED|PERIOD 1||76
1471578|NCT01922219|3603044|P1|NOT COMPLETED|Overall Study||9
1471579|NCT01922219|3603044|P1|COMPLETED|Overall Study||28
1471580|NCT01922219|3603044|P1|STARTED|Overall Study||37
1471581|NCT01922115|3603052|P2|NOT COMPLETED|Overall Study||7
1471582|NCT01922115|3603053|P1|NOT COMPLETED|Overall Study||7
1471583|NCT01922115|3603052|P2|COMPLETED|Overall Study||24
1471584|NCT01922115|3603053|P1|COMPLETED|Overall Study||21
1471585|NCT01922115|3603052|P2|STARTED|Overall Study||31
1471586|NCT01922115|3603053|P1|STARTED|Overall Study||28
1471587|NCT01922089|3603067|P2|NOT COMPLETED|Overall Study||30
1471588|NCT01922089|3603068|P1|NOT COMPLETED|Overall Study||39
1471589|NCT01922089|3603067|P2|COMPLETED|Overall Study||221
1471590|NCT01922089|3603068|P1|COMPLETED|Overall Study||208
1471591|NCT01922089|3603067|P2|Safety Set|Overall Study||251
1471592|NCT01922089|3603068|P1|Safety Set|Overall Study||246
1471593|NCT01922089|3603067|P2|STARTED|Overall Study||251
1471594|NCT01922089|3603068|P1|STARTED|Overall Study||247
1471595|NCT01922037|3603080|P2|NOT COMPLETED|Overall Study||174
1471596|NCT01922037|3603081|P1|NOT COMPLETED|Overall Study||10
1471597|NCT01922037|3603080|P2|COMPLETED|Overall Study||563
1471598|NCT01922037|3603081|P1|COMPLETED|Overall Study||59
1471599|NCT01922037|3603080|P2|Treated|Overall Study||732
1471600|NCT01922037|3603081|P1|Treated|Overall Study||69
1471601|NCT01922037|3603080|P2|STARTED|Overall Study||737
1471602|NCT01922037|3603081|P1|STARTED|Overall Study||69
1471603|NCT01922011|3603175|P2|NOT COMPLETED|Overall Study||5
1471604|NCT01922011|3603176|P1|NOT COMPLETED|Overall Study||6
1471605|NCT01922011|3603175|P2|COMPLETED|Overall Study||69
1471606|NCT01922011|3603176|P1|COMPLETED|Overall Study||69
1471607|NCT01922011|3603175|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
1471608|NCT01922011|3603176|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
1471609|NCT01922011|3603175|P2|Treated|Overall Study|Treated Participants|73
1471610|NCT01922011|3603176|P1|Treated|Overall Study|Treated Participants|73
1471611|NCT01922011|3603175|P2|STARTED|Overall Study|Randomized participants|74
1471612|NCT01922011|3603176|P1|STARTED|Overall Study|Randomized participants|75
1471613|NCT01921894|3603219|P3|NOT COMPLETED|Overall Study||0
1471614|NCT01921894|3603220|P2|NOT COMPLETED|Overall Study||0
1471615|NCT01921894|3603221|P1|NOT COMPLETED|Overall Study||0
1471616|NCT01921894|3603219|P3|COMPLETED|Overall Study||8
1471617|NCT01921894|3603220|P2|COMPLETED|Overall Study||8
1471618|NCT01921894|3603221|P1|COMPLETED|Overall Study||8
1471619|NCT01921894|3603219|P3|STARTED|Overall Study||8
1471620|NCT01921894|3603220|P2|STARTED|Overall Study||8
1471621|NCT01921894|3603221|P1|STARTED|Overall Study||8
1471622|NCT01921829|3603243|P2|NOT COMPLETED|Overall Study||1
1471623|NCT01921829|3603244|P1|NOT COMPLETED|Overall Study||0
1471624|NCT01921829|3603243|P2|COMPLETED|Overall Study||8
1471625|NCT01921829|3603244|P1|COMPLETED|Overall Study||10
1471626|NCT01921829|3603243|P2|STARTED|Overall Study||9
1471627|NCT01921829|3603244|P1|STARTED|Overall Study||10
1471628|NCT01921751|3603293|P3|NOT COMPLETED|Overall Study||0
1471629|NCT01921751|3603294|P2|NOT COMPLETED|Overall Study||0
1471630|NCT01921751|3603295|P1|NOT COMPLETED|Overall Study||0
1471631|NCT01921751|3603293|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
1471632|NCT01921751|3603294|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
1471633|NCT01921751|3603295|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
1471634|NCT01921751|3603293|P3|STARTED|Overall Study||5
1471635|NCT01921751|3603294|P2|STARTED|Overall Study||4
1471636|NCT01921751|3603295|P1|STARTED|Overall Study||4
1471637|NCT01921452|3603313|P1|NOT COMPLETED|Overall Study||0
1471638|NCT01921452|3603313|P1|COMPLETED|Overall Study||283
1471639|NCT01921452|3603313|P1|STARTED|Overall Study||283
1471640|NCT01921387|3603318|P1|NOT COMPLETED|Overall Study||1
1471641|NCT01921387|3603318|P1|COMPLETED|Overall Study||19
1471642|NCT01921387|3603318|P1|STARTED|Overall Study||20
1471643|NCT01921348|3603327|P2|NOT COMPLETED|Overall Study||2
1471644|NCT01921348|3603328|P1|NOT COMPLETED|Overall Study||1
1471645|NCT01921348|3603327|P2|COMPLETED|Overall Study||7
1471646|NCT01921348|3603328|P1|COMPLETED|Overall Study||8
1471647|NCT01921348|3603327|P2|STARTED|Overall Study||9
1471648|NCT01921348|3603328|P1|STARTED|Overall Study||9
1471649|NCT01921322|3603340|P2|NOT COMPLETED|Overall Study||17
1471650|NCT01921322|3603341|P1|NOT COMPLETED|Overall Study||15
1471651|NCT01921322|3603340|P2|COMPLETED|Overall Study||44
1471652|NCT01921322|3603341|P1|COMPLETED|Overall Study||42
1471653|NCT01921322|3603340|P2|STARTED|Overall Study||61
1471654|NCT01921322|3603341|P1|STARTED|Overall Study||57
1471655|NCT01921296|3603349|P1|NOT COMPLETED|Overall Study||0
1471656|NCT01921296|3603349|P1|COMPLETED|Overall Study||2
1471657|NCT01921296|3603349|P1|STARTED|Overall Study||2
1471658|NCT01921270|3603357|P1|NOT COMPLETED|Overall Study||1
1471659|NCT01921270|3603357|P1|COMPLETED|Overall Study||17
1471660|NCT01921270|3603357|P1|STARTED|Overall Study||18
1471661|NCT01921257|3603373|P1|NOT COMPLETED|Overall Study||3
1471662|NCT01921257|3603373|P1|COMPLETED|Overall Study||13
1471663|NCT01921257|3603373|P1|Active Treatment|Overall Study||13
1471664|NCT01921257|3603373|P1|Placebo run-in|Overall Study||16
1471665|NCT01921257|3603373|P1|STARTED|Overall Study||16
1471666|NCT01921205|3603380|P2|NOT COMPLETED|Overall Study||20
1471667|NCT01921205|3603381|P1|NOT COMPLETED|Overall Study||21
1471668|NCT01921205|3603380|P2|COMPLETED|Overall Study||151
1471669|NCT01921205|3603381|P1|COMPLETED|Overall Study||151
1471670|NCT01921205|3603380|P2|STARTED|Overall Study||171
1471671|NCT01921205|3603381|P1|STARTED|Overall Study||172
1471672|NCT01921166|3603411|P2|NOT COMPLETED|Overall Study||0
1471673|NCT01921166|3603412|P1|NOT COMPLETED|Overall Study||0
1471674|NCT01921166|3603411|P2|COMPLETED|Overall Study||15
1471675|NCT01921166|3603412|P1|COMPLETED|Overall Study||8
1471676|NCT01921166|3603411|P2|STARTED|Overall Study||15
1471677|NCT01921166|3603412|P1|STARTED|Overall Study||8
1471678|NCT01921101|3603422|P2|NOT COMPLETED|Overall Study||6
1471679|NCT01921101|3603423|P1|NOT COMPLETED|Overall Study||16
1471680|NCT01921101|3603422|P2|COMPLETED|Overall Study||32
1471681|NCT01921101|3603423|P1|COMPLETED|Overall Study||24
1471682|NCT01921101|3603422|P2|STARTED|Overall Study||38
1471683|NCT01921101|3603423|P1|STARTED|Overall Study||40
1471684|NCT01920958|3603431|P1|NOT COMPLETED|Overall Study||5
1471685|NCT01920958|3603431|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
1471686|NCT01920958|3603431|P1|STARTED|Overall Study||233
1471687|NCT01920893|3603449|P2|NOT COMPLETED|Overall Study||2
1471688|NCT01920893|3603450|P1|NOT COMPLETED|Overall Study||7
1471689|NCT01920893|3603449|P2|COMPLETED|Overall Study||28
1471690|NCT01920893|3603450|P1|COMPLETED|Overall Study||23
1471691|NCT01920893|3603449|P2|Treated (Safety Population)|Overall Study||30
1471692|NCT01920893|3603450|P1|Treated (Safety Population)|Overall Study||30
1471693|NCT01920893|3603449|P2|STARTED|Overall Study||30
1471694|NCT01920893|3603450|P1|STARTED|Overall Study||30
1471695|NCT01920854|3603483|P7|NOT COMPLETED|Overall Study||1
1471696|NCT01920854|3603484|P6|NOT COMPLETED|Overall Study||0
1471697|NCT01920854|3603485|P5|NOT COMPLETED|Overall Study||1
1471698|NCT01920854|3603486|P4|NOT COMPLETED|Overall Study||0
1471699|NCT01920854|3603487|P3|NOT COMPLETED|Overall Study||0
1471700|NCT01920854|3603488|P2|NOT COMPLETED|Overall Study||0
1471701|NCT01920854|3603489|P1|NOT COMPLETED|Overall Study||1
1471702|NCT01920854|3603483|P7|COMPLETED|Overall Study||5
1471703|NCT01920854|3603484|P6|COMPLETED|Overall Study||6
1471704|NCT01920854|3603485|P5|COMPLETED|Overall Study||5
1471705|NCT01920854|3603486|P4|COMPLETED|Overall Study||6
1471706|NCT01920854|3603487|P3|COMPLETED|Overall Study||6
1471707|NCT01920854|3603488|P2|COMPLETED|Overall Study||6
1471708|NCT01920854|3603489|P1|COMPLETED|Overall Study||11
1471709|NCT01920854|3603483|P7|STARTED|Overall Study||6
1471710|NCT01920854|3603484|P6|STARTED|Overall Study||6
1471711|NCT01920854|3603485|P5|STARTED|Overall Study||6
1471712|NCT01920854|3603486|P4|STARTED|Overall Study||6
1471713|NCT01920854|3603487|P3|STARTED|Overall Study||6
1471714|NCT01920854|3603488|P2|STARTED|Overall Study||6
1471715|NCT01920854|3603489|P1|STARTED|Overall Study||12
1471716|NCT01920802|3603616|P3|NOT COMPLETED|Overall Study||1
1471717|NCT01920802|3603617|P2|NOT COMPLETED|Overall Study||2
1471718|NCT01920802|3603618|P1|NOT COMPLETED|Overall Study||4
1471719|NCT01920802|3603616|P3|COMPLETED|Overall Study||10
1471720|NCT01920802|3603617|P2|COMPLETED|Overall Study||7
1471721|NCT01920802|3603618|P1|COMPLETED|Overall Study||7
1471722|NCT01920802|3603616|P3|STARTED|Overall Study||11
1471723|NCT01920802|3603617|P2|STARTED|Overall Study||9
1471724|NCT01920802|3603618|P1|STARTED|Overall Study||11
1471725|NCT01920594|3603649|P2|NOT COMPLETED|Overall Study||3
1471726|NCT01920594|3603650|P1|NOT COMPLETED|Overall Study||7
1471727|NCT01920594|3603649|P2|COMPLETED|Overall Study||25
1471728|NCT01920594|3603650|P1|COMPLETED|Overall Study||20
1471729|NCT01920594|3603649|P2|STARTED|Overall Study||28
1471730|NCT01920594|3603650|P1|STARTED|Overall Study||27
1471731|NCT01920568|3603700|P2|NOT COMPLETED|Overall Study||84
1471732|NCT01920568|3603701|P1|NOT COMPLETED|Overall Study||151
1471733|NCT01920568|3603700|P2|COMPLETED|Overall Study||75
1471734|NCT01920568|3603701|P1|COMPLETED|Overall Study||175
1471735|NCT01920568|3603700|P2|STARTED|Overall Study||159
1471736|NCT01920568|3603701|P1|STARTED|Overall Study||326
1471737|NCT01920555|3603727|P5|NOT COMPLETED|Overall Study||1
1471738|NCT01920555|3603728|P4|NOT COMPLETED|Overall Study||3
1471739|NCT01920555|3603729|P3|NOT COMPLETED|Overall Study||1
1471740|NCT01920555|3603730|P2|NOT COMPLETED|Overall Study||4
1471741|NCT01920555|3603731|P1|NOT COMPLETED|Overall Study||4
1471742|NCT01920555|3603727|P5|COMPLETED|Overall Study||18
1471743|NCT01920555|3603728|P4|COMPLETED|Overall Study||17
1471744|NCT01920555|3603729|P3|COMPLETED|Overall Study||21
1471745|NCT01920555|3603730|P2|COMPLETED|Overall Study||16
1471746|NCT01920555|3603731|P1|COMPLETED|Overall Study||14
1471747|NCT01920555|3603727|P5|STARTED|Overall Study||19
1471748|NCT01920555|3603728|P4|STARTED|Overall Study||20
1471749|NCT01920555|3603729|P3|STARTED|Overall Study||22
1471750|NCT01920555|3603730|P2|STARTED|Overall Study||20
1471751|NCT01920555|3603731|P1|STARTED|Overall Study||18
1471752|NCT01920282|3603791|P3|NOT COMPLETED|Overall Study||0
1471753|NCT01920282|3603792|P2|NOT COMPLETED|Overall Study||0
1471754|NCT01920282|3603793|P1|NOT COMPLETED|Overall Study||0
1471755|NCT01920282|3603791|P3|COMPLETED|Overall Study||15
1471756|NCT01920282|3603792|P2|COMPLETED|Overall Study||15
1471757|NCT01920282|3603793|P1|COMPLETED|Overall Study||15
1471758|NCT01920282|3603791|P3|STARTED|Overall Study||15
1471759|NCT01920282|3603792|P2|STARTED|Overall Study||15
1471760|NCT01920282|3603793|P1|STARTED|Overall Study||15
1471761|NCT01920178|3603806|P2|NOT COMPLETED|Overall Study||1
1471762|NCT01920178|3603807|P1|NOT COMPLETED|Overall Study||2
1471763|NCT01920178|3603806|P2|COMPLETED|Overall Study||1
1471764|NCT01920178|3603807|P1|COMPLETED|Overall Study||3
1471765|NCT01920178|3603806|P2|STARTED|Overall Study||2
1471766|NCT01920178|3603807|P1|STARTED|Overall Study||5
1471767|NCT01919996|3603817|P1|NOT COMPLETED|Overall Study||0
1471768|NCT01919996|3603817|P1|COMPLETED|Overall Study||8
1471769|NCT01919996|3603817|P1|STARTED|Overall Study||8
1471770|NCT01919801|3603825|P2|NOT COMPLETED|Overall Study||3
1471771|NCT01919801|3603826|P1|NOT COMPLETED|Overall Study||1
1471772|NCT01919801|3603825|P2|COMPLETED|Overall Study||57
1471773|NCT01919801|3603826|P1|COMPLETED|Overall Study||60
1471774|NCT01919801|3603825|P2|STARTED|Overall Study||60
1471775|NCT01919801|3603826|P1|STARTED|Overall Study||61
1471776|NCT01919723|3603851|P2|NOT COMPLETED|Overall Study||2
1471777|NCT01919723|3603852|P1|NOT COMPLETED|Overall Study||2
1471778|NCT01919723|3603851|P2|COMPLETED|Overall Study||33
1471779|NCT01919723|3603852|P1|COMPLETED|Overall Study||33
1471780|NCT01919723|3603851|P2|STARTED|Overall Study||35
1471781|NCT01919723|3603852|P1|STARTED|Overall Study||35
1471782|NCT01919606|3603866|P2|NOT COMPLETED|Overall Study||0
1471783|NCT01919606|3603867|P1|NOT COMPLETED|Overall Study||0
1471784|NCT01919606|3603866|P2|COMPLETED|Overall Study||0
1471785|NCT01919606|3603867|P1|COMPLETED|Overall Study||1
1471786|NCT01919606|3603866|P2|STARTED|Overall Study||0
1471787|NCT01919606|3603867|P1|STARTED|Overall Study||1
1471788|NCT01919450|3603879|P4|NOT COMPLETED|Overall Study||1
1471789|NCT01919450|3603880|P3|NOT COMPLETED|Overall Study||0
1471790|NCT01919450|3603881|P2|NOT COMPLETED|Overall Study||0
1471791|NCT01919450|3603882|P1|NOT COMPLETED|Overall Study||0
1471792|NCT01919450|3603879|P4|COMPLETED|Overall Study||19
1471793|NCT01919450|3603880|P3|COMPLETED|Overall Study||20
1471794|NCT01919450|3603881|P2|COMPLETED|Overall Study||20
1471795|NCT01919450|3603882|P1|COMPLETED|Overall Study||20
1471796|NCT01919450|3603879|P4|STARTED|Overall Study||20
1471797|NCT01919450|3603880|P3|STARTED|Overall Study||20
1471798|NCT01919450|3603881|P2|STARTED|Overall Study||20
1471799|NCT01919450|3603882|P1|STARTED|Overall Study||20
1471800|NCT01919307|3603892|P1|NOT COMPLETED|Overall Study||9
1471801|NCT01919307|3603892|P1|COMPLETED|Overall Study||20
1471802|NCT01919307|3603892|P1|STARTED|Overall Study||29
1471803|NCT01919229|3603902|P3|NOT COMPLETED|Overall Study||1
1471804|NCT01919229|3603903|P2|NOT COMPLETED|Overall Study||0
1471805|NCT01919229|3603904|P1|NOT COMPLETED|Overall Study||0
1471806|NCT01919229|3603902|P3|COMPLETED|Overall Study||3
1471807|NCT01919229|3603903|P2|COMPLETED|Overall Study||6
1471808|NCT01919229|3603904|P1|COMPLETED|Overall Study||4
1471809|NCT01919229|3603902|P3|STARTED|Overall Study||4
1471810|NCT01919229|3603903|P2|STARTED|Overall Study||6
1471811|NCT01919229|3603904|P1|STARTED|Overall Study||4
1471812|NCT01919216|3603936|P3|NOT COMPLETED|Overall Study||1
1471813|NCT01919216|3603937|P2|NOT COMPLETED|Overall Study||1
1471814|NCT01919216|3603938|P1|NOT COMPLETED|Overall Study||2
1471815|NCT01919216|3603936|P3|COMPLETED|Overall Study||4
1471816|NCT01919216|3603937|P2|COMPLETED|Overall Study||20
1471817|NCT01919216|3603938|P1|COMPLETED|Overall Study||26
1471818|NCT01919216|3603936|P3|STARTED|Overall Study||5
1471819|NCT01919216|3603937|P2|STARTED|Overall Study||21
1471820|NCT01919216|3603938|P1|STARTED|Overall Study||28
1471821|NCT01918800|3603948|P2|NOT COMPLETED|Overall Study||5
1471822|NCT01918800|3603949|P1|NOT COMPLETED|Overall Study||9
1471823|NCT01918800|3603948|P2|COMPLETED|Overall Study||104
1471824|NCT01918800|3603949|P1|COMPLETED|Overall Study||100
1471825|NCT01918800|3603948|P2|STARTED|Overall Study||109
1471826|NCT01918800|3603949|P1|STARTED|Overall Study||109
1471827|NCT01918371|3603969|P2|NOT COMPLETED|Overall Study||1
1471828|NCT01918371|3603970|P1|NOT COMPLETED|Overall Study||1
1471829|NCT01918371|3603969|P2|COMPLETED|Overall Study||156
1471830|NCT01918371|3603970|P1|COMPLETED|Overall Study||165
1471831|NCT01918371|3603969|P2|Participants With Complete Data|Overall Study||156
1471832|NCT01918371|3603970|P1|Participants With Complete Data|Overall Study||165
1471833|NCT01918371|3603969|P2|STARTED|Overall Study||157
1471834|NCT01918371|3603970|P1|STARTED|Overall Study||166
1471835|NCT01918332|3604048|P4|NOT COMPLETED|Overall Study||7
1471836|NCT01918332|3604049|P3|NOT COMPLETED|Overall Study||9
1471837|NCT01918332|3604050|P2|NOT COMPLETED|Overall Study||5
1471838|NCT01918332|3604051|P1|NOT COMPLETED|Overall Study||8
1471839|NCT01918332|3604048|P4|COMPLETED|Overall Study||38
1471840|NCT01918332|3604049|P3|COMPLETED|Overall Study||30
1471841|NCT01918332|3604050|P2|COMPLETED|Overall Study||36
1471842|NCT01918332|3604051|P1|COMPLETED|Overall Study||35
1471843|NCT01918332|3604048|P4|STARTED|Overall Study||45
1471844|NCT01918332|3604049|P3|STARTED|Overall Study||39
1471845|NCT01918332|3604050|P2|STARTED|Overall Study||41
1471846|NCT01918332|3604051|P1|STARTED|Overall Study||43
1471847|NCT01918306|3604063|P4|NOT COMPLETED|Overall Study||3
1471848|NCT01918306|3604064|P3|NOT COMPLETED|Overall Study||2
1471849|NCT01918306|3604065|P2|NOT COMPLETED|Overall Study||0
1471850|NCT01918306|3604066|P1|NOT COMPLETED|Overall Study||6
1471851|NCT01918306|3604063|P4|COMPLETED|Overall Study||0
1471852|NCT01918306|3604064|P3|COMPLETED|Overall Study||0
1471853|NCT01918306|3604065|P2|COMPLETED|Overall Study||0
1471854|NCT01918306|3604066|P1|COMPLETED|Overall Study||0
1471855|NCT01918306|3604063|P4|STARTED|Overall Study||3
1471856|NCT01918306|3604064|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
1471857|NCT01918306|3604065|P2|STARTED|Overall Study|No patients enrolled|0
1471858|NCT01918306|3604066|P1|STARTED|Overall Study||6
1471859|NCT01918085|3604088|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
1471860|NCT01918085|3604089|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
1471861|NCT01918085|3604088|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
1471862|NCT01918085|3604089|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
1471863|NCT01918085|3604088|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
1471864|NCT01918085|3604089|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
1471865|NCT01918085|3604088|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
1471866|NCT01918085|3604089|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
1471867|NCT01918085|3604088|P2|COMPLETED|Test Period 2: Strata Strip||11
1471868|NCT01918085|3604089|P1|COMPLETED|Test Period 2: Strata Strip||10
1471869|NCT01918085|3604088|P2|STARTED|Test Period 2: Strata Strip||11
1471870|NCT01918085|3604089|P1|STARTED|Test Period 2: Strata Strip||10
1471871|NCT01918085|3604088|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
1471872|NCT01918085|3604089|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
1471873|NCT01918085|3604088|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
1471874|NCT01918085|3604089|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
1471875|NCT01918085|3604088|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
1471876|NCT01918085|3604089|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
1471877|NCT01918085|3604088|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
1471878|NCT01918085|3604089|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
1471879|NCT01918085|3604088|P2|COMPLETED|Test Period 1: Strata Strip||11
1471880|NCT01918085|3604089|P1|COMPLETED|Test Period 1: Strata Strip||10
1471881|NCT01918085|3604088|P2|STARTED|Test Period 1: Strata Strip||12
1471882|NCT01918085|3604089|P1|STARTED|Test Period 1: Strata Strip||10
1471883|NCT01918033|3604100|P3|NOT COMPLETED|Overall Study||3
1471884|NCT01918033|3604101|P2|NOT COMPLETED|Overall Study||2
1471885|NCT01918033|3604102|P1|NOT COMPLETED|Overall Study||5
1471886|NCT01918033|3604100|P3|COMPLETED|Overall Study||199
1471887|NCT01918033|3604101|P2|COMPLETED|Overall Study||201
1471888|NCT01918033|3604102|P1|COMPLETED|Overall Study||198
1471889|NCT01918033|3604100|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
1471890|NCT01918033|3604101|P2|Treated|Overall Study||203
1471891|NCT01918033|3604102|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
1471892|NCT01918033|3604100|P3|STARTED|Overall Study||202
1471893|NCT01918033|3604101|P2|STARTED|Overall Study||203
1471894|NCT01918033|3604102|P1|STARTED|Overall Study||203
1471895|NCT01917812|3604143|P3|NOT COMPLETED|Overall Study||0
1471896|NCT01917812|3604144|P2|NOT COMPLETED|Overall Study||0
1471897|NCT01917812|3604145|P1|NOT COMPLETED|Overall Study||1
1471898|NCT01917812|3604143|P3|COMPLETED|Overall Study||16
1471899|NCT01917812|3604144|P2|COMPLETED|Overall Study||16
1471900|NCT01917812|3604145|P1|COMPLETED|Overall Study||15
1471901|NCT01917812|3604143|P3|STARTED|Overall Study||16
1471902|NCT01917812|3604144|P2|STARTED|Overall Study||16
1471903|NCT01917812|3604145|P1|STARTED|Overall Study||16
1471904|NCT01917773|3604165|P1|NOT COMPLETED|Overall Study||0
1471905|NCT01917773|3604165|P1|COMPLETED|Overall Study||13
1471906|NCT01917773|3604165|P1|STARTED|Overall Study||13
1471907|NCT01917656|3604173|P2|NOT COMPLETED|Overall Study||24
1471908|NCT01917656|3604174|P1|NOT COMPLETED|Overall Study||26
1471909|NCT01917656|3604173|P2|COMPLETED|Overall Study||147
1471910|NCT01917656|3604174|P1|COMPLETED|Overall Study||146
1471911|NCT01917656|3604173|P2|Exposed During Ramadan (Fasting)|Overall Study||163
1471912|NCT01917656|3604174|P1|Exposed During Ramadan (Fasting)|Overall Study||152
1471913|NCT01917656|3604173|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
1471914|NCT01917656|3604174|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
1471915|NCT01917656|3604173|P2|STARTED|Overall Study||171
1471916|NCT01917656|3604174|P1|STARTED|Overall Study||172
1471917|NCT01917526|3604200|P2|NOT COMPLETED|Overall Study||1
1471918|NCT01917526|3604201|P1|NOT COMPLETED|Overall Study||1
1471919|NCT01917526|3604200|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
1471920|NCT01917526|3604201|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
1471921|NCT01917526|3604200|P2|STARTED|Overall Study||250
1471922|NCT01917526|3604201|P1|STARTED|Overall Study||250
1471923|NCT01917513|3604211|P2|NOT COMPLETED|Overall Study||102
1471924|NCT01917513|3604212|P1|NOT COMPLETED|Overall Study||95
1471925|NCT01917513|3604211|P2|COMPLETED|Overall Study||396
1471926|NCT01917513|3604212|P1|COMPLETED|Overall Study||407
1471927|NCT01917513|3604211|P2|STARTED|Overall Study||498
1471928|NCT01917513|3604212|P1|STARTED|Overall Study||502
1471929|NCT01917344|3604218|P1|NOT COMPLETED|Overall Study||1
1471930|NCT01917344|3604218|P1|COMPLETED|Overall Study||9
1471931|NCT01917344|3604218|P1|STARTED|Overall Study||10
1471932|NCT01917214|3604222|P1|NOT COMPLETED|Overall Study||0
1471933|NCT01917214|3604222|P1|COMPLETED|Overall Study||212
1471934|NCT01917214|3604222|P1|STARTED|Overall Study||212
1471935|NCT01917006|3604238|P8|NOT COMPLETED|Open-label Period||2
1471936|NCT01917006|3604239|P7|NOT COMPLETED|Open-label Period||0
1471937|NCT01917006|3604240|P6|NOT COMPLETED|Open-label Period||0
1471938|NCT01917006|3604241|P5|NOT COMPLETED|Open-label Period||0
1471939|NCT01917006|3604242|P4|NOT COMPLETED|Open-label Period||0
1471940|NCT01917006|3604243|P3|NOT COMPLETED|Open-label Period||0
1471941|NCT01917006|3604244|P2|NOT COMPLETED|Open-label Period||0
1471942|NCT01917006|3604245|P1|NOT COMPLETED|Open-label Period||0
1471943|NCT01917006|3604238|P8|COMPLETED|Open-label Period||6
1471944|NCT01917006|3604239|P7|COMPLETED|Open-label Period||0
1471945|NCT01917006|3604240|P6|COMPLETED|Open-label Period||0
1471946|NCT01917006|3604241|P5|COMPLETED|Open-label Period||0
1471947|NCT01917006|3604242|P4|COMPLETED|Open-label Period||0
1471948|NCT01917006|3604243|P3|COMPLETED|Open-label Period||0
1471949|NCT01917006|3604244|P2|COMPLETED|Open-label Period||0
1471950|NCT01917006|3604245|P1|COMPLETED|Open-label Period||0
1471951|NCT01917006|3604238|P8|STARTED|Open-label Period||8
1471952|NCT01917006|3604239|P7|STARTED|Open-label Period||0
1471953|NCT01917006|3604240|P6|STARTED|Open-label Period||0
1471954|NCT01917006|3604241|P5|STARTED|Open-label Period||0
1471955|NCT01917006|3604242|P4|STARTED|Open-label Period||0
1471956|NCT01917006|3604243|P3|STARTED|Open-label Period||0
1471957|NCT01917006|3604244|P2|STARTED|Open-label Period||0
1471958|NCT01917006|3604245|P1|STARTED|Open-label Period||0
1471959|NCT01917006|3604238|P8|NOT COMPLETED|Randomized-treatment Period||0
1471960|NCT01917006|3604239|P7|NOT COMPLETED|Randomized-treatment Period||1
1471961|NCT01917006|3604240|P6|NOT COMPLETED|Randomized-treatment Period||1
1471962|NCT01917006|3604241|P5|NOT COMPLETED|Randomized-treatment Period||0
1471963|NCT01917006|3604242|P4|NOT COMPLETED|Randomized-treatment Period||1
1471964|NCT01917006|3604243|P3|NOT COMPLETED|Randomized-treatment Period||0
1471965|NCT01917006|3604244|P2|NOT COMPLETED|Randomized-treatment Period||0
1471966|NCT01917006|3604245|P1|NOT COMPLETED|Randomized-treatment Period||2
1471967|NCT01917006|3604238|P8|COMPLETED|Randomized-treatment Period||0
1471968|NCT01917006|3604239|P7|COMPLETED|Randomized-treatment Period||14
1471969|NCT01917006|3604240|P6|COMPLETED|Randomized-treatment Period||7
1471970|NCT01917006|3604241|P5|COMPLETED|Randomized-treatment Period||8
1471971|NCT01917006|3604242|P4|COMPLETED|Randomized-treatment Period||7
1471972|NCT01917006|3604243|P3|COMPLETED|Randomized-treatment Period||8
1471973|NCT01917006|3604244|P2|COMPLETED|Randomized-treatment Period||7
1471974|NCT01917006|3604245|P1|COMPLETED|Randomized-treatment Period||3
1471975|NCT01917006|3604238|P8|STARTED|Randomized-treatment Period||0
1471976|NCT01917006|3604239|P7|STARTED|Randomized-treatment Period||15
1471977|NCT01917006|3604240|P6|STARTED|Randomized-treatment Period||8
1471978|NCT01917006|3604241|P5|STARTED|Randomized-treatment Period||8
1471979|NCT01917006|3604242|P4|STARTED|Randomized-treatment Period||8
1471980|NCT01917006|3604243|P3|STARTED|Randomized-treatment Period||8
1471981|NCT01917006|3604244|P2|STARTED|Randomized-treatment Period||7
1471982|NCT01917006|3604245|P1|STARTED|Randomized-treatment Period||5
1471983|NCT01916980|3604278|P2|NOT COMPLETED|Overall Study||4
1471984|NCT01916980|3604279|P1|NOT COMPLETED|Overall Study||7
1471985|NCT01916980|3604278|P2|COMPLETED|Overall Study||25
1471986|NCT01916980|3604279|P1|COMPLETED|Overall Study||58
1471987|NCT01916980|3604278|P2|STARTED|Overall Study||29
1471988|NCT01916980|3604279|P1|STARTED|Overall Study||65
1471989|NCT01916967|3604298|P3|NOT COMPLETED|Overall Study||9
1471990|NCT01916967|3604299|P2|NOT COMPLETED|Overall Study||1
1471991|NCT01916967|3604300|P1|NOT COMPLETED|Overall Study||0
1471992|NCT01916967|3604298|P3|COMPLETED|Overall Study||71
1471993|NCT01916967|3604299|P2|COMPLETED|Overall Study||78
1471994|NCT01916967|3604300|P1|COMPLETED|Overall Study||80
1471995|NCT01916967|3604298|P3|STARTED|Overall Study||80
1471996|NCT01916967|3604299|P2|STARTED|Overall Study||79
1471997|NCT01916967|3604300|P1|STARTED|Overall Study||80
1471998|NCT01916941|3604343|P2|NOT COMPLETED|Overall Study||4
1471999|NCT01916941|3604344|P1|NOT COMPLETED|Overall Study||5
1472000|NCT01916941|3604343|P2|COMPLETED|Overall Study||14
1472001|NCT01916941|3604344|P1|COMPLETED|Overall Study||13
1472002|NCT01916941|3604343|P2|STARTED|Overall Study||18
1472003|NCT01916941|3604344|P1|STARTED|Overall Study||18
1472004|NCT01916928|3604350|P1|NOT COMPLETED|Overall Study||0
1472005|NCT01916928|3604350|P1|COMPLETED|Overall Study||50
1472006|NCT01916928|3604350|P1|STARTED|Overall Study||50
1472007|NCT01916824|3604356|P2|NOT COMPLETED|Overall Study||9
1472008|NCT01916824|3604357|P1|NOT COMPLETED|Overall Study||7
1472009|NCT01916824|3604356|P2|COMPLETED|Overall Study||20
1472010|NCT01916824|3604357|P1|COMPLETED|Overall Study||17
1472011|NCT01916824|3604356|P2|STARTED|Overall Study||29
1472012|NCT01916824|3604357|P1|STARTED|Overall Study||24
1472013|NCT01916681|3604367|P4|NOT COMPLETED|Overall Study||0
1472014|NCT01916681|3604368|P3|NOT COMPLETED|Overall Study||0
1472015|NCT01916681|3604369|P2|NOT COMPLETED|Overall Study||0
1472016|NCT01916681|3604370|P1|NOT COMPLETED|Overall Study||0
1472017|NCT01916681|3604367|P4|COMPLETED|Overall Study||125
1472018|NCT01916681|3604368|P3|COMPLETED|Overall Study||123
1472019|NCT01916681|3604369|P2|COMPLETED|Overall Study||120
1472020|NCT01916681|3604370|P1|COMPLETED|Overall Study||123
1472021|NCT01916681|3604367|P4|STARTED|Overall Study||125
1472022|NCT01916681|3604368|P3|STARTED|Overall Study||123
1472023|NCT01916681|3604369|P2|STARTED|Overall Study||120
1472024|NCT01916681|3604370|P1|STARTED|Overall Study||123
1472025|NCT01916629|3604410|P2|NOT COMPLETED|Overall Study||0
1472026|NCT01916629|3604411|P1|NOT COMPLETED|Overall Study||0
1472027|NCT01916629|3604410|P2|COMPLETED|Overall Study||5
1472028|NCT01916629|3604411|P1|COMPLETED|Overall Study||7
1472029|NCT01916629|3604410|P2|STARTED|Overall Study||5
1472030|NCT01916629|3604411|P1|STARTED|Overall Study||7
1472031|NCT01916590|3604419|P2|NOT COMPLETED|Overall Study||0
1472032|NCT01916590|3604420|P1|NOT COMPLETED|Overall Study||0
1472033|NCT01916590|3604419|P2|COMPLETED|Overall Study||3
1472034|NCT01916590|3604420|P1|COMPLETED|Overall Study||4
1472035|NCT01916590|3604419|P2|STARTED|Overall Study||3
1472036|NCT01916590|3604420|P1|STARTED|Overall Study||4
1472037|NCT01916304|3604426|P1|NOT COMPLETED|Overall Study||17
1472038|NCT01916304|3604426|P1|COMPLETED|Overall Study||84
1472039|NCT01916304|3604426|P1|Intent-to-Treat Set|Overall Study||84
1472040|NCT01916304|3604426|P1|Safety Set|Overall Study||101
1472041|NCT01916304|3604426|P1|STARTED|Overall Study||101
1472042|NCT01916226|3604438|P4|NOT COMPLETED|Overall Study||4
1472043|NCT01916226|3604439|P3|NOT COMPLETED|Overall Study||3
1472044|NCT01916226|3604440|P2|NOT COMPLETED|Overall Study||1
1472045|NCT01916226|3604441|P1|NOT COMPLETED|Overall Study||1
1472046|NCT01916226|3604438|P4|COMPLETED|Overall Study||167
1472047|NCT01916226|3604439|P3|COMPLETED|Overall Study||168
1472048|NCT01916226|3604440|P2|COMPLETED|Overall Study||169
1472049|NCT01916226|3604441|P1|COMPLETED|Overall Study||169
1472050|NCT01916226|3604438|P4|STARTED|Overall Study||171
1472051|NCT01916226|3604439|P3|STARTED|Overall Study||171
1472052|NCT01916226|3604440|P2|STARTED|Overall Study||170
1472053|NCT01916226|3604441|P1|STARTED|Overall Study||170
1472054|NCT01916109|3604475|P1|NOT COMPLETED|Overall Study||1
1472055|NCT01916109|3604475|P1|COMPLETED|Overall Study||3
1472056|NCT01916109|3604475|P1|STARTED|Overall Study||4
1472057|NCT01915940|3604481|P3|NOT COMPLETED|Treatment Period||4
1472058|NCT01915940|3604482|P2|NOT COMPLETED|Treatment Period||11
1472059|NCT01915940|3604483|P1|NOT COMPLETED|Treatment Period||0
1472060|NCT01915940|3604481|P3|COMPLETED|Treatment Period||62
1472061|NCT01915940|3604482|P2|COMPLETED|Treatment Period||53
1472062|NCT01915940|3604483|P1|COMPLETED|Treatment Period||0
1472063|NCT01915940|3604481|P3|STARTED|Treatment Period||66
1472064|NCT01915940|3604482|P2|STARTED|Treatment Period||64
1472065|NCT01915940|3604483|P1|STARTED|Treatment Period||0
1472066|NCT01915940|3604481|P3|NOT COMPLETED|Pre-randomization Washout Period||0
1472067|NCT01915940|3604482|P2|NOT COMPLETED|Pre-randomization Washout Period||0
1472068|NCT01915940|3604483|P1|NOT COMPLETED|Pre-randomization Washout Period||39
1472069|NCT01915940|3604481|P3|COMPLETED|Pre-randomization Washout Period||0
1472070|NCT01915940|3604482|P2|COMPLETED|Pre-randomization Washout Period||0
1472071|NCT01915940|3604483|P1|COMPLETED|Pre-randomization Washout Period||130
1472072|NCT01915940|3604481|P3|STARTED|Pre-randomization Washout Period||0
1472073|NCT01915940|3604482|P2|STARTED|Pre-randomization Washout Period||0
1472074|NCT01915940|3604483|P1|STARTED|Pre-randomization Washout Period||169
1472075|NCT01915914|3604499|P4|NOT COMPLETED|Follow-up Phase||2
1472076|NCT01915914|3604500|P3|NOT COMPLETED|Follow-up Phase||0
1472077|NCT01915914|3604501|P2|NOT COMPLETED|Follow-up Phase||0
1472078|NCT01915914|3604502|P1|NOT COMPLETED|Follow-up Phase||0
1472079|NCT01915914|3604499|P4|COMPLETED|Follow-up Phase||64
1472080|NCT01915914|3604500|P3|COMPLETED|Follow-up Phase||0
1472081|NCT01915914|3604501|P2|COMPLETED|Follow-up Phase||0
1472082|NCT01915914|3604502|P1|COMPLETED|Follow-up Phase||0
1472083|NCT01915914|3604499|P4|STARTED|Follow-up Phase||66
1472084|NCT01915914|3604500|P3|STARTED|Follow-up Phase||0
1472085|NCT01915914|3604501|P2|STARTED|Follow-up Phase||0
1472086|NCT01915914|3604502|P1|STARTED|Follow-up Phase||0
1472087|NCT01915914|3604499|P4|NOT COMPLETED|Maintenance Phase||0
1472088|NCT01915914|3604500|P3|NOT COMPLETED|Maintenance Phase||2
1472089|NCT01915914|3604501|P2|NOT COMPLETED|Maintenance Phase||6
1472090|NCT01915914|3604502|P1|NOT COMPLETED|Maintenance Phase||0
1472091|NCT01915914|3604499|P4|COMPLETED|Maintenance Phase||0
1472092|NCT01915914|3604500|P3|COMPLETED|Maintenance Phase||51
1472093|NCT01915914|3604501|P2|COMPLETED|Maintenance Phase||48
1472094|NCT01915914|3604502|P1|COMPLETED|Maintenance Phase||0
1472095|NCT01915914|3604499|P4|STARTED|Maintenance Phase||0
1472096|NCT01915914|3604500|P3|STARTED|Maintenance Phase||53
1472097|NCT01915914|3604501|P2|STARTED|Maintenance Phase||54
1472098|NCT01915914|3604502|P1|STARTED|Maintenance Phase||0
1472099|NCT01915914|3604499|P4|NOT COMPLETED|Acute Phase||0
1472100|NCT01915914|3604500|P3|NOT COMPLETED|Acute Phase||0
1472101|NCT01915914|3604501|P2|NOT COMPLETED|Acute Phase||0
1472102|NCT01915914|3604502|P1|NOT COMPLETED|Acute Phase||12
1472103|NCT01915914|3604499|P4|COMPLETED|Acute Phase||0
1472104|NCT01915914|3604500|P3|COMPLETED|Acute Phase||0
1472105|NCT01915914|3604501|P2|COMPLETED|Acute Phase||0
1472106|NCT01915914|3604502|P1|COMPLETED|Acute Phase||111
1472107|NCT01915914|3604499|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
1472108|NCT01915914|3604500|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
1472109|NCT01915914|3604501|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
1472110|NCT01915914|3604502|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
1472111|NCT01915914|3604499|P4|STARTED|Acute Phase||0
1472112|NCT01915914|3604500|P3|STARTED|Acute Phase||0
1472113|NCT01915914|3604501|P2|STARTED|Acute Phase||0
1472114|NCT01915914|3604502|P1|STARTED|Acute Phase||123
1472115|NCT01915849|3604534|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
1472116|NCT01915849|3604535|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
1472117|NCT01915849|3604536|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
1472118|NCT01915849|3604537|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
1472119|NCT01915849|3604534|P4|COMPLETED|Treatment Period 4 (4 Days)||3
1472120|NCT01915849|3604535|P3|COMPLETED|Treatment Period 4 (4 Days)||3
1472121|NCT01915849|3604536|P2|COMPLETED|Treatment Period 4 (4 Days)||3
1472122|NCT01915849|3604537|P1|COMPLETED|Treatment Period 4 (4 Days)||3
1472123|NCT01915849|3604534|P4|STARTED|Treatment Period 4 (4 Days)||3
1472124|NCT01915849|3604535|P3|STARTED|Treatment Period 4 (4 Days)||3
1472125|NCT01915849|3604536|P2|STARTED|Treatment Period 4 (4 Days)||3
1472126|NCT01915849|3604537|P1|STARTED|Treatment Period 4 (4 Days)||3
1472127|NCT01915849|3604534|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1472128|NCT01915849|3604535|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1472129|NCT01915849|3604536|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1472130|NCT01915849|3604537|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
1472131|NCT01915849|3604534|P4|COMPLETED|Treatment Period 3 (4 Days)||3
1472132|NCT01915849|3604535|P3|COMPLETED|Treatment Period 3 (4 Days)||3
1472133|NCT01915849|3604536|P2|COMPLETED|Treatment Period 3 (4 Days)||3
1472134|NCT01915849|3604537|P1|COMPLETED|Treatment Period 3 (4 Days)||3
1472135|NCT01915849|3604534|P4|STARTED|Treatment Period 3 (4 Days)||3
1472136|NCT01915849|3604535|P3|STARTED|Treatment Period 3 (4 Days)||3
1472137|NCT01915849|3604536|P2|STARTED|Treatment Period 3 (4 Days)||3
1472138|NCT01915849|3604537|P1|STARTED|Treatment Period 3 (4 Days)||3
1472139|NCT01915849|3604534|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1472140|NCT01915849|3604535|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1472141|NCT01915849|3604536|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1472142|NCT01915849|3604537|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1472143|NCT01915849|3604534|P4|COMPLETED|Treatment Period 2 (4 Days)||3
1472144|NCT01915849|3604535|P3|COMPLETED|Treatment Period 2 (4 Days)||3
1472145|NCT01915849|3604536|P2|COMPLETED|Treatment Period 2 (4 Days)||3
1472146|NCT01915849|3604537|P1|COMPLETED|Treatment Period 2 (4 Days)||3
1472147|NCT01915849|3604534|P4|STARTED|Treatment Period 2 (4 Days)||3
1472148|NCT01915849|3604535|P3|STARTED|Treatment Period 2 (4 Days)||3
1472149|NCT01915849|3604536|P2|STARTED|Treatment Period 2 (4 Days)||3
1472150|NCT01915849|3604537|P1|STARTED|Treatment Period 2 (4 Days)||3
1472151|NCT01915849|3604534|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1472152|NCT01915849|3604535|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1472153|NCT01915849|3604536|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1472154|NCT01915849|3604537|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
1472155|NCT01915849|3604534|P4|COMPLETED|Treatment Period 1 (4 Days)||3
1472156|NCT01915849|3604535|P3|COMPLETED|Treatment Period 1 (4 Days)||3
1472157|NCT01915849|3604536|P2|COMPLETED|Treatment Period 1 (4 Days)||3
1472158|NCT01915849|3604537|P1|COMPLETED|Treatment Period 1 (4 Days)||3
1472159|NCT01915849|3604534|P4|STARTED|Treatment Period 1 (4 Days)||3
1472160|NCT01915849|3604535|P3|STARTED|Treatment Period 1 (4 Days)||3
1472161|NCT01915849|3604536|P2|STARTED|Treatment Period 1 (4 Days)||3
1472162|NCT01915849|3604537|P1|STARTED|Treatment Period 1 (4 Days)||5
1472163|NCT01915823|3604549|P2|NOT COMPLETED|Overall Study||2
1472164|NCT01915823|3604550|P1|NOT COMPLETED|Overall Study||2
1472165|NCT01915823|3604549|P2|COMPLETED|Overall Study||173
1472166|NCT01915823|3604550|P1|COMPLETED|Overall Study||171
1472167|NCT01915823|3604549|P2|STARTED|Overall Study||175
1472168|NCT01915823|3604550|P1|STARTED|Overall Study||173
1472169|NCT01915732|3604562|P2|NOT COMPLETED|Overall Study||71
1472170|NCT01915732|3604563|P1|NOT COMPLETED|Overall Study||70
1472171|NCT01915732|3604562|P2|COMPLETED|Overall Study||445
1472172|NCT01915732|3604563|P1|COMPLETED|Overall Study||430
1472173|NCT01915732|3604562|P2|STARTED|Overall Study||516
1472174|NCT01915732|3604563|P1|STARTED|Overall Study||500
1472175|NCT01915173|3604591|P4|NOT COMPLETED|Overall Study||0
1472176|NCT01915173|3604592|P3|NOT COMPLETED|Overall Study||0
1472177|NCT01915173|3604593|P2|NOT COMPLETED|Overall Study||0
1472178|NCT01915173|3604594|P1|NOT COMPLETED|Overall Study||0
1472179|NCT01915173|3604591|P4|COMPLETED|Overall Study||6
1472180|NCT01915173|3604592|P3|COMPLETED|Overall Study||6
1472181|NCT01915173|3604593|P2|COMPLETED|Overall Study||6
1472182|NCT01915173|3604594|P1|COMPLETED|Overall Study||6
1472183|NCT01915173|3604591|P4|STARTED|Overall Study||6
1472184|NCT01915173|3604592|P3|STARTED|Overall Study||6
1472185|NCT01915173|3604593|P2|STARTED|Overall Study||6
1472186|NCT01915173|3604594|P1|STARTED|Overall Study||6
1472187|NCT01915108|3604616|P4|NOT COMPLETED|Overall Study||2
1472188|NCT01915108|3604617|P3|NOT COMPLETED|Overall Study||1
1472189|NCT01915108|3604618|P2|NOT COMPLETED|Overall Study||3
1472190|NCT01915108|3604619|P1|NOT COMPLETED|Overall Study||2
1472191|NCT01915108|3604616|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
1472192|NCT01915108|3604617|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
1472193|NCT01915108|3604618|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
1472194|NCT01915108|3604619|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
1472195|NCT01915108|3604616|P4|STARTED|Overall Study||32
1472196|NCT01915108|3604617|P3|STARTED|Overall Study||32
1472197|NCT01915108|3604618|P2|STARTED|Overall Study||32
1472198|NCT01915108|3604619|P1|STARTED|Overall Study||32
1472199|NCT01914926|3604631|P2|NOT COMPLETED|Overall Study||1
1472200|NCT01914926|3604632|P1|NOT COMPLETED|Overall Study||1
1472201|NCT01914926|3604631|P2|COMPLETED|Overall Study||24
1472202|NCT01914926|3604632|P1|COMPLETED|Overall Study||28
1472203|NCT01914926|3604631|P2|STARTED|Overall Study||25
1472204|NCT01914926|3604632|P1|STARTED|Overall Study||29
1472205|NCT01914757|3604641|P3|NOT COMPLETED|Overall Study||38
1472206|NCT01914757|3604642|P2|NOT COMPLETED|Overall Study||51
1472207|NCT01914757|3604643|P1|NOT COMPLETED|Overall Study||36
1472208|NCT01914757|3604641|P3|COMPLETED|Overall Study||402
1472209|NCT01914757|3604642|P2|COMPLETED|Overall Study||390
1472210|NCT01914757|3604643|P1|COMPLETED|Overall Study||389
1472211|NCT01914757|3604641|P3|STARTED|Overall Study||440
1472212|NCT01914757|3604642|P2|STARTED|Overall Study||441
1472213|NCT01914757|3604643|P1|STARTED|Overall Study||425
1472214|NCT01914679|3604717|P1|NOT COMPLETED|Overall Study||5
1472215|NCT01914679|3604717|P1|COMPLETED|Overall Study||12
1472216|NCT01914679|3604717|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
1472217|NCT01914679|3604717|P1|STARTED|Overall Study||17
1472218|NCT01914666|3604724|P3|NOT COMPLETED|Tapering Period||0
1472219|NCT01914666|3604725|P2|NOT COMPLETED|Tapering Period||0
1472220|NCT01914666|3604726|P1|NOT COMPLETED|Tapering Period||0
1472221|NCT01914666|3604724|P3|COMPLETED|Tapering Period||40
1472222|NCT01914666|3604725|P2|COMPLETED|Tapering Period||39
1472223|NCT01914666|3604726|P1|COMPLETED|Tapering Period||59
1472224|NCT01914666|3604724|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
1472225|NCT01914666|3604725|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
1472226|NCT01914666|3604726|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
1472227|NCT01914666|3604724|P3|NOT COMPLETED|Treatment Period||8
1472228|NCT01914666|3604725|P2|NOT COMPLETED|Treatment Period||6
1472229|NCT01914666|3604726|P1|NOT COMPLETED|Treatment Period||13
1472230|NCT01914666|3604724|P3|COMPLETED|Treatment Period||33
1472231|NCT01914666|3604725|P2|COMPLETED|Treatment Period||36
1472232|NCT01914666|3604726|P1|COMPLETED|Treatment Period||55
1472233|NCT01914666|3604724|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
1472234|NCT01914666|3604725|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
1472235|NCT01914666|3604726|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
1472236|NCT01914666|3604724|P3|STARTED|Treatment Period||41
1472237|NCT01914666|3604725|P2|STARTED|Treatment Period||42
1472238|NCT01914666|3604726|P1|STARTED|Treatment Period||68
1472239|NCT01914003|3604761|P2|NOT COMPLETED|Overall Study||12
1472240|NCT01914003|3604762|P1|NOT COMPLETED|Overall Study||8
1472241|NCT01914003|3604761|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
1472242|NCT01914003|3604762|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
1472243|NCT01914003|3604761|P2|STARTED|Overall Study||26
1472244|NCT01914003|3604762|P1|STARTED|Overall Study||27
1472245|NCT01913795|3604772|P4|NOT COMPLETED|Overall Study||1
1472246|NCT01913795|3604773|P3|NOT COMPLETED|Overall Study||0
1472247|NCT01913795|3604774|P2|NOT COMPLETED|Overall Study||3
1472248|NCT01913795|3604775|P1|NOT COMPLETED|Overall Study||0
1472249|NCT01913795|3604772|P4|COMPLETED|Overall Study||5
1472250|NCT01913795|3604773|P3|COMPLETED|Overall Study||9
1472251|NCT01913795|3604774|P2|COMPLETED|Overall Study||7
1472252|NCT01913795|3604775|P1|COMPLETED|Overall Study||4
1472253|NCT01913795|3604772|P4|STARTED|Overall Study||6
1472254|NCT01913795|3604773|P3|STARTED|Overall Study||9
1472255|NCT01913795|3604774|P2|STARTED|Overall Study||10
1472256|NCT01913795|3604775|P1|STARTED|Overall Study||4
1472257|NCT01913600|3604789|P1|NOT COMPLETED|Overall Study||1
1472258|NCT01913600|3604789|P1|COMPLETED|Overall Study||55
1472259|NCT01913600|3604789|P1|STARTED|Overall Study||56
1472260|NCT01913535|3604811|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
1472261|NCT01913535|3604812|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
1472262|NCT01913535|3604813|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
1472263|NCT01913535|3604814|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
1472264|NCT01913535|3604815|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
1472265|NCT01913535|3604811|P5|COMPLETED|Phase 2 (Days 3-5)||1
1472266|NCT01913535|3604812|P4|COMPLETED|Phase 2 (Days 3-5)||2
1472267|NCT01913535|3604813|P3|COMPLETED|Phase 2 (Days 3-5)||1
1472268|NCT01913535|3604814|P2|COMPLETED|Phase 2 (Days 3-5)||2
1472269|NCT01913535|3604815|P1|COMPLETED|Phase 2 (Days 3-5)||2
1472270|NCT01913535|3604811|P5|STARTED|Phase 2 (Days 3-5)||1
1472271|NCT01913535|3604812|P4|STARTED|Phase 2 (Days 3-5)||2
1472272|NCT01913535|3604813|P3|STARTED|Phase 2 (Days 3-5)||1
1472273|NCT01913535|3604814|P2|STARTED|Phase 2 (Days 3-5)||2
1472274|NCT01913535|3604815|P1|STARTED|Phase 2 (Days 3-5)||2
1472275|NCT01913535|3604811|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
1472276|NCT01913535|3604812|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
1472277|NCT01913535|3604813|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
1472278|NCT01913535|3604814|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
1472279|NCT01913535|3604815|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
1472280|NCT01913535|3604811|P5|COMPLETED|Phase 1 (Days 0-2)||1
1472281|NCT01913535|3604812|P4|COMPLETED|Phase 1 (Days 0-2)||2
1472282|NCT01913535|3604813|P3|COMPLETED|Phase 1 (Days 0-2)||1
1472283|NCT01913535|3604814|P2|COMPLETED|Phase 1 (Days 0-2)||2
1472284|NCT01913535|3604815|P1|COMPLETED|Phase 1 (Days 0-2)||2
1472285|NCT01913535|3604811|P5|STARTED|Phase 1 (Days 0-2)||1
1472286|NCT01913535|3604812|P4|STARTED|Phase 1 (Days 0-2)||2
1472287|NCT01913535|3604813|P3|STARTED|Phase 1 (Days 0-2)||1
1472288|NCT01913535|3604814|P2|STARTED|Phase 1 (Days 0-2)||2
1472289|NCT01913535|3604815|P1|STARTED|Phase 1 (Days 0-2)||2
1472290|NCT01913483|3604848|P2|NOT COMPLETED|Overall Study||22
1472291|NCT01913483|3604849|P1|NOT COMPLETED|Overall Study||21
1472292|NCT01913483|3604848|P2|COMPLETED|Overall Study||343
1472293|NCT01913483|3604849|P1|COMPLETED|Overall Study||346
1472294|NCT01913483|3604848|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
1472295|NCT01913483|3604849|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
1472296|NCT01913483|3604848|P2|STARTED|Overall Study||365
1472297|NCT01913483|3604849|P1|STARTED|Overall Study||367
1472298|NCT01913470|3604861|P2|NOT COMPLETED|Overall Study||3
1472299|NCT01913470|3604862|P1|NOT COMPLETED|Overall Study||0
1472300|NCT01913470|3604861|P2|COMPLETED|Overall Study||4
1472301|NCT01913470|3604862|P1|COMPLETED|Overall Study||5
1472302|NCT01913470|3604861|P2|STARTED|Overall Study||7
1472303|NCT01913470|3604862|P1|STARTED|Overall Study||5
1472304|NCT01913405|3604880|P1|NOT COMPLETED|Overall Study||2
1472305|NCT01913405|3604880|P1|COMPLETED|Overall Study||20
1472306|NCT01913405|3604880|P1|STARTED|Overall Study||22
1472307|NCT01913314|3604934|P1|NOT COMPLETED|Overall Study||0
1472308|NCT01913314|3604934|P1|COMPLETED|Overall Study||6
1472309|NCT01913314|3604934|P1|Received Study Drug|Overall Study||6
1472310|NCT01913314|3604934|P1|STARTED|Overall Study||6
1472311|NCT01913041|3604947|P1|NOT COMPLETED|Overall Study||39
1472312|NCT01913041|3604947|P1|COMPLETED|Overall Study||830
1472313|NCT01913041|3604947|P1|STARTED|Overall Study||869
1472314|NCT01912963|3604954|P3|NOT COMPLETED|Overall Study||7
1472315|NCT01912963|3604955|P2|NOT COMPLETED|Overall Study||19
1472316|NCT01912963|3604956|P1|NOT COMPLETED|Overall Study||6
1472317|NCT01912963|3604954|P3|COMPLETED|Overall Study||0
1472318|NCT01912963|3604955|P2|COMPLETED|Overall Study||0
1472319|NCT01912963|3604956|P1|COMPLETED|Overall Study||0
1472320|NCT01912963|3604954|P3|STARTED|Overall Study||7
1472321|NCT01912963|3604955|P2|STARTED|Overall Study||19
1472322|NCT01912963|3604956|P1|STARTED|Overall Study||6
1472323|NCT01912781|3604977|P2|NOT COMPLETED|Overall Study||0
1472324|NCT01912781|3604978|P1|NOT COMPLETED|Overall Study||2
1472325|NCT01912781|3604977|P2|COMPLETED|Overall Study||35
1472326|NCT01912781|3604978|P1|COMPLETED|Overall Study||69
1472327|NCT01912781|3604977|P2|STARTED|Overall Study||35
1472328|NCT01912781|3604978|P1|STARTED|Overall Study||71
1472329|NCT01912768|3605009|P2|NOT COMPLETED|Overall Study||4
1472330|NCT01912768|3605010|P1|NOT COMPLETED|Overall Study||10
1472331|NCT01912768|3605009|P2|COMPLETED|Overall Study||109
1472332|NCT01912768|3605010|P1|COMPLETED|Overall Study||229
1472333|NCT01912768|3605009|P2|STARTED|Overall Study||113
1472334|NCT01912768|3605010|P1|STARTED|Overall Study||239
1472335|NCT01912729|3605041|P2|NOT COMPLETED|Overall Study||1
1472336|NCT01912729|3605042|P1|NOT COMPLETED|Overall Study||0
1472337|NCT01912729|3605041|P2|COMPLETED|Overall Study||19
1472338|NCT01912729|3605042|P1|COMPLETED|Overall Study||20
1472339|NCT01912729|3605041|P2|STARTED|Overall Study||20
1472340|NCT01912729|3605042|P1|STARTED|Overall Study||20
1472341|NCT01912599|3605054|P2|NOT COMPLETED|Overall Study||1
1472342|NCT01912599|3605055|P1|NOT COMPLETED|Overall Study||0
1472343|NCT01912599|3605054|P2|COMPLETED|Overall Study||15
1472344|NCT01912599|3605055|P1|COMPLETED|Overall Study||20
1472345|NCT01912599|3605054|P2|STARTED|Overall Study||16
1472346|NCT01912599|3605055|P1|STARTED|Overall Study||20
1472347|NCT01912495|3605069|P1|NOT COMPLETED|Overall Study||0
1472348|NCT01912495|3605069|P1|COMPLETED|Overall Study||57
1472431|NCT01911780|3605195|P2|COMPLETED|Double-blind Period (8 Weeks)||61
1472349|NCT01912495|3605069|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
1472350|NCT01912404|3605080|P2|NOT COMPLETED|Overall Study||0
1472351|NCT01912404|3605081|P1|NOT COMPLETED|Overall Study||1
1472352|NCT01912404|3605080|P2|COMPLETED|Overall Study||2
1472353|NCT01912404|3605081|P1|COMPLETED|Overall Study||2
1472354|NCT01912404|3605080|P2|STARTED|Overall Study||2
1472355|NCT01912404|3605081|P1|STARTED|Overall Study||3
1472356|NCT01912352|3605087|P1|NOT COMPLETED|Overall Study||5
1472357|NCT01912352|3605087|P1|COMPLETED|Overall Study||78
1472358|NCT01912352|3605087|P1|STARTED|Overall Study||83
1472359|NCT01912339|3605094|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
1472360|NCT01912339|3605095|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
1472361|NCT01912339|3605096|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
1472362|NCT01912339|3605094|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
1472363|NCT01912339|3605095|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
1472364|NCT01912339|3605096|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
1472365|NCT01912339|3605094|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
1472366|NCT01912339|3605095|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
1472367|NCT01912339|3605096|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
1472368|NCT01912339|3605094|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
1472369|NCT01912339|3605095|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
1472370|NCT01912339|3605096|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
1472371|NCT01912339|3605094|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
1472372|NCT01912339|3605095|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
1472373|NCT01912339|3605096|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
1472374|NCT01912339|3605094|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
1472375|NCT01912339|3605095|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
1472376|NCT01912339|3605096|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
1472377|NCT01912339|3605094|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
1472378|NCT01912339|3605095|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
1472379|NCT01912339|3605096|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
1472380|NCT01912339|3605094|P3|COMPLETED|Blinded (0 to 3 Months)||0
1472381|NCT01912339|3605095|P2|COMPLETED|Blinded (0 to 3 Months)||61
1472382|NCT01912339|3605096|P1|COMPLETED|Blinded (0 to 3 Months)||134
1472383|NCT01912339|3605094|P3|STARTED|Blinded (0 to 3 Months)||0
1472384|NCT01912339|3605095|P2|STARTED|Blinded (0 to 3 Months)||61
1472385|NCT01912339|3605096|P1|STARTED|Blinded (0 to 3 Months)||136
1472386|NCT01912222|3605113|P3|NOT COMPLETED|Part B: Treatment Period||20
1472387|NCT01912222|3605114|P2|NOT COMPLETED|Part B: Treatment Period||15
1472388|NCT01912222|3605115|P1|NOT COMPLETED|Part B: Treatment Period||13
1472389|NCT01912222|3605113|P3|COMPLETED|Part B: Treatment Period||0
1472390|NCT01912222|3605114|P2|COMPLETED|Part B: Treatment Period||0
1472391|NCT01912222|3605115|P1|COMPLETED|Part B: Treatment Period||0
1472392|NCT01912222|3605113|P3|STARTED|Part B: Treatment Period||20
1472393|NCT01912222|3605114|P2|STARTED|Part B: Treatment Period||15
1472394|NCT01912222|3605115|P1|STARTED|Part B: Treatment Period||13
1472395|NCT01912222|3605113|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
1472396|NCT01912222|3605114|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
1472397|NCT01912222|3605115|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
1472398|NCT01912222|3605113|P3|COMPLETED|Part A: Pharmacokinetic Period||18
1472399|NCT01912222|3605114|P2|COMPLETED|Part A: Pharmacokinetic Period||13
1472400|NCT01912222|3605115|P1|COMPLETED|Part A: Pharmacokinetic Period||12
1472401|NCT01912222|3605113|P3|STARTED|Part A: Pharmacokinetic Period||20
1472402|NCT01912222|3605114|P2|STARTED|Part A: Pharmacokinetic Period||15
1472403|NCT01912222|3605115|P1|STARTED|Part A: Pharmacokinetic Period||13
1472404|NCT01911845|3605138|P1|NOT COMPLETED|Overall Study||6
1472405|NCT01911845|3605138|P1|COMPLETED|Overall Study||32
1472406|NCT01911845|3605138|P1|Completed Study Drug|Overall Study||37
1472407|NCT01911845|3605138|P1|STARTED|Overall Study||38
1472408|NCT01911819|3605155|P3|NOT COMPLETED|Overall Study||0
1472409|NCT01911819|3605156|P2|NOT COMPLETED|Overall Study||2
1472410|NCT01911819|3605157|P1|NOT COMPLETED|Overall Study||1
1472411|NCT01911819|3605155|P3|COMPLETED|Overall Study||10
1472412|NCT01911819|3605156|P2|COMPLETED|Overall Study||9
1472413|NCT01911819|3605157|P1|COMPLETED|Overall Study||9
1472414|NCT01911819|3605155|P3|STARTED|Overall Study||10
1472415|NCT01911819|3605156|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
1472416|NCT01911819|3605157|P1|STARTED|Overall Study||10
1472417|NCT01911793|3605170|P2|NOT COMPLETED|Overall Study||5
1472418|NCT01911793|3605171|P1|NOT COMPLETED|Overall Study||1
1472419|NCT01911793|3605170|P2|COMPLETED|Overall Study||0
1472420|NCT01911793|3605171|P1|COMPLETED|Overall Study||0
1472421|NCT01911793|3605170|P2|STARTED|Overall Study||5
1472422|NCT01911793|3605171|P1|STARTED|Overall Study||1
1472423|NCT01911780|3605195|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
1472424|NCT01911780|3605196|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
1472425|NCT01911780|3605195|P2|COMPLETED|Extension Period (52 Weeks)||58
1472426|NCT01911780|3605196|P1|COMPLETED|Extension Period (52 Weeks)||61
1472427|NCT01911780|3605195|P2|STARTED|Extension Period (52 Weeks)||61
1472428|NCT01911780|3605196|P1|STARTED|Extension Period (52 Weeks)||65
1472429|NCT01911780|3605195|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
1472430|NCT01911780|3605196|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
1472432|NCT01911780|3605196|P1|COMPLETED|Double-blind Period (8 Weeks)||65
1472433|NCT01911780|3605195|P2|STARTED|Double-blind Period (8 Weeks)||64
1472434|NCT01911780|3605196|P1|STARTED|Double-blind Period (8 Weeks)||68
1472435|NCT01911689|3605216|P2|NOT COMPLETED|Overall Study||0
1472436|NCT01911689|3605217|P1|NOT COMPLETED|Overall Study||0
1472437|NCT01911689|3605216|P2|COMPLETED|Overall Study||51
1472438|NCT01911689|3605217|P1|COMPLETED|Overall Study||117
1472439|NCT01911689|3605216|P2|STARTED|Overall Study||51
1472440|NCT01911689|3605217|P1|STARTED|Overall Study||117
1472441|NCT01911546|3605230|P1|NOT COMPLETED|Overall Study||6
1472442|NCT01911546|3605230|P1|COMPLETED|Overall Study||14
1472443|NCT01911546|3605230|P1|STARTED|Overall Study||20
1472444|NCT01911442|3605240|P3|NOT COMPLETED|Overall Study||12
1472445|NCT01911442|3605241|P2|NOT COMPLETED|Overall Study||4
1472446|NCT01911442|3605242|P1|NOT COMPLETED|Overall Study||6
1472447|NCT01911442|3605240|P3|COMPLETED|Overall Study||38
1472448|NCT01911442|3605241|P2|COMPLETED|Overall Study||47
1472449|NCT01911442|3605242|P1|COMPLETED|Overall Study||43
1472450|NCT01911442|3605240|P3|STARTED|Overall Study||50
1472451|NCT01911442|3605241|P2|STARTED|Overall Study||51
1472452|NCT01911442|3605242|P1|STARTED|Overall Study||49
1472453|NCT01911429|3605271|P3|NOT COMPLETED|Overall Study||20
1472454|NCT01911429|3605272|P2|NOT COMPLETED|Overall Study||10
1472455|NCT01911429|3605273|P1|NOT COMPLETED|Overall Study||12
1472456|NCT01911429|3605271|P3|COMPLETED|Overall Study||93
1472457|NCT01911429|3605272|P2|COMPLETED|Overall Study||96
1472458|NCT01911429|3605273|P1|COMPLETED|Overall Study||96
1472459|NCT01911429|3605271|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
1472460|NCT01911429|3605272|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
1472461|NCT01911429|3605273|P1|STARTED|Overall Study||108
1472462|NCT01911403|3605307|P2|NOT COMPLETED|Overall Study||3
1472463|NCT01911403|3605308|P1|NOT COMPLETED|Overall Study||9
1472464|NCT01911403|3605307|P2|COMPLETED|Overall Study||59
1472465|NCT01911403|3605308|P1|COMPLETED|Overall Study||52
1472466|NCT01911403|3605307|P2|STARTED|Overall Study||62
1472467|NCT01911403|3605308|P1|STARTED|Overall Study||61
1472468|NCT01911390|3605329|P4|NOT COMPLETED|Overall Study||1
1472469|NCT01911390|3605330|P3|NOT COMPLETED|Overall Study||1
1472470|NCT01911390|3605331|P2|NOT COMPLETED|Overall Study||0
1472471|NCT01911390|3605332|P1|NOT COMPLETED|Overall Study||1
1472472|NCT01911390|3605329|P4|COMPLETED|Overall Study||10
1472473|NCT01911390|3605330|P3|COMPLETED|Overall Study||9
1472474|NCT01911390|3605331|P2|COMPLETED|Overall Study||10
1472475|NCT01911390|3605332|P1|COMPLETED|Overall Study||9
1472476|NCT01911390|3605329|P4|STARTED|Overall Study||11
1472477|NCT01911390|3605330|P3|STARTED|Overall Study||10
1472478|NCT01911390|3605331|P2|STARTED|Overall Study||10
1472479|NCT01911390|3605332|P1|STARTED|Overall Study||10
1472480|NCT01911351|3605348|P2|NOT COMPLETED|Overall Study||0
1472481|NCT01911351|3605349|P1|NOT COMPLETED|Overall Study||0
1472482|NCT01911351|3605348|P2|COMPLETED|Overall Study||43
1472483|NCT01911351|3605349|P1|COMPLETED|Overall Study||39
1472484|NCT01911351|3605348|P2|STARTED|Overall Study||43
1472485|NCT01911351|3605349|P1|STARTED|Overall Study||39
1472486|NCT01911273|3605365|P2|NOT COMPLETED|Overall Study||2
1472487|NCT01911273|3605366|P1|NOT COMPLETED|Overall Study||1
1472488|NCT01911273|3605365|P2|COMPLETED|Overall Study||0
1472489|NCT01911273|3605366|P1|COMPLETED|Overall Study||0
1472490|NCT01911273|3605365|P2|STARTED|Overall Study||2
1472491|NCT01911273|3605366|P1|STARTED|Overall Study||1
1472492|NCT01911260|3605400|P4|NOT COMPLETED|Follow-up Period||12
1472493|NCT01911260|3605401|P3|NOT COMPLETED|Follow-up Period||15
1472494|NCT01911260|3605402|P2|NOT COMPLETED|Follow-up Period||20
1472495|NCT01911260|3605403|P1|NOT COMPLETED|Follow-up Period||13
1472496|NCT01911260|3605400|P4|COMPLETED|Follow-up Period||30
1472497|NCT01911260|3605401|P3|COMPLETED|Follow-up Period||24
1472498|NCT01911260|3605402|P2|COMPLETED|Follow-up Period||18
1472499|NCT01911260|3605403|P1|COMPLETED|Follow-up Period||27
1472500|NCT01911260|3605400|P4|STARTED|Follow-up Period||42
1472501|NCT01911260|3605401|P3|STARTED|Follow-up Period||39
1472502|NCT01911260|3605402|P2|STARTED|Follow-up Period||38
1472503|NCT01911260|3605403|P1|STARTED|Follow-up Period||40
1472504|NCT01911260|3605400|P4|NOT COMPLETED|Supplementation Period||8
1472505|NCT01911260|3605401|P3|NOT COMPLETED|Supplementation Period||10
1472506|NCT01911260|3605402|P2|NOT COMPLETED|Supplementation Period||12
1472507|NCT01911260|3605403|P1|NOT COMPLETED|Supplementation Period||10
1472508|NCT01911260|3605400|P4|COMPLETED|Supplementation Period||42
1472509|NCT01911260|3605401|P3|COMPLETED|Supplementation Period||39
1472510|NCT01911260|3605402|P2|COMPLETED|Supplementation Period||38
1472511|NCT01911260|3605403|P1|COMPLETED|Supplementation Period||40
1472512|NCT01911260|3605400|P4|STARTED|Supplementation Period||50
1472513|NCT01911260|3605401|P3|STARTED|Supplementation Period||49
1472514|NCT01911260|3605402|P2|STARTED|Supplementation Period||50
1472515|NCT01911260|3605403|P1|STARTED|Supplementation Period||50
1472516|NCT01911221|3605413|P1|NOT COMPLETED|Overall Study||0
1472517|NCT01911221|3605413|P1|COMPLETED|Overall Study||13
1472518|NCT01911221|3605413|P1|STARTED|Overall Study||13
1472519|NCT01911169|3605429|P2|NOT COMPLETED|Overall Study||0
1472520|NCT01911169|3605430|P1|NOT COMPLETED|Overall Study||0
1472521|NCT01911169|3605429|P2|COMPLETED|Overall Study||3
1472522|NCT01911169|3605430|P1|COMPLETED|Overall Study||6
1472523|NCT01911169|3605429|P2|STARTED|Overall Study||3
1472524|NCT01911169|3605430|P1|STARTED|Overall Study||6
1472525|NCT01911065|3605440|P2|NOT COMPLETED|Overall Study||0
1472526|NCT01911065|3605441|P1|NOT COMPLETED|Overall Study||0
1472527|NCT01911065|3605440|P2|COMPLETED|Overall Study||9
1472528|NCT01911065|3605441|P1|COMPLETED|Overall Study||45
1472529|NCT01911065|3605440|P2|STARTED|Overall Study||9
1472530|NCT01911065|3605441|P1|STARTED|Overall Study||45
1472531|NCT01910831|3605449|P1|NOT COMPLETED|Overall Study||1
1472532|NCT01910831|3605449|P1|COMPLETED|Overall Study||19
1472533|NCT01910831|3605449|P1|STARTED|Overall Study||20
1472534|NCT01910792|3605458|P2|NOT COMPLETED|Overall Study||0
1472535|NCT01910792|3605459|P1|NOT COMPLETED|Overall Study||0
1472536|NCT01910792|3605458|P2|COMPLETED|Overall Study||10
1472537|NCT01910792|3605459|P1|COMPLETED|Overall Study||9
1472538|NCT01910792|3605458|P2|STARTED|Overall Study||10
1472539|NCT01910792|3605459|P1|STARTED|Overall Study||9
1472540|NCT01910688|3605465|P1|NOT COMPLETED|Overall Study||5
1472541|NCT01910688|3605465|P1|COMPLETED|Overall Study||20
1472542|NCT01910688|3605465|P1|12months|Overall Study||22
1472543|NCT01910688|3605465|P1|3rd RFA Treatment|Overall Study||18
1472544|NCT01910688|3605465|P1|7.5months|Overall Study||24
1472545|NCT01910688|3605465|P1|2nd RFA Treatment|Overall Study||22
1472546|NCT01910688|3605465|P1|3.5month|Overall Study||25
1472547|NCT01910688|3605465|P1|STARTED|Overall Study||25
1472548|NCT01910636|3605474|P2|NOT COMPLETED|Overall Study||0
1472549|NCT01910636|3605475|P1|NOT COMPLETED|Overall Study||0
1472550|NCT01910636|3605474|P2|COMPLETED|Overall Study||63
1472551|NCT01910636|3605475|P1|COMPLETED|Overall Study||90
1472552|NCT01910636|3605474|P2|STARTED|Overall Study||63
1472553|NCT01910636|3605475|P1|STARTED|Overall Study||90
1472554|NCT01910441|3605489|P2|NOT COMPLETED|Overall Study||10
1472555|NCT01910441|3605490|P1|NOT COMPLETED|Overall Study||7
1472556|NCT01910441|3605489|P2|COMPLETED|Overall Study||37
1472557|NCT01910441|3605490|P1|COMPLETED|Overall Study||41
1472558|NCT01910441|3605489|P2|STARTED|Overall Study||47
1472559|NCT01910441|3605490|P1|STARTED|Overall Study||48
1472560|NCT01910402|3605498|P2|NOT COMPLETED|Continuation Phase||0
1472561|NCT01910402|3605499|P1|NOT COMPLETED|Continuation Phase||90
1472562|NCT01910402|3605498|P2|COMPLETED|Continuation Phase||0
1472563|NCT01910402|3605499|P1|COMPLETED|Continuation Phase||30
1472564|NCT01910402|3605498|P2|STARTED|Continuation Phase||0
1472565|NCT01910402|3605499|P1|STARTED|Continuation Phase||120
1472566|NCT01910402|3605498|P2|NOT COMPLETED|Randomized Phase||55
1472567|NCT01910402|3605499|P1|NOT COMPLETED|Randomized Phase||42
1472568|NCT01910402|3605498|P2|COMPLETED|Randomized Phase||192
1472569|NCT01910402|3605499|P1|COMPLETED|Randomized Phase||206
1472570|NCT01910402|3605498|P2|STARTED|Randomized Phase||247
1472571|NCT01910402|3605499|P1|STARTED|Randomized Phase||248
1472572|NCT01910389|3605569|P2|NOT COMPLETED|Overall Study||8
1472573|NCT01910389|3605570|P1|NOT COMPLETED|Overall Study||15
1472574|NCT01910389|3605569|P2|COMPLETED|Overall Study||0
1472575|NCT01910389|3605570|P1|COMPLETED|Overall Study||0
1472576|NCT01910389|3605569|P2|STARTED|Overall Study||8
1472577|NCT01910389|3605570|P1|STARTED|Overall Study||15
1472578|NCT01910311|3605600|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
1472579|NCT01910311|3605600|P1|COMPLETED|Period 2 (Days 3-32)||18
1472580|NCT01910311|3605600|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
1472581|NCT01910311|3605600|P1|Received Baricitinib|Period 2 (Days 3-32)||18
1472582|NCT01910311|3605600|P1|STARTED|Period 2 (Days 3-32)||18
1472583|NCT01910311|3605600|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
1472584|NCT01910311|3605600|P1|COMPLETED|Period 1 (Days 1-2)||18
1472585|NCT01910311|3605600|P1|Received Baricitinib|Period 1 (Days 1-2)||18
1472586|NCT01910311|3605600|P1|STARTED|Period 1 (Days 1-2)||18
1472587|NCT01910181|3605611|P1|NOT COMPLETED|Overall Study||46
1472588|NCT01910181|3605611|P1|COMPLETED|Overall Study||0
1472589|NCT01910181|3605611|P1|Expansion Cohort|Overall Study||26
1472590|NCT01910181|3605611|P1|PK Cohort|Overall Study||20
1472591|NCT01910181|3605611|P1|STARTED|Overall Study||46
1472592|NCT01910116|3605638|P2|NOT COMPLETED|Overall Study||16
1472593|NCT01910116|3605639|P1|NOT COMPLETED|Overall Study||14
1472594|NCT01910116|3605638|P2|COMPLETED|Overall Study||94
1472595|NCT01910116|3605639|P1|COMPLETED|Overall Study||96
1472596|NCT01910116|3605638|P2|Week 16|Overall Study||94
1472597|NCT01910116|3605639|P1|Week 16|Overall Study||96
1472598|NCT01910116|3605638|P2|Week 12|Overall Study||96
1472599|NCT01910116|3605639|P1|Week 12|Overall Study||97
1472600|NCT01910116|3605638|P2|Week 8|Overall Study||99
1472601|NCT01910116|3605639|P1|Week 8|Overall Study||98
1472602|NCT01910116|3605638|P2|Week 4|Overall Study||102
1472603|NCT01910116|3605639|P1|Week 4|Overall Study||106
1472604|NCT01910116|3605638|P2|STARTED|Overall Study||110
1472605|NCT01910116|3605639|P1|STARTED|Overall Study||110
1472606|NCT01910064|3605715|P1|NOT COMPLETED|Overall Study||45
1472607|NCT01910064|3605715|P1|COMPLETED|Overall Study||391
1472608|NCT01910064|3605715|P1|STARTED|Overall Study||436
1472609|NCT01909804|3605736|P12|NOT COMPLETED|Overall Study||3
1472610|NCT01909804|3605737|P11|NOT COMPLETED|Overall Study||1
1472611|NCT01909804|3605738|P10|NOT COMPLETED|Overall Study||1
1472612|NCT01909804|3605739|P9|NOT COMPLETED|Overall Study||0
1472613|NCT01909804|3605740|P8|NOT COMPLETED|Overall Study||1
1472614|NCT01909804|3605741|P7|NOT COMPLETED|Overall Study||2
1472615|NCT01909804|3605742|P6|NOT COMPLETED|Overall Study||4
1472616|NCT01909804|3605743|P5|NOT COMPLETED|Overall Study||8
1472617|NCT01909804|3605744|P4|NOT COMPLETED|Overall Study||0
1472618|NCT01909804|3605745|P3|NOT COMPLETED|Overall Study||0
1472619|NCT01909804|3605746|P2|NOT COMPLETED|Overall Study||1
1472620|NCT01909804|3605747|P1|NOT COMPLETED|Overall Study||4
1472621|NCT01909804|3605736|P12|COMPLETED|Overall Study||26
1472622|NCT01909804|3605737|P11|COMPLETED|Overall Study||26
1472623|NCT01909804|3605738|P10|COMPLETED|Overall Study||28
1472624|NCT01909804|3605739|P9|COMPLETED|Overall Study||27
1472625|NCT01909804|3605740|P8|COMPLETED|Overall Study||25
1472626|NCT01909804|3605741|P7|COMPLETED|Overall Study||25
1472627|NCT01909804|3605742|P6|COMPLETED|Overall Study||21
1472628|NCT01909804|3605743|P5|COMPLETED|Overall Study||18
1472629|NCT01909804|3605744|P4|COMPLETED|Overall Study||26
1472630|NCT01909804|3605745|P3|COMPLETED|Overall Study||27
1472631|NCT01909804|3605746|P2|COMPLETED|Overall Study||27
1472632|NCT01909804|3605747|P1|COMPLETED|Overall Study||22
1472633|NCT01909804|3605736|P12|STARTED|Overall Study||29
1472634|NCT01909804|3605737|P11|STARTED|Overall Study||27
1472635|NCT01909804|3605738|P10|STARTED|Overall Study||29
1472636|NCT01909804|3605739|P9|STARTED|Overall Study||27
1472637|NCT01909804|3605740|P8|STARTED|Overall Study||26
1472638|NCT01909804|3605741|P7|STARTED|Overall Study||27
1472639|NCT01909804|3605742|P6|STARTED|Overall Study||25
1472640|NCT01909804|3605743|P5|STARTED|Overall Study||26
1472641|NCT01909804|3605744|P4|STARTED|Overall Study||26
1472642|NCT01909804|3605745|P3|STARTED|Overall Study||27
1472643|NCT01909804|3605746|P2|STARTED|Overall Study||28
1472644|NCT01909804|3605747|P1|STARTED|Overall Study||26
1472645|NCT01909778|3605793|P1|NOT COMPLETED|Overall Study||1
1472646|NCT01909778|3605793|P1|COMPLETED|Overall Study||1
1472647|NCT01909778|3605793|P1|STARTED|Overall Study||2
1472648|NCT01909713|3605817|P1|NOT COMPLETED|Overall Study||0
1472649|NCT01909713|3605817|P1|COMPLETED|Overall Study||35
1472650|NCT01909713|3605817|P1|STARTED|Overall Study||35
1472651|NCT01909674|3605872|P2|NOT COMPLETED|Overall Study||2
1472652|NCT01909674|3605873|P1|NOT COMPLETED|Overall Study||5
1472653|NCT01909674|3605872|P2|COMPLETED|Overall Study||7
1472654|NCT01909674|3605873|P1|COMPLETED|Overall Study||7
1472655|NCT01909674|3605872|P2|STARTED|Overall Study||9
1472656|NCT01909674|3605873|P1|STARTED|Overall Study||12
1472657|NCT01909570|3605881|P2|NOT COMPLETED|Overall Study||27
1472658|NCT01909570|3605882|P1|NOT COMPLETED|Overall Study||27
1472659|NCT01909570|3605881|P2|COMPLETED|Overall Study||64
1472660|NCT01909570|3605882|P1|COMPLETED|Overall Study||57
1472661|NCT01909570|3605881|P2|STARTED|Overall Study||91
1472662|NCT01909570|3605882|P1|STARTED|Overall Study||84
1472663|NCT01909466|3605892|P2|NOT COMPLETED|Overall Study||23
1472664|NCT01909466|3605893|P1|NOT COMPLETED|Overall Study||22
1472665|NCT01909466|3605892|P2|COMPLETED|Overall Study||50
1472666|NCT01909466|3605893|P1|COMPLETED|Overall Study||46
1472667|NCT01909466|3605892|P2|STARTED|Overall Study||73
1472668|NCT01909466|3605893|P1|STARTED|Overall Study||68
1472669|NCT01909336|3605916|P3|NOT COMPLETED|Overall Study||3
1472670|NCT01909336|3605917|P2|NOT COMPLETED|Overall Study||3
1472671|NCT01909336|3605918|P1|NOT COMPLETED|Overall Study||4
1472672|NCT01909336|3605916|P3|COMPLETED|Overall Study||52
1472673|NCT01909336|3605917|P2|COMPLETED|Overall Study||50
1472674|NCT01909336|3605918|P1|COMPLETED|Overall Study||49
1472675|NCT01909336|3605916|P3|STARTED|Overall Study||55
1472676|NCT01909336|3605917|P2|STARTED|Overall Study||53
1472677|NCT01909336|3605918|P1|STARTED|Overall Study||53
1472678|NCT01909180|3605932|P1|NOT COMPLETED|Overall Study||0
1472679|NCT01909180|3605932|P1|COMPLETED|Overall Study||49
1472680|NCT01909180|3605932|P1|STARTED|Overall Study||49
1472681|NCT01909141|3605940|P2|NOT COMPLETED|Overall Study||0
1472682|NCT01909141|3605941|P1|NOT COMPLETED|Overall Study||0
1472683|NCT01909141|3605940|P2|COMPLETED|Overall Study||50
1472684|NCT01909141|3605941|P1|COMPLETED|Overall Study||50
1472685|NCT01909141|3605940|P2|STARTED|Overall Study||50
1472686|NCT01909141|3605941|P1|STARTED|Overall Study||50
1472687|NCT01909011|3605957|P2|NOT COMPLETED|Overall Study||0
1472688|NCT01909011|3605958|P1|NOT COMPLETED|Overall Study||0
1472689|NCT01909011|3605957|P2|COMPLETED|Overall Study||9
1472690|NCT01909011|3605958|P1|COMPLETED|Overall Study||7
1472691|NCT01909011|3605957|P2|STARTED|Overall Study||9
1472692|NCT01909011|3605958|P1|STARTED|Overall Study||7
1472693|NCT01908972|3605970|P2|NOT COMPLETED|Overall Study||0
1472694|NCT01908972|3605971|P1|NOT COMPLETED|Overall Study||2
1472695|NCT01908972|3605970|P2|COMPLETED|Overall Study||17
1472696|NCT01908972|3605971|P1|COMPLETED|Overall Study||15
1472697|NCT01908972|3605970|P2|STARTED|Overall Study||17
1472698|NCT01908972|3605971|P1|STARTED|Overall Study||17
1472699|NCT01908907|3606007|P2|NOT COMPLETED|Overall Study||0
1472700|NCT01908907|3606008|P1|NOT COMPLETED|Overall Study||2
1472701|NCT01908907|3606007|P2|COMPLETED|Overall Study||29
1472702|NCT01908907|3606008|P1|COMPLETED|Overall Study||29
1472703|NCT01908907|3606007|P2|STARTED|Overall Study||29
1472704|NCT01908907|3606008|P1|STARTED|Overall Study||31
1472705|NCT01908842|3606030|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
1472706|NCT01908842|3606031|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
1472707|NCT01908842|3606030|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
1472708|NCT01908842|3606031|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
1472709|NCT01908842|3606030|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
1472710|NCT01908842|3606031|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
1472711|NCT01908842|3606030|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
1472712|NCT01908842|3606031|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
1472713|NCT01908842|3606030|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
1472714|NCT01908842|3606031|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
1472715|NCT01908842|3606030|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
1472716|NCT01908842|3606031|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
1472717|NCT01908842|3606030|P2|NOT COMPLETED|Induction||31
1472718|NCT01908842|3606031|P1|NOT COMPLETED|Induction||26
1472719|NCT01908842|3606030|P2|COMPLETED|Induction||344
1472720|NCT01908842|3606031|P1|COMPLETED|Induction||357
1472721|NCT01908842|3606030|P2|STARTED|Induction||375
1472722|NCT01908842|3606031|P1|STARTED|Induction||383
1472723|NCT01908829|3606052|P3|NOT COMPLETED|Overall Study||39
1472724|NCT01908829|3606053|P2|NOT COMPLETED|Overall Study||49
1472725|NCT01908829|3606054|P1|NOT COMPLETED|Overall Study||49
1472726|NCT01908829|3606052|P3|COMPLETED|Overall Study||680
1472727|NCT01908829|3606053|P2|COMPLETED|Overall Study||679
1472728|NCT01908829|3606054|P1|COMPLETED|Overall Study||678
1472729|NCT01908829|3606052|P3|Treated With Double-blind Drug|Overall Study||719
1472730|NCT01908829|3606053|P2|Treated With Double-blind Drug|Overall Study||728
1472731|NCT01908829|3606054|P1|Treated With Double-blind Drug|Overall Study||725
1472732|NCT01908829|3606052|P3|STARTED|Overall Study||719
1472733|NCT01908829|3606053|P2|STARTED|Overall Study||728
1472734|NCT01908829|3606054|P1|STARTED|Overall Study||727
1472735|NCT01908803|3606169|P2|NOT COMPLETED|Overall Study||1
1472736|NCT01908803|3606170|P1|NOT COMPLETED|Overall Study||4
1472737|NCT01908803|3606169|P2|COMPLETED|Overall Study||23
1472738|NCT01908803|3606170|P1|COMPLETED|Overall Study||42
1472739|NCT01908803|3606169|P2|Treated|Overall Study||24
1472740|NCT01908803|3606170|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
1472741|NCT01908803|3606169|P2|STARTED|Overall Study||24
1472742|NCT01908803|3606170|P1|STARTED|Overall Study||46
1472743|NCT01908582|3606181|P1|NOT COMPLETED|Period 2||2
1472744|NCT01908582|3606181|P1|COMPLETED|Period 2||24
1472745|NCT01908582|3606181|P1|STARTED|Period 2||26
1472746|NCT01908582|3606181|P1|NOT COMPLETED|Period 1||0
1472747|NCT01908582|3606181|P1|COMPLETED|Period 1||26
1472748|NCT01908582|3606181|P1|Received at Least One Dose of Study Drug|Period 1||26
1472749|NCT01908582|3606181|P1|STARTED|Period 1||26
1472750|NCT01908140|3606194|P2|NOT COMPLETED|Overall Study||79
1472751|NCT01908140|3606195|P1|NOT COMPLETED|Overall Study||66
1472752|NCT01908140|3606194|P2|COMPLETED|Overall Study||386
1472753|NCT01908140|3606195|P1|COMPLETED|Overall Study||402
1472754|NCT01908140|3606194|P2|STARTED|Overall Study||465
1472755|NCT01908140|3606195|P1|STARTED|Overall Study||468
1472756|NCT01908127|3606205|P2|NOT COMPLETED|Overall Study||0
1472757|NCT01908127|3606206|P1|NOT COMPLETED|Overall Study||1
1472758|NCT01908127|3606205|P2|COMPLETED|Overall Study||23
1472759|NCT01908127|3606206|P1|COMPLETED|Overall Study||22
1472760|NCT01908127|3606205|P2|STARTED|Overall Study||23
1472761|NCT01908127|3606206|P1|STARTED|Overall Study||23
1472762|NCT01907906|3606216|P2|NOT COMPLETED|Overall Study||1
1472763|NCT01907906|3606217|P1|NOT COMPLETED|Overall Study||4
1472764|NCT01907906|3606216|P2|COMPLETED|Overall Study||12
1472765|NCT01907906|3606217|P1|COMPLETED|Overall Study||12
1472766|NCT01907906|3606216|P2|STARTED|Overall Study||13
1472767|NCT01907906|3606217|P1|STARTED|Overall Study||16
1472768|NCT01907854|3606297|P2|NOT COMPLETED|Overall Study||13
1472769|NCT01907854|3606298|P1|NOT COMPLETED|Overall Study||16
1472770|NCT01907854|3606297|P2|COMPLETED|Overall Study||191
1472771|NCT01907854|3606298|P1|COMPLETED|Overall Study||187
1472772|NCT01907854|3606297|P2|Exposed|Overall Study||204
1472773|NCT01907854|3606298|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
1472774|NCT01907854|3606297|P2|STARTED|Overall Study||204
1472775|NCT01907854|3606298|P1|STARTED|Overall Study||203
1472776|NCT01907815|3606318|P2|NOT COMPLETED|Overall Study||0
1472777|NCT01907815|3606319|P1|NOT COMPLETED|Overall Study||1
1472778|NCT01907815|3606318|P2|COMPLETED|Overall Study||7
1472779|NCT01907815|3606319|P1|COMPLETED|Overall Study||16
1472780|NCT01907815|3606318|P2|STARTED|Overall Study||7
1472781|NCT01907815|3606319|P1|STARTED|Overall Study||17
1472782|NCT01907516|3606335|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
1472783|NCT01907516|3606336|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
1472784|NCT01907516|3606335|P2|COMPLETED|Second Intervention (3 Weeks)||34
1472785|NCT01907516|3606336|P1|COMPLETED|Second Intervention (3 Weeks)||40
1472786|NCT01907516|3606335|P2|STARTED|Second Intervention (3 Weeks)||34
1472787|NCT01907516|3606336|P1|STARTED|Second Intervention (3 Weeks)||40
1472788|NCT01907516|3606335|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
1472789|NCT01907516|3606336|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
1472790|NCT01907516|3606335|P2|COMPLETED|First Intervention (3 Weeks)||34
1472791|NCT01907516|3606336|P1|COMPLETED|First Intervention (3 Weeks)||40
1472792|NCT01907516|3606335|P2|STARTED|First Intervention (3 Weeks)||50
1472793|NCT01907516|3606336|P1|STARTED|First Intervention (3 Weeks)||50
1472794|NCT01907490|3606343|P1|NOT COMPLETED|Overall Study||0
1472795|NCT01907490|3606343|P1|COMPLETED|Overall Study||38
1472796|NCT01907490|3606343|P1|STARTED|Overall Study||38
1472797|NCT01907334|3606347|P2|NOT COMPLETED|Overall Study||0
1472798|NCT01907334|3606348|P1|NOT COMPLETED|Overall Study||0
1472799|NCT01907334|3606347|P2|COMPLETED|Overall Study||4
1472800|NCT01907334|3606348|P1|COMPLETED|Overall Study||6
1472801|NCT01907334|3606347|P2|STARTED|Overall Study||4
1472802|NCT01907334|3606348|P1|STARTED|Overall Study||6
1472803|NCT01907321|3606353|P1|NOT COMPLETED|Overall Study||2
1472804|NCT01907321|3606353|P1|COMPLETED|Overall Study||12
1472805|NCT01907321|3606353|P1|STARTED|Overall Study||14
1472806|NCT01907269|3606360|P2|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
1472807|NCT01907269|3606361|P1|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
1472808|NCT01907269|3606360|P2|COMPLETED|18 Month Outcome Measures Post-intervent||970
1472809|NCT01907269|3606361|P1|COMPLETED|18 Month Outcome Measures Post-intervent||859
1472810|NCT01907269|3606360|P2|STARTED|18 Month Outcome Measures Post-intervent||1250
1472811|NCT01907269|3606361|P1|STARTED|18 Month Outcome Measures Post-intervent||1178
1472812|NCT01907269|3606360|P2|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
1472813|NCT01907269|3606361|P1|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
1472814|NCT01907269|3606360|P2|COMPLETED|6 Month Outcome Measures Post-interventi||1053
1472815|NCT01907269|3606361|P1|COMPLETED|6 Month Outcome Measures Post-interventi||953
1472816|NCT01907269|3606360|P2|STARTED|6 Month Outcome Measures Post-interventi||1342
1472817|NCT01907269|3606361|P1|STARTED|6 Month Outcome Measures Post-interventi||1342
1472818|NCT01907217|3606377|P2|NOT COMPLETED|Overall Study||2
1472819|NCT01907217|3606378|P1|NOT COMPLETED|Overall Study||0
1472820|NCT01907217|3606377|P2|COMPLETED|Overall Study||67
1472821|NCT01907217|3606378|P1|COMPLETED|Overall Study||69
1472822|NCT01907217|3606377|P2|STARTED|Overall Study||69
1472823|NCT01907217|3606378|P1|STARTED|Overall Study||69
1472824|NCT01907113|3606395|P5|NOT COMPLETED|Overall Study||0
1472825|NCT01907113|3606396|P4|NOT COMPLETED|Overall Study||0
1472826|NCT01907113|3606397|P3|NOT COMPLETED|Overall Study||0
1472827|NCT01907113|3606398|P2|NOT COMPLETED|Overall Study||0
1472828|NCT01907113|3606399|P1|NOT COMPLETED|Overall Study||0
1472829|NCT01907113|3606395|P5|COMPLETED|Overall Study||8
1472830|NCT01907113|3606396|P4|COMPLETED|Overall Study||8
1472831|NCT01907113|3606397|P3|COMPLETED|Overall Study||7
1472832|NCT01907113|3606398|P2|COMPLETED|Overall Study||9
1472833|NCT01907113|3606399|P1|COMPLETED|Overall Study||8
1472834|NCT01907113|3606395|P5|STARTED|Overall Study||8
1472835|NCT01907113|3606396|P4|STARTED|Overall Study||8
1472836|NCT01907113|3606397|P3|STARTED|Overall Study||7
1472837|NCT01907113|3606398|P2|STARTED|Overall Study||9
1472838|NCT01907113|3606399|P1|STARTED|Overall Study||8
1472839|NCT01907087|3606486|P1|NOT COMPLETED|Overall Study||1
1472840|NCT01907087|3606486|P1|COMPLETED|Overall Study||23
1472841|NCT01907087|3606486|P1|STARTED|Overall Study||24
1472842|NCT01906866|3606497|P2|NOT COMPLETED|Overall Study||21
1472843|NCT01906866|3606498|P1|NOT COMPLETED|Overall Study||9
1472844|NCT01906866|3606497|P2|COMPLETED|Overall Study||44
1472845|NCT01906866|3606498|P1|COMPLETED|Overall Study||51
1472846|NCT01906866|3606497|P2|STARTED|Overall Study||65
1472847|NCT01906866|3606498|P1|STARTED|Overall Study||60
1472848|NCT01906658|3606511|P4|NOT COMPLETED|Overall Study||0
1472849|NCT01906658|3606512|P3|NOT COMPLETED|Overall Study||3
1472850|NCT01906658|3606513|P2|NOT COMPLETED|Overall Study||1
1472851|NCT01906658|3606514|P1|NOT COMPLETED|Overall Study||2
1472852|NCT01906658|3606511|P4|COMPLETED|Overall Study||11
1472853|NCT01906658|3606512|P3|COMPLETED|Overall Study||7
1472854|NCT01906658|3606513|P2|COMPLETED|Overall Study||10
1472855|NCT01906658|3606514|P1|COMPLETED|Overall Study||9
1472856|NCT01906658|3606511|P4|STARTED|Overall Study||11
1472857|NCT01906658|3606512|P3|STARTED|Overall Study||10
1472858|NCT01906658|3606513|P2|STARTED|Overall Study||11
1472859|NCT01906658|3606514|P1|STARTED|Overall Study||11
1472860|NCT01906515|3606538|P2|NOT COMPLETED|Overall Study||0
1472861|NCT01906515|3606539|P1|NOT COMPLETED|Overall Study||0
1472862|NCT01906515|3606538|P2|COMPLETED|Overall Study||61
1472863|NCT01906515|3606539|P1|COMPLETED|Overall Study||45
1472864|NCT01906515|3606538|P2|STARTED|Overall Study||61
1472865|NCT01906515|3606539|P1|STARTED|Overall Study||45
1472866|NCT01906372|3606547|P1|NOT COMPLETED|Overall Study||2
1472867|NCT01906372|3606547|P1|COMPLETED|Overall Study||10
1472868|NCT01906372|3606547|P1|Visit 10: Follow up Phase Completed|Overall Study||8
1472869|NCT01906372|3606547|P1|Visit 7: Treatment Phase Completed|Overall Study||10
1472870|NCT01906372|3606547|P1|STARTED|Overall Study||12
1472871|NCT01905956|3606554|P2|NOT COMPLETED|Overall Study||11
1472872|NCT01905956|3606555|P1|NOT COMPLETED|Overall Study||6
1472873|NCT01905956|3606554|P2|COMPLETED|Overall Study|Per-protocol population|48
1472874|NCT01905956|3606555|P1|COMPLETED|Overall Study|Per-protocol population|54
1472875|NCT01905956|3606554|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
1472876|NCT01905956|3606555|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
1472877|NCT01905956|3606554|P2|STARTED|Overall Study|Randomized|59
1472878|NCT01905956|3606555|P1|STARTED|Overall Study|Randomized|60
1472879|NCT01905943|3606577|P1|NOT COMPLETED|Overall Study||972
1472880|NCT01905943|3606577|P1|COMPLETED|Overall Study|All patients provide reason at final analysis|0
1472881|NCT01905943|3606577|P1|STARTED|Overall Study||972
1472882|NCT01905683|3606694|P1|NOT COMPLETED|Overall Study||51
1472883|NCT01905683|3606694|P1|COMPLETED|Overall Study||319
1472884|NCT01905683|3606694|P1|STARTED|Overall Study||370
1472885|NCT01905657|3606710|P3|NOT COMPLETED|Overall Study||328
1472886|NCT01905657|3606711|P2|NOT COMPLETED|Overall Study||346
1472887|NCT01905657|3606712|P1|NOT COMPLETED|Overall Study||345
1472888|NCT01905657|3606710|P3|COMPLETED|Overall Study||15
1472889|NCT01905657|3606711|P2|COMPLETED|Overall Study||0
1472890|NCT01905657|3606712|P1|COMPLETED|Overall Study||0
1472891|NCT01905657|3606710|P3|Treated|Overall Study||309
1472892|NCT01905657|3606711|P2|Treated|Overall Study||343
1472893|NCT01905657|3606712|P1|Treated|Overall Study||339
1472894|NCT01905657|3606710|P3|STARTED|Overall Study||343
1472895|NCT01905657|3606711|P2|STARTED|Overall Study||346
1472896|NCT01905657|3606712|P1|STARTED|Overall Study||345
1472897|NCT01905553|3606737|P2|NOT COMPLETED|Period 2||0
1472898|NCT01905553|3606738|P1|NOT COMPLETED|Period 2||1
1472899|NCT01905553|3606737|P2|COMPLETED|Period 2||4
1472900|NCT01905553|3606738|P1|COMPLETED|Period 2||4
1472901|NCT01905553|3606737|P2|STARTED|Period 2||4
1472902|NCT01905553|3606738|P1|STARTED|Period 2||5
1472903|NCT01905553|3606737|P2|NOT COMPLETED|Period 1||0
1472904|NCT01905553|3606738|P1|NOT COMPLETED|Period 1||0
1472905|NCT01905553|3606737|P2|COMPLETED|Period 1||4
1472906|NCT01905553|3606738|P1|COMPLETED|Period 1||5
1472907|NCT01905553|3606737|P2|STARTED|Period 1||4
1472908|NCT01905553|3606738|P1|STARTED|Period 1||5
1472909|NCT01905540|3606752|P4|NOT COMPLETED|Period 3||1
1472910|NCT01905540|3606753|P3|NOT COMPLETED|Period 3||1
1472911|NCT01905540|3606754|P2|NOT COMPLETED|Period 3||0
1472912|NCT01905540|3606755|P1|NOT COMPLETED|Period 3||1
1472913|NCT01905540|3606752|P4|COMPLETED|Period 3||6
1472914|NCT01905540|3606753|P3|COMPLETED|Period 3||6
1472915|NCT01905540|3606754|P2|COMPLETED|Period 3||7
1472916|NCT01905540|3606755|P1|COMPLETED|Period 3||6
1472917|NCT01905540|3606752|P4|STARTED|Period 3||7
1472918|NCT01905540|3606753|P3|STARTED|Period 3||7
1472919|NCT01905540|3606754|P2|STARTED|Period 3||7
1472920|NCT01905540|3606755|P1|STARTED|Period 3||7
1472921|NCT01905540|3606752|P4|NOT COMPLETED|Period 2||0
1472922|NCT01905540|3606753|P3|NOT COMPLETED|Period 2||0
1472923|NCT01905540|3606754|P2|NOT COMPLETED|Period 2||0
1472924|NCT01905540|3606755|P1|NOT COMPLETED|Period 2||0
1472925|NCT01905540|3606752|P4|COMPLETED|Period 2||7
1472926|NCT01905540|3606753|P3|COMPLETED|Period 2||7
1472927|NCT01905540|3606754|P2|COMPLETED|Period 2||7
1472928|NCT01905540|3606755|P1|COMPLETED|Period 2||7
1472929|NCT01905540|3606752|P4|STARTED|Period 2||7
1472930|NCT01905540|3606753|P3|STARTED|Period 2||7
1472931|NCT01905540|3606754|P2|STARTED|Period 2||7
1472932|NCT01905540|3606755|P1|STARTED|Period 2||7
1472933|NCT01905540|3606752|P4|NOT COMPLETED|Period 1||0
1472934|NCT01905540|3606753|P3|NOT COMPLETED|Period 1||0
1472935|NCT01905540|3606754|P2|NOT COMPLETED|Period 1||0
1472936|NCT01905540|3606755|P1|NOT COMPLETED|Period 1||0
1472937|NCT01905540|3606752|P4|COMPLETED|Period 1||7
1472938|NCT01905540|3606753|P3|COMPLETED|Period 1||7
1472939|NCT01905540|3606754|P2|COMPLETED|Period 1||7
1472940|NCT01905540|3606755|P1|COMPLETED|Period 1||7
1472941|NCT01905540|3606752|P4|STARTED|Period 1||7
1472942|NCT01905540|3606753|P3|STARTED|Period 1||7
1472943|NCT01905540|3606754|P2|STARTED|Period 1||7
1472944|NCT01905540|3606755|P1|STARTED|Period 1||7
1472945|NCT01905423|3606777|P4|NOT COMPLETED|Overall Study||0
1472946|NCT01905423|3606778|P3|NOT COMPLETED|Overall Study||0
1472947|NCT01905423|3606779|P2|NOT COMPLETED|Overall Study||0
1472948|NCT01905423|3606780|P1|NOT COMPLETED|Overall Study||0
1472949|NCT01905423|3606777|P4|COMPLETED|Overall Study||3324
1472950|NCT01905423|3606778|P3|COMPLETED|Overall Study||4119
1472951|NCT01905423|3606779|P2|COMPLETED|Overall Study||4111
1472952|NCT01905423|3606780|P1|COMPLETED|Overall Study||7753
1472953|NCT01905423|3606777|P4|Year 3 Follow-up|Overall Study||0
1472954|NCT01905423|3606778|P3|Year 3 Follow-up|Overall Study||0
1472955|NCT01905423|3606779|P2|Year 3 Follow-up|Overall Study||1028
1472956|NCT01905423|3606780|P1|Year 3 Follow-up|Overall Study||1776
1472957|NCT01905423|3606777|P4|Year 2 Follow-up|Overall Study||0
1472958|NCT01905423|3606778|P3|Year 2 Follow-up|Overall Study||0
1472959|NCT01905423|3606779|P2|Year 2 Follow-up|Overall Study||1043
1472960|NCT01905423|3606780|P1|Year 2 Follow-up|Overall Study||1972
1472961|NCT01905423|3606777|P4|Year 1 Follow-up|Overall Study||1690
1472962|NCT01905423|3606778|P3|Year 1 Follow-up|Overall Study||2037
1472963|NCT01905423|3606779|P2|Year 1 Follow-up|Overall Study||1007
1472964|NCT01905423|3606780|P1|Year 1 Follow-up|Overall Study||1840
1472965|NCT01905423|3606777|P4|Baseline|Overall Study||1634
1472966|NCT01905423|3606778|P3|Baseline|Overall Study||2082
1472967|NCT01905423|3606779|P2|Baseline|Overall Study||1033
1472968|NCT01905423|3606780|P1|Baseline|Overall Study||2165
1472969|NCT01905423|3606777|P4|STARTED|Overall Study||3324
1472970|NCT01905423|3606778|P3|STARTED|Overall Study||4119
1472971|NCT01905423|3606779|P2|STARTED|Overall Study||4111
1472972|NCT01905423|3606780|P1|STARTED|Overall Study||7753
1472973|NCT01905267|3606790|P2|NOT COMPLETED|Overall Study||2
1472974|NCT01905267|3606791|P1|NOT COMPLETED|Overall Study||2
1472975|NCT01905267|3606790|P2|COMPLETED|Overall Study||14
1472976|NCT01905267|3606791|P1|COMPLETED|Overall Study||15
1472977|NCT01905267|3606790|P2|STARTED|Overall Study||16
1472978|NCT01905267|3606791|P1|STARTED|Overall Study||17
1472979|NCT01905254|3606799|P1|NOT COMPLETED|Overall Study||0
1472980|NCT01905254|3606799|P1|COMPLETED|Overall Study||34
1472981|NCT01905254|3606799|P1|STARTED|Overall Study||34
1472982|NCT01904864|3606805|P2|NOT COMPLETED|Overall Study||12
1472983|NCT01904864|3606806|P1|NOT COMPLETED|Overall Study||9
1472984|NCT01904864|3606805|P2|COMPLETED|Overall Study||28
1472985|NCT01904864|3606806|P1|COMPLETED|Overall Study||31
1472986|NCT01904864|3606805|P2|STARTED|Overall Study||40
1472987|NCT01904864|3606806|P1|STARTED|Overall Study||40
1472988|NCT01904773|3606812|P9|NOT COMPLETED|Sixth Intervention||0
1472989|NCT01904773|3606813|P8|NOT COMPLETED|Sixth Intervention||0
1472990|NCT01904773|3606814|P7|NOT COMPLETED|Sixth Intervention||0
1472991|NCT01904773|3606815|P6|NOT COMPLETED|Sixth Intervention||0
1472992|NCT01904773|3606816|P5|NOT COMPLETED|Sixth Intervention||0
1472993|NCT01904773|3606817|P4|NOT COMPLETED|Sixth Intervention||0
1472994|NCT01904773|3606818|P3|NOT COMPLETED|Sixth Intervention||0
1472995|NCT01904773|3606819|P2|NOT COMPLETED|Sixth Intervention||0
1472996|NCT01904773|3606820|P1|NOT COMPLETED|Sixth Intervention||0
1472997|NCT01904773|3606812|P9|COMPLETED|Sixth Intervention||4
1472998|NCT01904773|3606813|P8|COMPLETED|Sixth Intervention||2
1472999|NCT01904773|3606814|P7|COMPLETED|Sixth Intervention||3
1473000|NCT01904773|3606815|P6|COMPLETED|Sixth Intervention||4
1473001|NCT01904773|3606816|P5|COMPLETED|Sixth Intervention||3
1473002|NCT01904773|3606817|P4|COMPLETED|Sixth Intervention||2
1473003|NCT01904773|3606818|P3|COMPLETED|Sixth Intervention||1
1473004|NCT01904773|3606819|P2|COMPLETED|Sixth Intervention||0
1473005|NCT01904773|3606820|P1|COMPLETED|Sixth Intervention||0
1473006|NCT01904773|3606812|P9|STARTED|Sixth Intervention||4
1473007|NCT01904773|3606813|P8|STARTED|Sixth Intervention||2
1473008|NCT01904773|3606814|P7|STARTED|Sixth Intervention||3
1473009|NCT01904773|3606815|P6|STARTED|Sixth Intervention||4
1473010|NCT01904773|3606816|P5|STARTED|Sixth Intervention||3
1473011|NCT01904773|3606817|P4|STARTED|Sixth Intervention||2
1473012|NCT01904773|3606818|P3|STARTED|Sixth Intervention||1
1473013|NCT01904773|3606819|P2|STARTED|Sixth Intervention||0
1473014|NCT01904773|3606820|P1|STARTED|Sixth Intervention||0
1473015|NCT01904773|3606812|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1473016|NCT01904773|3606813|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1473017|NCT01904773|3606814|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1473018|NCT01904773|3606815|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1473019|NCT01904773|3606816|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1473020|NCT01904773|3606817|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1473021|NCT01904773|3606818|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1473022|NCT01904773|3606819|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
1473023|NCT01904773|3606820|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
1473024|NCT01904773|3606812|P9|COMPLETED|Placebo Washout Fifth Intervention||4
1473025|NCT01904773|3606813|P8|COMPLETED|Placebo Washout Fifth Intervention||2
1473026|NCT01904773|3606814|P7|COMPLETED|Placebo Washout Fifth Intervention||3
1473027|NCT01904773|3606815|P6|COMPLETED|Placebo Washout Fifth Intervention||4
1473028|NCT01904773|3606816|P5|COMPLETED|Placebo Washout Fifth Intervention||3
1473029|NCT01904773|3606817|P4|COMPLETED|Placebo Washout Fifth Intervention||2
1473030|NCT01904773|3606818|P3|COMPLETED|Placebo Washout Fifth Intervention||1
1473031|NCT01904773|3606819|P2|COMPLETED|Placebo Washout Fifth Intervention||0
1473032|NCT01904773|3606820|P1|COMPLETED|Placebo Washout Fifth Intervention||0
1473033|NCT01904773|3606812|P9|STARTED|Placebo Washout Fifth Intervention||4
1473034|NCT01904773|3606813|P8|STARTED|Placebo Washout Fifth Intervention||2
1473035|NCT01904773|3606814|P7|STARTED|Placebo Washout Fifth Intervention||3
1473036|NCT01904773|3606815|P6|STARTED|Placebo Washout Fifth Intervention||4
1473037|NCT01904773|3606816|P5|STARTED|Placebo Washout Fifth Intervention||3
1473038|NCT01904773|3606817|P4|STARTED|Placebo Washout Fifth Intervention||2
1473039|NCT01904773|3606818|P3|STARTED|Placebo Washout Fifth Intervention||1
1473040|NCT01904773|3606819|P2|STARTED|Placebo Washout Fifth Intervention||1
1473041|NCT01904773|3606820|P1|STARTED|Placebo Washout Fifth Intervention||0
1473042|NCT01904773|3606812|P9|NOT COMPLETED|Fifth Intervention||0
1473043|NCT01904773|3606813|P8|NOT COMPLETED|Fifth Intervention||1
1473044|NCT01904773|3606814|P7|NOT COMPLETED|Fifth Intervention||0
1473045|NCT01904773|3606815|P6|NOT COMPLETED|Fifth Intervention||0
1473046|NCT01904773|3606816|P5|NOT COMPLETED|Fifth Intervention||0
1473047|NCT01904773|3606817|P4|NOT COMPLETED|Fifth Intervention||0
1473048|NCT01904773|3606818|P3|NOT COMPLETED|Fifth Intervention||0
1473049|NCT01904773|3606819|P2|NOT COMPLETED|Fifth Intervention||0
1473050|NCT01904773|3606820|P1|NOT COMPLETED|Fifth Intervention||0
1473051|NCT01904773|3606812|P9|COMPLETED|Fifth Intervention||4
1473052|NCT01904773|3606813|P8|COMPLETED|Fifth Intervention||2
1473053|NCT01904773|3606814|P7|COMPLETED|Fifth Intervention||3
1473054|NCT01904773|3606815|P6|COMPLETED|Fifth Intervention||4
1473055|NCT01904773|3606816|P5|COMPLETED|Fifth Intervention||3
1473056|NCT01904773|3606817|P4|COMPLETED|Fifth Intervention||2
1473057|NCT01904773|3606818|P3|COMPLETED|Fifth Intervention||1
1473058|NCT01904773|3606819|P2|COMPLETED|Fifth Intervention||1
1473059|NCT01904773|3606820|P1|COMPLETED|Fifth Intervention||0
1473060|NCT01904773|3606812|P9|STARTED|Fifth Intervention||4
1473061|NCT01904773|3606813|P8|STARTED|Fifth Intervention||3
1473062|NCT01904773|3606814|P7|STARTED|Fifth Intervention||3
1473063|NCT01904773|3606815|P6|STARTED|Fifth Intervention||4
1473064|NCT01904773|3606816|P5|STARTED|Fifth Intervention||3
1473065|NCT01904773|3606817|P4|STARTED|Fifth Intervention||2
1473066|NCT01904773|3606818|P3|STARTED|Fifth Intervention||1
1473067|NCT01904773|3606819|P2|STARTED|Fifth Intervention||1
1473068|NCT01904773|3606820|P1|STARTED|Fifth Intervention||0
1473069|NCT01904773|3606812|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1473070|NCT01904773|3606813|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1473071|NCT01904773|3606814|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1473072|NCT01904773|3606815|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1473073|NCT01904773|3606816|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1473074|NCT01904773|3606817|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1473075|NCT01904773|3606818|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1473076|NCT01904773|3606819|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1473077|NCT01904773|3606820|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
1473078|NCT01904773|3606812|P9|COMPLETED|Placebo Washout Fourth Intervention||4
1473079|NCT01904773|3606813|P8|COMPLETED|Placebo Washout Fourth Intervention||3
1473080|NCT01904773|3606814|P7|COMPLETED|Placebo Washout Fourth Intervention||3
1473081|NCT01904773|3606815|P6|COMPLETED|Placebo Washout Fourth Intervention||4
1473082|NCT01904773|3606816|P5|COMPLETED|Placebo Washout Fourth Intervention||3
1473083|NCT01904773|3606817|P4|COMPLETED|Placebo Washout Fourth Intervention||2
1473084|NCT01904773|3606818|P3|COMPLETED|Placebo Washout Fourth Intervention||1
1473085|NCT01904773|3606819|P2|COMPLETED|Placebo Washout Fourth Intervention||1
1473086|NCT01904773|3606820|P1|COMPLETED|Placebo Washout Fourth Intervention||0
1473087|NCT01904773|3606812|P9|STARTED|Placebo Washout Fourth Intervention||4
1473088|NCT01904773|3606813|P8|STARTED|Placebo Washout Fourth Intervention||3
1473089|NCT01904773|3606814|P7|STARTED|Placebo Washout Fourth Intervention||3
1473090|NCT01904773|3606815|P6|STARTED|Placebo Washout Fourth Intervention||4
1473091|NCT01904773|3606816|P5|STARTED|Placebo Washout Fourth Intervention||3
1473092|NCT01904773|3606817|P4|STARTED|Placebo Washout Fourth Intervention||2
1473093|NCT01904773|3606818|P3|STARTED|Placebo Washout Fourth Intervention||1
1473094|NCT01904773|3606819|P2|STARTED|Placebo Washout Fourth Intervention||1
1473095|NCT01904773|3606820|P1|STARTED|Placebo Washout Fourth Intervention||0
1473096|NCT01904773|3606812|P9|NOT COMPLETED|Fourth Intervention||0
1473097|NCT01904773|3606813|P8|NOT COMPLETED|Fourth Intervention||0
1473098|NCT01904773|3606814|P7|NOT COMPLETED|Fourth Intervention||0
1473099|NCT01904773|3606815|P6|NOT COMPLETED|Fourth Intervention||0
1473100|NCT01904773|3606816|P5|NOT COMPLETED|Fourth Intervention||0
1473101|NCT01904773|3606817|P4|NOT COMPLETED|Fourth Intervention||0
1473102|NCT01904773|3606818|P3|NOT COMPLETED|Fourth Intervention||0
1473103|NCT01904773|3606819|P2|NOT COMPLETED|Fourth Intervention||0
1473104|NCT01904773|3606820|P1|NOT COMPLETED|Fourth Intervention||0
1473105|NCT01904773|3606812|P9|COMPLETED|Fourth Intervention||4
1473106|NCT01904773|3606813|P8|COMPLETED|Fourth Intervention||3
1473107|NCT01904773|3606814|P7|COMPLETED|Fourth Intervention||3
1473108|NCT01904773|3606815|P6|COMPLETED|Fourth Intervention||4
1473109|NCT01904773|3606816|P5|COMPLETED|Fourth Intervention||3
1473110|NCT01904773|3606817|P4|COMPLETED|Fourth Intervention||2
1473111|NCT01904773|3606818|P3|COMPLETED|Fourth Intervention||1
1473112|NCT01904773|3606819|P2|COMPLETED|Fourth Intervention||1
1473113|NCT01904773|3606820|P1|COMPLETED|Fourth Intervention||0
1473114|NCT01904773|3606812|P9|STARTED|Fourth Intervention||4
1473115|NCT01904773|3606813|P8|STARTED|Fourth Intervention||3
1473116|NCT01904773|3606814|P7|STARTED|Fourth Intervention||3
1473117|NCT01904773|3606815|P6|STARTED|Fourth Intervention||4
1473118|NCT01904773|3606816|P5|STARTED|Fourth Intervention||3
1473119|NCT01904773|3606817|P4|STARTED|Fourth Intervention||2
1473120|NCT01904773|3606818|P3|STARTED|Fourth Intervention||1
1473121|NCT01904773|3606819|P2|STARTED|Fourth Intervention||1
1473122|NCT01904773|3606820|P1|STARTED|Fourth Intervention||0
1473123|NCT01904773|3606812|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
1473124|NCT01904773|3606813|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
1473125|NCT01904773|3606814|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
1473126|NCT01904773|3606815|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
1473127|NCT01904773|3606816|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
1473128|NCT01904773|3606817|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
1473129|NCT01904773|3606818|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
1473130|NCT01904773|3606819|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
1473131|NCT01904773|3606820|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
1473132|NCT01904773|3606812|P9|COMPLETED|Placebo Washout Third Intervention||4
1473133|NCT01904773|3606813|P8|COMPLETED|Placebo Washout Third Intervention||3
1473134|NCT01904773|3606814|P7|COMPLETED|Placebo Washout Third Intervention||3
1473135|NCT01904773|3606815|P6|COMPLETED|Placebo Washout Third Intervention||4
1473136|NCT01904773|3606816|P5|COMPLETED|Placebo Washout Third Intervention||3
1473137|NCT01904773|3606817|P4|COMPLETED|Placebo Washout Third Intervention||2
1473138|NCT01904773|3606818|P3|COMPLETED|Placebo Washout Third Intervention||1
1473139|NCT01904773|3606819|P2|COMPLETED|Placebo Washout Third Intervention||1
1473140|NCT01904773|3606820|P1|COMPLETED|Placebo Washout Third Intervention||0
1473141|NCT01904773|3606812|P9|STARTED|Placebo Washout Third Intervention||4
1473142|NCT01904773|3606813|P8|STARTED|Placebo Washout Third Intervention||3
1473143|NCT01904773|3606814|P7|STARTED|Placebo Washout Third Intervention||3
1473144|NCT01904773|3606815|P6|STARTED|Placebo Washout Third Intervention||4
1473145|NCT01904773|3606816|P5|STARTED|Placebo Washout Third Intervention||3
1473146|NCT01904773|3606817|P4|STARTED|Placebo Washout Third Intervention||2
1473147|NCT01904773|3606818|P3|STARTED|Placebo Washout Third Intervention||1
1473148|NCT01904773|3606819|P2|STARTED|Placebo Washout Third Intervention||1
1473149|NCT01904773|3606820|P1|STARTED|Placebo Washout Third Intervention||0
1473150|NCT01904773|3606812|P9|NOT COMPLETED|Third Intervention||0
1473151|NCT01904773|3606813|P8|NOT COMPLETED|Third Intervention||0
1473152|NCT01904773|3606814|P7|NOT COMPLETED|Third Intervention||0
1473153|NCT01904773|3606815|P6|NOT COMPLETED|Third Intervention||0
1473154|NCT01904773|3606816|P5|NOT COMPLETED|Third Intervention||0
1473155|NCT01904773|3606817|P4|NOT COMPLETED|Third Intervention||0
1473156|NCT01904773|3606818|P3|NOT COMPLETED|Third Intervention||0
1473157|NCT01904773|3606819|P2|NOT COMPLETED|Third Intervention||0
1473158|NCT01904773|3606820|P1|NOT COMPLETED|Third Intervention||0
1473159|NCT01904773|3606812|P9|COMPLETED|Third Intervention||4
1473160|NCT01904773|3606813|P8|COMPLETED|Third Intervention||3
1473161|NCT01904773|3606814|P7|COMPLETED|Third Intervention||3
1473162|NCT01904773|3606815|P6|COMPLETED|Third Intervention||4
1473163|NCT01904773|3606816|P5|COMPLETED|Third Intervention||3
1473164|NCT01904773|3606817|P4|COMPLETED|Third Intervention||2
1473165|NCT01904773|3606818|P3|COMPLETED|Third Intervention||1
1473166|NCT01904773|3606819|P2|COMPLETED|Third Intervention||1
1473167|NCT01904773|3606820|P1|COMPLETED|Third Intervention||0
1473168|NCT01904773|3606812|P9|STARTED|Third Intervention||4
1473169|NCT01904773|3606813|P8|STARTED|Third Intervention||3
1473170|NCT01904773|3606814|P7|STARTED|Third Intervention||3
1473171|NCT01904773|3606815|P6|STARTED|Third Intervention||4
1473172|NCT01904773|3606816|P5|STARTED|Third Intervention||3
1473173|NCT01904773|3606817|P4|STARTED|Third Intervention||2
1473174|NCT01904773|3606818|P3|STARTED|Third Intervention||1
1473175|NCT01904773|3606819|P2|STARTED|Third Intervention||1
1473176|NCT01904773|3606820|P1|STARTED|Third Intervention||0
1473177|NCT01904773|3606812|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
1473178|NCT01904773|3606813|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
1473179|NCT01904773|3606814|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
1473180|NCT01904773|3606815|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
1473181|NCT01904773|3606816|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
1473182|NCT01904773|3606817|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
1473183|NCT01904773|3606818|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
1473184|NCT01904773|3606819|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
1473185|NCT01904773|3606820|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
1473186|NCT01904773|3606812|P9|COMPLETED|Placebo Washout Second Intervention||4
1473187|NCT01904773|3606813|P8|COMPLETED|Placebo Washout Second Intervention||3
1473188|NCT01904773|3606814|P7|COMPLETED|Placebo Washout Second Intervention||3
1473189|NCT01904773|3606815|P6|COMPLETED|Placebo Washout Second Intervention||4
1473190|NCT01904773|3606816|P5|COMPLETED|Placebo Washout Second Intervention||3
1473191|NCT01904773|3606817|P4|COMPLETED|Placebo Washout Second Intervention||2
1473192|NCT01904773|3606818|P3|COMPLETED|Placebo Washout Second Intervention||1
1473193|NCT01904773|3606819|P2|COMPLETED|Placebo Washout Second Intervention||1
1473194|NCT01904773|3606820|P1|COMPLETED|Placebo Washout Second Intervention||0
1473195|NCT01904773|3606812|P9|STARTED|Placebo Washout Second Intervention||4
1473196|NCT01904773|3606813|P8|STARTED|Placebo Washout Second Intervention||3
1473197|NCT01904773|3606814|P7|STARTED|Placebo Washout Second Intervention||3
1473198|NCT01904773|3606815|P6|STARTED|Placebo Washout Second Intervention||4
1473199|NCT01904773|3606816|P5|STARTED|Placebo Washout Second Intervention||3
1473200|NCT01904773|3606817|P4|STARTED|Placebo Washout Second Intervention||2
1473201|NCT01904773|3606818|P3|STARTED|Placebo Washout Second Intervention||1
1473202|NCT01904773|3606819|P2|STARTED|Placebo Washout Second Intervention||1
1473203|NCT01904773|3606820|P1|STARTED|Placebo Washout Second Intervention||0
1473204|NCT01904773|3606812|P9|NOT COMPLETED|Second Intervention||0
1473205|NCT01904773|3606813|P8|NOT COMPLETED|Second Intervention||0
1473206|NCT01904773|3606814|P7|NOT COMPLETED|Second Intervention||0
1473207|NCT01904773|3606815|P6|NOT COMPLETED|Second Intervention||0
1473208|NCT01904773|3606816|P5|NOT COMPLETED|Second Intervention||0
1473209|NCT01904773|3606817|P4|NOT COMPLETED|Second Intervention||0
1473210|NCT01904773|3606818|P3|NOT COMPLETED|Second Intervention||0
1473211|NCT01904773|3606819|P2|NOT COMPLETED|Second Intervention||0
1473212|NCT01904773|3606820|P1|NOT COMPLETED|Second Intervention||0
1473213|NCT01904773|3606812|P9|COMPLETED|Second Intervention||4
1473214|NCT01904773|3606813|P8|COMPLETED|Second Intervention||3
1473215|NCT01904773|3606814|P7|COMPLETED|Second Intervention||3
1473216|NCT01904773|3606815|P6|COMPLETED|Second Intervention||4
1473217|NCT01904773|3606816|P5|COMPLETED|Second Intervention||3
1473218|NCT01904773|3606817|P4|COMPLETED|Second Intervention||2
1473219|NCT01904773|3606818|P3|COMPLETED|Second Intervention||1
1473220|NCT01904773|3606819|P2|COMPLETED|Second Intervention||1
1473221|NCT01904773|3606820|P1|COMPLETED|Second Intervention||0
1473222|NCT01904773|3606812|P9|STARTED|Second Intervention||4
1473223|NCT01904773|3606813|P8|STARTED|Second Intervention||3
1473224|NCT01904773|3606814|P7|STARTED|Second Intervention||3
1473225|NCT01904773|3606815|P6|STARTED|Second Intervention||4
1473226|NCT01904773|3606816|P5|STARTED|Second Intervention||3
1473227|NCT01904773|3606817|P4|STARTED|Second Intervention||2
1473228|NCT01904773|3606818|P3|STARTED|Second Intervention||1
1473229|NCT01904773|3606819|P2|STARTED|Second Intervention||1
1473230|NCT01904773|3606820|P1|STARTED|Second Intervention||0
1473231|NCT01904773|3606812|P9|NOT COMPLETED|Placebo Washout First Intervention||0
1473232|NCT01904773|3606813|P8|NOT COMPLETED|Placebo Washout First Intervention||0
1473233|NCT01904773|3606814|P7|NOT COMPLETED|Placebo Washout First Intervention||0
1473234|NCT01904773|3606815|P6|NOT COMPLETED|Placebo Washout First Intervention||0
1473235|NCT01904773|3606816|P5|NOT COMPLETED|Placebo Washout First Intervention||0
1473236|NCT01904773|3606817|P4|NOT COMPLETED|Placebo Washout First Intervention||0
1473237|NCT01904773|3606818|P3|NOT COMPLETED|Placebo Washout First Intervention||0
1473238|NCT01904773|3606819|P2|NOT COMPLETED|Placebo Washout First Intervention||1
1473239|NCT01904773|3606820|P1|NOT COMPLETED|Placebo Washout First Intervention||0
1473240|NCT01904773|3606812|P9|COMPLETED|Placebo Washout First Intervention||4
1473241|NCT01904773|3606813|P8|COMPLETED|Placebo Washout First Intervention||3
1473242|NCT01904773|3606814|P7|COMPLETED|Placebo Washout First Intervention||3
1473243|NCT01904773|3606815|P6|COMPLETED|Placebo Washout First Intervention||4
1473244|NCT01904773|3606816|P5|COMPLETED|Placebo Washout First Intervention||3
1473245|NCT01904773|3606817|P4|COMPLETED|Placebo Washout First Intervention||2
1473246|NCT01904773|3606818|P3|COMPLETED|Placebo Washout First Intervention||1
1473247|NCT01904773|3606819|P2|COMPLETED|Placebo Washout First Intervention||1
1473248|NCT01904773|3606820|P1|COMPLETED|Placebo Washout First Intervention||0
1473249|NCT01904773|3606812|P9|STARTED|Placebo Washout First Intervention||4
1473250|NCT01904773|3606813|P8|STARTED|Placebo Washout First Intervention||3
1473251|NCT01904773|3606814|P7|STARTED|Placebo Washout First Intervention||3
1473252|NCT01904773|3606815|P6|STARTED|Placebo Washout First Intervention||4
1473253|NCT01904773|3606816|P5|STARTED|Placebo Washout First Intervention||3
1473254|NCT01904773|3606817|P4|STARTED|Placebo Washout First Intervention||2
1473255|NCT01904773|3606818|P3|STARTED|Placebo Washout First Intervention||1
1473256|NCT01904773|3606819|P2|STARTED|Placebo Washout First Intervention||2
1473257|NCT01904773|3606820|P1|STARTED|Placebo Washout First Intervention||0
1473258|NCT01904773|3606812|P9|NOT COMPLETED|First Intervention||0
1473259|NCT01904773|3606813|P8|NOT COMPLETED|First Intervention||0
1473260|NCT01904773|3606814|P7|NOT COMPLETED|First Intervention||1
1473261|NCT01904773|3606815|P6|NOT COMPLETED|First Intervention||0
1473262|NCT01904773|3606816|P5|NOT COMPLETED|First Intervention||0
1473263|NCT01904773|3606817|P4|NOT COMPLETED|First Intervention||0
1473264|NCT01904773|3606818|P3|NOT COMPLETED|First Intervention||0
1473265|NCT01904773|3606819|P2|NOT COMPLETED|First Intervention||0
1473266|NCT01904773|3606820|P1|NOT COMPLETED|First Intervention||0
1473267|NCT01904773|3606812|P9|COMPLETED|First Intervention||4
1473268|NCT01904773|3606813|P8|COMPLETED|First Intervention||3
1473269|NCT01904773|3606814|P7|COMPLETED|First Intervention||3
1473270|NCT01904773|3606815|P6|COMPLETED|First Intervention||4
1473271|NCT01904773|3606816|P5|COMPLETED|First Intervention||3
1473272|NCT01904773|3606817|P4|COMPLETED|First Intervention||2
1473273|NCT01904773|3606818|P3|COMPLETED|First Intervention||1
1473274|NCT01904773|3606819|P2|COMPLETED|First Intervention||2
1473275|NCT01904773|3606820|P1|COMPLETED|First Intervention||0
1473276|NCT01904773|3606812|P9|STARTED|First Intervention||4
1473277|NCT01904773|3606813|P8|STARTED|First Intervention||3
1473278|NCT01904773|3606814|P7|STARTED|First Intervention||4
1473279|NCT01904773|3606815|P6|STARTED|First Intervention||4
1473280|NCT01904773|3606816|P5|STARTED|First Intervention||3
1473281|NCT01904773|3606817|P4|STARTED|First Intervention||2
1473282|NCT01904773|3606818|P3|STARTED|First Intervention||1
1473283|NCT01904773|3606819|P2|STARTED|First Intervention||2
1473284|NCT01904773|3606820|P1|STARTED|First Intervention||0
1473285|NCT01904773|3606812|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473286|NCT01904773|3606813|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473287|NCT01904773|3606814|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473288|NCT01904773|3606815|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473289|NCT01904773|3606816|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473290|NCT01904773|3606817|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473291|NCT01904773|3606818|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473292|NCT01904773|3606819|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473293|NCT01904773|3606820|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
1473294|NCT01904773|3606812|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473295|NCT01904773|3606813|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473296|NCT01904773|3606814|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473297|NCT01904773|3606815|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473298|NCT01904773|3606816|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473299|NCT01904773|3606817|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473300|NCT01904773|3606818|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473301|NCT01904773|3606819|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473302|NCT01904773|3606820|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
1473303|NCT01904773|3606812|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473304|NCT01904773|3606813|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473305|NCT01904773|3606814|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473306|NCT01904773|3606815|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473307|NCT01904773|3606816|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473308|NCT01904773|3606817|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473309|NCT01904773|3606818|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473310|NCT01904773|3606819|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473311|NCT01904773|3606820|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
1473312|NCT01904773|3606812|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473313|NCT01904773|3606813|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473314|NCT01904773|3606814|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473315|NCT01904773|3606815|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473316|NCT01904773|3606816|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473317|NCT01904773|3606817|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473318|NCT01904773|3606818|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473406|NCT01904721|3606855|P5|STARTED|Overall Study||65
1473319|NCT01904773|3606819|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473320|NCT01904773|3606820|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
1473321|NCT01904773|3606812|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473322|NCT01904773|3606813|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473323|NCT01904773|3606814|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473324|NCT01904773|3606815|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473325|NCT01904773|3606816|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473326|NCT01904773|3606817|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473327|NCT01904773|3606818|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473328|NCT01904773|3606819|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
1473329|NCT01904773|3606820|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
1473330|NCT01904773|3606812|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473331|NCT01904773|3606813|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473332|NCT01904773|3606814|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473333|NCT01904773|3606815|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473334|NCT01904773|3606816|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473335|NCT01904773|3606817|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473336|NCT01904773|3606818|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473337|NCT01904773|3606819|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473338|NCT01904773|3606820|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473339|NCT01904773|3606812|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473340|NCT01904773|3606813|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473341|NCT01904773|3606814|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473342|NCT01904773|3606815|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473343|NCT01904773|3606816|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473344|NCT01904773|3606817|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473345|NCT01904773|3606818|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473346|NCT01904773|3606819|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473347|NCT01904773|3606820|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
1473348|NCT01904773|3606812|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473349|NCT01904773|3606813|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473350|NCT01904773|3606814|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473351|NCT01904773|3606815|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473352|NCT01904773|3606816|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473353|NCT01904773|3606817|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473354|NCT01904773|3606818|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473355|NCT01904773|3606819|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
1473356|NCT01904773|3606820|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
1473357|NCT01904773|3606812|P9|NOT COMPLETED|Screen||0
1473358|NCT01904773|3606813|P8|NOT COMPLETED|Screen||0
1473359|NCT01904773|3606814|P7|NOT COMPLETED|Screen||0
1473360|NCT01904773|3606815|P6|NOT COMPLETED|Screen||0
1473361|NCT01904773|3606816|P5|NOT COMPLETED|Screen||0
1473362|NCT01904773|3606817|P4|NOT COMPLETED|Screen||0
1473363|NCT01904773|3606818|P3|NOT COMPLETED|Screen||0
1473364|NCT01904773|3606819|P2|NOT COMPLETED|Screen||0
1473365|NCT01904773|3606820|P1|NOT COMPLETED|Screen||4
1473366|NCT01904773|3606812|P9|COMPLETED|Screen||0
1473367|NCT01904773|3606813|P8|COMPLETED|Screen||0
1473368|NCT01904773|3606814|P7|COMPLETED|Screen||0
1473369|NCT01904773|3606815|P6|COMPLETED|Screen||0
1473370|NCT01904773|3606816|P5|COMPLETED|Screen||0
1473371|NCT01904773|3606817|P4|COMPLETED|Screen||0
1473372|NCT01904773|3606818|P3|COMPLETED|Screen||0
1473373|NCT01904773|3606819|P2|COMPLETED|Screen||0
1473374|NCT01904773|3606820|P1|COMPLETED|Screen||24
1473375|NCT01904773|3606812|P9|STARTED|Screen||0
1473376|NCT01904773|3606813|P8|STARTED|Screen||0
1473377|NCT01904773|3606814|P7|STARTED|Screen||0
1473378|NCT01904773|3606815|P6|STARTED|Screen||0
1473379|NCT01904773|3606816|P5|STARTED|Screen||0
1473380|NCT01904773|3606817|P4|STARTED|Screen||0
1473381|NCT01904773|3606818|P3|STARTED|Screen||0
1473382|NCT01904773|3606819|P2|STARTED|Screen||0
1473383|NCT01904773|3606820|P1|STARTED|Screen||28
1473384|NCT01904760|3606837|P2|NOT COMPLETED|Overall Study||0
1473385|NCT01904760|3606838|P1|NOT COMPLETED|Overall Study||1
1473386|NCT01904760|3606837|P2|COMPLETED|Overall Study||40
1473387|NCT01904760|3606838|P1|COMPLETED|Overall Study||39
1473388|NCT01904760|3606837|P2|STARTED|Overall Study||40
1473389|NCT01904760|3606838|P1|STARTED|Overall Study||40
1473390|NCT01904721|3606853|P7|NOT COMPLETED|Overall Study||7
1473391|NCT01904721|3606854|P6|NOT COMPLETED|Overall Study||9
1473392|NCT01904721|3606855|P5|NOT COMPLETED|Overall Study||8
1473393|NCT01904721|3606856|P4|NOT COMPLETED|Overall Study||1
1473394|NCT01904721|3606857|P3|NOT COMPLETED|Overall Study||1
1473395|NCT01904721|3606858|P2|NOT COMPLETED|Overall Study||0
1473396|NCT01904721|3606859|P1|NOT COMPLETED|Overall Study||0
1473397|NCT01904721|3606853|P7|COMPLETED|Overall Study||57
1473398|NCT01904721|3606854|P6|COMPLETED|Overall Study||56
1473399|NCT01904721|3606855|P5|COMPLETED|Overall Study||57
1473400|NCT01904721|3606856|P4|COMPLETED|Overall Study||11
1473401|NCT01904721|3606857|P3|COMPLETED|Overall Study||11
1473402|NCT01904721|3606858|P2|COMPLETED|Overall Study||13
1473403|NCT01904721|3606859|P1|COMPLETED|Overall Study||13
1473404|NCT01904721|3606853|P7|STARTED|Overall Study||64
1473405|NCT01904721|3606854|P6|STARTED|Overall Study||65
1473407|NCT01904721|3606856|P4|STARTED|Overall Study||12
1473408|NCT01904721|3606857|P3|STARTED|Overall Study||12
1473409|NCT01904721|3606858|P2|STARTED|Overall Study||13
1473410|NCT01904721|3606859|P1|STARTED|Overall Study||13
1473411|NCT01904604|3606889|P3|NOT COMPLETED|Overall Study||0
1473412|NCT01904604|3606890|P2|NOT COMPLETED|Overall Study||4
1473413|NCT01904604|3606891|P1|NOT COMPLETED|Overall Study||3
1473414|NCT01904604|3606889|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|25
1473415|NCT01904604|3606890|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|21
1473416|NCT01904604|3606891|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|22
1473417|NCT01904604|3606889|P3|STARTED|Overall Study||25
1473418|NCT01904604|3606890|P2|STARTED|Overall Study||25
1473419|NCT01904604|3606891|P1|STARTED|Overall Study||25
1473420|NCT01904526|3606907|P1|NOT COMPLETED|Overall Study||0
1473421|NCT01904526|3606907|P1|COMPLETED|Overall Study||5
1473422|NCT01904526|3606907|P1|STARTED|Overall Study||5
1473423|NCT01904448|3606921|P1|NOT COMPLETED|Overall Study||0
1473424|NCT01904448|3606921|P1|COMPLETED|Overall Study||5
1473425|NCT01904448|3606921|P1|STARTED|Overall Study||5
1473426|NCT01904279|3606945|P2|NOT COMPLETED|Overall Study||3
1473427|NCT01904279|3606946|P1|NOT COMPLETED|Overall Study||3
1473428|NCT01904279|3606945|P2|COMPLETED|Overall Study||22
1473429|NCT01904279|3606946|P1|COMPLETED|Overall Study||24
1473430|NCT01904279|3606945|P2|STARTED|Overall Study||25
1473431|NCT01904279|3606946|P1|STARTED|Overall Study||27
1473432|NCT01904149|3606972|P6|NOT COMPLETED|Overall Study||3
1473433|NCT01904149|3606973|P5|NOT COMPLETED|Overall Study||5
1473434|NCT01904149|3606974|P4|NOT COMPLETED|Overall Study||4
1473435|NCT01904149|3606975|P3|NOT COMPLETED|Overall Study||2
1473436|NCT01904149|3606976|P2|NOT COMPLETED|Overall Study||11
1473437|NCT01904149|3606977|P1|NOT COMPLETED|Overall Study||5
1473438|NCT01904149|3606972|P6|COMPLETED|Overall Study||48
1473439|NCT01904149|3606973|P5|COMPLETED|Overall Study||46
1473440|NCT01904149|3606974|P4|COMPLETED|Overall Study||47
1473441|NCT01904149|3606975|P3|COMPLETED|Overall Study||148
1473442|NCT01904149|3606976|P2|COMPLETED|Overall Study||140
1473443|NCT01904149|3606977|P1|COMPLETED|Overall Study||147
1473444|NCT01904149|3606972|P6|Multiple-dose Phase|Overall Study||49
1473445|NCT01904149|3606973|P5|Multiple-dose Phase|Overall Study||48
1473446|NCT01904149|3606974|P4|Multiple-dose Phase|Overall Study||48
1473447|NCT01904149|3606975|P3|Multiple-dose Phase|Overall Study||149
1473448|NCT01904149|3606976|P2|Multiple-dose Phase|Overall Study||146
1473449|NCT01904149|3606977|P1|Multiple-dose Phase|Overall Study||150
1473450|NCT01904149|3606972|P6|Single-dose Phase|Overall Study||51
1473451|NCT01904149|3606973|P5|Single-dose Phase|Overall Study||51
1473452|NCT01904149|3606974|P4|Single-dose Phase|Overall Study||51
1473453|NCT01904149|3606975|P3|Single-dose Phase|Overall Study||150
1473454|NCT01904149|3606976|P2|Single-dose Phase|Overall Study||151
1473455|NCT01904149|3606977|P1|Single-dose Phase|Overall Study||152
1473456|NCT01904149|3606972|P6|STARTED|Overall Study||51
1473457|NCT01904149|3606973|P5|STARTED|Overall Study||51
1473458|NCT01904149|3606974|P4|STARTED|Overall Study||51
1473459|NCT01904149|3606975|P3|STARTED|Overall Study||150
1473460|NCT01904149|3606976|P2|STARTED|Overall Study||151
1473461|NCT01904149|3606977|P1|STARTED|Overall Study||152
1473462|NCT01904071|3607002|P3|NOT COMPLETED|Overall Study||0
1473463|NCT01904071|3607003|P2|NOT COMPLETED|Overall Study||0
1473464|NCT01904071|3607004|P1|NOT COMPLETED|Overall Study||0
1473465|NCT01904071|3607002|P3|COMPLETED|Overall Study||20
1473466|NCT01904071|3607003|P2|COMPLETED|Overall Study||20
1473467|NCT01904071|3607004|P1|COMPLETED|Overall Study||24
1473468|NCT01904071|3607002|P3|STARTED|Overall Study||20
1473469|NCT01904071|3607003|P2|STARTED|Overall Study||20
1473470|NCT01904071|3607004|P1|STARTED|Overall Study||24
1473471|NCT01904058|3607028|P4|NOT COMPLETED|Overall Study||1
1473472|NCT01904058|3607029|P3|NOT COMPLETED|Overall Study||1
1473473|NCT01904058|3607030|P2|NOT COMPLETED|Overall Study||0
1473474|NCT01904058|3607031|P1|NOT COMPLETED|Overall Study||3
1473475|NCT01904058|3607028|P4|COMPLETED|Overall Study||12
1473476|NCT01904058|3607029|P3|COMPLETED|Overall Study||10
1473477|NCT01904058|3607030|P2|COMPLETED|Overall Study||21
1473478|NCT01904058|3607031|P1|COMPLETED|Overall Study||18
1473479|NCT01904058|3607028|P4|STARTED|Overall Study||13
1473480|NCT01904058|3607029|P3|STARTED|Overall Study||11
1473481|NCT01904058|3607030|P2|STARTED|Overall Study||21
1473482|NCT01904058|3607031|P1|STARTED|Overall Study||21
1473483|NCT01903993|3607071|P2|NOT COMPLETED|Overall Study||95
1473484|NCT01903993|3607072|P1|NOT COMPLETED|Overall Study||123
1473485|NCT01903993|3607071|P2|COMPLETED|Overall Study||49
1473486|NCT01903993|3607072|P1|COMPLETED|Overall Study||20
1473487|NCT01903993|3607071|P2|Received Treatment|Overall Study||142
1473488|NCT01903993|3607072|P1|Received Treatment|Overall Study||135
1473489|NCT01903993|3607071|P2|STARTED|Overall Study||144
1473490|NCT01903993|3607072|P1|STARTED|Overall Study||143
1473491|NCT01903876|3607089|P2|NOT COMPLETED|Six-Month Follow-up Period||145
1473492|NCT01903876|3607090|P1|NOT COMPLETED|Six-Month Follow-up Period||91
1473493|NCT01903876|3607089|P2|COMPLETED|Six-Month Follow-up Period||123
1473494|NCT01903876|3607090|P1|COMPLETED|Six-Month Follow-up Period||92
1473495|NCT01903876|3607089|P2|STARTED|Six-Month Follow-up Period||268
1473496|NCT01903876|3607090|P1|STARTED|Six-Month Follow-up Period||183
1473497|NCT01903876|3607089|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
1473498|NCT01903876|3607090|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
1473499|NCT01903876|3607089|P2|COMPLETED|Baseline to Post-Intervention Period||268
1473500|NCT01903876|3607090|P1|COMPLETED|Baseline to Post-Intervention Period||183
1473501|NCT01903876|3607089|P2|STARTED|Baseline to Post-Intervention Period||376
1473502|NCT01903876|3607090|P1|STARTED|Baseline to Post-Intervention Period||367
1473503|NCT01903863|3607100|P2|NOT COMPLETED|Overall Study||0
1473504|NCT01903863|3607101|P1|NOT COMPLETED|Overall Study||2
1473505|NCT01903863|3607100|P2|COMPLETED|Overall Study||16
1473506|NCT01903863|3607101|P1|COMPLETED|Overall Study||13
1473507|NCT01903863|3607100|P2|STARTED|Overall Study||16
1473508|NCT01903863|3607101|P1|STARTED|Overall Study||15
1473509|NCT01903798|3607125|P4|NOT COMPLETED|Overall Study||0
1473510|NCT01903798|3607126|P3|NOT COMPLETED|Overall Study||0
1473511|NCT01903798|3607127|P2|NOT COMPLETED|Overall Study||0
1473512|NCT01903798|3607128|P1|NOT COMPLETED|Overall Study||0
1473513|NCT01903798|3607125|P4|COMPLETED|Overall Study||1
1473514|NCT01903798|3607126|P3|COMPLETED|Overall Study||1
1473515|NCT01903798|3607127|P2|COMPLETED|Overall Study||0
1473516|NCT01903798|3607128|P1|COMPLETED|Overall Study||2
1473517|NCT01903798|3607125|P4|STARTED|Overall Study||1
1473518|NCT01903798|3607126|P3|STARTED|Overall Study||1
1473519|NCT01903798|3607127|P2|STARTED|Overall Study||0
1473520|NCT01903798|3607128|P1|STARTED|Overall Study||2
1473521|NCT01903720|3607142|P1|NOT COMPLETED|Overall Study||12
1473522|NCT01903720|3607142|P1|COMPLETED|Overall Study||59
1473523|NCT01903720|3607142|P1|STARTED|Overall Study||71
1473524|NCT01903564|3607159|P2|NOT COMPLETED|Overall Study||0
1473525|NCT01903564|3607160|P1|NOT COMPLETED|Overall Study||0
1473526|NCT01903564|3607159|P2|COMPLETED|Overall Study||29
1473527|NCT01903564|3607160|P1|COMPLETED|Overall Study||10
1473528|NCT01903564|3607159|P2|STARTED|Overall Study||29
1473529|NCT01903564|3607160|P1|STARTED|Overall Study||10
1473530|NCT01903460|3607180|P4|NOT COMPLETED|Overall Study||1
1473531|NCT01903460|3607181|P3|NOT COMPLETED|Overall Study||0
1473532|NCT01903460|3607182|P2|NOT COMPLETED|Overall Study||0
1473533|NCT01903460|3607183|P1|NOT COMPLETED|Overall Study||0
1473534|NCT01903460|3607180|P4|COMPLETED|Overall Study||2
1473535|NCT01903460|3607181|P3|COMPLETED|Overall Study||3
1473536|NCT01903460|3607182|P2|COMPLETED|Overall Study||8
1473537|NCT01903460|3607183|P1|COMPLETED|Overall Study||6
1473538|NCT01903460|3607180|P4|STARTED|Overall Study||3
1473539|NCT01903460|3607181|P3|STARTED|Overall Study||3
1473540|NCT01903460|3607182|P2|STARTED|Overall Study||8
1473541|NCT01903460|3607183|P1|STARTED|Overall Study||6
1473542|NCT01903434|3607200|P2|NOT COMPLETED|Treatment Period 3||0
1473543|NCT01903434|3607201|P1|NOT COMPLETED|Treatment Period 3||0
1473544|NCT01903434|3607200|P2|COMPLETED|Treatment Period 3||28
1473545|NCT01903434|3607201|P1|COMPLETED|Treatment Period 3||29
1473546|NCT01903434|3607200|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
1473547|NCT01903434|3607201|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
1473548|NCT01903434|3607200|P2|STARTED|Treatment Period 3||28
1473549|NCT01903434|3607201|P1|STARTED|Treatment Period 3||29
1473550|NCT01903434|3607200|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1473551|NCT01903434|3607201|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1473552|NCT01903434|3607200|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
1473553|NCT01903434|3607201|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
1473554|NCT01903434|3607200|P2|STARTED|Washout Period 1 (at Least 14 Days)||28
1473555|NCT01903434|3607201|P1|STARTED|Washout Period 1 (at Least 14 Days)||29
1473556|NCT01903434|3607200|P2|NOT COMPLETED|Treatment Period 2||0
1473557|NCT01903434|3607201|P1|NOT COMPLETED|Treatment Period 2||0
1473558|NCT01903434|3607200|P2|COMPLETED|Treatment Period 2||28
1473559|NCT01903434|3607201|P1|COMPLETED|Treatment Period 2||29
1473560|NCT01903434|3607200|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
1473561|NCT01903434|3607201|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
1473562|NCT01903434|3607200|P2|STARTED|Treatment Period 2||28
1473563|NCT01903434|3607201|P1|STARTED|Treatment Period 2||29
1473564|NCT01903434|3607200|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
1473565|NCT01903434|3607201|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
1473566|NCT01903434|3607200|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
1473567|NCT01903434|3607201|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
1473568|NCT01903434|3607200|P2|STARTED|Washout Period 1 (at Least 14 Days)||30
1473569|NCT01903434|3607201|P1|STARTED|Washout Period 1 (at Least 14 Days)||30
1473570|NCT01903434|3607200|P2|NOT COMPLETED|Treatment Period 1||0
1473571|NCT01903434|3607201|P1|NOT COMPLETED|Treatment Period 1||0
1473572|NCT01903434|3607200|P2|COMPLETED|Treatment Period 1||30
1473573|NCT01903434|3607201|P1|COMPLETED|Treatment Period 1||30
1473574|NCT01903434|3607200|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
1473575|NCT01903434|3607201|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
1473576|NCT01903434|3607200|P2|STARTED|Treatment Period 1||30
1473577|NCT01903434|3607201|P1|STARTED|Treatment Period 1||30
1473578|NCT01903356|3607209|P1|NOT COMPLETED|Overall Study||15
1473579|NCT01903356|3607209|P1|COMPLETED|Overall Study||709
1473580|NCT01903356|3607209|P1|STARTED|Overall Study||724
1473581|NCT01903265|3607219|P2|NOT COMPLETED|Overall Study||17
1473582|NCT01903265|3607220|P1|NOT COMPLETED|Overall Study||14
1473583|NCT01903265|3607219|P2|COMPLETED|Overall Study||85
1473584|NCT01903265|3607220|P1|COMPLETED|Overall Study||89
1473585|NCT01903265|3607219|P2|STARTED|Overall Study||102
1473586|NCT01903265|3607220|P1|STARTED|Overall Study||103
1473587|NCT01903252|3607236|P6|NOT COMPLETED|Maintenance, Open-Label||18
1473588|NCT01903252|3607237|P5|NOT COMPLETED|Maintenance, Open-Label||21
1473589|NCT01903252|3607238|P4|NOT COMPLETED|Maintenance, Open-Label||6
1473590|NCT01903252|3607239|P3|NOT COMPLETED|Maintenance, Open-Label||0
1473591|NCT01903252|3607240|P2|NOT COMPLETED|Maintenance, Open-Label||0
1473592|NCT01903252|3607241|P1|NOT COMPLETED|Maintenance, Open-Label||0
1473593|NCT01903252|3607236|P6|COMPLETED|Maintenance, Open-Label||181
1473594|NCT01903252|3607237|P5|COMPLETED|Maintenance, Open-Label||253
1473595|NCT01903252|3607238|P4|COMPLETED|Maintenance, Open-Label||196
1473596|NCT01903252|3607239|P3|COMPLETED|Maintenance, Open-Label||0
1473597|NCT01903252|3607240|P2|COMPLETED|Maintenance, Open-Label||0
1473598|NCT01903252|3607241|P1|COMPLETED|Maintenance, Open-Label||0
1473599|NCT01903252|3607236|P6|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
1473600|NCT01903252|3607237|P5|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
1473601|NCT01903252|3607238|P4|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
1473602|NCT01903252|3607239|P3|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
1473603|NCT01903252|3607240|P2|STARTED|Maintenance, Open-Label||0
1473604|NCT01903252|3607241|P1|STARTED|Maintenance, Open-Label||0
1473605|NCT01903252|3607236|P6|NOT COMPLETED|Extended Induction, Open-Label||0
1473606|NCT01903252|3607237|P5|NOT COMPLETED|Extended Induction, Open-Label||0
1473607|NCT01903252|3607238|P4|NOT COMPLETED|Extended Induction, Open-Label||0
1473608|NCT01903252|3607239|P3|NOT COMPLETED|Extended Induction, Open-Label||23
1473609|NCT01903252|3607240|P2|NOT COMPLETED|Extended Induction, Open-Label||0
1473610|NCT01903252|3607241|P1|NOT COMPLETED|Extended Induction, Open-Label||0
1473611|NCT01903252|3607236|P6|COMPLETED|Extended Induction, Open-Label||0
1473612|NCT01903252|3607237|P5|COMPLETED|Extended Induction, Open-Label||0
1473613|NCT01903252|3607238|P4|COMPLETED|Extended Induction, Open-Label||0
1473614|NCT01903252|3607239|P3|COMPLETED|Extended Induction, Open-Label||220
1473615|NCT01903252|3607240|P2|COMPLETED|Extended Induction, Open-Label||0
1473616|NCT01903252|3607241|P1|COMPLETED|Extended Induction, Open-Label||0
1473617|NCT01903252|3607236|P6|STARTED|Extended Induction, Open-Label||0
1473618|NCT01903252|3607237|P5|STARTED|Extended Induction, Open-Label||0
1473619|NCT01903252|3607238|P4|STARTED|Extended Induction, Open-Label||0
1473620|NCT01903252|3607239|P3|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
1473621|NCT01903252|3607240|P2|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
1473622|NCT01903252|3607241|P1|STARTED|Extended Induction, Open-Label||0
1473623|NCT01903252|3607236|P6|NOT COMPLETED|Double-Blind Induction||0
1473624|NCT01903252|3607237|P5|NOT COMPLETED|Double-Blind Induction||0
1473625|NCT01903252|3607238|P4|NOT COMPLETED|Double-Blind Induction||0
1473626|NCT01903252|3607239|P3|NOT COMPLETED|Double-Blind Induction||0
1473627|NCT01903252|3607240|P2|NOT COMPLETED|Double-Blind Induction||41
1473628|NCT01903252|3607241|P1|NOT COMPLETED|Double-Blind Induction||39
1473629|NCT01903252|3607236|P6|COMPLETED|Double-Blind Induction||0
1473630|NCT01903252|3607237|P5|COMPLETED|Double-Blind Induction||0
1473631|NCT01903252|3607238|P4|COMPLETED|Double-Blind Induction||0
1473632|NCT01903252|3607239|P3|COMPLETED|Double-Blind Induction||0
1473633|NCT01903252|3607240|P2|COMPLETED|Double-Blind Induction||367
1473634|NCT01903252|3607241|P1|COMPLETED|Double-Blind Induction||370
1473635|NCT01903252|3607236|P6|STARTED|Double-Blind Induction||0
1473636|NCT01903252|3607237|P5|STARTED|Double-Blind Induction||0
1473637|NCT01903252|3607238|P4|STARTED|Double-Blind Induction||0
1473638|NCT01903252|3607239|P3|STARTED|Double-Blind Induction||0
1473639|NCT01903252|3607240|P2|STARTED|Double-Blind Induction||408
1473640|NCT01903252|3607241|P1|STARTED|Double-Blind Induction||409
1473641|NCT01903187|3607320|P2|NOT COMPLETED|12 Month||0
1473642|NCT01903187|3607321|P1|NOT COMPLETED|12 Month||0
1473643|NCT01903187|3607320|P2|COMPLETED|12 Month||0
1473644|NCT01903187|3607321|P1|COMPLETED|12 Month||2
1473645|NCT01903187|3607320|P2|STARTED|12 Month||0
1473646|NCT01903187|3607321|P1|STARTED|12 Month||2
1473647|NCT01903187|3607320|P2|NOT COMPLETED|6 Month||0
1473648|NCT01903187|3607321|P1|NOT COMPLETED|6 Month||0
1473649|NCT01903187|3607320|P2|COMPLETED|6 Month||0
1473650|NCT01903187|3607321|P1|COMPLETED|6 Month||2
1473651|NCT01903187|3607320|P2|STARTED|6 Month||0
1473652|NCT01903187|3607321|P1|STARTED|6 Month||2
1473653|NCT01903187|3607320|P2|NOT COMPLETED|3 Month||0
1473654|NCT01903187|3607321|P1|NOT COMPLETED|3 Month||0
1473655|NCT01903187|3607320|P2|COMPLETED|3 Month||0
1473656|NCT01903187|3607321|P1|COMPLETED|3 Month||2
1473657|NCT01903187|3607320|P2|STARTED|3 Month||0
1473658|NCT01903187|3607321|P1|STARTED|3 Month||2
1473659|NCT01903187|3607320|P2|NOT COMPLETED|1 Month||0
1473660|NCT01903187|3607321|P1|NOT COMPLETED|1 Month||0
1473661|NCT01903187|3607320|P2|COMPLETED|1 Month||2
1473662|NCT01903187|3607321|P1|COMPLETED|1 Month||2
1473663|NCT01903187|3607320|P2|STARTED|1 Month||2
1473664|NCT01903187|3607321|P1|STARTED|1 Month||2
1473665|NCT01903187|3607320|P2|NOT COMPLETED|Procedure||0
1473666|NCT01903187|3607321|P1|NOT COMPLETED|Procedure||0
1473667|NCT01903187|3607320|P2|COMPLETED|Procedure||2
1473668|NCT01903187|3607321|P1|COMPLETED|Procedure||2
1473669|NCT01903187|3607320|P2|STARTED|Procedure||2
1473670|NCT01903187|3607321|P1|STARTED|Procedure||2
1473671|NCT01903148|3607335|P1|NOT COMPLETED|Overall Study||0
1473672|NCT01903148|3607335|P1|COMPLETED|Overall Study||441
1473673|NCT01903148|3607335|P1|STARTED|Overall Study||441
1473674|NCT01903031|3607354|P3|NOT COMPLETED|Overall Study||5
1473675|NCT01903031|3607355|P2|NOT COMPLETED|Overall Study||3
1473676|NCT01903031|3607356|P1|NOT COMPLETED|Overall Study||2
1473677|NCT01903031|3607354|P3|COMPLETED|Overall Study||24
1473678|NCT01903031|3607355|P2|COMPLETED|Overall Study||25
1473679|NCT01903031|3607356|P1|COMPLETED|Overall Study||25
1473680|NCT01903031|3607354|P3|STARTED|Overall Study||29
1473681|NCT01903031|3607355|P2|STARTED|Overall Study||28
1473682|NCT01903031|3607356|P1|STARTED|Overall Study||27
1473683|NCT01903005|3607398|P1|NOT COMPLETED|Overall Study||373
1473684|NCT01903005|3607398|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
1473685|NCT01903005|3607398|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
1473686|NCT01902888|3607412|P1|NOT COMPLETED|Overall Study||3
1473687|NCT01902888|3607412|P1|COMPLETED|Overall Study||0
1473688|NCT01902888|3607412|P1|STARTED|Overall Study||3
1473689|NCT01902758|3607419|P2|NOT COMPLETED|Overall Study||0
1473690|NCT01902758|3607420|P1|NOT COMPLETED|Overall Study||0
1473691|NCT01902758|3607419|P2|COMPLETED|Overall Study||14
1473692|NCT01902758|3607420|P1|COMPLETED|Overall Study||14
1473693|NCT01902758|3607419|P2|STARTED|Overall Study||14
1473694|NCT01902758|3607420|P1|STARTED|Overall Study||14
1473695|NCT01902628|3607426|P1|NOT COMPLETED|Overall Study||83
1473696|NCT01902628|3607426|P1|COMPLETED|Overall Study||354
1473697|NCT01902628|3607426|P1|STARTED|Overall Study||437
1473698|NCT01902459|3607435|P2|NOT COMPLETED|Overall Study||0
1473699|NCT01902459|3607436|P1|NOT COMPLETED|Overall Study||0
1473700|NCT01902459|3607435|P2|COMPLETED|Overall Study||75
1473701|NCT01902459|3607436|P1|COMPLETED|Overall Study||75
1473702|NCT01902459|3607435|P2|STARTED|Overall Study||75
1473703|NCT01902459|3607436|P1|STARTED|Overall Study||75
1473704|NCT01902303|3607454|P2|NOT COMPLETED|Overall Study||24
1473705|NCT01902303|3607455|P1|NOT COMPLETED|Overall Study||23
1473706|NCT01902303|3607454|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
1473707|NCT01902303|3607455|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
1473708|NCT01902303|3607454|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
1473709|NCT01902303|3607455|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
1473710|NCT01902303|3607454|P2|STARTED|Overall Study|Allocated to active treatment|81
1473711|NCT01902303|3607455|P1|STARTED|Overall Study|Allocated to placebo|77
1473712|NCT01902134|3607469|P6|NOT COMPLETED|Overall Study||9
1473713|NCT01902134|3607470|P5|NOT COMPLETED|Overall Study||7
1473714|NCT01902134|3607471|P4|NOT COMPLETED|Overall Study||2
1473715|NCT01902134|3607472|P3|NOT COMPLETED|Overall Study||15
1473716|NCT01902134|3607473|P2|NOT COMPLETED|Overall Study||11
1473717|NCT01902134|3607474|P1|NOT COMPLETED|Overall Study||8
1473718|NCT01902134|3607469|P6|COMPLETED|Overall Study||45
1473719|NCT01902134|3607470|P5|COMPLETED|Overall Study||46
1473720|NCT01902134|3607471|P4|COMPLETED|Overall Study||52
1473721|NCT01902134|3607472|P3|COMPLETED|Overall Study||145
1473722|NCT01902134|3607473|P2|COMPLETED|Overall Study||150
1473723|NCT01902134|3607474|P1|COMPLETED|Overall Study||151
1473724|NCT01902134|3607469|P6|Multiple-dose Phase|Overall Study||52
1473725|NCT01902134|3607470|P5|Multiple-dose Phase|Overall Study||53
1473726|NCT01902134|3607471|P4|Multiple-dose Phase|Overall Study||54
1473727|NCT01902134|3607472|P3|Multiple-dose Phase|Overall Study||160
1473728|NCT01902134|3607473|P2|Multiple-dose Phase|Overall Study||160
1473729|NCT01902134|3607474|P1|Multiple-dose Phase|Overall Study||159
1473730|NCT01902134|3607469|P6|Single-dose Phase|Overall Study||54
1473731|NCT01902134|3607470|P5|Single-dose Phase|Overall Study||53
1473732|NCT01902134|3607471|P4|Single-dose Phase|Overall Study||54
1473733|NCT01902134|3607472|P3|Single-dose Phase|Overall Study||160
1473734|NCT01902134|3607473|P2|Single-dose Phase|Overall Study||161
1473735|NCT01902134|3607474|P1|Single-dose Phase|Overall Study||159
1473736|NCT01902134|3607469|P6|STARTED|Overall Study||54
1473737|NCT01902134|3607470|P5|STARTED|Overall Study||53
1473738|NCT01902134|3607471|P4|STARTED|Overall Study||54
1473739|NCT01902134|3607472|P3|STARTED|Overall Study||160
1473740|NCT01902134|3607473|P2|STARTED|Overall Study||161
1473741|NCT01902134|3607474|P1|STARTED|Overall Study||159
1473742|NCT01901848|3607498|P2|NOT COMPLETED|Removed From Analyses||0
1473743|NCT01901848|3607499|P1|NOT COMPLETED|Removed From Analyses||10
1473744|NCT01901848|3607498|P2|COMPLETED|Removed From Analyses||19
1473745|NCT01901848|3607499|P1|COMPLETED|Removed From Analyses||12
1473746|NCT01901848|3607498|P2|STARTED|Removed From Analyses||19
1473747|NCT01901848|3607499|P1|STARTED|Removed From Analyses||22
1473748|NCT01901848|3607498|P2|NOT COMPLETED|Randomized and Treated||6
1473749|NCT01901848|3607499|P1|NOT COMPLETED|Randomized and Treated||3
1473750|NCT01901848|3607498|P2|COMPLETED|Randomized and Treated||19
1473751|NCT01901848|3607499|P1|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
1473752|NCT01901848|3607498|P2|STARTED|Randomized and Treated||25
1473753|NCT01901848|3607499|P1|STARTED|Randomized and Treated||25
1473754|NCT01901809|3607511|P4|NOT COMPLETED|Overall Study||2
1473755|NCT01901809|3607512|P3|NOT COMPLETED|Overall Study||3
1473756|NCT01901809|3607513|P2|NOT COMPLETED|Overall Study||0
1473757|NCT01901809|3607514|P1|NOT COMPLETED|Overall Study||0
1473758|NCT01901809|3607511|P4|COMPLETED|Overall Study||22
1473759|NCT01901809|3607512|P3|COMPLETED|Overall Study||21
1473760|NCT01901809|3607513|P2|COMPLETED|Overall Study||23
1473761|NCT01901809|3607514|P1|COMPLETED|Overall Study||19
1473762|NCT01901809|3607511|P4|STARTED|Overall Study||24
1473763|NCT01901809|3607512|P3|STARTED|Overall Study||24
1473764|NCT01901809|3607513|P2|STARTED|Overall Study||23
1473765|NCT01901809|3607514|P1|STARTED|Overall Study||19
1473766|NCT01901653|3607541|P13|NOT COMPLETED|Overall Study||5
1473767|NCT01901653|3607542|P12|NOT COMPLETED|Overall Study||16
1473768|NCT01901653|3607543|P11|NOT COMPLETED|Overall Study||2
1473769|NCT01901653|3607544|P10|NOT COMPLETED|Overall Study||18
1473770|NCT01901653|3607545|P9|NOT COMPLETED|Overall Study||1
1473771|NCT01901653|3607546|P8|NOT COMPLETED|Overall Study||10
1473772|NCT01901653|3607547|P7|NOT COMPLETED|Overall Study||7
1473773|NCT01901653|3607548|P6|NOT COMPLETED|Overall Study||3
1473774|NCT01901653|3607549|P5|NOT COMPLETED|Overall Study||2
1473775|NCT01901653|3607550|P4|NOT COMPLETED|Overall Study||3
1473776|NCT01901653|3607551|P3|NOT COMPLETED|Overall Study||11
1473777|NCT01901653|3607552|P2|NOT COMPLETED|Overall Study||1
1473778|NCT01901653|3607553|P1|NOT COMPLETED|Overall Study||3
1473779|NCT01901653|3607541|P13|COMPLETED|Overall Study||0
1473780|NCT01901653|3607542|P12|COMPLETED|Overall Study||0
1473781|NCT01901653|3607543|P11|COMPLETED|Overall Study||0
1473782|NCT01901653|3607544|P10|COMPLETED|Overall Study||0
1473783|NCT01901653|3607545|P9|COMPLETED|Overall Study||0
1473784|NCT01901653|3607546|P8|COMPLETED|Overall Study||0
1473785|NCT01901653|3607547|P7|COMPLETED|Overall Study||0
1473786|NCT01901653|3607548|P6|COMPLETED|Overall Study||0
1473787|NCT01901653|3607549|P5|COMPLETED|Overall Study||0
1473788|NCT01901653|3607550|P4|COMPLETED|Overall Study||0
1473789|NCT01901653|3607551|P3|COMPLETED|Overall Study||0
1473790|NCT01901653|3607552|P2|COMPLETED|Overall Study||0
1473791|NCT01901653|3607553|P1|COMPLETED|Overall Study||0
1473792|NCT01901653|3607541|P13|STARTED|Overall Study||5
1473793|NCT01901653|3607542|P12|STARTED|Overall Study||16
1473794|NCT01901653|3607543|P11|STARTED|Overall Study||2
1473795|NCT01901653|3607544|P10|STARTED|Overall Study||18
1473796|NCT01901653|3607545|P9|STARTED|Overall Study||1
1473797|NCT01901653|3607546|P8|STARTED|Overall Study||10
1473798|NCT01901653|3607547|P7|STARTED|Overall Study||7
1473799|NCT01901653|3607548|P6|STARTED|Overall Study||3
1473800|NCT01901653|3607549|P5|STARTED|Overall Study||2
1473801|NCT01901653|3607550|P4|STARTED|Overall Study||3
1473802|NCT01901653|3607551|P3|STARTED|Overall Study||11
1473803|NCT01901653|3607552|P2|STARTED|Overall Study||1
1473804|NCT01901653|3607553|P1|STARTED|Overall Study||3
1473805|NCT01901588|3607597|P2|NOT COMPLETED|Overall Study||0
1473806|NCT01901588|3607598|P1|NOT COMPLETED|Overall Study||0
1473807|NCT01901588|3607597|P2|COMPLETED|Overall Study||31
1473808|NCT01901588|3607598|P1|COMPLETED|Overall Study||32
1473809|NCT01901588|3607597|P2|STARTED|Overall Study||31
1473810|NCT01901588|3607598|P1|STARTED|Overall Study||32
1473811|NCT01901575|3607614|P1|NOT COMPLETED|Overall Study||0
1473812|NCT01901575|3607614|P1|COMPLETED|Overall Study||16
1473813|NCT01901575|3607614|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
1473814|NCT01901393|3607621|P2|NOT COMPLETED|Overall Study||0
1473815|NCT01901393|3607622|P1|NOT COMPLETED|Overall Study||1
1473816|NCT01901393|3607621|P2|COMPLETED|Overall Study||49
1473817|NCT01901393|3607622|P1|COMPLETED|Overall Study||50
1473818|NCT01901393|3607621|P2|STARTED|Overall Study||49
1473819|NCT01901393|3607622|P1|STARTED|Overall Study||51
1473820|NCT01901341|3607640|P2|NOT COMPLETED|Overall Study||21
1473821|NCT01901341|3607641|P1|NOT COMPLETED|Overall Study||20
1473822|NCT01901341|3607640|P2|COMPLETED|Overall Study||1
1473823|NCT01901341|3607641|P1|COMPLETED|Overall Study||2
1473824|NCT01901341|3607640|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
1473825|NCT01901341|3607641|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
1473826|NCT01901341|3607640|P2|STARTED|Overall Study||22
1473827|NCT01901341|3607641|P1|STARTED|Overall Study||22
1473828|NCT01901328|3607655|P2|NOT COMPLETED|Overall Study||21
1473829|NCT01901328|3607656|P1|NOT COMPLETED|Overall Study||22
1473830|NCT01901328|3607655|P2|COMPLETED|Overall Study||2
1473831|NCT01901328|3607656|P1|COMPLETED|Overall Study||4
1473832|NCT01901328|3607655|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
1473833|NCT01901328|3607656|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
1473834|NCT01901328|3607655|P2|STARTED|Overall Study||23
1473835|NCT01901328|3607656|P1|STARTED|Overall Study||26
1473836|NCT01901302|3607670|P2|NOT COMPLETED|Overall Study||23
1473837|NCT01901302|3607671|P1|NOT COMPLETED|Overall Study||27
1473838|NCT01901302|3607670|P2|COMPLETED|Overall Study||7
1473839|NCT01901302|3607671|P1|COMPLETED|Overall Study||4
1473840|NCT01901302|3607670|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
1473841|NCT01901302|3607671|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
1473842|NCT01901302|3607670|P2|STARTED|Overall Study||30
1473843|NCT01901302|3607671|P1|STARTED|Overall Study||31
1473844|NCT01901289|3607683|P1|NOT COMPLETED|Overall Study||200
1473845|NCT01901289|3607683|P1|COMPLETED|Overall Study||0
1473846|NCT01901289|3607683|P1|12-Month Follow-up|Overall Study||175
1473847|NCT01901289|3607683|P1|STARTED|Overall Study||200
1473848|NCT01901250|3607689|P2|NOT COMPLETED|Overall Study||126
1473849|NCT01901250|3607690|P1|NOT COMPLETED|Overall Study||138
1473850|NCT01901250|3607689|P2|COMPLETED|Overall Study||139
1473851|NCT01901250|3607690|P1|COMPLETED|Overall Study||122
1473852|NCT01901250|3607689|P2|End of 1st Grade|Overall Study||151
1473853|NCT01901250|3607690|P1|End of 1st Grade|Overall Study||143
1473854|NCT01901250|3607689|P2|Start of 1st Grade|Overall Study||176
1473855|NCT01901250|3607690|P1|Start of 1st Grade|Overall Study||173
1473856|NCT01901250|3607689|P2|End of Kidergarten|Overall Study||212
1473857|NCT01901250|3607690|P1|End of Kidergarten|Overall Study||215
1473858|NCT01901250|3607689|P2|STARTED|Overall Study||265
1473859|NCT01901250|3607690|P1|STARTED|Overall Study||260
1473860|NCT01901224|3607696|P1|NOT COMPLETED|Overall Study||2
1473861|NCT01901224|3607696|P1|COMPLETED|Overall Study||0
1473862|NCT01901224|3607696|P1|STARTED|Overall Study||2
1473863|NCT01901211|3607707|P2|NOT COMPLETED|Second Ten-week Period||0
1473864|NCT01901211|3607708|P1|NOT COMPLETED|Second Ten-week Period||0
1473865|NCT01901211|3607707|P2|COMPLETED|Second Ten-week Period||5
1473866|NCT01901211|3607708|P1|COMPLETED|Second Ten-week Period||6
1473867|NCT01901211|3607707|P2|STARTED|Second Ten-week Period||5
1473868|NCT01901211|3607708|P1|STARTED|Second Ten-week Period||6
1473869|NCT01901211|3607707|P2|NOT COMPLETED|Washout (6 Weeks)||0
1473870|NCT01901211|3607708|P1|NOT COMPLETED|Washout (6 Weeks)||0
1473871|NCT01901211|3607707|P2|COMPLETED|Washout (6 Weeks)||5
1473872|NCT01901211|3607708|P1|COMPLETED|Washout (6 Weeks)||6
1473873|NCT01901211|3607707|P2|STARTED|Washout (6 Weeks)||5
1473874|NCT01901211|3607708|P1|STARTED|Washout (6 Weeks)||6
1473875|NCT01901211|3607707|P2|NOT COMPLETED|First Ten-week Period||0
1473876|NCT01901211|3607708|P1|NOT COMPLETED|First Ten-week Period||0
1473877|NCT01901211|3607707|P2|COMPLETED|First Ten-week Period||5
1473878|NCT01901211|3607708|P1|COMPLETED|First Ten-week Period||6
1473879|NCT01901211|3607707|P2|STARTED|First Ten-week Period||5
1473880|NCT01901211|3607708|P1|STARTED|First Ten-week Period||6
1473881|NCT01901185|3607731|P1|NOT COMPLETED|Overall Study||2
1473882|NCT01901185|3607731|P1|COMPLETED|Overall Study||75
1473883|NCT01901185|3607731|P1|Received Etanercept With Autoinjector A|Overall Study||75
1473884|NCT01901185|3607731|P1|STARTED|Overall Study||77
1473885|NCT01900665|3607740|P2|NOT COMPLETED|Open Label Period||859
1473886|NCT01900665|3607741|P1|NOT COMPLETED|Open Label Period||881
1473887|NCT01900665|3607740|P2|COMPLETED|Open Label Period||0
1473888|NCT01900665|3607741|P1|COMPLETED|Open Label Period||0
1473889|NCT01900665|3607740|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
1473890|NCT01900665|3607741|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
1473891|NCT01900665|3607740|P2|NOT COMPLETED|Placebo Controlled Period||164
1473892|NCT01900665|3607741|P1|NOT COMPLETED|Placebo Controlled Period||143
1473893|NCT01900665|3607740|P2|COMPLETED|Placebo Controlled Period||908
1473894|NCT01900665|3607741|P1|COMPLETED|Placebo Controlled Period||914
1473895|NCT01900665|3607740|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
1473896|NCT01900665|3607741|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
1473897|NCT01900665|3607740|P2|STARTED|Placebo Controlled Period||1072
1473898|NCT01900665|3607741|P1|STARTED|Placebo Controlled Period||1057
1473899|NCT01900652|3607784|P2|NOT COMPLETED|Overall Study||3
1473900|NCT01900652|3607785|P1|NOT COMPLETED|Overall Study||8
1473901|NCT01900652|3607784|P2|COMPLETED|Overall Study||25
1473902|NCT01900652|3607785|P1|COMPLETED|Overall Study||75
1473903|NCT01900652|3607784|P2|Post-Erlotinib Progression Tumor Sample|Overall Study||23
1473904|NCT01900652|3607785|P1|Post-Erlotinib Progression Tumor Sample|Overall Study||66
1473905|NCT01900652|3607784|P2|STARTED|Overall Study||28
1473906|NCT01900652|3607785|P1|STARTED|Overall Study||83
1473907|NCT01900444|3607819|P1|NOT COMPLETED|Overall Study||3
1473908|NCT01900444|3607819|P1|COMPLETED|Overall Study||116
1473909|NCT01900444|3607819|P1|STARTED|Overall Study||119
1473910|NCT01900431|3607832|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
1473911|NCT01900431|3607833|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
1473912|NCT01900431|3607834|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
1473913|NCT01900431|3607832|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
1473914|NCT01900431|3607833|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
1473915|NCT01900431|3607834|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
1473916|NCT01900431|3607832|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
1473917|NCT01900431|3607833|P2|STARTED|Open-Label Treatment Period (Part C)||0
1473918|NCT01900431|3607834|P1|STARTED|Open-Label Treatment Period (Part C)||0
1473919|NCT01900431|3607832|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
1473920|NCT01900431|3607833|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
1473921|NCT01900431|3607834|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
1473922|NCT01900431|3607832|P3|COMPLETED|Extended Treatment Period (Part B)||0
1473923|NCT01900431|3607833|P2|COMPLETED|Extended Treatment Period (Part B)||12
1473924|NCT01900431|3607834|P1|COMPLETED|Extended Treatment Period (Part B)||7
1473925|NCT01900431|3607832|P3|STARTED|Extended Treatment Period (Part B)||0
1473926|NCT01900431|3607833|P2|STARTED|Extended Treatment Period (Part B)||22
1473927|NCT01900431|3607834|P1|STARTED|Extended Treatment Period (Part B)||8
1473928|NCT01900431|3607832|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
1473929|NCT01900431|3607833|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
1473930|NCT01900431|3607834|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
1473931|NCT01900431|3607832|P3|COMPLETED|Principal Treatment Period (Part A)||0
1473932|NCT01900431|3607833|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
1473933|NCT01900431|3607834|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
1473934|NCT01900431|3607832|P3|STARTED|Principal Treatment Period (Part A)||0
1473935|NCT01900431|3607833|P2|STARTED|Principal Treatment Period (Part A)||38
1473936|NCT01900431|3607834|P1|STARTED|Principal Treatment Period (Part A)||20
1473937|NCT01900392|3607861|P3|NOT COMPLETED|Overall Study||0
1473938|NCT01900392|3607862|P2|NOT COMPLETED|Overall Study||1
1473939|NCT01900392|3607863|P1|NOT COMPLETED|Overall Study||1
1473940|NCT01900392|3607861|P3|COMPLETED|Overall Study||77
1473941|NCT01900392|3607862|P2|COMPLETED|Overall Study||74
1473942|NCT01900392|3607863|P1|COMPLETED|Overall Study||38
1473943|NCT01900392|3607861|P3|STARTED|Overall Study||77
1473944|NCT01900392|3607862|P2|STARTED|Overall Study||75
1473945|NCT01900392|3607863|P1|STARTED|Overall Study||39
1473946|NCT01900314|3607876|P2|NOT COMPLETED|Overall Study||4
1473947|NCT01900314|3607877|P1|NOT COMPLETED|Overall Study||4
1473948|NCT01900314|3607876|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
1473949|NCT01900314|3607877|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
1473950|NCT01900314|3607876|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
1473951|NCT01900314|3607877|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
1473952|NCT01900314|3607876|P2|STARTED|Overall Study||20
1473953|NCT01900314|3607877|P1|STARTED|Overall Study||20
1473954|NCT01900249|3607888|P3|NOT COMPLETED|Overall Study||4
1473955|NCT01900249|3607889|P2|NOT COMPLETED|Overall Study||5
1473956|NCT01900249|3607890|P1|NOT COMPLETED|Overall Study||3
1473957|NCT01900249|3607888|P3|COMPLETED|Overall Study||65
1473958|NCT01900249|3607889|P2|COMPLETED|Overall Study||63
1473959|NCT01900249|3607890|P1|COMPLETED|Overall Study||64
1473960|NCT01900249|3607888|P3|STARTED|Overall Study||69
1473961|NCT01900249|3607889|P2|STARTED|Overall Study||68
1473962|NCT01900249|3607890|P1|STARTED|Overall Study||67
1473963|NCT01900067|3607900|P2|NOT COMPLETED|Overall Study||13
1473964|NCT01900067|3607901|P1|NOT COMPLETED|Overall Study||12
1473965|NCT01900067|3607900|P2|COMPLETED|Overall Study||124
1473966|NCT01900067|3607901|P1|COMPLETED|Overall Study||122
1473967|NCT01900067|3607900|P2|STARTED|Overall Study||137
1473968|NCT01900067|3607901|P1|STARTED|Overall Study||134
1473969|NCT01900054|3607907|P1|NOT COMPLETED|Overall Study||2
1473970|NCT01900054|3607907|P1|COMPLETED|Overall Study||56
1473971|NCT01900054|3607907|P1|STARTED|Overall Study||58
1473972|NCT01899911|3607912|P1|NOT COMPLETED|Overall Study||0
1473973|NCT01899911|3607912|P1|COMPLETED|Overall Study||12
1473974|NCT01899911|3607912|P1|STARTED|Overall Study||12
1473975|NCT01899768|3607916|P1|NOT COMPLETED|Part C||0
1473976|NCT01899768|3607916|P1|COMPLETED|Part C||11
1473977|NCT01899768|3607916|P1|STARTED|Part C||11
1473978|NCT01899768|3607916|P1|NOT COMPLETED|Part B||2
1473979|NCT01899768|3607916|P1|COMPLETED|Part B||11
1473980|NCT01899768|3607916|P1|STARTED|Part B||13
1473981|NCT01899768|3607916|P1|NOT COMPLETED|Part A||3
1473982|NCT01899768|3607916|P1|COMPLETED|Part A||13
1473983|NCT01899768|3607916|P1|STARTED|Part A||16
1473984|NCT01899742|3607990|P2|NOT COMPLETED|Overall Study||16
1473985|NCT01899742|3607991|P1|NOT COMPLETED|Overall Study||17
1473986|NCT01899742|3607990|P2|COMPLETED|Overall Study||231
1473987|NCT01899742|3607991|P1|COMPLETED|Overall Study||230
1473988|NCT01899742|3607990|P2|STARTED|Overall Study||247
1473989|NCT01899742|3607991|P1|STARTED|Overall Study||247
1473990|NCT01899677|3608001|P2|NOT COMPLETED|Overall Study||7
1473991|NCT01899677|3608002|P1|NOT COMPLETED|Overall Study||10
1473992|NCT01899677|3608001|P2|COMPLETED|Overall Study||28
1473993|NCT01899677|3608002|P1|COMPLETED|Overall Study||25
1473994|NCT01899677|3608001|P2|STARTED|Overall Study||35
1473995|NCT01899677|3608002|P1|STARTED|Overall Study||35
1473996|NCT01899144|3608030|P1|NOT COMPLETED|Treatment Period 5||1
1473997|NCT01899144|3608030|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
1473998|NCT01899144|3608030|P1|STARTED|Treatment Period 5||58
1473999|NCT01899144|3608030|P1|NOT COMPLETED|Treatment Period 4||0
1474000|NCT01899144|3608030|P1|COMPLETED|Treatment Period 4||58
1474001|NCT01899144|3608030|P1|STARTED|Treatment Period 4||58
1474002|NCT01899144|3608030|P1|NOT COMPLETED|Treatment Period 3||2
1474003|NCT01899144|3608030|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
1474004|NCT01899144|3608030|P1|STARTED|Treatment Period 3||60
1474005|NCT01899144|3608030|P1|NOT COMPLETED|Treatment Period 2||1
1474006|NCT01899144|3608030|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
1474007|NCT01899144|3608030|P1|STARTED|Treatment Period 2||61
1474008|NCT01899144|3608030|P1|NOT COMPLETED|Treatment Period 1||0
1474009|NCT01899144|3608030|P1|COMPLETED|Treatment Period 1||61
1474010|NCT01899144|3608030|P1|STARTED|Treatment Period 1||61
1474011|NCT01898884|3608057|P9|NOT COMPLETED|Multiple Dose Period||1
1474012|NCT01898884|3608058|P8|NOT COMPLETED|Multiple Dose Period||0
1474013|NCT01898884|3608059|P7|NOT COMPLETED|Multiple Dose Period||1
1474014|NCT01898884|3608060|P6|NOT COMPLETED|Multiple Dose Period||0
1474015|NCT01898884|3608061|P5|NOT COMPLETED|Multiple Dose Period||0
1474016|NCT01898884|3608062|P4|NOT COMPLETED|Multiple Dose Period||0
1474017|NCT01898884|3608063|P3|NOT COMPLETED|Multiple Dose Period||0
1474018|NCT01898884|3608064|P2|NOT COMPLETED|Multiple Dose Period||0
1474019|NCT01898884|3608065|P1|NOT COMPLETED|Multiple Dose Period||0
1474020|NCT01898884|3608057|P9|COMPLETED|Multiple Dose Period||5
1474021|NCT01898884|3608058|P8|COMPLETED|Multiple Dose Period||6
1474022|NCT01898884|3608059|P7|COMPLETED|Multiple Dose Period||5
1474023|NCT01898884|3608060|P6|COMPLETED|Multiple Dose Period||6
1474024|NCT01898884|3608061|P5|COMPLETED|Multiple Dose Period||0
1474025|NCT01898884|3608062|P4|COMPLETED|Multiple Dose Period||0
1474026|NCT01898884|3608063|P3|COMPLETED|Multiple Dose Period||0
1474027|NCT01898884|3608064|P2|COMPLETED|Multiple Dose Period||0
1474028|NCT01898884|3608065|P1|COMPLETED|Multiple Dose Period||0
1474029|NCT01898884|3608057|P9|Treated|Multiple Dose Period||5
1474030|NCT01898884|3608058|P8|Treated|Multiple Dose Period||6
1474031|NCT01898884|3608059|P7|Treated|Multiple Dose Period||6
1474032|NCT01898884|3608060|P6|Treated|Multiple Dose Period||6
1474033|NCT01898884|3608061|P5|Treated|Multiple Dose Period||0
1474034|NCT01898884|3608062|P4|Treated|Multiple Dose Period||0
1474035|NCT01898884|3608063|P3|Treated|Multiple Dose Period||0
1474036|NCT01898884|3608064|P2|Treated|Multiple Dose Period||0
1474037|NCT01898884|3608065|P1|Treated|Multiple Dose Period||0
1474038|NCT01898884|3608057|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
1474039|NCT01898884|3608058|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
1474040|NCT01898884|3608059|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
1474041|NCT01898884|3608060|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
1474042|NCT01898884|3608061|P5|STARTED|Multiple Dose Period||0
1474043|NCT01898884|3608062|P4|STARTED|Multiple Dose Period||0
1474044|NCT01898884|3608063|P3|STARTED|Multiple Dose Period||0
1474045|NCT01898884|3608064|P2|STARTED|Multiple Dose Period||0
1474046|NCT01898884|3608065|P1|STARTED|Multiple Dose Period||0
1474047|NCT01898884|3608057|P9|NOT COMPLETED|Single Dose Period||0
1474048|NCT01898884|3608058|P8|NOT COMPLETED|Single Dose Period||0
1474049|NCT01898884|3608059|P7|NOT COMPLETED|Single Dose Period||0
1474050|NCT01898884|3608060|P6|NOT COMPLETED|Single Dose Period||0
1474051|NCT01898884|3608061|P5|NOT COMPLETED|Single Dose Period||0
1474052|NCT01898884|3608062|P4|NOT COMPLETED|Single Dose Period||0
1474053|NCT01898884|3608063|P3|NOT COMPLETED|Single Dose Period||0
1474054|NCT01898884|3608064|P2|NOT COMPLETED|Single Dose Period||0
1474055|NCT01898884|3608065|P1|NOT COMPLETED|Single Dose Period||0
1474056|NCT01898884|3608057|P9|COMPLETED|Single Dose Period||0
1474057|NCT01898884|3608058|P8|COMPLETED|Single Dose Period||0
1474058|NCT01898884|3608059|P7|COMPLETED|Single Dose Period||0
1474059|NCT01898884|3608060|P6|COMPLETED|Single Dose Period||0
1474060|NCT01898884|3608061|P5|COMPLETED|Single Dose Period||6
1474061|NCT01898884|3608062|P4|COMPLETED|Single Dose Period||6
1474062|NCT01898884|3608063|P3|COMPLETED|Single Dose Period||6
1474063|NCT01898884|3608064|P2|COMPLETED|Single Dose Period||6
1474064|NCT01898884|3608065|P1|COMPLETED|Single Dose Period||8
1474065|NCT01898884|3608057|P9|STARTED|Single Dose Period||0
1474066|NCT01898884|3608058|P8|STARTED|Single Dose Period||0
1474067|NCT01898884|3608059|P7|STARTED|Single Dose Period||0
1474068|NCT01898884|3608060|P6|STARTED|Single Dose Period||0
1474069|NCT01898884|3608061|P5|STARTED|Single Dose Period||6
1474070|NCT01898884|3608062|P4|STARTED|Single Dose Period||6
1474071|NCT01898884|3608063|P3|STARTED|Single Dose Period||6
1474072|NCT01898884|3608064|P2|STARTED|Single Dose Period||6
1474073|NCT01898884|3608065|P1|STARTED|Single Dose Period||8
1474074|NCT01898611|3608217|P2|NOT COMPLETED|Overall Study||1
1474075|NCT01898611|3608218|P1|NOT COMPLETED|Overall Study||0
1474076|NCT01898611|3608217|P2|COMPLETED|Overall Study||10
1474077|NCT01898611|3608218|P1|COMPLETED|Overall Study||5
1474078|NCT01898611|3608217|P2|STARTED|Overall Study||11
1474079|NCT01898611|3608218|P1|STARTED|Overall Study||5
1474080|NCT01898598|3608240|P2|NOT COMPLETED|Overall Study||2
1474081|NCT01898598|3608241|P1|NOT COMPLETED|Overall Study||4
1474082|NCT01898598|3608240|P2|COMPLETED|Overall Study||4
1474083|NCT01898598|3608241|P1|COMPLETED|Overall Study||8
1474084|NCT01898598|3608240|P2|Treated|Overall Study||5
1474085|NCT01898598|3608241|P1|Treated|Overall Study||11
1474086|NCT01898598|3608240|P2|STARTED|Overall Study||6
1474087|NCT01898598|3608241|P1|STARTED|Overall Study||12
1474088|NCT01898442|3608260|P3|NOT COMPLETED|Overall Study||3
1474089|NCT01898442|3608261|P2|NOT COMPLETED|Overall Study||2
1474090|NCT01898442|3608262|P1|NOT COMPLETED|Overall Study||1
1474091|NCT01898442|3608260|P3|COMPLETED|Overall Study||15
1474092|NCT01898442|3608261|P2|COMPLETED|Overall Study||15
1474093|NCT01898442|3608262|P1|COMPLETED|Overall Study||16
1474094|NCT01898442|3608260|P3|STARTED|Overall Study||18
1474095|NCT01898442|3608261|P2|STARTED|Overall Study||17
1474096|NCT01898442|3608262|P1|STARTED|Overall Study||17
1474097|NCT01898429|3608285|P3|NOT COMPLETED|Phase 3||0
1474098|NCT01898429|3608286|P2|NOT COMPLETED|Phase 3||0
1474099|NCT01898429|3608287|P1|NOT COMPLETED|Phase 3||0
1474100|NCT01898429|3608285|P3|COMPLETED|Phase 3||5
1474101|NCT01898429|3608286|P2|COMPLETED|Phase 3||0
1474102|NCT01898429|3608287|P1|COMPLETED|Phase 3||0
1474103|NCT01898429|3608285|P3|STARTED|Phase 3||5
1474104|NCT01898429|3608286|P2|STARTED|Phase 3||0
1474105|NCT01898429|3608287|P1|STARTED|Phase 3||0
1474106|NCT01898429|3608285|P3|NOT COMPLETED|Phase 2||0
1474107|NCT01898429|3608286|P2|NOT COMPLETED|Phase 2||0
1474108|NCT01898429|3608287|P1|NOT COMPLETED|Phase 2||0
1474109|NCT01898429|3608285|P3|COMPLETED|Phase 2||0
1474110|NCT01898429|3608286|P2|COMPLETED|Phase 2||5
1474111|NCT01898429|3608287|P1|COMPLETED|Phase 2||0
1474112|NCT01898429|3608285|P3|STARTED|Phase 2||0
1474113|NCT01898429|3608286|P2|STARTED|Phase 2||5
1474114|NCT01898429|3608287|P1|STARTED|Phase 2||0
1474115|NCT01898429|3608285|P3|NOT COMPLETED|Phase 1||0
1474116|NCT01898429|3608286|P2|NOT COMPLETED|Phase 1||0
1474117|NCT01898429|3608287|P1|NOT COMPLETED|Phase 1||0
1474118|NCT01898429|3608285|P3|COMPLETED|Phase 1||0
1474119|NCT01898429|3608286|P2|COMPLETED|Phase 1||0
1474120|NCT01898429|3608287|P1|COMPLETED|Phase 1||5
1474121|NCT01898429|3608285|P3|STARTED|Phase 1||0
1474122|NCT01898429|3608286|P2|STARTED|Phase 1||0
1474123|NCT01898429|3608287|P1|STARTED|Phase 1||5
1474124|NCT01898403|3608291|P1|NOT COMPLETED|Overall Study||0
1474125|NCT01898403|3608291|P1|COMPLETED|Overall Study||50
1474126|NCT01898403|3608291|P1|STARTED|Overall Study||50
1474127|NCT01898286|3608297|P1|NOT COMPLETED|Overall Study||3
1474128|NCT01898286|3608297|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
1474129|NCT01898286|3608297|P1|STARTED|Overall Study||38
1474130|NCT01898208|3608307|P3|NOT COMPLETED|Overall Study||37
1474131|NCT01898208|3608308|P2|NOT COMPLETED|Overall Study||49
1474132|NCT01898208|3608309|P1|NOT COMPLETED|Overall Study||40
1474133|NCT01898208|3608307|P3|COMPLETED|Overall Study||212
1474134|NCT01898208|3608308|P2|COMPLETED|Overall Study||198
1474135|NCT01898208|3608309|P1|COMPLETED|Overall Study||207
1474136|NCT01898208|3608307|P3|STARTED|Overall Study||249
1474137|NCT01898208|3608308|P2|STARTED|Overall Study||247
1474138|NCT01898208|3608309|P1|STARTED|Overall Study||247
1474139|NCT01898195|3608356|P3|NOT COMPLETED|Smoking Abstinence||36
1474140|NCT01898195|3608357|P2|NOT COMPLETED|Smoking Abstinence||38
1474141|NCT01898195|3608358|P1|NOT COMPLETED|Smoking Abstinence||35
1474142|NCT01898195|3608356|P3|COMPLETED|Smoking Abstinence||15
1474143|NCT01898195|3608357|P2|COMPLETED|Smoking Abstinence||16
1474144|NCT01898195|3608358|P1|COMPLETED|Smoking Abstinence||18
1474145|NCT01898195|3608356|P3|STARTED|Smoking Abstinence||51
1474146|NCT01898195|3608357|P2|STARTED|Smoking Abstinence||54
1474147|NCT01898195|3608358|P1|STARTED|Smoking Abstinence||53
1474148|NCT01898195|3608356|P3|NOT COMPLETED|Varenicline Adherence||36
1474149|NCT01898195|3608357|P2|NOT COMPLETED|Varenicline Adherence||38
1474150|NCT01898195|3608358|P1|NOT COMPLETED|Varenicline Adherence||35
1474151|NCT01898195|3608356|P3|COMPLETED|Varenicline Adherence||15
1474152|NCT01898195|3608357|P2|COMPLETED|Varenicline Adherence||16
1474153|NCT01898195|3608358|P1|COMPLETED|Varenicline Adherence||18
1474154|NCT01898195|3608356|P3|STARTED|Varenicline Adherence||51
1474155|NCT01898195|3608357|P2|STARTED|Varenicline Adherence||54
1474156|NCT01898195|3608358|P1|STARTED|Varenicline Adherence||53
1474157|NCT01898091|3608371|P2|NOT COMPLETED|Overall Study||6
1474158|NCT01898091|3608372|P1|NOT COMPLETED|Overall Study||2
1474159|NCT01898091|3608371|P2|COMPLETED|Overall Study||19
1474160|NCT01898091|3608372|P1|COMPLETED|Overall Study||23
1474161|NCT01898091|3608371|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
1474162|NCT01898091|3608372|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
1474163|NCT01898013|3608380|P2|NOT COMPLETED|Visit 6||5
1474164|NCT01898013|3608381|P1|NOT COMPLETED|Visit 6||3
1474165|NCT01898013|3608380|P2|COMPLETED|Visit 6||42
1474166|NCT01898013|3608381|P1|COMPLETED|Visit 6||41
1474167|NCT01898013|3608380|P2|STARTED|Visit 6||47
1474168|NCT01898013|3608381|P1|STARTED|Visit 6||44
1474169|NCT01898013|3608380|P2|NOT COMPLETED|Visit 5||1
1474170|NCT01898013|3608381|P1|NOT COMPLETED|Visit 5||1
1474171|NCT01898013|3608380|P2|COMPLETED|Visit 5||47
1474172|NCT01898013|3608381|P1|COMPLETED|Visit 5||44
1474173|NCT01898013|3608380|P2|STARTED|Visit 5||48
1474174|NCT01898013|3608381|P1|STARTED|Visit 5||45
1474175|NCT01898013|3608380|P2|NOT COMPLETED|Visit 4||1
1474176|NCT01898013|3608381|P1|NOT COMPLETED|Visit 4||0
1474177|NCT01898013|3608380|P2|COMPLETED|Visit 4||48
1474178|NCT01898013|3608381|P1|COMPLETED|Visit 4||45
1474179|NCT01898013|3608380|P2|STARTED|Visit 4||49
1474180|NCT01898013|3608381|P1|STARTED|Visit 4||45
1474181|NCT01898013|3608380|P2|NOT COMPLETED|Visit 3 (Randomization Visit)||0
1474182|NCT01898013|3608381|P1|NOT COMPLETED|Visit 3 (Randomization Visit)||0
1474183|NCT01898013|3608380|P2|COMPLETED|Visit 3 (Randomization Visit)||49
1474184|NCT01898013|3608381|P1|COMPLETED|Visit 3 (Randomization Visit)||45
1474185|NCT01898013|3608380|P2|STARTED|Visit 3 (Randomization Visit)||49
1474186|NCT01898013|3608381|P1|STARTED|Visit 3 (Randomization Visit)||45
1474187|NCT01897792|3608399|P2|NOT COMPLETED|Overall Study||0
1474188|NCT01897792|3608400|P1|NOT COMPLETED|Overall Study||0
1474189|NCT01897792|3608399|P2|COMPLETED|Overall Study||5
1474190|NCT01897792|3608400|P1|COMPLETED|Overall Study||6
1474191|NCT01897792|3608399|P2|STARTED|Overall Study||5
1474192|NCT01897792|3608400|P1|STARTED|Overall Study||6
1474193|NCT01897727|3608426|P2|NOT COMPLETED|Overall Study||1
1474194|NCT01897727|3608427|P1|NOT COMPLETED|Overall Study||0
1474195|NCT01897727|3608426|P2|COMPLETED|Overall Study||8
1474196|NCT01897727|3608427|P1|COMPLETED|Overall Study||8
1474197|NCT01897727|3608426|P2|STARTED|Overall Study||9
1474198|NCT01897727|3608427|P1|STARTED|Overall Study||8
1474199|NCT01897493|3608433|P1|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
1474200|NCT01897493|3608433|P1|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
1474201|NCT01897493|3608433|P1|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
1474202|NCT01897493|3608433|P1|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
1474203|NCT01897493|3608433|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
1474204|NCT01897493|3608433|P1|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
1474205|NCT01897493|3608433|P1|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
1474206|NCT01897493|3608433|P1|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
1474207|NCT01897402|3608448|P2|NOT COMPLETED|Overall Study||16
1474208|NCT01897402|3608449|P1|NOT COMPLETED|Overall Study||19
1474209|NCT01897402|3608448|P2|COMPLETED|Overall Study||244
1474210|NCT01897402|3608449|P1|COMPLETED|Overall Study||246
1474211|NCT01897402|3608448|P2|STARTED|Overall Study||260
1474212|NCT01897402|3608449|P1|STARTED|Overall Study||265
1474213|NCT01897285|3608461|P1|NOT COMPLETED|Overall Study||0
1474214|NCT01897285|3608461|P1|COMPLETED|Overall Study||20
1474215|NCT01897285|3608461|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
1474216|NCT01897233|3608469|P1|NOT COMPLETED|Part B (24 Weeks)||4
1474217|NCT01897233|3608469|P1|COMPLETED|Part B (24 Weeks)||54
1474218|NCT01897233|3608469|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
1474219|NCT01897233|3608469|P1|NOT COMPLETED|Part A (14 Days)||0
1474220|NCT01897233|3608469|P1|COMPLETED|Part A (14 Days)||10
1474221|NCT01897233|3608469|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
1474222|NCT01897233|3608469|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
1474223|NCT01897233|3608469|P1|STARTED|Part A (14 Days)||10
1474224|NCT01897077|3608493|P2|NOT COMPLETED|Overall Study||0
1474225|NCT01897077|3608494|P1|NOT COMPLETED|Overall Study||0
1474226|NCT01897077|3608493|P2|COMPLETED|Overall Study||5
1474227|NCT01897077|3608494|P1|COMPLETED|Overall Study||0
1474228|NCT01897077|3608493|P2|STARTED|Overall Study||5
1474229|NCT01897077|3608494|P1|STARTED|Overall Study||0
1474230|NCT01897025|3608512|P2|NOT COMPLETED|Overall Study||0
1474231|NCT01897025|3608513|P1|NOT COMPLETED|Overall Study||0
1474232|NCT01897025|3608512|P2|COMPLETED|Overall Study||9
1474233|NCT01897025|3608513|P1|COMPLETED|Overall Study||10
1474234|NCT01897025|3608512|P2|STARTED|Overall Study||9
1474235|NCT01897025|3608513|P1|STARTED|Overall Study||10
1474236|NCT01896986|3608521|P2|NOT COMPLETED|Overall Study||23
1474237|NCT01896986|3608522|P1|NOT COMPLETED|Overall Study||14
1474238|NCT01896986|3608521|P2|COMPLETED|Overall Study||0
1474239|NCT01896986|3608522|P1|COMPLETED|Overall Study||0
1474240|NCT01896986|3608521|P2|STARTED|Overall Study||23
1474241|NCT01896986|3608522|P1|STARTED|Overall Study||14
1474242|NCT01896934|3608528|P1|NOT COMPLETED|Overall Study||2
1474243|NCT01896934|3608528|P1|COMPLETED|Overall Study||19
1474244|NCT01896934|3608528|P1|STARTED|Overall Study||21
1474245|NCT01896895|3608537|P4|NOT COMPLETED|OLEX Period||0
1474246|NCT01896895|3608538|P3|NOT COMPLETED|OLEX Period||0
1474247|NCT01896895|3608539|P2|NOT COMPLETED|OLEX Period||0
1474248|NCT01896895|3608540|P1|NOT COMPLETED|OLEX Period||0
1474249|NCT01896895|3608537|P4|COMPLETED|OLEX Period||39
1474250|NCT01896895|3608538|P3|COMPLETED|OLEX Period||0
1474251|NCT01896895|3608539|P2|COMPLETED|OLEX Period||0
1474252|NCT01896895|3608540|P1|COMPLETED|OLEX Period||0
1474253|NCT01896895|3608537|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
1474254|NCT01896895|3608538|P3|STARTED|OLEX Period||0
1474255|NCT01896895|3608539|P2|STARTED|OLEX Period||0
1474256|NCT01896895|3608540|P1|STARTED|OLEX Period||0
1474257|NCT01896895|3608537|P4|NOT COMPLETED|Double-blind MP||0
1474258|NCT01896895|3608538|P3|NOT COMPLETED|Double-blind MP||3
1474259|NCT01896895|3608539|P2|NOT COMPLETED|Double-blind MP||2
1474260|NCT01896895|3608540|P1|NOT COMPLETED|Double-blind MP||1
1474261|NCT01896895|3608537|P4|COMPLETED|Double-blind MP||0
1474262|NCT01896895|3608538|P3|COMPLETED|Double-blind MP||16
1474263|NCT01896895|3608539|P2|COMPLETED|Double-blind MP||20
1474264|NCT01896895|3608540|P1|COMPLETED|Double-blind MP||19
1474265|NCT01896895|3608537|P4|STARTED|Double-blind MP||0
1474266|NCT01896895|3608538|P3|STARTED|Double-blind MP||19
1474267|NCT01896895|3608539|P2|STARTED|Double-blind MP||22
1474268|NCT01896895|3608540|P1|STARTED|Double-blind MP||20
1474269|NCT01896726|3608555|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
1474270|NCT01896726|3608555|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
1474271|NCT01896726|3608555|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
1474272|NCT01896726|3608555|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
1474273|NCT01896726|3608555|P1|STARTED|Treatment Period 2 (Days 23-31)||20
1474274|NCT01896726|3608555|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
1474275|NCT01896726|3608555|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
1474276|NCT01896726|3608555|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
1474277|NCT01896726|3608555|P1|STARTED|Treatment Period 1 (Days 1-22)||20
1474278|NCT01896700|3608570|P2|NOT COMPLETED|Overall Study||6
1474279|NCT01896700|3608571|P1|NOT COMPLETED|Overall Study||4
1474280|NCT01896700|3608570|P2|COMPLETED|Overall Study||6
1474281|NCT01896700|3608571|P1|COMPLETED|Overall Study||8
1474282|NCT01896700|3608570|P2|STARTED|Overall Study||12
1474283|NCT01896700|3608571|P1|STARTED|Overall Study||12
1474284|NCT01896687|3608593|P2|NOT COMPLETED|Overall Study||0
1474285|NCT01896687|3608594|P1|NOT COMPLETED|Overall Study||0
1474286|NCT01896687|3608593|P2|COMPLETED|Overall Study||15
1474287|NCT01896687|3608594|P1|COMPLETED|Overall Study||15
1474288|NCT01896687|3608593|P2|STARTED|Overall Study||15
1474289|NCT01896687|3608594|P1|STARTED|Overall Study||15
1474290|NCT01896557|3608602|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
1474291|NCT01896557|3608603|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
1474292|NCT01896557|3608602|P2|COMPLETED|Clopidogrel + GI Protector||44
1474293|NCT01896557|3608603|P1|COMPLETED|Clopidogrel + GI Protector||41
1474294|NCT01896557|3608602|P2|STARTED|Clopidogrel + GI Protector||48
1474295|NCT01896557|3608603|P1|STARTED|Clopidogrel + GI Protector||43
1474296|NCT01896557|3608602|P2|NOT COMPLETED|Clopidogrel Alone||0
1474297|NCT01896557|3608603|P1|NOT COMPLETED|Clopidogrel Alone||1
1474298|NCT01896557|3608602|P2|COMPLETED|Clopidogrel Alone||48
1474299|NCT01896557|3608603|P1|COMPLETED|Clopidogrel Alone||43
1474300|NCT01896557|3608602|P2|STARTED|Clopidogrel Alone||48
1474301|NCT01896557|3608603|P1|STARTED|Clopidogrel Alone||44
1474302|NCT01896544|3608618|P3|NOT COMPLETED|Overall Study||0
1474303|NCT01896544|3608619|P2|NOT COMPLETED|Overall Study||0
1474304|NCT01896544|3608620|P1|NOT COMPLETED|Overall Study||0
1474305|NCT01896544|3608618|P3|COMPLETED|Overall Study||10
1474306|NCT01896544|3608619|P2|COMPLETED|Overall Study||10
1474307|NCT01896544|3608620|P1|COMPLETED|Overall Study||10
1474308|NCT01896544|3608618|P3|STARTED|Overall Study||10
1474309|NCT01896544|3608619|P2|STARTED|Overall Study||10
1474310|NCT01896544|3608620|P1|STARTED|Overall Study||10
1474311|NCT01896297|3608640|P1|NOT COMPLETED|Overall Study||1
1474312|NCT01896297|3608640|P1|COMPLETED|Overall Study||59
1474313|NCT01896297|3608640|P1|STARTED|Overall Study||60
1474314|NCT01896232|3608647|P2|NOT COMPLETED|Overall Study||53
1474315|NCT01896232|3608648|P1|NOT COMPLETED|Overall Study||49
1474316|NCT01896232|3608647|P2|COMPLETED|Overall Study||287
1474317|NCT01896232|3608648|P1|COMPLETED|Overall Study||294
1474318|NCT01896232|3608647|P2|Received Treatment|Overall Study||338
1474319|NCT01896232|3608648|P1|Received Treatment|Overall Study||341
1474320|NCT01896232|3608647|P2|STARTED|Overall Study||340
1474321|NCT01896232|3608648|P1|STARTED|Overall Study||343
1474322|NCT01896206|3608668|P1|NOT COMPLETED|Overall Study||0
1474323|NCT01896206|3608668|P1|COMPLETED|Overall Study||21
1474324|NCT01896206|3608668|P1|STARTED|Overall Study||21
1474325|NCT01896193|3608676|P2|NOT COMPLETED|Overall Study||12
1474326|NCT01896193|3608677|P1|NOT COMPLETED|Overall Study||21
1474327|NCT01896193|3608676|P2|COMPLETED|Overall Study||53
1474328|NCT01896193|3608677|P1|COMPLETED|Overall Study||41
1474329|NCT01896193|3608676|P2|STARTED|Overall Study||65
1474330|NCT01896193|3608677|P1|STARTED|Overall Study||62
1474331|NCT01896115|3608703|P2|NOT COMPLETED|Overall Study||0
1474332|NCT01896115|3608704|P1|NOT COMPLETED|Overall Study||1
1474333|NCT01896115|3608703|P2|COMPLETED|Overall Study||24
1474334|NCT01896115|3608704|P1|COMPLETED|Overall Study||15
1474335|NCT01896115|3608703|P2|Phase 2 Steering|Overall Study||24
1474336|NCT01896115|3608704|P1|Phase 2 Steering|Overall Study||0
1474337|NCT01896115|3608703|P2|Phase 2 Single Contact|Overall Study||24
1474338|NCT01896115|3608704|P1|Phase 2 Single Contact|Overall Study||0
1474339|NCT01896115|3608703|P2|Phase 1 Ventral Steering|Overall Study||0
1474340|NCT01896115|3608704|P1|Phase 1 Ventral Steering|Overall Study||15
1474341|NCT01896115|3608703|P2|Phase 1 Dorsal Steering|Overall Study||0
1474342|NCT01896115|3608704|P1|Phase 1 Dorsal Steering|Overall Study||15
1474343|NCT01896115|3608703|P2|Phase 1 Conventional PW|Overall Study||0
1474344|NCT01896115|3608704|P1|Phase 1 Conventional PW|Overall Study||15
1474345|NCT01896115|3608703|P2|Phase 1 Short PW|Overall Study||0
1474346|NCT01896115|3608704|P1|Phase 1 Short PW|Overall Study||15
1474347|NCT01896115|3608703|P2|STARTED|Overall Study||24
1474348|NCT01896115|3608704|P1|STARTED|Overall Study||16
1474349|NCT01896050|3608729|P2|NOT COMPLETED|Overall Study||2
1474350|NCT01896050|3608730|P1|NOT COMPLETED|Overall Study||38
1474351|NCT01896050|3608729|P2|COMPLETED|Overall Study||20
1474352|NCT01896050|3608730|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
1474353|NCT01896050|3608729|P2|STARTED|Overall Study||22
1474354|NCT01896050|3608730|P1|STARTED|Overall Study||93
1474355|NCT01895972|3608740|P1|NOT COMPLETED|Overall Study||9
1474356|NCT01895972|3608740|P1|COMPLETED|Overall Study||121
1474357|NCT01895972|3608740|P1|STARTED|Overall Study||130
1474358|NCT01895946|3608747|P2|NOT COMPLETED|Overall Study||0
1474359|NCT01895946|3608748|P1|NOT COMPLETED|Overall Study||0
1474360|NCT01895946|3608747|P2|COMPLETED|Overall Study||12
1474361|NCT01895946|3608748|P1|COMPLETED|Overall Study||18
1474362|NCT01895946|3608747|P2|STARTED|Overall Study||12
1474363|NCT01895946|3608748|P1|STARTED|Overall Study||18
1474364|NCT01895634|3608766|P1|NOT COMPLETED|Overall Study||3
1474365|NCT01895634|3608766|P1|COMPLETED|Overall Study||46
1474366|NCT01895634|3608766|P1|STARTED|Overall Study||49
1474367|NCT01895608|3608778|P4|NOT COMPLETED|Overall Study||0
1474368|NCT01895608|3608779|P3|NOT COMPLETED|Overall Study||3
1474369|NCT01895608|3608780|P2|NOT COMPLETED|Overall Study||1
1474370|NCT01895608|3608781|P1|NOT COMPLETED|Overall Study||0
1474371|NCT01895608|3608778|P4|COMPLETED|Overall Study||6
1474372|NCT01895608|3608779|P3|COMPLETED|Overall Study||8
1474373|NCT01895608|3608780|P2|COMPLETED|Overall Study||6
1474374|NCT01895608|3608781|P1|COMPLETED|Overall Study||10
1474375|NCT01895608|3608778|P4|STARTED|Overall Study||6
1474376|NCT01895608|3608779|P3|STARTED|Overall Study||11
1474377|NCT01895608|3608780|P2|STARTED|Overall Study||7
1474378|NCT01895608|3608781|P1|STARTED|Overall Study||10
1474379|NCT01895543|3608811|P1|NOT COMPLETED|Overall Study||129
1474380|NCT01895543|3608811|P1|COMPLETED|Overall Study||282
1474465|NCT01895036|3608930|P1|STARTED|Overall Study||6
1474381|NCT01895543|3608811|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
1474382|NCT01895543|3608811|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
1474383|NCT01895543|3608811|P1|STARTED|Overall Study||411
1474384|NCT01895452|3608827|P2|NOT COMPLETED|Overall Study||28
1474385|NCT01895452|3608828|P1|NOT COMPLETED|Overall Study||4
1474386|NCT01895452|3608827|P2|COMPLETED|Overall Study||198
1474387|NCT01895452|3608828|P1|COMPLETED|Overall Study||61
1474388|NCT01895452|3608827|P2|STARTED|Overall Study||226
1474389|NCT01895452|3608828|P1|STARTED|Overall Study||65
1474390|NCT01895335|3608838|P1|NOT COMPLETED|Overall Study||215
1474391|NCT01895335|3608838|P1|COMPLETED|Overall Study||786
1474392|NCT01895335|3608838|P1|Treated|Overall Study||1000
1474393|NCT01895335|3608838|P1|STARTED|Overall Study||1001
1474394|NCT01895322|3608855|P1|NOT COMPLETED|Overall Study||13
1474395|NCT01895322|3608855|P1|COMPLETED|Overall Study||7
1474396|NCT01895322|3608855|P1|STARTED|Overall Study||20
1474397|NCT01895309|3608864|P2|NOT COMPLETED|Overall Study||51
1474398|NCT01895309|3608865|P1|NOT COMPLETED|Overall Study||40
1474399|NCT01895309|3608864|P2|COMPLETED|Overall Study||246
1474400|NCT01895309|3608865|P1|COMPLETED|Overall Study||259
1474401|NCT01895309|3608864|P2|STARTED|Overall Study||297
1474402|NCT01895309|3608865|P1|STARTED|Overall Study||299
1474403|NCT01895270|3608879|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
1474404|NCT01895270|3608880|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
1474405|NCT01895270|3608879|P2|COMPLETED|Isradipine Taper (W7-8)||0
1474406|NCT01895270|3608880|P1|COMPLETED|Isradipine Taper (W7-8)||2
1474407|NCT01895270|3608879|P2|STARTED|Isradipine Taper (W7-8)||2
1474408|NCT01895270|3608880|P1|STARTED|Isradipine Taper (W7-8)||2
1474409|NCT01895270|3608879|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
1474410|NCT01895270|3608880|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
1474411|NCT01895270|3608879|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
1474412|NCT01895270|3608880|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
1474413|NCT01895270|3608879|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
1474414|NCT01895270|3608880|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
1474415|NCT01895270|3608879|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
1474416|NCT01895270|3608880|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
1474417|NCT01895270|3608879|P2|COMPLETED|Study Medications Induction (W1-4)||8
1474418|NCT01895270|3608880|P1|COMPLETED|Study Medications Induction (W1-4)||5
1474419|NCT01895270|3608879|P2|STARTED|Study Medications Induction (W1-4)||14
1474420|NCT01895270|3608880|P1|STARTED|Study Medications Induction (W1-4)||11
1474421|NCT01895127|3608888|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
1474422|NCT01895127|3608889|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
1474423|NCT01895127|3608888|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
1474424|NCT01895127|3608889|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
1474425|NCT01895127|3608888|P2|STARTED|Long Term Follow-up (Month 3-12)||7
1474426|NCT01895127|3608889|P1|STARTED|Long Term Follow-up (Month 3-12)||3
1474427|NCT01895127|3608888|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
1474428|NCT01895127|3608889|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
1474429|NCT01895127|3608888|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
1474430|NCT01895127|3608889|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
1474431|NCT01895127|3608888|P2|STARTED|Month 3 Follow-up & Biopsy||7
1474432|NCT01895127|3608889|P1|STARTED|Month 3 Follow-up & Biopsy||3
1474433|NCT01895127|3608888|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
1474434|NCT01895127|3608889|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
1474435|NCT01895127|3608888|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
1474436|NCT01895127|3608889|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
1474437|NCT01895127|3608888|P2|STARTED|Treatment Period (Week 0-Month 3)||7
1474438|NCT01895127|3608889|P1|STARTED|Treatment Period (Week 0-Month 3)||3
1474439|NCT01895127|3608888|P2|NOT COMPLETED|Screening||0
1474440|NCT01895127|3608889|P1|NOT COMPLETED|Screening||0
1474441|NCT01895127|3608888|P2|COMPLETED|Screening||7
1474442|NCT01895127|3608889|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
1474443|NCT01895127|3608888|P2|STARTED|Screening||7
1474444|NCT01895127|3608889|P1|STARTED|Screening||4
1474445|NCT01895101|3608899|P3|NOT COMPLETED|Overall Study||5
1474446|NCT01895101|3608900|P2|NOT COMPLETED|Overall Study||5
1474447|NCT01895101|3608901|P1|NOT COMPLETED|Overall Study||1
1474448|NCT01895101|3608899|P3|COMPLETED|Overall Study||245
1474449|NCT01895101|3608900|P2|COMPLETED|Overall Study||245
1474450|NCT01895101|3608901|P1|COMPLETED|Overall Study||249
1474451|NCT01895101|3608899|P3|STARTED|Overall Study||250
1474452|NCT01895101|3608900|P2|STARTED|Overall Study||250
1474453|NCT01895101|3608901|P1|STARTED|Overall Study||250
1474454|NCT01895088|3608915|P1|NOT COMPLETED|Overall Study||18
1474455|NCT01895088|3608915|P1|COMPLETED|Overall Study||253
1474456|NCT01895088|3608915|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
1474457|NCT01895062|3608921|P2|NOT COMPLETED|Overall Study||0
1474458|NCT01895062|3608922|P1|NOT COMPLETED|Overall Study||0
1474459|NCT01895062|3608921|P2|COMPLETED|Overall Study||24
1474460|NCT01895062|3608922|P1|COMPLETED|Overall Study||30
1474461|NCT01895062|3608921|P2|STARTED|Overall Study||24
1474462|NCT01895062|3608922|P1|STARTED|Overall Study||30
1474463|NCT01895036|3608930|P1|NOT COMPLETED|Overall Study||0
1474464|NCT01895036|3608930|P1|COMPLETED|Overall Study||6
1474466|NCT01894984|3608936|P2|NOT COMPLETED|Overall Study||175
1474467|NCT01894984|3608937|P1|NOT COMPLETED|Overall Study||314
1474468|NCT01894984|3608936|P2|COMPLETED|Overall Study||69
1474469|NCT01894984|3608937|P1|COMPLETED|Overall Study||82
1474470|NCT01894984|3608936|P2|STARTED|Overall Study||244
1474471|NCT01894984|3608937|P1|STARTED|Overall Study||396
1474472|NCT01894919|3608966|P13|NOT COMPLETED|Overall Study||0
1474473|NCT01894919|3608967|P12|NOT COMPLETED|Overall Study||0
1474474|NCT01894919|3608968|P11|NOT COMPLETED|Overall Study||2
1474475|NCT01894919|3608969|P10|NOT COMPLETED|Overall Study||1
1474476|NCT01894919|3608970|P9|NOT COMPLETED|Overall Study||0
1474477|NCT01894919|3608971|P8|NOT COMPLETED|Overall Study||0
1474478|NCT01894919|3608972|P7|NOT COMPLETED|Overall Study||0
1474479|NCT01894919|3608973|P6|NOT COMPLETED|Overall Study||0
1474480|NCT01894919|3608974|P5|NOT COMPLETED|Overall Study||3
1474481|NCT01894919|3608975|P4|NOT COMPLETED|Overall Study||0
1474482|NCT01894919|3608976|P3|NOT COMPLETED|Overall Study||0
1474483|NCT01894919|3608977|P2|NOT COMPLETED|Overall Study||0
1474484|NCT01894919|3608978|P1|NOT COMPLETED|Overall Study||2
1474485|NCT01894919|3608966|P13|COMPLETED|Overall Study||50
1474486|NCT01894919|3608967|P12|COMPLETED|Overall Study||55
1474487|NCT01894919|3608968|P11|COMPLETED|Overall Study||98
1474488|NCT01894919|3608969|P10|COMPLETED|Overall Study||89
1474489|NCT01894919|3608970|P9|COMPLETED|Overall Study||91
1474490|NCT01894919|3608971|P8|COMPLETED|Overall Study||36
1474491|NCT01894919|3608972|P7|COMPLETED|Overall Study||32
1474492|NCT01894919|3608973|P6|COMPLETED|Overall Study||39
1474493|NCT01894919|3608974|P5|COMPLETED|Overall Study||78
1474494|NCT01894919|3608975|P4|COMPLETED|Overall Study||43
1474495|NCT01894919|3608976|P3|COMPLETED|Overall Study||89
1474496|NCT01894919|3608977|P2|COMPLETED|Overall Study||47
1474497|NCT01894919|3608978|P1|COMPLETED|Overall Study||96
1474498|NCT01894919|3608966|P13|STARTED|Overall Study||50
1474499|NCT01894919|3608967|P12|STARTED|Overall Study||55
1474500|NCT01894919|3608968|P11|STARTED|Overall Study||100
1474501|NCT01894919|3608969|P10|STARTED|Overall Study||90
1474502|NCT01894919|3608970|P9|STARTED|Overall Study||91
1474503|NCT01894919|3608971|P8|STARTED|Overall Study||36
1474504|NCT01894919|3608972|P7|STARTED|Overall Study||32
1474505|NCT01894919|3608973|P6|STARTED|Overall Study||39
1474506|NCT01894919|3608974|P5|STARTED|Overall Study||81
1474507|NCT01894919|3608975|P4|STARTED|Overall Study||43
1474508|NCT01894919|3608976|P3|STARTED|Overall Study||89
1474509|NCT01894919|3608977|P2|STARTED|Overall Study||47
1474510|NCT01894919|3608978|P1|STARTED|Overall Study||98
1474511|NCT01894906|3609100|P2|NOT COMPLETED|Overall Study||0
1474512|NCT01894906|3609101|P1|NOT COMPLETED|Overall Study||0
1474513|NCT01894906|3609100|P2|COMPLETED|Overall Study||6
1474514|NCT01894906|3609101|P1|COMPLETED|Overall Study||6
1474515|NCT01894906|3609100|P2|Treatment F|Overall Study||6
1474516|NCT01894906|3609101|P1|Treatment F|Overall Study||6
1474517|NCT01894906|3609100|P2|Treatment E|Overall Study||6
1474518|NCT01894906|3609101|P1|Treatment E|Overall Study||6
1474519|NCT01894906|3609100|P2|Treatment D|Overall Study||6
1474520|NCT01894906|3609101|P1|Treatment D|Overall Study||6
1474521|NCT01894906|3609100|P2|Treatment C|Overall Study||6
1474522|NCT01894906|3609101|P1|Treatment C|Overall Study||6
1474523|NCT01894906|3609100|P2|Treatment B|Overall Study||6
1474524|NCT01894906|3609101|P1|Treatment B|Overall Study||6
1474525|NCT01894906|3609100|P2|Treatment A|Overall Study||6
1474526|NCT01894906|3609101|P1|Treatment A|Overall Study||6
1474527|NCT01894906|3609100|P2|STARTED|Overall Study||6
1474528|NCT01894906|3609101|P1|STARTED|Overall Study||6
1474529|NCT01894672|3609131|P1|NOT COMPLETED|Overall Study||0
1474530|NCT01894672|3609131|P1|COMPLETED|Overall Study||7
1474531|NCT01894672|3609131|P1|STARTED|Overall Study||7
1474532|NCT01894620|3609139|P2|NOT COMPLETED|Overall Study||1
1474533|NCT01894620|3609140|P1|NOT COMPLETED|Overall Study||0
1474534|NCT01894620|3609139|P2|COMPLETED|Overall Study||4
1474535|NCT01894620|3609140|P1|COMPLETED|Overall Study||6
1474536|NCT01894620|3609139|P2|STARTED|Overall Study||5
1474537|NCT01894620|3609140|P1|STARTED|Overall Study||6
1474538|NCT01894607|3609148|P1|NOT COMPLETED|Overall Study||1
1474539|NCT01894607|3609148|P1|COMPLETED|Overall Study||10
1474540|NCT01894607|3609148|P1|STARTED|Overall Study||11
1474541|NCT01894581|3609155|P2|NOT COMPLETED|Overall Study||7
1474542|NCT01894581|3609156|P1|NOT COMPLETED|Overall Study||5
1474543|NCT01894581|3609155|P2|COMPLETED|Overall Study||12
1474544|NCT01894581|3609156|P1|COMPLETED|Overall Study||15
1474545|NCT01894581|3609155|P2|STARTED|Overall Study||19
1474546|NCT01894581|3609156|P1|STARTED|Overall Study||20
1474547|NCT01894555|3609162|P1|NOT COMPLETED|Overall Study||0
1474548|NCT01894555|3609162|P1|COMPLETED|Overall Study||33
1474549|NCT01894555|3609162|P1|STARTED|Overall Study||33
1474550|NCT01894503|3609166|P1|NOT COMPLETED|Overall Study||0
1474551|NCT01894503|3609166|P1|COMPLETED|Overall Study||5
1474552|NCT01894503|3609166|P1|STARTED|Overall Study||5
1474553|NCT01894477|3609173|P2|NOT COMPLETED|Overall Study||2
1474554|NCT01894477|3609174|P1|NOT COMPLETED|Overall Study||0
1474555|NCT01894477|3609173|P2|COMPLETED|Overall Study||65
1474556|NCT01894477|3609174|P1|COMPLETED|Overall Study||35
1474557|NCT01894477|3609173|P2|STARTED|Overall Study||67
1474558|NCT01894477|3609174|P1|STARTED|Overall Study||35
1474559|NCT01894256|3609185|P3|NOT COMPLETED|Part B||14
1474560|NCT01894256|3609186|P2|NOT COMPLETED|Part B||14
1474561|NCT01894256|3609187|P1|NOT COMPLETED|Part B||15
1474562|NCT01894256|3609185|P3|COMPLETED|Part B||0
1474563|NCT01894256|3609186|P2|COMPLETED|Part B||0
1474564|NCT01894256|3609187|P1|COMPLETED|Part B||0
1474565|NCT01894256|3609185|P3|STARTED|Part B||14
1474566|NCT01894256|3609186|P2|STARTED|Part B||14
1474567|NCT01894256|3609187|P1|STARTED|Part B||15
1474568|NCT01894256|3609185|P3|NOT COMPLETED|Part A||0
1474569|NCT01894256|3609186|P2|NOT COMPLETED|Part A||1
1474570|NCT01894256|3609187|P1|NOT COMPLETED|Part A||0
1474571|NCT01894256|3609185|P3|COMPLETED|Part A||14
1474572|NCT01894256|3609186|P2|COMPLETED|Part A||14
1474573|NCT01894256|3609187|P1|COMPLETED|Part A||15
1474574|NCT01894256|3609185|P3|STARTED|Part A||14
1474575|NCT01894256|3609186|P2|STARTED|Part A||15
1474576|NCT01894256|3609187|P1|STARTED|Part A||15
1474577|NCT01894230|3609233|P2|NOT COMPLETED|Overall Study||7
1474578|NCT01894230|3609234|P1|NOT COMPLETED|Overall Study||7
1474579|NCT01894230|3609233|P2|COMPLETED|Overall Study||69
1474580|NCT01894230|3609234|P1|COMPLETED|Overall Study||76
1474581|NCT01894230|3609233|P2|STARTED|Overall Study||76
1474582|NCT01894230|3609234|P1|STARTED|Overall Study||83
1474583|NCT01894100|3609260|P2|NOT COMPLETED|Overall Study||1
1474584|NCT01894100|3609261|P1|NOT COMPLETED|Overall Study||3
1474585|NCT01894100|3609260|P2|COMPLETED|Overall Study||14
1474586|NCT01894100|3609261|P1|COMPLETED|Overall Study||12
1474587|NCT01894100|3609260|P2|STARTED|Overall Study||15
1474588|NCT01894100|3609261|P1|STARTED|Overall Study||15
1474589|NCT01894087|3609271|P2|NOT COMPLETED|Overall Study||0
1474590|NCT01894087|3609272|P1|NOT COMPLETED|Overall Study||6
1474591|NCT01894087|3609271|P2|COMPLETED|Overall Study||102
1474592|NCT01894087|3609272|P1|COMPLETED|Overall Study||96
1474593|NCT01894087|3609271|P2|STARTED|Overall Study||102
1474594|NCT01894087|3609272|P1|STARTED|Overall Study||102
1474595|NCT01894022|3609286|P2|NOT COMPLETED|Overall Study||10
1474596|NCT01894022|3609287|P1|NOT COMPLETED|Overall Study||9
1474597|NCT01894022|3609286|P2|COMPLETED|Overall Study||0
1474598|NCT01894022|3609287|P1|COMPLETED|Overall Study||0
1474599|NCT01894022|3609286|P2|STARTED|Overall Study||10
1474600|NCT01894022|3609287|P1|STARTED|Overall Study||9
1474601|NCT01893905|3609341|P2|NOT COMPLETED|Overall Study||14
1474602|NCT01893905|3609342|P1|NOT COMPLETED|Overall Study||25
1474603|NCT01893905|3609341|P2|COMPLETED|Overall Study||64
1474604|NCT01893905|3609342|P1|COMPLETED|Overall Study||55
1474605|NCT01893905|3609341|P2|STARTED|Overall Study||78
1474606|NCT01893905|3609342|P1|STARTED|Overall Study||80
1474607|NCT01893879|3609350|P2|NOT COMPLETED|Overall Study||3
1474608|NCT01893879|3609351|P1|NOT COMPLETED|Overall Study||2
1474609|NCT01893879|3609350|P2|COMPLETED|Overall Study||4
1474610|NCT01893879|3609351|P1|COMPLETED|Overall Study||5
1474611|NCT01893879|3609350|P2|STARTED|Overall Study||7
1474612|NCT01893879|3609351|P1|STARTED|Overall Study||7
1474613|NCT01893632|3609359|P2|NOT COMPLETED|Overall Study||0
1474614|NCT01893632|3609360|P1|NOT COMPLETED|Overall Study||0
1474615|NCT01893632|3609359|P2|COMPLETED|Overall Study||1
1474616|NCT01893632|3609360|P1|COMPLETED|Overall Study||1
1474617|NCT01893632|3609359|P2|STARTED|Overall Study||1
1474618|NCT01893632|3609360|P1|STARTED|Overall Study||1
1474619|NCT01893567|3609366|P1|NOT COMPLETED|Overall Study||0
1474620|NCT01893567|3609366|P1|COMPLETED|Overall Study||28
1474621|NCT01893567|3609366|P1|STARTED|Overall Study||28
1474622|NCT01893411|3609373|P3|NOT COMPLETED|Overall Study||9
1474623|NCT01893411|3609374|P2|NOT COMPLETED|Overall Study||7
1474624|NCT01893411|3609375|P1|NOT COMPLETED|Overall Study||17
1474625|NCT01893411|3609373|P3|COMPLETED|Overall Study||69
1474626|NCT01893411|3609374|P2|COMPLETED|Overall Study||70
1474627|NCT01893411|3609375|P1|COMPLETED|Overall Study||139
1474628|NCT01893411|3609373|P3|STARTED|Overall Study||78
1474629|NCT01893411|3609374|P2|STARTED|Overall Study||77
1474630|NCT01893411|3609375|P1|STARTED|Overall Study||156
1474631|NCT01893359|3609440|P3|NOT COMPLETED|Overall Study||0
1474632|NCT01893359|3609441|P2|NOT COMPLETED|Overall Study||0
1474633|NCT01893359|3609442|P1|NOT COMPLETED|Overall Study||0
1474634|NCT01893359|3609440|P3|COMPLETED|Overall Study||0
1474635|NCT01893359|3609441|P2|COMPLETED|Overall Study||2
1474636|NCT01893359|3609442|P1|COMPLETED|Overall Study||0
1474637|NCT01893359|3609440|P3|STARTED|Overall Study||0
1474638|NCT01893359|3609441|P2|STARTED|Overall Study||2
1474639|NCT01893359|3609442|P1|STARTED|Overall Study||0
1474640|NCT01893346|3609457|P4|NOT COMPLETED|Overall Study||0
1474641|NCT01893346|3609458|P3|NOT COMPLETED|Overall Study||0
1474642|NCT01893346|3609459|P2|NOT COMPLETED|Overall Study||1
1474643|NCT01893346|3609460|P1|NOT COMPLETED|Overall Study||3
1474644|NCT01893346|3609457|P4|COMPLETED|Overall Study||8
1474645|NCT01893346|3609458|P3|COMPLETED|Overall Study||8
1474646|NCT01893346|3609459|P2|COMPLETED|Overall Study||7
1474647|NCT01893346|3609460|P1|COMPLETED|Overall Study||8
1474648|NCT01893346|3609457|P4|Patients Who Received Full Infusion|Overall Study||8
1474649|NCT01893346|3609458|P3|Patients Who Received Full Infusion|Overall Study||8
1474650|NCT01893346|3609459|P2|Patients Who Received Full Infusion|Overall Study||8
1474651|NCT01893346|3609460|P1|Patients Who Received Full Infusion|Overall Study||8
1474652|NCT01893346|3609457|P4|STARTED|Overall Study||8
1474653|NCT01893346|3609458|P3|STARTED|Overall Study||8
1474654|NCT01893346|3609459|P2|STARTED|Overall Study||8
1474655|NCT01893346|3609460|P1|STARTED|Overall Study||11
1474656|NCT01893281|3609474|P1|NOT COMPLETED|Overall Study||3
1474657|NCT01893281|3609474|P1|COMPLETED|Overall Study||75
1474744|NCT01892189|3609605|P9|STARTED|Washout Period 2 (7 Days)||1
1474658|NCT01893281|3609474|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
1474659|NCT01893281|3609474|P1|STARTED|Overall Study||78
1474660|NCT01893203|3609481|P1|NOT COMPLETED|Overall Study||1
1474661|NCT01893203|3609481|P1|COMPLETED|Overall Study||13
1474662|NCT01893203|3609481|P1|STARTED|Overall Study||14
1474663|NCT01892865|3609490|P2|NOT COMPLETED|Overall Study||0
1474664|NCT01892865|3609491|P1|NOT COMPLETED|Overall Study||0
1474665|NCT01892865|3609490|P2|COMPLETED|Overall Study||379
1474666|NCT01892865|3609491|P1|COMPLETED|Overall Study||356
1474667|NCT01892865|3609490|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
1474668|NCT01892865|3609491|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
1474669|NCT01892722|3609505|P2|NOT COMPLETED|Overall Study||20
1474670|NCT01892722|3609506|P1|NOT COMPLETED|Overall Study||7
1474671|NCT01892722|3609505|P2|COMPLETED|Overall Study||88
1474672|NCT01892722|3609506|P1|COMPLETED|Overall Study||100
1474673|NCT01892722|3609505|P2|Full Analysis Set|Overall Study||107
1474674|NCT01892722|3609506|P1|Full Analysis Set|Overall Study||107
1474675|NCT01892722|3609505|P2|STARTED|Overall Study||108
1474676|NCT01892722|3609506|P1|STARTED|Overall Study||107
1474677|NCT01892709|3609512|P1|NOT COMPLETED|Overall Study||0
1474678|NCT01892709|3609512|P1|COMPLETED|Overall Study||215
1474679|NCT01892709|3609512|P1|STARTED|Overall Study||215
1474680|NCT01892657|3609522|P1|NOT COMPLETED|Overall Study||18
1474681|NCT01892657|3609522|P1|COMPLETED|Overall Study||110
1474682|NCT01892657|3609522|P1|STARTED|Overall Study||128
1474683|NCT01892306|3609540|P2|NOT COMPLETED|Overall Study||6
1474684|NCT01892306|3609541|P1|NOT COMPLETED|Overall Study||5
1474685|NCT01892306|3609540|P2|COMPLETED|Overall Study||10
1474686|NCT01892306|3609541|P1|COMPLETED|Overall Study||8
1474687|NCT01892306|3609540|P2|STARTED|Overall Study||16
1474688|NCT01892306|3609541|P1|STARTED|Overall Study||13
1474689|NCT01892293|3609561|P1|NOT COMPLETED|Overall Study||4
1474690|NCT01892293|3609561|P1|COMPLETED|Overall Study||2
1474691|NCT01892293|3609561|P1|Received T-cell|Overall Study||2
1474692|NCT01892293|3609561|P1|STARTED|Overall Study||6
1474693|NCT01892267|3609569|P2|NOT COMPLETED|Overall Study||0
1474694|NCT01892267|3609570|P1|NOT COMPLETED|Overall Study||0
1474695|NCT01892267|3609569|P2|COMPLETED|Overall Study||10
1474696|NCT01892267|3609570|P1|COMPLETED|Overall Study||9
1474697|NCT01892267|3609569|P2|STARTED|Overall Study||10
1474698|NCT01892267|3609570|P1|STARTED|Overall Study||9
1474699|NCT01892189|3609605|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
1474700|NCT01892189|3609606|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
1474701|NCT01892189|3609607|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
1474702|NCT01892189|3609608|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
1474703|NCT01892189|3609609|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
1474704|NCT01892189|3609610|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
1474705|NCT01892189|3609611|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
1474706|NCT01892189|3609612|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
1474707|NCT01892189|3609613|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
1474708|NCT01892189|3609605|P9|COMPLETED|Third Intervention Period (1 Day)||1
1474709|NCT01892189|3609606|P8|COMPLETED|Third Intervention Period (1 Day)||3
1474710|NCT01892189|3609607|P7|COMPLETED|Third Intervention Period (1 Day)||2
1474711|NCT01892189|3609608|P6|COMPLETED|Third Intervention Period (1 Day)||2
1474712|NCT01892189|3609609|P5|COMPLETED|Third Intervention Period (1 Day)||3
1474713|NCT01892189|3609610|P4|COMPLETED|Third Intervention Period (1 Day)||2
1474714|NCT01892189|3609611|P3|COMPLETED|Third Intervention Period (1 Day)||1
1474715|NCT01892189|3609612|P2|COMPLETED|Third Intervention Period (1 Day)||3
1474716|NCT01892189|3609613|P1|COMPLETED|Third Intervention Period (1 Day)||3
1474717|NCT01892189|3609605|P9|STARTED|Third Intervention Period (1 Day)||1
1474718|NCT01892189|3609606|P8|STARTED|Third Intervention Period (1 Day)||3
1474719|NCT01892189|3609607|P7|STARTED|Third Intervention Period (1 Day)||2
1474720|NCT01892189|3609608|P6|STARTED|Third Intervention Period (1 Day)||2
1474721|NCT01892189|3609609|P5|STARTED|Third Intervention Period (1 Day)||3
1474722|NCT01892189|3609610|P4|STARTED|Third Intervention Period (1 Day)||2
1474723|NCT01892189|3609611|P3|STARTED|Third Intervention Period (1 Day)||1
1474724|NCT01892189|3609612|P2|STARTED|Third Intervention Period (1 Day)||3
1474725|NCT01892189|3609613|P1|STARTED|Third Intervention Period (1 Day)||3
1474726|NCT01892189|3609605|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
1474727|NCT01892189|3609606|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
1474728|NCT01892189|3609607|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
1474729|NCT01892189|3609608|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1474730|NCT01892189|3609609|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1474731|NCT01892189|3609610|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1474732|NCT01892189|3609611|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1474733|NCT01892189|3609612|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1474734|NCT01892189|3609613|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1474735|NCT01892189|3609605|P9|COMPLETED|Washout Period 2 (7 Days)||1
1474736|NCT01892189|3609606|P8|COMPLETED|Washout Period 2 (7 Days)||3
1474737|NCT01892189|3609607|P7|COMPLETED|Washout Period 2 (7 Days)||2
1474738|NCT01892189|3609608|P6|COMPLETED|Washout Period 2 (7 Days)||2
1474739|NCT01892189|3609609|P5|COMPLETED|Washout Period 2 (7 Days)||3
1474740|NCT01892189|3609610|P4|COMPLETED|Washout Period 2 (7 Days)||2
1474741|NCT01892189|3609611|P3|COMPLETED|Washout Period 2 (7 Days)||1
1474742|NCT01892189|3609612|P2|COMPLETED|Washout Period 2 (7 Days)||3
1474743|NCT01892189|3609613|P1|COMPLETED|Washout Period 2 (7 Days)||3
1474745|NCT01892189|3609606|P8|STARTED|Washout Period 2 (7 Days)||3
1474746|NCT01892189|3609607|P7|STARTED|Washout Period 2 (7 Days)||2
1474747|NCT01892189|3609608|P6|STARTED|Washout Period 2 (7 Days)||2
1474748|NCT01892189|3609609|P5|STARTED|Washout Period 2 (7 Days)||3
1474749|NCT01892189|3609610|P4|STARTED|Washout Period 2 (7 Days)||2
1474750|NCT01892189|3609611|P3|STARTED|Washout Period 2 (7 Days)||1
1474751|NCT01892189|3609612|P2|STARTED|Washout Period 2 (7 Days)||3
1474752|NCT01892189|3609613|P1|STARTED|Washout Period 2 (7 Days)||3
1474753|NCT01892189|3609605|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
1474754|NCT01892189|3609606|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
1474755|NCT01892189|3609607|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
1474756|NCT01892189|3609608|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
1474757|NCT01892189|3609609|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
1474758|NCT01892189|3609610|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
1474759|NCT01892189|3609611|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
1474760|NCT01892189|3609612|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
1474761|NCT01892189|3609613|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
1474762|NCT01892189|3609605|P9|COMPLETED|Second Intervention Period (1 Day)||1
1474763|NCT01892189|3609606|P8|COMPLETED|Second Intervention Period (1 Day)||3
1474764|NCT01892189|3609607|P7|COMPLETED|Second Intervention Period (1 Day)||2
1474765|NCT01892189|3609608|P6|COMPLETED|Second Intervention Period (1 Day)||2
1474766|NCT01892189|3609609|P5|COMPLETED|Second Intervention Period (1 Day)||3
1474767|NCT01892189|3609610|P4|COMPLETED|Second Intervention Period (1 Day)||2
1474768|NCT01892189|3609611|P3|COMPLETED|Second Intervention Period (1 Day)||1
1474769|NCT01892189|3609612|P2|COMPLETED|Second Intervention Period (1 Day)||3
1474770|NCT01892189|3609613|P1|COMPLETED|Second Intervention Period (1 Day)||3
1474771|NCT01892189|3609605|P9|STARTED|Second Intervention Period (1 Day)||1
1474772|NCT01892189|3609606|P8|STARTED|Second Intervention Period (1 Day)||3
1474773|NCT01892189|3609607|P7|STARTED|Second Intervention Period (1 Day)||2
1474774|NCT01892189|3609608|P6|STARTED|Second Intervention Period (1 Day)||2
1474775|NCT01892189|3609609|P5|STARTED|Second Intervention Period (1 Day)||3
1474776|NCT01892189|3609610|P4|STARTED|Second Intervention Period (1 Day)||2
1474777|NCT01892189|3609611|P3|STARTED|Second Intervention Period (1 Day)||1
1474778|NCT01892189|3609612|P2|STARTED|Second Intervention Period (1 Day)||3
1474779|NCT01892189|3609613|P1|STARTED|Second Intervention Period (1 Day)||3
1474780|NCT01892189|3609605|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
1474781|NCT01892189|3609606|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
1474782|NCT01892189|3609607|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
1474783|NCT01892189|3609608|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
1474784|NCT01892189|3609609|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1474785|NCT01892189|3609610|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
1474786|NCT01892189|3609611|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
1474787|NCT01892189|3609612|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1474788|NCT01892189|3609613|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1474789|NCT01892189|3609605|P9|COMPLETED|Washout Period 1 (7 Days)||1
1474790|NCT01892189|3609606|P8|COMPLETED|Washout Period 1 (7 Days)||3
1474791|NCT01892189|3609607|P7|COMPLETED|Washout Period 1 (7 Days)||2
1474792|NCT01892189|3609608|P6|COMPLETED|Washout Period 1 (7 Days)||2
1474793|NCT01892189|3609609|P5|COMPLETED|Washout Period 1 (7 Days)||3
1474794|NCT01892189|3609610|P4|COMPLETED|Washout Period 1 (7 Days)||2
1474795|NCT01892189|3609611|P3|COMPLETED|Washout Period 1 (7 Days)||1
1474796|NCT01892189|3609612|P2|COMPLETED|Washout Period 1 (7 Days)||3
1474797|NCT01892189|3609613|P1|COMPLETED|Washout Period 1 (7 Days)||3
1474798|NCT01892189|3609605|P9|STARTED|Washout Period 1 (7 Days)||3
1474799|NCT01892189|3609606|P8|STARTED|Washout Period 1 (7 Days)||3
1474800|NCT01892189|3609607|P7|STARTED|Washout Period 1 (7 Days)||3
1474801|NCT01892189|3609608|P6|STARTED|Washout Period 1 (7 Days)||3
1474802|NCT01892189|3609609|P5|STARTED|Washout Period 1 (7 Days)||3
1474803|NCT01892189|3609610|P4|STARTED|Washout Period 1 (7 Days)||3
1474804|NCT01892189|3609611|P3|STARTED|Washout Period 1 (7 Days)||3
1474805|NCT01892189|3609612|P2|STARTED|Washout Period 1 (7 Days)||3
1474806|NCT01892189|3609613|P1|STARTED|Washout Period 1 (7 Days)||3
1474807|NCT01892189|3609605|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
1474808|NCT01892189|3609606|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
1474809|NCT01892189|3609607|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
1474810|NCT01892189|3609608|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
1474811|NCT01892189|3609609|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
1474812|NCT01892189|3609610|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
1474813|NCT01892189|3609611|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
1474814|NCT01892189|3609612|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
1474815|NCT01892189|3609613|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
1474816|NCT01892189|3609605|P9|COMPLETED|First Intervention Period (1 Day)||3
1474817|NCT01892189|3609606|P8|COMPLETED|First Intervention Period (1 Day)||3
1474818|NCT01892189|3609607|P7|COMPLETED|First Intervention Period (1 Day)||3
1474819|NCT01892189|3609608|P6|COMPLETED|First Intervention Period (1 Day)||3
1474820|NCT01892189|3609609|P5|COMPLETED|First Intervention Period (1 Day)||3
1474821|NCT01892189|3609610|P4|COMPLETED|First Intervention Period (1 Day)||3
1474822|NCT01892189|3609611|P3|COMPLETED|First Intervention Period (1 Day)||3
1474823|NCT01892189|3609612|P2|COMPLETED|First Intervention Period (1 Day)||3
1474824|NCT01892189|3609613|P1|COMPLETED|First Intervention Period (1 Day)||3
1474825|NCT01892189|3609605|P9|STARTED|First Intervention Period (1 Day)||3
1474826|NCT01892189|3609606|P8|STARTED|First Intervention Period (1 Day)||3
1474827|NCT01892189|3609607|P7|STARTED|First Intervention Period (1 Day)||3
1474828|NCT01892189|3609608|P6|STARTED|First Intervention Period (1 Day)||3
1474829|NCT01892189|3609609|P5|STARTED|First Intervention Period (1 Day)||3
1474830|NCT01892189|3609610|P4|STARTED|First Intervention Period (1 Day)||3
1474831|NCT01892189|3609611|P3|STARTED|First Intervention Period (1 Day)||3
1474832|NCT01892189|3609612|P2|STARTED|First Intervention Period (1 Day)||3
1474833|NCT01892189|3609613|P1|STARTED|First Intervention Period (1 Day)||3
1474834|NCT01892163|3609655|P2|NOT COMPLETED|Overall Study||1
1474835|NCT01892163|3609656|P1|NOT COMPLETED|Overall Study||2
1474836|NCT01892163|3609655|P2|COMPLETED|Overall Study||49
1474837|NCT01892163|3609656|P1|COMPLETED|Overall Study||48
1474838|NCT01892163|3609655|P2|STARTED|Overall Study||50
1474839|NCT01892163|3609656|P1|STARTED|Overall Study||50
1474840|NCT01892020|3609668|P2|NOT COMPLETED|Period 2||0
1474841|NCT01892020|3609669|P1|NOT COMPLETED|Period 2||1
1474842|NCT01892020|3609668|P2|COMPLETED|Period 2||74
1474843|NCT01892020|3609669|P1|COMPLETED|Period 2||77
1474844|NCT01892020|3609668|P2|STARTED|Period 2||74
1474845|NCT01892020|3609669|P1|STARTED|Period 2||78
1474846|NCT01892020|3609668|P2|NOT COMPLETED|Period 1||6
1474847|NCT01892020|3609669|P1|NOT COMPLETED|Period 1||3
1474848|NCT01892020|3609668|P2|COMPLETED|Period 1||74
1474849|NCT01892020|3609669|P1|COMPLETED|Period 1||78
1474850|NCT01892020|3609668|P2|STARTED|Period 1||80
1474851|NCT01892020|3609669|P1|STARTED|Period 1||81
1474852|NCT01891994|3609687|P1|NOT COMPLETED|Overall Study||0
1474853|NCT01891994|3609687|P1|COMPLETED|Overall Study||40
1474854|NCT01891994|3609687|P1|STARTED|Overall Study||40
1474855|NCT01891968|3609691|P1|NOT COMPLETED|Overall Study||0
1474856|NCT01891968|3609691|P1|COMPLETED|Overall Study||15
1474857|NCT01891968|3609691|P1|STARTED|Overall Study||15
1474858|NCT01891890|3609698|P3|NOT COMPLETED|Overall Study||7
1474859|NCT01891890|3609699|P2|NOT COMPLETED|Overall Study||3
1474860|NCT01891890|3609700|P1|NOT COMPLETED|Overall Study||7
1474861|NCT01891890|3609698|P3|COMPLETED|Overall Study||14
1474862|NCT01891890|3609699|P2|COMPLETED|Overall Study||24
1474863|NCT01891890|3609700|P1|COMPLETED|Overall Study||17
1474864|NCT01891890|3609698|P3|STARTED|Overall Study||21
1474865|NCT01891890|3609699|P2|STARTED|Overall Study||27
1474866|NCT01891890|3609700|P1|STARTED|Overall Study||24
1474867|NCT01891864|3609743|P6|NOT COMPLETED|Extension Period||0
1474868|NCT01891864|3609744|P5|NOT COMPLETED|Extension Period||7
1474869|NCT01891864|3609745|P4|NOT COMPLETED|Extension Period||5
1474870|NCT01891864|3609746|P3|NOT COMPLETED|Extension Period||8
1474871|NCT01891864|3609747|P2|NOT COMPLETED|Extension Period||0
1474872|NCT01891864|3609748|P1|NOT COMPLETED|Extension Period||0
1474873|NCT01891864|3609743|P6|COMPLETED|Extension Period||90
1474874|NCT01891864|3609744|P5|COMPLETED|Extension Period||88
1474875|NCT01891864|3609745|P4|COMPLETED|Extension Period||137
1474876|NCT01891864|3609746|P3|COMPLETED|Extension Period||132
1474877|NCT01891864|3609747|P2|COMPLETED|Extension Period||0
1474878|NCT01891864|3609748|P1|COMPLETED|Extension Period||0
1474879|NCT01891864|3609743|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
1474880|NCT01891864|3609744|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
1474881|NCT01891864|3609745|P4|STARTED|Extension Period||142
1474882|NCT01891864|3609746|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
1474883|NCT01891864|3609747|P2|STARTED|Extension Period||0
1474884|NCT01891864|3609748|P1|STARTED|Extension Period||0
1474885|NCT01891864|3609743|P6|NOT COMPLETED|Treatment Period 2||5
1474886|NCT01891864|3609744|P5|NOT COMPLETED|Treatment Period 2||4
1474887|NCT01891864|3609745|P4|NOT COMPLETED|Treatment Period 2||9
1474888|NCT01891864|3609746|P3|NOT COMPLETED|Treatment Period 2||7
1474889|NCT01891864|3609747|P2|NOT COMPLETED|Treatment Period 2||0
1474890|NCT01891864|3609748|P1|NOT COMPLETED|Treatment Period 2||0
1474891|NCT01891864|3609743|P6|COMPLETED|Treatment Period 2||91
1474892|NCT01891864|3609744|P5|COMPLETED|Treatment Period 2||96
1474893|NCT01891864|3609745|P4|COMPLETED|Treatment Period 2||142
1474894|NCT01891864|3609746|P3|COMPLETED|Treatment Period 2||143
1474895|NCT01891864|3609747|P2|COMPLETED|Treatment Period 2||0
1474896|NCT01891864|3609748|P1|COMPLETED|Treatment Period 2||0
1474897|NCT01891864|3609743|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
1474898|NCT01891864|3609744|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
1474899|NCT01891864|3609745|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
1474900|NCT01891864|3609746|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
1474901|NCT01891864|3609747|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
1474902|NCT01891864|3609748|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
1474903|NCT01891864|3609743|P6|NOT COMPLETED|Treatment Period 1||0
1474904|NCT01891864|3609744|P5|NOT COMPLETED|Treatment Period 1||0
1474905|NCT01891864|3609745|P4|NOT COMPLETED|Treatment Period 1||0
1474906|NCT01891864|3609746|P3|NOT COMPLETED|Treatment Period 1||0
1474907|NCT01891864|3609747|P2|NOT COMPLETED|Treatment Period 1||12
1474908|NCT01891864|3609748|P1|NOT COMPLETED|Treatment Period 1||8
1474909|NCT01891864|3609743|P6|COMPLETED|Treatment Period 1||0
1474910|NCT01891864|3609744|P5|COMPLETED|Treatment Period 1||0
1474911|NCT01891864|3609745|P4|COMPLETED|Treatment Period 1||0
1474912|NCT01891864|3609746|P3|COMPLETED|Treatment Period 1||0
1474913|NCT01891864|3609747|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
1474914|NCT01891864|3609748|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
1474915|NCT01891864|3609743|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1474916|NCT01891864|3609744|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1474917|NCT01891864|3609745|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1474918|NCT01891864|3609746|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
1474919|NCT01891864|3609747|P2|STARTED|Treatment Period 1||267
1474920|NCT01891864|3609748|P1|STARTED|Treatment Period 1||264
1474921|NCT01891734|3609770|P2|NOT COMPLETED|Overall Study||3
1474922|NCT01891734|3609771|P1|NOT COMPLETED|Overall Study||3
1474923|NCT01891734|3609770|P2|COMPLETED|Overall Study||13
1474924|NCT01891734|3609771|P1|COMPLETED|Overall Study||14
1474925|NCT01891734|3609770|P2|STARTED|Overall Study||16
1474926|NCT01891734|3609771|P1|STARTED|Overall Study||17
1474927|NCT01891669|3609791|P10|NOT COMPLETED|Overall Study||2
1474928|NCT01891669|3609792|P9|NOT COMPLETED|Overall Study||1
1474929|NCT01891669|3609793|P8|NOT COMPLETED|Overall Study||4
1474930|NCT01891669|3609794|P7|NOT COMPLETED|Overall Study||1
1474931|NCT01891669|3609795|P6|NOT COMPLETED|Overall Study||0
1474932|NCT01891669|3609796|P5|NOT COMPLETED|Overall Study||0
1474933|NCT01891669|3609797|P4|NOT COMPLETED|Overall Study||0
1474934|NCT01891669|3609798|P3|NOT COMPLETED|Overall Study||0
1474935|NCT01891669|3609799|P2|NOT COMPLETED|Overall Study||1
1474936|NCT01891669|3609800|P1|NOT COMPLETED|Overall Study||2
1474937|NCT01891669|3609791|P10|COMPLETED|Overall Study||1
1474938|NCT01891669|3609792|P9|COMPLETED|Overall Study||2
1474939|NCT01891669|3609793|P8|COMPLETED|Overall Study||2
1474940|NCT01891669|3609794|P7|COMPLETED|Overall Study||1
1474941|NCT01891669|3609795|P6|COMPLETED|Overall Study||2
1474942|NCT01891669|3609796|P5|COMPLETED|Overall Study||2
1474943|NCT01891669|3609797|P4|COMPLETED|Overall Study||2
1474944|NCT01891669|3609798|P3|COMPLETED|Overall Study||2
1474945|NCT01891669|3609799|P2|COMPLETED|Overall Study||1
1474946|NCT01891669|3609800|P1|COMPLETED|Overall Study||0
1474947|NCT01891669|3609791|P10|STARTED|Overall Study||3
1474948|NCT01891669|3609792|P9|STARTED|Overall Study||3
1474949|NCT01891669|3609793|P8|STARTED|Overall Study||6
1474950|NCT01891669|3609794|P7|STARTED|Overall Study||2
1474951|NCT01891669|3609795|P6|STARTED|Overall Study||2
1474952|NCT01891669|3609796|P5|STARTED|Overall Study||2
1474953|NCT01891669|3609797|P4|STARTED|Overall Study||2
1474954|NCT01891669|3609798|P3|STARTED|Overall Study||2
1474955|NCT01891669|3609799|P2|STARTED|Overall Study||2
1474956|NCT01891669|3609800|P1|STARTED|Overall Study||2
1474957|NCT01891331|3609955|P4|NOT COMPLETED|Overall Study||2
1474958|NCT01891331|3609956|P3|NOT COMPLETED|Overall Study||1
1474959|NCT01891331|3609957|P2|NOT COMPLETED|Overall Study||2
1474960|NCT01891331|3609958|P1|NOT COMPLETED|Overall Study||2
1474961|NCT01891331|3609955|P4|COMPLETED|Overall Study||13
1474962|NCT01891331|3609956|P3|COMPLETED|Overall Study||13
1474963|NCT01891331|3609957|P2|COMPLETED|Overall Study||10
1474964|NCT01891331|3609958|P1|COMPLETED|Overall Study||12
1474965|NCT01891331|3609955|P4|STARTED|Overall Study||15
1474966|NCT01891331|3609956|P3|STARTED|Overall Study||14
1474967|NCT01891331|3609957|P2|STARTED|Overall Study||12
1474968|NCT01891331|3609958|P1|STARTED|Overall Study||14
1474969|NCT01891305|3609972|P4|NOT COMPLETED|Overall Study||0
1474970|NCT01891305|3609973|P3|NOT COMPLETED|Overall Study||3
1474971|NCT01891305|3609974|P2|NOT COMPLETED|Overall Study||1
1474972|NCT01891305|3609975|P1|NOT COMPLETED|Overall Study||3
1474973|NCT01891305|3609972|P4|COMPLETED|Overall Study||12
1474974|NCT01891305|3609973|P3|COMPLETED|Overall Study||11
1474975|NCT01891305|3609974|P2|COMPLETED|Overall Study||11
1474976|NCT01891305|3609975|P1|COMPLETED|Overall Study||9
1474977|NCT01891305|3609972|P4|STARTED|Overall Study||12
1474978|NCT01891305|3609973|P3|STARTED|Overall Study||14
1474979|NCT01891305|3609974|P2|STARTED|Overall Study||12
1474980|NCT01891305|3609975|P1|STARTED|Overall Study||12
1474981|NCT01890967|3609991|P6|NOT COMPLETED|Overall Study||13
1474982|NCT01890967|3609992|P5|NOT COMPLETED|Overall Study||10
1474983|NCT01890967|3609993|P4|NOT COMPLETED|Overall Study||11
1474984|NCT01890967|3609994|P3|NOT COMPLETED|Overall Study||10
1474985|NCT01890967|3609995|P2|NOT COMPLETED|Overall Study||11
1474986|NCT01890967|3609996|P1|NOT COMPLETED|Overall Study||10
1474987|NCT01890967|3609991|P6|COMPLETED|Overall Study||75
1474988|NCT01890967|3609992|P5|COMPLETED|Overall Study||77
1474989|NCT01890967|3609993|P4|COMPLETED|Overall Study||77
1474990|NCT01890967|3609994|P3|COMPLETED|Overall Study||78
1474991|NCT01890967|3609995|P2|COMPLETED|Overall Study||77
1474992|NCT01890967|3609996|P1|COMPLETED|Overall Study||78
1474993|NCT01890967|3609991|P6|Received at Least One Dose of Study Drug|Overall Study||87
1474994|NCT01890967|3609992|P5|Received at Least One Dose of Study Drug|Overall Study||86
1474995|NCT01890967|3609993|P4|Received at Least One Dose of Study Drug|Overall Study||86
1474996|NCT01890967|3609994|P3|Received at Least One Dose of Study Drug|Overall Study||86
1475090|NCT01890642|3610214|P2|NOT COMPLETED|Overall Study||0
1474997|NCT01890967|3609995|P2|Received at Least One Dose of Study Drug|Overall Study||87
1474998|NCT01890967|3609996|P1|Received at Least One Dose of Study Drug|Overall Study||87
1474999|NCT01890967|3609991|P6|STARTED|Overall Study||88
1475000|NCT01890967|3609992|P5|STARTED|Overall Study||87
1475001|NCT01890967|3609993|P4|STARTED|Overall Study||88
1475002|NCT01890967|3609994|P3|STARTED|Overall Study||88
1475003|NCT01890967|3609995|P2|STARTED|Overall Study||88
1475004|NCT01890967|3609996|P1|STARTED|Overall Study||88
1475005|NCT01890954|3610065|P2|NOT COMPLETED|Overall Study||0
1475006|NCT01890954|3610066|P1|NOT COMPLETED|Overall Study||1
1475007|NCT01890954|3610065|P2|COMPLETED|Overall Study||8
1475008|NCT01890954|3610066|P1|COMPLETED|Overall Study||8
1475009|NCT01890954|3610065|P2|STARTED|Overall Study||8
1475010|NCT01890954|3610066|P1|STARTED|Overall Study||9
1475011|NCT01890915|3610074|P2|NOT COMPLETED|Overall Study||1
1475012|NCT01890915|3610075|P1|NOT COMPLETED|Overall Study||3
1475013|NCT01890915|3610074|P2|COMPLETED|Overall Study||9
1475014|NCT01890915|3610075|P1|COMPLETED|Overall Study||8
1475015|NCT01890915|3610074|P2|STARTED|Overall Study||10
1475016|NCT01890915|3610075|P1|STARTED|Overall Study||11
1475017|NCT01890785|3610091|P6|NOT COMPLETED|Third Intervention||0
1475018|NCT01890785|3610092|P5|NOT COMPLETED|Third Intervention||0
1475019|NCT01890785|3610093|P4|NOT COMPLETED|Third Intervention||0
1475020|NCT01890785|3610094|P3|NOT COMPLETED|Third Intervention||0
1475021|NCT01890785|3610095|P2|NOT COMPLETED|Third Intervention||1
1475022|NCT01890785|3610096|P1|NOT COMPLETED|Third Intervention||0
1475023|NCT01890785|3610091|P6|COMPLETED|Third Intervention||5
1475024|NCT01890785|3610092|P5|COMPLETED|Third Intervention||5
1475025|NCT01890785|3610093|P4|COMPLETED|Third Intervention||5
1475026|NCT01890785|3610094|P3|COMPLETED|Third Intervention||5
1475027|NCT01890785|3610095|P2|COMPLETED|Third Intervention||4
1475028|NCT01890785|3610096|P1|COMPLETED|Third Intervention||5
1475029|NCT01890785|3610091|P6|STARTED|Third Intervention||5
1475030|NCT01890785|3610092|P5|STARTED|Third Intervention||5
1475031|NCT01890785|3610093|P4|STARTED|Third Intervention||5
1475032|NCT01890785|3610094|P3|STARTED|Third Intervention||5
1475033|NCT01890785|3610095|P2|STARTED|Third Intervention||5
1475034|NCT01890785|3610096|P1|STARTED|Third Intervention||5
1475035|NCT01890785|3610091|P6|NOT COMPLETED|Second Intervention||0
1475036|NCT01890785|3610092|P5|NOT COMPLETED|Second Intervention||0
1475037|NCT01890785|3610093|P4|NOT COMPLETED|Second Intervention||0
1475038|NCT01890785|3610094|P3|NOT COMPLETED|Second Intervention||0
1475039|NCT01890785|3610095|P2|NOT COMPLETED|Second Intervention||0
1475040|NCT01890785|3610096|P1|NOT COMPLETED|Second Intervention||0
1475041|NCT01890785|3610091|P6|COMPLETED|Second Intervention||5
1475042|NCT01890785|3610092|P5|COMPLETED|Second Intervention||5
1475043|NCT01890785|3610093|P4|COMPLETED|Second Intervention||5
1475044|NCT01890785|3610094|P3|COMPLETED|Second Intervention||5
1475045|NCT01890785|3610095|P2|COMPLETED|Second Intervention||5
1475046|NCT01890785|3610096|P1|COMPLETED|Second Intervention||5
1475047|NCT01890785|3610091|P6|STARTED|Second Intervention||5
1475048|NCT01890785|3610092|P5|STARTED|Second Intervention||5
1475049|NCT01890785|3610093|P4|STARTED|Second Intervention||5
1475050|NCT01890785|3610094|P3|STARTED|Second Intervention||5
1475051|NCT01890785|3610095|P2|STARTED|Second Intervention||5
1475052|NCT01890785|3610096|P1|STARTED|Second Intervention||5
1475053|NCT01890785|3610091|P6|NOT COMPLETED|First Intervention||0
1475054|NCT01890785|3610092|P5|NOT COMPLETED|First Intervention||0
1475055|NCT01890785|3610093|P4|NOT COMPLETED|First Intervention||0
1475056|NCT01890785|3610094|P3|NOT COMPLETED|First Intervention||0
1475057|NCT01890785|3610095|P2|NOT COMPLETED|First Intervention||0
1475058|NCT01890785|3610096|P1|NOT COMPLETED|First Intervention||0
1475059|NCT01890785|3610091|P6|COMPLETED|First Intervention||5
1475060|NCT01890785|3610092|P5|COMPLETED|First Intervention||5
1475061|NCT01890785|3610093|P4|COMPLETED|First Intervention||5
1475062|NCT01890785|3610094|P3|COMPLETED|First Intervention||5
1475063|NCT01890785|3610095|P2|COMPLETED|First Intervention||5
1475064|NCT01890785|3610096|P1|COMPLETED|First Intervention||5
1475065|NCT01890785|3610091|P6|STARTED|First Intervention||5
1475066|NCT01890785|3610092|P5|STARTED|First Intervention||5
1475067|NCT01890785|3610093|P4|STARTED|First Intervention||5
1475068|NCT01890785|3610094|P3|STARTED|First Intervention||5
1475069|NCT01890785|3610095|P2|STARTED|First Intervention||5
1475070|NCT01890785|3610096|P1|STARTED|First Intervention||5
1475071|NCT01890759|3610115|P2|NOT COMPLETED|Overall Study||12
1475072|NCT01890759|3610116|P1|NOT COMPLETED|Overall Study||2
1475073|NCT01890759|3610115|P2|COMPLETED|Overall Study||188
1475074|NCT01890759|3610116|P1|COMPLETED|Overall Study||98
1475075|NCT01890759|3610115|P2|STARTED|Overall Study||200
1475076|NCT01890759|3610116|P1|STARTED|Overall Study||100
1475077|NCT01890746|3610150|P2|NOT COMPLETED|Overall Study||74
1475078|NCT01890746|3610151|P1|NOT COMPLETED|Overall Study||74
1475079|NCT01890746|3610150|P2|COMPLETED|Overall Study||0
1475080|NCT01890746|3610151|P1|COMPLETED|Overall Study||0
1475081|NCT01890746|3610150|P2|STARTED|Overall Study||74
1475082|NCT01890746|3610151|P1|STARTED|Overall Study||74
1475083|NCT01890694|3610177|P2|NOT COMPLETED|Overall Study||1
1475084|NCT01890694|3610178|P1|NOT COMPLETED|Overall Study||1
1475085|NCT01890694|3610177|P2|COMPLETED|Overall Study||0
1475086|NCT01890694|3610178|P1|COMPLETED|Overall Study||0
1475087|NCT01890694|3610177|P2|STARTED|Overall Study||1
1475088|NCT01890694|3610178|P1|STARTED|Overall Study||1
1475089|NCT01890642|3610213|P3|NOT COMPLETED|Overall Study||0
1475091|NCT01890642|3610215|P1|NOT COMPLETED|Overall Study||0
1475092|NCT01890642|3610213|P3|COMPLETED|Overall Study||96
1475093|NCT01890642|3610214|P2|COMPLETED|Overall Study||53
1475094|NCT01890642|3610215|P1|COMPLETED|Overall Study||56
1475095|NCT01890642|3610213|P3|STARTED|Overall Study||96
1475096|NCT01890642|3610214|P2|STARTED|Overall Study||53
1475097|NCT01890642|3610215|P1|STARTED|Overall Study||56
1475098|NCT01890577|3610235|P1|NOT COMPLETED|Overall Study||28
1475099|NCT01890577|3610235|P1|COMPLETED|Overall Study||0
1475100|NCT01890577|3610235|P1|STARTED|Overall Study||28
1475101|NCT01890512|3610248|P1|NOT COMPLETED|Overall Study||3
1475102|NCT01890512|3610248|P1|COMPLETED|Overall Study||17
1475103|NCT01890512|3610248|P1|STARTED|Overall Study||20
1475104|NCT01890473|3610254|P2|NOT COMPLETED|Overall Study||0
1475105|NCT01890473|3610255|P1|NOT COMPLETED|Overall Study||2
1475106|NCT01890473|3610254|P2|COMPLETED|Overall Study||113
1475107|NCT01890473|3610255|P1|COMPLETED|Overall Study||109
1475108|NCT01890473|3610254|P2|STARTED|Overall Study||113
1475109|NCT01890473|3610255|P1|STARTED|Overall Study||111
1475110|NCT01890434|3610281|P1|NOT COMPLETED|Overall Study||20
1475111|NCT01890434|3610281|P1|COMPLETED|Overall Study||458
1475112|NCT01890434|3610281|P1|Evaluated for Efficacy|Overall Study||389
1475113|NCT01890434|3610281|P1|STARTED|Overall Study||478
1475114|NCT01890421|3610311|P1|NOT COMPLETED|Overall Study||11
1475115|NCT01890421|3610311|P1|COMPLETED|Overall Study||415
1475116|NCT01890421|3610311|P1|STARTED|Overall Study||426
1475117|NCT01890343|3610337|P3|NOT COMPLETED|Overall Study||0
1475118|NCT01890343|3610338|P2|NOT COMPLETED|Overall Study||0
1475119|NCT01890343|3610339|P1|NOT COMPLETED|Overall Study||0
1475120|NCT01890343|3610337|P3|COMPLETED|Overall Study||10
1475121|NCT01890343|3610338|P2|COMPLETED|Overall Study||10
1475122|NCT01890343|3610339|P1|COMPLETED|Overall Study||8
1475123|NCT01890343|3610337|P3|STARTED|Overall Study||10
1475124|NCT01890343|3610338|P2|STARTED|Overall Study||10
1475125|NCT01890343|3610339|P1|STARTED|Overall Study||8
1475126|NCT01890148|3610350|P1|NOT COMPLETED|Overall Study||1
1475127|NCT01890148|3610350|P1|COMPLETED|Overall Study||4
1475128|NCT01890148|3610350|P1|STARTED|Overall Study||5
1475129|NCT01890122|3610370|P4|NOT COMPLETED|Overall Study||59
1475130|NCT01890122|3610371|P3|NOT COMPLETED|Overall Study||13
1475131|NCT01890122|3610372|P2|NOT COMPLETED|Overall Study||37
1475132|NCT01890122|3610373|P1|NOT COMPLETED|Overall Study||27
1475133|NCT01890122|3610370|P4|COMPLETED|Overall Study||104
1475134|NCT01890122|3610371|P3|COMPLETED|Overall Study||146
1475135|NCT01890122|3610372|P2|COMPLETED|Overall Study||126
1475136|NCT01890122|3610373|P1|COMPLETED|Overall Study||135
1475137|NCT01890122|3610370|P4|Treated|Overall Study||163
1475138|NCT01890122|3610371|P3|Treated|Overall Study||159
1475139|NCT01890122|3610372|P2|Treated|Overall Study||162
1475140|NCT01890122|3610373|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
1475141|NCT01890122|3610370|P4|STARTED|Overall Study||163
1475142|NCT01890122|3610371|P3|STARTED|Overall Study||159
1475143|NCT01890122|3610372|P2|STARTED|Overall Study||163
1475144|NCT01890122|3610373|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
1475145|NCT01890031|3610440|P5|NOT COMPLETED|Overall Study||0
1475146|NCT01890031|3610441|P4|NOT COMPLETED|Overall Study||0
1475147|NCT01890031|3610442|P3|NOT COMPLETED|Overall Study||0
1475148|NCT01890031|3610443|P2|NOT COMPLETED|Overall Study||0
1475149|NCT01890031|3610444|P1|NOT COMPLETED|Overall Study||0
1475150|NCT01890031|3610440|P5|COMPLETED|Overall Study||8
1475151|NCT01890031|3610441|P4|COMPLETED|Overall Study||11
1475152|NCT01890031|3610442|P3|COMPLETED|Overall Study||12
1475153|NCT01890031|3610443|P2|COMPLETED|Overall Study||50
1475154|NCT01890031|3610444|P1|COMPLETED|Overall Study||50
1475155|NCT01890031|3610440|P5|STARTED|Overall Study||8
1475156|NCT01890031|3610441|P4|STARTED|Overall Study||11
1475157|NCT01890031|3610442|P3|STARTED|Overall Study||12
1475158|NCT01890031|3610443|P2|STARTED|Overall Study||50
1475159|NCT01890031|3610444|P1|STARTED|Overall Study||50
1475160|NCT01889797|3610463|P2|NOT COMPLETED|Overall Study||0
1475161|NCT01889797|3610464|P1|NOT COMPLETED|Overall Study||0
1475162|NCT01889797|3610463|P2|COMPLETED|Overall Study||16
1475163|NCT01889797|3610464|P1|COMPLETED|Overall Study||16
1475164|NCT01889797|3610463|P2|STARTED|Overall Study||16
1475165|NCT01889797|3610464|P1|STARTED|Overall Study||16
1475166|NCT01889667|3610479|P3|NOT COMPLETED|Overall Study||0
1475167|NCT01889667|3610480|P2|NOT COMPLETED|Overall Study||0
1475168|NCT01889667|3610481|P1|NOT COMPLETED|Overall Study||0
1475169|NCT01889667|3610479|P3|COMPLETED|Overall Study||10
1475170|NCT01889667|3610480|P2|COMPLETED|Overall Study||10
1475171|NCT01889667|3610481|P1|COMPLETED|Overall Study||10
1475172|NCT01889667|3610479|P3|STARTED|Overall Study||10
1475173|NCT01889667|3610480|P2|STARTED|Overall Study||10
1475174|NCT01889667|3610481|P1|STARTED|Overall Study||10
1475175|NCT01889563|3610503|P2|NOT COMPLETED|Overall Study||5
1475176|NCT01889563|3610504|P1|NOT COMPLETED|Overall Study||7
1475177|NCT01889563|3610503|P2|COMPLETED|Overall Study||10
1475178|NCT01889563|3610504|P1|COMPLETED|Overall Study||10
1475179|NCT01889563|3610503|P2|STARTED|Overall Study||15
1475180|NCT01889563|3610504|P1|STARTED|Overall Study||17
1475181|NCT01889420|3610512|P1|NOT COMPLETED|Overall Study||0
1475182|NCT01889420|3610512|P1|COMPLETED|Overall Study||1
1475183|NCT01889420|3610512|P1|STARTED|Overall Study||1
1475184|NCT01889355|3610518|P1|NOT COMPLETED|Overall Study||2
1475185|NCT01889355|3610518|P1|COMPLETED|Overall Study||113
1475186|NCT01889355|3610518|P1|STARTED|Overall Study||115
1475187|NCT01889251|3610524|P2|NOT COMPLETED|Overall Study||0
1475188|NCT01889251|3610525|P1|NOT COMPLETED|Overall Study||1
1475189|NCT01889251|3610524|P2|COMPLETED|Overall Study||57
1475190|NCT01889251|3610525|P1|COMPLETED|Overall Study||114
1475191|NCT01889251|3610524|P2|STARTED|Overall Study||57
1475192|NCT01889251|3610525|P1|STARTED|Overall Study||115
1475193|NCT01889238|3610531|P1|NOT COMPLETED|Overall Study||9
1475194|NCT01889238|3610531|P1|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
1475195|NCT01889238|3610531|P1|STARTED|Overall Study||118
1475196|NCT01888965|3610548|P1|NOT COMPLETED|Overall Study||9
1475197|NCT01888965|3610548|P1|COMPLETED|Overall Study||0
1475198|NCT01888965|3610548|P1|STARTED|Overall Study||9
1475199|NCT01888952|3610554|P1|NOT COMPLETED|Overall Study||0
1475200|NCT01888952|3610554|P1|COMPLETED|Overall Study||10
1475201|NCT01888952|3610554|P1|STARTED|Overall Study||10
1475202|NCT01888900|3610560|P2|NOT COMPLETED|Overall Study||2
1475203|NCT01888900|3610561|P1|NOT COMPLETED|Overall Study||0
1475204|NCT01888900|3610560|P2|COMPLETED|Overall Study||11
1475205|NCT01888900|3610561|P1|COMPLETED|Overall Study||22
1475206|NCT01888900|3610560|P2|STARTED|Overall Study||13
1475207|NCT01888900|3610561|P1|STARTED|Overall Study||22
1475208|NCT01888432|3610583|P2|NOT COMPLETED|24-month Analysis (FAS)||17
1475209|NCT01888432|3610584|P1|NOT COMPLETED|24-month Analysis (FAS)||17
1475210|NCT01888432|3610583|P2|COMPLETED|24-month Analysis (FAS)||125
1475211|NCT01888432|3610584|P1|COMPLETED|24-month Analysis (FAS)||125
1475212|NCT01888432|3610583|P2|STARTED|24-month Analysis (FAS)||142
1475213|NCT01888432|3610584|P1|STARTED|24-month Analysis (FAS)||142
1475214|NCT01888432|3610583|P2|NOT COMPLETED|12-month Analysis (FAS)||9
1475215|NCT01888432|3610584|P1|NOT COMPLETED|12-month Analysis (FAS)||11
1475216|NCT01888432|3610583|P2|COMPLETED|12-month Analysis (FAS)||133
1475217|NCT01888432|3610584|P1|COMPLETED|12-month Analysis (FAS)||131
1475218|NCT01888432|3610583|P2|STARTED|12-month Analysis (FAS)||142
1475219|NCT01888432|3610584|P1|STARTED|12-month Analysis (FAS)||142
1475220|NCT01888367|3610619|P3|NOT COMPLETED|Overall Study||5
1475221|NCT01888367|3610620|P2|NOT COMPLETED|Overall Study||5
1475222|NCT01888367|3610621|P1|NOT COMPLETED|Overall Study||8
1475223|NCT01888367|3610619|P3|COMPLETED|Overall Study||73
1475224|NCT01888367|3610620|P2|COMPLETED|Overall Study||66
1475225|NCT01888367|3610621|P1|COMPLETED|Overall Study||288
1475226|NCT01888367|3610619|P3|STARTED|Overall Study||78
1475227|NCT01888367|3610620|P2|STARTED|Overall Study||71
1475228|NCT01888367|3610621|P1|STARTED|Overall Study||296
1475229|NCT01888003|3610641|P3|NOT COMPLETED|Overall Study||40
1475230|NCT01888003|3610642|P2|NOT COMPLETED|Overall Study||6
1475231|NCT01888003|3610643|P1|NOT COMPLETED|Overall Study||5
1475232|NCT01888003|3610641|P3|COMPLETED|Overall Study||0
1475233|NCT01888003|3610642|P2|COMPLETED|Overall Study||0
1475234|NCT01888003|3610643|P1|COMPLETED|Overall Study||0
1475235|NCT01888003|3610641|P3|STARTED|Overall Study||40
1475236|NCT01888003|3610642|P2|STARTED|Overall Study||6
1475237|NCT01888003|3610643|P1|STARTED|Overall Study||5
1475238|NCT01887990|3610664|P4|NOT COMPLETED|Overall Study||0
1475239|NCT01887990|3610665|P3|NOT COMPLETED|Overall Study||0
1475240|NCT01887990|3610666|P2|NOT COMPLETED|Overall Study||0
1475241|NCT01887990|3610667|P1|NOT COMPLETED|Overall Study||0
1475242|NCT01887990|3610664|P4|COMPLETED|Overall Study||2
1475243|NCT01887990|3610665|P3|COMPLETED|Overall Study||2
1475244|NCT01887990|3610666|P2|COMPLETED|Overall Study||7
1475245|NCT01887990|3610667|P1|COMPLETED|Overall Study||7
1475246|NCT01887990|3610664|P4|STARTED|Overall Study||2
1475247|NCT01887990|3610665|P3|STARTED|Overall Study||2
1475248|NCT01887990|3610666|P2|STARTED|Overall Study||7
1475249|NCT01887990|3610667|P1|STARTED|Overall Study||7
1475250|NCT01887678|3610683|P2|NOT COMPLETED|Overall Study||28
1475251|NCT01887678|3610684|P1|NOT COMPLETED|Overall Study||17
1475252|NCT01887678|3610683|P2|COMPLETED|Overall Study||85
1475253|NCT01887678|3610684|P1|COMPLETED|Overall Study||102
1475254|NCT01887678|3610683|P2|STARTED|Overall Study||113
1475255|NCT01887678|3610684|P1|STARTED|Overall Study||119
1475256|NCT01887470|3610730|P4|NOT COMPLETED|Overall Study||0
1475257|NCT01887470|3610731|P3|NOT COMPLETED|Overall Study||0
1475258|NCT01887470|3610732|P2|NOT COMPLETED|Overall Study||0
1475259|NCT01887470|3610733|P1|NOT COMPLETED|Overall Study||0
1475260|NCT01887470|3610730|P4|COMPLETED|Overall Study||10
1475261|NCT01887470|3610731|P3|COMPLETED|Overall Study||10
1475262|NCT01887470|3610732|P2|COMPLETED|Overall Study||10
1475263|NCT01887470|3610733|P1|COMPLETED|Overall Study||10
1475264|NCT01887470|3610730|P4|STARTED|Overall Study||10
1475265|NCT01887470|3610731|P3|STARTED|Overall Study||10
1475266|NCT01887470|3610732|P2|STARTED|Overall Study||10
1475267|NCT01887470|3610733|P1|STARTED|Overall Study||10
1475268|NCT01887418|3610752|P3|NOT COMPLETED|Overall Study||1
1475269|NCT01887418|3610753|P2|NOT COMPLETED|Overall Study||0
1475270|NCT01887418|3610754|P1|NOT COMPLETED|Overall Study||0
1475271|NCT01887418|3610752|P3|COMPLETED|Overall Study||9
1475272|NCT01887418|3610753|P2|COMPLETED|Overall Study||14
1475273|NCT01887418|3610754|P1|COMPLETED|Overall Study||15
1475274|NCT01887418|3610752|P3|STARTED|Overall Study||10
1475275|NCT01887418|3610753|P2|STARTED|Overall Study||14
1475276|NCT01887418|3610754|P1|STARTED|Overall Study||15
1475277|NCT01887353|3610773|P2|NOT COMPLETED|Overall Study||3
1475278|NCT01887353|3610774|P1|NOT COMPLETED|Overall Study||4
1475279|NCT01887353|3610773|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
1475280|NCT01887353|3610774|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
1475281|NCT01887353|3610773|P2|STARTED|Overall Study||4
1475282|NCT01887353|3610774|P1|STARTED|Overall Study||4
1475283|NCT01887288|3610780|P1|NOT COMPLETED|Overall Study||16
1475284|NCT01887288|3610780|P1|COMPLETED|Overall Study||0
1475285|NCT01887288|3610780|P1|STARTED|Overall Study||16
1475286|NCT01887210|3610787|P2|NOT COMPLETED|Overall Study||4
1475287|NCT01887210|3610788|P1|NOT COMPLETED|Overall Study||1
1475288|NCT01887210|3610787|P2|COMPLETED|Overall Study||29
1475289|NCT01887210|3610788|P1|COMPLETED|Overall Study||32
1475290|NCT01887210|3610787|P2|STARTED|Overall Study||33
1475291|NCT01887210|3610788|P1|STARTED|Overall Study||33
1475292|NCT01887171|3610802|P2|NOT COMPLETED|Overall Study||0
1475293|NCT01887171|3610803|P1|NOT COMPLETED|Overall Study||0
1475294|NCT01887171|3610802|P2|COMPLETED|Overall Study||43
1475295|NCT01887171|3610803|P1|COMPLETED|Overall Study||43
1475296|NCT01887171|3610802|P2|STARTED|Overall Study||43
1475297|NCT01887171|3610803|P1|STARTED|Overall Study||43
1475298|NCT01887132|3610809|P1|NOT COMPLETED|Overall Study||0
1475299|NCT01887132|3610809|P1|COMPLETED|Overall Study||4
1475300|NCT01887132|3610809|P1|STARTED|Overall Study||4
1475301|NCT01886963|3610816|P2|NOT COMPLETED|Overall Study||4
1475302|NCT01886963|3610817|P1|NOT COMPLETED|Overall Study||5
1475303|NCT01886963|3610816|P2|COMPLETED|Overall Study||49
1475304|NCT01886963|3610817|P1|COMPLETED|Overall Study||46
1475305|NCT01886963|3610816|P2|12 Week Follow Up|Overall Study||22
1475306|NCT01886963|3610817|P1|12 Week Follow Up|Overall Study||24
1475307|NCT01886963|3610816|P2|4 Week Follow Up|Overall Study||26
1475308|NCT01886963|3610817|P1|4 Week Follow Up|Overall Study||24
1475309|NCT01886963|3610816|P2|2 Week Follow Up|Overall Study||35
1475310|NCT01886963|3610817|P1|2 Week Follow Up|Overall Study||38
1475311|NCT01886963|3610816|P2|STARTED|Overall Study||53
1475312|NCT01886963|3610817|P1|STARTED|Overall Study||51
1475313|NCT01886937|3610825|P2|NOT COMPLETED|Overall Study||0
1475314|NCT01886937|3610826|P1|NOT COMPLETED|Overall Study||0
1475315|NCT01886937|3610825|P2|COMPLETED|Overall Study||6
1475316|NCT01886937|3610826|P1|COMPLETED|Overall Study||7
1475317|NCT01886937|3610825|P2|STARTED|Overall Study||6
1475318|NCT01886937|3610826|P1|STARTED|Overall Study||7
1475319|NCT01886833|3610832|P1|NOT COMPLETED|Overall Study||204
1475320|NCT01886833|3610832|P1|COMPLETED|Overall Study||216
1475321|NCT01886833|3610832|P1|STARTED|Overall Study||420
1475322|NCT01886807|3610843|P3|NOT COMPLETED|Overall Study||10
1475323|NCT01886807|3610844|P2|NOT COMPLETED|Overall Study||10
1475324|NCT01886807|3610845|P1|NOT COMPLETED|Overall Study||5
1475325|NCT01886807|3610843|P3|COMPLETED|Overall Study||153
1475326|NCT01886807|3610844|P2|COMPLETED|Overall Study||145
1475327|NCT01886807|3610845|P1|COMPLETED|Overall Study||159
1475328|NCT01886807|3610843|P3|STARTED|Overall Study||163
1475329|NCT01886807|3610844|P2|STARTED|Overall Study||155
1475330|NCT01886807|3610845|P1|STARTED|Overall Study||164
1475331|NCT01886781|3610855|P2|NOT COMPLETED|Overall Study||2
1475332|NCT01886781|3610856|P1|NOT COMPLETED|Overall Study||14
1475333|NCT01886781|3610855|P2|COMPLETED|Overall Study||25
1475334|NCT01886781|3610856|P1|COMPLETED|Overall Study||40
1475335|NCT01886781|3610855|P2|STARTED|Overall Study||27
1475336|NCT01886781|3610856|P1|STARTED|Overall Study||54
1475337|NCT01886716|3610866|P4|NOT COMPLETED|1-Month Post Follow-Up||0
1475338|NCT01886716|3610867|P3|NOT COMPLETED|1-Month Post Follow-Up||0
1475339|NCT01886716|3610868|P2|NOT COMPLETED|1-Month Post Follow-Up||0
1475340|NCT01886716|3610869|P1|NOT COMPLETED|1-Month Post Follow-Up||0
1475341|NCT01886716|3610866|P4|COMPLETED|1-Month Post Follow-Up||14
1475342|NCT01886716|3610867|P3|COMPLETED|1-Month Post Follow-Up||19
1475343|NCT01886716|3610868|P2|COMPLETED|1-Month Post Follow-Up||17
1475344|NCT01886716|3610869|P1|COMPLETED|1-Month Post Follow-Up||20
1475345|NCT01886716|3610866|P4|STARTED|1-Month Post Follow-Up||14
1475346|NCT01886716|3610867|P3|STARTED|1-Month Post Follow-Up||19
1475347|NCT01886716|3610868|P2|STARTED|1-Month Post Follow-Up||17
1475348|NCT01886716|3610869|P1|STARTED|1-Month Post Follow-Up||20
1475349|NCT01886716|3610866|P4|NOT COMPLETED|1-Week Post Follow-Up||0
1475350|NCT01886716|3610867|P3|NOT COMPLETED|1-Week Post Follow-Up||0
1475351|NCT01886716|3610868|P2|NOT COMPLETED|1-Week Post Follow-Up||0
1475352|NCT01886716|3610869|P1|NOT COMPLETED|1-Week Post Follow-Up||0
1475353|NCT01886716|3610866|P4|COMPLETED|1-Week Post Follow-Up||14
1475354|NCT01886716|3610867|P3|COMPLETED|1-Week Post Follow-Up||19
1475355|NCT01886716|3610868|P2|COMPLETED|1-Week Post Follow-Up||17
1475356|NCT01886716|3610869|P1|COMPLETED|1-Week Post Follow-Up||20
1475357|NCT01886716|3610866|P4|STARTED|1-Week Post Follow-Up||14
1475358|NCT01886716|3610867|P3|STARTED|1-Week Post Follow-Up||19
1475359|NCT01886716|3610868|P2|STARTED|1-Week Post Follow-Up||17
1475360|NCT01886716|3610869|P1|STARTED|1-Week Post Follow-Up||20
1475361|NCT01886716|3610866|P4|NOT COMPLETED|Week 4||0
1475362|NCT01886716|3610867|P3|NOT COMPLETED|Week 4||0
1475363|NCT01886716|3610868|P2|NOT COMPLETED|Week 4||0
1475364|NCT01886716|3610869|P1|NOT COMPLETED|Week 4||0
1475365|NCT01886716|3610866|P4|COMPLETED|Week 4||14
1475366|NCT01886716|3610867|P3|COMPLETED|Week 4||19
1475367|NCT01886716|3610868|P2|COMPLETED|Week 4||17
1475368|NCT01886716|3610869|P1|COMPLETED|Week 4||20
1475369|NCT01886716|3610866|P4|STARTED|Week 4||14
1475370|NCT01886716|3610867|P3|STARTED|Week 4||19
1475371|NCT01886716|3610868|P2|STARTED|Week 4||17
1475372|NCT01886716|3610869|P1|STARTED|Week 4||20
1475373|NCT01886716|3610866|P4|NOT COMPLETED|Week 3||1
1475374|NCT01886716|3610867|P3|NOT COMPLETED|Week 3||0
1475375|NCT01886716|3610868|P2|NOT COMPLETED|Week 3||1
1475376|NCT01886716|3610869|P1|NOT COMPLETED|Week 3||1
1475377|NCT01886716|3610866|P4|COMPLETED|Week 3||14
1475378|NCT01886716|3610867|P3|COMPLETED|Week 3||19
1475379|NCT01886716|3610868|P2|COMPLETED|Week 3||17
1475380|NCT01886716|3610869|P1|COMPLETED|Week 3||20
1475381|NCT01886716|3610866|P4|STARTED|Week 3||15
1475382|NCT01886716|3610867|P3|STARTED|Week 3||19
1475383|NCT01886716|3610868|P2|STARTED|Week 3||18
1475384|NCT01886716|3610869|P1|STARTED|Week 3||21
1475385|NCT01886716|3610866|P4|NOT COMPLETED|Week 2||3
1475386|NCT01886716|3610867|P3|NOT COMPLETED|Week 2||1
1475387|NCT01886716|3610868|P2|NOT COMPLETED|Week 2||2
1475388|NCT01886716|3610869|P1|NOT COMPLETED|Week 2||3
1475389|NCT01886716|3610866|P4|COMPLETED|Week 2||15
1475390|NCT01886716|3610867|P3|COMPLETED|Week 2||19
1475391|NCT01886716|3610868|P2|COMPLETED|Week 2||18
1475392|NCT01886716|3610869|P1|COMPLETED|Week 2||21
1475393|NCT01886716|3610866|P4|STARTED|Week 2||18
1475394|NCT01886716|3610867|P3|STARTED|Week 2||20
1475395|NCT01886716|3610868|P2|STARTED|Week 2||20
1475396|NCT01886716|3610869|P1|STARTED|Week 2||24
1475397|NCT01886716|3610866|P4|NOT COMPLETED|Week 1||2
1475398|NCT01886716|3610867|P3|NOT COMPLETED|Week 1||2
1475399|NCT01886716|3610868|P2|NOT COMPLETED|Week 1||0
1475400|NCT01886716|3610869|P1|NOT COMPLETED|Week 1||0
1475401|NCT01886716|3610866|P4|COMPLETED|Week 1||18
1475402|NCT01886716|3610867|P3|COMPLETED|Week 1||20
1475403|NCT01886716|3610868|P2|COMPLETED|Week 1||20
1475404|NCT01886716|3610869|P1|COMPLETED|Week 1||24
1475405|NCT01886716|3610866|P4|STARTED|Week 1||20
1475406|NCT01886716|3610867|P3|STARTED|Week 1||22
1475407|NCT01886716|3610868|P2|STARTED|Week 1||20
1475408|NCT01886716|3610869|P1|STARTED|Week 1||24
1475409|NCT01886690|3610885|P2|NOT COMPLETED|Overall Study||2
1475410|NCT01886690|3610886|P1|NOT COMPLETED|Overall Study||0
1475411|NCT01886690|3610885|P2|COMPLETED|Overall Study||71
1475412|NCT01886690|3610886|P1|COMPLETED|Overall Study||75
1475413|NCT01886690|3610885|P2|STARTED|Overall Study||73
1475414|NCT01886690|3610886|P1|STARTED|Overall Study||75
1475415|NCT01886313|3610902|P2|NOT COMPLETED|Overall Study||1
1475416|NCT01886313|3610903|P1|NOT COMPLETED|Overall Study||1
1475417|NCT01886313|3610902|P2|COMPLETED|Overall Study||4
1475418|NCT01886313|3610903|P1|COMPLETED|Overall Study||5
1475419|NCT01886313|3610902|P2|STARTED|Overall Study||5
1475420|NCT01886313|3610903|P1|STARTED|Overall Study||6
1475421|NCT01886300|3610909|P1|NOT COMPLETED|Overall Study||16
1475422|NCT01886300|3610909|P1|COMPLETED|Overall Study||0
1475423|NCT01886300|3610909|P1|STARTED|Overall Study||16
1475424|NCT01886287|3610920|P1|NOT COMPLETED|Overall Study||2
1475425|NCT01886287|3610920|P1|COMPLETED|Overall Study||0
1475426|NCT01886287|3610920|P1|STARTED|Overall Study||2
1475427|NCT01886235|3610925|P1|NOT COMPLETED|Overall Study||0
1475428|NCT01886235|3610925|P1|COMPLETED|Overall Study||10
1475429|NCT01886235|3610925|P1|STARTED|Overall Study||10
1475430|NCT01885936|3610938|P2|NOT COMPLETED|Overall Study||0
1475431|NCT01885936|3610939|P1|NOT COMPLETED|Overall Study||1
1475432|NCT01885936|3610938|P2|COMPLETED|Overall Study||5
1475433|NCT01885936|3610939|P1|COMPLETED|Overall Study||7
1475434|NCT01885936|3610938|P2|STARTED|Overall Study||5
1475435|NCT01885936|3610939|P1|STARTED|Overall Study||8
1475436|NCT01885910|3610949|P1|NOT COMPLETED|Overall Study||8
1475437|NCT01885910|3610949|P1|COMPLETED|Overall Study||24
1475438|NCT01885910|3610949|P1|STARTED|Overall Study||32
1475439|NCT01885871|3610963|P1|NOT COMPLETED|Overall Study||0
1475440|NCT01885871|3610963|P1|COMPLETED|Overall Study||20
1475441|NCT01885871|3610963|P1|STARTED|Overall Study||20
1475442|NCT01885559|3610973|P2|NOT COMPLETED|Overall Study||36
1475443|NCT01885559|3610974|P1|NOT COMPLETED|Overall Study||24
1475444|NCT01885559|3610973|P2|COMPLETED|Overall Study||208
1475445|NCT01885559|3610974|P1|COMPLETED|Overall Study||218
1475446|NCT01885559|3610973|P2|STARTED|Overall Study||244
1475447|NCT01885559|3610974|P1|STARTED|Overall Study||242
1475448|NCT01885208|3610996|P2|NOT COMPLETED|Overall Study||38
1475449|NCT01885208|3610997|P1|NOT COMPLETED|Overall Study||32
1475450|NCT01885208|3610996|P2|COMPLETED|Overall Study||369
1475451|NCT01885208|3610997|P1|COMPLETED|Overall Study||374
1475452|NCT01885208|3610996|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
1475453|NCT01885208|3610997|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
1475454|NCT01885208|3610996|P2|Exposed|Overall Study||405
1475455|NCT01885208|3610997|P1|Exposed|Overall Study||404
1475456|NCT01885208|3610996|P2|STARTED|Overall Study||407
1475457|NCT01885208|3610997|P1|STARTED|Overall Study||406
1475458|NCT01885117|3611015|P2|NOT COMPLETED|Overall Study||0
1475459|NCT01885117|3611016|P1|NOT COMPLETED|Overall Study||0
1475460|NCT01885117|3611015|P2|COMPLETED|Overall Study||64
1475461|NCT01885117|3611016|P1|COMPLETED|Overall Study||61
1475462|NCT01885117|3611015|P2|STARTED|Overall Study||64
1475463|NCT01885117|3611016|P1|STARTED|Overall Study||61
1475464|NCT01885104|3611038|P2|NOT COMPLETED|Overall Study||1
1475465|NCT01885104|3611039|P1|NOT COMPLETED|Overall Study||2
1475466|NCT01885104|3611038|P2|COMPLETED|Overall Study||33
1475467|NCT01885104|3611039|P1|COMPLETED|Overall Study||29
1475468|NCT01885104|3611038|P2|STARTED|Overall Study||34
1475469|NCT01885104|3611039|P1|STARTED|Overall Study||31
1475470|NCT01885000|3611049|P2|NOT COMPLETED|Overall Study||2
1475471|NCT01885000|3611050|P1|NOT COMPLETED|Overall Study||2
1475472|NCT01885000|3611049|P2|COMPLETED|Overall Study||42
1475473|NCT01885000|3611050|P1|COMPLETED|Overall Study||46
1475474|NCT01885000|3611049|P2|STARTED|Overall Study||44
1475475|NCT01885000|3611050|P1|STARTED|Overall Study||48
1475476|NCT01884844|3611064|P2|NOT COMPLETED|Overall Study||5
1475477|NCT01884844|3611065|P1|NOT COMPLETED|Overall Study||3
1475478|NCT01884844|3611064|P2|COMPLETED|Overall Study||12
1475479|NCT01884844|3611065|P1|COMPLETED|Overall Study||13
1475480|NCT01884844|3611064|P2|STARTED|Overall Study||17
1475481|NCT01884844|3611065|P1|STARTED|Overall Study||16
1475482|NCT01884688|3611071|P1|NOT COMPLETED|Overall Study||2
1475483|NCT01884688|3611071|P1|COMPLETED|Overall Study||1
1475484|NCT01884688|3611071|P1|STARTED|Overall Study||3
1475485|NCT01884675|3611077|P2|NOT COMPLETED|Overall Study||2
1475486|NCT01884675|3611078|P1|NOT COMPLETED|Overall Study||3
1475487|NCT01884675|3611077|P2|COMPLETED|Overall Study||15
1475488|NCT01884675|3611078|P1|COMPLETED|Overall Study||13
1475489|NCT01884675|3611077|P2|STARTED|Overall Study||17
1475490|NCT01884675|3611078|P1|STARTED|Overall Study||16
1475491|NCT01884597|3611121|P3|NOT COMPLETED|Overall Study||1
1475492|NCT01884597|3611122|P2|NOT COMPLETED|Overall Study||1
1475493|NCT01884597|3611123|P1|NOT COMPLETED|Overall Study||1
1475494|NCT01884597|3611121|P3|COMPLETED|Overall Study||15
1475495|NCT01884597|3611122|P2|COMPLETED|Overall Study||2
1475496|NCT01884597|3611123|P1|COMPLETED|Overall Study||4
1475497|NCT01884597|3611121|P3|STARTED|Overall Study||16
1475498|NCT01884597|3611122|P2|STARTED|Overall Study||3
1475499|NCT01884597|3611123|P1|STARTED|Overall Study||5
1475500|NCT01884571|3611152|P1|NOT COMPLETED|Overall Study||8
1475501|NCT01884571|3611152|P1|COMPLETED|Overall Study||23
1475502|NCT01884571|3611152|P1|STARTED|Overall Study||31
1475503|NCT01884545|3611167|P4|NOT COMPLETED|Overall Study||9
1475504|NCT01884545|3611168|P3|NOT COMPLETED|Overall Study||14
1475505|NCT01884545|3611169|P2|NOT COMPLETED|Overall Study||18
1475506|NCT01884545|3611170|P1|NOT COMPLETED|Overall Study||13
1475507|NCT01884545|3611167|P4|COMPLETED|Overall Study||43
1475508|NCT01884545|3611168|P3|COMPLETED|Overall Study||35
1475509|NCT01884545|3611169|P2|COMPLETED|Overall Study||31
1475510|NCT01884545|3611170|P1|COMPLETED|Overall Study||37
1475511|NCT01884545|3611167|P4|STARTED|Overall Study||52
1475512|NCT01884545|3611168|P3|STARTED|Overall Study||49
1475513|NCT01884545|3611169|P2|STARTED|Overall Study||49
1475514|NCT01884545|3611170|P1|STARTED|Overall Study||50
1475515|NCT01884519|3611278|P2|NOT COMPLETED|Overall Study||0
1475516|NCT01884519|3611279|P1|NOT COMPLETED|Overall Study||0
1475517|NCT01884519|3611278|P2|COMPLETED|Overall Study||60
1475518|NCT01884519|3611279|P1|COMPLETED|Overall Study||60
1475519|NCT01884519|3611278|P2|STARTED|Overall Study||60
1475520|NCT01884519|3611279|P1|STARTED|Overall Study||60
1475521|NCT01884311|3611321|P1|NOT COMPLETED|Overall Study||5
1475522|NCT01884311|3611321|P1|COMPLETED|Overall Study||33
1475523|NCT01884311|3611321|P1|STARTED|Overall Study||38
1475524|NCT01884077|3611331|P2|NOT COMPLETED|Overall Study||10
1475525|NCT01884077|3611332|P1|NOT COMPLETED|Overall Study||8
1475526|NCT01884077|3611331|P2|COMPLETED|Overall Study||1
1475527|NCT01884077|3611332|P1|COMPLETED|Overall Study||0
1475528|NCT01884077|3611331|P2|STARTED|Overall Study||11
1475529|NCT01884077|3611332|P1|STARTED|Overall Study||8
1475530|NCT01884064|3611344|P2|NOT COMPLETED|Overall Study||0
1475531|NCT01884064|3611345|P1|NOT COMPLETED|Overall Study||0
1475532|NCT01884064|3611344|P2|COMPLETED|Overall Study||5
1475533|NCT01884064|3611345|P1|COMPLETED|Overall Study||12
1475534|NCT01884064|3611344|P2|STARTED|Overall Study||5
1475535|NCT01884064|3611345|P1|STARTED|Overall Study||12
1475536|NCT01884025|3611353|P2|NOT COMPLETED|Overall Study||4
1475537|NCT01884025|3611354|P1|NOT COMPLETED|Overall Study||3
1475538|NCT01884025|3611353|P2|COMPLETED|Overall Study||10
1475539|NCT01884025|3611354|P1|COMPLETED|Overall Study||10
1475540|NCT01884025|3611353|P2|STARTED|Overall Study||14
1475541|NCT01884025|3611354|P1|STARTED|Overall Study||13
1475542|NCT01883999|3611382|P1|NOT COMPLETED|Overall Study||3
1475543|NCT01883999|3611382|P1|COMPLETED|Overall Study||61
1475544|NCT01883999|3611382|P1|STARTED|Overall Study||64
1475545|NCT01883986|3611390|P2|NOT COMPLETED|Overall Study||1
1475546|NCT01883986|3611391|P1|NOT COMPLETED|Overall Study||3
1475547|NCT01883986|3611390|P2|COMPLETED|Overall Study|Completed study|19
1475548|NCT01883986|3611391|P1|COMPLETED|Overall Study|Received allocated intervention|17
1475549|NCT01883986|3611390|P2|Did Not Complete Study|Overall Study|Did not completed study|1
1475550|NCT01883986|3611391|P1|Did Not Complete Study|Overall Study||3
1475551|NCT01883986|3611390|P2|STARTED|Overall Study|Allocated to usual care arm|20
1475552|NCT01883986|3611391|P1|STARTED|Overall Study|Allocated to intervention arm|20
1475553|NCT01883908|3611405|P2|NOT COMPLETED|Overall Study||0
1475554|NCT01883908|3611406|P1|NOT COMPLETED|Overall Study||0
1475555|NCT01883908|3611405|P2|COMPLETED|Overall Study||1
1475556|NCT01883908|3611406|P1|COMPLETED|Overall Study||3
1475557|NCT01883908|3611405|P2|STARTED|Overall Study||1
1475558|NCT01883908|3611406|P1|STARTED|Overall Study||3
1475559|NCT01883895|3611414|P1|NOT COMPLETED|Overall Study||2
1475560|NCT01883895|3611414|P1|COMPLETED|Overall Study||32
1475561|NCT01883895|3611414|P1|STARTED|Overall Study||34
1475562|NCT01883804|3611419|P1|NOT COMPLETED|Overall Study||5
1475563|NCT01883804|3611419|P1|COMPLETED|Overall Study||20
1475564|NCT01883804|3611419|P1|STARTED|Overall Study||25
1475565|NCT01883635|3611428|P2|NOT COMPLETED|Overall Study||0
1475566|NCT01883635|3611429|P1|NOT COMPLETED|Overall Study||4
1475567|NCT01883635|3611428|P2|COMPLETED|Overall Study||20
1475568|NCT01883635|3611429|P1|COMPLETED|Overall Study||20
1475569|NCT01883635|3611428|P2|STARTED|Overall Study||20
1475570|NCT01883635|3611429|P1|STARTED|Overall Study||24
1475571|NCT01883453|3611443|P2|NOT COMPLETED|Overall Study||23
1475572|NCT01883453|3611444|P1|NOT COMPLETED|Overall Study||25
1475573|NCT01883453|3611443|P2|COMPLETED|Overall Study||50
1475574|NCT01883453|3611444|P1|COMPLETED|Overall Study||48
1475575|NCT01883453|3611443|P2|STARTED|Overall Study||73
1475576|NCT01883453|3611444|P1|STARTED|Overall Study||73
1475577|NCT01883440|3611452|P2|NOT COMPLETED|Overall Study||0
1475578|NCT01883440|3611453|P1|NOT COMPLETED|Overall Study||3
1475579|NCT01883440|3611452|P2|COMPLETED|Overall Study||45
1475580|NCT01883440|3611453|P1|COMPLETED|Overall Study||42
1475581|NCT01883440|3611452|P2|STARTED|Overall Study||45
1475582|NCT01883440|3611453|P1|STARTED|Overall Study||45
1475583|NCT01883427|3611463|P2|NOT COMPLETED|Overall Study||0
1475584|NCT01883427|3611464|P1|NOT COMPLETED|Overall Study||0
1475585|NCT01883427|3611463|P2|COMPLETED|Overall Study||20
1475586|NCT01883427|3611464|P1|COMPLETED|Overall Study||20
1475587|NCT01883427|3611463|P2|STARTED|Overall Study||20
1475588|NCT01883427|3611464|P1|STARTED|Overall Study||20
1475589|NCT01883141|3611470|P1|NOT COMPLETED|Overall Study||0
1475590|NCT01883141|3611470|P1|COMPLETED|Overall Study|Exit form with exit reason available|31
1475591|NCT01883141|3611470|P1|Multivein|Overall Study||23
1475592|NCT01883141|3611470|P1|Biv Pacing-Posterior|Overall Study||22
1475593|NCT01883141|3611470|P1|BiV Pacing-Anterior|Overall Study||23
1475594|NCT01883141|3611470|P1|Multispot-pacing|Overall Study||24
1475595|NCT01883141|3611470|P1|BiV Pacing-Standard Therapy|Overall Study||26
1475596|NCT01883141|3611470|P1|BiV Pacing-Mid|Overall Study||25
1475597|NCT01883141|3611470|P1|BiV Pacing-Distal|Overall Study||24
1475598|NCT01883141|3611470|P1|Usable EP Data|Overall Study||26
1475599|NCT01883141|3611470|P1|EP Study Performed|Overall Study||30
1475600|NCT01883141|3611470|P1|Passing Eligibility|Overall Study||30
1475601|NCT01883141|3611470|P1|STARTED|Overall Study||31
1475602|NCT01882985|3611479|P1|NOT COMPLETED|Overall Study||2
1475603|NCT01882985|3611479|P1|COMPLETED|Overall Study||12
1475604|NCT01882985|3611479|P1|STARTED|Overall Study||14
1475605|NCT01882907|3611488|P2|NOT COMPLETED|Overall Study||28
1475606|NCT01882907|3611489|P1|NOT COMPLETED|Overall Study||14
1475607|NCT01882907|3611488|P2|COMPLETED|Overall Study||83
1475608|NCT01882907|3611489|P1|COMPLETED|Overall Study||103
1475609|NCT01882907|3611488|P2|STARTED|Overall Study||111
1475610|NCT01882907|3611489|P1|STARTED|Overall Study||117
1475611|NCT01882868|3611495|P1|NOT COMPLETED|Overall Study||0
1475612|NCT01882868|3611495|P1|COMPLETED|Overall Study||62
1475613|NCT01882868|3611495|P1|STARTED|Overall Study||62
1475614|NCT01882829|3611525|P1|NOT COMPLETED|Overall Study||6
1475615|NCT01882829|3611525|P1|COMPLETED|Overall Study||14
1475616|NCT01882829|3611525|P1|STARTED|Overall Study||20
1475617|NCT01882803|3611539|P1|NOT COMPLETED|Overall Study||94
1475618|NCT01882803|3611539|P1|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
1475619|NCT01882803|3611539|P1|STARTED|Overall Study||129
1475620|NCT01882725|3611550|P1|NOT COMPLETED|Overall Study||0
1475621|NCT01882725|3611550|P1|COMPLETED|Overall Study||14
1475622|NCT01882725|3611550|P1|STARTED|Overall Study||14
1475623|NCT01882647|3611557|P2|NOT COMPLETED|Overall Study||6
1475624|NCT01882647|3611558|P1|NOT COMPLETED|Overall Study||2
1475625|NCT01882647|3611557|P2|COMPLETED|Overall Study||106
1475626|NCT01882647|3611558|P1|COMPLETED|Overall Study||108
1475627|NCT01882647|3611557|P2|STARTED|Overall Study||112
1475628|NCT01882647|3611558|P1|STARTED|Overall Study||110
1475629|NCT01882543|3611576|P2|NOT COMPLETED|Overall Study||3
1475630|NCT01882543|3611577|P1|NOT COMPLETED|Overall Study||4
1475631|NCT01882543|3611576|P2|COMPLETED|Overall Study||29
1475632|NCT01882543|3611577|P1|COMPLETED|Overall Study||33
1475633|NCT01882543|3611576|P2|STARTED|Overall Study||32
1475634|NCT01882543|3611577|P1|STARTED|Overall Study||37
1475635|NCT01882465|3611598|P7|NOT COMPLETED|Period 3||0
1475636|NCT01882465|3611599|P6|NOT COMPLETED|Period 3||0
1475637|NCT01882465|3611600|P5|NOT COMPLETED|Period 3||0
1475638|NCT01882465|3611601|P4|NOT COMPLETED|Period 3||0
1475639|NCT01882465|3611602|P3|NOT COMPLETED|Period 3||0
1475640|NCT01882465|3611603|P2|NOT COMPLETED|Period 3||0
1475641|NCT01882465|3611604|P1|NOT COMPLETED|Period 3||0
1475642|NCT01882465|3611598|P7|COMPLETED|Period 3||0
1475643|NCT01882465|3611599|P6|COMPLETED|Period 3||5
1475644|NCT01882465|3611600|P5|COMPLETED|Period 3||4
1475645|NCT01882465|3611601|P4|COMPLETED|Period 3||5
1475646|NCT01882465|3611602|P3|COMPLETED|Period 3||5
1475647|NCT01882465|3611603|P2|COMPLETED|Period 3||6
1475648|NCT01882465|3611604|P1|COMPLETED|Period 3||6
1475649|NCT01882465|3611598|P7|STARTED|Period 3||0
1475650|NCT01882465|3611599|P6|STARTED|Period 3||5
1475651|NCT01882465|3611600|P5|STARTED|Period 3||4
1475652|NCT01882465|3611601|P4|STARTED|Period 3||5
1475653|NCT01882465|3611602|P3|STARTED|Period 3||5
1475654|NCT01882465|3611603|P2|STARTED|Period 3||6
1475655|NCT01882465|3611604|P1|STARTED|Period 3||6
1475656|NCT01882465|3611598|P7|NOT COMPLETED|Period 2||0
1475657|NCT01882465|3611599|P6|NOT COMPLETED|Period 2||0
1475658|NCT01882465|3611600|P5|NOT COMPLETED|Period 2||1
1475659|NCT01882465|3611601|P4|NOT COMPLETED|Period 2||0
1475660|NCT01882465|3611602|P3|NOT COMPLETED|Period 2||0
1475661|NCT01882465|3611603|P2|NOT COMPLETED|Period 2||0
1475662|NCT01882465|3611604|P1|NOT COMPLETED|Period 2||0
1475663|NCT01882465|3611598|P7|COMPLETED|Period 2||0
1475664|NCT01882465|3611599|P6|COMPLETED|Period 2||5
1475665|NCT01882465|3611600|P5|COMPLETED|Period 2||4
1475666|NCT01882465|3611601|P4|COMPLETED|Period 2||5
1475667|NCT01882465|3611602|P3|COMPLETED|Period 2||5
1475668|NCT01882465|3611603|P2|COMPLETED|Period 2||6
1475669|NCT01882465|3611604|P1|COMPLETED|Period 2||6
1475670|NCT01882465|3611598|P7|STARTED|Period 2||0
1475671|NCT01882465|3611599|P6|STARTED|Period 2||5
1475672|NCT01882465|3611600|P5|STARTED|Period 2||5
1475673|NCT01882465|3611601|P4|STARTED|Period 2||5
1475674|NCT01882465|3611602|P3|STARTED|Period 2||5
1475675|NCT01882465|3611603|P2|STARTED|Period 2||6
1475676|NCT01882465|3611604|P1|STARTED|Period 2||6
1475677|NCT01882465|3611598|P7|NOT COMPLETED|Period 1||1
1475678|NCT01882465|3611599|P6|NOT COMPLETED|Period 1||0
1475679|NCT01882465|3611600|P5|NOT COMPLETED|Period 1||0
1475680|NCT01882465|3611601|P4|NOT COMPLETED|Period 1||1
1475681|NCT01882465|3611602|P3|NOT COMPLETED|Period 1||0
1475682|NCT01882465|3611603|P2|NOT COMPLETED|Period 1||0
1475683|NCT01882465|3611604|P1|NOT COMPLETED|Period 1||0
1475684|NCT01882465|3611598|P7|COMPLETED|Period 1||0
1475685|NCT01882465|3611599|P6|COMPLETED|Period 1||5
1475686|NCT01882465|3611600|P5|COMPLETED|Period 1||5
1475687|NCT01882465|3611601|P4|COMPLETED|Period 1||5
1475688|NCT01882465|3611602|P3|COMPLETED|Period 1||5
1475689|NCT01882465|3611603|P2|COMPLETED|Period 1||6
1475690|NCT01882465|3611604|P1|COMPLETED|Period 1||6
1475691|NCT01882465|3611598|P7|STARTED|Period 1||1
1475692|NCT01882465|3611599|P6|STARTED|Period 1||5
1475693|NCT01882465|3611600|P5|STARTED|Period 1||5
1475694|NCT01882465|3611601|P4|STARTED|Period 1||6
1475695|NCT01882465|3611602|P3|STARTED|Period 1||5
1475696|NCT01882465|3611603|P2|STARTED|Period 1||6
1475697|NCT01882465|3611604|P1|STARTED|Period 1||6
1475698|NCT01882439|3611616|P4|NOT COMPLETED|Overall Study||9
1475699|NCT01882439|3611617|P3|NOT COMPLETED|Overall Study||10
1475700|NCT01882439|3611618|P2|NOT COMPLETED|Overall Study||21
1475701|NCT01882439|3611619|P1|NOT COMPLETED|Overall Study||9
1475702|NCT01882439|3611616|P4|COMPLETED|Overall Study||56
1475703|NCT01882439|3611617|P3|COMPLETED|Overall Study||56
1475704|NCT01882439|3611618|P2|COMPLETED|Overall Study||111
1475705|NCT01882439|3611619|P1|COMPLETED|Overall Study||122
1475706|NCT01882439|3611616|P4|STARTED|Overall Study|Received treatment|65
1475707|NCT01882439|3611617|P3|STARTED|Overall Study|Received treatment|66
1475708|NCT01882439|3611618|P2|STARTED|Overall Study|Received treatment|132
1475709|NCT01882439|3611619|P1|STARTED|Overall Study|Received treatment|131
1475710|NCT01882413|3611799|P1|NOT COMPLETED|Overall Study||0
1475711|NCT01882413|3611799|P1|COMPLETED|Overall Study||204
1475712|NCT01882413|3611799|P1|STARTED|Overall Study||204
1475713|NCT01882257|3611816|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
1475714|NCT01882257|3611817|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
1475715|NCT01882257|3611818|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
1475716|NCT01882257|3611816|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
1475717|NCT01882257|3611817|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
1475718|NCT01882257|3611818|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
1475719|NCT01882257|3611816|P3|STARTED|Therapy Portion of Study (12 Months)||22
1475720|NCT01882257|3611817|P2|STARTED|Therapy Portion of Study (12 Months)||38
1475721|NCT01882257|3611818|P1|STARTED|Therapy Portion of Study (12 Months)||11
1475722|NCT01882257|3611816|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
1475723|NCT01882257|3611817|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
1475724|NCT01882257|3611818|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
1475725|NCT01882257|3611816|P3|COMPLETED|Study Origination to Beginning Therapy||22
1475726|NCT01882257|3611817|P2|COMPLETED|Study Origination to Beginning Therapy||38
1475727|NCT01882257|3611818|P1|COMPLETED|Study Origination to Beginning Therapy||11
1475728|NCT01882257|3611816|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
1475729|NCT01882257|3611817|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
1475730|NCT01882257|3611818|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
1475731|NCT01882257|3611816|P3|STARTED|Study Origination to Beginning Therapy||23
1475732|NCT01882257|3611817|P2|STARTED|Study Origination to Beginning Therapy||40
1475733|NCT01882257|3611818|P1|STARTED|Study Origination to Beginning Therapy||11
1475734|NCT01882062|3611825|P1|NOT COMPLETED|Overall Study||0
1475735|NCT01882062|3611825|P1|COMPLETED|Overall Study|18th of july 2013|10
1475736|NCT01882062|3611825|P1|STARTED|Overall Study|16th of may 2013|10
1475737|NCT01881984|3611829|P1|NOT COMPLETED|Overall Study||0
1475738|NCT01881984|3611829|P1|COMPLETED|Overall Study||4
1475739|NCT01881984|3611829|P1|STARTED|Overall Study||4
1475740|NCT01881932|3611837|P3|NOT COMPLETED|Overall Study||0
1475741|NCT01881932|3611838|P2|NOT COMPLETED|Overall Study||0
1475742|NCT01881932|3611839|P1|NOT COMPLETED|Overall Study||0
1475743|NCT01881932|3611837|P3|COMPLETED|Overall Study||13
1475744|NCT01881932|3611838|P2|COMPLETED|Overall Study||4
1475745|NCT01881932|3611839|P1|COMPLETED|Overall Study||2
1475746|NCT01881932|3611837|P3|STARTED|Overall Study||13
1475747|NCT01881932|3611838|P2|STARTED|Overall Study||4
1475748|NCT01881932|3611839|P1|STARTED|Overall Study||2
1475749|NCT01881867|3611849|P2|NOT COMPLETED|Overall Study||13
1475750|NCT01881867|3611850|P1|NOT COMPLETED|Overall Study||12
1475751|NCT01881867|3611849|P2|COMPLETED|Overall Study||15
1475752|NCT01881867|3611850|P1|COMPLETED|Overall Study||14
1475753|NCT01881867|3611849|P2|STARTED|Overall Study||28
1475754|NCT01881867|3611850|P1|STARTED|Overall Study||26
1475755|NCT01881828|3611858|P2|NOT COMPLETED|Overall Study||0
1475756|NCT01881828|3611859|P1|NOT COMPLETED|Overall Study||0
1475757|NCT01881828|3611858|P2|COMPLETED|Overall Study||69
1475758|NCT01881828|3611859|P1|COMPLETED|Overall Study||71
1475759|NCT01881828|3611858|P2|STARTED|Overall Study|23 excluded from randomization from enrollment|69
1475760|NCT01881828|3611859|P1|STARTED|Overall Study|23 excluded at randomization from enrollment|71
1475761|NCT01881776|3611882|P3|NOT COMPLETED|Overall Study||2
1475762|NCT01881776|3611883|P2|NOT COMPLETED|Overall Study||4
1475763|NCT01881776|3611884|P1|NOT COMPLETED|Overall Study||1
1475764|NCT01881776|3611882|P3|COMPLETED|Overall Study||20
1475765|NCT01881776|3611883|P2|COMPLETED|Overall Study||20
1475766|NCT01881776|3611884|P1|COMPLETED|Overall Study||23
1475767|NCT01881776|3611882|P3|STARTED|Overall Study||22
1475768|NCT01881776|3611883|P2|STARTED|Overall Study||24
1475769|NCT01881776|3611884|P1|STARTED|Overall Study||24
1475770|NCT01881737|3611910|P1|NOT COMPLETED|Overall Study||5
1475771|NCT01881737|3611910|P1|COMPLETED|Overall Study||10
1475772|NCT01881737|3611910|P1|Number Screened|Overall Study||15
1475773|NCT01881737|3611910|P1|STARTED|Overall Study|This is a pilot study|15
1475774|NCT01881230|3611922|P3|NOT COMPLETED|Overall Study||66
1475775|NCT01881230|3611923|P2|NOT COMPLETED|Overall Study||64
1475776|NCT01881230|3611924|P1|NOT COMPLETED|Overall Study||61
1475777|NCT01881230|3611922|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
1475778|NCT01881230|3611923|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
1475779|NCT01881230|3611924|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
1475780|NCT01881230|3611922|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
1475781|NCT01881230|3611923|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
1475782|NCT01881230|3611924|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
1475783|NCT01881230|3611922|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
1475784|NCT01881230|3611923|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
1475785|NCT01881230|3611924|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
1475786|NCT01881230|3611922|P3|STARTED|Overall Study||66
1475787|NCT01881230|3611923|P2|STARTED|Overall Study||64
1475788|NCT01881230|3611924|P1|STARTED|Overall Study||61
1475789|NCT01881126|3611952|P2|NOT COMPLETED|Overall Study||2
1475790|NCT01881126|3611953|P1|NOT COMPLETED|Overall Study||1
1475791|NCT01881126|3611952|P2|COMPLETED|Overall Study||44
1475792|NCT01881126|3611953|P1|COMPLETED|Overall Study||46
1475793|NCT01881126|3611952|P2|STARTED|Overall Study||46
1475794|NCT01881126|3611953|P1|STARTED|Overall Study||47
1475795|NCT01881113|3611961|P2|NOT COMPLETED|Overall Study||6
1475796|NCT01881113|3611962|P1|NOT COMPLETED|Overall Study||8
1475797|NCT01881113|3611961|P2|COMPLETED|Overall Study||44
1475798|NCT01881113|3611962|P1|COMPLETED|Overall Study||43
1475799|NCT01881113|3611961|P2|STARTED|Overall Study||50
1475800|NCT01881113|3611962|P1|STARTED|Overall Study||51
1475801|NCT01881087|3612019|P3|NOT COMPLETED|Overall Study||2
1475802|NCT01881087|3612020|P2|NOT COMPLETED|Overall Study||0
1475803|NCT01881087|3612021|P1|NOT COMPLETED|Overall Study||1
1475804|NCT01881087|3612019|P3|COMPLETED|Overall Study||60
1475805|NCT01881087|3612020|P2|COMPLETED|Overall Study||61
1475806|NCT01881087|3612021|P1|COMPLETED|Overall Study||59
1475807|NCT01881087|3612019|P3|STARTED|Overall Study||62
1475808|NCT01881087|3612020|P2|STARTED|Overall Study||61
1475809|NCT01881087|3612021|P1|STARTED|Overall Study||60
1475810|NCT01880840|3612034|P2|NOT COMPLETED|Overall Study||5
1475811|NCT01880840|3612035|P1|NOT COMPLETED|Overall Study||8
1475812|NCT01880840|3612034|P2|COMPLETED|Overall Study||91
1475813|NCT01880840|3612035|P1|COMPLETED|Overall Study||87
1475814|NCT01880840|3612034|P2|STARTED|Overall Study||96
1475815|NCT01880840|3612035|P1|STARTED|Overall Study||95
1475816|NCT01880736|3612045|P4|NOT COMPLETED|Overall Study||6
1475817|NCT01880736|3612046|P3|NOT COMPLETED|Overall Study||1
1475818|NCT01880736|3612047|P2|NOT COMPLETED|Overall Study||2
1475819|NCT01880736|3612048|P1|NOT COMPLETED|Overall Study||1
1475820|NCT01880736|3612045|P4|COMPLETED|Overall Study||108
1475821|NCT01880736|3612046|P3|COMPLETED|Overall Study||114
1475822|NCT01880736|3612047|P2|COMPLETED|Overall Study||113
1475823|NCT01880736|3612048|P1|COMPLETED|Overall Study||113
1475824|NCT01880736|3612045|P4|STARTED|Overall Study||114
1475825|NCT01880736|3612046|P3|STARTED|Overall Study||115
1475826|NCT01880736|3612047|P2|STARTED|Overall Study||115
1475827|NCT01880736|3612048|P1|STARTED|Overall Study||114
1475828|NCT01880723|3612092|P2|NOT COMPLETED|Overall Study||0
1475829|NCT01880723|3612093|P1|NOT COMPLETED|Overall Study||0
1475830|NCT01880723|3612092|P2|COMPLETED|Overall Study||16
1475831|NCT01880723|3612093|P1|COMPLETED|Overall Study||16
1475832|NCT01880723|3612092|P2|STARTED|Overall Study||16
1475833|NCT01880723|3612093|P1|STARTED|Overall Study||16
1475834|NCT01880697|3612109|P2|NOT COMPLETED|Overall Study||1
1475835|NCT01880697|3612110|P1|NOT COMPLETED|Overall Study||0
1475836|NCT01880697|3612109|P2|COMPLETED|Overall Study||62
1475837|NCT01880697|3612110|P1|COMPLETED|Overall Study||63
1475838|NCT01880697|3612109|P2|STARTED|Overall Study||63
1475839|NCT01880697|3612110|P1|STARTED|Overall Study||63
1475840|NCT01880593|3612132|P2|NOT COMPLETED|Overall Study||6
1475841|NCT01880593|3612133|P1|NOT COMPLETED|Overall Study||8
1475842|NCT01880593|3612132|P2|COMPLETED|Overall Study||10
1475843|NCT01880593|3612133|P1|COMPLETED|Overall Study||10
1475844|NCT01880593|3612132|P2|STARTED|Overall Study||16
1475845|NCT01880593|3612133|P1|STARTED|Overall Study||18
1475846|NCT01880515|3612153|P2|NOT COMPLETED|Overall Study||9
1475847|NCT01880515|3612154|P1|NOT COMPLETED|Overall Study||8
1475848|NCT01880515|3612153|P2|COMPLETED|Overall Study||45
1475849|NCT01880515|3612154|P1|COMPLETED|Overall Study||45
1475850|NCT01880515|3612153|P2|STARTED|Overall Study||54
1475851|NCT01880515|3612154|P1|STARTED|Overall Study||53
1475852|NCT01880437|3612165|P3|NOT COMPLETED|Overall Study||19
1475853|NCT01880437|3612166|P2|NOT COMPLETED|Overall Study||4
1475854|NCT01880437|3612167|P1|NOT COMPLETED|Overall Study||15
1475855|NCT01880437|3612165|P3|COMPLETED|Overall Study||0
1475856|NCT01880437|3612166|P2|COMPLETED|Overall Study||0
1475857|NCT01880437|3612167|P1|COMPLETED|Overall Study||0
1475858|NCT01880437|3612165|P3|STARTED|Overall Study||19
1475859|NCT01880437|3612166|P2|STARTED|Overall Study||4
1475860|NCT01880437|3612167|P1|STARTED|Overall Study||15
1475861|NCT01880424|3612193|P2|NOT COMPLETED|Overall Study||55
1475862|NCT01880424|3612194|P1|NOT COMPLETED|Overall Study||33
1475863|NCT01880424|3612193|P2|COMPLETED|Overall Study||367
1475864|NCT01880424|3612194|P1|COMPLETED|Overall Study||384
1475865|NCT01880424|3612193|P2|STARTED|Overall Study||422
1475866|NCT01880424|3612194|P1|STARTED|Overall Study||417
1475867|NCT01880320|3612219|P3|NOT COMPLETED|Overall Study||8
1475868|NCT01880320|3612220|P2|NOT COMPLETED|Overall Study||25
1475869|NCT01880320|3612221|P1|NOT COMPLETED|Overall Study||20
1475870|NCT01880320|3612219|P3|COMPLETED|Overall Study||61
1475871|NCT01880320|3612220|P2|COMPLETED|Overall Study||192
1475872|NCT01880320|3612221|P1|COMPLETED|Overall Study||197
1475873|NCT01880320|3612219|P3|STARTED|Overall Study||69
1475874|NCT01880320|3612220|P2|STARTED|Overall Study||217
1475875|NCT01880320|3612221|P1|STARTED|Overall Study||217
1475876|NCT01880099|3612238|P3|NOT COMPLETED|Overall Study||7
1475877|NCT01880099|3612239|P2|NOT COMPLETED|Overall Study||10
1475878|NCT01880099|3612240|P1|NOT COMPLETED|Overall Study||8
1475879|NCT01880099|3612238|P3|COMPLETED|Overall Study||15
1475880|NCT01880099|3612239|P2|COMPLETED|Overall Study||11
1475881|NCT01880099|3612240|P1|COMPLETED|Overall Study||9
1475882|NCT01880099|3612238|P3|STARTED|Overall Study||22
1475883|NCT01880099|3612239|P2|STARTED|Overall Study||21
1475884|NCT01880099|3612240|P1|STARTED|Overall Study||17
1475885|NCT01880086|3612250|P2|NOT COMPLETED|Overall Study||1
1475886|NCT01880086|3612251|P1|NOT COMPLETED|Overall Study||1
1475887|NCT01880086|3612250|P2|COMPLETED|Overall Study||6
1475888|NCT01880086|3612251|P1|COMPLETED|Overall Study||5
1475889|NCT01880086|3612250|P2|STARTED|Overall Study||7
1475890|NCT01880086|3612251|P1|STARTED|Overall Study||6
1475891|NCT01879852|3612271|P2|NOT COMPLETED|Overall Study||0
1475892|NCT01879852|3612272|P1|NOT COMPLETED|Overall Study||2
1475893|NCT01879852|3612271|P2|COMPLETED|Overall Study||13
1475894|NCT01879852|3612272|P1|COMPLETED|Overall Study||12
1475895|NCT01879852|3612271|P2|STARTED|Overall Study||13
1475896|NCT01879852|3612272|P1|STARTED|Overall Study||14
1475897|NCT01879800|3612286|P2|NOT COMPLETED|Overall Study||4
1475898|NCT01879800|3612287|P1|NOT COMPLETED|Overall Study||0
1475899|NCT01879800|3612286|P2|COMPLETED|Overall Study||26
1475900|NCT01879800|3612287|P1|COMPLETED|Overall Study||14
1475901|NCT01879800|3612286|P2|STARTED|Overall Study||30
1475902|NCT01879800|3612287|P1|STARTED|Overall Study||14
1475903|NCT01879735|3612299|P2|NOT COMPLETED|Overall Study||0
1475904|NCT01879735|3612300|P1|NOT COMPLETED|Overall Study||0
1475905|NCT01879735|3612299|P2|COMPLETED|Overall Study||16
1475906|NCT01879735|3612300|P1|COMPLETED|Overall Study||6
1475907|NCT01879735|3612299|P2|STARTED|Overall Study||16
1475908|NCT01879735|3612300|P1|STARTED|Overall Study||6
1475909|NCT01879722|3612316|P10|NOT COMPLETED|Overall Study||0
1475910|NCT01879722|3612317|P9|NOT COMPLETED|Overall Study||2
1475911|NCT01879722|3612318|P8|NOT COMPLETED|Overall Study||1
1475912|NCT01879722|3612319|P7|NOT COMPLETED|Overall Study||0
1475913|NCT01879722|3612320|P6|NOT COMPLETED|Overall Study||0
1475914|NCT01879722|3612321|P5|NOT COMPLETED|Overall Study||1
1475915|NCT01879722|3612322|P4|NOT COMPLETED|Overall Study||1
1475916|NCT01879722|3612323|P3|NOT COMPLETED|Overall Study||0
1475917|NCT01879722|3612324|P2|NOT COMPLETED|Overall Study||1
1475918|NCT01879722|3612325|P1|NOT COMPLETED|Overall Study||0
1475919|NCT01879722|3612316|P10|COMPLETED|Overall Study||6
1475920|NCT01879722|3612317|P9|COMPLETED|Overall Study||6
1475921|NCT01879722|3612318|P8|COMPLETED|Overall Study||7
1475922|NCT01879722|3612319|P7|COMPLETED|Overall Study||8
1475923|NCT01879722|3612320|P6|COMPLETED|Overall Study||9
1475924|NCT01879722|3612321|P5|COMPLETED|Overall Study||7
1475925|NCT01879722|3612322|P4|COMPLETED|Overall Study||7
1475926|NCT01879722|3612323|P3|COMPLETED|Overall Study||7
1475927|NCT01879722|3612324|P2|COMPLETED|Overall Study||7
1475928|NCT01879722|3612325|P1|COMPLETED|Overall Study||7
1475929|NCT01879722|3612316|P10|STARTED|Overall Study||6
1475930|NCT01879722|3612317|P9|STARTED|Overall Study||8
1475931|NCT01879722|3612318|P8|STARTED|Overall Study||8
1475932|NCT01879722|3612319|P7|STARTED|Overall Study||8
1475933|NCT01879722|3612320|P6|STARTED|Overall Study||9
1475934|NCT01879722|3612321|P5|STARTED|Overall Study||8
1475935|NCT01879722|3612322|P4|STARTED|Overall Study||8
1475936|NCT01879722|3612323|P3|STARTED|Overall Study||7
1475937|NCT01879722|3612324|P2|STARTED|Overall Study||8
1475938|NCT01879722|3612325|P1|STARTED|Overall Study||7
1475939|NCT01879683|3612473|P1|NOT COMPLETED|Overall Study||1
1475940|NCT01879683|3612473|P1|COMPLETED|Overall Study||9
1475941|NCT01879683|3612473|P1|STARTED|Overall Study||10
1475942|NCT01879618|3612480|P1|NOT COMPLETED|Overall Study||21
1475943|NCT01879618|3612480|P1|COMPLETED|Overall Study||131
1475944|NCT01879618|3612480|P1|STARTED|Overall Study||152
1475945|NCT01879579|3612487|P2|NOT COMPLETED|Overall Study||2
1475946|NCT01879579|3612488|P1|NOT COMPLETED|Overall Study||5
1475947|NCT01879579|3612487|P2|COMPLETED|Overall Study||26
1475948|NCT01879579|3612488|P1|COMPLETED|Overall Study||28
1475949|NCT01879579|3612487|P2|STARTED|Overall Study||28
1475950|NCT01879579|3612488|P1|STARTED|Overall Study||33
1475951|NCT01879553|3612518|P2|NOT COMPLETED|Overall Study||0
1475952|NCT01879553|3612519|P1|NOT COMPLETED|Overall Study||1
1475953|NCT01879553|3612518|P2|COMPLETED|Overall Study||63
1475954|NCT01879553|3612519|P1|COMPLETED|Overall Study||62
1475955|NCT01879553|3612518|P2|STARTED|Overall Study||63
1475956|NCT01879553|3612519|P1|STARTED|Overall Study||63
1475957|NCT01879540|3612540|P1|NOT COMPLETED|Overall Study||0
1475958|NCT01879540|3612540|P1|COMPLETED|Overall Study||63
1475959|NCT01879540|3612540|P1|STARTED|Overall Study||63
1475960|NCT01879410|3612553|P2|NOT COMPLETED|Overall Study||38
1475961|NCT01879410|3612554|P1|NOT COMPLETED|Overall Study||24
1475962|NCT01879410|3612553|P2|COMPLETED|Overall Study||312
1475963|NCT01879410|3612554|P1|COMPLETED|Overall Study||326
1475964|NCT01879410|3612553|P2|Intent-to-Treat Population|Overall Study||348
1475965|NCT01879410|3612554|P1|Intent-to-Treat Population|Overall Study||349
1475966|NCT01879410|3612553|P2|STARTED|Overall Study||350
1475967|NCT01879410|3612554|P1|STARTED|Overall Study||350
1475968|NCT01879371|3612568|P6|NOT COMPLETED|Overall Study||0
1475969|NCT01879371|3612569|P5|NOT COMPLETED|Overall Study||0
1475970|NCT01879371|3612570|P4|NOT COMPLETED|Overall Study||0
1475971|NCT01879371|3612571|P3|NOT COMPLETED|Overall Study||0
1475972|NCT01879371|3612572|P2|NOT COMPLETED|Overall Study||0
1475973|NCT01879371|3612573|P1|NOT COMPLETED|Overall Study||0
1475974|NCT01879371|3612568|P6|COMPLETED|Overall Study||6
1475975|NCT01879371|3612569|P5|COMPLETED|Overall Study||6
1475976|NCT01879371|3612570|P4|COMPLETED|Overall Study||6
1475977|NCT01879371|3612571|P3|COMPLETED|Overall Study||6
1475978|NCT01879371|3612572|P2|COMPLETED|Overall Study||6
1475979|NCT01879371|3612573|P1|COMPLETED|Overall Study||6
1475980|NCT01879371|3612568|P6|STARTED|Overall Study||6
1475981|NCT01879371|3612569|P5|STARTED|Overall Study||6
1475982|NCT01879371|3612570|P4|STARTED|Overall Study||6
1475983|NCT01879371|3612571|P3|STARTED|Overall Study||6
1475984|NCT01879371|3612572|P2|STARTED|Overall Study||6
1475985|NCT01879371|3612573|P1|STARTED|Overall Study||6
1475986|NCT01879345|3612590|P3|NOT COMPLETED|7-day Multiple-dose Period||0
1475987|NCT01879345|3612591|P2|NOT COMPLETED|7-day Multiple-dose Period||0
1475988|NCT01879345|3612592|P1|NOT COMPLETED|7-day Multiple-dose Period||0
1475989|NCT01879345|3612590|P3|COMPLETED|7-day Multiple-dose Period||6
1475990|NCT01879345|3612591|P2|COMPLETED|7-day Multiple-dose Period||6
1475991|NCT01879345|3612592|P1|COMPLETED|7-day Multiple-dose Period||6
1475992|NCT01879345|3612590|P3|STARTED|7-day Multiple-dose Period||6
1475993|NCT01879345|3612591|P2|STARTED|7-day Multiple-dose Period||6
1475994|NCT01879345|3612592|P1|STARTED|7-day Multiple-dose Period||6
1475995|NCT01879345|3612590|P3|NOT COMPLETED|Single-dose Period||0
1475996|NCT01879345|3612591|P2|NOT COMPLETED|Single-dose Period||0
1475997|NCT01879345|3612592|P1|NOT COMPLETED|Single-dose Period||0
1475998|NCT01879345|3612590|P3|COMPLETED|Single-dose Period||6
1475999|NCT01879345|3612591|P2|COMPLETED|Single-dose Period||6
1476000|NCT01879345|3612592|P1|COMPLETED|Single-dose Period||6
1476001|NCT01879345|3612590|P3|STARTED|Single-dose Period||6
1476002|NCT01879345|3612591|P2|STARTED|Single-dose Period||6
1476003|NCT01879345|3612592|P1|STARTED|Single-dose Period||6
1476004|NCT01879332|3612609|P3|NOT COMPLETED|Overall Study||4
1476005|NCT01879332|3612610|P2|NOT COMPLETED|Overall Study||6
1476006|NCT01879332|3612611|P1|NOT COMPLETED|Overall Study||6
1476007|NCT01879332|3612609|P3|COMPLETED|Overall Study||0
1476008|NCT01879332|3612610|P2|COMPLETED|Overall Study||0
1476009|NCT01879332|3612611|P1|COMPLETED|Overall Study||0
1476010|NCT01879332|3612609|P3|STARTED|Overall Study||4
1476011|NCT01879332|3612610|P2|STARTED|Overall Study||6
1476012|NCT01879332|3612611|P1|STARTED|Overall Study||6
1476013|NCT01879319|3612621|P2|NOT COMPLETED|Overall Study||5
1476014|NCT01879319|3612622|P1|NOT COMPLETED|Overall Study||2
1476015|NCT01879319|3612621|P2|COMPLETED|Overall Study||77
1476016|NCT01879319|3612622|P1|COMPLETED|Overall Study||80
1476017|NCT01879319|3612621|P2|Received Treatment|Overall Study||82
1476018|NCT01879319|3612622|P1|Received Treatment|Overall Study||82
1476019|NCT01879319|3612621|P2|STARTED|Overall Study||82
1476020|NCT01879319|3612622|P1|STARTED|Overall Study||82
1476021|NCT01879176|3612632|P2|NOT COMPLETED|Overall Study||6
1476022|NCT01879176|3612633|P1|NOT COMPLETED|Overall Study||8
1476023|NCT01879176|3612632|P2|COMPLETED|Overall Study||16
1476024|NCT01879176|3612633|P1|COMPLETED|Overall Study||16
1476025|NCT01879176|3612632|P2|STARTED|Overall Study||22
1476026|NCT01879176|3612633|P1|STARTED|Overall Study||24
1476027|NCT01879072|3612639|P1|NOT COMPLETED|Overall Study||151
1476028|NCT01879072|3612639|P1|COMPLETED|Overall Study||1709
1476029|NCT01879072|3612639|P1|STARTED|Overall Study||1860
1476030|NCT01879059|3612643|P1|NOT COMPLETED|Overall Study||0
1476031|NCT01879059|3612643|P1|COMPLETED|Overall Study||13
1476032|NCT01879059|3612643|P1|STARTED|Overall Study||13
1476033|NCT01878825|3612649|P2|NOT COMPLETED|Overall Study||0
1476034|NCT01878825|3612650|P1|NOT COMPLETED|Overall Study||0
1476035|NCT01878825|3612649|P2|COMPLETED|Overall Study||60
1476036|NCT01878825|3612650|P1|COMPLETED|Overall Study||60
1476037|NCT01878825|3612649|P2|STARTED|Overall Study||60
1476038|NCT01878825|3612650|P1|STARTED|Overall Study||60
1476039|NCT01878812|3612688|P2|NOT COMPLETED|Overall Study||0
1476040|NCT01878812|3612689|P1|NOT COMPLETED|Overall Study||0
1476041|NCT01878812|3612688|P2|COMPLETED|Overall Study||57
1476042|NCT01878812|3612689|P1|COMPLETED|Overall Study||60
1476043|NCT01878812|3612688|P2|STARTED|Overall Study||57
1476044|NCT01878812|3612689|P1|STARTED|Overall Study||60
1476045|NCT01878799|3612725|P2|NOT COMPLETED|Overall Study||0
1476046|NCT01878799|3612726|P1|NOT COMPLETED|Overall Study||1
1476047|NCT01878799|3612725|P2|COMPLETED|Overall Study||13
1476048|NCT01878799|3612726|P1|COMPLETED|Overall Study||36
1476049|NCT01878799|3612725|P2|STARTED|Overall Study||13
1476050|NCT01878799|3612726|P1|STARTED|Overall Study||37
1476051|NCT01878656|3612734|P2|NOT COMPLETED|Overall Study||0
1476052|NCT01878656|3612735|P1|NOT COMPLETED|Overall Study||0
1476053|NCT01878656|3612734|P2|COMPLETED|Overall Study||72
1476054|NCT01878656|3612735|P1|COMPLETED|Overall Study||72
1476055|NCT01878656|3612734|P2|STARTED|Overall Study||72
1476056|NCT01878656|3612735|P1|STARTED|Overall Study||72
1476057|NCT01878604|3612741|P1|NOT COMPLETED|Overall Study||0
1476058|NCT01878604|3612741|P1|COMPLETED|Overall Study||5
1476059|NCT01878604|3612741|P1|STARTED|Overall Study||5
1476060|NCT01878526|3612748|P2|NOT COMPLETED|Overall Study||2
1476061|NCT01878526|3612749|P1|NOT COMPLETED|Overall Study||3
1476062|NCT01878526|3612748|P2|COMPLETED|Overall Study||38
1476063|NCT01878526|3612749|P1|COMPLETED|Overall Study||37
1476064|NCT01878526|3612748|P2|STARTED|Overall Study||40
1476065|NCT01878526|3612749|P1|STARTED|Overall Study||40
1476066|NCT01878214|3612764|P2|NOT COMPLETED|Overall Study||44
1476067|NCT01878214|3612765|P1|NOT COMPLETED|Overall Study||53
1476068|NCT01878214|3612764|P2|COMPLETED|Overall Study||175
1476069|NCT01878214|3612765|P1|COMPLETED|Overall Study||170
1476070|NCT01878214|3612764|P2|STARTED|Overall Study||219
1476071|NCT01878214|3612765|P1|STARTED|Overall Study||223
1476072|NCT01878175|3612779|P1|NOT COMPLETED|Overall Study||2
1476073|NCT01878175|3612779|P1|COMPLETED|Overall Study||13
1476074|NCT01878175|3612779|P1|STARTED|Overall Study||15
1476075|NCT01878149|3612798|P2|NOT COMPLETED|Overall Study||2
1476076|NCT01878149|3612799|P1|NOT COMPLETED|Overall Study||2
1476077|NCT01878149|3612798|P2|COMPLETED|Overall Study||15
1476078|NCT01878149|3612799|P1|COMPLETED|Overall Study||19
1476079|NCT01878149|3612798|P2|STARTED|Overall Study||17
1476080|NCT01878149|3612799|P1|STARTED|Overall Study||21
1476081|NCT01878097|3612807|P2|NOT COMPLETED|Implementation Year 4||3007
1476082|NCT01878097|3612808|P1|NOT COMPLETED|Implementation Year 4||3604
1476083|NCT01878097|3612807|P2|COMPLETED|Implementation Year 4||6607
1476084|NCT01878097|3612808|P1|COMPLETED|Implementation Year 4||6981
1476085|NCT01878097|3612807|P2|STARTED|Implementation Year 4||9614
1476086|NCT01878097|3612808|P1|STARTED|Implementation Year 4||10585
1476087|NCT01878097|3612807|P2|NOT COMPLETED|Implementation Year 3||2980
1476088|NCT01878097|3612808|P1|NOT COMPLETED|Implementation Year 3||3494
1476089|NCT01878097|3612807|P2|COMPLETED|Implementation Year 3||6770
1476090|NCT01878097|3612808|P1|COMPLETED|Implementation Year 3||7046
1476091|NCT01878097|3612807|P2|STARTED|Implementation Year 3||9750
1476092|NCT01878097|3612808|P1|STARTED|Implementation Year 3||10540
1476093|NCT01878097|3612807|P2|NOT COMPLETED|Implementation Year 2||2841
1476094|NCT01878097|3612808|P1|NOT COMPLETED|Implementation Year 2||3281
1476095|NCT01878097|3612807|P2|COMPLETED|Implementation Year 2||6770
1476096|NCT01878097|3612808|P1|COMPLETED|Implementation Year 2||8286
1476097|NCT01878097|3612807|P2|STARTED|Implementation Year 2||9611
1476098|NCT01878097|3612808|P1|STARTED|Implementation Year 2||11567
1476099|NCT01878097|3612807|P2|NOT COMPLETED|Implementation Year 1||2549
1476100|NCT01878097|3612808|P1|NOT COMPLETED|Implementation Year 1||3202
1476101|NCT01878097|3612807|P2|COMPLETED|Implementation Year 1||7317
1476102|NCT01878097|3612808|P1|COMPLETED|Implementation Year 1||8540
1476103|NCT01878097|3612807|P2|STARTED|Implementation Year 1||9866
1476104|NCT01878097|3612808|P1|STARTED|Implementation Year 1||11742
1476105|NCT01878097|3612807|P2|NOT COMPLETED|Baseline||1800
1476106|NCT01878097|3612808|P1|NOT COMPLETED|Baseline||2497
1476107|NCT01878097|3612807|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
1476108|NCT01878097|3612808|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
1476109|NCT01878097|3612807|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
1476110|NCT01878097|3612808|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
1476111|NCT01878006|3612818|P2|NOT COMPLETED|Study Session 2||0
1476112|NCT01878006|3612819|P1|NOT COMPLETED|Study Session 2||0
1476113|NCT01878006|3612818|P2|COMPLETED|Study Session 2||5
1476114|NCT01878006|3612819|P1|COMPLETED|Study Session 2||5
1476115|NCT01878006|3612818|P2|STARTED|Study Session 2||5
1476116|NCT01878006|3612819|P1|STARTED|Study Session 2||5
1476117|NCT01878006|3612818|P2|NOT COMPLETED|Study Session 1||0
1476118|NCT01878006|3612819|P1|NOT COMPLETED|Study Session 1||0
1476119|NCT01878006|3612818|P2|COMPLETED|Study Session 1||5
1476120|NCT01878006|3612819|P1|COMPLETED|Study Session 1||5
1476121|NCT01878006|3612818|P2|STARTED|Study Session 1||5
1476122|NCT01878006|3612819|P1|STARTED|Study Session 1||5
1476123|NCT01877941|3612839|P1|NOT COMPLETED|Overall Study||0
1476124|NCT01877941|3612839|P1|COMPLETED|Overall Study||39
1476125|NCT01877941|3612839|P1|STARTED|Overall Study||39
1476126|NCT01877720|3612845|P2|NOT COMPLETED|Overall Study||0
1476127|NCT01877720|3612846|P1|NOT COMPLETED|Overall Study||1
1476128|NCT01877720|3612845|P2|COMPLETED|Overall Study||8
1476129|NCT01877720|3612846|P1|COMPLETED|Overall Study||7
1476130|NCT01877720|3612845|P2|2nd Intervention|Overall Study||8
1476131|NCT01877720|3612846|P1|2nd Intervention|Overall Study||7
1476132|NCT01877720|3612845|P2|1st Intervention|Overall Study||8
1476133|NCT01877720|3612846|P1|1st Intervention|Overall Study||7
1476134|NCT01877720|3612845|P2|STARTED|Overall Study||8
1476135|NCT01877720|3612846|P1|STARTED|Overall Study||8
1476136|NCT01877668|3612875|P5|NOT COMPLETED|Overall Study||10
1476137|NCT01877668|3612876|P4|NOT COMPLETED|Overall Study||8
1476138|NCT01877668|3612877|P3|NOT COMPLETED|Overall Study||12
1476139|NCT01877668|3612878|P2|NOT COMPLETED|Overall Study||8
1476140|NCT01877668|3612879|P1|NOT COMPLETED|Overall Study||11
1476141|NCT01877668|3612875|P5|COMPLETED|Overall Study||43
1476142|NCT01877668|3612876|P4|COMPLETED|Overall Study||44
1476143|NCT01877668|3612877|P3|COMPLETED|Overall Study||94
1476144|NCT01877668|3612878|P2|COMPLETED|Overall Study||96
1476145|NCT01877668|3612879|P1|COMPLETED|Overall Study||96
1476146|NCT01877668|3612875|P5|STARTED|Overall Study|Received treatment|53
1476147|NCT01877668|3612876|P4|STARTED|Overall Study|Received treatment|52
1476148|NCT01877668|3612877|P3|STARTED|Overall Study|Received treatment|106
1476149|NCT01877668|3612878|P2|STARTED|Overall Study|Received treatment|104
1476150|NCT01877668|3612879|P1|STARTED|Overall Study|Received treatment|107
1476151|NCT01877655|3613110|P2|NOT COMPLETED|Overall Study||97
1476152|NCT01877655|3613111|P1|NOT COMPLETED|Overall Study||98
1476153|NCT01877655|3613110|P2|COMPLETED|Overall Study||154
1476154|NCT01877655|3613111|P1|COMPLETED|Overall Study||165
1476155|NCT01877655|3613110|P2|Received Treatment|Overall Study||246
1476156|NCT01877655|3613111|P1|Received Treatment|Overall Study||255
1476157|NCT01877655|3613110|P2|STARTED|Overall Study||251
1476158|NCT01877655|3613111|P1|STARTED|Overall Study||263
1476159|NCT01877642|3613129|P7|NOT COMPLETED|Overall Study||0
1476160|NCT01877642|3613130|P6|NOT COMPLETED|Overall Study||0
1476161|NCT01877642|3613131|P5|NOT COMPLETED|Overall Study||0
1476162|NCT01877642|3613132|P4|NOT COMPLETED|Overall Study||0
1476163|NCT01877642|3613133|P3|NOT COMPLETED|Overall Study||0
1476164|NCT01877642|3613134|P2|NOT COMPLETED|Overall Study||0
1476165|NCT01877642|3613135|P1|NOT COMPLETED|Overall Study||0
1476166|NCT01877642|3613129|P7|COMPLETED|Overall Study||3
1476167|NCT01877642|3613130|P6|COMPLETED|Overall Study||3
1476168|NCT01877642|3613131|P5|COMPLETED|Overall Study||3
1476169|NCT01877642|3613132|P4|COMPLETED|Overall Study||3
1476170|NCT01877642|3613133|P3|COMPLETED|Overall Study||3
1476171|NCT01877642|3613134|P2|COMPLETED|Overall Study||3
1476172|NCT01877642|3613135|P1|COMPLETED|Overall Study||4
1476173|NCT01877642|3613129|P7|STARTED|Overall Study||3
1476174|NCT01877642|3613130|P6|STARTED|Overall Study||3
1476175|NCT01877642|3613131|P5|STARTED|Overall Study||3
1476176|NCT01877642|3613132|P4|STARTED|Overall Study||3
1476177|NCT01877642|3613133|P3|STARTED|Overall Study||3
1476178|NCT01877642|3613134|P2|STARTED|Overall Study||3
1476179|NCT01877642|3613135|P1|STARTED|Overall Study||4
1476180|NCT01877564|3613158|P2|NOT COMPLETED|Overall Study||0
1476181|NCT01877564|3613159|P1|NOT COMPLETED|Overall Study||0
1476182|NCT01877564|3613158|P2|COMPLETED|Overall Study||4
1476183|NCT01877564|3613159|P1|COMPLETED|Overall Study||6
1476184|NCT01877564|3613158|P2|STARTED|Overall Study||4
1476185|NCT01877564|3613159|P1|STARTED|Overall Study||6
1476186|NCT01877538|3613165|P1|NOT COMPLETED|Overall Study||0
1476187|NCT01877538|3613165|P1|COMPLETED|Overall Study||7
1476188|NCT01877538|3613165|P1|STARTED|Overall Study||7
1476189|NCT01877421|3613202|P18|NOT COMPLETED|Phase 2||0
1476190|NCT01877421|3613203|P17|NOT COMPLETED|Phase 2||0
1476191|NCT01877421|3613204|P16|NOT COMPLETED|Phase 2||1
1476192|NCT01877421|3613205|P15|NOT COMPLETED|Phase 2||0
1476193|NCT01877421|3613206|P14|NOT COMPLETED|Phase 2||0
1476194|NCT01877421|3613207|P13|NOT COMPLETED|Phase 2||1
1476195|NCT01877421|3613208|P12|NOT COMPLETED|Phase 2||0
1476196|NCT01877421|3613209|P11|NOT COMPLETED|Phase 2||2
1476197|NCT01877421|3613210|P10|NOT COMPLETED|Phase 2||0
1476198|NCT01877421|3613211|P9|NOT COMPLETED|Phase 2||1
1476199|NCT01877421|3613212|P8|NOT COMPLETED|Phase 2||0
1476200|NCT01877421|3613213|P7|NOT COMPLETED|Phase 2||1
1476201|NCT01877421|3613214|P6|NOT COMPLETED|Phase 2||0
1476202|NCT01877421|3613215|P5|NOT COMPLETED|Phase 2||0
1476203|NCT01877421|3613216|P4|NOT COMPLETED|Phase 2||0
1476204|NCT01877421|3613217|P3|NOT COMPLETED|Phase 2||0
1476205|NCT01877421|3613218|P2|NOT COMPLETED|Phase 2||0
1476206|NCT01877421|3613219|P1|NOT COMPLETED|Phase 2||0
1476207|NCT01877421|3613202|P18|COMPLETED|Phase 2||0
1476208|NCT01877421|3613203|P17|COMPLETED|Phase 2||0
1476209|NCT01877421|3613204|P16|COMPLETED|Phase 2||2
1476210|NCT01877421|3613205|P15|COMPLETED|Phase 2||7
1476211|NCT01877421|3613206|P14|COMPLETED|Phase 2||3
1476212|NCT01877421|3613207|P13|COMPLETED|Phase 2||6
1476213|NCT01877421|3613208|P12|COMPLETED|Phase 2||3
1476214|NCT01877421|3613209|P11|COMPLETED|Phase 2||5
1476215|NCT01877421|3613210|P10|COMPLETED|Phase 2||3
1476216|NCT01877421|3613211|P9|COMPLETED|Phase 2||5
1476217|NCT01877421|3613212|P8|COMPLETED|Phase 2||2
1476218|NCT01877421|3613213|P7|COMPLETED|Phase 2||6
1476219|NCT01877421|3613214|P6|COMPLETED|Phase 2||3
1476220|NCT01877421|3613215|P5|COMPLETED|Phase 2||7
1476221|NCT01877421|3613216|P4|COMPLETED|Phase 2||2
1476222|NCT01877421|3613217|P3|COMPLETED|Phase 2||4
1476223|NCT01877421|3613218|P2|COMPLETED|Phase 2||0
1476224|NCT01877421|3613219|P1|COMPLETED|Phase 2||0
1476225|NCT01877421|3613202|P18|STARTED|Phase 2||0
1476226|NCT01877421|3613203|P17|STARTED|Phase 2||0
1476227|NCT01877421|3613204|P16|STARTED|Phase 2||3
1476228|NCT01877421|3613205|P15|STARTED|Phase 2||7
1476229|NCT01877421|3613206|P14|STARTED|Phase 2||3
1476230|NCT01877421|3613207|P13|STARTED|Phase 2||7
1476231|NCT01877421|3613208|P12|STARTED|Phase 2||3
1476232|NCT01877421|3613209|P11|STARTED|Phase 2||7
1476233|NCT01877421|3613210|P10|STARTED|Phase 2||3
1476234|NCT01877421|3613211|P9|STARTED|Phase 2||6
1476235|NCT01877421|3613212|P8|STARTED|Phase 2||2
1476236|NCT01877421|3613213|P7|STARTED|Phase 2||7
1476237|NCT01877421|3613214|P6|STARTED|Phase 2||3
1476238|NCT01877421|3613215|P5|STARTED|Phase 2||7
1476239|NCT01877421|3613216|P4|STARTED|Phase 2||2
1476240|NCT01877421|3613217|P3|STARTED|Phase 2||4
1476241|NCT01877421|3613218|P2|STARTED|Phase 2||0
1476242|NCT01877421|3613219|P1|STARTED|Phase 2||0
1476243|NCT01877421|3613202|P18|NOT COMPLETED|Phase 1||0
1476244|NCT01877421|3613203|P17|NOT COMPLETED|Phase 1||0
1476245|NCT01877421|3613204|P16|NOT COMPLETED|Phase 1||0
1476246|NCT01877421|3613205|P15|NOT COMPLETED|Phase 1||0
1476247|NCT01877421|3613206|P14|NOT COMPLETED|Phase 1||0
1476248|NCT01877421|3613207|P13|NOT COMPLETED|Phase 1||0
1476249|NCT01877421|3613208|P12|NOT COMPLETED|Phase 1||0
1476250|NCT01877421|3613209|P11|NOT COMPLETED|Phase 1||0
1476251|NCT01877421|3613210|P10|NOT COMPLETED|Phase 1||0
1476252|NCT01877421|3613211|P9|NOT COMPLETED|Phase 1||0
1476253|NCT01877421|3613212|P8|NOT COMPLETED|Phase 1||0
1476254|NCT01877421|3613213|P7|NOT COMPLETED|Phase 1||0
1476255|NCT01877421|3613214|P6|NOT COMPLETED|Phase 1||0
1476256|NCT01877421|3613215|P5|NOT COMPLETED|Phase 1||0
1476257|NCT01877421|3613216|P4|NOT COMPLETED|Phase 1||0
1476258|NCT01877421|3613217|P3|NOT COMPLETED|Phase 1||0
1476259|NCT01877421|3613218|P2|NOT COMPLETED|Phase 1||0
1476260|NCT01877421|3613219|P1|NOT COMPLETED|Phase 1||0
1476261|NCT01877421|3613202|P18|COMPLETED|Phase 1||3
1476262|NCT01877421|3613203|P17|COMPLETED|Phase 1||7
1476263|NCT01877421|3613204|P16|COMPLETED|Phase 1||3
1476264|NCT01877421|3613205|P15|COMPLETED|Phase 1||7
1476265|NCT01877421|3613206|P14|COMPLETED|Phase 1||3
1476266|NCT01877421|3613207|P13|COMPLETED|Phase 1||7
1476267|NCT01877421|3613208|P12|COMPLETED|Phase 1||3
1476268|NCT01877421|3613209|P11|COMPLETED|Phase 1||7
1476269|NCT01877421|3613210|P10|COMPLETED|Phase 1||3
1476270|NCT01877421|3613211|P9|COMPLETED|Phase 1||7
1476271|NCT01877421|3613212|P8|COMPLETED|Phase 1||2
1476272|NCT01877421|3613213|P7|COMPLETED|Phase 1||4
1476273|NCT01877421|3613214|P6|COMPLETED|Phase 1||2
1476274|NCT01877421|3613215|P5|COMPLETED|Phase 1||4
1476275|NCT01877421|3613216|P4|COMPLETED|Phase 1||2
1476276|NCT01877421|3613217|P3|COMPLETED|Phase 1||4
1476277|NCT01877421|3613218|P2|COMPLETED|Phase 1||1
1476278|NCT01877421|3613219|P1|COMPLETED|Phase 1||2
1476279|NCT01877421|3613202|P18|STARTED|Phase 1||3
1476280|NCT01877421|3613203|P17|STARTED|Phase 1||7
1476281|NCT01877421|3613204|P16|STARTED|Phase 1||3
1476282|NCT01877421|3613205|P15|STARTED|Phase 1||7
1476283|NCT01877421|3613206|P14|STARTED|Phase 1||3
1476284|NCT01877421|3613207|P13|STARTED|Phase 1||7
1476285|NCT01877421|3613208|P12|STARTED|Phase 1||3
1476286|NCT01877421|3613209|P11|STARTED|Phase 1||7
1476287|NCT01877421|3613210|P10|STARTED|Phase 1||3
1476288|NCT01877421|3613211|P9|STARTED|Phase 1||7
1476289|NCT01877421|3613212|P8|STARTED|Phase 1||2
1476290|NCT01877421|3613213|P7|STARTED|Phase 1||4
1476291|NCT01877421|3613214|P6|STARTED|Phase 1||2
1476292|NCT01877421|3613215|P5|STARTED|Phase 1||4
1476293|NCT01877421|3613216|P4|STARTED|Phase 1||2
1476294|NCT01877421|3613217|P3|STARTED|Phase 1||4
1476295|NCT01877421|3613218|P2|STARTED|Phase 1||1
1476296|NCT01877421|3613219|P1|STARTED|Phase 1||2
1476297|NCT01877408|3613329|P2|NOT COMPLETED|Overall Study||2
1476298|NCT01877408|3613330|P1|NOT COMPLETED|Overall Study||0
1476299|NCT01877408|3613329|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
1476300|NCT01877408|3613330|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
1476301|NCT01877408|3613329|P2|STARTED|Overall Study||100
1476302|NCT01877408|3613330|P1|STARTED|Overall Study||50
1476303|NCT01877343|3613350|P7|NOT COMPLETED|Overall Study||0
1476304|NCT01877343|3613351|P6|NOT COMPLETED|Overall Study||0
1476305|NCT01877343|3613352|P5|NOT COMPLETED|Overall Study||0
1476306|NCT01877343|3613353|P4|NOT COMPLETED|Overall Study||0
1476307|NCT01877343|3613354|P3|NOT COMPLETED|Overall Study||0
1476308|NCT01877343|3613355|P2|NOT COMPLETED|Overall Study||0
1476309|NCT01877343|3613356|P1|NOT COMPLETED|Overall Study||0
1476310|NCT01877343|3613350|P7|COMPLETED|Overall Study||0
1476311|NCT01877343|3613351|P6|COMPLETED|Overall Study||5
1476312|NCT01877343|3613352|P5|COMPLETED|Overall Study||0
1476313|NCT01877343|3613353|P4|COMPLETED|Overall Study||0
1476314|NCT01877343|3613354|P3|COMPLETED|Overall Study||0
1476315|NCT01877343|3613355|P2|COMPLETED|Overall Study||3
1476316|NCT01877343|3613356|P1|COMPLETED|Overall Study||2
1476317|NCT01877343|3613350|P7|STARTED|Overall Study||0
1476318|NCT01877343|3613351|P6|STARTED|Overall Study||5
1476319|NCT01877343|3613352|P5|STARTED|Overall Study||0
1476320|NCT01877343|3613353|P4|STARTED|Overall Study||0
1476321|NCT01877343|3613354|P3|STARTED|Overall Study||0
1476322|NCT01877343|3613355|P2|STARTED|Overall Study||3
1476323|NCT01877343|3613356|P1|STARTED|Overall Study||2
1476324|NCT01877278|3613363|P2|NOT COMPLETED|Overall Study||3
1476325|NCT01877278|3613364|P1|NOT COMPLETED|Overall Study||3
1476326|NCT01877278|3613363|P2|COMPLETED|Overall Study||30
1476327|NCT01877278|3613364|P1|COMPLETED|Overall Study||30
1476328|NCT01877278|3613363|P2|STARTED|Overall Study||33
1476329|NCT01877278|3613364|P1|STARTED|Overall Study||33
1476330|NCT01877265|3613372|P6|NOT COMPLETED|Treatment Period 3||0
1476331|NCT01877265|3613373|P5|NOT COMPLETED|Treatment Period 3||0
1476332|NCT01877265|3613374|P4|NOT COMPLETED|Treatment Period 3||0
1476333|NCT01877265|3613375|P3|NOT COMPLETED|Treatment Period 3||0
1476334|NCT01877265|3613376|P2|NOT COMPLETED|Treatment Period 3||0
1476335|NCT01877265|3613377|P1|NOT COMPLETED|Treatment Period 3||1
1476336|NCT01877265|3613372|P6|COMPLETED|Treatment Period 3||2
1476337|NCT01877265|3613373|P5|COMPLETED|Treatment Period 3||3
1476338|NCT01877265|3613374|P4|COMPLETED|Treatment Period 3||3
1476339|NCT01877265|3613375|P3|COMPLETED|Treatment Period 3||2
1476340|NCT01877265|3613376|P2|COMPLETED|Treatment Period 3||3
1476341|NCT01877265|3613377|P1|COMPLETED|Treatment Period 3||2
1476342|NCT01877265|3613372|P6|Received at Least One Dose of Study Drug|Treatment Period 3||2
1476343|NCT01877265|3613373|P5|Received at Least One Dose of Study Drug|Treatment Period 3||3
1476344|NCT01877265|3613374|P4|Received at Least One Dose of Study Drug|Treatment Period 3||3
1476345|NCT01877265|3613375|P3|Received at Least One Dose of Study Drug|Treatment Period 3||2
1476346|NCT01877265|3613376|P2|Received at Least One Dose of Study Drug|Treatment Period 3||3
1476347|NCT01877265|3613377|P1|Received at Least One Dose of Study Drug|Treatment Period 3||3
1476348|NCT01877265|3613372|P6|STARTED|Treatment Period 3||2
1476349|NCT01877265|3613373|P5|STARTED|Treatment Period 3||3
1476350|NCT01877265|3613374|P4|STARTED|Treatment Period 3||3
1476351|NCT01877265|3613375|P3|STARTED|Treatment Period 3||2
1476352|NCT01877265|3613376|P2|STARTED|Treatment Period 3||3
1476353|NCT01877265|3613377|P1|STARTED|Treatment Period 3||3
1476354|NCT01877265|3613372|P6|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
1476355|NCT01877265|3613373|P5|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1476356|NCT01877265|3613374|P4|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1476357|NCT01877265|3613375|P3|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1476358|NCT01877265|3613376|P2|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1476359|NCT01877265|3613377|P1|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
1476360|NCT01877265|3613372|P6|COMPLETED|Washout Period 2 (at Least 14 Days)||2
1476361|NCT01877265|3613373|P5|COMPLETED|Washout Period 2 (at Least 14 Days)||3
1476362|NCT01877265|3613374|P4|COMPLETED|Washout Period 2 (at Least 14 Days)||3
1476363|NCT01877265|3613375|P3|COMPLETED|Washout Period 2 (at Least 14 Days)||2
1476364|NCT01877265|3613376|P2|COMPLETED|Washout Period 2 (at Least 14 Days)||3
1476365|NCT01877265|3613377|P1|COMPLETED|Washout Period 2 (at Least 14 Days)||3
1476366|NCT01877265|3613372|P6|STARTED|Washout Period 2 (at Least 14 Days)||3
1476367|NCT01877265|3613373|P5|STARTED|Washout Period 2 (at Least 14 Days)||3
1476368|NCT01877265|3613374|P4|STARTED|Washout Period 2 (at Least 14 Days)||3
1476369|NCT01877265|3613375|P3|STARTED|Washout Period 2 (at Least 14 Days)||2
1476370|NCT01877265|3613376|P2|STARTED|Washout Period 2 (at Least 14 Days)||3
1476371|NCT01877265|3613377|P1|STARTED|Washout Period 2 (at Least 14 Days)||3
1476372|NCT01877265|3613372|P6|NOT COMPLETED|Treatment Period 2||0
1476373|NCT01877265|3613373|P5|NOT COMPLETED|Treatment Period 2||0
1476374|NCT01877265|3613374|P4|NOT COMPLETED|Treatment Period 2||0
1476375|NCT01877265|3613375|P3|NOT COMPLETED|Treatment Period 2||0
1476376|NCT01877265|3613376|P2|NOT COMPLETED|Treatment Period 2||0
1476377|NCT01877265|3613377|P1|NOT COMPLETED|Treatment Period 2||0
1476378|NCT01877265|3613372|P6|COMPLETED|Treatment Period 2||3
1476379|NCT01877265|3613373|P5|COMPLETED|Treatment Period 2||3
1476380|NCT01877265|3613374|P4|COMPLETED|Treatment Period 2||3
1476381|NCT01877265|3613375|P3|COMPLETED|Treatment Period 2||2
1476382|NCT01877265|3613376|P2|COMPLETED|Treatment Period 2||3
1476383|NCT01877265|3613377|P1|COMPLETED|Treatment Period 2||3
1476384|NCT01877265|3613372|P6|Received at Least One Dose of Study Drug|Treatment Period 2||3
1476385|NCT01877265|3613373|P5|Received at Least One Dose of Study Drug|Treatment Period 2||3
1476386|NCT01877265|3613374|P4|Received at Least One Dose of Study Drug|Treatment Period 2||3
1476387|NCT01877265|3613375|P3|Received at Least One Dose of Study Drug|Treatment Period 2||2
1476388|NCT01877265|3613376|P2|Received at Least One Dose of Study Drug|Treatment Period 2||3
1476389|NCT01877265|3613377|P1|Received at Least One Dose of Study Drug|Treatment Period 2||3
1476390|NCT01877265|3613372|P6|STARTED|Treatment Period 2||3
1476391|NCT01877265|3613373|P5|STARTED|Treatment Period 2||3
1476392|NCT01877265|3613374|P4|STARTED|Treatment Period 2||3
1476393|NCT01877265|3613375|P3|STARTED|Treatment Period 2||2
1476394|NCT01877265|3613376|P2|STARTED|Treatment Period 2||3
1476395|NCT01877265|3613377|P1|STARTED|Treatment Period 2||3
1476396|NCT01877265|3613372|P6|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1476397|NCT01877265|3613373|P5|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1476398|NCT01877265|3613374|P4|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1476399|NCT01877265|3613375|P3|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1476400|NCT01877265|3613376|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1476401|NCT01877265|3613377|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
1476402|NCT01877265|3613372|P6|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1476403|NCT01877265|3613373|P5|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1476404|NCT01877265|3613374|P4|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1476405|NCT01877265|3613375|P3|COMPLETED|Washout Period 1 (at Least 14 Days)||2
1476406|NCT01877265|3613376|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1476407|NCT01877265|3613377|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||3
1476408|NCT01877265|3613372|P6|STARTED|Washout Period 1 (at Least 14 Days)||3
1476409|NCT01877265|3613373|P5|STARTED|Washout Period 1 (at Least 14 Days)||3
1476410|NCT01877265|3613374|P4|STARTED|Washout Period 1 (at Least 14 Days)||3
1476411|NCT01877265|3613375|P3|STARTED|Washout Period 1 (at Least 14 Days)||2
1476412|NCT01877265|3613376|P2|STARTED|Washout Period 1 (at Least 14 Days)||3
1476413|NCT01877265|3613377|P1|STARTED|Washout Period 1 (at Least 14 Days)||3
1476414|NCT01877265|3613372|P6|NOT COMPLETED|Treatment Period 1||0
1476415|NCT01877265|3613373|P5|NOT COMPLETED|Treatment Period 1||0
1476416|NCT01877265|3613374|P4|NOT COMPLETED|Treatment Period 1||0
1476417|NCT01877265|3613375|P3|NOT COMPLETED|Treatment Period 1||1
1476418|NCT01877265|3613376|P2|NOT COMPLETED|Treatment Period 1||0
1476419|NCT01877265|3613377|P1|NOT COMPLETED|Treatment Period 1||0
1476420|NCT01877265|3613372|P6|COMPLETED|Treatment Period 1||3
1476421|NCT01877265|3613373|P5|COMPLETED|Treatment Period 1||3
1476422|NCT01877265|3613374|P4|COMPLETED|Treatment Period 1||3
1476423|NCT01877265|3613375|P3|COMPLETED|Treatment Period 1||2
1476424|NCT01877265|3613376|P2|COMPLETED|Treatment Period 1||3
1476425|NCT01877265|3613377|P1|COMPLETED|Treatment Period 1||3
1476426|NCT01877265|3613372|P6|Received at Least One Dose of Study Drug|Treatment Period 1||3
1476427|NCT01877265|3613373|P5|Received at Least One Dose of Study Drug|Treatment Period 1||3
1476428|NCT01877265|3613374|P4|Received at Least One Dose of Study Drug|Treatment Period 1||3
1476429|NCT01877265|3613375|P3|Received at Least One Dose of Study Drug|Treatment Period 1||3
1476430|NCT01877265|3613376|P2|Received at Least One Dose of Study Drug|Treatment Period 1||3
1476431|NCT01877265|3613377|P1|Received at Least One Dose of Study Drug|Treatment Period 1||3
1476432|NCT01877265|3613372|P6|STARTED|Treatment Period 1||3
1476433|NCT01877265|3613373|P5|STARTED|Treatment Period 1||3
1476434|NCT01877265|3613374|P4|STARTED|Treatment Period 1||3
1476435|NCT01877265|3613375|P3|STARTED|Treatment Period 1||3
1476436|NCT01877265|3613376|P2|STARTED|Treatment Period 1||3
1476437|NCT01877265|3613377|P1|STARTED|Treatment Period 1||3
1476438|NCT01877239|3613394|P1|NOT COMPLETED|Overall Study||50
1476439|NCT01877239|3613394|P1|COMPLETED|Overall Study||61
1476440|NCT01877239|3613394|P1|Treated|Overall Study||76
1476441|NCT01877239|3613394|P1|STARTED|Overall Study||111
1476442|NCT01877161|3613400|P1|NOT COMPLETED|Third Session of Stimulation||0
1476443|NCT01877161|3613400|P1|COMPLETED|Third Session of Stimulation||12
1476444|NCT01877161|3613400|P1|STARTED|Third Session of Stimulation||12
1476445|NCT01877161|3613400|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
1476446|NCT01877161|3613400|P1|COMPLETED|Washout (at Least 3 Days)||12
1476447|NCT01877161|3613400|P1|STARTED|Washout (at Least 3 Days)||12
1476448|NCT01877161|3613400|P1|NOT COMPLETED|Second Session of Stimulation||0
1476449|NCT01877161|3613400|P1|COMPLETED|Second Session of Stimulation||12
1476450|NCT01877161|3613400|P1|STARTED|Second Session of Stimulation||12
1476451|NCT01877161|3613400|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
1476452|NCT01877161|3613400|P1|COMPLETED|Washout (at Least 3 Days)||12
1476453|NCT01877161|3613400|P1|STARTED|Washout (at Least 3 Days)||12
1476454|NCT01877161|3613400|P1|NOT COMPLETED|First Session of Stimulation||0
1476455|NCT01877161|3613400|P1|COMPLETED|First Session of Stimulation||12
1476456|NCT01877161|3613400|P1|STARTED|First Session of Stimulation||12
1476457|NCT01877148|3613410|P2|NOT COMPLETED|Overall Study||1
1476458|NCT01877148|3613411|P1|NOT COMPLETED|Overall Study||1
1476459|NCT01877148|3613410|P2|COMPLETED|Overall Study||5
1476460|NCT01877148|3613411|P1|COMPLETED|Overall Study||5
1476461|NCT01877148|3613410|P2|STARTED|Overall Study||6
1476462|NCT01877148|3613411|P1|STARTED|Overall Study||6
1476463|NCT01876992|3613425|P2|NOT COMPLETED|Overall Study||0
1476464|NCT01876992|3613426|P1|NOT COMPLETED|Overall Study||0
1476465|NCT01876992|3613425|P2|COMPLETED|Overall Study||5
1476466|NCT01876992|3613426|P1|COMPLETED|Overall Study||5
1476467|NCT01876992|3613425|P2|STARTED|Overall Study||5
1476468|NCT01876992|3613426|P1|STARTED|Overall Study||5
1476469|NCT01876979|3613440|P2|NOT COMPLETED|Overall Study||3
1476470|NCT01876979|3613441|P1|NOT COMPLETED|Overall Study||2
1476471|NCT01876979|3613440|P2|COMPLETED|Overall Study||0
1476472|NCT01876979|3613441|P1|COMPLETED|Overall Study||0
1476473|NCT01876979|3613440|P2|STARTED|Overall Study||3
1476474|NCT01876979|3613441|P1|STARTED|Overall Study||2
1476475|NCT01876823|3613447|P1|NOT COMPLETED|Overall Study||9
1476476|NCT01876823|3613447|P1|COMPLETED|Overall Study||26
1476477|NCT01876823|3613447|P1|STARTED|Overall Study||35
1476478|NCT01876810|3613460|P2|NOT COMPLETED|Overall Study||1
1476479|NCT01876810|3613461|P1|NOT COMPLETED|Overall Study||0
1476480|NCT01876810|3613460|P2|COMPLETED|Overall Study||13
1476481|NCT01876810|3613461|P1|COMPLETED|Overall Study||14
1476482|NCT01876810|3613460|P2|STARTED|Overall Study||14
1476483|NCT01876810|3613461|P1|STARTED|Overall Study||14
1476484|NCT01876784|3613473|P2|NOT COMPLETED|Overall Study||119
1476485|NCT01876784|3613474|P1|NOT COMPLETED|Overall Study||119
1476486|NCT01876784|3613473|P2|COMPLETED|Overall Study||0
1476487|NCT01876784|3613474|P1|COMPLETED|Overall Study||0
1476488|NCT01876784|3613473|P2|Treated|Overall Study||118
1476489|NCT01876784|3613474|P1|Treated|Overall Study||117
1476490|NCT01876784|3613473|P2|STARTED|Overall Study||119
1476491|NCT01876784|3613474|P1|STARTED|Overall Study||119
1476492|NCT01876732|3613480|P1|NOT COMPLETED|Overall Study||75
1476493|NCT01876732|3613480|P1|COMPLETED|Overall Study||57
1476494|NCT01876732|3613480|P1|STARTED|Overall Study||132
1476495|NCT01876706|3613485|P1|NOT COMPLETED|Overall Study||4
1476496|NCT01876706|3613485|P1|COMPLETED|Overall Study||47
1476497|NCT01876706|3613485|P1|12 Months|Overall Study||41
1476498|NCT01876706|3613485|P1|1 Month|Overall Study||51
1476499|NCT01876706|3613485|P1|STARTED|Overall Study||51
1476500|NCT01876420|3613502|P1|NOT COMPLETED|Overall Study||1
1476501|NCT01876420|3613502|P1|COMPLETED|Overall Study||59
1476502|NCT01876420|3613502|P1|STARTED|Overall Study||60
1476503|NCT01876381|3613514|P1|NOT COMPLETED|Overall Study||7
1476504|NCT01876381|3613514|P1|COMPLETED|Overall Study||16
1476505|NCT01876381|3613514|P1|STARTED|Overall Study||23
1476506|NCT01876368|3613521|P2|NOT COMPLETED|Overall Study||13
1476507|NCT01876368|3613522|P1|NOT COMPLETED|Overall Study||9
1476508|NCT01876368|3613521|P2|COMPLETED|Overall Study||175
1476509|NCT01876368|3613522|P1|COMPLETED|Overall Study||179
1476510|NCT01876368|3613521|P2|Safety Set (SAF)|Overall Study||187
1476511|NCT01876368|3613522|P1|Safety Set (SAF)|Overall Study||188
1476512|NCT01876368|3613521|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
1476513|NCT01876368|3613522|P1|Full Analysis Set (FAS)|Overall Study||188
1476514|NCT01876368|3613521|P2|STARTED|Overall Study||188
1476515|NCT01876368|3613522|P1|STARTED|Overall Study||188
1476516|NCT01876329|3613551|P3|NOT COMPLETED|Overall Study||0
1476517|NCT01876329|3613552|P2|NOT COMPLETED|Overall Study||0
1476518|NCT01876329|3613553|P1|NOT COMPLETED|Overall Study||0
1476519|NCT01876329|3613551|P3|COMPLETED|Overall Study||44
1476520|NCT01876329|3613552|P2|COMPLETED|Overall Study||36
1476521|NCT01876329|3613553|P1|COMPLETED|Overall Study||45
1476522|NCT01876329|3613551|P3|STARTED|Overall Study||44
1476523|NCT01876329|3613552|P2|STARTED|Overall Study||36
1476524|NCT01876329|3613553|P1|STARTED|Overall Study||45
1476525|NCT01875991|3613566|P2|NOT COMPLETED|Overall Study||6
1476526|NCT01875991|3613567|P1|NOT COMPLETED|Overall Study||7
1476527|NCT01875991|3613566|P2|COMPLETED|Overall Study||103
1476528|NCT01875991|3613567|P1|COMPLETED|Overall Study||101
1476529|NCT01875991|3613566|P2|Received Etanercept in Period 2|Overall Study||103
1476530|NCT01875991|3613567|P1|Received Etanercept in Period 2|Overall Study||102
1476531|NCT01875991|3613566|P2|Received Etanercept in Period 1|Overall Study||108
1476532|NCT01875991|3613567|P1|Received Etanercept in Period 1|Overall Study||108
1476533|NCT01875991|3613566|P2|STARTED|Overall Study||109
1476534|NCT01875991|3613567|P1|STARTED|Overall Study||108
1476535|NCT01875978|3613590|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
1476536|NCT01875978|3613591|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
1476537|NCT01875978|3613590|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
1476538|NCT01875978|3613591|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
1476539|NCT01875978|3613590|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
1476540|NCT01875978|3613591|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
1476541|NCT01875978|3613590|P2|NOT COMPLETED|Study 4weeks||0
1476542|NCT01875978|3613591|P1|NOT COMPLETED|Study 4weeks||0
1476543|NCT01875978|3613590|P2|COMPLETED|Study 4weeks||20
1476544|NCT01875978|3613591|P1|COMPLETED|Study 4weeks||20
1476545|NCT01875978|3613590|P2|STARTED|Study 4weeks||20
1476546|NCT01875978|3613591|P1|STARTED|Study 4weeks||20
1476547|NCT01875874|3613603|P1|NOT COMPLETED|Overall Study||3
1476548|NCT01875874|3613603|P1|COMPLETED|Overall Study||5
1476549|NCT01875874|3613603|P1|STARTED|Overall Study||8
1476550|NCT01875848|3613610|P2|NOT COMPLETED|Overall Study||0
1476551|NCT01875848|3613611|P1|NOT COMPLETED|Overall Study||2
1476552|NCT01875848|3613610|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
1476553|NCT01875848|3613611|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
1476554|NCT01875848|3613610|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
1476555|NCT01875848|3613611|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
1476556|NCT01875783|3613619|P1|NOT COMPLETED|Overall Study||0
1476557|NCT01875783|3613619|P1|COMPLETED|Overall Study||385
1476558|NCT01875783|3613619|P1|STARTED|Overall Study||385
1476559|NCT01875731|3613628|P2|NOT COMPLETED|Overall Study||0
1476560|NCT01875731|3613629|P1|NOT COMPLETED|Overall Study||1
1476561|NCT01875731|3613628|P2|COMPLETED|Overall Study||32
1476562|NCT01875731|3613629|P1|COMPLETED|Overall Study||33
1476563|NCT01875731|3613628|P2|STARTED|Overall Study||32
1476564|NCT01875731|3613629|P1|STARTED|Overall Study||34
1476565|NCT01875510|3613639|P2|NOT COMPLETED|Overall Study||0
1476566|NCT01875510|3613640|P1|NOT COMPLETED|Overall Study||0
1476567|NCT01875510|3613639|P2|COMPLETED|Overall Study||40
1476568|NCT01875510|3613640|P1|COMPLETED|Overall Study||40
1476569|NCT01875510|3613639|P2|STARTED|Overall Study||40
1476570|NCT01875510|3613640|P1|STARTED|Overall Study||40
1476571|NCT01875471|3613648|P2|NOT COMPLETED|Overall Study||1
1476572|NCT01875471|3613649|P1|NOT COMPLETED|Overall Study||1
1476573|NCT01875471|3613648|P2|COMPLETED|Overall Study||137
1476574|NCT01875471|3613649|P1|COMPLETED|Overall Study||136
1476575|NCT01875471|3613648|P2|Completed Per Protocol|Overall Study||123
1476576|NCT01875471|3613649|P1|Completed Per Protocol|Overall Study||127
1476577|NCT01875471|3613648|P2|STARTED|Overall Study||138
1476578|NCT01875471|3613649|P1|STARTED|Overall Study||137
1476579|NCT01875445|3613657|P2|NOT COMPLETED|Overall Study||0
1476580|NCT01875445|3613658|P1|NOT COMPLETED|Overall Study||7
1476581|NCT01875445|3613657|P2|COMPLETED|Overall Study||19
1476582|NCT01875445|3613658|P1|COMPLETED|Overall Study||12
1476583|NCT01875445|3613657|P2|STARTED|Overall Study||19
1476584|NCT01875445|3613658|P1|STARTED|Overall Study||19
1476585|NCT01875185|3613668|P2|NOT COMPLETED|Overall Study||48
1476586|NCT01875185|3613669|P1|NOT COMPLETED|Overall Study||52
1476587|NCT01875185|3613668|P2|COMPLETED|Overall Study||0
1476588|NCT01875185|3613669|P1|COMPLETED|Overall Study||0
1476589|NCT01875185|3613668|P2|STARTED|Overall Study||48
1476590|NCT01875185|3613669|P1|STARTED|Overall Study||52
1476591|NCT01875159|3613683|P2|NOT COMPLETED|Overall Study||0
1476592|NCT01875159|3613684|P1|NOT COMPLETED|Overall Study||3
1476593|NCT01875159|3613683|P2|COMPLETED|Overall Study||53
1476594|NCT01875159|3613684|P1|COMPLETED|Overall Study||42
1476595|NCT01875159|3613683|P2|STARTED|Overall Study||53
1476596|NCT01875159|3613684|P1|STARTED|Overall Study||45
1476597|NCT01874951|3613694|P2|NOT COMPLETED|Overall Study||0
1476598|NCT01874951|3613695|P1|NOT COMPLETED|Overall Study||0
1476599|NCT01874951|3613694|P2|COMPLETED|Overall Study||6
1476600|NCT01874951|3613695|P1|COMPLETED|Overall Study||6
1476601|NCT01874951|3613694|P2|STARTED|Overall Study||6
1476602|NCT01874951|3613695|P1|STARTED|Overall Study||6
1476603|NCT01874665|3613717|P2|NOT COMPLETED|Overall Study||15
1476604|NCT01874665|3613718|P1|NOT COMPLETED|Overall Study||30
1476605|NCT01874665|3613717|P2|COMPLETED|Overall Study||0
1476606|NCT01874665|3613718|P1|COMPLETED|Overall Study||0
1476607|NCT01874665|3613717|P2|STARTED|Overall Study||15
1476608|NCT01874665|3613718|P1|STARTED|Overall Study||30
1476609|NCT01874535|3613746|P2|NOT COMPLETED|Overall Study||44
1476610|NCT01874535|3613747|P1|NOT COMPLETED|Overall Study||55
1476611|NCT01874535|3613746|P2|COMPLETED|Overall Study||157
1476612|NCT01874535|3613747|P1|COMPLETED|Overall Study||152
1476613|NCT01874535|3613746|P2|STARTED|Overall Study||201
1476614|NCT01874535|3613747|P1|STARTED|Overall Study||207
1476615|NCT01874353|3613755|P2|NOT COMPLETED|Overall Study||37
1476616|NCT01874353|3613756|P1|NOT COMPLETED|Overall Study||55
1476617|NCT01874353|3613755|P2|COMPLETED|Overall Study||62
1476618|NCT01874353|3613756|P1|COMPLETED|Overall Study||141
1476619|NCT01874353|3613755|P2|STARTED|Overall Study||99
1476620|NCT01874353|3613756|P1|STARTED|Overall Study||196
1476621|NCT01874340|3613783|P4|NOT COMPLETED|Overall Study||5
1476622|NCT01874340|3613784|P3|NOT COMPLETED|Overall Study||8
1476623|NCT01874340|3613785|P2|NOT COMPLETED|Overall Study||8
1476624|NCT01874340|3613786|P1|NOT COMPLETED|Overall Study||6
1476625|NCT01874340|3613783|P4|COMPLETED|Overall Study||1
1476626|NCT01874340|3613784|P3|COMPLETED|Overall Study||0
1476627|NCT01874340|3613785|P2|COMPLETED|Overall Study||0
1476628|NCT01874340|3613786|P1|COMPLETED|Overall Study||0
1476629|NCT01874340|3613783|P4|STARTED|Overall Study||6
1476630|NCT01874340|3613784|P3|STARTED|Overall Study||8
1476631|NCT01874340|3613785|P2|STARTED|Overall Study||8
1476632|NCT01874340|3613786|P1|STARTED|Overall Study||6
1476633|NCT01874275|3613814|P2|NOT COMPLETED|Overall Study||0
1476634|NCT01874275|3613815|P1|NOT COMPLETED|Overall Study||1
1476635|NCT01874275|3613814|P2|COMPLETED|Overall Study||2
1476636|NCT01874275|3613815|P1|COMPLETED|Overall Study||3
1476637|NCT01874275|3613814|P2|STARTED|Overall Study||2
1476638|NCT01874275|3613815|P1|STARTED|Overall Study||4
1476639|NCT01874262|3613829|P2|NOT COMPLETED|Overall Study||3
1476640|NCT01874262|3613830|P1|NOT COMPLETED|Overall Study||5
1476641|NCT01874262|3613829|P2|COMPLETED|Overall Study||80
1476642|NCT01874262|3613830|P1|COMPLETED|Overall Study||86
1476643|NCT01874262|3613829|P2|Not Included Due to Tehnical Issues|Overall Study||3
1476644|NCT01874262|3613830|P1|Not Included Due to Tehnical Issues|Overall Study||3
1476645|NCT01874262|3613829|P2|Not Correctly Randomised|Overall Study||0
1476646|NCT01874262|3613830|P1|Not Correctly Randomised|Overall Study||2
1476647|NCT01874262|3613829|P2|STARTED|Overall Study||83
1476648|NCT01874262|3613830|P1|STARTED|Overall Study||91
1476649|NCT01874145|3613838|P2|NOT COMPLETED|Extension Period||4
1476650|NCT01874145|3613839|P1|NOT COMPLETED|Extension Period||6
1476651|NCT01874145|3613838|P2|COMPLETED|Extension Period||97
1476652|NCT01874145|3613839|P1|COMPLETED|Extension Period||91
1476653|NCT01874145|3613838|P2|Full Analysis Set|Extension Period||101
1476654|NCT01874145|3613839|P1|Full Analysis Set|Extension Period||95
1476655|NCT01874145|3613838|P2|STARTED|Extension Period|Non-Switchers|101
1476656|NCT01874145|3613839|P1|STARTED|Extension Period|Switchers|97
1476657|NCT01874145|3613838|P2|NOT COMPLETED|Core Period||7
1476658|NCT01874145|3613839|P1|NOT COMPLETED|Core Period||3
1476659|NCT01874145|3613838|P2|COMPLETED|Core Period||101
1476660|NCT01874145|3613839|P1|COMPLETED|Core Period||98
1476661|NCT01874145|3613838|P2|Full Analysis Set|Core Period||108
1476662|NCT01874145|3613839|P1|Full Analysis Set|Core Period||100
1476663|NCT01874145|3613838|P2|STARTED|Core Period||108
1476664|NCT01874145|3613839|P1|STARTED|Core Period||101
1476665|NCT01874132|3613878|P3|NOT COMPLETED|Overall Study||3
1476666|NCT01874132|3613879|P2|NOT COMPLETED|Overall Study||4
1476667|NCT01874132|3613880|P1|NOT COMPLETED|Overall Study||4
1476668|NCT01874132|3613878|P3|COMPLETED|Overall Study||19
1476669|NCT01874132|3613879|P2|COMPLETED|Overall Study||18
1476670|NCT01874132|3613880|P1|COMPLETED|Overall Study||18
1476671|NCT01874132|3613878|P3|STARTED|Overall Study||22
1476672|NCT01874132|3613879|P2|STARTED|Overall Study||22
1476673|NCT01874132|3613880|P1|STARTED|Overall Study||22
1476674|NCT01874119|3613891|P2|NOT COMPLETED|Second Intervention (6 Days)||0
1476675|NCT01874119|3613892|P1|NOT COMPLETED|Second Intervention (6 Days)||0
1476676|NCT01874119|3613891|P2|COMPLETED|Second Intervention (6 Days)||3
1476677|NCT01874119|3613892|P1|COMPLETED|Second Intervention (6 Days)||4
1476678|NCT01874119|3613891|P2|STARTED|Second Intervention (6 Days)||3
1476679|NCT01874119|3613892|P1|STARTED|Second Intervention (6 Days)||4
1476680|NCT01874119|3613891|P2|NOT COMPLETED|Washout (7 Days)||2
1476681|NCT01874119|3613892|P1|NOT COMPLETED|Washout (7 Days)||3
1476682|NCT01874119|3613891|P2|COMPLETED|Washout (7 Days)||3
1476683|NCT01874119|3613892|P1|COMPLETED|Washout (7 Days)||4
1476684|NCT01874119|3613891|P2|STARTED|Washout (7 Days)||5
1476685|NCT01874119|3613892|P1|STARTED|Washout (7 Days)||7
1476686|NCT01874119|3613891|P2|NOT COMPLETED|First Intervention (6 Days)||0
1476687|NCT01874119|3613892|P1|NOT COMPLETED|First Intervention (6 Days)||1
1476688|NCT01874119|3613891|P2|COMPLETED|First Intervention (6 Days)||5
1476689|NCT01874119|3613892|P1|COMPLETED|First Intervention (6 Days)||7
1476690|NCT01874119|3613891|P2|STARTED|First Intervention (6 Days)||5
1476691|NCT01874119|3613892|P1|STARTED|First Intervention (6 Days)||8
1476692|NCT01874054|3613898|P1|NOT COMPLETED|Follow-up Period||49
1476693|NCT01874054|3613898|P1|COMPLETED|Follow-up Period||2
1476694|NCT01874054|3613898|P1|STARTED|Follow-up Period|4 patients withdrew consent and did not enter the follow-up period.|51
1476695|NCT01874054|3613898|P1|NOT COMPLETED|Treatment Period||38
1476696|NCT01874054|3613898|P1|COMPLETED|Treatment Period||17
1476697|NCT01874054|3613898|P1|STARTED|Treatment Period||55
1476698|NCT01873989|3613909|P2|NOT COMPLETED|Overall Study||1
1476699|NCT01873989|3613910|P1|NOT COMPLETED|Overall Study||1
1476700|NCT01873989|3613909|P2|COMPLETED|Overall Study||6
1476701|NCT01873989|3613910|P1|COMPLETED|Overall Study||7
1476702|NCT01873989|3613909|P2|STARTED|Overall Study||7
1476703|NCT01873989|3613910|P1|STARTED|Overall Study||8
1476704|NCT01873950|3613920|P5|NOT COMPLETED|Period 5||0
1476705|NCT01873950|3613921|P4|NOT COMPLETED|Period 5||1
1476706|NCT01873950|3613922|P3|NOT COMPLETED|Period 5||0
1476707|NCT01873950|3613923|P2|NOT COMPLETED|Period 5||0
1476708|NCT01873950|3613924|P1|NOT COMPLETED|Period 5||0
1476709|NCT01873950|3613920|P5|COMPLETED|Period 5||4
1476710|NCT01873950|3613921|P4|COMPLETED|Period 5||3
1476711|NCT01873950|3613922|P3|COMPLETED|Period 5||4
1476712|NCT01873950|3613923|P2|COMPLETED|Period 5||5
1476713|NCT01873950|3613924|P1|COMPLETED|Period 5||4
1476714|NCT01873950|3613920|P5|STARTED|Period 5||4
1476715|NCT01873950|3613921|P4|STARTED|Period 5||4
1476716|NCT01873950|3613922|P3|STARTED|Period 5||4
1476717|NCT01873950|3613923|P2|STARTED|Period 5||5
1476718|NCT01873950|3613924|P1|STARTED|Period 5||4
1476719|NCT01873950|3613920|P5|NOT COMPLETED|Period 4||0
1476720|NCT01873950|3613921|P4|NOT COMPLETED|Period 4||0
1476721|NCT01873950|3613922|P3|NOT COMPLETED|Period 4||0
1476722|NCT01873950|3613923|P2|NOT COMPLETED|Period 4||0
1476723|NCT01873950|3613924|P1|NOT COMPLETED|Period 4||0
1476724|NCT01873950|3613920|P5|COMPLETED|Period 4||5
1476725|NCT01873950|3613921|P4|COMPLETED|Period 4||4
1476726|NCT01873950|3613922|P3|COMPLETED|Period 4||4
1476727|NCT01873950|3613923|P2|COMPLETED|Period 4||5
1476728|NCT01873950|3613924|P1|COMPLETED|Period 4||4
1476729|NCT01873950|3613920|P5|STARTED|Period 4||5
1476730|NCT01873950|3613921|P4|STARTED|Period 4||4
1476731|NCT01873950|3613922|P3|STARTED|Period 4||4
1476732|NCT01873950|3613923|P2|STARTED|Period 4||5
1476733|NCT01873950|3613924|P1|STARTED|Period 4||4
1476734|NCT01873950|3613920|P5|NOT COMPLETED|Period 3||0
1476735|NCT01873950|3613921|P4|NOT COMPLETED|Period 3||0
1476736|NCT01873950|3613922|P3|NOT COMPLETED|Period 3||0
1476737|NCT01873950|3613923|P2|NOT COMPLETED|Period 3||0
1476738|NCT01873950|3613924|P1|NOT COMPLETED|Period 3||0
1476739|NCT01873950|3613920|P5|COMPLETED|Period 3||4
1476740|NCT01873950|3613921|P4|COMPLETED|Period 3||5
1476741|NCT01873950|3613922|P3|COMPLETED|Period 3||5
1476742|NCT01873950|3613923|P2|COMPLETED|Period 3||4
1476743|NCT01873950|3613924|P1|COMPLETED|Period 3||4
1476744|NCT01873950|3613920|P5|STARTED|Period 3||4
1476745|NCT01873950|3613921|P4|STARTED|Period 3||5
1476746|NCT01873950|3613922|P3|STARTED|Period 3||5
1476747|NCT01873950|3613923|P2|STARTED|Period 3||4
1476748|NCT01873950|3613924|P1|STARTED|Period 3||4
1476749|NCT01873950|3613920|P5|NOT COMPLETED|Period 2||0
1476750|NCT01873950|3613921|P4|NOT COMPLETED|Period 2||0
1476751|NCT01873950|3613922|P3|NOT COMPLETED|Period 2||0
1476752|NCT01873950|3613923|P2|NOT COMPLETED|Period 2||0
1476753|NCT01873950|3613924|P1|NOT COMPLETED|Period 2||0
1476754|NCT01873950|3613920|P5|COMPLETED|Period 2||5
1476755|NCT01873950|3613921|P4|COMPLETED|Period 2||4
1476756|NCT01873950|3613922|P3|COMPLETED|Period 2||4
1476757|NCT01873950|3613923|P2|COMPLETED|Period 2||4
1476758|NCT01873950|3613924|P1|COMPLETED|Period 2||5
1476759|NCT01873950|3613920|P5|STARTED|Period 2||5
1476760|NCT01873950|3613921|P4|STARTED|Period 2||4
1476761|NCT01873950|3613922|P3|STARTED|Period 2||4
1476762|NCT01873950|3613923|P2|STARTED|Period 2||4
1476763|NCT01873950|3613924|P1|STARTED|Period 2||5
1476764|NCT01873950|3613920|P5|NOT COMPLETED|Period 1||0
1476765|NCT01873950|3613921|P4|NOT COMPLETED|Period 1||0
1476766|NCT01873950|3613922|P3|NOT COMPLETED|Period 1||0
1476767|NCT01873950|3613923|P2|NOT COMPLETED|Period 1||0
1476768|NCT01873950|3613924|P1|NOT COMPLETED|Period 1||0
1476769|NCT01873950|3613920|P5|COMPLETED|Period 1||4
1476770|NCT01873950|3613921|P4|COMPLETED|Period 1||4
1476771|NCT01873950|3613922|P3|COMPLETED|Period 1||5
1476772|NCT01873950|3613923|P2|COMPLETED|Period 1||4
1476773|NCT01873950|3613924|P1|COMPLETED|Period 1||5
1476774|NCT01873950|3613920|P5|STARTED|Period 1||4
1476775|NCT01873950|3613921|P4|STARTED|Period 1||4
1476776|NCT01873950|3613922|P3|STARTED|Period 1||5
1476777|NCT01873950|3613923|P2|STARTED|Period 1||4
1476778|NCT01873950|3613924|P1|STARTED|Period 1||5
1476779|NCT01873859|3613961|P2|NOT COMPLETED|Overall Study||4
1476780|NCT01873859|3613962|P1|NOT COMPLETED|Overall Study||0
1476781|NCT01873859|3613961|P2|COMPLETED|Overall Study||79
1476782|NCT01873859|3613962|P1|COMPLETED|Overall Study||83
1476783|NCT01873859|3613961|P2|STARTED|Overall Study||83
1476784|NCT01873859|3613962|P1|STARTED|Overall Study||83
1476785|NCT01873729|3613970|P1|NOT COMPLETED|Overall Study||1
1476786|NCT01873729|3613970|P1|COMPLETED|Overall Study||2
1476787|NCT01873729|3613970|P1|STARTED|Overall Study||3
1476788|NCT01873417|3613975|P1|NOT COMPLETED|Overall Study||35
1476789|NCT01873417|3613975|P1|COMPLETED|Overall Study||202
1476790|NCT01873417|3613975|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
1476791|NCT01873417|3613975|P1|STARTED|Overall Study||237
1476792|NCT01872910|3613992|P6|NOT COMPLETED|Overall Study||0
1476793|NCT01872910|3613993|P5|NOT COMPLETED|Overall Study||0
1476794|NCT01872910|3613994|P4|NOT COMPLETED|Overall Study||0
1476795|NCT01872910|3613995|P3|NOT COMPLETED|Overall Study||2
1476796|NCT01872910|3613996|P2|NOT COMPLETED|Overall Study||0
1476797|NCT01872910|3613997|P1|NOT COMPLETED|Overall Study||2
1476798|NCT01872910|3613992|P6|COMPLETED|Overall Study||3
1476799|NCT01872910|3613993|P5|COMPLETED|Overall Study||15
1476800|NCT01872910|3613994|P4|COMPLETED|Overall Study||15
1476801|NCT01872910|3613995|P3|COMPLETED|Overall Study||28
1476802|NCT01872910|3613996|P2|COMPLETED|Overall Study||31
1476803|NCT01872910|3613997|P1|COMPLETED|Overall Study||28
1476804|NCT01872910|3613992|P6|Received Any Study Drug|Overall Study||3
1476805|NCT01872910|3613993|P5|Received Any Study Drug|Overall Study||15
1476806|NCT01872910|3613994|P4|Received Any Study Drug|Overall Study||15
1476807|NCT01872910|3613995|P3|Received Any Study Drug|Overall Study||30
1476808|NCT01872910|3613996|P2|Received Any Study Drug|Overall Study||31
1476809|NCT01872910|3613997|P1|Received Any Study Drug|Overall Study||30
1476810|NCT01872910|3613992|P6|STARTED|Overall Study||3
1476811|NCT01872910|3613993|P5|STARTED|Overall Study||15
1476812|NCT01872910|3613994|P4|STARTED|Overall Study||15
1476813|NCT01872910|3613995|P3|STARTED|Overall Study||30
1476814|NCT01872910|3613996|P2|STARTED|Overall Study||31
1476815|NCT01872910|3613997|P1|STARTED|Overall Study||30
1476816|NCT01872819|3614037|P1|NOT COMPLETED|Overall Study||0
1476817|NCT01872819|3614037|P1|COMPLETED|Overall Study||14
1476818|NCT01872819|3614037|P1|STARTED|Overall Study||14
1476819|NCT01872715|3614042|P1|NOT COMPLETED|Overall Study||4
1476820|NCT01872715|3614042|P1|COMPLETED|Overall Study||20
1476821|NCT01872715|3614042|P1|STARTED|Overall Study||24
1476822|NCT01872689|3614061|P4|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
1476823|NCT01872689|3614062|P3|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
1476824|NCT01872689|3614063|P2|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
1476825|NCT01872689|3614064|P1|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
1476826|NCT01872689|3614061|P4|COMPLETED|Open-Label Period (Only For Monotherapy)||0
1476827|NCT01872689|3614062|P3|COMPLETED|Open-Label Period (Only For Monotherapy)||0
1476828|NCT01872689|3614063|P2|COMPLETED|Open-Label Period (Only For Monotherapy)||33
1476829|NCT01872689|3614064|P1|COMPLETED|Open-Label Period (Only For Monotherapy)||31
1476830|NCT01872689|3614061|P4|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
1476831|NCT01872689|3614062|P3|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
1476832|NCT01872689|3614063|P2|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
1476833|NCT01872689|3614064|P1|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
1476834|NCT01872689|3614061|P4|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
1476835|NCT01872689|3614062|P3|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
1476836|NCT01872689|3614063|P2|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
1476837|NCT01872689|3614064|P1|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
1476838|NCT01872689|3614061|P4|COMPLETED|Double-Blind/Placebo-Controlled Period||136
1476839|NCT01872689|3614062|P3|COMPLETED|Double-Blind/Placebo-Controlled Period||129
1476840|NCT01872689|3614063|P2|COMPLETED|Double-Blind/Placebo-Controlled Period||58
1476841|NCT01872689|3614064|P1|COMPLETED|Double-Blind/Placebo-Controlled Period||56
1476842|NCT01872689|3614061|P4|STARTED|Double-Blind/Placebo-Controlled Period||174
1476843|NCT01872689|3614062|P3|STARTED|Double-Blind/Placebo-Controlled Period||177
1476844|NCT01872689|3614063|P2|STARTED|Double-Blind/Placebo-Controlled Period||78
1476845|NCT01872689|3614064|P1|STARTED|Double-Blind/Placebo-Controlled Period||76
1476846|NCT01872611|3614140|P2|NOT COMPLETED|Overall Study||12
1476847|NCT01872611|3614141|P1|NOT COMPLETED|Overall Study||24
1476848|NCT01872611|3614140|P2|COMPLETED|Overall Study||292
1476849|NCT01872611|3614141|P1|COMPLETED|Overall Study||277
1476850|NCT01872611|3614140|P2|Full Analysis Set|Overall Study||293
1476851|NCT01872611|3614141|P1|Full Analysis Set|Overall Study||289
1476852|NCT01872611|3614140|P2|Treated (Safety Analysis Set)|Overall Study||295
1476853|NCT01872611|3614141|P1|Treated (Safety Analysis Set)|Overall Study||293
1476854|NCT01872611|3614140|P2|Randomized|Overall Study||304
1476855|NCT01872611|3614141|P1|Randomized|Overall Study||301
1476856|NCT01872611|3614140|P2|STARTED|Overall Study||304
1476857|NCT01872611|3614141|P1|STARTED|Overall Study||301
1476858|NCT01872078|3614163|P4|NOT COMPLETED|Overall Study||2
1476859|NCT01872078|3614164|P3|NOT COMPLETED|Overall Study||3
1476860|NCT01872078|3614165|P2|NOT COMPLETED|Overall Study||0
1476861|NCT01872078|3614166|P1|NOT COMPLETED|Overall Study||0
1476862|NCT01872078|3614163|P4|COMPLETED|Overall Study||15
1476863|NCT01872078|3614164|P3|COMPLETED|Overall Study||14
1476864|NCT01872078|3614165|P2|COMPLETED|Overall Study||15
1476865|NCT01872078|3614166|P1|COMPLETED|Overall Study||16
1476866|NCT01872078|3614163|P4|STARTED|Overall Study||17
1476867|NCT01872078|3614164|P3|STARTED|Overall Study||17
1476868|NCT01872078|3614165|P2|STARTED|Overall Study||15
1476869|NCT01872078|3614166|P1|STARTED|Overall Study||16
1476870|NCT01871870|3614176|P1|NOT COMPLETED|Overall Study||9
1476871|NCT01871870|3614176|P1|COMPLETED|Overall Study||11
1476872|NCT01871870|3614176|P1|STARTED|Overall Study||20
1476873|NCT01871805|3614187|P6|NOT COMPLETED|Phase II||87
1476874|NCT01871805|3614188|P5|NOT COMPLETED|Phase II||0
1476875|NCT01871805|3614189|P4|NOT COMPLETED|Phase II||0
1476876|NCT01871805|3614190|P3|NOT COMPLETED|Phase II||0
1476877|NCT01871805|3614191|P2|NOT COMPLETED|Phase II||0
1476878|NCT01871805|3614192|P1|NOT COMPLETED|Phase II||0
1476879|NCT01871805|3614187|P6|COMPLETED|Phase II||0
1476880|NCT01871805|3614188|P5|COMPLETED|Phase II||0
1476881|NCT01871805|3614189|P4|COMPLETED|Phase II||0
1476882|NCT01871805|3614190|P3|COMPLETED|Phase II||0
1476883|NCT01871805|3614191|P2|COMPLETED|Phase II||0
1476884|NCT01871805|3614192|P1|COMPLETED|Phase II||0
1476885|NCT01871805|3614187|P6|STARTED|Phase II||87
1476886|NCT01871805|3614188|P5|STARTED|Phase II||0
1476887|NCT01871805|3614189|P4|STARTED|Phase II||0
1476888|NCT01871805|3614190|P3|STARTED|Phase II||0
1476889|NCT01871805|3614191|P2|STARTED|Phase II||0
1476890|NCT01871805|3614192|P1|STARTED|Phase II||0
1476891|NCT01871805|3614187|P6|NOT COMPLETED|Phase I||0
1476892|NCT01871805|3614188|P5|NOT COMPLETED|Phase I||13
1476893|NCT01871805|3614189|P4|NOT COMPLETED|Phase I||7
1476894|NCT01871805|3614190|P3|NOT COMPLETED|Phase I||13
1476895|NCT01871805|3614191|P2|NOT COMPLETED|Phase I||7
1476896|NCT01871805|3614192|P1|NOT COMPLETED|Phase I||7
1476897|NCT01871805|3614187|P6|COMPLETED|Phase I||0
1476898|NCT01871805|3614188|P5|COMPLETED|Phase I||0
1476899|NCT01871805|3614189|P4|COMPLETED|Phase I||0
1476900|NCT01871805|3614190|P3|COMPLETED|Phase I||0
1476901|NCT01871805|3614191|P2|COMPLETED|Phase I||0
1476902|NCT01871805|3614192|P1|COMPLETED|Phase I||0
1476903|NCT01871805|3614187|P6|STARTED|Phase I||0
1476904|NCT01871805|3614188|P5|STARTED|Phase I||13
1476905|NCT01871805|3614189|P4|STARTED|Phase I||7
1476906|NCT01871805|3614190|P3|STARTED|Phase I||13
1476907|NCT01871805|3614191|P2|STARTED|Phase I||7
1476908|NCT01871805|3614192|P1|STARTED|Phase I||7
1476909|NCT01871558|3614264|P2|NOT COMPLETED|Overall Study||2
1476910|NCT01871558|3614265|P1|NOT COMPLETED|Overall Study||3
1476911|NCT01871558|3614264|P2|COMPLETED|Overall Study||19
1476912|NCT01871558|3614265|P1|COMPLETED|Overall Study||18
1476913|NCT01871558|3614264|P2|STARTED|Overall Study||21
1476914|NCT01871558|3614265|P1|STARTED|Overall Study||21
1476915|NCT01871532|3614285|P2|NOT COMPLETED|Overall Study||2
1476916|NCT01871532|3614286|P1|NOT COMPLETED|Overall Study||1
1476917|NCT01871532|3614285|P2|COMPLETED|Overall Study||10
1476918|NCT01871532|3614286|P1|COMPLETED|Overall Study||11
1476919|NCT01871532|3614285|P2|Subjects Received hCG Treatment|Overall Study||9
1476920|NCT01871532|3614286|P1|Subjects Received hCG Treatment|Overall Study||11
1476921|NCT01871532|3614285|P2|STARTED|Overall Study||12
1476922|NCT01871532|3614286|P1|STARTED|Overall Study||12
1476923|NCT01871519|3614320|P1|NOT COMPLETED|Overall Study||90
1476924|NCT01871519|3614320|P1|COMPLETED|Overall Study||260
1476925|NCT01871519|3614320|P1|STARTED|Overall Study||350
1476926|NCT01871441|3614341|P1|NOT COMPLETED|Overall Study||0
1476927|NCT01871441|3614341|P1|COMPLETED|Overall Study||4
1476928|NCT01871441|3614341|P1|STARTED|Overall Study||4
1476929|NCT01871402|3614350|P2|NOT COMPLETED|Overall Study||3
1476930|NCT01871402|3614351|P1|NOT COMPLETED|Overall Study||1
1476931|NCT01871402|3614350|P2|COMPLETED|Overall Study||108
1476932|NCT01871402|3614351|P1|COMPLETED|Overall Study||109
1476933|NCT01871402|3614350|P2|STARTED|Overall Study||111
1476934|NCT01871402|3614351|P1|STARTED|Overall Study||110
1476935|NCT01871285|3614369|P4|NOT COMPLETED|Second Intervention (1 Day)||0
1476936|NCT01871285|3614370|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1476937|NCT01871285|3614371|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1476938|NCT01871285|3614372|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1476939|NCT01871285|3614369|P4|COMPLETED|Second Intervention (1 Day)||2
1476940|NCT01871285|3614370|P3|COMPLETED|Second Intervention (1 Day)||3
1476941|NCT01871285|3614371|P2|COMPLETED|Second Intervention (1 Day)||14
1476942|NCT01871285|3614372|P1|COMPLETED|Second Intervention (1 Day)||17
1476943|NCT01871285|3614369|P4|STARTED|Second Intervention (1 Day)||2
1476944|NCT01871285|3614370|P3|STARTED|Second Intervention (1 Day)||3
1476945|NCT01871285|3614371|P2|STARTED|Second Intervention (1 Day)||14
1476946|NCT01871285|3614372|P1|STARTED|Second Intervention (1 Day)||17
1476947|NCT01871285|3614369|P4|NOT COMPLETED|First Intervention (1 Day)||0
1476948|NCT01871285|3614370|P3|NOT COMPLETED|First Intervention (1 Day)||1
1476949|NCT01871285|3614371|P2|NOT COMPLETED|First Intervention (1 Day)||1
1476950|NCT01871285|3614372|P1|NOT COMPLETED|First Intervention (1 Day)||1
1476951|NCT01871285|3614369|P4|COMPLETED|First Intervention (1 Day)||2
1476952|NCT01871285|3614370|P3|COMPLETED|First Intervention (1 Day)||3
1476953|NCT01871285|3614371|P2|COMPLETED|First Intervention (1 Day)||14
1476954|NCT01871285|3614372|P1|COMPLETED|First Intervention (1 Day)||17
1476955|NCT01871285|3614369|P4|STARTED|First Intervention (1 Day)||2
1476956|NCT01871285|3614370|P3|STARTED|First Intervention (1 Day)||4
1476957|NCT01871285|3614371|P2|STARTED|First Intervention (1 Day)||15
1476958|NCT01871285|3614372|P1|STARTED|First Intervention (1 Day)||18
1476959|NCT01871142|3614398|P1|NOT COMPLETED|Overall Study||1
1476960|NCT01871142|3614398|P1|COMPLETED|Overall Study||11
1476961|NCT01871142|3614398|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
1476962|NCT01871142|3614398|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
1476963|NCT01871142|3614398|P1|Received Placebo + Hypoxia|Overall Study||12
1476964|NCT01871142|3614398|P1|Received Placebo + Normoixa|Overall Study||11
1476965|NCT01871142|3614398|P1|STARTED|Overall Study||12
1476966|NCT01871090|3614414|P2|NOT COMPLETED|Overall Study||23
1476967|NCT01871090|3614415|P1|NOT COMPLETED|Overall Study||2
1476968|NCT01871090|3614414|P2|COMPLETED|Overall Study||25
1476969|NCT01871090|3614415|P1|COMPLETED|Overall Study||33
1476970|NCT01871090|3614414|P2|STARTED|Overall Study||48
1476971|NCT01871090|3614415|P1|STARTED|Overall Study||35
1476972|NCT01870999|3614428|P3|NOT COMPLETED|Overall Study||7
1476973|NCT01870999|3614429|P2|NOT COMPLETED|Overall Study||8
1476974|NCT01870999|3614430|P1|NOT COMPLETED|Overall Study||4
1476975|NCT01870999|3614428|P3|COMPLETED|Overall Study||4
1476976|NCT01870999|3614429|P2|COMPLETED|Overall Study||8
1476977|NCT01870999|3614430|P1|COMPLETED|Overall Study||10
1476978|NCT01870999|3614428|P3|Safety Population; Received Study Drug|Overall Study||10
1476979|NCT01870999|3614429|P2|Safety Population; Received Study Drug|Overall Study||15
1476980|NCT01870999|3614430|P1|Safety Population; Received Study Drug|Overall Study||14
1476981|NCT01870999|3614428|P3|STARTED|Overall Study||11
1476982|NCT01870999|3614429|P2|STARTED|Overall Study||16
1476983|NCT01870999|3614430|P1|STARTED|Overall Study||14
1476984|NCT01870973|3614488|P2|NOT COMPLETED|Overall Study||3
1476985|NCT01870973|3614489|P1|NOT COMPLETED|Overall Study||10
1476986|NCT01870973|3614488|P2|COMPLETED|Overall Study||49
1476987|NCT01870973|3614489|P1|COMPLETED|Overall Study||46
1476988|NCT01870973|3614488|P2|STARTED|Overall Study||52
1476989|NCT01870973|3614489|P1|STARTED|Overall Study||56
1476990|NCT01870921|3614495|P1|NOT COMPLETED|Overall Study||90
1476991|NCT01870921|3614495|P1|COMPLETED|Overall Study||1914
1476992|NCT01870921|3614495|P1|STARTED|Overall Study||2004
1476993|NCT01870856|3614503|P2|NOT COMPLETED|Overall Study||0
1476994|NCT01870856|3614504|P1|NOT COMPLETED|Overall Study||0
1476995|NCT01870856|3614503|P2|COMPLETED|Overall Study||27
1476996|NCT01870856|3614504|P1|COMPLETED|Overall Study||25
1476997|NCT01870856|3614503|P2|STARTED|Overall Study||27
1476998|NCT01870856|3614504|P1|STARTED|Overall Study||25
1476999|NCT01870843|3614514|P1|NOT COMPLETED|Overall Study||53
1477000|NCT01870843|3614514|P1|COMPLETED|Overall Study||208
1477001|NCT01870843|3614514|P1|STARTED|Overall Study||261
1477002|NCT01870778|3614529|P2|NOT COMPLETED|Overall Study||9
1477003|NCT01870778|3614530|P1|NOT COMPLETED|Overall Study||8
1477004|NCT01870778|3614529|P2|COMPLETED|Overall Study||3262
1477005|NCT01870778|3614530|P1|COMPLETED|Overall Study||3266
1477006|NCT01870778|3614529|P2|Biomarker Analysis Set|Overall Study||510
1477007|NCT01870778|3614530|P1|Biomarker Analysis Set|Overall Study||521
1477008|NCT01870778|3614529|P2|Full Analysis Set|Overall Study||3271
1477009|NCT01870778|3614530|P1|Full Analysis Set|Overall Study||3274
1477010|NCT01870778|3614529|P2|Safety Set|Overall Study||3248
1477011|NCT01870778|3614530|P1|Safety Set|Overall Study||3257
1477012|NCT01870778|3614529|P2|STARTED|Overall Study||3271
1477013|NCT01870778|3614530|P1|STARTED|Overall Study||3274
1477014|NCT01870739|3614556|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
1477015|NCT01870739|3614557|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
1477016|NCT01870739|3614556|P2|COMPLETED|Add-on Period (40 Weeks)||51
1477017|NCT01870739|3614557|P1|COMPLETED|Add-on Period (40 Weeks)||51
1477018|NCT01870739|3614556|P2|STARTED|Add-on Period (40 Weeks)||53
1477019|NCT01870739|3614557|P1|STARTED|Add-on Period (40 Weeks)||54
1477020|NCT01870739|3614556|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
1477021|NCT01870739|3614557|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
1477022|NCT01870739|3614556|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
1477023|NCT01870739|3614557|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
1477024|NCT01870739|3614556|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
1477025|NCT01870739|3614557|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
1477026|NCT01870739|3614556|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
1477027|NCT01870739|3614557|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
1477028|NCT01870739|3614556|P2|STARTED|Single Drug Treatment (12 Weeks)||57
1477029|NCT01870739|3614557|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
1477030|NCT01870726|3614596|P7|NOT COMPLETED|Overall Study||10
1477031|NCT01870726|3614597|P6|NOT COMPLETED|Overall Study||5
1477032|NCT01870726|3614598|P5|NOT COMPLETED|Overall Study||7
1477033|NCT01870726|3614599|P4|NOT COMPLETED|Overall Study||6
1477034|NCT01870726|3614600|P3|NOT COMPLETED|Overall Study||4
1477035|NCT01870726|3614601|P2|NOT COMPLETED|Overall Study||6
1477036|NCT01870726|3614602|P1|NOT COMPLETED|Overall Study||5
1477037|NCT01870726|3614596|P7|COMPLETED|Overall Study||0
1477038|NCT01870726|3614597|P6|COMPLETED|Overall Study||0
1477039|NCT01870726|3614598|P5|COMPLETED|Overall Study||0
1477040|NCT01870726|3614599|P4|COMPLETED|Overall Study||0
1477041|NCT01870726|3614600|P3|COMPLETED|Overall Study||0
1477042|NCT01870726|3614601|P2|COMPLETED|Overall Study||0
1477043|NCT01870726|3614602|P1|COMPLETED|Overall Study||0
1477044|NCT01870726|3614596|P7|STARTED|Overall Study||10
1477045|NCT01870726|3614597|P6|STARTED|Overall Study||5
1477046|NCT01870726|3614598|P5|STARTED|Overall Study||7
1477047|NCT01870726|3614599|P4|STARTED|Overall Study||6
1477048|NCT01870726|3614600|P3|STARTED|Overall Study||4
1477049|NCT01870726|3614601|P2|STARTED|Overall Study||6
1477050|NCT01870726|3614602|P1|STARTED|Overall Study||5
1477051|NCT01870596|3614687|P2|NOT COMPLETED|Overall Study||0
1477052|NCT01870596|3614688|P1|NOT COMPLETED|Overall Study||0
1477053|NCT01870596|3614687|P2|COMPLETED|Overall Study||18
1477054|NCT01870596|3614688|P1|COMPLETED|Overall Study||14
1477055|NCT01870596|3614687|P2|STARTED|Overall Study||18
1477056|NCT01870596|3614688|P1|STARTED|Overall Study||14
1477057|NCT01870583|3614697|P3|NOT COMPLETED|Overall Study||8
1477058|NCT01870583|3614698|P2|NOT COMPLETED|Overall Study||18
1477059|NCT01870583|3614699|P1|NOT COMPLETED|Overall Study||11
1477060|NCT01870583|3614697|P3|COMPLETED|Overall Study||455
1477061|NCT01870583|3614698|P2|COMPLETED|Overall Study||456
1477062|NCT01870583|3614699|P1|COMPLETED|Overall Study||456
1477063|NCT01870583|3614697|P3|STARTED|Overall Study||463
1477064|NCT01870583|3614698|P2|STARTED|Overall Study||474
1477065|NCT01870583|3614699|P1|STARTED|Overall Study||467
1477066|NCT01870388|3614709|P2|NOT COMPLETED|Overall Study||0
1477067|NCT01870388|3614710|P1|NOT COMPLETED|Overall Study||0
1477068|NCT01870388|3614709|P2|COMPLETED|Overall Study||8
1477069|NCT01870388|3614710|P1|COMPLETED|Overall Study||8
1477070|NCT01870388|3614709|P2|Received 1 Dose of Study Drug|Overall Study||8
1477071|NCT01870388|3614710|P1|Received 1 Dose of Study Drug|Overall Study||8
1477072|NCT01870388|3614709|P2|STARTED|Overall Study||8
1477073|NCT01870388|3614710|P1|STARTED|Overall Study||8
1477074|NCT01870076|3614722|P4|NOT COMPLETED|Overall Study||0
1477075|NCT01870076|3614723|P3|NOT COMPLETED|Overall Study||1
1477076|NCT01870076|3614724|P2|NOT COMPLETED|Overall Study||0
1477077|NCT01870076|3614725|P1|NOT COMPLETED|Overall Study||1
1477078|NCT01870076|3614722|P4|COMPLETED|Overall Study||11
1477079|NCT01870076|3614723|P3|COMPLETED|Overall Study||7
1477080|NCT01870076|3614724|P2|COMPLETED|Overall Study||12
1477081|NCT01870076|3614725|P1|COMPLETED|Overall Study||9
1477082|NCT01870076|3614722|P4|STARTED|Overall Study||11
1477083|NCT01870076|3614723|P3|STARTED|Overall Study||8
1477084|NCT01870076|3614724|P2|STARTED|Overall Study||12
1477085|NCT01870076|3614725|P1|STARTED|Overall Study||10
1477086|NCT01869959|3614743|P5|NOT COMPLETED|Treatment Period||0
1477087|NCT01869959|3614744|P4|NOT COMPLETED|Treatment Period||2
1477088|NCT01869959|3614745|P3|NOT COMPLETED|Treatment Period||3
1477089|NCT01869959|3614746|P2|NOT COMPLETED|Treatment Period||2
1477090|NCT01869959|3614747|P1|NOT COMPLETED|Treatment Period||1
1477091|NCT01869959|3614743|P5|COMPLETED|Treatment Period||0
1477092|NCT01869959|3614744|P4|COMPLETED|Treatment Period||8
1477093|NCT01869959|3614745|P3|COMPLETED|Treatment Period||12
1477094|NCT01869959|3614746|P2|COMPLETED|Treatment Period||8
1477095|NCT01869959|3614747|P1|COMPLETED|Treatment Period||10
1477096|NCT01869959|3614743|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
1477097|NCT01869959|3614744|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
1477098|NCT01869959|3614745|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
1477099|NCT01869959|3614746|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
1477100|NCT01869959|3614747|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
1477101|NCT01869959|3614743|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
1477102|NCT01869959|3614744|P4|STARTED|Treatment Period||10
1477103|NCT01869959|3614745|P3|STARTED|Treatment Period||15
1477104|NCT01869959|3614746|P2|STARTED|Treatment Period||10
1477105|NCT01869959|3614747|P1|STARTED|Treatment Period||11
1477106|NCT01869959|3614743|P5|NOT COMPLETED|Randomization Period||1
1477107|NCT01869959|3614744|P4|NOT COMPLETED|Randomization Period||0
1477108|NCT01869959|3614745|P3|NOT COMPLETED|Randomization Period||0
1477109|NCT01869959|3614746|P2|NOT COMPLETED|Randomization Period||0
1477110|NCT01869959|3614747|P1|NOT COMPLETED|Randomization Period||0
1477111|NCT01869959|3614743|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
1477112|NCT01869959|3614744|P4|COMPLETED|Randomization Period||0
1477113|NCT01869959|3614745|P3|COMPLETED|Randomization Period||0
1477114|NCT01869959|3614746|P2|COMPLETED|Randomization Period||0
1477115|NCT01869959|3614747|P1|COMPLETED|Randomization Period||0
1477116|NCT01869959|3614743|P5|STARTED|Randomization Period||47
1477117|NCT01869959|3614744|P4|STARTED|Randomization Period||0
1477118|NCT01869959|3614745|P3|STARTED|Randomization Period||0
1477119|NCT01869959|3614746|P2|STARTED|Randomization Period||0
1477120|NCT01869959|3614747|P1|STARTED|Randomization Period||0
1477121|NCT01869699|3614817|P2|NOT COMPLETED|Overall Study||0
1477122|NCT01869699|3614818|P1|NOT COMPLETED|Overall Study||1
1477123|NCT01869699|3614817|P2|COMPLETED|Overall Study||20
1477124|NCT01869699|3614818|P1|COMPLETED|Overall Study||20
1477125|NCT01869699|3614817|P2|STARTED|Overall Study||20
1477126|NCT01869699|3614818|P1|STARTED|Overall Study||21
1477127|NCT01869686|3614836|P1|NOT COMPLETED|Overall Study||0
1477128|NCT01869686|3614836|P1|COMPLETED|Overall Study||12
1477129|NCT01869686|3614836|P1|STARTED|Overall Study||12
1477130|NCT01869647|3614851|P3|NOT COMPLETED|Overall Study||0
1477131|NCT01869647|3614852|P2|NOT COMPLETED|Overall Study||6
1477132|NCT01869647|3614853|P1|NOT COMPLETED|Overall Study||1
1477133|NCT01869647|3614851|P3|COMPLETED|Overall Study||62
1477134|NCT01869647|3614852|P2|COMPLETED|Overall Study||130
1477135|NCT01869647|3614853|P1|COMPLETED|Overall Study||65
1477136|NCT01869647|3614851|P3|STARTED|Overall Study||62
1477137|NCT01869647|3614852|P2|STARTED|Overall Study||136
1477138|NCT01869647|3614853|P1|STARTED|Overall Study||66
1477139|NCT01869478|3614866|P2|NOT COMPLETED|Overall Study||0
1477140|NCT01869478|3614867|P1|NOT COMPLETED|Overall Study||0
1477141|NCT01869478|3614866|P2|COMPLETED|Overall Study||1
1477142|NCT01869478|3614867|P1|COMPLETED|Overall Study||0
1477143|NCT01869478|3614866|P2|STARTED|Overall Study||1
1477144|NCT01869478|3614867|P1|STARTED|Overall Study||0
1477145|NCT01869439|3614875|P1|NOT COMPLETED|Overall Study||0
1477146|NCT01869439|3614875|P1|COMPLETED|Overall Study||40
1477147|NCT01869439|3614875|P1|STARTED|Overall Study||40
1477148|NCT01869348|3614881|P2|NOT COMPLETED|Overall Study||1
1477149|NCT01869348|3614882|P1|NOT COMPLETED|Overall Study||1
1477150|NCT01869348|3614881|P2|COMPLETED|Overall Study||19
1477151|NCT01869348|3614882|P1|COMPLETED|Overall Study||19
1477152|NCT01869348|3614881|P2|STARTED|Overall Study||20
1477153|NCT01869348|3614882|P1|STARTED|Overall Study||20
1477154|NCT01869192|3614890|P2|NOT COMPLETED|Postoperative Chemotherapy||2
1477155|NCT01869192|3614891|P1|NOT COMPLETED|Postoperative Chemotherapy||0
1477156|NCT01869192|3614890|P2|COMPLETED|Postoperative Chemotherapy||31
1477157|NCT01869192|3614891|P1|COMPLETED|Postoperative Chemotherapy||32
1477158|NCT01869192|3614890|P2|STARTED|Postoperative Chemotherapy||33
1477159|NCT01869192|3614891|P1|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
1477160|NCT01869192|3614890|P2|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
1477161|NCT01869192|3614891|P1|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
1477162|NCT01869192|3614890|P2|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
1477163|NCT01869192|3614891|P1|COMPLETED|Preoperative Chemotherapy to Surgery||35
1477164|NCT01869192|3614890|P2|STARTED|Preoperative Chemotherapy to Surgery||35
1477165|NCT01869192|3614891|P1|STARTED|Preoperative Chemotherapy to Surgery||37
1477166|NCT01869075|3614905|P6|NOT COMPLETED|Phase 2||0
1477167|NCT01869075|3614906|P5|NOT COMPLETED|Phase 2||0
1477168|NCT01869075|3614907|P4|NOT COMPLETED|Phase 2||0
1477169|NCT01869075|3614908|P3|NOT COMPLETED|Phase 2||0
1477170|NCT01869075|3614909|P2|NOT COMPLETED|Phase 2||0
1477171|NCT01869075|3614910|P1|NOT COMPLETED|Phase 2||0
1477172|NCT01869075|3614905|P6|COMPLETED|Phase 2||45
1477173|NCT01869075|3614906|P5|COMPLETED|Phase 2||75
1477174|NCT01869075|3614907|P4|COMPLETED|Phase 2||45
1477175|NCT01869075|3614908|P3|COMPLETED|Phase 2||75
1477176|NCT01869075|3614909|P2|COMPLETED|Phase 2||30
1477177|NCT01869075|3614910|P1|COMPLETED|Phase 2||90
1477178|NCT01869075|3614905|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
1477179|NCT01869075|3614906|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
1477180|NCT01869075|3614907|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
1477181|NCT01869075|3614908|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
1477182|NCT01869075|3614909|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
1477183|NCT01869075|3614910|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
1477184|NCT01869075|3614905|P6|NOT COMPLETED|Phase 1||0
1477185|NCT01869075|3614906|P5|NOT COMPLETED|Phase 1||0
1477186|NCT01869075|3614907|P4|NOT COMPLETED|Phase 1||0
1477187|NCT01869075|3614908|P3|NOT COMPLETED|Phase 1||0
1477188|NCT01869075|3614909|P2|NOT COMPLETED|Phase 1||0
1477189|NCT01869075|3614910|P1|NOT COMPLETED|Phase 1||0
1477190|NCT01869075|3614905|P6|COMPLETED|Phase 1||90
1477191|NCT01869075|3614906|P5|COMPLETED|Phase 1||30
1477192|NCT01869075|3614907|P4|COMPLETED|Phase 1||75
1477193|NCT01869075|3614908|P3|COMPLETED|Phase 1||45
1477194|NCT01869075|3614909|P2|COMPLETED|Phase 1||75
1477195|NCT01869075|3614910|P1|COMPLETED|Phase 1||45
1477196|NCT01869075|3614905|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
1477197|NCT01869075|3614906|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
1477198|NCT01869075|3614907|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
1477199|NCT01869075|3614908|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
1477200|NCT01869075|3614909|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
1477201|NCT01869075|3614910|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
1477202|NCT01869075|3614905|P6|NOT COMPLETED|Phase 0 (Baseline)||0
1477203|NCT01869075|3614906|P5|NOT COMPLETED|Phase 0 (Baseline)||0
1477204|NCT01869075|3614907|P4|NOT COMPLETED|Phase 0 (Baseline)||0
1477205|NCT01869075|3614908|P3|NOT COMPLETED|Phase 0 (Baseline)||0
1477206|NCT01869075|3614909|P2|NOT COMPLETED|Phase 0 (Baseline)||0
1477207|NCT01869075|3614910|P1|NOT COMPLETED|Phase 0 (Baseline)||0
1477208|NCT01869075|3614905|P6|COMPLETED|Phase 0 (Baseline)||341
1477209|NCT01869075|3614906|P5|COMPLETED|Phase 0 (Baseline)||0
1477210|NCT01869075|3614907|P4|COMPLETED|Phase 0 (Baseline)||416
1477211|NCT01869075|3614908|P3|COMPLETED|Phase 0 (Baseline)||0
1477212|NCT01869075|3614909|P2|COMPLETED|Phase 0 (Baseline)||418
1477213|NCT01869075|3614910|P1|COMPLETED|Phase 0 (Baseline)||0
1477214|NCT01869075|3614905|P6|STARTED|Phase 0 (Baseline)||341
1477215|NCT01869075|3614906|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
1477216|NCT01869075|3614907|P4|STARTED|Phase 0 (Baseline)||416
1477217|NCT01869075|3614908|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
1477218|NCT01869075|3614909|P2|STARTED|Phase 0 (Baseline)||418
1477219|NCT01869075|3614910|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
1477220|NCT01868997|3614926|P2|NOT COMPLETED|Overall Study||6
1477221|NCT01868997|3614927|P1|NOT COMPLETED|Overall Study||7
1477222|NCT01868997|3614926|P2|COMPLETED|Overall Study||36
1477223|NCT01868997|3614927|P1|COMPLETED|Overall Study||38
1477224|NCT01868997|3614926|P2|STARTED|Overall Study|randomized and treated|42
1477225|NCT01868997|3614927|P1|STARTED|Overall Study|randomized and treated|45
1477226|NCT01868893|3614943|P1|NOT COMPLETED|Overall Study||20
1477227|NCT01868893|3614943|P1|COMPLETED|Overall Study||0
1477228|NCT01868893|3614943|P1|STARTED|Overall Study||20
1477229|NCT01868789|3614952|P2|NOT COMPLETED|Overall Study||2
1477230|NCT01868789|3614953|P1|NOT COMPLETED|Overall Study||2
1477231|NCT01868789|3614952|P2|COMPLETED|Overall Study||12
1477232|NCT01868789|3614953|P1|COMPLETED|Overall Study||7
1477233|NCT01868789|3614952|P2|STARTED|Overall Study||14
1477234|NCT01868789|3614953|P1|STARTED|Overall Study||9
1477235|NCT01868776|3614963|P2|NOT COMPLETED|Overall Study||0
1477236|NCT01868776|3614964|P1|NOT COMPLETED|Overall Study||0
1477237|NCT01868776|3614963|P2|COMPLETED|Overall Study||50
1477238|NCT01868776|3614964|P1|COMPLETED|Overall Study||50
1477239|NCT01868776|3614963|P2|STARTED|Overall Study||50
1477240|NCT01868776|3614964|P1|STARTED|Overall Study||50
1477241|NCT01868633|3614972|P2|NOT COMPLETED|Overall Study||0
1477242|NCT01868633|3614973|P1|NOT COMPLETED|Overall Study||0
1477243|NCT01868633|3614972|P2|COMPLETED|Overall Study||26
1477244|NCT01868633|3614973|P1|COMPLETED|Overall Study||26
1477245|NCT01868633|3614972|P2|STARTED|Overall Study||26
1477246|NCT01868633|3614973|P1|STARTED|Overall Study||26
1477247|NCT01868542|3614989|P2|NOT COMPLETED|Overall Study||2
1477248|NCT01868542|3614990|P1|NOT COMPLETED|Overall Study||0
1477249|NCT01868542|3614989|P2|COMPLETED|Overall Study||21
1477250|NCT01868542|3614990|P1|COMPLETED|Overall Study||23
1477251|NCT01868542|3614989|P2|STARTED|Overall Study||23
1477252|NCT01868542|3614990|P1|STARTED|Overall Study||23
1477253|NCT01868503|3615008|P1|NOT COMPLETED|Overall Study||2
1477254|NCT01868503|3615008|P1|COMPLETED|Overall Study||5
1477255|NCT01868503|3615008|P1|STARTED|Overall Study||7
1477256|NCT01868477|3615018|P2|NOT COMPLETED|Overall Study||5
1477257|NCT01868477|3615019|P1|NOT COMPLETED|Overall Study||4
1477258|NCT01868477|3615018|P2|COMPLETED|Overall Study||6
1477259|NCT01868477|3615019|P1|COMPLETED|Overall Study||8
1477260|NCT01868477|3615018|P2|Not Switched to EPO+DFX|Overall Study||0
1477261|NCT01868477|3615019|P1|Not Switched to EPO+DFX|Overall Study||7
1477262|NCT01868477|3615018|P2|Switched to EPO+DFX|Overall Study||0
1477263|NCT01868477|3615019|P1|Switched to EPO+DFX|Overall Study||5
1477264|NCT01868477|3615018|P2|STARTED|Overall Study||11
1477265|NCT01868477|3615019|P1|STARTED|Overall Study||12
1477266|NCT01868334|3615047|P4|NOT COMPLETED|Year 2 Pre-post Study||0
1477267|NCT01868334|3615048|P3|NOT COMPLETED|Year 2 Pre-post Study||0
1477268|NCT01868334|3615049|P2|NOT COMPLETED|Year 2 Pre-post Study||0
1477269|NCT01868334|3615050|P1|NOT COMPLETED|Year 2 Pre-post Study||0
1477270|NCT01868334|3615047|P4|COMPLETED|Year 2 Pre-post Study||19274
1477271|NCT01868334|3615048|P3|COMPLETED|Year 2 Pre-post Study||20904
1477272|NCT01868334|3615049|P2|COMPLETED|Year 2 Pre-post Study||8047
1477273|NCT01868334|3615050|P1|COMPLETED|Year 2 Pre-post Study||22324
1477274|NCT01868334|3615047|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
1477275|NCT01868334|3615048|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
1477276|NCT01868334|3615049|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
1477277|NCT01868334|3615050|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
1477278|NCT01868334|3615047|P4|NOT COMPLETED|Year 1 RCCT Study||0
1477279|NCT01868334|3615048|P3|NOT COMPLETED|Year 1 RCCT Study||0
1477280|NCT01868334|3615049|P2|NOT COMPLETED|Year 1 RCCT Study||0
1477281|NCT01868334|3615050|P1|NOT COMPLETED|Year 1 RCCT Study||0
1477282|NCT01868334|3615047|P4|COMPLETED|Year 1 RCCT Study||20904
1477283|NCT01868334|3615048|P3|COMPLETED|Year 1 RCCT Study||19274
1477284|NCT01868334|3615049|P2|COMPLETED|Year 1 RCCT Study||17185
1477285|NCT01868334|3615050|P1|COMPLETED|Year 1 RCCT Study||13186
1477286|NCT01868334|3615047|P4|STARTED|Year 1 RCCT Study||20904
1477287|NCT01868334|3615048|P3|STARTED|Year 1 RCCT Study||19274
1477288|NCT01868334|3615049|P2|STARTED|Year 1 RCCT Study||17185
1477289|NCT01868334|3615050|P1|STARTED|Year 1 RCCT Study||13186
1477290|NCT01868243|3615090|P2|NOT COMPLETED|Overall Study||1
1477291|NCT01868243|3615091|P1|NOT COMPLETED|Overall Study||0
1477292|NCT01868243|3615090|P2|COMPLETED|Overall Study||11
1477293|NCT01868243|3615091|P1|COMPLETED|Overall Study||15
1477294|NCT01868243|3615090|P2|STARTED|Overall Study||12
1477295|NCT01868243|3615091|P1|STARTED|Overall Study||15
1477296|NCT01868074|3615101|P2|NOT COMPLETED|Overall Study||4
1477297|NCT01868074|3615102|P1|NOT COMPLETED|Overall Study||7
1477298|NCT01868074|3615101|P2|COMPLETED|Overall Study||32
1477299|NCT01868074|3615102|P1|COMPLETED|Overall Study||29
1477300|NCT01868074|3615101|P2|STARTED|Overall Study||36
1477301|NCT01868074|3615102|P1|STARTED|Overall Study||36
1477302|NCT01868035|3615112|P1|NOT COMPLETED|Overall Study||7
1477303|NCT01868035|3615112|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
1477304|NCT01868035|3615112|P1|STARTED|Overall Study||15
1477305|NCT01868009|3615128|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
1477306|NCT01868009|3615129|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
1477307|NCT01868009|3615128|P2|COMPLETED|Period 2 (5-9 Days)||142
1477308|NCT01868009|3615129|P1|COMPLETED|Period 2 (5-9 Days)||141
1477309|NCT01868009|3615128|P2|STARTED|Period 2 (5-9 Days)||142
1477310|NCT01868009|3615129|P1|STARTED|Period 2 (5-9 Days)||143
1477311|NCT01868009|3615128|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
1477312|NCT01868009|3615129|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
1477313|NCT01868009|3615128|P2|COMPLETED|Period 1 (5-9 Days)||142
1477314|NCT01868009|3615129|P1|COMPLETED|Period 1 (5-9 Days)||143
1477315|NCT01868009|3615128|P2|STARTED|Period 1 (5-9 Days)||144
1477316|NCT01868009|3615129|P1|STARTED|Period 1 (5-9 Days)||143
1477317|NCT01867710|3615143|P4|NOT COMPLETED|Overall Study||7
1477318|NCT01867710|3615144|P3|NOT COMPLETED|Overall Study||9
1477319|NCT01867710|3615145|P2|NOT COMPLETED|Overall Study||7
1477320|NCT01867710|3615146|P1|NOT COMPLETED|Overall Study||8
1477321|NCT01867710|3615143|P4|COMPLETED|Overall Study||35
1477322|NCT01867710|3615144|P3|COMPLETED|Overall Study||31
1477323|NCT01867710|3615145|P2|COMPLETED|Overall Study||34
1477324|NCT01867710|3615146|P1|COMPLETED|Overall Study||33
1477325|NCT01867710|3615143|P4|Treated|Overall Study||42
1477326|NCT01867710|3615144|P3|Treated|Overall Study||39
1477327|NCT01867710|3615145|P2|Treated|Overall Study||41
1477328|NCT01867710|3615146|P1|Treated|Overall Study||41
1477329|NCT01867710|3615143|P4|STARTED|Overall Study||42
1477330|NCT01867710|3615144|P3|STARTED|Overall Study||40
1477331|NCT01867710|3615145|P2|STARTED|Overall Study||41
1477332|NCT01867710|3615146|P1|STARTED|Overall Study||41
1477333|NCT01867658|3615160|P1|NOT COMPLETED|Overall Study||9
1477334|NCT01867658|3615160|P1|COMPLETED|Overall Study||103
1477335|NCT01867658|3615160|P1|STARTED|Overall Study||112
1477336|NCT01867632|3615173|P2|NOT COMPLETED|Overall Study||0
1477337|NCT01867632|3615174|P1|NOT COMPLETED|Overall Study||0
1477338|NCT01867632|3615173|P2|COMPLETED|Overall Study||66
1477339|NCT01867632|3615174|P1|COMPLETED|Overall Study||65
1477340|NCT01867632|3615173|P2|STARTED|Overall Study||66
1477341|NCT01867632|3615174|P1|STARTED|Overall Study||65
1477342|NCT01867580|3615184|P2|NOT COMPLETED|Overall Study||24
1477343|NCT01867580|3615185|P1|NOT COMPLETED|Overall Study||28
1477344|NCT01867580|3615184|P2|COMPLETED|Overall Study||64
1477345|NCT01867580|3615185|P1|COMPLETED|Overall Study||65
1477346|NCT01867580|3615184|P2|STARTED|Overall Study||88
1477347|NCT01867580|3615185|P1|STARTED|Overall Study||93
1477348|NCT01867515|3615198|P3|NOT COMPLETED|Overall Study||11
1477349|NCT01867515|3615199|P2|NOT COMPLETED|Overall Study||1
1477350|NCT01867515|3615200|P1|NOT COMPLETED|Overall Study||0
1477351|NCT01867515|3615198|P3|COMPLETED|Overall Study||14
1477352|NCT01867515|3615199|P2|COMPLETED|Overall Study||11
1477353|NCT01867515|3615200|P1|COMPLETED|Overall Study||13
1477354|NCT01867515|3615198|P3|STARTED|Overall Study||25
1477355|NCT01867515|3615199|P2|STARTED|Overall Study||12
1477356|NCT01867515|3615200|P1|STARTED|Overall Study||13
1477357|NCT01867424|3615210|P2|NOT COMPLETED|Overall Study||1
1477358|NCT01867424|3615211|P1|NOT COMPLETED|Overall Study||2
1477359|NCT01867424|3615210|P2|COMPLETED|Overall Study||11
1477360|NCT01867424|3615211|P1|COMPLETED|Overall Study||10
1477361|NCT01867424|3615210|P2|STARTED|Overall Study||12
1477362|NCT01867424|3615211|P1|STARTED|Overall Study||12
1477363|NCT01867307|3615225|P2|NOT COMPLETED|Overall Study||3
1477364|NCT01867307|3615226|P1|NOT COMPLETED|Overall Study||3
1477365|NCT01867307|3615225|P2|COMPLETED|Overall Study||16
1477366|NCT01867307|3615226|P1|COMPLETED|Overall Study||15
1477367|NCT01867307|3615225|P2|STARTED|Overall Study|Started are the treated patients|19
1477368|NCT01867307|3615226|P1|STARTED|Overall Study|Started are the treated patients|18
1477369|NCT01867216|3615239|P7|NOT COMPLETED|Overall Study||1
1477370|NCT01867216|3615240|P6|NOT COMPLETED|Overall Study||0
1477371|NCT01867216|3615241|P5|NOT COMPLETED|Overall Study||1
1477372|NCT01867216|3615242|P4|NOT COMPLETED|Overall Study||0
1477373|NCT01867216|3615243|P3|NOT COMPLETED|Overall Study||0
1477374|NCT01867216|3615244|P2|NOT COMPLETED|Overall Study||0
1477375|NCT01867216|3615245|P1|NOT COMPLETED|Overall Study||4
1477376|NCT01867216|3615239|P7|COMPLETED|Overall Study||8
1477377|NCT01867216|3615240|P6|COMPLETED|Overall Study||8
1477378|NCT01867216|3615241|P5|COMPLETED|Overall Study||8
1477379|NCT01867216|3615242|P4|COMPLETED|Overall Study||8
1477380|NCT01867216|3615243|P3|COMPLETED|Overall Study||8
1477381|NCT01867216|3615244|P2|COMPLETED|Overall Study||8
1477382|NCT01867216|3615245|P1|COMPLETED|Overall Study||12
1477383|NCT01867216|3615239|P7|Received Study Drug|Overall Study||9
1477384|NCT01867216|3615240|P6|Received Study Drug|Overall Study||8
1477385|NCT01867216|3615241|P5|Received Study Drug|Overall Study||9
1477386|NCT01867216|3615242|P4|Received Study Drug|Overall Study||8
1477387|NCT01867216|3615243|P3|Received Study Drug|Overall Study||8
1477388|NCT01867216|3615244|P2|Received Study Drug|Overall Study||8
1477389|NCT01867216|3615245|P1|Received Study Drug|Overall Study||14
1477390|NCT01867216|3615239|P7|STARTED|Overall Study||9
1477391|NCT01867216|3615240|P6|STARTED|Overall Study||8
1477392|NCT01867216|3615241|P5|STARTED|Overall Study||9
1477393|NCT01867216|3615242|P4|STARTED|Overall Study||8
1477394|NCT01867216|3615243|P3|STARTED|Overall Study||8
1477395|NCT01867216|3615244|P2|STARTED|Overall Study||8
1477396|NCT01867216|3615245|P1|STARTED|Overall Study||16
1477397|NCT01867164|3615302|P2|NOT COMPLETED|Overall Study||0
1477398|NCT01867164|3615303|P1|NOT COMPLETED|Overall Study||0
1477399|NCT01867164|3615302|P2|COMPLETED|Overall Study||79
1477400|NCT01867164|3615303|P1|COMPLETED|Overall Study||81
1477401|NCT01867164|3615302|P2|STARTED|Overall Study||79
1477402|NCT01867164|3615303|P1|STARTED|Overall Study||81
1477403|NCT01867086|3615317|P1|NOT COMPLETED|Overall Study||1
1477404|NCT01867086|3615317|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
1477405|NCT01867086|3615317|P1|STARTED|Overall Study||1
1477406|NCT01867047|3615326|P2|NOT COMPLETED|Overall Study||5
1477407|NCT01867047|3615327|P1|NOT COMPLETED|Overall Study||8
1477408|NCT01867047|3615326|P2|COMPLETED|Overall Study||23
1477409|NCT01867047|3615327|P1|COMPLETED|Overall Study||23
1477410|NCT01867047|3615326|P2|STARTED|Overall Study||28
1477411|NCT01867047|3615327|P1|STARTED|Overall Study||31
1477412|NCT01867021|3615347|P2|NOT COMPLETED|Overall Study||10
1477413|NCT01867021|3615348|P1|NOT COMPLETED|Overall Study||2
1477414|NCT01867021|3615347|P2|COMPLETED|Overall Study||1440
1477415|NCT01867021|3615348|P1|COMPLETED|Overall Study||1450
1477416|NCT01867021|3615347|P2|STARTED|Overall Study||1450
1477417|NCT01867021|3615348|P1|STARTED|Overall Study||1452
1477418|NCT01866943|3615367|P2|NOT COMPLETED|Overall Study||22
1477419|NCT01866943|3615368|P1|NOT COMPLETED|Overall Study||19
1477420|NCT01866943|3615367|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
1477421|NCT01866943|3615368|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
1477422|NCT01866943|3615367|P2|STARTED|Overall Study||22
1477423|NCT01866943|3615368|P1|STARTED|Overall Study||19
1477424|NCT01866709|3615379|P2|NOT COMPLETED|Overall Study||0
1477425|NCT01866709|3615380|P1|NOT COMPLETED|Overall Study||1
1477426|NCT01866709|3615379|P2|COMPLETED|Overall Study||17
1477427|NCT01866709|3615380|P1|COMPLETED|Overall Study||14
1477428|NCT01866709|3615379|P2|STARTED|Overall Study||17
1477429|NCT01866709|3615380|P1|STARTED|Overall Study||15
1477430|NCT01866592|3615388|P1|NOT COMPLETED|Overall Study||23
1477431|NCT01866592|3615388|P1|COMPLETED|Overall Study||58
1477432|NCT01866592|3615388|P1|STARTED|Overall Study||81
1477433|NCT01866423|3615421|P1|NOT COMPLETED|Overall Study||4
1477434|NCT01866423|3615421|P1|COMPLETED|Overall Study||0
1477435|NCT01866423|3615421|P1|STARTED|Overall Study||4
1477436|NCT01866319|3615434|P3|NOT COMPLETED|Overall Study||277
1477437|NCT01866319|3615435|P2|NOT COMPLETED|Overall Study||279
1477438|NCT01866319|3615436|P1|NOT COMPLETED|Overall Study||277
1477439|NCT01866319|3615434|P3|COMPLETED|Overall Study||0
1477440|NCT01866319|3615435|P2|COMPLETED|Overall Study||0
1477441|NCT01866319|3615436|P1|COMPLETED|Overall Study||1
1477442|NCT01866319|3615434|P3|Treated|Overall Study||277
1477443|NCT01866319|3615435|P2|Treated|Overall Study||278
1477444|NCT01866319|3615436|P1|Treated|Overall Study||256
1477445|NCT01866319|3615434|P3|STARTED|Overall Study||277
1477446|NCT01866319|3615435|P2|STARTED|Overall Study||279
1477447|NCT01866319|3615436|P1|STARTED|Overall Study||278
1477448|NCT01866306|3615457|P7|NOT COMPLETED|Overall Study||0
1477449|NCT01866306|3615458|P6|NOT COMPLETED|Overall Study||0
1477450|NCT01866306|3615459|P5|NOT COMPLETED|Overall Study||0
1477451|NCT01866306|3615460|P4|NOT COMPLETED|Overall Study||0
1477452|NCT01866306|3615461|P3|NOT COMPLETED|Overall Study||0
1477453|NCT01866306|3615462|P2|NOT COMPLETED|Overall Study||0
1477454|NCT01866306|3615463|P1|NOT COMPLETED|Overall Study||0
1477455|NCT01866306|3615457|P7|COMPLETED|Overall Study||23
1477456|NCT01866306|3615458|P6|COMPLETED|Overall Study||6
1477457|NCT01866306|3615459|P5|COMPLETED|Overall Study||6
1477458|NCT01866306|3615460|P4|COMPLETED|Overall Study||6
1477459|NCT01866306|3615461|P3|COMPLETED|Overall Study||6
1477460|NCT01866306|3615462|P2|COMPLETED|Overall Study||6
1477461|NCT01866306|3615463|P1|COMPLETED|Overall Study||6
1477462|NCT01866306|3615457|P7|STARTED|Overall Study||23
1477463|NCT01866306|3615458|P6|STARTED|Overall Study||6
1477464|NCT01866306|3615459|P5|STARTED|Overall Study||6
1477465|NCT01866306|3615460|P4|STARTED|Overall Study||6
1477466|NCT01866306|3615461|P3|STARTED|Overall Study||6
1477467|NCT01866306|3615462|P2|STARTED|Overall Study||6
1477468|NCT01866306|3615463|P1|STARTED|Overall Study||6
1477469|NCT01866293|3615535|P1|NOT COMPLETED|Overall Study||2
1477470|NCT01866293|3615535|P1|COMPLETED|Overall Study||9
1477471|NCT01866293|3615535|P1|STARTED|Overall Study||11
1477472|NCT01866163|3615545|P2|NOT COMPLETED|Overall Study||4
1477473|NCT01866163|3615546|P1|NOT COMPLETED|Overall Study||10
1477474|NCT01866163|3615545|P2|COMPLETED|Overall Study||99
1477475|NCT01866163|3615546|P1|COMPLETED|Overall Study||313
1477476|NCT01866163|3615545|P2|STARTED|Overall Study||103
1477477|NCT01866163|3615546|P1|STARTED|Overall Study||323
1477478|NCT01866150|3615556|P1|NOT COMPLETED|Overall Study||0
1477479|NCT01866150|3615556|P1|COMPLETED|Overall Study||450
1477480|NCT01866150|3615556|P1|STARTED|Overall Study||450
1477481|NCT01865812|3615577|P1|NOT COMPLETED|Overall Study||2
1477482|NCT01865812|3615577|P1|COMPLETED|Overall Study||24
1477483|NCT01865812|3615577|P1|STARTED|Overall Study||26
1477484|NCT01865747|3615585|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
1477485|NCT01865747|3615586|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
1477486|NCT01865747|3615585|P2|COMPLETED|Primary Intent to Treat (PITT)||36
1477487|NCT01865747|3615586|P1|COMPLETED|Primary Intent to Treat (PITT)||56
1477568|NCT01864148|3615695|P1|COMPLETED|Overall Study||73
1477488|NCT01865747|3615585|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
1477489|NCT01865747|3615586|P1|STARTED|Primary Intent to Treat (PITT)||187
1477490|NCT01865747|3615585|P2|NOT COMPLETED|Overall Study (ITT)||255
1477491|NCT01865747|3615586|P1|NOT COMPLETED|Overall Study (ITT)||198
1477492|NCT01865747|3615585|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
1477493|NCT01865747|3615586|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
1477494|NCT01865747|3615585|P2|STARTED|Overall Study (ITT)||328
1477495|NCT01865747|3615586|P1|STARTED|Overall Study (ITT)||330
1477496|NCT01865708|3615596|P1|NOT COMPLETED|Overall Study||0
1477497|NCT01865708|3615596|P1|COMPLETED|Overall Study||10
1477498|NCT01865708|3615596|P1|STARTED|Overall Study||10
1477499|NCT01865084|3615604|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
1477500|NCT01865084|3615605|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
1477501|NCT01865084|3615606|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
1477502|NCT01865084|3615604|P3|COMPLETED|Open Label Extension (OLE) Period||158
1477503|NCT01865084|3615605|P2|COMPLETED|Open Label Extension (OLE) Period||139
1477504|NCT01865084|3615606|P1|COMPLETED|Open Label Extension (OLE) Period||0
1477505|NCT01865084|3615604|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
1477506|NCT01865084|3615605|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
1477507|NCT01865084|3615606|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
1477508|NCT01865084|3615604|P3|NOT COMPLETED|Double Blind Period (DB)||6
1477509|NCT01865084|3615605|P2|NOT COMPLETED|Double Blind Period (DB)||4
1477510|NCT01865084|3615606|P1|NOT COMPLETED|Double Blind Period (DB)||5
1477511|NCT01865084|3615604|P3|COMPLETED|Double Blind Period (DB)||107
1477512|NCT01865084|3615605|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
1477513|NCT01865084|3615606|P1|COMPLETED|Double Blind Period (DB)||111
1477514|NCT01865084|3615604|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
1477515|NCT01865084|3615605|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
1477516|NCT01865084|3615606|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
1477517|NCT01865084|3615604|P3|STARTED|Double Blind Period (DB)||113
1477518|NCT01865084|3615605|P2|STARTED|Double Blind Period (DB)||102
1477519|NCT01865084|3615606|P1|STARTED|Double Blind Period (DB)||116
1477520|NCT01864538|3615632|P1|NOT COMPLETED|Overall Study||11
1477521|NCT01864538|3615632|P1|COMPLETED|Overall Study||0
1477522|NCT01864538|3615632|P1|STARTED|Overall Study||11
1477523|NCT01864525|3615638|P2|NOT COMPLETED|Overall Study||0
1477524|NCT01864525|3615639|P1|NOT COMPLETED|Overall Study||1
1477525|NCT01864525|3615638|P2|COMPLETED|Overall Study||7
1477526|NCT01864525|3615639|P1|COMPLETED|Overall Study||9
1477527|NCT01864525|3615638|P2|STARTED|Overall Study||7
1477528|NCT01864525|3615639|P1|STARTED|Overall Study||10
1477529|NCT01864434|3615649|P2|NOT COMPLETED|Overall Study||0
1477530|NCT01864434|3615650|P1|NOT COMPLETED|Overall Study||0
1477531|NCT01864434|3615649|P2|COMPLETED|Overall Study||25
1477532|NCT01864434|3615650|P1|COMPLETED|Overall Study||25
1477533|NCT01864434|3615649|P2|STARTED|Overall Study||25
1477534|NCT01864434|3615650|P1|STARTED|Overall Study||25
1477535|NCT01864200|3615662|P2|NOT COMPLETED|Overall Study||3
1477536|NCT01864200|3615663|P1|NOT COMPLETED|Overall Study||2
1477537|NCT01864200|3615662|P2|COMPLETED|Overall Study||26
1477538|NCT01864200|3615663|P1|COMPLETED|Overall Study||43
1477539|NCT01864200|3615662|P2|STARTED|Overall Study||29
1477540|NCT01864200|3615663|P1|STARTED|Overall Study||45
1477541|NCT01864174|3615671|P2|NOT COMPLETED|Off Treatment Follow-Up||0
1477542|NCT01864174|3615672|P1|NOT COMPLETED|Off Treatment Follow-Up||3
1477543|NCT01864174|3615671|P2|COMPLETED|Off Treatment Follow-Up||1
1477544|NCT01864174|3615672|P1|COMPLETED|Off Treatment Follow-Up||6
1477545|NCT01864174|3615671|P2|STARTED|Off Treatment Follow-Up||1
1477546|NCT01864174|3615672|P1|STARTED|Off Treatment Follow-Up||9
1477547|NCT01864174|3615671|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
1477548|NCT01864174|3615672|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
1477549|NCT01864174|3615671|P2|COMPLETED|Double Blind - Compliant Randomized||245
1477550|NCT01864174|3615672|P1|COMPLETED|Double Blind - Compliant Randomized||245
1477551|NCT01864174|3615671|P2|STARTED|Double Blind - Compliant Randomized||271
1477552|NCT01864174|3615672|P1|STARTED|Double Blind - Compliant Randomized||268
1477553|NCT01864174|3615671|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
1477554|NCT01864174|3615672|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
1477555|NCT01864174|3615671|P2|COMPLETED|Double Blind Treatment - All Treated||271
1477556|NCT01864174|3615672|P1|COMPLETED|Double Blind Treatment - All Treated||268
1477557|NCT01864174|3615671|P2|STARTED|Double Blind Treatment - All Treated||285
1477558|NCT01864174|3615672|P1|STARTED|Double Blind Treatment - All Treated||283
1477559|NCT01864148|3615691|P5|NOT COMPLETED|Overall Study||23
1477560|NCT01864148|3615692|P4|NOT COMPLETED|Overall Study||26
1477561|NCT01864148|3615693|P3|NOT COMPLETED|Overall Study||11
1477562|NCT01864148|3615694|P2|NOT COMPLETED|Overall Study||5
1477563|NCT01864148|3615695|P1|NOT COMPLETED|Overall Study||20
1477564|NCT01864148|3615691|P5|COMPLETED|Overall Study||69
1477565|NCT01864148|3615692|P4|COMPLETED|Overall Study||68
1477566|NCT01864148|3615693|P3|COMPLETED|Overall Study||84
1477567|NCT01864148|3615694|P2|COMPLETED|Overall Study||40
1477569|NCT01864148|3615691|P5|Randomized and Dosed|Overall Study||92
1477570|NCT01864148|3615692|P4|Randomized and Dosed|Overall Study||93
1477571|NCT01864148|3615693|P3|Randomized and Dosed|Overall Study||95
1477572|NCT01864148|3615694|P2|Randomized and Dosed|Overall Study||45
1477573|NCT01864148|3615695|P1|Randomized and Dosed|Overall Study||93
1477574|NCT01864148|3615691|P5|STARTED|Overall Study||92
1477575|NCT01864148|3615692|P4|STARTED|Overall Study||94
1477576|NCT01864148|3615693|P3|STARTED|Overall Study||95
1477577|NCT01864148|3615694|P2|STARTED|Overall Study||45
1477578|NCT01864148|3615695|P1|STARTED|Overall Study||93
1477579|NCT01864005|3615724|P2|NOT COMPLETED|Overall Study||6
1477580|NCT01864005|3615725|P1|NOT COMPLETED|Overall Study||3
1477581|NCT01864005|3615724|P2|COMPLETED|Overall Study||25
1477582|NCT01864005|3615725|P1|COMPLETED|Overall Study||26
1477583|NCT01864005|3615724|P2|STARTED|Overall Study||31
1477584|NCT01864005|3615725|P1|STARTED|Overall Study||29
1477585|NCT01863953|3615742|P3|NOT COMPLETED|Overall Study||1
1477586|NCT01863953|3615743|P2|NOT COMPLETED|Overall Study||0
1477587|NCT01863953|3615744|P1|NOT COMPLETED|Overall Study||0
1477588|NCT01863953|3615742|P3|COMPLETED|Overall Study||37
1477589|NCT01863953|3615743|P2|COMPLETED|Overall Study||36
1477590|NCT01863953|3615744|P1|COMPLETED|Overall Study||38
1477591|NCT01863953|3615742|P3|STARTED|Overall Study||38
1477592|NCT01863953|3615743|P2|STARTED|Overall Study||36
1477593|NCT01863953|3615744|P1|STARTED|Overall Study||38
1477594|NCT01863771|3615758|P4|NOT COMPLETED|Maintenance Phase||43
1477595|NCT01863771|3615759|P3|NOT COMPLETED|Maintenance Phase||12
1477596|NCT01863771|3615760|P2|NOT COMPLETED|Maintenance Phase||5
1477597|NCT01863771|3615761|P1|NOT COMPLETED|Maintenance Phase||0
1477598|NCT01863771|3615758|P4|COMPLETED|Maintenance Phase||17
1477599|NCT01863771|3615759|P3|COMPLETED|Maintenance Phase||19
1477600|NCT01863771|3615760|P2|COMPLETED|Maintenance Phase||27
1477601|NCT01863771|3615761|P1|COMPLETED|Maintenance Phase||0
1477602|NCT01863771|3615758|P4|STARTED|Maintenance Phase||60
1477603|NCT01863771|3615759|P3|STARTED|Maintenance Phase||31
1477604|NCT01863771|3615760|P2|STARTED|Maintenance Phase||32
1477605|NCT01863771|3615761|P1|STARTED|Maintenance Phase||0
1477606|NCT01863771|3615758|P4|NOT COMPLETED|Induction Phase||0
1477607|NCT01863771|3615759|P3|NOT COMPLETED|Induction Phase||0
1477608|NCT01863771|3615760|P2|NOT COMPLETED|Induction Phase||0
1477609|NCT01863771|3615761|P1|NOT COMPLETED|Induction Phase||21
1477610|NCT01863771|3615758|P4|COMPLETED|Induction Phase||0
1477611|NCT01863771|3615759|P3|COMPLETED|Induction Phase||0
1477612|NCT01863771|3615760|P2|COMPLETED|Induction Phase||0
1477613|NCT01863771|3615761|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
1477614|NCT01863771|3615758|P4|STARTED|Induction Phase||0
1477615|NCT01863771|3615759|P3|STARTED|Induction Phase||0
1477616|NCT01863771|3615760|P2|STARTED|Induction Phase||0
1477617|NCT01863771|3615761|P1|STARTED|Induction Phase||144
1477618|NCT01863758|3615773|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
1477619|NCT01863758|3615773|P1|COMPLETED|Prophylactic Treatment-Phase II||64
1477620|NCT01863758|3615773|P1|STARTED|Prophylactic Treatment-Phase II||66
1477621|NCT01863758|3615773|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
1477622|NCT01863758|3615773|P1|COMPLETED|Prophylactic Treatment-Phase I||66
1477623|NCT01863758|3615773|P1|STARTED|Prophylactic Treatment-Phase I||66
1477624|NCT01863758|3615773|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
1477625|NCT01863758|3615773|P1|COMPLETED|Pharmacokinetic Assessment||66
1477626|NCT01863758|3615773|P1|STARTED|Pharmacokinetic Assessment||66
1477627|NCT01863680|3615781|P1|NOT COMPLETED|Overall Study||57
1477628|NCT01863680|3615781|P1|COMPLETED|Overall Study||121
1477629|NCT01863680|3615781|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
1477630|NCT01863680|3615781|P1|Subjects Received Study Drug|Overall Study||149
1477631|NCT01863680|3615781|P1|Subjects Received hCG Injection|Overall Study||162
1477632|NCT01863680|3615781|P1|Subjects Started COS Treatment|Overall Study||169
1477633|NCT01863680|3615781|P1|STARTED|Overall Study||178
1477634|NCT01863667|3615789|P2|NOT COMPLETED|Overall Study||32
1477635|NCT01863667|3615790|P1|NOT COMPLETED|Overall Study||33
1477636|NCT01863667|3615789|P2|COMPLETED|Overall Study||0
1477637|NCT01863667|3615790|P1|COMPLETED|Overall Study||0
1477638|NCT01863667|3615789|P2|STARTED|Overall Study||32
1477639|NCT01863667|3615790|P1|STARTED|Overall Study||33
1477640|NCT01863563|3615810|P1|NOT COMPLETED|Overall Study||0
1477641|NCT01863563|3615810|P1|COMPLETED|Overall Study||100
1477642|NCT01863563|3615810|P1|STARTED|Overall Study||100
1477643|NCT01863433|3615814|P1|NOT COMPLETED|Overall Study||1
1477644|NCT01863433|3615814|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
1477645|NCT01863433|3615814|P1|STARTED|Overall Study||120
1477646|NCT01863368|3615824|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
1477647|NCT01863368|3615825|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
1477648|NCT01863368|3615824|P2|COMPLETED|Phase II, Day 35 to Day 90||41
1477649|NCT01863368|3615825|P1|COMPLETED|Phase II, Day 35 to Day 90||41
1477650|NCT01863368|3615824|P2|STARTED|Phase II, Day 35 to Day 90||41
1477651|NCT01863368|3615825|P1|STARTED|Phase II, Day 35 to Day 90||43
1477652|NCT01863368|3615824|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
1477653|NCT01863368|3615825|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
1477654|NCT01863368|3615824|P2|COMPLETED|Phase I, Day 0 to Day 35||41
1477655|NCT01863368|3615825|P1|COMPLETED|Phase I, Day 0 to Day 35||43
1477656|NCT01863368|3615824|P2|Treated|Phase I, Day 0 to Day 35||47
1477657|NCT01863368|3615825|P1|Treated|Phase I, Day 0 to Day 35||46
1477658|NCT01863368|3615824|P2|STARTED|Phase I, Day 0 to Day 35||48
1477659|NCT01863368|3615825|P1|STARTED|Phase I, Day 0 to Day 35||46
1477660|NCT01863134|3615840|P2|NOT COMPLETED|Overall Study||0
1477661|NCT01863134|3615841|P1|NOT COMPLETED|Overall Study||0
1477662|NCT01863134|3615840|P2|COMPLETED|Overall Study||68
1477663|NCT01863134|3615841|P1|COMPLETED|Overall Study||72
1477664|NCT01863134|3615840|P2|STARTED|Overall Study||68
1477665|NCT01863134|3615841|P1|STARTED|Overall Study||72
1477666|NCT01862991|3615850|P3|NOT COMPLETED|Overall Study||1
1477667|NCT01862991|3615851|P2|NOT COMPLETED|Overall Study||1
1477668|NCT01862991|3615852|P1|NOT COMPLETED|Overall Study||3
1477669|NCT01862991|3615850|P3|COMPLETED|Overall Study||27
1477670|NCT01862991|3615851|P2|COMPLETED|Overall Study||27
1477671|NCT01862991|3615852|P1|COMPLETED|Overall Study||21
1477672|NCT01862991|3615850|P3|STARTED|Overall Study||28
1477673|NCT01862991|3615851|P2|STARTED|Overall Study||28
1477674|NCT01862991|3615852|P1|STARTED|Overall Study||24
1477675|NCT01862874|3615865|P2|NOT COMPLETED|Overall Study||77
1477676|NCT01862874|3615866|P1|NOT COMPLETED|Overall Study||79
1477677|NCT01862874|3615865|P2|COMPLETED|Overall Study||485
1477678|NCT01862874|3615866|P1|COMPLETED|Overall Study||483
1477679|NCT01862874|3615865|P2|Vaccination 3|Overall Study||532
1477680|NCT01862874|3615866|P1|Vaccination 3|Overall Study||530
1477681|NCT01862874|3615865|P2|Vaccination 2|Overall Study||542
1477682|NCT01862874|3615866|P1|Vaccination 2|Overall Study||539
1477683|NCT01862874|3615865|P2|Vaccination 1|Overall Study||562
1477684|NCT01862874|3615866|P1|Vaccination 1|Overall Study||561
1477685|NCT01862874|3615865|P2|STARTED|Overall Study|Randomized participants|562
1477686|NCT01862874|3615866|P1|STARTED|Overall Study|Randomized participants|562
1477687|NCT01862484|3615884|P2|NOT COMPLETED|Overall Study||8
1477688|NCT01862484|3615885|P1|NOT COMPLETED|Overall Study||2
1477689|NCT01862484|3615884|P2|COMPLETED|Overall Study||6
1477690|NCT01862484|3615885|P1|COMPLETED|Overall Study||13
1477691|NCT01862484|3615884|P2|STARTED|Overall Study||14
1477692|NCT01862484|3615885|P1|STARTED|Overall Study||15
1477693|NCT01862419|3615893|P2|NOT COMPLETED|Overall Study||0
1477694|NCT01862419|3615894|P1|NOT COMPLETED|Overall Study||0
1477695|NCT01862419|3615893|P2|COMPLETED|Overall Study||1192
1477696|NCT01862419|3615894|P1|COMPLETED|Overall Study||1201
1477697|NCT01862419|3615893|P2|STARTED|Overall Study||1192
1477698|NCT01862419|3615894|P1|STARTED|Overall Study||1201
1477699|NCT01862250|3615904|P1|NOT COMPLETED|Overall Study||4
1477700|NCT01862250|3615904|P1|COMPLETED|Overall Study||8
1477701|NCT01862250|3615904|P1|STARTED|Overall Study||12
1477702|NCT01862159|3615911|P1|NOT COMPLETED|Overall Study||0
1477703|NCT01862159|3615911|P1|COMPLETED|Overall Study||25038
1477704|NCT01862159|3615911|P1|STARTED|Overall Study||25038
1477705|NCT01862133|3615918|P2|NOT COMPLETED|Overall Study||0
1477706|NCT01862133|3615919|P1|NOT COMPLETED|Overall Study||0
1477707|NCT01862133|3615918|P2|COMPLETED|Overall Study||31
1477708|NCT01862133|3615919|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
1477709|NCT01862133|3615918|P2|Returned During 6 mo Study|Overall Study||31
1477710|NCT01862133|3615919|P1|Returned During 6 mo Study|Overall Study||92
1477711|NCT01862133|3615918|P2|STARTED|Overall Study||31
1477712|NCT01862133|3615919|P1|STARTED|Overall Study||105
1477713|NCT01862029|3615925|P1|NOT COMPLETED|Overall Study||1
1477714|NCT01862029|3615925|P1|COMPLETED|Overall Study||8
1477715|NCT01862029|3615925|P1|STARTED|Overall Study||9
1477716|NCT01861925|3615933|P3|NOT COMPLETED|Overall Study||0
1477717|NCT01861925|3615934|P2|NOT COMPLETED|Overall Study||0
1477718|NCT01861925|3615935|P1|NOT COMPLETED|Overall Study||0
1477719|NCT01861925|3615933|P3|COMPLETED|Overall Study||8
1477720|NCT01861925|3615934|P2|COMPLETED|Overall Study||8
1477721|NCT01861925|3615935|P1|COMPLETED|Overall Study||34
1477722|NCT01861925|3615933|P3|STARTED|Overall Study||8
1477723|NCT01861925|3615934|P2|STARTED|Overall Study||8
1477724|NCT01861925|3615935|P1|STARTED|Overall Study||34
1477725|NCT01861756|3615958|P2|NOT COMPLETED|Overall Study||18
1477726|NCT01861756|3615959|P1|NOT COMPLETED|Overall Study||13
1477727|NCT01861756|3615958|P2|COMPLETED|Overall Study||85
1477728|NCT01861756|3615959|P1|COMPLETED|Overall Study||88
1477729|NCT01861756|3615958|P2|STARTED|Overall Study||103
1477730|NCT01861756|3615959|P1|STARTED|Overall Study||101
1477731|NCT01861704|3615967|P2|NOT COMPLETED|Overall Study||3
1477732|NCT01861704|3615968|P1|NOT COMPLETED|Overall Study||3
1477733|NCT01861704|3615967|P2|COMPLETED|Overall Study||104
1477734|NCT01861704|3615968|P1|COMPLETED|Overall Study||67
1477735|NCT01861704|3615967|P2|STARTED|Overall Study||107
1477736|NCT01861704|3615968|P1|STARTED|Overall Study||70
1477737|NCT01861665|3615976|P2|NOT COMPLETED|Overall Study||0
1477738|NCT01861665|3615977|P1|NOT COMPLETED|Overall Study||0
1477739|NCT01861665|3615976|P2|COMPLETED|Overall Study||17
1477740|NCT01861665|3615977|P1|COMPLETED|Overall Study||10
1477741|NCT01861665|3615976|P2|STARTED|Overall Study||17
1477742|NCT01861665|3615977|P1|STARTED|Overall Study||10
1477743|NCT01861587|3615985|P2|NOT COMPLETED|Overall Study||0
1477744|NCT01861587|3615986|P1|NOT COMPLETED|Overall Study||0
1477745|NCT01861587|3615985|P2|COMPLETED|Overall Study||13
1477746|NCT01861587|3615986|P1|COMPLETED|Overall Study||14
1477747|NCT01861587|3615985|P2|STARTED|Overall Study||13
1477748|NCT01861587|3615986|P1|STARTED|Overall Study||14
1477749|NCT01861574|3616002|P4|NOT COMPLETED|Overall Study||0
1477750|NCT01861574|3616003|P3|NOT COMPLETED|Overall Study||0
1477751|NCT01861574|3616004|P2|NOT COMPLETED|Overall Study||0
1477752|NCT01861574|3616005|P1|NOT COMPLETED|Overall Study||0
1477753|NCT01861574|3616002|P4|COMPLETED|Overall Study||28
1477754|NCT01861574|3616003|P3|COMPLETED|Overall Study||27
1477755|NCT01861574|3616004|P2|COMPLETED|Overall Study||25
1477756|NCT01861574|3616005|P1|COMPLETED|Overall Study||28
1477757|NCT01861574|3616002|P4|STARTED|Overall Study||28
1477758|NCT01861574|3616003|P3|STARTED|Overall Study||27
1477759|NCT01861574|3616004|P2|STARTED|Overall Study||25
1477760|NCT01861574|3616005|P1|STARTED|Overall Study||28
1477761|NCT01861522|3616028|P2|NOT COMPLETED|Overall Study||0
1477762|NCT01861522|3616029|P1|NOT COMPLETED|Overall Study||3
1477763|NCT01861522|3616028|P2|COMPLETED|Overall Study||232
1477764|NCT01861522|3616029|P1|COMPLETED|Overall Study||237
1477765|NCT01861522|3616028|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
1477766|NCT01861522|3616029|P1|STARTED|Overall Study||240
1477767|NCT01861457|3616037|P2|NOT COMPLETED|Overall Study||0
1477768|NCT01861457|3616038|P1|NOT COMPLETED|Overall Study||0
1477769|NCT01861457|3616037|P2|COMPLETED|Overall Study||19
1477770|NCT01861457|3616038|P1|COMPLETED|Overall Study||20
1477771|NCT01861457|3616037|P2|STARTED|Overall Study||19
1477772|NCT01861457|3616038|P1|STARTED|Overall Study||20
1477773|NCT01861301|3616046|P1|NOT COMPLETED|Overall Study||0
1477774|NCT01861301|3616046|P1|COMPLETED|Overall Study||18
1477775|NCT01861301|3616046|P1|STARTED|Overall Study||18
1477776|NCT01860989|3616053|P1|NOT COMPLETED|Overall Study||5
1477777|NCT01860989|3616053|P1|COMPLETED|Overall Study||6
1477778|NCT01860989|3616053|P1|STARTED|Overall Study||11
1477779|NCT01860976|3616059|P2|NOT COMPLETED|Long Term Extension||107
1477780|NCT01860976|3616060|P1|NOT COMPLETED|Long Term Extension||113
1477781|NCT01860976|3616059|P2|COMPLETED|Long Term Extension||8
1477782|NCT01860976|3616060|P1|COMPLETED|Long Term Extension||0
1477783|NCT01860976|3616059|P2|STARTED|Long Term Extension||115
1477784|NCT01860976|3616060|P1|STARTED|Long Term Extension||113
1477785|NCT01860976|3616059|P2|NOT COMPLETED|Open-Label||64
1477786|NCT01860976|3616060|P1|NOT COMPLETED|Open-Label||74
1477787|NCT01860976|3616059|P2|COMPLETED|Open-Label||121
1477788|NCT01860976|3616060|P1|COMPLETED|Open-Label||123
1477789|NCT01860976|3616059|P2|STARTED|Open-Label||185
1477790|NCT01860976|3616060|P1|STARTED|Open-Label||197
1477791|NCT01860976|3616059|P2|NOT COMPLETED|Blinded Treatment||113
1477792|NCT01860976|3616060|P1|NOT COMPLETED|Blinded Treatment||88
1477793|NCT01860976|3616059|P2|COMPLETED|Blinded Treatment||98
1477794|NCT01860976|3616060|P1|COMPLETED|Blinded Treatment||125
1477795|NCT01860976|3616059|P2|STARTED|Blinded Treatment||211
1477796|NCT01860976|3616060|P1|STARTED|Blinded Treatment||213
1477797|NCT01860950|3616088|P6|NOT COMPLETED|Overall Study||0
1477798|NCT01860950|3616089|P5|NOT COMPLETED|Overall Study||0
1477799|NCT01860950|3616090|P4|NOT COMPLETED|Overall Study||0
1477800|NCT01860950|3616091|P3|NOT COMPLETED|Overall Study||0
1477801|NCT01860950|3616092|P2|NOT COMPLETED|Overall Study||0
1477802|NCT01860950|3616093|P1|NOT COMPLETED|Overall Study||0
1477803|NCT01860950|3616088|P6|COMPLETED|Overall Study||13
1477804|NCT01860950|3616089|P5|COMPLETED|Overall Study||14
1477805|NCT01860950|3616090|P4|COMPLETED|Overall Study||13
1477806|NCT01860950|3616091|P3|COMPLETED|Overall Study||10
1477807|NCT01860950|3616092|P2|COMPLETED|Overall Study||15
1477808|NCT01860950|3616093|P1|COMPLETED|Overall Study||14
1477809|NCT01860950|3616088|P6|STARTED|Overall Study||13
1477810|NCT01860950|3616089|P5|STARTED|Overall Study||14
1477811|NCT01860950|3616090|P4|STARTED|Overall Study||13
1477812|NCT01860950|3616091|P3|STARTED|Overall Study||10
1477813|NCT01860950|3616092|P2|STARTED|Overall Study||15
1477814|NCT01860950|3616093|P1|STARTED|Overall Study||14
1477815|NCT01860846|3616114|P1|NOT COMPLETED|Overall Study||33
1477816|NCT01860846|3616114|P1|COMPLETED|Overall Study||73
1477817|NCT01860846|3616114|P1|Month 12|Overall Study||73
1477818|NCT01860846|3616114|P1|Month 6|Overall Study||85
1477819|NCT01860846|3616114|P1|Month 4|Overall Study||82
1477820|NCT01860846|3616114|P1|Month 2|Overall Study||83
1477821|NCT01860846|3616114|P1|Month 1|Overall Study||97
1477822|NCT01860846|3616114|P1|STARTED|Overall Study||106
1477823|NCT01860703|3616125|P4|NOT COMPLETED|Overall Study||2
1477824|NCT01860703|3616126|P3|NOT COMPLETED|Overall Study||1
1477825|NCT01860703|3616127|P2|NOT COMPLETED|Overall Study||5
1477826|NCT01860703|3616128|P1|NOT COMPLETED|Overall Study||2
1477827|NCT01860703|3616125|P4|COMPLETED|Overall Study||10
1477828|NCT01860703|3616126|P3|COMPLETED|Overall Study||11
1477829|NCT01860703|3616127|P2|COMPLETED|Overall Study||8
1477830|NCT01860703|3616128|P1|COMPLETED|Overall Study||11
1477831|NCT01860703|3616125|P4|STARTED|Overall Study||12
1477832|NCT01860703|3616126|P3|STARTED|Overall Study||12
1477833|NCT01860703|3616127|P2|STARTED|Overall Study||13
1477834|NCT01860703|3616128|P1|STARTED|Overall Study||13
1477835|NCT01860677|3616160|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1477836|NCT01860677|3616161|P1|NOT COMPLETED|Second Intervention (1 Day)||7
1477837|NCT01860677|3616160|P2|COMPLETED|Second Intervention (1 Day)||0
1477838|NCT01860677|3616161|P1|COMPLETED|Second Intervention (1 Day)||1
1477839|NCT01860677|3616160|P2|STARTED|Second Intervention (1 Day)||0
1477840|NCT01860677|3616161|P1|STARTED|Second Intervention (1 Day)||8
1477841|NCT01860677|3616160|P2|NOT COMPLETED|First Intervention (1 Day)||0
1477842|NCT01860677|3616161|P1|NOT COMPLETED|First Intervention (1 Day)||0
1477843|NCT01860677|3616160|P2|COMPLETED|First Intervention (1 Day)||0
1477844|NCT01860677|3616161|P1|COMPLETED|First Intervention (1 Day)||8
1477845|NCT01860677|3616160|P2|STARTED|First Intervention (1 Day)||0
1477846|NCT01860677|3616161|P1|STARTED|First Intervention (1 Day)||8
1477847|NCT01860586|3616170|P1|NOT COMPLETED|Overall Study||0
1477848|NCT01860586|3616170|P1|COMPLETED|Overall Study||20
1477849|NCT01860586|3616170|P1|STARTED|Overall Study||20
1477850|NCT01860573|3616178|P2|NOT COMPLETED|Overall Study||0
1477851|NCT01860573|3616179|P1|NOT COMPLETED|Overall Study||0
1477852|NCT01860573|3616178|P2|COMPLETED|Overall Study||85
1477853|NCT01860573|3616179|P1|COMPLETED|Overall Study||83
1477854|NCT01860573|3616178|P2|STARTED|Overall Study||85
1477855|NCT01860573|3616179|P1|STARTED|Overall Study||83
1477856|NCT01860534|3616199|P2|NOT COMPLETED|ROP #2||0
1477857|NCT01860534|3616200|P1|NOT COMPLETED|ROP #2||1
1477858|NCT01860534|3616199|P2|COMPLETED|ROP #2||13
1477859|NCT01860534|3616200|P1|COMPLETED|ROP #2||13
1477860|NCT01860534|3616199|P2|STARTED|ROP #2||13
1477861|NCT01860534|3616200|P1|STARTED|ROP #2||14
1477862|NCT01860534|3616199|P2|NOT COMPLETED|ROP #1||1
1477863|NCT01860534|3616200|P1|NOT COMPLETED|ROP #1||0
1477864|NCT01860534|3616199|P2|COMPLETED|ROP #1||13
1477865|NCT01860534|3616200|P1|COMPLETED|ROP #1||14
1477866|NCT01860534|3616199|P2|STARTED|ROP #1||14
1477867|NCT01860534|3616200|P1|STARTED|ROP #1||14
1477868|NCT01860521|3616214|P2|NOT COMPLETED|Overall Study||0
1477869|NCT01860521|3616215|P1|NOT COMPLETED|Overall Study||0
1477870|NCT01860521|3616214|P2|COMPLETED|Overall Study|June 2013|52
1477871|NCT01860521|3616215|P1|COMPLETED|Overall Study|June 2013|52
1477872|NCT01860521|3616214|P2|STARTED|Overall Study|September 2011|52
1477873|NCT01860521|3616215|P1|STARTED|Overall Study|September 2011|52
1477874|NCT01860170|3616230|P3|NOT COMPLETED|Overall Study||0
1477875|NCT01860170|3616231|P2|NOT COMPLETED|Overall Study||0
1477876|NCT01860170|3616232|P1|NOT COMPLETED|Overall Study||0
1477877|NCT01860170|3616230|P3|COMPLETED|Overall Study||22
1477878|NCT01860170|3616231|P2|COMPLETED|Overall Study||3
1477879|NCT01860170|3616232|P1|COMPLETED|Overall Study||3
1477880|NCT01860170|3616230|P3|STARTED|Overall Study||22
1477881|NCT01860170|3616231|P2|STARTED|Overall Study||3
1477882|NCT01860170|3616232|P1|STARTED|Overall Study||3
1477883|NCT01860079|3616248|P2|NOT COMPLETED|Overall Study||22
1477884|NCT01860079|3616249|P1|NOT COMPLETED|Overall Study||14
1477885|NCT01860079|3616248|P2|COMPLETED|Overall Study||363
1477886|NCT01860079|3616249|P1|COMPLETED|Overall Study||370
1477887|NCT01860079|3616248|P2|STARTED|Overall Study||385
1477888|NCT01860079|3616249|P1|STARTED|Overall Study||384
1477889|NCT01860040|3616257|P2|NOT COMPLETED|Overall Study||0
1477890|NCT01860040|3616258|P1|NOT COMPLETED|Overall Study||1
1477891|NCT01860040|3616257|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
1477892|NCT01860040|3616258|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
1477893|NCT01860040|3616257|P2|STARTED|Overall Study|did not meet recruitment goal|0
1477894|NCT01860040|3616258|P1|STARTED|Overall Study|did not meet recruitment goal|1
1477895|NCT01859988|3616269|P6|NOT COMPLETED|Overall Study||19
1477896|NCT01859988|3616270|P5|NOT COMPLETED|Overall Study||23
1477897|NCT01859988|3616271|P4|NOT COMPLETED|Overall Study||10
1477898|NCT01859988|3616272|P3|NOT COMPLETED|Overall Study||28
1477899|NCT01859988|3616273|P2|NOT COMPLETED|Overall Study||12
1477900|NCT01859988|3616274|P1|NOT COMPLETED|Overall Study||11
1477901|NCT01859988|3616269|P6|COMPLETED|Overall Study||42
1477902|NCT01859988|3616270|P5|COMPLETED|Overall Study||42
1477903|NCT01859988|3616271|P4|COMPLETED|Overall Study||55
1477904|NCT01859988|3616272|P3|COMPLETED|Overall Study||34
1477905|NCT01859988|3616273|P2|COMPLETED|Overall Study||52
1477906|NCT01859988|3616274|P1|COMPLETED|Overall Study||52
1477907|NCT01859988|3616269|P6|Treated|Overall Study||61
1477908|NCT01859988|3616270|P5|Treated|Overall Study||65
1477909|NCT01859988|3616271|P4|Treated|Overall Study||65
1477910|NCT01859988|3616272|P3|Treated|Overall Study||61
1477911|NCT01859988|3616273|P2|Treated|Overall Study||64
1477912|NCT01859988|3616274|P1|Treated|Overall Study||63
1477913|NCT01859988|3616269|P6|STARTED|Overall Study||61
1477914|NCT01859988|3616270|P5|STARTED|Overall Study||65
1477915|NCT01859988|3616271|P4|STARTED|Overall Study||65
1477916|NCT01859988|3616272|P3|STARTED|Overall Study||62
1477917|NCT01859988|3616273|P2|STARTED|Overall Study||64
1477918|NCT01859988|3616274|P1|STARTED|Overall Study||63
1477919|NCT01859949|3616368|P2|NOT COMPLETED|Overall Study||17
1477920|NCT01859949|3616369|P1|NOT COMPLETED|Overall Study||14
1477921|NCT01859949|3616368|P2|COMPLETED|Overall Study||15
1477922|NCT01859949|3616369|P1|COMPLETED|Overall Study||15
1477923|NCT01859949|3616368|P2|STARTED|Overall Study|Treated participants|32
1477924|NCT01859949|3616369|P1|STARTED|Overall Study|Treated participants|29
1477925|NCT01859793|3616387|P2|NOT COMPLETED|2nd Intervention Period||0
1477926|NCT01859793|3616388|P1|NOT COMPLETED|2nd Intervention Period||0
1477927|NCT01859793|3616387|P2|COMPLETED|2nd Intervention Period||16
1477928|NCT01859793|3616388|P1|COMPLETED|2nd Intervention Period||14
1477929|NCT01859793|3616387|P2|STARTED|2nd Intervention Period||16
1477930|NCT01859793|3616388|P1|STARTED|2nd Intervention Period||14
1477931|NCT01859793|3616387|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
1477932|NCT01859793|3616388|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
1477933|NCT01859793|3616387|P2|COMPLETED|Washout Period (4 Weeks)||16
1477934|NCT01859793|3616388|P1|COMPLETED|Washout Period (4 Weeks)||14
1477935|NCT01859793|3616387|P2|STARTED|Washout Period (4 Weeks)||17
1477936|NCT01859793|3616388|P1|STARTED|Washout Period (4 Weeks)||15
1477937|NCT01859793|3616387|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
1477938|NCT01859793|3616388|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
1477939|NCT01859793|3616387|P2|COMPLETED|First Intervention (8 Weeks)||17
1477940|NCT01859793|3616388|P1|COMPLETED|First Intervention (8 Weeks)||15
1477941|NCT01859793|3616387|P2|STARTED|First Intervention (8 Weeks)||18
1477942|NCT01859793|3616388|P1|STARTED|First Intervention (8 Weeks)||20
1477943|NCT01859715|3616401|P3|NOT COMPLETED|Overall Study||23
1477944|NCT01859715|3616402|P2|NOT COMPLETED|Overall Study||8
1477945|NCT01859715|3616403|P1|NOT COMPLETED|Overall Study||16
1477946|NCT01859715|3616401|P3|COMPLETED|Overall Study||93
1477947|NCT01859715|3616402|P2|COMPLETED|Overall Study||83
1477948|NCT01859715|3616403|P1|COMPLETED|Overall Study||125
1477949|NCT01859715|3616401|P3|STARTED|Overall Study||116
1477950|NCT01859715|3616402|P2|STARTED|Overall Study||91
1477951|NCT01859715|3616403|P1|STARTED|Overall Study||141
1477952|NCT01859702|3616414|P1|NOT COMPLETED|Overall Study||5
1477953|NCT01859702|3616414|P1|COMPLETED|Overall Study||31
1477954|NCT01859702|3616414|P1|STARTED|Overall Study||36
1477955|NCT01859637|3616418|P1|NOT COMPLETED|Overall Study||0
1477956|NCT01859637|3616418|P1|COMPLETED|Overall Study||6
1477957|NCT01859637|3616418|P1|STARTED|Overall Study||6
1477958|NCT01859611|3616424|P1|NOT COMPLETED|Overall Study||8
1477959|NCT01859611|3616424|P1|COMPLETED|Overall Study||43
1477960|NCT01859611|3616424|P1|STARTED|Overall Study||51
1477961|NCT01859598|3616428|P1|NOT COMPLETED|Visit 3 at 6 Months||912
1477962|NCT01859598|3616428|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
1477963|NCT01859598|3616428|P1|STARTED|Visit 3 at 6 Months||17253
1477964|NCT01859598|3616428|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
1477965|NCT01859598|3616428|P1|COMPLETED|Visit 2 at 3 Months||17253
1477966|NCT01859598|3616428|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
1477967|NCT01859507|3616436|P1|NOT COMPLETED|Overall Study||4
1477968|NCT01859507|3616436|P1|COMPLETED|Overall Study||28
1477969|NCT01859507|3616436|P1|STARTED|Overall Study||32
1477970|NCT01859494|3616441|P1|NOT COMPLETED|Overall Study||1
1477971|NCT01859494|3616441|P1|COMPLETED|Overall Study||218
1477972|NCT01859494|3616441|P1|STARTED|Overall Study||219
1477973|NCT01859390|3616452|P2|NOT COMPLETED|Overall Study||7
1477974|NCT01859390|3616453|P1|NOT COMPLETED|Overall Study||1
1477975|NCT01859390|3616452|P2|COMPLETED|Overall Study||30
1477976|NCT01859390|3616453|P1|COMPLETED|Overall Study||35
1477977|NCT01859390|3616452|P2|Withdrawals|Overall Study||2
1477978|NCT01859390|3616453|P1|Withdrawals|Overall Study||2
1477979|NCT01859390|3616452|P2|STARTED|Overall Study||37
1477980|NCT01859390|3616453|P1|STARTED|Overall Study||36
1477981|NCT01859325|3616477|P3|NOT COMPLETED|Overall Study||0
1477982|NCT01859325|3616478|P2|NOT COMPLETED|Overall Study||4
1477983|NCT01859325|3616479|P1|NOT COMPLETED|Overall Study||3
1477984|NCT01859325|3616477|P3|COMPLETED|Overall Study||2
1477985|NCT01859325|3616478|P2|COMPLETED|Overall Study||12
1477986|NCT01859325|3616479|P1|COMPLETED|Overall Study||12
1477987|NCT01859325|3616477|P3|STARTED|Overall Study||2
1477988|NCT01859325|3616478|P2|STARTED|Overall Study||16
1477989|NCT01859325|3616479|P1|STARTED|Overall Study||15
1477990|NCT01859312|3616487|P1|NOT COMPLETED|Overall Study||0
1477991|NCT01859312|3616487|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
1477992|NCT01859312|3616487|P1|STARTED|Overall Study||8
1477993|NCT01859247|3616542|P8|NOT COMPLETED|Overall Study||0
1477994|NCT01859247|3616543|P7|NOT COMPLETED|Overall Study||0
1477995|NCT01859247|3616544|P6|NOT COMPLETED|Overall Study||0
1477996|NCT01859247|3616545|P5|NOT COMPLETED|Overall Study||0
1477997|NCT01859247|3616546|P4|NOT COMPLETED|Overall Study||0
1477998|NCT01859247|3616547|P3|NOT COMPLETED|Overall Study||0
1477999|NCT01859247|3616548|P2|NOT COMPLETED|Overall Study||0
1478000|NCT01859247|3616549|P1|NOT COMPLETED|Overall Study||0
1478001|NCT01859247|3616542|P8|COMPLETED|Overall Study||1
1478002|NCT01859247|3616543|P7|COMPLETED|Overall Study||1
1478003|NCT01859247|3616544|P6|COMPLETED|Overall Study||1
1478004|NCT01859247|3616545|P5|COMPLETED|Overall Study||1
1478005|NCT01859247|3616546|P4|COMPLETED|Overall Study||1
1478006|NCT01859247|3616547|P3|COMPLETED|Overall Study||1
1478007|NCT01859247|3616548|P2|COMPLETED|Overall Study||1
1478008|NCT01859247|3616549|P1|COMPLETED|Overall Study||1
1478009|NCT01859247|3616542|P8|STARTED|Overall Study||1
1478010|NCT01859247|3616543|P7|STARTED|Overall Study||1
1478011|NCT01859247|3616544|P6|STARTED|Overall Study||1
1478012|NCT01859247|3616545|P5|STARTED|Overall Study||1
1478013|NCT01859247|3616546|P4|STARTED|Overall Study||1
1478014|NCT01859247|3616547|P3|STARTED|Overall Study||1
1478015|NCT01859247|3616548|P2|STARTED|Overall Study||1
1478016|NCT01859247|3616549|P1|STARTED|Overall Study||1
1478017|NCT01859195|3616576|P2|NOT COMPLETED|Overall Study||0
1478018|NCT01859195|3616577|P1|NOT COMPLETED|Overall Study||0
1478019|NCT01859195|3616576|P2|COMPLETED|Overall Study||12
1478020|NCT01859195|3616577|P1|COMPLETED|Overall Study||24
1478021|NCT01859195|3616576|P2|STARTED|Overall Study||12
1478022|NCT01859195|3616577|P1|STARTED|Overall Study||24
1478023|NCT01859143|3616587|P2|NOT COMPLETED|Overall Study||0
1478024|NCT01859143|3616588|P1|NOT COMPLETED|Overall Study||2
1478025|NCT01859143|3616587|P2|COMPLETED|Overall Study||60
1478026|NCT01859143|3616588|P1|COMPLETED|Overall Study||238
1478027|NCT01859143|3616587|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
1478028|NCT01859143|3616588|P1|STARTED|Overall Study||240
1478029|NCT01859078|3616602|P1|NOT COMPLETED|Overall Study||0
1478030|NCT01859078|3616602|P1|COMPLETED|Overall Study||28
1478031|NCT01859078|3616602|P1|STARTED|Overall Study||28
1478032|NCT01859013|3616618|P2|NOT COMPLETED|Overall Study||5
1478033|NCT01859013|3616619|P1|NOT COMPLETED|Overall Study||4
1478034|NCT01859013|3616618|P2|COMPLETED|Overall Study||9
1478035|NCT01859013|3616619|P1|COMPLETED|Overall Study||12
1478036|NCT01859013|3616618|P2|STARTED|Overall Study||14
1478037|NCT01859013|3616619|P1|STARTED|Overall Study||16
1478038|NCT01858766|3616644|P19|NOT COMPLETED|Overall Study||4
1478039|NCT01858766|3616645|P18|NOT COMPLETED|Overall Study||4
1478040|NCT01858766|3616646|P17|NOT COMPLETED|Overall Study||3
1478041|NCT01858766|3616647|P16|NOT COMPLETED|Overall Study||6
1478042|NCT01858766|3616648|P15|NOT COMPLETED|Overall Study||8
1478043|NCT01858766|3616649|P14|NOT COMPLETED|Overall Study||3
1478044|NCT01858766|3616650|P13|NOT COMPLETED|Overall Study||5
1478045|NCT01858766|3616651|P12|NOT COMPLETED|Overall Study||5
1478046|NCT01858766|3616652|P11|NOT COMPLETED|Overall Study||0
1478047|NCT01858766|3616653|P10|NOT COMPLETED|Overall Study||0
1478048|NCT01858766|3616654|P9|NOT COMPLETED|Overall Study||0
1478049|NCT01858766|3616655|P8|NOT COMPLETED|Overall Study||2
1478050|NCT01858766|3616656|P7|NOT COMPLETED|Overall Study||0
1478051|NCT01858766|3616657|P6|NOT COMPLETED|Overall Study||4
1478052|NCT01858766|3616658|P5|NOT COMPLETED|Overall Study||1
1478053|NCT01858766|3616659|P4|NOT COMPLETED|Overall Study||0
1478054|NCT01858766|3616660|P3|NOT COMPLETED|Overall Study||1
1478055|NCT01858766|3616661|P2|NOT COMPLETED|Overall Study||0
1478056|NCT01858766|3616662|P1|NOT COMPLETED|Overall Study||1
1478057|NCT01858766|3616644|P19|COMPLETED|Overall Study||22
1478058|NCT01858766|3616645|P18|COMPLETED|Overall Study||23
1478059|NCT01858766|3616646|P17|COMPLETED|Overall Study||22
1478060|NCT01858766|3616647|P16|COMPLETED|Overall Study||20
1478061|NCT01858766|3616648|P15|COMPLETED|Overall Study||23
1478062|NCT01858766|3616649|P14|COMPLETED|Overall Study||26
1478063|NCT01858766|3616650|P13|COMPLETED|Overall Study||25
1478064|NCT01858766|3616651|P12|COMPLETED|Overall Study||25
1478065|NCT01858766|3616652|P11|COMPLETED|Overall Study||5
1478066|NCT01858766|3616653|P10|COMPLETED|Overall Study||4
1478067|NCT01858766|3616654|P9|COMPLETED|Overall Study||1
1478068|NCT01858766|3616655|P8|COMPLETED|Overall Study||5
1478069|NCT01858766|3616656|P7|COMPLETED|Overall Study||7
1478070|NCT01858766|3616657|P6|COMPLETED|Overall Study||24
1478071|NCT01858766|3616658|P5|COMPLETED|Overall Study||26
1478072|NCT01858766|3616659|P4|COMPLETED|Overall Study||10
1478073|NCT01858766|3616660|P3|COMPLETED|Overall Study||10
1478074|NCT01858766|3616661|P2|COMPLETED|Overall Study||28
1478075|NCT01858766|3616662|P1|COMPLETED|Overall Study||26
1478076|NCT01858766|3616644|P19|STARTED|Overall Study||26
1478077|NCT01858766|3616645|P18|STARTED|Overall Study||27
1478078|NCT01858766|3616646|P17|STARTED|Overall Study||25
1478079|NCT01858766|3616647|P16|STARTED|Overall Study||26
1478080|NCT01858766|3616648|P15|STARTED|Overall Study||31
1478081|NCT01858766|3616649|P14|STARTED|Overall Study||29
1478082|NCT01858766|3616650|P13|STARTED|Overall Study||30
1478083|NCT01858766|3616651|P12|STARTED|Overall Study||30
1478084|NCT01858766|3616652|P11|STARTED|Overall Study||5
1478085|NCT01858766|3616653|P10|STARTED|Overall Study||4
1478086|NCT01858766|3616654|P9|STARTED|Overall Study||1
1478087|NCT01858766|3616655|P8|STARTED|Overall Study||7
1478088|NCT01858766|3616656|P7|STARTED|Overall Study||7
1478089|NCT01858766|3616657|P6|STARTED|Overall Study||28
1478090|NCT01858766|3616658|P5|STARTED|Overall Study||27
1478091|NCT01858766|3616659|P4|STARTED|Overall Study||10
1478092|NCT01858766|3616660|P3|STARTED|Overall Study||11
1478093|NCT01858766|3616661|P2|STARTED|Overall Study||28
1478094|NCT01858766|3616662|P1|STARTED|Overall Study||27
1478095|NCT01858701|3616733|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
1478096|NCT01858701|3616734|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
1478097|NCT01858701|3616733|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
1478098|NCT01858701|3616734|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
1478099|NCT01858701|3616733|P2|STARTED|Period 2, Second 30 Days of Wear||17
1478100|NCT01858701|3616734|P1|STARTED|Period 2, Second 30 Days of Wear||18
1478101|NCT01858701|3616733|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
1478102|NCT01858701|3616734|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
1478103|NCT01858701|3616733|P2|COMPLETED|Washout Period, 1-13 Days||17
1478104|NCT01858701|3616734|P1|COMPLETED|Washout Period, 1-13 Days||18
1478105|NCT01858701|3616733|P2|STARTED|Washout Period, 1-13 Days||19
1478106|NCT01858701|3616734|P1|STARTED|Washout Period, 1-13 Days||20
1478107|NCT01858701|3616733|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
1478108|NCT01858701|3616734|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
1478109|NCT01858701|3616733|P2|COMPLETED|Period 1, First 30 Days of Wear||19
1478110|NCT01858701|3616734|P1|COMPLETED|Period 1, First 30 Days of Wear||20
1478111|NCT01858701|3616733|P2|STARTED|Period 1, First 30 Days of Wear||20
1478112|NCT01858701|3616734|P1|STARTED|Period 1, First 30 Days of Wear||20
1478113|NCT01858636|3616740|P1|NOT COMPLETED|Overall Study||28
1478114|NCT01858636|3616740|P1|COMPLETED|Overall Study||207
1478115|NCT01858636|3616740|P1|Device Deployment|Overall Study||211
1478116|NCT01858636|3616740|P1|STARTED|Overall Study|Subjects consented|235
1478117|NCT01858545|3616747|P2|NOT COMPLETED|Overall Study||6
1478118|NCT01858545|3616748|P1|NOT COMPLETED|Overall Study||4
1478119|NCT01858545|3616747|P2|COMPLETED|Overall Study||23
1478120|NCT01858545|3616748|P1|COMPLETED|Overall Study||23
1478121|NCT01858545|3616747|P2|STARTED|Overall Study||29
1478122|NCT01858545|3616748|P1|STARTED|Overall Study||27
1478123|NCT01858428|3616756|P2|NOT COMPLETED|Overall Study||10
1478124|NCT01858428|3616757|P1|NOT COMPLETED|Overall Study||1
1478125|NCT01858428|3616756|P2|COMPLETED|Overall Study||190
1478126|NCT01858428|3616757|P1|COMPLETED|Overall Study||99
1478127|NCT01858428|3616756|P2|STARTED|Overall Study||200
1478128|NCT01858428|3616757|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
1478129|NCT01858389|3616793|P2|NOT COMPLETED|Overall Study||25
1478130|NCT01858389|3616794|P1|NOT COMPLETED|Overall Study||16
1478131|NCT01858389|3616793|P2|COMPLETED|Overall Study||0
1478132|NCT01858389|3616794|P1|COMPLETED|Overall Study||0
1478133|NCT01858389|3616793|P2|Received Treatment|Overall Study||22
1478134|NCT01858389|3616794|P1|Received Treatment|Overall Study||16
1478135|NCT01858389|3616793|P2|STARTED|Overall Study|Enrolled|25
1478136|NCT01858389|3616794|P1|STARTED|Overall Study|Enrolled|16
1478137|NCT01858376|3616809|P1|NOT COMPLETED|Overall Study||4
1478138|NCT01858376|3616809|P1|COMPLETED|Overall Study||20
1478139|NCT01858376|3616809|P1|STARTED|Overall Study||24
1478140|NCT01857986|3616818|P2|NOT COMPLETED|Overall Study||7
1478141|NCT01857986|3616819|P1|NOT COMPLETED|Overall Study||5
1478142|NCT01857986|3616818|P2|COMPLETED|Overall Study||30
1478143|NCT01857986|3616819|P1|COMPLETED|Overall Study||34
1478144|NCT01857986|3616818|P2|STARTED|Overall Study||37
1478145|NCT01857986|3616819|P1|STARTED|Overall Study||39
1478146|NCT01857882|3616831|P2|NOT COMPLETED|Overall Study||0
1478147|NCT01857882|3616832|P1|NOT COMPLETED|Overall Study||0
1478148|NCT01857882|3616831|P2|COMPLETED|Overall Study||20
1478149|NCT01857882|3616832|P1|COMPLETED|Overall Study||21
1478150|NCT01857882|3616831|P2|STARTED|Overall Study||20
1478151|NCT01857882|3616832|P1|STARTED|Overall Study||21
1478152|NCT01857869|3616848|P10|NOT COMPLETED|Booster/Rechallenge Phase||0
1478153|NCT01857869|3616849|P9|NOT COMPLETED|Booster/Rechallenge Phase||0
1478154|NCT01857869|3616850|P8|NOT COMPLETED|Booster/Rechallenge Phase||0
1478155|NCT01857869|3616851|P7|NOT COMPLETED|Booster/Rechallenge Phase||0
1478156|NCT01857869|3616852|P6|NOT COMPLETED|Booster/Rechallenge Phase||0
1478157|NCT01857869|3616853|P5|NOT COMPLETED|Booster/Rechallenge Phase||0
1478158|NCT01857869|3616854|P4|NOT COMPLETED|Booster/Rechallenge Phase||2
1478159|NCT01857869|3616855|P3|NOT COMPLETED|Booster/Rechallenge Phase||0
1478160|NCT01857869|3616856|P2|NOT COMPLETED|Booster/Rechallenge Phase||0
1478161|NCT01857869|3616857|P1|NOT COMPLETED|Booster/Rechallenge Phase||0
1478162|NCT01857869|3616848|P10|COMPLETED|Booster/Rechallenge Phase||6
1478163|NCT01857869|3616849|P9|COMPLETED|Booster/Rechallenge Phase||3
1478164|NCT01857869|3616850|P8|COMPLETED|Booster/Rechallenge Phase||4
1478165|NCT01857869|3616851|P7|COMPLETED|Booster/Rechallenge Phase||5
1478166|NCT01857869|3616852|P6|COMPLETED|Booster/Rechallenge Phase||2
1478167|NCT01857869|3616853|P5|COMPLETED|Booster/Rechallenge Phase||10
1478168|NCT01857869|3616854|P4|COMPLETED|Booster/Rechallenge Phase||7
1478169|NCT01857869|3616855|P3|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1478170|NCT01857869|3616856|P2|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1478171|NCT01857869|3616857|P1|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1478172|NCT01857869|3616848|P10|STARTED|Booster/Rechallenge Phase||6
1478173|NCT01857869|3616849|P9|STARTED|Booster/Rechallenge Phase||3
1478174|NCT01857869|3616850|P8|STARTED|Booster/Rechallenge Phase||4
1478175|NCT01857869|3616851|P7|STARTED|Booster/Rechallenge Phase||5
1478176|NCT01857869|3616852|P6|STARTED|Booster/Rechallenge Phase||2
1478177|NCT01857869|3616853|P5|STARTED|Booster/Rechallenge Phase||10
1478178|NCT01857869|3616854|P4|STARTED|Booster/Rechallenge Phase||9
1478179|NCT01857869|3616855|P3|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1478180|NCT01857869|3616856|P2|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1478181|NCT01857869|3616857|P1|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
1478182|NCT01857869|3616848|P10|NOT COMPLETED|Primary/Challenge Phase||0
1478183|NCT01857869|3616849|P9|NOT COMPLETED|Primary/Challenge Phase||0
1478184|NCT01857869|3616850|P8|NOT COMPLETED|Primary/Challenge Phase||0
1478185|NCT01857869|3616851|P7|NOT COMPLETED|Primary/Challenge Phase||0
1478186|NCT01857869|3616852|P6|NOT COMPLETED|Primary/Challenge Phase||0
1478187|NCT01857869|3616853|P5|NOT COMPLETED|Primary/Challenge Phase||0
1478188|NCT01857869|3616854|P4|NOT COMPLETED|Primary/Challenge Phase||0
1478189|NCT01857869|3616855|P3|NOT COMPLETED|Primary/Challenge Phase||0
1478190|NCT01857869|3616856|P2|NOT COMPLETED|Primary/Challenge Phase||1
1478191|NCT01857869|3616857|P1|NOT COMPLETED|Primary/Challenge Phase||5
1478192|NCT01857869|3616848|P10|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478193|NCT01857869|3616849|P9|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478194|NCT01857869|3616850|P8|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478195|NCT01857869|3616851|P7|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478196|NCT01857869|3616852|P6|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478370|NCT01856595|3617233|P2|COMPLETED|Overall Study||11
1478197|NCT01857869|3616853|P5|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478198|NCT01857869|3616854|P4|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478199|NCT01857869|3616855|P3|COMPLETED|Primary/Challenge Phase||12
1478200|NCT01857869|3616856|P2|COMPLETED|Primary/Challenge Phase||16
1478201|NCT01857869|3616857|P1|COMPLETED|Primary/Challenge Phase||29
1478202|NCT01857869|3616848|P10|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478203|NCT01857869|3616849|P9|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478204|NCT01857869|3616850|P8|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478205|NCT01857869|3616851|P7|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478206|NCT01857869|3616852|P6|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478207|NCT01857869|3616853|P5|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478208|NCT01857869|3616854|P4|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
1478209|NCT01857869|3616855|P3|STARTED|Primary/Challenge Phase||12
1478210|NCT01857869|3616856|P2|STARTED|Primary/Challenge Phase||17
1478211|NCT01857869|3616857|P1|STARTED|Primary/Challenge Phase||34
1478212|NCT01857713|3616937|P1|NOT COMPLETED|Overall Study||6
1478213|NCT01857713|3616937|P1|COMPLETED|Overall Study||89
1478214|NCT01857713|3616937|P1|STARTED|Overall Study||95
1478215|NCT01857622|3616947|P3|NOT COMPLETED|Overall Study||2
1478216|NCT01857622|3616948|P2|NOT COMPLETED|Overall Study||1
1478217|NCT01857622|3616949|P1|NOT COMPLETED|Overall Study||11
1478218|NCT01857622|3616947|P3|COMPLETED|Overall Study||19
1478219|NCT01857622|3616948|P2|COMPLETED|Overall Study||21
1478220|NCT01857622|3616949|P1|COMPLETED|Overall Study||39
1478221|NCT01857622|3616947|P3|STARTED|Overall Study||21
1478222|NCT01857622|3616948|P2|STARTED|Overall Study||22
1478223|NCT01857622|3616949|P1|STARTED|Overall Study||50
1478224|NCT01857583|3616961|P4|NOT COMPLETED|Overall Study||4
1478225|NCT01857583|3616962|P3|NOT COMPLETED|Overall Study||3
1478226|NCT01857583|3616963|P2|NOT COMPLETED|Overall Study||1
1478227|NCT01857583|3616964|P1|NOT COMPLETED|Overall Study||1
1478228|NCT01857583|3616961|P4|COMPLETED|Overall Study||17
1478229|NCT01857583|3616962|P3|COMPLETED|Overall Study||19
1478230|NCT01857583|3616963|P2|COMPLETED|Overall Study||6
1478231|NCT01857583|3616964|P1|COMPLETED|Overall Study||29
1478232|NCT01857583|3616961|P4|Safety Analysis Population|Overall Study||20
1478233|NCT01857583|3616962|P3|Safety Analysis Population|Overall Study||22
1478234|NCT01857583|3616963|P2|Safety Analysis Population|Overall Study||7
1478235|NCT01857583|3616964|P1|Safety Analysis Population|Overall Study||30
1478236|NCT01857583|3616961|P4|STARTED|Overall Study||21
1478237|NCT01857583|3616962|P3|STARTED|Overall Study||22
1478238|NCT01857583|3616963|P2|STARTED|Overall Study||7
1478239|NCT01857583|3616964|P1|STARTED|Overall Study||30
1478240|NCT01857531|3616974|P1|NOT COMPLETED|Overall Study||4
1478241|NCT01857531|3616974|P1|COMPLETED|Overall Study||12
1478242|NCT01857531|3616974|P1|STARTED|Overall Study||16
1478243|NCT01857362|3616983|P2|NOT COMPLETED|Overall Study||0
1478244|NCT01857362|3616984|P1|NOT COMPLETED|Overall Study||0
1478245|NCT01857362|3616983|P2|COMPLETED|Overall Study||6
1478246|NCT01857362|3616984|P1|COMPLETED|Overall Study||6
1478247|NCT01857362|3616983|P2|STARTED|Overall Study||6
1478248|NCT01857362|3616984|P1|STARTED|Overall Study||6
1478249|NCT01857323|3616992|P1|NOT COMPLETED|Overall Study||64
1478250|NCT01857323|3616992|P1|COMPLETED|Overall Study||253
1478251|NCT01857323|3616992|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
1478252|NCT01857323|3616992|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
1478253|NCT01857297|3617003|P2|NOT COMPLETED|Overall Study||0
1478254|NCT01857297|3617004|P1|NOT COMPLETED|Overall Study||0
1478255|NCT01857297|3617003|P2|COMPLETED|Overall Study||60
1478256|NCT01857297|3617004|P1|COMPLETED|Overall Study||60
1478257|NCT01857297|3617003|P2|STARTED|Overall Study||60
1478258|NCT01857297|3617004|P1|STARTED|Overall Study||60
1478259|NCT01857258|3617018|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
1478260|NCT01857258|3617019|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
1478261|NCT01857258|3617018|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
1478262|NCT01857258|3617019|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
1478263|NCT01857258|3617018|P2|STARTED|Second Intervention (3 h Postprandially)||7
1478264|NCT01857258|3617019|P1|STARTED|Second Intervention (3 h Postprandially)||8
1478265|NCT01857258|3617018|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
1478266|NCT01857258|3617019|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
1478267|NCT01857258|3617018|P2|COMPLETED|Wash-out Period (7 Days)||7
1478268|NCT01857258|3617019|P1|COMPLETED|Wash-out Period (7 Days)||8
1478269|NCT01857258|3617018|P2|STARTED|Wash-out Period (7 Days)||7
1478270|NCT01857258|3617019|P1|STARTED|Wash-out Period (7 Days)||8
1478271|NCT01857258|3617018|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
1478272|NCT01857258|3617019|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
1478273|NCT01857258|3617018|P2|COMPLETED|First Intervention (3 h Postprandially)||7
1478274|NCT01857258|3617019|P1|COMPLETED|First Intervention (3 h Postprandially)||8
1478275|NCT01857258|3617018|P2|STARTED|First Intervention (3 h Postprandially)||7
1478276|NCT01857258|3617019|P1|STARTED|First Intervention (3 h Postprandially)||8
1478277|NCT01857206|3617041|P2|NOT COMPLETED|Overall Study||10
1478278|NCT01857206|3617042|P1|NOT COMPLETED|Overall Study||13
1478279|NCT01857206|3617041|P2|COMPLETED|Overall Study||673
1478280|NCT01857206|3617042|P1|COMPLETED|Overall Study||1359
1478281|NCT01857206|3617041|P2|STARTED|Overall Study||683
1478282|NCT01857206|3617042|P1|STARTED|Overall Study||1372
1478283|NCT01857102|3617060|P2|NOT COMPLETED|Period 2||0
1478284|NCT01857102|3617061|P1|NOT COMPLETED|Period 2||2
1478285|NCT01857102|3617060|P2|COMPLETED|Period 2||51
1478286|NCT01857102|3617061|P1|COMPLETED|Period 2||53
1478287|NCT01857102|3617060|P2|Neophytes|Period 2||4
1478288|NCT01857102|3617061|P1|Neophytes|Period 2||7
1478289|NCT01857102|3617060|P2|Habitual Users|Period 2||47
1478290|NCT01857102|3617061|P1|Habitual Users|Period 2||48
1478291|NCT01857102|3617060|P2|STARTED|Period 2||51
1478292|NCT01857102|3617061|P1|STARTED|Period 2||55
1478293|NCT01857102|3617060|P2|NOT COMPLETED|Period 1||5
1478294|NCT01857102|3617061|P1|NOT COMPLETED|Period 1||3
1478295|NCT01857102|3617060|P2|COMPLETED|Period 1||51
1478296|NCT01857102|3617061|P1|COMPLETED|Period 1||55
1478297|NCT01857102|3617060|P2|Neophtyes|Period 1||4
1478298|NCT01857102|3617061|P1|Neophtyes|Period 1||7
1478299|NCT01857102|3617060|P2|Habitual Users|Period 1||52
1478300|NCT01857102|3617061|P1|Habitual Users|Period 1||51
1478301|NCT01857102|3617060|P2|STARTED|Period 1||56
1478302|NCT01857102|3617061|P1|STARTED|Period 1||58
1478303|NCT01857063|3617071|P2|NOT COMPLETED|Period 2 (7 Days)||2
1478304|NCT01857063|3617072|P1|NOT COMPLETED|Period 2 (7 Days)||4
1478305|NCT01857063|3617071|P2|COMPLETED|Period 2 (7 Days)||104
1478306|NCT01857063|3617072|P1|COMPLETED|Period 2 (7 Days)||104
1478307|NCT01857063|3617071|P2|STARTED|Period 2 (7 Days)||106
1478308|NCT01857063|3617072|P1|STARTED|Period 2 (7 Days)||108
1478309|NCT01857063|3617071|P2|NOT COMPLETED|Period 1 (7 Days)||4
1478310|NCT01857063|3617072|P1|NOT COMPLETED|Period 1 (7 Days)||2
1478311|NCT01857063|3617071|P2|COMPLETED|Period 1 (7 Days)||106
1478312|NCT01857063|3617072|P1|COMPLETED|Period 1 (7 Days)||108
1478313|NCT01857063|3617071|P2|STARTED|Period 1 (7 Days)||110
1478314|NCT01857063|3617072|P1|STARTED|Period 1 (7 Days)||110
1478315|NCT01856933|3617098|P1|NOT COMPLETED|Overall Study||0
1478316|NCT01856933|3617098|P1|COMPLETED|Overall Study||6
1478317|NCT01856933|3617098|P1|STARTED|Overall Study||6
1478318|NCT01856907|3617105|P3|NOT COMPLETED|Overall Study||0
1478319|NCT01856907|3617106|P2|NOT COMPLETED|Overall Study||3
1478320|NCT01856907|3617107|P1|NOT COMPLETED|Overall Study||0
1478321|NCT01856907|3617105|P3|COMPLETED|Overall Study||12
1478322|NCT01856907|3617106|P2|COMPLETED|Overall Study||9
1478323|NCT01856907|3617107|P1|COMPLETED|Overall Study||12
1478324|NCT01856907|3617105|P3|STARTED|Overall Study||12
1478325|NCT01856907|3617106|P2|STARTED|Overall Study||12
1478326|NCT01856907|3617107|P1|STARTED|Overall Study||12
1478327|NCT01856764|3617147|P2|NOT COMPLETED|Overall Study||0
1478328|NCT01856764|3617148|P1|NOT COMPLETED|Overall Study||0
1478329|NCT01856764|3617147|P2|COMPLETED|Overall Study||20
1478330|NCT01856764|3617148|P1|COMPLETED|Overall Study||20
1478331|NCT01856764|3617147|P2|STARTED|Overall Study||20
1478332|NCT01856764|3617148|P1|STARTED|Overall Study||20
1478333|NCT01856686|3617160|P2|NOT COMPLETED|Overall Study||11
1478334|NCT01856686|3617161|P1|NOT COMPLETED|Overall Study||5
1478335|NCT01856686|3617160|P2|COMPLETED|Overall Study||22
1478336|NCT01856686|3617161|P1|COMPLETED|Overall Study||26
1478337|NCT01856686|3617160|P2|STARTED|Overall Study||33
1478338|NCT01856686|3617161|P1|STARTED|Overall Study||31
1478339|NCT01856673|3617204|P3|NOT COMPLETED|Overall Study||34
1478340|NCT01856673|3617205|P2|NOT COMPLETED|Overall Study||85
1478341|NCT01856673|3617206|P1|NOT COMPLETED|Overall Study||98
1478342|NCT01856673|3617204|P3|COMPLETED|Overall Study||137
1478343|NCT01856673|3617205|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
1478344|NCT01856673|3617206|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
1478345|NCT01856673|3617204|P3|Quibdó Participants|Overall Study||83
1478346|NCT01856673|3617205|P2|Quibdó Participants|Overall Study||86
1478347|NCT01856673|3617206|P1|Quibdó Participants|Overall Study||83
1478348|NCT01856673|3617204|P3|Buenaventura Participants|Overall Study||88
1478349|NCT01856673|3617205|P2|Buenaventura Participants|Overall Study||89
1478350|NCT01856673|3617206|P1|Buenaventura Participants|Overall Study||92
1478351|NCT01856673|3617204|P3|STARTED|Overall Study||171
1478352|NCT01856673|3617205|P2|STARTED|Overall Study||175
1478353|NCT01856673|3617206|P1|STARTED|Overall Study||175
1478354|NCT01856595|3617226|P9|NOT COMPLETED|Overall Study||0
1478355|NCT01856595|3617227|P8|NOT COMPLETED|Overall Study||0
1478356|NCT01856595|3617228|P7|NOT COMPLETED|Overall Study||1
1478357|NCT01856595|3617229|P6|NOT COMPLETED|Overall Study||0
1478358|NCT01856595|3617230|P5|NOT COMPLETED|Overall Study||0
1478359|NCT01856595|3617231|P4|NOT COMPLETED|Overall Study||0
1478360|NCT01856595|3617232|P3|NOT COMPLETED|Overall Study||0
1478361|NCT01856595|3617233|P2|NOT COMPLETED|Overall Study||1
1478362|NCT01856595|3617234|P1|NOT COMPLETED|Overall Study||0
1478363|NCT01856595|3617226|P9|COMPLETED|Overall Study||14
1478364|NCT01856595|3617227|P8|COMPLETED|Overall Study||10
1478365|NCT01856595|3617228|P7|COMPLETED|Overall Study||12
1478366|NCT01856595|3617229|P6|COMPLETED|Overall Study||12
1478367|NCT01856595|3617230|P5|COMPLETED|Overall Study||14
1478368|NCT01856595|3617231|P4|COMPLETED|Overall Study||12
1478369|NCT01856595|3617232|P3|COMPLETED|Overall Study||12
1478371|NCT01856595|3617234|P1|COMPLETED|Overall Study||18
1478372|NCT01856595|3617226|P9|STARTED|Overall Study||14
1478373|NCT01856595|3617227|P8|STARTED|Overall Study||10
1478374|NCT01856595|3617228|P7|STARTED|Overall Study||13
1478375|NCT01856595|3617229|P6|STARTED|Overall Study||12
1478376|NCT01856595|3617230|P5|STARTED|Overall Study||14
1478377|NCT01856595|3617231|P4|STARTED|Overall Study||12
1478378|NCT01856595|3617232|P3|STARTED|Overall Study||12
1478379|NCT01856595|3617233|P2|STARTED|Overall Study||12
1478380|NCT01856595|3617234|P1|STARTED|Overall Study||18
1478381|NCT01856569|3617467|P1|NOT COMPLETED|Overall Study||13
1478382|NCT01856569|3617467|P1|COMPLETED|Overall Study||139
1478383|NCT01856569|3617467|P1|Full Analysis Set|Overall Study||144
1478384|NCT01856569|3617467|P1|STARTED|Overall Study||152
1478385|NCT01856530|3617478|P2|NOT COMPLETED|Overall Study||0
1478386|NCT01856530|3617479|P1|NOT COMPLETED|Overall Study||0
1478387|NCT01856530|3617478|P2|COMPLETED|Overall Study||27
1478388|NCT01856530|3617479|P1|COMPLETED|Overall Study||27
1478389|NCT01856530|3617478|P2|STARTED|Overall Study||27
1478390|NCT01856530|3617479|P1|STARTED|Overall Study||27
1478391|NCT01856491|3617495|P1|NOT COMPLETED|Overall Study||15
1478392|NCT01856491|3617495|P1|COMPLETED|Overall Study||152
1478393|NCT01856491|3617495|P1|STARTED|Overall Study||167
1478394|NCT01856361|3617504|P2|NOT COMPLETED|Overall Study||0
1478395|NCT01856361|3617505|P1|NOT COMPLETED|Overall Study||0
1478396|NCT01856361|3617504|P2|COMPLETED|Overall Study||1
1478397|NCT01856361|3617505|P1|COMPLETED|Overall Study||1
1478398|NCT01856361|3617504|P2|STARTED|Overall Study||1
1478399|NCT01856361|3617505|P1|STARTED|Overall Study||1
1478400|NCT01856322|3617522|P3|NOT COMPLETED|Overall Study||3
1478401|NCT01856322|3617523|P2|NOT COMPLETED|Overall Study||0
1478402|NCT01856322|3617524|P1|NOT COMPLETED|Overall Study||0
1478403|NCT01856322|3617522|P3|COMPLETED|Overall Study||0
1478404|NCT01856322|3617523|P2|COMPLETED|Overall Study||0
1478405|NCT01856322|3617524|P1|COMPLETED|Overall Study||0
1478406|NCT01856322|3617522|P3|STARTED|Overall Study||3
1478407|NCT01856322|3617523|P2|STARTED|Overall Study||0
1478408|NCT01856322|3617524|P1|STARTED|Overall Study||0
1478409|NCT01856270|3617533|P2|NOT COMPLETED|Overall Study||12
1478410|NCT01856270|3617534|P1|NOT COMPLETED|Overall Study||11
1478411|NCT01856270|3617533|P2|COMPLETED|Overall Study||14
1478412|NCT01856270|3617534|P1|COMPLETED|Overall Study||13
1478413|NCT01856270|3617533|P2|STARTED|Overall Study||26
1478414|NCT01856270|3617534|P1|STARTED|Overall Study||24
1478415|NCT01856257|3617557|P4|NOT COMPLETED|Overall Study||2
1478416|NCT01856257|3617558|P3|NOT COMPLETED|Overall Study||0
1478417|NCT01856257|3617559|P2|NOT COMPLETED|Overall Study||1
1478418|NCT01856257|3617560|P1|NOT COMPLETED|Overall Study||3
1478419|NCT01856257|3617557|P4|COMPLETED|Overall Study||0
1478420|NCT01856257|3617558|P3|COMPLETED|Overall Study||11
1478421|NCT01856257|3617559|P2|COMPLETED|Overall Study||28
1478422|NCT01856257|3617560|P1|COMPLETED|Overall Study||26
1478423|NCT01856257|3617557|P4|STARTED|Overall Study||2
1478424|NCT01856257|3617558|P3|STARTED|Overall Study||11
1478425|NCT01856257|3617559|P2|STARTED|Overall Study||29
1478426|NCT01856257|3617560|P1|STARTED|Overall Study||29
1478427|NCT01856218|3617659|P1|NOT COMPLETED|Long-Term Extension Phase||0
1478428|NCT01856218|3617659|P1|COMPLETED|Long-Term Extension Phase||3
1478429|NCT01856218|3617659|P1|STARTED|Long-Term Extension Phase||3
1478430|NCT01856218|3617659|P1|NOT COMPLETED|First Phase||0
1478431|NCT01856218|3617659|P1|COMPLETED|First Phase||3
1478432|NCT01856218|3617659|P1|STARTED|First Phase||3
1478433|NCT01855997|3617673|P1|NOT COMPLETED|Overall Study||0
1478434|NCT01855997|3617673|P1|COMPLETED|Overall Study||1669
1478435|NCT01855997|3617673|P1|STARTED|Overall Study||1669
1478436|NCT01855958|3617728|P2|NOT COMPLETED|Overall Study||0
1478437|NCT01855958|3617729|P1|NOT COMPLETED|Overall Study||1
1478438|NCT01855958|3617728|P2|COMPLETED|Overall Study||13
1478439|NCT01855958|3617729|P1|COMPLETED|Overall Study||12
1478440|NCT01855958|3617728|P2|STARTED|Overall Study||13
1478441|NCT01855958|3617729|P1|STARTED|Overall Study||13
1478442|NCT01855945|3617759|P12|NOT COMPLETED|Overall Study||3
1478443|NCT01855945|3617760|P11|NOT COMPLETED|Overall Study||5
1478444|NCT01855945|3617761|P10|NOT COMPLETED|Overall Study||2
1478445|NCT01855945|3617762|P9|NOT COMPLETED|Overall Study||2
1478446|NCT01855945|3617763|P8|NOT COMPLETED|Overall Study||8
1478447|NCT01855945|3617764|P7|NOT COMPLETED|Overall Study||10
1478448|NCT01855945|3617765|P6|NOT COMPLETED|Overall Study||3
1478449|NCT01855945|3617766|P5|NOT COMPLETED|Overall Study||1
1478450|NCT01855945|3617767|P4|NOT COMPLETED|Overall Study||4
1478451|NCT01855945|3617768|P3|NOT COMPLETED|Overall Study||12
1478452|NCT01855945|3617769|P2|NOT COMPLETED|Overall Study||11
1478453|NCT01855945|3617770|P1|NOT COMPLETED|Overall Study||16
1478454|NCT01855945|3617759|P12|COMPLETED|Overall Study||49
1478455|NCT01855945|3617760|P11|COMPLETED|Overall Study||46
1478456|NCT01855945|3617761|P10|COMPLETED|Overall Study||49
1478457|NCT01855945|3617762|P9|COMPLETED|Overall Study||46
1478458|NCT01855945|3617763|P8|COMPLETED|Overall Study||47
1478459|NCT01855945|3617764|P7|COMPLETED|Overall Study||43
1478460|NCT01855945|3617765|P6|COMPLETED|Overall Study||50
1478461|NCT01855945|3617766|P5|COMPLETED|Overall Study||50
1478462|NCT01855945|3617767|P4|COMPLETED|Overall Study||49
1478463|NCT01855945|3617768|P3|COMPLETED|Overall Study||39
1478464|NCT01855945|3617769|P2|COMPLETED|Overall Study||44
1478465|NCT01855945|3617770|P1|COMPLETED|Overall Study||38
1478466|NCT01855945|3617759|P12|STARTED|Overall Study||52
1478467|NCT01855945|3617760|P11|STARTED|Overall Study||51
1478468|NCT01855945|3617761|P10|STARTED|Overall Study||51
1478469|NCT01855945|3617762|P9|STARTED|Overall Study||48
1478470|NCT01855945|3617763|P8|STARTED|Overall Study||55
1478471|NCT01855945|3617764|P7|STARTED|Overall Study||53
1478472|NCT01855945|3617765|P6|STARTED|Overall Study||53
1478473|NCT01855945|3617766|P5|STARTED|Overall Study||51
1478474|NCT01855945|3617767|P4|STARTED|Overall Study||53
1478475|NCT01855945|3617768|P3|STARTED|Overall Study||51
1478476|NCT01855945|3617769|P2|STARTED|Overall Study||55
1478477|NCT01855945|3617770|P1|STARTED|Overall Study||54
1478478|NCT01855919|3617906|P2|NOT COMPLETED|Overall Study||26
1478479|NCT01855919|3617907|P1|NOT COMPLETED|Overall Study||23
1478480|NCT01855919|3617906|P2|COMPLETED|Overall Study||200
1478481|NCT01855919|3617907|P1|COMPLETED|Overall Study||209
1478482|NCT01855919|3617906|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
1478483|NCT01855919|3617907|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
1478484|NCT01855919|3617906|P2|STARTED|Overall Study||226
1478485|NCT01855919|3617907|P1|STARTED|Overall Study||232
1478486|NCT01855789|3617939|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
1478487|NCT01855789|3617940|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
1478488|NCT01855789|3617941|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
1478489|NCT01855789|3617942|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
1478490|NCT01855789|3617939|P4|COMPLETED|2) Week 24 up to End of Study||250
1478491|NCT01855789|3617940|P3|COMPLETED|2) Week 24 up to End of Study||129
1478492|NCT01855789|3617941|P2|COMPLETED|2) Week 24 up to End of Study||132
1478493|NCT01855789|3617942|P1|COMPLETED|2) Week 24 up to End of Study||0
1478494|NCT01855789|3617939|P4|STARTED|2) Week 24 up to End of Study||308
1478495|NCT01855789|3617940|P3|STARTED|2) Week 24 up to End of Study||147
1478496|NCT01855789|3617941|P2|STARTED|2) Week 24 up to End of Study||147
1478497|NCT01855789|3617942|P1|STARTED|2) Week 24 up to End of Study||0
1478498|NCT01855789|3617939|P4|NOT COMPLETED|1) Baseline up to Week 24||0
1478499|NCT01855789|3617940|P3|NOT COMPLETED|1) Baseline up to Week 24||0
1478500|NCT01855789|3617941|P2|NOT COMPLETED|1) Baseline up to Week 24||0
1478501|NCT01855789|3617942|P1|NOT COMPLETED|1) Baseline up to Week 24||116
1478502|NCT01855789|3617939|P4|COMPLETED|1) Baseline up to Week 24||0
1478503|NCT01855789|3617940|P3|COMPLETED|1) Baseline up to Week 24||0
1478504|NCT01855789|3617941|P2|COMPLETED|1) Baseline up to Week 24||0
1478505|NCT01855789|3617942|P1|COMPLETED|1) Baseline up to Week 24||602
1478506|NCT01855789|3617939|P4|STARTED|1) Baseline up to Week 24||0
1478507|NCT01855789|3617940|P3|STARTED|1) Baseline up to Week 24||0
1478508|NCT01855789|3617941|P2|STARTED|1) Baseline up to Week 24||0
1478509|NCT01855789|3617942|P1|STARTED|1) Baseline up to Week 24||718
1478510|NCT01855425|3617964|P1|NOT COMPLETED|Overall Study||20
1478511|NCT01855425|3617964|P1|COMPLETED|Overall Study||76
1478512|NCT01855425|3617964|P1|STARTED|Overall Study||96
1478513|NCT01855074|3617968|P1|NOT COMPLETED|Overall Study||14
1478514|NCT01855074|3617968|P1|COMPLETED|Overall Study||66
1478515|NCT01855074|3617968|P1|Treated|Overall Study||79
1478516|NCT01855074|3617968|P1|STARTED|Overall Study||80
1478517|NCT01854944|3617980|P3|NOT COMPLETED|Overall Study||1
1478518|NCT01854944|3617981|P2|NOT COMPLETED|Overall Study||0
1478519|NCT01854944|3617982|P1|NOT COMPLETED|Overall Study||0
1478520|NCT01854944|3617980|P3|COMPLETED|Overall Study||3
1478521|NCT01854944|3617981|P2|COMPLETED|Overall Study||4
1478522|NCT01854944|3617982|P1|COMPLETED|Overall Study||4
1478523|NCT01854944|3617980|P3|STARTED|Overall Study||4
1478524|NCT01854944|3617981|P2|STARTED|Overall Study||4
1478525|NCT01854944|3617982|P1|STARTED|Overall Study||4
1478526|NCT01854905|3618032|P1|NOT COMPLETED|Overall Study||0
1478527|NCT01854905|3618032|P1|COMPLETED|Overall Study||400
1478528|NCT01854905|3618032|P1|STARTED|Overall Study||400
1478529|NCT01854827|3618036|P1|NOT COMPLETED|Overall Study||1
1478530|NCT01854827|3618036|P1|COMPLETED|Overall Study||29
1478531|NCT01854827|3618036|P1|STARTED|Overall Study||30
1478532|NCT01854710|3618048|P6|NOT COMPLETED|Overall Study||2
1478533|NCT01854710|3618049|P5|NOT COMPLETED|Overall Study||2
1478534|NCT01854710|3618050|P4|NOT COMPLETED|Overall Study||2
1478535|NCT01854710|3618051|P3|NOT COMPLETED|Overall Study||2
1478536|NCT01854710|3618052|P2|NOT COMPLETED|Overall Study||3
1478537|NCT01854710|3618053|P1|NOT COMPLETED|Overall Study||4
1478538|NCT01854710|3618048|P6|COMPLETED|Overall Study||8
1478539|NCT01854710|3618049|P5|COMPLETED|Overall Study||8
1478540|NCT01854710|3618050|P4|COMPLETED|Overall Study||8
1478541|NCT01854710|3618051|P3|COMPLETED|Overall Study||8
1478542|NCT01854710|3618052|P2|COMPLETED|Overall Study||7
1478543|NCT01854710|3618053|P1|COMPLETED|Overall Study||6
1478544|NCT01854710|3618048|P6|STARTED|Overall Study||10
1478545|NCT01854710|3618049|P5|STARTED|Overall Study||10
1478546|NCT01854710|3618050|P4|STARTED|Overall Study||10
1478547|NCT01854710|3618051|P3|STARTED|Overall Study||10
1478548|NCT01854710|3618052|P2|STARTED|Overall Study||10
1478549|NCT01854710|3618053|P1|STARTED|Overall Study||10
1478550|NCT01854697|3618074|P5|NOT COMPLETED|Overall Study||2
1478551|NCT01854697|3618075|P4|NOT COMPLETED|Overall Study||3
1478552|NCT01854697|3618076|P3|NOT COMPLETED|Overall Study||2
1478553|NCT01854697|3618077|P2|NOT COMPLETED|Overall Study||3
1478554|NCT01854697|3618078|P1|NOT COMPLETED|Overall Study||6
1478555|NCT01854697|3618074|P5|COMPLETED|Overall Study||39
1478556|NCT01854697|3618075|P4|COMPLETED|Overall Study||80
1478557|NCT01854697|3618076|P3|COMPLETED|Overall Study||82
1478558|NCT01854697|3618077|P2|COMPLETED|Overall Study||31
1478559|NCT01854697|3618078|P1|COMPLETED|Overall Study||63
1478560|NCT01854697|3618074|P5|STARTED|Overall Study||41
1478561|NCT01854697|3618075|P4|STARTED|Overall Study||83
1478562|NCT01854697|3618076|P3|STARTED|Overall Study||84
1478563|NCT01854697|3618077|P2|STARTED|Overall Study||34
1478564|NCT01854697|3618078|P1|STARTED|Overall Study||69
1478565|NCT01854658|3618122|P4|NOT COMPLETED|Overall Study||59
1478566|NCT01854658|3618123|P3|NOT COMPLETED|Overall Study||80
1478567|NCT01854658|3618124|P2|NOT COMPLETED|Overall Study||75
1478568|NCT01854658|3618125|P1|NOT COMPLETED|Overall Study||93
1478569|NCT01854658|3618122|P4|COMPLETED|Overall Study||165
1478570|NCT01854658|3618123|P3|COMPLETED|Overall Study||432
1478571|NCT01854658|3618124|P2|COMPLETED|Overall Study||365
1478572|NCT01854658|3618125|P1|COMPLETED|Overall Study||346
1478573|NCT01854658|3618122|P4|STARTED|Overall Study||224
1478574|NCT01854658|3618123|P3|STARTED|Overall Study||512
1478575|NCT01854658|3618124|P2|STARTED|Overall Study||440
1478576|NCT01854658|3618125|P1|STARTED|Overall Study||439
1478577|NCT01854645|3618160|P5|NOT COMPLETED|Overall Study||60
1478578|NCT01854645|3618161|P4|NOT COMPLETED|Overall Study||62
1478579|NCT01854645|3618162|P3|NOT COMPLETED|Overall Study||82
1478580|NCT01854645|3618163|P2|NOT COMPLETED|Overall Study||106
1478581|NCT01854645|3618164|P1|NOT COMPLETED|Overall Study||98
1478582|NCT01854645|3618160|P5|COMPLETED|Overall Study||160
1478583|NCT01854645|3618161|P4|COMPLETED|Overall Study||391
1478584|NCT01854645|3618162|P3|COMPLETED|Overall Study||370
1478585|NCT01854645|3618163|P2|COMPLETED|Overall Study||345
1478586|NCT01854645|3618164|P1|COMPLETED|Overall Study||429
1478587|NCT01854645|3618160|P5|STARTED|Overall Study||220
1478588|NCT01854645|3618161|P4|STARTED|Overall Study||453
1478589|NCT01854645|3618162|P3|STARTED|Overall Study||452
1478590|NCT01854645|3618163|P2|STARTED|Overall Study||451
1478591|NCT01854645|3618164|P1|STARTED|Overall Study||527
1478592|NCT01854632|3618203|P2|NOT COMPLETED|Overall Study||13
1478593|NCT01854632|3618204|P1|NOT COMPLETED|Overall Study||26
1478594|NCT01854632|3618203|P2|COMPLETED|Overall Study||574
1478595|NCT01854632|3618204|P1|COMPLETED|Overall Study||1148
1478596|NCT01854632|3618203|P2|STARTED|Overall Study||587
1478597|NCT01854632|3618204|P1|STARTED|Overall Study||1174
1478598|NCT01854593|3618212|P2|NOT COMPLETED|Overall Study||1
1478599|NCT01854593|3618213|P1|NOT COMPLETED|Overall Study||2
1478600|NCT01854593|3618212|P2|COMPLETED|Overall Study||34
1478601|NCT01854593|3618213|P1|COMPLETED|Overall Study||32
1478602|NCT01854593|3618212|P2|STARTED|Overall Study||35
1478603|NCT01854593|3618213|P1|STARTED|Overall Study||34
1478604|NCT01854528|3618245|P2|NOT COMPLETED|Overall Study||15
1478605|NCT01854528|3618246|P1|NOT COMPLETED|Overall Study||0
1478606|NCT01854528|3618245|P2|COMPLETED|Overall Study||32
1478607|NCT01854528|3618246|P1|COMPLETED|Overall Study||101
1478608|NCT01854528|3618245|P2|STARTED|Overall Study||47
1478609|NCT01854528|3618246|P1|STARTED|Overall Study||101
1478610|NCT01854281|3618266|P4|NOT COMPLETED|Overall Study||0
1478611|NCT01854281|3618267|P3|NOT COMPLETED|Overall Study||0
1478612|NCT01854281|3618268|P2|NOT COMPLETED|Overall Study||0
1478613|NCT01854281|3618269|P1|NOT COMPLETED|Overall Study||0
1478614|NCT01854281|3618266|P4|COMPLETED|Overall Study||8
1478615|NCT01854281|3618267|P3|COMPLETED|Overall Study||5
1478616|NCT01854281|3618268|P2|COMPLETED|Overall Study||19
1478617|NCT01854281|3618269|P1|COMPLETED|Overall Study||15
1478618|NCT01854281|3618266|P4|STARTED|Overall Study||8
1478619|NCT01854281|3618267|P3|STARTED|Overall Study||5
1478620|NCT01854281|3618268|P2|STARTED|Overall Study||19
1478621|NCT01854281|3618269|P1|STARTED|Overall Study||15
1478622|NCT01854268|3618279|P1|NOT COMPLETED|Overall Study||0
1478623|NCT01854268|3618279|P1|COMPLETED|Overall Study||25
1478624|NCT01854268|3618279|P1|STARTED|Overall Study||25
1478625|NCT01854242|3618285|P1|NOT COMPLETED|Overall Study||0
1478626|NCT01854242|3618285|P1|COMPLETED|Overall Study||50
1478627|NCT01854242|3618285|P1|STARTED|Overall Study||50
1478628|NCT01854177|3618289|P1|NOT COMPLETED|Overall Study||0
1478629|NCT01854177|3618289|P1|COMPLETED|Overall Study||10
1478630|NCT01854177|3618289|P1|STARTED|Overall Study||10
1478631|NCT01854138|3618299|P2|NOT COMPLETED|Overall Study||52
1478632|NCT01854138|3618300|P1|NOT COMPLETED|Overall Study||0
1478633|NCT01854138|3618299|P2|COMPLETED|Overall Study||196
1478634|NCT01854138|3618300|P1|COMPLETED|Overall Study||400
1478635|NCT01854138|3618299|P2|STARTED|Overall Study||248
1478636|NCT01854138|3618300|P1|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
1478637|NCT01854047|3618317|P5|NOT COMPLETED|Overall Study||19
1478638|NCT01854047|3618318|P4|NOT COMPLETED|Overall Study||15
1478639|NCT01854047|3618319|P3|NOT COMPLETED|Overall Study||13
1478640|NCT01854047|3618320|P2|NOT COMPLETED|Overall Study||8
1478641|NCT01854047|3618321|P1|NOT COMPLETED|Overall Study||12
1478642|NCT01854047|3618317|P5|COMPLETED|Overall Study||135
1478643|NCT01854047|3618318|P4|COMPLETED|Overall Study||142
1478644|NCT01854047|3618319|P3|COMPLETED|Overall Study||137
1478645|NCT01854047|3618320|P2|COMPLETED|Overall Study||149
1478646|NCT01854047|3618321|P1|COMPLETED|Overall Study||146
1478647|NCT01854047|3618317|P5|Completed 12-week Study Treatment|Overall Study||143
1478648|NCT01854047|3618318|P4|Completed 12-week Study Treatment|Overall Study||146
1478649|NCT01854047|3618319|P3|Completed 12-week Study Treatment|Overall Study||141
1478650|NCT01854047|3618320|P2|Completed 12-week Study Treatment|Overall Study||149
1478651|NCT01854047|3618321|P1|Completed 12-week Study Treatment|Overall Study||153
1478652|NCT01854047|3618317|P5|Treated|Overall Study||150
1478653|NCT01854047|3618318|P4|Treated|Overall Study||157
1478654|NCT01854047|3618319|P3|Treated|Overall Study||148
1478655|NCT01854047|3618320|P2|Treated|Overall Study||156
1478656|NCT01854047|3618321|P1|Treated|Overall Study||158
1478657|NCT01854047|3618317|P5|STARTED|Overall Study||154
1478658|NCT01854047|3618318|P4|STARTED|Overall Study||157
1478659|NCT01854047|3618319|P3|STARTED|Overall Study||150
1478660|NCT01854047|3618320|P2|STARTED|Overall Study||157
1478661|NCT01854047|3618321|P1|STARTED|Overall Study||158
1478662|NCT01854034|3618443|P1|NOT COMPLETED|Overall Study||0
1478663|NCT01854034|3618443|P1|COMPLETED|Overall Study||29
1478664|NCT01854034|3618443|P1|STARTED|Overall Study||29
1478665|NCT01853982|3618452|P2|NOT COMPLETED|Overall Study||1
1478666|NCT01853982|3618453|P1|NOT COMPLETED|Overall Study||2
1478667|NCT01853982|3618452|P2|COMPLETED|Overall Study||1
1478668|NCT01853982|3618453|P1|COMPLETED|Overall Study||0
1478669|NCT01853982|3618452|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
1478670|NCT01853982|3618453|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
1478671|NCT01853982|3618452|P2|STARTED|Overall Study||2
1478672|NCT01853982|3618453|P1|STARTED|Overall Study||2
1478673|NCT01853839|3618459|P1|NOT COMPLETED|Overall Study||429
1478674|NCT01853839|3618459|P1|COMPLETED|Overall Study||1663
1478675|NCT01853839|3618459|P1|STARTED|Overall Study||2092
1478676|NCT01853696|3618481|P2|NOT COMPLETED|Overall Study||5
1478677|NCT01853696|3618482|P1|NOT COMPLETED|Overall Study||6
1478678|NCT01853696|3618481|P2|COMPLETED|Overall Study||78
1478679|NCT01853696|3618482|P1|COMPLETED|Overall Study||78
1478680|NCT01853696|3618481|P2|STARTED|Overall Study||83
1478681|NCT01853696|3618482|P1|STARTED|Overall Study||84
1478682|NCT01853605|3618494|P4|NOT COMPLETED|Overall Study||0
1478683|NCT01853605|3618495|P3|NOT COMPLETED|Overall Study||0
1478684|NCT01853605|3618496|P2|NOT COMPLETED|Overall Study||0
1478685|NCT01853605|3618497|P1|NOT COMPLETED|Overall Study||0
1478686|NCT01853605|3618494|P4|COMPLETED|Overall Study||428
1478687|NCT01853605|3618495|P3|COMPLETED|Overall Study||751
1478688|NCT01853605|3618496|P2|COMPLETED|Overall Study||693
1478689|NCT01853605|3618497|P1|COMPLETED|Overall Study||1939
1478690|NCT01853605|3618494|P4|STARTED|Overall Study||428
1478691|NCT01853605|3618495|P3|STARTED|Overall Study||751
1478692|NCT01853605|3618496|P2|STARTED|Overall Study||693
1478693|NCT01853605|3618497|P1|STARTED|Overall Study||1939
1478694|NCT01853475|3618518|P3|NOT COMPLETED|Overall Study||0
1478695|NCT01853475|3618519|P2|NOT COMPLETED|Overall Study||1
1478696|NCT01853475|3618520|P1|NOT COMPLETED|Overall Study||0
1478697|NCT01853475|3618518|P3|COMPLETED|Overall Study||8
1478698|NCT01853475|3618519|P2|COMPLETED|Overall Study||7
1478699|NCT01853475|3618520|P1|COMPLETED|Overall Study||8
1478700|NCT01853475|3618518|P3|STARTED|Overall Study||8
1478701|NCT01853475|3618519|P2|STARTED|Overall Study||8
1478702|NCT01853475|3618520|P1|STARTED|Overall Study||8
1478703|NCT01853462|3618539|P2|NOT COMPLETED|Overall Study||1
1478704|NCT01853462|3618540|P1|NOT COMPLETED|Overall Study||1
1478705|NCT01853462|3618539|P2|COMPLETED|Overall Study||10
1478706|NCT01853462|3618540|P1|COMPLETED|Overall Study||10
1478707|NCT01853462|3618539|P2|STARTED|Overall Study||11
1478708|NCT01853462|3618540|P1|STARTED|Overall Study||11
1478709|NCT01853397|3618610|P4|NOT COMPLETED|Overall Study||2
1478710|NCT01853397|3618611|P3|NOT COMPLETED|Overall Study||0
1478711|NCT01853397|3618612|P2|NOT COMPLETED|Overall Study||0
1478712|NCT01853397|3618613|P1|NOT COMPLETED|Overall Study||0
1478713|NCT01853397|3618610|P4|COMPLETED|Overall Study||15
1478714|NCT01853397|3618611|P3|COMPLETED|Overall Study||17
1478715|NCT01853397|3618612|P2|COMPLETED|Overall Study||20
1478716|NCT01853397|3618613|P1|COMPLETED|Overall Study||18
1478717|NCT01853397|3618610|P4|STARTED|Overall Study||17
1478718|NCT01853397|3618611|P3|STARTED|Overall Study||17
1478719|NCT01853397|3618612|P2|STARTED|Overall Study||20
1478720|NCT01853397|3618613|P1|STARTED|Overall Study||18
1478721|NCT01853384|3618641|P2|NOT COMPLETED|Completed Follow up Visit 2||3
1478722|NCT01853384|3618642|P1|NOT COMPLETED|Completed Follow up Visit 2||3
1478723|NCT01853384|3618641|P2|COMPLETED|Completed Follow up Visit 2||91
1478724|NCT01853384|3618642|P1|COMPLETED|Completed Follow up Visit 2||93
1478725|NCT01853384|3618641|P2|STARTED|Completed Follow up Visit 2||94
1478726|NCT01853384|3618642|P1|STARTED|Completed Follow up Visit 2||96
1478727|NCT01853384|3618641|P2|NOT COMPLETED|Completed Follow up Visit 1||9
1478728|NCT01853384|3618642|P1|NOT COMPLETED|Completed Follow up Visit 1||14
1478729|NCT01853384|3618641|P2|COMPLETED|Completed Follow up Visit 1||85
1478730|NCT01853384|3618642|P1|COMPLETED|Completed Follow up Visit 1||82
1478731|NCT01853384|3618641|P2|STARTED|Completed Follow up Visit 1||94
1478732|NCT01853384|3618642|P1|STARTED|Completed Follow up Visit 1||96
1478733|NCT01853384|3618641|P2|NOT COMPLETED|Enrolled in Follow up Period||0
1478734|NCT01853384|3618642|P1|NOT COMPLETED|Enrolled in Follow up Period||0
1478735|NCT01853384|3618641|P2|COMPLETED|Enrolled in Follow up Period||94
1478736|NCT01853384|3618642|P1|COMPLETED|Enrolled in Follow up Period||96
1478737|NCT01853384|3618641|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
1478738|NCT01853384|3618642|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
1478739|NCT01853384|3618641|P2|STARTED|Enrolled in Follow up Period||94
1478740|NCT01853384|3618642|P1|STARTED|Enrolled in Follow up Period||96
1478741|NCT01853384|3618641|P2|NOT COMPLETED|Randomized||46
1478742|NCT01853384|3618642|P1|NOT COMPLETED|Randomized||62
1478743|NCT01853384|3618641|P2|COMPLETED|Randomized||75
1478744|NCT01853384|3618642|P1|COMPLETED|Randomized||69
1478745|NCT01853384|3618641|P2|STARTED|Randomized||121
1478746|NCT01853384|3618642|P1|STARTED|Randomized||131
1478747|NCT01853371|3618662|P2|NOT COMPLETED|Overall Study||2
1478748|NCT01853371|3618663|P1|NOT COMPLETED|Overall Study||0
1478749|NCT01853371|3618662|P2|COMPLETED|Overall Study||8
1478750|NCT01853371|3618663|P1|COMPLETED|Overall Study||10
1478751|NCT01853371|3618662|P2|STARTED|Overall Study||10
1478752|NCT01853371|3618663|P1|STARTED|Overall Study||10
1478753|NCT01853332|3618671|P1|NOT COMPLETED|Overall Study||59
1478754|NCT01853332|3618671|P1|COMPLETED|Overall Study||151
1478755|NCT01853332|3618671|P1|STARTED|Overall Study||210
1478756|NCT01853280|3618682|P2|NOT COMPLETED|Overall Study||6
1478757|NCT01853280|3618683|P1|NOT COMPLETED|Overall Study||2
1478758|NCT01853280|3618682|P2|COMPLETED|Overall Study||16
1478759|NCT01853280|3618683|P1|COMPLETED|Overall Study||20
1478760|NCT01853280|3618682|P2|STARTED|Overall Study||22
1478761|NCT01853280|3618683|P1|STARTED|Overall Study||22
1478762|NCT01853254|3618689|P1|NOT COMPLETED|Overall Study||104
1478763|NCT01853254|3618689|P1|COMPLETED|Overall Study||168
1478764|NCT01853254|3618689|P1|STARTED|Overall Study||272
1478765|NCT01853215|3618693|P1|NOT COMPLETED|Overall Study||0
1478766|NCT01853215|3618693|P1|COMPLETED|Overall Study||24
1478767|NCT01853215|3618693|P1|STARTED|Overall Study||24
1478768|NCT01853176|3618706|P2|NOT COMPLETED|Overall Study||0
1478769|NCT01853176|3618707|P1|NOT COMPLETED|Overall Study||4
1478770|NCT01853176|3618706|P2|COMPLETED|Overall Study||0
1478771|NCT01853176|3618707|P1|COMPLETED|Overall Study||0
1478772|NCT01853176|3618706|P2|STARTED|Overall Study||0
1478773|NCT01853176|3618707|P1|STARTED|Overall Study||4
1478774|NCT01853085|3618713|P1|NOT COMPLETED|Overall Study||235
1478775|NCT01853085|3618713|P1|COMPLETED|Overall Study||1595
1478776|NCT01853085|3618713|P1|STARTED|Overall Study||1830
1478777|NCT01853072|3618726|P2|NOT COMPLETED|Overall Study||21
1478778|NCT01853072|3618727|P1|NOT COMPLETED|Overall Study||12
1478779|NCT01853072|3618726|P2|COMPLETED|Overall Study||286
1478780|NCT01853072|3618727|P1|COMPLETED|Overall Study||296
1478781|NCT01853072|3618726|P2|Full Analysis Set|Overall Study||300
1478782|NCT01853072|3618727|P1|Full Analysis Set|Overall Study||298
1478783|NCT01853072|3618726|P2|Treated (Safety Analysis Set)|Overall Study||302
1478784|NCT01853072|3618727|P1|Treated (Safety Analysis Set)|Overall Study||301
1478785|NCT01853072|3618726|P2|Randomized|Overall Study||307
1478786|NCT01853072|3618727|P1|Randomized|Overall Study||308
1478787|NCT01853072|3618726|P2|STARTED|Overall Study||307
1478788|NCT01853072|3618727|P1|STARTED|Overall Study||308
1478789|NCT01853046|3618747|P2|NOT COMPLETED|Overall Study||6
1478790|NCT01853046|3618748|P1|NOT COMPLETED|Overall Study||18
1478791|NCT01853046|3618747|P2|COMPLETED|Overall Study||0
1478792|NCT01853046|3618748|P1|COMPLETED|Overall Study||0
1478793|NCT01853046|3618747|P2|Received Treatment|Overall Study||6
1478794|NCT01853046|3618748|P1|Received Treatment|Overall Study||18
1478795|NCT01853046|3618747|P2|STARTED|Overall Study||6
1478796|NCT01853046|3618748|P1|STARTED|Overall Study||18
1478797|NCT01852955|3618802|P2|NOT COMPLETED|Overall Study||3
1478798|NCT01852955|3618803|P1|NOT COMPLETED|Overall Study||2
1478799|NCT01852955|3618802|P2|COMPLETED|Overall Study||32
1478800|NCT01852955|3618803|P1|COMPLETED|Overall Study||33
1478801|NCT01852955|3618802|P2|STARTED|Overall Study||35
1478802|NCT01852955|3618803|P1|STARTED|Overall Study||35
1478803|NCT01852825|3618816|P3|NOT COMPLETED|Overall Study||0
1478804|NCT01852825|3618817|P2|NOT COMPLETED|Overall Study||0
1478805|NCT01852825|3618818|P1|NOT COMPLETED|Overall Study||2
1478806|NCT01852825|3618816|P3|COMPLETED|Overall Study||3
1478807|NCT01852825|3618817|P2|COMPLETED|Overall Study||7
1478808|NCT01852825|3618818|P1|COMPLETED|Overall Study||14
1478809|NCT01852825|3618816|P3|STARTED|Overall Study||3
1478810|NCT01852825|3618817|P2|STARTED|Overall Study||7
1478811|NCT01852825|3618818|P1|STARTED|Overall Study||16
1478812|NCT01852812|3618844|P3|NOT COMPLETED|Overall Study||1
1478813|NCT01852812|3618845|P2|NOT COMPLETED|Overall Study||1
1478814|NCT01852812|3618846|P1|NOT COMPLETED|Overall Study||0
1478815|NCT01852812|3618844|P3|COMPLETED|Overall Study||17
1478816|NCT01852812|3618845|P2|COMPLETED|Overall Study||17
1478817|NCT01852812|3618846|P1|COMPLETED|Overall Study||51
1478818|NCT01852812|3618844|P3|STARTED|Overall Study||18
1478819|NCT01852812|3618845|P2|STARTED|Overall Study||18
1478820|NCT01852812|3618846|P1|STARTED|Overall Study||51
1478821|NCT01852799|3618866|P1|NOT COMPLETED|Overall Study||18
1478822|NCT01852799|3618866|P1|COMPLETED|Overall Study||0
1478823|NCT01852799|3618866|P1|STARTED|Overall Study||18
1478824|NCT01852669|3618877|P2|NOT COMPLETED|Overall Study||1
1478825|NCT01852669|3618878|P1|NOT COMPLETED|Overall Study||0
1478826|NCT01852669|3618877|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
1478827|NCT01852669|3618878|P1|COMPLETED|Overall Study||71
1478828|NCT01852669|3618877|P2|STARTED|Overall Study||69
1478829|NCT01852669|3618878|P1|STARTED|Overall Study||71
1478830|NCT01852591|3618884|P1|NOT COMPLETED|Overall Study||3
1478831|NCT01852591|3618884|P1|COMPLETED|Overall Study||5
1478832|NCT01852591|3618884|P1|STARTED|Overall Study||8
1478833|NCT01852383|3618891|P1|NOT COMPLETED|Overall Study||11
1478834|NCT01852383|3618891|P1|COMPLETED|Overall Study||19
1478835|NCT01852383|3618891|P1|STARTED|Overall Study||30
1478836|NCT01852344|3618902|P4|NOT COMPLETED|Overall Study||0
1478837|NCT01852344|3618903|P3|NOT COMPLETED|Overall Study||0
1478838|NCT01852344|3618904|P2|NOT COMPLETED|Overall Study||0
1478839|NCT01852344|3618905|P1|NOT COMPLETED|Overall Study||0
1478840|NCT01852344|3618902|P4|COMPLETED|Overall Study||27
1478841|NCT01852344|3618903|P3|COMPLETED|Overall Study||27
1478842|NCT01852344|3618904|P2|COMPLETED|Overall Study||27
1478843|NCT01852344|3618905|P1|COMPLETED|Overall Study||27
1478844|NCT01852344|3618902|P4|Actual Participation in First Assignment|Overall Study||27
1478845|NCT01852344|3618903|P3|Actual Participation in First Assignment|Overall Study||27
1478846|NCT01852344|3618904|P2|Actual Participation in First Assignment|Overall Study||27
1478847|NCT01852344|3618905|P1|Actual Participation in First Assignment|Overall Study||27
1478848|NCT01852344|3618902|P4|STARTED|Overall Study||27
1478849|NCT01852344|3618903|P3|STARTED|Overall Study||27
1478850|NCT01852344|3618904|P2|STARTED|Overall Study||27
1478851|NCT01852344|3618905|P1|STARTED|Overall Study||27
1478852|NCT01852292|3618925|P2|NOT COMPLETED|Overall Study||79
1478853|NCT01852292|3618926|P1|NOT COMPLETED|Overall Study||79
1478854|NCT01852292|3618925|P2|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
1478855|NCT01852292|3618926|P1|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
1478856|NCT01852292|3618925|P2|STARTED|Overall Study||79
1478857|NCT01852292|3618926|P1|STARTED|Overall Study||79
1478858|NCT01852214|3618950|P2|NOT COMPLETED|Period 2||0
1478859|NCT01852214|3618951|P1|NOT COMPLETED|Period 2||0
1478860|NCT01852214|3618950|P2|COMPLETED|Period 2||20
1478861|NCT01852214|3618951|P1|COMPLETED|Period 2||25
1478862|NCT01852214|3618950|P2|STARTED|Period 2||20
1478863|NCT01852214|3618951|P1|STARTED|Period 2||25
1478864|NCT01852214|3618950|P2|NOT COMPLETED|Washout Period||1
1478865|NCT01852214|3618951|P1|NOT COMPLETED|Washout Period||0
1478866|NCT01852214|3618950|P2|COMPLETED|Washout Period||20
1478867|NCT01852214|3618951|P1|COMPLETED|Washout Period||25
1478868|NCT01852214|3618950|P2|STARTED|Washout Period||21
1478869|NCT01852214|3618951|P1|STARTED|Washout Period||25
1478870|NCT01852214|3618950|P2|NOT COMPLETED|Period 1||3
1478871|NCT01852214|3618951|P1|NOT COMPLETED|Period 1||1
1478872|NCT01852214|3618950|P2|COMPLETED|Period 1||21
1478873|NCT01852214|3618951|P1|COMPLETED|Period 1||25
1478874|NCT01852214|3618950|P2|STARTED|Period 1||24
1478875|NCT01852214|3618951|P1|STARTED|Period 1||26
1478876|NCT01852175|3618965|P2|NOT COMPLETED|Overall Study||0
1478877|NCT01852175|3618966|P1|NOT COMPLETED|Overall Study||0
1478878|NCT01852175|3618965|P2|COMPLETED|Overall Study||55
1478879|NCT01852175|3618966|P1|COMPLETED|Overall Study||55
1478880|NCT01852175|3618965|P2|STARTED|Overall Study||55
1478881|NCT01852175|3618966|P1|STARTED|Overall Study||55
1478882|NCT01852162|3618978|P2|NOT COMPLETED|Overall Study||1
1478883|NCT01852162|3618979|P1|NOT COMPLETED|Overall Study||4
1478884|NCT01852162|3618978|P2|COMPLETED|Overall Study||16
1478885|NCT01852162|3618979|P1|COMPLETED|Overall Study||14
1478886|NCT01852162|3618978|P2|STARTED|Overall Study||17
1478887|NCT01852162|3618979|P1|STARTED|Overall Study||18
1478888|NCT01852110|3618995|P6|NOT COMPLETED|Overall Study||0
1478889|NCT01852110|3618996|P5|NOT COMPLETED|Overall Study||0
1478890|NCT01852110|3618997|P4|NOT COMPLETED|Overall Study||0
1478891|NCT01852110|3618998|P3|NOT COMPLETED|Overall Study||0
1478892|NCT01852110|3618999|P2|NOT COMPLETED|Overall Study||46
1478893|NCT01852110|3619000|P1|NOT COMPLETED|Overall Study||50
1478894|NCT01852110|3618995|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1478895|NCT01852110|3618996|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1478896|NCT01852110|3618997|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1478897|NCT01852110|3618998|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1478898|NCT01852110|3618999|P2|COMPLETED|Overall Study||74
1478899|NCT01852110|3619000|P1|COMPLETED|Overall Study||70
1478900|NCT01852110|3618995|P6|Treated|Overall Study||0
1478901|NCT01852110|3618996|P5|Treated|Overall Study||0
1478902|NCT01852110|3618997|P4|Treated|Overall Study||0
1478903|NCT01852110|3618998|P3|Treated|Overall Study||0
1478904|NCT01852110|3618999|P2|Treated|Overall Study||120
1478905|NCT01852110|3619000|P1|Treated|Overall Study||119
1478906|NCT01852110|3618995|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1478907|NCT01852110|3618996|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1478908|NCT01852110|3618997|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1478909|NCT01852110|3618998|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
1478910|NCT01852110|3618999|P2|STARTED|Overall Study||120
1478911|NCT01852110|3619000|P1|STARTED|Overall Study||120
1478912|NCT01852032|3619028|P1|NOT COMPLETED|Overall Study||0
1478913|NCT01852032|3619028|P1|COMPLETED|Overall Study||23
1478914|NCT01852032|3619028|P1|STARTED|Overall Study||23
1478915|NCT01852019|3619038|P5|NOT COMPLETED|Day 8||0
1478916|NCT01852019|3619039|P4|NOT COMPLETED|Day 8||0
1478917|NCT01852019|3619040|P3|NOT COMPLETED|Day 8||0
1478918|NCT01852019|3619041|P2|NOT COMPLETED|Day 8||0
1478919|NCT01852019|3619042|P1|NOT COMPLETED|Day 8||0
1478920|NCT01852019|3619038|P5|COMPLETED|Day 8||6
1478921|NCT01852019|3619039|P4|COMPLETED|Day 8||6
1478922|NCT01852019|3619040|P3|COMPLETED|Day 8||0
1478923|NCT01852019|3619041|P2|COMPLETED|Day 8||0
1478924|NCT01852019|3619042|P1|COMPLETED|Day 8||0
1478925|NCT01852019|3619038|P5|STARTED|Day 8||6
1478926|NCT01852019|3619039|P4|STARTED|Day 8||6
1478927|NCT01852019|3619040|P3|STARTED|Day 8||0
1478928|NCT01852019|3619041|P2|STARTED|Day 8||0
1478929|NCT01852019|3619042|P1|STARTED|Day 8||0
1478930|NCT01852019|3619038|P5|NOT COMPLETED|Day 1||0
1478931|NCT01852019|3619039|P4|NOT COMPLETED|Day 1||0
1478932|NCT01852019|3619040|P3|NOT COMPLETED|Day 1||0
1478933|NCT01852019|3619041|P2|NOT COMPLETED|Day 1||0
1478934|NCT01852019|3619042|P1|NOT COMPLETED|Day 1||0
1478935|NCT01852019|3619038|P5|COMPLETED|Day 1||0
1478936|NCT01852019|3619039|P4|COMPLETED|Day 1||0
1478937|NCT01852019|3619040|P3|COMPLETED|Day 1||6
1478938|NCT01852019|3619041|P2|COMPLETED|Day 1||3
1478939|NCT01852019|3619042|P1|COMPLETED|Day 1||3
1478940|NCT01852019|3619038|P5|STARTED|Day 1||0
1478941|NCT01852019|3619039|P4|STARTED|Day 1||0
1478942|NCT01852019|3619040|P3|STARTED|Day 1||6
1478943|NCT01852019|3619041|P2|STARTED|Day 1||3
1478944|NCT01852019|3619042|P1|STARTED|Day 1||3
1478945|NCT01851876|3619063|P2|NOT COMPLETED|Overall Study||0
1478946|NCT01851876|3619064|P1|NOT COMPLETED|Overall Study||0
1478947|NCT01851876|3619063|P2|COMPLETED|Overall Study||62
1478948|NCT01851876|3619064|P1|COMPLETED|Overall Study||56
1478949|NCT01851876|3619063|P2|STARTED|Overall Study||62
1478950|NCT01851876|3619064|P1|STARTED|Overall Study||56
1478951|NCT01851863|3619074|P4|NOT COMPLETED|Overall Study||3
1478952|NCT01851863|3619075|P3|NOT COMPLETED|Overall Study||5
1478953|NCT01851863|3619076|P2|NOT COMPLETED|Overall Study||9
1478954|NCT01851863|3619077|P1|NOT COMPLETED|Overall Study||5
1478955|NCT01851863|3619074|P4|COMPLETED|Overall Study||63
1478956|NCT01851863|3619075|P3|COMPLETED|Overall Study||60
1478957|NCT01851863|3619076|P2|COMPLETED|Overall Study||57
1478958|NCT01851863|3619077|P1|COMPLETED|Overall Study||60
1478959|NCT01851863|3619074|P4|STARTED|Overall Study||66
1478960|NCT01851863|3619075|P3|STARTED|Overall Study||65
1478961|NCT01851863|3619076|P2|STARTED|Overall Study||66
1478962|NCT01851863|3619077|P1|STARTED|Overall Study||65
1478963|NCT01851772|3619098|P1|NOT COMPLETED|Overall Study||0
1478964|NCT01851772|3619098|P1|COMPLETED|Overall Study||3
1478965|NCT01851772|3619098|P1|STARTED|Overall Study||3
1478966|NCT01851720|3619106|P2|NOT COMPLETED|Overall Study||1
1478967|NCT01851720|3619107|P1|NOT COMPLETED|Overall Study||0
1478968|NCT01851720|3619106|P2|COMPLETED|Overall Study||0
1478969|NCT01851720|3619107|P1|COMPLETED|Overall Study||0
1478970|NCT01851720|3619106|P2|STARTED|Overall Study||1
1478971|NCT01851720|3619107|P1|STARTED|Overall Study||0
1478972|NCT01851655|3619115|P2|NOT COMPLETED|Overall Study||0
1478973|NCT01851655|3619116|P1|NOT COMPLETED|Overall Study||0
1478974|NCT01851655|3619115|P2|COMPLETED|Overall Study||12
1478975|NCT01851655|3619116|P1|COMPLETED|Overall Study||12
1478976|NCT01851655|3619115|P2|STARTED|Overall Study||12
1478977|NCT01851655|3619116|P1|STARTED|Overall Study||12
1478978|NCT01851590|3619137|P3|NOT COMPLETED|Overall Study||3
1478979|NCT01851590|3619138|P2|NOT COMPLETED|Overall Study||1
1478980|NCT01851590|3619139|P1|NOT COMPLETED|Overall Study||0
1478981|NCT01851590|3619137|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
1478982|NCT01851590|3619138|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
1478983|NCT01851590|3619139|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
1478984|NCT01851590|3619137|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
1478985|NCT01851590|3619138|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
1478986|NCT01851590|3619139|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
1478987|NCT01851590|3619137|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
1478988|NCT01851590|3619138|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
1478989|NCT01851590|3619139|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
1478990|NCT01851590|3619137|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
1478991|NCT01851590|3619138|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
1478992|NCT01851590|3619139|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
1478993|NCT01851590|3619137|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
1478994|NCT01851590|3619138|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
1478995|NCT01851590|3619139|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
1478996|NCT01851590|3619137|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
1478997|NCT01851590|3619138|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
1478998|NCT01851590|3619139|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
1478999|NCT01851330|3619162|P3|NOT COMPLETED|Overall Study||12
1479000|NCT01851330|3619163|P2|NOT COMPLETED|Overall Study||16
1479001|NCT01851330|3619164|P1|NOT COMPLETED|Overall Study||13
1479002|NCT01851330|3619162|P3|COMPLETED|Overall Study||204
1479003|NCT01851330|3619163|P2|COMPLETED|Overall Study||200
1479004|NCT01851330|3619164|P1|COMPLETED|Overall Study||202
1479005|NCT01851330|3619162|P3|STARTED|Overall Study||216
1479006|NCT01851330|3619163|P2|STARTED|Overall Study||216
1479007|NCT01851330|3619164|P1|STARTED|Overall Study||215
1479008|NCT01851174|3619199|P1|NOT COMPLETED|Overall Study||0
1479009|NCT01851174|3619199|P1|COMPLETED|Overall Study||15
1479010|NCT01851174|3619199|P1|STARTED|Overall Study||15
1479011|NCT01850745|3619207|P3|NOT COMPLETED|Overall Study||0
1479012|NCT01850745|3619208|P2|NOT COMPLETED|Overall Study||0
1479013|NCT01850745|3619209|P1|NOT COMPLETED|Overall Study||0
1479014|NCT01850745|3619207|P3|COMPLETED|Overall Study||131
1479015|NCT01850745|3619208|P2|COMPLETED|Overall Study||169
1479016|NCT01850745|3619209|P1|COMPLETED|Overall Study||147
1479017|NCT01850745|3619207|P3|STARTED|Overall Study||131
1479018|NCT01850745|3619208|P2|STARTED|Overall Study||169
1479019|NCT01850745|3619209|P1|STARTED|Overall Study||147
1479020|NCT01850641|3619217|P1|NOT COMPLETED|Overall Study||5
1479021|NCT01850641|3619217|P1|COMPLETED|Overall Study||30
1479022|NCT01850641|3619217|P1|STARTED|Overall Study||35
1479023|NCT01850615|3619231|P2|NOT COMPLETED|Overall Study||5
1479024|NCT01850615|3619232|P1|NOT COMPLETED|Overall Study||9
1479025|NCT01850615|3619231|P2|COMPLETED|Overall Study||115
1479026|NCT01850615|3619232|P1|COMPLETED|Overall Study||107
1479027|NCT01850615|3619231|P2|Exposed|Overall Study||120
1479028|NCT01850615|3619232|P1|Exposed|Overall Study||115
1479029|NCT01850615|3619231|P2|STARTED|Overall Study||120
1479030|NCT01850615|3619232|P1|STARTED|Overall Study||116
1479031|NCT01850602|3619250|P2|NOT COMPLETED|Overall Study||18
1479032|NCT01850602|3619251|P1|NOT COMPLETED|Overall Study||14
1479033|NCT01850602|3619250|P2|COMPLETED|Overall Study||87
1479034|NCT01850602|3619251|P1|COMPLETED|Overall Study||94
1479035|NCT01850602|3619250|P2|STARTED|Overall Study||105
1479036|NCT01850602|3619251|P1|STARTED|Overall Study||108
1479037|NCT01850589|3619265|P2|NOT COMPLETED|Overall Study||0
1479038|NCT01850589|3619266|P1|NOT COMPLETED|Overall Study||8
1479039|NCT01850589|3619265|P2|COMPLETED|Overall Study||22
1479040|NCT01850589|3619266|P1|COMPLETED|Overall Study||14
1479041|NCT01850589|3619265|P2|STARTED|Overall Study||22
1479042|NCT01850589|3619266|P1|STARTED|Overall Study||22
1479043|NCT01850550|3619274|P2|NOT COMPLETED|Overall Study||3
1479044|NCT01850550|3619275|P1|NOT COMPLETED|Overall Study||0
1479045|NCT01850550|3619274|P2|COMPLETED|Overall Study||37
1479046|NCT01850550|3619275|P1|COMPLETED|Overall Study||40
1479047|NCT01850550|3619274|P2|STARTED|Overall Study||40
1479048|NCT01850550|3619275|P1|STARTED|Overall Study||40
1479049|NCT01850485|3619285|P2|NOT COMPLETED|Overall Study||0
1479050|NCT01850485|3619286|P1|NOT COMPLETED|Overall Study||0
1479051|NCT01850485|3619285|P2|COMPLETED|Overall Study||13
1479052|NCT01850485|3619286|P1|COMPLETED|Overall Study||9
1479053|NCT01850485|3619285|P2|STARTED|Overall Study||13
1479054|NCT01850485|3619286|P1|STARTED|Overall Study||9
1479055|NCT01850394|3619307|P3|NOT COMPLETED|Overall Study||0
1479056|NCT01850394|3619308|P2|NOT COMPLETED|Overall Study||0
1479057|NCT01850394|3619309|P1|NOT COMPLETED|Overall Study||0
1479058|NCT01850394|3619307|P3|COMPLETED|Overall Study||45
1479059|NCT01850394|3619308|P2|COMPLETED|Overall Study||45
1479060|NCT01850394|3619309|P1|COMPLETED|Overall Study||45
1479061|NCT01850394|3619307|P3|STARTED|Overall Study||45
1479062|NCT01850394|3619308|P2|STARTED|Overall Study||45
1479063|NCT01850394|3619309|P1|STARTED|Overall Study||45
1479064|NCT01850030|3619331|P2|NOT COMPLETED|Overall Study||369
1479065|NCT01850030|3619332|P1|NOT COMPLETED|Overall Study||347
1479066|NCT01850030|3619331|P2|COMPLETED|Overall Study||142
1479067|NCT01850030|3619332|P1|COMPLETED|Overall Study||173
1479068|NCT01850030|3619331|P2|STARTED|Overall Study||511
1479069|NCT01850030|3619332|P1|STARTED|Overall Study||520
1479070|NCT01850004|3619344|P1|NOT COMPLETED|Overall Study||8
1479071|NCT01850004|3619344|P1|COMPLETED|Overall Study||76
1479072|NCT01850004|3619344|P1|STARTED|Overall Study||84
1479073|NCT01849848|3619351|P1|NOT COMPLETED|Overall Study||4
1479074|NCT01849848|3619351|P1|COMPLETED|Overall Study||13
1479075|NCT01849848|3619351|P1|STARTED|Overall Study||17
1479076|NCT01849770|3619368|P3|NOT COMPLETED|Overall Study||1
1479077|NCT01849770|3619369|P2|NOT COMPLETED|Overall Study||4
1479078|NCT01849770|3619370|P1|NOT COMPLETED|Overall Study||0
1479079|NCT01849770|3619368|P3|COMPLETED|Overall Study||19
1479080|NCT01849770|3619369|P2|COMPLETED|Overall Study||15
1479081|NCT01849770|3619370|P1|COMPLETED|Overall Study||20
1479082|NCT01849770|3619368|P3|STARTED|Overall Study||20
1479083|NCT01849770|3619369|P2|STARTED|Overall Study||19
1479084|NCT01849770|3619370|P1|STARTED|Overall Study||20
1479085|NCT01849692|3619413|P8|NOT COMPLETED|Overall Study||0
1479086|NCT01849692|3619414|P7|NOT COMPLETED|Overall Study||0
1479087|NCT01849692|3619415|P6|NOT COMPLETED|Overall Study||0
1479088|NCT01849692|3619416|P5|NOT COMPLETED|Overall Study||0
1479089|NCT01849692|3619417|P4|NOT COMPLETED|Overall Study||0
1479090|NCT01849692|3619418|P3|NOT COMPLETED|Overall Study||0
1479091|NCT01849692|3619419|P2|NOT COMPLETED|Overall Study||0
1479092|NCT01849692|3619420|P1|NOT COMPLETED|Overall Study||0
1479093|NCT01849692|3619413|P8|COMPLETED|Overall Study||3
1479094|NCT01849692|3619414|P7|COMPLETED|Overall Study||10
1479095|NCT01849692|3619415|P6|COMPLETED|Overall Study||3
1479096|NCT01849692|3619416|P5|COMPLETED|Overall Study||10
1479097|NCT01849692|3619417|P4|COMPLETED|Overall Study||3
1479098|NCT01849692|3619418|P3|COMPLETED|Overall Study||10
1479099|NCT01849692|3619419|P2|COMPLETED|Overall Study||3
1479100|NCT01849692|3619420|P1|COMPLETED|Overall Study||10
1479101|NCT01849692|3619413|P8|STARTED|Overall Study||3
1479102|NCT01849692|3619414|P7|STARTED|Overall Study||10
1479103|NCT01849692|3619415|P6|STARTED|Overall Study||3
1479104|NCT01849692|3619416|P5|STARTED|Overall Study||10
1479105|NCT01849692|3619417|P4|STARTED|Overall Study||3
1479106|NCT01849692|3619418|P3|STARTED|Overall Study||10
1479107|NCT01849692|3619419|P2|STARTED|Overall Study||3
1479108|NCT01849692|3619420|P1|STARTED|Overall Study||10
1479109|NCT01849588|3619449|P1|NOT COMPLETED|Overall Study||3
1479110|NCT01849588|3619449|P1|COMPLETED|Overall Study||0
1479111|NCT01849588|3619449|P1|STARTED|Overall Study||3
1479112|NCT01849562|3619459|P3|NOT COMPLETED|Overall Study||0
1479113|NCT01849562|3619460|P2|NOT COMPLETED|Overall Study||0
1479114|NCT01849562|3619461|P1|NOT COMPLETED|Overall Study||2
1479115|NCT01849562|3619459|P3|COMPLETED|Overall Study||10
1479116|NCT01849562|3619460|P2|COMPLETED|Overall Study||10
1479117|NCT01849562|3619461|P1|COMPLETED|Overall Study||8
1479118|NCT01849562|3619459|P3|STARTED|Overall Study||10
1479119|NCT01849562|3619460|P2|STARTED|Overall Study||10
1479120|NCT01849562|3619461|P1|STARTED|Overall Study||10
1479121|NCT01849497|3619474|P2|NOT COMPLETED|Overall Study||4
1479122|NCT01849497|3619475|P1|NOT COMPLETED|Overall Study||1
1479123|NCT01849497|3619474|P2|COMPLETED|Overall Study||70
1479124|NCT01849497|3619475|P1|COMPLETED|Overall Study||74
1479125|NCT01849497|3619474|P2|Received Treatment|Overall Study||74
1479126|NCT01849497|3619475|P1|Received Treatment|Overall Study||75
1479127|NCT01849497|3619474|P2|STARTED|Overall Study||74
1479128|NCT01849497|3619475|P1|STARTED|Overall Study||75
1479129|NCT01849458|3619483|P1|NOT COMPLETED|Overall Study||4
1479130|NCT01849458|3619483|P1|COMPLETED|Overall Study||46
1479131|NCT01849458|3619483|P1|6 Months Follow-up|Overall Study||50
1479132|NCT01849458|3619483|P1|STARTED|Overall Study||50
1479133|NCT01849419|3619493|P1|NOT COMPLETED|Overall Study||0
1479134|NCT01849419|3619493|P1|COMPLETED|Overall Study||65
1479135|NCT01849419|3619493|P1|STARTED|Overall Study||65
1479136|NCT01849289|3619522|P2|NOT COMPLETED|Overall Study||24
1479137|NCT01849289|3619523|P1|NOT COMPLETED|Overall Study||32
1479138|NCT01849289|3619522|P2|COMPLETED|Overall Study||254
1479139|NCT01849289|3619523|P1|COMPLETED|Overall Study||523
1479140|NCT01849289|3619522|P2|Exposed|Overall Study||278
1479141|NCT01849289|3619523|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
1479142|NCT01849289|3619522|P2|STARTED|Overall Study||278
1479143|NCT01849289|3619523|P1|STARTED|Overall Study||555
1479144|NCT01849276|3619539|P1|NOT COMPLETED|Followed for Survival for 5 Years||2
1479145|NCT01849276|3619539|P1|COMPLETED|Followed for Survival for 5 Years||0
1479146|NCT01849276|3619539|P1|STARTED|Followed for Survival for 5 Years||2
1479147|NCT01849276|3619539|P1|NOT COMPLETED|Completed Treatment||0
1479148|NCT01849276|3619539|P1|COMPLETED|Completed Treatment||2
1479149|NCT01849276|3619539|P1|STARTED|Completed Treatment||2
1479150|NCT01849276|3619539|P1|NOT COMPLETED|Registered to the Study||0
1479151|NCT01849276|3619539|P1|COMPLETED|Registered to the Study||2
1479152|NCT01849276|3619539|P1|STARTED|Registered to the Study||2
1479153|NCT01849263|3619551|P1|NOT COMPLETED|Overall Study||0
1479154|NCT01849263|3619551|P1|COMPLETED|Overall Study||40
1479155|NCT01849263|3619551|P1|STARTED|Overall Study||40
1479156|NCT01849068|3619563|P2|NOT COMPLETED|Overall Study||0
1479157|NCT01849068|3619564|P1|NOT COMPLETED|Overall Study||0
1479158|NCT01849068|3619563|P2|COMPLETED|Overall Study||10
1479159|NCT01849068|3619564|P1|COMPLETED|Overall Study||10
1479160|NCT01849068|3619563|P2|STARTED|Overall Study||10
1479161|NCT01849068|3619564|P1|STARTED|Overall Study||10
1479162|NCT01849055|3619582|P6|NOT COMPLETED|Overall Study||0
1479163|NCT01849055|3619583|P5|NOT COMPLETED|Overall Study||0
1479164|NCT01849055|3619584|P4|NOT COMPLETED|Overall Study||0
1479165|NCT01849055|3619585|P3|NOT COMPLETED|Overall Study||1
1479166|NCT01849055|3619586|P2|NOT COMPLETED|Overall Study||0
1479167|NCT01849055|3619587|P1|NOT COMPLETED|Overall Study||0
1479168|NCT01849055|3619582|P6|COMPLETED|Overall Study||8
1479169|NCT01849055|3619583|P5|COMPLETED|Overall Study||8
1479170|NCT01849055|3619584|P4|COMPLETED|Overall Study||8
1479171|NCT01849055|3619585|P3|COMPLETED|Overall Study||7
1479172|NCT01849055|3619586|P2|COMPLETED|Overall Study||8
1479173|NCT01849055|3619587|P1|COMPLETED|Overall Study||8
1479174|NCT01849055|3619582|P6|STARTED|Overall Study||8
1479175|NCT01849055|3619583|P5|STARTED|Overall Study||8
1479176|NCT01849055|3619584|P4|STARTED|Overall Study||8
1479177|NCT01849055|3619585|P3|STARTED|Overall Study||8
1479178|NCT01849055|3619586|P2|STARTED|Overall Study||8
1479179|NCT01849055|3619587|P1|STARTED|Overall Study||8
1479180|NCT01848990|3619622|P3|NOT COMPLETED|Overall Study||16
1479181|NCT01848990|3619623|P2|NOT COMPLETED|Overall Study||20
1479182|NCT01848990|3619624|P1|NOT COMPLETED|Overall Study||46
1479183|NCT01848990|3619622|P3|COMPLETED|Overall Study||98
1479184|NCT01848990|3619623|P2|COMPLETED|Overall Study||95
1479185|NCT01848990|3619624|P1|COMPLETED|Overall Study||181
1479186|NCT01848990|3619622|P3|Completed Month 6|Overall Study||103
1479187|NCT01848990|3619623|P2|Completed Month 6|Overall Study||106
1479188|NCT01848990|3619624|P1|Completed Month 6|Overall Study||194
1479189|NCT01848990|3619622|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
1479190|NCT01848990|3619623|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
1479191|NCT01848990|3619624|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
1479192|NCT01848990|3619622|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
1479193|NCT01848990|3619623|P2|STARTED|Overall Study||115
1479194|NCT01848990|3619624|P1|STARTED|Overall Study||227
1479195|NCT01848977|3619683|P1|NOT COMPLETED|Overall Study||0
1479196|NCT01848977|3619683|P1|COMPLETED|Overall Study||20
1479197|NCT01848977|3619683|P1|STARTED|Overall Study||20
1479198|NCT01848938|3619694|P2|NOT COMPLETED|Overall Study||1
1479199|NCT01848938|3619695|P1|NOT COMPLETED|Overall Study||1
1479200|NCT01848938|3619694|P2|COMPLETED|Overall Study||60
1479201|NCT01848938|3619695|P1|COMPLETED|Overall Study||61
1479202|NCT01848938|3619694|P2|STARTED|Overall Study||61
1479203|NCT01848938|3619695|P1|STARTED|Overall Study||62
1479204|NCT01848899|3619713|P2|NOT COMPLETED|Overall Study||0
1479205|NCT01848899|3619714|P1|NOT COMPLETED|Overall Study||0
1479206|NCT01848899|3619713|P2|COMPLETED|Overall Study||50
1479207|NCT01848899|3619714|P1|COMPLETED|Overall Study||50
1479208|NCT01848899|3619713|P2|STARTED|Overall Study||50
1479209|NCT01848899|3619714|P1|STARTED|Overall Study||50
1479210|NCT01848847|3619730|P2|NOT COMPLETED|Overall Study||3
1479211|NCT01848847|3619731|P1|NOT COMPLETED|Overall Study||2
1479212|NCT01848847|3619730|P2|COMPLETED|Overall Study||48
1479213|NCT01848847|3619731|P1|COMPLETED|Overall Study||49
1479214|NCT01848847|3619730|P2|STARTED|Overall Study||51
1479215|NCT01848847|3619731|P1|STARTED|Overall Study||51
1479216|NCT01848834|3619744|P5|NOT COMPLETED|Overall Study||132
1479217|NCT01848834|3619745|P4|NOT COMPLETED|Overall Study||37
1479218|NCT01848834|3619746|P3|NOT COMPLETED|Overall Study||32
1479219|NCT01848834|3619747|P2|NOT COMPLETED|Overall Study||60
1479220|NCT01848834|3619748|P1|NOT COMPLETED|Overall Study||30
1479221|NCT01848834|3619744|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
1479222|NCT01848834|3619745|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
1479223|NCT01848834|3619746|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
1479224|NCT01848834|3619747|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
1479225|NCT01848834|3619748|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
1479226|NCT01848834|3619744|P5|Treated|Overall Study||132
1479227|NCT01848834|3619745|P4|Treated|Overall Study||39
1479228|NCT01848834|3619746|P3|Treated|Overall Study||33
1479229|NCT01848834|3619747|P2|Treated|Overall Study||60
1479230|NCT01848834|3619748|P1|Treated|Overall Study||32
1479231|NCT01848834|3619744|P5|STARTED|Overall Study||132
1479232|NCT01848834|3619745|P4|STARTED|Overall Study||39
1479233|NCT01848834|3619746|P3|STARTED|Overall Study||33
1479234|NCT01848834|3619747|P2|STARTED|Overall Study||61
1479235|NCT01848834|3619748|P1|STARTED|Overall Study||32
1479236|NCT01848756|3619783|P1|NOT COMPLETED|Overall Study||3
1479237|NCT01848756|3619783|P1|COMPLETED|Overall Study|Cycle 1|12
1479238|NCT01848756|3619783|P1|STARTED|Overall Study||15
1479239|NCT01848366|3619793|P1|NOT COMPLETED|Overall Study||0
1479240|NCT01848366|3619793|P1|COMPLETED|Overall Study||8
1479241|NCT01848366|3619793|P1|STARTED|Overall Study||8
1479242|NCT01848288|3619797|P1|NOT COMPLETED|Overall Study||3
1479243|NCT01848288|3619797|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
1479244|NCT01848288|3619797|P1|STARTED|Overall Study||100
1479245|NCT01848210|3619808|P2|NOT COMPLETED|Overall Study||78
1479246|NCT01848210|3619809|P1|NOT COMPLETED|Overall Study||88
1479247|NCT01848210|3619808|P2|COMPLETED|Overall Study||340
1479248|NCT01848210|3619809|P1|COMPLETED|Overall Study||323
1479249|NCT01848210|3619808|P2|Per Protocol Population|Overall Study||245
1479250|NCT01848210|3619809|P1|Per Protocol Population|Overall Study||222
1479251|NCT01848210|3619808|P2|Intent-to-Treat (ITT) Population|Overall Study||388
1479252|NCT01848210|3619809|P1|Intent-to-Treat (ITT) Population|Overall Study||383
1479253|NCT01848210|3619808|P2|Safety Population-Received Study Drug|Overall Study||398
1479254|NCT01848210|3619809|P1|Safety Population-Received Study Drug|Overall Study||394
1479255|NCT01848210|3619808|P2|STARTED|Overall Study||418
1479256|NCT01848210|3619809|P1|STARTED|Overall Study||411
1479257|NCT01848184|3619821|P1|NOT COMPLETED|Overall Study||26
1479258|NCT01848184|3619821|P1|COMPLETED|Overall Study||100
1479259|NCT01848184|3619821|P1|STARTED|Overall Study||126
1479260|NCT01848145|3619831|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
1479261|NCT01848145|3619831|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
1479262|NCT01848145|3619831|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
1479263|NCT01848145|3619831|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
1479264|NCT01848145|3619831|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
1479265|NCT01848145|3619831|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
1479266|NCT01848145|3619831|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
1479267|NCT01848145|3619831|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
1479268|NCT01848145|3619831|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
1479269|NCT01848145|3619831|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
1479270|NCT01848145|3619831|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
1479271|NCT01848145|3619831|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
1479272|NCT01848145|3619831|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
1479273|NCT01848145|3619831|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
1479274|NCT01848145|3619831|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
1479275|NCT01848067|3619840|P1|NOT COMPLETED|Overall Study||0
1479276|NCT01848067|3619840|P1|COMPLETED|Overall Study||9
1479277|NCT01848067|3619840|P1|STARTED|Overall Study||9
1479278|NCT01848054|3619848|P2|NOT COMPLETED|Stabilization/Maintenance||40
1479279|NCT01848054|3619849|P1|NOT COMPLETED|Stabilization/Maintenance||40
1479280|NCT01848054|3619848|P2|COMPLETED|Stabilization/Maintenance||107
1479281|NCT01848054|3619849|P1|COMPLETED|Stabilization/Maintenance||92
1479282|NCT01848054|3619848|P2|STARTED|Stabilization/Maintenance||147
1479283|NCT01848054|3619849|P1|STARTED|Stabilization/Maintenance||132
1479284|NCT01848054|3619848|P2|NOT COMPLETED|Induction Phase||8
1479285|NCT01848054|3619849|P1|NOT COMPLETED|Induction Phase||23
1479286|NCT01848054|3619848|P2|COMPLETED|Induction Phase||147
1479287|NCT01848054|3619849|P1|COMPLETED|Induction Phase||132
1479288|NCT01848054|3619848|P2|STARTED|Induction Phase||155
1479289|NCT01848054|3619849|P1|STARTED|Induction Phase||155
1479290|NCT01847885|3619871|P3|NOT COMPLETED|Randomization||2
1479291|NCT01847885|3619872|P2|NOT COMPLETED|Randomization||4
1479292|NCT01847885|3619873|P1|NOT COMPLETED|Randomization||0
1479293|NCT01847885|3619871|P3|COMPLETED|Randomization||13
1479294|NCT01847885|3619872|P2|COMPLETED|Randomization||27
1479295|NCT01847885|3619873|P1|COMPLETED|Randomization||0
1479296|NCT01847885|3619871|P3|Per Protocol Set|Randomization||13
1479297|NCT01847885|3619872|P2|Per Protocol Set|Randomization||27
1479298|NCT01847885|3619873|P1|Per Protocol Set|Randomization||0
1479299|NCT01847885|3619871|P3|Safety Set|Randomization||13
1479300|NCT01847885|3619872|P2|Safety Set|Randomization||28
1479301|NCT01847885|3619873|P1|Safety Set|Randomization||0
1479302|NCT01847885|3619871|P3|Full Analysis Set|Randomization||15
1479303|NCT01847885|3619872|P2|Full Analysis Set|Randomization||28
1479304|NCT01847885|3619873|P1|Full Analysis Set|Randomization||0
1479305|NCT01847885|3619871|P3|STARTED|Randomization||15
1479306|NCT01847885|3619872|P2|STARTED|Randomization||31
1479307|NCT01847885|3619873|P1|STARTED|Randomization||0
1479308|NCT01847885|3619871|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
1479309|NCT01847885|3619872|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
1479310|NCT01847885|3619873|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
1479311|NCT01847885|3619871|P3|COMPLETED|Initial Enrollment (Consented)||0
1479312|NCT01847885|3619872|P2|COMPLETED|Initial Enrollment (Consented)||0
1479313|NCT01847885|3619873|P1|COMPLETED|Initial Enrollment (Consented)||40
1479314|NCT01847885|3619871|P3|Per Protocol Set|Initial Enrollment (Consented)||0
1479315|NCT01847885|3619872|P2|Per Protocol Set|Initial Enrollment (Consented)||0
1479316|NCT01847885|3619873|P1|Per Protocol Set|Initial Enrollment (Consented)||40
1479317|NCT01847885|3619871|P3|Safety Set|Initial Enrollment (Consented)||0
1479318|NCT01847885|3619872|P2|Safety Set|Initial Enrollment (Consented)||0
1479319|NCT01847885|3619873|P1|Safety Set|Initial Enrollment (Consented)||41
1479320|NCT01847885|3619871|P3|Full Analysis Set|Initial Enrollment (Consented)||0
1479321|NCT01847885|3619872|P2|Full Analysis Set|Initial Enrollment (Consented)||0
1479322|NCT01847885|3619873|P1|Full Analysis Set|Initial Enrollment (Consented)||43
1479323|NCT01847885|3619871|P3|Randomized|Initial Enrollment (Consented)||0
1479324|NCT01847885|3619872|P2|Randomized|Initial Enrollment (Consented)||0
1479325|NCT01847885|3619873|P1|Randomized|Initial Enrollment (Consented)||46
1479326|NCT01847885|3619871|P3|STARTED|Initial Enrollment (Consented)||0
1479327|NCT01847885|3619872|P2|STARTED|Initial Enrollment (Consented)||0
1479328|NCT01847885|3619873|P1|STARTED|Initial Enrollment (Consented)||88
1479329|NCT01847638|3619907|P2|NOT COMPLETED|Overall Study||0
1479330|NCT01847638|3619908|P1|NOT COMPLETED|Overall Study||0
1479331|NCT01847638|3619907|P2|COMPLETED|Overall Study||25
1479332|NCT01847638|3619908|P1|COMPLETED|Overall Study||25
1479333|NCT01847638|3619907|P2|STARTED|Overall Study||25
1479334|NCT01847638|3619908|P1|STARTED|Overall Study||25
1479335|NCT01847547|3619920|P2|NOT COMPLETED|Overall Study||0
1479336|NCT01847547|3619921|P1|NOT COMPLETED|Overall Study||0
1479337|NCT01847547|3619920|P2|COMPLETED|Overall Study||2991
1479338|NCT01847547|3619921|P1|COMPLETED|Overall Study||2991
1479339|NCT01847547|3619920|P2|STARTED|Overall Study||2991
1479340|NCT01847547|3619921|P1|STARTED|Overall Study||2991
1479341|NCT01847443|3619963|P4|NOT COMPLETED|Study Period 4||0
1479342|NCT01847443|3619964|P3|NOT COMPLETED|Study Period 4||0
1479343|NCT01847443|3619965|P2|NOT COMPLETED|Study Period 4||0
1479344|NCT01847443|3619966|P1|NOT COMPLETED|Study Period 4||0
1479345|NCT01847443|3619963|P4|COMPLETED|Study Period 4||21
1479346|NCT01847443|3619964|P3|COMPLETED|Study Period 4||21
1479347|NCT01847443|3619965|P2|COMPLETED|Study Period 4||19
1479348|NCT01847443|3619966|P1|COMPLETED|Study Period 4||16
1479349|NCT01847443|3619963|P4|STARTED|Study Period 4||21
1479350|NCT01847443|3619964|P3|STARTED|Study Period 4||21
1479351|NCT01847443|3619965|P2|STARTED|Study Period 4||19
1479352|NCT01847443|3619966|P1|STARTED|Study Period 4||16
1479353|NCT01847443|3619963|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
1479354|NCT01847443|3619964|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
1479355|NCT01847443|3619965|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
1479356|NCT01847443|3619966|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
1479357|NCT01847443|3619963|P4|COMPLETED|Washout Period Before Study Period 4||21
1479358|NCT01847443|3619964|P3|COMPLETED|Washout Period Before Study Period 4||21
1479359|NCT01847443|3619965|P2|COMPLETED|Washout Period Before Study Period 4||19
1479360|NCT01847443|3619966|P1|COMPLETED|Washout Period Before Study Period 4||16
1479361|NCT01847443|3619963|P4|STARTED|Washout Period Before Study Period 4||21
1479362|NCT01847443|3619964|P3|STARTED|Washout Period Before Study Period 4||21
1479363|NCT01847443|3619965|P2|STARTED|Washout Period Before Study Period 4||19
1479364|NCT01847443|3619966|P1|STARTED|Washout Period Before Study Period 4||18
1479365|NCT01847443|3619963|P4|NOT COMPLETED|Study Period 3||0
1479366|NCT01847443|3619964|P3|NOT COMPLETED|Study Period 3||0
1479367|NCT01847443|3619965|P2|NOT COMPLETED|Study Period 3||0
1479368|NCT01847443|3619966|P1|NOT COMPLETED|Study Period 3||0
1479369|NCT01847443|3619963|P4|COMPLETED|Study Period 3||21
1479370|NCT01847443|3619964|P3|COMPLETED|Study Period 3||21
1479371|NCT01847443|3619965|P2|COMPLETED|Study Period 3||19
1479372|NCT01847443|3619966|P1|COMPLETED|Study Period 3||18
1479373|NCT01847443|3619963|P4|STARTED|Study Period 3||21
1479374|NCT01847443|3619964|P3|STARTED|Study Period 3||21
1479375|NCT01847443|3619965|P2|STARTED|Study Period 3||19
1479376|NCT01847443|3619966|P1|STARTED|Study Period 3||18
1479377|NCT01847443|3619963|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
1479378|NCT01847443|3619964|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
1479379|NCT01847443|3619965|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
1479380|NCT01847443|3619966|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
1479381|NCT01847443|3619963|P4|COMPLETED|Washout Period Before Study Period 3||21
1479382|NCT01847443|3619964|P3|COMPLETED|Washout Period Before Study Period 3||21
1479383|NCT01847443|3619965|P2|COMPLETED|Washout Period Before Study Period 3||19
1479384|NCT01847443|3619966|P1|COMPLETED|Washout Period Before Study Period 3||18
1479385|NCT01847443|3619963|P4|STARTED|Washout Period Before Study Period 3||21
1479386|NCT01847443|3619964|P3|STARTED|Washout Period Before Study Period 3||21
1479387|NCT01847443|3619965|P2|STARTED|Washout Period Before Study Period 3||19
1479388|NCT01847443|3619966|P1|STARTED|Washout Period Before Study Period 3||19
1479389|NCT01847443|3619963|P4|NOT COMPLETED|Study Period 2||0
1479390|NCT01847443|3619964|P3|NOT COMPLETED|Study Period 2||0
1479391|NCT01847443|3619965|P2|NOT COMPLETED|Study Period 2||0
1479392|NCT01847443|3619966|P1|NOT COMPLETED|Study Period 2||0
1479393|NCT01847443|3619963|P4|COMPLETED|Study Period 2||21
1479394|NCT01847443|3619964|P3|COMPLETED|Study Period 2||21
1479395|NCT01847443|3619965|P2|COMPLETED|Study Period 2||19
1479396|NCT01847443|3619966|P1|COMPLETED|Study Period 2||19
1479397|NCT01847443|3619963|P4|STARTED|Study Period 2||21
1479398|NCT01847443|3619964|P3|STARTED|Study Period 2||21
1479399|NCT01847443|3619965|P2|STARTED|Study Period 2||19
1479400|NCT01847443|3619966|P1|STARTED|Study Period 2||19
1479401|NCT01847443|3619963|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
1479402|NCT01847443|3619964|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
1479403|NCT01847443|3619965|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
1479404|NCT01847443|3619966|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
1479405|NCT01847443|3619963|P4|COMPLETED|Washout Period Before Study Period 2||21
1479406|NCT01847443|3619964|P3|COMPLETED|Washout Period Before Study Period 2||21
1479407|NCT01847443|3619965|P2|COMPLETED|Washout Period Before Study Period 2||19
1479408|NCT01847443|3619966|P1|COMPLETED|Washout Period Before Study Period 2||19
1479409|NCT01847443|3619963|P4|STARTED|Washout Period Before Study Period 2||21
1479410|NCT01847443|3619964|P3|STARTED|Washout Period Before Study Period 2||21
1479411|NCT01847443|3619965|P2|STARTED|Washout Period Before Study Period 2||20
1479412|NCT01847443|3619966|P1|STARTED|Washout Period Before Study Period 2||21
1479413|NCT01847443|3619963|P4|NOT COMPLETED|Study Period 1||0
1479414|NCT01847443|3619964|P3|NOT COMPLETED|Study Period 1||0
1479415|NCT01847443|3619965|P2|NOT COMPLETED|Study Period 1||1
1479416|NCT01847443|3619966|P1|NOT COMPLETED|Study Period 1||0
1479417|NCT01847443|3619963|P4|COMPLETED|Study Period 1||21
1479418|NCT01847443|3619964|P3|COMPLETED|Study Period 1||21
1479419|NCT01847443|3619965|P2|COMPLETED|Study Period 1||20
1479420|NCT01847443|3619966|P1|COMPLETED|Study Period 1||21
1479421|NCT01847443|3619963|P4|STARTED|Study Period 1||21
1479422|NCT01847443|3619964|P3|STARTED|Study Period 1||21
1479423|NCT01847443|3619965|P2|STARTED|Study Period 1||21
1479424|NCT01847443|3619966|P1|STARTED|Study Period 1||21
1479425|NCT01847430|3619996|P1|NOT COMPLETED|Overall Study||0
1479426|NCT01847430|3619996|P1|COMPLETED|Overall Study||302
1479427|NCT01847430|3619996|P1|STARTED|Overall Study||302
1479428|NCT01847196|3620007|P1|NOT COMPLETED|Overall Study||0
1479429|NCT01847196|3620007|P1|COMPLETED|Overall Study||5
1479430|NCT01847196|3620007|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
1479431|NCT01847131|3620014|P2|NOT COMPLETED|Overall Study||0
1479432|NCT01847131|3620015|P1|NOT COMPLETED|Overall Study||0
1479433|NCT01847131|3620014|P2|COMPLETED|Overall Study||25
1479434|NCT01847131|3620015|P1|COMPLETED|Overall Study||25
1479435|NCT01847131|3620014|P2|STARTED|Overall Study||25
1479436|NCT01847131|3620015|P1|STARTED|Overall Study||25
1479437|NCT01847014|3620023|P1|NOT COMPLETED|Completion of Extension Study||4
1479438|NCT01847014|3620023|P1|COMPLETED|Completion of Extension Study||0
1479439|NCT01847014|3620023|P1|STARTED|Completion of Extension Study||4
1479440|NCT01847014|3620023|P1|NOT COMPLETED|Baseline Extension Visit||0
1479441|NCT01847014|3620023|P1|COMPLETED|Baseline Extension Visit||4
1479442|NCT01847014|3620023|P1|STARTED|Baseline Extension Visit||4
1479443|NCT01846741|3620027|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
1479444|NCT01846741|3620027|P1|COMPLETED|Implantation to 18-Month/End of Study||20
1479445|NCT01846741|3620027|P1|STARTED|Implantation to 18-Month/End of Study||20
1479446|NCT01846741|3620027|P1|NOT COMPLETED|Baseline Visit||2
1479447|NCT01846741|3620027|P1|COMPLETED|Baseline Visit||20
1479448|NCT01846741|3620027|P1|STARTED|Baseline Visit||22
1479449|NCT01846702|3620090|P7|NOT COMPLETED|Overall Study||0
1479450|NCT01846702|3620091|P6|NOT COMPLETED|Overall Study||0
1479451|NCT01846702|3620092|P5|NOT COMPLETED|Overall Study||0
1479452|NCT01846702|3620093|P4|NOT COMPLETED|Overall Study||0
1479453|NCT01846702|3620094|P3|NOT COMPLETED|Overall Study||1
1479454|NCT01846702|3620095|P2|NOT COMPLETED|Overall Study||0
1479455|NCT01846702|3620096|P1|NOT COMPLETED|Overall Study||0
1479456|NCT01846702|3620090|P7|COMPLETED|Overall Study||6
1479457|NCT01846702|3620091|P6|COMPLETED|Overall Study||6
1479458|NCT01846702|3620092|P5|COMPLETED|Overall Study||6
1479459|NCT01846702|3620093|P4|COMPLETED|Overall Study||6
1479460|NCT01846702|3620094|P3|COMPLETED|Overall Study||6
1479461|NCT01846702|3620095|P2|COMPLETED|Overall Study||6
1479462|NCT01846702|3620096|P1|COMPLETED|Overall Study||6
1479463|NCT01846702|3620090|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
1479464|NCT01846702|3620091|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
1479465|NCT01846702|3620092|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
1479466|NCT01846702|3620093|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
1479467|NCT01846702|3620094|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1479468|NCT01846702|3620095|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1479469|NCT01846702|3620096|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
1479470|NCT01846702|3620090|P7|STARTED|Overall Study||6
1479471|NCT01846702|3620091|P6|STARTED|Overall Study||6
1479472|NCT01846702|3620092|P5|STARTED|Overall Study||6
1479473|NCT01846702|3620093|P4|STARTED|Overall Study||6
1479474|NCT01846702|3620094|P3|STARTED|Overall Study||7
1479475|NCT01846702|3620095|P2|STARTED|Overall Study||6
1479476|NCT01846702|3620096|P1|STARTED|Overall Study||6
1479477|NCT01846624|3620175|P1|NOT COMPLETED|Overall Study||1
1479478|NCT01846624|3620175|P1|COMPLETED|Overall Study||12
1479479|NCT01846624|3620175|P1|STARTED|Overall Study||13
1479480|NCT01846507|3620183|P1|NOT COMPLETED|Overall Study||7
1479481|NCT01846507|3620183|P1|COMPLETED|Overall Study||25
1479482|NCT01846507|3620183|P1|STARTED|Overall Study||32
1479483|NCT01846455|3620205|P5|NOT COMPLETED|Overall Study||0
1479484|NCT01846455|3620206|P4|NOT COMPLETED|Overall Study||0
1479485|NCT01846455|3620207|P3|NOT COMPLETED|Overall Study||0
1479486|NCT01846455|3620208|P2|NOT COMPLETED|Overall Study||0
1479487|NCT01846455|3620209|P1|NOT COMPLETED|Overall Study||0
1479488|NCT01846455|3620205|P5|COMPLETED|Overall Study||8
1479489|NCT01846455|3620206|P4|COMPLETED|Overall Study||10
1479490|NCT01846455|3620207|P3|COMPLETED|Overall Study||8
1479491|NCT01846455|3620208|P2|COMPLETED|Overall Study||8
1479492|NCT01846455|3620209|P1|COMPLETED|Overall Study||9
1479493|NCT01846455|3620205|P5|PK Population|Overall Study||8
1479494|NCT01846455|3620206|P4|PK Population|Overall Study||6
1479495|NCT01846455|3620207|P3|PK Population|Overall Study||6
1479496|NCT01846455|3620208|P2|PK Population|Overall Study||7
1479497|NCT01846455|3620209|P1|PK Population|Overall Study||6
1479498|NCT01846455|3620205|P5|STARTED|Overall Study||8
1479499|NCT01846455|3620206|P4|STARTED|Overall Study||10
1479500|NCT01846455|3620207|P3|STARTED|Overall Study||8
1479501|NCT01846455|3620208|P2|STARTED|Overall Study||8
1479502|NCT01846455|3620209|P1|STARTED|Overall Study||9
1479503|NCT01846442|3620270|P4|NOT COMPLETED|Overall Study||3
1479504|NCT01846442|3620271|P3|NOT COMPLETED|Overall Study||4
1479505|NCT01846442|3620272|P2|NOT COMPLETED|Overall Study||6
1479506|NCT01846442|3620273|P1|NOT COMPLETED|Overall Study||6
1479507|NCT01846442|3620270|P4|COMPLETED|Overall Study||51
1479508|NCT01846442|3620271|P3|COMPLETED|Overall Study||52
1479509|NCT01846442|3620272|P2|COMPLETED|Overall Study||48
1479510|NCT01846442|3620273|P1|COMPLETED|Overall Study||48
1479511|NCT01846442|3620270|P4|ITT Population|Overall Study||54
1479512|NCT01846442|3620271|P3|ITT Population|Overall Study||56
1479513|NCT01846442|3620272|P2|ITT Population|Overall Study||53
1479514|NCT01846442|3620273|P1|ITT Population|Overall Study||53
1479515|NCT01846442|3620270|P4|Safety Population|Overall Study||54
1479516|NCT01846442|3620271|P3|Safety Population|Overall Study||56
1479517|NCT01846442|3620272|P2|Safety Population|Overall Study||53
1479518|NCT01846442|3620273|P1|Safety Population|Overall Study||54
1479519|NCT01846442|3620270|P4|STARTED|Overall Study||54
1479520|NCT01846442|3620271|P3|STARTED|Overall Study||56
1479521|NCT01846442|3620272|P2|STARTED|Overall Study||54
1479522|NCT01846442|3620273|P1|STARTED|Overall Study||54
1479523|NCT01846416|3620314|P3|NOT COMPLETED|Overall Study||13
1479524|NCT01846416|3620315|P2|NOT COMPLETED|Overall Study||93
1479525|NCT01846416|3620316|P1|NOT COMPLETED|Overall Study||31
1479526|NCT01846416|3620314|P3|COMPLETED|Overall Study||0
1479527|NCT01846416|3620315|P2|COMPLETED|Overall Study||0
1479528|NCT01846416|3620316|P1|COMPLETED|Overall Study||0
1479529|NCT01846416|3620314|P3|STARTED|Overall Study||13
1479530|NCT01846416|3620315|P2|STARTED|Overall Study||93
1479531|NCT01846416|3620316|P1|STARTED|Overall Study||31
1479532|NCT01846299|3620361|P2|NOT COMPLETED|Overall Study||10
1479533|NCT01846299|3620362|P1|NOT COMPLETED|Overall Study||12
1479534|NCT01846299|3620361|P2|COMPLETED|Overall Study||50
1479535|NCT01846299|3620362|P1|COMPLETED|Overall Study||106
1479536|NCT01846299|3620361|P2|Safety Set|Overall Study||58
1479537|NCT01846299|3620362|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
1479538|NCT01846299|3620361|P2|Full Analysis Set|Overall Study||60
1479539|NCT01846299|3620362|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
1479540|NCT01846299|3620361|P2|STARTED|Overall Study||60
1479541|NCT01846299|3620362|P1|STARTED|Overall Study||118
1479542|NCT01846221|3620400|P2|NOT COMPLETED|Overall Study||0
1479543|NCT01846221|3620401|P1|NOT COMPLETED|Overall Study||3
1479544|NCT01846221|3620400|P2|COMPLETED|Overall Study||51
1479545|NCT01846221|3620401|P1|COMPLETED|Overall Study||47
1479546|NCT01846221|3620400|P2|STARTED|Overall Study||51
1479547|NCT01846221|3620401|P1|STARTED|Overall Study||50
1479548|NCT01846208|3620418|P3|NOT COMPLETED|Overall Study||8
1479549|NCT01846208|3620419|P2|NOT COMPLETED|Overall Study||4
1479550|NCT01846208|3620420|P1|NOT COMPLETED|Overall Study||9
1479551|NCT01846208|3620418|P3|COMPLETED|Overall Study||32
1479552|NCT01846208|3620419|P2|COMPLETED|Overall Study||20
1479553|NCT01846208|3620420|P1|COMPLETED|Overall Study||19
1479554|NCT01846208|3620418|P3|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
1479555|NCT01846208|3620419|P2|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
1479556|NCT01846208|3620420|P1|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
1479557|NCT01846208|3620418|P3|Year 2 Desensitization OFC|Overall Study||33
1479558|NCT01846208|3620419|P2|Year 2 Desensitization OFC|Overall Study||20
1479559|NCT01846208|3620420|P1|Year 2 Desensitization OFC|Overall Study||19
1479560|NCT01846208|3620418|P3|Year 1 Desensitization OFC|Overall Study||34
1479561|NCT01846208|3620419|P2|Year 1 Desensitization OFC|Overall Study||20
1479562|NCT01846208|3620420|P1|Year 1 Desensitization OFC|Overall Study||23
1479563|NCT01846208|3620418|P3|Initiatiated Treatment|Overall Study||39
1479564|NCT01846208|3620419|P2|Initiatiated Treatment|Overall Study||23
1479565|NCT01846208|3620420|P1|Initiatiated Treatment|Overall Study||27
1479566|NCT01846208|3620418|P3|STARTED|Overall Study||40
1479567|NCT01846208|3620419|P2|STARTED|Overall Study||24
1479568|NCT01846208|3620420|P1|STARTED|Overall Study||28
1479569|NCT01846104|3620437|P1|NOT COMPLETED|Overall Study||1
1479570|NCT01846104|3620437|P1|COMPLETED|Overall Study||3
1479571|NCT01846104|3620437|P1|STARTED|Overall Study||4
1479572|NCT01846039|3620443|P1|NOT COMPLETED|Overall Study||2
1479573|NCT01846039|3620443|P1|COMPLETED|Overall Study||27
1479574|NCT01846039|3620443|P1|STARTED|Overall Study||29
1479575|NCT01845974|3620455|P2|NOT COMPLETED|Overall Study||0
1479576|NCT01845974|3620456|P1|NOT COMPLETED|Overall Study||1
1479577|NCT01845974|3620455|P2|COMPLETED|Overall Study||9
1479578|NCT01845974|3620456|P1|COMPLETED|Overall Study||3
1479579|NCT01845974|3620455|P2|STARTED|Overall Study||9
1479580|NCT01845974|3620456|P1|STARTED|Overall Study||4
1479581|NCT01845831|3620464|P5|NOT COMPLETED|Outpatient Phase||0
1479582|NCT01845831|3620465|P4|NOT COMPLETED|Outpatient Phase||0
1479583|NCT01845831|3620466|P3|NOT COMPLETED|Outpatient Phase||0
1479584|NCT01845831|3620467|P2|NOT COMPLETED|Outpatient Phase||0
1479585|NCT01845831|3620468|P1|NOT COMPLETED|Outpatient Phase||0
1479586|NCT01845831|3620464|P5|COMPLETED|Outpatient Phase||87
1479587|NCT01845831|3620465|P4|COMPLETED|Outpatient Phase||98
1479588|NCT01845831|3620466|P3|COMPLETED|Outpatient Phase||68
1479589|NCT01845831|3620467|P2|COMPLETED|Outpatient Phase||0
1479590|NCT01845831|3620468|P1|COMPLETED|Outpatient Phase||0
1479591|NCT01845831|3620464|P5|STARTED|Outpatient Phase||87
1479592|NCT01845831|3620465|P4|STARTED|Outpatient Phase||98
1479593|NCT01845831|3620466|P3|STARTED|Outpatient Phase||68
1479594|NCT01845831|3620467|P2|STARTED|Outpatient Phase||0
1479595|NCT01845831|3620468|P1|STARTED|Outpatient Phase||0
1479596|NCT01845831|3620464|P5|NOT COMPLETED|Inpatient Phase||0
1479597|NCT01845831|3620465|P4|NOT COMPLETED|Inpatient Phase||0
1479598|NCT01845831|3620466|P3|NOT COMPLETED|Inpatient Phase||0
1479599|NCT01845831|3620467|P2|NOT COMPLETED|Inpatient Phase||1
1479600|NCT01845831|3620468|P1|NOT COMPLETED|Inpatient Phase||1
1479601|NCT01845831|3620464|P5|COMPLETED|Inpatient Phase||0
1479602|NCT01845831|3620465|P4|COMPLETED|Inpatient Phase||0
1479603|NCT01845831|3620466|P3|COMPLETED|Inpatient Phase||0
1479604|NCT01845831|3620467|P2|COMPLETED|Inpatient Phase||138
1479605|NCT01845831|3620468|P1|COMPLETED|Inpatient Phase||139
1479606|NCT01845831|3620464|P5|STARTED|Inpatient Phase||0
1479607|NCT01845831|3620465|P4|STARTED|Inpatient Phase||0
1479608|NCT01845831|3620466|P3|STARTED|Inpatient Phase||0
1479609|NCT01845831|3620467|P2|STARTED|Inpatient Phase||139
1479610|NCT01845831|3620468|P1|STARTED|Inpatient Phase||140
1479611|NCT01845792|3620497|P2|NOT COMPLETED|Overall Study||0
1479612|NCT01845792|3620498|P1|NOT COMPLETED|Overall Study||0
1479613|NCT01845792|3620497|P2|COMPLETED|Overall Study||2
1479614|NCT01845792|3620498|P1|COMPLETED|Overall Study||5
1479615|NCT01845792|3620497|P2|STARTED|Overall Study||2
1479616|NCT01845792|3620498|P1|STARTED|Overall Study||5
1479617|NCT01845636|3620506|P1|NOT COMPLETED|Overall Study||4
1479618|NCT01845636|3620506|P1|COMPLETED|Overall Study||37
1479619|NCT01845636|3620506|P1|STARTED|Overall Study||41
1479620|NCT01845220|3620514|P2|NOT COMPLETED|Overall Study||0
1479621|NCT01845220|3620515|P1|NOT COMPLETED|Overall Study||0
1479622|NCT01845220|3620514|P2|COMPLETED|Overall Study||30
1479623|NCT01845220|3620515|P1|COMPLETED|Overall Study||30
1479624|NCT01845220|3620514|P2|STARTED|Overall Study||30
1479625|NCT01845220|3620515|P1|STARTED|Overall Study||30
1479626|NCT01845155|3620523|P2|NOT COMPLETED|Overall Study||0
1479627|NCT01845155|3620524|P1|NOT COMPLETED|Overall Study||1
1479628|NCT01845155|3620523|P2|COMPLETED|Overall Study||144
1479629|NCT01845155|3620524|P1|COMPLETED|Overall Study||145
1479630|NCT01845155|3620523|P2|STARTED|Overall Study||144
1479631|NCT01845155|3620524|P1|STARTED|Overall Study||146
1479632|NCT01845103|3620532|P1|NOT COMPLETED|Overall Study||0
1479633|NCT01845103|3620532|P1|COMPLETED|Overall Study||1
1479634|NCT01845103|3620532|P1|STARTED|Overall Study||1
1479635|NCT01845077|3620540|P6|NOT COMPLETED|Treatment Period 2||0
1479636|NCT01845077|3620541|P5|NOT COMPLETED|Treatment Period 2||0
1479637|NCT01845077|3620542|P4|NOT COMPLETED|Treatment Period 2||0
1479638|NCT01845077|3620543|P3|NOT COMPLETED|Treatment Period 2||0
1479639|NCT01845077|3620544|P2|NOT COMPLETED|Treatment Period 2||0
1479640|NCT01845077|3620545|P1|NOT COMPLETED|Treatment Period 2||0
1479641|NCT01845077|3620540|P6|COMPLETED|Treatment Period 2||11
1479642|NCT01845077|3620541|P5|COMPLETED|Treatment Period 2||11
1479643|NCT01845077|3620542|P4|COMPLETED|Treatment Period 2||10
1479644|NCT01845077|3620543|P3|COMPLETED|Treatment Period 2||11
1479645|NCT01845077|3620544|P2|COMPLETED|Treatment Period 2||11
1479646|NCT01845077|3620545|P1|COMPLETED|Treatment Period 2||11
1479647|NCT01845077|3620540|P6|STARTED|Treatment Period 2||11
1479648|NCT01845077|3620541|P5|STARTED|Treatment Period 2||11
1479649|NCT01845077|3620542|P4|STARTED|Treatment Period 2||10
1479650|NCT01845077|3620543|P3|STARTED|Treatment Period 2||11
1479651|NCT01845077|3620544|P2|STARTED|Treatment Period 2||11
1479652|NCT01845077|3620545|P1|STARTED|Treatment Period 2||11
1479653|NCT01845077|3620540|P6|NOT COMPLETED|Washout Period||1
1479654|NCT01845077|3620541|P5|NOT COMPLETED|Washout Period||1
1479655|NCT01845077|3620542|P4|NOT COMPLETED|Washout Period||2
1479656|NCT01845077|3620543|P3|NOT COMPLETED|Washout Period||1
1479657|NCT01845077|3620544|P2|NOT COMPLETED|Washout Period||1
1479658|NCT01845077|3620545|P1|NOT COMPLETED|Washout Period||1
1479659|NCT01845077|3620540|P6|COMPLETED|Washout Period||11
1479660|NCT01845077|3620541|P5|COMPLETED|Washout Period||11
1479661|NCT01845077|3620542|P4|COMPLETED|Washout Period||10
1479662|NCT01845077|3620543|P3|COMPLETED|Washout Period||11
1479663|NCT01845077|3620544|P2|COMPLETED|Washout Period||11
1479664|NCT01845077|3620545|P1|COMPLETED|Washout Period||11
1479665|NCT01845077|3620540|P6|STARTED|Washout Period||12
1479666|NCT01845077|3620541|P5|STARTED|Washout Period||12
1479667|NCT01845077|3620542|P4|STARTED|Washout Period||12
1479668|NCT01845077|3620543|P3|STARTED|Washout Period||12
1479669|NCT01845077|3620544|P2|STARTED|Washout Period||12
1479670|NCT01845077|3620545|P1|STARTED|Washout Period||12
1479671|NCT01845077|3620540|P6|NOT COMPLETED|Treatment Period 1||0
1479672|NCT01845077|3620541|P5|NOT COMPLETED|Treatment Period 1||0
1479673|NCT01845077|3620542|P4|NOT COMPLETED|Treatment Period 1||0
1479674|NCT01845077|3620543|P3|NOT COMPLETED|Treatment Period 1||0
1479675|NCT01845077|3620544|P2|NOT COMPLETED|Treatment Period 1||0
1479676|NCT01845077|3620545|P1|NOT COMPLETED|Treatment Period 1||0
1479677|NCT01845077|3620540|P6|COMPLETED|Treatment Period 1||12
1479678|NCT01845077|3620541|P5|COMPLETED|Treatment Period 1||12
1479679|NCT01845077|3620542|P4|COMPLETED|Treatment Period 1||12
1479680|NCT01845077|3620543|P3|COMPLETED|Treatment Period 1||12
1479681|NCT01845077|3620544|P2|COMPLETED|Treatment Period 1||12
1479682|NCT01845077|3620545|P1|COMPLETED|Treatment Period 1||12
1479683|NCT01845077|3620540|P6|STARTED|Treatment Period 1||12
1479684|NCT01845077|3620541|P5|STARTED|Treatment Period 1||12
1479685|NCT01845077|3620542|P4|STARTED|Treatment Period 1||12
1479686|NCT01845077|3620543|P3|STARTED|Treatment Period 1||12
1479687|NCT01845077|3620544|P2|STARTED|Treatment Period 1||12
1479688|NCT01845077|3620545|P1|STARTED|Treatment Period 1||12
1479689|NCT01845025|3620591|P2|NOT COMPLETED|Overall Study||77
1479690|NCT01845025|3620592|P1|NOT COMPLETED|Overall Study||85
1479691|NCT01845025|3620591|P2|COMPLETED|Overall Study||332
1479692|NCT01845025|3620592|P1|COMPLETED|Overall Study||326
1479693|NCT01845025|3620591|P2|STARTED|Overall Study||409
1479694|NCT01845025|3620592|P1|STARTED|Overall Study||411
1479695|NCT01844895|3620614|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
1479696|NCT01844895|3620614|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
1479697|NCT01844895|3620614|P1|STARTED|Day 29 - Day113 - Autoinjector||117
1479698|NCT01844895|3620614|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
1479699|NCT01844895|3620614|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
1479700|NCT01844895|3620614|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
1479701|NCT01844856|3620632|P2|NOT COMPLETED|Overall Study||16
1479702|NCT01844856|3620633|P1|NOT COMPLETED|Overall Study||24
1479703|NCT01844856|3620632|P2|COMPLETED|Overall Study||255
1479704|NCT01844856|3620633|P1|COMPLETED|Overall Study||246
1479705|NCT01844856|3620632|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
1479706|NCT01844856|3620633|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
1479707|NCT01844856|3620632|P2|STARTED|Overall Study||271
1479708|NCT01844856|3620633|P1|STARTED|Overall Study||270
1479709|NCT01844830|3620645|P2|NOT COMPLETED|Overall Study||0
1479710|NCT01844830|3620646|P1|NOT COMPLETED|Overall Study||1
1479711|NCT01844830|3620645|P2|COMPLETED|Overall Study||30
1479712|NCT01844830|3620646|P1|COMPLETED|Overall Study||59
1479713|NCT01844830|3620645|P2|400 µL Dose|Overall Study||10
1479714|NCT01844830|3620646|P1|400 µL Dose|Overall Study||20
1479715|NCT01844830|3620645|P2|200 µL Dose|Overall Study||12
1479716|NCT01844830|3620646|P1|200 µL Dose|Overall Study||24
1479717|NCT01844830|3620645|P2|100 µL Dose|Overall Study||8
1479718|NCT01844830|3620646|P1|100 µL Dose|Overall Study||16
1479719|NCT01844830|3620645|P2|STARTED|Overall Study||30
1479720|NCT01844830|3620646|P1|STARTED|Overall Study||60
1479721|NCT01844817|3620676|P2|NOT COMPLETED|Treatment||63
1479722|NCT01844817|3620677|P1|NOT COMPLETED|Treatment||64
1479723|NCT01844817|3620676|P2|COMPLETED|Treatment||0
1479724|NCT01844817|3620677|P1|COMPLETED|Treatment||0
1479725|NCT01844817|3620676|P2|STARTED|Treatment||63
1479726|NCT01844817|3620677|P1|STARTED|Treatment||64
1479727|NCT01844817|3620676|P2|NOT COMPLETED|Enrolled and Randomized||3
1479728|NCT01844817|3620677|P1|NOT COMPLETED|Enrolled and Randomized||2
1479729|NCT01844817|3620676|P2|COMPLETED|Enrolled and Randomized||63
1479730|NCT01844817|3620677|P1|COMPLETED|Enrolled and Randomized||64
1479731|NCT01844817|3620676|P2|STARTED|Enrolled and Randomized||66
1479732|NCT01844817|3620677|P1|STARTED|Enrolled and Randomized||66
1479733|NCT01844778|3620690|P3|NOT COMPLETED|Overall Study||4
1479734|NCT01844778|3620691|P2|NOT COMPLETED|Overall Study||3
1479735|NCT01844778|3620692|P1|NOT COMPLETED|Overall Study||2
1479736|NCT01844778|3620690|P3|COMPLETED|Overall Study||14
1479737|NCT01844778|3620691|P2|COMPLETED|Overall Study||25
1479738|NCT01844778|3620692|P1|COMPLETED|Overall Study||12
1479739|NCT01844778|3620690|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
1479740|NCT01844778|3620691|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
1479741|NCT01844778|3620692|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
1479742|NCT01844778|3620690|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
1479743|NCT01844778|3620691|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
1479744|NCT01844778|3620692|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
1479745|NCT01844778|3620690|P3|STARTED|Overall Study||18
1479746|NCT01844778|3620691|P2|STARTED|Overall Study||28
1479747|NCT01844778|3620692|P1|STARTED|Overall Study||14
1479748|NCT01844765|3620718|P2|NOT COMPLETED|Overall Study||6
1479749|NCT01844765|3620719|P1|NOT COMPLETED|Overall Study||9
1479750|NCT01844765|3620718|P2|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|19
1479751|NCT01844765|3620719|P1|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|25
1479752|NCT01844765|3620718|P2|Untreated|Overall Study||0
1479753|NCT01844765|3620719|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
1479754|NCT01844765|3620718|P2|Treated|Overall Study||25
1479755|NCT01844765|3620719|P1|Treated|Overall Study||33
1479756|NCT01844765|3620718|P2|STARTED|Overall Study||25
1479757|NCT01844765|3620719|P1|STARTED|Overall Study||34
1479758|NCT01844700|3620739|P2|NOT COMPLETED|Overall Study||1
1479759|NCT01844700|3620740|P1|NOT COMPLETED|Overall Study||3
1479760|NCT01844700|3620739|P2|COMPLETED|Overall Study||2
1479761|NCT01844700|3620740|P1|COMPLETED|Overall Study||1
1479762|NCT01844700|3620739|P2|STARTED|Overall Study||3
1479763|NCT01844700|3620740|P1|STARTED|Overall Study||4
1479764|NCT01844687|3620752|P1|NOT COMPLETED|Visit 8||0
1479765|NCT01844687|3620752|P1|COMPLETED|Visit 8||31
1479766|NCT01844687|3620752|P1|STARTED|Visit 8||31
1479767|NCT01844687|3620752|P1|NOT COMPLETED|Visit 7||0
1479768|NCT01844687|3620752|P1|COMPLETED|Visit 7||31
1479769|NCT01844687|3620752|P1|STARTED|Visit 7||31
1479770|NCT01844687|3620752|P1|NOT COMPLETED|Visit 6||0
1479771|NCT01844687|3620752|P1|COMPLETED|Visit 6||31
1479772|NCT01844687|3620752|P1|STARTED|Visit 6||31
1479773|NCT01844687|3620752|P1|NOT COMPLETED|Visit 5||0
1479774|NCT01844687|3620752|P1|COMPLETED|Visit 5||31
1479775|NCT01844687|3620752|P1|STARTED|Visit 5||31
1479776|NCT01844687|3620752|P1|NOT COMPLETED|Visit 4||4
1479777|NCT01844687|3620752|P1|COMPLETED|Visit 4||31
1479778|NCT01844687|3620752|P1|STARTED|Visit 4||35
1479779|NCT01844687|3620752|P1|NOT COMPLETED|Visit 3||5
1479780|NCT01844687|3620752|P1|COMPLETED|Visit 3||35
1479781|NCT01844687|3620752|P1|STARTED|Visit 3||40
1479782|NCT01844687|3620752|P1|NOT COMPLETED|Visit 2||2
1479783|NCT01844687|3620752|P1|COMPLETED|Visit 2||40
1479784|NCT01844687|3620752|P1|STARTED|Visit 2||42
1479785|NCT01844687|3620752|P1|NOT COMPLETED|Visit 1||8
1479786|NCT01844687|3620752|P1|COMPLETED|Visit 1||42
1479787|NCT01844687|3620752|P1|STARTED|Visit 1||50
1479788|NCT01844531|3620815|P4|NOT COMPLETED|Overall Study||0
1479789|NCT01844531|3620816|P3|NOT COMPLETED|Overall Study||0
1479790|NCT01844531|3620817|P2|NOT COMPLETED|Overall Study||1
1479791|NCT01844531|3620818|P1|NOT COMPLETED|Overall Study||0
1479792|NCT01844531|3620815|P4|COMPLETED|Overall Study||6
1479793|NCT01844531|3620816|P3|COMPLETED|Overall Study||6
1479794|NCT01844531|3620817|P2|COMPLETED|Overall Study||5
1479795|NCT01844531|3620818|P1|COMPLETED|Overall Study||6
1479796|NCT01844531|3620815|P4|STARTED|Overall Study||6
1479797|NCT01844531|3620816|P3|STARTED|Overall Study||6
1479798|NCT01844531|3620817|P2|STARTED|Overall Study||6
1479799|NCT01844531|3620818|P1|STARTED|Overall Study||6
1479800|NCT01844518|3620848|P1|NOT COMPLETED|Long-Term Extension||157
1479801|NCT01844518|3620848|P1|COMPLETED|Long-Term Extension|Study is on-going|0
1479802|NCT01844518|3620848|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
1479803|NCT01844518|3620848|P1|NOT COMPLETED|Short-Term (ST) Period||9
1479804|NCT01844518|3620848|P1|COMPLETED|Short-Term (ST) Period||164
1479805|NCT01844518|3620848|P1|STARTED|Short-Term (ST) Period||173
1479806|NCT01844505|3620865|P3|NOT COMPLETED|Overall Study||295
1479807|NCT01844505|3620866|P2|NOT COMPLETED|Overall Study||269
1479808|NCT01844505|3620867|P1|NOT COMPLETED|Overall Study||249
1479809|NCT01844505|3620865|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
1479810|NCT01844505|3620866|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
1479811|NCT01844505|3620867|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
1479812|NCT01844505|3620865|P3|STARTED|Overall Study||311
1479813|NCT01844505|3620866|P2|STARTED|Overall Study||313
1479814|NCT01844505|3620867|P1|STARTED|Overall Study||313
1479815|NCT01844479|3620917|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
1479816|NCT01844479|3620918|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
1479817|NCT01844479|3620917|P2|COMPLETED|Second Intervention up to 30 Minutes||13
1479818|NCT01844479|3620918|P1|COMPLETED|Second Intervention up to 30 Minutes||14
1479819|NCT01844479|3620917|P2|STARTED|Second Intervention up to 30 Minutes||13
1479820|NCT01844479|3620918|P1|STARTED|Second Intervention up to 30 Minutes||14
1479821|NCT01844479|3620917|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
1479822|NCT01844479|3620918|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
1479823|NCT01844479|3620917|P2|COMPLETED|First Intervention up to 30 Minutes||13
1479824|NCT01844479|3620918|P1|COMPLETED|First Intervention up to 30 Minutes||14
1479825|NCT01844479|3620917|P2|STARTED|First Intervention up to 30 Minutes||13
1479826|NCT01844479|3620918|P1|STARTED|First Intervention up to 30 Minutes||14
1479827|NCT01844388|3620948|P2|NOT COMPLETED|Overall Study||7
1479828|NCT01844388|3620949|P1|NOT COMPLETED|Overall Study||8
1479829|NCT01844388|3620948|P2|COMPLETED|Overall Study||114
1479830|NCT01844388|3620949|P1|COMPLETED|Overall Study||236
1479831|NCT01844388|3620948|P2|STARTED|Overall Study||121
1479832|NCT01844388|3620949|P1|STARTED|Overall Study||244
1479833|NCT01844206|3620961|P2|NOT COMPLETED|Overall Study||1
1479834|NCT01844206|3620962|P1|NOT COMPLETED|Overall Study||0
1479835|NCT01844206|3620961|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
1479836|NCT01844206|3620962|P1|COMPLETED|Overall Study||2
1479837|NCT01844206|3620961|P2|STARTED|Overall Study||3
1479838|NCT01844206|3620962|P1|STARTED|Overall Study||2
1479839|NCT01843972|3620978|P10|NOT COMPLETED|Overall Study||0
1479840|NCT01843972|3620979|P9|NOT COMPLETED|Overall Study||0
1479841|NCT01843972|3620980|P8|NOT COMPLETED|Overall Study||0
1479842|NCT01843972|3620981|P7|NOT COMPLETED|Overall Study||0
1479843|NCT01843972|3620982|P6|NOT COMPLETED|Overall Study||0
1479844|NCT01843972|3620983|P5|NOT COMPLETED|Overall Study||1
1479845|NCT01843972|3620984|P4|NOT COMPLETED|Overall Study||0
1479846|NCT01843972|3620985|P3|NOT COMPLETED|Overall Study||0
1479847|NCT01843972|3620986|P2|NOT COMPLETED|Overall Study||0
1479848|NCT01843972|3620987|P1|NOT COMPLETED|Overall Study||0
1479849|NCT01843972|3620978|P10|COMPLETED|Overall Study||12
1479850|NCT01843972|3620979|P9|COMPLETED|Overall Study||17
1479851|NCT01843972|3620980|P8|COMPLETED|Overall Study||5
1479852|NCT01843972|3620981|P7|COMPLETED|Overall Study||5
1479853|NCT01843972|3620982|P6|COMPLETED|Overall Study||6
1479854|NCT01843972|3620983|P5|COMPLETED|Overall Study||5
1479855|NCT01843972|3620984|P4|COMPLETED|Overall Study||6
1479856|NCT01843972|3620985|P3|COMPLETED|Overall Study||5
1479857|NCT01843972|3620986|P2|COMPLETED|Overall Study||6
1479858|NCT01843972|3620987|P1|COMPLETED|Overall Study||13
1479859|NCT01843972|3620978|P10|STARTED|Overall Study||12
1479860|NCT01843972|3620979|P9|STARTED|Overall Study||17
1479861|NCT01843972|3620980|P8|STARTED|Overall Study||5
1479862|NCT01843972|3620981|P7|STARTED|Overall Study||5
1479863|NCT01843972|3620982|P6|STARTED|Overall Study||6
1479864|NCT01843972|3620983|P5|STARTED|Overall Study||6
1479865|NCT01843972|3620984|P4|STARTED|Overall Study||6
1479866|NCT01843972|3620985|P3|STARTED|Overall Study||5
1479867|NCT01843972|3620986|P2|STARTED|Overall Study||6
1479868|NCT01843972|3620987|P1|STARTED|Overall Study||13
1479869|NCT01843933|3621057|P2|NOT COMPLETED|Overall Study||4
1479870|NCT01843933|3621058|P1|NOT COMPLETED|Overall Study||6
1479871|NCT01843933|3621057|P2|COMPLETED|Overall Study||103
1479872|NCT01843933|3621058|P1|COMPLETED|Overall Study||98
1479873|NCT01843933|3621057|P2|STARTED|Overall Study||107
1479874|NCT01843933|3621058|P1|STARTED|Overall Study||104
1479875|NCT01843920|3621066|P2|NOT COMPLETED|Overall Study||0
1479876|NCT01843920|3621067|P1|NOT COMPLETED|Overall Study||0
1479877|NCT01843920|3621066|P2|COMPLETED|Overall Study||9
1479878|NCT01843920|3621067|P1|COMPLETED|Overall Study||12
1479879|NCT01843920|3621066|P2|STARTED|Overall Study||9
1479880|NCT01843920|3621067|P1|STARTED|Overall Study||12
1479881|NCT01843842|3621077|P2|NOT COMPLETED|Overall Study||1
1479882|NCT01843842|3621078|P1|NOT COMPLETED|Overall Study||1
1479883|NCT01843842|3621077|P2|COMPLETED|Overall Study||151
1479884|NCT01843842|3621078|P1|COMPLETED|Overall Study||153
1479885|NCT01843842|3621077|P2|STARTED|Overall Study||152
1479886|NCT01843842|3621078|P1|STARTED|Overall Study||154
1479887|NCT01843777|3621100|P2|NOT COMPLETED|Overall Study||0
1479888|NCT01843777|3621101|P1|NOT COMPLETED|Overall Study||1
1479889|NCT01843777|3621100|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
1479890|NCT01843777|3621101|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
1479891|NCT01843777|3621100|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
1479892|NCT01843777|3621101|P1|Per Protocol Population|Overall Study||11
1479893|NCT01843777|3621100|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
1479894|NCT01843777|3621101|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
1479895|NCT01843673|3621109|P1|NOT COMPLETED|Overall Study||6
1479896|NCT01843673|3621109|P1|COMPLETED|Overall Study||10
1479897|NCT01843673|3621109|P1|STARTED|Overall Study||16
1479898|NCT01843660|3621121|P1|NOT COMPLETED|Overall Study||30
1479899|NCT01843660|3621121|P1|COMPLETED|Overall Study||1029
1479900|NCT01843660|3621121|P1|STARTED|Overall Study||1059
1479901|NCT01843621|3621139|P1|NOT COMPLETED|Overall Study||0
1479902|NCT01843621|3621139|P1|COMPLETED|Overall Study||7
1479903|NCT01843621|3621139|P1|STARTED|Overall Study||7
1479904|NCT01843465|3621156|P1|NOT COMPLETED|Overall Study||0
1479905|NCT01843465|3621156|P1|COMPLETED|Overall Study||34
1479906|NCT01843465|3621156|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
1479907|NCT01843374|3621162|P2|NOT COMPLETED|Overall Study||379
1479908|NCT01843374|3621163|P1|NOT COMPLETED|Overall Study||189
1479909|NCT01843374|3621162|P2|COMPLETED|Overall Study||3
1479910|NCT01843374|3621163|P1|COMPLETED|Overall Study||0
1479911|NCT01843374|3621162|P2|RANDOMIZED|Overall Study||382
1479912|NCT01843374|3621163|P1|RANDOMIZED|Overall Study||189
1479913|NCT01843374|3621162|P2|STARTED|Overall Study||382
1479914|NCT01843374|3621163|P1|STARTED|Overall Study||189
1479915|NCT01843348|3621190|P3|NOT COMPLETED|Overall Study||41
1479916|NCT01843348|3621191|P2|NOT COMPLETED|Overall Study||40
1479917|NCT01843348|3621192|P1|NOT COMPLETED|Overall Study||23
1479918|NCT01843348|3621190|P3|COMPLETED|Overall Study||158
1479919|NCT01843348|3621191|P2|COMPLETED|Overall Study||168
1479920|NCT01843348|3621192|P1|COMPLETED|Overall Study||182
1479921|NCT01843348|3621190|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
1479922|NCT01843348|3621191|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
1479923|NCT01843348|3621192|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
1479924|NCT01843348|3621190|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
1479925|NCT01843348|3621191|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
1479926|NCT01843348|3621192|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
1479927|NCT01843348|3621190|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
1479928|NCT01843348|3621191|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
1479929|NCT01843348|3621192|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
1479930|NCT01843348|3621190|P3|STARTED|Overall Study||199
1479931|NCT01843348|3621191|P2|STARTED|Overall Study||208
1479932|NCT01843348|3621192|P1|STARTED|Overall Study||205
1479933|NCT01843205|3621232|P2|NOT COMPLETED|Second Treatment (11 Days)||0
1479934|NCT01843205|3621233|P1|NOT COMPLETED|Second Treatment (11 Days)||0
1479935|NCT01843205|3621232|P2|COMPLETED|Second Treatment (11 Days)||4
1479936|NCT01843205|3621233|P1|COMPLETED|Second Treatment (11 Days)||4
1479937|NCT01843205|3621232|P2|STARTED|Second Treatment (11 Days)||4
1479938|NCT01843205|3621233|P1|STARTED|Second Treatment (11 Days)||4
1479939|NCT01843205|3621232|P2|NOT COMPLETED|First Treatment (11 Days)||0
1479940|NCT01843205|3621233|P1|NOT COMPLETED|First Treatment (11 Days)||1
1479941|NCT01843205|3621232|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
1479942|NCT01843205|3621233|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
1479943|NCT01843205|3621232|P2|STARTED|First Treatment (11 Days)||4
1479944|NCT01843205|3621233|P1|STARTED|First Treatment (11 Days)||5
1479945|NCT01843192|3621294|P3|NOT COMPLETED|Overall Study||2
1479946|NCT01843192|3621295|P2|NOT COMPLETED|Overall Study||6
1479947|NCT01843192|3621296|P1|NOT COMPLETED|Overall Study||2
1479948|NCT01843192|3621294|P3|COMPLETED|Overall Study||9
1479949|NCT01843192|3621295|P2|COMPLETED|Overall Study||28
1479950|NCT01843192|3621296|P1|COMPLETED|Overall Study||24
1479951|NCT01843192|3621294|P3|STARTED|Overall Study||11
1479952|NCT01843192|3621295|P2|STARTED|Overall Study||34
1479953|NCT01843192|3621296|P1|STARTED|Overall Study||26
1479954|NCT01842958|3621327|P2|NOT COMPLETED|Overall Study||1
1479955|NCT01842958|3621328|P1|NOT COMPLETED|Overall Study||1
1479956|NCT01842958|3621327|P2|COMPLETED|Overall Study||24
1479957|NCT01842958|3621328|P1|COMPLETED|Overall Study||24
1479958|NCT01842958|3621327|P2|Randomized|Overall Study||25
1479959|NCT01842958|3621328|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
1479960|NCT01842958|3621327|P2|STARTED|Overall Study||25
1479961|NCT01842958|3621328|P1|STARTED|Overall Study||25
1479962|NCT01842906|3621348|P2|NOT COMPLETED|Overall Study||0
1479963|NCT01842906|3621349|P1|NOT COMPLETED|Overall Study||0
1479964|NCT01842906|3621348|P2|COMPLETED|Overall Study||104
1479965|NCT01842906|3621349|P1|COMPLETED|Overall Study||115
1479966|NCT01842906|3621348|P2|STARTED|Overall Study||104
1479967|NCT01842906|3621349|P1|STARTED|Overall Study||115
1479968|NCT01842841|3621361|P1|NOT COMPLETED|Overall Study||0
1479969|NCT01842841|3621361|P1|COMPLETED|Overall Study||5
1479970|NCT01842841|3621361|P1|STARTED|Overall Study||5
1479971|NCT01842789|3621382|P2|NOT COMPLETED|Overall Study||0
1479972|NCT01842789|3621383|P1|NOT COMPLETED|Overall Study||0
1479973|NCT01842789|3621382|P2|COMPLETED|Overall Study||8
1479974|NCT01842789|3621383|P1|COMPLETED|Overall Study||10
1479975|NCT01842789|3621382|P2|STARTED|Overall Study||8
1479976|NCT01842789|3621383|P1|STARTED|Overall Study||10
1479977|NCT01842646|3621392|P1|NOT COMPLETED|Overall Study||0
1479978|NCT01842646|3621392|P1|COMPLETED|Overall Study||35
1479979|NCT01842646|3621392|P1|STARTED|Overall Study||35
1479980|NCT01842633|3621403|P3|NOT COMPLETED|Overall Study||0
1479981|NCT01842633|3621404|P2|NOT COMPLETED|Overall Study||2
1479982|NCT01842633|3621405|P1|NOT COMPLETED|Overall Study||3
1479983|NCT01842633|3621403|P3|COMPLETED|Overall Study||34
1479984|NCT01842633|3621404|P2|COMPLETED|Overall Study||64
1479985|NCT01842633|3621405|P1|COMPLETED|Overall Study||62
1479986|NCT01842633|3621403|P3|STARTED|Overall Study||34
1479987|NCT01842633|3621404|P2|STARTED|Overall Study||66
1479988|NCT01842633|3621405|P1|STARTED|Overall Study||65
1479989|NCT01842620|3621452|P2|NOT COMPLETED|Period 2||0
1479990|NCT01842620|3621453|P1|NOT COMPLETED|Period 2||0
1479991|NCT01842620|3621452|P2|COMPLETED|Period 2||12
1479992|NCT01842620|3621453|P1|COMPLETED|Period 2||12
1479993|NCT01842620|3621452|P2|STARTED|Period 2||12
1479994|NCT01842620|3621453|P1|STARTED|Period 2||12
1479995|NCT01842620|3621452|P2|NOT COMPLETED|Washout Period||0
1479996|NCT01842620|3621453|P1|NOT COMPLETED|Washout Period||0
1479997|NCT01842620|3621452|P2|COMPLETED|Washout Period||12
1479998|NCT01842620|3621453|P1|COMPLETED|Washout Period||12
1479999|NCT01842620|3621452|P2|STARTED|Washout Period||12
1480000|NCT01842620|3621453|P1|STARTED|Washout Period||12
1480001|NCT01842620|3621452|P2|NOT COMPLETED|Period 1||0
1480002|NCT01842620|3621453|P1|NOT COMPLETED|Period 1||1
1480003|NCT01842620|3621452|P2|COMPLETED|Period 1||12
1480004|NCT01842620|3621453|P1|COMPLETED|Period 1||12
1480005|NCT01842620|3621452|P2|STARTED|Period 1||12
1480006|NCT01842620|3621453|P1|STARTED|Period 1||13
1480007|NCT01842607|3621469|P1|NOT COMPLETED|Overall Study||66
1480008|NCT01842607|3621469|P1|COMPLETED|Overall Study||585
1480009|NCT01842607|3621469|P1|STARTED|Overall Study||651
1480010|NCT01842594|3621488|P1|NOT COMPLETED|Overall Study||3
1480011|NCT01842594|3621488|P1|COMPLETED|Overall Study||10
1480012|NCT01842594|3621488|P1|STARTED|Overall Study||13
1480013|NCT01842464|3621493|P1|NOT COMPLETED|Overall Study||0
1480014|NCT01842464|3621493|P1|COMPLETED|Overall Study||44
1480015|NCT01842464|3621493|P1|STARTED|Overall Study||44
1480016|NCT01842438|3621501|P2|NOT COMPLETED|T2: 6month Follow-up||4
1480017|NCT01842438|3621502|P1|NOT COMPLETED|T2: 6month Follow-up||4
1480018|NCT01842438|3621501|P2|COMPLETED|T2: 6month Follow-up||32
1480019|NCT01842438|3621502|P1|COMPLETED|T2: 6month Follow-up||32
1480020|NCT01842438|3621501|P2|STARTED|T2: 6month Follow-up||36
1480021|NCT01842438|3621502|P1|STARTED|T2: 6month Follow-up||36
1480022|NCT01842438|3621501|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
1480023|NCT01842438|3621502|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
1480024|NCT01842438|3621501|P2|COMPLETED|T1: Immediately After the Intervention||36
1480025|NCT01842438|3621502|P1|COMPLETED|T1: Immediately After the Intervention||36
1480026|NCT01842438|3621501|P2|STARTED|T1: Immediately After the Intervention||44
1480027|NCT01842438|3621502|P1|STARTED|T1: Immediately After the Intervention||42
1480028|NCT01842334|3621516|P2|NOT COMPLETED|Overall Study||4
1480029|NCT01842334|3621517|P1|NOT COMPLETED|Overall Study||3
1480030|NCT01842334|3621516|P2|COMPLETED|Overall Study||3
1480031|NCT01842334|3621517|P1|COMPLETED|Overall Study||2
1480032|NCT01842334|3621516|P2|STARTED|Overall Study||7
1480033|NCT01842334|3621517|P1|STARTED|Overall Study||5
1480034|NCT01841970|3621523|P1|NOT COMPLETED|Overall Study||11
1480035|NCT01841970|3621523|P1|COMPLETED|Overall Study||9
1480036|NCT01841970|3621523|P1|STARTED|Overall Study||20
1480037|NCT01841931|3621539|P1|NOT COMPLETED|Overall Study||4
1480038|NCT01841931|3621539|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
1480039|NCT01841931|3621539|P1|STARTED|Overall Study||4
1480040|NCT01841762|3621547|P1|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
1480041|NCT01841762|3621547|P1|COMPLETED|Post-Treatment Safety Follow-Up Period||269
1480042|NCT01841762|3621547|P1|STARTED|Post-Treatment Safety Follow-Up Period||284
1480043|NCT01841762|3621547|P1|NOT COMPLETED|Treatment Period||32
1480044|NCT01841762|3621547|P1|COMPLETED|Treatment Period||252
1480045|NCT01841762|3621547|P1|STARTED|Treatment Period||284
1480046|NCT01841762|3621547|P1|NOT COMPLETED|Screening Period||51
1480047|NCT01841762|3621547|P1|COMPLETED|Screening Period||284
1480048|NCT01841762|3621547|P1|STARTED|Screening Period||335
1480049|NCT01841697|3621557|P2|NOT COMPLETED|Overall Study||18
1480050|NCT01841697|3621558|P1|NOT COMPLETED|Overall Study||20
1480051|NCT01841697|3621557|P2|COMPLETED|Overall Study||302
1480052|NCT01841697|3621558|P1|COMPLETED|Overall Study||302
1480053|NCT01841697|3621557|P2|STARTED|Overall Study||320
1480054|NCT01841697|3621558|P1|STARTED|Overall Study||322
1480055|NCT01841632|3621574|P1|NOT COMPLETED|Overall Study||0
1480056|NCT01841632|3621574|P1|COMPLETED|Overall Study||3
1480057|NCT01841632|3621574|P1|STARTED|Overall Study||3
1480058|NCT01841619|3621579|P1|NOT COMPLETED|Overall Study||0
1480059|NCT01841619|3621579|P1|COMPLETED|Overall Study||16
1480060|NCT01841619|3621579|P1|STARTED|Overall Study||16
1480061|NCT01841606|3621589|P2|NOT COMPLETED|Overall Study||0
1480062|NCT01841606|3621590|P1|NOT COMPLETED|Overall Study||0
1480063|NCT01841606|3621589|P2|COMPLETED|Overall Study||27
1480064|NCT01841606|3621590|P1|COMPLETED|Overall Study||25
1480065|NCT01841606|3621589|P2|STARTED|Overall Study||27
1480066|NCT01841606|3621590|P1|STARTED|Overall Study||25
1480067|NCT01841593|3621598|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
1480068|NCT01841593|3621599|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
1480069|NCT01841593|3621598|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
1480070|NCT01841593|3621599|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
1480071|NCT01841593|3621598|P2|STARTED|Third Intervention (Days 15 to 21)||6
1480072|NCT01841593|3621599|P1|STARTED|Third Intervention (Days 15 to 21)||11
1480073|NCT01841593|3621598|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
1480074|NCT01841593|3621599|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
1480075|NCT01841593|3621598|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
1480076|NCT01841593|3621599|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
1480077|NCT01841593|3621598|P2|STARTED|Second Intervention (Days 8 to 14)||6
1480078|NCT01841593|3621599|P1|STARTED|Second Intervention (Days 8 to 14)||12
1480079|NCT01841593|3621598|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
1480080|NCT01841593|3621599|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
1480081|NCT01841593|3621598|P2|COMPLETED|First Intervention (Days 1 to 7)||6
1480082|NCT01841593|3621599|P1|COMPLETED|First Intervention (Days 1 to 7)||12
1480083|NCT01841593|3621598|P2|STARTED|First Intervention (Days 1 to 7)||7
1480084|NCT01841593|3621599|P1|STARTED|First Intervention (Days 1 to 7)||12
1480085|NCT01841567|3621615|P1|NOT COMPLETED|Overall Study||3
1480086|NCT01841567|3621615|P1|COMPLETED|Overall Study||57
1480087|NCT01841567|3621615|P1|STARTED|Overall Study||60
1480088|NCT01841216|3621622|P2|NOT COMPLETED|Overall Study||0
1480089|NCT01841216|3621623|P1|NOT COMPLETED|Overall Study||0
1480090|NCT01841216|3621622|P2|COMPLETED|Overall Study||15
1480091|NCT01841216|3621623|P1|COMPLETED|Overall Study||15
1480092|NCT01841216|3621622|P2|STARTED|Overall Study||15
1480093|NCT01841216|3621623|P1|STARTED|Overall Study||15
1480094|NCT01841021|3621631|P1|NOT COMPLETED|Overall Study||0
1480095|NCT01841021|3621631|P1|COMPLETED|Overall Study||1
1480096|NCT01841021|3621631|P1|STARTED|Overall Study||1
1480097|NCT01840943|3621643|P2|NOT COMPLETED|Overall Study||12
1480098|NCT01840943|3621644|P1|NOT COMPLETED|Overall Study||13
1480099|NCT01840943|3621643|P2|COMPLETED|Overall Study||0
1480100|NCT01840943|3621644|P1|COMPLETED|Overall Study||1
1480101|NCT01840943|3621643|P2|STARTED|Overall Study||12
1480102|NCT01840943|3621644|P1|STARTED|Overall Study||14
1480103|NCT01840605|3621680|P2|NOT COMPLETED|Overall Study||2
1480104|NCT01840605|3621681|P1|NOT COMPLETED|Overall Study||2
1480105|NCT01840605|3621680|P2|COMPLETED|Overall Study||150
1480106|NCT01840605|3621681|P1|COMPLETED|Overall Study||149
1480107|NCT01840605|3621680|P2|STARTED|Overall Study||152
1480108|NCT01840605|3621681|P1|STARTED|Overall Study||151
1480109|NCT01840410|3621695|P2|NOT COMPLETED|Overall Study||4
1480110|NCT01840410|3621696|P1|NOT COMPLETED|Overall Study||7
1480111|NCT01840410|3621695|P2|COMPLETED|Overall Study||55
1480112|NCT01840410|3621696|P1|COMPLETED|Overall Study||112
1480113|NCT01840410|3621695|P2|Full Analysis Set|Overall Study||59
1480114|NCT01840410|3621696|P1|Full Analysis Set|Overall Study||119
1480115|NCT01840410|3621695|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
1480116|NCT01840410|3621696|P1|Safety Set|Overall Study||119
1480117|NCT01840410|3621695|P2|STARTED|Overall Study||59
1480118|NCT01840410|3621696|P1|STARTED|Overall Study||119
1480119|NCT01840345|3621732|P1|NOT COMPLETED|Overall Study||1
1480120|NCT01840345|3621732|P1|COMPLETED|Overall Study||10
1480121|NCT01840345|3621732|P1|STARTED|Overall Study||11
1480122|NCT01840319|3621739|P1|NOT COMPLETED|Overall Study||0
1480123|NCT01840319|3621739|P1|COMPLETED|Overall Study||156
1480124|NCT01840319|3621739|P1|STARTED|Overall Study||156
1480125|NCT01840163|3621745|P2|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
1480126|NCT01840163|3621746|P1|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
1480127|NCT01840163|3621745|P2|COMPLETED|Systemic Follow Up-secondary Outcome||191
1480128|NCT01840163|3621746|P1|COMPLETED|Systemic Follow Up-secondary Outcome||174
1480129|NCT01840163|3621745|P2|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
1480130|NCT01840163|3621746|P1|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
1480131|NCT01840163|3621745|P2|NOT COMPLETED|First Follow up -Primary Outcome||16
1480132|NCT01840163|3621746|P1|NOT COMPLETED|First Follow up -Primary Outcome||19
1480133|NCT01840163|3621745|P2|COMPLETED|First Follow up -Primary Outcome||254
1480134|NCT01840163|3621746|P1|COMPLETED|First Follow up -Primary Outcome||248
1480135|NCT01840163|3621745|P2|STARTED|First Follow up -Primary Outcome||270
1480136|NCT01840163|3621746|P1|STARTED|First Follow up -Primary Outcome||267
1480137|NCT01840072|3621768|P2|NOT COMPLETED|Overall Study||47
1480138|NCT01840072|3621769|P1|NOT COMPLETED|Overall Study||7
1480139|NCT01840072|3621768|P2|COMPLETED|Overall Study||1986
1480140|NCT01840072|3621769|P1|COMPLETED|Overall Study||2031
1480141|NCT01840072|3621768|P2|STARTED|Overall Study||2033
1480142|NCT01840072|3621769|P1|STARTED|Overall Study||2038
1480143|NCT01839708|3621793|P2|NOT COMPLETED|Overall Study||67
1480144|NCT01839708|3621794|P1|NOT COMPLETED|Overall Study||76
1480145|NCT01839708|3621793|P2|COMPLETED|Overall Study||115
1480146|NCT01839708|3621794|P1|COMPLETED|Overall Study||311
1480147|NCT01839708|3621793|P2|STARTED|Overall Study||182
1480148|NCT01839708|3621794|P1|STARTED|Overall Study||387
1480149|NCT01839695|3621826|P1|NOT COMPLETED|Overall Study||0
1480150|NCT01839695|3621826|P1|COMPLETED|Overall Study||9
1480151|NCT01839695|3621826|P1|STARTED|Overall Study||9
1480152|NCT01839656|3621833|P2|NOT COMPLETED|Overall Study||16
1480153|NCT01839656|3621834|P1|NOT COMPLETED|Overall Study||3
1480154|NCT01839656|3621833|P2|COMPLETED|Overall Study||0
1480155|NCT01839656|3621834|P1|COMPLETED|Overall Study||2
1480156|NCT01839656|3621833|P2|Completed Loading Dose Period|Overall Study||15
1480157|NCT01839656|3621834|P1|Completed Loading Dose Period|Overall Study||4
1480158|NCT01839656|3621833|P2|STARTED|Overall Study||16
1480159|NCT01839656|3621834|P1|STARTED|Overall Study||5
1480160|NCT01839604|3621861|P5|NOT COMPLETED|Overall Study||0
1480161|NCT01839604|3621862|P4|NOT COMPLETED|Overall Study||0
1480162|NCT01839604|3621863|P3|NOT COMPLETED|Overall Study||0
1480163|NCT01839604|3621864|P2|NOT COMPLETED|Overall Study||0
1480164|NCT01839604|3621865|P1|NOT COMPLETED|Overall Study||0
1480165|NCT01839604|3621861|P5|COMPLETED|Overall Study||15
1480166|NCT01839604|3621862|P4|COMPLETED|Overall Study||5
1480167|NCT01839604|3621863|P3|COMPLETED|Overall Study||7
1480168|NCT01839604|3621864|P2|COMPLETED|Overall Study||6
1480169|NCT01839604|3621865|P1|COMPLETED|Overall Study||6
1480170|NCT01839604|3621861|P5|STARTED|Overall Study||15
1480171|NCT01839604|3621862|P4|STARTED|Overall Study||5
1480172|NCT01839604|3621863|P3|STARTED|Overall Study||7
1480173|NCT01839604|3621864|P2|STARTED|Overall Study||6
1480174|NCT01839604|3621865|P1|STARTED|Overall Study||6
1480175|NCT01839396|3621894|P2|NOT COMPLETED|Overall Study||0
1480176|NCT01839396|3621895|P1|NOT COMPLETED|Overall Study||0
1480177|NCT01839396|3621894|P2|COMPLETED|Overall Study||39
1480178|NCT01839396|3621895|P1|COMPLETED|Overall Study||121
1480179|NCT01839396|3621894|P2|STARTED|Overall Study||39
1480180|NCT01839396|3621895|P1|STARTED|Overall Study||121
1480181|NCT01839318|3621903|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
1480182|NCT01839318|3621904|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
1480183|NCT01839318|3621905|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
1480184|NCT01839318|3621906|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
1480185|NCT01839318|3621907|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
1480186|NCT01839318|3621908|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
1480187|NCT01839318|3621903|P6|COMPLETED|Period 3, Third Day of Wear||2
1480188|NCT01839318|3621904|P5|COMPLETED|Period 3, Third Day of Wear||7
1480189|NCT01839318|3621905|P4|COMPLETED|Period 3, Third Day of Wear||6
1480190|NCT01839318|3621906|P3|COMPLETED|Period 3, Third Day of Wear||5
1480191|NCT01839318|3621907|P2|COMPLETED|Period 3, Third Day of Wear||4
1480192|NCT01839318|3621908|P1|COMPLETED|Period 3, Third Day of Wear||4
1480193|NCT01839318|3621903|P6|STARTED|Period 3, Third Day of Wear||2
1480194|NCT01839318|3621904|P5|STARTED|Period 3, Third Day of Wear||7
1480195|NCT01839318|3621905|P4|STARTED|Period 3, Third Day of Wear||6
1480196|NCT01839318|3621906|P3|STARTED|Period 3, Third Day of Wear||5
1480197|NCT01839318|3621907|P2|STARTED|Period 3, Third Day of Wear||4
1480198|NCT01839318|3621908|P1|STARTED|Period 3, Third Day of Wear||4
1480199|NCT01839318|3621903|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
1480200|NCT01839318|3621904|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
1480201|NCT01839318|3621905|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
1480202|NCT01839318|3621906|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
1480203|NCT01839318|3621907|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
1480204|NCT01839318|3621908|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
1480205|NCT01839318|3621903|P6|COMPLETED|Period 2, Second Day of Wear||2
1480206|NCT01839318|3621904|P5|COMPLETED|Period 2, Second Day of Wear||7
1480207|NCT01839318|3621905|P4|COMPLETED|Period 2, Second Day of Wear||6
1480208|NCT01839318|3621906|P3|COMPLETED|Period 2, Second Day of Wear||5
1480209|NCT01839318|3621907|P2|COMPLETED|Period 2, Second Day of Wear||4
1480210|NCT01839318|3621908|P1|COMPLETED|Period 2, Second Day of Wear||4
1480211|NCT01839318|3621903|P6|STARTED|Period 2, Second Day of Wear||2
1480212|NCT01839318|3621904|P5|STARTED|Period 2, Second Day of Wear||7
1480213|NCT01839318|3621905|P4|STARTED|Period 2, Second Day of Wear||6
1480214|NCT01839318|3621906|P3|STARTED|Period 2, Second Day of Wear||5
1480215|NCT01839318|3621907|P2|STARTED|Period 2, Second Day of Wear||4
1480216|NCT01839318|3621908|P1|STARTED|Period 2, Second Day of Wear||4
1480217|NCT01839318|3621903|P6|NOT COMPLETED|Period 1, First Day of Wear||0
1480218|NCT01839318|3621904|P5|NOT COMPLETED|Period 1, First Day of Wear||0
1480219|NCT01839318|3621905|P4|NOT COMPLETED|Period 1, First Day of Wear||0
1480220|NCT01839318|3621906|P3|NOT COMPLETED|Period 1, First Day of Wear||0
1480221|NCT01839318|3621907|P2|NOT COMPLETED|Period 1, First Day of Wear||0
1480222|NCT01839318|3621908|P1|NOT COMPLETED|Period 1, First Day of Wear||0
1480223|NCT01839318|3621903|P6|COMPLETED|Period 1, First Day of Wear||2
1480224|NCT01839318|3621904|P5|COMPLETED|Period 1, First Day of Wear||7
1480225|NCT01839318|3621905|P4|COMPLETED|Period 1, First Day of Wear||6
1480226|NCT01839318|3621906|P3|COMPLETED|Period 1, First Day of Wear||5
1480227|NCT01839318|3621907|P2|COMPLETED|Period 1, First Day of Wear||4
1480228|NCT01839318|3621908|P1|COMPLETED|Period 1, First Day of Wear||4
1480229|NCT01839318|3621903|P6|STARTED|Period 1, First Day of Wear||2
1480230|NCT01839318|3621904|P5|STARTED|Period 1, First Day of Wear||7
1480231|NCT01839318|3621905|P4|STARTED|Period 1, First Day of Wear||6
1480232|NCT01839318|3621906|P3|STARTED|Period 1, First Day of Wear||5
1480233|NCT01839318|3621907|P2|STARTED|Period 1, First Day of Wear||4
1480234|NCT01839318|3621908|P1|STARTED|Period 1, First Day of Wear||4
1480235|NCT01839279|3621922|P3|NOT COMPLETED|Overall Study||2
1480236|NCT01839279|3621923|P2|NOT COMPLETED|Overall Study||2
1480237|NCT01839279|3621924|P1|NOT COMPLETED|Overall Study||13
1480238|NCT01839279|3621922|P3|COMPLETED|Overall Study||30
1480239|NCT01839279|3621923|P2|COMPLETED|Overall Study||30
1480240|NCT01839279|3621924|P1|COMPLETED|Overall Study||59
1480241|NCT01839279|3621922|P3|PK/QTc Analysis Set|Overall Study||0
1480242|NCT01839279|3621923|P2|PK/QTc Analysis Set|Overall Study||0
1480243|NCT01839279|3621924|P1|PK/QTc Analysis Set|Overall Study||70
1480244|NCT01839279|3621922|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
1480245|NCT01839279|3621923|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
1480246|NCT01839279|3621924|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
1480247|NCT01839279|3621922|P3|PK Analysis Set|Overall Study||0
1480248|NCT01839279|3621923|P2|PK Analysis Set|Overall Study||0
1480249|NCT01839279|3621924|P1|PK Analysis Set|Overall Study||70
1480250|NCT01839279|3621922|P3|QT/QTc Analysis Set|Overall Study||32
1480251|NCT01839279|3621923|P2|QT/QTc Analysis Set|Overall Study||32
1480252|NCT01839279|3621924|P1|QT/QTc Analysis Set|Overall Study||72
1480253|NCT01839279|3621922|P3|STARTED|Overall Study||32
1480254|NCT01839279|3621923|P2|STARTED|Overall Study||32
1480255|NCT01839279|3621924|P1|STARTED|Overall Study||72
1480256|NCT01839110|3621946|P3|NOT COMPLETED|Overall Study||3
1480257|NCT01839110|3621947|P2|NOT COMPLETED|Overall Study||2
1480258|NCT01839110|3621948|P1|NOT COMPLETED|Overall Study||3
1480259|NCT01839110|3621946|P3|COMPLETED|Overall Study||6
1480260|NCT01839110|3621947|P2|COMPLETED|Overall Study||4
1480261|NCT01839110|3621948|P1|COMPLETED|Overall Study||4
1480262|NCT01839110|3621946|P3|STARTED|Overall Study||9
1480263|NCT01839110|3621947|P2|STARTED|Overall Study||6
1480264|NCT01839110|3621948|P1|STARTED|Overall Study||7
1480265|NCT01839058|3621958|P2|NOT COMPLETED|Overall Study||3
1480266|NCT01839058|3621959|P1|NOT COMPLETED|Overall Study||4
1480267|NCT01839058|3621958|P2|COMPLETED|Overall Study||16
1480268|NCT01839058|3621959|P1|COMPLETED|Overall Study||17
1480269|NCT01839058|3621958|P2|STARTED|Overall Study||19
1480270|NCT01839058|3621959|P1|STARTED|Overall Study||21
1480271|NCT01838980|3621971|P1|NOT COMPLETED|Overall Study||0
1480272|NCT01838980|3621971|P1|COMPLETED|Overall Study||15
1480273|NCT01838980|3621971|P1|STARTED|Overall Study||15
1480274|NCT01838941|3621975|P1|NOT COMPLETED|Overall Study||2
1480275|NCT01838941|3621975|P1|COMPLETED|Overall Study||10
1480276|NCT01838941|3621975|P1|STARTED|Overall Study||12
1480277|NCT01838863|3621982|P2|NOT COMPLETED|Overall Study||9
1480278|NCT01838863|3621983|P1|NOT COMPLETED|Overall Study||10
1480279|NCT01838863|3621982|P2|COMPLETED|Overall Study||60
1480280|NCT01838863|3621983|P1|COMPLETED|Overall Study||65
1480281|NCT01838863|3621982|P2|STARTED|Overall Study||69
1480282|NCT01838863|3621983|P1|STARTED|Overall Study||75
1480283|NCT01838785|3622069|P1|NOT COMPLETED|Overall Study||0
1480284|NCT01838785|3622069|P1|COMPLETED|Overall Study||25
1480285|NCT01838785|3622069|P1|STARTED|Overall Study||25
1480286|NCT01838694|3622076|P2|NOT COMPLETED|Overall Study||1
1480287|NCT01838694|3622077|P1|NOT COMPLETED|Overall Study||0
1480288|NCT01838694|3622076|P2|COMPLETED|Overall Study||21
1480289|NCT01838694|3622077|P1|COMPLETED|Overall Study||8
1480290|NCT01838694|3622076|P2|STARTED|Overall Study||22
1480291|NCT01838694|3622077|P1|STARTED|Overall Study||8
1480292|NCT01838681|3622086|P4|NOT COMPLETED|Period B/A+||117
1480293|NCT01838681|3622087|P3|NOT COMPLETED|Period B/A+||95
1480294|NCT01838681|3622088|P2|NOT COMPLETED|Period B/A+||62
1480295|NCT01838681|3622089|P1|NOT COMPLETED|Period B/A+||0
1480296|NCT01838681|3622086|P4|COMPLETED|Period B/A+||653
1480297|NCT01838681|3622087|P3|COMPLETED|Period B/A+||349
1480298|NCT01838681|3622088|P2|COMPLETED|Period B/A+||380
1480299|NCT01838681|3622089|P1|COMPLETED|Period B/A+||0
1480300|NCT01838681|3622086|P4|STARTED|Period B/A+||770
1480301|NCT01838681|3622087|P3|STARTED|Period B/A+||444
1480302|NCT01838681|3622088|P2|STARTED|Period B/A+||442
1480303|NCT01838681|3622089|P1|STARTED|Period B/A+||0
1480304|NCT01838681|3622086|P4|NOT COMPLETED|Period A||0
1480305|NCT01838681|3622087|P3|NOT COMPLETED|Period A||0
1480306|NCT01838681|3622088|P2|NOT COMPLETED|Period A||0
1480307|NCT01838681|3622089|P1|NOT COMPLETED|Period A||325
1480308|NCT01838681|3622086|P4|COMPLETED|Period A||0
1480309|NCT01838681|3622087|P3|COMPLETED|Period A||0
1480310|NCT01838681|3622088|P2|COMPLETED|Period A||0
1480311|NCT01838681|3622089|P1|COMPLETED|Period A||1661
1480312|NCT01838681|3622086|P4|STARTED|Period A||0
1480313|NCT01838681|3622087|P3|STARTED|Period A||0
1480314|NCT01838681|3622088|P2|STARTED|Period A||0
1480315|NCT01838681|3622089|P1|STARTED|Period A||1986
1480316|NCT01838655|3622129|P1|NOT COMPLETED|Overall Study||0
1480317|NCT01838655|3622129|P1|COMPLETED|Overall Study||5
1480318|NCT01838655|3622129|P1|STARTED|Overall Study||5
1480319|NCT01838642|3622197|P1|NOT COMPLETED|Overall Study||1
1480320|NCT01838642|3622197|P1|COMPLETED|Overall Study||2
1480321|NCT01838642|3622197|P1|STARTED|Overall Study||3
1480322|NCT01838616|3622210|P2|NOT COMPLETED|Pick-up Arm||0
1480323|NCT01838616|3622211|P1|NOT COMPLETED|Pick-up Arm||15
1480324|NCT01838616|3622210|P2|COMPLETED|Pick-up Arm||0
1480325|NCT01838616|3622211|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
1480326|NCT01838616|3622210|P2|Full Analysis Set|Pick-up Arm||0
1480327|NCT01838616|3622211|P1|Full Analysis Set|Pick-up Arm||49
1480328|NCT01838616|3622210|P2|STARTED|Pick-up Arm||0
1480329|NCT01838616|3622211|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
1480330|NCT01838616|3622210|P2|NOT COMPLETED|Continuation Period||14
1480331|NCT01838616|3622211|P1|NOT COMPLETED|Continuation Period||14
1480332|NCT01838616|3622210|P2|COMPLETED|Continuation Period||48
1480333|NCT01838616|3622211|P1|COMPLETED|Continuation Period||86
1480334|NCT01838616|3622210|P2|Switched to Pick-up Arm|Continuation Period||7
1480335|NCT01838616|3622211|P1|Switched to Pick-up Arm|Continuation Period||0
1480336|NCT01838616|3622210|P2|STARTED|Continuation Period||62
1480337|NCT01838616|3622211|P1|STARTED|Continuation Period||100
1480338|NCT01838616|3622210|P2|NOT COMPLETED|Titration Period||66
1480339|NCT01838616|3622211|P1|NOT COMPLETED|Titration Period||30
1480340|NCT01838616|3622210|P2|COMPLETED|Titration Period||62
1480341|NCT01838616|3622211|P1|COMPLETED|Titration Period||100
1480342|NCT01838616|3622210|P2|Per Protocol Set|Titration Period||112
1480343|NCT01838616|3622211|P1|Per Protocol Set|Titration Period||117
1480344|NCT01838616|3622210|P2|Full Analysis Set|Titration Period||128
1480345|NCT01838616|3622211|P1|Full Analysis Set|Titration Period||130
1480346|NCT01838616|3622210|P2|Switched to Pick-up Arm|Titration Period||43
1480347|NCT01838616|3622211|P1|Switched to Pick-up Arm|Titration Period||0
1480348|NCT01838616|3622210|P2|Major Protocol Deviations|Titration Period||16
1480349|NCT01838616|3622211|P1|Major Protocol Deviations|Titration Period||13
1480350|NCT01838616|3622210|P2|No Post Baseline Pain Intensity Values|Titration Period||2
1480351|NCT01838616|3622211|P1|No Post Baseline Pain Intensity Values|Titration Period||0
1480352|NCT01838616|3622210|P2|STARTED|Titration Period||128
1480353|NCT01838616|3622211|P1|STARTED|Titration Period||130
1480354|NCT01838590|3622282|P2|NOT COMPLETED|Overall Study||5
1480355|NCT01838590|3622283|P1|NOT COMPLETED|Overall Study||12
1480356|NCT01838590|3622282|P2|COMPLETED|Overall Study||46
1480357|NCT01838590|3622283|P1|COMPLETED|Overall Study||40
1480358|NCT01838590|3622282|P2|STARTED|Overall Study||51
1480359|NCT01838590|3622283|P1|STARTED|Overall Study||52
1480360|NCT01838499|3622307|P2|NOT COMPLETED|Overall Study||17
1480361|NCT01838499|3622308|P1|NOT COMPLETED|Overall Study||24
1480362|NCT01838499|3622307|P2|COMPLETED|Overall Study||37
1480363|NCT01838499|3622308|P1|COMPLETED|Overall Study||31
1480364|NCT01838499|3622307|P2|STARTED|Overall Study||54
1480365|NCT01838499|3622308|P1|STARTED|Overall Study||55
1480366|NCT01838304|3622320|P2|NOT COMPLETED|Overall Study||0
1480367|NCT01838304|3622321|P1|NOT COMPLETED|Overall Study||1
1480368|NCT01838304|3622320|P2|COMPLETED|Overall Study||20
1480369|NCT01838304|3622321|P1|COMPLETED|Overall Study||19
1480370|NCT01838304|3622320|P2|STARTED|Overall Study||20
1480371|NCT01838304|3622321|P1|STARTED|Overall Study||20
1480372|NCT01838213|3622335|P2|NOT COMPLETED|Overall Study||191
1480373|NCT01838213|3622336|P1|NOT COMPLETED|Overall Study||166
1480374|NCT01838213|3622335|P2|COMPLETED|Overall Study||262
1480375|NCT01838213|3622336|P1|COMPLETED|Overall Study||81
1480376|NCT01838213|3622335|P2|STARTED|Overall Study||453
1480377|NCT01838213|3622336|P1|STARTED|Overall Study||247
1480378|NCT01838044|3622344|P2|NOT COMPLETED|Overall Study||16
1480379|NCT01838044|3622345|P1|NOT COMPLETED|Overall Study||8
1480380|NCT01838044|3622344|P2|COMPLETED|Overall Study||75
1480381|NCT01838044|3622345|P1|COMPLETED|Overall Study||81
1480382|NCT01838044|3622344|P2|STARTED|Overall Study||91
1480383|NCT01838044|3622345|P1|STARTED|Overall Study||89
1480384|NCT01837966|3622378|P2|NOT COMPLETED|Overall Study||1
1480385|NCT01837966|3622379|P1|NOT COMPLETED|Overall Study||2
1480386|NCT01837966|3622378|P2|COMPLETED|Overall Study||45
1480387|NCT01837966|3622379|P1|COMPLETED|Overall Study||45
1480388|NCT01837966|3622378|P2|STARTED|Overall Study||46
1480389|NCT01837966|3622379|P1|STARTED|Overall Study||47
1480390|NCT01837823|3622385|P1|NOT COMPLETED|Overall Study||6
1480391|NCT01837823|3622385|P1|COMPLETED|Overall Study||85
1480392|NCT01837823|3622385|P1|STARTED|Overall Study||91
1480393|NCT01837797|3622416|P5|NOT COMPLETED|Period 3||23
1480394|NCT01837797|3622417|P4|NOT COMPLETED|Period 3||0
1480395|NCT01837797|3622418|P3|NOT COMPLETED|Period 3||0
1480396|NCT01837797|3622419|P2|NOT COMPLETED|Period 3||0
1480397|NCT01837797|3622420|P1|NOT COMPLETED|Period 3||0
1480398|NCT01837797|3622416|P5|COMPLETED|Period 3||24
1480399|NCT01837797|3622417|P4|COMPLETED|Period 3||0
1480400|NCT01837797|3622418|P3|COMPLETED|Period 3||0
1480401|NCT01837797|3622419|P2|COMPLETED|Period 3||0
1480402|NCT01837797|3622420|P1|COMPLETED|Period 3||0
1480403|NCT01837797|3622416|P5|STARTED|Period 3||47
1480404|NCT01837797|3622417|P4|STARTED|Period 3||0
1480405|NCT01837797|3622418|P3|STARTED|Period 3||0
1480406|NCT01837797|3622419|P2|STARTED|Period 3||0
1480407|NCT01837797|3622420|P1|STARTED|Period 3||0
1480408|NCT01837797|3622416|P5|NOT COMPLETED|Period 2||0
1480409|NCT01837797|3622417|P4|NOT COMPLETED|Period 2||5
1480410|NCT01837797|3622418|P3|NOT COMPLETED|Period 2||2
1480411|NCT01837797|3622419|P2|NOT COMPLETED|Period 2||5
1480412|NCT01837797|3622420|P1|NOT COMPLETED|Period 2||0
1480413|NCT01837797|3622416|P5|COMPLETED|Period 2||0
1480414|NCT01837797|3622417|P4|COMPLETED|Period 2||1
1480415|NCT01837797|3622418|P3|COMPLETED|Period 2||1
1480416|NCT01837797|3622419|P2|COMPLETED|Period 2||1
1480417|NCT01837797|3622420|P1|COMPLETED|Period 2||0
1480418|NCT01837797|3622416|P5|STARTED|Period 2||0
1480419|NCT01837797|3622417|P4|STARTED|Period 2||6
1480420|NCT01837797|3622418|P3|STARTED|Period 2||3
1480421|NCT01837797|3622419|P2|STARTED|Period 2||6
1480422|NCT01837797|3622420|P1|STARTED|Period 2||0
1480423|NCT01837797|3622416|P5|NOT COMPLETED|Period 1||0
1480424|NCT01837797|3622417|P4|NOT COMPLETED|Period 1||0
1480425|NCT01837797|3622418|P3|NOT COMPLETED|Period 1||0
1480426|NCT01837797|3622419|P2|NOT COMPLETED|Period 1||0
1480427|NCT01837797|3622420|P1|NOT COMPLETED|Period 1||102
1480428|NCT01837797|3622416|P5|COMPLETED|Period 1||0
1480429|NCT01837797|3622417|P4|COMPLETED|Period 1||0
1480430|NCT01837797|3622418|P3|COMPLETED|Period 1||0
1480431|NCT01837797|3622419|P2|COMPLETED|Period 1||0
1480432|NCT01837797|3622420|P1|COMPLETED|Period 1||27
1480433|NCT01837797|3622416|P5|STARTED|Period 1||0
1480434|NCT01837797|3622417|P4|STARTED|Period 1||0
1480435|NCT01837797|3622418|P3|STARTED|Period 1||0
1480436|NCT01837797|3622419|P2|STARTED|Period 1||0
1480437|NCT01837797|3622420|P1|STARTED|Period 1||129
1480438|NCT01837719|3622455|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
1480439|NCT01837719|3622455|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
1480529|NCT01836471|3622693|P5|NOT COMPLETED|Overall Study||5
1480440|NCT01837719|3622455|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
1480441|NCT01837719|3622455|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
1480442|NCT01837719|3622455|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
1480443|NCT01837719|3622455|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
1480444|NCT01837719|3622455|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
1480445|NCT01837719|3622455|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
1480446|NCT01837719|3622455|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
1480447|NCT01837719|3622455|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
1480448|NCT01837719|3622455|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
1480449|NCT01837719|3622455|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
1480450|NCT01837719|3622455|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
1480451|NCT01837719|3622455|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
1480452|NCT01837719|3622455|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
1480453|NCT01837680|3622524|P2|NOT COMPLETED|Overall Study||8
1480454|NCT01837680|3622525|P1|NOT COMPLETED|Overall Study||10
1480455|NCT01837680|3622524|P2|COMPLETED|Overall Study||45
1480456|NCT01837680|3622525|P1|COMPLETED|Overall Study||42
1480457|NCT01837680|3622524|P2|STARTED|Overall Study||53
1480458|NCT01837680|3622525|P1|STARTED|Overall Study||52
1480459|NCT01837550|3622563|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
1480460|NCT01837550|3622564|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
1480461|NCT01837550|3622563|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
1480462|NCT01837550|3622564|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
1480463|NCT01837550|3622563|P2|STARTED|T0-T2, 6 Months Follow-up||37
1480464|NCT01837550|3622564|P1|STARTED|T0-T2, 6 Months Follow-up||37
1480465|NCT01837550|3622563|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
1480466|NCT01837550|3622564|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
1480467|NCT01837550|3622563|P2|COMPLETED|T0-T1, 5 Weeks||37
1480468|NCT01837550|3622564|P1|COMPLETED|T0-T1, 5 Weeks||37
1480469|NCT01837550|3622563|P2|STARTED|T0-T1, 5 Weeks||37
1480470|NCT01837550|3622564|P1|STARTED|T0-T1, 5 Weeks||37
1480471|NCT01837537|3622576|P1|NOT COMPLETED|Overall Study||0
1480472|NCT01837537|3622576|P1|COMPLETED|Overall Study||90
1480473|NCT01837537|3622576|P1|STARTED|Overall Study||90
1480474|NCT01837524|3622583|P2|NOT COMPLETED|Overall Study||2
1480475|NCT01837524|3622584|P1|NOT COMPLETED|Overall Study||3
1480476|NCT01837524|3622583|P2|COMPLETED|Overall Study||25
1480477|NCT01837524|3622584|P1|COMPLETED|Overall Study||25
1480478|NCT01837524|3622583|P2|STARTED|Overall Study||27
1480479|NCT01837524|3622584|P1|STARTED|Overall Study||28
1480480|NCT01836809|3622594|P4|NOT COMPLETED|Overall Study||2
1480481|NCT01836809|3622595|P3|NOT COMPLETED|Overall Study||0
1480482|NCT01836809|3622596|P2|NOT COMPLETED|Overall Study||0
1480483|NCT01836809|3622597|P1|NOT COMPLETED|Overall Study||0
1480484|NCT01836809|3622594|P4|COMPLETED|Overall Study||0
1480485|NCT01836809|3622595|P3|COMPLETED|Overall Study||0
1480486|NCT01836809|3622596|P2|COMPLETED|Overall Study||0
1480487|NCT01836809|3622597|P1|COMPLETED|Overall Study||0
1480488|NCT01836809|3622594|P4|STARTED|Overall Study||2
1480489|NCT01836809|3622595|P3|STARTED|Overall Study||0
1480490|NCT01836809|3622596|P2|STARTED|Overall Study||0
1480491|NCT01836809|3622597|P1|STARTED|Overall Study||0
1480492|NCT01836549|3622633|P7|NOT COMPLETED|Overall Study||1
1480493|NCT01836549|3622634|P6|NOT COMPLETED|Overall Study||0
1480494|NCT01836549|3622635|P5|NOT COMPLETED|Overall Study||0
1480495|NCT01836549|3622636|P4|NOT COMPLETED|Overall Study||1
1480496|NCT01836549|3622637|P3|NOT COMPLETED|Overall Study||1
1480497|NCT01836549|3622638|P2|NOT COMPLETED|Overall Study||0
1480498|NCT01836549|3622639|P1|NOT COMPLETED|Overall Study||0
1480499|NCT01836549|3622633|P7|COMPLETED|Overall Study||8
1480500|NCT01836549|3622634|P6|COMPLETED|Overall Study||4
1480501|NCT01836549|3622635|P5|COMPLETED|Overall Study||18
1480502|NCT01836549|3622636|P4|COMPLETED|Overall Study||8
1480503|NCT01836549|3622637|P3|COMPLETED|Overall Study||0
1480504|NCT01836549|3622638|P2|COMPLETED|Overall Study||1
1480505|NCT01836549|3622639|P1|COMPLETED|Overall Study||1
1480506|NCT01836549|3622633|P7|STARTED|Overall Study||9
1480507|NCT01836549|3622634|P6|STARTED|Overall Study||4
1480508|NCT01836549|3622635|P5|STARTED|Overall Study||18
1480509|NCT01836549|3622636|P4|STARTED|Overall Study||9
1480510|NCT01836549|3622637|P3|STARTED|Overall Study||1
1480511|NCT01836549|3622638|P2|STARTED|Overall Study||1
1480512|NCT01836549|3622639|P1|STARTED|Overall Study||1
1480513|NCT01836523|3622663|P4|NOT COMPLETED|Overall Study||74
1480514|NCT01836523|3622664|P3|NOT COMPLETED|Overall Study||91
1480515|NCT01836523|3622665|P2|NOT COMPLETED|Overall Study||85
1480516|NCT01836523|3622666|P1|NOT COMPLETED|Overall Study||51
1480517|NCT01836523|3622663|P4|COMPLETED|Overall Study||274
1480518|NCT01836523|3622664|P3|COMPLETED|Overall Study||258
1480519|NCT01836523|3622665|P2|COMPLETED|Overall Study||265
1480520|NCT01836523|3622666|P1|COMPLETED|Overall Study||300
1480521|NCT01836523|3622663|P4|Exposed|Overall Study||348
1480522|NCT01836523|3622664|P3|Exposed|Overall Study||347
1480523|NCT01836523|3622665|P2|Exposed|Overall Study||348
1480524|NCT01836523|3622666|P1|Exposed|Overall Study||350
1480525|NCT01836523|3622663|P4|STARTED|Overall Study||348
1480526|NCT01836523|3622664|P3|STARTED|Overall Study||349
1480527|NCT01836523|3622665|P2|STARTED|Overall Study||350
1480528|NCT01836523|3622666|P1|STARTED|Overall Study||351
1480530|NCT01836471|3622694|P4|NOT COMPLETED|Overall Study||2
1480531|NCT01836471|3622695|P3|NOT COMPLETED|Overall Study||2
1480532|NCT01836471|3622696|P2|NOT COMPLETED|Overall Study||9
1480533|NCT01836471|3622697|P1|NOT COMPLETED|Overall Study||11
1480534|NCT01836471|3622693|P5|COMPLETED|Overall Study||49
1480535|NCT01836471|3622694|P4|COMPLETED|Overall Study||40
1480536|NCT01836471|3622695|P3|COMPLETED|Overall Study||49
1480537|NCT01836471|3622696|P2|COMPLETED|Overall Study||85
1480538|NCT01836471|3622697|P1|COMPLETED|Overall Study||82
1480539|NCT01836471|3622693|P5|STARTED|Overall Study||54
1480540|NCT01836471|3622694|P4|STARTED|Overall Study||42
1480541|NCT01836471|3622695|P3|STARTED|Overall Study||51
1480542|NCT01836471|3622696|P2|STARTED|Overall Study||94
1480543|NCT01836471|3622697|P1|STARTED|Overall Study||93
1480544|NCT01836458|3622726|P4|NOT COMPLETED|Overall Study||6
1480545|NCT01836458|3622727|P3|NOT COMPLETED|Overall Study||5
1480546|NCT01836458|3622728|P2|NOT COMPLETED|Overall Study||2
1480547|NCT01836458|3622729|P1|NOT COMPLETED|Overall Study||3
1480548|NCT01836458|3622726|P4|COMPLETED|Overall Study||1
1480549|NCT01836458|3622727|P3|COMPLETED|Overall Study||2
1480550|NCT01836458|3622728|P2|COMPLETED|Overall Study||2
1480551|NCT01836458|3622729|P1|COMPLETED|Overall Study||4
1480552|NCT01836458|3622726|P4|STARTED|Overall Study||7
1480553|NCT01836458|3622727|P3|STARTED|Overall Study||7
1480554|NCT01836458|3622728|P2|STARTED|Overall Study||4
1480555|NCT01836458|3622729|P1|STARTED|Overall Study||7
1480556|NCT01836445|3622753|P2|NOT COMPLETED|12 Month STI Testing||77
1480557|NCT01836445|3622754|P1|NOT COMPLETED|12 Month STI Testing||80
1480558|NCT01836445|3622753|P2|COMPLETED|12 Month STI Testing||378
1480559|NCT01836445|3622754|P1|COMPLETED|12 Month STI Testing||365
1480560|NCT01836445|3622753|P2|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
1480561|NCT01836445|3622754|P1|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
1480562|NCT01836445|3622753|P2|NOT COMPLETED|12 Month Follow-up Assessment||64
1480563|NCT01836445|3622754|P1|NOT COMPLETED|12 Month Follow-up Assessment||75
1480564|NCT01836445|3622753|P2|COMPLETED|12 Month Follow-up Assessment||391
1480565|NCT01836445|3622754|P1|COMPLETED|12 Month Follow-up Assessment||370
1480566|NCT01836445|3622753|P2|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
1480567|NCT01836445|3622754|P1|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
1480568|NCT01836445|3622753|P2|NOT COMPLETED|6 Month Follow-up Assessment||75
1480569|NCT01836445|3622754|P1|NOT COMPLETED|6 Month Follow-up Assessment||103
1480570|NCT01836445|3622753|P2|COMPLETED|6 Month Follow-up Assessment||380
1480571|NCT01836445|3622754|P1|COMPLETED|6 Month Follow-up Assessment||342
1480572|NCT01836445|3622753|P2|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
1480573|NCT01836445|3622754|P1|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
1480574|NCT01836445|3622753|P2|NOT COMPLETED|3 Month Follow-up Assessment||47
1480575|NCT01836445|3622754|P1|NOT COMPLETED|3 Month Follow-up Assessment||97
1480576|NCT01836445|3622753|P2|COMPLETED|3 Month Follow-up Assessment||409
1480577|NCT01836445|3622754|P1|COMPLETED|3 Month Follow-up Assessment||348
1480578|NCT01836445|3622753|P2|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
1480579|NCT01836445|3622754|P1|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
1480580|NCT01836445|3622753|P2|NOT COMPLETED|Intervention Modules||22
1480581|NCT01836445|3622754|P1|NOT COMPLETED|Intervention Modules||70
1480582|NCT01836445|3622753|P2|COMPLETED|Intervention Modules||434
1480583|NCT01836445|3622754|P1|COMPLETED|Intervention Modules||375
1480584|NCT01836445|3622753|P2|STARTED|Intervention Modules||456
1480585|NCT01836445|3622754|P1|STARTED|Intervention Modules||445
1480586|NCT01836276|3622814|P2|NOT COMPLETED|Overall Study||51
1480587|NCT01836276|3622815|P1|NOT COMPLETED|Overall Study||28
1480588|NCT01836276|3622814|P2|COMPLETED|Overall Study||174
1480589|NCT01836276|3622815|P1|COMPLETED|Overall Study||196
1480590|NCT01836276|3622814|P2|Week 12|Overall Study||165
1480591|NCT01836276|3622815|P1|Week 12|Overall Study||183
1480592|NCT01836276|3622814|P2|Week 4|Overall Study||186
1480593|NCT01836276|3622815|P1|Week 4|Overall Study||198
1480594|NCT01836276|3622814|P2|STARTED|Overall Study||225
1480595|NCT01836276|3622815|P1|STARTED|Overall Study||224
1480596|NCT01836185|3622825|P4|NOT COMPLETED|Overall Study||0
1480597|NCT01836185|3622826|P3|NOT COMPLETED|Overall Study||0
1480598|NCT01836185|3622827|P2|NOT COMPLETED|Overall Study||0
1480599|NCT01836185|3622828|P1|NOT COMPLETED|Overall Study||0
1480600|NCT01836185|3622825|P4|COMPLETED|Overall Study||6
1480601|NCT01836185|3622826|P3|COMPLETED|Overall Study||8
1480602|NCT01836185|3622827|P2|COMPLETED|Overall Study||8
1480603|NCT01836185|3622828|P1|COMPLETED|Overall Study||10
1480604|NCT01836185|3622825|P4|Received Single Dose of Study Treatment|Overall Study||6
1480605|NCT01836185|3622826|P3|Received Single Dose of Study Treatment|Overall Study||8
1480606|NCT01836185|3622827|P2|Received Single Dose of Study Treatment|Overall Study||8
1480607|NCT01836185|3622828|P1|Received Single Dose of Study Treatment|Overall Study||10
1480608|NCT01836185|3622825|P4|STARTED|Overall Study||6
1480609|NCT01836185|3622826|P3|STARTED|Overall Study||8
1480610|NCT01836185|3622827|P2|STARTED|Overall Study||8
1480611|NCT01836185|3622828|P1|STARTED|Overall Study||10
1480612|NCT01836133|3622846|P1|NOT COMPLETED|Overall Study||0
1480613|NCT01836133|3622846|P1|COMPLETED|Overall Study||70
1480614|NCT01836133|3622846|P1|STARTED|Overall Study||70
1480615|NCT01836042|3622855|P3|NOT COMPLETED|Overall Study||0
1480616|NCT01836042|3622856|P2|NOT COMPLETED|Overall Study||0
1480617|NCT01836042|3622857|P1|NOT COMPLETED|Overall Study||0
1480618|NCT01836042|3622855|P3|COMPLETED|Overall Study||22
1480619|NCT01836042|3622856|P2|COMPLETED|Overall Study||35
1480620|NCT01836042|3622857|P1|COMPLETED|Overall Study||51
1480621|NCT01836042|3622855|P3|STARTED|Overall Study||22
1480622|NCT01836042|3622856|P2|STARTED|Overall Study||35
1480623|NCT01836042|3622857|P1|STARTED|Overall Study||51
1480624|NCT01835912|3622865|P1|NOT COMPLETED|Overall Study||0
1480625|NCT01835912|3622865|P1|COMPLETED|Overall Study||10
1480626|NCT01835912|3622865|P1|Chronic Placebo|Overall Study||10
1480627|NCT01835912|3622865|P1|Chronic|Overall Study||10
1480628|NCT01835912|3622865|P1|Acute Placebo|Overall Study||10
1480629|NCT01835912|3622865|P1|Acute|Overall Study||10
1480630|NCT01835912|3622865|P1|STARTED|Overall Study||10
1480631|NCT01835899|3622886|P3|NOT COMPLETED|Overall Study||1
1480632|NCT01835899|3622887|P2|NOT COMPLETED|Overall Study||1
1480633|NCT01835899|3622888|P1|NOT COMPLETED|Overall Study||0
1480634|NCT01835899|3622886|P3|COMPLETED|Overall Study||8
1480635|NCT01835899|3622887|P2|COMPLETED|Overall Study||8
1480636|NCT01835899|3622888|P1|COMPLETED|Overall Study||6
1480637|NCT01835899|3622886|P3|STARTED|Overall Study||9
1480638|NCT01835899|3622887|P2|STARTED|Overall Study||9
1480639|NCT01835899|3622888|P1|STARTED|Overall Study||6
1480640|NCT01835756|3622908|P2|NOT COMPLETED|Overall Study||0
1480641|NCT01835756|3622909|P1|NOT COMPLETED|Overall Study||0
1480642|NCT01835756|3622908|P2|COMPLETED|Overall Study||31
1480643|NCT01835756|3622909|P1|COMPLETED|Overall Study||31
1480644|NCT01835756|3622908|P2|STARTED|Overall Study||31
1480645|NCT01835756|3622909|P1|STARTED|Overall Study||31
1480646|NCT01835743|3622921|P2|NOT COMPLETED|Overall Study||0
1480647|NCT01835743|3622922|P1|NOT COMPLETED|Overall Study||0
1480648|NCT01835743|3622921|P2|COMPLETED|Overall Study||32
1480649|NCT01835743|3622922|P1|COMPLETED|Overall Study||37
1480650|NCT01835743|3622921|P2|STARTED|Overall Study||32
1480651|NCT01835743|3622922|P1|STARTED|Overall Study||37
1480652|NCT01835587|3622934|P4|NOT COMPLETED|Overall Study||9
1480653|NCT01835587|3622935|P3|NOT COMPLETED|Overall Study||2
1480654|NCT01835587|3622936|P2|NOT COMPLETED|Overall Study||4
1480655|NCT01835587|3622937|P1|NOT COMPLETED|Overall Study||2
1480656|NCT01835587|3622934|P4|COMPLETED|Overall Study||10
1480657|NCT01835587|3622935|P3|COMPLETED|Overall Study||2
1480658|NCT01835587|3622936|P2|COMPLETED|Overall Study||0
1480659|NCT01835587|3622937|P1|COMPLETED|Overall Study||1
1480660|NCT01835587|3622934|P4|STARTED|Overall Study||19
1480661|NCT01835587|3622935|P3|STARTED|Overall Study||4
1480662|NCT01835587|3622936|P2|STARTED|Overall Study||4
1480663|NCT01835587|3622937|P1|STARTED|Overall Study||3
1480664|NCT01835548|3622998|P3|NOT COMPLETED|Double-Blind Treatment Period||0
1480665|NCT01835548|3622999|P2|NOT COMPLETED|Double-Blind Treatment Period||2
1480666|NCT01835548|3623000|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1480667|NCT01835548|3622998|P3|COMPLETED|Double-Blind Treatment Period||0
1480668|NCT01835548|3622999|P2|COMPLETED|Double-Blind Treatment Period||39
1480669|NCT01835548|3623000|P1|COMPLETED|Double-Blind Treatment Period||44
1480670|NCT01835548|3622998|P3|STARTED|Double-Blind Treatment Period||0
1480671|NCT01835548|3622999|P2|STARTED|Double-Blind Treatment Period||41
1480672|NCT01835548|3623000|P1|STARTED|Double-Blind Treatment Period||44
1480673|NCT01835548|3622998|P3|NOT COMPLETED|Dose Stabilization Period||0
1480674|NCT01835548|3622999|P2|NOT COMPLETED|Dose Stabilization Period||0
1480675|NCT01835548|3623000|P1|NOT COMPLETED|Dose Stabilization Period||0
1480676|NCT01835548|3622998|P3|COMPLETED|Dose Stabilization Period||85
1480677|NCT01835548|3622999|P2|COMPLETED|Dose Stabilization Period||0
1480678|NCT01835548|3623000|P1|COMPLETED|Dose Stabilization Period||0
1480679|NCT01835548|3622998|P3|STARTED|Dose Stabilization Period||85
1480680|NCT01835548|3622999|P2|STARTED|Dose Stabilization Period||0
1480681|NCT01835548|3623000|P1|STARTED|Dose Stabilization Period||0
1480682|NCT01835548|3622998|P3|NOT COMPLETED|Dose Optimization Period||2
1480683|NCT01835548|3622999|P2|NOT COMPLETED|Dose Optimization Period||0
1480684|NCT01835548|3623000|P1|NOT COMPLETED|Dose Optimization Period||0
1480685|NCT01835548|3622998|P3|COMPLETED|Dose Optimization Period||85
1480686|NCT01835548|3622999|P2|COMPLETED|Dose Optimization Period||0
1480687|NCT01835548|3623000|P1|COMPLETED|Dose Optimization Period||0
1480688|NCT01835548|3622998|P3|STARTED|Dose Optimization Period||87
1480689|NCT01835548|3622999|P2|STARTED|Dose Optimization Period||0
1480690|NCT01835548|3623000|P1|STARTED|Dose Optimization Period||0
1480691|NCT01835548|3622998|P3|NOT COMPLETED|Screening/Washout Period||0
1480692|NCT01835548|3622999|P2|NOT COMPLETED|Screening/Washout Period||0
1480693|NCT01835548|3623000|P1|NOT COMPLETED|Screening/Washout Period||0
1480694|NCT01835548|3622998|P3|COMPLETED|Screening/Washout Period||87
1480695|NCT01835548|3622999|P2|COMPLETED|Screening/Washout Period||0
1480696|NCT01835548|3623000|P1|COMPLETED|Screening/Washout Period||0
1480697|NCT01835548|3622998|P3|STARTED|Screening/Washout Period||87
1480698|NCT01835548|3622999|P2|STARTED|Screening/Washout Period||0
1480699|NCT01835548|3623000|P1|STARTED|Screening/Washout Period||0
1480700|NCT01835496|3623020|P1|NOT COMPLETED|Overall Study||0
1480701|NCT01835496|3623020|P1|COMPLETED|Overall Study||8
1480702|NCT01835496|3623020|P1|STARTED|Overall Study||8
1480703|NCT01835470|3623029|P1|NOT COMPLETED|Long Term Treatment Period||2
1480704|NCT01835470|3623029|P1|COMPLETED|Long Term Treatment Period|Completed=Still on Treatment|18
1480705|NCT01835470|3623029|P1|STARTED|Long Term Treatment Period||20
1480706|NCT01835470|3623029|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
1480707|NCT01835470|3623029|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
1480708|NCT01835470|3623029|P1|STARTED|Short Term Treatment Period (to Week 16)||20
1480709|NCT01835431|3623041|P2|NOT COMPLETED|Overall Study||12
1480710|NCT01835431|3623042|P1|NOT COMPLETED|Overall Study||8
1480711|NCT01835431|3623041|P2|COMPLETED|Overall Study||168
1480712|NCT01835431|3623042|P1|COMPLETED|Overall Study||174
1480713|NCT01835431|3623041|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
1480714|NCT01835431|3623042|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
1480715|NCT01835431|3623041|P2|STARTED|Overall Study||180
1480716|NCT01835431|3623042|P1|STARTED|Overall Study||182
1480717|NCT01835379|3623062|P2|NOT COMPLETED|Overall Study||0
1480718|NCT01835379|3623063|P1|NOT COMPLETED|Overall Study||0
1480719|NCT01835379|3623062|P2|COMPLETED|Overall Study||41
1480720|NCT01835379|3623063|P1|COMPLETED|Overall Study||41
1480721|NCT01835379|3623062|P2|STARTED|Overall Study||41
1480722|NCT01835379|3623063|P1|STARTED|Overall Study||41
1480723|NCT01835262|3623073|P2|NOT COMPLETED|Overall Study||0
1480724|NCT01835262|3623074|P1|NOT COMPLETED|Overall Study||0
1480725|NCT01835262|3623073|P2|COMPLETED|Overall Study||45
1480726|NCT01835262|3623074|P1|COMPLETED|Overall Study||45
1480727|NCT01835262|3623073|P2|STARTED|Overall Study||45
1480728|NCT01835262|3623074|P1|STARTED|Overall Study||45
1480729|NCT01835158|3623082|P2|NOT COMPLETED|Overall Study||6
1480730|NCT01835158|3623083|P1|NOT COMPLETED|Overall Study||1
1480731|NCT01835158|3623082|P2|COMPLETED|Overall Study||72
1480732|NCT01835158|3623083|P1|COMPLETED|Overall Study||78
1480733|NCT01835158|3623082|P2|STARTED|Overall Study||78
1480734|NCT01835158|3623083|P1|STARTED|Overall Study||79
1480735|NCT01835132|3623093|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
1480736|NCT01835132|3623093|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
1480737|NCT01835132|3623093|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
1480738|NCT01835132|3623093|P1|NOT COMPLETED|1st Extension Phase||0
1480739|NCT01835132|3623093|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
1480740|NCT01835132|3623093|P1|STARTED|1st Extension Phase||6
1480741|NCT01835132|3623093|P1|NOT COMPLETED|Initial Phase||2
1480742|NCT01835132|3623093|P1|COMPLETED|Initial Phase||6
1480743|NCT01835132|3623093|P1|STARTED|Initial Phase||8
1480744|NCT01835015|3623138|P5|NOT COMPLETED|Overall Study||0
1480745|NCT01835015|3623139|P4|NOT COMPLETED|Overall Study||0
1480746|NCT01835015|3623140|P3|NOT COMPLETED|Overall Study||1
1480747|NCT01835015|3623141|P2|NOT COMPLETED|Overall Study||0
1480748|NCT01835015|3623142|P1|NOT COMPLETED|Overall Study||0
1480749|NCT01835015|3623138|P5|COMPLETED|Overall Study||6
1480750|NCT01835015|3623139|P4|COMPLETED|Overall Study||6
1480751|NCT01835015|3623140|P3|COMPLETED|Overall Study||6
1480752|NCT01835015|3623141|P2|COMPLETED|Overall Study||6
1480753|NCT01835015|3623142|P1|COMPLETED|Overall Study||6
1480754|NCT01835015|3623138|P5|STARTED|Overall Study||6
1480755|NCT01835015|3623139|P4|STARTED|Overall Study||6
1480756|NCT01835015|3623140|P3|STARTED|Overall Study||7
1480757|NCT01835015|3623141|P2|STARTED|Overall Study||6
1480758|NCT01835015|3623142|P1|STARTED|Overall Study||6
1480759|NCT01834651|3623215|P1|NOT COMPLETED|Overall Study||1
1480760|NCT01834651|3623215|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
1480761|NCT01834651|3623215|P1|STARTED|Overall Study||17
1480762|NCT01834586|3623225|P1|NOT COMPLETED|Overall Study||1
1480763|NCT01834586|3623225|P1|COMPLETED|Overall Study||29
1480764|NCT01834586|3623225|P1|STARTED|Overall Study||30
1480765|NCT01834404|3623232|P2|NOT COMPLETED|Overall Study||0
1480766|NCT01834404|3623233|P1|NOT COMPLETED|Overall Study||0
1480767|NCT01834404|3623232|P2|COMPLETED|Overall Study||12
1480768|NCT01834404|3623233|P1|COMPLETED|Overall Study||12
1480769|NCT01834404|3623232|P2|STARTED|Overall Study||12
1480770|NCT01834404|3623233|P1|STARTED|Overall Study||12
1480771|NCT01834274|3623265|P2|NOT COMPLETED|Overall Study||41
1480772|NCT01834274|3623266|P1|NOT COMPLETED|Overall Study||47
1480773|NCT01834274|3623265|P2|COMPLETED|Overall Study||5
1480774|NCT01834274|3623266|P1|COMPLETED|Overall Study||3
1480775|NCT01834274|3623265|P2|STARTED|Overall Study||46
1480776|NCT01834274|3623266|P1|STARTED|Overall Study||50
1480777|NCT01834261|3623278|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
1480778|NCT01834261|3623279|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
1480779|NCT01834261|3623278|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
1480780|NCT01834261|3623279|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
1480781|NCT01834261|3623278|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
1480782|NCT01834261|3623279|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
1480783|NCT01834261|3623278|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
1480784|NCT01834261|3623279|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
1480785|NCT01834261|3623278|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
1480786|NCT01834261|3623279|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
1480787|NCT01834261|3623278|P2|STARTED|MIT fMRI and MEG Resting State Study||10
1480788|NCT01834261|3623279|P1|STARTED|MIT fMRI and MEG Resting State Study||11
1480789|NCT01834222|3623289|P1|NOT COMPLETED|Overall Study||1
1480790|NCT01834222|3623289|P1|COMPLETED|Overall Study||658
1480791|NCT01834222|3623289|P1|Treated|Overall Study||658
1480792|NCT01834222|3623289|P1|STARTED|Overall Study||659
1480793|NCT01834144|3623300|P2|NOT COMPLETED|Overall Study||1
1480794|NCT01834144|3623301|P1|NOT COMPLETED|Overall Study||0
1480795|NCT01834144|3623300|P2|COMPLETED|Overall Study||2
1480796|NCT01834144|3623301|P1|COMPLETED|Overall Study||1
1480797|NCT01834144|3623300|P2|STARTED|Overall Study||3
1480798|NCT01834144|3623301|P1|STARTED|Overall Study||1
1480799|NCT01834027|3623309|P2|NOT COMPLETED|Overall Study||0
1480800|NCT01834027|3623310|P1|NOT COMPLETED|Overall Study||0
1480801|NCT01834027|3623309|P2|COMPLETED|Overall Study||28
1480802|NCT01834027|3623310|P1|COMPLETED|Overall Study||28
1480803|NCT01834027|3623309|P2|STARTED|Overall Study||28
1480804|NCT01834027|3623310|P1|STARTED|Overall Study||28
1480805|NCT01833988|3623320|P2|NOT COMPLETED|Overall Study||0
1480806|NCT01833988|3623321|P1|NOT COMPLETED|Overall Study||0
1480807|NCT01833988|3623320|P2|COMPLETED|Overall Study||16
1480808|NCT01833988|3623321|P1|COMPLETED|Overall Study||16
1480809|NCT01833988|3623320|P2|STARTED|Overall Study||16
1480810|NCT01833988|3623321|P1|STARTED|Overall Study||16
1480811|NCT01833936|3623377|P2|NOT COMPLETED|Overall Study||2
1480812|NCT01833936|3623378|P1|NOT COMPLETED|Overall Study||4
1480813|NCT01833936|3623377|P2|COMPLETED|Overall Study||18
1480814|NCT01833936|3623378|P1|COMPLETED|Overall Study||16
1480815|NCT01833936|3623377|P2|STARTED|Overall Study||20
1480816|NCT01833936|3623378|P1|STARTED|Overall Study||20
1480817|NCT01833897|3623384|P1|NOT COMPLETED|Overall Study||1
1480818|NCT01833897|3623384|P1|COMPLETED|Overall Study||7
1480819|NCT01833897|3623384|P1|STARTED|Overall Study||8
1480820|NCT01833845|3623392|P1|NOT COMPLETED|Overall Study||0
1480821|NCT01833845|3623392|P1|COMPLETED|Overall Study||4
1480822|NCT01833845|3623392|P1|STARTED|Overall Study||4
1480823|NCT01833741|3623396|P1|NOT COMPLETED|Overall Study||140
1480824|NCT01833741|3623396|P1|COMPLETED|Overall Study||997
1480825|NCT01833741|3623396|P1|STARTED|Overall Study||1137
1480826|NCT01833546|3623413|P4|NOT COMPLETED|Overall Study||0
1480827|NCT01833546|3623414|P3|NOT COMPLETED|Overall Study||0
1480828|NCT01833546|3623415|P2|NOT COMPLETED|Overall Study||0
1480829|NCT01833546|3623416|P1|NOT COMPLETED|Overall Study||0
1480830|NCT01833546|3623413|P4|COMPLETED|Overall Study||6
1480831|NCT01833546|3623414|P3|COMPLETED|Overall Study||8
1480832|NCT01833546|3623415|P2|COMPLETED|Overall Study||3
1480833|NCT01833546|3623416|P1|COMPLETED|Overall Study||3
1480834|NCT01833546|3623413|P4|STARTED|Overall Study||6
1480835|NCT01833546|3623414|P3|STARTED|Overall Study||8
1480836|NCT01833546|3623415|P2|STARTED|Overall Study||3
1480837|NCT01833546|3623416|P1|STARTED|Overall Study||3
1480838|NCT01833533|3623509|P2|NOT COMPLETED|Overall Study||21
1480839|NCT01833533|3623510|P1|NOT COMPLETED|Overall Study||6
1480840|NCT01833533|3623509|P2|COMPLETED|Overall Study||184
1480841|NCT01833533|3623510|P1|COMPLETED|Overall Study||94
1480842|NCT01833533|3623509|P2|STARTED|Overall Study||205
1480843|NCT01833533|3623510|P1|STARTED|Overall Study||100
1480844|NCT01833494|3623524|P1|NOT COMPLETED|Overall Study||45
1480845|NCT01833494|3623524|P1|COMPLETED|Overall Study||116
1480846|NCT01833494|3623524|P1|STARTED|Overall Study||161
1480847|NCT01833481|3623534|P3|NOT COMPLETED|Overall Study||0
1480848|NCT01833481|3623535|P2|NOT COMPLETED|Overall Study||0
1480849|NCT01833481|3623536|P1|NOT COMPLETED|Overall Study||0
1480850|NCT01833481|3623534|P3|COMPLETED|Overall Study||10
1480851|NCT01833481|3623535|P2|COMPLETED|Overall Study||10
1480852|NCT01833481|3623536|P1|COMPLETED|Overall Study||10
1480853|NCT01833481|3623534|P3|STARTED|Overall Study||10
1480854|NCT01833481|3623535|P2|STARTED|Overall Study||10
1480855|NCT01833481|3623536|P1|STARTED|Overall Study||10
1480856|NCT01833403|3623550|P1|NOT COMPLETED|Overall Study||0
1480857|NCT01833403|3623550|P1|COMPLETED|Overall Study||4
1480858|NCT01833403|3623550|P1|STARTED|Overall Study||4
1480859|NCT01833247|3623555|P1|NOT COMPLETED|Overall Study||0
1480860|NCT01833247|3623555|P1|COMPLETED|Overall Study||12
1480861|NCT01833247|3623555|P1|STARTED|Overall Study||12
1480862|NCT01833169|3623561|P1|NOT COMPLETED|Overall Study||146
1480863|NCT01833169|3623561|P1|COMPLETED|Overall Study||0
1480864|NCT01833169|3623561|P1|Consented to be Followed for Survival|Overall Study||128
1480865|NCT01833169|3623561|P1|STARTED|Overall Study||146
1480866|NCT01833130|3623574|P2|NOT COMPLETED|Overall Study||19
1480867|NCT01833130|3623575|P1|NOT COMPLETED|Overall Study||10
1480868|NCT01833130|3623574|P2|COMPLETED|Overall Study||8
1480869|NCT01833130|3623575|P1|COMPLETED|Overall Study||15
1480870|NCT01833130|3623574|P2|STARTED|Overall Study||27
1480871|NCT01833130|3623575|P1|STARTED|Overall Study||25
1480872|NCT01833117|3623613|P2|NOT COMPLETED|Overall Study||0
1480873|NCT01833117|3623614|P1|NOT COMPLETED|Overall Study||0
1480874|NCT01833117|3623613|P2|COMPLETED|Overall Study||19
1480875|NCT01833117|3623614|P1|COMPLETED|Overall Study||43
1480876|NCT01833117|3623613|P2|STARTED|Overall Study||19
1480877|NCT01833117|3623614|P1|STARTED|Overall Study||43
1480878|NCT01833078|3623622|P1|NOT COMPLETED|Overall Study||0
1480879|NCT01833078|3623622|P1|COMPLETED|Overall Study||5
1480880|NCT01833078|3623622|P1|STARTED|Overall Study||5
1480881|NCT01833065|3623630|P5|NOT COMPLETED|Overall Study||36
1480882|NCT01833065|3623631|P4|NOT COMPLETED|Overall Study||9
1480883|NCT01833065|3623632|P3|NOT COMPLETED|Overall Study||12
1480884|NCT01833065|3623633|P2|NOT COMPLETED|Overall Study||13
1480885|NCT01833065|3623634|P1|NOT COMPLETED|Overall Study||24
1480886|NCT01833065|3623630|P5|COMPLETED|Overall Study||74
1480887|NCT01833065|3623631|P4|COMPLETED|Overall Study||41
1480888|NCT01833065|3623632|P3|COMPLETED|Overall Study||23
1480889|NCT01833065|3623633|P2|COMPLETED|Overall Study||40
1480890|NCT01833065|3623634|P1|COMPLETED|Overall Study||41
1480891|NCT01833065|3623630|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
1480892|NCT01833065|3623631|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
1480893|NCT01833065|3623632|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
1480894|NCT01833065|3623633|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
1480895|NCT01833065|3623634|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
1480896|NCT01833065|3623630|P5|STARTED|Overall Study|Randomized patients - As treated|110
1480897|NCT01833065|3623631|P4|STARTED|Overall Study|Randomized patients - As treated|50
1480898|NCT01833065|3623632|P3|STARTED|Overall Study|Randomized patients - As treated|35
1480899|NCT01833065|3623633|P2|STARTED|Overall Study|Randomized patients - As treated|53
1480900|NCT01833065|3623634|P1|STARTED|Overall Study|Randomized patients - As treated|65
1480901|NCT01832766|3623665|P2|NOT COMPLETED|Second Intervention||0
1480902|NCT01832766|3623666|P1|NOT COMPLETED|Second Intervention||0
1480903|NCT01832766|3623665|P2|COMPLETED|Second Intervention||5
1480904|NCT01832766|3623666|P1|COMPLETED|Second Intervention||7
1480905|NCT01832766|3623665|P2|STARTED|Second Intervention||5
1480906|NCT01832766|3623666|P1|STARTED|Second Intervention||7
1480907|NCT01832766|3623665|P2|NOT COMPLETED|Washout||1
1480908|NCT01832766|3623666|P1|NOT COMPLETED|Washout||0
1480909|NCT01832766|3623665|P2|COMPLETED|Washout||5
1480910|NCT01832766|3623666|P1|COMPLETED|Washout||7
1480911|NCT01832766|3623665|P2|STARTED|Washout||6
1480912|NCT01832766|3623666|P1|STARTED|Washout||7
1480913|NCT01832766|3623665|P2|NOT COMPLETED|First Intervention||0
1480914|NCT01832766|3623666|P1|NOT COMPLETED|First Intervention||0
1480915|NCT01832766|3623665|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
1480916|NCT01832766|3623666|P1|COMPLETED|First Intervention||7
1480917|NCT01832766|3623665|P2|STARTED|First Intervention||6
1480918|NCT01832766|3623666|P1|STARTED|First Intervention||7
1480919|NCT01832506|3623679|P3|NOT COMPLETED|Overall Study||0
1480920|NCT01832506|3623680|P2|NOT COMPLETED|Overall Study||0
1480921|NCT01832506|3623681|P1|NOT COMPLETED|Overall Study||0
1480922|NCT01832506|3623679|P3|COMPLETED|Overall Study||6
1480923|NCT01832506|3623680|P2|COMPLETED|Overall Study||3
1480924|NCT01832506|3623681|P1|COMPLETED|Overall Study||3
1480925|NCT01832506|3623679|P3|STARTED|Overall Study||6
1480926|NCT01832506|3623680|P2|STARTED|Overall Study||3
1480927|NCT01832506|3623681|P1|STARTED|Overall Study||3
1480928|NCT01832493|3623732|P1|NOT COMPLETED|Overall Study||8
1480929|NCT01832493|3623732|P1|COMPLETED|Overall Study||42
1480930|NCT01832493|3623732|P1|STARTED|Overall Study||50
1480931|NCT01832259|3623741|P2|NOT COMPLETED|Overall Study||0
1480932|NCT01832259|3623742|P1|NOT COMPLETED|Overall Study||0
1480933|NCT01832259|3623741|P2|COMPLETED|Overall Study||15
1480934|NCT01832259|3623742|P1|COMPLETED|Overall Study||15
1480935|NCT01832259|3623741|P2|STARTED|Overall Study||15
1480936|NCT01832259|3623742|P1|STARTED|Overall Study||15
1480937|NCT01832155|3623754|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
1480938|NCT01832155|3623755|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
1480939|NCT01832155|3623754|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
1480940|NCT01832155|3623755|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
1480941|NCT01832155|3623754|P2|STARTED|End of Study: 4 - 8 Weeks||18
1480942|NCT01832155|3623755|P1|STARTED|End of Study: 4 - 8 Weeks||16
1480943|NCT01832155|3623754|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
1480944|NCT01832155|3623755|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
1480945|NCT01832155|3623754|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
1480946|NCT01832155|3623755|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
1480947|NCT01832155|3623754|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
1480948|NCT01832155|3623755|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
1480949|NCT01832155|3623754|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
1480950|NCT01832155|3623755|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
1480951|NCT01832155|3623754|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
1480952|NCT01832155|3623755|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
1480953|NCT01832155|3623754|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
1480954|NCT01832155|3623755|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
1480955|NCT01832090|3623778|P2|NOT COMPLETED|Overall Study||1
1480956|NCT01832090|3623779|P1|NOT COMPLETED|Overall Study||6
1480957|NCT01832090|3623778|P2|COMPLETED|Overall Study||28
1480958|NCT01832090|3623779|P1|COMPLETED|Overall Study||83
1480959|NCT01832090|3623778|P2|STARTED|Overall Study||29
1480960|NCT01832090|3623779|P1|STARTED|Overall Study||89
1480961|NCT01831934|3623824|P2|NOT COMPLETED|Overall Study||0
1480962|NCT01831934|3623825|P1|NOT COMPLETED|Overall Study||1
1480963|NCT01831934|3623824|P2|COMPLETED|Overall Study||10
1480964|NCT01831934|3623825|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
1480965|NCT01831934|3623824|P2|STARTED|Overall Study||10
1480966|NCT01831934|3623825|P1|STARTED|Overall Study||12
1480967|NCT01831921|3623833|P2|NOT COMPLETED|Overall Study||39
1480968|NCT01831921|3623834|P1|NOT COMPLETED|Overall Study||84
1480969|NCT01831921|3623833|P2|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
1480970|NCT01831921|3623834|P1|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
1480971|NCT01831921|3623833|P2|18 Months|Overall Study|Of 59 eligible for this visit.|49
1480972|NCT01831921|3623834|P1|18 Months|Overall Study|Of 118 eligible for this visit.|90
1480973|NCT01831921|3623833|P2|12 Months|Overall Study||62
1480974|NCT01831921|3623834|P1|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
1480975|NCT01831921|3623833|P2|6 Months|Overall Study||63
1480976|NCT01831921|3623834|P1|6 Months|Overall Study||122
1480977|NCT01831921|3623833|P2|STARTED|Overall Study||75
1480978|NCT01831921|3623834|P1|STARTED|Overall Study||150
1480979|NCT01831817|3623860|P4|NOT COMPLETED|Overall Study||0
1480980|NCT01831817|3623861|P3|NOT COMPLETED|Overall Study||0
1480981|NCT01831817|3623862|P2|NOT COMPLETED|Overall Study||0
1480982|NCT01831817|3623863|P1|NOT COMPLETED|Overall Study||4
1480983|NCT01831817|3623860|P4|COMPLETED|Overall Study||36
1480984|NCT01831817|3623861|P3|COMPLETED|Overall Study||35
1480985|NCT01831817|3623862|P2|COMPLETED|Overall Study||34
1480986|NCT01831817|3623863|P1|COMPLETED|Overall Study||31
1480987|NCT01831817|3623860|P4|STARTED|Overall Study||36
1480988|NCT01831817|3623861|P3|STARTED|Overall Study||35
1480989|NCT01831817|3623862|P2|STARTED|Overall Study||34
1480990|NCT01831817|3623863|P1|STARTED|Overall Study||35
1480991|NCT01831791|3623901|P1|NOT COMPLETED|Overall Study||10
1480992|NCT01831791|3623901|P1|COMPLETED|Overall Study||110
1480993|NCT01831791|3623901|P1|STARTED|Overall Study||120
1480994|NCT01831765|3623930|P3|NOT COMPLETED|Overall Study||42
1480995|NCT01831765|3623931|P2|NOT COMPLETED|Overall Study||27
1480996|NCT01831765|3623932|P1|NOT COMPLETED|Overall Study||44
1480997|NCT01831765|3623930|P3|COMPLETED|Overall Study||338
1480998|NCT01831765|3623931|P2|COMPLETED|Overall Study||355
1480999|NCT01831765|3623932|P1|COMPLETED|Overall Study||337
1481000|NCT01831765|3623930|P3|Completed 52 Weeks|Overall Study||338
1481001|NCT01831765|3623931|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
1481002|NCT01831765|3623932|P1|Completed 52 Weeks|Overall Study||337
1481003|NCT01831765|3623930|P3|Completed 26 Weeks|Overall Study||356
1481004|NCT01831765|3623931|P2|Completed 26 Weeks|Overall Study||355
1481005|NCT01831765|3623932|P1|Completed 26 Weeks|Overall Study||351
1481006|NCT01831765|3623930|P3|STARTED|Overall Study||380
1481007|NCT01831765|3623931|P2|STARTED|Overall Study||382
1481008|NCT01831765|3623932|P1|STARTED|Overall Study||381
1481009|NCT01831726|3623958|P1|NOT COMPLETED|Overall Study||80
1481010|NCT01831726|3623958|P1|COMPLETED|Overall Study||0
1481011|NCT01831726|3623958|P1|STARTED|Overall Study||80
1481012|NCT01831466|3623977|P12|NOT COMPLETED|Overall Study||4
1481013|NCT01831466|3623978|P11|NOT COMPLETED|Overall Study||2
1481014|NCT01831466|3623979|P10|NOT COMPLETED|Overall Study||5
1481015|NCT01831466|3623980|P9|NOT COMPLETED|Overall Study||3
1481016|NCT01831466|3623981|P8|NOT COMPLETED|Overall Study||2
1481017|NCT01831466|3623982|P7|NOT COMPLETED|Overall Study||1
1481018|NCT01831466|3623983|P6|NOT COMPLETED|Overall Study||26
1481019|NCT01831466|3623984|P5|NOT COMPLETED|Overall Study||17
1481020|NCT01831466|3623985|P4|NOT COMPLETED|Overall Study||19
1481021|NCT01831466|3623986|P3|NOT COMPLETED|Overall Study||23
1481022|NCT01831466|3623987|P2|NOT COMPLETED|Overall Study||18
1481023|NCT01831466|3623988|P1|NOT COMPLETED|Overall Study||16
1481024|NCT01831466|3623977|P12|COMPLETED|Overall Study||3
1481025|NCT01831466|3623978|P11|COMPLETED|Overall Study||4
1481026|NCT01831466|3623979|P10|COMPLETED|Overall Study||2
1481027|NCT01831466|3623980|P9|COMPLETED|Overall Study||4
1481028|NCT01831466|3623981|P8|COMPLETED|Overall Study||5
1481029|NCT01831466|3623982|P7|COMPLETED|Overall Study||6
1481030|NCT01831466|3623983|P6|COMPLETED|Overall Study||48
1481031|NCT01831466|3623984|P5|COMPLETED|Overall Study||57
1481032|NCT01831466|3623985|P4|COMPLETED|Overall Study||51
1481033|NCT01831466|3623986|P3|COMPLETED|Overall Study||48
1481034|NCT01831466|3623987|P2|COMPLETED|Overall Study||52
1481035|NCT01831466|3623988|P1|COMPLETED|Overall Study||55
1481036|NCT01831466|3623977|P12|STARTED|Overall Study|Treated|7
1481037|NCT01831466|3623978|P11|STARTED|Overall Study|Treated|6
1481038|NCT01831466|3623979|P10|STARTED|Overall Study|Treated|7
1481039|NCT01831466|3623980|P9|STARTED|Overall Study|Treated|7
1481040|NCT01831466|3623981|P8|STARTED|Overall Study|Treated|7
1481041|NCT01831466|3623982|P7|STARTED|Overall Study|Treated|7
1481042|NCT01831466|3623983|P6|STARTED|Overall Study|Treated|74
1481043|NCT01831466|3623984|P5|STARTED|Overall Study|Treated|74
1481044|NCT01831466|3623985|P4|STARTED|Overall Study|Treated|70
1481045|NCT01831466|3623986|P3|STARTED|Overall Study|Treated|71
1481046|NCT01831466|3623987|P2|STARTED|Overall Study|Treated|70
1481047|NCT01831466|3623988|P1|STARTED|Overall Study|Treated|71
1481048|NCT01831258|3624110|P2|NOT COMPLETED|Overall Study||3
1481049|NCT01831258|3624111|P1|NOT COMPLETED|Overall Study||5
1481050|NCT01831258|3624110|P2|COMPLETED|Overall Study||32
1481051|NCT01831258|3624111|P1|COMPLETED|Overall Study||30
1481052|NCT01831258|3624110|P2|STARTED|Overall Study||35
1481053|NCT01831258|3624111|P1|STARTED|Overall Study||35
1481054|NCT01831232|3624137|P1|NOT COMPLETED|Overall Study||0
1481055|NCT01831232|3624137|P1|COMPLETED|Overall Study||24
1481056|NCT01831232|3624137|P1|STARTED|Overall Study||24
1481057|NCT01831219|3624148|P2|NOT COMPLETED|Overall Study||24
1481058|NCT01831219|3624149|P1|NOT COMPLETED|Overall Study||33
1481059|NCT01831219|3624148|P2|COMPLETED|Overall Study||21
1481060|NCT01831219|3624149|P1|COMPLETED|Overall Study||40
1481061|NCT01831219|3624148|P2|STARTED|Overall Study||45
1481062|NCT01831219|3624149|P1|STARTED|Overall Study||73
1481063|NCT01831154|3624170|P3|NOT COMPLETED|Overall Study||0
1481064|NCT01831154|3624171|P2|NOT COMPLETED|Overall Study||0
1481065|NCT01831154|3624172|P1|NOT COMPLETED|Overall Study||0
1481066|NCT01831154|3624170|P3|COMPLETED|Overall Study||11
1481067|NCT01831154|3624171|P2|COMPLETED|Overall Study||11
1481068|NCT01831154|3624172|P1|COMPLETED|Overall Study||15
1481069|NCT01831154|3624170|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
1481070|NCT01831154|3624171|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
1481071|NCT01831154|3624172|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
1481072|NCT01831076|3624197|P2|NOT COMPLETED|Overall Study||1
1481073|NCT01831076|3624198|P1|NOT COMPLETED|Overall Study||1
1481074|NCT01831076|3624197|P2|COMPLETED|Overall Study||4
1481075|NCT01831076|3624198|P1|COMPLETED|Overall Study||30
1481076|NCT01831076|3624197|P2|STARTED|Overall Study||5
1481077|NCT01831076|3624198|P1|STARTED|Overall Study||31
1481078|NCT01830972|3624206|P2|NOT COMPLETED|Part IV||1
1481079|NCT01830972|3624207|P1|NOT COMPLETED|Part IV||3
1481080|NCT01830972|3624206|P2|COMPLETED|Part IV||10
1481081|NCT01830972|3624207|P1|COMPLETED|Part IV||39
1481082|NCT01830972|3624206|P2|STARTED|Part IV||11
1481083|NCT01830972|3624207|P1|STARTED|Part IV||42
1481084|NCT01830972|3624206|P2|NOT COMPLETED|Part III||0
1481085|NCT01830972|3624207|P1|NOT COMPLETED|Part III||2
1481086|NCT01830972|3624206|P2|COMPLETED|Part III||11
1481087|NCT01830972|3624207|P1|COMPLETED|Part III||42
1481088|NCT01830972|3624206|P2|STARTED|Part III||11
1481089|NCT01830972|3624207|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
1481090|NCT01830972|3624206|P2|NOT COMPLETED|Part II||2
1481091|NCT01830972|3624207|P1|NOT COMPLETED|Part II||2
1481092|NCT01830972|3624206|P2|COMPLETED|Part II||11
1481093|NCT01830972|3624207|P1|COMPLETED|Part II||44
1481094|NCT01830972|3624206|P2|STARTED|Part II|Entered study at Part 2|13
1481095|NCT01830972|3624207|P1|STARTED|Part II||46
1481096|NCT01830972|3624206|P2|NOT COMPLETED|Part I||0
1481097|NCT01830972|3624207|P1|NOT COMPLETED|Part I||0
1481098|NCT01830972|3624206|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
1481099|NCT01830972|3624207|P1|COMPLETED|Part I||46
1481100|NCT01830972|3624206|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
1481101|NCT01830972|3624207|P1|STARTED|Part I||46
1481102|NCT01830933|3624233|P2|NOT COMPLETED|Overall Study||232
1481103|NCT01830933|3624234|P1|NOT COMPLETED|Overall Study||168
1481104|NCT01830933|3624233|P2|COMPLETED|Overall Study||580
1481105|NCT01830933|3624234|P1|COMPLETED|Overall Study||655
1481106|NCT01830933|3624233|P2|Completed Meet-up|Overall Study||603
1481107|NCT01830933|3624234|P1|Completed Meet-up|Overall Study||675
1481108|NCT01830933|3624233|P2|STARTED|Overall Study||812
1481109|NCT01830933|3624234|P1|STARTED|Overall Study||823
1481110|NCT01830920|3624251|P5|NOT COMPLETED|Overall Study||8
1481111|NCT01830920|3624252|P4|NOT COMPLETED|Overall Study||16
1481112|NCT01830920|3624253|P3|NOT COMPLETED|Overall Study||8
1481113|NCT01830920|3624254|P2|NOT COMPLETED|Overall Study||6
1481114|NCT01830920|3624255|P1|NOT COMPLETED|Overall Study||21
1481115|NCT01830920|3624251|P5|COMPLETED|Overall Study||99
1481116|NCT01830920|3624252|P4|COMPLETED|Overall Study||109
1481117|NCT01830920|3624253|P3|COMPLETED|Overall Study||40
1481118|NCT01830920|3624254|P2|COMPLETED|Overall Study||40
1481119|NCT01830920|3624255|P1|COMPLETED|Overall Study||105
1481120|NCT01830920|3624251|P5|Received Allocated Drug|Overall Study||105
1481121|NCT01830920|3624252|P4|Received Allocated Drug|Overall Study||119
1481122|NCT01830920|3624253|P3|Received Allocated Drug|Overall Study||47
1481123|NCT01830920|3624254|P2|Received Allocated Drug|Overall Study||45
1481124|NCT01830920|3624255|P1|Received Allocated Drug|Overall Study||115
1481125|NCT01830920|3624251|P5|STARTED|Overall Study||107
1481126|NCT01830920|3624252|P4|STARTED|Overall Study||125
1481127|NCT01830920|3624253|P3|STARTED|Overall Study||48
1481128|NCT01830920|3624254|P2|STARTED|Overall Study||46
1481129|NCT01830920|3624255|P1|STARTED|Overall Study||126
1481130|NCT01830881|3624294|P2|NOT COMPLETED|Overall Study||1
1481131|NCT01830881|3624295|P1|NOT COMPLETED|Overall Study||0
1481132|NCT01830881|3624294|P2|COMPLETED|Overall Study||61
1481133|NCT01830881|3624295|P1|COMPLETED|Overall Study||62
1481134|NCT01830881|3624294|P2|STARTED|Overall Study||62
1481135|NCT01830881|3624295|P1|STARTED|Overall Study||62
1481136|NCT01830855|3624343|P4|NOT COMPLETED|Overall Study||82
1481137|NCT01830855|3624344|P3|NOT COMPLETED|Overall Study||66
1481138|NCT01830855|3624345|P2|NOT COMPLETED|Overall Study||61
1481139|NCT01830855|3624346|P1|NOT COMPLETED|Overall Study||155
1481140|NCT01830855|3624343|P4|COMPLETED|Overall Study||815
1481141|NCT01830855|3624344|P3|COMPLETED|Overall Study||521
1481142|NCT01830855|3624345|P2|COMPLETED|Overall Study||537
1481143|NCT01830855|3624346|P1|COMPLETED|Overall Study||1353
1481144|NCT01830855|3624343|P4|STARTED|Overall Study||897
1481145|NCT01830855|3624344|P3|STARTED|Overall Study||587
1481146|NCT01830855|3624345|P2|STARTED|Overall Study||598
1481147|NCT01830855|3624346|P1|STARTED|Overall Study||1508
1481148|NCT01830842|3624452|P2|NOT COMPLETED|Overall Study||2
1481149|NCT01830842|3624453|P1|NOT COMPLETED|Overall Study||5
1481150|NCT01830842|3624452|P2|COMPLETED|Overall Study||22
1481151|NCT01830842|3624453|P1|COMPLETED|Overall Study||25
1481152|NCT01830842|3624452|P2|STARTED|Overall Study||24
1481153|NCT01830842|3624453|P1|STARTED|Overall Study||30
1481154|NCT01830790|3624461|P2|NOT COMPLETED|Overall Study||0
1481155|NCT01830790|3624462|P1|NOT COMPLETED|Overall Study||0
1481156|NCT01830790|3624461|P2|COMPLETED|Overall Study||10
1481157|NCT01830790|3624462|P1|COMPLETED|Overall Study||0
1481158|NCT01830790|3624461|P2|STARTED|Overall Study||10
1481159|NCT01830790|3624462|P1|STARTED|Overall Study||0
1481160|NCT01830699|3624472|P2|NOT COMPLETED|Overall Study||0
1481161|NCT01830699|3624473|P1|NOT COMPLETED|Overall Study||0
1481162|NCT01830699|3624472|P2|COMPLETED|Overall Study||20
1481163|NCT01830699|3624473|P1|COMPLETED|Overall Study||13
1481164|NCT01830699|3624472|P2|STARTED|Overall Study||20
1481165|NCT01830699|3624473|P1|STARTED|Overall Study||13
1481166|NCT01830595|3624483|P2|NOT COMPLETED|Second Period||0
1481167|NCT01830595|3624484|P1|NOT COMPLETED|Second Period||0
1481168|NCT01830595|3624483|P2|COMPLETED|Second Period||23
1481169|NCT01830595|3624484|P1|COMPLETED|Second Period||23
1481170|NCT01830595|3624483|P2|STARTED|Second Period||23
1481171|NCT01830595|3624484|P1|STARTED|Second Period||23
1481172|NCT01830595|3624483|P2|NOT COMPLETED|Washout||2
1481173|NCT01830595|3624484|P1|NOT COMPLETED|Washout||2
1481174|NCT01830595|3624483|P2|COMPLETED|Washout||23
1481175|NCT01830595|3624484|P1|COMPLETED|Washout||23
1481176|NCT01830595|3624483|P2|STARTED|Washout||25
1481177|NCT01830595|3624484|P1|STARTED|Washout||25
1481178|NCT01830595|3624483|P2|NOT COMPLETED|First Period||3
1481179|NCT01830595|3624484|P1|NOT COMPLETED|First Period||1
1481180|NCT01830595|3624483|P2|COMPLETED|First Period||25
1481181|NCT01830595|3624484|P1|COMPLETED|First Period||25
1481182|NCT01830595|3624483|P2|Received at Least One Dose|First Period||28
1481183|NCT01830595|3624484|P1|Received at Least One Dose|First Period||26
1481184|NCT01830595|3624483|P2|STARTED|First Period||28
1481185|NCT01830595|3624484|P1|STARTED|First Period||26
1481186|NCT01830543|3624501|P3|NOT COMPLETED|Overall Study||214
1481187|NCT01830543|3624502|P2|NOT COMPLETED|Overall Study||152
1481188|NCT01830543|3624503|P1|NOT COMPLETED|Overall Study||159
1481189|NCT01830543|3624501|P3|COMPLETED|Overall Study||492
1481190|NCT01830543|3624502|P2|COMPLETED|Overall Study||557
1481191|NCT01830543|3624503|P1|COMPLETED|Overall Study||550
1481192|NCT01830543|3624501|P3|Treated|Overall Study||697
1481193|NCT01830543|3624502|P2|Treated|Overall Study||706
1481194|NCT01830543|3624503|P1|Treated|Overall Study||696
1481195|NCT01830543|3624501|P3|STARTED|Overall Study||706
1481196|NCT01830543|3624502|P2|STARTED|Overall Study||709
1481197|NCT01830543|3624503|P1|STARTED|Overall Study||709
1481198|NCT01830205|3624539|P4|NOT COMPLETED|Overall Study||0
1481199|NCT01830205|3624540|P3|NOT COMPLETED|Overall Study||0
1481200|NCT01830205|3624541|P2|NOT COMPLETED|Overall Study||0
1481201|NCT01830205|3624542|P1|NOT COMPLETED|Overall Study||0
1481202|NCT01830205|3624539|P4|COMPLETED|Overall Study||12
1481203|NCT01830205|3624540|P3|COMPLETED|Overall Study||6
1481204|NCT01830205|3624541|P2|COMPLETED|Overall Study||6
1481205|NCT01830205|3624542|P1|COMPLETED|Overall Study||12
1481206|NCT01830205|3624539|P4|STARTED|Overall Study||12
1481207|NCT01830205|3624540|P3|STARTED|Overall Study||6
1481208|NCT01830205|3624541|P2|STARTED|Overall Study||6
1481209|NCT01830205|3624542|P1|STARTED|Overall Study||12
1481210|NCT01830140|3624626|P2|NOT COMPLETED|Overall Study||4
1481211|NCT01830140|3624627|P1|NOT COMPLETED|Overall Study||7
1481212|NCT01830140|3624626|P2|COMPLETED|Overall Study||229
1481213|NCT01830140|3624627|P1|COMPLETED|Overall Study||226
1481214|NCT01830140|3624626|P2|STARTED|Overall Study||233
1481215|NCT01830140|3624627|P1|STARTED|Overall Study||233
1481216|NCT01830127|3624635|P2|NOT COMPLETED|Overall Study||9
1481217|NCT01830127|3624636|P1|NOT COMPLETED|Overall Study||5
1481218|NCT01830127|3624635|P2|COMPLETED|Overall Study||8
1481219|NCT01830127|3624636|P1|COMPLETED|Overall Study||13
1481220|NCT01830127|3624635|P2|STARTED|Overall Study||17
1481221|NCT01830127|3624636|P1|STARTED|Overall Study||18
1481222|NCT01829919|3624644|P1|NOT COMPLETED|Overall Study||0
1481223|NCT01829919|3624644|P1|COMPLETED|Overall Study||24
1481224|NCT01829919|3624644|P1|STARTED|Overall Study||24
1481225|NCT01829711|3624660|P1|NOT COMPLETED|Overall Study||80
1481226|NCT01829711|3624660|P1|COMPLETED|Overall Study||0
1481227|NCT01829711|3624660|P1|STARTED|Overall Study||80
1481228|NCT01829516|3624690|P2|NOT COMPLETED|2nd Intervention||0
1481229|NCT01829516|3624691|P1|NOT COMPLETED|2nd Intervention||0
1481230|NCT01829516|3624690|P2|COMPLETED|2nd Intervention||14
1481231|NCT01829516|3624691|P1|COMPLETED|2nd Intervention||18
1481232|NCT01829516|3624690|P2|STARTED|2nd Intervention||14
1481233|NCT01829516|3624691|P1|STARTED|2nd Intervention||18
1481234|NCT01829516|3624690|P2|NOT COMPLETED|Washout Period - 1 Week||0
1481235|NCT01829516|3624691|P1|NOT COMPLETED|Washout Period - 1 Week||0
1481236|NCT01829516|3624690|P2|COMPLETED|Washout Period - 1 Week||14
1481237|NCT01829516|3624691|P1|COMPLETED|Washout Period - 1 Week||18
1481238|NCT01829516|3624690|P2|STARTED|Washout Period - 1 Week||14
1481239|NCT01829516|3624691|P1|STARTED|Washout Period - 1 Week||18
1481240|NCT01829516|3624690|P2|NOT COMPLETED|First Intervention||0
1481241|NCT01829516|3624691|P1|NOT COMPLETED|First Intervention||0
1481242|NCT01829516|3624690|P2|COMPLETED|First Intervention||14
1481243|NCT01829516|3624691|P1|COMPLETED|First Intervention||18
1481244|NCT01829516|3624690|P2|STARTED|First Intervention||14
1481245|NCT01829516|3624691|P1|STARTED|First Intervention||18
1481246|NCT01829503|3624699|P1|NOT COMPLETED|Overall Study||0
1481247|NCT01829503|3624699|P1|COMPLETED|Overall Study||44
1481248|NCT01829503|3624699|P1|STARTED|Overall Study||44
1481249|NCT01829477|3624715|P2|NOT COMPLETED|Overall Study||15
1481250|NCT01829477|3624716|P1|NOT COMPLETED|Overall Study||16
1481251|NCT01829477|3624715|P2|COMPLETED|Overall Study||1
1481252|NCT01829477|3624716|P1|COMPLETED|Overall Study||1
1481253|NCT01829477|3624715|P2|STARTED|Overall Study||16
1481254|NCT01829477|3624716|P1|STARTED|Overall Study||17
1481255|NCT01829464|3624729|P3|NOT COMPLETED|Overall Study||26
1481256|NCT01829464|3624730|P2|NOT COMPLETED|Overall Study||29
1481257|NCT01829464|3624731|P1|NOT COMPLETED|Overall Study||28
1481258|NCT01829464|3624729|P3|COMPLETED|Overall Study||3
1481259|NCT01829464|3624730|P2|COMPLETED|Overall Study||2
1481260|NCT01829464|3624731|P1|COMPLETED|Overall Study||2
1481261|NCT01829464|3624729|P3|STARTED|Overall Study||29
1481262|NCT01829464|3624730|P2|STARTED|Overall Study||31
1481263|NCT01829464|3624731|P1|STARTED|Overall Study||30
1481264|NCT01829399|3624747|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
1481265|NCT01829399|3624748|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
1481266|NCT01829399|3624747|P2|COMPLETED|Visit 2 (One Month Later)||12
1481267|NCT01829399|3624748|P1|COMPLETED|Visit 2 (One Month Later)||12
1481268|NCT01829399|3624747|P2|STARTED|Visit 2 (One Month Later)||12
1481269|NCT01829399|3624748|P1|STARTED|Visit 2 (One Month Later)||12
1481270|NCT01829399|3624747|P2|NOT COMPLETED|Visit 1||0
1481271|NCT01829399|3624748|P1|NOT COMPLETED|Visit 1||0
1481272|NCT01829399|3624747|P2|COMPLETED|Visit 1||12
1481273|NCT01829399|3624748|P1|COMPLETED|Visit 1||12
1481274|NCT01829399|3624747|P2|STARTED|Visit 1||12
1481275|NCT01829399|3624748|P1|STARTED|Visit 1||12
1481276|NCT01829243|3624756|P2|NOT COMPLETED|Second Intervention||0
1481277|NCT01829243|3624757|P1|NOT COMPLETED|Second Intervention||0
1481278|NCT01829243|3624756|P2|COMPLETED|Second Intervention||13
1481279|NCT01829243|3624757|P1|COMPLETED|Second Intervention||7
1481280|NCT01829243|3624756|P2|STARTED|Second Intervention||13
1481281|NCT01829243|3624757|P1|STARTED|Second Intervention||7
1481282|NCT01829243|3624756|P2|NOT COMPLETED|Washout Period of 1 Week||0
1481283|NCT01829243|3624757|P1|NOT COMPLETED|Washout Period of 1 Week||0
1481284|NCT01829243|3624756|P2|COMPLETED|Washout Period of 1 Week||13
1481285|NCT01829243|3624757|P1|COMPLETED|Washout Period of 1 Week||7
1481286|NCT01829243|3624756|P2|STARTED|Washout Period of 1 Week||13
1481287|NCT01829243|3624757|P1|STARTED|Washout Period of 1 Week||7
1481288|NCT01829243|3624756|P2|NOT COMPLETED|First Intervention||2
1481289|NCT01829243|3624757|P1|NOT COMPLETED|First Intervention||4
1481290|NCT01829243|3624756|P2|COMPLETED|First Intervention||13
1481291|NCT01829243|3624757|P1|COMPLETED|First Intervention||7
1481292|NCT01829243|3624756|P2|STARTED|First Intervention||15
1481293|NCT01829243|3624757|P1|STARTED|First Intervention||11
1481294|NCT01829230|3624771|P2|NOT COMPLETED|Overall Study||4
1481295|NCT01829230|3624772|P1|NOT COMPLETED|Overall Study||1
1481296|NCT01829230|3624771|P2|COMPLETED|Overall Study||38
1481297|NCT01829230|3624772|P1|COMPLETED|Overall Study||39
1481298|NCT01829230|3624771|P2|STARTED|Overall Study||42
1481299|NCT01829230|3624772|P1|STARTED|Overall Study||40
1481300|NCT01829217|3624780|P1|NOT COMPLETED|Overall Study||0
1481301|NCT01829217|3624780|P1|COMPLETED|Overall Study||13
1481302|NCT01829217|3624780|P1|STARTED|Overall Study||13
1481303|NCT01829191|3624786|P2|NOT COMPLETED|Overall Study||14
1481304|NCT01829191|3624787|P1|NOT COMPLETED|Overall Study||7
1481305|NCT01829191|3624786|P2|COMPLETED|Overall Study||50
1481306|NCT01829191|3624787|P1|COMPLETED|Overall Study||56
1481307|NCT01829191|3624786|P2|STARTED|Overall Study||64
1481308|NCT01829191|3624787|P1|STARTED|Overall Study||63
1481309|NCT01829165|3624796|P2|NOT COMPLETED|Overall Study||0
1481310|NCT01829165|3624797|P1|NOT COMPLETED|Overall Study||2
1481311|NCT01829165|3624796|P2|COMPLETED|Overall Study||13
1481312|NCT01829165|3624797|P1|COMPLETED|Overall Study||18
1481313|NCT01829165|3624796|P2|STARTED|Overall Study||13
1481314|NCT01829165|3624797|P1|STARTED|Overall Study||20
1481315|NCT01829113|3624805|P2|NOT COMPLETED|Overall Study||78
1481316|NCT01829113|3624806|P1|NOT COMPLETED|Overall Study||77
1481317|NCT01829113|3624805|P2|COMPLETED|Overall Study||0
1481318|NCT01829113|3624806|P1|COMPLETED|Overall Study||0
1481319|NCT01829113|3624805|P2|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
1481320|NCT01829113|3624806|P1|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
1481321|NCT01829048|3624823|P5|NOT COMPLETED|Overall Study||0
1481322|NCT01829048|3624824|P4|NOT COMPLETED|Overall Study||2
1481323|NCT01829048|3624825|P3|NOT COMPLETED|Overall Study||0
1481324|NCT01829048|3624826|P2|NOT COMPLETED|Overall Study||0
1481325|NCT01829048|3624827|P1|NOT COMPLETED|Overall Study||0
1481326|NCT01829048|3624823|P5|COMPLETED|Overall Study||2
1481327|NCT01829048|3624824|P4|COMPLETED|Overall Study||12
1481328|NCT01829048|3624825|P3|COMPLETED|Overall Study||7
1481329|NCT01829048|3624826|P2|COMPLETED|Overall Study||8
1481330|NCT01829048|3624827|P1|COMPLETED|Overall Study||6
1481331|NCT01829048|3624823|P5|STARTED|Overall Study||2
1481332|NCT01829048|3624824|P4|STARTED|Overall Study||14
1481333|NCT01829048|3624825|P3|STARTED|Overall Study||7
1481334|NCT01829048|3624826|P2|STARTED|Overall Study||8
1481335|NCT01829048|3624827|P1|STARTED|Overall Study||6
1481336|NCT01828983|3624901|P2|NOT COMPLETED|Overall Study||0
1481337|NCT01828983|3624902|P1|NOT COMPLETED|Overall Study||0
1481338|NCT01828983|3624901|P2|COMPLETED|Overall Study||81
1481339|NCT01828983|3624902|P1|COMPLETED|Overall Study||80
1481340|NCT01828983|3624901|P2|STARTED|Overall Study||81
1481341|NCT01828983|3624902|P1|STARTED|Overall Study||80
1481342|NCT01828593|3624915|P3|NOT COMPLETED|Placebo-Free Phase||6
1481343|NCT01828593|3624916|P2|NOT COMPLETED|Placebo-Free Phase||6
1481344|NCT01828593|3624917|P1|NOT COMPLETED|Placebo-Free Phase||0
1481345|NCT01828593|3624915|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
1481346|NCT01828593|3624916|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
1481347|NCT01828593|3624917|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
1481348|NCT01828593|3624915|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
1481349|NCT01828593|3624916|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
1481350|NCT01828593|3624917|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
1481351|NCT01828593|3624915|P3|NOT COMPLETED|Placebo-Controlled Phase||1
1481352|NCT01828593|3624916|P2|NOT COMPLETED|Placebo-Controlled Phase||0
1481353|NCT01828593|3624917|P1|NOT COMPLETED|Placebo-Controlled Phase||0
1481354|NCT01828593|3624915|P3|COMPLETED|Placebo-Controlled Phase||32
1481355|NCT01828593|3624916|P2|COMPLETED|Placebo-Controlled Phase||34
1481356|NCT01828593|3624917|P1|COMPLETED|Placebo-Controlled Phase||36
1481357|NCT01828593|3624915|P3|STARTED|Placebo-Controlled Phase||33
1481358|NCT01828593|3624916|P2|STARTED|Placebo-Controlled Phase||34
1481359|NCT01828593|3624917|P1|STARTED|Placebo-Controlled Phase||36
1481360|NCT01828567|3624940|P2|NOT COMPLETED|Overall Study||10
1481361|NCT01828567|3624941|P1|NOT COMPLETED|Overall Study||31
1481362|NCT01828567|3624940|P2|COMPLETED|Overall Study||199
1481363|NCT01828567|3624941|P1|COMPLETED|Overall Study||177
1481364|NCT01828567|3624940|P2|1 Month|Overall Study||192
1481365|NCT01828567|3624941|P1|1 Month|Overall Study||172
1481366|NCT01828567|3624940|P2|STARTED|Overall Study||209
1481367|NCT01828567|3624941|P1|STARTED|Overall Study||208
1481368|NCT01828515|3624957|P2|NOT COMPLETED|Second Intervention (19 Days)||3
1481369|NCT01828515|3624958|P1|NOT COMPLETED|Second Intervention (19 Days)||0
1481370|NCT01828515|3624957|P2|COMPLETED|Second Intervention (19 Days)||5
1481371|NCT01828515|3624958|P1|COMPLETED|Second Intervention (19 Days)||6
1481372|NCT01828515|3624957|P2|STARTED|Second Intervention (19 Days)||8
1481373|NCT01828515|3624958|P1|STARTED|Second Intervention (19 Days)||6
1481374|NCT01828515|3624957|P2|NOT COMPLETED|Washout (23 Days)||1
1481375|NCT01828515|3624958|P1|NOT COMPLETED|Washout (23 Days)||5
1481376|NCT01828515|3624957|P2|COMPLETED|Washout (23 Days)||8
1481377|NCT01828515|3624958|P1|COMPLETED|Washout (23 Days)||6
1481378|NCT01828515|3624957|P2|STARTED|Washout (23 Days)||9
1481379|NCT01828515|3624958|P1|STARTED|Washout (23 Days)||11
1481380|NCT01828515|3624957|P2|NOT COMPLETED|First Intervention (19 Days)||2
1481381|NCT01828515|3624958|P1|NOT COMPLETED|First Intervention (19 Days)||2
1481382|NCT01828515|3624957|P2|COMPLETED|First Intervention (19 Days)||9
1481383|NCT01828515|3624958|P1|COMPLETED|First Intervention (19 Days)||11
1481384|NCT01828515|3624957|P2|STARTED|First Intervention (19 Days)||11
1481385|NCT01828515|3624958|P1|STARTED|First Intervention (19 Days)||13
1481386|NCT01828476|3624966|P2|NOT COMPLETED|Overall Study||0
1481387|NCT01828476|3624967|P1|NOT COMPLETED|Overall Study||0
1481388|NCT01828476|3624966|P2|COMPLETED|Overall Study||0
1481389|NCT01828476|3624967|P1|COMPLETED|Overall Study||13
1481390|NCT01828476|3624966|P2|STARTED|Overall Study||0
1481391|NCT01828476|3624967|P1|STARTED|Overall Study||13
1481392|NCT01828281|3624989|P2|NOT COMPLETED|Overall Study||0
1481393|NCT01828281|3624990|P1|NOT COMPLETED|Overall Study||1
1481394|NCT01828281|3624989|P2|COMPLETED|Overall Study||45
1481395|NCT01828281|3624990|P1|COMPLETED|Overall Study||44
1481396|NCT01828281|3624989|P2|STARTED|Overall Study||45
1481397|NCT01828281|3624990|P1|STARTED|Overall Study||45
1481398|NCT01828216|3625002|P2|NOT COMPLETED|Overall Study||0
1481399|NCT01828216|3625003|P1|NOT COMPLETED|Overall Study||0
1481400|NCT01828216|3625002|P2|COMPLETED|Overall Study||157
1481401|NCT01828216|3625003|P1|COMPLETED|Overall Study||159
1481402|NCT01828216|3625002|P2|STARTED|Overall Study||157
1481403|NCT01828216|3625003|P1|STARTED|Overall Study||159
1481404|NCT01828164|3625011|P1|NOT COMPLETED|Overall Study||17
1481405|NCT01828164|3625011|P1|COMPLETED|Overall Study||32
1481406|NCT01828164|3625011|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
1481407|NCT01828112|3625023|P2|NOT COMPLETED|Overall Study||108
1481408|NCT01828112|3625024|P1|NOT COMPLETED|Overall Study||82
1481409|NCT01828112|3625023|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
1481410|NCT01828112|3625024|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
1481411|NCT01828112|3625023|P2|Treated|Overall Study||113
1481412|NCT01828112|3625024|P1|Treated|Overall Study||115
1481413|NCT01828112|3625023|P2|Untreated|Overall Study||3
1481414|NCT01828112|3625024|P1|Untreated|Overall Study||0
1481415|NCT01828112|3625023|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
1481416|NCT01828112|3625024|P1|Untreated Patients|Overall Study||0
1481417|NCT01828112|3625023|P2|Discontinued From Study|Overall Study||10
1481418|NCT01828112|3625024|P1|Discontinued From Study|Overall Study||14
1481419|NCT01828112|3625023|P2|Entered Survival Follow-up Phase|Overall Study||19
1481420|NCT01828112|3625024|P1|Entered Survival Follow-up Phase|Overall Study||61
1481421|NCT01828112|3625023|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
1481422|NCT01828112|3625024|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
1481423|NCT01828112|3625023|P2|Entered Extension Treatment Phase|Overall Study||74
1481424|NCT01828112|3625024|P1|Entered Extension Treatment Phase|Overall Study||0
1481425|NCT01828112|3625023|P2|STARTED|Overall Study||116
1481426|NCT01828112|3625024|P1|STARTED|Overall Study||115
1481427|NCT01828099|3625032|P2|NOT COMPLETED|Overall Study||157
1481428|NCT01828099|3625033|P1|NOT COMPLETED|Overall Study||94
1481429|NCT01828099|3625032|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
1481430|NCT01828099|3625033|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
1481431|NCT01828099|3625032|P2|Discontinued From Study|Overall Study||29
1481432|NCT01828099|3625033|P1|Discontinued From Study|Overall Study||20
1481433|NCT01828099|3625032|P2|Entered Survival Follow-up Phase|Overall Study||31
1481434|NCT01828099|3625033|P1|Entered Survival Follow-up Phase|Overall Study||64
1481435|NCT01828099|3625032|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
1481436|NCT01828099|3625033|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
1481437|NCT01828099|3625032|P2|Entered Extension-treatment Phase|Overall Study||81
1481438|NCT01828099|3625033|P1|Entered Extension-treatment Phase|Overall Study||0
1481439|NCT01828099|3625032|P2|Discontinued From Treatment Phase|Overall Study||157
1481440|NCT01828099|3625033|P1|Discontinued From Treatment Phase|Overall Study||94
1481441|NCT01828099|3625032|P2|Treated|Overall Study||175
1481442|NCT01828099|3625033|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
1481443|NCT01828099|3625032|P2|Untreated Patients|Overall Study||12
1481444|NCT01828099|3625033|P1|Untreated Patients|Overall Study||0
1481445|NCT01828099|3625032|P2|STARTED|Overall Study||187
1481446|NCT01828099|3625033|P1|STARTED|Overall Study||189
1481447|NCT01827839|3625039|P1|NOT COMPLETED|Overall Study||3
1481448|NCT01827839|3625039|P1|COMPLETED|Overall Study||93
1481449|NCT01827839|3625039|P1|STARTED|Overall Study||96
1481450|NCT01827670|3625063|P2|NOT COMPLETED|Overall Study||3
1481451|NCT01827670|3625064|P1|NOT COMPLETED|Overall Study||3
1481452|NCT01827670|3625063|P2|COMPLETED|Overall Study||56
1481453|NCT01827670|3625064|P1|COMPLETED|Overall Study||57
1481454|NCT01827670|3625063|P2|STARTED|Overall Study||59
1481455|NCT01827670|3625064|P1|STARTED|Overall Study||60
1481456|NCT01827592|3625083|P3|NOT COMPLETED|Overall Study||76
1481457|NCT01827592|3625084|P2|NOT COMPLETED|Overall Study||80
1481458|NCT01827592|3625085|P1|NOT COMPLETED|Overall Study||74
1481459|NCT01827592|3625083|P3|COMPLETED|Overall Study||48
1481460|NCT01827592|3625084|P2|COMPLETED|Overall Study||46
1481461|NCT01827592|3625085|P1|COMPLETED|Overall Study||52
1481462|NCT01827592|3625083|P3|Safety Analysis Set|Overall Study||124
1481463|NCT01827592|3625084|P2|Safety Analysis Set|Overall Study||126
1481464|NCT01827592|3625085|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
1481465|NCT01827592|3625083|P3|STARTED|Overall Study|Randomized patients.|124
1481466|NCT01827592|3625084|P2|STARTED|Overall Study|Randomized patients.|126
1481467|NCT01827592|3625085|P1|STARTED|Overall Study|Randomized patients.|126
1481468|NCT01827475|3625117|P3|NOT COMPLETED|Overall Study||0
1481469|NCT01827475|3625118|P2|NOT COMPLETED|Overall Study||0
1481470|NCT01827475|3625119|P1|NOT COMPLETED|Overall Study||0
1481471|NCT01827475|3625117|P3|COMPLETED|Overall Study||30
1481472|NCT01827475|3625118|P2|COMPLETED|Overall Study||30
1481473|NCT01827475|3625119|P1|COMPLETED|Overall Study||30
1481474|NCT01827475|3625117|P3|STARTED|Overall Study||30
1481475|NCT01827475|3625118|P2|STARTED|Overall Study||30
1481476|NCT01827475|3625119|P1|STARTED|Overall Study||30
1481477|NCT01827462|3625133|P3|NOT COMPLETED|Overall Study||28
1481478|NCT01827462|3625134|P2|NOT COMPLETED|Overall Study||18
1481479|NCT01827462|3625135|P1|NOT COMPLETED|Overall Study||41
1481480|NCT01827462|3625133|P3|COMPLETED|Overall Study||12
1481481|NCT01827462|3625134|P2|COMPLETED|Overall Study||19
1481482|NCT01827462|3625135|P1|COMPLETED|Overall Study||18
1481483|NCT01827462|3625133|P3|STARTED|Overall Study||40
1481484|NCT01827462|3625134|P2|STARTED|Overall Study||37
1481485|NCT01827462|3625135|P1|STARTED|Overall Study||59
1481486|NCT01827371|3625150|P4|NOT COMPLETED|Overall Study||23
1481487|NCT01827371|3625151|P3|NOT COMPLETED|Overall Study||11
1481488|NCT01827371|3625152|P2|NOT COMPLETED|Overall Study||7
1481489|NCT01827371|3625153|P1|NOT COMPLETED|Overall Study||13
1481490|NCT01827371|3625150|P4|COMPLETED|Overall Study||97
1481491|NCT01827371|3625151|P3|COMPLETED|Overall Study||93
1481492|NCT01827371|3625152|P2|COMPLETED|Overall Study||89
1481493|NCT01827371|3625153|P1|COMPLETED|Overall Study||102
1481494|NCT01827371|3625150|P4|STARTED|Overall Study||120
1481495|NCT01827371|3625151|P3|STARTED|Overall Study||104
1481496|NCT01827371|3625152|P2|STARTED|Overall Study||96
1481497|NCT01827371|3625153|P1|STARTED|Overall Study||115
1481498|NCT01827358|3625177|P2|NOT COMPLETED|Overall Study||31
1481499|NCT01827358|3625178|P1|NOT COMPLETED|Overall Study||35
1481500|NCT01827358|3625177|P2|COMPLETED|Overall Study||44
1481501|NCT01827358|3625178|P1|COMPLETED|Overall Study||45
1481502|NCT01827358|3625177|P2|STARTED|Overall Study||75
1481503|NCT01827358|3625178|P1|STARTED|Overall Study||80
1481504|NCT01827332|3625212|P2|NOT COMPLETED|Overall Study||1
1481505|NCT01827332|3625213|P1|NOT COMPLETED|Overall Study||2
1481506|NCT01827332|3625212|P2|COMPLETED|Overall Study||7
1481507|NCT01827332|3625213|P1|COMPLETED|Overall Study||6
1481508|NCT01827332|3625212|P2|STARTED|Overall Study||8
1481509|NCT01827332|3625213|P1|STARTED|Overall Study||8
1481510|NCT01827319|3625221|P1|NOT COMPLETED|Overall Study||3
1481511|NCT01827319|3625221|P1|COMPLETED|Overall Study||200
1481512|NCT01827319|3625221|P1|STARTED|Overall Study||203
1481513|NCT01827306|3625229|P2|NOT COMPLETED|Overall Study||5
1481514|NCT01827306|3625230|P1|NOT COMPLETED|Overall Study||11
1481515|NCT01827306|3625229|P2|COMPLETED|Overall Study||8
1481516|NCT01827306|3625230|P1|COMPLETED|Overall Study||10
1481517|NCT01827306|3625229|P2|STARTED|Overall Study||13
1481518|NCT01827306|3625230|P1|STARTED|Overall Study||21
1481519|NCT01827267|3625244|P2|NOT COMPLETED|Overall Study||12
1481520|NCT01827267|3625245|P1|NOT COMPLETED|Overall Study||5
1481521|NCT01827267|3625244|P2|COMPLETED|Overall Study||32
1481522|NCT01827267|3625245|P1|COMPLETED|Overall Study||13
1481523|NCT01827267|3625244|P2|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
1481524|NCT01827267|3625245|P1|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
1481525|NCT01827267|3625244|P2|Received Study Drug|Overall Study||43
1481526|NCT01827267|3625245|P1|Received Study Drug|Overall Study||17
1481527|NCT01827267|3625244|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
1481528|NCT01827267|3625245|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
1481529|NCT01827254|3625260|P1|NOT COMPLETED|Overall Study||59
1481530|NCT01827254|3625260|P1|COMPLETED|Overall Study||2
1481531|NCT01827254|3625260|P1|Evaluable Population|Overall Study||52
1481532|NCT01827254|3625260|P1|STARTED|Overall Study||61
1481533|NCT01826981|3625285|P15|NOT COMPLETED|Overall Study||0
1481534|NCT01826981|3625286|P14|NOT COMPLETED|Overall Study||5
1481535|NCT01826981|3625287|P13|NOT COMPLETED|Overall Study||1
1481536|NCT01826981|3625288|P12|NOT COMPLETED|Overall Study||2
1481537|NCT01826981|3625289|P11|NOT COMPLETED|Overall Study||2
1481538|NCT01826981|3625290|P10|NOT COMPLETED|Overall Study||1
1481539|NCT01826981|3625291|P9|NOT COMPLETED|Overall Study||7
1481540|NCT01826981|3625292|P8|NOT COMPLETED|Overall Study||11
1481541|NCT01826981|3625293|P7|NOT COMPLETED|Overall Study||1
1481542|NCT01826981|3625294|P6|NOT COMPLETED|Overall Study||1
1481543|NCT01826981|3625295|P5|NOT COMPLETED|Overall Study||7
1481544|NCT01826981|3625296|P4|NOT COMPLETED|Overall Study||0
1481545|NCT01826981|3625297|P3|NOT COMPLETED|Overall Study||0
1481546|NCT01826981|3625298|P2|NOT COMPLETED|Overall Study||1
1481547|NCT01826981|3625299|P1|NOT COMPLETED|Overall Study||0
1481548|NCT01826981|3625285|P15|COMPLETED|Overall Study||8
1481549|NCT01826981|3625286|P14|COMPLETED|Overall Study||15
1481550|NCT01826981|3625287|P13|COMPLETED|Overall Study||25
1481551|NCT01826981|3625288|P12|COMPLETED|Overall Study||25
1481552|NCT01826981|3625289|P11|COMPLETED|Overall Study||22
1481553|NCT01826981|3625290|P10|COMPLETED|Overall Study||26
1481554|NCT01826981|3625291|P9|COMPLETED|Overall Study||13
1481555|NCT01826981|3625292|P8|COMPLETED|Overall Study||40
1481556|NCT01826981|3625293|P7|COMPLETED|Overall Study||24
1481557|NCT01826981|3625294|P6|COMPLETED|Overall Study||25
1481558|NCT01826981|3625295|P5|COMPLETED|Overall Study||18
1481559|NCT01826981|3625296|P4|COMPLETED|Overall Study||26
1481560|NCT01826981|3625297|P3|COMPLETED|Overall Study||25
1481561|NCT01826981|3625298|P2|COMPLETED|Overall Study||9
1481562|NCT01826981|3625299|P1|COMPLETED|Overall Study||19
1481563|NCT01826981|3625285|P15|STARTED|Overall Study||8
1481564|NCT01826981|3625286|P14|STARTED|Overall Study||20
1481565|NCT01826981|3625287|P13|STARTED|Overall Study||26
1481566|NCT01826981|3625288|P12|STARTED|Overall Study||27
1481567|NCT01826981|3625289|P11|STARTED|Overall Study||24
1481568|NCT01826981|3625290|P10|STARTED|Overall Study||27
1481569|NCT01826981|3625291|P9|STARTED|Overall Study||20
1481570|NCT01826981|3625292|P8|STARTED|Overall Study||51
1481571|NCT01826981|3625293|P7|STARTED|Overall Study||25
1481572|NCT01826981|3625294|P6|STARTED|Overall Study||26
1481573|NCT01826981|3625295|P5|STARTED|Overall Study||25
1481574|NCT01826981|3625296|P4|STARTED|Overall Study||26
1481575|NCT01826981|3625297|P3|STARTED|Overall Study||25
1481576|NCT01826981|3625298|P2|STARTED|Overall Study||10
1481577|NCT01826981|3625299|P1|STARTED|Overall Study||19
1481578|NCT01826851|3625447|P2|NOT COMPLETED|Overall Study||0
1481579|NCT01826851|3625448|P1|NOT COMPLETED|Overall Study||0
1481580|NCT01826851|3625447|P2|COMPLETED|Overall Study||41
1481581|NCT01826851|3625448|P1|COMPLETED|Overall Study||38
1481582|NCT01826851|3625447|P2|STARTED|Overall Study||41
1481583|NCT01826851|3625448|P1|STARTED|Overall Study||38
1481584|NCT01826812|3625468|P2|NOT COMPLETED|Overall Study||1
1481585|NCT01826812|3625469|P1|NOT COMPLETED|Overall Study||0
1481586|NCT01826812|3625468|P2|COMPLETED|Overall Study||32
1481587|NCT01826812|3625469|P1|COMPLETED|Overall Study||167
1481588|NCT01826812|3625468|P2|STARTED|Overall Study||33
1481589|NCT01826812|3625469|P1|STARTED|Overall Study||167
1481590|NCT01826604|3625485|P2|NOT COMPLETED|Overall Study||9
1481591|NCT01826604|3625486|P1|NOT COMPLETED|Overall Study||8
1481592|NCT01826604|3625485|P2|COMPLETED|Overall Study||148
1481593|NCT01826604|3625486|P1|COMPLETED|Overall Study||136
1481594|NCT01826604|3625485|P2|STARTED|Overall Study||157
1481595|NCT01826604|3625486|P1|STARTED|Overall Study||144
1481596|NCT01826513|3625497|P3|NOT COMPLETED|Overall Study||0
1481597|NCT01826513|3625498|P2|NOT COMPLETED|Overall Study||0
1481598|NCT01826513|3625499|P1|NOT COMPLETED|Overall Study||0
1481599|NCT01826513|3625497|P3|COMPLETED|Overall Study||10
1481600|NCT01826513|3625498|P2|COMPLETED|Overall Study||10
1481601|NCT01826513|3625499|P1|COMPLETED|Overall Study||5
1481602|NCT01826513|3625497|P3|STARTED|Overall Study||10
1481603|NCT01826513|3625498|P2|STARTED|Overall Study||10
1481604|NCT01826513|3625499|P1|STARTED|Overall Study||5
1481605|NCT01826422|3625530|P2|NOT COMPLETED|Overall Study||3
1481606|NCT01826422|3625531|P1|NOT COMPLETED|Overall Study||1
1481607|NCT01826422|3625530|P2|COMPLETED|Overall Study||19
1481608|NCT01826422|3625531|P1|COMPLETED|Overall Study||17
1481609|NCT01826422|3625530|P2|STARTED|Overall Study||22
1481610|NCT01826422|3625531|P1|STARTED|Overall Study||18
1481611|NCT01826370|3625575|P1|NOT COMPLETED|Overall Study||20
1481612|NCT01826370|3625575|P1|COMPLETED|Overall Study||658
1481613|NCT01826370|3625575|P1|STARTED|Overall Study||678
1481614|NCT01826227|3625581|P1|NOT COMPLETED|Overall Study||0
1481615|NCT01826227|3625581|P1|COMPLETED|Overall Study||5
1481616|NCT01826227|3625581|P1|STARTED|Overall Study||5
1481617|NCT01826214|3625587|P2|NOT COMPLETED|Overall Study||34
1481618|NCT01826214|3625588|P1|NOT COMPLETED|Overall Study||35
1481619|NCT01826214|3625587|P2|COMPLETED|Overall Study||0
1481620|NCT01826214|3625588|P1|COMPLETED|Overall Study||0
1481621|NCT01826214|3625587|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
1481622|NCT01826214|3625588|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
1481623|NCT01826214|3625587|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
1481624|NCT01826214|3625588|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
1481625|NCT01826214|3625587|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
1481626|NCT01826214|3625588|P1|STARTED|Overall Study||35
1481627|NCT01826201|3625606|P1|NOT COMPLETED|Overall Study||4
1481628|NCT01826201|3625606|P1|COMPLETED|Overall Study||17
1481629|NCT01826201|3625606|P1|STARTED|Overall Study|Subjects in each arm are same|21
1481630|NCT01825941|3625614|P2|NOT COMPLETED|Overall Study||1
1481631|NCT01825941|3625615|P1|NOT COMPLETED|Overall Study||4
1481632|NCT01825941|3625614|P2|COMPLETED|Overall Study||103
1481633|NCT01825941|3625615|P1|COMPLETED|Overall Study||100
1481634|NCT01825941|3625614|P2|STARTED|Overall Study||104
1481635|NCT01825941|3625615|P1|STARTED|Overall Study||104
1481636|NCT01825889|3625623|P2|NOT COMPLETED|Overall Study||0
1481637|NCT01825889|3625624|P1|NOT COMPLETED|Overall Study||0
1481638|NCT01825889|3625623|P2|COMPLETED|Overall Study||10
1481639|NCT01825889|3625624|P1|COMPLETED|Overall Study||10
1481640|NCT01825889|3625623|P2|Received One Dose of Study Drug|Overall Study||10
1481641|NCT01825889|3625624|P1|Received One Dose of Study Drug|Overall Study||10
1481642|NCT01825889|3625623|P2|STARTED|Overall Study||10
1481643|NCT01825889|3625624|P1|STARTED|Overall Study||10
1481644|NCT01825876|3625634|P2|NOT COMPLETED|Period 2||1
1481645|NCT01825876|3625635|P1|NOT COMPLETED|Period 2||0
1481646|NCT01825876|3625634|P2|COMPLETED|Period 2||16
1481647|NCT01825876|3625635|P1|COMPLETED|Period 2||0
1481648|NCT01825876|3625634|P2|Received 1 Dose of Study Drug|Period 2||17
1481649|NCT01825876|3625635|P1|Received 1 Dose of Study Drug|Period 2||0
1481650|NCT01825876|3625634|P2|STARTED|Period 2|Participants received a different treatment in Period 1.|17
1481651|NCT01825876|3625635|P1|STARTED|Period 2|Participants received a different treatment in Period 2.|0
1481652|NCT01825876|3625634|P2|NOT COMPLETED|Period 1||0
1481653|NCT01825876|3625635|P1|NOT COMPLETED|Period 1||0
1481654|NCT01825876|3625634|P2|COMPLETED|Period 1||0
1481655|NCT01825876|3625635|P1|COMPLETED|Period 1||17
1481656|NCT01825876|3625634|P2|Received 1 Dose of Study Drug|Period 1||0
1481657|NCT01825876|3625635|P1|Received 1 Dose of Study Drug|Period 1||17
1481658|NCT01825876|3625634|P2|STARTED|Period 1||0
1481659|NCT01825876|3625635|P1|STARTED|Period 1||17
1481660|NCT01825837|3625656|P4|NOT COMPLETED|PART II||0
1481661|NCT01825837|3625657|P3|NOT COMPLETED|PART II||19
1481662|NCT01825837|3625658|P2|NOT COMPLETED|PART II||14
1481663|NCT01825837|3625659|P1|NOT COMPLETED|PART II||19
1481664|NCT01825837|3625656|P4|COMPLETED|PART II||0
1481665|NCT01825837|3625657|P3|COMPLETED|PART II||7
1481666|NCT01825837|3625658|P2|COMPLETED|PART II||12
1481667|NCT01825837|3625659|P1|COMPLETED|PART II||16
1481668|NCT01825837|3625656|P4|Per-Protocol Population|PART II||0
1481669|NCT01825837|3625657|P3|Per-Protocol Population|PART II||24
1481670|NCT01825837|3625658|P2|Per-Protocol Population|PART II||23
1481671|NCT01825837|3625659|P1|Per-Protocol Population|PART II||32
1481672|NCT01825837|3625656|P4|Intent-to-Treat Population|PART II||0
1481673|NCT01825837|3625657|P3|Intent-to-Treat Population|PART II||26
1481674|NCT01825837|3625658|P2|Intent-to-Treat Population|PART II||25
1481675|NCT01825837|3625659|P1|Intent-to-Treat Population|PART II||34
1481676|NCT01825837|3625656|P4|Safety Population (Double-Blind)|PART II||0
1481677|NCT01825837|3625657|P3|Safety Population (Double-Blind)|PART II||26
1481678|NCT01825837|3625658|P2|Safety Population (Double-Blind)|PART II||26
1481679|NCT01825837|3625659|P1|Safety Population (Double-Blind)|PART II||35
1481680|NCT01825837|3625656|P4|Randomized Patients|PART II||0
1481681|NCT01825837|3625657|P3|Randomized Patients|PART II||26
1481682|NCT01825837|3625658|P2|Randomized Patients|PART II||26
1481683|NCT01825837|3625659|P1|Randomized Patients|PART II||35
1481684|NCT01825837|3625656|P4|STARTED|PART II||0
1481685|NCT01825837|3625657|P3|STARTED|PART II||26
1481686|NCT01825837|3625658|P2|STARTED|PART II||26
1481687|NCT01825837|3625659|P1|STARTED|PART II||35
1481688|NCT01825837|3625656|P4|NOT COMPLETED|PART I||17
1481689|NCT01825837|3625657|P3|NOT COMPLETED|PART I||0
1481690|NCT01825837|3625658|P2|NOT COMPLETED|PART I||0
1481691|NCT01825837|3625659|P1|NOT COMPLETED|PART I||0
1481692|NCT01825837|3625656|P4|COMPLETED|PART I||87
1481693|NCT01825837|3625657|P3|COMPLETED|PART I||0
1481694|NCT01825837|3625658|P2|COMPLETED|PART I||0
1481695|NCT01825837|3625659|P1|COMPLETED|PART I||0
1481696|NCT01825837|3625656|P4|Safety Population (Open-Label)|PART I||104
1481697|NCT01825837|3625657|P3|Safety Population (Open-Label)|PART I||0
1481698|NCT01825837|3625658|P2|Safety Population (Open-Label)|PART I||0
1481699|NCT01825837|3625659|P1|Safety Population (Open-Label)|PART I||0
1481700|NCT01825837|3625656|P4|Enrolled|PART I||104
1481701|NCT01825837|3625657|P3|Enrolled|PART I||0
1481702|NCT01825837|3625658|P2|Enrolled|PART I||0
1481703|NCT01825837|3625659|P1|Enrolled|PART I||0
1481704|NCT01825837|3625656|P4|STARTED|PART I||104
1481705|NCT01825837|3625657|P3|STARTED|PART I||0
1481706|NCT01825837|3625658|P2|STARTED|PART I||0
1481707|NCT01825837|3625659|P1|STARTED|PART I||0
1481708|NCT01825798|3625669|P2|NOT COMPLETED|Overall Study||5
1481709|NCT01825798|3625670|P1|NOT COMPLETED|Overall Study||2
1481710|NCT01825798|3625669|P2|COMPLETED|Overall Study||23
1481711|NCT01825798|3625670|P1|COMPLETED|Overall Study||30
1481712|NCT01825798|3625669|P2|STARTED|Overall Study||28
1481713|NCT01825798|3625670|P1|STARTED|Overall Study||32
1481714|NCT01825655|3625700|P2|NOT COMPLETED|Overall Study||0
1481715|NCT01825655|3625701|P1|NOT COMPLETED|Overall Study||0
1481716|NCT01825655|3625700|P2|COMPLETED|Overall Study||2
1481717|NCT01825655|3625701|P1|COMPLETED|Overall Study||0
1481718|NCT01825655|3625700|P2|STARTED|Overall Study||2
1481719|NCT01825655|3625701|P1|STARTED|Overall Study||0
1481720|NCT01825577|3625707|P1|NOT COMPLETED|Overall Study||8
1481721|NCT01825577|3625707|P1|COMPLETED|Overall Study||6
1481722|NCT01825577|3625707|P1|STARTED|Overall Study||14
1481723|NCT01825408|3625716|P4|NOT COMPLETED|Overall Study||0
1481724|NCT01825408|3625717|P3|NOT COMPLETED|Overall Study||0
1481725|NCT01825408|3625718|P2|NOT COMPLETED|Overall Study||0
1481726|NCT01825408|3625719|P1|NOT COMPLETED|Overall Study||0
1481727|NCT01825408|3625716|P4|COMPLETED|Overall Study||12
1481728|NCT01825408|3625717|P3|COMPLETED|Overall Study||14
1481729|NCT01825408|3625718|P2|COMPLETED|Overall Study||7
1481730|NCT01825408|3625719|P1|COMPLETED|Overall Study||7
1481731|NCT01825408|3625716|P4|STARTED|Overall Study||12
1481732|NCT01825408|3625717|P3|STARTED|Overall Study||14
1481733|NCT01825408|3625718|P2|STARTED|Overall Study||7
1481734|NCT01825408|3625719|P1|STARTED|Overall Study||7
1481735|NCT01825200|3625731|P2|NOT COMPLETED|Overall Study||7
1481736|NCT01825200|3625732|P1|NOT COMPLETED|Overall Study||5
1481737|NCT01825200|3625731|P2|COMPLETED|Overall Study||1314
1481738|NCT01825200|3625732|P1|COMPLETED|Overall Study||1314
1481739|NCT01825200|3625731|P2|STARTED|Overall Study||1321
1481740|NCT01825200|3625732|P1|STARTED|Overall Study||1319
1481741|NCT01825122|3625746|P2|NOT COMPLETED|Overall Study||19
1481742|NCT01825122|3625747|P1|NOT COMPLETED|Overall Study||10
1481743|NCT01825122|3625746|P2|COMPLETED|Overall Study||59
1481744|NCT01825122|3625747|P1|COMPLETED|Overall Study||67
1481745|NCT01825122|3625746|P2|STARTED|Overall Study||78
1481746|NCT01825122|3625747|P1|STARTED|Overall Study||77
1481747|NCT01824979|3625755|P2|NOT COMPLETED|Overall Study||13
1481748|NCT01824979|3625756|P1|NOT COMPLETED|Overall Study||13
1481749|NCT01824979|3625755|P2|COMPLETED|Overall Study||37
1481750|NCT01824979|3625756|P1|COMPLETED|Overall Study||37
1481751|NCT01824979|3625755|P2|STARTED|Overall Study||50
1481752|NCT01824979|3625756|P1|STARTED|Overall Study||50
1481753|NCT01824901|3625764|P4|NOT COMPLETED|Overall Study||0
1481754|NCT01824901|3625765|P3|NOT COMPLETED|Overall Study||0
1481755|NCT01824901|3625766|P2|NOT COMPLETED|Overall Study||0
1481756|NCT01824901|3625767|P1|NOT COMPLETED|Overall Study||0
1481757|NCT01824901|3625764|P4|COMPLETED|Overall Study||0
1481758|NCT01824901|3625765|P3|COMPLETED|Overall Study||0
1481759|NCT01824901|3625766|P2|COMPLETED|Overall Study||0
1481760|NCT01824901|3625767|P1|COMPLETED|Overall Study||2
1481761|NCT01824901|3625764|P4|STARTED|Overall Study||0
1481762|NCT01824901|3625765|P3|STARTED|Overall Study||0
1481763|NCT01824901|3625766|P2|STARTED|Overall Study||0
1481764|NCT01824901|3625767|P1|STARTED|Overall Study||2
1481765|NCT01824823|3625773|P2|NOT COMPLETED|Overall Study||1
1481766|NCT01824823|3625774|P1|NOT COMPLETED|Overall Study||2
1481767|NCT01824823|3625773|P2|COMPLETED|Overall Study||0
1481768|NCT01824823|3625774|P1|COMPLETED|Overall Study||0
1481769|NCT01824823|3625773|P2|STARTED|Overall Study||1
1481770|NCT01824823|3625774|P1|STARTED|Overall Study||2
1481771|NCT01824693|3625783|P3|NOT COMPLETED|Overall Study||15
1481772|NCT01824693|3625784|P2|NOT COMPLETED|Overall Study||7
1481773|NCT01824693|3625785|P1|NOT COMPLETED|Overall Study||1
1481774|NCT01824693|3625783|P3|COMPLETED|Overall Study||0
1481775|NCT01824693|3625784|P2|COMPLETED|Overall Study||2
1481776|NCT01824693|3625785|P1|COMPLETED|Overall Study||5
1481777|NCT01824693|3625783|P3|STARTED|Overall Study||15
1481778|NCT01824693|3625784|P2|STARTED|Overall Study||9
1481779|NCT01824693|3625785|P1|STARTED|Overall Study||6
1481780|NCT01824602|3625802|P4|NOT COMPLETED|Overall Study||5
1481781|NCT01824602|3625803|P3|NOT COMPLETED|Overall Study||4
1481782|NCT01824602|3625804|P2|NOT COMPLETED|Overall Study||0
1481783|NCT01824602|3625805|P1|NOT COMPLETED|Overall Study||1
1481784|NCT01824602|3625802|P4|COMPLETED|Overall Study||5
1481785|NCT01824602|3625803|P3|COMPLETED|Overall Study||5
1481786|NCT01824602|3625804|P2|COMPLETED|Overall Study||8
1481787|NCT01824602|3625805|P1|COMPLETED|Overall Study||10
1481788|NCT01824602|3625802|P4|Intent-to-treat Population|Overall Study||9
1481789|NCT01824602|3625803|P3|Intent-to-treat Population|Overall Study||9
1481790|NCT01824602|3625804|P2|Intent-to-treat Population|Overall Study||8
1481791|NCT01824602|3625805|P1|Intent-to-treat Population|Overall Study||11
1481792|NCT01824602|3625802|P4|Safety Population|Overall Study||10
1481793|NCT01824602|3625803|P3|Safety Population|Overall Study||9
1481794|NCT01824602|3625804|P2|Safety Population|Overall Study||8
1481795|NCT01824602|3625805|P1|Safety Population|Overall Study||11
1481796|NCT01824602|3625802|P4|STARTED|Overall Study||10
1481797|NCT01824602|3625803|P3|STARTED|Overall Study||9
1481798|NCT01824602|3625804|P2|STARTED|Overall Study||8
1481799|NCT01824602|3625805|P1|STARTED|Overall Study||11
1481800|NCT01824589|3625819|P4|NOT COMPLETED|Overall Study||0
1481801|NCT01824589|3625820|P3|NOT COMPLETED|Overall Study||0
1481802|NCT01824589|3625821|P2|NOT COMPLETED|Overall Study||0
1481803|NCT01824589|3625822|P1|NOT COMPLETED|Overall Study||0
1481804|NCT01824589|3625819|P4|COMPLETED|Overall Study||0
1481805|NCT01824589|3625820|P3|COMPLETED|Overall Study||0
1481806|NCT01824589|3625821|P2|COMPLETED|Overall Study||0
1481807|NCT01824589|3625822|P1|COMPLETED|Overall Study||1
1481808|NCT01824589|3625819|P4|STARTED|Overall Study||0
1481809|NCT01824589|3625820|P3|STARTED|Overall Study||0
1481810|NCT01824589|3625821|P2|STARTED|Overall Study||0
1481811|NCT01824589|3625822|P1|STARTED|Overall Study||1
1481812|NCT01824576|3625844|P1|NOT COMPLETED|Overall Study||2
1481813|NCT01824576|3625844|P1|COMPLETED|Overall Study||7
1481814|NCT01824576|3625844|P1|STARTED|Overall Study||9
1481815|NCT01824498|3625862|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1481816|NCT01824498|3625863|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1481817|NCT01824498|3625864|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1481818|NCT01824498|3625865|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1481819|NCT01824498|3625866|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1481820|NCT01824498|3625867|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
1481821|NCT01824498|3625862|P6|COMPLETED|3rd Intervention (8 Weeks)||4
1481822|NCT01824498|3625863|P5|COMPLETED|3rd Intervention (8 Weeks)||3
1481823|NCT01824498|3625864|P4|COMPLETED|3rd Intervention (8 Weeks)||2
1481824|NCT01824498|3625865|P3|COMPLETED|3rd Intervention (8 Weeks)||4
1481825|NCT01824498|3625866|P2|COMPLETED|3rd Intervention (8 Weeks)||2
1481826|NCT01824498|3625867|P1|COMPLETED|3rd Intervention (8 Weeks)||3
1481827|NCT01824498|3625862|P6|STARTED|3rd Intervention (8 Weeks)||4
1481828|NCT01824498|3625863|P5|STARTED|3rd Intervention (8 Weeks)||3
1481829|NCT01824498|3625864|P4|STARTED|3rd Intervention (8 Weeks)||2
1481830|NCT01824498|3625865|P3|STARTED|3rd Intervention (8 Weeks)||4
1481831|NCT01824498|3625866|P2|STARTED|3rd Intervention (8 Weeks)||2
1481832|NCT01824498|3625867|P1|STARTED|3rd Intervention (8 Weeks)||3
1481833|NCT01824498|3625862|P6|NOT COMPLETED|Washout (8 Weeks)||0
1481834|NCT01824498|3625863|P5|NOT COMPLETED|Washout (8 Weeks)||0
1481835|NCT01824498|3625864|P4|NOT COMPLETED|Washout (8 Weeks)||0
1481836|NCT01824498|3625865|P3|NOT COMPLETED|Washout (8 Weeks)||0
1481837|NCT01824498|3625866|P2|NOT COMPLETED|Washout (8 Weeks)||0
1481838|NCT01824498|3625867|P1|NOT COMPLETED|Washout (8 Weeks)||0
1481839|NCT01824498|3625862|P6|COMPLETED|Washout (8 Weeks)||4
1481840|NCT01824498|3625863|P5|COMPLETED|Washout (8 Weeks)||3
1481841|NCT01824498|3625864|P4|COMPLETED|Washout (8 Weeks)||2
1481842|NCT01824498|3625865|P3|COMPLETED|Washout (8 Weeks)||4
1481843|NCT01824498|3625866|P2|COMPLETED|Washout (8 Weeks)||2
1481844|NCT01824498|3625867|P1|COMPLETED|Washout (8 Weeks)||3
1481845|NCT01824498|3625862|P6|STARTED|Washout (8 Weeks)||4
1481846|NCT01824498|3625863|P5|STARTED|Washout (8 Weeks)||3
1481847|NCT01824498|3625864|P4|STARTED|Washout (8 Weeks)||2
1481848|NCT01824498|3625865|P3|STARTED|Washout (8 Weeks)||4
1481849|NCT01824498|3625866|P2|STARTED|Washout (8 Weeks)||2
1481850|NCT01824498|3625867|P1|STARTED|Washout (8 Weeks)||3
1481851|NCT01824498|3625862|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1481852|NCT01824498|3625863|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1481853|NCT01824498|3625864|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1481854|NCT01824498|3625865|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1481855|NCT01824498|3625866|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1481856|NCT01824498|3625867|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
1481857|NCT01824498|3625862|P6|COMPLETED|2nd Intervention (8 Weeks)||4
1481858|NCT01824498|3625863|P5|COMPLETED|2nd Intervention (8 Weeks)||3
1481859|NCT01824498|3625864|P4|COMPLETED|2nd Intervention (8 Weeks)||2
1481860|NCT01824498|3625865|P3|COMPLETED|2nd Intervention (8 Weeks)||4
1481861|NCT01824498|3625866|P2|COMPLETED|2nd Intervention (8 Weeks)||2
1481862|NCT01824498|3625867|P1|COMPLETED|2nd Intervention (8 Weeks)||3
1481863|NCT01824498|3625862|P6|STARTED|2nd Intervention (8 Weeks)||4
1481864|NCT01824498|3625863|P5|STARTED|2nd Intervention (8 Weeks)||3
1481865|NCT01824498|3625864|P4|STARTED|2nd Intervention (8 Weeks)||2
1481866|NCT01824498|3625865|P3|STARTED|2nd Intervention (8 Weeks)||4
1481867|NCT01824498|3625866|P2|STARTED|2nd Intervention (8 Weeks)||2
1481868|NCT01824498|3625867|P1|STARTED|2nd Intervention (8 Weeks)||3
1481869|NCT01824498|3625862|P6|NOT COMPLETED|Washout (8 Weeks)||0
1481870|NCT01824498|3625863|P5|NOT COMPLETED|Washout (8 Weeks)||1
1481871|NCT01824498|3625864|P4|NOT COMPLETED|Washout (8 Weeks)||1
1481872|NCT01824498|3625865|P3|NOT COMPLETED|Washout (8 Weeks)||2
1481873|NCT01824498|3625866|P2|NOT COMPLETED|Washout (8 Weeks)||0
1481874|NCT01824498|3625867|P1|NOT COMPLETED|Washout (8 Weeks)||2
1481875|NCT01824498|3625862|P6|COMPLETED|Washout (8 Weeks)||4
1481876|NCT01824498|3625863|P5|COMPLETED|Washout (8 Weeks)||3
1481877|NCT01824498|3625864|P4|COMPLETED|Washout (8 Weeks)||2
1481878|NCT01824498|3625865|P3|COMPLETED|Washout (8 Weeks)||4
1481879|NCT01824498|3625866|P2|COMPLETED|Washout (8 Weeks)||2
1481880|NCT01824498|3625867|P1|COMPLETED|Washout (8 Weeks)||3
1481881|NCT01824498|3625862|P6|STARTED|Washout (8 Weeks)||4
1481882|NCT01824498|3625863|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
1481883|NCT01824498|3625864|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
1481884|NCT01824498|3625865|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
1481885|NCT01824498|3625866|P2|STARTED|Washout (8 Weeks)||2
1481886|NCT01824498|3625867|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
1481887|NCT01824498|3625862|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
1481888|NCT01824498|3625863|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
1481889|NCT01824498|3625864|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
1481890|NCT01824498|3625865|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
1481891|NCT01824498|3625866|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
1481892|NCT01824498|3625867|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
1481893|NCT01824498|3625862|P6|COMPLETED|1st Intervention (8 Weeks)||4
1481894|NCT01824498|3625863|P5|COMPLETED|1st Intervention (8 Weeks)||4
1481895|NCT01824498|3625864|P4|COMPLETED|1st Intervention (8 Weeks)||3
1481896|NCT01824498|3625865|P3|COMPLETED|1st Intervention (8 Weeks)||6
1481897|NCT01824498|3625866|P2|COMPLETED|1st Intervention (8 Weeks)||2
1481898|NCT01824498|3625867|P1|COMPLETED|1st Intervention (8 Weeks)||5
1481899|NCT01824498|3625862|P6|STARTED|1st Intervention (8 Weeks)||4
1481900|NCT01824498|3625863|P5|STARTED|1st Intervention (8 Weeks)||4
1481901|NCT01824498|3625864|P4|STARTED|1st Intervention (8 Weeks)||3
1481902|NCT01824498|3625865|P3|STARTED|1st Intervention (8 Weeks)||6
1481903|NCT01824498|3625866|P2|STARTED|1st Intervention (8 Weeks)||2
1481904|NCT01824498|3625867|P1|STARTED|1st Intervention (8 Weeks)||5
1481905|NCT01824446|3625875|P1|NOT COMPLETED|Overall Study||0
1481906|NCT01824446|3625875|P1|COMPLETED|Overall Study||6
1481907|NCT01824446|3625875|P1|STARTED|Overall Study||6
1481908|NCT01824394|3625901|P3|NOT COMPLETED|Overall Study||74
1481909|NCT01824394|3625902|P2|NOT COMPLETED|Overall Study||116
1481910|NCT01824394|3625903|P1|NOT COMPLETED|Overall Study||119
1481911|NCT01824394|3625901|P3|COMPLETED|Overall Study||51
1481912|NCT01824394|3625902|P2|COMPLETED|Overall Study||53
1481913|NCT01824394|3625903|P1|COMPLETED|Overall Study||55
1481914|NCT01824394|3625901|P3|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
1481915|NCT01824394|3625902|P2|Per-Protocol Population|Overall Study||148
1481916|NCT01824394|3625903|P1|Per-Protocol Population|Overall Study||150
1481917|NCT01824394|3625901|P3|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
1481918|NCT01824394|3625902|P2|Safety Population|Overall Study||149
1481919|NCT01824394|3625903|P1|Safety Population|Overall Study||151
1481920|NCT01824394|3625901|P3|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
1481921|NCT01824394|3625902|P2|Intent to Treat Population|Overall Study||149
1481922|NCT01824394|3625903|P1|Intent to Treat Population|Overall Study||151
1481923|NCT01824394|3625901|P3|STARTED|Overall Study||125
1481924|NCT01824394|3625902|P2|STARTED|Overall Study||169
1481925|NCT01824394|3625903|P1|STARTED|Overall Study||174
1481926|NCT01824355|3625913|P1|NOT COMPLETED|Overall Study||3
1481927|NCT01824355|3625913|P1|COMPLETED|Overall Study||110
1481928|NCT01824355|3625913|P1|STARTED|Overall Study||113
1481929|NCT01824342|3625924|P2|NOT COMPLETED|Overall Study||5
1481930|NCT01824342|3625925|P1|NOT COMPLETED|Overall Study||9
1481931|NCT01824342|3625924|P2|COMPLETED|Overall Study||2
1481932|NCT01824342|3625925|P1|COMPLETED|Overall Study||2
1481933|NCT01824342|3625924|P2|STARTED|Overall Study||7
1481934|NCT01824342|3625925|P1|STARTED|Overall Study||11
1481935|NCT01824303|3625939|P2|NOT COMPLETED|Open Label Extension||0
1481936|NCT01824303|3625940|P1|NOT COMPLETED|Open Label Extension||0
1481937|NCT01824303|3625939|P2|COMPLETED|Open Label Extension||11
1481938|NCT01824303|3625940|P1|COMPLETED|Open Label Extension||12
1481939|NCT01824303|3625939|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
1481940|NCT01824303|3625940|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
1481941|NCT01824303|3625939|P2|NOT COMPLETED|Randomized Study||1
1481942|NCT01824303|3625940|P1|NOT COMPLETED|Randomized Study||2
1481943|NCT01824303|3625939|P2|COMPLETED|Randomized Study||13
1481944|NCT01824303|3625940|P1|COMPLETED|Randomized Study||14
1481945|NCT01824303|3625939|P2|STARTED|Randomized Study||14
1481946|NCT01824303|3625940|P1|STARTED|Randomized Study||16
1481947|NCT01824160|3625964|P1|NOT COMPLETED|Overall Study||0
1481948|NCT01824160|3625964|P1|COMPLETED|Overall Study||50
1481949|NCT01824160|3625964|P1|STARTED|Overall Study||50
1481950|NCT01823679|3625968|P1|NOT COMPLETED|Overall Study||1
1481951|NCT01823679|3625968|P1|COMPLETED|Overall Study||1
1481952|NCT01823679|3625968|P1|STARTED|Overall Study||2
1481953|NCT01823653|3625976|P1|NOT COMPLETED|Overall Study||0
1481954|NCT01823653|3625976|P1|COMPLETED|Overall Study||60
1481955|NCT01823653|3625976|P1|STARTED|Overall Study||60
1481956|NCT01823614|3625990|P6|NOT COMPLETED|Overall Study||0
1481957|NCT01823614|3625991|P5|NOT COMPLETED|Overall Study||0
1481958|NCT01823614|3625992|P4|NOT COMPLETED|Overall Study||0
1481959|NCT01823614|3625993|P3|NOT COMPLETED|Overall Study||0
1481960|NCT01823614|3625994|P2|NOT COMPLETED|Overall Study||0
1481961|NCT01823614|3625995|P1|NOT COMPLETED|Overall Study||0
1481962|NCT01823614|3625990|P6|COMPLETED|Overall Study||154
1481963|NCT01823614|3625991|P5|COMPLETED|Overall Study||172
1481964|NCT01823614|3625992|P4|COMPLETED|Overall Study||122
1481965|NCT01823614|3625993|P3|COMPLETED|Overall Study||176
1481966|NCT01823614|3625994|P2|COMPLETED|Overall Study||140
1481967|NCT01823614|3625995|P1|COMPLETED|Overall Study||179
1481968|NCT01823614|3625990|P6|STARTED|Overall Study||154
1481969|NCT01823614|3625991|P5|STARTED|Overall Study||172
1481970|NCT01823614|3625992|P4|STARTED|Overall Study||122
1481971|NCT01823614|3625993|P3|STARTED|Overall Study||176
1481972|NCT01823614|3625994|P2|STARTED|Overall Study||140
1481973|NCT01823614|3625995|P1|STARTED|Overall Study||179
1481974|NCT01823536|3626021|P6|NOT COMPLETED|Overall Study||0
1481975|NCT01823536|3626022|P5|NOT COMPLETED|Overall Study||2
1481976|NCT01823536|3626023|P4|NOT COMPLETED|Overall Study||2
1481977|NCT01823536|3626024|P3|NOT COMPLETED|Overall Study||1
1481978|NCT01823536|3626025|P2|NOT COMPLETED|Overall Study||2
1481979|NCT01823536|3626026|P1|NOT COMPLETED|Overall Study||2
1481980|NCT01823536|3626021|P6|COMPLETED|Overall Study||2
1481981|NCT01823536|3626022|P5|COMPLETED|Overall Study||99
1481982|NCT01823536|3626023|P4|COMPLETED|Overall Study||64
1481983|NCT01823536|3626024|P3|COMPLETED|Overall Study||119
1481984|NCT01823536|3626025|P2|COMPLETED|Overall Study||101
1481985|NCT01823536|3626026|P1|COMPLETED|Overall Study||71
1481986|NCT01823536|3626021|P6|STARTED|Overall Study||2
1481987|NCT01823536|3626022|P5|STARTED|Overall Study||101
1481988|NCT01823536|3626023|P4|STARTED|Overall Study||66
1481989|NCT01823536|3626024|P3|STARTED|Overall Study||120
1481990|NCT01823536|3626025|P2|STARTED|Overall Study||103
1481991|NCT01823536|3626026|P1|STARTED|Overall Study||73
1481992|NCT01823510|3626064|P2|NOT COMPLETED|Days 22-28||0
1481993|NCT01823510|3626065|P1|NOT COMPLETED|Days 22-28||0
1481994|NCT01823510|3626064|P2|COMPLETED|Days 22-28||10
1481995|NCT01823510|3626065|P1|COMPLETED|Days 22-28||10
1481996|NCT01823510|3626064|P2|STARTED|Days 22-28||10
1481997|NCT01823510|3626065|P1|STARTED|Days 22-28||10
1481998|NCT01823510|3626064|P2|NOT COMPLETED|Days 8-21||0
1481999|NCT01823510|3626065|P1|NOT COMPLETED|Days 8-21||0
1482000|NCT01823510|3626064|P2|COMPLETED|Days 8-21||10
1482001|NCT01823510|3626065|P1|COMPLETED|Days 8-21||10
1482002|NCT01823510|3626064|P2|STARTED|Days 8-21||10
1482003|NCT01823510|3626065|P1|STARTED|Days 8-21||10
1482004|NCT01823510|3626064|P2|NOT COMPLETED|Days 1-7||0
1482005|NCT01823510|3626065|P1|NOT COMPLETED|Days 1-7||0
1482006|NCT01823510|3626064|P2|COMPLETED|Days 1-7||10
1482007|NCT01823510|3626065|P1|COMPLETED|Days 1-7||10
1482008|NCT01823510|3626064|P2|STARTED|Days 1-7||10
1482009|NCT01823510|3626065|P1|STARTED|Days 1-7||10
1482010|NCT01823341|3626077|P1|NOT COMPLETED|Overall Study||15
1482011|NCT01823341|3626077|P1|COMPLETED|Overall Study||82
1482012|NCT01823341|3626077|P1|STARTED|Overall Study||97
1482013|NCT01823289|3626120|P1|NOT COMPLETED|Overall Study||24
1482014|NCT01823289|3626120|P1|COMPLETED|Overall Study||47
1482015|NCT01823289|3626120|P1|STARTED|Overall Study||71
1482016|NCT01823224|3626128|P2|NOT COMPLETED|Overall Study||11
1482017|NCT01823224|3626129|P1|NOT COMPLETED|Overall Study||6
1482018|NCT01823224|3626128|P2|COMPLETED|Overall Study||22
1482019|NCT01823224|3626129|P1|COMPLETED|Overall Study||28
1482020|NCT01823224|3626128|P2|STARTED|Overall Study||33
1482021|NCT01823224|3626129|P1|STARTED|Overall Study||34
1482022|NCT01823146|3626139|P2|NOT COMPLETED|Overall Study||2
1482023|NCT01823146|3626140|P1|NOT COMPLETED|Overall Study||2
1482024|NCT01823146|3626139|P2|COMPLETED|Overall Study||49
1482025|NCT01823146|3626140|P1|COMPLETED|Overall Study||53
1482026|NCT01823146|3626139|P2|STARTED|Overall Study||51
1482027|NCT01823146|3626140|P1|STARTED|Overall Study||55
1482028|NCT01822899|3626152|P2|NOT COMPLETED|Overall Study||18
1482029|NCT01822899|3626153|P1|NOT COMPLETED|Overall Study||24
1482030|NCT01822899|3626152|P2|COMPLETED|Overall Study||340
1482031|NCT01822899|3626153|P1|COMPLETED|Overall Study||334
1482032|NCT01822899|3626152|P2|STARTED|Overall Study||358
1482033|NCT01822899|3626153|P1|STARTED|Overall Study||358
1482034|NCT01822821|3626163|P2|NOT COMPLETED|Overall Study||1
1482035|NCT01822821|3626164|P1|NOT COMPLETED|Overall Study||2
1482036|NCT01822821|3626163|P2|COMPLETED|Overall Study||74
1482037|NCT01822821|3626164|P1|COMPLETED|Overall Study||73
1482038|NCT01822821|3626163|P2|STARTED|Overall Study||75
1482039|NCT01822821|3626164|P1|STARTED|Overall Study||75
1482040|NCT01822756|3626193|P5|NOT COMPLETED|Overall Study||7
1482041|NCT01822756|3626194|P4|NOT COMPLETED|Overall Study||4
1482042|NCT01822756|3626195|P3|NOT COMPLETED|Overall Study||10
1482043|NCT01822756|3626196|P2|NOT COMPLETED|Overall Study||4
1482044|NCT01822756|3626197|P1|NOT COMPLETED|Overall Study||16
1482045|NCT01822756|3626193|P5|COMPLETED|Overall Study||1
1482046|NCT01822756|3626194|P4|COMPLETED|Overall Study||0
1482047|NCT01822756|3626195|P3|COMPLETED|Overall Study||0
1482048|NCT01822756|3626196|P2|COMPLETED|Overall Study||0
1482049|NCT01822756|3626197|P1|COMPLETED|Overall Study||0
1482050|NCT01822756|3626193|P5|Discontinued From the Study|Overall Study||7
1482051|NCT01822756|3626194|P4|Discontinued From the Study|Overall Study||4
1482052|NCT01822756|3626195|P3|Discontinued From the Study|Overall Study||10
1482053|NCT01822756|3626196|P2|Discontinued From the Study|Overall Study||4
1482054|NCT01822756|3626197|P1|Discontinued From the Study|Overall Study||16
1482055|NCT01822756|3626193|P5|STARTED|Overall Study||8
1482056|NCT01822756|3626194|P4|STARTED|Overall Study||4
1482057|NCT01822756|3626195|P3|STARTED|Overall Study||10
1482058|NCT01822756|3626196|P2|STARTED|Overall Study||4
1482059|NCT01822756|3626197|P1|STARTED|Overall Study||16
1482060|NCT01822691|3626239|P1|NOT COMPLETED|Overall Study||2
1482061|NCT01822691|3626239|P1|COMPLETED|Overall Study||13
1482062|NCT01822691|3626239|P1|STARTED|Overall Study||15
1482063|NCT01822678|3626250|P3|NOT COMPLETED|Overall Study||11
1482064|NCT01822678|3626251|P2|NOT COMPLETED|Overall Study||15
1482065|NCT01822678|3626252|P1|NOT COMPLETED|Overall Study||12
1482066|NCT01822678|3626250|P3|COMPLETED|Overall Study||29
1482067|NCT01822678|3626251|P2|COMPLETED|Overall Study||49
1482068|NCT01822678|3626252|P1|COMPLETED|Overall Study||45
1482069|NCT01822678|3626250|P3|Per Protocol Population|Overall Study||34
1482070|NCT01822678|3626251|P2|Per Protocol Population|Overall Study||52
1482071|NCT01822678|3626252|P1|Per Protocol Population|Overall Study||45
1482072|NCT01822678|3626250|P3|Intention-to-Treat Population (ITT)|Overall Study||40
1482073|NCT01822678|3626251|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
1482074|NCT01822678|3626252|P1|Intention-to-Treat Population (ITT)|Overall Study||57
1482075|NCT01822678|3626250|P3|Safety Population|Overall Study||40
1482076|NCT01822678|3626251|P2|Safety Population|Overall Study||64
1482077|NCT01822678|3626252|P1|Safety Population|Overall Study||57
1482078|NCT01822678|3626250|P3|Treated|Overall Study||40
1482079|NCT01822678|3626251|P2|Treated|Overall Study||64
1482080|NCT01822678|3626252|P1|Treated|Overall Study||57
1482081|NCT01822678|3626250|P3|STARTED|Overall Study||40
1482082|NCT01822678|3626251|P2|STARTED|Overall Study||64
1482083|NCT01822678|3626252|P1|STARTED|Overall Study||57
1482084|NCT01822665|3626260|P1|NOT COMPLETED|Overall Study||8
1482085|NCT01822665|3626260|P1|COMPLETED|Overall Study||20
1482086|NCT01822665|3626260|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
1482087|NCT01822665|3626260|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
1482088|NCT01822665|3626260|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
1482089|NCT01822665|3626260|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
1482090|NCT01822665|3626260|P1|STARTED|Overall Study||28
1482091|NCT01822574|3626287|P3|NOT COMPLETED|Overall Study||0
1482092|NCT01822574|3626288|P2|NOT COMPLETED|Overall Study||0
1482093|NCT01822574|3626289|P1|NOT COMPLETED|Overall Study||0
1482094|NCT01822574|3626287|P3|COMPLETED|Overall Study||30
1482095|NCT01822574|3626288|P2|COMPLETED|Overall Study||30
1482096|NCT01822574|3626289|P1|COMPLETED|Overall Study||30
1482097|NCT01822574|3626287|P3|STARTED|Overall Study||30
1482098|NCT01822574|3626288|P2|STARTED|Overall Study||30
1482099|NCT01822574|3626289|P1|STARTED|Overall Study||30
1482100|NCT01822561|3626303|P1|NOT COMPLETED|Overall Study||2
1482101|NCT01822561|3626303|P1|COMPLETED|Overall Study||13
1482102|NCT01822561|3626303|P1|STARTED|Overall Study||15
1482103|NCT01822548|3626313|P2|NOT COMPLETED|Overall Study||0
1482104|NCT01822548|3626314|P1|NOT COMPLETED|Overall Study||0
1482105|NCT01822548|3626313|P2|COMPLETED|Overall Study||24
1482106|NCT01822548|3626314|P1|COMPLETED|Overall Study||40
1482107|NCT01822548|3626313|P2|Discontinued Intervention|Overall Study||5
1482108|NCT01822548|3626314|P1|Discontinued Intervention|Overall Study||0
1482109|NCT01822548|3626313|P2|STARTED|Overall Study||24
1482110|NCT01822548|3626314|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
1482111|NCT01822535|3626324|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
1482112|NCT01822535|3626325|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
1482113|NCT01822535|3626324|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
1482114|NCT01822535|3626325|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
1482115|NCT01822535|3626324|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
1482116|NCT01822535|3626325|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
1482117|NCT01822535|3626324|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
1482118|NCT01822535|3626325|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
1482119|NCT01822535|3626324|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
1482120|NCT01822535|3626325|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
1482121|NCT01822535|3626324|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
1482122|NCT01822535|3626325|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
1482123|NCT01822301|3626337|P1|NOT COMPLETED|Overall Study||0
1482124|NCT01822301|3626337|P1|COMPLETED|Overall Study||5
1482125|NCT01822301|3626337|P1|STARTED|Overall Study||5
1482126|NCT01822223|3626349|P2|NOT COMPLETED|Overall Study||1
1482127|NCT01822223|3626350|P1|NOT COMPLETED|Overall Study||0
1482128|NCT01822223|3626349|P2|COMPLETED|Overall Study||9
1482129|NCT01822223|3626350|P1|COMPLETED|Overall Study||10
1482130|NCT01822223|3626349|P2|STARTED|Overall Study||10
1482131|NCT01822223|3626350|P1|STARTED|Overall Study||10
1482132|NCT01822197|3626366|P1|NOT COMPLETED|Overall Study||0
1482133|NCT01822197|3626366|P1|COMPLETED|Overall Study||30
1482134|NCT01822197|3626366|P1|STARTED|Overall Study||30
1482135|NCT01822119|3626372|P1|NOT COMPLETED|Overall Study||0
1482136|NCT01822119|3626372|P1|COMPLETED|Overall Study||27
1482137|NCT01822119|3626372|P1|STARTED|Overall Study||27
1482138|NCT01821963|3626395|P1|NOT COMPLETED|Overall Study||1
1482139|NCT01821963|3626395|P1|COMPLETED|Overall Study||0
1482140|NCT01821963|3626395|P1|STARTED|Overall Study||1
1482141|NCT01821937|3626401|P2|NOT COMPLETED|Overall Study||3
1482142|NCT01821937|3626402|P1|NOT COMPLETED|Overall Study||0
1482143|NCT01821937|3626401|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
1482144|NCT01821937|3626402|P1|COMPLETED|Overall Study||10
1482145|NCT01821937|3626401|P2|STARTED|Overall Study||15
1482146|NCT01821937|3626402|P1|STARTED|Overall Study||10
1482147|NCT01821859|3626420|P1|NOT COMPLETED|Overall Study||5
1482148|NCT01821859|3626420|P1|COMPLETED|Overall Study||0
1482149|NCT01821859|3626420|P1|STARTED|Overall Study||5
1482150|NCT01821807|3626426|P2|NOT COMPLETED|Overall Study||1
1482151|NCT01821807|3626427|P1|NOT COMPLETED|Overall Study||3
1482152|NCT01821807|3626426|P2|COMPLETED|Overall Study||109
1482153|NCT01821807|3626427|P1|COMPLETED|Overall Study||147
1482154|NCT01821807|3626426|P2|STARTED|Overall Study||110
1482155|NCT01821807|3626427|P1|STARTED|Overall Study||150
1482156|NCT01821560|3626437|P2|NOT COMPLETED|Overall Study||7
1482157|NCT01821560|3626438|P1|NOT COMPLETED|Overall Study||6
1482158|NCT01821560|3626437|P2|COMPLETED|Overall Study||15
1482159|NCT01821560|3626438|P1|COMPLETED|Overall Study||16
1482160|NCT01821560|3626437|P2|STARTED|Overall Study||22
1482161|NCT01821560|3626438|P1|STARTED|Overall Study||22
1482162|NCT01821534|3626444|P1|NOT COMPLETED|Overall Study||0
1482163|NCT01821534|3626444|P1|COMPLETED|Overall Study||201
1482164|NCT01821534|3626444|P1|STARTED|Overall Study||201
1482165|NCT01821417|3626453|P2|NOT COMPLETED|Overall Study||0
1482166|NCT01821417|3626454|P1|NOT COMPLETED|Overall Study||0
1482167|NCT01821417|3626453|P2|COMPLETED|Overall Study||31
1482168|NCT01821417|3626454|P1|COMPLETED|Overall Study||37
1482169|NCT01821417|3626453|P2|STARTED|Overall Study||31
1482170|NCT01821417|3626454|P1|STARTED|Overall Study||37
1482171|NCT01821378|3626467|P3|NOT COMPLETED|Overall Study||42
1482172|NCT01821378|3626468|P2|NOT COMPLETED|Overall Study||54
1482173|NCT01821378|3626469|P1|NOT COMPLETED|Overall Study||27
1482174|NCT01821378|3626467|P3|COMPLETED|Overall Study||70
1482175|NCT01821378|3626468|P2|COMPLETED|Overall Study||145
1482176|NCT01821378|3626469|P1|COMPLETED|Overall Study||74
1482177|NCT01821378|3626467|P3|STARTED|Overall Study||112
1482178|NCT01821378|3626468|P2|STARTED|Overall Study||199
1482179|NCT01821378|3626469|P1|STARTED|Overall Study||101
1482180|NCT01821352|3626507|P2|NOT COMPLETED|Overall Study||0
1482181|NCT01821352|3626508|P1|NOT COMPLETED|Overall Study||0
1482182|NCT01821352|3626507|P2|COMPLETED|Overall Study||25
1482183|NCT01821352|3626508|P1|COMPLETED|Overall Study||28
1482184|NCT01821352|3626507|P2|STARTED|Overall Study||25
1482185|NCT01821352|3626508|P1|STARTED|Overall Study||28
1482186|NCT01821326|3626518|P1|NOT COMPLETED|Overall Study||0
1482187|NCT01821326|3626518|P1|COMPLETED|Overall Study||339
1482188|NCT01821326|3626518|P1|STARTED|Overall Study||339
1482189|NCT01821118|3626524|P2|NOT COMPLETED|Overall Study||1
1482190|NCT01821118|3626525|P1|NOT COMPLETED|Overall Study||0
1482191|NCT01821118|3626524|P2|COMPLETED|Overall Study||11
1482192|NCT01821118|3626525|P1|COMPLETED|Overall Study||24
1482193|NCT01821118|3626524|P2|STARTED|Overall Study||12
1482194|NCT01821118|3626525|P1|STARTED|Overall Study||24
1482195|NCT01821105|3626558|P1|NOT COMPLETED|Overall Study||0
1482196|NCT01821105|3626558|P1|COMPLETED|Overall Study||21
1482197|NCT01821105|3626558|P1|STARTED|Overall Study||21
1482198|NCT01820754|3626564|P1|NOT COMPLETED|Overall Study||0
1482199|NCT01820754|3626564|P1|COMPLETED|Overall Study||24
1482200|NCT01820754|3626564|P1|STARTED|Overall Study||24
1482201|NCT01820585|3626576|P4|NOT COMPLETED|Overall Study||49
1482202|NCT01820585|3626577|P3|NOT COMPLETED|Overall Study||34
1482203|NCT01820585|3626578|P2|NOT COMPLETED|Overall Study||32
1482204|NCT01820585|3626579|P1|NOT COMPLETED|Overall Study||27
1482205|NCT01820585|3626576|P4|COMPLETED|Overall Study||83
1482206|NCT01820585|3626577|P3|COMPLETED|Overall Study||101
1482207|NCT01820585|3626578|P2|COMPLETED|Overall Study||98
1482208|NCT01820585|3626579|P1|COMPLETED|Overall Study||104
1482209|NCT01820585|3626576|P4|Completed Maintenance Period|Overall Study||84
1482210|NCT01820585|3626577|P3|Completed Maintenance Period|Overall Study||101
1482211|NCT01820585|3626578|P2|Completed Maintenance Period|Overall Study||98
1482212|NCT01820585|3626579|P1|Completed Maintenance Period|Overall Study||105
1482213|NCT01820585|3626576|P4|Entered Maintenance Period|Overall Study||123
1482214|NCT01820585|3626577|P3|Entered Maintenance Period|Overall Study||131
1482215|NCT01820585|3626578|P2|Entered Maintenance Period|Overall Study||124
1482216|NCT01820585|3626579|P1|Entered Maintenance Period|Overall Study||128
1482217|NCT01820585|3626576|P4|Completed Titration Period|Overall Study||126
1482218|NCT01820585|3626577|P3|Completed Titration Period|Overall Study||131
1482219|NCT01820585|3626578|P2|Completed Titration Period|Overall Study||125
1482220|NCT01820585|3626579|P1|Completed Titration Period|Overall Study||128
1482221|NCT01820585|3626576|P4|Full Analysis Set|Overall Study||129
1482222|NCT01820585|3626577|P3|Full Analysis Set|Overall Study||135
1482223|NCT01820585|3626578|P2|Full Analysis Set|Overall Study||130
1482224|NCT01820585|3626579|P1|Full Analysis Set|Overall Study||131
1482225|NCT01820585|3626576|P4|Randomized and Treated|Overall Study||132
1482226|NCT01820585|3626577|P3|Randomized and Treated|Overall Study||135
1482227|NCT01820585|3626578|P2|Randomized and Treated|Overall Study||130
1482228|NCT01820585|3626579|P1|Randomized and Treated|Overall Study||131
1482229|NCT01820585|3626576|P4|STARTED|Overall Study||132
1482230|NCT01820585|3626577|P3|STARTED|Overall Study||135
1482231|NCT01820585|3626578|P2|STARTED|Overall Study||130
1482232|NCT01820585|3626579|P1|STARTED|Overall Study||131
1482233|NCT01820559|3626592|P3|NOT COMPLETED|Overall Study||29
1482234|NCT01820559|3626593|P2|NOT COMPLETED|Overall Study||13
1482235|NCT01820559|3626594|P1|NOT COMPLETED|Overall Study||14
1482236|NCT01820559|3626592|P3|COMPLETED|Overall Study||110
1482237|NCT01820559|3626593|P2|COMPLETED|Overall Study||122
1482238|NCT01820559|3626594|P1|COMPLETED|Overall Study||122
1482239|NCT01820559|3626592|P3|Completed Maintenance Period|Overall Study||110
1482240|NCT01820559|3626593|P2|Completed Maintenance Period|Overall Study||123
1482241|NCT01820559|3626594|P1|Completed Maintenance Period|Overall Study||122
1482242|NCT01820559|3626592|P3|Entered Maintenance Period|Overall Study||129
1482243|NCT01820559|3626593|P2|Entered Maintenance Period|Overall Study||133
1482244|NCT01820559|3626594|P1|Entered Maintenance Period|Overall Study||129
1482245|NCT01820559|3626592|P3|Completed Tutration Period|Overall Study||131
1482246|NCT01820559|3626593|P2|Completed Tutration Period|Overall Study||134
1482247|NCT01820559|3626594|P1|Completed Tutration Period|Overall Study||130
1482248|NCT01820559|3626592|P3|Randomized and Treated|Overall Study||139
1482249|NCT01820559|3626593|P2|Randomized and Treated|Overall Study||135
1482250|NCT01820559|3626594|P1|Randomized and Treated|Overall Study||136
1482251|NCT01820559|3626592|P3|STARTED|Overall Study||139
1482252|NCT01820559|3626593|P2|STARTED|Overall Study||135
1482253|NCT01820559|3626594|P1|STARTED|Overall Study||136
1482254|NCT01820416|3626605|P3|NOT COMPLETED|Overall Study||0
1482255|NCT01820416|3626606|P2|NOT COMPLETED|Overall Study||2
1482256|NCT01820416|3626607|P1|NOT COMPLETED|Overall Study||3
1482257|NCT01820416|3626605|P3|COMPLETED|Overall Study||11
1482258|NCT01820416|3626606|P2|COMPLETED|Overall Study||10
1482259|NCT01820416|3626607|P1|COMPLETED|Overall Study||9
1482260|NCT01820416|3626605|P3|STARTED|Overall Study||11
1482261|NCT01820416|3626606|P2|STARTED|Overall Study||12
1482262|NCT01820416|3626607|P1|STARTED|Overall Study||12
1482263|NCT01820364|3626615|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
1482264|NCT01820364|3626616|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
1482265|NCT01820364|3626615|P2|COMPLETED|Part II: LGX818 + MEK162||0
1482266|NCT01820364|3626616|P1|COMPLETED|Part II: LGX818 + MEK162||0
1482267|NCT01820364|3626615|P2|STARTED|Part II: LGX818 + MEK162||1
1482268|NCT01820364|3626616|P1|STARTED|Part II: LGX818 + MEK162||0
1482269|NCT01820364|3626615|P2|NOT COMPLETED|Part I: LGX818||0
1482270|NCT01820364|3626616|P1|NOT COMPLETED|Part I: LGX818||14
1482271|NCT01820364|3626615|P2|COMPLETED|Part I: LGX818||0
1482272|NCT01820364|3626616|P1|COMPLETED|Part I: LGX818||1
1482273|NCT01820364|3626615|P2|STARTED|Part I: LGX818||0
1482274|NCT01820364|3626616|P1|STARTED|Part I: LGX818||15
1482275|NCT01819935|3626630|P2|NOT COMPLETED|Overall Study||0
1482276|NCT01819935|3626631|P1|NOT COMPLETED|Overall Study||0
1482277|NCT01819935|3626630|P2|COMPLETED|Overall Study||4943
1482278|NCT01819935|3626631|P1|COMPLETED|Overall Study||328
1482279|NCT01819935|3626630|P2|STARTED|Overall Study||4943
1482280|NCT01819935|3626631|P1|STARTED|Overall Study||328
1482281|NCT01819922|3626651|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
1482282|NCT01819922|3626652|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
1482283|NCT01819922|3626651|P2|COMPLETED|Second Intervention Period (1 Day)||6
1482284|NCT01819922|3626652|P1|COMPLETED|Second Intervention Period (1 Day)||6
1482285|NCT01819922|3626651|P2|STARTED|Second Intervention Period (1 Day)||6
1482286|NCT01819922|3626652|P1|STARTED|Second Intervention Period (1 Day)||6
1482287|NCT01819922|3626651|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
1482288|NCT01819922|3626652|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
1482289|NCT01819922|3626651|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
1482290|NCT01819922|3626652|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
1482291|NCT01819922|3626651|P2|STARTED|Washout Period (at Least 7-10 Days)||6
1482292|NCT01819922|3626652|P1|STARTED|Washout Period (at Least 7-10 Days)||6
1482293|NCT01819922|3626651|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
1482294|NCT01819922|3626652|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
1482295|NCT01819922|3626651|P2|COMPLETED|First Intervention Period (1 Day)||6
1482296|NCT01819922|3626652|P1|COMPLETED|First Intervention Period (1 Day)||6
1482297|NCT01819922|3626651|P2|STARTED|First Intervention Period (1 Day)||6
1482298|NCT01819922|3626652|P1|STARTED|First Intervention Period (1 Day)||6
1482299|NCT01819883|3626738|P2|NOT COMPLETED|Overall Study||0
1482300|NCT01819883|3626739|P1|NOT COMPLETED|Overall Study||4
1482301|NCT01819883|3626738|P2|COMPLETED|Overall Study||20
1482302|NCT01819883|3626739|P1|COMPLETED|Overall Study||16
1482303|NCT01819883|3626738|P2|STARTED|Overall Study||20
1482304|NCT01819883|3626739|P1|STARTED|Overall Study||20
1482305|NCT01819844|3626745|P1|NOT COMPLETED|Overall Study||0
1482306|NCT01819844|3626745|P1|COMPLETED|Overall Study||12
1482307|NCT01819844|3626745|P1|STARTED|Overall Study||12
1482308|NCT01819727|3626760|P2|NOT COMPLETED|Overall Study||28
1482309|NCT01819727|3626761|P1|NOT COMPLETED|Overall Study||20
1482310|NCT01819727|3626760|P2|COMPLETED|Overall Study||102
1482311|NCT01819727|3626761|P1|COMPLETED|Overall Study||111
1482312|NCT01819727|3626760|P2|STARTED|Overall Study||130
1482313|NCT01819727|3626761|P1|STARTED|Overall Study||131
1482314|NCT01819415|3626775|P4|NOT COMPLETED|Overall Study||2
1482315|NCT01819415|3626776|P3|NOT COMPLETED|Overall Study||1
1482316|NCT01819415|3626777|P2|NOT COMPLETED|Overall Study||4
1482317|NCT01819415|3626778|P1|NOT COMPLETED|Overall Study||3
1482318|NCT01819415|3626775|P4|COMPLETED|Overall Study||8
1482319|NCT01819415|3626776|P3|COMPLETED|Overall Study||9
1482320|NCT01819415|3626777|P2|COMPLETED|Overall Study||6
1482321|NCT01819415|3626778|P1|COMPLETED|Overall Study||7
1482322|NCT01819415|3626775|P4|STARTED|Overall Study||10
1482323|NCT01819415|3626776|P3|STARTED|Overall Study||10
1482324|NCT01819415|3626777|P2|STARTED|Overall Study||10
1482325|NCT01819415|3626778|P1|STARTED|Overall Study||10
1482326|NCT01819311|3626790|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
1482327|NCT01819311|3626791|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
1482328|NCT01819311|3626790|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
1482329|NCT01819311|3626791|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
1482330|NCT01819311|3626790|P2|STARTED|Follow-up Phase (8 Weeks)||30
1482331|NCT01819311|3626791|P1|STARTED|Follow-up Phase (8 Weeks)||31
1482332|NCT01819311|3626790|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
1482333|NCT01819311|3626791|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
1482334|NCT01819311|3626790|P2|COMPLETED|Treatment Phase (4 Weeks)||30
1482335|NCT01819311|3626791|P1|COMPLETED|Treatment Phase (4 Weeks)||31
1482336|NCT01819311|3626790|P2|STARTED|Treatment Phase (4 Weeks)||31
1482337|NCT01819311|3626791|P1|STARTED|Treatment Phase (4 Weeks)||33
1482338|NCT01819272|3626813|P6|NOT COMPLETED|Overall Study||7
1482339|NCT01819272|3626814|P5|NOT COMPLETED|Overall Study||4
1482340|NCT01819272|3626815|P4|NOT COMPLETED|Overall Study||5
1482341|NCT01819272|3626816|P3|NOT COMPLETED|Overall Study||3
1482342|NCT01819272|3626817|P2|NOT COMPLETED|Overall Study||3
1482343|NCT01819272|3626818|P1|NOT COMPLETED|Overall Study||6
1482344|NCT01819272|3626813|P6|COMPLETED|Overall Study||33
1482345|NCT01819272|3626814|P5|COMPLETED|Overall Study||36
1482346|NCT01819272|3626815|P4|COMPLETED|Overall Study||35
1482347|NCT01819272|3626816|P3|COMPLETED|Overall Study||37
1482348|NCT01819272|3626817|P2|COMPLETED|Overall Study||36
1482349|NCT01819272|3626818|P1|COMPLETED|Overall Study||35
1482350|NCT01819272|3626813|P6|STARTED|Overall Study||40
1482351|NCT01819272|3626814|P5|STARTED|Overall Study||40
1482352|NCT01819272|3626815|P4|STARTED|Overall Study||40
1482353|NCT01819272|3626816|P3|STARTED|Overall Study||40
1482354|NCT01819272|3626817|P2|STARTED|Overall Study||39
1482355|NCT01819272|3626818|P1|STARTED|Overall Study||41
1482356|NCT01819194|3626844|P1|NOT COMPLETED|Overall Study||2
1482357|NCT01819194|3626844|P1|COMPLETED|Overall Study||60
1482358|NCT01819194|3626844|P1|STARTED|Overall Study||62
1482359|NCT01819129|3626851|P2|NOT COMPLETED|Overall Study||39
1482360|NCT01819129|3626852|P1|NOT COMPLETED|Overall Study||44
1482361|NCT01819129|3626851|P2|COMPLETED|Overall Study||305
1482362|NCT01819129|3626852|P1|COMPLETED|Overall Study||301
1482363|NCT01819129|3626851|P2|Exposed|Overall Study||341
1482364|NCT01819129|3626852|P1|Exposed|Overall Study||341
1482365|NCT01819129|3626851|P2|STARTED|Overall Study||344
1482366|NCT01819129|3626852|P1|STARTED|Overall Study||345
1482367|NCT01818752|3626866|P2|NOT COMPLETED|Overall Study||198
1482368|NCT01818752|3626867|P1|NOT COMPLETED|Overall Study||187
1482369|NCT01818752|3626866|P2|COMPLETED|Overall Study|Completed treatment|280
1482370|NCT01818752|3626867|P1|COMPLETED|Overall Study|Completed treatment|290
1482371|NCT01818752|3626866|P2|Received Treatment|Overall Study||474
1482372|NCT01818752|3626867|P1|Received Treatment|Overall Study||470
1482373|NCT01818752|3626866|P2|STARTED|Overall Study||478
1482374|NCT01818752|3626867|P1|STARTED|Overall Study||477
1482375|NCT01818700|3626885|P1|NOT COMPLETED|Overall Study||104
1482376|NCT01818700|3626885|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
1482377|NCT01818700|3626885|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
1482378|NCT01818700|3626885|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
1482379|NCT01818700|3626885|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
1482380|NCT01818700|3626885|P1|STARTED|Overall Study|The No. of enrolled patients|245
1482381|NCT01818596|3626896|P2|NOT COMPLETED|Overall Study||6
1482382|NCT01818596|3626897|P1|NOT COMPLETED|Overall Study||246
1482383|NCT01818596|3626896|P2|COMPLETED|Overall Study||0
1482384|NCT01818596|3626897|P1|COMPLETED|Overall Study||0
1482385|NCT01818596|3626896|P2|STARTED|Overall Study||6
1482386|NCT01818596|3626897|P1|STARTED|Overall Study||246
1482387|NCT01818531|3626930|P2|NOT COMPLETED|Overall Study||2
1482388|NCT01818531|3626931|P1|NOT COMPLETED|Overall Study||1
1482389|NCT01818531|3626930|P2|COMPLETED|Overall Study||73
1482390|NCT01818531|3626931|P1|COMPLETED|Overall Study||74
1482391|NCT01818531|3626930|P2|STARTED|Overall Study||75
1482392|NCT01818531|3626931|P1|STARTED|Overall Study||75
1482393|NCT01818427|3626947|P2|NOT COMPLETED|Overall Study||13
1482394|NCT01818427|3626948|P1|NOT COMPLETED|Overall Study||9
1482395|NCT01818427|3626947|P2|COMPLETED|Overall Study||271
1482396|NCT01818427|3626948|P1|COMPLETED|Overall Study||230
1482397|NCT01818427|3626947|P2|STARTED|Overall Study||284
1482398|NCT01818427|3626948|P1|STARTED|Overall Study||239
1482399|NCT01818414|3626964|P2|NOT COMPLETED|Overall Study||0
1482400|NCT01818414|3626965|P1|NOT COMPLETED|Overall Study||0
1482401|NCT01818414|3626964|P2|COMPLETED|Overall Study||15
1482402|NCT01818414|3626965|P1|COMPLETED|Overall Study||14
1482403|NCT01818414|3626964|P2|STARTED|Overall Study||15
1482404|NCT01818414|3626965|P1|STARTED|Overall Study||14
1482405|NCT01818336|3626979|P2|NOT COMPLETED|Overall Study||12
1482406|NCT01818336|3626980|P1|NOT COMPLETED|Overall Study||0
1482407|NCT01818336|3626979|P2|COMPLETED|Overall Study||47
1482408|NCT01818336|3626980|P1|COMPLETED|Overall Study||391
1482409|NCT01818336|3626979|P2|STARTED|Overall Study||59
1482410|NCT01818336|3626980|P1|STARTED|Overall Study||391
1482411|NCT01818297|3626988|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
1482412|NCT01818297|3626989|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
1482413|NCT01818297|3626988|P2|COMPLETED|Open Label Phase (3-12 Months)||19
1482414|NCT01818297|3626989|P1|COMPLETED|Open Label Phase (3-12 Months)||14
1482415|NCT01818297|3626988|P2|STARTED|Open Label Phase (3-12 Months)||29
1482416|NCT01818297|3626989|P1|STARTED|Open Label Phase (3-12 Months)||32
1482417|NCT01818297|3626988|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
1482418|NCT01818297|3626989|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
1482419|NCT01818297|3626988|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
1482420|NCT01818297|3626989|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
1482421|NCT01818297|3626988|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
1482422|NCT01818297|3626989|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
1482423|NCT01818297|3626988|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
1482424|NCT01818297|3626989|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
1482425|NCT01818297|3626988|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
1482426|NCT01818297|3626989|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
1482427|NCT01818245|3627007|P2|NOT COMPLETED|Intervention C||0
1482428|NCT01818245|3627008|P1|NOT COMPLETED|Intervention C||0
1482429|NCT01818245|3627007|P2|COMPLETED|Intervention C||0
1482430|NCT01818245|3627008|P1|COMPLETED|Intervention C||30
1482431|NCT01818245|3627007|P2|STARTED|Intervention C||0
1482432|NCT01818245|3627008|P1|STARTED|Intervention C||30
1482433|NCT01818245|3627007|P2|NOT COMPLETED|Washout (16-28 Days)||0
1482434|NCT01818245|3627008|P1|NOT COMPLETED|Washout (16-28 Days)||0
1482435|NCT01818245|3627007|P2|COMPLETED|Washout (16-28 Days)||0
1482436|NCT01818245|3627008|P1|COMPLETED|Washout (16-28 Days)||30
1482437|NCT01818245|3627007|P2|STARTED|Washout (16-28 Days)||0
1482438|NCT01818245|3627008|P1|STARTED|Washout (16-28 Days)||30
1482439|NCT01818245|3627007|P2|NOT COMPLETED|Intervention B||0
1482440|NCT01818245|3627008|P1|NOT COMPLETED|Intervention B||0
1482441|NCT01818245|3627007|P2|COMPLETED|Intervention B||0
1482442|NCT01818245|3627008|P1|COMPLETED|Intervention B||30
1482443|NCT01818245|3627007|P2|STARTED|Intervention B||0
1482444|NCT01818245|3627008|P1|STARTED|Intervention B||30
1482445|NCT01818245|3627007|P2|NOT COMPLETED|Washout (16-28 Days)||0
1482446|NCT01818245|3627008|P1|NOT COMPLETED|Washout (16-28 Days)||0
1482447|NCT01818245|3627007|P2|COMPLETED|Washout (16-28 Days)||0
1482448|NCT01818245|3627008|P1|COMPLETED|Washout (16-28 Days)||30
1482449|NCT01818245|3627007|P2|STARTED|Washout (16-28 Days)||0
1482450|NCT01818245|3627008|P1|STARTED|Washout (16-28 Days)||30
1482451|NCT01818245|3627007|P2|NOT COMPLETED|Intervention A||0
1482452|NCT01818245|3627008|P1|NOT COMPLETED|Intervention A||0
1482453|NCT01818245|3627007|P2|COMPLETED|Intervention A||22
1482454|NCT01818245|3627008|P1|COMPLETED|Intervention A||30
1482455|NCT01818245|3627007|P2|Received One Dose of Study Drug|Intervention A||22
1482456|NCT01818245|3627008|P1|Received One Dose of Study Drug|Intervention A||30
1482457|NCT01818245|3627007|P2|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
1482458|NCT01818245|3627008|P1|STARTED|Intervention A||30
1482459|NCT01818141|3627032|P2|NOT COMPLETED|Overall Study||3
1482460|NCT01818141|3627033|P1|NOT COMPLETED|Overall Study||3
1482461|NCT01818141|3627032|P2|COMPLETED|Overall Study||13
1482462|NCT01818141|3627033|P1|COMPLETED|Overall Study||15
1482463|NCT01818141|3627032|P2|STARTED|Overall Study||16
1482464|NCT01818141|3627033|P1|STARTED|Overall Study||18
1482465|NCT01818063|3627043|P2|NOT COMPLETED|Overall Study||0
1482466|NCT01818063|3627044|P1|NOT COMPLETED|Overall Study||0
1482467|NCT01818063|3627043|P2|COMPLETED|Overall Study||4
1482468|NCT01818063|3627044|P1|COMPLETED|Overall Study||5
1482469|NCT01818063|3627043|P2|STARTED|Overall Study||4
1482470|NCT01818063|3627044|P1|STARTED|Overall Study||5
1482471|NCT01817907|3627052|P2|NOT COMPLETED|Second Intervention||0
1482472|NCT01817907|3627053|P1|NOT COMPLETED|Second Intervention||0
1482473|NCT01817907|3627052|P2|COMPLETED|Second Intervention||7
1482474|NCT01817907|3627053|P1|COMPLETED|Second Intervention||8
1482475|NCT01817907|3627052|P2|STARTED|Second Intervention||7
1482476|NCT01817907|3627053|P1|STARTED|Second Intervention||8
1482477|NCT01817907|3627052|P2|NOT COMPLETED|Washout Period||0
1482478|NCT01817907|3627053|P1|NOT COMPLETED|Washout Period||0
1482479|NCT01817907|3627052|P2|COMPLETED|Washout Period||7
1482480|NCT01817907|3627053|P1|COMPLETED|Washout Period||8
1482481|NCT01817907|3627052|P2|STARTED|Washout Period||7
1482482|NCT01817907|3627053|P1|STARTED|Washout Period||8
1482483|NCT01817907|3627052|P2|NOT COMPLETED|First Intervention||0
1482484|NCT01817907|3627053|P1|NOT COMPLETED|First Intervention||0
1482485|NCT01817907|3627052|P2|COMPLETED|First Intervention||7
1482486|NCT01817907|3627053|P1|COMPLETED|First Intervention||8
1482487|NCT01817907|3627052|P2|STARTED|First Intervention||7
1482488|NCT01817907|3627053|P1|STARTED|First Intervention||8
1482489|NCT01817855|3627065|P4|NOT COMPLETED|Overall Study||0
1482490|NCT01817855|3627066|P3|NOT COMPLETED|Overall Study||2
1482491|NCT01817855|3627067|P2|NOT COMPLETED|Overall Study||2
1482492|NCT01817855|3627068|P1|NOT COMPLETED|Overall Study||0
1482493|NCT01817855|3627065|P4|COMPLETED|Overall Study||5
1482494|NCT01817855|3627066|P3|COMPLETED|Overall Study||9
1482495|NCT01817855|3627067|P2|COMPLETED|Overall Study||6
1482496|NCT01817855|3627068|P1|COMPLETED|Overall Study||23
1482497|NCT01817855|3627065|P4|STARTED|Overall Study||5
1482498|NCT01817855|3627066|P3|STARTED|Overall Study||11
1482499|NCT01817855|3627067|P2|STARTED|Overall Study||8
1482500|NCT01817855|3627068|P1|STARTED|Overall Study||23
1482501|NCT01817790|3627098|P2|NOT COMPLETED|Overall Study||8
1482502|NCT01817790|3627099|P1|NOT COMPLETED|Overall Study||4
1482503|NCT01817790|3627098|P2|COMPLETED|Overall Study||304
1482504|NCT01817790|3627099|P1|COMPLETED|Overall Study||310
1482505|NCT01817790|3627098|P2|STARTED|Overall Study||312
1482506|NCT01817790|3627099|P1|STARTED|Overall Study||314
1482507|NCT01817777|3627143|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
1482508|NCT01817777|3627144|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
1482509|NCT01817777|3627145|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
1482510|NCT01817777|3627143|P3|COMPLETED|Interventional Phase (20 Weeks)||10
1482511|NCT01817777|3627144|P2|COMPLETED|Interventional Phase (20 Weeks)||11
1482512|NCT01817777|3627145|P1|COMPLETED|Interventional Phase (20 Weeks)||0
1482513|NCT01817777|3627143|P3|STARTED|Interventional Phase (20 Weeks)||15
1482514|NCT01817777|3627144|P2|STARTED|Interventional Phase (20 Weeks)||16
1482515|NCT01817777|3627145|P1|STARTED|Interventional Phase (20 Weeks)||0
1482516|NCT01817777|3627143|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
1482517|NCT01817777|3627144|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
1482518|NCT01817777|3627145|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
1482519|NCT01817777|3627143|P3|COMPLETED|Observational Phase (8 Weeks)||0
1482520|NCT01817777|3627144|P2|COMPLETED|Observational Phase (8 Weeks)||0
1482521|NCT01817777|3627145|P1|COMPLETED|Observational Phase (8 Weeks)||31
1482522|NCT01817777|3627143|P3|STARTED|Observational Phase (8 Weeks)||0
1482523|NCT01817777|3627144|P2|STARTED|Observational Phase (8 Weeks)||0
1482524|NCT01817777|3627145|P1|STARTED|Observational Phase (8 Weeks)||36
1482525|NCT01817764|3627169|P2|NOT COMPLETED|Overall Study||38
1482526|NCT01817764|3627170|P1|NOT COMPLETED|Overall Study||34
1482527|NCT01817764|3627169|P2|COMPLETED|Overall Study||315
1482528|NCT01817764|3627170|P1|COMPLETED|Overall Study||319
1482529|NCT01817764|3627169|P2|STARTED|Overall Study||353
1482530|NCT01817764|3627170|P1|STARTED|Overall Study||353
1482531|NCT01817725|3627178|P1|NOT COMPLETED|Overall Study||1
1482532|NCT01817725|3627178|P1|COMPLETED|Overall Study||19
1482533|NCT01817725|3627178|P1|STARTED|Overall Study||20
1482534|NCT01817491|3627185|P2|NOT COMPLETED|Overall Study||0
1482535|NCT01817491|3627186|P1|NOT COMPLETED|Overall Study||4
1482536|NCT01817491|3627185|P2|COMPLETED|Overall Study||28
1482537|NCT01817491|3627186|P1|COMPLETED|Overall Study||28
1482538|NCT01817491|3627185|P2|STARTED|Overall Study||28
1482539|NCT01817491|3627186|P1|STARTED|Overall Study||32
1482540|NCT01817374|3627232|P1|NOT COMPLETED|Overall Study||0
1482541|NCT01817374|3627232|P1|COMPLETED|Overall Study||6
1482542|NCT01817374|3627232|P1|STARTED|Overall Study||6
1482543|NCT01816893|3627246|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
1482544|NCT01816893|3627247|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
1482545|NCT01816893|3627246|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
1482546|NCT01816893|3627247|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
1482547|NCT01816893|3627246|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
1482548|NCT01816893|3627247|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
1482549|NCT01816893|3627246|P2|NOT COMPLETED|Washout Period||0
1482550|NCT01816893|3627247|P1|NOT COMPLETED|Washout Period||2
1482551|NCT01816893|3627246|P2|COMPLETED|Washout Period||11
1482552|NCT01816893|3627247|P1|COMPLETED|Washout Period||9
1482553|NCT01816893|3627246|P2|STARTED|Washout Period||11
1482554|NCT01816893|3627247|P1|STARTED|Washout Period||11
1482555|NCT01816893|3627246|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
1482556|NCT01816893|3627247|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
1482557|NCT01816893|3627246|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
1482558|NCT01816893|3627247|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
1482559|NCT01816893|3627246|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
1482560|NCT01816893|3627247|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
1482561|NCT01816776|3627259|P2|NOT COMPLETED|Overall Study||8
1482562|NCT01816776|3627260|P1|NOT COMPLETED|Overall Study||13
1482563|NCT01816776|3627259|P2|COMPLETED|Overall Study||70
1482564|NCT01816776|3627260|P1|COMPLETED|Overall Study||60
1482565|NCT01816776|3627259|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
1482566|NCT01816776|3627260|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
1482567|NCT01816776|3627259|P2|STARTED|Overall Study||78
1482568|NCT01816776|3627260|P1|STARTED|Overall Study||73
1482569|NCT01816685|3627282|P2|NOT COMPLETED|Overall Study||11
1482570|NCT01816685|3627283|P1|NOT COMPLETED|Overall Study||10
1482571|NCT01816685|3627282|P2|COMPLETED|Overall Study||56
1482572|NCT01816685|3627283|P1|COMPLETED|Overall Study||58
1482573|NCT01816685|3627282|P2|STARTED|Overall Study||67
1482574|NCT01816685|3627283|P1|STARTED|Overall Study||68
1482575|NCT01816477|3627293|P2|NOT COMPLETED|Overall Study||1
1482576|NCT01816477|3627294|P1|NOT COMPLETED|Overall Study||16
1482577|NCT01816477|3627293|P2|COMPLETED|Overall Study||41
1482578|NCT01816477|3627294|P1|COMPLETED|Overall Study||27
1482579|NCT01816477|3627293|P2|STARTED|Overall Study||42
1482580|NCT01816477|3627294|P1|STARTED|Overall Study||43
1482581|NCT01816451|3627307|P3|NOT COMPLETED|Overall Study||0
1482582|NCT01816451|3627308|P2|NOT COMPLETED|Overall Study||0
1482583|NCT01816451|3627309|P1|NOT COMPLETED|Overall Study||0
1482584|NCT01816451|3627307|P3|COMPLETED|Overall Study||8
1482585|NCT01816451|3627308|P2|COMPLETED|Overall Study||11
1482586|NCT01816451|3627309|P1|COMPLETED|Overall Study||13
1482587|NCT01816451|3627307|P3|STARTED|Overall Study||8
1482588|NCT01816451|3627308|P2|STARTED|Overall Study||11
1482589|NCT01816451|3627309|P1|STARTED|Overall Study||13
1482590|NCT01816295|3627348|P2|NOT COMPLETED|OLE Phase||56
1482591|NCT01816295|3627349|P1|NOT COMPLETED|OLE Phase||53
1482592|NCT01816295|3627348|P2|COMPLETED|OLE Phase||227
1482593|NCT01816295|3627349|P1|COMPLETED|OLE Phase||222
1482594|NCT01816295|3627348|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
1482595|NCT01816295|3627349|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
1482596|NCT01816295|3627348|P2|NOT COMPLETED|Double Blind Phase||56
1482597|NCT01816295|3627349|P1|NOT COMPLETED|Double Blind Phase||63
1482598|NCT01816295|3627348|P2|COMPLETED|Double Blind Phase||302
1482599|NCT01816295|3627349|P1|COMPLETED|Double Blind Phase||294
1482600|NCT01816295|3627348|P2|Received Study Drug|Double Blind Phase||354
1482601|NCT01816295|3627349|P1|Received Study Drug|Double Blind Phase||356
1482602|NCT01816295|3627348|P2|STARTED|Double Blind Phase||358
1482603|NCT01816295|3627349|P1|STARTED|Double Blind Phase||357
1482604|NCT01816243|3627364|P1|NOT COMPLETED|Overall Study||12
1482605|NCT01816243|3627364|P1|COMPLETED|Overall Study||27
1482606|NCT01816243|3627364|P1|STARTED|Overall Study||39
1482607|NCT01816074|3627375|P4|NOT COMPLETED|Phase 2||1
1482608|NCT01816074|3627376|P3|NOT COMPLETED|Phase 2||0
1482609|NCT01816074|3627377|P2|NOT COMPLETED|Phase 2||2
1482610|NCT01816074|3627378|P1|NOT COMPLETED|Phase 2||2
1482611|NCT01816074|3627375|P4|COMPLETED|Phase 2||9
1482612|NCT01816074|3627376|P3|COMPLETED|Phase 2||10
1482613|NCT01816074|3627377|P2|COMPLETED|Phase 2||7
1482614|NCT01816074|3627378|P1|COMPLETED|Phase 2||9
1482615|NCT01816074|3627375|P4|STARTED|Phase 2||10
1482616|NCT01816074|3627376|P3|STARTED|Phase 2||10
1482617|NCT01816074|3627377|P2|STARTED|Phase 2||9
1482618|NCT01816074|3627378|P1|STARTED|Phase 2||11
1482619|NCT01816074|3627375|P4|NOT COMPLETED|Phase 1||0
1482620|NCT01816074|3627376|P3|NOT COMPLETED|Phase 1||1
1482621|NCT01816074|3627377|P2|NOT COMPLETED|Phase 1||0
1482622|NCT01816074|3627378|P1|NOT COMPLETED|Phase 1||0
1482623|NCT01816074|3627375|P4|COMPLETED|Phase 1||10
1482624|NCT01816074|3627376|P3|COMPLETED|Phase 1||10
1482625|NCT01816074|3627377|P2|COMPLETED|Phase 1||9
1482626|NCT01816074|3627378|P1|COMPLETED|Phase 1||11
1482627|NCT01816074|3627375|P4|STARTED|Phase 1||10
1482628|NCT01816074|3627376|P3|STARTED|Phase 1||11
1482629|NCT01816074|3627377|P2|STARTED|Phase 1||9
1482630|NCT01816074|3627378|P1|STARTED|Phase 1||11
1482631|NCT01816048|3627406|P1|NOT COMPLETED|Overall Study||6
1482632|NCT01816048|3627406|P1|COMPLETED|Overall Study||2
1482633|NCT01816048|3627406|P1|STARTED|Overall Study||8
1482634|NCT01815918|3627421|P2|NOT COMPLETED|Overall Study||19
1482635|NCT01815918|3627422|P1|NOT COMPLETED|Overall Study||18
1482636|NCT01815918|3627421|P2|COMPLETED|Overall Study||11
1482637|NCT01815918|3627422|P1|COMPLETED|Overall Study||12
1482638|NCT01815918|3627421|P2|STARTED|Overall Study||30
1482639|NCT01815918|3627422|P1|STARTED|Overall Study||30
1482640|NCT01815840|3627438|P2|NOT COMPLETED|Overall Study||63
1482641|NCT01815840|3627439|P1|NOT COMPLETED|Overall Study||59
1482642|NCT01815840|3627438|P2|COMPLETED|Overall Study||50
1482643|NCT01815840|3627439|P1|COMPLETED|Overall Study||57
1482644|NCT01815840|3627438|P2|STARTED|Overall Study||113
1482645|NCT01815840|3627439|P1|STARTED|Overall Study||116
1482646|NCT01815736|3627469|P2|NOT COMPLETED|Overall Study||478
1482647|NCT01815736|3627470|P1|NOT COMPLETED|Overall Study||961
1482648|NCT01815736|3627469|P2|COMPLETED|Overall Study||2
1482649|NCT01815736|3627470|P1|COMPLETED|Overall Study||2
1482650|NCT01815736|3627469|P2|STARTED|Overall Study||480
1482651|NCT01815736|3627470|P1|STARTED|Overall Study||963
1482652|NCT01815671|3627486|P2|NOT COMPLETED|Overall Study||0
1482653|NCT01815671|3627487|P1|NOT COMPLETED|Overall Study||0
1482654|NCT01815671|3627486|P2|COMPLETED|Overall Study||85
1482655|NCT01815671|3627487|P1|COMPLETED|Overall Study||88
1482656|NCT01815671|3627486|P2|STARTED|Overall Study||85
1482657|NCT01815671|3627487|P1|STARTED|Overall Study||88
1482658|NCT01815645|3627499|P2|NOT COMPLETED|Overall Study||0
1482659|NCT01815645|3627500|P1|NOT COMPLETED|Overall Study||0
1482660|NCT01815645|3627499|P2|COMPLETED|Overall Study||33
1482661|NCT01815645|3627500|P1|COMPLETED|Overall Study||32
1482662|NCT01815645|3627499|P2|STARTED|Overall Study||33
1482663|NCT01815645|3627500|P1|STARTED|Overall Study||32
1482664|NCT01815515|3627516|P1|NOT COMPLETED|Overall Study||0
1482665|NCT01815515|3627516|P1|COMPLETED|Overall Study||17
1482666|NCT01815515|3627516|P1|STARTED|Overall Study||17
1482667|NCT01815502|3627523|P2|NOT COMPLETED|Overall Study||0
1482668|NCT01815502|3627524|P1|NOT COMPLETED|Overall Study||0
1482669|NCT01815502|3627523|P2|COMPLETED|Overall Study||10
1482670|NCT01815502|3627524|P1|COMPLETED|Overall Study||10
1482671|NCT01815502|3627523|P2|STARTED|Overall Study||10
1482672|NCT01815502|3627524|P1|STARTED|Overall Study||10
1482673|NCT01815138|3627538|P2|NOT COMPLETED|Overall Study||6
1482674|NCT01815138|3627539|P1|NOT COMPLETED|Overall Study||8
1482675|NCT01815138|3627538|P2|COMPLETED|Overall Study||31
1482676|NCT01815138|3627539|P1|COMPLETED|Overall Study||26
1482677|NCT01815138|3627538|P2|STARTED|Overall Study||37
1482678|NCT01815138|3627539|P1|STARTED|Overall Study||34
1482679|NCT01815099|3627551|P1|NOT COMPLETED|Overall Study||2
1482680|NCT01815099|3627551|P1|COMPLETED|Overall Study||2
1482681|NCT01815099|3627551|P1|Began rTMS Treatment|Overall Study||3
1482682|NCT01815099|3627551|P1|STARTED|Overall Study||4
1482683|NCT01815008|3627556|P1|NOT COMPLETED|Overall Study||4
1482684|NCT01815008|3627556|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
1482685|NCT01815008|3627556|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
1482686|NCT01814878|3627565|P2|NOT COMPLETED|Overall Study||30
1482687|NCT01814878|3627566|P1|NOT COMPLETED|Overall Study||46
1482688|NCT01814878|3627565|P2|COMPLETED|Overall Study||128
1482689|NCT01814878|3627566|P1|COMPLETED|Overall Study||116
1482690|NCT01814878|3627565|P2|STARTED|Overall Study||158
1482691|NCT01814878|3627566|P1|STARTED|Overall Study||162
1482692|NCT01814800|3627586|P1|NOT COMPLETED|Overall Study||5
1482693|NCT01814800|3627586|P1|COMPLETED|Overall Study||54
1482694|NCT01814800|3627586|P1|STARTED|Overall Study||59
1482695|NCT01814787|3627625|P2|NOT COMPLETED|Overall Study||0
1482696|NCT01814787|3627626|P1|NOT COMPLETED|Overall Study||0
1482697|NCT01814787|3627625|P2|COMPLETED|Overall Study||684
1482698|NCT01814787|3627626|P1|COMPLETED|Overall Study||685
1482699|NCT01814787|3627625|P2|STARTED|Overall Study||684
1482700|NCT01814787|3627626|P1|STARTED|Overall Study||685
1482701|NCT01814774|3627632|P1|NOT COMPLETED|Overall Study||0
1482702|NCT01814774|3627632|P1|COMPLETED|Overall Study||48
1482703|NCT01814774|3627632|P1|STARTED|Overall Study||48
1482704|NCT01814761|3627646|P2|NOT COMPLETED|Overall Study||30
1482705|NCT01814761|3627647|P1|NOT COMPLETED|Overall Study||8
1482706|NCT01814761|3627646|P2|COMPLETED|Overall Study||240
1482707|NCT01814761|3627647|P1|COMPLETED|Overall Study||34
1482708|NCT01814761|3627646|P2|STARTED|Overall Study||270
1482709|NCT01814761|3627647|P1|STARTED|Overall Study||42
1482710|NCT01814748|3627661|P2|NOT COMPLETED|Overall Study||7
1482711|NCT01814748|3627662|P1|NOT COMPLETED|Overall Study||8
1482712|NCT01814748|3627661|P2|COMPLETED|Overall Study||94
1482713|NCT01814748|3627662|P1|COMPLETED|Overall Study||94
1482714|NCT01814748|3627661|P2|STARTED|Overall Study||101
1482715|NCT01814748|3627662|P1|STARTED|Overall Study||102
1482716|NCT01814722|3627685|P3|NOT COMPLETED|Overall Study||0
1482717|NCT01814722|3627686|P2|NOT COMPLETED|Overall Study||0
1482718|NCT01814722|3627687|P1|NOT COMPLETED|Overall Study||0
1482719|NCT01814722|3627685|P3|COMPLETED|Overall Study||6
1482720|NCT01814722|3627686|P2|COMPLETED|Overall Study||21
1482721|NCT01814722|3627687|P1|COMPLETED|Overall Study||36
1482722|NCT01814722|3627685|P3|STARTED|Overall Study||6
1482723|NCT01814722|3627686|P2|STARTED|Overall Study||21
1482724|NCT01814722|3627687|P1|STARTED|Overall Study||36
1482725|NCT01814696|3627706|P2|NOT COMPLETED|Overall Study||0
1482726|NCT01814696|3627707|P1|NOT COMPLETED|Overall Study||2
1482727|NCT01814696|3627706|P2|COMPLETED|Overall Study||11
1482728|NCT01814696|3627707|P1|COMPLETED|Overall Study||13
1482729|NCT01814696|3627706|P2|STARTED|Overall Study||11
1482730|NCT01814696|3627707|P1|STARTED|Overall Study||15
1482731|NCT01814670|3627725|P1|NOT COMPLETED|Overall Study||12
1482732|NCT01814670|3627725|P1|COMPLETED|Overall Study||173
1482733|NCT01814670|3627725|P1|STARTED|Overall Study||185
1482734|NCT01814553|3627735|P2|NOT COMPLETED|Overall Study||22
1482735|NCT01814553|3627736|P1|NOT COMPLETED|Overall Study||18
1482736|NCT01814553|3627735|P2|COMPLETED|Overall Study||0
1482737|NCT01814553|3627736|P1|COMPLETED|Overall Study||0
1482738|NCT01814553|3627735|P2|STARTED|Overall Study||22
1482739|NCT01814553|3627736|P1|STARTED|Overall Study||18
1482740|NCT01814397|3627750|P1|NOT COMPLETED|Overall Study||14
1482741|NCT01814397|3627750|P1|COMPLETED|Overall Study||36
1482742|NCT01814397|3627750|P1|3 Month Evaluation|Overall Study||43
1482743|NCT01814397|3627750|P1|STARTED|Overall Study||50
1482744|NCT01814371|3627759|P2|NOT COMPLETED|Overall Study||27
1482745|NCT01814371|3627760|P1|NOT COMPLETED|Overall Study||30
1482746|NCT01814371|3627759|P2|COMPLETED|Overall Study||199
1482747|NCT01814371|3627760|P1|COMPLETED|Overall Study||218
1482748|NCT01814371|3627759|P2|STARTED|Overall Study||226
1482749|NCT01814371|3627760|P1|STARTED|Overall Study||248
1482750|NCT01814332|3627793|P2|NOT COMPLETED|Overall Study||16
1482751|NCT01814332|3627794|P1|NOT COMPLETED|Overall Study||16
1482752|NCT01814332|3627793|P2|COMPLETED|Overall Study||49
1482753|NCT01814332|3627794|P1|COMPLETED|Overall Study||47
1482754|NCT01814332|3627793|P2|STARTED|Overall Study||65
1482755|NCT01814332|3627794|P1|STARTED|Overall Study||63
1482756|NCT01814241|3627806|P1|NOT COMPLETED|Overall Study||4
1482757|NCT01814241|3627806|P1|COMPLETED|Overall Study||16
1482758|NCT01814241|3627806|P1|STARTED|Overall Study||20
1482759|NCT01814137|3627816|P2|NOT COMPLETED|Overall Study||5
1482760|NCT01814137|3627817|P1|NOT COMPLETED|Overall Study||5
1482761|NCT01814137|3627816|P2|COMPLETED|Overall Study||15
1482762|NCT01814137|3627817|P1|COMPLETED|Overall Study||15
1482763|NCT01814137|3627816|P2|STARTED|Overall Study||20
1482764|NCT01814137|3627817|P1|STARTED|Overall Study||20
1482765|NCT01814046|3627833|P3|NOT COMPLETED|Retreatment||0
1482766|NCT01814046|3627834|P2|NOT COMPLETED|Retreatment||0
1482767|NCT01814046|3627835|P1|NOT COMPLETED|Retreatment||0
1482768|NCT01814046|3627833|P3|COMPLETED|Retreatment||3
1482769|NCT01814046|3627834|P2|COMPLETED|Retreatment||0
1482770|NCT01814046|3627835|P1|COMPLETED|Retreatment||0
1482771|NCT01814046|3627833|P3|STARTED|Retreatment||3
1482772|NCT01814046|3627834|P2|STARTED|Retreatment||0
1482773|NCT01814046|3627835|P1|STARTED|Retreatment||0
1482774|NCT01814046|3627833|P3|NOT COMPLETED|Drug Administration||0
1482775|NCT01814046|3627834|P2|NOT COMPLETED|Drug Administration||0
1482776|NCT01814046|3627835|P1|NOT COMPLETED|Drug Administration||1
1482777|NCT01814046|3627833|P3|COMPLETED|Drug Administration||0
1482778|NCT01814046|3627834|P2|COMPLETED|Drug Administration||2
1482779|NCT01814046|3627835|P1|COMPLETED|Drug Administration||21
1482780|NCT01814046|3627833|P3|STARTED|Drug Administration||0
1482781|NCT01814046|3627834|P2|STARTED|Drug Administration||2
1482782|NCT01814046|3627835|P1|STARTED|Drug Administration||22
1482783|NCT01813890|3627849|P3|NOT COMPLETED|Overall Study||6
1482784|NCT01813890|3627850|P2|NOT COMPLETED|Overall Study||4
1482785|NCT01813890|3627851|P1|NOT COMPLETED|Overall Study||9
1482786|NCT01813890|3627849|P3|COMPLETED|Overall Study||13
1482787|NCT01813890|3627850|P2|COMPLETED|Overall Study||17
1482788|NCT01813890|3627851|P1|COMPLETED|Overall Study||11
1482789|NCT01813890|3627849|P3|STARTED|Overall Study||19
1482790|NCT01813890|3627850|P2|STARTED|Overall Study||21
1482791|NCT01813890|3627851|P1|STARTED|Overall Study||20
1482792|NCT01813721|3627880|P1|NOT COMPLETED|Overall Study||64
1482793|NCT01813721|3627880|P1|COMPLETED|Overall Study||943
1482794|NCT01813721|3627880|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
1482795|NCT01813474|3627935|P3|NOT COMPLETED|Overall Study||11
1482796|NCT01813474|3627936|P2|NOT COMPLETED|Overall Study||7
1482797|NCT01813474|3627937|P1|NOT COMPLETED|Overall Study||3
1482798|NCT01813474|3627935|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
1482799|NCT01813474|3627936|P2|COMPLETED|Overall Study||0
1482800|NCT01813474|3627937|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
1482801|NCT01813474|3627935|P3|STARTED|Overall Study||12
1482802|NCT01813474|3627936|P2|STARTED|Overall Study||7
1482803|NCT01813474|3627937|P1|STARTED|Overall Study||4
1482804|NCT01813422|3627961|P2|NOT COMPLETED|Overall Study||16
1482805|NCT01813422|3627962|P1|NOT COMPLETED|Overall Study||20
1482806|NCT01813422|3627961|P2|COMPLETED|Overall Study||468
1482807|NCT01813422|3627962|P1|COMPLETED|Overall Study||466
1482808|NCT01813422|3627961|P2|Received Treatment|Overall Study||484
1482809|NCT01813422|3627962|P1|Received Treatment|Overall Study||484
1482810|NCT01813422|3627961|P2|STARTED|Overall Study||484
1482811|NCT01813422|3627962|P1|STARTED|Overall Study||486
1482812|NCT01813214|3627976|P2|NOT COMPLETED|Overall Study||0
1482813|NCT01813214|3627977|P1|NOT COMPLETED|Overall Study||0
1482814|NCT01813214|3627976|P2|COMPLETED|Overall Study||2
1482815|NCT01813214|3627977|P1|COMPLETED|Overall Study||3
1482816|NCT01813214|3627976|P2|STARTED|Overall Study||2
1482817|NCT01813214|3627977|P1|STARTED|Overall Study||3
1482818|NCT01813110|3627987|P2|NOT COMPLETED|Overall Study||1
1482819|NCT01813110|3627988|P1|NOT COMPLETED|Overall Study||0
1482820|NCT01813110|3627987|P2|COMPLETED|Overall Study||10
1482821|NCT01813110|3627988|P1|COMPLETED|Overall Study||10
1482822|NCT01813110|3627987|P2|STARTED|Overall Study||11
1482823|NCT01813110|3627988|P1|STARTED|Overall Study||10
1482824|NCT01813019|3628000|P2|NOT COMPLETED|Overall Study||6
1482825|NCT01813019|3628001|P1|NOT COMPLETED|Overall Study||7
1482826|NCT01813019|3628000|P2|COMPLETED|Overall Study||20
1482827|NCT01813019|3628001|P1|COMPLETED|Overall Study||17
1482828|NCT01813019|3628000|P2|STARTED|Overall Study||26
1482829|NCT01813019|3628001|P1|STARTED|Overall Study||24
1482830|NCT01812837|3628012|P3|NOT COMPLETED|Overall Study||0
1482831|NCT01812837|3628013|P2|NOT COMPLETED|Overall Study||1
1482832|NCT01812837|3628014|P1|NOT COMPLETED|Overall Study||2
1482833|NCT01812837|3628012|P3|COMPLETED|Overall Study||17
1482834|NCT01812837|3628013|P2|COMPLETED|Overall Study||16
1482835|NCT01812837|3628014|P1|COMPLETED|Overall Study||15
1482836|NCT01812837|3628012|P3|STARTED|Overall Study||17
1482837|NCT01812837|3628013|P2|STARTED|Overall Study||17
1482838|NCT01812837|3628014|P1|STARTED|Overall Study||17
1482839|NCT01812707|3628026|P4|NOT COMPLETED|Overall Study||2
1482840|NCT01812707|3628027|P3|NOT COMPLETED|Overall Study||0
1482841|NCT01812707|3628028|P2|NOT COMPLETED|Overall Study||0
1482842|NCT01812707|3628029|P1|NOT COMPLETED|Overall Study||2
1482843|NCT01812707|3628026|P4|COMPLETED|Overall Study||23
1482844|NCT01812707|3628027|P3|COMPLETED|Overall Study||25
1482845|NCT01812707|3628028|P2|COMPLETED|Overall Study||25
1482846|NCT01812707|3628029|P1|COMPLETED|Overall Study||23
1482847|NCT01812707|3628026|P4|Treated|Overall Study||25
1482848|NCT01812707|3628027|P3|Treated|Overall Study||25
1482849|NCT01812707|3628028|P2|Treated|Overall Study||25
1482850|NCT01812707|3628029|P1|Treated|Overall Study||25
1482851|NCT01812707|3628026|P4|STARTED|Overall Study||25
1482852|NCT01812707|3628027|P3|STARTED|Overall Study||25
1482853|NCT01812707|3628028|P2|STARTED|Overall Study||25
1482854|NCT01812707|3628029|P1|STARTED|Overall Study||25
1482855|NCT01812681|3628065|P2|NOT COMPLETED|Overall Study||0
1482856|NCT01812681|3628066|P1|NOT COMPLETED|Overall Study||3
1482857|NCT01812681|3628065|P2|COMPLETED|Overall Study||24
1482858|NCT01812681|3628066|P1|COMPLETED|Overall Study||57
1482859|NCT01812681|3628065|P2|STARTED|Overall Study||24
1482860|NCT01812681|3628066|P1|STARTED|Overall Study||60
1482861|NCT01812655|3628077|P3|NOT COMPLETED|Overall Study||0
1482862|NCT01812655|3628078|P2|NOT COMPLETED|Overall Study||1
1482863|NCT01812655|3628079|P1|NOT COMPLETED|Overall Study||1
1482864|NCT01812655|3628077|P3|COMPLETED|Overall Study||10
1482865|NCT01812655|3628078|P2|COMPLETED|Overall Study||10
1482866|NCT01812655|3628079|P1|COMPLETED|Overall Study||8
1482867|NCT01812655|3628077|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
1482868|NCT01812655|3628078|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
1482869|NCT01812655|3628079|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
1482870|NCT01812473|3628095|P2|NOT COMPLETED|Overall Study||0
1482871|NCT01812473|3628096|P1|NOT COMPLETED|Overall Study||0
1482872|NCT01812473|3628095|P2|COMPLETED|Overall Study||13
1482873|NCT01812473|3628096|P1|COMPLETED|Overall Study||22
1482874|NCT01812473|3628095|P2|STARTED|Overall Study||13
1482875|NCT01812473|3628096|P1|STARTED|Overall Study||22
1482876|NCT01812057|3628104|P2|NOT COMPLETED|Overall Study||0
1482877|NCT01812057|3628105|P1|NOT COMPLETED|Overall Study||2
1482878|NCT01812057|3628104|P2|COMPLETED|Overall Study||24
1482879|NCT01812057|3628105|P1|COMPLETED|Overall Study||23
1482880|NCT01812057|3628104|P2|STARTED|Overall Study||24
1482881|NCT01812057|3628105|P1|STARTED|Overall Study||25
1482882|NCT01812044|3628146|P3|NOT COMPLETED|Overall Study||0
1482883|NCT01812044|3628147|P2|NOT COMPLETED|Overall Study||0
1482884|NCT01812044|3628148|P1|NOT COMPLETED|Overall Study||0
1482885|NCT01812044|3628146|P3|COMPLETED|Overall Study||16
1482886|NCT01812044|3628147|P2|COMPLETED|Overall Study||17
1482887|NCT01812044|3628148|P1|COMPLETED|Overall Study||17
1482888|NCT01812044|3628146|P3|STARTED|Overall Study||16
1482889|NCT01812044|3628147|P2|STARTED|Overall Study||17
1482890|NCT01812044|3628148|P1|STARTED|Overall Study||17
1482891|NCT01812005|3628179|P2|NOT COMPLETED|Overall Study||0
1482892|NCT01812005|3628180|P1|NOT COMPLETED|Overall Study||0
1482893|NCT01812005|3628179|P2|COMPLETED|Overall Study||13
1482894|NCT01812005|3628180|P1|COMPLETED|Overall Study||1
1482895|NCT01812005|3628179|P2|STARTED|Overall Study||13
1482896|NCT01812005|3628180|P1|STARTED|Overall Study||1
1482897|NCT01811953|3628208|P6|NOT COMPLETED|Overall Study||1
1482898|NCT01811953|3628209|P5|NOT COMPLETED|Overall Study||1
1482899|NCT01811953|3628210|P4|NOT COMPLETED|Overall Study||1
1482900|NCT01811953|3628211|P3|NOT COMPLETED|Overall Study||0
1482901|NCT01811953|3628212|P2|NOT COMPLETED|Overall Study||0
1482902|NCT01811953|3628213|P1|NOT COMPLETED|Overall Study||0
1482903|NCT01811953|3628208|P6|COMPLETED|Overall Study||11
1482904|NCT01811953|3628209|P5|COMPLETED|Overall Study||11
1482905|NCT01811953|3628210|P4|COMPLETED|Overall Study||5
1482906|NCT01811953|3628211|P3|COMPLETED|Overall Study||6
1482907|NCT01811953|3628212|P2|COMPLETED|Overall Study||6
1482908|NCT01811953|3628213|P1|COMPLETED|Overall Study||6
1482909|NCT01811953|3628208|P6|STARTED|Overall Study||12
1482910|NCT01811953|3628209|P5|STARTED|Overall Study||12
1482911|NCT01811953|3628210|P4|STARTED|Overall Study||6
1482912|NCT01811953|3628211|P3|STARTED|Overall Study||6
1482913|NCT01811953|3628212|P2|STARTED|Overall Study||6
1482914|NCT01811953|3628213|P1|STARTED|Overall Study||6
1482915|NCT01811940|3628259|P2|NOT COMPLETED|Overall Study||26
1482916|NCT01811940|3628260|P1|NOT COMPLETED|Overall Study||22
1482917|NCT01811940|3628259|P2|COMPLETED|Overall Study||37
1482918|NCT01811940|3628260|P1|COMPLETED|Overall Study||42
1482919|NCT01811940|3628259|P2|STARTED|Overall Study||63
1482920|NCT01811940|3628260|P1|STARTED|Overall Study||64
1482921|NCT01811732|3628270|P2|NOT COMPLETED|Overall Study||58
1482922|NCT01811732|3628271|P1|NOT COMPLETED|Overall Study||55
1482923|NCT01811732|3628270|P2|COMPLETED|Overall Study||271
1482924|NCT01811732|3628271|P1|COMPLETED|Overall Study||276
1482925|NCT01811732|3628270|P2|STARTED|Overall Study||329
1482926|NCT01811732|3628271|P1|STARTED|Overall Study||331
1482927|NCT01811706|3628281|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
1482928|NCT01811706|3628282|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
1482929|NCT01811706|3628281|P2|COMPLETED|Second Intervention (4 Weeks)||10
1482930|NCT01811706|3628282|P1|COMPLETED|Second Intervention (4 Weeks)||9
1482931|NCT01811706|3628281|P2|STARTED|Second Intervention (4 Weeks)||10
1482932|NCT01811706|3628282|P1|STARTED|Second Intervention (4 Weeks)||9
1482933|NCT01811706|3628281|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
1482934|NCT01811706|3628282|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
1482935|NCT01811706|3628281|P2|COMPLETED|Washout ( 2 Weeks)||10
1482936|NCT01811706|3628282|P1|COMPLETED|Washout ( 2 Weeks)||9
1482937|NCT01811706|3628281|P2|STARTED|Washout ( 2 Weeks)||10
1482938|NCT01811706|3628282|P1|STARTED|Washout ( 2 Weeks)||9
1482939|NCT01811706|3628281|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
1482940|NCT01811706|3628282|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
1482941|NCT01811706|3628281|P2|COMPLETED|First Intervention ( 4 Weeks)||10
1482942|NCT01811706|3628282|P1|COMPLETED|First Intervention ( 4 Weeks)||9
1482943|NCT01811706|3628281|P2|STARTED|First Intervention ( 4 Weeks)||10
1482944|NCT01811706|3628282|P1|STARTED|First Intervention ( 4 Weeks)||10
1482945|NCT01811680|3628292|P1|NOT COMPLETED|Overall Study||0
1482946|NCT01811680|3628292|P1|COMPLETED|Overall Study||10
1482947|NCT01811680|3628292|P1|STARTED|Overall Study||10
1482948|NCT01811563|3628299|P2|NOT COMPLETED|Overall Study||3
1482949|NCT01811563|3628300|P1|NOT COMPLETED|Overall Study||5
1482950|NCT01811563|3628299|P2|COMPLETED|Overall Study||20
1482951|NCT01811563|3628300|P1|COMPLETED|Overall Study||20
1482952|NCT01811563|3628299|P2|STARTED|Overall Study||23
1482953|NCT01811563|3628300|P1|STARTED|Overall Study||25
1482954|NCT01811485|3628329|P3|NOT COMPLETED|Overall Study||5
1482955|NCT01811485|3628330|P2|NOT COMPLETED|Overall Study||4
1482956|NCT01811485|3628331|P1|NOT COMPLETED|Overall Study||2
1482957|NCT01811485|3628329|P3|COMPLETED|Overall Study||51
1482958|NCT01811485|3628330|P2|COMPLETED|Overall Study||55
1482959|NCT01811485|3628331|P1|COMPLETED|Overall Study||54
1482960|NCT01811485|3628329|P3|STARTED|Overall Study||56
1482961|NCT01811485|3628330|P2|STARTED|Overall Study||59
1482962|NCT01811485|3628331|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
1482963|NCT01811472|3628351|P3|NOT COMPLETED|Overall Study||5
1482964|NCT01811472|3628352|P2|NOT COMPLETED|Overall Study||0
1482965|NCT01811472|3628353|P1|NOT COMPLETED|Overall Study||2
1482966|NCT01811472|3628351|P3|COMPLETED|Overall Study||16
1482967|NCT01811472|3628352|P2|COMPLETED|Overall Study||11
1482968|NCT01811472|3628353|P1|COMPLETED|Overall Study||18
1482969|NCT01811472|3628351|P3|STARTED|Overall Study||21
1482970|NCT01811472|3628352|P2|STARTED|Overall Study||11
1482971|NCT01811472|3628353|P1|STARTED|Overall Study||20
1482972|NCT01811355|3628398|P2|NOT COMPLETED|Second Dose||0
1482973|NCT01811355|3628399|P1|NOT COMPLETED|Second Dose||0
1482974|NCT01811355|3628398|P2|COMPLETED|Second Dose||12
1482975|NCT01811355|3628399|P1|COMPLETED|Second Dose||9
1482976|NCT01811355|3628398|P2|STARTED|Second Dose||12
1482977|NCT01811355|3628399|P1|STARTED|Second Dose||9
1482978|NCT01811355|3628398|P2|NOT COMPLETED|Washout||0
1482979|NCT01811355|3628399|P1|NOT COMPLETED|Washout||0
1482980|NCT01811355|3628398|P2|COMPLETED|Washout||12
1482981|NCT01811355|3628399|P1|COMPLETED|Washout||9
1482982|NCT01811355|3628398|P2|STARTED|Washout||12
1482983|NCT01811355|3628399|P1|STARTED|Washout||9
1482984|NCT01811355|3628398|P2|NOT COMPLETED|First Dose||0
1482985|NCT01811355|3628399|P1|NOT COMPLETED|First Dose||2
1482986|NCT01811355|3628398|P2|COMPLETED|First Dose||12
1482987|NCT01811355|3628399|P1|COMPLETED|First Dose||9
1482988|NCT01811355|3628398|P2|STARTED|First Dose||12
1482989|NCT01811355|3628399|P1|STARTED|First Dose||11
1482990|NCT01811316|3628410|P3|NOT COMPLETED|Overall Study||0
1482991|NCT01811316|3628411|P2|NOT COMPLETED|Overall Study||0
1482992|NCT01811316|3628412|P1|NOT COMPLETED|Overall Study||3
1482993|NCT01811316|3628410|P3|COMPLETED|Overall Study||19
1482994|NCT01811316|3628411|P2|COMPLETED|Overall Study||22
1482995|NCT01811316|3628412|P1|COMPLETED|Overall Study||18
1482996|NCT01811316|3628410|P3|Visit 12 Weeks|Overall Study||19
1482997|NCT01811316|3628411|P2|Visit 12 Weeks|Overall Study||22
1482998|NCT01811316|3628412|P1|Visit 12 Weeks|Overall Study||18
1482999|NCT01811316|3628410|P3|Visit 4 Weeks|Overall Study||19
1483000|NCT01811316|3628411|P2|Visit 4 Weeks|Overall Study||22
1483001|NCT01811316|3628412|P1|Visit 4 Weeks|Overall Study||19
1483002|NCT01811316|3628410|P3|STARTED|Overall Study||19
1483003|NCT01811316|3628411|P2|STARTED|Overall Study||22
1483004|NCT01811316|3628412|P1|STARTED|Overall Study||21
1483005|NCT01811303|3628429|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
1483006|NCT01811303|3628430|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
1483007|NCT01811303|3628431|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
1483008|NCT01811303|3628432|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
1483009|NCT01811303|3628429|P4|COMPLETED|Fourth Intervention (1 Day)||2
1483010|NCT01811303|3628430|P3|COMPLETED|Fourth Intervention (1 Day)||4
1483011|NCT01811303|3628431|P2|COMPLETED|Fourth Intervention (1 Day)||4
1483012|NCT01811303|3628432|P1|COMPLETED|Fourth Intervention (1 Day)||4
1483013|NCT01811303|3628429|P4|STARTED|Fourth Intervention (1 Day)||2
1483014|NCT01811303|3628430|P3|STARTED|Fourth Intervention (1 Day)||4
1483015|NCT01811303|3628431|P2|STARTED|Fourth Intervention (1 Day)||4
1483016|NCT01811303|3628432|P1|STARTED|Fourth Intervention (1 Day)||4
1483017|NCT01811303|3628429|P4|NOT COMPLETED|Washout (2 Days or More)||0
1483018|NCT01811303|3628430|P3|NOT COMPLETED|Washout (2 Days or More)||0
1483019|NCT01811303|3628431|P2|NOT COMPLETED|Washout (2 Days or More)||0
1483020|NCT01811303|3628432|P1|NOT COMPLETED|Washout (2 Days or More)||0
1483021|NCT01811303|3628429|P4|COMPLETED|Washout (2 Days or More)||2
1483022|NCT01811303|3628430|P3|COMPLETED|Washout (2 Days or More)||4
1483023|NCT01811303|3628431|P2|COMPLETED|Washout (2 Days or More)||4
1483024|NCT01811303|3628432|P1|COMPLETED|Washout (2 Days or More)||4
1483025|NCT01811303|3628429|P4|STARTED|Washout (2 Days or More)||2
1483026|NCT01811303|3628430|P3|STARTED|Washout (2 Days or More)||4
1483027|NCT01811303|3628431|P2|STARTED|Washout (2 Days or More)||4
1483028|NCT01811303|3628432|P1|STARTED|Washout (2 Days or More)||4
1483029|NCT01811303|3628429|P4|NOT COMPLETED|Third Intervention (1 Day)||0
1483030|NCT01811303|3628430|P3|NOT COMPLETED|Third Intervention (1 Day)||0
1483031|NCT01811303|3628431|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1483032|NCT01811303|3628432|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1483033|NCT01811303|3628429|P4|COMPLETED|Third Intervention (1 Day)||2
1483034|NCT01811303|3628430|P3|COMPLETED|Third Intervention (1 Day)||4
1483035|NCT01811303|3628431|P2|COMPLETED|Third Intervention (1 Day)||4
1483036|NCT01811303|3628432|P1|COMPLETED|Third Intervention (1 Day)||4
1483037|NCT01811303|3628429|P4|STARTED|Third Intervention (1 Day)||2
1483038|NCT01811303|3628430|P3|STARTED|Third Intervention (1 Day)||4
1483039|NCT01811303|3628431|P2|STARTED|Third Intervention (1 Day)||4
1483040|NCT01811303|3628432|P1|STARTED|Third Intervention (1 Day)||4
1483041|NCT01811303|3628429|P4|NOT COMPLETED|Washout (2 Days or More)||0
1483042|NCT01811303|3628430|P3|NOT COMPLETED|Washout (2 Days or More)||0
1483043|NCT01811303|3628431|P2|NOT COMPLETED|Washout (2 Days or More)||0
1483044|NCT01811303|3628432|P1|NOT COMPLETED|Washout (2 Days or More)||0
1483045|NCT01811303|3628429|P4|COMPLETED|Washout (2 Days or More)||2
1483046|NCT01811303|3628430|P3|COMPLETED|Washout (2 Days or More)||4
1483047|NCT01811303|3628431|P2|COMPLETED|Washout (2 Days or More)||4
1483048|NCT01811303|3628432|P1|COMPLETED|Washout (2 Days or More)||4
1483049|NCT01811303|3628429|P4|STARTED|Washout (2 Days or More)||2
1483050|NCT01811303|3628430|P3|STARTED|Washout (2 Days or More)||4
1483051|NCT01811303|3628431|P2|STARTED|Washout (2 Days or More)||4
1483052|NCT01811303|3628432|P1|STARTED|Washout (2 Days or More)||4
1483053|NCT01811303|3628429|P4|NOT COMPLETED|Second Intervention (1 Day)||0
1483054|NCT01811303|3628430|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1483055|NCT01811303|3628431|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1483056|NCT01811303|3628432|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1483057|NCT01811303|3628429|P4|COMPLETED|Second Intervention (1 Day)||2
1483058|NCT01811303|3628430|P3|COMPLETED|Second Intervention (1 Day)||4
1483059|NCT01811303|3628431|P2|COMPLETED|Second Intervention (1 Day)||4
1483060|NCT01811303|3628432|P1|COMPLETED|Second Intervention (1 Day)||4
1483061|NCT01811303|3628429|P4|STARTED|Second Intervention (1 Day)||2
1483062|NCT01811303|3628430|P3|STARTED|Second Intervention (1 Day)||4
1483063|NCT01811303|3628431|P2|STARTED|Second Intervention (1 Day)||4
1483064|NCT01811303|3628432|P1|STARTED|Second Intervention (1 Day)||4
1483065|NCT01811303|3628429|P4|NOT COMPLETED|Washout (2 Days or More)||0
1483066|NCT01811303|3628430|P3|NOT COMPLETED|Washout (2 Days or More)||0
1483067|NCT01811303|3628431|P2|NOT COMPLETED|Washout (2 Days or More)||0
1483068|NCT01811303|3628432|P1|NOT COMPLETED|Washout (2 Days or More)||0
1483069|NCT01811303|3628429|P4|COMPLETED|Washout (2 Days or More)||2
1483070|NCT01811303|3628430|P3|COMPLETED|Washout (2 Days or More)||4
1483071|NCT01811303|3628431|P2|COMPLETED|Washout (2 Days or More)||4
1483072|NCT01811303|3628432|P1|COMPLETED|Washout (2 Days or More)||4
1483073|NCT01811303|3628429|P4|STARTED|Washout (2 Days or More)||2
1483074|NCT01811303|3628430|P3|STARTED|Washout (2 Days or More)||4
1483075|NCT01811303|3628431|P2|STARTED|Washout (2 Days or More)||4
1483076|NCT01811303|3628432|P1|STARTED|Washout (2 Days or More)||4
1483077|NCT01811303|3628429|P4|NOT COMPLETED|First Intervention (1 Day)||0
1483078|NCT01811303|3628430|P3|NOT COMPLETED|First Intervention (1 Day)||0
1483079|NCT01811303|3628431|P2|NOT COMPLETED|First Intervention (1 Day)||0
1483080|NCT01811303|3628432|P1|NOT COMPLETED|First Intervention (1 Day)||0
1483081|NCT01811303|3628429|P4|COMPLETED|First Intervention (1 Day)||2
1483082|NCT01811303|3628430|P3|COMPLETED|First Intervention (1 Day)||4
1483083|NCT01811303|3628431|P2|COMPLETED|First Intervention (1 Day)||4
1483084|NCT01811303|3628432|P1|COMPLETED|First Intervention (1 Day)||4
1483085|NCT01811303|3628429|P4|STARTED|First Intervention (1 Day)||2
1483086|NCT01811303|3628430|P3|STARTED|First Intervention (1 Day)||4
1483087|NCT01811303|3628431|P2|STARTED|First Intervention (1 Day)||4
1483088|NCT01811303|3628432|P1|STARTED|First Intervention (1 Day)||4
1483089|NCT01811238|3628440|P1|NOT COMPLETED|Overall Study||81
1483090|NCT01811238|3628440|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
1483091|NCT01811238|3628440|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
1483092|NCT01811238|3628440|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
1483093|NCT01811238|3628440|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
1483094|NCT01811238|3628440|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
1483095|NCT01811212|3628449|P1|NOT COMPLETED|Overall Study||0
1483096|NCT01811212|3628449|P1|COMPLETED|Overall Study||25
1483097|NCT01811212|3628449|P1|STARTED|Overall Study||25
1483098|NCT01811186|3628464|P2|NOT COMPLETED|Overall Study||62
1483099|NCT01811186|3628465|P1|NOT COMPLETED|Overall Study||71
1483100|NCT01811186|3628464|P2|COMPLETED|Overall Study||64
1483101|NCT01811186|3628465|P1|COMPLETED|Overall Study||61
1483102|NCT01811186|3628464|P2|STARTED|Overall Study||126
1483103|NCT01811186|3628465|P1|STARTED|Overall Study||132
1483104|NCT01810952|3628483|P2|NOT COMPLETED|Overall Study||0
1483105|NCT01810952|3628484|P1|NOT COMPLETED|Overall Study||0
1483106|NCT01810952|3628483|P2|COMPLETED|Overall Study||17
1483107|NCT01810952|3628484|P1|COMPLETED|Overall Study||20
1483108|NCT01810952|3628483|P2|STARTED|Overall Study||17
1483109|NCT01810952|3628484|P1|STARTED|Overall Study||20
1483110|NCT01810939|3628498|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
1483111|NCT01810939|3628499|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
1483112|NCT01810939|3628500|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
1483113|NCT01810939|3628498|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
1483114|NCT01810939|3628499|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
1483115|NCT01810939|3628500|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
1483116|NCT01810939|3628498|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
1483117|NCT01810939|3628499|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
1483118|NCT01810939|3628500|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
1483119|NCT01810939|3628498|P3|NOT COMPLETED|Part A Treatment Period||0
1483120|NCT01810939|3628499|P2|NOT COMPLETED|Part A Treatment Period||0
1483121|NCT01810939|3628500|P1|NOT COMPLETED|Part A Treatment Period||24
1483122|NCT01810939|3628498|P3|COMPLETED|Part A Treatment Period||0
1483123|NCT01810939|3628499|P2|COMPLETED|Part A Treatment Period||0
1483124|NCT01810939|3628500|P1|COMPLETED|Part A Treatment Period||219
1483125|NCT01810939|3628498|P3|STARTED|Part A Treatment Period||0
1483126|NCT01810939|3628499|P2|STARTED|Part A Treatment Period||0
1483127|NCT01810939|3628500|P1|STARTED|Part A Treatment Period||243
1483128|NCT01810783|3628513|P1|NOT COMPLETED|Overall Study||109
1483129|NCT01810783|3628513|P1|COMPLETED|Overall Study||101
1483130|NCT01810783|3628513|P1|STARTED|Overall Study||210
1483131|NCT01810692|3628519|P2|NOT COMPLETED|Overall Study||0
1483132|NCT01810692|3628520|P1|NOT COMPLETED|Overall Study||0
1483133|NCT01810692|3628519|P2|COMPLETED|Overall Study||77
1483134|NCT01810692|3628520|P1|COMPLETED|Overall Study||77
1483135|NCT01810692|3628519|P2|STARTED|Overall Study||77
1483136|NCT01810692|3628520|P1|STARTED|Overall Study||77
1483137|NCT01810666|3628532|P1|NOT COMPLETED|Overall Study||0
1483138|NCT01810666|3628532|P1|COMPLETED|Overall Study||30
1483139|NCT01810666|3628532|P1|STARTED|Overall Study||30
1483140|NCT01810432|3628538|P2|NOT COMPLETED|Period 2||2
1483141|NCT01810432|3628539|P1|NOT COMPLETED|Period 2||4
1483142|NCT01810432|3628538|P2|COMPLETED|Period 2||17
1483143|NCT01810432|3628539|P1|COMPLETED|Period 2||15
1483144|NCT01810432|3628538|P2|Received at Least 1 Dose of Study Drug|Period 2||19
1483145|NCT01810432|3628539|P1|Received at Least 1 Dose of Study Drug|Period 2||19
1483146|NCT01810432|3628538|P2|STARTED|Period 2||19
1483147|NCT01810432|3628539|P1|STARTED|Period 2||19
1483148|NCT01810432|3628538|P2|NOT COMPLETED|Washout||1
1483149|NCT01810432|3628539|P1|NOT COMPLETED|Washout||1
1483150|NCT01810432|3628538|P2|COMPLETED|Washout||19
1483151|NCT01810432|3628539|P1|COMPLETED|Washout||19
1483152|NCT01810432|3628538|P2|STARTED|Washout||20
1483153|NCT01810432|3628539|P1|STARTED|Washout||20
1483154|NCT01810432|3628538|P2|NOT COMPLETED|Period 1||0
1483155|NCT01810432|3628539|P1|NOT COMPLETED|Period 1||0
1483156|NCT01810432|3628538|P2|COMPLETED|Period 1||20
1483157|NCT01810432|3628539|P1|COMPLETED|Period 1||20
1483158|NCT01810432|3628538|P2|Received at Least 1 Dose of Study Drug|Period 1||20
1483159|NCT01810432|3628539|P1|Received at Least 1 Dose of Study Drug|Period 1||20
1483160|NCT01810432|3628538|P2|STARTED|Period 1||20
1483161|NCT01810432|3628539|P1|STARTED|Period 1||20
1483162|NCT01810380|3628552|P3|NOT COMPLETED|Overall Study||32
1483163|NCT01810380|3628553|P2|NOT COMPLETED|Overall Study||38
1483164|NCT01810380|3628554|P1|NOT COMPLETED|Overall Study||55
1483165|NCT01810380|3628552|P3|COMPLETED|Overall Study||122
1483166|NCT01810380|3628553|P2|COMPLETED|Overall Study||113
1483167|NCT01810380|3628554|P1|COMPLETED|Overall Study||108
1483168|NCT01810380|3628552|P3|Treated|Overall Study||153
1483169|NCT01810380|3628553|P2|Treated|Overall Study||150
1483170|NCT01810380|3628554|P1|Treated|Overall Study||161
1483171|NCT01810380|3628552|P3|STARTED|Overall Study||154
1483172|NCT01810380|3628553|P2|STARTED|Overall Study||151
1483173|NCT01810380|3628554|P1|STARTED|Overall Study||163
1483174|NCT01810302|3628615|P2|NOT COMPLETED|Overall Study||1
1483175|NCT01810302|3628616|P1|NOT COMPLETED|Overall Study||1
1483176|NCT01810302|3628615|P2|COMPLETED|Overall Study||0
1483177|NCT01810302|3628616|P1|COMPLETED|Overall Study||0
1483178|NCT01810302|3628615|P2|STARTED|Overall Study||1
1483179|NCT01810302|3628616|P1|STARTED|Overall Study||1
1483180|NCT01810289|3628626|P2|NOT COMPLETED|Overall Study||0
1483181|NCT01810289|3628627|P1|NOT COMPLETED|Overall Study||0
1483182|NCT01810289|3628626|P2|COMPLETED|Overall Study||4747
1483183|NCT01810289|3628627|P1|COMPLETED|Overall Study||7277
1483184|NCT01810289|3628626|P2|STARTED|Overall Study||4747
1483185|NCT01810289|3628627|P1|STARTED|Overall Study||7277
1483186|NCT01810263|3628643|P2|NOT COMPLETED|Overall Study||7
1483187|NCT01810263|3628644|P1|NOT COMPLETED|Overall Study||8
1483188|NCT01810263|3628643|P2|COMPLETED|Overall Study||11
1483189|NCT01810263|3628644|P1|COMPLETED|Overall Study|2014 July|8
1483190|NCT01810263|3628643|P2|STARTED|Overall Study||18
1483191|NCT01810263|3628644|P1|STARTED|Overall Study||16
1483192|NCT01810042|3628650|P1|NOT COMPLETED|Overall Study||10
1483193|NCT01810042|3628650|P1|COMPLETED|Overall Study||39
1483194|NCT01810042|3628650|P1|STARTED|Overall Study||49
1483195|NCT01810016|3628660|P3|NOT COMPLETED|Overall Study||1
1483196|NCT01810016|3628661|P2|NOT COMPLETED|Overall Study||1
1483197|NCT01810016|3628662|P1|NOT COMPLETED|Overall Study||1
1483198|NCT01810016|3628660|P3|COMPLETED|Overall Study||0
1483199|NCT01810016|3628661|P2|COMPLETED|Overall Study||1
1483200|NCT01810016|3628662|P1|COMPLETED|Overall Study||4
1483201|NCT01810016|3628660|P3|STARTED|Overall Study||1
1483202|NCT01810016|3628661|P2|STARTED|Overall Study||2
1483203|NCT01810016|3628662|P1|STARTED|Overall Study||5
1483204|NCT01809938|3628673|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
1483205|NCT01809938|3628674|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
1483206|NCT01809938|3628673|P2|COMPLETED|Second Intervention (170 Minutes)||5
1483207|NCT01809938|3628674|P1|COMPLETED|Second Intervention (170 Minutes)||5
1483208|NCT01809938|3628673|P2|STARTED|Second Intervention (170 Minutes)||5
1483209|NCT01809938|3628674|P1|STARTED|Second Intervention (170 Minutes)||5
1483210|NCT01809938|3628673|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
1483211|NCT01809938|3628674|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
1483212|NCT01809938|3628673|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
1483213|NCT01809938|3628674|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
1483214|NCT01809938|3628673|P2|STARTED|Washout (Not Less Than 24 Hours)||5
1483215|NCT01809938|3628674|P1|STARTED|Washout (Not Less Than 24 Hours)||5
1483216|NCT01809938|3628673|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
1483217|NCT01809938|3628674|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
1483218|NCT01809938|3628673|P2|COMPLETED|First Intervention (170 Minutes)||5
1483219|NCT01809938|3628674|P1|COMPLETED|First Intervention (170 Minutes)||5
1483220|NCT01809938|3628673|P2|STARTED|First Intervention (170 Minutes)||5
1483221|NCT01809938|3628674|P1|STARTED|First Intervention (170 Minutes)||5
1483222|NCT01809899|3628683|P2|NOT COMPLETED|Overall Study||0
1483223|NCT01809899|3628684|P1|NOT COMPLETED|Overall Study||0
1483224|NCT01809899|3628683|P2|COMPLETED|Overall Study||4
1483225|NCT01809899|3628684|P1|COMPLETED|Overall Study||8
1483226|NCT01809899|3628683|P2|STARTED|Overall Study||4
1483227|NCT01809899|3628684|P1|STARTED|Overall Study||8
1483228|NCT01809834|3628692|P1|NOT COMPLETED|Overall Study||0
1483229|NCT01809834|3628692|P1|COMPLETED|Overall Study||44
1483230|NCT01809834|3628692|P1|STARTED|Overall Study||44
1483231|NCT01809639|3628720|P2|NOT COMPLETED|Overall Study||0
1483232|NCT01809639|3628721|P1|NOT COMPLETED|Overall Study||0
1483233|NCT01809639|3628720|P2|COMPLETED|Overall Study||7
1483234|NCT01809639|3628721|P1|COMPLETED|Overall Study||18
1483235|NCT01809639|3628720|P2|STARTED|Overall Study||7
1483236|NCT01809639|3628721|P1|STARTED|Overall Study||18
1483237|NCT01809327|3628732|P5|NOT COMPLETED|Overall Study||25
1483238|NCT01809327|3628733|P4|NOT COMPLETED|Overall Study||12
1483239|NCT01809327|3628734|P3|NOT COMPLETED|Overall Study||22
1483240|NCT01809327|3628735|P2|NOT COMPLETED|Overall Study||26
1483241|NCT01809327|3628736|P1|NOT COMPLETED|Overall Study||32
1483242|NCT01809327|3628732|P5|COMPLETED|Overall Study||212
1483243|NCT01809327|3628733|P4|COMPLETED|Overall Study||225
1483244|NCT01809327|3628734|P3|COMPLETED|Overall Study||216
1483245|NCT01809327|3628735|P2|COMPLETED|Overall Study||211
1483246|NCT01809327|3628736|P1|COMPLETED|Overall Study||205
1483247|NCT01809327|3628732|P5|STARTED|Overall Study||237
1483248|NCT01809327|3628733|P4|STARTED|Overall Study||237
1483249|NCT01809327|3628734|P3|STARTED|Overall Study||238
1483250|NCT01809327|3628735|P2|STARTED|Overall Study||237
1483251|NCT01809327|3628736|P1|STARTED|Overall Study||237
1483252|NCT01809314|3628778|P1|NOT COMPLETED|Overall Study||745
1483253|NCT01809314|3628778|P1|COMPLETED|Overall Study||422
1483254|NCT01809314|3628778|P1|STARTED|Overall Study||1167
1483255|NCT01809262|3628784|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483256|NCT01809262|3628785|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483257|NCT01809262|3628786|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483258|NCT01809262|3628787|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483259|NCT01809262|3628788|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483260|NCT01809262|3628789|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483261|NCT01809262|3628790|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483262|NCT01809262|3628791|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483263|NCT01809262|3628792|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483264|NCT01809262|3628793|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
1483265|NCT01809262|3628784|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
1483266|NCT01809262|3628785|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1483267|NCT01809262|3628786|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
1483268|NCT01809262|3628787|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1483269|NCT01809262|3628788|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1483270|NCT01809262|3628789|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1483271|NCT01809262|3628790|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1483272|NCT01809262|3628791|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
1483273|NCT01809262|3628792|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
1483274|NCT01809262|3628793|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
1483275|NCT01809262|3628784|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
1483276|NCT01809262|3628785|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
1483277|NCT01809262|3628786|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
1483278|NCT01809262|3628787|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
1483279|NCT01809262|3628788|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
1483280|NCT01809262|3628789|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
1483281|NCT01809262|3628790|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
1483282|NCT01809262|3628791|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
1483283|NCT01809262|3628792|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
1483284|NCT01809262|3628793|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
1483285|NCT01809262|3628784|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483286|NCT01809262|3628785|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483287|NCT01809262|3628786|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483288|NCT01809262|3628787|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483289|NCT01809262|3628788|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483290|NCT01809262|3628789|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483291|NCT01809262|3628790|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483292|NCT01809262|3628791|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483293|NCT01809262|3628792|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483294|NCT01809262|3628793|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
1483295|NCT01809262|3628784|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
1483296|NCT01809262|3628785|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1483297|NCT01809262|3628786|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
1483298|NCT01809262|3628787|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1483299|NCT01809262|3628788|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1483300|NCT01809262|3628789|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1483301|NCT01809262|3628790|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1483302|NCT01809262|3628791|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
1483303|NCT01809262|3628792|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
1483304|NCT01809262|3628793|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
1483305|NCT01809262|3628784|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
1483306|NCT01809262|3628785|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
1483307|NCT01809262|3628786|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
1483308|NCT01809262|3628787|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
1483309|NCT01809262|3628788|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
1483310|NCT01809262|3628789|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
1483311|NCT01809262|3628790|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
1483312|NCT01809262|3628791|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
1483313|NCT01809262|3628792|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
1483314|NCT01809262|3628793|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
1483315|NCT01809262|3628784|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1483316|NCT01809262|3628785|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1483317|NCT01809262|3628786|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1483318|NCT01809262|3628787|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1483319|NCT01809262|3628788|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1483320|NCT01809262|3628789|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1483321|NCT01809262|3628790|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1483322|NCT01809262|3628791|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1483323|NCT01809262|3628792|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
1483324|NCT01809262|3628793|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
1483325|NCT01809262|3628784|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
1483326|NCT01809262|3628785|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
1483327|NCT01809262|3628786|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
1483328|NCT01809262|3628787|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
1483329|NCT01809262|3628788|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
1483330|NCT01809262|3628789|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
1483331|NCT01809262|3628790|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
1483332|NCT01809262|3628791|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
1483333|NCT01809262|3628792|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
1483334|NCT01809262|3628793|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
1483335|NCT01809262|3628784|P10|STARTED|Period 3 (Third Dose + Washout)||4
1483336|NCT01809262|3628785|P9|STARTED|Period 3 (Third Dose + Washout)||3
1483337|NCT01809262|3628786|P8|STARTED|Period 3 (Third Dose + Washout)||4
1483338|NCT01809262|3628787|P7|STARTED|Period 3 (Third Dose + Washout)||3
1483339|NCT01809262|3628788|P6|STARTED|Period 3 (Third Dose + Washout)||3
1483340|NCT01809262|3628789|P5|STARTED|Period 3 (Third Dose + Washout)||3
1483341|NCT01809262|3628790|P4|STARTED|Period 3 (Third Dose + Washout)||3
1483342|NCT01809262|3628791|P3|STARTED|Period 3 (Third Dose + Washout)||4
1483343|NCT01809262|3628792|P2|STARTED|Period 3 (Third Dose + Washout)||4
1483344|NCT01809262|3628793|P1|STARTED|Period 3 (Third Dose + Washout)||4
1483345|NCT01809262|3628784|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483346|NCT01809262|3628785|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483347|NCT01809262|3628786|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483348|NCT01809262|3628787|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483349|NCT01809262|3628788|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483350|NCT01809262|3628789|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483351|NCT01809262|3628790|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483352|NCT01809262|3628791|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483353|NCT01809262|3628792|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483354|NCT01809262|3628793|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
1483355|NCT01809262|3628784|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
1483356|NCT01809262|3628785|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
1483357|NCT01809262|3628786|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
1483358|NCT01809262|3628787|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
1483359|NCT01809262|3628788|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
1483360|NCT01809262|3628789|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
1483361|NCT01809262|3628790|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
1483362|NCT01809262|3628791|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
1483363|NCT01809262|3628792|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
1483364|NCT01809262|3628793|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
1483365|NCT01809262|3628784|P10|STARTED|Period 2 (Second Dose + Washout)||4
1483366|NCT01809262|3628785|P9|STARTED|Period 2 (Second Dose + Washout)||3
1483367|NCT01809262|3628786|P8|STARTED|Period 2 (Second Dose + Washout)||4
1483368|NCT01809262|3628787|P7|STARTED|Period 2 (Second Dose + Washout)||3
1483369|NCT01809262|3628788|P6|STARTED|Period 2 (Second Dose + Washout)||3
1483370|NCT01809262|3628789|P5|STARTED|Period 2 (Second Dose + Washout)||3
1483371|NCT01809262|3628790|P4|STARTED|Period 2 (Second Dose + Washout)||3
1483372|NCT01809262|3628791|P3|STARTED|Period 2 (Second Dose + Washout)||4
1483373|NCT01809262|3628792|P2|STARTED|Period 2 (Second Dose + Washout)||4
1483374|NCT01809262|3628793|P1|STARTED|Period 2 (Second Dose + Washout)||4
1483375|NCT01809262|3628784|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1483376|NCT01809262|3628785|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1483377|NCT01809262|3628786|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1483378|NCT01809262|3628787|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1483379|NCT01809262|3628788|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1483380|NCT01809262|3628789|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
1483381|NCT01809262|3628790|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1483382|NCT01809262|3628791|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1483383|NCT01809262|3628792|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1483384|NCT01809262|3628793|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
1483385|NCT01809262|3628784|P10|COMPLETED|Period 1 (First Dose + Washout)||4
1483386|NCT01809262|3628785|P9|COMPLETED|Period 1 (First Dose + Washout)||3
1483387|NCT01809262|3628786|P8|COMPLETED|Period 1 (First Dose + Washout)||4
1483388|NCT01809262|3628787|P7|COMPLETED|Period 1 (First Dose + Washout)||3
1483389|NCT01809262|3628788|P6|COMPLETED|Period 1 (First Dose + Washout)||3
1483390|NCT01809262|3628789|P5|COMPLETED|Period 1 (First Dose + Washout)||3
1483391|NCT01809262|3628790|P4|COMPLETED|Period 1 (First Dose + Washout)||3
1483392|NCT01809262|3628791|P3|COMPLETED|Period 1 (First Dose + Washout)||4
1483393|NCT01809262|3628792|P2|COMPLETED|Period 1 (First Dose + Washout)||4
1483394|NCT01809262|3628793|P1|COMPLETED|Period 1 (First Dose + Washout)||4
1483395|NCT01809262|3628784|P10|STARTED|Period 1 (First Dose + Washout)||4
1483396|NCT01809262|3628785|P9|STARTED|Period 1 (First Dose + Washout)||3
1483397|NCT01809262|3628786|P8|STARTED|Period 1 (First Dose + Washout)||4
1483398|NCT01809262|3628787|P7|STARTED|Period 1 (First Dose + Washout)||3
1483399|NCT01809262|3628788|P6|STARTED|Period 1 (First Dose + Washout)||3
1483400|NCT01809262|3628789|P5|STARTED|Period 1 (First Dose + Washout)||4
1483401|NCT01809262|3628790|P4|STARTED|Period 1 (First Dose + Washout)||3
1483402|NCT01809262|3628791|P3|STARTED|Period 1 (First Dose + Washout)||4
1483403|NCT01809262|3628792|P2|STARTED|Period 1 (First Dose + Washout)||4
1483404|NCT01809262|3628793|P1|STARTED|Period 1 (First Dose + Washout)||4
1483405|NCT01809210|3628867|P7|NOT COMPLETED|Overall Study||5
1483406|NCT01809210|3628868|P6|NOT COMPLETED|Overall Study||3
1483407|NCT01809210|3628869|P5|NOT COMPLETED|Overall Study||2
1483408|NCT01809210|3628870|P4|NOT COMPLETED|Overall Study||1
1483409|NCT01809210|3628871|P3|NOT COMPLETED|Overall Study||3
1483410|NCT01809210|3628872|P2|NOT COMPLETED|Overall Study||1
1483411|NCT01809210|3628873|P1|NOT COMPLETED|Overall Study||1
1483412|NCT01809210|3628867|P7|COMPLETED|Overall Study||7
1483413|NCT01809210|3628868|P6|COMPLETED|Overall Study||12
1483414|NCT01809210|3628869|P5|COMPLETED|Overall Study||4
1483415|NCT01809210|3628870|P4|COMPLETED|Overall Study||2
1483416|NCT01809210|3628871|P3|COMPLETED|Overall Study||4
1483417|NCT01809210|3628872|P2|COMPLETED|Overall Study||8
1483418|NCT01809210|3628873|P1|COMPLETED|Overall Study||2
1483419|NCT01809210|3628867|P7|STARTED|Overall Study||12
1483420|NCT01809210|3628868|P6|STARTED|Overall Study||15
1483421|NCT01809210|3628869|P5|STARTED|Overall Study||6
1483422|NCT01809210|3628870|P4|STARTED|Overall Study||3
1483423|NCT01809210|3628871|P3|STARTED|Overall Study||7
1483424|NCT01809210|3628872|P2|STARTED|Overall Study||9
1483425|NCT01809210|3628873|P1|STARTED|Overall Study||3
1483426|NCT01809197|3628947|P2|NOT COMPLETED|Overall Study||8
1483427|NCT01809197|3628948|P1|NOT COMPLETED|Overall Study||10
1483428|NCT01809197|3628947|P2|COMPLETED|Overall Study||177
1483429|NCT01809197|3628948|P1|COMPLETED|Overall Study||177
1483430|NCT01809197|3628947|P2|STARTED|Overall Study||185
1483431|NCT01809197|3628948|P1|STARTED|Overall Study||187
1483432|NCT01809106|3628958|P4|NOT COMPLETED|Overall Study||4
1483433|NCT01809106|3628959|P3|NOT COMPLETED|Overall Study||3
1483434|NCT01809106|3628960|P2|NOT COMPLETED|Overall Study||5
1483435|NCT01809106|3628961|P1|NOT COMPLETED|Overall Study||8
1483436|NCT01809106|3628958|P4|COMPLETED|Overall Study||124
1483437|NCT01809106|3628959|P3|COMPLETED|Overall Study||127
1483438|NCT01809106|3628960|P2|COMPLETED|Overall Study||125
1483439|NCT01809106|3628961|P1|COMPLETED|Overall Study||122
1483440|NCT01809106|3628958|P4|STARTED|Overall Study||128
1483441|NCT01809106|3628959|P3|STARTED|Overall Study||130
1483442|NCT01809106|3628960|P2|STARTED|Overall Study||130
1483443|NCT01809106|3628961|P1|STARTED|Overall Study||130
1483444|NCT01809054|3628981|P2|NOT COMPLETED|Overall Study||0
1483445|NCT01809054|3628982|P1|NOT COMPLETED|Overall Study||0
1483446|NCT01809054|3628981|P2|COMPLETED|Overall Study||22
1483447|NCT01809054|3628982|P1|COMPLETED|Overall Study||27
1483448|NCT01809054|3628981|P2|STARTED|Overall Study||22
1483449|NCT01809054|3628982|P1|STARTED|Overall Study||27
1483450|NCT01808963|3628990|P1|NOT COMPLETED|Overall Study||0
1483451|NCT01808963|3628990|P1|COMPLETED|Overall Study||13
1483452|NCT01808963|3628990|P1|STARTED|Overall Study||13
1483453|NCT01808950|3628997|P3|NOT COMPLETED|Overall Study||0
1483454|NCT01808950|3628998|P2|NOT COMPLETED|Overall Study||0
1483455|NCT01808950|3628999|P1|NOT COMPLETED|Overall Study||0
1483456|NCT01808950|3628997|P3|COMPLETED|Overall Study||0
1483457|NCT01808950|3628998|P2|COMPLETED|Overall Study||3
1483458|NCT01808950|3628999|P1|COMPLETED|Overall Study||1
1483459|NCT01808950|3628997|P3|STARTED|Overall Study||0
1483460|NCT01808950|3628998|P2|STARTED|Overall Study||3
1483461|NCT01808950|3628999|P1|STARTED|Overall Study||1
1483462|NCT01808755|3629010|P2|NOT COMPLETED|Overall Study||0
1483463|NCT01808755|3629011|P1|NOT COMPLETED|Overall Study||0
1483464|NCT01808755|3629010|P2|COMPLETED|Overall Study||30
1483465|NCT01808755|3629011|P1|COMPLETED|Overall Study||30
1483466|NCT01808755|3629010|P2|STARTED|Overall Study||30
1483467|NCT01808755|3629011|P1|STARTED|Overall Study||30
1483468|NCT01808651|3629019|P3|NOT COMPLETED|Study Period 2||0
1483469|NCT01808651|3629020|P2|NOT COMPLETED|Study Period 2||0
1483470|NCT01808651|3629021|P1|NOT COMPLETED|Study Period 2||0
1483471|NCT01808651|3629019|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
1483472|NCT01808651|3629020|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
1483473|NCT01808651|3629021|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
1483474|NCT01808651|3629019|P3|STARTED|Study Period 2||33
1483475|NCT01808651|3629020|P2|STARTED|Study Period 2||52
1483476|NCT01808651|3629021|P1|STARTED|Study Period 2||77
1483477|NCT01808651|3629019|P3|NOT COMPLETED|Study Period 1||5
1483478|NCT01808651|3629020|P2|NOT COMPLETED|Study Period 1||17
1483479|NCT01808651|3629021|P1|NOT COMPLETED|Study Period 1||26
1483480|NCT01808651|3629019|P3|COMPLETED|Study Period 1||31
1483481|NCT01808651|3629020|P2|COMPLETED|Study Period 1||48
1483482|NCT01808651|3629021|P1|COMPLETED|Study Period 1||73
1483483|NCT01808651|3629019|P3|Received at Least One Dose of Study Drug|Study Period 1||36
1483484|NCT01808651|3629020|P2|Received at Least One Dose of Study Drug|Study Period 1||65
1483485|NCT01808651|3629021|P1|Received at Least One Dose of Study Drug|Study Period 1||98
1483486|NCT01808651|3629019|P3|STARTED|Study Period 1||36
1483487|NCT01808651|3629020|P2|STARTED|Study Period 1||65
1483488|NCT01808651|3629021|P1|STARTED|Study Period 1||99
1483489|NCT01808612|3629056|P3|NOT COMPLETED|Discontinuation Period||0
1483490|NCT01808612|3629057|P2|NOT COMPLETED|Discontinuation Period||1
1483491|NCT01808612|3629058|P1|NOT COMPLETED|Discontinuation Period||2
1483492|NCT01808612|3629056|P3|COMPLETED|Discontinuation Period||145
1483493|NCT01808612|3629057|P2|COMPLETED|Discontinuation Period||37
1483494|NCT01808612|3629058|P1|COMPLETED|Discontinuation Period||85
1483495|NCT01808612|3629056|P3|STARTED|Discontinuation Period||145
1483496|NCT01808612|3629057|P2|STARTED|Discontinuation Period||38
1483497|NCT01808612|3629058|P1|STARTED|Discontinuation Period||87
1483498|NCT01808612|3629056|P3|NOT COMPLETED|Treatment Period||14
1483499|NCT01808612|3629057|P2|NOT COMPLETED|Treatment Period||7
1483500|NCT01808612|3629058|P1|NOT COMPLETED|Treatment Period||15
1483501|NCT01808612|3629056|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
1483502|NCT01808612|3629057|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
1483503|NCT01808612|3629058|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
1483504|NCT01808612|3629056|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
1483505|NCT01808612|3629057|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
1483506|NCT01808612|3629058|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
1483507|NCT01808612|3629056|P3|STARTED|Treatment Period||260
1483508|NCT01808612|3629057|P2|STARTED|Treatment Period||84
1483509|NCT01808612|3629058|P1|STARTED|Treatment Period||169
1483510|NCT01808560|3629090|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
1483511|NCT01808560|3629091|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
1483512|NCT01808560|3629092|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
1483513|NCT01808560|3629090|P3|COMPLETED|4-Month After Cataract Surgery||13
1483514|NCT01808560|3629091|P2|COMPLETED|4-Month After Cataract Surgery||0
1483515|NCT01808560|3629092|P1|COMPLETED|4-Month After Cataract Surgery||0
1483516|NCT01808560|3629090|P3|STARTED|4-Month After Cataract Surgery||13
1483517|NCT01808560|3629091|P2|STARTED|4-Month After Cataract Surgery||0
1483518|NCT01808560|3629092|P1|STARTED|4-Month After Cataract Surgery||0
1483519|NCT01808560|3629090|P3|NOT COMPLETED|Crossover Treatment||0
1483520|NCT01808560|3629091|P2|NOT COMPLETED|Crossover Treatment||0
1483521|NCT01808560|3629092|P1|NOT COMPLETED|Crossover Treatment||0
1483522|NCT01808560|3629090|P3|COMPLETED|Crossover Treatment||13
1483523|NCT01808560|3629091|P2|COMPLETED|Crossover Treatment||0
1483524|NCT01808560|3629092|P1|COMPLETED|Crossover Treatment||0
1483525|NCT01808560|3629090|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
1483526|NCT01808560|3629091|P2|STARTED|Crossover Treatment||0
1483527|NCT01808560|3629092|P1|STARTED|Crossover Treatment||0
1483528|NCT01808560|3629090|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
1483529|NCT01808560|3629091|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
1483530|NCT01808560|3629092|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
1483531|NCT01808560|3629090|P3|COMPLETED|3-Month After Cataract Surgery||0
1483532|NCT01808560|3629091|P2|COMPLETED|3-Month After Cataract Surgery||13
1483533|NCT01808560|3629092|P1|COMPLETED|3-Month After Cataract Surgery||17
1483534|NCT01808560|3629090|P3|STARTED|3-Month After Cataract Surgery||0
1483535|NCT01808560|3629091|P2|STARTED|3-Month After Cataract Surgery||13
1483536|NCT01808560|3629092|P1|STARTED|3-Month After Cataract Surgery||17
1483537|NCT01808560|3629090|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
1483538|NCT01808560|3629091|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
1483539|NCT01808560|3629092|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
1483540|NCT01808560|3629090|P3|COMPLETED|1-Month After Cataract Surgery||0
1483541|NCT01808560|3629091|P2|COMPLETED|1-Month After Cataract Surgery||13
1483542|NCT01808560|3629092|P1|COMPLETED|1-Month After Cataract Surgery||16
1483543|NCT01808560|3629090|P3|STARTED|1-Month After Cataract Surgery||0
1483544|NCT01808560|3629091|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
1483545|NCT01808560|3629092|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
1483546|NCT01808560|3629090|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
1483547|NCT01808560|3629091|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
1483548|NCT01808560|3629092|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
1483549|NCT01808560|3629090|P3|COMPLETED|Randomization and Treatment Allocation||0
1483550|NCT01808560|3629091|P2|COMPLETED|Randomization and Treatment Allocation||16
1483551|NCT01808560|3629092|P1|COMPLETED|Randomization and Treatment Allocation||18
1483552|NCT01808560|3629090|P3|STARTED|Randomization and Treatment Allocation||0
1483553|NCT01808560|3629091|P2|STARTED|Randomization and Treatment Allocation||16
1483554|NCT01808560|3629092|P1|STARTED|Randomization and Treatment Allocation||18
1483555|NCT01808547|3629117|P2|NOT COMPLETED|Overall Study||46
1483556|NCT01808547|3629118|P1|NOT COMPLETED|Overall Study||37
1483557|NCT01808547|3629117|P2|COMPLETED|Overall Study||48
1483558|NCT01808547|3629118|P1|COMPLETED|Overall Study||137
1483559|NCT01808547|3629117|P2|mITT Population|Overall Study||85
1483560|NCT01808547|3629118|P1|mITT Population|Overall Study||168
1483561|NCT01808547|3629117|P2|Safety Population|Overall Study||85
1483562|NCT01808547|3629118|P1|Safety Population|Overall Study||170
1483563|NCT01808547|3629117|P2|STARTED|Overall Study||94
1483564|NCT01808547|3629118|P1|STARTED|Overall Study||174
1483565|NCT01808534|3629124|P1|NOT COMPLETED|Overall Study||4
1483566|NCT01808534|3629124|P1|COMPLETED|Overall Study||1
1483567|NCT01808534|3629124|P1|STARTED|Overall Study||5
1483568|NCT01808508|3629135|P3|NOT COMPLETED|Overall Study||0
1483569|NCT01808508|3629136|P2|NOT COMPLETED|Overall Study||0
1483570|NCT01808508|3629137|P1|NOT COMPLETED|Overall Study||1
1483571|NCT01808508|3629135|P3|COMPLETED|Overall Study||3
1483572|NCT01808508|3629136|P2|COMPLETED|Overall Study||9
1483573|NCT01808508|3629137|P1|COMPLETED|Overall Study||10
1483574|NCT01808508|3629135|P3|STARTED|Overall Study||3
1483575|NCT01808508|3629136|P2|STARTED|Overall Study||9
1483576|NCT01808508|3629137|P1|STARTED|Overall Study||11
1483577|NCT01808339|3629154|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1483578|NCT01808339|3629155|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1483579|NCT01808339|3629156|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1483580|NCT01808339|3629157|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1483581|NCT01808339|3629158|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1483582|NCT01808339|3629159|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1483583|NCT01808339|3629154|P6|COMPLETED|Treatment Period 3 (14 Days)||5
1483584|NCT01808339|3629155|P5|COMPLETED|Treatment Period 3 (14 Days)||4
1483585|NCT01808339|3629156|P4|COMPLETED|Treatment Period 3 (14 Days)||2
1483586|NCT01808339|3629157|P3|COMPLETED|Treatment Period 3 (14 Days)||3
1483587|NCT01808339|3629158|P2|COMPLETED|Treatment Period 3 (14 Days)||3
1483588|NCT01808339|3629159|P1|COMPLETED|Treatment Period 3 (14 Days)||4
1483589|NCT01808339|3629154|P6|STARTED|Treatment Period 3 (14 Days)||5
1483590|NCT01808339|3629155|P5|STARTED|Treatment Period 3 (14 Days)||4
1483591|NCT01808339|3629156|P4|STARTED|Treatment Period 3 (14 Days)||2
1483592|NCT01808339|3629157|P3|STARTED|Treatment Period 3 (14 Days)||4
1483593|NCT01808339|3629158|P2|STARTED|Treatment Period 3 (14 Days)||3
1483594|NCT01808339|3629159|P1|STARTED|Treatment Period 3 (14 Days)||4
1483595|NCT01808339|3629154|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1483596|NCT01808339|3629155|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1483597|NCT01808339|3629156|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1483598|NCT01808339|3629157|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1483599|NCT01808339|3629158|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1483600|NCT01808339|3629159|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
1483601|NCT01808339|3629154|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
1483602|NCT01808339|3629155|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
1483603|NCT01808339|3629156|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
1483604|NCT01808339|3629157|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
1483605|NCT01808339|3629158|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
1483606|NCT01808339|3629159|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
1483607|NCT01808339|3629154|P6|STARTED|Washout Period 2 (14-21 Days)||5
1483608|NCT01808339|3629155|P5|STARTED|Washout Period 2 (14-21 Days)||4
1483609|NCT01808339|3629156|P4|STARTED|Washout Period 2 (14-21 Days)||2
1483610|NCT01808339|3629157|P3|STARTED|Washout Period 2 (14-21 Days)||4
1483611|NCT01808339|3629158|P2|STARTED|Washout Period 2 (14-21 Days)||3
1483612|NCT01808339|3629159|P1|STARTED|Washout Period 2 (14-21 Days)||4
1483613|NCT01808339|3629154|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1483614|NCT01808339|3629155|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1483615|NCT01808339|3629156|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1483616|NCT01808339|3629157|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1483617|NCT01808339|3629158|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1483618|NCT01808339|3629159|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1483619|NCT01808339|3629154|P6|COMPLETED|Treatment Period 2 (14 Days)||5
1483620|NCT01808339|3629155|P5|COMPLETED|Treatment Period 2 (14 Days)||4
1483621|NCT01808339|3629156|P4|COMPLETED|Treatment Period 2 (14 Days)||2
1483622|NCT01808339|3629157|P3|COMPLETED|Treatment Period 2 (14 Days)||4
1483623|NCT01808339|3629158|P2|COMPLETED|Treatment Period 2 (14 Days)||3
1483624|NCT01808339|3629159|P1|COMPLETED|Treatment Period 2 (14 Days)||4
1483625|NCT01808339|3629154|P6|STARTED|Treatment Period 2 (14 Days)||5
1483626|NCT01808339|3629155|P5|STARTED|Treatment Period 2 (14 Days)||4
1483627|NCT01808339|3629156|P4|STARTED|Treatment Period 2 (14 Days)||2
1483628|NCT01808339|3629157|P3|STARTED|Treatment Period 2 (14 Days)||4
1483629|NCT01808339|3629158|P2|STARTED|Treatment Period 2 (14 Days)||3
1483630|NCT01808339|3629159|P1|STARTED|Treatment Period 2 (14 Days)||4
1483631|NCT01808339|3629154|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1483632|NCT01808339|3629155|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1483633|NCT01808339|3629156|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1483634|NCT01808339|3629157|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1483635|NCT01808339|3629158|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1483636|NCT01808339|3629159|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
1483637|NCT01808339|3629154|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
1483638|NCT01808339|3629155|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
1483639|NCT01808339|3629156|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
1483640|NCT01808339|3629157|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
1483641|NCT01808339|3629158|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
1483642|NCT01808339|3629159|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
1483643|NCT01808339|3629154|P6|STARTED|Washout Period 1 (14-21 Days)||5
1483644|NCT01808339|3629155|P5|STARTED|Washout Period 1 (14-21 Days)||4
1483645|NCT01808339|3629156|P4|STARTED|Washout Period 1 (14-21 Days)||2
1483646|NCT01808339|3629157|P3|STARTED|Washout Period 1 (14-21 Days)||4
1483647|NCT01808339|3629158|P2|STARTED|Washout Period 1 (14-21 Days)||3
1483648|NCT01808339|3629159|P1|STARTED|Washout Period 1 (14-21 Days)||4
1483649|NCT01808339|3629154|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1483650|NCT01808339|3629155|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1483651|NCT01808339|3629156|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1483652|NCT01808339|3629157|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1483653|NCT01808339|3629158|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1483654|NCT01808339|3629159|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1483655|NCT01808339|3629154|P6|COMPLETED|Treatment Period 1 (14 Days)||5
1483656|NCT01808339|3629155|P5|COMPLETED|Treatment Period 1 (14 Days)||4
1483657|NCT01808339|3629156|P4|COMPLETED|Treatment Period 1 (14 Days)||2
1483658|NCT01808339|3629157|P3|COMPLETED|Treatment Period 1 (14 Days)||4
1483659|NCT01808339|3629158|P2|COMPLETED|Treatment Period 1 (14 Days)||3
1483660|NCT01808339|3629159|P1|COMPLETED|Treatment Period 1 (14 Days)||4
1483661|NCT01808339|3629154|P6|STARTED|Treatment Period 1 (14 Days)||6
1483662|NCT01808339|3629155|P5|STARTED|Treatment Period 1 (14 Days)||6
1483663|NCT01808339|3629156|P4|STARTED|Treatment Period 1 (14 Days)||4
1483664|NCT01808339|3629157|P3|STARTED|Treatment Period 1 (14 Days)||4
1483665|NCT01808339|3629158|P2|STARTED|Treatment Period 1 (14 Days)||4
1483666|NCT01808339|3629159|P1|STARTED|Treatment Period 1 (14 Days)||4
1483667|NCT01808326|3629176|P1|NOT COMPLETED|Overall Study||0
1483668|NCT01808326|3629176|P1|COMPLETED|Overall Study||5
1483669|NCT01808326|3629176|P1|STARTED|Overall Study||5
1483670|NCT01808313|3629203|P1|NOT COMPLETED|Overall Study||10
1483671|NCT01808313|3629203|P1|COMPLETED|Overall Study||123
1483672|NCT01808313|3629203|P1|STARTED|Overall Study||133
1483673|NCT01808261|3629233|P2|NOT COMPLETED|Overall Study||33
1483674|NCT01808261|3629234|P1|NOT COMPLETED|Overall Study||36
1483675|NCT01808261|3629233|P2|COMPLETED|Overall Study||32
1483676|NCT01808261|3629234|P1|COMPLETED|Overall Study||32
1483677|NCT01808261|3629233|P2|STARTED|Overall Study||65
1483678|NCT01808261|3629234|P1|STARTED|Overall Study||68
1483679|NCT01808248|3629290|P1|NOT COMPLETED|Overall Study||5
1483680|NCT01808248|3629290|P1|COMPLETED|Overall Study||42
1483681|NCT01808248|3629290|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
1483682|NCT01808248|3629290|P1|STARTED|Overall Study||47
1483683|NCT01808209|3629304|P2|NOT COMPLETED|Overall Study||1
1483684|NCT01808209|3629305|P1|NOT COMPLETED|Overall Study||0
1483685|NCT01808209|3629304|P2|COMPLETED|Overall Study||26
1483686|NCT01808209|3629305|P1|COMPLETED|Overall Study||33
1483687|NCT01808209|3629304|P2|STARTED|Overall Study||27
1483688|NCT01808209|3629305|P1|STARTED|Overall Study||33
1483689|NCT01808144|3629349|P2|NOT COMPLETED|Overall Study||48
1483690|NCT01808144|3629350|P1|NOT COMPLETED|Overall Study||40
1483691|NCT01808144|3629349|P2|COMPLETED|Overall Study||51
1483692|NCT01808144|3629350|P1|COMPLETED|Overall Study||57
1483693|NCT01808144|3629349|P2|STARTED|Overall Study||99
1483694|NCT01808144|3629350|P1|STARTED|Overall Study||97
1483695|NCT01808118|3629358|P3|NOT COMPLETED|Period 2||8
1483696|NCT01808118|3629359|P2|NOT COMPLETED|Period 2||13
1483697|NCT01808118|3629360|P1|NOT COMPLETED|Period 2||0
1483698|NCT01808118|3629358|P3|COMPLETED|Period 2||144
1483699|NCT01808118|3629359|P2|COMPLETED|Period 2||140
1483700|NCT01808118|3629360|P1|COMPLETED|Period 2||0
1483701|NCT01808118|3629358|P3|STARTED|Period 2||152
1483702|NCT01808118|3629359|P2|STARTED|Period 2||153
1483703|NCT01808118|3629360|P1|STARTED|Period 2||0
1483704|NCT01808118|3629358|P3|NOT COMPLETED|Period 1||0
1483705|NCT01808118|3629359|P2|NOT COMPLETED|Period 1||0
1483706|NCT01808118|3629360|P1|NOT COMPLETED|Period 1||368
1483707|NCT01808118|3629358|P3|COMPLETED|Period 1||0
1483708|NCT01808118|3629359|P2|COMPLETED|Period 1||0
1483709|NCT01808118|3629360|P1|COMPLETED|Period 1||305
1483710|NCT01808118|3629358|P3|STARTED|Period 1||0
1483711|NCT01808118|3629359|P2|STARTED|Period 1||0
1483712|NCT01808118|3629360|P1|STARTED|Period 1||673
1483713|NCT01808092|3629423|P2|NOT COMPLETED|Overall Study||45
1483714|NCT01808092|3629424|P1|NOT COMPLETED|Overall Study||54
1483715|NCT01808092|3629423|P2|COMPLETED|Overall Study||363
1483716|NCT01808092|3629424|P1|COMPLETED|Overall Study||355
1483717|NCT01808092|3629423|P2|STARTED|Overall Study||408
1483718|NCT01808092|3629424|P1|STARTED|Overall Study||409
1483719|NCT01808066|3629526|P1|NOT COMPLETED|Overall Study||15
1483720|NCT01808066|3629526|P1|COMPLETED|Overall Study||6
1483721|NCT01808066|3629526|P1|STARTED|Overall Study||21
1483722|NCT01807949|3629537|P3|NOT COMPLETED|Overall Study||9
1483723|NCT01807949|3629538|P2|NOT COMPLETED|Overall Study||7
1483724|NCT01807949|3629539|P1|NOT COMPLETED|Overall Study||2
1483725|NCT01807949|3629537|P3|COMPLETED|Overall Study||180
1483726|NCT01807949|3629538|P2|COMPLETED|Overall Study||180
1483727|NCT01807949|3629539|P1|COMPLETED|Overall Study||185
1483728|NCT01807949|3629537|P3|STARTED|Overall Study||189
1483729|NCT01807949|3629538|P2|STARTED|Overall Study||187
1483730|NCT01807949|3629539|P1|STARTED|Overall Study||187
1483731|NCT01807923|3629591|P3|NOT COMPLETED|Overall Study||11
1483732|NCT01807923|3629592|P2|NOT COMPLETED|Overall Study||6
1483733|NCT01807923|3629593|P1|NOT COMPLETED|Overall Study||5
1483734|NCT01807923|3629591|P3|COMPLETED|Overall Study||176
1483735|NCT01807923|3629592|P2|COMPLETED|Overall Study||179
1483736|NCT01807923|3629593|P1|COMPLETED|Overall Study||182
1483737|NCT01807923|3629591|P3|STARTED|Overall Study||187
1483738|NCT01807923|3629592|P2|STARTED|Overall Study||185
1483739|NCT01807923|3629593|P1|STARTED|Overall Study||187
1483740|NCT01807871|3629644|P2|NOT COMPLETED|Overall Study||218
1483741|NCT01807871|3629645|P1|NOT COMPLETED|Overall Study||178
1483742|NCT01807871|3629644|P2|COMPLETED|Overall Study||127
1483743|NCT01807871|3629645|P1|COMPLETED|Overall Study||178
1483744|NCT01807871|3629644|P2|STARTED|Overall Study||345
1483745|NCT01807871|3629645|P1|STARTED|Overall Study||356
1483746|NCT01807650|3629655|P1|NOT COMPLETED|Overall Study||20
1483747|NCT01807650|3629655|P1|COMPLETED|Overall Study||92
1483748|NCT01807650|3629655|P1|STARTED|Overall Study||112
1483749|NCT01807637|3629708|P2|NOT COMPLETED|One Month||0
1483750|NCT01807637|3629709|P1|NOT COMPLETED|One Month||0
1483751|NCT01807637|3629708|P2|COMPLETED|One Month||2
1483752|NCT01807637|3629709|P1|COMPLETED|One Month||4
1483753|NCT01807637|3629708|P2|STARTED|One Month||2
1483754|NCT01807637|3629709|P1|STARTED|One Month||4
1483755|NCT01807637|3629708|P2|NOT COMPLETED|One Week||0
1483756|NCT01807637|3629709|P1|NOT COMPLETED|One Week||0
1483757|NCT01807637|3629708|P2|COMPLETED|One Week||2
1483758|NCT01807637|3629709|P1|COMPLETED|One Week||4
1483759|NCT01807637|3629708|P2|STARTED|One Week||2
1483760|NCT01807637|3629709|P1|STARTED|One Week||4
1483761|NCT01807637|3629708|P2|NOT COMPLETED|Baseline||0
1483762|NCT01807637|3629709|P1|NOT COMPLETED|Baseline||0
1483763|NCT01807637|3629708|P2|COMPLETED|Baseline||2
1483764|NCT01807637|3629709|P1|COMPLETED|Baseline||4
1483765|NCT01807637|3629708|P2|STARTED|Baseline||2
1483766|NCT01807637|3629709|P1|STARTED|Baseline||4
1483767|NCT01807624|3629725|P1|NOT COMPLETED|Overall Study||0
1483768|NCT01807624|3629725|P1|COMPLETED|Overall Study||24
1483769|NCT01807624|3629725|P1|STARTED|Overall Study||24
1483770|NCT01807585|3629744|P3|NOT COMPLETED|Overall Study||6
1483771|NCT01807585|3629745|P2|NOT COMPLETED|Overall Study||4
1483772|NCT01807585|3629746|P1|NOT COMPLETED|Overall Study||1
1483773|NCT01807585|3629744|P3|COMPLETED|Overall Study||108
1483774|NCT01807585|3629745|P2|COMPLETED|Overall Study||104
1483775|NCT01807585|3629746|P1|COMPLETED|Overall Study||19
1483776|NCT01807585|3629744|P3|3 Mos|Overall Study||113
1483777|NCT01807585|3629745|P2|3 Mos|Overall Study||108
1483778|NCT01807585|3629746|P1|3 Mos|Overall Study||20
1483779|NCT01807585|3629744|P3|STARTED|Overall Study||114
1483780|NCT01807585|3629745|P2|STARTED|Overall Study||108
1483781|NCT01807585|3629746|P1|STARTED|Overall Study||20
1483782|NCT01807520|3629762|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
1483783|NCT01807520|3629763|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
1483784|NCT01807520|3629764|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1483785|NCT01807520|3629765|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1483786|NCT01807520|3629766|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1483787|NCT01807520|3629767|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1483788|NCT01807520|3629768|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
1483789|NCT01807520|3629762|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
1483790|NCT01807520|3629763|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
1483791|NCT01807520|3629764|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
1483792|NCT01807520|3629765|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
1483793|NCT01807520|3629766|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
1483794|NCT01807520|3629767|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
1483795|NCT01807520|3629768|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
1483796|NCT01807520|3629762|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
1483797|NCT01807520|3629763|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
1483798|NCT01807520|3629764|P5|STARTED|Follow-up Period (132-140 Weeks)||0
1483799|NCT01807520|3629765|P4|STARTED|Follow-up Period (132-140 Weeks)||0
1483800|NCT01807520|3629766|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
1483801|NCT01807520|3629767|P2|STARTED|Follow-up Period (132-140 Weeks)||0
1483802|NCT01807520|3629768|P1|STARTED|Follow-up Period (132-140 Weeks)||0
1483803|NCT01807520|3629762|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1483804|NCT01807520|3629763|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1483805|NCT01807520|3629764|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
1483806|NCT01807520|3629765|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
1483807|NCT01807520|3629766|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1483808|NCT01807520|3629767|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
1483809|NCT01807520|3629768|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
1483810|NCT01807520|3629762|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1483811|NCT01807520|3629763|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1483812|NCT01807520|3629764|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
1483813|NCT01807520|3629765|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
1483814|NCT01807520|3629766|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
1483815|NCT01807520|3629767|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
1483816|NCT01807520|3629768|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
1483817|NCT01807520|3629762|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
1483818|NCT01807520|3629763|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
1483819|NCT01807520|3629764|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
1483820|NCT01807520|3629765|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
1483821|NCT01807520|3629766|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
1483822|NCT01807520|3629767|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
1483823|NCT01807520|3629768|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
1483824|NCT01807520|3629762|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
1483825|NCT01807520|3629763|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
1483826|NCT01807520|3629764|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
1483827|NCT01807520|3629765|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
1483828|NCT01807520|3629766|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
1483829|NCT01807520|3629767|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
1483830|NCT01807520|3629768|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
1483831|NCT01807520|3629762|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
1483832|NCT01807520|3629763|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
1483833|NCT01807520|3629764|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
1483834|NCT01807520|3629765|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
1483835|NCT01807520|3629766|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
1483836|NCT01807520|3629767|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
1483837|NCT01807520|3629768|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
1483838|NCT01807520|3629762|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1483839|NCT01807520|3629763|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1483840|NCT01807520|3629764|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1483841|NCT01807520|3629765|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1483842|NCT01807520|3629766|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
1483843|NCT01807520|3629767|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
1483844|NCT01807520|3629768|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
1483845|NCT01807520|3629762|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1483846|NCT01807520|3629763|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1483847|NCT01807520|3629764|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1483848|NCT01807520|3629765|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
1483849|NCT01807520|3629766|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
1483850|NCT01807520|3629767|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
1483851|NCT01807520|3629768|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
1483852|NCT01807520|3629762|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
1483853|NCT01807520|3629763|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
1483854|NCT01807520|3629764|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
1483855|NCT01807520|3629765|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
1483856|NCT01807520|3629766|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
1483857|NCT01807520|3629767|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
1483858|NCT01807520|3629768|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
1483859|NCT01807520|3629762|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
1483860|NCT01807520|3629763|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
1483861|NCT01807520|3629764|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
1483862|NCT01807520|3629765|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
1483863|NCT01807520|3629766|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
1483864|NCT01807520|3629767|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
1483865|NCT01807520|3629768|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
1483866|NCT01807520|3629762|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
1483867|NCT01807520|3629763|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
1483868|NCT01807520|3629764|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
1483869|NCT01807520|3629765|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
1483870|NCT01807520|3629766|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
1483871|NCT01807520|3629767|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
1483872|NCT01807520|3629768|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
1483873|NCT01807455|3629787|P1|NOT COMPLETED|Overall Study||0
1483874|NCT01807455|3629787|P1|COMPLETED|Overall Study||12
1483875|NCT01807455|3629787|P1|STARTED|Overall Study||12
1483876|NCT01807234|3629801|P6|NOT COMPLETED|Overall Study||4
1483877|NCT01807234|3629802|P5|NOT COMPLETED|Overall Study||4
1483878|NCT01807234|3629803|P4|NOT COMPLETED|Overall Study||2
1483879|NCT01807234|3629804|P3|NOT COMPLETED|Overall Study||2
1483880|NCT01807234|3629805|P2|NOT COMPLETED|Overall Study||6
1483881|NCT01807234|3629806|P1|NOT COMPLETED|Overall Study||5
1483882|NCT01807234|3629801|P6|COMPLETED|Overall Study||8
1483883|NCT01807234|3629802|P5|COMPLETED|Overall Study||8
1483884|NCT01807234|3629803|P4|COMPLETED|Overall Study||10
1483885|NCT01807234|3629804|P3|COMPLETED|Overall Study||10
1483886|NCT01807234|3629805|P2|COMPLETED|Overall Study||6
1483887|NCT01807234|3629806|P1|COMPLETED|Overall Study||7
1483888|NCT01807234|3629801|P6|Completed Only 1 Attack|Overall Study||1
1483889|NCT01807234|3629802|P5|Completed Only 1 Attack|Overall Study||0
1483890|NCT01807234|3629803|P4|Completed Only 1 Attack|Overall Study||1
1483891|NCT01807234|3629804|P3|Completed Only 1 Attack|Overall Study||0
1483892|NCT01807234|3629805|P2|Completed Only 1 Attack|Overall Study||1
1483893|NCT01807234|3629806|P1|Completed Only 1 Attack|Overall Study||2
1483894|NCT01807234|3629801|P6|Randomized, But Did Not Take Drug|Overall Study||3
1483895|NCT01807234|3629802|P5|Randomized, But Did Not Take Drug|Overall Study||4
1483896|NCT01807234|3629803|P4|Randomized, But Did Not Take Drug|Overall Study||1
1483897|NCT01807234|3629804|P3|Randomized, But Did Not Take Drug|Overall Study||2
1483898|NCT01807234|3629805|P2|Randomized, But Did Not Take Drug|Overall Study||5
1483899|NCT01807234|3629806|P1|Randomized, But Did Not Take Drug|Overall Study||3
1483900|NCT01807234|3629801|P6|STARTED|Overall Study||12
1483901|NCT01807234|3629802|P5|STARTED|Overall Study||12
1483902|NCT01807234|3629803|P4|STARTED|Overall Study||12
1483903|NCT01807234|3629804|P3|STARTED|Overall Study||12
1483904|NCT01807234|3629805|P2|STARTED|Overall Study||12
1483905|NCT01807234|3629806|P1|STARTED|Overall Study||12
1483906|NCT01807156|3629841|P1|NOT COMPLETED|Overall Study||1
1483907|NCT01807156|3629841|P1|COMPLETED|Overall Study||6
1483908|NCT01807156|3629841|P1|STARTED|Overall Study||7
1483909|NCT01807000|3629846|P1|NOT COMPLETED|Overall Study||0
1483910|NCT01807000|3629846|P1|COMPLETED|Overall Study||6
1483911|NCT01807000|3629846|P1|STARTED|Overall Study||6
1483912|NCT01806961|3629865|P1|NOT COMPLETED|Overall Study||16
1483913|NCT01806961|3629865|P1|COMPLETED|Overall Study||0
1483914|NCT01806961|3629865|P1|STARTED|Overall Study||16
1483915|NCT01806896|3629871|P2|NOT COMPLETED|Overall Study||0
1483916|NCT01806896|3629872|P1|NOT COMPLETED|Overall Study||3
1483917|NCT01806896|3629871|P2|COMPLETED|Overall Study||17
1483918|NCT01806896|3629872|P1|COMPLETED|Overall Study||17
1483919|NCT01806896|3629871|P2|Received Treatment|Overall Study||17
1483920|NCT01806896|3629872|P1|Received Treatment|Overall Study||19
1483921|NCT01806896|3629871|P2|STARTED|Overall Study||17
1483922|NCT01806896|3629872|P1|STARTED|Overall Study||20
1483923|NCT01806857|3629900|P2|NOT COMPLETED|Overall Study||0
1483924|NCT01806857|3629901|P1|NOT COMPLETED|Overall Study||1
1483925|NCT01806857|3629900|P2|COMPLETED|Overall Study||29
1483926|NCT01806857|3629901|P1|COMPLETED|Overall Study||30
1483927|NCT01806857|3629900|P2|STARTED|Overall Study||29
1483928|NCT01806857|3629901|P1|STARTED|Overall Study||31
1483929|NCT01806779|3629939|P3|NOT COMPLETED|Overall Study||23
1483930|NCT01806779|3629940|P2|NOT COMPLETED|Overall Study||44
1483931|NCT01806779|3629941|P1|NOT COMPLETED|Overall Study||42
1483932|NCT01806779|3629939|P3|COMPLETED|Overall Study||0
1483933|NCT01806779|3629940|P2|COMPLETED|Overall Study||40
1483934|NCT01806779|3629941|P1|COMPLETED|Overall Study||48
1483935|NCT01806779|3629939|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
1483936|NCT01806779|3629940|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
1483937|NCT01806779|3629941|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
1483938|NCT01806779|3629939|P3|Randomized at Visit 2|Overall Study||0
1483939|NCT01806779|3629940|P2|Randomized at Visit 2|Overall Study||84
1483940|NCT01806779|3629941|P1|Randomized at Visit 2|Overall Study||90
1483941|NCT01806779|3629939|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
1483942|NCT01806779|3629940|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
1483943|NCT01806779|3629941|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
1483944|NCT01806779|3629939|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
1483945|NCT01806779|3629940|P2|STARTED|Overall Study||84
1483946|NCT01806779|3629941|P1|STARTED|Overall Study||90
1483947|NCT01806714|3629956|P2|NOT COMPLETED|Overall Study||170
1483948|NCT01806714|3629957|P1|NOT COMPLETED|Overall Study||200
1483949|NCT01806714|3629956|P2|COMPLETED|Overall Study||1919
1483950|NCT01806714|3629957|P1|COMPLETED|Overall Study||1893
1483951|NCT01806714|3629956|P2|STARTED|Overall Study||2089
1483952|NCT01806714|3629957|P1|STARTED|Overall Study||2093
1483953|NCT01806662|3629967|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
1483954|NCT01806662|3629968|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
1483955|NCT01806662|3629967|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
1483956|NCT01806662|3629968|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
1483957|NCT01806662|3629967|P2|STARTED|Second Intervention (Weeks 16-32)||15
1483958|NCT01806662|3629968|P1|STARTED|Second Intervention (Weeks 16-32)||12
1483959|NCT01806662|3629967|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
1483960|NCT01806662|3629968|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
1483961|NCT01806662|3629967|P2|COMPLETED|First Intervention (Weeks 0-16)||15
1483962|NCT01806662|3629968|P1|COMPLETED|First Intervention (Weeks 0-16)||12
1483963|NCT01806662|3629967|P2|Received Intervention|First Intervention (Weeks 0-16)||15
1483964|NCT01806662|3629968|P1|Received Intervention|First Intervention (Weeks 0-16)||12
1483965|NCT01806662|3629967|P2|STARTED|First Intervention (Weeks 0-16)||16
1483966|NCT01806662|3629968|P1|STARTED|First Intervention (Weeks 0-16)||16
1483967|NCT01806623|3629974|P1|NOT COMPLETED|Overall Study||58
1483968|NCT01806623|3629974|P1|COMPLETED|Overall Study||99
1483969|NCT01806623|3629974|P1|STARTED|Overall Study||157
1483970|NCT01806597|3629994|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
1483971|NCT01806597|3629995|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1483972|NCT01806597|3629996|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1483973|NCT01806597|3629997|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1483974|NCT01806597|3629998|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1483975|NCT01806597|3629999|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1483976|NCT01806597|3629994|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
1483977|NCT01806597|3629995|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
1483978|NCT01806597|3629996|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1483979|NCT01806597|3629997|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1483980|NCT01806597|3629998|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1483981|NCT01806597|3629999|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
1483982|NCT01806597|3629994|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
1483983|NCT01806597|3629995|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
1483984|NCT01806597|3629996|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
1483985|NCT01806597|3629997|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
1483986|NCT01806597|3629998|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
1483987|NCT01806597|3629999|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
1483988|NCT01806597|3629994|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
1483989|NCT01806597|3629995|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
1483990|NCT01806597|3629996|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
1483991|NCT01806597|3629997|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
1483992|NCT01806597|3629998|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
1483993|NCT01806597|3629999|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
1483994|NCT01806597|3629994|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
1483995|NCT01806597|3629995|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
1483996|NCT01806597|3629996|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
1483997|NCT01806597|3629997|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
1483998|NCT01806597|3629998|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
1483999|NCT01806597|3629999|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
1484000|NCT01806597|3629994|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
1484001|NCT01806597|3629995|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
1484002|NCT01806597|3629996|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
1484003|NCT01806597|3629997|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
1484004|NCT01806597|3629998|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
1484005|NCT01806597|3629999|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
1484006|NCT01806597|3629994|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
1484007|NCT01806597|3629995|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
1484008|NCT01806597|3629996|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
1484009|NCT01806597|3629997|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
1484010|NCT01806597|3629998|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
1484011|NCT01806597|3629999|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
1484012|NCT01806597|3629994|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
1484013|NCT01806597|3629995|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
1484014|NCT01806597|3629996|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
1484015|NCT01806597|3629997|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
1484016|NCT01806597|3629998|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
1484017|NCT01806597|3629999|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
1484018|NCT01806597|3629994|P6|STARTED|Period 1 (Baseline to Week 16)||0
1484019|NCT01806597|3629995|P5|STARTED|Period 1 (Baseline to Week 16)||68
1484020|NCT01806597|3629996|P4|STARTED|Period 1 (Baseline to Week 16)||0
1484021|NCT01806597|3629997|P3|STARTED|Period 1 (Baseline to Week 16)||0
1484022|NCT01806597|3629998|P2|STARTED|Period 1 (Baseline to Week 16)||69
1484023|NCT01806597|3629999|P1|STARTED|Period 1 (Baseline to Week 16)||68
1484024|NCT01806584|3630035|P2|NOT COMPLETED|Overall Study||18
1484025|NCT01806584|3630036|P1|NOT COMPLETED|Overall Study||14
1484026|NCT01806584|3630035|P2|COMPLETED|Overall Study||0
1484027|NCT01806584|3630036|P1|COMPLETED|Overall Study||0
1484028|NCT01806584|3630035|P2|STARTED|Overall Study||18
1484029|NCT01806584|3630036|P1|STARTED|Overall Study||14
1484030|NCT01806545|3630050|P2|NOT COMPLETED|Overall Study||5
1484031|NCT01806545|3630051|P1|NOT COMPLETED|Overall Study||6
1484032|NCT01806545|3630050|P2|COMPLETED|Overall Study||30
1484033|NCT01806545|3630051|P1|COMPLETED|Overall Study||23
1484034|NCT01806545|3630050|P2|STARTED|Overall Study||35
1484035|NCT01806545|3630051|P1|STARTED|Overall Study||29
1484036|NCT01806389|3630073|P1|NOT COMPLETED|Overall Study||4
1484037|NCT01806389|3630073|P1|COMPLETED|Overall Study||10
1484038|NCT01806389|3630073|P1|STARTED|Overall Study||14
1484039|NCT01806298|3630087|P1|NOT COMPLETED|Overall Study||10
1484040|NCT01806298|3630087|P1|COMPLETED|Overall Study||68
1484041|NCT01806298|3630087|P1|STARTED|Overall Study||78
1484042|NCT01806051|3630097|P1|NOT COMPLETED|Overall Study||6
1484043|NCT01806051|3630097|P1|COMPLETED|Overall Study||0
1484044|NCT01806051|3630097|P1|STARTED|Overall Study||6
1484045|NCT01805895|3630105|P2|NOT COMPLETED|Overall Study||0
1484046|NCT01805895|3630106|P1|NOT COMPLETED|Overall Study||0
1484047|NCT01805895|3630105|P2|COMPLETED|Overall Study||8
1484048|NCT01805895|3630106|P1|COMPLETED|Overall Study||8
1484049|NCT01805895|3630105|P2|STARTED|Overall Study||8
1484050|NCT01805895|3630106|P1|STARTED|Overall Study||8
1484051|NCT01805882|3630123|P9|NOT COMPLETED|Overall Study||1
1484052|NCT01805882|3630124|P8|NOT COMPLETED|Overall Study||0
1484053|NCT01805882|3630125|P7|NOT COMPLETED|Overall Study||2
1484054|NCT01805882|3630126|P6|NOT COMPLETED|Overall Study||1
1484055|NCT01805882|3630127|P5|NOT COMPLETED|Overall Study||0
1484056|NCT01805882|3630128|P4|NOT COMPLETED|Overall Study||2
1484057|NCT01805882|3630129|P3|NOT COMPLETED|Overall Study||1
1484058|NCT01805882|3630130|P2|NOT COMPLETED|Overall Study||0
1484059|NCT01805882|3630131|P1|NOT COMPLETED|Overall Study||0
1484060|NCT01805882|3630123|P9|COMPLETED|Overall Study||24
1484061|NCT01805882|3630124|P8|COMPLETED|Overall Study||25
1484062|NCT01805882|3630125|P7|COMPLETED|Overall Study||48
1484063|NCT01805882|3630126|P6|COMPLETED|Overall Study||20
1484064|NCT01805882|3630127|P5|COMPLETED|Overall Study||14
1484065|NCT01805882|3630128|P4|COMPLETED|Overall Study||32
1484066|NCT01805882|3630129|P3|COMPLETED|Overall Study||19
1484067|NCT01805882|3630130|P2|COMPLETED|Overall Study||20
1484068|NCT01805882|3630131|P1|COMPLETED|Overall Study||20
1484069|NCT01805882|3630123|P9|STARTED|Overall Study||25
1484070|NCT01805882|3630124|P8|STARTED|Overall Study||25
1484071|NCT01805882|3630125|P7|STARTED|Overall Study||50
1484072|NCT01805882|3630126|P6|STARTED|Overall Study||21
1484073|NCT01805882|3630127|P5|STARTED|Overall Study||14
1484074|NCT01805882|3630128|P4|STARTED|Overall Study||34
1484075|NCT01805882|3630129|P3|STARTED|Overall Study||20
1484076|NCT01805882|3630130|P2|STARTED|Overall Study||20
1484077|NCT01805882|3630131|P1|STARTED|Overall Study||20
1484078|NCT01805687|3630151|P1|NOT COMPLETED|Overall Study||0
1484079|NCT01805687|3630151|P1|COMPLETED|Overall Study||25
1484080|NCT01805687|3630151|P1|STARTED|Overall Study||25
1484081|NCT01805440|3630158|P3|NOT COMPLETED|Overall Study||0
1484082|NCT01805440|3630159|P2|NOT COMPLETED|Overall Study||0
1484083|NCT01805440|3630160|P1|NOT COMPLETED|Overall Study||1
1484084|NCT01805440|3630158|P3|COMPLETED|Overall Study||26
1484085|NCT01805440|3630159|P2|COMPLETED|Overall Study||17
1484086|NCT01805440|3630160|P1|COMPLETED|Overall Study||18
1484087|NCT01805440|3630158|P3|STARTED|Overall Study||26
1484088|NCT01805440|3630159|P2|STARTED|Overall Study||17
1484089|NCT01805440|3630160|P1|STARTED|Overall Study||19
1484090|NCT01805323|3630173|P1|NOT COMPLETED|Overall Study||0
1484091|NCT01805323|3630173|P1|COMPLETED|Overall Study||101
1484092|NCT01805323|3630173|P1|STARTED|Overall Study||101
1484093|NCT01805297|3630180|P2|NOT COMPLETED|Overall Study||3
1484094|NCT01805297|3630181|P1|NOT COMPLETED|Overall Study||2
1484095|NCT01805297|3630180|P2|COMPLETED|Overall Study||3
1484096|NCT01805297|3630181|P1|COMPLETED|Overall Study||4
1484097|NCT01805297|3630180|P2|STARTED|Overall Study||6
1484098|NCT01805297|3630181|P1|STARTED|Overall Study||6
1484099|NCT01805180|3630195|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
1484100|NCT01805180|3630196|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
1484101|NCT01805180|3630197|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
1484102|NCT01805180|3630195|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
1484103|NCT01805180|3630196|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
1484104|NCT01805180|3630197|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
1484105|NCT01805180|3630195|P3|STARTED|Pivotal Randomization Through Study Exit||20
1484106|NCT01805180|3630196|P2|STARTED|Pivotal Randomization Through Study Exit||22
1484107|NCT01805180|3630197|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
1484108|NCT01805180|3630195|P3|NOT COMPLETED|Lead-in Donor Phase||0
1484109|NCT01805180|3630196|P2|NOT COMPLETED|Lead-in Donor Phase||0
1484110|NCT01805180|3630197|P1|NOT COMPLETED|Lead-in Donor Phase||1
1484111|NCT01805180|3630195|P3|COMPLETED|Lead-in Donor Phase||0
1484112|NCT01805180|3630196|P2|COMPLETED|Lead-in Donor Phase||0
1484113|NCT01805180|3630197|P1|COMPLETED|Lead-in Donor Phase||6
1484114|NCT01805180|3630195|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
1484115|NCT01805180|3630196|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
1484116|NCT01805180|3630197|P1|STARTED|Lead-in Donor Phase||7
1484117|NCT01805089|3630222|P2|NOT COMPLETED|Overall Study||4
1484118|NCT01805089|3630223|P1|NOT COMPLETED|Overall Study||5
1484119|NCT01805089|3630222|P2|COMPLETED|Overall Study||43
1484120|NCT01805089|3630223|P1|COMPLETED|Overall Study||43
1484121|NCT01805089|3630222|P2|STARTED|Overall Study||47
1484122|NCT01805089|3630223|P1|STARTED|Overall Study||48
1484123|NCT01804946|3630235|P2|NOT COMPLETED|Overall Study||4
1484124|NCT01804946|3630236|P1|NOT COMPLETED|Overall Study||2
1484125|NCT01804946|3630235|P2|COMPLETED|Overall Study||76
1484126|NCT01804946|3630236|P1|COMPLETED|Overall Study||79
1484127|NCT01804946|3630235|P2|STARTED|Overall Study||80
1484128|NCT01804946|3630236|P1|STARTED|Overall Study||81
1484129|NCT01804881|3630260|P2|NOT COMPLETED|Overall Study||4
1484130|NCT01804881|3630261|P1|NOT COMPLETED|Overall Study||5
1484131|NCT01804881|3630260|P2|COMPLETED|Overall Study||10
1484132|NCT01804881|3630261|P1|COMPLETED|Overall Study||11
1484133|NCT01804881|3630260|P2|STARTED|Overall Study||14
1484134|NCT01804881|3630261|P1|STARTED|Overall Study||16
1484135|NCT01804842|3630274|P3|NOT COMPLETED|Overall Study||1
1484136|NCT01804842|3630275|P2|NOT COMPLETED|Overall Study||2
1484137|NCT01804842|3630276|P1|NOT COMPLETED|Overall Study||3
1484138|NCT01804842|3630274|P3|COMPLETED|Overall Study||8
1484139|NCT01804842|3630275|P2|COMPLETED|Overall Study||6
1484140|NCT01804842|3630276|P1|COMPLETED|Overall Study||6
1484141|NCT01804842|3630274|P3|Completed Treatment C|Overall Study||9
1484142|NCT01804842|3630275|P2|Completed Treatment C|Overall Study||7
1484143|NCT01804842|3630276|P1|Completed Treatment C|Overall Study||7
1484144|NCT01804842|3630274|P3|Completed Treatment B|Overall Study||8
1484145|NCT01804842|3630275|P2|Completed Treatment B|Overall Study||8
1484146|NCT01804842|3630276|P1|Completed Treatment B|Overall Study||8
1484147|NCT01804842|3630274|P3|Completed Treatment A|Overall Study||8
1484148|NCT01804842|3630275|P2|Completed Treatment A|Overall Study||6
1484149|NCT01804842|3630276|P1|Completed Treatment A|Overall Study||9
1484150|NCT01804842|3630274|P3|STARTED|Overall Study||9
1484151|NCT01804842|3630275|P2|STARTED|Overall Study||8
1484152|NCT01804842|3630276|P1|STARTED|Overall Study||9
1484153|NCT01804673|3630293|P1|NOT COMPLETED|Overall Study||140
1484154|NCT01804673|3630293|P1|COMPLETED|Overall Study||34
1484155|NCT01804673|3630293|P1|Completed Hour 72|Overall Study||36
1484156|NCT01804673|3630293|P1|Completed Hour 48|Overall Study||79
1484157|NCT01804673|3630293|P1|Completed Hour 24|Overall Study||170
1484158|NCT01804673|3630293|P1|STARTED|Overall Study||174
1484159|NCT01804257|3630309|P1|NOT COMPLETED|Overall Study||1
1484160|NCT01804257|3630309|P1|COMPLETED|Overall Study||27
1484161|NCT01804257|3630309|P1|STARTED|Overall Study||28
1484162|NCT01804140|3630313|P1|NOT COMPLETED|Overall Study||114
1484163|NCT01804140|3630313|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
1484164|NCT01804140|3630313|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
1484165|NCT01804101|3630320|P2|NOT COMPLETED|Overall Study||0
1484166|NCT01804101|3630321|P1|NOT COMPLETED|Overall Study||0
1484167|NCT01804101|3630320|P2|COMPLETED|Overall Study||10
1484168|NCT01804101|3630321|P1|COMPLETED|Overall Study||38
1484169|NCT01804101|3630320|P2|STARTED|Overall Study||10
1484170|NCT01804101|3630321|P1|STARTED|Overall Study||38
1484171|NCT01804075|3630331|P2|NOT COMPLETED|Overall Study||0
1484172|NCT01804075|3630332|P1|NOT COMPLETED|Overall Study||0
1484173|NCT01804075|3630331|P2|COMPLETED|Overall Study||16
1484174|NCT01804075|3630332|P1|COMPLETED|Overall Study||15
1484175|NCT01804075|3630331|P2|STARTED|Overall Study||16
1484176|NCT01804075|3630332|P1|STARTED|Overall Study||15
1484177|NCT01804062|3630340|P1|NOT COMPLETED|Overall Study||0
1484178|NCT01804062|3630340|P1|COMPLETED|Overall Study||30
1484179|NCT01804062|3630340|P1|STARTED|Overall Study||30
1484180|NCT01804036|3630347|P2|NOT COMPLETED|Overall Study||20
1484181|NCT01804036|3630348|P1|NOT COMPLETED|Overall Study||13
1484182|NCT01804036|3630347|P2|COMPLETED|Overall Study||21
1484183|NCT01804036|3630348|P1|COMPLETED|Overall Study||18
1484184|NCT01804036|3630347|P2|STARTED|Overall Study||41
1484185|NCT01804036|3630348|P1|STARTED|Overall Study||31
1484186|NCT01803737|3630382|P2|NOT COMPLETED|Overall Study||3
1484187|NCT01803737|3630383|P1|NOT COMPLETED|Overall Study||1
1484188|NCT01803737|3630382|P2|COMPLETED|Overall Study||10
1484189|NCT01803737|3630383|P1|COMPLETED|Overall Study||12
1484190|NCT01803737|3630382|P2|STARTED|Overall Study||13
1484191|NCT01803737|3630383|P1|STARTED|Overall Study||13
1484192|NCT01803711|3630407|P2|NOT COMPLETED|Overall Study||1
1484193|NCT01803711|3630408|P1|NOT COMPLETED|Overall Study||1
1484194|NCT01803711|3630407|P2|COMPLETED|Overall Study||2
1484195|NCT01803711|3630408|P1|COMPLETED|Overall Study||1
1484196|NCT01803711|3630407|P2|STARTED|Overall Study||3
1484197|NCT01803711|3630408|P1|STARTED|Overall Study||2
1484198|NCT01803646|3630426|P2|NOT COMPLETED|Overall Study||10
1484199|NCT01803646|3630427|P1|NOT COMPLETED|Overall Study||17
1484200|NCT01803646|3630426|P2|COMPLETED|Overall Study||129
1484201|NCT01803646|3630427|P1|COMPLETED|Overall Study||187
1484202|NCT01803646|3630426|P2|STARTED|Overall Study||139
1484203|NCT01803646|3630427|P1|STARTED|Overall Study||204
1484204|NCT01803607|3630439|P2|NOT COMPLETED|Overall Study||67
1484205|NCT01803607|3630440|P1|NOT COMPLETED|Overall Study||68
1484206|NCT01803607|3630439|P2|COMPLETED|Overall Study||0
1484207|NCT01803607|3630440|P1|COMPLETED|Overall Study||0
1484208|NCT01803607|3630439|P2|STARTED|Overall Study||67
1484209|NCT01803607|3630440|P1|STARTED|Overall Study||68
1484210|NCT01803464|3630464|P4|NOT COMPLETED|Overall Study||0
1484211|NCT01803464|3630465|P3|NOT COMPLETED|Overall Study||4
1484212|NCT01803464|3630466|P2|NOT COMPLETED|Overall Study||0
1484213|NCT01803464|3630467|P1|NOT COMPLETED|Overall Study||1
1484214|NCT01803464|3630464|P4|COMPLETED|Overall Study||10
1484215|NCT01803464|3630465|P3|COMPLETED|Overall Study||6
1484216|NCT01803464|3630466|P2|COMPLETED|Overall Study||4
1484217|NCT01803464|3630467|P1|COMPLETED|Overall Study||4
1484218|NCT01803464|3630464|P4|STARTED|Overall Study||10
1484219|NCT01803464|3630465|P3|STARTED|Overall Study||10
1484220|NCT01803464|3630466|P2|STARTED|Overall Study||4
1484221|NCT01803464|3630467|P1|STARTED|Overall Study||5
1484222|NCT01802775|3630487|P2|NOT COMPLETED|Overall Study||12
1484223|NCT01802775|3630488|P1|NOT COMPLETED|Overall Study||6
1484224|NCT01802775|3630487|P2|COMPLETED|Overall Study||89
1484225|NCT01802775|3630488|P1|COMPLETED|Overall Study||96
1484226|NCT01802775|3630487|P2|Received Drug (Safety Analysis Set)|Overall Study||100
1484227|NCT01802775|3630488|P1|Received Drug (Safety Analysis Set)|Overall Study||101
1484228|NCT01802775|3630487|P2|STARTED|Overall Study||101
1484229|NCT01802775|3630488|P1|STARTED|Overall Study||102
1484230|NCT01802632|3630510|P6|NOT COMPLETED|Overall Study||28
1484231|NCT01802632|3630511|P5|NOT COMPLETED|Overall Study||12
1484232|NCT01802632|3630512|P4|NOT COMPLETED|Overall Study||60
1484233|NCT01802632|3630513|P3|NOT COMPLETED|Overall Study||271
1484234|NCT01802632|3630514|P2|NOT COMPLETED|Overall Study||31
1484235|NCT01802632|3630515|P1|NOT COMPLETED|Overall Study||201
1484236|NCT01802632|3630510|P6|COMPLETED|Overall Study||0
1484237|NCT01802632|3630511|P5|COMPLETED|Overall Study||0
1484238|NCT01802632|3630512|P4|COMPLETED|Overall Study||0
1484239|NCT01802632|3630513|P3|COMPLETED|Overall Study||0
1484240|NCT01802632|3630514|P2|COMPLETED|Overall Study||0
1484241|NCT01802632|3630515|P1|COMPLETED|Overall Study||0
1484242|NCT01802632|3630510|P6|STARTED|Overall Study||28
1484243|NCT01802632|3630511|P5|STARTED|Overall Study||12
1484244|NCT01802632|3630512|P4|STARTED|Overall Study||60
1484245|NCT01802632|3630513|P3|STARTED|Overall Study||271
1484246|NCT01802632|3630514|P2|STARTED|Overall Study||31
1484247|NCT01802632|3630515|P1|STARTED|Overall Study||201
1484248|NCT01802554|3630531|P2|NOT COMPLETED|Overall Study||6
1484249|NCT01802554|3630532|P1|NOT COMPLETED|Overall Study||8
1484250|NCT01802554|3630531|P2|COMPLETED|Overall Study||43
1484251|NCT01802554|3630532|P1|COMPLETED|Overall Study||43
1484252|NCT01802554|3630531|P2|STARTED|Overall Study||49
1484253|NCT01802554|3630532|P1|STARTED|Overall Study||51
1484254|NCT01802515|3630549|P3|NOT COMPLETED|Overall Study||0
1484255|NCT01802515|3630550|P2|NOT COMPLETED|Overall Study||0
1484256|NCT01802515|3630551|P1|NOT COMPLETED|Overall Study||3
1484257|NCT01802515|3630549|P3|COMPLETED|Overall Study||4
1484258|NCT01802515|3630550|P2|COMPLETED|Overall Study||5
1484259|NCT01802515|3630551|P1|COMPLETED|Overall Study||2
1484260|NCT01802515|3630549|P3|STARTED|Overall Study||4
1484261|NCT01802515|3630550|P2|STARTED|Overall Study||5
1484262|NCT01802515|3630551|P1|STARTED|Overall Study||5
1484263|NCT01802333|3630565|P3|NOT COMPLETED|Overall Study||63
1484264|NCT01802333|3630566|P2|NOT COMPLETED|Overall Study||61
1484265|NCT01802333|3630567|P1|NOT COMPLETED|Overall Study||49
1484266|NCT01802333|3630565|P3|COMPLETED|Overall Study||161
1484267|NCT01802333|3630566|P2|COMPLETED|Overall Study||206
1484268|NCT01802333|3630567|P1|COMPLETED|Overall Study||214
1484269|NCT01802333|3630565|P3|Known Cytogenetic Risk at Baseline|Overall Study||210
1484270|NCT01802333|3630566|P2|Known Cytogenetic Risk at Baseline|Overall Study||250
1484271|NCT01802333|3630567|P1|Known Cytogenetic Risk at Baseline|Overall Study||252
1484272|NCT01802333|3630565|P3|Known NPM1 Status at Baseline|Overall Study||142
1484273|NCT01802333|3630566|P2|Known NPM1 Status at Baseline|Overall Study||156
1484274|NCT01802333|3630567|P1|Known NPM1 Status at Baseline|Overall Study||169
1484275|NCT01802333|3630565|P3|High Risk Patients Achieved CR/CRi|Overall Study||29
1484276|NCT01802333|3630566|P2|High Risk Patients Achieved CR/CRi|Overall Study||40
1484277|NCT01802333|3630567|P1|High Risk Patients Achieved CR/CRi|Overall Study||38
1484278|NCT01802333|3630565|P3|High Risk Patients|Overall Study||38
1484279|NCT01802333|3630566|P2|High Risk Patients|Overall Study||61
1484280|NCT01802333|3630567|P1|High Risk Patients|Overall Study||60
1484281|NCT01802333|3630565|P3|STARTED|Overall Study||224
1484282|NCT01802333|3630566|P2|STARTED|Overall Study||267
1484283|NCT01802333|3630567|P1|STARTED|Overall Study||263
1484284|NCT01802320|3630594|P1|NOT COMPLETED|Overall Study||2
1484285|NCT01802320|3630594|P1|COMPLETED|Overall Study||16
1484286|NCT01802320|3630594|P1|STARTED|Overall Study||18
1484287|NCT01802151|3630603|P4|NOT COMPLETED|Overall Study||0
1484288|NCT01802151|3630604|P3|NOT COMPLETED|Overall Study||2
1484289|NCT01802151|3630605|P2|NOT COMPLETED|Overall Study||0
1484290|NCT01802151|3630606|P1|NOT COMPLETED|Overall Study||0
1484291|NCT01802151|3630603|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
1484292|NCT01802151|3630604|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
1484293|NCT01802151|3630605|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
1484294|NCT01802151|3630606|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
1484295|NCT01802151|3630603|P4|STARTED|Overall Study||20
1484296|NCT01802151|3630604|P3|STARTED|Overall Study||22
1484297|NCT01802151|3630605|P2|STARTED|Overall Study||21
1484298|NCT01802151|3630606|P1|STARTED|Overall Study||20
1484299|NCT01802073|3630670|P2|NOT COMPLETED|Overall Study||11
1484300|NCT01802073|3630671|P1|NOT COMPLETED|Overall Study||5
1484301|NCT01802073|3630670|P2|COMPLETED|Overall Study||9
1484302|NCT01802073|3630671|P1|COMPLETED|Overall Study||9
1484303|NCT01802073|3630670|P2|STARTED|Overall Study||20
1484304|NCT01802073|3630671|P1|STARTED|Overall Study||14
1484305|NCT01801982|3630687|P1|NOT COMPLETED|Overall Study||1
1484306|NCT01801982|3630687|P1|COMPLETED|Overall Study||0
1484307|NCT01801982|3630687|P1|STARTED|Overall Study||1
1484308|NCT01801917|3630701|P4|NOT COMPLETED|Extension - All Active||0
1484309|NCT01801917|3630702|P3|NOT COMPLETED|Extension - All Active||0
1484310|NCT01801917|3630703|P2|NOT COMPLETED|Extension - All Active||0
1484311|NCT01801917|3630704|P1|NOT COMPLETED|Extension - All Active||0
1484312|NCT01801917|3630701|P4|COMPLETED|Extension - All Active||0
1484313|NCT01801917|3630702|P3|COMPLETED|Extension - All Active||3
1484314|NCT01801917|3630703|P2|COMPLETED|Extension - All Active||0
1484315|NCT01801917|3630704|P1|COMPLETED|Extension - All Active||6
1484316|NCT01801917|3630701|P4|STARTED|Extension - All Active||0
1484317|NCT01801917|3630702|P3|STARTED|Extension - All Active||3
1484318|NCT01801917|3630703|P2|STARTED|Extension - All Active||0
1484319|NCT01801917|3630704|P1|STARTED|Extension - All Active||6
1484320|NCT01801917|3630701|P4|NOT COMPLETED|Period 1 - Randomized||0
1484321|NCT01801917|3630702|P3|NOT COMPLETED|Period 1 - Randomized||1
1484322|NCT01801917|3630703|P2|NOT COMPLETED|Period 1 - Randomized||0
1484323|NCT01801917|3630704|P1|NOT COMPLETED|Period 1 - Randomized||1
1484324|NCT01801917|3630701|P4|COMPLETED|Period 1 - Randomized||1
1484325|NCT01801917|3630702|P3|COMPLETED|Period 1 - Randomized||3
1484326|NCT01801917|3630703|P2|COMPLETED|Period 1 - Randomized||2
1484327|NCT01801917|3630704|P1|COMPLETED|Period 1 - Randomized||6
1484328|NCT01801917|3630701|P4|STARTED|Period 1 - Randomized||1
1484329|NCT01801917|3630702|P3|STARTED|Period 1 - Randomized||4
1484330|NCT01801917|3630703|P2|STARTED|Period 1 - Randomized||2
1484331|NCT01801917|3630704|P1|STARTED|Period 1 - Randomized||7
1484332|NCT01801735|3630724|P1|NOT COMPLETED|Overall Study||210
1484333|NCT01801735|3630724|P1|COMPLETED|Overall Study||390
1484334|NCT01801735|3630724|P1|STARTED|Overall Study||600
1484335|NCT01801475|3630731|P5|NOT COMPLETED|Overall Study||1
1484336|NCT01801475|3630732|P4|NOT COMPLETED|Overall Study||0
1484337|NCT01801475|3630733|P3|NOT COMPLETED|Overall Study||0
1484338|NCT01801475|3630734|P2|NOT COMPLETED|Overall Study||0
1484339|NCT01801475|3630735|P1|NOT COMPLETED|Overall Study||0
1484340|NCT01801475|3630731|P5|COMPLETED|Overall Study||39
1484341|NCT01801475|3630732|P4|COMPLETED|Overall Study||10
1484342|NCT01801475|3630733|P3|COMPLETED|Overall Study||10
1484343|NCT01801475|3630734|P2|COMPLETED|Overall Study||30
1484344|NCT01801475|3630735|P1|COMPLETED|Overall Study||10
1484345|NCT01801475|3630731|P5|STARTED|Overall Study||40
1484346|NCT01801475|3630732|P4|STARTED|Overall Study||10
1484347|NCT01801475|3630733|P3|STARTED|Overall Study||10
1484348|NCT01801475|3630734|P2|STARTED|Overall Study||30
1484349|NCT01801475|3630735|P1|STARTED|Overall Study||10
1484350|NCT01801449|3630746|P1|NOT COMPLETED|Overall Study||0
1484351|NCT01801449|3630746|P1|COMPLETED|Overall Study||6
1484352|NCT01801449|3630746|P1|STARTED|Overall Study||6
1484353|NCT01801436|3630760|P1|NOT COMPLETED|Overall Study||9
1484354|NCT01801436|3630760|P1|COMPLETED|Overall Study||5
1484355|NCT01801436|3630760|P1|STARTED|Overall Study||14
1484356|NCT01801358|3630798|P6|NOT COMPLETED|Overall Study||8
1484357|NCT01801358|3630799|P5|NOT COMPLETED|Overall Study||6
1484358|NCT01801358|3630800|P4|NOT COMPLETED|Overall Study||6
1484359|NCT01801358|3630801|P3|NOT COMPLETED|Overall Study||6
1484360|NCT01801358|3630802|P2|NOT COMPLETED|Overall Study||6
1484361|NCT01801358|3630803|P1|NOT COMPLETED|Overall Study||6
1484362|NCT01801358|3630798|P6|COMPLETED|Overall Study||0
1484363|NCT01801358|3630799|P5|COMPLETED|Overall Study||0
1484364|NCT01801358|3630800|P4|COMPLETED|Overall Study||0
1484365|NCT01801358|3630801|P3|COMPLETED|Overall Study||0
1484366|NCT01801358|3630802|P2|COMPLETED|Overall Study||0
1484367|NCT01801358|3630803|P1|COMPLETED|Overall Study||0
1484368|NCT01801358|3630798|P6|STARTED|Overall Study||8
1484369|NCT01801358|3630799|P5|STARTED|Overall Study||6
1484370|NCT01801358|3630800|P4|STARTED|Overall Study||6
1484371|NCT01801358|3630801|P3|STARTED|Overall Study||6
1484372|NCT01801358|3630802|P2|STARTED|Overall Study||6
1484373|NCT01801358|3630803|P1|STARTED|Overall Study||6
1484374|NCT01801280|3630925|P4|NOT COMPLETED|Period 4||0
1484375|NCT01801280|3630926|P3|NOT COMPLETED|Period 4||1
1484376|NCT01801280|3630927|P2|NOT COMPLETED|Period 4||0
1484377|NCT01801280|3630928|P1|NOT COMPLETED|Period 4||0
1484378|NCT01801280|3630925|P4|COMPLETED|Period 4||5
1484379|NCT01801280|3630926|P3|COMPLETED|Period 4||4
1484380|NCT01801280|3630927|P2|COMPLETED|Period 4||4
1484381|NCT01801280|3630928|P1|COMPLETED|Period 4||4
1484382|NCT01801280|3630925|P4|STARTED|Period 4||5
1484383|NCT01801280|3630926|P3|STARTED|Period 4||5
1484384|NCT01801280|3630927|P2|STARTED|Period 4||4
1484385|NCT01801280|3630928|P1|STARTED|Period 4||4
1484386|NCT01801280|3630925|P4|NOT COMPLETED|Period 3||0
1484387|NCT01801280|3630926|P3|NOT COMPLETED|Period 3||0
1484388|NCT01801280|3630927|P2|NOT COMPLETED|Period 3||0
1484389|NCT01801280|3630928|P1|NOT COMPLETED|Period 3||0
1484390|NCT01801280|3630925|P4|COMPLETED|Period 3||5
1484391|NCT01801280|3630926|P3|COMPLETED|Period 3||5
1484392|NCT01801280|3630927|P2|COMPLETED|Period 3||4
1484393|NCT01801280|3630928|P1|COMPLETED|Period 3||4
1484394|NCT01801280|3630925|P4|STARTED|Period 3||5
1484395|NCT01801280|3630926|P3|STARTED|Period 3||5
1484396|NCT01801280|3630927|P2|STARTED|Period 3||4
1484397|NCT01801280|3630928|P1|STARTED|Period 3||4
1484398|NCT01801280|3630925|P4|NOT COMPLETED|Period 2||0
1484399|NCT01801280|3630926|P3|NOT COMPLETED|Period 2||0
1484400|NCT01801280|3630927|P2|NOT COMPLETED|Period 2||0
1484401|NCT01801280|3630928|P1|NOT COMPLETED|Period 2||1
1484402|NCT01801280|3630925|P4|COMPLETED|Period 2||5
1484403|NCT01801280|3630926|P3|COMPLETED|Period 2||5
1484404|NCT01801280|3630927|P2|COMPLETED|Period 2||4
1484405|NCT01801280|3630928|P1|COMPLETED|Period 2||4
1484406|NCT01801280|3630925|P4|STARTED|Period 2||5
1484407|NCT01801280|3630926|P3|STARTED|Period 2||5
1484408|NCT01801280|3630927|P2|STARTED|Period 2||4
1484409|NCT01801280|3630928|P1|STARTED|Period 2||5
1484410|NCT01801280|3630925|P4|NOT COMPLETED|Period 1||0
1484411|NCT01801280|3630926|P3|NOT COMPLETED|Period 1||0
1484412|NCT01801280|3630927|P2|NOT COMPLETED|Period 1||1
1484413|NCT01801280|3630928|P1|NOT COMPLETED|Period 1||0
1484414|NCT01801280|3630925|P4|COMPLETED|Period 1||5
1484415|NCT01801280|3630926|P3|COMPLETED|Period 1||5
1484416|NCT01801280|3630927|P2|COMPLETED|Period 1||4
1484417|NCT01801280|3630928|P1|COMPLETED|Period 1||5
1484418|NCT01801280|3630925|P4|STARTED|Period 1||5
1484419|NCT01801280|3630926|P3|STARTED|Period 1||5
1484420|NCT01801280|3630927|P2|STARTED|Period 1||5
1484421|NCT01801280|3630928|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
1484422|NCT01801124|3630938|P1|NOT COMPLETED|Overall Study||0
1484423|NCT01801124|3630938|P1|COMPLETED|Overall Study||13
1484424|NCT01801124|3630938|P1|STARTED|Overall Study||13
1484425|NCT01801111|3630943|P1|NOT COMPLETED|Overall Study||138
1484426|NCT01801111|3630943|P1|COMPLETED|Overall Study||0
1484427|NCT01801111|3630943|P1|STARTED|Overall Study||138
1484428|NCT01800968|3630984|P2|NOT COMPLETED|Overall Study||32
1484429|NCT01800968|3630985|P1|NOT COMPLETED|Overall Study||36
1484430|NCT01800968|3630984|P2|COMPLETED|Overall Study||114
1484431|NCT01800968|3630985|P1|COMPLETED|Overall Study||118
1484432|NCT01800968|3630984|P2|STARTED|Overall Study||146
1484433|NCT01800968|3630985|P1|STARTED|Overall Study||154
1484434|NCT01800916|3631027|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
1484435|NCT01800916|3631028|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
1484436|NCT01800916|3631029|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
1484437|NCT01800916|3631030|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
1484438|NCT01800916|3631031|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
1484439|NCT01800916|3631032|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
1484440|NCT01800916|3631033|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
1484441|NCT01800916|3631034|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
1484442|NCT01800916|3631035|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
1484443|NCT01800916|3631027|P9|COMPLETED|Test Period 3 (1 Week)||7
1484444|NCT01800916|3631028|P8|COMPLETED|Test Period 3 (1 Week)||7
1484445|NCT01800916|3631029|P7|COMPLETED|Test Period 3 (1 Week)||7
1484446|NCT01800916|3631030|P6|COMPLETED|Test Period 3 (1 Week)||7
1484447|NCT01800916|3631031|P5|COMPLETED|Test Period 3 (1 Week)||7
1484448|NCT01800916|3631032|P4|COMPLETED|Test Period 3 (1 Week)||6
1484449|NCT01800916|3631033|P3|COMPLETED|Test Period 3 (1 Week)||7
1484450|NCT01800916|3631034|P2|COMPLETED|Test Period 3 (1 Week)||7
1484451|NCT01800916|3631035|P1|COMPLETED|Test Period 3 (1 Week)||7
1484452|NCT01800916|3631027|P9|STARTED|Test Period 3 (1 Week)||7
1484453|NCT01800916|3631028|P8|STARTED|Test Period 3 (1 Week)||7
1484454|NCT01800916|3631029|P7|STARTED|Test Period 3 (1 Week)||7
1484455|NCT01800916|3631030|P6|STARTED|Test Period 3 (1 Week)||7
1484456|NCT01800916|3631031|P5|STARTED|Test Period 3 (1 Week)||7
1484457|NCT01800916|3631032|P4|STARTED|Test Period 3 (1 Week)||6
1484458|NCT01800916|3631033|P3|STARTED|Test Period 3 (1 Week)||7
1484459|NCT01800916|3631034|P2|STARTED|Test Period 3 (1 Week)||7
1484460|NCT01800916|3631035|P1|STARTED|Test Period 3 (1 Week)||7
1484461|NCT01800916|3631027|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
1484462|NCT01800916|3631028|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
1484463|NCT01800916|3631029|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
1484464|NCT01800916|3631030|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
1484465|NCT01800916|3631031|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
1484466|NCT01800916|3631032|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
1484467|NCT01800916|3631033|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
1484468|NCT01800916|3631034|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
1484469|NCT01800916|3631035|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
1484470|NCT01800916|3631027|P9|COMPLETED|Test Period 2 (1 Week)||7
1484471|NCT01800916|3631028|P8|COMPLETED|Test Period 2 (1 Week)||7
1484472|NCT01800916|3631029|P7|COMPLETED|Test Period 2 (1 Week)||7
1484473|NCT01800916|3631030|P6|COMPLETED|Test Period 2 (1 Week)||7
1484474|NCT01800916|3631031|P5|COMPLETED|Test Period 2 (1 Week)||7
1484475|NCT01800916|3631032|P4|COMPLETED|Test Period 2 (1 Week)||6
1484476|NCT01800916|3631033|P3|COMPLETED|Test Period 2 (1 Week)||7
1484477|NCT01800916|3631034|P2|COMPLETED|Test Period 2 (1 Week)||7
1484478|NCT01800916|3631035|P1|COMPLETED|Test Period 2 (1 Week)||7
1484479|NCT01800916|3631027|P9|STARTED|Test Period 2 (1 Week)||7
1484480|NCT01800916|3631028|P8|STARTED|Test Period 2 (1 Week)||7
1484481|NCT01800916|3631029|P7|STARTED|Test Period 2 (1 Week)||7
1484482|NCT01800916|3631030|P6|STARTED|Test Period 2 (1 Week)||7
1484483|NCT01800916|3631031|P5|STARTED|Test Period 2 (1 Week)||7
1484484|NCT01800916|3631032|P4|STARTED|Test Period 2 (1 Week)||6
1484485|NCT01800916|3631033|P3|STARTED|Test Period 2 (1 Week)||7
1484486|NCT01800916|3631034|P2|STARTED|Test Period 2 (1 Week)||7
1484487|NCT01800916|3631035|P1|STARTED|Test Period 2 (1 Week)||7
1484488|NCT01800916|3631027|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
1484489|NCT01800916|3631028|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
1484490|NCT01800916|3631029|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
1484491|NCT01800916|3631030|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
1484492|NCT01800916|3631031|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
1484493|NCT01800916|3631032|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
1484494|NCT01800916|3631033|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
1484495|NCT01800916|3631034|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
1484496|NCT01800916|3631035|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
1484497|NCT01800916|3631027|P9|COMPLETED|Test Period 1 (1 Week)||7
1484498|NCT01800916|3631028|P8|COMPLETED|Test Period 1 (1 Week)||7
1484499|NCT01800916|3631029|P7|COMPLETED|Test Period 1 (1 Week)||7
1484500|NCT01800916|3631030|P6|COMPLETED|Test Period 1 (1 Week)||7
1484501|NCT01800916|3631031|P5|COMPLETED|Test Period 1 (1 Week)||7
1484502|NCT01800916|3631032|P4|COMPLETED|Test Period 1 (1 Week)||6
1484503|NCT01800916|3631033|P3|COMPLETED|Test Period 1 (1 Week)||7
1484504|NCT01800916|3631034|P2|COMPLETED|Test Period 1 (1 Week)||7
1484505|NCT01800916|3631035|P1|COMPLETED|Test Period 1 (1 Week)||7
1484506|NCT01800916|3631027|P9|STARTED|Test Period 1 (1 Week)||7
1484507|NCT01800916|3631028|P8|STARTED|Test Period 1 (1 Week)||7
1484508|NCT01800916|3631029|P7|STARTED|Test Period 1 (1 Week)||7
1484509|NCT01800916|3631030|P6|STARTED|Test Period 1 (1 Week)||7
1484510|NCT01800916|3631031|P5|STARTED|Test Period 1 (1 Week)||8
1484511|NCT01800916|3631032|P4|STARTED|Test Period 1 (1 Week)||7
1484512|NCT01800916|3631033|P3|STARTED|Test Period 1 (1 Week)||7
1484513|NCT01800916|3631034|P2|STARTED|Test Period 1 (1 Week)||7
1484514|NCT01800916|3631035|P1|STARTED|Test Period 1 (1 Week)||7
1484515|NCT01800903|3631045|P6|NOT COMPLETED|Third Test Period||0
1484516|NCT01800903|3631046|P5|NOT COMPLETED|Third Test Period||0
1484517|NCT01800903|3631047|P4|NOT COMPLETED|Third Test Period||0
1484518|NCT01800903|3631048|P3|NOT COMPLETED|Third Test Period||0
1484519|NCT01800903|3631049|P2|NOT COMPLETED|Third Test Period||0
1484520|NCT01800903|3631050|P1|NOT COMPLETED|Third Test Period||0
1484521|NCT01800903|3631045|P6|COMPLETED|Third Test Period||6
1484522|NCT01800903|3631046|P5|COMPLETED|Third Test Period||6
1484523|NCT01800903|3631047|P4|COMPLETED|Third Test Period||7
1484524|NCT01800903|3631048|P3|COMPLETED|Third Test Period||4
1484525|NCT01800903|3631049|P2|COMPLETED|Third Test Period||6
1484526|NCT01800903|3631050|P1|COMPLETED|Third Test Period||6
1484527|NCT01800903|3631045|P6|STARTED|Third Test Period||6
1484528|NCT01800903|3631046|P5|STARTED|Third Test Period||6
1484529|NCT01800903|3631047|P4|STARTED|Third Test Period||7
1484530|NCT01800903|3631048|P3|STARTED|Third Test Period||4
1484531|NCT01800903|3631049|P2|STARTED|Third Test Period||6
1484532|NCT01800903|3631050|P1|STARTED|Third Test Period||6
1484533|NCT01800903|3631045|P6|NOT COMPLETED|Second Test Period||0
1484534|NCT01800903|3631046|P5|NOT COMPLETED|Second Test Period||0
1484535|NCT01800903|3631047|P4|NOT COMPLETED|Second Test Period||0
1484536|NCT01800903|3631048|P3|NOT COMPLETED|Second Test Period||0
1484537|NCT01800903|3631049|P2|NOT COMPLETED|Second Test Period||0
1484538|NCT01800903|3631050|P1|NOT COMPLETED|Second Test Period||1
1484539|NCT01800903|3631045|P6|COMPLETED|Second Test Period||6
1484540|NCT01800903|3631046|P5|COMPLETED|Second Test Period||6
1484541|NCT01800903|3631047|P4|COMPLETED|Second Test Period||7
1484542|NCT01800903|3631048|P3|COMPLETED|Second Test Period||4
1484543|NCT01800903|3631049|P2|COMPLETED|Second Test Period||6
1484544|NCT01800903|3631050|P1|COMPLETED|Second Test Period||6
1484545|NCT01800903|3631045|P6|STARTED|Second Test Period||6
1484546|NCT01800903|3631046|P5|STARTED|Second Test Period||6
1484547|NCT01800903|3631047|P4|STARTED|Second Test Period||7
1484548|NCT01800903|3631048|P3|STARTED|Second Test Period||4
1484549|NCT01800903|3631049|P2|STARTED|Second Test Period||6
1484550|NCT01800903|3631050|P1|STARTED|Second Test Period||7
1484551|NCT01800903|3631045|P6|NOT COMPLETED|First Test Period||0
1484552|NCT01800903|3631046|P5|NOT COMPLETED|First Test Period||0
1484553|NCT01800903|3631047|P4|NOT COMPLETED|First Test Period||0
1484554|NCT01800903|3631048|P3|NOT COMPLETED|First Test Period||0
1484555|NCT01800903|3631049|P2|NOT COMPLETED|First Test Period||0
1484556|NCT01800903|3631050|P1|NOT COMPLETED|First Test Period||0
1484557|NCT01800903|3631045|P6|COMPLETED|First Test Period||6
1484558|NCT01800903|3631046|P5|COMPLETED|First Test Period||6
1484559|NCT01800903|3631047|P4|COMPLETED|First Test Period||7
1484560|NCT01800903|3631048|P3|COMPLETED|First Test Period||4
1484561|NCT01800903|3631049|P2|COMPLETED|First Test Period||6
1484562|NCT01800903|3631050|P1|COMPLETED|First Test Period||7
1484563|NCT01800903|3631045|P6|STARTED|First Test Period||6
1484564|NCT01800903|3631046|P5|STARTED|First Test Period||6
1484565|NCT01800903|3631047|P4|STARTED|First Test Period||7
1484566|NCT01800903|3631048|P3|STARTED|First Test Period||4
1484567|NCT01800903|3631049|P2|STARTED|First Test Period||6
1484568|NCT01800903|3631050|P1|STARTED|First Test Period||7
1484569|NCT01800890|3631056|P9|NOT COMPLETED|Test Period 3||0
1484570|NCT01800890|3631057|P8|NOT COMPLETED|Test Period 3||0
1484571|NCT01800890|3631058|P7|NOT COMPLETED|Test Period 3||0
1484572|NCT01800890|3631059|P6|NOT COMPLETED|Test Period 3||0
1484573|NCT01800890|3631060|P5|NOT COMPLETED|Test Period 3||0
1484574|NCT01800890|3631061|P4|NOT COMPLETED|Test Period 3||0
1484575|NCT01800890|3631062|P3|NOT COMPLETED|Test Period 3||0
1484576|NCT01800890|3631063|P2|NOT COMPLETED|Test Period 3||0
1484577|NCT01800890|3631064|P1|NOT COMPLETED|Test Period 3||0
1484578|NCT01800890|3631056|P9|COMPLETED|Test Period 3||3
1484579|NCT01800890|3631057|P8|COMPLETED|Test Period 3||3
1484580|NCT01800890|3631058|P7|COMPLETED|Test Period 3||3
1484581|NCT01800890|3631059|P6|COMPLETED|Test Period 3||4
1484582|NCT01800890|3631060|P5|COMPLETED|Test Period 3||4
1484583|NCT01800890|3631061|P4|COMPLETED|Test Period 3||2
1484584|NCT01800890|3631062|P3|COMPLETED|Test Period 3||3
1484585|NCT01800890|3631063|P2|COMPLETED|Test Period 3||3
1484586|NCT01800890|3631064|P1|COMPLETED|Test Period 3||3
1484587|NCT01800890|3631056|P9|STARTED|Test Period 3||3
1484588|NCT01800890|3631057|P8|STARTED|Test Period 3||3
1484589|NCT01800890|3631058|P7|STARTED|Test Period 3||3
1484590|NCT01800890|3631059|P6|STARTED|Test Period 3||4
1484591|NCT01800890|3631060|P5|STARTED|Test Period 3||4
1484592|NCT01800890|3631061|P4|STARTED|Test Period 3||2
1484593|NCT01800890|3631062|P3|STARTED|Test Period 3||3
1484594|NCT01800890|3631063|P2|STARTED|Test Period 3||3
1484595|NCT01800890|3631064|P1|STARTED|Test Period 3||3
1484596|NCT01800890|3631056|P9|NOT COMPLETED|Test Period 2||0
1484597|NCT01800890|3631057|P8|NOT COMPLETED|Test Period 2||0
1484598|NCT01800890|3631058|P7|NOT COMPLETED|Test Period 2||0
1484599|NCT01800890|3631059|P6|NOT COMPLETED|Test Period 2||0
1484600|NCT01800890|3631060|P5|NOT COMPLETED|Test Period 2||0
1484601|NCT01800890|3631061|P4|NOT COMPLETED|Test Period 2||0
1484602|NCT01800890|3631062|P3|NOT COMPLETED|Test Period 2||0
1484603|NCT01800890|3631063|P2|NOT COMPLETED|Test Period 2||0
1484604|NCT01800890|3631064|P1|NOT COMPLETED|Test Period 2||0
1484605|NCT01800890|3631056|P9|COMPLETED|Test Period 2||3
1484606|NCT01800890|3631057|P8|COMPLETED|Test Period 2||3
1484607|NCT01800890|3631058|P7|COMPLETED|Test Period 2||3
1484608|NCT01800890|3631059|P6|COMPLETED|Test Period 2||4
1484609|NCT01800890|3631060|P5|COMPLETED|Test Period 2||4
1484610|NCT01800890|3631061|P4|COMPLETED|Test Period 2||2
1484611|NCT01800890|3631062|P3|COMPLETED|Test Period 2||3
1484612|NCT01800890|3631063|P2|COMPLETED|Test Period 2||3
1484613|NCT01800890|3631064|P1|COMPLETED|Test Period 2||3
1484614|NCT01800890|3631056|P9|STARTED|Test Period 2||3
1484615|NCT01800890|3631057|P8|STARTED|Test Period 2||3
1484616|NCT01800890|3631058|P7|STARTED|Test Period 2||3
1484617|NCT01800890|3631059|P6|STARTED|Test Period 2||4
1484618|NCT01800890|3631060|P5|STARTED|Test Period 2||4
1484619|NCT01800890|3631061|P4|STARTED|Test Period 2||2
1484620|NCT01800890|3631062|P3|STARTED|Test Period 2||3
1484621|NCT01800890|3631063|P2|STARTED|Test Period 2||3
1484622|NCT01800890|3631064|P1|STARTED|Test Period 2||3
1484623|NCT01800890|3631056|P9|NOT COMPLETED|Test Period 1||0
1484624|NCT01800890|3631057|P8|NOT COMPLETED|Test Period 1||0
1484625|NCT01800890|3631058|P7|NOT COMPLETED|Test Period 1||0
1484626|NCT01800890|3631059|P6|NOT COMPLETED|Test Period 1||0
1484627|NCT01800890|3631060|P5|NOT COMPLETED|Test Period 1||0
1484628|NCT01800890|3631061|P4|NOT COMPLETED|Test Period 1||1
1484629|NCT01800890|3631062|P3|NOT COMPLETED|Test Period 1||0
1484630|NCT01800890|3631063|P2|NOT COMPLETED|Test Period 1||0
1484631|NCT01800890|3631064|P1|NOT COMPLETED|Test Period 1||0
1484632|NCT01800890|3631056|P9|COMPLETED|Test Period 1||3
1484633|NCT01800890|3631057|P8|COMPLETED|Test Period 1||3
1484634|NCT01800890|3631058|P7|COMPLETED|Test Period 1||3
1484635|NCT01800890|3631059|P6|COMPLETED|Test Period 1||4
1484636|NCT01800890|3631060|P5|COMPLETED|Test Period 1||4
1484637|NCT01800890|3631061|P4|COMPLETED|Test Period 1||2
1484638|NCT01800890|3631062|P3|COMPLETED|Test Period 1||3
1484639|NCT01800890|3631063|P2|COMPLETED|Test Period 1||3
1484640|NCT01800890|3631064|P1|COMPLETED|Test Period 1||3
1484641|NCT01800890|3631056|P9|STARTED|Test Period 1||3
1484642|NCT01800890|3631057|P8|STARTED|Test Period 1||3
1484643|NCT01800890|3631058|P7|STARTED|Test Period 1||3
1484644|NCT01800890|3631059|P6|STARTED|Test Period 1||4
1484645|NCT01800890|3631060|P5|STARTED|Test Period 1||4
1484646|NCT01800890|3631061|P4|STARTED|Test Period 1||3
1484647|NCT01800890|3631062|P3|STARTED|Test Period 1||3
1484648|NCT01800890|3631063|P2|STARTED|Test Period 1||3
1484649|NCT01800890|3631064|P1|STARTED|Test Period 1||3
1484650|NCT01800786|3631076|P2|NOT COMPLETED|Overall Study||1
1484651|NCT01800786|3631077|P1|NOT COMPLETED|Overall Study||2
1484652|NCT01800786|3631076|P2|COMPLETED|Overall Study||15
1484653|NCT01800786|3631077|P1|COMPLETED|Overall Study||15
1484654|NCT01800786|3631076|P2|STARTED|Overall Study||16
1484655|NCT01800786|3631077|P1|STARTED|Overall Study||17
1484656|NCT01800318|3631087|P4|NOT COMPLETED|Overall Study||1
1484657|NCT01800318|3631088|P3|NOT COMPLETED|Overall Study||1
1484658|NCT01800318|3631089|P2|NOT COMPLETED|Overall Study||5
1484659|NCT01800318|3631090|P1|NOT COMPLETED|Overall Study||2
1484660|NCT01800318|3631087|P4|COMPLETED|Overall Study||39
1484661|NCT01800318|3631088|P3|COMPLETED|Overall Study||40
1484662|NCT01800318|3631089|P2|COMPLETED|Overall Study||37
1484663|NCT01800318|3631090|P1|COMPLETED|Overall Study||37
1484664|NCT01800318|3631087|P4|STARTED|Overall Study||40
1484665|NCT01800318|3631088|P3|STARTED|Overall Study||41
1484666|NCT01800318|3631089|P2|STARTED|Overall Study||42
1484667|NCT01800318|3631090|P1|STARTED|Overall Study||39
1484668|NCT01800162|3631119|P3|NOT COMPLETED|Overall Study||0
1484669|NCT01800162|3631120|P2|NOT COMPLETED|Overall Study||0
1484670|NCT01800162|3631121|P1|NOT COMPLETED|Overall Study||0
1484671|NCT01800162|3631119|P3|COMPLETED|Overall Study||1
1484672|NCT01800162|3631120|P2|COMPLETED|Overall Study||0
1484673|NCT01800162|3631121|P1|COMPLETED|Overall Study||1
1484674|NCT01800162|3631119|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
1484675|NCT01800162|3631120|P2|STARTED|Overall Study||0
1484676|NCT01800162|3631121|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
1484677|NCT01799993|3631147|P2|NOT COMPLETED|Overall Study||128
1484678|NCT01799993|3631148|P1|NOT COMPLETED|Overall Study||133
1484679|NCT01799993|3631147|P2|COMPLETED|Overall Study||235
1484680|NCT01799993|3631148|P1|COMPLETED|Overall Study||229
1484681|NCT01799993|3631147|P2|mITT Population|Overall Study||253
1484682|NCT01799993|3631148|P1|mITT Population|Overall Study||255
1484683|NCT01799993|3631147|P2|ITT Population|Overall Study||358
1484684|NCT01799993|3631148|P1|ITT Population|Overall Study||354
1484685|NCT01799993|3631147|P2|STARTED|Overall Study||363
1484686|NCT01799993|3631148|P1|STARTED|Overall Study||362
1484687|NCT01799941|3631180|P1|NOT COMPLETED|Overall Study||96
1484688|NCT01799941|3631180|P1|COMPLETED|Overall Study||271
1484689|NCT01799941|3631180|P1|STARTED|Overall Study||367
1484690|NCT01799720|3631237|P3|NOT COMPLETED|Overall Study||1
1484691|NCT01799720|3631238|P2|NOT COMPLETED|Overall Study||1
1484692|NCT01799720|3631239|P1|NOT COMPLETED|Overall Study||3
1484693|NCT01799720|3631237|P3|COMPLETED|Overall Study||18
1484694|NCT01799720|3631238|P2|COMPLETED|Overall Study||17
1484695|NCT01799720|3631239|P1|COMPLETED|Overall Study||17
1484696|NCT01799720|3631237|P3|Began the Treatment and Finished it|Overall Study||18
1484697|NCT01799720|3631238|P2|Began the Treatment and Finished it|Overall Study||17
1484698|NCT01799720|3631239|P1|Began the Treatment and Finished it|Overall Study||17
1484699|NCT01799720|3631237|P3|Began the Treatment|Overall Study||19
1484700|NCT01799720|3631238|P2|Began the Treatment|Overall Study||18
1484701|NCT01799720|3631239|P1|Began the Treatment|Overall Study||20
1484702|NCT01799720|3631237|P3|STARTED|Overall Study||19
1484703|NCT01799720|3631238|P2|STARTED|Overall Study||18
1484704|NCT01799720|3631239|P1|STARTED|Overall Study||20
1484705|NCT01799590|3631277|P3|NOT COMPLETED|Overall Study||14
1484706|NCT01799590|3631278|P2|NOT COMPLETED|Overall Study||16
1484707|NCT01799590|3631279|P1|NOT COMPLETED|Overall Study||26
1484708|NCT01799590|3631277|P3|COMPLETED|Overall Study||77
1484709|NCT01799590|3631278|P2|COMPLETED|Overall Study||78
1484710|NCT01799590|3631279|P1|COMPLETED|Overall Study||85
1484711|NCT01799590|3631277|P3|STARTED|Overall Study||91
1484712|NCT01799590|3631278|P2|STARTED|Overall Study||94
1484713|NCT01799590|3631279|P1|STARTED|Overall Study||111
1484714|NCT01799278|3631314|P1|NOT COMPLETED|Overall Study||0
1484715|NCT01799278|3631314|P1|COMPLETED|Overall Study||60
1484716|NCT01799278|3631314|P1|STARTED|Overall Study||60
1484717|NCT01799239|3631322|P2|NOT COMPLETED|Period 2 (7 Days)||1
1484718|NCT01799239|3631323|P1|NOT COMPLETED|Period 2 (7 Days)||2
1484719|NCT01799239|3631322|P2|COMPLETED|Period 2 (7 Days)||14
1484720|NCT01799239|3631323|P1|COMPLETED|Period 2 (7 Days)||11
1484721|NCT01799239|3631322|P2|STARTED|Period 2 (7 Days)||15
1484722|NCT01799239|3631323|P1|STARTED|Period 2 (7 Days)||13
1484723|NCT01799239|3631322|P2|NOT COMPLETED|Period 1 (7 Days)||1
1484724|NCT01799239|3631323|P1|NOT COMPLETED|Period 1 (7 Days)||3
1484725|NCT01799239|3631322|P2|COMPLETED|Period 1 (7 Days)||15
1484726|NCT01799239|3631323|P1|COMPLETED|Period 1 (7 Days)||12
1484727|NCT01799239|3631322|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
1484728|NCT01799239|3631323|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
1484729|NCT01799226|3631331|P2|NOT COMPLETED|Overall Study||0
1484730|NCT01799226|3631332|P1|NOT COMPLETED|Overall Study||2
1484731|NCT01799226|3631331|P2|COMPLETED|Overall Study||16
1484732|NCT01799226|3631332|P1|COMPLETED|Overall Study||14
1484733|NCT01799226|3631331|P2|Left Stent Side|Overall Study||8
1484734|NCT01799226|3631332|P1|Left Stent Side|Overall Study||8
1484735|NCT01799226|3631331|P2|Right Stent Side|Overall Study||8
1484736|NCT01799226|3631332|P1|Right Stent Side|Overall Study||8
1484737|NCT01799226|3631331|P2|STARTED|Overall Study||16
1484738|NCT01799226|3631332|P1|STARTED|Overall Study||16
1484739|NCT01798992|3631344|P4|NOT COMPLETED|Overall Study||1
1484740|NCT01798992|3631345|P3|NOT COMPLETED|Overall Study||2
1484741|NCT01798992|3631346|P2|NOT COMPLETED|Overall Study||2
1484742|NCT01798992|3631347|P1|NOT COMPLETED|Overall Study||0
1484743|NCT01798992|3631344|P4|COMPLETED|Overall Study||16
1484744|NCT01798992|3631345|P3|COMPLETED|Overall Study||14
1484745|NCT01798992|3631346|P2|COMPLETED|Overall Study||17
1484746|NCT01798992|3631347|P1|COMPLETED|Overall Study||4
1484747|NCT01798992|3631344|P4|STARTED|Overall Study||17
1484748|NCT01798992|3631345|P3|STARTED|Overall Study||16
1484749|NCT01798992|3631346|P2|STARTED|Overall Study||19
1484750|NCT01798992|3631347|P1|STARTED|Overall Study||4
1484751|NCT01798966|3631361|P1|NOT COMPLETED|Overall Study||0
1484752|NCT01798966|3631361|P1|COMPLETED|Overall Study||10
1484753|NCT01798966|3631361|P1|STARTED|Overall Study||10
1484754|NCT01798927|3631367|P1|NOT COMPLETED|Overall Study||1
1484755|NCT01798927|3631367|P1|COMPLETED|Overall Study||3
1484756|NCT01798927|3631367|P1|STARTED|Overall Study||4
1484757|NCT01798706|3631375|P2|NOT COMPLETED|Overall Study||21
1484758|NCT01798706|3631376|P1|NOT COMPLETED|Overall Study||21
1484759|NCT01798706|3631375|P2|COMPLETED|Overall Study||153
1484760|NCT01798706|3631376|P1|COMPLETED|Overall Study||155
1484761|NCT01798706|3631375|P2|STARTED|Overall Study||174
1484762|NCT01798706|3631376|P1|STARTED|Overall Study||176
1484763|NCT01798641|3631404|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1484764|NCT01798641|3631405|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1484765|NCT01798641|3631404|P2|COMPLETED|Second Intervention (6 Weeks)||19
1484766|NCT01798641|3631405|P1|COMPLETED|Second Intervention (6 Weeks)||19
1484767|NCT01798641|3631404|P2|STARTED|Second Intervention (6 Weeks)||19
1484768|NCT01798641|3631405|P1|STARTED|Second Intervention (6 Weeks)||19
1484769|NCT01798641|3631404|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
1484770|NCT01798641|3631405|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
1484771|NCT01798641|3631404|P2|COMPLETED|First Intervention (6 Weeks)||19
1484772|NCT01798641|3631405|P1|COMPLETED|First Intervention (6 Weeks)||19
1484773|NCT01798641|3631404|P2|STARTED|First Intervention (6 Weeks)||19
1484774|NCT01798641|3631405|P1|STARTED|First Intervention (6 Weeks)||19
1484775|NCT01798550|3631421|P2|NOT COMPLETED|Overall Study||6
1484776|NCT01798550|3631422|P1|NOT COMPLETED|Overall Study||2
1484777|NCT01798550|3631421|P2|COMPLETED|Overall Study||26
1484778|NCT01798550|3631422|P1|COMPLETED|Overall Study||28
1484779|NCT01798550|3631421|P2|STARTED|Overall Study||32
1484780|NCT01798550|3631422|P1|STARTED|Overall Study||30
1484781|NCT01798485|3631438|P2|NOT COMPLETED|Overall Study||290
1484782|NCT01798485|3631439|P1|NOT COMPLETED|Overall Study||346
1484783|NCT01798485|3631438|P2|COMPLETED|Overall Study||59
1484784|NCT01798485|3631439|P1|COMPLETED|Overall Study||1
1484785|NCT01798485|3631438|P2|Randomized as of 19 October 2015|Overall Study||337
1484786|NCT01798485|3631439|P1|Randomized as of 19 October 2015|Overall Study||335
1484787|NCT01798485|3631438|P2|Safety Population as of 23 Dec 2015|Overall Study||342
1484788|NCT01798485|3631439|P1|Safety Population as of 23 Dec 2015|Overall Study||338
1484789|NCT01798485|3631438|P2|STARTED|Overall Study||349
1484790|NCT01798485|3631439|P1|STARTED|Overall Study||347
1484791|NCT01798394|3631475|P2|NOT COMPLETED|Overall Study||3
1484792|NCT01798394|3631476|P1|NOT COMPLETED|Overall Study||3
1484793|NCT01798394|3631475|P2|COMPLETED|Overall Study||19
1484794|NCT01798394|3631476|P1|COMPLETED|Overall Study||21
1484795|NCT01798394|3631475|P2|STARTED|Overall Study||22
1484796|NCT01798394|3631476|P1|STARTED|Overall Study||24
1484797|NCT01798316|3631496|P2|NOT COMPLETED|Overall Study||0
1484798|NCT01798316|3631497|P1|NOT COMPLETED|Overall Study||0
1484799|NCT01798316|3631496|P2|COMPLETED|Overall Study||53
1484800|NCT01798316|3631497|P1|COMPLETED|Overall Study||52
1484801|NCT01798316|3631496|P2|STARTED|Overall Study||53
1484802|NCT01798316|3631497|P1|STARTED|Overall Study||52
1484803|NCT01798264|3631519|P4|NOT COMPLETED|Overall Study||4
1484804|NCT01798264|3631520|P3|NOT COMPLETED|Overall Study||0
1484805|NCT01798264|3631521|P2|NOT COMPLETED|Overall Study||0
1484806|NCT01798264|3631522|P1|NOT COMPLETED|Overall Study||1
1484807|NCT01798264|3631519|P4|COMPLETED|Overall Study||7
1484808|NCT01798264|3631520|P3|COMPLETED|Overall Study||10
1484809|NCT01798264|3631521|P2|COMPLETED|Overall Study||11
1484810|NCT01798264|3631522|P1|COMPLETED|Overall Study||11
1484811|NCT01798264|3631519|P4|STARTED|Overall Study||11
1484812|NCT01798264|3631520|P3|STARTED|Overall Study||10
1484813|NCT01798264|3631521|P2|STARTED|Overall Study||11
1484814|NCT01798264|3631522|P1|STARTED|Overall Study||12
1484815|NCT01798225|3631546|P2|NOT COMPLETED|Overall Study||3
1484816|NCT01798225|3631547|P1|NOT COMPLETED|Overall Study||0
1484817|NCT01798225|3631546|P2|COMPLETED|Overall Study||53
1484818|NCT01798225|3631547|P1|COMPLETED|Overall Study||57
1484819|NCT01798225|3631546|P2|STARTED|Overall Study||56
1484820|NCT01798225|3631547|P1|STARTED|Overall Study||57
1484821|NCT01798186|3631559|P4|NOT COMPLETED|Overall Study||0
1484822|NCT01798186|3631560|P3|NOT COMPLETED|Overall Study||0
1484823|NCT01798186|3631561|P2|NOT COMPLETED|Overall Study||0
1484824|NCT01798186|3631562|P1|NOT COMPLETED|Overall Study||0
1484825|NCT01798186|3631559|P4|COMPLETED|Overall Study||8
1484826|NCT01798186|3631560|P3|COMPLETED|Overall Study||6
1484827|NCT01798186|3631561|P2|COMPLETED|Overall Study||6
1484828|NCT01798186|3631562|P1|COMPLETED|Overall Study||6
1484829|NCT01798186|3631559|P4|STARTED|Overall Study||8
1484830|NCT01798186|3631560|P3|STARTED|Overall Study||6
1484831|NCT01798186|3631561|P2|STARTED|Overall Study||6
1484832|NCT01798186|3631562|P1|STARTED|Overall Study||6
1484833|NCT01798134|3631576|P1|NOT COMPLETED|Overall Study||16
1484834|NCT01798134|3631576|P1|COMPLETED|Overall Study||9
1484835|NCT01798134|3631576|P1|STARTED|Overall Study||25
1484836|NCT01798056|3631585|P2|NOT COMPLETED|Overall Study||25
1484837|NCT01798056|3631586|P1|NOT COMPLETED|Overall Study||27
1484838|NCT01798056|3631585|P2|COMPLETED|Overall Study||90
1484839|NCT01798056|3631586|P1|COMPLETED|Overall Study||90
1484840|NCT01798056|3631585|P2|STARTED|Overall Study||115
1484841|NCT01798056|3631586|P1|STARTED|Overall Study||117
1484842|NCT01798004|3631620|P1|NOT COMPLETED|Overall Study||87
1484843|NCT01798004|3631620|P1|COMPLETED|Overall Study||63
1484844|NCT01798004|3631620|P1|STARTED|Overall Study||150
1484845|NCT01797783|3631626|P2|NOT COMPLETED|Overall Study||1
1484846|NCT01797783|3631627|P1|NOT COMPLETED|Overall Study||2
1484847|NCT01797783|3631626|P2|COMPLETED|Overall Study||26
1484848|NCT01797783|3631627|P1|COMPLETED|Overall Study||50
1484849|NCT01797783|3631626|P2|STARTED|Overall Study||27
1484850|NCT01797783|3631627|P1|STARTED|Overall Study||52
1484851|NCT01797731|3631651|P2|NOT COMPLETED|Overall Study||3
1484852|NCT01797731|3631652|P1|NOT COMPLETED|Overall Study||3
1484853|NCT01797731|3631651|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
1484854|NCT01797731|3631652|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
1484855|NCT01797731|3631651|P2|STARTED|Overall Study||50
1484856|NCT01797731|3631652|P1|STARTED|Overall Study||50
1484857|NCT01797705|3631660|P1|NOT COMPLETED|Overall Study||5
1484858|NCT01797705|3631660|P1|COMPLETED|Overall Study||28
1484859|NCT01797705|3631660|P1|STARTED|Overall Study||33
1484860|NCT01797575|3631668|P4|NOT COMPLETED|Week 8 Re-Randomization||3
1484861|NCT01797575|3631669|P3|NOT COMPLETED|Week 8 Re-Randomization||1
1484862|NCT01797575|3631670|P2|NOT COMPLETED|Week 8 Re-Randomization||0
1484863|NCT01797575|3631671|P1|NOT COMPLETED|Week 8 Re-Randomization||0
1484864|NCT01797575|3631668|P4|COMPLETED|Week 8 Re-Randomization||7
1484865|NCT01797575|3631669|P3|COMPLETED|Week 8 Re-Randomization||4
1484866|NCT01797575|3631670|P2|COMPLETED|Week 8 Re-Randomization||5
1484867|NCT01797575|3631671|P1|COMPLETED|Week 8 Re-Randomization||4
1484868|NCT01797575|3631668|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
1484869|NCT01797575|3631669|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
1484870|NCT01797575|3631670|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
1484871|NCT01797575|3631671|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
1484872|NCT01797575|3631668|P4|NOT COMPLETED|Baseline Allocation||7
1484873|NCT01797575|3631669|P3|NOT COMPLETED|Baseline Allocation||5
1484874|NCT01797575|3631670|P2|NOT COMPLETED|Baseline Allocation||1
1484875|NCT01797575|3631671|P1|NOT COMPLETED|Baseline Allocation||1
1484876|NCT01797575|3631668|P4|COMPLETED|Baseline Allocation||8
1484877|NCT01797575|3631669|P3|COMPLETED|Baseline Allocation||4
1484878|NCT01797575|3631670|P2|COMPLETED|Baseline Allocation||8
1484879|NCT01797575|3631671|P1|COMPLETED|Baseline Allocation||4
1484880|NCT01797575|3631668|P4|STARTED|Baseline Allocation||15
1484881|NCT01797575|3631669|P3|STARTED|Baseline Allocation||9
1484882|NCT01797575|3631670|P2|STARTED|Baseline Allocation||9
1484883|NCT01797575|3631671|P1|STARTED|Baseline Allocation||5
1484884|NCT01797536|3631725|P4|NOT COMPLETED|Overall Study||0
1484885|NCT01797536|3631726|P3|NOT COMPLETED|Overall Study||0
1484886|NCT01797536|3631727|P2|NOT COMPLETED|Overall Study||1
1484887|NCT01797536|3631728|P1|NOT COMPLETED|Overall Study||0
1484888|NCT01797536|3631725|P4|COMPLETED|Overall Study||8
1484889|NCT01797536|3631726|P3|COMPLETED|Overall Study||7
1484890|NCT01797536|3631727|P2|COMPLETED|Overall Study||10
1484891|NCT01797536|3631728|P1|COMPLETED|Overall Study||8
1484892|NCT01797536|3631725|P4|STARTED|Overall Study||8
1484893|NCT01797536|3631726|P3|STARTED|Overall Study||7
1484894|NCT01797536|3631727|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
1484895|NCT01797536|3631728|P1|STARTED|Overall Study||8
1484896|NCT01797484|3631760|P2|NOT COMPLETED|Overall Study||0
1484897|NCT01797484|3631761|P1|NOT COMPLETED|Overall Study||0
1484898|NCT01797484|3631760|P2|COMPLETED|Overall Study||10
1484899|NCT01797484|3631761|P1|COMPLETED|Overall Study||10
1484900|NCT01797484|3631760|P2|STARTED|Overall Study||10
1484901|NCT01797484|3631761|P1|STARTED|Overall Study||10
1484902|NCT01797471|3631767|P1|NOT COMPLETED|Overall Study||0
1484903|NCT01797471|3631767|P1|COMPLETED|Overall Study||1
1484904|NCT01797471|3631767|P1|STARTED|Overall Study||1
1484905|NCT01797458|3631779|P3|NOT COMPLETED|Overall Study||7
1484906|NCT01797458|3631780|P2|NOT COMPLETED|Overall Study||9
1484907|NCT01797458|3631781|P1|NOT COMPLETED|Overall Study||12
1484908|NCT01797458|3631779|P3|COMPLETED|Overall Study||58
1484909|NCT01797458|3631780|P2|COMPLETED|Overall Study||43
1484910|NCT01797458|3631781|P1|COMPLETED|Overall Study||40
1484911|NCT01797458|3631779|P3|STARTED|Overall Study||65
1484912|NCT01797458|3631780|P2|STARTED|Overall Study||52
1484913|NCT01797458|3631781|P1|STARTED|Overall Study||52
1484914|NCT01797445|3631800|P2|NOT COMPLETED|Overall Study||437
1484915|NCT01797445|3631801|P1|NOT COMPLETED|Overall Study||435
1484916|NCT01797445|3631800|P2|COMPLETED|Overall Study||0
1484917|NCT01797445|3631801|P1|COMPLETED|Overall Study||0
1484918|NCT01797445|3631800|P2|STARTED|Overall Study||437
1484919|NCT01797445|3631801|P1|STARTED|Overall Study||435
1484920|NCT01797380|3631841|P2|NOT COMPLETED|Overall Study||2
1484921|NCT01797380|3631842|P1|NOT COMPLETED|Overall Study||3
1484922|NCT01797380|3631841|P2|COMPLETED|Overall Study||0
1484923|NCT01797380|3631842|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
1484924|NCT01797380|3631841|P2|STARTED|Overall Study||2
1484925|NCT01797380|3631842|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
1484926|NCT01797328|3631850|P2|NOT COMPLETED|Overall Study||0
1484927|NCT01797328|3631851|P1|NOT COMPLETED|Overall Study||2
1484928|NCT01797328|3631850|P2|COMPLETED|Overall Study||12
1484929|NCT01797328|3631851|P1|COMPLETED|Overall Study||14
1484930|NCT01797328|3631850|P2|STARTED|Overall Study||12
1484931|NCT01797328|3631851|P1|STARTED|Overall Study||16
1484932|NCT01797120|3631859|P2|NOT COMPLETED|Overall Study||65
1484933|NCT01797120|3631860|P1|NOT COMPLETED|Overall Study||66
1484934|NCT01797120|3631859|P2|COMPLETED|Overall Study||0
1484935|NCT01797120|3631860|P1|COMPLETED|Overall Study||0
1484936|NCT01797120|3631859|P2|STARTED|Overall Study||65
1484937|NCT01797120|3631860|P1|STARTED|Overall Study||66
1484938|NCT01797094|3631874|P2|NOT COMPLETED|Overall Study||2
1484939|NCT01797094|3631875|P1|NOT COMPLETED|Overall Study||6
1484940|NCT01797094|3631874|P2|COMPLETED|Overall Study||51
1484941|NCT01797094|3631875|P1|COMPLETED|Overall Study||42
1484942|NCT01797094|3631874|P2|STARTED|Overall Study||53
1484943|NCT01797094|3631875|P1|STARTED|Overall Study||48
1484944|NCT01797081|3631897|P4|NOT COMPLETED|Overall Study||9
1484945|NCT01797081|3631898|P3|NOT COMPLETED|Overall Study||5
1484946|NCT01797081|3631899|P2|NOT COMPLETED|Overall Study||4
1484947|NCT01797081|3631900|P1|NOT COMPLETED|Overall Study||14
1484948|NCT01797081|3631897|P4|COMPLETED|Overall Study||40
1484949|NCT01797081|3631898|P3|COMPLETED|Overall Study||43
1484950|NCT01797081|3631899|P2|COMPLETED|Overall Study||95
1484951|NCT01797081|3631900|P1|COMPLETED|Overall Study||90
1484952|NCT01797081|3631897|P4|STARTED|Overall Study||49
1484953|NCT01797081|3631898|P3|STARTED|Overall Study||48
1484954|NCT01797081|3631899|P2|STARTED|Overall Study||99
1484955|NCT01797081|3631900|P1|STARTED|Overall Study||104
1484956|NCT01797029|3631919|P2|NOT COMPLETED|Overall Study||61
1484957|NCT01797029|3631920|P1|NOT COMPLETED|Overall Study||159
1484958|NCT01797029|3631919|P2|COMPLETED|Overall Study||526
1484959|NCT01797029|3631920|P1|COMPLETED|Overall Study||1015
1484960|NCT01797029|3631919|P2|STARTED|Overall Study||587
1484961|NCT01797029|3631920|P1|STARTED|Overall Study||1174
1484962|NCT01796977|3631928|P1|NOT COMPLETED|Overall Study||0
1484963|NCT01796977|3631928|P1|COMPLETED|Overall Study||27
1484964|NCT01796977|3631928|P1|STARTED|Overall Study||27
1484965|NCT01796964|3631941|P2|NOT COMPLETED|Overall Study||3
1484966|NCT01796964|3631942|P1|NOT COMPLETED|Overall Study||3
1484967|NCT01796964|3631941|P2|COMPLETED|Overall Study||42
1484968|NCT01796964|3631942|P1|COMPLETED|Overall Study||41
1484969|NCT01796964|3631941|P2|STARTED|Overall Study||45
1484970|NCT01796964|3631942|P1|STARTED|Overall Study||44
1484971|NCT01796860|3631964|P1|NOT COMPLETED|Overall Study||3
1484972|NCT01796860|3631964|P1|COMPLETED|Overall Study||7
1484973|NCT01796860|3631964|P1|STARTED|Overall Study||10
1484974|NCT01796548|3631970|P1|NOT COMPLETED|Overall Study||3
1484975|NCT01796548|3631970|P1|COMPLETED|Overall Study||14
1484976|NCT01796548|3631970|P1|Treated|Overall Study||15
1484977|NCT01796548|3631970|P1|STARTED|Overall Study||17
1484978|NCT01796301|3631984|P2|NOT COMPLETED|Overall Study||20
1484979|NCT01796301|3631985|P1|NOT COMPLETED|Overall Study||18
1484980|NCT01796301|3631984|P2|COMPLETED|Overall Study||198
1484981|NCT01796301|3631985|P1|COMPLETED|Overall Study||200
1484982|NCT01796301|3631984|P2|Received Treatment|Overall Study||218
1484983|NCT01796301|3631985|P1|Received Treatment|Overall Study||214
1484984|NCT01796301|3631984|P2|STARTED|Overall Study||218
1484985|NCT01796301|3631985|P1|STARTED|Overall Study||218
1484986|NCT01796236|3632021|P2|NOT COMPLETED|Overall Study||2
1484987|NCT01796236|3632022|P1|NOT COMPLETED|Overall Study||2
1484988|NCT01796236|3632021|P2|COMPLETED|Overall Study||50
1484989|NCT01796236|3632022|P1|COMPLETED|Overall Study||49
1484990|NCT01796236|3632021|P2|STARTED|Overall Study||52
1484991|NCT01796236|3632022|P1|STARTED|Overall Study||51
1484992|NCT01795937|3632041|P3|NOT COMPLETED|Overall Study||0
1484993|NCT01795937|3632042|P2|NOT COMPLETED|Overall Study||1
1484994|NCT01795937|3632043|P1|NOT COMPLETED|Overall Study||1
1484995|NCT01795937|3632041|P3|COMPLETED|Overall Study||17
1484996|NCT01795937|3632042|P2|COMPLETED|Overall Study||15
1484997|NCT01795937|3632043|P1|COMPLETED|Overall Study||17
1484998|NCT01795937|3632041|P3|STARTED|Overall Study||17
1484999|NCT01795937|3632042|P2|STARTED|Overall Study||16
1485000|NCT01795937|3632043|P1|STARTED|Overall Study||18
1485001|NCT01795898|3632072|P1|NOT COMPLETED|Overall Study||60
1485002|NCT01795898|3632072|P1|COMPLETED|Overall Study||177
1485003|NCT01795898|3632072|P1|STARTED|Overall Study||237
1485004|NCT01795859|3632082|P2|NOT COMPLETED|Overall Study||2
1485005|NCT01795859|3632083|P1|NOT COMPLETED|Overall Study||1
1485006|NCT01795859|3632082|P2|COMPLETED|Overall Study||43
1485007|NCT01795859|3632083|P1|COMPLETED|Overall Study||44
1485008|NCT01795859|3632082|P2|STARTED|Overall Study||45
1485009|NCT01795859|3632083|P1|STARTED|Overall Study||45
1485010|NCT01795716|3632099|P2|NOT COMPLETED|Second Intervention (13 Days)||0
1485011|NCT01795716|3632100|P1|NOT COMPLETED|Second Intervention (13 Days)||0
1485012|NCT01795716|3632099|P2|COMPLETED|Second Intervention (13 Days)||11
1485013|NCT01795716|3632100|P1|COMPLETED|Second Intervention (13 Days)||10
1485014|NCT01795716|3632099|P2|STARTED|Second Intervention (13 Days)||11
1485015|NCT01795716|3632100|P1|STARTED|Second Intervention (13 Days)||10
1485016|NCT01795716|3632099|P2|NOT COMPLETED|Washout (10 Days)||0
1485017|NCT01795716|3632100|P1|NOT COMPLETED|Washout (10 Days)||0
1485018|NCT01795716|3632099|P2|COMPLETED|Washout (10 Days)||11
1485019|NCT01795716|3632100|P1|COMPLETED|Washout (10 Days)||10
1485020|NCT01795716|3632099|P2|STARTED|Washout (10 Days)||11
1485021|NCT01795716|3632100|P1|STARTED|Washout (10 Days)||10
1485022|NCT01795716|3632099|P2|NOT COMPLETED|First Intervention (13 Days)||0
1485023|NCT01795716|3632100|P1|NOT COMPLETED|First Intervention (13 Days)||0
1485024|NCT01795716|3632099|P2|COMPLETED|First Intervention (13 Days)||11
1485025|NCT01795716|3632100|P1|COMPLETED|First Intervention (13 Days)||10
1485026|NCT01795716|3632099|P2|STARTED|First Intervention (13 Days)||11
1485027|NCT01795716|3632100|P1|STARTED|First Intervention (13 Days)||10
1485028|NCT01795547|3632108|P2|NOT COMPLETED|Overall Study||64
1485029|NCT01795547|3632109|P1|NOT COMPLETED|Overall Study||48
1485030|NCT01795547|3632108|P2|COMPLETED|Overall Study||83
1485031|NCT01795547|3632109|P1|COMPLETED|Overall Study||100
1485032|NCT01795547|3632108|P2|STARTED|Overall Study||147
1485033|NCT01795547|3632109|P1|STARTED|Overall Study||148
1485034|NCT01795534|3632131|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
1485035|NCT01795534|3632132|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
1485036|NCT01795534|3632131|P2|COMPLETED|Second Intervention (Second Shot)||5
1485037|NCT01795534|3632132|P1|COMPLETED|Second Intervention (Second Shot)||5
1485038|NCT01795534|3632131|P2|STARTED|Second Intervention (Second Shot)||5
1485039|NCT01795534|3632132|P1|STARTED|Second Intervention (Second Shot)||5
1485040|NCT01795534|3632131|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
1485041|NCT01795534|3632132|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
1485042|NCT01795534|3632131|P2|COMPLETED|Wash Out Period (4 Days)||5
1485043|NCT01795534|3632132|P1|COMPLETED|Wash Out Period (4 Days)||5
1485044|NCT01795534|3632131|P2|STARTED|Wash Out Period (4 Days)||5
1485045|NCT01795534|3632132|P1|STARTED|Wash Out Period (4 Days)||5
1485046|NCT01795534|3632131|P2|NOT COMPLETED|First Intervention (First Shot)||0
1485047|NCT01795534|3632132|P1|NOT COMPLETED|First Intervention (First Shot)||0
1485048|NCT01795534|3632131|P2|COMPLETED|First Intervention (First Shot)||5
1485049|NCT01795534|3632132|P1|COMPLETED|First Intervention (First Shot)||5
1485050|NCT01795534|3632131|P2|STARTED|First Intervention (First Shot)||5
1485051|NCT01795534|3632132|P1|STARTED|First Intervention (First Shot)||5
1485052|NCT01795495|3632141|P3|NOT COMPLETED|Overall Study||2
1485053|NCT01795495|3632142|P2|NOT COMPLETED|Overall Study||0
1485054|NCT01795495|3632143|P1|NOT COMPLETED|Overall Study||1
1485055|NCT01795495|3632141|P3|COMPLETED|Overall Study||19
1485056|NCT01795495|3632142|P2|COMPLETED|Overall Study||22
1485057|NCT01795495|3632143|P1|COMPLETED|Overall Study||19
1485058|NCT01795495|3632141|P3|STARTED|Overall Study||21
1485059|NCT01795495|3632142|P2|STARTED|Overall Study||22
1485060|NCT01795495|3632143|P1|STARTED|Overall Study||20
1485061|NCT01794949|3632156|P2|NOT COMPLETED|Overall Study||0
1485062|NCT01794949|3632157|P1|NOT COMPLETED|Overall Study||1
1485063|NCT01794949|3632156|P2|COMPLETED|Overall Study||1
1485064|NCT01794949|3632157|P1|COMPLETED|Overall Study||6
1485065|NCT01794949|3632156|P2|6 Month Follow-up|Overall Study||1
1485066|NCT01794949|3632157|P1|6 Month Follow-up|Overall Study||6
1485067|NCT01794949|3632156|P2|STARTED|Overall Study||1
1485068|NCT01794949|3632157|P1|STARTED|Overall Study||7
1485069|NCT01794936|3632163|P1|NOT COMPLETED|Overall Study||0
1485070|NCT01794936|3632163|P1|COMPLETED|Overall Study||9
1485071|NCT01794936|3632163|P1|STARTED|Overall Study||9
1485072|NCT01794845|3632168|P1|NOT COMPLETED|Overall Study||1
1485073|NCT01794845|3632168|P1|COMPLETED|Overall Study||4
1485074|NCT01794845|3632168|P1|STARTED|Overall Study||5
1485075|NCT01794806|3632177|P2|NOT COMPLETED|Overall Study||1
1485076|NCT01794806|3632178|P1|NOT COMPLETED|Overall Study||5
1485077|NCT01794806|3632177|P2|COMPLETED|Overall Study||27
1485078|NCT01794806|3632178|P1|COMPLETED|Overall Study||26
1485079|NCT01794806|3632177|P2|4 Weeks|Overall Study||27
1485080|NCT01794806|3632178|P1|4 Weeks|Overall Study||26
1485081|NCT01794806|3632177|P2|1 Week|Overall Study||28
1485082|NCT01794806|3632178|P1|1 Week|Overall Study||28
1485083|NCT01794806|3632177|P2|STARTED|Overall Study||28
1485084|NCT01794806|3632178|P1|STARTED|Overall Study||31
1485085|NCT01794741|3632190|P2|NOT COMPLETED|Overall Study||9
1485086|NCT01794741|3632191|P1|NOT COMPLETED|Overall Study||19
1485087|NCT01794741|3632190|P2|COMPLETED|Overall Study||92
1485088|NCT01794741|3632191|P1|COMPLETED|Overall Study||285
1485089|NCT01794741|3632190|P2|STARTED|Overall Study||101
1485090|NCT01794741|3632191|P1|STARTED|Overall Study||304
1485091|NCT01794455|3632199|P2|NOT COMPLETED|Overall Study||0
1485092|NCT01794455|3632200|P1|NOT COMPLETED|Overall Study||0
1485093|NCT01794455|3632199|P2|COMPLETED|Overall Study||1
1485094|NCT01794455|3632200|P1|COMPLETED|Overall Study||0
1485095|NCT01794455|3632199|P2|STARTED|Overall Study||1
1485096|NCT01794455|3632200|P1|STARTED|Overall Study||0
1485097|NCT01794039|3632218|P2|NOT COMPLETED|Overall Study||0
1485098|NCT01794039|3632219|P1|NOT COMPLETED|Overall Study||0
1485099|NCT01794039|3632218|P2|COMPLETED|Overall Study||4
1485100|NCT01794039|3632219|P1|COMPLETED|Overall Study||5
1485101|NCT01794039|3632218|P2|STARTED|Overall Study||4
1485102|NCT01794039|3632219|P1|STARTED|Overall Study||5
1485103|NCT01794000|3632231|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
1485104|NCT01794000|3632232|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
1485105|NCT01794000|3632231|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
1485106|NCT01794000|3632232|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
1485107|NCT01794000|3632231|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
1485108|NCT01794000|3632232|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
1485109|NCT01794000|3632231|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
1485110|NCT01794000|3632232|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
1485111|NCT01794000|3632231|P2|COMPLETED|Double-Blind Phase (DBP)||4
1485112|NCT01794000|3632232|P1|COMPLETED|Double-Blind Phase (DBP)||2
1485113|NCT01794000|3632231|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
1485114|NCT01794000|3632232|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
1485115|NCT01794000|3632231|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
1485116|NCT01794000|3632232|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
1485117|NCT01794000|3632231|P2|STARTED|Double-Blind Phase (DBP)||170
1485118|NCT01794000|3632232|P1|STARTED|Double-Blind Phase (DBP)||171
1485119|NCT01793935|3632265|P2|NOT COMPLETED|Overall Study||3
1485120|NCT01793935|3632266|P1|NOT COMPLETED|Overall Study||6
1485121|NCT01793935|3632265|P2|COMPLETED|Overall Study||31
1485122|NCT01793935|3632266|P1|COMPLETED|Overall Study||28
1485123|NCT01793935|3632265|P2|STARTED|Overall Study||34
1485124|NCT01793935|3632266|P1|STARTED|Overall Study||34
1485125|NCT01793883|3632303|P3|NOT COMPLETED|Overall Study||8
1485126|NCT01793883|3632304|P2|NOT COMPLETED|Overall Study||10
1485127|NCT01793883|3632305|P1|NOT COMPLETED|Overall Study||12
1485128|NCT01793883|3632303|P3|COMPLETED|Overall Study||204
1485129|NCT01793883|3632304|P2|COMPLETED|Overall Study||204
1485130|NCT01793883|3632305|P1|COMPLETED|Overall Study||201
1485131|NCT01793883|3632303|P3|STARTED|Overall Study||212
1485132|NCT01793883|3632304|P2|STARTED|Overall Study||214
1485133|NCT01793883|3632305|P1|STARTED|Overall Study||213
1485134|NCT01793688|3632313|P1|NOT COMPLETED|Overall Study||2
1485135|NCT01793688|3632313|P1|COMPLETED|Overall Study||980
1485136|NCT01793688|3632313|P1|STARTED|Overall Study||982
1485137|NCT01793285|3632320|P1|NOT COMPLETED|Overall Study||0
1485138|NCT01793285|3632320|P1|COMPLETED|Overall Study||85
1485139|NCT01793285|3632320|P1|STARTED|Overall Study||85
1485140|NCT01793142|3632340|P1|NOT COMPLETED|Overall Study||7
1485141|NCT01793142|3632340|P1|COMPLETED|Overall Study||3423
1485142|NCT01793142|3632340|P1|Treated|Overall Study||3423
1485143|NCT01793142|3632340|P1|STARTED|Overall Study||3430
1485144|NCT01792986|3632351|P1|NOT COMPLETED|Overall Study||0
1485145|NCT01792986|3632351|P1|COMPLETED|Overall Study||12
1485146|NCT01792986|3632351|P1|STARTED|Overall Study||12
1485147|NCT01792830|3632370|P11|NOT COMPLETED|Overall Study||3
1485148|NCT01792830|3632371|P10|NOT COMPLETED|Overall Study||0
1485149|NCT01792830|3632372|P9|NOT COMPLETED|Overall Study||9
1485150|NCT01792830|3632373|P8|NOT COMPLETED|Overall Study||1
1485151|NCT01792830|3632374|P7|NOT COMPLETED|Overall Study||2
1485152|NCT01792830|3632375|P6|NOT COMPLETED|Overall Study||1
1485153|NCT01792830|3632376|P5|NOT COMPLETED|Overall Study||1
1485154|NCT01792830|3632377|P4|NOT COMPLETED|Overall Study||3
1485155|NCT01792830|3632378|P3|NOT COMPLETED|Overall Study||0
1485156|NCT01792830|3632379|P2|NOT COMPLETED|Overall Study||0
1485157|NCT01792830|3632380|P1|NOT COMPLETED|Overall Study||25
1485158|NCT01792830|3632370|P11|COMPLETED|Overall Study||9
1485159|NCT01792830|3632371|P10|COMPLETED|Overall Study||4
1485160|NCT01792830|3632372|P9|COMPLETED|Overall Study||11
1485161|NCT01792830|3632373|P8|COMPLETED|Overall Study||6
1485162|NCT01792830|3632374|P7|COMPLETED|Overall Study||12
1485163|NCT01792830|3632375|P6|COMPLETED|Overall Study||3
1485164|NCT01792830|3632376|P5|COMPLETED|Overall Study||1
1485165|NCT01792830|3632377|P4|COMPLETED|Overall Study||18
1485166|NCT01792830|3632378|P3|COMPLETED|Overall Study||4
1485167|NCT01792830|3632379|P2|COMPLETED|Overall Study||3
1485168|NCT01792830|3632380|P1|COMPLETED|Overall Study||59
1485169|NCT01792830|3632370|P11|STARTED|Overall Study||12
1485170|NCT01792830|3632371|P10|STARTED|Overall Study||4
1485171|NCT01792830|3632372|P9|STARTED|Overall Study||20
1485172|NCT01792830|3632373|P8|STARTED|Overall Study||7
1485173|NCT01792830|3632374|P7|STARTED|Overall Study||14
1485174|NCT01792830|3632375|P6|STARTED|Overall Study||4
1485175|NCT01792830|3632376|P5|STARTED|Overall Study||2
1485176|NCT01792830|3632377|P4|STARTED|Overall Study||21
1485177|NCT01792830|3632378|P3|STARTED|Overall Study||4
1485178|NCT01792830|3632379|P2|STARTED|Overall Study||3
1485179|NCT01792830|3632380|P1|STARTED|Overall Study||84
1485180|NCT01792817|3632449|P3|NOT COMPLETED|Phase 2 Open Label||26
1485181|NCT01792817|3632450|P2|NOT COMPLETED|Phase 2 Open Label||0
1485182|NCT01792817|3632451|P1|NOT COMPLETED|Phase 2 Open Label||0
1485183|NCT01792817|3632449|P3|COMPLETED|Phase 2 Open Label||74
1485184|NCT01792817|3632450|P2|COMPLETED|Phase 2 Open Label||0
1485185|NCT01792817|3632451|P1|COMPLETED|Phase 2 Open Label||0
1485186|NCT01792817|3632449|P3|STARTED|Phase 2 Open Label||100
1485187|NCT01792817|3632450|P2|STARTED|Phase 2 Open Label||0
1485188|NCT01792817|3632451|P1|STARTED|Phase 2 Open Label||0
1485189|NCT01792817|3632449|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
1485190|NCT01792817|3632450|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
1485191|NCT01792817|3632451|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
1485192|NCT01792817|3632449|P3|COMPLETED|Phase 1 Double Blind Period||0
1485193|NCT01792817|3632450|P2|COMPLETED|Phase 1 Double Blind Period||42
1485194|NCT01792817|3632451|P1|COMPLETED|Phase 1 Double Blind Period||58
1485195|NCT01792817|3632449|P3|STARTED|Phase 1 Double Blind Period||0
1485196|NCT01792817|3632450|P2|STARTED|Phase 1 Double Blind Period||73
1485197|NCT01792817|3632451|P1|STARTED|Phase 1 Double Blind Period||77
1485198|NCT01792635|3632467|P3|NOT COMPLETED|Part B||4
1485199|NCT01792635|3632468|P2|NOT COMPLETED|Part B||4
1485200|NCT01792635|3632469|P1|NOT COMPLETED|Part B||0
1485201|NCT01792635|3632467|P3|COMPLETED|Part B||3
1485202|NCT01792635|3632468|P2|COMPLETED|Part B||2
1485203|NCT01792635|3632469|P1|COMPLETED|Part B||0
1485204|NCT01792635|3632467|P3|STARTED|Part B||7
1485205|NCT01792635|3632468|P2|STARTED|Part B||6
1485206|NCT01792635|3632469|P1|STARTED|Part B||0
1485207|NCT01792635|3632467|P3|NOT COMPLETED|Part A||0
1485208|NCT01792635|3632468|P2|NOT COMPLETED|Part A||0
1485209|NCT01792635|3632469|P1|NOT COMPLETED|Part A||0
1485210|NCT01792635|3632467|P3|COMPLETED|Part A||0
1485211|NCT01792635|3632468|P2|COMPLETED|Part A||0
1485212|NCT01792635|3632469|P1|COMPLETED|Part A||6
1485213|NCT01792635|3632467|P3|STARTED|Part A||0
1485214|NCT01792635|3632468|P2|STARTED|Part A||0
1485215|NCT01792635|3632469|P1|STARTED|Part A||6
1485216|NCT01792518|3632497|P2|NOT COMPLETED|Overall Study||7
1485217|NCT01792518|3632498|P1|NOT COMPLETED|Overall Study||8
1485218|NCT01792518|3632497|P2|COMPLETED|Overall Study||175
1485219|NCT01792518|3632498|P1|COMPLETED|Overall Study||170
1485220|NCT01792518|3632497|P2|STARTED|Overall Study||182
1485221|NCT01792518|3632498|P1|STARTED|Overall Study||178
1485222|NCT01792284|3632508|P3|NOT COMPLETED|Randomization Period 2||0
1485223|NCT01792284|3632509|P2|NOT COMPLETED|Randomization Period 2||3
1485224|NCT01792284|3632510|P1|NOT COMPLETED|Randomization Period 2||0
1485225|NCT01792284|3632508|P3|COMPLETED|Randomization Period 2||85
1485226|NCT01792284|3632509|P2|COMPLETED|Randomization Period 2||87
1485227|NCT01792284|3632510|P1|COMPLETED|Randomization Period 2||0
1485228|NCT01792284|3632508|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
1485229|NCT01792284|3632509|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
1485230|NCT01792284|3632510|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
1485231|NCT01792284|3632508|P3|STARTED|Randomization Period 2||85
1485232|NCT01792284|3632509|P2|STARTED|Randomization Period 2||90
1485233|NCT01792284|3632510|P1|STARTED|Randomization Period 2||0
1485234|NCT01792284|3632508|P3|NOT COMPLETED|Randomization Period 1||5
1485235|NCT01792284|3632509|P2|NOT COMPLETED|Randomization Period 1||2
1485236|NCT01792284|3632510|P1|NOT COMPLETED|Randomization Period 1||0
1485237|NCT01792284|3632508|P3|COMPLETED|Randomization Period 1||85
1485238|NCT01792284|3632509|P2|COMPLETED|Randomization Period 1||90
1485239|NCT01792284|3632510|P1|COMPLETED|Randomization Period 1||0
1485240|NCT01792284|3632508|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
1485241|NCT01792284|3632509|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
1485242|NCT01792284|3632510|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
1485243|NCT01792284|3632508|P3|STARTED|Randomization Period 1||90
1485244|NCT01792284|3632509|P2|STARTED|Randomization Period 1||92
1485245|NCT01792284|3632510|P1|STARTED|Randomization Period 1||0
1485246|NCT01792284|3632508|P3|NOT COMPLETED|Lead-in Period||0
1485247|NCT01792284|3632509|P2|NOT COMPLETED|Lead-in Period||0
1485248|NCT01792284|3632510|P1|NOT COMPLETED|Lead-in Period||30
1485249|NCT01792284|3632508|P3|COMPLETED|Lead-in Period||0
1485250|NCT01792284|3632509|P2|COMPLETED|Lead-in Period||0
1485251|NCT01792284|3632510|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
1485252|NCT01792284|3632508|P3|STARTED|Lead-in Period||0
1485253|NCT01792284|3632509|P2|STARTED|Lead-in Period||0
1485254|NCT01792284|3632510|P1|STARTED|Lead-in Period||212
1485255|NCT01792024|3632548|P1|NOT COMPLETED|Overall Study||0
1485256|NCT01792024|3632548|P1|COMPLETED|Overall Study||27
1485257|NCT01792024|3632548|P1|STARTED|Overall Study||27
1485258|NCT01791972|3632558|P2|NOT COMPLETED|Overall Study||0
1485259|NCT01791972|3632559|P1|NOT COMPLETED|Overall Study||0
1485260|NCT01791972|3632558|P2|COMPLETED|Overall Study||19
1485261|NCT01791972|3632559|P1|COMPLETED|Overall Study||19
1485262|NCT01791972|3632558|P2|STARTED|Overall Study||19
1485263|NCT01791972|3632559|P1|STARTED|Overall Study||19
1485264|NCT01791894|3632569|P1|NOT COMPLETED|Overall Study||1
1485265|NCT01791894|3632569|P1|COMPLETED|Overall Study||4
1485266|NCT01791894|3632569|P1|STARTED|Overall Study||5
1485267|NCT01791803|3632580|P4|NOT COMPLETED|Overall Study||5
1485268|NCT01791803|3632581|P3|NOT COMPLETED|Overall Study||2
1485269|NCT01791803|3632582|P2|NOT COMPLETED|Overall Study||2
1485270|NCT01791803|3632583|P1|NOT COMPLETED|Overall Study||0
1485271|NCT01791803|3632580|P4|COMPLETED|Overall Study||37
1485272|NCT01791803|3632581|P3|COMPLETED|Overall Study||38
1485273|NCT01791803|3632582|P2|COMPLETED|Overall Study||39
1485274|NCT01791803|3632583|P1|COMPLETED|Overall Study||41
1485275|NCT01791803|3632580|P4|STARTED|Overall Study||42
1485276|NCT01791803|3632581|P3|STARTED|Overall Study||40
1485277|NCT01791803|3632582|P2|STARTED|Overall Study||41
1485278|NCT01791803|3632583|P1|STARTED|Overall Study||41
1485279|NCT01791725|3632601|P3|NOT COMPLETED|Overall Study||0
1485280|NCT01791725|3632602|P2|NOT COMPLETED|Overall Study||1
1485281|NCT01791725|3632603|P1|NOT COMPLETED|Overall Study||0
1485282|NCT01791725|3632601|P3|COMPLETED|Overall Study||6
1485283|NCT01791725|3632602|P2|COMPLETED|Overall Study||4
1485284|NCT01791725|3632603|P1|COMPLETED|Overall Study||12
1485285|NCT01791725|3632601|P3|STARTED|Overall Study||6
1485286|NCT01791725|3632602|P2|STARTED|Overall Study||5
1485287|NCT01791725|3632603|P1|STARTED|Overall Study||12
1485288|NCT01791517|3632626|P12|NOT COMPLETED|Phase II||1
1485289|NCT01791517|3632627|P11|NOT COMPLETED|Phase II||1
1485290|NCT01791517|3632628|P10|NOT COMPLETED|Phase II||3
1485291|NCT01791517|3632629|P9|NOT COMPLETED|Phase II||2
1485292|NCT01791517|3632630|P8|NOT COMPLETED|Phase II||3
1485293|NCT01791517|3632631|P7|NOT COMPLETED|Phase II||2
1485294|NCT01791517|3632632|P6|NOT COMPLETED|Phase II||4
1485295|NCT01791517|3632633|P5|NOT COMPLETED|Phase II||2
1485296|NCT01791517|3632634|P4|NOT COMPLETED|Phase II||0
1485297|NCT01791517|3632635|P3|NOT COMPLETED|Phase II||1
1485298|NCT01791517|3632636|P2|NOT COMPLETED|Phase II||0
1485299|NCT01791517|3632637|P1|NOT COMPLETED|Phase II||2
1485300|NCT01791517|3632626|P12|COMPLETED|Phase II||17
1485301|NCT01791517|3632627|P11|COMPLETED|Phase II||15
1485302|NCT01791517|3632628|P10|COMPLETED|Phase II||15
1485303|NCT01791517|3632629|P9|COMPLETED|Phase II||17
1485304|NCT01791517|3632630|P8|COMPLETED|Phase II||17
1485305|NCT01791517|3632631|P7|COMPLETED|Phase II||17
1485306|NCT01791517|3632632|P6|COMPLETED|Phase II||14
1485307|NCT01791517|3632633|P5|COMPLETED|Phase II||16
1485308|NCT01791517|3632634|P4|COMPLETED|Phase II||15
1485309|NCT01791517|3632635|P3|COMPLETED|Phase II||15
1485310|NCT01791517|3632636|P2|COMPLETED|Phase II||14
1485311|NCT01791517|3632637|P1|COMPLETED|Phase II||15
1485312|NCT01791517|3632626|P12|STARTED|Phase II||18
1485313|NCT01791517|3632627|P11|STARTED|Phase II||16
1485314|NCT01791517|3632628|P10|STARTED|Phase II||18
1485315|NCT01791517|3632629|P9|STARTED|Phase II||19
1485316|NCT01791517|3632630|P8|STARTED|Phase II||20
1485317|NCT01791517|3632631|P7|STARTED|Phase II||19
1485318|NCT01791517|3632632|P6|STARTED|Phase II||18
1485319|NCT01791517|3632633|P5|STARTED|Phase II||18
1485320|NCT01791517|3632634|P4|STARTED|Phase II||15
1485321|NCT01791517|3632635|P3|STARTED|Phase II||16
1485322|NCT01791517|3632636|P2|STARTED|Phase II||14
1485323|NCT01791517|3632637|P1|STARTED|Phase II||17
1485324|NCT01791517|3632626|P12|NOT COMPLETED|Phase I: Period 4||0
1485325|NCT01791517|3632627|P11|NOT COMPLETED|Phase I: Period 4||0
1485326|NCT01791517|3632628|P10|NOT COMPLETED|Phase I: Period 4||0
1485327|NCT01791517|3632629|P9|NOT COMPLETED|Phase I: Period 4||0
1485328|NCT01791517|3632630|P8|NOT COMPLETED|Phase I: Period 4||0
1485329|NCT01791517|3632631|P7|NOT COMPLETED|Phase I: Period 4||0
1485330|NCT01791517|3632632|P6|NOT COMPLETED|Phase I: Period 4||0
1485331|NCT01791517|3632633|P5|NOT COMPLETED|Phase I: Period 4||0
1485332|NCT01791517|3632634|P4|NOT COMPLETED|Phase I: Period 4||0
1485333|NCT01791517|3632635|P3|NOT COMPLETED|Phase I: Period 4||0
1485334|NCT01791517|3632636|P2|NOT COMPLETED|Phase I: Period 4||0
1485335|NCT01791517|3632637|P1|NOT COMPLETED|Phase I: Period 4||0
1485336|NCT01791517|3632626|P12|COMPLETED|Phase I: Period 4||18
1485337|NCT01791517|3632627|P11|COMPLETED|Phase I: Period 4||16
1485338|NCT01791517|3632628|P10|COMPLETED|Phase I: Period 4||18
1485339|NCT01791517|3632629|P9|COMPLETED|Phase I: Period 4||19
1485340|NCT01791517|3632630|P8|COMPLETED|Phase I: Period 4||20
1485341|NCT01791517|3632631|P7|COMPLETED|Phase I: Period 4||19
1485342|NCT01791517|3632632|P6|COMPLETED|Phase I: Period 4||18
1485343|NCT01791517|3632633|P5|COMPLETED|Phase I: Period 4||18
1485344|NCT01791517|3632634|P4|COMPLETED|Phase I: Period 4||15
1485345|NCT01791517|3632635|P3|COMPLETED|Phase I: Period 4||16
1485346|NCT01791517|3632636|P2|COMPLETED|Phase I: Period 4||14
1485347|NCT01791517|3632637|P1|COMPLETED|Phase I: Period 4||17
1485348|NCT01791517|3632626|P12|STARTED|Phase I: Period 4||18
1485349|NCT01791517|3632627|P11|STARTED|Phase I: Period 4||16
1485350|NCT01791517|3632628|P10|STARTED|Phase I: Period 4||18
1485351|NCT01791517|3632629|P9|STARTED|Phase I: Period 4||19
1485352|NCT01791517|3632630|P8|STARTED|Phase I: Period 4||20
1485353|NCT01791517|3632631|P7|STARTED|Phase I: Period 4||19
1485354|NCT01791517|3632632|P6|STARTED|Phase I: Period 4||18
1485355|NCT01791517|3632633|P5|STARTED|Phase I: Period 4||18
1485356|NCT01791517|3632634|P4|STARTED|Phase I: Period 4||15
1485357|NCT01791517|3632635|P3|STARTED|Phase I: Period 4||16
1485358|NCT01791517|3632636|P2|STARTED|Phase I: Period 4||14
1485359|NCT01791517|3632637|P1|STARTED|Phase I: Period 4||17
1485360|NCT01791517|3632626|P12|NOT COMPLETED|Phase I: Period 3||1
1485361|NCT01791517|3632627|P11|NOT COMPLETED|Phase I: Period 3||0
1485362|NCT01791517|3632628|P10|NOT COMPLETED|Phase I: Period 3||0
1485363|NCT01791517|3632629|P9|NOT COMPLETED|Phase I: Period 3||0
1485364|NCT01791517|3632630|P8|NOT COMPLETED|Phase I: Period 3||0
1485365|NCT01791517|3632631|P7|NOT COMPLETED|Phase I: Period 3||0
1485366|NCT01791517|3632632|P6|NOT COMPLETED|Phase I: Period 3||0
1485367|NCT01791517|3632633|P5|NOT COMPLETED|Phase I: Period 3||1
1485368|NCT01791517|3632634|P4|NOT COMPLETED|Phase I: Period 3||1
1485369|NCT01791517|3632635|P3|NOT COMPLETED|Phase I: Period 3||0
1485370|NCT01791517|3632636|P2|NOT COMPLETED|Phase I: Period 3||1
1485371|NCT01791517|3632637|P1|NOT COMPLETED|Phase I: Period 3||0
1485372|NCT01791517|3632626|P12|COMPLETED|Phase I: Period 3||18
1485373|NCT01791517|3632627|P11|COMPLETED|Phase I: Period 3||16
1485374|NCT01791517|3632628|P10|COMPLETED|Phase I: Period 3||18
1485375|NCT01791517|3632629|P9|COMPLETED|Phase I: Period 3||19
1485376|NCT01791517|3632630|P8|COMPLETED|Phase I: Period 3||20
1485377|NCT01791517|3632631|P7|COMPLETED|Phase I: Period 3||19
1485378|NCT01791517|3632632|P6|COMPLETED|Phase I: Period 3||18
1485379|NCT01791517|3632633|P5|COMPLETED|Phase I: Period 3||18
1485380|NCT01791517|3632634|P4|COMPLETED|Phase I: Period 3||15
1485381|NCT01791517|3632635|P3|COMPLETED|Phase I: Period 3||16
1485382|NCT01791517|3632636|P2|COMPLETED|Phase I: Period 3||14
1485383|NCT01791517|3632637|P1|COMPLETED|Phase I: Period 3||17
1485384|NCT01791517|3632626|P12|STARTED|Phase I: Period 3||19
1485385|NCT01791517|3632627|P11|STARTED|Phase I: Period 3||16
1485386|NCT01791517|3632628|P10|STARTED|Phase I: Period 3||18
1485387|NCT01791517|3632629|P9|STARTED|Phase I: Period 3||19
1485388|NCT01791517|3632630|P8|STARTED|Phase I: Period 3||20
1485389|NCT01791517|3632631|P7|STARTED|Phase I: Period 3||19
1485390|NCT01791517|3632632|P6|STARTED|Phase I: Period 3||18
1485391|NCT01791517|3632633|P5|STARTED|Phase I: Period 3||19
1485392|NCT01791517|3632634|P4|STARTED|Phase I: Period 3||16
1485393|NCT01791517|3632635|P3|STARTED|Phase I: Period 3||16
1485394|NCT01791517|3632636|P2|STARTED|Phase I: Period 3||15
1485395|NCT01791517|3632637|P1|STARTED|Phase I: Period 3||17
1485396|NCT01791517|3632626|P12|NOT COMPLETED|Phase I: Period 2||0
1485397|NCT01791517|3632627|P11|NOT COMPLETED|Phase I: Period 2||2
1485398|NCT01791517|3632628|P10|NOT COMPLETED|Phase I: Period 2||1
1485399|NCT01791517|3632629|P9|NOT COMPLETED|Phase I: Period 2||0
1485400|NCT01791517|3632630|P8|NOT COMPLETED|Phase I: Period 2||0
1485401|NCT01791517|3632631|P7|NOT COMPLETED|Phase I: Period 2||0
1485402|NCT01791517|3632632|P6|NOT COMPLETED|Phase I: Period 2||1
1485403|NCT01791517|3632633|P5|NOT COMPLETED|Phase I: Period 2||0
1485404|NCT01791517|3632634|P4|NOT COMPLETED|Phase I: Period 2||1
1485405|NCT01791517|3632635|P3|NOT COMPLETED|Phase I: Period 2||2
1485406|NCT01791517|3632636|P2|NOT COMPLETED|Phase I: Period 2||3
1485407|NCT01791517|3632637|P1|NOT COMPLETED|Phase I: Period 2||1
1485408|NCT01791517|3632626|P12|COMPLETED|Phase I: Period 2||19
1485409|NCT01791517|3632627|P11|COMPLETED|Phase I: Period 2||16
1485410|NCT01791517|3632628|P10|COMPLETED|Phase I: Period 2||18
1485411|NCT01791517|3632629|P9|COMPLETED|Phase I: Period 2||19
1485412|NCT01791517|3632630|P8|COMPLETED|Phase I: Period 2||20
1485413|NCT01791517|3632631|P7|COMPLETED|Phase I: Period 2||19
1485414|NCT01791517|3632632|P6|COMPLETED|Phase I: Period 2||18
1485415|NCT01791517|3632633|P5|COMPLETED|Phase I: Period 2||19
1485416|NCT01791517|3632634|P4|COMPLETED|Phase I: Period 2||16
1485417|NCT01791517|3632635|P3|COMPLETED|Phase I: Period 2||16
1485418|NCT01791517|3632636|P2|COMPLETED|Phase I: Period 2||15
1485419|NCT01791517|3632637|P1|COMPLETED|Phase I: Period 2||17
1485420|NCT01791517|3632626|P12|STARTED|Phase I: Period 2||19
1485421|NCT01791517|3632627|P11|STARTED|Phase I: Period 2||18
1485422|NCT01791517|3632628|P10|STARTED|Phase I: Period 2||19
1485423|NCT01791517|3632629|P9|STARTED|Phase I: Period 2||19
1485424|NCT01791517|3632630|P8|STARTED|Phase I: Period 2||20
1485425|NCT01791517|3632631|P7|STARTED|Phase I: Period 2||19
1485426|NCT01791517|3632632|P6|STARTED|Phase I: Period 2||19
1485427|NCT01791517|3632633|P5|STARTED|Phase I: Period 2||19
1485428|NCT01791517|3632634|P4|STARTED|Phase I: Period 2||17
1485429|NCT01791517|3632635|P3|STARTED|Phase I: Period 2||18
1485430|NCT01791517|3632636|P2|STARTED|Phase I: Period 2||18
1485431|NCT01791517|3632637|P1|STARTED|Phase I: Period 2||18
1485432|NCT01791517|3632626|P12|NOT COMPLETED|Phase I: Period 1||1
1485433|NCT01791517|3632627|P11|NOT COMPLETED|Phase I: Period 1||0
1485434|NCT01791517|3632628|P10|NOT COMPLETED|Phase I: Period 1||1
1485435|NCT01791517|3632629|P9|NOT COMPLETED|Phase I: Period 1||1
1485436|NCT01791517|3632630|P8|NOT COMPLETED|Phase I: Period 1||0
1485437|NCT01791517|3632631|P7|NOT COMPLETED|Phase I: Period 1||1
1485438|NCT01791517|3632632|P6|NOT COMPLETED|Phase I: Period 1||1
1485439|NCT01791517|3632633|P5|NOT COMPLETED|Phase I: Period 1||1
1485440|NCT01791517|3632634|P4|NOT COMPLETED|Phase I: Period 1||2
1485441|NCT01791517|3632635|P3|NOT COMPLETED|Phase I: Period 1||2
1485442|NCT01791517|3632636|P2|NOT COMPLETED|Phase I: Period 1||2
1485443|NCT01791517|3632637|P1|NOT COMPLETED|Phase I: Period 1||1
1485444|NCT01791517|3632626|P12|COMPLETED|Phase I: Period 1||19
1485445|NCT01791517|3632627|P11|COMPLETED|Phase I: Period 1||18
1485446|NCT01791517|3632628|P10|COMPLETED|Phase I: Period 1||19
1485447|NCT01791517|3632629|P9|COMPLETED|Phase I: Period 1||19
1485448|NCT01791517|3632630|P8|COMPLETED|Phase I: Period 1||20
1485449|NCT01791517|3632631|P7|COMPLETED|Phase I: Period 1||19
1485450|NCT01791517|3632632|P6|COMPLETED|Phase I: Period 1||19
1485451|NCT01791517|3632633|P5|COMPLETED|Phase I: Period 1||19
1485452|NCT01791517|3632634|P4|COMPLETED|Phase I: Period 1||17
1485453|NCT01791517|3632635|P3|COMPLETED|Phase I: Period 1||18
1485454|NCT01791517|3632636|P2|COMPLETED|Phase I: Period 1||18
1485455|NCT01791517|3632637|P1|COMPLETED|Phase I: Period 1||18
1485456|NCT01791517|3632626|P12|STARTED|Phase I: Period 1||20
1485457|NCT01791517|3632627|P11|STARTED|Phase I: Period 1||18
1485458|NCT01791517|3632628|P10|STARTED|Phase I: Period 1||20
1485459|NCT01791517|3632629|P9|STARTED|Phase I: Period 1||20
1485460|NCT01791517|3632630|P8|STARTED|Phase I: Period 1||20
1485461|NCT01791517|3632631|P7|STARTED|Phase I: Period 1||20
1485462|NCT01791517|3632632|P6|STARTED|Phase I: Period 1||20
1485463|NCT01791517|3632633|P5|STARTED|Phase I: Period 1||20
1485464|NCT01791517|3632634|P4|STARTED|Phase I: Period 1||19
1485465|NCT01791517|3632635|P3|STARTED|Phase I: Period 1||20
1485466|NCT01791517|3632636|P2|STARTED|Phase I: Period 1||20
1485467|NCT01791517|3632637|P1|STARTED|Phase I: Period 1||19
1485468|NCT01791491|3632663|P1|NOT COMPLETED|Overall Study||0
1485469|NCT01791491|3632663|P1|COMPLETED|Overall Study||9
1485470|NCT01791491|3632663|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
1485471|NCT01791465|3632675|P1|NOT COMPLETED|Overall Study||0
1485472|NCT01791465|3632675|P1|COMPLETED|Overall Study||6
1485473|NCT01791465|3632675|P1|STARTED|Overall Study||6
1485474|NCT01791413|3632701|P2|NOT COMPLETED|Overall Study||1
1485475|NCT01791413|3632702|P1|NOT COMPLETED|Overall Study||5
1485476|NCT01791413|3632701|P2|COMPLETED|Overall Study||19
1485477|NCT01791413|3632702|P1|COMPLETED|Overall Study||15
1485478|NCT01791413|3632701|P2|STARTED|Overall Study||20
1485479|NCT01791413|3632702|P1|STARTED|Overall Study||20
1485480|NCT01791244|3632711|P2|NOT COMPLETED|Overall Study||18
1485481|NCT01791244|3632712|P1|NOT COMPLETED|Overall Study||15
1485482|NCT01791244|3632711|P2|COMPLETED|Overall Study||29
1485483|NCT01791244|3632712|P1|COMPLETED|Overall Study||31
1485484|NCT01791244|3632711|P2|Intent to Treat (ITT)|Overall Study||39
1485485|NCT01791244|3632712|P1|Intent to Treat (ITT)|Overall Study||38
1485486|NCT01791244|3632711|P2|STARTED|Overall Study||47
1485487|NCT01791244|3632712|P1|STARTED|Overall Study||46
1485488|NCT01791205|3632748|P2|NOT COMPLETED|Phase II||0
1485489|NCT01791205|3632749|P1|NOT COMPLETED|Phase II||12
1485490|NCT01791205|3632748|P2|COMPLETED|Phase II||0
1485491|NCT01791205|3632749|P1|COMPLETED|Phase II||92
1485492|NCT01791205|3632748|P2|STARTED|Phase II||0
1485493|NCT01791205|3632749|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
1485494|NCT01791205|3632748|P2|NOT COMPLETED|Phase I||0
1485495|NCT01791205|3632749|P1|NOT COMPLETED|Phase I||0
1485496|NCT01791205|3632748|P2|COMPLETED|Phase I||152
1485497|NCT01791205|3632749|P1|COMPLETED|Phase I||152
1485498|NCT01791205|3632748|P2|STARTED|Phase I||152
1485499|NCT01791205|3632749|P1|STARTED|Phase I||152
1485500|NCT01791153|3632833|P4|NOT COMPLETED|Overall Study||5
1485501|NCT01791153|3632834|P3|NOT COMPLETED|Overall Study||6
1485502|NCT01791153|3632835|P2|NOT COMPLETED|Overall Study||8
1485503|NCT01791153|3632836|P1|NOT COMPLETED|Overall Study||15
1485504|NCT01791153|3632833|P4|COMPLETED|Overall Study|Completed Study to Week 52|46
1485505|NCT01791153|3632834|P3|COMPLETED|Overall Study|Completed Study to Week 52|44
1485506|NCT01791153|3632835|P2|COMPLETED|Overall Study|Completed Study to Week 52|41
1485507|NCT01791153|3632836|P1|COMPLETED|Overall Study|Completed Study to Week 52|85
1485508|NCT01791153|3632833|P4|STARTED|Overall Study||51
1485509|NCT01791153|3632834|P3|STARTED|Overall Study||50
1485510|NCT01791153|3632835|P2|STARTED|Overall Study||49
1485511|NCT01791153|3632836|P1|STARTED|Overall Study||100
1485512|NCT01790828|3632892|P1|NOT COMPLETED|Overall Study||34
1485513|NCT01790828|3632892|P1|COMPLETED|Overall Study||8
1485514|NCT01790828|3632892|P1|STARTED|Overall Study||42
1485515|NCT01790750|3632915|P1|NOT COMPLETED|Overall Study||0
1485516|NCT01790750|3632915|P1|COMPLETED|Overall Study||50
1485517|NCT01790750|3632915|P1|STARTED|Overall Study||50
1485518|NCT01790685|3632922|P2|NOT COMPLETED|Overall Study||0
1485519|NCT01790685|3632923|P1|NOT COMPLETED|Overall Study||0
1485520|NCT01790685|3632922|P2|COMPLETED|Overall Study||17
1485521|NCT01790685|3632923|P1|COMPLETED|Overall Study||23
1485522|NCT01790685|3632922|P2|STARTED|Overall Study||17
1485523|NCT01790685|3632923|P1|STARTED|Overall Study||23
1485524|NCT01790659|3632931|P2|NOT COMPLETED|Overall Study||6
1485525|NCT01790659|3632932|P1|NOT COMPLETED|Overall Study||6
1485526|NCT01790659|3632931|P2|COMPLETED|Overall Study||192
1485527|NCT01790659|3632932|P1|COMPLETED|Overall Study||195
1485528|NCT01790659|3632931|P2|STARTED|Overall Study||198
1485529|NCT01790659|3632932|P1|STARTED|Overall Study||201
1485530|NCT01790633|3632950|P2|NOT COMPLETED|Overall Study||5
1485531|NCT01790633|3632951|P1|NOT COMPLETED|Overall Study||48
1485532|NCT01790633|3632950|P2|COMPLETED|Overall Study||159
1485533|NCT01790633|3632951|P1|COMPLETED|Overall Study||115
1485534|NCT01790633|3632950|P2|STARTED|Overall Study||164
1485535|NCT01790633|3632951|P1|STARTED|Overall Study||163
1485536|NCT01790594|3632964|P3|NOT COMPLETED|Overall Study||3
1485537|NCT01790594|3632965|P2|NOT COMPLETED|Overall Study||3
1485538|NCT01790594|3632966|P1|NOT COMPLETED|Overall Study||5
1485539|NCT01790594|3632964|P3|COMPLETED|Overall Study||0
1485540|NCT01790594|3632965|P2|COMPLETED|Overall Study||18
1485541|NCT01790594|3632966|P1|COMPLETED|Overall Study||17
1485542|NCT01790594|3632964|P3|STARTED|Overall Study||3
1485543|NCT01790594|3632965|P2|STARTED|Overall Study||21
1485544|NCT01790594|3632966|P1|STARTED|Overall Study||22
1485545|NCT01790581|3633034|P2|NOT COMPLETED|Overall Study||0
1485546|NCT01790581|3633035|P1|NOT COMPLETED|Overall Study||0
1485547|NCT01790581|3633034|P2|COMPLETED|Overall Study||12
1485548|NCT01790581|3633035|P1|COMPLETED|Overall Study||12
1485549|NCT01790581|3633034|P2|STARTED|Overall Study||12
1485550|NCT01790581|3633035|P1|STARTED|Overall Study||12
1485551|NCT01790568|3633043|P2|NOT COMPLETED|Overall Study||1
1485552|NCT01790568|3633044|P1|NOT COMPLETED|Overall Study||0
1485553|NCT01790568|3633043|P2|COMPLETED|Overall Study||25
1485554|NCT01790568|3633044|P1|COMPLETED|Overall Study||12
1485555|NCT01790568|3633043|P2|STARTED|Overall Study||26
1485556|NCT01790568|3633044|P1|STARTED|Overall Study||12
1485557|NCT01790516|3633052|P2|NOT COMPLETED|Overall Study||0
1485558|NCT01790516|3633053|P1|NOT COMPLETED|Overall Study||1
1485559|NCT01790516|3633052|P2|COMPLETED|Overall Study||1
1485560|NCT01790516|3633053|P1|COMPLETED|Overall Study||0
1485561|NCT01790516|3633052|P2|STARTED|Overall Study||1
1485562|NCT01790516|3633053|P1|STARTED|Overall Study||1
1485563|NCT01790490|3633062|P3|NOT COMPLETED|Overall Study||0
1485564|NCT01790490|3633063|P2|NOT COMPLETED|Overall Study||0
1485565|NCT01790490|3633064|P1|NOT COMPLETED|Overall Study||0
1485566|NCT01790490|3633062|P3|COMPLETED|Overall Study||2
1485567|NCT01790490|3633063|P2|COMPLETED|Overall Study||3
1485568|NCT01790490|3633064|P1|COMPLETED|Overall Study||3
1485569|NCT01790490|3633062|P3|STARTED|Overall Study||2
1485570|NCT01790490|3633063|P2|STARTED|Overall Study||3
1485571|NCT01790490|3633064|P1|STARTED|Overall Study||3
1485572|NCT01790438|3633077|P2|NOT COMPLETED|Overall Study||11
1485573|NCT01790438|3633078|P1|NOT COMPLETED|Overall Study||35
1485574|NCT01790438|3633077|P2|COMPLETED|Overall Study||202
1485575|NCT01790438|3633078|P1|COMPLETED|Overall Study||393
1485576|NCT01790438|3633077|P2|Received at Least One Dose of Study Drug|Overall Study||212
1485577|NCT01790438|3633078|P1|Received at Least One Dose of Study Drug|Overall Study||427
1485578|NCT01790438|3633077|P2|STARTED|Overall Study||213
1485579|NCT01790438|3633078|P1|STARTED|Overall Study||428
1485580|NCT01790178|3633130|P2|NOT COMPLETED|Overall Study||0
1485581|NCT01790178|3633131|P1|NOT COMPLETED|Overall Study||0
1485582|NCT01790178|3633130|P2|COMPLETED|Overall Study||24
1485583|NCT01790178|3633131|P1|COMPLETED|Overall Study||16
1485584|NCT01790178|3633130|P2|STARTED|Overall Study||24
1485585|NCT01790178|3633131|P1|STARTED|Overall Study||16
1485586|NCT01789970|3633147|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
1485587|NCT01789970|3633148|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
1485588|NCT01789970|3633149|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1485589|NCT01789970|3633147|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
1485590|NCT01789970|3633148|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
1485591|NCT01789970|3633149|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1485592|NCT01789970|3633147|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
1485593|NCT01789970|3633148|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
1485594|NCT01789970|3633149|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
1485595|NCT01789970|3633147|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
1485596|NCT01789970|3633148|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
1485597|NCT01789970|3633149|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
1485598|NCT01789970|3633147|P3|NOT COMPLETED|Open-label Titration Period||0
1485599|NCT01789970|3633148|P2|NOT COMPLETED|Open-label Titration Period||0
1485600|NCT01789970|3633149|P1|NOT COMPLETED|Open-label Titration Period||254
1485601|NCT01789970|3633147|P3|COMPLETED|Open-label Titration Period||0
1485602|NCT01789970|3633148|P2|COMPLETED|Open-label Titration Period||0
1485603|NCT01789970|3633149|P1|COMPLETED|Open-label Titration Period||371
1485604|NCT01789970|3633147|P3|Safety Analysis Set|Open-label Titration Period||0
1485605|NCT01789970|3633148|P2|Safety Analysis Set|Open-label Titration Period||0
1485606|NCT01789970|3633149|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
1485607|NCT01789970|3633147|P3|STARTED|Open-label Titration Period||0
1485608|NCT01789970|3633148|P2|STARTED|Open-label Titration Period||0
1485609|NCT01789970|3633149|P1|STARTED|Open-label Titration Period||625
1485610|NCT01789905|3633181|P1|NOT COMPLETED|Overall Study||0
1485611|NCT01789905|3633181|P1|COMPLETED|Overall Study||116
1485612|NCT01789905|3633181|P1|STARTED|Overall Study||116
1485613|NCT01789814|3633189|P2|NOT COMPLETED|Overall Study||0
1485614|NCT01789814|3633190|P1|NOT COMPLETED|Overall Study||0
1485615|NCT01789814|3633189|P2|COMPLETED|Overall Study||12
1485616|NCT01789814|3633190|P1|COMPLETED|Overall Study||12
1485617|NCT01789814|3633189|P2|STARTED|Overall Study||12
1485618|NCT01789814|3633190|P1|STARTED|Overall Study||12
1485619|NCT01789775|3633198|P2|NOT COMPLETED|Overall Study||7
1485620|NCT01789775|3633199|P1|NOT COMPLETED|Overall Study||2
1485621|NCT01789775|3633198|P2|COMPLETED|Overall Study||50
1485622|NCT01789775|3633199|P1|COMPLETED|Overall Study||53
1485623|NCT01789775|3633198|P2|STARTED|Overall Study||57
1485624|NCT01789775|3633199|P1|STARTED|Overall Study||55
1485625|NCT01789606|3633207|P2|NOT COMPLETED|Overall Study||450
1485626|NCT01789606|3633208|P1|NOT COMPLETED|Overall Study||23
1485627|NCT01789606|3633207|P2|COMPLETED|Overall Study||382
1485628|NCT01789606|3633208|P1|COMPLETED|Overall Study||228
1485629|NCT01789606|3633207|P2|STARTED|Overall Study||832
1485630|NCT01789606|3633208|P1|STARTED|Overall Study||251
1485631|NCT01789567|3633226|P1|NOT COMPLETED|Overall Study||6
1485632|NCT01789567|3633226|P1|COMPLETED|Overall Study||14
1485633|NCT01789567|3633226|P1|STARTED|Overall Study||20
1485634|NCT01789476|3633235|P2|NOT COMPLETED|Overall Study||2
1485635|NCT01789476|3633236|P1|NOT COMPLETED|Overall Study||8
1485636|NCT01789476|3633235|P2|COMPLETED|Overall Study||15
1485637|NCT01789476|3633236|P1|COMPLETED|Overall Study||26
1485638|NCT01789476|3633235|P2|STARTED|Overall Study||17
1485639|NCT01789476|3633236|P1|STARTED|Overall Study||34
1485640|NCT01789255|3633246|P1|NOT COMPLETED|Overall Study||0
1485641|NCT01789255|3633246|P1|COMPLETED|Overall Study||12
1485642|NCT01789255|3633246|P1|STARTED|Overall Study||12
1485643|NCT01789138|3633258|P2|NOT COMPLETED|Overall Study||52
1485644|NCT01789138|3633259|P1|NOT COMPLETED|Overall Study||41
1485645|NCT01789138|3633258|P2|COMPLETED|Overall Study||206
1485646|NCT01789138|3633259|P1|COMPLETED|Overall Study||213
1485647|NCT01789138|3633258|P2|STARTED|Overall Study||258
1485648|NCT01789138|3633259|P1|STARTED|Overall Study||254
1485649|NCT01788943|3633269|P2|NOT COMPLETED|Overall Study||0
1485650|NCT01788943|3633270|P1|NOT COMPLETED|Overall Study||1
1485651|NCT01788943|3633269|P2|COMPLETED|Overall Study||12
1485652|NCT01788943|3633270|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
1485653|NCT01788943|3633269|P2|STARTED|Overall Study||12
1485654|NCT01788943|3633270|P1|STARTED|Overall Study|Recruitment for study began.|13
1485655|NCT01788631|3633280|P2|NOT COMPLETED|Overall Study||1
1485656|NCT01788631|3633281|P1|NOT COMPLETED|Overall Study||3
1485657|NCT01788631|3633280|P2|COMPLETED|Overall Study||43
1485658|NCT01788631|3633281|P1|COMPLETED|Overall Study||49
1485659|NCT01788631|3633280|P2|Randomized|Overall Study||47
1485660|NCT01788631|3633281|P1|Randomized|Overall Study||53
1485661|NCT01788631|3633280|P2|STARTED|Overall Study||44
1485662|NCT01788631|3633281|P1|STARTED|Overall Study||52
1485663|NCT01788566|3633299|P1|NOT COMPLETED|Overall Study||8
1485664|NCT01788566|3633299|P1|COMPLETED|Overall Study||53
1485665|NCT01788566|3633299|P1|STARTED|Overall Study||61
1485666|NCT01788358|3633309|P1|NOT COMPLETED|Overall Study||98
1485667|NCT01788358|3633309|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
1485668|NCT01788358|3633309|P1|Completed Week 52|Overall Study||193
1485669|NCT01788358|3633309|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
1485670|NCT01788358|3633309|P1|Completed Week 28|Overall Study||417
1485671|NCT01788358|3633309|P1|Treated|Overall Study||508
1485672|NCT01788358|3633309|P1|STARTED|Overall Study||508
1485673|NCT01788228|3633323|P2|NOT COMPLETED|Overall Study||0
1485674|NCT01788228|3633324|P1|NOT COMPLETED|Overall Study||1
1485675|NCT01788228|3633323|P2|COMPLETED|Overall Study||1
1485676|NCT01788228|3633324|P1|COMPLETED|Overall Study||48
1485677|NCT01788228|3633323|P2|STARTED|Overall Study||1
1485678|NCT01788228|3633324|P1|STARTED|Overall Study||49
1485679|NCT01788215|3633343|P2|NOT COMPLETED|Overall Study||1
1485680|NCT01788215|3633344|P1|NOT COMPLETED|Overall Study||2
1485681|NCT01788215|3633343|P2|COMPLETED|Overall Study||4
1485682|NCT01788215|3633344|P1|COMPLETED|Overall Study||3
1485683|NCT01788215|3633343|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
1485684|NCT01788215|3633344|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
1485685|NCT01788215|3633343|P2|STARTED|Overall Study||5
1485686|NCT01788215|3633344|P1|STARTED|Overall Study||5
1485687|NCT01788163|3633373|P9|NOT COMPLETED|Overall Study||16
1485688|NCT01788163|3633374|P8|NOT COMPLETED|Overall Study||48
1485689|NCT01788163|3633375|P7|NOT COMPLETED|Overall Study||1
1485690|NCT01788163|3633376|P6|NOT COMPLETED|Overall Study||7
1485691|NCT01788163|3633377|P5|NOT COMPLETED|Overall Study||0
1485692|NCT01788163|3633378|P4|NOT COMPLETED|Overall Study||0
1485693|NCT01788163|3633379|P3|NOT COMPLETED|Overall Study||0
1485694|NCT01788163|3633380|P2|NOT COMPLETED|Overall Study||0
1485695|NCT01788163|3633381|P1|NOT COMPLETED|Overall Study||55
1485696|NCT01788163|3633373|P9|COMPLETED|Overall Study||956
1485697|NCT01788163|3633374|P8|COMPLETED|Overall Study||254
1485698|NCT01788163|3633375|P7|COMPLETED|Overall Study||49
1485699|NCT01788163|3633376|P6|COMPLETED|Overall Study||95
1485700|NCT01788163|3633377|P5|COMPLETED|Overall Study||94
1485701|NCT01788163|3633378|P4|COMPLETED|Overall Study||71
1485702|NCT01788163|3633379|P3|COMPLETED|Overall Study||62
1485703|NCT01788163|3633380|P2|COMPLETED|Overall Study||271
1485704|NCT01788163|3633381|P1|COMPLETED|Overall Study||1403
1485705|NCT01788163|3633373|P9|STARTED|Overall Study||972
1485706|NCT01788163|3633374|P8|STARTED|Overall Study||302
1485707|NCT01788163|3633375|P7|STARTED|Overall Study||50
1485708|NCT01788163|3633376|P6|STARTED|Overall Study||102
1485709|NCT01788163|3633377|P5|STARTED|Overall Study||94
1485710|NCT01788163|3633378|P4|STARTED|Overall Study||71
1485711|NCT01788163|3633379|P3|STARTED|Overall Study||62
1485712|NCT01788163|3633380|P2|STARTED|Overall Study||271
1485713|NCT01788163|3633381|P1|STARTED|Overall Study||1458
1485714|NCT01788046|3633544|P2|NOT COMPLETED|Overall Study||37
1485715|NCT01788046|3633545|P1|NOT COMPLETED|Overall Study||56
1485716|NCT01788046|3633544|P2|COMPLETED|Overall Study||218
1485717|NCT01788046|3633545|P1|COMPLETED|Overall Study||204
1485718|NCT01788046|3633544|P2|Received Treatment|Overall Study||252
1485719|NCT01788046|3633545|P1|Received Treatment|Overall Study||259
1485720|NCT01788046|3633544|P2|STARTED|Overall Study||255
1485721|NCT01788046|3633545|P1|STARTED|Overall Study||260
1485722|NCT01787916|3633561|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
1485723|NCT01787916|3633562|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
1485724|NCT01787916|3633561|P2|COMPLETED|Second Intervention (24 Weeks)||7
1485725|NCT01787916|3633562|P1|COMPLETED|Second Intervention (24 Weeks)||8
1485726|NCT01787916|3633561|P2|STARTED|Second Intervention (24 Weeks)||7
1485727|NCT01787916|3633562|P1|STARTED|Second Intervention (24 Weeks)||8
1485728|NCT01787916|3633561|P2|NOT COMPLETED|Washout (4 Weeks)||0
1485729|NCT01787916|3633562|P1|NOT COMPLETED|Washout (4 Weeks)||0
1485730|NCT01787916|3633561|P2|COMPLETED|Washout (4 Weeks)||7
1485731|NCT01787916|3633562|P1|COMPLETED|Washout (4 Weeks)||8
1485732|NCT01787916|3633561|P2|STARTED|Washout (4 Weeks)||7
1485733|NCT01787916|3633562|P1|STARTED|Washout (4 Weeks)||8
1485734|NCT01787916|3633561|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
1485735|NCT01787916|3633562|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
1485736|NCT01787916|3633561|P2|COMPLETED|First Intervention (24 Weeks)||7
1485737|NCT01787916|3633562|P1|COMPLETED|First Intervention (24 Weeks)||8
1485738|NCT01787916|3633561|P2|STARTED|First Intervention (24 Weeks)||7
1485739|NCT01787916|3633562|P1|STARTED|First Intervention (24 Weeks)||8
1485740|NCT01787838|3633568|P1|NOT COMPLETED|Overall Study||1413
1485741|NCT01787838|3633568|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
1485742|NCT01787838|3633568|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
1485743|NCT01787825|3633572|P2|NOT COMPLETED|Overall Study||1
1485744|NCT01787825|3633573|P1|NOT COMPLETED|Overall Study||6
1485745|NCT01787825|3633572|P2|COMPLETED|Overall Study||60
1485746|NCT01787825|3633573|P1|COMPLETED|Overall Study||54
1485747|NCT01787825|3633572|P2|STARTED|Overall Study||61
1485748|NCT01787825|3633573|P1|STARTED|Overall Study||60
1485749|NCT01787799|3633584|P1|NOT COMPLETED|Overall Study||0
1485750|NCT01787799|3633584|P1|COMPLETED|Overall Study||100
1485751|NCT01787799|3633584|P1|STARTED|Overall Study||100
1485752|NCT01787760|3633591|P3|NOT COMPLETED|Overall Study||5
1485753|NCT01787760|3633592|P2|NOT COMPLETED|Overall Study||16
1485754|NCT01787760|3633593|P1|NOT COMPLETED|Overall Study||26
1485755|NCT01787760|3633591|P3|COMPLETED|Overall Study||46
1485756|NCT01787760|3633592|P2|COMPLETED|Overall Study||34
1485757|NCT01787760|3633593|P1|COMPLETED|Overall Study||25
1485758|NCT01787760|3633591|P3|STARTED|Overall Study||51
1485759|NCT01787760|3633592|P2|STARTED|Overall Study||50
1485760|NCT01787760|3633593|P1|STARTED|Overall Study||51
1485761|NCT01787591|3633607|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
1485762|NCT01787591|3633608|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
1485763|NCT01787591|3633609|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
1485764|NCT01787591|3633610|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
1485765|NCT01787591|3633607|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
1485766|NCT01787591|3633608|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
1485767|NCT01787591|3633609|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
1485768|NCT01787591|3633610|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
1485769|NCT01787591|3633607|P4|STARTED|Period 4 (Cross-over Arm 4)||5
1485770|NCT01787591|3633608|P3|STARTED|Period 4 (Cross-over Arm 4)||5
1485771|NCT01787591|3633609|P2|STARTED|Period 4 (Cross-over Arm 4)||5
1485772|NCT01787591|3633610|P1|STARTED|Period 4 (Cross-over Arm 4)||5
1485773|NCT01787591|3633607|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
1485774|NCT01787591|3633608|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
1485775|NCT01787591|3633609|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
1485776|NCT01787591|3633610|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
1485777|NCT01787591|3633607|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
1485778|NCT01787591|3633608|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
1485779|NCT01787591|3633609|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
1485780|NCT01787591|3633610|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
1485781|NCT01787591|3633607|P4|STARTED|Period 3 (Cross-over Arm 3)||5
1485782|NCT01787591|3633608|P3|STARTED|Period 3 (Cross-over Arm 3)||5
1485783|NCT01787591|3633609|P2|STARTED|Period 3 (Cross-over Arm 3)||5
1485784|NCT01787591|3633610|P1|STARTED|Period 3 (Cross-over Arm 3)||5
1485785|NCT01787591|3633607|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
1485786|NCT01787591|3633608|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
1485787|NCT01787591|3633609|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
1485788|NCT01787591|3633610|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
1485789|NCT01787591|3633607|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
1485790|NCT01787591|3633608|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
1485791|NCT01787591|3633609|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
1485792|NCT01787591|3633610|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
1485793|NCT01787591|3633607|P4|STARTED|Period 2 (Cross-over Arm 2)||5
1485794|NCT01787591|3633608|P3|STARTED|Period 2 (Cross-over Arm 2)||5
1485795|NCT01787591|3633609|P2|STARTED|Period 2 (Cross-over Arm 2)||5
1485796|NCT01787591|3633610|P1|STARTED|Period 2 (Cross-over Arm 2)||5
1485797|NCT01787591|3633607|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
1485798|NCT01787591|3633608|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
1485799|NCT01787591|3633609|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
1485800|NCT01787591|3633610|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
1485801|NCT01787591|3633607|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
1485802|NCT01787591|3633608|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
1485803|NCT01787591|3633609|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
1485804|NCT01787591|3633610|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
1485805|NCT01787591|3633607|P4|STARTED|Period 1 (Cross-over Arm 1)||6
1485806|NCT01787591|3633608|P3|STARTED|Period 1 (Cross-over Arm 1)||5
1485807|NCT01787591|3633609|P2|STARTED|Period 1 (Cross-over Arm 1)||5
1485808|NCT01787591|3633610|P1|STARTED|Period 1 (Cross-over Arm 1)||5
1485809|NCT01787461|3633638|P2|NOT COMPLETED|Overall Study||9
1485810|NCT01787461|3633639|P1|NOT COMPLETED|Overall Study||14
1485811|NCT01787461|3633638|P2|COMPLETED|Overall Study||89
1485812|NCT01787461|3633639|P1|COMPLETED|Overall Study||82
1485813|NCT01787461|3633638|P2|STARTED|Overall Study||98
1485814|NCT01787461|3633639|P1|STARTED|Overall Study||96
1485815|NCT01787383|3633667|P2|NOT COMPLETED|Overall Study||22
1485816|NCT01787383|3633668|P1|NOT COMPLETED|Overall Study||9
1485817|NCT01787383|3633667|P2|COMPLETED|Overall Study||76
1485818|NCT01787383|3633668|P1|COMPLETED|Overall Study||92
1485819|NCT01787383|3633667|P2|STARTED|Overall Study||98
1485820|NCT01787383|3633668|P1|STARTED|Overall Study||101
1485821|NCT01787331|3633688|P1|NOT COMPLETED|Overall Study||0
1485822|NCT01787331|3633688|P1|COMPLETED|Overall Study||21
1485823|NCT01787331|3633688|P1|STARTED|Overall Study||21
1485824|NCT01787279|3633695|P1|NOT COMPLETED|Overall Study||3
1485825|NCT01787279|3633695|P1|COMPLETED|Overall Study||56
1485826|NCT01787279|3633695|P1|STARTED|Overall Study||59
1485827|NCT01787240|3633706|P2|NOT COMPLETED|Overall Study||1
1485828|NCT01787240|3633707|P1|NOT COMPLETED|Overall Study||5
1485829|NCT01787240|3633706|P2|COMPLETED|Overall Study||4
1485830|NCT01787240|3633707|P1|COMPLETED|Overall Study||10
1485831|NCT01787240|3633706|P2|STARTED|Overall Study||5
1485832|NCT01787240|3633707|P1|STARTED|Overall Study||15
1485833|NCT01787188|3633721|P3|NOT COMPLETED|Overall Study||18
1485834|NCT01787188|3633722|P2|NOT COMPLETED|Overall Study||18
1485835|NCT01787188|3633723|P1|NOT COMPLETED|Overall Study||17
1485836|NCT01787188|3633721|P3|COMPLETED|Overall Study||116
1485837|NCT01787188|3633722|P2|COMPLETED|Overall Study||112
1485838|NCT01787188|3633723|P1|COMPLETED|Overall Study||122
1485839|NCT01787188|3633721|P3|STARTED|Overall Study||134
1485840|NCT01787188|3633722|P2|STARTED|Overall Study||130
1485841|NCT01787188|3633723|P1|STARTED|Overall Study||139
1485842|NCT01787175|3633778|P2|NOT COMPLETED|Overall Study||0
1485843|NCT01787175|3633779|P1|NOT COMPLETED|Overall Study||0
1485844|NCT01787175|3633778|P2|COMPLETED|Overall Study||28
1485845|NCT01787175|3633779|P1|COMPLETED|Overall Study||30
1485846|NCT01787175|3633778|P2|STARTED|Overall Study||28
1485847|NCT01787175|3633779|P1|STARTED|Overall Study||30
1485848|NCT01787032|3633795|P6|NOT COMPLETED|Overall Study||1
1485849|NCT01787032|3633796|P5|NOT COMPLETED|Overall Study||1
1485850|NCT01787032|3633797|P4|NOT COMPLETED|Overall Study||0
1485851|NCT01787032|3633798|P3|NOT COMPLETED|Overall Study||0
1485852|NCT01787032|3633799|P2|NOT COMPLETED|Overall Study||0
1485853|NCT01787032|3633800|P1|NOT COMPLETED|Overall Study||0
1485854|NCT01787032|3633795|P6|COMPLETED|Overall Study||3
1485855|NCT01787032|3633796|P5|COMPLETED|Overall Study||3
1485856|NCT01787032|3633797|P4|COMPLETED|Overall Study||3
1485857|NCT01787032|3633798|P3|COMPLETED|Overall Study||3
1485858|NCT01787032|3633799|P2|COMPLETED|Overall Study||3
1485859|NCT01787032|3633800|P1|COMPLETED|Overall Study||3
1485860|NCT01787032|3633795|P6|Received T2|Overall Study||4
1485861|NCT01787032|3633796|P5|Received T2|Overall Study||4
1485862|NCT01787032|3633797|P4|Received T2|Overall Study||3
1485863|NCT01787032|3633798|P3|Received T2|Overall Study||3
1485864|NCT01787032|3633799|P2|Received T2|Overall Study||3
1485865|NCT01787032|3633800|P1|Received T2|Overall Study||3
1485866|NCT01787032|3633795|P6|Received T1|Overall Study||4
1485867|NCT01787032|3633796|P5|Received T1|Overall Study||3
1485868|NCT01787032|3633797|P4|Received T1|Overall Study||3
1485869|NCT01787032|3633798|P3|Received T1|Overall Study||3
1485870|NCT01787032|3633799|P2|Received T1|Overall Study||3
1485871|NCT01787032|3633800|P1|Received T1|Overall Study||3
1485872|NCT01787032|3633795|P6|Received R|Overall Study||3
1485873|NCT01787032|3633796|P5|Received R|Overall Study||4
1485874|NCT01787032|3633797|P4|Received R|Overall Study||3
1485875|NCT01787032|3633798|P3|Received R|Overall Study||3
1485876|NCT01787032|3633799|P2|Received R|Overall Study||3
1485877|NCT01787032|3633800|P1|Received R|Overall Study||3
1485878|NCT01787032|3633795|P6|STARTED|Overall Study||4
1485879|NCT01787032|3633796|P5|STARTED|Overall Study||4
1485880|NCT01787032|3633797|P4|STARTED|Overall Study||3
1485881|NCT01787032|3633798|P3|STARTED|Overall Study||3
1485882|NCT01787032|3633799|P2|STARTED|Overall Study||3
1485883|NCT01787032|3633800|P1|STARTED|Overall Study||3
1485884|NCT01786993|3633824|P2|NOT COMPLETED|Overall Study||10
1485885|NCT01786993|3633825|P1|NOT COMPLETED|Overall Study||12
1485886|NCT01786993|3633824|P2|COMPLETED|Overall Study||170
1485887|NCT01786993|3633825|P1|COMPLETED|Overall Study||189
1485888|NCT01786993|3633824|P2|Per Protocol Population at 9 Months|Overall Study||170
1485889|NCT01786993|3633825|P1|Per Protocol Population at 9 Months|Overall Study||189
1485890|NCT01786993|3633824|P2|STARTED|Overall Study||180
1485891|NCT01786993|3633825|P1|STARTED|Overall Study||201
1485892|NCT01786967|3633832|P1|NOT COMPLETED|Overall Study||0
1485893|NCT01786967|3633832|P1|COMPLETED|Overall Study||61
1485894|NCT01786967|3633832|P1|Metabolizer Status Undetermined|Overall Study||3
1485895|NCT01786967|3633832|P1|Poor Metabolizers|Overall Study||4
1485896|NCT01786967|3633832|P1|Extensive Metabolizers|Overall Study||54
1485897|NCT01786967|3633832|P1|STARTED|Overall Study||61
1485898|NCT01786954|3633841|P2|NOT COMPLETED|Overall Study||0
1485899|NCT01786954|3633842|P1|NOT COMPLETED|Overall Study||0
1485900|NCT01786954|3633841|P2|COMPLETED|Overall Study||34
1485901|NCT01786954|3633842|P1|COMPLETED|Overall Study||34
1485902|NCT01786954|3633841|P2|STARTED|Overall Study||34
1485903|NCT01786954|3633842|P1|STARTED|Overall Study||34
1485904|NCT01786902|3633854|P2|NOT COMPLETED|Overall Study||3
1485905|NCT01786902|3633855|P1|NOT COMPLETED|Overall Study||4
1485906|NCT01786902|3633854|P2|COMPLETED|Overall Study||31
1485907|NCT01786902|3633855|P1|COMPLETED|Overall Study||32
1485908|NCT01786902|3633854|P2|STARTED|Overall Study||34
1485909|NCT01786902|3633855|P1|STARTED|Overall Study||36
1485910|NCT01786876|3633865|P1|NOT COMPLETED|Overall Study||0
1485911|NCT01786876|3633865|P1|COMPLETED|Overall Study||6
1485912|NCT01786876|3633865|P1|STARTED|Overall Study||6
1485913|NCT01786707|3633884|P2|NOT COMPLETED|Overall Study||1
1485914|NCT01786707|3633885|P1|NOT COMPLETED|Overall Study||1
1485915|NCT01786707|3633884|P2|COMPLETED|Overall Study||0
1485916|NCT01786707|3633885|P1|COMPLETED|Overall Study||0
1485917|NCT01786707|3633884|P2|STARTED|Overall Study||1
1485918|NCT01786707|3633885|P1|STARTED|Overall Study||1
1485919|NCT01786668|3633897|P4|NOT COMPLETED|Overall Study||4
1485920|NCT01786668|3633898|P3|NOT COMPLETED|Overall Study||5
1485921|NCT01786668|3633899|P2|NOT COMPLETED|Overall Study||1
1485922|NCT01786668|3633900|P1|NOT COMPLETED|Overall Study||1
1485923|NCT01786668|3633897|P4|COMPLETED|Overall Study||47
1485924|NCT01786668|3633898|P3|COMPLETED|Overall Study||47
1485925|NCT01786668|3633899|P2|COMPLETED|Overall Study||51
1485926|NCT01786668|3633900|P1|COMPLETED|Overall Study||51
1485927|NCT01786668|3633897|P4|STARTED|Overall Study||51
1485928|NCT01786668|3633898|P3|STARTED|Overall Study||52
1485929|NCT01786668|3633899|P2|STARTED|Overall Study||52
1485930|NCT01786668|3633900|P1|STARTED|Overall Study||52
1485931|NCT01786629|3634000|P2|NOT COMPLETED|Overall Study||5
1485932|NCT01786629|3634001|P1|NOT COMPLETED|Overall Study||0
1485933|NCT01786629|3634000|P2|COMPLETED|Overall Study||164
1485934|NCT01786629|3634001|P1|COMPLETED|Overall Study||169
1485935|NCT01786629|3634000|P2|STARTED|Overall Study||169
1485936|NCT01786629|3634001|P1|STARTED|Overall Study||169
1485937|NCT01786551|3634007|P1|NOT COMPLETED|Overall Study||2
1485938|NCT01786551|3634007|P1|COMPLETED|Overall Study||14
1485939|NCT01786551|3634007|P1|STARTED|Overall Study||16
1485940|NCT01786330|3634015|P2|NOT COMPLETED|Overall Study||3
1485941|NCT01786330|3634016|P1|NOT COMPLETED|Overall Study||1
1485942|NCT01786330|3634015|P2|COMPLETED|Overall Study||27
1485943|NCT01786330|3634016|P1|COMPLETED|Overall Study||29
1485944|NCT01786330|3634015|P2|STARTED|Overall Study||30
1485945|NCT01786330|3634016|P1|STARTED|Overall Study||30
1485946|NCT01786252|3634030|P2|NOT COMPLETED|Overall Study||0
1485947|NCT01786252|3634031|P1|NOT COMPLETED|Overall Study||0
1485948|NCT01786252|3634030|P2|COMPLETED|Overall Study||8
1485949|NCT01786252|3634031|P1|COMPLETED|Overall Study||7
1485950|NCT01786252|3634030|P2|STARTED|Overall Study||8
1485951|NCT01786252|3634031|P1|STARTED|Overall Study||7
1485952|NCT01786239|3634045|P2|NOT COMPLETED|Overall Study||11
1485953|NCT01786239|3634046|P1|NOT COMPLETED|Overall Study||11
1485954|NCT01786239|3634045|P2|COMPLETED|Overall Study||14
1485955|NCT01786239|3634046|P1|COMPLETED|Overall Study||14
1485956|NCT01786239|3634045|P2|STARTED|Overall Study||25
1485957|NCT01786239|3634046|P1|STARTED|Overall Study||25
1485958|NCT01786174|3634054|P2|NOT COMPLETED|Overall Study||0
1485959|NCT01786174|3634055|P1|NOT COMPLETED|Overall Study||2
1485960|NCT01786174|3634054|P2|COMPLETED|Overall Study||10
1485961|NCT01786174|3634055|P1|COMPLETED|Overall Study||16
1485962|NCT01786174|3634054|P2|Randomized|Overall Study||11
1485963|NCT01786174|3634055|P1|Randomized|Overall Study||19
1485964|NCT01786174|3634054|P2|STARTED|Overall Study||10
1485965|NCT01786174|3634055|P1|STARTED|Overall Study||18
1485966|NCT01786161|3634071|P2|NOT COMPLETED|Overall Study||0
1485967|NCT01786161|3634072|P1|NOT COMPLETED|Overall Study||0
1485968|NCT01786161|3634071|P2|COMPLETED|Overall Study||22
1485969|NCT01786161|3634072|P1|COMPLETED|Overall Study||22
1485970|NCT01786161|3634071|P2|STARTED|Overall Study||22
1485971|NCT01786161|3634072|P1|STARTED|Overall Study||22
1485972|NCT01786109|3634085|P3|NOT COMPLETED|Overall Study||2
1485973|NCT01786109|3634086|P2|NOT COMPLETED|Overall Study||0
1485974|NCT01786109|3634087|P1|NOT COMPLETED|Overall Study||1
1485975|NCT01786109|3634085|P3|COMPLETED|Overall Study||25
1485976|NCT01786109|3634086|P2|COMPLETED|Overall Study||24
1485977|NCT01786109|3634087|P1|COMPLETED|Overall Study||23
1485978|NCT01786109|3634085|P3|STARTED|Overall Study||27
1485979|NCT01786109|3634086|P2|STARTED|Overall Study||24
1485980|NCT01786109|3634087|P1|STARTED|Overall Study||24
1485981|NCT01785875|3634116|P3|NOT COMPLETED|Overall Study||107
1485982|NCT01785875|3634117|P2|NOT COMPLETED|Overall Study||289
1485983|NCT01785875|3634118|P1|NOT COMPLETED|Overall Study||294
1485984|NCT01785875|3634116|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
1485985|NCT01785875|3634117|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
1485986|NCT01785875|3634118|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
1485987|NCT01785875|3634116|P3|Received Etelcalcetide|Overall Study||123
1485988|NCT01785875|3634117|P2|Received Etelcalcetide|Overall Study||384
1485989|NCT01785875|3634118|P1|Received Etelcalcetide|Overall Study||383
1485990|NCT01785875|3634116|P3|STARTED|Overall Study||123
1485991|NCT01785875|3634117|P2|STARTED|Overall Study||384
1485992|NCT01785875|3634118|P1|STARTED|Overall Study||384
1485993|NCT01785849|3634187|P2|NOT COMPLETED|Overall Study||34
1485994|NCT01785849|3634188|P1|NOT COMPLETED|Overall Study||61
1485995|NCT01785849|3634187|P2|COMPLETED|Overall Study||220
1485996|NCT01785849|3634188|P1|COMPLETED|Overall Study||193
1485997|NCT01785849|3634187|P2|Received Treatment|Overall Study||251
1485998|NCT01785849|3634188|P1|Received Treatment|Overall Study||254
1485999|NCT01785849|3634187|P2|STARTED|Overall Study||254
1486000|NCT01785849|3634188|P1|STARTED|Overall Study||254
1486001|NCT01785628|3634206|P2|NOT COMPLETED|Overall Study||3
1486002|NCT01785628|3634207|P1|NOT COMPLETED|Overall Study||2
1486003|NCT01785628|3634206|P2|COMPLETED|Overall Study||12
1486004|NCT01785628|3634207|P1|COMPLETED|Overall Study||13
1486005|NCT01785628|3634206|P2|STARTED|Overall Study||15
1486006|NCT01785628|3634207|P1|STARTED|Overall Study||15
1486007|NCT01785615|3634230|P4|NOT COMPLETED|Atorvastatin Phase||0
1486008|NCT01785615|3634231|P3|NOT COMPLETED|Atorvastatin Phase||0
1486009|NCT01785615|3634232|P2|NOT COMPLETED|Atorvastatin Phase||0
1486010|NCT01785615|3634233|P1|NOT COMPLETED|Atorvastatin Phase||0
1486011|NCT01785615|3634230|P4|COMPLETED|Atorvastatin Phase||0
1486012|NCT01785615|3634231|P3|COMPLETED|Atorvastatin Phase||0
1486013|NCT01785615|3634232|P2|COMPLETED|Atorvastatin Phase||44
1486014|NCT01785615|3634233|P1|COMPLETED|Atorvastatin Phase||44
1486015|NCT01785615|3634230|P4|STARTED|Atorvastatin Phase||0
1486016|NCT01785615|3634231|P3|STARTED|Atorvastatin Phase||0
1486017|NCT01785615|3634232|P2|STARTED|Atorvastatin Phase||44
1486018|NCT01785615|3634233|P1|STARTED|Atorvastatin Phase||44
1486019|NCT01785615|3634230|P4|NOT COMPLETED|Dietary Phase||24
1486020|NCT01785615|3634231|P3|NOT COMPLETED|Dietary Phase||0
1486021|NCT01785615|3634232|P2|NOT COMPLETED|Dietary Phase||0
1486022|NCT01785615|3634233|P1|NOT COMPLETED|Dietary Phase||0
1486023|NCT01785615|3634230|P4|COMPLETED|Dietary Phase||116
1486024|NCT01785615|3634231|P3|COMPLETED|Dietary Phase||35
1486025|NCT01785615|3634232|P2|COMPLETED|Dietary Phase||0
1486026|NCT01785615|3634233|P1|COMPLETED|Dietary Phase||0
1486027|NCT01785615|3634230|P4|STARTED|Dietary Phase||140
1486028|NCT01785615|3634231|P3|STARTED|Dietary Phase||35
1486029|NCT01785615|3634232|P2|STARTED|Dietary Phase||0
1486030|NCT01785615|3634233|P1|STARTED|Dietary Phase||0
1486031|NCT01785602|3634305|P2|NOT COMPLETED|Overall Study||9
1486032|NCT01785602|3634306|P1|NOT COMPLETED|Overall Study||13
1486033|NCT01785602|3634305|P2|COMPLETED|Overall Study||18
1486034|NCT01785602|3634306|P1|COMPLETED|Overall Study||63
1486035|NCT01785602|3634305|P2|STARTED|Overall Study||27
1486036|NCT01785602|3634306|P1|STARTED|Overall Study||76
1486037|NCT01785524|3634316|P2|NOT COMPLETED|Overall Study||2
1486038|NCT01785524|3634317|P1|NOT COMPLETED|Overall Study||2
1486039|NCT01785524|3634316|P2|COMPLETED|Overall Study||2
1486040|NCT01785524|3634317|P1|COMPLETED|Overall Study||5
1486041|NCT01785524|3634316|P2|STARTED|Overall Study||4
1486042|NCT01785524|3634317|P1|STARTED|Overall Study||7
1486043|NCT01785472|3634336|P3|NOT COMPLETED|Overall Study||22
1486044|NCT01785472|3634337|P2|NOT COMPLETED|Overall Study||19
1486045|NCT01785472|3634338|P1|NOT COMPLETED|Overall Study||24
1486046|NCT01785472|3634336|P3|COMPLETED|Overall Study||464
1486047|NCT01785472|3634337|P2|COMPLETED|Overall Study||454
1486048|NCT01785472|3634338|P1|COMPLETED|Overall Study||455
1486049|NCT01785472|3634336|P3|Safety Set (SAF)|Overall Study||484
1486050|NCT01785472|3634337|P2|Safety Set (SAF)|Overall Study||472
1486051|NCT01785472|3634338|P1|Safety Set (SAF)|Overall Study||478
1486052|NCT01785472|3634336|P3|Full Analysis Set (FAS)|Overall Study||484
1486053|NCT01785472|3634337|P2|Full Analysis Set (FAS)|Overall Study||472
1486054|NCT01785472|3634338|P1|Full Analysis Set (FAS)|Overall Study||479
1486055|NCT01785472|3634336|P3|STARTED|Overall Study||486
1486056|NCT01785472|3634337|P2|STARTED|Overall Study||473
1486057|NCT01785472|3634338|P1|STARTED|Overall Study||479
1486058|NCT01785186|3634385|P5|NOT COMPLETED|Overall Study||6
1486059|NCT01785186|3634386|P4|NOT COMPLETED|Overall Study||5
1486060|NCT01785186|3634387|P3|NOT COMPLETED|Overall Study||5
1486061|NCT01785186|3634388|P2|NOT COMPLETED|Overall Study||6
1486062|NCT01785186|3634389|P1|NOT COMPLETED|Overall Study||6
1486063|NCT01785186|3634385|P5|COMPLETED|Overall Study||117
1486064|NCT01785186|3634386|P4|COMPLETED|Overall Study||58
1486065|NCT01785186|3634387|P3|COMPLETED|Overall Study||52
1486066|NCT01785186|3634388|P2|COMPLETED|Overall Study||57
1486067|NCT01785186|3634389|P1|COMPLETED|Overall Study||53
1486068|NCT01785186|3634385|P5|STARTED|Overall Study||123
1486069|NCT01785186|3634386|P4|STARTED|Overall Study||63
1486070|NCT01785186|3634387|P3|STARTED|Overall Study||57
1486071|NCT01785186|3634388|P2|STARTED|Overall Study||63
1486072|NCT01785186|3634389|P1|STARTED|Overall Study||59
1486073|NCT01785160|3634411|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
1486074|NCT01785160|3634411|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
1486075|NCT01785160|3634411|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
1486076|NCT01785160|3634411|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
1486077|NCT01785160|3634411|P1|COMPLETED|Washout Period of at Least 7 Days||23
1486078|NCT01785160|3634411|P1|STARTED|Washout Period of at Least 7 Days||24
1486079|NCT01785160|3634411|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
1486080|NCT01785160|3634411|P1|COMPLETED|Treatment Period 1: Raltegravir||24
1486081|NCT01785160|3634411|P1|STARTED|Treatment Period 1: Raltegravir||25
1486082|NCT01785134|3634421|P2|NOT COMPLETED|Overall Study||7
1486083|NCT01785134|3634422|P1|NOT COMPLETED|Overall Study||12
1486084|NCT01785134|3634421|P2|COMPLETED|Overall Study||33
1486085|NCT01785134|3634422|P1|COMPLETED|Overall Study||29
1486086|NCT01785134|3634421|P2|STARTED|Overall Study||40
1486087|NCT01785134|3634422|P1|STARTED|Overall Study||41
1486088|NCT01785095|3634436|P1|NOT COMPLETED|Overall Study||3
1486089|NCT01785095|3634436|P1|COMPLETED|Overall Study||24
1486090|NCT01785095|3634436|P1|STARTED|Overall Study||27
1486091|NCT01784965|3634446|P2|NOT COMPLETED|Overall Study||11
1486092|NCT01784965|3634447|P1|NOT COMPLETED|Overall Study||6
1486093|NCT01784965|3634446|P2|COMPLETED|Overall Study||24
1486094|NCT01784965|3634447|P1|COMPLETED|Overall Study||27
1486095|NCT01784965|3634446|P2|STARTED|Overall Study||35
1486096|NCT01784965|3634447|P1|STARTED|Overall Study||33
1486097|NCT01784770|3634457|P1|NOT COMPLETED|Overall Study||0
1486098|NCT01784770|3634457|P1|COMPLETED|Overall Study||21
1486099|NCT01784770|3634457|P1|STARTED|Overall Study||21
1486100|NCT01784666|3634465|P3|NOT COMPLETED|Overall Study||0
1486101|NCT01784666|3634466|P2|NOT COMPLETED|Overall Study||0
1486102|NCT01784666|3634467|P1|NOT COMPLETED|Overall Study||0
1486103|NCT01784666|3634465|P3|COMPLETED|Overall Study||1
1486104|NCT01784666|3634466|P2|COMPLETED|Overall Study||0
1486105|NCT01784666|3634467|P1|COMPLETED|Overall Study||1
1486106|NCT01784666|3634465|P3|STARTED|Overall Study||1
1486107|NCT01784666|3634466|P2|STARTED|Overall Study||0
1486108|NCT01784666|3634467|P1|STARTED|Overall Study||1
1486109|NCT01784614|3634475|P8|NOT COMPLETED|Period 4||0
1486110|NCT01784614|3634476|P7|NOT COMPLETED|Period 4||0
1486111|NCT01784614|3634477|P6|NOT COMPLETED|Period 4||0
1486112|NCT01784614|3634478|P5|NOT COMPLETED|Period 4||0
1486113|NCT01784614|3634479|P4|NOT COMPLETED|Period 4||0
1486114|NCT01784614|3634480|P3|NOT COMPLETED|Period 4||0
1486115|NCT01784614|3634481|P2|NOT COMPLETED|Period 4||0
1486116|NCT01784614|3634482|P1|NOT COMPLETED|Period 4||0
1486117|NCT01784614|3634475|P8|COMPLETED|Period 4||2
1486118|NCT01784614|3634476|P7|COMPLETED|Period 4||3
1486119|NCT01784614|3634477|P6|COMPLETED|Period 4||3
1486120|NCT01784614|3634478|P5|COMPLETED|Period 4||3
1486121|NCT01784614|3634479|P4|COMPLETED|Period 4||3
1486122|NCT01784614|3634480|P3|COMPLETED|Period 4||3
1486123|NCT01784614|3634481|P2|COMPLETED|Period 4||2
1486124|NCT01784614|3634482|P1|COMPLETED|Period 4||3
1486125|NCT01784614|3634475|P8|STARTED|Period 4||2
1486126|NCT01784614|3634476|P7|STARTED|Period 4||3
1486127|NCT01784614|3634477|P6|STARTED|Period 4||3
1486128|NCT01784614|3634478|P5|STARTED|Period 4||3
1486129|NCT01784614|3634479|P4|STARTED|Period 4||3
1486130|NCT01784614|3634480|P3|STARTED|Period 4||3
1486131|NCT01784614|3634481|P2|STARTED|Period 4||2
1486132|NCT01784614|3634482|P1|STARTED|Period 4||3
1486133|NCT01784614|3634475|P8|NOT COMPLETED|Period 3||0
1486134|NCT01784614|3634476|P7|NOT COMPLETED|Period 3||0
1486135|NCT01784614|3634477|P6|NOT COMPLETED|Period 3||0
1486136|NCT01784614|3634478|P5|NOT COMPLETED|Period 3||0
1486137|NCT01784614|3634479|P4|NOT COMPLETED|Period 3||0
1486138|NCT01784614|3634480|P3|NOT COMPLETED|Period 3||0
1486139|NCT01784614|3634481|P2|NOT COMPLETED|Period 3||0
1486140|NCT01784614|3634482|P1|NOT COMPLETED|Period 3||0
1486141|NCT01784614|3634475|P8|COMPLETED|Period 3||2
1486142|NCT01784614|3634476|P7|COMPLETED|Period 3||3
1486143|NCT01784614|3634477|P6|COMPLETED|Period 3||3
1486144|NCT01784614|3634478|P5|COMPLETED|Period 3||3
1486145|NCT01784614|3634479|P4|COMPLETED|Period 3||3
1486146|NCT01784614|3634480|P3|COMPLETED|Period 3||3
1486147|NCT01784614|3634481|P2|COMPLETED|Period 3||2
1486148|NCT01784614|3634482|P1|COMPLETED|Period 3||3
1486149|NCT01784614|3634475|P8|STARTED|Period 3||2
1486150|NCT01784614|3634476|P7|STARTED|Period 3||3
1486151|NCT01784614|3634477|P6|STARTED|Period 3||3
1486152|NCT01784614|3634478|P5|STARTED|Period 3||3
1486153|NCT01784614|3634479|P4|STARTED|Period 3||3
1486154|NCT01784614|3634480|P3|STARTED|Period 3||3
1486155|NCT01784614|3634481|P2|STARTED|Period 3||2
1486156|NCT01784614|3634482|P1|STARTED|Period 3||3
1486157|NCT01784614|3634475|P8|NOT COMPLETED|Period 2||0
1486158|NCT01784614|3634476|P7|NOT COMPLETED|Period 2||0
1486159|NCT01784614|3634477|P6|NOT COMPLETED|Period 2||0
1486160|NCT01784614|3634478|P5|NOT COMPLETED|Period 2||0
1486161|NCT01784614|3634479|P4|NOT COMPLETED|Period 2||0
1486162|NCT01784614|3634480|P3|NOT COMPLETED|Period 2||0
1486163|NCT01784614|3634481|P2|NOT COMPLETED|Period 2||0
1486164|NCT01784614|3634482|P1|NOT COMPLETED|Period 2||0
1486165|NCT01784614|3634475|P8|COMPLETED|Period 2||2
1486166|NCT01784614|3634476|P7|COMPLETED|Period 2||3
1486167|NCT01784614|3634477|P6|COMPLETED|Period 2||3
1486168|NCT01784614|3634478|P5|COMPLETED|Period 2||3
1486169|NCT01784614|3634479|P4|COMPLETED|Period 2||3
1486170|NCT01784614|3634480|P3|COMPLETED|Period 2||3
1486171|NCT01784614|3634481|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
1486172|NCT01784614|3634482|P1|COMPLETED|Period 2||3
1486173|NCT01784614|3634475|P8|STARTED|Period 2||2
1486174|NCT01784614|3634476|P7|STARTED|Period 2||3
1486175|NCT01784614|3634477|P6|STARTED|Period 2||3
1486176|NCT01784614|3634478|P5|STARTED|Period 2||3
1486177|NCT01784614|3634479|P4|STARTED|Period 2||3
1486178|NCT01784614|3634480|P3|STARTED|Period 2||3
1486179|NCT01784614|3634481|P2|STARTED|Period 2||3
1486180|NCT01784614|3634482|P1|STARTED|Period 2||3
1486181|NCT01784614|3634475|P8|NOT COMPLETED|Period 1||0
1486182|NCT01784614|3634476|P7|NOT COMPLETED|Period 1||0
1486183|NCT01784614|3634477|P6|NOT COMPLETED|Period 1||0
1486184|NCT01784614|3634478|P5|NOT COMPLETED|Period 1||0
1486185|NCT01784614|3634479|P4|NOT COMPLETED|Period 1||0
1486186|NCT01784614|3634480|P3|NOT COMPLETED|Period 1||0
1486187|NCT01784614|3634481|P2|NOT COMPLETED|Period 1||0
1486188|NCT01784614|3634482|P1|NOT COMPLETED|Period 1||0
1486189|NCT01784614|3634475|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
1486190|NCT01784614|3634476|P7|COMPLETED|Period 1||3
1486191|NCT01784614|3634477|P6|COMPLETED|Period 1||3
1486192|NCT01784614|3634478|P5|COMPLETED|Period 1||3
1486193|NCT01784614|3634479|P4|COMPLETED|Period 1||3
1486194|NCT01784614|3634480|P3|COMPLETED|Period 1||3
1486195|NCT01784614|3634481|P2|COMPLETED|Period 1||3
1486196|NCT01784614|3634482|P1|COMPLETED|Period 1||3
1486197|NCT01784614|3634475|P8|Received at Least 1 Dose of Study Drug|Period 1||3
1486198|NCT01784614|3634476|P7|Received at Least 1 Dose of Study Drug|Period 1||3
1486199|NCT01784614|3634477|P6|Received at Least 1 Dose of Study Drug|Period 1||3
1486200|NCT01784614|3634478|P5|Received at Least 1 Dose of Study Drug|Period 1||3
1486201|NCT01784614|3634479|P4|Received at Least 1 Dose of Study Drug|Period 1||3
1486202|NCT01784614|3634480|P3|Received at Least 1 Dose of Study Drug|Period 1||3
1486203|NCT01784614|3634481|P2|Received at Least 1 Dose of Study Drug|Period 1||3
1486204|NCT01784614|3634482|P1|Received at Least 1 Dose of Study Drug|Period 1||3
1486205|NCT01784614|3634475|P8|STARTED|Period 1||3
1486206|NCT01784614|3634476|P7|STARTED|Period 1||3
1486207|NCT01784614|3634477|P6|STARTED|Period 1||3
1486208|NCT01784614|3634478|P5|STARTED|Period 1||3
1486209|NCT01784614|3634479|P4|STARTED|Period 1||3
1486210|NCT01784614|3634480|P3|STARTED|Period 1||3
1486211|NCT01784614|3634481|P2|STARTED|Period 1||3
1486212|NCT01784614|3634482|P1|STARTED|Period 1||3
1486213|NCT01784055|3634516|P1|NOT COMPLETED|Overall Study||26
1486214|NCT01784055|3634516|P1|COMPLETED|Overall Study||100
1486215|NCT01784055|3634516|P1|STARTED|Overall Study||126
1486216|NCT01784029|3634523|P3|NOT COMPLETED|Overall Study||22
1486217|NCT01784029|3634524|P2|NOT COMPLETED|Overall Study||20
1486218|NCT01784029|3634525|P1|NOT COMPLETED|Overall Study||19
1486219|NCT01784029|3634523|P3|COMPLETED|Overall Study||41
1486220|NCT01784029|3634524|P2|COMPLETED|Overall Study||39
1486221|NCT01784029|3634525|P1|COMPLETED|Overall Study||42
1486222|NCT01784029|3634523|P3|STARTED|Overall Study||63
1486223|NCT01784029|3634524|P2|STARTED|Overall Study||59
1486224|NCT01784029|3634525|P1|STARTED|Overall Study||61
1486225|NCT01783938|3634535|P2|NOT COMPLETED|Overall Study||53
1486226|NCT01783938|3634536|P1|NOT COMPLETED|Overall Study||47
1486227|NCT01783938|3634535|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
1486228|NCT01783938|3634536|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
1486229|NCT01783938|3634535|P2|STARTED|Overall Study||70
1486230|NCT01783938|3634536|P1|STARTED|Overall Study||68
1486231|NCT01783912|3634551|P3|NOT COMPLETED|Overall Study||23
1486232|NCT01783912|3634552|P2|NOT COMPLETED|Overall Study||46
1486233|NCT01783912|3634553|P1|NOT COMPLETED|Overall Study||30
1486234|NCT01783912|3634551|P3|COMPLETED|Overall Study||25
1486235|NCT01783912|3634552|P2|COMPLETED|Overall Study||58
1486236|NCT01783912|3634553|P1|COMPLETED|Overall Study||88
1486237|NCT01783912|3634551|P3|STARTED|Overall Study||48
1486238|NCT01783912|3634552|P2|STARTED|Overall Study||104
1486239|NCT01783912|3634553|P1|STARTED|Overall Study||118
1486240|NCT01783886|3634564|P3|NOT COMPLETED|Overall Study||10
1486241|NCT01783886|3634565|P2|NOT COMPLETED|Overall Study||11
1486242|NCT01783886|3634566|P1|NOT COMPLETED|Overall Study||5
1486243|NCT01783886|3634564|P3|COMPLETED|Overall Study||117
1486244|NCT01783886|3634565|P2|COMPLETED|Overall Study||116
1486245|NCT01783886|3634566|P1|COMPLETED|Overall Study||122
1486246|NCT01783886|3634564|P3|Participants Received Treatment|Overall Study||124
1486247|NCT01783886|3634565|P2|Participants Received Treatment|Overall Study||127
1486248|NCT01783886|3634566|P1|Participants Received Treatment|Overall Study||127
1486249|NCT01783886|3634564|P3|STARTED|Overall Study||127
1486250|NCT01783886|3634565|P2|STARTED|Overall Study||127
1486251|NCT01783886|3634566|P1|STARTED|Overall Study||127
1486252|NCT01783860|3634594|P2|NOT COMPLETED|Overall Study||0
1486253|NCT01783860|3634595|P1|NOT COMPLETED|Overall Study||0
1486254|NCT01783860|3634594|P2|COMPLETED|Overall Study||50
1486255|NCT01783860|3634595|P1|COMPLETED|Overall Study||50
1486256|NCT01783860|3634594|P2|STARTED|Overall Study||50
1486257|NCT01783860|3634595|P1|STARTED|Overall Study||50
1486258|NCT01783847|3634614|P3|NOT COMPLETED|Overall Study||0
1486259|NCT01783847|3634615|P2|NOT COMPLETED|Overall Study||1
1486260|NCT01783847|3634616|P1|NOT COMPLETED|Overall Study||16
1486261|NCT01783847|3634614|P3|COMPLETED|Overall Study||16
1486262|NCT01783847|3634615|P2|COMPLETED|Overall Study||15
1486263|NCT01783847|3634616|P1|COMPLETED|Overall Study||69
1486264|NCT01783847|3634614|P3|STARTED|Overall Study||16
1486265|NCT01783847|3634615|P2|STARTED|Overall Study||16
1486266|NCT01783847|3634616|P1|STARTED|Overall Study||85
1486267|NCT01783821|3634626|P2|NOT COMPLETED|Overall Study||1
1486268|NCT01783821|3634627|P1|NOT COMPLETED|Overall Study||1
1486269|NCT01783821|3634626|P2|COMPLETED|Overall Study||30
1486270|NCT01783821|3634627|P1|COMPLETED|Overall Study||29
1486271|NCT01783821|3634626|P2|STARTED|Overall Study||31
1486272|NCT01783821|3634627|P1|STARTED|Overall Study||30
1486273|NCT01783743|3634645|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
1486274|NCT01783743|3634646|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
1486275|NCT01783743|3634645|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
1486276|NCT01783743|3634646|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
1486277|NCT01783743|3634645|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
1486278|NCT01783743|3634646|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
1486279|NCT01783743|3634645|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
1486280|NCT01783743|3634646|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
1486281|NCT01783743|3634645|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
1486282|NCT01783743|3634646|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
1486283|NCT01783743|3634645|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
1486284|NCT01783743|3634646|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
1486285|NCT01783743|3634645|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
1486286|NCT01783743|3634646|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
1486382|NCT01783054|3634928|P1|STARTED|Overall Study||2
1486287|NCT01783743|3634645|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
1486288|NCT01783743|3634646|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
1486289|NCT01783743|3634645|P2|STARTED|Screening of Subjects by CTA During MDA||13964
1486290|NCT01783743|3634646|P1|STARTED|Screening of Subjects by CTA During MDA||13509
1486291|NCT01783730|3634660|P1|NOT COMPLETED|Overall Study||6
1486292|NCT01783730|3634660|P1|COMPLETED|Overall Study||157
1486293|NCT01783730|3634660|P1|STARTED|Overall Study||163
1486294|NCT01783678|3634685|P6|NOT COMPLETED|Overall Study||5
1486295|NCT01783678|3634686|P5|NOT COMPLETED|Overall Study||7
1486296|NCT01783678|3634687|P4|NOT COMPLETED|Overall Study||8
1486297|NCT01783678|3634688|P3|NOT COMPLETED|Overall Study||1
1486298|NCT01783678|3634689|P2|NOT COMPLETED|Overall Study||18
1486299|NCT01783678|3634690|P1|NOT COMPLETED|Overall Study||2
1486300|NCT01783678|3634685|P6|COMPLETED|Overall Study||26
1486301|NCT01783678|3634686|P5|COMPLETED|Overall Study||42
1486302|NCT01783678|3634687|P4|COMPLETED|Overall Study||50
1486303|NCT01783678|3634688|P3|COMPLETED|Overall Study||5
1486304|NCT01783678|3634689|P2|COMPLETED|Overall Study||94
1486305|NCT01783678|3634690|P1|COMPLETED|Overall Study||17
1486306|NCT01783678|3634685|P6|STARTED|Overall Study||31
1486307|NCT01783678|3634686|P5|STARTED|Overall Study||49
1486308|NCT01783678|3634687|P4|STARTED|Overall Study||58
1486309|NCT01783678|3634688|P3|STARTED|Overall Study||6
1486310|NCT01783678|3634689|P2|STARTED|Overall Study||112
1486311|NCT01783678|3634690|P1|STARTED|Overall Study||19
1486312|NCT01783639|3634762|P1|NOT COMPLETED|Overall Study||0
1486313|NCT01783639|3634762|P1|COMPLETED|Overall Study||120
1486314|NCT01783639|3634762|P1|STARTED|Overall Study||120
1486315|NCT01783574|3634768|P2|NOT COMPLETED|Overall Study||9
1486316|NCT01783574|3634769|P1|NOT COMPLETED|Overall Study||5
1486317|NCT01783574|3634768|P2|COMPLETED|Overall Study||41
1486318|NCT01783574|3634769|P1|COMPLETED|Overall Study||46
1486319|NCT01783574|3634768|P2|STARTED|Overall Study||50
1486320|NCT01783574|3634769|P1|STARTED|Overall Study||51
1486321|NCT01783561|3634781|P2|NOT COMPLETED|Overall Study||0
1486322|NCT01783561|3634782|P1|NOT COMPLETED|Overall Study||0
1486323|NCT01783561|3634781|P2|COMPLETED|Overall Study||10
1486324|NCT01783561|3634782|P1|COMPLETED|Overall Study||11
1486325|NCT01783561|3634781|P2|STARTED|Overall Study||10
1486326|NCT01783561|3634782|P1|STARTED|Overall Study||11
1486327|NCT01783548|3634794|P2|NOT COMPLETED|Overall Study||18
1486328|NCT01783548|3634795|P1|NOT COMPLETED|Overall Study||34
1486329|NCT01783548|3634794|P2|COMPLETED|Overall Study||167
1486330|NCT01783548|3634795|P1|COMPLETED|Overall Study||328
1486331|NCT01783548|3634794|P2|Full Analysis Set (FAS)|Overall Study||184
1486332|NCT01783548|3634795|P1|Full Analysis Set (FAS)|Overall Study||358
1486333|NCT01783548|3634794|P2|STARTED|Overall Study|Randomized|185
1486334|NCT01783548|3634795|P1|STARTED|Overall Study|Randomized|362
1486335|NCT01783496|3634813|P6|NOT COMPLETED|Overall Study||1
1486336|NCT01783496|3634814|P5|NOT COMPLETED|Overall Study||0
1486337|NCT01783496|3634815|P4|NOT COMPLETED|Overall Study||2
1486338|NCT01783496|3634816|P3|NOT COMPLETED|Overall Study||0
1486339|NCT01783496|3634817|P2|NOT COMPLETED|Overall Study||0
1486340|NCT01783496|3634818|P1|NOT COMPLETED|Overall Study||1
1486341|NCT01783496|3634813|P6|COMPLETED|Overall Study||4
1486342|NCT01783496|3634814|P5|COMPLETED|Overall Study||5
1486343|NCT01783496|3634815|P4|COMPLETED|Overall Study||8
1486344|NCT01783496|3634816|P3|COMPLETED|Overall Study||10
1486345|NCT01783496|3634817|P2|COMPLETED|Overall Study||10
1486346|NCT01783496|3634818|P1|COMPLETED|Overall Study||9
1486347|NCT01783496|3634813|P6|STARTED|Overall Study||5
1486348|NCT01783496|3634814|P5|STARTED|Overall Study||5
1486349|NCT01783496|3634815|P4|STARTED|Overall Study||10
1486350|NCT01783496|3634816|P3|STARTED|Overall Study||10
1486351|NCT01783496|3634817|P2|STARTED|Overall Study||10
1486352|NCT01783496|3634818|P1|STARTED|Overall Study||10
1486353|NCT01783483|3634846|P2|NOT COMPLETED|Overall Study||15
1486354|NCT01783483|3634847|P1|NOT COMPLETED|Overall Study||20
1486355|NCT01783483|3634846|P2|COMPLETED|Overall Study||101
1486356|NCT01783483|3634847|P1|COMPLETED|Overall Study||100
1486357|NCT01783483|3634846|P2|STARTED|Overall Study||116
1486358|NCT01783483|3634847|P1|STARTED|Overall Study||120
1486359|NCT01783470|3634875|P2|NOT COMPLETED|Overall Study||0
1486360|NCT01783470|3634876|P1|NOT COMPLETED|Overall Study||0
1486361|NCT01783470|3634875|P2|COMPLETED|Overall Study||6
1486362|NCT01783470|3634876|P1|COMPLETED|Overall Study||6
1486363|NCT01783470|3634875|P2|STARTED|Overall Study|Single-dose|6
1486364|NCT01783470|3634876|P1|STARTED|Overall Study||6
1486365|NCT01783418|3634885|P2|NOT COMPLETED|Overall Study||0
1486366|NCT01783418|3634886|P1|NOT COMPLETED|Overall Study||1
1486367|NCT01783418|3634885|P2|COMPLETED|Overall Study||6
1486368|NCT01783418|3634886|P1|COMPLETED|Overall Study||7
1486369|NCT01783418|3634885|P2|STARTED|Overall Study||6
1486370|NCT01783418|3634886|P1|STARTED|Overall Study||8
1486371|NCT01783236|3634906|P2|NOT COMPLETED|Overall Study||0
1486372|NCT01783236|3634907|P1|NOT COMPLETED|Overall Study||2
1486373|NCT01783236|3634906|P2|COMPLETED|Overall Study||8
1486374|NCT01783236|3634907|P1|COMPLETED|Overall Study||6
1486375|NCT01783236|3634906|P2|STARTED|Overall Study||8
1486376|NCT01783236|3634907|P1|STARTED|Overall Study||8
1486377|NCT01783080|3634921|P1|NOT COMPLETED|Overall Study||0
1486378|NCT01783080|3634921|P1|COMPLETED|Overall Study||16
1486379|NCT01783080|3634921|P1|STARTED|Overall Study||16
1486380|NCT01783054|3634928|P1|NOT COMPLETED|Overall Study||0
1486381|NCT01783054|3634928|P1|COMPLETED|Overall Study||2
1486383|NCT01783015|3634939|P3|NOT COMPLETED|Open Label Treatment||6
1486384|NCT01783015|3634940|P2|NOT COMPLETED|Open Label Treatment||0
1486385|NCT01783015|3634941|P1|NOT COMPLETED|Open Label Treatment||0
1486386|NCT01783015|3634939|P3|COMPLETED|Open Label Treatment||5
1486387|NCT01783015|3634940|P2|COMPLETED|Open Label Treatment||0
1486388|NCT01783015|3634941|P1|COMPLETED|Open Label Treatment||0
1486389|NCT01783015|3634939|P3|STARTED|Open Label Treatment||11
1486390|NCT01783015|3634940|P2|STARTED|Open Label Treatment||0
1486391|NCT01783015|3634941|P1|STARTED|Open Label Treatment||0
1486392|NCT01783015|3634939|P3|NOT COMPLETED|Blinded Treatment||0
1486393|NCT01783015|3634940|P2|NOT COMPLETED|Blinded Treatment||3
1486394|NCT01783015|3634941|P1|NOT COMPLETED|Blinded Treatment||2
1486395|NCT01783015|3634939|P3|COMPLETED|Blinded Treatment||0
1486396|NCT01783015|3634940|P2|COMPLETED|Blinded Treatment||2
1486397|NCT01783015|3634941|P1|COMPLETED|Blinded Treatment||9
1486398|NCT01783015|3634939|P3|Treated|Blinded Treatment||0
1486399|NCT01783015|3634940|P2|Treated|Blinded Treatment||5
1486400|NCT01783015|3634941|P1|Treated|Blinded Treatment||11
1486401|NCT01783015|3634939|P3|STARTED|Blinded Treatment||0
1486402|NCT01783015|3634940|P2|STARTED|Blinded Treatment||5
1486403|NCT01783015|3634941|P1|STARTED|Blinded Treatment||11
1486404|NCT01782963|3635026|P1|NOT COMPLETED|Overall Study||0
1486405|NCT01782963|3635026|P1|COMPLETED|Overall Study||50
1486406|NCT01782963|3635026|P1|STARTED|Overall Study||50
1486407|NCT01782898|3635041|P2|NOT COMPLETED|Overall Study||6
1486408|NCT01782898|3635042|P1|NOT COMPLETED|Overall Study||6
1486409|NCT01782898|3635041|P2|COMPLETED|Overall Study||29
1486410|NCT01782898|3635042|P1|COMPLETED|Overall Study||29
1486411|NCT01782898|3635041|P2|STARTED|Overall Study||35
1486412|NCT01782898|3635042|P1|STARTED|Overall Study||35
1486413|NCT01782885|3635054|P2|NOT COMPLETED|Overall Study||6
1486414|NCT01782885|3635055|P1|NOT COMPLETED|Overall Study||4
1486415|NCT01782885|3635054|P2|COMPLETED|Overall Study||33
1486416|NCT01782885|3635055|P1|COMPLETED|Overall Study||32
1486417|NCT01782885|3635054|P2|STARTED|Overall Study||39
1486418|NCT01782885|3635055|P1|STARTED|Overall Study||36
1486419|NCT01782872|3635081|P4|NOT COMPLETED|Overall Study||1
1486420|NCT01782872|3635082|P3|NOT COMPLETED|Overall Study||0
1486421|NCT01782872|3635083|P2|NOT COMPLETED|Overall Study||1
1486422|NCT01782872|3635084|P1|NOT COMPLETED|Overall Study||0
1486423|NCT01782872|3635081|P4|COMPLETED|Overall Study||19
1486424|NCT01782872|3635082|P3|COMPLETED|Overall Study||20
1486425|NCT01782872|3635083|P2|COMPLETED|Overall Study||19
1486426|NCT01782872|3635084|P1|COMPLETED|Overall Study||20
1486427|NCT01782872|3635081|P4|STARTED|Overall Study||20
1486428|NCT01782872|3635082|P3|STARTED|Overall Study||20
1486429|NCT01782872|3635083|P2|STARTED|Overall Study||20
1486430|NCT01782872|3635084|P1|STARTED|Overall Study||20
1486431|NCT01782859|3635108|P2|NOT COMPLETED|Overall Study||7
1486432|NCT01782859|3635109|P1|NOT COMPLETED|Overall Study||6
1486433|NCT01782859|3635108|P2|COMPLETED|Overall Study||13
1486434|NCT01782859|3635109|P1|COMPLETED|Overall Study||14
1486435|NCT01782859|3635108|P2|STARTED|Overall Study||20
1486436|NCT01782859|3635109|P1|STARTED|Overall Study||20
1486437|NCT01782833|3635123|P1|NOT COMPLETED|Overall Study||270
1486438|NCT01782833|3635123|P1|COMPLETED|Overall Study||3365
1486439|NCT01782833|3635123|P1|STARTED|Overall Study||3635
1486440|NCT01782742|3635131|P2|NOT COMPLETED|Open Label Phase||0
1486441|NCT01782742|3635132|P1|NOT COMPLETED|Open Label Phase||0
1486442|NCT01782742|3635131|P2|COMPLETED|Open Label Phase||0
1486443|NCT01782742|3635132|P1|COMPLETED|Open Label Phase||19
1486444|NCT01782742|3635131|P2|STARTED|Open Label Phase||0
1486445|NCT01782742|3635132|P1|STARTED|Open Label Phase||19
1486446|NCT01782742|3635131|P2|NOT COMPLETED|Double-blind Treatment Phase||0
1486447|NCT01782742|3635132|P1|NOT COMPLETED|Double-blind Treatment Phase||1
1486448|NCT01782742|3635131|P2|COMPLETED|Double-blind Treatment Phase||4
1486449|NCT01782742|3635132|P1|COMPLETED|Double-blind Treatment Phase||15
1486450|NCT01782742|3635131|P2|STARTED|Double-blind Treatment Phase||4
1486451|NCT01782742|3635132|P1|STARTED|Double-blind Treatment Phase||16
1486452|NCT01782690|3635165|P1|NOT COMPLETED|Overall Study||299
1486453|NCT01782690|3635165|P1|COMPLETED|Overall Study||39
1486454|NCT01782690|3635165|P1|STARTED|Overall Study||338
1486455|NCT01782664|3635187|P6|NOT COMPLETED|Overall Study||0
1486456|NCT01782664|3635188|P5|NOT COMPLETED|Overall Study||0
1486457|NCT01782664|3635189|P4|NOT COMPLETED|Overall Study||5
1486458|NCT01782664|3635190|P3|NOT COMPLETED|Overall Study||4
1486459|NCT01782664|3635191|P2|NOT COMPLETED|Overall Study||5
1486460|NCT01782664|3635192|P1|NOT COMPLETED|Overall Study||6
1486461|NCT01782664|3635187|P6|COMPLETED|Overall Study||2
1486462|NCT01782664|3635188|P5|COMPLETED|Overall Study||6
1486463|NCT01782664|3635189|P4|COMPLETED|Overall Study||9
1486464|NCT01782664|3635190|P3|COMPLETED|Overall Study||12
1486465|NCT01782664|3635191|P2|COMPLETED|Overall Study||10
1486466|NCT01782664|3635192|P1|COMPLETED|Overall Study||8
1486467|NCT01782664|3635187|P6|STARTED|Overall Study||2
1486468|NCT01782664|3635188|P5|STARTED|Overall Study||6
1486469|NCT01782664|3635189|P4|STARTED|Overall Study||14
1486470|NCT01782664|3635190|P3|STARTED|Overall Study||16
1486471|NCT01782664|3635191|P2|STARTED|Overall Study||15
1486472|NCT01782664|3635192|P1|STARTED|Overall Study||14
1486473|NCT01782495|3635349|P11|NOT COMPLETED|Overall Study||0
1486474|NCT01782495|3635350|P10|NOT COMPLETED|Overall Study||0
1486475|NCT01782495|3635351|P9|NOT COMPLETED|Overall Study||0
1486476|NCT01782495|3635352|P8|NOT COMPLETED|Overall Study||3
1486477|NCT01782495|3635353|P7|NOT COMPLETED|Overall Study||0
1486478|NCT01782495|3635354|P6|NOT COMPLETED|Overall Study||0
1486479|NCT01782495|3635355|P5|NOT COMPLETED|Overall Study||0
1486480|NCT01782495|3635356|P4|NOT COMPLETED|Overall Study||0
1486481|NCT01782495|3635357|P3|NOT COMPLETED|Overall Study||0
1486482|NCT01782495|3635358|P2|NOT COMPLETED|Overall Study||1
1486483|NCT01782495|3635359|P1|NOT COMPLETED|Overall Study||0
1486484|NCT01782495|3635349|P11|COMPLETED|Overall Study||1
1486485|NCT01782495|3635350|P10|COMPLETED|Overall Study||2
1486486|NCT01782495|3635351|P9|COMPLETED|Overall Study||3
1486487|NCT01782495|3635352|P8|COMPLETED|Overall Study||6
1486488|NCT01782495|3635353|P7|COMPLETED|Overall Study||12
1486489|NCT01782495|3635354|P6|COMPLETED|Overall Study||22
1486490|NCT01782495|3635355|P5|COMPLETED|Overall Study||2
1486491|NCT01782495|3635356|P4|COMPLETED|Overall Study||4
1486492|NCT01782495|3635357|P3|COMPLETED|Overall Study||13
1486493|NCT01782495|3635358|P2|COMPLETED|Overall Study||26
1486494|NCT01782495|3635359|P1|COMPLETED|Overall Study||34
1486495|NCT01782495|3635349|P11|STARTED|Overall Study||1
1486496|NCT01782495|3635350|P10|STARTED|Overall Study||2
1486497|NCT01782495|3635351|P9|STARTED|Overall Study||3
1486498|NCT01782495|3635352|P8|STARTED|Overall Study||9
1486499|NCT01782495|3635353|P7|STARTED|Overall Study||12
1486500|NCT01782495|3635354|P6|STARTED|Overall Study||22
1486501|NCT01782495|3635355|P5|STARTED|Overall Study||2
1486502|NCT01782495|3635356|P4|STARTED|Overall Study||4
1486503|NCT01782495|3635357|P3|STARTED|Overall Study||13
1486504|NCT01782495|3635358|P2|STARTED|Overall Study||27
1486505|NCT01782495|3635359|P1|STARTED|Overall Study||34
1486506|NCT01782482|3635418|P2|NOT COMPLETED|Overall Study||10
1486507|NCT01782482|3635419|P1|NOT COMPLETED|Overall Study||10
1486508|NCT01782482|3635418|P2|COMPLETED|Overall Study||270
1486509|NCT01782482|3635419|P1|COMPLETED|Overall Study||271
1486510|NCT01782482|3635418|P2|STARTED|Overall Study||280
1486511|NCT01782482|3635419|P1|STARTED|Overall Study||281
1486512|NCT01782469|3635427|P1|NOT COMPLETED|Overall Study||1
1486513|NCT01782469|3635427|P1|COMPLETED|Overall Study||15
1486514|NCT01782469|3635427|P1|STARTED|Overall Study||16
1486515|NCT01782326|3635437|P2|NOT COMPLETED|Double-blind Treatment||320
1486516|NCT01782326|3635438|P1|NOT COMPLETED|Double-blind Treatment||278
1486517|NCT01782326|3635437|P2|COMPLETED|Double-blind Treatment||1360
1486518|NCT01782326|3635438|P1|COMPLETED|Double-blind Treatment||1400
1486519|NCT01782326|3635437|P2|STARTED|Double-blind Treatment||1680
1486520|NCT01782326|3635438|P1|STARTED|Double-blind Treatment||1678
1486521|NCT01782326|3635437|P2|NOT COMPLETED|Planned Treatment Epoch||208
1486522|NCT01782326|3635438|P1|NOT COMPLETED|Planned Treatment Epoch||202
1486523|NCT01782326|3635437|P2|COMPLETED|Planned Treatment Epoch||1474
1486524|NCT01782326|3635438|P1|COMPLETED|Planned Treatment Epoch||1478
1486525|NCT01782326|3635437|P2|Urine Cortisol Set|Planned Treatment Epoch||269
1486526|NCT01782326|3635438|P1|Urine Cortisol Set|Planned Treatment Epoch||266
1486527|NCT01782326|3635437|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
1486528|NCT01782326|3635438|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
1486529|NCT01782326|3635437|P2|Serial Spirometry Set|Planned Treatment Epoch||279
1486530|NCT01782326|3635438|P1|Serial Spirometry Set|Planned Treatment Epoch||280
1486531|NCT01782326|3635437|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
1486532|NCT01782326|3635438|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
1486533|NCT01782326|3635437|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
1486534|NCT01782326|3635438|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
1486535|NCT01782326|3635437|P2|STARTED|Planned Treatment Epoch||1682
1486536|NCT01782326|3635438|P1|STARTED|Planned Treatment Epoch||1680
1486537|NCT01782313|3635498|P1|NOT COMPLETED|Survival Follow up||1
1486538|NCT01782313|3635498|P1|COMPLETED|Survival Follow up||57
1486539|NCT01782313|3635498|P1|STARTED|Survival Follow up||58
1486540|NCT01782313|3635498|P1|NOT COMPLETED|Continued Treatment After 16 Weeks||7
1486541|NCT01782313|3635498|P1|COMPLETED|Continued Treatment After 16 Weeks||18
1486542|NCT01782313|3635498|P1|STARTED|Continued Treatment After 16 Weeks||25
1486543|NCT01782313|3635498|P1|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
1486544|NCT01782313|3635498|P1|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
1486545|NCT01782313|3635498|P1|STARTED|Treated Cycle 4/Reached 16 Week Response||31
1486546|NCT01782313|3635498|P1|NOT COMPLETED|Treated Cycle 3||21
1486547|NCT01782313|3635498|P1|COMPLETED|Treated Cycle 3||31
1486548|NCT01782313|3635498|P1|STARTED|Treated Cycle 3||52
1486549|NCT01782313|3635498|P1|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
1486550|NCT01782313|3635498|P1|COMPLETED|Reached First Response/Completed 2 Cycle||52
1486551|NCT01782313|3635498|P1|STARTED|Reached First Response/Completed 2 Cycle||58
1486552|NCT01782222|3635512|P3|NOT COMPLETED|Overall Study||4
1486553|NCT01782222|3635513|P2|NOT COMPLETED|Overall Study||11
1486554|NCT01782222|3635514|P1|NOT COMPLETED|Overall Study||8
1486555|NCT01782222|3635512|P3|COMPLETED|Overall Study||37
1486556|NCT01782222|3635513|P2|COMPLETED|Overall Study||30
1486557|NCT01782222|3635514|P1|COMPLETED|Overall Study||32
1486558|NCT01782222|3635512|P3|STARTED|Overall Study||41
1486559|NCT01782222|3635513|P2|STARTED|Overall Study||41
1486560|NCT01782222|3635514|P1|STARTED|Overall Study||40
1486561|NCT01781975|3635548|P2|NOT COMPLETED|Overall Study||1
1486562|NCT01781975|3635549|P1|NOT COMPLETED|Overall Study||2
1486563|NCT01781975|3635548|P2|COMPLETED|Overall Study||21
1486564|NCT01781975|3635549|P1|COMPLETED|Overall Study||43
1486565|NCT01781975|3635548|P2|Follow-Up Period|Overall Study||21
1486566|NCT01781975|3635549|P1|Follow-Up Period|Overall Study||43
1486567|NCT01781975|3635548|P2|Treatment Period|Overall Study||22
1486568|NCT01781975|3635549|P1|Treatment Period|Overall Study||44
1486569|NCT01781975|3635548|P2|STARTED|Overall Study||22
1486570|NCT01781975|3635549|P1|STARTED|Overall Study||45
1486571|NCT01781962|3635555|P1|NOT COMPLETED|Overall Study||5
1486572|NCT01781962|3635555|P1|COMPLETED|Overall Study||201
1486573|NCT01781962|3635555|P1|STARTED|Overall Study||206
1486574|NCT01781832|3635561|P1|NOT COMPLETED|Overall Study||1
1486575|NCT01781832|3635561|P1|COMPLETED|Overall Study||25
1486576|NCT01781832|3635561|P1|STARTED|Overall Study||26
1486577|NCT01781806|3635568|P2|NOT COMPLETED|Overall Study||3
1486578|NCT01781806|3635569|P1|NOT COMPLETED|Overall Study||79
1486579|NCT01781806|3635568|P2|COMPLETED|Overall Study||1
1486580|NCT01781806|3635569|P1|COMPLETED|Overall Study||218
1486581|NCT01781806|3635568|P2|Week 48|Overall Study||1
1486582|NCT01781806|3635569|P1|Week 48|Overall Study||222
1486583|NCT01781806|3635568|P2|Week 36|Overall Study||1
1486584|NCT01781806|3635569|P1|Week 36|Overall Study||247
1486585|NCT01781806|3635568|P2|Week 24|Overall Study||1
1486586|NCT01781806|3635569|P1|Week 24|Overall Study||260
1486587|NCT01781806|3635568|P2|Week 12|Overall Study||2
1486588|NCT01781806|3635569|P1|Week 12|Overall Study||272
1486589|NCT01781806|3635568|P2|Week 8|Overall Study||4
1486590|NCT01781806|3635569|P1|Week 8|Overall Study||278
1486591|NCT01781806|3635568|P2|Week 4|Overall Study||4
1486592|NCT01781806|3635569|P1|Week 4|Overall Study||284
1486593|NCT01781806|3635568|P2|Week 0|Overall Study||4
1486594|NCT01781806|3635569|P1|Week 0|Overall Study||297
1486595|NCT01781806|3635568|P2|STARTED|Overall Study||4
1486596|NCT01781806|3635569|P1|STARTED|Overall Study||297
1486597|NCT01781637|3635581|P2|NOT COMPLETED|Overall Study||6
1486598|NCT01781637|3635582|P1|NOT COMPLETED|Overall Study||4
1486599|NCT01781637|3635581|P2|COMPLETED|Overall Study||2
1486600|NCT01781637|3635582|P1|COMPLETED|Overall Study||24
1486601|NCT01781637|3635581|P2|STARTED|Overall Study||8
1486602|NCT01781637|3635582|P1|STARTED|Overall Study||28
1486603|NCT01781481|3635590|P1|NOT COMPLETED|Overall Study||0
1486604|NCT01781481|3635590|P1|COMPLETED|Overall Study||148
1486605|NCT01781481|3635590|P1|STARTED|Overall Study||148
1486606|NCT01781403|3635649|P3|NOT COMPLETED|Overall Study||0
1486607|NCT01781403|3635650|P2|NOT COMPLETED|Overall Study||0
1486608|NCT01781403|3635651|P1|NOT COMPLETED|Overall Study||0
1486609|NCT01781403|3635649|P3|COMPLETED|Overall Study||18
1486610|NCT01781403|3635650|P2|COMPLETED|Overall Study||2
1486611|NCT01781403|3635651|P1|COMPLETED|Overall Study||2
1486612|NCT01781403|3635649|P3|STARTED|Overall Study||18
1486613|NCT01781403|3635650|P2|STARTED|Overall Study||2
1486614|NCT01781403|3635651|P1|STARTED|Overall Study||2
1486615|NCT01781299|3635669|P2|NOT COMPLETED|Overall Study||1
1486616|NCT01781299|3635670|P1|NOT COMPLETED|Overall Study||0
1486617|NCT01781299|3635669|P2|COMPLETED|Overall Study||4
1486618|NCT01781299|3635670|P1|COMPLETED|Overall Study||4
1486619|NCT01781299|3635669|P2|STARTED|Overall Study||5
1486620|NCT01781299|3635670|P1|STARTED|Overall Study||4
1486621|NCT01781286|3635678|P6|NOT COMPLETED|Overall Study||1
1486622|NCT01781286|3635679|P5|NOT COMPLETED|Overall Study||0
1486623|NCT01781286|3635680|P4|NOT COMPLETED|Overall Study||1
1486624|NCT01781286|3635681|P3|NOT COMPLETED|Overall Study||2
1486625|NCT01781286|3635682|P2|NOT COMPLETED|Overall Study||0
1486626|NCT01781286|3635683|P1|NOT COMPLETED|Overall Study||2
1486627|NCT01781286|3635678|P6|COMPLETED|Overall Study||2
1486628|NCT01781286|3635679|P5|COMPLETED|Overall Study||6
1486629|NCT01781286|3635680|P4|COMPLETED|Overall Study||7
1486630|NCT01781286|3635681|P3|COMPLETED|Overall Study||7
1486631|NCT01781286|3635682|P2|COMPLETED|Overall Study||4
1486632|NCT01781286|3635683|P1|COMPLETED|Overall Study||5
1486633|NCT01781286|3635678|P6|Started 3rd Intervention|Overall Study||2
1486634|NCT01781286|3635679|P5|Started 3rd Intervention|Overall Study||6
1486635|NCT01781286|3635680|P4|Started 3rd Intervention|Overall Study||7
1486636|NCT01781286|3635681|P3|Started 3rd Intervention|Overall Study||7
1486637|NCT01781286|3635682|P2|Started 3rd Intervention|Overall Study||4
1486638|NCT01781286|3635683|P1|Started 3rd Intervention|Overall Study||5
1486639|NCT01781286|3635678|P6|Started 2nd Intervention|Overall Study||2
1486640|NCT01781286|3635679|P5|Started 2nd Intervention|Overall Study||6
1486641|NCT01781286|3635680|P4|Started 2nd Intervention|Overall Study||8
1486642|NCT01781286|3635681|P3|Started 2nd Intervention|Overall Study||9
1486643|NCT01781286|3635682|P2|Started 2nd Intervention|Overall Study||4
1486644|NCT01781286|3635683|P1|Started 2nd Intervention|Overall Study||5
1486645|NCT01781286|3635678|P6|Started 1st Intervention|Overall Study||2
1486646|NCT01781286|3635679|P5|Started 1st Intervention|Overall Study||6
1486647|NCT01781286|3635680|P4|Started 1st Intervention|Overall Study||8
1486648|NCT01781286|3635681|P3|Started 1st Intervention|Overall Study||9
1486649|NCT01781286|3635682|P2|Started 1st Intervention|Overall Study||4
1486650|NCT01781286|3635683|P1|Started 1st Intervention|Overall Study||6
1486651|NCT01781286|3635678|P6|STARTED|Overall Study||3
1486652|NCT01781286|3635679|P5|STARTED|Overall Study||6
1486653|NCT01781286|3635680|P4|STARTED|Overall Study||8
1486654|NCT01781286|3635681|P3|STARTED|Overall Study||9
1486655|NCT01781286|3635682|P2|STARTED|Overall Study||4
1486656|NCT01781286|3635683|P1|STARTED|Overall Study||7
1486657|NCT01781234|3635708|P2|NOT COMPLETED|Overall Study||3
1486658|NCT01781234|3635709|P1|NOT COMPLETED|Overall Study||9
1486659|NCT01781234|3635708|P2|COMPLETED|Overall Study||21
1486660|NCT01781234|3635709|P1|COMPLETED|Overall Study||18
1486661|NCT01781234|3635708|P2|STARTED|Overall Study||24
1486662|NCT01781234|3635709|P1|STARTED|Overall Study||27
1486663|NCT01781208|3635719|P1|NOT COMPLETED|Overall Study||0
1486664|NCT01781208|3635719|P1|COMPLETED|Overall Study||62
1486665|NCT01781208|3635719|P1|Overall Study|Overall Study||62
1486666|NCT01781208|3635719|P1|STARTED|Overall Study||62
1486667|NCT01781169|3635726|P2|NOT COMPLETED|Overall Study||0
1486668|NCT01781169|3635727|P1|NOT COMPLETED|Overall Study||1
1486669|NCT01781169|3635726|P2|COMPLETED|Overall Study||21
1486670|NCT01781169|3635727|P1|COMPLETED|Overall Study||21
1486671|NCT01781169|3635726|P2|STARTED|Overall Study||21
1486672|NCT01781169|3635727|P1|STARTED|Overall Study||22
1486673|NCT01781078|3635735|P3|NOT COMPLETED|Overall Study||16
1486674|NCT01781078|3635736|P2|NOT COMPLETED|Overall Study||5
1486675|NCT01781078|3635737|P1|NOT COMPLETED|Overall Study||12
1486676|NCT01781078|3635735|P3|COMPLETED|Overall Study||0
1486677|NCT01781078|3635736|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
1486678|NCT01781078|3635737|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
1486679|NCT01781078|3635735|P3|STARTED|Overall Study||16
1486680|NCT01781078|3635736|P2|STARTED|Overall Study|Randomized post implantation|118
1486681|NCT01781078|3635737|P1|STARTED|Overall Study|Randomized post implantation|229
1486682|NCT01781026|3635747|P1|NOT COMPLETED|Overall Study||2
1486683|NCT01781026|3635747|P1|COMPLETED|Overall Study||0
1486684|NCT01781026|3635747|P1|STARTED|Overall Study||2
1486685|NCT01780987|3635753|P2|NOT COMPLETED|Overall Study||6
1486686|NCT01780987|3635754|P1|NOT COMPLETED|Overall Study||3
1486687|NCT01780987|3635753|P2|COMPLETED|Overall Study||34
1486688|NCT01780987|3635754|P1|COMPLETED|Overall Study||37
1486689|NCT01780987|3635753|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
1486690|NCT01780987|3635754|P1|STARTED|Overall Study||40
1486691|NCT01780974|3635772|P2|NOT COMPLETED|Overall Study||3
1486692|NCT01780974|3635773|P1|NOT COMPLETED|Overall Study||2
1486693|NCT01780974|3635772|P2|COMPLETED|Overall Study||18
1486694|NCT01780974|3635773|P1|COMPLETED|Overall Study||19
1486695|NCT01780974|3635772|P2|STARTED|Overall Study||21
1486696|NCT01780974|3635773|P1|STARTED|Overall Study||21
1486697|NCT01780935|3635783|P2|NOT COMPLETED|Overall Study||336
1486698|NCT01780935|3635784|P1|NOT COMPLETED|Overall Study||335
1486699|NCT01780935|3635783|P2|COMPLETED|Overall Study||0
1486700|NCT01780935|3635784|P1|COMPLETED|Overall Study||0
1486701|NCT01780935|3635783|P2|Safety Set|Overall Study||336
1486702|NCT01780935|3635784|P1|Safety Set|Overall Study||334
1486703|NCT01780935|3635783|P2|STARTED|Overall Study||336
1486704|NCT01780935|3635784|P1|STARTED|Overall Study||335
1486705|NCT01780922|3635814|P6|NOT COMPLETED|Third Intervention (1 Day)||0
1486706|NCT01780922|3635815|P5|NOT COMPLETED|Third Intervention (1 Day)||0
1486707|NCT01780922|3635816|P4|NOT COMPLETED|Third Intervention (1 Day)||0
1486708|NCT01780922|3635817|P3|NOT COMPLETED|Third Intervention (1 Day)||0
1486709|NCT01780922|3635818|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1486710|NCT01780922|3635819|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1486711|NCT01780922|3635814|P6|COMPLETED|Third Intervention (1 Day)||2
1486712|NCT01780922|3635815|P5|COMPLETED|Third Intervention (1 Day)||2
1486713|NCT01780922|3635816|P4|COMPLETED|Third Intervention (1 Day)||2
1486714|NCT01780922|3635817|P3|COMPLETED|Third Intervention (1 Day)||2
1486715|NCT01780922|3635818|P2|COMPLETED|Third Intervention (1 Day)||2
1486716|NCT01780922|3635819|P1|COMPLETED|Third Intervention (1 Day)||2
1486717|NCT01780922|3635814|P6|STARTED|Third Intervention (1 Day)||2
1486718|NCT01780922|3635815|P5|STARTED|Third Intervention (1 Day)||2
1486719|NCT01780922|3635816|P4|STARTED|Third Intervention (1 Day)||2
1486720|NCT01780922|3635817|P3|STARTED|Third Intervention (1 Day)||2
1486721|NCT01780922|3635818|P2|STARTED|Third Intervention (1 Day)||2
1486722|NCT01780922|3635819|P1|STARTED|Third Intervention (1 Day)||2
1486723|NCT01780922|3635814|P6|NOT COMPLETED|Washout (7 Days)||0
1486724|NCT01780922|3635815|P5|NOT COMPLETED|Washout (7 Days)||0
1486725|NCT01780922|3635816|P4|NOT COMPLETED|Washout (7 Days)||0
1486726|NCT01780922|3635817|P3|NOT COMPLETED|Washout (7 Days)||0
1486727|NCT01780922|3635818|P2|NOT COMPLETED|Washout (7 Days)||0
1486728|NCT01780922|3635819|P1|NOT COMPLETED|Washout (7 Days)||0
1486729|NCT01780922|3635814|P6|COMPLETED|Washout (7 Days)||2
1486730|NCT01780922|3635815|P5|COMPLETED|Washout (7 Days)||2
1486731|NCT01780922|3635816|P4|COMPLETED|Washout (7 Days)||2
1486732|NCT01780922|3635817|P3|COMPLETED|Washout (7 Days)||2
1486733|NCT01780922|3635818|P2|COMPLETED|Washout (7 Days)||2
1486734|NCT01780922|3635819|P1|COMPLETED|Washout (7 Days)||2
1486735|NCT01780922|3635814|P6|STARTED|Washout (7 Days)||2
1486736|NCT01780922|3635815|P5|STARTED|Washout (7 Days)||2
1486737|NCT01780922|3635816|P4|STARTED|Washout (7 Days)||2
1486738|NCT01780922|3635817|P3|STARTED|Washout (7 Days)||2
1486739|NCT01780922|3635818|P2|STARTED|Washout (7 Days)||2
1486740|NCT01780922|3635819|P1|STARTED|Washout (7 Days)||2
1486741|NCT01780922|3635814|P6|NOT COMPLETED|Second Intervention (1 Day)||0
1486742|NCT01780922|3635815|P5|NOT COMPLETED|Second Intervention (1 Day)||0
1486743|NCT01780922|3635816|P4|NOT COMPLETED|Second Intervention (1 Day)||0
1486744|NCT01780922|3635817|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1486745|NCT01780922|3635818|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1486746|NCT01780922|3635819|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1486747|NCT01780922|3635814|P6|COMPLETED|Second Intervention (1 Day)||2
1486748|NCT01780922|3635815|P5|COMPLETED|Second Intervention (1 Day)||2
1486749|NCT01780922|3635816|P4|COMPLETED|Second Intervention (1 Day)||2
1486750|NCT01780922|3635817|P3|COMPLETED|Second Intervention (1 Day)||2
1486751|NCT01780922|3635818|P2|COMPLETED|Second Intervention (1 Day)||2
1486752|NCT01780922|3635819|P1|COMPLETED|Second Intervention (1 Day)||2
1486753|NCT01780922|3635814|P6|STARTED|Second Intervention (1 Day)||2
1486754|NCT01780922|3635815|P5|STARTED|Second Intervention (1 Day)||2
1486755|NCT01780922|3635816|P4|STARTED|Second Intervention (1 Day)||2
1486756|NCT01780922|3635817|P3|STARTED|Second Intervention (1 Day)||2
1486757|NCT01780922|3635818|P2|STARTED|Second Intervention (1 Day)||2
1486758|NCT01780922|3635819|P1|STARTED|Second Intervention (1 Day)||2
1486759|NCT01780922|3635814|P6|NOT COMPLETED|Washout (7 Days)||0
1486760|NCT01780922|3635815|P5|NOT COMPLETED|Washout (7 Days)||0
1486761|NCT01780922|3635816|P4|NOT COMPLETED|Washout (7 Days)||0
1486762|NCT01780922|3635817|P3|NOT COMPLETED|Washout (7 Days)||0
1486763|NCT01780922|3635818|P2|NOT COMPLETED|Washout (7 Days)||0
1486764|NCT01780922|3635819|P1|NOT COMPLETED|Washout (7 Days)||0
1486765|NCT01780922|3635814|P6|COMPLETED|Washout (7 Days)||2
1486766|NCT01780922|3635815|P5|COMPLETED|Washout (7 Days)||2
1486767|NCT01780922|3635816|P4|COMPLETED|Washout (7 Days)||2
1486768|NCT01780922|3635817|P3|COMPLETED|Washout (7 Days)||2
1486769|NCT01780922|3635818|P2|COMPLETED|Washout (7 Days)||2
1486770|NCT01780922|3635819|P1|COMPLETED|Washout (7 Days)||2
1486771|NCT01780922|3635814|P6|STARTED|Washout (7 Days)||2
1486772|NCT01780922|3635815|P5|STARTED|Washout (7 Days)||2
1486773|NCT01780922|3635816|P4|STARTED|Washout (7 Days)||2
1486774|NCT01780922|3635817|P3|STARTED|Washout (7 Days)||2
1486775|NCT01780922|3635818|P2|STARTED|Washout (7 Days)||2
1486776|NCT01780922|3635819|P1|STARTED|Washout (7 Days)||2
1486777|NCT01780922|3635814|P6|NOT COMPLETED|First Intervention (1 Day)||0
1486778|NCT01780922|3635815|P5|NOT COMPLETED|First Intervention (1 Day)||0
1486779|NCT01780922|3635816|P4|NOT COMPLETED|First Intervention (1 Day)||0
1486780|NCT01780922|3635817|P3|NOT COMPLETED|First Intervention (1 Day)||0
1486781|NCT01780922|3635818|P2|NOT COMPLETED|First Intervention (1 Day)||0
1486782|NCT01780922|3635819|P1|NOT COMPLETED|First Intervention (1 Day)||0
1486783|NCT01780922|3635814|P6|COMPLETED|First Intervention (1 Day)||2
1486784|NCT01780922|3635815|P5|COMPLETED|First Intervention (1 Day)||2
1486785|NCT01780922|3635816|P4|COMPLETED|First Intervention (1 Day)||2
1486786|NCT01780922|3635817|P3|COMPLETED|First Intervention (1 Day)||2
1486787|NCT01780922|3635818|P2|COMPLETED|First Intervention (1 Day)||2
1486788|NCT01780922|3635819|P1|COMPLETED|First Intervention (1 Day)||2
1486789|NCT01780922|3635814|P6|STARTED|First Intervention (1 Day)||2
1486790|NCT01780922|3635815|P5|STARTED|First Intervention (1 Day)||2
1486791|NCT01780922|3635816|P4|STARTED|First Intervention (1 Day)||2
1486792|NCT01780922|3635817|P3|STARTED|First Intervention (1 Day)||2
1486793|NCT01780922|3635818|P2|STARTED|First Intervention (1 Day)||2
1486794|NCT01780922|3635819|P1|STARTED|First Intervention (1 Day)||2
1486795|NCT01780870|3635874|P2|NOT COMPLETED|Overall Study||0
1486796|NCT01780870|3635875|P1|NOT COMPLETED|Overall Study||0
1486797|NCT01780870|3635874|P2|COMPLETED|Overall Study||5
1486798|NCT01780870|3635875|P1|COMPLETED|Overall Study||0
1486799|NCT01780870|3635874|P2|STARTED|Overall Study||5
1486800|NCT01780870|3635875|P1|STARTED|Overall Study||0
1486801|NCT01780584|3635888|P3|NOT COMPLETED|Overall Study||2
1486802|NCT01780584|3635889|P2|NOT COMPLETED|Overall Study||1
1486803|NCT01780584|3635890|P1|NOT COMPLETED|Overall Study||1
1486804|NCT01780584|3635888|P3|COMPLETED|Overall Study||13
1486805|NCT01780584|3635889|P2|COMPLETED|Overall Study||14
1486806|NCT01780584|3635890|P1|COMPLETED|Overall Study||14
1486807|NCT01780584|3635888|P3|STARTED|Overall Study||15
1486808|NCT01780584|3635889|P2|STARTED|Overall Study||15
1486809|NCT01780584|3635890|P1|STARTED|Overall Study||15
1486810|NCT01780545|3635912|P2|NOT COMPLETED|Overall Study||2
1486811|NCT01780545|3635913|P1|NOT COMPLETED|Overall Study||4
1486812|NCT01780545|3635912|P2|COMPLETED|Overall Study||99
1486813|NCT01780545|3635913|P1|COMPLETED|Overall Study||95
1486814|NCT01780545|3635912|P2|STARTED|Overall Study||101
1486815|NCT01780545|3635913|P1|STARTED|Overall Study||99
1486816|NCT01780506|3635931|P2|NOT COMPLETED|Open-Label Extension Phase||1
1486817|NCT01780506|3635932|P1|NOT COMPLETED|Open-Label Extension Phase||0
1486818|NCT01780506|3635931|P2|COMPLETED|Open-Label Extension Phase||94
1486819|NCT01780506|3635932|P1|COMPLETED|Open-Label Extension Phase||90
1486820|NCT01780506|3635931|P2|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
1486821|NCT01780506|3635932|P1|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
1486822|NCT01780506|3635931|P2|NOT COMPLETED|Double-Blind Phase||78
1486823|NCT01780506|3635932|P1|NOT COMPLETED|Double-Blind Phase||70
1486824|NCT01780506|3635931|P2|COMPLETED|Double-Blind Phase||356
1486825|NCT01780506|3635932|P1|COMPLETED|Double-Blind Phase||368
1486826|NCT01780506|3635931|P2|STARTED|Double-Blind Phase||434
1486827|NCT01780506|3635932|P1|STARTED|Double-Blind Phase||438
1486828|NCT01780389|3635986|P1|NOT COMPLETED|Overall Study||1
1486829|NCT01780389|3635986|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
1486830|NCT01780389|3635986|P1|STARTED|Overall Study||5
1486831|NCT01780350|3635997|P1|NOT COMPLETED|Overall Study||0
1486832|NCT01780350|3635997|P1|COMPLETED|Overall Study||200
1486833|NCT01780350|3635997|P1|STARTED|Overall Study||200
1486834|NCT01780337|3636004|P2|NOT COMPLETED|Overall Study||0
1486835|NCT01780337|3636005|P1|NOT COMPLETED|Overall Study||0
1486836|NCT01780337|3636004|P2|COMPLETED|Overall Study||6
1486837|NCT01780337|3636005|P1|COMPLETED|Overall Study||6
1486838|NCT01780337|3636004|P2|STARTED|Overall Study||6
1486839|NCT01780337|3636005|P1|STARTED|Overall Study||6
1486840|NCT01780324|3636017|P2|NOT COMPLETED|Overall Study||6
1486841|NCT01780324|3636018|P1|NOT COMPLETED|Overall Study||1
1486842|NCT01780324|3636017|P2|COMPLETED|Overall Study||33
1486843|NCT01780324|3636018|P1|COMPLETED|Overall Study||40
1486844|NCT01780324|3636017|P2|STARTED|Overall Study||39
1486845|NCT01780324|3636018|P1|STARTED|Overall Study||41
1486846|NCT01779869|3636024|P1|NOT COMPLETED|Overall Study||2
1486847|NCT01779869|3636024|P1|COMPLETED|Overall Study||14
1486848|NCT01779869|3636024|P1|STARTED|Overall Study||16
1486849|NCT01779648|3636030|P2|NOT COMPLETED|Overall Study||0
1486850|NCT01779648|3636031|P1|NOT COMPLETED|Overall Study||1
1486851|NCT01779648|3636030|P2|COMPLETED|Overall Study||27
1486852|NCT01779648|3636031|P1|COMPLETED|Overall Study||27
1486853|NCT01779648|3636030|P2|STARTED|Overall Study||27
1486854|NCT01779648|3636031|P1|STARTED|Overall Study||28
1486855|NCT01779440|3636061|P2|NOT COMPLETED|Overall Study||5
1486856|NCT01779440|3636062|P1|NOT COMPLETED|Overall Study||3
1486857|NCT01779440|3636061|P2|COMPLETED|Overall Study||23
1486858|NCT01779440|3636062|P1|COMPLETED|Overall Study||27
1486859|NCT01779440|3636061|P2|STARTED|Overall Study||28
1486860|NCT01779440|3636062|P1|STARTED|Overall Study||30
1486861|NCT01779375|3636072|P2|NOT COMPLETED|Overall Study||3
1486862|NCT01779375|3636073|P1|NOT COMPLETED|Overall Study||2
1486863|NCT01779375|3636072|P2|COMPLETED|Overall Study||41
1486864|NCT01779375|3636073|P1|COMPLETED|Overall Study||45
1486865|NCT01779375|3636072|P2|STARTED|Overall Study||44
1486866|NCT01779375|3636073|P1|STARTED|Overall Study||47
1486867|NCT01779219|3636089|P2|NOT COMPLETED|Overall Study||0
1486868|NCT01779219|3636090|P1|NOT COMPLETED|Overall Study||0
1486869|NCT01779219|3636089|P2|COMPLETED|Overall Study|First interim analysis|21
1486870|NCT01779219|3636090|P1|COMPLETED|Overall Study|First interim analysis|21
1486871|NCT01779219|3636089|P2|STARTED|Overall Study|First interim analysis|21
1486872|NCT01779219|3636090|P1|STARTED|Overall Study|First interim analysis|21
1486873|NCT01779167|3636102|P1|NOT COMPLETED|Overall Study||1
1486874|NCT01779167|3636102|P1|COMPLETED|Overall Study||3
1486875|NCT01779167|3636102|P1|STARTED|Overall Study||4
1486876|NCT01779024|3636111|P2|NOT COMPLETED|2nd Visit - Functional MRI||0
1486877|NCT01779024|3636112|P1|NOT COMPLETED|2nd Visit - Functional MRI||0
1486878|NCT01779024|3636111|P2|COMPLETED|2nd Visit - Functional MRI||6
1486879|NCT01779024|3636112|P1|COMPLETED|2nd Visit - Functional MRI||5
1486880|NCT01779024|3636111|P2|STARTED|2nd Visit - Functional MRI||6
1486881|NCT01779024|3636112|P1|STARTED|2nd Visit - Functional MRI||5
1486882|NCT01779024|3636111|P2|NOT COMPLETED|1st Visit - Functional MRI||2
1486883|NCT01779024|3636112|P1|NOT COMPLETED|1st Visit - Functional MRI||2
1486884|NCT01779024|3636111|P2|COMPLETED|1st Visit - Functional MRI||5
1486885|NCT01779024|3636112|P1|COMPLETED|1st Visit - Functional MRI||4
1486886|NCT01779024|3636111|P2|STARTED|1st Visit - Functional MRI||7
1486887|NCT01779024|3636112|P1|STARTED|1st Visit - Functional MRI||6
1486888|NCT01779024|3636111|P2|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
1486889|NCT01779024|3636112|P1|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
1486890|NCT01779024|3636111|P2|COMPLETED|2nd Visit - Alcohol Self-Administration||9
1486891|NCT01779024|3636112|P1|COMPLETED|2nd Visit - Alcohol Self-Administration||6
1486892|NCT01779024|3636111|P2|STARTED|2nd Visit - Alcohol Self-Administration||9
1486893|NCT01779024|3636112|P1|STARTED|2nd Visit - Alcohol Self-Administration||8
1486894|NCT01779024|3636111|P2|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
1486895|NCT01779024|3636112|P1|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
1486896|NCT01779024|3636111|P2|COMPLETED|1st Visit - Alcohol Self-Administration||9
1486897|NCT01779024|3636112|P1|COMPLETED|1st Visit - Alcohol Self-Administration||8
1486898|NCT01779024|3636111|P2|STARTED|1st Visit - Alcohol Self-Administration||9
1486899|NCT01779024|3636112|P1|STARTED|1st Visit - Alcohol Self-Administration||8
1486900|NCT01778985|3636120|P2|NOT COMPLETED|Overall Study||3
1486901|NCT01778985|3636121|P1|NOT COMPLETED|Overall Study||7
1486902|NCT01778985|3636120|P2|COMPLETED|Overall Study||12
1486903|NCT01778985|3636121|P1|COMPLETED|Overall Study||8
1486904|NCT01778985|3636120|P2|STARTED|Overall Study||15
1486905|NCT01778985|3636121|P1|STARTED|Overall Study||15
1486906|NCT01778855|3636167|P2|NOT COMPLETED|Overall Study||1
1486907|NCT01778855|3636168|P1|NOT COMPLETED|Overall Study||0
1486908|NCT01778855|3636167|P2|COMPLETED|Overall Study||3
1486909|NCT01778855|3636168|P1|COMPLETED|Overall Study||2
1486910|NCT01778855|3636167|P2|STARTED|Overall Study||4
1486911|NCT01778855|3636168|P1|STARTED|Overall Study||2
1486912|NCT01778751|3636176|P2|NOT COMPLETED|Overall Study||2
1486913|NCT01778751|3636177|P1|NOT COMPLETED|Overall Study||2
1486914|NCT01778751|3636176|P2|COMPLETED|Overall Study||23
1486915|NCT01778751|3636177|P1|COMPLETED|Overall Study||23
1486916|NCT01778751|3636176|P2|STARTED|Overall Study||25
1486917|NCT01778751|3636177|P1|STARTED|Overall Study||25
1486918|NCT01778634|3636191|P2|NOT COMPLETED|Overall Study||0
1486919|NCT01778634|3636192|P1|NOT COMPLETED|Overall Study||0
1486920|NCT01778634|3636191|P2|COMPLETED|Overall Study||60
1486921|NCT01778634|3636192|P1|COMPLETED|Overall Study||61
1486922|NCT01778634|3636191|P2|STARTED|Overall Study||60
1486923|NCT01778634|3636192|P1|STARTED|Overall Study||61
1486924|NCT01778530|3636228|P1|NOT COMPLETED|Overall Study||2
1486925|NCT01778530|3636228|P1|COMPLETED|Overall Study||0
1486926|NCT01778530|3636228|P1|STARTED|Overall Study||2
1486927|NCT01778426|3636235|P2|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
1486928|NCT01778426|3636236|P1|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
1486929|NCT01778426|3636235|P2|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
1486930|NCT01778426|3636236|P1|COMPLETED|Intention-To-Treat (ITT) - Completer||198
1486931|NCT01778426|3636235|P2|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
1486932|NCT01778426|3636236|P1|STARTED|Intention-To-Treat (ITT) - Completer||198
1486933|NCT01778426|3636235|P2|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
1486934|NCT01778426|3636236|P1|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
1486935|NCT01778426|3636235|P2|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
1486936|NCT01778426|3636236|P1|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
1486937|NCT01778426|3636235|P2|STARTED|Overall Study - Full Analysis Set (FAS)||138
1486938|NCT01778426|3636236|P1|STARTED|Overall Study - Full Analysis Set (FAS)||264
1486939|NCT01778296|3636252|P1|NOT COMPLETED|Overall Study||0
1486940|NCT01778296|3636252|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
1486941|NCT01778296|3636252|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
1486942|NCT01778127|3636259|P3|NOT COMPLETED|Overall Study||6
1486943|NCT01778127|3636260|P2|NOT COMPLETED|Overall Study||2
1486944|NCT01778127|3636261|P1|NOT COMPLETED|Overall Study||8
1486945|NCT01778127|3636259|P3|COMPLETED|Overall Study||26
1486946|NCT01778127|3636260|P2|COMPLETED|Overall Study||31
1486947|NCT01778127|3636261|P1|COMPLETED|Overall Study||25
1486948|NCT01778127|3636259|P3|STARTED|Overall Study||32
1486949|NCT01778127|3636260|P2|STARTED|Overall Study||33
1486950|NCT01778127|3636261|P1|STARTED|Overall Study||33
1486951|NCT01778062|3636304|P2|NOT COMPLETED|Overall Study||11
1486952|NCT01778062|3636305|P1|NOT COMPLETED|Overall Study||6
1486953|NCT01778062|3636304|P2|COMPLETED|Overall Study||57
1486954|NCT01778062|3636305|P1|COMPLETED|Overall Study||62
1486955|NCT01778062|3636304|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
1486956|NCT01778062|3636305|P1|Intent to Treat (ITT)|Overall Study||68
1486957|NCT01778062|3636304|P2|Safety Set|Overall Study||68
1486958|NCT01778062|3636305|P1|Safety Set|Overall Study||68
1486959|NCT01778062|3636304|P2|STARTED|Overall Study||68
1486960|NCT01778062|3636305|P1|STARTED|Overall Study||68
1486961|NCT01778049|3636319|P6|NOT COMPLETED|Double Blind Treatment Period||7
1486962|NCT01778049|3636320|P5|NOT COMPLETED|Double Blind Treatment Period||12
1486963|NCT01778049|3636321|P4|NOT COMPLETED|Double Blind Treatment Period||12
1486964|NCT01778049|3636322|P3|NOT COMPLETED|Double Blind Treatment Period||15
1486965|NCT01778049|3636323|P2|NOT COMPLETED|Double Blind Treatment Period||0
1486966|NCT01778049|3636324|P1|NOT COMPLETED|Double Blind Treatment Period||0
1486967|NCT01778049|3636319|P6|COMPLETED|Double Blind Treatment Period||105
1486968|NCT01778049|3636320|P5|COMPLETED|Double Blind Treatment Period||102
1486969|NCT01778049|3636321|P4|COMPLETED|Double Blind Treatment Period||118
1486970|NCT01778049|3636322|P3|COMPLETED|Double Blind Treatment Period||111
1486971|NCT01778049|3636323|P2|COMPLETED|Double Blind Treatment Period||0
1486972|NCT01778049|3636324|P1|COMPLETED|Double Blind Treatment Period||0
1486973|NCT01778049|3636319|P6|STARTED|Double Blind Treatment Period||112
1486974|NCT01778049|3636320|P5|STARTED|Double Blind Treatment Period||114
1486975|NCT01778049|3636321|P4|STARTED|Double Blind Treatment Period||130
1486976|NCT01778049|3636322|P3|STARTED|Double Blind Treatment Period||126
1486977|NCT01778049|3636323|P2|STARTED|Double Blind Treatment Period||0
1486978|NCT01778049|3636324|P1|STARTED|Double Blind Treatment Period||0
1486979|NCT01778049|3636319|P6|NOT COMPLETED|Open Label Treatment Period||0
1486980|NCT01778049|3636320|P5|NOT COMPLETED|Open Label Treatment Period||0
1486981|NCT01778049|3636321|P4|NOT COMPLETED|Open Label Treatment Period||0
1486982|NCT01778049|3636322|P3|NOT COMPLETED|Open Label Treatment Period||0
1486983|NCT01778049|3636323|P2|NOT COMPLETED|Open Label Treatment Period||129
1486984|NCT01778049|3636324|P1|NOT COMPLETED|Open Label Treatment Period||98
1486985|NCT01778049|3636319|P6|COMPLETED|Open Label Treatment Period||0
1486986|NCT01778049|3636320|P5|COMPLETED|Open Label Treatment Period||0
1486987|NCT01778049|3636321|P4|COMPLETED|Open Label Treatment Period||0
1486988|NCT01778049|3636322|P3|COMPLETED|Open Label Treatment Period||0
1486989|NCT01778049|3636323|P2|COMPLETED|Open Label Treatment Period||226
1486990|NCT01778049|3636324|P1|COMPLETED|Open Label Treatment Period||256
1486991|NCT01778049|3636319|P6|STARTED|Open Label Treatment Period||0
1486992|NCT01778049|3636320|P5|STARTED|Open Label Treatment Period||0
1486993|NCT01778049|3636321|P4|STARTED|Open Label Treatment Period||0
1486994|NCT01778049|3636322|P3|STARTED|Open Label Treatment Period||0
1486995|NCT01778049|3636323|P2|STARTED|Open Label Treatment Period||355
1486996|NCT01778049|3636324|P1|STARTED|Open Label Treatment Period||354
1486997|NCT01778023|3636342|P2|NOT COMPLETED|Overall Study||3
1486998|NCT01778023|3636343|P1|NOT COMPLETED|Overall Study||0
1486999|NCT01778023|3636342|P2|COMPLETED|Overall Study||15
1487000|NCT01778023|3636343|P1|COMPLETED|Overall Study||36
1487001|NCT01778023|3636342|P2|Exposed|Overall Study||15
1487002|NCT01778023|3636343|P1|Exposed|Overall Study||36
1487003|NCT01778023|3636342|P2|STARTED|Overall Study||18
1487004|NCT01778023|3636343|P1|STARTED|Overall Study||36
1487005|NCT01778010|3636360|P1|NOT COMPLETED|Overall Study||5
1487006|NCT01778010|3636360|P1|COMPLETED|Overall Study||8
1487007|NCT01778010|3636360|P1|STARTED|Overall Study||13
1487008|NCT01777997|3636401|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
1487009|NCT01777997|3636401|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
1487010|NCT01777997|3636401|P1|STARTED|Weeks 48 to 72/96 on ART||28
1487011|NCT01777997|3636401|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
1487012|NCT01777997|3636401|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
1487013|NCT01777997|3636401|P1|STARTED|Weeks 0 to 24/48 on ART||36
1487014|NCT01777997|3636401|P1|NOT COMPLETED|12 Week lead-in of no ART||2
1487015|NCT01777997|3636401|P1|COMPLETED|12 Week lead-in of no ART||36
1487016|NCT01777997|3636401|P1|STARTED|12 Week lead-in of no ART||38
1487017|NCT01777945|3636413|P1|NOT COMPLETED|Overall Study||0
1487018|NCT01777945|3636413|P1|COMPLETED|Overall Study||46
1487019|NCT01777945|3636413|P1|Evaluable Participants|Overall Study||45
1487020|NCT01777945|3636413|P1|STARTED|Overall Study||46
1487021|NCT01777932|3636423|P1|NOT COMPLETED|Overall Study||205
1487022|NCT01777932|3636423|P1|COMPLETED|Overall Study||15
1487023|NCT01777932|3636423|P1|STARTED|Overall Study||220
1487024|NCT01777854|3636437|P2|NOT COMPLETED|Overall Study||3
1487025|NCT01777854|3636438|P1|NOT COMPLETED|Overall Study||3
1487026|NCT01777854|3636437|P2|COMPLETED|Overall Study||0
1487027|NCT01777854|3636438|P1|COMPLETED|Overall Study||0
1487028|NCT01777854|3636437|P2|STARTED|Overall Study||3
1487029|NCT01777854|3636438|P1|STARTED|Overall Study||3
1487030|NCT01777776|3636446|P4|NOT COMPLETED|Overall Study||4
1487031|NCT01777776|3636447|P3|NOT COMPLETED|Overall Study||6
1487032|NCT01777776|3636448|P2|NOT COMPLETED|Overall Study||12
1487033|NCT01777776|3636449|P1|NOT COMPLETED|Overall Study||6
1487034|NCT01777776|3636446|P4|COMPLETED|Overall Study||0
1487035|NCT01777776|3636447|P3|COMPLETED|Overall Study||0
1487036|NCT01777776|3636448|P2|COMPLETED|Overall Study||0
1487037|NCT01777776|3636449|P1|COMPLETED|Overall Study||0
1487038|NCT01777776|3636446|P4|STARTED|Overall Study||4
1487039|NCT01777776|3636447|P3|STARTED|Overall Study||6
1487040|NCT01777776|3636448|P2|STARTED|Overall Study||12
1487041|NCT01777776|3636449|P1|STARTED|Overall Study||6
1487042|NCT01777763|3636508|P2|NOT COMPLETED|Overall Study||47
1487043|NCT01777763|3636509|P1|NOT COMPLETED|Overall Study||4
1487044|NCT01777763|3636508|P2|COMPLETED|Overall Study||163
1487045|NCT01777763|3636509|P1|COMPLETED|Overall Study||16
1487046|NCT01777763|3636508|P2|STARTED|Overall Study||210
1487047|NCT01777763|3636509|P1|STARTED|Overall Study||20
1487048|NCT01777620|3636533|P2|NOT COMPLETED|Overall Study||0
1487049|NCT01777620|3636534|P1|NOT COMPLETED|Overall Study||1
1487050|NCT01777620|3636533|P2|COMPLETED|Overall Study||62
1487051|NCT01777620|3636534|P1|COMPLETED|Overall Study||62
1487052|NCT01777620|3636533|P2|STARTED|Overall Study||62
1487053|NCT01777620|3636534|P1|STARTED|Overall Study||63
1487054|NCT01777581|3636560|P2|NOT COMPLETED|Overall Study||2
1487055|NCT01777581|3636561|P1|NOT COMPLETED|Overall Study||3
1487056|NCT01777581|3636560|P2|COMPLETED|Overall Study||3
1487057|NCT01777581|3636561|P1|COMPLETED|Overall Study||5
1487058|NCT01777581|3636560|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
1487059|NCT01777581|3636561|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
1487060|NCT01777542|3636579|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
1487061|NCT01777542|3636580|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
1487062|NCT01777542|3636579|P2|COMPLETED|Second Intervention (20 Weeks)||14
1487063|NCT01777542|3636580|P1|COMPLETED|Second Intervention (20 Weeks)||15
1487064|NCT01777542|3636579|P2|STARTED|Second Intervention (20 Weeks)||15
1487065|NCT01777542|3636580|P1|STARTED|Second Intervention (20 Weeks)||15
1487066|NCT01777542|3636579|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
1487067|NCT01777542|3636580|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
1487068|NCT01777542|3636579|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
1487069|NCT01777542|3636580|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
1487070|NCT01777542|3636579|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
1487071|NCT01777542|3636580|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
1487072|NCT01777542|3636579|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
1487073|NCT01777542|3636580|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
1487074|NCT01777542|3636579|P2|COMPLETED|First Intervention (20 Weeks)||15
1487075|NCT01777542|3636580|P1|COMPLETED|First Intervention (20 Weeks)||15
1487076|NCT01777542|3636579|P2|STARTED|First Intervention (20 Weeks)||15
1487077|NCT01777542|3636580|P1|STARTED|First Intervention (20 Weeks)||15
1487078|NCT01777438|3636621|P2|NOT COMPLETED|Overall Study||0
1487079|NCT01777438|3636622|P1|NOT COMPLETED|Overall Study||0
1487080|NCT01777438|3636621|P2|COMPLETED|Overall Study||82
1487081|NCT01777438|3636622|P1|COMPLETED|Overall Study||352
1487082|NCT01777438|3636621|P2|STARTED|Overall Study||82
1487083|NCT01777438|3636622|P1|STARTED|Overall Study||352
1487084|NCT01777425|3636634|P1|NOT COMPLETED|Overall Study||0
1487085|NCT01777425|3636634|P1|COMPLETED|Overall Study||389
1487086|NCT01777425|3636634|P1|STARTED|Overall Study||389
1487087|NCT01777412|3636640|P1|NOT COMPLETED|Overall Study||0
1487088|NCT01777412|3636640|P1|COMPLETED|Overall Study||10
1487089|NCT01777412|3636640|P1|STARTED|Overall Study||10
1487090|NCT01777334|3636648|P2|NOT COMPLETED|Overall Study||63
1487091|NCT01777334|3636649|P1|NOT COMPLETED|Overall Study||53
1487092|NCT01777334|3636648|P2|COMPLETED|Overall Study||388
1487093|NCT01777334|3636649|P1|COMPLETED|Overall Study||401
1487094|NCT01777334|3636648|P2|STARTED|Overall Study||451
1487095|NCT01777334|3636649|P1|STARTED|Overall Study||454
1487096|NCT01777321|3636659|P2|NOT COMPLETED|Overall Study||1
1487097|NCT01777321|3636660|P1|NOT COMPLETED|Overall Study||0
1487098|NCT01777321|3636659|P2|COMPLETED|Overall Study||29
1487099|NCT01777321|3636660|P1|COMPLETED|Overall Study||30
1487100|NCT01777321|3636659|P2|STARTED|Overall Study||30
1487101|NCT01777321|3636660|P1|STARTED|Overall Study||30
1487102|NCT01777282|3636701|P5|NOT COMPLETED|Overall Study||7
1487103|NCT01777282|3636702|P4|NOT COMPLETED|Overall Study||2
1487104|NCT01777282|3636703|P3|NOT COMPLETED|Overall Study||6
1487105|NCT01777282|3636704|P2|NOT COMPLETED|Overall Study||4
1487106|NCT01777282|3636705|P1|NOT COMPLETED|Overall Study||11
1487107|NCT01777282|3636701|P5|COMPLETED|Overall Study||54
1487108|NCT01777282|3636702|P4|COMPLETED|Overall Study||59
1487109|NCT01777282|3636703|P3|COMPLETED|Overall Study||59
1487110|NCT01777282|3636704|P2|COMPLETED|Overall Study||63
1487111|NCT01777282|3636705|P1|COMPLETED|Overall Study||109
1487112|NCT01777282|3636701|P5|Completing Follow-up Period|Overall Study||54
1487113|NCT01777282|3636702|P4|Completing Follow-up Period|Overall Study||59
1487114|NCT01777282|3636703|P3|Completing Follow-up Period|Overall Study||59
1487115|NCT01777282|3636704|P2|Completing Follow-up Period|Overall Study||63
1487116|NCT01777282|3636705|P1|Completing Follow-up Period|Overall Study||109
1487117|NCT01777282|3636701|P5|Completing Treatment Period|Overall Study||54
1487118|NCT01777282|3636702|P4|Completing Treatment Period|Overall Study||59
1487119|NCT01777282|3636703|P3|Completing Treatment Period|Overall Study||59
1487120|NCT01777282|3636704|P2|Completing Treatment Period|Overall Study||63
1487121|NCT01777282|3636705|P1|Completing Treatment Period|Overall Study||109
1487122|NCT01777282|3636701|P5|STARTED|Overall Study||61
1487123|NCT01777282|3636702|P4|STARTED|Overall Study||61
1487124|NCT01777282|3636703|P3|STARTED|Overall Study||65
1487125|NCT01777282|3636704|P2|STARTED|Overall Study||67
1487126|NCT01777282|3636705|P1|STARTED|Overall Study||120
1487127|NCT01777269|3636749|P2|NOT COMPLETED|Overall Study||59
1487128|NCT01777269|3636750|P1|NOT COMPLETED|Overall Study||55
1487129|NCT01777269|3636749|P2|COMPLETED|Overall Study||184
1487130|NCT01777269|3636750|P1|COMPLETED|Overall Study||191
1487131|NCT01777269|3636749|P2|STARTED|Overall Study||243
1487132|NCT01777269|3636750|P1|STARTED|Overall Study||246
1487133|NCT01777217|3636778|P2|NOT COMPLETED|Overall Study||0
1487134|NCT01777217|3636779|P1|NOT COMPLETED|Overall Study||0
1487135|NCT01777217|3636778|P2|COMPLETED|Overall Study||4
1487136|NCT01777217|3636779|P1|COMPLETED|Overall Study||4
1487137|NCT01777217|3636778|P2|STARTED|Overall Study||4
1487138|NCT01777217|3636779|P1|STARTED|Overall Study||4
1487139|NCT01777191|3636787|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
1487140|NCT01777191|3636788|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
1487141|NCT01777191|3636787|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
1487142|NCT01777191|3636788|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
1487143|NCT01777191|3636787|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
1487144|NCT01777191|3636788|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
1487145|NCT01777191|3636787|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
1487146|NCT01777191|3636788|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
1487147|NCT01777191|3636787|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
1487148|NCT01777191|3636788|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
1487149|NCT01777191|3636787|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
1487150|NCT01777191|3636788|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
1487151|NCT01777126|3636818|P2|NOT COMPLETED|Overall Study||0
1487152|NCT01777126|3636819|P1|NOT COMPLETED|Overall Study||0
1487153|NCT01777126|3636818|P2|COMPLETED|Overall Study||46
1487154|NCT01777126|3636819|P1|COMPLETED|Overall Study||48
1487155|NCT01777126|3636818|P2|STARTED|Overall Study||46
1487156|NCT01777126|3636819|P1|STARTED|Overall Study||48
1487157|NCT01776645|3636842|P2|NOT COMPLETED|Overall Study||14
1487158|NCT01776645|3636843|P1|NOT COMPLETED|Overall Study||14
1487159|NCT01776645|3636842|P2|COMPLETED|Overall Study||14
1487160|NCT01776645|3636843|P1|COMPLETED|Overall Study||14
1487161|NCT01776645|3636842|P2|STARTED|Overall Study||28
1487162|NCT01776645|3636843|P1|STARTED|Overall Study||28
1487163|NCT01776554|3636851|P2|NOT COMPLETED|Overall Study||23
1487164|NCT01776554|3636852|P1|NOT COMPLETED|Overall Study||17
1487165|NCT01776554|3636851|P2|COMPLETED|Overall Study||307
1487166|NCT01776554|3636852|P1|COMPLETED|Overall Study||315
1487167|NCT01776554|3636851|P2|STARTED|Overall Study||330
1487168|NCT01776554|3636852|P1|STARTED|Overall Study||332
1487169|NCT01776541|3636895|P2|NOT COMPLETED|Overall Study||75
1487170|NCT01776541|3636896|P1|NOT COMPLETED|Overall Study||56
1487171|NCT01776541|3636895|P2|COMPLETED|Overall Study||416
1487172|NCT01776541|3636896|P1|COMPLETED|Overall Study||432
1487173|NCT01776541|3636895|P2|STARTED|Overall Study||491
1487174|NCT01776541|3636896|P1|STARTED|Overall Study||488
1487175|NCT01776424|3636918|P3|NOT COMPLETED|Overall Study||24
1487176|NCT01776424|3636919|P2|NOT COMPLETED|Overall Study||19
1487177|NCT01776424|3636920|P1|NOT COMPLETED|Overall Study||20
1487178|NCT01776424|3636918|P3|COMPLETED|Overall Study||9102
1487179|NCT01776424|3636919|P2|COMPLETED|Overall Study||9098
1487180|NCT01776424|3636920|P1|COMPLETED|Overall Study||9132
1487181|NCT01776424|3636918|P3|Treated|Overall Study||9107
1487182|NCT01776424|3636919|P2|Treated|Overall Study||9110
1487183|NCT01776424|3636920|P1|Treated|Overall Study||9134
1487184|NCT01776424|3636918|P3|STARTED|Overall Study||9126
1487185|NCT01776424|3636919|P2|STARTED|Overall Study||9117
1487186|NCT01776424|3636920|P1|STARTED|Overall Study||9152
1487187|NCT01776268|3636942|P2|NOT COMPLETED|Overall Study||0
1487188|NCT01776268|3636943|P1|NOT COMPLETED|Overall Study||0
1487189|NCT01776268|3636942|P2|COMPLETED|Overall Study||51
1487190|NCT01776268|3636943|P1|COMPLETED|Overall Study||48
1487191|NCT01776268|3636942|P2|STARTED|Overall Study||51
1487192|NCT01776268|3636943|P1|STARTED|Overall Study||48
1487193|NCT01776008|3636951|P1|NOT COMPLETED|Overall Study||2
1487194|NCT01776008|3636951|P1|COMPLETED|Overall Study||14
1487195|NCT01776008|3636951|P1|STARTED|Overall Study||16
1487196|NCT01775995|3636965|P2|NOT COMPLETED|Overall Study||1
1487197|NCT01775995|3636966|P1|NOT COMPLETED|Overall Study||1
1487198|NCT01775995|3636965|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
1487199|NCT01775995|3636966|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
1487200|NCT01775995|3636965|P2|STARTED|Overall Study||14
1487201|NCT01775995|3636966|P1|STARTED|Overall Study||21
1487202|NCT01775865|3637029|P3|NOT COMPLETED|Overall Study||0
1487203|NCT01775865|3637030|P2|NOT COMPLETED|Overall Study||1
1487204|NCT01775865|3637031|P1|NOT COMPLETED|Overall Study||3
1487205|NCT01775865|3637029|P3|COMPLETED|Overall Study||17
1487206|NCT01775865|3637030|P2|COMPLETED|Overall Study||13
1487207|NCT01775865|3637031|P1|COMPLETED|Overall Study||11
1487208|NCT01775865|3637029|P3|STARTED|Overall Study||17
1487209|NCT01775865|3637030|P2|STARTED|Overall Study||14
1487210|NCT01775865|3637031|P1|STARTED|Overall Study||14
1487211|NCT01775852|3637047|P2|NOT COMPLETED|Overall Study||1
1487212|NCT01775852|3637048|P1|NOT COMPLETED|Overall Study||0
1487213|NCT01775852|3637047|P2|COMPLETED|Overall Study||13
1487214|NCT01775852|3637048|P1|COMPLETED|Overall Study||31
1487215|NCT01775852|3637047|P2|STARTED|Overall Study||14
1487216|NCT01775852|3637048|P1|STARTED|Overall Study||31
1487217|NCT01775800|3637062|P2|NOT COMPLETED|Overall Study||0
1487218|NCT01775800|3637063|P1|NOT COMPLETED|Overall Study||0
1487219|NCT01775800|3637062|P2|COMPLETED|Overall Study||8
1487220|NCT01775800|3637063|P1|COMPLETED|Overall Study||8
1487221|NCT01775800|3637062|P2|STARTED|Overall Study||8
1487222|NCT01775800|3637063|P1|STARTED|Overall Study||8
1487223|NCT01775787|3637070|P2|NOT COMPLETED|Second 7-10 Days||2
1487224|NCT01775787|3637071|P1|NOT COMPLETED|Second 7-10 Days||0
1487225|NCT01775787|3637070|P2|COMPLETED|Second 7-10 Days||6
1487226|NCT01775787|3637071|P1|COMPLETED|Second 7-10 Days||12
1487227|NCT01775787|3637070|P2|STARTED|Second 7-10 Days||8
1487228|NCT01775787|3637071|P1|STARTED|Second 7-10 Days||12
1487229|NCT01775787|3637070|P2|NOT COMPLETED|First 7-10 Days||6
1487230|NCT01775787|3637071|P1|NOT COMPLETED|First 7-10 Days||1
1487231|NCT01775787|3637070|P2|COMPLETED|First 7-10 Days||8
1487232|NCT01775787|3637071|P1|COMPLETED|First 7-10 Days||12
1487233|NCT01775787|3637070|P2|STARTED|First 7-10 Days||14
1487234|NCT01775787|3637071|P1|STARTED|First 7-10 Days||13
1487235|NCT01775774|3637082|P3|NOT COMPLETED|Overall Study||0
1487236|NCT01775774|3637083|P2|NOT COMPLETED|Overall Study||0
1487237|NCT01775774|3637084|P1|NOT COMPLETED|Overall Study||0
1487238|NCT01775774|3637082|P3|COMPLETED|Overall Study||3
1487239|NCT01775774|3637083|P2|COMPLETED|Overall Study||3
1487240|NCT01775774|3637084|P1|COMPLETED|Overall Study||3
1487241|NCT01775774|3637082|P3|STARTED|Overall Study||3
1487242|NCT01775774|3637083|P2|STARTED|Overall Study||3
1487243|NCT01775774|3637084|P1|STARTED|Overall Study||3
1487244|NCT01775735|3637112|P2|NOT COMPLETED|Open Label (24 Months)||4
1487245|NCT01775735|3637113|P1|NOT COMPLETED|Open Label (24 Months)||1
1487246|NCT01775735|3637112|P2|COMPLETED|Open Label (24 Months)||3
1487247|NCT01775735|3637113|P1|COMPLETED|Open Label (24 Months)||7
1487248|NCT01775735|3637112|P2|STARTED|Open Label (24 Months)||7
1487249|NCT01775735|3637113|P1|STARTED|Open Label (24 Months)||8
1487250|NCT01775735|3637112|P2|NOT COMPLETED|Intervention (6 Months)||0
1487251|NCT01775735|3637113|P1|NOT COMPLETED|Intervention (6 Months)||0
1487252|NCT01775735|3637112|P2|COMPLETED|Intervention (6 Months)||7
1487253|NCT01775735|3637113|P1|COMPLETED|Intervention (6 Months)||8
1487254|NCT01775735|3637112|P2|STARTED|Intervention (6 Months)||7
1487255|NCT01775735|3637113|P1|STARTED|Intervention (6 Months)||8
1487256|NCT01775722|3637119|P1|NOT COMPLETED|Overall Study||2
1487257|NCT01775722|3637119|P1|COMPLETED|Overall Study||20
1487258|NCT01775722|3637119|P1|STARTED|Overall Study||22
1487259|NCT01775670|3637127|P2|NOT COMPLETED|Overall Study||1
1487260|NCT01775670|3637128|P1|NOT COMPLETED|Overall Study||1
1487261|NCT01775670|3637127|P2|COMPLETED|Overall Study||2
1487262|NCT01775670|3637128|P1|COMPLETED|Overall Study||0
1487263|NCT01775670|3637127|P2|STARTED|Overall Study||3
1487264|NCT01775670|3637128|P1|STARTED|Overall Study||1
1487265|NCT01775553|3637154|P1|NOT COMPLETED|Overall Study||13
1487266|NCT01775553|3637154|P1|COMPLETED|Overall Study||0
1487267|NCT01775553|3637154|P1|STARTED|Overall Study||13
1487268|NCT01775189|3637162|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1487269|NCT01775189|3637163|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1487270|NCT01775189|3637164|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1487271|NCT01775189|3637165|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1487272|NCT01775189|3637166|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1487273|NCT01775189|3637167|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1487274|NCT01775189|3637168|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1487275|NCT01775189|3637162|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
1487276|NCT01775189|3637163|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
1487277|NCT01775189|3637164|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
1487278|NCT01775189|3637165|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
1487279|NCT01775189|3637166|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
1487280|NCT01775189|3637167|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
1487281|NCT01775189|3637168|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
1487282|NCT01775189|3637162|P7|STARTED|Treatment Phase: Fourth Intervention||7
1487283|NCT01775189|3637163|P6|STARTED|Treatment Phase: Fourth Intervention||7
1487284|NCT01775189|3637164|P5|STARTED|Treatment Phase: Fourth Intervention||8
1487285|NCT01775189|3637165|P4|STARTED|Treatment Phase: Fourth Intervention||6
1487286|NCT01775189|3637166|P3|STARTED|Treatment Phase: Fourth Intervention||0
1487287|NCT01775189|3637167|P2|STARTED|Treatment Phase: Fourth Intervention||0
1487288|NCT01775189|3637168|P1|STARTED|Treatment Phase: Fourth Intervention||0
1487289|NCT01775189|3637162|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
1487290|NCT01775189|3637163|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1487291|NCT01775189|3637164|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1487292|NCT01775189|3637165|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
1487293|NCT01775189|3637166|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1487294|NCT01775189|3637167|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1487295|NCT01775189|3637168|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1487296|NCT01775189|3637162|P7|COMPLETED|Treatment Phase: Washout Period 3||7
1487297|NCT01775189|3637163|P6|COMPLETED|Treatment Phase: Washout Period 3||7
1487298|NCT01775189|3637164|P5|COMPLETED|Treatment Phase: Washout Period 3||8
1487299|NCT01775189|3637165|P4|COMPLETED|Treatment Phase: Washout Period 3||6
1487300|NCT01775189|3637166|P3|COMPLETED|Treatment Phase: Washout Period 3||0
1487301|NCT01775189|3637167|P2|COMPLETED|Treatment Phase: Washout Period 3||0
1487302|NCT01775189|3637168|P1|COMPLETED|Treatment Phase: Washout Period 3||0
1487303|NCT01775189|3637162|P7|STARTED|Treatment Phase: Washout Period 3||8
1487304|NCT01775189|3637163|P6|STARTED|Treatment Phase: Washout Period 3||7
1487305|NCT01775189|3637164|P5|STARTED|Treatment Phase: Washout Period 3||8
1487306|NCT01775189|3637165|P4|STARTED|Treatment Phase: Washout Period 3||7
1487307|NCT01775189|3637166|P3|STARTED|Treatment Phase: Washout Period 3||0
1487308|NCT01775189|3637167|P2|STARTED|Treatment Phase: Washout Period 3||0
1487309|NCT01775189|3637168|P1|STARTED|Treatment Phase: Washout Period 3||0
1487310|NCT01775189|3637162|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
1487311|NCT01775189|3637163|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
1487312|NCT01775189|3637164|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
1487313|NCT01775189|3637165|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
1487314|NCT01775189|3637166|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
1487315|NCT01775189|3637167|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
1487316|NCT01775189|3637168|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
1487317|NCT01775189|3637162|P7|COMPLETED|Treatment Phase: Third Intervention||8
1487318|NCT01775189|3637163|P6|COMPLETED|Treatment Phase: Third Intervention||7
1487319|NCT01775189|3637164|P5|COMPLETED|Treatment Phase: Third Intervention||8
1487320|NCT01775189|3637165|P4|COMPLETED|Treatment Phase: Third Intervention||7
1487321|NCT01775189|3637166|P3|COMPLETED|Treatment Phase: Third Intervention||0
1487322|NCT01775189|3637167|P2|COMPLETED|Treatment Phase: Third Intervention||0
1487323|NCT01775189|3637168|P1|COMPLETED|Treatment Phase: Third Intervention||0
1487324|NCT01775189|3637162|P7|STARTED|Treatment Phase: Third Intervention||8
1487325|NCT01775189|3637163|P6|STARTED|Treatment Phase: Third Intervention||7
1487326|NCT01775189|3637164|P5|STARTED|Treatment Phase: Third Intervention||8
1487327|NCT01775189|3637165|P4|STARTED|Treatment Phase: Third Intervention||7
1487328|NCT01775189|3637166|P3|STARTED|Treatment Phase: Third Intervention||0
1487329|NCT01775189|3637167|P2|STARTED|Treatment Phase: Third Intervention||0
1487330|NCT01775189|3637168|P1|STARTED|Treatment Phase: Third Intervention||0
1487331|NCT01775189|3637162|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1487332|NCT01775189|3637163|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1487333|NCT01775189|3637164|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1487334|NCT01775189|3637165|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
1487335|NCT01775189|3637166|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1487336|NCT01775189|3637167|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1487337|NCT01775189|3637168|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1487338|NCT01775189|3637162|P7|COMPLETED|Treatment Phase: Washout Period 2||8
1487339|NCT01775189|3637163|P6|COMPLETED|Treatment Phase: Washout Period 2||7
1487340|NCT01775189|3637164|P5|COMPLETED|Treatment Phase: Washout Period 2||8
1487341|NCT01775189|3637165|P4|COMPLETED|Treatment Phase: Washout Period 2||7
1487342|NCT01775189|3637166|P3|COMPLETED|Treatment Phase: Washout Period 2||0
1487343|NCT01775189|3637167|P2|COMPLETED|Treatment Phase: Washout Period 2||0
1487344|NCT01775189|3637168|P1|COMPLETED|Treatment Phase: Washout Period 2||0
1487345|NCT01775189|3637162|P7|STARTED|Treatment Phase: Washout Period 2||8
1487346|NCT01775189|3637163|P6|STARTED|Treatment Phase: Washout Period 2||7
1487347|NCT01775189|3637164|P5|STARTED|Treatment Phase: Washout Period 2||8
1487348|NCT01775189|3637165|P4|STARTED|Treatment Phase: Washout Period 2||8
1487349|NCT01775189|3637166|P3|STARTED|Treatment Phase: Washout Period 2||0
1487350|NCT01775189|3637167|P2|STARTED|Treatment Phase: Washout Period 2||0
1487351|NCT01775189|3637168|P1|STARTED|Treatment Phase: Washout Period 2||0
1487352|NCT01775189|3637162|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
1487353|NCT01775189|3637163|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
1487354|NCT01775189|3637164|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
1487355|NCT01775189|3637165|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
1487356|NCT01775189|3637166|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
1487357|NCT01775189|3637167|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
1487358|NCT01775189|3637168|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
1487359|NCT01775189|3637162|P7|COMPLETED|Treatment Phase: Second Intervention||8
1487360|NCT01775189|3637163|P6|COMPLETED|Treatment Phase: Second Intervention||7
1487361|NCT01775189|3637164|P5|COMPLETED|Treatment Phase: Second Intervention||8
1487362|NCT01775189|3637165|P4|COMPLETED|Treatment Phase: Second Intervention||8
1487363|NCT01775189|3637166|P3|COMPLETED|Treatment Phase: Second Intervention||0
1487364|NCT01775189|3637167|P2|COMPLETED|Treatment Phase: Second Intervention||0
1487365|NCT01775189|3637168|P1|COMPLETED|Treatment Phase: Second Intervention||0
1487366|NCT01775189|3637162|P7|STARTED|Treatment Phase: Second Intervention||8
1487367|NCT01775189|3637163|P6|STARTED|Treatment Phase: Second Intervention||7
1487368|NCT01775189|3637164|P5|STARTED|Treatment Phase: Second Intervention||8
1487369|NCT01775189|3637165|P4|STARTED|Treatment Phase: Second Intervention||8
1487370|NCT01775189|3637166|P3|STARTED|Treatment Phase: Second Intervention||0
1487371|NCT01775189|3637167|P2|STARTED|Treatment Phase: Second Intervention||0
1487372|NCT01775189|3637168|P1|STARTED|Treatment Phase: Second Intervention||0
1487373|NCT01775189|3637162|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1487374|NCT01775189|3637163|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
1487375|NCT01775189|3637164|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1487376|NCT01775189|3637165|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1487377|NCT01775189|3637166|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1487378|NCT01775189|3637167|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1487379|NCT01775189|3637168|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1487380|NCT01775189|3637162|P7|COMPLETED|Treatment Phase: Washout Period 1||8
1487381|NCT01775189|3637163|P6|COMPLETED|Treatment Phase: Washout Period 1||7
1487382|NCT01775189|3637164|P5|COMPLETED|Treatment Phase: Washout Period 1||8
1487383|NCT01775189|3637165|P4|COMPLETED|Treatment Phase: Washout Period 1||8
1487384|NCT01775189|3637166|P3|COMPLETED|Treatment Phase: Washout Period 1||0
1487385|NCT01775189|3637167|P2|COMPLETED|Treatment Phase: Washout Period 1||0
1487386|NCT01775189|3637168|P1|COMPLETED|Treatment Phase: Washout Period 1||0
1487387|NCT01775189|3637162|P7|STARTED|Treatment Phase: Washout Period 1||8
1487388|NCT01775189|3637163|P6|STARTED|Treatment Phase: Washout Period 1||8
1487389|NCT01775189|3637164|P5|STARTED|Treatment Phase: Washout Period 1||8
1487390|NCT01775189|3637165|P4|STARTED|Treatment Phase: Washout Period 1||8
1487391|NCT01775189|3637166|P3|STARTED|Treatment Phase: Washout Period 1||0
1487392|NCT01775189|3637167|P2|STARTED|Treatment Phase: Washout Period 1||0
1487393|NCT01775189|3637168|P1|STARTED|Treatment Phase: Washout Period 1||0
1487394|NCT01775189|3637162|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
1487395|NCT01775189|3637163|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
1487396|NCT01775189|3637164|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
1487397|NCT01775189|3637165|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
1487398|NCT01775189|3637166|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
1487399|NCT01775189|3637167|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
1487400|NCT01775189|3637168|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
1487401|NCT01775189|3637162|P7|COMPLETED|Treatment Phase: First Intervention||8
1487402|NCT01775189|3637163|P6|COMPLETED|Treatment Phase: First Intervention||8
1487403|NCT01775189|3637164|P5|COMPLETED|Treatment Phase: First Intervention||8
1487404|NCT01775189|3637165|P4|COMPLETED|Treatment Phase: First Intervention||8
1487405|NCT01775189|3637166|P3|COMPLETED|Treatment Phase: First Intervention||0
1487406|NCT01775189|3637167|P2|COMPLETED|Treatment Phase: First Intervention||0
1487407|NCT01775189|3637168|P1|COMPLETED|Treatment Phase: First Intervention||0
1487408|NCT01775189|3637162|P7|STARTED|Treatment Phase: First Intervention||8
1487409|NCT01775189|3637163|P6|STARTED|Treatment Phase: First Intervention||8
1487410|NCT01775189|3637164|P5|STARTED|Treatment Phase: First Intervention||8
1487411|NCT01775189|3637165|P4|STARTED|Treatment Phase: First Intervention||8
1487412|NCT01775189|3637166|P3|STARTED|Treatment Phase: First Intervention||0
1487413|NCT01775189|3637167|P2|STARTED|Treatment Phase: First Intervention||0
1487414|NCT01775189|3637168|P1|STARTED|Treatment Phase: First Intervention||0
1487415|NCT01775189|3637162|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1487416|NCT01775189|3637163|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1487417|NCT01775189|3637164|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1487418|NCT01775189|3637165|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1487419|NCT01775189|3637166|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
1487420|NCT01775189|3637167|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
1487421|NCT01775189|3637168|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1487422|NCT01775189|3637162|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
1487423|NCT01775189|3637163|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
1487424|NCT01775189|3637164|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
1487425|NCT01775189|3637165|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
1487426|NCT01775189|3637166|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
1487427|NCT01775189|3637167|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
1487428|NCT01775189|3637168|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
1487429|NCT01775189|3637162|P7|STARTED|Drug Discrimination Phase: Day 2||0
1487430|NCT01775189|3637163|P6|STARTED|Drug Discrimination Phase: Day 2||0
1487431|NCT01775189|3637164|P5|STARTED|Drug Discrimination Phase: Day 2||0
1487432|NCT01775189|3637165|P4|STARTED|Drug Discrimination Phase: Day 2||0
1487433|NCT01775189|3637166|P3|STARTED|Drug Discrimination Phase: Day 2||23
1487434|NCT01775189|3637167|P2|STARTED|Drug Discrimination Phase: Day 2||19
1487435|NCT01775189|3637168|P1|STARTED|Drug Discrimination Phase: Day 2||0
1487436|NCT01775189|3637162|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1487437|NCT01775189|3637163|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1487438|NCT01775189|3637164|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1487439|NCT01775189|3637165|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1487440|NCT01775189|3637166|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1487441|NCT01775189|3637167|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
1487442|NCT01775189|3637168|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1487443|NCT01775189|3637162|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
1487444|NCT01775189|3637163|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
1487445|NCT01775189|3637164|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
1487446|NCT01775189|3637165|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
1487447|NCT01775189|3637166|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
1487448|NCT01775189|3637167|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
1487449|NCT01775189|3637168|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
1487450|NCT01775189|3637162|P7|STARTED|Drug Discrimination Phase: Day 1||0
1487451|NCT01775189|3637163|P6|STARTED|Drug Discrimination Phase: Day 1||0
1487452|NCT01775189|3637164|P5|STARTED|Drug Discrimination Phase: Day 1||0
1487453|NCT01775189|3637165|P4|STARTED|Drug Discrimination Phase: Day 1||0
1487454|NCT01775189|3637166|P3|STARTED|Drug Discrimination Phase: Day 1||23
1487455|NCT01775189|3637167|P2|STARTED|Drug Discrimination Phase: Day 1||22
1487456|NCT01775189|3637168|P1|STARTED|Drug Discrimination Phase: Day 1||0
1487457|NCT01775189|3637162|P7|NOT COMPLETED|Naloxone Challenge Phase||0
1487458|NCT01775189|3637163|P6|NOT COMPLETED|Naloxone Challenge Phase||0
1487459|NCT01775189|3637164|P5|NOT COMPLETED|Naloxone Challenge Phase||0
1487460|NCT01775189|3637165|P4|NOT COMPLETED|Naloxone Challenge Phase||0
1487461|NCT01775189|3637166|P3|NOT COMPLETED|Naloxone Challenge Phase||0
1487462|NCT01775189|3637167|P2|NOT COMPLETED|Naloxone Challenge Phase||0
1487463|NCT01775189|3637168|P1|NOT COMPLETED|Naloxone Challenge Phase||0
1487464|NCT01775189|3637162|P7|COMPLETED|Naloxone Challenge Phase||0
1487465|NCT01775189|3637163|P6|COMPLETED|Naloxone Challenge Phase||0
1487466|NCT01775189|3637164|P5|COMPLETED|Naloxone Challenge Phase||0
1487467|NCT01775189|3637165|P4|COMPLETED|Naloxone Challenge Phase||0
1487468|NCT01775189|3637166|P3|COMPLETED|Naloxone Challenge Phase||0
1487469|NCT01775189|3637167|P2|COMPLETED|Naloxone Challenge Phase||0
1487470|NCT01775189|3637168|P1|COMPLETED|Naloxone Challenge Phase||45
1487471|NCT01775189|3637162|P7|STARTED|Naloxone Challenge Phase||0
1487472|NCT01775189|3637163|P6|STARTED|Naloxone Challenge Phase||0
1487473|NCT01775189|3637164|P5|STARTED|Naloxone Challenge Phase||0
1487474|NCT01775189|3637165|P4|STARTED|Naloxone Challenge Phase||0
1487475|NCT01775189|3637166|P3|STARTED|Naloxone Challenge Phase||0
1487476|NCT01775189|3637167|P2|STARTED|Naloxone Challenge Phase||0
1487477|NCT01775189|3637168|P1|STARTED|Naloxone Challenge Phase||45
1487478|NCT01775137|3637387|P1|NOT COMPLETED|Overall Study||11
1487479|NCT01775137|3637387|P1|COMPLETED|Overall Study||34
1487480|NCT01775137|3637387|P1|STARTED|Overall Study||45
1487481|NCT01775124|3637414|P2|NOT COMPLETED|Extension Period||18
1487482|NCT01775124|3637415|P1|NOT COMPLETED|Extension Period||12
1487483|NCT01775124|3637414|P2|COMPLETED|Extension Period||138
1487484|NCT01775124|3637415|P1|COMPLETED|Extension Period||145
1487485|NCT01775124|3637414|P2|STARTED|Extension Period||156
1487486|NCT01775124|3637415|P1|STARTED|Extension Period||157
1487487|NCT01775124|3637414|P2|NOT COMPLETED|Core Period||10
1487488|NCT01775124|3637415|P1|NOT COMPLETED|Core Period||11
1487489|NCT01775124|3637414|P2|COMPLETED|Core Period||156
1487490|NCT01775124|3637415|P1|COMPLETED|Core Period||157
1487491|NCT01775124|3637414|P2|Safety Set|Core Period||166
1487492|NCT01775124|3637415|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
1487493|NCT01775124|3637414|P2|Per Protocol Set|Core Period||155
1487494|NCT01775124|3637415|P1|Per Protocol Set|Core Period||157
1487495|NCT01775124|3637414|P2|Full Analysis Set|Core Period||166
1487496|NCT01775124|3637415|P1|Full Analysis Set|Core Period||167
1487497|NCT01775124|3637414|P2|STARTED|Core Period||166
1487498|NCT01775124|3637415|P1|STARTED|Core Period||168
1487499|NCT01774981|3637450|P8|NOT COMPLETED|Overall Study||1
1487500|NCT01774981|3637451|P7|NOT COMPLETED|Overall Study||0
1487501|NCT01774981|3637452|P6|NOT COMPLETED|Overall Study||1
1487502|NCT01774981|3637453|P5|NOT COMPLETED|Overall Study||1
1487503|NCT01774981|3637454|P4|NOT COMPLETED|Overall Study||0
1487504|NCT01774981|3637455|P3|NOT COMPLETED|Overall Study||0
1487505|NCT01774981|3637456|P2|NOT COMPLETED|Overall Study||0
1487506|NCT01774981|3637457|P1|NOT COMPLETED|Overall Study||0
1487507|NCT01774981|3637450|P8|COMPLETED|Overall Study||11
1487508|NCT01774981|3637451|P7|COMPLETED|Overall Study||13
1487509|NCT01774981|3637452|P6|COMPLETED|Overall Study||13
1487510|NCT01774981|3637453|P5|COMPLETED|Overall Study||5
1487511|NCT01774981|3637454|P4|COMPLETED|Overall Study||4
1487512|NCT01774981|3637455|P3|COMPLETED|Overall Study||4
1487513|NCT01774981|3637456|P2|COMPLETED|Overall Study||4
1487514|NCT01774981|3637457|P1|COMPLETED|Overall Study||3
1487515|NCT01774981|3637450|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
1487516|NCT01774981|3637451|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
1487517|NCT01774981|3637452|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
1487518|NCT01774981|3637453|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
1487519|NCT01774981|3637454|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
1487520|NCT01774981|3637455|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
1487521|NCT01774981|3637456|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
1487522|NCT01774981|3637457|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1487523|NCT01774981|3637450|P8|STARTED|Overall Study||12
1487524|NCT01774981|3637451|P7|STARTED|Overall Study||13
1487525|NCT01774981|3637452|P6|STARTED|Overall Study||14
1487526|NCT01774981|3637453|P5|STARTED|Overall Study||6
1487527|NCT01774981|3637454|P4|STARTED|Overall Study||4
1487528|NCT01774981|3637455|P3|STARTED|Overall Study||4
1487529|NCT01774981|3637456|P2|STARTED|Overall Study||4
1487530|NCT01774981|3637457|P1|STARTED|Overall Study||3
1487531|NCT01774968|3637489|P2|NOT COMPLETED|Overall Study||35
1487532|NCT01774968|3637490|P1|NOT COMPLETED|Overall Study||30
1487533|NCT01774968|3637489|P2|COMPLETED|Overall Study||128
1487534|NCT01774968|3637490|P1|COMPLETED|Overall Study||132
1487535|NCT01774968|3637489|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
1487536|NCT01774968|3637490|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
1487537|NCT01774968|3637489|P2|STARTED|Overall Study||163
1487538|NCT01774968|3637490|P1|STARTED|Overall Study||162
1487539|NCT01774929|3637524|P1|NOT COMPLETED|Overall Study||3
1487540|NCT01774929|3637524|P1|COMPLETED|Overall Study||32
1487541|NCT01774929|3637524|P1|STARTED|Overall Study||35
1487542|NCT01774903|3637530|P1|NOT COMPLETED|Overall Study||11
1487543|NCT01774903|3637530|P1|COMPLETED|Overall Study||34
1487544|NCT01774903|3637530|P1|STARTED|Overall Study||45
1487545|NCT01774851|3637539|P2|NOT COMPLETED|Overall Study||0
1487546|NCT01774851|3637540|P1|NOT COMPLETED|Overall Study||0
1487547|NCT01774851|3637539|P2|COMPLETED|Overall Study||42
1487548|NCT01774851|3637540|P1|COMPLETED|Overall Study||42
1487549|NCT01774851|3637539|P2|STARTED|Overall Study||42
1487550|NCT01774851|3637540|P1|STARTED|Overall Study||42
1487551|NCT01774786|3637548|P2|NOT COMPLETED|Overall Study||392
1487552|NCT01774786|3637549|P1|NOT COMPLETED|Overall Study||388
1487553|NCT01774786|3637548|P2|COMPLETED|Overall Study||0
1487554|NCT01774786|3637549|P1|COMPLETED|Overall Study||0
1487555|NCT01774786|3637548|P2|Received at Least One Dose of Placebo|Overall Study||388
1487556|NCT01774786|3637549|P1|Received at Least One Dose of Placebo|Overall Study||0
1487557|NCT01774786|3637548|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
1487558|NCT01774786|3637549|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
1487559|NCT01774786|3637548|P2|Did Not Receive Study Drug|Overall Study||3
1487560|NCT01774786|3637549|P1|Did Not Receive Study Drug|Overall Study||4
1487561|NCT01774786|3637548|P2|STARTED|Overall Study||392
1487562|NCT01774786|3637549|P1|STARTED|Overall Study||388
1487563|NCT01774721|3637579|P2|NOT COMPLETED|Overall Study||225
1487564|NCT01774721|3637580|P1|NOT COMPLETED|Overall Study||227
1487565|NCT01774721|3637579|P2|COMPLETED|Overall Study||0
1487566|NCT01774721|3637580|P1|COMPLETED|Overall Study||0
1487567|NCT01774721|3637579|P2|Treated|Overall Study||224
1487568|NCT01774721|3637580|P1|Treated|Overall Study||227
1487569|NCT01774721|3637579|P2|STARTED|Overall Study||225
1487570|NCT01774721|3637580|P1|STARTED|Overall Study||227
1487571|NCT01774604|3637624|P2|NOT COMPLETED|Overall Study||0
1487572|NCT01774604|3637625|P1|NOT COMPLETED|Overall Study||0
1487573|NCT01774604|3637624|P2|COMPLETED|Overall Study||226
1487574|NCT01774604|3637625|P1|COMPLETED|Overall Study||223
1487575|NCT01774604|3637624|P2|STARTED|Overall Study||226
1487576|NCT01774604|3637625|P1|STARTED|Overall Study||223
1487577|NCT01774591|3637645|P2|NOT COMPLETED|Overall Study||4
1487578|NCT01774591|3637646|P1|NOT COMPLETED|Overall Study||1
1487579|NCT01774591|3637645|P2|COMPLETED|Overall Study||7
1487580|NCT01774591|3637646|P1|COMPLETED|Overall Study||9
1487581|NCT01774591|3637645|P2|STARTED|Overall Study||11
1487582|NCT01774591|3637646|P1|STARTED|Overall Study||10
1487583|NCT01774344|3637658|P2|NOT COMPLETED|Overall Study||148
1487584|NCT01774344|3637659|P1|NOT COMPLETED|Overall Study||32
1487585|NCT01774344|3637658|P2|COMPLETED|Overall Study||231
1487586|NCT01774344|3637659|P1|COMPLETED|Overall Study||162
1487587|NCT01774344|3637658|P2|Treated|Overall Study||374
1487588|NCT01774344|3637659|P1|Treated|Overall Study||193
1487589|NCT01774344|3637658|P2|STARTED|Overall Study||379
1487590|NCT01774344|3637659|P1|STARTED|Overall Study||194
1487591|NCT01774305|3637675|P2|NOT COMPLETED|Overall Study||0
1487592|NCT01774305|3637676|P1|NOT COMPLETED|Overall Study||1
1487593|NCT01774305|3637675|P2|COMPLETED|Overall Study||71
1487594|NCT01774305|3637676|P1|COMPLETED|Overall Study||70
1487595|NCT01774305|3637675|P2|STARTED|Overall Study||71
1487596|NCT01774305|3637676|P1|STARTED|Overall Study||71
1487597|NCT01774253|3637684|P1|NOT COMPLETED|Overall Study||9
1487598|NCT01774253|3637684|P1|COMPLETED|Overall Study||0
1487599|NCT01774253|3637684|P1|STARTED|Overall Study||9
1487600|NCT01774149|3637694|P2|NOT COMPLETED|Overall Study||3
1487601|NCT01774149|3637695|P1|NOT COMPLETED|Overall Study||1
1487602|NCT01774149|3637694|P2|COMPLETED|Overall Study||12
1487603|NCT01774149|3637695|P1|COMPLETED|Overall Study||14
1487604|NCT01774149|3637694|P2|STARTED|Overall Study||15
1487605|NCT01774149|3637695|P1|STARTED|Overall Study||15
1487606|NCT01774110|3637703|P1|NOT COMPLETED|Overall Study||7
1487607|NCT01774110|3637703|P1|COMPLETED|Overall Study||5
1487608|NCT01774110|3637703|P1|STARTED|Overall Study||12
1487609|NCT01774097|3637711|P2|NOT COMPLETED|Overall Study||2
1487610|NCT01774097|3637712|P1|NOT COMPLETED|Overall Study||2
1487611|NCT01774097|3637711|P2|COMPLETED|Overall Study||40
1487612|NCT01774097|3637712|P1|COMPLETED|Overall Study||38
1487613|NCT01774097|3637711|P2|STARTED|Overall Study||42
1487614|NCT01774097|3637712|P1|STARTED|Overall Study||40
1487615|NCT01774084|3637742|P2|NOT COMPLETED|Overall Study||0
1487616|NCT01774084|3637743|P1|NOT COMPLETED|Overall Study||1
1487617|NCT01774084|3637742|P2|COMPLETED|Overall Study||12
1487618|NCT01774084|3637743|P1|COMPLETED|Overall Study||10
1487619|NCT01774084|3637742|P2|STARTED|Overall Study||12
1487620|NCT01774084|3637743|P1|STARTED|Overall Study||11
1487621|NCT01774045|3637753|P2|NOT COMPLETED|Overall Study||0
1487622|NCT01774045|3637754|P1|NOT COMPLETED|Overall Study||0
1487623|NCT01774045|3637753|P2|COMPLETED|Overall Study||7
1487624|NCT01774045|3637754|P1|COMPLETED|Overall Study||23
1487625|NCT01774045|3637753|P2|STARTED|Overall Study||7
1487626|NCT01774045|3637754|P1|STARTED|Overall Study||23
1487627|NCT01773954|3637768|P1|NOT COMPLETED|Overall Study||9
1487628|NCT01773954|3637768|P1|COMPLETED|Overall Study||31
1487629|NCT01773954|3637768|P1|STARTED|Overall Study||40
1487630|NCT01773889|3637773|P1|NOT COMPLETED|Overall Study||2
1487631|NCT01773889|3637773|P1|COMPLETED|Overall Study||0
1487632|NCT01773889|3637773|P1|STARTED|Overall Study||2
1487633|NCT01773473|3637779|P2|NOT COMPLETED|Overall Study||19
1487634|NCT01773473|3637780|P1|NOT COMPLETED|Overall Study||16
1487635|NCT01773473|3637779|P2|COMPLETED|Overall Study||177
1487636|NCT01773473|3637780|P1|COMPLETED|Overall Study||191
1487637|NCT01773473|3637779|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
1487638|NCT01773473|3637780|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
1487639|NCT01773473|3637779|P2|STARTED|Overall Study||196
1487640|NCT01773473|3637780|P1|STARTED|Overall Study||207
1487641|NCT01773291|3637801|P3|NOT COMPLETED|Overall Study||1
1487642|NCT01773291|3637802|P2|NOT COMPLETED|Overall Study||0
1487643|NCT01773291|3637803|P1|NOT COMPLETED|Overall Study||1
1487644|NCT01773291|3637801|P3|COMPLETED|Overall Study||6
1487645|NCT01773291|3637802|P2|COMPLETED|Overall Study||9
1487646|NCT01773291|3637803|P1|COMPLETED|Overall Study||7
1487647|NCT01773291|3637801|P3|STARTED|Overall Study||7
1487648|NCT01773291|3637802|P2|STARTED|Overall Study||9
1487649|NCT01773291|3637803|P1|STARTED|Overall Study||8
1487650|NCT01773226|3637814|P1|NOT COMPLETED|Overall Study||1
1487651|NCT01773226|3637814|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
1487652|NCT01773226|3637814|P1|STARTED|Overall Study||11
1487653|NCT01773135|3637824|P1|NOT COMPLETED|Overall Study||0
1487654|NCT01773135|3637824|P1|COMPLETED|Overall Study||262
1487655|NCT01773135|3637824|P1|STARTED|Overall Study||262
1487656|NCT01773122|3637833|P4|NOT COMPLETED|Overall Study||1
1487657|NCT01773122|3637834|P3|NOT COMPLETED|Overall Study||0
1487658|NCT01773122|3637835|P2|NOT COMPLETED|Overall Study||1
1487659|NCT01773122|3637836|P1|NOT COMPLETED|Overall Study||3
1487660|NCT01773122|3637833|P4|COMPLETED|Overall Study||18
1487661|NCT01773122|3637834|P3|COMPLETED|Overall Study||19
1487662|NCT01773122|3637835|P2|COMPLETED|Overall Study||18
1487663|NCT01773122|3637836|P1|COMPLETED|Overall Study||17
1487664|NCT01773122|3637833|P4|STARTED|Overall Study||19
1487665|NCT01773122|3637834|P3|STARTED|Overall Study||19
1487666|NCT01773122|3637835|P2|STARTED|Overall Study||19
1487667|NCT01773122|3637836|P1|STARTED|Overall Study||20
1487668|NCT01773070|3637850|P1|NOT COMPLETED|Overall Study||81
1487669|NCT01773070|3637850|P1|COMPLETED|Overall Study||397
1487670|NCT01773070|3637850|P1|STARTED|Overall Study||478
1487671|NCT01772823|3637860|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
1487672|NCT01772823|3637861|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
1487673|NCT01772823|3637860|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
1487674|NCT01772823|3637861|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
1487675|NCT01772823|3637860|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
1487676|NCT01772823|3637861|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
1487677|NCT01772823|3637860|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
1487678|NCT01772823|3637861|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
1487679|NCT01772823|3637860|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
1487680|NCT01772823|3637861|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
1487681|NCT01772823|3637860|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
1487682|NCT01772823|3637861|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
1487683|NCT01772823|3637860|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
1487684|NCT01772823|3637861|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
1487685|NCT01772823|3637860|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
1487686|NCT01772823|3637861|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
1487687|NCT01772823|3637860|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
1487688|NCT01772823|3637861|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
1487689|NCT01772758|3637961|P4|NOT COMPLETED|Overall Study||0
1487690|NCT01772758|3637962|P3|NOT COMPLETED|Overall Study||0
1487691|NCT01772758|3637963|P2|NOT COMPLETED|Overall Study||0
1487692|NCT01772758|3637964|P1|NOT COMPLETED|Overall Study||0
1487693|NCT01772758|3637961|P4|COMPLETED|Overall Study||17
1487694|NCT01772758|3637962|P3|COMPLETED|Overall Study||12
1487695|NCT01772758|3637963|P2|COMPLETED|Overall Study||17
1487696|NCT01772758|3637964|P1|COMPLETED|Overall Study||18
1487697|NCT01772758|3637961|P4|STARTED|Overall Study||17
1487698|NCT01772758|3637962|P3|STARTED|Overall Study||12
1487699|NCT01772758|3637963|P2|STARTED|Overall Study||17
1487700|NCT01772758|3637964|P1|STARTED|Overall Study||18
1487701|NCT01772654|3637976|P2|NOT COMPLETED|Overall Study||0
1487702|NCT01772654|3637977|P1|NOT COMPLETED|Overall Study||0
1487703|NCT01772654|3637976|P2|COMPLETED|Overall Study||15
1487704|NCT01772654|3637977|P1|COMPLETED|Overall Study||2
1487705|NCT01772654|3637976|P2|STARTED|Overall Study||15
1487706|NCT01772654|3637977|P1|STARTED|Overall Study||2
1487707|NCT01772576|3637983|P1|NOT COMPLETED|Overall Study||34
1487708|NCT01772576|3637983|P1|COMPLETED|Overall Study||133
1487709|NCT01772576|3637983|P1|STARTED|Overall Study||167
1487710|NCT01772550|3637995|P3|NOT COMPLETED|Overall Study||6
1487711|NCT01772550|3637996|P2|NOT COMPLETED|Overall Study||1
1487712|NCT01772550|3637997|P1|NOT COMPLETED|Overall Study||1
1487713|NCT01772550|3637995|P3|COMPLETED|Overall Study||27
1487714|NCT01772550|3637996|P2|COMPLETED|Overall Study||102
1487715|NCT01772550|3637997|P1|COMPLETED|Overall Study||101
1487716|NCT01772550|3637995|P3|CT Cardiac|Overall Study||1
1487717|NCT01772550|3637996|P2|CT Cardiac|Overall Study||7
1487718|NCT01772550|3637997|P1|CT Cardiac|Overall Study||7
1487719|NCT01772550|3637995|P3|CT Kidney|Overall Study||6
1487720|NCT01772550|3637996|P2|CT Kidney|Overall Study||19
1487721|NCT01772550|3637997|P1|CT Kidney|Overall Study||12
1487722|NCT01772550|3637995|P3|CT Liver|Overall Study||8
1487723|NCT01772550|3637996|P2|CT Liver|Overall Study||14
1487724|NCT01772550|3637997|P1|CT Liver|Overall Study||18
1487725|NCT01772550|3637995|P3|CT Angiogram|Overall Study||4
1487726|NCT01772550|3637996|P2|CT Angiogram|Overall Study||25
1487727|NCT01772550|3637997|P1|CT Angiogram|Overall Study||24
1487728|NCT01772550|3637995|P3|CT Pancreas|Overall Study||8
1487729|NCT01772550|3637996|P2|CT Pancreas|Overall Study||36
1487730|NCT01772550|3637997|P1|CT Pancreas|Overall Study||40
1487731|NCT01772550|3637995|P3|STARTED|Overall Study||33
1487732|NCT01772550|3637996|P2|STARTED|Overall Study||103
1487733|NCT01772550|3637997|P1|STARTED|Overall Study||102
1487734|NCT01772537|3638038|P3|NOT COMPLETED|Overall Study||0
1487735|NCT01772537|3638039|P2|NOT COMPLETED|Overall Study||0
1487736|NCT01772537|3638040|P1|NOT COMPLETED|Overall Study||1
1487737|NCT01772537|3638038|P3|COMPLETED|Overall Study||6
1487738|NCT01772537|3638039|P2|COMPLETED|Overall Study||3
1487739|NCT01772537|3638040|P1|COMPLETED|Overall Study||4
1487740|NCT01772537|3638038|P3|STARTED|Overall Study||6
1487741|NCT01772537|3638039|P2|STARTED|Overall Study||3
1487742|NCT01772537|3638040|P1|STARTED|Overall Study||5
1487743|NCT01772368|3638054|P1|NOT COMPLETED|Overall Study||7
1487744|NCT01772368|3638054|P1|COMPLETED|Overall Study||65
1487745|NCT01772368|3638054|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
1487746|NCT01772368|3638054|P1|Received FS MDPI 100/50 mcg|Overall Study||68
1487747|NCT01772368|3638054|P1|Received FS MDPI 100/25 mcg|Overall Study||67
1487748|NCT01772368|3638054|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
1487749|NCT01772368|3638054|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
1487750|NCT01772368|3638054|P1|Received Fp MDPI 100 mcg|Overall Study||67
1487751|NCT01772368|3638054|P1|STARTED|Overall Study||72
1487752|NCT01772316|3638100|P1|NOT COMPLETED|Overall Study||7
1487753|NCT01772316|3638100|P1|COMPLETED|Overall Study||40
1487754|NCT01772316|3638100|P1|STARTED|Overall Study||47
1487755|NCT01772147|3638121|P3|NOT COMPLETED|Overall Study||18
1487756|NCT01772147|3638122|P2|NOT COMPLETED|Overall Study||25
1487757|NCT01772147|3638123|P1|NOT COMPLETED|Overall Study||31
1487758|NCT01772147|3638121|P3|COMPLETED|Overall Study||184
1487759|NCT01772147|3638122|P2|COMPLETED|Overall Study||178
1487760|NCT01772147|3638123|P1|COMPLETED|Overall Study||170
1487761|NCT01772147|3638121|P3|STARTED|Overall Study||202
1487762|NCT01772147|3638122|P2|STARTED|Overall Study||203
1487763|NCT01772147|3638123|P1|STARTED|Overall Study||201
1487764|NCT01772134|3638143|P3|NOT COMPLETED|Overall Study||22
1487765|NCT01772134|3638144|P2|NOT COMPLETED|Overall Study||14
1487766|NCT01772134|3638145|P1|NOT COMPLETED|Overall Study||29
1487767|NCT01772134|3638143|P3|COMPLETED|Overall Study||184
1487768|NCT01772134|3638144|P2|COMPLETED|Overall Study||190
1487769|NCT01772134|3638145|P1|COMPLETED|Overall Study||178
1487770|NCT01772134|3638143|P3|Received Randomized Study Medication|Overall Study||205
1487771|NCT01772134|3638144|P2|Received Randomized Study Medication|Overall Study||204
1487772|NCT01772134|3638145|P1|Received Randomized Study Medication|Overall Study||205
1487773|NCT01772134|3638143|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
1487774|NCT01772134|3638144|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
1487775|NCT01772134|3638145|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
1487776|NCT01771991|3638164|P2|NOT COMPLETED|Overall Study||6
1487777|NCT01771991|3638165|P1|NOT COMPLETED|Overall Study||8
1487778|NCT01771991|3638164|P2|COMPLETED|Overall Study||30
1487779|NCT01771991|3638165|P1|COMPLETED|Overall Study||30
1487780|NCT01771991|3638164|P2|Started Treatment|Overall Study||34
1487781|NCT01771991|3638165|P1|Started Treatment|Overall Study||37
1487782|NCT01771991|3638164|P2|STARTED|Overall Study||36
1487783|NCT01771991|3638165|P1|STARTED|Overall Study||38
1487784|NCT01771965|3638173|P2|NOT COMPLETED|Overall Study||5
1487785|NCT01771965|3638174|P1|NOT COMPLETED|Overall Study||3
1487786|NCT01771965|3638173|P2|COMPLETED|Overall Study||4
1487787|NCT01771965|3638174|P1|COMPLETED|Overall Study||7
1487788|NCT01771965|3638173|P2|STARTED|Overall Study||9
1487789|NCT01771965|3638174|P1|STARTED|Overall Study||10
1487790|NCT01771913|3638182|P2|NOT COMPLETED|Overall Study||0
1487791|NCT01771913|3638183|P1|NOT COMPLETED|Overall Study||1
1487792|NCT01771913|3638182|P2|COMPLETED|Overall Study||11
1487793|NCT01771913|3638183|P1|COMPLETED|Overall Study||8
1487794|NCT01771913|3638182|P2|STARTED|Overall Study||11
1487795|NCT01771913|3638183|P1|STARTED|Overall Study||9
1487796|NCT01771666|3638193|P1|NOT COMPLETED|Overall Study||0
1487797|NCT01771666|3638193|P1|COMPLETED|Overall Study||23
1487798|NCT01771666|3638193|P1|STARTED|Overall Study||23
1487799|NCT01771172|3638198|P1|NOT COMPLETED|Overall Study||2
1487800|NCT01771172|3638198|P1|COMPLETED|Overall Study||46
1487801|NCT01771172|3638198|P1|STARTED|Overall Study||48
1487802|NCT01770860|3638202|P1|NOT COMPLETED|Overall Study||6
1487803|NCT01770860|3638202|P1|COMPLETED|Overall Study||40
1487804|NCT01770860|3638202|P1|Randomization|Overall Study|One participant withdrew before randomization|45
1487805|NCT01770860|3638202|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
1487806|NCT01770743|3638250|P5|NOT COMPLETED|Overall Study||2
1487807|NCT01770743|3638251|P4|NOT COMPLETED|Overall Study||2
1487808|NCT01770743|3638252|P3|NOT COMPLETED|Overall Study||1
1487809|NCT01770743|3638253|P2|NOT COMPLETED|Overall Study||3
1487810|NCT01770743|3638254|P1|NOT COMPLETED|Overall Study||2
1487811|NCT01770743|3638250|P5|COMPLETED|Overall Study||21
1487812|NCT01770743|3638251|P4|COMPLETED|Overall Study||42
1487813|NCT01770743|3638252|P3|COMPLETED|Overall Study||22
1487814|NCT01770743|3638253|P2|COMPLETED|Overall Study||31
1487815|NCT01770743|3638254|P1|COMPLETED|Overall Study||42
1487816|NCT01770743|3638250|P5|Treated|Overall Study||23
1487817|NCT01770743|3638251|P4|Treated|Overall Study||44
1487818|NCT01770743|3638252|P3|Treated|Overall Study||23
1487819|NCT01770743|3638253|P2|Treated|Overall Study||34
1487820|NCT01770743|3638254|P1|Treated|Overall Study||44
1487821|NCT01770743|3638250|P5|STARTED|Overall Study||23
1487822|NCT01770743|3638251|P4|STARTED|Overall Study||44
1487823|NCT01770743|3638252|P3|STARTED|Overall Study||23
1487824|NCT01770743|3638253|P2|STARTED|Overall Study||34
1487825|NCT01770743|3638254|P1|STARTED|Overall Study||44
1487826|NCT01770691|3638306|P1|NOT COMPLETED|Overall Study||0
1487827|NCT01770691|3638306|P1|COMPLETED|Overall Study||7
1487828|NCT01770691|3638306|P1|STARTED|Overall Study||7
1487829|NCT01770652|3638317|P4|NOT COMPLETED|Overall Study||0
1487830|NCT01770652|3638318|P3|NOT COMPLETED|Overall Study||0
1487831|NCT01770652|3638319|P2|NOT COMPLETED|Overall Study||0
1487832|NCT01770652|3638320|P1|NOT COMPLETED|Overall Study||0
1487833|NCT01770652|3638317|P4|COMPLETED|Overall Study||8
1487834|NCT01770652|3638318|P3|COMPLETED|Overall Study||8
1487835|NCT01770652|3638319|P2|COMPLETED|Overall Study||8
1487836|NCT01770652|3638320|P1|COMPLETED|Overall Study||8
1487837|NCT01770652|3638317|P4|STARTED|Overall Study||8
1487838|NCT01770652|3638318|P3|STARTED|Overall Study||8
1487839|NCT01770652|3638319|P2|STARTED|Overall Study||8
1487840|NCT01770652|3638320|P1|STARTED|Overall Study||8
1487841|NCT01770509|3638356|P2|NOT COMPLETED|Overall Study||3
1487842|NCT01770509|3638357|P1|NOT COMPLETED|Overall Study||1
1487843|NCT01770509|3638356|P2|COMPLETED|Overall Study||14
1487844|NCT01770509|3638357|P1|COMPLETED|Overall Study||11
1487845|NCT01770509|3638356|P2|STARTED|Overall Study||17
1487846|NCT01770509|3638357|P1|STARTED|Overall Study||12
1487847|NCT01770483|3638373|P2|NOT COMPLETED|Overall Study||0
1487848|NCT01770483|3638374|P1|NOT COMPLETED|Overall Study||0
1487849|NCT01770483|3638373|P2|COMPLETED|Overall Study||33
1487850|NCT01770483|3638374|P1|COMPLETED|Overall Study||33
1487851|NCT01770483|3638373|P2|STARTED|Overall Study||33
1487852|NCT01770483|3638374|P1|STARTED|Overall Study||33
1487853|NCT01770431|3638384|P2|NOT COMPLETED|Overall Study||32
1487854|NCT01770431|3638385|P1|NOT COMPLETED|Overall Study||10
1487855|NCT01770431|3638384|P2|COMPLETED|Overall Study||316
1487856|NCT01770431|3638385|P1|COMPLETED|Overall Study||686
1487857|NCT01770431|3638384|P2|STARTED|Overall Study||348
1487858|NCT01770431|3638385|P1|STARTED|Overall Study||696
1487859|NCT01770392|3638393|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
1487860|NCT01770392|3638393|P1|COMPLETED|Nintedanib+ Rifampicin||25
1487861|NCT01770392|3638393|P1|STARTED|Nintedanib+ Rifampicin||25
1487862|NCT01770392|3638393|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
1487863|NCT01770392|3638393|P1|COMPLETED|Washout Period of at Least 14 Days||25
1487864|NCT01770392|3638393|P1|STARTED|Washout Period of at Least 14 Days||26
1487865|NCT01770392|3638393|P1|NOT COMPLETED|Nintedanib||0
1487866|NCT01770392|3638393|P1|COMPLETED|Nintedanib||26
1487867|NCT01770392|3638393|P1|STARTED|Nintedanib||26
1487868|NCT01770379|3638408|P3|NOT COMPLETED|Overall Study||42
1487869|NCT01770379|3638409|P2|NOT COMPLETED|Overall Study||44
1487870|NCT01770379|3638410|P1|NOT COMPLETED|Overall Study||39
1487871|NCT01770379|3638408|P3|COMPLETED|Overall Study||39
1487872|NCT01770379|3638409|P2|COMPLETED|Overall Study||37
1487873|NCT01770379|3638410|P1|COMPLETED|Overall Study||41
1487874|NCT01770379|3638408|P3|STARTED|Overall Study||81
1487875|NCT01770379|3638409|P2|STARTED|Overall Study||81
1487876|NCT01770379|3638410|P1|STARTED|Overall Study||80
1487877|NCT01770366|3638429|P2|NOT COMPLETED|Overall Study||2
1487878|NCT01770366|3638430|P1|NOT COMPLETED|Overall Study||2
1487879|NCT01770366|3638429|P2|COMPLETED|Overall Study||4
1487880|NCT01770366|3638430|P1|COMPLETED|Overall Study||2
1487881|NCT01770366|3638429|P2|STARTED|Overall Study||6
1487882|NCT01770366|3638430|P1|STARTED|Overall Study||4
1487883|NCT01770314|3638438|P2|NOT COMPLETED|Overall Study||0
1487884|NCT01770314|3638439|P1|NOT COMPLETED|Overall Study||0
1487885|NCT01770314|3638438|P2|COMPLETED|Overall Study||90
1487886|NCT01770314|3638439|P1|COMPLETED|Overall Study||86
1487887|NCT01770314|3638438|P2|Contributed Data to One-month Follow-up|Overall Study||66
1487888|NCT01770314|3638439|P1|Contributed Data to One-month Follow-up|Overall Study||61
1487889|NCT01770314|3638438|P2|Contributed Data to Post-test|Overall Study||67
1487890|NCT01770314|3638439|P1|Contributed Data to Post-test|Overall Study||65
1487891|NCT01770314|3638438|P2|Contributed Data to Baseline|Overall Study||72
1487892|NCT01770314|3638439|P1|Contributed Data to Baseline|Overall Study||68
1487893|NCT01770314|3638438|P2|STARTED|Overall Study||90
1487894|NCT01770314|3638439|P1|STARTED|Overall Study||86
1487895|NCT01770145|3638447|P1|NOT COMPLETED|Treatment||4
1487896|NCT01770145|3638447|P1|COMPLETED|Treatment||97
1487897|NCT01770145|3638447|P1|STARTED|Treatment||101
1487898|NCT01770145|3638447|P1|NOT COMPLETED|Baseline||26
1487899|NCT01770145|3638447|P1|COMPLETED|Baseline||101
1487900|NCT01770145|3638447|P1|STARTED|Baseline||127
1487901|NCT01769612|3638452|P1|NOT COMPLETED|Overall Study||0
1487902|NCT01769612|3638452|P1|COMPLETED|Overall Study||168
1487903|NCT01769612|3638452|P1|STARTED|Overall Study||168
1487904|NCT01769586|3638460|P2|NOT COMPLETED|Overall Study||0
1487905|NCT01769586|3638461|P1|NOT COMPLETED|Overall Study||0
1487906|NCT01769586|3638460|P2|COMPLETED|Overall Study||100
1487907|NCT01769586|3638461|P1|COMPLETED|Overall Study||100
1487908|NCT01769586|3638460|P2|STARTED|Overall Study||100
1487909|NCT01769586|3638461|P1|STARTED|Overall Study||100
1487910|NCT01769508|3638467|P1|NOT COMPLETED|Overall Study||6
1487911|NCT01769508|3638467|P1|COMPLETED|Overall Study||6
1487912|NCT01769508|3638467|P1|STARTED|Overall Study||12
1487913|NCT01769456|3638476|P1|NOT COMPLETED|Overall Study||37
1487914|NCT01769456|3638476|P1|COMPLETED|Overall Study||41
1487915|NCT01769456|3638476|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
1487916|NCT01769443|3638497|P2|NOT COMPLETED|Overall Study||0
1487917|NCT01769443|3638498|P1|NOT COMPLETED|Overall Study||1
1487918|NCT01769443|3638497|P2|COMPLETED|Overall Study||1
1487919|NCT01769443|3638498|P1|COMPLETED|Overall Study||0
1487920|NCT01769443|3638497|P2|STARTED|Overall Study||1
1487921|NCT01769443|3638498|P1|STARTED|Overall Study||1
1487922|NCT01769391|3638542|P2|NOT COMPLETED|Overall Study||9
1487923|NCT01769391|3638543|P1|NOT COMPLETED|Overall Study||17
1487924|NCT01769391|3638542|P2|COMPLETED|Overall Study||48
1487925|NCT01769391|3638543|P1|COMPLETED|Overall Study||93
1487926|NCT01769391|3638542|P2|Received at Least One Dose of Study Drug|Overall Study||55
1487927|NCT01769391|3638543|P1|Received at Least One Dose of Study Drug|Overall Study||106
1487928|NCT01769391|3638542|P2|STARTED|Overall Study||57
1487929|NCT01769391|3638543|P1|STARTED|Overall Study||110
1487930|NCT01769378|3638562|P2|NOT COMPLETED|Overall Study||4
1487931|NCT01769378|3638563|P1|NOT COMPLETED|Overall Study||25
1487932|NCT01769378|3638562|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
1487933|NCT01769378|3638563|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
1487934|NCT01769378|3638562|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
1487935|NCT01769378|3638563|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
1487936|NCT01769378|3638562|P2|STARTED|Overall Study||60
1487937|NCT01769378|3638563|P1|STARTED|Overall Study||240
1487938|NCT01769365|3638601|P3|NOT COMPLETED|Overall Study||2
1487939|NCT01769365|3638602|P2|NOT COMPLETED|Overall Study||2
1487940|NCT01769365|3638603|P1|NOT COMPLETED|Overall Study||0
1487941|NCT01769365|3638601|P3|COMPLETED|Overall Study||101
1487942|NCT01769365|3638602|P2|COMPLETED|Overall Study||100
1487943|NCT01769365|3638603|P1|COMPLETED|Overall Study||102
1487944|NCT01769365|3638601|P3|STARTED|Overall Study||103
1487945|NCT01769365|3638602|P2|STARTED|Overall Study||102
1487946|NCT01769365|3638603|P1|STARTED|Overall Study||102
1487947|NCT01769352|3638615|P4|NOT COMPLETED|Overall Study||0
1487948|NCT01769352|3638616|P3|NOT COMPLETED|Overall Study||0
1487949|NCT01769352|3638617|P2|NOT COMPLETED|Overall Study||0
1487950|NCT01769352|3638618|P1|NOT COMPLETED|Overall Study||0
1487951|NCT01769352|3638615|P4|COMPLETED|Overall Study||8
1487952|NCT01769352|3638616|P3|COMPLETED|Overall Study||9
1487953|NCT01769352|3638617|P2|COMPLETED|Overall Study||12
1487954|NCT01769352|3638618|P1|COMPLETED|Overall Study||13
1487955|NCT01769352|3638615|P4|STARTED|Overall Study||8
1487956|NCT01769352|3638616|P3|STARTED|Overall Study||9
1487957|NCT01769352|3638617|P2|STARTED|Overall Study||12
1487958|NCT01769352|3638618|P1|STARTED|Overall Study||13
1487959|NCT01769339|3638643|P1|NOT COMPLETED|Overall Study||43
1487960|NCT01769339|3638643|P1|COMPLETED|Overall Study||72
1487961|NCT01769339|3638643|P1|STARTED|Overall Study||115
1487962|NCT01769326|3638654|P4|NOT COMPLETED|Overall Study||0
1487963|NCT01769326|3638655|P3|NOT COMPLETED|Overall Study||1
1487964|NCT01769326|3638656|P2|NOT COMPLETED|Overall Study||4
1487965|NCT01769326|3638657|P1|NOT COMPLETED|Overall Study||2
1487966|NCT01769326|3638654|P4|COMPLETED|Overall Study||8
1487967|NCT01769326|3638655|P3|COMPLETED|Overall Study||8
1487968|NCT01769326|3638656|P2|COMPLETED|Overall Study||8
1487969|NCT01769326|3638657|P1|COMPLETED|Overall Study||9
1487970|NCT01769326|3638654|P4|STARTED|Overall Study||8
1487971|NCT01769326|3638655|P3|STARTED|Overall Study||9
1487972|NCT01769326|3638656|P2|STARTED|Overall Study||12
1487973|NCT01769326|3638657|P1|STARTED|Overall Study||11
1487974|NCT01769248|3638669|P2|NOT COMPLETED|Overall Study||12
1487975|NCT01769248|3638670|P1|NOT COMPLETED|Overall Study||28
1487976|NCT01769248|3638669|P2|COMPLETED|Overall Study||58
1487977|NCT01769248|3638670|P1|COMPLETED|Overall Study||42
1487978|NCT01769248|3638669|P2|Participants Who Crossed-over|Overall Study||12
1487979|NCT01769248|3638670|P1|Participants Who Crossed-over|Overall Study||28
1487980|NCT01769248|3638669|P2|STARTED|Overall Study||70
1487981|NCT01769248|3638670|P1|STARTED|Overall Study||70
1487982|NCT01769222|3638682|P2|NOT COMPLETED|Overall Study||0
1487983|NCT01769222|3638683|P1|NOT COMPLETED|Overall Study||0
1487984|NCT01769222|3638682|P2|COMPLETED|Overall Study||0
1487985|NCT01769222|3638683|P1|COMPLETED|Overall Study||3
1487986|NCT01769222|3638682|P2|STARTED|Overall Study||0
1487987|NCT01769222|3638683|P1|STARTED|Overall Study||3
1487988|NCT01769209|3638697|P1|NOT COMPLETED|Overall Study||0
1487989|NCT01769209|3638697|P1|COMPLETED|Overall Study||18
1487990|NCT01769209|3638697|P1|STARTED|Overall Study||18
1487991|NCT01769196|3638710|P2|NOT COMPLETED|Overall Study||272
1487992|NCT01769196|3638711|P1|NOT COMPLETED|Overall Study||272
1487993|NCT01769196|3638710|P2|COMPLETED|Overall Study||0
1487994|NCT01769196|3638711|P1|COMPLETED|Overall Study||0
1487995|NCT01769196|3638710|P2|STARTED|Overall Study||272
1487996|NCT01769196|3638711|P1|STARTED|Overall Study||272
1487997|NCT01769105|3638741|P2|NOT COMPLETED|Cross-over||0
1487998|NCT01769105|3638742|P1|NOT COMPLETED|Cross-over||5
1487999|NCT01769105|3638741|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
1488000|NCT01769105|3638742|P1|COMPLETED|Cross-over||9
1488001|NCT01769105|3638741|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
1488002|NCT01769105|3638742|P1|STARTED|Cross-over||14
1488003|NCT01769105|3638741|P2|NOT COMPLETED|First Intervention||2
1488004|NCT01769105|3638742|P1|NOT COMPLETED|First Intervention||2
1488005|NCT01769105|3638741|P2|COMPLETED|First Intervention||17
1488006|NCT01769105|3638742|P1|COMPLETED|First Intervention||14
1488007|NCT01769105|3638741|P2|STARTED|First Intervention||19
1488008|NCT01769105|3638742|P1|STARTED|First Intervention||16
1488009|NCT01768832|3638764|P3|NOT COMPLETED|Overall Study||9
1488010|NCT01768832|3638765|P2|NOT COMPLETED|Overall Study||4
1488011|NCT01768832|3638766|P1|NOT COMPLETED|Overall Study||10
1488012|NCT01768832|3638764|P3|COMPLETED|Overall Study||26
1488013|NCT01768832|3638765|P2|COMPLETED|Overall Study||39
1488014|NCT01768832|3638766|P1|COMPLETED|Overall Study||31
1488015|NCT01768832|3638764|P3|STARTED|Overall Study||35
1488016|NCT01768832|3638765|P2|STARTED|Overall Study||43
1488017|NCT01768832|3638766|P1|STARTED|Overall Study||41
1488018|NCT01768676|3638800|P2|NOT COMPLETED|Overall Study||31
1488019|NCT01768676|3638801|P1|NOT COMPLETED|Overall Study||24
1488020|NCT01768676|3638800|P2|COMPLETED|Overall Study||60
1488021|NCT01768676|3638801|P1|COMPLETED|Overall Study||66
1488022|NCT01768676|3638800|P2|STARTED|Overall Study||91
1488023|NCT01768676|3638801|P1|STARTED|Overall Study||90
1488024|NCT01768572|3638818|P3|NOT COMPLETED|Overall Study||6
1488025|NCT01768572|3638819|P2|NOT COMPLETED|Overall Study||12
1488026|NCT01768572|3638820|P1|NOT COMPLETED|Overall Study||9
1488027|NCT01768572|3638818|P3|COMPLETED|Overall Study||96
1488028|NCT01768572|3638819|P2|COMPLETED|Overall Study||39
1488029|NCT01768572|3638820|P1|COMPLETED|Overall Study||40
1488030|NCT01768572|3638818|P3|STARTED|Overall Study||102
1488031|NCT01768572|3638819|P2|STARTED|Overall Study||51
1488032|NCT01768572|3638820|P1|STARTED|Overall Study||49
1488033|NCT01768559|3638831|P3|NOT COMPLETED|Overall Study||13
1488034|NCT01768559|3638832|P2|NOT COMPLETED|Overall Study||17
1488035|NCT01768559|3638833|P1|NOT COMPLETED|Overall Study||30
1488036|NCT01768559|3638831|P3|COMPLETED|Overall Study||285
1488037|NCT01768559|3638832|P2|COMPLETED|Overall Study||281
1488038|NCT01768559|3638833|P1|COMPLETED|Overall Study||268
1488039|NCT01768559|3638831|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
1488040|NCT01768559|3638832|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
1488041|NCT01768559|3638833|P1|Treated|Overall Study||298
1488042|NCT01768559|3638831|P3|STARTED|Overall Study||298
1488043|NCT01768559|3638832|P2|STARTED|Overall Study||298
1488044|NCT01768559|3638833|P1|STARTED|Overall Study||298
1488045|NCT01768325|3638883|P2|NOT COMPLETED|Overall Study||0
1488046|NCT01768325|3638884|P1|NOT COMPLETED|Overall Study||0
1488047|NCT01768325|3638883|P2|COMPLETED|Overall Study||41
1488048|NCT01768325|3638884|P1|COMPLETED|Overall Study||37
1488049|NCT01768325|3638883|P2|STARTED|Overall Study||41
1488050|NCT01768325|3638884|P1|STARTED|Overall Study||37
1488051|NCT01768286|3638898|P4|NOT COMPLETED|Overall Study||1
1488052|NCT01768286|3638899|P3|NOT COMPLETED|Overall Study||2
1488053|NCT01768286|3638900|P2|NOT COMPLETED|Overall Study||4
1488054|NCT01768286|3638901|P1|NOT COMPLETED|Overall Study||7
1488055|NCT01768286|3638898|P4|COMPLETED|Overall Study||110
1488056|NCT01768286|3638899|P3|COMPLETED|Overall Study||108
1488057|NCT01768286|3638900|P2|COMPLETED|Overall Study||107
1488058|NCT01768286|3638901|P1|COMPLETED|Overall Study||102
1488059|NCT01768286|3638898|P4|STARTED|Overall Study||111
1488060|NCT01768286|3638899|P3|STARTED|Overall Study||110
1488061|NCT01768286|3638900|P2|STARTED|Overall Study||111
1488062|NCT01768286|3638901|P1|STARTED|Overall Study||109
1488063|NCT01768117|3638963|P1|NOT COMPLETED|Overall Study||6
1488064|NCT01768117|3638963|P1|COMPLETED|Overall Study||7
1488065|NCT01768117|3638963|P1|STARTED|Overall Study||13
1488066|NCT01768013|3638971|P1|NOT COMPLETED|Overall Study||0
1488067|NCT01768013|3638971|P1|COMPLETED|Overall Study||13
1488068|NCT01768013|3638971|P1|STARTED|Overall Study||13
1488069|NCT01768000|3639004|P4|NOT COMPLETED|Overall Study||2
1488070|NCT01768000|3639005|P3|NOT COMPLETED|Overall Study||1
1488071|NCT01768000|3639006|P2|NOT COMPLETED|Overall Study||2
1488072|NCT01768000|3639007|P1|NOT COMPLETED|Overall Study||1
1488073|NCT01768000|3639004|P4|COMPLETED|Overall Study||8
1488074|NCT01768000|3639005|P3|COMPLETED|Overall Study||9
1488075|NCT01768000|3639006|P2|COMPLETED|Overall Study||8
1488076|NCT01768000|3639007|P1|COMPLETED|Overall Study||9
1488077|NCT01768000|3639004|P4|STARTED|Overall Study||10
1488078|NCT01768000|3639005|P3|STARTED|Overall Study||10
1488079|NCT01768000|3639006|P2|STARTED|Overall Study||10
1488080|NCT01768000|3639007|P1|STARTED|Overall Study||10
1488081|NCT01767987|3639027|P2|NOT COMPLETED|Overall Study||1
1488082|NCT01767987|3639028|P1|NOT COMPLETED|Overall Study||4
1488083|NCT01767987|3639027|P2|COMPLETED|Overall Study||1
1488084|NCT01767987|3639028|P1|COMPLETED|Overall Study||0
1488085|NCT01767987|3639027|P2|STARTED|Overall Study||2
1488086|NCT01767987|3639028|P1|STARTED|Overall Study||4
1488087|NCT01767935|3639050|P1|NOT COMPLETED|Overall Study||0
1488088|NCT01767935|3639050|P1|COMPLETED|Overall Study||1
1488089|NCT01767935|3639050|P1|STARTED|Overall Study||1
1488090|NCT01767701|3639058|P1|NOT COMPLETED|Overall Study||0
1488091|NCT01767701|3639058|P1|COMPLETED|Overall Study||20
1488092|NCT01767701|3639058|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
1488093|NCT01767688|3639071|P2|NOT COMPLETED|Overall Study||0
1488094|NCT01767688|3639072|P1|NOT COMPLETED|Overall Study||0
1488095|NCT01767688|3639071|P2|COMPLETED|Overall Study||8
1488096|NCT01767688|3639072|P1|COMPLETED|Overall Study||8
1488097|NCT01767688|3639071|P2|STARTED|Overall Study||8
1488098|NCT01767688|3639072|P1|STARTED|Overall Study||8
1488099|NCT01767597|3639094|P2|NOT COMPLETED|Overall Study||1
1488100|NCT01767597|3639095|P1|NOT COMPLETED|Overall Study||4
1488101|NCT01767597|3639094|P2|COMPLETED|Overall Study||499
1488102|NCT01767597|3639095|P1|COMPLETED|Overall Study||496
1488103|NCT01767597|3639094|P2|STARTED|Overall Study||500
1488104|NCT01767597|3639095|P1|STARTED|Overall Study||500
1488105|NCT01767519|3639104|P3|NOT COMPLETED|Overall Study||5
1488106|NCT01767519|3639105|P2|NOT COMPLETED|Overall Study||13
1488107|NCT01767519|3639106|P1|NOT COMPLETED|Overall Study||14
1488108|NCT01767519|3639104|P3|COMPLETED|Overall Study||55
1488109|NCT01767519|3639105|P2|COMPLETED|Overall Study||138
1488110|NCT01767519|3639106|P1|COMPLETED|Overall Study||131
1488111|NCT01767519|3639104|P3|STARTED|Overall Study||60
1488112|NCT01767519|3639105|P2|STARTED|Overall Study||151
1488113|NCT01767519|3639106|P1|STARTED|Overall Study||145
1488114|NCT01767506|3639134|P2|NOT COMPLETED|Overall Study||0
1488115|NCT01767506|3639135|P1|NOT COMPLETED|Overall Study||0
1488116|NCT01767506|3639134|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
1488117|NCT01767506|3639135|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
1488118|NCT01767506|3639134|P2|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|0
1488119|NCT01767506|3639135|P1|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|0
1488120|NCT01767467|3639147|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
1488121|NCT01767467|3639148|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
1488122|NCT01767467|3639147|P2|COMPLETED|End of Study Phase (up to Month 13)||216
1488123|NCT01767467|3639148|P1|COMPLETED|End of Study Phase (up to Month 13)||236
1488124|NCT01767467|3639147|P2|STARTED|End of Study Phase (up to Month 13)||279
1488125|NCT01767467|3639148|P1|STARTED|End of Study Phase (up to Month 13)||283
1488126|NCT01767467|3639147|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
1488127|NCT01767467|3639148|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
1488128|NCT01767467|3639147|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
1488129|NCT01767467|3639148|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
1488130|NCT01767467|3639147|P2|STARTED|Vaccination Phase (up to Month 2)||279
1488131|NCT01767467|3639148|P1|STARTED|Vaccination Phase (up to Month 2)||283
1488132|NCT01767415|3639196|P1|NOT COMPLETED|Overall Study||0
1488133|NCT01767415|3639196|P1|COMPLETED|Overall Study||10
1488134|NCT01767415|3639196|P1|STARTED|Overall Study||10
1488135|NCT01767376|3639204|P3|NOT COMPLETED|Overall Study||0
1488136|NCT01767376|3639205|P2|NOT COMPLETED|Overall Study||3
1488137|NCT01767376|3639206|P1|NOT COMPLETED|Overall Study||4
1488138|NCT01767376|3639204|P3|COMPLETED|Overall Study||232
1488139|NCT01767376|3639205|P2|COMPLETED|Overall Study||225
1488140|NCT01767376|3639206|P1|COMPLETED|Overall Study||227
1488141|NCT01767376|3639204|P3|STARTED|Overall Study||232
1488142|NCT01767376|3639205|P2|STARTED|Overall Study||228
1488143|NCT01767376|3639206|P1|STARTED|Overall Study||231
1488144|NCT01767285|3639253|P2|NOT COMPLETED|Overall Study||6
1488145|NCT01767285|3639254|P1|NOT COMPLETED|Overall Study||7
1488146|NCT01767285|3639253|P2|COMPLETED|Overall Study||24
1488147|NCT01767285|3639254|P1|COMPLETED|Overall Study||22
1488148|NCT01767285|3639253|P2|STARTED|Overall Study||30
1488149|NCT01767285|3639254|P1|STARTED|Overall Study||29
1488150|NCT01767155|3639272|P2|NOT COMPLETED|Overall Study||15
1488151|NCT01767155|3639273|P1|NOT COMPLETED|Overall Study||13
1488152|NCT01767155|3639272|P2|COMPLETED|Overall Study||240
1488153|NCT01767155|3639273|P1|COMPLETED|Overall Study||243
1488154|NCT01767155|3639272|P2|Safety Population (SAF)|Overall Study||249
1488155|NCT01767155|3639273|P1|Safety Population (SAF)|Overall Study||252
1488156|NCT01767155|3639272|P2|Modified ITT (mITT)|Overall Study||249
1488157|NCT01767155|3639273|P1|Modified ITT (mITT)|Overall Study||252
1488158|NCT01767155|3639272|P2|STARTED|Overall Study|Patients allocated to doxorubicin|255
1488159|NCT01767155|3639273|P1|STARTED|Overall Study|Patients allocated to AEZS-108|256
1488160|NCT01767116|3639287|P2|NOT COMPLETED|Overall Study||2
1488161|NCT01767116|3639288|P1|NOT COMPLETED|Overall Study||2
1488162|NCT01767116|3639287|P2|COMPLETED|Overall Study||207
1488163|NCT01767116|3639288|P1|COMPLETED|Overall Study||208
1488164|NCT01767116|3639287|P2|STARTED|Overall Study||209
1488165|NCT01767116|3639288|P1|STARTED|Overall Study||210
1488166|NCT01767103|3639307|P3|NOT COMPLETED|Overall Study||0
1488167|NCT01767103|3639308|P2|NOT COMPLETED|Overall Study||0
1488168|NCT01767103|3639309|P1|NOT COMPLETED|Overall Study||0
1488169|NCT01767103|3639307|P3|COMPLETED|Overall Study||7
1488170|NCT01767103|3639308|P2|COMPLETED|Overall Study||7
1488171|NCT01767103|3639309|P1|COMPLETED|Overall Study||7
1488172|NCT01767103|3639307|P3|STARTED|Overall Study||7
1488173|NCT01767103|3639308|P2|STARTED|Overall Study||7
1488174|NCT01767103|3639309|P1|STARTED|Overall Study||7
1488175|NCT01767064|3639337|P2|NOT COMPLETED|Overall Study||0
1488176|NCT01767064|3639338|P1|NOT COMPLETED|Overall Study||0
1488177|NCT01767064|3639337|P2|COMPLETED|Overall Study||7
1488178|NCT01767064|3639338|P1|COMPLETED|Overall Study||7
1488179|NCT01767064|3639337|P2|STARTED|Overall Study||7
1488180|NCT01767064|3639338|P1|STARTED|Overall Study||7
1488181|NCT01766921|3639346|P2|NOT COMPLETED|Overall Study||17
1488182|NCT01766921|3639347|P1|NOT COMPLETED|Overall Study||24
1488183|NCT01766921|3639346|P2|COMPLETED|Overall Study||676
1488184|NCT01766921|3639347|P1|COMPLETED|Overall Study||676
1488185|NCT01766921|3639346|P2|STARTED|Overall Study||693
1488186|NCT01766921|3639347|P1|STARTED|Overall Study||700
1488187|NCT01766778|3639368|P2|NOT COMPLETED|Overall Study||4
1488188|NCT01766778|3639369|P1|NOT COMPLETED|Overall Study||5
1488189|NCT01766778|3639368|P2|COMPLETED|Overall Study||57
1488190|NCT01766778|3639369|P1|COMPLETED|Overall Study||51
1488191|NCT01766778|3639368|P2|STARTED|Overall Study||61
1488192|NCT01766778|3639369|P1|STARTED|Overall Study|Intent to treat population|56
1488193|NCT01766713|3639387|P2|NOT COMPLETED|Overall Study||2
1488194|NCT01766713|3639388|P1|NOT COMPLETED|Overall Study||2
1488195|NCT01766713|3639387|P2|COMPLETED|Overall Study||23
1488196|NCT01766713|3639388|P1|COMPLETED|Overall Study||23
1488197|NCT01766713|3639387|P2|STARTED|Overall Study||25
1488198|NCT01766713|3639388|P1|STARTED|Overall Study||25
1488199|NCT01766466|3639396|P4|NOT COMPLETED|Day 5||0
1488200|NCT01766466|3639397|P3|NOT COMPLETED|Day 5||0
1488201|NCT01766466|3639398|P2|NOT COMPLETED|Day 5||0
1488202|NCT01766466|3639399|P1|NOT COMPLETED|Day 5||0
1488203|NCT01766466|3639396|P4|COMPLETED|Day 5||6
1488204|NCT01766466|3639397|P3|COMPLETED|Day 5||0
1488205|NCT01766466|3639398|P2|COMPLETED|Day 5||6
1488206|NCT01766466|3639399|P1|COMPLETED|Day 5||0
1488207|NCT01766466|3639396|P4|STARTED|Day 5||6
1488208|NCT01766466|3639397|P3|STARTED|Day 5||0
1488209|NCT01766466|3639398|P2|STARTED|Day 5||6
1488210|NCT01766466|3639399|P1|STARTED|Day 5||0
1488211|NCT01766466|3639396|P4|NOT COMPLETED|Day 1||0
1488212|NCT01766466|3639397|P3|NOT COMPLETED|Day 1||0
1488213|NCT01766466|3639398|P2|NOT COMPLETED|Day 1||0
1488214|NCT01766466|3639399|P1|NOT COMPLETED|Day 1||0
1488215|NCT01766466|3639396|P4|COMPLETED|Day 1||0
1488216|NCT01766466|3639397|P3|COMPLETED|Day 1||6
1488217|NCT01766466|3639398|P2|COMPLETED|Day 1||0
1488218|NCT01766466|3639399|P1|COMPLETED|Day 1||6
1488219|NCT01766466|3639396|P4|STARTED|Day 1||0
1488220|NCT01766466|3639397|P3|STARTED|Day 1||6
1488221|NCT01766466|3639398|P2|STARTED|Day 1||0
1488222|NCT01766466|3639399|P1|STARTED|Day 1||6
1488223|NCT01766440|3639412|P1|NOT COMPLETED|Overall Study||1
1488224|NCT01766440|3639412|P1|COMPLETED|Overall Study||17
1488225|NCT01766440|3639412|P1|STARTED|Overall Study||18
1488226|NCT01766336|3639423|P2|NOT COMPLETED|Overall Study||75
1488227|NCT01766336|3639424|P1|NOT COMPLETED|Overall Study||90
1488228|NCT01766336|3639423|P2|COMPLETED|Overall Study||71
1488229|NCT01766336|3639424|P1|COMPLETED|Overall Study||60
1488230|NCT01766336|3639423|P2|STARTED|Overall Study||146
1488231|NCT01766336|3639424|P1|STARTED|Overall Study||150
1488232|NCT01766310|3639432|P2|NOT COMPLETED|Overall Study||3
1488233|NCT01766310|3639433|P1|NOT COMPLETED|Overall Study||1
1488234|NCT01766310|3639432|P2|COMPLETED|Overall Study||23
1488235|NCT01766310|3639433|P1|COMPLETED|Overall Study||23
1488236|NCT01766310|3639432|P2|STARTED|Overall Study||26
1488237|NCT01766310|3639433|P1|STARTED|Overall Study||24
1488238|NCT01766206|3639441|P1|NOT COMPLETED|Overall Study||51
1488239|NCT01766206|3639441|P1|COMPLETED|Overall Study||3888
1488240|NCT01766206|3639441|P1|STARTED|Overall Study||3939
1488241|NCT01766102|3639450|P2|NOT COMPLETED|Overall Study||0
1488242|NCT01766102|3639451|P1|NOT COMPLETED|Overall Study||0
1488243|NCT01766102|3639450|P2|COMPLETED|Overall Study||36
1488244|NCT01766102|3639451|P1|COMPLETED|Overall Study||36
1488245|NCT01766102|3639450|P2|STARTED|Overall Study||36
1488246|NCT01766102|3639451|P1|STARTED|Overall Study||36
1488247|NCT01766076|3639461|P2|NOT COMPLETED|Overall Study||0
1488248|NCT01766076|3639462|P1|NOT COMPLETED|Overall Study||0
1488249|NCT01766076|3639461|P2|COMPLETED|Overall Study||15
1488250|NCT01766076|3639462|P1|COMPLETED|Overall Study||15
1488251|NCT01766076|3639461|P2|STARTED|Overall Study||15
1488252|NCT01766076|3639462|P1|STARTED|Overall Study||15
1488253|NCT01766050|3639468|P1|NOT COMPLETED|Overall Study||4
1488254|NCT01766050|3639468|P1|COMPLETED|Overall Study||18
1488255|NCT01766050|3639468|P1|STARTED|Overall Study||22
1488256|NCT01766037|3639603|P2|NOT COMPLETED|Overall Study||29
1488257|NCT01766037|3639604|P1|NOT COMPLETED|Overall Study||29
1488258|NCT01766037|3639603|P2|COMPLETED|Overall Study||31
1488259|NCT01766037|3639604|P1|COMPLETED|Overall Study||82
1488260|NCT01766037|3639603|P2|STARTED|Overall Study||60
1488261|NCT01766037|3639604|P1|STARTED|Overall Study||111
1488262|NCT01766024|3639641|P2|NOT COMPLETED|Overall Study||0
1488263|NCT01766024|3639642|P1|NOT COMPLETED|Overall Study||0
1488264|NCT01766024|3639641|P2|COMPLETED|Overall Study||16
1488265|NCT01766024|3639642|P1|COMPLETED|Overall Study||16
1488266|NCT01766024|3639641|P2|STARTED|Overall Study||16
1488267|NCT01766024|3639642|P1|STARTED|Overall Study||16
1488268|NCT01765972|3639652|P4|NOT COMPLETED|Overall Study||0
1488269|NCT01765972|3639653|P3|NOT COMPLETED|Overall Study||0
1488270|NCT01765972|3639654|P2|NOT COMPLETED|Overall Study||0
1488271|NCT01765972|3639655|P1|NOT COMPLETED|Overall Study||0
1488272|NCT01765972|3639652|P4|COMPLETED|Overall Study||6
1488273|NCT01765972|3639653|P3|COMPLETED|Overall Study||6
1488274|NCT01765972|3639654|P2|COMPLETED|Overall Study||6
1488275|NCT01765972|3639655|P1|COMPLETED|Overall Study||6
1488276|NCT01765972|3639652|P4|STARTED|Overall Study||6
1488277|NCT01765972|3639653|P3|STARTED|Overall Study||6
1488278|NCT01765972|3639654|P2|STARTED|Overall Study||6
1488279|NCT01765972|3639655|P1|STARTED|Overall Study||6
1488280|NCT01765803|3639665|P1|NOT COMPLETED|Overall Study||0
1488281|NCT01765803|3639665|P1|COMPLETED|Overall Study||6
1488282|NCT01765803|3639665|P1|STARTED|Overall Study||6
1488283|NCT01765764|3639673|P3|NOT COMPLETED|Post-treatment Period||0
1488284|NCT01765764|3639674|P2|NOT COMPLETED|Post-treatment Period||0
1488285|NCT01765764|3639675|P1|NOT COMPLETED|Post-treatment Period||0
1488286|NCT01765764|3639673|P3|COMPLETED|Post-treatment Period||112
1488287|NCT01765764|3639674|P2|COMPLETED|Post-treatment Period||107
1488288|NCT01765764|3639675|P1|COMPLETED|Post-treatment Period||114
1488289|NCT01765764|3639673|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
1488290|NCT01765764|3639674|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
1488291|NCT01765764|3639675|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
1488292|NCT01765764|3639673|P3|NOT COMPLETED|Treatment Period||6
1488293|NCT01765764|3639674|P2|NOT COMPLETED|Treatment Period||9
1488294|NCT01765764|3639675|P1|NOT COMPLETED|Treatment Period||3
1488295|NCT01765764|3639673|P3|COMPLETED|Treatment Period||115
1488296|NCT01765764|3639674|P2|COMPLETED|Treatment Period||109
1488297|NCT01765764|3639675|P1|COMPLETED|Treatment Period||115
1488298|NCT01765764|3639673|P3|STARTED|Treatment Period||121
1488299|NCT01765764|3639674|P2|STARTED|Treatment Period||118
1488300|NCT01765764|3639675|P1|STARTED|Treatment Period||118
1488301|NCT01765751|3639695|P3|NOT COMPLETED|Overall Study||1
1488302|NCT01765751|3639696|P2|NOT COMPLETED|Overall Study||2
1488303|NCT01765751|3639697|P1|NOT COMPLETED|Overall Study||0
1488304|NCT01765751|3639695|P3|COMPLETED|Overall Study||15
1488305|NCT01765751|3639696|P2|COMPLETED|Overall Study||14
1488306|NCT01765751|3639697|P1|COMPLETED|Overall Study||16
1488307|NCT01765751|3639695|P3|STARTED|Overall Study||16
1488308|NCT01765751|3639696|P2|STARTED|Overall Study||16
1488309|NCT01765751|3639697|P1|STARTED|Overall Study||16
1488310|NCT01765673|3639729|P1|NOT COMPLETED|Overall Study||1
1488311|NCT01765673|3639729|P1|COMPLETED|Overall Study||11
1488312|NCT01765673|3639729|P1|STARTED|Overall Study||12
1488313|NCT01765582|3639755|P3|NOT COMPLETED|Overall Study||95
1488314|NCT01765582|3639756|P2|NOT COMPLETED|Overall Study||92
1488315|NCT01765582|3639757|P1|NOT COMPLETED|Overall Study||93
1488316|NCT01765582|3639755|P3|COMPLETED|Overall Study||0
1488317|NCT01765582|3639756|P2|COMPLETED|Overall Study||0
1488318|NCT01765582|3639757|P1|COMPLETED|Overall Study||0
1488319|NCT01765582|3639755|P3|STARTED|Overall Study||95
1488320|NCT01765582|3639756|P2|STARTED|Overall Study||92
1488321|NCT01765582|3639757|P1|STARTED|Overall Study||93
1488322|NCT01765569|3639790|P1|NOT COMPLETED|Period C||1
1488323|NCT01765569|3639790|P1|COMPLETED|Period C||27
1488324|NCT01765569|3639790|P1|STARTED|Period C||28
1488325|NCT01765569|3639790|P1|NOT COMPLETED|Period B||1
1488326|NCT01765569|3639790|P1|COMPLETED|Period B||28
1488327|NCT01765569|3639790|P1|STARTED|Period B||29
1488328|NCT01765569|3639790|P1|NOT COMPLETED|Period A||0
1488329|NCT01765569|3639790|P1|COMPLETED|Period A||29
1488330|NCT01765569|3639790|P1|STARTED|Period A||29
1488331|NCT01765543|3639811|P1|NOT COMPLETED|Overall Study||3
1488332|NCT01765543|3639811|P1|COMPLETED|Overall Study||24
1488333|NCT01765543|3639811|P1|STARTED|Overall Study||27
1488334|NCT01765530|3639835|P2|NOT COMPLETED|Overall Study||1
1488335|NCT01765530|3639836|P1|NOT COMPLETED|Overall Study||1
1488336|NCT01765530|3639835|P2|COMPLETED|Overall Study||36
1488337|NCT01765530|3639836|P1|COMPLETED|Overall Study||36
1488338|NCT01765530|3639835|P2|STARTED|Overall Study||37
1488339|NCT01765530|3639836|P1|STARTED|Overall Study||37
1488340|NCT01765465|3639846|P2|NOT COMPLETED|Overall Study||4
1488341|NCT01765465|3639847|P1|NOT COMPLETED|Overall Study||7
1488342|NCT01765465|3639846|P2|COMPLETED|Overall Study||63
1488343|NCT01765465|3639847|P1|COMPLETED|Overall Study||64
1488344|NCT01765465|3639846|P2|STARTED|Overall Study||67
1488345|NCT01765465|3639847|P1|STARTED|Overall Study||71
1488346|NCT01765426|3639863|P4|NOT COMPLETED|Overall Study||0
1488347|NCT01765426|3639864|P3|NOT COMPLETED|Overall Study||0
1488348|NCT01765426|3639865|P2|NOT COMPLETED|Overall Study||1
1488349|NCT01765426|3639866|P1|NOT COMPLETED|Overall Study||0
1488350|NCT01765426|3639863|P4|COMPLETED|Overall Study||15
1488351|NCT01765426|3639864|P3|COMPLETED|Overall Study||17
1488352|NCT01765426|3639865|P2|COMPLETED|Overall Study||16
1488353|NCT01765426|3639866|P1|COMPLETED|Overall Study||18
1488354|NCT01765426|3639863|P4|Completed All Vaccinations|Overall Study||15
1488355|NCT01765426|3639864|P3|Completed All Vaccinations|Overall Study||17
1488356|NCT01765426|3639865|P2|Completed All Vaccinations|Overall Study||16
1488357|NCT01765426|3639866|P1|Completed All Vaccinations|Overall Study||17
1488358|NCT01765426|3639863|P4|STARTED|Overall Study||15
1488359|NCT01765426|3639864|P3|STARTED|Overall Study||17
1488360|NCT01765426|3639865|P2|STARTED|Overall Study||17
1488361|NCT01765426|3639866|P1|STARTED|Overall Study||18
1488362|NCT01765270|3639922|P2|NOT COMPLETED|Overall Study||1
1488363|NCT01765270|3639923|P1|NOT COMPLETED|Overall Study||1
1488364|NCT01765270|3639922|P2|COMPLETED|Overall Study||6
1488365|NCT01765270|3639923|P1|COMPLETED|Overall Study||4
1488366|NCT01765270|3639922|P2|STARTED|Overall Study||7
1488367|NCT01765270|3639923|P1|STARTED|Overall Study||5
1488368|NCT01765192|3639945|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
1488369|NCT01765192|3639946|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
1488370|NCT01765192|3639945|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
1488371|NCT01765192|3639946|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
1488372|NCT01765192|3639945|P2|STARTED|End of Treatment Period 2 to Final Visit||28
1488373|NCT01765192|3639946|P1|STARTED|End of Treatment Period 2 to Final Visit||30
1488374|NCT01765192|3639945|P2|NOT COMPLETED|Treatment Period 2||2
1488375|NCT01765192|3639946|P1|NOT COMPLETED|Treatment Period 2||0
1488376|NCT01765192|3639945|P2|COMPLETED|Treatment Period 2||28
1488377|NCT01765192|3639946|P1|COMPLETED|Treatment Period 2||30
1488378|NCT01765192|3639945|P2|STARTED|Treatment Period 2||30
1488379|NCT01765192|3639946|P1|STARTED|Treatment Period 2||30
1488380|NCT01765192|3639945|P2|NOT COMPLETED|Washout Period||1
1488381|NCT01765192|3639946|P1|NOT COMPLETED|Washout Period||2
1488382|NCT01765192|3639945|P2|COMPLETED|Washout Period||30
1488383|NCT01765192|3639946|P1|COMPLETED|Washout Period||30
1488384|NCT01765192|3639945|P2|STARTED|Washout Period||31
1488385|NCT01765192|3639946|P1|STARTED|Washout Period||32
1488386|NCT01765192|3639945|P2|NOT COMPLETED|Treatment Period 1||1
1488387|NCT01765192|3639946|P1|NOT COMPLETED|Treatment Period 1||0
1488388|NCT01765192|3639945|P2|COMPLETED|Treatment Period 1||31
1488389|NCT01765192|3639946|P1|COMPLETED|Treatment Period 1||32
1488390|NCT01765192|3639945|P2|STARTED|Treatment Period 1||32
1488391|NCT01765192|3639946|P1|STARTED|Treatment Period 1||32
1488392|NCT01765179|3639964|P1|NOT COMPLETED|Overall Study||27
1488393|NCT01765179|3639964|P1|COMPLETED|Overall Study||117
1488394|NCT01765179|3639964|P1|STARTED|Overall Study||144
1488395|NCT01765153|3639971|P2|NOT COMPLETED|Rest Phase 2||1
1488396|NCT01765153|3639972|P1|NOT COMPLETED|Rest Phase 2||2
1488397|NCT01765153|3639971|P2|COMPLETED|Rest Phase 2||7
1488398|NCT01765153|3639972|P1|COMPLETED|Rest Phase 2||8
1488399|NCT01765153|3639971|P2|STARTED|Rest Phase 2||8
1488400|NCT01765153|3639972|P1|STARTED|Rest Phase 2||10
1488401|NCT01765153|3639971|P2|NOT COMPLETED|Training Phase 2||1
1488402|NCT01765153|3639972|P1|NOT COMPLETED|Training Phase 2||0
1488403|NCT01765153|3639971|P2|COMPLETED|Training Phase 2||8
1488404|NCT01765153|3639972|P1|COMPLETED|Training Phase 2||10
1488405|NCT01765153|3639971|P2|STARTED|Training Phase 2||9
1488406|NCT01765153|3639972|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
1488407|NCT01765153|3639971|P2|NOT COMPLETED|Rest Phase 1||1
1488408|NCT01765153|3639972|P1|NOT COMPLETED|Rest Phase 1||0
1488409|NCT01765153|3639971|P2|COMPLETED|Rest Phase 1||9
1488410|NCT01765153|3639972|P1|COMPLETED|Rest Phase 1||9
1488411|NCT01765153|3639971|P2|STARTED|Rest Phase 1||10
1488412|NCT01765153|3639972|P1|STARTED|Rest Phase 1||9
1488413|NCT01765153|3639971|P2|NOT COMPLETED|Training Phase 1||1
1488414|NCT01765153|3639972|P1|NOT COMPLETED|Training Phase 1||1
1488415|NCT01765153|3639971|P2|COMPLETED|Training Phase 1||10
1488416|NCT01765153|3639972|P1|COMPLETED|Training Phase 1||9
1488417|NCT01765153|3639971|P2|STARTED|Training Phase 1||11
1488418|NCT01765153|3639972|P1|STARTED|Training Phase 1||10
1488419|NCT01764997|3640079|P5|NOT COMPLETED|Study Drug Treatment Period||36
1488420|NCT01764997|3640080|P4|NOT COMPLETED|Study Drug Treatment Period||0
1488421|NCT01764997|3640081|P3|NOT COMPLETED|Study Drug Treatment Period||0
1488422|NCT01764997|3640082|P2|NOT COMPLETED|Study Drug Treatment Period||1
1488423|NCT01764997|3640083|P1|NOT COMPLETED|Study Drug Treatment Period||0
1488424|NCT01764997|3640079|P5|COMPLETED|Study Drug Treatment Period||286
1488425|NCT01764997|3640080|P4|COMPLETED|Study Drug Treatment Period||13
1488426|NCT01764997|3640081|P3|COMPLETED|Study Drug Treatment Period||13
1488427|NCT01764997|3640082|P2|COMPLETED|Study Drug Treatment Period||16
1488428|NCT01764997|3640083|P1|COMPLETED|Study Drug Treatment Period||0
1488429|NCT01764997|3640079|P5|STARTED|Study Drug Treatment Period||322
1488430|NCT01764997|3640080|P4|STARTED|Study Drug Treatment Period||13
1488431|NCT01764997|3640081|P3|STARTED|Study Drug Treatment Period||13
1488432|NCT01764997|3640082|P2|STARTED|Study Drug Treatment Period||17
1488433|NCT01764997|3640083|P1|STARTED|Study Drug Treatment Period||0
1488434|NCT01764997|3640079|P5|NOT COMPLETED|Run-in Period||0
1488435|NCT01764997|3640080|P4|NOT COMPLETED|Run-in Period||0
1488436|NCT01764997|3640081|P3|NOT COMPLETED|Run-in Period||0
1488437|NCT01764997|3640082|P2|NOT COMPLETED|Run-in Period||0
1488438|NCT01764997|3640083|P1|NOT COMPLETED|Run-in Period||38
1488439|NCT01764997|3640079|P5|COMPLETED|Run-in Period||0
1488440|NCT01764997|3640080|P4|COMPLETED|Run-in Period||0
1488441|NCT01764997|3640081|P3|COMPLETED|Run-in Period||0
1488442|NCT01764997|3640082|P2|COMPLETED|Run-in Period||0
1488443|NCT01764997|3640083|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
1488444|NCT01764997|3640079|P5|STARTED|Run-in Period||0
1488445|NCT01764997|3640080|P4|STARTED|Run-in Period||0
1488446|NCT01764997|3640081|P3|STARTED|Run-in Period||0
1488447|NCT01764997|3640082|P2|STARTED|Run-in Period||0
1488448|NCT01764997|3640083|P1|STARTED|Run-in Period||776
1488449|NCT01764945|3640110|P8|NOT COMPLETED|Overall Study||0
1488450|NCT01764945|3640111|P7|NOT COMPLETED|Overall Study||1
1488451|NCT01764945|3640112|P6|NOT COMPLETED|Overall Study||0
1488452|NCT01764945|3640113|P5|NOT COMPLETED|Overall Study||0
1488453|NCT01764945|3640114|P4|NOT COMPLETED|Overall Study||0
1488454|NCT01764945|3640115|P3|NOT COMPLETED|Overall Study||0
1488455|NCT01764945|3640116|P2|NOT COMPLETED|Overall Study||1
1488456|NCT01764945|3640117|P1|NOT COMPLETED|Overall Study||0
1488457|NCT01764945|3640110|P8|COMPLETED|Overall Study||9
1488458|NCT01764945|3640111|P7|COMPLETED|Overall Study||8
1488459|NCT01764945|3640112|P6|COMPLETED|Overall Study||8
1488460|NCT01764945|3640113|P5|COMPLETED|Overall Study||10
1488461|NCT01764945|3640114|P4|COMPLETED|Overall Study||5
1488462|NCT01764945|3640115|P3|COMPLETED|Overall Study||5
1488463|NCT01764945|3640116|P2|COMPLETED|Overall Study||4
1488464|NCT01764945|3640117|P1|COMPLETED|Overall Study||5
1488465|NCT01764945|3640110|P8|STARTED|Overall Study||9
1488466|NCT01764945|3640111|P7|STARTED|Overall Study||9
1488467|NCT01764945|3640112|P6|STARTED|Overall Study||8
1488468|NCT01764945|3640113|P5|STARTED|Overall Study||10
1488469|NCT01764945|3640114|P4|STARTED|Overall Study||5
1488470|NCT01764945|3640115|P3|STARTED|Overall Study||5
1488471|NCT01764945|3640116|P2|STARTED|Overall Study||5
1488472|NCT01764945|3640117|P1|STARTED|Overall Study||5
1488473|NCT01764919|3640151|P1|NOT COMPLETED|Overall Study||0
1488474|NCT01764919|3640151|P1|COMPLETED|Overall Study||4
1488475|NCT01764919|3640151|P1|STARTED|Overall Study||4
1488476|NCT01764841|3640163|P4|NOT COMPLETED|Overall Study||19
1488477|NCT01764841|3640164|P3|NOT COMPLETED|Overall Study||14
1488478|NCT01764841|3640165|P2|NOT COMPLETED|Overall Study||26
1488479|NCT01764841|3640166|P1|NOT COMPLETED|Overall Study||23
1488480|NCT01764841|3640163|P4|COMPLETED|Overall Study||49
1488481|NCT01764841|3640164|P3|COMPLETED|Overall Study||56
1488482|NCT01764841|3640165|P2|COMPLETED|Overall Study||111
1488483|NCT01764841|3640166|P1|COMPLETED|Overall Study||118
1488484|NCT01764841|3640163|P4|Participants Received Treatment|Overall Study|safety population|68
1488485|NCT01764841|3640164|P3|Participants Received Treatment|Overall Study|safety population|69
1488486|NCT01764841|3640165|P2|Participants Received Treatment|Overall Study|safety population|136
1488487|NCT01764841|3640166|P1|Participants Received Treatment|Overall Study|safety population|141
1488488|NCT01764841|3640163|P4|STARTED|Overall Study||68
1488489|NCT01764841|3640164|P3|STARTED|Overall Study||70
1488490|NCT01764841|3640165|P2|STARTED|Overall Study||137
1488491|NCT01764841|3640166|P1|STARTED|Overall Study||141
1488492|NCT01764685|3640200|P2|NOT COMPLETED|Overall Study||1
1488493|NCT01764685|3640201|P1|NOT COMPLETED|Overall Study||0
1488494|NCT01764685|3640200|P2|COMPLETED|Overall Study||3
1488495|NCT01764685|3640201|P1|COMPLETED|Overall Study||0
1488496|NCT01764685|3640200|P2|STARTED|Overall Study||4
1488497|NCT01764685|3640201|P1|STARTED|Overall Study||0
1488498|NCT01764633|3640209|P2|NOT COMPLETED|Overall Study||93
1488499|NCT01764633|3640210|P1|NOT COMPLETED|Overall Study||118
1488500|NCT01764633|3640209|P2|COMPLETED|Overall Study||13691
1488501|NCT01764633|3640210|P1|COMPLETED|Overall Study||13662
1488502|NCT01764633|3640209|P2|Received Treatment|Overall Study||13769
1488503|NCT01764633|3640210|P1|Received Treatment|Overall Study||13756
1488504|NCT01764633|3640209|P2|STARTED|Overall Study||13784
1488505|NCT01764633|3640210|P1|STARTED|Overall Study||13780
1488506|NCT01764607|3640232|P1|NOT COMPLETED|Overall Study||0
1488507|NCT01764607|3640232|P1|COMPLETED|Overall Study||1
1488508|NCT01764607|3640232|P1|STARTED|Overall Study||1
1488509|NCT01764386|3640239|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
1488510|NCT01764386|3640240|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
1488511|NCT01764386|3640239|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
1488512|NCT01764386|3640240|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
1488513|NCT01764386|3640239|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
1488514|NCT01764386|3640240|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
1488515|NCT01764386|3640239|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
1488516|NCT01764386|3640240|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
1488517|NCT01764386|3640239|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
1488518|NCT01764386|3640240|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
1488519|NCT01764386|3640239|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
1488520|NCT01764386|3640240|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
1488521|NCT01764386|3640239|P2|STARTED|Controlled Treatment Period (CTP)||89
1488522|NCT01764386|3640240|P1|STARTED|Controlled Treatment Period (CTP)||153
1488523|NCT01764022|3640283|P2|NOT COMPLETED|Overall Study||14
1488524|NCT01764022|3640284|P1|NOT COMPLETED|Overall Study||8
1488525|NCT01764022|3640283|P2|COMPLETED|Overall Study||96
1488526|NCT01764022|3640284|P1|COMPLETED|Overall Study||107
1488527|NCT01764022|3640283|P2|Received at Least 1 Dose of Study Drug|Overall Study||110
1488528|NCT01764022|3640284|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
1488529|NCT01764022|3640283|P2|STARTED|Overall Study||110
1488530|NCT01764022|3640284|P1|STARTED|Overall Study||115
1488531|NCT01763996|3640316|P2|NOT COMPLETED|Treatment Period 2||1
1488532|NCT01763996|3640317|P1|NOT COMPLETED|Treatment Period 2||0
1488533|NCT01763996|3640316|P2|COMPLETED|Treatment Period 2||14
1488534|NCT01763996|3640317|P1|COMPLETED|Treatment Period 2||15
1488535|NCT01763996|3640316|P2|STARTED|Treatment Period 2||15
1488536|NCT01763996|3640317|P1|STARTED|Treatment Period 2||15
1488537|NCT01763996|3640316|P2|NOT COMPLETED|Treatment Period 1||0
1488538|NCT01763996|3640317|P1|NOT COMPLETED|Treatment Period 1||0
1488539|NCT01763996|3640316|P2|COMPLETED|Treatment Period 1||15
1488540|NCT01763996|3640317|P1|COMPLETED|Treatment Period 1||15
1488541|NCT01763996|3640316|P2|STARTED|Treatment Period 1||15
1488542|NCT01763996|3640317|P1|STARTED|Treatment Period 1||15
1488543|NCT01763918|3640347|P4|NOT COMPLETED|Overall Study||2
1488544|NCT01763918|3640348|P3|NOT COMPLETED|Overall Study||10
1488545|NCT01763918|3640349|P2|NOT COMPLETED|Overall Study||1
1488546|NCT01763918|3640350|P1|NOT COMPLETED|Overall Study||6
1488547|NCT01763918|3640347|P4|COMPLETED|Overall Study||108
1488548|NCT01763918|3640348|P3|COMPLETED|Overall Study||101
1488549|NCT01763918|3640349|P2|COMPLETED|Overall Study||54
1488550|NCT01763918|3640350|P1|COMPLETED|Overall Study||49
1488551|NCT01763918|3640347|P4|Received Treatment|Overall Study||110
1488552|NCT01763918|3640348|P3|Received Treatment|Overall Study||110
1488553|NCT01763918|3640349|P2|Received Treatment|Overall Study||55
1488554|NCT01763918|3640350|P1|Received Treatment|Overall Study||54
1488555|NCT01763918|3640347|P4|STARTED|Overall Study||110
1488556|NCT01763918|3640348|P3|STARTED|Overall Study||111
1488557|NCT01763918|3640349|P2|STARTED|Overall Study||55
1488558|NCT01763918|3640350|P1|STARTED|Overall Study||55
1488559|NCT01763905|3640448|P4|NOT COMPLETED|Overall Study||1
1488560|NCT01763905|3640449|P3|NOT COMPLETED|Overall Study||9
1488561|NCT01763905|3640450|P2|NOT COMPLETED|Overall Study||1
1488562|NCT01763905|3640451|P1|NOT COMPLETED|Overall Study||6
1488563|NCT01763905|3640448|P4|COMPLETED|Overall Study||101
1488564|NCT01763905|3640449|P3|COMPLETED|Overall Study||94
1488565|NCT01763905|3640450|P2|COMPLETED|Overall Study||50
1488566|NCT01763905|3640451|P1|COMPLETED|Overall Study||45
1488567|NCT01763905|3640448|P4|STARTED|Overall Study||102
1488568|NCT01763905|3640449|P3|STARTED|Overall Study||103
1488569|NCT01763905|3640450|P2|STARTED|Overall Study||51
1488570|NCT01763905|3640451|P1|STARTED|Overall Study||51
1488571|NCT01763866|3640569|P24|NOT COMPLETED|Overall Study||2
1488572|NCT01763866|3640570|P23|NOT COMPLETED|Overall Study||3
1488573|NCT01763866|3640571|P22|NOT COMPLETED|Overall Study||1
1488574|NCT01763866|3640572|P21|NOT COMPLETED|Overall Study||4
1488575|NCT01763866|3640573|P20|NOT COMPLETED|Overall Study||2
1488576|NCT01763866|3640574|P19|NOT COMPLETED|Overall Study||6
1488577|NCT01763866|3640575|P18|NOT COMPLETED|Overall Study||1
1488578|NCT01763866|3640576|P17|NOT COMPLETED|Overall Study||1
1488579|NCT01763866|3640577|P16|NOT COMPLETED|Overall Study||3
1488580|NCT01763866|3640578|P15|NOT COMPLETED|Overall Study||12
1488581|NCT01763866|3640579|P14|NOT COMPLETED|Overall Study||0
1488582|NCT01763866|3640580|P13|NOT COMPLETED|Overall Study||4
1488583|NCT01763866|3640581|P12|NOT COMPLETED|Overall Study||2
1488584|NCT01763866|3640582|P11|NOT COMPLETED|Overall Study||8
1488585|NCT01763866|3640583|P10|NOT COMPLETED|Overall Study||1
1488586|NCT01763866|3640584|P9|NOT COMPLETED|Overall Study||3
1488587|NCT01763866|3640585|P8|NOT COMPLETED|Overall Study||0
1488588|NCT01763866|3640586|P7|NOT COMPLETED|Overall Study||7
1488589|NCT01763866|3640587|P6|NOT COMPLETED|Overall Study||3
1488590|NCT01763866|3640588|P5|NOT COMPLETED|Overall Study||2
1488591|NCT01763866|3640589|P4|NOT COMPLETED|Overall Study||0
1488592|NCT01763866|3640590|P3|NOT COMPLETED|Overall Study||5
1488593|NCT01763866|3640591|P2|NOT COMPLETED|Overall Study||1
1488594|NCT01763866|3640592|P1|NOT COMPLETED|Overall Study||2
1488595|NCT01763866|3640569|P24|COMPLETED|Overall Study||113
1488596|NCT01763866|3640570|P23|COMPLETED|Overall Study||109
1488597|NCT01763866|3640571|P22|COMPLETED|Overall Study||54
1488598|NCT01763866|3640572|P21|COMPLETED|Overall Study||52
1488599|NCT01763866|3640573|P20|COMPLETED|Overall Study||110
1488600|NCT01763866|3640574|P19|COMPLETED|Overall Study||105
1488601|NCT01763866|3640575|P18|COMPLETED|Overall Study||55
1488602|NCT01763866|3640576|P17|COMPLETED|Overall Study||55
1488603|NCT01763866|3640577|P16|COMPLETED|Overall Study||112
1488604|NCT01763866|3640578|P15|COMPLETED|Overall Study||102
1488605|NCT01763866|3640579|P14|COMPLETED|Overall Study||57
1488606|NCT01763866|3640580|P13|COMPLETED|Overall Study||54
1488607|NCT01763866|3640581|P12|COMPLETED|Overall Study||108
1488608|NCT01763866|3640582|P11|COMPLETED|Overall Study||102
1488609|NCT01763866|3640583|P10|COMPLETED|Overall Study||53
1488610|NCT01763866|3640584|P9|COMPLETED|Overall Study||53
1488611|NCT01763866|3640585|P8|COMPLETED|Overall Study||55
1488612|NCT01763866|3640586|P7|COMPLETED|Overall Study||48
1488613|NCT01763866|3640587|P6|COMPLETED|Overall Study||107
1488614|NCT01763866|3640588|P5|COMPLETED|Overall Study||108
1488615|NCT01763866|3640589|P4|COMPLETED|Overall Study||55
1488616|NCT01763866|3640590|P3|COMPLETED|Overall Study||51
1488617|NCT01763866|3640591|P2|COMPLETED|Overall Study||54
1488618|NCT01763866|3640592|P1|COMPLETED|Overall Study||54
1488619|NCT01763866|3640569|P24|Received Treatment|Overall Study||115
1488620|NCT01763866|3640570|P23|Received Treatment|Overall Study||112
1488621|NCT01763866|3640571|P22|Received Treatment|Overall Study||55
1488622|NCT01763866|3640572|P21|Received Treatment|Overall Study||56
1488623|NCT01763866|3640573|P20|Received Treatment|Overall Study||112
1488624|NCT01763866|3640574|P19|Received Treatment|Overall Study||111
1488625|NCT01763866|3640575|P18|Received Treatment|Overall Study||55
1488626|NCT01763866|3640576|P17|Received Treatment|Overall Study||56
1488627|NCT01763866|3640577|P16|Received Treatment|Overall Study||115
1488628|NCT01763866|3640578|P15|Received Treatment|Overall Study||113
1488629|NCT01763866|3640579|P14|Received Treatment|Overall Study||57
1488630|NCT01763866|3640580|P13|Received Treatment|Overall Study||58
1488631|NCT01763866|3640581|P12|Received Treatment|Overall Study||110
1488632|NCT01763866|3640582|P11|Received Treatment|Overall Study||109
1488633|NCT01763866|3640583|P10|Received Treatment|Overall Study||54
1488634|NCT01763866|3640584|P9|Received Treatment|Overall Study||56
1488635|NCT01763866|3640585|P8|Received Treatment|Overall Study||55
1488636|NCT01763866|3640586|P7|Received Treatment|Overall Study||55
1488637|NCT01763866|3640587|P6|Received Treatment|Overall Study||110
1488638|NCT01763866|3640588|P5|Received Treatment|Overall Study||110
1488639|NCT01763866|3640589|P4|Received Treatment|Overall Study||55
1488640|NCT01763866|3640590|P3|Received Treatment|Overall Study||56
1488641|NCT01763866|3640591|P2|Received Treatment|Overall Study||55
1488642|NCT01763866|3640592|P1|Received Treatment|Overall Study||56
1488643|NCT01763866|3640569|P24|STARTED|Overall Study||115
1488644|NCT01763866|3640570|P23|STARTED|Overall Study||112
1488645|NCT01763866|3640571|P22|STARTED|Overall Study||55
1488646|NCT01763866|3640572|P21|STARTED|Overall Study||56
1488647|NCT01763866|3640573|P20|STARTED|Overall Study||112
1488648|NCT01763866|3640574|P19|STARTED|Overall Study||111
1488649|NCT01763866|3640575|P18|STARTED|Overall Study||56
1488650|NCT01763866|3640576|P17|STARTED|Overall Study||56
1488651|NCT01763866|3640577|P16|STARTED|Overall Study||115
1488652|NCT01763866|3640578|P15|STARTED|Overall Study||114
1488653|NCT01763866|3640579|P14|STARTED|Overall Study||57
1488654|NCT01763866|3640580|P13|STARTED|Overall Study||58
1488655|NCT01763866|3640581|P12|STARTED|Overall Study||110
1488656|NCT01763866|3640582|P11|STARTED|Overall Study||110
1488657|NCT01763866|3640583|P10|STARTED|Overall Study||54
1488658|NCT01763866|3640584|P9|STARTED|Overall Study||56
1488659|NCT01763866|3640585|P8|STARTED|Overall Study||55
1488660|NCT01763866|3640586|P7|STARTED|Overall Study||55
1488661|NCT01763866|3640587|P6|STARTED|Overall Study||110
1488662|NCT01763866|3640588|P5|STARTED|Overall Study||110
1488663|NCT01763866|3640589|P4|STARTED|Overall Study||55
1488664|NCT01763866|3640590|P3|STARTED|Overall Study||56
1488665|NCT01763866|3640591|P2|STARTED|Overall Study||55
1488666|NCT01763866|3640592|P1|STARTED|Overall Study||56
1488667|NCT01763827|3641152|P6|NOT COMPLETED|Overall Study||2
1488668|NCT01763827|3641153|P5|NOT COMPLETED|Overall Study||6
1488669|NCT01763827|3641154|P4|NOT COMPLETED|Overall Study||1
1488670|NCT01763827|3641155|P3|NOT COMPLETED|Overall Study||4
1488671|NCT01763827|3641156|P2|NOT COMPLETED|Overall Study||1
1488672|NCT01763827|3641157|P1|NOT COMPLETED|Overall Study||3
1488673|NCT01763827|3641152|P6|COMPLETED|Overall Study||151
1488674|NCT01763827|3641153|P5|COMPLETED|Overall Study||147
1488675|NCT01763827|3641154|P4|COMPLETED|Overall Study||76
1488676|NCT01763827|3641155|P3|COMPLETED|Overall Study||73
1488677|NCT01763827|3641156|P2|COMPLETED|Overall Study||77
1488678|NCT01763827|3641157|P1|COMPLETED|Overall Study||74
1488679|NCT01763827|3641152|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
1488680|NCT01763827|3641153|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
1488681|NCT01763827|3641154|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
1488682|NCT01763827|3641155|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
1488683|NCT01763827|3641156|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
1488684|NCT01763827|3641157|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
1488685|NCT01763827|3641152|P6|STARTED|Overall Study||153
1488686|NCT01763827|3641153|P5|STARTED|Overall Study||153
1488687|NCT01763827|3641154|P4|STARTED|Overall Study||77
1488688|NCT01763827|3641155|P3|STARTED|Overall Study||77
1488689|NCT01763827|3641156|P2|STARTED|Overall Study||78
1488690|NCT01763827|3641157|P1|STARTED|Overall Study||77
1488691|NCT01763645|3641299|P2|NOT COMPLETED|Overall Study||24
1488692|NCT01763645|3641300|P1|NOT COMPLETED|Overall Study||26
1488693|NCT01763645|3641299|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
1488694|NCT01763645|3641300|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
1488695|NCT01763645|3641299|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
1488696|NCT01763645|3641300|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
1488697|NCT01763645|3641299|P2|STARTED|Overall Study||69
1488698|NCT01763645|3641300|P1|STARTED|Overall Study||69
1488699|NCT01763567|3641318|P1|NOT COMPLETED|Overall Study||0
1488700|NCT01763567|3641318|P1|COMPLETED|Overall Study||19
1488701|NCT01763567|3641318|P1|STARTED|Overall Study||19
1488702|NCT01763047|3641328|P2|NOT COMPLETED|Period 2||5
1488703|NCT01763047|3641329|P1|NOT COMPLETED|Period 2||4
1488704|NCT01763047|3641328|P2|COMPLETED|Period 2||121
1488705|NCT01763047|3641329|P1|COMPLETED|Period 2||126
1488706|NCT01763047|3641328|P2|Hyperopes|Period 2||54
1488707|NCT01763047|3641329|P1|Hyperopes|Period 2||56
1488708|NCT01763047|3641328|P2|Myopes|Period 2||72
1488709|NCT01763047|3641329|P1|Myopes|Period 2||74
1488710|NCT01763047|3641328|P2|STARTED|Period 2||126
1488711|NCT01763047|3641329|P1|STARTED|Period 2||130
1488712|NCT01763047|3641328|P2|NOT COMPLETED|Period 1||11
1488713|NCT01763047|3641329|P1|NOT COMPLETED|Period 1||9
1488714|NCT01763047|3641328|P2|COMPLETED|Period 1||126
1488715|NCT01763047|3641329|P1|COMPLETED|Period 1||130
1488716|NCT01763047|3641328|P2|Hyperopes|Period 1||61
1488717|NCT01763047|3641329|P1|Hyperopes|Period 1||62
1488718|NCT01763047|3641328|P2|Myopes|Period 1||76
1488719|NCT01763047|3641329|P1|Myopes|Period 1||77
1488720|NCT01763047|3641328|P2|STARTED|Period 1||137
1488721|NCT01763047|3641329|P1|STARTED|Period 1||139
1488722|NCT01762982|3641345|P1|NOT COMPLETED|Overall Study||0
1488723|NCT01762982|3641345|P1|COMPLETED|Overall Study||36
1488724|NCT01762982|3641345|P1|Received Empty Finn Chamber|Overall Study||36
1488725|NCT01762982|3641345|P1|Received SLS|Overall Study||36
1488726|NCT01762982|3641345|P1|Received Benzalkonium Chloride|Overall Study||36
1488727|NCT01762982|3641345|P1|Received Saline Water|Overall Study||36
1488728|NCT01762982|3641345|P1|STARTED|Overall Study||36
1488729|NCT01762943|3641368|P2|NOT COMPLETED|Overall Study||2
1488730|NCT01762943|3641369|P1|NOT COMPLETED|Overall Study||4
1488731|NCT01762943|3641368|P2|COMPLETED|Overall Study||15
1488732|NCT01762943|3641369|P1|COMPLETED|Overall Study||15
1488733|NCT01762943|3641368|P2|Withdrawal|Overall Study||15
1488734|NCT01762943|3641369|P1|Withdrawal|Overall Study||15
1488735|NCT01762943|3641368|P2|Addback|Overall Study||15
1488736|NCT01762943|3641369|P1|Addback|Overall Study||16
1488737|NCT01762943|3641368|P2|Hypogonadism|Overall Study||15
1488738|NCT01762943|3641369|P1|Hypogonadism|Overall Study||18
1488739|NCT01762943|3641368|P2|STARTED|Overall Study||17
1488740|NCT01762943|3641369|P1|STARTED|Overall Study||19
1488741|NCT01762904|3641377|P1|NOT COMPLETED|Overall Study||0
1488742|NCT01762904|3641377|P1|COMPLETED|Overall Study|October, 2013|135
1488743|NCT01762904|3641377|P1|STARTED|Overall Study|January, 2013|135
1488744|NCT01762800|3641386|P2|NOT COMPLETED|Overall Study||21
1488745|NCT01762800|3641387|P1|NOT COMPLETED|Overall Study||19
1488746|NCT01762800|3641386|P2|COMPLETED|Overall Study||183
1488747|NCT01762800|3641387|P1|COMPLETED|Overall Study||183
1488748|NCT01762800|3641386|P2|STARTED|Overall Study||204
1488749|NCT01762800|3641387|P1|STARTED|Overall Study||202
1488750|NCT01762761|3641461|P2|NOT COMPLETED|Overall Study||4
1488751|NCT01762761|3641462|P1|NOT COMPLETED|Overall Study||2
1488752|NCT01762761|3641461|P2|COMPLETED|Overall Study||100
1488753|NCT01762761|3641462|P1|COMPLETED|Overall Study||49
1488754|NCT01762761|3641461|P2|STARTED|Overall Study||104
1488755|NCT01762761|3641462|P1|STARTED|Overall Study||51
1488756|NCT01762722|3641516|P2|NOT COMPLETED|Overall Study||0
1488757|NCT01762722|3641517|P1|NOT COMPLETED|Overall Study||0
1488758|NCT01762722|3641516|P2|COMPLETED|Overall Study||11
1488759|NCT01762722|3641517|P1|COMPLETED|Overall Study||12
1488760|NCT01762722|3641516|P2|STARTED|Overall Study||11
1488761|NCT01762722|3641517|P1|STARTED|Overall Study||12
1488762|NCT01762501|3641525|P2|NOT COMPLETED|Overall Study||23
1488763|NCT01762501|3641526|P1|NOT COMPLETED|Overall Study||27
1488764|NCT01762501|3641525|P2|COMPLETED|Overall Study||336
1488765|NCT01762501|3641526|P1|COMPLETED|Overall Study||332
1488766|NCT01762501|3641525|P2|STARTED|Overall Study||359
1488767|NCT01762501|3641526|P1|STARTED|Overall Study||359
1488768|NCT01762345|3641540|P1|NOT COMPLETED|Overall Study||7
1488769|NCT01762345|3641540|P1|COMPLETED|Overall Study||76
1488770|NCT01762345|3641540|P1|STARTED|Overall Study||83
1488771|NCT01762059|3641550|P1|NOT COMPLETED|Overall Study||0
1488772|NCT01762059|3641550|P1|COMPLETED|Overall Study||20
1488773|NCT01762059|3641550|P1|STARTED|Overall Study||20
1488774|NCT01761747|3641577|P1|NOT COMPLETED|Overall Study||1
1488775|NCT01761747|3641577|P1|COMPLETED|Overall Study||2
1488776|NCT01761747|3641577|P1|STARTED|Overall Study||3
1488777|NCT01761565|3641588|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
1488778|NCT01761565|3641588|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
1488779|NCT01761565|3641588|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
1488780|NCT01761565|3641588|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
1488781|NCT01761565|3641588|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
1488782|NCT01761565|3641588|P1|STARTED|Single Dose of SUF NT 15 mcg||40
1488783|NCT01761279|3641597|P1|NOT COMPLETED|Overall Study||0
1488784|NCT01761279|3641597|P1|COMPLETED|Overall Study||84
1488785|NCT01761279|3641597|P1|STARTED|Overall Study||84
1488786|NCT01761266|3641612|P2|NOT COMPLETED|Overall Study||476
1488787|NCT01761266|3641613|P1|NOT COMPLETED|Overall Study||478
1488788|NCT01761266|3641612|P2|COMPLETED|Overall Study||0
1488789|NCT01761266|3641613|P1|COMPLETED|Overall Study||0
1488790|NCT01761266|3641612|P2|Treated|Overall Study||475
1488791|NCT01761266|3641613|P1|Treated|Overall Study||476
1488792|NCT01761266|3641612|P2|STARTED|Overall Study||476
1488793|NCT01761266|3641613|P1|STARTED|Overall Study||478
1488794|NCT01761175|3641641|P2|NOT COMPLETED|Overall Study||0
1488795|NCT01761175|3641642|P1|NOT COMPLETED|Overall Study||0
1488796|NCT01761175|3641641|P2|COMPLETED|Overall Study||112
1488797|NCT01761175|3641642|P1|COMPLETED|Overall Study||112
1488798|NCT01761175|3641641|P2|STARTED|Overall Study||112
1488799|NCT01761175|3641642|P1|STARTED|Overall Study||112
1488800|NCT01761162|3641670|P1|NOT COMPLETED|Overall Study||3
1488801|NCT01761162|3641670|P1|COMPLETED|Overall Study||226
1488802|NCT01761162|3641670|P1|STARTED|Overall Study||229
1488803|NCT01761019|3641678|P1|NOT COMPLETED|Overall Study||0
1488804|NCT01761019|3641678|P1|COMPLETED|Overall Study||8
1488805|NCT01761019|3641678|P1|STARTED|Overall Study||8
1488806|NCT01760993|3641686|P1|NOT COMPLETED|Overall Study||0
1488807|NCT01760993|3641686|P1|COMPLETED|Overall Study||0
1488808|NCT01760993|3641686|P1|STARTED|Overall Study||0
1488809|NCT01760954|3641707|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
1488810|NCT01760954|3641708|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
1488811|NCT01760954|3641709|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
1488812|NCT01760954|3641710|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
1488813|NCT01760954|3641707|P4|COMPLETED|Post-treatment Follow-up (12 Months)||67
1488814|NCT01760954|3641708|P3|COMPLETED|Post-treatment Follow-up (12 Months)||65
1488815|NCT01760954|3641709|P2|COMPLETED|Post-treatment Follow-up (12 Months)||83
1488816|NCT01760954|3641710|P1|COMPLETED|Post-treatment Follow-up (12 Months)||96
1488817|NCT01760954|3641707|P4|STARTED|Post-treatment Follow-up (12 Months)||87
1488818|NCT01760954|3641708|P3|STARTED|Post-treatment Follow-up (12 Months)||86
1488819|NCT01760954|3641709|P2|STARTED|Post-treatment Follow-up (12 Months)||118
1488820|NCT01760954|3641710|P1|STARTED|Post-treatment Follow-up (12 Months)||126
1488821|NCT01760954|3641707|P4|NOT COMPLETED|Treatment Period (6 Months)||26
1488822|NCT01760954|3641708|P3|NOT COMPLETED|Treatment Period (6 Months)||21
1488823|NCT01760954|3641709|P2|NOT COMPLETED|Treatment Period (6 Months)||28
1488824|NCT01760954|3641710|P1|NOT COMPLETED|Treatment Period (6 Months)||33
1488825|NCT01760954|3641707|P4|COMPLETED|Treatment Period (6 Months)||83
1488826|NCT01760954|3641708|P3|COMPLETED|Treatment Period (6 Months)||87
1488827|NCT01760954|3641709|P2|COMPLETED|Treatment Period (6 Months)||110
1488828|NCT01760954|3641710|P1|COMPLETED|Treatment Period (6 Months)||116
1488829|NCT01760954|3641707|P4|STARTED|Treatment Period (6 Months)||109
1488830|NCT01760954|3641708|P3|STARTED|Treatment Period (6 Months)||108
1488831|NCT01760954|3641709|P2|STARTED|Treatment Period (6 Months)||138
1488832|NCT01760954|3641710|P1|STARTED|Treatment Period (6 Months)||149
1488833|NCT01760941|3641788|P1|NOT COMPLETED|Overall Study||0
1488834|NCT01760941|3641788|P1|COMPLETED|Overall Study||1
1488835|NCT01760941|3641788|P1|STARTED|Overall Study||1
1488836|NCT01760889|3641798|P3|NOT COMPLETED|Overall Study||0
1488837|NCT01760889|3641799|P2|NOT COMPLETED|Overall Study||0
1488838|NCT01760889|3641800|P1|NOT COMPLETED|Overall Study||0
1488839|NCT01760889|3641798|P3|COMPLETED|Overall Study||0
1488840|NCT01760889|3641799|P2|COMPLETED|Overall Study||0
1488841|NCT01760889|3641800|P1|COMPLETED|Overall Study||0
1488842|NCT01760889|3641798|P3|STARTED|Overall Study||0
1488843|NCT01760889|3641799|P2|STARTED|Overall Study||0
1488844|NCT01760889|3641800|P1|STARTED|Overall Study||0
1488845|NCT01760876|3641847|P1|NOT COMPLETED|Overall Study||6
1488846|NCT01760876|3641847|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
1488847|NCT01760876|3641847|P1|STARTED|Overall Study||106
1488848|NCT01760785|3641853|P2|NOT COMPLETED|Overall Study||0
1488849|NCT01760785|3641854|P1|NOT COMPLETED|Overall Study||0
1488850|NCT01760785|3641853|P2|COMPLETED|Overall Study||27
1488851|NCT01760785|3641854|P1|COMPLETED|Overall Study||23
1488852|NCT01760785|3641853|P2|STARTED|Overall Study||27
1488853|NCT01760785|3641854|P1|STARTED|Overall Study||23
1488854|NCT01760473|3641860|P1|NOT COMPLETED|Overall Study||15
1488855|NCT01760473|3641860|P1|COMPLETED|Overall Study||12
1488856|NCT01760473|3641860|P1|STARTED|Overall Study||27
1488857|NCT01760304|3641883|P2|NOT COMPLETED|Overall Study||0
1488858|NCT01760304|3641884|P1|NOT COMPLETED|Overall Study||0
1488859|NCT01760304|3641883|P2|COMPLETED|Overall Study||3
1488860|NCT01760304|3641884|P1|COMPLETED|Overall Study||2
1488861|NCT01760304|3641883|P2|STARTED|Overall Study||3
1488862|NCT01760304|3641884|P1|STARTED|Overall Study||2
1488863|NCT01760187|3641904|P5|NOT COMPLETED|Overall Study||0
1488864|NCT01760187|3641905|P4|NOT COMPLETED|Overall Study||2
1488865|NCT01760187|3641906|P3|NOT COMPLETED|Overall Study||0
1488866|NCT01760187|3641907|P2|NOT COMPLETED|Overall Study||0
1488867|NCT01760187|3641908|P1|NOT COMPLETED|Overall Study||1
1488868|NCT01760187|3641904|P5|COMPLETED|Overall Study||16
1488869|NCT01760187|3641905|P4|COMPLETED|Overall Study||10
1488870|NCT01760187|3641906|P3|COMPLETED|Overall Study||12
1488871|NCT01760187|3641907|P2|COMPLETED|Overall Study||12
1488872|NCT01760187|3641908|P1|COMPLETED|Overall Study||19
1488873|NCT01760187|3641904|P5|STARTED|Overall Study||16
1488874|NCT01760187|3641905|P4|STARTED|Overall Study||12
1488875|NCT01760187|3641906|P3|STARTED|Overall Study||12
1488876|NCT01760187|3641907|P2|STARTED|Overall Study||12
1488877|NCT01760187|3641908|P1|STARTED|Overall Study||20
1488878|NCT01759602|3642136|P1|NOT COMPLETED|Overall Study||0
1488879|NCT01759602|3642136|P1|COMPLETED|Overall Study||10
1488880|NCT01759602|3642136|P1|STARTED|Overall Study||10
1488881|NCT01759511|3642144|P1|NOT COMPLETED|Overall Study||34
1488882|NCT01759511|3642144|P1|COMPLETED|Overall Study||0
1488883|NCT01759511|3642144|P1|STARTED|Overall Study||34
1488884|NCT01759446|3642157|P5|NOT COMPLETED|Overall Study||0
1488885|NCT01759446|3642158|P4|NOT COMPLETED|Overall Study||1
1488886|NCT01759446|3642159|P3|NOT COMPLETED|Overall Study||1
1488887|NCT01759446|3642160|P2|NOT COMPLETED|Overall Study||1
1488888|NCT01759446|3642161|P1|NOT COMPLETED|Overall Study||1
1488889|NCT01759446|3642157|P5|COMPLETED|Overall Study||8
1488890|NCT01759446|3642158|P4|COMPLETED|Overall Study||8
1488891|NCT01759446|3642159|P3|COMPLETED|Overall Study||8
1488892|NCT01759446|3642160|P2|COMPLETED|Overall Study||8
1488893|NCT01759446|3642161|P1|COMPLETED|Overall Study||8
1488894|NCT01759446|3642157|P5|STARTED|Overall Study||8
1488895|NCT01759446|3642158|P4|STARTED|Overall Study||9
1488896|NCT01759446|3642159|P3|STARTED|Overall Study||9
1488897|NCT01759446|3642160|P2|STARTED|Overall Study||9
1488898|NCT01759446|3642161|P1|STARTED|Overall Study||9
1488899|NCT01759420|3642173|P1|NOT COMPLETED|Overall Study||6
1488900|NCT01759420|3642173|P1|COMPLETED|Overall Study||22
1488901|NCT01759420|3642173|P1|STARTED|Overall Study||28
1488902|NCT01759407|3642180|P2|NOT COMPLETED|Overall Study||2
1488903|NCT01759407|3642181|P1|NOT COMPLETED|Overall Study||0
1488904|NCT01759407|3642180|P2|COMPLETED|Overall Study||7
1488905|NCT01759407|3642181|P1|COMPLETED|Overall Study||10
1488906|NCT01759407|3642180|P2|STARTED|Overall Study||9
1488907|NCT01759407|3642181|P1|STARTED|Overall Study||10
1488908|NCT01759381|3642193|P2|NOT COMPLETED|Overall Study||0
1488909|NCT01759381|3642194|P1|NOT COMPLETED|Overall Study||1
1488910|NCT01759381|3642193|P2|COMPLETED|Overall Study||11
1488911|NCT01759381|3642194|P1|COMPLETED|Overall Study||7
1488912|NCT01759381|3642193|P2|STARTED|Overall Study||11
1488913|NCT01759381|3642194|P1|STARTED|Overall Study||8
1488914|NCT01759368|3642202|P2|NOT COMPLETED|Overall Study||0
1488915|NCT01759368|3642203|P1|NOT COMPLETED|Overall Study||1
1488916|NCT01759368|3642202|P2|COMPLETED|Overall Study||47
1488917|NCT01759368|3642203|P1|COMPLETED|Overall Study||46
1488918|NCT01759368|3642202|P2|STARTED|Overall Study||47
1488919|NCT01759368|3642203|P1|STARTED|Overall Study||47
1488920|NCT01759290|3642221|P1|NOT COMPLETED|Overall Study||81
1488921|NCT01759290|3642221|P1|COMPLETED|Overall Study||1719
1488922|NCT01759290|3642221|P1|STARTED|Overall Study||1800
1488923|NCT01759264|3642281|P1|NOT COMPLETED|Overall Study||10
1488924|NCT01759264|3642281|P1|COMPLETED|Overall Study||91
1488925|NCT01759264|3642281|P1|STARTED|Overall Study||101
1488926|NCT01759251|3642294|P1|NOT COMPLETED|Follow-up Period||0
1488927|NCT01759251|3642294|P1|COMPLETED|Follow-up Period||305
1488928|NCT01759251|3642294|P1|STARTED|Follow-up Period||305
1488929|NCT01759251|3642294|P1|NOT COMPLETED|60 Days Treatment Period||0
1488930|NCT01759251|3642294|P1|COMPLETED|60 Days Treatment Period||305
1488931|NCT01759251|3642294|P1|STARTED|60 Days Treatment Period||305
1488932|NCT01759251|3642294|P1|NOT COMPLETED|30 Days Treatment Period||4
1488933|NCT01759251|3642294|P1|COMPLETED|30 Days Treatment Period||305
1488934|NCT01759251|3642294|P1|STARTED|30 Days Treatment Period||309
1488935|NCT01759160|3642300|P2|NOT COMPLETED|Overall Study||0
1488936|NCT01759160|3642301|P1|NOT COMPLETED|Overall Study||0
1488937|NCT01759160|3642300|P2|COMPLETED|Overall Study||30
1488938|NCT01759160|3642301|P1|COMPLETED|Overall Study||30
1488939|NCT01759160|3642300|P2|STARTED|Overall Study||30
1488940|NCT01759160|3642301|P1|STARTED|Overall Study||30
1488941|NCT01758900|3642309|P2|NOT COMPLETED|Overall Study||8
1488942|NCT01758900|3642310|P1|NOT COMPLETED|Overall Study||7
1488943|NCT01758900|3642309|P2|COMPLETED|Overall Study||100
1488944|NCT01758900|3642310|P1|COMPLETED|Overall Study||99
1488945|NCT01758900|3642309|P2|STARTED|Overall Study||108
1488946|NCT01758900|3642310|P1|STARTED|Overall Study||106
1488947|NCT01758588|3642330|P2|NOT COMPLETED|Overall Study||0
1488948|NCT01758588|3642331|P1|NOT COMPLETED|Overall Study||0
1488949|NCT01758588|3642330|P2|COMPLETED|Overall Study||3
1488950|NCT01758588|3642331|P1|COMPLETED|Overall Study||5
1488951|NCT01758588|3642330|P2|STARTED|Overall Study||3
1488952|NCT01758588|3642331|P1|STARTED|Overall Study||5
1488953|NCT01758432|3642348|P7|NOT COMPLETED|Overall Study||0
1488954|NCT01758432|3642349|P6|NOT COMPLETED|Overall Study||0
1488955|NCT01758432|3642350|P5|NOT COMPLETED|Overall Study||0
1488956|NCT01758432|3642351|P4|NOT COMPLETED|Overall Study||0
1488957|NCT01758432|3642352|P3|NOT COMPLETED|Overall Study||0
1488958|NCT01758432|3642353|P2|NOT COMPLETED|Overall Study||0
1488959|NCT01758432|3642354|P1|NOT COMPLETED|Overall Study||0
1488960|NCT01758432|3642348|P7|COMPLETED|Overall Study||6
1488961|NCT01758432|3642349|P6|COMPLETED|Overall Study||6
1488962|NCT01758432|3642350|P5|COMPLETED|Overall Study||6
1488963|NCT01758432|3642351|P4|COMPLETED|Overall Study||6
1488964|NCT01758432|3642352|P3|COMPLETED|Overall Study||6
1488965|NCT01758432|3642353|P2|COMPLETED|Overall Study||6
1488966|NCT01758432|3642354|P1|COMPLETED|Overall Study||18
1488967|NCT01758432|3642348|P7|STARTED|Overall Study||6
1488968|NCT01758432|3642349|P6|STARTED|Overall Study||6
1488969|NCT01758432|3642350|P5|STARTED|Overall Study||6
1488970|NCT01758432|3642351|P4|STARTED|Overall Study||6
1488971|NCT01758432|3642352|P3|STARTED|Overall Study||6
1488972|NCT01758432|3642353|P2|STARTED|Overall Study||6
1488973|NCT01758432|3642354|P1|STARTED|Overall Study||18
1488974|NCT01758289|3642426|P1|NOT COMPLETED|Overall Study||53
1488975|NCT01758289|3642426|P1|COMPLETED|Overall Study||52
1488976|NCT01758289|3642426|P1|STARTED|Overall Study||105
1488977|NCT01757964|3642445|P2|NOT COMPLETED|Overall Study||0
1488978|NCT01757964|3642446|P1|NOT COMPLETED|Overall Study||0
1488979|NCT01757964|3642445|P2|COMPLETED|Overall Study||4
1488980|NCT01757964|3642446|P1|COMPLETED|Overall Study||9
1488981|NCT01757964|3642445|P2|STARTED|Overall Study||4
1488982|NCT01757964|3642446|P1|STARTED|Overall Study||9
1488983|NCT01757847|3642452|P2|NOT COMPLETED|Overall Study||4
1488984|NCT01757847|3642453|P1|NOT COMPLETED|Overall Study||3
1488985|NCT01757847|3642452|P2|COMPLETED|Overall Study||42
1488986|NCT01757847|3642453|P1|COMPLETED|Overall Study||41
1488987|NCT01757847|3642452|P2|STARTED|Overall Study||46
1488988|NCT01757847|3642453|P1|STARTED|Overall Study||44
1488989|NCT01757821|3642461|P1|NOT COMPLETED|Overall Study||1
1488990|NCT01757821|3642461|P1|COMPLETED|Overall Study|10 subjects|10
1488991|NCT01757821|3642461|P1|STARTED|Overall Study|11 subjects|11
1488992|NCT01757717|3642469|P1|NOT COMPLETED|Overall Study||0
1488993|NCT01757717|3642469|P1|COMPLETED|Overall Study||3
1488994|NCT01757717|3642469|P1|STARTED|Overall Study||3
1488995|NCT01757704|3642476|P2|NOT COMPLETED|Overall Study||3
1488996|NCT01757704|3642477|P1|NOT COMPLETED|Overall Study||1
1488997|NCT01757704|3642476|P2|COMPLETED|Overall Study||10
1488998|NCT01757704|3642477|P1|COMPLETED|Overall Study||10
1488999|NCT01757704|3642476|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
1489000|NCT01757704|3642477|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
1489001|NCT01757691|3642495|P2|NOT COMPLETED|Overall Study||0
1489002|NCT01757691|3642496|P1|NOT COMPLETED|Overall Study||2
1489003|NCT01757691|3642495|P2|COMPLETED|Overall Study||0
1489004|NCT01757691|3642496|P1|COMPLETED|Overall Study||0
1489005|NCT01757691|3642495|P2|STARTED|Overall Study||0
1489006|NCT01757691|3642496|P1|STARTED|Overall Study||2
1489007|NCT01757678|3642509|P1|NOT COMPLETED|Overall Study||0
1489008|NCT01757678|3642509|P1|COMPLETED|Overall Study||276
1489009|NCT01757678|3642509|P1|STARTED|Overall Study||276
1489010|NCT01757561|3642525|P4|NOT COMPLETED|Overall Study||9
1489011|NCT01757561|3642526|P3|NOT COMPLETED|Overall Study||7
1489012|NCT01757561|3642527|P2|NOT COMPLETED|Overall Study||6
1489013|NCT01757561|3642528|P1|NOT COMPLETED|Overall Study||6
1489014|NCT01757561|3642525|P4|COMPLETED|Overall Study||25
1489015|NCT01757561|3642526|P3|COMPLETED|Overall Study||31
1489016|NCT01757561|3642527|P2|COMPLETED|Overall Study||28
1489017|NCT01757561|3642528|P1|COMPLETED|Overall Study||32
1489018|NCT01757561|3642525|P4|STARTED|Overall Study||34
1489019|NCT01757561|3642526|P3|STARTED|Overall Study||38
1489020|NCT01757561|3642527|P2|STARTED|Overall Study||34
1489021|NCT01757561|3642528|P1|STARTED|Overall Study||38
1489022|NCT01757405|3642544|P2|NOT COMPLETED|Overall Study||2
1489023|NCT01757405|3642545|P1|NOT COMPLETED|Overall Study||1
1489024|NCT01757405|3642544|P2|COMPLETED|Overall Study||18
1489025|NCT01757405|3642545|P1|COMPLETED|Overall Study||17
1489026|NCT01757405|3642544|P2|STARTED|Overall Study||20
1489027|NCT01757405|3642545|P1|STARTED|Overall Study||18
1489028|NCT01757275|3642563|P2|NOT COMPLETED|Overall Study||13
1489029|NCT01757275|3642564|P1|NOT COMPLETED|Overall Study||9
1489030|NCT01757275|3642563|P2|COMPLETED|Overall Study||98
1489031|NCT01757275|3642564|P1|COMPLETED|Overall Study||102
1489032|NCT01757275|3642563|P2|STARTED|Overall Study||111
1489033|NCT01757275|3642564|P1|STARTED|Overall Study||111
1489034|NCT01757197|3642586|P1|NOT COMPLETED|Overall Study||2
1489035|NCT01757197|3642586|P1|COMPLETED|Overall Study||0
1489036|NCT01757197|3642586|P1|STARTED|Overall Study||2
1489037|NCT01757184|3642595|P2|NOT COMPLETED|Open-Label Period||0
1489038|NCT01757184|3642596|P1|NOT COMPLETED|Open-Label Period||0
1489039|NCT01757184|3642595|P2|COMPLETED|Open-Label Period|This period is currently ongoing.|30
1489040|NCT01757184|3642596|P1|COMPLETED|Open-Label Period|This period is currently ongoing.|35
1489041|NCT01757184|3642595|P2|STARTED|Open-Label Period||30
1489042|NCT01757184|3642596|P1|STARTED|Open-Label Period||35
1489043|NCT01757184|3642595|P2|NOT COMPLETED|Double-Blind Period||0
1489044|NCT01757184|3642596|P1|NOT COMPLETED|Double-Blind Period||1
1489045|NCT01757184|3642595|P2|COMPLETED|Double-Blind Period||30
1489046|NCT01757184|3642596|P1|COMPLETED|Double-Blind Period||35
1489047|NCT01757184|3642595|P2|STARTED|Double-Blind Period||30
1489048|NCT01757184|3642596|P1|STARTED|Double-Blind Period||36
1489049|NCT01757171|3642620|P2|NOT COMPLETED|Overall Study||1
1489050|NCT01757171|3642621|P1|NOT COMPLETED|Overall Study||8
1489051|NCT01757171|3642620|P2|COMPLETED|Overall Study||23
1489052|NCT01757171|3642621|P1|COMPLETED|Overall Study||53
1489053|NCT01757171|3642620|P2|STARTED|Overall Study||24
1489054|NCT01757171|3642621|P1|STARTED|Overall Study||61
1489055|NCT01756976|3642635|P2|NOT COMPLETED|Overall Study||0
1489056|NCT01756976|3642636|P1|NOT COMPLETED|Overall Study||3
1489057|NCT01756976|3642635|P2|COMPLETED|Overall Study||8
1489058|NCT01756976|3642636|P1|COMPLETED|Overall Study||73
1489059|NCT01756976|3642635|P2|STARTED|Overall Study||8
1489060|NCT01756976|3642636|P1|STARTED|Overall Study||76
1489061|NCT01756586|3642644|P2|NOT COMPLETED|Overall Study||2
1489062|NCT01756586|3642645|P1|NOT COMPLETED|Overall Study||2
1489063|NCT01756586|3642644|P2|COMPLETED|Overall Study||0
1489064|NCT01756586|3642645|P1|COMPLETED|Overall Study||0
1489065|NCT01756586|3642644|P2|STARTED|Overall Study||2
1489066|NCT01756586|3642645|P1|STARTED|Overall Study||2
1489067|NCT01756391|3642651|P1|NOT COMPLETED|Overall Study||32
1489068|NCT01756391|3642651|P1|COMPLETED|Overall Study||319
1489069|NCT01756391|3642651|P1|STARTED|Overall Study||351
1489070|NCT01756300|3642655|P1|NOT COMPLETED|Overall Study||2
1489071|NCT01756300|3642655|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
1489072|NCT01756300|3642655|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
1489073|NCT01756274|3642677|P1|NOT COMPLETED|Overall Study||3
1489074|NCT01756274|3642677|P1|COMPLETED|Overall Study||159
1489075|NCT01756274|3642677|P1|STARTED|Overall Study||162
1489076|NCT01756235|3642684|P1|NOT COMPLETED|Overall Study||2
1489077|NCT01756235|3642684|P1|COMPLETED|Overall Study||460
1489078|NCT01756235|3642684|P1|STARTED|Overall Study||462
1489079|NCT01756157|3642705|P2|NOT COMPLETED|Second Intervention Period||0
1489080|NCT01756157|3642706|P1|NOT COMPLETED|Second Intervention Period||0
1489081|NCT01756157|3642705|P2|COMPLETED|Second Intervention Period||22
1489082|NCT01756157|3642706|P1|COMPLETED|Second Intervention Period||22
1489083|NCT01756157|3642705|P2|STARTED|Second Intervention Period||22
1489084|NCT01756157|3642706|P1|STARTED|Second Intervention Period||22
1489085|NCT01756157|3642705|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1489086|NCT01756157|3642706|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1489087|NCT01756157|3642705|P2|COMPLETED|Washout Period (at Least 7 Days)||22
1489088|NCT01756157|3642706|P1|COMPLETED|Washout Period (at Least 7 Days)||22
1489089|NCT01756157|3642705|P2|STARTED|Washout Period (at Least 7 Days)||22
1489090|NCT01756157|3642706|P1|STARTED|Washout Period (at Least 7 Days)||22
1489091|NCT01756157|3642705|P2|NOT COMPLETED|First Intervention Period||2
1489092|NCT01756157|3642706|P1|NOT COMPLETED|First Intervention Period||1
1489093|NCT01756157|3642705|P2|COMPLETED|First Intervention Period||22
1489094|NCT01756157|3642706|P1|COMPLETED|First Intervention Period||22
1489095|NCT01756157|3642705|P2|STARTED|First Intervention Period||24
1489096|NCT01756157|3642706|P1|STARTED|First Intervention Period||23
1489097|NCT01756079|3642720|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
1489098|NCT01756079|3642720|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
1489099|NCT01756079|3642720|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
1489100|NCT01756079|3642720|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
1489101|NCT01756079|3642720|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
1489102|NCT01756079|3642720|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
1489103|NCT01756079|3642720|P1|STARTED|Lead-in: Day 0 to Week 4||58
1489104|NCT01756053|3642726|P2|NOT COMPLETED|Period 2 (10 Days)||2
1489105|NCT01756053|3642727|P1|NOT COMPLETED|Period 2 (10 Days)||0
1489106|NCT01756053|3642726|P2|COMPLETED|Period 2 (10 Days)||6
1489107|NCT01756053|3642727|P1|COMPLETED|Period 2 (10 Days)||7
1489108|NCT01756053|3642726|P2|STARTED|Period 2 (10 Days)||8
1489109|NCT01756053|3642727|P1|STARTED|Period 2 (10 Days)||7
1489110|NCT01756053|3642726|P2|NOT COMPLETED|Washout Period (~21 Days)||0
1489111|NCT01756053|3642727|P1|NOT COMPLETED|Washout Period (~21 Days)||0
1489112|NCT01756053|3642726|P2|COMPLETED|Washout Period (~21 Days)||8
1489113|NCT01756053|3642727|P1|COMPLETED|Washout Period (~21 Days)||7
1489114|NCT01756053|3642726|P2|STARTED|Washout Period (~21 Days)||8
1489115|NCT01756053|3642727|P1|STARTED|Washout Period (~21 Days)||7
1489116|NCT01756053|3642726|P2|NOT COMPLETED|Period 1 (10 Days)||1
1489117|NCT01756053|3642727|P1|NOT COMPLETED|Period 1 (10 Days)||1
1489118|NCT01756053|3642726|P2|COMPLETED|Period 1 (10 Days)||8
1489119|NCT01756053|3642727|P1|COMPLETED|Period 1 (10 Days)||7
1489120|NCT01756053|3642726|P2|STARTED|Period 1 (10 Days)||9
1489121|NCT01756053|3642727|P1|STARTED|Period 1 (10 Days)||8
1489122|NCT01755702|3642747|P1|NOT COMPLETED|Period III||0
1489123|NCT01755702|3642747|P1|COMPLETED|Period III||58
1489124|NCT01755702|3642747|P1|Received Ibuprofen|Period III||18
1489125|NCT01755702|3642747|P1|Received Paracetamol/Caffeine|Period III||10
1489126|NCT01755702|3642747|P1|Received Placebo|Period III||13
1489127|NCT01755702|3642747|P1|Received Paracetamol|Period III||17
1489128|NCT01755702|3642747|P1|STARTED|Period III||58
1489129|NCT01755702|3642747|P1|NOT COMPLETED|Washout Period II||5
1489130|NCT01755702|3642747|P1|COMPLETED|Washout Period II||58
1489131|NCT01755702|3642747|P1|STARTED|Washout Period II||63
1489132|NCT01755702|3642747|P1|NOT COMPLETED|Period II||0
1489133|NCT01755702|3642747|P1|COMPLETED|Period II||63
1489134|NCT01755702|3642747|P1|Received Paracetamol|Period II||17
1489135|NCT01755702|3642747|P1|Received Paracetamol/Caffeine|Period II||20
1489136|NCT01755702|3642747|P1|Received Placebo|Period II||15
1489137|NCT01755702|3642747|P1|Received Ibuprofen|Period II||11
1489138|NCT01755702|3642747|P1|STARTED|Period II||63
1489139|NCT01755702|3642747|P1|NOT COMPLETED|Wash Out Period I||3
1489140|NCT01755702|3642747|P1|COMPLETED|Wash Out Period I||63
1489141|NCT01755702|3642747|P1|STARTED|Wash Out Period I||66
1489142|NCT01755702|3642747|P1|NOT COMPLETED|Period I||0
1489143|NCT01755702|3642747|P1|COMPLETED|Period I||66
1489144|NCT01755702|3642747|P1|Received Paracetamol/Caffeine|Period I||17
1489145|NCT01755702|3642747|P1|Received Ibuprofen|Period I||16
1489146|NCT01755702|3642747|P1|Received Placebo|Period I||17
1489147|NCT01755702|3642747|P1|Received Paracetamol|Period I||16
1489148|NCT01755702|3642747|P1|STARTED|Period I||66
1489149|NCT01755689|3642794|P5|NOT COMPLETED|Overall Study||6
1489150|NCT01755689|3642795|P4|NOT COMPLETED|Overall Study||6
1489151|NCT01755689|3642796|P3|NOT COMPLETED|Overall Study||6
1489152|NCT01755689|3642797|P2|NOT COMPLETED|Overall Study||5
1489153|NCT01755689|3642798|P1|NOT COMPLETED|Overall Study||3
1489154|NCT01755689|3642794|P5|COMPLETED|Overall Study||255
1489155|NCT01755689|3642795|P4|COMPLETED|Overall Study||254
1489156|NCT01755689|3642796|P3|COMPLETED|Overall Study||255
1489157|NCT01755689|3642797|P2|COMPLETED|Overall Study||254
1489158|NCT01755689|3642798|P1|COMPLETED|Overall Study||256
1489159|NCT01755689|3642794|P5|STARTED|Overall Study||261
1489160|NCT01755689|3642795|P4|STARTED|Overall Study||260
1489161|NCT01755689|3642796|P3|STARTED|Overall Study||261
1489162|NCT01755689|3642797|P2|STARTED|Overall Study||259
1489163|NCT01755689|3642798|P1|STARTED|Overall Study||259
1489164|NCT01755637|3642873|P2|NOT COMPLETED|Period 2||0
1489165|NCT01755637|3642874|P1|NOT COMPLETED|Period 2||0
1489166|NCT01755637|3642873|P2|COMPLETED|Period 2||27
1489167|NCT01755637|3642874|P1|COMPLETED|Period 2||28
1489168|NCT01755637|3642873|P2|STARTED|Period 2||27
1489169|NCT01755637|3642874|P1|STARTED|Period 2||28
1489170|NCT01755637|3642873|P2|NOT COMPLETED|Period 1||1
1489171|NCT01755637|3642874|P1|NOT COMPLETED|Period 1||0
1489172|NCT01755637|3642873|P2|COMPLETED|Period 1||27
1489173|NCT01755637|3642874|P1|COMPLETED|Period 1||28
1489174|NCT01755637|3642873|P2|STARTED|Period 1||28
1489175|NCT01755637|3642874|P1|STARTED|Period 1||28
1489176|NCT01755546|3642892|P1|NOT COMPLETED|Long Term Treatment||121
1489177|NCT01755546|3642892|P1|COMPLETED|Long Term Treatment||103
1489178|NCT01755546|3642892|P1|STARTED|Long Term Treatment||224
1489179|NCT01755546|3642892|P1|NOT COMPLETED|Titration Phase||70
1489180|NCT01755546|3642892|P1|COMPLETED|Titration Phase||224
1489181|NCT01755546|3642892|P1|STARTED|Titration Phase||294
1489182|NCT01755546|3642892|P1|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
1489183|NCT01755546|3642892|P1|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
1489184|NCT01755546|3642892|P1|STARTED|Screened and Taper (Rollover and DeNovo)||304
1489185|NCT01755455|3642896|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1489186|NCT01755455|3642897|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1489187|NCT01755455|3642896|P2|COMPLETED|Second Intervention (6 Weeks)||11
1489188|NCT01755455|3642897|P1|COMPLETED|Second Intervention (6 Weeks)||11
1489189|NCT01755455|3642896|P2|STARTED|Second Intervention (6 Weeks)||11
1489190|NCT01755455|3642897|P1|STARTED|Second Intervention (6 Weeks)||11
1489191|NCT01755455|3642896|P2|NOT COMPLETED|Washout (4 Weeks)||0
1489192|NCT01755455|3642897|P1|NOT COMPLETED|Washout (4 Weeks)||0
1489193|NCT01755455|3642896|P2|COMPLETED|Washout (4 Weeks)||11
1489194|NCT01755455|3642897|P1|COMPLETED|Washout (4 Weeks)||11
1489195|NCT01755455|3642896|P2|STARTED|Washout (4 Weeks)||11
1489196|NCT01755455|3642897|P1|STARTED|Washout (4 Weeks)||11
1489197|NCT01755455|3642896|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
1489198|NCT01755455|3642897|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
1489199|NCT01755455|3642896|P2|COMPLETED|First Intervention (6 Weeks)||11
1489200|NCT01755455|3642897|P1|COMPLETED|First Intervention (6 Weeks)||11
1489201|NCT01755455|3642896|P2|STARTED|First Intervention (6 Weeks)||11
1489202|NCT01755455|3642897|P1|STARTED|First Intervention (6 Weeks)||11
1489203|NCT01755416|3642909|P2|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
1489204|NCT01755416|3642910|P1|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
1489205|NCT01755416|3642909|P2|COMPLETED|Second Intervention (Upto 2 Days)||7
1489206|NCT01755416|3642910|P1|COMPLETED|Second Intervention (Upto 2 Days)||8
1489207|NCT01755416|3642909|P2|STARTED|Second Intervention (Upto 2 Days)||7
1489208|NCT01755416|3642910|P1|STARTED|Second Intervention (Upto 2 Days)||8
1489209|NCT01755416|3642909|P2|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
1489210|NCT01755416|3642910|P1|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
1489211|NCT01755416|3642909|P2|COMPLETED|First Intervention ( Upto 2 Days)||7
1489212|NCT01755416|3642910|P1|COMPLETED|First Intervention ( Upto 2 Days)||8
1489213|NCT01755416|3642909|P2|STARTED|First Intervention ( Upto 2 Days)||9
1489214|NCT01755416|3642910|P1|STARTED|First Intervention ( Upto 2 Days)||9
1489215|NCT01755234|3642918|P2|NOT COMPLETED|Overall Study||8
1489216|NCT01755234|3642919|P1|NOT COMPLETED|Overall Study||15
1489217|NCT01755234|3642918|P2|COMPLETED|Overall Study||37
1489218|NCT01755234|3642919|P1|COMPLETED|Overall Study||30
1489219|NCT01755234|3642918|P2|STARTED|Overall Study||45
1489220|NCT01755234|3642919|P1|STARTED|Overall Study||45
1489221|NCT01755169|3642935|P4|NOT COMPLETED|Overall Study||0
1489222|NCT01755169|3642936|P3|NOT COMPLETED|Overall Study||0
1489223|NCT01755169|3642937|P2|NOT COMPLETED|Overall Study||0
1489224|NCT01755169|3642938|P1|NOT COMPLETED|Overall Study||0
1489225|NCT01755169|3642935|P4|COMPLETED|Overall Study||1
1489226|NCT01755169|3642936|P3|COMPLETED|Overall Study||0
1489227|NCT01755169|3642937|P2|COMPLETED|Overall Study||1
1489228|NCT01755169|3642938|P1|COMPLETED|Overall Study||2
1489229|NCT01755169|3642935|P4|STARTED|Overall Study||1
1489230|NCT01755169|3642936|P3|STARTED|Overall Study||0
1489231|NCT01755169|3642937|P2|STARTED|Overall Study||1
1489232|NCT01755169|3642938|P1|STARTED|Overall Study||2
1489233|NCT01755156|3642950|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
1489234|NCT01755156|3642951|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
1489235|NCT01755156|3642950|P2|COMPLETED|Phase B (Weeks 24-104)||141
1489236|NCT01755156|3642951|P1|COMPLETED|Phase B (Weeks 24-104)||144
1489237|NCT01755156|3642950|P2|STARTED|Phase B (Weeks 24-104)||177
1489238|NCT01755156|3642951|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
1489239|NCT01755156|3642950|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
1489240|NCT01755156|3642951|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
1489241|NCT01755156|3642950|P2|COMPLETED|Phase A (Weeks 0-24)||177
1489242|NCT01755156|3642951|P1|COMPLETED|Phase A (Weeks 0-24)||184
1489243|NCT01755156|3642950|P2|STARTED|Phase A (Weeks 0-24)||201
1489244|NCT01755156|3642951|P1|STARTED|Phase A (Weeks 0-24)||201
1489245|NCT01755143|3642997|P2|NOT COMPLETED|Overall Study||3
1489246|NCT01755143|3642998|P1|NOT COMPLETED|Overall Study||11
1489247|NCT01755143|3642997|P2|COMPLETED|Overall Study||86
1489248|NCT01755143|3642998|P1|COMPLETED|Overall Study||166
1489249|NCT01755143|3642997|P2|STARTED|Overall Study||89
1489250|NCT01755143|3642998|P1|STARTED|Overall Study||177
1489251|NCT01755091|3643015|P3|NOT COMPLETED|Overall Study||7
1489252|NCT01755091|3643016|P2|NOT COMPLETED|Overall Study||3
1489253|NCT01755091|3643017|P1|NOT COMPLETED|Overall Study||9
1489254|NCT01755091|3643015|P3|COMPLETED|Overall Study||20
1489255|NCT01755091|3643016|P2|COMPLETED|Overall Study||19
1489256|NCT01755091|3643017|P1|COMPLETED|Overall Study||17
1489257|NCT01755091|3643015|P3|STARTED|Overall Study||27
1489258|NCT01755091|3643016|P2|STARTED|Overall Study||22
1489259|NCT01755091|3643017|P1|STARTED|Overall Study||26
1489260|NCT01755026|3643042|P2|NOT COMPLETED|Overall Study||1
1489261|NCT01755026|3643043|P1|NOT COMPLETED|Overall Study||2
1489262|NCT01755026|3643042|P2|COMPLETED|Overall Study||11
1489263|NCT01755026|3643043|P1|COMPLETED|Overall Study||9
1489264|NCT01755026|3643042|P2|STARTED|Overall Study||12
1489265|NCT01755026|3643043|P1|STARTED|Overall Study||11
1489266|NCT01754987|3643051|P2|NOT COMPLETED|Overall Study||0
1489267|NCT01754987|3643052|P1|NOT COMPLETED|Overall Study||0
1489268|NCT01754987|3643051|P2|COMPLETED|Overall Study||0
1489269|NCT01754987|3643052|P1|COMPLETED|Overall Study||5
1489270|NCT01754987|3643051|P2|STARTED|Overall Study||0
1489271|NCT01754987|3643052|P1|STARTED|Overall Study||5
1489272|NCT01754922|3643066|P2|NOT COMPLETED|Overall Study||1
1489273|NCT01754922|3643067|P1|NOT COMPLETED|Overall Study||0
1489274|NCT01754922|3643066|P2|COMPLETED|Overall Study||17
1489275|NCT01754922|3643067|P1|COMPLETED|Overall Study||32
1489276|NCT01754922|3643066|P2|STARTED|Overall Study||18
1489277|NCT01754922|3643067|P1|STARTED|Overall Study||32
1489278|NCT01754766|3643080|P3|NOT COMPLETED|Overall Study||0
1489279|NCT01754766|3643081|P2|NOT COMPLETED|Overall Study||1
1489280|NCT01754766|3643082|P1|NOT COMPLETED|Overall Study||1
1489281|NCT01754766|3643080|P3|COMPLETED|Overall Study||30
1489282|NCT01754766|3643081|P2|COMPLETED|Overall Study||28
1489283|NCT01754766|3643082|P1|COMPLETED|Overall Study||30
1489284|NCT01754766|3643080|P3|STARTED|Overall Study||30
1489285|NCT01754766|3643081|P2|STARTED|Overall Study||29
1489286|NCT01754766|3643082|P1|STARTED|Overall Study||31
1489287|NCT01754727|3643096|P1|NOT COMPLETED|Overall Study||2
1489288|NCT01754727|3643096|P1|COMPLETED|Overall Study||450
1489289|NCT01754727|3643096|P1|STARTED|Overall Study||452
1489290|NCT01754714|3643114|P4|NOT COMPLETED|Overall Study||1
1489291|NCT01754714|3643115|P3|NOT COMPLETED|Overall Study||2
1489292|NCT01754714|3643116|P2|NOT COMPLETED|Overall Study||1
1489293|NCT01754714|3643117|P1|NOT COMPLETED|Overall Study||0
1489294|NCT01754714|3643114|P4|COMPLETED|Overall Study||27
1489295|NCT01754714|3643115|P3|COMPLETED|Overall Study||24
1489296|NCT01754714|3643116|P2|COMPLETED|Overall Study||26
1489297|NCT01754714|3643117|P1|COMPLETED|Overall Study||27
1489298|NCT01754714|3643114|P4|STARTED|Overall Study||28
1489299|NCT01754714|3643115|P3|STARTED|Overall Study||26
1489300|NCT01754714|3643116|P2|STARTED|Overall Study||27
1489301|NCT01754714|3643117|P1|STARTED|Overall Study||27
1489302|NCT01754623|3643207|P1|NOT COMPLETED|Overall Study||0
1489303|NCT01754623|3643207|P1|COMPLETED|Overall Study||9
1489304|NCT01754623|3643207|P1|STARTED|Overall Study||9
1489305|NCT01754519|3643214|P1|NOT COMPLETED|Overall Study||0
1489306|NCT01754519|3643214|P1|COMPLETED|Overall Study||1
1489307|NCT01754519|3643214|P1|STARTED|Overall Study||1
1489308|NCT01754493|3643223|P1|NOT COMPLETED|Overall Study||7
1489309|NCT01754493|3643223|P1|COMPLETED|Overall Study||10
1489310|NCT01754493|3643223|P1|STARTED|Overall Study||17
1489311|NCT01754480|3643233|P2|NOT COMPLETED|Primary Part II||11
1489312|NCT01754480|3643234|P1|NOT COMPLETED|Primary Part II||15
1489313|NCT01754480|3643233|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
1489314|NCT01754480|3643234|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
1489315|NCT01754480|3643233|P2|Completed Study up to Week 6|Primary Part II||108
1489316|NCT01754480|3643234|P1|Completed Study up to Week 6|Primary Part II||100
1489317|NCT01754480|3643233|P2|STARTED|Primary Part II||113
1489318|NCT01754480|3643234|P1|STARTED|Primary Part II||111
1489319|NCT01754480|3643233|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
1489320|NCT01754480|3643234|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
1489321|NCT01754480|3643233|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
1489322|NCT01754480|3643234|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
1489323|NCT01754480|3643233|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
1489324|NCT01754480|3643234|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
1489325|NCT01754480|3643233|P2|STARTED|Part I + Part II (Overall Study)||162
1489326|NCT01754480|3643234|P1|STARTED|Part I + Part II (Overall Study)||163
1489327|NCT01754467|3643248|P1|NOT COMPLETED|Overall Study||1
1489328|NCT01754467|3643248|P1|COMPLETED|Overall Study||8
1489329|NCT01754467|3643248|P1|STARTED|Overall Study||9
1489330|NCT01754402|3643258|P3|NOT COMPLETED|Overall Study||4
1489331|NCT01754402|3643259|P2|NOT COMPLETED|Overall Study||2
1489332|NCT01754402|3643260|P1|NOT COMPLETED|Overall Study||2
1489333|NCT01754402|3643258|P3|COMPLETED|Overall Study||26
1489334|NCT01754402|3643259|P2|COMPLETED|Overall Study||0
1489335|NCT01754402|3643260|P1|COMPLETED|Overall Study||4
1489336|NCT01754402|3643258|P3|STARTED|Overall Study||30
1489337|NCT01754402|3643259|P2|STARTED|Overall Study||2
1489338|NCT01754402|3643260|P1|STARTED|Overall Study||6
1489339|NCT01754389|3643272|P3|NOT COMPLETED|Overall Study||0
1489340|NCT01754389|3643273|P2|NOT COMPLETED|Overall Study||0
1489341|NCT01754389|3643274|P1|NOT COMPLETED|Overall Study||0
1489342|NCT01754389|3643272|P3|COMPLETED|Overall Study||47
1489343|NCT01754389|3643273|P2|COMPLETED|Overall Study||45
1489344|NCT01754389|3643274|P1|COMPLETED|Overall Study||46
1489345|NCT01754389|3643272|P3|STARTED|Overall Study||47
1489346|NCT01754389|3643273|P2|STARTED|Overall Study||45
1489347|NCT01754389|3643274|P1|STARTED|Overall Study||46
1489348|NCT01754376|3643294|P1|NOT COMPLETED|Overall Study||3
1489349|NCT01754376|3643294|P1|COMPLETED|Overall Study||3
1489350|NCT01754376|3643294|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
1489351|NCT01754376|3643294|P1|STARTED|Overall Study||6
1489352|NCT01754259|3643305|P2|NOT COMPLETED|Overall Study||6
1489353|NCT01754259|3643306|P1|NOT COMPLETED|Overall Study||5
1489354|NCT01754259|3643305|P2|COMPLETED|Overall Study||18
1489355|NCT01754259|3643306|P1|COMPLETED|Overall Study||18
1489356|NCT01754259|3643305|P2|STARTED|Overall Study||24
1489357|NCT01754259|3643306|P1|STARTED|Overall Study||23
1489358|NCT01754194|3643316|P2|NOT COMPLETED|Overall Study||27
1489359|NCT01754194|3643317|P1|NOT COMPLETED|Overall Study||52
1489360|NCT01754194|3643316|P2|COMPLETED|Overall Study||97
1489361|NCT01754194|3643317|P1|COMPLETED|Overall Study||117
1489362|NCT01754194|3643316|P2|STARTED|Overall Study||124
1489363|NCT01754194|3643317|P1|STARTED|Overall Study||169
1489364|NCT01754129|3643337|P1|NOT COMPLETED|Overall Study||33
1489365|NCT01754129|3643337|P1|COMPLETED|Overall Study||115
1489366|NCT01754129|3643337|P1|Visit 3 (Year 2)|Overall Study||115
1489367|NCT01754129|3643337|P1|Visit 2 (Year 1)|Overall Study||129
1489368|NCT01754129|3643337|P1|Visit 1 (Enrollment Day)|Overall Study||145
1489369|NCT01754129|3643337|P1|STARTED|Overall Study||148
1489370|NCT01753999|3643360|P2|NOT COMPLETED|Period 2 -Cross to Alternate Arm||26
1489371|NCT01753999|3643361|P1|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
1489372|NCT01753999|3643360|P2|COMPLETED|Period 2 -Cross to Alternate Arm||86
1489373|NCT01753999|3643361|P1|COMPLETED|Period 2 -Cross to Alternate Arm||99
1489374|NCT01753999|3643360|P2|STARTED|Period 2 -Cross to Alternate Arm||112
1489375|NCT01753999|3643361|P1|STARTED|Period 2 -Cross to Alternate Arm||116
1489376|NCT01753999|3643360|P2|NOT COMPLETED|Period 1 - Initial Assignment||50
1489377|NCT01753999|3643361|P1|NOT COMPLETED|Period 1 - Initial Assignment||39
1489378|NCT01753999|3643360|P2|COMPLETED|Period 1 - Initial Assignment||112
1489379|NCT01753999|3643361|P1|COMPLETED|Period 1 - Initial Assignment||116
1489380|NCT01753999|3643360|P2|STARTED|Period 1 - Initial Assignment||162
1489381|NCT01753999|3643361|P1|STARTED|Period 1 - Initial Assignment||155
1489382|NCT01753856|3643371|P2|NOT COMPLETED|Overall Study||2
1489383|NCT01753856|3643372|P1|NOT COMPLETED|Overall Study||3
1489384|NCT01753856|3643371|P2|COMPLETED|Overall Study||34
1489385|NCT01753856|3643372|P1|COMPLETED|Overall Study||30
1489386|NCT01753856|3643371|P2|Completed 3-Month Bone Biopsy|Overall Study||35
1489387|NCT01753856|3643372|P1|Completed 3-Month Bone Biopsy|Overall Study||31
1489388|NCT01753856|3643371|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
1489389|NCT01753856|3643372|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
1489390|NCT01753856|3643371|P2|STARTED|Overall Study||36
1489391|NCT01753856|3643372|P1|STARTED|Overall Study||33
1489392|NCT01753713|3643424|P2|NOT COMPLETED|Overall Study||0
1489393|NCT01753713|3643425|P1|NOT COMPLETED|Overall Study||0
1489394|NCT01753713|3643424|P2|COMPLETED|Overall Study||19
1489395|NCT01753713|3643425|P1|COMPLETED|Overall Study||14
1489396|NCT01753713|3643424|P2|STARTED|Overall Study||19
1489397|NCT01753713|3643425|P1|STARTED|Overall Study||14
1489398|NCT01753570|3643444|P3|NOT COMPLETED|Overall Study||1
1489399|NCT01753570|3643445|P2|NOT COMPLETED|Overall Study||5
1489400|NCT01753570|3643446|P1|NOT COMPLETED|Overall Study||2
1489401|NCT01753570|3643444|P3|COMPLETED|Overall Study||13
1489402|NCT01753570|3643445|P2|COMPLETED|Overall Study||25
1489403|NCT01753570|3643446|P1|COMPLETED|Overall Study||28
1489404|NCT01753570|3643444|P3|STARTED|Overall Study||14
1489405|NCT01753570|3643445|P2|STARTED|Overall Study||30
1489406|NCT01753570|3643446|P1|STARTED|Overall Study||30
1489407|NCT01753557|3643470|P2|NOT COMPLETED|Overall Study||0
1489408|NCT01753557|3643471|P1|NOT COMPLETED|Overall Study||0
1489409|NCT01753557|3643470|P2|COMPLETED|Overall Study||19
1489410|NCT01753557|3643471|P1|COMPLETED|Overall Study||35
1489411|NCT01753557|3643470|P2|STARTED|Overall Study||19
1489412|NCT01753557|3643471|P1|STARTED|Overall Study||35
1489413|NCT01753518|3643489|P2|NOT COMPLETED|Postpartum Follow-up||15
1489414|NCT01753518|3643490|P1|NOT COMPLETED|Postpartum Follow-up||22
1489415|NCT01753518|3643489|P2|COMPLETED|Postpartum Follow-up||88
1489416|NCT01753518|3643490|P1|COMPLETED|Postpartum Follow-up||81
1489417|NCT01753518|3643489|P2|STARTED|Postpartum Follow-up||103
1489418|NCT01753518|3643490|P1|STARTED|Postpartum Follow-up||103
1489419|NCT01753518|3643489|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
1489420|NCT01753518|3643490|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
1489421|NCT01753518|3643489|P2|COMPLETED|Intention-to-Treat Analysis||103
1489422|NCT01753518|3643490|P1|COMPLETED|Intention-to-Treat Analysis||103
1489423|NCT01753518|3643489|P2|STARTED|Intention-to-Treat Analysis||110
1489424|NCT01753518|3643490|P1|STARTED|Intention-to-Treat Analysis||110
1489425|NCT01753336|3643512|P1|NOT COMPLETED|Overall Study||20
1489426|NCT01753336|3643512|P1|COMPLETED|Overall Study||92
1489427|NCT01753336|3643512|P1|Cycle 3|Overall Study||93
1489428|NCT01753336|3643512|P1|Cycle 2|Overall Study||98
1489429|NCT01753336|3643512|P1|Cycle 1|Overall Study||112
1489430|NCT01753336|3643512|P1|STARTED|Overall Study||112
1489431|NCT01753323|3643524|P3|NOT COMPLETED|Overall Study||9
1489432|NCT01753323|3643525|P2|NOT COMPLETED|Overall Study||0
1489433|NCT01753323|3643526|P1|NOT COMPLETED|Overall Study||1
1489434|NCT01753323|3643524|P3|COMPLETED|Overall Study||13
1489435|NCT01753323|3643525|P2|COMPLETED|Overall Study||10
1489436|NCT01753323|3643526|P1|COMPLETED|Overall Study||10
1489437|NCT01753323|3643524|P3|Intent-to-treat Analysis Set|Overall Study||22
1489438|NCT01753323|3643525|P2|Intent-to-treat Analysis Set|Overall Study||10
1489439|NCT01753323|3643526|P1|Intent-to-treat Analysis Set|Overall Study||11
1489440|NCT01753323|3643524|P3|Safety Set|Overall Study||22
1489441|NCT01753323|3643525|P2|Safety Set|Overall Study||10
1489442|NCT01753323|3643526|P1|Safety Set|Overall Study||11
1489443|NCT01753323|3643524|P3|Pharmacokinetic(PK) Set|Overall Study||21
1489444|NCT01753323|3643525|P2|Pharmacokinetic(PK) Set|Overall Study||10
1489445|NCT01753323|3643526|P1|Pharmacokinetic(PK) Set|Overall Study||10
1489446|NCT01753323|3643524|P3|Pharmacodynamic (PD) Set|Overall Study||21
1489447|NCT01753323|3643525|P2|Pharmacodynamic (PD) Set|Overall Study||10
1489448|NCT01753323|3643526|P1|Pharmacodynamic (PD) Set|Overall Study||10
1489449|NCT01753323|3643524|P3|STARTED|Overall Study||22
1489450|NCT01753323|3643525|P2|STARTED|Overall Study||10
1489451|NCT01753323|3643526|P1|STARTED|Overall Study||11
1489452|NCT01753310|3643564|P2|NOT COMPLETED|Overall Study||24
1489453|NCT01753310|3643565|P1|NOT COMPLETED|Overall Study||32
1489454|NCT01753310|3643564|P2|COMPLETED|Overall Study||21
1489455|NCT01753310|3643565|P1|COMPLETED|Overall Study||57
1489456|NCT01753310|3643564|P2|STARTED|Overall Study||45
1489457|NCT01753310|3643565|P1|STARTED|Overall Study||89
1489458|NCT01753115|3643588|P3|NOT COMPLETED|Overall Study||14
1489459|NCT01753115|3643589|P2|NOT COMPLETED|Overall Study||15
1489460|NCT01753115|3643590|P1|NOT COMPLETED|Overall Study||12
1489461|NCT01753115|3643588|P3|COMPLETED|Overall Study||56
1489462|NCT01753115|3643589|P2|COMPLETED|Overall Study||25
1489463|NCT01753115|3643590|P1|COMPLETED|Overall Study||32
1489464|NCT01753115|3643588|P3|Treated|Overall Study||67
1489465|NCT01753115|3643589|P2|Treated|Overall Study||39
1489466|NCT01753115|3643590|P1|Treated|Overall Study||38
1489467|NCT01753115|3643588|P3|STARTED|Overall Study||70
1489468|NCT01753115|3643589|P2|STARTED|Overall Study||40
1489469|NCT01753115|3643590|P1|STARTED|Overall Study||44
1489470|NCT01753076|3643600|P2|NOT COMPLETED|Overall Study||46
1489471|NCT01753076|3643601|P1|NOT COMPLETED|Overall Study||41
1489472|NCT01753076|3643600|P2|COMPLETED|Overall Study||106
1489473|NCT01753076|3643601|P1|COMPLETED|Overall Study||110
1489474|NCT01753076|3643600|P2|STARTED|Overall Study||152
1489475|NCT01753076|3643601|P1|STARTED|Overall Study||151
1489476|NCT01752907|3643627|P2|NOT COMPLETED|Overall Study||20
1489477|NCT01752907|3643628|P1|NOT COMPLETED|Overall Study||12
1489478|NCT01752907|3643627|P2|COMPLETED|Overall Study||133
1489479|NCT01752907|3643628|P1|COMPLETED|Overall Study||139
1489480|NCT01752907|3643627|P2|Received Pegfilgrastim|Overall Study||151
1489481|NCT01752907|3643628|P1|Received Pegfilgrastim|Overall Study||149
1489482|NCT01752907|3643627|P2|STARTED|Overall Study||153
1489483|NCT01752907|3643628|P1|STARTED|Overall Study||151
1489484|NCT01752855|3643648|P2|NOT COMPLETED|Overall Study||4
1489485|NCT01752855|3643649|P1|NOT COMPLETED|Overall Study||1
1489486|NCT01752855|3643648|P2|COMPLETED|Overall Study||40
1489487|NCT01752855|3643649|P1|COMPLETED|Overall Study||43
1489488|NCT01752855|3643648|P2|STARTED|Overall Study||44
1489489|NCT01752855|3643649|P1|STARTED|Overall Study||44
1489490|NCT01752712|3643665|P2|NOT COMPLETED|Overall Study||10
1489491|NCT01752712|3643666|P1|NOT COMPLETED|Overall Study||9
1489492|NCT01752712|3643665|P2|COMPLETED|Overall Study||21
1489493|NCT01752712|3643666|P1|COMPLETED|Overall Study||22
1489494|NCT01752712|3643665|P2|STARTED|Overall Study||31
1489495|NCT01752712|3643666|P1|STARTED|Overall Study||31
1489496|NCT01752400|3643682|P1|NOT COMPLETED|Overall Study||0
1489497|NCT01752400|3643682|P1|COMPLETED|Overall Study||6
1489498|NCT01752400|3643682|P1|STARTED|Overall Study||6
1489499|NCT01752023|3643695|P2|NOT COMPLETED|Overall Study||1
1489500|NCT01752023|3643696|P1|NOT COMPLETED|Overall Study||2
1489501|NCT01752023|3643695|P2|COMPLETED|Overall Study||0
1489502|NCT01752023|3643696|P1|COMPLETED|Overall Study||0
1489503|NCT01752023|3643695|P2|STARTED|Overall Study||1
1489504|NCT01752023|3643696|P1|STARTED|Overall Study||2
1489505|NCT01751971|3643714|P2|NOT COMPLETED|Overall Study||1
1489506|NCT01751971|3643715|P1|NOT COMPLETED|Overall Study||2
1489507|NCT01751971|3643714|P2|COMPLETED|Overall Study||24
1489508|NCT01751971|3643715|P1|COMPLETED|Overall Study||20
1489509|NCT01751971|3643714|P2|STARTED|Overall Study||25
1489510|NCT01751971|3643715|P1|STARTED|Overall Study||22
1489511|NCT01751906|3643732|P2|NOT COMPLETED|Overall Study||47
1489512|NCT01751906|3643733|P1|NOT COMPLETED|Overall Study||84
1489513|NCT01751906|3643732|P2|COMPLETED|Overall Study||639
1489514|NCT01751906|3643733|P1|COMPLETED|Overall Study||1238
1489515|NCT01751906|3643732|P2|STARTED|Overall Study||686
1489516|NCT01751906|3643733|P1|STARTED|Overall Study||1322
1489517|NCT01751867|3643937|P2|NOT COMPLETED|Overall Study||99
1489518|NCT01751867|3643938|P1|NOT COMPLETED|Overall Study||36
1489519|NCT01751867|3643937|P2|COMPLETED|Overall Study||0
1489520|NCT01751867|3643938|P1|COMPLETED|Overall Study||0
1489521|NCT01751867|3643937|P2|Treated|Overall Study||98
1489522|NCT01751867|3643938|P1|Treated|Overall Study||34
1489523|NCT01751867|3643937|P2|STARTED|Overall Study||99
1489524|NCT01751867|3643938|P1|STARTED|Overall Study||36
1489525|NCT01751802|3643958|P2|NOT COMPLETED|Overall Study||2
1489526|NCT01751802|3643959|P1|NOT COMPLETED|Overall Study||4
1489527|NCT01751802|3643958|P2|COMPLETED|Overall Study||2
1489528|NCT01751802|3643959|P1|COMPLETED|Overall Study||1
1489529|NCT01751802|3643958|P2|Completed Period 3|Overall Study||1
1489530|NCT01751802|3643959|P1|Completed Period 3|Overall Study||2
1489531|NCT01751802|3643958|P2|Completed Period 2|Overall Study||1
1489532|NCT01751802|3643959|P1|Completed Period 2|Overall Study||2
1489533|NCT01751802|3643958|P2|Completed Period 1|Overall Study||4
1489534|NCT01751802|3643959|P1|Completed Period 1|Overall Study||2
1489535|NCT01751802|3643958|P2|STARTED|Overall Study||4
1489536|NCT01751802|3643959|P1|STARTED|Overall Study||5
1489537|NCT01751724|3643973|P2|NOT COMPLETED|Overall Study||2
1489538|NCT01751724|3643974|P1|NOT COMPLETED|Overall Study||1
1489539|NCT01751724|3643973|P2|COMPLETED|Overall Study||42
1489540|NCT01751724|3643974|P1|COMPLETED|Overall Study||41
1489541|NCT01751724|3643973|P2|STARTED|Overall Study||44
1489542|NCT01751724|3643974|P1|STARTED|Overall Study||42
1489543|NCT01751412|3644000|P1|NOT COMPLETED|Overall Study||1
1489544|NCT01751412|3644000|P1|COMPLETED|Overall Study||11
1489545|NCT01751412|3644000|P1|STARTED|Overall Study||12
1489546|NCT01751399|3644014|P4|NOT COMPLETED|Overall Study||0
1489547|NCT01751399|3644015|P3|NOT COMPLETED|Overall Study||0
1489548|NCT01751399|3644016|P2|NOT COMPLETED|Overall Study||0
1489549|NCT01751399|3644017|P1|NOT COMPLETED|Overall Study||0
1489550|NCT01751399|3644014|P4|COMPLETED|Overall Study||7
1489551|NCT01751399|3644015|P3|COMPLETED|Overall Study||8
1489552|NCT01751399|3644016|P2|COMPLETED|Overall Study||8
1489553|NCT01751399|3644017|P1|COMPLETED|Overall Study||12
1489554|NCT01751399|3644014|P4|Received 1 Dose of Study Drug|Overall Study||7
1489555|NCT01751399|3644015|P3|Received 1 Dose of Study Drug|Overall Study||8
1489556|NCT01751399|3644016|P2|Received 1 Dose of Study Drug|Overall Study||8
1489557|NCT01751399|3644017|P1|Received 1 Dose of Study Drug|Overall Study||12
1489558|NCT01751399|3644014|P4|STARTED|Overall Study||7
1489559|NCT01751399|3644015|P3|STARTED|Overall Study||8
1489560|NCT01751399|3644016|P2|STARTED|Overall Study||8
1489561|NCT01751399|3644017|P1|STARTED|Overall Study||12
1489562|NCT01751386|3644033|P2|NOT COMPLETED|Overall Study||3
1489563|NCT01751386|3644034|P1|NOT COMPLETED|Overall Study||2
1489564|NCT01751386|3644033|P2|COMPLETED|Overall Study||16
1489565|NCT01751386|3644034|P1|COMPLETED|Overall Study||18
1489566|NCT01751386|3644033|P2|STARTED|Overall Study||19
1489567|NCT01751386|3644034|P1|STARTED|Overall Study||20
1489568|NCT01751308|3644045|P5|NOT COMPLETED|Phase 2||0
1489569|NCT01751308|3644046|P4|NOT COMPLETED|Phase 2||0
1489570|NCT01751308|3644047|P3|NOT COMPLETED|Phase 2||0
1489571|NCT01751308|3644048|P2|NOT COMPLETED|Phase 2||0
1489572|NCT01751308|3644049|P1|NOT COMPLETED|Phase 2||0
1489573|NCT01751308|3644045|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
1489574|NCT01751308|3644046|P4|COMPLETED|Phase 2||0
1489575|NCT01751308|3644047|P3|COMPLETED|Phase 2||0
1489576|NCT01751308|3644048|P2|COMPLETED|Phase 2||0
1489577|NCT01751308|3644049|P1|COMPLETED|Phase 2||0
1489578|NCT01751308|3644045|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
1489579|NCT01751308|3644046|P4|STARTED|Phase 2||0
1489580|NCT01751308|3644047|P3|STARTED|Phase 2||0
1489581|NCT01751308|3644048|P2|STARTED|Phase 2||0
1489582|NCT01751308|3644049|P1|STARTED|Phase 2||0
1489583|NCT01751308|3644045|P5|NOT COMPLETED|Phase 1||0
1489584|NCT01751308|3644046|P4|NOT COMPLETED|Phase 1||0
1489585|NCT01751308|3644047|P3|NOT COMPLETED|Phase 1||0
1489586|NCT01751308|3644048|P2|NOT COMPLETED|Phase 1||0
1489587|NCT01751308|3644049|P1|NOT COMPLETED|Phase 1||0
1489588|NCT01751308|3644045|P5|COMPLETED|Phase 1||0
1489589|NCT01751308|3644046|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
1489590|NCT01751308|3644047|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
1489591|NCT01751308|3644048|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
1489592|NCT01751308|3644049|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
1489593|NCT01751308|3644045|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
1489594|NCT01751308|3644046|P4|STARTED|Phase 1||7
1489595|NCT01751308|3644047|P3|STARTED|Phase 1||7
1489596|NCT01751308|3644048|P2|STARTED|Phase 1||3
1489597|NCT01751308|3644049|P1|STARTED|Phase 1||6
1489598|NCT01751178|3644089|P3|NOT COMPLETED|Overall Study||2
1489599|NCT01751178|3644090|P2|NOT COMPLETED|Overall Study||0
1489600|NCT01751178|3644091|P1|NOT COMPLETED|Overall Study||3
1489601|NCT01751178|3644089|P3|COMPLETED|Overall Study||105
1489602|NCT01751178|3644090|P2|COMPLETED|Overall Study||109
1489603|NCT01751178|3644091|P1|COMPLETED|Overall Study||105
1489604|NCT01751178|3644089|P3|STARTED|Overall Study||107
1489605|NCT01751178|3644090|P2|STARTED|Overall Study||109
1489606|NCT01751178|3644091|P1|STARTED|Overall Study||108
1489607|NCT01751165|3644111|P3|NOT COMPLETED|Overall Study||3
1489608|NCT01751165|3644112|P2|NOT COMPLETED|Overall Study||3
1489609|NCT01751165|3644113|P1|NOT COMPLETED|Overall Study||2
1489610|NCT01751165|3644111|P3|COMPLETED|Overall Study||113
1489611|NCT01751165|3644112|P2|COMPLETED|Overall Study||116
1489612|NCT01751165|3644113|P1|COMPLETED|Overall Study||117
1489613|NCT01751165|3644111|P3|STARTED|Overall Study||116
1489614|NCT01751165|3644112|P2|STARTED|Overall Study||119
1489615|NCT01751165|3644113|P1|STARTED|Overall Study||119
1489616|NCT01751113|3644153|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
1489617|NCT01751113|3644154|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1489618|NCT01751113|3644155|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1489619|NCT01751113|3644156|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1489620|NCT01751113|3644157|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1489621|NCT01751113|3644158|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
1489622|NCT01751113|3644153|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
1489623|NCT01751113|3644154|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
1489624|NCT01751113|3644155|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
1489625|NCT01751113|3644156|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
1489626|NCT01751113|3644157|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
1489627|NCT01751113|3644158|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
1489628|NCT01751113|3644153|P6|STARTED|Treatment Period 3 (4 Weeks)||10
1489629|NCT01751113|3644154|P5|STARTED|Treatment Period 3 (4 Weeks)||8
1489630|NCT01751113|3644155|P4|STARTED|Treatment Period 3 (4 Weeks)||8
1489631|NCT01751113|3644156|P3|STARTED|Treatment Period 3 (4 Weeks)||9
1489632|NCT01751113|3644157|P2|STARTED|Treatment Period 3 (4 Weeks)||8
1489633|NCT01751113|3644158|P1|STARTED|Treatment Period 3 (4 Weeks)||8
1489634|NCT01751113|3644153|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1489635|NCT01751113|3644154|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1489636|NCT01751113|3644155|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1489637|NCT01751113|3644156|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1489638|NCT01751113|3644157|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1489639|NCT01751113|3644158|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
1489640|NCT01751113|3644153|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
1489641|NCT01751113|3644154|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
1489642|NCT01751113|3644155|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
1489643|NCT01751113|3644156|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
1489644|NCT01751113|3644157|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
1489645|NCT01751113|3644158|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
1489646|NCT01751113|3644153|P6|STARTED|Washout Period 2 (2 Weeks)||10
1489647|NCT01751113|3644154|P5|STARTED|Washout Period 2 (2 Weeks)||8
1489648|NCT01751113|3644155|P4|STARTED|Washout Period 2 (2 Weeks)||8
1489649|NCT01751113|3644156|P3|STARTED|Washout Period 2 (2 Weeks)||9
1489650|NCT01751113|3644157|P2|STARTED|Washout Period 2 (2 Weeks)||8
1489651|NCT01751113|3644158|P1|STARTED|Washout Period 2 (2 Weeks)||8
1489652|NCT01751113|3644153|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1489653|NCT01751113|3644154|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1489654|NCT01751113|3644155|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1489655|NCT01751113|3644156|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1489656|NCT01751113|3644157|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1489657|NCT01751113|3644158|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
1489658|NCT01751113|3644153|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
1489659|NCT01751113|3644154|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
1489660|NCT01751113|3644155|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
1489661|NCT01751113|3644156|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
1489662|NCT01751113|3644157|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
1489663|NCT01751113|3644158|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
1489664|NCT01751113|3644153|P6|STARTED|Treatment Period 2 (4 Weeks)||10
1489665|NCT01751113|3644154|P5|STARTED|Treatment Period 2 (4 Weeks)||8
1489666|NCT01751113|3644155|P4|STARTED|Treatment Period 2 (4 Weeks)||8
1489667|NCT01751113|3644156|P3|STARTED|Treatment Period 2 (4 Weeks)||9
1489668|NCT01751113|3644157|P2|STARTED|Treatment Period 2 (4 Weeks)||8
1489669|NCT01751113|3644158|P1|STARTED|Treatment Period 2 (4 Weeks)||8
1489670|NCT01751113|3644153|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1489671|NCT01751113|3644154|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1489672|NCT01751113|3644155|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1489673|NCT01751113|3644156|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1489674|NCT01751113|3644157|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1489675|NCT01751113|3644158|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
1489676|NCT01751113|3644153|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
1489677|NCT01751113|3644154|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
1489678|NCT01751113|3644155|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
1489679|NCT01751113|3644156|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
1489680|NCT01751113|3644157|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
1489681|NCT01751113|3644158|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
1489682|NCT01751113|3644153|P6|STARTED|Washout Period 1 (2 Weeks)||10
1489683|NCT01751113|3644154|P5|STARTED|Washout Period 1 (2 Weeks)||8
1489684|NCT01751113|3644155|P4|STARTED|Washout Period 1 (2 Weeks)||8
1489685|NCT01751113|3644156|P3|STARTED|Washout Period 1 (2 Weeks)||9
1489686|NCT01751113|3644157|P2|STARTED|Washout Period 1 (2 Weeks)||8
1489687|NCT01751113|3644158|P1|STARTED|Washout Period 1 (2 Weeks)||8
1489688|NCT01751113|3644153|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1489689|NCT01751113|3644154|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
1489690|NCT01751113|3644155|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
1489691|NCT01751113|3644156|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1489692|NCT01751113|3644157|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1489693|NCT01751113|3644158|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
1489694|NCT01751113|3644153|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
1489695|NCT01751113|3644154|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
1489696|NCT01751113|3644155|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
1489697|NCT01751113|3644156|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
1489698|NCT01751113|3644157|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
1489699|NCT01751113|3644158|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
1489700|NCT01751113|3644153|P6|STARTED|Treatment Period 1 (4 Weeks)||10
1489701|NCT01751113|3644154|P5|STARTED|Treatment Period 1 (4 Weeks)||9
1489702|NCT01751113|3644155|P4|STARTED|Treatment Period 1 (4 Weeks)||9
1489703|NCT01751113|3644156|P3|STARTED|Treatment Period 1 (4 Weeks)||9
1489704|NCT01751113|3644157|P2|STARTED|Treatment Period 1 (4 Weeks)||8
1489705|NCT01751113|3644158|P1|STARTED|Treatment Period 1 (4 Weeks)||8
1489706|NCT01751087|3644199|P3|NOT COMPLETED|Overall Study||1
1489707|NCT01751087|3644200|P2|NOT COMPLETED|Overall Study||0
1489708|NCT01751087|3644201|P1|NOT COMPLETED|Overall Study||1
1489709|NCT01751087|3644199|P3|COMPLETED|Overall Study||99
1489710|NCT01751087|3644200|P2|COMPLETED|Overall Study||100
1489711|NCT01751087|3644201|P1|COMPLETED|Overall Study||99
1489712|NCT01751087|3644199|P3|STARTED|Overall Study||100
1489713|NCT01751087|3644200|P2|STARTED|Overall Study||100
1489714|NCT01751087|3644201|P1|STARTED|Overall Study||100
1489715|NCT01751022|3644236|P3|NOT COMPLETED|Overall Study||27
1489716|NCT01751022|3644237|P2|NOT COMPLETED|Overall Study||44
1489717|NCT01751022|3644238|P1|NOT COMPLETED|Overall Study||56
1489718|NCT01751022|3644236|P3|COMPLETED|Overall Study|6 month visit|273
1489719|NCT01751022|3644237|P2|COMPLETED|Overall Study|6 month visit|282
1489720|NCT01751022|3644238|P1|COMPLETED|Overall Study|6 month visit|443
1489721|NCT01751022|3644236|P3|STARTED|Overall Study||300
1489722|NCT01751022|3644237|P2|STARTED|Overall Study||326
1489723|NCT01751022|3644238|P1|STARTED|Overall Study||499
1489724|NCT01750931|3644270|P2|NOT COMPLETED|Period 2||0
1489725|NCT01750931|3644271|P1|NOT COMPLETED|Period 2||0
1489726|NCT01750931|3644270|P2|COMPLETED|Period 2||14
1489727|NCT01750931|3644271|P1|COMPLETED|Period 2||14
1489728|NCT01750931|3644270|P2|STARTED|Period 2||14
1489729|NCT01750931|3644271|P1|STARTED|Period 2||14
1489730|NCT01750931|3644270|P2|NOT COMPLETED|Wash Out||0
1489731|NCT01750931|3644271|P1|NOT COMPLETED|Wash Out||0
1489732|NCT01750931|3644270|P2|COMPLETED|Wash Out||14
1489733|NCT01750931|3644271|P1|COMPLETED|Wash Out||14
1489734|NCT01750931|3644270|P2|STARTED|Wash Out||14
1489735|NCT01750931|3644271|P1|STARTED|Wash Out||14
1489736|NCT01750931|3644270|P2|NOT COMPLETED|Period 1||0
1489737|NCT01750931|3644271|P1|NOT COMPLETED|Period 1||0
1489738|NCT01750931|3644270|P2|COMPLETED|Period 1||14
1489739|NCT01750931|3644271|P1|COMPLETED|Period 1||14
1489740|NCT01750931|3644270|P2|STARTED|Period 1||14
1489741|NCT01750931|3644271|P1|STARTED|Period 1||14
1489742|NCT01750840|3644289|P1|NOT COMPLETED|Overall Study||4
1489743|NCT01750840|3644289|P1|COMPLETED|Overall Study||4
1489744|NCT01750840|3644289|P1|STARTED|Overall Study||8
1489745|NCT01750684|3644296|P2|NOT COMPLETED|Overall Study||2
1489746|NCT01750684|3644297|P1|NOT COMPLETED|Overall Study||2
1489747|NCT01750684|3644296|P2|COMPLETED|Overall Study||5
1489748|NCT01750684|3644297|P1|COMPLETED|Overall Study||4
1489749|NCT01750684|3644296|P2|STARTED|Overall Study||7
1489750|NCT01750684|3644297|P1|STARTED|Overall Study||6
1489751|NCT01750502|3644307|P2|NOT COMPLETED|Overall Study||0
1489752|NCT01750502|3644308|P1|NOT COMPLETED|Overall Study||0
1489753|NCT01750502|3644307|P2|COMPLETED|Overall Study||186
1489754|NCT01750502|3644308|P1|COMPLETED|Overall Study||70
1489755|NCT01750502|3644307|P2|STARTED|Overall Study||186
1489756|NCT01750502|3644308|P1|STARTED|Overall Study||70
1489757|NCT01750398|3644321|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
1489758|NCT01750398|3644321|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
1489759|NCT01750398|3644321|P1|STARTED|Bipolar Androgen Thearpy Phase||29
1489760|NCT01750398|3644321|P1|NOT COMPLETED|ADT Lead In Phase||4
1489761|NCT01750398|3644321|P1|COMPLETED|ADT Lead In Phase||29
1489762|NCT01750398|3644321|P1|STARTED|ADT Lead In Phase||33
1489763|NCT01750346|3644334|P3|NOT COMPLETED|Overall Study||0
1489764|NCT01750346|3644335|P2|NOT COMPLETED|Overall Study||0
1489765|NCT01750346|3644336|P1|NOT COMPLETED|Overall Study||1
1489766|NCT01750346|3644334|P3|COMPLETED|Overall Study||3
1489767|NCT01750346|3644335|P2|COMPLETED|Overall Study||2
1489768|NCT01750346|3644336|P1|COMPLETED|Overall Study||2
1489769|NCT01750346|3644334|P3|STARTED|Overall Study||3
1489770|NCT01750346|3644335|P2|STARTED|Overall Study||2
1489771|NCT01750346|3644336|P1|STARTED|Overall Study||3
1489772|NCT01750294|3644362|P1|NOT COMPLETED|Overall Study||2
1489773|NCT01750294|3644362|P1|COMPLETED|Overall Study||12
1489774|NCT01750294|3644362|P1|STARTED|Overall Study||14
1489775|NCT01750281|3644369|P3|NOT COMPLETED|Overall Study||84
1489776|NCT01750281|3644370|P2|NOT COMPLETED|Overall Study||85
1489777|NCT01750281|3644371|P1|NOT COMPLETED|Overall Study||43
1489778|NCT01750281|3644369|P3|COMPLETED|Overall Study||0
1489779|NCT01750281|3644370|P2|COMPLETED|Overall Study||0
1489780|NCT01750281|3644371|P1|COMPLETED|Overall Study||0
1489781|NCT01750281|3644369|P3|Did Not Receive Treatment|Overall Study||0
1489782|NCT01750281|3644370|P2|Did Not Receive Treatment|Overall Study||1
1489783|NCT01750281|3644371|P1|Did Not Receive Treatment|Overall Study||0
1489784|NCT01750281|3644369|P3|Received Treatment|Overall Study||84
1489785|NCT01750281|3644370|P2|Received Treatment|Overall Study||84
1489786|NCT01750281|3644371|P1|Received Treatment|Overall Study||43
1489787|NCT01750281|3644369|P3|STARTED|Overall Study||84
1489788|NCT01750281|3644370|P2|STARTED|Overall Study||85
1489789|NCT01750281|3644371|P1|STARTED|Overall Study||43
1489790|NCT01750255|3644384|P2|NOT COMPLETED|Overall Study||5
1489791|NCT01750255|3644385|P1|NOT COMPLETED|Overall Study||6
1489792|NCT01750255|3644384|P2|COMPLETED|Overall Study||38
1489793|NCT01750255|3644385|P1|COMPLETED|Overall Study||43
1489794|NCT01750255|3644384|P2|STARTED|Overall Study||43
1489795|NCT01750255|3644385|P1|STARTED|Overall Study||49
1489796|NCT01750242|3644401|P1|NOT COMPLETED|Overall Study||3
1489797|NCT01750242|3644401|P1|COMPLETED|Overall Study||20
1489798|NCT01750242|3644401|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
1489799|NCT01750242|3644401|P1|STARTED|Overall Study||23
1489800|NCT01750229|3644406|P1|NOT COMPLETED|Long-term Follow-up Phase||3
1489801|NCT01750229|3644406|P1|COMPLETED|Long-term Follow-up Phase||25
1489802|NCT01750229|3644406|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
1489803|NCT01750229|3644406|P1|NOT COMPLETED|Randomized Crossover Phase||2
1489804|NCT01750229|3644406|P1|COMPLETED|Randomized Crossover Phase||28
1489805|NCT01750229|3644406|P1|Protocol Violation|Randomized Crossover Phase||4
1489806|NCT01750229|3644406|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
1489807|NCT01750229|3644406|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
1489808|NCT01750229|3644406|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
1489809|NCT01750229|3644406|P1|Subject Received Sham|Randomized Crossover Phase||24
1489810|NCT01750229|3644406|P1|STARTED|Randomized Crossover Phase||30
1489811|NCT01750086|3644418|P2|NOT COMPLETED|Overall Study||1
1489812|NCT01750086|3644419|P1|NOT COMPLETED|Overall Study||1
1489813|NCT01750086|3644418|P2|COMPLETED|Overall Study||13
1489814|NCT01750086|3644419|P1|COMPLETED|Overall Study||12
1489815|NCT01750086|3644418|P2|STARTED|Overall Study||14
1489816|NCT01750086|3644419|P1|STARTED|Overall Study||13
1489817|NCT01749982|3644429|P4|NOT COMPLETED|Overall Study||3
1489818|NCT01749982|3644430|P3|NOT COMPLETED|Overall Study||0
1489819|NCT01749982|3644431|P2|NOT COMPLETED|Overall Study||0
1489820|NCT01749982|3644432|P1|NOT COMPLETED|Overall Study||0
1489821|NCT01749982|3644429|P4|COMPLETED|Overall Study||12
1489822|NCT01749982|3644430|P3|COMPLETED|Overall Study||15
1489823|NCT01749982|3644431|P2|COMPLETED|Overall Study||15
1489824|NCT01749982|3644432|P1|COMPLETED|Overall Study||15
1489825|NCT01749982|3644429|P4|STARTED|Overall Study||15
1489826|NCT01749982|3644430|P3|STARTED|Overall Study||15
1489827|NCT01749982|3644431|P2|STARTED|Overall Study||15
1489828|NCT01749982|3644432|P1|STARTED|Overall Study||15
1489829|NCT01749956|3644450|P1|NOT COMPLETED|Overall Study||15
1489830|NCT01749956|3644450|P1|COMPLETED|Overall Study||24
1489831|NCT01749956|3644450|P1|STARTED|Overall Study||39
1489832|NCT01749930|3644462|P2|NOT COMPLETED|Overall Study||12
1489833|NCT01749930|3644463|P1|NOT COMPLETED|Overall Study||30
1489834|NCT01749930|3644462|P2|COMPLETED|Overall Study|randomized population|125
1489835|NCT01749930|3644463|P1|COMPLETED|Overall Study|randomized population|253
1489836|NCT01749930|3644462|P2|STARTED|Overall Study|randomized population|137
1489837|NCT01749930|3644463|P1|STARTED|Overall Study|randomized population|283
1489838|NCT01749904|3644479|P2|NOT COMPLETED|Overall Study||11
1489839|NCT01749904|3644480|P1|NOT COMPLETED|Overall Study||22
1489840|NCT01749904|3644479|P2|COMPLETED|Overall Study|randomized population|123
1489841|NCT01749904|3644480|P1|COMPLETED|Overall Study|randomized population|264
1489842|NCT01749904|3644479|P2|STARTED|Overall Study|randomized population|134
1489843|NCT01749904|3644480|P1|STARTED|Overall Study|randomized population|286
1489844|NCT01749800|3644497|P3|NOT COMPLETED|Overall Study||0
1489845|NCT01749800|3644498|P2|NOT COMPLETED|Overall Study||1
1489846|NCT01749800|3644499|P1|NOT COMPLETED|Overall Study||3
1489847|NCT01749800|3644497|P3|COMPLETED|Overall Study||0
1489848|NCT01749800|3644498|P2|COMPLETED|Overall Study||0
1489849|NCT01749800|3644499|P1|COMPLETED|Overall Study||3
1489850|NCT01749800|3644497|P3|STARTED|Overall Study||0
1489851|NCT01749800|3644498|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
1489852|NCT01749800|3644499|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
1489853|NCT01749735|3644509|P2|NOT COMPLETED|Overall Study||0
1489854|NCT01749735|3644510|P1|NOT COMPLETED|Overall Study||1
1489855|NCT01749735|3644509|P2|COMPLETED|Overall Study||0
1489856|NCT01749735|3644510|P1|COMPLETED|Overall Study||1
1489857|NCT01749735|3644509|P2|STARTED|Overall Study||0
1489858|NCT01749735|3644510|P1|STARTED|Overall Study||2
1489859|NCT01749631|3644518|P1|NOT COMPLETED|Overall Study||0
1489860|NCT01749631|3644518|P1|COMPLETED|Overall Study||97
1489861|NCT01749631|3644518|P1|STARTED|Overall Study||97
1489862|NCT01749605|3644530|P2|NOT COMPLETED|Overall Study||3
1489863|NCT01749605|3644531|P1|NOT COMPLETED|Overall Study||4
1489864|NCT01749605|3644530|P2|COMPLETED|Overall Study||14
1489865|NCT01749605|3644531|P1|COMPLETED|Overall Study||14
1489866|NCT01749605|3644530|P2|STARTED|Overall Study||17
1489867|NCT01749605|3644531|P1|STARTED|Overall Study||18
1489868|NCT01749501|3644539|P2|NOT COMPLETED|Overall Study||0
1489869|NCT01749501|3644540|P1|NOT COMPLETED|Overall Study||0
1489870|NCT01749501|3644539|P2|COMPLETED|Overall Study||23
1489871|NCT01749501|3644540|P1|COMPLETED|Overall Study||22
1489872|NCT01749501|3644539|P2|STARTED|Overall Study||23
1489873|NCT01749501|3644540|P1|STARTED|Overall Study||22
1489874|NCT01749410|3644548|P1|NOT COMPLETED|Overall Study||0
1489875|NCT01749410|3644548|P1|COMPLETED|Overall Study||33
1489876|NCT01749410|3644548|P1|STARTED|Overall Study||33
1489877|NCT01748955|3644554|P2|NOT COMPLETED|Overall Study||5
1489878|NCT01748955|3644555|P1|NOT COMPLETED|Overall Study||3
1489879|NCT01748955|3644554|P2|COMPLETED|Overall Study||4
1489880|NCT01748955|3644555|P1|COMPLETED|Overall Study||3
1489881|NCT01748955|3644554|P2|STARTED|Overall Study||9
1489882|NCT01748955|3644555|P1|STARTED|Overall Study||6
1489883|NCT01748942|3644565|P2|NOT COMPLETED|Overall Study||4
1489884|NCT01748942|3644566|P1|NOT COMPLETED|Overall Study||4
1489885|NCT01748942|3644565|P2|COMPLETED|Overall Study||33
1489886|NCT01748942|3644566|P1|COMPLETED|Overall Study||35
1489887|NCT01748942|3644565|P2|STARTED|Overall Study||37
1489888|NCT01748942|3644566|P1|STARTED|Overall Study||39
1489889|NCT01748916|3644586|P6|NOT COMPLETED|Overall Study||0
1489890|NCT01748916|3644587|P5|NOT COMPLETED|Overall Study||0
1489891|NCT01748916|3644588|P4|NOT COMPLETED|Overall Study||0
1489892|NCT01748916|3644589|P3|NOT COMPLETED|Overall Study||0
1489893|NCT01748916|3644590|P2|NOT COMPLETED|Overall Study||0
1489894|NCT01748916|3644591|P1|NOT COMPLETED|Overall Study||0
1489895|NCT01748916|3644586|P6|COMPLETED|Overall Study||3
1489896|NCT01748916|3644587|P5|COMPLETED|Overall Study||3
1489897|NCT01748916|3644588|P4|COMPLETED|Overall Study||3
1489898|NCT01748916|3644589|P3|COMPLETED|Overall Study||2
1489899|NCT01748916|3644590|P2|COMPLETED|Overall Study||3
1489900|NCT01748916|3644591|P1|COMPLETED|Overall Study||2
1489901|NCT01748916|3644586|P6|STARTED|Overall Study||3
1489902|NCT01748916|3644587|P5|STARTED|Overall Study||3
1489903|NCT01748916|3644588|P4|STARTED|Overall Study||3
1489904|NCT01748916|3644589|P3|STARTED|Overall Study||2
1489905|NCT01748916|3644590|P2|STARTED|Overall Study||3
1489906|NCT01748916|3644591|P1|STARTED|Overall Study||2
1489907|NCT01748890|3644599|P1|NOT COMPLETED|Overall Study||4
1489908|NCT01748890|3644599|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
1489909|NCT01748890|3644599|P1|STARTED|Overall Study||4
1489910|NCT01748799|3644611|P8|NOT COMPLETED|Overall Study||0
1489911|NCT01748799|3644612|P7|NOT COMPLETED|Overall Study||1
1489912|NCT01748799|3644613|P6|NOT COMPLETED|Overall Study||1
1489913|NCT01748799|3644614|P5|NOT COMPLETED|Overall Study||0
1489914|NCT01748799|3644615|P4|NOT COMPLETED|Overall Study||0
1489915|NCT01748799|3644616|P3|NOT COMPLETED|Overall Study||0
1489916|NCT01748799|3644617|P2|NOT COMPLETED|Overall Study||0
1489917|NCT01748799|3644618|P1|NOT COMPLETED|Overall Study||5
1489918|NCT01748799|3644611|P8|COMPLETED|Overall Study||1
1489919|NCT01748799|3644612|P7|COMPLETED|Overall Study||1
1489920|NCT01748799|3644613|P6|COMPLETED|Overall Study||1
1489921|NCT01748799|3644614|P5|COMPLETED|Overall Study||1
1489922|NCT01748799|3644615|P4|COMPLETED|Overall Study||2
1489923|NCT01748799|3644616|P3|COMPLETED|Overall Study||1
1489924|NCT01748799|3644617|P2|COMPLETED|Overall Study||1
1489925|NCT01748799|3644618|P1|COMPLETED|Overall Study||1
1489926|NCT01748799|3644611|P8|Completed Self-titrated Sativex|Overall Study||1
1489927|NCT01748799|3644612|P7|Completed Self-titrated Sativex|Overall Study||1
1489928|NCT01748799|3644613|P6|Completed Self-titrated Sativex|Overall Study||1
1489929|NCT01748799|3644614|P5|Completed Self-titrated Sativex|Overall Study||1
1489930|NCT01748799|3644615|P4|Completed Self-titrated Sativex|Overall Study||2
1489931|NCT01748799|3644616|P3|Completed Self-titrated Sativex|Overall Study||1
1489932|NCT01748799|3644617|P2|Completed Self-titrated Sativex|Overall Study||1
1489933|NCT01748799|3644618|P1|Completed Self-titrated Sativex|Overall Study||1
1489934|NCT01748799|3644611|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
1489935|NCT01748799|3644612|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
1489936|NCT01748799|3644613|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
1489937|NCT01748799|3644614|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
1489938|NCT01748799|3644615|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
1489939|NCT01748799|3644616|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
1489940|NCT01748799|3644617|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
1489941|NCT01748799|3644618|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
1489942|NCT01748799|3644611|P8|Completed Self-titrated Placebo|Overall Study||1
1489943|NCT01748799|3644612|P7|Completed Self-titrated Placebo|Overall Study||1
1489944|NCT01748799|3644613|P6|Completed Self-titrated Placebo|Overall Study||2
1489945|NCT01748799|3644614|P5|Completed Self-titrated Placebo|Overall Study||1
1489946|NCT01748799|3644615|P4|Completed Self-titrated Placebo|Overall Study||2
1489947|NCT01748799|3644616|P3|Completed Self-titrated Placebo|Overall Study||1
1489948|NCT01748799|3644617|P2|Completed Self-titrated Placebo|Overall Study||1
1489949|NCT01748799|3644618|P1|Completed Self-titrated Placebo|Overall Study||4
1489950|NCT01748799|3644611|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
1489951|NCT01748799|3644612|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
1489952|NCT01748799|3644613|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
1489953|NCT01748799|3644614|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
1489954|NCT01748799|3644615|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
1489955|NCT01748799|3644616|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
1489956|NCT01748799|3644617|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
1489957|NCT01748799|3644618|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
1489958|NCT01748799|3644611|P8|Completed Fixed Dose Sativex|Overall Study||1
1489959|NCT01748799|3644612|P7|Completed Fixed Dose Sativex|Overall Study||1
1489960|NCT01748799|3644613|P6|Completed Fixed Dose Sativex|Overall Study||1
1489961|NCT01748799|3644614|P5|Completed Fixed Dose Sativex|Overall Study||1
1489962|NCT01748799|3644615|P4|Completed Fixed Dose Sativex|Overall Study||2
1489963|NCT01748799|3644616|P3|Completed Fixed Dose Sativex|Overall Study||1
1489964|NCT01748799|3644617|P2|Completed Fixed Dose Sativex|Overall Study||1
1489965|NCT01748799|3644618|P1|Completed Fixed Dose Sativex|Overall Study||1
1489966|NCT01748799|3644611|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
1489967|NCT01748799|3644612|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
1489968|NCT01748799|3644613|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
1489969|NCT01748799|3644614|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
1489970|NCT01748799|3644615|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
1489971|NCT01748799|3644616|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
1489972|NCT01748799|3644617|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
1489973|NCT01748799|3644618|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
1489974|NCT01748799|3644611|P8|Completed Fixed Dose Placebo|Overall Study||1
1489975|NCT01748799|3644612|P7|Completed Fixed Dose Placebo|Overall Study||1
1489976|NCT01748799|3644613|P6|Completed Fixed Dose Placebo|Overall Study||1
1489977|NCT01748799|3644614|P5|Completed Fixed Dose Placebo|Overall Study||1
1489978|NCT01748799|3644615|P4|Completed Fixed Dose Placebo|Overall Study||2
1489979|NCT01748799|3644616|P3|Completed Fixed Dose Placebo|Overall Study||1
1489980|NCT01748799|3644617|P2|Completed Fixed Dose Placebo|Overall Study||1
1489981|NCT01748799|3644618|P1|Completed Fixed Dose Placebo|Overall Study||2
1489982|NCT01748799|3644611|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
1489983|NCT01748799|3644612|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
1489984|NCT01748799|3644613|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
1489985|NCT01748799|3644614|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
1489986|NCT01748799|3644615|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
1489987|NCT01748799|3644616|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
1489988|NCT01748799|3644617|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
1489989|NCT01748799|3644618|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
1489990|NCT01748799|3644611|P8|STARTED|Overall Study||1
1489991|NCT01748799|3644612|P7|STARTED|Overall Study||2
1489992|NCT01748799|3644613|P6|STARTED|Overall Study||2
1489993|NCT01748799|3644614|P5|STARTED|Overall Study||1
1489994|NCT01748799|3644615|P4|STARTED|Overall Study||2
1489995|NCT01748799|3644616|P3|STARTED|Overall Study||1
1489996|NCT01748799|3644617|P2|STARTED|Overall Study||1
1489997|NCT01748799|3644618|P1|STARTED|Overall Study||6
1489998|NCT01748760|3644654|P2|NOT COMPLETED|Overall Study||2
1489999|NCT01748760|3644655|P1|NOT COMPLETED|Overall Study||6
1490000|NCT01748760|3644654|P2|COMPLETED|Overall Study||23
1490001|NCT01748760|3644655|P1|COMPLETED|Overall Study||19
1490002|NCT01748760|3644654|P2|STARTED|Overall Study||25
1490003|NCT01748760|3644655|P1|STARTED|Overall Study||25
1490004|NCT01748695|3644661|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
1490005|NCT01748695|3644662|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
1490006|NCT01748695|3644661|P2|COMPLETED|Second Intervention (4 Weeks)||11
1490007|NCT01748695|3644662|P1|COMPLETED|Second Intervention (4 Weeks)||14
1490008|NCT01748695|3644661|P2|STARTED|Second Intervention (4 Weeks)||11
1490009|NCT01748695|3644662|P1|STARTED|Second Intervention (4 Weeks)||14
1490010|NCT01748695|3644661|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
1490011|NCT01748695|3644662|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
1490012|NCT01748695|3644661|P2|COMPLETED|First Intervention (4 Weeks)||11
1490013|NCT01748695|3644662|P1|COMPLETED|First Intervention (4 Weeks)||14
1490014|NCT01748695|3644661|P2|STARTED|First Intervention (4 Weeks)||11
1490015|NCT01748695|3644662|P1|STARTED|First Intervention (4 Weeks)||14
1490016|NCT01748643|3644672|P2|NOT COMPLETED|Overall Study||0
1490017|NCT01748643|3644673|P1|NOT COMPLETED|Overall Study||0
1490018|NCT01748643|3644672|P2|COMPLETED|Overall Study||30
1490019|NCT01748643|3644673|P1|COMPLETED|Overall Study||30
1490020|NCT01748643|3644672|P2|STARTED|Overall Study||30
1490021|NCT01748643|3644673|P1|STARTED|Overall Study||30
1490022|NCT01748292|3644691|P2|NOT COMPLETED|Overall Study||12
1490023|NCT01748292|3644692|P1|NOT COMPLETED|Overall Study||2
1490024|NCT01748292|3644691|P2|COMPLETED|Overall Study||28
1490025|NCT01748292|3644692|P1|COMPLETED|Overall Study||18
1490026|NCT01748292|3644691|P2|STARTED|Overall Study||40
1490027|NCT01748292|3644692|P1|STARTED|Overall Study||20
1490028|NCT01748240|3644708|P1|NOT COMPLETED|Overall Study||0
1490029|NCT01748240|3644708|P1|COMPLETED|Overall Study||21
1490030|NCT01748240|3644708|P1|STARTED|Overall Study||21
1490031|NCT01748227|3644712|P1|NOT COMPLETED|Overall Study||3
1490032|NCT01748227|3644712|P1|COMPLETED|Overall Study||17
1490033|NCT01748227|3644712|P1|STARTED|Overall Study||20
1490034|NCT01748162|3644722|P2|NOT COMPLETED|Overall Study||5
1490035|NCT01748162|3644723|P1|NOT COMPLETED|Overall Study||5
1490036|NCT01748162|3644722|P2|COMPLETED|Overall Study||0
1490037|NCT01748162|3644723|P1|COMPLETED|Overall Study||0
1490038|NCT01748162|3644722|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
1490039|NCT01748162|3644723|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
1490040|NCT01748162|3644722|P2|Completed 6 Month Initial Treatment|Overall Study||0
1490041|NCT01748162|3644723|P1|Completed 6 Month Initial Treatment|Overall Study||0
1490042|NCT01748162|3644722|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
1490043|NCT01748162|3644723|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
1490044|NCT01748162|3644722|P2|STARTED|Overall Study||5
1490045|NCT01748162|3644723|P1|STARTED|Overall Study||5
1490046|NCT01748071|3644734|P3|NOT COMPLETED|Overall Study||0
1490047|NCT01748071|3644735|P2|NOT COMPLETED|Overall Study||2
1490048|NCT01748071|3644736|P1|NOT COMPLETED|Overall Study||2
1490049|NCT01748071|3644734|P3|COMPLETED|Overall Study||40
1490050|NCT01748071|3644735|P2|COMPLETED|Overall Study||38
1490051|NCT01748071|3644736|P1|COMPLETED|Overall Study||38
1490052|NCT01748071|3644734|P3|STARTED|Overall Study||40
1490053|NCT01748071|3644735|P2|STARTED|Overall Study||40
1490054|NCT01748071|3644736|P1|STARTED|Overall Study||40
1490055|NCT01748045|3644758|P2|NOT COMPLETED|Overall Study||0
1490056|NCT01748045|3644759|P1|NOT COMPLETED|Overall Study||0
1490057|NCT01748045|3644758|P2|COMPLETED|Overall Study||1
1490058|NCT01748045|3644759|P1|COMPLETED|Overall Study||2
1490059|NCT01748045|3644758|P2|STARTED|Overall Study||1
1490060|NCT01748045|3644759|P1|STARTED|Overall Study||2
1490061|NCT01747928|3644785|P8|NOT COMPLETED|Overall Study||0
1490062|NCT01747928|3644786|P7|NOT COMPLETED|Overall Study||0
1490063|NCT01747928|3644787|P6|NOT COMPLETED|Overall Study||0
1490064|NCT01747928|3644788|P5|NOT COMPLETED|Overall Study||0
1490065|NCT01747928|3644789|P4|NOT COMPLETED|Overall Study||0
1490066|NCT01747928|3644790|P3|NOT COMPLETED|Overall Study||0
1490067|NCT01747928|3644791|P2|NOT COMPLETED|Overall Study||0
1490068|NCT01747928|3644792|P1|NOT COMPLETED|Overall Study||0
1490069|NCT01747928|3644785|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1490070|NCT01747928|3644786|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1490071|NCT01747928|3644787|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1490072|NCT01747928|3644788|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1490073|NCT01747928|3644789|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1490074|NCT01747928|3644790|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1490075|NCT01747928|3644791|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1490076|NCT01747928|3644792|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
1490077|NCT01747928|3644785|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1490078|NCT01747928|3644786|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1490079|NCT01747928|3644787|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1490080|NCT01747928|3644788|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1490081|NCT01747928|3644789|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1490082|NCT01747928|3644790|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1490083|NCT01747928|3644791|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1490084|NCT01747928|3644792|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
1490085|NCT01747850|3644999|P3|NOT COMPLETED|Overall Study||6
1490086|NCT01747850|3645000|P2|NOT COMPLETED|Overall Study||7
1490087|NCT01747850|3645001|P1|NOT COMPLETED|Overall Study||1
1490088|NCT01747850|3644999|P3|COMPLETED|Overall Study||14
1490089|NCT01747850|3645000|P2|COMPLETED|Overall Study||13
1490090|NCT01747850|3645001|P1|COMPLETED|Overall Study||4
1490091|NCT01747850|3644999|P3|STARTED|Overall Study||20
1490092|NCT01747850|3645000|P2|STARTED|Overall Study||20
1490093|NCT01747850|3645001|P1|STARTED|Overall Study||5
1490094|NCT01747811|3645023|P2|NOT COMPLETED|Overall Study||4
1490095|NCT01747811|3645024|P1|NOT COMPLETED|Overall Study||2
1490096|NCT01747811|3645023|P2|COMPLETED|Overall Study||12
1490097|NCT01747811|3645024|P1|COMPLETED|Overall Study||14
1490098|NCT01747811|3645023|P2|STARTED|Overall Study||16
1490099|NCT01747811|3645024|P1|STARTED|Overall Study||16
1490100|NCT01747772|3645040|P1|NOT COMPLETED|Overall Study||9
1490101|NCT01747772|3645040|P1|COMPLETED|Overall Study||171
1490102|NCT01747772|3645040|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
1490103|NCT01747772|3645040|P1|STARTED|Overall Study||180
1490104|NCT01747655|3645048|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
1490105|NCT01747655|3645049|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
1490106|NCT01747655|3645048|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
1490107|NCT01747655|3645049|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
1490108|NCT01747655|3645048|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
1490109|NCT01747655|3645049|P1|STARTED|PEG-J Period (Continued Treatment)||41
1490110|NCT01747655|3645048|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
1490111|NCT01747655|3645049|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
1490112|NCT01747655|3645048|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
1490113|NCT01747655|3645049|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
1490114|NCT01747655|3645048|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
1490115|NCT01747655|3645049|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
1490116|NCT01747655|3645048|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
1490117|NCT01747655|3645049|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
1490118|NCT01747655|3645048|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
1490119|NCT01747655|3645049|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
1490120|NCT01747655|3645048|P2|STARTED|Temporary Naso-jejunal Tube Period||0
1490121|NCT01747655|3645049|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
1490122|NCT01747629|3645079|P2|NOT COMPLETED|Overall Study||6
1490123|NCT01747629|3645080|P1|NOT COMPLETED|Overall Study||8
1490124|NCT01747629|3645079|P2|COMPLETED|Overall Study||69
1490125|NCT01747629|3645080|P1|COMPLETED|Overall Study||77
1490126|NCT01747629|3645079|P2|Treated|Overall Study|Safety set and full analysis set|75
1490127|NCT01747629|3645080|P1|Treated|Overall Study|Safety set and full analysis set|84
1490128|NCT01747629|3645079|P2|STARTED|Overall Study||75
1490129|NCT01747629|3645080|P1|STARTED|Overall Study||85
1490130|NCT01747551|3645114|P2|NOT COMPLETED|Overall Study||21
1490131|NCT01747551|3645115|P1|NOT COMPLETED|Overall Study||43
1490132|NCT01747551|3645114|P2|COMPLETED|Overall Study||0
1490133|NCT01747551|3645115|P1|COMPLETED|Overall Study||0
1490134|NCT01747551|3645114|P2|STARTED|Overall Study||21
1490135|NCT01747551|3645115|P1|STARTED|Overall Study||43
1490136|NCT01747343|3645127|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
1490137|NCT01747343|3645127|P1|COMPLETED|Underwear/Differential Reinforcement||4
1490138|NCT01747343|3645127|P1|STARTED|Underwear/Differential Reinforcement||4
1490139|NCT01747343|3645127|P1|NOT COMPLETED|Underwear||0
1490140|NCT01747343|3645127|P1|COMPLETED|Underwear||4
1490141|NCT01747343|3645127|P1|STARTED|Underwear||4
1490142|NCT01747343|3645127|P1|NOT COMPLETED|Baseline||0
1490143|NCT01747343|3645127|P1|COMPLETED|Baseline||4
1490144|NCT01747343|3645127|P1|STARTED|Baseline||4
1490145|NCT01747330|3645133|P1|NOT COMPLETED|Overall Study||0
1490146|NCT01747330|3645133|P1|COMPLETED|Overall Study||40
1490147|NCT01747330|3645133|P1|STARTED|Overall Study||40
1490148|NCT01746979|3645147|P2|NOT COMPLETED|Overall Study||347
1490149|NCT01746979|3645148|P1|NOT COMPLETED|Overall Study||346
1490150|NCT01746979|3645147|P2|COMPLETED|Overall Study||0
1490151|NCT01746979|3645148|P1|COMPLETED|Overall Study||0
1490152|NCT01746979|3645147|P2|STARTED|Overall Study||347
1490153|NCT01746979|3645148|P1|STARTED|Overall Study||346
1490154|NCT01746940|3645160|P4|NOT COMPLETED|Safety Second Phase||0
1490155|NCT01746940|3645161|P3|NOT COMPLETED|Safety Second Phase||0
1490156|NCT01746940|3645162|P2|NOT COMPLETED|Safety Second Phase||0
1490157|NCT01746940|3645163|P1|NOT COMPLETED|Safety Second Phase||0
1490158|NCT01746940|3645160|P4|COMPLETED|Safety Second Phase||0
1490159|NCT01746940|3645161|P3|COMPLETED|Safety Second Phase||0
1490160|NCT01746940|3645162|P2|COMPLETED|Safety Second Phase||18
1490161|NCT01746940|3645163|P1|COMPLETED|Safety Second Phase||18
1490162|NCT01746940|3645160|P4|STARTED|Safety Second Phase||0
1490163|NCT01746940|3645161|P3|STARTED|Safety Second Phase||0
1490164|NCT01746940|3645162|P2|STARTED|Safety Second Phase||18
1490165|NCT01746940|3645163|P1|STARTED|Safety Second Phase||18
1490166|NCT01746940|3645160|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
1490167|NCT01746940|3645161|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
1490168|NCT01746940|3645162|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
1490169|NCT01746940|3645163|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
1490170|NCT01746940|3645160|P4|COMPLETED|Safety and Efficacy First Phase||0
1490171|NCT01746940|3645161|P3|COMPLETED|Safety and Efficacy First Phase||40
1490172|NCT01746940|3645162|P2|COMPLETED|Safety and Efficacy First Phase||41
1490173|NCT01746940|3645163|P1|COMPLETED|Safety and Efficacy First Phase||39
1490174|NCT01746940|3645160|P4|STARTED|Safety and Efficacy First Phase||3
1490175|NCT01746940|3645161|P3|STARTED|Safety and Efficacy First Phase||40
1490176|NCT01746940|3645162|P2|STARTED|Safety and Efficacy First Phase||41
1490177|NCT01746940|3645163|P1|STARTED|Safety and Efficacy First Phase||39
1490178|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1490179|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1490180|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1490181|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1490182|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1490183|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1490184|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1490185|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1490186|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
1490187|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Sixth Intervention||5
1490188|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Sixth Intervention||6
1490189|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Sixth Intervention||5
1490190|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Sixth Intervention||5
1490191|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Sixth Intervention||6
1490192|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Sixth Intervention||5
1490193|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Sixth Intervention||0
1490194|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Sixth Intervention||0
1490195|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Sixth Intervention||0
1490196|NCT01746901|3645171|P9|STARTED|Treatment Phase: Sixth Intervention||5
1490197|NCT01746901|3645172|P8|STARTED|Treatment Phase: Sixth Intervention||6
1490198|NCT01746901|3645173|P7|STARTED|Treatment Phase: Sixth Intervention||5
1490199|NCT01746901|3645174|P6|STARTED|Treatment Phase: Sixth Intervention||5
1490200|NCT01746901|3645175|P5|STARTED|Treatment Phase: Sixth Intervention||6
1490201|NCT01746901|3645176|P4|STARTED|Treatment Phase: Sixth Intervention||5
1490202|NCT01746901|3645177|P3|STARTED|Treatment Phase: Sixth Intervention||0
1490203|NCT01746901|3645178|P2|STARTED|Treatment Phase: Sixth Intervention||0
1490204|NCT01746901|3645179|P1|STARTED|Treatment Phase: Sixth Intervention||0
1490205|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1490206|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1490207|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1490208|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1490209|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1490210|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1490211|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1490212|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1490213|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Washout Period 5||0
1490214|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Washout Period 5||5
1490215|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Washout Period 5||6
1490216|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Washout Period 5||5
1490217|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Washout Period 5||5
1490218|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Washout Period 5||6
1490219|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Washout Period 5||5
1490220|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Washout Period 5||0
1490221|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Washout Period 5||0
1490222|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Washout Period 5||0
1490223|NCT01746901|3645171|P9|STARTED|Treatment Phase: Washout Period 5||5
1490224|NCT01746901|3645172|P8|STARTED|Treatment Phase: Washout Period 5||6
1490225|NCT01746901|3645173|P7|STARTED|Treatment Phase: Washout Period 5||5
1490226|NCT01746901|3645174|P6|STARTED|Treatment Phase: Washout Period 5||5
1490227|NCT01746901|3645175|P5|STARTED|Treatment Phase: Washout Period 5||6
1490228|NCT01746901|3645176|P4|STARTED|Treatment Phase: Washout Period 5||5
1490229|NCT01746901|3645177|P3|STARTED|Treatment Phase: Washout Period 5||0
1490230|NCT01746901|3645178|P2|STARTED|Treatment Phase: Washout Period 5||0
1490231|NCT01746901|3645179|P1|STARTED|Treatment Phase: Washout Period 5||0
1490232|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1490233|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1490234|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1490235|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1490236|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1490237|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1490238|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1490239|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1490240|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
1490241|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Fifth Intervention||5
1490242|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Fifth Intervention||6
1490243|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Fifth Intervention||5
1490244|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Fifth Intervention||5
1490245|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Fifth Intervention||6
1490246|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Fifth Intervention||5
1490247|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Fifth Intervention||0
1490248|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Fifth Intervention||0
1490249|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Fifth Intervention||0
1490250|NCT01746901|3645171|P9|STARTED|Treatment Phase: Fifth Intervention||5
1490251|NCT01746901|3645172|P8|STARTED|Treatment Phase: Fifth Intervention||6
1490252|NCT01746901|3645173|P7|STARTED|Treatment Phase: Fifth Intervention||5
1490253|NCT01746901|3645174|P6|STARTED|Treatment Phase: Fifth Intervention||5
1490254|NCT01746901|3645175|P5|STARTED|Treatment Phase: Fifth Intervention||6
1490255|NCT01746901|3645176|P4|STARTED|Treatment Phase: Fifth Intervention||5
1490256|NCT01746901|3645177|P3|STARTED|Treatment Phase: Fifth Intervention||0
1490257|NCT01746901|3645178|P2|STARTED|Treatment Phase: Fifth Intervention||0
1490258|NCT01746901|3645179|P1|STARTED|Treatment Phase: Fifth Intervention||0
1490259|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1490260|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1490261|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1490262|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1490263|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1490264|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1490265|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1490266|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1490267|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Washout Period 4||0
1490268|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Washout Period 4||5
1490269|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Washout Period 4||6
1490270|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Washout Period 4||5
1490271|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Washout Period 4||5
1490272|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Washout Period 4||6
1490273|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Washout Period 4||5
1490274|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Washout Period 4||0
1490275|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Washout Period 4||0
1490276|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Washout Period 4||0
1490277|NCT01746901|3645171|P9|STARTED|Treatment Phase: Washout Period 4||5
1490278|NCT01746901|3645172|P8|STARTED|Treatment Phase: Washout Period 4||6
1490279|NCT01746901|3645173|P7|STARTED|Treatment Phase: Washout Period 4||5
1490280|NCT01746901|3645174|P6|STARTED|Treatment Phase: Washout Period 4||5
1490281|NCT01746901|3645175|P5|STARTED|Treatment Phase: Washout Period 4||6
1490282|NCT01746901|3645176|P4|STARTED|Treatment Phase: Washout Period 4||5
1490283|NCT01746901|3645177|P3|STARTED|Treatment Phase: Washout Period 4||0
1490284|NCT01746901|3645178|P2|STARTED|Treatment Phase: Washout Period 4||0
1490285|NCT01746901|3645179|P1|STARTED|Treatment Phase: Washout Period 4||0
1490286|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
1490287|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1490288|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
1490289|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
1490290|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1490291|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
1490292|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1490293|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1490294|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
1490295|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Fourth Intervention||5
1490296|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Fourth Intervention||6
1490297|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Fourth Intervention||5
1490298|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Fourth Intervention||5
1490299|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Fourth Intervention||6
1490300|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Fourth Intervention||5
1490301|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
1490302|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
1490303|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
1490304|NCT01746901|3645171|P9|STARTED|Treatment Phase: Fourth Intervention||7
1490305|NCT01746901|3645172|P8|STARTED|Treatment Phase: Fourth Intervention||6
1490306|NCT01746901|3645173|P7|STARTED|Treatment Phase: Fourth Intervention||6
1490307|NCT01746901|3645174|P6|STARTED|Treatment Phase: Fourth Intervention||6
1490308|NCT01746901|3645175|P5|STARTED|Treatment Phase: Fourth Intervention||6
1490309|NCT01746901|3645176|P4|STARTED|Treatment Phase: Fourth Intervention||6
1490310|NCT01746901|3645177|P3|STARTED|Treatment Phase: Fourth Intervention||0
1490311|NCT01746901|3645178|P2|STARTED|Treatment Phase: Fourth Intervention||0
1490312|NCT01746901|3645179|P1|STARTED|Treatment Phase: Fourth Intervention||0
1490313|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1490314|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1490315|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1490316|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1490317|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1490318|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1490319|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1490320|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1490321|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
1490322|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Washout Period 3||7
1490323|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Washout Period 3||6
1490324|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Washout Period 3||6
1490325|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Washout Period 3||6
1490326|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Washout Period 3||6
1490327|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Washout Period 3||6
1490328|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Washout Period 3||0
1490329|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Washout Period 3||0
1490330|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Washout Period 3||0
1490331|NCT01746901|3645171|P9|STARTED|Treatment Phase: Washout Period 3||7
1490332|NCT01746901|3645172|P8|STARTED|Treatment Phase: Washout Period 3||6
1490333|NCT01746901|3645173|P7|STARTED|Treatment Phase: Washout Period 3||6
1490334|NCT01746901|3645174|P6|STARTED|Treatment Phase: Washout Period 3||6
1490335|NCT01746901|3645175|P5|STARTED|Treatment Phase: Washout Period 3||6
1490336|NCT01746901|3645176|P4|STARTED|Treatment Phase: Washout Period 3||6
1490337|NCT01746901|3645177|P3|STARTED|Treatment Phase: Washout Period 3||0
1490338|NCT01746901|3645178|P2|STARTED|Treatment Phase: Washout Period 3||0
1490339|NCT01746901|3645179|P1|STARTED|Treatment Phase: Washout Period 3||0
1490340|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Third Intervention||0
1490341|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
1490342|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Third Intervention||1
1490343|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Third Intervention||1
1490344|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
1490345|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
1490346|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
1490347|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
1490348|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
1490349|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Third Intervention||7
1490350|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Third Intervention||6
1490351|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Third Intervention||6
1490352|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Third Intervention||6
1490353|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Third Intervention||6
1490354|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Third Intervention||6
1490355|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Third Intervention||0
1490356|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Third Intervention||0
1490357|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Third Intervention||0
1490358|NCT01746901|3645171|P9|STARTED|Treatment Phase: Third Intervention||7
1490359|NCT01746901|3645172|P8|STARTED|Treatment Phase: Third Intervention||6
1490360|NCT01746901|3645173|P7|STARTED|Treatment Phase: Third Intervention||7
1490361|NCT01746901|3645174|P6|STARTED|Treatment Phase: Third Intervention||7
1490362|NCT01746901|3645175|P5|STARTED|Treatment Phase: Third Intervention||6
1490363|NCT01746901|3645176|P4|STARTED|Treatment Phase: Third Intervention||6
1490364|NCT01746901|3645177|P3|STARTED|Treatment Phase: Third Intervention||0
1490365|NCT01746901|3645178|P2|STARTED|Treatment Phase: Third Intervention||0
1490366|NCT01746901|3645179|P1|STARTED|Treatment Phase: Third Intervention||0
1490367|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1490368|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1490369|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1490370|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1490371|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1490372|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1490373|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1490374|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1490375|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
1490376|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Washout Period 2||7
1490377|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Washout Period 2||6
1490378|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Washout Period 2||7
1490379|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Washout Period 2||7
1490380|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Washout Period 2||6
1490381|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Washout Period 2||6
1490382|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Washout Period 2||0
1490383|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Washout Period 2||0
1490384|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Washout Period 2||0
1490385|NCT01746901|3645171|P9|STARTED|Treatment Phase: Washout Period 2||7
1490386|NCT01746901|3645172|P8|STARTED|Treatment Phase: Washout Period 2||6
1490387|NCT01746901|3645173|P7|STARTED|Treatment Phase: Washout Period 2||7
1490388|NCT01746901|3645174|P6|STARTED|Treatment Phase: Washout Period 2||7
1490389|NCT01746901|3645175|P5|STARTED|Treatment Phase: Washout Period 2||6
1490390|NCT01746901|3645176|P4|STARTED|Treatment Phase: Washout Period 2||6
1490391|NCT01746901|3645177|P3|STARTED|Treatment Phase: Washout Period 2||0
1490392|NCT01746901|3645178|P2|STARTED|Treatment Phase: Washout Period 2||0
1490393|NCT01746901|3645179|P1|STARTED|Treatment Phase: Washout Period 2||0
1490394|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
1490395|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Second Intervention||1
1490396|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
1490397|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
1490398|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
1490399|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
1490400|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
1490401|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
1490402|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
1490403|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Second Intervention||7
1490404|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Second Intervention||6
1490405|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Second Intervention||7
1490406|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Second Intervention||7
1490407|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Second Intervention||6
1490408|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Second Intervention||6
1490409|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Second Intervention||0
1490410|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Second Intervention||0
1490411|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Second Intervention||0
1490412|NCT01746901|3645171|P9|STARTED|Treatment Phase: Second Intervention||7
1490413|NCT01746901|3645172|P8|STARTED|Treatment Phase: Second Intervention||7
1490414|NCT01746901|3645173|P7|STARTED|Treatment Phase: Second Intervention||7
1490415|NCT01746901|3645174|P6|STARTED|Treatment Phase: Second Intervention||7
1490416|NCT01746901|3645175|P5|STARTED|Treatment Phase: Second Intervention||6
1490417|NCT01746901|3645176|P4|STARTED|Treatment Phase: Second Intervention||6
1490418|NCT01746901|3645177|P3|STARTED|Treatment Phase: Second Intervention||0
1490419|NCT01746901|3645178|P2|STARTED|Treatment Phase: Second Intervention||0
1490420|NCT01746901|3645179|P1|STARTED|Treatment Phase: Second Intervention||0
1490421|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1490422|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1490423|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1490424|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1490425|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1490426|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1490427|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1490428|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1490429|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
1490430|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: Washout Period 1||7
1490431|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: Washout Period 1||7
1490432|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: Washout Period 1||7
1490433|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: Washout Period 1||7
1490434|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: Washout Period 1||6
1490435|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: Washout Period 1||6
1490436|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: Washout Period 1||0
1490437|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: Washout Period 1||0
1490438|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: Washout Period 1||0
1490439|NCT01746901|3645171|P9|STARTED|Treatment Phase: Washout Period 1||7
1490440|NCT01746901|3645172|P8|STARTED|Treatment Phase: Washout Period 1||7
1490441|NCT01746901|3645173|P7|STARTED|Treatment Phase: Washout Period 1||7
1490442|NCT01746901|3645174|P6|STARTED|Treatment Phase: Washout Period 1||7
1490443|NCT01746901|3645175|P5|STARTED|Treatment Phase: Washout Period 1||6
1490444|NCT01746901|3645176|P4|STARTED|Treatment Phase: Washout Period 1||6
1490445|NCT01746901|3645177|P3|STARTED|Treatment Phase: Washout Period 1||0
1490446|NCT01746901|3645178|P2|STARTED|Treatment Phase: Washout Period 1||0
1490447|NCT01746901|3645179|P1|STARTED|Treatment Phase: Washout Period 1||0
1490448|NCT01746901|3645171|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
1490449|NCT01746901|3645172|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
1490450|NCT01746901|3645173|P7|NOT COMPLETED|Treatment Phase: First Intervention||1
1490451|NCT01746901|3645174|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
1490452|NCT01746901|3645175|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
1490453|NCT01746901|3645176|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
1490454|NCT01746901|3645177|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
1490455|NCT01746901|3645178|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
1490456|NCT01746901|3645179|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
1490457|NCT01746901|3645171|P9|COMPLETED|Treatment Phase: First Intervention||7
1490458|NCT01746901|3645172|P8|COMPLETED|Treatment Phase: First Intervention||7
1490459|NCT01746901|3645173|P7|COMPLETED|Treatment Phase: First Intervention||7
1490460|NCT01746901|3645174|P6|COMPLETED|Treatment Phase: First Intervention||7
1490461|NCT01746901|3645175|P5|COMPLETED|Treatment Phase: First Intervention||6
1490462|NCT01746901|3645176|P4|COMPLETED|Treatment Phase: First Intervention||6
1490463|NCT01746901|3645177|P3|COMPLETED|Treatment Phase: First Intervention||0
1490464|NCT01746901|3645178|P2|COMPLETED|Treatment Phase: First Intervention||0
1490465|NCT01746901|3645179|P1|COMPLETED|Treatment Phase: First Intervention||0
1490466|NCT01746901|3645171|P9|STARTED|Treatment Phase: First Intervention||7
1490467|NCT01746901|3645172|P8|STARTED|Treatment Phase: First Intervention||7
1490468|NCT01746901|3645173|P7|STARTED|Treatment Phase: First Intervention||8
1490469|NCT01746901|3645174|P6|STARTED|Treatment Phase: First Intervention||7
1490470|NCT01746901|3645175|P5|STARTED|Treatment Phase: First Intervention||6
1490471|NCT01746901|3645176|P4|STARTED|Treatment Phase: First Intervention||6
1490472|NCT01746901|3645177|P3|STARTED|Treatment Phase: First Intervention||0
1490473|NCT01746901|3645178|P2|STARTED|Treatment Phase: First Intervention||0
1490474|NCT01746901|3645179|P1|STARTED|Treatment Phase: First Intervention||0
1490475|NCT01746901|3645171|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1490476|NCT01746901|3645172|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1490477|NCT01746901|3645173|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1490478|NCT01746901|3645174|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1490479|NCT01746901|3645175|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1490480|NCT01746901|3645176|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1490481|NCT01746901|3645177|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
1490482|NCT01746901|3645178|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
1490483|NCT01746901|3645179|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1490484|NCT01746901|3645171|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
1490485|NCT01746901|3645172|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
1490486|NCT01746901|3645173|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
1490487|NCT01746901|3645174|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
1490488|NCT01746901|3645175|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
1490489|NCT01746901|3645176|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
1490490|NCT01746901|3645177|P3|COMPLETED|Drug Discrimination Phase: Day 2||22
1490491|NCT01746901|3645178|P2|COMPLETED|Drug Discrimination Phase: Day 2||19
1490492|NCT01746901|3645179|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
1490493|NCT01746901|3645171|P9|STARTED|Drug Discrimination Phase: Day 2||0
1490494|NCT01746901|3645172|P8|STARTED|Drug Discrimination Phase: Day 2||0
1490495|NCT01746901|3645173|P7|STARTED|Drug Discrimination Phase: Day 2||0
1490496|NCT01746901|3645174|P6|STARTED|Drug Discrimination Phase: Day 2||0
1490497|NCT01746901|3645175|P5|STARTED|Drug Discrimination Phase: Day 2||0
1490498|NCT01746901|3645176|P4|STARTED|Drug Discrimination Phase: Day 2||0
1490499|NCT01746901|3645177|P3|STARTED|Drug Discrimination Phase: Day 2||36
1490500|NCT01746901|3645178|P2|STARTED|Drug Discrimination Phase: Day 2||33
1490501|NCT01746901|3645179|P1|STARTED|Drug Discrimination Phase: Day 2||0
1490502|NCT01746901|3645171|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1490503|NCT01746901|3645172|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1490504|NCT01746901|3645173|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1490505|NCT01746901|3645174|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1490506|NCT01746901|3645175|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1490507|NCT01746901|3645176|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1490508|NCT01746901|3645177|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1490509|NCT01746901|3645178|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
1490510|NCT01746901|3645179|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1490511|NCT01746901|3645171|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
1490512|NCT01746901|3645172|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
1490513|NCT01746901|3645173|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
1490514|NCT01746901|3645174|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
1490515|NCT01746901|3645175|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
1490516|NCT01746901|3645176|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
1490517|NCT01746901|3645177|P3|COMPLETED|Drug Discrimination Phase: Day 1||36
1490518|NCT01746901|3645178|P2|COMPLETED|Drug Discrimination Phase: Day 1||33
1490519|NCT01746901|3645179|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
1490520|NCT01746901|3645171|P9|STARTED|Drug Discrimination Phase: Day 1||0
1490521|NCT01746901|3645172|P8|STARTED|Drug Discrimination Phase: Day 1||0
1490522|NCT01746901|3645173|P7|STARTED|Drug Discrimination Phase: Day 1||0
1490523|NCT01746901|3645174|P6|STARTED|Drug Discrimination Phase: Day 1||0
1490524|NCT01746901|3645175|P5|STARTED|Drug Discrimination Phase: Day 1||0
1490525|NCT01746901|3645176|P4|STARTED|Drug Discrimination Phase: Day 1||0
1490526|NCT01746901|3645177|P3|STARTED|Drug Discrimination Phase: Day 1||36
1490527|NCT01746901|3645178|P2|STARTED|Drug Discrimination Phase: Day 1||36
1490528|NCT01746901|3645179|P1|STARTED|Drug Discrimination Phase: Day 1||0
1490529|NCT01746901|3645171|P9|NOT COMPLETED|Naloxone Challenge Phase||0
1490530|NCT01746901|3645172|P8|NOT COMPLETED|Naloxone Challenge Phase||0
1490531|NCT01746901|3645173|P7|NOT COMPLETED|Naloxone Challenge Phase||0
1490532|NCT01746901|3645174|P6|NOT COMPLETED|Naloxone Challenge Phase||0
1490533|NCT01746901|3645175|P5|NOT COMPLETED|Naloxone Challenge Phase||0
1490534|NCT01746901|3645176|P4|NOT COMPLETED|Naloxone Challenge Phase||0
1490535|NCT01746901|3645177|P3|NOT COMPLETED|Naloxone Challenge Phase||0
1490536|NCT01746901|3645178|P2|NOT COMPLETED|Naloxone Challenge Phase||0
1490537|NCT01746901|3645179|P1|NOT COMPLETED|Naloxone Challenge Phase||3
1490538|NCT01746901|3645171|P9|COMPLETED|Naloxone Challenge Phase||0
1490539|NCT01746901|3645172|P8|COMPLETED|Naloxone Challenge Phase||0
1490540|NCT01746901|3645173|P7|COMPLETED|Naloxone Challenge Phase||0
1490541|NCT01746901|3645174|P6|COMPLETED|Naloxone Challenge Phase||0
1490542|NCT01746901|3645175|P5|COMPLETED|Naloxone Challenge Phase||0
1490543|NCT01746901|3645176|P4|COMPLETED|Naloxone Challenge Phase||0
1490544|NCT01746901|3645177|P3|COMPLETED|Naloxone Challenge Phase||0
1490545|NCT01746901|3645178|P2|COMPLETED|Naloxone Challenge Phase||0
1490546|NCT01746901|3645179|P1|COMPLETED|Naloxone Challenge Phase||72
1490547|NCT01746901|3645171|P9|STARTED|Naloxone Challenge Phase||0
1490548|NCT01746901|3645172|P8|STARTED|Naloxone Challenge Phase||0
1490549|NCT01746901|3645173|P7|STARTED|Naloxone Challenge Phase||0
1490550|NCT01746901|3645174|P6|STARTED|Naloxone Challenge Phase||0
1490551|NCT01746901|3645175|P5|STARTED|Naloxone Challenge Phase||0
1490552|NCT01746901|3645176|P4|STARTED|Naloxone Challenge Phase||0
1490553|NCT01746901|3645177|P3|STARTED|Naloxone Challenge Phase||0
1490554|NCT01746901|3645178|P2|STARTED|Naloxone Challenge Phase||0
1490555|NCT01746901|3645179|P1|STARTED|Naloxone Challenge Phase||75
1490556|NCT01746862|3645502|P2|NOT COMPLETED|Overall Study||3
1490557|NCT01746862|3645503|P1|NOT COMPLETED|Overall Study||8
1490558|NCT01746862|3645502|P2|COMPLETED|Overall Study||27
1490559|NCT01746862|3645503|P1|COMPLETED|Overall Study||52
1490560|NCT01746862|3645502|P2|Treated|Overall Study||30
1490561|NCT01746862|3645503|P1|Treated|Overall Study||59
1490562|NCT01746862|3645502|P2|STARTED|Overall Study||30
1490563|NCT01746862|3645503|P1|STARTED|Overall Study||60
1490564|NCT01746784|3645528|P5|NOT COMPLETED|Overall Study||0
1490565|NCT01746784|3645529|P4|NOT COMPLETED|Overall Study||0
1490566|NCT01746784|3645530|P3|NOT COMPLETED|Overall Study||0
1490567|NCT01746784|3645531|P2|NOT COMPLETED|Overall Study||0
1490568|NCT01746784|3645532|P1|NOT COMPLETED|Overall Study||0
1490569|NCT01746784|3645528|P5|COMPLETED|Overall Study||19
1490570|NCT01746784|3645529|P4|COMPLETED|Overall Study||9
1490571|NCT01746784|3645530|P3|COMPLETED|Overall Study||9
1490572|NCT01746784|3645531|P2|COMPLETED|Overall Study||10
1490573|NCT01746784|3645532|P1|COMPLETED|Overall Study||19
1490574|NCT01746784|3645528|P5|Enrolled|Overall Study||19
1490575|NCT01746784|3645529|P4|Enrolled|Overall Study||9
1490576|NCT01746784|3645530|P3|Enrolled|Overall Study||9
1490577|NCT01746784|3645531|P2|Enrolled|Overall Study||10
1490578|NCT01746784|3645532|P1|Enrolled|Overall Study||19
1490579|NCT01746784|3645528|P5|STARTED|Overall Study||19
1490580|NCT01746784|3645529|P4|STARTED|Overall Study||9
1490581|NCT01746784|3645530|P3|STARTED|Overall Study||9
1490582|NCT01746784|3645531|P2|STARTED|Overall Study||10
1490583|NCT01746784|3645532|P1|STARTED|Overall Study||19
1490584|NCT01746732|3645554|P3|NOT COMPLETED|Period 2||4
1490585|NCT01746732|3645555|P2|NOT COMPLETED|Period 2||0
1490586|NCT01746732|3645556|P1|NOT COMPLETED|Period 2||0
1490587|NCT01746732|3645554|P3|COMPLETED|Period 2||7
1490588|NCT01746732|3645555|P2|COMPLETED|Period 2||10
1490589|NCT01746732|3645556|P1|COMPLETED|Period 2||0
1490590|NCT01746732|3645554|P3|STARTED|Period 2||11
1490591|NCT01746732|3645555|P2|STARTED|Period 2||10
1490592|NCT01746732|3645556|P1|STARTED|Period 2||0
1490593|NCT01746732|3645554|P3|NOT COMPLETED|Period 1||0
1490594|NCT01746732|3645555|P2|NOT COMPLETED|Period 1||1
1490595|NCT01746732|3645556|P1|NOT COMPLETED|Period 1||0
1490596|NCT01746732|3645554|P3|COMPLETED|Period 1||11
1490597|NCT01746732|3645555|P2|COMPLETED|Period 1||10
1490598|NCT01746732|3645556|P1|COMPLETED|Period 1||0
1490599|NCT01746732|3645554|P3|STARTED|Period 1||11
1490600|NCT01746732|3645555|P2|STARTED|Period 1||11
1490601|NCT01746732|3645556|P1|STARTED|Period 1||0
1490602|NCT01746732|3645554|P3|NOT COMPLETED|Lead-In Period||0
1490603|NCT01746732|3645555|P2|NOT COMPLETED|Lead-In Period||0
1490604|NCT01746732|3645556|P1|NOT COMPLETED|Lead-In Period||1
1490605|NCT01746732|3645554|P3|COMPLETED|Lead-In Period||0
1490606|NCT01746732|3645555|P2|COMPLETED|Lead-In Period||0
1490607|NCT01746732|3645556|P1|COMPLETED|Lead-In Period||22
1490608|NCT01746732|3645554|P3|Participants Received at Least 1 Dose|Lead-In Period||0
1490609|NCT01746732|3645555|P2|Participants Received at Least 1 Dose|Lead-In Period||0
1490610|NCT01746732|3645556|P1|Participants Received at Least 1 Dose|Lead-In Period||22
1490611|NCT01746732|3645554|P3|STARTED|Lead-In Period||0
1490612|NCT01746732|3645555|P2|STARTED|Lead-In Period||0
1490613|NCT01746732|3645556|P1|STARTED|Lead-In Period||23
1490614|NCT01746511|3645579|P2|NOT COMPLETED|Overall Study||0
1490615|NCT01746511|3645580|P1|NOT COMPLETED|Overall Study||0
1490616|NCT01746511|3645579|P2|COMPLETED|Overall Study||39
1490617|NCT01746511|3645580|P1|COMPLETED|Overall Study||40
1490618|NCT01746511|3645579|P2|STARTED|Overall Study||39
1490619|NCT01746511|3645580|P1|STARTED|Overall Study||40
1490620|NCT01746368|3645596|P2|NOT COMPLETED|Overall Study||1
1490621|NCT01746368|3645597|P1|NOT COMPLETED|Overall Study||2
1490622|NCT01746368|3645596|P2|COMPLETED|Overall Study||16
1490623|NCT01746368|3645597|P1|COMPLETED|Overall Study||31
1490624|NCT01746368|3645596|P2|Analyzed for Satisfaction|Overall Study||16
1490625|NCT01746368|3645597|P1|Analyzed for Satisfaction|Overall Study||30
1490626|NCT01746368|3645596|P2|Analyzed for AD Completion Rate|Overall Study||17
1490627|NCT01746368|3645597|P1|Analyzed for AD Completion Rate|Overall Study||32
1490628|NCT01746368|3645596|P2|Assessment Completed|Overall Study||16
1490629|NCT01746368|3645597|P1|Assessment Completed|Overall Study||31
1490630|NCT01746368|3645596|P2|Recieved Allocated Intervention|Overall Study||8
1490631|NCT01746368|3645597|P1|Recieved Allocated Intervention|Overall Study||31
1490632|NCT01746368|3645596|P2|STARTED|Overall Study||17
1490633|NCT01746368|3645597|P1|STARTED|Overall Study||33
1490634|NCT01746264|3645605|P1|NOT COMPLETED|Overall Study||0
1490635|NCT01746264|3645605|P1|COMPLETED|Overall Study||19
1490636|NCT01746264|3645605|P1|STARTED|Overall Study||19
1490637|NCT01746173|3645624|P1|NOT COMPLETED|Overall Study||2
1490638|NCT01746173|3645624|P1|COMPLETED|Overall Study||3
1490639|NCT01746173|3645624|P1|STARTED|Overall Study||5
1490640|NCT01746108|3645632|P3|NOT COMPLETED|Overall Study||0
1490641|NCT01746108|3645633|P2|NOT COMPLETED|Overall Study||4
1490642|NCT01746108|3645634|P1|NOT COMPLETED|Overall Study||0
1490643|NCT01746108|3645632|P3|COMPLETED|Overall Study||6
1490644|NCT01746108|3645633|P2|COMPLETED|Overall Study||24
1490645|NCT01746108|3645634|P1|COMPLETED|Overall Study||18
1490646|NCT01746108|3645632|P3|STARTED|Overall Study||6
1490647|NCT01746108|3645633|P2|STARTED|Overall Study||28
1490648|NCT01746108|3645634|P1|STARTED|Overall Study||18
1490649|NCT01746043|3645674|P4|NOT COMPLETED|Overall Study||0
1490650|NCT01746043|3645675|P3|NOT COMPLETED|Overall Study||0
1490651|NCT01746043|3645676|P2|NOT COMPLETED|Overall Study||0
1490652|NCT01746043|3645677|P1|NOT COMPLETED|Overall Study||0
1490653|NCT01746043|3645674|P4|COMPLETED|Overall Study||5
1490654|NCT01746043|3645675|P3|COMPLETED|Overall Study||5
1490655|NCT01746043|3645676|P2|COMPLETED|Overall Study||4
1490656|NCT01746043|3645677|P1|COMPLETED|Overall Study||5
1490657|NCT01746043|3645674|P4|STARTED|Overall Study||5
1490658|NCT01746043|3645675|P3|STARTED|Overall Study||5
1490659|NCT01746043|3645676|P2|STARTED|Overall Study||4
1490660|NCT01746043|3645677|P1|STARTED|Overall Study||5
1490661|NCT01745952|3645687|P3|NOT COMPLETED|Overall Study||0
1490662|NCT01745952|3645688|P2|NOT COMPLETED|Overall Study||1
1490663|NCT01745952|3645689|P1|NOT COMPLETED|Overall Study||1
1490664|NCT01745952|3645687|P3|COMPLETED|Overall Study||3
1490665|NCT01745952|3645688|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
1490666|NCT01745952|3645689|P1|COMPLETED|Overall Study||3
1490667|NCT01745952|3645687|P3|STARTED|Overall Study||3
1490668|NCT01745952|3645688|P2|STARTED|Overall Study||4
1490669|NCT01745952|3645689|P1|STARTED|Overall Study||4
1490670|NCT01745913|3645715|P2|NOT COMPLETED|Overall Study||1
1490671|NCT01745913|3645716|P1|NOT COMPLETED|Overall Study||1
1490672|NCT01745913|3645715|P2|COMPLETED|Overall Study||0
1490673|NCT01745913|3645716|P1|COMPLETED|Overall Study||0
1490674|NCT01745913|3645715|P2|STARTED|Overall Study||1
1490675|NCT01745913|3645716|P1|STARTED|Overall Study||1
1490676|NCT01745848|3645732|P1|NOT COMPLETED|Overall Study||6
1490677|NCT01745848|3645732|P1|COMPLETED|Overall Study||20
1490678|NCT01745848|3645732|P1|STARTED|Overall Study||26
1490679|NCT01745393|3645739|P2|NOT COMPLETED|12-month Follow-up||5
1490680|NCT01745393|3645740|P1|NOT COMPLETED|12-month Follow-up||6
1490681|NCT01745393|3645739|P2|COMPLETED|12-month Follow-up||151
1490682|NCT01745393|3645740|P1|COMPLETED|12-month Follow-up||136
1490683|NCT01745393|3645739|P2|STARTED|12-month Follow-up||156
1490684|NCT01745393|3645740|P1|STARTED|12-month Follow-up||142
1490685|NCT01745393|3645739|P2|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
1490686|NCT01745393|3645740|P1|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
1490687|NCT01745393|3645739|P2|COMPLETED|Treatment to End-of-treatment Assessment||156
1490688|NCT01745393|3645740|P1|COMPLETED|Treatment to End-of-treatment Assessment||142
1490689|NCT01745393|3645739|P2|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
1490690|NCT01745393|3645740|P1|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
1490691|NCT01745393|3645739|P2|STARTED|Treatment to End-of-treatment Assessment||164
1490692|NCT01745393|3645740|P1|STARTED|Treatment to End-of-treatment Assessment||163
1490693|NCT01745380|3645752|P2|NOT COMPLETED|Overall Study||1
1490694|NCT01745380|3645753|P1|NOT COMPLETED|Overall Study||1
1490695|NCT01745380|3645752|P2|COMPLETED|Overall Study||49
1490696|NCT01745380|3645753|P1|COMPLETED|Overall Study||99
1490697|NCT01745380|3645752|P2|STARTED|Overall Study||50
1490698|NCT01745380|3645753|P1|STARTED|Overall Study||100
1490699|NCT01745146|3645791|P2|NOT COMPLETED|Overall Study||3
1490700|NCT01745146|3645792|P1|NOT COMPLETED|Overall Study||3
1490701|NCT01745146|3645791|P2|COMPLETED|Overall Study||57
1490702|NCT01745146|3645792|P1|COMPLETED|Overall Study||27
1490703|NCT01745146|3645791|P2|Analysis|Overall Study||57
1490704|NCT01745146|3645792|P1|Analysis|Overall Study||27
1490705|NCT01745146|3645791|P2|Primary Outcome Assessment|Overall Study||57
1490706|NCT01745146|3645792|P1|Primary Outcome Assessment|Overall Study||27
1490707|NCT01745146|3645791|P2|Allocation to Intervention|Overall Study||60
1490708|NCT01745146|3645792|P1|Allocation to Intervention|Overall Study||30
1490709|NCT01745146|3645791|P2|STARTED|Overall Study||60
1490710|NCT01745146|3645792|P1|STARTED|Overall Study||30
1490711|NCT01745133|3645802|P3|NOT COMPLETED|Overall Study||4
1490712|NCT01745133|3645803|P2|NOT COMPLETED|Overall Study||4
1490713|NCT01745133|3645804|P1|NOT COMPLETED|Overall Study||6
1490714|NCT01745133|3645802|P3|COMPLETED|Overall Study||15
1490715|NCT01745133|3645803|P2|COMPLETED|Overall Study||16
1490716|NCT01745133|3645804|P1|COMPLETED|Overall Study||13
1490717|NCT01745133|3645802|P3|STARTED|Overall Study||19
1490718|NCT01745133|3645803|P2|STARTED|Overall Study||20
1490719|NCT01745133|3645804|P1|STARTED|Overall Study||19
1490720|NCT01745094|3645816|P4|NOT COMPLETED|Overall Study||3
1490721|NCT01745094|3645817|P3|NOT COMPLETED|Overall Study||12
1490722|NCT01745094|3645818|P2|NOT COMPLETED|Overall Study||0
1490723|NCT01745094|3645819|P1|NOT COMPLETED|Overall Study||5
1490724|NCT01745094|3645816|P4|COMPLETED|Overall Study||90
1490725|NCT01745094|3645817|P3|COMPLETED|Overall Study||46
1490726|NCT01745094|3645818|P2|COMPLETED|Overall Study||37
1490727|NCT01745094|3645819|P1|COMPLETED|Overall Study||30
1490728|NCT01745094|3645816|P4|STARTED|Overall Study||93
1490729|NCT01745094|3645817|P3|STARTED|Overall Study||58
1490730|NCT01745094|3645818|P2|STARTED|Overall Study||37
1490731|NCT01745094|3645819|P1|STARTED|Overall Study||35
1490732|NCT01745055|3645885|P1|NOT COMPLETED|Overall Study||0
1490733|NCT01745055|3645885|P1|COMPLETED|Overall Study||12
1490734|NCT01745055|3645885|P1|STARTED|Overall Study||12
1490735|NCT01744977|3645920|P2|NOT COMPLETED|Overall Study||5
1490736|NCT01744977|3645921|P1|NOT COMPLETED|Overall Study||11
1490737|NCT01744977|3645920|P2|COMPLETED|Overall Study||115
1490738|NCT01744977|3645921|P1|COMPLETED|Overall Study||109
1490739|NCT01744977|3645920|P2|6 Month Completed|Overall Study||115
1490740|NCT01744977|3645921|P1|6 Month Completed|Overall Study||113
1490741|NCT01744977|3645920|P2|STARTED|Overall Study||120
1490742|NCT01744977|3645921|P1|STARTED|Overall Study||120
1490743|NCT01744860|3645929|P1|NOT COMPLETED|Overall Study||0
1490744|NCT01744860|3645929|P1|COMPLETED|Overall Study||420
1490745|NCT01744860|3645929|P1|STARTED|Overall Study||420
1490746|NCT01744821|3645967|P4|NOT COMPLETED|Overall Study||0
1490747|NCT01744821|3645968|P3|NOT COMPLETED|Overall Study||0
1490748|NCT01744821|3645969|P2|NOT COMPLETED|Overall Study||0
1490749|NCT01744821|3645970|P1|NOT COMPLETED|Overall Study||0
1490750|NCT01744821|3645967|P4|COMPLETED|Overall Study||1
1490751|NCT01744821|3645968|P3|COMPLETED|Overall Study||2
1490752|NCT01744821|3645969|P2|COMPLETED|Overall Study||3
1490753|NCT01744821|3645970|P1|COMPLETED|Overall Study||1
1490754|NCT01744821|3645967|P4|STARTED|Overall Study||1
1490755|NCT01744821|3645968|P3|STARTED|Overall Study||2
1490756|NCT01744821|3645969|P2|STARTED|Overall Study||3
1490757|NCT01744821|3645970|P1|STARTED|Overall Study||1
1490758|NCT01744782|3645992|P1|NOT COMPLETED|Overall Study||1
1490759|NCT01744782|3645992|P1|COMPLETED|Overall Study||16
1490760|NCT01744782|3645992|P1|STARTED|Overall Study||17
1490761|NCT01744730|3646005|P5|NOT COMPLETED|Overall Study||0
1490762|NCT01744730|3646006|P4|NOT COMPLETED|Overall Study||0
1490763|NCT01744730|3646007|P3|NOT COMPLETED|Overall Study||0
1490764|NCT01744730|3646008|P2|NOT COMPLETED|Overall Study||0
1490765|NCT01744730|3646009|P1|NOT COMPLETED|Overall Study||0
1490766|NCT01744730|3646005|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
1490767|NCT01744730|3646006|P4|COMPLETED|Overall Study||11
1490768|NCT01744730|3646007|P3|COMPLETED|Overall Study||4
1490769|NCT01744730|3646008|P2|COMPLETED|Overall Study||3
1490770|NCT01744730|3646009|P1|COMPLETED|Overall Study||4
1490771|NCT01744730|3646005|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
1490772|NCT01744730|3646006|P4|STARTED|Overall Study||11
1490773|NCT01744730|3646007|P3|STARTED|Overall Study||4
1490774|NCT01744730|3646008|P2|STARTED|Overall Study||3
1490775|NCT01744730|3646009|P1|STARTED|Overall Study||4
1490776|NCT01744691|3646052|P1|NOT COMPLETED|Overall Study||43
1490777|NCT01744691|3646052|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
1490778|NCT01744691|3646052|P1|STARTED|Overall Study|Participants who received study treatment|144
1490779|NCT01744574|3646061|P4|NOT COMPLETED|Overall Study||11
1490780|NCT01744574|3646062|P3|NOT COMPLETED|Overall Study||20
1490781|NCT01744574|3646063|P2|NOT COMPLETED|Overall Study||25
1490782|NCT01744574|3646064|P1|NOT COMPLETED|Overall Study||24
1490783|NCT01744574|3646061|P4|COMPLETED|Overall Study||40
1490784|NCT01744574|3646062|P3|COMPLETED|Overall Study||32
1490785|NCT01744574|3646063|P2|COMPLETED|Overall Study||31
1490786|NCT01744574|3646064|P1|COMPLETED|Overall Study||33
1490787|NCT01744574|3646061|P4|STARTED|Overall Study||51
1490788|NCT01744574|3646062|P3|STARTED|Overall Study||52
1490789|NCT01744574|3646063|P2|STARTED|Overall Study||56
1490790|NCT01744574|3646064|P1|STARTED|Overall Study||57
1490791|NCT01744496|3646100|P2|NOT COMPLETED|Maintenance Period||4
1490792|NCT01744496|3646101|P1|NOT COMPLETED|Maintenance Period||4
1490793|NCT01744496|3646100|P2|COMPLETED|Maintenance Period||29
1490794|NCT01744496|3646101|P1|COMPLETED|Maintenance Period||27
1490795|NCT01744496|3646100|P2|STARTED|Maintenance Period||33
1490796|NCT01744496|3646101|P1|STARTED|Maintenance Period||31
1490797|NCT01744496|3646100|P2|NOT COMPLETED|Titration Period||2
1490798|NCT01744496|3646101|P1|NOT COMPLETED|Titration Period||2
1490799|NCT01744496|3646100|P2|COMPLETED|Titration Period||33
1490800|NCT01744496|3646101|P1|COMPLETED|Titration Period||31
1490801|NCT01744496|3646100|P2|STARTED|Titration Period||35
1490802|NCT01744496|3646101|P1|STARTED|Titration Period||33
1490803|NCT01744483|3646122|P3|NOT COMPLETED|Overall Study||28
1490804|NCT01744483|3646123|P2|NOT COMPLETED|Overall Study||22
1490805|NCT01744483|3646124|P1|NOT COMPLETED|Overall Study||29
1490806|NCT01744483|3646122|P3|COMPLETED|Overall Study||10
1490807|NCT01744483|3646123|P2|COMPLETED|Overall Study||13
1490808|NCT01744483|3646124|P1|COMPLETED|Overall Study||15
1490809|NCT01744483|3646122|P3|STARTED|Overall Study||38
1490810|NCT01744483|3646123|P2|STARTED|Overall Study||35
1490811|NCT01744483|3646124|P1|STARTED|Overall Study||44
1490812|NCT01744392|3646132|P1|NOT COMPLETED|Overall Study||1
1490813|NCT01744392|3646132|P1|COMPLETED|Overall Study||22
1490814|NCT01744392|3646132|P1|STARTED|Overall Study||23
1490815|NCT01744353|3646148|P3|NOT COMPLETED|Overall Study||0
1490816|NCT01744353|3646149|P2|NOT COMPLETED|Overall Study||0
1490817|NCT01744353|3646150|P1|NOT COMPLETED|Overall Study||0
1490818|NCT01744353|3646148|P3|COMPLETED|Overall Study||3
1490819|NCT01744353|3646149|P2|COMPLETED|Overall Study||26
1490820|NCT01744353|3646150|P1|COMPLETED|Overall Study||6
1490821|NCT01744353|3646148|P3|STARTED|Overall Study||3
1490822|NCT01744353|3646149|P2|STARTED|Overall Study||26
1490823|NCT01744353|3646150|P1|STARTED|Overall Study||6
1490824|NCT01744340|3646161|P2|NOT COMPLETED|Overall Study||0
1490825|NCT01744340|3646162|P1|NOT COMPLETED|Overall Study||0
1490826|NCT01744340|3646161|P2|COMPLETED|Overall Study||15
1490827|NCT01744340|3646162|P1|COMPLETED|Overall Study||8
1490828|NCT01744340|3646161|P2|STARTED|Overall Study||15
1490829|NCT01744340|3646162|P1|STARTED|Overall Study||8
1490830|NCT01744197|3646172|P2|NOT COMPLETED|Overall Study||3
1490831|NCT01744197|3646173|P1|NOT COMPLETED|Overall Study||4
1490832|NCT01744197|3646172|P2|COMPLETED|Overall Study||26
1490833|NCT01744197|3646173|P1|COMPLETED|Overall Study||28
1490834|NCT01744197|3646172|P2|STARTED|Overall Study||29
1490835|NCT01744197|3646173|P1|STARTED|Overall Study||32
1490836|NCT01744093|3646185|P2|NOT COMPLETED|Overall Study||1
1490837|NCT01744093|3646186|P1|NOT COMPLETED|Overall Study||6
1490838|NCT01744093|3646185|P2|COMPLETED|Overall Study||8
1490839|NCT01744093|3646186|P1|COMPLETED|Overall Study||12
1490840|NCT01744093|3646185|P2|STARTED|Overall Study||9
1490841|NCT01744093|3646186|P1|STARTED|Overall Study||18
1490842|NCT01743963|3646196|P2|NOT COMPLETED|Overall Study||0
1490843|NCT01743963|3646197|P1|NOT COMPLETED|Overall Study||0
1490844|NCT01743963|3646196|P2|COMPLETED|Overall Study||17
1490845|NCT01743963|3646197|P1|COMPLETED|Overall Study||21
1490846|NCT01743963|3646196|P2|STARTED|Overall Study||17
1490847|NCT01743963|3646197|P1|STARTED|Overall Study||21
1490848|NCT01743729|3646205|P2|NOT COMPLETED|Overall Study||12
1490849|NCT01743729|3646206|P1|NOT COMPLETED|Overall Study||37
1490850|NCT01743729|3646205|P2|COMPLETED|Overall Study||348
1490851|NCT01743729|3646206|P1|COMPLETED|Overall Study||321
1490852|NCT01743729|3646205|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
1490853|NCT01743729|3646206|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
1490854|NCT01743521|3646218|P4|NOT COMPLETED|Overall Study||0
1490855|NCT01743521|3646219|P3|NOT COMPLETED|Overall Study||0
1490856|NCT01743521|3646220|P2|NOT COMPLETED|Overall Study||0
1490857|NCT01743521|3646221|P1|NOT COMPLETED|Overall Study||0
1490858|NCT01743521|3646218|P4|COMPLETED|Overall Study||2
1490859|NCT01743521|3646219|P3|COMPLETED|Overall Study||2
1490860|NCT01743521|3646220|P2|COMPLETED|Overall Study||3
1490861|NCT01743521|3646221|P1|COMPLETED|Overall Study||7
1490862|NCT01743521|3646218|P4|STARTED|Overall Study||2
1490863|NCT01743521|3646219|P3|STARTED|Overall Study||2
1490864|NCT01743521|3646220|P2|STARTED|Overall Study||3
1490865|NCT01743521|3646221|P1|STARTED|Overall Study||7
1490866|NCT01743469|3646275|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
1490867|NCT01743469|3646276|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
1490868|NCT01743469|3646277|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
1490869|NCT01743469|3646278|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
1490870|NCT01743469|3646275|P4|COMPLETED|Follow-up Period - Post-Treatment||5
1490871|NCT01743469|3646276|P3|COMPLETED|Follow-up Period - Post-Treatment||14
1490872|NCT01743469|3646277|P2|COMPLETED|Follow-up Period - Post-Treatment||5
1490873|NCT01743469|3646278|P1|COMPLETED|Follow-up Period - Post-Treatment||6
1490874|NCT01743469|3646275|P4|STARTED|Follow-up Period - Post-Treatment||21
1490875|NCT01743469|3646276|P3|STARTED|Follow-up Period - Post-Treatment||37
1490876|NCT01743469|3646277|P2|STARTED|Follow-up Period - Post-Treatment||53
1490877|NCT01743469|3646278|P1|STARTED|Follow-up Period - Post-Treatment||51
1490878|NCT01743469|3646275|P4|NOT COMPLETED|Active Treatment Phase||21
1490879|NCT01743469|3646276|P3|NOT COMPLETED|Active Treatment Phase||38
1490880|NCT01743469|3646277|P2|NOT COMPLETED|Active Treatment Phase||55
1490881|NCT01743469|3646278|P1|NOT COMPLETED|Active Treatment Phase||53
1490882|NCT01743469|3646275|P4|COMPLETED|Active Treatment Phase||0
1490883|NCT01743469|3646276|P3|COMPLETED|Active Treatment Phase||0
1490884|NCT01743469|3646277|P2|COMPLETED|Active Treatment Phase||0
1490885|NCT01743469|3646278|P1|COMPLETED|Active Treatment Phase||0
1490886|NCT01743469|3646275|P4|STARTED|Active Treatment Phase||21
1490887|NCT01743469|3646276|P3|STARTED|Active Treatment Phase||38
1490888|NCT01743469|3646277|P2|STARTED|Active Treatment Phase||55
1490889|NCT01743469|3646278|P1|STARTED|Active Treatment Phase||53
1490890|NCT01743092|3646318|P2|NOT COMPLETED|Overall Study||15
1490891|NCT01743092|3646319|P1|NOT COMPLETED|Overall Study||14
1490892|NCT01743092|3646318|P2|COMPLETED|Overall Study||11
1490893|NCT01743092|3646319|P1|COMPLETED|Overall Study||19
1490894|NCT01743092|3646318|P2|STARTED|Overall Study||26
1490895|NCT01743092|3646319|P1|STARTED|Overall Study||33
1490896|NCT01743027|3646331|P4|NOT COMPLETED|Overall Study||1
1490897|NCT01743027|3646332|P3|NOT COMPLETED|Overall Study||9
1490898|NCT01743027|3646333|P2|NOT COMPLETED|Overall Study||5
1490899|NCT01743027|3646334|P1|NOT COMPLETED|Overall Study||5
1490900|NCT01743027|3646331|P4|COMPLETED|Overall Study||48
1490901|NCT01743027|3646332|P3|COMPLETED|Overall Study||90
1490902|NCT01743027|3646333|P2|COMPLETED|Overall Study||94
1490903|NCT01743027|3646334|P1|COMPLETED|Overall Study||93
1490904|NCT01743027|3646331|P4|STARTED|Overall Study||49
1490905|NCT01743027|3646332|P3|STARTED|Overall Study||99
1490906|NCT01743027|3646333|P2|STARTED|Overall Study||99
1490907|NCT01743027|3646334|P1|STARTED|Overall Study||98
1490908|NCT01743001|3646374|P2|NOT COMPLETED|Overall Study||0
1490909|NCT01743001|3646375|P1|NOT COMPLETED|Overall Study||3
1490910|NCT01743001|3646374|P2|COMPLETED|Overall Study||112
1490911|NCT01743001|3646375|P1|COMPLETED|Overall Study||111
1490912|NCT01743001|3646374|P2|STARTED|Overall Study||112
1490913|NCT01743001|3646375|P1|STARTED|Overall Study||114
1490914|NCT01742936|3646389|P2|NOT COMPLETED|Overall Study||0
1490915|NCT01742936|3646390|P1|NOT COMPLETED|Overall Study||0
1490916|NCT01742936|3646389|P2|COMPLETED|Overall Study||50
1490917|NCT01742936|3646390|P1|COMPLETED|Overall Study||50
1490918|NCT01742936|3646389|P2|STARTED|Overall Study||50
1490919|NCT01742936|3646390|P1|STARTED|Overall Study||50
1490920|NCT01742897|3646398|P1|NOT COMPLETED|Overall Study||5
1490921|NCT01742897|3646398|P1|COMPLETED|Overall Study||30
1490922|NCT01742897|3646398|P1|Treated|Overall Study||33
1490923|NCT01742897|3646398|P1|STARTED|Overall Study||35
1490924|NCT01742832|3646404|P2|NOT COMPLETED|Overall Study||5
1490925|NCT01742832|3646405|P1|NOT COMPLETED|Overall Study||1
1490926|NCT01742832|3646404|P2|COMPLETED|Overall Study||23
1490927|NCT01742832|3646405|P1|COMPLETED|Overall Study||19
1490928|NCT01742832|3646404|P2|STARTED|Overall Study||28
1490929|NCT01742832|3646405|P1|STARTED|Overall Study||20
1490930|NCT01742364|3646415|P4|NOT COMPLETED|Overall Study||0
1490931|NCT01742364|3646416|P3|NOT COMPLETED|Overall Study||0
1490932|NCT01742364|3646417|P2|NOT COMPLETED|Overall Study||0
1490933|NCT01742364|3646418|P1|NOT COMPLETED|Overall Study||0
1490934|NCT01742364|3646415|P4|COMPLETED|Overall Study||15
1490935|NCT01742364|3646416|P3|COMPLETED|Overall Study||15
1490936|NCT01742364|3646417|P2|COMPLETED|Overall Study||33
1490937|NCT01742364|3646418|P1|COMPLETED|Overall Study||33
1490938|NCT01742364|3646415|P4|STARTED|Overall Study||15
1490939|NCT01742364|3646416|P3|STARTED|Overall Study||15
1490940|NCT01742364|3646417|P2|STARTED|Overall Study||33
1490941|NCT01742364|3646418|P1|STARTED|Overall Study||33
1490942|NCT01742091|3646450|P6|NOT COMPLETED|Overall Study||2
1490943|NCT01742091|3646451|P5|NOT COMPLETED|Overall Study||1
1490944|NCT01742091|3646452|P4|NOT COMPLETED|Overall Study||1
1490945|NCT01742091|3646453|P3|NOT COMPLETED|Overall Study||0
1490946|NCT01742091|3646454|P2|NOT COMPLETED|Overall Study||0
1490947|NCT01742091|3646455|P1|NOT COMPLETED|Overall Study||0
1490948|NCT01742091|3646450|P6|COMPLETED|Overall Study||10
1490949|NCT01742091|3646451|P5|COMPLETED|Overall Study||7
1490950|NCT01742091|3646452|P4|COMPLETED|Overall Study||8
1490951|NCT01742091|3646453|P3|COMPLETED|Overall Study||10
1490952|NCT01742091|3646454|P2|COMPLETED|Overall Study||11
1490953|NCT01742091|3646455|P1|COMPLETED|Overall Study||9
1490954|NCT01742091|3646450|P6|RECEIVED STUDY DRUG|Overall Study||12
1490955|NCT01742091|3646451|P5|RECEIVED STUDY DRUG|Overall Study||8
1490956|NCT01742091|3646452|P4|RECEIVED STUDY DRUG|Overall Study||9
1490957|NCT01742091|3646453|P3|RECEIVED STUDY DRUG|Overall Study||10
1490958|NCT01742091|3646454|P2|RECEIVED STUDY DRUG|Overall Study||11
1490959|NCT01742091|3646455|P1|RECEIVED STUDY DRUG|Overall Study||9
1490960|NCT01742091|3646450|P6|STARTED|Overall Study||12
1490961|NCT01742091|3646451|P5|STARTED|Overall Study||8
1490962|NCT01742091|3646452|P4|STARTED|Overall Study||9
1490963|NCT01742091|3646453|P3|STARTED|Overall Study||10
1490964|NCT01742091|3646454|P2|STARTED|Overall Study||11
1490965|NCT01742091|3646455|P1|STARTED|Overall Study||9
1490966|NCT01741792|3646495|P3|NOT COMPLETED|Overall Study||12
1490967|NCT01741792|3646496|P2|NOT COMPLETED|Overall Study||1
1490968|NCT01741792|3646497|P1|NOT COMPLETED|Overall Study||6
1490969|NCT01741792|3646495|P3|COMPLETED|Overall Study||2
1490970|NCT01741792|3646496|P2|COMPLETED|Overall Study||1
1490971|NCT01741792|3646497|P1|COMPLETED|Overall Study||3
1490972|NCT01741792|3646495|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
1490973|NCT01741792|3646496|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
1490974|NCT01741792|3646497|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
1490975|NCT01741792|3646495|P3|STARTED|Overall Study||14
1490976|NCT01741792|3646496|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
1490977|NCT01741792|3646497|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
1490978|NCT01741701|3646564|P2|NOT COMPLETED|Overall Study||2
1490979|NCT01741701|3646565|P1|NOT COMPLETED|Overall Study||5
1490980|NCT01741701|3646564|P2|COMPLETED|Overall Study||13
1490981|NCT01741701|3646565|P1|COMPLETED|Overall Study||13
1490982|NCT01741701|3646564|P2|STARTED|Overall Study||15
1490983|NCT01741701|3646565|P1|STARTED|Overall Study||18
1490984|NCT01741688|3646581|P1|NOT COMPLETED|Overall Study||3
1490985|NCT01741688|3646581|P1|COMPLETED|Overall Study||13
1490986|NCT01741688|3646581|P1|STARTED|Overall Study||16
1490987|NCT01741480|3646600|P2|NOT COMPLETED|Overall Study||0
1490988|NCT01741480|3646601|P1|NOT COMPLETED|Overall Study||0
1490989|NCT01741480|3646600|P2|COMPLETED|Overall Study||286
1490990|NCT01741480|3646601|P1|COMPLETED|Overall Study||285
1490991|NCT01741480|3646600|P2|STARTED|Overall Study||286
1490992|NCT01741480|3646601|P1|STARTED|Overall Study||285
1490993|NCT01741350|3646609|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
1490994|NCT01741350|3646610|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
1490995|NCT01741350|3646609|P2|COMPLETED|12-Month Follow-up Assessment||109
1490996|NCT01741350|3646610|P1|COMPLETED|12-Month Follow-up Assessment||111
1490997|NCT01741350|3646609|P2|STARTED|12-Month Follow-up Assessment||111
1490998|NCT01741350|3646610|P1|STARTED|12-Month Follow-up Assessment||114
1490999|NCT01741350|3646609|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
1491000|NCT01741350|3646610|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
1491001|NCT01741350|3646609|P2|COMPLETED|6-Month Follow-up Assessment||111
1491002|NCT01741350|3646610|P1|COMPLETED|6-Month Follow-up Assessment||114
1491003|NCT01741350|3646609|P2|STARTED|6-Month Follow-up Assessment||119
1491004|NCT01741350|3646610|P1|STARTED|6-Month Follow-up Assessment||129
1491005|NCT01741350|3646609|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
1491006|NCT01741350|3646610|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
1491007|NCT01741350|3646609|P2|COMPLETED|3-Month Follow-up Assessment||119
1491008|NCT01741350|3646610|P1|COMPLETED|3-Month Follow-up Assessment||129
1491009|NCT01741350|3646609|P2|STARTED|3-Month Follow-up Assessment||141
1491010|NCT01741350|3646610|P1|STARTED|3-Month Follow-up Assessment||135
1491011|NCT01741350|3646609|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
1491012|NCT01741350|3646610|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
1491013|NCT01741350|3646609|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
1491014|NCT01741350|3646610|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
1491015|NCT01741350|3646609|P2|STARTED|Post Intervention Assessment (at Week 4)||155
1491016|NCT01741350|3646610|P1|STARTED|Post Intervention Assessment (at Week 4)||149
1491017|NCT01741350|3646609|P2|NOT COMPLETED|Study Intervention||0
1491018|NCT01741350|3646610|P1|NOT COMPLETED|Study Intervention||0
1491019|NCT01741350|3646609|P2|COMPLETED|Study Intervention||155
1491020|NCT01741350|3646610|P1|COMPLETED|Study Intervention||149
1491021|NCT01741350|3646609|P2|STARTED|Study Intervention||155
1491022|NCT01741350|3646610|P1|STARTED|Study Intervention||149
1491023|NCT01741272|3646746|P2|NOT COMPLETED|Overall Study||0
1491024|NCT01741272|3646747|P1|NOT COMPLETED|Overall Study||0
1491025|NCT01741272|3646746|P2|COMPLETED|Overall Study||97
1491026|NCT01741272|3646747|P1|COMPLETED|Overall Study||92
1491027|NCT01741272|3646746|P2|STARTED|Overall Study||97
1491028|NCT01741272|3646747|P1|STARTED|Overall Study||92
1491029|NCT01741259|3646763|P2|NOT COMPLETED|Overall Study||6
1491030|NCT01741259|3646764|P1|NOT COMPLETED|Overall Study||6
1491031|NCT01741259|3646763|P2|COMPLETED|Overall Study||129
1491032|NCT01741259|3646764|P1|COMPLETED|Overall Study||127
1491033|NCT01741259|3646763|P2|STARTED|Overall Study||135
1491034|NCT01741259|3646764|P1|STARTED|Overall Study||133
1491035|NCT01741012|3646818|P1|NOT COMPLETED|Overall Study||3
1491036|NCT01741012|3646818|P1|COMPLETED|Overall Study||34
1491037|NCT01741012|3646818|P1|STARTED|Overall Study||37
1491038|NCT01740817|3646825|P2|NOT COMPLETED|Second Intervention (48 h)||0
1491039|NCT01740817|3646826|P1|NOT COMPLETED|Second Intervention (48 h)||0
1491040|NCT01740817|3646825|P2|COMPLETED|Second Intervention (48 h)||4
1491041|NCT01740817|3646826|P1|COMPLETED|Second Intervention (48 h)||8
1491042|NCT01740817|3646825|P2|STARTED|Second Intervention (48 h)||4
1491043|NCT01740817|3646826|P1|STARTED|Second Intervention (48 h)||8
1491044|NCT01740817|3646825|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
1491045|NCT01740817|3646826|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
1491046|NCT01740817|3646825|P2|COMPLETED|Washout (4-6 Weeks)||4
1491047|NCT01740817|3646826|P1|COMPLETED|Washout (4-6 Weeks)||8
1491048|NCT01740817|3646825|P2|STARTED|Washout (4-6 Weeks)||4
1491049|NCT01740817|3646826|P1|STARTED|Washout (4-6 Weeks)||8
1491050|NCT01740817|3646825|P2|NOT COMPLETED|First Intervention (48 h)||0
1491051|NCT01740817|3646826|P1|NOT COMPLETED|First Intervention (48 h)||0
1491052|NCT01740817|3646825|P2|COMPLETED|First Intervention (48 h)||4
1491053|NCT01740817|3646826|P1|COMPLETED|First Intervention (48 h)||8
1491054|NCT01740817|3646825|P2|STARTED|First Intervention (48 h)||4
1491055|NCT01740817|3646826|P1|STARTED|First Intervention (48 h)||8
1491056|NCT01740726|3646838|P2|NOT COMPLETED|Overall Study||0
1491057|NCT01740726|3646839|P1|NOT COMPLETED|Overall Study||0
1491058|NCT01740726|3646838|P2|COMPLETED|Overall Study||1
1491059|NCT01740726|3646839|P1|COMPLETED|Overall Study||0
1491060|NCT01740726|3646838|P2|STARTED|Overall Study||1
1491061|NCT01740726|3646839|P1|STARTED|Overall Study||0
1491062|NCT01740713|3646864|P3|NOT COMPLETED|Overall Study||1
1491063|NCT01740713|3646865|P2|NOT COMPLETED|Overall Study||2
1491064|NCT01740713|3646866|P1|NOT COMPLETED|Overall Study||0
1491065|NCT01740713|3646864|P3|COMPLETED|Overall Study||6
1491066|NCT01740713|3646865|P2|COMPLETED|Overall Study||6
1491067|NCT01740713|3646866|P1|COMPLETED|Overall Study||6
1491068|NCT01740713|3646864|P3|STARTED|Overall Study||7
1491069|NCT01740713|3646865|P2|STARTED|Overall Study||8
1491070|NCT01740713|3646866|P1|STARTED|Overall Study||6
1491071|NCT01740440|3646890|P1|NOT COMPLETED|Overall Study||3
1491072|NCT01740440|3646890|P1|COMPLETED|Overall Study||27
1491073|NCT01740440|3646890|P1|STARTED|Overall Study||30
1491074|NCT01740427|3646898|P2|NOT COMPLETED|Overall Study||222
1491075|NCT01740427|3646899|P1|NOT COMPLETED|Overall Study||444
1491076|NCT01740427|3646898|P2|COMPLETED|Overall Study||0
1491077|NCT01740427|3646899|P1|COMPLETED|Overall Study||0
1491078|NCT01740427|3646898|P2|STARTED|Overall Study||222
1491079|NCT01740427|3646899|P1|STARTED|Overall Study||444
1491080|NCT01740414|3646928|P2|NOT COMPLETED|Overall Study||8
1491081|NCT01740414|3646929|P1|NOT COMPLETED|Overall Study||9
1491082|NCT01740414|3646928|P2|COMPLETED|Overall Study||8
1491083|NCT01740414|3646929|P1|COMPLETED|Overall Study||3
1491084|NCT01740414|3646928|P2|STARTED|Overall Study||16
1491085|NCT01740414|3646929|P1|STARTED|Overall Study||12
1491086|NCT01740401|3646951|P1|NOT COMPLETED|Overall Study||10
1491087|NCT01740401|3646951|P1|COMPLETED|Overall Study||0
1491088|NCT01740401|3646951|P1|STARTED|Overall Study||10
1491089|NCT01740388|3646960|P2|NOT COMPLETED|Overall Study||44
1491090|NCT01740388|3646961|P1|NOT COMPLETED|Overall Study||46
1491091|NCT01740388|3646960|P2|COMPLETED|Overall Study||28
1491092|NCT01740388|3646961|P1|COMPLETED|Overall Study||18
1491093|NCT01740388|3646960|P2|STARTED|Overall Study||72
1491094|NCT01740388|3646961|P1|STARTED|Overall Study||64
1491095|NCT01740362|3646981|P4|NOT COMPLETED|Overall Study||0
1491096|NCT01740362|3646982|P3|NOT COMPLETED|Overall Study||0
1491097|NCT01740362|3646983|P2|NOT COMPLETED|Overall Study||0
1491098|NCT01740362|3646984|P1|NOT COMPLETED|Overall Study||0
1491099|NCT01740362|3646981|P4|COMPLETED|Overall Study||6
1491100|NCT01740362|3646982|P3|COMPLETED|Overall Study||6
1491101|NCT01740362|3646983|P2|COMPLETED|Overall Study||6
1491102|NCT01740362|3646984|P1|COMPLETED|Overall Study||6
1491103|NCT01740362|3646981|P4|STARTED|Overall Study||6
1491104|NCT01740362|3646982|P3|STARTED|Overall Study||6
1491105|NCT01740362|3646983|P2|STARTED|Overall Study||6
1491106|NCT01740362|3646984|P1|STARTED|Overall Study||6
1491107|NCT01740297|3647013|P3|NOT COMPLETED|Overall Study||98
1491108|NCT01740297|3647014|P2|NOT COMPLETED|Overall Study||100
1491109|NCT01740297|3647015|P1|NOT COMPLETED|Overall Study||19
1491110|NCT01740297|3647013|P3|COMPLETED|Overall Study||0
1491111|NCT01740297|3647014|P2|COMPLETED|Overall Study||0
1491112|NCT01740297|3647015|P1|COMPLETED|Overall Study||0
1491113|NCT01740297|3647013|P3|Received Ipilimumab|Overall Study||92
1491114|NCT01740297|3647014|P2|Received Ipilimumab|Overall Study||95
1491115|NCT01740297|3647015|P1|Received Ipilimumab|Overall Study||18
1491116|NCT01740297|3647013|P3|Received Talimogene Laherparepvec|Overall Study||95
1491117|NCT01740297|3647014|P2|Received Talimogene Laherparepvec|Overall Study||0
1491118|NCT01740297|3647015|P1|Received Talimogene Laherparepvec|Overall Study||19
1491119|NCT01740297|3647013|P3|STARTED|Overall Study||98
1491120|NCT01740297|3647014|P2|STARTED|Overall Study||100
1491121|NCT01740297|3647015|P1|STARTED|Overall Study||19
1491122|NCT01740206|3647047|P2|NOT COMPLETED|Overall Study||0
1491123|NCT01740206|3647048|P1|NOT COMPLETED|Overall Study||0
1491124|NCT01740206|3647047|P2|COMPLETED|Overall Study||34
1491125|NCT01740206|3647048|P1|COMPLETED|Overall Study||14
1491126|NCT01740206|3647047|P2|STARTED|Overall Study||34
1491127|NCT01740206|3647048|P1|STARTED|Overall Study||14
1491128|NCT01740154|3647064|P1|NOT COMPLETED|Overall Study||1
1491129|NCT01740154|3647064|P1|COMPLETED|Overall Study||12
1491130|NCT01740154|3647064|P1|STARTED|Overall Study||13
1491131|NCT01740128|3647072|P2|NOT COMPLETED|Overall Study||7
1491132|NCT01740128|3647073|P1|NOT COMPLETED|Overall Study||6
1491133|NCT01740128|3647072|P2|COMPLETED|Overall Study||4
1491134|NCT01740128|3647073|P1|COMPLETED|Overall Study||4
1491135|NCT01740128|3647072|P2|STARTED|Overall Study||11
1491136|NCT01740128|3647073|P1|STARTED|Overall Study||10
1491137|NCT01740089|3647102|P3|NOT COMPLETED|After 12 Weeks||11
1491138|NCT01740089|3647103|P2|NOT COMPLETED|After 12 Weeks||3
1491139|NCT01740089|3647104|P1|NOT COMPLETED|After 12 Weeks||7
1491140|NCT01740089|3647102|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
1491141|NCT01740089|3647103|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
1491142|NCT01740089|3647104|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
1491143|NCT01740089|3647102|P3|STARTED|After 12 Weeks||48
1491144|NCT01740089|3647103|P2|STARTED|After 12 Weeks||48
1491145|NCT01740089|3647104|P1|STARTED|After 12 Weeks||50
1491146|NCT01740089|3647102|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
1491147|NCT01740089|3647103|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
1491148|NCT01740089|3647104|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
1491149|NCT01740089|3647102|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
1491150|NCT01740089|3647103|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
1491151|NCT01740089|3647104|P1|COMPLETED|First 12 Weeks of Treatment||50
1491152|NCT01740089|3647102|P3|STARTED|First 12 Weeks of Treatment||50
1491153|NCT01740089|3647103|P2|STARTED|First 12 Weeks of Treatment||50
1491154|NCT01740089|3647104|P1|STARTED|First 12 Weeks of Treatment||50
1491155|NCT01739803|3647122|P2|NOT COMPLETED|Overall Study||6
1491156|NCT01739803|3647123|P1|NOT COMPLETED|Overall Study||9
1491157|NCT01739803|3647122|P2|COMPLETED|Overall Study||68
1491158|NCT01739803|3647123|P1|COMPLETED|Overall Study||67
1491159|NCT01739803|3647122|P2|STARTED|Overall Study||74
1491160|NCT01739803|3647123|P1|STARTED|Overall Study||76
1491161|NCT01739790|3647135|P2|NOT COMPLETED|Overall Study||4
1491162|NCT01739790|3647136|P1|NOT COMPLETED|Overall Study||2
1491163|NCT01739790|3647135|P2|COMPLETED|Overall Study||23
1491164|NCT01739790|3647136|P1|COMPLETED|Overall Study||22
1491165|NCT01739790|3647135|P2|STARTED|Overall Study||27
1491166|NCT01739790|3647136|P1|STARTED|Overall Study||24
1491167|NCT01739595|3647145|P3|NOT COMPLETED|Overall Study||2
1491168|NCT01739595|3647146|P2|NOT COMPLETED|Overall Study||1
1491169|NCT01739595|3647147|P1|NOT COMPLETED|Overall Study||13
1491170|NCT01739595|3647145|P3|COMPLETED|Overall Study||45
1491171|NCT01739595|3647146|P2|COMPLETED|Overall Study||21
1491172|NCT01739595|3647147|P1|COMPLETED|Overall Study||99
1491173|NCT01739595|3647145|P3|STARTED|Overall Study||47
1491174|NCT01739595|3647146|P2|STARTED|Overall Study||22
1491175|NCT01739595|3647147|P1|STARTED|Overall Study||112
1491176|NCT01739361|3647157|P2|NOT COMPLETED|Overall Study||1
1491177|NCT01739361|3647158|P1|NOT COMPLETED|Overall Study||3
1491178|NCT01739361|3647157|P2|COMPLETED|Overall Study||22
1491179|NCT01739361|3647158|P1|COMPLETED|Overall Study||18
1491180|NCT01739361|3647157|P2|STARTED|Overall Study||23
1491181|NCT01739361|3647158|P1|STARTED|Overall Study||21
1491182|NCT01739348|3647172|P4|NOT COMPLETED|Part II (Extension Study)||396
1491183|NCT01739348|3647173|P3|NOT COMPLETED|Part II (Extension Study)||61
1491184|NCT01739348|3647174|P2|NOT COMPLETED|Part II (Extension Study)||366
1491185|NCT01739348|3647175|P1|NOT COMPLETED|Part II (Extension Study)||379
1491186|NCT01739348|3647172|P4|COMPLETED|Part II (Extension Study)||0
1491187|NCT01739348|3647173|P3|COMPLETED|Part II (Extension Study)||0
1491188|NCT01739348|3647174|P2|COMPLETED|Part II (Extension Study)||0
1491189|NCT01739348|3647175|P1|COMPLETED|Part II (Extension Study)||0
1491190|NCT01739348|3647172|P4|Treated|Part II (Extension Study)||394
1491191|NCT01739348|3647173|P3|Treated|Part II (Extension Study)||61
1491192|NCT01739348|3647174|P2|Treated|Part II (Extension Study)||365
1491193|NCT01739348|3647175|P1|Treated|Part II (Extension Study)||379
1491194|NCT01739348|3647172|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
1491195|NCT01739348|3647173|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
1491196|NCT01739348|3647174|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
1491197|NCT01739348|3647175|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
1491198|NCT01739348|3647172|P4|NOT COMPLETED|Part I (Base Study)||189
1491199|NCT01739348|3647173|P3|NOT COMPLETED|Part I (Base Study)||26
1491200|NCT01739348|3647174|P2|NOT COMPLETED|Part I (Base Study)||203
1491201|NCT01739348|3647175|P1|NOT COMPLETED|Part I (Base Study)||202
1491202|NCT01739348|3647172|P4|COMPLETED|Part I (Base Study)||516
1491203|NCT01739348|3647173|P3|COMPLETED|Part I (Base Study)||77
1491204|NCT01739348|3647174|P2|COMPLETED|Part I (Base Study)||497
1491205|NCT01739348|3647175|P1|COMPLETED|Part I (Base Study)||501
1491206|NCT01739348|3647172|P4|Treated|Part I (Base Study)||705
1491207|NCT01739348|3647173|P3|Treated|Part I (Base Study)||103
1491208|NCT01739348|3647174|P2|Treated|Part I (Base Study)||700
1491209|NCT01739348|3647175|P1|Treated|Part I (Base Study)||702
1491210|NCT01739348|3647172|P4|STARTED|Part I (Base Study)||705
1491211|NCT01739348|3647173|P3|STARTED|Part I (Base Study)||103
1491212|NCT01739348|3647174|P2|STARTED|Part I (Base Study)||700
1491213|NCT01739348|3647175|P1|STARTED|Part I (Base Study)||703
1491214|NCT01739335|3647247|P2|NOT COMPLETED|Overall Study||5
1491215|NCT01739335|3647248|P1|NOT COMPLETED|Overall Study||7
1491216|NCT01739335|3647247|P2|COMPLETED|Overall Study||35
1491217|NCT01739335|3647248|P1|COMPLETED|Overall Study||34
1491218|NCT01739335|3647247|P2|STARTED|Overall Study||40
1491219|NCT01739335|3647248|P1|STARTED|Overall Study||41
1491220|NCT01739231|3647286|P4|NOT COMPLETED|Part B||2
1491221|NCT01739231|3647287|P3|NOT COMPLETED|Part B||2
1491222|NCT01739231|3647288|P2|NOT COMPLETED|Part B||5
1491223|NCT01739231|3647289|P1|NOT COMPLETED|Part B||7
1491224|NCT01739231|3647286|P4|COMPLETED|Part B||19
1491225|NCT01739231|3647287|P3|COMPLETED|Part B||10
1491226|NCT01739231|3647288|P2|COMPLETED|Part B||12
1491227|NCT01739231|3647289|P1|COMPLETED|Part B||13
1491228|NCT01739231|3647286|P4|Challenged|Part B||21
1491229|NCT01739231|3647287|P3|Challenged|Part B||10
1491230|NCT01739231|3647288|P2|Challenged|Part B||13
1491231|NCT01739231|3647289|P1|Challenged|Part B||13
1491232|NCT01739231|3647286|P4|STARTED|Part B||21
1491233|NCT01739231|3647287|P3|STARTED|Part B||12
1491234|NCT01739231|3647288|P2|STARTED|Part B||17
1491235|NCT01739231|3647289|P1|STARTED|Part B||20
1491236|NCT01739231|3647286|P4|NOT COMPLETED|Part A||0
1491237|NCT01739231|3647287|P3|NOT COMPLETED|Part A||0
1491238|NCT01739231|3647288|P2|NOT COMPLETED|Part A||7
1491239|NCT01739231|3647289|P1|NOT COMPLETED|Part A||4
1491240|NCT01739231|3647286|P4|COMPLETED|Part A||0
1491241|NCT01739231|3647287|P3|COMPLETED|Part A||12
1491242|NCT01739231|3647288|P2|COMPLETED|Part A||17
1491243|NCT01739231|3647289|P1|COMPLETED|Part A||20
1491244|NCT01739231|3647286|P4|Received All 3 Vaccinations|Part A||0
1491245|NCT01739231|3647287|P3|Received All 3 Vaccinations|Part A||12
1491246|NCT01739231|3647288|P2|Received All 3 Vaccinations|Part A||20
1491247|NCT01739231|3647289|P1|Received All 3 Vaccinations|Part A||21
1491248|NCT01739231|3647286|P4|STARTED|Part A||0
1491249|NCT01739231|3647287|P3|STARTED|Part A||12
1491250|NCT01739231|3647288|P2|STARTED|Part A||24
1491251|NCT01739231|3647289|P1|STARTED|Part A||24
1491252|NCT01738984|3647458|P2|NOT COMPLETED|Overall Study||39
1491253|NCT01738984|3647459|P1|NOT COMPLETED|Overall Study||64
1491254|NCT01738984|3647458|P2|COMPLETED|Overall Study||210
1491255|NCT01738984|3647459|P1|COMPLETED|Overall Study||186
1491256|NCT01738984|3647458|P2|STARTED|Overall Study||249
1491257|NCT01738984|3647459|P1|STARTED|Overall Study||250
1491258|NCT01738971|3647472|P3|NOT COMPLETED|Overall Study||17
1491259|NCT01738971|3647473|P2|NOT COMPLETED|Overall Study||30
1491260|NCT01738971|3647474|P1|NOT COMPLETED|Overall Study||19
1491261|NCT01738971|3647472|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
1491262|NCT01738971|3647473|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
1491263|NCT01738971|3647474|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
1491264|NCT01738971|3647472|P3|STARTED|Overall Study|56 participants recruited to this arm|56
1491265|NCT01738971|3647473|P2|STARTED|Overall Study|58 participants recruited to this arm|58
1491266|NCT01738971|3647474|P1|STARTED|Overall Study|54 participants recruited to this arm|54
1491267|NCT01738919|3647490|P2|NOT COMPLETED|Overall Study||3
1491268|NCT01738919|3647491|P1|NOT COMPLETED|Overall Study||1
1491269|NCT01738919|3647490|P2|COMPLETED|Overall Study||14
1491270|NCT01738919|3647491|P1|COMPLETED|Overall Study||14
1491271|NCT01738919|3647490|P2|STARTED|Overall Study||17
1491272|NCT01738919|3647491|P1|STARTED|Overall Study||15
1491273|NCT01738750|3647509|P2|NOT COMPLETED|Overall Study||0
1491274|NCT01738750|3647510|P1|NOT COMPLETED|Overall Study||0
1491275|NCT01738750|3647509|P2|COMPLETED|Overall Study||51
1491276|NCT01738750|3647510|P1|COMPLETED|Overall Study||49
1491277|NCT01738750|3647509|P2|STARTED|Overall Study||51
1491278|NCT01738750|3647510|P1|STARTED|Overall Study||49
1491279|NCT01738737|3647523|P5|NOT COMPLETED|Overall Study||4
1491280|NCT01738737|3647524|P4|NOT COMPLETED|Overall Study||4
1491281|NCT01738737|3647525|P3|NOT COMPLETED|Overall Study||4
1491282|NCT01738737|3647526|P2|NOT COMPLETED|Overall Study||4
1491283|NCT01738737|3647527|P1|NOT COMPLETED|Overall Study||4
1491284|NCT01738737|3647523|P5|COMPLETED|Overall Study||25
1491285|NCT01738737|3647524|P4|COMPLETED|Overall Study||25
1491286|NCT01738737|3647525|P3|COMPLETED|Overall Study||25
1491287|NCT01738737|3647526|P2|COMPLETED|Overall Study||25
1491288|NCT01738737|3647527|P1|COMPLETED|Overall Study||25
1491289|NCT01738737|3647523|P5|STARTED|Overall Study||29
1491290|NCT01738737|3647524|P4|STARTED|Overall Study||29
1491291|NCT01738737|3647525|P3|STARTED|Overall Study||29
1491292|NCT01738737|3647526|P2|STARTED|Overall Study||29
1491293|NCT01738737|3647527|P1|STARTED|Overall Study||29
1491294|NCT01738698|3647563|P4|NOT COMPLETED|Overall Study||0
1491295|NCT01738698|3647564|P3|NOT COMPLETED|Overall Study||0
1491296|NCT01738698|3647565|P2|NOT COMPLETED|Overall Study||0
1491297|NCT01738698|3647566|P1|NOT COMPLETED|Overall Study||0
1491298|NCT01738698|3647563|P4|COMPLETED|Overall Study||0
1491299|NCT01738698|3647564|P3|COMPLETED|Overall Study||0
1491300|NCT01738698|3647565|P2|COMPLETED|Overall Study||0
1491301|NCT01738698|3647566|P1|COMPLETED|Overall Study||0
1491302|NCT01738698|3647563|P4|STARTED|Overall Study||0
1491303|NCT01738698|3647564|P3|STARTED|Overall Study||0
1491304|NCT01738698|3647565|P2|STARTED|Overall Study||0
1491305|NCT01738698|3647566|P1|STARTED|Overall Study||0
1491306|NCT01738672|3647632|P1|NOT COMPLETED|Overall Study||5
1491307|NCT01738672|3647632|P1|COMPLETED|Overall Study||11
1491308|NCT01738672|3647632|P1|STARTED|Overall Study||16
1491309|NCT01738646|3647641|P1|NOT COMPLETED|Overall Study||2
1491310|NCT01738646|3647641|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
1491311|NCT01738646|3647641|P1|STARTED|Overall Study||40
1491312|NCT01738581|3647651|P2|NOT COMPLETED|Overall Study||0
1491313|NCT01738581|3647652|P1|NOT COMPLETED|Overall Study||1
1491314|NCT01738581|3647651|P2|COMPLETED|Overall Study||4
1491315|NCT01738581|3647652|P1|COMPLETED|Overall Study||4
1491316|NCT01738581|3647651|P2|STARTED|Overall Study||4
1491317|NCT01738581|3647652|P1|STARTED|Overall Study||5
1491318|NCT01738503|3647676|P7|NOT COMPLETED|PET Imaging Sub-study||1
1491319|NCT01738503|3647677|P6|NOT COMPLETED|PET Imaging Sub-study||2
1491320|NCT01738503|3647678|P5|NOT COMPLETED|PET Imaging Sub-study||0
1491321|NCT01738503|3647679|P4|NOT COMPLETED|PET Imaging Sub-study||0
1491322|NCT01738503|3647680|P3|NOT COMPLETED|PET Imaging Sub-study||0
1491323|NCT01738503|3647681|P2|NOT COMPLETED|PET Imaging Sub-study||0
1491324|NCT01738503|3647682|P1|NOT COMPLETED|PET Imaging Sub-study||0
1491325|NCT01738503|3647676|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
1491326|NCT01738503|3647677|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
1491327|NCT01738503|3647678|P5|COMPLETED|PET Imaging Sub-study||0
1491328|NCT01738503|3647679|P4|COMPLETED|PET Imaging Sub-study||0
1491329|NCT01738503|3647680|P3|COMPLETED|PET Imaging Sub-study||0
1491330|NCT01738503|3647681|P2|COMPLETED|PET Imaging Sub-study||0
1491331|NCT01738503|3647682|P1|COMPLETED|PET Imaging Sub-study||0
1491332|NCT01738503|3647676|P7|STARTED|PET Imaging Sub-study||2
1491333|NCT01738503|3647677|P6|STARTED|PET Imaging Sub-study||3
1491334|NCT01738503|3647678|P5|STARTED|PET Imaging Sub-study||0
1491335|NCT01738503|3647679|P4|STARTED|PET Imaging Sub-study||0
1491336|NCT01738503|3647680|P3|STARTED|PET Imaging Sub-study||0
1491337|NCT01738503|3647681|P2|STARTED|PET Imaging Sub-study||0
1491338|NCT01738503|3647682|P1|STARTED|PET Imaging Sub-study||0
1491339|NCT01738503|3647676|P7|NOT COMPLETED|Treatment Period||8
1491340|NCT01738503|3647677|P6|NOT COMPLETED|Treatment Period||6
1491341|NCT01738503|3647678|P5|NOT COMPLETED|Treatment Period||8
1491342|NCT01738503|3647679|P4|NOT COMPLETED|Treatment Period||6
1491343|NCT01738503|3647680|P3|NOT COMPLETED|Treatment Period||5
1491344|NCT01738503|3647681|P2|NOT COMPLETED|Treatment Period||5
1491345|NCT01738503|3647682|P1|NOT COMPLETED|Treatment Period||0
1491346|NCT01738503|3647676|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
1491347|NCT01738503|3647677|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
1491348|NCT01738503|3647678|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
1491349|NCT01738503|3647679|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
1491350|NCT01738503|3647680|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
1491351|NCT01738503|3647681|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
1491352|NCT01738503|3647682|P1|COMPLETED|Treatment Period||0
1491353|NCT01738503|3647676|P7|STARTED|Treatment Period||14
1491354|NCT01738503|3647677|P6|STARTED|Treatment Period||15
1491355|NCT01738503|3647678|P5|STARTED|Treatment Period||15
1491356|NCT01738503|3647679|P4|STARTED|Treatment Period||15
1491357|NCT01738503|3647680|P3|STARTED|Treatment Period||15
1491358|NCT01738503|3647681|P2|STARTED|Treatment Period||15
1491359|NCT01738503|3647682|P1|STARTED|Treatment Period||0
1491360|NCT01738503|3647676|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491361|NCT01738503|3647677|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491362|NCT01738503|3647678|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491363|NCT01738503|3647679|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491364|NCT01738503|3647680|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491365|NCT01738503|3647681|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491366|NCT01738503|3647682|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
1491367|NCT01738503|3647676|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491368|NCT01738503|3647677|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491369|NCT01738503|3647678|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491370|NCT01738503|3647679|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491371|NCT01738503|3647680|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491372|NCT01738503|3647681|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
1491373|NCT01738503|3647682|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
1491374|NCT01738503|3647676|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
1491375|NCT01738503|3647677|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
1491376|NCT01738503|3647678|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
1491377|NCT01738503|3647679|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
1491378|NCT01738503|3647680|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
1491379|NCT01738503|3647681|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
1491380|NCT01738503|3647682|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
1491381|NCT01738477|3647880|P2|NOT COMPLETED|Overall Study||4
1491382|NCT01738477|3647881|P1|NOT COMPLETED|Overall Study||1
1491383|NCT01738477|3647880|P2|COMPLETED|Overall Study||124
1491384|NCT01738477|3647881|P1|COMPLETED|Overall Study||36
1491385|NCT01738477|3647880|P2|STARTED|Overall Study||128
1491386|NCT01738477|3647881|P1|STARTED|Overall Study||37
1491387|NCT01738438|3647909|P1|NOT COMPLETED|Overall Study||35
1491388|NCT01738438|3647909|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1491389|NCT01738438|3647909|P1|STARTED|Overall Study||35
1491390|NCT01738321|3647917|P2|NOT COMPLETED|Overall Study||0
1491391|NCT01738321|3647918|P1|NOT COMPLETED|Overall Study||0
1491392|NCT01738321|3647917|P2|COMPLETED|Overall Study||30
1491393|NCT01738321|3647918|P1|COMPLETED|Overall Study||33
1491394|NCT01738321|3647917|P2|STARTED|Overall Study||30
1491395|NCT01738321|3647918|P1|STARTED|Overall Study||33
1491396|NCT01738191|3647926|P2|NOT COMPLETED|Overall Study||1
1491397|NCT01738191|3647927|P1|NOT COMPLETED|Overall Study||4
1491398|NCT01738191|3647926|P2|COMPLETED|Overall Study||14
1491399|NCT01738191|3647927|P1|COMPLETED|Overall Study||11
1491400|NCT01738191|3647926|P2|STARTED|Overall Study||15
1491401|NCT01738191|3647927|P1|STARTED|Overall Study||15
1491402|NCT01737996|3647950|P3|NOT COMPLETED|Overall Study||2
1491403|NCT01737996|3647951|P2|NOT COMPLETED|Overall Study||1
1491404|NCT01737996|3647952|P1|NOT COMPLETED|Overall Study||0
1491405|NCT01737996|3647950|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
1491406|NCT01737996|3647951|P2|COMPLETED|Overall Study||7
1491407|NCT01737996|3647952|P1|COMPLETED|Overall Study||8
1491408|NCT01737996|3647950|P3|STARTED|Overall Study||16
1491409|NCT01737996|3647951|P2|STARTED|Overall Study||8
1491410|NCT01737996|3647952|P1|STARTED|Overall Study||8
1491411|NCT01737944|3647993|P4|NOT COMPLETED|Overall Study||0
1491412|NCT01737944|3647994|P3|NOT COMPLETED|Overall Study||0
1491413|NCT01737944|3647995|P2|NOT COMPLETED|Overall Study||0
1491414|NCT01737944|3647996|P1|NOT COMPLETED|Overall Study||0
1491415|NCT01737944|3647993|P4|COMPLETED|Overall Study||9
1491416|NCT01737944|3647994|P3|COMPLETED|Overall Study||9
1491417|NCT01737944|3647995|P2|COMPLETED|Overall Study||9
1491418|NCT01737944|3647996|P1|COMPLETED|Overall Study||9
1491419|NCT01737944|3647993|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
1491420|NCT01737944|3647994|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
1491421|NCT01737944|3647995|P2|STARTED|Overall Study||9
1491422|NCT01737944|3647996|P1|STARTED|Overall Study||9
1491423|NCT01737931|3648014|P3|NOT COMPLETED|Overall Study||1
1491424|NCT01737931|3648015|P2|NOT COMPLETED|Overall Study||2
1491425|NCT01737931|3648016|P1|NOT COMPLETED|Overall Study||0
1491426|NCT01737931|3648014|P3|COMPLETED|Overall Study||38
1491427|NCT01737931|3648015|P2|COMPLETED|Overall Study||38
1491428|NCT01737931|3648016|P1|COMPLETED|Overall Study||38
1491429|NCT01737931|3648014|P3|STARTED|Overall Study||39
1491430|NCT01737931|3648015|P2|STARTED|Overall Study||40
1491431|NCT01737931|3648016|P1|STARTED|Overall Study||38
1491432|NCT01737879|3648031|P1|NOT COMPLETED|Overall Study||41
1491433|NCT01737879|3648031|P1|COMPLETED|Overall Study||0
1491434|NCT01737879|3648031|P1|Transitioned to Epoetin Alfa|Overall Study||0
1491435|NCT01737879|3648031|P1|Received Peginesatide|Overall Study||34
1491436|NCT01737879|3648031|P1|STARTED|Overall Study||41
1491437|NCT01737840|3648040|P2|NOT COMPLETED|Overall Study||2
1491438|NCT01737840|3648041|P1|NOT COMPLETED|Overall Study||2
1491439|NCT01737840|3648040|P2|COMPLETED|Overall Study||33
1491440|NCT01737840|3648041|P1|COMPLETED|Overall Study||33
1491441|NCT01737840|3648040|P2|STARTED|Overall Study||35
1491442|NCT01737840|3648041|P1|STARTED|Overall Study||35
1491443|NCT01737762|3648051|P2|NOT COMPLETED|Overall Study||17
1491444|NCT01737762|3648052|P1|NOT COMPLETED|Overall Study||20
1491445|NCT01737762|3648051|P2|COMPLETED|Overall Study||61
1491446|NCT01737762|3648052|P1|COMPLETED|Overall Study||57
1491447|NCT01737762|3648051|P2|STARTED|Overall Study||78
1491448|NCT01737762|3648052|P1|STARTED|Overall Study||77
1491449|NCT01737710|3648065|P5|NOT COMPLETED|Overall Study||0
1491450|NCT01737710|3648066|P4|NOT COMPLETED|Overall Study||0
1491451|NCT01737710|3648067|P3|NOT COMPLETED|Overall Study||3
1491452|NCT01737710|3648068|P2|NOT COMPLETED|Overall Study||4
1491453|NCT01737710|3648069|P1|NOT COMPLETED|Overall Study||2
1491454|NCT01737710|3648065|P5|COMPLETED|Overall Study||21
1491455|NCT01737710|3648066|P4|COMPLETED|Overall Study||23
1491456|NCT01737710|3648067|P3|COMPLETED|Overall Study||102
1491457|NCT01737710|3648068|P2|COMPLETED|Overall Study||101
1491458|NCT01737710|3648069|P1|COMPLETED|Overall Study||112
1491459|NCT01737710|3648065|P5|STARTED|Overall Study||21
1491460|NCT01737710|3648066|P4|STARTED|Overall Study||23
1491461|NCT01737710|3648067|P3|STARTED|Overall Study||105
1491462|NCT01737710|3648068|P2|STARTED|Overall Study||105
1491463|NCT01737710|3648069|P1|STARTED|Overall Study||114
1491464|NCT01737697|3648111|P15|NOT COMPLETED|Subacute Phase||1
1491465|NCT01737697|3648112|P14|NOT COMPLETED|Subacute Phase||2
1491466|NCT01737697|3648113|P13|NOT COMPLETED|Subacute Phase||2
1491467|NCT01737697|3648114|P12|NOT COMPLETED|Subacute Phase||3
1491468|NCT01737697|3648115|P11|NOT COMPLETED|Subacute Phase||6
1491469|NCT01737697|3648116|P10|NOT COMPLETED|Subacute Phase||2
1491470|NCT01737697|3648117|P9|NOT COMPLETED|Subacute Phase||2
1491471|NCT01737697|3648118|P8|NOT COMPLETED|Subacute Phase||3
1491472|NCT01737697|3648119|P7|NOT COMPLETED|Subacute Phase||1
1491473|NCT01737697|3648120|P6|NOT COMPLETED|Subacute Phase||3
1491474|NCT01737697|3648121|P5|NOT COMPLETED|Subacute Phase||0
1491475|NCT01737697|3648122|P4|NOT COMPLETED|Subacute Phase||0
1491476|NCT01737697|3648123|P3|NOT COMPLETED|Subacute Phase||0
1491477|NCT01737697|3648124|P2|NOT COMPLETED|Subacute Phase||0
1491478|NCT01737697|3648125|P1|NOT COMPLETED|Subacute Phase||0
1491479|NCT01737697|3648111|P15|COMPLETED|Subacute Phase||49
1491480|NCT01737697|3648112|P14|COMPLETED|Subacute Phase||44
1491481|NCT01737697|3648113|P13|COMPLETED|Subacute Phase||61
1491482|NCT01737697|3648114|P12|COMPLETED|Subacute Phase||58
1491483|NCT01737697|3648115|P11|COMPLETED|Subacute Phase||59
1491484|NCT01737697|3648116|P10|COMPLETED|Subacute Phase||66
1491485|NCT01737697|3648117|P9|COMPLETED|Subacute Phase||52
1491486|NCT01737697|3648118|P8|COMPLETED|Subacute Phase||43
1491487|NCT01737697|3648119|P7|COMPLETED|Subacute Phase||48
1491488|NCT01737697|3648120|P6|COMPLETED|Subacute Phase||38
1491489|NCT01737697|3648121|P5|COMPLETED|Subacute Phase||0
1491490|NCT01737697|3648122|P4|COMPLETED|Subacute Phase||0
1491491|NCT01737697|3648123|P3|COMPLETED|Subacute Phase||0
1491492|NCT01737697|3648124|P2|COMPLETED|Subacute Phase||0
1491493|NCT01737697|3648125|P1|COMPLETED|Subacute Phase||0
1491494|NCT01737697|3648111|P15|STARTED|Subacute Phase||50
1491495|NCT01737697|3648112|P14|STARTED|Subacute Phase||46
1491496|NCT01737697|3648113|P13|STARTED|Subacute Phase||63
1491497|NCT01737697|3648114|P12|STARTED|Subacute Phase||61
1491498|NCT01737697|3648115|P11|STARTED|Subacute Phase||65
1491499|NCT01737697|3648116|P10|STARTED|Subacute Phase||68
1491500|NCT01737697|3648117|P9|STARTED|Subacute Phase||54
1491501|NCT01737697|3648118|P8|STARTED|Subacute Phase||46
1491502|NCT01737697|3648119|P7|STARTED|Subacute Phase||49
1491503|NCT01737697|3648120|P6|STARTED|Subacute Phase||41
1491504|NCT01737697|3648121|P5|STARTED|Subacute Phase||0
1491505|NCT01737697|3648122|P4|STARTED|Subacute Phase||0
1491506|NCT01737697|3648123|P3|STARTED|Subacute Phase||0
1491507|NCT01737697|3648124|P2|STARTED|Subacute Phase||0
1491508|NCT01737697|3648125|P1|STARTED|Subacute Phase||0
1491509|NCT01737697|3648111|P15|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491510|NCT01737697|3648112|P14|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491511|NCT01737697|3648113|P13|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491512|NCT01737697|3648114|P12|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491513|NCT01737697|3648115|P11|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491514|NCT01737697|3648116|P10|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491515|NCT01737697|3648117|P9|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491516|NCT01737697|3648118|P8|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491517|NCT01737697|3648119|P7|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491518|NCT01737697|3648120|P6|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
1491519|NCT01737697|3648121|P5|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
1491520|NCT01737697|3648122|P4|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
1491521|NCT01737697|3648123|P3|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
1491522|NCT01737697|3648124|P2|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
1491523|NCT01737697|3648125|P1|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
1491524|NCT01737697|3648111|P15|COMPLETED|Acute Phase-Initial 48 Hours||0
1491525|NCT01737697|3648112|P14|COMPLETED|Acute Phase-Initial 48 Hours||0
1491526|NCT01737697|3648113|P13|COMPLETED|Acute Phase-Initial 48 Hours||0
1491527|NCT01737697|3648114|P12|COMPLETED|Acute Phase-Initial 48 Hours||0
1491528|NCT01737697|3648115|P11|COMPLETED|Acute Phase-Initial 48 Hours||0
1491529|NCT01737697|3648116|P10|COMPLETED|Acute Phase-Initial 48 Hours||0
1491530|NCT01737697|3648117|P9|COMPLETED|Acute Phase-Initial 48 Hours||0
1491531|NCT01737697|3648118|P8|COMPLETED|Acute Phase-Initial 48 Hours||0
1491532|NCT01737697|3648119|P7|COMPLETED|Acute Phase-Initial 48 Hours||0
1491533|NCT01737697|3648120|P6|COMPLETED|Acute Phase-Initial 48 Hours||0
1491534|NCT01737697|3648121|P5|COMPLETED|Acute Phase-Initial 48 Hours||140
1491535|NCT01737697|3648122|P4|COMPLETED|Acute Phase-Initial 48 Hours||152
1491536|NCT01737697|3648123|P3|COMPLETED|Acute Phase-Initial 48 Hours||137
1491537|NCT01737697|3648124|P2|COMPLETED|Acute Phase-Initial 48 Hours||150
1491538|NCT01737697|3648125|P1|COMPLETED|Acute Phase-Initial 48 Hours||157
1491539|NCT01737697|3648111|P15|STARTED|Acute Phase-Initial 48 Hours||0
1491540|NCT01737697|3648112|P14|STARTED|Acute Phase-Initial 48 Hours||0
1491541|NCT01737697|3648113|P13|STARTED|Acute Phase-Initial 48 Hours||0
1491542|NCT01737697|3648114|P12|STARTED|Acute Phase-Initial 48 Hours||0
1491543|NCT01737697|3648115|P11|STARTED|Acute Phase-Initial 48 Hours||0
1491544|NCT01737697|3648116|P10|STARTED|Acute Phase-Initial 48 Hours||0
1491545|NCT01737697|3648117|P9|STARTED|Acute Phase-Initial 48 Hours||0
1491546|NCT01737697|3648118|P8|STARTED|Acute Phase-Initial 48 Hours||0
1491547|NCT01737697|3648119|P7|STARTED|Acute Phase-Initial 48 Hours||0
1491548|NCT01737697|3648120|P6|STARTED|Acute Phase-Initial 48 Hours||0
1491549|NCT01737697|3648121|P5|STARTED|Acute Phase-Initial 48 Hours||143
1491550|NCT01737697|3648122|P4|STARTED|Acute Phase-Initial 48 Hours||158
1491551|NCT01737697|3648123|P3|STARTED|Acute Phase-Initial 48 Hours||141
1491552|NCT01737697|3648124|P2|STARTED|Acute Phase-Initial 48 Hours||154
1491553|NCT01737697|3648125|P1|STARTED|Acute Phase-Initial 48 Hours||158
1491554|NCT01737684|3648214|P3|NOT COMPLETED|Overall Study||0
1491555|NCT01737684|3648215|P2|NOT COMPLETED|Overall Study||0
1491556|NCT01737684|3648216|P1|NOT COMPLETED|Overall Study||0
1491557|NCT01737684|3648214|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
1491558|NCT01737684|3648215|P2|COMPLETED|Overall Study||8
1491559|NCT01737684|3648216|P1|COMPLETED|Overall Study||8
1491560|NCT01737684|3648214|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
1491561|NCT01737684|3648215|P2|STARTED|Overall Study||8
1491562|NCT01737684|3648216|P1|STARTED|Overall Study||8
1491563|NCT01737593|3648235|P3|NOT COMPLETED|Overall Study||0
1491564|NCT01737593|3648236|P2|NOT COMPLETED|Overall Study||0
1491565|NCT01737593|3648237|P1|NOT COMPLETED|Overall Study||0
1491566|NCT01737593|3648235|P3|COMPLETED|Overall Study||39
1491567|NCT01737593|3648236|P2|COMPLETED|Overall Study||32
1491568|NCT01737593|3648237|P1|COMPLETED|Overall Study||37
1491569|NCT01737593|3648235|P3|STARTED|Overall Study||39
1491570|NCT01737593|3648236|P2|STARTED|Overall Study||32
1491571|NCT01737593|3648237|P1|STARTED|Overall Study||37
1491572|NCT01737268|3648266|P1|NOT COMPLETED|Overall Study||9
1491573|NCT01737268|3648266|P1|COMPLETED|Overall Study||11
1491574|NCT01737268|3648266|P1|Treated|Overall Study||20
1491575|NCT01737268|3648266|P1|STARTED|Overall Study||20
1491576|NCT01737021|3648280|P2|NOT COMPLETED|Overall Study||3
1491577|NCT01737021|3648281|P1|NOT COMPLETED|Overall Study||5
1491578|NCT01737021|3648280|P2|COMPLETED|Overall Study||6
1491579|NCT01737021|3648281|P1|COMPLETED|Overall Study||17
1491580|NCT01737021|3648280|P2|STARTED|Overall Study||9
1491581|NCT01737021|3648281|P1|STARTED|Overall Study||22
1491582|NCT01736930|3648287|P1|NOT COMPLETED|Overall Study||1
1491583|NCT01736930|3648287|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
1491584|NCT01736930|3648287|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
1491585|NCT01736917|3648327|P1|NOT COMPLETED|Overall Study||11
1491586|NCT01736917|3648327|P1|COMPLETED|Overall Study||54
1491587|NCT01736917|3648327|P1|STARTED|Overall Study||65
1491588|NCT01736696|3648341|P7|NOT COMPLETED|Overall Study||0
1491589|NCT01736696|3648342|P6|NOT COMPLETED|Overall Study||0
1491590|NCT01736696|3648343|P5|NOT COMPLETED|Overall Study||0
1491591|NCT01736696|3648344|P4|NOT COMPLETED|Overall Study||0
1491592|NCT01736696|3648345|P3|NOT COMPLETED|Overall Study||1
1491593|NCT01736696|3648346|P2|NOT COMPLETED|Overall Study||0
1491594|NCT01736696|3648347|P1|NOT COMPLETED|Overall Study||0
1491595|NCT01736696|3648341|P7|COMPLETED|Overall Study||13
1491596|NCT01736696|3648342|P6|COMPLETED|Overall Study||8
1491597|NCT01736696|3648343|P5|COMPLETED|Overall Study||9
1491598|NCT01736696|3648344|P4|COMPLETED|Overall Study||9
1491599|NCT01736696|3648345|P3|COMPLETED|Overall Study||9
1491600|NCT01736696|3648346|P2|COMPLETED|Overall Study||5
1491601|NCT01736696|3648347|P1|COMPLETED|Overall Study||5
1491602|NCT01736696|3648341|P7|STARTED|Overall Study||13
1491603|NCT01736696|3648342|P6|STARTED|Overall Study||8
1491604|NCT01736696|3648343|P5|STARTED|Overall Study||9
1491605|NCT01736696|3648344|P4|STARTED|Overall Study||9
1491606|NCT01736696|3648345|P3|STARTED|Overall Study||10
1491607|NCT01736696|3648346|P2|STARTED|Overall Study||5
1491608|NCT01736696|3648347|P1|STARTED|Overall Study||5
1491609|NCT01736657|3648664|P1|NOT COMPLETED|Overall Study||1
1491610|NCT01736657|3648664|P1|COMPLETED|Overall Study||72
1491611|NCT01736657|3648664|P1|STARTED|Overall Study||73
1491612|NCT01736579|3648673|P2|NOT COMPLETED|Overall Study||2
1491613|NCT01736579|3648674|P1|NOT COMPLETED|Overall Study||2
1491614|NCT01736579|3648673|P2|COMPLETED|Overall Study||0
1491615|NCT01736579|3648674|P1|COMPLETED|Overall Study||0
1491616|NCT01736579|3648673|P2|STARTED|Overall Study||2
1491617|NCT01736579|3648674|P1|STARTED|Overall Study||2
1491618|NCT01736566|3648713|P5|NOT COMPLETED|Long Term Follow-up||1
1491619|NCT01736566|3648714|P4|NOT COMPLETED|Long Term Follow-up||0
1491620|NCT01736566|3648715|P3|NOT COMPLETED|Long Term Follow-up||49
1491621|NCT01736566|3648716|P2|NOT COMPLETED|Long Term Follow-up||0
1491622|NCT01736566|3648717|P1|NOT COMPLETED|Long Term Follow-up||42
1491623|NCT01736566|3648713|P5|COMPLETED|Long Term Follow-up||0
1491624|NCT01736566|3648714|P4|COMPLETED|Long Term Follow-up||0
1491625|NCT01736566|3648715|P3|COMPLETED|Long Term Follow-up||0
1491626|NCT01736566|3648716|P2|COMPLETED|Long Term Follow-up||0
1491627|NCT01736566|3648717|P1|COMPLETED|Long Term Follow-up||0
1491628|NCT01736566|3648713|P5|STARTED|Long Term Follow-up||1
1491629|NCT01736566|3648714|P4|STARTED|Long Term Follow-up||0
1491630|NCT01736566|3648715|P3|STARTED|Long Term Follow-up||49
1491631|NCT01736566|3648716|P2|STARTED|Long Term Follow-up||0
1491632|NCT01736566|3648717|P1|STARTED|Long Term Follow-up||42
1491633|NCT01736566|3648713|P5|NOT COMPLETED|Main Study||4
1491634|NCT01736566|3648714|P4|NOT COMPLETED|Main Study||1
1491635|NCT01736566|3648715|P3|NOT COMPLETED|Main Study||1
1491636|NCT01736566|3648716|P2|NOT COMPLETED|Main Study||0
1491637|NCT01736566|3648717|P1|NOT COMPLETED|Main Study||1
1491638|NCT01736566|3648713|P5|COMPLETED|Main Study||6
1491639|NCT01736566|3648714|P4|COMPLETED|Main Study||51
1491640|NCT01736566|3648715|P3|COMPLETED|Main Study||49
1491641|NCT01736566|3648716|P2|COMPLETED|Main Study||50
1491642|NCT01736566|3648717|P1|COMPLETED|Main Study||50
1491643|NCT01736566|3648713|P5|STARTED|Main Study||10
1491644|NCT01736566|3648714|P4|STARTED|Main Study||52
1491645|NCT01736566|3648715|P3|STARTED|Main Study||50
1491646|NCT01736566|3648716|P2|STARTED|Main Study||50
1491647|NCT01736566|3648717|P1|STARTED|Main Study||51
1491648|NCT01736553|3648802|P2|NOT COMPLETED|Overall Study||4
1491649|NCT01736553|3648803|P1|NOT COMPLETED|Overall Study||19
1491650|NCT01736553|3648802|P2|COMPLETED|Overall Study||23
1491651|NCT01736553|3648803|P1|COMPLETED|Overall Study||7
1491652|NCT01736553|3648802|P2|STARTED|Overall Study||27
1491653|NCT01736553|3648803|P1|STARTED|Overall Study||26
1491654|NCT01736540|3648854|P1|NOT COMPLETED|Overall Study||15
1491655|NCT01736540|3648854|P1|COMPLETED|Overall Study||228
1491656|NCT01736540|3648854|P1|STARTED|Overall Study||243
1491657|NCT01736527|3648911|P1|NOT COMPLETED|Overall Study||0
1491658|NCT01736527|3648911|P1|COMPLETED|Overall Study||12
1491659|NCT01736527|3648911|P1|STARTED|Overall Study||12
1491660|NCT01736475|3648920|P2|NOT COMPLETED|Overall Study||0
1491661|NCT01736475|3648921|P1|NOT COMPLETED|Overall Study||12
1491662|NCT01736475|3648920|P2|COMPLETED|Overall Study||17
1491663|NCT01736475|3648921|P1|COMPLETED|Overall Study||109
1491664|NCT01736475|3648920|P2|STARTED|Overall Study||17
1491665|NCT01736475|3648921|P1|STARTED|Overall Study||121
1491666|NCT01736397|3648976|P2|NOT COMPLETED|Overall Study||24
1491667|NCT01736397|3648977|P1|NOT COMPLETED|Overall Study||14
1491668|NCT01736397|3648976|P2|COMPLETED|Overall Study||50
1491669|NCT01736397|3648977|P1|COMPLETED|Overall Study||61
1491670|NCT01736397|3648976|P2|STARTED|Overall Study||74
1491671|NCT01736397|3648977|P1|STARTED|Overall Study||75
1491672|NCT01736254|3648989|P1|NOT COMPLETED|Period 3 (Days 13 to 23)||1
1491673|NCT01736254|3648989|P1|COMPLETED|Period 3 (Days 13 to 23)||20
1491674|NCT01736254|3648989|P1|STARTED|Period 3 (Days 13 to 23)||21
1491675|NCT01736254|3648989|P1|NOT COMPLETED|Period 2 (Days 2 to 12)||3
1491676|NCT01736254|3648989|P1|COMPLETED|Period 2 (Days 2 to 12)||21
1491677|NCT01736254|3648989|P1|STARTED|Period 2 (Days 2 to 12)||24
1491678|NCT01736254|3648989|P1|NOT COMPLETED|Period 1 (Day 1)||0
1491679|NCT01736254|3648989|P1|COMPLETED|Period 1 (Day 1)||24
1491680|NCT01736254|3648989|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
1491681|NCT01736254|3648989|P1|STARTED|Period 1 (Day 1)||24
1491682|NCT01736241|3649013|P7|NOT COMPLETED|Overall Study||0
1491683|NCT01736241|3649014|P6|NOT COMPLETED|Overall Study||0
1491684|NCT01736241|3649015|P5|NOT COMPLETED|Overall Study||0
1491685|NCT01736241|3649016|P4|NOT COMPLETED|Overall Study||0
1491686|NCT01736241|3649017|P3|NOT COMPLETED|Overall Study||0
1491687|NCT01736241|3649018|P2|NOT COMPLETED|Overall Study||0
1491688|NCT01736241|3649019|P1|NOT COMPLETED|Overall Study||0
1491689|NCT01736241|3649013|P7|COMPLETED|Overall Study||6
1491690|NCT01736241|3649014|P6|COMPLETED|Overall Study||6
1491691|NCT01736241|3649015|P5|COMPLETED|Overall Study||6
1491692|NCT01736241|3649016|P4|COMPLETED|Overall Study||5
1491693|NCT01736241|3649017|P3|COMPLETED|Overall Study||6
1491694|NCT01736241|3649018|P2|COMPLETED|Overall Study||6
1491695|NCT01736241|3649019|P1|COMPLETED|Overall Study||6
1491696|NCT01736241|3649013|P7|Received at Least One Dose of Study Drug|Overall Study||6
1491697|NCT01736241|3649014|P6|Received at Least One Dose of Study Drug|Overall Study||6
1491698|NCT01736241|3649015|P5|Received at Least One Dose of Study Drug|Overall Study||6
1491699|NCT01736241|3649016|P4|Received at Least One Dose of Study Drug|Overall Study||5
1491700|NCT01736241|3649017|P3|Received at Least One Dose of Study Drug|Overall Study||6
1491701|NCT01736241|3649018|P2|Received at Least One Dose of Study Drug|Overall Study||6
1491702|NCT01736241|3649019|P1|Received at Least One Dose of Study Drug|Overall Study||6
1491703|NCT01736241|3649013|P7|STARTED|Overall Study||6
1491704|NCT01736241|3649014|P6|STARTED|Overall Study||6
1491705|NCT01736241|3649015|P5|STARTED|Overall Study||6
1491706|NCT01736241|3649016|P4|STARTED|Overall Study||5
1491707|NCT01736241|3649017|P3|STARTED|Overall Study||6
1491708|NCT01736241|3649018|P2|STARTED|Overall Study||6
1491709|NCT01736241|3649019|P1|STARTED|Overall Study||6
1491710|NCT01736215|3649054|P1|NOT COMPLETED|Overall Study||14
1491711|NCT01736215|3649054|P1|COMPLETED|Overall Study||19
1491712|NCT01736215|3649054|P1|Treated|Overall Study||25
1491713|NCT01736215|3649054|P1|STARTED|Overall Study||33
1491714|NCT01736176|3649066|P1|NOT COMPLETED|Overall Study||11
1491715|NCT01736176|3649066|P1|COMPLETED|Overall Study||28
1491716|NCT01736176|3649066|P1|Received LCIG|Overall Study||38
1491717|NCT01736176|3649066|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
1491718|NCT01735916|3649113|P3|NOT COMPLETED|Overall Study||7
1491719|NCT01735916|3649114|P2|NOT COMPLETED|Overall Study||19
1491720|NCT01735916|3649115|P1|NOT COMPLETED|Overall Study||18
1491721|NCT01735916|3649113|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
1491722|NCT01735916|3649114|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
1491723|NCT01735916|3649115|P1|COMPLETED|Overall Study||0
1491724|NCT01735916|3649113|P3|STARTED|Overall Study||7
1491725|NCT01735916|3649114|P2|STARTED|Overall Study||19
1491726|NCT01735916|3649115|P1|STARTED|Overall Study||18
1491727|NCT01735877|3649136|P2|NOT COMPLETED|Overall Study||0
1491728|NCT01735877|3649137|P1|NOT COMPLETED|Overall Study||1
1491729|NCT01735877|3649136|P2|COMPLETED|Overall Study||21
1491730|NCT01735877|3649137|P1|COMPLETED|Overall Study||26
1491731|NCT01735877|3649136|P2|STARTED|Overall Study||21
1491732|NCT01735877|3649137|P1|STARTED|Overall Study||27
1491733|NCT01735630|3649153|P2|NOT COMPLETED|Overall Study||18
1491734|NCT01735630|3649154|P1|NOT COMPLETED|Overall Study||18
1491735|NCT01735630|3649153|P2|COMPLETED|Overall Study||157
1491736|NCT01735630|3649154|P1|COMPLETED|Overall Study||157
1491737|NCT01735630|3649153|P2|STARTED|Overall Study||175
1491738|NCT01735630|3649154|P1|STARTED|Overall Study||175
1491739|NCT01735617|3649168|P1|NOT COMPLETED|Overall Study||0
1491740|NCT01735617|3649168|P1|COMPLETED|Overall Study||16
1491741|NCT01735617|3649168|P1|STARTED|Overall Study||16
1491742|NCT01735396|3649181|P1|NOT COMPLETED|Overall Study||1
1491743|NCT01735396|3649181|P1|COMPLETED|Overall Study||10
1491744|NCT01735396|3649181|P1|STARTED|Overall Study||11
1491745|NCT01735214|3649190|P1|NOT COMPLETED|Overall Study||0
1491746|NCT01735214|3649190|P1|COMPLETED|Overall Study||358
1491747|NCT01735214|3649190|P1|STARTED|Overall Study||358
1491748|NCT01735201|3649210|P8|NOT COMPLETED|Overall Study||2
1491749|NCT01735201|3649211|P7|NOT COMPLETED|Overall Study||3
1491750|NCT01735201|3649212|P6|NOT COMPLETED|Overall Study||5
1491751|NCT01735201|3649213|P5|NOT COMPLETED|Overall Study||1
1491752|NCT01735201|3649214|P4|NOT COMPLETED|Overall Study||2
1491753|NCT01735201|3649215|P3|NOT COMPLETED|Overall Study||0
1491754|NCT01735201|3649216|P2|NOT COMPLETED|Overall Study||1
1491755|NCT01735201|3649217|P1|NOT COMPLETED|Overall Study||3
1491756|NCT01735201|3649210|P8|COMPLETED|Overall Study||42
1491757|NCT01735201|3649211|P7|COMPLETED|Overall Study||42
1491758|NCT01735201|3649212|P6|COMPLETED|Overall Study||40
1491759|NCT01735201|3649213|P5|COMPLETED|Overall Study||44
1491760|NCT01735201|3649214|P4|COMPLETED|Overall Study||42
1491761|NCT01735201|3649215|P3|COMPLETED|Overall Study||44
1491762|NCT01735201|3649216|P2|COMPLETED|Overall Study||43
1491763|NCT01735201|3649217|P1|COMPLETED|Overall Study||42
1491764|NCT01735201|3649210|P8|STARTED|Overall Study||44
1491765|NCT01735201|3649211|P7|STARTED|Overall Study||45
1491766|NCT01735201|3649212|P6|STARTED|Overall Study||45
1491767|NCT01735201|3649213|P5|STARTED|Overall Study||45
1491768|NCT01735201|3649214|P4|STARTED|Overall Study||44
1491769|NCT01735201|3649215|P3|STARTED|Overall Study||44
1491770|NCT01735201|3649216|P2|STARTED|Overall Study||44
1491771|NCT01735201|3649217|P1|STARTED|Overall Study||45
1491772|NCT01735175|3649253|P2|NOT COMPLETED|Overall Study||13
1491773|NCT01735175|3649254|P1|NOT COMPLETED|Overall Study||29
1491774|NCT01735175|3649253|P2|COMPLETED|Overall Study||144
1491775|NCT01735175|3649254|P1|COMPLETED|Overall Study||130
1491776|NCT01735175|3649253|P2|Completed the 6-month SFU Visit|Overall Study||138
1491777|NCT01735175|3649254|P1|Completed the 6-month SFU Visit|Overall Study||120
1491778|NCT01735175|3649253|P2|Completed All Treatments as Planned|Overall Study||150
1491779|NCT01735175|3649254|P1|Completed All Treatments as Planned|Overall Study||140
1491780|NCT01735175|3649253|P2|Completed All Cycles|Overall Study||150
1491781|NCT01735175|3649254|P1|Completed All Cycles|Overall Study||141
1491782|NCT01735175|3649253|P2|STARTED|Overall Study||157
1491783|NCT01735175|3649254|P1|STARTED|Overall Study||159
1491784|NCT01734993|3649274|P1|NOT COMPLETED|Overall Study||2
1491785|NCT01734993|3649274|P1|COMPLETED|Overall Study||9
1491786|NCT01734993|3649274|P1|STARTED|Overall Study||11
1491787|NCT01734889|3649300|P1|NOT COMPLETED|Overall Study||0
1491788|NCT01734889|3649300|P1|COMPLETED|Overall Study||18
1491789|NCT01734889|3649300|P1|STARTED|Overall Study||18
1491790|NCT01734785|3649311|P4|NOT COMPLETED|Double−Blind Period||0
1491791|NCT01734785|3649312|P3|NOT COMPLETED|Double−Blind Period||5
1491792|NCT01734785|3649313|P2|NOT COMPLETED|Double−Blind Period||9
1491793|NCT01734785|3649314|P1|NOT COMPLETED|Double−Blind Period||5
1491794|NCT01734785|3649311|P4|COMPLETED|Double−Blind Period||0
1491795|NCT01734785|3649312|P3|COMPLETED|Double−Blind Period||105
1491796|NCT01734785|3649313|P2|COMPLETED|Double−Blind Period||103
1491797|NCT01734785|3649314|P1|COMPLETED|Double−Blind Period||106
1491798|NCT01734785|3649311|P4|STARTED|Double−Blind Period||0
1491799|NCT01734785|3649312|P3|STARTED|Double−Blind Period||110
1491800|NCT01734785|3649313|P2|STARTED|Double−Blind Period||112
1491801|NCT01734785|3649314|P1|STARTED|Double−Blind Period||111
1491802|NCT01734785|3649311|P4|NOT COMPLETED|Open−Label Period||273
1491803|NCT01734785|3649312|P3|NOT COMPLETED|Open−Label Period||0
1491804|NCT01734785|3649313|P2|NOT COMPLETED|Open−Label Period||0
1491805|NCT01734785|3649314|P1|NOT COMPLETED|Open−Label Period||0
1491806|NCT01734785|3649311|P4|COMPLETED|Open−Label Period||333
1491807|NCT01734785|3649312|P3|COMPLETED|Open−Label Period||0
1491808|NCT01734785|3649313|P2|COMPLETED|Open−Label Period||0
1491809|NCT01734785|3649314|P1|COMPLETED|Open−Label Period||0
1491810|NCT01734785|3649311|P4|STARTED|Open−Label Period||606
1491811|NCT01734785|3649312|P3|STARTED|Open−Label Period||0
1491812|NCT01734785|3649313|P2|STARTED|Open−Label Period||0
1491813|NCT01734785|3649314|P1|STARTED|Open−Label Period||0
1491814|NCT01734772|3649331|P2|NOT COMPLETED|Overall Study||3
1491815|NCT01734772|3649332|P1|NOT COMPLETED|Overall Study||1
1491816|NCT01734772|3649331|P2|COMPLETED|Overall Study||21
1491817|NCT01734772|3649332|P1|COMPLETED|Overall Study||23
1491818|NCT01734772|3649331|P2|STARTED|Overall Study||24
1491819|NCT01734772|3649332|P1|STARTED|Overall Study||24
1491820|NCT01734746|3649349|P1|NOT COMPLETED|Overall Study||1
1491821|NCT01734746|3649349|P1|COMPLETED|Overall Study||21
1491822|NCT01734746|3649349|P1|STARTED|Overall Study||22
1491823|NCT01734655|3649355|P1|NOT COMPLETED|Overall Study||0
1491824|NCT01734655|3649355|P1|COMPLETED|Overall Study||40
1491825|NCT01734655|3649355|P1|STARTED|Overall Study||40
1491826|NCT01734551|3649366|P2|NOT COMPLETED|Overall Study||0
1491827|NCT01734551|3649367|P1|NOT COMPLETED|Overall Study||0
1491828|NCT01734551|3649366|P2|COMPLETED|Overall Study||16
1491829|NCT01734551|3649367|P1|COMPLETED|Overall Study||15
1491830|NCT01734551|3649366|P2|STARTED|Overall Study||16
1491831|NCT01734551|3649367|P1|STARTED|Overall Study||15
1491832|NCT01734434|3649383|P4|NOT COMPLETED|Overall Study||23
1491833|NCT01734434|3649384|P3|NOT COMPLETED|Overall Study||129
1491834|NCT01734434|3649385|P2|NOT COMPLETED|Overall Study||12
1491835|NCT01734434|3649386|P1|NOT COMPLETED|Overall Study||10
1491836|NCT01734434|3649383|P4|COMPLETED|Overall Study||228
1491837|NCT01734434|3649384|P3|COMPLETED|Overall Study||1863
1491838|NCT01734434|3649385|P2|COMPLETED|Overall Study||488
1491839|NCT01734434|3649386|P1|COMPLETED|Overall Study||490
1491840|NCT01734434|3649383|P4|STARTED|Overall Study||251
1491841|NCT01734434|3649384|P3|STARTED|Overall Study||1992
1491842|NCT01734434|3649385|P2|STARTED|Overall Study||500
1491843|NCT01734434|3649386|P1|STARTED|Overall Study||500
1491844|NCT01734395|3649408|P1|NOT COMPLETED|Overall Study||410
1491845|NCT01734395|3649408|P1|COMPLETED|Overall Study||1472
1491846|NCT01734395|3649408|P1|STARTED|Overall Study||1882
1491847|NCT01734317|3649414|P1|NOT COMPLETED|Overall Study||0
1491848|NCT01734317|3649414|P1|COMPLETED|Overall Study||10
1491849|NCT01734317|3649414|P1|STARTED|Overall Study||10
1491850|NCT01734239|3649420|P2|NOT COMPLETED|Overall Study||0
1491851|NCT01734239|3649421|P1|NOT COMPLETED|Overall Study||0
1491852|NCT01734239|3649420|P2|COMPLETED|Overall Study||50
1491853|NCT01734239|3649421|P1|COMPLETED|Overall Study||52
1491854|NCT01734239|3649420|P2|STARTED|Overall Study||50
1491855|NCT01734239|3649421|P1|STARTED|Overall Study||52
1491856|NCT01734161|3649436|P2|NOT COMPLETED|Overall Study||8
1491857|NCT01734161|3649437|P1|NOT COMPLETED|Overall Study||6
1491858|NCT01734161|3649436|P2|COMPLETED|Overall Study||53
1491859|NCT01734161|3649437|P1|COMPLETED|Overall Study||55
1491860|NCT01734161|3649436|P2|STARTED|Overall Study||61
1491861|NCT01734161|3649437|P1|STARTED|Overall Study||61
1491862|NCT01733953|3649445|P2|NOT COMPLETED|Overall Study||7
1491863|NCT01733953|3649446|P1|NOT COMPLETED|Overall Study||5
1491864|NCT01733953|3649445|P2|COMPLETED|Overall Study||6
1491865|NCT01733953|3649446|P1|COMPLETED|Overall Study||9
1491866|NCT01733953|3649445|P2|STARTED|Overall Study||13
1491867|NCT01733953|3649446|P1|STARTED|Overall Study||14
1491868|NCT01733758|3649466|P4|NOT COMPLETED|Overall Study||8
1491869|NCT01733758|3649467|P3|NOT COMPLETED|Overall Study||15
1491870|NCT01733758|3649468|P2|NOT COMPLETED|Overall Study||12
1491871|NCT01733758|3649469|P1|NOT COMPLETED|Overall Study||15
1491872|NCT01733758|3649466|P4|COMPLETED|Overall Study||95
1491873|NCT01733758|3649467|P3|COMPLETED|Overall Study||135
1491874|NCT01733758|3649468|P2|COMPLETED|Overall Study||148
1491875|NCT01733758|3649469|P1|COMPLETED|Overall Study||62
1491876|NCT01733758|3649466|P4|STARTED|Overall Study||103
1491877|NCT01733758|3649467|P3|STARTED|Overall Study||150
1491878|NCT01733758|3649468|P2|STARTED|Overall Study||160
1491879|NCT01733758|3649469|P1|STARTED|Overall Study||77
1491880|NCT01733745|3649522|P2|NOT COMPLETED|Overall Study||0
1491881|NCT01733745|3649523|P1|NOT COMPLETED|Overall Study||0
1491882|NCT01733745|3649522|P2|COMPLETED|Overall Study||13
1491883|NCT01733745|3649523|P1|COMPLETED|Overall Study||13
1491884|NCT01733745|3649522|P2|STARTED|Overall Study||13
1491885|NCT01733745|3649523|P1|STARTED|Overall Study||13
1491886|NCT01733732|3649535|P2|NOT COMPLETED|Overall Study||0
1491887|NCT01733732|3649536|P1|NOT COMPLETED|Overall Study||2
1491888|NCT01733732|3649535|P2|COMPLETED|Overall Study||27
1491889|NCT01733732|3649536|P1|COMPLETED|Overall Study||25
1491890|NCT01733732|3649535|P2|STARTED|Overall Study||27
1491891|NCT01733732|3649536|P1|STARTED|Overall Study||27
1491892|NCT01733680|3649572|P2|NOT COMPLETED|Overall Study||1
1491893|NCT01733680|3649573|P1|NOT COMPLETED|Overall Study||0
1491894|NCT01733680|3649572|P2|COMPLETED|Overall Study||0
1491895|NCT01733680|3649573|P1|COMPLETED|Overall Study||2
1491896|NCT01733680|3649572|P2|STARTED|Overall Study||1
1491897|NCT01733680|3649573|P1|STARTED|Overall Study||2
1491898|NCT01733407|3649585|P2|NOT COMPLETED|Overall Study||0
1491899|NCT01733407|3649586|P1|NOT COMPLETED|Overall Study||2
1491900|NCT01733407|3649585|P2|COMPLETED|Overall Study||9
1491901|NCT01733407|3649586|P1|COMPLETED|Overall Study||7
1491902|NCT01733407|3649585|P2|STARTED|Overall Study||9
1491903|NCT01733407|3649586|P1|STARTED|Overall Study||9
1491904|NCT01733368|3649602|P1|NOT COMPLETED|Overall Study||31
1491905|NCT01733368|3649602|P1|COMPLETED|Overall Study||167
1491906|NCT01733368|3649602|P1|STARTED|Overall Study||198
1491907|NCT01733329|3649612|P2|NOT COMPLETED|Overall Study||1
1491908|NCT01733329|3649613|P1|NOT COMPLETED|Overall Study||2
1491909|NCT01733329|3649612|P2|COMPLETED|Overall Study||60
1491910|NCT01733329|3649613|P1|COMPLETED|Overall Study||60
1491911|NCT01733329|3649612|P2|STARTED|Overall Study||61
1491912|NCT01733329|3649613|P1|STARTED|Overall Study||62
1491913|NCT01733316|3649625|P1|NOT COMPLETED|Long Term Extension Phase||5
1491914|NCT01733316|3649625|P1|COMPLETED|Long Term Extension Phase||33
1491915|NCT01733316|3649625|P1|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
1491916|NCT01733316|3649625|P1|NOT COMPLETED|RP103 Phase||1
1491917|NCT01733316|3649625|P1|COMPLETED|RP103 Phase||40
1491918|NCT01733316|3649625|P1|STARTED|RP103 Phase||41
1491919|NCT01733316|3649625|P1|NOT COMPLETED|Cystagon® Phase||0
1491920|NCT01733316|3649625|P1|COMPLETED|Cystagon® Phase||41
1491921|NCT01733316|3649625|P1|STARTED|Cystagon® Phase||41
1491922|NCT01733277|3649641|P2|NOT COMPLETED|Overall Study||0
1491923|NCT01733277|3649642|P1|NOT COMPLETED|Overall Study||0
1491924|NCT01733277|3649641|P2|COMPLETED|Overall Study||25
1491925|NCT01733277|3649642|P1|COMPLETED|Overall Study||25
1491926|NCT01733277|3649641|P2|STARTED|Overall Study||25
1491927|NCT01733277|3649642|P1|STARTED|Overall Study||25
1491928|NCT01733212|3649654|P2|NOT COMPLETED|Overall Study||0
1491929|NCT01733212|3649655|P1|NOT COMPLETED|Overall Study||0
1491930|NCT01733212|3649654|P2|COMPLETED|Overall Study||123
1491931|NCT01733212|3649655|P1|COMPLETED|Overall Study||116
1491932|NCT01733212|3649654|P2|STARTED|Overall Study||123
1491933|NCT01733212|3649655|P1|STARTED|Overall Study||116
1491934|NCT01733121|3649663|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
1491935|NCT01733121|3649664|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
1491936|NCT01733121|3649663|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
1491937|NCT01733121|3649664|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
1491938|NCT01733121|3649663|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
1491939|NCT01733121|3649664|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
1491940|NCT01733121|3649663|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
1491941|NCT01733121|3649664|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
1491942|NCT01733121|3649663|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
1491943|NCT01733121|3649664|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
1491944|NCT01733121|3649663|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
1491945|NCT01733121|3649664|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
1491946|NCT01733069|3649678|P2|NOT COMPLETED|Overall Study||0
1491947|NCT01733069|3649679|P1|NOT COMPLETED|Overall Study||0
1491948|NCT01733069|3649678|P2|COMPLETED|Overall Study||1598
1491949|NCT01733069|3649679|P1|COMPLETED|Overall Study||264
1491950|NCT01733069|3649678|P2|STARTED|Overall Study||1598
1491951|NCT01733069|3649679|P1|STARTED|Overall Study||264
1491952|NCT01733056|3649688|P3|NOT COMPLETED|Overall Study||0
1491953|NCT01733056|3649689|P2|NOT COMPLETED|Overall Study||0
1491954|NCT01733056|3649690|P1|NOT COMPLETED|Overall Study||0
1491955|NCT01733056|3649688|P3|COMPLETED|Overall Study||12
1491956|NCT01733056|3649689|P2|COMPLETED|Overall Study||10
1491957|NCT01733056|3649690|P1|COMPLETED|Overall Study||21
1491958|NCT01733056|3649688|P3|STARTED|Overall Study||12
1491959|NCT01733056|3649689|P2|STARTED|Overall Study||10
1491960|NCT01733056|3649690|P1|STARTED|Overall Study||21
1491961|NCT01732926|3649706|P2|NOT COMPLETED|Overall Study||110
1491962|NCT01732926|3649707|P1|NOT COMPLETED|Overall Study||267
1491963|NCT01732926|3649706|P2|COMPLETED|Overall Study||45
1491964|NCT01732926|3649707|P1|COMPLETED|Overall Study||53
1491965|NCT01732926|3649706|P2|STARTED|Overall Study||155
1491966|NCT01732926|3649707|P1|STARTED|Overall Study||320
1491967|NCT01732913|3649723|P2|NOT COMPLETED|Overall Study||69
1491968|NCT01732913|3649724|P1|NOT COMPLETED|Overall Study||156
1491969|NCT01732913|3649723|P2|COMPLETED|Overall Study||28
1491970|NCT01732913|3649724|P1|COMPLETED|Overall Study||42
1491971|NCT01732913|3649723|P2|STARTED|Overall Study||97
1491972|NCT01732913|3649724|P1|STARTED|Overall Study||198
1491973|NCT01732835|3649738|P1|NOT COMPLETED|2-year Extended Follow-up||5
1491974|NCT01732835|3649738|P1|COMPLETED|2-year Extended Follow-up||39
1491975|NCT01732835|3649738|P1|STARTED|2-year Extended Follow-up||44
1491976|NCT01732835|3649738|P1|NOT COMPLETED|6-month Primary Endpoint||24
1491977|NCT01732835|3649738|P1|COMPLETED|6-month Primary Endpoint||44
1491978|NCT01732835|3649738|P1|STARTED|6-month Primary Endpoint||68
1491979|NCT01732822|3649771|P2|NOT COMPLETED|Overall Study||113
1491980|NCT01732822|3649772|P1|NOT COMPLETED|Overall Study||123
1491981|NCT01732822|3649771|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
1491982|NCT01732822|3649772|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
1491983|NCT01732822|3649771|P2|STARTED|Overall Study||6955
1491984|NCT01732822|3649772|P1|STARTED|Overall Study||6930
1491985|NCT01732796|3649845|P3|NOT COMPLETED|Overall Study||13
1491986|NCT01732796|3649846|P2|NOT COMPLETED|Overall Study||42
1491987|NCT01732796|3649847|P1|NOT COMPLETED|Overall Study||46
1491988|NCT01732796|3649845|P3|COMPLETED|Overall Study||38
1491989|NCT01732796|3649846|P2|COMPLETED|Overall Study||169
1491990|NCT01732796|3649847|P1|COMPLETED|Overall Study||162
1491991|NCT01732796|3649845|P3|STARTED|Overall Study||51
1491992|NCT01732796|3649846|P2|STARTED|Overall Study||211
1491993|NCT01732796|3649847|P1|STARTED|Overall Study||208
1491994|NCT01732783|3649866|P3|NOT COMPLETED|Overall Study||10
1491995|NCT01732783|3649867|P2|NOT COMPLETED|Overall Study||32
1491996|NCT01732783|3649868|P1|NOT COMPLETED|Overall Study||135
1491997|NCT01732783|3649866|P3|COMPLETED|Overall Study|Completed 12-month observation period.|2
1491998|NCT01732783|3649867|P2|COMPLETED|Overall Study|Completed 12-month observation period.|5
1491999|NCT01732783|3649868|P1|COMPLETED|Overall Study|Completed 12-month observation period.|29
1492000|NCT01732783|3649866|P3|STARTED|Overall Study||12
1492001|NCT01732783|3649867|P2|STARTED|Overall Study||37
1492002|NCT01732783|3649868|P1|STARTED|Overall Study||164
1492003|NCT01732770|3649932|P2|NOT COMPLETED|Overall Study||8
1492004|NCT01732770|3649933|P1|NOT COMPLETED|Overall Study||10
1492005|NCT01732770|3649932|P2|COMPLETED|Overall Study||313
1492006|NCT01732770|3649933|P1|COMPLETED|Overall Study||312
1492007|NCT01732770|3649932|P2|Received Study Treatment|Overall Study||320
1492008|NCT01732770|3649933|P1|Received Study Treatment|Overall Study||320
1492009|NCT01732770|3649932|P2|STARTED|Overall Study||321
1492010|NCT01732770|3649933|P1|STARTED|Overall Study||322
1492011|NCT01732757|3649948|P3|NOT COMPLETED|Overall Study||0
1492012|NCT01732757|3649949|P2|NOT COMPLETED|Overall Study||0
1492013|NCT01732757|3649950|P1|NOT COMPLETED|Overall Study||1
1492014|NCT01732757|3649948|P3|COMPLETED|Overall Study||52
1492015|NCT01732757|3649949|P2|COMPLETED|Overall Study||52
1492016|NCT01732757|3649950|P1|COMPLETED|Overall Study||52
1492017|NCT01732757|3649948|P3|STARTED|Overall Study||52
1492018|NCT01732757|3649949|P2|STARTED|Overall Study||52
1492019|NCT01732757|3649950|P1|STARTED|Overall Study||53
1492020|NCT01732692|3649990|P2|NOT COMPLETED|Overall Study||1
1492021|NCT01732692|3649991|P1|NOT COMPLETED|Overall Study||0
1492022|NCT01732692|3649990|P2|COMPLETED|Overall Study||69
1492023|NCT01732692|3649991|P1|COMPLETED|Overall Study||70
1492024|NCT01732692|3649990|P2|STARTED|Overall Study||70
1492025|NCT01732692|3649991|P1|STARTED|Overall Study||70
1492026|NCT01732640|3650005|P2|NOT COMPLETED|Overall Study||2
1492027|NCT01732640|3650006|P1|NOT COMPLETED|Overall Study||0
1492028|NCT01732640|3650005|P2|COMPLETED|Overall Study||1
1492029|NCT01732640|3650006|P1|COMPLETED|Overall Study||6
1492030|NCT01732640|3650005|P2|STARTED|Overall Study||3
1492031|NCT01732640|3650006|P1|STARTED|Overall Study||6
1492032|NCT01732588|3650024|P3|NOT COMPLETED|Third Intervention (7 Days)||0
1492033|NCT01732588|3650025|P2|NOT COMPLETED|Third Intervention (7 Days)||0
1492034|NCT01732588|3650026|P1|NOT COMPLETED|Third Intervention (7 Days)||0
1492035|NCT01732588|3650024|P3|COMPLETED|Third Intervention (7 Days)||4
1492036|NCT01732588|3650025|P2|COMPLETED|Third Intervention (7 Days)||2
1492037|NCT01732588|3650026|P1|COMPLETED|Third Intervention (7 Days)||4
1492038|NCT01732588|3650024|P3|STARTED|Third Intervention (7 Days)||4
1492039|NCT01732588|3650025|P2|STARTED|Third Intervention (7 Days)||2
1492040|NCT01732588|3650026|P1|STARTED|Third Intervention (7 Days)||4
1492041|NCT01732588|3650024|P3|NOT COMPLETED|Second Intervention (7 Days)||0
1492042|NCT01732588|3650025|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1492043|NCT01732588|3650026|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1492044|NCT01732588|3650024|P3|COMPLETED|Second Intervention (7 Days)||4
1492045|NCT01732588|3650025|P2|COMPLETED|Second Intervention (7 Days)||2
1492046|NCT01732588|3650026|P1|COMPLETED|Second Intervention (7 Days)||4
1492047|NCT01732588|3650024|P3|STARTED|Second Intervention (7 Days)||4
1492048|NCT01732588|3650025|P2|STARTED|Second Intervention (7 Days)||2
1492049|NCT01732588|3650026|P1|STARTED|Second Intervention (7 Days)||4
1492050|NCT01732588|3650024|P3|NOT COMPLETED|First Intervention (7 Days)||0
1492051|NCT01732588|3650025|P2|NOT COMPLETED|First Intervention (7 Days)||1
1492052|NCT01732588|3650026|P1|NOT COMPLETED|First Intervention (7 Days)||0
1492053|NCT01732588|3650024|P3|COMPLETED|First Intervention (7 Days)||4
1492054|NCT01732588|3650025|P2|COMPLETED|First Intervention (7 Days)||2
1492055|NCT01732588|3650026|P1|COMPLETED|First Intervention (7 Days)||4
1492056|NCT01732588|3650024|P3|STARTED|First Intervention (7 Days)||4
1492057|NCT01732588|3650025|P2|STARTED|First Intervention (7 Days)||3
1492058|NCT01732588|3650026|P1|STARTED|First Intervention (7 Days)||4
1492059|NCT01732549|3650042|P2|NOT COMPLETED|Overall Study||73
1492060|NCT01732549|3650043|P1|NOT COMPLETED|Overall Study||71
1492061|NCT01732549|3650042|P2|COMPLETED|Overall Study||0
1492062|NCT01732549|3650043|P1|COMPLETED|Overall Study||0
1492063|NCT01732549|3650042|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
1492064|NCT01732549|3650043|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
1492065|NCT01732549|3650042|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
1492066|NCT01732549|3650043|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
1492067|NCT01732549|3650042|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
1492068|NCT01732549|3650043|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
1492069|NCT01732549|3650042|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
1492070|NCT01732549|3650043|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
1492071|NCT01732549|3650042|P2|STARTED|Overall Study||73
1492072|NCT01732549|3650043|P1|STARTED|Overall Study||71
1492073|NCT01732536|3650065|P2|NOT COMPLETED|Overall Study||1
1492074|NCT01732536|3650066|P1|NOT COMPLETED|Overall Study||1
1492075|NCT01732536|3650065|P2|COMPLETED|Overall Study||46
1492076|NCT01732536|3650066|P1|COMPLETED|Overall Study||52
1492077|NCT01732536|3650065|P2|STARTED|Overall Study||47
1492078|NCT01732536|3650066|P1|STARTED|Overall Study||53
1492079|NCT01732510|3650089|P7|NOT COMPLETED|Overall Study||8
1492080|NCT01732510|3650090|P6|NOT COMPLETED|Overall Study||13
1492081|NCT01732510|3650091|P5|NOT COMPLETED|Overall Study||5
1492082|NCT01732510|3650092|P4|NOT COMPLETED|Overall Study||5
1492083|NCT01732510|3650093|P3|NOT COMPLETED|Overall Study||4
1492084|NCT01732510|3650094|P2|NOT COMPLETED|Overall Study||5
1492085|NCT01732510|3650095|P1|NOT COMPLETED|Overall Study||1
1492086|NCT01732510|3650089|P7|COMPLETED|Overall Study||0
1492087|NCT01732510|3650090|P6|COMPLETED|Overall Study||0
1492088|NCT01732510|3650091|P5|COMPLETED|Overall Study||3
1492089|NCT01732510|3650092|P4|COMPLETED|Overall Study||5
1492090|NCT01732510|3650093|P3|COMPLETED|Overall Study||4
1492091|NCT01732510|3650094|P2|COMPLETED|Overall Study||4
1492092|NCT01732510|3650095|P1|COMPLETED|Overall Study||8
1492093|NCT01732510|3650089|P7|STARTED|Overall Study||8
1492094|NCT01732510|3650090|P6|STARTED|Overall Study||13
1492095|NCT01732510|3650091|P5|STARTED|Overall Study||8
1492096|NCT01732510|3650092|P4|STARTED|Overall Study||10
1492097|NCT01732510|3650093|P3|STARTED|Overall Study||8
1492098|NCT01732510|3650094|P2|STARTED|Overall Study||9
1492099|NCT01732510|3650095|P1|STARTED|Overall Study||9
1492100|NCT01732484|3650174|P1|NOT COMPLETED|Overall Study||26
1492101|NCT01732484|3650174|P1|COMPLETED|Overall Study||74
1492102|NCT01732484|3650174|P1|Allocation|Overall Study||100
1492103|NCT01732484|3650174|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
1492104|NCT01732484|3650174|P1|STARTED|Overall Study||100
1492105|NCT01732471|3650182|P1|NOT COMPLETED|Overall Study||1
1492106|NCT01732471|3650182|P1|COMPLETED|Overall Study||89
1492107|NCT01732471|3650182|P1|STARTED|Overall Study||90
1492108|NCT01732458|3650193|P4|NOT COMPLETED|Overall Study||2
1492109|NCT01732458|3650194|P3|NOT COMPLETED|Overall Study||3
1492110|NCT01732458|3650195|P2|NOT COMPLETED|Overall Study||5
1492111|NCT01732458|3650196|P1|NOT COMPLETED|Overall Study||3
1492112|NCT01732458|3650193|P4|COMPLETED|Overall Study||50
1492113|NCT01732458|3650194|P3|COMPLETED|Overall Study||55
1492114|NCT01732458|3650195|P2|COMPLETED|Overall Study||53
1492115|NCT01732458|3650196|P1|COMPLETED|Overall Study||57
1492116|NCT01732458|3650193|P4|Treated|Overall Study||52
1492117|NCT01732458|3650194|P3|Treated|Overall Study||56
1492118|NCT01732458|3650195|P2|Treated|Overall Study||55
1492119|NCT01732458|3650196|P1|Treated|Overall Study||57
1492120|NCT01732458|3650193|P4|STARTED|Overall Study||52
1492121|NCT01732458|3650194|P3|STARTED|Overall Study||58
1492122|NCT01732458|3650195|P2|STARTED|Overall Study||58
1492123|NCT01732458|3650196|P1|STARTED|Overall Study||60
1492124|NCT01732445|3650258|P1|NOT COMPLETED|Overall Study||0
1492125|NCT01732445|3650258|P1|COMPLETED|Overall Study||14
1492126|NCT01732445|3650258|P1|STARTED|Overall Study||14
1492127|NCT01732263|3650267|P2|NOT COMPLETED|Overall Study||0
1492128|NCT01732263|3650268|P1|NOT COMPLETED|Overall Study||0
1492129|NCT01732263|3650267|P2|COMPLETED|Overall Study||20
1492130|NCT01732263|3650268|P1|COMPLETED|Overall Study||23
1492131|NCT01732263|3650267|P2|STARTED|Overall Study||20
1492132|NCT01732263|3650268|P1|STARTED|Overall Study||23
1492133|NCT01732107|3650308|P1|NOT COMPLETED|Overall Study||13
1492134|NCT01732107|3650308|P1|COMPLETED|Overall Study||0
1492135|NCT01732107|3650308|P1|STARTED|Overall Study||13
1492136|NCT01731990|3650325|P2|NOT COMPLETED|Overall Study||8
1492137|NCT01731990|3650326|P1|NOT COMPLETED|Overall Study||4
1492138|NCT01731990|3650325|P2|COMPLETED|Overall Study||12
1492139|NCT01731990|3650326|P1|COMPLETED|Overall Study||14
1492140|NCT01731990|3650325|P2|STARTED|Overall Study||20
1492141|NCT01731990|3650326|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
1492142|NCT01731938|3650342|P2|NOT COMPLETED|Primary Part II||13
1492143|NCT01731938|3650343|P1|NOT COMPLETED|Primary Part II||13
1492144|NCT01731938|3650342|P2|COMPLETED|Primary Part II||95
1492145|NCT01731938|3650343|P1|COMPLETED|Primary Part II||103
1492146|NCT01731938|3650342|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
1492147|NCT01731938|3650343|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
1492148|NCT01731938|3650342|P2|NOT COMPLETED|Preliminary Part I||8
1492149|NCT01731938|3650343|P1|NOT COMPLETED|Preliminary Part I||3
1492150|NCT01731938|3650342|P2|COMPLETED|Preliminary Part I||44
1492151|NCT01731938|3650343|P1|COMPLETED|Preliminary Part I||48
1492152|NCT01731938|3650342|P2|STARTED|Preliminary Part I||52
1492153|NCT01731938|3650343|P1|STARTED|Preliminary Part I||51
1492154|NCT01731470|3650355|P1|NOT COMPLETED|Overall Study||2
1492155|NCT01731470|3650355|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
1492156|NCT01731470|3650355|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
1492157|NCT01731119|3650360|P1|NOT COMPLETED|Overall Study||2
1492158|NCT01731119|3650360|P1|COMPLETED|Overall Study||7
1492159|NCT01731119|3650360|P1|STARTED|Overall Study||9
1492160|NCT01731041|3650370|P2|NOT COMPLETED|Overall Study||0
1492161|NCT01731041|3650371|P1|NOT COMPLETED|Overall Study||0
1492162|NCT01731041|3650370|P2|COMPLETED|Overall Study||30
1492163|NCT01731041|3650371|P1|COMPLETED|Overall Study||30
1492164|NCT01731041|3650370|P2|STARTED|Overall Study||30
1492165|NCT01731041|3650371|P1|STARTED|Overall Study||30
1492166|NCT01731002|3650382|P3|NOT COMPLETED|Overall Study||3
1492167|NCT01731002|3650383|P2|NOT COMPLETED|Overall Study||4
1492168|NCT01731002|3650384|P1|NOT COMPLETED|Overall Study||4
1492169|NCT01731002|3650382|P3|COMPLETED|Overall Study||74
1492170|NCT01731002|3650383|P2|COMPLETED|Overall Study||68
1492171|NCT01731002|3650384|P1|COMPLETED|Overall Study||71
1492172|NCT01731002|3650382|P3|STARTED|Overall Study||77
1492173|NCT01731002|3650383|P2|STARTED|Overall Study||72
1492174|NCT01731002|3650384|P1|STARTED|Overall Study||75
1492175|NCT01730846|3650398|P3|NOT COMPLETED|Overall Study||0
1492176|NCT01730846|3650399|P2|NOT COMPLETED|Overall Study||0
1492177|NCT01730846|3650400|P1|NOT COMPLETED|Overall Study||0
1492178|NCT01730846|3650398|P3|COMPLETED|Overall Study||13
1492179|NCT01730846|3650399|P2|COMPLETED|Overall Study||11
1492180|NCT01730846|3650400|P1|COMPLETED|Overall Study||11
1492181|NCT01730846|3650398|P3|STARTED|Overall Study||13
1492182|NCT01730846|3650399|P2|STARTED|Overall Study||11
1492183|NCT01730846|3650400|P1|STARTED|Overall Study||11
1492184|NCT01730378|3650413|P2|NOT COMPLETED|Overall Study||0
1492185|NCT01730378|3650414|P1|NOT COMPLETED|Overall Study||1
1492186|NCT01730378|3650413|P2|COMPLETED|Overall Study||47
1492187|NCT01730378|3650414|P1|COMPLETED|Overall Study||83
1492188|NCT01730378|3650413|P2|STARTED|Overall Study||47
1492189|NCT01730378|3650414|P1|STARTED|Overall Study||84
1492190|NCT01730339|3650445|P2|NOT COMPLETED|Overall Study||3
1492191|NCT01730339|3650446|P1|NOT COMPLETED|Overall Study||5
1492192|NCT01730339|3650445|P2|COMPLETED|Overall Study||52
1492193|NCT01730339|3650446|P1|COMPLETED|Overall Study||40
1492194|NCT01730339|3650445|P2|STARTED|Overall Study||55
1492195|NCT01730339|3650446|P1|STARTED|Overall Study||45
1492196|NCT01730053|3650486|P6|NOT COMPLETED|Overall Study||13
1492197|NCT01730053|3650487|P5|NOT COMPLETED|Overall Study||9
1492198|NCT01730053|3650488|P4|NOT COMPLETED|Overall Study||8
1492199|NCT01730053|3650489|P3|NOT COMPLETED|Overall Study||11
1492200|NCT01730053|3650490|P2|NOT COMPLETED|Overall Study||14
1492201|NCT01730053|3650491|P1|NOT COMPLETED|Overall Study||5
1492202|NCT01730053|3650486|P6|COMPLETED|Overall Study||41
1492203|NCT01730053|3650487|P5|COMPLETED|Overall Study||44
1492204|NCT01730053|3650488|P4|COMPLETED|Overall Study||45
1492205|NCT01730053|3650489|P3|COMPLETED|Overall Study||38
1492206|NCT01730053|3650490|P2|COMPLETED|Overall Study||34
1492207|NCT01730053|3650491|P1|COMPLETED|Overall Study||43
1492208|NCT01730053|3650486|P6|Treated|Overall Study||54
1492209|NCT01730053|3650487|P5|Treated|Overall Study||53
1492210|NCT01730053|3650488|P4|Treated|Overall Study||53
1492211|NCT01730053|3650489|P3|Treated|Overall Study||49
1492212|NCT01730053|3650490|P2|Treated|Overall Study||48
1492213|NCT01730053|3650491|P1|Treated|Overall Study||48
1492214|NCT01730053|3650486|P6|STARTED|Overall Study||54
1492215|NCT01730053|3650487|P5|STARTED|Overall Study||53
1492216|NCT01730053|3650488|P4|STARTED|Overall Study||53
1492217|NCT01730053|3650489|P3|STARTED|Overall Study||49
1492218|NCT01730053|3650490|P2|STARTED|Overall Study||48
1492219|NCT01730053|3650491|P1|STARTED|Overall Study||48
1492220|NCT01730040|3650650|P7|NOT COMPLETED|Overall Study||9
1492221|NCT01730040|3650651|P6|NOT COMPLETED|Overall Study||7
1492222|NCT01730040|3650652|P5|NOT COMPLETED|Overall Study||6
1492223|NCT01730040|3650653|P4|NOT COMPLETED|Overall Study||8
1492224|NCT01730040|3650654|P3|NOT COMPLETED|Overall Study||11
1492225|NCT01730040|3650655|P2|NOT COMPLETED|Overall Study||15
1492226|NCT01730040|3650656|P1|NOT COMPLETED|Overall Study||13
1492227|NCT01730040|3650650|P7|COMPLETED|Overall Study||38
1492228|NCT01730040|3650651|P6|COMPLETED|Overall Study||40
1492229|NCT01730040|3650652|P5|COMPLETED|Overall Study||39
1492230|NCT01730040|3650653|P4|COMPLETED|Overall Study||39
1492231|NCT01730040|3650654|P3|COMPLETED|Overall Study||46
1492232|NCT01730040|3650655|P2|COMPLETED|Overall Study||40
1492233|NCT01730040|3650656|P1|COMPLETED|Overall Study||44
1492234|NCT01730040|3650650|P7|Treated|Overall Study||47
1492235|NCT01730040|3650651|P6|Treated|Overall Study||46
1492236|NCT01730040|3650652|P5|Treated|Overall Study||45
1492237|NCT01730040|3650653|P4|Treated|Overall Study||47
1492238|NCT01730040|3650654|P3|Treated|Overall Study||57
1492239|NCT01730040|3650655|P2|Treated|Overall Study||55
1492240|NCT01730040|3650656|P1|Treated|Overall Study||57
1492241|NCT01730040|3650650|P7|STARTED|Overall Study||47
1492242|NCT01730040|3650651|P6|STARTED|Overall Study||47
1492243|NCT01730040|3650652|P5|STARTED|Overall Study||45
1492244|NCT01730040|3650653|P4|STARTED|Overall Study||47
1492245|NCT01730040|3650654|P3|STARTED|Overall Study||57
1492246|NCT01730040|3650655|P2|STARTED|Overall Study||55
1492247|NCT01730040|3650656|P1|STARTED|Overall Study||57
1492248|NCT01729923|3650833|P1|NOT COMPLETED|Overall Study||27
1492249|NCT01729923|3650833|P1|COMPLETED|Overall Study||0
1492250|NCT01729923|3650833|P1|STARTED|Overall Study||27
1492251|NCT01729871|3650845|P2|NOT COMPLETED|Overall Study||23
1492252|NCT01729871|3650846|P1|NOT COMPLETED|Overall Study||12
1492253|NCT01729871|3650845|P2|COMPLETED|Overall Study||101
1492254|NCT01729871|3650846|P1|COMPLETED|Overall Study||112
1492255|NCT01729871|3650845|P2|STARTED|Overall Study||124
1492256|NCT01729871|3650846|P1|STARTED|Overall Study||124
1492257|NCT01729845|3650865|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
1492258|NCT01729845|3650866|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
1492259|NCT01729845|3650867|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
1492260|NCT01729845|3650865|P3|COMPLETED|Efficacy of Dec/MEC||0
1492261|NCT01729845|3650866|P2|COMPLETED|Efficacy of Dec/MEC||22
1492262|NCT01729845|3650867|P1|COMPLETED|Efficacy of Dec/MEC||0
1492263|NCT01729845|3650865|P3|STARTED|Efficacy of Dec/MEC||0
1492264|NCT01729845|3650866|P2|STARTED|Efficacy of Dec/MEC||22
1492265|NCT01729845|3650867|P1|STARTED|Efficacy of Dec/MEC||0
1492266|NCT01729845|3650865|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
1492267|NCT01729845|3650866|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
1492268|NCT01729845|3650867|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
1492269|NCT01729845|3650865|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
1492270|NCT01729845|3650866|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
1492271|NCT01729845|3650867|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
1492272|NCT01729845|3650865|P3|STARTED|Safety/Tolerability of Dec/MEC||12
1492273|NCT01729845|3650866|P2|STARTED|Safety/Tolerability of Dec/MEC||34
1492274|NCT01729845|3650867|P1|STARTED|Safety/Tolerability of Dec/MEC||6
1492275|NCT01729819|3650880|P2|NOT COMPLETED|Overall Study||7
1492276|NCT01729819|3650881|P1|NOT COMPLETED|Overall Study||6
1492277|NCT01729819|3650880|P2|COMPLETED|Overall Study||50
1492278|NCT01729819|3650881|P1|COMPLETED|Overall Study||43
1492279|NCT01729819|3650880|P2|STARTED|Overall Study||57
1492280|NCT01729819|3650881|P1|STARTED|Overall Study||49
1492281|NCT01729754|3650900|P10|NOT COMPLETED|Part 3||7
1492282|NCT01729754|3650901|P9|NOT COMPLETED|Part 3||1
1492283|NCT01729754|3650902|P8|NOT COMPLETED|Part 3||3
1492284|NCT01729754|3650903|P7|NOT COMPLETED|Part 3||0
1492285|NCT01729754|3650904|P6|NOT COMPLETED|Part 3||13
1492286|NCT01729754|3650905|P5|NOT COMPLETED|Part 3||4
1492287|NCT01729754|3650906|P4|NOT COMPLETED|Part 3||0
1492288|NCT01729754|3650907|P3|NOT COMPLETED|Part 3||5
1492289|NCT01729754|3650908|P2|NOT COMPLETED|Part 3||5
1492290|NCT01729754|3650909|P1|NOT COMPLETED|Part 3||0
1492291|NCT01729754|3650900|P10|COMPLETED|Part 3||114
1492292|NCT01729754|3650901|P9|COMPLETED|Part 3||65
1492293|NCT01729754|3650902|P8|COMPLETED|Part 3||66
1492294|NCT01729754|3650903|P7|COMPLETED|Part 3||0
1492295|NCT01729754|3650904|P6|COMPLETED|Part 3||224
1492296|NCT01729754|3650905|P5|COMPLETED|Part 3||17
1492297|NCT01729754|3650906|P4|COMPLETED|Part 3||0
1492298|NCT01729754|3650907|P3|COMPLETED|Part 3||105
1492299|NCT01729754|3650908|P2|COMPLETED|Part 3||165
1492300|NCT01729754|3650909|P1|COMPLETED|Part 3||0
1492301|NCT01729754|3650900|P10|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
1492302|NCT01729754|3650901|P9|STARTED|Part 3||66
1492303|NCT01729754|3650902|P8|STARTED|Part 3||69
1492304|NCT01729754|3650903|P7|STARTED|Part 3||0
1492305|NCT01729754|3650904|P6|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
1492306|NCT01729754|3650905|P5|STARTED|Part 3||21
1492307|NCT01729754|3650906|P4|STARTED|Part 3||0
1492308|NCT01729754|3650907|P3|STARTED|Part 3||110
1492309|NCT01729754|3650908|P2|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
1492310|NCT01729754|3650909|P1|STARTED|Part 3||0
1492311|NCT01729754|3650900|P10|NOT COMPLETED|Part 2||12
1492312|NCT01729754|3650901|P9|NOT COMPLETED|Part 2||4
1492313|NCT01729754|3650902|P8|NOT COMPLETED|Part 2||3
1492314|NCT01729754|3650903|P7|NOT COMPLETED|Part 2||0
1492315|NCT01729754|3650904|P6|NOT COMPLETED|Part 2||0
1492316|NCT01729754|3650905|P5|NOT COMPLETED|Part 2||0
1492317|NCT01729754|3650906|P4|NOT COMPLETED|Part 2||5
1492318|NCT01729754|3650907|P3|NOT COMPLETED|Part 2||0
1492319|NCT01729754|3650908|P2|NOT COMPLETED|Part 2||0
1492320|NCT01729754|3650909|P1|NOT COMPLETED|Part 2||6
1492321|NCT01729754|3650900|P10|COMPLETED|Part 2||277
1492322|NCT01729754|3650901|P9|COMPLETED|Part 2||66
1492323|NCT01729754|3650902|P8|COMPLETED|Part 2||69
1492324|NCT01729754|3650903|P7|COMPLETED|Part 2||0
1492325|NCT01729754|3650904|P6|COMPLETED|Part 2||268
1492326|NCT01729754|3650905|P5|COMPLETED|Part 2||21
1492327|NCT01729754|3650906|P4|COMPLETED|Part 2||0
1492328|NCT01729754|3650907|P3|COMPLETED|Part 2||110
1492329|NCT01729754|3650908|P2|COMPLETED|Part 2||184
1492330|NCT01729754|3650909|P1|COMPLETED|Part 2||0
1492331|NCT01729754|3650900|P10|STARTED|Part 2||289
1492332|NCT01729754|3650901|P9|STARTED|Part 2||70
1492333|NCT01729754|3650902|P8|STARTED|Part 2||72
1492334|NCT01729754|3650903|P7|STARTED|Part 2||0
1492335|NCT01729754|3650904|P6|STARTED|Part 2||268
1492336|NCT01729754|3650905|P5|STARTED|Part 2||21
1492337|NCT01729754|3650906|P4|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
1492338|NCT01729754|3650907|P3|STARTED|Part 2||110
1492339|NCT01729754|3650908|P2|STARTED|Part 2||184
1492340|NCT01729754|3650909|P1|STARTED|Part 2||6
1492341|NCT01729754|3650900|P10|NOT COMPLETED|Part 1||24
1492342|NCT01729754|3650901|P9|NOT COMPLETED|Part 1||0
1492343|NCT01729754|3650902|P8|NOT COMPLETED|Part 1||0
1492344|NCT01729754|3650903|P7|NOT COMPLETED|Part 1||14
1492345|NCT01729754|3650904|P6|NOT COMPLETED|Part 1||0
1492346|NCT01729754|3650905|P5|NOT COMPLETED|Part 1||0
1492347|NCT01729754|3650906|P4|NOT COMPLETED|Part 1||12
1492348|NCT01729754|3650907|P3|NOT COMPLETED|Part 1||0
1492349|NCT01729754|3650908|P2|NOT COMPLETED|Part 1||0
1492350|NCT01729754|3650909|P1|NOT COMPLETED|Part 1||14
1492351|NCT01729754|3650900|P10|COMPLETED|Part 1||289
1492352|NCT01729754|3650901|P9|COMPLETED|Part 1||70
1492353|NCT01729754|3650902|P8|COMPLETED|Part 1||72
1492354|NCT01729754|3650903|P7|COMPLETED|Part 1||0
1492355|NCT01729754|3650904|P6|COMPLETED|Part 1||268
1492356|NCT01729754|3650905|P5|COMPLETED|Part 1||21
1492357|NCT01729754|3650906|P4|COMPLETED|Part 1||6
1492358|NCT01729754|3650907|P3|COMPLETED|Part 1||110
1492359|NCT01729754|3650908|P2|COMPLETED|Part 1||184
1492360|NCT01729754|3650909|P1|COMPLETED|Part 1||6
1492361|NCT01729754|3650900|P10|STARTED|Part 1||313
1492362|NCT01729754|3650901|P9|STARTED|Part 1||70
1492363|NCT01729754|3650902|P8|STARTED|Part 1||72
1492364|NCT01729754|3650903|P7|STARTED|Part 1||14
1492365|NCT01729754|3650904|P6|STARTED|Part 1||268
1492366|NCT01729754|3650905|P5|STARTED|Part 1||21
1492367|NCT01729754|3650906|P4|STARTED|Part 1||18
1492368|NCT01729754|3650907|P3|STARTED|Part 1||110
1492369|NCT01729754|3650908|P2|STARTED|Part 1||184
1492370|NCT01729754|3650909|P1|STARTED|Part 1||20
1492371|NCT01729728|3651116|P3|NOT COMPLETED|Overall Study||1
1492372|NCT01729728|3651117|P2|NOT COMPLETED|Overall Study||6
1492373|NCT01729728|3651118|P1|NOT COMPLETED|Overall Study||1
1492374|NCT01729728|3651116|P3|COMPLETED|Overall Study||16
1492375|NCT01729728|3651117|P2|COMPLETED|Overall Study||22
1492376|NCT01729728|3651118|P1|COMPLETED|Overall Study||20
1492377|NCT01729728|3651116|P3|STARTED|Overall Study||17
1492378|NCT01729728|3651117|P2|STARTED|Overall Study||28
1492379|NCT01729728|3651118|P1|STARTED|Overall Study||21
1492380|NCT01729559|3651251|P2|NOT COMPLETED|Overall Study||28
1492381|NCT01729559|3651252|P1|NOT COMPLETED|Overall Study||31
1492382|NCT01729559|3651251|P2|COMPLETED|Overall Study||216
1492383|NCT01729559|3651252|P1|COMPLETED|Overall Study||220
1492384|NCT01729559|3651251|P2|STARTED|Overall Study||244
1492385|NCT01729559|3651252|P1|STARTED|Overall Study||251
1492386|NCT01729338|3651264|P1|NOT COMPLETED|Overall Study||2
1492387|NCT01729338|3651264|P1|COMPLETED|Overall Study||14
1492388|NCT01729338|3651264|P1|STARTED|Overall Study||16
1492389|NCT01729247|3651279|P1|NOT COMPLETED|Overall Study||0
1492390|NCT01729247|3651279|P1|COMPLETED|Overall Study||50
1492391|NCT01729247|3651279|P1|STARTED|Overall Study||50
1492392|NCT01729039|3651295|P2|NOT COMPLETED|Overall Study||12
1492393|NCT01729039|3651296|P1|NOT COMPLETED|Overall Study||10
1492394|NCT01729039|3651295|P2|COMPLETED|Overall Study||14
1492395|NCT01729039|3651296|P1|COMPLETED|Overall Study||13
1492396|NCT01729039|3651295|P2|STARTED|Overall Study||26
1492397|NCT01729039|3651296|P1|STARTED|Overall Study||23
1492398|NCT01729026|3651312|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
1492399|NCT01729026|3651313|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
1492400|NCT01729026|3651312|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
1492401|NCT01729026|3651313|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
1492402|NCT01729026|3651312|P2|STARTED|3-month to 6-month (Final) Follow-up||8
1492403|NCT01729026|3651313|P1|STARTED|3-month to 6-month (Final) Follow-up||7
1492404|NCT01729026|3651312|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
1492405|NCT01729026|3651313|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
1492406|NCT01729026|3651312|P2|COMPLETED|Randomization to 3-month Follow-up||8
1492407|NCT01729026|3651313|P1|COMPLETED|Randomization to 3-month Follow-up||7
1492408|NCT01729026|3651312|P2|STARTED|Randomization to 3-month Follow-up||10
1492409|NCT01729026|3651313|P1|STARTED|Randomization to 3-month Follow-up||9
1492410|NCT01728792|3651324|P5|NOT COMPLETED|Overall Study||0
1492411|NCT01728792|3651325|P4|NOT COMPLETED|Overall Study||3
1492412|NCT01728792|3651326|P3|NOT COMPLETED|Overall Study||4
1492413|NCT01728792|3651327|P2|NOT COMPLETED|Overall Study||2
1492414|NCT01728792|3651328|P1|NOT COMPLETED|Overall Study||3
1492415|NCT01728792|3651324|P5|COMPLETED|Overall Study||16
1492416|NCT01728792|3651325|P4|COMPLETED|Overall Study||14
1492417|NCT01728792|3651326|P3|COMPLETED|Overall Study||13
1492418|NCT01728792|3651327|P2|COMPLETED|Overall Study||14
1492419|NCT01728792|3651328|P1|COMPLETED|Overall Study||11
1492420|NCT01728792|3651324|P5|STARTED|Overall Study||16
1492421|NCT01728792|3651325|P4|STARTED|Overall Study||17
1492422|NCT01728792|3651326|P3|STARTED|Overall Study||17
1492423|NCT01728792|3651327|P2|STARTED|Overall Study||16
1492424|NCT01728792|3651328|P1|STARTED|Overall Study||14
1492425|NCT01728584|3651379|P4|NOT COMPLETED|Overall Study||1
1492426|NCT01728584|3651380|P3|NOT COMPLETED|Overall Study||1
1492427|NCT01728584|3651381|P2|NOT COMPLETED|Overall Study||0
1492428|NCT01728584|3651382|P1|NOT COMPLETED|Overall Study||8
1492429|NCT01728584|3651379|P4|COMPLETED|Overall Study||29
1492430|NCT01728584|3651380|P3|COMPLETED|Overall Study||30
1492431|NCT01728584|3651381|P2|COMPLETED|Overall Study||30
1492432|NCT01728584|3651382|P1|COMPLETED|Overall Study||28
1492433|NCT01728584|3651379|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
1492434|NCT01728584|3651380|P3|STARTED|Overall Study|Randomized|31
1492435|NCT01728584|3651381|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
1492436|NCT01728584|3651382|P1|STARTED|Overall Study|Randomized|36
1492437|NCT01728376|3651440|P6|NOT COMPLETED|Overall Study||2
1492438|NCT01728376|3651441|P5|NOT COMPLETED|Overall Study||2
1492439|NCT01728376|3651442|P4|NOT COMPLETED|Overall Study||2
1492440|NCT01728376|3651443|P3|NOT COMPLETED|Overall Study||2
1492441|NCT01728376|3651444|P2|NOT COMPLETED|Overall Study||2
1492442|NCT01728376|3651445|P1|NOT COMPLETED|Overall Study||4
1492443|NCT01728376|3651440|P6|COMPLETED|Overall Study||5
1492444|NCT01728376|3651441|P5|COMPLETED|Overall Study||12
1492445|NCT01728376|3651442|P4|COMPLETED|Overall Study||7
1492446|NCT01728376|3651443|P3|COMPLETED|Overall Study||17
1492447|NCT01728376|3651444|P2|COMPLETED|Overall Study||9
1492448|NCT01728376|3651445|P1|COMPLETED|Overall Study||18
1492449|NCT01728376|3651440|P6|Treated|Overall Study||7
1492450|NCT01728376|3651441|P5|Treated|Overall Study||14
1492451|NCT01728376|3651442|P4|Treated|Overall Study||9
1492452|NCT01728376|3651443|P3|Treated|Overall Study||19
1492453|NCT01728376|3651444|P2|Treated|Overall Study||10
1492454|NCT01728376|3651445|P1|Treated|Overall Study||22
1492455|NCT01728376|3651440|P6|STARTED|Overall Study||7
1492456|NCT01728376|3651441|P5|STARTED|Overall Study||14
1492457|NCT01728376|3651442|P4|STARTED|Overall Study||9
1492458|NCT01728376|3651443|P3|STARTED|Overall Study||19
1492459|NCT01728376|3651444|P2|STARTED|Overall Study||11
1492460|NCT01728376|3651445|P1|STARTED|Overall Study||22
1492461|NCT01728337|3651507|P1|NOT COMPLETED|Overall Study||0
1492462|NCT01728337|3651507|P1|COMPLETED|Overall Study||80
1492463|NCT01728337|3651507|P1|STARTED|Overall Study||80
1492464|NCT01728324|3651518|P3|NOT COMPLETED|Termination of RBV||15
1492465|NCT01728324|3651519|P2|NOT COMPLETED|Termination of RBV||37
1492466|NCT01728324|3651520|P1|NOT COMPLETED|Termination of RBV||39
1492467|NCT01728324|3651518|P3|COMPLETED|Termination of RBV||57
1492468|NCT01728324|3651519|P2|COMPLETED|Termination of RBV||176
1492469|NCT01728324|3651520|P1|COMPLETED|Termination of RBV||172
1492470|NCT01728324|3651518|P3|STARTED|Termination of RBV||72
1492471|NCT01728324|3651519|P2|STARTED|Termination of RBV||213
1492472|NCT01728324|3651520|P1|STARTED|Termination of RBV||211
1492473|NCT01728324|3651518|P3|NOT COMPLETED|Termination of FDV||14
1492474|NCT01728324|3651519|P2|NOT COMPLETED|Termination of FDV||36
1492475|NCT01728324|3651520|P1|NOT COMPLETED|Termination of FDV||38
1492476|NCT01728324|3651518|P3|COMPLETED|Termination of FDV||58
1492477|NCT01728324|3651519|P2|COMPLETED|Termination of FDV||177
1492478|NCT01728324|3651520|P1|COMPLETED|Termination of FDV||173
1492479|NCT01728324|3651518|P3|STARTED|Termination of FDV||72
1492480|NCT01728324|3651519|P2|STARTED|Termination of FDV||213
1492481|NCT01728324|3651520|P1|STARTED|Termination of FDV||211
1492482|NCT01728324|3651518|P3|NOT COMPLETED|Termination of DBV||14
1492483|NCT01728324|3651519|P2|NOT COMPLETED|Termination of DBV||36
1492484|NCT01728324|3651520|P1|NOT COMPLETED|Termination of DBV||38
1492485|NCT01728324|3651518|P3|COMPLETED|Termination of DBV||58
1492486|NCT01728324|3651519|P2|COMPLETED|Termination of DBV||177
1492487|NCT01728324|3651520|P1|COMPLETED|Termination of DBV||173
1492488|NCT01728324|3651518|P3|STARTED|Termination of DBV||72
1492489|NCT01728324|3651519|P2|STARTED|Termination of DBV||213
1492490|NCT01728324|3651520|P1|STARTED|Termination of DBV||211
1492491|NCT01728246|3651541|P2|NOT COMPLETED|Overall Study||36
1492492|NCT01728246|3651542|P1|NOT COMPLETED|Overall Study||36
1492493|NCT01728246|3651541|P2|COMPLETED|Overall Study||195
1492494|NCT01728246|3651542|P1|COMPLETED|Overall Study||206
1492495|NCT01728246|3651541|P2|STARTED|Overall Study||231
1492496|NCT01728246|3651542|P1|STARTED|Overall Study||242
1492497|NCT01728116|3651560|P2|NOT COMPLETED|Overall Study||47
1492498|NCT01728116|3651561|P1|NOT COMPLETED|Overall Study||161
1492499|NCT01728116|3651560|P2|COMPLETED|Overall Study|Completed to Week 52|60
1492500|NCT01728116|3651561|P1|COMPLETED|Overall Study|Completed to Week 78|52
1492501|NCT01728116|3651560|P2|STARTED|Overall Study|Sham mITT subjects|107
1492502|NCT01728116|3651561|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
1492503|NCT01728077|3651586|P2|NOT COMPLETED|Overall Study||5
1492504|NCT01728077|3651587|P1|NOT COMPLETED|Overall Study||8
1492505|NCT01728077|3651586|P2|COMPLETED|Overall Study||2
1492506|NCT01728077|3651587|P1|COMPLETED|Overall Study||11
1492507|NCT01728077|3651586|P2|STARTED|Overall Study||7
1492508|NCT01728077|3651587|P1|STARTED|Overall Study||19
1492509|NCT01727895|3651602|P2|NOT COMPLETED|Overall Study||0
1492510|NCT01727895|3651603|P1|NOT COMPLETED|Overall Study||0
1492511|NCT01727895|3651602|P2|COMPLETED|Overall Study||5
1492512|NCT01727895|3651603|P1|COMPLETED|Overall Study||10
1492513|NCT01727895|3651602|P2|STARTED|Overall Study||5
1492514|NCT01727895|3651603|P1|STARTED|Overall Study||10
1492515|NCT01727791|3651609|P1|NOT COMPLETED|Overall Study||0
1492516|NCT01727791|3651609|P1|COMPLETED|Overall Study||10
1492517|NCT01727791|3651609|P1|STARTED|Overall Study||10
1492518|NCT01727726|3651642|P3|NOT COMPLETED|Overall Study||20
1492519|NCT01727726|3651643|P2|NOT COMPLETED|Overall Study||14
1492520|NCT01727726|3651644|P1|NOT COMPLETED|Overall Study||26
1492521|NCT01727726|3651642|P3|COMPLETED|Overall Study||186
1492522|NCT01727726|3651643|P2|COMPLETED|Overall Study||86
1492523|NCT01727726|3651644|P1|COMPLETED|Overall Study||171
1492524|NCT01727726|3651642|P3|STARTED|Overall Study||206
1492525|NCT01727726|3651643|P2|STARTED|Overall Study||100
1492526|NCT01727726|3651644|P1|STARTED|Overall Study||197
1492527|NCT01727713|3651676|P1|NOT COMPLETED|Overall Study||35
1492528|NCT01727713|3651676|P1|COMPLETED|Overall Study||75
1492529|NCT01727713|3651676|P1|STARTED|Overall Study||110
1492530|NCT01727700|3651703|P3|NOT COMPLETED|Overall Study||2
1492531|NCT01727700|3651704|P2|NOT COMPLETED|Overall Study||10
1492532|NCT01727700|3651705|P1|NOT COMPLETED|Overall Study||2
1492533|NCT01727700|3651703|P3|COMPLETED|Overall Study||42
1492534|NCT01727700|3651704|P2|COMPLETED|Overall Study||35
1492535|NCT01727700|3651705|P1|COMPLETED|Overall Study||42
1492536|NCT01727700|3651703|P3|STARTED|Overall Study||44
1492537|NCT01727700|3651704|P2|STARTED|Overall Study||45
1492538|NCT01727700|3651705|P1|STARTED|Overall Study||44
1492539|NCT01727505|3651728|P2|NOT COMPLETED|Second 24 Hours||1
1492540|NCT01727505|3651729|P1|NOT COMPLETED|Second 24 Hours||0
1492541|NCT01727505|3651728|P2|COMPLETED|Second 24 Hours||10
1492542|NCT01727505|3651729|P1|COMPLETED|Second 24 Hours||14
1492543|NCT01727505|3651728|P2|STARTED|Second 24 Hours||11
1492544|NCT01727505|3651729|P1|STARTED|Second 24 Hours||14
1492545|NCT01727505|3651728|P2|NOT COMPLETED|First 24 Hours||1
1492546|NCT01727505|3651729|P1|NOT COMPLETED|First 24 Hours||0
1492547|NCT01727505|3651728|P2|COMPLETED|First 24 Hours||11
1492548|NCT01727505|3651729|P1|COMPLETED|First 24 Hours||14
1492549|NCT01727505|3651728|P2|STARTED|First 24 Hours||12
1492550|NCT01727505|3651729|P1|STARTED|First 24 Hours||14
1492551|NCT01727414|3651747|P2|NOT COMPLETED|Overall Study||0
1492552|NCT01727414|3651748|P1|NOT COMPLETED|Overall Study||3
1492553|NCT01727414|3651747|P2|COMPLETED|Overall Study||45
1492554|NCT01727414|3651748|P1|COMPLETED|Overall Study||123
1492555|NCT01727414|3651747|P2|STARTED|Overall Study||45
1492556|NCT01727414|3651748|P1|STARTED|Overall Study||126
1492557|NCT01727297|3651754|P2|NOT COMPLETED|Overall Study||51
1492558|NCT01727297|3651755|P1|NOT COMPLETED|Overall Study||102
1492559|NCT01727297|3651754|P2|COMPLETED|Overall Study||0
1492560|NCT01727297|3651755|P1|COMPLETED|Overall Study||293
1492561|NCT01727297|3651754|P2|STARTED|Overall Study||51
1492562|NCT01727297|3651755|P1|STARTED|Overall Study||395
1492563|NCT01727258|3651771|P3|NOT COMPLETED|Overall Study||1
1492564|NCT01727258|3651772|P2|NOT COMPLETED|Overall Study||3
1492565|NCT01727258|3651773|P1|NOT COMPLETED|Overall Study||2
1492566|NCT01727258|3651771|P3|COMPLETED|Overall Study||50
1492567|NCT01727258|3651772|P2|COMPLETED|Overall Study||48
1492568|NCT01727258|3651773|P1|COMPLETED|Overall Study||49
1492569|NCT01727258|3651771|P3|STARTED|Overall Study||51
1492570|NCT01727258|3651772|P2|STARTED|Overall Study||51
1492571|NCT01727258|3651773|P1|STARTED|Overall Study||51
1492572|NCT01727180|3651796|P1|NOT COMPLETED|Overall Study||0
1492573|NCT01727180|3651796|P1|COMPLETED|Overall Study||108
1492574|NCT01727180|3651796|P1|STARTED|Overall Study||108
1492575|NCT01727167|3651802|P2|NOT COMPLETED|Overall Study||0
1492576|NCT01727167|3651803|P1|NOT COMPLETED|Overall Study||0
1492577|NCT01727167|3651802|P2|COMPLETED|Overall Study||0
1492578|NCT01727167|3651803|P1|COMPLETED|Overall Study||1
1492579|NCT01727167|3651802|P2|STARTED|Overall Study||0
1492580|NCT01727167|3651803|P1|STARTED|Overall Study||1
1492581|NCT01727141|3651815|P4|NOT COMPLETED|Overall Study||15
1492582|NCT01727141|3651816|P3|NOT COMPLETED|Overall Study||3
1492583|NCT01727141|3651817|P2|NOT COMPLETED|Overall Study||9
1492584|NCT01727141|3651818|P1|NOT COMPLETED|Overall Study||5
1492585|NCT01727141|3651815|P4|COMPLETED|Overall Study||246
1492586|NCT01727141|3651816|P3|COMPLETED|Overall Study||258
1492587|NCT01727141|3651817|P2|COMPLETED|Overall Study||251
1492588|NCT01727141|3651818|P1|COMPLETED|Overall Study||255
1492589|NCT01727141|3651815|P4|Full Analysis Set|Overall Study||261
1492590|NCT01727141|3651816|P3|Full Analysis Set|Overall Study||261
1492591|NCT01727141|3651817|P2|Full Analysis Set|Overall Study||260
1492592|NCT01727141|3651818|P1|Full Analysis Set|Overall Study||258
1492593|NCT01727141|3651815|P4|Safety Set|Overall Study||260
1492594|NCT01727141|3651816|P3|Safety Set|Overall Study||262
1492595|NCT01727141|3651817|P2|Safety Set|Overall Study||260
1492596|NCT01727141|3651818|P1|Safety Set|Overall Study||258
1492597|NCT01727141|3651815|P4|STARTED|Overall Study||261
1492598|NCT01727141|3651816|P3|STARTED|Overall Study||261
1492599|NCT01727141|3651817|P2|STARTED|Overall Study||260
1492600|NCT01727141|3651818|P1|STARTED|Overall Study||260
1492601|NCT01727089|3651870|P2|NOT COMPLETED|Overall Study||0
1492602|NCT01727089|3651871|P1|NOT COMPLETED|Overall Study||0
1492603|NCT01727089|3651870|P2|COMPLETED|Overall Study||30
1492604|NCT01727089|3651871|P1|COMPLETED|Overall Study||29
1492605|NCT01727089|3651870|P2|STARTED|Overall Study||30
1492606|NCT01727089|3651871|P1|STARTED|Overall Study||29
1492607|NCT01727024|3651883|P2|NOT COMPLETED|Period 2||0
1492608|NCT01727024|3651884|P1|NOT COMPLETED|Period 2||0
1492609|NCT01727024|3651883|P2|COMPLETED|Period 2||64
1492610|NCT01727024|3651884|P1|COMPLETED|Period 2||68
1492611|NCT01727024|3651883|P2|STARTED|Period 2||64
1492612|NCT01727024|3651884|P1|STARTED|Period 2||68
1492613|NCT01727024|3651883|P2|NOT COMPLETED|Period 1||4
1492614|NCT01727024|3651884|P1|NOT COMPLETED|Period 1||3
1492615|NCT01727024|3651883|P2|COMPLETED|Period 1||64
1492616|NCT01727024|3651884|P1|COMPLETED|Period 1||68
1492617|NCT01727024|3651883|P2|STARTED|Period 1||68
1492618|NCT01727024|3651884|P1|STARTED|Period 1||71
1492619|NCT01726803|3651899|P2|NOT COMPLETED|Overall Study||1
1492620|NCT01726803|3651900|P1|NOT COMPLETED|Overall Study||7
1492621|NCT01726803|3651899|P2|COMPLETED|Overall Study||107
1492622|NCT01726803|3651900|P1|COMPLETED|Overall Study||105
1492623|NCT01726803|3651899|P2|STARTED|Overall Study||108
1492624|NCT01726803|3651900|P1|STARTED|Overall Study||112
1492625|NCT01726673|3651922|P2|NOT COMPLETED|Overall Study||3
1492626|NCT01726673|3651923|P1|NOT COMPLETED|Overall Study||6
1492627|NCT01726673|3651922|P2|COMPLETED|Overall Study||21
1492628|NCT01726673|3651923|P1|COMPLETED|Overall Study||24
1492629|NCT01726673|3651922|P2|STARTED|Overall Study||24
1492630|NCT01726673|3651923|P1|STARTED|Overall Study||30
1492631|NCT01726621|3651933|P1|NOT COMPLETED|Overall Study||4
1492632|NCT01726621|3651933|P1|COMPLETED|Overall Study||51
1492633|NCT01726621|3651933|P1|STARTED|Overall Study||55
1492634|NCT01726517|3651942|P5|NOT COMPLETED|Overall Study||0
1492635|NCT01726517|3651943|P4|NOT COMPLETED|Overall Study||0
1492636|NCT01726517|3651944|P3|NOT COMPLETED|Overall Study||1
1492637|NCT01726517|3651945|P2|NOT COMPLETED|Overall Study||0
1492638|NCT01726517|3651946|P1|NOT COMPLETED|Overall Study||0
1492639|NCT01726517|3651942|P5|COMPLETED|Overall Study||21
1492640|NCT01726517|3651943|P4|COMPLETED|Overall Study||19
1492641|NCT01726517|3651944|P3|COMPLETED|Overall Study||18
1492642|NCT01726517|3651945|P2|COMPLETED|Overall Study||21
1492643|NCT01726517|3651946|P1|COMPLETED|Overall Study||20
1492644|NCT01726517|3651942|P5|STARTED|Overall Study||21
1492645|NCT01726517|3651943|P4|STARTED|Overall Study||19
1492646|NCT01726517|3651944|P3|STARTED|Overall Study||19
1492647|NCT01726517|3651945|P2|STARTED|Overall Study||21
1492648|NCT01726517|3651946|P1|STARTED|Overall Study||20
1492649|NCT01726504|3651975|P2|NOT COMPLETED|Overall Study||28
1492650|NCT01726504|3651976|P1|NOT COMPLETED|Overall Study||12
1492651|NCT01726504|3651975|P2|COMPLETED|Overall Study||511
1492652|NCT01726504|3651976|P1|COMPLETED|Overall Study||524
1492653|NCT01726504|3651975|P2|STARTED|Overall Study||539
1492654|NCT01726504|3651976|P1|STARTED|Overall Study||536
1492655|NCT01726335|3652002|P1|NOT COMPLETED|Overall Study||24
1492656|NCT01726335|3652002|P1|COMPLETED|Overall Study||29
1492657|NCT01726335|3652002|P1|STARTED|Overall Study||53
1492658|NCT01726049|3652020|P2|NOT COMPLETED|Overall Study||4
1492659|NCT01726049|3652021|P1|NOT COMPLETED|Overall Study||5
1492660|NCT01726049|3652020|P2|COMPLETED|Overall Study||22
1492661|NCT01726049|3652021|P1|COMPLETED|Overall Study||21
1492662|NCT01726049|3652020|P2|STARTED|Overall Study||26
1492663|NCT01726049|3652021|P1|STARTED|Overall Study||26
1492664|NCT01726023|3652035|P2|NOT COMPLETED|Overall Study||26
1492665|NCT01726023|3652036|P1|NOT COMPLETED|Overall Study||29
1492666|NCT01726023|3652035|P2|COMPLETED|Overall Study||196
1492667|NCT01726023|3652036|P1|COMPLETED|Overall Study||190
1492668|NCT01726023|3652035|P2|STARTED|Overall Study||222
1492669|NCT01726023|3652036|P1|STARTED|Overall Study||219
1492670|NCT01725984|3652128|P2|NOT COMPLETED|Overall Study||0
1492671|NCT01725984|3652129|P1|NOT COMPLETED|Overall Study||0
1492672|NCT01725984|3652128|P2|COMPLETED|Overall Study||41
1492673|NCT01725984|3652129|P1|COMPLETED|Overall Study||39
1492674|NCT01725984|3652128|P2|STARTED|Overall Study||41
1492675|NCT01725984|3652129|P1|STARTED|Overall Study||39
1492676|NCT01725750|3652155|P2|NOT COMPLETED|Overall Study||10
1492677|NCT01725750|3652156|P1|NOT COMPLETED|Overall Study||2
1492678|NCT01725750|3652155|P2|COMPLETED|Overall Study||34
1492679|NCT01725750|3652156|P1|COMPLETED|Overall Study||42
1492680|NCT01725750|3652155|P2|STARTED|Overall Study||44
1492681|NCT01725750|3652156|P1|STARTED|Overall Study||44
1492682|NCT01725529|3652183|P3|NOT COMPLETED|Overall Study||10
1492683|NCT01725529|3652184|P2|NOT COMPLETED|Overall Study||16
1492684|NCT01725529|3652185|P1|NOT COMPLETED|Overall Study||15
1492685|NCT01725529|3652183|P3|COMPLETED|Overall Study||142
1492686|NCT01725529|3652184|P2|COMPLETED|Overall Study||137
1492687|NCT01725529|3652185|P1|COMPLETED|Overall Study||137
1492688|NCT01725529|3652183|P3|STARTED|Overall Study||152
1492689|NCT01725529|3652184|P2|STARTED|Overall Study||153
1492690|NCT01725529|3652185|P1|STARTED|Overall Study||152
1492691|NCT01725451|3652211|P4|NOT COMPLETED|Period 6||0
1492692|NCT01725451|3652212|P3|NOT COMPLETED|Period 6||0
1492693|NCT01725451|3652213|P2|NOT COMPLETED|Period 6||0
1492694|NCT01725451|3652214|P1|NOT COMPLETED|Period 6||0
1492695|NCT01725451|3652211|P4|COMPLETED|Period 6||7
1492696|NCT01725451|3652212|P3|COMPLETED|Period 6||6
1492697|NCT01725451|3652213|P2|COMPLETED|Period 6||6
1492698|NCT01725451|3652214|P1|COMPLETED|Period 6||7
1492699|NCT01725451|3652211|P4|STARTED|Period 6||7
1492700|NCT01725451|3652212|P3|STARTED|Period 6||6
1492701|NCT01725451|3652213|P2|STARTED|Period 6||6
1492702|NCT01725451|3652214|P1|STARTED|Period 6||7
1492703|NCT01725451|3652211|P4|NOT COMPLETED|Washout From Period 5||0
1492704|NCT01725451|3652212|P3|NOT COMPLETED|Washout From Period 5||0
1492705|NCT01725451|3652213|P2|NOT COMPLETED|Washout From Period 5||0
1492706|NCT01725451|3652214|P1|NOT COMPLETED|Washout From Period 5||0
1492707|NCT01725451|3652211|P4|COMPLETED|Washout From Period 5||7
1492708|NCT01725451|3652212|P3|COMPLETED|Washout From Period 5||6
1492709|NCT01725451|3652213|P2|COMPLETED|Washout From Period 5||6
1492710|NCT01725451|3652214|P1|COMPLETED|Washout From Period 5||7
1492711|NCT01725451|3652211|P4|STARTED|Washout From Period 5||7
1492712|NCT01725451|3652212|P3|STARTED|Washout From Period 5||6
1492713|NCT01725451|3652213|P2|STARTED|Washout From Period 5||6
1492714|NCT01725451|3652214|P1|STARTED|Washout From Period 5||7
1492715|NCT01725451|3652211|P4|NOT COMPLETED|Period 5||0
1492716|NCT01725451|3652212|P3|NOT COMPLETED|Period 5||0
1492717|NCT01725451|3652213|P2|NOT COMPLETED|Period 5||0
1492718|NCT01725451|3652214|P1|NOT COMPLETED|Period 5||0
1492719|NCT01725451|3652211|P4|COMPLETED|Period 5||7
1492720|NCT01725451|3652212|P3|COMPLETED|Period 5||6
1492721|NCT01725451|3652213|P2|COMPLETED|Period 5||6
1492722|NCT01725451|3652214|P1|COMPLETED|Period 5||7
1492723|NCT01725451|3652211|P4|STARTED|Period 5||7
1492724|NCT01725451|3652212|P3|STARTED|Period 5||6
1492725|NCT01725451|3652213|P2|STARTED|Period 5||6
1492726|NCT01725451|3652214|P1|STARTED|Period 5||7
1492727|NCT01725451|3652211|P4|NOT COMPLETED|Washout From Period 4||0
1492728|NCT01725451|3652212|P3|NOT COMPLETED|Washout From Period 4||0
1492729|NCT01725451|3652213|P2|NOT COMPLETED|Washout From Period 4||0
1492730|NCT01725451|3652214|P1|NOT COMPLETED|Washout From Period 4||0
1492731|NCT01725451|3652211|P4|COMPLETED|Washout From Period 4||7
1492732|NCT01725451|3652212|P3|COMPLETED|Washout From Period 4||6
1492733|NCT01725451|3652213|P2|COMPLETED|Washout From Period 4||6
1492734|NCT01725451|3652214|P1|COMPLETED|Washout From Period 4||7
1492735|NCT01725451|3652211|P4|STARTED|Washout From Period 4||7
1492736|NCT01725451|3652212|P3|STARTED|Washout From Period 4||6
1492737|NCT01725451|3652213|P2|STARTED|Washout From Period 4||6
1492738|NCT01725451|3652214|P1|STARTED|Washout From Period 4||7
1492739|NCT01725451|3652211|P4|NOT COMPLETED|Period 4||0
1492740|NCT01725451|3652212|P3|NOT COMPLETED|Period 4||1
1492741|NCT01725451|3652213|P2|NOT COMPLETED|Period 4||0
1492742|NCT01725451|3652214|P1|NOT COMPLETED|Period 4||0
1492743|NCT01725451|3652211|P4|COMPLETED|Period 4||7
1492744|NCT01725451|3652212|P3|COMPLETED|Period 4||6
1492745|NCT01725451|3652213|P2|COMPLETED|Period 4||6
1492746|NCT01725451|3652214|P1|COMPLETED|Period 4||7
1492747|NCT01725451|3652211|P4|STARTED|Period 4||7
1492748|NCT01725451|3652212|P3|STARTED|Period 4||7
1492749|NCT01725451|3652213|P2|STARTED|Period 4||6
1492750|NCT01725451|3652214|P1|STARTED|Period 4||7
1492751|NCT01725451|3652211|P4|NOT COMPLETED|Washout From Period 3||0
1492752|NCT01725451|3652212|P3|NOT COMPLETED|Washout From Period 3||1
1492753|NCT01725451|3652213|P2|NOT COMPLETED|Washout From Period 3||1
1492754|NCT01725451|3652214|P1|NOT COMPLETED|Washout From Period 3||0
1492755|NCT01725451|3652211|P4|COMPLETED|Washout From Period 3||7
1492756|NCT01725451|3652212|P3|COMPLETED|Washout From Period 3||7
1492757|NCT01725451|3652213|P2|COMPLETED|Washout From Period 3||6
1492758|NCT01725451|3652214|P1|COMPLETED|Washout From Period 3||7
1492759|NCT01725451|3652211|P4|STARTED|Washout From Period 3||7
1492760|NCT01725451|3652212|P3|STARTED|Washout From Period 3||8
1492761|NCT01725451|3652213|P2|STARTED|Washout From Period 3||7
1492762|NCT01725451|3652214|P1|STARTED|Washout From Period 3||7
1492763|NCT01725451|3652211|P4|NOT COMPLETED|Period 3||0
1492764|NCT01725451|3652212|P3|NOT COMPLETED|Period 3||0
1492765|NCT01725451|3652213|P2|NOT COMPLETED|Period 3||0
1492766|NCT01725451|3652214|P1|NOT COMPLETED|Period 3||0
1492767|NCT01725451|3652211|P4|COMPLETED|Period 3||7
1492768|NCT01725451|3652212|P3|COMPLETED|Period 3||8
1492769|NCT01725451|3652213|P2|COMPLETED|Period 3||7
1492770|NCT01725451|3652214|P1|COMPLETED|Period 3||7
1492771|NCT01725451|3652211|P4|STARTED|Period 3||7
1492772|NCT01725451|3652212|P3|STARTED|Period 3||8
1492773|NCT01725451|3652213|P2|STARTED|Period 3||7
1492774|NCT01725451|3652214|P1|STARTED|Period 3||7
1492775|NCT01725451|3652211|P4|NOT COMPLETED|Washout From Period 2||0
1492776|NCT01725451|3652212|P3|NOT COMPLETED|Washout From Period 2||0
1492777|NCT01725451|3652213|P2|NOT COMPLETED|Washout From Period 2||0
1492778|NCT01725451|3652214|P1|NOT COMPLETED|Washout From Period 2||0
1492779|NCT01725451|3652211|P4|COMPLETED|Washout From Period 2||7
1492780|NCT01725451|3652212|P3|COMPLETED|Washout From Period 2||8
1492781|NCT01725451|3652213|P2|COMPLETED|Washout From Period 2||7
1492782|NCT01725451|3652214|P1|COMPLETED|Washout From Period 2||7
1492783|NCT01725451|3652211|P4|STARTED|Washout From Period 2||7
1492784|NCT01725451|3652212|P3|STARTED|Washout From Period 2||8
1492785|NCT01725451|3652213|P2|STARTED|Washout From Period 2||7
1492786|NCT01725451|3652214|P1|STARTED|Washout From Period 2||7
1492787|NCT01725451|3652211|P4|NOT COMPLETED|Period 2||0
1492788|NCT01725451|3652212|P3|NOT COMPLETED|Period 2||0
1492789|NCT01725451|3652213|P2|NOT COMPLETED|Period 2||0
1492790|NCT01725451|3652214|P1|NOT COMPLETED|Period 2||0
1492791|NCT01725451|3652211|P4|COMPLETED|Period 2||7
1492792|NCT01725451|3652212|P3|COMPLETED|Period 2||8
1492793|NCT01725451|3652213|P2|COMPLETED|Period 2||7
1492794|NCT01725451|3652214|P1|COMPLETED|Period 2||7
1492795|NCT01725451|3652211|P4|STARTED|Period 2||7
1492796|NCT01725451|3652212|P3|STARTED|Period 2||8
1492797|NCT01725451|3652213|P2|STARTED|Period 2||7
1492798|NCT01725451|3652214|P1|STARTED|Period 2||7
1492799|NCT01725451|3652211|P4|NOT COMPLETED|Washout From Period 1||0
1492800|NCT01725451|3652212|P3|NOT COMPLETED|Washout From Period 1||0
1492801|NCT01725451|3652213|P2|NOT COMPLETED|Washout From Period 1||0
1492802|NCT01725451|3652214|P1|NOT COMPLETED|Washout From Period 1||0
1492803|NCT01725451|3652211|P4|COMPLETED|Washout From Period 1||7
1492804|NCT01725451|3652212|P3|COMPLETED|Washout From Period 1||8
1492805|NCT01725451|3652213|P2|COMPLETED|Washout From Period 1||7
1492806|NCT01725451|3652214|P1|COMPLETED|Washout From Period 1||7
1492807|NCT01725451|3652211|P4|STARTED|Washout From Period 1||7
1492808|NCT01725451|3652212|P3|STARTED|Washout From Period 1||8
1492809|NCT01725451|3652213|P2|STARTED|Washout From Period 1||7
1492810|NCT01725451|3652214|P1|STARTED|Washout From Period 1||7
1492811|NCT01725451|3652211|P4|NOT COMPLETED|Period 1||0
1492812|NCT01725451|3652212|P3|NOT COMPLETED|Period 1||0
1492813|NCT01725451|3652213|P2|NOT COMPLETED|Period 1||0
1492814|NCT01725451|3652214|P1|NOT COMPLETED|Period 1||1
1492815|NCT01725451|3652211|P4|COMPLETED|Period 1||7
1492816|NCT01725451|3652212|P3|COMPLETED|Period 1||8
1492817|NCT01725451|3652213|P2|COMPLETED|Period 1||7
1492818|NCT01725451|3652214|P1|COMPLETED|Period 1||7
1492819|NCT01725451|3652211|P4|STARTED|Period 1||7
1492820|NCT01725451|3652212|P3|STARTED|Period 1||8
1492821|NCT01725451|3652213|P2|STARTED|Period 1||7
1492822|NCT01725451|3652214|P1|STARTED|Period 1||8
1492823|NCT01725386|3652236|P2|NOT COMPLETED|Overall Study||46
1492824|NCT01725386|3652237|P1|NOT COMPLETED|Overall Study||175
1492825|NCT01725386|3652236|P2|COMPLETED|Overall Study||17
1492826|NCT01725386|3652237|P1|COMPLETED|Overall Study||13
1492827|NCT01725386|3652236|P2|STARTED|Overall Study||63
1492828|NCT01725386|3652237|P1|STARTED|Overall Study||188
1492829|NCT01725308|3652256|P3|NOT COMPLETED|Treatment Period II||64
1492830|NCT01725308|3652257|P2|NOT COMPLETED|Treatment Period II||29
1492831|NCT01725308|3652258|P1|NOT COMPLETED|Treatment Period II||55
1492832|NCT01725308|3652256|P3|COMPLETED|Treatment Period II||74
1492833|NCT01725308|3652257|P2|COMPLETED|Treatment Period II||31
1492834|NCT01725308|3652258|P1|COMPLETED|Treatment Period II||79
1492835|NCT01725308|3652256|P3|Treated|Treatment Period II||130
1492836|NCT01725308|3652257|P2|Treated|Treatment Period II||53
1492837|NCT01725308|3652258|P1|Treated|Treatment Period II||120
1492838|NCT01725308|3652256|P3|STARTED|Treatment Period II||138
1492839|NCT01725308|3652257|P2|STARTED|Treatment Period II||60
1492840|NCT01725308|3652258|P1|STARTED|Treatment Period II||134
1492841|NCT01725308|3652256|P3|NOT COMPLETED|Treatment Period I||41
1492842|NCT01725308|3652257|P2|NOT COMPLETED|Treatment Period I||14
1492843|NCT01725308|3652258|P1|NOT COMPLETED|Treatment Period I||44
1492844|NCT01725308|3652256|P3|COMPLETED|Treatment Period I||138
1492845|NCT01725308|3652257|P2|COMPLETED|Treatment Period I||60
1492846|NCT01725308|3652258|P1|COMPLETED|Treatment Period I||134
1492847|NCT01725308|3652256|P3|Treated|Treatment Period I||179
1492848|NCT01725308|3652257|P2|Treated|Treatment Period I||74
1492849|NCT01725308|3652258|P1|Treated|Treatment Period I||177
1492850|NCT01725308|3652256|P3|STARTED|Treatment Period I||179
1492851|NCT01725308|3652257|P2|STARTED|Treatment Period I||74
1492852|NCT01725308|3652258|P1|STARTED|Treatment Period I||178
1492853|NCT01725282|3652405|P4|NOT COMPLETED|Overall Study||7
1492854|NCT01725282|3652406|P3|NOT COMPLETED|Overall Study||8
1492855|NCT01725282|3652407|P2|NOT COMPLETED|Overall Study||5
1492856|NCT01725282|3652408|P1|NOT COMPLETED|Overall Study||2
1492857|NCT01725282|3652405|P4|COMPLETED|Overall Study||36
1492858|NCT01725282|3652406|P3|COMPLETED|Overall Study||33
1492859|NCT01725282|3652407|P2|COMPLETED|Overall Study||39
1492860|NCT01725282|3652408|P1|COMPLETED|Overall Study||42
1492861|NCT01725282|3652405|P4|STARTED|Overall Study||43
1492862|NCT01725282|3652406|P3|STARTED|Overall Study||41
1492863|NCT01725282|3652407|P2|STARTED|Overall Study||44
1492864|NCT01725282|3652408|P1|STARTED|Overall Study||44
1492865|NCT01725217|3652441|P3|NOT COMPLETED|Overall Study||0
1492866|NCT01725217|3652442|P2|NOT COMPLETED|Overall Study||0
1492867|NCT01725217|3652443|P1|NOT COMPLETED|Overall Study||1
1492868|NCT01725217|3652441|P3|COMPLETED|Overall Study||66
1492869|NCT01725217|3652442|P2|COMPLETED|Overall Study||66
1492870|NCT01725217|3652443|P1|COMPLETED|Overall Study||65
1492871|NCT01725217|3652441|P3|STARTED|Overall Study||66
1492872|NCT01725217|3652442|P2|STARTED|Overall Study||66
1492873|NCT01725217|3652443|P1|STARTED|Overall Study||66
1492874|NCT01725126|3652477|P6|NOT COMPLETED|Overall Study||0
1492875|NCT01725126|3652478|P5|NOT COMPLETED|Overall Study||0
1492876|NCT01725126|3652479|P4|NOT COMPLETED|Overall Study||1
1492877|NCT01725126|3652480|P3|NOT COMPLETED|Overall Study||0
1492878|NCT01725126|3652481|P2|NOT COMPLETED|Overall Study||1
1492879|NCT01725126|3652482|P1|NOT COMPLETED|Overall Study||0
1492880|NCT01725126|3652477|P6|COMPLETED|Overall Study||12
1492881|NCT01725126|3652478|P5|COMPLETED|Overall Study||6
1492882|NCT01725126|3652479|P4|COMPLETED|Overall Study||13
1492883|NCT01725126|3652480|P3|COMPLETED|Overall Study||6
1492884|NCT01725126|3652481|P2|COMPLETED|Overall Study||10
1492885|NCT01725126|3652482|P1|COMPLETED|Overall Study||4
1492886|NCT01725126|3652477|P6|STARTED|Overall Study||12
1492887|NCT01725126|3652478|P5|STARTED|Overall Study||6
1492888|NCT01725126|3652479|P4|STARTED|Overall Study||14
1492889|NCT01725126|3652480|P3|STARTED|Overall Study||6
1492890|NCT01725126|3652481|P2|STARTED|Overall Study||11
1492891|NCT01725126|3652482|P1|STARTED|Overall Study||4
1492892|NCT01724528|3652680|P2|NOT COMPLETED|Overall Study||3
1492893|NCT01724528|3652681|P1|NOT COMPLETED|Overall Study||4
1492894|NCT01724528|3652680|P2|COMPLETED|Overall Study||170
1492895|NCT01724528|3652681|P1|COMPLETED|Overall Study||169
1492896|NCT01724528|3652680|P2|STARTED|Overall Study||173
1492897|NCT01724528|3652681|P1|STARTED|Overall Study||173
1492898|NCT01724359|3652695|P1|NOT COMPLETED|Overall Study||31
1492899|NCT01724359|3652695|P1|COMPLETED|Overall Study||64
1492900|NCT01724359|3652695|P1|STARTED|Overall Study||95
1492901|NCT01724216|3652708|P1|NOT COMPLETED|Overall Study||1
1492902|NCT01724216|3652708|P1|COMPLETED|Overall Study||10
1492903|NCT01724216|3652708|P1|STARTED|Overall Study||11
1492904|NCT01724177|3652712|P1|NOT COMPLETED|Overall Study||26
1492905|NCT01724177|3652712|P1|COMPLETED|Overall Study||0
1492906|NCT01724177|3652712|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
1492907|NCT01724177|3652712|P1|STARTED|Overall Study||26
1492908|NCT01724021|3652725|P2|NOT COMPLETED|Overall Study||133
1492909|NCT01724021|3652726|P1|NOT COMPLETED|Overall Study||127
1492910|NCT01724021|3652725|P2|COMPLETED|Overall Study||236
1492911|NCT01724021|3652726|P1|COMPLETED|Overall Study||244
1492912|NCT01724021|3652725|P2|STARTED|Overall Study||369
1492913|NCT01724021|3652726|P1|STARTED|Overall Study||371
1492914|NCT01723904|3652758|P1|NOT COMPLETED|Overall Study||11
1492915|NCT01723904|3652758|P1|COMPLETED|Overall Study||79
1492916|NCT01723904|3652758|P1|STARTED|Overall Study||90
1492917|NCT01723722|3652770|P2|NOT COMPLETED|Overall Study||0
1492918|NCT01723722|3652771|P1|NOT COMPLETED|Overall Study||0
1492919|NCT01723722|3652770|P2|COMPLETED|Overall Study||20
1492920|NCT01723722|3652771|P1|COMPLETED|Overall Study||20
1492921|NCT01723722|3652770|P2|STARTED|Overall Study||20
1492922|NCT01723722|3652771|P1|STARTED|Overall Study||20
1492923|NCT01723397|3652779|P2|NOT COMPLETED|Study Period 2||1
1492924|NCT01723397|3652780|P1|NOT COMPLETED|Study Period 2||0
1492925|NCT01723397|3652779|P2|COMPLETED|Study Period 2||5
1492926|NCT01723397|3652780|P1|COMPLETED|Study Period 2||7
1492927|NCT01723397|3652779|P2|STARTED|Study Period 2||6
1492928|NCT01723397|3652780|P1|STARTED|Study Period 2||7
1492929|NCT01723397|3652779|P2|NOT COMPLETED|Washout||0
1492930|NCT01723397|3652780|P1|NOT COMPLETED|Washout||0
1492931|NCT01723397|3652779|P2|COMPLETED|Washout||6
1492932|NCT01723397|3652780|P1|COMPLETED|Washout||7
1492933|NCT01723397|3652779|P2|STARTED|Washout||6
1492934|NCT01723397|3652780|P1|STARTED|Washout||7
1492935|NCT01723397|3652779|P2|NOT COMPLETED|Study Period 1||1
1492936|NCT01723397|3652780|P1|NOT COMPLETED|Study Period 1||0
1492937|NCT01723397|3652779|P2|COMPLETED|Study Period 1||6
1492938|NCT01723397|3652780|P1|COMPLETED|Study Period 1||7
1492939|NCT01723397|3652779|P2|STARTED|Study Period 1||7
1492940|NCT01723397|3652780|P1|STARTED|Study Period 1||7
1492941|NCT01723254|3652794|P8|NOT COMPLETED|Overall Study||3
1492942|NCT01723254|3652795|P7|NOT COMPLETED|Overall Study||1
1492943|NCT01723254|3652796|P6|NOT COMPLETED|Overall Study||2
1492944|NCT01723254|3652797|P5|NOT COMPLETED|Overall Study||2
1492945|NCT01723254|3652798|P4|NOT COMPLETED|Overall Study||2
1492946|NCT01723254|3652799|P3|NOT COMPLETED|Overall Study||3
1492947|NCT01723254|3652800|P2|NOT COMPLETED|Overall Study||3
1492948|NCT01723254|3652801|P1|NOT COMPLETED|Overall Study||1
1492949|NCT01723254|3652794|P8|COMPLETED|Overall Study||60
1492950|NCT01723254|3652795|P7|COMPLETED|Overall Study||19
1492951|NCT01723254|3652796|P6|COMPLETED|Overall Study||18
1492952|NCT01723254|3652797|P5|COMPLETED|Overall Study||18
1492953|NCT01723254|3652798|P4|COMPLETED|Overall Study||18
1492954|NCT01723254|3652799|P3|COMPLETED|Overall Study||17
1492955|NCT01723254|3652800|P2|COMPLETED|Overall Study||18
1492956|NCT01723254|3652801|P1|COMPLETED|Overall Study||5
1492957|NCT01723254|3652794|P8|STARTED|Overall Study||63
1492958|NCT01723254|3652795|P7|STARTED|Overall Study||20
1492959|NCT01723254|3652796|P6|STARTED|Overall Study||20
1492960|NCT01723254|3652797|P5|STARTED|Overall Study||20
1492961|NCT01723254|3652798|P4|STARTED|Overall Study||20
1492962|NCT01723254|3652799|P3|STARTED|Overall Study||20
1492963|NCT01723254|3652800|P2|STARTED|Overall Study||21
1492964|NCT01723254|3652801|P1|STARTED|Overall Study||6
1492965|NCT01723228|3652853|P2|NOT COMPLETED|Overall Study||11
1492966|NCT01723228|3652854|P1|NOT COMPLETED|Overall Study||8
1492967|NCT01723228|3652853|P2|COMPLETED|Overall Study||73
1492968|NCT01723228|3652854|P1|COMPLETED|Overall Study||78
1492969|NCT01723228|3652853|P2|STARTED|Overall Study||84
1492970|NCT01723228|3652854|P1|STARTED|Overall Study||86
1492971|NCT01722994|3652872|P2|NOT COMPLETED|Overall Study||17
1492972|NCT01722994|3652873|P1|NOT COMPLETED|Overall Study||25
1492973|NCT01722994|3652872|P2|COMPLETED|Overall Study||31
1492974|NCT01722994|3652873|P1|COMPLETED|Overall Study||24
1492975|NCT01722994|3652872|P2|STARTED|Overall Study||48
1492976|NCT01722994|3652873|P1|STARTED|Overall Study||49
1492977|NCT01722929|3652887|P1|NOT COMPLETED|Overall Study||0
1492978|NCT01722929|3652887|P1|COMPLETED|Overall Study||4
1492979|NCT01722929|3652887|P1|STARTED|Overall Study||4
1492980|NCT01722877|3652892|P1|NOT COMPLETED|Overall Study||2
1492981|NCT01722877|3652892|P1|COMPLETED|Overall Study||27
1492982|NCT01722877|3652892|P1|STARTED|Overall Study||29
1492983|NCT01722734|3652902|P3|NOT COMPLETED|Overall Study||2
1492984|NCT01722734|3652903|P2|NOT COMPLETED|Overall Study||1
1492985|NCT01722734|3652904|P1|NOT COMPLETED|Overall Study||2
1492986|NCT01722734|3652902|P3|COMPLETED|Overall Study||307
1492987|NCT01722734|3652903|P2|COMPLETED|Overall Study||276
1492988|NCT01722734|3652904|P1|COMPLETED|Overall Study||552
1492989|NCT01722734|3652902|P3|STARTED|Overall Study||309
1492990|NCT01722734|3652903|P2|STARTED|Overall Study||277
1492991|NCT01722734|3652904|P1|STARTED|Overall Study||554
1492992|NCT01722643|3652914|P2|NOT COMPLETED|Overall Study||1
1492993|NCT01722643|3652915|P1|NOT COMPLETED|Overall Study||0
1492994|NCT01722643|3652914|P2|COMPLETED|Overall Study||30
1492995|NCT01722643|3652915|P1|COMPLETED|Overall Study||30
1492996|NCT01722643|3652914|P2|STARTED|Overall Study||31
1492997|NCT01722643|3652915|P1|STARTED|Overall Study||30
1492998|NCT01722552|3652923|P1|NOT COMPLETED|Overall Study||4
1492999|NCT01722552|3652923|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
1493000|NCT01722552|3652923|P1|STARTED|Overall Study|Number of subjects enrolled|120
1493001|NCT01722487|3652933|P2|NOT COMPLETED|Overall Study||7
1493002|NCT01722487|3652934|P1|NOT COMPLETED|Overall Study||2
1493003|NCT01722487|3652933|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
1493004|NCT01722487|3652934|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
1493005|NCT01722487|3652933|P2|STARTED|Overall Study||133
1493006|NCT01722487|3652934|P1|STARTED|Overall Study||136
1493007|NCT01722435|3652952|P1|NOT COMPLETED|Overall Study||0
1493008|NCT01722435|3652952|P1|COMPLETED|Overall Study||78
1493009|NCT01722435|3652952|P1|STARTED|Overall Study||78
1493010|NCT01722331|3652963|P7|NOT COMPLETED|Part 3||2
1493011|NCT01722331|3652964|P6|NOT COMPLETED|Part 3||3
1493012|NCT01722331|3652965|P5|NOT COMPLETED|Part 3||0
1493013|NCT01722331|3652966|P4|NOT COMPLETED|Part 3||1
1493014|NCT01722331|3652967|P3|NOT COMPLETED|Part 3||0
1493015|NCT01722331|3652968|P2|NOT COMPLETED|Part 3||17
1493016|NCT01722331|3652969|P1|NOT COMPLETED|Part 3||15
1493017|NCT01722331|3652963|P7|COMPLETED|Part 3||65
1493018|NCT01722331|3652964|P6|COMPLETED|Part 3||59
1493019|NCT01722331|3652965|P5|COMPLETED|Part 3||0
1493020|NCT01722331|3652966|P4|COMPLETED|Part 3||18
1493021|NCT01722331|3652967|P3|COMPLETED|Part 3||0
1493022|NCT01722331|3652968|P2|COMPLETED|Part 3||232
1493023|NCT01722331|3652969|P1|COMPLETED|Part 3||264
1493024|NCT01722331|3652963|P7|STARTED|Part 3||67
1493025|NCT01722331|3652964|P6|STARTED|Part 3||62
1493026|NCT01722331|3652965|P5|STARTED|Part 3||0
1493027|NCT01722331|3652966|P4|STARTED|Part 3||19
1493028|NCT01722331|3652967|P3|STARTED|Part 3||0
1493029|NCT01722331|3652968|P2|STARTED|Part 3||249
1493030|NCT01722331|3652969|P1|STARTED|Part 3||279
1493031|NCT01722331|3652963|P7|NOT COMPLETED|Part 2||7
1493032|NCT01722331|3652964|P6|NOT COMPLETED|Part 2||10
1493033|NCT01722331|3652965|P5|NOT COMPLETED|Part 2||0
1493034|NCT01722331|3652966|P4|NOT COMPLETED|Part 2||0
1493035|NCT01722331|3652967|P3|NOT COMPLETED|Part 2||31
1493036|NCT01722331|3652968|P2|NOT COMPLETED|Part 2||0
1493037|NCT01722331|3652969|P1|NOT COMPLETED|Part 2||19
1493038|NCT01722331|3652963|P7|COMPLETED|Part 2||67
1493039|NCT01722331|3652964|P6|COMPLETED|Part 2||62
1493040|NCT01722331|3652965|P5|COMPLETED|Part 2||0
1493041|NCT01722331|3652966|P4|COMPLETED|Part 2||19
1493042|NCT01722331|3652967|P3|COMPLETED|Part 2||0
1493043|NCT01722331|3652968|P2|COMPLETED|Part 2||249
1493044|NCT01722331|3652969|P1|COMPLETED|Part 2||279
1493045|NCT01722331|3652963|P7|STARTED|Part 2||74
1493046|NCT01722331|3652964|P6|STARTED|Part 2||72
1493047|NCT01722331|3652965|P5|STARTED|Part 2||0
1493048|NCT01722331|3652966|P4|STARTED|Part 2||19
1493049|NCT01722331|3652967|P3|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
1493050|NCT01722331|3652968|P2|STARTED|Part 2||249
1493051|NCT01722331|3652969|P1|STARTED|Part 2||298
1493052|NCT01722331|3652963|P7|NOT COMPLETED|Part 1||0
1493053|NCT01722331|3652964|P6|NOT COMPLETED|Part 1||0
1493054|NCT01722331|3652965|P5|NOT COMPLETED|Part 1||9
1493055|NCT01722331|3652966|P4|NOT COMPLETED|Part 1||0
1493056|NCT01722331|3652967|P3|NOT COMPLETED|Part 1||9
1493057|NCT01722331|3652968|P2|NOT COMPLETED|Part 1||0
1493058|NCT01722331|3652969|P1|NOT COMPLETED|Part 1||10
1493059|NCT01722331|3652963|P7|COMPLETED|Part 1||74
1493060|NCT01722331|3652964|P6|COMPLETED|Part 1||72
1493061|NCT01722331|3652965|P5|COMPLETED|Part 1||0
1493062|NCT01722331|3652966|P4|COMPLETED|Part 1||19
1493063|NCT01722331|3652967|P3|COMPLETED|Part 1||32
1493064|NCT01722331|3652968|P2|COMPLETED|Part 1||249
1493065|NCT01722331|3652969|P1|COMPLETED|Part 1||298
1493066|NCT01722331|3652963|P7|STARTED|Part 1||74
1493067|NCT01722331|3652964|P6|STARTED|Part 1||72
1493068|NCT01722331|3652965|P5|STARTED|Part 1||9
1493069|NCT01722331|3652966|P4|STARTED|Part 1||19
1493070|NCT01722331|3652967|P3|STARTED|Part 1||41
1493071|NCT01722331|3652968|P2|STARTED|Part 1||249
1493072|NCT01722331|3652969|P1|STARTED|Part 1||308
1493073|NCT01722318|3653013|P5|NOT COMPLETED|Overall Study||18
1493074|NCT01722318|3653014|P4|NOT COMPLETED|Overall Study||20
1493075|NCT01722318|3653015|P3|NOT COMPLETED|Overall Study||20
1493076|NCT01722318|3653016|P2|NOT COMPLETED|Overall Study||20
1493077|NCT01722318|3653017|P1|NOT COMPLETED|Overall Study||14
1493078|NCT01722318|3653013|P5|COMPLETED|Overall Study||68
1493079|NCT01722318|3653014|P4|COMPLETED|Overall Study||65
1493080|NCT01722318|3653015|P3|COMPLETED|Overall Study||66
1493081|NCT01722318|3653016|P2|COMPLETED|Overall Study||65
1493082|NCT01722318|3653017|P1|COMPLETED|Overall Study||72
1493083|NCT01722318|3653013|P5|STARTED|Overall Study||86
1493084|NCT01722318|3653014|P4|STARTED|Overall Study||85
1493085|NCT01722318|3653015|P3|STARTED|Overall Study||86
1493086|NCT01722318|3653016|P2|STARTED|Overall Study||85
1493087|NCT01722318|3653017|P1|STARTED|Overall Study||86
1493088|NCT01722292|3653047|P3|NOT COMPLETED|Overall Study||0
1493089|NCT01722292|3653048|P2|NOT COMPLETED|Overall Study||0
1493090|NCT01722292|3653049|P1|NOT COMPLETED|Overall Study||0
1493091|NCT01722292|3653047|P3|COMPLETED|Overall Study||14
1493092|NCT01722292|3653048|P2|COMPLETED|Overall Study||6
1493093|NCT01722292|3653049|P1|COMPLETED|Overall Study||6
1493094|NCT01722292|3653047|P3|Received at Least One Dose of Study Drug|Overall Study||14
1493095|NCT01722292|3653048|P2|Received at Least One Dose of Study Drug|Overall Study||6
1493096|NCT01722292|3653049|P1|Received at Least One Dose of Study Drug|Overall Study||6
1493097|NCT01722292|3653047|P3|STARTED|Overall Study||14
1493098|NCT01722292|3653048|P2|STARTED|Overall Study||6
1493099|NCT01722292|3653049|P1|STARTED|Overall Study||6
1493100|NCT01722266|3653085|P4|NOT COMPLETED|Overall Study||0
1493101|NCT01722266|3653086|P3|NOT COMPLETED|Overall Study||5
1493102|NCT01722266|3653087|P2|NOT COMPLETED|Overall Study||3
1493103|NCT01722266|3653088|P1|NOT COMPLETED|Overall Study||1
1493191|NCT01721330|3653279|P1|NOT COMPLETED|Overall Study||0
1493104|NCT01722266|3653085|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
1493105|NCT01722266|3653086|P3|COMPLETED|Overall Study||13
1493106|NCT01722266|3653087|P2|COMPLETED|Overall Study||15
1493107|NCT01722266|3653088|P1|COMPLETED|Overall Study||17
1493108|NCT01722266|3653085|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
1493109|NCT01722266|3653086|P3|STARTED|Overall Study||18
1493110|NCT01722266|3653087|P2|STARTED|Overall Study||18
1493111|NCT01722266|3653088|P1|STARTED|Overall Study||18
1493112|NCT01722162|3653116|P2|NOT COMPLETED|Overall Study||6
1493113|NCT01722162|3653117|P1|NOT COMPLETED|Overall Study||5
1493114|NCT01722162|3653116|P2|COMPLETED|Overall Study||18
1493115|NCT01722162|3653117|P1|COMPLETED|Overall Study||18
1493116|NCT01722162|3653116|P2|STARTED|Overall Study||24
1493117|NCT01722162|3653117|P1|STARTED|Overall Study||23
1493118|NCT01722097|3653127|P2|NOT COMPLETED|Overall Study||5
1493119|NCT01722097|3653128|P1|NOT COMPLETED|Overall Study||6
1493120|NCT01722097|3653127|P2|COMPLETED|Overall Study||50
1493121|NCT01722097|3653128|P1|COMPLETED|Overall Study||49
1493122|NCT01722097|3653127|P2|STARTED|Overall Study||55
1493123|NCT01722097|3653128|P1|STARTED|Overall Study||55
1493124|NCT01722071|3653136|P2|NOT COMPLETED|Overall Study||0
1493125|NCT01722071|3653137|P1|NOT COMPLETED|Overall Study||1
1493126|NCT01722071|3653136|P2|COMPLETED|Overall Study||10
1493127|NCT01722071|3653137|P1|COMPLETED|Overall Study||9
1493128|NCT01722071|3653136|P2|STARTED|Overall Study||10
1493129|NCT01722071|3653137|P1|STARTED|Overall Study||10
1493130|NCT01722045|3653143|P1|NOT COMPLETED|Overall Study||28
1493131|NCT01722045|3653143|P1|COMPLETED|Overall Study||126
1493132|NCT01722045|3653143|P1|STARTED|Overall Study||154
1493133|NCT01721967|3653153|P1|NOT COMPLETED|Overall Study||3
1493134|NCT01721967|3653153|P1|COMPLETED|Overall Study||11
1493135|NCT01721967|3653153|P1|STARTED|Overall Study||14
1493136|NCT01721837|3653162|P1|NOT COMPLETED|Overall Study||0
1493137|NCT01721837|3653162|P1|COMPLETED|Overall Study||2120
1493138|NCT01721837|3653162|P1|STARTED|Overall Study||2120
1493139|NCT01721772|3653168|P2|NOT COMPLETED|Overall Study||192
1493140|NCT01721772|3653169|P1|NOT COMPLETED|Overall Study||111
1493141|NCT01721772|3653168|P2|COMPLETED|Overall Study|Continuing in treatment period|13
1493142|NCT01721772|3653169|P1|COMPLETED|Overall Study|Continuing in treatment period|95
1493143|NCT01721772|3653168|P2|STARTED|Overall Study||205
1493144|NCT01721772|3653169|P1|STARTED|Overall Study||206
1493145|NCT01721759|3653189|P1|NOT COMPLETED|Overall Study||102
1493146|NCT01721759|3653189|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
1493147|NCT01721759|3653189|P1|STARTED|Overall Study||117
1493148|NCT01721746|3653197|P3|NOT COMPLETED|Follow-Up Period||0
1493149|NCT01721746|3653198|P2|NOT COMPLETED|Follow-Up Period||0
1493150|NCT01721746|3653199|P1|NOT COMPLETED|Follow-Up Period||0
1493151|NCT01721746|3653197|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
1493152|NCT01721746|3653198|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
1493153|NCT01721746|3653199|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
1493154|NCT01721746|3653197|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
1493155|NCT01721746|3653198|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
1493156|NCT01721746|3653199|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
1493157|NCT01721746|3653197|P3|NOT COMPLETED|Treatment Period||57
1493158|NCT01721746|3653198|P2|NOT COMPLETED|Treatment Period||45
1493159|NCT01721746|3653199|P1|NOT COMPLETED|Treatment Period||233
1493160|NCT01721746|3653197|P3|COMPLETED|Treatment Period||0
1493161|NCT01721746|3653198|P2|COMPLETED|Treatment Period||0
1493162|NCT01721746|3653199|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
1493163|NCT01721746|3653197|P3|STARTED|Treatment Period||57
1493164|NCT01721746|3653198|P2|STARTED|Treatment Period||45
1493165|NCT01721746|3653199|P1|STARTED|Treatment Period||268
1493166|NCT01721681|3653215|P1|NOT COMPLETED|Overall Study||0
1493167|NCT01721681|3653215|P1|COMPLETED|Overall Study||9
1493168|NCT01721681|3653215|P1|STARTED|Overall Study||9
1493169|NCT01721603|3653221|P1|NOT COMPLETED|Overall Study||0
1493170|NCT01721603|3653221|P1|COMPLETED|Overall Study||2
1493171|NCT01721603|3653221|P1|STARTED|Overall Study||2
1493172|NCT01721564|3653232|P1|NOT COMPLETED|Overall Study||0
1493173|NCT01721564|3653232|P1|COMPLETED|Overall Study||8
1493174|NCT01721564|3653232|P1|STARTED|Overall Study||8
1493175|NCT01721486|3653239|P2|NOT COMPLETED|Overall Study||1
1493176|NCT01721486|3653240|P1|NOT COMPLETED|Overall Study||1
1493177|NCT01721486|3653239|P2|COMPLETED|Overall Study||19
1493178|NCT01721486|3653240|P1|COMPLETED|Overall Study||20
1493179|NCT01721486|3653239|P2|STARTED|Overall Study||20
1493180|NCT01721486|3653240|P1|STARTED|Overall Study||21
1493181|NCT01721460|3653252|P1|NOT COMPLETED|Overall Study||1
1493182|NCT01721460|3653252|P1|COMPLETED|Overall Study||5
1493183|NCT01721460|3653252|P1|STARTED|Overall Study||6
1493184|NCT01721408|3653261|P2|NOT COMPLETED|Overall Study||24
1493185|NCT01721408|3653262|P1|NOT COMPLETED|Overall Study||36
1493186|NCT01721408|3653261|P2|COMPLETED|Overall Study||207
1493187|NCT01721408|3653262|P1|COMPLETED|Overall Study||196
1493188|NCT01721408|3653261|P2|STARTED|Overall Study|Number of participants treated.|231
1493189|NCT01721408|3653262|P1|STARTED|Overall Study|Number of participants treated.|232
1493190|NCT01721330|3653278|P2|NOT COMPLETED|Overall Study||1
1493192|NCT01721330|3653278|P2|COMPLETED|Overall Study||1
1493193|NCT01721330|3653279|P1|COMPLETED|Overall Study||1
1493194|NCT01721330|3653278|P2|STARTED|Overall Study||2
1493195|NCT01721330|3653279|P1|STARTED|Overall Study||1
1493196|NCT01721317|3653287|P2|NOT COMPLETED|Overall Study||4
1493197|NCT01721317|3653288|P1|NOT COMPLETED|Overall Study||2
1493198|NCT01721317|3653287|P2|COMPLETED|Overall Study||0
1493199|NCT01721317|3653288|P1|COMPLETED|Overall Study||0
1493200|NCT01721317|3653287|P2|STARTED|Overall Study||4
1493201|NCT01721317|3653288|P1|STARTED|Overall Study||2
1493202|NCT01721226|3653356|P2|NOT COMPLETED|Overall Study||7
1493203|NCT01721226|3653357|P1|NOT COMPLETED|Overall Study||5
1493204|NCT01721226|3653356|P2|COMPLETED|Overall Study||50
1493205|NCT01721226|3653357|P1|COMPLETED|Overall Study||50
1493206|NCT01721226|3653356|P2|Week 24|Overall Study||50
1493207|NCT01721226|3653357|P1|Week 24|Overall Study||50
1493208|NCT01721226|3653356|P2|Week 12|Overall Study||53
1493209|NCT01721226|3653357|P1|Week 12|Overall Study||48
1493210|NCT01721226|3653356|P2|Baseline|Overall Study||57
1493211|NCT01721226|3653357|P1|Baseline|Overall Study||53
1493212|NCT01721226|3653356|P2|STARTED|Overall Study||57
1493213|NCT01721226|3653357|P1|STARTED|Overall Study||55
1493214|NCT01721200|3653367|P2|NOT COMPLETED|Overall Study||5
1493215|NCT01721200|3653368|P1|NOT COMPLETED|Overall Study||3
1493216|NCT01721200|3653367|P2|COMPLETED|Overall Study||58
1493217|NCT01721200|3653368|P1|COMPLETED|Overall Study||59
1493218|NCT01721200|3653367|P2|Completed 2 Week Follow-up|Overall Study||61
1493219|NCT01721200|3653368|P1|Completed 2 Week Follow-up|Overall Study||60
1493220|NCT01721200|3653367|P2|STARTED|Overall Study||63
1493221|NCT01721200|3653368|P1|STARTED|Overall Study||62
1493222|NCT01721161|3653393|P2|NOT COMPLETED|Overall Study||7
1493223|NCT01721161|3653394|P1|NOT COMPLETED|Overall Study||4
1493224|NCT01721161|3653393|P2|COMPLETED|Overall Study||34
1493225|NCT01721161|3653394|P1|COMPLETED|Overall Study||37
1493226|NCT01721161|3653393|P2|STARTED|Overall Study||41
1493227|NCT01721161|3653394|P1|STARTED|Overall Study||41
1493228|NCT01721109|3653417|P1|NOT COMPLETED|Overall Study||7
1493229|NCT01721109|3653417|P1|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
1493230|NCT01721109|3653417|P1|STARTED|Overall Study||50
1493231|NCT01721096|3653432|P2|NOT COMPLETED|Overall Study||10
1493232|NCT01721096|3653433|P1|NOT COMPLETED|Overall Study||27
1493233|NCT01721096|3653432|P2|COMPLETED|Overall Study||203
1493234|NCT01721096|3653433|P1|COMPLETED|Overall Study||296
1493235|NCT01721096|3653432|P2|STARTED|Overall Study||213
1493236|NCT01721096|3653433|P1|STARTED|Overall Study||323
1493237|NCT01721070|3653582|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
1493238|NCT01721070|3653582|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
1493239|NCT01721070|3653582|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
1493240|NCT01721070|3653582|P1|NOT COMPLETED|SUF NT 15 mcg||0
1493241|NCT01721070|3653582|P1|COMPLETED|SUF NT 15 mcg||19
1493242|NCT01721070|3653582|P1|STARTED|SUF NT 15 mcg||19
1493243|NCT01721057|3653593|P7|NOT COMPLETED|Follow Up||0
1493244|NCT01721057|3653594|P6|NOT COMPLETED|Follow Up||0
1493245|NCT01721057|3653595|P5|NOT COMPLETED|Follow Up||0
1493246|NCT01721057|3653596|P4|NOT COMPLETED|Follow Up||0
1493247|NCT01721057|3653597|P3|NOT COMPLETED|Follow Up||0
1493248|NCT01721057|3653598|P2|NOT COMPLETED|Follow Up||0
1493249|NCT01721057|3653599|P1|NOT COMPLETED|Follow Up||0
1493250|NCT01721057|3653593|P7|COMPLETED|Follow Up||22
1493251|NCT01721057|3653594|P6|COMPLETED|Follow Up||19
1493252|NCT01721057|3653595|P5|COMPLETED|Follow Up||17
1493253|NCT01721057|3653596|P4|COMPLETED|Follow Up||0
1493254|NCT01721057|3653597|P3|COMPLETED|Follow Up||0
1493255|NCT01721057|3653598|P2|COMPLETED|Follow Up||0
1493256|NCT01721057|3653599|P1|COMPLETED|Follow Up||0
1493257|NCT01721057|3653593|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
1493258|NCT01721057|3653594|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
1493259|NCT01721057|3653595|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
1493260|NCT01721057|3653596|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
1493261|NCT01721057|3653597|P3|STARTED|Follow Up||0
1493262|NCT01721057|3653598|P2|STARTED|Follow Up||0
1493263|NCT01721057|3653599|P1|STARTED|Follow Up||0
1493264|NCT01721057|3653593|P7|NOT COMPLETED|Rescue Period||0
1493265|NCT01721057|3653594|P6|NOT COMPLETED|Rescue Period||0
1493266|NCT01721057|3653595|P5|NOT COMPLETED|Rescue Period||0
1493267|NCT01721057|3653596|P4|NOT COMPLETED|Rescue Period||3
1493268|NCT01721057|3653597|P3|NOT COMPLETED|Rescue Period||0
1493269|NCT01721057|3653598|P2|NOT COMPLETED|Rescue Period||0
1493270|NCT01721057|3653599|P1|NOT COMPLETED|Rescue Period||0
1493271|NCT01721057|3653593|P7|COMPLETED|Rescue Period||0
1493272|NCT01721057|3653594|P6|COMPLETED|Rescue Period||0
1493273|NCT01721057|3653595|P5|COMPLETED|Rescue Period||0
1493274|NCT01721057|3653596|P4|COMPLETED|Rescue Period||88
1493275|NCT01721057|3653597|P3|COMPLETED|Rescue Period||0
1493276|NCT01721057|3653598|P2|COMPLETED|Rescue Period||0
1493277|NCT01721057|3653599|P1|COMPLETED|Rescue Period||0
1493278|NCT01721057|3653593|P7|STARTED|Rescue Period||0
1493279|NCT01721057|3653594|P6|STARTED|Rescue Period||0
1493280|NCT01721057|3653595|P5|STARTED|Rescue Period||0
1493281|NCT01721057|3653596|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
1493282|NCT01721057|3653597|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1493283|NCT01721057|3653598|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1493284|NCT01721057|3653599|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1493285|NCT01721057|3653593|P7|NOT COMPLETED|Treatment Period||0
1493286|NCT01721057|3653594|P6|NOT COMPLETED|Treatment Period||0
1493287|NCT01721057|3653595|P5|NOT COMPLETED|Treatment Period||0
1493288|NCT01721057|3653596|P4|NOT COMPLETED|Treatment Period||0
1493289|NCT01721057|3653597|P3|NOT COMPLETED|Treatment Period||23
1493290|NCT01721057|3653598|P2|NOT COMPLETED|Treatment Period||19
1493291|NCT01721057|3653599|P1|NOT COMPLETED|Treatment Period||28
1493292|NCT01721057|3653593|P7|COMPLETED|Treatment Period||0
1493293|NCT01721057|3653594|P6|COMPLETED|Treatment Period||0
1493294|NCT01721057|3653595|P5|COMPLETED|Treatment Period||0
1493295|NCT01721057|3653596|P4|COMPLETED|Treatment Period||0
1493296|NCT01721057|3653597|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
1493297|NCT01721057|3653598|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
1493298|NCT01721057|3653599|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
1493299|NCT01721057|3653593|P7|Rescued|Treatment Period||0
1493300|NCT01721057|3653594|P6|Rescued|Treatment Period||0
1493301|NCT01721057|3653595|P5|Rescued|Treatment Period||0
1493302|NCT01721057|3653596|P4|Rescued|Treatment Period||0
1493303|NCT01721057|3653597|P3|Rescued|Treatment Period||15
1493304|NCT01721057|3653598|P2|Rescued|Treatment Period||21
1493305|NCT01721057|3653599|P1|Rescued|Treatment Period||55
1493306|NCT01721057|3653593|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
1493307|NCT01721057|3653594|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
1493308|NCT01721057|3653595|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
1493309|NCT01721057|3653596|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
1493310|NCT01721057|3653597|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
1493311|NCT01721057|3653598|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
1493312|NCT01721057|3653599|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
1493313|NCT01721057|3653593|P7|STARTED|Treatment Period||0
1493314|NCT01721057|3653594|P6|STARTED|Treatment Period||0
1493315|NCT01721057|3653595|P5|STARTED|Treatment Period||0
1493316|NCT01721057|3653596|P4|STARTED|Treatment Period||0
1493317|NCT01721057|3653597|P3|STARTED|Treatment Period||227
1493318|NCT01721057|3653598|P2|STARTED|Treatment Period||229
1493319|NCT01721057|3653599|P1|STARTED|Treatment Period||228
1493320|NCT01721044|3653672|P3|NOT COMPLETED|Follow Up||0
1493321|NCT01721044|3653673|P2|NOT COMPLETED|Follow Up||0
1493322|NCT01721044|3653674|P1|NOT COMPLETED|Follow Up||0
1493323|NCT01721044|3653672|P3|COMPLETED|Follow Up||20
1493324|NCT01721044|3653673|P2|COMPLETED|Follow Up||9
1493325|NCT01721044|3653674|P1|COMPLETED|Follow Up||19
1493326|NCT01721044|3653672|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
1493327|NCT01721044|3653673|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
1493328|NCT01721044|3653674|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
1493329|NCT01721044|3653672|P3|NOT COMPLETED|Treatment Period||19
1493330|NCT01721044|3653673|P2|NOT COMPLETED|Treatment Period||17
1493331|NCT01721044|3653674|P1|NOT COMPLETED|Treatment Period||32
1493332|NCT01721044|3653672|P3|COMPLETED|Treatment Period||158
1493333|NCT01721044|3653673|P2|COMPLETED|Treatment Period||157
1493334|NCT01721044|3653674|P1|COMPLETED|Treatment Period||144
1493335|NCT01721044|3653672|P3|Rescue Week 16-24|Treatment Period||33
1493336|NCT01721044|3653673|P2|Rescue Week 16-24|Treatment Period||38
1493337|NCT01721044|3653674|P1|Rescue Week 16-24|Treatment Period||56
1493338|NCT01721044|3653672|P3|STARTED|Treatment Period||177
1493339|NCT01721044|3653673|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
1493340|NCT01721044|3653674|P1|STARTED|Treatment Period||176
1493341|NCT01720797|3653747|P2|NOT COMPLETED|Overall Study||0
1493342|NCT01720797|3653748|P1|NOT COMPLETED|Overall Study||3
1493343|NCT01720797|3653747|P2|COMPLETED|Overall Study||9
1493344|NCT01720797|3653748|P1|COMPLETED|Overall Study||9
1493345|NCT01720797|3653747|P2|STARTED|Overall Study||9
1493346|NCT01720797|3653748|P1|STARTED|Overall Study||12
1493347|NCT01720602|3653754|P1|NOT COMPLETED|Overall Study||5
1493348|NCT01720602|3653754|P1|COMPLETED|Overall Study||10
1493349|NCT01720602|3653754|P1|STARTED|Overall Study||15
1493350|NCT01720446|3653764|P4|NOT COMPLETED|Overall Study||20
1493351|NCT01720446|3653765|P3|NOT COMPLETED|Overall Study||20
1493352|NCT01720446|3653766|P2|NOT COMPLETED|Overall Study||11
1493353|NCT01720446|3653767|P1|NOT COMPLETED|Overall Study||14
1493354|NCT01720446|3653764|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
1493355|NCT01720446|3653765|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
1493356|NCT01720446|3653766|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
1493357|NCT01720446|3653767|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
1493358|NCT01720446|3653764|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
1493359|NCT01720446|3653765|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
1493360|NCT01720446|3653766|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
1493361|NCT01720446|3653767|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
1493362|NCT01720446|3653764|P4|STARTED|Overall Study||825
1493363|NCT01720446|3653765|P3|STARTED|Overall Study||824
1493364|NCT01720446|3653766|P2|STARTED|Overall Study||822
1493365|NCT01720446|3653767|P1|STARTED|Overall Study||826
1493366|NCT01720316|3653828|P2|NOT COMPLETED|Open-label Glycine||0
1493367|NCT01720316|3653829|P1|NOT COMPLETED|Open-label Glycine||0
1493368|NCT01720316|3653828|P2|COMPLETED|Open-label Glycine||1
1493369|NCT01720316|3653829|P1|COMPLETED|Open-label Glycine||1
1493370|NCT01720316|3653828|P2|STARTED|Open-label Glycine||1
1493371|NCT01720316|3653829|P1|STARTED|Open-label Glycine||1
1493372|NCT01720316|3653828|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
1493373|NCT01720316|3653829|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
1493374|NCT01720316|3653828|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
1493375|NCT01720316|3653829|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
1493376|NCT01720316|3653828|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
1493377|NCT01720316|3653829|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
1493378|NCT01720277|3653877|P2|NOT COMPLETED|Overall Study||558
1493379|NCT01720277|3653878|P1|NOT COMPLETED|Overall Study||503
1493380|NCT01720277|3653877|P2|COMPLETED|Overall Study|intent-to-treat approach|938
1493381|NCT01720277|3653878|P1|COMPLETED|Overall Study|intent-to-treat approach|958
1493382|NCT01720277|3653877|P2|STARTED|Overall Study||1496
1493383|NCT01720277|3653878|P1|STARTED|Overall Study||1461
1493384|NCT01720251|3653891|P3|NOT COMPLETED|Overall Study||0
1493385|NCT01720251|3653892|P2|NOT COMPLETED|Overall Study||2
1493386|NCT01720251|3653893|P1|NOT COMPLETED|Overall Study||1
1493387|NCT01720251|3653891|P3|COMPLETED|Overall Study||82
1493388|NCT01720251|3653892|P2|COMPLETED|Overall Study||77
1493389|NCT01720251|3653893|P1|COMPLETED|Overall Study||78
1493390|NCT01720251|3653891|P3|STARTED|Overall Study||82
1493391|NCT01720251|3653892|P2|STARTED|Overall Study||79
1493392|NCT01720251|3653893|P1|STARTED|Overall Study||79
1493393|NCT01720173|3653901|P1|NOT COMPLETED|Overall Study||0
1493394|NCT01720173|3653901|P1|COMPLETED|Overall Study||30
1493395|NCT01720173|3653901|P1|STARTED|Overall Study||30
1493396|NCT01720043|3653909|P1|NOT COMPLETED|Overall Study||1
1493397|NCT01720043|3653909|P1|COMPLETED|Overall Study||7
1493398|NCT01720043|3653909|P1|STARTED|Overall Study||8
1493399|NCT01719861|3653913|P1|NOT COMPLETED|Cycle 2||1
1493400|NCT01719861|3653913|P1|COMPLETED|Cycle 2||1
1493401|NCT01719861|3653913|P1|STARTED|Cycle 2||2
1493402|NCT01719861|3653913|P1|NOT COMPLETED|Cycle 1||4
1493403|NCT01719861|3653913|P1|COMPLETED|Cycle 1||2
1493404|NCT01719861|3653913|P1|STARTED|Cycle 1||6
1493405|NCT01719783|3653923|P2|NOT COMPLETED|Dose 2||0
1493406|NCT01719783|3653924|P1|NOT COMPLETED|Dose 2||1
1493407|NCT01719783|3653923|P2|COMPLETED|Dose 2||10
1493408|NCT01719783|3653924|P1|COMPLETED|Dose 2||29
1493409|NCT01719783|3653923|P2|STARTED|Dose 2||10
1493410|NCT01719783|3653924|P1|STARTED|Dose 2||30
1493411|NCT01719783|3653923|P2|NOT COMPLETED|Dose 1||0
1493412|NCT01719783|3653924|P1|NOT COMPLETED|Dose 1||0
1493413|NCT01719783|3653923|P2|COMPLETED|Dose 1||10
1493414|NCT01719783|3653924|P1|COMPLETED|Dose 1||30
1493415|NCT01719783|3653923|P2|STARTED|Dose 1||10
1493416|NCT01719783|3653924|P1|STARTED|Dose 1||30
1493417|NCT01719757|3654010|P1|NOT COMPLETED|Overall Study||101
1493418|NCT01719757|3654010|P1|COMPLETED|Overall Study||258
1493419|NCT01719757|3654010|P1|STARTED|Overall Study||359
1493420|NCT01719744|3654018|P1|NOT COMPLETED|Overall Study||0
1493421|NCT01719744|3654018|P1|COMPLETED|Overall Study||25
1493422|NCT01719744|3654018|P1|STARTED|Overall Study||25
1493423|NCT01719653|3654029|P5|NOT COMPLETED|Overall Study||21
1493424|NCT01719653|3654030|P4|NOT COMPLETED|Overall Study||18
1493425|NCT01719653|3654031|P3|NOT COMPLETED|Overall Study||18
1493426|NCT01719653|3654032|P2|NOT COMPLETED|Overall Study||13
1493427|NCT01719653|3654033|P1|NOT COMPLETED|Overall Study||9
1493428|NCT01719653|3654029|P5|COMPLETED|Overall Study||200
1493429|NCT01719653|3654030|P4|COMPLETED|Overall Study||200
1493430|NCT01719653|3654031|P3|COMPLETED|Overall Study||200
1493431|NCT01719653|3654032|P2|COMPLETED|Overall Study||200
1493432|NCT01719653|3654033|P1|COMPLETED|Overall Study||200
1493433|NCT01719653|3654029|P5|STARTED|Overall Study||221
1493434|NCT01719653|3654030|P4|STARTED|Overall Study||218
1493435|NCT01719653|3654031|P3|STARTED|Overall Study||218
1493436|NCT01719653|3654032|P2|STARTED|Overall Study||213
1493437|NCT01719653|3654033|P1|STARTED|Overall Study||209
1493438|NCT01719224|3654055|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
1493439|NCT01719224|3654056|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
1493440|NCT01719224|3654055|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
1493441|NCT01719224|3654056|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
1493442|NCT01719224|3654055|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
1493443|NCT01719224|3654056|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
1493444|NCT01719224|3654055|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
1493445|NCT01719224|3654056|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
1493446|NCT01719224|3654055|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
1493447|NCT01719224|3654056|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
1493448|NCT01719224|3654055|P2|STARTED|Intervention 1: Sleeping Position 1||18
1493449|NCT01719224|3654056|P1|STARTED|Intervention 1: Sleeping Position 1||18
1493450|NCT01719172|3654065|P1|NOT COMPLETED|Overall Study||2
1493451|NCT01719172|3654065|P1|COMPLETED|Overall Study||28
1493452|NCT01719172|3654065|P1|STARTED|Overall Study||30
1493453|NCT01719003|3654079|P9|NOT COMPLETED|Overall Study||4
1493454|NCT01719003|3654080|P8|NOT COMPLETED|Overall Study||20
1493455|NCT01719003|3654081|P7|NOT COMPLETED|Overall Study||20
1493456|NCT01719003|3654082|P6|NOT COMPLETED|Overall Study||12
1493457|NCT01719003|3654083|P5|NOT COMPLETED|Overall Study||17
1493458|NCT01719003|3654084|P4|NOT COMPLETED|Overall Study||13
1493459|NCT01719003|3654085|P3|NOT COMPLETED|Overall Study||17
1493460|NCT01719003|3654086|P2|NOT COMPLETED|Overall Study||17
1493461|NCT01719003|3654087|P1|NOT COMPLETED|Overall Study||9
1493462|NCT01719003|3654079|P9|COMPLETED|Overall Study||49
1493463|NCT01719003|3654080|P8|COMPLETED|Overall Study||151
1493464|NCT01719003|3654081|P7|COMPLETED|Overall Study||150
1493465|NCT01719003|3654082|P6|COMPLETED|Overall Study||160
1493466|NCT01719003|3654083|P5|COMPLETED|Overall Study||150
1493467|NCT01719003|3654084|P4|COMPLETED|Overall Study||156
1493468|NCT01719003|3654085|P3|COMPLETED|Overall Study||154
1493469|NCT01719003|3654086|P2|COMPLETED|Overall Study||153
1493470|NCT01719003|3654087|P1|COMPLETED|Overall Study||161
1493471|NCT01719003|3654079|P9|STARTED|Overall Study||53
1493472|NCT01719003|3654080|P8|STARTED|Overall Study||171
1493473|NCT01719003|3654081|P7|STARTED|Overall Study||170
1493474|NCT01719003|3654082|P6|STARTED|Overall Study||172
1493475|NCT01719003|3654083|P5|STARTED|Overall Study||167
1493476|NCT01719003|3654084|P4|STARTED|Overall Study||169
1493477|NCT01719003|3654085|P3|STARTED|Overall Study||171
1493478|NCT01719003|3654086|P2|STARTED|Overall Study||170
1493479|NCT01719003|3654087|P1|STARTED|Overall Study||170
1493480|NCT01718691|3654124|P2|NOT COMPLETED|Overall Study||1
1493481|NCT01718691|3654125|P1|NOT COMPLETED|Overall Study||18
1493482|NCT01718691|3654124|P2|COMPLETED|Overall Study||9
1493483|NCT01718691|3654125|P1|COMPLETED|Overall Study||42
1493484|NCT01718691|3654124|P2|STARTED|Overall Study||10
1493485|NCT01718691|3654125|P1|STARTED|Overall Study||60
1493486|NCT01718535|3654168|P10|NOT COMPLETED|Overall Study||0
1493487|NCT01718535|3654169|P9|NOT COMPLETED|Overall Study||0
1493488|NCT01718535|3654170|P8|NOT COMPLETED|Overall Study||0
1493489|NCT01718535|3654171|P7|NOT COMPLETED|Overall Study||0
1493490|NCT01718535|3654172|P6|NOT COMPLETED|Overall Study||0
1493491|NCT01718535|3654173|P5|NOT COMPLETED|Overall Study||0
1493492|NCT01718535|3654174|P4|NOT COMPLETED|Overall Study||1
1493493|NCT01718535|3654175|P3|NOT COMPLETED|Overall Study||0
1493494|NCT01718535|3654176|P2|NOT COMPLETED|Overall Study||0
1493495|NCT01718535|3654177|P1|NOT COMPLETED|Overall Study||1
1493496|NCT01718535|3654168|P10|COMPLETED|Overall Study||1
1493497|NCT01718535|3654169|P9|COMPLETED|Overall Study||15
1493498|NCT01718535|3654170|P8|COMPLETED|Overall Study||6
1493499|NCT01718535|3654171|P7|COMPLETED|Overall Study||11
1493500|NCT01718535|3654172|P6|COMPLETED|Overall Study||40
1493501|NCT01718535|3654173|P5|COMPLETED|Overall Study||1
1493502|NCT01718535|3654174|P4|COMPLETED|Overall Study||7
1493503|NCT01718535|3654175|P3|COMPLETED|Overall Study||19
1493504|NCT01718535|3654176|P2|COMPLETED|Overall Study||95
1493505|NCT01718535|3654177|P1|COMPLETED|Overall Study||130
1493506|NCT01718535|3654168|P10|First Pass|Overall Study||1
1493507|NCT01718535|3654169|P9|First Pass|Overall Study||15
1493508|NCT01718535|3654170|P8|First Pass|Overall Study||6
1493509|NCT01718535|3654171|P7|First Pass|Overall Study||11
1493510|NCT01718535|3654172|P6|First Pass|Overall Study||39
1493511|NCT01718535|3654173|P5|First Pass|Overall Study||1
1493512|NCT01718535|3654174|P4|First Pass|Overall Study||7
1493513|NCT01718535|3654175|P3|First Pass|Overall Study||19
1493514|NCT01718535|3654176|P2|First Pass|Overall Study||94
1493515|NCT01718535|3654177|P1|First Pass|Overall Study||128
1493516|NCT01718535|3654168|P10|STARTED|Overall Study||1
1493517|NCT01718535|3654169|P9|STARTED|Overall Study||15
1493518|NCT01718535|3654170|P8|STARTED|Overall Study||6
1493519|NCT01718535|3654171|P7|STARTED|Overall Study||11
1493520|NCT01718535|3654172|P6|STARTED|Overall Study||40
1493521|NCT01718535|3654173|P5|STARTED|Overall Study||1
1493522|NCT01718535|3654174|P4|STARTED|Overall Study||8
1493523|NCT01718535|3654175|P3|STARTED|Overall Study||19
1493524|NCT01718535|3654176|P2|STARTED|Overall Study||95
1493525|NCT01718535|3654177|P1|STARTED|Overall Study||131
1493526|NCT01718509|3654201|P2|NOT COMPLETED|Overall Study||48
1493527|NCT01718509|3654202|P1|NOT COMPLETED|Overall Study||48
1493528|NCT01718509|3654201|P2|COMPLETED|Overall Study||147
1493529|NCT01718509|3654202|P1|COMPLETED|Overall Study||147
1493530|NCT01718509|3654201|P2|STARTED|Overall Study||195
1493531|NCT01718509|3654202|P1|STARTED|Overall Study||195
1493532|NCT01718483|3654248|P2|NOT COMPLETED|Overall Study||34
1493533|NCT01718483|3654249|P1|NOT COMPLETED|Overall Study||34
1493534|NCT01718483|3654248|P2|COMPLETED|Overall Study||158
1493535|NCT01718483|3654249|P1|COMPLETED|Overall Study||157
1493536|NCT01718483|3654248|P2|Treated|Overall Study||192
1493537|NCT01718483|3654249|P1|Treated|Overall Study||187
1493538|NCT01718483|3654248|P2|STARTED|Overall Study||192
1493539|NCT01718483|3654249|P1|STARTED|Overall Study||191
1493540|NCT01718353|3654295|P2|NOT COMPLETED|Overall Study||5
1493541|NCT01718353|3654296|P1|NOT COMPLETED|Overall Study||12
1493542|NCT01718353|3654295|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
1493621|NCT01717768|3654480|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493543|NCT01718353|3654296|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
1493544|NCT01718353|3654295|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
1493545|NCT01718353|3654296|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
1493546|NCT01718353|3654295|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
1493547|NCT01718353|3654296|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
1493548|NCT01718353|3654295|P2|Treated|Overall Study||22
1493549|NCT01718353|3654296|P1|Treated|Overall Study||39
1493550|NCT01718353|3654295|P2|STARTED|Overall Study||22
1493551|NCT01718353|3654296|P1|STARTED|Overall Study||41
1493552|NCT01718028|3654314|P2|NOT COMPLETED|Overall Study||0
1493553|NCT01718028|3654315|P1|NOT COMPLETED|Overall Study||0
1493554|NCT01718028|3654314|P2|COMPLETED|Overall Study||24
1493555|NCT01718028|3654315|P1|COMPLETED|Overall Study||25
1493556|NCT01718028|3654314|P2|STARTED|Overall Study||24
1493557|NCT01718028|3654315|P1|STARTED|Overall Study||25
1493558|NCT01717989|3654327|P1|NOT COMPLETED|Overall Study||1066
1493559|NCT01717989|3654327|P1|COMPLETED|Overall Study||1182
1493560|NCT01717989|3654327|P1|STARTED|Overall Study||2248
1493561|NCT01717976|3654395|P2|NOT COMPLETED|Overall Study||1
1493562|NCT01717976|3654396|P1|NOT COMPLETED|Overall Study||0
1493563|NCT01717976|3654395|P2|COMPLETED|Overall Study||256
1493564|NCT01717976|3654396|P1|COMPLETED|Overall Study||257
1493565|NCT01717976|3654395|P2|STARTED|Overall Study||257
1493566|NCT01717976|3654396|P1|STARTED|Overall Study||257
1493567|NCT01717898|3654410|P4|NOT COMPLETED|Overall Study||0
1493568|NCT01717898|3654411|P3|NOT COMPLETED|Overall Study||0
1493569|NCT01717898|3654412|P2|NOT COMPLETED|Overall Study||0
1493570|NCT01717898|3654413|P1|NOT COMPLETED|Overall Study||6
1493571|NCT01717898|3654410|P4|COMPLETED|Overall Study||0
1493572|NCT01717898|3654411|P3|COMPLETED|Overall Study||0
1493573|NCT01717898|3654412|P2|COMPLETED|Overall Study||0
1493574|NCT01717898|3654413|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
1493575|NCT01717898|3654410|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
1493576|NCT01717898|3654411|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
1493577|NCT01717898|3654412|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
1493578|NCT01717898|3654413|P1|STARTED|Overall Study||6
1493579|NCT01717872|3654440|P2|NOT COMPLETED|Overall Study||0
1493580|NCT01717872|3654441|P1|NOT COMPLETED|Overall Study||0
1493581|NCT01717872|3654440|P2|COMPLETED|Overall Study||25
1493582|NCT01717872|3654441|P1|COMPLETED|Overall Study||25
1493583|NCT01717872|3654440|P2|STARTED|Overall Study||25
1493584|NCT01717872|3654441|P1|STARTED|Overall Study||25
1493585|NCT01717859|3654451|P1|NOT COMPLETED|Overall Study||10
1493586|NCT01717859|3654451|P1|COMPLETED|Overall Study||44
1493587|NCT01717859|3654451|P1|3 Month|Overall Study||50
1493588|NCT01717859|3654451|P1|STARTED|Overall Study||54
1493589|NCT01717768|3654472|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493590|NCT01717768|3654473|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493591|NCT01717768|3654474|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
1493592|NCT01717768|3654475|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493593|NCT01717768|3654476|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
1493594|NCT01717768|3654477|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493595|NCT01717768|3654478|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493596|NCT01717768|3654479|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493597|NCT01717768|3654480|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493598|NCT01717768|3654481|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493599|NCT01717768|3654482|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493600|NCT01717768|3654483|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493601|NCT01717768|3654472|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493602|NCT01717768|3654473|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493603|NCT01717768|3654474|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
1493604|NCT01717768|3654475|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493605|NCT01717768|3654476|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
1493606|NCT01717768|3654477|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493607|NCT01717768|3654478|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493608|NCT01717768|3654479|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493609|NCT01717768|3654480|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493610|NCT01717768|3654481|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493611|NCT01717768|3654482|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493612|NCT01717768|3654483|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493613|NCT01717768|3654472|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493614|NCT01717768|3654473|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493615|NCT01717768|3654474|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
1493616|NCT01717768|3654475|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493617|NCT01717768|3654476|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
1493618|NCT01717768|3654477|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493619|NCT01717768|3654478|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493620|NCT01717768|3654479|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493622|NCT01717768|3654481|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493623|NCT01717768|3654482|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493624|NCT01717768|3654483|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
1493625|NCT01717768|3654472|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
1493626|NCT01717768|3654473|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493627|NCT01717768|3654474|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493628|NCT01717768|3654475|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493629|NCT01717768|3654476|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493630|NCT01717768|3654477|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493631|NCT01717768|3654478|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493632|NCT01717768|3654479|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493633|NCT01717768|3654480|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493634|NCT01717768|3654481|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493635|NCT01717768|3654482|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493636|NCT01717768|3654483|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493637|NCT01717768|3654472|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
1493638|NCT01717768|3654473|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
1493639|NCT01717768|3654474|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493640|NCT01717768|3654475|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
1493641|NCT01717768|3654476|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493642|NCT01717768|3654477|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
1493643|NCT01717768|3654478|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493644|NCT01717768|3654479|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493645|NCT01717768|3654480|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493646|NCT01717768|3654481|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493647|NCT01717768|3654482|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493648|NCT01717768|3654483|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493649|NCT01717768|3654472|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
1493650|NCT01717768|3654473|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
1493651|NCT01717768|3654474|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493652|NCT01717768|3654475|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
1493653|NCT01717768|3654476|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493654|NCT01717768|3654477|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
1493655|NCT01717768|3654478|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493656|NCT01717768|3654479|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493657|NCT01717768|3654480|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493658|NCT01717768|3654481|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493659|NCT01717768|3654482|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493660|NCT01717768|3654483|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
1493661|NCT01717768|3654472|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493662|NCT01717768|3654473|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493663|NCT01717768|3654474|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493664|NCT01717768|3654475|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493665|NCT01717768|3654476|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493666|NCT01717768|3654477|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493667|NCT01717768|3654478|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493668|NCT01717768|3654479|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493669|NCT01717768|3654480|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493670|NCT01717768|3654481|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493671|NCT01717768|3654482|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493672|NCT01717768|3654483|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493673|NCT01717768|3654472|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493674|NCT01717768|3654473|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493675|NCT01717768|3654474|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493676|NCT01717768|3654475|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493677|NCT01717768|3654476|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493678|NCT01717768|3654477|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493679|NCT01717768|3654478|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
1493680|NCT01717768|3654479|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
1493681|NCT01717768|3654480|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
1493682|NCT01717768|3654481|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493683|NCT01717768|3654482|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493684|NCT01717768|3654483|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493685|NCT01717768|3654472|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493686|NCT01717768|3654473|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493687|NCT01717768|3654474|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493688|NCT01717768|3654475|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493689|NCT01717768|3654476|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493690|NCT01717768|3654477|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493691|NCT01717768|3654478|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
1493692|NCT01717768|3654479|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
1493693|NCT01717768|3654480|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
1493694|NCT01717768|3654481|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493695|NCT01717768|3654482|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493696|NCT01717768|3654483|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
1493697|NCT01717768|3654472|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493698|NCT01717768|3654473|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493699|NCT01717768|3654474|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493700|NCT01717768|3654475|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493701|NCT01717768|3654476|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493702|NCT01717768|3654477|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493703|NCT01717768|3654478|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493704|NCT01717768|3654479|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493705|NCT01717768|3654480|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493706|NCT01717768|3654481|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493707|NCT01717768|3654482|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493708|NCT01717768|3654483|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493709|NCT01717768|3654472|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493710|NCT01717768|3654473|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493711|NCT01717768|3654474|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493712|NCT01717768|3654475|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493713|NCT01717768|3654476|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493714|NCT01717768|3654477|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493715|NCT01717768|3654478|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
1493716|NCT01717768|3654479|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
1493717|NCT01717768|3654480|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
1493718|NCT01717768|3654481|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493719|NCT01717768|3654482|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493720|NCT01717768|3654483|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493721|NCT01717768|3654472|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493722|NCT01717768|3654473|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493723|NCT01717768|3654474|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493724|NCT01717768|3654475|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493725|NCT01717768|3654476|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493726|NCT01717768|3654477|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493727|NCT01717768|3654478|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
1493728|NCT01717768|3654479|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
1493729|NCT01717768|3654480|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
1493730|NCT01717768|3654481|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493731|NCT01717768|3654482|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493732|NCT01717768|3654483|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
1493733|NCT01717768|3654472|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493734|NCT01717768|3654473|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493735|NCT01717768|3654474|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493736|NCT01717768|3654475|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493737|NCT01717768|3654476|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493738|NCT01717768|3654477|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493739|NCT01717768|3654478|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493740|NCT01717768|3654479|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493741|NCT01717768|3654480|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493742|NCT01717768|3654481|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493743|NCT01717768|3654482|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493744|NCT01717768|3654483|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493745|NCT01717768|3654472|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493746|NCT01717768|3654473|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493747|NCT01717768|3654474|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493748|NCT01717768|3654475|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493749|NCT01717768|3654476|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493750|NCT01717768|3654477|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493751|NCT01717768|3654478|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
1493752|NCT01717768|3654479|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
1493753|NCT01717768|3654480|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
1493754|NCT01717768|3654481|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493755|NCT01717768|3654482|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493756|NCT01717768|3654483|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493757|NCT01717768|3654472|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493758|NCT01717768|3654473|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493759|NCT01717768|3654474|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493760|NCT01717768|3654475|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493761|NCT01717768|3654476|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493762|NCT01717768|3654477|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493763|NCT01717768|3654478|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
1493764|NCT01717768|3654479|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
1493765|NCT01717768|3654480|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
1493766|NCT01717768|3654481|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493767|NCT01717768|3654482|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493768|NCT01717768|3654483|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
1493769|NCT01717768|3654472|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493770|NCT01717768|3654473|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493771|NCT01717768|3654474|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493772|NCT01717768|3654475|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493773|NCT01717768|3654476|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493774|NCT01717768|3654477|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493775|NCT01717768|3654478|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493776|NCT01717768|3654479|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493777|NCT01717768|3654480|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493778|NCT01717768|3654481|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493779|NCT01717768|3654482|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493780|NCT01717768|3654483|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
1493781|NCT01717768|3654472|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
1493782|NCT01717768|3654473|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
1493783|NCT01717768|3654474|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
1493784|NCT01717768|3654475|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
1493785|NCT01717768|3654476|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
1493786|NCT01717768|3654477|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
1493787|NCT01717768|3654478|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
1493788|NCT01717768|3654479|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
1493789|NCT01717768|3654480|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
1493790|NCT01717768|3654481|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
1493791|NCT01717768|3654482|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
1493792|NCT01717768|3654483|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
1493793|NCT01717768|3654472|P12|STARTED|Part 2 (Duration of 15 Days)||0
1493794|NCT01717768|3654473|P11|STARTED|Part 2 (Duration of 15 Days)||0
1493795|NCT01717768|3654474|P10|STARTED|Part 2 (Duration of 15 Days)||0
1493796|NCT01717768|3654475|P9|STARTED|Part 2 (Duration of 15 Days)||0
1493797|NCT01717768|3654476|P8|STARTED|Part 2 (Duration of 15 Days)||0
1493798|NCT01717768|3654477|P7|STARTED|Part 2 (Duration of 15 Days)||0
1493799|NCT01717768|3654478|P6|STARTED|Part 2 (Duration of 15 Days)||0
1493800|NCT01717768|3654479|P5|STARTED|Part 2 (Duration of 15 Days)||0
1493801|NCT01717768|3654480|P4|STARTED|Part 2 (Duration of 15 Days)||0
1493802|NCT01717768|3654481|P3|STARTED|Part 2 (Duration of 15 Days)||17
1493803|NCT01717768|3654482|P2|STARTED|Part 2 (Duration of 15 Days)||0
1493804|NCT01717768|3654483|P1|STARTED|Part 2 (Duration of 15 Days)||0
1493805|NCT01717768|3654472|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493806|NCT01717768|3654473|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493807|NCT01717768|3654474|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493808|NCT01717768|3654475|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493809|NCT01717768|3654476|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493810|NCT01717768|3654477|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493811|NCT01717768|3654478|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493812|NCT01717768|3654479|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493813|NCT01717768|3654480|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493814|NCT01717768|3654481|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493815|NCT01717768|3654482|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
1493816|NCT01717768|3654483|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
1493817|NCT01717768|3654472|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
1493818|NCT01717768|3654473|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
1493819|NCT01717768|3654474|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
1493820|NCT01717768|3654475|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
1493821|NCT01717768|3654476|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
1493822|NCT01717768|3654477|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
1493823|NCT01717768|3654478|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
1493824|NCT01717768|3654479|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
1493825|NCT01717768|3654480|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
1493826|NCT01717768|3654481|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
1493827|NCT01717768|3654482|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
1493828|NCT01717768|3654483|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
1493829|NCT01717768|3654472|P12|STARTED|Part 1 (Duration of 15 Days)||0
1493830|NCT01717768|3654473|P11|STARTED|Part 1 (Duration of 15 Days)||0
1493831|NCT01717768|3654474|P10|STARTED|Part 1 (Duration of 15 Days)||0
1493832|NCT01717768|3654475|P9|STARTED|Part 1 (Duration of 15 Days)||0
1493833|NCT01717768|3654476|P8|STARTED|Part 1 (Duration of 15 Days)||0
1493834|NCT01717768|3654477|P7|STARTED|Part 1 (Duration of 15 Days)||0
1493835|NCT01717768|3654478|P6|STARTED|Part 1 (Duration of 15 Days)||0
1493836|NCT01717768|3654479|P5|STARTED|Part 1 (Duration of 15 Days)||0
1493837|NCT01717768|3654480|P4|STARTED|Part 1 (Duration of 15 Days)||0
1493838|NCT01717768|3654481|P3|STARTED|Part 1 (Duration of 15 Days)||0
1493839|NCT01717768|3654482|P2|STARTED|Part 1 (Duration of 15 Days)||17
1493840|NCT01717768|3654483|P1|STARTED|Part 1 (Duration of 15 Days)||17
1493841|NCT01717638|3654534|P13|NOT COMPLETED|Overall Study||19
1493842|NCT01717638|3654535|P12|NOT COMPLETED|Overall Study||0
1493843|NCT01717638|3654536|P11|NOT COMPLETED|Overall Study||0
1493844|NCT01717638|3654537|P10|NOT COMPLETED|Overall Study||1
1493845|NCT01717638|3654538|P9|NOT COMPLETED|Overall Study||2
1493846|NCT01717638|3654539|P8|NOT COMPLETED|Overall Study||1
1493847|NCT01717638|3654540|P7|NOT COMPLETED|Overall Study||2
1493848|NCT01717638|3654541|P6|NOT COMPLETED|Overall Study||1
1493849|NCT01717638|3654542|P5|NOT COMPLETED|Overall Study||1
1493850|NCT01717638|3654543|P4|NOT COMPLETED|Overall Study||0
1493851|NCT01717638|3654544|P3|NOT COMPLETED|Overall Study||1
1493852|NCT01717638|3654545|P2|NOT COMPLETED|Overall Study||1
1493853|NCT01717638|3654546|P1|NOT COMPLETED|Overall Study||0
1493854|NCT01717638|3654534|P13|COMPLETED|Overall Study||190
1493855|NCT01717638|3654535|P12|COMPLETED|Overall Study||12
1493856|NCT01717638|3654536|P11|COMPLETED|Overall Study||11
1493857|NCT01717638|3654537|P10|COMPLETED|Overall Study||99
1493858|NCT01717638|3654538|P9|COMPLETED|Overall Study||26
1493859|NCT01717638|3654539|P8|COMPLETED|Overall Study||28
1493860|NCT01717638|3654540|P7|COMPLETED|Overall Study||41
1493861|NCT01717638|3654541|P6|COMPLETED|Overall Study||54
1493862|NCT01717638|3654542|P5|COMPLETED|Overall Study||63
1493863|NCT01717638|3654543|P4|COMPLETED|Overall Study||66
1493864|NCT01717638|3654544|P3|COMPLETED|Overall Study||59
1493865|NCT01717638|3654545|P2|COMPLETED|Overall Study||60
1493866|NCT01717638|3654546|P1|COMPLETED|Overall Study||67
1493867|NCT01717638|3654534|P13|STARTED|Overall Study||209
1493868|NCT01717638|3654535|P12|STARTED|Overall Study||12
1493869|NCT01717638|3654536|P11|STARTED|Overall Study||11
1493870|NCT01717638|3654537|P10|STARTED|Overall Study||100
1493871|NCT01717638|3654538|P9|STARTED|Overall Study||28
1493872|NCT01717638|3654539|P8|STARTED|Overall Study||29
1493873|NCT01717638|3654540|P7|STARTED|Overall Study||43
1493874|NCT01717638|3654541|P6|STARTED|Overall Study||55
1493875|NCT01717638|3654542|P5|STARTED|Overall Study||64
1493876|NCT01717638|3654543|P4|STARTED|Overall Study||66
1493877|NCT01717638|3654544|P3|STARTED|Overall Study||60
1493878|NCT01717638|3654545|P2|STARTED|Overall Study||61
1493879|NCT01717638|3654546|P1|STARTED|Overall Study||67
1493880|NCT01717456|3654690|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
1493881|NCT01717456|3654691|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
1493882|NCT01717456|3654690|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
1493883|NCT01717456|3654691|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
1493884|NCT01717456|3654690|P2|STARTED|Follow-Up 6 Months After End of Tx||6
1493885|NCT01717456|3654691|P1|STARTED|Follow-Up 6 Months After End of Tx||11
1493886|NCT01717456|3654690|P2|NOT COMPLETED|End of Treatment||2
1493887|NCT01717456|3654691|P1|NOT COMPLETED|End of Treatment||0
1493888|NCT01717456|3654690|P2|COMPLETED|End of Treatment||6
1493889|NCT01717456|3654691|P1|COMPLETED|End of Treatment||11
1493890|NCT01717456|3654690|P2|STARTED|End of Treatment||8
1493891|NCT01717456|3654691|P1|STARTED|End of Treatment||11
1493892|NCT01717391|3654759|P1|NOT COMPLETED|Overall Study||9
1493893|NCT01717391|3654759|P1|COMPLETED|Overall Study||27
1493894|NCT01717391|3654759|P1|STARTED|Overall Study||36
1493895|NCT01717326|3654788|P20|NOT COMPLETED|Overall Study||6
1493896|NCT01717326|3654789|P19|NOT COMPLETED|Overall Study||4
1493897|NCT01717326|3654790|P18|NOT COMPLETED|Overall Study||0
1493898|NCT01717326|3654791|P17|NOT COMPLETED|Overall Study||1
1493899|NCT01717326|3654792|P16|NOT COMPLETED|Overall Study||3
1493900|NCT01717326|3654793|P15|NOT COMPLETED|Overall Study||0
1493901|NCT01717326|3654794|P14|NOT COMPLETED|Overall Study||0
1493902|NCT01717326|3654795|P13|NOT COMPLETED|Overall Study||1
1493903|NCT01717326|3654796|P12|NOT COMPLETED|Overall Study||0
1493904|NCT01717326|3654797|P11|NOT COMPLETED|Overall Study||2
1493905|NCT01717326|3654798|P10|NOT COMPLETED|Overall Study||2
1493906|NCT01717326|3654799|P9|NOT COMPLETED|Overall Study||0
1493907|NCT01717326|3654800|P8|NOT COMPLETED|Overall Study||0
1493908|NCT01717326|3654801|P7|NOT COMPLETED|Overall Study||1
1493909|NCT01717326|3654802|P6|NOT COMPLETED|Overall Study||0
1493910|NCT01717326|3654803|P5|NOT COMPLETED|Overall Study||2
1493911|NCT01717326|3654804|P4|NOT COMPLETED|Overall Study||2
1493912|NCT01717326|3654805|P3|NOT COMPLETED|Overall Study||0
1493913|NCT01717326|3654806|P2|NOT COMPLETED|Overall Study||1
1493914|NCT01717326|3654807|P1|NOT COMPLETED|Overall Study||3
1493915|NCT01717326|3654788|P20|COMPLETED|Overall Study||15
1493916|NCT01717326|3654789|P19|COMPLETED|Overall Study||16
1493917|NCT01717326|3654790|P18|COMPLETED|Overall Study||31
1493918|NCT01717326|3654791|P17|COMPLETED|Overall Study||29
1493919|NCT01717326|3654792|P16|COMPLETED|Overall Study||27
1493920|NCT01717326|3654793|P15|COMPLETED|Overall Study||29
1493921|NCT01717326|3654794|P14|COMPLETED|Overall Study||32
1493922|NCT01717326|3654795|P13|COMPLETED|Overall Study||32
1493923|NCT01717326|3654796|P12|COMPLETED|Overall Study||33
1493924|NCT01717326|3654797|P11|COMPLETED|Overall Study||30
1493925|NCT01717326|3654798|P10|COMPLETED|Overall Study||29
1493926|NCT01717326|3654799|P9|COMPLETED|Overall Study||32
1493927|NCT01717326|3654800|P8|COMPLETED|Overall Study||29
1493928|NCT01717326|3654801|P7|COMPLETED|Overall Study||30
1493929|NCT01717326|3654802|P6|COMPLETED|Overall Study||31
1493930|NCT01717326|3654803|P5|COMPLETED|Overall Study||31
1493931|NCT01717326|3654804|P4|COMPLETED|Overall Study||28
1493932|NCT01717326|3654805|P3|COMPLETED|Overall Study||13
1493933|NCT01717326|3654806|P2|COMPLETED|Overall Study||26
1493934|NCT01717326|3654807|P1|COMPLETED|Overall Study||22
1493935|NCT01717326|3654788|P20|Treated|Overall Study||21
1493936|NCT01717326|3654789|P19|Treated|Overall Study||20
1493937|NCT01717326|3654790|P18|Treated|Overall Study||31
1493938|NCT01717326|3654791|P17|Treated|Overall Study||30
1493939|NCT01717326|3654792|P16|Treated|Overall Study||30
1493940|NCT01717326|3654793|P15|Treated|Overall Study||29
1493941|NCT01717326|3654794|P14|Treated|Overall Study||32
1493942|NCT01717326|3654795|P13|Treated|Overall Study||33
1493943|NCT01717326|3654796|P12|Treated|Overall Study||33
1493944|NCT01717326|3654797|P11|Treated|Overall Study||32
1493945|NCT01717326|3654798|P10|Treated|Overall Study||31
1493946|NCT01717326|3654799|P9|Treated|Overall Study||32
1493947|NCT01717326|3654800|P8|Treated|Overall Study||29
1493948|NCT01717326|3654801|P7|Treated|Overall Study||31
1493949|NCT01717326|3654802|P6|Treated|Overall Study||31
1493950|NCT01717326|3654803|P5|Treated|Overall Study||33
1493951|NCT01717326|3654804|P4|Treated|Overall Study||30
1493952|NCT01717326|3654805|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
1493953|NCT01717326|3654806|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
1493954|NCT01717326|3654807|P1|Treated|Overall Study||25
1493955|NCT01717326|3654788|P20|STARTED|Overall Study||21
1493956|NCT01717326|3654789|P19|STARTED|Overall Study||20
1493957|NCT01717326|3654790|P18|STARTED|Overall Study||31
1493958|NCT01717326|3654791|P17|STARTED|Overall Study||30
1493959|NCT01717326|3654792|P16|STARTED|Overall Study||30
1493960|NCT01717326|3654793|P15|STARTED|Overall Study||29
1493961|NCT01717326|3654794|P14|STARTED|Overall Study||32
1493962|NCT01717326|3654795|P13|STARTED|Overall Study||33
1493963|NCT01717326|3654796|P12|STARTED|Overall Study||33
1493964|NCT01717326|3654797|P11|STARTED|Overall Study||32
1493965|NCT01717326|3654798|P10|STARTED|Overall Study||31
1493966|NCT01717326|3654799|P9|STARTED|Overall Study||32
1493967|NCT01717326|3654800|P8|STARTED|Overall Study||29
1493968|NCT01717326|3654801|P7|STARTED|Overall Study||31
1493969|NCT01717326|3654802|P6|STARTED|Overall Study||31
1493970|NCT01717326|3654803|P5|STARTED|Overall Study||33
1493971|NCT01717326|3654804|P4|STARTED|Overall Study||30
1493972|NCT01717326|3654805|P3|STARTED|Overall Study||13
1493973|NCT01717326|3654806|P2|STARTED|Overall Study||27
1493974|NCT01717326|3654807|P1|STARTED|Overall Study||25
1493975|NCT01717313|3655071|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
1493976|NCT01717313|3655072|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
1493977|NCT01717313|3655071|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
1493978|NCT01717313|3655072|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
1493979|NCT01717313|3655071|P2|STARTED|Phase B (Weeks 24 to 54)||151
1493980|NCT01717313|3655072|P1|STARTED|Phase B (Weeks 24 to 54)||146
1493981|NCT01717313|3655071|P2|NOT COMPLETED|Interphase||0
1493982|NCT01717313|3655072|P1|NOT COMPLETED|Interphase||1
1493983|NCT01717313|3655071|P2|COMPLETED|Interphase||151
1493984|NCT01717313|3655072|P1|COMPLETED|Interphase||146
1493985|NCT01717313|3655071|P2|STARTED|Interphase||151
1493986|NCT01717313|3655072|P1|STARTED|Interphase||147
1493987|NCT01717313|3655071|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
1493988|NCT01717313|3655072|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
1493989|NCT01717313|3655071|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
1493990|NCT01717313|3655072|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
1493991|NCT01717313|3655071|P2|STARTED|Phase A (Weeks 0 to 24)||164
1493992|NCT01717313|3655072|P1|STARTED|Phase A (Weeks 0 to 24)||165
1493993|NCT01717287|3655110|P2|NOT COMPLETED|Overall Study||3
1493994|NCT01717287|3655111|P1|NOT COMPLETED|Overall Study||0
1493995|NCT01717287|3655110|P2|COMPLETED|Overall Study||25
1493996|NCT01717287|3655111|P1|COMPLETED|Overall Study||4
1493997|NCT01717287|3655110|P2|STARTED|Overall Study||28
1493998|NCT01717287|3655111|P1|STARTED|Overall Study||4
1493999|NCT01717209|3655133|P1|NOT COMPLETED|Overall Study||0
1494000|NCT01717209|3655133|P1|COMPLETED|Overall Study||14
1494001|NCT01717209|3655133|P1|STARTED|Overall Study||14
1494002|NCT01717053|3655142|P1|NOT COMPLETED|Overall Study||4
1494003|NCT01717053|3655142|P1|COMPLETED|Overall Study||33
1494004|NCT01717053|3655142|P1|STARTED|Overall Study||37
1494005|NCT01717040|3655148|P2|NOT COMPLETED|Overall Study||5
1494006|NCT01717040|3655149|P1|NOT COMPLETED|Overall Study||5
1494007|NCT01717040|3655148|P2|COMPLETED|Overall Study||15
1494008|NCT01717040|3655149|P1|COMPLETED|Overall Study||12
1494009|NCT01717040|3655148|P2|STARTED|Overall Study||20
1494010|NCT01717040|3655149|P1|STARTED|Overall Study||17
1494011|NCT01717014|3655155|P1|NOT COMPLETED|Overall Study||0
1494012|NCT01717014|3655155|P1|COMPLETED|Overall Study||8
1494013|NCT01717014|3655155|P1|STARTED|Overall Study||8
1494014|NCT01716754|3655167|P4|NOT COMPLETED|Overall Study||8
1494015|NCT01716754|3655168|P3|NOT COMPLETED|Overall Study||14
1494016|NCT01716754|3655169|P2|NOT COMPLETED|Overall Study||4
1494017|NCT01716754|3655170|P1|NOT COMPLETED|Overall Study||11
1494018|NCT01716754|3655167|P4|COMPLETED|Overall Study||89
1494019|NCT01716754|3655168|P3|COMPLETED|Overall Study||121
1494020|NCT01716754|3655169|P2|COMPLETED|Overall Study||36
1494021|NCT01716754|3655170|P1|COMPLETED|Overall Study||188
1494022|NCT01716754|3655167|P4|Safety Set|Overall Study||96
1494023|NCT01716754|3655168|P3|Safety Set|Overall Study||131
1494024|NCT01716754|3655169|P2|Safety Set|Overall Study||40
1494025|NCT01716754|3655170|P1|Safety Set|Overall Study||199
1494026|NCT01716754|3655167|P4|FAS|Overall Study||96
1494027|NCT01716754|3655168|P3|FAS|Overall Study||131
1494028|NCT01716754|3655169|P2|FAS|Overall Study||40
1494029|NCT01716754|3655170|P1|FAS|Overall Study||199
1494030|NCT01716754|3655167|P4|STARTED|Overall Study||97
1494031|NCT01716754|3655168|P3|STARTED|Overall Study||135
1494032|NCT01716754|3655169|P2|STARTED|Overall Study||40
1494033|NCT01716754|3655170|P1|STARTED|Overall Study||199
1494034|NCT01716663|3655191|P1|NOT COMPLETED|Overall Study||6
1494035|NCT01716663|3655191|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
1494204|NCT01716156|3655360|P3|COMPLETED|Overall Study||11
1494036|NCT01716663|3655191|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
1494037|NCT01716663|3655191|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
1494038|NCT01716585|3655201|P2|NOT COMPLETED|Open-label Treatment||7
1494039|NCT01716585|3655202|P1|NOT COMPLETED|Open-label Treatment||0
1494040|NCT01716585|3655201|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
1494041|NCT01716585|3655202|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
1494042|NCT01716585|3655201|P2|STARTED|Open-label Treatment||157
1494043|NCT01716585|3655202|P1|STARTED|Open-label Treatment|not applicable to this arm|0
1494044|NCT01716585|3655201|P2|NOT COMPLETED|Double-blind Treatment||2
1494045|NCT01716585|3655202|P1|NOT COMPLETED|Double-blind Treatment||13
1494046|NCT01716585|3655201|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
1494047|NCT01716585|3655202|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
1494048|NCT01716585|3655201|P2|Randomized But Not Treated|Double-blind Treatment||1
1494049|NCT01716585|3655202|P1|Randomized But Not Treated|Double-blind Treatment||4
1494050|NCT01716585|3655201|P2|STARTED|Double-blind Treatment||159
1494051|NCT01716585|3655202|P1|STARTED|Double-blind Treatment||477
1494052|NCT01716559|3655214|P1|NOT COMPLETED|Overall Study||111
1494053|NCT01716559|3655214|P1|COMPLETED|Overall Study||49
1494054|NCT01716559|3655214|P1|STARTED|Overall Study||160
1494055|NCT01716520|3655222|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
1494056|NCT01716520|3655223|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1494057|NCT01716520|3655224|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1494058|NCT01716520|3655225|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1494059|NCT01716520|3655226|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1494060|NCT01716520|3655227|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1494061|NCT01716520|3655222|P6|COMPLETED|Treatment Period 3 (14 Days)||23
1494062|NCT01716520|3655223|P5|COMPLETED|Treatment Period 3 (14 Days)||29
1494063|NCT01716520|3655224|P4|COMPLETED|Treatment Period 3 (14 Days)||28
1494064|NCT01716520|3655225|P3|COMPLETED|Treatment Period 3 (14 Days)||25
1494065|NCT01716520|3655226|P2|COMPLETED|Treatment Period 3 (14 Days)||27
1494066|NCT01716520|3655227|P1|COMPLETED|Treatment Period 3 (14 Days)||27
1494067|NCT01716520|3655222|P6|STARTED|Treatment Period 3 (14 Days)||25
1494068|NCT01716520|3655223|P5|STARTED|Treatment Period 3 (14 Days)||29
1494069|NCT01716520|3655224|P4|STARTED|Treatment Period 3 (14 Days)||28
1494070|NCT01716520|3655225|P3|STARTED|Treatment Period 3 (14 Days)||26
1494071|NCT01716520|3655226|P2|STARTED|Treatment Period 3 (14 Days)||27
1494072|NCT01716520|3655227|P1|STARTED|Treatment Period 3 (14 Days)||27
1494073|NCT01716520|3655222|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
1494074|NCT01716520|3655223|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1494075|NCT01716520|3655224|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
1494076|NCT01716520|3655225|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
1494077|NCT01716520|3655226|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
1494078|NCT01716520|3655227|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
1494079|NCT01716520|3655222|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
1494080|NCT01716520|3655223|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
1494081|NCT01716520|3655224|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
1494082|NCT01716520|3655225|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
1494083|NCT01716520|3655226|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
1494084|NCT01716520|3655227|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
1494085|NCT01716520|3655222|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
1494086|NCT01716520|3655223|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
1494087|NCT01716520|3655224|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
1494088|NCT01716520|3655225|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
1494089|NCT01716520|3655226|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
1494090|NCT01716520|3655227|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
1494091|NCT01716520|3655222|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1494092|NCT01716520|3655223|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
1494093|NCT01716520|3655224|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1494094|NCT01716520|3655225|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1494095|NCT01716520|3655226|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1494096|NCT01716520|3655227|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1494097|NCT01716520|3655222|P6|COMPLETED|Treatment Period 2 (14 Days)||27
1494098|NCT01716520|3655223|P5|COMPLETED|Treatment Period 2 (14 Days)||29
1494099|NCT01716520|3655224|P4|COMPLETED|Treatment Period 2 (14 Days)||28
1494100|NCT01716520|3655225|P3|COMPLETED|Treatment Period 2 (14 Days)||27
1494101|NCT01716520|3655226|P2|COMPLETED|Treatment Period 2 (14 Days)||28
1494102|NCT01716520|3655227|P1|COMPLETED|Treatment Period 2 (14 Days)||29
1494103|NCT01716520|3655222|P6|STARTED|Treatment Period 2 (14 Days)||27
1494104|NCT01716520|3655223|P5|STARTED|Treatment Period 2 (14 Days)||31
1494105|NCT01716520|3655224|P4|STARTED|Treatment Period 2 (14 Days)||29
1494106|NCT01716520|3655225|P3|STARTED|Treatment Period 2 (14 Days)||27
1494107|NCT01716520|3655226|P2|STARTED|Treatment Period 2 (14 Days)||28
1494108|NCT01716520|3655227|P1|STARTED|Treatment Period 2 (14 Days)||29
1494109|NCT01716520|3655222|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
1494110|NCT01716520|3655223|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1494111|NCT01716520|3655224|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1494112|NCT01716520|3655225|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
1494113|NCT01716520|3655226|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
1494114|NCT01716520|3655227|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
1494115|NCT01716520|3655222|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
1494116|NCT01716520|3655223|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
1494117|NCT01716520|3655224|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
1494118|NCT01716520|3655225|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
1494119|NCT01716520|3655226|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
1494120|NCT01716520|3655227|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
1494121|NCT01716520|3655222|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
1494122|NCT01716520|3655223|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
1494123|NCT01716520|3655224|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
1494124|NCT01716520|3655225|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
1494125|NCT01716520|3655226|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
1494126|NCT01716520|3655227|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
1494127|NCT01716520|3655222|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1494128|NCT01716520|3655223|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1494129|NCT01716520|3655224|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1494130|NCT01716520|3655225|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1494131|NCT01716520|3655226|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1494132|NCT01716520|3655227|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1494133|NCT01716520|3655222|P6|COMPLETED|Treatment Period 1 (14 Days)||29
1494134|NCT01716520|3655223|P5|COMPLETED|Treatment Period 1 (14 Days)||31
1494135|NCT01716520|3655224|P4|COMPLETED|Treatment Period 1 (14 Days)||29
1494136|NCT01716520|3655225|P3|COMPLETED|Treatment Period 1 (14 Days)||28
1494137|NCT01716520|3655226|P2|COMPLETED|Treatment Period 1 (14 Days)||29
1494138|NCT01716520|3655227|P1|COMPLETED|Treatment Period 1 (14 Days)||29
1494139|NCT01716520|3655222|P6|STARTED|Treatment Period 1 (14 Days)||30
1494140|NCT01716520|3655223|P5|STARTED|Treatment Period 1 (14 Days)||31
1494141|NCT01716520|3655224|P4|STARTED|Treatment Period 1 (14 Days)||30
1494142|NCT01716520|3655225|P3|STARTED|Treatment Period 1 (14 Days)||30
1494143|NCT01716520|3655226|P2|STARTED|Treatment Period 1 (14 Days)||30
1494144|NCT01716520|3655227|P1|STARTED|Treatment Period 1 (14 Days)||31
1494145|NCT01716468|3655243|P1|NOT COMPLETED|Overall Study||6
1494146|NCT01716468|3655243|P1|COMPLETED|Overall Study||11
1494147|NCT01716468|3655243|P1|STARTED|Overall Study||17
1494148|NCT01716455|3655253|P6|NOT COMPLETED|Overall Study||0
1494149|NCT01716455|3655254|P5|NOT COMPLETED|Overall Study||0
1494150|NCT01716455|3655255|P4|NOT COMPLETED|Overall Study||0
1494151|NCT01716455|3655256|P3|NOT COMPLETED|Overall Study||0
1494152|NCT01716455|3655257|P2|NOT COMPLETED|Overall Study||0
1494153|NCT01716455|3655258|P1|NOT COMPLETED|Overall Study||0
1494154|NCT01716455|3655253|P6|COMPLETED|Overall Study||8
1494155|NCT01716455|3655254|P5|COMPLETED|Overall Study||26
1494156|NCT01716455|3655255|P4|COMPLETED|Overall Study||8
1494157|NCT01716455|3655256|P3|COMPLETED|Overall Study||8
1494158|NCT01716455|3655257|P2|COMPLETED|Overall Study||8
1494159|NCT01716455|3655258|P1|COMPLETED|Overall Study||8
1494160|NCT01716455|3655253|P6|STARTED|Overall Study||8
1494161|NCT01716455|3655254|P5|STARTED|Overall Study||26
1494162|NCT01716455|3655255|P4|STARTED|Overall Study||8
1494163|NCT01716455|3655256|P3|STARTED|Overall Study||8
1494164|NCT01716455|3655257|P2|STARTED|Overall Study||8
1494165|NCT01716455|3655258|P1|STARTED|Overall Study||8
1494166|NCT01716234|3655282|P7|NOT COMPLETED|Overall Study||0
1494167|NCT01716234|3655283|P6|NOT COMPLETED|Overall Study||14
1494168|NCT01716234|3655284|P5|NOT COMPLETED|Overall Study||5
1494169|NCT01716234|3655285|P4|NOT COMPLETED|Overall Study||12
1494170|NCT01716234|3655286|P3|NOT COMPLETED|Overall Study||5
1494171|NCT01716234|3655287|P2|NOT COMPLETED|Overall Study||10
1494172|NCT01716234|3655288|P1|NOT COMPLETED|Overall Study||10
1494173|NCT01716234|3655282|P7|COMPLETED|Overall Study||1
1494174|NCT01716234|3655283|P6|COMPLETED|Overall Study||18
1494175|NCT01716234|3655284|P5|COMPLETED|Overall Study||10
1494176|NCT01716234|3655285|P4|COMPLETED|Overall Study||16
1494177|NCT01716234|3655286|P3|COMPLETED|Overall Study||15
1494178|NCT01716234|3655287|P2|COMPLETED|Overall Study||12
1494179|NCT01716234|3655288|P1|COMPLETED|Overall Study||14
1494180|NCT01716234|3655282|P7|Treated|Overall Study||1
1494181|NCT01716234|3655283|P6|Treated|Overall Study||30
1494182|NCT01716234|3655284|P5|Treated|Overall Study||15
1494183|NCT01716234|3655285|P4|Treated|Overall Study||28
1494184|NCT01716234|3655286|P3|Treated|Overall Study||19
1494185|NCT01716234|3655287|P2|Treated|Overall Study||21
1494186|NCT01716234|3655288|P1|Treated|Overall Study||22
1494187|NCT01716234|3655282|P7|STARTED|Overall Study||1
1494188|NCT01716234|3655283|P6|STARTED|Overall Study||32
1494189|NCT01716234|3655284|P5|STARTED|Overall Study||15
1494190|NCT01716234|3655285|P4|STARTED|Overall Study||28
1494191|NCT01716234|3655286|P3|STARTED|Overall Study||20
1494192|NCT01716234|3655287|P2|STARTED|Overall Study||22
1494193|NCT01716234|3655288|P1|STARTED|Overall Study||24
1494194|NCT01716221|3655325|P1|NOT COMPLETED|Overall Study||0
1494195|NCT01716221|3655325|P1|COMPLETED|Overall Study||1
1494196|NCT01716221|3655325|P1|STARTED|Overall Study||1
1494197|NCT01716169|3655351|P1|NOT COMPLETED|Overall Study||4
1494198|NCT01716169|3655351|P1|COMPLETED|Overall Study||6
1494199|NCT01716169|3655351|P1|Standard of Care Dressings Used|Overall Study||7
1494200|NCT01716169|3655351|P1|STARTED|Overall Study||10
1494201|NCT01716156|3655360|P3|NOT COMPLETED|Overall Study||2
1494202|NCT01716156|3655361|P2|NOT COMPLETED|Overall Study||1
1494203|NCT01716156|3655362|P1|NOT COMPLETED|Overall Study||2
1494205|NCT01716156|3655361|P2|COMPLETED|Overall Study||3
1494206|NCT01716156|3655362|P1|COMPLETED|Overall Study||7
1494207|NCT01716156|3655360|P3|STARTED|Overall Study||13
1494208|NCT01716156|3655361|P2|STARTED|Overall Study||4
1494209|NCT01716156|3655362|P1|STARTED|Overall Study||9
1494210|NCT01716104|3655388|P2|NOT COMPLETED|Overall Study||7
1494211|NCT01716104|3655389|P1|NOT COMPLETED|Overall Study||6
1494212|NCT01716104|3655388|P2|COMPLETED|Overall Study||117
1494213|NCT01716104|3655389|P1|COMPLETED|Overall Study||119
1494214|NCT01716104|3655388|P2|STARTED|Overall Study||124
1494215|NCT01716104|3655389|P1|STARTED|Overall Study||125
1494216|NCT01716052|3655415|P2|NOT COMPLETED|Overall Study||1
1494217|NCT01716052|3655416|P1|NOT COMPLETED|Overall Study||1
1494218|NCT01716052|3655415|P2|COMPLETED|Overall Study||0
1494219|NCT01716052|3655416|P1|COMPLETED|Overall Study||0
1494220|NCT01716052|3655415|P2|STARTED|Overall Study||1
1494221|NCT01716052|3655416|P1|STARTED|Overall Study||1
1494222|NCT01716013|3655424|P2|NOT COMPLETED|Overall Study||0
1494223|NCT01716013|3655425|P1|NOT COMPLETED|Overall Study||3
1494224|NCT01716013|3655424|P2|COMPLETED|Overall Study||54
1494225|NCT01716013|3655425|P1|COMPLETED|Overall Study||105
1494226|NCT01716013|3655424|P2|STARTED|Overall Study||54
1494227|NCT01716013|3655425|P1|STARTED|Overall Study||108
1494228|NCT01715948|3655437|P1|NOT COMPLETED|Overall Study||1
1494229|NCT01715948|3655437|P1|COMPLETED|Overall Study||8
1494230|NCT01715948|3655437|P1|STARTED|Overall Study||9
1494231|NCT01715896|3655458|P2|NOT COMPLETED|Overall Study||11
1494232|NCT01715896|3655459|P1|NOT COMPLETED|Overall Study||3
1494233|NCT01715896|3655458|P2|COMPLETED|Overall Study||59
1494234|NCT01715896|3655459|P1|COMPLETED|Overall Study||65
1494235|NCT01715896|3655458|P2|STARTED|Overall Study||70
1494236|NCT01715896|3655459|P1|STARTED|Overall Study||68
1494237|NCT01715883|3655522|P1|NOT COMPLETED|Overall Study||1
1494238|NCT01715883|3655522|P1|COMPLETED|Overall Study||2
1494239|NCT01715883|3655522|P1|STARTED|Overall Study||3
1494240|NCT01715857|3655532|P1|NOT COMPLETED|Overall Study||96
1494241|NCT01715857|3655532|P1|COMPLETED|Overall Study||4004
1494242|NCT01715857|3655532|P1|STARTED|Overall Study||4100
1494243|NCT01715831|3655542|P1|NOT COMPLETED|Overall Study||1
1494244|NCT01715831|3655542|P1|COMPLETED|Overall Study||25
1494245|NCT01715831|3655542|P1|STARTED|Overall Study||26
1494246|NCT01715415|3655560|P2|NOT COMPLETED|Open-label Treatment||2
1494247|NCT01715415|3655561|P1|NOT COMPLETED|Open-label Treatment||0
1494248|NCT01715415|3655560|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
1494249|NCT01715415|3655561|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
1494250|NCT01715415|3655560|P2|STARTED|Open-label Treatment||96
1494251|NCT01715415|3655561|P1|STARTED|Open-label Treatment|not applicable to this arm|0
1494252|NCT01715415|3655560|P2|NOT COMPLETED|Double-blind Treatment||2
1494253|NCT01715415|3655561|P1|NOT COMPLETED|Double-blind Treatment||5
1494254|NCT01715415|3655560|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
1494255|NCT01715415|3655561|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
1494256|NCT01715415|3655560|P2|Randomized But Not Treated|Double-blind Treatment||1
1494257|NCT01715415|3655561|P1|Randomized But Not Treated|Double-blind Treatment||0
1494258|NCT01715415|3655560|P2|STARTED|Double-blind Treatment||98
1494259|NCT01715415|3655561|P1|STARTED|Double-blind Treatment||297
1494260|NCT01715298|3655575|P2|NOT COMPLETED|Overall Study||11
1494261|NCT01715298|3655576|P1|NOT COMPLETED|Overall Study||7
1494262|NCT01715298|3655575|P2|COMPLETED|Overall Study||205
1494263|NCT01715298|3655576|P1|COMPLETED|Overall Study||209
1494264|NCT01715298|3655575|P2|Full Analysis Set (FAS)|Overall Study||214
1494265|NCT01715298|3655576|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
1494266|NCT01715298|3655575|P2|STARTED|Overall Study||216
1494267|NCT01715298|3655576|P1|STARTED|Overall Study||216
1494268|NCT01715285|3655614|P2|NOT COMPLETED|Overall Study||602
1494269|NCT01715285|3655615|P1|NOT COMPLETED|Overall Study||597
1494270|NCT01715285|3655614|P2|COMPLETED|Overall Study||0
1494271|NCT01715285|3655615|P1|COMPLETED|Overall Study||0
1494272|NCT01715285|3655614|P2|Safety Population|Overall Study||602
1494273|NCT01715285|3655615|P1|Safety Population|Overall Study||597
1494274|NCT01715285|3655614|P2|ITT Population|Overall Study||602
1494275|NCT01715285|3655615|P1|ITT Population|Overall Study||597
1494276|NCT01715285|3655614|P2|STARTED|Overall Study||602
1494277|NCT01715285|3655615|P1|STARTED|Overall Study||597
1494278|NCT01715207|3655635|P2|NOT COMPLETED|Overall Study||1
1494279|NCT01715207|3655636|P1|NOT COMPLETED|Overall Study||1
1494280|NCT01715207|3655635|P2|COMPLETED|Overall Study||14
1494281|NCT01715207|3655636|P1|COMPLETED|Overall Study||14
1494282|NCT01715207|3655635|P2|STARTED|Overall Study||15
1494283|NCT01715207|3655636|P1|STARTED|Overall Study||15
1494284|NCT01715129|3655644|P1|NOT COMPLETED|Overall Study||9
1494285|NCT01715129|3655644|P1|COMPLETED|Overall Study||117
1494286|NCT01715129|3655644|P1|STARTED|Overall Study||126
1494287|NCT01715064|3655663|P2|NOT COMPLETED|Overall Study||0
1494288|NCT01715064|3655664|P1|NOT COMPLETED|Overall Study||0
1494289|NCT01715064|3655663|P2|COMPLETED|Overall Study||18
1494290|NCT01715064|3655664|P1|COMPLETED|Overall Study||18
1494291|NCT01715064|3655663|P2|STARTED|Overall Study||18
1494292|NCT01715064|3655664|P1|STARTED|Overall Study||18
1494293|NCT01714947|3655670|P1|NOT COMPLETED|Part B||3
1494294|NCT01714947|3655670|P1|COMPLETED|Part B||0
1494295|NCT01714947|3655670|P1|STARTED|Part B||3
1494296|NCT01714947|3655670|P1|NOT COMPLETED|Part A||0
1494297|NCT01714947|3655670|P1|COMPLETED|Part A||3
1494298|NCT01714947|3655670|P1|STARTED|Part A||3
1494299|NCT01714921|3655699|P1|NOT COMPLETED|Overall Study||193
1494300|NCT01714921|3655699|P1|COMPLETED|Overall Study||311
1494301|NCT01714921|3655699|P1|STARTED|Overall Study||504
1494302|NCT01714817|3655711|P2|NOT COMPLETED|Overall Study||42
1494303|NCT01714817|3655712|P1|NOT COMPLETED|Overall Study||48
1494304|NCT01714817|3655711|P2|COMPLETED|Overall Study|Completed = continued study through Year 1|161
1494305|NCT01714817|3655712|P1|COMPLETED|Overall Study|Completed = continued study through Year 1|155
1494306|NCT01714817|3655711|P2|Treated|Overall Study||203
1494307|NCT01714817|3655712|P1|Treated|Overall Study||202
1494308|NCT01714817|3655711|P2|STARTED|Overall Study||203
1494309|NCT01714817|3655712|P1|STARTED|Overall Study||203
1494310|NCT01714804|3655733|P2|NOT COMPLETED|Overall Study||0
1494311|NCT01714804|3655734|P1|NOT COMPLETED|Overall Study||1
1494312|NCT01714804|3655733|P2|COMPLETED|Overall Study||30
1494313|NCT01714804|3655734|P1|COMPLETED|Overall Study||29
1494314|NCT01714804|3655733|P2|STARTED|Overall Study||30
1494315|NCT01714804|3655734|P1|STARTED|Overall Study||30
1494316|NCT01714635|3655745|P3|NOT COMPLETED|Overall Study||2
1494317|NCT01714635|3655746|P2|NOT COMPLETED|Overall Study||0
1494318|NCT01714635|3655747|P1|NOT COMPLETED|Overall Study||2
1494319|NCT01714635|3655745|P3|COMPLETED|Overall Study||146
1494320|NCT01714635|3655746|P2|COMPLETED|Overall Study||150
1494321|NCT01714635|3655747|P1|COMPLETED|Overall Study||145
1494322|NCT01714635|3655745|P3|STARTED|Overall Study||148
1494323|NCT01714635|3655746|P2|STARTED|Overall Study||150
1494324|NCT01714635|3655747|P1|STARTED|Overall Study||147
1494325|NCT01714609|3655763|P2|NOT COMPLETED|Overall Study||0
1494326|NCT01714609|3655764|P1|NOT COMPLETED|Overall Study||1
1494327|NCT01714609|3655763|P2|COMPLETED|Overall Study||5
1494328|NCT01714609|3655764|P1|COMPLETED|Overall Study||4
1494329|NCT01714609|3655763|P2|STARTED|Overall Study||5
1494330|NCT01714609|3655764|P1|STARTED|Overall Study||5
1494331|NCT01714544|3655770|P1|NOT COMPLETED|Overall Study||3
1494332|NCT01714544|3655770|P1|COMPLETED|Overall Study||57
1494333|NCT01714544|3655770|P1|STARTED|Overall Study||60
1494334|NCT01714505|3655774|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
1494335|NCT01714505|3655775|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
1494336|NCT01714505|3655774|P2|COMPLETED|Admission 2 (40 Hours)||9
1494337|NCT01714505|3655775|P1|COMPLETED|Admission 2 (40 Hours)||9
1494338|NCT01714505|3655774|P2|STARTED|Admission 2 (40 Hours)||9
1494339|NCT01714505|3655775|P1|STARTED|Admission 2 (40 Hours)||9
1494340|NCT01714505|3655774|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
1494341|NCT01714505|3655775|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
1494342|NCT01714505|3655774|P2|COMPLETED|Admission 1 (40 Hours)||9
1494343|NCT01714505|3655775|P1|COMPLETED|Admission 1 (40 Hours)||9
1494344|NCT01714505|3655774|P2|STARTED|Admission 1 (40 Hours)||10
1494345|NCT01714505|3655775|P1|STARTED|Admission 1 (40 Hours)||10
1494346|NCT01714492|3655785|P1|NOT COMPLETED|Overall Study||0
1494347|NCT01714492|3655785|P1|COMPLETED|Overall Study||8
1494348|NCT01714492|3655785|P1|STARTED|Overall Study||8
1494349|NCT01714336|3655796|P2|NOT COMPLETED|Overall Study||0
1494350|NCT01714336|3655797|P1|NOT COMPLETED|Overall Study||0
1494351|NCT01714336|3655796|P2|COMPLETED|Overall Study||69
1494352|NCT01714336|3655797|P1|COMPLETED|Overall Study||69
1494353|NCT01714336|3655796|P2|STARTED|Overall Study||69
1494354|NCT01714336|3655797|P1|STARTED|Overall Study||69
1494355|NCT01714323|3655819|P2|NOT COMPLETED|Overall Study||172
1494356|NCT01714323|3655820|P1|NOT COMPLETED|Overall Study||164
1494357|NCT01714323|3655819|P2|COMPLETED|Overall Study||508
1494358|NCT01714323|3655820|P1|COMPLETED|Overall Study||513
1494359|NCT01714323|3655819|P2|STARTED|Overall Study||680
1494360|NCT01714323|3655820|P1|STARTED|Overall Study||677
1494361|NCT01714310|3655841|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
1494362|NCT01714310|3655842|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
1494363|NCT01714310|3655843|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
1494364|NCT01714310|3655841|P3|COMPLETED|Double Blind Adjunctive Treatment||0
1494365|NCT01714310|3655842|P2|COMPLETED|Double Blind Adjunctive Treatment||11
1494366|NCT01714310|3655843|P1|COMPLETED|Double Blind Adjunctive Treatment||10
1494367|NCT01714310|3655841|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
1494368|NCT01714310|3655842|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
1494369|NCT01714310|3655843|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
1494370|NCT01714310|3655841|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
1494371|NCT01714310|3655842|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
1494372|NCT01714310|3655843|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
1494373|NCT01714310|3655841|P3|COMPLETED|Open Lisdexamfetamine Titration||30
1494374|NCT01714310|3655842|P2|COMPLETED|Open Lisdexamfetamine Titration||0
1494375|NCT01714310|3655843|P1|COMPLETED|Open Lisdexamfetamine Titration||0
1494376|NCT01714310|3655841|P3|STARTED|Open Lisdexamfetamine Titration||34
1494377|NCT01714310|3655842|P2|STARTED|Open Lisdexamfetamine Titration||0
1494378|NCT01714310|3655843|P1|STARTED|Open Lisdexamfetamine Titration||0
1494379|NCT01714232|3655890|P1|NOT COMPLETED|Overall Study||0
1494380|NCT01714232|3655890|P1|COMPLETED|Overall Study||106
1494381|NCT01714232|3655890|P1|STARTED|Overall Study||106
1494382|NCT01714024|3655899|P3|NOT COMPLETED|Overall Study||3
1494383|NCT01714024|3655900|P2|NOT COMPLETED|Overall Study||6
1494384|NCT01714024|3655901|P1|NOT COMPLETED|Overall Study||1
1494385|NCT01714024|3655899|P3|COMPLETED|Overall Study||8
1494386|NCT01714024|3655900|P2|COMPLETED|Overall Study||12
1494387|NCT01714024|3655901|P1|COMPLETED|Overall Study||12
1494388|NCT01714024|3655899|P3|STARTED|Overall Study||11
1494389|NCT01714024|3655900|P2|STARTED|Overall Study||18
1494390|NCT01714024|3655901|P1|STARTED|Overall Study||13
1494391|NCT01713998|3655921|P3|NOT COMPLETED|Overall Study||2
1494392|NCT01713998|3655922|P2|NOT COMPLETED|Overall Study||0
1494393|NCT01713998|3655923|P1|NOT COMPLETED|Overall Study||3
1494394|NCT01713998|3655921|P3|COMPLETED|Overall Study||14
1494395|NCT01713998|3655922|P2|COMPLETED|Overall Study||15
1494396|NCT01713998|3655923|P1|COMPLETED|Overall Study||13
1494397|NCT01713998|3655921|P3|STARTED|Overall Study||16
1494398|NCT01713998|3655922|P2|STARTED|Overall Study||15
1494399|NCT01713998|3655923|P1|STARTED|Overall Study||16
1494400|NCT01713946|3655944|P3|NOT COMPLETED|Overall Study||44
1494401|NCT01713946|3655945|P2|NOT COMPLETED|Overall Study||45
1494402|NCT01713946|3655946|P1|NOT COMPLETED|Overall Study||43
1494403|NCT01713946|3655944|P3|COMPLETED|Overall Study||75
1494404|NCT01713946|3655945|P2|COMPLETED|Overall Study||85
1494405|NCT01713946|3655946|P1|COMPLETED|Overall Study||74
1494406|NCT01713946|3655944|P3|Did Not Cont. in Post-Ext Phase|Overall Study||0
1494407|NCT01713946|3655945|P2|Did Not Cont. in Post-Ext Phase|Overall Study||2
1494408|NCT01713946|3655946|P1|Did Not Cont. in Post-Ext Phase|Overall Study||1
1494409|NCT01713946|3655944|P3|Did Not Continue in Ext Phase|Overall Study||0
1494410|NCT01713946|3655945|P2|Did Not Continue in Ext Phase|Overall Study||3
1494411|NCT01713946|3655946|P1|Did Not Continue in Ext Phase|Overall Study||0
1494412|NCT01713946|3655944|P3|Completed Post-Ext Phase|Overall Study||75
1494413|NCT01713946|3655945|P2|Completed Post-Ext Phase|Overall Study||85
1494414|NCT01713946|3655946|P1|Completed Post-Ext Phase|Overall Study||74
1494415|NCT01713946|3655944|P3|Continued in Post-Ext. Phase|Overall Study||81
1494416|NCT01713946|3655945|P2|Continued in Post-Ext. Phase|Overall Study||90
1494417|NCT01713946|3655946|P1|Continued in Post-Ext. Phase|Overall Study||78
1494418|NCT01713946|3655944|P3|Completed Ext. Phase|Overall Study||81
1494419|NCT01713946|3655945|P2|Completed Ext. Phase|Overall Study||92
1494420|NCT01713946|3655946|P1|Completed Ext. Phase|Overall Study||79
1494421|NCT01713946|3655944|P3|Continued in Ext. Phase|Overall Study||114
1494422|NCT01713946|3655945|P2|Continued in Ext. Phase|Overall Study||119
1494423|NCT01713946|3655946|P1|Continued in Ext. Phase|Overall Study||110
1494424|NCT01713946|3655944|P3|Completed Core Phase|Overall Study||114
1494425|NCT01713946|3655945|P2|Completed Core Phase|Overall Study||122
1494426|NCT01713946|3655946|P1|Completed Core Phase|Overall Study||110
1494427|NCT01713946|3655944|P3|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
1494428|NCT01713946|3655945|P2|STARTED|Overall Study||130
1494429|NCT01713946|3655946|P1|STARTED|Overall Study||117
1494430|NCT01713933|3656037|P1|NOT COMPLETED|Overall Study||6
1494431|NCT01713933|3656037|P1|COMPLETED|Overall Study||31
1494432|NCT01713933|3656037|P1|STARTED|Overall Study||37
1494433|NCT01713686|3656049|P1|NOT COMPLETED|Overall Study||15
1494434|NCT01713686|3656049|P1|COMPLETED|Overall Study||110
1494435|NCT01713686|3656049|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
1494436|NCT01713660|3656058|P1|NOT COMPLETED|Overall Study||0
1494437|NCT01713660|3656058|P1|COMPLETED|Overall Study||37
1494438|NCT01713660|3656058|P1|STARTED|Overall Study||37
1494439|NCT01713621|3656066|P2|NOT COMPLETED|Overall Study||16
1494440|NCT01713621|3656067|P1|NOT COMPLETED|Overall Study||7
1494441|NCT01713621|3656066|P2|COMPLETED|Overall Study||1
1494442|NCT01713621|3656067|P1|COMPLETED|Overall Study||1
1494443|NCT01713621|3656066|P2|STARTED|Overall Study||17
1494444|NCT01713621|3656067|P1|STARTED|Overall Study||8
1494445|NCT01713608|3656077|P4|NOT COMPLETED|Overall Study||0
1494446|NCT01713608|3656078|P3|NOT COMPLETED|Overall Study||0
1494447|NCT01713608|3656079|P2|NOT COMPLETED|Overall Study||0
1494448|NCT01713608|3656080|P1|NOT COMPLETED|Overall Study||0
1494449|NCT01713608|3656077|P4|COMPLETED|Overall Study||12
1494450|NCT01713608|3656078|P3|COMPLETED|Overall Study||8
1494451|NCT01713608|3656079|P2|COMPLETED|Overall Study||6
1494452|NCT01713608|3656080|P1|COMPLETED|Overall Study||8
1494453|NCT01713608|3656077|P4|STARTED|Overall Study||12
1494454|NCT01713608|3656078|P3|STARTED|Overall Study||8
1494455|NCT01713608|3656079|P2|STARTED|Overall Study||6
1494456|NCT01713608|3656080|P1|STARTED|Overall Study||8
1494457|NCT01713582|3656119|P21|NOT COMPLETED|Overall Study||15
1494458|NCT01713582|3656120|P20|NOT COMPLETED|Overall Study||5
1494459|NCT01713582|3656121|P19|NOT COMPLETED|Overall Study||5
1494460|NCT01713582|3656122|P18|NOT COMPLETED|Overall Study||3
1494461|NCT01713582|3656123|P17|NOT COMPLETED|Overall Study||7
1494462|NCT01713582|3656124|P16|NOT COMPLETED|Overall Study||6
1494463|NCT01713582|3656125|P15|NOT COMPLETED|Overall Study||7
1494464|NCT01713582|3656126|P14|NOT COMPLETED|Overall Study||4
1494465|NCT01713582|3656127|P13|NOT COMPLETED|Overall Study||3
1494466|NCT01713582|3656128|P12|NOT COMPLETED|Overall Study||5
1494467|NCT01713582|3656129|P11|NOT COMPLETED|Overall Study||16
1494468|NCT01713582|3656130|P10|NOT COMPLETED|Overall Study||18
1494469|NCT01713582|3656131|P9|NOT COMPLETED|Overall Study||6
1494470|NCT01713582|3656132|P8|NOT COMPLETED|Overall Study||6
1494471|NCT01713582|3656133|P7|NOT COMPLETED|Overall Study||7
1494472|NCT01713582|3656134|P6|NOT COMPLETED|Overall Study||8
1494473|NCT01713582|3656135|P5|NOT COMPLETED|Overall Study||4
1494474|NCT01713582|3656136|P4|NOT COMPLETED|Overall Study||3
1494475|NCT01713582|3656137|P3|NOT COMPLETED|Overall Study||4
1494476|NCT01713582|3656138|P2|NOT COMPLETED|Overall Study||3
1494477|NCT01713582|3656139|P1|NOT COMPLETED|Overall Study||3
1494478|NCT01713582|3656119|P21|COMPLETED|Overall Study||0
1494479|NCT01713582|3656120|P20|COMPLETED|Overall Study||0
1494480|NCT01713582|3656121|P19|COMPLETED|Overall Study||0
1494481|NCT01713582|3656122|P18|COMPLETED|Overall Study||0
1494482|NCT01713582|3656123|P17|COMPLETED|Overall Study||0
1494483|NCT01713582|3656124|P16|COMPLETED|Overall Study||0
1494484|NCT01713582|3656125|P15|COMPLETED|Overall Study||0
1494485|NCT01713582|3656126|P14|COMPLETED|Overall Study||0
1494486|NCT01713582|3656127|P13|COMPLETED|Overall Study||0
1494487|NCT01713582|3656128|P12|COMPLETED|Overall Study||0
1494488|NCT01713582|3656129|P11|COMPLETED|Overall Study||0
1494489|NCT01713582|3656130|P10|COMPLETED|Overall Study||0
1494490|NCT01713582|3656131|P9|COMPLETED|Overall Study||0
1494491|NCT01713582|3656132|P8|COMPLETED|Overall Study||0
1494492|NCT01713582|3656133|P7|COMPLETED|Overall Study||0
1494493|NCT01713582|3656134|P6|COMPLETED|Overall Study||0
1494494|NCT01713582|3656135|P5|COMPLETED|Overall Study||0
1494495|NCT01713582|3656136|P4|COMPLETED|Overall Study||0
1494496|NCT01713582|3656137|P3|COMPLETED|Overall Study||0
1494497|NCT01713582|3656138|P2|COMPLETED|Overall Study||0
1494498|NCT01713582|3656139|P1|COMPLETED|Overall Study||0
1494499|NCT01713582|3656119|P21|STARTED|Overall Study|Number treated|15
1494500|NCT01713582|3656120|P20|STARTED|Overall Study|Number treated|5
1494501|NCT01713582|3656121|P19|STARTED|Overall Study|Number treated|5
1494502|NCT01713582|3656122|P18|STARTED|Overall Study|Number treated|3
1494503|NCT01713582|3656123|P17|STARTED|Overall Study|Number treated|7
1494504|NCT01713582|3656124|P16|STARTED|Overall Study|Number treated|6
1494505|NCT01713582|3656125|P15|STARTED|Overall Study|Number treated|7
1494506|NCT01713582|3656126|P14|STARTED|Overall Study|Number treated|4
1494507|NCT01713582|3656127|P13|STARTED|Overall Study|Number treated|3
1494508|NCT01713582|3656128|P12|STARTED|Overall Study|Number treated|5
1494509|NCT01713582|3656129|P11|STARTED|Overall Study|Number treated|16
1494510|NCT01713582|3656130|P10|STARTED|Overall Study|Number treated|18
1494511|NCT01713582|3656131|P9|STARTED|Overall Study|Number treated|6
1494512|NCT01713582|3656132|P8|STARTED|Overall Study|Number treated|6
1494513|NCT01713582|3656133|P7|STARTED|Overall Study|Number treated|7
1494514|NCT01713582|3656134|P6|STARTED|Overall Study|Number treated|8
1494515|NCT01713582|3656135|P5|STARTED|Overall Study|Number treated|4
1494516|NCT01713582|3656136|P4|STARTED|Overall Study|Number treated|3
1494517|NCT01713582|3656137|P3|STARTED|Overall Study|Number treated|4
1494518|NCT01713582|3656138|P2|STARTED|Overall Study|Number treated|3
1494519|NCT01713582|3656139|P1|STARTED|Overall Study|Number treated|3
1494520|NCT01713530|3656302|P2|NOT COMPLETED|Overall Study||19
1494521|NCT01713530|3656303|P1|NOT COMPLETED|Overall Study||25
1494522|NCT01713530|3656302|P2|COMPLETED|Overall Study||117
1494523|NCT01713530|3656303|P1|COMPLETED|Overall Study||113
1494524|NCT01713530|3656302|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
1494525|NCT01713530|3656303|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
1494526|NCT01713530|3656302|P2|STARTED|Overall Study||136
1494527|NCT01713530|3656303|P1|STARTED|Overall Study||138
1494528|NCT01713400|3656321|P2|NOT COMPLETED|Overall Study||0
1494529|NCT01713400|3656322|P1|NOT COMPLETED|Overall Study||0
1494530|NCT01713400|3656321|P2|COMPLETED|Overall Study||15
1494531|NCT01713400|3656322|P1|COMPLETED|Overall Study||15
1494532|NCT01713400|3656321|P2|STARTED|Overall Study||15
1494533|NCT01713400|3656322|P1|STARTED|Overall Study||15
1494534|NCT01713348|3656334|P4|NOT COMPLETED|Overall Study||0
1494535|NCT01713348|3656335|P3|NOT COMPLETED|Overall Study||2
1494536|NCT01713348|3656336|P2|NOT COMPLETED|Overall Study||2
1494537|NCT01713348|3656337|P1|NOT COMPLETED|Overall Study||4
1494538|NCT01713348|3656334|P4|COMPLETED|Overall Study||15
1494539|NCT01713348|3656335|P3|COMPLETED|Overall Study||28
1494540|NCT01713348|3656336|P2|COMPLETED|Overall Study||11
1494541|NCT01713348|3656337|P1|COMPLETED|Overall Study||25
1494542|NCT01713348|3656334|P4|STARTED|Overall Study||15
1494543|NCT01713348|3656335|P3|STARTED|Overall Study||30
1494544|NCT01713348|3656336|P2|STARTED|Overall Study||13
1494545|NCT01713348|3656337|P1|STARTED|Overall Study||29
1494546|NCT01713283|3656367|P2|NOT COMPLETED|Overall Study||3
1494547|NCT01713283|3656368|P1|NOT COMPLETED|Overall Study||11
1494548|NCT01713283|3656367|P2|COMPLETED|Overall Study||26
1494549|NCT01713283|3656368|P1|COMPLETED|Overall Study||20
1494550|NCT01713283|3656367|P2|STARTED|Overall Study||29
1494551|NCT01713283|3656368|P1|STARTED|Overall Study||31
1494552|NCT01713036|3656390|P1|NOT COMPLETED|Overall Study||1
1494553|NCT01713036|3656390|P1|COMPLETED|Overall Study||5
1494554|NCT01713036|3656390|P1|STARTED|Overall Study||6
1494555|NCT01712984|3656430|P3|NOT COMPLETED|Overall Study||10
1494556|NCT01712984|3656431|P2|NOT COMPLETED|Overall Study||16
1494557|NCT01712984|3656432|P1|NOT COMPLETED|Overall Study||16
1494558|NCT01712984|3656430|P3|COMPLETED|Overall Study||836
1494559|NCT01712984|3656431|P2|COMPLETED|Overall Study||821
1494560|NCT01712984|3656432|P1|COMPLETED|Overall Study||1656
1494561|NCT01712984|3656430|P3|STARTED|Overall Study||846
1494562|NCT01712984|3656431|P2|STARTED|Overall Study||837
1494563|NCT01712984|3656432|P1|STARTED|Overall Study||1672
1494564|NCT01712854|3656452|P1|NOT COMPLETED|Overall Study||1
1494565|NCT01712854|3656452|P1|COMPLETED|Overall Study||8
1494566|NCT01712854|3656452|P1|STARTED|Overall Study||9
1494567|NCT01712776|3656459|P2|NOT COMPLETED|Overall Study||0
1494568|NCT01712776|3656460|P1|NOT COMPLETED|Overall Study||0
1494569|NCT01712776|3656459|P2|COMPLETED|Overall Study||50
1494570|NCT01712776|3656460|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
1494571|NCT01712776|3656459|P2|STARTED|Overall Study||50
1494572|NCT01712776|3656460|P1|STARTED|Overall Study||50
1494573|NCT01712711|3656468|P2|NOT COMPLETED|Overall Study||0
1494574|NCT01712711|3656469|P1|NOT COMPLETED|Overall Study||0
1494575|NCT01712711|3656468|P2|COMPLETED|Overall Study||20
1494576|NCT01712711|3656469|P1|COMPLETED|Overall Study||20
1494577|NCT01712711|3656468|P2|STARTED|Overall Study||20
1494578|NCT01712711|3656469|P1|STARTED|Overall Study||20
1494579|NCT01712685|3656475|P1|NOT COMPLETED|Overall Study||1
1494580|NCT01712685|3656475|P1|COMPLETED|Overall Study||11
1494581|NCT01712685|3656475|P1|STARTED|Overall Study||12
1494582|NCT01712516|3656491|P4|NOT COMPLETED|Overall Study||13
1494583|NCT01712516|3656492|P3|NOT COMPLETED|Overall Study||6
1494584|NCT01712516|3656493|P2|NOT COMPLETED|Overall Study||10
1494585|NCT01712516|3656494|P1|NOT COMPLETED|Overall Study||6
1494586|NCT01712516|3656491|P4|COMPLETED|Overall Study||236
1494587|NCT01712516|3656492|P3|COMPLETED|Overall Study||245
1494588|NCT01712516|3656493|P2|COMPLETED|Overall Study||241
1494589|NCT01712516|3656494|P1|COMPLETED|Overall Study||244
1494590|NCT01712516|3656491|P4|Full Analysis Set|Overall Study||247
1494591|NCT01712516|3656492|P3|Full Analysis Set|Overall Study||250
1494592|NCT01712516|3656493|P2|Full Analysis Set|Overall Study||251
1494593|NCT01712516|3656494|P1|Full Analysis Set|Overall Study||250
1494594|NCT01712516|3656491|P4|Safety Set|Overall Study||248
1494595|NCT01712516|3656492|P3|Safety Set|Overall Study||251
1494596|NCT01712516|3656493|P2|Safety Set|Overall Study||251
1494597|NCT01712516|3656494|P1|Safety Set|Overall Study||250
1494598|NCT01712516|3656491|P4|STARTED|Overall Study||249
1494599|NCT01712516|3656492|P3|STARTED|Overall Study||251
1494600|NCT01712516|3656493|P2|STARTED|Overall Study||251
1494601|NCT01712516|3656494|P1|STARTED|Overall Study||250
1494602|NCT01712490|3656546|P2|NOT COMPLETED|Overall Study||670
1494603|NCT01712490|3656547|P1|NOT COMPLETED|Overall Study||664
1494604|NCT01712490|3656546|P2|COMPLETED|Overall Study||0
1494605|NCT01712490|3656547|P1|COMPLETED|Overall Study||0
1494606|NCT01712490|3656546|P2|Treated|Overall Study||659
1494607|NCT01712490|3656547|P1|Treated|Overall Study||662
1494608|NCT01712490|3656546|P2|STARTED|Overall Study||670
1494609|NCT01712490|3656547|P1|STARTED|Overall Study||664
1494610|NCT01712399|3656584|P1|NOT COMPLETED|Overall Study||397
1494611|NCT01712399|3656584|P1|COMPLETED|Overall Study||0
1494612|NCT01712399|3656584|P1|STARTED|Overall Study||397
1494613|NCT01712360|3656601|P4|NOT COMPLETED|Overall Study||2
1494614|NCT01712360|3656602|P3|NOT COMPLETED|Overall Study||0
1494615|NCT01712360|3656603|P2|NOT COMPLETED|Overall Study||1
1494616|NCT01712360|3656604|P1|NOT COMPLETED|Overall Study||0
1494617|NCT01712360|3656601|P4|COMPLETED|Overall Study||4
1494618|NCT01712360|3656602|P3|COMPLETED|Overall Study||6
1494619|NCT01712360|3656603|P2|COMPLETED|Overall Study||21
1494620|NCT01712360|3656604|P1|COMPLETED|Overall Study||22
1494621|NCT01712360|3656601|P4|STARTED|Overall Study||6
1494622|NCT01712360|3656602|P3|STARTED|Overall Study||6
1494623|NCT01712360|3656603|P2|STARTED|Overall Study||22
1494624|NCT01712360|3656604|P1|STARTED|Overall Study||22
1494625|NCT01712334|3656630|P2|NOT COMPLETED|Treatment Period 2||0
1494626|NCT01712334|3656631|P1|NOT COMPLETED|Treatment Period 2||0
1494627|NCT01712334|3656630|P2|COMPLETED|Treatment Period 2||41
1494628|NCT01712334|3656631|P1|COMPLETED|Treatment Period 2||44
1494629|NCT01712334|3656630|P2|STARTED|Treatment Period 2||41
1494630|NCT01712334|3656631|P1|STARTED|Treatment Period 2||44
1494631|NCT01712334|3656630|P2|NOT COMPLETED|Treatment Period 1||2
1494632|NCT01712334|3656631|P1|NOT COMPLETED|Treatment Period 1||0
1494633|NCT01712334|3656630|P2|COMPLETED|Treatment Period 1||41
1494634|NCT01712334|3656631|P1|COMPLETED|Treatment Period 1||44
1494635|NCT01712334|3656630|P2|Received Treatment|Treatment Period 1||41
1494636|NCT01712334|3656631|P1|Received Treatment|Treatment Period 1||44
1494637|NCT01712334|3656630|P2|STARTED|Treatment Period 1||43
1494638|NCT01712334|3656631|P1|STARTED|Treatment Period 1||44
1494639|NCT01712256|3656639|P1|NOT COMPLETED|Overall Study||1
1494640|NCT01712256|3656639|P1|COMPLETED|Overall Study||32
1494641|NCT01712256|3656639|P1|STARTED|Overall Study||33
1494642|NCT01712204|3656650|P2|NOT COMPLETED|Overall Study||5
1494643|NCT01712204|3656651|P1|NOT COMPLETED|Overall Study||8
1494644|NCT01712204|3656650|P2|COMPLETED|Overall Study||36
1494645|NCT01712204|3656651|P1|COMPLETED|Overall Study||33
1494646|NCT01712204|3656650|P2|STARTED|Overall Study||41
1494647|NCT01712204|3656651|P1|STARTED|Overall Study||41
1494648|NCT01712178|3656659|P2|NOT COMPLETED|Overall Study||3
1494649|NCT01712178|3656660|P1|NOT COMPLETED|Overall Study||1
1494650|NCT01712178|3656659|P2|COMPLETED|Overall Study||47
1494651|NCT01712178|3656660|P1|COMPLETED|Overall Study||49
1494652|NCT01712178|3656659|P2|STARTED|Overall Study||50
1494653|NCT01712178|3656660|P1|STARTED|Overall Study||50
1494654|NCT01712074|3656685|P3|NOT COMPLETED|Double Blind Period||8
1494655|NCT01712074|3656686|P2|NOT COMPLETED|Double Blind Period||14
1494656|NCT01712074|3656687|P1|NOT COMPLETED|Double Blind Period||0
1494657|NCT01712074|3656685|P3|COMPLETED|Double Blind Period||86
1494658|NCT01712074|3656686|P2|COMPLETED|Double Blind Period||77
1494659|NCT01712074|3656687|P1|COMPLETED|Double Blind Period||0
1494660|NCT01712074|3656685|P3|STARTED|Double Blind Period||94
1494661|NCT01712074|3656686|P2|STARTED|Double Blind Period||91
1494662|NCT01712074|3656687|P1|STARTED|Double Blind Period||0
1494663|NCT01712074|3656685|P3|NOT COMPLETED|Placebo Run-in Period||0
1494664|NCT01712074|3656686|P2|NOT COMPLETED|Placebo Run-in Period||0
1494665|NCT01712074|3656687|P1|NOT COMPLETED|Placebo Run-in Period||10
1494666|NCT01712074|3656685|P3|COMPLETED|Placebo Run-in Period||0
1494667|NCT01712074|3656686|P2|COMPLETED|Placebo Run-in Period||0
1494668|NCT01712074|3656687|P1|COMPLETED|Placebo Run-in Period||185
1494669|NCT01712074|3656685|P3|STARTED|Placebo Run-in Period||0
1494670|NCT01712074|3656686|P2|STARTED|Placebo Run-in Period||0
1494671|NCT01712074|3656687|P1|STARTED|Placebo Run-in Period||195
1494672|NCT01712061|3656743|P3|NOT COMPLETED|Overall Study||11
1494673|NCT01712061|3656744|P2|NOT COMPLETED|Overall Study||26
1494674|NCT01712061|3656745|P1|NOT COMPLETED|Overall Study||10
1494675|NCT01712061|3656743|P3|COMPLETED|Overall Study||45
1494676|NCT01712061|3656744|P2|COMPLETED|Overall Study||114
1494677|NCT01712061|3656745|P1|COMPLETED|Overall Study||20
1494678|NCT01712061|3656743|P3|STARTED|Overall Study||56
1494679|NCT01712061|3656744|P2|STARTED|Overall Study||140
1494680|NCT01712061|3656745|P1|STARTED|Overall Study||30
1494681|NCT01712009|3656785|P3|NOT COMPLETED|Overall Study||21
1494682|NCT01712009|3656786|P2|NOT COMPLETED|Overall Study||29
1494683|NCT01712009|3656787|P1|NOT COMPLETED|Overall Study||38
1494684|NCT01712009|3656785|P3|COMPLETED|Overall Study||181
1494685|NCT01712009|3656786|P2|COMPLETED|Overall Study||171
1494686|NCT01712009|3656787|P1|COMPLETED|Overall Study||160
1494687|NCT01712009|3656785|P3|Received Naproxen / Loratadine|Overall Study||198
1494688|NCT01712009|3656786|P2|Received Naproxen / Loratadine|Overall Study||193
1494689|NCT01712009|3656787|P1|Received Naproxen / Loratadine|Overall Study||0
1494690|NCT01712009|3656785|P3|Received Pegfilgrastim|Overall Study||200
1494691|NCT01712009|3656786|P2|Received Pegfilgrastim|Overall Study||196
1494692|NCT01712009|3656787|P1|Received Pegfilgrastim|Overall Study||191
1494693|NCT01712009|3656785|P3|STARTED|Overall Study||202
1494694|NCT01712009|3656786|P2|STARTED|Overall Study||200
1494695|NCT01712009|3656787|P1|STARTED|Overall Study||198
1494696|NCT01711918|3656813|P1|NOT COMPLETED|Overall Study||2
1494697|NCT01711918|3656813|P1|COMPLETED|Overall Study||7
1494698|NCT01711918|3656813|P1|STARTED|Overall Study||9
1494699|NCT01711866|3656821|P1|NOT COMPLETED|Overall Study||8
1494700|NCT01711866|3656821|P1|COMPLETED|Overall Study||79
1494701|NCT01711866|3656821|P1|STARTED|Overall Study||87
1494702|NCT01711853|3656826|P1|NOT COMPLETED|Overall Study||3
1494703|NCT01711853|3656826|P1|COMPLETED|Overall Study||16
1494704|NCT01711853|3656826|P1|STARTED|Overall Study||19
1494705|NCT01711736|3656833|P2|NOT COMPLETED|Overall Study||8
1494706|NCT01711736|3656834|P1|NOT COMPLETED|Overall Study||12
1494707|NCT01711736|3656833|P2|COMPLETED|Overall Study|Up to Day 180|294
1494708|NCT01711736|3656834|P1|COMPLETED|Overall Study|Up to Day 180|287
1494709|NCT01711736|3656833|P2|STARTED|Overall Study||302
1494710|NCT01711736|3656834|P1|STARTED|Overall Study||299
1494711|NCT01711645|3656862|P1|NOT COMPLETED|Overall Study||19
1494712|NCT01711645|3656862|P1|COMPLETED|Overall Study||36
1494713|NCT01711645|3656862|P1|STARTED|Overall Study||55
1494714|NCT01711619|3656899|P2|NOT COMPLETED|Overall Study||24
1494715|NCT01711619|3656900|P1|NOT COMPLETED|Overall Study||18
1494716|NCT01711619|3656899|P2|COMPLETED|Overall Study||36
1494717|NCT01711619|3656900|P1|COMPLETED|Overall Study||38
1494718|NCT01711619|3656899|P2|STARTED|Overall Study||60
1494719|NCT01711619|3656900|P1|STARTED|Overall Study||56
1494720|NCT01711424|3656912|P1|NOT COMPLETED|Overall Study||0
1494721|NCT01711424|3656912|P1|COMPLETED|Overall Study||1209
1494722|NCT01711424|3656912|P1|STARTED|Overall Study||1209
1494723|NCT01711359|3656922|P3|NOT COMPLETED|Follow Up||28
1494724|NCT01711359|3656923|P2|NOT COMPLETED|Follow Up||15
1494725|NCT01711359|3656924|P1|NOT COMPLETED|Follow Up||25
1494726|NCT01711359|3656922|P3|COMPLETED|Follow Up||0
1494727|NCT01711359|3656923|P2|COMPLETED|Follow Up||0
1494728|NCT01711359|3656924|P1|COMPLETED|Follow Up||0
1494729|NCT01711359|3656922|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
1494730|NCT01711359|3656923|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
1494731|NCT01711359|3656924|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
1494732|NCT01711359|3656922|P3|NOT COMPLETED|Treatment Period||42
1494733|NCT01711359|3656923|P2|NOT COMPLETED|Treatment Period||24
1494734|NCT01711359|3656924|P1|NOT COMPLETED|Treatment Period||52
1494735|NCT01711359|3656922|P3|COMPLETED|Treatment Period||173
1494736|NCT01711359|3656923|P2|COMPLETED|Treatment Period||136
1494737|NCT01711359|3656924|P1|COMPLETED|Treatment Period||161
1494738|NCT01711359|3656922|P3|Rescued|Treatment Period||6
1494739|NCT01711359|3656923|P2|Rescued|Treatment Period||7
1494740|NCT01711359|3656924|P1|Rescued|Treatment Period||26
1494741|NCT01711359|3656922|P3|Received at Least One Dose of Study Drug|Treatment Period||215
1494742|NCT01711359|3656923|P2|Received at Least One Dose of Study Drug|Treatment Period||159
1494743|NCT01711359|3656924|P1|Received at Least One Dose of Study Drug|Treatment Period||210
1494744|NCT01711359|3656922|P3|STARTED|Treatment Period||215
1494745|NCT01711359|3656923|P2|STARTED|Treatment Period||160
1494746|NCT01711359|3656924|P1|STARTED|Treatment Period||213
1494747|NCT01711216|3656995|P1|NOT COMPLETED|Overall Study||217
1494748|NCT01711216|3656995|P1|COMPLETED|Overall Study||782
1494749|NCT01711216|3656995|P1|STARTED|Overall Study||999
1494750|NCT01711177|3657019|P3|NOT COMPLETED|Overall Study||0
1494751|NCT01711177|3657020|P2|NOT COMPLETED|Overall Study||0
1494752|NCT01711177|3657021|P1|NOT COMPLETED|Overall Study||0
1494753|NCT01711177|3657019|P3|COMPLETED|Overall Study||3
1494754|NCT01711177|3657020|P2|COMPLETED|Overall Study||3
1494755|NCT01711177|3657021|P1|COMPLETED|Overall Study||10
1494756|NCT01711177|3657019|P3|STARTED|Overall Study||3
1494757|NCT01711177|3657020|P2|STARTED|Overall Study||3
1494758|NCT01711177|3657021|P1|STARTED|Overall Study||10
1494759|NCT01710839|3657031|P2|NOT COMPLETED|Overall Study||6
1494760|NCT01710839|3657032|P1|NOT COMPLETED|Overall Study||1
1494761|NCT01710839|3657031|P2|COMPLETED|Overall Study||0
1494762|NCT01710839|3657032|P1|COMPLETED|Overall Study||23
1494763|NCT01710839|3657031|P2|STARTED|Overall Study||6
1494764|NCT01710839|3657032|P1|STARTED|Overall Study||24
1494765|NCT01710800|3657054|P1|NOT COMPLETED|Overall Study||22
1494766|NCT01710800|3657054|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
1494767|NCT01710800|3657054|P1|Received Placebo Intervention|Overall Study||45
1494768|NCT01710800|3657054|P1|Received PPI Intervention|Overall Study||44
1494769|NCT01710800|3657054|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
1494770|NCT01710787|3657063|P3|NOT COMPLETED|Overall Study||0
1494771|NCT01710787|3657064|P2|NOT COMPLETED|Overall Study||0
1494772|NCT01710787|3657065|P1|NOT COMPLETED|Overall Study||0
1494773|NCT01710787|3657063|P3|COMPLETED|Overall Study||22
1494774|NCT01710787|3657064|P2|COMPLETED|Overall Study||44
1494775|NCT01710787|3657065|P1|COMPLETED|Overall Study||44
1494776|NCT01710787|3657063|P3|STARTED|Overall Study||22
1494777|NCT01710787|3657064|P2|STARTED|Overall Study||44
1494778|NCT01710787|3657065|P1|STARTED|Overall Study||44
1494779|NCT01710709|3657118|P1|NOT COMPLETED|Overall Study||173
1494780|NCT01710709|3657118|P1|COMPLETED|Overall Study||291
1494781|NCT01710709|3657118|P1|STARTED|Overall Study||464
1494782|NCT01710657|3657133|P3|NOT COMPLETED|Overall Study||32
1494783|NCT01710657|3657134|P2|NOT COMPLETED|Overall Study||12
1494784|NCT01710657|3657135|P1|NOT COMPLETED|Overall Study||18
1494785|NCT01710657|3657133|P3|COMPLETED|Overall Study||148
1494786|NCT01710657|3657134|P2|COMPLETED|Overall Study||171
1494787|NCT01710657|3657135|P1|COMPLETED|Overall Study||166
1494788|NCT01710657|3657133|P3|Maintenance Period (12 Weeks)|Overall Study||168
1494789|NCT01710657|3657134|P2|Maintenance Period (12 Weeks)|Overall Study||175
1494790|NCT01710657|3657135|P1|Maintenance Period (12 Weeks)|Overall Study||176
1494791|NCT01710657|3657133|P3|Titration Period (4 Weeks)|Overall Study||180
1494792|NCT01710657|3657134|P2|Titration Period (4 Weeks)|Overall Study||183
1494793|NCT01710657|3657135|P1|Titration Period (4 Weeks)|Overall Study||184
1494794|NCT01710657|3657133|P3|STARTED|Overall Study||180
1494795|NCT01710657|3657134|P2|STARTED|Overall Study||183
1494796|NCT01710657|3657135|P1|STARTED|Overall Study||184
1494797|NCT01710527|3657152|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
1494798|NCT01710527|3657153|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
1494799|NCT01710527|3657152|P2|COMPLETED|Period 3: Intervention Period 2||15
1494800|NCT01710527|3657153|P1|COMPLETED|Period 3: Intervention Period 2||16
1494801|NCT01710527|3657152|P2|STARTED|Period 3: Intervention Period 2||15
1494802|NCT01710527|3657153|P1|STARTED|Period 3: Intervention Period 2||16
1494803|NCT01710527|3657152|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
1494804|NCT01710527|3657153|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1494805|NCT01710527|3657152|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
1494806|NCT01710527|3657153|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
1494807|NCT01710527|3657152|P2|STARTED|Period 2: Washout Period (7 Days)||16
1494808|NCT01710527|3657153|P1|STARTED|Period 2: Washout Period (7 Days)||16
1494809|NCT01710527|3657152|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
1494810|NCT01710527|3657153|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
1494811|NCT01710527|3657152|P2|COMPLETED|Period 1: Intervention Period 1||16
1494812|NCT01710527|3657153|P1|COMPLETED|Period 1: Intervention Period 1||16
1494813|NCT01710527|3657152|P2|STARTED|Period 1: Intervention Period 1||16
1494814|NCT01710527|3657153|P1|STARTED|Period 1: Intervention Period 1||16
1494815|NCT01710514|3657179|P2|NOT COMPLETED|Overall Study||7
1494816|NCT01710514|3657180|P1|NOT COMPLETED|Overall Study||7
1494817|NCT01710514|3657179|P2|COMPLETED|Overall Study||47
1494818|NCT01710514|3657180|P1|COMPLETED|Overall Study||47
1494819|NCT01710514|3657179|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
1494820|NCT01710514|3657180|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
1494821|NCT01710514|3657179|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
1494822|NCT01710514|3657180|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
1494823|NCT01710514|3657179|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
1494824|NCT01710514|3657180|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
1494825|NCT01710514|3657179|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
1494826|NCT01710514|3657180|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
1494827|NCT01710514|3657179|P2|STARTED|Overall Study||54
1494828|NCT01710514|3657180|P1|STARTED|Overall Study||54
1494829|NCT01710501|3657201|P3|NOT COMPLETED|Overall Study||0
1494830|NCT01710501|3657202|P2|NOT COMPLETED|Overall Study||0
1494831|NCT01710501|3657203|P1|NOT COMPLETED|Overall Study||2
1494832|NCT01710501|3657201|P3|COMPLETED|Overall Study||30
1494833|NCT01710501|3657202|P2|COMPLETED|Overall Study||28
1494834|NCT01710501|3657203|P1|COMPLETED|Overall Study||27
1494835|NCT01710501|3657201|P3|STARTED|Overall Study||30
1494836|NCT01710501|3657202|P2|STARTED|Overall Study||28
1494837|NCT01710501|3657203|P1|STARTED|Overall Study||29
1494838|NCT01710358|3657235|P3|NOT COMPLETED|Follow-up Period||0
1494839|NCT01710358|3657236|P2|NOT COMPLETED|Follow-up Period||0
1494840|NCT01710358|3657237|P1|NOT COMPLETED|Follow-up Period||0
1494841|NCT01710358|3657235|P3|COMPLETED|Follow-up Period||20
1494842|NCT01710358|3657236|P2|COMPLETED|Follow-up Period||76
1494843|NCT01710358|3657237|P1|COMPLETED|Follow-up Period||33
1494844|NCT01710358|3657235|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
1494845|NCT01710358|3657236|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
1494846|NCT01710358|3657237|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
1494847|NCT01710358|3657235|P3|NOT COMPLETED|Rescue Period||0
1494848|NCT01710358|3657236|P2|NOT COMPLETED|Rescue Period||31
1494849|NCT01710358|3657237|P1|NOT COMPLETED|Rescue Period||0
1494850|NCT01710358|3657235|P3|COMPLETED|Rescue Period||0
1494851|NCT01710358|3657236|P2|COMPLETED|Rescue Period||196
1494852|NCT01710358|3657237|P1|COMPLETED|Rescue Period||0
1494853|NCT01710358|3657235|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1494854|NCT01710358|3657236|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
1494855|NCT01710358|3657237|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
1494856|NCT01710358|3657235|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
1494857|NCT01710358|3657236|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
1494858|NCT01710358|3657237|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
1494859|NCT01710358|3657235|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
1494860|NCT01710358|3657236|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
1494861|NCT01710358|3657237|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
1494862|NCT01710358|3657235|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
1494863|NCT01710358|3657236|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
1494864|NCT01710358|3657237|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
1494865|NCT01710358|3657235|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
1494866|NCT01710358|3657236|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
1494867|NCT01710358|3657237|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
1494868|NCT01710358|3657235|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
1494869|NCT01710358|3657236|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
1494870|NCT01710358|3657237|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
1494871|NCT01710358|3657235|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
1494872|NCT01710358|3657236|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
1494873|NCT01710358|3657237|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
1494874|NCT01710358|3657235|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
1494875|NCT01710358|3657236|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
1494876|NCT01710358|3657237|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
1494877|NCT01710358|3657235|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
1494878|NCT01710358|3657236|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
1494879|NCT01710358|3657237|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
1494880|NCT01710358|3657235|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
1494881|NCT01710358|3657236|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
1494882|NCT01710358|3657237|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
1494883|NCT01710358|3657235|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
1494884|NCT01710358|3657236|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
1494885|NCT01710358|3657237|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
1494886|NCT01710345|3657308|P3|NOT COMPLETED|Overall Study||1
1494887|NCT01710345|3657309|P2|NOT COMPLETED|Overall Study||5
1494888|NCT01710345|3657310|P1|NOT COMPLETED|Overall Study||3
1494889|NCT01710345|3657308|P3|COMPLETED|Overall Study||19
1494890|NCT01710345|3657309|P2|COMPLETED|Overall Study||35
1494891|NCT01710345|3657310|P1|COMPLETED|Overall Study||37
1494892|NCT01710345|3657308|P3|STARTED|Overall Study||20
1494893|NCT01710345|3657309|P2|STARTED|Overall Study||40
1494894|NCT01710345|3657310|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
1494895|NCT01710332|3657320|P2|NOT COMPLETED|Overall Study||0
1494896|NCT01710332|3657321|P1|NOT COMPLETED|Overall Study||0
1494897|NCT01710332|3657320|P2|COMPLETED|Overall Study||6
1494898|NCT01710332|3657321|P1|COMPLETED|Overall Study||6
1494899|NCT01710332|3657320|P2|STARTED|Overall Study||6
1494900|NCT01710332|3657321|P1|STARTED|Overall Study||6
1494901|NCT01710254|3657329|P1|NOT COMPLETED|Overall Study||0
1494902|NCT01710254|3657329|P1|COMPLETED|Overall Study||30
1494903|NCT01710254|3657329|P1|STARTED|Overall Study||30
1494904|NCT01710046|3657337|P2|NOT COMPLETED|Overall Study||0
1494905|NCT01710046|3657338|P1|NOT COMPLETED|Overall Study||1
1494906|NCT01710046|3657337|P2|COMPLETED|Overall Study||3
1494907|NCT01710046|3657338|P1|COMPLETED|Overall Study||8
1494908|NCT01710046|3657337|P2|STARTED|Overall Study||3
1494909|NCT01710046|3657338|P1|STARTED|Overall Study||9
1494910|NCT01710033|3657378|P5|NOT COMPLETED|Stage 2||1
1494911|NCT01710033|3657379|P4|NOT COMPLETED|Stage 2||0
1494912|NCT01710033|3657380|P3|NOT COMPLETED|Stage 2||0
1494913|NCT01710033|3657381|P2|NOT COMPLETED|Stage 2||0
1494914|NCT01710033|3657382|P1|NOT COMPLETED|Stage 2||0
1494915|NCT01710033|3657378|P5|COMPLETED|Stage 2||3
1494916|NCT01710033|3657379|P4|COMPLETED|Stage 2||0
1494917|NCT01710033|3657380|P3|COMPLETED|Stage 2||0
1494918|NCT01710033|3657381|P2|COMPLETED|Stage 2||0
1494919|NCT01710033|3657382|P1|COMPLETED|Stage 2||0
1494920|NCT01710033|3657378|P5|STARTED|Stage 2||4
1494921|NCT01710033|3657379|P4|STARTED|Stage 2||0
1494922|NCT01710033|3657380|P3|STARTED|Stage 2||0
1494923|NCT01710033|3657381|P2|STARTED|Stage 2||0
1494924|NCT01710033|3657382|P1|STARTED|Stage 2||0
1494925|NCT01710033|3657378|P5|NOT COMPLETED|Stage 1||0
1494926|NCT01710033|3657379|P4|NOT COMPLETED|Stage 1||0
1494927|NCT01710033|3657380|P3|NOT COMPLETED|Stage 1||0
1494928|NCT01710033|3657381|P2|NOT COMPLETED|Stage 1||0
1494929|NCT01710033|3657382|P1|NOT COMPLETED|Stage 1||0
1494930|NCT01710033|3657378|P5|COMPLETED|Stage 1||0
1494931|NCT01710033|3657379|P4|COMPLETED|Stage 1||6
1494932|NCT01710033|3657380|P3|COMPLETED|Stage 1||6
1494933|NCT01710033|3657381|P2|COMPLETED|Stage 1||6
1494934|NCT01710033|3657382|P1|COMPLETED|Stage 1||6
1494935|NCT01710033|3657378|P5|STARTED|Stage 1||0
1494936|NCT01710033|3657379|P4|STARTED|Stage 1||6
1494937|NCT01710033|3657380|P3|STARTED|Stage 1||6
1494938|NCT01710033|3657381|P2|STARTED|Stage 1||6
1494939|NCT01710033|3657382|P1|STARTED|Stage 1||6
1494940|NCT01710020|3657463|P1|NOT COMPLETED|Period 2||0
1494941|NCT01710020|3657463|P1|COMPLETED|Period 2||11
1494942|NCT01710020|3657463|P1|STARTED|Period 2||11
1494943|NCT01710020|3657463|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1494944|NCT01710020|3657463|P1|COMPLETED|Washout Period (at Least 14 Days)||11
1494945|NCT01710020|3657463|P1|STARTED|Washout Period (at Least 14 Days)||11
1494946|NCT01710020|3657463|P1|NOT COMPLETED|Period 1||1
1494947|NCT01710020|3657463|P1|COMPLETED|Period 1||11
1494948|NCT01710020|3657463|P1|STARTED|Period 1||12
1494949|NCT01709903|3657482|P2|NOT COMPLETED|Overall Study||39
1494950|NCT01709903|3657483|P1|NOT COMPLETED|Overall Study||29
1494951|NCT01709903|3657482|P2|COMPLETED|Overall Study||333
1494952|NCT01709903|3657483|P1|COMPLETED|Overall Study||343
1494953|NCT01709903|3657482|P2|STARTED|Overall Study|Randomized set|372
1494954|NCT01709903|3657483|P1|STARTED|Overall Study|Randomized set|372
1494955|NCT01709864|3657507|P2|NOT COMPLETED|Overall Study||11
1494956|NCT01709864|3657508|P1|NOT COMPLETED|Overall Study||7
1494957|NCT01709864|3657507|P2|COMPLETED|Overall Study||208
1494958|NCT01709864|3657508|P1|COMPLETED|Overall Study||215
1494959|NCT01709864|3657507|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
1494960|NCT01709864|3657508|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
1494961|NCT01709864|3657507|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
1494962|NCT01709864|3657508|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
1494963|NCT01709864|3657507|P2|STARTED|Overall Study||219
1494964|NCT01709864|3657508|P1|STARTED|Overall Study||222
1494965|NCT01709799|3657545|P3|NOT COMPLETED|Overall Study||3
1494966|NCT01709799|3657546|P2|NOT COMPLETED|Overall Study||3
1494967|NCT01709799|3657547|P1|NOT COMPLETED|Overall Study||3
1494968|NCT01709799|3657545|P3|COMPLETED|Overall Study||15
1494969|NCT01709799|3657546|P2|COMPLETED|Overall Study||18
1494970|NCT01709799|3657547|P1|COMPLETED|Overall Study||22
1494971|NCT01709799|3657545|P3|STARTED|Overall Study||18
1494972|NCT01709799|3657546|P2|STARTED|Overall Study||21
1494973|NCT01709799|3657547|P1|STARTED|Overall Study||25
1494974|NCT01709786|3657570|P1|NOT COMPLETED|Overall Study||0
1494975|NCT01709786|3657570|P1|COMPLETED|Overall Study||88
1494976|NCT01709786|3657570|P1|STARTED|Overall Study||88
1494977|NCT01709708|3657579|P2|NOT COMPLETED|Overall Study||2
1494978|NCT01709708|3657580|P1|NOT COMPLETED|Overall Study||1
1494979|NCT01709708|3657579|P2|COMPLETED|Overall Study||12
1494980|NCT01709708|3657580|P1|COMPLETED|Overall Study||26
1494981|NCT01709708|3657579|P2|STARTED|Overall Study||14
1494982|NCT01709708|3657580|P1|STARTED|Overall Study||27
1494983|NCT01709695|3657604|P2|NOT COMPLETED|Overall Study||1
1494984|NCT01709695|3657605|P1|NOT COMPLETED|Overall Study||1
1494985|NCT01709695|3657604|P2|COMPLETED|Overall Study||13
1494986|NCT01709695|3657605|P1|COMPLETED|Overall Study||12
1494987|NCT01709695|3657604|P2|STARTED|Overall Study||14
1494988|NCT01709695|3657605|P1|STARTED|Overall Study||13
1494989|NCT01709578|3657630|P3|NOT COMPLETED|Overall Study||51
1494990|NCT01709578|3657631|P2|NOT COMPLETED|Overall Study||56
1494991|NCT01709578|3657632|P1|NOT COMPLETED|Overall Study||80
1494992|NCT01709578|3657630|P3|COMPLETED|Overall Study||133
1494993|NCT01709578|3657631|P2|COMPLETED|Overall Study||125
1494994|NCT01709578|3657632|P1|COMPLETED|Overall Study||101
1494995|NCT01709578|3657630|P3|STARTED|Overall Study||184
1494996|NCT01709578|3657631|P2|STARTED|Overall Study||181
1494997|NCT01709578|3657632|P1|STARTED|Overall Study||181
1494998|NCT01709513|3657763|P3|NOT COMPLETED|Overall Study||30
1494999|NCT01709513|3657764|P2|NOT COMPLETED|Overall Study||43
1495000|NCT01709513|3657765|P1|NOT COMPLETED|Overall Study||21
1495001|NCT01709513|3657763|P3|COMPLETED|Overall Study||96
1495002|NCT01709513|3657764|P2|COMPLETED|Overall Study||82
1495003|NCT01709513|3657765|P1|COMPLETED|Overall Study||42
1495004|NCT01709513|3657763|P3|Treated|Overall Study||126
1495005|NCT01709513|3657764|P2|Treated|Overall Study||124
1495006|NCT01709513|3657765|P1|Treated|Overall Study||63
1495007|NCT01709513|3657763|P3|STARTED|Overall Study||126
1495008|NCT01709513|3657764|P2|STARTED|Overall Study||125
1495009|NCT01709513|3657765|P1|STARTED|Overall Study||63
1495010|NCT01709500|3657826|P2|NOT COMPLETED|Overall Study||82
1495011|NCT01709500|3657827|P1|NOT COMPLETED|Overall Study||167
1495012|NCT01709500|3657826|P2|COMPLETED|Overall Study||0
1495013|NCT01709500|3657827|P1|COMPLETED|Overall Study||0
1495014|NCT01709500|3657826|P2|Treated|Overall Study||81
1495015|NCT01709500|3657827|P1|Treated|Overall Study||167
1495016|NCT01709500|3657826|P2|STARTED|Overall Study||82
1495017|NCT01709500|3657827|P1|STARTED|Overall Study||167
1495018|NCT01709474|3657883|P2|NOT COMPLETED|Overall Study||0
1495019|NCT01709474|3657884|P1|NOT COMPLETED|Overall Study||0
1495020|NCT01709474|3657883|P2|COMPLETED|Overall Study||4
1495021|NCT01709474|3657884|P1|COMPLETED|Overall Study||3
1495022|NCT01709474|3657883|P2|STARTED|Overall Study||4
1495023|NCT01709474|3657884|P1|STARTED|Overall Study||3
1495024|NCT01709422|3657894|P2|NOT COMPLETED|Overall Study||0
1495025|NCT01709422|3657895|P1|NOT COMPLETED|Overall Study||0
1495026|NCT01709422|3657894|P2|COMPLETED|Overall Study||70
1495027|NCT01709422|3657895|P1|COMPLETED|Overall Study||70
1495028|NCT01709422|3657894|P2|STARTED|Overall Study||70
1495029|NCT01709422|3657895|P1|STARTED|Overall Study||70
1495030|NCT01709409|3657905|P2|NOT COMPLETED|Overall Study||0
1495031|NCT01709409|3657906|P1|NOT COMPLETED|Overall Study||1
1495032|NCT01709409|3657905|P2|COMPLETED|Overall Study||45
1495033|NCT01709409|3657906|P1|COMPLETED|Overall Study||42
1495034|NCT01709409|3657905|P2|STARTED|Overall Study||45
1495035|NCT01709409|3657906|P1|STARTED|Overall Study||43
1495036|NCT01709383|3657914|P2|NOT COMPLETED|Overall Study||0
1495037|NCT01709383|3657915|P1|NOT COMPLETED|Overall Study||1
1495038|NCT01709383|3657914|P2|COMPLETED|Overall Study||14
1495039|NCT01709383|3657915|P1|COMPLETED|Overall Study||23
1495040|NCT01709383|3657914|P2|Included in Analysis|Overall Study||13
1495041|NCT01709383|3657915|P1|Included in Analysis|Overall Study||22
1495042|NCT01709383|3657914|P2|Completed Follow-ups|Overall Study||14
1495043|NCT01709383|3657915|P1|Completed Follow-ups|Overall Study||23
1495044|NCT01709383|3657914|P2|Completed Treatment|Overall Study||14
1495045|NCT01709383|3657915|P1|Completed Treatment|Overall Study||24
1495046|NCT01709383|3657914|P2|STARTED|Overall Study||14
1495047|NCT01709383|3657915|P1|STARTED|Overall Study||24
1495048|NCT01709331|3657933|P1|NOT COMPLETED|Overall Study||1
1495049|NCT01709331|3657933|P1|COMPLETED|Overall Study||17
1495050|NCT01709331|3657933|P1|STARTED|Overall Study||18
1495051|NCT01709305|3657939|P5|NOT COMPLETED|Phase 2||47
1495052|NCT01709305|3657940|P4|NOT COMPLETED|Phase 2||48
1495053|NCT01709305|3657941|P3|NOT COMPLETED|Phase 2||45
1495054|NCT01709305|3657942|P2|NOT COMPLETED|Phase 2||52
1495055|NCT01709305|3657943|P1|NOT COMPLETED|Phase 2||0
1495056|NCT01709305|3657939|P5|COMPLETED|Phase 2||507
1495057|NCT01709305|3657940|P4|COMPLETED|Phase 2||508
1495058|NCT01709305|3657941|P3|COMPLETED|Phase 2||505
1495059|NCT01709305|3657942|P2|COMPLETED|Phase 2||500
1495060|NCT01709305|3657943|P1|COMPLETED|Phase 2||0
1495061|NCT01709305|3657939|P5|STARTED|Phase 2||554
1495062|NCT01709305|3657940|P4|STARTED|Phase 2||556
1495063|NCT01709305|3657941|P3|STARTED|Phase 2||550
1495064|NCT01709305|3657942|P2|STARTED|Phase 2||552
1495065|NCT01709305|3657943|P1|STARTED|Phase 2||0
1495066|NCT01709305|3657939|P5|NOT COMPLETED|Phase 1||0
1495067|NCT01709305|3657940|P4|NOT COMPLETED|Phase 1||0
1495068|NCT01709305|3657941|P3|NOT COMPLETED|Phase 1||0
1495069|NCT01709305|3657942|P2|NOT COMPLETED|Phase 1||0
1495070|NCT01709305|3657943|P1|NOT COMPLETED|Phase 1||637
1495071|NCT01709305|3657939|P5|COMPLETED|Phase 1||0
1495072|NCT01709305|3657940|P4|COMPLETED|Phase 1||0
1495073|NCT01709305|3657941|P3|COMPLETED|Phase 1||0
1495074|NCT01709305|3657942|P2|COMPLETED|Phase 1||0
1495075|NCT01709305|3657943|P1|COMPLETED|Phase 1||4933
1495076|NCT01709305|3657939|P5|STARTED|Phase 1||0
1495077|NCT01709305|3657940|P4|STARTED|Phase 1||0
1495078|NCT01709305|3657941|P3|STARTED|Phase 1||0
1495079|NCT01709305|3657942|P2|STARTED|Phase 1||0
1495080|NCT01709305|3657943|P1|STARTED|Phase 1||5570
1495081|NCT01709227|3657980|P2|NOT COMPLETED|Overall Study||9
1495082|NCT01709227|3657981|P1|NOT COMPLETED|Overall Study||1
1495083|NCT01709227|3657980|P2|COMPLETED|Overall Study||32
1495084|NCT01709227|3657981|P1|COMPLETED|Overall Study||31
1495085|NCT01709227|3657980|P2|STARTED|Overall Study||41
1495086|NCT01709227|3657981|P1|STARTED|Overall Study||32
1495087|NCT01709162|3658007|P2|NOT COMPLETED|Overall Study||5
1495088|NCT01709162|3658008|P1|NOT COMPLETED|Overall Study||6
1495089|NCT01709162|3658007|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
1495090|NCT01709162|3658008|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
1495091|NCT01709162|3658007|P2|Still Receiving Treatment|Overall Study||0
1495092|NCT01709162|3658008|P1|Still Receiving Treatment|Overall Study||0
1495093|NCT01709162|3658007|P2|Received Treatment|Overall Study||4
1495094|NCT01709162|3658008|P1|Received Treatment|Overall Study||18
1495095|NCT01709162|3658007|P2|STARTED|Overall Study|Randomized|5
1495096|NCT01709162|3658008|P1|STARTED|Overall Study|Randomized|18
1495097|NCT01709136|3658020|P1|NOT COMPLETED|Overall Study||0
1495098|NCT01709136|3658020|P1|COMPLETED|Overall Study||3
1495099|NCT01709136|3658020|P1|STARTED|Overall Study||3
1495100|NCT01709110|3658029|P2|NOT COMPLETED|Overall Study||168
1495101|NCT01709110|3658030|P1|NOT COMPLETED|Overall Study||185
1495102|NCT01709110|3658029|P2|COMPLETED|Overall Study||515
1495103|NCT01709110|3658030|P1|COMPLETED|Overall Study||498
1495104|NCT01709110|3658029|P2|Received at Least One Dose of Study Drug|Overall Study||680
1495105|NCT01709110|3658030|P1|Received at Least One Dose of Study Drug|Overall Study||680
1495106|NCT01709110|3658029|P2|STARTED|Overall Study||683
1495107|NCT01709110|3658030|P1|STARTED|Overall Study||683
1495108|NCT01709084|3658060|P2|NOT COMPLETED|Overall Study||15
1495109|NCT01709084|3658061|P1|NOT COMPLETED|Overall Study||16
1495110|NCT01709084|3658060|P2|COMPLETED|Overall Study||198
1495111|NCT01709084|3658061|P1|COMPLETED|Overall Study||197
1495112|NCT01709084|3658060|P2|Treated|Overall Study||211
1495113|NCT01709084|3658061|P1|Treated|Overall Study||213
1495114|NCT01709084|3658060|P2|STARTED|Overall Study||213
1495115|NCT01709084|3658061|P1|STARTED|Overall Study||213
1495116|NCT01708967|3658079|P2|NOT COMPLETED|Overall Study||7
1495117|NCT01708967|3658080|P1|NOT COMPLETED|Overall Study||0
1495118|NCT01708967|3658079|P2|COMPLETED|Overall Study||43
1495119|NCT01708967|3658080|P1|COMPLETED|Overall Study||50
1495120|NCT01708967|3658079|P2|STARTED|Overall Study||50
1495121|NCT01708967|3658080|P1|STARTED|Overall Study||50
1495122|NCT01708954|3658089|P3|NOT COMPLETED|Step 2||0
1495123|NCT01708954|3658090|P2|NOT COMPLETED|Step 2||7
1495124|NCT01708954|3658091|P1|NOT COMPLETED|Step 2||13
1495125|NCT01708954|3658089|P3|COMPLETED|Step 2||0
1495126|NCT01708954|3658090|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
1495127|NCT01708954|3658091|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
1495128|NCT01708954|3658089|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
1495129|NCT01708954|3658090|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
1495130|NCT01708954|3658091|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
1495131|NCT01708954|3658089|P3|NOT COMPLETED|Step 1||43
1495132|NCT01708954|3658090|P2|NOT COMPLETED|Step 1||40
1495133|NCT01708954|3658091|P1|NOT COMPLETED|Step 1||42
1495134|NCT01708954|3658089|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
1495135|NCT01708954|3658090|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
1495136|NCT01708954|3658091|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
1495137|NCT01708954|3658089|P3|Patients With MET Status Data Available|Step 1||24
1495138|NCT01708954|3658090|P2|Patients With MET Status Data Available|Step 1||32
1495139|NCT01708954|3658091|P1|Patients With MET Status Data Available|Step 1||30
1495140|NCT01708954|3658089|P3|Eligible and Treated|Step 1||35
1495141|NCT01708954|3658090|P2|Eligible and Treated|Step 1||38
1495142|NCT01708954|3658091|P1|Eligible and Treated|Step 1||38
1495143|NCT01708954|3658089|P3|Started Protocol Therapy|Step 1||39
1495144|NCT01708954|3658090|P2|Started Protocol Therapy|Step 1||40
1495145|NCT01708954|3658091|P1|Started Protocol Therapy|Step 1||40
1495146|NCT01708954|3658089|P3|STARTED|Step 1||43
1495147|NCT01708954|3658090|P2|STARTED|Step 1||40
1495148|NCT01708954|3658091|P1|STARTED|Step 1||42
1495149|NCT01708915|3658116|P4|NOT COMPLETED|Overall Study||33
1495150|NCT01708915|3658117|P3|NOT COMPLETED|Overall Study||46
1495151|NCT01708915|3658118|P2|NOT COMPLETED|Overall Study||62
1495152|NCT01708915|3658119|P1|NOT COMPLETED|Overall Study||86
1495153|NCT01708915|3658116|P4|COMPLETED|Overall Study||169
1495154|NCT01708915|3658117|P3|COMPLETED|Overall Study||152
1495155|NCT01708915|3658118|P2|COMPLETED|Overall Study||139
1495156|NCT01708915|3658119|P1|COMPLETED|Overall Study||118
1495157|NCT01708915|3658116|P4|STARTED|Overall Study||202
1495158|NCT01708915|3658117|P3|STARTED|Overall Study||198
1495159|NCT01708915|3658118|P2|STARTED|Overall Study||201
1495160|NCT01708915|3658119|P1|STARTED|Overall Study||204
1495161|NCT01708902|3658148|P7|NOT COMPLETED|Overall Study||7
1495162|NCT01708902|3658149|P6|NOT COMPLETED|Overall Study||7
1495163|NCT01708902|3658150|P5|NOT COMPLETED|Overall Study||16
1495164|NCT01708902|3658151|P4|NOT COMPLETED|Overall Study||10
1495165|NCT01708902|3658152|P3|NOT COMPLETED|Overall Study||17
1495166|NCT01708902|3658153|P2|NOT COMPLETED|Overall Study||8
1495167|NCT01708902|3658154|P1|NOT COMPLETED|Overall Study||17
1495168|NCT01708902|3658148|P7|COMPLETED|Overall Study||65
1495169|NCT01708902|3658149|P6|COMPLETED|Overall Study||64
1495170|NCT01708902|3658150|P5|COMPLETED|Overall Study||131
1495171|NCT01708902|3658151|P4|COMPLETED|Overall Study||137
1495172|NCT01708902|3658152|P3|COMPLETED|Overall Study||127
1495173|NCT01708902|3658153|P2|COMPLETED|Overall Study||137
1495174|NCT01708902|3658154|P1|COMPLETED|Overall Study||130
1495175|NCT01708902|3658148|P7|STARTED|Overall Study||72
1495176|NCT01708902|3658149|P6|STARTED|Overall Study||71
1495177|NCT01708902|3658150|P5|STARTED|Overall Study||147
1495178|NCT01708902|3658151|P4|STARTED|Overall Study||147
1495179|NCT01708902|3658152|P3|STARTED|Overall Study||144
1495180|NCT01708902|3658153|P2|STARTED|Overall Study||145
1495181|NCT01708902|3658154|P1|STARTED|Overall Study||147
1495182|NCT01708525|3658213|P1|NOT COMPLETED|Overall Study||0
1495183|NCT01708525|3658213|P1|COMPLETED|Overall Study||2
1495184|NCT01708525|3658213|P1|STARTED|Overall Study||2
1495185|NCT01708317|3658218|P1|NOT COMPLETED|Final Education Period||0
1495186|NCT01708317|3658218|P1|COMPLETED|Final Education Period||909
1495187|NCT01708317|3658218|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
1495188|NCT01708317|3658218|P1|NOT COMPLETED|ACASI + Education Period||0
1495189|NCT01708317|3658218|P1|COMPLETED|ACASI + Education Period||2601
1495190|NCT01708317|3658218|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
1495191|NCT01708317|3658218|P1|NOT COMPLETED|Initial Education Period||0
1495192|NCT01708317|3658218|P1|COMPLETED|Initial Education Period||982
1495193|NCT01708317|3658218|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
1495194|NCT01708317|3658218|P1|NOT COMPLETED|2010 Control Period||0
1495195|NCT01708317|3658218|P1|COMPLETED|2010 Control Period||3929
1495196|NCT01708317|3658218|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
1495197|NCT01708291|3658227|P2|NOT COMPLETED|Overall Study||1
1495198|NCT01708291|3658228|P1|NOT COMPLETED|Overall Study||2
1495199|NCT01708291|3658227|P2|COMPLETED|Overall Study||20
1495200|NCT01708291|3658228|P1|COMPLETED|Overall Study||19
1495201|NCT01708291|3658227|P2|STARTED|Overall Study||21
1495202|NCT01708291|3658228|P1|STARTED|Overall Study||21
1495203|NCT01708278|3658240|P6|NOT COMPLETED|Overall Study||0
1495204|NCT01708278|3658241|P5|NOT COMPLETED|Overall Study||0
1495205|NCT01708278|3658242|P4|NOT COMPLETED|Overall Study||0
1495206|NCT01708278|3658243|P3|NOT COMPLETED|Overall Study||0
1495207|NCT01708278|3658244|P2|NOT COMPLETED|Overall Study||0
1495208|NCT01708278|3658245|P1|NOT COMPLETED|Overall Study||0
1495209|NCT01708278|3658240|P6|COMPLETED|Overall Study||1
1495210|NCT01708278|3658241|P5|COMPLETED|Overall Study||1
1495211|NCT01708278|3658242|P4|COMPLETED|Overall Study||2
1495212|NCT01708278|3658243|P3|COMPLETED|Overall Study||2
1495213|NCT01708278|3658244|P2|COMPLETED|Overall Study||2
1495214|NCT01708278|3658245|P1|COMPLETED|Overall Study||1
1495215|NCT01708278|3658240|P6|STARTED|Overall Study||1
1495216|NCT01708278|3658241|P5|STARTED|Overall Study||1
1495217|NCT01708278|3658242|P4|STARTED|Overall Study||2
1495218|NCT01708278|3658243|P3|STARTED|Overall Study||2
1495219|NCT01708278|3658244|P2|STARTED|Overall Study||2
1495220|NCT01708278|3658245|P1|STARTED|Overall Study||1
1495221|NCT01708213|3658259|P1|NOT COMPLETED|Overall Study||1
1495222|NCT01708213|3658259|P1|COMPLETED|Overall Study||71
1495223|NCT01708213|3658259|P1|STARTED|Overall Study||72
1495224|NCT01708187|3658267|P2|NOT COMPLETED|Overall Study||1
1495225|NCT01708187|3658268|P1|NOT COMPLETED|Overall Study||0
1495226|NCT01708187|3658267|P2|COMPLETED|Overall Study||0
1495227|NCT01708187|3658268|P1|COMPLETED|Overall Study||1
1495228|NCT01708187|3658267|P2|STARTED|Overall Study||1
1495229|NCT01708187|3658268|P1|STARTED|Overall Study||1
1495230|NCT01708174|3658277|P3|NOT COMPLETED|Survival Follow-up||0
1495231|NCT01708174|3658278|P2|NOT COMPLETED|Survival Follow-up||0
1495232|NCT01708174|3658279|P1|NOT COMPLETED|Survival Follow-up||0
1495233|NCT01708174|3658277|P3|COMPLETED|Survival Follow-up||0
1495234|NCT01708174|3658278|P2|COMPLETED|Survival Follow-up||10
1495235|NCT01708174|3658279|P1|COMPLETED|Survival Follow-up||1
1495236|NCT01708174|3658277|P3|STARTED|Survival Follow-up||0
1495237|NCT01708174|3658278|P2|STARTED|Survival Follow-up||10
1495238|NCT01708174|3658279|P1|STARTED|Survival Follow-up||1
1495239|NCT01708174|3658277|P3|NOT COMPLETED|Treatment Period||1
1495240|NCT01708174|3658278|P2|NOT COMPLETED|Treatment Period||2
1495241|NCT01708174|3658279|P1|NOT COMPLETED|Treatment Period||1
1495242|NCT01708174|3658277|P3|COMPLETED|Treatment Period||3
1495243|NCT01708174|3658278|P2|COMPLETED|Treatment Period||14
1495244|NCT01708174|3658279|P1|COMPLETED|Treatment Period||1
1495245|NCT01708174|3658277|P3|Pharmacokinetic Analysis Set|Treatment Period||0
1495246|NCT01708174|3658278|P2|Pharmacokinetic Analysis Set|Treatment Period||13
1495247|NCT01708174|3658279|P1|Pharmacokinetic Analysis Set|Treatment Period||2
1495248|NCT01708174|3658277|P3|STARTED|Treatment Period||4
1495249|NCT01708174|3658278|P2|STARTED|Treatment Period||16
1495250|NCT01708174|3658279|P1|STARTED|Treatment Period||2
1495251|NCT01708161|3658311|P6|NOT COMPLETED|Overall Study||1
1495252|NCT01708161|3658312|P5|NOT COMPLETED|Overall Study||6
1495253|NCT01708161|3658313|P4|NOT COMPLETED|Overall Study||16
1495254|NCT01708161|3658314|P3|NOT COMPLETED|Overall Study||10
1495255|NCT01708161|3658315|P2|NOT COMPLETED|Overall Study||10
1495256|NCT01708161|3658316|P1|NOT COMPLETED|Overall Study||4
1495257|NCT01708161|3658311|P6|COMPLETED|Overall Study||0
1495258|NCT01708161|3658312|P5|COMPLETED|Overall Study||0
1495259|NCT01708161|3658313|P4|COMPLETED|Overall Study||0
1495260|NCT01708161|3658314|P3|COMPLETED|Overall Study||0
1495261|NCT01708161|3658315|P2|COMPLETED|Overall Study||0
1495262|NCT01708161|3658316|P1|COMPLETED|Overall Study||0
1495263|NCT01708161|3658311|P6|STARTED|Overall Study||1
1495264|NCT01708161|3658312|P5|STARTED|Overall Study||6
1495265|NCT01708161|3658313|P4|STARTED|Overall Study||16
1495266|NCT01708161|3658314|P3|STARTED|Overall Study||10
1495267|NCT01708161|3658315|P2|STARTED|Overall Study||10
1495268|NCT01708161|3658316|P1|STARTED|Overall Study||4
1495269|NCT01708122|3658358|P2|NOT COMPLETED|Overall Study||0
1495270|NCT01708122|3658359|P1|NOT COMPLETED|Overall Study||0
1495271|NCT01708122|3658358|P2|COMPLETED|Overall Study||26
1495272|NCT01708122|3658359|P1|COMPLETED|Overall Study||27
1495273|NCT01708122|3658358|P2|STARTED|Overall Study||26
1495274|NCT01708122|3658359|P1|STARTED|Overall Study||27
1495275|NCT01708057|3658367|P3|NOT COMPLETED|Overall Study||1
1495276|NCT01708057|3658368|P2|NOT COMPLETED|Overall Study||1
1495277|NCT01708057|3658369|P1|NOT COMPLETED|Overall Study||1
1495278|NCT01708057|3658367|P3|COMPLETED|Overall Study||0
1495279|NCT01708057|3658368|P2|COMPLETED|Overall Study||0
1495280|NCT01708057|3658369|P1|COMPLETED|Overall Study||0
1495281|NCT01708057|3658367|P3|STARTED|Overall Study||1
1495282|NCT01708057|3658368|P2|STARTED|Overall Study||1
1495283|NCT01708057|3658369|P1|STARTED|Overall Study||1
1495284|NCT01707667|3658427|P2|NOT COMPLETED|Period 2||0
1495285|NCT01707667|3658428|P1|NOT COMPLETED|Period 2||0
1495286|NCT01707667|3658427|P2|COMPLETED|Period 2||6
1495287|NCT01707667|3658428|P1|COMPLETED|Period 2||6
1495288|NCT01707667|3658427|P2|STARTED|Period 2||6
1495289|NCT01707667|3658428|P1|STARTED|Period 2||6
1495290|NCT01707667|3658427|P2|NOT COMPLETED|Period 1||0
1495291|NCT01707667|3658428|P1|NOT COMPLETED|Period 1||1
1495292|NCT01707667|3658427|P2|COMPLETED|Period 1||6
1495293|NCT01707667|3658428|P1|COMPLETED|Period 1||6
1495294|NCT01707667|3658427|P2|STARTED|Period 1||6
1495295|NCT01707667|3658428|P1|STARTED|Period 1||7
1495296|NCT01707654|3658446|P1|NOT COMPLETED|Overall Study||0
1495297|NCT01707654|3658446|P1|COMPLETED|Overall Study||9
1495298|NCT01707654|3658446|P1|STARTED|Overall Study||9
1495299|NCT01707381|3658450|P2|NOT COMPLETED|Period 2||0
1495300|NCT01707381|3658451|P1|NOT COMPLETED|Period 2||0
1495301|NCT01707381|3658450|P2|COMPLETED|Period 2||11
1495302|NCT01707381|3658451|P1|COMPLETED|Period 2||10
1495303|NCT01707381|3658450|P2|STARTED|Period 2||11
1495304|NCT01707381|3658451|P1|STARTED|Period 2||10
1495305|NCT01707381|3658450|P2|NOT COMPLETED|Period 1||2
1495306|NCT01707381|3658451|P1|NOT COMPLETED|Period 1||2
1495307|NCT01707381|3658450|P2|COMPLETED|Period 1||11
1495308|NCT01707381|3658451|P1|COMPLETED|Period 1||10
1495309|NCT01707381|3658450|P2|STARTED|Period 1||13
1495310|NCT01707381|3658451|P1|STARTED|Period 1||12
1495311|NCT01707368|3658461|P1|NOT COMPLETED|Overall Study||168
1495312|NCT01707368|3658461|P1|COMPLETED|Overall Study||393
1495313|NCT01707368|3658461|P1|STARTED|Overall Study||561
1495314|NCT01707290|3658470|P2|NOT COMPLETED|Overall Study||1
1495315|NCT01707290|3658471|P1|NOT COMPLETED|Overall Study||86
1495316|NCT01707290|3658470|P2|COMPLETED|Overall Study||3
1495317|NCT01707290|3658471|P1|COMPLETED|Overall Study||35
1495318|NCT01707290|3658470|P2|STARTED|Overall Study||4
1495319|NCT01707290|3658471|P1|STARTED|Overall Study||121
1495320|NCT01707238|3658494|P2|NOT COMPLETED|Overall Study||0
1495321|NCT01707238|3658495|P1|NOT COMPLETED|Overall Study||0
1495322|NCT01707238|3658494|P2|COMPLETED|Overall Study||52
1495323|NCT01707238|3658495|P1|COMPLETED|Overall Study||48
1495324|NCT01707238|3658494|P2|STARTED|Overall Study||52
1495325|NCT01707238|3658495|P1|STARTED|Overall Study||48
1495326|NCT01707225|3658511|P1|NOT COMPLETED|Overall Study||0
1495327|NCT01707225|3658511|P1|COMPLETED|Overall Study||10
1495328|NCT01707225|3658511|P1|STARTED|Overall Study||10
1495329|NCT01707095|3658518|P2|NOT COMPLETED|Overall Study||0
1495330|NCT01707095|3658519|P1|NOT COMPLETED|Overall Study||0
1495331|NCT01707095|3658518|P2|COMPLETED|Overall Study||42
1495332|NCT01707095|3658519|P1|COMPLETED|Overall Study||42
1495333|NCT01707095|3658518|P2|STARTED|Overall Study||42
1495334|NCT01707095|3658519|P1|STARTED|Overall Study||42
1495335|NCT01707043|3658529|P2|NOT COMPLETED|Overall Study||0
1495336|NCT01707043|3658530|P1|NOT COMPLETED|Overall Study||0
1495337|NCT01707043|3658529|P2|COMPLETED|Overall Study||10
1495338|NCT01707043|3658530|P1|COMPLETED|Overall Study||10
1495339|NCT01707043|3658529|P2|STARTED|Overall Study||10
1495340|NCT01707043|3658530|P1|STARTED|Overall Study||10
1495341|NCT01706965|3658540|P2|NOT COMPLETED|Overall Study||1
1495342|NCT01706965|3658541|P1|NOT COMPLETED|Overall Study||1
1495343|NCT01706965|3658540|P2|COMPLETED|Overall Study||12
1495344|NCT01706965|3658541|P1|COMPLETED|Overall Study||13
1495345|NCT01706965|3658540|P2|STARTED|Overall Study||13
1495346|NCT01706965|3658541|P1|STARTED|Overall Study||14
1495347|NCT01706952|3658549|P1|NOT COMPLETED|Overall Study||8
1495348|NCT01706952|3658549|P1|COMPLETED|Overall Study||37
1495349|NCT01706952|3658549|P1|STARTED|Overall Study||45
1495350|NCT01706926|3658565|P4|NOT COMPLETED|Overall Study||5
1495351|NCT01706926|3658566|P3|NOT COMPLETED|Overall Study||6
1495352|NCT01706926|3658567|P2|NOT COMPLETED|Overall Study||4
1495353|NCT01706926|3658568|P1|NOT COMPLETED|Overall Study||6
1495354|NCT01706926|3658565|P4|COMPLETED|Overall Study||74
1495355|NCT01706926|3658566|P3|COMPLETED|Overall Study||79
1495356|NCT01706926|3658567|P2|COMPLETED|Overall Study||77
1495357|NCT01706926|3658568|P1|COMPLETED|Overall Study||75
1495358|NCT01706926|3658565|P4|STARTED|Overall Study||79
1495359|NCT01706926|3658566|P3|STARTED|Overall Study||85
1495360|NCT01706926|3658567|P2|STARTED|Overall Study||81
1495361|NCT01706926|3658568|P1|STARTED|Overall Study||81
1495362|NCT01706822|3658677|P1|NOT COMPLETED|Overall Study||0
1495363|NCT01706822|3658677|P1|COMPLETED|Overall Study||8
1495364|NCT01706822|3658677|P1|STARTED|Overall Study||8
1495365|NCT01706770|3658687|P2|NOT COMPLETED|Overall Study||0
1495366|NCT01706770|3658688|P1|NOT COMPLETED|Overall Study||2
1495367|NCT01706770|3658687|P2|COMPLETED|Overall Study||17
1495368|NCT01706770|3658688|P1|COMPLETED|Overall Study||31
1495369|NCT01706770|3658687|P2|STARTED|Overall Study||17
1495370|NCT01706770|3658688|P1|STARTED|Overall Study||33
1495371|NCT01706666|3658699|P3|NOT COMPLETED|Overall Study||0
1495372|NCT01706666|3658700|P2|NOT COMPLETED|Overall Study||0
1495373|NCT01706666|3658701|P1|NOT COMPLETED|Overall Study||0
1495374|NCT01706666|3658699|P3|COMPLETED|Overall Study||1
1495375|NCT01706666|3658700|P2|COMPLETED|Overall Study||1
1495376|NCT01706666|3658701|P1|COMPLETED|Overall Study||1
1495377|NCT01706666|3658699|P3|STARTED|Overall Study||1
1495378|NCT01706666|3658700|P2|STARTED|Overall Study||1
1495379|NCT01706666|3658701|P1|STARTED|Overall Study||1
1495380|NCT01706588|3658720|P5|NOT COMPLETED|Overall Study||0
1495381|NCT01706588|3658721|P4|NOT COMPLETED|Overall Study||0
1495382|NCT01706588|3658722|P3|NOT COMPLETED|Overall Study||0
1495383|NCT01706588|3658723|P2|NOT COMPLETED|Overall Study||0
1495384|NCT01706588|3658724|P1|NOT COMPLETED|Overall Study||0
1495385|NCT01706588|3658720|P5|COMPLETED|Overall Study||16
1495386|NCT01706588|3658721|P4|COMPLETED|Overall Study||14
1495387|NCT01706588|3658722|P3|COMPLETED|Overall Study||15
1495388|NCT01706588|3658723|P2|COMPLETED|Overall Study||15
1495389|NCT01706588|3658724|P1|COMPLETED|Overall Study||15
1495390|NCT01706588|3658720|P5|STARTED|Overall Study||16
1495391|NCT01706588|3658721|P4|STARTED|Overall Study||14
1495392|NCT01706588|3658722|P3|STARTED|Overall Study||15
1495393|NCT01706588|3658723|P2|STARTED|Overall Study||15
1495394|NCT01706588|3658724|P1|STARTED|Overall Study||15
1495395|NCT01706575|3658736|P1|NOT COMPLETED|Overall Study||12
1495396|NCT01706575|3658736|P1|COMPLETED|Overall Study||64
1495397|NCT01706575|3658736|P1|Treated|Overall Study||70
1495398|NCT01706575|3658736|P1|STARTED|Overall Study||76
1495399|NCT01706549|3658747|P1|NOT COMPLETED|Overall Study||0
1495400|NCT01706549|3658747|P1|COMPLETED|Overall Study||16
1495401|NCT01706549|3658747|P1|STARTED|Overall Study||16
1495402|NCT01706536|3658757|P5|NOT COMPLETED|Overall Study||2
1495403|NCT01706536|3658758|P4|NOT COMPLETED|Overall Study||4
1495404|NCT01706536|3658759|P3|NOT COMPLETED|Overall Study||5
1495405|NCT01706536|3658760|P2|NOT COMPLETED|Overall Study||4
1495406|NCT01706536|3658761|P1|NOT COMPLETED|Overall Study||4
1495407|NCT01706536|3658757|P5|COMPLETED|Overall Study||57
1495408|NCT01706536|3658758|P4|COMPLETED|Overall Study||53
1495409|NCT01706536|3658759|P3|COMPLETED|Overall Study||49
1495410|NCT01706536|3658760|P2|COMPLETED|Overall Study||51
1495411|NCT01706536|3658761|P1|COMPLETED|Overall Study||53
1495412|NCT01706536|3658757|P5|STARTED|Overall Study||59
1495413|NCT01706536|3658758|P4|STARTED|Overall Study||57
1495414|NCT01706536|3658759|P3|STARTED|Overall Study||54
1495415|NCT01706536|3658760|P2|STARTED|Overall Study||55
1495416|NCT01706536|3658761|P1|STARTED|Overall Study||57
1495417|NCT01706458|3658820|P2|NOT COMPLETED|Overall Study||4
1495418|NCT01706458|3658821|P1|NOT COMPLETED|Overall Study||3
1495419|NCT01706458|3658820|P2|COMPLETED|Overall Study||5
1495420|NCT01706458|3658821|P1|COMPLETED|Overall Study||6
1495421|NCT01706458|3658820|P2|STARTED|Overall Study||9
1495422|NCT01706458|3658821|P1|STARTED|Overall Study||9
1495423|NCT01706328|3658845|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
1495424|NCT01706328|3658846|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
1495425|NCT01706328|3658847|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
1495426|NCT01706328|3658845|P3|COMPLETED|12-week Double-blind Treatment Period||371
1495427|NCT01706328|3658846|P2|COMPLETED|12-week Double-blind Treatment Period||366
1495428|NCT01706328|3658847|P1|COMPLETED|12-week Double-blind Treatment Period||0
1495429|NCT01706328|3658845|P3|STARTED|12-week Double-blind Treatment Period||416
1495430|NCT01706328|3658846|P2|STARTED|12-week Double-blind Treatment Period||412
1495431|NCT01706328|3658847|P1|STARTED|12-week Double-blind Treatment Period||0
1495432|NCT01706328|3658845|P3|NOT COMPLETED|2-week Run-in Period||0
1495433|NCT01706328|3658846|P2|NOT COMPLETED|2-week Run-in Period||0
1495434|NCT01706328|3658847|P1|NOT COMPLETED|2-week Run-in Period||165
1495435|NCT01706328|3658845|P3|COMPLETED|2-week Run-in Period||0
1495436|NCT01706328|3658846|P2|COMPLETED|2-week Run-in Period||0
1495437|NCT01706328|3658847|P1|COMPLETED|2-week Run-in Period||828
1495438|NCT01706328|3658845|P3|STARTED|2-week Run-in Period||0
1495439|NCT01706328|3658846|P2|STARTED|2-week Run-in Period||0
1495440|NCT01706328|3658847|P1|STARTED|2-week Run-in Period||993
1495441|NCT01706263|3658857|P1|NOT COMPLETED|Overall Study||0
1495442|NCT01706263|3658857|P1|COMPLETED|Overall Study||28
1495443|NCT01706263|3658857|P1|STARTED|Overall Study||28
1495444|NCT01706250|3658866|P1|NOT COMPLETED|Overall Study||2
1495445|NCT01706250|3658866|P1|COMPLETED|Overall Study||18
1495446|NCT01706250|3658866|P1|STARTED|Overall Study||20
1495447|NCT01706159|3658897|P2|NOT COMPLETED|Overall Study||2
1495448|NCT01706159|3658898|P1|NOT COMPLETED|Overall Study||8
1495449|NCT01706159|3658897|P2|COMPLETED|Overall Study||4
1495450|NCT01706159|3658898|P1|COMPLETED|Overall Study||6
1495451|NCT01706159|3658897|P2|Completers (With Baron Score at Week 8)|Overall Study||3
1495452|NCT01706159|3658898|P1|Completers (With Baron Score at Week 8)|Overall Study||6
1495453|NCT01706159|3658897|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
1495454|NCT01706159|3658898|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
1495455|NCT01706159|3658897|P2|STARTED|Overall Study||6
1495456|NCT01706159|3658898|P1|STARTED|Overall Study||14
1495457|NCT01706146|3658912|P1|NOT COMPLETED|Overall Study||6
1495458|NCT01706146|3658912|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
1495459|NCT01706146|3658912|P1|STARTED|Overall Study||59
1495460|NCT01705730|3658917|P1|NOT COMPLETED|Overall Study||9
1495461|NCT01705730|3658917|P1|COMPLETED|Overall Study||59
1495462|NCT01705730|3658917|P1|STARTED|Overall Study|Participants who received study drug|68
1495463|NCT01705717|3658957|P2|NOT COMPLETED|Overall Study||5
1495464|NCT01705717|3658958|P1|NOT COMPLETED|Overall Study||2
1495465|NCT01705717|3658957|P2|COMPLETED|Overall Study||7
1495466|NCT01705717|3658958|P1|COMPLETED|Overall Study||35
1495467|NCT01705717|3658957|P2|STARTED|Overall Study||12
1495468|NCT01705717|3658958|P1|STARTED|Overall Study||37
1495469|NCT01705691|3658975|P2|NOT COMPLETED|Overall Study||6
1495470|NCT01705691|3658976|P1|NOT COMPLETED|Overall Study||3
1495471|NCT01705691|3658975|P2|COMPLETED|Overall Study||24
1495472|NCT01705691|3658976|P1|COMPLETED|Overall Study||16
1495473|NCT01705691|3658975|P2|STARTED|Overall Study||30
1495474|NCT01705691|3658976|P1|STARTED|Overall Study||19
1495475|NCT01705652|3658996|P2|NOT COMPLETED|Overall Study||3
1495476|NCT01705652|3658997|P1|NOT COMPLETED|Overall Study||3
1495477|NCT01705652|3658996|P2|COMPLETED|Overall Study||9
1495478|NCT01705652|3658997|P1|COMPLETED|Overall Study||6
1495479|NCT01705652|3658996|P2|STARTED|Overall Study||12
1495480|NCT01705652|3658997|P1|STARTED|Overall Study||9
1495481|NCT01705587|3659005|P2|NOT COMPLETED|Overall Study||1
1495482|NCT01705587|3659006|P1|NOT COMPLETED|Overall Study||0
1495483|NCT01705587|3659005|P2|COMPLETED|Overall Study||5
1495484|NCT01705587|3659006|P1|COMPLETED|Overall Study||7
1495485|NCT01705587|3659005|P2|STARTED|Overall Study||6
1495486|NCT01705587|3659006|P1|STARTED|Overall Study||7
1495487|NCT01705574|3659024|P2|NOT COMPLETED|Overall Study||163
1495488|NCT01705574|3659025|P1|NOT COMPLETED|Overall Study||167
1495489|NCT01705574|3659024|P2|COMPLETED|Overall Study||127
1495490|NCT01705574|3659025|P1|COMPLETED|Overall Study||126
1495491|NCT01705574|3659024|P2|STARTED|Overall Study||290
1495492|NCT01705574|3659025|P1|STARTED|Overall Study||293
1495493|NCT01705496|3659033|P1|NOT COMPLETED|Overall Study||4
1495494|NCT01705496|3659033|P1|COMPLETED|Overall Study||19
1495495|NCT01705496|3659033|P1|STARTED|Overall Study||23
1495496|NCT01705145|3659043|P1|NOT COMPLETED|Part B||1
1495497|NCT01705145|3659043|P1|COMPLETED|Part B||33
1495498|NCT01705145|3659043|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
1495499|NCT01705145|3659043|P1|NOT COMPLETED|Part A||0
1495500|NCT01705145|3659043|P1|COMPLETED|Part A||9
1495501|NCT01705145|3659043|P1|STARTED|Part A||9
1495502|NCT01705106|3659071|P1|NOT COMPLETED|Overall Study||0
1495503|NCT01705106|3659071|P1|COMPLETED|Overall Study||21
1495504|NCT01705106|3659071|P1|STARTED|Overall Study||21
1495505|NCT01705080|3659083|P4|NOT COMPLETED|Overall Study||42
1495506|NCT01705080|3659084|P3|NOT COMPLETED|Overall Study||5
1495507|NCT01705080|3659085|P2|NOT COMPLETED|Overall Study||16
1495508|NCT01705080|3659086|P1|NOT COMPLETED|Overall Study||15
1495509|NCT01705080|3659083|P4|COMPLETED|Overall Study||9
1495510|NCT01705080|3659084|P3|COMPLETED|Overall Study||27
1495511|NCT01705080|3659085|P2|COMPLETED|Overall Study||98
1495512|NCT01705080|3659086|P1|COMPLETED|Overall Study||142
1495513|NCT01705080|3659083|P4|1 Month|Overall Study||10
1495514|NCT01705080|3659084|P3|1 Month|Overall Study||27
1495515|NCT01705080|3659085|P2|1 Month|Overall Study||97
1495516|NCT01705080|3659086|P1|1 Month|Overall Study||148
1495517|NCT01705080|3659083|P4|Procedure|Overall Study||10
1495518|NCT01705080|3659084|P3|Procedure|Overall Study||29
1495519|NCT01705080|3659085|P2|Procedure|Overall Study||103
1495520|NCT01705080|3659086|P1|Procedure|Overall Study||149
1495521|NCT01705080|3659083|P4|STARTED|Overall Study||51
1495522|NCT01705080|3659084|P3|STARTED|Overall Study||32
1495523|NCT01705080|3659085|P2|STARTED|Overall Study||114
1495524|NCT01705080|3659086|P1|STARTED|Overall Study||157
1495525|NCT01704976|3659098|P2|NOT COMPLETED|Overall Study||2
1495526|NCT01704976|3659099|P1|NOT COMPLETED|Overall Study||1
1495527|NCT01704976|3659098|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
1495528|NCT01704976|3659099|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
1495529|NCT01704976|3659098|P2|STARTED|Overall Study||13
1495530|NCT01704976|3659099|P1|STARTED|Overall Study||14
1495531|NCT01704846|3659115|P2|NOT COMPLETED|Treatment Period 4||0
1495532|NCT01704846|3659116|P1|NOT COMPLETED|Treatment Period 4||0
1495533|NCT01704846|3659115|P2|COMPLETED|Treatment Period 4||29
1495534|NCT01704846|3659116|P1|COMPLETED|Treatment Period 4||30
1495535|NCT01704846|3659115|P2|STARTED|Treatment Period 4||29
1495536|NCT01704846|3659116|P1|STARTED|Treatment Period 4||30
1495537|NCT01704846|3659115|P2|NOT COMPLETED|Treatment Period 3||0
1495538|NCT01704846|3659116|P1|NOT COMPLETED|Treatment Period 3||0
1495539|NCT01704846|3659115|P2|COMPLETED|Treatment Period 3||29
1495540|NCT01704846|3659116|P1|COMPLETED|Treatment Period 3||30
1495541|NCT01704846|3659115|P2|STARTED|Treatment Period 3||29
1495542|NCT01704846|3659116|P1|STARTED|Treatment Period 3||30
1495543|NCT01704846|3659115|P2|NOT COMPLETED|Treatment Period 2||1
1495544|NCT01704846|3659116|P1|NOT COMPLETED|Treatment Period 2||0
1495545|NCT01704846|3659115|P2|COMPLETED|Treatment Period 2||29
1495546|NCT01704846|3659116|P1|COMPLETED|Treatment Period 2||30
1495547|NCT01704846|3659115|P2|STARTED|Treatment Period 2||30
1495548|NCT01704846|3659116|P1|STARTED|Treatment Period 2||30
1495549|NCT01704846|3659115|P2|NOT COMPLETED|Treatment Period 1||0
1495550|NCT01704846|3659116|P1|NOT COMPLETED|Treatment Period 1||0
1495551|NCT01704846|3659115|P2|COMPLETED|Treatment Period 1||30
1495552|NCT01704846|3659116|P1|COMPLETED|Treatment Period 1||30
1495553|NCT01704846|3659115|P2|STARTED|Treatment Period 1||30
1495554|NCT01704846|3659116|P1|STARTED|Treatment Period 1||30
1495555|NCT01704781|3659139|P5|NOT COMPLETED|Overall Study||0
1495556|NCT01704781|3659140|P4|NOT COMPLETED|Overall Study||0
1495557|NCT01704781|3659141|P3|NOT COMPLETED|Overall Study||0
1495558|NCT01704781|3659142|P2|NOT COMPLETED|Overall Study||0
1495559|NCT01704781|3659143|P1|NOT COMPLETED|Overall Study||0
1495560|NCT01704781|3659139|P5|COMPLETED|Overall Study||12
1495561|NCT01704781|3659140|P4|COMPLETED|Overall Study||12
1495562|NCT01704781|3659141|P3|COMPLETED|Overall Study||6
1495563|NCT01704781|3659142|P2|COMPLETED|Overall Study||3
1495564|NCT01704781|3659143|P1|COMPLETED|Overall Study||3
1495565|NCT01704781|3659139|P5|STARTED|Overall Study||12
1495566|NCT01704781|3659140|P4|STARTED|Overall Study||12
1495567|NCT01704781|3659141|P3|STARTED|Overall Study||6
1495568|NCT01704781|3659142|P2|STARTED|Overall Study||3
1495569|NCT01704781|3659143|P1|STARTED|Overall Study||3
1495570|NCT01704755|3659171|P2|NOT COMPLETED|Overall Study||7
1495571|NCT01704755|3659172|P1|NOT COMPLETED|Overall Study||12
1495572|NCT01704755|3659171|P2|COMPLETED|Overall Study||165
1495573|NCT01704755|3659172|P1|COMPLETED|Overall Study||196
1495574|NCT01704755|3659171|P2|Completed Study Drug|Overall Study||163
1495575|NCT01704755|3659172|P1|Completed Study Drug|Overall Study||204
1495576|NCT01704755|3659171|P2|STARTED|Overall Study||172
1495577|NCT01704755|3659172|P1|STARTED|Overall Study||208
1495578|NCT01704651|3659186|P2|NOT COMPLETED|Overall Study||7
1495579|NCT01704651|3659187|P1|NOT COMPLETED|Overall Study||5
1495580|NCT01704651|3659186|P2|COMPLETED|Overall Study||68
1495581|NCT01704651|3659187|P1|COMPLETED|Overall Study||66
1495582|NCT01704651|3659186|P2|STARTED|Overall Study||75
1495583|NCT01704651|3659187|P1|STARTED|Overall Study||71
1495584|NCT01704599|3659195|P1|NOT COMPLETED|Overall Study||1
1495585|NCT01704599|3659195|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
1495586|NCT01704599|3659195|P1|STARTED|Overall Study|Study was started January 22, 2010|8
1495587|NCT01704521|3659224|P2|NOT COMPLETED|Overall Study||0
1495588|NCT01704521|3659225|P1|NOT COMPLETED|Overall Study||0
1495589|NCT01704521|3659224|P2|COMPLETED|Overall Study||2
1495590|NCT01704521|3659225|P1|COMPLETED|Overall Study||3
1495591|NCT01704521|3659224|P2|STARTED|Overall Study||2
1495592|NCT01704521|3659225|P1|STARTED|Overall Study||3
1495593|NCT01704495|3659235|P4|NOT COMPLETED|Optional Safety Extension||31
1495594|NCT01704495|3659236|P3|NOT COMPLETED|Optional Safety Extension||31
1495595|NCT01704495|3659237|P2|NOT COMPLETED|Optional Safety Extension||33
1495596|NCT01704495|3659238|P1|NOT COMPLETED|Optional Safety Extension||29
1495597|NCT01704495|3659235|P4|COMPLETED|Optional Safety Extension||85
1495598|NCT01704495|3659236|P3|COMPLETED|Optional Safety Extension||83
1495599|NCT01704495|3659237|P2|COMPLETED|Optional Safety Extension||88
1495600|NCT01704495|3659238|P1|COMPLETED|Optional Safety Extension||87
1495601|NCT01704495|3659235|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
1495602|NCT01704495|3659236|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
1495603|NCT01704495|3659237|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
1495604|NCT01704495|3659238|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
1495605|NCT01704495|3659235|P4|NOT COMPLETED|Subjects Randomized||17
1495606|NCT01704495|3659236|P3|NOT COMPLETED|Subjects Randomized||16
1495607|NCT01704495|3659237|P2|NOT COMPLETED|Subjects Randomized||15
1495608|NCT01704495|3659238|P1|NOT COMPLETED|Subjects Randomized||22
1495609|NCT01704495|3659235|P4|COMPLETED|Subjects Randomized||145
1495610|NCT01704495|3659236|P3|COMPLETED|Subjects Randomized||144
1495611|NCT01704495|3659237|P2|COMPLETED|Subjects Randomized||141
1495612|NCT01704495|3659238|P1|COMPLETED|Subjects Randomized||140
1495613|NCT01704495|3659235|P4|STARTED|Subjects Randomized||162
1495614|NCT01704495|3659236|P3|STARTED|Subjects Randomized||160
1495615|NCT01704495|3659237|P2|STARTED|Subjects Randomized||156
1495616|NCT01704495|3659238|P1|STARTED|Subjects Randomized||162
1495617|NCT01704404|3659412|P6|NOT COMPLETED|Overall Study||0
1495618|NCT01704404|3659413|P5|NOT COMPLETED|Overall Study||1
1495619|NCT01704404|3659414|P4|NOT COMPLETED|Overall Study||3
1495620|NCT01704404|3659415|P3|NOT COMPLETED|Overall Study||1
1495621|NCT01704404|3659416|P2|NOT COMPLETED|Overall Study||1
1495622|NCT01704404|3659417|P1|NOT COMPLETED|Overall Study||1
1495623|NCT01704404|3659412|P6|COMPLETED|Overall Study||9
1495624|NCT01704404|3659413|P5|COMPLETED|Overall Study||10
1495625|NCT01704404|3659414|P4|COMPLETED|Overall Study||8
1495626|NCT01704404|3659415|P3|COMPLETED|Overall Study||9
1495627|NCT01704404|3659416|P2|COMPLETED|Overall Study||9
1495628|NCT01704404|3659417|P1|COMPLETED|Overall Study||10
1495629|NCT01704404|3659412|P6|STARTED|Overall Study||9
1495630|NCT01704404|3659413|P5|STARTED|Overall Study||11
1495631|NCT01704404|3659414|P4|STARTED|Overall Study||11
1495632|NCT01704404|3659415|P3|STARTED|Overall Study||10
1495633|NCT01704404|3659416|P2|STARTED|Overall Study||10
1495634|NCT01704404|3659417|P1|STARTED|Overall Study||11
1495635|NCT01704287|3659454|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||45
1495636|NCT01704287|3659455|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||53
1495637|NCT01704287|3659456|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
1495638|NCT01704287|3659457|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
1495639|NCT01704287|3659458|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
1495640|NCT01704287|3659454|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||0
1495641|NCT01704287|3659455|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||0
1495642|NCT01704287|3659456|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
1495643|NCT01704287|3659457|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
1495644|NCT01704287|3659458|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
1495645|NCT01704287|3659454|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
1495646|NCT01704287|3659455|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
1495647|NCT01704287|3659456|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
1495648|NCT01704287|3659457|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
1495649|NCT01704287|3659458|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
1495650|NCT01704287|3659454|P5|NOT COMPLETED|Initial Treatment Period||0
1495651|NCT01704287|3659455|P4|NOT COMPLETED|Initial Treatment Period||0
1495652|NCT01704287|3659456|P3|NOT COMPLETED|Initial Treatment Period||179
1495653|NCT01704287|3659457|P2|NOT COMPLETED|Initial Treatment Period||181
1495654|NCT01704287|3659458|P1|NOT COMPLETED|Initial Treatment Period||180
1495655|NCT01704287|3659454|P5|COMPLETED|Initial Treatment Period||0
1495656|NCT01704287|3659455|P4|COMPLETED|Initial Treatment Period||0
1495657|NCT01704287|3659456|P3|COMPLETED|Initial Treatment Period||0
1495658|NCT01704287|3659457|P2|COMPLETED|Initial Treatment Period||0
1495659|NCT01704287|3659458|P1|COMPLETED|Initial Treatment Period||0
1495660|NCT01704287|3659454|P5|Treated|Initial Treatment Period||0
1495661|NCT01704287|3659455|P4|Treated|Initial Treatment Period||0
1495662|NCT01704287|3659456|P3|Treated|Initial Treatment Period||171
1495663|NCT01704287|3659457|P2|Treated|Initial Treatment Period||179
1495664|NCT01704287|3659458|P1|Treated|Initial Treatment Period||178
1495665|NCT01704287|3659454|P5|STARTED|Initial Treatment Period||0
1495666|NCT01704287|3659455|P4|STARTED|Initial Treatment Period||0
1495667|NCT01704287|3659456|P3|STARTED|Initial Treatment Period||179
1495668|NCT01704287|3659457|P2|STARTED|Initial Treatment Period||181
1495669|NCT01704287|3659458|P1|STARTED|Initial Treatment Period||180
1495670|NCT01704261|3659493|P2|NOT COMPLETED|Overall Study||15
1495671|NCT01704261|3659494|P1|NOT COMPLETED|Overall Study||13
1495672|NCT01704261|3659493|P2|COMPLETED|Overall Study||138
1495673|NCT01704261|3659494|P1|COMPLETED|Overall Study||141
1495674|NCT01704261|3659493|P2|STARTED|Overall Study||153
1495675|NCT01704261|3659494|P1|STARTED|Overall Study||154
1495676|NCT01704196|3659510|P2|NOT COMPLETED|Overall Study||24
1495677|NCT01704196|3659511|P1|NOT COMPLETED|Overall Study||19
1495678|NCT01704196|3659510|P2|COMPLETED|Overall Study||65
1495679|NCT01704196|3659511|P1|COMPLETED|Overall Study||71
1495680|NCT01704196|3659510|P2|STARTED|Overall Study||89
1495681|NCT01704196|3659511|P1|STARTED|Overall Study||90
1495682|NCT01704079|3659521|P2|NOT COMPLETED|Overall Study||23
1495683|NCT01704079|3659522|P1|NOT COMPLETED|Overall Study||14
1495684|NCT01704079|3659521|P2|COMPLETED|Overall Study||121
1495685|NCT01704079|3659522|P1|COMPLETED|Overall Study||58
1495686|NCT01704079|3659521|P2|Entered Extension Study|Overall Study||102
1495687|NCT01704079|3659522|P1|Entered Extension Study|Overall Study||53
1495688|NCT01704079|3659521|P2|STARTED|Overall Study||144
1495689|NCT01704079|3659522|P1|STARTED|Overall Study||72
1495690|NCT01703988|3659538|P4|NOT COMPLETED|Overall Study||1
1495691|NCT01703988|3659539|P3|NOT COMPLETED|Overall Study||0
1495692|NCT01703988|3659540|P2|NOT COMPLETED|Overall Study||0
1495693|NCT01703988|3659541|P1|NOT COMPLETED|Overall Study||0
1495694|NCT01703988|3659538|P4|COMPLETED|Overall Study||8
1495695|NCT01703988|3659539|P3|COMPLETED|Overall Study||9
1495696|NCT01703988|3659540|P2|COMPLETED|Overall Study||8
1495697|NCT01703988|3659541|P1|COMPLETED|Overall Study||8
1495698|NCT01703988|3659538|P4|STARTED|Overall Study||9
1495699|NCT01703988|3659539|P3|STARTED|Overall Study||9
1495700|NCT01703988|3659540|P2|STARTED|Overall Study||8
1495701|NCT01703988|3659541|P1|STARTED|Overall Study||8
1495702|NCT01703858|3659571|P3|NOT COMPLETED|Overall Study||0
1495703|NCT01703858|3659572|P2|NOT COMPLETED|Overall Study||1
1495704|NCT01703858|3659573|P1|NOT COMPLETED|Overall Study||0
1495705|NCT01703858|3659571|P3|COMPLETED|Overall Study||5
1495706|NCT01703858|3659572|P2|COMPLETED|Overall Study||4
1495707|NCT01703858|3659573|P1|COMPLETED|Overall Study||5
1495708|NCT01703858|3659571|P3|STARTED|Overall Study||5
1495709|NCT01703858|3659572|P2|STARTED|Overall Study||5
1495710|NCT01703858|3659573|P1|STARTED|Overall Study||5
1495711|NCT01703845|3659598|P2|NOT COMPLETED|Overall Study||0
1495712|NCT01703845|3659599|P1|NOT COMPLETED|Overall Study||3
1495713|NCT01703845|3659598|P2|COMPLETED|Overall Study||16
1495714|NCT01703845|3659599|P1|COMPLETED|Overall Study||13
1495715|NCT01703845|3659598|P2|STARTED|Overall Study|started are actually the randomized|16
1495716|NCT01703845|3659599|P1|STARTED|Overall Study|started are actually the randomized|16
1495717|NCT01703832|3659636|P2|NOT COMPLETED|Overall Study||0
1495718|NCT01703832|3659637|P1|NOT COMPLETED|Overall Study||1
1495719|NCT01703832|3659636|P2|COMPLETED|Overall Study||32
1495720|NCT01703832|3659637|P1|COMPLETED|Overall Study||32
1495721|NCT01703832|3659636|P2|STARTED|Overall Study||32
1495722|NCT01703832|3659637|P1|STARTED|Overall Study||33
1495723|NCT01703819|3659669|P2|NOT COMPLETED|Overall Study||2
1495724|NCT01703819|3659670|P1|NOT COMPLETED|Overall Study||0
1495725|NCT01703819|3659669|P2|COMPLETED|Overall Study||30
1495726|NCT01703819|3659670|P1|COMPLETED|Overall Study||34
1495727|NCT01703819|3659669|P2|STARTED|Overall Study||32
1495728|NCT01703819|3659670|P1|STARTED|Overall Study||34
1495729|NCT01703741|3659700|P1|NOT COMPLETED|Overall Study||18
1495730|NCT01703741|3659700|P1|COMPLETED|Overall Study||127
1495731|NCT01703741|3659700|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
1495732|NCT01703741|3659700|P1|STARTED|Overall Study||145
1495733|NCT01703702|3659718|P2|NOT COMPLETED|Overall Study||22
1495734|NCT01703702|3659719|P1|NOT COMPLETED|Overall Study||36
1495735|NCT01703702|3659718|P2|COMPLETED|Overall Study||288
1495736|NCT01703702|3659719|P1|COMPLETED|Overall Study||272
1495737|NCT01703702|3659718|P2|STARTED|Overall Study||310
1495738|NCT01703702|3659719|P1|STARTED|Overall Study||308
1495739|NCT01703663|3659736|P2|NOT COMPLETED|Second Treatment Period||0
1495740|NCT01703663|3659737|P1|NOT COMPLETED|Second Treatment Period||0
1495741|NCT01703663|3659736|P2|COMPLETED|Second Treatment Period||8
1495742|NCT01703663|3659737|P1|COMPLETED|Second Treatment Period||11
1495743|NCT01703663|3659736|P2|STARTED|Second Treatment Period||8
1495744|NCT01703663|3659737|P1|STARTED|Second Treatment Period||11
1495745|NCT01703663|3659736|P2|NOT COMPLETED|First Treatment Period||0
1495746|NCT01703663|3659737|P1|NOT COMPLETED|First Treatment Period||0
1495747|NCT01703663|3659736|P2|COMPLETED|First Treatment Period||20
1495748|NCT01703663|3659737|P1|COMPLETED|First Treatment Period||20
1495749|NCT01703663|3659736|P2|STARTED|First Treatment Period||20
1495750|NCT01703663|3659737|P1|STARTED|First Treatment Period||20
1495751|NCT01703286|3659743|P6|NOT COMPLETED|Period 3 Including Washout||0
1495752|NCT01703286|3659744|P5|NOT COMPLETED|Period 3 Including Washout||0
1495753|NCT01703286|3659745|P4|NOT COMPLETED|Period 3 Including Washout||0
1495754|NCT01703286|3659746|P3|NOT COMPLETED|Period 3 Including Washout||0
1495755|NCT01703286|3659747|P2|NOT COMPLETED|Period 3 Including Washout||0
1495756|NCT01703286|3659748|P1|NOT COMPLETED|Period 3 Including Washout||0
1495757|NCT01703286|3659743|P6|COMPLETED|Period 3 Including Washout||6
1495758|NCT01703286|3659744|P5|COMPLETED|Period 3 Including Washout||7
1495759|NCT01703286|3659745|P4|COMPLETED|Period 3 Including Washout||5
1495760|NCT01703286|3659746|P3|COMPLETED|Period 3 Including Washout||7
1495761|NCT01703286|3659747|P2|COMPLETED|Period 3 Including Washout||7
1495762|NCT01703286|3659748|P1|COMPLETED|Period 3 Including Washout||7
1495763|NCT01703286|3659743|P6|STARTED|Period 3 Including Washout||6
1495764|NCT01703286|3659744|P5|STARTED|Period 3 Including Washout||7
1495765|NCT01703286|3659745|P4|STARTED|Period 3 Including Washout||5
1495766|NCT01703286|3659746|P3|STARTED|Period 3 Including Washout||7
1495767|NCT01703286|3659747|P2|STARTED|Period 3 Including Washout||7
1495768|NCT01703286|3659748|P1|STARTED|Period 3 Including Washout||7
1495769|NCT01703286|3659743|P6|NOT COMPLETED|Period 2 Including Washout||0
1495770|NCT01703286|3659744|P5|NOT COMPLETED|Period 2 Including Washout||0
1495771|NCT01703286|3659745|P4|NOT COMPLETED|Period 2 Including Washout||1
1495772|NCT01703286|3659746|P3|NOT COMPLETED|Period 2 Including Washout||0
1495773|NCT01703286|3659747|P2|NOT COMPLETED|Period 2 Including Washout||0
1495774|NCT01703286|3659748|P1|NOT COMPLETED|Period 2 Including Washout||0
1495775|NCT01703286|3659743|P6|COMPLETED|Period 2 Including Washout||6
1495776|NCT01703286|3659744|P5|COMPLETED|Period 2 Including Washout||7
1495777|NCT01703286|3659745|P4|COMPLETED|Period 2 Including Washout||5
1495778|NCT01703286|3659746|P3|COMPLETED|Period 2 Including Washout||7
1495779|NCT01703286|3659747|P2|COMPLETED|Period 2 Including Washout||7
1495780|NCT01703286|3659748|P1|COMPLETED|Period 2 Including Washout||7
1495781|NCT01703286|3659743|P6|STARTED|Period 2 Including Washout||6
1495782|NCT01703286|3659744|P5|STARTED|Period 2 Including Washout||7
1495783|NCT01703286|3659745|P4|STARTED|Period 2 Including Washout||6
1495784|NCT01703286|3659746|P3|STARTED|Period 2 Including Washout||7
1495785|NCT01703286|3659747|P2|STARTED|Period 2 Including Washout||7
1495786|NCT01703286|3659748|P1|STARTED|Period 2 Including Washout||7
1495787|NCT01703286|3659743|P6|NOT COMPLETED|Period 1 Including Washout||1
1495788|NCT01703286|3659744|P5|NOT COMPLETED|Period 1 Including Washout||0
1495789|NCT01703286|3659745|P4|NOT COMPLETED|Period 1 Including Washout||1
1495790|NCT01703286|3659746|P3|NOT COMPLETED|Period 1 Including Washout||0
1495791|NCT01703286|3659747|P2|NOT COMPLETED|Period 1 Including Washout||0
1495792|NCT01703286|3659748|P1|NOT COMPLETED|Period 1 Including Washout||0
1495793|NCT01703286|3659743|P6|COMPLETED|Period 1 Including Washout||6
1495794|NCT01703286|3659744|P5|COMPLETED|Period 1 Including Washout||7
1495795|NCT01703286|3659745|P4|COMPLETED|Period 1 Including Washout||6
1495796|NCT01703286|3659746|P3|COMPLETED|Period 1 Including Washout||7
1495797|NCT01703286|3659747|P2|COMPLETED|Period 1 Including Washout||7
1495798|NCT01703286|3659748|P1|COMPLETED|Period 1 Including Washout||7
1495799|NCT01703286|3659743|P6|STARTED|Period 1 Including Washout||7
1495800|NCT01703286|3659744|P5|STARTED|Period 1 Including Washout||7
1495801|NCT01703286|3659745|P4|STARTED|Period 1 Including Washout||7
1495802|NCT01703286|3659746|P3|STARTED|Period 1 Including Washout||7
1495803|NCT01703286|3659747|P2|STARTED|Period 1 Including Washout||7
1495804|NCT01703286|3659748|P1|STARTED|Period 1 Including Washout||7
1495805|NCT01703260|3659771|P3|NOT COMPLETED|Overall Study||3
1495806|NCT01703260|3659772|P2|NOT COMPLETED|Overall Study||4
1495807|NCT01703260|3659773|P1|NOT COMPLETED|Overall Study||3
1495808|NCT01703260|3659771|P3|COMPLETED|Overall Study||3
1495809|NCT01703260|3659772|P2|COMPLETED|Overall Study||3
1495810|NCT01703260|3659773|P1|COMPLETED|Overall Study||4
1495811|NCT01703260|3659771|P3|STARTED|Overall Study||6
1495812|NCT01703260|3659772|P2|STARTED|Overall Study||7
1495813|NCT01703260|3659773|P1|STARTED|Overall Study||7
1495814|NCT01703221|3659799|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
1495815|NCT01703221|3659800|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
1495816|NCT01703221|3659801|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
1495817|NCT01703221|3659799|P3|COMPLETED|Phase B - (Week 25 to 52)||75
1495818|NCT01703221|3659800|P2|COMPLETED|Phase B - (Week 25 to 52)||147
1495819|NCT01703221|3659801|P1|COMPLETED|Phase B - (Week 25 to 52)||143
1495820|NCT01703221|3659799|P3|STARTED|Phase B - (Week 25 to 52)||80
1495821|NCT01703221|3659800|P2|STARTED|Phase B - (Week 25 to 52)||161
1495822|NCT01703221|3659801|P1|STARTED|Phase B - (Week 25 to 52)||159
1495823|NCT01703221|3659799|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
1495824|NCT01703221|3659800|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
1495825|NCT01703221|3659801|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
1495826|NCT01703221|3659799|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
1495827|NCT01703221|3659800|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
1495828|NCT01703221|3659801|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
1495829|NCT01703221|3659799|P3|STARTED|Phase A (Up to 24 Weeks)||83
1495830|NCT01703221|3659800|P2|STARTED|Phase A (Up to 24 Weeks)||165
1495831|NCT01703221|3659801|P1|STARTED|Phase A (Up to 24 Weeks)||166
1495832|NCT01703208|3659832|P2|NOT COMPLETED|Overall Study||2102
1495833|NCT01703208|3659833|P1|NOT COMPLETED|Overall Study||2100
1495834|NCT01703208|3659832|P2|COMPLETED|Overall Study||0
1495835|NCT01703208|3659833|P1|COMPLETED|Overall Study||0
1495836|NCT01703208|3659832|P2|Treated|Overall Study||2100
1495837|NCT01703208|3659833|P1|Treated|Overall Study||2092
1495838|NCT01703208|3659832|P2|STARTED|Overall Study||2102
1495839|NCT01703208|3659833|P1|STARTED|Overall Study||2100
1495840|NCT01703169|3659887|P1|NOT COMPLETED|Overall Study||0
1495841|NCT01703169|3659887|P1|COMPLETED|Overall Study||13
1495842|NCT01703169|3659887|P1|STARTED|Overall Study||13
1495843|NCT01703091|3659897|P2|NOT COMPLETED|Overall Study||4
1495844|NCT01703091|3659898|P1|NOT COMPLETED|Overall Study||9
1495845|NCT01703091|3659897|P2|COMPLETED|Overall Study||95
1495846|NCT01703091|3659898|P1|COMPLETED|Overall Study||89
1495847|NCT01703091|3659897|P2|Received at Least One Dose of Study Drug|Overall Study||98
1495848|NCT01703091|3659898|P1|Received at Least One Dose of Study Drug|Overall Study||94
1495849|NCT01703091|3659897|P2|STARTED|Overall Study||99
1495850|NCT01703091|3659898|P1|STARTED|Overall Study||98
1495851|NCT01703065|3659916|P2|NOT COMPLETED|Overall Study||0
1495852|NCT01703065|3659917|P1|NOT COMPLETED|Overall Study||1
1495853|NCT01703065|3659916|P2|COMPLETED|Overall Study||0
1495854|NCT01703065|3659917|P1|COMPLETED|Overall Study||8
1495855|NCT01703065|3659916|P2|STARTED|Overall Study||0
1495856|NCT01703065|3659917|P1|STARTED|Overall Study||9
1495857|NCT01703000|3659930|P1|NOT COMPLETED|Overall Study||1
1495858|NCT01703000|3659930|P1|COMPLETED|Overall Study||99
1495859|NCT01703000|3659930|P1|STARTED|Overall Study||100
1495860|NCT01702987|3659963|P2|NOT COMPLETED|Overall Study||0
1495861|NCT01702987|3659964|P1|NOT COMPLETED|Overall Study||1
1495862|NCT01702987|3659963|P2|COMPLETED|Overall Study||12
1495863|NCT01702987|3659964|P1|COMPLETED|Overall Study||9
1495864|NCT01702987|3659963|P2|STARTED|Overall Study||12
1495865|NCT01702987|3659964|P1|STARTED|Overall Study||10
1495866|NCT01702961|3659970|P1|NOT COMPLETED|Overall Study||47
1495867|NCT01702961|3659970|P1|COMPLETED|Overall Study||28
1495868|NCT01702961|3659970|P1|STARTED|Overall Study||75
1495869|NCT01702909|3659976|P1|NOT COMPLETED|Overall Study||0
1495870|NCT01702909|3659976|P1|COMPLETED|Overall Study||7
1495871|NCT01702909|3659976|P1|STARTED|Overall Study||7
1495872|NCT01702896|3659982|P1|NOT COMPLETED|Overall Study||8
1495873|NCT01702896|3659982|P1|COMPLETED|Overall Study||0
1495874|NCT01702896|3659982|P1|STARTED|Overall Study||8
1495875|NCT01702532|3659990|P2|NOT COMPLETED|Overall Study||1
1495876|NCT01702532|3659991|P1|NOT COMPLETED|Overall Study||0
1495877|NCT01702532|3659990|P2|COMPLETED|Overall Study||160
1495878|NCT01702532|3659991|P1|COMPLETED|Overall Study||161
1495879|NCT01702532|3659990|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
1495880|NCT01702532|3659991|P1|Safety Population|Overall Study||161
1495881|NCT01702532|3659990|P2|STARTED|Overall Study||161
1495882|NCT01702532|3659991|P1|STARTED|Overall Study||161
1495883|NCT01702519|3660001|P2|NOT COMPLETED|Period 2||0
1495884|NCT01702519|3660002|P1|NOT COMPLETED|Period 2||0
1495885|NCT01702519|3660001|P2|COMPLETED|Period 2||18
1495886|NCT01702519|3660002|P1|COMPLETED|Period 2||19
1495887|NCT01702519|3660001|P2|STARTED|Period 2||18
1495888|NCT01702519|3660002|P1|STARTED|Period 2||19
1495889|NCT01702519|3660001|P2|NOT COMPLETED|Washout Period||2
1495890|NCT01702519|3660002|P1|NOT COMPLETED|Washout Period||1
1495891|NCT01702519|3660001|P2|COMPLETED|Washout Period||18
1495892|NCT01702519|3660002|P1|COMPLETED|Washout Period||19
1495893|NCT01702519|3660001|P2|STARTED|Washout Period||20
1495894|NCT01702519|3660002|P1|STARTED|Washout Period||20
1495895|NCT01702519|3660001|P2|NOT COMPLETED|Period 1||0
1495896|NCT01702519|3660002|P1|NOT COMPLETED|Period 1||0
1495897|NCT01702519|3660001|P2|COMPLETED|Period 1||20
1495898|NCT01702519|3660002|P1|COMPLETED|Period 1||20
1495899|NCT01702519|3660001|P2|STARTED|Period 1||20
1495900|NCT01702519|3660002|P1|STARTED|Period 1||20
1495901|NCT01702454|3660020|P2|NOT COMPLETED|Overall Study||8
1495902|NCT01702454|3660021|P1|NOT COMPLETED|Overall Study||3
1495903|NCT01702454|3660020|P2|COMPLETED|Overall Study||221
1495904|NCT01702454|3660021|P1|COMPLETED|Overall Study||238
1495905|NCT01702454|3660020|P2|STARTED|Overall Study||229
1495906|NCT01702454|3660021|P1|STARTED|Overall Study||241
1495907|NCT01702428|3660103|P4|NOT COMPLETED|Overall Study||57
1495908|NCT01702428|3660104|P3|NOT COMPLETED|Overall Study||53
1495909|NCT01702428|3660105|P2|NOT COMPLETED|Overall Study||70
1495910|NCT01702428|3660106|P1|NOT COMPLETED|Overall Study||64
1495911|NCT01702428|3660103|P4|COMPLETED|Overall Study||1232
1495912|NCT01702428|3660104|P3|COMPLETED|Overall Study||1190
1495913|NCT01702428|3660105|P2|COMPLETED|Overall Study||1162
1495914|NCT01702428|3660106|P1|COMPLETED|Overall Study||1175
1495915|NCT01702428|3660103|P4|STARTED|Overall Study||1289
1495916|NCT01702428|3660104|P3|STARTED|Overall Study||1243
1495917|NCT01702428|3660105|P2|STARTED|Overall Study||1232
1495918|NCT01702428|3660106|P1|STARTED|Overall Study||1239
1495919|NCT01702363|3660193|P1|NOT COMPLETED|Overall Study||20
1495920|NCT01702363|3660193|P1|COMPLETED|Overall Study||111
1495921|NCT01702363|3660193|P1|STARTED|Overall Study||131
1495922|NCT01702311|3660210|P2|NOT COMPLETED|Overall Study||13
1495923|NCT01702311|3660211|P1|NOT COMPLETED|Overall Study||16
1495924|NCT01702311|3660210|P2|COMPLETED|Overall Study||100
1495925|NCT01702311|3660211|P1|COMPLETED|Overall Study||106
1495926|NCT01702311|3660210|P2|STARTED|Overall Study||113
1495927|NCT01702311|3660211|P1|STARTED|Overall Study||122
1495928|NCT01702298|3660241|P1|NOT COMPLETED|Overall Study||1
1495929|NCT01702298|3660241|P1|COMPLETED|Overall Study||41
1495930|NCT01702298|3660241|P1|STARTED|Overall Study||42
1495931|NCT01702259|3660254|P2|NOT COMPLETED|Overall Study||0
1495932|NCT01702259|3660255|P1|NOT COMPLETED|Overall Study||0
1495933|NCT01702259|3660254|P2|COMPLETED|Overall Study||34
1495934|NCT01702259|3660255|P1|COMPLETED|Overall Study||34
1495935|NCT01702259|3660254|P2|STARTED|Overall Study||34
1495936|NCT01702259|3660255|P1|STARTED|Overall Study||34
1495937|NCT01702246|3660269|P1|NOT COMPLETED|Overall Study||5
1495938|NCT01702246|3660269|P1|COMPLETED|Overall Study||19
1495939|NCT01702246|3660269|P1|STARTED|Overall Study||24
1495940|NCT01702233|3660281|P3|NOT COMPLETED|Overall Study||5
1495941|NCT01702233|3660282|P2|NOT COMPLETED|Overall Study||3
1495942|NCT01702233|3660283|P1|NOT COMPLETED|Overall Study||6
1495943|NCT01702233|3660281|P3|COMPLETED|Overall Study||31
1495944|NCT01702233|3660282|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
1495945|NCT01702233|3660283|P1|COMPLETED|Overall Study||66
1495946|NCT01702233|3660281|P3|Per Protocol Set|Overall Study||27
1495947|NCT01702233|3660282|P2|Per Protocol Set|Overall Study||58
1495948|NCT01702233|3660283|P1|Per Protocol Set|Overall Study||58
1495949|NCT01702233|3660281|P3|Full Analysis Set (ITT)|Overall Study||31
1495950|NCT01702233|3660282|P2|Full Analysis Set (ITT)|Overall Study||63
1495951|NCT01702233|3660283|P1|Full Analysis Set (ITT)|Overall Study||66
1495952|NCT01702233|3660281|P3|STARTED|Overall Study||36
1495953|NCT01702233|3660282|P2|STARTED|Overall Study||67
1495954|NCT01702233|3660283|P1|STARTED|Overall Study||72
1495955|NCT01702025|3660323|P4|NOT COMPLETED|Overall Study||0
1495956|NCT01702025|3660324|P3|NOT COMPLETED|Overall Study||1
1495957|NCT01702025|3660325|P2|NOT COMPLETED|Overall Study||1
1495958|NCT01702025|3660326|P1|NOT COMPLETED|Overall Study||2
1495959|NCT01702025|3660323|P4|COMPLETED|Overall Study||10
1495960|NCT01702025|3660324|P3|COMPLETED|Overall Study||9
1495961|NCT01702025|3660325|P2|COMPLETED|Overall Study||9
1495962|NCT01702025|3660326|P1|COMPLETED|Overall Study||9
1495963|NCT01702025|3660323|P4|STARTED|Overall Study||10
1495964|NCT01702025|3660324|P3|STARTED|Overall Study||10
1495965|NCT01702025|3660325|P2|STARTED|Overall Study||10
1495966|NCT01702025|3660326|P1|STARTED|Overall Study||11
1495967|NCT01701999|3660342|P2|NOT COMPLETED|Overall Study||0
1495968|NCT01701999|3660343|P1|NOT COMPLETED|Overall Study||0
1495969|NCT01701999|3660342|P2|COMPLETED|Overall Study||37
1495970|NCT01701999|3660343|P1|COMPLETED|Overall Study||8
1495971|NCT01701999|3660342|P2|STARTED|Overall Study||37
1495972|NCT01701999|3660343|P1|STARTED|Overall Study||8
1495973|NCT01701973|3660355|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495974|NCT01701973|3660356|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495975|NCT01701973|3660357|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495976|NCT01701973|3660358|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495977|NCT01701973|3660359|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495978|NCT01701973|3660360|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495979|NCT01701973|3660361|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495980|NCT01701973|3660362|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495981|NCT01701973|3660355|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
1495982|NCT01701973|3660356|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
1495983|NCT01701973|3660357|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
1495984|NCT01701973|3660358|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
1495985|NCT01701973|3660359|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
1495986|NCT01701973|3660360|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
1495987|NCT01701973|3660361|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495988|NCT01701973|3660362|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
1495989|NCT01701973|3660355|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
1495990|NCT01701973|3660356|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
1495991|NCT01701973|3660357|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
1495992|NCT01701973|3660358|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
1495993|NCT01701973|3660359|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
1495994|NCT01701973|3660360|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
1495995|NCT01701973|3660361|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
1495996|NCT01701973|3660362|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
1495997|NCT01701973|3660355|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1495998|NCT01701973|3660356|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1495999|NCT01701973|3660357|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1496000|NCT01701973|3660358|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1496001|NCT01701973|3660359|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1496002|NCT01701973|3660360|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1496003|NCT01701973|3660361|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1496004|NCT01701973|3660362|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
1496005|NCT01701973|3660355|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
1496006|NCT01701973|3660356|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
1496007|NCT01701973|3660357|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
1496008|NCT01701973|3660358|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
1496009|NCT01701973|3660359|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
1496010|NCT01701973|3660360|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
1496011|NCT01701973|3660361|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
1496012|NCT01701973|3660362|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
1496013|NCT01701973|3660355|P8|STARTED|Aim 2: First Intervention (1 Day)||4
1496014|NCT01701973|3660356|P7|STARTED|Aim 2: First Intervention (1 Day)||5
1496015|NCT01701973|3660357|P6|STARTED|Aim 2: First Intervention (1 Day)||3
1496016|NCT01701973|3660358|P5|STARTED|Aim 2: First Intervention (1 Day)||2
1496017|NCT01701973|3660359|P4|STARTED|Aim 2: First Intervention (1 Day)||4
1496018|NCT01701973|3660360|P3|STARTED|Aim 2: First Intervention (1 Day)||5
1496019|NCT01701973|3660361|P2|STARTED|Aim 2: First Intervention (1 Day)||0
1496020|NCT01701973|3660362|P1|STARTED|Aim 2: First Intervention (1 Day)||0
1496021|NCT01701973|3660355|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496022|NCT01701973|3660356|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496023|NCT01701973|3660357|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496024|NCT01701973|3660358|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496025|NCT01701973|3660359|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496026|NCT01701973|3660360|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496027|NCT01701973|3660361|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496028|NCT01701973|3660362|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496029|NCT01701973|3660355|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496030|NCT01701973|3660356|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496031|NCT01701973|3660357|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496032|NCT01701973|3660358|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496033|NCT01701973|3660359|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496034|NCT01701973|3660360|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
1496035|NCT01701973|3660361|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
1496036|NCT01701973|3660362|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
1496037|NCT01701973|3660355|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
1496038|NCT01701973|3660356|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
1496039|NCT01701973|3660357|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
1496040|NCT01701973|3660358|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
1496041|NCT01701973|3660359|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
1496042|NCT01701973|3660360|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
1496043|NCT01701973|3660361|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
1496044|NCT01701973|3660362|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
1496045|NCT01701973|3660355|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1496046|NCT01701973|3660356|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1496047|NCT01701973|3660357|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1496048|NCT01701973|3660358|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1496049|NCT01701973|3660359|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1496050|NCT01701973|3660360|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1496051|NCT01701973|3660361|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
1496052|NCT01701973|3660362|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
1496053|NCT01701973|3660355|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
1496054|NCT01701973|3660356|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
1496055|NCT01701973|3660357|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
1496056|NCT01701973|3660358|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
1496057|NCT01701973|3660359|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
1496058|NCT01701973|3660360|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
1496059|NCT01701973|3660361|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
1496060|NCT01701973|3660362|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
1496061|NCT01701973|3660355|P8|STARTED|Aim 1: First Intervention (1 Day)||0
1496062|NCT01701973|3660356|P7|STARTED|Aim 1: First Intervention (1 Day)||0
1496063|NCT01701973|3660357|P6|STARTED|Aim 1: First Intervention (1 Day)||0
1496064|NCT01701973|3660358|P5|STARTED|Aim 1: First Intervention (1 Day)||0
1496065|NCT01701973|3660359|P4|STARTED|Aim 1: First Intervention (1 Day)||0
1496066|NCT01701973|3660360|P3|STARTED|Aim 1: First Intervention (1 Day)||0
1496067|NCT01701973|3660361|P2|STARTED|Aim 1: First Intervention (1 Day)||21
1496068|NCT01701973|3660362|P1|STARTED|Aim 1: First Intervention (1 Day)||23
1496069|NCT01701674|3660409|P1|NOT COMPLETED|Overall Study||1
1496070|NCT01701674|3660409|P1|COMPLETED|Overall Study||12
1496071|NCT01701674|3660409|P1|STARTED|Overall Study||13
1496072|NCT01701622|3660416|P1|NOT COMPLETED|Overall Study||0
1496073|NCT01701622|3660416|P1|COMPLETED|Overall Study||1
1496074|NCT01701622|3660416|P1|STARTED|Overall Study||1
1496075|NCT01701505|3660427|P6|NOT COMPLETED|Overall Study||0
1496076|NCT01701505|3660428|P5|NOT COMPLETED|Overall Study||0
1496077|NCT01701505|3660429|P4|NOT COMPLETED|Overall Study||0
1496078|NCT01701505|3660430|P3|NOT COMPLETED|Overall Study||0
1496079|NCT01701505|3660431|P2|NOT COMPLETED|Overall Study||0
1496080|NCT01701505|3660432|P1|NOT COMPLETED|Overall Study||0
1496081|NCT01701505|3660427|P6|COMPLETED|Overall Study||8
1496082|NCT01701505|3660428|P5|COMPLETED|Overall Study||8
1496083|NCT01701505|3660429|P4|COMPLETED|Overall Study||8
1496084|NCT01701505|3660430|P3|COMPLETED|Overall Study||8
1496085|NCT01701505|3660431|P2|COMPLETED|Overall Study||8
1496086|NCT01701505|3660432|P1|COMPLETED|Overall Study||8
1496087|NCT01701505|3660427|P6|STARTED|Overall Study||8
1496088|NCT01701505|3660428|P5|STARTED|Overall Study||8
1496089|NCT01701505|3660429|P4|STARTED|Overall Study||8
1496090|NCT01701505|3660430|P3|STARTED|Overall Study||8
1496091|NCT01701505|3660431|P2|STARTED|Overall Study||8
1496092|NCT01701505|3660432|P1|STARTED|Overall Study||8
1496093|NCT01701414|3660484|P2|NOT COMPLETED|Overall Study||1
1496094|NCT01701414|3660485|P1|NOT COMPLETED|Overall Study||1
1496095|NCT01701414|3660484|P2|COMPLETED|Overall Study||18
1496096|NCT01701414|3660485|P1|COMPLETED|Overall Study||18
1496097|NCT01701414|3660484|P2|STARTED|Overall Study||19
1496098|NCT01701414|3660485|P1|STARTED|Overall Study||19
1496099|NCT01701401|3660495|P4|NOT COMPLETED|Overall Study||6
1496100|NCT01701401|3660496|P3|NOT COMPLETED|Overall Study||5
1496101|NCT01701401|3660497|P2|NOT COMPLETED|Overall Study||9
1496102|NCT01701401|3660498|P1|NOT COMPLETED|Overall Study||10
1496103|NCT01701401|3660495|P4|COMPLETED|Overall Study||212
1496104|NCT01701401|3660496|P3|COMPLETED|Overall Study||212
1496105|NCT01701401|3660497|P2|COMPLETED|Overall Study||209
1496106|NCT01701401|3660498|P1|COMPLETED|Overall Study||207
1496107|NCT01701401|3660495|P4|STARTED|Overall Study||218
1496108|NCT01701401|3660496|P3|STARTED|Overall Study||217
1496109|NCT01701401|3660497|P2|STARTED|Overall Study||218
1496110|NCT01701401|3660498|P1|STARTED|Overall Study||217
1496111|NCT01701375|3660544|P1|NOT COMPLETED|Overall Study||0
1496112|NCT01701375|3660544|P1|COMPLETED|Overall Study||2
1496113|NCT01701375|3660544|P1|STARTED|Overall Study||2
1496114|NCT01701362|3660550|P2|NOT COMPLETED|Overall Study||56
1496115|NCT01701362|3660551|P1|NOT COMPLETED|Overall Study||42
1496116|NCT01701362|3660550|P2|COMPLETED|Overall Study||211
1496117|NCT01701362|3660551|P1|COMPLETED|Overall Study||233
1496118|NCT01701362|3660550|P2|TREATED|Overall Study||265
1496119|NCT01701362|3660551|P1|TREATED|Overall Study||274
1496120|NCT01701362|3660550|P2|STARTED|Overall Study||267
1496121|NCT01701362|3660551|P1|STARTED|Overall Study||275
1496122|NCT01701271|3660579|P1|NOT COMPLETED|Overall Study||0
1496123|NCT01701271|3660579|P1|COMPLETED|Overall Study||20
1496124|NCT01701271|3660579|P1|STARTED|Overall Study||20
1496125|NCT01701258|3660589|P13|NOT COMPLETED|EEG (Session 4)||0
1496126|NCT01701258|3660590|P12|NOT COMPLETED|EEG (Session 4)||0
1496127|NCT01701258|3660591|P11|NOT COMPLETED|EEG (Session 4)||0
1496128|NCT01701258|3660592|P10|NOT COMPLETED|EEG (Session 4)||0
1496129|NCT01701258|3660593|P9|NOT COMPLETED|EEG (Session 4)||0
1496130|NCT01701258|3660594|P8|NOT COMPLETED|EEG (Session 4)||0
1496131|NCT01701258|3660595|P7|NOT COMPLETED|EEG (Session 4)||0
1496132|NCT01701258|3660596|P6|NOT COMPLETED|EEG (Session 4)||0
1496133|NCT01701258|3660597|P5|NOT COMPLETED|EEG (Session 4)||0
1496134|NCT01701258|3660598|P4|NOT COMPLETED|EEG (Session 4)||0
1496135|NCT01701258|3660599|P3|NOT COMPLETED|EEG (Session 4)||0
1496136|NCT01701258|3660600|P2|NOT COMPLETED|EEG (Session 4)||0
1496137|NCT01701258|3660601|P1|NOT COMPLETED|EEG (Session 4)||0
1496138|NCT01701258|3660589|P13|COMPLETED|EEG (Session 4)||0
1496139|NCT01701258|3660590|P12|COMPLETED|EEG (Session 4)||0
1496140|NCT01701258|3660591|P11|COMPLETED|EEG (Session 4)||17
1496141|NCT01701258|3660592|P10|COMPLETED|EEG (Session 4)||0
1496142|NCT01701258|3660593|P9|COMPLETED|EEG (Session 4)||0
1496143|NCT01701258|3660594|P8|COMPLETED|EEG (Session 4)||16
1496144|NCT01701258|3660595|P7|COMPLETED|EEG (Session 4)||0
1496145|NCT01701258|3660596|P6|COMPLETED|EEG (Session 4)||0
1496146|NCT01701258|3660597|P5|COMPLETED|EEG (Session 4)||14
1496147|NCT01701258|3660598|P4|COMPLETED|EEG (Session 4)||0
1496148|NCT01701258|3660599|P3|COMPLETED|EEG (Session 4)||0
1496149|NCT01701258|3660600|P2|COMPLETED|EEG (Session 4)||19
1496150|NCT01701258|3660601|P1|COMPLETED|EEG (Session 4)||0
1496151|NCT01701258|3660589|P13|STARTED|EEG (Session 4)||0
1496152|NCT01701258|3660590|P12|STARTED|EEG (Session 4)||0
1496153|NCT01701258|3660591|P11|STARTED|EEG (Session 4)||17
1496154|NCT01701258|3660592|P10|STARTED|EEG (Session 4)||0
1496155|NCT01701258|3660593|P9|STARTED|EEG (Session 4)||0
1496156|NCT01701258|3660594|P8|STARTED|EEG (Session 4)||16
1496157|NCT01701258|3660595|P7|STARTED|EEG (Session 4)||0
1496158|NCT01701258|3660596|P6|STARTED|EEG (Session 4)||0
1496159|NCT01701258|3660597|P5|STARTED|EEG (Session 4)||14
1496160|NCT01701258|3660598|P4|STARTED|EEG (Session 4)||0
1496161|NCT01701258|3660599|P3|STARTED|EEG (Session 4)||0
1496162|NCT01701258|3660600|P2|STARTED|EEG (Session 4)||19
1496163|NCT01701258|3660601|P1|STARTED|EEG (Session 4)||0
1496164|NCT01701258|3660589|P13|NOT COMPLETED|PET (Session 3)||0
1496165|NCT01701258|3660590|P12|NOT COMPLETED|PET (Session 3)||0
1496166|NCT01701258|3660591|P11|NOT COMPLETED|PET (Session 3)||0
1496167|NCT01701258|3660592|P10|NOT COMPLETED|PET (Session 3)||0
1496168|NCT01701258|3660593|P9|NOT COMPLETED|PET (Session 3)||0
1496169|NCT01701258|3660594|P8|NOT COMPLETED|PET (Session 3)||0
1496170|NCT01701258|3660595|P7|NOT COMPLETED|PET (Session 3)||0
1496171|NCT01701258|3660596|P6|NOT COMPLETED|PET (Session 3)||0
1496172|NCT01701258|3660597|P5|NOT COMPLETED|PET (Session 3)||0
1496173|NCT01701258|3660598|P4|NOT COMPLETED|PET (Session 3)||0
1496174|NCT01701258|3660599|P3|NOT COMPLETED|PET (Session 3)||0
1496175|NCT01701258|3660600|P2|NOT COMPLETED|PET (Session 3)||0
1496176|NCT01701258|3660601|P1|NOT COMPLETED|PET (Session 3)||0
1496177|NCT01701258|3660589|P13|COMPLETED|PET (Session 3)||0
1496178|NCT01701258|3660590|P12|COMPLETED|PET (Session 3)||0
1496179|NCT01701258|3660591|P11|COMPLETED|PET (Session 3)||18
1496180|NCT01701258|3660592|P10|COMPLETED|PET (Session 3)||0
1496181|NCT01701258|3660593|P9|COMPLETED|PET (Session 3)||0
1496182|NCT01701258|3660594|P8|COMPLETED|PET (Session 3)||19
1496183|NCT01701258|3660595|P7|COMPLETED|PET (Session 3)||0
1496184|NCT01701258|3660596|P6|COMPLETED|PET (Session 3)||0
1496185|NCT01701258|3660597|P5|COMPLETED|PET (Session 3)||16
1496186|NCT01701258|3660598|P4|COMPLETED|PET (Session 3)||0
1496187|NCT01701258|3660599|P3|COMPLETED|PET (Session 3)||0
1496188|NCT01701258|3660600|P2|COMPLETED|PET (Session 3)||20
1496189|NCT01701258|3660601|P1|COMPLETED|PET (Session 3)||0
1496190|NCT01701258|3660589|P13|STARTED|PET (Session 3)||0
1496191|NCT01701258|3660590|P12|STARTED|PET (Session 3)||0
1496192|NCT01701258|3660591|P11|STARTED|PET (Session 3)||18
1496193|NCT01701258|3660592|P10|STARTED|PET (Session 3)||0
1496194|NCT01701258|3660593|P9|STARTED|PET (Session 3)||0
1496195|NCT01701258|3660594|P8|STARTED|PET (Session 3)||19
1496196|NCT01701258|3660595|P7|STARTED|PET (Session 3)||0
1496197|NCT01701258|3660596|P6|STARTED|PET (Session 3)||0
1496198|NCT01701258|3660597|P5|STARTED|PET (Session 3)||16
1496199|NCT01701258|3660598|P4|STARTED|PET (Session 3)||0
1496200|NCT01701258|3660599|P3|STARTED|PET (Session 3)||0
1496201|NCT01701258|3660600|P2|STARTED|PET (Session 3)||20
1496202|NCT01701258|3660601|P1|STARTED|PET (Session 3)||0
1496203|NCT01701258|3660589|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496204|NCT01701258|3660590|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496205|NCT01701258|3660591|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496206|NCT01701258|3660592|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496207|NCT01701258|3660593|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496208|NCT01701258|3660594|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496209|NCT01701258|3660595|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496210|NCT01701258|3660596|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496211|NCT01701258|3660597|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496212|NCT01701258|3660598|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496213|NCT01701258|3660599|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496214|NCT01701258|3660600|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496215|NCT01701258|3660601|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
1496216|NCT01701258|3660589|P13|COMPLETED|Drug+fMRI (Session 2)||7
1496217|NCT01701258|3660590|P12|COMPLETED|Drug+fMRI (Session 2)||10
1496218|NCT01701258|3660591|P11|COMPLETED|Drug+fMRI (Session 2)||0
1496219|NCT01701258|3660592|P10|COMPLETED|Drug+fMRI (Session 2)||6
1496220|NCT01701258|3660593|P9|COMPLETED|Drug+fMRI (Session 2)||6
1496221|NCT01701258|3660594|P8|COMPLETED|Drug+fMRI (Session 2)||0
1496222|NCT01701258|3660595|P7|COMPLETED|Drug+fMRI (Session 2)||8
1496223|NCT01701258|3660596|P6|COMPLETED|Drug+fMRI (Session 2)||9
1496224|NCT01701258|3660597|P5|COMPLETED|Drug+fMRI (Session 2)||0
1496225|NCT01701258|3660598|P4|COMPLETED|Drug+fMRI (Session 2)||11
1496226|NCT01701258|3660599|P3|COMPLETED|Drug+fMRI (Session 2)||11
1496227|NCT01701258|3660600|P2|COMPLETED|Drug+fMRI (Session 2)||0
1496228|NCT01701258|3660601|P1|COMPLETED|Drug+fMRI (Session 2)||0
1496229|NCT01701258|3660589|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
1496230|NCT01701258|3660590|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
1496231|NCT01701258|3660591|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
1496232|NCT01701258|3660592|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
1496233|NCT01701258|3660593|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
1496234|NCT01701258|3660594|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
1496235|NCT01701258|3660595|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
1496236|NCT01701258|3660596|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
1496237|NCT01701258|3660597|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
1496238|NCT01701258|3660598|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
1496239|NCT01701258|3660599|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
1496240|NCT01701258|3660600|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
1496241|NCT01701258|3660601|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
1496242|NCT01701258|3660589|P13|STARTED|Drug+fMRI (Session 2)||7
1496243|NCT01701258|3660590|P12|STARTED|Drug+fMRI (Session 2)||10
1496244|NCT01701258|3660591|P11|STARTED|Drug+fMRI (Session 2)||0
1496245|NCT01701258|3660592|P10|STARTED|Drug+fMRI (Session 2)||6
1496246|NCT01701258|3660593|P9|STARTED|Drug+fMRI (Session 2)||6
1496247|NCT01701258|3660594|P8|STARTED|Drug+fMRI (Session 2)||0
1496248|NCT01701258|3660595|P7|STARTED|Drug+fMRI (Session 2)||8
1496249|NCT01701258|3660596|P6|STARTED|Drug+fMRI (Session 2)||9
1496250|NCT01701258|3660597|P5|STARTED|Drug+fMRI (Session 2)||0
1496251|NCT01701258|3660598|P4|STARTED|Drug+fMRI (Session 2)||11
1496252|NCT01701258|3660599|P3|STARTED|Drug+fMRI (Session 2)||11
1496253|NCT01701258|3660600|P2|STARTED|Drug+fMRI (Session 2)||0
1496254|NCT01701258|3660601|P1|STARTED|Drug+fMRI (Session 2)||0
1496255|NCT01701258|3660589|P13|NOT COMPLETED|Assessment and Scheduling||0
1496256|NCT01701258|3660590|P12|NOT COMPLETED|Assessment and Scheduling||0
1496257|NCT01701258|3660591|P11|NOT COMPLETED|Assessment and Scheduling||0
1496258|NCT01701258|3660592|P10|NOT COMPLETED|Assessment and Scheduling||0
1496259|NCT01701258|3660593|P9|NOT COMPLETED|Assessment and Scheduling||0
1496260|NCT01701258|3660594|P8|NOT COMPLETED|Assessment and Scheduling||0
1496261|NCT01701258|3660595|P7|NOT COMPLETED|Assessment and Scheduling||0
1496262|NCT01701258|3660596|P6|NOT COMPLETED|Assessment and Scheduling||0
1496263|NCT01701258|3660597|P5|NOT COMPLETED|Assessment and Scheduling||0
1496264|NCT01701258|3660598|P4|NOT COMPLETED|Assessment and Scheduling||0
1496265|NCT01701258|3660599|P3|NOT COMPLETED|Assessment and Scheduling||0
1496266|NCT01701258|3660600|P2|NOT COMPLETED|Assessment and Scheduling||0
1496267|NCT01701258|3660601|P1|NOT COMPLETED|Assessment and Scheduling||83
1496268|NCT01701258|3660589|P13|COMPLETED|Assessment and Scheduling||0
1496269|NCT01701258|3660590|P12|COMPLETED|Assessment and Scheduling||0
1496270|NCT01701258|3660591|P11|COMPLETED|Assessment and Scheduling||0
1496271|NCT01701258|3660592|P10|COMPLETED|Assessment and Scheduling||0
1496272|NCT01701258|3660593|P9|COMPLETED|Assessment and Scheduling||0
1496273|NCT01701258|3660594|P8|COMPLETED|Assessment and Scheduling||0
1496274|NCT01701258|3660595|P7|COMPLETED|Assessment and Scheduling||0
1496275|NCT01701258|3660596|P6|COMPLETED|Assessment and Scheduling||0
1496276|NCT01701258|3660597|P5|COMPLETED|Assessment and Scheduling||0
1496277|NCT01701258|3660598|P4|COMPLETED|Assessment and Scheduling||0
1496278|NCT01701258|3660599|P3|COMPLETED|Assessment and Scheduling||0
1496279|NCT01701258|3660600|P2|COMPLETED|Assessment and Scheduling||0
1496280|NCT01701258|3660601|P1|COMPLETED|Assessment and Scheduling||70
1496281|NCT01701258|3660589|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496282|NCT01701258|3660590|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496283|NCT01701258|3660591|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496284|NCT01701258|3660592|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496285|NCT01701258|3660593|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496286|NCT01701258|3660594|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496287|NCT01701258|3660595|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496288|NCT01701258|3660596|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496289|NCT01701258|3660597|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496290|NCT01701258|3660598|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496291|NCT01701258|3660599|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496292|NCT01701258|3660600|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
1496293|NCT01701258|3660601|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
1496294|NCT01701258|3660589|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
1496295|NCT01701258|3660590|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
1496296|NCT01701258|3660591|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
1496297|NCT01701258|3660592|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
1496298|NCT01701258|3660593|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
1496299|NCT01701258|3660594|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
1496300|NCT01701258|3660595|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
1496301|NCT01701258|3660596|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
1496302|NCT01701258|3660597|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
1496303|NCT01701258|3660598|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
1496304|NCT01701258|3660599|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
1496305|NCT01701258|3660600|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
1496306|NCT01701258|3660601|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
1496307|NCT01701258|3660589|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496308|NCT01701258|3660590|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496309|NCT01701258|3660591|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496310|NCT01701258|3660592|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496311|NCT01701258|3660593|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496312|NCT01701258|3660594|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496313|NCT01701258|3660595|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496314|NCT01701258|3660596|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496315|NCT01701258|3660597|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496316|NCT01701258|3660598|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496317|NCT01701258|3660599|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496318|NCT01701258|3660600|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
1496319|NCT01701258|3660601|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
1496320|NCT01701258|3660589|P13|Eligible After Screening Visit|Assessment and Scheduling||0
1496321|NCT01701258|3660590|P12|Eligible After Screening Visit|Assessment and Scheduling||0
1496322|NCT01701258|3660591|P11|Eligible After Screening Visit|Assessment and Scheduling||0
1496323|NCT01701258|3660592|P10|Eligible After Screening Visit|Assessment and Scheduling||0
1496324|NCT01701258|3660593|P9|Eligible After Screening Visit|Assessment and Scheduling||0
1496325|NCT01701258|3660594|P8|Eligible After Screening Visit|Assessment and Scheduling||0
1496326|NCT01701258|3660595|P7|Eligible After Screening Visit|Assessment and Scheduling||0
1496327|NCT01701258|3660596|P6|Eligible After Screening Visit|Assessment and Scheduling||0
1496328|NCT01701258|3660597|P5|Eligible After Screening Visit|Assessment and Scheduling||0
1496329|NCT01701258|3660598|P4|Eligible After Screening Visit|Assessment and Scheduling||0
1496330|NCT01701258|3660599|P3|Eligible After Screening Visit|Assessment and Scheduling||0
1496331|NCT01701258|3660600|P2|Eligible After Screening Visit|Assessment and Scheduling||0
1496332|NCT01701258|3660601|P1|Eligible After Screening Visit|Assessment and Scheduling||96
1496333|NCT01701258|3660589|P13|STARTED|Assessment and Scheduling||0
1496334|NCT01701258|3660590|P12|STARTED|Assessment and Scheduling||0
1496335|NCT01701258|3660591|P11|STARTED|Assessment and Scheduling||0
1496336|NCT01701258|3660592|P10|STARTED|Assessment and Scheduling||0
1496337|NCT01701258|3660593|P9|STARTED|Assessment and Scheduling||0
1496338|NCT01701258|3660594|P8|STARTED|Assessment and Scheduling||0
1496339|NCT01701258|3660595|P7|STARTED|Assessment and Scheduling||0
1496340|NCT01701258|3660596|P6|STARTED|Assessment and Scheduling||0
1496341|NCT01701258|3660597|P5|STARTED|Assessment and Scheduling||0
1496342|NCT01701258|3660598|P4|STARTED|Assessment and Scheduling||0
1496343|NCT01701258|3660599|P3|STARTED|Assessment and Scheduling||0
1496344|NCT01701258|3660600|P2|STARTED|Assessment and Scheduling||0
1496345|NCT01701258|3660601|P1|STARTED|Assessment and Scheduling||153
1496346|NCT01701245|3660655|P2|NOT COMPLETED|Overall Study||15
1496347|NCT01701245|3660656|P1|NOT COMPLETED|Overall Study||12
1496348|NCT01701245|3660655|P2|COMPLETED|Overall Study||33
1496349|NCT01701245|3660656|P1|COMPLETED|Overall Study||37
1496350|NCT01701245|3660655|P2|FAS Matched Data|Overall Study||32
1496351|NCT01701245|3660656|P1|FAS Matched Data|Overall Study||42
1496352|NCT01701245|3660655|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
1496353|NCT01701245|3660656|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
1496354|NCT01701245|3660655|P2|STARTED|Overall Study||48
1496355|NCT01701245|3660656|P1|STARTED|Overall Study||49
1496356|NCT01701115|3660670|P2|NOT COMPLETED|Overall Study||0
1496357|NCT01701115|3660671|P1|NOT COMPLETED|Overall Study||2
1496358|NCT01701115|3660670|P2|COMPLETED|Overall Study||77
1496359|NCT01701115|3660671|P1|COMPLETED|Overall Study||75
1496360|NCT01701115|3660670|P2|STARTED|Overall Study||77
1496361|NCT01701115|3660671|P1|STARTED|Overall Study||77
1496362|NCT01701102|3660687|P4|NOT COMPLETED|Overall Study||0
1496363|NCT01701102|3660688|P3|NOT COMPLETED|Overall Study||0
1496364|NCT01701102|3660689|P2|NOT COMPLETED|Overall Study||0
1496365|NCT01701102|3660690|P1|NOT COMPLETED|Overall Study||0
1496366|NCT01701102|3660687|P4|COMPLETED|Overall Study||18
1496367|NCT01701102|3660688|P3|COMPLETED|Overall Study||10
1496368|NCT01701102|3660689|P2|COMPLETED|Overall Study||6
1496369|NCT01701102|3660690|P1|COMPLETED|Overall Study||22
1496370|NCT01701102|3660687|P4|STARTED|Overall Study||18
1496371|NCT01701102|3660688|P3|STARTED|Overall Study||10
1496372|NCT01701102|3660689|P2|STARTED|Overall Study||6
1496373|NCT01701102|3660690|P1|STARTED|Overall Study||22
1496374|NCT01701063|3660703|P3|NOT COMPLETED|Overall Study||2
1496375|NCT01701063|3660704|P2|NOT COMPLETED|Overall Study||1
1496376|NCT01701063|3660705|P1|NOT COMPLETED|Overall Study||0
1496377|NCT01701063|3660703|P3|COMPLETED|Overall Study||8
1496378|NCT01701063|3660704|P2|COMPLETED|Overall Study||18
1496379|NCT01701063|3660705|P1|COMPLETED|Overall Study||13
1496380|NCT01701063|3660703|P3|STARTED|Overall Study||10
1496381|NCT01701063|3660704|P2|STARTED|Overall Study||19
1496382|NCT01701063|3660705|P1|STARTED|Overall Study||13
1496383|NCT01701037|3660747|P1|NOT COMPLETED|Overall Study||0
1496384|NCT01701037|3660747|P1|COMPLETED|Overall Study||13
1496385|NCT01701037|3660747|P1|STARTED|Overall Study||13
1496386|NCT01701024|3660758|P2|NOT COMPLETED|Overall Study||9
1496387|NCT01701024|3660759|P1|NOT COMPLETED|Overall Study||10
1496388|NCT01701024|3660758|P2|COMPLETED|Overall Study||236
1496389|NCT01701024|3660759|P1|COMPLETED|Overall Study||243
1496390|NCT01701024|3660758|P2|STARTED|Overall Study||245
1496391|NCT01701024|3660759|P1|STARTED|Overall Study||253
1496392|NCT01701011|3660774|P3|NOT COMPLETED|Overall Study||34
1496393|NCT01701011|3660775|P2|NOT COMPLETED|Overall Study||24
1496394|NCT01701011|3660776|P1|NOT COMPLETED|Overall Study||35
1496395|NCT01701011|3660774|P3|COMPLETED|Overall Study||90
1496396|NCT01701011|3660775|P2|COMPLETED|Overall Study||102
1496397|NCT01701011|3660776|P1|COMPLETED|Overall Study||92
1496398|NCT01701011|3660774|P3|STARTED|Overall Study||124
1496399|NCT01701011|3660775|P2|STARTED|Overall Study||126
1496400|NCT01701011|3660776|P1|STARTED|Overall Study||127
1496401|NCT01700985|3660789|P2|NOT COMPLETED|Overall Study||1
1496402|NCT01700985|3660790|P1|NOT COMPLETED|Overall Study||0
1496403|NCT01700985|3660789|P2|COMPLETED|Overall Study||20
1496404|NCT01700985|3660790|P1|COMPLETED|Overall Study||23
1496405|NCT01700985|3660789|P2|STARTED|Overall Study||21
1496406|NCT01700985|3660790|P1|STARTED|Overall Study||23
1496407|NCT01700959|3660812|P6|NOT COMPLETED|Overall Study||25
1496408|NCT01700959|3660813|P5|NOT COMPLETED|Overall Study||27
1496409|NCT01700959|3660814|P4|NOT COMPLETED|Overall Study||35
1496410|NCT01700959|3660815|P3|NOT COMPLETED|Overall Study||40
1496411|NCT01700959|3660816|P2|NOT COMPLETED|Overall Study||24
1496412|NCT01700959|3660817|P1|NOT COMPLETED|Overall Study||27
1496413|NCT01700959|3660812|P6|COMPLETED|Overall Study||72
1496414|NCT01700959|3660813|P5|COMPLETED|Overall Study||69
1496415|NCT01700959|3660814|P4|COMPLETED|Overall Study||70
1496416|NCT01700959|3660815|P3|COMPLETED|Overall Study||65
1496417|NCT01700959|3660816|P2|COMPLETED|Overall Study||64
1496418|NCT01700959|3660817|P1|COMPLETED|Overall Study||62
1496419|NCT01700959|3660812|P6|STARTED|Overall Study||97
1496420|NCT01700959|3660813|P5|STARTED|Overall Study||96
1496421|NCT01700959|3660814|P4|STARTED|Overall Study||105
1496422|NCT01700959|3660815|P3|STARTED|Overall Study||105
1496423|NCT01700959|3660816|P2|STARTED|Overall Study||88
1496424|NCT01700959|3660817|P1|STARTED|Overall Study||89
1496425|NCT01700907|3660841|P2|NOT COMPLETED|Overall Study||0
1496426|NCT01700907|3660842|P1|NOT COMPLETED|Overall Study||0
1496427|NCT01700907|3660841|P2|COMPLETED|Overall Study||10
1496428|NCT01700907|3660842|P1|COMPLETED|Overall Study||10
1496429|NCT01700907|3660841|P2|STARTED|Overall Study||10
1496430|NCT01700907|3660842|P1|STARTED|Overall Study||10
1496431|NCT01700816|3660858|P2|NOT COMPLETED|Overall Study||0
1496432|NCT01700816|3660859|P1|NOT COMPLETED|Overall Study||0
1496433|NCT01700816|3660858|P2|COMPLETED|Overall Study||19
1496434|NCT01700816|3660859|P1|COMPLETED|Overall Study||21
1496435|NCT01700816|3660858|P2|STARTED|Overall Study||19
1496436|NCT01700816|3660859|P1|STARTED|Overall Study||21
1496437|NCT01700530|3660888|P3|NOT COMPLETED|Overall Study||1
1496438|NCT01700530|3660889|P2|NOT COMPLETED|Overall Study||3
1496439|NCT01700530|3660890|P1|NOT COMPLETED|Overall Study||0
1496440|NCT01700530|3660888|P3|COMPLETED|Overall Study||19
1496441|NCT01700530|3660889|P2|COMPLETED|Overall Study||18
1496442|NCT01700530|3660890|P1|COMPLETED|Overall Study||9
1496443|NCT01700530|3660888|P3|STARTED|Overall Study||20
1496444|NCT01700530|3660889|P2|STARTED|Overall Study||21
1496445|NCT01700530|3660890|P1|STARTED|Overall Study||9
1496446|NCT01700517|3660904|P3|NOT COMPLETED|Overall Study||0
1496447|NCT01700517|3660905|P2|NOT COMPLETED|Overall Study||0
1496448|NCT01700517|3660906|P1|NOT COMPLETED|Overall Study||0
1496449|NCT01700517|3660904|P3|COMPLETED|Overall Study||40
1496450|NCT01700517|3660905|P2|COMPLETED|Overall Study||40
1496451|NCT01700517|3660906|P1|COMPLETED|Overall Study||40
1496452|NCT01700517|3660904|P3|STARTED|Overall Study||40
1496453|NCT01700517|3660905|P2|STARTED|Overall Study||40
1496454|NCT01700517|3660906|P1|STARTED|Overall Study||40
1496455|NCT01700439|3660914|P1|NOT COMPLETED|Overall Study||889
1496456|NCT01700439|3660914|P1|COMPLETED|Overall Study||0
1496457|NCT01700439|3660914|P1|2 Year|Overall Study||215
1496458|NCT01700439|3660914|P1|1 Year|Overall Study||573
1496459|NCT01700439|3660914|P1|3 Month|Overall Study||778
1496460|NCT01700439|3660914|P1|Discharge|Overall Study||831
1496461|NCT01700439|3660914|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
1496462|NCT01700439|3660914|P1|STARTED|Overall Study||889
1496463|NCT01700387|3660939|P2|NOT COMPLETED|Overall Study||4
1496464|NCT01700387|3660940|P1|NOT COMPLETED|Overall Study||4
1496465|NCT01700387|3660939|P2|COMPLETED|Overall Study||6
1496466|NCT01700387|3660940|P1|COMPLETED|Overall Study||6
1496467|NCT01700387|3660939|P2|STARTED|Overall Study||10
1496468|NCT01700387|3660940|P1|STARTED|Overall Study||10
1496469|NCT01700348|3660950|P1|NOT COMPLETED|Overall Study||23
1496470|NCT01700348|3660950|P1|COMPLETED|Overall Study||93
1496471|NCT01700348|3660950|P1|STARTED|Overall Study||116
1496472|NCT01700335|3660954|P2|NOT COMPLETED|Overall Study||4
1496473|NCT01700335|3660955|P1|NOT COMPLETED|Overall Study||1
1496474|NCT01700335|3660954|P2|COMPLETED|Overall Study||2
1496475|NCT01700335|3660955|P1|COMPLETED|Overall Study||2
1496476|NCT01700335|3660954|P2|STARTED|Overall Study||6
1496477|NCT01700335|3660955|P1|STARTED|Overall Study||3
1496478|NCT01700192|3660968|P2|NOT COMPLETED|Overall Study||128
1496479|NCT01700192|3660969|P1|NOT COMPLETED|Overall Study||180
1496480|NCT01700192|3660968|P2|COMPLETED|Overall Study||613
1496481|NCT01700192|3660969|P1|COMPLETED|Overall Study||561
1496482|NCT01700192|3660968|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
1496483|NCT01700192|3660969|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
1496484|NCT01700192|3660968|P2|Treated|Overall Study||741
1496485|NCT01700192|3660969|P1|Treated|Overall Study||740
1496486|NCT01700192|3660968|P2|STARTED|Overall Study||741
1496487|NCT01700192|3660969|P1|STARTED|Overall Study||741
1496488|NCT01700179|3660987|P1|NOT COMPLETED|Overall Study||2
1496489|NCT01700179|3660987|P1|COMPLETED|Overall Study||6
1496490|NCT01700179|3660987|P1|STARTED|Overall Study||8
1496491|NCT01700140|3660994|P3|NOT COMPLETED|Overall Study||1
1496492|NCT01700140|3660995|P2|NOT COMPLETED|Overall Study||9
1496493|NCT01700140|3660996|P1|NOT COMPLETED|Overall Study||6
1496494|NCT01700140|3660994|P3|COMPLETED|Overall Study||61
1496495|NCT01700140|3660995|P2|COMPLETED|Overall Study||57
1496496|NCT01700140|3660996|P1|COMPLETED|Overall Study||55
1496497|NCT01700140|3660994|P3|STARTED|Overall Study||62
1496498|NCT01700140|3660995|P2|STARTED|Overall Study||66
1496499|NCT01700140|3660996|P1|STARTED|Overall Study||61
1496500|NCT01700036|3661028|P1|NOT COMPLETED|Overall Study||0
1496501|NCT01700036|3661028|P1|COMPLETED|Overall Study||40
1496502|NCT01700036|3661028|P1|STARTED|Overall Study||40
1496503|NCT01699867|3661037|P1|NOT COMPLETED|Overall Study||3
1496504|NCT01699867|3661037|P1|COMPLETED|Overall Study||47
1496505|NCT01699867|3661037|P1|STARTED|Overall Study||50
1496506|NCT01699815|3661044|P2|NOT COMPLETED|Overall Study||8
1496507|NCT01699815|3661045|P1|NOT COMPLETED|Overall Study||5
1496508|NCT01699815|3661044|P2|COMPLETED|Overall Study||56
1496509|NCT01699815|3661045|P1|COMPLETED|Overall Study||57
1496510|NCT01699815|3661044|P2|STARTED|Overall Study||64
1496511|NCT01699815|3661045|P1|STARTED|Overall Study||62
1496512|NCT01699789|3661057|P2|NOT COMPLETED|Overall Study||126
1496513|NCT01699789|3661058|P1|NOT COMPLETED|Overall Study||102
1496514|NCT01699789|3661057|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
1496515|NCT01699789|3661058|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
1496516|NCT01699789|3661057|P2|12-Month Follow-Up|Overall Study||369
1496517|NCT01699789|3661058|P1|12-Month Follow-Up|Overall Study||364
1496518|NCT01699789|3661057|P2|6-Month Follow-Up|Overall Study||379
1496519|NCT01699789|3661058|P1|6-Month Follow-Up|Overall Study||380
1496520|NCT01699789|3661057|P2|Baseline|Overall Study||488
1496521|NCT01699789|3661058|P1|Baseline|Overall Study||492
1496522|NCT01699789|3661057|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
1496523|NCT01699789|3661058|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
1496524|NCT01699763|3661120|P1|NOT COMPLETED|Overall Study||0
1496525|NCT01699763|3661120|P1|COMPLETED|Overall Study||112
1496526|NCT01699763|3661120|P1|STARTED|Overall Study||112
1496527|NCT01699750|3661128|P2|NOT COMPLETED|Overall Study||3
1496528|NCT01699750|3661129|P1|NOT COMPLETED|Overall Study||0
1496529|NCT01699750|3661128|P2|COMPLETED|Overall Study||33
1496530|NCT01699750|3661129|P1|COMPLETED|Overall Study||34
1496531|NCT01699750|3661128|P2|STARTED|Overall Study||36
1496532|NCT01699750|3661129|P1|STARTED|Overall Study||34
1496533|NCT01699698|3661153|P2|NOT COMPLETED|Overall Study||5
1496534|NCT01699698|3661154|P1|NOT COMPLETED|Overall Study||2
1496535|NCT01699698|3661153|P2|COMPLETED|Overall Study||56
1496536|NCT01699698|3661154|P1|COMPLETED|Overall Study||42
1496537|NCT01699698|3661153|P2|STARTED|Overall Study||61
1496538|NCT01699698|3661154|P1|STARTED|Overall Study||44
1496539|NCT01699685|3661164|P2|NOT COMPLETED|Period 2||0
1496540|NCT01699685|3661165|P1|NOT COMPLETED|Period 2||1
1496541|NCT01699685|3661164|P2|COMPLETED|Period 2||36
1496542|NCT01699685|3661165|P1|COMPLETED|Period 2||35
1496543|NCT01699685|3661164|P2|STARTED|Period 2||36
1496544|NCT01699685|3661165|P1|STARTED|Period 2||36
1496545|NCT01699685|3661164|P2|NOT COMPLETED|Period 1||3
1496546|NCT01699685|3661165|P1|NOT COMPLETED|Period 1||3
1496547|NCT01699685|3661164|P2|COMPLETED|Period 1||36
1496548|NCT01699685|3661165|P1|COMPLETED|Period 1||36
1496549|NCT01699685|3661164|P2|Full Analysis Population (FAS)|Period 1||38
1496550|NCT01699685|3661165|P1|Full Analysis Population (FAS)|Period 1||38
1496551|NCT01699685|3661164|P2|Safety Population|Period 1||38
1496552|NCT01699685|3661165|P1|Safety Population|Period 1||39
1496553|NCT01699685|3661164|P2|STARTED|Period 1||39
1496554|NCT01699685|3661165|P1|STARTED|Period 1||39
1496555|NCT01699607|3661183|P2|NOT COMPLETED|Overall Study||0
1496556|NCT01699607|3661184|P1|NOT COMPLETED|Overall Study||0
1496557|NCT01699607|3661183|P2|COMPLETED|Overall Study||4
1496558|NCT01699607|3661184|P1|COMPLETED|Overall Study||6
1496559|NCT01699607|3661183|P2|STARTED|Overall Study||4
1496560|NCT01699607|3661184|P1|STARTED|Overall Study||6
1496561|NCT01699373|3661191|P2|NOT COMPLETED|Overall Study||0
1496562|NCT01699373|3661192|P1|NOT COMPLETED|Overall Study||0
1496563|NCT01699373|3661191|P2|COMPLETED|Overall Study||85
1496564|NCT01699373|3661192|P1|COMPLETED|Overall Study||85
1496565|NCT01699373|3661191|P2|STARTED|Overall Study||85
1496566|NCT01699373|3661192|P1|STARTED|Overall Study||85
1496567|NCT01699178|3661200|P2|NOT COMPLETED|Overall Study||32
1496568|NCT01699178|3661201|P1|NOT COMPLETED|Overall Study||19
1496569|NCT01699178|3661200|P2|COMPLETED|Overall Study||62
1496570|NCT01699178|3661201|P1|COMPLETED|Overall Study||69
1496571|NCT01699178|3661200|P2|STARTED|Overall Study||94
1496572|NCT01699178|3661201|P1|STARTED|Overall Study||88
1496573|NCT01699087|3661217|P1|NOT COMPLETED|Overall Study||24
1496574|NCT01699087|3661217|P1|COMPLETED|Overall Study||152
1496575|NCT01699087|3661217|P1|Treated|Overall Study||161
1496576|NCT01699087|3661217|P1|STARTED|Overall Study||176
1496577|NCT01699022|3661231|P1|NOT COMPLETED|Overall Study||3
1496578|NCT01699022|3661231|P1|COMPLETED|Overall Study||14
1496579|NCT01699022|3661231|P1|STARTED|Overall Study||17
1496580|NCT01698814|3661246|P2|NOT COMPLETED|Overall Study||3
1496581|NCT01698814|3661247|P1|NOT COMPLETED|Overall Study||2
1496582|NCT01698814|3661246|P2|COMPLETED|Overall Study||166
1496583|NCT01698814|3661247|P1|COMPLETED|Overall Study||329
1496584|NCT01698814|3661246|P2|STARTED|Overall Study||169
1496585|NCT01698814|3661247|P1|STARTED|Overall Study||331
1496586|NCT01698801|3661253|P1|NOT COMPLETED|Follow Up Phase||5
1496587|NCT01698801|3661253|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
1496588|NCT01698801|3661253|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
1496589|NCT01698801|3661253|P1|NOT COMPLETED|Treatment Phase||11
1496590|NCT01698801|3661253|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
1496591|NCT01698801|3661253|P1|STARTED|Treatment Phase||26
1496592|NCT01698775|3661264|P2|NOT COMPLETED|Phase B||11
1496593|NCT01698775|3661265|P1|NOT COMPLETED|Phase B||14
1496594|NCT01698775|3661264|P2|COMPLETED|Phase B||86
1496595|NCT01698775|3661265|P1|COMPLETED|Phase B||84
1496596|NCT01698775|3661264|P2|STARTED|Phase B||97
1496597|NCT01698775|3661265|P1|STARTED|Phase B||98
1496598|NCT01698775|3661264|P2|NOT COMPLETED|Phase A||9
1496599|NCT01698775|3661265|P1|NOT COMPLETED|Phase A||9
1496600|NCT01698775|3661264|P2|COMPLETED|Phase A||97
1496601|NCT01698775|3661265|P1|COMPLETED|Phase A||98
1496602|NCT01698775|3661264|P2|STARTED|Phase A||106
1496603|NCT01698775|3661265|P1|STARTED|Phase A||107
1496604|NCT01698710|3661291|P1|NOT COMPLETED|Overall Study||0
1496605|NCT01698710|3661291|P1|COMPLETED|Overall Study||5
1496606|NCT01698710|3661291|P1|STARTED|Overall Study||5
1496607|NCT01698684|3661300|P3|NOT COMPLETED|Overall Study||21
1496608|NCT01698684|3661301|P2|NOT COMPLETED|Overall Study||23
1496609|NCT01698684|3661302|P1|NOT COMPLETED|Overall Study||29
1496610|NCT01698684|3661300|P3|COMPLETED|Overall Study||127
1496611|NCT01698684|3661301|P2|COMPLETED|Overall Study||124
1496612|NCT01698684|3661302|P1|COMPLETED|Overall Study||116
1496613|NCT01698684|3661300|P3|Safety Population|Overall Study||146
1496614|NCT01698684|3661301|P2|Safety Population|Overall Study||146
1496615|NCT01698684|3661302|P1|Safety Population|Overall Study||143
1496616|NCT01698684|3661300|P3|ITT Population|Overall Study||139
1496617|NCT01698684|3661301|P2|ITT Population|Overall Study||139
1496618|NCT01698684|3661302|P1|ITT Population|Overall Study||136
1496619|NCT01698684|3661300|P3|STARTED|Overall Study||148
1496620|NCT01698684|3661301|P2|STARTED|Overall Study||147
1496621|NCT01698684|3661302|P1|STARTED|Overall Study||145
1496622|NCT01698554|3661314|P4|NOT COMPLETED|Overall Study||2
1496623|NCT01698554|3661315|P3|NOT COMPLETED|Overall Study||2
1496624|NCT01698554|3661316|P2|NOT COMPLETED|Overall Study||10
1496625|NCT01698554|3661317|P1|NOT COMPLETED|Overall Study||6
1496626|NCT01698554|3661314|P4|COMPLETED|Overall Study||77
1496627|NCT01698554|3661315|P3|COMPLETED|Overall Study||73
1496628|NCT01698554|3661316|P2|COMPLETED|Overall Study||147
1496629|NCT01698554|3661317|P1|COMPLETED|Overall Study||147
1496630|NCT01698554|3661314|P4|STARTED|Overall Study||79
1496631|NCT01698554|3661315|P3|STARTED|Overall Study||75
1496632|NCT01698554|3661316|P2|STARTED|Overall Study||157
1496633|NCT01698554|3661317|P1|STARTED|Overall Study||153
1496634|NCT01698528|3661345|P2|NOT COMPLETED|Overall Study||4
1496635|NCT01698528|3661346|P1|NOT COMPLETED|Overall Study||1
1496636|NCT01698528|3661345|P2|COMPLETED|Overall Study||16
1496637|NCT01698528|3661346|P1|COMPLETED|Overall Study||19
1496638|NCT01698528|3661345|P2|STARTED|Overall Study||20
1496639|NCT01698528|3661346|P1|STARTED|Overall Study||20
1496640|NCT01698502|3661362|P2|NOT COMPLETED|Overall Study||0
1496641|NCT01698502|3661363|P1|NOT COMPLETED|Overall Study||0
1496642|NCT01698502|3661362|P2|COMPLETED|Overall Study||10
1496643|NCT01698502|3661363|P1|COMPLETED|Overall Study||11
1496644|NCT01698502|3661362|P2|STARTED|Overall Study||10
1496645|NCT01698502|3661363|P1|STARTED|Overall Study||11
1496646|NCT01698333|3661371|P1|NOT COMPLETED|Overall Study||0
1496647|NCT01698333|3661371|P1|COMPLETED|Overall Study||25
1496648|NCT01698333|3661371|P1|STARTED|Overall Study||25
1496649|NCT01698320|3661377|P3|NOT COMPLETED|40-Week Open-Label Period||10
1496650|NCT01698320|3661378|P2|NOT COMPLETED|40-Week Open-Label Period||19
1496651|NCT01698320|3661379|P1|NOT COMPLETED|40-Week Open-Label Period||0
1496652|NCT01698320|3661377|P3|COMPLETED|40-Week Open-Label Period||146
1496653|NCT01698320|3661378|P2|COMPLETED|40-Week Open-Label Period||146
1496654|NCT01698320|3661379|P1|COMPLETED|40-Week Open-Label Period||0
1496655|NCT01698320|3661377|P3|STARTED|40-Week Open-Label Period||156
1496656|NCT01698320|3661378|P2|STARTED|40-Week Open-Label Period||165
1496657|NCT01698320|3661379|P1|STARTED|40-Week Open-Label Period||0
1496658|NCT01698320|3661377|P3|NOT COMPLETED|12-Week Double-Blind Period||12
1496659|NCT01698320|3661378|P2|NOT COMPLETED|12-Week Double-Blind Period||4
1496660|NCT01698320|3661379|P1|NOT COMPLETED|12-Week Double-Blind Period||0
1496661|NCT01698320|3661377|P3|COMPLETED|12-Week Double-Blind Period||156
1496662|NCT01698320|3661378|P2|COMPLETED|12-Week Double-Blind Period||165
1496663|NCT01698320|3661379|P1|COMPLETED|12-Week Double-Blind Period||0
1496664|NCT01698320|3661377|P3|Safety Population|12-Week Double-Blind Period||168
1496665|NCT01698320|3661378|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
1496666|NCT01698320|3661379|P1|Safety Population|12-Week Double-Blind Period||0
1496667|NCT01698320|3661377|P3|STARTED|12-Week Double-Blind Period||168
1496668|NCT01698320|3661378|P2|STARTED|12-Week Double-Blind Period||169
1496669|NCT01698320|3661379|P1|STARTED|12-Week Double-Blind Period||0
1496670|NCT01698320|3661377|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
1496671|NCT01698320|3661378|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
1496672|NCT01698320|3661379|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
1496673|NCT01698320|3661377|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
1496674|NCT01698320|3661378|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
1496675|NCT01698320|3661379|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
1496676|NCT01698320|3661377|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
1496677|NCT01698320|3661378|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
1496678|NCT01698320|3661379|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
1496679|NCT01698268|3661399|P2|NOT COMPLETED|Overall Study||1
1496680|NCT01698268|3661400|P1|NOT COMPLETED|Overall Study||2
1496681|NCT01698268|3661399|P2|COMPLETED|Overall Study||24
1496682|NCT01698268|3661400|P1|COMPLETED|Overall Study||23
1496683|NCT01698268|3661399|P2|STARTED|Overall Study||25
1496684|NCT01698268|3661400|P1|STARTED|Overall Study||25
1496685|NCT01698008|3661408|P2|NOT COMPLETED|Overall Study||2
1496686|NCT01698008|3661409|P1|NOT COMPLETED|Overall Study||1
1496687|NCT01698008|3661408|P2|COMPLETED|Overall Study||0
1496688|NCT01698008|3661409|P1|COMPLETED|Overall Study||2
1496689|NCT01698008|3661408|P2|STARTED|Overall Study||2
1496690|NCT01698008|3661409|P1|STARTED|Overall Study||3
1496691|NCT01697969|3661415|P1|NOT COMPLETED|Overall Study||3
1496692|NCT01697969|3661415|P1|COMPLETED|Overall Study||10
1496693|NCT01697969|3661415|P1|STARTED|Overall Study||13
1496694|NCT01697956|3661422|P2|NOT COMPLETED|Overall Study||1
1496695|NCT01697956|3661423|P1|NOT COMPLETED|Overall Study||1
1496696|NCT01697956|3661422|P2|COMPLETED|Overall Study||31
1496697|NCT01697956|3661423|P1|COMPLETED|Overall Study||66
1496698|NCT01697956|3661422|P2|Per Protocol Population|Overall Study||31
1496699|NCT01697956|3661423|P1|Per Protocol Population|Overall Study||66
1496700|NCT01697956|3661422|P2|STARTED|Overall Study|enrolled and randomized|32
1496701|NCT01697956|3661423|P1|STARTED|Overall Study|enrolled and randomized|67
1496702|NCT01697748|3661453|P2|NOT COMPLETED|Overall Study||68
1496703|NCT01697748|3661454|P1|NOT COMPLETED|Overall Study||58
1496704|NCT01697748|3661453|P2|COMPLETED|Overall Study||260
1496705|NCT01697748|3661454|P1|COMPLETED|Overall Study||271
1496706|NCT01697748|3661453|P2|STARTED|Overall Study||328
1496707|NCT01697748|3661454|P1|STARTED|Overall Study||329
1496708|NCT01697696|3661464|P2|NOT COMPLETED|Overall Study||47
1496709|NCT01697696|3661465|P1|NOT COMPLETED|Overall Study||47
1496710|NCT01697696|3661464|P2|COMPLETED|Overall Study||210
1496711|NCT01697696|3661465|P1|COMPLETED|Overall Study||207
1496712|NCT01697696|3661464|P2|Full Analysis Set (FAS)|Overall Study||255
1496713|NCT01697696|3661465|P1|Full Analysis Set (FAS)|Overall Study||251
1496714|NCT01697696|3661464|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
1496715|NCT01697696|3661465|P1|Safety Set|Overall Study||251
1496716|NCT01697696|3661464|P2|STARTED|Overall Study||257
1496717|NCT01697696|3661465|P1|STARTED|Overall Study||254
1496718|NCT01697592|3661497|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
1496719|NCT01697592|3661498|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
1496720|NCT01697592|3661499|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
1496721|NCT01697592|3661500|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
1496722|NCT01697592|3661501|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
1496723|NCT01697592|3661502|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
1496724|NCT01697592|3661503|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
1496725|NCT01697592|3661504|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
1496726|NCT01697592|3661505|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
1496727|NCT01697592|3661506|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
1496728|NCT01697592|3661497|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
1496729|NCT01697592|3661498|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
1496730|NCT01697592|3661499|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
1496731|NCT01697592|3661500|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
1496732|NCT01697592|3661501|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
1496733|NCT01697592|3661502|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
1496734|NCT01697592|3661503|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
1496735|NCT01697592|3661504|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
1496736|NCT01697592|3661505|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
1496737|NCT01697592|3661506|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
1496738|NCT01697592|3661497|P10|STARTED|Phase B (Week 25 to Week 52)||30
1496739|NCT01697592|3661498|P9|STARTED|Phase B (Week 25 to Week 52)||34
1496740|NCT01697592|3661499|P8|STARTED|Phase B (Week 25 to Week 52)||33
1496741|NCT01697592|3661500|P7|STARTED|Phase B (Week 25 to Week 52)||32
1496742|NCT01697592|3661501|P6|STARTED|Phase B (Week 25 to Week 52)||62
1496743|NCT01697592|3661502|P5|STARTED|Phase B (Week 25 to Week 52)||67
1496744|NCT01697592|3661503|P4|STARTED|Phase B (Week 25 to Week 52)||63
1496745|NCT01697592|3661504|P3|STARTED|Phase B (Week 25 to Week 52)||65
1496746|NCT01697592|3661505|P2|STARTED|Phase B (Week 25 to Week 52)||62
1496747|NCT01697592|3661506|P1|STARTED|Phase B (Week 25 to Week 52)||123
1496748|NCT01697592|3661497|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
1496749|NCT01697592|3661498|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
1496750|NCT01697592|3661499|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
1496751|NCT01697592|3661500|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
1496752|NCT01697592|3661501|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
1496753|NCT01697592|3661502|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
1496754|NCT01697592|3661503|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
1496755|NCT01697592|3661504|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
1496756|NCT01697592|3661505|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
1496757|NCT01697592|3661506|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
1496758|NCT01697592|3661497|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
1496759|NCT01697592|3661498|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
1496760|NCT01697592|3661499|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
1496761|NCT01697592|3661500|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
1496762|NCT01697592|3661501|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
1496763|NCT01697592|3661502|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
1496764|NCT01697592|3661503|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
1496765|NCT01697592|3661504|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
1496766|NCT01697592|3661505|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
1496767|NCT01697592|3661506|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
1496768|NCT01697592|3661497|P10|STARTED|Phase A (Up to 24 Weeks)||32
1496769|NCT01697592|3661498|P9|STARTED|Phase A (Up to 24 Weeks)||34
1496770|NCT01697592|3661499|P8|STARTED|Phase A (Up to 24 Weeks)||33
1496771|NCT01697592|3661500|P7|STARTED|Phase A (Up to 24 Weeks)||34
1496772|NCT01697592|3661501|P6|STARTED|Phase A (Up to 24 Weeks)||63
1496773|NCT01697592|3661502|P5|STARTED|Phase A (Up to 24 Weeks)||67
1496774|NCT01697592|3661503|P4|STARTED|Phase A (Up to 24 Weeks)||65
1496775|NCT01697592|3661504|P3|STARTED|Phase A (Up to 24 Weeks)||66
1496776|NCT01697592|3661505|P2|STARTED|Phase A (Up to 24 Weeks)||65
1496777|NCT01697592|3661506|P1|STARTED|Phase A (Up to 24 Weeks)||126
1496778|NCT01697579|3661575|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
1496779|NCT01697579|3661576|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
1496780|NCT01697579|3661577|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1496781|NCT01697579|3661578|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1496782|NCT01697579|3661579|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1496783|NCT01697579|3661580|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1496784|NCT01697579|3661581|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
1496785|NCT01697579|3661575|P7|COMPLETED|Optional Extension-Cycles 2-6||37
1496786|NCT01697579|3661576|P6|COMPLETED|Optional Extension-Cycles 2-6||12
1496787|NCT01697579|3661577|P5|COMPLETED|Optional Extension-Cycles 2-6||0
1496788|NCT01697579|3661578|P4|COMPLETED|Optional Extension-Cycles 2-6||0
1496789|NCT01697579|3661579|P3|COMPLETED|Optional Extension-Cycles 2-6||0
1496790|NCT01697579|3661580|P2|COMPLETED|Optional Extension-Cycles 2-6||0
1496791|NCT01697579|3661581|P1|COMPLETED|Optional Extension-Cycles 2-6||0
1496792|NCT01697579|3661575|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
1496793|NCT01697579|3661576|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
1496794|NCT01697579|3661577|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
1496795|NCT01697579|3661578|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
1496796|NCT01697579|3661579|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
1496797|NCT01697579|3661580|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
1496798|NCT01697579|3661581|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
1496799|NCT01697579|3661575|P7|NOT COMPLETED|Base Study-Cycle 1||0
1496800|NCT01697579|3661576|P6|NOT COMPLETED|Base Study-Cycle 1||0
1496801|NCT01697579|3661577|P5|NOT COMPLETED|Base Study-Cycle 1||3
1496802|NCT01697579|3661578|P4|NOT COMPLETED|Base Study-Cycle 1||1
1496803|NCT01697579|3661579|P3|NOT COMPLETED|Base Study-Cycle 1||1
1496804|NCT01697579|3661580|P2|NOT COMPLETED|Base Study-Cycle 1||1
1496805|NCT01697579|3661581|P1|NOT COMPLETED|Base Study-Cycle 1||2
1496806|NCT01697579|3661575|P7|COMPLETED|Base Study-Cycle 1||0
1496807|NCT01697579|3661576|P6|COMPLETED|Base Study-Cycle 1||0
1496808|NCT01697579|3661577|P5|COMPLETED|Base Study-Cycle 1||35
1496809|NCT01697579|3661578|P4|COMPLETED|Base Study-Cycle 1||40
1496810|NCT01697579|3661579|P3|COMPLETED|Base Study-Cycle 1||43
1496811|NCT01697579|3661580|P2|COMPLETED|Base Study-Cycle 1||42
1496812|NCT01697579|3661581|P1|COMPLETED|Base Study-Cycle 1||72
1496813|NCT01697579|3661575|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
1496814|NCT01697579|3661576|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
1496815|NCT01697579|3661577|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
1496816|NCT01697579|3661578|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
1496817|NCT01697579|3661579|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
1496818|NCT01697579|3661580|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
1496819|NCT01697579|3661581|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
1496820|NCT01697501|3661693|P1|NOT COMPLETED|Overall Study||2
1496821|NCT01697501|3661693|P1|COMPLETED|Overall Study||86
1496822|NCT01697501|3661693|P1|STARTED|Overall Study||88
1496823|NCT01697462|3661736|P1|NOT COMPLETED|Overall Study||77
1496824|NCT01697462|3661736|P1|COMPLETED|Overall Study||181
1496825|NCT01697462|3661736|P1|STARTED|Overall Study||258
1496826|NCT01697449|3661743|P1|NOT COMPLETED|Overall Study||90
1496827|NCT01697449|3661743|P1|COMPLETED|Overall Study||101
1496828|NCT01697449|3661743|P1|STARTED|Overall Study||191
1496829|NCT01697358|3661754|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
1496830|NCT01697358|3661755|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
1496831|NCT01697358|3661754|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
1496832|NCT01697358|3661755|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
1496833|NCT01697358|3661754|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
1496834|NCT01697358|3661755|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
1496835|NCT01697358|3661754|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
1496836|NCT01697358|3661755|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
1496837|NCT01697358|3661754|P2|COMPLETED|Period I: Randomization to 6 Months||107
1496838|NCT01697358|3661755|P1|COMPLETED|Period I: Randomization to 6 Months||97
1496839|NCT01697358|3661754|P2|STARTED|Period I: Randomization to 6 Months||108
1496840|NCT01697358|3661755|P1|STARTED|Period I: Randomization to 6 Months||110
1496841|NCT01697345|3661771|P1|NOT COMPLETED|Overall Study||1
1496842|NCT01697345|3661771|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
1496843|NCT01697345|3661771|P1|STARTED|Overall Study||13
1496844|NCT01697332|3661790|P1|NOT COMPLETED|Overall Study||0
1496845|NCT01697332|3661790|P1|COMPLETED|Overall Study||1
1496846|NCT01697332|3661790|P1|STARTED|Overall Study||1
1496847|NCT01697319|3661796|P1|NOT COMPLETED|Extension Phase||15
1496848|NCT01697319|3661796|P1|COMPLETED|Extension Phase||0
1496849|NCT01697319|3661796|P1|STARTED|Extension Phase||15
1496850|NCT01697319|3661796|P1|NOT COMPLETED|Primary Phase||1
1496851|NCT01697319|3661796|P1|COMPLETED|Primary Phase||15
1496852|NCT01697319|3661796|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
1496853|NCT01696994|3661805|P2|NOT COMPLETED|Overall Study||8437
1496854|NCT01696994|3661806|P1|NOT COMPLETED|Overall Study||5192
1496855|NCT01696994|3661805|P2|COMPLETED|Overall Study||30668
1496856|NCT01696994|3661806|P1|COMPLETED|Overall Study||33919
1496857|NCT01696994|3661805|P2|STARTED|Overall Study||39105
1496858|NCT01696994|3661806|P1|STARTED|Overall Study||39111
1496859|NCT01696981|3661834|P2|NOT COMPLETED|Overall Study||10374
1496860|NCT01696981|3661835|P1|NOT COMPLETED|Overall Study||1201
1496861|NCT01696981|3661834|P2|COMPLETED|Overall Study||67071
1496862|NCT01696981|3661835|P1|COMPLETED|Overall Study||76254
1496863|NCT01696981|3661834|P2|STARTED|Overall Study||77445
1496864|NCT01696981|3661835|P1|STARTED|Overall Study||77455
1496865|NCT01696968|3661855|P2|NOT COMPLETED|Overall Study||6812
1496866|NCT01696968|3661856|P1|NOT COMPLETED|Overall Study||1201
1496867|NCT01696968|3661855|P2|COMPLETED|Overall Study||70633
1496868|NCT01696968|3661856|P1|COMPLETED|Overall Study||76255
1496869|NCT01696968|3661855|P2|STARTED|Overall Study||77445
1496870|NCT01696968|3661856|P1|STARTED|Overall Study||77456
1496871|NCT01696955|3661878|P2|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
1496872|NCT01696955|3661879|P1|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
1496873|NCT01696955|3661878|P2|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
1496874|NCT01696955|3661879|P1|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
1496875|NCT01696955|3661878|P2|STARTED|Failure on Cetuximab-Received Tivantinib||15
1496876|NCT01696955|3661879|P1|STARTED|Failure on Cetuximab-Received Tivantinib||0
1496877|NCT01696955|3661878|P2|NOT COMPLETED|Main Study||1
1496878|NCT01696955|3661879|P1|NOT COMPLETED|Main Study||2
1496879|NCT01696955|3661878|P2|COMPLETED|Main Study||38
1496880|NCT01696955|3661879|P1|COMPLETED|Main Study||40
1496881|NCT01696955|3661878|P2|STARTED|Main Study||39
1496882|NCT01696955|3661879|P1|STARTED|Main Study||42
1496883|NCT01696942|3661904|P2|NOT COMPLETED|Overall Study||3
1496884|NCT01696942|3661905|P1|NOT COMPLETED|Overall Study||2
1496885|NCT01696942|3661904|P2|COMPLETED|Overall Study||2
1496886|NCT01696942|3661905|P1|COMPLETED|Overall Study||3
1496887|NCT01696942|3661904|P2|STARTED|Overall Study||5
1496888|NCT01696942|3661905|P1|STARTED|Overall Study||5
1496889|NCT01696929|3661913|P1|NOT COMPLETED|Overall Study||1
1496890|NCT01696929|3661913|P1|COMPLETED|Overall Study||5
1496891|NCT01696929|3661913|P1|STARTED|Overall Study||6
1496892|NCT01696877|3661920|P2|NOT COMPLETED|Overall Study||1
1496893|NCT01696877|3661921|P1|NOT COMPLETED|Overall Study||0
1496894|NCT01696877|3661920|P2|COMPLETED|Overall Study||13
1496895|NCT01696877|3661921|P1|COMPLETED|Overall Study||15
1496896|NCT01696877|3661920|P2|STARTED|Overall Study||14
1496897|NCT01696877|3661921|P1|STARTED|Overall Study||15
1496898|NCT01696773|3661935|P2|NOT COMPLETED|Day 28, Second Intervention||0
1496899|NCT01696773|3661936|P1|NOT COMPLETED|Day 28, Second Intervention||0
1496900|NCT01696773|3661935|P2|COMPLETED|Day 28, Second Intervention||6
1496901|NCT01696773|3661936|P1|COMPLETED|Day 28, Second Intervention||5
1496902|NCT01696773|3661935|P2|STARTED|Day 28, Second Intervention||6
1496903|NCT01696773|3661936|P1|STARTED|Day 28, Second Intervention||5
1496904|NCT01696773|3661935|P2|NOT COMPLETED|Days 15-27, Washout||0
1496905|NCT01696773|3661936|P1|NOT COMPLETED|Days 15-27, Washout||1
1496906|NCT01696773|3661935|P2|COMPLETED|Days 15-27, Washout||6
1496907|NCT01696773|3661936|P1|COMPLETED|Days 15-27, Washout||5
1496908|NCT01696773|3661935|P2|STARTED|Days 15-27, Washout||6
1496909|NCT01696773|3661936|P1|STARTED|Days 15-27, Washout||6
1496910|NCT01696773|3661935|P2|NOT COMPLETED|Day 14, First Intervention||0
1496911|NCT01696773|3661936|P1|NOT COMPLETED|Day 14, First Intervention||0
1496912|NCT01696773|3661935|P2|COMPLETED|Day 14, First Intervention||6
1496913|NCT01696773|3661936|P1|COMPLETED|Day 14, First Intervention||6
1496914|NCT01696773|3661935|P2|STARTED|Day 14, First Intervention||6
1496915|NCT01696773|3661936|P1|STARTED|Day 14, First Intervention||6
1496916|NCT01696773|3661935|P2|NOT COMPLETED|Days 1-13, Washout||0
1496917|NCT01696773|3661936|P1|NOT COMPLETED|Days 1-13, Washout||0
1496918|NCT01696773|3661935|P2|COMPLETED|Days 1-13, Washout||6
1496919|NCT01696773|3661936|P1|COMPLETED|Days 1-13, Washout||6
1496920|NCT01696773|3661935|P2|STARTED|Days 1-13, Washout||6
1496921|NCT01696773|3661936|P1|STARTED|Days 1-13, Washout||6
1496922|NCT01696760|3661944|P2|NOT COMPLETED|Overall Study||0
1496923|NCT01696760|3661945|P1|NOT COMPLETED|Overall Study||0
1496924|NCT01696760|3661944|P2|COMPLETED|Overall Study||3
1496925|NCT01696760|3661945|P1|COMPLETED|Overall Study||9
1496926|NCT01696760|3661944|P2|STARTED|Overall Study||3
1496927|NCT01696760|3661945|P1|STARTED|Overall Study||9
1496928|NCT01696695|3661963|P1|NOT COMPLETED|Overall Study||882
1496929|NCT01696695|3661963|P1|COMPLETED|Overall Study||0
1496930|NCT01696695|3661963|P1|STARTED|Overall Study||882
1496931|NCT01696643|3661975|P2|NOT COMPLETED|Overall Study||535
1496932|NCT01696643|3661976|P1|NOT COMPLETED|Overall Study||529
1496933|NCT01696643|3661975|P2|COMPLETED|Overall Study||169
1496934|NCT01696643|3661976|P1|COMPLETED|Overall Study||174
1496935|NCT01696643|3661975|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
1496936|NCT01696643|3661976|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
1496937|NCT01696643|3661975|P2|STARTED|Overall Study||704
1496938|NCT01696643|3661976|P1|STARTED|Overall Study||703
1496939|NCT01696357|3661993|P2|NOT COMPLETED|Overall Study||1
1496940|NCT01696357|3661994|P1|NOT COMPLETED|Overall Study||2
1496941|NCT01696357|3661993|P2|COMPLETED|Overall Study||41
1496942|NCT01696357|3661994|P1|COMPLETED|Overall Study||40
1496943|NCT01696357|3661993|P2|STARTED|Overall Study||42
1496944|NCT01696357|3661994|P1|STARTED|Overall Study||42
1496945|NCT01696214|3662004|P4|NOT COMPLETED|Overall Study||0
1496946|NCT01696214|3662005|P3|NOT COMPLETED|Overall Study||0
1496947|NCT01696214|3662006|P2|NOT COMPLETED|Overall Study||1
1496948|NCT01696214|3662007|P1|NOT COMPLETED|Overall Study||0
1496949|NCT01696214|3662004|P4|COMPLETED|Overall Study||5
1496950|NCT01696214|3662005|P3|COMPLETED|Overall Study||5
1496951|NCT01696214|3662006|P2|COMPLETED|Overall Study||4
1496952|NCT01696214|3662007|P1|COMPLETED|Overall Study||5
1496953|NCT01696214|3662004|P4|STARTED|Overall Study||5
1496954|NCT01696214|3662005|P3|STARTED|Overall Study||5
1496955|NCT01696214|3662006|P2|STARTED|Overall Study||5
1496956|NCT01696214|3662007|P1|STARTED|Overall Study||5
1496957|NCT01696188|3662027|P2|NOT COMPLETED|Overall Study||1
1496958|NCT01696188|3662028|P1|NOT COMPLETED|Overall Study||1
1496959|NCT01696188|3662027|P2|COMPLETED|Overall Study||42
1496960|NCT01696188|3662028|P1|COMPLETED|Overall Study||40
1496961|NCT01696188|3662027|P2|STARTED|Overall Study||43
1496962|NCT01696188|3662028|P1|STARTED|Overall Study||41
1496963|NCT01696084|3662042|P2|NOT COMPLETED|Overall Study||146
1496964|NCT01696084|3662043|P1|NOT COMPLETED|Overall Study||131
1496965|NCT01696084|3662042|P2|COMPLETED|Overall Study||10
1496966|NCT01696084|3662043|P1|COMPLETED|Overall Study||22
1496967|NCT01696084|3662042|P2|STARTED|Overall Study||156
1496968|NCT01696084|3662043|P1|STARTED|Overall Study||153
1496969|NCT01696071|3662059|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
1496970|NCT01696071|3662060|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
1496971|NCT01696071|3662059|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
1496972|NCT01696071|3662060|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
1496973|NCT01696071|3662059|P2|STARTED|Treatment Period 2: 4 Weeks||47
1496974|NCT01696071|3662060|P1|STARTED|Treatment Period 2: 4 Weeks||51
1496975|NCT01696071|3662059|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
1496976|NCT01696071|3662060|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
1496977|NCT01696071|3662059|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
1496978|NCT01696071|3662060|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
1496979|NCT01696071|3662059|P2|STARTED|Treatment Period 1: 4 Weeks||47
1496980|NCT01696071|3662060|P1|STARTED|Treatment Period 1: 4 Weeks||51
1496981|NCT01696058|3662088|P2|NOT COMPLETED|Overall Study||31
1496982|NCT01696058|3662089|P1|NOT COMPLETED|Overall Study||43
1496983|NCT01696058|3662088|P2|COMPLETED|Overall Study||538
1496984|NCT01696058|3662089|P1|COMPLETED|Overall Study||523
1496985|NCT01696058|3662088|P2|STARTED|Overall Study||569
1496986|NCT01696058|3662089|P1|STARTED|Overall Study||566
1496987|NCT01696045|3662117|P2|NOT COMPLETED|Overall Study||7
1496988|NCT01696045|3662118|P1|NOT COMPLETED|Overall Study||3
1496989|NCT01696045|3662117|P2|COMPLETED|Overall Study||1
1496990|NCT01696045|3662118|P1|COMPLETED|Overall Study||1
1496991|NCT01696045|3662117|P2|STARTED|Overall Study||8
1496992|NCT01696045|3662118|P1|STARTED|Overall Study||4
1496993|NCT01695993|3662137|P3|NOT COMPLETED|Overall Study||6
1496994|NCT01695993|3662138|P2|NOT COMPLETED|Overall Study||5
1496995|NCT01695993|3662139|P1|NOT COMPLETED|Overall Study||5
1496996|NCT01695993|3662137|P3|COMPLETED|Overall Study||75
1496997|NCT01695993|3662138|P2|COMPLETED|Overall Study||75
1496998|NCT01695993|3662139|P1|COMPLETED|Overall Study||76
1496999|NCT01695993|3662137|P3|STARTED|Overall Study||81
1497000|NCT01695993|3662138|P2|STARTED|Overall Study||80
1497001|NCT01695993|3662139|P1|STARTED|Overall Study||81
1497002|NCT01695772|3662147|P1|NOT COMPLETED|Overall Study||38
1497003|NCT01695772|3662147|P1|COMPLETED|Overall Study||12
1497004|NCT01695772|3662147|P1|STARTED|Overall Study||50
1497005|NCT01695746|3662159|P1|NOT COMPLETED|Overall Study||12
1497006|NCT01695746|3662159|P1|COMPLETED|Overall Study||96
1497007|NCT01695746|3662159|P1|STARTED|Overall Study||108
1497008|NCT01695668|3662175|P2|NOT COMPLETED|Overall Study||17
1497009|NCT01695668|3662176|P1|NOT COMPLETED|Overall Study||15
1497010|NCT01695668|3662175|P2|COMPLETED|Overall Study||20
1497011|NCT01695668|3662176|P1|COMPLETED|Overall Study||23
1497012|NCT01695668|3662175|P2|STARTED|Overall Study||37
1497013|NCT01695668|3662176|P1|STARTED|Overall Study||38
1497014|NCT01695369|3662182|P1|NOT COMPLETED|Overall Study||0
1497015|NCT01695369|3662182|P1|COMPLETED|Overall Study||61
1497016|NCT01695369|3662182|P1|STARTED|Overall Study||61
1497017|NCT01695330|3662188|P2|NOT COMPLETED|Overall Study||0
1497018|NCT01695330|3662189|P1|NOT COMPLETED|Overall Study||47
1497019|NCT01695330|3662188|P2|COMPLETED|Overall Study||0
1497020|NCT01695330|3662189|P1|COMPLETED|Overall Study||5
1497021|NCT01695330|3662188|P2|STARTED|Overall Study||0
1497022|NCT01695330|3662189|P1|STARTED|Overall Study||52
1497023|NCT01695304|3662195|P2|NOT COMPLETED|Overall Study||0
1497024|NCT01695304|3662196|P1|NOT COMPLETED|Overall Study||0
1497025|NCT01695304|3662195|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
1497026|NCT01695304|3662196|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
1497027|NCT01695304|3662195|P2|STARTED|Overall Study||120
1497028|NCT01695304|3662196|P1|STARTED|Overall Study||120
1497029|NCT01695239|3662208|P4|NOT COMPLETED|Overall Study||6
1497030|NCT01695239|3662209|P3|NOT COMPLETED|Overall Study||10
1497031|NCT01695239|3662210|P2|NOT COMPLETED|Overall Study||4
1497032|NCT01695239|3662211|P1|NOT COMPLETED|Overall Study||15
1497033|NCT01695239|3662208|P4|COMPLETED|Overall Study||97
1497034|NCT01695239|3662209|P3|COMPLETED|Overall Study||97
1497035|NCT01695239|3662210|P2|COMPLETED|Overall Study||97
1497036|NCT01695239|3662211|P1|COMPLETED|Overall Study||91
1497037|NCT01695239|3662208|P4|Classified as Inadequate Responder (IR)|Overall Study||10
1497038|NCT01695239|3662209|P3|Classified as Inadequate Responder (IR)|Overall Study||11
1497039|NCT01695239|3662210|P2|Classified as Inadequate Responder (IR)|Overall Study||9
1497040|NCT01695239|3662211|P1|Classified as Inadequate Responder (IR)|Overall Study||27
1497041|NCT01695239|3662208|P4|Received at Least 1 Dose of Study Drug|Overall Study||102
1497042|NCT01695239|3662209|P3|Received at Least 1 Dose of Study Drug|Overall Study||107
1497043|NCT01695239|3662210|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
1497044|NCT01695239|3662211|P1|Received at Least 1 Dose of Study Drug|Overall Study||106
1497045|NCT01695239|3662208|P4|STARTED|Overall Study||103
1497046|NCT01695239|3662209|P3|STARTED|Overall Study||107
1497047|NCT01695239|3662210|P2|STARTED|Overall Study||101
1497048|NCT01695239|3662211|P1|STARTED|Overall Study||106
1497049|NCT01695044|3662302|P1|NOT COMPLETED|Overall Study||102
1497050|NCT01695044|3662302|P1|COMPLETED|Overall Study||17
1497051|NCT01695044|3662302|P1|STARTED|Overall Study||119
1497052|NCT01694966|3662315|P3|NOT COMPLETED|Overall Study||34
1497053|NCT01694966|3662316|P2|NOT COMPLETED|Overall Study||15
1497054|NCT01694966|3662317|P1|NOT COMPLETED|Overall Study||34
1497055|NCT01694966|3662315|P3|COMPLETED|Overall Study||464
1497056|NCT01694966|3662316|P2|COMPLETED|Overall Study||232
1497057|NCT01694966|3662317|P1|COMPLETED|Overall Study||470
1497058|NCT01694966|3662315|P3|STARTED|Overall Study||498
1497059|NCT01694966|3662316|P2|STARTED|Overall Study||247
1497060|NCT01694966|3662317|P1|STARTED|Overall Study||504
1497061|NCT01694771|3662327|P2|NOT COMPLETED|Overall Study||40
1497062|NCT01694771|3662328|P1|NOT COMPLETED|Overall Study||40
1497063|NCT01694771|3662327|P2|COMPLETED|Overall Study||525
1497064|NCT01694771|3662328|P1|COMPLETED|Overall Study||527
1497065|NCT01694771|3662327|P2|STARTED|Overall Study||565
1497066|NCT01694771|3662328|P1|STARTED|Overall Study||567
1497067|NCT01694706|3662352|P3|NOT COMPLETED|Overall Study||0
1497068|NCT01694706|3662353|P2|NOT COMPLETED|Overall Study||1
1497069|NCT01694706|3662354|P1|NOT COMPLETED|Overall Study||1
1497070|NCT01694706|3662352|P3|COMPLETED|Overall Study||5
1497071|NCT01694706|3662353|P2|COMPLETED|Overall Study||4
1497072|NCT01694706|3662354|P1|COMPLETED|Overall Study||4
1497073|NCT01694706|3662352|P3|Received Faldaprevir Fed|Overall Study||5
1497074|NCT01694706|3662353|P2|Received Faldaprevir Fed|Overall Study||5
1497075|NCT01694706|3662354|P1|Received Faldaprevir Fed|Overall Study||4
1497076|NCT01694706|3662352|P3|Received Faldaprevir +OMP|Overall Study||5
1497077|NCT01694706|3662353|P2|Received Faldaprevir +OMP|Overall Study||5
1497078|NCT01694706|3662354|P1|Received Faldaprevir +OMP|Overall Study||5
1497079|NCT01694706|3662352|P3|Received Faldaprevir|Overall Study||5
1497080|NCT01694706|3662353|P2|Received Faldaprevir|Overall Study||5
1497081|NCT01694706|3662354|P1|Received Faldaprevir|Overall Study||5
1497082|NCT01694706|3662352|P3|STARTED|Overall Study||5
1497083|NCT01694706|3662353|P2|STARTED|Overall Study||5
1497084|NCT01694706|3662354|P1|STARTED|Overall Study||5
1497085|NCT01694667|3662371|P2|NOT COMPLETED|Overall Study||0
1497086|NCT01694667|3662372|P1|NOT COMPLETED|Overall Study||0
1497087|NCT01694667|3662371|P2|COMPLETED|Overall Study||28
1497088|NCT01694667|3662372|P1|COMPLETED|Overall Study||29
1497089|NCT01694667|3662371|P2|STARTED|Overall Study||28
1497090|NCT01694667|3662372|P1|STARTED|Overall Study||29
1497091|NCT01694641|3662390|P2|NOT COMPLETED|Overall Study||10
1497092|NCT01694641|3662391|P1|NOT COMPLETED|Overall Study||12
1497093|NCT01694641|3662390|P2|COMPLETED|Overall Study||71
1497094|NCT01694641|3662391|P1|COMPLETED|Overall Study||68
1497095|NCT01694641|3662390|P2|STARTED|Overall Study||81
1497096|NCT01694641|3662391|P1|STARTED|Overall Study||80
1497097|NCT01694420|3662399|P1|NOT COMPLETED|Overall Study||3
1497098|NCT01694420|3662399|P1|COMPLETED|Overall Study||30
1497099|NCT01694420|3662399|P1|STARTED|Overall Study||33
1497100|NCT01694199|3662410|P2|NOT COMPLETED|Overall Study||0
1497101|NCT01694199|3662411|P1|NOT COMPLETED|Overall Study||0
1497102|NCT01694199|3662410|P2|COMPLETED|Overall Study||68
1497103|NCT01694199|3662411|P1|COMPLETED|Overall Study||71
1497104|NCT01694199|3662410|P2|STARTED|Overall Study||68
1497105|NCT01694199|3662411|P1|STARTED|Overall Study||71
1497106|NCT01694121|3662427|P2|NOT COMPLETED|Overall Study||0
1497107|NCT01694121|3662428|P1|NOT COMPLETED|Overall Study||1
1497108|NCT01694121|3662427|P2|COMPLETED|Overall Study||227
1497109|NCT01694121|3662428|P1|COMPLETED|Overall Study||227
1497110|NCT01694121|3662427|P2|STARTED|Overall Study||227
1497111|NCT01694121|3662428|P1|STARTED|Overall Study||228
1497112|NCT01694108|3662442|P2|NOT COMPLETED|Overall Study||0
1497113|NCT01694108|3662443|P1|NOT COMPLETED|Overall Study||0
1497114|NCT01694108|3662442|P2|COMPLETED|Overall Study|100% follow-up|2133
1497115|NCT01694108|3662443|P1|COMPLETED|Overall Study|100% follow-up|2129
1497116|NCT01694108|3662442|P2|STARTED|Overall Study||2133
1497117|NCT01694108|3662443|P1|STARTED|Overall Study||2129
1497118|NCT01693900|3662499|P2|NOT COMPLETED|Overall Study||0
1497119|NCT01693900|3662500|P1|NOT COMPLETED|Overall Study||0
1497120|NCT01693900|3662499|P2|COMPLETED|Overall Study||25
1497121|NCT01693900|3662500|P1|COMPLETED|Overall Study||25
1497122|NCT01693900|3662499|P2|STARTED|Overall Study||25
1497123|NCT01693900|3662500|P1|STARTED|Overall Study||25
1497124|NCT01693653|3662514|P2|NOT COMPLETED|Overall Study||0
1497125|NCT01693653|3662515|P1|NOT COMPLETED|Overall Study||0
1497126|NCT01693653|3662514|P2|COMPLETED|Overall Study||0
1497127|NCT01693653|3662515|P1|COMPLETED|Overall Study||1
1497128|NCT01693653|3662514|P2|STARTED|Overall Study||0
1497129|NCT01693653|3662515|P1|STARTED|Overall Study||1
1497130|NCT01693614|3662542|P3|NOT COMPLETED|Overall Study||24
1497131|NCT01693614|3662543|P2|NOT COMPLETED|Overall Study||22
1497132|NCT01693614|3662544|P1|NOT COMPLETED|Overall Study||26
1497133|NCT01693614|3662542|P3|COMPLETED|Overall Study||0
1497134|NCT01693614|3662543|P2|COMPLETED|Overall Study||0
1497135|NCT01693614|3662544|P1|COMPLETED|Overall Study||0
1497136|NCT01693614|3662542|P3|STARTED|Overall Study||24
1497137|NCT01693614|3662543|P2|STARTED|Overall Study||22
1497138|NCT01693614|3662544|P1|STARTED|Overall Study||26
1497139|NCT01693484|3662566|P1|NOT COMPLETED|Overall Study||13
1497140|NCT01693484|3662566|P1|COMPLETED|Overall Study|Study closed by PI|0
1497141|NCT01693484|3662566|P1|STARTED|Overall Study||13
1497142|NCT01693367|3662572|P2|NOT COMPLETED|Overall Study||2
1497143|NCT01693367|3662573|P1|NOT COMPLETED|Overall Study||1
1497144|NCT01693367|3662572|P2|COMPLETED|Overall Study||1
1497145|NCT01693367|3662573|P1|COMPLETED|Overall Study||1
1497146|NCT01693367|3662572|P2|STARTED|Overall Study||3
1497147|NCT01693367|3662573|P1|STARTED|Overall Study||2
1497148|NCT01693185|3662591|P2|NOT COMPLETED|Overall Study||6
1497149|NCT01693185|3662592|P1|NOT COMPLETED|Overall Study||0
1497150|NCT01693185|3662591|P2|COMPLETED|Overall Study||27
1497151|NCT01693185|3662592|P1|COMPLETED|Overall Study||27
1497152|NCT01693185|3662591|P2|STARTED|Overall Study||33
1497153|NCT01693185|3662592|P1|STARTED|Overall Study||27
1497154|NCT01693120|3662608|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
1497155|NCT01693120|3662608|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
1497156|NCT01693120|3662608|P1|STARTED|Phased RF Study Procedure and Follow-up||129
1497157|NCT01693120|3662608|P1|NOT COMPLETED|Enrollment||70
1497158|NCT01693120|3662608|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
1497159|NCT01693120|3662608|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
1497160|NCT01693068|3662617|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
1497161|NCT01693068|3662618|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
1497162|NCT01693068|3662619|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
1497163|NCT01693068|3662617|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
1497164|NCT01693068|3662618|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
1497165|NCT01693068|3662619|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
1497166|NCT01693068|3662617|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
1497167|NCT01693068|3662618|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
1497168|NCT01693068|3662619|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
1497169|NCT01693068|3662617|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
1497170|NCT01693068|3662618|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
1497171|NCT01693068|3662619|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
1497172|NCT01693068|3662617|P3|NOT COMPLETED|Randomization Period||0
1497173|NCT01693068|3662618|P2|NOT COMPLETED|Randomization Period||5
1497174|NCT01693068|3662619|P1|NOT COMPLETED|Randomization Period||2
1497175|NCT01693068|3662617|P3|COMPLETED|Randomization Period||0
1497176|NCT01693068|3662618|P2|COMPLETED|Randomization Period||125
1497177|NCT01693068|3662619|P1|COMPLETED|Randomization Period||62
1497178|NCT01693068|3662617|P3|Treated|Randomization Period||0
1497179|NCT01693068|3662618|P2|Treated|Randomization Period||130
1497180|NCT01693068|3662619|P1|Treated|Randomization Period||61
1497181|NCT01693068|3662617|P3|STARTED|Randomization Period||0
1497182|NCT01693068|3662618|P2|STARTED|Randomization Period||130
1497183|NCT01693068|3662619|P1|STARTED|Randomization Period||64
1497184|NCT01693029|3662651|P2|NOT COMPLETED|Overall Study||57
1497185|NCT01693029|3662652|P1|NOT COMPLETED|Overall Study||44
1497186|NCT01693029|3662651|P2|COMPLETED|Overall Study||161
1497187|NCT01693029|3662652|P1|COMPLETED|Overall Study||173
1497188|NCT01693029|3662651|P2|STARTED|Overall Study||218
1497189|NCT01693029|3662652|P1|STARTED|Overall Study||217
1497190|NCT01692951|3662668|P4|NOT COMPLETED|Overall Study||0
1497191|NCT01692951|3662669|P3|NOT COMPLETED|Overall Study||0
1497192|NCT01692951|3662670|P2|NOT COMPLETED|Overall Study||0
1497193|NCT01692951|3662671|P1|NOT COMPLETED|Overall Study||0
1497194|NCT01692951|3662668|P4|COMPLETED|Overall Study||54
1497195|NCT01692951|3662669|P3|COMPLETED|Overall Study||18
1497196|NCT01692951|3662670|P2|COMPLETED|Overall Study||111
1497197|NCT01692951|3662671|P1|COMPLETED|Overall Study||37
1497198|NCT01692951|3662668|P4|STARTED|Overall Study||54
1497199|NCT01692951|3662669|P3|STARTED|Overall Study||18
1497200|NCT01692951|3662670|P2|STARTED|Overall Study||111
1497201|NCT01692951|3662671|P1|STARTED|Overall Study||37
1497202|NCT01692938|3662683|P2|NOT COMPLETED|Overall Study||4
1497203|NCT01692938|3662684|P1|NOT COMPLETED|Overall Study||4
1497204|NCT01692938|3662683|P2|COMPLETED|Overall Study||12
1497205|NCT01692938|3662684|P1|COMPLETED|Overall Study||12
1497206|NCT01692938|3662683|P2|STARTED|Overall Study||16
1497207|NCT01692938|3662684|P1|STARTED|Overall Study||16
1497208|NCT01692782|3662695|P3|NOT COMPLETED|Overall Study||10
1497209|NCT01692782|3662696|P2|NOT COMPLETED|Overall Study||56
1497210|NCT01692782|3662697|P1|NOT COMPLETED|Overall Study||20
1497211|NCT01692782|3662695|P3|COMPLETED|Overall Study||100
1497212|NCT01692782|3662696|P2|COMPLETED|Overall Study||59
1497213|NCT01692782|3662697|P1|COMPLETED|Overall Study||96
1497214|NCT01692782|3662695|P3|STARTED|Overall Study||110
1497215|NCT01692782|3662696|P2|STARTED|Overall Study||115
1497216|NCT01692782|3662697|P1|STARTED|Overall Study||116
1497217|NCT01692756|3662724|P4|NOT COMPLETED|Overall Study||0
1497218|NCT01692756|3662725|P3|NOT COMPLETED|Overall Study||2
1497219|NCT01692756|3662726|P2|NOT COMPLETED|Overall Study||1
1497220|NCT01692756|3662727|P1|NOT COMPLETED|Overall Study||1
1497221|NCT01692756|3662724|P4|COMPLETED|Overall Study||12
1497222|NCT01692756|3662725|P3|COMPLETED|Overall Study||11
1497223|NCT01692756|3662726|P2|COMPLETED|Overall Study||11
1497224|NCT01692756|3662727|P1|COMPLETED|Overall Study||11
1497225|NCT01692756|3662724|P4|STARTED|Overall Study||12
1497226|NCT01692756|3662725|P3|STARTED|Overall Study||13
1497227|NCT01692756|3662726|P2|STARTED|Overall Study||12
1497228|NCT01692756|3662727|P1|STARTED|Overall Study||12
1497229|NCT01692730|3662787|P2|NOT COMPLETED|Overall Study||227
1497230|NCT01692730|3662788|P1|NOT COMPLETED|Overall Study||225
1497231|NCT01692730|3662787|P2|COMPLETED|Overall Study||502
1497232|NCT01692730|3662788|P1|COMPLETED|Overall Study||498
1497233|NCT01692730|3662787|P2|STARTED|Overall Study||729
1497234|NCT01692730|3662788|P1|STARTED|Overall Study||723
1497235|NCT01692691|3662796|P1|NOT COMPLETED|Overall Study||0
1497236|NCT01692691|3662796|P1|COMPLETED|Overall Study||1
1497237|NCT01692691|3662796|P1|STARTED|Overall Study||1
1497238|NCT01692626|3662802|P2|NOT COMPLETED|Overall Study||6
1497239|NCT01692626|3662803|P1|NOT COMPLETED|Overall Study||4
1497240|NCT01692626|3662802|P2|COMPLETED|Overall Study||1
1497241|NCT01692626|3662803|P1|COMPLETED|Overall Study||2
1497242|NCT01692626|3662802|P2|STARTED|Overall Study||7
1497243|NCT01692626|3662803|P1|STARTED|Overall Study||6
1497244|NCT01692340|3662811|P3|NOT COMPLETED|Overall Study||0
1497245|NCT01692340|3662812|P2|NOT COMPLETED|Overall Study||0
1497246|NCT01692340|3662813|P1|NOT COMPLETED|Overall Study||0
1497247|NCT01692340|3662811|P3|COMPLETED|Overall Study||0
1497248|NCT01692340|3662812|P2|COMPLETED|Overall Study||4
1497249|NCT01692340|3662813|P1|COMPLETED|Overall Study||8
1497250|NCT01692340|3662811|P3|STARTED|Overall Study||0
1497251|NCT01692340|3662812|P2|STARTED|Overall Study||4
1497252|NCT01692340|3662813|P1|STARTED|Overall Study||8
1497253|NCT01692301|3662830|P2|NOT COMPLETED|Overall Study||42
1497254|NCT01692301|3662831|P1|NOT COMPLETED|Overall Study||45
1497255|NCT01692301|3662830|P2|COMPLETED|Overall Study||183
1497256|NCT01692301|3662831|P1|COMPLETED|Overall Study||184
1497257|NCT01692301|3662830|P2|STARTED|Overall Study||225
1497258|NCT01692301|3662831|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
1497259|NCT01692275|3662863|P2|NOT COMPLETED|Overall Study||59
1497260|NCT01692275|3662864|P1|NOT COMPLETED|Overall Study||66
1497261|NCT01692275|3662863|P2|COMPLETED|Overall Study||316
1497262|NCT01692275|3662864|P1|COMPLETED|Overall Study||309
1497263|NCT01692275|3662863|P2|STARTED|Overall Study||375
1497264|NCT01692275|3662864|P1|STARTED|Overall Study||375
1497265|NCT01692197|3662924|P1|NOT COMPLETED|Overall Study||3
1497266|NCT01692197|3662924|P1|COMPLETED|Overall Study||40
1497267|NCT01692197|3662924|P1|STARTED|Overall Study||43
1497268|NCT01691898|3662937|P6|NOT COMPLETED|Overall Study||40
1497269|NCT01691898|3662938|P5|NOT COMPLETED|Overall Study||39
1497270|NCT01691898|3662939|P4|NOT COMPLETED|Overall Study||9
1497271|NCT01691898|3662940|P3|NOT COMPLETED|Overall Study||18
1497272|NCT01691898|3662941|P2|NOT COMPLETED|Overall Study||58
1497273|NCT01691898|3662942|P1|NOT COMPLETED|Overall Study||60
1497274|NCT01691898|3662937|P6|COMPLETED|Overall Study||0
1497275|NCT01691898|3662938|P5|COMPLETED|Overall Study||0
1497276|NCT01691898|3662939|P4|COMPLETED|Overall Study||0
1497277|NCT01691898|3662940|P3|COMPLETED|Overall Study||2
1497278|NCT01691898|3662941|P2|COMPLETED|Overall Study||1
1497279|NCT01691898|3662942|P1|COMPLETED|Overall Study||3
1497280|NCT01691898|3662937|P6|STARTED|Overall Study||40
1497281|NCT01691898|3662938|P5|STARTED|Overall Study||39
1497282|NCT01691898|3662939|P4|STARTED|Overall Study||9
1497283|NCT01691898|3662940|P3|STARTED|Overall Study||20
1497284|NCT01691898|3662941|P2|STARTED|Overall Study||59
1497285|NCT01691898|3662942|P1|STARTED|Overall Study||63
1497286|NCT01691885|3663088|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
1497287|NCT01691885|3663089|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
1497288|NCT01691885|3663088|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
1497289|NCT01691885|3663089|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
1497290|NCT01691885|3663088|P2|STARTED|Treatment Period 2 (7-14 Days)||21
1497291|NCT01691885|3663089|P1|STARTED|Treatment Period 2 (7-14 Days)||21
1497292|NCT01691885|3663088|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
1497293|NCT01691885|3663089|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
1497294|NCT01691885|3663088|P2|COMPLETED|Washout Period (7-9 Days)||21
1497295|NCT01691885|3663089|P1|COMPLETED|Washout Period (7-9 Days)||21
1497296|NCT01691885|3663088|P2|STARTED|Washout Period (7-9 Days)||22
1497297|NCT01691885|3663089|P1|STARTED|Washout Period (7-9 Days)||21
1497298|NCT01691885|3663088|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
1497299|NCT01691885|3663089|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
1497300|NCT01691885|3663088|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
1497301|NCT01691885|3663089|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
1497302|NCT01691885|3663088|P2|STARTED|Treatment Period 1(7-14 Days)||23
1497303|NCT01691885|3663089|P1|STARTED|Treatment Period 1(7-14 Days)||22
1497304|NCT01691859|3663095|P1|NOT COMPLETED|Overall Study||347
1497305|NCT01691859|3663095|P1|COMPLETED|Overall Study||0
1497306|NCT01691859|3663095|P1|STARTED|Overall Study||347
1497307|NCT01691794|3663117|P3|NOT COMPLETED|Overall Study||10
1497308|NCT01691794|3663118|P2|NOT COMPLETED|Overall Study||18
1497309|NCT01691794|3663119|P1|NOT COMPLETED|Overall Study||1
1497310|NCT01691794|3663117|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
1497311|NCT01691794|3663118|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
1497312|NCT01691794|3663119|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
1497313|NCT01691794|3663117|P3|STARTED|Overall Study||23
1497314|NCT01691794|3663118|P2|STARTED|Overall Study||33
1497315|NCT01691794|3663119|P1|STARTED|Overall Study||3
1497316|NCT01691781|3663135|P2|NOT COMPLETED|Overall Study||7
1497317|NCT01691781|3663136|P1|NOT COMPLETED|Overall Study||7
1497318|NCT01691781|3663135|P2|COMPLETED|Overall Study||15
1497319|NCT01691781|3663136|P1|COMPLETED|Overall Study||12
1497320|NCT01691781|3663135|P2|STARTED|Overall Study||22
1497321|NCT01691781|3663136|P1|STARTED|Overall Study||19
1497322|NCT01691690|3663148|P2|NOT COMPLETED|Overall Study||4
1497323|NCT01691690|3663149|P1|NOT COMPLETED|Overall Study||7
1497324|NCT01691690|3663148|P2|COMPLETED|Overall Study||121
1497325|NCT01691690|3663149|P1|COMPLETED|Overall Study||118
1497326|NCT01691690|3663148|P2|STARTED|Overall Study||125
1497327|NCT01691690|3663149|P1|STARTED|Overall Study||125
1497328|NCT01691612|3663159|P1|NOT COMPLETED|Overall Study||7
1497329|NCT01691612|3663159|P1|COMPLETED|Overall Study||7
1497330|NCT01691612|3663159|P1|Second Visit (Bronchoscopy)|Overall Study||7
1497331|NCT01691612|3663159|P1|First Visit (Allergen Challenge)|Overall Study||8
1497332|NCT01691612|3663159|P1|STARTED|Overall Study||14
1497333|NCT01691560|3663170|P4|NOT COMPLETED|Overall Study||0
1497334|NCT01691560|3663171|P3|NOT COMPLETED|Overall Study||0
1497335|NCT01691560|3663172|P2|NOT COMPLETED|Overall Study||0
1497336|NCT01691560|3663173|P1|NOT COMPLETED|Overall Study||0
1497337|NCT01691560|3663170|P4|COMPLETED|Overall Study||33
1497338|NCT01691560|3663171|P3|COMPLETED|Overall Study||34
1497339|NCT01691560|3663172|P2|COMPLETED|Overall Study||33
1497340|NCT01691560|3663173|P1|COMPLETED|Overall Study||34
1497341|NCT01691560|3663170|P4|STARTED|Overall Study||33
1497342|NCT01691560|3663171|P3|STARTED|Overall Study||34
1497343|NCT01691560|3663172|P2|STARTED|Overall Study||33
1497344|NCT01691560|3663173|P1|STARTED|Overall Study||34
1497345|NCT01691534|3663210|P7|NOT COMPLETED|Overall Study||1
1497346|NCT01691534|3663211|P6|NOT COMPLETED|Overall Study||1
1497347|NCT01691534|3663212|P5|NOT COMPLETED|Overall Study||0
1497348|NCT01691534|3663213|P4|NOT COMPLETED|Overall Study||1
1497349|NCT01691534|3663214|P3|NOT COMPLETED|Overall Study||1
1497350|NCT01691534|3663215|P2|NOT COMPLETED|Overall Study||1
1497351|NCT01691534|3663216|P1|NOT COMPLETED|Overall Study||0
1497352|NCT01691534|3663210|P7|COMPLETED|Overall Study||14
1497353|NCT01691534|3663211|P6|COMPLETED|Overall Study||14
1497354|NCT01691534|3663212|P5|COMPLETED|Overall Study||15
1497355|NCT01691534|3663213|P4|COMPLETED|Overall Study||14
1497356|NCT01691534|3663214|P3|COMPLETED|Overall Study||14
1497357|NCT01691534|3663215|P2|COMPLETED|Overall Study||14
1497358|NCT01691534|3663216|P1|COMPLETED|Overall Study||15
1497359|NCT01691534|3663210|P7|STARTED|Overall Study||15
1497360|NCT01691534|3663211|P6|STARTED|Overall Study||15
1497361|NCT01691534|3663212|P5|STARTED|Overall Study||15
1497362|NCT01691534|3663213|P4|STARTED|Overall Study||15
1497363|NCT01691534|3663214|P3|STARTED|Overall Study||15
1497364|NCT01691534|3663215|P2|STARTED|Overall Study||15
1497365|NCT01691534|3663216|P1|STARTED|Overall Study||15
1497366|NCT01691521|3663270|P3|NOT COMPLETED|Overall Study||9
1497367|NCT01691521|3663271|P2|NOT COMPLETED|Overall Study||16
1497368|NCT01691521|3663272|P1|NOT COMPLETED|Overall Study||12
1497369|NCT01691521|3663270|P3|COMPLETED|Overall Study||185
1497370|NCT01691521|3663271|P2|COMPLETED|Overall Study||175
1497371|NCT01691521|3663272|P1|COMPLETED|Overall Study||179
1497372|NCT01691521|3663270|P3|STARTED|Overall Study||194
1497373|NCT01691521|3663271|P2|STARTED|Overall Study||191
1497374|NCT01691521|3663272|P1|STARTED|Overall Study||191
1497375|NCT01691508|3663294|P2|NOT COMPLETED|Overall Study||3
1497376|NCT01691508|3663295|P1|NOT COMPLETED|Overall Study||4
1497377|NCT01691508|3663294|P2|COMPLETED|Overall Study||66
1497378|NCT01691508|3663295|P1|COMPLETED|Overall Study||62
1497379|NCT01691508|3663294|P2|STARTED|Overall Study||69
1497380|NCT01691508|3663295|P1|STARTED|Overall Study||66
1497381|NCT01691482|3663309|P2|NOT COMPLETED|Treatment Period 2||2
1497382|NCT01691482|3663310|P1|NOT COMPLETED|Treatment Period 2||1
1497383|NCT01691482|3663309|P2|COMPLETED|Treatment Period 2||26
1497384|NCT01691482|3663310|P1|COMPLETED|Treatment Period 2||27
1497385|NCT01691482|3663309|P2|STARTED|Treatment Period 2||28
1497386|NCT01691482|3663310|P1|STARTED|Treatment Period 2||28
1497387|NCT01691482|3663309|P2|NOT COMPLETED|Treatment Period 1||0
1497388|NCT01691482|3663310|P1|NOT COMPLETED|Treatment Period 1||0
1497389|NCT01691482|3663309|P2|COMPLETED|Treatment Period 1||28
1497390|NCT01691482|3663310|P1|COMPLETED|Treatment Period 1||28
1497391|NCT01691482|3663309|P2|STARTED|Treatment Period 1||28
1497392|NCT01691482|3663310|P1|STARTED|Treatment Period 1||28
1497393|NCT01691430|3663328|P2|NOT COMPLETED|Overall Study||20
1497394|NCT01691430|3663329|P1|NOT COMPLETED|Overall Study||22
1497395|NCT01691430|3663328|P2|COMPLETED|Overall Study||73
1497396|NCT01691430|3663329|P1|COMPLETED|Overall Study||70
1497397|NCT01691430|3663328|P2|Received Medication|Overall Study||93
1497398|NCT01691430|3663329|P1|Received Medication|Overall Study||92
1497399|NCT01691430|3663328|P2|STARTED|Overall Study||93
1497400|NCT01691430|3663329|P1|STARTED|Overall Study||92
1497401|NCT01691339|3663357|P4|NOT COMPLETED|Overall Study||0
1497402|NCT01691339|3663358|P3|NOT COMPLETED|Overall Study||0
1497403|NCT01691339|3663359|P2|NOT COMPLETED|Overall Study||0
1497404|NCT01691339|3663360|P1|NOT COMPLETED|Overall Study||0
1497405|NCT01691339|3663357|P4|COMPLETED|Overall Study||49
1497406|NCT01691339|3663358|P3|COMPLETED|Overall Study||51
1497407|NCT01691339|3663359|P2|COMPLETED|Overall Study||50
1497408|NCT01691339|3663360|P1|COMPLETED|Overall Study||50
1497409|NCT01691339|3663357|P4|STARTED|Overall Study||49
1497410|NCT01691339|3663358|P3|STARTED|Overall Study||51
1497411|NCT01691339|3663359|P2|STARTED|Overall Study||50
1497412|NCT01691339|3663360|P1|STARTED|Overall Study||50
1497413|NCT01691326|3663388|P2|NOT COMPLETED|Overall Study||0
1497414|NCT01691326|3663389|P1|NOT COMPLETED|Overall Study||0
1497415|NCT01691326|3663388|P2|COMPLETED|Overall Study||30
1497416|NCT01691326|3663389|P1|COMPLETED|Overall Study||30
1497417|NCT01691326|3663388|P2|STARTED|Overall Study||30
1497418|NCT01691326|3663389|P1|STARTED|Overall Study||30
1497419|NCT01691313|3663407|P4|NOT COMPLETED|Overall Study||0
1497420|NCT01691313|3663408|P3|NOT COMPLETED|Overall Study||0
1497421|NCT01691313|3663409|P2|NOT COMPLETED|Overall Study||0
1497422|NCT01691313|3663410|P1|NOT COMPLETED|Overall Study||0
1497423|NCT01691313|3663407|P4|COMPLETED|Overall Study||25
1497424|NCT01691313|3663408|P3|COMPLETED|Overall Study||25
1497425|NCT01691313|3663409|P2|COMPLETED|Overall Study||32
1497426|NCT01691313|3663410|P1|COMPLETED|Overall Study||22
1497427|NCT01691313|3663407|P4|STARTED|Overall Study||25
1497428|NCT01691313|3663408|P3|STARTED|Overall Study||25
1497429|NCT01691313|3663409|P2|STARTED|Overall Study||32
1497430|NCT01691313|3663410|P1|STARTED|Overall Study||22
1497431|NCT01691248|3663426|P2|NOT COMPLETED|Overall Study||114
1497432|NCT01691248|3663427|P1|NOT COMPLETED|Overall Study||111
1497433|NCT01691248|3663426|P2|COMPLETED|Overall Study||192
1497434|NCT01691248|3663427|P1|COMPLETED|Overall Study||194
1497435|NCT01691248|3663426|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
1497436|NCT01691248|3663427|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
1497437|NCT01691248|3663426|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
1497438|NCT01691248|3663427|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
1497439|NCT01691248|3663426|P2|STARTED|Overall Study|Randomized|306
1497440|NCT01691248|3663427|P1|STARTED|Overall Study|Randomized|305
1497441|NCT01691105|3663439|P2|NOT COMPLETED|12 Month Biochemical Verification||502
1497442|NCT01691105|3663440|P1|NOT COMPLETED|12 Month Biochemical Verification||424
1497443|NCT01691105|3663439|P2|COMPLETED|12 Month Biochemical Verification||65
1497444|NCT01691105|3663440|P1|COMPLETED|12 Month Biochemical Verification||53
1497445|NCT01691105|3663439|P2|STARTED|12 Month Biochemical Verification||567
1497446|NCT01691105|3663440|P1|STARTED|12 Month Biochemical Verification||477
1497447|NCT01691105|3663439|P2|NOT COMPLETED|12 Month Follow-up||101
1497448|NCT01691105|3663440|P1|NOT COMPLETED|12 Month Follow-up||72
1497449|NCT01691105|3663439|P2|COMPLETED|12 Month Follow-up||466
1497450|NCT01691105|3663440|P1|COMPLETED|12 Month Follow-up||405
1497451|NCT01691105|3663439|P2|STARTED|12 Month Follow-up||567
1497452|NCT01691105|3663440|P1|STARTED|12 Month Follow-up||477
1497453|NCT01691105|3663439|P2|NOT COMPLETED|6 Month Follow-up||71
1497454|NCT01691105|3663440|P1|NOT COMPLETED|6 Month Follow-up||52
1497455|NCT01691105|3663439|P2|COMPLETED|6 Month Follow-up||496
1497456|NCT01691105|3663440|P1|COMPLETED|6 Month Follow-up||425
1497457|NCT01691105|3663439|P2|STARTED|6 Month Follow-up||567
1497458|NCT01691105|3663440|P1|STARTED|6 Month Follow-up||477
1497459|NCT01691105|3663439|P2|NOT COMPLETED|1 Month Follow-up||41
1497460|NCT01691105|3663440|P1|NOT COMPLETED|1 Month Follow-up||43
1497461|NCT01691105|3663439|P2|COMPLETED|1 Month Follow-up||526
1497462|NCT01691105|3663440|P1|COMPLETED|1 Month Follow-up||434
1497463|NCT01691105|3663439|P2|STARTED|1 Month Follow-up||567
1497464|NCT01691105|3663440|P1|STARTED|1 Month Follow-up||477
1497465|NCT01691105|3663439|P2|NOT COMPLETED|Baseline||0
1497466|NCT01691105|3663440|P1|NOT COMPLETED|Baseline||0
1497467|NCT01691105|3663439|P2|COMPLETED|Baseline||567
1497468|NCT01691105|3663440|P1|COMPLETED|Baseline||477
1497469|NCT01691105|3663439|P2|STARTED|Baseline||567
1497470|NCT01691105|3663440|P1|STARTED|Baseline||477
1497471|NCT01691092|3663460|P1|NOT COMPLETED|Overall Study||41
1497472|NCT01691092|3663460|P1|COMPLETED|Overall Study||38
1497473|NCT01691092|3663460|P1|STARTED|Overall Study||79
1497474|NCT01691027|3663464|P1|NOT COMPLETED|Video Games Training||0
1497475|NCT01691027|3663464|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
1497476|NCT01691027|3663464|P1|STARTED|Video Games Training|Four subjects started video game training module|4
1497477|NCT01691027|3663464|P1|NOT COMPLETED|Line and Circle Tracing Training||0
1497478|NCT01691027|3663464|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
1497479|NCT01691027|3663464|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
1497480|NCT01691027|3663464|P1|NOT COMPLETED|Scotoma Awareness||0
1497481|NCT01691027|3663464|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
1497482|NCT01691027|3663464|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
1497483|NCT01691014|3663473|P4|NOT COMPLETED|Overall Study||5
1497484|NCT01691014|3663474|P3|NOT COMPLETED|Overall Study||11
1497485|NCT01691014|3663475|P2|NOT COMPLETED|Overall Study||15
1497486|NCT01691014|3663476|P1|NOT COMPLETED|Overall Study||3
1497487|NCT01691014|3663473|P4|COMPLETED|Overall Study||4
1497488|NCT01691014|3663474|P3|COMPLETED|Overall Study||25
1497489|NCT01691014|3663475|P2|COMPLETED|Overall Study||11
1497490|NCT01691014|3663476|P1|COMPLETED|Overall Study||5
1497491|NCT01691014|3663473|P4|STARTED|Overall Study||9
1497492|NCT01691014|3663474|P3|STARTED|Overall Study||36
1497493|NCT01691014|3663475|P2|STARTED|Overall Study||26
1497494|NCT01691014|3663476|P1|STARTED|Overall Study||8
1497495|NCT01690988|3663521|P3|NOT COMPLETED|Overall Study||7
1497496|NCT01690988|3663522|P2|NOT COMPLETED|Overall Study||5
1497497|NCT01690988|3663523|P1|NOT COMPLETED|Overall Study||6
1497498|NCT01690988|3663521|P3|COMPLETED|Overall Study||216
1497499|NCT01690988|3663522|P2|COMPLETED|Overall Study||217
1497500|NCT01690988|3663523|P1|COMPLETED|Overall Study||221
1497501|NCT01690988|3663521|P3|STARTED|Overall Study||223
1497502|NCT01690988|3663522|P2|STARTED|Overall Study||222
1497503|NCT01690988|3663523|P1|STARTED|Overall Study||227
1497504|NCT01690923|3663548|P2|NOT COMPLETED|Overall Study||1
1497505|NCT01690923|3663549|P1|NOT COMPLETED|Overall Study||0
1497506|NCT01690923|3663548|P2|COMPLETED|Overall Study||10
1497507|NCT01690923|3663549|P1|COMPLETED|Overall Study||10
1497508|NCT01690923|3663548|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
1497509|NCT01690923|3663549|P1|STARTED|Overall Study||10
1497510|NCT01690663|3663558|P4|NOT COMPLETED|Overall Study||4
1497511|NCT01690663|3663559|P3|NOT COMPLETED|Overall Study||3
1497512|NCT01690663|3663560|P2|NOT COMPLETED|Overall Study||3
1497513|NCT01690663|3663561|P1|NOT COMPLETED|Overall Study||3
1497514|NCT01690663|3663558|P4|COMPLETED|Overall Study||20
1497515|NCT01690663|3663559|P3|COMPLETED|Overall Study||19
1497516|NCT01690663|3663560|P2|COMPLETED|Overall Study||17
1497517|NCT01690663|3663561|P1|COMPLETED|Overall Study||20
1497518|NCT01690663|3663558|P4|STARTED|Overall Study||24
1497519|NCT01690663|3663559|P3|STARTED|Overall Study||22
1497520|NCT01690663|3663560|P2|STARTED|Overall Study||20
1497521|NCT01690663|3663561|P1|STARTED|Overall Study||23
1497522|NCT01690546|3663575|P1|NOT COMPLETED|Overall Study||9
1497523|NCT01690546|3663575|P1|COMPLETED|Overall Study||26
1497524|NCT01690546|3663575|P1|Extended Release Injectable NTX|Overall Study||27
1497525|NCT01690546|3663575|P1|STARTED|Overall Study||35
1497526|NCT01690299|3663591|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
1497527|NCT01690299|3663592|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
1497528|NCT01690299|3663593|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
1497529|NCT01690299|3663594|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1497530|NCT01690299|3663595|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1497531|NCT01690299|3663596|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1497532|NCT01690299|3663591|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
1497533|NCT01690299|3663592|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
1497534|NCT01690299|3663593|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
1497535|NCT01690299|3663594|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1497536|NCT01690299|3663595|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1497537|NCT01690299|3663596|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
1497538|NCT01690299|3663591|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
1497539|NCT01690299|3663592|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
1497540|NCT01690299|3663593|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
1497541|NCT01690299|3663594|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
1497542|NCT01690299|3663595|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
1497543|NCT01690299|3663596|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
1497544|NCT01690299|3663591|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
1497545|NCT01690299|3663592|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
1497546|NCT01690299|3663593|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
1497547|NCT01690299|3663594|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
1497548|NCT01690299|3663595|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
1497549|NCT01690299|3663596|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
1497550|NCT01690299|3663591|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1497551|NCT01690299|3663592|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1497552|NCT01690299|3663593|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1497553|NCT01690299|3663594|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
1497554|NCT01690299|3663595|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
1497555|NCT01690299|3663596|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
1497556|NCT01690299|3663591|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1497557|NCT01690299|3663592|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1497558|NCT01690299|3663593|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
1497559|NCT01690299|3663594|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
1497560|NCT01690299|3663595|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
1497561|NCT01690299|3663596|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
1497562|NCT01690299|3663591|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
1497563|NCT01690299|3663592|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
1497564|NCT01690299|3663593|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
1497565|NCT01690299|3663594|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
1497566|NCT01690299|3663595|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
1497567|NCT01690299|3663596|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
1497568|NCT01690299|3663591|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
1497569|NCT01690299|3663592|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
1497570|NCT01690299|3663593|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
1497571|NCT01690299|3663594|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
1497572|NCT01690299|3663595|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
1497573|NCT01690299|3663596|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
1497574|NCT01690273|3663641|P3|NOT COMPLETED|Overall Study||0
1497575|NCT01690273|3663642|P2|NOT COMPLETED|Overall Study||0
1497576|NCT01690273|3663643|P1|NOT COMPLETED|Overall Study||0
1497577|NCT01690273|3663641|P3|COMPLETED|Overall Study||20
1497578|NCT01690273|3663642|P2|COMPLETED|Overall Study||17
1497579|NCT01690273|3663643|P1|COMPLETED|Overall Study||18
1497580|NCT01690273|3663641|P3|STARTED|Overall Study||20
1497581|NCT01690273|3663642|P2|STARTED|Overall Study||17
1497582|NCT01690273|3663643|P1|STARTED|Overall Study||18
1497583|NCT01690143|3663693|P1|NOT COMPLETED|Overall Study||1
1497584|NCT01690143|3663693|P1|COMPLETED|Overall Study||44
1497585|NCT01690143|3663693|P1|STARTED|Overall Study||45
1497586|NCT01690130|3663703|P2|NOT COMPLETED|Overall Study||0
1497587|NCT01690130|3663704|P1|NOT COMPLETED|Overall Study||1
1497588|NCT01690130|3663703|P2|COMPLETED|Overall Study||9
1497589|NCT01690130|3663704|P1|COMPLETED|Overall Study||9
1497590|NCT01690130|3663703|P2|STARTED|Overall Study||9
1497591|NCT01690130|3663704|P1|STARTED|Overall Study||10
1497592|NCT01690117|3663714|P2|NOT COMPLETED|Overall Study||14
1497593|NCT01690117|3663715|P1|NOT COMPLETED|Overall Study||16
1497594|NCT01690117|3663714|P2|COMPLETED|Overall Study||31
1497595|NCT01690117|3663715|P1|COMPLETED|Overall Study||31
1497596|NCT01690117|3663714|P2|Post-Measurement|Overall Study||40
1497597|NCT01690117|3663715|P1|Post-Measurement|Overall Study||41
1497598|NCT01690117|3663714|P2|STARTED|Overall Study||45
1497599|NCT01690117|3663715|P1|STARTED|Overall Study||47
1497600|NCT01690052|3663751|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
1497601|NCT01690052|3663752|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
1497602|NCT01690052|3663751|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
1497603|NCT01690052|3663752|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
1497604|NCT01690052|3663751|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
1497605|NCT01690052|3663752|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
1497606|NCT01690052|3663751|P2|NOT COMPLETED|Washout Period of 1 Week||0
1497607|NCT01690052|3663752|P1|NOT COMPLETED|Washout Period of 1 Week||0
1497608|NCT01690052|3663751|P2|COMPLETED|Washout Period of 1 Week||6
1497609|NCT01690052|3663752|P1|COMPLETED|Washout Period of 1 Week||6
1497610|NCT01690052|3663751|P2|STARTED|Washout Period of 1 Week||6
1497611|NCT01690052|3663752|P1|STARTED|Washout Period of 1 Week||6
1497612|NCT01690052|3663751|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
1497613|NCT01690052|3663752|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
1497614|NCT01690052|3663751|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
1497615|NCT01690052|3663752|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
1497616|NCT01690052|3663751|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
1497617|NCT01690052|3663752|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
1497618|NCT01690000|3663760|P2|NOT COMPLETED|Overall Study||6
1497619|NCT01690000|3663761|P1|NOT COMPLETED|Overall Study||3
1497620|NCT01690000|3663760|P2|COMPLETED|Overall Study||35
1497621|NCT01690000|3663761|P1|COMPLETED|Overall Study||37
1497622|NCT01690000|3663760|P2|STARTED|Overall Study||41
1497623|NCT01690000|3663761|P1|STARTED|Overall Study||40
1497624|NCT01689974|3663769|P2|NOT COMPLETED|Overall Study||5
1497625|NCT01689974|3663770|P1|NOT COMPLETED|Overall Study||5
1497626|NCT01689974|3663769|P2|COMPLETED|Overall Study||0
1497627|NCT01689974|3663770|P1|COMPLETED|Overall Study||0
1497628|NCT01689974|3663769|P2|STARTED|Overall Study||5
1497629|NCT01689974|3663770|P1|STARTED|Overall Study||5
1497630|NCT01689909|3663778|P2|NOT COMPLETED|Overall Study||0
1497631|NCT01689909|3663779|P1|NOT COMPLETED|Overall Study||0
1497632|NCT01689909|3663778|P2|COMPLETED|Overall Study||52
1497633|NCT01689909|3663779|P1|COMPLETED|Overall Study||51
1497634|NCT01689909|3663778|P2|STARTED|Overall Study||52
1497635|NCT01689909|3663779|P1|STARTED|Overall Study||51
1497636|NCT01689857|3663799|P2|NOT COMPLETED|Overall Study||2
1497637|NCT01689857|3663800|P1|NOT COMPLETED|Overall Study||5
1497638|NCT01689857|3663799|P2|COMPLETED|Overall Study||18
1497639|NCT01689857|3663800|P1|COMPLETED|Overall Study||15
1497640|NCT01689857|3663799|P2|STARTED|Overall Study||20
1497641|NCT01689857|3663800|P1|STARTED|Overall Study||20
1497642|NCT01689779|3663808|P2|NOT COMPLETED|Overall Study||0
1497643|NCT01689779|3663809|P1|NOT COMPLETED|Overall Study||0
1497644|NCT01689779|3663808|P2|COMPLETED|Overall Study||32
1497645|NCT01689779|3663809|P1|COMPLETED|Overall Study||28
1497646|NCT01689779|3663808|P2|STARTED|Overall Study||32
1497647|NCT01689779|3663809|P1|STARTED|Overall Study||28
1497648|NCT01689649|3663825|P1|NOT COMPLETED|Overall Study||22
1497649|NCT01689649|3663825|P1|COMPLETED|Overall Study||117
1497650|NCT01689649|3663825|P1|STARTED|Overall Study||139
1497651|NCT01689532|3663837|P2|NOT COMPLETED|Overall Study||9
1497652|NCT01689532|3663838|P1|NOT COMPLETED|Overall Study||14
1497653|NCT01689532|3663837|P2|COMPLETED|Overall Study||52
1497654|NCT01689532|3663838|P1|COMPLETED|Overall Study||47
1497655|NCT01689532|3663837|P2|STARTED|Overall Study||61
1497656|NCT01689532|3663838|P1|STARTED|Overall Study||61
1497657|NCT01689519|3663902|P2|NOT COMPLETED|Overall Study||138
1497658|NCT01689519|3663903|P1|NOT COMPLETED|Overall Study||166
1497659|NCT01689519|3663902|P2|COMPLETED|Overall Study||109
1497660|NCT01689519|3663903|P1|COMPLETED|Overall Study||82
1497661|NCT01689519|3663902|P2|Received Treatment|Overall Study||246
1497662|NCT01689519|3663903|P1|Received Treatment|Overall Study||247
1497663|NCT01689519|3663902|P2|STARTED|Overall Study||247
1497664|NCT01689519|3663903|P1|STARTED|Overall Study||248
1497665|NCT01689441|3663919|P2|NOT COMPLETED|Overall Study||0
1497666|NCT01689441|3663920|P1|NOT COMPLETED|Overall Study||0
1497667|NCT01689441|3663919|P2|COMPLETED|Overall Study||31
1497668|NCT01689441|3663920|P1|COMPLETED|Overall Study||36
1497669|NCT01689441|3663919|P2|STARTED|Overall Study||31
1497670|NCT01689441|3663920|P1|STARTED|Overall Study||36
1497671|NCT01689363|3663930|P8|NOT COMPLETED|Overall Study||0
1497672|NCT01689363|3663931|P7|NOT COMPLETED|Overall Study||0
1497673|NCT01689363|3663932|P6|NOT COMPLETED|Overall Study||0
1497674|NCT01689363|3663933|P5|NOT COMPLETED|Overall Study||0
1497675|NCT01689363|3663934|P4|NOT COMPLETED|Overall Study||0
1497676|NCT01689363|3663935|P3|NOT COMPLETED|Overall Study||0
1497677|NCT01689363|3663936|P2|NOT COMPLETED|Overall Study||1
1497678|NCT01689363|3663937|P1|NOT COMPLETED|Overall Study||0
1497679|NCT01689363|3663930|P8|COMPLETED|Overall Study||32
1497680|NCT01689363|3663931|P7|COMPLETED|Overall Study||32
1497681|NCT01689363|3663932|P6|COMPLETED|Overall Study||31
1497682|NCT01689363|3663933|P5|COMPLETED|Overall Study||31
1497683|NCT01689363|3663934|P4|COMPLETED|Overall Study||31
1497684|NCT01689363|3663935|P3|COMPLETED|Overall Study||32
1497685|NCT01689363|3663936|P2|COMPLETED|Overall Study||31
1497686|NCT01689363|3663937|P1|COMPLETED|Overall Study||32
1497687|NCT01689363|3663930|P8|STARTED|Overall Study||32
1497688|NCT01689363|3663931|P7|STARTED|Overall Study||32
1497689|NCT01689363|3663932|P6|STARTED|Overall Study||31
1497690|NCT01689363|3663933|P5|STARTED|Overall Study||31
1497691|NCT01689363|3663934|P4|STARTED|Overall Study||31
1497692|NCT01689363|3663935|P3|STARTED|Overall Study||32
1497693|NCT01689363|3663936|P2|STARTED|Overall Study||32
1497694|NCT01689363|3663937|P1|STARTED|Overall Study||32
1497695|NCT01689350|3663983|P2|NOT COMPLETED|Overall Study||0
1497696|NCT01689350|3663984|P1|NOT COMPLETED|Overall Study||0
1497697|NCT01689350|3663983|P2|COMPLETED|Overall Study||45
1497698|NCT01689350|3663984|P1|COMPLETED|Overall Study||47
1497699|NCT01689350|3663983|P2|STARTED|Overall Study||45
1497700|NCT01689350|3663984|P1|STARTED|Overall Study||47
1497701|NCT01689337|3663992|P1|NOT COMPLETED|Overall Study||1
1497702|NCT01689337|3663992|P1|COMPLETED|Overall Study||0
1497703|NCT01689337|3663992|P1|STARTED|Overall Study||1
1497704|NCT01689324|3664007|P1|NOT COMPLETED|Overall Study||0
1497705|NCT01689324|3664007|P1|COMPLETED|Overall Study||43
1497706|NCT01689324|3664007|P1|STARTED|Overall Study||43
1497707|NCT01689207|3664031|P11|NOT COMPLETED|Overall Study||0
1497708|NCT01689207|3664032|P10|NOT COMPLETED|Overall Study||0
1497709|NCT01689207|3664033|P9|NOT COMPLETED|Overall Study||1
1497710|NCT01689207|3664034|P8|NOT COMPLETED|Overall Study||0
1497711|NCT01689207|3664035|P7|NOT COMPLETED|Overall Study||0
1497712|NCT01689207|3664036|P6|NOT COMPLETED|Overall Study||1
1497713|NCT01689207|3664037|P5|NOT COMPLETED|Overall Study||2
1497714|NCT01689207|3664038|P4|NOT COMPLETED|Overall Study||0
1497715|NCT01689207|3664039|P3|NOT COMPLETED|Overall Study||0
1497716|NCT01689207|3664040|P2|NOT COMPLETED|Overall Study||1
1497717|NCT01689207|3664041|P1|NOT COMPLETED|Overall Study||0
1497718|NCT01689207|3664031|P11|COMPLETED|Overall Study|Subjects completed study|8
1497719|NCT01689207|3664032|P10|COMPLETED|Overall Study|Subjects completed study|10
1497720|NCT01689207|3664033|P9|COMPLETED|Overall Study|Subjects completed study|5
1497721|NCT01689207|3664034|P8|COMPLETED|Overall Study|Subjects completed study|10
1497722|NCT01689207|3664035|P7|COMPLETED|Overall Study|Subjects completed study|10
1497723|NCT01689207|3664036|P6|COMPLETED|Overall Study|Subjects completed study|7
1497724|NCT01689207|3664037|P5|COMPLETED|Overall Study|Subjects completed study|2
1497725|NCT01689207|3664038|P4|COMPLETED|Overall Study|Subjects completed study|8
1497726|NCT01689207|3664039|P3|COMPLETED|Overall Study|Subjects completed study|16
1497727|NCT01689207|3664040|P2|COMPLETED|Overall Study|Subjects completed study|7
1497728|NCT01689207|3664041|P1|COMPLETED|Overall Study|Subjects completed study|4
1497729|NCT01689207|3664031|P11|STARTED|Overall Study|Subjects randomised|8
1497730|NCT01689207|3664032|P10|STARTED|Overall Study|Subjects randomised|10
1497731|NCT01689207|3664033|P9|STARTED|Overall Study|Subjects randomised|6
1497732|NCT01689207|3664034|P8|STARTED|Overall Study|Subjects randomised|10
1497733|NCT01689207|3664035|P7|STARTED|Overall Study|Subjects randomised|10
1497734|NCT01689207|3664036|P6|STARTED|Overall Study|Subjects randomised|8
1497735|NCT01689207|3664037|P5|STARTED|Overall Study|Subjects randomised|4
1497736|NCT01689207|3664038|P4|STARTED|Overall Study|Subjects randomised|8
1497737|NCT01689207|3664039|P3|STARTED|Overall Study|Subjects randomised|16
1497738|NCT01689207|3664040|P2|STARTED|Overall Study|Subjects randomised|8
1497739|NCT01689207|3664041|P1|STARTED|Overall Study|Subjects randomised|4
1497740|NCT01689155|3664137|P1|NOT COMPLETED|Overall Study||0
1497741|NCT01689155|3664137|P1|COMPLETED|Overall Study||116
1497742|NCT01689155|3664137|P1|STARTED|Overall Study||116
1497743|NCT01688921|3664148|P2|NOT COMPLETED|Overall Study||15
1497744|NCT01688921|3664149|P1|NOT COMPLETED|Overall Study||16
1497745|NCT01688921|3664148|P2|COMPLETED|Overall Study||608
1497746|NCT01688921|3664149|P1|COMPLETED|Overall Study||611
1497747|NCT01688921|3664148|P2|STARTED|Overall Study||623
1497748|NCT01688921|3664149|P1|STARTED|Overall Study||627
1497749|NCT01688882|3664174|P2|NOT COMPLETED|Overall Study||1
1497750|NCT01688882|3664175|P1|NOT COMPLETED|Overall Study||3
1497751|NCT01688882|3664174|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
1497752|NCT01688882|3664175|P1|COMPLETED|Overall Study||10
1497753|NCT01688882|3664174|P2|Safety Follow-up|Overall Study||5
1497754|NCT01688882|3664175|P1|Safety Follow-up|Overall Study||11
1497755|NCT01688882|3664174|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
1497756|NCT01688882|3664175|P1|STARTED|Overall Study||13
1497757|NCT01688843|3664189|P1|NOT COMPLETED|Overall Study||0
1497758|NCT01688843|3664189|P1|COMPLETED|Overall Study||1060
1497759|NCT01688843|3664189|P1|STARTED|Overall Study||1060
1497760|NCT01688830|3664220|P21|NOT COMPLETED|Overall Study||0
1497761|NCT01688830|3664221|P20|NOT COMPLETED|Overall Study||0
1497762|NCT01688830|3664222|P19|NOT COMPLETED|Overall Study||0
1497763|NCT01688830|3664223|P18|NOT COMPLETED|Overall Study||0
1497764|NCT01688830|3664224|P17|NOT COMPLETED|Overall Study||0
1497765|NCT01688830|3664225|P16|NOT COMPLETED|Overall Study||0
1497766|NCT01688830|3664226|P15|NOT COMPLETED|Overall Study||0
1497767|NCT01688830|3664227|P14|NOT COMPLETED|Overall Study||0
1497768|NCT01688830|3664228|P13|NOT COMPLETED|Overall Study||0
1497769|NCT01688830|3664229|P12|NOT COMPLETED|Overall Study||0
1497770|NCT01688830|3664230|P11|NOT COMPLETED|Overall Study||1
1497771|NCT01688830|3664231|P10|NOT COMPLETED|Overall Study||0
1497772|NCT01688830|3664232|P9|NOT COMPLETED|Overall Study||0
1497773|NCT01688830|3664233|P8|NOT COMPLETED|Overall Study||0
1497774|NCT01688830|3664234|P7|NOT COMPLETED|Overall Study||0
1497775|NCT01688830|3664235|P6|NOT COMPLETED|Overall Study||0
1497776|NCT01688830|3664236|P5|NOT COMPLETED|Overall Study||0
1497777|NCT01688830|3664237|P4|NOT COMPLETED|Overall Study||0
1497778|NCT01688830|3664238|P3|NOT COMPLETED|Overall Study||0
1497779|NCT01688830|3664239|P2|NOT COMPLETED|Overall Study||0
1497780|NCT01688830|3664240|P1|NOT COMPLETED|Overall Study||0
1497781|NCT01688830|3664220|P21|COMPLETED|Overall Study||9
1497782|NCT01688830|3664221|P20|COMPLETED|Overall Study||3
1497783|NCT01688830|3664222|P19|COMPLETED|Overall Study||8
1497784|NCT01688830|3664223|P18|COMPLETED|Overall Study||9
1497785|NCT01688830|3664224|P17|COMPLETED|Overall Study||9
1497786|NCT01688830|3664225|P16|COMPLETED|Overall Study||9
1497787|NCT01688830|3664226|P15|COMPLETED|Overall Study||6
1497788|NCT01688830|3664227|P14|COMPLETED|Overall Study||6
1497789|NCT01688830|3664228|P13|COMPLETED|Overall Study||6
1497790|NCT01688830|3664229|P12|COMPLETED|Overall Study||6
1497791|NCT01688830|3664230|P11|COMPLETED|Overall Study||5
1497792|NCT01688830|3664231|P10|COMPLETED|Overall Study||6
1497793|NCT01688830|3664232|P9|COMPLETED|Overall Study||6
1497794|NCT01688830|3664233|P8|COMPLETED|Overall Study||6
1497795|NCT01688830|3664234|P7|COMPLETED|Overall Study||12
1497796|NCT01688830|3664235|P6|COMPLETED|Overall Study||6
1497797|NCT01688830|3664236|P5|COMPLETED|Overall Study||5
1497798|NCT01688830|3664237|P4|COMPLETED|Overall Study||6
1497799|NCT01688830|3664238|P3|COMPLETED|Overall Study||6
1497800|NCT01688830|3664239|P2|COMPLETED|Overall Study||6
1497801|NCT01688830|3664240|P1|COMPLETED|Overall Study||21
1497802|NCT01688830|3664220|P21|STARTED|Overall Study||9
1497803|NCT01688830|3664221|P20|STARTED|Overall Study||3
1497804|NCT01688830|3664222|P19|STARTED|Overall Study||8
1497805|NCT01688830|3664223|P18|STARTED|Overall Study||9
1497806|NCT01688830|3664224|P17|STARTED|Overall Study||9
1497807|NCT01688830|3664225|P16|STARTED|Overall Study||9
1497808|NCT01688830|3664226|P15|STARTED|Overall Study||6
1497809|NCT01688830|3664227|P14|STARTED|Overall Study||6
1497810|NCT01688830|3664228|P13|STARTED|Overall Study||6
1497811|NCT01688830|3664229|P12|STARTED|Overall Study||6
1497812|NCT01688830|3664230|P11|STARTED|Overall Study||6
1497813|NCT01688830|3664231|P10|STARTED|Overall Study||6
1497814|NCT01688830|3664232|P9|STARTED|Overall Study||6
1497815|NCT01688830|3664233|P8|STARTED|Overall Study||6
1497816|NCT01688830|3664234|P7|STARTED|Overall Study||12
1497817|NCT01688830|3664235|P6|STARTED|Overall Study||6
1497818|NCT01688830|3664236|P5|STARTED|Overall Study||5
1497819|NCT01688830|3664237|P4|STARTED|Overall Study||6
1497820|NCT01688830|3664238|P3|STARTED|Overall Study||6
1497821|NCT01688830|3664239|P2|STARTED|Overall Study||6
1497822|NCT01688830|3664240|P1|STARTED|Overall Study||21
1497823|NCT01688726|3664386|P2|NOT COMPLETED|Overall Study||1
1497824|NCT01688726|3664387|P1|NOT COMPLETED|Overall Study||1
1497825|NCT01688726|3664386|P2|COMPLETED|Overall Study||44
1497826|NCT01688726|3664387|P1|COMPLETED|Overall Study||45
1497827|NCT01688726|3664386|P2|STARTED|Overall Study||45
1497828|NCT01688726|3664387|P1|STARTED|Overall Study||46
1497829|NCT01688635|3664399|P2|NOT COMPLETED|Period 4||0
1497830|NCT01688635|3664400|P1|NOT COMPLETED|Period 4||0
1497831|NCT01688635|3664399|P2|COMPLETED|Period 4||42
1497832|NCT01688635|3664400|P1|COMPLETED|Period 4||40
1497833|NCT01688635|3664399|P2|STARTED|Period 4||42
1497834|NCT01688635|3664400|P1|STARTED|Period 4||40
1497835|NCT01688635|3664399|P2|NOT COMPLETED|Washout 3||0
1497836|NCT01688635|3664400|P1|NOT COMPLETED|Washout 3||1
1497837|NCT01688635|3664399|P2|COMPLETED|Washout 3||42
1497838|NCT01688635|3664400|P1|COMPLETED|Washout 3||40
1497839|NCT01688635|3664399|P2|STARTED|Washout 3||42
1497840|NCT01688635|3664400|P1|STARTED|Washout 3||41
1497841|NCT01688635|3664399|P2|NOT COMPLETED|Period 3||0
1497842|NCT01688635|3664400|P1|NOT COMPLETED|Period 3||0
1497843|NCT01688635|3664399|P2|COMPLETED|Period 3||42
1497844|NCT01688635|3664400|P1|COMPLETED|Period 3||41
1497845|NCT01688635|3664399|P2|STARTED|Period 3||42
1497846|NCT01688635|3664400|P1|STARTED|Period 3||41
1497847|NCT01688635|3664399|P2|NOT COMPLETED|Washout 2||2
1497848|NCT01688635|3664400|P1|NOT COMPLETED|Washout 2||3
1497849|NCT01688635|3664399|P2|COMPLETED|Washout 2||42
1497850|NCT01688635|3664400|P1|COMPLETED|Washout 2||41
1497851|NCT01688635|3664399|P2|STARTED|Washout 2||44
1497852|NCT01688635|3664400|P1|STARTED|Washout 2||44
1497853|NCT01688635|3664399|P2|NOT COMPLETED|Period 2||0
1497854|NCT01688635|3664400|P1|NOT COMPLETED|Period 2||0
1497855|NCT01688635|3664399|P2|COMPLETED|Period 2||44
1497856|NCT01688635|3664400|P1|COMPLETED|Period 2||44
1497857|NCT01688635|3664399|P2|STARTED|Period 2||44
1497858|NCT01688635|3664400|P1|STARTED|Period 2||44
1497859|NCT01688635|3664399|P2|NOT COMPLETED|Washout 1||2
1497860|NCT01688635|3664400|P1|NOT COMPLETED|Washout 1||1
1497861|NCT01688635|3664399|P2|COMPLETED|Washout 1||44
1497862|NCT01688635|3664400|P1|COMPLETED|Washout 1||44
1497863|NCT01688635|3664399|P2|STARTED|Washout 1||46
1497864|NCT01688635|3664400|P1|STARTED|Washout 1||45
1497865|NCT01688635|3664399|P2|NOT COMPLETED|Period 1||0
1497866|NCT01688635|3664400|P1|NOT COMPLETED|Period 1||0
1497867|NCT01688635|3664399|P2|COMPLETED|Period 1||46
1497868|NCT01688635|3664400|P1|COMPLETED|Period 1||45
1497869|NCT01688635|3664399|P2|Received at Least 1 Dose of Study Drug|Period 1||46
1497870|NCT01688635|3664400|P1|Received at Least 1 Dose of Study Drug|Period 1||45
1497871|NCT01688635|3664399|P2|STARTED|Period 1||46
1497872|NCT01688635|3664400|P1|STARTED|Period 1||45
1497873|NCT01688609|3664412|P1|NOT COMPLETED|Overall Study||0
1497874|NCT01688609|3664412|P1|COMPLETED|Overall Study||18
1497875|NCT01688609|3664412|P1|STARTED|Overall Study||18
1497876|NCT01688466|3664422|P2|NOT COMPLETED|Overall Study||7
1497877|NCT01688466|3664423|P1|NOT COMPLETED|Overall Study||2
1497878|NCT01688466|3664422|P2|COMPLETED|Overall Study||10
1497879|NCT01688466|3664423|P1|COMPLETED|Overall Study||15
1497880|NCT01688466|3664422|P2|STARTED|Overall Study||17
1497881|NCT01688466|3664423|P1|STARTED|Overall Study||17
1497882|NCT01688336|3664431|P1|NOT COMPLETED|Overall Study||0
1497883|NCT01688336|3664431|P1|COMPLETED|Overall Study||9
1497884|NCT01688336|3664431|P1|STARTED|Overall Study||9
1497885|NCT01688310|3664443|P2|NOT COMPLETED|Overall Study||0
1497886|NCT01688310|3664444|P1|NOT COMPLETED|Overall Study||0
1497887|NCT01688310|3664443|P2|COMPLETED|Overall Study||100
1497888|NCT01688310|3664444|P1|COMPLETED|Overall Study||100
1497889|NCT01688310|3664443|P2|STARTED|Overall Study||100
1497890|NCT01688310|3664444|P1|STARTED|Overall Study||100
1497891|NCT01688102|3664464|P2|NOT COMPLETED|Overall Study||18
1497892|NCT01688102|3664465|P1|NOT COMPLETED|Overall Study||16
1497893|NCT01688102|3664464|P2|COMPLETED|Overall Study||40
1497894|NCT01688102|3664465|P1|COMPLETED|Overall Study||44
1497895|NCT01688102|3664464|P2|STARTED|Overall Study||58
1497896|NCT01688102|3664465|P1|STARTED|Overall Study||60
1497897|NCT01688050|3664493|P1|NOT COMPLETED|Overall Study||50
1497898|NCT01688050|3664493|P1|COMPLETED|Overall Study||0
1497899|NCT01688050|3664493|P1|30 Days|Overall Study||50
1497900|NCT01688050|3664493|P1|STARTED|Overall Study||50
1497901|NCT01688037|3664502|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
1497902|NCT01688037|3664503|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
1497903|NCT01688037|3664504|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
1497904|NCT01688037|3664502|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
1497905|NCT01688037|3664503|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
1497906|NCT01688037|3664504|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
1497907|NCT01688037|3664502|P3|STARTED|Follow-up Period (Week 12 to 16)||17
1497908|NCT01688037|3664503|P2|STARTED|Follow-up Period (Week 12 to 16)||22
1497909|NCT01688037|3664504|P1|STARTED|Follow-up Period (Week 12 to 16)||42
1497910|NCT01688037|3664502|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
1497911|NCT01688037|3664503|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
1497912|NCT01688037|3664504|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
1497913|NCT01688037|3664502|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
1497914|NCT01688037|3664503|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
1497915|NCT01688037|3664504|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
1497916|NCT01688037|3664502|P3|STARTED|Open-Label Period (Week 6 to 12)||21
1497917|NCT01688037|3664503|P2|STARTED|Open-Label Period (Week 6 to 12)||25
1497918|NCT01688037|3664504|P1|STARTED|Open-Label Period (Week 6 to 12)||47
1497919|NCT01688037|3664502|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
1497920|NCT01688037|3664503|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
1497921|NCT01688037|3664504|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
1497922|NCT01688037|3664502|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
1497923|NCT01688037|3664503|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
1497924|NCT01688037|3664504|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
1497925|NCT01688037|3664502|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
1497926|NCT01688037|3664503|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
1497927|NCT01688037|3664504|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
1497928|NCT01687998|3664520|P2|NOT COMPLETED|Overall Study||120
1497929|NCT01687998|3664521|P1|NOT COMPLETED|Overall Study||112
1497930|NCT01687998|3664520|P2|COMPLETED|Overall Study||5934
1497931|NCT01687998|3664521|P1|COMPLETED|Overall Study||5926
1497932|NCT01687998|3664520|P2|Received at Least One Dose of Study Drug|Overall Study||6052
1497933|NCT01687998|3664521|P1|Received at Least One Dose of Study Drug|Overall Study||6036
1497934|NCT01687998|3664520|P2|STARTED|Overall Study||6054
1497935|NCT01687998|3664521|P1|STARTED|Overall Study||6038
1497936|NCT01687972|3664539|P2|NOT COMPLETED|Overall Study||0
1497937|NCT01687972|3664540|P1|NOT COMPLETED|Overall Study||0
1497938|NCT01687972|3664539|P2|COMPLETED|Overall Study||44
1497939|NCT01687972|3664540|P1|COMPLETED|Overall Study||44
1497940|NCT01687972|3664539|P2|STARTED|Overall Study||44
1497941|NCT01687972|3664540|P1|STARTED|Overall Study||44
1497942|NCT01687790|3664550|P1|NOT COMPLETED|Overall Study||0
1497943|NCT01687790|3664550|P1|COMPLETED|Overall Study||60
1497944|NCT01687790|3664550|P1|STARTED|Overall Study||60
1497945|NCT01687712|3664557|P2|NOT COMPLETED|Cycle 3||24
1497946|NCT01687712|3664558|P1|NOT COMPLETED|Cycle 3||24
1497947|NCT01687712|3664557|P2|COMPLETED|Cycle 3||0
1497948|NCT01687712|3664558|P1|COMPLETED|Cycle 3||4
1497949|NCT01687712|3664557|P2|Clinical Pregnancy|Cycle 3||0
1497950|NCT01687712|3664558|P1|Clinical Pregnancy|Cycle 3||5
1497951|NCT01687712|3664557|P2|Biochemically Pregnant|Cycle 3||2
1497952|NCT01687712|3664558|P1|Biochemically Pregnant|Cycle 3||7
1497953|NCT01687712|3664557|P2|Embryo Transfer|Cycle 3||24
1497954|NCT01687712|3664558|P1|Embryo Transfer|Cycle 3||26
1497955|NCT01687712|3664557|P2|Fertilization Performed|Cycle 3||24
1497956|NCT01687712|3664558|P1|Fertilization Performed|Cycle 3||27
1497957|NCT01687712|3664557|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
1497958|NCT01687712|3664558|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
1497959|NCT01687712|3664557|P2|Received hCG|Cycle 3||24
1497960|NCT01687712|3664558|P1|Received hCG|Cycle 3||27
1497961|NCT01687712|3664557|P2|STARTED|Cycle 3||24
1497962|NCT01687712|3664558|P1|STARTED|Cycle 3||28
1497963|NCT01687712|3664557|P2|NOT COMPLETED|Cycle 2||95
1497964|NCT01687712|3664558|P1|NOT COMPLETED|Cycle 2||93
1497965|NCT01687712|3664557|P2|COMPLETED|Cycle 2||25
1497966|NCT01687712|3664558|P1|COMPLETED|Cycle 2||16
1497967|NCT01687712|3664557|P2|Clinical Pregnancy|Cycle 2||26
1497968|NCT01687712|3664558|P1|Clinical Pregnancy|Cycle 2||17
1497969|NCT01687712|3664557|P2|Biochemical Pregnancy|Cycle 2||43
1497970|NCT01687712|3664558|P1|Biochemical Pregnancy|Cycle 2||35
1497971|NCT01687712|3664557|P2|Embryo Transfer|Cycle 2||117
1497972|NCT01687712|3664558|P1|Embryo Transfer|Cycle 2||101
1497973|NCT01687712|3664557|P2|Fertilization Performed|Cycle 2||119
1497974|NCT01687712|3664558|P1|Fertilization Performed|Cycle 2||106
1497975|NCT01687712|3664557|P2|Oocyte/Ovum Pick Up|Cycle 2||119
1497976|NCT01687712|3664558|P1|Oocyte/Ovum Pick Up|Cycle 2||107
1497977|NCT01687712|3664557|P2|Received hCG|Cycle 2||119
1497978|NCT01687712|3664558|P1|Received hCG|Cycle 2||107
1497979|NCT01687712|3664557|P2|STARTED|Cycle 2||120
1497980|NCT01687712|3664558|P1|STARTED|Cycle 2||109
1497981|NCT01687712|3664557|P2|NOT COMPLETED|Cycle 1||429
1497982|NCT01687712|3664558|P1|NOT COMPLETED|Cycle 1||448
1497983|NCT01687712|3664557|P2|COMPLETED|Cycle 1||122
1497984|NCT01687712|3664558|P1|COMPLETED|Cycle 1||101
1497985|NCT01687712|3664557|P2|Clinical Pregnancy|Cycle 1||138
1497986|NCT01687712|3664558|P1|Clinical Pregnancy|Cycle 1||114
1497987|NCT01687712|3664557|P2|Biochemical Pregnancy|Cycle 1||203
1497988|NCT01687712|3664558|P1|Biochemical Pregnancy|Cycle 1||163
1497989|NCT01687712|3664557|P2|Embryo Transfer|Cycle 1||483
1497990|NCT01687712|3664558|P1|Embryo Transfer|Cycle 1||466
1497991|NCT01687712|3664557|P2|Fertilization Performed|Cycle 1||512
1497992|NCT01687712|3664558|P1|Fertilization Performed|Cycle 1||508
1497993|NCT01687712|3664557|P2|Oocyte/Ovum Pick Up|Cycle 1||517
1497994|NCT01687712|3664558|P1|Oocyte/Ovum Pick Up|Cycle 1||513
1497995|NCT01687712|3664557|P2|Received hCG|Cycle 1||520
1497996|NCT01687712|3664558|P1|Received hCG|Cycle 1||516
1497997|NCT01687712|3664557|P2|STARTED|Cycle 1||551
1497998|NCT01687712|3664558|P1|STARTED|Cycle 1||549
1497999|NCT01687478|3664598|P2|NOT COMPLETED|Overall Study||39
1498000|NCT01687478|3664599|P1|NOT COMPLETED|Overall Study||32
1498001|NCT01687478|3664598|P2|COMPLETED|Overall Study||49
1498002|NCT01687478|3664599|P1|COMPLETED|Overall Study||56
1498003|NCT01687478|3664598|P2|Safety Analysis Set|Overall Study||87
1498004|NCT01687478|3664599|P1|Safety Analysis Set|Overall Study||88
1498005|NCT01687478|3664598|P2|STARTED|Overall Study||88
1498006|NCT01687478|3664599|P1|STARTED|Overall Study||88
1498007|NCT01687400|3664621|P1|NOT COMPLETED|Overall Study||0
1498008|NCT01687400|3664621|P1|COMPLETED|Overall Study||114
1498009|NCT01687400|3664621|P1|STARTED|Overall Study||114
1498010|NCT01687296|3664634|P2|NOT COMPLETED|Overall Study||5
1498011|NCT01687296|3664635|P1|NOT COMPLETED|Overall Study||7
1498012|NCT01687296|3664634|P2|COMPLETED|Overall Study||123
1498013|NCT01687296|3664635|P1|COMPLETED|Overall Study||116
1498014|NCT01687296|3664634|P2|STARTED|Overall Study||128
1498015|NCT01687296|3664635|P1|STARTED|Overall Study||123
1498016|NCT01687283|3664657|P2|NOT COMPLETED|Overall Study||27
1498017|NCT01687283|3664658|P1|NOT COMPLETED|Overall Study||35
1498018|NCT01687283|3664657|P2|COMPLETED|Overall Study||130
1498019|NCT01687283|3664658|P1|COMPLETED|Overall Study||123
1498020|NCT01687283|3664657|P2|STARTED|Overall Study||157
1498021|NCT01687283|3664658|P1|STARTED|Overall Study||158
1498022|NCT01687270|3664681|P1|NOT COMPLETED|Overall Study||12
1498023|NCT01687270|3664681|P1|COMPLETED|Overall Study||28
1498024|NCT01687270|3664681|P1|STARTED|Overall Study||40
1498025|NCT01687257|3664692|P3|NOT COMPLETED|Overall Study||6
1498026|NCT01687257|3664693|P2|NOT COMPLETED|Overall Study||4
1498027|NCT01687257|3664694|P1|NOT COMPLETED|Overall Study||8
1498028|NCT01687257|3664692|P3|COMPLETED|Overall Study||15
1498029|NCT01687257|3664693|P2|COMPLETED|Overall Study||0
1498030|NCT01687257|3664694|P1|COMPLETED|Overall Study||17
1498031|NCT01687257|3664692|P3|STARTED|Overall Study||21
1498032|NCT01687257|3664693|P2|STARTED|Overall Study||4
1498033|NCT01687257|3664694|P1|STARTED|Overall Study||25
1498034|NCT01687244|3664722|P2|NOT COMPLETED|Overall Study||0
1498035|NCT01687244|3664723|P1|NOT COMPLETED|Overall Study||0
1498036|NCT01687244|3664722|P2|COMPLETED|Overall Study||19
1498037|NCT01687244|3664723|P1|COMPLETED|Overall Study||21
1498038|NCT01687244|3664722|P2|STARTED|Overall Study||19
1498039|NCT01687244|3664723|P1|STARTED|Overall Study||21
1498040|NCT01687218|3664759|P6|NOT COMPLETED|Overall Study||0
1498041|NCT01687218|3664760|P5|NOT COMPLETED|Overall Study||1
1498042|NCT01687218|3664761|P4|NOT COMPLETED|Overall Study||2
1498043|NCT01687218|3664762|P3|NOT COMPLETED|Overall Study||1
1498044|NCT01687218|3664763|P2|NOT COMPLETED|Overall Study||3
1498045|NCT01687218|3664764|P1|NOT COMPLETED|Overall Study||3
1498046|NCT01687218|3664759|P6|COMPLETED|Overall Study||32
1498047|NCT01687218|3664760|P5|COMPLETED|Overall Study||32
1498048|NCT01687218|3664761|P4|COMPLETED|Overall Study||32
1498049|NCT01687218|3664762|P3|COMPLETED|Overall Study||30
1498050|NCT01687218|3664763|P2|COMPLETED|Overall Study||29
1498051|NCT01687218|3664764|P1|COMPLETED|Overall Study||30
1498052|NCT01687218|3664759|P6|STARTED|Overall Study||32
1498053|NCT01687218|3664760|P5|STARTED|Overall Study||33
1498054|NCT01687218|3664761|P4|STARTED|Overall Study||34
1498055|NCT01687218|3664762|P3|STARTED|Overall Study||31
1498056|NCT01687218|3664763|P2|STARTED|Overall Study||32
1498057|NCT01687218|3664764|P1|STARTED|Overall Study||33
1498058|NCT01687179|3664784|P2|NOT COMPLETED|Overall Study||4
1498059|NCT01687179|3664785|P1|NOT COMPLETED|Overall Study||1
1498060|NCT01687179|3664784|P2|COMPLETED|Overall Study||6
1498061|NCT01687179|3664785|P1|COMPLETED|Overall Study||2
1498062|NCT01687179|3664784|P2|STARTED|Overall Study||10
1498063|NCT01687179|3664785|P1|STARTED|Overall Study||3
1498064|NCT01687166|3664795|P4|NOT COMPLETED|Overall Study||2
1498065|NCT01687166|3664796|P3|NOT COMPLETED|Overall Study||14
1498066|NCT01687166|3664797|P2|NOT COMPLETED|Overall Study||27
1498067|NCT01687166|3664798|P1|NOT COMPLETED|Overall Study||28
1498068|NCT01687166|3664795|P4|COMPLETED|Overall Study||1
1498069|NCT01687166|3664796|P3|COMPLETED|Overall Study||42
1498070|NCT01687166|3664797|P2|COMPLETED|Overall Study||145
1498071|NCT01687166|3664798|P1|COMPLETED|Overall Study||139
1498072|NCT01687166|3664795|P4|STARTED|Overall Study||3
1498073|NCT01687166|3664796|P3|STARTED|Overall Study||56
1498074|NCT01687166|3664797|P2|STARTED|Overall Study||172
1498075|NCT01687166|3664798|P1|STARTED|Overall Study||167
1498076|NCT01687114|3664810|P1|NOT COMPLETED|Overall Study||0
1498077|NCT01687114|3664810|P1|COMPLETED|Overall Study||5
1498078|NCT01687114|3664810|P1|STARTED|Overall Study||5
1498079|NCT01687101|3664814|P1|NOT COMPLETED|Overall Study||7
1498080|NCT01687101|3664814|P1|COMPLETED|Overall Study||25
1498081|NCT01687101|3664814|P1|STARTED|Overall Study||32
1498082|NCT01687088|3664820|P2|NOT COMPLETED|Overall Study||0
1498083|NCT01687088|3664821|P1|NOT COMPLETED|Overall Study||0
1498084|NCT01687088|3664820|P2|COMPLETED|Overall Study||50
1498085|NCT01687088|3664821|P1|COMPLETED|Overall Study||50
1498086|NCT01687088|3664820|P2|STARTED|Overall Study||50
1498087|NCT01687088|3664821|P1|STARTED|Overall Study||50
1498088|NCT01687036|3664827|P1|NOT COMPLETED|Overall Study||0
1498089|NCT01687036|3664827|P1|COMPLETED|Overall Study||10
1498090|NCT01687036|3664827|P1|STARTED|Overall Study||10
1498091|NCT01686958|3664839|P1|NOT COMPLETED|Overall Study||1
1498092|NCT01686958|3664839|P1|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
1498093|NCT01686958|3664839|P1|STARTED|Overall Study||30
1498094|NCT01686932|3664852|P2|NOT COMPLETED|Period 2||0
1498095|NCT01686932|3664853|P1|NOT COMPLETED|Period 2||0
1498096|NCT01686932|3664852|P2|COMPLETED|Period 2||25
1498097|NCT01686932|3664853|P1|COMPLETED|Period 2||24
1498098|NCT01686932|3664852|P2|STARTED|Period 2||25
1498099|NCT01686932|3664853|P1|STARTED|Period 2||24
1498100|NCT01686932|3664852|P2|NOT COMPLETED|Period 1||1
1498101|NCT01686932|3664853|P1|NOT COMPLETED|Period 1||1
1498102|NCT01686932|3664852|P2|COMPLETED|Period 1||25
1498103|NCT01686932|3664853|P1|COMPLETED|Period 1||24
1498104|NCT01686932|3664852|P2|STARTED|Period 1||26
1498105|NCT01686932|3664853|P1|STARTED|Period 1||25
1498106|NCT01686828|3664883|P4|NOT COMPLETED|Overall Study||0
1498107|NCT01686828|3664884|P3|NOT COMPLETED|Overall Study||1
1498108|NCT01686828|3664885|P2|NOT COMPLETED|Overall Study||1
1498109|NCT01686828|3664886|P1|NOT COMPLETED|Overall Study||1
1498110|NCT01686828|3664883|P4|COMPLETED|Overall Study||13
1498111|NCT01686828|3664884|P3|COMPLETED|Overall Study||12
1498112|NCT01686828|3664885|P2|COMPLETED|Overall Study||13
1498113|NCT01686828|3664886|P1|COMPLETED|Overall Study||12
1498114|NCT01686828|3664883|P4|STARTED|Overall Study||13
1498115|NCT01686828|3664884|P3|STARTED|Overall Study||13
1498116|NCT01686828|3664885|P2|STARTED|Overall Study||14
1498117|NCT01686828|3664886|P1|STARTED|Overall Study||13
1498118|NCT01686646|3664908|P4|NOT COMPLETED|Overall Study||0
1498119|NCT01686646|3664909|P3|NOT COMPLETED|Overall Study||0
1498120|NCT01686646|3664910|P2|NOT COMPLETED|Overall Study||0
1498121|NCT01686646|3664911|P1|NOT COMPLETED|Overall Study||0
1498122|NCT01686646|3664908|P4|COMPLETED|Overall Study||75
1498123|NCT01686646|3664909|P3|COMPLETED|Overall Study||75
1498124|NCT01686646|3664910|P2|COMPLETED|Overall Study||45
1498125|NCT01686646|3664911|P1|COMPLETED|Overall Study||45
1498126|NCT01686646|3664908|P4|Safety Population|Overall Study||75
1498127|NCT01686646|3664909|P3|Safety Population|Overall Study||74
1498128|NCT01686646|3664910|P2|Safety Population|Overall Study||45
1498129|NCT01686646|3664911|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
1498130|NCT01686646|3664908|P4|Intent to Treat Population|Overall Study||75
1498131|NCT01686646|3664909|P3|Intent to Treat Population|Overall Study||75
1498132|NCT01686646|3664910|P2|Intent to Treat Population|Overall Study||45
1498133|NCT01686646|3664911|P1|Intent to Treat Population|Overall Study||45
1498134|NCT01686646|3664908|P4|STARTED|Overall Study||75
1498135|NCT01686646|3664909|P3|STARTED|Overall Study||75
1498136|NCT01686646|3664910|P2|STARTED|Overall Study||45
1498137|NCT01686646|3664911|P1|STARTED|Overall Study||45
1498138|NCT01686633|3664960|P3|NOT COMPLETED|Overall Study||25
1498139|NCT01686633|3664961|P2|NOT COMPLETED|Overall Study||32
1498140|NCT01686633|3664962|P1|NOT COMPLETED|Overall Study||51
1498141|NCT01686633|3664960|P3|COMPLETED|Overall Study||321
1498142|NCT01686633|3664961|P2|COMPLETED|Overall Study||314
1498143|NCT01686633|3664962|P1|COMPLETED|Overall Study||296
1498144|NCT01686633|3664960|P3|STARTED|Overall Study||346
1498145|NCT01686633|3664961|P2|STARTED|Overall Study||346
1498146|NCT01686633|3664962|P1|STARTED|Overall Study||347
1498147|NCT01686581|3664985|P1|NOT COMPLETED|Overall Study||177
1498148|NCT01686581|3664985|P1|COMPLETED|Overall Study||464
1498149|NCT01686581|3664985|P1|Completed 24 Months|Overall Study||128
1498150|NCT01686581|3664985|P1|Safety Analysis Set; Received Study Drug|Overall Study||633
1498151|NCT01686581|3664985|P1|STARTED|Overall Study||641
1498152|NCT01686568|3664998|P2|NOT COMPLETED|Sub-Study||2
1498153|NCT01686568|3664999|P1|NOT COMPLETED|Sub-Study||2
1498154|NCT01686568|3664998|P2|COMPLETED|Sub-Study||9
1498155|NCT01686568|3664999|P1|COMPLETED|Sub-Study||12
1498156|NCT01686568|3664998|P2|STARTED|Sub-Study||11
1498157|NCT01686568|3664999|P1|STARTED|Sub-Study||14
1498158|NCT01686568|3664998|P2|NOT COMPLETED|Main Study||4
1498159|NCT01686568|3664999|P1|NOT COMPLETED|Main Study||2
1498160|NCT01686568|3664998|P2|COMPLETED|Main Study||11
1498161|NCT01686568|3664999|P1|COMPLETED|Main Study||14
1498162|NCT01686568|3664998|P2|STARTED|Main Study||15
1498163|NCT01686568|3664999|P1|STARTED|Main Study||16
1498164|NCT01686503|3665025|P4|NOT COMPLETED|Overall Study||1
1498165|NCT01686503|3665026|P3|NOT COMPLETED|Overall Study||2
1498166|NCT01686503|3665027|P2|NOT COMPLETED|Overall Study||3
1498167|NCT01686503|3665028|P1|NOT COMPLETED|Overall Study||1
1498168|NCT01686503|3665025|P4|COMPLETED|Overall Study||32
1498169|NCT01686503|3665026|P3|COMPLETED|Overall Study||64
1498170|NCT01686503|3665027|P2|COMPLETED|Overall Study||63
1498171|NCT01686503|3665028|P1|COMPLETED|Overall Study||65
1498172|NCT01686503|3665025|P4|STARTED|Overall Study||33
1498173|NCT01686503|3665026|P3|STARTED|Overall Study||66
1498174|NCT01686503|3665027|P2|STARTED|Overall Study||66
1498175|NCT01686503|3665028|P1|STARTED|Overall Study||66
1498176|NCT01686451|3665044|P2|NOT COMPLETED|Overall Study||0
1498177|NCT01686451|3665045|P1|NOT COMPLETED|Overall Study||0
1498178|NCT01686451|3665044|P2|COMPLETED|Overall Study||27
1498179|NCT01686451|3665045|P1|COMPLETED|Overall Study||33
1498180|NCT01686451|3665044|P2|STARTED|Overall Study||27
1498181|NCT01686451|3665045|P1|STARTED|Overall Study||33
1498182|NCT01686165|3665073|P1|NOT COMPLETED|Overall Study||0
1498183|NCT01686165|3665073|P1|COMPLETED|Overall Study||5
1498184|NCT01686165|3665073|P1|STARTED|Overall Study||5
1498185|NCT01685996|3665082|P2|NOT COMPLETED|Overall Study||13
1498186|NCT01685996|3665083|P1|NOT COMPLETED|Overall Study||16
1498187|NCT01685996|3665082|P2|COMPLETED|Overall Study||27
1498188|NCT01685996|3665083|P1|COMPLETED|Overall Study||18
1498189|NCT01685996|3665082|P2|STARTED|Overall Study||40
1498190|NCT01685996|3665083|P1|STARTED|Overall Study||34
1498191|NCT01685983|3665091|P1|NOT COMPLETED|Overall Study||82
1498192|NCT01685983|3665091|P1|COMPLETED|Overall Study||0
1498193|NCT01685983|3665091|P1|STARTED|Overall Study||82
1498194|NCT01685840|3665103|P2|NOT COMPLETED|Overall Study||332
1498195|NCT01685840|3665104|P1|NOT COMPLETED|Overall Study||329
1498196|NCT01685840|3665103|P2|COMPLETED|Overall Study||114
1498197|NCT01685840|3665104|P1|COMPLETED|Overall Study||119
1498198|NCT01685840|3665103|P2|STARTED|Overall Study||446
1498199|NCT01685840|3665104|P1|STARTED|Overall Study||448
1498200|NCT01685801|3665148|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
1498201|NCT01685801|3665149|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
1498202|NCT01685801|3665150|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
1498203|NCT01685801|3665151|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
1498204|NCT01685801|3665148|P4|COMPLETED|Open-label Period (8 Weeks)||4
1498205|NCT01685801|3665149|P3|COMPLETED|Open-label Period (8 Weeks)||7
1498206|NCT01685801|3665150|P2|COMPLETED|Open-label Period (8 Weeks)||5
1498207|NCT01685801|3665151|P1|COMPLETED|Open-label Period (8 Weeks)||5
1498208|NCT01685801|3665148|P4|STARTED|Open-label Period (8 Weeks)||4
1498209|NCT01685801|3665149|P3|STARTED|Open-label Period (8 Weeks)||7
1498210|NCT01685801|3665150|P2|STARTED|Open-label Period (8 Weeks)||5
1498211|NCT01685801|3665151|P1|STARTED|Open-label Period (8 Weeks)||5
1498212|NCT01685801|3665148|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
1498213|NCT01685801|3665149|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
1498214|NCT01685801|3665150|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
1498215|NCT01685801|3665151|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
1498216|NCT01685801|3665148|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
1498217|NCT01685801|3665149|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
1498218|NCT01685801|3665150|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
1498219|NCT01685801|3665151|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
1498220|NCT01685801|3665148|P4|STARTED|Washout Period 2 (4 Weeks)||4
1498221|NCT01685801|3665149|P3|STARTED|Washout Period 2 (4 Weeks)||7
1498222|NCT01685801|3665150|P2|STARTED|Washout Period 2 (4 Weeks)||5
1498223|NCT01685801|3665151|P1|STARTED|Washout Period 2 (4 Weeks)||5
1498224|NCT01685801|3665148|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
1498225|NCT01685801|3665149|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
1498226|NCT01685801|3665150|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
1498227|NCT01685801|3665151|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
1498228|NCT01685801|3665148|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
1498229|NCT01685801|3665149|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
1498230|NCT01685801|3665150|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
1498231|NCT01685801|3665151|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
1498232|NCT01685801|3665148|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
1498233|NCT01685801|3665149|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
1498234|NCT01685801|3665150|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
1498235|NCT01685801|3665151|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
1498236|NCT01685801|3665148|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
1498237|NCT01685801|3665149|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
1498238|NCT01685801|3665150|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
1498239|NCT01685801|3665151|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
1498240|NCT01685801|3665148|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
1498241|NCT01685801|3665149|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
1498242|NCT01685801|3665150|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
1498243|NCT01685801|3665151|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
1498244|NCT01685801|3665148|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
1498245|NCT01685801|3665149|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
1498246|NCT01685801|3665150|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
1498247|NCT01685801|3665151|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
1498248|NCT01685801|3665148|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
1498249|NCT01685801|3665149|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
1498250|NCT01685801|3665150|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
1498251|NCT01685801|3665151|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
1498252|NCT01685801|3665148|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
1498253|NCT01685801|3665149|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
1498254|NCT01685801|3665150|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
1498255|NCT01685801|3665151|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
1498256|NCT01685801|3665148|P4|STARTED|Washout Period 1 (4 Weeks)||5
1498257|NCT01685801|3665149|P3|STARTED|Washout Period 1 (4 Weeks)||7
1498258|NCT01685801|3665150|P2|STARTED|Washout Period 1 (4 Weeks)||6
1498259|NCT01685801|3665151|P1|STARTED|Washout Period 1 (4 Weeks)||5
1498260|NCT01685801|3665148|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
1498261|NCT01685801|3665149|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
1498262|NCT01685801|3665150|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
1498263|NCT01685801|3665151|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
1498264|NCT01685801|3665148|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
1498265|NCT01685801|3665149|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
1498266|NCT01685801|3665150|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
1498267|NCT01685801|3665151|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
1498268|NCT01685801|3665148|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
1498269|NCT01685801|3665149|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
1498270|NCT01685801|3665150|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
1498271|NCT01685801|3665151|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
1498272|NCT01685801|3665148|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1498273|NCT01685801|3665149|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1498274|NCT01685801|3665150|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1498275|NCT01685801|3665151|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
1498276|NCT01685801|3665148|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
1498277|NCT01685801|3665149|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
1498278|NCT01685801|3665150|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
1498279|NCT01685801|3665151|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
1498280|NCT01685801|3665148|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
1498281|NCT01685801|3665149|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
1498282|NCT01685801|3665150|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
1498283|NCT01685801|3665151|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
1498284|NCT01685697|3665173|P2|NOT COMPLETED|Overall Study||3
1498285|NCT01685697|3665174|P1|NOT COMPLETED|Overall Study||3
1498286|NCT01685697|3665173|P2|COMPLETED|Overall Study||28
1498287|NCT01685697|3665174|P1|COMPLETED|Overall Study||28
1498288|NCT01685697|3665173|P2|STARTED|Overall Study||31
1498289|NCT01685697|3665174|P1|STARTED|Overall Study||31
1498290|NCT01685684|3665182|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
1498291|NCT01685684|3665183|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
1498292|NCT01685684|3665184|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
1498293|NCT01685684|3665182|P3|COMPLETED|Double-blind Maintenance Phase||100
1498294|NCT01685684|3665183|P2|COMPLETED|Double-blind Maintenance Phase||122
1498295|NCT01685684|3665184|P1|COMPLETED|Double-blind Maintenance Phase||0
1498296|NCT01685684|3665182|P3|STARTED|Double-blind Maintenance Phase||196
1498297|NCT01685684|3665183|P2|STARTED|Double-blind Maintenance Phase||193
1498298|NCT01685684|3665184|P1|STARTED|Double-blind Maintenance Phase||0
1498299|NCT01685684|3665182|P3|NOT COMPLETED|Titration Phase||0
1498300|NCT01685684|3665183|P2|NOT COMPLETED|Titration Phase||0
1498301|NCT01685684|3665184|P1|NOT COMPLETED|Titration Phase||351
1498302|NCT01685684|3665182|P3|COMPLETED|Titration Phase||0
1498303|NCT01685684|3665183|P2|COMPLETED|Titration Phase||0
1498304|NCT01685684|3665184|P1|COMPLETED|Titration Phase||389
1498305|NCT01685684|3665182|P3|STARTED|Titration Phase||0
1498306|NCT01685684|3665183|P2|STARTED|Titration Phase||0
1498307|NCT01685684|3665184|P1|STARTED|Titration Phase||740
1498308|NCT01685606|3665208|P1|NOT COMPLETED|Overall Study||1
1498309|NCT01685606|3665208|P1|COMPLETED|Overall Study||5
1498310|NCT01685606|3665208|P1|STARTED|Overall Study||6
1498311|NCT01685567|3665213|P1|NOT COMPLETED|Overall Study||0
1498312|NCT01685567|3665213|P1|COMPLETED|Overall Study||219
1498313|NCT01685567|3665213|P1|STARTED|Overall Study||219
1498314|NCT01685463|3665223|P2|NOT COMPLETED|Overall Study||0
1498315|NCT01685463|3665224|P1|NOT COMPLETED|Overall Study||0
1498316|NCT01685463|3665223|P2|COMPLETED|Overall Study||8
1498317|NCT01685463|3665224|P1|COMPLETED|Overall Study||10
1498318|NCT01685463|3665223|P2|STARTED|Overall Study||8
1498319|NCT01685463|3665224|P1|STARTED|Overall Study||10
1498320|NCT01685437|3665236|P1|NOT COMPLETED|Overall Study||31
1498321|NCT01685437|3665236|P1|COMPLETED|Overall Study||158
1498322|NCT01685437|3665236|P1|STARTED|Overall Study||189
1498323|NCT01685372|3665250|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
1498324|NCT01685372|3665251|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
1498325|NCT01685372|3665250|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
1498326|NCT01685372|3665251|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
1498327|NCT01685372|3665250|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
1498328|NCT01685372|3665251|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
1498329|NCT01685372|3665250|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
1498330|NCT01685372|3665251|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
1498331|NCT01685372|3665250|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
1498332|NCT01685372|3665251|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
1498333|NCT01685372|3665250|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
1498334|NCT01685372|3665251|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
1498335|NCT01685372|3665250|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
1498336|NCT01685372|3665251|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
1498337|NCT01685372|3665250|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
1498338|NCT01685372|3665251|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
1498339|NCT01685372|3665250|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
1498340|NCT01685372|3665251|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
1498341|NCT01685320|3665273|P2|NOT COMPLETED|Overall Study||0
1498342|NCT01685320|3665274|P1|NOT COMPLETED|Overall Study||0
1498343|NCT01685320|3665273|P2|COMPLETED|Overall Study||15
1498344|NCT01685320|3665274|P1|COMPLETED|Overall Study||15
1498345|NCT01685320|3665273|P2|STARTED|Overall Study||15
1498346|NCT01685320|3665274|P1|STARTED|Overall Study||15
1498347|NCT01685242|3665284|P2|NOT COMPLETED|Overall Study||3
1498348|NCT01685242|3665285|P1|NOT COMPLETED|Overall Study||1
1498349|NCT01685242|3665284|P2|COMPLETED|Overall Study||47
1498350|NCT01685242|3665285|P1|COMPLETED|Overall Study||49
1498351|NCT01685242|3665284|P2|STARTED|Overall Study||50
1498352|NCT01685242|3665285|P1|STARTED|Overall Study||50
1498353|NCT01685216|3665339|P1|NOT COMPLETED|Overall Study||1
1498354|NCT01685216|3665339|P1|COMPLETED|Overall Study||6
1498355|NCT01685216|3665339|P1|STARTED|Overall Study||7
1498356|NCT01685203|3665356|P7|NOT COMPLETED|Overall Study||0
1498357|NCT01685203|3665357|P6|NOT COMPLETED|Overall Study||3
1498358|NCT01685203|3665358|P5|NOT COMPLETED|Overall Study||0
1498359|NCT01685203|3665359|P4|NOT COMPLETED|Overall Study||1
1498360|NCT01685203|3665360|P3|NOT COMPLETED|Overall Study||0
1498361|NCT01685203|3665361|P2|NOT COMPLETED|Overall Study||3
1498362|NCT01685203|3665362|P1|NOT COMPLETED|Overall Study||4
1498363|NCT01685203|3665356|P7|COMPLETED|Overall Study||52
1498364|NCT01685203|3665357|P6|COMPLETED|Overall Study||44
1498365|NCT01685203|3665358|P5|COMPLETED|Overall Study||49
1498366|NCT01685203|3665359|P4|COMPLETED|Overall Study||41
1498367|NCT01685203|3665360|P3|COMPLETED|Overall Study||40
1498368|NCT01685203|3665361|P2|COMPLETED|Overall Study||39
1498369|NCT01685203|3665362|P1|COMPLETED|Overall Study||40
1498370|NCT01685203|3665356|P7|Completed Study Drug|Overall Study||52
1498371|NCT01685203|3665357|P6|Completed Study Drug|Overall Study||43
1498372|NCT01685203|3665358|P5|Completed Study Drug|Overall Study||49
1498373|NCT01685203|3665359|P4|Completed Study Drug|Overall Study||42
1498374|NCT01685203|3665360|P3|Completed Study Drug|Overall Study||39
1498375|NCT01685203|3665361|P2|Completed Study Drug|Overall Study||40
1498376|NCT01685203|3665362|P1|Completed Study Drug|Overall Study||42
1498377|NCT01685203|3665356|P7|STARTED|Overall Study||52
1498378|NCT01685203|3665357|P6|STARTED|Overall Study||47
1498379|NCT01685203|3665358|P5|STARTED|Overall Study||49
1498380|NCT01685203|3665359|P4|STARTED|Overall Study||42
1498381|NCT01685203|3665360|P3|STARTED|Overall Study||40
1498382|NCT01685203|3665361|P2|STARTED|Overall Study||42
1498383|NCT01685203|3665362|P1|STARTED|Overall Study||44
1498384|NCT01685060|3665406|P1|NOT COMPLETED|Overall Study||140
1498385|NCT01685060|3665406|P1|COMPLETED|Overall Study||0
1498386|NCT01685060|3665406|P1|Discontinued From Study|Overall Study||35
1498387|NCT01685060|3665406|P1|Entered Survival Follow up|Overall Study||98
1498388|NCT01685060|3665406|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
1498389|NCT01685060|3665406|P1|STARTED|Overall Study||140
1498390|NCT01685021|3665421|P1|NOT COMPLETED|Overall Study||16
1498391|NCT01685021|3665421|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
1498392|NCT01685021|3665421|P1|STARTED|Overall Study||22
1498393|NCT01684930|3665432|P2|NOT COMPLETED|Overall Study||1
1498394|NCT01684930|3665433|P1|NOT COMPLETED|Overall Study||3
1498395|NCT01684930|3665432|P2|COMPLETED|Overall Study||13
1498396|NCT01684930|3665433|P1|COMPLETED|Overall Study||9
1498397|NCT01684930|3665432|P2|STARTED|Overall Study||14
1498398|NCT01684930|3665433|P1|STARTED|Overall Study||12
1498399|NCT01684878|3665453|P4|NOT COMPLETED|Part 2: Randomized Phase||78
1498400|NCT01684878|3665454|P3|NOT COMPLETED|Part 2: Randomized Phase||78
1498401|NCT01684878|3665455|P2|NOT COMPLETED|Part 2: Randomized Phase||0
1498402|NCT01684878|3665456|P1|NOT COMPLETED|Part 2: Randomized Phase||0
1498403|NCT01684878|3665453|P4|COMPLETED|Part 2: Randomized Phase||0
1498404|NCT01684878|3665454|P3|COMPLETED|Part 2: Randomized Phase||0
1498405|NCT01684878|3665455|P2|COMPLETED|Part 2: Randomized Phase||0
1498406|NCT01684878|3665456|P1|COMPLETED|Part 2: Randomized Phase||0
1498407|NCT01684878|3665453|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
1498408|NCT01684878|3665454|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
1498409|NCT01684878|3665455|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
1498410|NCT01684878|3665456|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
1498411|NCT01684878|3665453|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
1498412|NCT01684878|3665454|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
1498413|NCT01684878|3665455|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
1498414|NCT01684878|3665456|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
1498415|NCT01684878|3665453|P4|STARTED|Part 2: Randomized Phase||78
1498416|NCT01684878|3665454|P3|STARTED|Part 2: Randomized Phase||78
1498417|NCT01684878|3665455|P2|STARTED|Part 2: Randomized Phase||0
1498418|NCT01684878|3665456|P1|STARTED|Part 2: Randomized Phase||0
1498419|NCT01684878|3665453|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
1498420|NCT01684878|3665454|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
1498421|NCT01684878|3665455|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
1498422|NCT01684878|3665456|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
1498423|NCT01684878|3665453|P4|COMPLETED|Part 1: Safety Run in Phase||0
1498424|NCT01684878|3665454|P3|COMPLETED|Part 1: Safety Run in Phase||0
1498425|NCT01684878|3665455|P2|COMPLETED|Part 1: Safety Run in Phase||5
1498426|NCT01684878|3665456|P1|COMPLETED|Part 1: Safety Run in Phase||6
1498427|NCT01684878|3665453|P4|STARTED|Part 1: Safety Run in Phase||0
1498428|NCT01684878|3665454|P3|STARTED|Part 1: Safety Run in Phase||0
1498429|NCT01684878|3665455|P2|STARTED|Part 1: Safety Run in Phase||28
1498430|NCT01684878|3665456|P1|STARTED|Part 1: Safety Run in Phase||22
1498431|NCT01684839|3665480|P1|NOT COMPLETED|Overall Study||0
1498432|NCT01684839|3665480|P1|COMPLETED|Overall Study||9
1498433|NCT01684839|3665480|P1|STARTED|Overall Study||9
1498434|NCT01684826|3665484|P1|NOT COMPLETED|Overall Study||10
1498435|NCT01684826|3665484|P1|COMPLETED|Overall Study||39
1498436|NCT01684826|3665484|P1|Collected Dose and Image Information|Overall Study||39
1498437|NCT01684826|3665484|P1|STARTED|Overall Study||49
1498438|NCT01684748|3665492|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
1498439|NCT01684748|3665493|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
1498440|NCT01684748|3665492|P2|COMPLETED|Second Intervention - 8 Weeks||8
1498441|NCT01684748|3665493|P1|COMPLETED|Second Intervention - 8 Weeks||8
1498442|NCT01684748|3665492|P2|STARTED|Second Intervention - 8 Weeks||8
1498443|NCT01684748|3665493|P1|STARTED|Second Intervention - 8 Weeks||8
1498444|NCT01684748|3665492|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
1498445|NCT01684748|3665493|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
1498446|NCT01684748|3665492|P2|COMPLETED|First Intervention - 8 Weeks||8
1498447|NCT01684748|3665493|P1|COMPLETED|First Intervention - 8 Weeks||8
1498448|NCT01684748|3665492|P2|STARTED|First Intervention - 8 Weeks||10
1498449|NCT01684748|3665493|P1|STARTED|First Intervention - 8 Weeks||10
1498450|NCT01684592|3665502|P2|NOT COMPLETED|Overall Study||24
1498451|NCT01684592|3665503|P1|NOT COMPLETED|Overall Study||26
1498452|NCT01684592|3665502|P2|COMPLETED|Overall Study||40
1498453|NCT01684592|3665503|P1|COMPLETED|Overall Study||38
1498454|NCT01684592|3665502|P2|STARTED|Overall Study||64
1498455|NCT01684592|3665503|P1|STARTED|Overall Study||64
1498456|NCT01684566|3665523|P2|NOT COMPLETED|Overall Study||7
1498457|NCT01684566|3665524|P1|NOT COMPLETED|Overall Study||16
1498458|NCT01684566|3665523|P2|COMPLETED|Overall Study||49
1498459|NCT01684566|3665524|P1|COMPLETED|Overall Study||44
1498460|NCT01684566|3665523|P2|Treated (ITT)|Overall Study||52
1498461|NCT01684566|3665524|P1|Treated (ITT)|Overall Study||57
1498462|NCT01684566|3665523|P2|STARTED|Overall Study||56
1498463|NCT01684566|3665524|P1|STARTED|Overall Study||60
1498464|NCT01684436|3665546|P1|NOT COMPLETED|Overall Study||1
1498465|NCT01684436|3665546|P1|COMPLETED|Overall Study||29
1498466|NCT01684436|3665546|P1|STARTED|Overall Study||30
1498467|NCT01684423|3665560|P5|NOT COMPLETED|Overall Study||0
1498468|NCT01684423|3665561|P4|NOT COMPLETED|Overall Study||0
1498469|NCT01684423|3665562|P3|NOT COMPLETED|Overall Study||1
1498470|NCT01684423|3665563|P2|NOT COMPLETED|Overall Study||0
1498471|NCT01684423|3665564|P1|NOT COMPLETED|Overall Study||0
1498472|NCT01684423|3665560|P5|COMPLETED|Overall Study||7
1498473|NCT01684423|3665561|P4|COMPLETED|Overall Study||19
1498474|NCT01684423|3665562|P3|COMPLETED|Overall Study||12
1498475|NCT01684423|3665563|P2|COMPLETED|Overall Study||13
1498476|NCT01684423|3665564|P1|COMPLETED|Overall Study||11
1498477|NCT01684423|3665560|P5|STARTED|Overall Study||7
1498478|NCT01684423|3665561|P4|STARTED|Overall Study||19
1498479|NCT01684423|3665562|P3|STARTED|Overall Study||13
1498480|NCT01684423|3665563|P2|STARTED|Overall Study||13
1498481|NCT01684423|3665564|P1|STARTED|Overall Study||11
1498482|NCT01684410|3665601|P3|NOT COMPLETED|Overall Study||0
1498483|NCT01684410|3665602|P2|NOT COMPLETED|Overall Study||0
1498484|NCT01684410|3665603|P1|NOT COMPLETED|Overall Study||0
1498485|NCT01684410|3665601|P3|COMPLETED|Overall Study||10
1498486|NCT01684410|3665602|P2|COMPLETED|Overall Study||10
1498487|NCT01684410|3665603|P1|COMPLETED|Overall Study||10
1498488|NCT01684410|3665601|P3|STARTED|Overall Study||10
1498489|NCT01684410|3665602|P2|STARTED|Overall Study||10
1498490|NCT01684410|3665603|P1|STARTED|Overall Study||10
1498491|NCT01684215|3665621|P4|NOT COMPLETED|Overall Study||43
1498492|NCT01684215|3665622|P3|NOT COMPLETED|Overall Study||6
1498493|NCT01684215|3665623|P2|NOT COMPLETED|Overall Study||6
1498494|NCT01684215|3665624|P1|NOT COMPLETED|Overall Study||6
1498495|NCT01684215|3665621|P4|COMPLETED|Overall Study||0
1498496|NCT01684215|3665622|P3|COMPLETED|Overall Study||0
1498497|NCT01684215|3665623|P2|COMPLETED|Overall Study||0
1498498|NCT01684215|3665624|P1|COMPLETED|Overall Study||0
1498499|NCT01684215|3665621|P4|Treated|Overall Study||42
1498500|NCT01684215|3665622|P3|Treated|Overall Study||6
1498501|NCT01684215|3665623|P2|Treated|Overall Study||6
1498502|NCT01684215|3665624|P1|Treated|Overall Study||6
1498503|NCT01684215|3665621|P4|STARTED|Overall Study||43
1498504|NCT01684215|3665622|P3|STARTED|Overall Study||6
1498505|NCT01684215|3665623|P2|STARTED|Overall Study||6
1498506|NCT01684215|3665624|P1|STARTED|Overall Study||6
1498507|NCT01684046|3665698|P2|NOT COMPLETED|Period 2, Second 30 Days||0
1498508|NCT01684046|3665699|P1|NOT COMPLETED|Period 2, Second 30 Days||0
1498509|NCT01684046|3665698|P2|COMPLETED|Period 2, Second 30 Days||93
1498510|NCT01684046|3665699|P1|COMPLETED|Period 2, Second 30 Days||97
1498511|NCT01684046|3665698|P2|STARTED|Period 2, Second 30 Days||93
1498512|NCT01684046|3665699|P1|STARTED|Period 2, Second 30 Days||97
1498513|NCT01684046|3665698|P2|NOT COMPLETED|Period 1, First 30 Days||2
1498514|NCT01684046|3665699|P1|NOT COMPLETED|Period 1, First 30 Days||0
1498515|NCT01684046|3665698|P2|COMPLETED|Period 1, First 30 Days||93
1498516|NCT01684046|3665699|P1|COMPLETED|Period 1, First 30 Days||97
1498517|NCT01684046|3665698|P2|STARTED|Period 1, First 30 Days||95
1498518|NCT01684046|3665699|P1|STARTED|Period 1, First 30 Days||97
1498519|NCT01684033|3665705|P2|NOT COMPLETED|Period 2, Second 30 Days||0
1498520|NCT01684033|3665706|P1|NOT COMPLETED|Period 2, Second 30 Days||1
1498521|NCT01684033|3665705|P2|COMPLETED|Period 2, Second 30 Days||98
1498522|NCT01684033|3665706|P1|COMPLETED|Period 2, Second 30 Days||94
1498523|NCT01684033|3665705|P2|STARTED|Period 2, Second 30 Days||98
1498524|NCT01684033|3665706|P1|STARTED|Period 2, Second 30 Days||95
1498525|NCT01684033|3665705|P2|NOT COMPLETED|Period 1, First 30 Days||1
1498526|NCT01684033|3665706|P1|NOT COMPLETED|Period 1, First 30 Days||4
1498527|NCT01684033|3665705|P2|COMPLETED|Period 1, First 30 Days||98
1498528|NCT01684033|3665706|P1|COMPLETED|Period 1, First 30 Days||95
1498529|NCT01684033|3665705|P2|STARTED|Period 1, First 30 Days||99
1498530|NCT01684033|3665706|P1|STARTED|Period 1, First 30 Days||99
1498531|NCT01684007|3665716|P2|NOT COMPLETED|Overall Study||0
1498532|NCT01684007|3665717|P1|NOT COMPLETED|Overall Study||0
1498533|NCT01684007|3665716|P2|COMPLETED|Overall Study||50
1498534|NCT01684007|3665717|P1|COMPLETED|Overall Study||53
1498535|NCT01684007|3665716|P2|STARTED|Overall Study||50
1498536|NCT01684007|3665717|P1|STARTED|Overall Study||53
1498537|NCT01683864|3665728|P3|NOT COMPLETED|Overall Study||0
1498538|NCT01683864|3665729|P2|NOT COMPLETED|Overall Study||0
1498539|NCT01683864|3665730|P1|NOT COMPLETED|Overall Study||0
1498540|NCT01683864|3665728|P3|COMPLETED|Overall Study||0
1498541|NCT01683864|3665729|P2|COMPLETED|Overall Study||0
1498542|NCT01683864|3665730|P1|COMPLETED|Overall Study||0
1498543|NCT01683864|3665728|P3|STARTED|Overall Study||0
1498544|NCT01683864|3665729|P2|STARTED|Overall Study||0
1498545|NCT01683864|3665730|P1|STARTED|Overall Study||0
1498546|NCT01683838|3665740|P2|NOT COMPLETED|Overall Study||12
1498547|NCT01683838|3665741|P1|NOT COMPLETED|Overall Study||26
1498548|NCT01683838|3665740|P2|COMPLETED|Overall Study||88
1498549|NCT01683838|3665741|P1|COMPLETED|Overall Study||78
1498550|NCT01683838|3665740|P2|Efficacy Population|Overall Study||93
1498551|NCT01683838|3665741|P1|Efficacy Population|Overall Study||89
1498552|NCT01683838|3665740|P2|Safety Population|Overall Study||100
1498553|NCT01683838|3665741|P1|Safety Population|Overall Study||103
1498554|NCT01683838|3665740|P2|Intent to Treat (ITT) Population|Overall Study||100
1498555|NCT01683838|3665741|P1|Intent to Treat (ITT) Population|Overall Study||103
1498556|NCT01683838|3665740|P2|STARTED|Overall Study||100
1498557|NCT01683838|3665741|P1|STARTED|Overall Study||104
1498558|NCT01683812|3665763|P1|NOT COMPLETED|Overall Study||0
1498559|NCT01683812|3665763|P1|COMPLETED|Overall Study||23
1498560|NCT01683812|3665763|P1|STARTED|Overall Study||23
1498561|NCT01683630|3665770|P2|NOT COMPLETED|Overall Study||0
1498562|NCT01683630|3665771|P1|NOT COMPLETED|Overall Study||0
1498563|NCT01683630|3665770|P2|COMPLETED|Overall Study||445
1498564|NCT01683630|3665771|P1|COMPLETED|Overall Study||1404
1498565|NCT01683630|3665770|P2|STARTED|Overall Study||445
1498566|NCT01683630|3665771|P1|STARTED|Overall Study||1404
1498567|NCT01683604|3665781|P1|NOT COMPLETED|Overall Study||5
1498568|NCT01683604|3665781|P1|COMPLETED|Overall Study||32
1498569|NCT01683604|3665781|P1|STARTED|Overall Study||37
1498570|NCT01683526|3665946|P2|NOT COMPLETED|Overall Study||0
1498571|NCT01683526|3665947|P1|NOT COMPLETED|Overall Study||0
1498572|NCT01683526|3665946|P2|COMPLETED|Overall Study||57
1498573|NCT01683526|3665947|P1|COMPLETED|Overall Study||60
1498574|NCT01683526|3665946|P2|STARTED|Overall Study||57
1498575|NCT01683526|3665947|P1|STARTED|Overall Study||60
1498576|NCT01683409|3665966|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
1498577|NCT01683409|3665967|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
1498578|NCT01683409|3665968|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
1498579|NCT01683409|3665969|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
1498580|NCT01683409|3665970|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
1498581|NCT01683409|3665966|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
1498582|NCT01683409|3665967|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
1498583|NCT01683409|3665968|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
1498584|NCT01683409|3665969|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
1498585|NCT01683409|3665970|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
1498586|NCT01683409|3665966|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
1498587|NCT01683409|3665967|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
1498588|NCT01683409|3665968|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
1498589|NCT01683409|3665969|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
1498590|NCT01683409|3665970|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
1498591|NCT01683409|3665966|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
1498592|NCT01683409|3665967|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
1498593|NCT01683409|3665968|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
1498594|NCT01683409|3665969|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
1498595|NCT01683409|3665970|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
1498596|NCT01683409|3665966|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
1498597|NCT01683409|3665967|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
1498598|NCT01683409|3665968|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
1498599|NCT01683409|3665969|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
1498600|NCT01683409|3665970|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
1498601|NCT01683409|3665966|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
1498602|NCT01683409|3665967|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
1498603|NCT01683409|3665968|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
1498604|NCT01683409|3665969|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
1498605|NCT01683409|3665970|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
1498606|NCT01683409|3665966|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
1498607|NCT01683409|3665967|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
1498608|NCT01683409|3665968|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
1498609|NCT01683409|3665969|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
1498610|NCT01683409|3665970|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
1498611|NCT01683409|3665966|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
1498612|NCT01683409|3665967|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
1498613|NCT01683409|3665968|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
1498614|NCT01683409|3665969|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
1498615|NCT01683409|3665970|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
1498616|NCT01683409|3665966|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
1498617|NCT01683409|3665967|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
1498618|NCT01683409|3665968|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
1498619|NCT01683409|3665969|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
1498620|NCT01683409|3665970|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
1498621|NCT01683409|3665966|P5|STARTED|Treatment Period (Weeks 1-24)||25
1498622|NCT01683409|3665967|P4|STARTED|Treatment Period (Weeks 1-24)||26
1498623|NCT01683409|3665968|P3|STARTED|Treatment Period (Weeks 1-24)||27
1498624|NCT01683409|3665969|P2|STARTED|Treatment Period (Weeks 1-24)||25
1498625|NCT01683409|3665970|P1|STARTED|Treatment Period (Weeks 1-24)||27
1498626|NCT01683383|3666013|P2|NOT COMPLETED|Overall Study||0
1498627|NCT01683383|3666014|P1|NOT COMPLETED|Overall Study||1
1498628|NCT01683383|3666013|P2|COMPLETED|Overall Study||51
1498629|NCT01683383|3666014|P1|COMPLETED|Overall Study||49
1498630|NCT01683383|3666013|P2|Transported and Treated|Overall Study||51
1498631|NCT01683383|3666014|P1|Transported and Treated|Overall Study||49
1498632|NCT01683383|3666013|P2|STARTED|Overall Study||51
1498633|NCT01683383|3666014|P1|STARTED|Overall Study||50
1498634|NCT01683266|3666030|P2|NOT COMPLETED|Overall Study||50
1498635|NCT01683266|3666031|P1|NOT COMPLETED|Overall Study||55
1498636|NCT01683266|3666030|P2|COMPLETED|Overall Study||225
1498637|NCT01683266|3666031|P1|COMPLETED|Overall Study||219
1498638|NCT01683266|3666030|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
1498639|NCT01683266|3666031|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
1498640|NCT01683266|3666030|P2|STARTED|Overall Study||275
1498641|NCT01683266|3666031|P1|STARTED|Overall Study||274
1498642|NCT01683058|3666059|P1|NOT COMPLETED|Overall Study||29
1498643|NCT01683058|3666059|P1|COMPLETED|Overall Study||45
1498644|NCT01683058|3666059|P1|STARTED|Overall Study||74
1498645|NCT01683019|3666090|P3|NOT COMPLETED|Overall Study||4
1498646|NCT01683019|3666091|P2|NOT COMPLETED|Overall Study||1
1498647|NCT01683019|3666092|P1|NOT COMPLETED|Overall Study||2
1498648|NCT01683019|3666090|P3|COMPLETED|Overall Study||15
1498649|NCT01683019|3666091|P2|COMPLETED|Overall Study||14
1498650|NCT01683019|3666092|P1|COMPLETED|Overall Study||16
1498651|NCT01683019|3666090|P3|STARTED|Overall Study||19
1498652|NCT01683019|3666091|P2|STARTED|Overall Study||15
1498653|NCT01683019|3666092|P1|STARTED|Overall Study||18
1498654|NCT01682954|3666102|P2|NOT COMPLETED|Overall Study||5
1498655|NCT01682954|3666103|P1|NOT COMPLETED|Overall Study||5
1498656|NCT01682954|3666102|P2|COMPLETED|Overall Study||33
1498657|NCT01682954|3666103|P1|COMPLETED|Overall Study||35
1498658|NCT01682954|3666102|P2|STARTED|Overall Study||38
1498659|NCT01682954|3666103|P1|STARTED|Overall Study||40
1498660|NCT01682876|3666115|P4|NOT COMPLETED|Overall Study||19
1498661|NCT01682876|3666116|P3|NOT COMPLETED|Overall Study||11
1498662|NCT01682876|3666117|P2|NOT COMPLETED|Overall Study||20
1498663|NCT01682876|3666118|P1|NOT COMPLETED|Overall Study||21
1498664|NCT01682876|3666115|P4|COMPLETED|Overall Study||157
1498665|NCT01682876|3666116|P3|COMPLETED|Overall Study||169
1498666|NCT01682876|3666117|P2|COMPLETED|Overall Study||163
1498667|NCT01682876|3666118|P1|COMPLETED|Overall Study||155
1498668|NCT01682876|3666115|P4|STARTED|Overall Study||176
1498669|NCT01682876|3666116|P3|STARTED|Overall Study||180
1498670|NCT01682876|3666117|P2|STARTED|Overall Study||183
1498671|NCT01682876|3666118|P1|STARTED|Overall Study||176
1498672|NCT01682863|3666164|P3|NOT COMPLETED|Overall Study||24
1498673|NCT01682863|3666165|P2|NOT COMPLETED|Overall Study||17
1498674|NCT01682863|3666166|P1|NOT COMPLETED|Overall Study||27
1498675|NCT01682863|3666164|P3|COMPLETED|Overall Study||183
1498676|NCT01682863|3666165|P2|COMPLETED|Overall Study||187
1498677|NCT01682863|3666166|P1|COMPLETED|Overall Study||177
1498678|NCT01682863|3666164|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
1498679|NCT01682863|3666165|P2|Randomized Set|Overall Study||204
1498680|NCT01682863|3666166|P1|Randomized Set|Overall Study||204
1498681|NCT01682863|3666164|P3|Full Analysis Set (FAS)|Overall Study||206
1498682|NCT01682863|3666165|P2|Full Analysis Set (FAS)|Overall Study||204
1498683|NCT01682863|3666166|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
1498684|NCT01682863|3666164|P3|Safety Set|Overall Study||206
1498685|NCT01682863|3666165|P2|Safety Set|Overall Study||204
1498686|NCT01682863|3666166|P1|Safety Set|Overall Study||204
1498687|NCT01682863|3666164|P3|STARTED|Overall Study||207
1498688|NCT01682863|3666165|P2|STARTED|Overall Study||204
1498689|NCT01682863|3666166|P1|STARTED|Overall Study||204
1498690|NCT01682837|3666195|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
1498691|NCT01682837|3666195|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
1498692|NCT01682837|3666195|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
1498693|NCT01682837|3666195|P1|Received KCl|Fourth Intervention (4 Weeks)||8
1498694|NCT01682837|3666195|P1|Received KCit|Fourth Intervention (4 Weeks)||9
1498695|NCT01682837|3666195|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
1498696|NCT01682837|3666195|P1|STARTED|Fourth Intervention (4 Weeks)||30
1498697|NCT01682837|3666195|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
1498698|NCT01682837|3666195|P1|COMPLETED|Third Intervention (4 Weeks)||30
1498699|NCT01682837|3666195|P1|Received Placebo|Third Intervention (4 Weeks)||7
1498700|NCT01682837|3666195|P1|Received KCl|Third Intervention (4 Weeks)||7
1498701|NCT01682837|3666195|P1|Received KCit|Third Intervention (4 Weeks)||7
1498702|NCT01682837|3666195|P1|Received KMgCit|Third Intervention (4 Weeks)||9
1498703|NCT01682837|3666195|P1|STARTED|Third Intervention (4 Weeks)||30
1498704|NCT01682837|3666195|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
1498705|NCT01682837|3666195|P1|COMPLETED|Second Intervention (4 Weeks)||30
1498706|NCT01682837|3666195|P1|Received Placebo|Second Intervention (4 Weeks)||9
1498707|NCT01682837|3666195|P1|Received KCl|Second Intervention (4 Weeks)||8
1498708|NCT01682837|3666195|P1|Received KCit|Second Intervention (4 Weeks)||6
1498709|NCT01682837|3666195|P1|Received KMgCit|Second Intervention (4 Weeks)||7
1498710|NCT01682837|3666195|P1|STARTED|Second Intervention (4 Weeks)||30
1498711|NCT01682837|3666195|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
1498712|NCT01682837|3666195|P1|COMPLETED|First Intervention (4 Weeks)||30
1498713|NCT01682837|3666195|P1|Received Placebo|First Intervention (4 Weeks)||7
1498714|NCT01682837|3666195|P1|Received KCl|First Intervention (4 Weeks)||7
1498715|NCT01682837|3666195|P1|Received KCit|First Intervention (4 Weeks)||8
1498716|NCT01682837|3666195|P1|Received KMgCit|First Intervention (4 Weeks)||8
1498717|NCT01682837|3666195|P1|STARTED|First Intervention (4 Weeks)||30
1498718|NCT01682837|3666195|P1|NOT COMPLETED|Baseline||5
1498719|NCT01682837|3666195|P1|COMPLETED|Baseline||30
1498720|NCT01682837|3666195|P1|STARTED|Baseline||35
1498721|NCT01682759|3666239|P2|NOT COMPLETED|Overall Study||70
1498722|NCT01682759|3666240|P1|NOT COMPLETED|Overall Study||69
1498723|NCT01682759|3666239|P2|COMPLETED|Overall Study||305
1498724|NCT01682759|3666240|P1|COMPLETED|Overall Study||307
1498725|NCT01682759|3666239|P2|Treated|Overall Study||375
1498726|NCT01682759|3666240|P1|Treated|Overall Study||375
1498727|NCT01682759|3666239|P2|STARTED|Overall Study||375
1498728|NCT01682759|3666240|P1|STARTED|Overall Study||376
1498729|NCT01682720|3666264|P4|NOT COMPLETED|Overall Study||39
1498730|NCT01682720|3666265|P3|NOT COMPLETED|Overall Study||7
1498731|NCT01682720|3666266|P2|NOT COMPLETED|Overall Study||5
1498732|NCT01682720|3666267|P1|NOT COMPLETED|Overall Study||85
1498733|NCT01682720|3666264|P4|COMPLETED|Overall Study||211
1498734|NCT01682720|3666265|P3|COMPLETED|Overall Study||5
1498735|NCT01682720|3666266|P2|COMPLETED|Overall Study||69
1498736|NCT01682720|3666267|P1|COMPLETED|Overall Study||0
1498737|NCT01682720|3666264|P4|Included in Full Analysis Set|Overall Study||250
1498738|NCT01682720|3666265|P3|Included in Full Analysis Set|Overall Study||11
1498739|NCT01682720|3666266|P2|Included in Full Analysis Set|Overall Study||73
1498740|NCT01682720|3666267|P1|Included in Full Analysis Set|Overall Study||0
1498741|NCT01682720|3666264|P4|STARTED|Overall Study||250
1498742|NCT01682720|3666265|P3|STARTED|Overall Study||12
1498743|NCT01682720|3666266|P2|STARTED|Overall Study||74
1498744|NCT01682720|3666267|P1|STARTED|Overall Study||85
1498745|NCT01682681|3666284|P1|NOT COMPLETED|Overall Study||332
1498746|NCT01682681|3666284|P1|COMPLETED|Overall Study||902
1498747|NCT01682681|3666284|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
1498748|NCT01682681|3666284|P1|STARTED|Overall Study||1234
1498749|NCT01682642|3666294|P2|NOT COMPLETED|Overall Study||1
1498750|NCT01682642|3666295|P1|NOT COMPLETED|Overall Study||0
1498751|NCT01682642|3666294|P2|COMPLETED|Overall Study||58
1498752|NCT01682642|3666295|P1|COMPLETED|Overall Study||61
1498753|NCT01682642|3666294|P2|STARTED|Overall Study||59
1498754|NCT01682642|3666295|P1|STARTED|Overall Study||61
1498755|NCT01682603|3666313|P1|NOT COMPLETED|Overall Study||3
1498756|NCT01682603|3666313|P1|COMPLETED|Overall Study||34
1498757|NCT01682603|3666313|P1|STARTED|Overall Study||37
1498758|NCT01682538|3666327|P1|NOT COMPLETED|Overall Study||0
1498759|NCT01682538|3666327|P1|COMPLETED|Overall Study||12
1498760|NCT01682538|3666327|P1|STARTED|Overall Study||12
1498761|NCT01682512|3666358|P3|NOT COMPLETED|Overall Study||18
1498762|NCT01682512|3666359|P2|NOT COMPLETED|Overall Study||71
1498763|NCT01682512|3666360|P1|NOT COMPLETED|Overall Study||72
1498764|NCT01682512|3666358|P3|COMPLETED|Overall Study||48
1498765|NCT01682512|3666359|P2|COMPLETED|Overall Study||40
1498766|NCT01682512|3666360|P1|COMPLETED|Overall Study||44
1498767|NCT01682512|3666358|P3|Randomized in Part-II|Overall Study||0
1498768|NCT01682512|3666359|P2|Randomized in Part-II|Overall Study||46
1498769|NCT01682512|3666360|P1|Randomized in Part-II|Overall Study||50
1498770|NCT01682512|3666358|P3|Randomized in Part-I|Overall Study||66
1498771|NCT01682512|3666359|P2|Randomized in Part-I|Overall Study||65
1498772|NCT01682512|3666360|P1|Randomized in Part-I|Overall Study||66
1498773|NCT01682512|3666358|P3|STARTED|Overall Study||66
1498774|NCT01682512|3666359|P2|STARTED|Overall Study||111
1498775|NCT01682512|3666360|P1|STARTED|Overall Study||116
1498776|NCT01682460|3666385|P1|NOT COMPLETED|Overall Study||4
1498777|NCT01682460|3666385|P1|COMPLETED|Overall Study||11
1498778|NCT01682460|3666385|P1|STARTED|Overall Study||15
1498779|NCT01682135|3666403|P3|NOT COMPLETED|Overall Study||0
1498780|NCT01682135|3666404|P2|NOT COMPLETED|Overall Study||0
1498781|NCT01682135|3666405|P1|NOT COMPLETED|Overall Study||0
1498782|NCT01682135|3666403|P3|COMPLETED|Overall Study||12
1498783|NCT01682135|3666404|P2|COMPLETED|Overall Study||10
1498784|NCT01682135|3666405|P1|COMPLETED|Overall Study||6
1498785|NCT01682135|3666403|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
1498786|NCT01682135|3666404|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
1498787|NCT01682135|3666405|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
1498788|NCT01682135|3666403|P3|STARTED|Overall Study||12
1498789|NCT01682135|3666404|P2|STARTED|Overall Study||10
1498790|NCT01682135|3666405|P1|STARTED|Overall Study||6
1498791|NCT01682083|3666439|P2|NOT COMPLETED|Overall Study||155
1498792|NCT01682083|3666440|P1|NOT COMPLETED|Overall Study||107
1498793|NCT01682083|3666439|P2|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
1498794|NCT01682083|3666440|P1|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
1498795|NCT01682083|3666439|P2|STARTED|Overall Study||432
1498796|NCT01682083|3666440|P1|STARTED|Overall Study||438
1498797|NCT01682044|3666452|P1|NOT COMPLETED|Overall Study||4
1498798|NCT01682044|3666452|P1|COMPLETED|Overall Study||16
1498799|NCT01682044|3666452|P1|STARTED|Overall Study||20
1498800|NCT01682031|3666464|P2|NOT COMPLETED|Overall Study||5
1498801|NCT01682031|3666465|P1|NOT COMPLETED|Overall Study||1
1498802|NCT01682031|3666464|P2|COMPLETED|Overall Study||5
1498803|NCT01682031|3666465|P1|COMPLETED|Overall Study||7
1498804|NCT01682031|3666464|P2|STARTED|Overall Study||10
1498805|NCT01682031|3666465|P1|STARTED|Overall Study||8
1498806|NCT01681992|3666488|P3|NOT COMPLETED|Overall Study||83
1498807|NCT01681992|3666489|P2|NOT COMPLETED|Overall Study||70
1498808|NCT01681992|3666490|P1|NOT COMPLETED|Overall Study||66
1498809|NCT01681992|3666488|P3|COMPLETED|Overall Study||1443
1498810|NCT01681992|3666489|P2|COMPLETED|Overall Study||1427
1498811|NCT01681992|3666490|P1|COMPLETED|Overall Study||1427
1498812|NCT01681992|3666488|P3|STARTED|Overall Study||1526
1498813|NCT01681992|3666489|P2|STARTED|Overall Study||1497
1498814|NCT01681992|3666490|P1|STARTED|Overall Study||1493
1498815|NCT01681849|3666579|P3|NOT COMPLETED|Overall Study||39
1498816|NCT01681849|3666580|P2|NOT COMPLETED|Overall Study||7
1498817|NCT01681849|3666581|P1|NOT COMPLETED|Overall Study||8
1498818|NCT01681849|3666579|P3|COMPLETED|Overall Study||17
1498819|NCT01681849|3666580|P2|COMPLETED|Overall Study||6
1498820|NCT01681849|3666581|P1|COMPLETED|Overall Study||7
1498821|NCT01681849|3666579|P3|STARTED|Overall Study||56
1498822|NCT01681849|3666580|P2|STARTED|Overall Study||13
1498823|NCT01681849|3666581|P1|STARTED|Overall Study||15
1498824|NCT01681836|3666590|P2|NOT COMPLETED|Second Intervention||1
1498825|NCT01681836|3666591|P1|NOT COMPLETED|Second Intervention||0
1498826|NCT01681836|3666590|P2|COMPLETED|Second Intervention||4
1498827|NCT01681836|3666591|P1|COMPLETED|Second Intervention||6
1498828|NCT01681836|3666590|P2|STARTED|Second Intervention||5
1498829|NCT01681836|3666591|P1|STARTED|Second Intervention||6
1498830|NCT01681836|3666590|P2|NOT COMPLETED|Washout Period of 3-7 Days||0
1498831|NCT01681836|3666591|P1|NOT COMPLETED|Washout Period of 3-7 Days||0
1498832|NCT01681836|3666590|P2|COMPLETED|Washout Period of 3-7 Days||5
1498833|NCT01681836|3666591|P1|COMPLETED|Washout Period of 3-7 Days||6
1498834|NCT01681836|3666590|P2|STARTED|Washout Period of 3-7 Days||5
1498835|NCT01681836|3666591|P1|STARTED|Washout Period of 3-7 Days||6
1498836|NCT01681836|3666590|P2|NOT COMPLETED|First Intervention||0
1498837|NCT01681836|3666591|P1|NOT COMPLETED|First Intervention||0
1498838|NCT01681836|3666590|P2|COMPLETED|First Intervention||5
1498839|NCT01681836|3666591|P1|COMPLETED|First Intervention||6
1498840|NCT01681836|3666590|P2|STARTED|First Intervention||5
1498841|NCT01681836|3666591|P1|STARTED|First Intervention||6
1498842|NCT01681628|3666617|P2|NOT COMPLETED|19 Months Follow-up||43
1498843|NCT01681628|3666618|P1|NOT COMPLETED|19 Months Follow-up||62
1498844|NCT01681628|3666617|P2|COMPLETED|19 Months Follow-up||64
1498845|NCT01681628|3666618|P1|COMPLETED|19 Months Follow-up||52
1498846|NCT01681628|3666617|P2|STARTED|19 Months Follow-up||107
1498847|NCT01681628|3666618|P1|STARTED|19 Months Follow-up||114
1498848|NCT01681628|3666617|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
1498849|NCT01681628|3666618|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
1498850|NCT01681628|3666617|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
1498851|NCT01681628|3666618|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
1498852|NCT01681628|3666617|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
1498853|NCT01681628|3666618|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
1498854|NCT01681628|3666617|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
1498855|NCT01681628|3666618|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
1498856|NCT01681628|3666617|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
1498857|NCT01681628|3666618|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
1498858|NCT01681628|3666617|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
1498859|NCT01681628|3666618|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
1498860|NCT01681576|3666631|P2|NOT COMPLETED|Period 2||1
1498861|NCT01681576|3666632|P1|NOT COMPLETED|Period 2||4
1498862|NCT01681576|3666631|P2|COMPLETED|Period 2||35
1498863|NCT01681576|3666632|P1|COMPLETED|Period 2||30
1498864|NCT01681576|3666631|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
1498865|NCT01681576|3666632|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
1498866|NCT01681576|3666631|P2|NOT COMPLETED|Period 1||0
1498867|NCT01681576|3666632|P1|NOT COMPLETED|Period 1||2
1498868|NCT01681576|3666631|P2|COMPLETED|Period 1||36
1498869|NCT01681576|3666632|P1|COMPLETED|Period 1||34
1498870|NCT01681576|3666631|P2|STARTED|Period 1||36
1498871|NCT01681576|3666632|P1|STARTED|Period 1||36
1498872|NCT01681511|3666648|P2|NOT COMPLETED|Overall Study||14
1498873|NCT01681511|3666649|P1|NOT COMPLETED|Overall Study||18
1498874|NCT01681511|3666648|P2|COMPLETED|Overall Study||35
1498875|NCT01681511|3666649|P1|COMPLETED|Overall Study||28
1498876|NCT01681511|3666648|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
1498877|NCT01681511|3666649|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
1498878|NCT01681511|3666648|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
1498879|NCT01681511|3666649|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
1498880|NCT01681511|3666648|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
1498881|NCT01681511|3666649|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
1498882|NCT01681472|3666667|P4|NOT COMPLETED|Overall Study||0
1498883|NCT01681472|3666668|P3|NOT COMPLETED|Overall Study||0
1498884|NCT01681472|3666669|P2|NOT COMPLETED|Overall Study||1
1498885|NCT01681472|3666670|P1|NOT COMPLETED|Overall Study||0
1498886|NCT01681472|3666667|P4|COMPLETED|Overall Study||8
1498887|NCT01681472|3666668|P3|COMPLETED|Overall Study||8
1498888|NCT01681472|3666669|P2|COMPLETED|Overall Study||7
1498889|NCT01681472|3666670|P1|COMPLETED|Overall Study||8
1498890|NCT01681472|3666667|P4|STARTED|Overall Study||8
1498891|NCT01681472|3666668|P3|STARTED|Overall Study||8
1498892|NCT01681472|3666669|P2|STARTED|Overall Study||8
1498893|NCT01681472|3666670|P1|STARTED|Overall Study||8
1498894|NCT01681433|3666682|P2|NOT COMPLETED|Overall Study||33
1498895|NCT01681433|3666683|P1|NOT COMPLETED|Overall Study||32
1498896|NCT01681433|3666682|P2|COMPLETED|Overall Study||3
1498897|NCT01681433|3666683|P1|COMPLETED|Overall Study||4
1498898|NCT01681433|3666682|P2|STARTED|Overall Study||36
1498899|NCT01681433|3666683|P1|STARTED|Overall Study||36
1498900|NCT01681368|3666701|P1|NOT COMPLETED|Overall Study||2
1498901|NCT01681368|3666701|P1|COMPLETED|Overall Study||9
1498902|NCT01681368|3666701|P1|STARTED|Overall Study||11
1498903|NCT01681277|3666718|P5|NOT COMPLETED|Overall Study||0
1498904|NCT01681277|3666719|P4|NOT COMPLETED|Overall Study||0
1498905|NCT01681277|3666720|P3|NOT COMPLETED|Overall Study||0
1498906|NCT01681277|3666721|P2|NOT COMPLETED|Overall Study||0
1498907|NCT01681277|3666722|P1|NOT COMPLETED|Overall Study||1
1498908|NCT01681277|3666718|P5|COMPLETED|Overall Study||9
1498909|NCT01681277|3666719|P4|COMPLETED|Overall Study||9
1498910|NCT01681277|3666720|P3|COMPLETED|Overall Study||9
1498911|NCT01681277|3666721|P2|COMPLETED|Overall Study||9
1498912|NCT01681277|3666722|P1|COMPLETED|Overall Study||11
1498913|NCT01681277|3666718|P5|STARTED|Overall Study||9
1498914|NCT01681277|3666719|P4|STARTED|Overall Study||9
1498915|NCT01681277|3666720|P3|STARTED|Overall Study||9
1498916|NCT01681277|3666721|P2|STARTED|Overall Study||9
1498917|NCT01681277|3666722|P1|STARTED|Overall Study||12
1498918|NCT01681212|3666763|P1|NOT COMPLETED|Overall Study||6
1498919|NCT01681212|3666763|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
1498920|NCT01681212|3666763|P1|Received Treatment|Overall Study||15
1498921|NCT01681212|3666763|P1|STARTED|Overall Study|Enrolled|21
1498922|NCT01681121|3666771|P2|NOT COMPLETED|Overall Study||11
1498923|NCT01681121|3666772|P1|NOT COMPLETED|Overall Study||8
1498924|NCT01681121|3666771|P2|COMPLETED|Overall Study||38
1498925|NCT01681121|3666772|P1|COMPLETED|Overall Study||36
1498926|NCT01681121|3666771|P2|STARTED|Overall Study||49
1498927|NCT01681121|3666772|P1|STARTED|Overall Study||44
1498928|NCT01681095|3666780|P2|NOT COMPLETED|Overall Study||0
1498929|NCT01681095|3666781|P1|NOT COMPLETED|Overall Study||0
1498930|NCT01681095|3666780|P2|COMPLETED|Overall Study||55
1498931|NCT01681095|3666781|P1|COMPLETED|Overall Study||55
1498932|NCT01681095|3666780|P2|STARTED|Overall Study||55
1498933|NCT01681095|3666781|P1|STARTED|Overall Study||55
1498934|NCT01681069|3666821|P2|NOT COMPLETED|Overall Study||7
1498935|NCT01681069|3666822|P1|NOT COMPLETED|Overall Study||5
1498936|NCT01681069|3666821|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
1498937|NCT01681069|3666822|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
1498938|NCT01681069|3666821|P2|Full Analysis Set (FAS)|Overall Study||60
1498939|NCT01681069|3666822|P1|Full Analysis Set (FAS)|Overall Study||57
1498940|NCT01681069|3666821|P2|STARTED|Overall Study||60
1498941|NCT01681069|3666822|P1|STARTED|Overall Study||60
1498942|NCT01681030|3666835|P3|NOT COMPLETED|Overall Study||0
1498943|NCT01681030|3666836|P2|NOT COMPLETED|Overall Study||0
1498944|NCT01681030|3666837|P1|NOT COMPLETED|Overall Study||0
1498945|NCT01681030|3666835|P3|COMPLETED|Overall Study||11
1498946|NCT01681030|3666836|P2|COMPLETED|Overall Study||18
1498947|NCT01681030|3666837|P1|COMPLETED|Overall Study||13
1498948|NCT01681030|3666835|P3|STARTED|Overall Study||11
1498949|NCT01681030|3666836|P2|STARTED|Overall Study||18
1498950|NCT01681030|3666837|P1|STARTED|Overall Study||13
1498951|NCT01681004|3666859|P2|NOT COMPLETED|Study Completion||8
1498952|NCT01681004|3666860|P1|NOT COMPLETED|Study Completion||12
1498953|NCT01681004|3666859|P2|COMPLETED|Study Completion||36
1498954|NCT01681004|3666860|P1|COMPLETED|Study Completion||89
1498955|NCT01681004|3666859|P2|STARTED|Study Completion||44
1498956|NCT01681004|3666860|P1|STARTED|Study Completion||101
1498957|NCT01681004|3666859|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
1498958|NCT01681004|3666860|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
1498959|NCT01681004|3666859|P2|COMPLETED|Primary Endpoint: 6 Months||44
1498960|NCT01681004|3666860|P1|COMPLETED|Primary Endpoint: 6 Months||101
1498961|NCT01681004|3666859|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
1498962|NCT01681004|3666860|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
1498963|NCT01681004|3666859|P2|STARTED|Primary Endpoint: 6 Months||46
1498964|NCT01681004|3666860|P1|STARTED|Primary Endpoint: 6 Months||102
1498965|NCT01680991|3666917|P3|NOT COMPLETED|Overall Study||4
1498966|NCT01680991|3666918|P2|NOT COMPLETED|Overall Study||19
1498967|NCT01680991|3666919|P1|NOT COMPLETED|Overall Study||8
1498968|NCT01680991|3666917|P3|COMPLETED|Overall Study||9
1498969|NCT01680991|3666918|P2|COMPLETED|Overall Study||4
1498970|NCT01680991|3666919|P1|COMPLETED|Overall Study||4
1498971|NCT01680991|3666917|P3|STARTED|Overall Study||13
1498972|NCT01680991|3666918|P2|STARTED|Overall Study||23
1498973|NCT01680991|3666919|P1|STARTED|Overall Study||12
1498974|NCT01680900|3666980|P2|NOT COMPLETED|Overall Study||1
1498975|NCT01680900|3666981|P1|NOT COMPLETED|Overall Study||4
1498976|NCT01680900|3666980|P2|COMPLETED|Overall Study||11
1498977|NCT01680900|3666981|P1|COMPLETED|Overall Study||20
1498978|NCT01680900|3666980|P2|STARTED|Overall Study||12
1498979|NCT01680900|3666981|P1|STARTED|Overall Study||24
1498980|NCT01680861|3666999|P2|NOT COMPLETED|First 12 Months Post-transplant||0
1498981|NCT01680861|3667000|P1|NOT COMPLETED|First 12 Months Post-transplant||0
1498982|NCT01680861|3666999|P2|COMPLETED|First 12 Months Post-transplant||15
1498983|NCT01680861|3667000|P1|COMPLETED|First 12 Months Post-transplant||15
1498984|NCT01680861|3666999|P2|STARTED|First 12 Months Post-transplant||15
1498985|NCT01680861|3667000|P1|STARTED|First 12 Months Post-transplant||15
1498986|NCT01680861|3666999|P2|NOT COMPLETED|Early Post-transplant Period||1
1498987|NCT01680861|3667000|P1|NOT COMPLETED|Early Post-transplant Period||1
1498988|NCT01680861|3666999|P2|COMPLETED|Early Post-transplant Period||15
1498989|NCT01680861|3667000|P1|COMPLETED|Early Post-transplant Period||15
1498990|NCT01680861|3666999|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
1498991|NCT01680861|3667000|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
1498992|NCT01680848|3667018|P1|NOT COMPLETED|Overall Study||93
1498993|NCT01680848|3667018|P1|COMPLETED|Overall Study||189
1498994|NCT01680848|3667018|P1|STARTED|Overall Study||282
1498995|NCT01680783|3667024|P2|NOT COMPLETED|Overall Study||0
1498996|NCT01680783|3667025|P1|NOT COMPLETED|Overall Study||0
1498997|NCT01680783|3667024|P2|COMPLETED|Overall Study||44
1498998|NCT01680783|3667025|P1|COMPLETED|Overall Study||39
1498999|NCT01680783|3667024|P2|STARTED|Overall Study||44
1499000|NCT01680783|3667025|P1|STARTED|Overall Study||39
1499001|NCT01680666|3667033|P2|NOT COMPLETED|Overall Study||0
1499002|NCT01680666|3667034|P1|NOT COMPLETED|Overall Study||0
1499003|NCT01680666|3667033|P2|COMPLETED|Overall Study||66
1499004|NCT01680666|3667034|P1|COMPLETED|Overall Study||84
1499005|NCT01680666|3667033|P2|STARTED|Overall Study||66
1499006|NCT01680666|3667034|P1|STARTED|Overall Study||84
1499007|NCT01680653|3667048|P1|NOT COMPLETED|Overall Study||0
1499008|NCT01680653|3667048|P1|COMPLETED|Overall Study||57
1499009|NCT01680653|3667048|P1|STARTED|Overall Study||57
1499010|NCT01680549|3667060|P2|NOT COMPLETED|Overall Study||8
1499011|NCT01680549|3667061|P1|NOT COMPLETED|Overall Study||5
1499012|NCT01680549|3667060|P2|COMPLETED|Overall Study||17
1499013|NCT01680549|3667061|P1|COMPLETED|Overall Study||20
1499014|NCT01680549|3667060|P2|STARTED|Overall Study||25
1499015|NCT01680549|3667061|P1|STARTED|Overall Study||25
1499016|NCT01680497|3667073|P1|NOT COMPLETED|Overall Study||2
1499017|NCT01680497|3667073|P1|COMPLETED|Overall Study||68
1499018|NCT01680497|3667073|P1|STARTED|Overall Study||70
1499019|NCT01680458|3667083|P1|NOT COMPLETED|Overall Study||3
1499020|NCT01680458|3667083|P1|COMPLETED|Overall Study||27
1499021|NCT01680458|3667083|P1|STARTED|Overall Study||30
1499022|NCT01680341|3667094|P2|NOT COMPLETED|Overall Study||17
1499023|NCT01680341|3667095|P1|NOT COMPLETED|Overall Study||21
1499024|NCT01680341|3667094|P2|COMPLETED|Overall Study||119
1499025|NCT01680341|3667095|P1|COMPLETED|Overall Study||115
1499026|NCT01680341|3667094|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
1499027|NCT01680341|3667095|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
1499028|NCT01680341|3667094|P2|STARTED|Overall Study||136
1499029|NCT01680341|3667095|P1|STARTED|Overall Study||136
1499030|NCT01680328|3667115|P1|NOT COMPLETED|Overall Study||2
1499031|NCT01680328|3667115|P1|COMPLETED|Overall Study||80
1499032|NCT01680328|3667115|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
1499033|NCT01680328|3667115|P1|STARTED|Overall Study||82
1499034|NCT01680172|3667153|P2|NOT COMPLETED|Overall Study||0
1499035|NCT01680172|3667154|P1|NOT COMPLETED|Overall Study||0
1499036|NCT01680172|3667153|P2|COMPLETED|Overall Study||2
1499037|NCT01680172|3667154|P1|COMPLETED|Overall Study||3
1499038|NCT01680172|3667153|P2|STARTED|Overall Study||2
1499039|NCT01680172|3667154|P1|STARTED|Overall Study||3
1499040|NCT01680159|3667166|P1|NOT COMPLETED|Increased Dose Period||8
1499041|NCT01680159|3667166|P1|COMPLETED|Increased Dose Period||43
1499042|NCT01680159|3667166|P1|STARTED|Increased Dose Period||51
1499043|NCT01680159|3667166|P1|NOT COMPLETED|Screening Period||7
1499044|NCT01680159|3667166|P1|COMPLETED|Screening Period||39
1499045|NCT01680159|3667166|P1|STARTED|Screening Period||46
1499046|NCT01680016|3667193|P4|NOT COMPLETED|Overall Study||5
1499047|NCT01680016|3667194|P3|NOT COMPLETED|Overall Study||5
1499048|NCT01680016|3667195|P2|NOT COMPLETED|Overall Study||8
1499049|NCT01680016|3667196|P1|NOT COMPLETED|Overall Study||6
1499050|NCT01680016|3667193|P4|COMPLETED|Overall Study||195
1499051|NCT01680016|3667194|P3|COMPLETED|Overall Study||196
1499052|NCT01680016|3667195|P2|COMPLETED|Overall Study||114
1499053|NCT01680016|3667196|P1|COMPLETED|Overall Study||115
1499054|NCT01680016|3667193|P4|STARTED|Overall Study||200
1499055|NCT01680016|3667194|P3|STARTED|Overall Study||201
1499056|NCT01680016|3667195|P2|STARTED|Overall Study||122
1499057|NCT01680016|3667196|P1|STARTED|Overall Study||121
1499058|NCT01679613|3667258|P4|NOT COMPLETED|Overall Study||2
1499059|NCT01679613|3667259|P3|NOT COMPLETED|Overall Study||2
1499060|NCT01679613|3667260|P2|NOT COMPLETED|Overall Study||1
1499061|NCT01679613|3667261|P1|NOT COMPLETED|Overall Study||0
1499062|NCT01679613|3667258|P4|COMPLETED|Overall Study||11
1499063|NCT01679613|3667259|P3|COMPLETED|Overall Study||11
1499064|NCT01679613|3667260|P2|COMPLETED|Overall Study||3
1499065|NCT01679613|3667261|P1|COMPLETED|Overall Study||4
1499066|NCT01679613|3667258|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
1499067|NCT01679613|3667259|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
1499068|NCT01679613|3667260|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
1499069|NCT01679613|3667261|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
1499070|NCT01679613|3667258|P4|Received Nintedanib (Main)|Overall Study||11
1499071|NCT01679613|3667259|P3|Received Nintedanib (Main)|Overall Study||13
1499072|NCT01679613|3667260|P2|Received Nintedanib (Main)|Overall Study||0
1499073|NCT01679613|3667261|P1|Received Nintedanib (Main)|Overall Study||0
1499074|NCT01679613|3667258|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
1499075|NCT01679613|3667259|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
1499076|NCT01679613|3667260|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
1499077|NCT01679613|3667261|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
1499078|NCT01679613|3667258|P4|Received Nintedanib (Pilot)|Overall Study||0
1499079|NCT01679613|3667259|P3|Received Nintedanib (Pilot)|Overall Study||0
1499080|NCT01679613|3667260|P2|Received Nintedanib (Pilot)|Overall Study||3
1499081|NCT01679613|3667261|P1|Received Nintedanib (Pilot)|Overall Study||4
1499082|NCT01679613|3667258|P4|STARTED|Overall Study||13
1499083|NCT01679613|3667259|P3|STARTED|Overall Study||13
1499084|NCT01679613|3667260|P2|STARTED|Overall Study||4
1499085|NCT01679613|3667261|P1|STARTED|Overall Study||4
1499086|NCT01679600|3667274|P2|NOT COMPLETED|Overall Study||0
1499087|NCT01679600|3667275|P1|NOT COMPLETED|Overall Study||0
1499088|NCT01679600|3667274|P2|COMPLETED|Overall Study||7
1499089|NCT01679600|3667275|P1|COMPLETED|Overall Study||7
1499090|NCT01679600|3667274|P2|STARTED|Overall Study||7
1499091|NCT01679600|3667275|P1|STARTED|Overall Study||7
1499092|NCT01679314|3667283|P2|NOT COMPLETED|Overall Study||0
1499093|NCT01679314|3667284|P1|NOT COMPLETED|Overall Study||2
1499094|NCT01679314|3667283|P2|COMPLETED|Overall Study||28
1499095|NCT01679314|3667284|P1|COMPLETED|Overall Study||24
1499096|NCT01679314|3667283|P2|STARTED|Overall Study||28
1499097|NCT01679314|3667284|P1|STARTED|Overall Study||26
1499098|NCT01679301|3667302|P3|NOT COMPLETED|Study Period||0
1499099|NCT01679301|3667303|P2|NOT COMPLETED|Study Period||0
1499100|NCT01679301|3667304|P1|NOT COMPLETED|Study Period||0
1499101|NCT01679301|3667302|P3|COMPLETED|Study Period||4
1499102|NCT01679301|3667303|P2|COMPLETED|Study Period||4
1499103|NCT01679301|3667304|P1|COMPLETED|Study Period||0
1499104|NCT01679301|3667302|P3|STARTED|Study Period||4
1499105|NCT01679301|3667303|P2|STARTED|Study Period||4
1499106|NCT01679301|3667304|P1|STARTED|Study Period||0
1499107|NCT01679301|3667302|P3|NOT COMPLETED|Screening Period||0
1499108|NCT01679301|3667303|P2|NOT COMPLETED|Screening Period||0
1499109|NCT01679301|3667304|P1|NOT COMPLETED|Screening Period||3
1499110|NCT01679301|3667302|P3|COMPLETED|Screening Period||0
1499111|NCT01679301|3667303|P2|COMPLETED|Screening Period||0
1499112|NCT01679301|3667304|P1|COMPLETED|Screening Period||8
1499113|NCT01679301|3667302|P3|STARTED|Screening Period||0
1499114|NCT01679301|3667303|P2|STARTED|Screening Period||0
1499115|NCT01679301|3667304|P1|STARTED|Screening Period||11
1499116|NCT01679236|3667312|P2|NOT COMPLETED|Overall Study||15
1499117|NCT01679236|3667313|P1|NOT COMPLETED|Overall Study||15
1499118|NCT01679236|3667312|P2|COMPLETED|Overall Study||10
1499119|NCT01679236|3667313|P1|COMPLETED|Overall Study||15
1499120|NCT01679236|3667312|P2|STARTED|Overall Study||25
1499121|NCT01679236|3667313|P1|STARTED|Overall Study||30
1499122|NCT01679197|3667319|P1|NOT COMPLETED|Overall Study||4
1499123|NCT01679197|3667319|P1|COMPLETED|Overall Study||19
1499124|NCT01679197|3667319|P1|STARTED|Overall Study||23
1499125|NCT01679028|3667338|P6|NOT COMPLETED|Overall Study||0
1499126|NCT01679028|3667339|P5|NOT COMPLETED|Overall Study||0
1499127|NCT01679028|3667340|P4|NOT COMPLETED|Overall Study||0
1499128|NCT01679028|3667341|P3|NOT COMPLETED|Overall Study||0
1499129|NCT01679028|3667342|P2|NOT COMPLETED|Overall Study||0
1499130|NCT01679028|3667343|P1|NOT COMPLETED|Overall Study||0
1499131|NCT01679028|3667338|P6|COMPLETED|Overall Study||6
1499132|NCT01679028|3667339|P5|COMPLETED|Overall Study||2
1499133|NCT01679028|3667340|P4|COMPLETED|Overall Study||4
1499134|NCT01679028|3667341|P3|COMPLETED|Overall Study||2
1499135|NCT01679028|3667342|P2|COMPLETED|Overall Study||4
1499136|NCT01679028|3667343|P1|COMPLETED|Overall Study||2
1499137|NCT01679028|3667338|P6|STARTED|Overall Study||6
1499138|NCT01679028|3667339|P5|STARTED|Overall Study||2
1499139|NCT01679028|3667340|P4|STARTED|Overall Study||4
1499140|NCT01679028|3667341|P3|STARTED|Overall Study||2
1499141|NCT01679028|3667342|P2|STARTED|Overall Study||4
1499142|NCT01679028|3667343|P1|STARTED|Overall Study||2
1499143|NCT01679002|3667360|P3|NOT COMPLETED|Overall Study||0
1499144|NCT01679002|3667361|P2|NOT COMPLETED|Overall Study||1
1499145|NCT01679002|3667362|P1|NOT COMPLETED|Overall Study||1
1499146|NCT01679002|3667360|P3|COMPLETED|Overall Study||4
1499147|NCT01679002|3667361|P2|COMPLETED|Overall Study||3
1499148|NCT01679002|3667362|P1|COMPLETED|Overall Study||3
1499149|NCT01679002|3667360|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
1499150|NCT01679002|3667361|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
1499151|NCT01679002|3667362|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
1499152|NCT01679002|3667360|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
1499153|NCT01679002|3667361|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
1499154|NCT01679002|3667362|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
1499155|NCT01679002|3667360|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
1499156|NCT01679002|3667361|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
1499157|NCT01679002|3667362|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
1499158|NCT01679002|3667360|P3|STARTED|Overall Study||4
1499159|NCT01679002|3667361|P2|STARTED|Overall Study||4
1499160|NCT01679002|3667362|P1|STARTED|Overall Study||4
1499161|NCT01678976|3667378|P2|NOT COMPLETED|Second Period||0
1499162|NCT01678976|3667379|P1|NOT COMPLETED|Second Period||0
1499163|NCT01678976|3667378|P2|COMPLETED|Second Period||6
1499164|NCT01678976|3667379|P1|COMPLETED|Second Period||6
1499165|NCT01678976|3667378|P2|STARTED|Second Period||6
1499166|NCT01678976|3667379|P1|STARTED|Second Period||6
1499167|NCT01678976|3667378|P2|NOT COMPLETED|First Period||1
1499168|NCT01678976|3667379|P1|NOT COMPLETED|First Period||0
1499169|NCT01678976|3667378|P2|COMPLETED|First Period||6
1499170|NCT01678976|3667379|P1|COMPLETED|First Period||6
1499171|NCT01678976|3667378|P2|STARTED|First Period||7
1499172|NCT01678976|3667379|P1|STARTED|First Period||6
1499173|NCT01678911|3667389|P2|NOT COMPLETED|Second Intervention||0
1499174|NCT01678911|3667390|P1|NOT COMPLETED|Second Intervention||2
1499175|NCT01678911|3667389|P2|COMPLETED|Second Intervention||1
1499176|NCT01678911|3667390|P1|COMPLETED|Second Intervention||2
1499177|NCT01678911|3667389|P2|STARTED|Second Intervention||1
1499178|NCT01678911|3667390|P1|STARTED|Second Intervention||4
1499179|NCT01678911|3667389|P2|NOT COMPLETED|First Intervention||0
1499180|NCT01678911|3667390|P1|NOT COMPLETED|First Intervention||0
1499181|NCT01678911|3667389|P2|COMPLETED|First Intervention||1
1499182|NCT01678911|3667390|P1|COMPLETED|First Intervention||4
1499183|NCT01678911|3667389|P2|Cross Over|First Intervention||1
1499184|NCT01678911|3667390|P1|Cross Over|First Intervention||4
1499185|NCT01678911|3667389|P2|STARTED|First Intervention||1
1499186|NCT01678911|3667390|P1|STARTED|First Intervention||4
1499187|NCT01678885|3667406|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
1499188|NCT01678885|3667407|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1499189|NCT01678885|3667408|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1499190|NCT01678885|3667409|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1499191|NCT01678885|3667410|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1499192|NCT01678885|3667406|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
1499193|NCT01678885|3667407|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1499194|NCT01678885|3667408|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1499195|NCT01678885|3667409|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1499196|NCT01678885|3667410|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
1499197|NCT01678885|3667406|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
1499198|NCT01678885|3667407|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
1499199|NCT01678885|3667408|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
1499200|NCT01678885|3667409|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
1499201|NCT01678885|3667410|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
1499202|NCT01678885|3667406|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
1499203|NCT01678885|3667407|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
1499204|NCT01678885|3667408|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
1499205|NCT01678885|3667409|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
1499206|NCT01678885|3667410|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
1499207|NCT01678885|3667406|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
1499208|NCT01678885|3667407|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
1499209|NCT01678885|3667408|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
1499210|NCT01678885|3667409|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
1499211|NCT01678885|3667410|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
1499212|NCT01678885|3667406|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
1499213|NCT01678885|3667407|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
1499214|NCT01678885|3667408|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
1499215|NCT01678885|3667409|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
1499216|NCT01678885|3667410|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
1499217|NCT01678846|3667420|P2|NOT COMPLETED|Overall Study||0
1499218|NCT01678846|3667421|P1|NOT COMPLETED|Overall Study||0
1499219|NCT01678846|3667420|P2|COMPLETED|Overall Study||1899
1499220|NCT01678846|3667421|P1|COMPLETED|Overall Study||1921
1499221|NCT01678846|3667420|P2|STARTED|Overall Study||1899
1499222|NCT01678846|3667421|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
1499223|NCT01678820|3667436|P3|NOT COMPLETED|Overall Study||57
1499224|NCT01678820|3667437|P2|NOT COMPLETED|Overall Study||63
1499225|NCT01678820|3667438|P1|NOT COMPLETED|Overall Study||62
1499226|NCT01678820|3667436|P3|COMPLETED|Overall Study||43
1499227|NCT01678820|3667437|P2|COMPLETED|Overall Study||36
1499228|NCT01678820|3667438|P1|COMPLETED|Overall Study||38
1499229|NCT01678820|3667436|P3|Treated With Double-blind Study Drug|Overall Study||98
1499230|NCT01678820|3667437|P2|Treated With Double-blind Study Drug|Overall Study||97
1499231|NCT01678820|3667438|P1|Treated With Double-blind Study Drug|Overall Study||100
1499232|NCT01678820|3667436|P3|STARTED|Overall Study||100
1499233|NCT01678820|3667437|P2|STARTED|Overall Study||99
1499234|NCT01678820|3667438|P1|STARTED|Overall Study||100
1499235|NCT01678807|3667483|P3|NOT COMPLETED|Overall Study||0
1499236|NCT01678807|3667484|P2|NOT COMPLETED|Overall Study||5
1499237|NCT01678807|3667485|P1|NOT COMPLETED|Overall Study||4
1499238|NCT01678807|3667483|P3|COMPLETED|Overall Study||65
1499239|NCT01678807|3667484|P2|COMPLETED|Overall Study||60
1499240|NCT01678807|3667485|P1|COMPLETED|Overall Study||61
1499241|NCT01678807|3667483|P3|STARTED|Overall Study||65
1499242|NCT01678807|3667484|P2|STARTED|Overall Study||65
1499243|NCT01678807|3667485|P1|STARTED|Overall Study||65
1499244|NCT01678443|3667496|P1|NOT COMPLETED|Overall Study||0
1499245|NCT01678443|3667496|P1|COMPLETED|Overall Study||2
1499246|NCT01678443|3667496|P1|STARTED|Overall Study||2
1499247|NCT01678313|3667503|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
1499248|NCT01678313|3667504|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
1499249|NCT01678313|3667503|P2|COMPLETED|Prostate Biopsy at 3 Months||37
1499250|NCT01678313|3667504|P1|COMPLETED|Prostate Biopsy at 3 Months||45
1499251|NCT01678313|3667503|P2|STARTED|Prostate Biopsy at 3 Months||49
1499252|NCT01678313|3667504|P1|STARTED|Prostate Biopsy at 3 Months||56
1499253|NCT01678313|3667503|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
1499254|NCT01678313|3667504|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
1499255|NCT01678313|3667503|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
1499256|NCT01678313|3667504|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
1499257|NCT01678313|3667503|P2|STARTED|PSA >4 ng/dL at 3 Months||58
1499258|NCT01678313|3667504|P1|STARTED|PSA >4 ng/dL at 3 Months||64
1499259|NCT01678313|3667503|P2|NOT COMPLETED|Completed the 3-month Therapy||12
1499260|NCT01678313|3667504|P1|NOT COMPLETED|Completed the 3-month Therapy||6
1499261|NCT01678313|3667503|P2|COMPLETED|Completed the 3-month Therapy||58
1499262|NCT01678313|3667504|P1|COMPLETED|Completed the 3-month Therapy||64
1499263|NCT01678313|3667503|P2|STARTED|Completed the 3-month Therapy||70
1499264|NCT01678313|3667504|P1|STARTED|Completed the 3-month Therapy||70
1499265|NCT01678196|3667522|P2|NOT COMPLETED|Overall Study||0
1499266|NCT01678196|3667523|P1|NOT COMPLETED|Overall Study||0
1499267|NCT01678196|3667522|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
1499268|NCT01678196|3667523|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
1499269|NCT01678196|3667522|P2|STARTED|Overall Study||32
1499270|NCT01678196|3667523|P1|STARTED|Overall Study||34
1499271|NCT01678131|3667538|P3|NOT COMPLETED|Overall Study||2
1499272|NCT01678131|3667539|P2|NOT COMPLETED|Overall Study||1
1499273|NCT01678131|3667540|P1|NOT COMPLETED|Overall Study||0
1499274|NCT01678131|3667538|P3|COMPLETED|Overall Study||9
1499275|NCT01678131|3667539|P2|COMPLETED|Overall Study||9
1499276|NCT01678131|3667540|P1|COMPLETED|Overall Study||10
1499277|NCT01678131|3667538|P3|STARTED|Overall Study||11
1499278|NCT01678131|3667539|P2|STARTED|Overall Study||10
1499279|NCT01678131|3667540|P1|STARTED|Overall Study||10
1499280|NCT01677988|3667548|P1|NOT COMPLETED|Overall Study||2
1499281|NCT01677988|3667548|P1|COMPLETED|Overall Study||1
1499282|NCT01677988|3667548|P1|STARTED|Overall Study||3
1499283|NCT01677936|3667561|P2|NOT COMPLETED|Overall Study||5
1499284|NCT01677936|3667562|P1|NOT COMPLETED|Overall Study||9
1499285|NCT01677936|3667561|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
1499286|NCT01677936|3667562|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
1499287|NCT01677936|3667561|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
1499288|NCT01677936|3667562|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
1499289|NCT01677910|3667573|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
1499290|NCT01677910|3667574|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1499291|NCT01677910|3667575|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1499292|NCT01677910|3667576|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
1499293|NCT01677910|3667573|P4|COMPLETED|Open-Label Extension Period (OLE)||79
1499294|NCT01677910|3667574|P3|COMPLETED|Open-Label Extension Period (OLE)||0
1499295|NCT01677910|3667575|P2|COMPLETED|Open-Label Extension Period (OLE)||0
1499296|NCT01677910|3667576|P1|COMPLETED|Open-Label Extension Period (OLE)||0
1499297|NCT01677910|3667573|P4|STARTED|Open-Label Extension Period (OLE)||115
1499298|NCT01677910|3667574|P3|STARTED|Open-Label Extension Period (OLE)||0
1499299|NCT01677910|3667575|P2|STARTED|Open-Label Extension Period (OLE)||0
1499300|NCT01677910|3667576|P1|STARTED|Open-Label Extension Period (OLE)||0
1499301|NCT01677910|3667573|P4|NOT COMPLETED|Double-Blind Treatment Period||0
1499302|NCT01677910|3667574|P3|NOT COMPLETED|Double-Blind Treatment Period||7
1499303|NCT01677910|3667575|P2|NOT COMPLETED|Double-Blind Treatment Period||3
1499304|NCT01677910|3667576|P1|NOT COMPLETED|Double-Blind Treatment Period||7
1499305|NCT01677910|3667573|P4|COMPLETED|Double-Blind Treatment Period||0
1499306|NCT01677910|3667574|P3|COMPLETED|Double-Blind Treatment Period||38
1499307|NCT01677910|3667575|P2|COMPLETED|Double-Blind Treatment Period||42
1499308|NCT01677910|3667576|P1|COMPLETED|Double-Blind Treatment Period||38
1499309|NCT01677910|3667573|P4|STARTED|Double-Blind Treatment Period||0
1499310|NCT01677910|3667574|P3|STARTED|Double-Blind Treatment Period||45
1499311|NCT01677910|3667575|P2|STARTED|Double-Blind Treatment Period||45
1499312|NCT01677910|3667576|P1|STARTED|Double-Blind Treatment Period||45
1499313|NCT01677858|3667603|P5|NOT COMPLETED|Overall Study||85
1499314|NCT01677858|3667604|P4|NOT COMPLETED|Overall Study||6
1499315|NCT01677858|3667605|P3|NOT COMPLETED|Overall Study||14
1499316|NCT01677858|3667606|P2|NOT COMPLETED|Overall Study||2
1499317|NCT01677858|3667607|P1|NOT COMPLETED|Overall Study||3
1499318|NCT01677858|3667603|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
1499319|NCT01677858|3667604|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
1499320|NCT01677858|3667605|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
1499321|NCT01677858|3667606|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
1499322|NCT01677858|3667607|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
1499323|NCT01677858|3667603|P5|STARTED|Overall Study||89
1499324|NCT01677858|3667604|P4|STARTED|Overall Study||6
1499325|NCT01677858|3667605|P3|STARTED|Overall Study||15
1499326|NCT01677858|3667606|P2|STARTED|Overall Study||3
1499327|NCT01677858|3667607|P1|STARTED|Overall Study||3
1499328|NCT01677767|3667680|P1|NOT COMPLETED|Overall Study||22
1499329|NCT01677767|3667680|P1|COMPLETED|Overall Study||102
1499330|NCT01677767|3667680|P1|STARTED|Overall Study||124
1499331|NCT01677624|3667694|P1|NOT COMPLETED|Overall Study||1
1499332|NCT01677624|3667694|P1|COMPLETED|Overall Study||27
1499333|NCT01677624|3667694|P1|STARTED|Overall Study||28
1499334|NCT01677507|3667699|P2|NOT COMPLETED|Second Assigment||5
1499335|NCT01677507|3667700|P1|NOT COMPLETED|Second Assigment||3
1499336|NCT01677507|3667699|P2|COMPLETED|Second Assigment||51
1499337|NCT01677507|3667700|P1|COMPLETED|Second Assigment||60
1499338|NCT01677507|3667699|P2|STARTED|Second Assigment||56
1499339|NCT01677507|3667700|P1|STARTED|Second Assigment||63
1499340|NCT01677507|3667699|P2|NOT COMPLETED|Initial Assignment||2
1499341|NCT01677507|3667700|P1|NOT COMPLETED|Initial Assignment||0
1499342|NCT01677507|3667699|P2|COMPLETED|Initial Assignment||56
1499343|NCT01677507|3667700|P1|COMPLETED|Initial Assignment||63
1499344|NCT01677507|3667699|P2|STARTED|Initial Assignment||58
1499345|NCT01677507|3667700|P1|STARTED|Initial Assignment||63
1499346|NCT01677377|3667713|P3|NOT COMPLETED|Overall Study||6
1499347|NCT01677377|3667714|P2|NOT COMPLETED|Overall Study||1
1499348|NCT01677377|3667715|P1|NOT COMPLETED|Overall Study||1
1499349|NCT01677377|3667713|P3|COMPLETED|Overall Study||9
1499350|NCT01677377|3667714|P2|COMPLETED|Overall Study||14
1499351|NCT01677377|3667715|P1|COMPLETED|Overall Study||14
1499352|NCT01677377|3667713|P3|STARTED|Overall Study||15
1499353|NCT01677377|3667714|P2|STARTED|Overall Study||15
1499354|NCT01677377|3667715|P1|STARTED|Overall Study||15
1499355|NCT01677299|3667916|P4|NOT COMPLETED|Overall Study||1
1499356|NCT01677299|3667917|P3|NOT COMPLETED|Overall Study||1
1499357|NCT01677299|3667918|P2|NOT COMPLETED|Overall Study||3
1499358|NCT01677299|3667919|P1|NOT COMPLETED|Overall Study||0
1499359|NCT01677299|3667916|P4|COMPLETED|Overall Study||5
1499360|NCT01677299|3667917|P3|COMPLETED|Overall Study||5
1499361|NCT01677299|3667918|P2|COMPLETED|Overall Study||3
1499362|NCT01677299|3667919|P1|COMPLETED|Overall Study||6
1499363|NCT01677299|3667916|P4|STARTED|Overall Study||6
1499364|NCT01677299|3667917|P3|STARTED|Overall Study||6
1499365|NCT01677299|3667918|P2|STARTED|Overall Study||6
1499366|NCT01677299|3667919|P1|STARTED|Overall Study||6
1499367|NCT01677286|3667941|P1|NOT COMPLETED|Overall Study||11
1499368|NCT01677286|3667941|P1|COMPLETED|Overall Study||14
1499369|NCT01677286|3667941|P1|STARTED|Overall Study||25
1499370|NCT01677195|3667951|P3|NOT COMPLETED|Overall Study||30
1499371|NCT01677195|3667952|P2|NOT COMPLETED|Overall Study||32
1499372|NCT01677195|3667953|P1|NOT COMPLETED|Overall Study||29
1499373|NCT01677195|3667951|P3|COMPLETED|Overall Study||50
1499374|NCT01677195|3667952|P2|COMPLETED|Overall Study||51
1499375|NCT01677195|3667953|P1|COMPLETED|Overall Study||42
1499376|NCT01677195|3667951|P3|STARTED|Overall Study||80
1499377|NCT01677195|3667952|P2|STARTED|Overall Study||83
1499378|NCT01677195|3667953|P1|STARTED|Overall Study||71
1499379|NCT01677182|3667964|P3|NOT COMPLETED|Overall Study||39
1499380|NCT01677182|3667965|P2|NOT COMPLETED|Overall Study||28
1499381|NCT01677182|3667966|P1|NOT COMPLETED|Overall Study||34
1499382|NCT01677182|3667964|P3|COMPLETED|Overall Study||143
1499383|NCT01677182|3667965|P2|COMPLETED|Overall Study||141
1499384|NCT01677182|3667966|P1|COMPLETED|Overall Study||150
1499385|NCT01677182|3667964|P3|STARTED|Overall Study||182
1499386|NCT01677182|3667965|P2|STARTED|Overall Study||169
1499387|NCT01677182|3667966|P1|STARTED|Overall Study||184
1499388|NCT01676961|3667998|P1|NOT COMPLETED|Overall Study||5
1499389|NCT01676961|3667998|P1|COMPLETED|Overall Study||0
1499390|NCT01676961|3667998|P1|STARTED|Overall Study||5
1499391|NCT01676896|3668006|P3|NOT COMPLETED|Overall Study||19
1499392|NCT01676896|3668007|P2|NOT COMPLETED|Overall Study||7
1499393|NCT01676896|3668008|P1|NOT COMPLETED|Overall Study||12
1499394|NCT01676896|3668006|P3|COMPLETED|Overall Study||81
1499395|NCT01676896|3668007|P2|COMPLETED|Overall Study||89
1499396|NCT01676896|3668008|P1|COMPLETED|Overall Study||84
1499397|NCT01676896|3668006|P3|STARTED|Overall Study||100
1499398|NCT01676896|3668007|P2|STARTED|Overall Study||96
1499399|NCT01676896|3668008|P1|STARTED|Overall Study||96
1499400|NCT01676727|3668103|P1|NOT COMPLETED|Overall Study||32
1499401|NCT01676727|3668103|P1|COMPLETED|Overall Study||68
1499402|NCT01676727|3668103|P1|Implanted|Overall Study||92
1499403|NCT01676727|3668103|P1|STARTED|Overall Study||100
1499404|NCT01676714|3668108|P1|NOT COMPLETED|Overall Study||0
1499405|NCT01676714|3668108|P1|COMPLETED|Overall Study||10
1499406|NCT01676714|3668108|P1|STARTED|Overall Study||10
1499407|NCT01676701|3668117|P2|NOT COMPLETED|Overall Study||4
1499408|NCT01676701|3668118|P1|NOT COMPLETED|Overall Study||4
1499409|NCT01676701|3668117|P2|COMPLETED|Overall Study||0
1499410|NCT01676701|3668118|P1|COMPLETED|Overall Study||0
1499411|NCT01676701|3668117|P2|Completed Post-Treatment Follow-Up|Overall Study||4
1499412|NCT01676701|3668118|P1|Completed Post-Treatment Follow-Up|Overall Study||4
1499413|NCT01676701|3668117|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
1499414|NCT01676701|3668118|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
1499415|NCT01676701|3668117|P2|STARTED|Overall Study||4
1499416|NCT01676701|3668118|P1|STARTED|Overall Study||4
1499417|NCT01676532|3668144|P1|NOT COMPLETED|Overall Study||0
1499418|NCT01676532|3668144|P1|COMPLETED|Overall Study||127
1499419|NCT01676532|3668144|P1|STARTED|Overall Study||127
1499420|NCT01676415|3668155|P2|NOT COMPLETED|Overall Study||0
1499421|NCT01676415|3668156|P1|NOT COMPLETED|Overall Study||0
1499422|NCT01676415|3668155|P2|COMPLETED|Overall Study||5
1499423|NCT01676415|3668156|P1|COMPLETED|Overall Study||4
1499424|NCT01676415|3668155|P2|STARTED|Overall Study||5
1499425|NCT01676415|3668156|P1|STARTED|Overall Study||4
1499426|NCT01676298|3668176|P8|NOT COMPLETED|Overall Study||0
1499427|NCT01676298|3668177|P7|NOT COMPLETED|Overall Study||0
1499428|NCT01676298|3668178|P6|NOT COMPLETED|Overall Study||0
1499429|NCT01676298|3668179|P5|NOT COMPLETED|Overall Study||0
1499430|NCT01676298|3668180|P4|NOT COMPLETED|Overall Study||0
1499431|NCT01676298|3668181|P3|NOT COMPLETED|Overall Study||0
1499432|NCT01676298|3668182|P2|NOT COMPLETED|Overall Study||0
1499433|NCT01676298|3668183|P1|NOT COMPLETED|Overall Study||0
1499434|NCT01676298|3668176|P8|COMPLETED|Overall Study||1
1499435|NCT01676298|3668177|P7|COMPLETED|Overall Study||1
1499436|NCT01676298|3668178|P6|COMPLETED|Overall Study||1
1499437|NCT01676298|3668179|P5|COMPLETED|Overall Study||1
1499438|NCT01676298|3668180|P4|COMPLETED|Overall Study||1
1499439|NCT01676298|3668181|P3|COMPLETED|Overall Study||1
1499440|NCT01676298|3668182|P2|COMPLETED|Overall Study||1
1499441|NCT01676298|3668183|P1|COMPLETED|Overall Study||1
1499442|NCT01676298|3668176|P8|Participated in All Tests|Overall Study||1
1499443|NCT01676298|3668177|P7|Participated in All Tests|Overall Study||1
1499444|NCT01676298|3668178|P6|Participated in All Tests|Overall Study||1
1499445|NCT01676298|3668179|P5|Participated in All Tests|Overall Study||1
1499446|NCT01676298|3668180|P4|Participated in All Tests|Overall Study||1
1499447|NCT01676298|3668181|P3|Participated in All Tests|Overall Study||1
1499448|NCT01676298|3668182|P2|Participated in All Tests|Overall Study||1
1499449|NCT01676298|3668183|P1|Participated in All Tests|Overall Study||1
1499450|NCT01676298|3668176|P8|All Genotypes Confirmed With Reference|Overall Study||1
1499451|NCT01676298|3668177|P7|All Genotypes Confirmed With Reference|Overall Study||1
1499452|NCT01676298|3668178|P6|All Genotypes Confirmed With Reference|Overall Study||1
1499453|NCT01676298|3668179|P5|All Genotypes Confirmed With Reference|Overall Study||1
1499454|NCT01676298|3668180|P4|All Genotypes Confirmed With Reference|Overall Study||1
1499455|NCT01676298|3668181|P3|All Genotypes Confirmed With Reference|Overall Study||1
1499456|NCT01676298|3668182|P2|All Genotypes Confirmed With Reference|Overall Study||1
1499457|NCT01676298|3668183|P1|All Genotypes Confirmed With Reference|Overall Study||1
1499458|NCT01676298|3668176|P8|STARTED|Overall Study||1
1499459|NCT01676298|3668177|P7|STARTED|Overall Study||1
1499460|NCT01676298|3668178|P6|STARTED|Overall Study||1
1499461|NCT01676298|3668179|P5|STARTED|Overall Study||1
1499462|NCT01676298|3668180|P4|STARTED|Overall Study||1
1499463|NCT01676298|3668181|P3|STARTED|Overall Study||1
1499464|NCT01676298|3668182|P2|STARTED|Overall Study||1
1499465|NCT01676298|3668183|P1|STARTED|Overall Study||1
1499466|NCT01676220|3668203|P2|NOT COMPLETED|Overall Study||125
1499467|NCT01676220|3668204|P1|NOT COMPLETED|Overall Study||102
1499468|NCT01676220|3668203|P2|COMPLETED|Overall Study||314
1499469|NCT01676220|3668204|P1|COMPLETED|Overall Study||337
1499470|NCT01676220|3668203|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
1499471|NCT01676220|3668204|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
1499472|NCT01676220|3668203|P2|Treated|Overall Study||438
1499473|NCT01676220|3668204|P1|Treated|Overall Study||435
1499474|NCT01676220|3668203|P2|STARTED|Overall Study||439
1499475|NCT01676220|3668204|P1|STARTED|Overall Study||439
1499476|NCT01676116|3668236|P2|NOT COMPLETED|Overall Study||29
1499477|NCT01676116|3668237|P1|NOT COMPLETED|Overall Study||16
1499478|NCT01676116|3668236|P2|COMPLETED|Overall Study||117
1499479|NCT01676116|3668237|P1|COMPLETED|Overall Study||276
1499480|NCT01676116|3668236|P2|STARTED|Overall Study||146
1499481|NCT01676116|3668237|P1|STARTED|Overall Study||292
1499482|NCT01676012|3668259|P1|NOT COMPLETED|Overall Study||3
1499483|NCT01676012|3668259|P1|COMPLETED|Overall Study||29
1499484|NCT01676012|3668259|P1|STARTED|Overall Study||32
1499485|NCT01675830|3668263|P1|NOT COMPLETED|Overall Study||0
1499486|NCT01675830|3668263|P1|COMPLETED|Overall Study||10
1499487|NCT01675830|3668263|P1|STARTED|Overall Study||10
1499488|NCT01675661|3668270|P2|NOT COMPLETED|Overall Study||46
1499489|NCT01675661|3668271|P1|NOT COMPLETED|Overall Study||40
1499490|NCT01675661|3668270|P2|COMPLETED|Overall Study||103
1499491|NCT01675661|3668271|P1|COMPLETED|Overall Study||113
1499492|NCT01675661|3668270|P2|STARTED|Overall Study||149
1499493|NCT01675661|3668271|P1|STARTED|Overall Study||153
1499494|NCT01675635|3668279|P2|NOT COMPLETED|Overall Study||0
1499495|NCT01675635|3668280|P1|NOT COMPLETED|Overall Study||0
1499496|NCT01675635|3668279|P2|COMPLETED|Overall Study||117
1499497|NCT01675635|3668280|P1|COMPLETED|Overall Study||117
1499498|NCT01675635|3668279|P2|STARTED|Overall Study||117
1499499|NCT01675635|3668280|P1|STARTED|Overall Study||117
1499500|NCT01675622|3668300|P2|NOT COMPLETED|Overall Study||24
1499501|NCT01675622|3668301|P1|NOT COMPLETED|Overall Study||26
1499502|NCT01675622|3668300|P2|COMPLETED|Overall Study||96
1499503|NCT01675622|3668301|P1|COMPLETED|Overall Study||96
1499504|NCT01675622|3668300|P2|STARTED|Overall Study||120
1499505|NCT01675622|3668301|P1|STARTED|Overall Study||122
1499506|NCT01675544|3668325|P1|NOT COMPLETED|Overall Study||2
1499507|NCT01675544|3668325|P1|COMPLETED|Overall Study||44
1499508|NCT01675544|3668325|P1|STARTED|Overall Study||46
1499509|NCT01675531|3668330|P1|NOT COMPLETED|Overall Study||25
1499510|NCT01675531|3668330|P1|COMPLETED|Overall Study||41
1499511|NCT01675531|3668330|P1|STARTED|Overall Study||66
1499512|NCT01675492|3668337|P1|NOT COMPLETED|Overall Study||42
1499513|NCT01675492|3668337|P1|COMPLETED|Overall Study||42
1499514|NCT01675492|3668337|P1|STARTED|Overall Study||84
1499515|NCT01675479|3668342|P1|NOT COMPLETED|Overall Study||11
1499516|NCT01675479|3668342|P1|COMPLETED|Overall Study||58
1499517|NCT01675479|3668342|P1|STARTED|Overall Study||69
1499518|NCT01675453|3668349|P2|NOT COMPLETED|Overall Study||0
1499519|NCT01675453|3668350|P1|NOT COMPLETED|Overall Study||0
1499520|NCT01675453|3668349|P2|COMPLETED|Overall Study||20
1499521|NCT01675453|3668350|P1|COMPLETED|Overall Study||20
1499522|NCT01675453|3668349|P2|STARTED|Overall Study||20
1499523|NCT01675453|3668350|P1|STARTED|Overall Study||20
1499524|NCT01675427|3668356|P1|NOT COMPLETED|Overall Study||34
1499525|NCT01675427|3668356|P1|COMPLETED|Overall Study||4732
1499526|NCT01675427|3668356|P1|STARTED|Overall Study||4766
1499527|NCT01675167|3668643|P3|NOT COMPLETED|Double-blind Treatment Phase||110
1499528|NCT01675167|3668644|P2|NOT COMPLETED|Double-blind Treatment Phase||48
1499529|NCT01675167|3668645|P1|NOT COMPLETED|Double-blind Treatment Phase||0
1499530|NCT01675167|3668643|P3|COMPLETED|Double-blind Treatment Phase||147
1499531|NCT01675167|3668644|P2|COMPLETED|Double-blind Treatment Phase||206
1499532|NCT01675167|3668645|P1|COMPLETED|Double-blind Treatment Phase||0
1499533|NCT01675167|3668643|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
1499534|NCT01675167|3668644|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
1499535|NCT01675167|3668645|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
1499536|NCT01675167|3668643|P3|NOT COMPLETED|Open-label Titration Phase||0
1499537|NCT01675167|3668644|P2|NOT COMPLETED|Open-label Titration Phase||0
1499538|NCT01675167|3668645|P1|NOT COMPLETED|Open-label Titration Phase||304
1499539|NCT01675167|3668643|P3|COMPLETED|Open-label Titration Phase||0
1499540|NCT01675167|3668644|P2|COMPLETED|Open-label Titration Phase||0
1499541|NCT01675167|3668645|P1|COMPLETED|Open-label Titration Phase||511
1499542|NCT01675167|3668643|P3|STARTED|Open-label Titration Phase||0
1499543|NCT01675167|3668644|P2|STARTED|Open-label Titration Phase||0
1499544|NCT01675167|3668645|P1|STARTED|Open-label Titration Phase||815
1499545|NCT01675141|3668667|P1|NOT COMPLETED|Overall Study||11
1499546|NCT01675141|3668667|P1|COMPLETED|Overall Study||0
1499547|NCT01675141|3668667|P1|STARTED|Overall Study||11
1499548|NCT01675128|3668680|P3|NOT COMPLETED|Overall Study||1
1499549|NCT01675128|3668681|P2|NOT COMPLETED|Overall Study||2
1499550|NCT01675128|3668682|P1|NOT COMPLETED|Overall Study||2
1499551|NCT01675128|3668680|P3|COMPLETED|Overall Study||9
1499552|NCT01675128|3668681|P2|COMPLETED|Overall Study||8
1499553|NCT01675128|3668682|P1|COMPLETED|Overall Study||2
1499554|NCT01675128|3668680|P3|STARTED|Overall Study||10
1499555|NCT01675128|3668681|P2|STARTED|Overall Study||10
1499556|NCT01675128|3668682|P1|STARTED|Overall Study||4
1499557|NCT01675063|3668704|P1|NOT COMPLETED|Overall Study||0
1499558|NCT01675063|3668704|P1|COMPLETED|Overall Study||77
1499559|NCT01675063|3668704|P1|STARTED|Overall Study||77
1499560|NCT01675050|3668710|P2|NOT COMPLETED|Second Period Treatment||0
1499561|NCT01675050|3668711|P1|NOT COMPLETED|Second Period Treatment||0
1499562|NCT01675050|3668710|P2|COMPLETED|Second Period Treatment||2
1499563|NCT01675050|3668711|P1|COMPLETED|Second Period Treatment||1
1499564|NCT01675050|3668710|P2|STARTED|Second Period Treatment||2
1499565|NCT01675050|3668711|P1|STARTED|Second Period Treatment||1
1499566|NCT01675050|3668710|P2|NOT COMPLETED|Wash Out Period||0
1499567|NCT01675050|3668711|P1|NOT COMPLETED|Wash Out Period||0
1499568|NCT01675050|3668710|P2|COMPLETED|Wash Out Period||2
1499569|NCT01675050|3668711|P1|COMPLETED|Wash Out Period||1
1499570|NCT01675050|3668710|P2|STARTED|Wash Out Period||2
1499571|NCT01675050|3668711|P1|STARTED|Wash Out Period||1
1499572|NCT01675050|3668710|P2|NOT COMPLETED|Period One Treatment||0
1499573|NCT01675050|3668711|P1|NOT COMPLETED|Period One Treatment||1
1499574|NCT01675050|3668710|P2|COMPLETED|Period One Treatment||2
1499575|NCT01675050|3668711|P1|COMPLETED|Period One Treatment||1
1499576|NCT01675050|3668710|P2|STARTED|Period One Treatment||2
1499577|NCT01675050|3668711|P1|STARTED|Period One Treatment||2
1499578|NCT01675011|3668721|P2|NOT COMPLETED|Overall Study||1
1499579|NCT01675011|3668722|P1|NOT COMPLETED|Overall Study||3
1499580|NCT01675011|3668721|P2|COMPLETED|Overall Study||0
1499581|NCT01675011|3668722|P1|COMPLETED|Overall Study||0
1499582|NCT01675011|3668721|P2|STARTED|Overall Study||1
1499583|NCT01675011|3668722|P1|STARTED|Overall Study||3
1499584|NCT01674725|3668730|P2|NOT COMPLETED|Overall Study||1
1499585|NCT01674725|3668731|P1|NOT COMPLETED|Overall Study||3
1499586|NCT01674725|3668730|P2|COMPLETED|Overall Study||94
1499587|NCT01674725|3668731|P1|COMPLETED|Overall Study||89
1499588|NCT01674725|3668730|P2|STARTED|Overall Study||95
1499589|NCT01674725|3668731|P1|STARTED|Overall Study||92
1499590|NCT01674712|3668750|P5|NOT COMPLETED|Overall Study||11
1499591|NCT01674712|3668751|P4|NOT COMPLETED|Overall Study||8
1499592|NCT01674712|3668752|P3|NOT COMPLETED|Overall Study||9
1499593|NCT01674712|3668753|P2|NOT COMPLETED|Overall Study||9
1499594|NCT01674712|3668754|P1|NOT COMPLETED|Overall Study||10
1499595|NCT01674712|3668750|P5|COMPLETED|Overall Study||102
1499596|NCT01674712|3668751|P4|COMPLETED|Overall Study||108
1499597|NCT01674712|3668752|P3|COMPLETED|Overall Study||106
1499598|NCT01674712|3668753|P2|COMPLETED|Overall Study||108
1499599|NCT01674712|3668754|P1|COMPLETED|Overall Study||104
1499600|NCT01674712|3668750|P5|Safety Subject Sample|Overall Study||112
1499601|NCT01674712|3668751|P4|Safety Subject Sample|Overall Study||115
1499602|NCT01674712|3668752|P3|Safety Subject Sample|Overall Study||113
1499603|NCT01674712|3668753|P2|Safety Subject Sample|Overall Study||117
1499604|NCT01674712|3668754|P1|Safety Subject Sample|Overall Study||111
1499605|NCT01674712|3668750|P5|Full Analysis Subject Sample|Overall Study||111
1499606|NCT01674712|3668751|P4|Full Analysis Subject Sample|Overall Study||112
1499607|NCT01674712|3668752|P3|Full Analysis Subject Sample|Overall Study||110
1499608|NCT01674712|3668753|P2|Full Analysis Subject Sample|Overall Study||114
1499609|NCT01674712|3668754|P1|Full Analysis Subject Sample|Overall Study||109
1499610|NCT01674712|3668750|P5|STARTED|Overall Study||113
1499611|NCT01674712|3668751|P4|STARTED|Overall Study||116
1499612|NCT01674712|3668752|P3|STARTED|Overall Study||115
1499613|NCT01674712|3668753|P2|STARTED|Overall Study||117
1499614|NCT01674712|3668754|P1|STARTED|Overall Study||114
1499615|NCT01674647|3668778|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
1499616|NCT01674647|3668779|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
1499617|NCT01674647|3668778|P2|COMPLETED|30-day Safety Follow-up Period||446
1499618|NCT01674647|3668779|P1|COMPLETED|30-day Safety Follow-up Period||924
1499619|NCT01674647|3668778|P2|STARTED|30-day Safety Follow-up Period||487
1499620|NCT01674647|3668779|P1|STARTED|30-day Safety Follow-up Period||982
1499621|NCT01674647|3668778|P2|NOT COMPLETED|Treatment Period||102
1499622|NCT01674647|3668779|P1|NOT COMPLETED|Treatment Period||156
1499623|NCT01674647|3668778|P2|COMPLETED|Treatment Period||400
1499624|NCT01674647|3668779|P1|COMPLETED|Treatment Period||846
1499625|NCT01674647|3668778|P2|Subjects Received Treatment|Treatment Period||499
1499626|NCT01674647|3668779|P1|Subjects Received Treatment|Treatment Period||988
1499627|NCT01674647|3668778|P2|STARTED|Treatment Period||502
1499628|NCT01674647|3668779|P1|STARTED|Treatment Period||1002
1499629|NCT01674634|3668805|P1|NOT COMPLETED|Overall Study||6
1499630|NCT01674634|3668805|P1|COMPLETED|Overall Study||709
1499631|NCT01674634|3668805|P1|STARTED|Overall Study||715
1499632|NCT01674621|3668825|P5|NOT COMPLETED|Overall Study||6
1499633|NCT01674621|3668826|P4|NOT COMPLETED|Overall Study||7
1499634|NCT01674621|3668827|P3|NOT COMPLETED|Overall Study||8
1499635|NCT01674621|3668828|P2|NOT COMPLETED|Overall Study||5
1499636|NCT01674621|3668829|P1|NOT COMPLETED|Overall Study||6
1499637|NCT01674621|3668825|P5|COMPLETED|Overall Study||45
1499638|NCT01674621|3668826|P4|COMPLETED|Overall Study||41
1499639|NCT01674621|3668827|P3|COMPLETED|Overall Study||43
1499640|NCT01674621|3668828|P2|COMPLETED|Overall Study||45
1499641|NCT01674621|3668829|P1|COMPLETED|Overall Study||44
1499642|NCT01674621|3668825|P5|STARTED|Overall Study||51
1499643|NCT01674621|3668826|P4|STARTED|Overall Study||48
1499644|NCT01674621|3668827|P3|STARTED|Overall Study||51
1499645|NCT01674621|3668828|P2|STARTED|Overall Study||50
1499646|NCT01674621|3668829|P1|STARTED|Overall Study||50
1499647|NCT01674569|3668851|P6|NOT COMPLETED|Overall Study||2
1499648|NCT01674569|3668852|P5|NOT COMPLETED|Overall Study||2
1499649|NCT01674569|3668853|P4|NOT COMPLETED|Overall Study||1
1499650|NCT01674569|3668854|P3|NOT COMPLETED|Overall Study||2
1499651|NCT01674569|3668855|P2|NOT COMPLETED|Overall Study||3
1499652|NCT01674569|3668856|P1|NOT COMPLETED|Overall Study||0
1499653|NCT01674569|3668851|P6|COMPLETED|Overall Study||1
1499654|NCT01674569|3668852|P5|COMPLETED|Overall Study||5
1499655|NCT01674569|3668853|P4|COMPLETED|Overall Study||9
1499656|NCT01674569|3668854|P3|COMPLETED|Overall Study||2
1499657|NCT01674569|3668855|P2|COMPLETED|Overall Study||5
1499658|NCT01674569|3668856|P1|COMPLETED|Overall Study||3
1499659|NCT01674569|3668851|P6|STARTED|Overall Study||3
1499660|NCT01674569|3668852|P5|STARTED|Overall Study||7
1499661|NCT01674569|3668853|P4|STARTED|Overall Study||10
1499662|NCT01674569|3668854|P3|STARTED|Overall Study||4
1499663|NCT01674569|3668855|P2|STARTED|Overall Study||8
1499664|NCT01674569|3668856|P1|STARTED|Overall Study||3
1499665|NCT01674478|3668862|P2|NOT COMPLETED|Overall Study||0
1499666|NCT01674478|3668863|P1|NOT COMPLETED|Overall Study||0
1499667|NCT01674478|3668862|P2|COMPLETED|Overall Study||9
1499668|NCT01674478|3668863|P1|COMPLETED|Overall Study||9
1499669|NCT01674478|3668862|P2|STARTED|Overall Study||9
1499670|NCT01674478|3668863|P1|STARTED|Overall Study||9
1499671|NCT01674062|3668877|P2|NOT COMPLETED|Overall Study||29
1499672|NCT01674062|3668878|P1|NOT COMPLETED|Overall Study||66
1499673|NCT01674062|3668877|P2|COMPLETED|Overall Study||0
1499674|NCT01674062|3668878|P1|COMPLETED|Overall Study||0
1499675|NCT01674062|3668877|P2|STARTED|Overall Study||29
1499676|NCT01674062|3668878|P1|STARTED|Overall Study||66
1499677|NCT01674010|3668893|P3|NOT COMPLETED|Randomization Phase 2||61
1499678|NCT01674010|3668894|P2|NOT COMPLETED|Randomization Phase 2||62
1499679|NCT01674010|3668895|P1|NOT COMPLETED|Randomization Phase 2||0
1499680|NCT01674010|3668893|P3|COMPLETED|Randomization Phase 2||3
1499681|NCT01674010|3668894|P2|COMPLETED|Randomization Phase 2||3
1499682|NCT01674010|3668895|P1|COMPLETED|Randomization Phase 2||0
1499683|NCT01674010|3668893|P3|STARTED|Randomization Phase 2||64
1499684|NCT01674010|3668894|P2|STARTED|Randomization Phase 2||65
1499685|NCT01674010|3668895|P1|STARTED|Randomization Phase 2||0
1499686|NCT01674010|3668893|P3|NOT COMPLETED|Open Treatment Phase 1||0
1499687|NCT01674010|3668894|P2|NOT COMPLETED|Open Treatment Phase 1||0
1499688|NCT01674010|3668895|P1|NOT COMPLETED|Open Treatment Phase 1||180
1499689|NCT01674010|3668893|P3|COMPLETED|Open Treatment Phase 1||0
1499690|NCT01674010|3668894|P2|COMPLETED|Open Treatment Phase 1||0
1499691|NCT01674010|3668895|P1|COMPLETED|Open Treatment Phase 1||129
1499692|NCT01674010|3668893|P3|STARTED|Open Treatment Phase 1||0
1499693|NCT01674010|3668894|P2|STARTED|Open Treatment Phase 1||0
1499694|NCT01674010|3668895|P1|STARTED|Open Treatment Phase 1||309
1499695|NCT01673984|3668914|P2|NOT COMPLETED|Overall Study||6
1499696|NCT01673984|3668915|P1|NOT COMPLETED|Overall Study||10
1499697|NCT01673984|3668914|P2|COMPLETED|Overall Study||1
1499698|NCT01673984|3668915|P1|COMPLETED|Overall Study||4
1499699|NCT01673984|3668914|P2|STARTED|Overall Study||7
1499700|NCT01673984|3668915|P1|STARTED|Overall Study||14
1499701|NCT01673919|3668933|P1|NOT COMPLETED|Overall Study||0
1499702|NCT01673919|3668933|P1|COMPLETED|Overall Study||7
1499703|NCT01673919|3668933|P1|STARTED|Overall Study||7
1499704|NCT01673893|3668957|P1|NOT COMPLETED|Overall Study||0
1499705|NCT01673893|3668957|P1|COMPLETED|Overall Study||59
1499706|NCT01673893|3668957|P1|STARTED|Overall Study||59
1499707|NCT01673867|3668965|P2|NOT COMPLETED|Treatment||268
1499708|NCT01673867|3668966|P1|NOT COMPLETED|Treatment||244
1499709|NCT01673867|3668965|P2|COMPLETED|Treatment||0
1499710|NCT01673867|3668966|P1|COMPLETED|Treatment||43
1499711|NCT01673867|3668965|P2|STARTED|Treatment||268
1499712|NCT01673867|3668966|P1|STARTED|Treatment||287
1499713|NCT01673867|3668965|P2|NOT COMPLETED|Randomization||22
1499714|NCT01673867|3668966|P1|NOT COMPLETED|Randomization||5
1499715|NCT01673867|3668965|P2|COMPLETED|Randomization||268
1499716|NCT01673867|3668966|P1|COMPLETED|Randomization||287
1499717|NCT01673867|3668965|P2|STARTED|Randomization||290
1499718|NCT01673867|3668966|P1|STARTED|Randomization||292
1499719|NCT01673854|3668992|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
1499720|NCT01673854|3668992|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
1499721|NCT01673854|3668992|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
1499722|NCT01673854|3668992|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
1499723|NCT01673854|3668992|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
1499724|NCT01673854|3668992|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
1499725|NCT01673854|3668992|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
1499726|NCT01673854|3668992|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
1499727|NCT01673854|3668992|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
1499728|NCT01673828|3669002|P2|NOT COMPLETED|Overall Study||0
1499729|NCT01673828|3669003|P1|NOT COMPLETED|Overall Study||0
1499730|NCT01673828|3669002|P2|COMPLETED|Overall Study||6
1499731|NCT01673828|3669003|P1|COMPLETED|Overall Study||7
1499732|NCT01673828|3669002|P2|STARTED|Overall Study||6
1499733|NCT01673828|3669003|P1|STARTED|Overall Study||7
1499734|NCT01673802|3669009|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
1499735|NCT01673802|3669009|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
1499736|NCT01673802|3669009|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
1499737|NCT01673802|3669009|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
1499738|NCT01673802|3669009|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
1499739|NCT01673802|3669009|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
1499740|NCT01673698|3669015|P2|NOT COMPLETED|Overall Study||13
1499741|NCT01673698|3669016|P1|NOT COMPLETED|Overall Study||51
1499742|NCT01673698|3669015|P2|COMPLETED|Overall Study||126
1499743|NCT01673698|3669016|P1|COMPLETED|Overall Study||136
1499744|NCT01673698|3669015|P2|STARTED|Overall Study||139
1499745|NCT01673698|3669016|P1|STARTED|Overall Study||187
1499746|NCT01673620|3669026|P2|NOT COMPLETED|Overall Study||0
1499747|NCT01673620|3669027|P1|NOT COMPLETED|Overall Study||1
1499748|NCT01673620|3669026|P2|COMPLETED|Overall Study||22
1499749|NCT01673620|3669027|P1|COMPLETED|Overall Study||46
1499750|NCT01673620|3669026|P2|STARTED|Overall Study||22
1499751|NCT01673620|3669027|P1|STARTED|Overall Study||47
1499752|NCT01673594|3669037|P2|NOT COMPLETED|Overall Study||6
1499753|NCT01673594|3669038|P1|NOT COMPLETED|Overall Study||6
1499754|NCT01673594|3669037|P2|COMPLETED|Overall Study||13
1499755|NCT01673594|3669038|P1|COMPLETED|Overall Study||12
1499756|NCT01673594|3669037|P2|STARTED|Overall Study||19
1499757|NCT01673594|3669038|P1|STARTED|Overall Study||18
1499758|NCT01673568|3669048|P2|NOT COMPLETED|Overall Study||0
1499759|NCT01673568|3669049|P1|NOT COMPLETED|Overall Study||0
1499760|NCT01673568|3669048|P2|COMPLETED|Overall Study||28
1499761|NCT01673568|3669049|P1|COMPLETED|Overall Study||28
1499762|NCT01673568|3669048|P2|STARTED|Overall Study||28
1499763|NCT01673568|3669049|P1|STARTED|Overall Study||28
1499764|NCT01673490|3669057|P1|NOT COMPLETED|Overall Study||7
1499765|NCT01673490|3669057|P1|COMPLETED|Overall Study||52
1499766|NCT01673490|3669057|P1|STARTED|Overall Study||59
1499767|NCT01673425|3669070|P1|NOT COMPLETED|Overall Study||1
1499768|NCT01673425|3669070|P1|COMPLETED|Overall Study||4
1499769|NCT01673425|3669070|P1|STARTED|Overall Study||5
1499770|NCT01673347|3669074|P1|NOT COMPLETED|Overall Study||7
1499771|NCT01673347|3669074|P1|COMPLETED|Overall Study||17
1499772|NCT01673347|3669074|P1|STARTED|Overall Study||24
1499773|NCT01673282|3669083|P2|NOT COMPLETED|Overall Study||26
1499774|NCT01673282|3669084|P1|NOT COMPLETED|Overall Study||33
1499775|NCT01673282|3669083|P2|COMPLETED|Overall Study||132
1499776|NCT01673282|3669084|P1|COMPLETED|Overall Study||120
1499777|NCT01673282|3669083|P2|STARTED|Overall Study||158
1499778|NCT01673282|3669084|P1|STARTED|Overall Study||153
1499779|NCT01673256|3669090|P1|NOT COMPLETED|Overall Study||0
1499780|NCT01673256|3669090|P1|COMPLETED|Overall Study||90
1499781|NCT01673256|3669090|P1|STARTED|Overall Study||90
1499782|NCT01673191|3669096|P2|NOT COMPLETED|Overall Study||0
1499783|NCT01673191|3669097|P1|NOT COMPLETED|Overall Study||0
1499784|NCT01673191|3669096|P2|COMPLETED|Overall Study||11
1499785|NCT01673191|3669097|P1|COMPLETED|Overall Study||26
1499786|NCT01673191|3669096|P2|STARTED|Overall Study||11
1499787|NCT01673191|3669097|P1|STARTED|Overall Study||26
1499788|NCT01673178|3669120|P5|NOT COMPLETED|Overall Study||2
1499789|NCT01673178|3669121|P4|NOT COMPLETED|Overall Study||8
1499790|NCT01673178|3669122|P3|NOT COMPLETED|Overall Study||3
1499791|NCT01673178|3669123|P2|NOT COMPLETED|Overall Study||2
1499792|NCT01673178|3669124|P1|NOT COMPLETED|Overall Study||3
1499793|NCT01673178|3669120|P5|COMPLETED|Overall Study||19
1499794|NCT01673178|3669121|P4|COMPLETED|Overall Study||14
1499795|NCT01673178|3669122|P3|COMPLETED|Overall Study||18
1499796|NCT01673178|3669123|P2|COMPLETED|Overall Study||19
1499797|NCT01673178|3669124|P1|COMPLETED|Overall Study||19
1499798|NCT01673178|3669120|P5|STARTED|Overall Study||21
1499799|NCT01673178|3669121|P4|STARTED|Overall Study||22
1499800|NCT01673178|3669122|P3|STARTED|Overall Study||21
1499801|NCT01673178|3669123|P2|STARTED|Overall Study||21
1499802|NCT01673178|3669124|P1|STARTED|Overall Study||22
1499803|NCT01673126|3669363|P2|NOT COMPLETED|Overall Study||3
1499804|NCT01673126|3669364|P1|NOT COMPLETED|Overall Study||4
1499805|NCT01673126|3669363|P2|COMPLETED|Overall Study||23
1499806|NCT01673126|3669364|P1|COMPLETED|Overall Study||32
1499807|NCT01673126|3669363|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
1499808|NCT01673126|3669364|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
1499809|NCT01673113|3669372|P2|NOT COMPLETED|Overall Study||0
1499810|NCT01673113|3669373|P1|NOT COMPLETED|Overall Study||0
1499811|NCT01673113|3669372|P2|COMPLETED|Overall Study||11
1499812|NCT01673113|3669373|P1|COMPLETED|Overall Study||11
1499813|NCT01673113|3669372|P2|STARTED|Overall Study||11
1499814|NCT01673113|3669373|P1|STARTED|Overall Study||11
1499815|NCT01673022|3669380|P1|NOT COMPLETED|Overall Study||8
1499816|NCT01673022|3669380|P1|COMPLETED|Overall Study||422
1499817|NCT01673022|3669380|P1|STARTED|Overall Study||430
1499818|NCT01673009|3669384|P1|NOT COMPLETED|Overall Study||13
1499819|NCT01673009|3669384|P1|COMPLETED|Overall Study||23
1499820|NCT01673009|3669384|P1|STARTED|Overall Study||36
1499821|NCT01672996|3669396|P3|NOT COMPLETED|Overall Study||0
1499822|NCT01672996|3669397|P2|NOT COMPLETED|Overall Study||0
1499823|NCT01672996|3669398|P1|NOT COMPLETED|Overall Study||0
1499824|NCT01672996|3669396|P3|COMPLETED|Overall Study||6
1499825|NCT01672996|3669397|P2|COMPLETED|Overall Study||30
1499826|NCT01672996|3669398|P1|COMPLETED|Overall Study||30
1499827|NCT01672996|3669396|P3|STARTED|Overall Study||6
1499828|NCT01672996|3669397|P2|STARTED|Overall Study||30
1499829|NCT01672996|3669398|P1|STARTED|Overall Study||30
1499830|NCT01672983|3669434|P6|NOT COMPLETED|Overall Study||0
1499831|NCT01672983|3669435|P5|NOT COMPLETED|Overall Study||0
1499832|NCT01672983|3669436|P4|NOT COMPLETED|Overall Study||0
1499833|NCT01672983|3669437|P3|NOT COMPLETED|Overall Study||0
1499834|NCT01672983|3669438|P2|NOT COMPLETED|Overall Study||0
1499835|NCT01672983|3669439|P1|NOT COMPLETED|Overall Study||0
1499836|NCT01672983|3669434|P6|COMPLETED|Overall Study||18
1499837|NCT01672983|3669435|P5|COMPLETED|Overall Study||19
1499838|NCT01672983|3669436|P4|COMPLETED|Overall Study||18
1499839|NCT01672983|3669437|P3|COMPLETED|Overall Study||19
1499840|NCT01672983|3669438|P2|COMPLETED|Overall Study||18
1499841|NCT01672983|3669439|P1|COMPLETED|Overall Study||18
1499842|NCT01672983|3669434|P6|Completed Study Drug|Overall Study||17
1499843|NCT01672983|3669435|P5|Completed Study Drug|Overall Study||12
1499844|NCT01672983|3669436|P4|Completed Study Drug|Overall Study||18
1499845|NCT01672983|3669437|P3|Completed Study Drug|Overall Study||18
1499846|NCT01672983|3669438|P2|Completed Study Drug|Overall Study||17
1499847|NCT01672983|3669439|P1|Completed Study Drug|Overall Study||18
1499848|NCT01672983|3669434|P6|STARTED|Overall Study||18
1499849|NCT01672983|3669435|P5|STARTED|Overall Study||19
1499850|NCT01672983|3669436|P4|STARTED|Overall Study||18
1499851|NCT01672983|3669437|P3|STARTED|Overall Study||19
1499852|NCT01672983|3669438|P2|STARTED|Overall Study||18
1499853|NCT01672983|3669439|P1|STARTED|Overall Study||18
1499854|NCT01672970|3669469|P1|NOT COMPLETED|Overall Study||47
1499855|NCT01672970|3669469|P1|COMPLETED|Overall Study||244
1499856|NCT01672970|3669469|P1|Treated|Overall Study||290
1499857|NCT01672970|3669469|P1|STARTED|Overall Study||291
1499858|NCT01672957|3669505|P1|NOT COMPLETED|Overall Study||55
1499859|NCT01672957|3669505|P1|COMPLETED|Overall Study||73
1499860|NCT01672957|3669505|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
1499861|NCT01672957|3669505|P1|STARTED|Overall Study||128
1499862|NCT01672892|3669520|P2|NOT COMPLETED|Overall Study||3
1499863|NCT01672892|3669521|P1|NOT COMPLETED|Overall Study||8
1499864|NCT01672892|3669520|P2|COMPLETED|Overall Study|Eligible subjects available for analysis|149
1499865|NCT01672892|3669521|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|129
1499866|NCT01672892|3669520|P2|STARTED|Overall Study||152
1499867|NCT01672892|3669521|P1|STARTED|Overall Study||137
1499868|NCT01672827|3669535|P1|NOT COMPLETED|Overall Study||0
1499869|NCT01672827|3669535|P1|COMPLETED|Overall Study||276
1499870|NCT01672827|3669535|P1|STARTED|Overall Study||276
1499871|NCT01672788|3669541|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1499872|NCT01672788|3669542|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1499873|NCT01672788|3669543|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1499874|NCT01672788|3669544|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1499875|NCT01672788|3669541|P4|COMPLETED|Treatment Period 4 (3 Days)||8
1499876|NCT01672788|3669542|P3|COMPLETED|Treatment Period 4 (3 Days)||9
1499877|NCT01672788|3669543|P2|COMPLETED|Treatment Period 4 (3 Days)||9
1499878|NCT01672788|3669544|P1|COMPLETED|Treatment Period 4 (3 Days)||9
1499879|NCT01672788|3669541|P4|STARTED|Treatment Period 4 (3 Days)||8
1499880|NCT01672788|3669542|P3|STARTED|Treatment Period 4 (3 Days)||9
1499881|NCT01672788|3669543|P2|STARTED|Treatment Period 4 (3 Days)||9
1499882|NCT01672788|3669544|P1|STARTED|Treatment Period 4 (3 Days)||9
1499883|NCT01672788|3669541|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
1499884|NCT01672788|3669542|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
1499885|NCT01672788|3669543|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
1499886|NCT01672788|3669544|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
1499887|NCT01672788|3669541|P4|COMPLETED|Washout Period 3 (7 Days)||8
1499888|NCT01672788|3669542|P3|COMPLETED|Washout Period 3 (7 Days)||9
1499889|NCT01672788|3669543|P2|COMPLETED|Washout Period 3 (7 Days)||9
1499890|NCT01672788|3669544|P1|COMPLETED|Washout Period 3 (7 Days)||9
1499891|NCT01672788|3669541|P4|STARTED|Washout Period 3 (7 Days)||8
1499892|NCT01672788|3669542|P3|STARTED|Washout Period 3 (7 Days)||9
1499893|NCT01672788|3669543|P2|STARTED|Washout Period 3 (7 Days)||9
1499894|NCT01672788|3669544|P1|STARTED|Washout Period 3 (7 Days)||9
1499895|NCT01672788|3669541|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1499896|NCT01672788|3669542|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1499897|NCT01672788|3669543|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1499898|NCT01672788|3669544|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1499899|NCT01672788|3669541|P4|COMPLETED|Treatment Period 3 (3 Days)||8
1499900|NCT01672788|3669542|P3|COMPLETED|Treatment Period 3 (3 Days)||9
1499901|NCT01672788|3669543|P2|COMPLETED|Treatment Period 3 (3 Days)||9
1499902|NCT01672788|3669544|P1|COMPLETED|Treatment Period 3 (3 Days)||9
1499903|NCT01672788|3669541|P4|STARTED|Treatment Period 3 (3 Days)||8
1499904|NCT01672788|3669542|P3|STARTED|Treatment Period 3 (3 Days)||9
1499905|NCT01672788|3669543|P2|STARTED|Treatment Period 3 (3 Days)||9
1499906|NCT01672788|3669544|P1|STARTED|Treatment Period 3 (3 Days)||9
1499907|NCT01672788|3669541|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
1499908|NCT01672788|3669542|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1499909|NCT01672788|3669543|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1499910|NCT01672788|3669544|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1499911|NCT01672788|3669541|P4|COMPLETED|Washout Period 2 (7 Days)||8
1499912|NCT01672788|3669542|P3|COMPLETED|Washout Period 2 (7 Days)||9
1499913|NCT01672788|3669543|P2|COMPLETED|Washout Period 2 (7 Days)||9
1499914|NCT01672788|3669544|P1|COMPLETED|Washout Period 2 (7 Days)||9
1499915|NCT01672788|3669541|P4|STARTED|Washout Period 2 (7 Days)||9
1499916|NCT01672788|3669542|P3|STARTED|Washout Period 2 (7 Days)||9
1499917|NCT01672788|3669543|P2|STARTED|Washout Period 2 (7 Days)||9
1499918|NCT01672788|3669544|P1|STARTED|Washout Period 2 (7 Days)||9
1499919|NCT01672788|3669541|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1499920|NCT01672788|3669542|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1499921|NCT01672788|3669543|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1499922|NCT01672788|3669544|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1499923|NCT01672788|3669541|P4|COMPLETED|Treatment Period 2 (3 Days)||9
1499924|NCT01672788|3669542|P3|COMPLETED|Treatment Period 2 (3 Days)||9
1499925|NCT01672788|3669543|P2|COMPLETED|Treatment Period 2 (3 Days)||9
1499926|NCT01672788|3669544|P1|COMPLETED|Treatment Period 2 (3 Days)||9
1499927|NCT01672788|3669541|P4|STARTED|Treatment Period 2 (3 Days)||9
1499928|NCT01672788|3669542|P3|STARTED|Treatment Period 2 (3 Days)||9
1499929|NCT01672788|3669543|P2|STARTED|Treatment Period 2 (3 Days)||9
1499930|NCT01672788|3669544|P1|STARTED|Treatment Period 2 (3 Days)||9
1499931|NCT01672788|3669541|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1499932|NCT01672788|3669542|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1499933|NCT01672788|3669543|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1499934|NCT01672788|3669544|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1499935|NCT01672788|3669541|P4|COMPLETED|Washout Period 1 (7 Days)||9
1499936|NCT01672788|3669542|P3|COMPLETED|Washout Period 1 (7 Days)||9
1499937|NCT01672788|3669543|P2|COMPLETED|Washout Period 1 (7 Days)||9
1499938|NCT01672788|3669544|P1|COMPLETED|Washout Period 1 (7 Days)||9
1499939|NCT01672788|3669541|P4|STARTED|Washout Period 1 (7 Days)||9
1499940|NCT01672788|3669542|P3|STARTED|Washout Period 1 (7 Days)||9
1499941|NCT01672788|3669543|P2|STARTED|Washout Period 1 (7 Days)||9
1499942|NCT01672788|3669544|P1|STARTED|Washout Period 1 (7 Days)||9
1499943|NCT01672788|3669541|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1499944|NCT01672788|3669542|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1499945|NCT01672788|3669543|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1499946|NCT01672788|3669544|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1499947|NCT01672788|3669541|P4|COMPLETED|Treatment Period 1 (3 Days)||9
1499948|NCT01672788|3669542|P3|COMPLETED|Treatment Period 1 (3 Days)||9
1499949|NCT01672788|3669543|P2|COMPLETED|Treatment Period 1 (3 Days)||9
1499950|NCT01672788|3669544|P1|COMPLETED|Treatment Period 1 (3 Days)||9
1499951|NCT01672788|3669541|P4|STARTED|Treatment Period 1 (3 Days)||9
1499952|NCT01672788|3669542|P3|STARTED|Treatment Period 1 (3 Days)||9
1499953|NCT01672788|3669543|P2|STARTED|Treatment Period 1 (3 Days)||9
1499954|NCT01672788|3669544|P1|STARTED|Treatment Period 1 (3 Days)||9
1499955|NCT01672736|3669574|P1|NOT COMPLETED|Overall Study||3
1499956|NCT01672736|3669574|P1|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
1499957|NCT01672736|3669574|P1|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
1499958|NCT01672723|3669578|P2|NOT COMPLETED|Second Intervention||0
1499959|NCT01672723|3669579|P1|NOT COMPLETED|Second Intervention||0
1499960|NCT01672723|3669578|P2|COMPLETED|Second Intervention||15
1499961|NCT01672723|3669579|P1|COMPLETED|Second Intervention||16
1499962|NCT01672723|3669578|P2|STARTED|Second Intervention||15
1499963|NCT01672723|3669579|P1|STARTED|Second Intervention||16
1499964|NCT01672723|3669578|P2|NOT COMPLETED|Washout Period of 10 Days||0
1499965|NCT01672723|3669579|P1|NOT COMPLETED|Washout Period of 10 Days||0
1499966|NCT01672723|3669578|P2|COMPLETED|Washout Period of 10 Days||15
1499967|NCT01672723|3669579|P1|COMPLETED|Washout Period of 10 Days||16
1499968|NCT01672723|3669578|P2|STARTED|Washout Period of 10 Days||15
1499969|NCT01672723|3669579|P1|STARTED|Washout Period of 10 Days||16
1499970|NCT01672723|3669578|P2|NOT COMPLETED|First Intervention||0
1499971|NCT01672723|3669579|P1|NOT COMPLETED|First Intervention||3
1499972|NCT01672723|3669578|P2|COMPLETED|First Intervention||15
1499973|NCT01672723|3669579|P1|COMPLETED|First Intervention||16
1499974|NCT01672723|3669578|P2|STARTED|First Intervention||15
1499975|NCT01672723|3669579|P1|STARTED|First Intervention||19
1499976|NCT01672710|3669591|P2|NOT COMPLETED|3 Month Follow up||4
1499977|NCT01672710|3669592|P1|NOT COMPLETED|3 Month Follow up||6
1499978|NCT01672710|3669591|P2|COMPLETED|3 Month Follow up||5
1499979|NCT01672710|3669592|P1|COMPLETED|3 Month Follow up||16
1499980|NCT01672710|3669591|P2|STARTED|3 Month Follow up||9
1499981|NCT01672710|3669592|P1|STARTED|3 Month Follow up||22
1499982|NCT01672710|3669591|P2|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
1499983|NCT01672710|3669592|P1|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
1499984|NCT01672710|3669591|P2|COMPLETED|Waitlist Assessed After Sauna Regimen||9
1499985|NCT01672710|3669592|P1|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
1499986|NCT01672710|3669591|P2|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
1499987|NCT01672710|3669592|P1|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
1499988|NCT01672710|3669591|P2|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
1499989|NCT01672710|3669592|P1|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
1499990|NCT01672710|3669591|P2|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
1499991|NCT01672710|3669592|P1|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
1499992|NCT01672710|3669591|P2|STARTED|Controlled Comparison 5 Week Follow-up||10
1499993|NCT01672710|3669592|P1|STARTED|Controlled Comparison 5 Week Follow-up||22
1499994|NCT01672658|3669604|P2|NOT COMPLETED|Overall Study||1
1499995|NCT01672658|3669605|P1|NOT COMPLETED|Overall Study||0
1499996|NCT01672658|3669604|P2|COMPLETED|Overall Study||14
1499997|NCT01672658|3669605|P1|COMPLETED|Overall Study||16
1499998|NCT01672658|3669604|P2|STARTED|Overall Study||15
1499999|NCT01672658|3669605|P1|STARTED|Overall Study||16
1500000|NCT01672294|3669629|P4|NOT COMPLETED|Overall Study||13
1500001|NCT01672294|3669630|P3|NOT COMPLETED|Overall Study||11
1500002|NCT01672294|3669631|P2|NOT COMPLETED|Overall Study||21
1500003|NCT01672294|3669632|P1|NOT COMPLETED|Overall Study||6
1500004|NCT01672294|3669629|P4|COMPLETED|Overall Study||59
1500005|NCT01672294|3669630|P3|COMPLETED|Overall Study||61
1500006|NCT01672294|3669631|P2|COMPLETED|Overall Study||50
1500007|NCT01672294|3669632|P1|COMPLETED|Overall Study||65
1500008|NCT01672294|3669629|P4|STARTED|Overall Study||72
1500009|NCT01672294|3669630|P3|STARTED|Overall Study||72
1500010|NCT01672294|3669631|P2|STARTED|Overall Study||71
1500011|NCT01672294|3669632|P1|STARTED|Overall Study||71
1500012|NCT01672242|3669654|P2|NOT COMPLETED|Period 2||0
1500013|NCT01672242|3669655|P1|NOT COMPLETED|Period 2||0
1500014|NCT01672242|3669654|P2|COMPLETED|Period 2||2
1500015|NCT01672242|3669655|P1|COMPLETED|Period 2||4
1500016|NCT01672242|3669654|P2|STARTED|Period 2||2
1500017|NCT01672242|3669655|P1|STARTED|Period 2||4
1500018|NCT01672242|3669654|P2|NOT COMPLETED|Period 1||0
1500019|NCT01672242|3669655|P1|NOT COMPLETED|Period 1||0
1500020|NCT01672242|3669654|P2|COMPLETED|Period 1||2
1500021|NCT01672242|3669655|P1|COMPLETED|Period 1||4
1500022|NCT01672242|3669654|P2|STARTED|Period 1||2
1500023|NCT01672242|3669655|P1|STARTED|Period 1||4
1500024|NCT01671839|3669661|P1|NOT COMPLETED|Overall Study||5
1500025|NCT01671839|3669661|P1|COMPLETED|Overall Study||50
1500026|NCT01671839|3669661|P1|STARTED|Overall Study||55
1500027|NCT01671748|3669672|P2|NOT COMPLETED|12 Week Treatment Phase||0
1500028|NCT01671748|3669673|P1|NOT COMPLETED|12 Week Treatment Phase||0
1500029|NCT01671748|3669672|P2|COMPLETED|12 Week Treatment Phase||17
1500030|NCT01671748|3669673|P1|COMPLETED|12 Week Treatment Phase||19
1500031|NCT01671748|3669672|P2|STARTED|12 Week Treatment Phase||17
1500032|NCT01671748|3669673|P1|STARTED|12 Week Treatment Phase||19
1500033|NCT01671748|3669672|P2|NOT COMPLETED|4 Week run-in Phase||0
1500034|NCT01671748|3669673|P1|NOT COMPLETED|4 Week run-in Phase||11
1500035|NCT01671748|3669672|P2|COMPLETED|4 Week run-in Phase||0
1500036|NCT01671748|3669673|P1|COMPLETED|4 Week run-in Phase||36
1500037|NCT01671748|3669672|P2|STARTED|4 Week run-in Phase||0
1500038|NCT01671748|3669673|P1|STARTED|4 Week run-in Phase||47
1500039|NCT01671605|3669693|P2|NOT COMPLETED|Overall Study||0
1500040|NCT01671605|3669694|P1|NOT COMPLETED|Overall Study||0
1500041|NCT01671605|3669693|P2|COMPLETED|Overall Study||31
1500042|NCT01671605|3669694|P1|COMPLETED|Overall Study||72
1500043|NCT01671605|3669693|P2|STARTED|Overall Study||31
1500044|NCT01671605|3669694|P1|STARTED|Overall Study||72
1500045|NCT01671488|3669700|P1|NOT COMPLETED|Overall Study||1
1500046|NCT01671488|3669700|P1|COMPLETED|Overall Study||10
1500047|NCT01671488|3669700|P1|STARTED|Overall Study||11
1500048|NCT01671319|3669706|P1|NOT COMPLETED|Overall Study||1
1500049|NCT01671319|3669706|P1|COMPLETED|Overall Study||41
1500050|NCT01671319|3669706|P1|STARTED|Overall Study||42
1500051|NCT01671293|3669714|P2|NOT COMPLETED|Overall Study||2
1500052|NCT01671293|3669715|P1|NOT COMPLETED|Overall Study||3
1500053|NCT01671293|3669714|P2|COMPLETED|Overall Study||32
1500054|NCT01671293|3669715|P1|COMPLETED|Overall Study||33
1500055|NCT01671293|3669714|P2|STARTED|Overall Study||34
1500056|NCT01671293|3669715|P1|STARTED|Overall Study||36
1500057|NCT01671280|3669721|P1|NOT COMPLETED|Overall Study||2
1500058|NCT01671280|3669721|P1|COMPLETED|Overall Study||401
1500059|NCT01671280|3669721|P1|STARTED|Overall Study|The number is enrollment.|403
1500060|NCT01671176|3669727|P1|NOT COMPLETED|Overall Study||0
1500061|NCT01671176|3669727|P1|COMPLETED|Overall Study||30
1500062|NCT01671176|3669727|P1|STARTED|Overall Study||30
1500063|NCT01671111|3669732|P1|NOT COMPLETED|Overall Study||30
1500064|NCT01671111|3669732|P1|COMPLETED|Overall Study||0
1500065|NCT01671111|3669732|P1|STARTED|Overall Study||30
1500066|NCT01671059|3669742|P1|NOT COMPLETED|Overall Study||5
1500067|NCT01671059|3669742|P1|COMPLETED|Overall Study||75
1500068|NCT01671059|3669742|P1|STARTED|Overall Study||80
1500069|NCT01670825|3669767|P2|NOT COMPLETED|Overall Study||0
1500070|NCT01670825|3669768|P1|NOT COMPLETED|Overall Study||0
1500071|NCT01670825|3669767|P2|COMPLETED|Overall Study||39
1500072|NCT01670825|3669768|P1|COMPLETED|Overall Study||42
1500073|NCT01670825|3669767|P2|STARTED|Overall Study||39
1500074|NCT01670825|3669768|P1|STARTED|Overall Study||42
1500075|NCT01670721|3669834|P1|NOT COMPLETED|Overall Study||53
1500076|NCT01670721|3669834|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
1500077|NCT01670721|3669834|P1|STARTED|Overall Study||175
1500078|NCT01670656|3669846|P5|NOT COMPLETED|Overall Study||11
1500079|NCT01670656|3669847|P4|NOT COMPLETED|Overall Study||6
1500080|NCT01670656|3669848|P3|NOT COMPLETED|Overall Study||8
1500081|NCT01670656|3669849|P2|NOT COMPLETED|Overall Study||7
1500082|NCT01670656|3669850|P1|NOT COMPLETED|Overall Study||3
1500083|NCT01670656|3669846|P5|COMPLETED|Overall Study||79
1500084|NCT01670656|3669847|P4|COMPLETED|Overall Study||79
1500085|NCT01670656|3669848|P3|COMPLETED|Overall Study||79
1500086|NCT01670656|3669849|P2|COMPLETED|Overall Study||84
1500087|NCT01670656|3669850|P1|COMPLETED|Overall Study||83
1500088|NCT01670656|3669846|P5|Treated|Overall Study||90
1500089|NCT01670656|3669847|P4|Treated|Overall Study||85
1500090|NCT01670656|3669848|P3|Treated|Overall Study||86
1500091|NCT01670656|3669849|P2|Treated|Overall Study||91
1500092|NCT01670656|3669850|P1|Treated|Overall Study||86
1500093|NCT01670656|3669846|P5|STARTED|Overall Study||90
1500094|NCT01670656|3669847|P4|STARTED|Overall Study||85
1500095|NCT01670656|3669848|P3|STARTED|Overall Study||87
1500096|NCT01670656|3669849|P2|STARTED|Overall Study||91
1500097|NCT01670656|3669850|P1|STARTED|Overall Study||86
1500098|NCT01670526|3669879|P2|NOT COMPLETED|Overall Study||6
1500099|NCT01670526|3669880|P1|NOT COMPLETED|Overall Study||12
1500100|NCT01670526|3669879|P2|COMPLETED|Overall Study||39
1500101|NCT01670526|3669880|P1|COMPLETED|Overall Study||37
1500102|NCT01670526|3669879|P2|STARTED|Overall Study||45
1500103|NCT01670526|3669880|P1|STARTED|Overall Study||49
1500104|NCT01670487|3669894|P2|NOT COMPLETED|Overall Study||0
1500105|NCT01670487|3669895|P1|NOT COMPLETED|Overall Study||0
1500106|NCT01670487|3669894|P2|COMPLETED|Overall Study||150
1500107|NCT01670487|3669895|P1|COMPLETED|Overall Study||150
1500108|NCT01670487|3669894|P2|STARTED|Overall Study||150
1500109|NCT01670487|3669895|P1|STARTED|Overall Study||150
1500110|NCT01670292|3669901|P1|NOT COMPLETED|Overall Study||14
1500111|NCT01670292|3669901|P1|COMPLETED|Overall Study||68
1500112|NCT01670292|3669901|P1|STARTED|Overall Study||82
1500113|NCT01670279|3669942|P4|NOT COMPLETED|Overall Study||1
1500114|NCT01670279|3669943|P3|NOT COMPLETED|Overall Study||0
1500115|NCT01670279|3669944|P2|NOT COMPLETED|Overall Study||2
1500116|NCT01670279|3669945|P1|NOT COMPLETED|Overall Study||0
1500117|NCT01670279|3669942|P4|COMPLETED|Overall Study||4
1500118|NCT01670279|3669943|P3|COMPLETED|Overall Study||0
1500119|NCT01670279|3669944|P2|COMPLETED|Overall Study||5
1500120|NCT01670279|3669945|P1|COMPLETED|Overall Study||6
1500121|NCT01670279|3669942|P4|STARTED|Overall Study||5
1500122|NCT01670279|3669943|P3|STARTED|Overall Study||0
1500123|NCT01670279|3669944|P2|STARTED|Overall Study||7
1500124|NCT01670279|3669945|P1|STARTED|Overall Study||6
1500125|NCT01670201|3669980|P1|NOT COMPLETED|Overall Study||0
1500126|NCT01670201|3669980|P1|COMPLETED|Overall Study||8
1500127|NCT01670201|3669980|P1|STARTED|Overall Study||8
1500128|NCT01670188|3669987|P2|NOT COMPLETED|Overall Study||1
1500129|NCT01670188|3669988|P1|NOT COMPLETED|Overall Study||0
1500130|NCT01670188|3669987|P2|COMPLETED|Overall Study||39
1500131|NCT01670188|3669988|P1|COMPLETED|Overall Study||38
1500132|NCT01670188|3669987|P2|STARTED|Overall Study||40
1500133|NCT01670188|3669988|P1|STARTED|Overall Study||38
1500134|NCT01670045|3669994|P1|NOT COMPLETED|Overall Study||16
1500135|NCT01670045|3669994|P1|COMPLETED|Overall Study||27
1500136|NCT01670045|3669994|P1|STARTED|Overall Study||43
1500137|NCT01670019|3670012|P2|NOT COMPLETED|Overall Study||0
1500138|NCT01670019|3670013|P1|NOT COMPLETED|Overall Study||9
1500139|NCT01670019|3670012|P2|COMPLETED|Overall Study||23
1500140|NCT01670019|3670013|P1|COMPLETED|Overall Study||14
1500141|NCT01670019|3670012|P2|STARTED|Overall Study||23
1500142|NCT01670019|3670013|P1|STARTED|Overall Study||23
1500143|NCT01669902|3670027|P1|NOT COMPLETED|Overall Study||29
1500144|NCT01669902|3670027|P1|COMPLETED|Overall Study||78
1500145|NCT01669902|3670027|P1|STARTED|Overall Study||107
1500146|NCT01669863|3670054|P1|NOT COMPLETED|Overall Study||0
1500147|NCT01669863|3670054|P1|COMPLETED|Overall Study||6
1500148|NCT01669863|3670054|P1|STARTED|Overall Study||6
1500149|NCT01669811|3670062|P2|NOT COMPLETED|Overall Study||11
1500150|NCT01669811|3670063|P1|NOT COMPLETED|Overall Study||3
1500151|NCT01669811|3670062|P2|COMPLETED|Overall Study||131
1500152|NCT01669811|3670063|P1|COMPLETED|Overall Study||142
1500153|NCT01669811|3670062|P2|STARTED|Overall Study||142
1500154|NCT01669811|3670063|P1|STARTED|Overall Study||145
1500155|NCT01669798|3670081|P1|NOT COMPLETED|Overall Study||5
1500156|NCT01669798|3670081|P1|COMPLETED|Overall Study||27
1500157|NCT01669798|3670081|P1|STARTED|Overall Study||32
1500158|NCT01669785|3670097|P3|NOT COMPLETED|Overall Study||0
1500159|NCT01669785|3670098|P2|NOT COMPLETED|Overall Study||0
1500160|NCT01669785|3670099|P1|NOT COMPLETED|Overall Study||0
1500161|NCT01669785|3670097|P3|COMPLETED|Overall Study||46
1500162|NCT01669785|3670098|P2|COMPLETED|Overall Study||48
1500163|NCT01669785|3670099|P1|COMPLETED|Overall Study||45
1500164|NCT01669785|3670097|P3|STARTED|Overall Study||46
1500165|NCT01669785|3670098|P2|STARTED|Overall Study||48
1500166|NCT01669785|3670099|P1|STARTED|Overall Study||45
1500167|NCT01669720|3670136|P2|NOT COMPLETED|Overall Study||0
1500168|NCT01669720|3670137|P1|NOT COMPLETED|Overall Study||0
1500169|NCT01669720|3670136|P2|COMPLETED|Overall Study||3
1500170|NCT01669720|3670137|P1|COMPLETED|Overall Study||7
1500171|NCT01669720|3670136|P2|STARTED|Overall Study||3
1500172|NCT01669720|3670137|P1|STARTED|Overall Study||7
1500173|NCT01669642|3670150|P6|NOT COMPLETED|Overall Study||10
1500174|NCT01669642|3670151|P5|NOT COMPLETED|Overall Study||0
1500175|NCT01669642|3670152|P4|NOT COMPLETED|Overall Study||1
1500176|NCT01669642|3670153|P3|NOT COMPLETED|Overall Study||0
1500177|NCT01669642|3670154|P2|NOT COMPLETED|Overall Study||0
1500178|NCT01669642|3670155|P1|NOT COMPLETED|Overall Study||0
1500179|NCT01669642|3670150|P6|COMPLETED|Overall Study||0
1500180|NCT01669642|3670151|P5|COMPLETED|Overall Study||20
1500181|NCT01669642|3670152|P4|COMPLETED|Overall Study||20
1500182|NCT01669642|3670153|P3|COMPLETED|Overall Study||20
1500183|NCT01669642|3670154|P2|COMPLETED|Overall Study||20
1500184|NCT01669642|3670155|P1|COMPLETED|Overall Study||20
1500185|NCT01669642|3670150|P6|STARTED|Overall Study||10
1500186|NCT01669642|3670151|P5|STARTED|Overall Study||20
1500187|NCT01669642|3670152|P4|STARTED|Overall Study||21
1500188|NCT01669642|3670153|P3|STARTED|Overall Study||20
1500189|NCT01669642|3670154|P2|STARTED|Overall Study||20
1500190|NCT01669642|3670155|P1|STARTED|Overall Study||20
1500191|NCT01669629|3670187|P2|NOT COMPLETED|Period 2||0
1500192|NCT01669629|3670188|P1|NOT COMPLETED|Period 2||0
1500193|NCT01669629|3670187|P2|COMPLETED|Period 2||89
1500194|NCT01669629|3670188|P1|COMPLETED|Period 2||91
1500195|NCT01669629|3670187|P2|STARTED|Period 2||89
1500196|NCT01669629|3670188|P1|STARTED|Period 2||91
1500197|NCT01669629|3670187|P2|NOT COMPLETED|Period 1||2
1500198|NCT01669629|3670188|P1|NOT COMPLETED|Period 1||1
1500199|NCT01669629|3670187|P2|COMPLETED|Period 1||89
1500200|NCT01669629|3670188|P1|COMPLETED|Period 1||91
1500201|NCT01669629|3670187|P2|STARTED|Period 1||91
1500202|NCT01669629|3670188|P1|STARTED|Period 1||92
1500203|NCT01669603|3670204|P2|NOT COMPLETED|Overall Study||38
1500204|NCT01669603|3670205|P1|NOT COMPLETED|Overall Study||37
1500205|NCT01669603|3670204|P2|COMPLETED|Overall Study||57
1500206|NCT01669603|3670205|P1|COMPLETED|Overall Study||58
1500207|NCT01669603|3670204|P2|STARTED|Overall Study||95
1500208|NCT01669603|3670205|P1|STARTED|Overall Study||95
1500209|NCT01669577|3670211|P1|NOT COMPLETED|Overall Study||134
1500210|NCT01669577|3670211|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
1500211|NCT01669577|3670211|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
1500212|NCT01669434|3670217|P2|NOT COMPLETED|Overall Study||7
1500213|NCT01669434|3670218|P1|NOT COMPLETED|Overall Study||9
1500214|NCT01669434|3670217|P2|COMPLETED|Overall Study||138
1500215|NCT01669434|3670218|P1|COMPLETED|Overall Study||137
1500216|NCT01669434|3670217|P2|STARTED|Overall Study||145
1500217|NCT01669434|3670218|P1|STARTED|Overall Study||146
1500218|NCT01669174|3670236|P2|NOT COMPLETED|Overall Study||6
1500219|NCT01669174|3670237|P1|NOT COMPLETED|Overall Study||6
1500220|NCT01669174|3670236|P2|COMPLETED|Overall Study||28
1500221|NCT01669174|3670237|P1|COMPLETED|Overall Study||27
1500222|NCT01669174|3670236|P2|STARTED|Overall Study||34
1500223|NCT01669174|3670237|P1|STARTED|Overall Study||33
1500224|NCT01669148|3670248|P1|NOT COMPLETED|Overall Study||70
1500225|NCT01669148|3670248|P1|COMPLETED|Overall Study||426
1500226|NCT01669148|3670248|P1|STARTED|Overall Study||496
1500227|NCT01669122|3670253|P1|NOT COMPLETED|Period IV||0
1500228|NCT01669122|3670253|P1|COMPLETED|Period IV||37
1500229|NCT01669122|3670253|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
1500230|NCT01669122|3670253|P1|NOT COMPLETED|Period III||0
1500231|NCT01669122|3670253|P1|COMPLETED|Period III||37
1500232|NCT01669122|3670253|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
1500233|NCT01669122|3670253|P1|NOT COMPLETED|Washout Period III||0
1500234|NCT01669122|3670253|P1|COMPLETED|Washout Period III||37
1500235|NCT01669122|3670253|P1|STARTED|Washout Period III||37
1500236|NCT01669122|3670253|P1|NOT COMPLETED|Washout Period II||2
1500237|NCT01669122|3670253|P1|COMPLETED|Washout Period II||37
1500238|NCT01669122|3670253|P1|STARTED|Washout Period II||39
1500239|NCT01669122|3670253|P1|NOT COMPLETED|Period II||0
1500240|NCT01669122|3670253|P1|COMPLETED|Period II||39
1500241|NCT01669122|3670253|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
1500242|NCT01669122|3670253|P1|NOT COMPLETED|Washout Period I||0
1500243|NCT01669122|3670253|P1|COMPLETED|Washout Period I||39
1500244|NCT01669122|3670253|P1|STARTED|Washout Period I||39
1500245|NCT01669122|3670253|P1|NOT COMPLETED|Period I||1
1500246|NCT01669122|3670253|P1|COMPLETED|Period I||39
1500247|NCT01669122|3670253|P1|Safety Population|Period I||39
1500248|NCT01669122|3670253|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
1500249|NCT01668836|3670287|P4|NOT COMPLETED|Overall Study||0
1500250|NCT01668836|3670288|P3|NOT COMPLETED|Overall Study||0
1500251|NCT01668836|3670289|P2|NOT COMPLETED|Overall Study||0
1500252|NCT01668836|3670290|P1|NOT COMPLETED|Overall Study||0
1500253|NCT01668836|3670287|P4|COMPLETED|Overall Study||12
1500254|NCT01668836|3670288|P3|COMPLETED|Overall Study||12
1500255|NCT01668836|3670289|P2|COMPLETED|Overall Study||12
1500256|NCT01668836|3670290|P1|COMPLETED|Overall Study||12
1500257|NCT01668836|3670287|P4|STARTED|Overall Study||12
1500258|NCT01668836|3670288|P3|STARTED|Overall Study||12
1500259|NCT01668836|3670289|P2|STARTED|Overall Study||12
1500260|NCT01668836|3670290|P1|STARTED|Overall Study||12
1500261|NCT01668797|3670346|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
1500262|NCT01668797|3670347|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
1500263|NCT01668797|3670348|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
1500264|NCT01668797|3670349|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
1500265|NCT01668797|3670346|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
1500266|NCT01668797|3670347|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
1500267|NCT01668797|3670348|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
1500268|NCT01668797|3670349|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
1500269|NCT01668797|3670346|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
1500270|NCT01668797|3670347|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
1500271|NCT01668797|3670348|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
1500272|NCT01668797|3670349|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
1500273|NCT01668797|3670346|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
1500274|NCT01668797|3670347|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
1500275|NCT01668797|3670348|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
1500276|NCT01668797|3670349|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
1500277|NCT01668797|3670346|P4|COMPLETED|Phase B (Stabilization Phase)||0
1500278|NCT01668797|3670347|P3|COMPLETED|Phase B (Stabilization Phase)||0
1500279|NCT01668797|3670348|P2|COMPLETED|Phase B (Stabilization Phase)||202
1500280|NCT01668797|3670349|P1|COMPLETED|Phase B (Stabilization Phase)||0
1500281|NCT01668797|3670346|P4|STARTED|Phase B (Stabilization Phase)||0
1500282|NCT01668797|3670347|P3|STARTED|Phase B (Stabilization Phase)||0
1500283|NCT01668797|3670348|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
1500284|NCT01668797|3670349|P1|STARTED|Phase B (Stabilization Phase)||0
1500285|NCT01668797|3670346|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
1500286|NCT01668797|3670347|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
1500287|NCT01668797|3670348|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
1500288|NCT01668797|3670349|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
1500289|NCT01668797|3670346|P4|COMPLETED|Phase A (Conversion Phase)||0
1500290|NCT01668797|3670347|P3|COMPLETED|Phase A (Conversion Phase)||0
1500291|NCT01668797|3670348|P2|COMPLETED|Phase A (Conversion Phase)||0
1500292|NCT01668797|3670349|P1|COMPLETED|Phase A (Conversion Phase)||346
1500293|NCT01668797|3670346|P4|STARTED|Phase A (Conversion Phase)||0
1500294|NCT01668797|3670347|P3|STARTED|Phase A (Conversion Phase)||0
1500295|NCT01668797|3670348|P2|STARTED|Phase A (Conversion Phase)||0
1500296|NCT01668797|3670349|P1|STARTED|Phase A (Conversion Phase)||406
1500297|NCT01668784|3670414|P2|NOT COMPLETED|Treated (Overall)||369
1500298|NCT01668784|3670415|P1|NOT COMPLETED|Treated (Overall)||339
1500299|NCT01668784|3670414|P2|COMPLETED|Treated (Overall)||28
1500300|NCT01668784|3670415|P1|COMPLETED|Treated (Overall)||67
1500301|NCT01668784|3670414|P2|STARTED|Treated (Overall)||397
1500302|NCT01668784|3670415|P1|STARTED|Treated (Overall)||406
1500303|NCT01668784|3670414|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
1500304|NCT01668784|3670415|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
1500305|NCT01668784|3670414|P2|COMPLETED|Randomized (Pre-treatment)||397
1500306|NCT01668784|3670415|P1|COMPLETED|Randomized (Pre-treatment)||406
1500307|NCT01668784|3670414|P2|STARTED|Randomized (Pre-treatment)||411
1500308|NCT01668784|3670415|P1|STARTED|Randomized (Pre-treatment)||410
1500309|NCT01668667|3670443|P4|NOT COMPLETED|Overall Study||23
1500310|NCT01668667|3670444|P3|NOT COMPLETED|Overall Study||31
1500311|NCT01668667|3670445|P2|NOT COMPLETED|Overall Study||26
1500312|NCT01668667|3670446|P1|NOT COMPLETED|Overall Study||31
1500313|NCT01668667|3670443|P4|COMPLETED|Overall Study||102
1500314|NCT01668667|3670444|P3|COMPLETED|Overall Study||94
1500315|NCT01668667|3670445|P2|COMPLETED|Overall Study||99
1500316|NCT01668667|3670446|P1|COMPLETED|Overall Study||95
1500317|NCT01668667|3670443|P4|STARTED|Overall Study||125
1500318|NCT01668667|3670444|P3|STARTED|Overall Study||125
1500319|NCT01668667|3670445|P2|STARTED|Overall Study||125
1500320|NCT01668667|3670446|P1|STARTED|Overall Study||126
1500321|NCT01668654|3670468|P1|NOT COMPLETED|Overall Study||4
1500322|NCT01668654|3670468|P1|COMPLETED|Overall Study||0
1500323|NCT01668654|3670468|P1|STARTED|Overall Study||4
1500324|NCT01668628|3670511|P3|NOT COMPLETED|Overall Study||0
1500325|NCT01668628|3670512|P2|NOT COMPLETED|Overall Study||0
1500326|NCT01668628|3670513|P1|NOT COMPLETED|Overall Study||2
1500327|NCT01668628|3670511|P3|COMPLETED|Overall Study||367
1500328|NCT01668628|3670512|P2|COMPLETED|Overall Study||359
1500329|NCT01668628|3670513|P1|COMPLETED|Overall Study||347
1500330|NCT01668628|3670511|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
1500331|NCT01668628|3670512|P2|STARTED|Overall Study||359
1500332|NCT01668628|3670513|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
1500333|NCT01668589|3670529|P4|NOT COMPLETED|Overall Study||35
1500334|NCT01668589|3670530|P3|NOT COMPLETED|Overall Study||35
1500335|NCT01668589|3670531|P2|NOT COMPLETED|Overall Study||58
1500336|NCT01668589|3670532|P1|NOT COMPLETED|Overall Study||139
1500337|NCT01668589|3670529|P4|COMPLETED|Overall Study||266
1500338|NCT01668589|3670530|P3|COMPLETED|Overall Study||265
1500339|NCT01668589|3670531|P2|COMPLETED|Overall Study||242
1500340|NCT01668589|3670532|P1|COMPLETED|Overall Study||461
1500341|NCT01668589|3670529|P4|Received Denosumab|Overall Study||301
1500342|NCT01668589|3670530|P3|Received Denosumab|Overall Study||300
1500343|NCT01668589|3670531|P2|Received Denosumab|Overall Study||300
1500344|NCT01668589|3670532|P1|Received Denosumab|Overall Study||599
1500345|NCT01668589|3670529|P4|STARTED|Overall Study||301
1500346|NCT01668589|3670530|P3|STARTED|Overall Study||300
1500347|NCT01668589|3670531|P2|STARTED|Overall Study||300
1500348|NCT01668589|3670532|P1|STARTED|Overall Study||600
1500349|NCT01668173|3670570|P1|NOT COMPLETED|Overall Study||7
1500350|NCT01668173|3670570|P1|COMPLETED|Overall Study||0
1500351|NCT01668173|3670570|P1|STARTED|Overall Study||7
1500352|NCT01668030|3670574|P2|NOT COMPLETED|Overall Study||0
1500353|NCT01668030|3670575|P1|NOT COMPLETED|Overall Study||0
1500354|NCT01668030|3670574|P2|COMPLETED|Overall Study||10
1500355|NCT01668030|3670575|P1|COMPLETED|Overall Study||10
1500356|NCT01668030|3670574|P2|STARTED|Overall Study||10
1500357|NCT01668030|3670575|P1|STARTED|Overall Study||10
1500358|NCT01668017|3670585|P5|NOT COMPLETED|Overall Study||0
1500359|NCT01668017|3670586|P4|NOT COMPLETED|Overall Study||0
1500360|NCT01668017|3670587|P3|NOT COMPLETED|Overall Study||0
1500361|NCT01668017|3670588|P2|NOT COMPLETED|Overall Study||0
1500362|NCT01668017|3670589|P1|NOT COMPLETED|Overall Study||0
1500363|NCT01668017|3670585|P5|COMPLETED|Overall Study||2
1500364|NCT01668017|3670586|P4|COMPLETED|Overall Study||5
1500365|NCT01668017|3670587|P3|COMPLETED|Overall Study||6
1500366|NCT01668017|3670588|P2|COMPLETED|Overall Study||9
1500367|NCT01668017|3670589|P1|COMPLETED|Overall Study||4
1500368|NCT01668017|3670585|P5|STARTED|Overall Study||2
1500369|NCT01668017|3670586|P4|STARTED|Overall Study||5
1500370|NCT01668017|3670587|P3|STARTED|Overall Study||6
1500371|NCT01668017|3670588|P2|STARTED|Overall Study||9
1500372|NCT01668017|3670589|P1|STARTED|Overall Study||4
1500373|NCT01668004|3670696|P1|NOT COMPLETED|Overall Study||25
1500374|NCT01668004|3670696|P1|COMPLETED|Overall Study||76
1500375|NCT01668004|3670696|P1|Treated|Overall Study||101
1500376|NCT01668004|3670696|P1|STARTED|Overall Study||101
1500377|NCT01667978|3670709|P2|NOT COMPLETED|Overall Study||0
1500378|NCT01667978|3670710|P1|NOT COMPLETED|Overall Study||2
1500379|NCT01667978|3670709|P2|COMPLETED|Overall Study||17
1500380|NCT01667978|3670710|P1|COMPLETED|Overall Study||16
1500381|NCT01667978|3670709|P2|STARTED|Overall Study||17
1500382|NCT01667978|3670710|P1|STARTED|Overall Study||18
1500383|NCT01667926|3670718|P3|NOT COMPLETED|Overall Study||11
1500384|NCT01667926|3670719|P2|NOT COMPLETED|Overall Study||4
1500385|NCT01667926|3670720|P1|NOT COMPLETED|Overall Study||5
1500386|NCT01667926|3670718|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
1500387|NCT01667926|3670719|P2|COMPLETED|Overall Study||9
1500388|NCT01667926|3670720|P1|COMPLETED|Overall Study||8
1500389|NCT01667926|3670718|P3|STARTED|Overall Study||11
1500390|NCT01667926|3670719|P2|STARTED|Overall Study||13
1500391|NCT01667926|3670720|P1|STARTED|Overall Study||13
1500392|NCT01667900|3670733|P20|NOT COMPLETED|Part B||0
1500393|NCT01667900|3670734|P19|NOT COMPLETED|Part B||0
1500394|NCT01667900|3670735|P18|NOT COMPLETED|Part B||0
1500395|NCT01667900|3670736|P17|NOT COMPLETED|Part B||1
1500396|NCT01667900|3670737|P16|NOT COMPLETED|Part B||0
1500397|NCT01667900|3670738|P15|NOT COMPLETED|Part B||0
1500398|NCT01667900|3670739|P14|NOT COMPLETED|Part B||0
1500399|NCT01667900|3670740|P13|NOT COMPLETED|Part B||0
1500400|NCT01667900|3670741|P12|NOT COMPLETED|Part B||0
1500401|NCT01667900|3670742|P11|NOT COMPLETED|Part B||0
1500402|NCT01667900|3670743|P10|NOT COMPLETED|Part B||0
1500403|NCT01667900|3670744|P9|NOT COMPLETED|Part B||0
1500404|NCT01667900|3670745|P8|NOT COMPLETED|Part B||0
1500405|NCT01667900|3670746|P7|NOT COMPLETED|Part B||0
1500406|NCT01667900|3670747|P6|NOT COMPLETED|Part B||0
1500407|NCT01667900|3670748|P5|NOT COMPLETED|Part B||0
1500408|NCT01667900|3670749|P4|NOT COMPLETED|Part B||0
1500409|NCT01667900|3670750|P3|NOT COMPLETED|Part B||0
1500410|NCT01667900|3670751|P2|NOT COMPLETED|Part B||0
1500411|NCT01667900|3670752|P1|NOT COMPLETED|Part B||0
1500412|NCT01667900|3670733|P20|COMPLETED|Part B||10
1500413|NCT01667900|3670734|P19|COMPLETED|Part B||10
1500414|NCT01667900|3670735|P18|COMPLETED|Part B||11
1500415|NCT01667900|3670736|P17|COMPLETED|Part B||10
1500416|NCT01667900|3670737|P16|COMPLETED|Part B||0
1500417|NCT01667900|3670738|P15|COMPLETED|Part B||0
1500418|NCT01667900|3670739|P14|COMPLETED|Part B||0
1500419|NCT01667900|3670740|P13|COMPLETED|Part B||0
1500420|NCT01667900|3670741|P12|COMPLETED|Part B||0
1500421|NCT01667900|3670742|P11|COMPLETED|Part B||0
1500422|NCT01667900|3670743|P10|COMPLETED|Part B||0
1500423|NCT01667900|3670744|P9|COMPLETED|Part B||0
1500424|NCT01667900|3670745|P8|COMPLETED|Part B||0
1500425|NCT01667900|3670746|P7|COMPLETED|Part B||0
1500426|NCT01667900|3670747|P6|COMPLETED|Part B||0
1500427|NCT01667900|3670748|P5|COMPLETED|Part B||0
1500428|NCT01667900|3670749|P4|COMPLETED|Part B||0
1500429|NCT01667900|3670750|P3|COMPLETED|Part B||0
1500430|NCT01667900|3670751|P2|COMPLETED|Part B||0
1500431|NCT01667900|3670752|P1|COMPLETED|Part B||0
1500432|NCT01667900|3670733|P20|STARTED|Part B||10
1500433|NCT01667900|3670734|P19|STARTED|Part B||10
1500434|NCT01667900|3670735|P18|STARTED|Part B||11
1500435|NCT01667900|3670736|P17|STARTED|Part B||11
1500436|NCT01667900|3670737|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
1500437|NCT01667900|3670738|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
1500438|NCT01667900|3670739|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
1500439|NCT01667900|3670740|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
1500440|NCT01667900|3670741|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
1500441|NCT01667900|3670742|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
1500442|NCT01667900|3670743|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
1500443|NCT01667900|3670744|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
1500444|NCT01667900|3670745|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
1500445|NCT01667900|3670746|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
1500446|NCT01667900|3670747|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
1500447|NCT01667900|3670748|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
1500448|NCT01667900|3670749|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
1500449|NCT01667900|3670750|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
1500450|NCT01667900|3670751|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
1500451|NCT01667900|3670752|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
1500452|NCT01667900|3670733|P20|NOT COMPLETED|Part A, Period 3||0
1500453|NCT01667900|3670734|P19|NOT COMPLETED|Part A, Period 3||0
1500454|NCT01667900|3670735|P18|NOT COMPLETED|Part A, Period 3||0
1500455|NCT01667900|3670736|P17|NOT COMPLETED|Part A, Period 3||0
1500456|NCT01667900|3670737|P16|NOT COMPLETED|Part A, Period 3||0
1500457|NCT01667900|3670738|P15|NOT COMPLETED|Part A, Period 3||0
1500458|NCT01667900|3670739|P14|NOT COMPLETED|Part A, Period 3||0
1500459|NCT01667900|3670740|P13|NOT COMPLETED|Part A, Period 3||0
1500460|NCT01667900|3670741|P12|NOT COMPLETED|Part A, Period 3||0
1500461|NCT01667900|3670742|P11|NOT COMPLETED|Part A, Period 3||0
1500462|NCT01667900|3670743|P10|NOT COMPLETED|Part A, Period 3||0
1500463|NCT01667900|3670744|P9|NOT COMPLETED|Part A, Period 3||0
1500464|NCT01667900|3670745|P8|NOT COMPLETED|Part A, Period 3||0
1500465|NCT01667900|3670746|P7|NOT COMPLETED|Part A, Period 3||0
1500466|NCT01667900|3670747|P6|NOT COMPLETED|Part A, Period 3||0
1500467|NCT01667900|3670748|P5|NOT COMPLETED|Part A, Period 3||0
1500468|NCT01667900|3670749|P4|NOT COMPLETED|Part A, Period 3||0
1500469|NCT01667900|3670750|P3|NOT COMPLETED|Part A, Period 3||0
1500470|NCT01667900|3670751|P2|NOT COMPLETED|Part A, Period 3||0
1500471|NCT01667900|3670752|P1|NOT COMPLETED|Part A, Period 3||0
1500472|NCT01667900|3670733|P20|COMPLETED|Part A, Period 3||0
1500473|NCT01667900|3670734|P19|COMPLETED|Part A, Period 3||0
1500474|NCT01667900|3670735|P18|COMPLETED|Part A, Period 3||0
1500475|NCT01667900|3670736|P17|COMPLETED|Part A, Period 3||0
1500476|NCT01667900|3670737|P16|COMPLETED|Part A, Period 3||1
1500477|NCT01667900|3670738|P15|COMPLETED|Part A, Period 3||1
1500478|NCT01667900|3670739|P14|COMPLETED|Part A, Period 3||1
1500479|NCT01667900|3670740|P13|COMPLETED|Part A, Period 3||1
1500480|NCT01667900|3670741|P12|COMPLETED|Part A, Period 3||1
1500481|NCT01667900|3670742|P11|COMPLETED|Part A, Period 3||1
1500482|NCT01667900|3670743|P10|COMPLETED|Part A, Period 3||1
1500483|NCT01667900|3670744|P9|COMPLETED|Part A, Period 3||1
1500484|NCT01667900|3670745|P8|COMPLETED|Part A, Period 3||1
1500485|NCT01667900|3670746|P7|COMPLETED|Part A, Period 3||1
1500486|NCT01667900|3670747|P6|COMPLETED|Part A, Period 3||1
1500487|NCT01667900|3670748|P5|COMPLETED|Part A, Period 3||1
1500488|NCT01667900|3670749|P4|COMPLETED|Part A, Period 3||1
1500489|NCT01667900|3670750|P3|COMPLETED|Part A, Period 3||1
1500490|NCT01667900|3670751|P2|COMPLETED|Part A, Period 3||1
1500491|NCT01667900|3670752|P1|COMPLETED|Part A, Period 3||1
1500492|NCT01667900|3670733|P20|STARTED|Part A, Period 3||0
1500493|NCT01667900|3670734|P19|STARTED|Part A, Period 3||0
1500494|NCT01667900|3670735|P18|STARTED|Part A, Period 3||0
1500495|NCT01667900|3670736|P17|STARTED|Part A, Period 3||0
1500496|NCT01667900|3670737|P16|STARTED|Part A, Period 3||1
1500497|NCT01667900|3670738|P15|STARTED|Part A, Period 3||1
1500498|NCT01667900|3670739|P14|STARTED|Part A, Period 3||1
1500499|NCT01667900|3670740|P13|STARTED|Part A, Period 3||1
1500500|NCT01667900|3670741|P12|STARTED|Part A, Period 3||1
1500501|NCT01667900|3670742|P11|STARTED|Part A, Period 3||1
1500502|NCT01667900|3670743|P10|STARTED|Part A, Period 3||1
1500503|NCT01667900|3670744|P9|STARTED|Part A, Period 3||1
1500504|NCT01667900|3670745|P8|STARTED|Part A, Period 3||1
1500505|NCT01667900|3670746|P7|STARTED|Part A, Period 3||1
1500506|NCT01667900|3670747|P6|STARTED|Part A, Period 3||1
1500507|NCT01667900|3670748|P5|STARTED|Part A, Period 3||1
1500508|NCT01667900|3670749|P4|STARTED|Part A, Period 3||1
1500509|NCT01667900|3670750|P3|STARTED|Part A, Period 3||1
1500510|NCT01667900|3670751|P2|STARTED|Part A, Period 3||1
1500511|NCT01667900|3670752|P1|STARTED|Part A, Period 3||1
1500512|NCT01667900|3670733|P20|NOT COMPLETED|Part A, Washout 2||0
1500513|NCT01667900|3670734|P19|NOT COMPLETED|Part A, Washout 2||0
1500514|NCT01667900|3670735|P18|NOT COMPLETED|Part A, Washout 2||0
1500515|NCT01667900|3670736|P17|NOT COMPLETED|Part A, Washout 2||0
1500516|NCT01667900|3670737|P16|NOT COMPLETED|Part A, Washout 2||0
1500517|NCT01667900|3670738|P15|NOT COMPLETED|Part A, Washout 2||0
1500518|NCT01667900|3670739|P14|NOT COMPLETED|Part A, Washout 2||0
1500519|NCT01667900|3670740|P13|NOT COMPLETED|Part A, Washout 2||0
1500520|NCT01667900|3670741|P12|NOT COMPLETED|Part A, Washout 2||0
1500521|NCT01667900|3670742|P11|NOT COMPLETED|Part A, Washout 2||0
1500522|NCT01667900|3670743|P10|NOT COMPLETED|Part A, Washout 2||0
1500523|NCT01667900|3670744|P9|NOT COMPLETED|Part A, Washout 2||0
1500524|NCT01667900|3670745|P8|NOT COMPLETED|Part A, Washout 2||0
1500525|NCT01667900|3670746|P7|NOT COMPLETED|Part A, Washout 2||0
1500526|NCT01667900|3670747|P6|NOT COMPLETED|Part A, Washout 2||0
1500527|NCT01667900|3670748|P5|NOT COMPLETED|Part A, Washout 2||0
1500528|NCT01667900|3670749|P4|NOT COMPLETED|Part A, Washout 2||0
1500529|NCT01667900|3670750|P3|NOT COMPLETED|Part A, Washout 2||0
1500530|NCT01667900|3670751|P2|NOT COMPLETED|Part A, Washout 2||0
1500531|NCT01667900|3670752|P1|NOT COMPLETED|Part A, Washout 2||0
1500532|NCT01667900|3670733|P20|COMPLETED|Part A, Washout 2||0
1500533|NCT01667900|3670734|P19|COMPLETED|Part A, Washout 2||0
1500534|NCT01667900|3670735|P18|COMPLETED|Part A, Washout 2||0
1500535|NCT01667900|3670736|P17|COMPLETED|Part A, Washout 2||0
1500536|NCT01667900|3670737|P16|COMPLETED|Part A, Washout 2||1
1500537|NCT01667900|3670738|P15|COMPLETED|Part A, Washout 2||1
1500538|NCT01667900|3670739|P14|COMPLETED|Part A, Washout 2||1
1500539|NCT01667900|3670740|P13|COMPLETED|Part A, Washout 2||1
1500540|NCT01667900|3670741|P12|COMPLETED|Part A, Washout 2||1
1500541|NCT01667900|3670742|P11|COMPLETED|Part A, Washout 2||1
1500542|NCT01667900|3670743|P10|COMPLETED|Part A, Washout 2||1
1500543|NCT01667900|3670744|P9|COMPLETED|Part A, Washout 2||1
1500544|NCT01667900|3670745|P8|COMPLETED|Part A, Washout 2||1
1500545|NCT01667900|3670746|P7|COMPLETED|Part A, Washout 2||1
1500546|NCT01667900|3670747|P6|COMPLETED|Part A, Washout 2||1
1500547|NCT01667900|3670748|P5|COMPLETED|Part A, Washout 2||1
1500548|NCT01667900|3670749|P4|COMPLETED|Part A, Washout 2||1
1500549|NCT01667900|3670750|P3|COMPLETED|Part A, Washout 2||1
1500550|NCT01667900|3670751|P2|COMPLETED|Part A, Washout 2||1
1500551|NCT01667900|3670752|P1|COMPLETED|Part A, Washout 2||1
1500552|NCT01667900|3670733|P20|STARTED|Part A, Washout 2||0
1500553|NCT01667900|3670734|P19|STARTED|Part A, Washout 2||0
1500554|NCT01667900|3670735|P18|STARTED|Part A, Washout 2||0
1500555|NCT01667900|3670736|P17|STARTED|Part A, Washout 2||0
1500556|NCT01667900|3670737|P16|STARTED|Part A, Washout 2||1
1500557|NCT01667900|3670738|P15|STARTED|Part A, Washout 2||1
1500558|NCT01667900|3670739|P14|STARTED|Part A, Washout 2||1
1500559|NCT01667900|3670740|P13|STARTED|Part A, Washout 2||1
1500560|NCT01667900|3670741|P12|STARTED|Part A, Washout 2||1
1500561|NCT01667900|3670742|P11|STARTED|Part A, Washout 2||1
1500562|NCT01667900|3670743|P10|STARTED|Part A, Washout 2||1
1500563|NCT01667900|3670744|P9|STARTED|Part A, Washout 2||1
1500564|NCT01667900|3670745|P8|STARTED|Part A, Washout 2||1
1500565|NCT01667900|3670746|P7|STARTED|Part A, Washout 2||1
1500566|NCT01667900|3670747|P6|STARTED|Part A, Washout 2||1
1500567|NCT01667900|3670748|P5|STARTED|Part A, Washout 2||1
1500568|NCT01667900|3670749|P4|STARTED|Part A, Washout 2||1
1500569|NCT01667900|3670750|P3|STARTED|Part A, Washout 2||1
1500570|NCT01667900|3670751|P2|STARTED|Part A, Washout 2||1
1500571|NCT01667900|3670752|P1|STARTED|Part A, Washout 2||1
1500572|NCT01667900|3670733|P20|NOT COMPLETED|Part A, Period 2||0
1500573|NCT01667900|3670734|P19|NOT COMPLETED|Part A, Period 2||0
1500574|NCT01667900|3670735|P18|NOT COMPLETED|Part A, Period 2||0
1500575|NCT01667900|3670736|P17|NOT COMPLETED|Part A, Period 2||0
1500576|NCT01667900|3670737|P16|NOT COMPLETED|Part A, Period 2||0
1500577|NCT01667900|3670738|P15|NOT COMPLETED|Part A, Period 2||0
1500578|NCT01667900|3670739|P14|NOT COMPLETED|Part A, Period 2||0
1500579|NCT01667900|3670740|P13|NOT COMPLETED|Part A, Period 2||0
1500580|NCT01667900|3670741|P12|NOT COMPLETED|Part A, Period 2||0
1500581|NCT01667900|3670742|P11|NOT COMPLETED|Part A, Period 2||0
1500582|NCT01667900|3670743|P10|NOT COMPLETED|Part A, Period 2||0
1500583|NCT01667900|3670744|P9|NOT COMPLETED|Part A, Period 2||0
1500584|NCT01667900|3670745|P8|NOT COMPLETED|Part A, Period 2||0
1500585|NCT01667900|3670746|P7|NOT COMPLETED|Part A, Period 2||0
1500586|NCT01667900|3670747|P6|NOT COMPLETED|Part A, Period 2||0
1500587|NCT01667900|3670748|P5|NOT COMPLETED|Part A, Period 2||0
1500588|NCT01667900|3670749|P4|NOT COMPLETED|Part A, Period 2||0
1500589|NCT01667900|3670750|P3|NOT COMPLETED|Part A, Period 2||0
1500590|NCT01667900|3670751|P2|NOT COMPLETED|Part A, Period 2||0
1500591|NCT01667900|3670752|P1|NOT COMPLETED|Part A, Period 2||0
1500592|NCT01667900|3670733|P20|COMPLETED|Part A, Period 2||0
1500593|NCT01667900|3670734|P19|COMPLETED|Part A, Period 2||0
1500594|NCT01667900|3670735|P18|COMPLETED|Part A, Period 2||0
1500595|NCT01667900|3670736|P17|COMPLETED|Part A, Period 2||0
1500596|NCT01667900|3670737|P16|COMPLETED|Part A, Period 2||1
1500597|NCT01667900|3670738|P15|COMPLETED|Part A, Period 2||1
1500598|NCT01667900|3670739|P14|COMPLETED|Part A, Period 2||1
1500599|NCT01667900|3670740|P13|COMPLETED|Part A, Period 2||1
1500600|NCT01667900|3670741|P12|COMPLETED|Part A, Period 2||1
1500601|NCT01667900|3670742|P11|COMPLETED|Part A, Period 2||1
1500602|NCT01667900|3670743|P10|COMPLETED|Part A, Period 2||1
1500603|NCT01667900|3670744|P9|COMPLETED|Part A, Period 2||1
1500604|NCT01667900|3670745|P8|COMPLETED|Part A, Period 2||1
1500605|NCT01667900|3670746|P7|COMPLETED|Part A, Period 2||1
1500606|NCT01667900|3670747|P6|COMPLETED|Part A, Period 2||1
1500607|NCT01667900|3670748|P5|COMPLETED|Part A, Period 2||1
1500608|NCT01667900|3670749|P4|COMPLETED|Part A, Period 2||1
1500609|NCT01667900|3670750|P3|COMPLETED|Part A, Period 2||1
1500610|NCT01667900|3670751|P2|COMPLETED|Part A, Period 2||1
1500611|NCT01667900|3670752|P1|COMPLETED|Part A, Period 2||1
1500612|NCT01667900|3670733|P20|STARTED|Part A, Period 2||0
1500613|NCT01667900|3670734|P19|STARTED|Part A, Period 2||0
1500614|NCT01667900|3670735|P18|STARTED|Part A, Period 2||0
1500615|NCT01667900|3670736|P17|STARTED|Part A, Period 2||0
1500616|NCT01667900|3670737|P16|STARTED|Part A, Period 2||1
1500617|NCT01667900|3670738|P15|STARTED|Part A, Period 2||1
1500618|NCT01667900|3670739|P14|STARTED|Part A, Period 2||1
1500619|NCT01667900|3670740|P13|STARTED|Part A, Period 2||1
1500620|NCT01667900|3670741|P12|STARTED|Part A, Period 2||1
1500621|NCT01667900|3670742|P11|STARTED|Part A, Period 2||1
1500622|NCT01667900|3670743|P10|STARTED|Part A, Period 2||1
1500623|NCT01667900|3670744|P9|STARTED|Part A, Period 2||1
1500624|NCT01667900|3670745|P8|STARTED|Part A, Period 2||1
1500625|NCT01667900|3670746|P7|STARTED|Part A, Period 2||1
1500626|NCT01667900|3670747|P6|STARTED|Part A, Period 2||1
1500627|NCT01667900|3670748|P5|STARTED|Part A, Period 2||1
1500628|NCT01667900|3670749|P4|STARTED|Part A, Period 2||1
1500629|NCT01667900|3670750|P3|STARTED|Part A, Period 2||1
1500630|NCT01667900|3670751|P2|STARTED|Part A, Period 2||1
1500631|NCT01667900|3670752|P1|STARTED|Part A, Period 2||1
1500632|NCT01667900|3670733|P20|NOT COMPLETED|Part A, Washout 1||0
1500633|NCT01667900|3670734|P19|NOT COMPLETED|Part A, Washout 1||0
1500634|NCT01667900|3670735|P18|NOT COMPLETED|Part A, Washout 1||0
1500635|NCT01667900|3670736|P17|NOT COMPLETED|Part A, Washout 1||0
1500636|NCT01667900|3670737|P16|NOT COMPLETED|Part A, Washout 1||0
1500637|NCT01667900|3670738|P15|NOT COMPLETED|Part A, Washout 1||0
1500638|NCT01667900|3670739|P14|NOT COMPLETED|Part A, Washout 1||0
1500639|NCT01667900|3670740|P13|NOT COMPLETED|Part A, Washout 1||0
1500640|NCT01667900|3670741|P12|NOT COMPLETED|Part A, Washout 1||0
1500641|NCT01667900|3670742|P11|NOT COMPLETED|Part A, Washout 1||0
1500642|NCT01667900|3670743|P10|NOT COMPLETED|Part A, Washout 1||0
1500643|NCT01667900|3670744|P9|NOT COMPLETED|Part A, Washout 1||0
1500644|NCT01667900|3670745|P8|NOT COMPLETED|Part A, Washout 1||0
1500645|NCT01667900|3670746|P7|NOT COMPLETED|Part A, Washout 1||0
1500646|NCT01667900|3670747|P6|NOT COMPLETED|Part A, Washout 1||0
1500647|NCT01667900|3670748|P5|NOT COMPLETED|Part A, Washout 1||0
1500648|NCT01667900|3670749|P4|NOT COMPLETED|Part A, Washout 1||0
1500649|NCT01667900|3670750|P3|NOT COMPLETED|Part A, Washout 1||0
1500650|NCT01667900|3670751|P2|NOT COMPLETED|Part A, Washout 1||0
1500651|NCT01667900|3670752|P1|NOT COMPLETED|Part A, Washout 1||0
1500652|NCT01667900|3670733|P20|COMPLETED|Part A, Washout 1||0
1500653|NCT01667900|3670734|P19|COMPLETED|Part A, Washout 1||0
1500654|NCT01667900|3670735|P18|COMPLETED|Part A, Washout 1||0
1500655|NCT01667900|3670736|P17|COMPLETED|Part A, Washout 1||0
1500656|NCT01667900|3670737|P16|COMPLETED|Part A, Washout 1||1
1500657|NCT01667900|3670738|P15|COMPLETED|Part A, Washout 1||1
1500658|NCT01667900|3670739|P14|COMPLETED|Part A, Washout 1||1
1500659|NCT01667900|3670740|P13|COMPLETED|Part A, Washout 1||1
1500660|NCT01667900|3670741|P12|COMPLETED|Part A, Washout 1||1
1500661|NCT01667900|3670742|P11|COMPLETED|Part A, Washout 1||1
1500662|NCT01667900|3670743|P10|COMPLETED|Part A, Washout 1||1
1500663|NCT01667900|3670744|P9|COMPLETED|Part A, Washout 1||1
1500664|NCT01667900|3670745|P8|COMPLETED|Part A, Washout 1||1
1500665|NCT01667900|3670746|P7|COMPLETED|Part A, Washout 1||1
1500666|NCT01667900|3670747|P6|COMPLETED|Part A, Washout 1||1
1500667|NCT01667900|3670748|P5|COMPLETED|Part A, Washout 1||1
1500668|NCT01667900|3670749|P4|COMPLETED|Part A, Washout 1||1
1500669|NCT01667900|3670750|P3|COMPLETED|Part A, Washout 1||1
1500670|NCT01667900|3670751|P2|COMPLETED|Part A, Washout 1||1
1500671|NCT01667900|3670752|P1|COMPLETED|Part A, Washout 1||1
1500672|NCT01667900|3670733|P20|STARTED|Part A, Washout 1||0
1500673|NCT01667900|3670734|P19|STARTED|Part A, Washout 1||0
1500674|NCT01667900|3670735|P18|STARTED|Part A, Washout 1||0
1500675|NCT01667900|3670736|P17|STARTED|Part A, Washout 1||0
1500676|NCT01667900|3670737|P16|STARTED|Part A, Washout 1||1
1500677|NCT01667900|3670738|P15|STARTED|Part A, Washout 1||1
1500678|NCT01667900|3670739|P14|STARTED|Part A, Washout 1||1
1500679|NCT01667900|3670740|P13|STARTED|Part A, Washout 1||1
1500680|NCT01667900|3670741|P12|STARTED|Part A, Washout 1||1
1500681|NCT01667900|3670742|P11|STARTED|Part A, Washout 1||1
1500682|NCT01667900|3670743|P10|STARTED|Part A, Washout 1||1
1500683|NCT01667900|3670744|P9|STARTED|Part A, Washout 1||1
1500684|NCT01667900|3670745|P8|STARTED|Part A, Washout 1||1
1500685|NCT01667900|3670746|P7|STARTED|Part A, Washout 1||1
1500686|NCT01667900|3670747|P6|STARTED|Part A, Washout 1||1
1500687|NCT01667900|3670748|P5|STARTED|Part A, Washout 1||1
1500688|NCT01667900|3670749|P4|STARTED|Part A, Washout 1||1
1500689|NCT01667900|3670750|P3|STARTED|Part A, Washout 1||1
1500690|NCT01667900|3670751|P2|STARTED|Part A, Washout 1||1
1500691|NCT01667900|3670752|P1|STARTED|Part A, Washout 1||1
1500692|NCT01667900|3670733|P20|NOT COMPLETED|Part A, Period 1||0
1500693|NCT01667900|3670734|P19|NOT COMPLETED|Part A, Period 1||0
1500694|NCT01667900|3670735|P18|NOT COMPLETED|Part A, Period 1||0
1500695|NCT01667900|3670736|P17|NOT COMPLETED|Part A, Period 1||0
1500696|NCT01667900|3670737|P16|NOT COMPLETED|Part A, Period 1||0
1500697|NCT01667900|3670738|P15|NOT COMPLETED|Part A, Period 1||0
1500698|NCT01667900|3670739|P14|NOT COMPLETED|Part A, Period 1||0
1500699|NCT01667900|3670740|P13|NOT COMPLETED|Part A, Period 1||0
1500700|NCT01667900|3670741|P12|NOT COMPLETED|Part A, Period 1||0
1500701|NCT01667900|3670742|P11|NOT COMPLETED|Part A, Period 1||0
1500702|NCT01667900|3670743|P10|NOT COMPLETED|Part A, Period 1||0
1500703|NCT01667900|3670744|P9|NOT COMPLETED|Part A, Period 1||0
1500704|NCT01667900|3670745|P8|NOT COMPLETED|Part A, Period 1||0
1500705|NCT01667900|3670746|P7|NOT COMPLETED|Part A, Period 1||0
1500706|NCT01667900|3670747|P6|NOT COMPLETED|Part A, Period 1||0
1500707|NCT01667900|3670748|P5|NOT COMPLETED|Part A, Period 1||0
1500708|NCT01667900|3670749|P4|NOT COMPLETED|Part A, Period 1||0
1500709|NCT01667900|3670750|P3|NOT COMPLETED|Part A, Period 1||0
1500710|NCT01667900|3670751|P2|NOT COMPLETED|Part A, Period 1||0
1500711|NCT01667900|3670752|P1|NOT COMPLETED|Part A, Period 1||0
1500712|NCT01667900|3670733|P20|COMPLETED|Part A, Period 1||0
1500713|NCT01667900|3670734|P19|COMPLETED|Part A, Period 1||0
1500714|NCT01667900|3670735|P18|COMPLETED|Part A, Period 1||0
1500715|NCT01667900|3670736|P17|COMPLETED|Part A, Period 1||0
1500716|NCT01667900|3670737|P16|COMPLETED|Part A, Period 1||1
1500717|NCT01667900|3670738|P15|COMPLETED|Part A, Period 1||1
1500718|NCT01667900|3670739|P14|COMPLETED|Part A, Period 1||1
1500719|NCT01667900|3670740|P13|COMPLETED|Part A, Period 1||1
1500720|NCT01667900|3670741|P12|COMPLETED|Part A, Period 1||1
1500721|NCT01667900|3670742|P11|COMPLETED|Part A, Period 1||1
1500722|NCT01667900|3670743|P10|COMPLETED|Part A, Period 1||1
1500723|NCT01667900|3670744|P9|COMPLETED|Part A, Period 1||1
1500724|NCT01667900|3670745|P8|COMPLETED|Part A, Period 1||1
1500725|NCT01667900|3670746|P7|COMPLETED|Part A, Period 1||1
1500726|NCT01667900|3670747|P6|COMPLETED|Part A, Period 1||1
1500727|NCT01667900|3670748|P5|COMPLETED|Part A, Period 1||1
1500728|NCT01667900|3670749|P4|COMPLETED|Part A, Period 1||1
1500729|NCT01667900|3670750|P3|COMPLETED|Part A, Period 1||1
1500730|NCT01667900|3670751|P2|COMPLETED|Part A, Period 1||1
1500731|NCT01667900|3670752|P1|COMPLETED|Part A, Period 1||1
1500732|NCT01667900|3670733|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
1500733|NCT01667900|3670734|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
1500734|NCT01667900|3670735|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
1500735|NCT01667900|3670736|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
1500736|NCT01667900|3670737|P16|STARTED|Part A, Period 1||1
1500737|NCT01667900|3670738|P15|STARTED|Part A, Period 1||1
1500738|NCT01667900|3670739|P14|STARTED|Part A, Period 1||1
1500739|NCT01667900|3670740|P13|STARTED|Part A, Period 1||1
1500740|NCT01667900|3670741|P12|STARTED|Part A, Period 1||1
1500741|NCT01667900|3670742|P11|STARTED|Part A, Period 1||1
1500742|NCT01667900|3670743|P10|STARTED|Part A, Period 1||1
1500743|NCT01667900|3670744|P9|STARTED|Part A, Period 1||1
1500744|NCT01667900|3670745|P8|STARTED|Part A, Period 1||1
1500745|NCT01667900|3670746|P7|STARTED|Part A, Period 1||1
1500746|NCT01667900|3670747|P6|STARTED|Part A, Period 1||1
1500747|NCT01667900|3670748|P5|STARTED|Part A, Period 1||1
1500748|NCT01667900|3670749|P4|STARTED|Part A, Period 1||1
1500749|NCT01667900|3670750|P3|STARTED|Part A, Period 1||1
1500750|NCT01667900|3670751|P2|STARTED|Part A, Period 1||1
1500751|NCT01667900|3670752|P1|STARTED|Part A, Period 1||1
1500752|NCT01667848|3670792|P2|NOT COMPLETED|Overall Study||0
1500753|NCT01667848|3670793|P1|NOT COMPLETED|Overall Study||0
1500754|NCT01667848|3670792|P2|COMPLETED|Overall Study||81
1500755|NCT01667848|3670793|P1|COMPLETED|Overall Study||67
1500756|NCT01667848|3670792|P2|STARTED|Overall Study||81
1500757|NCT01667848|3670793|P1|STARTED|Overall Study||67
1500758|NCT01667796|3670803|P2|NOT COMPLETED|Overall Study||1
1500759|NCT01667796|3670804|P1|NOT COMPLETED|Overall Study||3
1500760|NCT01667796|3670803|P2|COMPLETED|Overall Study||29
1500761|NCT01667796|3670804|P1|COMPLETED|Overall Study||24
1500762|NCT01667796|3670803|P2|STARTED|Overall Study||30
1500763|NCT01667796|3670804|P1|STARTED|Overall Study||27
1500764|NCT01667731|3670822|P5|NOT COMPLETED|Overall Study||28
1500765|NCT01667731|3670823|P4|NOT COMPLETED|Overall Study||2
1500766|NCT01667731|3670824|P3|NOT COMPLETED|Overall Study||2
1500767|NCT01667731|3670825|P2|NOT COMPLETED|Overall Study||16
1500768|NCT01667731|3670826|P1|NOT COMPLETED|Overall Study||5
1500769|NCT01667731|3670822|P5|COMPLETED|Overall Study||87
1500770|NCT01667731|3670823|P4|COMPLETED|Overall Study||15
1500771|NCT01667731|3670824|P3|COMPLETED|Overall Study||22
1500772|NCT01667731|3670825|P2|COMPLETED|Overall Study||26
1500773|NCT01667731|3670826|P1|COMPLETED|Overall Study||21
1500774|NCT01667731|3670822|P5|STARTED|Overall Study||115
1500775|NCT01667731|3670823|P4|STARTED|Overall Study||17
1500776|NCT01667731|3670824|P3|STARTED|Overall Study||24
1500777|NCT01667731|3670825|P2|STARTED|Overall Study||42
1500778|NCT01667731|3670826|P1|STARTED|Overall Study||26
1500779|NCT01667679|3670881|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
1500780|NCT01667679|3670882|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
1500781|NCT01667679|3670881|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
1500782|NCT01667679|3670882|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
1500783|NCT01667679|3670881|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
1500784|NCT01667679|3670882|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
1500785|NCT01667679|3670881|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
1500786|NCT01667679|3670882|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
1500787|NCT01667679|3670881|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
1500788|NCT01667679|3670882|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
1500789|NCT01667679|3670881|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
1500790|NCT01667679|3670882|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
1500791|NCT01667536|3670940|P1|NOT COMPLETED|Overall Study||0
1500792|NCT01667536|3670940|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
1500793|NCT01667536|3670940|P1|STARTED|Overall Study||105
1500794|NCT01667471|3670951|P1|NOT COMPLETED|Overall Study||0
1500795|NCT01667471|3670951|P1|COMPLETED|Overall Study||7
1500796|NCT01667471|3670951|P1|STARTED|Overall Study||7
1500797|NCT01667432|3670967|P1|NOT COMPLETED|Overall Study||57
1500798|NCT01667432|3670967|P1|COMPLETED|Overall Study||84
1500799|NCT01667432|3670967|P1|STARTED|Overall Study||141
1500800|NCT01667419|3670976|P4|NOT COMPLETED|Overall Study||91
1500801|NCT01667419|3670977|P3|NOT COMPLETED|Overall Study||93
1500802|NCT01667419|3670978|P2|NOT COMPLETED|Overall Study||157
1500803|NCT01667419|3670979|P1|NOT COMPLETED|Overall Study||157
1500804|NCT01667419|3670976|P4|COMPLETED|Overall Study||0
1500805|NCT01667419|3670977|P3|COMPLETED|Overall Study||0
1500806|NCT01667419|3670978|P2|COMPLETED|Overall Study||0
1500807|NCT01667419|3670979|P1|COMPLETED|Overall Study||0
1500808|NCT01667419|3670976|P4|STARTED|Overall Study||91
1500809|NCT01667419|3670977|P3|STARTED|Overall Study||93
1500810|NCT01667419|3670978|P2|STARTED|Overall Study||157
1500811|NCT01667419|3670979|P1|STARTED|Overall Study||157
1500812|NCT01667250|3671009|P3|NOT COMPLETED|Randomised Period||0
1500813|NCT01667250|3671010|P2|NOT COMPLETED|Randomised Period||1
1500814|NCT01667250|3671011|P1|NOT COMPLETED|Randomised Period||1
1500815|NCT01667250|3671009|P3|COMPLETED|Randomised Period||0
1500816|NCT01667250|3671010|P2|COMPLETED|Randomised Period||28
1500817|NCT01667250|3671011|P1|COMPLETED|Randomised Period||29
1500818|NCT01667250|3671009|P3|STARTED|Randomised Period||0
1500819|NCT01667250|3671010|P2|STARTED|Randomised Period||29
1500820|NCT01667250|3671011|P1|STARTED|Randomised Period||30
1500821|NCT01667250|3671009|P3|NOT COMPLETED|Run-in (no Treatment)||14
1500822|NCT01667250|3671010|P2|NOT COMPLETED|Run-in (no Treatment)||0
1500823|NCT01667250|3671011|P1|NOT COMPLETED|Run-in (no Treatment)||0
1500824|NCT01667250|3671009|P3|COMPLETED|Run-in (no Treatment)||59
1500825|NCT01667250|3671010|P2|COMPLETED|Run-in (no Treatment)||0
1500826|NCT01667250|3671011|P1|COMPLETED|Run-in (no Treatment)||0
1500827|NCT01667250|3671009|P3|STARTED|Run-in (no Treatment)||73
1500828|NCT01667250|3671010|P2|STARTED|Run-in (no Treatment)||0
1500829|NCT01667250|3671011|P1|STARTED|Run-in (no Treatment)||0
1500830|NCT01667224|3671027|P2|NOT COMPLETED|Overall Study||2
1500831|NCT01667224|3671028|P1|NOT COMPLETED|Overall Study||4
1500832|NCT01667224|3671027|P2|COMPLETED|Overall Study||38
1500833|NCT01667224|3671028|P1|COMPLETED|Overall Study||36
1500834|NCT01667224|3671027|P2|STARTED|Overall Study||40
1500835|NCT01667224|3671028|P1|STARTED|Overall Study||40
1500836|NCT01667107|3671042|P2|NOT COMPLETED|Overall Study||7
1500837|NCT01667107|3671043|P1|NOT COMPLETED|Overall Study||4
1500838|NCT01667107|3671042|P2|COMPLETED|Overall Study||11
1500839|NCT01667107|3671043|P1|COMPLETED|Overall Study||4
1500840|NCT01667107|3671042|P2|STARTED|Overall Study||18
1500841|NCT01667107|3671043|P1|STARTED|Overall Study||8
1500842|NCT01667029|3671059|P2|NOT COMPLETED|Overall Study||1
1500843|NCT01667029|3671060|P1|NOT COMPLETED|Overall Study||1
1500844|NCT01667029|3671059|P2|COMPLETED|Overall Study||3
1500845|NCT01667029|3671060|P1|COMPLETED|Overall Study||3
1500846|NCT01667029|3671059|P2|STARTED|Overall Study||4
1500847|NCT01667029|3671060|P1|STARTED|Overall Study||4
1500848|NCT01666951|3671102|P2|NOT COMPLETED|Overall Study||1
1500849|NCT01666951|3671103|P1|NOT COMPLETED|Overall Study||1
1500850|NCT01666951|3671102|P2|COMPLETED|Overall Study||17
1500851|NCT01666951|3671103|P1|COMPLETED|Overall Study||17
1500852|NCT01666951|3671102|P2|STARTED|Overall Study||18
1500853|NCT01666951|3671103|P1|STARTED|Overall Study||18
1500854|NCT01666912|3671141|P2|NOT COMPLETED|Overall Study||11
1500855|NCT01666912|3671142|P1|NOT COMPLETED|Overall Study||21
1500856|NCT01666912|3671141|P2|COMPLETED|Overall Study||37
1500857|NCT01666912|3671142|P1|COMPLETED|Overall Study||27
1500858|NCT01666912|3671141|P2|STARTED|Overall Study||48
1500859|NCT01666912|3671142|P1|STARTED|Overall Study||48
1500860|NCT01666782|3671154|P2|NOT COMPLETED|Overall Study||1
1500861|NCT01666782|3671155|P1|NOT COMPLETED|Overall Study||4
1500862|NCT01666782|3671154|P2|COMPLETED|Overall Study||50
1500863|NCT01666782|3671155|P1|COMPLETED|Overall Study||50
1500864|NCT01666782|3671154|P2|STARTED|Overall Study||51
1500865|NCT01666782|3671155|P1|STARTED|Overall Study||54
1500866|NCT01666314|3671179|P4|NOT COMPLETED|Overall Study||36
1500867|NCT01666314|3671180|P3|NOT COMPLETED|Overall Study||36
1500868|NCT01666314|3671181|P2|NOT COMPLETED|Overall Study||32
1500869|NCT01666314|3671182|P1|NOT COMPLETED|Overall Study||33
1500870|NCT01666314|3671179|P4|COMPLETED|Overall Study||0
1500871|NCT01666314|3671180|P3|COMPLETED|Overall Study||0
1500872|NCT01666314|3671181|P2|COMPLETED|Overall Study||0
1500873|NCT01666314|3671182|P1|COMPLETED|Overall Study||0
1500874|NCT01666314|3671179|P4|STARTED|Overall Study||36
1500875|NCT01666314|3671180|P3|STARTED|Overall Study||36
1500876|NCT01666314|3671181|P2|STARTED|Overall Study||32
1500877|NCT01666314|3671182|P1|STARTED|Overall Study||33
1500878|NCT01666210|3671293|P2|NOT COMPLETED|Overall Study||1
1500879|NCT01666210|3671294|P1|NOT COMPLETED|Overall Study||2
1500880|NCT01666210|3671293|P2|COMPLETED|Overall Study||29
1500881|NCT01666210|3671294|P1|COMPLETED|Overall Study||28
1500882|NCT01666210|3671293|P2|STARTED|Overall Study||30
1500883|NCT01666210|3671294|P1|STARTED|Overall Study||30
1500884|NCT01666197|3671306|P2|NOT COMPLETED|Overall Study||0
1500885|NCT01666197|3671307|P1|NOT COMPLETED|Overall Study||0
1500886|NCT01666197|3671306|P2|COMPLETED|Overall Study||50
1500887|NCT01666197|3671307|P1|COMPLETED|Overall Study||50
1500888|NCT01666197|3671306|P2|STARTED|Overall Study||50
1500889|NCT01666197|3671307|P1|STARTED|Overall Study||50
1500890|NCT01666145|3671313|P1|NOT COMPLETED|Overall Study||0
1500891|NCT01666145|3671313|P1|COMPLETED|Overall Study||14
1500892|NCT01666145|3671313|P1|STARTED|Overall Study||14
1500893|NCT01666119|3671318|P1|NOT COMPLETED|Overall Study||52
1500894|NCT01666119|3671318|P1|COMPLETED|Overall Study||197
1500895|NCT01666119|3671318|P1|STARTED|Overall Study||249
1500896|NCT01666002|3671325|P2|NOT COMPLETED|Overall Study||0
1500897|NCT01666002|3671326|P1|NOT COMPLETED|Overall Study||5
1500898|NCT01666002|3671325|P2|COMPLETED|Overall Study||10
1500899|NCT01666002|3671326|P1|COMPLETED|Overall Study||12
1500900|NCT01666002|3671325|P2|STARTED|Overall Study||10
1500901|NCT01666002|3671326|P1|STARTED|Overall Study||17
1500902|NCT01665950|3671337|P3|NOT COMPLETED|Overall Study||1
1500903|NCT01665950|3671338|P2|NOT COMPLETED|Overall Study||0
1500904|NCT01665950|3671339|P1|NOT COMPLETED|Overall Study||1
1500905|NCT01665950|3671337|P3|COMPLETED|Overall Study||1
1500906|NCT01665950|3671338|P2|COMPLETED|Overall Study||0
1500907|NCT01665950|3671339|P1|COMPLETED|Overall Study||1
1500908|NCT01665950|3671337|P3|STARTED|Overall Study||2
1500909|NCT01665950|3671338|P2|STARTED|Overall Study||0
1500910|NCT01665950|3671339|P1|STARTED|Overall Study||2
1500911|NCT01665911|3671347|P1|NOT COMPLETED|Overall Study||6
1500912|NCT01665911|3671347|P1|COMPLETED|Overall Study||22
1500913|NCT01665911|3671347|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
1500914|NCT01665911|3671347|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
1500915|NCT01665911|3671347|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
1500916|NCT01665911|3671347|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
1500917|NCT01665911|3671347|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
1500918|NCT01665911|3671347|P1|STARTED|Overall Study||28
1500919|NCT01665807|3671356|P3|NOT COMPLETED|Overall Study||1
1500920|NCT01665807|3671357|P2|NOT COMPLETED|Overall Study||0
1500921|NCT01665807|3671358|P1|NOT COMPLETED|Overall Study||2
1500922|NCT01665807|3671356|P3|COMPLETED|Overall Study||401
1500923|NCT01665807|3671357|P2|COMPLETED|Overall Study||58
1500924|NCT01665807|3671358|P1|COMPLETED|Overall Study||409
1500925|NCT01665807|3671356|P3|STARTED|Overall Study||402
1500926|NCT01665807|3671357|P2|STARTED|Overall Study||58
1500927|NCT01665807|3671358|P1|STARTED|Overall Study||411
1500928|NCT01665768|3671369|P1|NOT COMPLETED|Overall Study||23
1500929|NCT01665768|3671369|P1|COMPLETED|Overall Study||26
1500930|NCT01665768|3671369|P1|STARTED|Overall Study||49
1500931|NCT01665599|3671374|P1|NOT COMPLETED|Overall Study||8
1500932|NCT01665599|3671374|P1|COMPLETED|Overall Study||172
1500933|NCT01665599|3671374|P1|STARTED|Overall Study||180
1500934|NCT01665508|3671394|P1|NOT COMPLETED|Overall Study||5
1500935|NCT01665508|3671394|P1|COMPLETED|Overall Study||7
1500936|NCT01665508|3671394|P1|STARTED|Overall Study||12
1500937|NCT01665430|3671410|P1|NOT COMPLETED|Overall Study||9
1500938|NCT01665430|3671410|P1|COMPLETED|Overall Study||29
1500939|NCT01665430|3671410|P1|STARTED|Overall Study||38
1500940|NCT01665170|3671426|P2|NOT COMPLETED|Overall Study||0
1500941|NCT01665170|3671427|P1|NOT COMPLETED|Overall Study||0
1500942|NCT01665170|3671426|P2|COMPLETED|Overall Study||30
1500943|NCT01665170|3671427|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
1500944|NCT01665170|3671426|P2|After TSST|Overall Study||30
1500945|NCT01665170|3671427|P1|After TSST|Overall Study||30
1500946|NCT01665170|3671426|P2|During TSST|Overall Study||30
1500947|NCT01665170|3671427|P1|During TSST|Overall Study||30
1500948|NCT01665170|3671426|P2|Bevore TSST|Overall Study||30
1500949|NCT01665170|3671427|P1|Bevore TSST|Overall Study||30
1500950|NCT01665170|3671426|P2|STARTED|Overall Study||30
1500951|NCT01665170|3671427|P1|STARTED|Overall Study|First patient in|30
1500952|NCT01665157|3671478|P3|NOT COMPLETED|Overall Study||0
1500953|NCT01665157|3671479|P2|NOT COMPLETED|Overall Study||0
1500954|NCT01665157|3671480|P1|NOT COMPLETED|Overall Study||0
1500955|NCT01665157|3671478|P3|COMPLETED|Overall Study||60
1500956|NCT01665157|3671479|P2|COMPLETED|Overall Study||60
1500957|NCT01665157|3671480|P1|COMPLETED|Overall Study||60
1500958|NCT01665157|3671478|P3|STARTED|Overall Study||60
1500959|NCT01665157|3671479|P2|STARTED|Overall Study||60
1500960|NCT01665157|3671480|P1|STARTED|Overall Study||60
1500961|NCT01665144|3671508|P2|NOT COMPLETED|Overall Study||122
1500962|NCT01665144|3671509|P1|NOT COMPLETED|Overall Study||202
1500963|NCT01665144|3671508|P2|COMPLETED|Overall Study||424
1500964|NCT01665144|3671509|P1|COMPLETED|Overall Study||903
1500965|NCT01665144|3671508|P2|Full Analysis Set|Overall Study||546
1500966|NCT01665144|3671509|P1|Full Analysis Set|Overall Study||1099
1500967|NCT01665144|3671508|P2|Safety Set|Overall Study||546
1500968|NCT01665144|3671509|P1|Safety Set|Overall Study||1099
1500969|NCT01665144|3671508|P2|STARTED|Overall Study||546
1500970|NCT01665144|3671509|P1|STARTED|Overall Study||1105
1500971|NCT01665053|3671517|P2|NOT COMPLETED|Overall Study||15
1500972|NCT01665053|3671518|P1|NOT COMPLETED|Overall Study||32
1500973|NCT01665053|3671517|P2|COMPLETED|Overall Study||831
1500974|NCT01665053|3671518|P1|COMPLETED|Overall Study||806
1500975|NCT01665053|3671517|P2|Death With No 12-month Clinical FU|Overall Study||9
1500976|NCT01665053|3671518|P1|Death With No 12-month Clinical FU|Overall Study||9
1500977|NCT01665053|3671517|P2|No 12-Month F/U|Overall Study||15
1500978|NCT01665053|3671518|P1|No 12-Month F/U|Overall Study||32
1500979|NCT01665053|3671517|P2|Completed 12-Month Clinical F/U|Overall Study||822
1500980|NCT01665053|3671518|P1|Completed 12-Month Clinical F/U|Overall Study||797
1500981|NCT01665053|3671517|P2|STARTED|Overall Study||846
1500982|NCT01665053|3671518|P1|STARTED|Overall Study||838
1500983|NCT01664975|3671558|P2|NOT COMPLETED|Overall Study||3
1500984|NCT01664975|3671559|P1|NOT COMPLETED|Overall Study||5
1500985|NCT01664975|3671558|P2|COMPLETED|Overall Study||51
1500986|NCT01664975|3671559|P1|COMPLETED|Overall Study||52
1500987|NCT01664975|3671558|P2|STARTED|Overall Study||54
1500988|NCT01664975|3671559|P1|STARTED|Overall Study||57
1500989|NCT01664949|3671567|P2|NOT COMPLETED|Overall Study||25
1500990|NCT01664949|3671568|P1|NOT COMPLETED|Overall Study||24
1500991|NCT01664949|3671567|P2|COMPLETED|Overall Study||211
1500992|NCT01664949|3671568|P1|COMPLETED|Overall Study||200
1500993|NCT01664949|3671567|P2|STARTED|Overall Study||236
1500994|NCT01664949|3671568|P1|STARTED|Overall Study||224
1500995|NCT01664923|3671584|P2|NOT COMPLETED|Overall Study||158
1500996|NCT01664923|3671585|P1|NOT COMPLETED|Overall Study||93
1500997|NCT01664923|3671584|P2|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|40
1500998|NCT01664923|3671585|P1|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|105
1500999|NCT01664923|3671584|P2|Received Study Treatment|Overall Study||198
1501000|NCT01664923|3671585|P1|Received Study Treatment|Overall Study||197
1501001|NCT01664923|3671584|P2|STARTED|Overall Study||198
1501002|NCT01664923|3671585|P1|STARTED|Overall Study||198
1501003|NCT01664858|3671606|P3|NOT COMPLETED|Overall Study||6
1501004|NCT01664858|3671607|P2|NOT COMPLETED|Overall Study||13
1501005|NCT01664858|3671608|P1|NOT COMPLETED|Overall Study||14
1501006|NCT01664858|3671606|P3|COMPLETED|Overall Study||234
1501007|NCT01664858|3671607|P2|COMPLETED|Overall Study||468
1501008|NCT01664858|3671608|P1|COMPLETED|Overall Study||467
1501009|NCT01664858|3671606|P3|STARTED|Overall Study||240
1501010|NCT01664858|3671607|P2|STARTED|Overall Study||481
1501011|NCT01664858|3671608|P1|STARTED|Overall Study||481
1501012|NCT01664806|3671624|P2|NOT COMPLETED|Overall Study||0
1501013|NCT01664806|3671625|P1|NOT COMPLETED|Overall Study||0
1501014|NCT01664806|3671624|P2|COMPLETED|Overall Study||20
1501015|NCT01664806|3671625|P1|COMPLETED|Overall Study||20
1501016|NCT01664806|3671624|P2|STARTED|Overall Study||20
1501017|NCT01664806|3671625|P1|STARTED|Overall Study||20
1501018|NCT01664793|3671635|P2|NOT COMPLETED|Overall Study||0
1501019|NCT01664793|3671636|P1|NOT COMPLETED|Overall Study||0
1501020|NCT01664793|3671635|P2|COMPLETED|Overall Study||38626
1501021|NCT01664793|3671636|P1|COMPLETED|Overall Study||49039
1501022|NCT01664793|3671635|P2|STARTED|Overall Study||38626
1501023|NCT01664793|3671636|P1|STARTED|Overall Study||49039
1501024|NCT01664624|3671648|P4|NOT COMPLETED|Overall Study||0
1501025|NCT01664624|3671649|P3|NOT COMPLETED|Overall Study||0
1501026|NCT01664624|3671650|P2|NOT COMPLETED|Overall Study||1
1501027|NCT01664624|3671651|P1|NOT COMPLETED|Overall Study||0
1501028|NCT01664624|3671648|P4|COMPLETED|Overall Study||9
1501029|NCT01664624|3671649|P3|COMPLETED|Overall Study||10
1501030|NCT01664624|3671650|P2|COMPLETED|Overall Study||10
1501031|NCT01664624|3671651|P1|COMPLETED|Overall Study||10
1501032|NCT01664624|3671648|P4|STARTED|Overall Study||9
1501033|NCT01664624|3671649|P3|STARTED|Overall Study||10
1501034|NCT01664624|3671650|P2|STARTED|Overall Study||11
1501035|NCT01664624|3671651|P1|STARTED|Overall Study||10
1501036|NCT01664559|3671683|P2|NOT COMPLETED|Overall Study||0
1501037|NCT01664559|3671684|P1|NOT COMPLETED|Overall Study||0
1501038|NCT01664559|3671683|P2|COMPLETED|Overall Study||33
1501039|NCT01664559|3671684|P1|COMPLETED|Overall Study||34
1501040|NCT01664559|3671683|P2|STARTED|Overall Study||33
1501041|NCT01664559|3671684|P1|STARTED|Overall Study||34
1501042|NCT01664533|3671698|P1|NOT COMPLETED|Overall Study||57
1501043|NCT01664533|3671698|P1|COMPLETED|Overall Study||0
1501044|NCT01664533|3671698|P1|STARTED|Overall Study||57
1501045|NCT01664494|3671706|P1|NOT COMPLETED|Overall Study||193
1501046|NCT01664494|3671706|P1|COMPLETED|Overall Study||370
1501047|NCT01664494|3671706|P1|STARTED|Overall Study||563
1501048|NCT01664247|3671713|P2|NOT COMPLETED|Overall Study||41
1501049|NCT01664247|3671714|P1|NOT COMPLETED|Overall Study||14
1501050|NCT01664247|3671713|P2|COMPLETED|Overall Study||131
1501051|NCT01664247|3671714|P1|COMPLETED|Overall Study||160
1501052|NCT01664247|3671713|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
1501053|NCT01664247|3671714|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
1501054|NCT01664247|3671713|P2|STARTED|Overall Study||172
1501055|NCT01664247|3671714|P1|STARTED|Overall Study||174
1501056|NCT01664117|3671736|P1|NOT COMPLETED|Overall Study||0
1501057|NCT01664117|3671736|P1|COMPLETED|Overall Study||209
1501058|NCT01664117|3671736|P1|STARTED|Overall Study||209
1501059|NCT01664104|3671791|P1|NOT COMPLETED|Overall Study||16
1501060|NCT01664104|3671791|P1|COMPLETED|Overall Study||120
1501061|NCT01664104|3671791|P1|STARTED|Overall Study||136
1501062|NCT01664052|3671860|P2|NOT COMPLETED|Phase 2||4
1501063|NCT01664052|3671861|P1|NOT COMPLETED|Phase 2||0
1501064|NCT01664052|3671860|P2|COMPLETED|Phase 2||31
1501065|NCT01664052|3671861|P1|COMPLETED|Phase 2||0
1501066|NCT01664052|3671860|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
1501067|NCT01664052|3671861|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
1501068|NCT01664052|3671860|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
1501069|NCT01664052|3671861|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
1501070|NCT01664052|3671860|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
1501071|NCT01664052|3671861|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
1501072|NCT01664052|3671860|P2|HSG 1 Hour Post Placement|Phase 2||31
1501073|NCT01664052|3671861|P1|HSG 1 Hour Post Placement|Phase 2||0
1501074|NCT01664052|3671860|P2|Insert Placed|Phase 2||31
1501075|NCT01664052|3671861|P1|Insert Placed|Phase 2||0
1501076|NCT01664052|3671860|P2|STARTED|Phase 2||35
1501077|NCT01664052|3671861|P1|STARTED|Phase 2|Screened and enrolled|0
1501078|NCT01664052|3671860|P2|NOT COMPLETED|Phase 1||0
1501079|NCT01664052|3671861|P1|NOT COMPLETED|Phase 1||7
1501080|NCT01664052|3671860|P2|COMPLETED|Phase 1||0
1501081|NCT01664052|3671861|P1|COMPLETED|Phase 1||24
1501082|NCT01664052|3671860|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
1501083|NCT01664052|3671861|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
1501084|NCT01664052|3671860|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
1501085|NCT01664052|3671861|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
1501086|NCT01664052|3671860|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
1501087|NCT01664052|3671861|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
1501088|NCT01664052|3671860|P2|HSG 1 Hour Post Placement|Phase 1||0
1501089|NCT01664052|3671861|P1|HSG 1 Hour Post Placement|Phase 1||24
1501090|NCT01664052|3671860|P2|Insert Placed in at Least One Tube|Phase 1||0
1501091|NCT01664052|3671861|P1|Insert Placed in at Least One Tube|Phase 1||25
1501092|NCT01664052|3671860|P2|STARTED|Phase 1||0
1501093|NCT01664052|3671861|P1|STARTED|Phase 1|Screening and enrollment|31
1501094|NCT01664039|3671879|P2|NOT COMPLETED|Overall Study||9
1501095|NCT01664039|3671880|P1|NOT COMPLETED|Overall Study||6
1501096|NCT01664039|3671879|P2|COMPLETED|Overall Study||43
1501097|NCT01664039|3671880|P1|COMPLETED|Overall Study||46
1501098|NCT01664039|3671879|P2|STARTED|Overall Study||52
1501099|NCT01664039|3671880|P1|STARTED|Overall Study||52
1501100|NCT01663987|3671902|P2|NOT COMPLETED|Overall Study||6
1501101|NCT01663987|3671903|P1|NOT COMPLETED|Overall Study||13
1501102|NCT01663987|3671902|P2|COMPLETED|Overall Study||34
1501103|NCT01663987|3671903|P1|COMPLETED|Overall Study||26
1501104|NCT01663987|3671902|P2|STARTED|Overall Study||40
1501105|NCT01663987|3671903|P1|STARTED|Overall Study||39
1501106|NCT01663922|3671931|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
1501107|NCT01663922|3671932|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
1501108|NCT01663922|3671931|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
1501109|NCT01663922|3671932|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
1501110|NCT01663922|3671931|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
1501111|NCT01663922|3671932|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
1501112|NCT01663922|3671931|P2|NOT COMPLETED|Washout (7 Days)||0
1501113|NCT01663922|3671932|P1|NOT COMPLETED|Washout (7 Days)||0
1501114|NCT01663922|3671931|P2|COMPLETED|Washout (7 Days)||9
1501115|NCT01663922|3671932|P1|COMPLETED|Washout (7 Days)||8
1501116|NCT01663922|3671931|P2|STARTED|Washout (7 Days)||9
1501117|NCT01663922|3671932|P1|STARTED|Washout (7 Days)||8
1501118|NCT01663922|3671931|P2|NOT COMPLETED|Second Intervention (14 Days)||0
1501119|NCT01663922|3671932|P1|NOT COMPLETED|Second Intervention (14 Days)||0
1501120|NCT01663922|3671931|P2|COMPLETED|Second Intervention (14 Days)||9
1501121|NCT01663922|3671932|P1|COMPLETED|Second Intervention (14 Days)||8
1501122|NCT01663922|3671931|P2|STARTED|Second Intervention (14 Days)||9
1501123|NCT01663922|3671932|P1|STARTED|Second Intervention (14 Days)||8
1501124|NCT01663922|3671931|P2|NOT COMPLETED|Washout (7 Days)||0
1501125|NCT01663922|3671932|P1|NOT COMPLETED|Washout (7 Days)||0
1501126|NCT01663922|3671931|P2|COMPLETED|Washout (7 Days)||9
1501127|NCT01663922|3671932|P1|COMPLETED|Washout (7 Days)||8
1501128|NCT01663922|3671931|P2|STARTED|Washout (7 Days)||9
1501129|NCT01663922|3671932|P1|STARTED|Washout (7 Days)||8
1501130|NCT01663922|3671931|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
1501131|NCT01663922|3671932|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
1501132|NCT01663922|3671931|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
1501133|NCT01663922|3671932|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
1501134|NCT01663922|3671931|P2|STARTED|First Intervention (14 Days or 5 Days)||9
1501135|NCT01663922|3671932|P1|STARTED|First Intervention (14 Days or 5 Days)||8
1501136|NCT01663779|3671939|P2|NOT COMPLETED|Overall Study||0
1501137|NCT01663779|3671940|P1|NOT COMPLETED|Overall Study||0
1501138|NCT01663779|3671939|P2|COMPLETED|Overall Study||23
1501139|NCT01663779|3671940|P1|COMPLETED|Overall Study||27
1501140|NCT01663779|3671939|P2|STARTED|Overall Study||23
1501141|NCT01663779|3671940|P1|STARTED|Overall Study||27
1501142|NCT01663740|3671948|P2|NOT COMPLETED|Overall Study||8
1501143|NCT01663740|3671949|P1|NOT COMPLETED|Overall Study||16
1501144|NCT01663740|3671948|P2|COMPLETED|Overall Study||13
1501145|NCT01663740|3671949|P1|COMPLETED|Overall Study||22
1501146|NCT01663740|3671948|P2|STARTED|Overall Study|Safety Population|21
1501147|NCT01663740|3671949|P1|STARTED|Overall Study|Safety Population|38
1501148|NCT01663727|3672009|P2|NOT COMPLETED|Overall Study||238
1501149|NCT01663727|3672010|P1|NOT COMPLETED|Overall Study||242
1501150|NCT01663727|3672009|P2|COMPLETED|Overall Study||1
1501151|NCT01663727|3672010|P1|COMPLETED|Overall Study||0
1501152|NCT01663727|3672009|P2|STARTED|Overall Study||239
1501153|NCT01663727|3672010|P1|STARTED|Overall Study||242
1501154|NCT01663714|3672042|P1|NOT COMPLETED|Long-Term Follow-Up||6
1501155|NCT01663714|3672042|P1|COMPLETED|Long-Term Follow-Up||16
1501156|NCT01663714|3672042|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
1501157|NCT01663714|3672042|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
1501158|NCT01663714|3672042|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
1501159|NCT01663714|3672042|P1|STARTED|Dosimetric and Therapeutic Treatment||30
1501160|NCT01663636|3672071|P2|NOT COMPLETED|Parent SMS Acceptability Assessment||0
1501161|NCT01663636|3672072|P1|NOT COMPLETED|Parent SMS Acceptability Assessment||0
1501162|NCT01663636|3672071|P2|COMPLETED|Parent SMS Acceptability Assessment||130
1501163|NCT01663636|3672072|P1|COMPLETED|Parent SMS Acceptability Assessment||135
1501164|NCT01663636|3672071|P2|STARTED|Parent SMS Acceptability Assessment||130
1501165|NCT01663636|3672072|P1|STARTED|Parent SMS Acceptability Assessment||135
1501166|NCT01663636|3672071|P2|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
1501167|NCT01663636|3672072|P1|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
1501168|NCT01663636|3672071|P2|COMPLETED|Infant SMS Reminder Feasibility Study||130
1501169|NCT01663636|3672072|P1|COMPLETED|Infant SMS Reminder Feasibility Study||135
1501170|NCT01663636|3672071|P2|STARTED|Infant SMS Reminder Feasibility Study||161
1501171|NCT01663636|3672072|P1|STARTED|Infant SMS Reminder Feasibility Study||160
1501172|NCT01663623|3672080|P2|NOT COMPLETED|Overall Study||20
1501173|NCT01663623|3672081|P1|NOT COMPLETED|Overall Study||12
1501174|NCT01663623|3672080|P2|COMPLETED|Overall Study||33
1501175|NCT01663623|3672081|P1|COMPLETED|Overall Study||40
1501176|NCT01663623|3672080|P2|STARTED|Overall Study||53
1501177|NCT01663623|3672081|P1|STARTED|Overall Study||52
1501178|NCT01663532|3672091|P2|NOT COMPLETED|Overall Study||107
1501179|NCT01663532|3672092|P1|NOT COMPLETED|Overall Study||74
1501180|NCT01663532|3672091|P2|COMPLETED|Overall Study||65
1501181|NCT01663532|3672092|P1|COMPLETED|Overall Study||94
1501182|NCT01663532|3672091|P2|STARTED|Overall Study||172
1501183|NCT01663532|3672092|P1|STARTED|Overall Study||168
1501184|NCT01663506|3672110|P1|NOT COMPLETED|Overall Study||8
1501185|NCT01663506|3672110|P1|COMPLETED|Overall Study||15
1501186|NCT01663506|3672110|P1|STARTED|Overall Study||23
1501187|NCT01663363|3672139|P1|NOT COMPLETED|Overall Study||0
1501188|NCT01663363|3672139|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
1501189|NCT01663363|3672139|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
1501190|NCT01663285|3672144|P1|NOT COMPLETED|Overall Study||0
1501191|NCT01663285|3672144|P1|COMPLETED|Overall Study||1
1501192|NCT01663285|3672144|P1|STARTED|Overall Study||1
1501193|NCT01663272|3672150|P3|NOT COMPLETED|Overall Study||0
1501194|NCT01663272|3672151|P2|NOT COMPLETED|Overall Study||0
1501195|NCT01663272|3672152|P1|NOT COMPLETED|Overall Study||0
1501196|NCT01663272|3672150|P3|COMPLETED|Overall Study||1
1501197|NCT01663272|3672151|P2|COMPLETED|Overall Study||6
1501198|NCT01663272|3672152|P1|COMPLETED|Overall Study||5
1501199|NCT01663272|3672150|P3|STARTED|Overall Study||1
1501200|NCT01663272|3672151|P2|STARTED|Overall Study||6
1501201|NCT01663272|3672152|P1|STARTED|Overall Study||5
1501202|NCT01663233|3672159|P2|NOT COMPLETED|Overall Study||7
1501203|NCT01663233|3672160|P1|NOT COMPLETED|Overall Study||4
1501204|NCT01663233|3672159|P2|COMPLETED|Overall Study||129
1501205|NCT01663233|3672160|P1|COMPLETED|Overall Study||126
1501206|NCT01663233|3672159|P2|STARTED|Overall Study||136
1501207|NCT01663233|3672160|P1|STARTED|Overall Study||130
1501208|NCT01663103|3672184|P2|NOT COMPLETED|Overall Study||2
1501209|NCT01663103|3672185|P1|NOT COMPLETED|Overall Study||3
1501210|NCT01663103|3672184|P2|COMPLETED|Overall Study||19
1501211|NCT01663103|3672185|P1|COMPLETED|Overall Study||18
1501212|NCT01663103|3672184|P2|STARTED|Overall Study||21
1501213|NCT01663103|3672185|P1|STARTED|Overall Study||21
1501214|NCT01663012|3672201|P1|NOT COMPLETED|Overall Study||0
1501215|NCT01663012|3672201|P1|COMPLETED|Overall Study||20
1501216|NCT01663012|3672201|P1|STARTED|Overall Study||20
1501217|NCT01662999|3672213|P6|NOT COMPLETED|Period 3||0
1501218|NCT01662999|3672214|P5|NOT COMPLETED|Period 3||0
1501219|NCT01662999|3672215|P4|NOT COMPLETED|Period 3||0
1501220|NCT01662999|3672216|P3|NOT COMPLETED|Period 3||0
1501221|NCT01662999|3672217|P2|NOT COMPLETED|Period 3||1
1501222|NCT01662999|3672218|P1|NOT COMPLETED|Period 3||0
1501223|NCT01662999|3672213|P6|COMPLETED|Period 3||7
1501224|NCT01662999|3672214|P5|COMPLETED|Period 3||7
1501225|NCT01662999|3672215|P4|COMPLETED|Period 3||7
1501226|NCT01662999|3672216|P3|COMPLETED|Period 3||7
1501227|NCT01662999|3672217|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
1501228|NCT01662999|3672218|P1|COMPLETED|Period 3||7
1501229|NCT01662999|3672213|P6|STARTED|Period 3||7
1501230|NCT01662999|3672214|P5|STARTED|Period 3||7
1501231|NCT01662999|3672215|P4|STARTED|Period 3||7
1501232|NCT01662999|3672216|P3|STARTED|Period 3||7
1501233|NCT01662999|3672217|P2|STARTED|Period 3||7
1501234|NCT01662999|3672218|P1|STARTED|Period 3||7
1501235|NCT01662999|3672213|P6|NOT COMPLETED|Period 2||0
1501236|NCT01662999|3672214|P5|NOT COMPLETED|Period 2||0
1501237|NCT01662999|3672215|P4|NOT COMPLETED|Period 2||0
1501238|NCT01662999|3672216|P3|NOT COMPLETED|Period 2||0
1501239|NCT01662999|3672217|P2|NOT COMPLETED|Period 2||0
1501240|NCT01662999|3672218|P1|NOT COMPLETED|Period 2||0
1501241|NCT01662999|3672213|P6|COMPLETED|Period 2||7
1501242|NCT01662999|3672214|P5|COMPLETED|Period 2||7
1501243|NCT01662999|3672215|P4|COMPLETED|Period 2||7
1501244|NCT01662999|3672216|P3|COMPLETED|Period 2||7
1501245|NCT01662999|3672217|P2|COMPLETED|Period 2||7
1501246|NCT01662999|3672218|P1|COMPLETED|Period 2||7
1501247|NCT01662999|3672213|P6|STARTED|Period 2||7
1501248|NCT01662999|3672214|P5|STARTED|Period 2||7
1501249|NCT01662999|3672215|P4|STARTED|Period 2||7
1501250|NCT01662999|3672216|P3|STARTED|Period 2||7
1501251|NCT01662999|3672217|P2|STARTED|Period 2||7
1501252|NCT01662999|3672218|P1|STARTED|Period 2||7
1501253|NCT01662999|3672213|P6|NOT COMPLETED|Period 1||0
1501254|NCT01662999|3672214|P5|NOT COMPLETED|Period 1||0
1501255|NCT01662999|3672215|P4|NOT COMPLETED|Period 1||0
1501256|NCT01662999|3672216|P3|NOT COMPLETED|Period 1||0
1501257|NCT01662999|3672217|P2|NOT COMPLETED|Period 1||0
1501258|NCT01662999|3672218|P1|NOT COMPLETED|Period 1||0
1501259|NCT01662999|3672213|P6|COMPLETED|Period 1||7
1501260|NCT01662999|3672214|P5|COMPLETED|Period 1||7
1501261|NCT01662999|3672215|P4|COMPLETED|Period 1||7
1501262|NCT01662999|3672216|P3|COMPLETED|Period 1||7
1501263|NCT01662999|3672217|P2|COMPLETED|Period 1||7
1501264|NCT01662999|3672218|P1|COMPLETED|Period 1||7
1501265|NCT01662999|3672213|P6|STARTED|Period 1||7
1501266|NCT01662999|3672214|P5|STARTED|Period 1||7
1501267|NCT01662999|3672215|P4|STARTED|Period 1||7
1501268|NCT01662999|3672216|P3|STARTED|Period 1||7
1501269|NCT01662999|3672217|P2|STARTED|Period 1||7
1501270|NCT01662999|3672218|P1|STARTED|Period 1||7
1501271|NCT01662986|3672289|P2|NOT COMPLETED|Overall Study||13
1501272|NCT01662986|3672290|P1|NOT COMPLETED|Overall Study||18
1501273|NCT01662986|3672289|P2|COMPLETED|Overall Study||26
1501274|NCT01662986|3672290|P1|COMPLETED|Overall Study||22
1501275|NCT01662986|3672289|P2|STARTED|Overall Study||39
1501276|NCT01662986|3672290|P1|STARTED|Overall Study||40
1501277|NCT01662908|3672324|P2|NOT COMPLETED|Overall Study||5
1501278|NCT01662908|3672325|P1|NOT COMPLETED|Overall Study||6
1501279|NCT01662908|3672324|P2|COMPLETED|Overall Study||23
1501280|NCT01662908|3672325|P1|COMPLETED|Overall Study||50
1501281|NCT01662908|3672324|P2|STARTED|Overall Study||28
1501282|NCT01662908|3672325|P1|STARTED|Overall Study||56
1501283|NCT01662882|3672342|P3|NOT COMPLETED|Overall Study||0
1501284|NCT01662882|3672343|P2|NOT COMPLETED|Overall Study||0
1501285|NCT01662882|3672344|P1|NOT COMPLETED|Overall Study||0
1501286|NCT01662882|3672342|P3|COMPLETED|Overall Study||15
1501287|NCT01662882|3672343|P2|COMPLETED|Overall Study||18
1501288|NCT01662882|3672344|P1|COMPLETED|Overall Study||15
1501289|NCT01662882|3672342|P3|STARTED|Overall Study||15
1501290|NCT01662882|3672343|P2|STARTED|Overall Study||18
1501291|NCT01662882|3672344|P1|STARTED|Overall Study||15
1501292|NCT01662856|3672357|P2|NOT COMPLETED|Primary Part II||2
1501293|NCT01662856|3672358|P1|NOT COMPLETED|Primary Part II||10
1501294|NCT01662856|3672357|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
1501295|NCT01662856|3672358|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
1501296|NCT01662856|3672357|P2|Completed Study up to Week 6|Primary Part II||56
1501297|NCT01662856|3672358|P1|Completed Study up to Week 6|Primary Part II||106
1501298|NCT01662856|3672357|P2|STARTED|Primary Part II||57
1501299|NCT01662856|3672358|P1|STARTED|Primary Part II||109
1501300|NCT01662856|3672357|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
1501301|NCT01662856|3672358|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
1501302|NCT01662856|3672357|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
1501303|NCT01662856|3672358|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
1501304|NCT01662856|3672357|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
1501305|NCT01662856|3672358|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
1501306|NCT01662856|3672357|P2|STARTED|Part I + Part II (Overall Study)||57
1501307|NCT01662856|3672358|P1|STARTED|Part I + Part II (Overall Study)||168
1501308|NCT01662791|3672372|P2|NOT COMPLETED|Part 2 - Interventional||0
1501309|NCT01662791|3672373|P1|NOT COMPLETED|Part 2 - Interventional||0
1501310|NCT01662791|3672372|P2|COMPLETED|Part 2 - Interventional||0
1501311|NCT01662791|3672373|P1|COMPLETED|Part 2 - Interventional||8
1501312|NCT01662791|3672372|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
1501313|NCT01662791|3672373|P1|STARTED|Part 2 - Interventional||8
1501314|NCT01662791|3672372|P2|NOT COMPLETED|Part 1 - Observational||0
1501315|NCT01662791|3672373|P1|NOT COMPLETED|Part 1 - Observational||0
1501316|NCT01662791|3672372|P2|COMPLETED|Part 1 - Observational||41
1501317|NCT01662791|3672373|P1|COMPLETED|Part 1 - Observational||8
1501318|NCT01662791|3672372|P2|STARTED|Part 1 - Observational||41
1501319|NCT01662791|3672373|P1|STARTED|Part 1 - Observational||8
1501320|NCT01662765|3672397|P2|NOT COMPLETED|Overall Study||2
1501321|NCT01662765|3672398|P1|NOT COMPLETED|Overall Study||1
1501322|NCT01662765|3672397|P2|COMPLETED|Overall Study||40
1501323|NCT01662765|3672398|P1|COMPLETED|Overall Study||41
1501324|NCT01662765|3672397|P2|STARTED|Overall Study||42
1501325|NCT01662765|3672398|P1|STARTED|Overall Study||42
1501326|NCT01662648|3672412|P2|NOT COMPLETED|Overall Study||178
1501327|NCT01662648|3672413|P1|NOT COMPLETED|Overall Study||147
1501328|NCT01662648|3672412|P2|COMPLETED|Overall Study||419
1501329|NCT01662648|3672413|P1|COMPLETED|Overall Study||373
1501330|NCT01662648|3672412|P2|STARTED|Overall Study||597
1501331|NCT01662648|3672413|P1|STARTED|Overall Study||520
1501332|NCT01662635|3672435|P1|NOT COMPLETED|Overall Study||30
1501333|NCT01662635|3672435|P1|COMPLETED|Overall Study||200
1501334|NCT01662635|3672435|P1|STARTED|Overall Study||230
1501335|NCT01662583|3672444|P3|NOT COMPLETED|Overall Study||0
1501336|NCT01662583|3672445|P2|NOT COMPLETED|Overall Study||0
1501337|NCT01662583|3672446|P1|NOT COMPLETED|Overall Study||0
1501338|NCT01662583|3672444|P3|COMPLETED|Overall Study||219
1501339|NCT01662583|3672445|P2|COMPLETED|Overall Study||225
1501340|NCT01662583|3672446|P1|COMPLETED|Overall Study||216
1501341|NCT01662583|3672444|P3|STARTED|Overall Study||219
1501342|NCT01662583|3672445|P2|STARTED|Overall Study||225
1501343|NCT01662583|3672446|P1|STARTED|Overall Study||216
1501344|NCT01662531|3672459|P1|NOT COMPLETED|Overall Study||0
1501345|NCT01662531|3672459|P1|COMPLETED|Overall Study||27
1501346|NCT01662531|3672459|P1|STARTED|Overall Study||27
1501347|NCT01662505|3672486|P3|NOT COMPLETED|Overall Study||8
1501348|NCT01662505|3672487|P2|NOT COMPLETED|Overall Study||4
1501349|NCT01662505|3672488|P1|NOT COMPLETED|Overall Study||7
1501350|NCT01662505|3672486|P3|COMPLETED|Overall Study||0
1501351|NCT01662505|3672487|P2|COMPLETED|Overall Study||0
1501352|NCT01662505|3672488|P1|COMPLETED|Overall Study||0
1501353|NCT01662505|3672486|P3|STARTED|Overall Study||8
1501354|NCT01662505|3672487|P2|STARTED|Overall Study||4
1501355|NCT01662505|3672488|P1|STARTED|Overall Study||7
1501356|NCT01662492|3672512|P3|NOT COMPLETED|Overall Study||6
1501357|NCT01662492|3672513|P2|NOT COMPLETED|Overall Study||1
1501358|NCT01662492|3672514|P1|NOT COMPLETED|Overall Study||3
1501359|NCT01662492|3672512|P3|COMPLETED|Overall Study||31
1501360|NCT01662492|3672513|P2|COMPLETED|Overall Study||42
1501361|NCT01662492|3672514|P1|COMPLETED|Overall Study||42
1501362|NCT01662492|3672512|P3|STARTED|Overall Study||37
1501363|NCT01662492|3672513|P2|STARTED|Overall Study||43
1501364|NCT01662492|3672514|P1|STARTED|Overall Study||45
1501365|NCT01662440|3672538|P4|NOT COMPLETED|Overall Study||4
1501366|NCT01662440|3672539|P3|NOT COMPLETED|Overall Study||6
1501367|NCT01662440|3672540|P2|NOT COMPLETED|Overall Study||6
1501368|NCT01662440|3672541|P1|NOT COMPLETED|Overall Study||9
1501369|NCT01662440|3672538|P4|COMPLETED|Overall Study||52
1501370|NCT01662440|3672539|P3|COMPLETED|Overall Study||215
1501371|NCT01662440|3672540|P2|COMPLETED|Overall Study||211
1501372|NCT01662440|3672541|P1|COMPLETED|Overall Study||158
1501373|NCT01662440|3672538|P4|STARTED|Overall Study||56
1501374|NCT01662440|3672539|P3|STARTED|Overall Study||221
1501375|NCT01662440|3672540|P2|STARTED|Overall Study||217
1501376|NCT01662440|3672541|P1|STARTED|Overall Study||167
1501377|NCT01662362|3672589|P1|NOT COMPLETED|Overall Study||38
1501378|NCT01662362|3672589|P1|COMPLETED|Overall Study||25
1501379|NCT01662362|3672589|P1|STARTED|Overall Study||63
1501380|NCT01662336|3672594|P1|NOT COMPLETED|Overall Study||66
1501381|NCT01662336|3672594|P1|COMPLETED|Overall Study||107
1501382|NCT01662336|3672594|P1|Completed Month 12 Visit|Overall Study||109
1501383|NCT01662336|3672594|P1|Completed Month 6 Visit|Overall Study||142
1501384|NCT01662336|3672594|P1|STARTED|Overall Study||173
1501385|NCT01662310|3672620|P5|NOT COMPLETED|Open-Label Extension Phase||10
1501386|NCT01662310|3672621|P4|NOT COMPLETED|Open-Label Extension Phase||11
1501387|NCT01662310|3672622|P3|NOT COMPLETED|Open-Label Extension Phase||0
1501388|NCT01662310|3672623|P2|NOT COMPLETED|Open-Label Extension Phase||0
1501389|NCT01662310|3672624|P1|NOT COMPLETED|Open-Label Extension Phase||0
1501390|NCT01662310|3672620|P5|COMPLETED|Open-Label Extension Phase||49
1501391|NCT01662310|3672621|P4|COMPLETED|Open-Label Extension Phase||36
1501392|NCT01662310|3672622|P3|COMPLETED|Open-Label Extension Phase||0
1501393|NCT01662310|3672623|P2|COMPLETED|Open-Label Extension Phase||0
1501394|NCT01662310|3672624|P1|COMPLETED|Open-Label Extension Phase||0
1501395|NCT01662310|3672620|P5|STARTED|Open-Label Extension Phase||59
1501396|NCT01662310|3672621|P4|STARTED|Open-Label Extension Phase||47
1501397|NCT01662310|3672622|P3|STARTED|Open-Label Extension Phase||0
1501398|NCT01662310|3672623|P2|STARTED|Open-Label Extension Phase||0
1501399|NCT01662310|3672624|P1|STARTED|Open-Label Extension Phase||0
1501400|NCT01662310|3672620|P5|NOT COMPLETED|Double-Blind Phase||0
1501401|NCT01662310|3672621|P4|NOT COMPLETED|Double-Blind Phase||0
1501402|NCT01662310|3672622|P3|NOT COMPLETED|Double-Blind Phase||5
1501403|NCT01662310|3672623|P2|NOT COMPLETED|Double-Blind Phase||15
1501404|NCT01662310|3672624|P1|NOT COMPLETED|Double-Blind Phase||0
1501405|NCT01662310|3672620|P5|COMPLETED|Double-Blind Phase||0
1501406|NCT01662310|3672621|P4|COMPLETED|Double-Blind Phase||0
1501407|NCT01662310|3672622|P3|COMPLETED|Double-Blind Phase||66
1501408|NCT01662310|3672623|P2|COMPLETED|Double-Blind Phase||50
1501409|NCT01662310|3672624|P1|COMPLETED|Double-Blind Phase||0
1501410|NCT01662310|3672620|P5|Treated|Double-Blind Phase||0
1501411|NCT01662310|3672621|P4|Treated|Double-Blind Phase||0
1501412|NCT01662310|3672622|P3|Treated|Double-Blind Phase||71
1501413|NCT01662310|3672623|P2|Treated|Double-Blind Phase||64
1501414|NCT01662310|3672624|P1|Treated|Double-Blind Phase||0
1501415|NCT01662310|3672620|P5|STARTED|Double-Blind Phase||0
1501416|NCT01662310|3672621|P4|STARTED|Double-Blind Phase||0
1501417|NCT01662310|3672622|P3|STARTED|Double-Blind Phase||71
1501418|NCT01662310|3672623|P2|STARTED|Double-Blind Phase||65
1501419|NCT01662310|3672624|P1|STARTED|Double-Blind Phase||0
1501420|NCT01662310|3672620|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
1501421|NCT01662310|3672621|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
1501422|NCT01662310|3672622|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
1501423|NCT01662310|3672623|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
1501424|NCT01662310|3672624|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
1501425|NCT01662310|3672620|P5|COMPLETED|Run-In or Stabilization Phase||0
1501426|NCT01662310|3672621|P4|COMPLETED|Run-In or Stabilization Phase||0
1501427|NCT01662310|3672622|P3|COMPLETED|Run-In or Stabilization Phase||0
1501428|NCT01662310|3672623|P2|COMPLETED|Run-In or Stabilization Phase||0
1501429|NCT01662310|3672624|P1|COMPLETED|Run-In or Stabilization Phase||136
1501430|NCT01662310|3672620|P5|STARTED|Run-In or Stabilization Phase||0
1501431|NCT01662310|3672621|P4|STARTED|Run-In or Stabilization Phase||0
1501432|NCT01662310|3672622|P3|STARTED|Run-In or Stabilization Phase||0
1501433|NCT01662310|3672623|P2|STARTED|Run-In or Stabilization Phase||0
1501434|NCT01662310|3672624|P1|STARTED|Run-In or Stabilization Phase||201
1501435|NCT01662297|3672658|P2|NOT COMPLETED|Overall Study||0
1501436|NCT01662297|3672659|P1|NOT COMPLETED|Overall Study||0
1501437|NCT01662297|3672658|P2|COMPLETED|Overall Study||1
1501438|NCT01662297|3672659|P1|COMPLETED|Overall Study||0
1501439|NCT01662297|3672658|P2|STARTED|Overall Study||1
1501440|NCT01662297|3672659|P1|STARTED|Overall Study||0
1501441|NCT01662115|3672684|P3|NOT COMPLETED|Overall Study||0
1501442|NCT01662115|3672685|P2|NOT COMPLETED|Overall Study||0
1501443|NCT01662115|3672686|P1|NOT COMPLETED|Overall Study||0
1501444|NCT01662115|3672684|P3|COMPLETED|Overall Study||0
1501445|NCT01662115|3672685|P2|COMPLETED|Overall Study||2
1501446|NCT01662115|3672686|P1|COMPLETED|Overall Study||2
1501447|NCT01662115|3672684|P3|STARTED|Overall Study||0
1501448|NCT01662115|3672685|P2|STARTED|Overall Study||2
1501449|NCT01662115|3672686|P1|STARTED|Overall Study||2
1501450|NCT01662102|3672705|P2|NOT COMPLETED|Overall Study||0
1501451|NCT01662102|3672706|P1|NOT COMPLETED|Overall Study||1
1501452|NCT01662102|3672705|P2|COMPLETED|Overall Study||0
1501453|NCT01662102|3672706|P1|COMPLETED|Overall Study||0
1501454|NCT01662102|3672705|P2|STARTED|Overall Study||0
1501455|NCT01662102|3672706|P1|STARTED|Overall Study||1
1501456|NCT01662063|3672714|P3|NOT COMPLETED|Overall Study||1
1501457|NCT01662063|3672715|P2|NOT COMPLETED|Overall Study||29
1501458|NCT01662063|3672716|P1|NOT COMPLETED|Overall Study||5
1501459|NCT01662063|3672714|P3|COMPLETED|Overall Study||0
1501460|NCT01662063|3672715|P2|COMPLETED|Overall Study||144
1501461|NCT01662063|3672716|P1|COMPLETED|Overall Study||39
1501462|NCT01662063|3672714|P3|STARTED|Overall Study||1
1501463|NCT01662063|3672715|P2|STARTED|Overall Study||173
1501464|NCT01662063|3672716|P1|STARTED|Overall Study||44
1501465|NCT01662024|3672795|P1|NOT COMPLETED|Overall Study||5
1501466|NCT01662024|3672795|P1|COMPLETED|Overall Study||15
1501467|NCT01662024|3672795|P1|STARTED|Overall Study||20
1501468|NCT01661972|3672807|P2|NOT COMPLETED|Overall Study||4
1501469|NCT01661972|3672808|P1|NOT COMPLETED|Overall Study||2
1501470|NCT01661972|3672807|P2|COMPLETED|Overall Study||46
1501471|NCT01661972|3672808|P1|COMPLETED|Overall Study||11
1501472|NCT01661972|3672807|P2|STARTED|Overall Study||50
1501473|NCT01661972|3672808|P1|STARTED|Overall Study||13
1501474|NCT01661933|3672818|P1|NOT COMPLETED|High-dose Gluten Challenge||2
1501475|NCT01661933|3672818|P1|COMPLETED|High-dose Gluten Challenge||8
1501476|NCT01661933|3672818|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
1501477|NCT01661933|3672818|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
1501478|NCT01661933|3672818|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
1501479|NCT01661933|3672818|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
1501480|NCT01661933|3672818|P1|NOT COMPLETED|Gluten Micro-challenge||0
1501481|NCT01661933|3672818|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
1501482|NCT01661933|3672818|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
1501483|NCT01661881|3672825|P1|NOT COMPLETED|Overall Study||1
1501484|NCT01661881|3672825|P1|COMPLETED|Overall Study||22
1501485|NCT01661881|3672825|P1|STARTED|Overall Study||23
1501486|NCT01661790|3672833|P2|NOT COMPLETED|Overall Study||2
1501487|NCT01661790|3672834|P1|NOT COMPLETED|Overall Study||0
1501488|NCT01661790|3672833|P2|COMPLETED|Overall Study||34
1501489|NCT01661790|3672834|P1|COMPLETED|Overall Study||36
1501490|NCT01661790|3672833|P2|STARTED|Overall Study||36
1501491|NCT01661790|3672834|P1|STARTED|Overall Study||36
1501492|NCT01661764|3672846|P6|NOT COMPLETED|Overall Study||2
1501493|NCT01661764|3672847|P5|NOT COMPLETED|Overall Study||3
1501494|NCT01661764|3672848|P4|NOT COMPLETED|Overall Study||2
1501495|NCT01661764|3672849|P3|NOT COMPLETED|Overall Study||3
1501496|NCT01661764|3672850|P2|NOT COMPLETED|Overall Study||5
1501497|NCT01661764|3672851|P1|NOT COMPLETED|Overall Study||2
1501498|NCT01661764|3672846|P6|COMPLETED|Overall Study||18
1501499|NCT01661764|3672847|P5|COMPLETED|Overall Study||16
1501500|NCT01661764|3672848|P4|COMPLETED|Overall Study||24
1501501|NCT01661764|3672849|P3|COMPLETED|Overall Study||22
1501502|NCT01661764|3672850|P2|COMPLETED|Overall Study||20
1501503|NCT01661764|3672851|P1|COMPLETED|Overall Study||24
1501504|NCT01661764|3672846|P6|STARTED|Overall Study||20
1501505|NCT01661764|3672847|P5|STARTED|Overall Study||19
1501506|NCT01661764|3672848|P4|STARTED|Overall Study||26
1501507|NCT01661764|3672849|P3|STARTED|Overall Study||25
1501508|NCT01661764|3672850|P2|STARTED|Overall Study||25
1501509|NCT01661764|3672851|P1|STARTED|Overall Study||26
1501510|NCT01661712|3672915|P2|NOT COMPLETED|Overall Study||0
1501511|NCT01661712|3672916|P1|NOT COMPLETED|Overall Study||0
1501512|NCT01661712|3672915|P2|COMPLETED|Overall Study|sham stimulation night|18
1501513|NCT01661712|3672916|P1|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
1501514|NCT01661712|3672915|P2|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
1501515|NCT01661712|3672916|P1|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
1501516|NCT01661712|3672915|P2|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
1501517|NCT01661712|3672916|P1|STARTED|Overall Study|initial sham stimulation night|18
1501518|NCT01661621|3672934|P2|NOT COMPLETED|Overall Study||0
1501519|NCT01661621|3672935|P1|NOT COMPLETED|Overall Study||0
1501520|NCT01661621|3672934|P2|COMPLETED|Overall Study||279
1501521|NCT01661621|3672935|P1|COMPLETED|Overall Study||116
1501522|NCT01661621|3672934|P2|STARTED|Overall Study||279
1501523|NCT01661621|3672935|P1|STARTED|Overall Study||116
1501524|NCT01661595|3672959|P4|NOT COMPLETED|Phase 2: Week 5-8.||0
1501525|NCT01661595|3672960|P3|NOT COMPLETED|Phase 2: Week 5-8.||1
1501526|NCT01661595|3672961|P2|NOT COMPLETED|Phase 2: Week 5-8.||0
1501527|NCT01661595|3672962|P1|NOT COMPLETED|Phase 2: Week 5-8.||0
1501528|NCT01661595|3672959|P4|COMPLETED|Phase 2: Week 5-8.||4
1501529|NCT01661595|3672960|P3|COMPLETED|Phase 2: Week 5-8.||4
1501530|NCT01661595|3672961|P2|COMPLETED|Phase 2: Week 5-8.||4
1501531|NCT01661595|3672962|P1|COMPLETED|Phase 2: Week 5-8.||4
1501532|NCT01661595|3672959|P4|STARTED|Phase 2: Week 5-8.||4
1501533|NCT01661595|3672960|P3|STARTED|Phase 2: Week 5-8.||5
1501534|NCT01661595|3672961|P2|STARTED|Phase 2: Week 5-8.||4
1501535|NCT01661595|3672962|P1|STARTED|Phase 2: Week 5-8.||4
1501536|NCT01661595|3672959|P4|NOT COMPLETED|Phase 1: Week 0-4||0
1501537|NCT01661595|3672960|P3|NOT COMPLETED|Phase 1: Week 0-4||0
1501538|NCT01661595|3672961|P2|NOT COMPLETED|Phase 1: Week 0-4||0
1501539|NCT01661595|3672962|P1|NOT COMPLETED|Phase 1: Week 0-4||1
1501540|NCT01661595|3672959|P4|COMPLETED|Phase 1: Week 0-4||4
1501541|NCT01661595|3672960|P3|COMPLETED|Phase 1: Week 0-4||5
1501542|NCT01661595|3672961|P2|COMPLETED|Phase 1: Week 0-4||4
1501543|NCT01661595|3672962|P1|COMPLETED|Phase 1: Week 0-4||4
1501544|NCT01661595|3672959|P4|STARTED|Phase 1: Week 0-4||4
1501545|NCT01661595|3672960|P3|STARTED|Phase 1: Week 0-4||5
1501546|NCT01661595|3672961|P2|STARTED|Phase 1: Week 0-4||4
1501547|NCT01661595|3672962|P1|STARTED|Phase 1: Week 0-4||5
1501548|NCT01661270|3673069|P2|NOT COMPLETED|Overall Study||0
1501549|NCT01661270|3673070|P1|NOT COMPLETED|Overall Study||0
1501550|NCT01661270|3673069|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
1501551|NCT01661270|3673070|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
1501552|NCT01661270|3673069|P2|Other Reasons|Overall Study||2
1501553|NCT01661270|3673070|P1|Other Reasons|Overall Study||0
1501554|NCT01661270|3673069|P2|Participant’s Request|Overall Study|Met EOT criteria|48
1501555|NCT01661270|3673070|P1|Participant’s Request|Overall Study|Met EOT criteria|15
1501556|NCT01661270|3673069|P2|Physician Decision|Overall Study|Met EOT criteria|8
1501557|NCT01661270|3673070|P1|Physician Decision|Overall Study|Met EOT criteria|1
1501558|NCT01661270|3673069|P2|Disease Progression|Overall Study|Met EOT criteria|118
1501559|NCT01661270|3673070|P1|Disease Progression|Overall Study|Met EOT criteria|67
1501560|NCT01661270|3673069|P2|Adverse Event|Overall Study|Met EOT criteria|47
1501561|NCT01661270|3673070|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
1501562|NCT01661270|3673069|P2|STARTED|Overall Study||223
1501563|NCT01661270|3673070|P1|STARTED|Overall Study||109
1501564|NCT01661205|3673081|P1|NOT COMPLETED|Overall Study||2
1501565|NCT01661205|3673081|P1|COMPLETED|Overall Study||24
1501566|NCT01661205|3673081|P1|STARTED|Overall Study||26
1501567|NCT01661179|3673092|P1|NOT COMPLETED|Overall Study||6
1501568|NCT01661179|3673092|P1|COMPLETED|Overall Study||8
1501569|NCT01661179|3673092|P1|STARTED|Overall Study||14
1501570|NCT01661140|3673096|P3|NOT COMPLETED|Double-Blind Period||50
1501571|NCT01661140|3673097|P2|NOT COMPLETED|Double-Blind Period||41
1501572|NCT01661140|3673098|P1|NOT COMPLETED|Double-Blind Period||0
1501573|NCT01661140|3673096|P3|COMPLETED|Double-Blind Period||86
1501574|NCT01661140|3673097|P2|COMPLETED|Double-Blind Period||95
1501575|NCT01661140|3673098|P1|COMPLETED|Double-Blind Period||0
1501576|NCT01661140|3673096|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
1501577|NCT01661140|3673097|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
1501578|NCT01661140|3673098|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
1501579|NCT01661140|3673096|P3|NOT COMPLETED|Open-Label Period||0
1501580|NCT01661140|3673097|P2|NOT COMPLETED|Open-Label Period||0
1501581|NCT01661140|3673098|P1|NOT COMPLETED|Open-Label Period||76
1501582|NCT01661140|3673096|P3|COMPLETED|Open-Label Period||0
1501583|NCT01661140|3673097|P2|COMPLETED|Open-Label Period||0
1501584|NCT01661140|3673098|P1|COMPLETED|Open-Label Period||351
1501585|NCT01661140|3673096|P3|STARTED|Open-Label Period||0
1501586|NCT01661140|3673097|P2|STARTED|Open-Label Period||0
1501587|NCT01661140|3673098|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
1501588|NCT01661114|3673139|P1|NOT COMPLETED|Overall Study||0
1501589|NCT01661114|3673139|P1|COMPLETED|Overall Study||39
1501590|NCT01661114|3673139|P1|STARTED|Overall Study||39
1501591|NCT01661088|3673144|P1|NOT COMPLETED|IMRT With FDR Gemcitabine||2
1501592|NCT01661088|3673144|P1|COMPLETED|IMRT With FDR Gemcitabine||19
1501593|NCT01661088|3673144|P1|STARTED|IMRT With FDR Gemcitabine||21
1501594|NCT01661088|3673144|P1|NOT COMPLETED|FOLFIRINOX||4
1501595|NCT01661088|3673144|P1|COMPLETED|FOLFIRINOX||21
1501596|NCT01661088|3673144|P1|STARTED|FOLFIRINOX||25
1501597|NCT01661062|3673150|P1|NOT COMPLETED|Overall Study||5
1501598|NCT01661062|3673150|P1|COMPLETED|Overall Study||18
1501599|NCT01661062|3673150|P1|STARTED|Overall Study||23
1501600|NCT01660906|3673155|P1|NOT COMPLETED|Overall Study||3
1501601|NCT01660906|3673155|P1|COMPLETED|Overall Study||36
1501602|NCT01660906|3673155|P1|STARTED|Overall Study||39
1501603|NCT01660893|3673167|P3|NOT COMPLETED|Overall Study||0
1501604|NCT01660893|3673168|P2|NOT COMPLETED|Overall Study||0
1501605|NCT01660893|3673169|P1|NOT COMPLETED|Overall Study||0
1501606|NCT01660893|3673167|P3|COMPLETED|Overall Study||6
1501607|NCT01660893|3673168|P2|COMPLETED|Overall Study||10
1501608|NCT01660893|3673169|P1|COMPLETED|Overall Study||10
1501609|NCT01660893|3673167|P3|STARTED|Overall Study||6
1501610|NCT01660893|3673168|P2|STARTED|Overall Study||10
1501611|NCT01660893|3673169|P1|STARTED|Overall Study||10
1501612|NCT01660815|3673216|P1|NOT COMPLETED|Overall Study||0
1501613|NCT01660815|3673216|P1|COMPLETED|Overall Study||7
1501614|NCT01660815|3673216|P1|STARTED|Overall Study||7
1501615|NCT01660802|3673223|P2|NOT COMPLETED|Overall Study||11
1501616|NCT01660802|3673224|P1|NOT COMPLETED|Overall Study||4
1501617|NCT01660802|3673223|P2|COMPLETED|Overall Study||121
1501618|NCT01660802|3673224|P1|COMPLETED|Overall Study||126
1501619|NCT01660802|3673223|P2|STARTED|Overall Study||132
1501620|NCT01660802|3673224|P1|STARTED|Overall Study||130
1501621|NCT01660763|3673238|P2|NOT COMPLETED|Overall Study||61
1501622|NCT01660763|3673239|P1|NOT COMPLETED|Overall Study||100
1501623|NCT01660763|3673238|P2|COMPLETED|Overall Study||43
1501624|NCT01660763|3673239|P1|COMPLETED|Overall Study||215
1501625|NCT01660763|3673238|P2|STARTED|Overall Study||104
1501626|NCT01660763|3673239|P1|STARTED|Overall Study||315
1501627|NCT01660737|3673245|P1|NOT COMPLETED|Overall Study||0
1501628|NCT01660737|3673245|P1|COMPLETED|Overall Study||123
1501629|NCT01660737|3673245|P1|STARTED|Overall Study||123
1501630|NCT01660698|3673262|P2|NOT COMPLETED|Overall Study||0
1501631|NCT01660698|3673263|P1|NOT COMPLETED|Overall Study||0
1501632|NCT01660698|3673262|P2|COMPLETED|Overall Study||10
1501633|NCT01660698|3673263|P1|COMPLETED|Overall Study||10
1501634|NCT01660698|3673262|P2|STARTED|Overall Study||10
1501635|NCT01660698|3673263|P1|STARTED|Overall Study||10
1501636|NCT01660672|3673273|P1|NOT COMPLETED|Overall Study||0
1501637|NCT01660672|3673273|P1|COMPLETED|Overall Study||7
1501638|NCT01660672|3673273|P1|STARTED|Overall Study||7
1501639|NCT01660451|3673287|P3|NOT COMPLETED|Overall Study||105
1501640|NCT01660451|3673288|P2|NOT COMPLETED|Overall Study||17
1501641|NCT01660451|3673289|P1|NOT COMPLETED|Overall Study||17
1501642|NCT01660451|3673287|P3|COMPLETED|Overall Study||37
1501643|NCT01660451|3673288|P2|COMPLETED|Overall Study||34
1501644|NCT01660451|3673289|P1|COMPLETED|Overall Study||16
1501645|NCT01660451|3673287|P3|STARTED|Overall Study||142
1501646|NCT01660451|3673288|P2|STARTED|Overall Study||51
1501647|NCT01660451|3673289|P1|STARTED|Overall Study||33
1501648|NCT01660412|3673317|P2|NOT COMPLETED|Overall Study||3
1501649|NCT01660412|3673318|P1|NOT COMPLETED|Overall Study||0
1501650|NCT01660412|3673317|P2|COMPLETED|Overall Study||28
1501651|NCT01660412|3673318|P1|COMPLETED|Overall Study||29
1501652|NCT01660412|3673317|P2|Injection 4|Overall Study||31
1501653|NCT01660412|3673318|P1|Injection 4|Overall Study||29
1501654|NCT01660412|3673317|P2|Injection 3|Overall Study||31
1501655|NCT01660412|3673318|P1|Injection 3|Overall Study||29
1501656|NCT01660412|3673317|P2|Injection 2|Overall Study||31
1501657|NCT01660412|3673318|P1|Injection 2|Overall Study||29
1501658|NCT01660412|3673317|P2|Injection 1|Overall Study||31
1501659|NCT01660412|3673318|P1|Injection 1|Overall Study||29
1501660|NCT01660412|3673317|P2|Other|Overall Study||4
1501661|NCT01660412|3673318|P1|Other|Overall Study||2
1501662|NCT01660412|3673317|P2|Appendicular Structures|Overall Study||11
1501663|NCT01660412|3673318|P1|Appendicular Structures|Overall Study||17
1501664|NCT01660412|3673317|P2|Thorax|Overall Study||9
1501665|NCT01660412|3673318|P1|Thorax|Overall Study||9
1501666|NCT01660412|3673317|P2|Head|Overall Study||4
1501667|NCT01660412|3673318|P1|Head|Overall Study||1
1501668|NCT01660412|3673317|P2|STARTED|Overall Study||31
1501669|NCT01660412|3673318|P1|STARTED|Overall Study||29
1501670|NCT01660334|3673324|P1|NOT COMPLETED|Overall Study||1
1501671|NCT01660334|3673324|P1|COMPLETED|Overall Study||12
1501672|NCT01660334|3673324|P1|STARTED|Overall Study||13
1501673|NCT01660321|3673329|P1|NOT COMPLETED|Overall Study||0
1501674|NCT01660321|3673329|P1|COMPLETED|Overall Study||26
1501675|NCT01660321|3673329|P1|STARTED|Overall Study||26
1501676|NCT01660230|3673353|P12|NOT COMPLETED|Overall Study||0
1501677|NCT01660230|3673354|P11|NOT COMPLETED|Overall Study||0
1501678|NCT01660230|3673355|P10|NOT COMPLETED|Overall Study||0
1501679|NCT01660230|3673356|P9|NOT COMPLETED|Overall Study||0
1501680|NCT01660230|3673357|P8|NOT COMPLETED|Overall Study||0
1501681|NCT01660230|3673358|P7|NOT COMPLETED|Overall Study||0
1501682|NCT01660230|3673359|P6|NOT COMPLETED|Overall Study||0
1501683|NCT01660230|3673360|P5|NOT COMPLETED|Overall Study||0
1501684|NCT01660230|3673361|P4|NOT COMPLETED|Overall Study||0
1501685|NCT01660230|3673362|P3|NOT COMPLETED|Overall Study||0
1501686|NCT01660230|3673363|P2|NOT COMPLETED|Overall Study||0
1501687|NCT01660230|3673364|P1|NOT COMPLETED|Overall Study||0
1501688|NCT01660230|3673353|P12|COMPLETED|Overall Study||14
1501689|NCT01660230|3673354|P11|COMPLETED|Overall Study||6
1501690|NCT01660230|3673355|P10|COMPLETED|Overall Study||6
1501691|NCT01660230|3673356|P9|COMPLETED|Overall Study||6
1501692|NCT01660230|3673357|P8|COMPLETED|Overall Study||6
1501693|NCT01660230|3673358|P7|COMPLETED|Overall Study||4
1501694|NCT01660230|3673359|P6|COMPLETED|Overall Study||2
1501695|NCT01660230|3673360|P5|COMPLETED|Overall Study||4
1501696|NCT01660230|3673361|P4|COMPLETED|Overall Study||4
1501697|NCT01660230|3673362|P3|COMPLETED|Overall Study||4
1501698|NCT01660230|3673363|P2|COMPLETED|Overall Study||4
1501699|NCT01660230|3673364|P1|COMPLETED|Overall Study||4
1501700|NCT01660230|3673353|P12|STARTED|Overall Study||14
1501701|NCT01660230|3673354|P11|STARTED|Overall Study||6
1501702|NCT01660230|3673355|P10|STARTED|Overall Study||6
1501703|NCT01660230|3673356|P9|STARTED|Overall Study||6
1501704|NCT01660230|3673357|P8|STARTED|Overall Study||6
1501705|NCT01660230|3673358|P7|STARTED|Overall Study||4
1501706|NCT01660230|3673359|P6|STARTED|Overall Study||2
1501707|NCT01660230|3673360|P5|STARTED|Overall Study||4
1501708|NCT01660230|3673361|P4|STARTED|Overall Study||4
1501709|NCT01660230|3673362|P3|STARTED|Overall Study||4
1501710|NCT01660230|3673363|P2|STARTED|Overall Study||4
1501711|NCT01660230|3673364|P1|STARTED|Overall Study||4
1501712|NCT01660191|3673536|P3|NOT COMPLETED|End of Treatment||1
1501713|NCT01660191|3673537|P2|NOT COMPLETED|End of Treatment||6
1501714|NCT01660191|3673538|P1|NOT COMPLETED|End of Treatment||1
1501715|NCT01660191|3673536|P3|COMPLETED|End of Treatment||43
1501716|NCT01660191|3673537|P2|COMPLETED|End of Treatment||39
1501717|NCT01660191|3673538|P1|COMPLETED|End of Treatment||44
1501718|NCT01660191|3673536|P3|STARTED|End of Treatment||44
1501719|NCT01660191|3673537|P2|STARTED|End of Treatment||45
1501720|NCT01660191|3673538|P1|STARTED|End of Treatment||45
1501721|NCT01660191|3673536|P3|NOT COMPLETED|Randomization||0
1501722|NCT01660191|3673537|P2|NOT COMPLETED|Randomization||0
1501723|NCT01660191|3673538|P1|NOT COMPLETED|Randomization||0
1501724|NCT01660191|3673536|P3|COMPLETED|Randomization||44
1501725|NCT01660191|3673537|P2|COMPLETED|Randomization||45
1501726|NCT01660191|3673538|P1|COMPLETED|Randomization||45
1501727|NCT01660191|3673536|P3|STARTED|Randomization||44
1501728|NCT01660191|3673537|P2|STARTED|Randomization||45
1501729|NCT01660191|3673538|P1|STARTED|Randomization||45
1501730|NCT01660191|3673536|P3|NOT COMPLETED|Enrollment and Washout||0
1501731|NCT01660191|3673537|P2|NOT COMPLETED|Enrollment and Washout||0
1501732|NCT01660191|3673538|P1|NOT COMPLETED|Enrollment and Washout||0
1501733|NCT01660191|3673536|P3|COMPLETED|Enrollment and Washout||44
1501734|NCT01660191|3673537|P2|COMPLETED|Enrollment and Washout||45
1501735|NCT01660191|3673538|P1|COMPLETED|Enrollment and Washout||45
1501736|NCT01660191|3673536|P3|STARTED|Enrollment and Washout||44
1501737|NCT01660191|3673537|P2|STARTED|Enrollment and Washout||45
1501738|NCT01660191|3673538|P1|STARTED|Enrollment and Washout||45
1501739|NCT01660022|3673567|P6|NOT COMPLETED|Second Sequence (42 Days)||0
1501740|NCT01660022|3673568|P5|NOT COMPLETED|Second Sequence (42 Days)||0
1501741|NCT01660022|3673569|P4|NOT COMPLETED|Second Sequence (42 Days)||0
1501742|NCT01660022|3673570|P3|NOT COMPLETED|Second Sequence (42 Days)||0
1501743|NCT01660022|3673571|P2|NOT COMPLETED|Second Sequence (42 Days)||0
1501744|NCT01660022|3673572|P1|NOT COMPLETED|Second Sequence (42 Days)||0
1501745|NCT01660022|3673567|P6|COMPLETED|Second Sequence (42 Days)||16
1501746|NCT01660022|3673568|P5|COMPLETED|Second Sequence (42 Days)||6
1501747|NCT01660022|3673569|P4|COMPLETED|Second Sequence (42 Days)||7
1501748|NCT01660022|3673570|P3|COMPLETED|Second Sequence (42 Days)||8
1501749|NCT01660022|3673571|P2|COMPLETED|Second Sequence (42 Days)||7
1501750|NCT01660022|3673572|P1|COMPLETED|Second Sequence (42 Days)||8
1501751|NCT01660022|3673567|P6|STARTED|Second Sequence (42 Days)||16
1501752|NCT01660022|3673568|P5|STARTED|Second Sequence (42 Days)||6
1501753|NCT01660022|3673569|P4|STARTED|Second Sequence (42 Days)||7
1501754|NCT01660022|3673570|P3|STARTED|Second Sequence (42 Days)||8
1501755|NCT01660022|3673571|P2|STARTED|Second Sequence (42 Days)||7
1501756|NCT01660022|3673572|P1|STARTED|Second Sequence (42 Days)||8
1501757|NCT01660022|3673567|P6|NOT COMPLETED|First Sequence (7 Days)||4
1501758|NCT01660022|3673568|P5|NOT COMPLETED|First Sequence (7 Days)||1
1501759|NCT01660022|3673569|P4|NOT COMPLETED|First Sequence (7 Days)||1
1501760|NCT01660022|3673570|P3|NOT COMPLETED|First Sequence (7 Days)||0
1501761|NCT01660022|3673571|P2|NOT COMPLETED|First Sequence (7 Days)||1
1501762|NCT01660022|3673572|P1|NOT COMPLETED|First Sequence (7 Days)||0
1501763|NCT01660022|3673567|P6|COMPLETED|First Sequence (7 Days)||16
1501764|NCT01660022|3673568|P5|COMPLETED|First Sequence (7 Days)||6
1501765|NCT01660022|3673569|P4|COMPLETED|First Sequence (7 Days)||7
1501766|NCT01660022|3673570|P3|COMPLETED|First Sequence (7 Days)||8
1501767|NCT01660022|3673571|P2|COMPLETED|First Sequence (7 Days)||7
1501768|NCT01660022|3673572|P1|COMPLETED|First Sequence (7 Days)||8
1501769|NCT01660022|3673567|P6|STARTED|First Sequence (7 Days)||20
1501770|NCT01660022|3673568|P5|STARTED|First Sequence (7 Days)||7
1501771|NCT01660022|3673569|P4|STARTED|First Sequence (7 Days)||8
1501772|NCT01660022|3673570|P3|STARTED|First Sequence (7 Days)||8
1501773|NCT01660022|3673571|P2|STARTED|First Sequence (7 Days)||8
1501774|NCT01660022|3673572|P1|STARTED|First Sequence (7 Days)||8
1501775|NCT01659996|3673631|P3|NOT COMPLETED|Overall Study||11
1501776|NCT01659996|3673632|P2|NOT COMPLETED|Overall Study||7
1501777|NCT01659996|3673633|P1|NOT COMPLETED|Overall Study||8
1501778|NCT01659996|3673631|P3|COMPLETED|Overall Study||461
1501779|NCT01659996|3673632|P2|COMPLETED|Overall Study||388
1501780|NCT01659996|3673633|P1|COMPLETED|Overall Study||413
1501781|NCT01659996|3673631|P3|STARTED|Overall Study||472
1501782|NCT01659996|3673632|P2|STARTED|Overall Study||395
1501783|NCT01659996|3673633|P1|STARTED|Overall Study||421
1501784|NCT01659853|3673665|P2|NOT COMPLETED|Treatment Period 2||0
1501785|NCT01659853|3673666|P1|NOT COMPLETED|Treatment Period 2||0
1501786|NCT01659853|3673665|P2|COMPLETED|Treatment Period 2||35
1501787|NCT01659853|3673666|P1|COMPLETED|Treatment Period 2||33
1501788|NCT01659853|3673665|P2|STARTED|Treatment Period 2||35
1501789|NCT01659853|3673666|P1|STARTED|Treatment Period 2||33
1501790|NCT01659853|3673665|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
1501791|NCT01659853|3673666|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
1501792|NCT01659853|3673665|P2|COMPLETED|Washout , 3 to 7 Days||35
1501793|NCT01659853|3673666|P1|COMPLETED|Washout , 3 to 7 Days||33
1501794|NCT01659853|3673665|P2|STARTED|Washout , 3 to 7 Days||35
1501795|NCT01659853|3673666|P1|STARTED|Washout , 3 to 7 Days||35
1501796|NCT01659853|3673665|P2|NOT COMPLETED|Treatment Period 1||0
1501797|NCT01659853|3673666|P1|NOT COMPLETED|Treatment Period 1||0
1501798|NCT01659853|3673665|P2|COMPLETED|Treatment Period 1||35
1501799|NCT01659853|3673666|P1|COMPLETED|Treatment Period 1||35
1501800|NCT01659853|3673665|P2|STARTED|Treatment Period 1||35
1501801|NCT01659853|3673666|P1|STARTED|Treatment Period 1||35
1501802|NCT01659736|3673676|P2|NOT COMPLETED|3-month Follow-up||1
1501803|NCT01659736|3673677|P1|NOT COMPLETED|3-month Follow-up||0
1501804|NCT01659736|3673676|P2|COMPLETED|3-month Follow-up||9
1501805|NCT01659736|3673677|P1|COMPLETED|3-month Follow-up||9
1501806|NCT01659736|3673676|P2|STARTED|3-month Follow-up||10
1501807|NCT01659736|3673677|P1|STARTED|3-month Follow-up||9
1501808|NCT01659736|3673676|P2|NOT COMPLETED|Treatment Period||2
1501809|NCT01659736|3673677|P1|NOT COMPLETED|Treatment Period||5
1501810|NCT01659736|3673676|P2|COMPLETED|Treatment Period||10
1501811|NCT01659736|3673677|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
1501812|NCT01659736|3673676|P2|STARTED|Treatment Period||12
1501813|NCT01659736|3673677|P1|STARTED|Treatment Period||14
1501814|NCT01659567|3673691|P1|NOT COMPLETED|Overall Study||123
1501815|NCT01659567|3673691|P1|COMPLETED|Overall Study||393
1501816|NCT01659567|3673691|P1|STARTED|Overall Study||516
1501817|NCT01659554|3673708|P1|NOT COMPLETED|Overall Study||4
1501818|NCT01659554|3673708|P1|COMPLETED|Overall Study||0
1501819|NCT01659554|3673708|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
1501820|NCT01659320|3673715|P1|NOT COMPLETED|Overall Study||3
1501821|NCT01659320|3673715|P1|COMPLETED|Overall Study||13
1501822|NCT01659320|3673715|P1|STARTED|Overall Study||16
1501823|NCT01659268|3673721|P2|NOT COMPLETED|Overall Study||0
1501824|NCT01659268|3673722|P1|NOT COMPLETED|Overall Study||0
1501825|NCT01659268|3673721|P2|COMPLETED|Overall Study||8
1501826|NCT01659268|3673722|P1|COMPLETED|Overall Study||9
1501827|NCT01659268|3673721|P2|STARTED|Overall Study||8
1501828|NCT01659268|3673722|P1|STARTED|Overall Study||9
1501829|NCT01659125|3673734|P1|NOT COMPLETED|Overall Study||14
1501830|NCT01659125|3673734|P1|COMPLETED|Overall Study||12
1501831|NCT01659125|3673734|P1|Completed 6-month Follow-up|Overall Study||12
1501832|NCT01659125|3673734|P1|Completed 3-month Follow-up|Overall Study||16
1501833|NCT01659125|3673734|P1|Completed the Posttreatment Assessment|Overall Study||17
1501834|NCT01659125|3673734|P1|Initiated Treatment|Overall Study||24
1501835|NCT01659125|3673734|P1|STARTED|Overall Study||26
1501836|NCT01659021|3673741|P2|NOT COMPLETED|Overall Study||37
1501837|NCT01659021|3673742|P1|NOT COMPLETED|Overall Study||88
1501838|NCT01659021|3673741|P2|COMPLETED|Overall Study||50
1501839|NCT01659021|3673742|P1|COMPLETED|Overall Study||86
1501840|NCT01659021|3673741|P2|Randomized and Treated|Overall Study||86
1501841|NCT01659021|3673742|P1|Randomized and Treated|Overall Study||173
1501842|NCT01659021|3673741|P2|STARTED|Overall Study||87
1501843|NCT01659021|3673742|P1|STARTED|Overall Study||174
1501844|NCT01658943|3673760|P2|NOT COMPLETED|Overall Study||67
1501845|NCT01658943|3673761|P1|NOT COMPLETED|Overall Study||70
1501846|NCT01658943|3673760|P2|COMPLETED|Overall Study||0
1501847|NCT01658943|3673761|P1|COMPLETED|Overall Study||0
1501848|NCT01658943|3673760|P2|Eligible and Began Protocol Therapy|Overall Study||58
1501849|NCT01658943|3673761|P1|Eligible and Began Protocol Therapy|Overall Study||62
1501850|NCT01658943|3673760|P2|Eligible|Overall Study||58
1501851|NCT01658943|3673761|P1|Eligible|Overall Study||63
1501852|NCT01658943|3673760|P2|STARTED|Overall Study||67
1501853|NCT01658943|3673761|P1|STARTED|Overall Study||70
1501854|NCT01658904|3673776|P3|NOT COMPLETED|Overall Study||0
1501855|NCT01658904|3673777|P2|NOT COMPLETED|Overall Study||0
1501856|NCT01658904|3673778|P1|NOT COMPLETED|Overall Study||2
1501857|NCT01658904|3673776|P3|COMPLETED|Overall Study||0
1501858|NCT01658904|3673777|P2|COMPLETED|Overall Study||0
1501859|NCT01658904|3673778|P1|COMPLETED|Overall Study||1
1501860|NCT01658904|3673776|P3|STARTED|Overall Study||0
1501861|NCT01658904|3673777|P2|STARTED|Overall Study||0
1501862|NCT01658904|3673778|P1|STARTED|Overall Study||3
1501863|NCT01658839|3673795|P1|NOT COMPLETED|Overall Study||0
1501864|NCT01658839|3673795|P1|COMPLETED|Overall Study||25
1501865|NCT01658839|3673795|P1|STARTED|Overall Study||25
1501866|NCT01658813|3673804|P1|NOT COMPLETED|Overall Study||3
1501867|NCT01658813|3673804|P1|COMPLETED|Overall Study||15
1501868|NCT01658813|3673804|P1|Treated|Overall Study||18
1501869|NCT01658813|3673804|P1|Eligible|Overall Study||18
1501870|NCT01658813|3673804|P1|STARTED|Overall Study||18
1501871|NCT01658735|3673815|P3|NOT COMPLETED|Overall Study||4
1501872|NCT01658735|3673816|P2|NOT COMPLETED|Overall Study||7
1501873|NCT01658735|3673817|P1|NOT COMPLETED|Overall Study||5
1501874|NCT01658735|3673815|P3|COMPLETED|Overall Study||34
1501875|NCT01658735|3673816|P2|COMPLETED|Overall Study||29
1501876|NCT01658735|3673817|P1|COMPLETED|Overall Study||34
1501877|NCT01658735|3673815|P3|STARTED|Overall Study||38
1501878|NCT01658735|3673816|P2|STARTED|Overall Study||36
1501879|NCT01658735|3673817|P1|STARTED|Overall Study||39
1501880|NCT01658657|3673848|P2|NOT COMPLETED|Overall Study||3
1501881|NCT01658657|3673849|P1|NOT COMPLETED|Overall Study||3
1501882|NCT01658657|3673848|P2|COMPLETED|Overall Study||7
1501883|NCT01658657|3673849|P1|COMPLETED|Overall Study||4
1501884|NCT01658657|3673848|P2|STARTED|Overall Study||10
1501885|NCT01658657|3673849|P1|STARTED|Overall Study||7
1501886|NCT01658579|3673859|P4|NOT COMPLETED|Treatment Period B||1
1501887|NCT01658579|3673860|P3|NOT COMPLETED|Treatment Period B||0
1501888|NCT01658579|3673861|P2|NOT COMPLETED|Treatment Period B||0
1501889|NCT01658579|3673862|P1|NOT COMPLETED|Treatment Period B||0
1501890|NCT01658579|3673859|P4|COMPLETED|Treatment Period B||12
1501891|NCT01658579|3673860|P3|COMPLETED|Treatment Period B||14
1501892|NCT01658579|3673861|P2|COMPLETED|Treatment Period B||15
1501893|NCT01658579|3673862|P1|COMPLETED|Treatment Period B||14
1501894|NCT01658579|3673859|P4|STARTED|Treatment Period B||13
1501895|NCT01658579|3673860|P3|STARTED|Treatment Period B||14
1501896|NCT01658579|3673861|P2|STARTED|Treatment Period B||15
1501897|NCT01658579|3673862|P1|STARTED|Treatment Period B||14
1501898|NCT01658579|3673859|P4|NOT COMPLETED|Treatment Period A||1
1501899|NCT01658579|3673860|P3|NOT COMPLETED|Treatment Period A||1
1501900|NCT01658579|3673861|P2|NOT COMPLETED|Treatment Period A||0
1501901|NCT01658579|3673862|P1|NOT COMPLETED|Treatment Period A||1
1501902|NCT01658579|3673859|P4|COMPLETED|Treatment Period A||13
1501903|NCT01658579|3673860|P3|COMPLETED|Treatment Period A||14
1501904|NCT01658579|3673861|P2|COMPLETED|Treatment Period A||15
1501905|NCT01658579|3673862|P1|COMPLETED|Treatment Period A||14
1501906|NCT01658579|3673859|P4|STARTED|Treatment Period A||14
1501907|NCT01658579|3673860|P3|STARTED|Treatment Period A||15
1501908|NCT01658579|3673861|P2|STARTED|Treatment Period A||15
1501909|NCT01658579|3673862|P1|STARTED|Treatment Period A||15
1501910|NCT01658514|3673890|P3|NOT COMPLETED|Overall Study||2
1501911|NCT01658514|3673891|P2|NOT COMPLETED|Overall Study||0
1501912|NCT01658514|3673892|P1|NOT COMPLETED|Overall Study||1
1501913|NCT01658514|3673890|P3|COMPLETED|Overall Study||12
1501914|NCT01658514|3673891|P2|COMPLETED|Overall Study||11
1501915|NCT01658514|3673892|P1|COMPLETED|Overall Study||13
1501916|NCT01658514|3673890|P3|Completed - Severe RI Cohort Only|Overall Study||3
1501917|NCT01658514|3673891|P2|Completed - Severe RI Cohort Only|Overall Study||2
1501918|NCT01658514|3673892|P1|Completed - Severe RI Cohort Only|Overall Study||3
1501919|NCT01658514|3673890|P3|Started - Severe RI Cohort Only|Overall Study||3
1501920|NCT01658514|3673891|P2|Started - Severe RI Cohort Only|Overall Study||2
1501921|NCT01658514|3673892|P1|Started - Severe RI Cohort Only|Overall Study||3
1501922|NCT01658514|3673890|P3|Completed - Moderate RI Cohort Only|Overall Study||2
1501923|NCT01658514|3673891|P2|Completed - Moderate RI Cohort Only|Overall Study||4
1501924|NCT01658514|3673892|P1|Completed - Moderate RI Cohort Only|Overall Study||3
1501925|NCT01658514|3673890|P3|Started - Moderate RI Cohort Only|Overall Study||4
1501926|NCT01658514|3673891|P2|Started - Moderate RI Cohort Only|Overall Study||4
1501927|NCT01658514|3673892|P1|Started - Moderate RI Cohort Only|Overall Study||4
1501928|NCT01658514|3673890|P3|Completed - Mild RI Cohort Only|Overall Study||4
1501929|NCT01658514|3673891|P2|Completed - Mild RI Cohort Only|Overall Study||3
1501930|NCT01658514|3673892|P1|Completed - Mild RI Cohort Only|Overall Study||4
1501931|NCT01658514|3673890|P3|Started - Mild RI Cohort Only|Overall Study||4
1501932|NCT01658514|3673891|P2|Started - Mild RI Cohort Only|Overall Study||3
1501933|NCT01658514|3673892|P1|Started - Mild RI Cohort Only|Overall Study||4
1501934|NCT01658514|3673890|P3|Completed - Normal RF Cohort Only|Overall Study||3
1501935|NCT01658514|3673891|P2|Completed - Normal RF Cohort Only|Overall Study||2
1501936|NCT01658514|3673892|P1|Completed - Normal RF Cohort Only|Overall Study||3
1501937|NCT01658514|3673890|P3|Started - Normal RF Cohort Only|Overall Study||3
1501938|NCT01658514|3673891|P2|Started - Normal RF Cohort Only|Overall Study||2
1501939|NCT01658514|3673892|P1|Started - Normal RF Cohort Only|Overall Study||3
1501940|NCT01658514|3673890|P3|Completed Treatment C|Overall Study||12
1501941|NCT01658514|3673891|P2|Completed Treatment C|Overall Study||11
1501942|NCT01658514|3673892|P1|Completed Treatment C|Overall Study||13
1501943|NCT01658514|3673890|P3|Completed Treatment B|Overall Study||14
1501944|NCT01658514|3673891|P2|Completed Treatment B|Overall Study||11
1501945|NCT01658514|3673892|P1|Completed Treatment B|Overall Study||13
1501946|NCT01658514|3673890|P3|Completed Treatment A|Overall Study||12
1501947|NCT01658514|3673891|P2|Completed Treatment A|Overall Study||11
1501948|NCT01658514|3673892|P1|Completed Treatment A|Overall Study||14
1501949|NCT01658514|3673890|P3|STARTED|Overall Study||14
1501950|NCT01658514|3673891|P2|STARTED|Overall Study||11
1501951|NCT01658514|3673892|P1|STARTED|Overall Study||14
1501952|NCT01658436|3673903|P2|NOT COMPLETED|Overall Study||11
1501953|NCT01658436|3673904|P1|NOT COMPLETED|Overall Study||20
1501954|NCT01658436|3673903|P2|COMPLETED|Overall Study||0
1501955|NCT01658436|3673904|P1|COMPLETED|Overall Study||0
1501956|NCT01658436|3673903|P2|STARTED|Overall Study||11
1501957|NCT01658436|3673904|P1|STARTED|Overall Study||20
1501958|NCT01658228|3673913|P2|NOT COMPLETED|Overall Study||8
1501959|NCT01658228|3673914|P1|NOT COMPLETED|Overall Study||7
1501960|NCT01658228|3673913|P2|COMPLETED|Overall Study||23
1501961|NCT01658228|3673914|P1|COMPLETED|Overall Study||23
1501962|NCT01658228|3673913|P2|STARTED|Overall Study||31
1501963|NCT01658228|3673914|P1|STARTED|Overall Study||30
1501964|NCT01658150|3673924|P1|NOT COMPLETED|Overall Study||1
1501965|NCT01658150|3673924|P1|COMPLETED|Overall Study||10
1501966|NCT01658150|3673924|P1|STARTED|Overall Study||11
1501967|NCT01658072|3673946|P2|NOT COMPLETED|Overall Study||2
1501968|NCT01658072|3673947|P1|NOT COMPLETED|Overall Study||4
1501969|NCT01658072|3673946|P2|COMPLETED|Overall Study||43
1501970|NCT01658072|3673947|P1|COMPLETED|Overall Study||41
1501971|NCT01658072|3673946|P2|STARTED|Overall Study||45
1501972|NCT01658072|3673947|P1|STARTED|Overall Study||45
1501973|NCT01658020|3673955|P2|NOT COMPLETED|Overall Study||9
1501974|NCT01658020|3673956|P1|NOT COMPLETED|Overall Study||8
1501975|NCT01658020|3673955|P2|COMPLETED|Overall Study||158
1501976|NCT01658020|3673956|P1|COMPLETED|Overall Study||167
1501977|NCT01658020|3673955|P2|STARTED|Overall Study||167
1501978|NCT01658020|3673956|P1|STARTED|Overall Study||175
1501979|NCT01657903|3673972|P1|NOT COMPLETED|Overall Study||2
1501980|NCT01657903|3673972|P1|COMPLETED|Overall Study||54
1501981|NCT01657903|3673972|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
1501982|NCT01657903|3673972|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
1501983|NCT01657903|3673972|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
1501984|NCT01657903|3673972|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
1501985|NCT01657903|3673972|P1|STARTED|Overall Study||56
1501986|NCT01657877|3673994|P1|NOT COMPLETED|Overall Study||14
1501987|NCT01657877|3673994|P1|COMPLETED|Overall Study||65
1501988|NCT01657877|3673994|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
1501989|NCT01657877|3673994|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
1501990|NCT01657877|3673994|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
1501991|NCT01657877|3673994|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
1501992|NCT01657877|3673994|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
1501993|NCT01657877|3673994|P1|STARTED|Overall Study||79
1501994|NCT01657799|3674014|P3|NOT COMPLETED|Overall Study||102
1501995|NCT01657799|3674015|P2|NOT COMPLETED|Overall Study||103
1501996|NCT01657799|3674016|P1|NOT COMPLETED|Overall Study||102
1501997|NCT01657799|3674014|P3|COMPLETED|Overall Study||0
1501998|NCT01657799|3674015|P2|COMPLETED|Overall Study||0
1501999|NCT01657799|3674016|P1|COMPLETED|Overall Study||0
1502000|NCT01657799|3674014|P3|Received Treatment|Overall Study||102
1502001|NCT01657799|3674015|P2|Received Treatment|Overall Study||103
1502002|NCT01657799|3674016|P1|Received Treatment|Overall Study||101
1502003|NCT01657799|3674014|P3|STARTED|Overall Study||102
1502004|NCT01657799|3674015|P2|STARTED|Overall Study||103
1502005|NCT01657799|3674016|P1|STARTED|Overall Study||102
1502006|NCT01657617|3674033|P1|NOT COMPLETED|Overall Study||0
1502007|NCT01657617|3674033|P1|COMPLETED|Overall Study||35
1502008|NCT01657617|3674033|P1|STARTED|Overall Study||35
1502009|NCT01657461|3674040|P2|NOT COMPLETED|Overall Study||20
1502010|NCT01657461|3674041|P1|NOT COMPLETED|Overall Study||10
1502011|NCT01657461|3674040|P2|COMPLETED|Overall Study||78
1502012|NCT01657461|3674041|P1|COMPLETED|Overall Study||88
1502013|NCT01657461|3674040|P2|STARTED|Overall Study||98
1502014|NCT01657461|3674041|P1|STARTED|Overall Study||98
1502015|NCT01657370|3674071|P6|NOT COMPLETED|Overall Study||4
1502016|NCT01657370|3674072|P5|NOT COMPLETED|Overall Study||7
1502017|NCT01657370|3674073|P4|NOT COMPLETED|Overall Study||5
1502018|NCT01657370|3674074|P3|NOT COMPLETED|Overall Study||7
1502019|NCT01657370|3674075|P2|NOT COMPLETED|Overall Study||4
1502020|NCT01657370|3674076|P1|NOT COMPLETED|Overall Study||6
1502021|NCT01657370|3674071|P6|COMPLETED|Overall Study||27
1502022|NCT01657370|3674072|P5|COMPLETED|Overall Study||27
1502023|NCT01657370|3674073|P4|COMPLETED|Overall Study||28
1502024|NCT01657370|3674074|P3|COMPLETED|Overall Study||25
1502025|NCT01657370|3674075|P2|COMPLETED|Overall Study||28
1502026|NCT01657370|3674076|P1|COMPLETED|Overall Study||27
1502027|NCT01657370|3674071|P6|STARTED|Overall Study||31
1502028|NCT01657370|3674072|P5|STARTED|Overall Study||34
1502029|NCT01657370|3674073|P4|STARTED|Overall Study||33
1502030|NCT01657370|3674074|P3|STARTED|Overall Study||32
1502031|NCT01657370|3674075|P2|STARTED|Overall Study||32
1502032|NCT01657370|3674076|P1|STARTED|Overall Study||33
1502033|NCT01657305|3674158|P1|NOT COMPLETED|Overall Study||25
1502034|NCT01657305|3674158|P1|COMPLETED|Overall Study||82
1502035|NCT01657305|3674158|P1|STARTED|Overall Study||107
1502036|NCT01657292|3674208|P1|NOT COMPLETED|Overall Study||10
1502037|NCT01657292|3674208|P1|COMPLETED|Overall Study||51
1502038|NCT01657292|3674208|P1|STARTED|Overall Study||61
1502039|NCT01657266|3674217|P2|NOT COMPLETED|Overall Study||5
1502040|NCT01657266|3674218|P1|NOT COMPLETED|Overall Study||4
1502041|NCT01657266|3674217|P2|COMPLETED|Overall Study||70
1502042|NCT01657266|3674218|P1|COMPLETED|Overall Study||69
1502043|NCT01657266|3674217|P2|STARTED|Overall Study||75
1502044|NCT01657266|3674218|P1|STARTED|Overall Study||73
1502045|NCT01657253|3674240|P2|NOT COMPLETED|Overall Study||18
1502046|NCT01657253|3674241|P1|NOT COMPLETED|Overall Study||17
1502047|NCT01657253|3674240|P2|COMPLETED|Overall Study||72
1502048|NCT01657253|3674241|P1|COMPLETED|Overall Study||76
1502049|NCT01657253|3674240|P2|STARTED|Overall Study||90
1502050|NCT01657253|3674241|P1|STARTED|Overall Study||93
1502051|NCT01657032|3674253|P2|NOT COMPLETED|Overall Study||7
1502052|NCT01657032|3674254|P1|NOT COMPLETED|Overall Study||0
1502053|NCT01657032|3674253|P2|COMPLETED|Overall Study||37
1502054|NCT01657032|3674254|P1|COMPLETED|Overall Study||44
1502055|NCT01657032|3674253|P2|STARTED|Overall Study||44
1502056|NCT01657032|3674254|P1|STARTED|Overall Study||44
1502057|NCT01657019|3674280|P1|NOT COMPLETED|Overall Study||235
1502058|NCT01657019|3674280|P1|COMPLETED|Overall Study||369
1502059|NCT01657019|3674280|P1|STARTED|Overall Study||604
1502060|NCT01656967|3674294|P2|NOT COMPLETED|Overall Study||2
1502061|NCT01656967|3674295|P1|NOT COMPLETED|Overall Study||4
1502062|NCT01656967|3674294|P2|COMPLETED|Overall Study||31
1502063|NCT01656967|3674295|P1|COMPLETED|Overall Study||29
1502064|NCT01656967|3674294|P2|ETT Insertion|Overall Study||31
1502065|NCT01656967|3674295|P1|ETT Insertion|Overall Study||29
1502066|NCT01656967|3674294|P2|SGA Placement|Overall Study||33
1502067|NCT01656967|3674295|P1|SGA Placement|Overall Study||32
1502068|NCT01656967|3674294|P2|STARTED|Overall Study||33
1502069|NCT01656967|3674295|P1|STARTED|Overall Study||33
1502070|NCT01656889|3674321|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
1502071|NCT01656889|3674322|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
1502072|NCT01656889|3674321|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
1502073|NCT01656889|3674322|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
1502074|NCT01656889|3674321|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
1502075|NCT01656889|3674322|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
1502076|NCT01656889|3674321|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
1502077|NCT01656889|3674322|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
1502078|NCT01656889|3674321|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
1502079|NCT01656889|3674322|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
1502080|NCT01656889|3674321|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
1502081|NCT01656889|3674322|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
1502082|NCT01656850|3674342|P2|NOT COMPLETED|Second Intervention (3 Months)||0
1502083|NCT01656850|3674343|P1|NOT COMPLETED|Second Intervention (3 Months)||0
1502084|NCT01656850|3674342|P2|COMPLETED|Second Intervention (3 Months)||16
1502085|NCT01656850|3674343|P1|COMPLETED|Second Intervention (3 Months)||17
1502086|NCT01656850|3674342|P2|STARTED|Second Intervention (3 Months)||16
1502087|NCT01656850|3674343|P1|STARTED|Second Intervention (3 Months)||17
1502088|NCT01656850|3674342|P2|NOT COMPLETED|Washout (2 Weeks)||0
1502089|NCT01656850|3674343|P1|NOT COMPLETED|Washout (2 Weeks)||0
1502090|NCT01656850|3674342|P2|COMPLETED|Washout (2 Weeks)||16
1502091|NCT01656850|3674343|P1|COMPLETED|Washout (2 Weeks)||17
1502092|NCT01656850|3674342|P2|STARTED|Washout (2 Weeks)||16
1502093|NCT01656850|3674343|P1|STARTED|Washout (2 Weeks)||17
1502094|NCT01656850|3674342|P2|NOT COMPLETED|First Intervention (3 Months)||4
1502095|NCT01656850|3674343|P1|NOT COMPLETED|First Intervention (3 Months)||3
1502096|NCT01656850|3674342|P2|COMPLETED|First Intervention (3 Months)||16
1502097|NCT01656850|3674343|P1|COMPLETED|First Intervention (3 Months)||17
1502098|NCT01656850|3674342|P2|STARTED|First Intervention (3 Months)||20
1502099|NCT01656850|3674343|P1|STARTED|First Intervention (3 Months)||20
1502100|NCT01656772|3674423|P2|NOT COMPLETED|Overall Study||0
1502101|NCT01656772|3674424|P1|NOT COMPLETED|Overall Study||0
1502102|NCT01656772|3674423|P2|COMPLETED|Overall Study||77
1502103|NCT01656772|3674424|P1|COMPLETED|Overall Study||43
1502104|NCT01656772|3674423|P2|STARTED|Overall Study||77
1502105|NCT01656772|3674424|P1|STARTED|Overall Study||43
1502106|NCT01656759|3674434|P2|NOT COMPLETED|Overall Study||3
1502107|NCT01656759|3674435|P1|NOT COMPLETED|Overall Study||2
1502108|NCT01656759|3674434|P2|COMPLETED|Overall Study||22
1502109|NCT01656759|3674435|P1|COMPLETED|Overall Study||25
1502110|NCT01656759|3674434|P2|STARTED|Overall Study||25
1502111|NCT01656759|3674435|P1|STARTED|Overall Study||27
1502112|NCT01656486|3674447|P1|NOT COMPLETED|Overall Study||0
1502113|NCT01656486|3674447|P1|COMPLETED|Overall Study||1
1502114|NCT01656486|3674447|P1|STARTED|Overall Study||1
1502115|NCT01656460|3674451|P4|NOT COMPLETED|Overall Study||0
1502116|NCT01656460|3674452|P3|NOT COMPLETED|Overall Study||0
1502117|NCT01656460|3674453|P2|NOT COMPLETED|Overall Study||0
1502118|NCT01656460|3674454|P1|NOT COMPLETED|Overall Study||0
1502119|NCT01656460|3674451|P4|COMPLETED|Overall Study||3
1502120|NCT01656460|3674452|P3|COMPLETED|Overall Study||3
1502121|NCT01656460|3674453|P2|COMPLETED|Overall Study||3
1502122|NCT01656460|3674454|P1|COMPLETED|Overall Study||3
1502123|NCT01656460|3674451|P4|STARTED|Overall Study||3
1502124|NCT01656460|3674452|P3|STARTED|Overall Study||3
1502125|NCT01656460|3674453|P2|STARTED|Overall Study||3
1502126|NCT01656460|3674454|P1|STARTED|Overall Study||3
1502127|NCT01656434|3674466|P2|NOT COMPLETED|Overall Study||580
1502128|NCT01656434|3674467|P1|NOT COMPLETED|Overall Study||2401
1502129|NCT01656434|3674466|P2|COMPLETED|Overall Study||40
1502130|NCT01656434|3674467|P1|COMPLETED|Overall Study||152
1502131|NCT01656434|3674466|P2|Treated|Overall Study||604
1502132|NCT01656434|3674467|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
1502133|NCT01656434|3674466|P2|STARTED|Overall Study||620
1502134|NCT01656434|3674467|P1|STARTED|Overall Study||2553
1502135|NCT01656408|3674493|P10|NOT COMPLETED|Overall Study||3
1502136|NCT01656408|3674494|P9|NOT COMPLETED|Overall Study||2
1502137|NCT01656408|3674495|P8|NOT COMPLETED|Overall Study||1
1502138|NCT01656408|3674496|P7|NOT COMPLETED|Overall Study||1
1502139|NCT01656408|3674497|P6|NOT COMPLETED|Overall Study||2
1502140|NCT01656408|3674498|P5|NOT COMPLETED|Overall Study||1
1502141|NCT01656408|3674499|P4|NOT COMPLETED|Overall Study||0
1502142|NCT01656408|3674500|P3|NOT COMPLETED|Overall Study||2
1502143|NCT01656408|3674501|P2|NOT COMPLETED|Overall Study||0
1502144|NCT01656408|3674502|P1|NOT COMPLETED|Overall Study||1
1502145|NCT01656408|3674493|P10|COMPLETED|Overall Study||15
1502146|NCT01656408|3674494|P9|COMPLETED|Overall Study||16
1502147|NCT01656408|3674495|P8|COMPLETED|Overall Study||7
1502148|NCT01656408|3674496|P7|COMPLETED|Overall Study||9
1502149|NCT01656408|3674497|P6|COMPLETED|Overall Study||7
1502150|NCT01656408|3674498|P5|COMPLETED|Overall Study||8
1502151|NCT01656408|3674499|P4|COMPLETED|Overall Study||7
1502152|NCT01656408|3674500|P3|COMPLETED|Overall Study||6
1502153|NCT01656408|3674501|P2|COMPLETED|Overall Study||8
1502154|NCT01656408|3674502|P1|COMPLETED|Overall Study||7
1502155|NCT01656408|3674493|P10|STARTED|Overall Study||18
1502156|NCT01656408|3674494|P9|STARTED|Overall Study||18
1502157|NCT01656408|3674495|P8|STARTED|Overall Study||8
1502158|NCT01656408|3674496|P7|STARTED|Overall Study||10
1502159|NCT01656408|3674497|P6|STARTED|Overall Study||9
1502160|NCT01656408|3674498|P5|STARTED|Overall Study||9
1502161|NCT01656408|3674499|P4|STARTED|Overall Study||7
1502162|NCT01656408|3674500|P3|STARTED|Overall Study||8
1502163|NCT01656408|3674501|P2|STARTED|Overall Study||8
1502164|NCT01656408|3674502|P1|STARTED|Overall Study||8
1502165|NCT01656395|3674697|P8|NOT COMPLETED|Overall Study||0
1502166|NCT01656395|3674698|P7|NOT COMPLETED|Overall Study||0
1502167|NCT01656395|3674699|P6|NOT COMPLETED|Overall Study||40
1502168|NCT01656395|3674700|P5|NOT COMPLETED|Overall Study||14
1502169|NCT01656395|3674701|P4|NOT COMPLETED|Overall Study||12
1502170|NCT01656395|3674702|P3|NOT COMPLETED|Overall Study||36
1502171|NCT01656395|3674703|P2|NOT COMPLETED|Overall Study||34
1502172|NCT01656395|3674704|P1|NOT COMPLETED|Overall Study||17
1502173|NCT01656395|3674697|P8|COMPLETED|Overall Study||0
1502174|NCT01656395|3674698|P7|COMPLETED|Overall Study||0
1502175|NCT01656395|3674699|P6|COMPLETED|Overall Study||94
1502176|NCT01656395|3674700|P5|COMPLETED|Overall Study||46
1502177|NCT01656395|3674701|P4|COMPLETED|Overall Study||41
1502178|NCT01656395|3674702|P3|COMPLETED|Overall Study||106
1502179|NCT01656395|3674703|P2|COMPLETED|Overall Study||93
1502180|NCT01656395|3674704|P1|COMPLETED|Overall Study||43
1502181|NCT01656395|3674697|P8|Treated Participants|Overall Study||0
1502182|NCT01656395|3674698|P7|Treated Participants|Overall Study||0
1502183|NCT01656395|3674699|P6|Treated Participants|Overall Study||126
1502184|NCT01656395|3674700|P5|Treated Participants|Overall Study||60
1502185|NCT01656395|3674701|P4|Treated Participants|Overall Study||52
1502186|NCT01656395|3674702|P3|Treated Participants|Overall Study||135
1502187|NCT01656395|3674703|P2|Treated Participants|Overall Study||126
1502188|NCT01656395|3674704|P1|Treated Participants|Overall Study||58
1502189|NCT01656395|3674697|P8|STARTED|Overall Study||0
1502190|NCT01656395|3674698|P7|STARTED|Overall Study||0
1502191|NCT01656395|3674699|P6|STARTED|Overall Study||134
1502192|NCT01656395|3674700|P5|STARTED|Overall Study||60
1502193|NCT01656395|3674701|P4|STARTED|Overall Study||53
1502194|NCT01656395|3674702|P3|STARTED|Overall Study||142
1502195|NCT01656395|3674703|P2|STARTED|Overall Study||127
1502196|NCT01656395|3674704|P1|STARTED|Overall Study||60
1502197|NCT01656304|3674790|P1|NOT COMPLETED|Overall Study||1
1502198|NCT01656304|3674790|P1|COMPLETED|Overall Study||15
1502199|NCT01656304|3674790|P1|STARTED|Overall Study||16
1502200|NCT01656252|3674799|P1|NOT COMPLETED|Phase II||0
1502201|NCT01656252|3674799|P1|COMPLETED|Phase II||0
1502202|NCT01656252|3674799|P1|STARTED|Phase II||0
1502203|NCT01656252|3674799|P1|NOT COMPLETED|Phase I||0
1502204|NCT01656252|3674799|P1|COMPLETED|Phase I||14
1502205|NCT01656252|3674799|P1|STARTED|Phase I||14
1502206|NCT01656161|3674831|P1|NOT COMPLETED|Overall Study||7
1502207|NCT01656161|3674831|P1|COMPLETED|Overall Study|Per protocol analysis set|113
1502208|NCT01656161|3674831|P1|Received Triptorelin at Day 169|Overall Study||115
1502209|NCT01656161|3674831|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
1502210|NCT01656161|3674831|P1|STARTED|Overall Study|Intention to treat analysis set|120
1502211|NCT01656031|3674845|P1|NOT COMPLETED|Overall Study||0
1502212|NCT01656031|3674845|P1|COMPLETED|Overall Study||39
1502213|NCT01656031|3674845|P1|STARTED|Overall Study||39
1502214|NCT01655823|3674854|P5|NOT COMPLETED|Overall Study||1
1502215|NCT01655823|3674855|P4|NOT COMPLETED|Overall Study||1
1502216|NCT01655823|3674856|P3|NOT COMPLETED|Overall Study||0
1502217|NCT01655823|3674857|P2|NOT COMPLETED|Overall Study||2
1502218|NCT01655823|3674858|P1|NOT COMPLETED|Overall Study||0
1502219|NCT01655823|3674854|P5|COMPLETED|Overall Study||25
1502220|NCT01655823|3674855|P4|COMPLETED|Overall Study||24
1502221|NCT01655823|3674856|P3|COMPLETED|Overall Study||24
1502222|NCT01655823|3674857|P2|COMPLETED|Overall Study||23
1502223|NCT01655823|3674858|P1|COMPLETED|Overall Study||25
1502224|NCT01655823|3674854|P5|STARTED|Overall Study||26
1502225|NCT01655823|3674855|P4|STARTED|Overall Study||25
1502226|NCT01655823|3674856|P3|STARTED|Overall Study||24
1502227|NCT01655823|3674857|P2|STARTED|Overall Study||25
1502228|NCT01655823|3674858|P1|STARTED|Overall Study||25
1502229|NCT01655719|3674870|P1|NOT COMPLETED|Overall Study||0
1502230|NCT01655719|3674870|P1|COMPLETED|Overall Study||1
1502231|NCT01655719|3674870|P1|STARTED|Overall Study||1
1502232|NCT01655498|3674876|P1|NOT COMPLETED|Overall Study||5
1502233|NCT01655498|3674876|P1|COMPLETED|Overall Study||56
1502234|NCT01655498|3674876|P1|STARTED|Overall Study||61
1502235|NCT01655381|3674883|P1|NOT COMPLETED|Overall Study||3
1502236|NCT01655381|3674883|P1|COMPLETED|Overall Study||12
1502237|NCT01655381|3674883|P1|STARTED|Overall Study||15
1502238|NCT01655329|3674903|P1|NOT COMPLETED|Overall Study||0
1502239|NCT01655329|3674903|P1|COMPLETED|Overall Study||10
1502240|NCT01655329|3674903|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
1502241|NCT01655069|3674923|P4|NOT COMPLETED|Overall Study||4
1502242|NCT01655069|3674924|P3|NOT COMPLETED|Overall Study||2
1502243|NCT01655069|3674925|P2|NOT COMPLETED|Overall Study||12
1502244|NCT01655069|3674926|P1|NOT COMPLETED|Overall Study||8
1502245|NCT01655069|3674923|P4|COMPLETED|Overall Study||11
1502246|NCT01655069|3674924|P3|COMPLETED|Overall Study||12
1502247|NCT01655069|3674925|P2|COMPLETED|Overall Study||46
1502248|NCT01655069|3674926|P1|COMPLETED|Overall Study||53
1502249|NCT01655069|3674923|P4|Full Analysis Set (FAS)|Overall Study||15
1502250|NCT01655069|3674924|P3|Full Analysis Set (FAS)|Overall Study||14
1502251|NCT01655069|3674925|P2|Full Analysis Set (FAS)|Overall Study||57
1502252|NCT01655069|3674926|P1|Full Analysis Set (FAS)|Overall Study||60
1502253|NCT01655069|3674923|P4|Safety Analysis Set (SAF)|Overall Study||15
1502254|NCT01655069|3674924|P3|Safety Analysis Set (SAF)|Overall Study||14
1502255|NCT01655069|3674925|P2|Safety Analysis Set (SAF)|Overall Study||57
1502256|NCT01655069|3674926|P1|Safety Analysis Set (SAF)|Overall Study||61
1502257|NCT01655069|3674923|P4|STARTED|Overall Study||15
1502258|NCT01655069|3674924|P3|STARTED|Overall Study||14
1502259|NCT01655069|3674925|P2|STARTED|Overall Study||58
1502260|NCT01655069|3674926|P1|STARTED|Overall Study||61
1502261|NCT01655043|3674941|P1|NOT COMPLETED|Overall Study||0
1502262|NCT01655043|3674941|P1|COMPLETED|Overall Study||20
1502263|NCT01655043|3674941|P1|STARTED|Overall Study||20
1502264|NCT01654887|3674947|P2|NOT COMPLETED|Overall Study||0
1502265|NCT01654887|3674948|P1|NOT COMPLETED|Overall Study||0
1502266|NCT01654887|3674947|P2|COMPLETED|Overall Study||88
1502267|NCT01654887|3674948|P1|COMPLETED|Overall Study||103
1502268|NCT01654887|3674947|P2|STARTED|Overall Study||88
1502269|NCT01654887|3674948|P1|STARTED|Overall Study||103
1502270|NCT01654861|3674964|P1|NOT COMPLETED|Overall Study||0
1502271|NCT01654861|3674964|P1|COMPLETED|Overall Study||3
1502272|NCT01654861|3674964|P1|STARTED|Overall Study||3
1502273|NCT01654796|3674972|P3|NOT COMPLETED|Overall Study||1
1502274|NCT01654796|3674973|P2|NOT COMPLETED|Overall Study||3
1502275|NCT01654796|3674974|P1|NOT COMPLETED|Overall Study||1
1502276|NCT01654796|3674972|P3|COMPLETED|Overall Study||28
1502277|NCT01654796|3674973|P2|COMPLETED|Overall Study||26
1502278|NCT01654796|3674974|P1|COMPLETED|Overall Study||25
1502279|NCT01654796|3674972|P3|STARTED|Overall Study||29
1502280|NCT01654796|3674973|P2|STARTED|Overall Study||29
1502281|NCT01654796|3674974|P1|STARTED|Overall Study||26
1502282|NCT01654666|3674986|P3|NOT COMPLETED|Overall Study||14
1502283|NCT01654666|3674987|P2|NOT COMPLETED|Overall Study||13
1502284|NCT01654666|3674988|P1|NOT COMPLETED|Overall Study||15
1502285|NCT01654666|3674986|P3|COMPLETED|Overall Study||49
1502286|NCT01654666|3674987|P2|COMPLETED|Overall Study||50
1502287|NCT01654666|3674988|P1|COMPLETED|Overall Study||48
1502288|NCT01654666|3674986|P3|Primary Analysis|Overall Study||54
1502289|NCT01654666|3674987|P2|Primary Analysis|Overall Study||56
1502290|NCT01654666|3674988|P1|Primary Analysis|Overall Study||52
1502291|NCT01654666|3674986|P3|STARTED|Overall Study||63
1502292|NCT01654666|3674987|P2|STARTED|Overall Study||63
1502293|NCT01654666|3674988|P1|STARTED|Overall Study||63
1502294|NCT01654601|3675013|P2|NOT COMPLETED|2nd Administration||1
1502295|NCT01654601|3675014|P1|NOT COMPLETED|2nd Administration||1
1502296|NCT01654601|3675013|P2|COMPLETED|2nd Administration||11
1502297|NCT01654601|3675014|P1|COMPLETED|2nd Administration||11
1502298|NCT01654601|3675013|P2|STARTED|2nd Administration||12
1502299|NCT01654601|3675014|P1|STARTED|2nd Administration||12
1502300|NCT01654601|3675013|P2|NOT COMPLETED|1st Administration||2
1502301|NCT01654601|3675014|P1|NOT COMPLETED|1st Administration||2
1502302|NCT01654601|3675013|P2|COMPLETED|1st Administration||12
1502303|NCT01654601|3675014|P1|COMPLETED|1st Administration||12
1502304|NCT01654601|3675013|P2|STARTED|1st Administration||14
1502305|NCT01654601|3675014|P1|STARTED|1st Administration||14
1502306|NCT01654549|3675028|P2|NOT COMPLETED|Overall Study||1
1502307|NCT01654549|3675029|P1|NOT COMPLETED|Overall Study||0
1502308|NCT01654549|3675028|P2|COMPLETED|Overall Study||19
1502309|NCT01654549|3675029|P1|COMPLETED|Overall Study||20
1502310|NCT01654549|3675028|P2|STARTED|Overall Study||20
1502311|NCT01654549|3675029|P1|STARTED|Overall Study||20
1502312|NCT01654536|3675041|P2|NOT COMPLETED|Overall Study||38
1502313|NCT01654536|3675042|P1|NOT COMPLETED|Overall Study||44
1502314|NCT01654536|3675041|P2|COMPLETED|Overall Study||331
1502315|NCT01654536|3675042|P1|COMPLETED|Overall Study||324
1502316|NCT01654536|3675041|P2|STARTED|Overall Study||369
1502317|NCT01654536|3675042|P1|STARTED|Overall Study||368
1502318|NCT01654523|3675078|P1|NOT COMPLETED|Overall Study||1
1502319|NCT01654523|3675078|P1|COMPLETED|Overall Study||19
1502320|NCT01654523|3675078|P1|STARTED|Overall Study||20
1502321|NCT01654302|3675084|P2|NOT COMPLETED|Second Intervention (Day 7)||1
1502322|NCT01654302|3675085|P1|NOT COMPLETED|Second Intervention (Day 7)||1
1502323|NCT01654302|3675084|P2|COMPLETED|Second Intervention (Day 7)||19
1502324|NCT01654302|3675085|P1|COMPLETED|Second Intervention (Day 7)||19
1502325|NCT01654302|3675084|P2|STARTED|Second Intervention (Day 7)||20
1502326|NCT01654302|3675085|P1|STARTED|Second Intervention (Day 7)||20
1502327|NCT01654302|3675084|P2|NOT COMPLETED|First Intervention (Day 1)||0
1502328|NCT01654302|3675085|P1|NOT COMPLETED|First Intervention (Day 1)||0
1502329|NCT01654302|3675084|P2|COMPLETED|First Intervention (Day 1)||20
1502330|NCT01654302|3675085|P1|COMPLETED|First Intervention (Day 1)||20
1502331|NCT01654302|3675084|P2|STARTED|First Intervention (Day 1)||20
1502332|NCT01654302|3675085|P1|STARTED|First Intervention (Day 1)||20
1502333|NCT01654289|3675094|P3|NOT COMPLETED|Overall Study||5
1502334|NCT01654289|3675095|P2|NOT COMPLETED|Overall Study||28
1502335|NCT01654289|3675096|P1|NOT COMPLETED|Overall Study||27
1502336|NCT01654289|3675094|P3|COMPLETED|Overall Study||133
1502337|NCT01654289|3675095|P2|COMPLETED|Overall Study||109
1502338|NCT01654289|3675096|P1|COMPLETED|Overall Study||111
1502339|NCT01654289|3675094|P3|STARTED|Overall Study||138
1502340|NCT01654289|3675095|P2|STARTED|Overall Study||137
1502341|NCT01654289|3675096|P1|STARTED|Overall Study||138
1502342|NCT01654276|3675134|P1|NOT COMPLETED|Overall Study||6
1502343|NCT01654276|3675134|P1|COMPLETED|Overall Study||18
1502344|NCT01654276|3675134|P1|Visit 4 (6months)|Overall Study||18
1502345|NCT01654276|3675134|P1|Visit 3 (4 Months)|Overall Study||18
1502346|NCT01654276|3675134|P1|Visit 2 (2 Months)|Overall Study||19
1502347|NCT01654276|3675134|P1|STARTED|Overall Study||24
1502348|NCT01654263|3675158|P6|NOT COMPLETED|Overall Study||1
1502349|NCT01654263|3675159|P5|NOT COMPLETED|Overall Study||1
1502350|NCT01654263|3675160|P4|NOT COMPLETED|Overall Study||1
1502351|NCT01654263|3675161|P3|NOT COMPLETED|Overall Study||2
1502352|NCT01654263|3675162|P2|NOT COMPLETED|Overall Study||0
1502353|NCT01654263|3675163|P1|NOT COMPLETED|Overall Study||0
1502354|NCT01654263|3675158|P6|COMPLETED|Overall Study||148
1502355|NCT01654263|3675159|P5|COMPLETED|Overall Study||139
1502356|NCT01654263|3675160|P4|COMPLETED|Overall Study||144
1502357|NCT01654263|3675161|P3|COMPLETED|Overall Study||137
1502358|NCT01654263|3675162|P2|COMPLETED|Overall Study||147
1502359|NCT01654263|3675163|P1|COMPLETED|Overall Study||164
1502360|NCT01654263|3675158|P6|STARTED|Overall Study||149
1502361|NCT01654263|3675159|P5|STARTED|Overall Study||140
1502362|NCT01654263|3675160|P4|STARTED|Overall Study||145
1502363|NCT01654263|3675161|P3|STARTED|Overall Study||139
1502364|NCT01654263|3675162|P2|STARTED|Overall Study||147
1502365|NCT01654263|3675163|P1|STARTED|Overall Study||164
1502366|NCT01654250|3675188|P2|NOT COMPLETED|Overall Study||0
1502367|NCT01654250|3675189|P1|NOT COMPLETED|Overall Study||1
1502368|NCT01654250|3675188|P2|COMPLETED|Overall Study||42
1502369|NCT01654250|3675189|P1|COMPLETED|Overall Study||43
1502370|NCT01654250|3675188|P2|STARTED|Overall Study||42
1502371|NCT01654250|3675189|P1|STARTED|Overall Study||44
1502372|NCT01654224|3675206|P2|NOT COMPLETED|Overall Study||12
1502373|NCT01654224|3675207|P1|NOT COMPLETED|Overall Study||6
1502374|NCT01654224|3675206|P2|COMPLETED|Overall Study||98
1502375|NCT01654224|3675207|P1|COMPLETED|Overall Study||89
1502376|NCT01654224|3675206|P2|STARTED|Overall Study||110
1502377|NCT01654224|3675207|P1|STARTED|Overall Study||95
1502378|NCT01654107|3675219|P2|NOT COMPLETED|Overall Study||8
1502379|NCT01654107|3675220|P1|NOT COMPLETED|Overall Study||3
1502380|NCT01654107|3675219|P2|COMPLETED|Overall Study||22
1502381|NCT01654107|3675220|P1|COMPLETED|Overall Study||25
1502382|NCT01654107|3675219|P2|STARTED|Overall Study||30
1502383|NCT01654107|3675220|P1|STARTED|Overall Study||28
1502384|NCT01653964|3675226|P1|NOT COMPLETED|Overall Study||0
1502385|NCT01653964|3675226|P1|COMPLETED|Overall Study||82
1502386|NCT01653964|3675226|P1|STARTED|Overall Study||82
1502387|NCT01653912|3675232|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
1502388|NCT01653912|3675233|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1502389|NCT01653912|3675234|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1502390|NCT01653912|3675235|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1502391|NCT01653912|3675236|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1502392|NCT01653912|3675237|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
1502393|NCT01653912|3675232|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
1502394|NCT01653912|3675233|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
1502395|NCT01653912|3675234|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
1502396|NCT01653912|3675235|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
1502397|NCT01653912|3675236|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
1502398|NCT01653912|3675237|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
1502399|NCT01653912|3675232|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
1502400|NCT01653912|3675233|P5|STARTED|Phase 2: GSK2110183 125 mg||0
1502401|NCT01653912|3675234|P4|STARTED|Phase 2: GSK2110183 125 mg||0
1502402|NCT01653912|3675235|P3|STARTED|Phase 2: GSK2110183 125 mg||0
1502403|NCT01653912|3675236|P2|STARTED|Phase 2: GSK2110183 125 mg||0
1502404|NCT01653912|3675237|P1|STARTED|Phase 2: GSK2110183 125 mg||0
1502405|NCT01653912|3675232|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502406|NCT01653912|3675233|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502407|NCT01653912|3675234|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502408|NCT01653912|3675235|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502409|NCT01653912|3675236|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502410|NCT01653912|3675237|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502411|NCT01653912|3675232|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502412|NCT01653912|3675233|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
1502413|NCT01653912|3675234|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502414|NCT01653912|3675235|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502415|NCT01653912|3675236|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502416|NCT01653912|3675237|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502417|NCT01653912|3675232|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502418|NCT01653912|3675233|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
1502419|NCT01653912|3675234|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502420|NCT01653912|3675235|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502421|NCT01653912|3675236|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502422|NCT01653912|3675237|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
1502423|NCT01653912|3675232|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502424|NCT01653912|3675233|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502425|NCT01653912|3675234|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
1502426|NCT01653912|3675235|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502427|NCT01653912|3675236|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502428|NCT01653912|3675237|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502429|NCT01653912|3675232|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502430|NCT01653912|3675233|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502431|NCT01653912|3675234|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
1502432|NCT01653912|3675235|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502433|NCT01653912|3675236|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502434|NCT01653912|3675237|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502435|NCT01653912|3675232|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502436|NCT01653912|3675233|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502437|NCT01653912|3675234|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
1502438|NCT01653912|3675235|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502439|NCT01653912|3675236|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502440|NCT01653912|3675237|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
1502441|NCT01653912|3675232|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502442|NCT01653912|3675233|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502443|NCT01653912|3675234|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502444|NCT01653912|3675235|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
1502445|NCT01653912|3675236|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502446|NCT01653912|3675237|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502447|NCT01653912|3675232|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502448|NCT01653912|3675233|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502449|NCT01653912|3675234|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502450|NCT01653912|3675235|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
1502451|NCT01653912|3675236|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502452|NCT01653912|3675237|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502453|NCT01653912|3675232|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502454|NCT01653912|3675233|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502455|NCT01653912|3675234|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502456|NCT01653912|3675235|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
1502457|NCT01653912|3675236|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502458|NCT01653912|3675237|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
1502459|NCT01653912|3675232|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502460|NCT01653912|3675233|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502461|NCT01653912|3675234|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502462|NCT01653912|3675235|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502463|NCT01653912|3675236|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
1502464|NCT01653912|3675237|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502465|NCT01653912|3675232|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502466|NCT01653912|3675233|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502467|NCT01653912|3675234|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502468|NCT01653912|3675235|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502469|NCT01653912|3675236|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
1502470|NCT01653912|3675237|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502471|NCT01653912|3675232|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502472|NCT01653912|3675233|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502473|NCT01653912|3675234|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502474|NCT01653912|3675235|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502475|NCT01653912|3675236|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
1502476|NCT01653912|3675237|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
1502477|NCT01653912|3675232|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502478|NCT01653912|3675233|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502479|NCT01653912|3675234|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502480|NCT01653912|3675235|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502481|NCT01653912|3675236|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502482|NCT01653912|3675237|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502483|NCT01653912|3675232|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502484|NCT01653912|3675233|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502485|NCT01653912|3675234|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502486|NCT01653912|3675235|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502487|NCT01653912|3675236|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502488|NCT01653912|3675237|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
1502489|NCT01653912|3675232|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502490|NCT01653912|3675233|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502491|NCT01653912|3675234|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502492|NCT01653912|3675235|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502493|NCT01653912|3675236|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
1502494|NCT01653912|3675237|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
1502495|NCT01653782|3675255|P3|NOT COMPLETED|Overall Study||6
1502496|NCT01653782|3675256|P2|NOT COMPLETED|Overall Study||18
1502497|NCT01653782|3675257|P1|NOT COMPLETED|Overall Study||16
1502498|NCT01653782|3675255|P3|COMPLETED|Overall Study||46
1502499|NCT01653782|3675256|P2|COMPLETED|Overall Study||37
1502500|NCT01653782|3675257|P1|COMPLETED|Overall Study||36
1502501|NCT01653782|3675255|P3|STARTED|Overall Study||52
1502502|NCT01653782|3675256|P2|STARTED|Overall Study||55
1502503|NCT01653782|3675257|P1|STARTED|Overall Study||52
1502504|NCT01653743|3675267|P2|NOT COMPLETED|Overall Study||0
1502505|NCT01653743|3675268|P1|NOT COMPLETED|Overall Study||4
1502506|NCT01653743|3675267|P2|COMPLETED|Overall Study||27
1502507|NCT01653743|3675268|P1|COMPLETED|Overall Study||50
1502508|NCT01653743|3675267|P2|STARTED|Overall Study||27
1502509|NCT01653743|3675268|P1|STARTED|Overall Study||54
1502510|NCT01653587|3675284|P2|NOT COMPLETED|Overall Study||0
1502511|NCT01653587|3675285|P1|NOT COMPLETED|Overall Study||0
1502512|NCT01653587|3675284|P2|COMPLETED|Overall Study||120
1502513|NCT01653587|3675285|P1|COMPLETED|Overall Study||120
1502514|NCT01653587|3675284|P2|STARTED|Overall Study||120
1502515|NCT01653587|3675285|P1|STARTED|Overall Study||120
1502516|NCT01653509|3675297|P2|NOT COMPLETED|Overall Study||0
1502517|NCT01653509|3675298|P1|NOT COMPLETED|Overall Study||0
1502518|NCT01653509|3675297|P2|COMPLETED|Overall Study||13
1502519|NCT01653509|3675298|P1|COMPLETED|Overall Study||12
1502520|NCT01653509|3675297|P2|STARTED|Overall Study||13
1502521|NCT01653509|3675298|P1|STARTED|Overall Study||12
1502522|NCT01653418|3675316|P1|NOT COMPLETED|Overall Study||0
1502523|NCT01653418|3675316|P1|COMPLETED|Overall Study||10
1502524|NCT01653418|3675316|P1|STARTED|Overall Study||10
1502525|NCT01653327|3675328|P1|NOT COMPLETED|Overall Study||1
1502526|NCT01653327|3675328|P1|COMPLETED|Overall Study||10
1502527|NCT01653327|3675328|P1|STARTED|Overall Study||11
1502528|NCT01653262|3675336|P1|NOT COMPLETED|Overall Study||3
1502529|NCT01653262|3675336|P1|COMPLETED|Overall Study||26
1502530|NCT01653262|3675336|P1|STARTED|Overall Study||29
1502531|NCT01653158|3675349|P8|NOT COMPLETED|Overall Study||15
1502532|NCT01653158|3675350|P7|NOT COMPLETED|Overall Study||2
1502533|NCT01653158|3675351|P6|NOT COMPLETED|Overall Study||1
1502534|NCT01653158|3675352|P5|NOT COMPLETED|Overall Study||1
1502535|NCT01653158|3675353|P4|NOT COMPLETED|Overall Study||2
1502536|NCT01653158|3675354|P3|NOT COMPLETED|Overall Study||0
1502537|NCT01653158|3675355|P2|NOT COMPLETED|Overall Study||0
1502538|NCT01653158|3675356|P1|NOT COMPLETED|Overall Study||1
1502539|NCT01653158|3675349|P8|COMPLETED|Overall Study||4
1502540|NCT01653158|3675350|P7|COMPLETED|Overall Study||7
1502541|NCT01653158|3675351|P6|COMPLETED|Overall Study||2
1502542|NCT01653158|3675352|P5|COMPLETED|Overall Study||2
1502543|NCT01653158|3675353|P4|COMPLETED|Overall Study||1
1502544|NCT01653158|3675354|P3|COMPLETED|Overall Study||3
1502545|NCT01653158|3675355|P2|COMPLETED|Overall Study||3
1502546|NCT01653158|3675356|P1|COMPLETED|Overall Study||2
1502547|NCT01653158|3675349|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
1502548|NCT01653158|3675350|P7|STARTED|Overall Study||9
1502549|NCT01653158|3675351|P6|STARTED|Overall Study||3
1502550|NCT01653158|3675352|P5|STARTED|Overall Study||3
1502551|NCT01653158|3675353|P4|STARTED|Overall Study||3
1502552|NCT01653158|3675354|P3|STARTED|Overall Study||3
1502553|NCT01653158|3675355|P2|STARTED|Overall Study||3
1502554|NCT01653158|3675356|P1|STARTED|Overall Study||3
1502555|NCT01653132|3675628|P2|NOT COMPLETED|Second Intervention||0
1502556|NCT01653132|3675629|P1|NOT COMPLETED|Second Intervention||0
1502557|NCT01653132|3675628|P2|COMPLETED|Second Intervention||5
1502558|NCT01653132|3675629|P1|COMPLETED|Second Intervention||4
1502559|NCT01653132|3675628|P2|STARTED|Second Intervention||5
1502560|NCT01653132|3675629|P1|STARTED|Second Intervention||4
1502561|NCT01653132|3675628|P2|NOT COMPLETED|Washout 1-2 Months||0
1502562|NCT01653132|3675629|P1|NOT COMPLETED|Washout 1-2 Months||0
1502563|NCT01653132|3675628|P2|COMPLETED|Washout 1-2 Months||5
1502564|NCT01653132|3675629|P1|COMPLETED|Washout 1-2 Months||4
1502565|NCT01653132|3675628|P2|STARTED|Washout 1-2 Months||5
1502566|NCT01653132|3675629|P1|STARTED|Washout 1-2 Months||4
1502567|NCT01653132|3675628|P2|NOT COMPLETED|First Intervention||0
1502568|NCT01653132|3675629|P1|NOT COMPLETED|First Intervention||1
1502569|NCT01653132|3675628|P2|COMPLETED|First Intervention||5
1502570|NCT01653132|3675629|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
1502571|NCT01653132|3675628|P2|STARTED|First Intervention||5
1502572|NCT01653132|3675629|P1|STARTED|First Intervention||5
1502573|NCT01653028|3675648|P5|NOT COMPLETED|Overall Study||0
1502574|NCT01653028|3675649|P4|NOT COMPLETED|Overall Study||0
1502575|NCT01653028|3675650|P3|NOT COMPLETED|Overall Study||0
1502576|NCT01653028|3675651|P2|NOT COMPLETED|Overall Study||0
1502577|NCT01653028|3675652|P1|NOT COMPLETED|Overall Study||0
1502578|NCT01653028|3675648|P5|COMPLETED|Overall Study||29
1502579|NCT01653028|3675649|P4|COMPLETED|Overall Study||10
1502580|NCT01653028|3675650|P3|COMPLETED|Overall Study||11
1502581|NCT01653028|3675651|P2|COMPLETED|Overall Study||10
1502582|NCT01653028|3675652|P1|COMPLETED|Overall Study||12
1502583|NCT01653028|3675648|P5|STARTED|Overall Study||29
1502584|NCT01653028|3675649|P4|STARTED|Overall Study||10
1502585|NCT01653028|3675650|P3|STARTED|Overall Study||11
1502586|NCT01653028|3675651|P2|STARTED|Overall Study||10
1502587|NCT01653028|3675652|P1|STARTED|Overall Study||12
1502588|NCT01652885|3675679|P1|NOT COMPLETED|Overall Study||1
1502589|NCT01652885|3675679|P1|COMPLETED|Overall Study||22
1502590|NCT01652885|3675679|P1|STARTED|Overall Study||23
1502591|NCT01652872|3675706|P2|NOT COMPLETED|Overall Study||153
1502592|NCT01652872|3675707|P1|NOT COMPLETED|Overall Study||145
1502593|NCT01652872|3675706|P2|COMPLETED|Overall Study||226
1502594|NCT01652872|3675707|P1|COMPLETED|Overall Study||232
1502595|NCT01652872|3675706|P2|Received Investigational Product|Overall Study||377
1502596|NCT01652872|3675707|P1|Received Investigational Product|Overall Study||377
1502597|NCT01652872|3675706|P2|STARTED|Overall Study||379
1502598|NCT01652872|3675707|P1|STARTED|Overall Study||377
1502599|NCT01652729|3675724|P3|NOT COMPLETED|Overall Study||14
1502600|NCT01652729|3675725|P2|NOT COMPLETED|Overall Study||13
1502601|NCT01652729|3675726|P1|NOT COMPLETED|Overall Study||27
1502602|NCT01652729|3675724|P3|COMPLETED|Overall Study||47
1502603|NCT01652729|3675725|P2|COMPLETED|Overall Study||109
1502604|NCT01652729|3675726|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
1502605|NCT01652729|3675724|P3|Meal Test Evaluable|Overall Study||15
1502606|NCT01652729|3675725|P2|Meal Test Evaluable|Overall Study||31
1502607|NCT01652729|3675726|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
1502608|NCT01652729|3675724|P3|Meal Test Subjects|Overall Study||20
1502609|NCT01652729|3675725|P2|Meal Test Subjects|Overall Study||41
1502610|NCT01652729|3675726|P1|Meal Test Subjects|Overall Study||60
1502611|NCT01652729|3675724|P3|Evaluable|Overall Study||43
1502612|NCT01652729|3675725|P2|Evaluable|Overall Study||91
1502613|NCT01652729|3675726|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
1502614|NCT01652729|3675724|P3|Treated|Overall Study||61
1502615|NCT01652729|3675725|P2|Treated|Overall Study||122
1502616|NCT01652729|3675726|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
1502617|NCT01652729|3675724|P3|Modified Intent-to-Treat|Overall Study||61
1502618|NCT01652729|3675725|P2|Modified Intent-to-Treat|Overall Study||122
1502619|NCT01652729|3675726|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
1502620|NCT01652729|3675724|P3|STARTED|Overall Study||61
1502621|NCT01652729|3675725|P2|STARTED|Overall Study||122
1502622|NCT01652729|3675726|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
1502623|NCT01652716|3675748|P2|NOT COMPLETED|Overall Study||46
1502624|NCT01652716|3675749|P1|NOT COMPLETED|Overall Study||56
1502625|NCT01652716|3675748|P2|COMPLETED|Overall Study|* completed study|102
1502626|NCT01652716|3675749|P1|COMPLETED|Overall Study|* completed study|173
1502627|NCT01652716|3675748|P2|Completed 28-week|Overall Study||118
1502628|NCT01652716|3675749|P1|Completed 28-week|Overall Study||197
1502629|NCT01652716|3675748|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
1502630|NCT01652716|3675749|P1|STARTED|Overall Study||229
1502631|NCT01652703|3675769|P6|NOT COMPLETED|Overall Study||2
1502632|NCT01652703|3675770|P5|NOT COMPLETED|Overall Study||1
1502633|NCT01652703|3675771|P4|NOT COMPLETED|Overall Study||2
1502634|NCT01652703|3675772|P3|NOT COMPLETED|Overall Study||3
1502635|NCT01652703|3675773|P2|NOT COMPLETED|Overall Study||1
1502636|NCT01652703|3675774|P1|NOT COMPLETED|Overall Study||0
1502637|NCT01652703|3675769|P6|COMPLETED|Overall Study||51
1502638|NCT01652703|3675770|P5|COMPLETED|Overall Study||51
1502639|NCT01652703|3675771|P4|COMPLETED|Overall Study||50
1502640|NCT01652703|3675772|P3|COMPLETED|Overall Study||47
1502641|NCT01652703|3675773|P2|COMPLETED|Overall Study||50
1502642|NCT01652703|3675774|P1|COMPLETED|Overall Study||52
1502643|NCT01652703|3675769|P6|Received Treatment|Overall Study||53
1502644|NCT01652703|3675770|P5|Received Treatment|Overall Study||51
1502645|NCT01652703|3675771|P4|Received Treatment|Overall Study||52
1502646|NCT01652703|3675772|P3|Received Treatment|Overall Study||49
1502647|NCT01652703|3675773|P2|Received Treatment|Overall Study||50
1502648|NCT01652703|3675774|P1|Received Treatment|Overall Study||52
1502649|NCT01652703|3675769|P6|STARTED|Overall Study||53
1502650|NCT01652703|3675770|P5|STARTED|Overall Study||52
1502651|NCT01652703|3675771|P4|STARTED|Overall Study||52
1502652|NCT01652703|3675772|P3|STARTED|Overall Study||50
1502653|NCT01652703|3675773|P2|STARTED|Overall Study||51
1502654|NCT01652703|3675774|P1|STARTED|Overall Study||52
1502655|NCT01652690|3675832|P2|NOT COMPLETED|Overall Study||21
1502656|NCT01652690|3675833|P1|NOT COMPLETED|Overall Study||35
1502657|NCT01652690|3675832|P2|COMPLETED|Overall Study||279
1502658|NCT01652690|3675833|P1|COMPLETED|Overall Study||265
1502659|NCT01652690|3675832|P2|STARTED|Overall Study||300
1502660|NCT01652690|3675833|P1|STARTED|Overall Study||300
1502661|NCT01652664|3675867|P2|NOT COMPLETED|Overall Study||1
1502662|NCT01652664|3675868|P1|NOT COMPLETED|Overall Study||6
1502663|NCT01652664|3675867|P2|COMPLETED|Overall Study||74
1502664|NCT01652664|3675868|P1|COMPLETED|Overall Study||71
1502665|NCT01652664|3675867|P2|STARTED|Overall Study||75
1502666|NCT01652664|3675868|P1|STARTED|Overall Study||77
1502667|NCT01652573|3675877|P2|NOT COMPLETED|Overall Study||1
1502668|NCT01652573|3675878|P1|NOT COMPLETED|Overall Study||0
1502669|NCT01652573|3675877|P2|COMPLETED|Overall Study||10
1502670|NCT01652573|3675878|P1|COMPLETED|Overall Study||10
1502671|NCT01652573|3675877|P2|STARTED|Overall Study||11
1502672|NCT01652573|3675878|P1|STARTED|Overall Study||10
1502673|NCT01652495|3675920|P2|NOT COMPLETED|Overall Study||2
1502674|NCT01652495|3675921|P1|NOT COMPLETED|Overall Study||2
1502675|NCT01652495|3675920|P2|COMPLETED|Overall Study||20
1502676|NCT01652495|3675921|P1|COMPLETED|Overall Study||20
1502677|NCT01652495|3675920|P2|STARTED|Overall Study||22
1502678|NCT01652495|3675921|P1|STARTED|Overall Study||22
1502679|NCT01652287|3675933|P2|NOT COMPLETED|Overall Study||0
1502680|NCT01652287|3675934|P1|NOT COMPLETED|Overall Study||2
1502681|NCT01652287|3675933|P2|COMPLETED|Overall Study||31
1502682|NCT01652287|3675934|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
1502683|NCT01652287|3675933|P2|STARTED|Overall Study||31
1502684|NCT01652287|3675934|P1|STARTED|Overall Study||31
1502685|NCT01652040|3675942|P2|NOT COMPLETED|Overall Study||2
1502686|NCT01652040|3675943|P1|NOT COMPLETED|Overall Study||2
1502687|NCT01652040|3675942|P2|COMPLETED|Overall Study||11
1502688|NCT01652040|3675943|P1|COMPLETED|Overall Study||11
1502689|NCT01652040|3675942|P2|STARTED|Overall Study||13
1502690|NCT01652040|3675943|P1|STARTED|Overall Study||13
1502691|NCT01652001|3675953|P2|NOT COMPLETED|Overall Study||6
1502692|NCT01652001|3675954|P1|NOT COMPLETED|Overall Study||9
1502693|NCT01652001|3675953|P2|COMPLETED|Overall Study||79
1502694|NCT01652001|3675954|P1|COMPLETED|Overall Study||91
1502695|NCT01652001|3675953|P2|STARTED|Overall Study||85
1502696|NCT01652001|3675954|P1|STARTED|Overall Study||100
1502697|NCT01651949|3675965|P3|NOT COMPLETED|Overall Study||31
1502698|NCT01651949|3675966|P2|NOT COMPLETED|Overall Study||86
1502699|NCT01651949|3675967|P1|NOT COMPLETED|Overall Study||53
1502700|NCT01651949|3675965|P3|COMPLETED|Overall Study||282
1502701|NCT01651949|3675966|P2|COMPLETED|Overall Study||1015
1502702|NCT01651949|3675967|P1|COMPLETED|Overall Study||1053
1502703|NCT01651949|3675965|P3|Vaccination 3|Overall Study||291
1502704|NCT01651949|3675966|P2|Vaccination 3|Overall Study||1037
1502705|NCT01651949|3675967|P1|Vaccination 3|Overall Study||1067
1502706|NCT01651949|3675965|P3|Vaccination 2|Overall Study||298
1502707|NCT01651949|3675966|P2|Vaccination 2|Overall Study||1069
1502708|NCT01651949|3675967|P1|Vaccination 2|Overall Study||1089
1502709|NCT01651949|3675965|P3|Vaccination 1|Overall Study||313
1502710|NCT01651949|3675966|P2|Vaccination 1|Overall Study||1099
1502711|NCT01651949|3675967|P1|Vaccination 1|Overall Study||1103
1502712|NCT01651949|3675965|P3|STARTED|Overall Study||313
1502713|NCT01651949|3675966|P2|STARTED|Overall Study||1101
1502714|NCT01651949|3675967|P1|STARTED|Overall Study||1106
1502715|NCT01651936|3675987|P3|NOT COMPLETED|Extension Study||14
1502716|NCT01651936|3675988|P2|NOT COMPLETED|Extension Study||0
1502717|NCT01651936|3675989|P1|NOT COMPLETED|Extension Study||0
1502718|NCT01651936|3675987|P3|COMPLETED|Extension Study||0
1502719|NCT01651936|3675988|P2|COMPLETED|Extension Study||0
1502720|NCT01651936|3675989|P1|COMPLETED|Extension Study||0
1502721|NCT01651936|3675987|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
1502722|NCT01651936|3675988|P2|STARTED|Extension Study||0
1502723|NCT01651936|3675989|P1|STARTED|Extension Study||0
1502724|NCT01651936|3675987|P3|NOT COMPLETED|Base Study||0
1502725|NCT01651936|3675988|P2|NOT COMPLETED|Base Study||25
1502726|NCT01651936|3675989|P1|NOT COMPLETED|Base Study||27
1502727|NCT01651936|3675987|P3|COMPLETED|Base Study||0
1502728|NCT01651936|3675988|P2|COMPLETED|Base Study||1
1502729|NCT01651936|3675989|P1|COMPLETED|Base Study||3
1502730|NCT01651936|3675987|P3|STARTED|Base Study||0
1502731|NCT01651936|3675988|P2|STARTED|Base Study||26
1502732|NCT01651936|3675989|P1|STARTED|Base Study||30
1502733|NCT01651806|3676015|P5|NOT COMPLETED|Overall Study||0
1502734|NCT01651806|3676016|P4|NOT COMPLETED|Overall Study||0
1502735|NCT01651806|3676017|P3|NOT COMPLETED|Overall Study||0
1502736|NCT01651806|3676018|P2|NOT COMPLETED|Overall Study||0
1502737|NCT01651806|3676019|P1|NOT COMPLETED|Overall Study||0
1502738|NCT01651806|3676015|P5|COMPLETED|Overall Study||8
1502739|NCT01651806|3676016|P4|COMPLETED|Overall Study||7
1502740|NCT01651806|3676017|P3|COMPLETED|Overall Study||25
1502741|NCT01651806|3676018|P2|COMPLETED|Overall Study||12
1502742|NCT01651806|3676019|P1|COMPLETED|Overall Study||13
1502743|NCT01651806|3676015|P5|STARTED|Overall Study||8
1502744|NCT01651806|3676016|P4|STARTED|Overall Study||7
1502745|NCT01651806|3676017|P3|STARTED|Overall Study||25
1502746|NCT01651806|3676018|P2|STARTED|Overall Study||12
1502747|NCT01651806|3676019|P1|STARTED|Overall Study||13
1502748|NCT01651793|3676036|P4|NOT COMPLETED|Overall Study||1
1502749|NCT01651793|3676037|P3|NOT COMPLETED|Overall Study||0
1502750|NCT01651793|3676038|P2|NOT COMPLETED|Overall Study||0
1502751|NCT01651793|3676039|P1|NOT COMPLETED|Overall Study||0
1502752|NCT01651793|3676036|P4|COMPLETED|Overall Study||5
1502753|NCT01651793|3676037|P3|COMPLETED|Overall Study||6
1502754|NCT01651793|3676038|P2|COMPLETED|Overall Study||6
1502755|NCT01651793|3676039|P1|COMPLETED|Overall Study||6
1502756|NCT01651793|3676036|P4|STARTED|Overall Study||6
1502757|NCT01651793|3676037|P3|STARTED|Overall Study||6
1502758|NCT01651793|3676038|P2|STARTED|Overall Study||6
1502759|NCT01651793|3676039|P1|STARTED|Overall Study||6
1502760|NCT01651780|3676059|P2|NOT COMPLETED|Overall Study||10
1502761|NCT01651780|3676060|P1|NOT COMPLETED|Overall Study||11
1502762|NCT01651780|3676059|P2|COMPLETED|Overall Study||388
1502763|NCT01651780|3676060|P1|COMPLETED|Overall Study||394
1502764|NCT01651780|3676059|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
1502765|NCT01651780|3676060|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
1502766|NCT01651780|3676059|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
1502767|NCT01651780|3676060|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
1502768|NCT01651780|3676059|P2|Intent-To-Treat (ITT) Population|Overall Study||398
1502769|NCT01651780|3676060|P1|Intent-To-Treat (ITT) Population|Overall Study||404
1502770|NCT01651780|3676059|P2|STARTED|Overall Study||398
1502771|NCT01651780|3676060|P1|STARTED|Overall Study||405
1502772|NCT01651403|3676092|P2|NOT COMPLETED|Overall Study||29
1502773|NCT01651403|3676093|P1|NOT COMPLETED|Overall Study||55
1502774|NCT01651403|3676092|P2|COMPLETED|Overall Study||1
1502775|NCT01651403|3676093|P1|COMPLETED|Overall Study||5
1502776|NCT01651403|3676092|P2|STARTED|Overall Study||30
1502777|NCT01651403|3676093|P1|STARTED|Overall Study||60
1502778|NCT01651351|3676121|P2|NOT COMPLETED|Overall Study||0
1502779|NCT01651351|3676122|P1|NOT COMPLETED|Overall Study||0
1502780|NCT01651351|3676121|P2|COMPLETED|Overall Study||15
1502781|NCT01651351|3676122|P1|COMPLETED|Overall Study||15
1502782|NCT01651351|3676121|P2|STARTED|Overall Study||15
1502783|NCT01651351|3676122|P1|STARTED|Overall Study||15
1502784|NCT01651260|3676139|P1|NOT COMPLETED|Overall Study||3
1502785|NCT01651260|3676139|P1|COMPLETED|Overall Study||62
1502786|NCT01651260|3676139|P1|STARTED|Overall Study||65
1502787|NCT01651208|3676146|P2|NOT COMPLETED|Overall Study||16
1502788|NCT01651208|3676147|P1|NOT COMPLETED|Overall Study||14
1502789|NCT01651208|3676146|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
1502790|NCT01651208|3676147|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
1502791|NCT01651208|3676146|P2|STARTED|Overall Study||225
1502792|NCT01651208|3676147|P1|STARTED|Overall Study||227
1502793|NCT01651104|3676155|P1|NOT COMPLETED|Overall Study||0
1502794|NCT01651104|3676155|P1|COMPLETED|Overall Study||63
1502795|NCT01651104|3676155|P1|STARTED|Overall Study||63
1502796|NCT01651039|3676162|P1|NOT COMPLETED|Overall Study||30
1502797|NCT01651039|3676162|P1|COMPLETED|Overall Study||2
1502798|NCT01651039|3676162|P1|STARTED|Overall Study||32
1502799|NCT01651000|3676175|P2|NOT COMPLETED|Overall Study||28
1502800|NCT01651000|3676176|P1|NOT COMPLETED|Overall Study||10
1502801|NCT01651000|3676175|P2|COMPLETED|Overall Study||113
1502802|NCT01651000|3676176|P1|COMPLETED|Overall Study||62
1502803|NCT01651000|3676175|P2|Entered Extension Study|Overall Study||93
1502804|NCT01651000|3676176|P1|Entered Extension Study|Overall Study||50
1502805|NCT01651000|3676175|P2|STARTED|Overall Study||141
1502806|NCT01651000|3676176|P1|STARTED|Overall Study||72
1502807|NCT01650844|3676190|P2|NOT COMPLETED|Overall Study||4
1502808|NCT01650844|3676191|P1|NOT COMPLETED|Overall Study||1
1502809|NCT01650844|3676190|P2|COMPLETED|Overall Study||196
1502810|NCT01650844|3676191|P1|COMPLETED|Overall Study||199
1502811|NCT01650844|3676190|P2|STARTED|Overall Study||200
1502812|NCT01650844|3676191|P1|STARTED|Overall Study||200
1502813|NCT01650831|3676197|P1|NOT COMPLETED|Overall Study||1
1502814|NCT01650831|3676197|P1|COMPLETED|Overall Study||112
1502815|NCT01650831|3676197|P1|STARTED|Overall Study||113
1502816|NCT01650805|3676207|P2|NOT COMPLETED|Overall Study||0
1502817|NCT01650805|3676208|P1|NOT COMPLETED|Overall Study||1
1502818|NCT01650805|3676207|P2|COMPLETED|Overall Study||152
1502819|NCT01650805|3676208|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
1502820|NCT01650805|3676207|P2|STARTED|Overall Study||152
1502821|NCT01650805|3676208|P1|STARTED|Overall Study|Started means patient has been randomized.|155
1502822|NCT01650779|3676218|P1|NOT COMPLETED|Overall Study||1
1502823|NCT01650779|3676218|P1|COMPLETED|Overall Study||14
1502824|NCT01650779|3676218|P1|STARTED|Overall Study||15
1502825|NCT01650636|3676227|P2|NOT COMPLETED|9 Month Visit||0
1502826|NCT01650636|3676228|P1|NOT COMPLETED|9 Month Visit||0
1502827|NCT01650636|3676227|P2|COMPLETED|9 Month Visit||129
1502828|NCT01650636|3676228|P1|COMPLETED|9 Month Visit||135
1502829|NCT01650636|3676227|P2|STARTED|9 Month Visit||129
1502830|NCT01650636|3676228|P1|STARTED|9 Month Visit||135
1502831|NCT01650636|3676227|P2|NOT COMPLETED|Washout up to 9 Months||3
1502832|NCT01650636|3676228|P1|NOT COMPLETED|Washout up to 9 Months||6
1502833|NCT01650636|3676227|P2|COMPLETED|Washout up to 9 Months||129
1502834|NCT01650636|3676228|P1|COMPLETED|Washout up to 9 Months||135
1502835|NCT01650636|3676227|P2|STARTED|Washout up to 9 Months||132
1502836|NCT01650636|3676228|P1|STARTED|Washout up to 9 Months||141
1502837|NCT01650636|3676227|P2|NOT COMPLETED|5 Month Visit||0
1502838|NCT01650636|3676228|P1|NOT COMPLETED|5 Month Visit||0
1502839|NCT01650636|3676227|P2|COMPLETED|5 Month Visit||132
1502840|NCT01650636|3676228|P1|COMPLETED|5 Month Visit||141
1502841|NCT01650636|3676227|P2|STARTED|5 Month Visit||132
1502842|NCT01650636|3676228|P1|STARTED|5 Month Visit||141
1502843|NCT01650636|3676227|P2|NOT COMPLETED|Washout up to 5 Months||18
1502844|NCT01650636|3676228|P1|NOT COMPLETED|Washout up to 5 Months||9
1502845|NCT01650636|3676227|P2|COMPLETED|Washout up to 5 Months||132
1502846|NCT01650636|3676228|P1|COMPLETED|Washout up to 5 Months||141
1502847|NCT01650636|3676227|P2|STARTED|Washout up to 5 Months||150
1502848|NCT01650636|3676228|P1|STARTED|Washout up to 5 Months||150
1502849|NCT01650636|3676227|P2|NOT COMPLETED|Intervention Phase||0
1502850|NCT01650636|3676228|P1|NOT COMPLETED|Intervention Phase||0
1502851|NCT01650636|3676227|P2|COMPLETED|Intervention Phase||150
1502852|NCT01650636|3676228|P1|COMPLETED|Intervention Phase||150
1502853|NCT01650636|3676227|P2|STARTED|Intervention Phase||150
1502854|NCT01650636|3676228|P1|STARTED|Intervention Phase||150
1502855|NCT01650545|3676248|P2|NOT COMPLETED|Overall Study||0
1502856|NCT01650545|3676249|P1|NOT COMPLETED|Overall Study||0
1502857|NCT01650545|3676248|P2|COMPLETED|Overall Study||10
1502858|NCT01650545|3676249|P1|COMPLETED|Overall Study||11
1502859|NCT01650545|3676248|P2|STARTED|Overall Study||10
1502860|NCT01650545|3676249|P1|STARTED|Overall Study||11
1502861|NCT01650519|3676261|P2|NOT COMPLETED|Overall Study||0
1502862|NCT01650519|3676262|P1|NOT COMPLETED|Overall Study||1
1502863|NCT01650519|3676261|P2|COMPLETED|Overall Study||31
1502864|NCT01650519|3676262|P1|COMPLETED|Overall Study||19
1502865|NCT01650519|3676261|P2|STARTED|Overall Study||31
1502866|NCT01650519|3676262|P1|STARTED|Overall Study||20
1502867|NCT01650350|3676280|P1|NOT COMPLETED|Overall Study||0
1502868|NCT01650350|3676280|P1|COMPLETED|Overall Study||7
1502869|NCT01650350|3676280|P1|STARTED|Overall Study||7
1502870|NCT01650324|3676290|P5|NOT COMPLETED|Overall Study||0
1502871|NCT01650324|3676291|P4|NOT COMPLETED|Overall Study||0
1502872|NCT01650324|3676292|P3|NOT COMPLETED|Overall Study||0
1502873|NCT01650324|3676293|P2|NOT COMPLETED|Overall Study||0
1502874|NCT01650324|3676294|P1|NOT COMPLETED|Overall Study||0
1502875|NCT01650324|3676290|P5|COMPLETED|Overall Study||6
1502876|NCT01650324|3676291|P4|COMPLETED|Overall Study||6
1502877|NCT01650324|3676292|P3|COMPLETED|Overall Study||6
1502878|NCT01650324|3676293|P2|COMPLETED|Overall Study||6
1502879|NCT01650324|3676294|P1|COMPLETED|Overall Study||8
1502880|NCT01650324|3676290|P5|STARTED|Overall Study||6
1502881|NCT01650324|3676291|P4|STARTED|Overall Study||6
1502882|NCT01650324|3676292|P3|STARTED|Overall Study||6
1502883|NCT01650324|3676293|P2|STARTED|Overall Study||6
1502884|NCT01650324|3676294|P1|STARTED|Overall Study||8
1502885|NCT01650285|3676323|P1|NOT COMPLETED|Overall Study||1
1502886|NCT01650285|3676323|P1|COMPLETED|Overall Study||4
1502887|NCT01650285|3676323|P1|STARTED|Overall Study||5
1502888|NCT01650246|3676328|P1|NOT COMPLETED|Overall Study||143
1502889|NCT01650246|3676328|P1|COMPLETED|Overall Study||0
1502890|NCT01650246|3676328|P1|STARTED|Overall Study||143
1502891|NCT01649856|3676335|P2|NOT COMPLETED|Overall Study||78
1502892|NCT01649856|3676336|P1|NOT COMPLETED|Overall Study||139
1502893|NCT01649856|3676335|P2|COMPLETED|Overall Study||125
1502894|NCT01649856|3676336|P1|COMPLETED|Overall Study||230
1502895|NCT01649856|3676335|P2|STARTED|Overall Study||203
1502896|NCT01649856|3676336|P1|STARTED|Overall Study||369
1502897|NCT01649804|3676368|P1|NOT COMPLETED|Overall Study||8
1502898|NCT01649804|3676368|P1|COMPLETED|Overall Study||4
1502899|NCT01649804|3676368|P1|STARTED|Overall Study||12
1502900|NCT01649791|3676380|P1|NOT COMPLETED|Overall Study||3
1502901|NCT01649791|3676380|P1|COMPLETED|Overall Study||5
1502902|NCT01649791|3676380|P1|STARTED|Overall Study||8
1502903|NCT01649765|3676389|P2|NOT COMPLETED|Overall Study||8
1502904|NCT01649765|3676390|P1|NOT COMPLETED|Overall Study||9
1502905|NCT01649765|3676389|P2|COMPLETED|Overall Study||45
1502906|NCT01649765|3676390|P1|COMPLETED|Overall Study||31
1502907|NCT01649765|3676389|P2|STARTED|Overall Study||53
1502908|NCT01649765|3676390|P1|STARTED|Overall Study||40
1502909|NCT01649609|3676418|P2|NOT COMPLETED|Overall Study||0
1502910|NCT01649609|3676419|P1|NOT COMPLETED|Overall Study||0
1502911|NCT01649609|3676418|P2|COMPLETED|Overall Study||20
1502912|NCT01649609|3676419|P1|COMPLETED|Overall Study||20
1502913|NCT01649609|3676418|P2|STARTED|Overall Study||20
1502914|NCT01649609|3676419|P1|STARTED|Overall Study||20
1502915|NCT01649596|3676429|P2|NOT COMPLETED|Overall Study||0
1502916|NCT01649596|3676430|P1|NOT COMPLETED|Overall Study||0
1502917|NCT01649596|3676429|P2|COMPLETED|Overall Study||48
1502918|NCT01649596|3676430|P1|COMPLETED|Overall Study||46
1502919|NCT01649596|3676429|P2|STARTED|Overall Study||48
1502920|NCT01649596|3676430|P1|STARTED|Overall Study||46
1502921|NCT01649557|3676441|P3|NOT COMPLETED|Overall Study||9
1502922|NCT01649557|3676442|P2|NOT COMPLETED|Overall Study||14
1502923|NCT01649557|3676443|P1|NOT COMPLETED|Overall Study||44
1502924|NCT01649557|3676441|P3|COMPLETED|Overall Study||15
1502925|NCT01649557|3676442|P2|COMPLETED|Overall Study||27
1502926|NCT01649557|3676443|P1|COMPLETED|Overall Study||135
1502927|NCT01649557|3676441|P3|52-week Enrollers|Overall Study||2
1502928|NCT01649557|3676442|P2|52-week Enrollers|Overall Study||6
1502929|NCT01649557|3676443|P1|52-week Enrollers|Overall Study||20
1502930|NCT01649557|3676441|P3|6-week Enrollers|Overall Study||22
1502931|NCT01649557|3676442|P2|6-week Enrollers|Overall Study||35
1502932|NCT01649557|3676443|P1|6-week Enrollers|Overall Study||159
1502933|NCT01649557|3676441|P3|STARTED|Overall Study||24
1502934|NCT01649557|3676442|P2|STARTED|Overall Study||41
1502935|NCT01649557|3676443|P1|STARTED|Overall Study||179
1502936|NCT01649505|3676480|P2|NOT COMPLETED|Overall Study||1
1502937|NCT01649505|3676481|P1|NOT COMPLETED|Overall Study||1
1502938|NCT01649505|3676480|P2|COMPLETED|Overall Study||0
1502939|NCT01649505|3676481|P1|COMPLETED|Overall Study||0
1502940|NCT01649505|3676480|P2|STARTED|Overall Study||1
1502941|NCT01649505|3676481|P1|STARTED|Overall Study||1
1502942|NCT01649362|3676489|P2|NOT COMPLETED|Overall Study||14
1502943|NCT01649362|3676490|P1|NOT COMPLETED|Overall Study||1
1502944|NCT01649362|3676489|P2|COMPLETED|Overall Study||40
1502945|NCT01649362|3676490|P1|COMPLETED|Overall Study||46
1502946|NCT01649362|3676489|P2|STARTED|Overall Study||54
1502947|NCT01649362|3676490|P1|STARTED|Overall Study||47
1502948|NCT01649297|3676505|P5|NOT COMPLETED|Overall Study||4
1502949|NCT01649297|3676506|P4|NOT COMPLETED|Overall Study||19
1502950|NCT01649297|3676507|P3|NOT COMPLETED|Overall Study||17
1502951|NCT01649297|3676508|P2|NOT COMPLETED|Overall Study||13
1502952|NCT01649297|3676509|P1|NOT COMPLETED|Overall Study||14
1502953|NCT01649297|3676505|P5|COMPLETED|Overall Study||103
1502954|NCT01649297|3676506|P4|COMPLETED|Overall Study||201
1502955|NCT01649297|3676507|P3|COMPLETED|Overall Study||202
1502956|NCT01649297|3676508|P2|COMPLETED|Overall Study||205
1502957|NCT01649297|3676509|P1|COMPLETED|Overall Study||205
1502958|NCT01649297|3676505|P5|STARTED|Overall Study|randomised|107
1502959|NCT01649297|3676506|P4|STARTED|Overall Study|randomised|220
1502960|NCT01649297|3676507|P3|STARTED|Overall Study|randomised|219
1502961|NCT01649297|3676508|P2|STARTED|Overall Study|randomised|218
1502962|NCT01649297|3676509|P1|STARTED|Overall Study|randomised|219
1502963|NCT01649271|3676528|P2|NOT COMPLETED|Overall Study||7
1502964|NCT01649271|3676529|P1|NOT COMPLETED|Overall Study||6
1502965|NCT01649271|3676528|P2|COMPLETED|Overall Study||0
1502966|NCT01649271|3676529|P1|COMPLETED|Overall Study||0
1502967|NCT01649271|3676528|P2|STARTED|Overall Study||7
1502968|NCT01649271|3676529|P1|STARTED|Overall Study||6
1502969|NCT01649232|3676544|P2|NOT COMPLETED|Overall Study||0
1502970|NCT01649232|3676545|P1|NOT COMPLETED|Overall Study||2
1502971|NCT01649232|3676544|P2|COMPLETED|Overall Study||30
1502972|NCT01649232|3676545|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
1502973|NCT01649232|3676544|P2|STARTED|Overall Study||30
1502974|NCT01649232|3676545|P1|STARTED|Overall Study||30
1502975|NCT01649180|3676565|P1|NOT COMPLETED|Overall Study||0
1502976|NCT01649180|3676565|P1|COMPLETED|Overall Study||3
1502977|NCT01649180|3676565|P1|STARTED|Overall Study||3
1502978|NCT01648920|3676573|P1|NOT COMPLETED|Overall Study||0
1502979|NCT01648920|3676573|P1|COMPLETED|Overall Study||50
1502980|NCT01648920|3676573|P1|STARTED|Overall Study||50
1502981|NCT01648790|3676597|P5|NOT COMPLETED|Treatment 5||0
1502982|NCT01648790|3676598|P4|NOT COMPLETED|Treatment 5||0
1502983|NCT01648790|3676599|P3|NOT COMPLETED|Treatment 5||0
1502984|NCT01648790|3676600|P2|NOT COMPLETED|Treatment 5||0
1502985|NCT01648790|3676601|P1|NOT COMPLETED|Treatment 5||0
1502986|NCT01648790|3676597|P5|COMPLETED|Treatment 5||4
1502987|NCT01648790|3676598|P4|COMPLETED|Treatment 5||3
1502988|NCT01648790|3676599|P3|COMPLETED|Treatment 5||4
1502989|NCT01648790|3676600|P2|COMPLETED|Treatment 5||4
1502990|NCT01648790|3676601|P1|COMPLETED|Treatment 5||4
1502991|NCT01648790|3676597|P5|STARTED|Treatment 5||4
1502992|NCT01648790|3676598|P4|STARTED|Treatment 5||3
1502993|NCT01648790|3676599|P3|STARTED|Treatment 5||4
1502994|NCT01648790|3676600|P2|STARTED|Treatment 5||4
1502995|NCT01648790|3676601|P1|STARTED|Treatment 5||4
1502996|NCT01648790|3676597|P5|NOT COMPLETED|Treatment 4||0
1502997|NCT01648790|3676598|P4|NOT COMPLETED|Treatment 4||0
1502998|NCT01648790|3676599|P3|NOT COMPLETED|Treatment 4||0
1502999|NCT01648790|3676600|P2|NOT COMPLETED|Treatment 4||0
1503000|NCT01648790|3676601|P1|NOT COMPLETED|Treatment 4||0
1503001|NCT01648790|3676597|P5|COMPLETED|Treatment 4||4
1503002|NCT01648790|3676598|P4|COMPLETED|Treatment 4||3
1503003|NCT01648790|3676599|P3|COMPLETED|Treatment 4||4
1503004|NCT01648790|3676600|P2|COMPLETED|Treatment 4||4
1503005|NCT01648790|3676601|P1|COMPLETED|Treatment 4||4
1503006|NCT01648790|3676597|P5|STARTED|Treatment 4||4
1503007|NCT01648790|3676598|P4|STARTED|Treatment 4||3
1503008|NCT01648790|3676599|P3|STARTED|Treatment 4||4
1503009|NCT01648790|3676600|P2|STARTED|Treatment 4||4
1503010|NCT01648790|3676601|P1|STARTED|Treatment 4||4
1503011|NCT01648790|3676597|P5|NOT COMPLETED|Treatment 3||0
1503012|NCT01648790|3676598|P4|NOT COMPLETED|Treatment 3||1
1503013|NCT01648790|3676599|P3|NOT COMPLETED|Treatment 3||0
1503014|NCT01648790|3676600|P2|NOT COMPLETED|Treatment 3||0
1503015|NCT01648790|3676601|P1|NOT COMPLETED|Treatment 3||0
1503016|NCT01648790|3676597|P5|COMPLETED|Treatment 3||4
1503017|NCT01648790|3676598|P4|COMPLETED|Treatment 3||3
1503018|NCT01648790|3676599|P3|COMPLETED|Treatment 3||4
1503019|NCT01648790|3676600|P2|COMPLETED|Treatment 3||4
1503020|NCT01648790|3676601|P1|COMPLETED|Treatment 3||4
1503021|NCT01648790|3676597|P5|STARTED|Treatment 3||4
1503022|NCT01648790|3676598|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
1503023|NCT01648790|3676599|P3|STARTED|Treatment 3||4
1503024|NCT01648790|3676600|P2|STARTED|Treatment 3||4
1503025|NCT01648790|3676601|P1|STARTED|Treatment 3||4
1503026|NCT01648790|3676597|P5|NOT COMPLETED|Treatment 2||0
1503027|NCT01648790|3676598|P4|NOT COMPLETED|Treatment 2||0
1503028|NCT01648790|3676599|P3|NOT COMPLETED|Treatment 2||0
1503029|NCT01648790|3676600|P2|NOT COMPLETED|Treatment 2||0
1503030|NCT01648790|3676601|P1|NOT COMPLETED|Treatment 2||0
1503031|NCT01648790|3676597|P5|COMPLETED|Treatment 2||4
1503032|NCT01648790|3676598|P4|COMPLETED|Treatment 2||4
1503033|NCT01648790|3676599|P3|COMPLETED|Treatment 2||4
1503034|NCT01648790|3676600|P2|COMPLETED|Treatment 2||4
1503035|NCT01648790|3676601|P1|COMPLETED|Treatment 2||4
1503036|NCT01648790|3676597|P5|STARTED|Treatment 2||4
1503037|NCT01648790|3676598|P4|STARTED|Treatment 2||4
1503038|NCT01648790|3676599|P3|STARTED|Treatment 2||4
1503039|NCT01648790|3676600|P2|STARTED|Treatment 2||4
1503040|NCT01648790|3676601|P1|STARTED|Treatment 2||4
1503041|NCT01648790|3676597|P5|NOT COMPLETED|Treatment 1||0
1503042|NCT01648790|3676598|P4|NOT COMPLETED|Treatment 1||0
1503043|NCT01648790|3676599|P3|NOT COMPLETED|Treatment 1||0
1503044|NCT01648790|3676600|P2|NOT COMPLETED|Treatment 1||0
1503045|NCT01648790|3676601|P1|NOT COMPLETED|Treatment 1||0
1503046|NCT01648790|3676597|P5|COMPLETED|Treatment 1||4
1503047|NCT01648790|3676598|P4|COMPLETED|Treatment 1||4
1503048|NCT01648790|3676599|P3|COMPLETED|Treatment 1||4
1503049|NCT01648790|3676600|P2|COMPLETED|Treatment 1||4
1503050|NCT01648790|3676601|P1|COMPLETED|Treatment 1||4
1503051|NCT01648790|3676597|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
1503052|NCT01648790|3676598|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
1503053|NCT01648790|3676599|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
1503054|NCT01648790|3676600|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
1503055|NCT01648790|3676601|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
1503056|NCT01648790|3676597|P5|STARTED|Treatment 1||4
1503057|NCT01648790|3676598|P4|STARTED|Treatment 1||4
1503058|NCT01648790|3676599|P3|STARTED|Treatment 1||4
1503059|NCT01648790|3676600|P2|STARTED|Treatment 1||4
1503060|NCT01648790|3676601|P1|STARTED|Treatment 1||4
1503061|NCT01648699|3676622|P1|NOT COMPLETED|Overall Study||5
1503062|NCT01648699|3676622|P1|COMPLETED|Overall Study||15
1503063|NCT01648699|3676622|P1|STARTED|Overall Study||20
1503064|NCT01648582|3676651|P3|NOT COMPLETED|Overall Study||32
1503065|NCT01648582|3676652|P2|NOT COMPLETED|Overall Study||38
1503066|NCT01648582|3676653|P1|NOT COMPLETED|Overall Study||32
1503067|NCT01648582|3676651|P3|COMPLETED|Overall Study||227
1503068|NCT01648582|3676652|P2|COMPLETED|Overall Study||219
1503069|NCT01648582|3676653|P1|COMPLETED|Overall Study||226
1503070|NCT01648582|3676651|P3|Modified Intent-to-Treat Population|Overall Study||250
1503071|NCT01648582|3676652|P2|Modified Intent-to-Treat Population|Overall Study||252
1503072|NCT01648582|3676653|P1|Modified Intent-to-Treat Population|Overall Study||253
1503073|NCT01648582|3676651|P3|Received at Least One Dose of Study Drug|Overall Study||259
1503074|NCT01648582|3676652|P2|Received at Least One Dose of Study Drug|Overall Study||257
1503075|NCT01648582|3676653|P1|Received at Least One Dose of Study Drug|Overall Study||258
1503076|NCT01648582|3676651|P3|STARTED|Overall Study||259
1503077|NCT01648582|3676652|P2|STARTED|Overall Study||257
1503078|NCT01648582|3676653|P1|STARTED|Overall Study||258
1503079|NCT01648530|3676722|P1|NOT COMPLETED|Overall Study||10874
1503080|NCT01648530|3676722|P1|COMPLETED|Overall Study||5915
1503081|NCT01648530|3676722|P1|STARTED|Overall Study||16789
1503082|NCT01648491|3676728|P1|NOT COMPLETED|Overall Study||0
1503083|NCT01648491|3676728|P1|COMPLETED|Overall Study||1
1503084|NCT01648491|3676728|P1|STARTED|Overall Study||1
1503085|NCT01648452|3676735|P1|NOT COMPLETED|Overall Study||0
1503086|NCT01648452|3676735|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
1503087|NCT01648452|3676735|P1|STARTED|Overall Study||5
1503088|NCT01648348|3676756|P6|NOT COMPLETED|Overall Study||6
1503089|NCT01648348|3676757|P5|NOT COMPLETED|Overall Study||3
1503090|NCT01648348|3676758|P4|NOT COMPLETED|Overall Study||0
1503091|NCT01648348|3676759|P3|NOT COMPLETED|Overall Study||1
1503092|NCT01648348|3676760|P2|NOT COMPLETED|Overall Study||0
1503093|NCT01648348|3676761|P1|NOT COMPLETED|Overall Study||2
1503094|NCT01648348|3676756|P6|COMPLETED|Overall Study||43
1503095|NCT01648348|3676757|P5|COMPLETED|Overall Study||49
1503096|NCT01648348|3676758|P4|COMPLETED|Overall Study||3
1503097|NCT01648348|3676759|P3|COMPLETED|Overall Study||3
1503098|NCT01648348|3676760|P2|COMPLETED|Overall Study||3
1503099|NCT01648348|3676761|P1|COMPLETED|Overall Study||3
1503100|NCT01648348|3676756|P6|STARTED|Overall Study||49
1503101|NCT01648348|3676757|P5|STARTED|Overall Study||52
1503102|NCT01648348|3676758|P4|STARTED|Overall Study||3
1503103|NCT01648348|3676759|P3|STARTED|Overall Study||4
1503104|NCT01648348|3676760|P2|STARTED|Overall Study||3
1503105|NCT01648348|3676761|P1|STARTED|Overall Study||5
1503106|NCT01648322|3676790|P4|NOT COMPLETED|Overall Study||4
1503107|NCT01648322|3676791|P3|NOT COMPLETED|Overall Study||5
1503108|NCT01648322|3676792|P2|NOT COMPLETED|Overall Study||5
1503109|NCT01648322|3676793|P1|NOT COMPLETED|Overall Study||2
1503110|NCT01648322|3676790|P4|COMPLETED|Overall Study||61
1503111|NCT01648322|3676791|P3|COMPLETED|Overall Study||60
1503112|NCT01648322|3676792|P2|COMPLETED|Overall Study||62
1503113|NCT01648322|3676793|P1|COMPLETED|Overall Study||33
1503114|NCT01648322|3676790|P4|STARTED|Overall Study||65
1503115|NCT01648322|3676791|P3|STARTED|Overall Study||65
1503116|NCT01648322|3676792|P2|STARTED|Overall Study||67
1503117|NCT01648322|3676793|P1|STARTED|Overall Study||35
1503118|NCT01648283|3676837|P1|NOT COMPLETED|Overall Study||14
1503119|NCT01648283|3676837|P1|COMPLETED|Overall Study||64
1503120|NCT01648283|3676837|P1|STARTED|Overall Study||78
1503121|NCT01648140|3676847|P4|NOT COMPLETED|Overall Study||2
1503122|NCT01648140|3676848|P3|NOT COMPLETED|Overall Study||8
1503123|NCT01648140|3676849|P2|NOT COMPLETED|Overall Study||12
1503124|NCT01648140|3676850|P1|NOT COMPLETED|Overall Study||12
1503125|NCT01648140|3676847|P4|COMPLETED|Overall Study||11
1503126|NCT01648140|3676848|P3|COMPLETED|Overall Study||9
1503127|NCT01648140|3676849|P2|COMPLETED|Overall Study||28
1503128|NCT01648140|3676850|P1|COMPLETED|Overall Study||29
1503129|NCT01648140|3676847|P4|STARTED|Overall Study||13
1503130|NCT01648140|3676848|P3|STARTED|Overall Study||17
1503131|NCT01648140|3676849|P2|STARTED|Overall Study||40
1503132|NCT01648140|3676850|P1|STARTED|Overall Study||41
1503133|NCT01648101|3677015|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
1503134|NCT01648101|3677016|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
1503135|NCT01648101|3677017|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
1503136|NCT01648101|3677015|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
1503137|NCT01648101|3677016|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
1503138|NCT01648101|3677017|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
1503139|NCT01648101|3677015|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
1503140|NCT01648101|3677016|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
1503141|NCT01648101|3677017|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
1503142|NCT01648101|3677015|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
1503143|NCT01648101|3677016|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
1503144|NCT01648101|3677017|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
1503145|NCT01648101|3677015|P3|COMPLETED|Transition Phase (4 Weeks)||5
1503146|NCT01648101|3677016|P2|COMPLETED|Transition Phase (4 Weeks)||13
1503147|NCT01648101|3677017|P1|COMPLETED|Transition Phase (4 Weeks)||12
1503148|NCT01648101|3677015|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
1503149|NCT01648101|3677016|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
1503150|NCT01648101|3677017|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
1503151|NCT01648101|3677015|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
1503152|NCT01648101|3677016|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
1503153|NCT01648101|3677017|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
1503154|NCT01648101|3677015|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
1503155|NCT01648101|3677016|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
1503156|NCT01648101|3677017|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
1503157|NCT01648101|3677015|P3|STARTED|Maintenance Phase (12 Weeks)||18
1503158|NCT01648101|3677016|P2|STARTED|Maintenance Phase (12 Weeks)||23
1503159|NCT01648101|3677017|P1|STARTED|Maintenance Phase (12 Weeks)||23
1503160|NCT01648101|3677015|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
1503161|NCT01648101|3677016|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
1503162|NCT01648101|3677017|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
1503163|NCT01648101|3677015|P3|COMPLETED|Titration Phase (4 Weeks)||18
1503164|NCT01648101|3677016|P2|COMPLETED|Titration Phase (4 Weeks)||23
1503165|NCT01648101|3677017|P1|COMPLETED|Titration Phase (4 Weeks)||23
1503166|NCT01648101|3677015|P3|STARTED|Titration Phase (4 Weeks)||24
1503167|NCT01648101|3677016|P2|STARTED|Titration Phase (4 Weeks)||26
1503168|NCT01648101|3677017|P1|STARTED|Titration Phase (4 Weeks)||25
1503169|NCT01647945|3677069|P4|NOT COMPLETED|Overall Study||1
1503170|NCT01647945|3677070|P3|NOT COMPLETED|Overall Study||2
1503171|NCT01647945|3677071|P2|NOT COMPLETED|Overall Study||0
1503172|NCT01647945|3677072|P1|NOT COMPLETED|Overall Study||0
1503173|NCT01647945|3677069|P4|COMPLETED|Overall Study||5
1503174|NCT01647945|3677070|P3|COMPLETED|Overall Study||3
1503175|NCT01647945|3677071|P2|COMPLETED|Overall Study||6
1503176|NCT01647945|3677072|P1|COMPLETED|Overall Study||6
1503177|NCT01647945|3677069|P4|STARTED|Overall Study||6
1503178|NCT01647945|3677070|P3|STARTED|Overall Study||5
1503179|NCT01647945|3677071|P2|STARTED|Overall Study||6
1503180|NCT01647945|3677072|P1|STARTED|Overall Study||6
1503181|NCT01647737|3677092|P2|NOT COMPLETED|Overall Study||5
1503182|NCT01647737|3677093|P1|NOT COMPLETED|Overall Study||4
1503183|NCT01647737|3677092|P2|COMPLETED|Overall Study||25
1503184|NCT01647737|3677093|P1|COMPLETED|Overall Study||26
1503185|NCT01647737|3677092|P2|STARTED|Overall Study||30
1503186|NCT01647737|3677093|P1|STARTED|Overall Study||30
1503187|NCT01647711|3677104|P5|NOT COMPLETED|Overall Study||6
1503188|NCT01647711|3677105|P4|NOT COMPLETED|Overall Study||11
1503189|NCT01647711|3677106|P3|NOT COMPLETED|Overall Study||9
1503190|NCT01647711|3677107|P2|NOT COMPLETED|Overall Study||3
1503191|NCT01647711|3677108|P1|NOT COMPLETED|Overall Study||6
1503192|NCT01647711|3677104|P5|COMPLETED|Overall Study||0
1503193|NCT01647711|3677105|P4|COMPLETED|Overall Study||0
1503194|NCT01647711|3677106|P3|COMPLETED|Overall Study||0
1503195|NCT01647711|3677107|P2|COMPLETED|Overall Study||0
1503196|NCT01647711|3677108|P1|COMPLETED|Overall Study||0
1503197|NCT01647711|3677104|P5|STARTED|Overall Study||6
1503198|NCT01647711|3677105|P4|STARTED|Overall Study||11
1503199|NCT01647711|3677106|P3|STARTED|Overall Study||9
1503200|NCT01647711|3677107|P2|STARTED|Overall Study||3
1503201|NCT01647711|3677108|P1|STARTED|Overall Study||6
1503202|NCT01647542|3677136|P3|NOT COMPLETED|Overall Study||72
1503203|NCT01647542|3677137|P2|NOT COMPLETED|Overall Study||73
1503204|NCT01647542|3677138|P1|NOT COMPLETED|Overall Study||76
1503205|NCT01647542|3677136|P3|COMPLETED|Overall Study||59
1503206|NCT01647542|3677137|P2|COMPLETED|Overall Study||58
1503207|NCT01647542|3677138|P1|COMPLETED|Overall Study||55
1503208|NCT01647542|3677136|P3|STARTED|Overall Study||131
1503209|NCT01647542|3677137|P2|STARTED|Overall Study||131
1503210|NCT01647542|3677138|P1|STARTED|Overall Study||131
1503211|NCT01647464|3677155|P1|NOT COMPLETED|Overall Study||0
1503212|NCT01647464|3677155|P1|COMPLETED|Overall Study||10
1503213|NCT01647464|3677155|P1|STARTED|Overall Study||10
1503214|NCT01647438|3677161|P2|NOT COMPLETED|Overall Study||0
1503215|NCT01647438|3677162|P1|NOT COMPLETED|Overall Study||0
1503216|NCT01647438|3677161|P2|COMPLETED|Overall Study||31
1503217|NCT01647438|3677162|P1|COMPLETED|Overall Study||32
1503218|NCT01647438|3677161|P2|STARTED|Overall Study||31
1503219|NCT01647438|3677162|P1|STARTED|Overall Study||32
1503220|NCT01647282|3677172|P2|NOT COMPLETED|Overall Study||5
1503221|NCT01647282|3677173|P1|NOT COMPLETED|Overall Study||7
1503222|NCT01647282|3677172|P2|COMPLETED|Overall Study||25
1503223|NCT01647282|3677173|P1|COMPLETED|Overall Study||23
1503224|NCT01647282|3677172|P2|STARTED|Overall Study||30
1503225|NCT01647282|3677173|P1|STARTED|Overall Study||30
1503226|NCT01647217|3677183|P2|NOT COMPLETED|Overall Study||1
1503227|NCT01647217|3677184|P1|NOT COMPLETED|Overall Study||1
1503228|NCT01647217|3677183|P2|COMPLETED|Overall Study||8
1503229|NCT01647217|3677184|P1|COMPLETED|Overall Study||7
1503230|NCT01647217|3677183|P2|STARTED|Overall Study||9
1503231|NCT01647217|3677184|P1|STARTED|Overall Study||8
1503232|NCT01646827|3677194|P2|NOT COMPLETED|Overall Study||5
1503233|NCT01646827|3677195|P1|NOT COMPLETED|Overall Study||2
1503234|NCT01646827|3677194|P2|COMPLETED|Overall Study||14
1503235|NCT01646827|3677195|P1|COMPLETED|Overall Study||16
1503236|NCT01646827|3677194|P2|STARTED|Overall Study||19
1503237|NCT01646827|3677195|P1|STARTED|Overall Study||18
1503238|NCT01646814|3677225|P2|NOT COMPLETED|Overall Study||6
1503239|NCT01646814|3677226|P1|NOT COMPLETED|Overall Study||11
1503240|NCT01646814|3677225|P2|COMPLETED|Overall Study||120
1503241|NCT01646814|3677226|P1|COMPLETED|Overall Study||110
1503242|NCT01646814|3677225|P2|STARTED|Overall Study||126
1503243|NCT01646814|3677226|P1|STARTED|Overall Study||121
1503244|NCT01646762|3677232|P1|NOT COMPLETED|Overall Study||0
1503245|NCT01646762|3677232|P1|COMPLETED|Overall Study||13
1503246|NCT01646762|3677232|P1|STARTED|Overall Study||13
1503247|NCT01646671|3677244|P3|NOT COMPLETED|Overall Study||0
1503248|NCT01646671|3677245|P2|NOT COMPLETED|Overall Study||0
1503249|NCT01646671|3677246|P1|NOT COMPLETED|Overall Study||0
1503250|NCT01646671|3677244|P3|COMPLETED|Overall Study||21
1503251|NCT01646671|3677245|P2|COMPLETED|Overall Study||11
1503252|NCT01646671|3677246|P1|COMPLETED|Overall Study||3
1503253|NCT01646671|3677244|P3|STARTED|Overall Study||21
1503254|NCT01646671|3677245|P2|STARTED|Overall Study||11
1503255|NCT01646671|3677246|P1|STARTED|Overall Study||3
1503256|NCT01646398|3677282|P2|NOT COMPLETED|Overall Study||0
1503257|NCT01646398|3677283|P1|NOT COMPLETED|Overall Study||1
1503258|NCT01646398|3677282|P2|COMPLETED|Overall Study||382
1503259|NCT01646398|3677283|P1|COMPLETED|Overall Study||381
1503260|NCT01646398|3677282|P2|STARTED|Overall Study||382
1503261|NCT01646398|3677283|P1|STARTED|Overall Study||382
1503262|NCT01646385|3677299|P2|NOT COMPLETED|Overall Study||871
1503263|NCT01646385|3677300|P1|NOT COMPLETED|Overall Study||838
1503264|NCT01646385|3677299|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
1503265|NCT01646385|3677300|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
1503266|NCT01646385|3677299|P2|STARTED|Overall Study||2864
1503267|NCT01646385|3677300|P1|STARTED|Overall Study||3529
1503268|NCT01646346|3677331|P1|NOT COMPLETED|Overall Study||0
1503269|NCT01646346|3677331|P1|COMPLETED|Overall Study||46
1503270|NCT01646346|3677331|P1|STARTED|Overall Study||46
1503271|NCT01646320|3677343|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
1503272|NCT01646320|3677344|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
1503273|NCT01646320|3677343|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
1503274|NCT01646320|3677344|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
1503275|NCT01646320|3677343|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
1503276|NCT01646320|3677344|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
1503277|NCT01646320|3677343|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
1503278|NCT01646320|3677344|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
1503279|NCT01646320|3677343|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
1503280|NCT01646320|3677344|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
1503281|NCT01646320|3677343|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
1503282|NCT01646320|3677344|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
1503283|NCT01646268|3677360|P2|NOT COMPLETED|Overall Study||16
1503284|NCT01646268|3677361|P1|NOT COMPLETED|Overall Study||11
1503285|NCT01646268|3677360|P2|COMPLETED|Overall Study||107
1503286|NCT01646268|3677361|P1|COMPLETED|Overall Study||113
1503287|NCT01646268|3677360|P2|STARTED|Overall Study||123
1503288|NCT01646268|3677361|P1|STARTED|Overall Study||124
1503289|NCT01646255|3677375|P2|NOT COMPLETED|Overall Study||14
1503290|NCT01646255|3677376|P1|NOT COMPLETED|Overall Study||21
1503291|NCT01646255|3677375|P2|COMPLETED|Overall Study||160
1503292|NCT01646255|3677376|P1|COMPLETED|Overall Study||151
1503293|NCT01646255|3677375|P2|STARTED|Overall Study||174
1503294|NCT01646255|3677376|P1|STARTED|Overall Study||172
1503295|NCT01646216|3677408|P2|NOT COMPLETED|Overall Study||13
1503296|NCT01646216|3677409|P1|NOT COMPLETED|Overall Study||11
1503297|NCT01646216|3677408|P2|COMPLETED|Overall Study||4
1503298|NCT01646216|3677409|P1|COMPLETED|Overall Study||6
1503299|NCT01646216|3677408|P2|STARTED|Overall Study||17
1503300|NCT01646216|3677409|P1|STARTED|Overall Study||17
1503301|NCT01646177|3677432|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1503302|NCT01646177|3677433|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1503303|NCT01646177|3677434|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1503304|NCT01646177|3677435|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1503305|NCT01646177|3677432|P4|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1503306|NCT01646177|3677433|P3|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1503307|NCT01646177|3677434|P2|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1503308|NCT01646177|3677435|P1|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1503309|NCT01646177|3677432|P4|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1503310|NCT01646177|3677433|P3|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1503311|NCT01646177|3677434|P2|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1503312|NCT01646177|3677435|P1|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1503313|NCT01646177|3677432|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
1503314|NCT01646177|3677433|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
1503315|NCT01646177|3677434|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
1503316|NCT01646177|3677435|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
1503317|NCT01646177|3677432|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
1503409|NCT01645098|3677755|P2|STARTED|Overall Study||29
1503318|NCT01646177|3677433|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
1503319|NCT01646177|3677434|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
1503320|NCT01646177|3677435|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
1503321|NCT01646177|3677432|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
1503322|NCT01646177|3677433|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
1503323|NCT01646177|3677434|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
1503324|NCT01646177|3677435|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
1503325|NCT01646151|3677513|P1|NOT COMPLETED|Overall Study||170
1503326|NCT01646151|3677513|P1|COMPLETED|Overall Study||2410
1503327|NCT01646151|3677513|P1|STARTED|Overall Study||2580
1503328|NCT01646138|3677529|P5|NOT COMPLETED|Overall Study||2
1503329|NCT01646138|3677530|P4|NOT COMPLETED|Overall Study||0
1503330|NCT01646138|3677531|P3|NOT COMPLETED|Overall Study||0
1503331|NCT01646138|3677532|P2|NOT COMPLETED|Overall Study||0
1503332|NCT01646138|3677533|P1|NOT COMPLETED|Overall Study||0
1503333|NCT01646138|3677529|P5|COMPLETED|Overall Study||13
1503334|NCT01646138|3677530|P4|COMPLETED|Overall Study||19
1503335|NCT01646138|3677531|P3|COMPLETED|Overall Study||5
1503336|NCT01646138|3677532|P2|COMPLETED|Overall Study||4
1503337|NCT01646138|3677533|P1|COMPLETED|Overall Study||5
1503338|NCT01646138|3677529|P5|STARTED|Overall Study||15
1503339|NCT01646138|3677530|P4|STARTED|Overall Study||19
1503340|NCT01646138|3677531|P3|STARTED|Overall Study||5
1503341|NCT01646138|3677532|P2|STARTED|Overall Study||4
1503342|NCT01646138|3677533|P1|STARTED|Overall Study||5
1503343|NCT01646125|3677547|P2|NOT COMPLETED|Overall Study||28
1503344|NCT01646125|3677548|P1|NOT COMPLETED|Overall Study||31
1503345|NCT01646125|3677547|P2|COMPLETED|Overall Study||0
1503346|NCT01646125|3677548|P1|COMPLETED|Overall Study||0
1503347|NCT01646125|3677547|P2|STARTED|Overall Study||28
1503348|NCT01646125|3677548|P1|STARTED|Overall Study||31
1503349|NCT01646073|3677573|P2|NOT COMPLETED|Period B (12 Weeks)||13
1503350|NCT01646073|3677574|P1|NOT COMPLETED|Period B (12 Weeks)||1
1503351|NCT01646073|3677573|P2|COMPLETED|Period B (12 Weeks)||320
1503352|NCT01646073|3677574|P1|COMPLETED|Period B (12 Weeks)||84
1503353|NCT01646073|3677573|P2|STARTED|Period B (12 Weeks)||333
1503354|NCT01646073|3677574|P1|STARTED|Period B (12 Weeks)||85
1503355|NCT01646073|3677573|P2|NOT COMPLETED|Period A (12 Weeks)||5
1503356|NCT01646073|3677574|P1|NOT COMPLETED|Period A (12 Weeks)||2
1503357|NCT01646073|3677573|P2|COMPLETED|Period A (12 Weeks)||333
1503358|NCT01646073|3677574|P1|COMPLETED|Period A (12 Weeks)||85
1503359|NCT01646073|3677573|P2|STARTED|Period A (12 Weeks)||338
1503360|NCT01646073|3677574|P1|STARTED|Period A (12 Weeks)||87
1503361|NCT01646021|3677615|P2|NOT COMPLETED|Overall Study||141
1503362|NCT01646021|3677616|P1|NOT COMPLETED|Overall Study||139
1503363|NCT01646021|3677615|P2|COMPLETED|Overall Study||0
1503364|NCT01646021|3677616|P1|COMPLETED|Overall Study||0
1503365|NCT01646021|3677615|P2|Treated|Overall Study||139
1503366|NCT01646021|3677616|P1|Treated|Overall Study||139
1503367|NCT01646021|3677615|P2|STARTED|Overall Study||141
1503368|NCT01646021|3677616|P1|STARTED|Overall Study||139
1503369|NCT01645930|3677653|P1|NOT COMPLETED|Overall Study||43
1503370|NCT01645930|3677653|P1|COMPLETED|Overall Study||0
1503371|NCT01645930|3677653|P1|STARTED|Overall Study||43
1503372|NCT01645735|3677670|P2|NOT COMPLETED|Overall Study||1
1503373|NCT01645735|3677671|P1|NOT COMPLETED|Overall Study||4
1503374|NCT01645735|3677670|P2|COMPLETED|Overall Study||16
1503375|NCT01645735|3677671|P1|COMPLETED|Overall Study||28
1503376|NCT01645735|3677670|P2|STARTED|Overall Study||17
1503377|NCT01645735|3677671|P1|STARTED|Overall Study||32
1503378|NCT01645709|3677685|P2|NOT COMPLETED|Overall Study||0
1503379|NCT01645709|3677686|P1|NOT COMPLETED|Overall Study||0
1503380|NCT01645709|3677685|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
1503381|NCT01645709|3677686|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
1503382|NCT01645709|3677685|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
1503383|NCT01645709|3677686|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
1503384|NCT01645280|3677713|P5|NOT COMPLETED|Overall Study||8
1503385|NCT01645280|3677714|P4|NOT COMPLETED|Overall Study||6
1503386|NCT01645280|3677715|P3|NOT COMPLETED|Overall Study||6
1503387|NCT01645280|3677716|P2|NOT COMPLETED|Overall Study||3
1503388|NCT01645280|3677717|P1|NOT COMPLETED|Overall Study||6
1503389|NCT01645280|3677713|P5|COMPLETED|Overall Study||47
1503390|NCT01645280|3677714|P4|COMPLETED|Overall Study||48
1503391|NCT01645280|3677715|P3|COMPLETED|Overall Study||49
1503392|NCT01645280|3677716|P2|COMPLETED|Overall Study||51
1503393|NCT01645280|3677717|P1|COMPLETED|Overall Study||49
1503394|NCT01645280|3677713|P5|STARTED|Overall Study||55
1503395|NCT01645280|3677714|P4|STARTED|Overall Study||54
1503396|NCT01645280|3677715|P3|STARTED|Overall Study||55
1503397|NCT01645280|3677716|P2|STARTED|Overall Study||54
1503398|NCT01645280|3677717|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
1503399|NCT01645176|3677745|P1|NOT COMPLETED|Overall Study||5
1503400|NCT01645176|3677745|P1|COMPLETED|Overall Study||16
1503401|NCT01645176|3677745|P1|STARTED|Overall Study||21
1503402|NCT01645111|3677749|P1|NOT COMPLETED|Overall Study||15
1503403|NCT01645111|3677749|P1|COMPLETED|Overall Study||35
1503404|NCT01645111|3677749|P1|STARTED|Overall Study||50
1503405|NCT01645098|3677755|P2|NOT COMPLETED|Overall Study||0
1503406|NCT01645098|3677756|P1|NOT COMPLETED|Overall Study||0
1503407|NCT01645098|3677755|P2|COMPLETED|Overall Study||29
1503408|NCT01645098|3677756|P1|COMPLETED|Overall Study||24
1503410|NCT01645098|3677756|P1|STARTED|Overall Study||24
1503411|NCT01645059|3677770|P1|NOT COMPLETED|Overall Study||0
1503412|NCT01645059|3677770|P1|COMPLETED|Overall Study||129
1503413|NCT01645059|3677770|P1|STARTED|Overall Study||129
1503414|NCT01644734|3677788|P1|NOT COMPLETED|Overall Study||266
1503415|NCT01644734|3677788|P1|COMPLETED|Overall Study||1016
1503416|NCT01644734|3677788|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
1503417|NCT01644695|3677793|P1|NOT COMPLETED|Overall Study||0
1503418|NCT01644695|3677793|P1|COMPLETED|Overall Study||85
1503419|NCT01644695|3677793|P1|STARTED|Overall Study||85
1503420|NCT01644643|3677802|P4|NOT COMPLETED|Overall Study||10
1503421|NCT01644643|3677803|P3|NOT COMPLETED|Overall Study||5
1503422|NCT01644643|3677804|P2|NOT COMPLETED|Overall Study||0
1503423|NCT01644643|3677805|P1|NOT COMPLETED|Overall Study||2
1503424|NCT01644643|3677802|P4|COMPLETED|Overall Study||143
1503425|NCT01644643|3677803|P3|COMPLETED|Overall Study||148
1503426|NCT01644643|3677804|P2|COMPLETED|Overall Study||12
1503427|NCT01644643|3677805|P1|COMPLETED|Overall Study||13
1503428|NCT01644643|3677802|P4|STARTED|Overall Study||153
1503429|NCT01644643|3677803|P3|STARTED|Overall Study||153
1503430|NCT01644643|3677804|P2|STARTED|Overall Study||12
1503431|NCT01644643|3677805|P1|STARTED|Overall Study||15
1503432|NCT01644617|3677970|P3|NOT COMPLETED|Overall Study||7
1503433|NCT01644617|3677971|P2|NOT COMPLETED|Overall Study||5
1503434|NCT01644617|3677972|P1|NOT COMPLETED|Overall Study||6
1503435|NCT01644617|3677970|P3|COMPLETED|Overall Study||34
1503436|NCT01644617|3677971|P2|COMPLETED|Overall Study||36
1503437|NCT01644617|3677972|P1|COMPLETED|Overall Study||36
1503438|NCT01644617|3677970|P3|STARTED|Overall Study||41
1503439|NCT01644617|3677971|P2|STARTED|Overall Study||41
1503440|NCT01644617|3677972|P1|STARTED|Overall Study||42
1503441|NCT01644500|3678025|P3|NOT COMPLETED|Overall Study||15
1503442|NCT01644500|3678026|P2|NOT COMPLETED|Overall Study||24
1503443|NCT01644500|3678027|P1|NOT COMPLETED|Overall Study||22
1503444|NCT01644500|3678025|P3|COMPLETED|Overall Study||230
1503445|NCT01644500|3678026|P2|COMPLETED|Overall Study||224
1503446|NCT01644500|3678027|P1|COMPLETED|Overall Study||222
1503447|NCT01644500|3678025|P3|Modified Intent-to-treat Population|Overall Study||242
1503448|NCT01644500|3678026|P2|Modified Intent-to-treat Population|Overall Study||239
1503449|NCT01644500|3678027|P1|Modified Intent-to-treat Population|Overall Study||239
1503450|NCT01644500|3678025|P3|Received at Least One Dose of Study Drug|Overall Study||243
1503451|NCT01644500|3678026|P2|Received at Least One Dose of Study Drug|Overall Study||248
1503452|NCT01644500|3678027|P1|Received at Least One Dose of Study Drug|Overall Study||244
1503453|NCT01644500|3678025|P3|STARTED|Overall Study||245
1503454|NCT01644500|3678026|P2|STARTED|Overall Study||248
1503455|NCT01644500|3678027|P1|STARTED|Overall Study||244
1503456|NCT01644474|3678097|P2|NOT COMPLETED|Overall Study||8
1503457|NCT01644474|3678098|P1|NOT COMPLETED|Overall Study||7
1503458|NCT01644474|3678097|P2|COMPLETED|Overall Study||44
1503459|NCT01644474|3678098|P1|COMPLETED|Overall Study||44
1503460|NCT01644474|3678097|P2|Treated|Overall Study||52
1503461|NCT01644474|3678098|P1|Treated|Overall Study||51
1503462|NCT01644474|3678097|P2|STARTED|Overall Study|Randomized|52
1503463|NCT01644474|3678098|P1|STARTED|Overall Study|Randomized|51
1503464|NCT01644396|3678138|P1|NOT COMPLETED|Overall Study||0
1503465|NCT01644396|3678138|P1|COMPLETED|Overall Study||50
1503466|NCT01644396|3678138|P1|STARTED|Overall Study||50
1503467|NCT01644331|3678182|P2|NOT COMPLETED|Overall Study||10
1503468|NCT01644331|3678183|P1|NOT COMPLETED|Overall Study||11
1503469|NCT01644331|3678182|P2|COMPLETED|Overall Study||118
1503470|NCT01644331|3678183|P1|COMPLETED|Overall Study||118
1503471|NCT01644331|3678182|P2|STARTED|Overall Study||128
1503472|NCT01644331|3678183|P1|STARTED|Overall Study||129
1503473|NCT01644292|3678215|P1|NOT COMPLETED|Overall Study||0
1503474|NCT01644292|3678215|P1|COMPLETED|Overall Study||2
1503475|NCT01644292|3678215|P1|STARTED|Overall Study||2
1503476|NCT01644240|3678222|P3|NOT COMPLETED|Overall Study||0
1503477|NCT01644240|3678223|P2|NOT COMPLETED|Overall Study||0
1503478|NCT01644240|3678224|P1|NOT COMPLETED|Overall Study||0
1503479|NCT01644240|3678222|P3|COMPLETED|Overall Study||6
1503480|NCT01644240|3678223|P2|COMPLETED|Overall Study||4
1503481|NCT01644240|3678224|P1|COMPLETED|Overall Study||6
1503482|NCT01644240|3678222|P3|STARTED|Overall Study||6
1503483|NCT01644240|3678223|P2|STARTED|Overall Study||4
1503484|NCT01644240|3678224|P1|STARTED|Overall Study||6
1503485|NCT01644188|3678282|P2|NOT COMPLETED|Overall Study||75
1503486|NCT01644188|3678283|P1|NOT COMPLETED|Overall Study||122
1503487|NCT01644188|3678282|P2|COMPLETED|Overall Study||166
1503488|NCT01644188|3678283|P1|COMPLETED|Overall Study||357
1503489|NCT01644188|3678282|P2|Treated|Overall Study||241
1503490|NCT01644188|3678283|P1|Treated|Overall Study||479
1503491|NCT01644188|3678282|P2|STARTED|Overall Study|Randomized|241
1503492|NCT01644188|3678283|P1|STARTED|Overall Study|Randomized|479
1503493|NCT01644175|3678341|P2|NOT COMPLETED|Overall Study||53
1503494|NCT01644175|3678342|P1|NOT COMPLETED|Overall Study||32
1503495|NCT01644175|3678341|P2|COMPLETED|Overall Study||156
1503496|NCT01644175|3678342|P1|COMPLETED|Overall Study||75
1503497|NCT01644175|3678341|P2|Treated|Overall Study||207
1503498|NCT01644175|3678342|P1|Treated|Overall Study||107
1503499|NCT01644175|3678341|P2|STARTED|Overall Study|Randomized|209
1503500|NCT01644175|3678342|P1|STARTED|Overall Study|Randomized|107
1503501|NCT01644058|3678392|P1|NOT COMPLETED|Overall Study||0
1503502|NCT01644058|3678392|P1|COMPLETED|Overall Study||18
1503503|NCT01644058|3678392|P1|STARTED|Overall Study||18
1503504|NCT01643928|3678402|P5|NOT COMPLETED|Overall Study||2
1503505|NCT01643928|3678403|P4|NOT COMPLETED|Overall Study||3
1503506|NCT01643928|3678404|P3|NOT COMPLETED|Overall Study||3
1503507|NCT01643928|3678405|P2|NOT COMPLETED|Overall Study||2
1503508|NCT01643928|3678406|P1|NOT COMPLETED|Overall Study||10
1503509|NCT01643928|3678402|P5|COMPLETED|Overall Study||28
1503510|NCT01643928|3678403|P4|COMPLETED|Overall Study||27
1503511|NCT01643928|3678404|P3|COMPLETED|Overall Study||30
1503512|NCT01643928|3678405|P2|COMPLETED|Overall Study||30
1503513|NCT01643928|3678406|P1|COMPLETED|Overall Study||48
1503514|NCT01643928|3678402|P5|STARTED|Overall Study||30
1503515|NCT01643928|3678403|P4|STARTED|Overall Study||30
1503516|NCT01643928|3678404|P3|STARTED|Overall Study||33
1503517|NCT01643928|3678405|P2|STARTED|Overall Study||32
1503518|NCT01643928|3678406|P1|STARTED|Overall Study||58
1503519|NCT01643902|3678691|P1|NOT COMPLETED|Overall Study||0
1503520|NCT01643902|3678691|P1|COMPLETED|Overall Study||20
1503521|NCT01643902|3678691|P1|STARTED|Overall Study||20
1503522|NCT01643876|3678696|P1|NOT COMPLETED|Overall Study||0
1503523|NCT01643876|3678696|P1|COMPLETED|Overall Study||48
1503524|NCT01643876|3678696|P1|STARTED|Overall Study||48
1503525|NCT01643798|3678701|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
1503526|NCT01643798|3678702|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
1503527|NCT01643798|3678701|P2|COMPLETED|Pretreatment 2 and Stimulation||8
1503528|NCT01643798|3678702|P1|COMPLETED|Pretreatment 2 and Stimulation||6
1503529|NCT01643798|3678701|P2|STARTED|Pretreatment 2 and Stimulation||8
1503530|NCT01643798|3678702|P1|STARTED|Pretreatment 2 and Stimulation||6
1503531|NCT01643798|3678701|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
1503532|NCT01643798|3678702|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
1503533|NCT01643798|3678701|P2|COMPLETED|Pretreatment 1 and Stimulation||8
1503534|NCT01643798|3678702|P1|COMPLETED|Pretreatment 1 and Stimulation||6
1503535|NCT01643798|3678701|P2|STARTED|Pretreatment 1 and Stimulation||8
1503536|NCT01643798|3678702|P1|STARTED|Pretreatment 1 and Stimulation||7
1503537|NCT01643668|3678713|P1|NOT COMPLETED|Overall Study||1
1503538|NCT01643668|3678713|P1|COMPLETED|Overall Study||33
1503539|NCT01643668|3678713|P1|STARTED|Overall Study||34
1503540|NCT01643616|3678727|P2|NOT COMPLETED|Overall Study||0
1503541|NCT01643616|3678728|P1|NOT COMPLETED|Overall Study||0
1503542|NCT01643616|3678727|P2|COMPLETED|Overall Study||125
1503543|NCT01643616|3678728|P1|COMPLETED|Overall Study||125
1503544|NCT01643616|3678727|P2|STARTED|Overall Study||125
1503545|NCT01643616|3678728|P1|STARTED|Overall Study||125
1503546|NCT01643525|3678738|P1|NOT COMPLETED|Overall Study||0
1503547|NCT01643525|3678738|P1|COMPLETED|Overall Study||29
1503548|NCT01643525|3678738|P1|STARTED|Overall Study||29
1503549|NCT01643213|3678744|P2|NOT COMPLETED|Overall Study||0
1503550|NCT01643213|3678745|P1|NOT COMPLETED|Overall Study||1
1503551|NCT01643213|3678744|P2|COMPLETED|Overall Study||14
1503552|NCT01643213|3678745|P1|COMPLETED|Overall Study||12
1503553|NCT01643213|3678744|P2|STARTED|Overall Study||14
1503554|NCT01643213|3678745|P1|STARTED|Overall Study||13
1503555|NCT01643044|3678753|P2|NOT COMPLETED|Overall Study||5
1503556|NCT01643044|3678754|P1|NOT COMPLETED|Overall Study||4
1503557|NCT01643044|3678753|P2|COMPLETED|Overall Study||19
1503558|NCT01643044|3678754|P1|COMPLETED|Overall Study||20
1503559|NCT01643044|3678753|P2|STARTED|Overall Study||24
1503560|NCT01643044|3678754|P1|STARTED|Overall Study||24
1503561|NCT01642914|3678763|P3|NOT COMPLETED|Overall Study||40
1503562|NCT01642914|3678764|P2|NOT COMPLETED|Overall Study||32
1503563|NCT01642914|3678765|P1|NOT COMPLETED|Overall Study||46
1503564|NCT01642914|3678763|P3|COMPLETED|Overall Study||120
1503565|NCT01642914|3678764|P2|COMPLETED|Overall Study||122
1503566|NCT01642914|3678765|P1|COMPLETED|Overall Study||127
1503567|NCT01642914|3678763|P3|STARTED|Overall Study||160
1503568|NCT01642914|3678764|P2|STARTED|Overall Study||154
1503569|NCT01642914|3678765|P1|STARTED|Overall Study||173
1503570|NCT01642732|3678840|P1|NOT COMPLETED|Overall Study||1
1503571|NCT01642732|3678840|P1|COMPLETED|Overall Study||0
1503572|NCT01642732|3678840|P1|STARTED|Overall Study||1
1503573|NCT01642615|3678845|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
1503574|NCT01642615|3678846|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
1503575|NCT01642615|3678847|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
1503576|NCT01642615|3678845|P3|COMPLETED|Double Blind Maintenance Phase||20
1503577|NCT01642615|3678846|P2|COMPLETED|Double Blind Maintenance Phase||18
1503578|NCT01642615|3678847|P1|COMPLETED|Double Blind Maintenance Phase||0
1503579|NCT01642615|3678845|P3|STARTED|Double Blind Maintenance Phase||26
1503580|NCT01642615|3678846|P2|STARTED|Double Blind Maintenance Phase||25
1503581|NCT01642615|3678847|P1|STARTED|Double Blind Maintenance Phase||0
1503582|NCT01642615|3678845|P3|NOT COMPLETED|Open Label Maintenance Phase||0
1503583|NCT01642615|3678846|P2|NOT COMPLETED|Open Label Maintenance Phase||0
1503584|NCT01642615|3678847|P1|NOT COMPLETED|Open Label Maintenance Phase||5
1503585|NCT01642615|3678845|P3|COMPLETED|Open Label Maintenance Phase||0
1503586|NCT01642615|3678846|P2|COMPLETED|Open Label Maintenance Phase||0
1503587|NCT01642615|3678847|P1|COMPLETED|Open Label Maintenance Phase||58
1503588|NCT01642615|3678845|P3|Safety Analysis Set|Open Label Maintenance Phase||0
1503589|NCT01642615|3678846|P2|Safety Analysis Set|Open Label Maintenance Phase||0
1503590|NCT01642615|3678847|P1|Safety Analysis Set|Open Label Maintenance Phase||62
1503591|NCT01642615|3678845|P3|STARTED|Open Label Maintenance Phase||0
1503592|NCT01642615|3678846|P2|STARTED|Open Label Maintenance Phase||0
1503593|NCT01642615|3678847|P1|STARTED|Open Label Maintenance Phase||63
1503594|NCT01642602|3678861|P1|NOT COMPLETED|Overall Study||2
1503595|NCT01642602|3678861|P1|COMPLETED|Overall Study||102
1503596|NCT01642602|3678861|P1|STARTED|Overall Study||104
1503597|NCT01642589|3678868|P2|NOT COMPLETED|Overall Study||1
1503598|NCT01642589|3678869|P1|NOT COMPLETED|Overall Study||1
1503599|NCT01642589|3678868|P2|COMPLETED|Overall Study||99
1503600|NCT01642589|3678869|P1|COMPLETED|Overall Study||199
1503601|NCT01642589|3678868|P2|STARTED|Overall Study||100
1503602|NCT01642589|3678869|P1|STARTED|Overall Study||200
1503603|NCT01642485|3678883|P8|NOT COMPLETED|Period 2, Day 3||0
1503604|NCT01642485|3678884|P7|NOT COMPLETED|Period 2, Day 3||0
1503605|NCT01642485|3678885|P6|NOT COMPLETED|Period 2, Day 3||0
1503606|NCT01642485|3678886|P5|NOT COMPLETED|Period 2, Day 3||0
1503607|NCT01642485|3678887|P4|NOT COMPLETED|Period 2, Day 3||0
1503608|NCT01642485|3678888|P3|NOT COMPLETED|Period 2, Day 3||0
1503609|NCT01642485|3678889|P2|NOT COMPLETED|Period 2, Day 3||0
1503610|NCT01642485|3678890|P1|NOT COMPLETED|Period 2, Day 3||0
1503611|NCT01642485|3678883|P8|COMPLETED|Period 2, Day 3||4
1503612|NCT01642485|3678884|P7|COMPLETED|Period 2, Day 3||4
1503613|NCT01642485|3678885|P6|COMPLETED|Period 2, Day 3||4
1503614|NCT01642485|3678886|P5|COMPLETED|Period 2, Day 3||4
1503615|NCT01642485|3678887|P4|COMPLETED|Period 2, Day 3||4
1503616|NCT01642485|3678888|P3|COMPLETED|Period 2, Day 3||4
1503617|NCT01642485|3678889|P2|COMPLETED|Period 2, Day 3||4
1503618|NCT01642485|3678890|P1|COMPLETED|Period 2, Day 3||4
1503619|NCT01642485|3678883|P8|STARTED|Period 2, Day 3||4
1503620|NCT01642485|3678884|P7|STARTED|Period 2, Day 3||4
1503621|NCT01642485|3678885|P6|STARTED|Period 2, Day 3||4
1503622|NCT01642485|3678886|P5|STARTED|Period 2, Day 3||4
1503623|NCT01642485|3678887|P4|STARTED|Period 2, Day 3||4
1503624|NCT01642485|3678888|P3|STARTED|Period 2, Day 3||4
1503625|NCT01642485|3678889|P2|STARTED|Period 2, Day 3||4
1503626|NCT01642485|3678890|P1|STARTED|Period 2, Day 3||4
1503627|NCT01642485|3678883|P8|NOT COMPLETED|Period 2, Day 2||0
1503628|NCT01642485|3678884|P7|NOT COMPLETED|Period 2, Day 2||0
1503629|NCT01642485|3678885|P6|NOT COMPLETED|Period 2, Day 2||0
1503630|NCT01642485|3678886|P5|NOT COMPLETED|Period 2, Day 2||0
1503631|NCT01642485|3678887|P4|NOT COMPLETED|Period 2, Day 2||0
1503632|NCT01642485|3678888|P3|NOT COMPLETED|Period 2, Day 2||0
1503633|NCT01642485|3678889|P2|NOT COMPLETED|Period 2, Day 2||0
1503634|NCT01642485|3678890|P1|NOT COMPLETED|Period 2, Day 2||0
1503635|NCT01642485|3678883|P8|COMPLETED|Period 2, Day 2||4
1503636|NCT01642485|3678884|P7|COMPLETED|Period 2, Day 2||4
1503637|NCT01642485|3678885|P6|COMPLETED|Period 2, Day 2||4
1503638|NCT01642485|3678886|P5|COMPLETED|Period 2, Day 2||4
1503639|NCT01642485|3678887|P4|COMPLETED|Period 2, Day 2||4
1503640|NCT01642485|3678888|P3|COMPLETED|Period 2, Day 2||4
1503641|NCT01642485|3678889|P2|COMPLETED|Period 2, Day 2||4
1503642|NCT01642485|3678890|P1|COMPLETED|Period 2, Day 2||4
1503643|NCT01642485|3678883|P8|STARTED|Period 2, Day 2||4
1503644|NCT01642485|3678884|P7|STARTED|Period 2, Day 2||4
1503645|NCT01642485|3678885|P6|STARTED|Period 2, Day 2||4
1503646|NCT01642485|3678886|P5|STARTED|Period 2, Day 2||4
1503647|NCT01642485|3678887|P4|STARTED|Period 2, Day 2||4
1503648|NCT01642485|3678888|P3|STARTED|Period 2, Day 2||4
1503649|NCT01642485|3678889|P2|STARTED|Period 2, Day 2||4
1503650|NCT01642485|3678890|P1|STARTED|Period 2, Day 2||4
1503651|NCT01642485|3678883|P8|NOT COMPLETED|Period 2, Day 1||0
1503652|NCT01642485|3678884|P7|NOT COMPLETED|Period 2, Day 1||0
1503653|NCT01642485|3678885|P6|NOT COMPLETED|Period 2, Day 1||0
1503654|NCT01642485|3678886|P5|NOT COMPLETED|Period 2, Day 1||0
1503655|NCT01642485|3678887|P4|NOT COMPLETED|Period 2, Day 1||0
1503656|NCT01642485|3678888|P3|NOT COMPLETED|Period 2, Day 1||0
1503657|NCT01642485|3678889|P2|NOT COMPLETED|Period 2, Day 1||0
1503658|NCT01642485|3678890|P1|NOT COMPLETED|Period 2, Day 1||0
1503659|NCT01642485|3678883|P8|COMPLETED|Period 2, Day 1||4
1503660|NCT01642485|3678884|P7|COMPLETED|Period 2, Day 1||4
1503661|NCT01642485|3678885|P6|COMPLETED|Period 2, Day 1||4
1503662|NCT01642485|3678886|P5|COMPLETED|Period 2, Day 1||4
1503663|NCT01642485|3678887|P4|COMPLETED|Period 2, Day 1||4
1503664|NCT01642485|3678888|P3|COMPLETED|Period 2, Day 1||4
1503665|NCT01642485|3678889|P2|COMPLETED|Period 2, Day 1||4
1503666|NCT01642485|3678890|P1|COMPLETED|Period 2, Day 1||4
1503667|NCT01642485|3678883|P8|STARTED|Period 2, Day 1||4
1503668|NCT01642485|3678884|P7|STARTED|Period 2, Day 1||4
1503669|NCT01642485|3678885|P6|STARTED|Period 2, Day 1||4
1503670|NCT01642485|3678886|P5|STARTED|Period 2, Day 1||4
1503671|NCT01642485|3678887|P4|STARTED|Period 2, Day 1||4
1503672|NCT01642485|3678888|P3|STARTED|Period 2, Day 1||4
1503673|NCT01642485|3678889|P2|STARTED|Period 2, Day 1||4
1503674|NCT01642485|3678890|P1|STARTED|Period 2, Day 1||4
1503675|NCT01642485|3678883|P8|NOT COMPLETED|Period 1, Day 3||0
1503676|NCT01642485|3678884|P7|NOT COMPLETED|Period 1, Day 3||0
1503677|NCT01642485|3678885|P6|NOT COMPLETED|Period 1, Day 3||0
1503678|NCT01642485|3678886|P5|NOT COMPLETED|Period 1, Day 3||0
1503679|NCT01642485|3678887|P4|NOT COMPLETED|Period 1, Day 3||0
1503680|NCT01642485|3678888|P3|NOT COMPLETED|Period 1, Day 3||0
1503681|NCT01642485|3678889|P2|NOT COMPLETED|Period 1, Day 3||0
1503682|NCT01642485|3678890|P1|NOT COMPLETED|Period 1, Day 3||0
1503683|NCT01642485|3678883|P8|COMPLETED|Period 1, Day 3||4
1503684|NCT01642485|3678884|P7|COMPLETED|Period 1, Day 3||4
1503685|NCT01642485|3678885|P6|COMPLETED|Period 1, Day 3||4
1503686|NCT01642485|3678886|P5|COMPLETED|Period 1, Day 3||4
1503687|NCT01642485|3678887|P4|COMPLETED|Period 1, Day 3||4
1503688|NCT01642485|3678888|P3|COMPLETED|Period 1, Day 3||4
1503689|NCT01642485|3678889|P2|COMPLETED|Period 1, Day 3||4
1503690|NCT01642485|3678890|P1|COMPLETED|Period 1, Day 3||4
1503691|NCT01642485|3678883|P8|STARTED|Period 1, Day 3||4
1503692|NCT01642485|3678884|P7|STARTED|Period 1, Day 3||4
1503693|NCT01642485|3678885|P6|STARTED|Period 1, Day 3||4
1503694|NCT01642485|3678886|P5|STARTED|Period 1, Day 3||4
1503695|NCT01642485|3678887|P4|STARTED|Period 1, Day 3||4
1503696|NCT01642485|3678888|P3|STARTED|Period 1, Day 3||4
1503697|NCT01642485|3678889|P2|STARTED|Period 1, Day 3||4
1503698|NCT01642485|3678890|P1|STARTED|Period 1, Day 3||4
1503699|NCT01642485|3678883|P8|NOT COMPLETED|Period 1, Day 2||0
1503700|NCT01642485|3678884|P7|NOT COMPLETED|Period 1, Day 2||0
1503701|NCT01642485|3678885|P6|NOT COMPLETED|Period 1, Day 2||0
1503702|NCT01642485|3678886|P5|NOT COMPLETED|Period 1, Day 2||0
1503703|NCT01642485|3678887|P4|NOT COMPLETED|Period 1, Day 2||0
1503704|NCT01642485|3678888|P3|NOT COMPLETED|Period 1, Day 2||0
1503705|NCT01642485|3678889|P2|NOT COMPLETED|Period 1, Day 2||0
1503706|NCT01642485|3678890|P1|NOT COMPLETED|Period 1, Day 2||0
1503707|NCT01642485|3678883|P8|COMPLETED|Period 1, Day 2||4
1503708|NCT01642485|3678884|P7|COMPLETED|Period 1, Day 2||4
1503709|NCT01642485|3678885|P6|COMPLETED|Period 1, Day 2||4
1503710|NCT01642485|3678886|P5|COMPLETED|Period 1, Day 2||4
1503711|NCT01642485|3678887|P4|COMPLETED|Period 1, Day 2||4
1503712|NCT01642485|3678888|P3|COMPLETED|Period 1, Day 2||4
1503713|NCT01642485|3678889|P2|COMPLETED|Period 1, Day 2||4
1503714|NCT01642485|3678890|P1|COMPLETED|Period 1, Day 2||4
1503715|NCT01642485|3678883|P8|STARTED|Period 1, Day 2||4
1503716|NCT01642485|3678884|P7|STARTED|Period 1, Day 2||4
1503717|NCT01642485|3678885|P6|STARTED|Period 1, Day 2||4
1503718|NCT01642485|3678886|P5|STARTED|Period 1, Day 2||4
1503719|NCT01642485|3678887|P4|STARTED|Period 1, Day 2||4
1503720|NCT01642485|3678888|P3|STARTED|Period 1, Day 2||4
1503721|NCT01642485|3678889|P2|STARTED|Period 1, Day 2||4
1503722|NCT01642485|3678890|P1|STARTED|Period 1, Day 2||4
1503723|NCT01642485|3678883|P8|NOT COMPLETED|Period 1, Day 1||0
1503724|NCT01642485|3678884|P7|NOT COMPLETED|Period 1, Day 1||0
1503725|NCT01642485|3678885|P6|NOT COMPLETED|Period 1, Day 1||0
1503726|NCT01642485|3678886|P5|NOT COMPLETED|Period 1, Day 1||0
1503727|NCT01642485|3678887|P4|NOT COMPLETED|Period 1, Day 1||0
1503728|NCT01642485|3678888|P3|NOT COMPLETED|Period 1, Day 1||0
1503729|NCT01642485|3678889|P2|NOT COMPLETED|Period 1, Day 1||0
1503730|NCT01642485|3678890|P1|NOT COMPLETED|Period 1, Day 1||0
1503731|NCT01642485|3678883|P8|COMPLETED|Period 1, Day 1||4
1503732|NCT01642485|3678884|P7|COMPLETED|Period 1, Day 1||4
1503733|NCT01642485|3678885|P6|COMPLETED|Period 1, Day 1||4
1503734|NCT01642485|3678886|P5|COMPLETED|Period 1, Day 1||4
1503735|NCT01642485|3678887|P4|COMPLETED|Period 1, Day 1||4
1503736|NCT01642485|3678888|P3|COMPLETED|Period 1, Day 1||4
1503737|NCT01642485|3678889|P2|COMPLETED|Period 1, Day 1||4
1503738|NCT01642485|3678890|P1|COMPLETED|Period 1, Day 1||4
1503739|NCT01642485|3678883|P8|STARTED|Period 1, Day 1||4
1503740|NCT01642485|3678884|P7|STARTED|Period 1, Day 1||4
1503741|NCT01642485|3678885|P6|STARTED|Period 1, Day 1||4
1503742|NCT01642485|3678886|P5|STARTED|Period 1, Day 1||4
1503743|NCT01642485|3678887|P4|STARTED|Period 1, Day 1||4
1503744|NCT01642485|3678888|P3|STARTED|Period 1, Day 1||4
1503745|NCT01642485|3678889|P2|STARTED|Period 1, Day 1||4
1503746|NCT01642485|3678890|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
1503747|NCT01642407|3678908|P1|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
1503748|NCT01642407|3678908|P1|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
1503749|NCT01642407|3678908|P1|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
1503750|NCT01642407|3678908|P1|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
1503751|NCT01642407|3678908|P1|COMPLETED|Part 1 (Screening Till Week 16)||3
1503752|NCT01642407|3678908|P1|STARTED|Part 1 (Screening Till Week 16)||6
1503753|NCT01642277|3678955|P2|NOT COMPLETED|Overall Study||0
1503754|NCT01642277|3678956|P1|NOT COMPLETED|Overall Study||24
1503755|NCT01642277|3678955|P2|COMPLETED|Overall Study||60
1503756|NCT01642277|3678956|P1|COMPLETED|Overall Study||50
1503757|NCT01642277|3678955|P2|STARTED|Overall Study||60
1503758|NCT01642277|3678956|P1|STARTED|Overall Study||74
1503759|NCT01642238|3678965|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1503760|NCT01642238|3678966|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1503761|NCT01642238|3678965|P2|COMPLETED|Second Intervention (1 Day)||8
1503762|NCT01642238|3678966|P1|COMPLETED|Second Intervention (1 Day)||7
1503763|NCT01642238|3678965|P2|STARTED|Second Intervention (1 Day)||8
1503764|NCT01642238|3678966|P1|STARTED|Second Intervention (1 Day)||7
1503765|NCT01642238|3678965|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
1503766|NCT01642238|3678966|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
1503767|NCT01642238|3678965|P2|COMPLETED|Washout (1-2 Weeks)||8
1503768|NCT01642238|3678966|P1|COMPLETED|Washout (1-2 Weeks)||7
1503769|NCT01642238|3678965|P2|STARTED|Washout (1-2 Weeks)||8
1503770|NCT01642238|3678966|P1|STARTED|Washout (1-2 Weeks)||7
1503771|NCT01642238|3678965|P2|NOT COMPLETED|First Intervention (1 Day)||0
1503772|NCT01642238|3678966|P1|NOT COMPLETED|First Intervention (1 Day)||0
1503773|NCT01642238|3678965|P2|COMPLETED|First Intervention (1 Day)||8
1503774|NCT01642238|3678966|P1|COMPLETED|First Intervention (1 Day)||7
1503775|NCT01642238|3678965|P2|STARTED|First Intervention (1 Day)||8
1503776|NCT01642238|3678966|P1|STARTED|First Intervention (1 Day)||7
1503777|NCT01642212|3678988|P5|NOT COMPLETED|Open-label Extension||8
1503778|NCT01642212|3678989|P4|NOT COMPLETED|Open-label Extension||10
1503779|NCT01642212|3678990|P3|NOT COMPLETED|Open-label Extension||0
1503780|NCT01642212|3678991|P2|NOT COMPLETED|Open-label Extension||0
1503781|NCT01642212|3678992|P1|NOT COMPLETED|Open-label Extension||0
1503782|NCT01642212|3678988|P5|COMPLETED|Open-label Extension||37
1503783|NCT01642212|3678989|P4|COMPLETED|Open-label Extension||27
1503784|NCT01642212|3678990|P3|COMPLETED|Open-label Extension||0
1503785|NCT01642212|3678991|P2|COMPLETED|Open-label Extension||0
1503786|NCT01642212|3678992|P1|COMPLETED|Open-label Extension||0
1503787|NCT01642212|3678988|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
1503788|NCT01642212|3678989|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
1503789|NCT01642212|3678990|P3|STARTED|Open-label Extension||0
1503790|NCT01642212|3678991|P2|STARTED|Open-label Extension||0
1503791|NCT01642212|3678992|P1|STARTED|Open-label Extension||0
1503792|NCT01642212|3678988|P5|NOT COMPLETED|Double-blind Treatment||0
1503793|NCT01642212|3678989|P4|NOT COMPLETED|Double-blind Treatment||0
1503794|NCT01642212|3678990|P3|NOT COMPLETED|Double-blind Treatment||2
1503795|NCT01642212|3678991|P2|NOT COMPLETED|Double-blind Treatment||3
1503796|NCT01642212|3678992|P1|NOT COMPLETED|Double-blind Treatment||0
1503797|NCT01642212|3678988|P5|COMPLETED|Double-blind Treatment||0
1503798|NCT01642212|3678989|P4|COMPLETED|Double-blind Treatment||0
1503799|NCT01642212|3678990|P3|COMPLETED|Double-blind Treatment||49
1503800|NCT01642212|3678991|P2|COMPLETED|Double-blind Treatment||39
1503801|NCT01642212|3678992|P1|COMPLETED|Double-blind Treatment||0
1503802|NCT01642212|3678988|P5|STARTED|Double-blind Treatment||0
1503803|NCT01642212|3678989|P4|STARTED|Double-blind Treatment||0
1503804|NCT01642212|3678990|P3|STARTED|Double-blind Treatment||51
1503805|NCT01642212|3678991|P2|STARTED|Double-blind Treatment||42
1503806|NCT01642212|3678992|P1|STARTED|Double-blind Treatment||0
1503807|NCT01642212|3678988|P5|NOT COMPLETED|Single-blind Baseline||0
1503808|NCT01642212|3678989|P4|NOT COMPLETED|Single-blind Baseline||0
1503809|NCT01642212|3678990|P3|NOT COMPLETED|Single-blind Baseline||0
1503810|NCT01642212|3678991|P2|NOT COMPLETED|Single-blind Baseline||0
1503811|NCT01642212|3678992|P1|NOT COMPLETED|Single-blind Baseline||26
1503812|NCT01642212|3678988|P5|COMPLETED|Single-blind Baseline||0
1503813|NCT01642212|3678989|P4|COMPLETED|Single-blind Baseline||0
1503814|NCT01642212|3678990|P3|COMPLETED|Single-blind Baseline||0
1503815|NCT01642212|3678991|P2|COMPLETED|Single-blind Baseline||0
1503816|NCT01642212|3678992|P1|COMPLETED|Single-blind Baseline||93
1503817|NCT01642212|3678988|P5|STARTED|Single-blind Baseline||0
1503818|NCT01642212|3678989|P4|STARTED|Single-blind Baseline||0
1503819|NCT01642212|3678990|P3|STARTED|Single-blind Baseline||0
1503820|NCT01642212|3678991|P2|STARTED|Single-blind Baseline||0
1503821|NCT01642212|3678992|P1|STARTED|Single-blind Baseline||119
1503822|NCT01642147|3679042|P2|NOT COMPLETED|Overall Study||0
1503823|NCT01642147|3679043|P1|NOT COMPLETED|Overall Study||0
1503824|NCT01642147|3679042|P2|COMPLETED|Overall Study||30
1503825|NCT01642147|3679043|P1|COMPLETED|Overall Study||30
1503826|NCT01642147|3679042|P2|STARTED|Overall Study||30
1503827|NCT01642147|3679043|P1|STARTED|Overall Study||30
1503828|NCT01642082|3679071|P1|NOT COMPLETED|Overall Study||0
1503829|NCT01642082|3679071|P1|COMPLETED|Overall Study||28
1503830|NCT01642082|3679071|P1|STARTED|Overall Study||28
1503831|NCT01642004|3679087|P2|NOT COMPLETED|Treatment||127
1503832|NCT01642004|3679088|P1|NOT COMPLETED|Treatment||110
1503833|NCT01642004|3679087|P2|COMPLETED|Treatment||2
1503834|NCT01642004|3679088|P1|COMPLETED|Treatment||21
1503835|NCT01642004|3679087|P2|STARTED|Treatment||129
1503836|NCT01642004|3679088|P1|STARTED|Treatment||131
1503837|NCT01642004|3679087|P2|NOT COMPLETED|Randomization||8
1503838|NCT01642004|3679088|P1|NOT COMPLETED|Randomization||4
1503839|NCT01642004|3679087|P2|COMPLETED|Randomization||129
1503840|NCT01642004|3679088|P1|COMPLETED|Randomization||131
1503841|NCT01642004|3679087|P2|STARTED|Randomization||137
1503842|NCT01642004|3679088|P1|STARTED|Randomization||135
1503843|NCT01641991|3679122|P4|NOT COMPLETED|Overall Study||16
1503844|NCT01641991|3679123|P3|NOT COMPLETED|Overall Study||17
1503845|NCT01641991|3679124|P2|NOT COMPLETED|Overall Study||8
1503846|NCT01641991|3679125|P1|NOT COMPLETED|Overall Study||9
1503847|NCT01641991|3679122|P4|COMPLETED|Overall Study||66
1503848|NCT01641991|3679123|P3|COMPLETED|Overall Study||65
1503849|NCT01641991|3679124|P2|COMPLETED|Overall Study||74
1503850|NCT01641991|3679125|P1|COMPLETED|Overall Study||73
1503851|NCT01641991|3679122|P4|STARTED|Overall Study||82
1503852|NCT01641991|3679123|P3|STARTED|Overall Study||82
1503853|NCT01641991|3679124|P2|STARTED|Overall Study||82
1503854|NCT01641991|3679125|P1|STARTED|Overall Study||82
1503855|NCT01641978|3679201|P1|NOT COMPLETED|Overall Study||0
1503856|NCT01641978|3679201|P1|COMPLETED|Overall Study||125
1503857|NCT01641978|3679201|P1|STARTED|Overall Study||125
1503858|NCT01641952|3679209|P1|NOT COMPLETED|Overall Study||34
1503859|NCT01641952|3679209|P1|COMPLETED|Overall Study||471
1503860|NCT01641952|3679209|P1|Treated|Overall Study||504
1503861|NCT01641952|3679209|P1|STARTED|Overall Study||505
1503862|NCT01641939|3679225|P3|NOT COMPLETED|Overall Study||70
1503863|NCT01641939|3679226|P2|NOT COMPLETED|Overall Study||228
1503864|NCT01641939|3679227|P1|NOT COMPLETED|Overall Study||117
1503865|NCT01641939|3679225|P3|COMPLETED|Overall Study||0
1503866|NCT01641939|3679226|P2|COMPLETED|Overall Study||0
1503867|NCT01641939|3679227|P1|COMPLETED|Overall Study||0
1503868|NCT01641939|3679225|P3|Stage 2|Overall Study||0
1503869|NCT01641939|3679226|P2|Stage 2|Overall Study||153
1503870|NCT01641939|3679227|P1|Stage 2|Overall Study||80
1503871|NCT01641939|3679225|P3|Stage 1|Overall Study||70
1503872|NCT01641939|3679226|P2|Stage 1|Overall Study||75
1503873|NCT01641939|3679227|P1|Stage 1|Overall Study||37
1503874|NCT01641939|3679225|P3|STARTED|Overall Study||70
1503875|NCT01641939|3679226|P2|STARTED|Overall Study||228
1503876|NCT01641939|3679227|P1|STARTED|Overall Study||117
1503877|NCT01641926|3679270|P4|NOT COMPLETED|Overall Study||4
1503878|NCT01641926|3679271|P3|NOT COMPLETED|Overall Study||11
1503879|NCT01641926|3679272|P2|NOT COMPLETED|Overall Study||15
1503880|NCT01641926|3679273|P1|NOT COMPLETED|Overall Study||28
1503881|NCT01641926|3679270|P4|COMPLETED|Overall Study||53
1503882|NCT01641926|3679271|P3|COMPLETED|Overall Study||46
1503883|NCT01641926|3679272|P2|COMPLETED|Overall Study||130
1503884|NCT01641926|3679273|P1|COMPLETED|Overall Study||115
1503885|NCT01641926|3679270|P4|Treated (All Participants as Treated)|Overall Study||57
1503886|NCT01641926|3679271|P3|Treated (All Participants as Treated)|Overall Study||56
1503887|NCT01641926|3679272|P2|Treated (All Participants as Treated)|Overall Study||144
1503888|NCT01641926|3679273|P1|Treated (All Participants as Treated)|Overall Study||142
1503889|NCT01641926|3679270|P4|STARTED|Overall Study||57
1503890|NCT01641926|3679271|P3|STARTED|Overall Study||57
1503891|NCT01641926|3679272|P2|STARTED|Overall Study||145
1503892|NCT01641926|3679273|P1|STARTED|Overall Study||143
1503893|NCT01641900|3679301|P2|NOT COMPLETED|Overall Study||2
1503894|NCT01641900|3679302|P1|NOT COMPLETED|Overall Study||2
1503895|NCT01641900|3679301|P2|COMPLETED|Overall Study||29
1503896|NCT01641900|3679302|P1|COMPLETED|Overall Study||26
1503897|NCT01641900|3679301|P2|Completed Drug Intervention|Overall Study||29
1503898|NCT01641900|3679302|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
1503899|NCT01641900|3679301|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
1503900|NCT01641900|3679302|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
1503901|NCT01641900|3679301|P2|STARTED|Overall Study||31
1503902|NCT01641900|3679302|P1|STARTED|Overall Study||28
1503903|NCT01641861|3679314|P2|NOT COMPLETED|Overall Study||25
1503904|NCT01641861|3679315|P1|NOT COMPLETED|Overall Study||35
1503905|NCT01641861|3679314|P2|COMPLETED|Overall Study||217
1503906|NCT01641861|3679315|P1|COMPLETED|Overall Study||211
1503907|NCT01641861|3679314|P2|STARTED|Overall Study||242
1503908|NCT01641861|3679315|P1|STARTED|Overall Study||246
1503909|NCT01641835|3679329|P1|NOT COMPLETED|Overall Study||0
1503910|NCT01641835|3679329|P1|COMPLETED|Overall Study||303
1503911|NCT01641835|3679329|P1|STARTED|Overall Study||303
1503912|NCT01641822|3679336|P3|NOT COMPLETED|Comparative Phase||10
1503913|NCT01641822|3679337|P2|NOT COMPLETED|Comparative Phase||6
1503914|NCT01641822|3679338|P1|NOT COMPLETED|Comparative Phase||0
1503915|NCT01641822|3679336|P3|COMPLETED|Comparative Phase||37
1503916|NCT01641822|3679337|P2|COMPLETED|Comparative Phase||37
1503917|NCT01641822|3679338|P1|COMPLETED|Comparative Phase||0
1503918|NCT01641822|3679336|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
1503919|NCT01641822|3679337|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
1503920|NCT01641822|3679338|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
1503921|NCT01641822|3679336|P3|STARTED|Comparative Phase||47
1503922|NCT01641822|3679337|P2|STARTED|Comparative Phase||43
1503923|NCT01641822|3679338|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
1503924|NCT01641822|3679336|P3|NOT COMPLETED|Run-in Phase||0
1503925|NCT01641822|3679337|P2|NOT COMPLETED|Run-in Phase||0
1503926|NCT01641822|3679338|P1|NOT COMPLETED|Run-in Phase||14
1503927|NCT01641822|3679336|P3|COMPLETED|Run-in Phase||0
1503928|NCT01641822|3679337|P2|COMPLETED|Run-in Phase||0
1503929|NCT01641822|3679338|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
1503930|NCT01641822|3679336|P3|STARTED|Run-in Phase||0
1503931|NCT01641822|3679337|P2|STARTED|Run-in Phase||0
1503932|NCT01641822|3679338|P1|STARTED|Run-in Phase||107
1503933|NCT01641692|3679355|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
1503934|NCT01641692|3679356|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
1503935|NCT01641692|3679357|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
1503936|NCT01641692|3679358|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
1503937|NCT01641692|3679359|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
1503938|NCT01641692|3679360|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
1503939|NCT01641692|3679361|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
1503940|NCT01641692|3679362|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
1503941|NCT01641692|3679355|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
1503942|NCT01641692|3679356|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
1503943|NCT01641692|3679357|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
1503944|NCT01641692|3679358|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
1503945|NCT01641692|3679359|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
1503946|NCT01641692|3679360|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
1504016|NCT01641692|3679358|P5|COMPLETED|Treatment Period 2||37
1503947|NCT01641692|3679361|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
1503948|NCT01641692|3679362|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
1503949|NCT01641692|3679355|P8|STARTED|Washout Period 3 or Follow-up||38
1503950|NCT01641692|3679356|P7|STARTED|Washout Period 3 or Follow-up||33
1503951|NCT01641692|3679357|P6|STARTED|Washout Period 3 or Follow-up||39
1503952|NCT01641692|3679358|P5|STARTED|Washout Period 3 or Follow-up||40
1503953|NCT01641692|3679359|P4|STARTED|Washout Period 3 or Follow-up||42
1503954|NCT01641692|3679360|P3|STARTED|Washout Period 3 or Follow-up||37
1503955|NCT01641692|3679361|P2|STARTED|Washout Period 3 or Follow-up||32
1503956|NCT01641692|3679362|P1|STARTED|Washout Period 3 or Follow-up||43
1503957|NCT01641692|3679355|P8|NOT COMPLETED|Treatment Period 3||0
1503958|NCT01641692|3679356|P7|NOT COMPLETED|Treatment Period 3||2
1503959|NCT01641692|3679357|P6|NOT COMPLETED|Treatment Period 3||0
1503960|NCT01641692|3679358|P5|NOT COMPLETED|Treatment Period 3||0
1503961|NCT01641692|3679359|P4|NOT COMPLETED|Treatment Period 3||0
1503962|NCT01641692|3679360|P3|NOT COMPLETED|Treatment Period 3||1
1503963|NCT01641692|3679361|P2|NOT COMPLETED|Treatment Period 3||1
1503964|NCT01641692|3679362|P1|NOT COMPLETED|Treatment Period 3||0
1503965|NCT01641692|3679355|P8|COMPLETED|Treatment Period 3||38
1503966|NCT01641692|3679356|P7|COMPLETED|Treatment Period 3||33
1503967|NCT01641692|3679357|P6|COMPLETED|Treatment Period 3||39
1503968|NCT01641692|3679358|P5|COMPLETED|Treatment Period 3||40
1503969|NCT01641692|3679359|P4|COMPLETED|Treatment Period 3||42
1503970|NCT01641692|3679360|P3|COMPLETED|Treatment Period 3||37
1503971|NCT01641692|3679361|P2|COMPLETED|Treatment Period 3||32
1503972|NCT01641692|3679362|P1|COMPLETED|Treatment Period 3||43
1503973|NCT01641692|3679355|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
1503974|NCT01641692|3679356|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
1503975|NCT01641692|3679357|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
1503976|NCT01641692|3679358|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
1503977|NCT01641692|3679359|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
1503978|NCT01641692|3679360|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
1503979|NCT01641692|3679361|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
1503980|NCT01641692|3679362|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
1503981|NCT01641692|3679355|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
1503982|NCT01641692|3679356|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
1503983|NCT01641692|3679357|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
1503984|NCT01641692|3679358|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
1503985|NCT01641692|3679359|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
1503986|NCT01641692|3679360|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
1503987|NCT01641692|3679361|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
1503988|NCT01641692|3679362|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
1503989|NCT01641692|3679355|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
1503990|NCT01641692|3679356|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
1503991|NCT01641692|3679357|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
1503992|NCT01641692|3679358|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
1503993|NCT01641692|3679359|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
1503994|NCT01641692|3679360|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
1503995|NCT01641692|3679361|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
1503996|NCT01641692|3679362|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
1503997|NCT01641692|3679355|P8|STARTED|Washout Period 2 (12-14 Days)||35
1503998|NCT01641692|3679356|P7|STARTED|Washout Period 2 (12-14 Days)||43
1503999|NCT01641692|3679357|P6|STARTED|Washout Period 2 (12-14 Days)||43
1504000|NCT01641692|3679358|P5|STARTED|Washout Period 2 (12-14 Days)||37
1504001|NCT01641692|3679359|P4|STARTED|Washout Period 2 (12-14 Days)||41
1504002|NCT01641692|3679360|P3|STARTED|Washout Period 2 (12-14 Days)||40
1504003|NCT01641692|3679361|P2|STARTED|Washout Period 2 (12-14 Days)||46
1504004|NCT01641692|3679362|P1|STARTED|Washout Period 2 (12-14 Days)||30
1504005|NCT01641692|3679355|P8|NOT COMPLETED|Treatment Period 2||1
1504006|NCT01641692|3679356|P7|NOT COMPLETED|Treatment Period 2||0
1504007|NCT01641692|3679357|P6|NOT COMPLETED|Treatment Period 2||2
1504008|NCT01641692|3679358|P5|NOT COMPLETED|Treatment Period 2||0
1504009|NCT01641692|3679359|P4|NOT COMPLETED|Treatment Period 2||0
1504010|NCT01641692|3679360|P3|NOT COMPLETED|Treatment Period 2||0
1504011|NCT01641692|3679361|P2|NOT COMPLETED|Treatment Period 2||0
1504012|NCT01641692|3679362|P1|NOT COMPLETED|Treatment Period 2||3
1504013|NCT01641692|3679355|P8|COMPLETED|Treatment Period 2||35
1504014|NCT01641692|3679356|P7|COMPLETED|Treatment Period 2||43
1504015|NCT01641692|3679357|P6|COMPLETED|Treatment Period 2||43
1504017|NCT01641692|3679359|P4|COMPLETED|Treatment Period 2||41
1504018|NCT01641692|3679360|P3|COMPLETED|Treatment Period 2||40
1504019|NCT01641692|3679361|P2|COMPLETED|Treatment Period 2||46
1504020|NCT01641692|3679362|P1|COMPLETED|Treatment Period 2||30
1504021|NCT01641692|3679355|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
1504022|NCT01641692|3679356|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
1504023|NCT01641692|3679357|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
1504024|NCT01641692|3679358|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
1504025|NCT01641692|3679359|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
1504026|NCT01641692|3679360|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
1504027|NCT01641692|3679361|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
1504028|NCT01641692|3679362|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
1504029|NCT01641692|3679355|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
1504030|NCT01641692|3679356|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
1504031|NCT01641692|3679357|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
1504032|NCT01641692|3679358|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
1504033|NCT01641692|3679359|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
1504034|NCT01641692|3679360|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
1504035|NCT01641692|3679361|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
1504036|NCT01641692|3679362|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
1504037|NCT01641692|3679355|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
1504038|NCT01641692|3679356|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
1504039|NCT01641692|3679357|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
1504040|NCT01641692|3679358|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
1504041|NCT01641692|3679359|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
1504042|NCT01641692|3679360|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
1504043|NCT01641692|3679361|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
1504044|NCT01641692|3679362|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
1504045|NCT01641692|3679355|P8|STARTED|Washout Period 1 (12-14 Days)||48
1504046|NCT01641692|3679356|P7|STARTED|Washout Period 1 (12-14 Days)||38
1504047|NCT01641692|3679357|P6|STARTED|Washout Period 1 (12-14 Days)||37
1504048|NCT01641692|3679358|P5|STARTED|Washout Period 1 (12-14 Days)||39
1504049|NCT01641692|3679359|P4|STARTED|Washout Period 1 (12-14 Days)||41
1504050|NCT01641692|3679360|P3|STARTED|Washout Period 1 (12-14 Days)||50
1504051|NCT01641692|3679361|P2|STARTED|Washout Period 1 (12-14 Days)||45
1504052|NCT01641692|3679362|P1|STARTED|Washout Period 1 (12-14 Days)||40
1504053|NCT01641692|3679355|P8|NOT COMPLETED|Treatment Period 1||3
1504054|NCT01641692|3679356|P7|NOT COMPLETED|Treatment Period 1||0
1504055|NCT01641692|3679357|P6|NOT COMPLETED|Treatment Period 1||2
1504056|NCT01641692|3679358|P5|NOT COMPLETED|Treatment Period 1||4
1504057|NCT01641692|3679359|P4|NOT COMPLETED|Treatment Period 1||0
1504058|NCT01641692|3679360|P3|NOT COMPLETED|Treatment Period 1||1
1504059|NCT01641692|3679361|P2|NOT COMPLETED|Treatment Period 1||0
1504060|NCT01641692|3679362|P1|NOT COMPLETED|Treatment Period 1||2
1504061|NCT01641692|3679355|P8|COMPLETED|Treatment Period 1||48
1504062|NCT01641692|3679356|P7|COMPLETED|Treatment Period 1||38
1504063|NCT01641692|3679357|P6|COMPLETED|Treatment Period 1||37
1504064|NCT01641692|3679358|P5|COMPLETED|Treatment Period 1||39
1504065|NCT01641692|3679359|P4|COMPLETED|Treatment Period 1||41
1504066|NCT01641692|3679360|P3|COMPLETED|Treatment Period 1||50
1504067|NCT01641692|3679361|P2|COMPLETED|Treatment Period 1||45
1504068|NCT01641692|3679362|P1|COMPLETED|Treatment Period 1||40
1504069|NCT01641692|3679355|P8|STARTED|Treatment Period 1||51
1504070|NCT01641692|3679356|P7|STARTED|Treatment Period 1||38
1504071|NCT01641692|3679357|P6|STARTED|Treatment Period 1||39
1504072|NCT01641692|3679358|P5|STARTED|Treatment Period 1||43
1504073|NCT01641692|3679359|P4|STARTED|Treatment Period 1||41
1504074|NCT01641692|3679360|P3|STARTED|Treatment Period 1||51
1504075|NCT01641692|3679361|P2|STARTED|Treatment Period 1||45
1504076|NCT01641692|3679362|P1|STARTED|Treatment Period 1||42
1504077|NCT01641653|3679551|P2|NOT COMPLETED|Overall Study||0
1504078|NCT01641653|3679552|P1|NOT COMPLETED|Overall Study||0
1504079|NCT01641653|3679551|P2|COMPLETED|Overall Study||30
1504080|NCT01641653|3679552|P1|COMPLETED|Overall Study||30
1504081|NCT01641653|3679551|P2|STARTED|Overall Study||30
1504082|NCT01641653|3679552|P1|STARTED|Overall Study||30
1504083|NCT01641640|3679562|P1|NOT COMPLETED|Overall Study||36
1504084|NCT01641640|3679562|P1|COMPLETED|Overall Study||292
1504085|NCT01641640|3679562|P1|Enrolled and Treated|Overall Study||327
1504086|NCT01641640|3679562|P1|STARTED|Overall Study||328
1504087|NCT01641471|3679573|P2|NOT COMPLETED|Overall Study||27
1504088|NCT01641471|3679574|P1|NOT COMPLETED|Overall Study||23
1504089|NCT01641471|3679573|P2|COMPLETED|Overall Study||31
1504090|NCT01641471|3679574|P1|COMPLETED|Overall Study||35
1504091|NCT01641471|3679573|P2|STARTED|Overall Study||58
1504092|NCT01641471|3679574|P1|STARTED|Overall Study||58
1504093|NCT01641380|3679588|P2|NOT COMPLETED|Third Injection Cycle||5
1504094|NCT01641380|3679589|P1|NOT COMPLETED|Third Injection Cycle||3
1504095|NCT01641380|3679588|P2|COMPLETED|Third Injection Cycle||33
1504096|NCT01641380|3679589|P1|COMPLETED|Third Injection Cycle||36
1504097|NCT01641380|3679588|P2|STARTED|Third Injection Cycle||38
1504098|NCT01641380|3679589|P1|STARTED|Third Injection Cycle||39
1504099|NCT01641380|3679588|P2|NOT COMPLETED|Second Injection Cycle||6
1504100|NCT01641380|3679589|P1|NOT COMPLETED|Second Injection Cycle||4
1504101|NCT01641380|3679588|P2|COMPLETED|Second Injection Cycle||38
1504102|NCT01641380|3679589|P1|COMPLETED|Second Injection Cycle||39
1504103|NCT01641380|3679588|P2|STARTED|Second Injection Cycle||44
1504104|NCT01641380|3679589|P1|STARTED|Second Injection Cycle||43
1504105|NCT01641380|3679588|P2|NOT COMPLETED|First Injection Cycle||6
1504106|NCT01641380|3679589|P1|NOT COMPLETED|First Injection Cycle||7
1504107|NCT01641380|3679588|P2|COMPLETED|First Injection Cycle||44
1504108|NCT01641380|3679589|P1|COMPLETED|First Injection Cycle||43
1504109|NCT01641380|3679588|P2|STARTED|First Injection Cycle||50
1504110|NCT01641380|3679589|P1|STARTED|First Injection Cycle||50
1504111|NCT01641367|3679601|P6|NOT COMPLETED|Overall Study||1
1504112|NCT01641367|3679602|P5|NOT COMPLETED|Overall Study||3
1504113|NCT01641367|3679603|P4|NOT COMPLETED|Overall Study||0
1504114|NCT01641367|3679604|P3|NOT COMPLETED|Overall Study||4
1504115|NCT01641367|3679605|P2|NOT COMPLETED|Overall Study||1
1504116|NCT01641367|3679606|P1|NOT COMPLETED|Overall Study||34
1504117|NCT01641367|3679601|P6|COMPLETED|Overall Study||33
1504118|NCT01641367|3679602|P5|COMPLETED|Overall Study||67
1504119|NCT01641367|3679603|P4|COMPLETED|Overall Study||8
1504120|NCT01641367|3679604|P3|COMPLETED|Overall Study||68
1504121|NCT01641367|3679605|P2|COMPLETED|Overall Study||73
1504122|NCT01641367|3679606|P1|COMPLETED|Overall Study||253
1504123|NCT01641367|3679601|P6|STARTED|Overall Study||34
1504124|NCT01641367|3679602|P5|STARTED|Overall Study||70
1504125|NCT01641367|3679603|P4|STARTED|Overall Study||8
1504126|NCT01641367|3679604|P3|STARTED|Overall Study||72
1504127|NCT01641367|3679605|P2|STARTED|Overall Study||74
1504128|NCT01641367|3679606|P1|STARTED|Overall Study||287
1504129|NCT01641237|3679621|P4|NOT COMPLETED|Period IV||0
1504130|NCT01641237|3679622|P3|NOT COMPLETED|Period IV||0
1504131|NCT01641237|3679623|P2|NOT COMPLETED|Period IV||0
1504132|NCT01641237|3679624|P1|NOT COMPLETED|Period IV||0
1504133|NCT01641237|3679621|P4|COMPLETED|Period IV||15
1504134|NCT01641237|3679622|P3|COMPLETED|Period IV||15
1504135|NCT01641237|3679623|P2|COMPLETED|Period IV||15
1504136|NCT01641237|3679624|P1|COMPLETED|Period IV||15
1504137|NCT01641237|3679621|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
1504138|NCT01641237|3679622|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
1504139|NCT01641237|3679623|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
1504140|NCT01641237|3679624|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
1504141|NCT01641237|3679621|P4|NOT COMPLETED|Period III||0
1504142|NCT01641237|3679622|P3|NOT COMPLETED|Period III||0
1504143|NCT01641237|3679623|P2|NOT COMPLETED|Period III||0
1504144|NCT01641237|3679624|P1|NOT COMPLETED|Period III||1
1504145|NCT01641237|3679621|P4|COMPLETED|Period III||16
1504146|NCT01641237|3679622|P3|COMPLETED|Period III||15
1504147|NCT01641237|3679623|P2|COMPLETED|Period III||14
1504148|NCT01641237|3679624|P1|COMPLETED|Period III||15
1504149|NCT01641237|3679621|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
1504150|NCT01641237|3679622|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
1504151|NCT01641237|3679623|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
1504152|NCT01641237|3679624|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
1504153|NCT01641237|3679621|P4|NOT COMPLETED|Period II||0
1504154|NCT01641237|3679622|P3|NOT COMPLETED|Period II||0
1504155|NCT01641237|3679623|P2|NOT COMPLETED|Period II||0
1504156|NCT01641237|3679624|P1|NOT COMPLETED|Period II||1
1504157|NCT01641237|3679621|P4|COMPLETED|Period II||15
1504158|NCT01641237|3679622|P3|COMPLETED|Period II||16
1504159|NCT01641237|3679623|P2|COMPLETED|Period II||16
1504160|NCT01641237|3679624|P1|COMPLETED|Period II||14
1504161|NCT01641237|3679621|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
1504162|NCT01641237|3679622|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
1504163|NCT01641237|3679623|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
1504164|NCT01641237|3679624|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
1504165|NCT01641237|3679621|P4|NOT COMPLETED|Period I||0
1504166|NCT01641237|3679622|P3|NOT COMPLETED|Period I||0
1504167|NCT01641237|3679623|P2|NOT COMPLETED|Period I||0
1504168|NCT01641237|3679624|P1|NOT COMPLETED|Period I||0
1504169|NCT01641237|3679621|P4|COMPLETED|Period I||15
1504170|NCT01641237|3679622|P3|COMPLETED|Period I||15
1504171|NCT01641237|3679623|P2|COMPLETED|Period I||16
1504172|NCT01641237|3679624|P1|COMPLETED|Period I||16
1504173|NCT01641237|3679621|P4|STARTED|Period I||15
1504174|NCT01641237|3679622|P3|STARTED|Period I||15
1504175|NCT01641237|3679623|P2|STARTED|Period I||16
1504176|NCT01641237|3679624|P1|STARTED|Period I||16
1504177|NCT01641159|3679648|P2|NOT COMPLETED|Overall Study||2
1504178|NCT01641159|3679649|P1|NOT COMPLETED|Overall Study||2
1504179|NCT01641159|3679648|P2|COMPLETED|Overall Study||25
1504180|NCT01641159|3679649|P1|COMPLETED|Overall Study||33
1504181|NCT01641159|3679648|P2|STARTED|Overall Study||27
1504182|NCT01641159|3679649|P1|STARTED|Overall Study||35
1504183|NCT01641133|3679660|P3|NOT COMPLETED|Overall Study||8
1504184|NCT01641133|3679661|P2|NOT COMPLETED|Overall Study||9
1504185|NCT01641133|3679662|P1|NOT COMPLETED|Overall Study||10
1504186|NCT01641133|3679660|P3|COMPLETED|Overall Study||90
1504187|NCT01641133|3679661|P2|COMPLETED|Overall Study||90
1504188|NCT01641133|3679662|P1|COMPLETED|Overall Study||87
1504189|NCT01641133|3679660|P3|STARTED|Overall Study||98
1504190|NCT01641133|3679661|P2|STARTED|Overall Study||99
1504191|NCT01641133|3679662|P1|STARTED|Overall Study||97
1504192|NCT01641120|3679700|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
1504193|NCT01641120|3679700|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
1504194|NCT01641120|3679700|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
1504195|NCT01641120|3679700|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
1504196|NCT01641120|3679700|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
1504197|NCT01641120|3679700|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
1504198|NCT01641081|3679712|P10|NOT COMPLETED|Period 5||0
1504199|NCT01641081|3679713|P9|NOT COMPLETED|Period 5||0
1504200|NCT01641081|3679714|P8|NOT COMPLETED|Period 5||0
1504201|NCT01641081|3679715|P7|NOT COMPLETED|Period 5||0
1504202|NCT01641081|3679716|P6|NOT COMPLETED|Period 5||0
1504203|NCT01641081|3679717|P5|NOT COMPLETED|Period 5||0
1504204|NCT01641081|3679718|P4|NOT COMPLETED|Period 5||0
1504205|NCT01641081|3679719|P3|NOT COMPLETED|Period 5||2
1504206|NCT01641081|3679720|P2|NOT COMPLETED|Period 5||0
1504207|NCT01641081|3679721|P1|NOT COMPLETED|Period 5||0
1504208|NCT01641081|3679712|P10|COMPLETED|Period 5||14
1504209|NCT01641081|3679713|P9|COMPLETED|Period 5||14
1504210|NCT01641081|3679714|P8|COMPLETED|Period 5||14
1504211|NCT01641081|3679715|P7|COMPLETED|Period 5||16
1504212|NCT01641081|3679716|P6|COMPLETED|Period 5||18
1504213|NCT01641081|3679717|P5|COMPLETED|Period 5||16
1504214|NCT01641081|3679718|P4|COMPLETED|Period 5||20
1504215|NCT01641081|3679719|P3|COMPLETED|Period 5||12
1504216|NCT01641081|3679720|P2|COMPLETED|Period 5||17
1504217|NCT01641081|3679721|P1|COMPLETED|Period 5||16
1504218|NCT01641081|3679712|P10|STARTED|Period 5||14
1504219|NCT01641081|3679713|P9|STARTED|Period 5||14
1504220|NCT01641081|3679714|P8|STARTED|Period 5||14
1504221|NCT01641081|3679715|P7|STARTED|Period 5||16
1504222|NCT01641081|3679716|P6|STARTED|Period 5||18
1504223|NCT01641081|3679717|P5|STARTED|Period 5||16
1504224|NCT01641081|3679718|P4|STARTED|Period 5||20
1504225|NCT01641081|3679719|P3|STARTED|Period 5||14
1504226|NCT01641081|3679720|P2|STARTED|Period 5||17
1504227|NCT01641081|3679721|P1|STARTED|Period 5||16
1504228|NCT01641081|3679712|P10|NOT COMPLETED|Period 4||0
1504229|NCT01641081|3679713|P9|NOT COMPLETED|Period 4||0
1504230|NCT01641081|3679714|P8|NOT COMPLETED|Period 4||0
1504231|NCT01641081|3679715|P7|NOT COMPLETED|Period 4||0
1504232|NCT01641081|3679716|P6|NOT COMPLETED|Period 4||0
1504233|NCT01641081|3679717|P5|NOT COMPLETED|Period 4||0
1504234|NCT01641081|3679718|P4|NOT COMPLETED|Period 4||1
1504235|NCT01641081|3679719|P3|NOT COMPLETED|Period 4||0
1504236|NCT01641081|3679720|P2|NOT COMPLETED|Period 4||1
1504237|NCT01641081|3679721|P1|NOT COMPLETED|Period 4||0
1504238|NCT01641081|3679712|P10|COMPLETED|Period 4||14
1504239|NCT01641081|3679713|P9|COMPLETED|Period 4||14
1504240|NCT01641081|3679714|P8|COMPLETED|Period 4||14
1504241|NCT01641081|3679715|P7|COMPLETED|Period 4||16
1504242|NCT01641081|3679716|P6|COMPLETED|Period 4||18
1504243|NCT01641081|3679717|P5|COMPLETED|Period 4||16
1504244|NCT01641081|3679718|P4|COMPLETED|Period 4||20
1504245|NCT01641081|3679719|P3|COMPLETED|Period 4||14
1504246|NCT01641081|3679720|P2|COMPLETED|Period 4||17
1504247|NCT01641081|3679721|P1|COMPLETED|Period 4||16
1504248|NCT01641081|3679712|P10|STARTED|Period 4||14
1504249|NCT01641081|3679713|P9|STARTED|Period 4||14
1504250|NCT01641081|3679714|P8|STARTED|Period 4||14
1504251|NCT01641081|3679715|P7|STARTED|Period 4||16
1504252|NCT01641081|3679716|P6|STARTED|Period 4||18
1504253|NCT01641081|3679717|P5|STARTED|Period 4||16
1504254|NCT01641081|3679718|P4|STARTED|Period 4||21
1504255|NCT01641081|3679719|P3|STARTED|Period 4||14
1504256|NCT01641081|3679720|P2|STARTED|Period 4||18
1504257|NCT01641081|3679721|P1|STARTED|Period 4||16
1504258|NCT01641081|3679712|P10|NOT COMPLETED|Period 3||0
1504259|NCT01641081|3679713|P9|NOT COMPLETED|Period 3||1
1504260|NCT01641081|3679714|P8|NOT COMPLETED|Period 3||0
1504261|NCT01641081|3679715|P7|NOT COMPLETED|Period 3||0
1504262|NCT01641081|3679716|P6|NOT COMPLETED|Period 3||0
1504263|NCT01641081|3679717|P5|NOT COMPLETED|Period 3||0
1504264|NCT01641081|3679718|P4|NOT COMPLETED|Period 3||0
1504265|NCT01641081|3679719|P3|NOT COMPLETED|Period 3||1
1504266|NCT01641081|3679720|P2|NOT COMPLETED|Period 3||0
1504267|NCT01641081|3679721|P1|NOT COMPLETED|Period 3||0
1504268|NCT01641081|3679712|P10|COMPLETED|Period 3||14
1504269|NCT01641081|3679713|P9|COMPLETED|Period 3||14
1504270|NCT01641081|3679714|P8|COMPLETED|Period 3||14
1504271|NCT01641081|3679715|P7|COMPLETED|Period 3||16
1504272|NCT01641081|3679716|P6|COMPLETED|Period 3||18
1504273|NCT01641081|3679717|P5|COMPLETED|Period 3||16
1504274|NCT01641081|3679718|P4|COMPLETED|Period 3||21
1504275|NCT01641081|3679719|P3|COMPLETED|Period 3||14
1504276|NCT01641081|3679720|P2|COMPLETED|Period 3||18
1504277|NCT01641081|3679721|P1|COMPLETED|Period 3||16
1504278|NCT01641081|3679712|P10|STARTED|Period 3||14
1504279|NCT01641081|3679713|P9|STARTED|Period 3||15
1504280|NCT01641081|3679714|P8|STARTED|Period 3||14
1504281|NCT01641081|3679715|P7|STARTED|Period 3||16
1504282|NCT01641081|3679716|P6|STARTED|Period 3||18
1504283|NCT01641081|3679717|P5|STARTED|Period 3||16
1504284|NCT01641081|3679718|P4|STARTED|Period 3||21
1504285|NCT01641081|3679719|P3|STARTED|Period 3||15
1504286|NCT01641081|3679720|P2|STARTED|Period 3||18
1504287|NCT01641081|3679721|P1|STARTED|Period 3||16
1504288|NCT01641081|3679712|P10|NOT COMPLETED|Period 2||0
1504289|NCT01641081|3679713|P9|NOT COMPLETED|Period 2||0
1504290|NCT01641081|3679714|P8|NOT COMPLETED|Period 2||0
1504291|NCT01641081|3679715|P7|NOT COMPLETED|Period 2||2
1504292|NCT01641081|3679716|P6|NOT COMPLETED|Period 2||1
1504293|NCT01641081|3679717|P5|NOT COMPLETED|Period 2||0
1504294|NCT01641081|3679718|P4|NOT COMPLETED|Period 2||1
1504295|NCT01641081|3679719|P3|NOT COMPLETED|Period 2||0
1504296|NCT01641081|3679720|P2|NOT COMPLETED|Period 2||0
1504297|NCT01641081|3679721|P1|NOT COMPLETED|Period 2||1
1504298|NCT01641081|3679712|P10|COMPLETED|Period 2||14
1504299|NCT01641081|3679713|P9|COMPLETED|Period 2||15
1504300|NCT01641081|3679714|P8|COMPLETED|Period 2||14
1504301|NCT01641081|3679715|P7|COMPLETED|Period 2||16
1504302|NCT01641081|3679716|P6|COMPLETED|Period 2||18
1504303|NCT01641081|3679717|P5|COMPLETED|Period 2||16
1504304|NCT01641081|3679718|P4|COMPLETED|Period 2||21
1504305|NCT01641081|3679719|P3|COMPLETED|Period 2||15
1504306|NCT01641081|3679720|P2|COMPLETED|Period 2||18
1504307|NCT01641081|3679721|P1|COMPLETED|Period 2||16
1504308|NCT01641081|3679712|P10|STARTED|Period 2||14
1504309|NCT01641081|3679713|P9|STARTED|Period 2||15
1504310|NCT01641081|3679714|P8|STARTED|Period 2||14
1504311|NCT01641081|3679715|P7|STARTED|Period 2||18
1504312|NCT01641081|3679716|P6|STARTED|Period 2||19
1504313|NCT01641081|3679717|P5|STARTED|Period 2||16
1504314|NCT01641081|3679718|P4|STARTED|Period 2||22
1504315|NCT01641081|3679719|P3|STARTED|Period 2||15
1504316|NCT01641081|3679720|P2|STARTED|Period 2||18
1504317|NCT01641081|3679721|P1|STARTED|Period 2||17
1504318|NCT01641081|3679712|P10|NOT COMPLETED|Period 1||0
1504319|NCT01641081|3679713|P9|NOT COMPLETED|Period 1||0
1504320|NCT01641081|3679714|P8|NOT COMPLETED|Period 1||3
1504321|NCT01641081|3679715|P7|NOT COMPLETED|Period 1||1
1504322|NCT01641081|3679716|P6|NOT COMPLETED|Period 1||0
1504323|NCT01641081|3679717|P5|NOT COMPLETED|Period 1||1
1504324|NCT01641081|3679718|P4|NOT COMPLETED|Period 1||0
1504325|NCT01641081|3679719|P3|NOT COMPLETED|Period 1||0
1504326|NCT01641081|3679720|P2|NOT COMPLETED|Period 1||0
1504327|NCT01641081|3679721|P1|NOT COMPLETED|Period 1||1
1504328|NCT01641081|3679712|P10|COMPLETED|Period 1||14
1504329|NCT01641081|3679713|P9|COMPLETED|Period 1||15
1504330|NCT01641081|3679714|P8|COMPLETED|Period 1||14
1504331|NCT01641081|3679715|P7|COMPLETED|Period 1||18
1504332|NCT01641081|3679716|P6|COMPLETED|Period 1||19
1504333|NCT01641081|3679717|P5|COMPLETED|Period 1||16
1504334|NCT01641081|3679718|P4|COMPLETED|Period 1||22
1504335|NCT01641081|3679719|P3|COMPLETED|Period 1||15
1504336|NCT01641081|3679720|P2|COMPLETED|Period 1||18
1504337|NCT01641081|3679721|P1|COMPLETED|Period 1||17
1504338|NCT01641081|3679712|P10|STARTED|Period 1||14
1504339|NCT01641081|3679713|P9|STARTED|Period 1||15
1504340|NCT01641081|3679714|P8|STARTED|Period 1||17
1504341|NCT01641081|3679715|P7|STARTED|Period 1||19
1504342|NCT01641081|3679716|P6|STARTED|Period 1||19
1504343|NCT01641081|3679717|P5|STARTED|Period 1||17
1504344|NCT01641081|3679718|P4|STARTED|Period 1||22
1504345|NCT01641081|3679719|P3|STARTED|Period 1||15
1504346|NCT01641081|3679720|P2|STARTED|Period 1||18
1504347|NCT01641081|3679721|P1|STARTED|Period 1||18
1504348|NCT01641042|3679740|P2|NOT COMPLETED|Overall Study||0
1504349|NCT01641042|3679741|P1|NOT COMPLETED|Overall Study||0
1504350|NCT01641042|3679740|P2|COMPLETED|Overall Study||43
1504351|NCT01641042|3679741|P1|COMPLETED|Overall Study||43
1504352|NCT01641042|3679740|P2|STARTED|Overall Study||43
1504353|NCT01641042|3679741|P1|STARTED|Overall Study||43
1504354|NCT01640964|3679790|P3|NOT COMPLETED|Overall Study||3
1504355|NCT01640964|3679791|P2|NOT COMPLETED|Overall Study||1
1504356|NCT01640964|3679792|P1|NOT COMPLETED|Overall Study||1
1504357|NCT01640964|3679790|P3|COMPLETED|Overall Study||3
1504358|NCT01640964|3679791|P2|COMPLETED|Overall Study||19
1504359|NCT01640964|3679792|P1|COMPLETED|Overall Study||19
1504360|NCT01640964|3679790|P3|STARTED|Overall Study||6
1504361|NCT01640964|3679791|P2|STARTED|Overall Study||20
1504362|NCT01640964|3679792|P1|STARTED|Overall Study||20
1504363|NCT01640951|3679815|P8|NOT COMPLETED|Overall Study||16
1504364|NCT01640951|3679816|P7|NOT COMPLETED|Overall Study||18
1504365|NCT01640951|3679817|P6|NOT COMPLETED|Overall Study||47
1504366|NCT01640951|3679818|P5|NOT COMPLETED|Overall Study||13
1504367|NCT01640951|3679819|P4|NOT COMPLETED|Overall Study||45
1504368|NCT01640951|3679820|P3|NOT COMPLETED|Overall Study||42
1504369|NCT01640951|3679821|P2|NOT COMPLETED|Overall Study||15
1504370|NCT01640951|3679822|P1|NOT COMPLETED|Overall Study||46
1504371|NCT01640951|3679815|P8|COMPLETED|Overall Study||17
1504372|NCT01640951|3679816|P7|COMPLETED|Overall Study||94
1504373|NCT01640951|3679817|P6|COMPLETED|Overall Study||13
1504374|NCT01640951|3679818|P5|COMPLETED|Overall Study||82
1504375|NCT01640951|3679819|P4|COMPLETED|Overall Study||10
1504376|NCT01640951|3679820|P3|COMPLETED|Overall Study||126
1504377|NCT01640951|3679821|P2|COMPLETED|Overall Study||60
1504378|NCT01640951|3679822|P1|COMPLETED|Overall Study||31
1504379|NCT01640951|3679815|P8|STARTED|Overall Study||33
1504380|NCT01640951|3679816|P7|STARTED|Overall Study||112
1504381|NCT01640951|3679817|P6|STARTED|Overall Study||60
1504382|NCT01640951|3679818|P5|STARTED|Overall Study||95
1504383|NCT01640951|3679819|P4|STARTED|Overall Study||55
1504384|NCT01640951|3679820|P3|STARTED|Overall Study||168
1504385|NCT01640951|3679821|P2|STARTED|Overall Study||75
1504386|NCT01640951|3679822|P1|STARTED|Overall Study||77
1504387|NCT01640925|3679924|P2|NOT COMPLETED|Overall Study||11
1504388|NCT01640925|3679925|P1|NOT COMPLETED|Overall Study||14
1504389|NCT01640925|3679924|P2|COMPLETED|Overall Study||164
1504390|NCT01640925|3679925|P1|COMPLETED|Overall Study||161
1504391|NCT01640925|3679924|P2|STARTED|Overall Study||175
1504392|NCT01640925|3679925|P1|STARTED|Overall Study||175
1504393|NCT01640873|3679939|P2|NOT COMPLETED|Overall Study||1
1504394|NCT01640873|3679940|P1|NOT COMPLETED|Overall Study||2
1504395|NCT01640873|3679939|P2|COMPLETED|Overall Study||10
1504396|NCT01640873|3679940|P1|COMPLETED|Overall Study||20
1504397|NCT01640873|3679939|P2|STARTED|Overall Study||11
1504398|NCT01640873|3679940|P1|STARTED|Overall Study||22
1504399|NCT01640834|3679959|P3|NOT COMPLETED|Overall Study||0
1504400|NCT01640834|3679960|P2|NOT COMPLETED|Overall Study||0
1504401|NCT01640834|3679961|P1|NOT COMPLETED|Overall Study||0
1504402|NCT01640834|3679959|P3|COMPLETED|Overall Study||4
1504403|NCT01640834|3679960|P2|COMPLETED|Overall Study||8
1504404|NCT01640834|3679961|P1|COMPLETED|Overall Study||8
1504405|NCT01640834|3679959|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
1504406|NCT01640834|3679960|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
1504407|NCT01640834|3679961|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
1504408|NCT01640834|3679959|P3|STARTED|Overall Study||4
1504409|NCT01640834|3679960|P2|STARTED|Overall Study||8
1504410|NCT01640834|3679961|P1|STARTED|Overall Study||8
1504411|NCT01640548|3679988|P1|NOT COMPLETED|Overall Study||0
1504412|NCT01640548|3679988|P1|COMPLETED|Overall Study||309
1504413|NCT01640548|3679988|P1|STARTED|Overall Study||309
1504414|NCT01640379|3680004|P2|NOT COMPLETED|Overall Study||12
1504415|NCT01640379|3680005|P1|NOT COMPLETED|Overall Study||14
1504416|NCT01640379|3680004|P2|COMPLETED|Overall Study||125
1504417|NCT01640379|3680005|P1|COMPLETED|Overall Study||135
1504418|NCT01640379|3680004|P2|STARTED|Overall Study||137
1504419|NCT01640379|3680005|P1|STARTED|Overall Study||149
1504420|NCT01640353|3680013|P1|NOT COMPLETED|Overall Study||45
1504421|NCT01640353|3680013|P1|COMPLETED|Overall Study||149
1504422|NCT01640353|3680013|P1|Month 18|Overall Study||150
1504423|NCT01640353|3680013|P1|Month 12|Overall Study||160
1504424|NCT01640353|3680013|P1|Month 6|Overall Study||168
1504425|NCT01640353|3680013|P1|Month 3|Overall Study||169
1504426|NCT01640353|3680013|P1|Month 1|Overall Study||171
1504427|NCT01640353|3680013|P1|Treated|Overall Study||172
1504428|NCT01640353|3680013|P1|STARTED|Overall Study||194
1504429|NCT01640340|3680025|P2|NOT COMPLETED|Overall Study||0
1504430|NCT01640340|3680026|P1|NOT COMPLETED|Overall Study||0
1504431|NCT01640340|3680025|P2|COMPLETED|Overall Study||20
1504432|NCT01640340|3680026|P1|COMPLETED|Overall Study||20
1504433|NCT01640340|3680025|P2|Overall Complete Response Rate|Overall Study||20
1504434|NCT01640340|3680026|P1|Overall Complete Response Rate|Overall Study||20
1504435|NCT01640340|3680025|P2|STARTED|Overall Study||20
1504436|NCT01640340|3680026|P1|STARTED|Overall Study||20
1504437|NCT01640327|3680046|P2|NOT COMPLETED|Overall Study||0
1504438|NCT01640327|3680047|P1|NOT COMPLETED|Overall Study||0
1504439|NCT01640327|3680046|P2|COMPLETED|Overall Study||63
1504440|NCT01640327|3680047|P1|COMPLETED|Overall Study||63
1504441|NCT01640327|3680046|P2|STARTED|Overall Study||63
1504442|NCT01640327|3680047|P1|STARTED|Overall Study||63
1504443|NCT01640314|3680061|P2|NOT COMPLETED|Overall Study||1
1504444|NCT01640314|3680062|P1|NOT COMPLETED|Overall Study||0
1504445|NCT01640314|3680061|P2|COMPLETED|Overall Study||62
1504446|NCT01640314|3680062|P1|COMPLETED|Overall Study||63
1504447|NCT01640314|3680061|P2|STARTED|Overall Study||63
1504448|NCT01640314|3680062|P1|STARTED|Overall Study||63
1504449|NCT01640197|3680078|P2|NOT COMPLETED|Overall Study||0
1504450|NCT01640197|3680079|P1|NOT COMPLETED|Overall Study||0
1504451|NCT01640197|3680078|P2|COMPLETED|Overall Study||30
1504452|NCT01640197|3680079|P1|COMPLETED|Overall Study||30
1504453|NCT01640197|3680078|P2|STARTED|Overall Study||30
1504454|NCT01640197|3680079|P1|STARTED|Overall Study||30
1504455|NCT01640184|3680100|P3|NOT COMPLETED|Overall Study||2
1504456|NCT01640184|3680101|P2|NOT COMPLETED|Overall Study||2
1504457|NCT01640184|3680102|P1|NOT COMPLETED|Overall Study||8
1504458|NCT01640184|3680100|P3|COMPLETED|Overall Study||20
1504459|NCT01640184|3680101|P2|COMPLETED|Overall Study||21
1504460|NCT01640184|3680102|P1|COMPLETED|Overall Study||26
1504461|NCT01640184|3680100|P3|STARTED|Overall Study||22
1504462|NCT01640184|3680101|P2|STARTED|Overall Study||23
1504463|NCT01640184|3680102|P1|STARTED|Overall Study||34
1504464|NCT01640171|3680124|P1|NOT COMPLETED|Overall Study||0
1504465|NCT01640171|3680124|P1|COMPLETED|Overall Study||57
1504466|NCT01640171|3680124|P1|STARTED|Overall Study||57
1504467|NCT01640054|3680131|P1|NOT COMPLETED|Overall Study||6
1504468|NCT01640054|3680131|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
1504469|NCT01640054|3680131|P1|Did Not Receive Treatment|Overall Study||0
1504470|NCT01640054|3680131|P1|STARTED|Overall Study|Patients who received treatment|115
1504471|NCT01639833|3680141|P2|NOT COMPLETED|Overall Study||4
1504472|NCT01639833|3680142|P1|NOT COMPLETED|Overall Study||6
1504473|NCT01639833|3680141|P2|COMPLETED|Overall Study||41
1504474|NCT01639833|3680142|P1|COMPLETED|Overall Study||39
1504475|NCT01639833|3680141|P2|STARTED|Overall Study||45
1504476|NCT01639833|3680142|P1|STARTED|Overall Study||45
1504477|NCT01639755|3680150|P1|NOT COMPLETED|Overall Study||19
1504478|NCT01639755|3680150|P1|COMPLETED|Overall Study||0
1504479|NCT01639755|3680150|P1|STARTED|Overall Study||19
1504480|NCT01639742|3680158|P1|NOT COMPLETED|Overall Study||18
1504481|NCT01639742|3680158|P1|COMPLETED|Overall Study||0
1504482|NCT01639742|3680158|P1|STARTED|Overall Study||18
1504483|NCT01639729|3680166|P6|NOT COMPLETED|Overall Study||0
1504484|NCT01639729|3680167|P5|NOT COMPLETED|Overall Study||0
1504485|NCT01639729|3680168|P4|NOT COMPLETED|Overall Study||1
1504486|NCT01639729|3680169|P3|NOT COMPLETED|Overall Study||1
1504487|NCT01639729|3680170|P2|NOT COMPLETED|Overall Study||0
1504488|NCT01639729|3680171|P1|NOT COMPLETED|Overall Study||1
1504489|NCT01639729|3680166|P6|COMPLETED|Overall Study||4
1504490|NCT01639729|3680167|P5|COMPLETED|Overall Study||4
1504491|NCT01639729|3680168|P4|COMPLETED|Overall Study||4
1504492|NCT01639729|3680169|P3|COMPLETED|Overall Study||3
1504493|NCT01639729|3680170|P2|COMPLETED|Overall Study||4
1504494|NCT01639729|3680171|P1|COMPLETED|Overall Study||3
1504495|NCT01639729|3680166|P6|STARTED|Overall Study||4
1504496|NCT01639729|3680167|P5|STARTED|Overall Study||4
1504497|NCT01639729|3680168|P4|STARTED|Overall Study||5
1504498|NCT01639729|3680169|P3|STARTED|Overall Study||4
1504499|NCT01639729|3680170|P2|STARTED|Overall Study||4
1504500|NCT01639729|3680171|P1|STARTED|Overall Study||4
1504501|NCT01639703|3680193|P1|NOT COMPLETED|Overall Study||12
1504502|NCT01639703|3680193|P1|COMPLETED|Overall Study||84
1504503|NCT01639703|3680193|P1|STARTED|Overall Study||96
1504504|NCT01639560|3680236|P2|NOT COMPLETED|Overall Study||29
1504505|NCT01639560|3680237|P1|NOT COMPLETED|Overall Study||19
1504506|NCT01639560|3680236|P2|COMPLETED|Overall Study||19
1504507|NCT01639560|3680237|P1|COMPLETED|Overall Study||26
1504508|NCT01639560|3680236|P2|End of Treatment|Overall Study||20
1504509|NCT01639560|3680237|P1|End of Treatment|Overall Study||28
1504510|NCT01639560|3680236|P2|STARTED|Overall Study||48
1504511|NCT01639560|3680237|P1|STARTED|Overall Study||45
1504512|NCT01639495|3680249|P1|NOT COMPLETED|Overall Study||16
1504513|NCT01639495|3680249|P1|COMPLETED|Overall Study||132
1504514|NCT01639495|3680249|P1|Primary Effectiveness Cohort|Overall Study||138
1504515|NCT01639495|3680249|P1|Safety Cohort|Overall Study||144
1504516|NCT01639495|3680249|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
1504517|NCT01639469|3680259|P2|NOT COMPLETED|Overall Study||3
1504518|NCT01639469|3680260|P1|NOT COMPLETED|Overall Study||5
1504519|NCT01639469|3680259|P2|COMPLETED|Overall Study||77
1504520|NCT01639469|3680260|P1|COMPLETED|Overall Study||84
1504521|NCT01639469|3680259|P2|STARTED|Overall Study||80
1504522|NCT01639469|3680260|P1|STARTED|Overall Study||89
1504523|NCT01639443|3680268|P2|NOT COMPLETED|Overall Study||0
1504524|NCT01639443|3680269|P1|NOT COMPLETED|Overall Study||0
1504525|NCT01639443|3680268|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
1504526|NCT01639443|3680269|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
1504527|NCT01639443|3680268|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
1504528|NCT01639443|3680269|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
1504529|NCT01639352|3680285|P1|NOT COMPLETED|Overall Study||0
1504530|NCT01639352|3680285|P1|COMPLETED|Overall Study||20
1504531|NCT01639352|3680285|P1|STARTED|Overall Study||20
1504532|NCT01639222|3680294|P1|NOT COMPLETED|Overall Study||0
1504533|NCT01639222|3680294|P1|COMPLETED|Overall Study||55
1504534|NCT01639222|3680294|P1|STARTED|Overall Study||55
1504535|NCT01639157|3680304|P2|NOT COMPLETED|Overall Study||0
1504536|NCT01639157|3680305|P1|NOT COMPLETED|Overall Study||0
1504537|NCT01639157|3680304|P2|COMPLETED|Overall Study||5
1504538|NCT01639157|3680305|P1|COMPLETED|Overall Study||4
1504539|NCT01639157|3680304|P2|STARTED|Overall Study||5
1504540|NCT01639157|3680305|P1|STARTED|Overall Study||4
1504541|NCT01639144|3680365|P2|NOT COMPLETED|Overall Study||5
1504542|NCT01639144|3680366|P1|NOT COMPLETED|Overall Study||10
1504543|NCT01639144|3680365|P2|COMPLETED|Overall Study||250
1504544|NCT01639144|3680366|P1|COMPLETED|Overall Study||250
1504545|NCT01639144|3680365|P2|STARTED|Overall Study||255
1504546|NCT01639144|3680366|P1|STARTED|Overall Study||260
1504547|NCT01639040|3680374|P2|NOT COMPLETED|Overall Study||0
1504548|NCT01639040|3680375|P1|NOT COMPLETED|Overall Study||1
1504549|NCT01639040|3680374|P2|COMPLETED|Overall Study||21
1504550|NCT01639040|3680375|P1|COMPLETED|Overall Study||9
1504551|NCT01639040|3680374|P2|STARTED|Overall Study||21
1504552|NCT01639040|3680375|P1|STARTED|Overall Study||10
1504553|NCT01639001|3680393|P2|NOT COMPLETED|Overall Study||103
1504554|NCT01639001|3680394|P1|NOT COMPLETED|Overall Study||104
1504555|NCT01639001|3680393|P2|COMPLETED|Overall Study||0
1504556|NCT01639001|3680394|P1|COMPLETED|Overall Study||0
1504557|NCT01639001|3680393|P2|Treated|Overall Study||101
1504558|NCT01639001|3680394|P1|Treated|Overall Study||104
1504559|NCT01639001|3680393|P2|STARTED|Overall Study||103
1504560|NCT01639001|3680394|P1|STARTED|Overall Study||104
1504561|NCT01638819|3680440|P2|NOT COMPLETED|Overall Study||0
1504562|NCT01638819|3680441|P1|NOT COMPLETED|Overall Study||1
1504563|NCT01638819|3680440|P2|COMPLETED|Overall Study||15
1504564|NCT01638819|3680441|P1|COMPLETED|Overall Study||14
1504565|NCT01638819|3680440|P2|Second Intervention (24 Weeks)|Overall Study||15
1504566|NCT01638819|3680441|P1|Second Intervention (24 Weeks)|Overall Study||14
1504567|NCT01638819|3680440|P2|First Intervention (8 Weeks)|Overall Study||15
1504568|NCT01638819|3680441|P1|First Intervention (8 Weeks)|Overall Study||15
1504569|NCT01638819|3680440|P2|STARTED|Overall Study||15
1504570|NCT01638819|3680441|P1|STARTED|Overall Study||15
1504571|NCT01638559|3680450|P1|NOT COMPLETED|Overall Study||0
1504572|NCT01638559|3680450|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint.|88
1504573|NCT01638559|3680450|P1|STARTED|Overall Study||88
1504574|NCT01638546|3680456|P2|NOT COMPLETED|Overall Study||3
1504575|NCT01638546|3680457|P1|NOT COMPLETED|Overall Study||1
1504576|NCT01638546|3680456|P2|COMPLETED|Overall Study||42
1504577|NCT01638546|3680457|P1|COMPLETED|Overall Study||51
1504578|NCT01638546|3680456|P2|STARTED|Overall Study||45
1504579|NCT01638546|3680457|P1|STARTED|Overall Study||52
1504580|NCT01638507|3680465|P1|NOT COMPLETED|Overall Study||6
1504581|NCT01638507|3680465|P1|COMPLETED|Overall Study||224
1504582|NCT01638507|3680465|P1|STARTED|Overall Study||230
1504583|NCT01638468|3680478|P1|NOT COMPLETED|Overall Study||0
1504584|NCT01638468|3680478|P1|COMPLETED|Overall Study||7
1504585|NCT01638468|3680478|P1|STARTED|Overall Study||7
1504586|NCT01638312|3680494|P2|NOT COMPLETED|Overall Study||0
1504587|NCT01638312|3680495|P1|NOT COMPLETED|Overall Study||0
1504588|NCT01638312|3680494|P2|COMPLETED|Overall Study||30
1504589|NCT01638312|3680495|P1|COMPLETED|Overall Study||20
1504590|NCT01638312|3680494|P2|STARTED|Overall Study||30
1504591|NCT01638312|3680495|P1|STARTED|Overall Study||20
1504592|NCT01638000|3680503|P2|NOT COMPLETED|Overall Study||71
1504593|NCT01638000|3680504|P1|NOT COMPLETED|Overall Study||60
1504594|NCT01638000|3680503|P2|COMPLETED|Overall Study||873
1504595|NCT01638000|3680504|P1|COMPLETED|Overall Study||883
1504596|NCT01638000|3680503|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
1504597|NCT01638000|3680504|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
1504598|NCT01638000|3680503|P2|STARTED|Overall Study||944
1504599|NCT01638000|3680504|P1|STARTED|Overall Study||943
1504600|NCT01637961|3680602|P1|NOT COMPLETED|Overall Study||2
1504601|NCT01637961|3680602|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
1504602|NCT01637961|3680602|P1|STARTED|Overall Study||23
1504603|NCT01637935|3680617|P2|NOT COMPLETED|Overall Study||0
1504604|NCT01637935|3680618|P1|NOT COMPLETED|Overall Study||0
1504605|NCT01637935|3680617|P2|COMPLETED|Overall Study||158918
1504606|NCT01637935|3680618|P1|COMPLETED|Overall Study||34181
1504607|NCT01637935|3680617|P2|STARTED|Overall Study||158918
1504608|NCT01637935|3680618|P1|STARTED|Overall Study||34181
1504609|NCT01637922|3680634|P2|NOT COMPLETED|Overall Study||5
1504610|NCT01637922|3680635|P1|NOT COMPLETED|Overall Study||2
1504611|NCT01637922|3680634|P2|COMPLETED|Overall Study||14
1504612|NCT01637922|3680635|P1|COMPLETED|Overall Study||13
1504613|NCT01637922|3680634|P2|STARTED|Overall Study||19
1504614|NCT01637922|3680635|P1|STARTED|Overall Study||15
1504615|NCT01637870|3680658|P1|NOT COMPLETED|Overall Study||0
1504616|NCT01637870|3680658|P1|COMPLETED|Overall Study||110
1504617|NCT01637870|3680658|P1|STARTED|Overall Study||110
1504618|NCT01637584|3680664|P2|NOT COMPLETED|Overall Study||3
1504619|NCT01637584|3680665|P1|NOT COMPLETED|Overall Study||1
1504620|NCT01637584|3680664|P2|COMPLETED|Overall Study||17
1504621|NCT01637584|3680665|P1|COMPLETED|Overall Study||19
1504622|NCT01637584|3680664|P2|STARTED|Overall Study||20
1504623|NCT01637584|3680665|P1|STARTED|Overall Study||20
1504624|NCT01637272|3680672|P1|NOT COMPLETED|Overall Study||20
1504625|NCT01637272|3680672|P1|COMPLETED|Overall Study||23
1504626|NCT01637272|3680672|P1|Completed Core But Did no Enter Ext..|Overall Study||4
1504627|NCT01637272|3680672|P1|Entered Extension Phase|Overall Study||27
1504628|NCT01637272|3680672|P1|Completed Core Phase (sc + LAR)|Overall Study||31
1504629|NCT01637272|3680672|P1|Completed sc Phase|Overall Study||33
1504630|NCT01637272|3680672|P1|STARTED|Overall Study||43
1504631|NCT01637246|3680734|P1|NOT COMPLETED|Overall Study||2139
1504632|NCT01637246|3680734|P1|COMPLETED|Overall Study||2246
1504633|NCT01637246|3680734|P1|STARTED|Overall Study||4385
1504634|NCT01637090|3680742|P1|NOT COMPLETED|Overall Study||3
1504635|NCT01637090|3680742|P1|COMPLETED|Overall Study||0
1504636|NCT01637090|3680742|P1|STARTED|Overall Study||3
1504637|NCT01637077|3680752|P2|NOT COMPLETED|Overall Study||1
1504638|NCT01637077|3680753|P1|NOT COMPLETED|Overall Study||4
1504639|NCT01637077|3680752|P2|COMPLETED|Overall Study||22
1504640|NCT01637077|3680753|P1|COMPLETED|Overall Study||19
1504641|NCT01637077|3680752|P2|STARTED|Overall Study||23
1504642|NCT01637077|3680753|P1|STARTED|Overall Study||23
1504643|NCT01636986|3680781|P2|NOT COMPLETED|Overall Study||2
1504644|NCT01636986|3680782|P1|NOT COMPLETED|Overall Study||0
1504645|NCT01636986|3680781|P2|COMPLETED|Overall Study||30
1504646|NCT01636986|3680782|P1|COMPLETED|Overall Study||30
1504647|NCT01636986|3680781|P2|STARTED|Overall Study||32
1504648|NCT01636986|3680782|P1|STARTED|Overall Study||30
1504649|NCT01636960|3680788|P1|NOT COMPLETED|Maintenance Phase||7
1504650|NCT01636960|3680788|P1|COMPLETED|Maintenance Phase||0
1504651|NCT01636960|3680788|P1|STARTED|Maintenance Phase||7
1504652|NCT01636960|3680788|P1|NOT COMPLETED|Induction Phase||2
1504653|NCT01636960|3680788|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
1504654|NCT01636960|3680788|P1|STARTED|Induction Phase||9
1504655|NCT01636947|3680796|P2|NOT COMPLETED|Overall Study||11
1504656|NCT01636947|3680797|P1|NOT COMPLETED|Overall Study||12
1504657|NCT01636947|3680796|P2|COMPLETED|Overall Study||239
1504658|NCT01636947|3680797|P1|COMPLETED|Overall Study||232
1504659|NCT01636947|3680796|P2|Treated|Overall Study||248
1504660|NCT01636947|3680797|P1|Treated|Overall Study||242
1504661|NCT01636947|3680796|P2|STARTED|Overall Study||250
1504662|NCT01636947|3680797|P1|STARTED|Overall Study||244
1504663|NCT01636882|3680817|P1|NOT COMPLETED|Overall Study||0
1504664|NCT01636882|3680817|P1|COMPLETED|Overall Study||16
1504665|NCT01636882|3680817|P1|STARTED|Overall Study||16
1504666|NCT01636778|3680821|P3|NOT COMPLETED|Follow-up Period After Part 2||4
1504667|NCT01636778|3680822|P2|NOT COMPLETED|Follow-up Period After Part 2||0
1504668|NCT01636778|3680823|P1|NOT COMPLETED|Follow-up Period After Part 2||0
1504669|NCT01636778|3680821|P3|COMPLETED|Follow-up Period After Part 2||37
1504670|NCT01636778|3680822|P2|COMPLETED|Follow-up Period After Part 2||0
1504671|NCT01636778|3680823|P1|COMPLETED|Follow-up Period After Part 2||0
1504672|NCT01636778|3680821|P3|STARTED|Follow-up Period After Part 2||41
1504673|NCT01636778|3680822|P2|STARTED|Follow-up Period After Part 2||0
1504674|NCT01636778|3680823|P1|STARTED|Follow-up Period After Part 2||0
1504675|NCT01636778|3680821|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
1504676|NCT01636778|3680822|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
1504677|NCT01636778|3680823|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
1504678|NCT01636778|3680821|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
1504679|NCT01636778|3680822|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
1504680|NCT01636778|3680823|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
1504681|NCT01636778|3680821|P3|STARTED|Antiviral Treatment Period (Part 2)||0
1504682|NCT01636778|3680822|P2|STARTED|Antiviral Treatment Period (Part 2)||41
1504683|NCT01636778|3680823|P1|STARTED|Antiviral Treatment Period (Part 2)||0
1504684|NCT01636778|3680821|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
1504685|NCT01636778|3680822|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
1504686|NCT01636778|3680823|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
1504687|NCT01636778|3680821|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
1504688|NCT01636778|3680822|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
1504689|NCT01636778|3680823|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
1504690|NCT01636778|3680821|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
1504691|NCT01636778|3680822|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
1504692|NCT01636778|3680823|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
1504693|NCT01636765|3680886|P1|NOT COMPLETED|Overall Study||0
1504694|NCT01636765|3680886|P1|COMPLETED|Overall Study||104
1504695|NCT01636765|3680886|P1|STARTED|Overall Study||104
1504696|NCT01636713|3680894|P3|NOT COMPLETED|Overall Study||23
1504697|NCT01636713|3680895|P2|NOT COMPLETED|Overall Study||28
1504698|NCT01636713|3680896|P1|NOT COMPLETED|Overall Study||32
1504699|NCT01636713|3680894|P3|COMPLETED|Overall Study||170
1504700|NCT01636713|3680895|P2|COMPLETED|Overall Study||166
1504701|NCT01636713|3680896|P1|COMPLETED|Overall Study||161
1504702|NCT01636713|3680894|P3|STARTED|Overall Study||193
1504703|NCT01636713|3680895|P2|STARTED|Overall Study||194
1504704|NCT01636713|3680896|P1|STARTED|Overall Study||193
1504705|NCT01636687|3680913|P5|NOT COMPLETED|Follow-up Period||1
1504706|NCT01636687|3680914|P4|NOT COMPLETED|Follow-up Period||0
1504707|NCT01636687|3680915|P3|NOT COMPLETED|Follow-up Period||0
1504708|NCT01636687|3680916|P2|NOT COMPLETED|Follow-up Period||0
1504709|NCT01636687|3680917|P1|NOT COMPLETED|Follow-up Period||1
1504710|NCT01636687|3680913|P5|COMPLETED|Follow-up Period||1
1504711|NCT01636687|3680914|P4|COMPLETED|Follow-up Period||20
1504712|NCT01636687|3680915|P3|COMPLETED|Follow-up Period||21
1504713|NCT01636687|3680916|P2|COMPLETED|Follow-up Period||45
1504714|NCT01636687|3680917|P1|COMPLETED|Follow-up Period||37
1504715|NCT01636687|3680913|P5|STARTED|Follow-up Period||2
1504716|NCT01636687|3680914|P4|STARTED|Follow-up Period||20
1504717|NCT01636687|3680915|P3|STARTED|Follow-up Period||21
1504718|NCT01636687|3680916|P2|STARTED|Follow-up Period||45
1504719|NCT01636687|3680917|P1|STARTED|Follow-up Period||38
1504720|NCT01636687|3680913|P5|NOT COMPLETED|Extension Period||0
1504721|NCT01636687|3680914|P4|NOT COMPLETED|Extension Period||28
1504722|NCT01636687|3680915|P3|NOT COMPLETED|Extension Period||25
1504723|NCT01636687|3680916|P2|NOT COMPLETED|Extension Period||54
1504724|NCT01636687|3680917|P1|NOT COMPLETED|Extension Period||47
1504725|NCT01636687|3680913|P5|COMPLETED|Extension Period||0
1504726|NCT01636687|3680914|P4|COMPLETED|Extension Period||0
1504727|NCT01636687|3680915|P3|COMPLETED|Extension Period||0
1504728|NCT01636687|3680916|P2|COMPLETED|Extension Period||0
1504729|NCT01636687|3680917|P1|COMPLETED|Extension Period||0
1504730|NCT01636687|3680913|P5|STARTED|Extension Period||0
1504731|NCT01636687|3680914|P4|STARTED|Extension Period||28
1504732|NCT01636687|3680915|P3|STARTED|Extension Period||25
1504733|NCT01636687|3680916|P2|STARTED|Extension Period||54
1504734|NCT01636687|3680917|P1|STARTED|Extension Period||47
1504735|NCT01636687|3680913|P5|NOT COMPLETED|Maintenance Period||2
1504736|NCT01636687|3680914|P4|NOT COMPLETED|Maintenance Period||0
1504737|NCT01636687|3680915|P3|NOT COMPLETED|Maintenance Period||2
1504738|NCT01636687|3680916|P2|NOT COMPLETED|Maintenance Period||2
1504739|NCT01636687|3680917|P1|NOT COMPLETED|Maintenance Period||8
1504740|NCT01636687|3680913|P5|COMPLETED|Maintenance Period||1
1504741|NCT01636687|3680914|P4|COMPLETED|Maintenance Period||28
1504742|NCT01636687|3680915|P3|COMPLETED|Maintenance Period||26
1504743|NCT01636687|3680916|P2|COMPLETED|Maintenance Period||58
1504744|NCT01636687|3680917|P1|COMPLETED|Maintenance Period||50
1504745|NCT01636687|3680913|P5|STARTED|Maintenance Period||3
1504746|NCT01636687|3680914|P4|STARTED|Maintenance Period||28
1504747|NCT01636687|3680915|P3|STARTED|Maintenance Period||28
1504748|NCT01636687|3680916|P2|STARTED|Maintenance Period||60
1504749|NCT01636687|3680917|P1|STARTED|Maintenance Period||58
1504750|NCT01636687|3680913|P5|NOT COMPLETED|Induction Period||2
1504751|NCT01636687|3680914|P4|NOT COMPLETED|Induction Period||0
1504752|NCT01636687|3680915|P3|NOT COMPLETED|Induction Period||0
1504753|NCT01636687|3680916|P2|NOT COMPLETED|Induction Period||0
1504754|NCT01636687|3680917|P1|NOT COMPLETED|Induction Period||3
1504755|NCT01636687|3680913|P5|COMPLETED|Induction Period||59
1504756|NCT01636687|3680914|P4|COMPLETED|Induction Period||0
1504757|NCT01636687|3680915|P3|COMPLETED|Induction Period||0
1504758|NCT01636687|3680916|P2|COMPLETED|Induction Period||60
1504759|NCT01636687|3680917|P1|COMPLETED|Induction Period||58
1504760|NCT01636687|3680913|P5|STARTED|Induction Period||61
1504761|NCT01636687|3680914|P4|STARTED|Induction Period||0
1504762|NCT01636687|3680915|P3|STARTED|Induction Period||0
1504763|NCT01636687|3680916|P2|STARTED|Induction Period||60
1504764|NCT01636687|3680917|P1|STARTED|Induction Period||61
1504765|NCT01636661|3681006|P2|NOT COMPLETED|Overall Study||0
1504766|NCT01636661|3681007|P1|NOT COMPLETED|Overall Study||0
1504767|NCT01636661|3681006|P2|COMPLETED|Overall Study||6
1504768|NCT01636661|3681007|P1|COMPLETED|Overall Study||5
1504769|NCT01636661|3681006|P2|STARTED|Overall Study||6
1504770|NCT01636661|3681007|P1|STARTED|Overall Study||5
1504771|NCT01636466|3681017|P2|NOT COMPLETED|Overall Study||0
1504772|NCT01636466|3681018|P1|NOT COMPLETED|Overall Study||1
1504773|NCT01636466|3681017|P2|COMPLETED|Overall Study||0
1504774|NCT01636466|3681018|P1|COMPLETED|Overall Study||0
1504775|NCT01636466|3681017|P2|STARTED|Overall Study||0
1504776|NCT01636466|3681018|P1|STARTED|Overall Study||1
1504777|NCT01636453|3681026|P1|NOT COMPLETED|Overall Study||8
1504778|NCT01636453|3681026|P1|COMPLETED|Overall Study||112
1504779|NCT01636453|3681026|P1|STARTED|Overall Study||120
1504780|NCT01636414|3681045|P3|NOT COMPLETED|Overall Study||9
1504781|NCT01636414|3681046|P2|NOT COMPLETED|Overall Study||6
1504782|NCT01636414|3681047|P1|NOT COMPLETED|Overall Study||3
1504783|NCT01636414|3681045|P3|COMPLETED|Overall Study||65
1504784|NCT01636414|3681046|P2|COMPLETED|Overall Study||60
1504785|NCT01636414|3681047|P1|COMPLETED|Overall Study||61
1504786|NCT01636414|3681045|P3|STARTED|Overall Study||74
1504787|NCT01636414|3681046|P2|STARTED|Overall Study||66
1504788|NCT01636414|3681047|P1|STARTED|Overall Study||64
1504789|NCT01636362|3681058|P1|NOT COMPLETED|Overall Study||8
1504790|NCT01636362|3681058|P1|COMPLETED|Overall Study||37
1504791|NCT01636362|3681058|P1|STARTED|Overall Study||45
1504792|NCT01636297|3681067|P3|NOT COMPLETED|Overall Study||1
1504793|NCT01636297|3681068|P2|NOT COMPLETED|Overall Study||4
1504794|NCT01636297|3681069|P1|NOT COMPLETED|Overall Study||4
1504795|NCT01636297|3681067|P3|COMPLETED|Overall Study||19
1504796|NCT01636297|3681068|P2|COMPLETED|Overall Study||36
1504797|NCT01636297|3681069|P1|COMPLETED|Overall Study||36
1504798|NCT01636297|3681067|P3|STARTED|Overall Study||20
1504799|NCT01636297|3681068|P2|STARTED|Overall Study||40
1504800|NCT01636297|3681069|P1|STARTED|Overall Study||40
1504801|NCT01636258|3681085|P2|NOT COMPLETED|Overall Study||0
1504802|NCT01636258|3681086|P1|NOT COMPLETED|Overall Study||1
1504803|NCT01636258|3681085|P2|COMPLETED|Overall Study||14
1504804|NCT01636258|3681086|P1|COMPLETED|Overall Study||12
1504805|NCT01636258|3681085|P2|STARTED|Overall Study||14
1504806|NCT01636258|3681086|P1|STARTED|Overall Study||13
1504807|NCT01636206|3681102|P2|NOT COMPLETED|Overall Study||51
1504808|NCT01636206|3681103|P1|NOT COMPLETED|Overall Study||19
1504809|NCT01636206|3681102|P2|COMPLETED|Overall Study||170
1504810|NCT01636206|3681103|P1|COMPLETED|Overall Study||92
1504811|NCT01636206|3681102|P2|STARTED|Overall Study||221
1504812|NCT01636206|3681103|P1|STARTED|Overall Study||111
1504813|NCT01636102|3681111|P2|NOT COMPLETED|Overall Study||0
1504814|NCT01636102|3681112|P1|NOT COMPLETED|Overall Study||0
1504815|NCT01636102|3681111|P2|COMPLETED|Overall Study||63
1504816|NCT01636102|3681112|P1|COMPLETED|Overall Study||63
1504817|NCT01636102|3681111|P2|STARTED|Overall Study||63
1504818|NCT01636102|3681112|P1|STARTED|Overall Study||63
1504819|NCT01636076|3681126|P2|NOT COMPLETED|Overall Study||25
1504820|NCT01636076|3681127|P1|NOT COMPLETED|Overall Study||17
1504821|NCT01636076|3681126|P2|COMPLETED|Overall Study||288
1504822|NCT01636076|3681127|P1|COMPLETED|Overall Study||299
1504823|NCT01636076|3681126|P2|STARTED|Overall Study||313
1504824|NCT01636076|3681127|P1|STARTED|Overall Study||316
1504825|NCT01636063|3681189|P2|NOT COMPLETED|Overall Study||0
1504826|NCT01636063|3681190|P1|NOT COMPLETED|Overall Study||0
1504827|NCT01636063|3681189|P2|COMPLETED|Overall Study||21
1504828|NCT01636063|3681190|P1|COMPLETED|Overall Study||21
1504829|NCT01636063|3681189|P2|STARTED|Overall Study||21
1504830|NCT01636063|3681190|P1|STARTED|Overall Study||21
1504831|NCT01635933|3681198|P2|NOT COMPLETED|Overall Study||8
1504832|NCT01635933|3681199|P1|NOT COMPLETED|Overall Study||2
1504833|NCT01635933|3681198|P2|COMPLETED|Overall Study||177
1504834|NCT01635933|3681199|P1|COMPLETED|Overall Study||176
1504835|NCT01635933|3681198|P2|STARTED|Overall Study||185
1504836|NCT01635933|3681199|P1|STARTED|Overall Study||178
1504837|NCT01635920|3681211|P2|NOT COMPLETED|Overall Study||1
1504838|NCT01635920|3681212|P1|NOT COMPLETED|Overall Study||3
1504839|NCT01635920|3681211|P2|COMPLETED|Overall Study||125
1504840|NCT01635920|3681212|P1|COMPLETED|Overall Study||122
1504841|NCT01635920|3681211|P2|STARTED|Overall Study||126
1504842|NCT01635920|3681212|P1|STARTED|Overall Study||125
1504843|NCT01635881|3681220|P1|NOT COMPLETED|Overall Study||0
1504844|NCT01635881|3681220|P1|COMPLETED|Overall Study||60
1504845|NCT01635881|3681220|P1|STARTED|Overall Study||60
1504846|NCT01635855|3681225|P1|NOT COMPLETED|Overall Study||4
1504847|NCT01635855|3681225|P1|COMPLETED|Overall Study||113
1504848|NCT01635855|3681225|P1|STARTED|Overall Study||117
1504849|NCT01635764|3681234|P1|NOT COMPLETED|Overall Study||273
1504850|NCT01635764|3681234|P1|COMPLETED|Overall Study||235
1504851|NCT01635764|3681234|P1|STARTED|Overall Study||508
1504852|NCT01635504|3681262|P1|NOT COMPLETED|Overall Study||0
1504853|NCT01635504|3681262|P1|COMPLETED|Overall Study||5
1504854|NCT01635504|3681262|P1|STARTED|Overall Study||5
1504855|NCT01635439|3681269|P2|NOT COMPLETED|Overall Study||0
1504856|NCT01635439|3681270|P1|NOT COMPLETED|Overall Study||0
1504857|NCT01635439|3681269|P2|COMPLETED|Overall Study||100
1504858|NCT01635439|3681270|P1|COMPLETED|Overall Study||100
1504859|NCT01635439|3681269|P2|STARTED|Overall Study||100
1504860|NCT01635439|3681270|P1|STARTED|Overall Study||100
1504861|NCT01635244|3681287|P3|NOT COMPLETED|Overall Study||2
1504862|NCT01635244|3681288|P2|NOT COMPLETED|Overall Study||1
1504863|NCT01635244|3681289|P1|NOT COMPLETED|Overall Study||1
1504864|NCT01635244|3681287|P3|COMPLETED|Overall Study||18
1504865|NCT01635244|3681288|P2|COMPLETED|Overall Study||21
1504866|NCT01635244|3681289|P1|COMPLETED|Overall Study||17
1504867|NCT01635244|3681287|P3|STARTED|Overall Study||20
1504868|NCT01635244|3681288|P2|STARTED|Overall Study||22
1504869|NCT01635244|3681289|P1|STARTED|Overall Study||18
1504870|NCT01635218|3681300|P3|NOT COMPLETED|Overall Study||6
1504871|NCT01635218|3681301|P2|NOT COMPLETED|Overall Study||7
1504872|NCT01635218|3681302|P1|NOT COMPLETED|Overall Study||3
1504873|NCT01635218|3681300|P3|COMPLETED|Overall Study||37
1504874|NCT01635218|3681301|P2|COMPLETED|Overall Study||39
1504875|NCT01635218|3681302|P1|COMPLETED|Overall Study||41
1504876|NCT01635218|3681300|P3|STARTED|Overall Study||43
1504877|NCT01635218|3681301|P2|STARTED|Overall Study||46
1504878|NCT01635218|3681302|P1|STARTED|Overall Study||44
1504879|NCT01635062|3681324|P2|NOT COMPLETED|Overall Study||0
1504880|NCT01635062|3681325|P1|NOT COMPLETED|Overall Study||0
1504881|NCT01635062|3681324|P2|COMPLETED|Overall Study||9
1504882|NCT01635062|3681325|P1|COMPLETED|Overall Study||9
1504883|NCT01635062|3681324|P2|Post-Randomization Sodium Loaded|Overall Study||9
1504884|NCT01635062|3681325|P1|Post-Randomization Sodium Loaded|Overall Study||9
1504885|NCT01635062|3681324|P2|Post-randomization Sodium Restriction|Overall Study||9
1504886|NCT01635062|3681325|P1|Post-randomization Sodium Restriction|Overall Study||9
1504887|NCT01635062|3681324|P2|Sodium Loading Baseline Visit|Overall Study||9
1504888|NCT01635062|3681325|P1|Sodium Loading Baseline Visit|Overall Study||9
1504889|NCT01635062|3681324|P2|Sodium Restriction Baseline Visit|Overall Study||9
1504890|NCT01635062|3681325|P1|Sodium Restriction Baseline Visit|Overall Study||9
1504891|NCT01635062|3681324|P2|STARTED|Overall Study||9
1504892|NCT01635062|3681325|P1|STARTED|Overall Study||9
1504893|NCT01634854|3681337|P2|NOT COMPLETED|Overall Study||7
1504894|NCT01634854|3681338|P1|NOT COMPLETED|Overall Study||2
1504895|NCT01634854|3681337|P2|COMPLETED|Overall Study||59
1504896|NCT01634854|3681338|P1|COMPLETED|Overall Study||62
1504897|NCT01634854|3681337|P2|STARTED|Overall Study||66
1504898|NCT01634854|3681338|P1|STARTED|Overall Study||64
1504899|NCT01634659|3681358|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
1504900|NCT01634659|3681359|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
1504901|NCT01634659|3681358|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
1504902|NCT01634659|3681359|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
1504903|NCT01634659|3681358|P2|STARTED|Period 2 - Second 8 Days of Wear||158
1504904|NCT01634659|3681359|P1|STARTED|Period 2 - Second 8 Days of Wear||155
1504905|NCT01634659|3681358|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
1504906|NCT01634659|3681359|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
1504907|NCT01634659|3681358|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
1504908|NCT01634659|3681359|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
1504909|NCT01634659|3681358|P2|STARTED|Period 1 - First 8 Days of Wear||158
1504910|NCT01634659|3681359|P1|STARTED|Period 1 - First 8 Days of Wear||155
1504911|NCT01634620|3681369|P1|NOT COMPLETED|Overall Study||0
1504912|NCT01634620|3681369|P1|COMPLETED|Overall Study||200
1504913|NCT01634620|3681369|P1|STARTED|Overall Study||200
1504914|NCT01634555|3681389|P1|NOT COMPLETED|Overall Study||17
1504915|NCT01634555|3681389|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|12
1504916|NCT01634555|3681389|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
1504917|NCT01634555|3681389|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
1504918|NCT01634555|3681389|P1|STARTED|Overall Study||29
1504919|NCT01634360|3681399|P2|NOT COMPLETED|Overall Study||136
1504920|NCT01634360|3681400|P1|NOT COMPLETED|Overall Study||49
1504921|NCT01634360|3681399|P2|COMPLETED|Overall Study||0
1504922|NCT01634360|3681400|P1|COMPLETED|Overall Study||0
1504923|NCT01634360|3681399|P2|STARTED|Overall Study||136
1504924|NCT01634360|3681400|P1|STARTED|Overall Study||49
1504925|NCT01634269|3681410|P1|NOT COMPLETED|Overall Study||2
1504926|NCT01634269|3681410|P1|COMPLETED|Overall Study||18
1504927|NCT01634269|3681410|P1|24 Month|Overall Study||18
1504928|NCT01634269|3681410|P1|12 Month|Overall Study||20
1504929|NCT01634269|3681410|P1|6 Month|Overall Study||20
1504930|NCT01634269|3681410|P1|30 Days|Overall Study||20
1504931|NCT01634269|3681410|P1|STARTED|Overall Study||20
1504932|NCT01634256|3681457|P2|NOT COMPLETED|Overall Study||8
1504933|NCT01634256|3681458|P1|NOT COMPLETED|Overall Study||4
1504934|NCT01634256|3681457|P2|COMPLETED|Overall Study||22
1504935|NCT01634256|3681458|P1|COMPLETED|Overall Study||26
1504936|NCT01634256|3681457|P2|STARTED|Overall Study||30
1504937|NCT01634256|3681458|P1|STARTED|Overall Study||30
1504938|NCT01634243|3681474|P2|NOT COMPLETED|Overall Study||5
1504939|NCT01634243|3681475|P1|NOT COMPLETED|Overall Study||6
1504940|NCT01634243|3681474|P2|COMPLETED|Overall Study||38
1504941|NCT01634243|3681475|P1|COMPLETED|Overall Study||15
1504942|NCT01634243|3681474|P2|STARTED|Overall Study||43
1504943|NCT01634243|3681475|P1|STARTED|Overall Study||21
1504944|NCT01634165|3681501|P4|NOT COMPLETED|Period 4||0
1504945|NCT01634165|3681502|P3|NOT COMPLETED|Period 4||0
1504946|NCT01634165|3681503|P2|NOT COMPLETED|Period 4||0
1504947|NCT01634165|3681504|P1|NOT COMPLETED|Period 4||0
1504948|NCT01634165|3681501|P4|COMPLETED|Period 4||6
1504949|NCT01634165|3681502|P3|COMPLETED|Period 4||6
1504950|NCT01634165|3681503|P2|COMPLETED|Period 4||5
1504951|NCT01634165|3681504|P1|COMPLETED|Period 4||6
1504952|NCT01634165|3681501|P4|STARTED|Period 4||6
1504953|NCT01634165|3681502|P3|STARTED|Period 4||6
1504954|NCT01634165|3681503|P2|STARTED|Period 4||5
1504955|NCT01634165|3681504|P1|STARTED|Period 4||6
1504956|NCT01634165|3681501|P4|NOT COMPLETED|Period 3||0
1504957|NCT01634165|3681502|P3|NOT COMPLETED|Period 3||0
1504958|NCT01634165|3681503|P2|NOT COMPLETED|Period 3||0
1504959|NCT01634165|3681504|P1|NOT COMPLETED|Period 3||0
1504960|NCT01634165|3681501|P4|COMPLETED|Period 3||6
1504961|NCT01634165|3681502|P3|COMPLETED|Period 3||6
1504962|NCT01634165|3681503|P2|COMPLETED|Period 3||5
1504963|NCT01634165|3681504|P1|COMPLETED|Period 3||6
1504964|NCT01634165|3681501|P4|STARTED|Period 3||6
1504965|NCT01634165|3681502|P3|STARTED|Period 3||6
1504966|NCT01634165|3681503|P2|STARTED|Period 3||5
1504967|NCT01634165|3681504|P1|STARTED|Period 3||6
1504968|NCT01634165|3681501|P4|NOT COMPLETED|Period 2||0
1504969|NCT01634165|3681502|P3|NOT COMPLETED|Period 2||0
1504970|NCT01634165|3681503|P2|NOT COMPLETED|Period 2||1
1504971|NCT01634165|3681504|P1|NOT COMPLETED|Period 2||0
1504972|NCT01634165|3681501|P4|COMPLETED|Period 2||6
1504973|NCT01634165|3681502|P3|COMPLETED|Period 2||6
1504974|NCT01634165|3681503|P2|COMPLETED|Period 2||5
1504975|NCT01634165|3681504|P1|COMPLETED|Period 2||6
1504976|NCT01634165|3681501|P4|STARTED|Period 2||6
1504977|NCT01634165|3681502|P3|STARTED|Period 2||6
1504978|NCT01634165|3681503|P2|STARTED|Period 2||6
1504979|NCT01634165|3681504|P1|STARTED|Period 2||6
1504980|NCT01634165|3681501|P4|NOT COMPLETED|Period 1||0
1504981|NCT01634165|3681502|P3|NOT COMPLETED|Period 1||0
1504982|NCT01634165|3681503|P2|NOT COMPLETED|Period 1||0
1504983|NCT01634165|3681504|P1|NOT COMPLETED|Period 1||0
1504984|NCT01634165|3681501|P4|COMPLETED|Period 1||6
1504985|NCT01634165|3681502|P3|COMPLETED|Period 1||6
1504986|NCT01634165|3681503|P2|COMPLETED|Period 1||6
1504987|NCT01634165|3681504|P1|COMPLETED|Period 1||6
1504988|NCT01634165|3681501|P4|Received at Least 1 Dose of Study Drug|Period 1||6
1504989|NCT01634165|3681502|P3|Received at Least 1 Dose of Study Drug|Period 1||6
1504990|NCT01634165|3681503|P2|Received at Least 1 Dose of Study Drug|Period 1||6
1504991|NCT01634165|3681504|P1|Received at Least 1 Dose of Study Drug|Period 1||6
1504992|NCT01634165|3681501|P4|STARTED|Period 1||6
1504993|NCT01634165|3681502|P3|STARTED|Period 1||6
1504994|NCT01634165|3681503|P2|STARTED|Period 1||6
1504995|NCT01634165|3681504|P1|STARTED|Period 1||6
1504996|NCT01634152|3681537|P3|NOT COMPLETED|Overall Study||4
1504997|NCT01634152|3681538|P2|NOT COMPLETED|Overall Study||1
1504998|NCT01634152|3681539|P1|NOT COMPLETED|Overall Study||4
1504999|NCT01634152|3681537|P3|COMPLETED|Overall Study||126
1505000|NCT01634152|3681538|P2|COMPLETED|Overall Study||136
1505001|NCT01634152|3681539|P1|COMPLETED|Overall Study||130
1505002|NCT01634152|3681537|P3|STARTED|Overall Study||130
1505003|NCT01634152|3681538|P2|STARTED|Overall Study||137
1505004|NCT01634152|3681539|P1|STARTED|Overall Study||134
1505005|NCT01634139|3681622|P3|NOT COMPLETED|Overall Study||5
1505006|NCT01634139|3681623|P2|NOT COMPLETED|Overall Study||6
1505007|NCT01634139|3681624|P1|NOT COMPLETED|Overall Study||10
1505008|NCT01634139|3681622|P3|COMPLETED|Overall Study||130
1505009|NCT01634139|3681623|P2|COMPLETED|Overall Study||130
1505010|NCT01634139|3681624|P1|COMPLETED|Overall Study||122
1505011|NCT01634139|3681622|P3|STARTED|Overall Study||135
1505012|NCT01634139|3681623|P2|STARTED|Overall Study||136
1505013|NCT01634139|3681624|P1|STARTED|Overall Study||132
1505014|NCT01634113|3681725|P3|NOT COMPLETED|Overall Study||1
1505015|NCT01634113|3681726|P2|NOT COMPLETED|Overall Study||0
1505016|NCT01634113|3681727|P1|NOT COMPLETED|Overall Study||0
1505017|NCT01634113|3681725|P3|COMPLETED|Overall Study||31
1505018|NCT01634113|3681726|P2|COMPLETED|Overall Study||36
1505019|NCT01634113|3681727|P1|COMPLETED|Overall Study||34
1505020|NCT01634113|3681725|P3|STARTED|Overall Study||32
1505021|NCT01634113|3681726|P2|STARTED|Overall Study||36
1505022|NCT01634113|3681727|P1|STARTED|Overall Study||34
1505023|NCT01634100|3681771|P6|NOT COMPLETED|Overall Study||0
1505024|NCT01634100|3681772|P5|NOT COMPLETED|Overall Study||0
1505025|NCT01634100|3681773|P4|NOT COMPLETED|Overall Study||0
1505026|NCT01634100|3681774|P3|NOT COMPLETED|Overall Study||1
1505027|NCT01634100|3681775|P2|NOT COMPLETED|Overall Study||0
1505028|NCT01634100|3681776|P1|NOT COMPLETED|Overall Study||1
1505029|NCT01634100|3681771|P6|COMPLETED|Overall Study||3
1505030|NCT01634100|3681772|P5|COMPLETED|Overall Study||3
1505031|NCT01634100|3681773|P4|COMPLETED|Overall Study||3
1505032|NCT01634100|3681774|P3|COMPLETED|Overall Study||2
1505033|NCT01634100|3681775|P2|COMPLETED|Overall Study||3
1505034|NCT01634100|3681776|P1|COMPLETED|Overall Study||2
1505035|NCT01634100|3681771|P6|Received Empa + Probenecid|Overall Study||3
1505036|NCT01634100|3681772|P5|Received Empa + Probenecid|Overall Study||3
1505037|NCT01634100|3681773|P4|Received Empa + Probenecid|Overall Study||3
1505038|NCT01634100|3681774|P3|Received Empa + Probenecid|Overall Study||2
1505039|NCT01634100|3681775|P2|Received Empa + Probenecid|Overall Study||3
1505040|NCT01634100|3681776|P1|Received Empa + Probenecid|Overall Study||2
1505041|NCT01634100|3681771|P6|Received Empa + Rifampicin|Overall Study||3
1505042|NCT01634100|3681772|P5|Received Empa + Rifampicin|Overall Study||3
1505043|NCT01634100|3681773|P4|Received Empa + Rifampicin|Overall Study||3
1505044|NCT01634100|3681774|P3|Received Empa + Rifampicin|Overall Study||3
1505045|NCT01634100|3681775|P2|Received Empa + Rifampicin|Overall Study||3
1505046|NCT01634100|3681776|P1|Received Empa + Rifampicin|Overall Study||3
1505047|NCT01634100|3681771|P6|Received Empa Alone|Overall Study||3
1505048|NCT01634100|3681772|P5|Received Empa Alone|Overall Study||3
1505049|NCT01634100|3681773|P4|Received Empa Alone|Overall Study||3
1505050|NCT01634100|3681774|P3|Received Empa Alone|Overall Study||3
1505051|NCT01634100|3681775|P2|Received Empa Alone|Overall Study||3
1505052|NCT01634100|3681776|P1|Received Empa Alone|Overall Study||3
1505053|NCT01634100|3681771|P6|STARTED|Overall Study||3
1505054|NCT01634100|3681772|P5|STARTED|Overall Study||3
1505055|NCT01634100|3681773|P4|STARTED|Overall Study||3
1505056|NCT01634100|3681774|P3|STARTED|Overall Study||3
1505057|NCT01634100|3681775|P2|STARTED|Overall Study||3
1505058|NCT01634100|3681776|P1|STARTED|Overall Study||3
1505059|NCT01633944|3681792|P3|NOT COMPLETED|Double-blind Treatment Phase||58
1505060|NCT01633944|3681793|P2|NOT COMPLETED|Double-blind Treatment Phase||54
1505061|NCT01633944|3681794|P1|NOT COMPLETED|Double-blind Treatment Phase||0
1505062|NCT01633944|3681792|P3|COMPLETED|Double-blind Treatment Phase||174
1505063|NCT01633944|3681793|P2|COMPLETED|Double-blind Treatment Phase||176
1505064|NCT01633944|3681794|P1|COMPLETED|Double-blind Treatment Phase||0
1505065|NCT01633944|3681792|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
1505066|NCT01633944|3681793|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
1505067|NCT01633944|3681794|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
1505068|NCT01633944|3681792|P3|NOT COMPLETED|Open-label Titration Phase||0
1505069|NCT01633944|3681793|P2|NOT COMPLETED|Open-label Titration Phase||0
1505070|NCT01633944|3681794|P1|NOT COMPLETED|Open-label Titration Phase||290
1505071|NCT01633944|3681792|P3|COMPLETED|Open-label Titration Phase||0
1505072|NCT01633944|3681793|P2|COMPLETED|Open-label Titration Phase||0
1505073|NCT01633944|3681794|P1|COMPLETED|Open-label Titration Phase||462
1505074|NCT01633944|3681792|P3|STARTED|Open-label Titration Phase||0
1505075|NCT01633944|3681793|P2|STARTED|Open-label Titration Phase||0
1505076|NCT01633944|3681794|P1|STARTED|Open-label Titration Phase||752
1505077|NCT01633892|3681814|P1|NOT COMPLETED|Overall Study||0
1505078|NCT01633892|3681814|P1|COMPLETED|Overall Study||5
1505079|NCT01633892|3681814|P1|STARTED|Overall Study||5
1505080|NCT01633853|3681824|P2|NOT COMPLETED|Overall Study||0
1505081|NCT01633853|3681825|P1|NOT COMPLETED|Overall Study||0
1505082|NCT01633853|3681824|P2|COMPLETED|Overall Study||100
1505083|NCT01633853|3681825|P1|COMPLETED|Overall Study||104
1505084|NCT01633853|3681824|P2|STARTED|Overall Study||100
1505085|NCT01633853|3681825|P1|STARTED|Overall Study||104
1505086|NCT01633827|3681839|P2|NOT COMPLETED|Second Intervention||0
1505087|NCT01633827|3681840|P1|NOT COMPLETED|Second Intervention||0
1505088|NCT01633827|3681839|P2|COMPLETED|Second Intervention||11
1505089|NCT01633827|3681840|P1|COMPLETED|Second Intervention||11
1505090|NCT01633827|3681839|P2|STARTED|Second Intervention||11
1505091|NCT01633827|3681840|P1|STARTED|Second Intervention||11
1505092|NCT01633827|3681839|P2|NOT COMPLETED|Washout Period||0
1505093|NCT01633827|3681840|P1|NOT COMPLETED|Washout Period||0
1505094|NCT01633827|3681839|P2|COMPLETED|Washout Period||11
1505095|NCT01633827|3681840|P1|COMPLETED|Washout Period||11
1505096|NCT01633827|3681839|P2|STARTED|Washout Period||11
1505097|NCT01633827|3681840|P1|STARTED|Washout Period||11
1505098|NCT01633827|3681839|P2|NOT COMPLETED|First Intervention||0
1505099|NCT01633827|3681840|P1|NOT COMPLETED|First Intervention||0
1505100|NCT01633827|3681839|P2|COMPLETED|First Intervention||11
1505101|NCT01633827|3681840|P1|COMPLETED|First Intervention||11
1505102|NCT01633827|3681839|P2|STARTED|First Intervention||11
1505103|NCT01633827|3681840|P1|STARTED|First Intervention||11
1505104|NCT01633814|3681853|P1|NOT COMPLETED|Overall Study||0
1505105|NCT01633814|3681853|P1|COMPLETED|Overall Study||4
1505106|NCT01633814|3681853|P1|STARTED|Overall Study||4
1505107|NCT01633788|3681862|P4|NOT COMPLETED|Overall Study||13
1505108|NCT01633788|3681863|P3|NOT COMPLETED|Overall Study||10
1505109|NCT01633788|3681864|P2|NOT COMPLETED|Overall Study||8
1505110|NCT01633788|3681865|P1|NOT COMPLETED|Overall Study||7
1505111|NCT01633788|3681862|P4|COMPLETED|Overall Study||45
1505112|NCT01633788|3681863|P3|COMPLETED|Overall Study||49
1505113|NCT01633788|3681864|P2|COMPLETED|Overall Study||50
1505114|NCT01633788|3681865|P1|COMPLETED|Overall Study||50
1505115|NCT01633788|3681862|P4|STARTED|Overall Study||58
1505116|NCT01633788|3681863|P3|STARTED|Overall Study||59
1505117|NCT01633788|3681864|P2|STARTED|Overall Study||58
1505118|NCT01633788|3681865|P1|STARTED|Overall Study||57
1505119|NCT01633320|3681885|P2|NOT COMPLETED|Overall Study||0
1505120|NCT01633320|3681886|P1|NOT COMPLETED|Overall Study||0
1505121|NCT01633320|3681885|P2|COMPLETED|Overall Study||68
1505122|NCT01633320|3681886|P1|COMPLETED|Overall Study||132
1505123|NCT01633320|3681885|P2|STARTED|Overall Study||68
1505124|NCT01633320|3681886|P1|STARTED|Overall Study||132
1505125|NCT01632995|3681894|P1|NOT COMPLETED|Main Study Follow-up Period||120
1505126|NCT01632995|3681894|P1|COMPLETED|Main Study Follow-up Period||437
1505127|NCT01632995|3681894|P1|STARTED|Main Study Follow-up Period||557
1505128|NCT01632995|3681894|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
1505129|NCT01632995|3681894|P1|COMPLETED|Pre-screening to Enrollment Period||557
1505130|NCT01632995|3681894|P1|STARTED|Pre-screening to Enrollment Period||1069
1505131|NCT01632904|3681909|P2|NOT COMPLETED|Overall Study||6
1505132|NCT01632904|3681910|P1|NOT COMPLETED|Overall Study||7
1505133|NCT01632904|3681909|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
1505134|NCT01632904|3681910|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
1505135|NCT01632904|3681909|P2|STARTED|Overall Study||56
1505136|NCT01632904|3681910|P1|STARTED|Overall Study||54
1505137|NCT01632878|3681921|P1|NOT COMPLETED|Treatment||158
1505138|NCT01632878|3681921|P1|COMPLETED|Treatment||1105
1505139|NCT01632878|3681921|P1|STARTED|Treatment||1263
1505140|NCT01632878|3681921|P1|NOT COMPLETED|Screening||268
1505141|NCT01632878|3681921|P1|COMPLETED|Screening||1263
1505142|NCT01632878|3681921|P1|STARTED|Screening||1531
1505143|NCT01632800|3681925|P1|NOT COMPLETED|Overall Study||1
1505144|NCT01632800|3681925|P1|COMPLETED|Overall Study||25
1505145|NCT01632800|3681925|P1|STARTED|Overall Study||26
1505146|NCT01632735|3681931|P2|NOT COMPLETED|Overall Study||3
1505147|NCT01632735|3681932|P1|NOT COMPLETED|Overall Study||4
1505148|NCT01632735|3681931|P2|COMPLETED|Overall Study||37
1505149|NCT01632735|3681932|P1|COMPLETED|Overall Study||36
1505150|NCT01632735|3681931|P2|STARTED|Overall Study||40
1505151|NCT01632735|3681932|P1|STARTED|Overall Study||40
1505152|NCT01632709|3681948|P4|NOT COMPLETED|Overall Study||1
1505153|NCT01632709|3681949|P3|NOT COMPLETED|Overall Study||0
1505154|NCT01632709|3681950|P2|NOT COMPLETED|Overall Study||1
1505155|NCT01632709|3681951|P1|NOT COMPLETED|Overall Study||2
1505156|NCT01632709|3681948|P4|COMPLETED|Overall Study||3
1505157|NCT01632709|3681949|P3|COMPLETED|Overall Study||5
1505158|NCT01632709|3681950|P2|COMPLETED|Overall Study||2
1505159|NCT01632709|3681951|P1|COMPLETED|Overall Study||2
1505160|NCT01632709|3681948|P4|Completed Visit 2 (Received Injection)|Overall Study||3
1505161|NCT01632709|3681949|P3|Completed Visit 2 (Received Injection)|Overall Study||5
1505162|NCT01632709|3681950|P2|Completed Visit 2 (Received Injection)|Overall Study||2
1505163|NCT01632709|3681951|P1|Completed Visit 2 (Received Injection)|Overall Study||4
1505164|NCT01632709|3681948|P4|STARTED|Overall Study||4
1505165|NCT01632709|3681949|P3|STARTED|Overall Study||5
1505166|NCT01632709|3681950|P2|STARTED|Overall Study||3
1505167|NCT01632709|3681951|P1|STARTED|Overall Study||4
1505168|NCT01632683|3681977|P2|NOT COMPLETED|Overall Study||0
1505169|NCT01632683|3681978|P1|NOT COMPLETED|Overall Study||0
1505170|NCT01632683|3681977|P2|COMPLETED|Overall Study||552
1505171|NCT01632683|3681978|P1|COMPLETED|Overall Study||548
1505172|NCT01632683|3681977|P2|STARTED|Overall Study||552
1505173|NCT01632683|3681978|P1|STARTED|Overall Study||548
1505174|NCT01632579|3681992|P9|NOT COMPLETED|Period 3 (Third Intervention)||0
1505175|NCT01632579|3681993|P8|NOT COMPLETED|Period 3 (Third Intervention)||0
1505176|NCT01632579|3681994|P7|NOT COMPLETED|Period 3 (Third Intervention)||0
1505177|NCT01632579|3681995|P6|NOT COMPLETED|Period 3 (Third Intervention)||0
1505178|NCT01632579|3681996|P5|NOT COMPLETED|Period 3 (Third Intervention)||0
1505179|NCT01632579|3681997|P4|NOT COMPLETED|Period 3 (Third Intervention)||0
1505180|NCT01632579|3681998|P3|NOT COMPLETED|Period 3 (Third Intervention)||0
1505181|NCT01632579|3681999|P2|NOT COMPLETED|Period 3 (Third Intervention)||0
1505182|NCT01632579|3682000|P1|NOT COMPLETED|Period 3 (Third Intervention)||0
1505183|NCT01632579|3681992|P9|COMPLETED|Period 3 (Third Intervention)||2
1505184|NCT01632579|3681993|P8|COMPLETED|Period 3 (Third Intervention)||6
1505185|NCT01632579|3681994|P7|COMPLETED|Period 3 (Third Intervention)||2
1505186|NCT01632579|3681995|P6|COMPLETED|Period 3 (Third Intervention)||2
1505187|NCT01632579|3681996|P5|COMPLETED|Period 3 (Third Intervention)||6
1505188|NCT01632579|3681997|P4|COMPLETED|Period 3 (Third Intervention)||2
1505189|NCT01632579|3681998|P3|COMPLETED|Period 3 (Third Intervention)||2
1505190|NCT01632579|3681999|P2|COMPLETED|Period 3 (Third Intervention)||6
1505191|NCT01632579|3682000|P1|COMPLETED|Period 3 (Third Intervention)||0
1505192|NCT01632579|3681992|P9|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1505193|NCT01632579|3681993|P8|Received at Least 1 Dose|Period 3 (Third Intervention)||6
1505194|NCT01632579|3681994|P7|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1505195|NCT01632579|3681995|P6|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1505196|NCT01632579|3681996|P5|Received at Least 1 Dose|Period 3 (Third Intervention)||6
1505197|NCT01632579|3681997|P4|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1505198|NCT01632579|3681998|P3|Received at Least 1 Dose|Period 3 (Third Intervention)||2
1505199|NCT01632579|3681999|P2|Received at Least 1 Dose|Period 3 (Third Intervention)||6
1505200|NCT01632579|3682000|P1|Received at Least 1 Dose|Period 3 (Third Intervention)||0
1505201|NCT01632579|3681992|P9|STARTED|Period 3 (Third Intervention)||2
1505202|NCT01632579|3681993|P8|STARTED|Period 3 (Third Intervention)||6
1505203|NCT01632579|3681994|P7|STARTED|Period 3 (Third Intervention)||2
1505204|NCT01632579|3681995|P6|STARTED|Period 3 (Third Intervention)||2
1505205|NCT01632579|3681996|P5|STARTED|Period 3 (Third Intervention)||6
1505206|NCT01632579|3681997|P4|STARTED|Period 3 (Third Intervention)||2
1505207|NCT01632579|3681998|P3|STARTED|Period 3 (Third Intervention)||2
1505208|NCT01632579|3681999|P2|STARTED|Period 3 (Third Intervention)||6
1505209|NCT01632579|3682000|P1|STARTED|Period 3 (Third Intervention)||0
1505210|NCT01632579|3681992|P9|NOT COMPLETED|Washout Period||0
1505211|NCT01632579|3681993|P8|NOT COMPLETED|Washout Period||0
1505212|NCT01632579|3681994|P7|NOT COMPLETED|Washout Period||0
1505213|NCT01632579|3681995|P6|NOT COMPLETED|Washout Period||0
1505214|NCT01632579|3681996|P5|NOT COMPLETED|Washout Period||0
1505215|NCT01632579|3681997|P4|NOT COMPLETED|Washout Period||0
1505216|NCT01632579|3681998|P3|NOT COMPLETED|Washout Period||0
1505217|NCT01632579|3681999|P2|NOT COMPLETED|Washout Period||0
1505218|NCT01632579|3682000|P1|NOT COMPLETED|Washout Period||0
1505219|NCT01632579|3681992|P9|COMPLETED|Washout Period||2
1505220|NCT01632579|3681993|P8|COMPLETED|Washout Period||6
1505221|NCT01632579|3681994|P7|COMPLETED|Washout Period||2
1505222|NCT01632579|3681995|P6|COMPLETED|Washout Period||2
1505223|NCT01632579|3681996|P5|COMPLETED|Washout Period||6
1505224|NCT01632579|3681997|P4|COMPLETED|Washout Period||2
1505225|NCT01632579|3681998|P3|COMPLETED|Washout Period||2
1505226|NCT01632579|3681999|P2|COMPLETED|Washout Period||6
1505227|NCT01632579|3682000|P1|COMPLETED|Washout Period||0
1505228|NCT01632579|3681992|P9|STARTED|Washout Period||2
1505229|NCT01632579|3681993|P8|STARTED|Washout Period||6
1505230|NCT01632579|3681994|P7|STARTED|Washout Period||2
1505231|NCT01632579|3681995|P6|STARTED|Washout Period||2
1505232|NCT01632579|3681996|P5|STARTED|Washout Period||6
1505233|NCT01632579|3681997|P4|STARTED|Washout Period||2
1505234|NCT01632579|3681998|P3|STARTED|Washout Period||2
1505235|NCT01632579|3681999|P2|STARTED|Washout Period||6
1505236|NCT01632579|3682000|P1|STARTED|Washout Period||0
1505237|NCT01632579|3681992|P9|NOT COMPLETED|Period 2 (Second Intervention)||0
1505238|NCT01632579|3681993|P8|NOT COMPLETED|Period 2 (Second Intervention)||0
1505239|NCT01632579|3681994|P7|NOT COMPLETED|Period 2 (Second Intervention)||0
1505240|NCT01632579|3681995|P6|NOT COMPLETED|Period 2 (Second Intervention)||0
1505241|NCT01632579|3681996|P5|NOT COMPLETED|Period 2 (Second Intervention)||0
1505242|NCT01632579|3681997|P4|NOT COMPLETED|Period 2 (Second Intervention)||0
1505243|NCT01632579|3681998|P3|NOT COMPLETED|Period 2 (Second Intervention)||0
1505244|NCT01632579|3681999|P2|NOT COMPLETED|Period 2 (Second Intervention)||0
1505245|NCT01632579|3682000|P1|NOT COMPLETED|Period 2 (Second Intervention)||1
1505246|NCT01632579|3681992|P9|COMPLETED|Period 2 (Second Intervention)||2
1505247|NCT01632579|3681993|P8|COMPLETED|Period 2 (Second Intervention)||6
1505248|NCT01632579|3681994|P7|COMPLETED|Period 2 (Second Intervention)||2
1505249|NCT01632579|3681995|P6|COMPLETED|Period 2 (Second Intervention)||2
1505250|NCT01632579|3681996|P5|COMPLETED|Period 2 (Second Intervention)||6
1505251|NCT01632579|3681997|P4|COMPLETED|Period 2 (Second Intervention)||2
1505252|NCT01632579|3681998|P3|COMPLETED|Period 2 (Second Intervention)||2
1505253|NCT01632579|3681999|P2|COMPLETED|Period 2 (Second Intervention)||6
1505254|NCT01632579|3682000|P1|COMPLETED|Period 2 (Second Intervention)||0
1505255|NCT01632579|3681992|P9|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1505256|NCT01632579|3681993|P8|Received at Least 1 Dose|Period 2 (Second Intervention)||6
1505257|NCT01632579|3681994|P7|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1505258|NCT01632579|3681995|P6|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1505259|NCT01632579|3681996|P5|Received at Least 1 Dose|Period 2 (Second Intervention)||6
1505260|NCT01632579|3681997|P4|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1505261|NCT01632579|3681998|P3|Received at Least 1 Dose|Period 2 (Second Intervention)||2
1505262|NCT01632579|3681999|P2|Received at Least 1 Dose|Period 2 (Second Intervention)||6
1505263|NCT01632579|3682000|P1|Received at Least 1 Dose|Period 2 (Second Intervention)||1
1505264|NCT01632579|3681992|P9|STARTED|Period 2 (Second Intervention)||2
1505265|NCT01632579|3681993|P8|STARTED|Period 2 (Second Intervention)||6
1505266|NCT01632579|3681994|P7|STARTED|Period 2 (Second Intervention)||2
1505267|NCT01632579|3681995|P6|STARTED|Period 2 (Second Intervention)||2
1505268|NCT01632579|3681996|P5|STARTED|Period 2 (Second Intervention)||6
1505269|NCT01632579|3681997|P4|STARTED|Period 2 (Second Intervention)||2
1505270|NCT01632579|3681998|P3|STARTED|Period 2 (Second Intervention)||2
1505271|NCT01632579|3681999|P2|STARTED|Period 2 (Second Intervention)||6
1505272|NCT01632579|3682000|P1|STARTED|Period 2 (Second Intervention)||1
1505273|NCT01632579|3681992|P9|NOT COMPLETED|Washout Period||0
1505274|NCT01632579|3681993|P8|NOT COMPLETED|Washout Period||0
1505275|NCT01632579|3681994|P7|NOT COMPLETED|Washout Period||0
1505276|NCT01632579|3681995|P6|NOT COMPLETED|Washout Period||0
1505277|NCT01632579|3681996|P5|NOT COMPLETED|Washout Period||0
1505278|NCT01632579|3681997|P4|NOT COMPLETED|Washout Period||0
1505279|NCT01632579|3681998|P3|NOT COMPLETED|Washout Period||0
1505280|NCT01632579|3681999|P2|NOT COMPLETED|Washout Period||0
1505281|NCT01632579|3682000|P1|NOT COMPLETED|Washout Period||1
1505282|NCT01632579|3681992|P9|COMPLETED|Washout Period||2
1505283|NCT01632579|3681993|P8|COMPLETED|Washout Period||6
1505284|NCT01632579|3681994|P7|COMPLETED|Washout Period||2
1505285|NCT01632579|3681995|P6|COMPLETED|Washout Period||2
1505286|NCT01632579|3681996|P5|COMPLETED|Washout Period||6
1505287|NCT01632579|3681997|P4|COMPLETED|Washout Period||2
1505288|NCT01632579|3681998|P3|COMPLETED|Washout Period||2
1505289|NCT01632579|3681999|P2|COMPLETED|Washout Period||6
1505290|NCT01632579|3682000|P1|COMPLETED|Washout Period||1
1505291|NCT01632579|3681992|P9|STARTED|Washout Period||2
1505292|NCT01632579|3681993|P8|STARTED|Washout Period||6
1505293|NCT01632579|3681994|P7|STARTED|Washout Period||2
1505294|NCT01632579|3681995|P6|STARTED|Washout Period||2
1505295|NCT01632579|3681996|P5|STARTED|Washout Period||6
1505296|NCT01632579|3681997|P4|STARTED|Washout Period||2
1505297|NCT01632579|3681998|P3|STARTED|Washout Period||2
1505298|NCT01632579|3681999|P2|STARTED|Washout Period||6
1505299|NCT01632579|3682000|P1|STARTED|Washout Period||2
1505300|NCT01632579|3681992|P9|NOT COMPLETED|Period 1 (First Intervention)||0
1505301|NCT01632579|3681993|P8|NOT COMPLETED|Period 1 (First Intervention)||0
1505302|NCT01632579|3681994|P7|NOT COMPLETED|Period 1 (First Intervention)||0
1505303|NCT01632579|3681995|P6|NOT COMPLETED|Period 1 (First Intervention)||0
1505304|NCT01632579|3681996|P5|NOT COMPLETED|Period 1 (First Intervention)||0
1505305|NCT01632579|3681997|P4|NOT COMPLETED|Period 1 (First Intervention)||0
1505306|NCT01632579|3681998|P3|NOT COMPLETED|Period 1 (First Intervention)||0
1505307|NCT01632579|3681999|P2|NOT COMPLETED|Period 1 (First Intervention)||0
1505308|NCT01632579|3682000|P1|NOT COMPLETED|Period 1 (First Intervention)||0
1505309|NCT01632579|3681992|P9|COMPLETED|Period 1 (First Intervention)||2
1505310|NCT01632579|3681993|P8|COMPLETED|Period 1 (First Intervention)||6
1505311|NCT01632579|3681994|P7|COMPLETED|Period 1 (First Intervention)||2
1505312|NCT01632579|3681995|P6|COMPLETED|Period 1 (First Intervention)||2
1505313|NCT01632579|3681996|P5|COMPLETED|Period 1 (First Intervention)||6
1505314|NCT01632579|3681997|P4|COMPLETED|Period 1 (First Intervention)||2
1505315|NCT01632579|3681998|P3|COMPLETED|Period 1 (First Intervention)||2
1505316|NCT01632579|3681999|P2|COMPLETED|Period 1 (First Intervention)||6
1505317|NCT01632579|3682000|P1|COMPLETED|Period 1 (First Intervention)||2
1505318|NCT01632579|3681992|P9|Received at Least 1 Dose|Period 1 (First Intervention)||2
1505319|NCT01632579|3681993|P8|Received at Least 1 Dose|Period 1 (First Intervention)||6
1505320|NCT01632579|3681994|P7|Received at Least 1 Dose|Period 1 (First Intervention)||2
1505321|NCT01632579|3681995|P6|Received at Least 1 Dose|Period 1 (First Intervention)||2
1505322|NCT01632579|3681996|P5|Received at Least 1 Dose|Period 1 (First Intervention)||6
1505323|NCT01632579|3681997|P4|Received at Least 1 Dose|Period 1 (First Intervention)||2
1505324|NCT01632579|3681998|P3|Received at Least 1 Dose|Period 1 (First Intervention)||2
1505325|NCT01632579|3681999|P2|Received at Least 1 Dose|Period 1 (First Intervention)||6
1505326|NCT01632579|3682000|P1|Received at Least 1 Dose|Period 1 (First Intervention)||2
1505327|NCT01632579|3681992|P9|STARTED|Period 1 (First Intervention)||2
1505328|NCT01632579|3681993|P8|STARTED|Period 1 (First Intervention)||6
1505329|NCT01632579|3681994|P7|STARTED|Period 1 (First Intervention)||2
1505330|NCT01632579|3681995|P6|STARTED|Period 1 (First Intervention)||2
1505331|NCT01632579|3681996|P5|STARTED|Period 1 (First Intervention)||6
1505332|NCT01632579|3681997|P4|STARTED|Period 1 (First Intervention)||2
1505333|NCT01632579|3681998|P3|STARTED|Period 1 (First Intervention)||2
1505334|NCT01632579|3681999|P2|STARTED|Period 1 (First Intervention)||6
1505335|NCT01632579|3682000|P1|STARTED|Period 1 (First Intervention)||2
1505336|NCT01632423|3682062|P1|NOT COMPLETED|Overall Study||246
1505337|NCT01632423|3682062|P1|COMPLETED|Overall Study||10091
1505338|NCT01632423|3682062|P1|STARTED|Overall Study||10337
1505339|NCT01632345|3682075|P7|NOT COMPLETED|Treatment: Part II||11
1505340|NCT01632345|3682076|P6|NOT COMPLETED|Treatment: Part II||11
1505341|NCT01632345|3682077|P5|NOT COMPLETED|Treatment: Part II||0
1505342|NCT01632345|3682078|P4|NOT COMPLETED|Treatment: Part II||0
1505343|NCT01632345|3682079|P3|NOT COMPLETED|Treatment: Part II||0
1505344|NCT01632345|3682080|P2|NOT COMPLETED|Treatment: Part II||0
1505345|NCT01632345|3682081|P1|NOT COMPLETED|Treatment: Part II||0
1505346|NCT01632345|3682075|P7|COMPLETED|Treatment: Part II||55
1505347|NCT01632345|3682076|P6|COMPLETED|Treatment: Part II||55
1505348|NCT01632345|3682077|P5|COMPLETED|Treatment: Part II||0
1505349|NCT01632345|3682078|P4|COMPLETED|Treatment: Part II||0
1505350|NCT01632345|3682079|P3|COMPLETED|Treatment: Part II||0
1505351|NCT01632345|3682080|P2|COMPLETED|Treatment: Part II||0
1505352|NCT01632345|3682081|P1|COMPLETED|Treatment: Part II||0
1505353|NCT01632345|3682075|P7|Treated|Treatment: Part II||66
1505354|NCT01632345|3682076|P6|Treated|Treatment: Part II||66
1505355|NCT01632345|3682077|P5|Treated|Treatment: Part II||0
1505356|NCT01632345|3682078|P4|Treated|Treatment: Part II||0
1505357|NCT01632345|3682079|P3|Treated|Treatment: Part II||0
1505358|NCT01632345|3682080|P2|Treated|Treatment: Part II||0
1505359|NCT01632345|3682081|P1|Treated|Treatment: Part II||0
1505360|NCT01632345|3682075|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
1505361|NCT01632345|3682076|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
1505362|NCT01632345|3682077|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1505363|NCT01632345|3682078|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1505364|NCT01632345|3682079|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1505365|NCT01632345|3682080|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1505366|NCT01632345|3682081|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
1505367|NCT01632345|3682075|P7|NOT COMPLETED|Treatment: Part I||0
1505368|NCT01632345|3682076|P6|NOT COMPLETED|Treatment: Part I||0
1505369|NCT01632345|3682077|P5|NOT COMPLETED|Treatment: Part I||13
1505370|NCT01632345|3682078|P4|NOT COMPLETED|Treatment: Part I||8
1505371|NCT01632345|3682079|P3|NOT COMPLETED|Treatment: Part I||10
1505372|NCT01632345|3682080|P2|NOT COMPLETED|Treatment: Part I||15
1505373|NCT01632345|3682081|P1|NOT COMPLETED|Treatment: Part I||12
1505374|NCT01632345|3682075|P7|COMPLETED|Treatment: Part I||0
1505375|NCT01632345|3682076|P6|COMPLETED|Treatment: Part I||0
1505376|NCT01632345|3682077|P5|COMPLETED|Treatment: Part I||30
1505377|NCT01632345|3682078|P4|COMPLETED|Treatment: Part I||33
1505378|NCT01632345|3682079|P3|COMPLETED|Treatment: Part I||32
1505379|NCT01632345|3682080|P2|COMPLETED|Treatment: Part I||28
1505380|NCT01632345|3682081|P1|COMPLETED|Treatment: Part I||29
1505381|NCT01632345|3682075|P7|Treated|Treatment: Part I||0
1505382|NCT01632345|3682076|P6|Treated|Treatment: Part I||0
1505383|NCT01632345|3682077|P5|Treated|Treatment: Part I||43
1505384|NCT01632345|3682078|P4|Treated|Treatment: Part I||41
1505385|NCT01632345|3682079|P3|Treated|Treatment: Part I||42
1505386|NCT01632345|3682080|P2|Treated|Treatment: Part I||43
1505387|NCT01632345|3682081|P1|Treated|Treatment: Part I||40
1505388|NCT01632345|3682075|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
1505389|NCT01632345|3682076|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
1505390|NCT01632345|3682077|P5|STARTED|Treatment: Part I||43
1505391|NCT01632345|3682078|P4|STARTED|Treatment: Part I||41
1505392|NCT01632345|3682079|P3|STARTED|Treatment: Part I||42
1505393|NCT01632345|3682080|P2|STARTED|Treatment: Part I||43
1505394|NCT01632345|3682081|P1|STARTED|Treatment: Part I||41
1505395|NCT01632345|3682075|P7|NOT COMPLETED|Randomized Participants||0
1505396|NCT01632345|3682076|P6|NOT COMPLETED|Randomized Participants||0
1505397|NCT01632345|3682077|P5|NOT COMPLETED|Randomized Participants||0
1505398|NCT01632345|3682078|P4|NOT COMPLETED|Randomized Participants||0
1505399|NCT01632345|3682079|P3|NOT COMPLETED|Randomized Participants||0
1505400|NCT01632345|3682080|P2|NOT COMPLETED|Randomized Participants||0
1505401|NCT01632345|3682081|P1|NOT COMPLETED|Randomized Participants||0
1505402|NCT01632345|3682075|P7|COMPLETED|Randomized Participants||66
1505403|NCT01632345|3682076|P6|COMPLETED|Randomized Participants||66
1505404|NCT01632345|3682077|P5|COMPLETED|Randomized Participants||43
1505405|NCT01632345|3682078|P4|COMPLETED|Randomized Participants||41
1505406|NCT01632345|3682079|P3|COMPLETED|Randomized Participants||42
1505407|NCT01632345|3682080|P2|COMPLETED|Randomized Participants||43
1505408|NCT01632345|3682081|P1|COMPLETED|Randomized Participants||41
1505409|NCT01632345|3682075|P7|STARTED|Randomized Participants||66
1505410|NCT01632345|3682076|P6|STARTED|Randomized Participants||66
1505411|NCT01632345|3682077|P5|STARTED|Randomized Participants||43
1505412|NCT01632345|3682078|P4|STARTED|Randomized Participants||41
1505413|NCT01632345|3682079|P3|STARTED|Randomized Participants||42
1505414|NCT01632345|3682080|P2|STARTED|Randomized Participants||43
1505415|NCT01632345|3682081|P1|STARTED|Randomized Participants||41
1505416|NCT01632306|3682143|P3|NOT COMPLETED|Overall Study||0
1505417|NCT01632306|3682144|P2|NOT COMPLETED|Overall Study||0
1505418|NCT01632306|3682145|P1|NOT COMPLETED|Overall Study||1
1505419|NCT01632306|3682143|P3|COMPLETED|Overall Study||0
1505420|NCT01632306|3682144|P2|COMPLETED|Overall Study||10
1505421|NCT01632306|3682145|P1|COMPLETED|Overall Study||2
1505422|NCT01632306|3682143|P3|Received at Least One Dose of Study Drug|Overall Study||0
1505423|NCT01632306|3682144|P2|Received at Least One Dose of Study Drug|Overall Study||10
1505424|NCT01632306|3682145|P1|Received at Least One Dose of Study Drug|Overall Study||3
1505425|NCT01632306|3682143|P3|STARTED|Overall Study||0
1505426|NCT01632306|3682144|P2|STARTED|Overall Study||10
1505427|NCT01632306|3682145|P1|STARTED|Overall Study||3
1505428|NCT01632280|3682161|P2|NOT COMPLETED|Overall Study||0
1505429|NCT01632280|3682162|P1|NOT COMPLETED|Overall Study||1
1505430|NCT01632280|3682161|P2|COMPLETED|Overall Study||6
1505431|NCT01632280|3682162|P1|COMPLETED|Overall Study||5
1505432|NCT01632280|3682161|P2|STARTED|Overall Study||6
1505433|NCT01632280|3682162|P1|STARTED|Overall Study||6
1505434|NCT01632267|3682172|P1|NOT COMPLETED|Overall Study||7
1505435|NCT01632267|3682172|P1|COMPLETED|Overall Study||97
1505436|NCT01632267|3682172|P1|STARTED|Overall Study||104
1505437|NCT01632215|3682178|P2|NOT COMPLETED|Overall Study||1
1505438|NCT01632215|3682179|P1|NOT COMPLETED|Overall Study||2
1505439|NCT01632215|3682178|P2|COMPLETED|Overall Study||19
1505440|NCT01632215|3682179|P1|COMPLETED|Overall Study||18
1505441|NCT01632215|3682178|P2|STARTED|Overall Study||20
1505442|NCT01632215|3682179|P1|STARTED|Overall Study||20
1505443|NCT01632150|3682185|P1|NOT COMPLETED|Overall Study||40
1505444|NCT01632150|3682185|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
1505445|NCT01632150|3682185|P1|Received Cyclophosphamide|Overall Study||11
1505446|NCT01632150|3682185|P1|STARTED|Overall Study||40
1505447|NCT01632020|3682194|P2|NOT COMPLETED|Overall Study||0
1505448|NCT01632020|3682195|P1|NOT COMPLETED|Overall Study||2
1505449|NCT01632020|3682194|P2|COMPLETED|Overall Study||3
1505450|NCT01632020|3682195|P1|COMPLETED|Overall Study||2
1505451|NCT01632020|3682194|P2|STARTED|Overall Study||3
1505452|NCT01632020|3682195|P1|STARTED|Overall Study||4
1505453|NCT01631929|3682205|P2|NOT COMPLETED|Overall Study||0
1505454|NCT01631929|3682206|P1|NOT COMPLETED|Overall Study||0
1505455|NCT01631929|3682205|P2|COMPLETED|Overall Study||6
1505456|NCT01631929|3682206|P1|COMPLETED|Overall Study||6
1505457|NCT01631929|3682205|P2|STARTED|Overall Study||6
1505458|NCT01631929|3682206|P1|STARTED|Overall Study||6
1505459|NCT01631864|3682214|P2|NOT COMPLETED|Overall Study||4
1505460|NCT01631864|3682215|P1|NOT COMPLETED|Overall Study||2
1505461|NCT01631864|3682214|P2|COMPLETED|Overall Study||44
1505462|NCT01631864|3682215|P1|COMPLETED|Overall Study||48
1505463|NCT01631864|3682214|P2|STARTED|Overall Study||48
1505464|NCT01631864|3682215|P1|STARTED|Overall Study||50
1505465|NCT01631825|3682227|P1|NOT COMPLETED|Overall Study||65
1505466|NCT01631825|3682227|P1|COMPLETED|Overall Study||256
1505467|NCT01631825|3682227|P1|STARTED|Overall Study||321
1505468|NCT01631812|3682247|P1|NOT COMPLETED|Overall Study||37
1505469|NCT01631812|3682247|P1|COMPLETED|Overall Study||93
1505470|NCT01631812|3682247|P1|STARTED|Overall Study||130
1505471|NCT01631747|3682257|P2|NOT COMPLETED|One Year Infant Outcomes||9
1505472|NCT01631747|3682258|P1|NOT COMPLETED|One Year Infant Outcomes||13
1505473|NCT01631747|3682257|P2|COMPLETED|One Year Infant Outcomes||130
1505474|NCT01631747|3682258|P1|COMPLETED|One Year Infant Outcomes||123
1505475|NCT01631747|3682257|P2|STARTED|One Year Infant Outcomes||139
1505476|NCT01631747|3682258|P1|STARTED|One Year Infant Outcomes||136
1505477|NCT01631747|3682257|P2|NOT COMPLETED|Live Birth||1
1505478|NCT01631747|3682258|P1|NOT COMPLETED|Live Birth||4
1505479|NCT01631747|3682257|P2|COMPLETED|Live Birth||139
1505480|NCT01631747|3682258|P1|COMPLETED|Live Birth||136
1505481|NCT01631747|3682257|P2|STARTED|Live Birth||140
1505482|NCT01631747|3682258|P1|STARTED|Live Birth||140
1505483|NCT01631747|3682257|P2|NOT COMPLETED|Randomization Through End of Pregnancy||0
1505484|NCT01631747|3682258|P1|NOT COMPLETED|Randomization Through End of Pregnancy||1
1505485|NCT01631747|3682257|P2|COMPLETED|Randomization Through End of Pregnancy||140
1505486|NCT01631747|3682258|P1|COMPLETED|Randomization Through End of Pregnancy||140
1505487|NCT01631747|3682257|P2|STARTED|Randomization Through End of Pregnancy||140
1505488|NCT01631747|3682258|P1|STARTED|Randomization Through End of Pregnancy||141
1505489|NCT01631682|3682300|P4|NOT COMPLETED|Overall Study||2
1505490|NCT01631682|3682301|P3|NOT COMPLETED|Overall Study||31
1505491|NCT01631682|3682302|P2|NOT COMPLETED|Overall Study||45
1505492|NCT01631682|3682303|P1|NOT COMPLETED|Overall Study||31
1505493|NCT01631682|3682300|P4|COMPLETED|Overall Study||5
1505494|NCT01631682|3682301|P3|COMPLETED|Overall Study||13
1505495|NCT01631682|3682302|P2|COMPLETED|Overall Study||21
1505496|NCT01631682|3682303|P1|COMPLETED|Overall Study||24
1505497|NCT01631682|3682300|P4|STARTED|Overall Study||7
1505498|NCT01631682|3682301|P3|STARTED|Overall Study||44
1505499|NCT01631682|3682302|P2|STARTED|Overall Study||66
1505500|NCT01631682|3682303|P1|STARTED|Overall Study||55
1505501|NCT01631656|3682315|P2|NOT COMPLETED|Overall Study||0
1505502|NCT01631656|3682316|P1|NOT COMPLETED|Overall Study||0
1505503|NCT01631656|3682315|P2|COMPLETED|Overall Study||5
1505504|NCT01631656|3682316|P1|COMPLETED|Overall Study||5
1505505|NCT01631656|3682315|P2|STARTED|Overall Study||5
1505506|NCT01631656|3682316|P1|STARTED|Overall Study||5
1505507|NCT01631630|3682324|P2|NOT COMPLETED|Overall Study||0
1505508|NCT01631630|3682325|P1|NOT COMPLETED|Overall Study||3
1505509|NCT01631630|3682324|P2|COMPLETED|Overall Study||8
1505510|NCT01631630|3682325|P1|COMPLETED|Overall Study||5
1505511|NCT01631630|3682324|P2|STARTED|Overall Study||8
1505512|NCT01631630|3682325|P1|STARTED|Overall Study||8
1505513|NCT01631435|3682435|P1|NOT COMPLETED|Overall Study||9
1505514|NCT01631435|3682435|P1|COMPLETED|Overall Study||66
1505515|NCT01631435|3682435|P1|STARTED|Overall Study||75
1505516|NCT01631331|3682440|P1|NOT COMPLETED|Overall Study||4
1505517|NCT01631331|3682440|P1|COMPLETED|Overall Study||11
1505518|NCT01631331|3682440|P1|STARTED|Overall Study||15
1505519|NCT01631227|3682449|P2|NOT COMPLETED|Overall Study||22
1505520|NCT01631227|3682450|P1|NOT COMPLETED|Overall Study||30
1505521|NCT01631227|3682449|P2|COMPLETED|Overall Study||310
1505522|NCT01631227|3682450|P1|COMPLETED|Overall Study||303
1505523|NCT01631227|3682449|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
1505524|NCT01631227|3682450|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
1505525|NCT01631227|3682449|P2|Safety Subject Sample|Overall Study||332
1505526|NCT01631227|3682450|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
1505527|NCT01631227|3682449|P2|STARTED|Overall Study||332
1505528|NCT01631227|3682450|P1|STARTED|Overall Study||333
1505529|NCT01631214|3682458|P2|NOT COMPLETED|Overall Study||523
1505530|NCT01631214|3682459|P1|NOT COMPLETED|Overall Study||544
1505531|NCT01631214|3682458|P2|COMPLETED|Overall Study||1523
1505532|NCT01631214|3682459|P1|COMPLETED|Overall Study||1503
1505533|NCT01631214|3682458|P2|Completed Primary Analysis Period|Overall Study||1574
1505534|NCT01631214|3682459|P1|Completed Primary Analysis Period|Overall Study||1576
1505535|NCT01631214|3682458|P2|Completed Double-blind Period|Overall Study||1831
1505536|NCT01631214|3682459|P1|Completed Double-blind Period|Overall Study||1823
1505537|NCT01631214|3682458|P2|Received Double-blind Treatment|Overall Study||2038
1505538|NCT01631214|3682459|P1|Received Double-blind Treatment|Overall Study||2040
1505539|NCT01631214|3682458|P2|STARTED|Overall Study||2046
1505540|NCT01631214|3682459|P1|STARTED|Overall Study||2047
1505541|NCT01631149|3682523|P2|NOT COMPLETED|Overall Study||0
1505542|NCT01631149|3682524|P1|NOT COMPLETED|Overall Study||0
1505543|NCT01631149|3682523|P2|COMPLETED|Overall Study||12
1505544|NCT01631149|3682524|P1|COMPLETED|Overall Study||12
1505545|NCT01631149|3682523|P2|STARTED|Overall Study||12
1505546|NCT01631149|3682524|P1|STARTED|Overall Study||12
1505547|NCT01631110|3682540|P2|NOT COMPLETED|Overall Study||0
1505548|NCT01631110|3682541|P1|NOT COMPLETED|Overall Study||0
1505549|NCT01631110|3682540|P2|COMPLETED|Overall Study||55
1505550|NCT01631110|3682541|P1|COMPLETED|Overall Study||55
1505551|NCT01631110|3682540|P2|STARTED|Overall Study||55
1505552|NCT01631110|3682541|P1|STARTED|Overall Study||55
1505553|NCT01631071|3682555|P2|NOT COMPLETED|Overall Study||0
1505554|NCT01631071|3682556|P1|NOT COMPLETED|Overall Study||0
1505555|NCT01631071|3682555|P2|COMPLETED|Overall Study||55
1505556|NCT01631071|3682556|P1|COMPLETED|Overall Study||55
1505557|NCT01631071|3682555|P2|STARTED|Overall Study||55
1505558|NCT01631071|3682556|P1|STARTED|Overall Study||55
1505559|NCT01630811|3682568|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
1505560|NCT01630811|3682569|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
1505561|NCT01630811|3682568|P2|COMPLETED|Second Washout (4 Weeks)||6
1505562|NCT01630811|3682569|P1|COMPLETED|Second Washout (4 Weeks)||6
1505563|NCT01630811|3682568|P2|STARTED|Second Washout (4 Weeks)||6
1505564|NCT01630811|3682569|P1|STARTED|Second Washout (4 Weeks)||6
1505565|NCT01630811|3682568|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
1505566|NCT01630811|3682569|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
1505567|NCT01630811|3682568|P2|COMPLETED|Second Intervention (8 Weeks)||6
1505568|NCT01630811|3682569|P1|COMPLETED|Second Intervention (8 Weeks)||6
1505569|NCT01630811|3682568|P2|STARTED|Second Intervention (8 Weeks)||6
1505570|NCT01630811|3682569|P1|STARTED|Second Intervention (8 Weeks)||7
1505571|NCT01630811|3682568|P2|NOT COMPLETED|Washout (4 Weeks)||0
1505572|NCT01630811|3682569|P1|NOT COMPLETED|Washout (4 Weeks)||0
1505573|NCT01630811|3682568|P2|COMPLETED|Washout (4 Weeks)||6
1505574|NCT01630811|3682569|P1|COMPLETED|Washout (4 Weeks)||7
1505575|NCT01630811|3682568|P2|STARTED|Washout (4 Weeks)||6
1505576|NCT01630811|3682569|P1|STARTED|Washout (4 Weeks)||7
1505577|NCT01630811|3682568|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
1505578|NCT01630811|3682569|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
1505579|NCT01630811|3682568|P2|COMPLETED|First Intervention (8 Weeks)||6
1505580|NCT01630811|3682569|P1|COMPLETED|First Intervention (8 Weeks)||7
1505581|NCT01630811|3682568|P2|STARTED|First Intervention (8 Weeks)||6
1505582|NCT01630811|3682569|P1|STARTED|First Intervention (8 Weeks)||7
1505583|NCT01630694|3682581|P2|NOT COMPLETED|Overall Study||0
1505584|NCT01630694|3682582|P1|NOT COMPLETED|Overall Study||0
1505585|NCT01630694|3682581|P2|COMPLETED|Overall Study||16
1505586|NCT01630694|3682582|P1|COMPLETED|Overall Study||12
1505587|NCT01630694|3682581|P2|STARTED|Overall Study||16
1505588|NCT01630694|3682582|P1|STARTED|Overall Study||12
1505589|NCT01630616|3682596|P6|NOT COMPLETED|Overall Study||0
1505590|NCT01630616|3682597|P5|NOT COMPLETED|Overall Study||0
1505591|NCT01630616|3682598|P4|NOT COMPLETED|Overall Study||3
1505592|NCT01630616|3682599|P3|NOT COMPLETED|Overall Study||0
1505593|NCT01630616|3682600|P2|NOT COMPLETED|Overall Study||0
1505594|NCT01630616|3682601|P1|NOT COMPLETED|Overall Study||0
1505595|NCT01630616|3682596|P6|COMPLETED|Overall Study||2
1505596|NCT01630616|3682597|P5|COMPLETED|Overall Study||6
1505597|NCT01630616|3682598|P4|COMPLETED|Overall Study||9
1505598|NCT01630616|3682599|P3|COMPLETED|Overall Study||3
1505599|NCT01630616|3682600|P2|COMPLETED|Overall Study||3
1505600|NCT01630616|3682601|P1|COMPLETED|Overall Study||5
1505601|NCT01630616|3682596|P6|STARTED|Overall Study||2
1505602|NCT01630616|3682597|P5|STARTED|Overall Study||6
1505603|NCT01630616|3682598|P4|STARTED|Overall Study||12
1505604|NCT01630616|3682599|P3|STARTED|Overall Study||3
1505605|NCT01630616|3682600|P2|STARTED|Overall Study||3
1505606|NCT01630616|3682601|P1|STARTED|Overall Study||5
1505607|NCT01630135|3682676|P2|NOT COMPLETED|Overall Study||2
1505608|NCT01630135|3682677|P1|NOT COMPLETED|Overall Study||0
1505609|NCT01630135|3682676|P2|COMPLETED|Overall Study||128
1505610|NCT01630135|3682677|P1|COMPLETED|Overall Study||131
1505611|NCT01630135|3682676|P2|STARTED|Overall Study||130
1505612|NCT01630135|3682677|P1|STARTED|Overall Study||131
1505613|NCT01630109|3682716|P3|NOT COMPLETED|Overall Study||0
1505614|NCT01630109|3682717|P2|NOT COMPLETED|Overall Study||0
1505615|NCT01630109|3682718|P1|NOT COMPLETED|Overall Study||0
1505616|NCT01630109|3682716|P3|COMPLETED|Overall Study||3
1505617|NCT01630109|3682717|P2|COMPLETED|Overall Study||1
1505618|NCT01630109|3682718|P1|COMPLETED|Overall Study||1
1505619|NCT01630109|3682716|P3|STARTED|Overall Study||3
1505620|NCT01630109|3682717|P2|STARTED|Overall Study||1
1505621|NCT01630109|3682718|P1|STARTED|Overall Study||1
1505622|NCT01629953|3682740|P2|NOT COMPLETED|Overall Study||15
1505623|NCT01629953|3682741|P1|NOT COMPLETED|Overall Study||13
1505624|NCT01629953|3682740|P2|COMPLETED|Overall Study||60
1505625|NCT01629953|3682741|P1|COMPLETED|Overall Study||52
1505626|NCT01629953|3682740|P2|STARTED|Overall Study||75
1505627|NCT01629953|3682741|P1|STARTED|Overall Study||65
1505628|NCT01629862|3682751|P2|NOT COMPLETED|Overall Study||2
1505629|NCT01629862|3682752|P1|NOT COMPLETED|Overall Study||2
1505630|NCT01629862|3682751|P2|COMPLETED|Overall Study||23
1505631|NCT01629862|3682752|P1|COMPLETED|Overall Study||26
1505632|NCT01629862|3682751|P2|STARTED|Overall Study||25
1505633|NCT01629862|3682752|P1|STARTED|Overall Study||28
1505634|NCT01629823|3682761|P3|NOT COMPLETED|Washout Period||0
1505635|NCT01629823|3682762|P2|NOT COMPLETED|Washout Period||6
1505636|NCT01629823|3682763|P1|NOT COMPLETED|Washout Period||3
1505637|NCT01629823|3682761|P3|COMPLETED|Washout Period||50
1505638|NCT01629823|3682762|P2|COMPLETED|Washout Period||51
1505639|NCT01629823|3682763|P1|COMPLETED|Washout Period||51
1505640|NCT01629823|3682761|P3|STARTED|Washout Period||50
1505641|NCT01629823|3682762|P2|STARTED|Washout Period||57
1505642|NCT01629823|3682763|P1|STARTED|Washout Period||54
1505643|NCT01629823|3682761|P3|NOT COMPLETED|Trial Period||10
1505644|NCT01629823|3682762|P2|NOT COMPLETED|Trial Period||13
1505645|NCT01629823|3682763|P1|NOT COMPLETED|Trial Period||13
1505646|NCT01629823|3682761|P3|COMPLETED|Trial Period||49
1505647|NCT01629823|3682762|P2|COMPLETED|Trial Period||56
1505648|NCT01629823|3682763|P1|COMPLETED|Trial Period||53
1505649|NCT01629823|3682761|P3|STARTED|Trial Period||59
1505650|NCT01629823|3682762|P2|STARTED|Trial Period||69
1505651|NCT01629823|3682763|P1|STARTED|Trial Period||66
1505652|NCT01629797|3682771|P1|NOT COMPLETED|Overall Study||18
1505653|NCT01629797|3682771|P1|COMPLETED|Overall Study||82
1505654|NCT01629797|3682771|P1|STARTED|Overall Study||100
1505655|NCT01629784|3682778|P1|NOT COMPLETED|Overall Study||6
1505656|NCT01629784|3682778|P1|COMPLETED|Overall Study||25
1505657|NCT01629784|3682778|P1|STARTED|Overall Study||31
1505658|NCT01629771|3682787|P2|NOT COMPLETED|Overall Study||0
1505659|NCT01629771|3682788|P1|NOT COMPLETED|Overall Study||0
1505660|NCT01629771|3682787|P2|COMPLETED|Overall Study||36
1505661|NCT01629771|3682788|P1|COMPLETED|Overall Study||36
1505662|NCT01629771|3682787|P2|STARTED|Overall Study||36
1505663|NCT01629771|3682788|P1|STARTED|Overall Study||36
1505664|NCT01629706|3682798|P1|NOT COMPLETED|Phase 2 Habitual||10
1505665|NCT01629706|3682798|P1|COMPLETED|Phase 2 Habitual||48
1505666|NCT01629706|3682798|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
1505667|NCT01629706|3682798|P1|NOT COMPLETED|Phase 1 PureVision||9
1505668|NCT01629706|3682798|P1|COMPLETED|Phase 1 PureVision||35
1505669|NCT01629706|3682798|P1|STARTED|Phase 1 PureVision||44
1505670|NCT01629693|3682826|P2|NOT COMPLETED|Overall Study||10
1505671|NCT01629693|3682827|P1|NOT COMPLETED|Overall Study||5
1505672|NCT01629693|3682826|P2|COMPLETED|Overall Study||178
1505673|NCT01629693|3682827|P1|COMPLETED|Overall Study||188
1505674|NCT01629693|3682826|P2|STARTED|Overall Study||188
1505675|NCT01629693|3682827|P1|STARTED|Overall Study||193
1505676|NCT01629667|3682836|P3|NOT COMPLETED|Overall Study||45
1505677|NCT01629667|3682837|P2|NOT COMPLETED|Overall Study||41
1505678|NCT01629667|3682838|P1|NOT COMPLETED|Overall Study||47
1505679|NCT01629667|3682836|P3|COMPLETED|Overall Study||14
1505680|NCT01629667|3682837|P2|COMPLETED|Overall Study||17
1505681|NCT01629667|3682838|P1|COMPLETED|Overall Study||12
1505682|NCT01629667|3682836|P3|Randomized and Treated|Overall Study||59
1505683|NCT01629667|3682837|P2|Randomized and Treated|Overall Study||57
1505684|NCT01629667|3682838|P1|Randomized and Treated|Overall Study||57
1505685|NCT01629667|3682836|P3|STARTED|Overall Study||59
1505686|NCT01629667|3682837|P2|STARTED|Overall Study||58
1505687|NCT01629667|3682838|P1|STARTED|Overall Study||59
1505688|NCT01629589|3682922|P2|NOT COMPLETED|Overall Study||7
1505689|NCT01629589|3682923|P1|NOT COMPLETED|Overall Study||8
1505690|NCT01629589|3682922|P2|COMPLETED|Overall Study||204
1505691|NCT01629589|3682923|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
1505692|NCT01629589|3682922|P2|STARTED|Overall Study||211
1505693|NCT01629589|3682923|P1|STARTED|Overall Study||212
1505694|NCT01629290|3682939|P1|NOT COMPLETED|Overall Study||0
1505695|NCT01629290|3682939|P1|COMPLETED|Overall Study||15
1505696|NCT01629290|3682939|P1|STARTED|Overall Study||15
1505697|NCT01629134|3682949|P1|NOT COMPLETED|Overall Study||0
1505698|NCT01629134|3682949|P1|COMPLETED|Overall Study||62
1505699|NCT01629134|3682949|P1|STARTED|Overall Study||62
1505700|NCT01628965|3682962|P1|NOT COMPLETED|Overall Study||49
1505701|NCT01628965|3682962|P1|COMPLETED|Overall Study||94
1505702|NCT01628965|3682962|P1|STARTED|Overall Study||143
1505703|NCT01628926|3682971|P3|NOT COMPLETED|Overall Study||17
1505704|NCT01628926|3682972|P2|NOT COMPLETED|Overall Study||23
1505705|NCT01628926|3682973|P1|NOT COMPLETED|Overall Study||26
1505706|NCT01628926|3682971|P3|COMPLETED|Overall Study||68
1505707|NCT01628926|3682972|P2|COMPLETED|Overall Study||144
1505708|NCT01628926|3682973|P1|COMPLETED|Overall Study||142
1505709|NCT01628926|3682971|P3|STARTED|Overall Study||85
1505710|NCT01628926|3682972|P2|STARTED|Overall Study||167
1505711|NCT01628926|3682973|P1|STARTED|Overall Study||168
1505712|NCT01628913|3683022|P2|NOT COMPLETED|Overall Study||31
1505713|NCT01628913|3683023|P1|NOT COMPLETED|Overall Study||31
1505714|NCT01628913|3683022|P2|COMPLETED|Overall Study||0
1505715|NCT01628913|3683023|P1|COMPLETED|Overall Study||0
1505716|NCT01628913|3683022|P2|STARTED|Overall Study||31
1505717|NCT01628913|3683023|P1|STARTED|Overall Study||31
1505718|NCT01628848|3683037|P2|NOT COMPLETED|Overall Study||14
1505719|NCT01628848|3683038|P1|NOT COMPLETED|Overall Study||12
1505720|NCT01628848|3683037|P2|COMPLETED|Overall Study||73
1505721|NCT01628848|3683038|P1|COMPLETED|Overall Study||75
1505722|NCT01628848|3683037|P2|STARTED|Overall Study||87
1505723|NCT01628848|3683038|P1|STARTED|Overall Study||87
1505724|NCT01628692|3683072|P6|NOT COMPLETED|Overall Study||9
1505725|NCT01628692|3683073|P5|NOT COMPLETED|Overall Study||4
1505726|NCT01628692|3683074|P4|NOT COMPLETED|Overall Study||1
1505727|NCT01628692|3683075|P3|NOT COMPLETED|Overall Study||8
1505728|NCT01628692|3683076|P2|NOT COMPLETED|Overall Study||6
1505729|NCT01628692|3683077|P1|NOT COMPLETED|Overall Study||7
1505730|NCT01628692|3683072|P6|COMPLETED|Overall Study||0
1505731|NCT01628692|3683073|P5|COMPLETED|Overall Study||8
1505732|NCT01628692|3683074|P4|COMPLETED|Overall Study||19
1505733|NCT01628692|3683075|P3|COMPLETED|Overall Study||43
1505734|NCT01628692|3683076|P2|COMPLETED|Overall Study||17
1505735|NCT01628692|3683077|P1|COMPLETED|Overall Study||46
1505736|NCT01628692|3683072|P6|STARTED|Overall Study||9
1505737|NCT01628692|3683073|P5|STARTED|Overall Study||12
1505738|NCT01628692|3683074|P4|STARTED|Overall Study||20
1505739|NCT01628692|3683075|P3|STARTED|Overall Study||51
1505740|NCT01628692|3683076|P2|STARTED|Overall Study||23
1505741|NCT01628692|3683077|P1|STARTED|Overall Study||53
1505742|NCT01628614|3683121|P1|NOT COMPLETED|Overall Study||1775
1505743|NCT01628614|3683121|P1|COMPLETED|Overall Study||3037
1505744|NCT01628614|3683121|P1|STARTED|Overall Study||4812
1505745|NCT01628601|3683127|P1|NOT COMPLETED|Overall Study||41
1505746|NCT01628601|3683127|P1|COMPLETED|Overall Study||351
1505747|NCT01628601|3683127|P1|STARTED|Overall Study||392
1505748|NCT01628588|3683135|P1|NOT COMPLETED|Overall Study||16
1505749|NCT01628588|3683135|P1|COMPLETED|Overall Study||838
1505750|NCT01628588|3683135|P1|STARTED|Overall Study||854
1505751|NCT01628510|3683145|P2|NOT COMPLETED|Overall Study||5
1505752|NCT01628510|3683146|P1|NOT COMPLETED|Overall Study||3
1505753|NCT01628510|3683145|P2|COMPLETED|Overall Study||44
1505754|NCT01628510|3683146|P1|COMPLETED|Overall Study||48
1505755|NCT01628510|3683145|P2|STARTED|Overall Study||49
1505756|NCT01628510|3683146|P1|STARTED|Overall Study||51
1505757|NCT01628367|3683156|P2|NOT COMPLETED|Overall Study||0
1505758|NCT01628367|3683157|P1|NOT COMPLETED|Overall Study||1
1505759|NCT01628367|3683156|P2|COMPLETED|Overall Study||16
1505760|NCT01628367|3683157|P1|COMPLETED|Overall Study||15
1505761|NCT01628367|3683156|P2|STARTED|Overall Study||16
1505762|NCT01628367|3683157|P1|STARTED|Overall Study||16
1505763|NCT01628250|3683169|P2|NOT COMPLETED|Overall Study||0
1505764|NCT01628250|3683170|P1|NOT COMPLETED|Overall Study||0
1505765|NCT01628250|3683169|P2|COMPLETED|Overall Study||50
1505766|NCT01628250|3683170|P1|COMPLETED|Overall Study||49
1505767|NCT01628250|3683169|P2|STARTED|Overall Study||50
1505768|NCT01628250|3683170|P1|STARTED|Overall Study||49
1505769|NCT01628198|3683176|P1|NOT COMPLETED|Overall Study||18
1505770|NCT01628198|3683176|P1|COMPLETED|Overall Study||20
1505771|NCT01628198|3683176|P1|STARTED|Overall Study||38
1505772|NCT01628120|3683189|P1|NOT COMPLETED|Overall Study||44
1505773|NCT01628120|3683189|P1|COMPLETED|Overall Study||129
1505774|NCT01628120|3683189|P1|Treated|Overall Study||170
1505775|NCT01628120|3683189|P1|STARTED|Overall Study||173
1505776|NCT01628107|3683214|P1|NOT COMPLETED|Overall Study||119
1505777|NCT01628107|3683214|P1|COMPLETED|Overall Study||295
1505778|NCT01628107|3683214|P1|Treated|Overall Study||406
1505779|NCT01628107|3683214|P1|STARTED|Overall Study||414
1505780|NCT01628042|3683243|P4|NOT COMPLETED|Overall Study||0
1505781|NCT01628042|3683244|P3|NOT COMPLETED|Overall Study||0
1505782|NCT01628042|3683245|P2|NOT COMPLETED|Overall Study||0
1505783|NCT01628042|3683246|P1|NOT COMPLETED|Overall Study||0
1505784|NCT01628042|3683243|P4|COMPLETED|Overall Study||8
1505785|NCT01628042|3683244|P3|COMPLETED|Overall Study||8
1505786|NCT01628042|3683245|P2|COMPLETED|Overall Study||8
1505787|NCT01628042|3683246|P1|COMPLETED|Overall Study||8
1505788|NCT01628042|3683243|P4|STARTED|Overall Study||8
1505789|NCT01628042|3683244|P3|STARTED|Overall Study||8
1505790|NCT01628042|3683245|P2|STARTED|Overall Study||8
1505791|NCT01628042|3683246|P1|STARTED|Overall Study||8
1505792|NCT01627899|3683264|P1|NOT COMPLETED|Overall Study||5
1505793|NCT01627899|3683264|P1|COMPLETED|Overall Study||0
1505794|NCT01627899|3683264|P1|STARTED|Overall Study||5
1505795|NCT01627860|3683274|P2|NOT COMPLETED|Overall Study||6
1505796|NCT01627860|3683275|P1|NOT COMPLETED|Overall Study||12
1505797|NCT01627860|3683274|P2|COMPLETED|Overall Study||14
1505798|NCT01627860|3683275|P1|COMPLETED|Overall Study||23
1505799|NCT01627860|3683274|P2|STARTED|Overall Study||20
1505800|NCT01627860|3683275|P1|STARTED|Overall Study||35
1505801|NCT01627782|3683289|P4|NOT COMPLETED|Overall Study||6
1505802|NCT01627782|3683290|P3|NOT COMPLETED|Overall Study||15
1505803|NCT01627782|3683291|P2|NOT COMPLETED|Overall Study||6
1505804|NCT01627782|3683292|P1|NOT COMPLETED|Overall Study||16
1505805|NCT01627782|3683289|P4|COMPLETED|Overall Study||11
1505806|NCT01627782|3683290|P3|COMPLETED|Overall Study||1
1505807|NCT01627782|3683291|P2|COMPLETED|Overall Study||12
1505808|NCT01627782|3683292|P1|COMPLETED|Overall Study||1
1505809|NCT01627782|3683289|P4|Treated|Overall Study||17
1505810|NCT01627782|3683290|P3|Treated|Overall Study||16
1505811|NCT01627782|3683291|P2|Treated|Overall Study||18
1505812|NCT01627782|3683292|P1|Treated|Overall Study||16
1505813|NCT01627782|3683289|P4|STARTED|Overall Study||17
1505814|NCT01627782|3683290|P3|STARTED|Overall Study||16
1505815|NCT01627782|3683291|P2|STARTED|Overall Study||18
1505816|NCT01627782|3683292|P1|STARTED|Overall Study||17
1505817|NCT01627561|3683350|P2|NOT COMPLETED|Overall Study||3
1505818|NCT01627561|3683351|P1|NOT COMPLETED|Overall Study||0
1505819|NCT01627561|3683350|P2|COMPLETED|Overall Study||71
1505820|NCT01627561|3683351|P1|COMPLETED|Overall Study||74
1505821|NCT01627561|3683350|P2|STARTED|Overall Study||74
1505822|NCT01627561|3683351|P1|STARTED|Overall Study||74
1505823|NCT01627340|3683399|P2|NOT COMPLETED|Overall Study||4
1505824|NCT01627340|3683400|P1|NOT COMPLETED|Overall Study||12
1505825|NCT01627340|3683399|P2|COMPLETED|Overall Study||254
1505826|NCT01627340|3683400|P1|COMPLETED|Overall Study||404
1505827|NCT01627340|3683399|P2|STARTED|Overall Study||258
1505828|NCT01627340|3683400|P1|STARTED|Overall Study||416
1505829|NCT01627327|3683418|P2|NOT COMPLETED|Overall Study||39
1505830|NCT01627327|3683419|P1|NOT COMPLETED|Overall Study||19
1505831|NCT01627327|3683418|P2|COMPLETED|Overall Study||274
1505832|NCT01627327|3683419|P1|COMPLETED|Overall Study||291
1505833|NCT01627327|3683418|P2|STARTED|Overall Study||313
1505834|NCT01627327|3683419|P1|STARTED|Overall Study||310
1505835|NCT01627249|3683432|P3|NOT COMPLETED|Overall Study||12
1505836|NCT01627249|3683433|P2|NOT COMPLETED|Overall Study||12
1505837|NCT01627249|3683434|P1|NOT COMPLETED|Overall Study||16
1505838|NCT01627249|3683432|P3|COMPLETED|Overall Study||206
1505839|NCT01627249|3683433|P2|COMPLETED|Overall Study||206
1505840|NCT01627249|3683434|P1|COMPLETED|Overall Study||208
1505841|NCT01627249|3683432|P3|STARTED|Overall Study||218
1505842|NCT01627249|3683433|P2|STARTED|Overall Study||218
1505843|NCT01627249|3683434|P1|STARTED|Overall Study||224
1505844|NCT01627002|3683471|P9|NOT COMPLETED|Overall Study||0
1505845|NCT01627002|3683472|P8|NOT COMPLETED|Overall Study||0
1505846|NCT01627002|3683473|P7|NOT COMPLETED|Overall Study||0
1505847|NCT01627002|3683474|P6|NOT COMPLETED|Overall Study||0
1505848|NCT01627002|3683475|P5|NOT COMPLETED|Overall Study||0
1505849|NCT01627002|3683476|P4|NOT COMPLETED|Overall Study||0
1505850|NCT01627002|3683477|P3|NOT COMPLETED|Overall Study||0
1505851|NCT01627002|3683478|P2|NOT COMPLETED|Overall Study||0
1505852|NCT01627002|3683479|P1|NOT COMPLETED|Overall Study||0
1505853|NCT01627002|3683471|P9|COMPLETED|Overall Study||7
1505854|NCT01627002|3683472|P8|COMPLETED|Overall Study||5
1505855|NCT01627002|3683473|P7|COMPLETED|Overall Study||10
1505856|NCT01627002|3683474|P6|COMPLETED|Overall Study||9
1505857|NCT01627002|3683475|P5|COMPLETED|Overall Study||2
1505858|NCT01627002|3683476|P4|COMPLETED|Overall Study||4
1505859|NCT01627002|3683477|P3|COMPLETED|Overall Study||4
1505860|NCT01627002|3683478|P2|COMPLETED|Overall Study||4
1505861|NCT01627002|3683479|P1|COMPLETED|Overall Study||4
1505862|NCT01627002|3683471|P9|STARTED|Overall Study||7
1505863|NCT01627002|3683472|P8|STARTED|Overall Study||5
1505864|NCT01627002|3683473|P7|STARTED|Overall Study||10
1505865|NCT01627002|3683474|P6|STARTED|Overall Study||9
1505866|NCT01627002|3683475|P5|STARTED|Overall Study||2
1505867|NCT01627002|3683476|P4|STARTED|Overall Study||4
1505868|NCT01627002|3683477|P3|STARTED|Overall Study||4
1505869|NCT01627002|3683478|P2|STARTED|Overall Study||4
1505870|NCT01627002|3683479|P1|STARTED|Overall Study||4
1505871|NCT01626820|3683532|P2|NOT COMPLETED|Overall Study||0
1505872|NCT01626820|3683533|P1|NOT COMPLETED|Overall Study||0
1505873|NCT01626820|3683532|P2|COMPLETED|Overall Study||57
1505874|NCT01626820|3683533|P1|COMPLETED|Overall Study||56
1505875|NCT01626820|3683532|P2|STARTED|Overall Study||57
1505876|NCT01626820|3683533|P1|STARTED|Overall Study||56
1505877|NCT01626690|3683555|P2|NOT COMPLETED|Overall Study||0
1505878|NCT01626690|3683556|P1|NOT COMPLETED|Overall Study||2
1505879|NCT01626690|3683555|P2|COMPLETED|Overall Study||51
1505880|NCT01626690|3683556|P1|COMPLETED|Overall Study||47
1505881|NCT01626690|3683555|P2|STARTED|Overall Study||51
1505882|NCT01626690|3683556|P1|STARTED|Overall Study||49
1505883|NCT01626664|3683578|P3|NOT COMPLETED|Crossover Period||0
1505884|NCT01626664|3683579|P2|NOT COMPLETED|Crossover Period||0
1505885|NCT01626664|3683580|P1|NOT COMPLETED|Crossover Period||0
1505886|NCT01626664|3683578|P3|COMPLETED|Crossover Period||18
1505887|NCT01626664|3683579|P2|COMPLETED|Crossover Period||0
1505888|NCT01626664|3683580|P1|COMPLETED|Crossover Period||0
1505889|NCT01626664|3683578|P3|STARTED|Crossover Period||18
1505890|NCT01626664|3683579|P2|STARTED|Crossover Period||0
1505891|NCT01626664|3683580|P1|STARTED|Crossover Period||0
1505892|NCT01626664|3683578|P3|NOT COMPLETED|Randomization Period||0
1505893|NCT01626664|3683579|P2|NOT COMPLETED|Randomization Period||0
1505894|NCT01626664|3683580|P1|NOT COMPLETED|Randomization Period||0
1505895|NCT01626664|3683578|P3|COMPLETED|Randomization Period||0
1505896|NCT01626664|3683579|P2|COMPLETED|Randomization Period||24
1505897|NCT01626664|3683580|P1|COMPLETED|Randomization Period||47
1505898|NCT01626664|3683578|P3|STARTED|Randomization Period||0
1505899|NCT01626664|3683579|P2|STARTED|Randomization Period||24
1505900|NCT01626664|3683580|P1|STARTED|Randomization Period||47
1505901|NCT01626456|3683595|P2|NOT COMPLETED|Overall Study||117
1505902|NCT01626456|3683596|P1|NOT COMPLETED|Overall Study||35
1505903|NCT01626456|3683595|P2|COMPLETED|Overall Study||251
1505904|NCT01626456|3683596|P1|COMPLETED|Overall Study||75
1505905|NCT01626456|3683595|P2|STARTED|Overall Study||368
1505906|NCT01626456|3683596|P1|STARTED|Overall Study||110
1505907|NCT01626391|3683626|P2|NOT COMPLETED|Overall Study||0
1505908|NCT01626391|3683627|P1|NOT COMPLETED|Overall Study||2
1505909|NCT01626391|3683626|P2|COMPLETED|Overall Study||4
1505910|NCT01626391|3683627|P1|COMPLETED|Overall Study||3
1505911|NCT01626391|3683626|P2|STARTED|Overall Study||4
1505912|NCT01626391|3683627|P1|STARTED|Overall Study||5
1505913|NCT01626352|3683633|P1|NOT COMPLETED|Overall Study||10
1505914|NCT01626352|3683633|P1|COMPLETED|Overall Study||12
1505915|NCT01626352|3683633|P1|STARTED|Overall Study||22
1505916|NCT01626118|3683647|P4|NOT COMPLETED|Overall Study||3
1505917|NCT01626118|3683648|P3|NOT COMPLETED|Overall Study||2
1505918|NCT01626118|3683649|P2|NOT COMPLETED|Overall Study||2
1505919|NCT01626118|3683650|P1|NOT COMPLETED|Overall Study||2
1505920|NCT01626118|3683647|P4|COMPLETED|Overall Study||91
1505921|NCT01626118|3683648|P3|COMPLETED|Overall Study||90
1505922|NCT01626118|3683649|P2|COMPLETED|Overall Study||91
1505923|NCT01626118|3683650|P1|COMPLETED|Overall Study||92
1505924|NCT01626118|3683647|P4|STARTED|Overall Study||94
1505925|NCT01626118|3683648|P3|STARTED|Overall Study||92
1505926|NCT01626118|3683649|P2|STARTED|Overall Study||93
1505927|NCT01626118|3683650|P1|STARTED|Overall Study||94
1505928|NCT01626092|3683688|P1|NOT COMPLETED|Overall Study||0
1505929|NCT01626092|3683688|P1|COMPLETED|Overall Study||3
1505930|NCT01626092|3683688|P1|STARTED|Overall Study||3
1505931|NCT01625910|3683696|P2|NOT COMPLETED|Overall Study||4
1505932|NCT01625910|3683697|P1|NOT COMPLETED|Overall Study||3
1505933|NCT01625910|3683696|P2|COMPLETED|Overall Study||33
1505934|NCT01625910|3683697|P1|COMPLETED|Overall Study||32
1505935|NCT01625910|3683696|P2|STARTED|Overall Study||37
1505936|NCT01625910|3683697|P1|STARTED|Overall Study||35
1505937|NCT01625845|3683707|P2|NOT COMPLETED|Overall Study||3
1505938|NCT01625845|3683708|P1|NOT COMPLETED|Overall Study||5
1505939|NCT01625845|3683707|P2|COMPLETED|Overall Study||3
1505940|NCT01625845|3683708|P1|COMPLETED|Overall Study||5
1505941|NCT01625845|3683707|P2|STARTED|Overall Study||6
1505942|NCT01625845|3683708|P1|STARTED|Overall Study||10
1505943|NCT01625689|3683728|P2|NOT COMPLETED|Overall Study||1
1505944|NCT01625689|3683729|P1|NOT COMPLETED|Overall Study||2
1505945|NCT01625689|3683728|P2|COMPLETED|Overall Study||149
1505946|NCT01625689|3683729|P1|COMPLETED|Overall Study||148
1505947|NCT01625689|3683728|P2|STARTED|Overall Study||150
1505948|NCT01625689|3683729|P1|STARTED|Overall Study||150
1505949|NCT01625507|3683739|P1|NOT COMPLETED|Overall Study||10
1505950|NCT01625507|3683739|P1|COMPLETED|Overall Study||63
1505951|NCT01625507|3683739|P1|STARTED|Overall Study||73
1505952|NCT01625455|3683754|P2|NOT COMPLETED|Overall Study||0
1505953|NCT01625455|3683755|P1|NOT COMPLETED|Overall Study||0
1505954|NCT01625455|3683754|P2|COMPLETED|Overall Study||3
1505955|NCT01625455|3683755|P1|COMPLETED|Overall Study||2
1505956|NCT01625455|3683754|P2|STARTED|Overall Study||3
1505957|NCT01625455|3683755|P1|STARTED|Overall Study||2
1505958|NCT01625416|3683765|P2|NOT COMPLETED|Overall Study||7
1505959|NCT01625416|3683766|P1|NOT COMPLETED|Overall Study||9
1505960|NCT01625416|3683765|P2|COMPLETED|Overall Study||54
1505961|NCT01625416|3683766|P1|COMPLETED|Overall Study||51
1505962|NCT01625416|3683765|P2|STARTED|Overall Study||61
1505963|NCT01625416|3683766|P1|STARTED|Overall Study||60
1505964|NCT01625377|3683784|P2|NOT COMPLETED|Overall Study||22
1505965|NCT01625377|3683785|P1|NOT COMPLETED|Overall Study||7
1505966|NCT01625377|3683784|P2|COMPLETED|Overall Study||71
1505967|NCT01625377|3683785|P1|COMPLETED|Overall Study||88
1505968|NCT01625377|3683784|P2|Intent to Treat Population|Overall Study||90
1505969|NCT01625377|3683785|P1|Intent to Treat Population|Overall Study||93
1505970|NCT01625377|3683784|P2|Safety Set of Population|Overall Study||90
1505971|NCT01625377|3683785|P1|Safety Set of Population|Overall Study||94
1505972|NCT01625377|3683784|P2|STARTED|Overall Study||93
1505973|NCT01625377|3683785|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
1505974|NCT01625338|3683818|P3|NOT COMPLETED|Overall Study||39
1505975|NCT01625338|3683819|P2|NOT COMPLETED|Overall Study||44
1505976|NCT01625338|3683820|P1|NOT COMPLETED|Overall Study||32
1505977|NCT01625338|3683818|P3|COMPLETED|Overall Study||181
1505978|NCT01625338|3683819|P2|COMPLETED|Overall Study||156
1505979|NCT01625338|3683820|P1|COMPLETED|Overall Study||82
1505980|NCT01625338|3683818|P3|STARTED|Overall Study||220
1505981|NCT01625338|3683819|P2|STARTED|Overall Study||200
1505982|NCT01625338|3683820|P1|STARTED|Overall Study||114
1505983|NCT01625221|3683840|P1|NOT COMPLETED|Overall Study||7
1505984|NCT01625221|3683840|P1|COMPLETED|Overall Study||28
1505985|NCT01625221|3683840|P1|STARTED|Overall Study||35
1505986|NCT01625182|3683847|P2|NOT COMPLETED|Overall Study||11
1505987|NCT01625182|3683848|P1|NOT COMPLETED|Overall Study||20
1505988|NCT01625182|3683847|P2|COMPLETED|Overall Study||41
1505989|NCT01625182|3683848|P1|COMPLETED|Overall Study||34
1505990|NCT01625182|3683847|P2|STARTED|Overall Study||52
1505991|NCT01625182|3683848|P1|STARTED|Overall Study||54
1505992|NCT01625169|3683861|P1|NOT COMPLETED|Overall Study||0
1505993|NCT01625169|3683861|P1|COMPLETED|Overall Study||9
1505994|NCT01625169|3683861|P1|STARTED|Overall Study||9
1505995|NCT01625104|3683876|P2|NOT COMPLETED|Overall Study||0
1505996|NCT01625104|3683877|P1|NOT COMPLETED|Overall Study||0
1505997|NCT01625104|3683876|P2|COMPLETED|Overall Study||434
1505998|NCT01625104|3683877|P1|COMPLETED|Overall Study||448
1505999|NCT01625104|3683876|P2|STARTED|Overall Study||434
1506000|NCT01625104|3683877|P1|STARTED|Overall Study||448
1506001|NCT01625091|3683885|P2|NOT COMPLETED|Post-intervention||2
1506002|NCT01625091|3683886|P1|NOT COMPLETED|Post-intervention||4
1506003|NCT01625091|3683885|P2|COMPLETED|Post-intervention||85
1506004|NCT01625091|3683886|P1|COMPLETED|Post-intervention||81
1506005|NCT01625091|3683885|P2|7 Months|Post-intervention||85
1506006|NCT01625091|3683886|P1|7 Months|Post-intervention||81
1506007|NCT01625091|3683885|P2|STARTED|Post-intervention||87
1506008|NCT01625091|3683886|P1|STARTED|Post-intervention||85
1506009|NCT01625091|3683885|P2|NOT COMPLETED|Intervention||11
1506010|NCT01625091|3683886|P1|NOT COMPLETED|Intervention||11
1506011|NCT01625091|3683885|P2|COMPLETED|Intervention||87
1506012|NCT01625091|3683886|P1|COMPLETED|Intervention||85
1506013|NCT01625091|3683885|P2|4 Months|Intervention||87
1506014|NCT01625091|3683886|P1|4 Months|Intervention||85
1506015|NCT01625091|3683885|P2|2 Months|Intervention||93
1506016|NCT01625091|3683886|P1|2 Months|Intervention||90
1506017|NCT01625091|3683885|P2|STARTED|Intervention||98
1506018|NCT01625091|3683886|P1|STARTED|Intervention||96
1506019|NCT01624974|3683900|P2|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
1506020|NCT01624974|3683901|P1|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
1506021|NCT01624974|3683900|P2|COMPLETED|Period V of Treatment (4 Weeks)||42
1506022|NCT01624974|3683901|P1|COMPLETED|Period V of Treatment (4 Weeks)||39
1506023|NCT01624974|3683900|P2|STARTED|Period V of Treatment (4 Weeks)||42
1506024|NCT01624974|3683901|P1|STARTED|Period V of Treatment (4 Weeks)||44
1506025|NCT01624974|3683900|P2|NOT COMPLETED|Period IV Washout (4 Weeks)||3
1506026|NCT01624974|3683901|P1|NOT COMPLETED|Period IV Washout (4 Weeks)||3
1506027|NCT01624974|3683900|P2|COMPLETED|Period IV Washout (4 Weeks)||42
1506028|NCT01624974|3683901|P1|COMPLETED|Period IV Washout (4 Weeks)||44
1506029|NCT01624974|3683900|P2|STARTED|Period IV Washout (4 Weeks)||45
1506030|NCT01624974|3683901|P1|STARTED|Period IV Washout (4 Weeks)||47
1506031|NCT01624974|3683900|P2|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
1506032|NCT01624974|3683901|P1|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
1506033|NCT01624974|3683900|P2|COMPLETED|Period III of Treatment (4 Weeks)||45
1506034|NCT01624974|3683901|P1|COMPLETED|Period III of Treatment (4 Weeks)||47
1506035|NCT01624974|3683900|P2|STARTED|Period III of Treatment (4 Weeks)||53
1506036|NCT01624974|3683901|P1|STARTED|Period III of Treatment (4 Weeks)||54
1506037|NCT01624948|3683925|P2|NOT COMPLETED|Overall Study||0
1506038|NCT01624948|3683926|P1|NOT COMPLETED|Overall Study||0
1506039|NCT01624948|3683925|P2|COMPLETED|Overall Study||20
1506040|NCT01624948|3683926|P1|COMPLETED|Overall Study||20
1506041|NCT01624948|3683925|P2|STARTED|Overall Study||20
1506042|NCT01624948|3683926|P1|STARTED|Overall Study||20
1506043|NCT01624870|3683942|P1|NOT COMPLETED|Overall Study||27
1506044|NCT01624870|3683942|P1|COMPLETED|Overall Study|Completed 6 month follow up|173
1506045|NCT01624870|3683942|P1|STARTED|Overall Study|provided informed consent|200
1506046|NCT01624740|3683950|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
1506047|NCT01624740|3683951|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
1506048|NCT01624740|3683950|P2|COMPLETED|Second Intervention (3-4 Days)||9
1506049|NCT01624740|3683951|P1|COMPLETED|Second Intervention (3-4 Days)||8
1506050|NCT01624740|3683950|P2|STARTED|Second Intervention (3-4 Days)||9
1506051|NCT01624740|3683951|P1|STARTED|Second Intervention (3-4 Days)||9
1506052|NCT01624740|3683950|P2|NOT COMPLETED|Washout (1 Hour)||0
1506053|NCT01624740|3683951|P1|NOT COMPLETED|Washout (1 Hour)||0
1506054|NCT01624740|3683950|P2|COMPLETED|Washout (1 Hour)||9
1506055|NCT01624740|3683951|P1|COMPLETED|Washout (1 Hour)||9
1506056|NCT01624740|3683950|P2|STARTED|Washout (1 Hour)||9
1506057|NCT01624740|3683951|P1|STARTED|Washout (1 Hour)||9
1506058|NCT01624740|3683950|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
1506059|NCT01624740|3683951|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
1506060|NCT01624740|3683950|P2|COMPLETED|First Intervention (3-4 Days)||9
1506061|NCT01624740|3683951|P1|COMPLETED|First Intervention (3-4 Days)||9
1506062|NCT01624740|3683950|P2|STARTED|First Intervention (3-4 Days)||9
1506063|NCT01624740|3683951|P1|STARTED|First Intervention (3-4 Days)||9
1506064|NCT01624662|3683962|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
1506065|NCT01624662|3683963|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
1506066|NCT01624662|3683964|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
1506067|NCT01624662|3683965|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
1506068|NCT01624662|3683962|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
1506069|NCT01624662|3683963|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
1506070|NCT01624662|3683964|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
1506071|NCT01624662|3683965|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
1506072|NCT01624662|3683962|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||79
1506073|NCT01624662|3683963|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||72
1506074|NCT01624662|3683964|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||78
1506075|NCT01624662|3683965|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||70
1506076|NCT01624662|3683962|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
1506077|NCT01624662|3683963|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
1506078|NCT01624662|3683964|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
1506079|NCT01624662|3683965|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
1506080|NCT01624662|3683962|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
1506081|NCT01624662|3683963|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
1506082|NCT01624662|3683964|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
1506083|NCT01624662|3683965|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
1506084|NCT01624662|3683962|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
1506085|NCT01624662|3683963|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
1506086|NCT01624662|3683964|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
1506087|NCT01624662|3683965|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
1506088|NCT01624467|3684036|P1|NOT COMPLETED|Overall Study||31
1506089|NCT01624467|3684036|P1|COMPLETED|Overall Study||44
1506090|NCT01624467|3684036|P1|Received at Least One Dose of Study Drug|Overall Study||75
1506091|NCT01624467|3684036|P1|STARTED|Overall Study||75
1506092|NCT01624363|3684049|P1|NOT COMPLETED|Overall Study||0
1506093|NCT01624363|3684049|P1|COMPLETED|Overall Study||341
1506094|NCT01624363|3684049|P1|STARTED|Overall Study||341
1506095|NCT01624350|3684053|P1|NOT COMPLETED|Overall Study||25
1506096|NCT01624350|3684053|P1|COMPLETED|Overall Study||75
1506097|NCT01624350|3684053|P1|STARTED|Overall Study||100
1506098|NCT01624259|3684075|P2|NOT COMPLETED|Overall Study||31
1506099|NCT01624259|3684076|P1|NOT COMPLETED|Overall Study||30
1506100|NCT01624259|3684075|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
1506101|NCT01624259|3684076|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
1506102|NCT01624259|3684075|P2|Received at Least One Dose of Study Drug|Overall Study||300
1506103|NCT01624259|3684076|P1|Received at Least One Dose of Study Drug|Overall Study||299
1506104|NCT01624259|3684075|P2|STARTED|Overall Study||300
1506105|NCT01624259|3684076|P1|STARTED|Overall Study||299
1506106|NCT01624233|3684125|P1|NOT COMPLETED|Period 6: Follow-up||9
1506107|NCT01624233|3684125|P1|COMPLETED|Period 6: Follow-up||79
1506108|NCT01624233|3684125|P1|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
1506109|NCT01624233|3684125|P1|NOT COMPLETED|Period 5 - Retreatment Period||10
1506110|NCT01624233|3684125|P1|COMPLETED|Period 5 - Retreatment Period||70
1506111|NCT01624233|3684125|P1|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
1506112|NCT01624233|3684125|P1|NOT COMPLETED|Period 4 - Drug Free Period||61
1506113|NCT01624233|3684125|P1|COMPLETED|Period 4 - Drug Free Period||9
1506114|NCT01624233|3684125|P1|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
1506115|NCT01624233|3684125|P1|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
1506116|NCT01624233|3684125|P1|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
1506117|NCT01624233|3684125|P1|NOT COMPLETED|Period 3 - Maintenance||7
1506118|NCT01624233|3684125|P1|COMPLETED|Period 3 - Maintenance||83
1506119|NCT01624233|3684125|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
1506120|NCT01624233|3684125|P1|STARTED|Period 3 - Maintenance||90
1506121|NCT01624233|3684125|P1|NOT COMPLETED|Period 2 - Induction||1
1506122|NCT01624233|3684125|P1|COMPLETED|Period 2 - Induction||90
1506123|NCT01624233|3684125|P1|Plaque Ps|Period 2 - Induction||78
1506124|NCT01624233|3684125|P1|Pustular Ps|Period 2 - Induction||5
1506125|NCT01624233|3684125|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
1506126|NCT01624233|3684125|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
1506127|NCT01624233|3684125|P1|STARTED|Period 2 - Induction||91
1506128|NCT01624194|3684157|P2|NOT COMPLETED|Overall Study||0
1506129|NCT01624194|3684158|P1|NOT COMPLETED|Overall Study||2
1506130|NCT01624194|3684157|P2|COMPLETED|Overall Study||18
1506131|NCT01624194|3684158|P1|COMPLETED|Overall Study||14
1506132|NCT01624194|3684157|P2|STARTED|Overall Study||18
1506133|NCT01624194|3684158|P1|STARTED|Overall Study||16
1506134|NCT01624168|3684199|P3|NOT COMPLETED|Overall Study||6
1506135|NCT01624168|3684200|P2|NOT COMPLETED|Overall Study||12
1506136|NCT01624168|3684201|P1|NOT COMPLETED|Overall Study||4
1506137|NCT01624168|3684199|P3|COMPLETED|Overall Study||22
1506138|NCT01624168|3684200|P2|COMPLETED|Overall Study||16
1506139|NCT01624168|3684201|P1|COMPLETED|Overall Study||15
1506140|NCT01624168|3684199|P3|STARTED|Overall Study||28
1506141|NCT01624168|3684200|P2|STARTED|Overall Study||28
1506142|NCT01624168|3684201|P1|STARTED|Overall Study||19
1506143|NCT01623869|3684224|P1|NOT COMPLETED|Overall Study||0
1506144|NCT01623869|3684224|P1|COMPLETED|Overall Study||16
1506145|NCT01623869|3684224|P1|STARTED|Overall Study||16
1506146|NCT01623830|3684232|P2|NOT COMPLETED|Overall Study||9
1506147|NCT01623830|3684233|P1|NOT COMPLETED|Overall Study||7
1506148|NCT01623830|3684232|P2|COMPLETED|Overall Study||35
1506149|NCT01623830|3684233|P1|COMPLETED|Overall Study||38
1506150|NCT01623830|3684232|P2|STARTED|Overall Study||44
1506151|NCT01623830|3684233|P1|STARTED|Overall Study||45
1506152|NCT01623739|3684249|P2|NOT COMPLETED|Overall Study||4
1506153|NCT01623739|3684250|P1|NOT COMPLETED|Overall Study||2
1506154|NCT01623739|3684249|P2|COMPLETED|Overall Study||15
1506155|NCT01623739|3684250|P1|COMPLETED|Overall Study||17
1506156|NCT01623739|3684249|P2|STARTED|Overall Study||19
1506157|NCT01623739|3684250|P1|STARTED|Overall Study||19
1506158|NCT01623596|3684267|P2|NOT COMPLETED|Overall Study||100
1506159|NCT01623596|3684268|P1|NOT COMPLETED|Overall Study||62
1506160|NCT01623596|3684267|P2|COMPLETED|Overall Study||339
1506161|NCT01623596|3684268|P1|COMPLETED|Overall Study||374
1506162|NCT01623596|3684267|P2|On Switched Treatment|Overall Study||214
1506163|NCT01623596|3684268|P1|On Switched Treatment|Overall Study||22
1506164|NCT01623596|3684267|P2|On Randomized Treatment|Overall Study||125
1506165|NCT01623596|3684268|P1|On Randomized Treatment|Overall Study||352
1506166|NCT01623596|3684267|P2|STARTED|Overall Study||439
1506167|NCT01623596|3684268|P1|STARTED|Overall Study||436
1506168|NCT01623479|3684284|P1|NOT COMPLETED|Overall Study||0
1506169|NCT01623479|3684284|P1|COMPLETED|Overall Study||585
1506170|NCT01623479|3684284|P1|STARTED|Overall Study||585
1506171|NCT01623466|3684292|P2|NOT COMPLETED|Overall Study||0
1506172|NCT01623466|3684293|P1|NOT COMPLETED|Overall Study||1
1506173|NCT01623466|3684292|P2|COMPLETED|Overall Study||18
1506174|NCT01623466|3684293|P1|COMPLETED|Overall Study||17
1506175|NCT01623466|3684292|P2|STARTED|Overall Study||18
1506176|NCT01623466|3684293|P1|STARTED|Overall Study||18
1506177|NCT01623323|3684307|P1|NOT COMPLETED|Overall Study||104
1506178|NCT01623323|3684307|P1|COMPLETED|Overall Study||601
1506179|NCT01623323|3684307|P1|STARTED|Overall Study||705
1506180|NCT01623310|3684311|P1|NOT COMPLETED|Overall Study||79
1506181|NCT01623310|3684311|P1|COMPLETED|Overall Study||144
1506182|NCT01623310|3684311|P1|STARTED|Overall Study||223
1506183|NCT01623271|3684320|P1|NOT COMPLETED|Overall Study||2
1506184|NCT01623271|3684320|P1|COMPLETED|Overall Study||3
1506185|NCT01623271|3684320|P1|STARTED|Overall Study||5
1506186|NCT01623154|3684324|P1|NOT COMPLETED|Overall Study||4
1506187|NCT01623154|3684324|P1|COMPLETED|Overall Study||95
1506188|NCT01623154|3684324|P1|Available for Analysis|Overall Study||95
1506189|NCT01623154|3684324|P1|STARTED|Overall Study||99
1506190|NCT01623115|3684332|P2|NOT COMPLETED|Overall Study||77
1506191|NCT01623115|3684333|P1|NOT COMPLETED|Overall Study||33
1506192|NCT01623115|3684332|P2|COMPLETED|Overall Study||246
1506193|NCT01623115|3684333|P1|COMPLETED|Overall Study||130
1506194|NCT01623115|3684332|P2|Treated|Overall Study||322
1506195|NCT01623115|3684333|P1|Treated|Overall Study||163
1506196|NCT01623115|3684332|P2|STARTED|Overall Study|Randomized|323
1506197|NCT01623115|3684333|P1|STARTED|Overall Study|Randomized|163
1506198|NCT01623050|3684393|P1|NOT COMPLETED|Overall Study||9
1506199|NCT01623050|3684393|P1|COMPLETED|Overall Study||27
1506200|NCT01623050|3684393|P1|Treated|Overall Study||34
1506201|NCT01623050|3684393|P1|STARTED|Overall Study||36
1506202|NCT01622673|3684407|P6|NOT COMPLETED|Treatment Period 5||0
1506203|NCT01622673|3684408|P5|NOT COMPLETED|Treatment Period 5||0
1506204|NCT01622673|3684409|P4|NOT COMPLETED|Treatment Period 5||0
1506205|NCT01622673|3684410|P3|NOT COMPLETED|Treatment Period 5||0
1506206|NCT01622673|3684411|P2|NOT COMPLETED|Treatment Period 5||0
1506207|NCT01622673|3684412|P1|NOT COMPLETED|Treatment Period 5||0
1506208|NCT01622673|3684407|P6|COMPLETED|Treatment Period 5||4
1506209|NCT01622673|3684408|P5|COMPLETED|Treatment Period 5||4
1506210|NCT01622673|3684409|P4|COMPLETED|Treatment Period 5||4
1506211|NCT01622673|3684410|P3|COMPLETED|Treatment Period 5||4
1506212|NCT01622673|3684411|P2|COMPLETED|Treatment Period 5||3
1506213|NCT01622673|3684412|P1|COMPLETED|Treatment Period 5||4
1506214|NCT01622673|3684407|P6|STARTED|Treatment Period 5||4
1506215|NCT01622673|3684408|P5|STARTED|Treatment Period 5||4
1506216|NCT01622673|3684409|P4|STARTED|Treatment Period 5||4
1506217|NCT01622673|3684410|P3|STARTED|Treatment Period 5||4
1506218|NCT01622673|3684411|P2|STARTED|Treatment Period 5||3
1506219|NCT01622673|3684412|P1|STARTED|Treatment Period 5||4
1506220|NCT01622673|3684407|P6|NOT COMPLETED|Treatment Period 4||0
1506221|NCT01622673|3684408|P5|NOT COMPLETED|Treatment Period 4||0
1506222|NCT01622673|3684409|P4|NOT COMPLETED|Treatment Period 4||0
1506223|NCT01622673|3684410|P3|NOT COMPLETED|Treatment Period 4||0
1506224|NCT01622673|3684411|P2|NOT COMPLETED|Treatment Period 4||0
1506225|NCT01622673|3684412|P1|NOT COMPLETED|Treatment Period 4||0
1506226|NCT01622673|3684407|P6|COMPLETED|Treatment Period 4||4
1506227|NCT01622673|3684408|P5|COMPLETED|Treatment Period 4||4
1506228|NCT01622673|3684409|P4|COMPLETED|Treatment Period 4||4
1506229|NCT01622673|3684410|P3|COMPLETED|Treatment Period 4||4
1506230|NCT01622673|3684411|P2|COMPLETED|Treatment Period 4||3
1506231|NCT01622673|3684412|P1|COMPLETED|Treatment Period 4||4
1506232|NCT01622673|3684407|P6|STARTED|Treatment Period 4||4
1506233|NCT01622673|3684408|P5|STARTED|Treatment Period 4||4
1506234|NCT01622673|3684409|P4|STARTED|Treatment Period 4||4
1506235|NCT01622673|3684410|P3|STARTED|Treatment Period 4||4
1506236|NCT01622673|3684411|P2|STARTED|Treatment Period 4||3
1506237|NCT01622673|3684412|P1|STARTED|Treatment Period 4||4
1506238|NCT01622673|3684407|P6|NOT COMPLETED|Treatment Period 3||0
1506239|NCT01622673|3684408|P5|NOT COMPLETED|Treatment Period 3||0
1506240|NCT01622673|3684409|P4|NOT COMPLETED|Treatment Period 3||0
1506241|NCT01622673|3684410|P3|NOT COMPLETED|Treatment Period 3||0
1506242|NCT01622673|3684411|P2|NOT COMPLETED|Treatment Period 3||1
1506243|NCT01622673|3684412|P1|NOT COMPLETED|Treatment Period 3||0
1506244|NCT01622673|3684407|P6|COMPLETED|Treatment Period 3||4
1506245|NCT01622673|3684408|P5|COMPLETED|Treatment Period 3||4
1506246|NCT01622673|3684409|P4|COMPLETED|Treatment Period 3||4
1506247|NCT01622673|3684410|P3|COMPLETED|Treatment Period 3||4
1506248|NCT01622673|3684411|P2|COMPLETED|Treatment Period 3||3
1506249|NCT01622673|3684412|P1|COMPLETED|Treatment Period 3||4
1506250|NCT01622673|3684407|P6|STARTED|Treatment Period 3||4
1506251|NCT01622673|3684408|P5|STARTED|Treatment Period 3||4
1506252|NCT01622673|3684409|P4|STARTED|Treatment Period 3||4
1506253|NCT01622673|3684410|P3|STARTED|Treatment Period 3||4
1506254|NCT01622673|3684411|P2|STARTED|Treatment Period 3||4
1506255|NCT01622673|3684412|P1|STARTED|Treatment Period 3||4
1506256|NCT01622673|3684407|P6|NOT COMPLETED|Treatment Period 2||0
1506257|NCT01622673|3684408|P5|NOT COMPLETED|Treatment Period 2||0
1506258|NCT01622673|3684409|P4|NOT COMPLETED|Treatment Period 2||1
1506259|NCT01622673|3684410|P3|NOT COMPLETED|Treatment Period 2||0
1506260|NCT01622673|3684411|P2|NOT COMPLETED|Treatment Period 2||0
1506261|NCT01622673|3684412|P1|NOT COMPLETED|Treatment Period 2||0
1506262|NCT01622673|3684407|P6|COMPLETED|Treatment Period 2||4
1506263|NCT01622673|3684408|P5|COMPLETED|Treatment Period 2||4
1506264|NCT01622673|3684409|P4|COMPLETED|Treatment Period 2||4
1506265|NCT01622673|3684410|P3|COMPLETED|Treatment Period 2||4
1506266|NCT01622673|3684411|P2|COMPLETED|Treatment Period 2||4
1506267|NCT01622673|3684412|P1|COMPLETED|Treatment Period 2||4
1506268|NCT01622673|3684407|P6|STARTED|Treatment Period 2||4
1506269|NCT01622673|3684408|P5|STARTED|Treatment Period 2||4
1506270|NCT01622673|3684409|P4|STARTED|Treatment Period 2||5
1506271|NCT01622673|3684410|P3|STARTED|Treatment Period 2||4
1506272|NCT01622673|3684411|P2|STARTED|Treatment Period 2||4
1506273|NCT01622673|3684412|P1|STARTED|Treatment Period 2||4
1506274|NCT01622673|3684407|P6|NOT COMPLETED|Treatment Period 1||0
1506275|NCT01622673|3684408|P5|NOT COMPLETED|Treatment Period 1||0
1506276|NCT01622673|3684409|P4|NOT COMPLETED|Treatment Period 1||1
1506277|NCT01622673|3684410|P3|NOT COMPLETED|Treatment Period 1||0
1506278|NCT01622673|3684411|P2|NOT COMPLETED|Treatment Period 1||1
1506279|NCT01622673|3684412|P1|NOT COMPLETED|Treatment Period 1||0
1506280|NCT01622673|3684407|P6|COMPLETED|Treatment Period 1||4
1506281|NCT01622673|3684408|P5|COMPLETED|Treatment Period 1||4
1506282|NCT01622673|3684409|P4|COMPLETED|Treatment Period 1||5
1506283|NCT01622673|3684410|P3|COMPLETED|Treatment Period 1||4
1506284|NCT01622673|3684411|P2|COMPLETED|Treatment Period 1||4
1506285|NCT01622673|3684412|P1|COMPLETED|Treatment Period 1||4
1506286|NCT01622673|3684407|P6|STARTED|Treatment Period 1||4
1506287|NCT01622673|3684408|P5|STARTED|Treatment Period 1||4
1506288|NCT01622673|3684409|P4|STARTED|Treatment Period 1||6
1506289|NCT01622673|3684410|P3|STARTED|Treatment Period 1||4
1506290|NCT01622673|3684411|P2|STARTED|Treatment Period 1||5
1506291|NCT01622673|3684412|P1|STARTED|Treatment Period 1||4
1506292|NCT01622660|3684447|P1|NOT COMPLETED|Overall Study||1
1506293|NCT01622660|3684447|P1|COMPLETED|Overall Study||1
1506294|NCT01622660|3684447|P1|STARTED|Overall Study||2
1506295|NCT01622569|3684455|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
1506296|NCT01622569|3684456|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
1506297|NCT01622569|3684457|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
1506298|NCT01622569|3684458|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
1506299|NCT01622569|3684455|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
1506300|NCT01622569|3684456|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
1506301|NCT01622569|3684457|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
1506302|NCT01622569|3684458|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
1506303|NCT01622569|3684455|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||75
1506304|NCT01622569|3684456|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||67
1506305|NCT01622569|3684457|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||72
1506306|NCT01622569|3684458|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||68
1506307|NCT01622569|3684455|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
1506308|NCT01622569|3684456|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
1506309|NCT01622569|3684457|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
1506310|NCT01622569|3684458|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
1506311|NCT01622569|3684455|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
1506312|NCT01622569|3684456|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
1506313|NCT01622569|3684457|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
1506314|NCT01622569|3684458|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
1506315|NCT01622569|3684455|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
1506316|NCT01622569|3684456|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
1506317|NCT01622569|3684457|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
1506318|NCT01622569|3684458|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
1506319|NCT01622348|3684528|P3|NOT COMPLETED|Overall Study||1
1506320|NCT01622348|3684529|P2|NOT COMPLETED|Overall Study||0
1506321|NCT01622348|3684530|P1|NOT COMPLETED|Overall Study||1
1506322|NCT01622348|3684528|P3|COMPLETED|Overall Study||14
1506323|NCT01622348|3684529|P2|COMPLETED|Overall Study||14
1506324|NCT01622348|3684530|P1|COMPLETED|Overall Study||14
1506325|NCT01622348|3684528|P3|STARTED|Overall Study||15
1506326|NCT01622348|3684529|P2|STARTED|Overall Study||14
1506327|NCT01622348|3684530|P1|STARTED|Overall Study||15
1506328|NCT01622296|3684538|P2|NOT COMPLETED|Second Intervention||0
1506329|NCT01622296|3684539|P1|NOT COMPLETED|Second Intervention||0
1506330|NCT01622296|3684538|P2|COMPLETED|Second Intervention||10
1506331|NCT01622296|3684539|P1|COMPLETED|Second Intervention||10
1506332|NCT01622296|3684538|P2|STARTED|Second Intervention||10
1506333|NCT01622296|3684539|P1|STARTED|Second Intervention||10
1506334|NCT01622296|3684538|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
1506335|NCT01622296|3684539|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
1506336|NCT01622296|3684538|P2|COMPLETED|Washout Period of at Least 1 Week||10
1506337|NCT01622296|3684539|P1|COMPLETED|Washout Period of at Least 1 Week||10
1506338|NCT01622296|3684538|P2|STARTED|Washout Period of at Least 1 Week||10
1506339|NCT01622296|3684539|P1|STARTED|Washout Period of at Least 1 Week||10
1506340|NCT01622296|3684538|P2|NOT COMPLETED|First Intervention||0
1506341|NCT01622296|3684539|P1|NOT COMPLETED|First Intervention||0
1506342|NCT01622296|3684538|P2|COMPLETED|First Intervention||10
1506343|NCT01622296|3684539|P1|COMPLETED|First Intervention||10
1506344|NCT01622296|3684538|P2|STARTED|First Intervention||10
1506345|NCT01622296|3684539|P1|STARTED|First Intervention||10
1506346|NCT01622257|3684547|P3|NOT COMPLETED|Overall Study||0
1506347|NCT01622257|3684548|P2|NOT COMPLETED|Overall Study||0
1506348|NCT01622257|3684549|P1|NOT COMPLETED|Overall Study||0
1506349|NCT01622257|3684547|P3|COMPLETED|Overall Study||66
1506350|NCT01622257|3684548|P2|COMPLETED|Overall Study||66
1506351|NCT01622257|3684549|P1|COMPLETED|Overall Study||66
1506352|NCT01622257|3684547|P3|STARTED|Overall Study||66
1506353|NCT01622257|3684548|P2|STARTED|Overall Study||66
1506354|NCT01622257|3684549|P1|STARTED|Overall Study||66
1506355|NCT01622231|3684569|P1|NOT COMPLETED|Overall Study||2
1506356|NCT01622231|3684569|P1|COMPLETED|Overall Study||59
1506357|NCT01622231|3684569|P1|STARTED|Overall Study||61
1506358|NCT01621880|3684599|P2|NOT COMPLETED|Overall Study||5
1506359|NCT01621880|3684600|P1|NOT COMPLETED|Overall Study||10
1506360|NCT01621880|3684599|P2|COMPLETED|Overall Study||49
1506361|NCT01621880|3684600|P1|COMPLETED|Overall Study||48
1506362|NCT01621880|3684599|P2|STARTED|Overall Study||54
1506363|NCT01621880|3684600|P1|STARTED|Overall Study||58
1506364|NCT01621802|3684614|P6|NOT COMPLETED|Overall Study||12
1506365|NCT01621802|3684615|P5|NOT COMPLETED|Overall Study||35
1506366|NCT01621802|3684616|P4|NOT COMPLETED|Overall Study||11
1506367|NCT01621802|3684617|P3|NOT COMPLETED|Overall Study||33
1506368|NCT01621802|3684618|P2|NOT COMPLETED|Overall Study||23
1506369|NCT01621802|3684619|P1|NOT COMPLETED|Overall Study||47
1506370|NCT01621802|3684614|P6|COMPLETED|Overall Study||477
1506371|NCT01621802|3684615|P5|COMPLETED|Overall Study||1284
1506372|NCT01621802|3684616|P4|COMPLETED|Overall Study||292
1506373|NCT01621802|3684617|P3|COMPLETED|Overall Study||763
1506374|NCT01621802|3684618|P2|COMPLETED|Overall Study||275
1506375|NCT01621802|3684619|P1|COMPLETED|Overall Study||755
1506376|NCT01621802|3684614|P6|STARTED|Overall Study||489
1506377|NCT01621802|3684615|P5|STARTED|Overall Study||1319
1506378|NCT01621802|3684616|P4|STARTED|Overall Study||303
1506379|NCT01621802|3684617|P3|STARTED|Overall Study||796
1506380|NCT01621802|3684618|P2|STARTED|Overall Study||298
1506381|NCT01621802|3684619|P1|STARTED|Overall Study||802
1506382|NCT01621776|3684726|P3|NOT COMPLETED|Overall Study||0
1506383|NCT01621776|3684727|P2|NOT COMPLETED|Overall Study||0
1506384|NCT01621776|3684728|P1|NOT COMPLETED|Overall Study||0
1506385|NCT01621776|3684726|P3|COMPLETED|Overall Study||18
1506386|NCT01621776|3684727|P2|COMPLETED|Overall Study||40
1506387|NCT01621776|3684728|P1|COMPLETED|Overall Study||41
1506388|NCT01621776|3684726|P3|STARTED|Overall Study||18
1506389|NCT01621776|3684727|P2|STARTED|Overall Study||40
1506390|NCT01621776|3684728|P1|STARTED|Overall Study||41
1506391|NCT01621672|3684744|P2|NOT COMPLETED|Overall Study||0
1506392|NCT01621672|3684745|P1|NOT COMPLETED|Overall Study||0
1506393|NCT01621672|3684744|P2|COMPLETED|Overall Study||17
1506394|NCT01621672|3684745|P1|COMPLETED|Overall Study||25
1506395|NCT01621672|3684744|P2|STARTED|Overall Study||17
1506396|NCT01621672|3684745|P1|STARTED|Overall Study||25
1506397|NCT01621633|3684755|P4|NOT COMPLETED|Overall Study||0
1506398|NCT01621633|3684756|P3|NOT COMPLETED|Overall Study||0
1506399|NCT01621633|3684757|P2|NOT COMPLETED|Overall Study||0
1506400|NCT01621633|3684758|P1|NOT COMPLETED|Overall Study||0
1506401|NCT01621633|3684755|P4|COMPLETED|Overall Study||8
1506402|NCT01621633|3684756|P3|COMPLETED|Overall Study||8
1506403|NCT01621633|3684757|P2|COMPLETED|Overall Study||8
1506404|NCT01621633|3684758|P1|COMPLETED|Overall Study||8
1506405|NCT01621633|3684755|P4|STARTED|Overall Study||8
1506406|NCT01621633|3684756|P3|STARTED|Overall Study||8
1506407|NCT01621633|3684757|P2|STARTED|Overall Study||8
1506408|NCT01621633|3684758|P1|STARTED|Overall Study||8
1506409|NCT01621477|3684780|P1|NOT COMPLETED|Overall Study||0
1506410|NCT01621477|3684780|P1|COMPLETED|Overall Study||17
1506411|NCT01621477|3684780|P1|STARTED|Overall Study||17
1506412|NCT01621191|3684790|P1|NOT COMPLETED|Overall Study||25
1506413|NCT01621191|3684790|P1|COMPLETED|Overall Study||124
1506414|NCT01621191|3684790|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
1506415|NCT01621191|3684790|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
1506416|NCT01621191|3684790|P1|STARTED|Overall Study||149
1506417|NCT01621178|3684804|P3|NOT COMPLETED|Overall Study||36
1506418|NCT01621178|3684805|P2|NOT COMPLETED|Overall Study||30
1506419|NCT01621178|3684806|P1|NOT COMPLETED|Overall Study||31
1506420|NCT01621178|3684804|P3|COMPLETED|Overall Study||157
1506421|NCT01621178|3684805|P2|COMPLETED|Overall Study||160
1506422|NCT01621178|3684806|P1|COMPLETED|Overall Study||163
1506423|NCT01621178|3684804|P3|Modified Intent to Treat Population|Overall Study||183
1506424|NCT01621178|3684805|P2|Modified Intent to Treat Population|Overall Study||180
1506425|NCT01621178|3684806|P1|Modified Intent to Treat Population|Overall Study||186
1506426|NCT01621178|3684804|P3|Received at Least One Dose of Study Drug|Overall Study||192
1506427|NCT01621178|3684805|P2|Received at Least One Dose of Study Drug|Overall Study||190
1506428|NCT01621178|3684806|P1|Received at Least One Dose of Study Drug|Overall Study||194
1506429|NCT01621178|3684804|P3|STARTED|Overall Study||193
1506430|NCT01621178|3684805|P2|STARTED|Overall Study||190
1506431|NCT01621178|3684806|P1|STARTED|Overall Study||194
1506432|NCT01621126|3684898|P1|NOT COMPLETED|Overall Study||6
1506433|NCT01621126|3684898|P1|COMPLETED|Overall Study||34
1506434|NCT01621126|3684898|P1|STARTED|Overall Study||40
1506435|NCT01621009|3684906|P4|NOT COMPLETED|Overall Study||53
1506436|NCT01621009|3684907|P3|NOT COMPLETED|Overall Study||63
1506437|NCT01621009|3684908|P2|NOT COMPLETED|Overall Study||51
1506438|NCT01621009|3684909|P1|NOT COMPLETED|Overall Study||43
1506439|NCT01621009|3684906|P4|COMPLETED|Overall Study||60
1506440|NCT01621009|3684907|P3|COMPLETED|Overall Study||58
1506441|NCT01621009|3684908|P2|COMPLETED|Overall Study||65
1506442|NCT01621009|3684909|P1|COMPLETED|Overall Study||70
1506443|NCT01621009|3684906|P4|STARTED|Overall Study||113
1506444|NCT01621009|3684907|P3|STARTED|Overall Study||121
1506445|NCT01621009|3684908|P2|STARTED|Overall Study||116
1506446|NCT01621009|3684909|P1|STARTED|Overall Study||113
1506447|NCT01620983|3684920|P3|NOT COMPLETED|Overall Study||15
1506448|NCT01620983|3684921|P2|NOT COMPLETED|Overall Study||22
1506449|NCT01620983|3684922|P1|NOT COMPLETED|Overall Study||19
1506450|NCT01620983|3684920|P3|COMPLETED|Overall Study||122
1506451|NCT01620983|3684921|P2|COMPLETED|Overall Study||113
1506452|NCT01620983|3684922|P1|COMPLETED|Overall Study||111
1506453|NCT01620983|3684920|P3|STARTED|Overall Study||137
1506454|NCT01620983|3684921|P2|STARTED|Overall Study||135
1506455|NCT01620983|3684922|P1|STARTED|Overall Study||130
1506456|NCT01620762|3684951|P3|NOT COMPLETED|Overall Study||53
1506457|NCT01620762|3684952|P2|NOT COMPLETED|Overall Study||58
1506458|NCT01620762|3684953|P1|NOT COMPLETED|Overall Study||48
1506459|NCT01620762|3684951|P3|COMPLETED|Overall Study||417
1506460|NCT01620762|3684952|P2|COMPLETED|Overall Study||412
1506461|NCT01620762|3684953|P1|COMPLETED|Overall Study||420
1506462|NCT01620762|3684951|P3|STARTED|Overall Study||470
1506463|NCT01620762|3684952|P2|STARTED|Overall Study||470
1506464|NCT01620762|3684953|P1|STARTED|Overall Study||468
1506465|NCT01620593|3684981|P2|NOT COMPLETED|Overall Study||1
1506466|NCT01620593|3684982|P1|NOT COMPLETED|Overall Study||4
1506467|NCT01620593|3684981|P2|COMPLETED|Overall Study||19
1506468|NCT01620593|3684982|P1|COMPLETED|Overall Study||17
1506469|NCT01620593|3684981|P2|STARTED|Overall Study||20
1506470|NCT01620593|3684982|P1|STARTED|Overall Study||21
1506471|NCT01620528|3684999|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||14
1506472|NCT01620528|3685000|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||17
1506473|NCT01620528|3685001|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||20
1506474|NCT01620528|3684999|P3|COMPLETED|Post-Treatment Follow-Up Period||37
1506475|NCT01620528|3685000|P2|COMPLETED|Post-Treatment Follow-Up Period||31
1506476|NCT01620528|3685001|P1|COMPLETED|Post-Treatment Follow-Up Period||48
1506477|NCT01620528|3684999|P3|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
1506478|NCT01620528|3685000|P2|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
1506479|NCT01620528|3685001|P1|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
1506480|NCT01620528|3684999|P3|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
1506481|NCT01620528|3685000|P2|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
1506482|NCT01620528|3685001|P1|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
1506483|NCT01620528|3684999|P3|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
1506484|NCT01620528|3685000|P2|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
1506485|NCT01620528|3685001|P1|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
1506486|NCT01620528|3684999|P3|NOT COMPLETED|Treatment Period||66
1506487|NCT01620528|3685000|P2|NOT COMPLETED|Treatment Period||53
1506488|NCT01620528|3685001|P1|NOT COMPLETED|Treatment Period||100
1506489|NCT01620528|3684999|P3|COMPLETED|Treatment Period||183
1506490|NCT01620528|3685000|P2|COMPLETED|Treatment Period||196
1506491|NCT01620528|3685001|P1|COMPLETED|Treatment Period||274
1506492|NCT01620528|3684999|P3|STARTED|Treatment Period|1 subject did not receive study drug|249
1506493|NCT01620528|3685000|P2|STARTED|Treatment Period||249
1506494|NCT01620528|3685001|P1|STARTED|Treatment Period||374
1506495|NCT01620489|3685341|P2|NOT COMPLETED|Overall Study||34
1506496|NCT01620489|3685342|P1|NOT COMPLETED|Overall Study||35
1506497|NCT01620489|3685341|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
1506498|NCT01620489|3685342|P1|COMPLETED|Overall Study||105
1506499|NCT01620489|3685341|P2|Exposed|Overall Study|2 subjects did not take trial product|137
1506500|NCT01620489|3685342|P1|Exposed|Overall Study||140
1506501|NCT01620489|3685341|P2|STARTED|Overall Study||139
1506502|NCT01620489|3685342|P1|STARTED|Overall Study||140
1506503|NCT01620255|3685363|P5|NOT COMPLETED|Overall Study||6
1506504|NCT01620255|3685364|P4|NOT COMPLETED|Overall Study||3
1506505|NCT01620255|3685365|P3|NOT COMPLETED|Overall Study||2
1506506|NCT01620255|3685366|P2|NOT COMPLETED|Overall Study||6
1506507|NCT01620255|3685367|P1|NOT COMPLETED|Overall Study||4
1506508|NCT01620255|3685363|P5|COMPLETED|Overall Study||64
1506509|NCT01620255|3685364|P4|COMPLETED|Overall Study||70
1506510|NCT01620255|3685365|P3|COMPLETED|Overall Study||68
1506511|NCT01620255|3685366|P2|COMPLETED|Overall Study||65
1506512|NCT01620255|3685367|P1|COMPLETED|Overall Study||69
1506513|NCT01620255|3685363|P5|Treated|Overall Study||70
1506514|NCT01620255|3685364|P4|Treated|Overall Study||73
1506515|NCT01620255|3685365|P3|Treated|Overall Study||70
1506516|NCT01620255|3685366|P2|Treated|Overall Study||71
1506517|NCT01620255|3685367|P1|Treated|Overall Study||73
1506518|NCT01620255|3685363|P5|STARTED|Overall Study||70
1506519|NCT01620255|3685364|P4|STARTED|Overall Study||73
1506520|NCT01620255|3685365|P3|STARTED|Overall Study||70
1506521|NCT01620255|3685366|P2|STARTED|Overall Study||71
1506522|NCT01620255|3685367|P1|STARTED|Overall Study||73
1506523|NCT01620177|3685444|P1|NOT COMPLETED|Overall Study||79
1506524|NCT01620177|3685444|P1|COMPLETED|Overall Study||19
1506525|NCT01620177|3685444|P1|STARTED|Overall Study||98
1506526|NCT01620138|3685469|P2|NOT COMPLETED|Overall Study||0
1506527|NCT01620138|3685470|P1|NOT COMPLETED|Overall Study||6
1506528|NCT01620138|3685469|P2|COMPLETED|Overall Study||9
1506529|NCT01620138|3685470|P1|COMPLETED|Overall Study||6
1506530|NCT01620138|3685469|P2|STARTED|Overall Study||9
1506531|NCT01620138|3685470|P1|STARTED|Overall Study||12
1506532|NCT01620086|3685478|P3|NOT COMPLETED|Overall Study||0
1506533|NCT01620086|3685479|P2|NOT COMPLETED|Overall Study||7
1506534|NCT01620086|3685480|P1|NOT COMPLETED|Overall Study||5
1506535|NCT01620086|3685478|P3|COMPLETED|Overall Study||2
1506536|NCT01620086|3685479|P2|COMPLETED|Overall Study||4
1506537|NCT01620086|3685480|P1|COMPLETED|Overall Study||8
1506538|NCT01620086|3685478|P3|STARTED|Overall Study||2
1506539|NCT01620086|3685479|P2|STARTED|Overall Study||11
1506540|NCT01620086|3685480|P1|STARTED|Overall Study||13
1506541|NCT01620060|3685499|P1|NOT COMPLETED|Overall Study||15
1506542|NCT01620060|3685499|P1|COMPLETED|Overall Study||90
1506543|NCT01620060|3685499|P1|STARTED|Overall Study||105
1506544|NCT01620047|3685508|P3|NOT COMPLETED|Overall Study||0
1506545|NCT01620047|3685509|P2|NOT COMPLETED|Overall Study||0
1506546|NCT01620047|3685510|P1|NOT COMPLETED|Overall Study||0
1506547|NCT01620047|3685508|P3|COMPLETED|Overall Study||20
1506548|NCT01620047|3685509|P2|COMPLETED|Overall Study||20
1506549|NCT01620047|3685510|P1|COMPLETED|Overall Study||20
1506550|NCT01620047|3685508|P3|STARTED|Overall Study||20
1506551|NCT01620047|3685509|P2|STARTED|Overall Study||20
1506552|NCT01620047|3685510|P1|STARTED|Overall Study||20
1506553|NCT01619982|3685520|P2|NOT COMPLETED|Overall Study||0
1506554|NCT01619982|3685521|P1|NOT COMPLETED|Overall Study||0
1506555|NCT01619982|3685520|P2|COMPLETED|Overall Study||12
1506556|NCT01619982|3685521|P1|COMPLETED|Overall Study||20
1506557|NCT01619982|3685520|P2|STARTED|Overall Study||12
1506558|NCT01619982|3685521|P1|STARTED|Overall Study||20
1506559|NCT01619878|3685537|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
1506560|NCT01619878|3685537|P1|COMPLETED|Follow-up at 12 Months of Age||17
1506561|NCT01619878|3685537|P1|STARTED|Follow-up at 12 Months of Age||20
1506562|NCT01619878|3685537|P1|NOT COMPLETED|6 Week Follow-up Phase||1
1506563|NCT01619878|3685537|P1|COMPLETED|6 Week Follow-up Phase||19
1506564|NCT01619878|3685537|P1|STARTED|6 Week Follow-up Phase||20
1506565|NCT01619800|3685551|P2|NOT COMPLETED|Overall Study||0
1506566|NCT01619800|3685552|P1|NOT COMPLETED|Overall Study||2
1506567|NCT01619800|3685551|P2|COMPLETED|Overall Study||0
1506568|NCT01619800|3685552|P1|COMPLETED|Overall Study||0
1506569|NCT01619800|3685551|P2|STARTED|Overall Study||0
1506570|NCT01619800|3685552|P1|STARTED|Overall Study||2
1506571|NCT01619787|3685560|P1|NOT COMPLETED|Overall Study||5
1506572|NCT01619787|3685560|P1|COMPLETED|Overall Study||212
1506573|NCT01619787|3685560|P1|STARTED|Overall Study||217
1506574|NCT01619774|3685569|P1|NOT COMPLETED|Overall Study||0
1506575|NCT01619774|3685569|P1|COMPLETED|Overall Study||23
1506576|NCT01619774|3685569|P1|STARTED|Overall Study||23
1506577|NCT01619579|3685577|P2|NOT COMPLETED|Overall Study||3
1506578|NCT01619579|3685578|P1|NOT COMPLETED|Overall Study||0
1506579|NCT01619579|3685577|P2|COMPLETED|Overall Study||14
1506580|NCT01619579|3685578|P1|COMPLETED|Overall Study||5
1506581|NCT01619579|3685577|P2|STARTED|Overall Study||17
1506582|NCT01619579|3685578|P1|STARTED|Overall Study||5
1506583|NCT01619423|3685592|P4|NOT COMPLETED|Part 2b||0
1506584|NCT01619423|3685593|P3|NOT COMPLETED|Part 2b||0
1506585|NCT01619423|3685594|P2|NOT COMPLETED|Part 2b||0
1506586|NCT01619423|3685595|P1|NOT COMPLETED|Part 2b||0
1506587|NCT01619423|3685592|P4|COMPLETED|Part 2b||0
1506588|NCT01619423|3685593|P3|COMPLETED|Part 2b||45
1506589|NCT01619423|3685594|P2|COMPLETED|Part 2b||44
1506590|NCT01619423|3685595|P1|COMPLETED|Part 2b||45
1506591|NCT01619423|3685592|P4|STARTED|Part 2b||0
1506592|NCT01619423|3685593|P3|STARTED|Part 2b||45
1506593|NCT01619423|3685594|P2|STARTED|Part 2b||44
1506594|NCT01619423|3685595|P1|STARTED|Part 2b||45
1506595|NCT01619423|3685592|P4|NOT COMPLETED|Part 2a||0
1506596|NCT01619423|3685593|P3|NOT COMPLETED|Part 2a||0
1506597|NCT01619423|3685594|P2|NOT COMPLETED|Part 2a||0
1506598|NCT01619423|3685595|P1|NOT COMPLETED|Part 2a||0
1506599|NCT01619423|3685592|P4|COMPLETED|Part 2a||11
1506600|NCT01619423|3685593|P3|COMPLETED|Part 2a||0
1506601|NCT01619423|3685594|P2|COMPLETED|Part 2a||13
1506602|NCT01619423|3685595|P1|COMPLETED|Part 2a||15
1506603|NCT01619423|3685592|P4|STARTED|Part 2a||11
1506604|NCT01619423|3685593|P3|STARTED|Part 2a||0
1506605|NCT01619423|3685594|P2|STARTED|Part 2a||13
1506606|NCT01619423|3685595|P1|STARTED|Part 2a||15
1506607|NCT01619423|3685592|P4|NOT COMPLETED|Part 1 (Dose Escalation)||0
1506608|NCT01619423|3685593|P3|NOT COMPLETED|Part 1 (Dose Escalation)||0
1506609|NCT01619423|3685594|P2|NOT COMPLETED|Part 1 (Dose Escalation)||2
1506610|NCT01619423|3685595|P1|NOT COMPLETED|Part 1 (Dose Escalation)||0
1506611|NCT01619423|3685592|P4|COMPLETED|Part 1 (Dose Escalation)||5
1506612|NCT01619423|3685593|P3|COMPLETED|Part 1 (Dose Escalation)||3
1506613|NCT01619423|3685594|P2|COMPLETED|Part 1 (Dose Escalation)||3
1506614|NCT01619423|3685595|P1|COMPLETED|Part 1 (Dose Escalation)||0
1506615|NCT01619423|3685592|P4|STARTED|Part 1 (Dose Escalation)||5
1506616|NCT01619423|3685593|P3|STARTED|Part 1 (Dose Escalation)||3
1506617|NCT01619423|3685594|P2|STARTED|Part 1 (Dose Escalation)||5
1506618|NCT01619423|3685595|P1|STARTED|Part 1 (Dose Escalation)||0
1506619|NCT01619085|3685606|P1|NOT COMPLETED|Overall Study||369
1506620|NCT01619085|3685606|P1|COMPLETED|Overall Study|Total 341 patients did not complete the trial.|366
1506621|NCT01619085|3685606|P1|STARTED|Overall Study|27 patients were ongoing on trial at database lock. 1 patient was not treated with trial drugs.|735
1506622|NCT01619059|3685612|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
1506623|NCT01619059|3685613|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
1506624|NCT01619059|3685612|P2|COMPLETED|Long-Term (LT) Treatment Period||133
1506625|NCT01619059|3685613|P1|COMPLETED|Long-Term (LT) Treatment Period||147
1506626|NCT01619059|3685612|P2|STARTED|Long-Term (LT) Treatment Period||142
1506627|NCT01619059|3685613|P1|STARTED|Long-Term (LT) Treatment Period||155
1506628|NCT01619059|3685612|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
1506629|NCT01619059|3685613|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
1506630|NCT01619059|3685612|P2|COMPLETED|Short-Term (ST) Treatment Period||142
1506631|NCT01619059|3685613|P1|COMPLETED|Short-Term (ST) Treatment Period||156
1506632|NCT01619059|3685612|P2|STARTED|Short-Term (ST) Treatment Period||153
1506633|NCT01619059|3685613|P1|STARTED|Short-Term (ST) Treatment Period||162
1506634|NCT01618968|3685629|P4|NOT COMPLETED|Overall Study||1
1506635|NCT01618968|3685630|P3|NOT COMPLETED|Overall Study||0
1506636|NCT01618968|3685631|P2|NOT COMPLETED|Overall Study||0
1506637|NCT01618968|3685632|P1|NOT COMPLETED|Overall Study||1
1506638|NCT01618968|3685629|P4|COMPLETED|Overall Study||11
1506639|NCT01618968|3685630|P3|COMPLETED|Overall Study||12
1506640|NCT01618968|3685631|P2|COMPLETED|Overall Study||12
1506641|NCT01618968|3685632|P1|COMPLETED|Overall Study||12
1506642|NCT01618968|3685629|P4|Received Treatment C|Overall Study||11
1506643|NCT01618968|3685630|P3|Received Treatment C|Overall Study||12
1506644|NCT01618968|3685631|P2|Received Treatment C|Overall Study||12
1506645|NCT01618968|3685632|P1|Received Treatment C|Overall Study||12
1506646|NCT01618968|3685629|P4|Received Treatment B|Overall Study||12
1506647|NCT01618968|3685630|P3|Received Treatment B|Overall Study||12
1506648|NCT01618968|3685631|P2|Received Treatment B|Overall Study||12
1506649|NCT01618968|3685632|P1|Received Treatment B|Overall Study||13
1506650|NCT01618968|3685629|P4|Received Treatment A|Overall Study||11
1506651|NCT01618968|3685630|P3|Received Treatment A|Overall Study||12
1506652|NCT01618968|3685631|P2|Received Treatment A|Overall Study||12
1506653|NCT01618968|3685632|P1|Received Treatment A|Overall Study||12
1506654|NCT01618968|3685629|P4|STARTED|Overall Study||12
1506655|NCT01618968|3685630|P3|STARTED|Overall Study||12
1506656|NCT01618968|3685631|P2|STARTED|Overall Study||12
1506657|NCT01618968|3685632|P1|STARTED|Overall Study||13
1506658|NCT01618955|3685651|P4|NOT COMPLETED|Overall Study||0
1506659|NCT01618955|3685652|P3|NOT COMPLETED|Overall Study||0
1506660|NCT01618955|3685653|P2|NOT COMPLETED|Overall Study||0
1506661|NCT01618955|3685654|P1|NOT COMPLETED|Overall Study||0
1506662|NCT01618955|3685651|P4|COMPLETED|Overall Study||20
1506663|NCT01618955|3685652|P3|COMPLETED|Overall Study||31
1506664|NCT01618955|3685653|P2|COMPLETED|Overall Study||30
1506665|NCT01618955|3685654|P1|COMPLETED|Overall Study||20
1506666|NCT01618955|3685651|P4|STARTED|Overall Study||20
1506667|NCT01618955|3685652|P3|STARTED|Overall Study||31
1506668|NCT01618955|3685653|P2|STARTED|Overall Study||30
1506669|NCT01618955|3685654|P1|STARTED|Overall Study||20
1506670|NCT01618942|3685678|P2|NOT COMPLETED|Overall Study||0
1506671|NCT01618942|3685679|P1|NOT COMPLETED|Overall Study||0
1506672|NCT01618942|3685678|P2|COMPLETED|Overall Study||50
1506673|NCT01618942|3685679|P1|COMPLETED|Overall Study||50
1506674|NCT01618942|3685678|P2|STARTED|Overall Study||50
1506675|NCT01618942|3685679|P1|STARTED|Overall Study||50
1506676|NCT01618864|3685699|P1|NOT COMPLETED|Overall Study||4
1506677|NCT01618864|3685699|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
1506678|NCT01618864|3685699|P1|Completed 2 Weeks|Overall Study||19
1506679|NCT01618864|3685699|P1|STARTED|Overall Study||23
1506680|NCT01618838|3685708|P1|NOT COMPLETED|Overall Study||4
1506681|NCT01618838|3685708|P1|COMPLETED|Overall Study||0
1506682|NCT01618838|3685708|P1|STARTED|Overall Study||4
1506683|NCT01618708|3685716|P2|NOT COMPLETED|Overall Study||46
1506684|NCT01618708|3685717|P1|NOT COMPLETED|Overall Study||44
1506685|NCT01618708|3685716|P2|COMPLETED|Overall Study||136
1506686|NCT01618708|3685717|P1|COMPLETED|Overall Study||131
1506687|NCT01618708|3685716|P2|Treated|Overall Study||180
1506688|NCT01618708|3685717|P1|Treated|Overall Study||172
1506689|NCT01618708|3685716|P2|STARTED|Overall Study||182
1506690|NCT01618708|3685717|P1|STARTED|Overall Study||175
1506691|NCT01618669|3685731|P2|NOT COMPLETED|Overall Study||23
1506692|NCT01618669|3685732|P1|NOT COMPLETED|Overall Study||34
1506693|NCT01618669|3685731|P2|COMPLETED|Overall Study||546
1506694|NCT01618669|3685732|P1|COMPLETED|Overall Study||544
1506695|NCT01618669|3685731|P2|Received Treatment|Overall Study||567
1506696|NCT01618669|3685732|P1|Received Treatment|Overall Study||575
1506697|NCT01618669|3685731|P2|STARTED|Overall Study||569
1506698|NCT01618669|3685732|P1|STARTED|Overall Study||578
1506699|NCT01618422|3685778|P2|NOT COMPLETED|Overall Study||0
1506700|NCT01618422|3685779|P1|NOT COMPLETED|Overall Study||0
1506701|NCT01618422|3685778|P2|COMPLETED|Overall Study||111
1506702|NCT01618422|3685779|P1|COMPLETED|Overall Study||114
1506703|NCT01618422|3685778|P2|STARTED|Overall Study||111
1506704|NCT01618422|3685779|P1|STARTED|Overall Study||114
1506705|NCT01618344|3685785|P1|NOT COMPLETED|Overall Study||9
1506706|NCT01618344|3685785|P1|COMPLETED|Overall Study||23
1506707|NCT01618344|3685785|P1|STARTED|Overall Study||32
1506708|NCT01618266|3685789|P1|NOT COMPLETED|Overall Study||96
1506709|NCT01618266|3685789|P1|COMPLETED|Overall Study||279
1506710|NCT01618266|3685789|P1|STARTED|Overall Study||375
1506711|NCT01618240|3685804|P1|NOT COMPLETED|Overall Study||0
1506712|NCT01618240|3685804|P1|COMPLETED|Overall Study||30
1506713|NCT01618240|3685804|P1|STARTED|Overall Study||30
1506714|NCT01618227|3685811|P2|NOT COMPLETED|Overall Study||2
1506715|NCT01618227|3685812|P1|NOT COMPLETED|Overall Study||0
1506716|NCT01618227|3685811|P2|COMPLETED|Overall Study||0
1506717|NCT01618227|3685812|P1|COMPLETED|Overall Study||2
1506718|NCT01618227|3685811|P2|STARTED|Overall Study||2
1506719|NCT01618227|3685812|P1|STARTED|Overall Study||2
1506720|NCT01618214|3685826|P2|NOT COMPLETED|Overall Study||13
1506721|NCT01618214|3685827|P1|NOT COMPLETED|Overall Study||10
1506722|NCT01618214|3685826|P2|COMPLETED|Overall Study||159
1506723|NCT01618214|3685827|P1|COMPLETED|Overall Study||162
1506724|NCT01618214|3685826|P2|Exposed|Overall Study||172
1506725|NCT01618214|3685827|P1|Exposed|Overall Study||172
1506726|NCT01618214|3685826|P2|STARTED|Overall Study||172
1506727|NCT01618214|3685827|P1|STARTED|Overall Study||172
1506728|NCT01618162|3685843|P2|NOT COMPLETED|Overall Study||35
1506729|NCT01618162|3685844|P1|NOT COMPLETED|Overall Study||38
1506730|NCT01618162|3685843|P2|COMPLETED|Overall Study||111
1506731|NCT01618162|3685844|P1|COMPLETED|Overall Study||251
1506732|NCT01618162|3685843|P2|Exposed|Overall Study||146
1506733|NCT01618162|3685844|P1|Exposed|Overall Study||288
1506734|NCT01618162|3685843|P2|STARTED|Overall Study||146
1506735|NCT01618162|3685844|P1|STARTED|Overall Study||289
1506736|NCT01618019|3685864|P2|NOT COMPLETED|Overall Study||14
1506737|NCT01618019|3685865|P1|NOT COMPLETED|Overall Study||14
1506738|NCT01618019|3685864|P2|COMPLETED|Overall Study||40
1506739|NCT01618019|3685865|P1|COMPLETED|Overall Study||41
1506740|NCT01618019|3685864|P2|STARTED|Overall Study||54
1506741|NCT01618019|3685865|P1|STARTED|Overall Study||55
1506742|NCT01617967|3685891|P6|NOT COMPLETED|Overall Study||1
1506743|NCT01617967|3685892|P5|NOT COMPLETED|Overall Study||0
1506744|NCT01617967|3685893|P4|NOT COMPLETED|Overall Study||1
1506745|NCT01617967|3685894|P3|NOT COMPLETED|Overall Study||0
1506746|NCT01617967|3685895|P2|NOT COMPLETED|Overall Study||0
1506747|NCT01617967|3685896|P1|NOT COMPLETED|Overall Study||1
1506748|NCT01617967|3685891|P6|COMPLETED|Overall Study||8
1506749|NCT01617967|3685892|P5|COMPLETED|Overall Study||3
1506750|NCT01617967|3685893|P4|COMPLETED|Overall Study||6
1506751|NCT01617967|3685894|P3|COMPLETED|Overall Study||3
1506752|NCT01617967|3685895|P2|COMPLETED|Overall Study||3
1506753|NCT01617967|3685896|P1|COMPLETED|Overall Study||3
1506754|NCT01617967|3685891|P6|STARTED|Overall Study||9
1506755|NCT01617967|3685892|P5|STARTED|Overall Study||3
1506756|NCT01617967|3685893|P4|STARTED|Overall Study||7
1506757|NCT01617967|3685894|P3|STARTED|Overall Study||3
1506758|NCT01617967|3685895|P2|STARTED|Overall Study||3
1506759|NCT01617967|3685896|P1|STARTED|Overall Study||4
1506760|NCT01617681|3685950|P5|NOT COMPLETED|Period 2 Open Label||6
1506761|NCT01617681|3685951|P4|NOT COMPLETED|Period 2 Open Label||0
1506762|NCT01617681|3685952|P3|NOT COMPLETED|Period 2 Open Label||0
1506763|NCT01617681|3685953|P2|NOT COMPLETED|Period 2 Open Label||0
1506764|NCT01617681|3685954|P1|NOT COMPLETED|Period 2 Open Label||0
1506765|NCT01617681|3685950|P5|COMPLETED|Period 2 Open Label||114
1506766|NCT01617681|3685951|P4|COMPLETED|Period 2 Open Label||0
1506767|NCT01617681|3685952|P3|COMPLETED|Period 2 Open Label||0
1506768|NCT01617681|3685953|P2|COMPLETED|Period 2 Open Label||0
1506769|NCT01617681|3685954|P1|COMPLETED|Period 2 Open Label||0
1506770|NCT01617681|3685950|P5|STARTED|Period 2 Open Label||120
1506771|NCT01617681|3685951|P4|STARTED|Period 2 Open Label||0
1506772|NCT01617681|3685952|P3|STARTED|Period 2 Open Label||0
1506773|NCT01617681|3685953|P2|STARTED|Period 2 Open Label||0
1506774|NCT01617681|3685954|P1|STARTED|Period 2 Open Label||0
1506775|NCT01617681|3685950|P5|NOT COMPLETED|Period 1 Double Blind||0
1506776|NCT01617681|3685951|P4|NOT COMPLETED|Period 1 Double Blind||2
1506777|NCT01617681|3685952|P3|NOT COMPLETED|Period 1 Double Blind||1
1506778|NCT01617681|3685953|P2|NOT COMPLETED|Period 1 Double Blind||1
1506779|NCT01617681|3685954|P1|NOT COMPLETED|Period 1 Double Blind||3
1506780|NCT01617681|3685950|P5|COMPLETED|Period 1 Double Blind||0
1506781|NCT01617681|3685951|P4|COMPLETED|Period 1 Double Blind||29
1506782|NCT01617681|3685952|P3|COMPLETED|Period 1 Double Blind||32
1506783|NCT01617681|3685953|P2|COMPLETED|Period 1 Double Blind||30
1506784|NCT01617681|3685954|P1|COMPLETED|Period 1 Double Blind||29
1506785|NCT01617681|3685950|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
1506786|NCT01617681|3685951|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
1506787|NCT01617681|3685952|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
1506788|NCT01617681|3685953|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
1506789|NCT01617681|3685954|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
1506790|NCT01617681|3685950|P5|STARTED|Period 1 Double Blind||0
1506791|NCT01617681|3685951|P4|STARTED|Period 1 Double Blind||31
1506792|NCT01617681|3685952|P3|STARTED|Period 1 Double Blind||33
1506793|NCT01617681|3685953|P2|STARTED|Period 1 Double Blind||31
1506794|NCT01617681|3685954|P1|STARTED|Period 1 Double Blind||32
1506795|NCT01617668|3685975|P4|NOT COMPLETED|Overall Study||15
1506796|NCT01617668|3685976|P3|NOT COMPLETED|Overall Study||23
1506797|NCT01617668|3685977|P2|NOT COMPLETED|Overall Study||9
1506798|NCT01617668|3685978|P1|NOT COMPLETED|Overall Study||13
1506799|NCT01617668|3685975|P4|COMPLETED|Overall Study||38
1506800|NCT01617668|3685976|P3|COMPLETED|Overall Study||32
1506801|NCT01617668|3685977|P2|COMPLETED|Overall Study||41
1506802|NCT01617668|3685978|P1|COMPLETED|Overall Study||38
1506803|NCT01617668|3685975|P4|Randomized Patients|Overall Study||55
1506804|NCT01617668|3685976|P3|Randomized Patients|Overall Study||55
1506805|NCT01617668|3685977|P2|Randomized Patients|Overall Study||54
1506806|NCT01617668|3685978|P1|Randomized Patients|Overall Study||51
1506807|NCT01617668|3685975|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
1506808|NCT01617668|3685976|P3|STARTED|Overall Study||55
1506809|NCT01617668|3685977|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
1506810|NCT01617668|3685978|P1|STARTED|Overall Study||51
1506811|NCT01617655|3686019|P2|NOT COMPLETED|Overall Study||29
1506812|NCT01617655|3686020|P1|NOT COMPLETED|Overall Study||9
1506813|NCT01617655|3686019|P2|COMPLETED|Overall Study||43
1506814|NCT01617655|3686020|P1|COMPLETED|Overall Study||26
1506815|NCT01617655|3686019|P2|Treated|Overall Study||72
1506816|NCT01617655|3686020|P1|Treated|Overall Study||35
1506817|NCT01617655|3686019|P2|STARTED|Overall Study|Randomized|72
1506818|NCT01617655|3686020|P1|STARTED|Overall Study|Randomized|35
1506819|NCT01617629|3686080|P1|NOT COMPLETED|Overall Study||6
1506820|NCT01617629|3686080|P1|COMPLETED|Overall Study||3
1506821|NCT01617629|3686080|P1|STARTED|Overall Study||9
1506822|NCT01617603|3686088|P3|NOT COMPLETED|Overall Study||1
1506823|NCT01617603|3686089|P2|NOT COMPLETED|Overall Study||2
1506824|NCT01617603|3686090|P1|NOT COMPLETED|Overall Study||3
1506825|NCT01617603|3686088|P3|COMPLETED|Overall Study||20
1506826|NCT01617603|3686089|P2|COMPLETED|Overall Study||19
1506827|NCT01617603|3686090|P1|COMPLETED|Overall Study||17
1506828|NCT01617603|3686088|P3|STARTED|Overall Study||21
1506829|NCT01617603|3686089|P2|STARTED|Overall Study||21
1506830|NCT01617603|3686090|P1|STARTED|Overall Study||20
1506831|NCT01617577|3686100|P2|NOT COMPLETED|Overall Study||0
1506832|NCT01617577|3686101|P1|NOT COMPLETED|Overall Study||0
1506833|NCT01617577|3686100|P2|COMPLETED|Overall Study||3
1506834|NCT01617577|3686101|P1|COMPLETED|Overall Study||5
1506835|NCT01617577|3686100|P2|STARTED|Overall Study||3
1506836|NCT01617577|3686101|P1|STARTED|Overall Study||5
1506837|NCT01617460|3686108|P1|NOT COMPLETED|Overall Study||40
1506838|NCT01617460|3686108|P1|COMPLETED|Overall Study||46
1506839|NCT01617460|3686108|P1|STARTED|Overall Study||86
1506840|NCT01617447|3686114|P2|NOT COMPLETED|Overall Study||3
1506841|NCT01617447|3686115|P1|NOT COMPLETED|Overall Study||0
1506842|NCT01617447|3686114|P2|COMPLETED|Overall Study||42
1506843|NCT01617447|3686115|P1|COMPLETED|Overall Study||47
1506844|NCT01617447|3686114|P2|STARTED|Overall Study||45
1506845|NCT01617447|3686115|P1|STARTED|Overall Study||47
1506846|NCT01617434|3686123|P2|NOT COMPLETED|Overall Study||51
1506847|NCT01617434|3686124|P1|NOT COMPLETED|Overall Study||35
1506848|NCT01617434|3686123|P2|COMPLETED|Overall Study||174
1506849|NCT01617434|3686124|P1|COMPLETED|Overall Study||191
1506850|NCT01617434|3686123|P2|Exposed|Overall Study||225
1506851|NCT01617434|3686124|P1|Exposed|Overall Study||225
1506852|NCT01617434|3686123|P2|STARTED|Overall Study||225
1506853|NCT01617434|3686124|P1|STARTED|Overall Study||226
1506854|NCT01617369|3686146|P1|NOT COMPLETED|Overall Study||0
1506855|NCT01617369|3686146|P1|COMPLETED|Overall Study||12
1506856|NCT01617369|3686146|P1|STARTED|Overall Study||12
1506857|NCT01617187|3686156|P4|NOT COMPLETED|Treatment Through Study Completion||10
1506858|NCT01617187|3686157|P3|NOT COMPLETED|Treatment Through Study Completion||5
1506859|NCT01617187|3686158|P2|NOT COMPLETED|Treatment Through Study Completion||11
1506860|NCT01617187|3686159|P1|NOT COMPLETED|Treatment Through Study Completion||11
1506861|NCT01617187|3686156|P4|COMPLETED|Treatment Through Study Completion||91
1506862|NCT01617187|3686157|P3|COMPLETED|Treatment Through Study Completion||41
1506863|NCT01617187|3686158|P2|COMPLETED|Treatment Through Study Completion||102
1506864|NCT01617187|3686159|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
1506865|NCT01617187|3686156|P4|STARTED|Treatment Through Study Completion|Treated|101
1506866|NCT01617187|3686157|P3|STARTED|Treatment Through Study Completion|Treated|46
1506867|NCT01617187|3686158|P2|STARTED|Treatment Through Study Completion|Treated|113
1506868|NCT01617187|3686159|P1|STARTED|Treatment Through Study Completion|Treated|97
1506869|NCT01617187|3686156|P4|NOT COMPLETED|Randomization Through Start Treatment||2
1506870|NCT01617187|3686157|P3|NOT COMPLETED|Randomization Through Start Treatment||0
1506871|NCT01617187|3686158|P2|NOT COMPLETED|Randomization Through Start Treatment||0
1506872|NCT01617187|3686159|P1|NOT COMPLETED|Randomization Through Start Treatment||1
1506873|NCT01617187|3686156|P4|COMPLETED|Randomization Through Start Treatment||101
1506874|NCT01617187|3686157|P3|COMPLETED|Randomization Through Start Treatment||46
1506875|NCT01617187|3686158|P2|COMPLETED|Randomization Through Start Treatment||113
1506876|NCT01617187|3686159|P1|COMPLETED|Randomization Through Start Treatment||97
1506877|NCT01617187|3686156|P4|STARTED|Randomization Through Start Treatment|Randomized|103
1506878|NCT01617187|3686157|P3|STARTED|Randomization Through Start Treatment|Randomized|46
1506879|NCT01617187|3686158|P2|STARTED|Randomization Through Start Treatment|Randomized|113
1506880|NCT01617187|3686159|P1|STARTED|Randomization Through Start Treatment|Randomized|98
1506881|NCT01617148|3686229|P1|NOT COMPLETED|Overall Study||0
1506882|NCT01617148|3686229|P1|COMPLETED|Overall Study||26
1506883|NCT01617148|3686229|P1|STARTED|Overall Study||26
1506884|NCT01617083|3686243|P3|NOT COMPLETED|Overall Study||0
1506885|NCT01617083|3686244|P2|NOT COMPLETED|Overall Study||0
1506886|NCT01617083|3686245|P1|NOT COMPLETED|Overall Study||0
1506887|NCT01617083|3686243|P3|COMPLETED|Overall Study||15
1506888|NCT01617083|3686244|P2|COMPLETED|Overall Study||14
1506889|NCT01617083|3686245|P1|COMPLETED|Overall Study||18
1506890|NCT01617083|3686243|P3|STARTED|Overall Study||15
1506891|NCT01617083|3686244|P2|STARTED|Overall Study||14
1506892|NCT01617083|3686245|P1|STARTED|Overall Study||18
1506893|NCT01617070|3686256|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
1506894|NCT01617070|3686256|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
1506895|NCT01617070|3686256|P1|STARTED|BH4 and LNAA (4 Weeks)||10
1506896|NCT01617070|3686256|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
1506897|NCT01617070|3686256|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
1506898|NCT01617070|3686256|P1|STARTED|BH4 Therapy (4 Weeks)||10
1506899|NCT01617070|3686256|P1|NOT COMPLETED|Washout (4 Weeks)||0
1506900|NCT01617070|3686256|P1|COMPLETED|Washout (4 Weeks)||10
1506901|NCT01617070|3686256|P1|STARTED|Washout (4 Weeks)||10
1506902|NCT01617070|3686256|P1|NOT COMPLETED|LNAA (4 Weeks)||0
1506903|NCT01617070|3686256|P1|COMPLETED|LNAA (4 Weeks)||10
1506904|NCT01617070|3686256|P1|STARTED|LNAA (4 Weeks)||10
1506905|NCT01617005|3686274|P1|NOT COMPLETED|Overall Study||2
1506906|NCT01617005|3686274|P1|COMPLETED|Overall Study||48
1506907|NCT01617005|3686274|P1|STARTED|Overall Study||50
1506908|NCT01616953|3686283|P2|NOT COMPLETED|Overall Study||0
1506909|NCT01616953|3686284|P1|NOT COMPLETED|Overall Study||2
1506910|NCT01616953|3686283|P2|COMPLETED|Overall Study||8
1506911|NCT01616953|3686284|P1|COMPLETED|Overall Study||8
1506912|NCT01616953|3686283|P2|6 Months Post-loading|Overall Study||8
1506913|NCT01616953|3686284|P1|6 Months Post-loading|Overall Study||8
1506914|NCT01616953|3686283|P2|Implant Uncovery|Overall Study||8
1506915|NCT01616953|3686284|P1|Implant Uncovery|Overall Study||8
1506916|NCT01616953|3686283|P2|Implant Placement Surgery|Overall Study||8
1506917|NCT01616953|3686284|P1|Implant Placement Surgery|Overall Study||9
1506918|NCT01616953|3686283|P2|STARTED|Overall Study||8
1506919|NCT01616953|3686284|P1|STARTED|Overall Study||10
1506920|NCT01616771|3686292|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
1506921|NCT01616771|3686292|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
1506922|NCT01616771|3686292|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
1506923|NCT01616771|3686292|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
1506924|NCT01616771|3686292|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
1506925|NCT01616771|3686292|P1|STARTED|GVL Selected by Weight for 5 Sec||23
1506926|NCT01616771|3686292|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
1506927|NCT01616771|3686292|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
1506928|NCT01616771|3686292|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
1506929|NCT01616693|3686305|P4|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
1506930|NCT01616693|3686306|P3|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
1506931|NCT01616693|3686307|P2|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
1506932|NCT01616693|3686308|P1|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
1506933|NCT01616693|3686305|P4|COMPLETED|Blood Analyzed for Immunogenicity||135
1506934|NCT01616693|3686306|P3|COMPLETED|Blood Analyzed for Immunogenicity||136
1506935|NCT01616693|3686307|P2|COMPLETED|Blood Analyzed for Immunogenicity||143
1506936|NCT01616693|3686308|P1|COMPLETED|Blood Analyzed for Immunogenicity||137
1506937|NCT01616693|3686305|P4|STARTED|Blood Analyzed for Immunogenicity||136
1506938|NCT01616693|3686306|P3|STARTED|Blood Analyzed for Immunogenicity||142
1506939|NCT01616693|3686307|P2|STARTED|Blood Analyzed for Immunogenicity||145
1506940|NCT01616693|3686308|P1|STARTED|Blood Analyzed for Immunogenicity||141
1506941|NCT01616693|3686305|P4|NOT COMPLETED|Received Both Vaccines||19
1506942|NCT01616693|3686306|P3|NOT COMPLETED|Received Both Vaccines||12
1506943|NCT01616693|3686307|P2|NOT COMPLETED|Received Both Vaccines||10
1506944|NCT01616693|3686308|P1|NOT COMPLETED|Received Both Vaccines||13
1506945|NCT01616693|3686305|P4|COMPLETED|Received Both Vaccines||136
1506946|NCT01616693|3686306|P3|COMPLETED|Received Both Vaccines||142
1506947|NCT01616693|3686307|P2|COMPLETED|Received Both Vaccines||145
1506948|NCT01616693|3686308|P1|COMPLETED|Received Both Vaccines||141
1506949|NCT01616693|3686305|P4|STARTED|Received Both Vaccines||155
1506950|NCT01616693|3686306|P3|STARTED|Received Both Vaccines||154
1506951|NCT01616693|3686307|P2|STARTED|Received Both Vaccines||155
1506952|NCT01616693|3686308|P1|STARTED|Received Both Vaccines||154
1506953|NCT01616693|3686305|P4|NOT COMPLETED|Evaluated for Safety||0
1506954|NCT01616693|3686306|P3|NOT COMPLETED|Evaluated for Safety||1
1506955|NCT01616693|3686307|P2|NOT COMPLETED|Evaluated for Safety||0
1506956|NCT01616693|3686308|P1|NOT COMPLETED|Evaluated for Safety||1
1506957|NCT01616693|3686305|P4|COMPLETED|Evaluated for Safety||155
1506958|NCT01616693|3686306|P3|COMPLETED|Evaluated for Safety||154
1506959|NCT01616693|3686307|P2|COMPLETED|Evaluated for Safety||155
1506960|NCT01616693|3686308|P1|COMPLETED|Evaluated for Safety||154
1506961|NCT01616693|3686305|P4|STARTED|Evaluated for Safety||155
1506962|NCT01616693|3686306|P3|STARTED|Evaluated for Safety||155
1506963|NCT01616693|3686307|P2|STARTED|Evaluated for Safety||155
1506964|NCT01616693|3686308|P1|STARTED|Evaluated for Safety||155
1506965|NCT01616576|3686360|P2|NOT COMPLETED|Overall Study||0
1506966|NCT01616576|3686361|P1|NOT COMPLETED|Overall Study||0
1506967|NCT01616576|3686360|P2|COMPLETED|Overall Study||18
1506968|NCT01616576|3686361|P1|COMPLETED|Overall Study||18
1506969|NCT01616576|3686360|P2|STARTED|Overall Study||18
1506970|NCT01616576|3686361|P1|STARTED|Overall Study||18
1506971|NCT01616459|3686374|P4|NOT COMPLETED|Overall Study||8
1506972|NCT01616459|3686375|P3|NOT COMPLETED|Overall Study||10
1506973|NCT01616459|3686376|P2|NOT COMPLETED|Overall Study||17
1506974|NCT01616459|3686377|P1|NOT COMPLETED|Overall Study||4
1506975|NCT01616459|3686374|P4|COMPLETED|Overall Study||233
1506976|NCT01616459|3686375|P3|COMPLETED|Overall Study||220
1506977|NCT01616459|3686376|P2|COMPLETED|Overall Study||223
1506978|NCT01616459|3686377|P1|COMPLETED|Overall Study||236
1506979|NCT01616459|3686374|P4|STARTED|Overall Study||241
1506980|NCT01616459|3686375|P3|STARTED|Overall Study||230
1506981|NCT01616459|3686376|P2|STARTED|Overall Study||240
1506982|NCT01616459|3686377|P1|STARTED|Overall Study||240
1506983|NCT01616173|3686466|P3|NOT COMPLETED|Overall Study||0
1506984|NCT01616173|3686467|P2|NOT COMPLETED|Overall Study||2
1506985|NCT01616173|3686468|P1|NOT COMPLETED|Overall Study||0
1506986|NCT01616173|3686466|P3|COMPLETED|Overall Study||27
1506987|NCT01616173|3686467|P2|COMPLETED|Overall Study||24
1506988|NCT01616173|3686468|P1|COMPLETED|Overall Study||27
1506989|NCT01616173|3686466|P3|STARTED|Overall Study||27
1506990|NCT01616173|3686467|P2|STARTED|Overall Study||26
1506991|NCT01616173|3686468|P1|STARTED|Overall Study||27
1506992|NCT01616160|3686482|P1|NOT COMPLETED|Overall Study||2
1506993|NCT01616160|3686482|P1|COMPLETED|Overall Study||9
1506994|NCT01616160|3686482|P1|STARTED|Overall Study||11
1506995|NCT01616056|3686487|P1|NOT COMPLETED|Overall Study||1
1506996|NCT01616056|3686487|P1|COMPLETED|Overall Study||19
1506997|NCT01616056|3686487|P1|STARTED|Overall Study||20
1506998|NCT01615939|3686501|P2|NOT COMPLETED|Overall Study||0
1506999|NCT01615939|3686502|P1|NOT COMPLETED|Overall Study||5
1507000|NCT01615939|3686501|P2|COMPLETED|Overall Study||4
1507001|NCT01615939|3686502|P1|COMPLETED|Overall Study||8
1507002|NCT01615939|3686501|P2|STARTED|Overall Study||4
1507003|NCT01615939|3686502|P1|STARTED|Overall Study||13
1507004|NCT01615822|3686515|P3|NOT COMPLETED|Period 2||2
1507005|NCT01615822|3686516|P2|NOT COMPLETED|Period 2||1
1507006|NCT01615822|3686517|P1|NOT COMPLETED|Period 2||0
1507007|NCT01615822|3686515|P3|COMPLETED|Period 2||4
1507008|NCT01615822|3686516|P2|COMPLETED|Period 2||8
1507009|NCT01615822|3686517|P1|COMPLETED|Period 2||7
1507010|NCT01615822|3686515|P3|STARTED|Period 2||6
1507011|NCT01615822|3686516|P2|STARTED|Period 2||9
1507012|NCT01615822|3686517|P1|STARTED|Period 2||7
1507013|NCT01615822|3686515|P3|NOT COMPLETED|Period 1||0
1507014|NCT01615822|3686516|P2|NOT COMPLETED|Period 1||2
1507015|NCT01615822|3686517|P1|NOT COMPLETED|Period 1||1
1507016|NCT01615822|3686515|P3|COMPLETED|Period 1||6
1507017|NCT01615822|3686516|P2|COMPLETED|Period 1||9
1507018|NCT01615822|3686517|P1|COMPLETED|Period 1||7
1507019|NCT01615822|3686515|P3|STARTED|Period 1||6
1507020|NCT01615822|3686516|P2|STARTED|Period 1||11
1507021|NCT01615822|3686517|P1|STARTED|Period 1||8
1507022|NCT01615809|3686534|P1|NOT COMPLETED|Overall Study||10
1507023|NCT01615809|3686534|P1|COMPLETED|Overall Study||22
1507024|NCT01615809|3686534|P1|STARTED|Overall Study|basal visit|32
1507025|NCT01615731|3686542|P2|NOT COMPLETED|Overall Study||2
1507026|NCT01615731|3686543|P1|NOT COMPLETED|Overall Study||3
1507027|NCT01615731|3686542|P2|COMPLETED|Overall Study||24
1507028|NCT01615731|3686543|P1|COMPLETED|Overall Study||21
1507029|NCT01615731|3686542|P2|STARTED|Overall Study||26
1507030|NCT01615731|3686543|P1|STARTED|Overall Study||24
1507031|NCT01615484|3686565|P2|NOT COMPLETED|Overall Study||0
1507032|NCT01615484|3686566|P1|NOT COMPLETED|Overall Study||0
1507033|NCT01615484|3686565|P2|COMPLETED|Overall Study||24
1507034|NCT01615484|3686566|P1|COMPLETED|Overall Study||0
1507035|NCT01615484|3686565|P2|STARTED|Overall Study||24
1507036|NCT01615484|3686566|P1|STARTED|Overall Study||0
1507037|NCT01615367|3686584|P2|NOT COMPLETED|Overall Study||6
1507038|NCT01615367|3686585|P1|NOT COMPLETED|Overall Study||5
1507039|NCT01615367|3686584|P2|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
1507040|NCT01615367|3686585|P1|COMPLETED|Overall Study||14
1507041|NCT01615367|3686584|P2|STARTED|Overall Study||19
1507042|NCT01615367|3686585|P1|STARTED|Overall Study||19
1507043|NCT01615328|3686605|P2|NOT COMPLETED|Overall Study||5
1507044|NCT01615328|3686606|P1|NOT COMPLETED|Overall Study||3
1507045|NCT01615328|3686605|P2|COMPLETED|Overall Study||38
1507046|NCT01615328|3686606|P1|COMPLETED|Overall Study||39
1507047|NCT01615328|3686605|P2|STARTED|Overall Study||43
1507048|NCT01615328|3686606|P1|STARTED|Overall Study||42
1507049|NCT01615263|3686618|P2|NOT COMPLETED|Overall Study||2
1507050|NCT01615263|3686619|P1|NOT COMPLETED|Overall Study||0
1507051|NCT01615263|3686618|P2|COMPLETED|Overall Study||18
1507052|NCT01615263|3686619|P1|COMPLETED|Overall Study||20
1507053|NCT01615263|3686618|P2|STARTED|Overall Study||20
1507054|NCT01615263|3686619|P1|STARTED|Overall Study||20
1507055|NCT01615198|3686633|P2|NOT COMPLETED|Overall Study||19
1507056|NCT01615198|3686634|P1|NOT COMPLETED|Overall Study||24
1507057|NCT01615198|3686633|P2|COMPLETED|Overall Study||273
1507058|NCT01615198|3686634|P1|COMPLETED|Overall Study||272
1507059|NCT01615198|3686633|P2|ABPM Dipper Status Subset|Overall Study||84
1507060|NCT01615198|3686634|P1|ABPM Dipper Status Subset|Overall Study||82
1507061|NCT01615198|3686633|P2|Safety Set|Overall Study||292
1507062|NCT01615198|3686634|P1|Safety Set|Overall Study||296
1507063|NCT01615198|3686633|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
1507064|NCT01615198|3686634|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
1507065|NCT01615198|3686633|P2|Full Analysis Set|Overall Study||292
1507066|NCT01615198|3686634|P1|Full Analysis Set|Overall Study||296
1507067|NCT01615198|3686633|P2|STARTED|Overall Study||292
1507068|NCT01615198|3686634|P1|STARTED|Overall Study||296
1507069|NCT01615029|3686667|P5|NOT COMPLETED|Overall Study||32
1507070|NCT01615029|3686668|P4|NOT COMPLETED|Overall Study||3
1507071|NCT01615029|3686669|P3|NOT COMPLETED|Overall Study||4
1507072|NCT01615029|3686670|P2|NOT COMPLETED|Overall Study||3
1507073|NCT01615029|3686671|P1|NOT COMPLETED|Overall Study||3
1507074|NCT01615029|3686667|P5|COMPLETED|Overall Study||0
1507075|NCT01615029|3686668|P4|COMPLETED|Overall Study||0
1507076|NCT01615029|3686669|P3|COMPLETED|Overall Study||0
1507077|NCT01615029|3686670|P2|COMPLETED|Overall Study||0
1507078|NCT01615029|3686671|P1|COMPLETED|Overall Study||0
1507079|NCT01615029|3686667|P5|STARTED|Overall Study||32
1507080|NCT01615029|3686668|P4|STARTED|Overall Study||3
1507081|NCT01615029|3686669|P3|STARTED|Overall Study||4
1507082|NCT01615029|3686670|P2|STARTED|Overall Study||3
1507083|NCT01615029|3686671|P1|STARTED|Overall Study||3
1507084|NCT01614912|3686692|P1|NOT COMPLETED|Overall Study||125
1507085|NCT01614912|3686692|P1|COMPLETED|Overall Study||159
1507086|NCT01614912|3686692|P1|STARTED|Overall Study||284
1507087|NCT01614899|3686706|P3|NOT COMPLETED|Overall Study||42
1507088|NCT01614899|3686707|P2|NOT COMPLETED|Overall Study||39
1507089|NCT01614899|3686708|P1|NOT COMPLETED|Overall Study||44
1507090|NCT01614899|3686706|P3|COMPLETED|Overall Study||110
1507091|NCT01614899|3686707|P2|COMPLETED|Overall Study||116
1507092|NCT01614899|3686708|P1|COMPLETED|Overall Study||106
1507093|NCT01614899|3686706|P3|STARTED|Overall Study||152
1507094|NCT01614899|3686707|P2|STARTED|Overall Study||155
1507095|NCT01614899|3686708|P1|STARTED|Overall Study||150
1507096|NCT01614886|3686739|P2|NOT COMPLETED|Overall Study||26
1507097|NCT01614886|3686740|P1|NOT COMPLETED|Overall Study||20
1507098|NCT01614886|3686739|P2|COMPLETED|Overall Study||83
1507099|NCT01614886|3686740|P1|COMPLETED|Overall Study||87
1507100|NCT01614886|3686739|P2|Full Analysis Set (FAS)|Overall Study||105
1507101|NCT01614886|3686740|P1|Full Analysis Set (FAS)|Overall Study||104
1507102|NCT01614886|3686739|P2|Safety Population (SAF)|Overall Study||108
1507103|NCT01614886|3686740|P1|Safety Population (SAF)|Overall Study||107
1507104|NCT01614886|3686739|P2|STARTED|Overall Study||109
1507105|NCT01614886|3686740|P1|STARTED|Overall Study||107
1507106|NCT01614795|3686758|P4|NOT COMPLETED|Overall Study||12
1507107|NCT01614795|3686759|P3|NOT COMPLETED|Overall Study||11
1507108|NCT01614795|3686760|P2|NOT COMPLETED|Overall Study||12
1507109|NCT01614795|3686761|P1|NOT COMPLETED|Overall Study||11
1507110|NCT01614795|3686758|P4|COMPLETED|Overall Study||0
1507111|NCT01614795|3686759|P3|COMPLETED|Overall Study||0
1507112|NCT01614795|3686760|P2|COMPLETED|Overall Study||0
1507113|NCT01614795|3686761|P1|COMPLETED|Overall Study||0
1507114|NCT01614795|3686758|P4|STARTED|Overall Study||12
1507115|NCT01614795|3686759|P3|STARTED|Overall Study||11
1507116|NCT01614795|3686760|P2|STARTED|Overall Study||12
1507117|NCT01614795|3686761|P1|STARTED|Overall Study||11
1507118|NCT01614769|3686781|P6|NOT COMPLETED|Period 3||0
1507119|NCT01614769|3686782|P5|NOT COMPLETED|Period 3||0
1507120|NCT01614769|3686783|P4|NOT COMPLETED|Period 3||0
1507121|NCT01614769|3686784|P3|NOT COMPLETED|Period 3||1
1507122|NCT01614769|3686785|P2|NOT COMPLETED|Period 3||0
1507123|NCT01614769|3686786|P1|NOT COMPLETED|Period 3||0
1507124|NCT01614769|3686781|P6|COMPLETED|Period 3||1
1507125|NCT01614769|3686782|P5|COMPLETED|Period 3||1
1507126|NCT01614769|3686783|P4|COMPLETED|Period 3||0
1507127|NCT01614769|3686784|P3|COMPLETED|Period 3||1
1507128|NCT01614769|3686785|P2|COMPLETED|Period 3||1
1507129|NCT01614769|3686786|P1|COMPLETED|Period 3||1
1507130|NCT01614769|3686781|P6|STARTED|Period 3||1
1507131|NCT01614769|3686782|P5|STARTED|Period 3||1
1507132|NCT01614769|3686783|P4|STARTED|Period 3||0
1507133|NCT01614769|3686784|P3|STARTED|Period 3||2
1507134|NCT01614769|3686785|P2|STARTED|Period 3||1
1507135|NCT01614769|3686786|P1|STARTED|Period 3||1
1507136|NCT01614769|3686781|P6|NOT COMPLETED|7-Day Washout||0
1507137|NCT01614769|3686782|P5|NOT COMPLETED|7-Day Washout||0
1507138|NCT01614769|3686783|P4|NOT COMPLETED|7-Day Washout||0
1507139|NCT01614769|3686784|P3|NOT COMPLETED|7-Day Washout||0
1507140|NCT01614769|3686785|P2|NOT COMPLETED|7-Day Washout||0
1507141|NCT01614769|3686786|P1|NOT COMPLETED|7-Day Washout||0
1507142|NCT01614769|3686781|P6|COMPLETED|7-Day Washout||1
1507143|NCT01614769|3686782|P5|COMPLETED|7-Day Washout||1
1507144|NCT01614769|3686783|P4|COMPLETED|7-Day Washout||0
1507145|NCT01614769|3686784|P3|COMPLETED|7-Day Washout||2
1507146|NCT01614769|3686785|P2|COMPLETED|7-Day Washout||1
1507147|NCT01614769|3686786|P1|COMPLETED|7-Day Washout||1
1507148|NCT01614769|3686781|P6|STARTED|7-Day Washout||1
1507149|NCT01614769|3686782|P5|STARTED|7-Day Washout||1
1507150|NCT01614769|3686783|P4|STARTED|7-Day Washout||0
1507151|NCT01614769|3686784|P3|STARTED|7-Day Washout||2
1507152|NCT01614769|3686785|P2|STARTED|7-Day Washout||1
1507153|NCT01614769|3686786|P1|STARTED|7-Day Washout||1
1507154|NCT01614769|3686781|P6|NOT COMPLETED|Period 2||0
1507155|NCT01614769|3686782|P5|NOT COMPLETED|Period 2||0
1507156|NCT01614769|3686783|P4|NOT COMPLETED|Period 2||0
1507157|NCT01614769|3686784|P3|NOT COMPLETED|Period 2||0
1507158|NCT01614769|3686785|P2|NOT COMPLETED|Period 2||0
1507159|NCT01614769|3686786|P1|NOT COMPLETED|Period 2||0
1507160|NCT01614769|3686781|P6|COMPLETED|Period 2||1
1507161|NCT01614769|3686782|P5|COMPLETED|Period 2||1
1507162|NCT01614769|3686783|P4|COMPLETED|Period 2||0
1507163|NCT01614769|3686784|P3|COMPLETED|Period 2||2
1507164|NCT01614769|3686785|P2|COMPLETED|Period 2||1
1507165|NCT01614769|3686786|P1|COMPLETED|Period 2||1
1507166|NCT01614769|3686781|P6|STARTED|Period 2||1
1507167|NCT01614769|3686782|P5|STARTED|Period 2||1
1507168|NCT01614769|3686783|P4|STARTED|Period 2||0
1507169|NCT01614769|3686784|P3|STARTED|Period 2||2
1507170|NCT01614769|3686785|P2|STARTED|Period 2||1
1507171|NCT01614769|3686786|P1|STARTED|Period 2||1
1507172|NCT01614769|3686781|P6|NOT COMPLETED|7-Day Washout||0
1507173|NCT01614769|3686782|P5|NOT COMPLETED|7-Day Washout||0
1507174|NCT01614769|3686783|P4|NOT COMPLETED|7-Day Washout||0
1507175|NCT01614769|3686784|P3|NOT COMPLETED|7-Day Washout||0
1507176|NCT01614769|3686785|P2|NOT COMPLETED|7-Day Washout||0
1507177|NCT01614769|3686786|P1|NOT COMPLETED|7-Day Washout||0
1507178|NCT01614769|3686781|P6|COMPLETED|7-Day Washout||1
1507179|NCT01614769|3686782|P5|COMPLETED|7-Day Washout||1
1507180|NCT01614769|3686783|P4|COMPLETED|7-Day Washout||0
1507181|NCT01614769|3686784|P3|COMPLETED|7-Day Washout||2
1507182|NCT01614769|3686785|P2|COMPLETED|7-Day Washout||1
1507183|NCT01614769|3686786|P1|COMPLETED|7-Day Washout||1
1507184|NCT01614769|3686781|P6|STARTED|7-Day Washout||1
1507185|NCT01614769|3686782|P5|STARTED|7-Day Washout||1
1507186|NCT01614769|3686783|P4|STARTED|7-Day Washout||0
1507187|NCT01614769|3686784|P3|STARTED|7-Day Washout||2
1507188|NCT01614769|3686785|P2|STARTED|7-Day Washout||1
1507189|NCT01614769|3686786|P1|STARTED|7-Day Washout||1
1507190|NCT01614769|3686781|P6|NOT COMPLETED|Period 1||1
1507191|NCT01614769|3686782|P5|NOT COMPLETED|Period 1||0
1507192|NCT01614769|3686783|P4|NOT COMPLETED|Period 1||2
1507193|NCT01614769|3686784|P3|NOT COMPLETED|Period 1||0
1507194|NCT01614769|3686785|P2|NOT COMPLETED|Period 1||0
1507195|NCT01614769|3686786|P1|NOT COMPLETED|Period 1||1
1507196|NCT01614769|3686781|P6|COMPLETED|Period 1||1
1507197|NCT01614769|3686782|P5|COMPLETED|Period 1||1
1507198|NCT01614769|3686783|P4|COMPLETED|Period 1||0
1507199|NCT01614769|3686784|P3|COMPLETED|Period 1||2
1507200|NCT01614769|3686785|P2|COMPLETED|Period 1||1
1507201|NCT01614769|3686786|P1|COMPLETED|Period 1||1
1507202|NCT01614769|3686781|P6|STARTED|Period 1||2
1507203|NCT01614769|3686782|P5|STARTED|Period 1||1
1507204|NCT01614769|3686783|P4|STARTED|Period 1||2
1507205|NCT01614769|3686784|P3|STARTED|Period 1||2
1507206|NCT01614769|3686785|P2|STARTED|Period 1||1
1507207|NCT01614769|3686786|P1|STARTED|Period 1||2
1507208|NCT01614613|3686800|P1|NOT COMPLETED|Overall Study||0
1507209|NCT01614613|3686800|P1|COMPLETED|Overall Study||146
1507210|NCT01614613|3686800|P1|STARTED|Overall Study||146
1507211|NCT01614600|3686808|P1|NOT COMPLETED|Overall Study||4
1507212|NCT01614600|3686808|P1|COMPLETED|Overall Study||84
1507213|NCT01614600|3686808|P1|STARTED|Overall Study||88
1507214|NCT01614574|3686812|P1|NOT COMPLETED|Overall Study||0
1507215|NCT01614574|3686812|P1|COMPLETED|Overall Study||6
1507216|NCT01614574|3686812|P1|STARTED|Overall Study||6
1507217|NCT01614509|3686828|P2|NOT COMPLETED|Overall Study||3
1507218|NCT01614509|3686829|P1|NOT COMPLETED|Overall Study||1
1507219|NCT01614509|3686828|P2|COMPLETED|Overall Study||18
1507220|NCT01614509|3686829|P1|COMPLETED|Overall Study||23
1507221|NCT01614509|3686828|P2|STARTED|Overall Study||21
1507222|NCT01614509|3686829|P1|STARTED|Overall Study||24
1507223|NCT01614470|3686839|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1507224|NCT01614470|3686840|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1507225|NCT01614470|3686841|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1507226|NCT01614470|3686839|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
1507227|NCT01614470|3686840|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1507228|NCT01614470|3686841|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
1507229|NCT01614470|3686839|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
1507230|NCT01614470|3686840|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
1507231|NCT01614470|3686841|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
1507232|NCT01614470|3686839|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
1507233|NCT01614470|3686840|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
1507234|NCT01614470|3686841|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
1507235|NCT01614470|3686839|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
1507236|NCT01614470|3686840|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
1507237|NCT01614470|3686841|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
1507238|NCT01614470|3686839|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
1507239|NCT01614470|3686840|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
1507240|NCT01614470|3686841|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
1507241|NCT01614470|3686839|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
1507242|NCT01614470|3686840|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
1507243|NCT01614470|3686841|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
1507244|NCT01614470|3686839|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
1507245|NCT01614470|3686840|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
1507246|NCT01614470|3686841|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
1507247|NCT01614470|3686839|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
1507248|NCT01614470|3686840|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
1507249|NCT01614470|3686841|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
1507250|NCT01614470|3686839|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
1507251|NCT01614470|3686840|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
1507252|NCT01614470|3686841|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
1507253|NCT01614470|3686839|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
1507254|NCT01614470|3686840|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
1507255|NCT01614470|3686841|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
1507256|NCT01614470|3686839|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
1507257|NCT01614470|3686840|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
1507258|NCT01614470|3686841|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
1507259|NCT01614457|3686863|P2|NOT COMPLETED|Overall Study||0
1507260|NCT01614457|3686864|P1|NOT COMPLETED|Overall Study||2
1507261|NCT01614457|3686863|P2|COMPLETED|Overall Study||35
1507262|NCT01614457|3686864|P1|COMPLETED|Overall Study||32
1507263|NCT01614457|3686863|P2|STARTED|Overall Study||35
1507264|NCT01614457|3686864|P1|STARTED|Overall Study||34
1507265|NCT01614392|3686882|P2|NOT COMPLETED|Overall Study||3
1507266|NCT01614392|3686883|P1|NOT COMPLETED|Overall Study||1
1507267|NCT01614392|3686882|P2|COMPLETED|Overall Study||24
1507268|NCT01614392|3686883|P1|COMPLETED|Overall Study||24
1507269|NCT01614392|3686882|P2|STARTED|Overall Study||27
1507270|NCT01614392|3686883|P1|STARTED|Overall Study||25
1507271|NCT01614249|3686891|P2|NOT COMPLETED|Overall Study||23
1507272|NCT01614249|3686892|P1|NOT COMPLETED|Overall Study||11
1507273|NCT01614249|3686891|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
1507274|NCT01614249|3686892|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
1507275|NCT01614249|3686891|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
1507276|NCT01614249|3686892|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
1507367|NCT01613027|3687199|P1|STARTED|Overall Study||135
1507277|NCT01614249|3686891|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
1507278|NCT01614249|3686892|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
1507279|NCT01614249|3686891|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
1507280|NCT01614249|3686892|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
1507281|NCT01614210|3686898|P1|NOT COMPLETED|Overall Study||0
1507282|NCT01614210|3686898|P1|COMPLETED|Overall Study||52
1507283|NCT01614210|3686898|P1|STARTED|Overall Study||52
1507284|NCT01614093|3686906|P1|NOT COMPLETED|Overall Study||1
1507285|NCT01614093|3686906|P1|COMPLETED|Overall Study||16
1507286|NCT01614093|3686906|P1|STARTED|Overall Study||17
1507287|NCT01613768|3686911|P1|NOT COMPLETED|Overall Study||0
1507288|NCT01613768|3686911|P1|COMPLETED|Overall Study||29
1507289|NCT01613768|3686911|P1|STARTED|Overall Study||29
1507290|NCT01613716|3686919|P1|NOT COMPLETED|Overall Study||7
1507291|NCT01613716|3686919|P1|COMPLETED|Overall Study||23
1507292|NCT01613716|3686919|P1|STARTED|Overall Study||30
1507293|NCT01613599|3686924|P1|NOT COMPLETED|Overall Study||25
1507294|NCT01613599|3686924|P1|COMPLETED|Overall Study||72
1507295|NCT01613599|3686924|P1|STARTED|Overall Study||97
1507296|NCT01613417|3686939|P2|NOT COMPLETED|Second Injection||0
1507297|NCT01613417|3686940|P1|NOT COMPLETED|Second Injection||0
1507298|NCT01613417|3686939|P2|COMPLETED|Second Injection||109
1507299|NCT01613417|3686940|P1|COMPLETED|Second Injection||100
1507300|NCT01613417|3686939|P2|STARTED|Second Injection||109
1507301|NCT01613417|3686940|P1|STARTED|Second Injection||100
1507302|NCT01613417|3686939|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
1507303|NCT01613417|3686940|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
1507304|NCT01613417|3686939|P2|COMPLETED|Washout (no Second Injection/MRI)||109
1507305|NCT01613417|3686940|P1|COMPLETED|Washout (no Second Injection/MRI)||100
1507306|NCT01613417|3686939|P2|STARTED|Washout (no Second Injection/MRI)||116
1507307|NCT01613417|3686940|P1|STARTED|Washout (no Second Injection/MRI)||113
1507308|NCT01613417|3686939|P2|NOT COMPLETED|First Injection||0
1507309|NCT01613417|3686940|P1|NOT COMPLETED|First Injection||0
1507310|NCT01613417|3686939|P2|COMPLETED|First Injection||116
1507311|NCT01613417|3686940|P1|COMPLETED|First Injection||113
1507312|NCT01613417|3686939|P2|STARTED|First Injection||116
1507313|NCT01613417|3686940|P1|STARTED|First Injection||113
1507314|NCT01613378|3686977|P1|NOT COMPLETED|Overall Study||39
1507315|NCT01613378|3686977|P1|COMPLETED|Overall Study||161
1507316|NCT01613378|3686977|P1|STARTED|Overall Study||200
1507317|NCT01613339|3686995|P2|NOT COMPLETED|Overall Study||1
1507318|NCT01613339|3686996|P1|NOT COMPLETED|Overall Study||3
1507319|NCT01613339|3686995|P2|COMPLETED|Overall Study||21
1507320|NCT01613339|3686996|P1|COMPLETED|Overall Study||21
1507321|NCT01613339|3686995|P2|STARTED|Overall Study||22
1507322|NCT01613339|3686996|P1|STARTED|Overall Study||24
1507323|NCT01613326|3687007|P2|NOT COMPLETED|Overall Study||14
1507324|NCT01613326|3687008|P1|NOT COMPLETED|Overall Study||13
1507325|NCT01613326|3687007|P2|COMPLETED|Overall Study||316
1507326|NCT01613326|3687008|P1|COMPLETED|Overall Study||314
1507327|NCT01613326|3687007|P2|STARTED|Overall Study||330
1507328|NCT01613326|3687008|P1|STARTED|Overall Study||327
1507329|NCT01613313|3687042|P4|NOT COMPLETED|Overall Study||0
1507330|NCT01613313|3687043|P3|NOT COMPLETED|Overall Study||0
1507331|NCT01613313|3687044|P2|NOT COMPLETED|Overall Study||0
1507332|NCT01613313|3687045|P1|NOT COMPLETED|Overall Study||0
1507333|NCT01613313|3687042|P4|COMPLETED|Overall Study||4
1507334|NCT01613313|3687043|P3|COMPLETED|Overall Study||4
1507335|NCT01613313|3687044|P2|COMPLETED|Overall Study||4
1507336|NCT01613313|3687045|P1|COMPLETED|Overall Study||2
1507337|NCT01613313|3687042|P4|STARTED|Overall Study||4
1507338|NCT01613313|3687043|P3|STARTED|Overall Study||4
1507339|NCT01613313|3687044|P2|STARTED|Overall Study||4
1507340|NCT01613313|3687045|P1|STARTED|Overall Study||2
1507341|NCT01613248|3687065|P6|NOT COMPLETED|Overall Study||38
1507342|NCT01613248|3687066|P5|NOT COMPLETED|Overall Study||35
1507343|NCT01613248|3687067|P4|NOT COMPLETED|Overall Study||38
1507344|NCT01613248|3687068|P3|NOT COMPLETED|Overall Study||33
1507345|NCT01613248|3687069|P2|NOT COMPLETED|Overall Study||34
1507346|NCT01613248|3687070|P1|NOT COMPLETED|Overall Study||29
1507347|NCT01613248|3687065|P6|COMPLETED|Overall Study||102
1507348|NCT01613248|3687066|P5|COMPLETED|Overall Study||104
1507349|NCT01613248|3687067|P4|COMPLETED|Overall Study||101
1507350|NCT01613248|3687068|P3|COMPLETED|Overall Study||106
1507351|NCT01613248|3687069|P2|COMPLETED|Overall Study||104
1507352|NCT01613248|3687070|P1|COMPLETED|Overall Study||110
1507353|NCT01613248|3687065|P6|STARTED|Overall Study||140
1507354|NCT01613248|3687066|P5|STARTED|Overall Study||139
1507355|NCT01613248|3687067|P4|STARTED|Overall Study||139
1507356|NCT01613248|3687068|P3|STARTED|Overall Study||139
1507357|NCT01613248|3687069|P2|STARTED|Overall Study||138
1507358|NCT01613248|3687070|P1|STARTED|Overall Study||139
1507359|NCT01613131|3687170|P2|NOT COMPLETED|Overall Study||5
1507360|NCT01613131|3687171|P1|NOT COMPLETED|Overall Study||3
1507361|NCT01613131|3687170|P2|COMPLETED|Overall Study||13
1507362|NCT01613131|3687171|P1|COMPLETED|Overall Study||17
1507363|NCT01613131|3687170|P2|STARTED|Overall Study||18
1507364|NCT01613131|3687171|P1|STARTED|Overall Study||20
1507365|NCT01613027|3687199|P1|NOT COMPLETED|Overall Study||8
1507366|NCT01613027|3687199|P1|COMPLETED|Overall Study||127
1507368|NCT01613014|3687220|P2|NOT COMPLETED|Overall Study||12
1507369|NCT01613014|3687221|P1|NOT COMPLETED|Overall Study||18
1507370|NCT01613014|3687220|P2|COMPLETED|Overall Study||63
1507371|NCT01613014|3687221|P1|COMPLETED|Overall Study||57
1507372|NCT01613014|3687220|P2|STARTED|Overall Study||75
1507373|NCT01613014|3687221|P1|STARTED|Overall Study||75
1507374|NCT01612884|3687229|P2|NOT COMPLETED|Overall Study||0
1507375|NCT01612884|3687230|P1|NOT COMPLETED|Overall Study||0
1507376|NCT01612884|3687229|P2|COMPLETED|Overall Study||18
1507377|NCT01612884|3687230|P1|COMPLETED|Overall Study||19
1507378|NCT01612884|3687229|P2|STARTED|Overall Study||18
1507379|NCT01612884|3687230|P1|STARTED|Overall Study||19
1507380|NCT01612858|3687242|P2|NOT COMPLETED|Overall Study||1
1507381|NCT01612858|3687243|P1|NOT COMPLETED|Overall Study||5
1507382|NCT01612858|3687242|P2|COMPLETED|Overall Study||3
1507383|NCT01612858|3687243|P1|COMPLETED|Overall Study||11
1507384|NCT01612858|3687242|P2|STARTED|Overall Study||4
1507385|NCT01612858|3687243|P1|STARTED|Overall Study||16
1507386|NCT01612767|3687251|P1|NOT COMPLETED|Overall Study||42
1507387|NCT01612767|3687251|P1|COMPLETED|Overall Study||287
1507388|NCT01612767|3687251|P1|STARTED|Overall Study||329
1507389|NCT01612702|3687307|P2|NOT COMPLETED|Overall Study||11
1507390|NCT01612702|3687308|P1|NOT COMPLETED|Overall Study||11
1507391|NCT01612702|3687307|P2|COMPLETED|Overall Study||134
1507392|NCT01612702|3687308|P1|COMPLETED|Overall Study||135
1507393|NCT01612702|3687307|P2|STARTED|Overall Study||145
1507394|NCT01612702|3687308|P1|STARTED|Overall Study||146
1507395|NCT01612676|3687322|P4|NOT COMPLETED|Overall Study||3
1507396|NCT01612676|3687323|P3|NOT COMPLETED|Overall Study||1
1507397|NCT01612676|3687324|P2|NOT COMPLETED|Overall Study||4
1507398|NCT01612676|3687325|P1|NOT COMPLETED|Overall Study||2
1507399|NCT01612676|3687322|P4|COMPLETED|Overall Study||10
1507400|NCT01612676|3687323|P3|COMPLETED|Overall Study||4
1507401|NCT01612676|3687324|P2|COMPLETED|Overall Study||3
1507402|NCT01612676|3687325|P1|COMPLETED|Overall Study||4
1507403|NCT01612676|3687322|P4|Dosed|Overall Study||13
1507404|NCT01612676|3687323|P3|Dosed|Overall Study||5
1507405|NCT01612676|3687324|P2|Dosed|Overall Study||7
1507406|NCT01612676|3687325|P1|Dosed|Overall Study||5
1507407|NCT01612676|3687322|P4|STARTED|Overall Study||13
1507408|NCT01612676|3687323|P3|STARTED|Overall Study||5
1507409|NCT01612676|3687324|P2|STARTED|Overall Study||7
1507410|NCT01612676|3687325|P1|STARTED|Overall Study||6
1507411|NCT01612546|3687381|P1|NOT COMPLETED|Overall Study||0
1507412|NCT01612546|3687381|P1|COMPLETED|Overall Study||10
1507413|NCT01612546|3687381|P1|STARTED|Overall Study||10
1507414|NCT01612494|3687391|P2|NOT COMPLETED|Overall Study||0
1507415|NCT01612494|3687392|P1|NOT COMPLETED|Overall Study||0
1507416|NCT01612494|3687391|P2|COMPLETED|Overall Study||23
1507417|NCT01612494|3687392|P1|COMPLETED|Overall Study||21
1507418|NCT01612494|3687391|P2|STARTED|Overall Study||23
1507419|NCT01612494|3687392|P1|STARTED|Overall Study||21
1507420|NCT01612351|3687398|P1|NOT COMPLETED|Post-Operative Treatment||0
1507421|NCT01612351|3687398|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
1507422|NCT01612351|3687398|P1|STARTED|Post-Operative Treatment||39
1507423|NCT01612351|3687398|P1|NOT COMPLETED|Transoral Surgery||0
1507424|NCT01612351|3687398|P1|COMPLETED|Transoral Surgery||39
1507425|NCT01612351|3687398|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
1507426|NCT01612351|3687398|P1|NOT COMPLETED|Chemotherapy||0
1507427|NCT01612351|3687398|P1|COMPLETED|Chemotherapy||40
1507428|NCT01612351|3687398|P1|STARTED|Chemotherapy||40
1507429|NCT01612221|3687412|P2|NOT COMPLETED|Overall Study||0
1507430|NCT01612221|3687413|P1|NOT COMPLETED|Overall Study||0
1507431|NCT01612221|3687412|P2|COMPLETED|Overall Study||50
1507432|NCT01612221|3687413|P1|COMPLETED|Overall Study||50
1507433|NCT01612221|3687412|P2|STARTED|Overall Study||50
1507434|NCT01612221|3687413|P1|STARTED|Overall Study||50
1507435|NCT01612156|3687423|P2|NOT COMPLETED|Overall Study||0
1507436|NCT01612156|3687424|P1|NOT COMPLETED|Overall Study||2
1507437|NCT01612156|3687423|P2|COMPLETED|Overall Study||48
1507438|NCT01612156|3687424|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
1507439|NCT01612156|3687423|P2|STARTED|Overall Study||48
1507440|NCT01612156|3687424|P1|STARTED|Overall Study||42
1507441|NCT01612000|3687436|P4|NOT COMPLETED|Overall Study||10
1507442|NCT01612000|3687437|P3|NOT COMPLETED|Overall Study||7
1507443|NCT01612000|3687438|P2|NOT COMPLETED|Overall Study||5
1507444|NCT01612000|3687439|P1|NOT COMPLETED|Overall Study||9
1507445|NCT01612000|3687436|P4|COMPLETED|Overall Study||76
1507446|NCT01612000|3687437|P3|COMPLETED|Overall Study||78
1507447|NCT01612000|3687438|P2|COMPLETED|Overall Study||81
1507448|NCT01612000|3687439|P1|COMPLETED|Overall Study||75
1507449|NCT01612000|3687436|P4|STARTED|Overall Study||86
1507450|NCT01612000|3687437|P3|STARTED|Overall Study||85
1507451|NCT01612000|3687438|P2|STARTED|Overall Study||86
1507452|NCT01612000|3687439|P1|STARTED|Overall Study||84
1507453|NCT01611974|3687464|P3|NOT COMPLETED|Overall Study||16
1507454|NCT01611974|3687465|P2|NOT COMPLETED|Overall Study||15
1507455|NCT01611974|3687466|P1|NOT COMPLETED|Overall Study||15
1507456|NCT01611974|3687464|P3|COMPLETED|Overall Study||24
1507457|NCT01611974|3687465|P2|COMPLETED|Overall Study||25
1507458|NCT01611974|3687466|P1|COMPLETED|Overall Study||25
1507459|NCT01611974|3687464|P3|STARTED|Overall Study||40
1507460|NCT01611974|3687465|P2|STARTED|Overall Study||40
1507461|NCT01611974|3687466|P1|STARTED|Overall Study||40
1507462|NCT01611948|3687503|P2|NOT COMPLETED|Overall Study||12
1507463|NCT01611948|3687504|P1|NOT COMPLETED|Overall Study||14
1507464|NCT01611948|3687503|P2|COMPLETED|Overall Study||26
1507465|NCT01611948|3687504|P1|COMPLETED|Overall Study||18
1507466|NCT01611948|3687503|P2|STARTED|Overall Study||38
1507467|NCT01611948|3687504|P1|STARTED|Overall Study||32
1507468|NCT01611883|3687512|P2|NOT COMPLETED|Overall Study||1
1507469|NCT01611883|3687513|P1|NOT COMPLETED|Overall Study||1
1507470|NCT01611883|3687512|P2|COMPLETED|Overall Study||76
1507471|NCT01611883|3687513|P1|COMPLETED|Overall Study||74
1507472|NCT01611883|3687512|P2|STARTED|Overall Study||77
1507473|NCT01611883|3687513|P1|STARTED|Overall Study||75
1507474|NCT01611857|3687539|P2|NOT COMPLETED|Overall Study||2
1507475|NCT01611857|3687540|P1|NOT COMPLETED|Overall Study||0
1507476|NCT01611857|3687539|P2|COMPLETED|Overall Study||32
1507477|NCT01611857|3687540|P1|COMPLETED|Overall Study||15
1507478|NCT01611857|3687539|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
1507479|NCT01611857|3687540|P1|Tivantinib 360 mg|Overall Study||7
1507480|NCT01611857|3687539|P2|Tivantinib 240 mg|Overall Study||0
1507481|NCT01611857|3687540|P1|Tivantinib 240 mg|Overall Study||3
1507482|NCT01611857|3687539|P2|Tivantinib 120 mg|Overall Study||0
1507483|NCT01611857|3687540|P1|Tivantinib 120 mg|Overall Study||5
1507484|NCT01611857|3687539|P2|STARTED|Overall Study||34
1507485|NCT01611857|3687540|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
1507486|NCT01611792|3687552|P2|NOT COMPLETED|Followup: at 6 Months||13
1507487|NCT01611792|3687553|P1|NOT COMPLETED|Followup: at 6 Months||6
1507488|NCT01611792|3687552|P2|COMPLETED|Followup: at 6 Months||7
1507489|NCT01611792|3687553|P1|COMPLETED|Followup: at 6 Months||11
1507490|NCT01611792|3687552|P2|STARTED|Followup: at 6 Months||20
1507491|NCT01611792|3687553|P1|STARTED|Followup: at 6 Months||17
1507492|NCT01611792|3687552|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
1507493|NCT01611792|3687553|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
1507494|NCT01611792|3687552|P2|COMPLETED|Follow-up: at 11 Weeks||20
1507495|NCT01611792|3687553|P1|COMPLETED|Follow-up: at 11 Weeks||17
1507496|NCT01611792|3687552|P2|STARTED|Follow-up: at 11 Weeks||20
1507497|NCT01611792|3687553|P1|STARTED|Follow-up: at 11 Weeks||17
1507498|NCT01611792|3687552|P2|NOT COMPLETED|Initial Period: Time 0||9
1507499|NCT01611792|3687553|P1|NOT COMPLETED|Initial Period: Time 0||12
1507500|NCT01611792|3687552|P2|COMPLETED|Initial Period: Time 0||20
1507501|NCT01611792|3687553|P1|COMPLETED|Initial Period: Time 0||17
1507502|NCT01611792|3687552|P2|STARTED|Initial Period: Time 0||29
1507503|NCT01611792|3687553|P1|STARTED|Initial Period: Time 0||29
1507504|NCT01611779|3687569|P1|NOT COMPLETED|Overall Study||0
1507505|NCT01611779|3687569|P1|COMPLETED|Overall Study||5
1507506|NCT01611779|3687569|P1|STARTED|Overall Study||5
1507507|NCT01611662|3687578|P1|NOT COMPLETED|Overall Study||1
1507508|NCT01611662|3687578|P1|COMPLETED|Overall Study||31
1507509|NCT01611662|3687578|P1|STARTED|Overall Study||32
1507510|NCT01611571|3687585|P3|NOT COMPLETED|Overall Study||1
1507511|NCT01611571|3687586|P2|NOT COMPLETED|Overall Study||0
1507512|NCT01611571|3687587|P1|NOT COMPLETED|Overall Study||1
1507513|NCT01611571|3687585|P3|COMPLETED|Overall Study||9
1507514|NCT01611571|3687586|P2|COMPLETED|Overall Study||10
1507515|NCT01611571|3687587|P1|COMPLETED|Overall Study||10
1507516|NCT01611571|3687585|P3|STARTED|Overall Study||10
1507517|NCT01611571|3687586|P2|STARTED|Overall Study||10
1507518|NCT01611571|3687587|P1|STARTED|Overall Study||11
1507519|NCT01611558|3687607|P1|NOT COMPLETED|Maintenance Phase||2
1507520|NCT01611558|3687607|P1|COMPLETED|Maintenance Phase||0
1507521|NCT01611558|3687607|P1|STARTED|Maintenance Phase||2
1507522|NCT01611558|3687607|P1|NOT COMPLETED|Induction Phase||38
1507523|NCT01611558|3687607|P1|COMPLETED|Induction Phase||2
1507524|NCT01611558|3687607|P1|STARTED|Induction Phase||40
1507525|NCT01611259|3687613|P1|NOT COMPLETED|Overall Study||14
1507526|NCT01611259|3687613|P1|COMPLETED|Overall Study||34
1507527|NCT01611259|3687613|P1|STARTED|Overall Study||48
1507528|NCT01611194|3687619|P2|NOT COMPLETED|Overall Study||3
1507529|NCT01611194|3687620|P1|NOT COMPLETED|Overall Study||0
1507530|NCT01611194|3687619|P2|COMPLETED|Overall Study||32
1507531|NCT01611194|3687620|P1|COMPLETED|Overall Study||36
1507532|NCT01611194|3687619|P2|STARTED|Overall Study||35
1507533|NCT01611194|3687620|P1|STARTED|Overall Study||36
1507534|NCT01610791|3687656|P1|NOT COMPLETED|Overall Study||21
1507535|NCT01610791|3687656|P1|COMPLETED|Overall Study||100
1507536|NCT01610791|3687656|P1|STARTED|Overall Study||121
1507537|NCT01610752|3687680|P3|NOT COMPLETED|Overall Study||4
1507538|NCT01610752|3687681|P2|NOT COMPLETED|Overall Study||0
1507539|NCT01610752|3687682|P1|NOT COMPLETED|Overall Study||0
1507540|NCT01610752|3687680|P3|COMPLETED|Overall Study||13
1507541|NCT01610752|3687681|P2|COMPLETED|Overall Study||19
1507542|NCT01610752|3687682|P1|COMPLETED|Overall Study||18
1507543|NCT01610752|3687680|P3|STARTED|Overall Study||17
1507544|NCT01610752|3687681|P2|STARTED|Overall Study||19
1507545|NCT01610752|3687682|P1|STARTED|Overall Study||18
1507546|NCT01610713|3687704|P2|NOT COMPLETED|Overall Study||1
1507547|NCT01610713|3687705|P1|NOT COMPLETED|Overall Study||6
1507548|NCT01610713|3687704|P2|COMPLETED|Overall Study||76
1507549|NCT01610713|3687705|P1|COMPLETED|Overall Study||71
1507550|NCT01610713|3687704|P2|STARTED|Overall Study||77
1507551|NCT01610713|3687705|P1|STARTED|Overall Study||77
1507552|NCT01610700|3687763|P2|NOT COMPLETED|Overall Study||3
1507553|NCT01610700|3687764|P1|NOT COMPLETED|Overall Study||3
1507554|NCT01610700|3687763|P2|COMPLETED|Overall Study||77
1507555|NCT01610700|3687764|P1|COMPLETED|Overall Study||77
1507556|NCT01610700|3687763|P2|STARTED|Overall Study||80
1507557|NCT01610700|3687764|P1|STARTED|Overall Study||80
1507558|NCT01610687|3687818|P1|NOT COMPLETED|Overall Study||67
1507559|NCT01610687|3687818|P1|COMPLETED|Overall Study||70
1507560|NCT01610687|3687818|P1|STARTED|Overall Study||137
1507561|NCT01610596|3687831|P2|NOT COMPLETED|Overall Study||1
1507562|NCT01610596|3687832|P1|NOT COMPLETED|Overall Study||0
1507563|NCT01610596|3687831|P2|COMPLETED|Overall Study||35
1507564|NCT01610596|3687832|P1|COMPLETED|Overall Study||36
1507565|NCT01610596|3687831|P2|STARTED|Overall Study||36
1507566|NCT01610596|3687832|P1|STARTED|Overall Study||36
1507567|NCT01610570|3687848|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1507568|NCT01610570|3687849|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1507569|NCT01610570|3687850|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1507570|NCT01610570|3687851|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1507571|NCT01610570|3687848|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1507572|NCT01610570|3687849|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1507573|NCT01610570|3687850|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1507574|NCT01610570|3687851|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
1507575|NCT01610570|3687848|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
1507576|NCT01610570|3687849|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
1507577|NCT01610570|3687850|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
1507578|NCT01610570|3687851|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
1507579|NCT01610570|3687848|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1507580|NCT01610570|3687849|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1507581|NCT01610570|3687850|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1507582|NCT01610570|3687851|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1507583|NCT01610570|3687848|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
1507584|NCT01610570|3687849|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1507585|NCT01610570|3687850|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1507586|NCT01610570|3687851|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
1507587|NCT01610570|3687848|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
1507588|NCT01610570|3687849|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
1507589|NCT01610570|3687850|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
1507590|NCT01610570|3687851|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
1507591|NCT01610570|3687848|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1507592|NCT01610570|3687849|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1507593|NCT01610570|3687850|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1507594|NCT01610570|3687851|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1507595|NCT01610570|3687848|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1507596|NCT01610570|3687849|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1507597|NCT01610570|3687850|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
1507598|NCT01610570|3687851|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
1507599|NCT01610570|3687848|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
1507600|NCT01610570|3687849|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
1507601|NCT01610570|3687850|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
1507602|NCT01610570|3687851|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
1507603|NCT01610557|3687890|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
1507604|NCT01610557|3687891|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
1507605|NCT01610557|3687892|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
1507606|NCT01610557|3687893|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
1507607|NCT01610557|3687894|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
1507608|NCT01610557|3687890|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
1507609|NCT01610557|3687891|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1507610|NCT01610557|3687892|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1507611|NCT01610557|3687893|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1507612|NCT01610557|3687894|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1507613|NCT01610557|3687890|P5|STARTED|Post-36-Week Extension Phase||55
1507614|NCT01610557|3687891|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1507615|NCT01610557|3687892|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1507616|NCT01610557|3687893|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1507617|NCT01610557|3687894|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
1507618|NCT01610557|3687890|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
1507619|NCT01610557|3687891|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
1507620|NCT01610557|3687892|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
1507621|NCT01610557|3687893|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
1507622|NCT01610557|3687894|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
1507623|NCT01610557|3687890|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
1507624|NCT01610557|3687891|P4|COMPLETED|36-Week Randomized Crossover Phase||13
1507625|NCT01610557|3687892|P3|COMPLETED|36-Week Randomized Crossover Phase||14
1507626|NCT01610557|3687893|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
1507627|NCT01610557|3687894|P1|COMPLETED|36-Week Randomized Crossover Phase||16
1507628|NCT01610557|3687890|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
1507629|NCT01610557|3687891|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
1507630|NCT01610557|3687892|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
1507631|NCT01610557|3687893|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
1507632|NCT01610557|3687894|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
1507633|NCT01610492|3687907|P1|NOT COMPLETED|Overall Study||6
1507634|NCT01610492|3687907|P1|COMPLETED|Overall Study||8
1507635|NCT01610492|3687907|P1|STARTED|Overall Study||14
1507636|NCT01610453|3687951|P1|NOT COMPLETED|Overall Study||0
1507637|NCT01610453|3687951|P1|COMPLETED|Overall Study||150
1507638|NCT01610453|3687951|P1|STARTED|Overall Study||150
1507639|NCT01610414|3687958|P2|NOT COMPLETED|After Month 25||53
1507640|NCT01610414|3687959|P1|NOT COMPLETED|After Month 25||48
1507641|NCT01610414|3687958|P2|COMPLETED|After Month 25||871
1507642|NCT01610414|3687959|P1|COMPLETED|After Month 25||874
1507643|NCT01610414|3687958|P2|STARTED|After Month 25||924
1507644|NCT01610414|3687959|P1|STARTED|After Month 25||922
1507645|NCT01610414|3687958|P2|NOT COMPLETED|Month 13 - Month 25||70
1507646|NCT01610414|3687959|P1|NOT COMPLETED|Month 13 - Month 25||65
1507647|NCT01610414|3687958|P2|COMPLETED|Month 13 - Month 25||854
1507648|NCT01610414|3687959|P1|COMPLETED|Month 13 - Month 25||857
1507649|NCT01610414|3687958|P2|STARTED|Month 13 - Month 25||924
1507650|NCT01610414|3687959|P1|STARTED|Month 13 - Month 25||922
1507651|NCT01610414|3687958|P2|NOT COMPLETED|Study Start - Month 13||129
1507652|NCT01610414|3687959|P1|NOT COMPLETED|Study Start - Month 13||115
1507653|NCT01610414|3687958|P2|COMPLETED|Study Start - Month 13||795
1507654|NCT01610414|3687959|P1|COMPLETED|Study Start - Month 13||807
1507655|NCT01610414|3687958|P2|STARTED|Study Start - Month 13||924
1507656|NCT01610414|3687959|P1|STARTED|Study Start - Month 13||922
1507657|NCT01610297|3687988|P1|NOT COMPLETED|Overall Study||1
1507658|NCT01610297|3687988|P1|COMPLETED|Overall Study||26
1507659|NCT01610297|3687988|P1|STARTED|Overall Study||27
1507660|NCT01610271|3687998|P2|NOT COMPLETED|Overall Study||4
1507661|NCT01610271|3687999|P1|NOT COMPLETED|Overall Study||2
1507662|NCT01610271|3687998|P2|COMPLETED|Overall Study||146
1507663|NCT01610271|3687999|P1|COMPLETED|Overall Study||148
1507664|NCT01610271|3687998|P2|STARTED|Overall Study||150
1507665|NCT01610271|3687999|P1|STARTED|Overall Study||150
1507666|NCT01610167|3688014|P3|NOT COMPLETED|Overall Study||2
1507667|NCT01610167|3688015|P2|NOT COMPLETED|Overall Study||0
1507668|NCT01610167|3688016|P1|NOT COMPLETED|Overall Study||0
1507669|NCT01610167|3688014|P3|COMPLETED|Overall Study||48
1507670|NCT01610167|3688015|P2|COMPLETED|Overall Study||49
1507671|NCT01610167|3688016|P1|COMPLETED|Overall Study||52
1507672|NCT01610167|3688014|P3|STARTED|Overall Study||50
1507673|NCT01610167|3688015|P2|STARTED|Overall Study||49
1507674|NCT01610167|3688016|P1|STARTED|Overall Study||52
1507675|NCT01610154|3688036|P1|NOT COMPLETED|Overall Study||1
1507676|NCT01610154|3688036|P1|COMPLETED|Overall Study||84
1507677|NCT01610154|3688036|P1|STARTED|Overall Study||85
1507678|NCT01610076|3688053|P2|NOT COMPLETED|Overall Study||5
1507679|NCT01610076|3688054|P1|NOT COMPLETED|Overall Study||3
1507680|NCT01610076|3688053|P2|COMPLETED|Overall Study||100
1507681|NCT01610076|3688054|P1|COMPLETED|Overall Study||100
1507682|NCT01610076|3688053|P2|STARTED|Overall Study||105
1507683|NCT01610076|3688054|P1|STARTED|Overall Study||103
1507684|NCT01610063|3688065|P2|NOT COMPLETED|Overall Study||20
1507685|NCT01610063|3688066|P1|NOT COMPLETED|Overall Study||42
1507686|NCT01610063|3688065|P2|COMPLETED|Overall Study||93
1507687|NCT01610063|3688066|P1|COMPLETED|Overall Study||72
1507688|NCT01610063|3688065|P2|Completed 8-week|Overall Study||93
1507689|NCT01610063|3688066|P1|Completed 8-week|Overall Study||72
1507690|NCT01610063|3688065|P2|Completed 4-week|Overall Study||98
1507691|NCT01610063|3688066|P1|Completed 4-week|Overall Study||86
1507692|NCT01610063|3688065|P2|Completed 2-week|Overall Study||105
1507693|NCT01610063|3688066|P1|Completed 2-week|Overall Study||97
1507694|NCT01610063|3688065|P2|Baseline|Overall Study||113
1507695|NCT01610063|3688066|P1|Baseline|Overall Study||114
1507696|NCT01610063|3688065|P2|STARTED|Overall Study||113
1507697|NCT01610063|3688066|P1|STARTED|Overall Study||114
1507698|NCT01610037|3688089|P3|NOT COMPLETED|Treatment and Follow up Period||26
1507699|NCT01610037|3688090|P2|NOT COMPLETED|Treatment and Follow up Period||28
1507700|NCT01610037|3688091|P1|NOT COMPLETED|Treatment and Follow up Period||25
1507701|NCT01610037|3688089|P3|COMPLETED|Treatment and Follow up Period||378
1507702|NCT01610037|3688090|P2|COMPLETED|Treatment and Follow up Period||377
1507703|NCT01610037|3688091|P1|COMPLETED|Treatment and Follow up Period||382
1507704|NCT01610037|3688089|P3|STARTED|Treatment and Follow up Period||404
1507705|NCT01610037|3688090|P2|STARTED|Treatment and Follow up Period||405
1507706|NCT01610037|3688091|P1|STARTED|Treatment and Follow up Period||407
1507707|NCT01610037|3688089|P3|NOT COMPLETED|All Patients||84
1507708|NCT01610037|3688090|P2|NOT COMPLETED|All Patients||51
1507709|NCT01610037|3688091|P1|NOT COMPLETED|All Patients||59
1507710|NCT01610037|3688089|P3|COMPLETED|All Patients||320
1507711|NCT01610037|3688090|P2|COMPLETED|All Patients||354
1507712|NCT01610037|3688091|P1|COMPLETED|All Patients||348
1507713|NCT01610037|3688089|P3|Full Analysis Set (FAS)|All Patients||403
1507714|NCT01610037|3688090|P2|Full Analysis Set (FAS)|All Patients||405
1507715|NCT01610037|3688091|P1|Full Analysis Set (FAS)|All Patients||407
1507716|NCT01610037|3688089|P3|Randomized Set (RAN)|All Patients||404
1507717|NCT01610037|3688090|P2|Randomized Set (RAN)|All Patients||405
1507718|NCT01610037|3688091|P1|Randomized Set (RAN)|All Patients||407
1507719|NCT01610037|3688089|P3|STARTED|All Patients||404
1507720|NCT01610037|3688090|P2|STARTED|All Patients||405
1507721|NCT01610037|3688091|P1|STARTED|All Patients||407
1507722|NCT01610011|3688134|P2|NOT COMPLETED|Overall Study||0
1507723|NCT01610011|3688135|P1|NOT COMPLETED|Overall Study||10
1507724|NCT01610011|3688134|P2|COMPLETED|Overall Study||2
1507725|NCT01610011|3688135|P1|COMPLETED|Overall Study||9
1507726|NCT01610011|3688134|P2|STARTED|Overall Study||2
1507727|NCT01610011|3688135|P1|STARTED|Overall Study||19
1507728|NCT01609933|3688141|P1|NOT COMPLETED|Overall Study||4
1507729|NCT01609933|3688141|P1|COMPLETED|Overall Study||28
1507730|NCT01609933|3688141|P1|STARTED|Overall Study||32
1507731|NCT01609790|3688151|P3|NOT COMPLETED|Overall Study||8
1507732|NCT01609790|3688152|P2|NOT COMPLETED|Overall Study||7
1507733|NCT01609790|3688153|P1|NOT COMPLETED|Overall Study||1
1507734|NCT01609790|3688151|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
1507735|NCT01609790|3688152|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
1507736|NCT01609790|3688153|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
1507737|NCT01609790|3688151|P3|STARTED|Overall Study||65
1507738|NCT01609790|3688152|P2|STARTED|Overall Study||65
1507739|NCT01609790|3688153|P1|STARTED|Overall Study||7
1507740|NCT01609582|3688172|P2|NOT COMPLETED|Overall Study||1604
1507741|NCT01609582|3688173|P1|NOT COMPLETED|Overall Study||1603
1507742|NCT01609582|3688172|P2|COMPLETED|Overall Study||0
1507743|NCT01609582|3688173|P1|COMPLETED|Overall Study||0
1507744|NCT01609582|3688172|P2|Treated|Overall Study||1601
1507745|NCT01609582|3688173|P1|Treated|Overall Study||1603
1507746|NCT01609582|3688172|P2|STARTED|Overall Study||1604
1507747|NCT01609582|3688173|P1|STARTED|Overall Study||1603
1507748|NCT01609543|3688181|P1|NOT COMPLETED|Overall Study||42
1507749|NCT01609543|3688181|P1|COMPLETED|Overall Study||20
1507750|NCT01609543|3688181|P1|STARTED|Overall Study||62
1507751|NCT01609478|3688190|P3|NOT COMPLETED|Overall Study||9
1507752|NCT01609478|3688191|P2|NOT COMPLETED|Overall Study||2
1507753|NCT01609478|3688192|P1|NOT COMPLETED|Overall Study||7
1507754|NCT01609478|3688190|P3|COMPLETED|Overall Study||107
1507755|NCT01609478|3688191|P2|COMPLETED|Overall Study||106
1507756|NCT01609478|3688192|P1|COMPLETED|Overall Study||104
1507757|NCT01609478|3688190|P3|Full Analysis Set (FAS)|Overall Study||115
1507758|NCT01609478|3688191|P2|Full Analysis Set (FAS)|Overall Study||108
1507759|NCT01609478|3688192|P1|Full Analysis Set (FAS)|Overall Study||110
1507760|NCT01609478|3688190|P3|STARTED|Overall Study||116
1507761|NCT01609478|3688191|P2|STARTED|Overall Study||108
1507762|NCT01609478|3688192|P1|STARTED|Overall Study||111
1507763|NCT01609348|3688258|P2|NOT COMPLETED|Overall Study||0
1507764|NCT01609348|3688259|P1|NOT COMPLETED|Overall Study||0
1507765|NCT01609348|3688258|P2|COMPLETED|Overall Study||2
1507766|NCT01609348|3688259|P1|COMPLETED|Overall Study||3
1507767|NCT01609348|3688258|P2|STARTED|Overall Study||2
1507768|NCT01609348|3688259|P1|STARTED|Overall Study||3
1507769|NCT01609257|3688267|P2|NOT COMPLETED|Overall Study||8
1507770|NCT01609257|3688268|P1|NOT COMPLETED|Overall Study||6
1507771|NCT01609257|3688267|P2|COMPLETED|Overall Study||57
1507772|NCT01609257|3688268|P1|COMPLETED|Overall Study||61
1507773|NCT01609257|3688267|P2|Received Challenge Product|Overall Study||53
1507774|NCT01609257|3688268|P1|Received Challenge Product|Overall Study||56
1507775|NCT01609257|3688267|P2|Received 2 Doses|Overall Study||64
1507776|NCT01609257|3688268|P1|Received 2 Doses|Overall Study||63
1507777|NCT01609257|3688267|P2|STARTED|Overall Study||65
1507778|NCT01609257|3688268|P1|STARTED|Overall Study||67
1507779|NCT01609062|3688340|P2|NOT COMPLETED|Extension Phase||10
1507780|NCT01609062|3688341|P1|NOT COMPLETED|Extension Phase||15
1507781|NCT01609062|3688340|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
1507782|NCT01609062|3688341|P1|COMPLETED|Extension Phase||0
1507783|NCT01609062|3688340|P2|STARTED|Extension Phase||10
1507784|NCT01609062|3688341|P1|STARTED|Extension Phase||15
1507785|NCT01609062|3688340|P2|NOT COMPLETED|Primary Phase||0
1507786|NCT01609062|3688341|P1|NOT COMPLETED|Primary Phase||0
1507787|NCT01609062|3688340|P2|COMPLETED|Primary Phase||10
1507788|NCT01609062|3688341|P1|COMPLETED|Primary Phase||15
1507789|NCT01609062|3688340|P2|STARTED|Primary Phase||10
1507790|NCT01609062|3688341|P1|STARTED|Primary Phase||15
1507791|NCT01609023|3688384|P1|NOT COMPLETED|Overall Study||33
1507792|NCT01609023|3688384|P1|COMPLETED|Overall Study||34
1507793|NCT01609023|3688384|P1|STARTED|Overall Study||67
1507794|NCT01609010|3688396|P2|NOT COMPLETED|Overall Study||37
1507795|NCT01609010|3688397|P1|NOT COMPLETED|Overall Study||43
1507796|NCT01609010|3688396|P2|COMPLETED|Overall Study||120
1507797|NCT01609010|3688397|P1|COMPLETED|Overall Study||113
1507798|NCT01609010|3688396|P2|Entering Cycle 2|Overall Study||124
1507799|NCT01609010|3688397|P1|Entering Cycle 2|Overall Study||120
1507800|NCT01609010|3688396|P2|STARTED|Overall Study||157
1507801|NCT01609010|3688397|P1|STARTED|Overall Study||156
1507802|NCT01608971|3688423|P2|NOT COMPLETED|Overall Study||0
1507803|NCT01608971|3688424|P1|NOT COMPLETED|Overall Study||0
1507804|NCT01608971|3688423|P2|COMPLETED|Overall Study||15
1507805|NCT01608971|3688424|P1|COMPLETED|Overall Study||15
1507806|NCT01608971|3688423|P2|STARTED|Overall Study||15
1507807|NCT01608971|3688424|P1|STARTED|Overall Study||15
1507808|NCT01608815|3688439|P3|NOT COMPLETED|Overall Study||0
1507809|NCT01608815|3688440|P2|NOT COMPLETED|Overall Study||0
1507810|NCT01608815|3688441|P1|NOT COMPLETED|Overall Study||0
1507811|NCT01608815|3688439|P3|COMPLETED|Overall Study||5
1507812|NCT01608815|3688440|P2|COMPLETED|Overall Study||7
1507813|NCT01608815|3688441|P1|COMPLETED|Overall Study||188
1507814|NCT01608815|3688439|P3|STARTED|Overall Study||5
1507815|NCT01608815|3688440|P2|STARTED|Overall Study||7
1507816|NCT01608815|3688441|P1|STARTED|Overall Study||188
1507817|NCT01608724|3688458|P1|NOT COMPLETED|Overall Study||243
1507818|NCT01608724|3688458|P1|COMPLETED|Overall Study||1180
1507819|NCT01608724|3688458|P1|Treated|Overall Study||1361
1507820|NCT01608724|3688458|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
1507821|NCT01608672|3688465|P1|NOT COMPLETED|Overall Study||0
1507822|NCT01608672|3688465|P1|COMPLETED|Overall Study||207
1507823|NCT01608672|3688465|P1|STARTED|Overall Study||207
1507824|NCT01608659|3688471|P1|NOT COMPLETED|Overall Study||16
1507825|NCT01608659|3688471|P1|COMPLETED|Overall Study||94
1507826|NCT01608659|3688471|P1|STARTED|Overall Study||110
1507827|NCT01608490|3688479|P2|NOT COMPLETED|Overall Study||0
1507828|NCT01608490|3688480|P1|NOT COMPLETED|Overall Study||0
1507829|NCT01608490|3688479|P2|COMPLETED|Overall Study||157
1507830|NCT01608490|3688480|P1|COMPLETED|Overall Study||158
1507831|NCT01608490|3688479|P2|STARTED|Overall Study||157
1507832|NCT01608490|3688480|P1|STARTED|Overall Study||158
1507833|NCT01608321|3688490|P2|NOT COMPLETED|Overall Study||0
1507834|NCT01608321|3688491|P1|NOT COMPLETED|Overall Study||1
1507835|NCT01608321|3688490|P2|COMPLETED|Overall Study||4
1507836|NCT01608321|3688491|P1|COMPLETED|Overall Study||12
1507837|NCT01608321|3688490|P2|STARTED|Overall Study||4
1507838|NCT01608321|3688491|P1|STARTED|Overall Study||13
1507839|NCT01608308|3688499|P2|NOT COMPLETED|Overall Study||2
1507840|NCT01608308|3688500|P1|NOT COMPLETED|Overall Study||0
1507841|NCT01608308|3688499|P2|COMPLETED|Overall Study||29
1507842|NCT01608308|3688500|P1|COMPLETED|Overall Study||31
1507843|NCT01608308|3688499|P2|STARTED|Overall Study||31
1507844|NCT01608308|3688500|P1|STARTED|Overall Study||31
1507845|NCT01608295|3688524|P2|NOT COMPLETED|Overall Study||5
1507846|NCT01608295|3688525|P1|NOT COMPLETED|Overall Study||6
1507847|NCT01608295|3688524|P2|COMPLETED|Overall Study||25
1507848|NCT01608295|3688525|P1|COMPLETED|Overall Study||20
1507849|NCT01608295|3688524|P2|STARTED|Overall Study||30
1507850|NCT01608295|3688525|P1|STARTED|Overall Study||26
1507851|NCT01608100|3688536|P1|NOT COMPLETED|Overall Study||0
1507852|NCT01608100|3688536|P1|COMPLETED|Overall Study||1101
1507853|NCT01608100|3688536|P1|STARTED|Overall Study||1101
1507854|NCT01607853|3688560|P1|NOT COMPLETED|Overall Study||0
1507855|NCT01607853|3688560|P1|COMPLETED|Overall Study||24
1507856|NCT01607853|3688560|P1|STARTED|Overall Study||24
1507857|NCT01607658|3688671|P4|NOT COMPLETED|Overall Study||11
1507858|NCT01607658|3688672|P3|NOT COMPLETED|Overall Study||11
1507859|NCT01607658|3688673|P2|NOT COMPLETED|Overall Study||11
1507860|NCT01607658|3688674|P1|NOT COMPLETED|Overall Study||9
1507861|NCT01607658|3688671|P4|COMPLETED|Overall Study||52
1507862|NCT01607658|3688672|P3|COMPLETED|Overall Study||47
1507863|NCT01607658|3688673|P2|COMPLETED|Overall Study||56
1507864|NCT01607658|3688674|P1|COMPLETED|Overall Study||56
1507865|NCT01607658|3688671|P4|STARTED|Overall Study||63
1507866|NCT01607658|3688672|P3|STARTED|Overall Study||58
1507867|NCT01607658|3688673|P2|STARTED|Overall Study||67
1507868|NCT01607658|3688674|P1|STARTED|Overall Study||65
1507869|NCT01607645|3688698|P2|NOT COMPLETED|Overall Study||0
1507870|NCT01607645|3688699|P1|NOT COMPLETED|Overall Study||0
1507871|NCT01607645|3688698|P2|COMPLETED|Overall Study||3
1507872|NCT01607645|3688699|P1|COMPLETED|Overall Study||4
1507873|NCT01607645|3688698|P2|STARTED|Overall Study||3
1507874|NCT01607645|3688699|P1|STARTED|Overall Study||4
1507875|NCT01607593|3688729|P1|NOT COMPLETED|Overall Study||93
1507876|NCT01607593|3688729|P1|COMPLETED|Overall Study||29
1507877|NCT01607593|3688729|P1|STARTED|Overall Study||122
1507878|NCT01607554|3688735|P1|NOT COMPLETED|Overall Study||2
1507879|NCT01607554|3688735|P1|COMPLETED|Overall Study||0
1507880|NCT01607554|3688735|P1|STARTED|Overall Study||2
1507881|NCT01607476|3688748|P3|NOT COMPLETED|Overall Study||3
1507882|NCT01607476|3688749|P2|NOT COMPLETED|Overall Study||0
1507883|NCT01607476|3688750|P1|NOT COMPLETED|Overall Study||1
1507884|NCT01607476|3688748|P3|COMPLETED|Overall Study||30
1507885|NCT01607476|3688749|P2|COMPLETED|Overall Study||30
1507886|NCT01607476|3688750|P1|COMPLETED|Overall Study||24
1507887|NCT01607476|3688748|P3|STARTED|Overall Study||33
1507888|NCT01607476|3688749|P2|STARTED|Overall Study||30
1507889|NCT01607476|3688750|P1|STARTED|Overall Study||25
1507890|NCT01607450|3688768|P7|NOT COMPLETED|Overall Study||0
1507891|NCT01607450|3688769|P6|NOT COMPLETED|Overall Study||0
1507892|NCT01607450|3688770|P5|NOT COMPLETED|Overall Study||0
1507893|NCT01607450|3688771|P4|NOT COMPLETED|Overall Study||0
1507894|NCT01607450|3688772|P3|NOT COMPLETED|Overall Study||0
1507895|NCT01607450|3688773|P2|NOT COMPLETED|Overall Study||0
1507896|NCT01607450|3688774|P1|NOT COMPLETED|Overall Study||0
1507897|NCT01607450|3688768|P7|COMPLETED|Overall Study||0
1507898|NCT01607450|3688769|P6|COMPLETED|Overall Study||0
1507899|NCT01607450|3688770|P5|COMPLETED|Overall Study||1
1507900|NCT01607450|3688771|P4|COMPLETED|Overall Study||11
1507901|NCT01607450|3688772|P3|COMPLETED|Overall Study||7
1507902|NCT01607450|3688773|P2|COMPLETED|Overall Study||8
1507903|NCT01607450|3688774|P1|COMPLETED|Overall Study||6
1507904|NCT01607450|3688768|P7|STARTED|Overall Study||0
1507905|NCT01607450|3688769|P6|STARTED|Overall Study||0
1507906|NCT01607450|3688770|P5|STARTED|Overall Study||1
1507907|NCT01607450|3688771|P4|STARTED|Overall Study||11
1507908|NCT01607450|3688772|P3|STARTED|Overall Study||7
1507909|NCT01607450|3688773|P2|STARTED|Overall Study||8
1507910|NCT01607450|3688774|P1|STARTED|Overall Study||6
1507911|NCT01607411|3688818|P4|NOT COMPLETED|Period IV||0
1507912|NCT01607411|3688819|P3|NOT COMPLETED|Period IV||0
1507913|NCT01607411|3688820|P2|NOT COMPLETED|Period IV||0
1507914|NCT01607411|3688821|P1|NOT COMPLETED|Period IV||0
1507915|NCT01607411|3688818|P4|COMPLETED|Period IV||14
1507916|NCT01607411|3688819|P3|COMPLETED|Period IV||14
1507917|NCT01607411|3688820|P2|COMPLETED|Period IV||14
1507918|NCT01607411|3688821|P1|COMPLETED|Period IV||13
1507919|NCT01607411|3688818|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
1507920|NCT01607411|3688819|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
1507921|NCT01607411|3688820|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
1507922|NCT01607411|3688821|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
1507923|NCT01607411|3688818|P4|NOT COMPLETED|Period III||0
1507924|NCT01607411|3688819|P3|NOT COMPLETED|Period III||0
1507925|NCT01607411|3688820|P2|NOT COMPLETED|Period III||0
1507926|NCT01607411|3688821|P1|NOT COMPLETED|Period III||0
1507927|NCT01607411|3688818|P4|COMPLETED|Period III||13
1507928|NCT01607411|3688819|P3|COMPLETED|Period III||14
1507929|NCT01607411|3688820|P2|COMPLETED|Period III||14
1507930|NCT01607411|3688821|P1|COMPLETED|Period III||14
1507931|NCT01607411|3688818|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
1507932|NCT01607411|3688819|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
1507933|NCT01607411|3688820|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
1507934|NCT01607411|3688821|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
1507935|NCT01607411|3688818|P4|NOT COMPLETED|Period II||0
1507936|NCT01607411|3688819|P3|NOT COMPLETED|Period II||0
1507937|NCT01607411|3688820|P2|NOT COMPLETED|Period II||0
1507938|NCT01607411|3688821|P1|NOT COMPLETED|Period II||0
1507939|NCT01607411|3688818|P4|COMPLETED|Period II||14
1507940|NCT01607411|3688819|P3|COMPLETED|Period II||13
1507941|NCT01607411|3688820|P2|COMPLETED|Period II||14
1507942|NCT01607411|3688821|P1|COMPLETED|Period II||14
1507943|NCT01607411|3688818|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
1507944|NCT01607411|3688819|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
1507945|NCT01607411|3688820|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
1507946|NCT01607411|3688821|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
1507947|NCT01607411|3688818|P4|NOT COMPLETED|Period I||0
1507948|NCT01607411|3688819|P3|NOT COMPLETED|Period I||0
1507949|NCT01607411|3688820|P2|NOT COMPLETED|Period I||0
1507950|NCT01607411|3688821|P1|NOT COMPLETED|Period I||0
1507951|NCT01607411|3688818|P4|COMPLETED|Period I||14
1507952|NCT01607411|3688819|P3|COMPLETED|Period I||14
1507953|NCT01607411|3688820|P2|COMPLETED|Period I||13
1507954|NCT01607411|3688821|P1|COMPLETED|Period I||14
1507955|NCT01607411|3688818|P4|STARTED|Period I||14
1507956|NCT01607411|3688819|P3|STARTED|Period I||14
1507957|NCT01607411|3688820|P2|STARTED|Period I||13
1507958|NCT01607411|3688821|P1|STARTED|Period I||14
1507959|NCT01607398|3688844|P2|NOT COMPLETED|Overall Study||2
1507960|NCT01607398|3688845|P1|NOT COMPLETED|Overall Study||2
1507961|NCT01607398|3688844|P2|COMPLETED|Overall Study||26
1507962|NCT01607398|3688845|P1|COMPLETED|Overall Study||26
1507963|NCT01607398|3688844|P2|STARTED|Overall Study||28
1507964|NCT01607398|3688845|P1|STARTED|Overall Study||28
1507965|NCT01607346|3688889|P1|NOT COMPLETED|Overall Study||3
1507966|NCT01607346|3688889|P1|COMPLETED|Overall Study||7
1507967|NCT01607346|3688889|P1|STARTED|Overall Study||10
1507968|NCT01607320|3688905|P2|NOT COMPLETED|Overall Study||0
1507969|NCT01607320|3688906|P1|NOT COMPLETED|Overall Study||0
1507970|NCT01607320|3688905|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
1507971|NCT01607320|3688906|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
1507972|NCT01607320|3688905|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
1507973|NCT01607320|3688906|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
1507974|NCT01607203|3688913|P2|NOT COMPLETED|Overall Study||0
1507975|NCT01607203|3688914|P1|NOT COMPLETED|Overall Study||0
1507976|NCT01607203|3688913|P2|COMPLETED|Overall Study||61
1507977|NCT01607203|3688914|P1|COMPLETED|Overall Study||59
1507978|NCT01607203|3688913|P2|STARTED|Overall Study||61
1507979|NCT01607203|3688914|P1|STARTED|Overall Study||59
1507980|NCT01607112|3688926|P2|NOT COMPLETED|Overall Study||0
1507981|NCT01607112|3688927|P1|NOT COMPLETED|Overall Study||0
1507982|NCT01607112|3688926|P2|COMPLETED|Overall Study||59
1507983|NCT01607112|3688927|P1|COMPLETED|Overall Study||60
1507984|NCT01607112|3688926|P2|STARTED|Overall Study||59
1507985|NCT01607112|3688927|P1|STARTED|Overall Study||60
1507986|NCT01606852|3688963|P2|NOT COMPLETED|Overall Study||0
1507987|NCT01606852|3688964|P1|NOT COMPLETED|Overall Study||0
1507988|NCT01606852|3688963|P2|COMPLETED|Overall Study||8
1507989|NCT01606852|3688964|P1|COMPLETED|Overall Study||7
1507990|NCT01606852|3688963|P2|STARTED|Overall Study||8
1507991|NCT01606852|3688964|P1|STARTED|Overall Study||7
1507992|NCT01606800|3688974|P2|NOT COMPLETED|Overall Study||2
1507993|NCT01606800|3688975|P1|NOT COMPLETED|Overall Study||5
1507994|NCT01606800|3688974|P2|COMPLETED|Overall Study||21
1507995|NCT01606800|3688975|P1|COMPLETED|Overall Study||17
1507996|NCT01606800|3688974|P2|Treated|Overall Study||23
1507997|NCT01606800|3688975|P1|Treated|Overall Study||22
1507998|NCT01606800|3688974|P2|STARTED|Overall Study||23
1507999|NCT01606800|3688975|P1|STARTED|Overall Study||22
1508000|NCT01606787|3688983|P2|NOT COMPLETED|Overall Study||7
1508001|NCT01606787|3688984|P1|NOT COMPLETED|Overall Study||4
1508002|NCT01606787|3688983|P2|COMPLETED|Overall Study||98
1508003|NCT01606787|3688984|P1|COMPLETED|Overall Study||101
1508004|NCT01606787|3688983|P2|STARTED|Overall Study||105
1508005|NCT01606787|3688984|P1|STARTED|Overall Study||105
1508006|NCT01606761|3688995|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
1508007|NCT01606761|3688996|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
1508008|NCT01606761|3688997|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
1508009|NCT01606761|3688998|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
1508010|NCT01606761|3688999|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
1508011|NCT01606761|3688995|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
1508012|NCT01606761|3688996|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
1508013|NCT01606761|3688997|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
1508014|NCT01606761|3688998|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
1508015|NCT01606761|3688999|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
1508016|NCT01606761|3688995|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
1508017|NCT01606761|3688996|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
1508018|NCT01606761|3688997|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
1508019|NCT01606761|3688998|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
1508020|NCT01606761|3688999|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
1508021|NCT01606761|3688995|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
1508022|NCT01606761|3688996|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
1508023|NCT01606761|3688997|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
1508024|NCT01606761|3688998|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
1508025|NCT01606761|3688999|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
1508026|NCT01606761|3688995|P5|NOT COMPLETED|Week 24 to Week 52||20
1508027|NCT01606761|3688996|P4|NOT COMPLETED|Week 24 to Week 52||17
1508028|NCT01606761|3688997|P3|NOT COMPLETED|Week 24 to Week 52||33
1508029|NCT01606761|3688998|P2|NOT COMPLETED|Week 24 to Week 52||33
1508030|NCT01606761|3688999|P1|NOT COMPLETED|Week 24 to Week 52||0
1508031|NCT01606761|3688995|P5|COMPLETED|Week 24 to Week 52||106
1508032|NCT01606761|3688996|P4|COMPLETED|Week 24 to Week 52||109
1508033|NCT01606761|3688997|P3|COMPLETED|Week 24 to Week 52||212
1508034|NCT01606761|3688998|P2|COMPLETED|Week 24 to Week 52||204
1508035|NCT01606761|3688999|P1|COMPLETED|Week 24 to Week 52||0
1508036|NCT01606761|3688995|P5|Treated|Week 24 to Week 52||126
1508037|NCT01606761|3688996|P4|Treated|Week 24 to Week 52||124
1508038|NCT01606761|3688997|P3|Treated|Week 24 to Week 52||245
1508039|NCT01606761|3688998|P2|Treated|Week 24 to Week 52||237
1508040|NCT01606761|3688999|P1|Treated|Week 24 to Week 52||0
1508041|NCT01606761|3688995|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
1508042|NCT01606761|3688996|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
1508043|NCT01606761|3688997|P3|STARTED|Week 24 to Week 52||245
1508044|NCT01606761|3688998|P2|STARTED|Week 24 to Week 52||237
1508045|NCT01606761|3688999|P1|STARTED|Week 24 to Week 52||0
1508046|NCT01606761|3688995|P5|NOT COMPLETED|Prior to Week 24||0
1508047|NCT01606761|3688996|P4|NOT COMPLETED|Prior to Week 24||0
1508048|NCT01606761|3688997|P3|NOT COMPLETED|Prior to Week 24||47
1508049|NCT01606761|3688998|P2|NOT COMPLETED|Prior to Week 24||55
1508050|NCT01606761|3688999|P1|NOT COMPLETED|Prior to Week 24||42
1508051|NCT01606761|3688995|P5|COMPLETED|Prior to Week 24||0
1508052|NCT01606761|3688996|P4|COMPLETED|Prior to Week 24||0
1508053|NCT01606761|3688997|P3|COMPLETED|Prior to Week 24||245
1508054|NCT01606761|3688998|P2|COMPLETED|Prior to Week 24||237
1508055|NCT01606761|3688999|P1|COMPLETED|Prior to Week 24||252
1508056|NCT01606761|3688995|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
1508057|NCT01606761|3688996|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
1508058|NCT01606761|3688997|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
1508059|NCT01606761|3688998|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
1508060|NCT01606761|3688999|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
1508061|NCT01606761|3688995|P5|STARTED|Prior to Week 24||0
1508062|NCT01606761|3688996|P4|STARTED|Prior to Week 24||0
1508063|NCT01606761|3688997|P3|STARTED|Prior to Week 24||292
1508064|NCT01606761|3688998|P2|STARTED|Prior to Week 24||292
1508065|NCT01606761|3688999|P1|STARTED|Prior to Week 24||294
1508066|NCT01606748|3689025|P2|NOT COMPLETED|Overall Study||0
1508067|NCT01606748|3689026|P1|NOT COMPLETED|Overall Study||3
1508068|NCT01606748|3689025|P2|COMPLETED|Overall Study||17
1508069|NCT01606748|3689026|P1|COMPLETED|Overall Study||15
1508070|NCT01606748|3689025|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
1508071|NCT01606748|3689026|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
1508072|NCT01606748|3689025|P2|STARTED|Overall Study||17
1508073|NCT01606748|3689026|P1|STARTED|Overall Study||18
1508074|NCT01606735|3689057|P3|NOT COMPLETED|Overall Study||0
1508075|NCT01606735|3689058|P2|NOT COMPLETED|Overall Study||0
1508076|NCT01606735|3689059|P1|NOT COMPLETED|Overall Study||0
1508077|NCT01606735|3689057|P3|COMPLETED|Overall Study||58
1508078|NCT01606735|3689058|P2|COMPLETED|Overall Study||56
1508079|NCT01606735|3689059|P1|COMPLETED|Overall Study||58
1508080|NCT01606735|3689057|P3|STARTED|Overall Study||58
1508081|NCT01606735|3689058|P2|STARTED|Overall Study||56
1508082|NCT01606735|3689059|P1|STARTED|Overall Study||58
1508083|NCT01606709|3689069|P2|NOT COMPLETED|Overall Study||0
1508084|NCT01606709|3689070|P1|NOT COMPLETED|Overall Study||0
1508085|NCT01606709|3689069|P2|COMPLETED|Overall Study||3
1508086|NCT01606709|3689070|P1|COMPLETED|Overall Study||4
1508087|NCT01606709|3689069|P2|STARTED|Overall Study||3
1508088|NCT01606709|3689070|P1|STARTED|Overall Study||4
1508089|NCT01606670|3689078|P1|NOT COMPLETED|Overall Study||16
1508090|NCT01606670|3689078|P1|COMPLETED|Overall Study||77
1508091|NCT01606670|3689078|P1|Full Analysis Set|Overall Study||70
1508092|NCT01606670|3689078|P1|Safety Set|Overall Study||93
1508093|NCT01606670|3689078|P1|STARTED|Overall Study||93
1508094|NCT01606319|3689088|P2|NOT COMPLETED|Overall Study||40
1508095|NCT01606319|3689089|P1|NOT COMPLETED|Overall Study||34
1508096|NCT01606319|3689088|P2|COMPLETED|Overall Study||110
1508097|NCT01606319|3689089|P1|COMPLETED|Overall Study||116
1508098|NCT01606319|3689088|P2|STARTED|Overall Study||150
1508099|NCT01606319|3689089|P1|STARTED|Overall Study||150
1508100|NCT01606306|3689107|P6|NOT COMPLETED|Overall Study||11
1508101|NCT01606306|3689108|P5|NOT COMPLETED|Overall Study||11
1508102|NCT01606306|3689109|P4|NOT COMPLETED|Overall Study||13
1508103|NCT01606306|3689110|P3|NOT COMPLETED|Overall Study||14
1508104|NCT01606306|3689111|P2|NOT COMPLETED|Overall Study||10
1508105|NCT01606306|3689112|P1|NOT COMPLETED|Overall Study||15
1508106|NCT01606306|3689107|P6|COMPLETED|Overall Study||36
1508107|NCT01606306|3689108|P5|COMPLETED|Overall Study||41
1508108|NCT01606306|3689109|P4|COMPLETED|Overall Study||38
1508109|NCT01606306|3689110|P3|COMPLETED|Overall Study||37
1508110|NCT01606306|3689111|P2|COMPLETED|Overall Study||39
1508111|NCT01606306|3689112|P1|COMPLETED|Overall Study||35
1508112|NCT01606306|3689107|P6|Completed Third Treatment Period|Overall Study||36
1508113|NCT01606306|3689108|P5|Completed Third Treatment Period|Overall Study||41
1508114|NCT01606306|3689109|P4|Completed Third Treatment Period|Overall Study||38
1508115|NCT01606306|3689110|P3|Completed Third Treatment Period|Overall Study||37
1508116|NCT01606306|3689111|P2|Completed Third Treatment Period|Overall Study||39
1508117|NCT01606306|3689112|P1|Completed Third Treatment Period|Overall Study||35
1508118|NCT01606306|3689107|P6|Completed Second Treatment Period|Overall Study||41
1508119|NCT01606306|3689108|P5|Completed Second Treatment Period|Overall Study||46
1508120|NCT01606306|3689109|P4|Completed Second Treatment Period|Overall Study||44
1508121|NCT01606306|3689110|P3|Completed Second Treatment Period|Overall Study||43
1508122|NCT01606306|3689111|P2|Completed Second Treatment Period|Overall Study||38
1508123|NCT01606306|3689112|P1|Completed Second Treatment Period|Overall Study||41
1508124|NCT01606306|3689107|P6|Completed First Treatment Period|Overall Study||44
1508125|NCT01606306|3689108|P5|Completed First Treatment Period|Overall Study||47
1508126|NCT01606306|3689109|P4|Completed First Treatment Period|Overall Study||45
1508127|NCT01606306|3689110|P3|Completed First Treatment Period|Overall Study||47
1508128|NCT01606306|3689111|P2|Completed First Treatment Period|Overall Study||47
1508129|NCT01606306|3689112|P1|Completed First Treatment Period|Overall Study||43
1508130|NCT01606306|3689107|P6|STARTED|Overall Study||47
1508131|NCT01606306|3689108|P5|STARTED|Overall Study||52
1508132|NCT01606306|3689109|P4|STARTED|Overall Study||51
1508133|NCT01606306|3689110|P3|STARTED|Overall Study||51
1508134|NCT01606306|3689111|P2|STARTED|Overall Study||49
1508135|NCT01606306|3689112|P1|STARTED|Overall Study||50
1508136|NCT01606254|3689122|P4|NOT COMPLETED|Overall Study||3
1508137|NCT01606254|3689123|P3|NOT COMPLETED|Overall Study||0
1508138|NCT01606254|3689124|P2|NOT COMPLETED|Overall Study||4
1508139|NCT01606254|3689125|P1|NOT COMPLETED|Overall Study||2
1508140|NCT01606254|3689122|P4|COMPLETED|Overall Study||11
1508141|NCT01606254|3689123|P3|COMPLETED|Overall Study||14
1508142|NCT01606254|3689124|P2|COMPLETED|Overall Study||10
1508143|NCT01606254|3689125|P1|COMPLETED|Overall Study||12
1508144|NCT01606254|3689122|P4|STARTED|Overall Study||14
1508145|NCT01606254|3689123|P3|STARTED|Overall Study||14
1508146|NCT01606254|3689124|P2|STARTED|Overall Study||14
1508147|NCT01606254|3689125|P1|STARTED|Overall Study||14
1508148|NCT01606228|3689207|P1|NOT COMPLETED|Overall Study||29
1508149|NCT01606228|3689207|P1|COMPLETED|Overall Study||159
1508150|NCT01606228|3689207|P1|STARTED|Overall Study||188
1508151|NCT01606202|3689224|P2|NOT COMPLETED|Overall Study||3
1508152|NCT01606202|3689225|P1|NOT COMPLETED|Overall Study||7
1508153|NCT01606202|3689224|P2|COMPLETED|Overall Study||57
1508154|NCT01606202|3689225|P1|COMPLETED|Overall Study||49
1508155|NCT01606202|3689224|P2|STARTED|Overall Study||60
1508156|NCT01606202|3689225|P1|STARTED|Overall Study||56
1508157|NCT01606189|3689257|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
1508158|NCT01606189|3689258|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1508159|NCT01606189|3689259|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1508160|NCT01606189|3689260|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1508161|NCT01606189|3689261|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1508162|NCT01606189|3689262|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
1508163|NCT01606189|3689257|P6|COMPLETED|Third Intenvention (14-20 Days)||6
1508164|NCT01606189|3689258|P5|COMPLETED|Third Intenvention (14-20 Days)||8
1508165|NCT01606189|3689259|P4|COMPLETED|Third Intenvention (14-20 Days)||8
1508166|NCT01606189|3689260|P3|COMPLETED|Third Intenvention (14-20 Days)||8
1508167|NCT01606189|3689261|P2|COMPLETED|Third Intenvention (14-20 Days)||8
1508168|NCT01606189|3689262|P1|COMPLETED|Third Intenvention (14-20 Days)||8
1508169|NCT01606189|3689257|P6|STARTED|Third Intenvention (14-20 Days)||7
1508170|NCT01606189|3689258|P5|STARTED|Third Intenvention (14-20 Days)||8
1508171|NCT01606189|3689259|P4|STARTED|Third Intenvention (14-20 Days)||8
1508172|NCT01606189|3689260|P3|STARTED|Third Intenvention (14-20 Days)||8
1508173|NCT01606189|3689261|P2|STARTED|Third Intenvention (14-20 Days)||8
1508174|NCT01606189|3689262|P1|STARTED|Third Intenvention (14-20 Days)||8
1508175|NCT01606189|3689257|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
1508176|NCT01606189|3689258|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1508177|NCT01606189|3689259|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1508178|NCT01606189|3689260|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1508179|NCT01606189|3689261|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1508180|NCT01606189|3689262|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
1508181|NCT01606189|3689257|P6|COMPLETED|Second Intenvention (14-20 Days)||7
1508182|NCT01606189|3689258|P5|COMPLETED|Second Intenvention (14-20 Days)||8
1508183|NCT01606189|3689259|P4|COMPLETED|Second Intenvention (14-20 Days)||8
1508184|NCT01606189|3689260|P3|COMPLETED|Second Intenvention (14-20 Days)||8
1508185|NCT01606189|3689261|P2|COMPLETED|Second Intenvention (14-20 Days)||8
1508186|NCT01606189|3689262|P1|COMPLETED|Second Intenvention (14-20 Days)||8
1508187|NCT01606189|3689257|P6|STARTED|Second Intenvention (14-20 Days)||8
1508188|NCT01606189|3689258|P5|STARTED|Second Intenvention (14-20 Days)||8
1508189|NCT01606189|3689259|P4|STARTED|Second Intenvention (14-20 Days)||8
1508190|NCT01606189|3689260|P3|STARTED|Second Intenvention (14-20 Days)||8
1508191|NCT01606189|3689261|P2|STARTED|Second Intenvention (14-20 Days)||8
1508192|NCT01606189|3689262|P1|STARTED|Second Intenvention (14-20 Days)||8
1508193|NCT01606189|3689257|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
1508194|NCT01606189|3689258|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
1508195|NCT01606189|3689259|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
1508196|NCT01606189|3689260|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
1508197|NCT01606189|3689261|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
1508198|NCT01606189|3689262|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
1508199|NCT01606189|3689257|P6|COMPLETED|First Intenvention (14-20 Days)||8
1508200|NCT01606189|3689258|P5|COMPLETED|First Intenvention (14-20 Days)||8
1508201|NCT01606189|3689259|P4|COMPLETED|First Intenvention (14-20 Days)||8
1508202|NCT01606189|3689260|P3|COMPLETED|First Intenvention (14-20 Days)||8
1508203|NCT01606189|3689261|P2|COMPLETED|First Intenvention (14-20 Days)||8
1508204|NCT01606189|3689262|P1|COMPLETED|First Intenvention (14-20 Days)||8
1508205|NCT01606189|3689257|P6|STARTED|First Intenvention (14-20 Days)||8
1508206|NCT01606189|3689258|P5|STARTED|First Intenvention (14-20 Days)||8
1508207|NCT01606189|3689259|P4|STARTED|First Intenvention (14-20 Days)||8
1508208|NCT01606189|3689260|P3|STARTED|First Intenvention (14-20 Days)||8
1508209|NCT01606189|3689261|P2|STARTED|First Intenvention (14-20 Days)||8
1508210|NCT01606189|3689262|P1|STARTED|First Intenvention (14-20 Days)||8
1508211|NCT01606176|3689296|P2|NOT COMPLETED|Overall Study||3
1508212|NCT01606176|3689297|P1|NOT COMPLETED|Overall Study||4
1508213|NCT01606176|3689296|P2|COMPLETED|Overall Study||31
1508214|NCT01606176|3689297|P1|COMPLETED|Overall Study||32
1508215|NCT01606176|3689296|P2|STARTED|Overall Study||34
1508216|NCT01606176|3689297|P1|STARTED|Overall Study||36
1508217|NCT01606150|3689333|P2|NOT COMPLETED|Overall Study||0
1508218|NCT01606150|3689334|P1|NOT COMPLETED|Overall Study||0
1508219|NCT01606150|3689333|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
1508220|NCT01606150|3689334|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
1508221|NCT01606150|3689333|P2|STARTED|Overall Study||0
1508222|NCT01606150|3689334|P1|STARTED|Overall Study||0
1508223|NCT01606137|3689342|P1|NOT COMPLETED|Overall Study||262
1508224|NCT01606137|3689342|P1|COMPLETED|Overall Study||245
1508225|NCT01606137|3689342|P1|STARTED|Overall Study||507
1508226|NCT01606124|3689364|P2|NOT COMPLETED|Overall Study||0
1508227|NCT01606124|3689365|P1|NOT COMPLETED|Overall Study||0
1508228|NCT01606124|3689364|P2|COMPLETED|Overall Study||20
1508229|NCT01606124|3689365|P1|COMPLETED|Overall Study||19
1508230|NCT01606124|3689364|P2|STARTED|Overall Study||20
1508231|NCT01606124|3689365|P1|STARTED|Overall Study||19
1508232|NCT01606007|3689376|P3|NOT COMPLETED|Overall Study||10
1508233|NCT01606007|3689377|P2|NOT COMPLETED|Overall Study||19
1508234|NCT01606007|3689378|P1|NOT COMPLETED|Overall Study||15
1508235|NCT01606007|3689376|P3|COMPLETED|Overall Study||169
1508236|NCT01606007|3689377|P2|COMPLETED|Overall Study||160
1508237|NCT01606007|3689378|P1|COMPLETED|Overall Study||161
1508238|NCT01606007|3689376|P3|STARTED|Overall Study||179
1508239|NCT01606007|3689377|P2|STARTED|Overall Study||179
1508240|NCT01606007|3689378|P1|STARTED|Overall Study||176
1508241|NCT01605942|3689400|P2|NOT COMPLETED|Overall Study||0
1508242|NCT01605942|3689401|P1|NOT COMPLETED|Overall Study||0
1508243|NCT01605942|3689400|P2|COMPLETED|Overall Study||2
1508244|NCT01605942|3689401|P1|COMPLETED|Overall Study||6
1508245|NCT01605942|3689400|P2|STARTED|Overall Study||2
1508246|NCT01605942|3689401|P1|STARTED|Overall Study||6
1508247|NCT01605916|3689413|P5|NOT COMPLETED|Overall Study||6
1508248|NCT01605916|3689414|P4|NOT COMPLETED|Overall Study||6
1508249|NCT01605916|3689415|P3|NOT COMPLETED|Overall Study||3
1508250|NCT01605916|3689416|P2|NOT COMPLETED|Overall Study||4
1508251|NCT01605916|3689417|P1|NOT COMPLETED|Overall Study||4
1508252|NCT01605916|3689413|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
1508253|NCT01605916|3689414|P4|COMPLETED|Overall Study||0
1508254|NCT01605916|3689415|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
1508255|NCT01605916|3689416|P2|COMPLETED|Overall Study||0
1508256|NCT01605916|3689417|P1|COMPLETED|Overall Study||0
1508257|NCT01605916|3689413|P5|STARTED|Overall Study||7
1508258|NCT01605916|3689414|P4|STARTED|Overall Study||6
1508259|NCT01605916|3689415|P3|STARTED|Overall Study||4
1508260|NCT01605916|3689416|P2|STARTED|Overall Study||4
1508261|NCT01605916|3689417|P1|STARTED|Overall Study||4
1508262|NCT01605903|3689492|P2|NOT COMPLETED|Overall Study||0
1508263|NCT01605903|3689493|P1|NOT COMPLETED|Overall Study||0
1508264|NCT01605903|3689492|P2|COMPLETED|Overall Study||343
1508265|NCT01605903|3689493|P1|COMPLETED|Overall Study||345
1508266|NCT01605903|3689492|P2|STARTED|Overall Study||343
1508267|NCT01605903|3689493|P1|STARTED|Overall Study||345
1508268|NCT01605890|3689499|P1|NOT COMPLETED|Overall Study||2
1508269|NCT01605890|3689499|P1|COMPLETED|Overall Study||28
1508270|NCT01605890|3689499|P1|STARTED|Overall Study||30
1508271|NCT01605877|3689514|P1|NOT COMPLETED|Overall Study||1
1508272|NCT01605877|3689514|P1|COMPLETED|Overall Study||63
1508273|NCT01605877|3689514|P1|STARTED|Overall Study||64
1508274|NCT01605825|3689578|P2|NOT COMPLETED|Overall Study||3
1508275|NCT01605825|3689579|P1|NOT COMPLETED|Overall Study||10
1508276|NCT01605825|3689578|P2|COMPLETED|Overall Study||25
1508277|NCT01605825|3689579|P1|COMPLETED|Overall Study||45
1508278|NCT01605825|3689578|P2|STARTED|Overall Study||28
1508279|NCT01605825|3689579|P1|STARTED|Overall Study||55
1508280|NCT01605799|3689587|P2|NOT COMPLETED|Overall Study||1
1508281|NCT01605799|3689588|P1|NOT COMPLETED|Overall Study||2
1508282|NCT01605799|3689587|P2|COMPLETED|Overall Study||15
1508283|NCT01605799|3689588|P1|COMPLETED|Overall Study||15
1508284|NCT01605799|3689587|P2|STARTED|Overall Study||16
1508285|NCT01605799|3689588|P1|STARTED|Overall Study||17
1508286|NCT01605669|3689596|P1|NOT COMPLETED|Overall Study||0
1508287|NCT01605669|3689596|P1|COMPLETED|Overall Study||50
1508288|NCT01605669|3689596|P1|STARTED|Overall Study||50
1508289|NCT01605617|3689603|P2|NOT COMPLETED|Second Intervention||0
1508290|NCT01605617|3689604|P1|NOT COMPLETED|Second Intervention||0
1508291|NCT01605617|3689603|P2|COMPLETED|Second Intervention||0
1508292|NCT01605617|3689604|P1|COMPLETED|Second Intervention||0
1508293|NCT01605617|3689603|P2|STARTED|Second Intervention||0
1508294|NCT01605617|3689604|P1|STARTED|Second Intervention||0
1508295|NCT01605617|3689603|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
1508296|NCT01605617|3689604|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
1508297|NCT01605617|3689603|P2|COMPLETED|Washout Period of 4 Weeks||0
1508298|NCT01605617|3689604|P1|COMPLETED|Washout Period of 4 Weeks||0
1508299|NCT01605617|3689603|P2|STARTED|Washout Period of 4 Weeks||1
1508300|NCT01605617|3689604|P1|STARTED|Washout Period of 4 Weeks||2
1508301|NCT01605617|3689603|P2|NOT COMPLETED|First Intervention||1
1508302|NCT01605617|3689604|P1|NOT COMPLETED|First Intervention||0
1508303|NCT01605617|3689603|P2|COMPLETED|First Intervention||1
1508304|NCT01605617|3689604|P1|COMPLETED|First Intervention||2
1508305|NCT01605617|3689603|P2|STARTED|First Intervention||2
1508306|NCT01605617|3689604|P1|STARTED|First Intervention||2
1508307|NCT01605552|3689624|P2|NOT COMPLETED|Overall Study||2
1508308|NCT01605552|3689625|P1|NOT COMPLETED|Overall Study||6
1508309|NCT01605552|3689624|P2|COMPLETED|Overall Study||14
1508310|NCT01605552|3689625|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
1508311|NCT01605552|3689624|P2|STARTED|Overall Study||16
1508312|NCT01605552|3689625|P1|STARTED|Overall Study||13
1508313|NCT01605539|3689639|P3|NOT COMPLETED|Overall Study||0
1508314|NCT01605539|3689640|P2|NOT COMPLETED|Overall Study||1
1508315|NCT01605539|3689641|P1|NOT COMPLETED|Overall Study||0
1508316|NCT01605539|3689639|P3|COMPLETED|Overall Study||4
1508317|NCT01605539|3689640|P2|COMPLETED|Overall Study||2
1508318|NCT01605539|3689641|P1|COMPLETED|Overall Study||3
1508319|NCT01605539|3689639|P3|STARTED|Overall Study||4
1508320|NCT01605539|3689640|P2|STARTED|Overall Study||3
1508321|NCT01605539|3689641|P1|STARTED|Overall Study||3
1508322|NCT01605461|3689663|P1|NOT COMPLETED|Overall Study||4
1508323|NCT01605461|3689663|P1|COMPLETED|Overall Study||8
1508324|NCT01605461|3689663|P1|STARTED|Overall Study||12
1508325|NCT01605435|3689672|P2|NOT COMPLETED|Overall Study||0
1508326|NCT01605435|3689673|P1|NOT COMPLETED|Overall Study||0
1508327|NCT01605435|3689672|P2|COMPLETED|Overall Study||3
1508328|NCT01605435|3689673|P1|COMPLETED|Overall Study||2
1508329|NCT01605435|3689672|P2|STARTED|Overall Study||3
1508330|NCT01605435|3689673|P1|STARTED|Overall Study||2
1508331|NCT01605370|3689722|P2|NOT COMPLETED|Overall Study||0
1508332|NCT01605370|3689723|P1|NOT COMPLETED|Overall Study||1
1508333|NCT01605370|3689722|P2|COMPLETED|Overall Study||0
1508334|NCT01605370|3689723|P1|COMPLETED|Overall Study||0
1508335|NCT01605370|3689722|P2|STARTED|Overall Study||0
1508336|NCT01605370|3689723|P1|STARTED|Overall Study||1
1508337|NCT01605292|3689731|P2|NOT COMPLETED|Overall Study||0
1508338|NCT01605292|3689732|P1|NOT COMPLETED|Overall Study||0
1508339|NCT01605292|3689731|P2|COMPLETED|Overall Study||347
1508340|NCT01605292|3689732|P1|COMPLETED|Overall Study||351
1508341|NCT01605292|3689731|P2|STARTED|Overall Study||347
1508342|NCT01605292|3689732|P1|STARTED|Overall Study||351
1508343|NCT01605227|3689758|P2|NOT COMPLETED|Overall Study||329
1508344|NCT01605227|3689759|P1|NOT COMPLETED|Overall Study||621
1508345|NCT01605227|3689758|P2|COMPLETED|Overall Study||17
1508346|NCT01605227|3689759|P1|COMPLETED|Overall Study||61
1508347|NCT01605227|3689758|P2|STARTED|Overall Study||346
1508348|NCT01605227|3689759|P1|STARTED|Overall Study||682
1508349|NCT01605019|3689771|P2|NOT COMPLETED|Overall Study||0
1508350|NCT01605019|3689772|P1|NOT COMPLETED|Overall Study||3
1508351|NCT01605019|3689771|P2|COMPLETED|Overall Study||0
1508352|NCT01605019|3689772|P1|COMPLETED|Overall Study||1
1508353|NCT01605019|3689771|P2|STARTED|Overall Study||0
1508354|NCT01605019|3689772|P1|STARTED|Overall Study||4
1508355|NCT01604941|3689782|P6|NOT COMPLETED|Overall Study||7
1508356|NCT01604941|3689783|P5|NOT COMPLETED|Overall Study||1
1508357|NCT01604941|3689784|P4|NOT COMPLETED|Overall Study||3
1508358|NCT01604941|3689785|P3|NOT COMPLETED|Overall Study||3
1508359|NCT01604941|3689786|P2|NOT COMPLETED|Overall Study||4
1508360|NCT01604941|3689787|P1|NOT COMPLETED|Overall Study||11
1508361|NCT01604941|3689782|P6|COMPLETED|Overall Study||0
1508362|NCT01604941|3689783|P5|COMPLETED|Overall Study||3
1508363|NCT01604941|3689784|P4|COMPLETED|Overall Study||0
1508364|NCT01604941|3689785|P3|COMPLETED|Overall Study||0
1508365|NCT01604941|3689786|P2|COMPLETED|Overall Study||0
1508366|NCT01604941|3689787|P1|COMPLETED|Overall Study||0
1508367|NCT01604941|3689782|P6|STARTED|Overall Study||7
1508368|NCT01604941|3689783|P5|STARTED|Overall Study||4
1508369|NCT01604941|3689784|P4|STARTED|Overall Study||3
1508370|NCT01604941|3689785|P3|STARTED|Overall Study||3
1508371|NCT01604941|3689786|P2|STARTED|Overall Study||4
1508372|NCT01604941|3689787|P1|STARTED|Overall Study||11
1508373|NCT01604850|3689815|P2|NOT COMPLETED|Overall Study||30
1508374|NCT01604850|3689816|P1|NOT COMPLETED|Overall Study||52
1508375|NCT01604850|3689815|P2|COMPLETED|Overall Study||69
1508376|NCT01604850|3689816|P1|COMPLETED|Overall Study||51
1508377|NCT01604850|3689815|P2|Enrolled and Treated|Overall Study||98
1508378|NCT01604850|3689816|P1|Enrolled and Treated|Overall Study||103
1508379|NCT01604850|3689815|P2|STARTED|Overall Study||99
1508380|NCT01604850|3689816|P1|STARTED|Overall Study||103
1508381|NCT01604785|3689834|P2|NOT COMPLETED|Overall Study||1
1508382|NCT01604785|3689835|P1|NOT COMPLETED|Overall Study||7
1508383|NCT01604785|3689834|P2|COMPLETED|Overall Study||36
1508384|NCT01604785|3689835|P1|COMPLETED|Overall Study||30
1508385|NCT01604785|3689834|P2|STARTED|Overall Study||37
1508386|NCT01604785|3689835|P1|STARTED|Overall Study||37
1508387|NCT01604772|3689845|P1|NOT COMPLETED|Overall Study||0
1508388|NCT01604772|3689845|P1|COMPLETED|Overall Study||16
1508389|NCT01604772|3689845|P1|STARTED|Overall Study||16
1508390|NCT01604408|3689853|P2|NOT COMPLETED|Observation Period||3
1508391|NCT01604408|3689854|P1|NOT COMPLETED|Observation Period||1
1508392|NCT01604408|3689853|P2|COMPLETED|Observation Period||84
1508393|NCT01604408|3689854|P1|COMPLETED|Observation Period||85
1508394|NCT01604408|3689853|P2|STARTED|Observation Period||87
1508395|NCT01604408|3689854|P1|STARTED|Observation Period||86
1508396|NCT01604408|3689853|P2|NOT COMPLETED|Treatment Period 6||2
1508397|NCT01604408|3689854|P1|NOT COMPLETED|Treatment Period 6||2
1508398|NCT01604408|3689853|P2|COMPLETED|Treatment Period 6||87
1508399|NCT01604408|3689854|P1|COMPLETED|Treatment Period 6||86
1508400|NCT01604408|3689853|P2|STARTED|Treatment Period 6||89
1508401|NCT01604408|3689854|P1|STARTED|Treatment Period 6||88
1508402|NCT01604408|3689853|P2|NOT COMPLETED|Treatment Period 5||0
1508403|NCT01604408|3689854|P1|NOT COMPLETED|Treatment Period 5||4
1508404|NCT01604408|3689853|P2|COMPLETED|Treatment Period 5||89
1508405|NCT01604408|3689854|P1|COMPLETED|Treatment Period 5||88
1508406|NCT01604408|3689853|P2|STARTED|Treatment Period 5||89
1508407|NCT01604408|3689854|P1|STARTED|Treatment Period 5||92
1508408|NCT01604408|3689853|P2|NOT COMPLETED|Treatment Period 4||2
1508409|NCT01604408|3689854|P1|NOT COMPLETED|Treatment Period 4||3
1508410|NCT01604408|3689853|P2|COMPLETED|Treatment Period 4||89
1508411|NCT01604408|3689854|P1|COMPLETED|Treatment Period 4||92
1508412|NCT01604408|3689853|P2|STARTED|Treatment Period 4||91
1508413|NCT01604408|3689854|P1|STARTED|Treatment Period 4||95
1508414|NCT01604408|3689853|P2|NOT COMPLETED|Treatment Period 3||5
1508415|NCT01604408|3689854|P1|NOT COMPLETED|Treatment Period 3||5
1508416|NCT01604408|3689853|P2|COMPLETED|Treatment Period 3||91
1508417|NCT01604408|3689854|P1|COMPLETED|Treatment Period 3||95
1508418|NCT01604408|3689853|P2|STARTED|Treatment Period 3||96
1508419|NCT01604408|3689854|P1|STARTED|Treatment Period 3||100
1508420|NCT01604408|3689853|P2|NOT COMPLETED|Treatment Period 2||2
1508421|NCT01604408|3689854|P1|NOT COMPLETED|Treatment Period 2||2
1508422|NCT01604408|3689853|P2|COMPLETED|Treatment Period 2||96
1508423|NCT01604408|3689854|P1|COMPLETED|Treatment Period 2||100
1508424|NCT01604408|3689853|P2|STARTED|Treatment Period 2||98
1508425|NCT01604408|3689854|P1|STARTED|Treatment Period 2||102
1508426|NCT01604408|3689853|P2|NOT COMPLETED|Treatment Period 1||1
1508427|NCT01604408|3689854|P1|NOT COMPLETED|Treatment Period 1||0
1508428|NCT01604408|3689853|P2|COMPLETED|Treatment Period 1||98
1508429|NCT01604408|3689854|P1|COMPLETED|Treatment Period 1||102
1508430|NCT01604408|3689853|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
1508431|NCT01604408|3689854|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
1508432|NCT01604408|3689853|P2|STARTED|Treatment Period 1||99
1508433|NCT01604408|3689854|P1|STARTED|Treatment Period 1||102
1508434|NCT01604343|3689869|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
1508435|NCT01604343|3689870|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
1508436|NCT01604343|3689871|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
1508437|NCT01604343|3689872|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
1508438|NCT01604343|3689873|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
1508439|NCT01604343|3689869|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
1508440|NCT01604343|3689870|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
1508441|NCT01604343|3689871|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
1508442|NCT01604343|3689872|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
1508443|NCT01604343|3689873|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
1508444|NCT01604343|3689869|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
1508445|NCT01604343|3689870|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
1508446|NCT01604343|3689871|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
1508447|NCT01604343|3689872|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
1508448|NCT01604343|3689873|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
1508449|NCT01604343|3689869|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
1508450|NCT01604343|3689870|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
1508451|NCT01604343|3689871|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
1508452|NCT01604343|3689872|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
1508453|NCT01604343|3689873|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
1508454|NCT01604343|3689869|P5|NOT COMPLETED|Week 52 to Week 104||41
1508455|NCT01604343|3689870|P4|NOT COMPLETED|Week 52 to Week 104||46
1508456|NCT01604343|3689871|P3|NOT COMPLETED|Week 52 to Week 104||67
1508457|NCT01604343|3689872|P2|NOT COMPLETED|Week 52 to Week 104||43
1508458|NCT01604343|3689873|P1|NOT COMPLETED|Week 52 to Week 104||0
1508459|NCT01604343|3689869|P5|COMPLETED|Week 52 to Week 104||429
1508460|NCT01604343|3689870|P4|COMPLETED|Week 52 to Week 104||195
1508461|NCT01604343|3689871|P3|COMPLETED|Week 52 to Week 104||414
1508462|NCT01604343|3689872|P2|COMPLETED|Week 52 to Week 104||200
1508463|NCT01604343|3689873|P1|COMPLETED|Week 52 to Week 104||0
1508464|NCT01604343|3689869|P5|Treated|Week 52 to Week 104||470
1508465|NCT01604343|3689870|P4|Treated|Week 52 to Week 104||241
1508466|NCT01604343|3689871|P3|Treated|Week 52 to Week 104||481
1508467|NCT01604343|3689872|P2|Treated|Week 52 to Week 104||242
1508468|NCT01604343|3689873|P1|Treated|Week 52 to Week 104||0
1508469|NCT01604343|3689869|P5|STARTED|Week 52 to Week 104||470
1508470|NCT01604343|3689870|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
1508471|NCT01604343|3689871|P3|STARTED|Week 52 to Week 104||481
1508472|NCT01604343|3689872|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
1508473|NCT01604343|3689873|P1|STARTED|Week 52 to Week 104||0
1508474|NCT01604343|3689869|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
1508475|NCT01604343|3689870|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
1508476|NCT01604343|3689871|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
1508477|NCT01604343|3689872|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
1508478|NCT01604343|3689873|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
1508479|NCT01604343|3689869|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
1508480|NCT01604343|3689870|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
1508481|NCT01604343|3689871|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
1508482|NCT01604343|3689872|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
1508483|NCT01604343|3689873|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
1508484|NCT01604343|3689869|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
1508485|NCT01604343|3689870|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
1508486|NCT01604343|3689871|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
1508487|NCT01604343|3689872|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
1508488|NCT01604343|3689873|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
1508489|NCT01604343|3689869|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
1508490|NCT01604343|3689870|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
1508491|NCT01604343|3689871|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
1508492|NCT01604343|3689872|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
1508493|NCT01604343|3689873|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
1508494|NCT01604343|3689869|P5|STARTED|Prior to W52 Administration(Through W52)||557
1508495|NCT01604343|3689870|P4|STARTED|Prior to W52 Administration(Through W52)||0
1508496|NCT01604343|3689871|P3|STARTED|Prior to W52 Administration(Through W52)||557
1508497|NCT01604343|3689872|P2|STARTED|Prior to W52 Administration(Through W52)||0
1508498|NCT01604343|3689873|P1|STARTED|Prior to W52 Administration(Through W52)||556
1508499|NCT01604278|3689984|P2|NOT COMPLETED|Overall Study||13
1508500|NCT01604278|3689985|P1|NOT COMPLETED|Overall Study||14
1508501|NCT01604278|3689984|P2|COMPLETED|Overall Study||210
1508502|NCT01604278|3689985|P1|COMPLETED|Overall Study||212
1508594|NCT01603121|3690371|P2|STARTED|First Intervention, 10 Hours||0
1508503|NCT01604278|3689984|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
1508504|NCT01604278|3689985|P1|Full Analysis Set|Overall Study||226
1508505|NCT01604278|3689984|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
1508506|NCT01604278|3689985|P1|Safety Set|Overall Study||226
1508507|NCT01604278|3689984|P2|STARTED|Overall Study||223
1508508|NCT01604278|3689985|P1|STARTED|Overall Study||226
1508509|NCT01604265|3690011|P2|NOT COMPLETED|Overall Study||0
1508510|NCT01604265|3690012|P1|NOT COMPLETED|Overall Study||2
1508511|NCT01604265|3690011|P2|COMPLETED|Overall Study||32
1508512|NCT01604265|3690012|P1|COMPLETED|Overall Study||32
1508513|NCT01604265|3690011|P2|STARTED|Overall Study||32
1508514|NCT01604265|3690012|P1|STARTED|Overall Study||34
1508515|NCT01604122|3690048|P2|NOT COMPLETED|Overall Study||0
1508516|NCT01604122|3690049|P1|NOT COMPLETED|Overall Study||0
1508517|NCT01604122|3690048|P2|COMPLETED|Overall Study||32
1508518|NCT01604122|3690049|P1|COMPLETED|Overall Study||60
1508519|NCT01604122|3690048|P2|STARTED|Overall Study||32
1508520|NCT01604122|3690049|P1|STARTED|Overall Study||60
1508521|NCT01604109|3690096|P2|NOT COMPLETED|Overall Study||34
1508522|NCT01604109|3690097|P1|NOT COMPLETED|Overall Study||33
1508523|NCT01604109|3690096|P2|COMPLETED|Overall Study||112
1508524|NCT01604109|3690097|P1|COMPLETED|Overall Study||117
1508525|NCT01604109|3690096|P2|STARTED|Overall Study||146
1508526|NCT01604109|3690097|P1|STARTED|Overall Study||150
1508527|NCT01603940|3690105|P2|NOT COMPLETED|Overall Study||0
1508528|NCT01603940|3690106|P1|NOT COMPLETED|Overall Study||0
1508529|NCT01603940|3690105|P2|COMPLETED|Overall Study||14
1508530|NCT01603940|3690106|P1|COMPLETED|Overall Study||16
1508531|NCT01603940|3690105|P2|STARTED|Overall Study||14
1508532|NCT01603940|3690106|P1|STARTED|Overall Study||16
1508533|NCT01603875|3690123|P3|NOT COMPLETED|Overall Study||9
1508534|NCT01603875|3690124|P2|NOT COMPLETED|Overall Study||8
1508535|NCT01603875|3690125|P1|NOT COMPLETED|Overall Study||7
1508536|NCT01603875|3690123|P3|COMPLETED|Overall Study||26
1508537|NCT01603875|3690124|P2|COMPLETED|Overall Study||27
1508538|NCT01603875|3690125|P1|COMPLETED|Overall Study||28
1508539|NCT01603875|3690123|P3|STARTED|Overall Study||35
1508540|NCT01603875|3690124|P2|STARTED|Overall Study||35
1508541|NCT01603875|3690125|P1|STARTED|Overall Study||35
1508542|NCT01603628|3690148|P3|NOT COMPLETED|Overall Study||2
1508543|NCT01603628|3690149|P2|NOT COMPLETED|Overall Study||3
1508544|NCT01603628|3690150|P1|NOT COMPLETED|Overall Study||3
1508545|NCT01603628|3690148|P3|COMPLETED|Overall Study||128
1508546|NCT01603628|3690149|P2|COMPLETED|Overall Study||123
1508547|NCT01603628|3690150|P1|COMPLETED|Overall Study||125
1508548|NCT01603628|3690148|P3|Safety Population: Received Treatment|Overall Study||128
1508549|NCT01603628|3690149|P2|Safety Population: Received Treatment|Overall Study||126
1508550|NCT01603628|3690150|P1|Safety Population: Received Treatment|Overall Study||128
1508551|NCT01603628|3690148|P3|STARTED|Overall Study||130
1508552|NCT01603628|3690149|P2|STARTED|Overall Study||126
1508553|NCT01603628|3690150|P1|STARTED|Overall Study||128
1508554|NCT01603602|3690170|P3|NOT COMPLETED|Overall Study||1
1508555|NCT01603602|3690171|P2|NOT COMPLETED|Overall Study||0
1508556|NCT01603602|3690172|P1|NOT COMPLETED|Overall Study||2
1508557|NCT01603602|3690170|P3|COMPLETED|Overall Study||79
1508558|NCT01603602|3690171|P2|COMPLETED|Overall Study||78
1508559|NCT01603602|3690172|P1|COMPLETED|Overall Study||75
1508560|NCT01603602|3690170|P3|STARTED|Overall Study||80
1508561|NCT01603602|3690171|P2|STARTED|Overall Study||78
1508562|NCT01603602|3690172|P1|STARTED|Overall Study||77
1508563|NCT01603459|3690192|P1|NOT COMPLETED|Overall Study||18
1508564|NCT01603459|3690192|P1|COMPLETED|Overall Study||137
1508565|NCT01603459|3690192|P1|STARTED|Overall Study||155
1508566|NCT01603420|3690314|P2|NOT COMPLETED|Overall Study||0
1508567|NCT01603420|3690315|P1|NOT COMPLETED|Overall Study||0
1508568|NCT01603420|3690314|P2|COMPLETED|Overall Study||1
1508569|NCT01603420|3690315|P1|COMPLETED|Overall Study||1
1508570|NCT01603420|3690314|P2|STARTED|Overall Study||1
1508571|NCT01603420|3690315|P1|STARTED|Overall Study||1
1508572|NCT01603394|3690343|P1|NOT COMPLETED|Overall Study||1
1508573|NCT01603394|3690343|P1|COMPLETED|Overall Study||8
1508574|NCT01603394|3690343|P1|STARTED|Overall Study||9
1508575|NCT01603355|3690358|P1|NOT COMPLETED|Overall Study||2
1508576|NCT01603355|3690358|P1|COMPLETED|Overall Study||1
1508577|NCT01603355|3690358|P1|STARTED|Overall Study||3
1508578|NCT01603277|3690364|P2|NOT COMPLETED|Overall Study||18
1508579|NCT01603277|3690365|P1|NOT COMPLETED|Overall Study||14
1508580|NCT01603277|3690364|P2|COMPLETED|Overall Study||64
1508581|NCT01603277|3690365|P1|COMPLETED|Overall Study||64
1508582|NCT01603277|3690364|P2|STARTED|Overall Study||82
1508583|NCT01603277|3690365|P1|STARTED|Overall Study||78
1508584|NCT01603121|3690371|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
1508585|NCT01603121|3690372|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
1508586|NCT01603121|3690371|P2|COMPLETED|Second Intervention, 10 Hours||0
1508587|NCT01603121|3690372|P1|COMPLETED|Second Intervention, 10 Hours||0
1508588|NCT01603121|3690371|P2|STARTED|Second Intervention, 10 Hours||0
1508589|NCT01603121|3690372|P1|STARTED|Second Intervention, 10 Hours||1
1508590|NCT01603121|3690371|P2|NOT COMPLETED|First Intervention, 10 Hours||0
1508591|NCT01603121|3690372|P1|NOT COMPLETED|First Intervention, 10 Hours||0
1508592|NCT01603121|3690371|P2|COMPLETED|First Intervention, 10 Hours||0
1508593|NCT01603121|3690372|P1|COMPLETED|First Intervention, 10 Hours||1
1508595|NCT01603121|3690372|P1|STARTED|First Intervention, 10 Hours||1
1508596|NCT01603082|3690384|P2|NOT COMPLETED|Overall Study||1
1508597|NCT01603082|3690385|P1|NOT COMPLETED|Overall Study||2
1508598|NCT01603082|3690384|P2|COMPLETED|Overall Study|Completed the study|48
1508599|NCT01603082|3690385|P1|COMPLETED|Overall Study|Completed the study.|49
1508600|NCT01603082|3690384|P2|STARTED|Overall Study|Randomized|49
1508601|NCT01603082|3690385|P1|STARTED|Overall Study|Randomized|51
1508602|NCT01603056|3690395|P2|NOT COMPLETED|Overall Study||14
1508603|NCT01603056|3690396|P1|NOT COMPLETED|Overall Study||34
1508604|NCT01603056|3690395|P2|COMPLETED|Overall Study||190
1508605|NCT01603056|3690396|P1|COMPLETED|Overall Study||379
1508606|NCT01603056|3690395|P2|STARTED|Overall Study||204
1508607|NCT01603056|3690396|P1|STARTED|Overall Study||413
1508608|NCT01603043|3690426|P2|NOT COMPLETED|Overall Study||3
1508609|NCT01603043|3690427|P1|NOT COMPLETED|Overall Study||7
1508610|NCT01603043|3690426|P2|COMPLETED|Overall Study||0
1508611|NCT01603043|3690427|P1|COMPLETED|Overall Study||0
1508612|NCT01603043|3690426|P2|STARTED|Overall Study||3
1508613|NCT01603043|3690427|P1|STARTED|Overall Study||7
1508614|NCT01602965|3690439|P2|NOT COMPLETED|Overall Study||2
1508615|NCT01602965|3690440|P1|NOT COMPLETED|Overall Study||4
1508616|NCT01602965|3690439|P2|COMPLETED|Overall Study||18
1508617|NCT01602965|3690440|P1|COMPLETED|Overall Study||16
1508618|NCT01602965|3690439|P2|STARTED|Overall Study||20
1508619|NCT01602965|3690440|P1|STARTED|Overall Study||20
1508620|NCT01602744|3690448|P2|NOT COMPLETED|Overall Study||23
1508621|NCT01602744|3690449|P1|NOT COMPLETED|Overall Study||30
1508622|NCT01602744|3690448|P2|COMPLETED|Overall Study||160
1508623|NCT01602744|3690449|P1|COMPLETED|Overall Study||146
1508624|NCT01602744|3690448|P2|STARTED|Overall Study||183
1508625|NCT01602744|3690449|P1|STARTED|Overall Study||176
1508626|NCT01602731|3690465|P1|NOT COMPLETED|Overall Study||30
1508627|NCT01602731|3690465|P1|COMPLETED|Overall Study||15
1508628|NCT01602731|3690465|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
1508629|NCT01602731|3690465|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
1508630|NCT01602731|3690465|P1|STARTED|Overall Study||45
1508631|NCT01602679|3690473|P2|NOT COMPLETED|Overall Study||0
1508632|NCT01602679|3690474|P1|NOT COMPLETED|Overall Study||0
1508633|NCT01602679|3690473|P2|COMPLETED|Overall Study||3
1508634|NCT01602679|3690474|P1|COMPLETED|Overall Study||4
1508635|NCT01602679|3690473|P2|STARTED|Overall Study||3
1508636|NCT01602679|3690474|P1|STARTED|Overall Study||4
1508637|NCT01602562|3690486|P2|NOT COMPLETED|Overall Study||3
1508638|NCT01602562|3690487|P1|NOT COMPLETED|Overall Study||5
1508639|NCT01602562|3690486|P2|COMPLETED|Overall Study||16
1508640|NCT01602562|3690487|P1|COMPLETED|Overall Study||16
1508641|NCT01602562|3690486|P2|STARTED|Overall Study||19
1508642|NCT01602562|3690487|P1|STARTED|Overall Study||21
1508643|NCT01602549|3690523|P2|NOT COMPLETED|Overall Study||1
1508644|NCT01602549|3690524|P1|NOT COMPLETED|Overall Study||1
1508645|NCT01602549|3690523|P2|COMPLETED|Overall Study||37
1508646|NCT01602549|3690524|P1|COMPLETED|Overall Study||18
1508647|NCT01602549|3690523|P2|STARTED|Overall Study||38
1508648|NCT01602549|3690524|P1|STARTED|Overall Study||19
1508649|NCT01602510|3690603|P3|NOT COMPLETED|Randomized Phase||73
1508650|NCT01602510|3690604|P2|NOT COMPLETED|Randomized Phase||74
1508651|NCT01602510|3690605|P1|NOT COMPLETED|Randomized Phase||0
1508652|NCT01602510|3690603|P3|COMPLETED|Randomized Phase||58
1508653|NCT01602510|3690604|P2|COMPLETED|Randomized Phase||59
1508654|NCT01602510|3690605|P1|COMPLETED|Randomized Phase||0
1508655|NCT01602510|3690603|P3|STARTED|Randomized Phase||131
1508656|NCT01602510|3690604|P2|STARTED|Randomized Phase||133
1508657|NCT01602510|3690605|P1|STARTED|Randomized Phase||0
1508658|NCT01602510|3690603|P3|NOT COMPLETED|Open Label Phase||0
1508659|NCT01602510|3690604|P2|NOT COMPLETED|Open Label Phase||0
1508660|NCT01602510|3690605|P1|NOT COMPLETED|Open Label Phase||303
1508661|NCT01602510|3690603|P3|COMPLETED|Open Label Phase||0
1508662|NCT01602510|3690604|P2|COMPLETED|Open Label Phase||0
1508663|NCT01602510|3690605|P1|COMPLETED|Open Label Phase||117
1508664|NCT01602510|3690603|P3|STARTED|Open Label Phase||0
1508665|NCT01602510|3690604|P2|STARTED|Open Label Phase||0
1508666|NCT01602510|3690605|P1|STARTED|Open Label Phase||420
1508667|NCT01602484|3690631|P2|NOT COMPLETED|Overall Study||1
1508668|NCT01602484|3690632|P1|NOT COMPLETED|Overall Study||0
1508669|NCT01602484|3690631|P2|COMPLETED|Overall Study||24
1508670|NCT01602484|3690632|P1|COMPLETED|Overall Study||25
1508671|NCT01602484|3690631|P2|STARTED|Overall Study||25
1508672|NCT01602484|3690632|P1|STARTED|Overall Study||25
1508673|NCT01602471|3690644|P1|NOT COMPLETED|Overall Study||0
1508674|NCT01602471|3690644|P1|COMPLETED|Overall Study||4
1508675|NCT01602471|3690644|P1|STARTED|Overall Study||4
1508676|NCT01602380|3690650|P2|NOT COMPLETED|Overall Study||101
1508677|NCT01602380|3690651|P1|NOT COMPLETED|Overall Study||93
1508678|NCT01602380|3690650|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
1508679|NCT01602380|3690651|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
1508680|NCT01602380|3690650|P2|STARTED|Overall Study||232
1508681|NCT01602380|3690651|P1|STARTED|Overall Study||230
1508682|NCT01602341|3690675|P2|NOT COMPLETED|Overall Study||1
1508683|NCT01602341|3690676|P1|NOT COMPLETED|Overall Study||0
1508684|NCT01602341|3690675|P2|COMPLETED|Overall Study||41
1508685|NCT01602341|3690676|P1|COMPLETED|Overall Study||44
1508686|NCT01602341|3690675|P2|STARTED|Overall Study||42
1508687|NCT01602341|3690676|P1|STARTED|Overall Study||44
1508688|NCT01602315|3690717|P7|NOT COMPLETED|Overall Study||29
1508689|NCT01602315|3690718|P6|NOT COMPLETED|Overall Study||35
1508690|NCT01602315|3690719|P5|NOT COMPLETED|Overall Study||71
1508691|NCT01602315|3690720|P4|NOT COMPLETED|Overall Study||6
1508692|NCT01602315|3690721|P3|NOT COMPLETED|Overall Study||18
1508693|NCT01602315|3690722|P2|NOT COMPLETED|Overall Study||5
1508694|NCT01602315|3690723|P1|NOT COMPLETED|Overall Study||16
1508695|NCT01602315|3690717|P7|COMPLETED|Overall Study||0
1508696|NCT01602315|3690718|P6|COMPLETED|Overall Study||0
1508697|NCT01602315|3690719|P5|COMPLETED|Overall Study||0
1508698|NCT01602315|3690720|P4|COMPLETED|Overall Study||0
1508699|NCT01602315|3690721|P3|COMPLETED|Overall Study||0
1508700|NCT01602315|3690722|P2|COMPLETED|Overall Study||0
1508701|NCT01602315|3690723|P1|COMPLETED|Overall Study||0
1508702|NCT01602315|3690717|P7|STARTED|Overall Study||29
1508703|NCT01602315|3690718|P6|STARTED|Overall Study||35
1508704|NCT01602315|3690719|P5|STARTED|Overall Study||71
1508705|NCT01602315|3690720|P4|STARTED|Overall Study||6
1508706|NCT01602315|3690721|P3|STARTED|Overall Study||18
1508707|NCT01602315|3690722|P2|STARTED|Overall Study||5
1508708|NCT01602315|3690723|P1|STARTED|Overall Study||16
1508709|NCT01602224|3690812|P3|NOT COMPLETED|Overall Study||6
1508710|NCT01602224|3690813|P2|NOT COMPLETED|Overall Study||8
1508711|NCT01602224|3690814|P1|NOT COMPLETED|Overall Study||8
1508712|NCT01602224|3690812|P3|COMPLETED|Overall Study||66
1508713|NCT01602224|3690813|P2|COMPLETED|Overall Study||66
1508714|NCT01602224|3690814|P1|COMPLETED|Overall Study||66
1508715|NCT01602224|3690812|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
1508716|NCT01602224|3690813|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
1508717|NCT01602224|3690814|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
1508718|NCT01602224|3690812|P3|STARTED|Overall Study||72
1508719|NCT01602224|3690813|P2|STARTED|Overall Study||74
1508720|NCT01602224|3690814|P1|STARTED|Overall Study||74
1508721|NCT01602198|3690860|P2|NOT COMPLETED|Overall Study||0
1508722|NCT01602198|3690861|P1|NOT COMPLETED|Overall Study||0
1508723|NCT01602198|3690860|P2|COMPLETED|Overall Study||1
1508724|NCT01602198|3690861|P1|COMPLETED|Overall Study||0
1508725|NCT01602198|3690860|P2|STARTED|Overall Study||1
1508726|NCT01602198|3690861|P1|STARTED|Overall Study||0
1508727|NCT01602068|3690869|P2|NOT COMPLETED|Overall Study||0
1508728|NCT01602068|3690870|P1|NOT COMPLETED|Overall Study||0
1508729|NCT01602068|3690869|P2|COMPLETED|Overall Study||22
1508730|NCT01602068|3690870|P1|COMPLETED|Overall Study||23
1508731|NCT01602068|3690869|P2|STARTED|Overall Study|Day before surgery|22
1508732|NCT01602068|3690870|P1|STARTED|Overall Study|Day before surgery|23
1508733|NCT01602016|3690876|P1|NOT COMPLETED|Overall Study||0
1508734|NCT01602016|3690876|P1|COMPLETED|Overall Study||0
1508735|NCT01602016|3690876|P1|STARTED|Overall Study||0
1508736|NCT01601977|3690883|P1|NOT COMPLETED|Overall Study||0
1508737|NCT01601977|3690883|P1|COMPLETED|Overall Study||10
1508738|NCT01601977|3690883|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
1508739|NCT01601847|3690903|P2|NOT COMPLETED|Overall Study||10
1508740|NCT01601847|3690904|P1|NOT COMPLETED|Overall Study||13
1508741|NCT01601847|3690903|P2|COMPLETED|Overall Study||137
1508742|NCT01601847|3690904|P1|COMPLETED|Overall Study||140
1508743|NCT01601847|3690903|P2|STARTED|Overall Study||147
1508744|NCT01601847|3690904|P1|STARTED|Overall Study||153
1508745|NCT01601821|3690916|P2|NOT COMPLETED|Overall Study||29
1508746|NCT01601821|3690917|P1|NOT COMPLETED|Overall Study||29
1508747|NCT01601821|3690916|P2|COMPLETED|Overall Study||91
1508748|NCT01601821|3690917|P1|COMPLETED|Overall Study||96
1508749|NCT01601821|3690916|P2|STARTED|Overall Study||120
1508750|NCT01601821|3690917|P1|STARTED|Overall Study||125
1508751|NCT01601782|3690947|P1|NOT COMPLETED|Overall Study||0
1508752|NCT01601782|3690947|P1|COMPLETED|Overall Study||16
1508753|NCT01601782|3690947|P1|STARTED|Overall Study||16
1508754|NCT01601704|3690953|P2|NOT COMPLETED|Overall Study||4
1508755|NCT01601704|3690954|P1|NOT COMPLETED|Overall Study||1
1508756|NCT01601704|3690953|P2|COMPLETED|Overall Study||4450
1508757|NCT01601704|3690954|P1|COMPLETED|Overall Study||4455
1508758|NCT01601704|3690953|P2|Treated|Overall Study||4450
1508759|NCT01601704|3690954|P1|Treated|Overall Study||4455
1508760|NCT01601704|3690953|P2|STARTED|Overall Study||4454
1508761|NCT01601704|3690954|P1|STARTED|Overall Study||4456
1508762|NCT01601691|3690968|P1|NOT COMPLETED|Overall Study||0
1508763|NCT01601691|3690968|P1|COMPLETED|Overall Study||10
1508764|NCT01601691|3690968|P1|STARTED|Overall Study||10
1508765|NCT01601626|3690975|P3|NOT COMPLETED|Overall Study||2
1508766|NCT01601626|3690976|P2|NOT COMPLETED|Overall Study||5
1508767|NCT01601626|3690977|P1|NOT COMPLETED|Overall Study||3
1508768|NCT01601626|3690975|P3|COMPLETED|Overall Study||21
1508769|NCT01601626|3690976|P2|COMPLETED|Overall Study||19
1508770|NCT01601626|3690977|P1|COMPLETED|Overall Study||21
1508771|NCT01601626|3690975|P3|STARTED|Overall Study||23
1508772|NCT01601626|3690976|P2|STARTED|Overall Study||24
1508773|NCT01601626|3690977|P1|STARTED|Overall Study||24
1508774|NCT01601470|3691060|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
1508775|NCT01601470|3691060|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
1508776|NCT01601470|3691060|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
1508777|NCT01601470|3691060|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
1508778|NCT01601470|3691060|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
1508779|NCT01601470|3691060|P1|NOT COMPLETED|Period 2 - LCZ696||1
1508780|NCT01601470|3691060|P1|COMPLETED|Period 2 - LCZ696||27
1508781|NCT01601470|3691060|P1|Safety Set|Period 2 - LCZ696||27
1508782|NCT01601470|3691060|P1|PK Analysis Set|Period 2 - LCZ696||27
1508783|NCT01601470|3691060|P1|STARTED|Period 2 - LCZ696||28
1508784|NCT01601470|3691060|P1|NOT COMPLETED|Period 1 - Sildenafil||0
1508785|NCT01601470|3691060|P1|COMPLETED|Period 1 - Sildenafil||28
1508786|NCT01601470|3691060|P1|Safety Set|Period 1 - Sildenafil||28
1508787|NCT01601470|3691060|P1|PK Analysis Set|Period 1 - Sildenafil||28
1508788|NCT01601470|3691060|P1|STARTED|Period 1 - Sildenafil||28
1508789|NCT01601431|3691077|P2|NOT COMPLETED|Overall Study||3
1508790|NCT01601431|3691078|P1|NOT COMPLETED|Overall Study||12
1508791|NCT01601431|3691077|P2|COMPLETED|Overall Study||214
1508792|NCT01601431|3691078|P1|COMPLETED|Overall Study||211
1508793|NCT01601431|3691077|P2|STARTED|Overall Study||217
1508794|NCT01601431|3691078|P1|STARTED|Overall Study||223
1508795|NCT01601236|3691090|P6|NOT COMPLETED|Overall Study||1
1508796|NCT01601236|3691091|P5|NOT COMPLETED|Overall Study||3
1508797|NCT01601236|3691092|P4|NOT COMPLETED|Overall Study||2
1508798|NCT01601236|3691093|P3|NOT COMPLETED|Overall Study||6
1508799|NCT01601236|3691094|P2|NOT COMPLETED|Overall Study||1
1508800|NCT01601236|3691095|P1|NOT COMPLETED|Overall Study||5
1508801|NCT01601236|3691090|P6|COMPLETED|Overall Study||0
1508802|NCT01601236|3691091|P5|COMPLETED|Overall Study||0
1508803|NCT01601236|3691092|P4|COMPLETED|Overall Study||4
1508804|NCT01601236|3691093|P3|COMPLETED|Overall Study||8
1508805|NCT01601236|3691094|P2|COMPLETED|Overall Study||2
1508806|NCT01601236|3691095|P1|COMPLETED|Overall Study||2
1508807|NCT01601236|3691090|P6|STARTED|Overall Study||1
1508808|NCT01601236|3691091|P5|STARTED|Overall Study||3
1508809|NCT01601236|3691092|P4|STARTED|Overall Study||6
1508810|NCT01601236|3691093|P3|STARTED|Overall Study||14
1508811|NCT01601236|3691094|P2|STARTED|Overall Study||3
1508812|NCT01601236|3691095|P1|STARTED|Overall Study||7
1508813|NCT01601132|3691131|P1|NOT COMPLETED|Overall Study||2
1508814|NCT01601132|3691131|P1|COMPLETED|Overall Study||28
1508815|NCT01601132|3691131|P1|STARTED|Overall Study||30
1508816|NCT01600950|3691148|P2|NOT COMPLETED|Period 2||0
1508817|NCT01600950|3691149|P1|NOT COMPLETED|Period 2||0
1508818|NCT01600950|3691148|P2|COMPLETED|Period 2||10
1508819|NCT01600950|3691149|P1|COMPLETED|Period 2||10
1508820|NCT01600950|3691148|P2|STARTED|Period 2||10
1508821|NCT01600950|3691149|P1|STARTED|Period 2||10
1508822|NCT01600950|3691148|P2|NOT COMPLETED|Period 1||0
1508823|NCT01600950|3691149|P1|NOT COMPLETED|Period 1||0
1508824|NCT01600950|3691148|P2|COMPLETED|Period 1||10
1508825|NCT01600950|3691149|P1|COMPLETED|Period 1||10
1508826|NCT01600950|3691148|P2|STARTED|Period 1||10
1508827|NCT01600950|3691149|P1|STARTED|Period 1||10
1508828|NCT01600885|3691165|P2|NOT COMPLETED|Second Period||0
1508829|NCT01600885|3691166|P1|NOT COMPLETED|Second Period||0
1508830|NCT01600885|3691165|P2|COMPLETED|Second Period||8
1508831|NCT01600885|3691166|P1|COMPLETED|Second Period||8
1508832|NCT01600885|3691165|P2|STARTED|Second Period||8
1508833|NCT01600885|3691166|P1|STARTED|Second Period||8
1508834|NCT01600885|3691165|P2|NOT COMPLETED|Wash Out Period||0
1508835|NCT01600885|3691166|P1|NOT COMPLETED|Wash Out Period||0
1508836|NCT01600885|3691165|P2|COMPLETED|Wash Out Period||8
1508837|NCT01600885|3691166|P1|COMPLETED|Wash Out Period||8
1508838|NCT01600885|3691165|P2|STARTED|Wash Out Period||8
1508839|NCT01600885|3691166|P1|STARTED|Wash Out Period||8
1508840|NCT01600885|3691165|P2|NOT COMPLETED|First Period||1
1508841|NCT01600885|3691166|P1|NOT COMPLETED|First Period||2
1508842|NCT01600885|3691165|P2|COMPLETED|First Period||8
1508843|NCT01600885|3691166|P1|COMPLETED|First Period||8
1508844|NCT01600885|3691165|P2|STARTED|First Period||9
1508845|NCT01600885|3691166|P1|STARTED|First Period||10
1508846|NCT01600729|3691176|P1|NOT COMPLETED|Overall Study||1
1508847|NCT01600729|3691176|P1|COMPLETED|Overall Study||65
1508848|NCT01600729|3691176|P1|STARTED|Overall Study||66
1508849|NCT01600716|3691183|P2|NOT COMPLETED|Overall Study||7
1508850|NCT01600716|3691184|P1|NOT COMPLETED|Overall Study||7
1508851|NCT01600716|3691183|P2|COMPLETED|Overall Study||71
1508852|NCT01600716|3691184|P1|COMPLETED|Overall Study||59
1508853|NCT01600716|3691183|P2|STARTED|Overall Study||78
1508854|NCT01600716|3691184|P1|STARTED|Overall Study||66
1508855|NCT01600703|3691200|P2|NOT COMPLETED|Second Intervention||0
1508856|NCT01600703|3691201|P1|NOT COMPLETED|Second Intervention||0
1508857|NCT01600703|3691200|P2|COMPLETED|Second Intervention||8
1508858|NCT01600703|3691201|P1|COMPLETED|Second Intervention||7
1508859|NCT01600703|3691200|P2|STARTED|Second Intervention||8
1508860|NCT01600703|3691201|P1|STARTED|Second Intervention||7
1508861|NCT01600703|3691200|P2|NOT COMPLETED|First Intervention||0
1508862|NCT01600703|3691201|P1|NOT COMPLETED|First Intervention||0
1508863|NCT01600703|3691200|P2|COMPLETED|First Intervention||8
1508864|NCT01600703|3691201|P1|COMPLETED|First Intervention||7
1508865|NCT01600703|3691200|P2|STARTED|First Intervention||8
1508866|NCT01600703|3691201|P1|STARTED|First Intervention||7
1508867|NCT01600677|3691211|P2|NOT COMPLETED|Overall Study||0
1508868|NCT01600677|3691212|P1|NOT COMPLETED|Overall Study||0
1508869|NCT01600677|3691211|P2|COMPLETED|Overall Study||4
1508870|NCT01600677|3691212|P1|COMPLETED|Overall Study||7
1508871|NCT01600677|3691211|P2|STARTED|Overall Study||4
1508872|NCT01600677|3691212|P1|STARTED|Overall Study||7
1508873|NCT01600586|3691224|P2|NOT COMPLETED|Overall Study||3
1508874|NCT01600586|3691225|P1|NOT COMPLETED|Overall Study||3
1508875|NCT01600586|3691224|P2|COMPLETED|Overall Study||48
1508876|NCT01600586|3691225|P1|COMPLETED|Overall Study||46
1508877|NCT01600586|3691224|P2|STARTED|Overall Study||51
1508878|NCT01600586|3691225|P1|STARTED|Overall Study||49
1508879|NCT01600495|3691241|P2|NOT COMPLETED|Overall Study||0
1508880|NCT01600495|3691242|P1|NOT COMPLETED|Overall Study||0
1508881|NCT01600495|3691241|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
1508882|NCT01600495|3691242|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
1508883|NCT01600495|3691241|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
1508884|NCT01600495|3691242|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
1508885|NCT01600482|3691256|P2|NOT COMPLETED|Overall Study||0
1508886|NCT01600482|3691257|P1|NOT COMPLETED|Overall Study||0
1508887|NCT01600482|3691256|P2|COMPLETED|Overall Study||59
1508888|NCT01600482|3691257|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
1508889|NCT01600482|3691256|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
1508890|NCT01600482|3691257|P1|STARTED|Overall Study||148
1508891|NCT01600326|3691277|P2|NOT COMPLETED|Overall Study||1
1508892|NCT01600326|3691278|P1|NOT COMPLETED|Overall Study||1
1508893|NCT01600326|3691277|P2|COMPLETED|Overall Study||14
1508894|NCT01600326|3691278|P1|COMPLETED|Overall Study||14
1508895|NCT01600326|3691277|P2|Primary Outcome Measure Data Collection|Overall Study||15
1508896|NCT01600326|3691278|P1|Primary Outcome Measure Data Collection|Overall Study||15
1508897|NCT01600326|3691277|P2|STARTED|Overall Study||15
1508898|NCT01600326|3691278|P1|STARTED|Overall Study||15
1508899|NCT01600287|3691288|P2|NOT COMPLETED|Overall Study||0
1508900|NCT01600287|3691289|P1|NOT COMPLETED|Overall Study||0
1508901|NCT01600287|3691288|P2|COMPLETED|Overall Study||20
1508902|NCT01600287|3691289|P1|COMPLETED|Overall Study||20
1508903|NCT01600287|3691288|P2|STARTED|Overall Study||20
1508904|NCT01600287|3691289|P1|STARTED|Overall Study||20
1508905|NCT01600222|3691329|P1|NOT COMPLETED|Overall Study||2
1508906|NCT01600222|3691329|P1|COMPLETED|Overall Study||35
1508907|NCT01600222|3691329|P1|STARTED|Overall Study||37
1508908|NCT01600092|3691354|P2|NOT COMPLETED|Overall Study||16
1508909|NCT01600092|3691355|P1|NOT COMPLETED|Overall Study||18
1508910|NCT01600092|3691354|P2|COMPLETED|Overall Study||491
1508911|NCT01600092|3691355|P1|COMPLETED|Overall Study||495
1508912|NCT01600092|3691354|P2|Received All 3 Vaccinations|Overall Study||494
1508913|NCT01600092|3691355|P1|Received All 3 Vaccinations|Overall Study||500
1508914|NCT01600092|3691354|P2|Received at Least 1 Vaccination|Overall Study||504
1508915|NCT01600092|3691355|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
1508916|NCT01600092|3691354|P2|STARTED|Overall Study||507
1508917|NCT01600092|3691355|P1|STARTED|Overall Study||513
1508918|NCT01600053|3691369|P1|NOT COMPLETED|Overall Study||11
1508919|NCT01600053|3691369|P1|COMPLETED|Overall Study||0
1508920|NCT01600053|3691369|P1|STARTED|Overall Study||11
1508921|NCT01600014|3691374|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
1508922|NCT01600014|3691375|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
1508923|NCT01600014|3691374|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
1508924|NCT01600014|3691375|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
1508925|NCT01600014|3691374|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
1508926|NCT01600014|3691375|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
1508927|NCT01600014|3691374|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
1508928|NCT01600014|3691375|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
1508929|NCT01600014|3691374|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
1508930|NCT01600014|3691375|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
1508931|NCT01600014|3691374|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
1508932|NCT01600014|3691375|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
1508933|NCT01600014|3691374|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
1508934|NCT01600014|3691375|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
1508935|NCT01600014|3691374|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
1508936|NCT01600014|3691375|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
1508937|NCT01600014|3691374|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
1508938|NCT01600014|3691375|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
1508939|NCT01599832|3691393|P1|NOT COMPLETED|Overall Study||0
1508940|NCT01599832|3691393|P1|COMPLETED|Overall Study||20
1508941|NCT01599832|3691393|P1|STARTED|Overall Study||20
1508942|NCT01599806|3691403|P2|NOT COMPLETED|Overall Study||41
1508943|NCT01599806|3691404|P1|NOT COMPLETED|Overall Study||43
1508944|NCT01599806|3691403|P2|COMPLETED|Overall Study||476
1508945|NCT01599806|3691404|P1|COMPLETED|Overall Study||473
1508946|NCT01599806|3691403|P2|STARTED|Overall Study||517
1508947|NCT01599806|3691404|P1|STARTED|Overall Study||516
1508948|NCT01599741|3691528|P1|NOT COMPLETED|Overall Study||3
1508949|NCT01599741|3691528|P1|COMPLETED|Overall Study||48
1508950|NCT01599741|3691528|P1|Collected Dose and Image Information|Overall Study||48
1508951|NCT01599741|3691528|P1|STARTED|Overall Study||51
1508952|NCT01599650|3691537|P3|NOT COMPLETED|Overall Study||27
1508953|NCT01599650|3691538|P2|NOT COMPLETED|Overall Study||26
1508954|NCT01599650|3691539|P1|NOT COMPLETED|Overall Study||22
1508955|NCT01599650|3691537|P3|COMPLETED|Overall Study||65
1508956|NCT01599650|3691538|P2|COMPLETED|Overall Study||154
1508957|NCT01599650|3691539|P1|COMPLETED|Overall Study||161
1508958|NCT01599650|3691537|P3|Completed 6 Mos|Overall Study||80
1508959|NCT01599650|3691538|P2|Completed 6 Mos|Overall Study||170
1508960|NCT01599650|3691539|P1|Completed 6 Mos|Overall Study||174
1508961|NCT01599650|3691537|P3|STARTED|Overall Study||92
1508962|NCT01599650|3691538|P2|STARTED|Overall Study||180
1508963|NCT01599650|3691539|P1|STARTED|Overall Study||183
1508964|NCT01599637|3691578|P3|NOT COMPLETED|Overall Study||0
1508965|NCT01599637|3691579|P2|NOT COMPLETED|Overall Study||2
1508966|NCT01599637|3691580|P1|NOT COMPLETED|Overall Study||1
1508967|NCT01599637|3691578|P3|COMPLETED|Overall Study||10
1508968|NCT01599637|3691579|P2|COMPLETED|Overall Study||8
1508969|NCT01599637|3691580|P1|COMPLETED|Overall Study||19
1508970|NCT01599637|3691578|P3|STARTED|Overall Study||10
1508971|NCT01599637|3691579|P2|STARTED|Overall Study||10
1508972|NCT01599637|3691580|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
1508973|NCT01599585|3691627|P2|NOT COMPLETED|Overall Study||17
1508974|NCT01599585|3691628|P1|NOT COMPLETED|Overall Study||22
1508975|NCT01599585|3691627|P2|COMPLETED|Overall Study||42
1508976|NCT01599585|3691628|P1|COMPLETED|Overall Study||40
1508977|NCT01599585|3691627|P2|STARTED|Overall Study||59
1508978|NCT01599585|3691628|P1|STARTED|Overall Study||62
1508979|NCT01599325|3691666|P1|NOT COMPLETED|Overall Study||57
1508980|NCT01599325|3691666|P1|COMPLETED|Overall Study|Participants still on study treatment at time of study closure|15
1508981|NCT01599325|3691666|P1|Pharmacokinetic (PK) Population|Overall Study|Includes all participants with evaluable azacitidine plasma PK profiles.|12
1508982|NCT01599325|3691666|P1|Intent to Treat (ITT) Population|Overall Study|Includes all participants who were enrolled into the study|72
1508983|NCT01599325|3691666|P1|STARTED|Overall Study||72
1508984|NCT01599234|3691688|P2|NOT COMPLETED|Overall Study||15
1508985|NCT01599234|3691689|P1|NOT COMPLETED|Overall Study||17
1508986|NCT01599234|3691688|P2|COMPLETED|Overall Study||155
1508987|NCT01599234|3691689|P1|COMPLETED|Overall Study||150
1508988|NCT01599234|3691688|P2|STARTED|Overall Study||170
1508989|NCT01599234|3691689|P1|STARTED|Overall Study||167
1508990|NCT01599104|3691714|P3|NOT COMPLETED|Overall Study||26
1508991|NCT01599104|3691715|P2|NOT COMPLETED|Overall Study||14
1508992|NCT01599104|3691716|P1|NOT COMPLETED|Overall Study||16
1508993|NCT01599104|3691714|P3|COMPLETED|Overall Study||363
1508994|NCT01599104|3691715|P2|COMPLETED|Overall Study||371
1508995|NCT01599104|3691716|P1|COMPLETED|Overall Study||371
1508996|NCT01599104|3691714|P3|STARTED|Overall Study||389
1508997|NCT01599104|3691715|P2|STARTED|Overall Study||385
1508998|NCT01599104|3691716|P1|STARTED|Overall Study||387
1508999|NCT01598987|3691754|P1|NOT COMPLETED|Baseline to 24 Month||8
1509000|NCT01598987|3691754|P1|COMPLETED|Baseline to 24 Month||48
1509001|NCT01598987|3691754|P1|STARTED|Baseline to 24 Month||56
1509002|NCT01598987|3691754|P1|NOT COMPLETED|Baseline to Month 12||6
1509003|NCT01598987|3691754|P1|COMPLETED|Baseline to Month 12||50
1509004|NCT01598987|3691754|P1|STARTED|Baseline to Month 12||56
1509005|NCT01598896|3691790|P2|NOT COMPLETED|Overall Study||2
1509006|NCT01598896|3691791|P1|NOT COMPLETED|Overall Study||0
1509007|NCT01598896|3691790|P2|COMPLETED|Overall Study||2
1509008|NCT01598896|3691791|P1|COMPLETED|Overall Study||3
1509009|NCT01598896|3691790|P2|STARTED|Overall Study||4
1509010|NCT01598896|3691791|P1|STARTED|Overall Study||3
1509011|NCT01598779|3691803|P1|NOT COMPLETED|Overall Study||0
1509012|NCT01598779|3691803|P1|COMPLETED|Overall Study||150
1509013|NCT01598779|3691803|P1|STARTED|Overall Study||150
1509014|NCT01598740|3691809|P2|NOT COMPLETED|Period 2||0
1509015|NCT01598740|3691810|P1|NOT COMPLETED|Period 2||1
1509016|NCT01598740|3691809|P2|COMPLETED|Period 2||9
1509017|NCT01598740|3691810|P1|COMPLETED|Period 2||7
1509018|NCT01598740|3691809|P2|STARTED|Period 2||9
1509019|NCT01598740|3691810|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
1509020|NCT01598740|3691809|P2|NOT COMPLETED|Period 1||0
1509021|NCT01598740|3691810|P1|NOT COMPLETED|Period 1||0
1509022|NCT01598740|3691809|P2|COMPLETED|Period 1||9
1509023|NCT01598740|3691810|P1|COMPLETED|Period 1||9
1509024|NCT01598740|3691809|P2|STARTED|Period 1||9
1509025|NCT01598740|3691810|P1|STARTED|Period 1||9
1509026|NCT01598701|3691820|P2|NOT COMPLETED|Overall Study||9
1509027|NCT01598701|3691821|P1|NOT COMPLETED|Overall Study||5
1509028|NCT01598701|3691820|P2|COMPLETED|Overall Study||41
1509029|NCT01598701|3691821|P1|COMPLETED|Overall Study||45
1509030|NCT01598701|3691820|P2|STARTED|Overall Study||50
1509031|NCT01598701|3691821|P1|STARTED|Overall Study||50
1509032|NCT01598662|3691837|P2|NOT COMPLETED|Overall Study||21
1509033|NCT01598662|3691838|P1|NOT COMPLETED|Overall Study||11
1509034|NCT01598662|3691837|P2|COMPLETED|Overall Study||0
1509035|NCT01598662|3691838|P1|COMPLETED|Overall Study||0
1509036|NCT01598662|3691837|P2|Patients Returned for 6 wk Postpartum|Overall Study||2
1509037|NCT01598662|3691838|P1|Patients Returned for 6 wk Postpartum|Overall Study||0
1509038|NCT01598662|3691837|P2|Patients Who Received IUD|Overall Study||18
1509039|NCT01598662|3691838|P1|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
1509040|NCT01598662|3691837|P2|STARTED|Overall Study||21
1509041|NCT01598662|3691838|P1|STARTED|Overall Study||11
1509042|NCT01598610|3691844|P1|NOT COMPLETED|Overall Study||1
1509043|NCT01598610|3691844|P1|COMPLETED|Overall Study||219
1509044|NCT01598610|3691844|P1|STARTED|Overall Study||220
1509045|NCT01598545|3691853|P1|NOT COMPLETED|Overall Study||0
1509046|NCT01598545|3691853|P1|COMPLETED|Overall Study||20
1509047|NCT01598545|3691853|P1|STARTED|Overall Study||20
1509048|NCT01598532|3691861|P1|NOT COMPLETED|Overall Study||11
1509049|NCT01598532|3691861|P1|COMPLETED|Overall Study||11
1509050|NCT01598532|3691861|P1|STARTED|Overall Study||22
1509051|NCT01598506|3691870|P1|NOT COMPLETED|Overall Study||2
1509052|NCT01598506|3691870|P1|COMPLETED|Overall Study||20
1509053|NCT01598506|3691870|P1|STARTED|Overall Study||22
1509054|NCT01598428|3691875|P1|NOT COMPLETED|Overall Study||0
1509055|NCT01598428|3691875|P1|COMPLETED|Overall Study||20
1509056|NCT01598428|3691875|P1|STARTED|Overall Study||20
1509057|NCT01598350|3691884|P1|NOT COMPLETED|Overall Study||0
1509058|NCT01598350|3691884|P1|COMPLETED|Overall Study||6
1509059|NCT01598350|3691884|P1|STARTED|Overall Study||6
1509060|NCT01598311|3691890|P2|NOT COMPLETED|Overall Study||61
1509061|NCT01598311|3691891|P1|NOT COMPLETED|Overall Study||47
1509062|NCT01598311|3691890|P2|COMPLETED|Overall Study||244
1509063|NCT01598311|3691891|P1|COMPLETED|Overall Study||256
1509064|NCT01598311|3691890|P2|Treated and Confirmed CDAD|Overall Study||292
1509065|NCT01598311|3691891|P1|Treated and Confirmed CDAD|Overall Study||285
1509066|NCT01598311|3691890|P2|Treated|Overall Study||301
1509067|NCT01598311|3691891|P1|Treated|Overall Study||294
1509068|NCT01598311|3691890|P2|STARTED|Overall Study||305
1509069|NCT01598311|3691891|P1|STARTED|Overall Study||303
1509070|NCT01598298|3691907|P2|NOT COMPLETED|Overall Study||41
1509071|NCT01598298|3691908|P1|NOT COMPLETED|Overall Study||40
1509072|NCT01598298|3691907|P2|COMPLETED|Overall Study||108
1509073|NCT01598298|3691908|P1|COMPLETED|Overall Study||110
1509074|NCT01598298|3691907|P2|Patients Evaluable for Adverse Events|Overall Study||141
1509075|NCT01598298|3691908|P1|Patients Evaluable for Adverse Events|Overall Study||138
1509076|NCT01598298|3691907|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
1509077|NCT01598298|3691908|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
1509078|NCT01598298|3691907|P2|STARTED|Overall Study||149
1509079|NCT01598298|3691908|P1|STARTED|Overall Study||150
1509080|NCT01598207|3691920|P2|NOT COMPLETED|Overall Study||0
1509081|NCT01598207|3691921|P1|NOT COMPLETED|Overall Study||1
1509082|NCT01598207|3691920|P2|COMPLETED|Overall Study||6
1509083|NCT01598207|3691921|P1|COMPLETED|Overall Study||6
1509084|NCT01598207|3691920|P2|STARTED|Overall Study||6
1509085|NCT01598207|3691921|P1|STARTED|Overall Study||7
1509086|NCT01598194|3691941|P2|NOT COMPLETED|Overall Study||0
1509087|NCT01598194|3691942|P1|NOT COMPLETED|Overall Study||0
1509088|NCT01598194|3691941|P2|COMPLETED|Overall Study||30
1509089|NCT01598194|3691942|P1|COMPLETED|Overall Study||30
1509090|NCT01598194|3691941|P2|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
1509091|NCT01598194|3691942|P1|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
1509092|NCT01598194|3691941|P2|1 Pass With 22Gpc for Cytology|Overall Study||30
1509093|NCT01598194|3691942|P1|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
1509094|NCT01598194|3691941|P2|2 Passes With 25G for Cytology|Overall Study||30
1509095|NCT01598194|3691942|P1|2 Passes With 25G for Cytology|Overall Study||30
1509096|NCT01598194|3691941|P2|STARTED|Overall Study||30
1509097|NCT01598194|3691942|P1|STARTED|Overall Study||30
1509098|NCT01598129|3691952|P1|NOT COMPLETED|Overall Study||9
1509099|NCT01598129|3691952|P1|COMPLETED|Overall Study||3
1509100|NCT01598129|3691952|P1|STARTED|Overall Study||12
1509101|NCT01598064|3691963|P2|NOT COMPLETED|Overall Study||0
1509102|NCT01598064|3691964|P1|NOT COMPLETED|Overall Study||0
1509103|NCT01598064|3691963|P2|COMPLETED|Overall Study||24
1509104|NCT01598064|3691964|P1|COMPLETED|Overall Study||25
1509105|NCT01598064|3691963|P2|STARTED|Overall Study||24
1509106|NCT01598064|3691964|P1|STARTED|Overall Study||25
1509107|NCT01598025|3691974|P2|NOT COMPLETED|Overall Study||3
1509108|NCT01598025|3691975|P1|NOT COMPLETED|Overall Study||0
1509109|NCT01598025|3691974|P2|COMPLETED|Overall Study||0
1509110|NCT01598025|3691975|P1|COMPLETED|Overall Study||0
1509111|NCT01598025|3691974|P2|STARTED|Overall Study||3
1509112|NCT01598025|3691975|P1|STARTED|Overall Study||0
1509113|NCT01597908|3691984|P2|NOT COMPLETED|Overall Study||352
1509114|NCT01597908|3691985|P1|NOT COMPLETED|Overall Study||352
1509115|NCT01597908|3691984|P2|COMPLETED|Overall Study||0
1509116|NCT01597908|3691985|P1|COMPLETED|Overall Study||0
1509117|NCT01597908|3691984|P2|Ongoing|Overall Study||202
1509118|NCT01597908|3691985|P1|Ongoing|Overall Study||236
1509119|NCT01597908|3691984|P2|STARTED|Overall Study||352
1509120|NCT01597908|3691985|P1|STARTED|Overall Study||352
1509121|NCT01597843|3692000|P3|NOT COMPLETED|Overall Study||0
1509122|NCT01597843|3692001|P2|NOT COMPLETED|Overall Study||0
1509123|NCT01597843|3692002|P1|NOT COMPLETED|Overall Study||0
1509124|NCT01597843|3692000|P3|COMPLETED|Overall Study||81
1509125|NCT01597843|3692001|P2|COMPLETED|Overall Study||122
1509126|NCT01597843|3692002|P1|COMPLETED|Overall Study||79
1509127|NCT01597843|3692000|P3|Survey 3 Responses|Overall Study||76
1509128|NCT01597843|3692001|P2|Survey 3 Responses|Overall Study||56
1509129|NCT01597843|3692002|P1|Survey 3 Responses|Overall Study||65
1509130|NCT01597843|3692000|P3|Survey 2 Responses|Overall Study||58
1509131|NCT01597843|3692001|P2|Survey 2 Responses|Overall Study||42
1509132|NCT01597843|3692002|P1|Survey 2 Responses|Overall Study||52
1509133|NCT01597843|3692000|P3|Survey 1 Responses|Overall Study||59
1509134|NCT01597843|3692001|P2|Survey 1 Responses|Overall Study||71
1509135|NCT01597843|3692002|P1|Survey 1 Responses|Overall Study||45
1509136|NCT01597843|3692000|P3|STARTED|Overall Study||81
1509137|NCT01597843|3692001|P2|STARTED|Overall Study||122
1509138|NCT01597843|3692002|P1|STARTED|Overall Study||79
1509139|NCT01597791|3692012|P2|NOT COMPLETED|Overall Study||10
1509140|NCT01597791|3692013|P1|NOT COMPLETED|Overall Study||8
1509141|NCT01597791|3692012|P2|COMPLETED|Overall Study||18
1509142|NCT01597791|3692013|P1|COMPLETED|Overall Study||20
1509143|NCT01597791|3692012|P2|STARTED|Overall Study||28
1509144|NCT01597791|3692013|P1|STARTED|Overall Study||28
1509145|NCT01597635|3692022|P3|NOT COMPLETED|Part B||4
1509146|NCT01597635|3692023|P2|NOT COMPLETED|Part B||6
1509147|NCT01597635|3692024|P1|NOT COMPLETED|Part B||0
1509148|NCT01597635|3692022|P3|COMPLETED|Part B||15
1509149|NCT01597635|3692023|P2|COMPLETED|Part B||14
1509150|NCT01597635|3692024|P1|COMPLETED|Part B||0
1509151|NCT01597635|3692022|P3|STARTED|Part B||19
1509152|NCT01597635|3692023|P2|STARTED|Part B||20
1509153|NCT01597635|3692024|P1|STARTED|Part B||0
1509154|NCT01597635|3692022|P3|NOT COMPLETED|Part A||0
1509155|NCT01597635|3692023|P2|NOT COMPLETED|Part A||0
1509156|NCT01597635|3692024|P1|NOT COMPLETED|Part A||3
1509157|NCT01597635|3692022|P3|COMPLETED|Part A||0
1509158|NCT01597635|3692023|P2|COMPLETED|Part A||0
1509159|NCT01597635|3692024|P1|COMPLETED|Part A||2
1509160|NCT01597635|3692022|P3|STARTED|Part A||0
1509161|NCT01597635|3692023|P2|STARTED|Part A||0
1509162|NCT01597635|3692024|P1|STARTED|Part A||5
1509163|NCT01597596|3692089|P2|NOT COMPLETED|Overall Study||1
1509164|NCT01597596|3692090|P1|NOT COMPLETED|Overall Study||1
1509165|NCT01597596|3692089|P2|COMPLETED|Overall Study||2
1509166|NCT01597596|3692090|P1|COMPLETED|Overall Study||0
1509167|NCT01597596|3692089|P2|STARTED|Overall Study||3
1509168|NCT01597596|3692090|P1|STARTED|Overall Study||1
1509169|NCT01597505|3692104|P2|NOT COMPLETED|Overall Study||33
1509170|NCT01597505|3692105|P1|NOT COMPLETED|Overall Study||44
1509171|NCT01597505|3692104|P2|COMPLETED|Overall Study||265
1509172|NCT01597505|3692105|P1|COMPLETED|Overall Study||264
1509173|NCT01597505|3692104|P2|Treated|Overall Study||286
1509174|NCT01597505|3692105|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
1509175|NCT01597505|3692104|P2|STARTED|Overall Study|Randomized participants|298
1509176|NCT01597505|3692105|P1|STARTED|Overall Study|Randomized participants|308
1509177|NCT01597492|3692139|P2|NOT COMPLETED|Overall Study||4
1509178|NCT01597492|3692140|P1|NOT COMPLETED|Overall Study||6
1509179|NCT01597492|3692139|P2|COMPLETED|Overall Study||41
1509180|NCT01597492|3692140|P1|COMPLETED|Overall Study||28
1509181|NCT01597492|3692139|P2|STARTED|Overall Study||45
1509182|NCT01597492|3692140|P1|STARTED|Overall Study||34
1509183|NCT01597479|3692148|P2|NOT COMPLETED|Overall Study||0
1509184|NCT01597479|3692149|P1|NOT COMPLETED|Overall Study||2
1509185|NCT01597479|3692148|P2|COMPLETED|Overall Study||26
1509186|NCT01597479|3692149|P1|COMPLETED|Overall Study||24
1509187|NCT01597479|3692148|P2|STARTED|Overall Study||26
1509188|NCT01597479|3692149|P1|STARTED|Overall Study||26
1509189|NCT01597440|3692158|P2|NOT COMPLETED|Overall Study||0
1509190|NCT01597440|3692159|P1|NOT COMPLETED|Overall Study||0
1509191|NCT01597440|3692158|P2|COMPLETED|Overall Study||0
1509192|NCT01597440|3692159|P1|COMPLETED|Overall Study||1
1509193|NCT01597440|3692158|P2|STARTED|Overall Study||0
1509194|NCT01597440|3692159|P1|STARTED|Overall Study||1
1509195|NCT01597388|3692176|P9|NOT COMPLETED|Overall Study||0
1509196|NCT01597388|3692177|P8|NOT COMPLETED|Overall Study||0
1509197|NCT01597388|3692178|P7|NOT COMPLETED|Overall Study||0
1509198|NCT01597388|3692179|P6|NOT COMPLETED|Overall Study||0
1509199|NCT01597388|3692180|P5|NOT COMPLETED|Overall Study||0
1509200|NCT01597388|3692181|P4|NOT COMPLETED|Overall Study||0
1509201|NCT01597388|3692182|P3|NOT COMPLETED|Overall Study||0
1509202|NCT01597388|3692183|P2|NOT COMPLETED|Overall Study||0
1509203|NCT01597388|3692184|P1|NOT COMPLETED|Overall Study||0
1509204|NCT01597388|3692176|P9|COMPLETED|Overall Study||2
1509205|NCT01597388|3692177|P8|COMPLETED|Overall Study||5
1509206|NCT01597388|3692178|P7|COMPLETED|Overall Study||8
1509207|NCT01597388|3692179|P6|COMPLETED|Overall Study||4
1509208|NCT01597388|3692180|P5|COMPLETED|Overall Study||37
1509209|NCT01597388|3692181|P4|COMPLETED|Overall Study||10
1509210|NCT01597388|3692182|P3|COMPLETED|Overall Study||14
1509211|NCT01597388|3692183|P2|COMPLETED|Overall Study||13
1509212|NCT01597388|3692184|P1|COMPLETED|Overall Study||6
1509213|NCT01597388|3692176|P9|STARTED|Overall Study||2
1509214|NCT01597388|3692177|P8|STARTED|Overall Study||5
1509215|NCT01597388|3692178|P7|STARTED|Overall Study||8
1509216|NCT01597388|3692179|P6|STARTED|Overall Study||4
1509217|NCT01597388|3692180|P5|STARTED|Overall Study||37
1509218|NCT01597388|3692181|P4|STARTED|Overall Study||10
1509219|NCT01597388|3692182|P3|STARTED|Overall Study||14
1509220|NCT01597388|3692183|P2|STARTED|Overall Study||13
1509221|NCT01597388|3692184|P1|STARTED|Overall Study||6
1509222|NCT01597375|3692435|P2|NOT COMPLETED|Second Intervention||1
1509223|NCT01597375|3692436|P1|NOT COMPLETED|Second Intervention||1
1509224|NCT01597375|3692435|P2|COMPLETED|Second Intervention||21
1509225|NCT01597375|3692436|P1|COMPLETED|Second Intervention||19
1509226|NCT01597375|3692435|P2|STARTED|Second Intervention||22
1509227|NCT01597375|3692436|P1|STARTED|Second Intervention||20
1509228|NCT01597375|3692435|P2|NOT COMPLETED|Washout (2 Weeks)||0
1509229|NCT01597375|3692436|P1|NOT COMPLETED|Washout (2 Weeks)||1
1509230|NCT01597375|3692435|P2|COMPLETED|Washout (2 Weeks)||22
1509231|NCT01597375|3692436|P1|COMPLETED|Washout (2 Weeks)||20
1509232|NCT01597375|3692435|P2|STARTED|Washout (2 Weeks)||22
1509233|NCT01597375|3692436|P1|STARTED|Washout (2 Weeks)||21
1509234|NCT01597375|3692435|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
1509235|NCT01597375|3692436|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
1509236|NCT01597375|3692435|P2|COMPLETED|First Intervention (4 Weeks)||22
1509237|NCT01597375|3692436|P1|COMPLETED|First Intervention (4 Weeks)||21
1509238|NCT01597375|3692435|P2|STARTED|First Intervention (4 Weeks)||23
1509239|NCT01597375|3692436|P1|STARTED|First Intervention (4 Weeks)||23
1509240|NCT01597245|3692457|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
1509241|NCT01597245|3692458|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
1509242|NCT01597245|3692459|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
1509243|NCT01597245|3692460|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||118
1509244|NCT01597245|3692461|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
1509245|NCT01597245|3692462|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
1509246|NCT01597245|3692463|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||37
1509247|NCT01597245|3692464|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
1509248|NCT01597245|3692465|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||159
1509249|NCT01597245|3692466|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1509250|NCT01597245|3692467|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1509251|NCT01597245|3692468|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1509252|NCT01597245|3692469|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1509253|NCT01597245|3692457|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
1509254|NCT01597245|3692458|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
1509255|NCT01597245|3692459|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
1509256|NCT01597245|3692460|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||14
1509257|NCT01597245|3692461|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
1509258|NCT01597245|3692462|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1509259|NCT01597245|3692463|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||150
1509260|NCT01597245|3692464|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
1509261|NCT01597245|3692465|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||17
1509262|NCT01597245|3692466|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1509263|NCT01597245|3692467|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1509264|NCT01597245|3692468|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1509265|NCT01597245|3692469|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
1509266|NCT01597245|3692457|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
1509267|NCT01597245|3692458|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
1509268|NCT01597245|3692459|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
1509269|NCT01597245|3692460|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
1509270|NCT01597245|3692461|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
1509271|NCT01597245|3692462|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
1509272|NCT01597245|3692463|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
1509273|NCT01597245|3692464|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
1509274|NCT01597245|3692465|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
1509275|NCT01597245|3692466|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1509276|NCT01597245|3692467|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1509277|NCT01597245|3692468|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1509278|NCT01597245|3692469|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
1509279|NCT01597245|3692457|P13|STARTED|Maintenance Period (Week 12 to Week 60)||49
1509280|NCT01597245|3692458|P12|STARTED|Maintenance Period (Week 12 to Week 60)||75
1509281|NCT01597245|3692459|P11|STARTED|Maintenance Period (Week 12 to Week 60)||200
1509282|NCT01597245|3692460|P10|STARTED|Maintenance Period (Week 12 to Week 60)||132
1509283|NCT01597245|3692461|P9|STARTED|Maintenance Period (Week 12 to Week 60)||155
1509284|NCT01597245|3692462|P8|STARTED|Maintenance Period (Week 12 to Week 60)||3
1509285|NCT01597245|3692463|P7|STARTED|Maintenance Period (Week 12 to Week 60)||187
1509286|NCT01597245|3692464|P6|STARTED|Maintenance Period (Week 12 to Week 60)||181
1509287|NCT01597245|3692465|P5|STARTED|Maintenance Period (Week 12 to Week 60)||176
1509288|NCT01597245|3692466|P4|STARTED|Maintenance Period (Week 12 to Week 60)||0
1509289|NCT01597245|3692467|P3|STARTED|Maintenance Period (Week 12 to Week 60)||0
1509290|NCT01597245|3692468|P2|STARTED|Maintenance Period (Week 12 to Week 60)||0
1509291|NCT01597245|3692469|P1|STARTED|Maintenance Period (Week 12 to Week 60)||0
1509292|NCT01597245|3692457|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1509293|NCT01597245|3692458|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1509294|NCT01597245|3692459|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1509295|NCT01597245|3692460|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1509296|NCT01597245|3692461|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1509297|NCT01597245|3692462|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1509298|NCT01597245|3692463|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1509299|NCT01597245|3692464|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1509300|NCT01597245|3692465|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
1509301|NCT01597245|3692466|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
1509302|NCT01597245|3692467|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
1509303|NCT01597245|3692468|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
1509304|NCT01597245|3692469|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
1509305|NCT01597245|3692457|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
1509306|NCT01597245|3692458|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
1509307|NCT01597245|3692459|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
1509308|NCT01597245|3692460|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
1509309|NCT01597245|3692461|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
1509310|NCT01597245|3692462|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
1509311|NCT01597245|3692463|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
1509312|NCT01597245|3692464|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
1509313|NCT01597245|3692465|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
1509314|NCT01597245|3692466|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
1509315|NCT01597245|3692467|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
1509316|NCT01597245|3692468|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
1509317|NCT01597245|3692469|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
1509318|NCT01597245|3692457|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1509319|NCT01597245|3692458|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1509320|NCT01597245|3692459|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1509321|NCT01597245|3692460|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1509322|NCT01597245|3692461|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1509323|NCT01597245|3692462|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1509324|NCT01597245|3692463|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1509325|NCT01597245|3692464|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1509326|NCT01597245|3692465|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
1509327|NCT01597245|3692466|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
1509328|NCT01597245|3692467|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
1509329|NCT01597245|3692468|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
1509330|NCT01597245|3692469|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
1509331|NCT01597245|3692457|P13|STARTED|Induction Period (Week 0 - Week 12)||0
1509332|NCT01597245|3692458|P12|STARTED|Induction Period (Week 0 - Week 12)||0
1509333|NCT01597245|3692459|P11|STARTED|Induction Period (Week 0 - Week 12)||0
1509334|NCT01597245|3692460|P10|STARTED|Induction Period (Week 0 - Week 12)||0
1509335|NCT01597245|3692461|P9|STARTED|Induction Period (Week 0 - Week 12)||0
1509336|NCT01597245|3692462|P8|STARTED|Induction Period (Week 0 - Week 12)||0
1509337|NCT01597245|3692463|P7|STARTED|Induction Period (Week 0 - Week 12)||0
1509338|NCT01597245|3692464|P6|STARTED|Induction Period (Week 0 - Week 12)||0
1509339|NCT01597245|3692465|P5|STARTED|Induction Period (Week 0 - Week 12)||0
1509340|NCT01597245|3692466|P4|STARTED|Induction Period (Week 0 - Week 12)||351
1509341|NCT01597245|3692467|P3|STARTED|Induction Period (Week 0 - Week 12)||347
1509342|NCT01597245|3692468|P2|STARTED|Induction Period (Week 0 - Week 12)||358
1509343|NCT01597245|3692469|P1|STARTED|Induction Period (Week 0 - Week 12)||168
1509344|NCT01597141|3692554|P2|NOT COMPLETED|Overall Study||0
1509345|NCT01597141|3692555|P1|NOT COMPLETED|Overall Study||0
1509346|NCT01597141|3692554|P2|COMPLETED|Overall Study||50
1509347|NCT01597141|3692555|P1|COMPLETED|Overall Study||50
1509348|NCT01597141|3692554|P2|STARTED|Overall Study||50
1509349|NCT01597141|3692555|P1|STARTED|Overall Study||50
1509350|NCT01597128|3692565|P2|NOT COMPLETED|Overall Study||0
1509351|NCT01597128|3692566|P1|NOT COMPLETED|Overall Study||0
1509352|NCT01597128|3692565|P2|COMPLETED|Overall Study||17
1509353|NCT01597128|3692566|P1|COMPLETED|Overall Study||18
1509354|NCT01597128|3692565|P2|STARTED|Overall Study||17
1509355|NCT01597128|3692566|P1|STARTED|Overall Study||18
1509356|NCT01597050|3692592|P2|NOT COMPLETED|Overall Study||0
1509357|NCT01597050|3692593|P1|NOT COMPLETED|Overall Study||1
1509358|NCT01597050|3692592|P2|COMPLETED|Overall Study||18
1509359|NCT01597050|3692593|P1|COMPLETED|Overall Study||35
1509360|NCT01597050|3692592|P2|STARTED|Overall Study||18
1509361|NCT01597050|3692593|P1|STARTED|Overall Study||36
1509362|NCT01596972|3692601|P2|NOT COMPLETED|Overall Study||14
1509363|NCT01596972|3692602|P1|NOT COMPLETED|Overall Study||1
1509364|NCT01596972|3692601|P2|COMPLETED|Overall Study||12
1509365|NCT01596972|3692602|P1|COMPLETED|Overall Study||24
1509366|NCT01596972|3692601|P2|STARTED|Overall Study||26
1509367|NCT01596972|3692602|P1|STARTED|Overall Study||25
1509368|NCT01596842|3692614|P2|NOT COMPLETED|Overall Study||0
1509369|NCT01596842|3692615|P1|NOT COMPLETED|Overall Study||2
1509370|NCT01596842|3692614|P2|COMPLETED|Overall Study||7
1509371|NCT01596842|3692615|P1|COMPLETED|Overall Study||8
1509372|NCT01596842|3692614|P2|STARTED|Overall Study||7
1509373|NCT01596842|3692615|P1|STARTED|Overall Study||10
1509374|NCT01596582|3692625|P2|NOT COMPLETED|Overall Study||7
1509375|NCT01596582|3692626|P1|NOT COMPLETED|Overall Study||4
1509376|NCT01596582|3692625|P2|COMPLETED|Overall Study||173
1509377|NCT01596582|3692626|P1|COMPLETED|Overall Study||168
1509378|NCT01596582|3692625|P2|STARTED|Overall Study||180
1509379|NCT01596582|3692626|P1|STARTED|Overall Study||172
1509380|NCT01596504|3692653|P3|NOT COMPLETED|Overall Study||1
1509381|NCT01596504|3692654|P2|NOT COMPLETED|Overall Study||3
1509382|NCT01596504|3692655|P1|NOT COMPLETED|Overall Study||2
1509383|NCT01596504|3692653|P3|COMPLETED|Overall Study||46
1509384|NCT01596504|3692654|P2|COMPLETED|Overall Study||44
1509385|NCT01596504|3692655|P1|COMPLETED|Overall Study||46
1509386|NCT01596504|3692653|P3|STARTED|Overall Study||47
1509387|NCT01596504|3692654|P2|STARTED|Overall Study||47
1509388|NCT01596504|3692655|P1|STARTED|Overall Study||48
1509389|NCT01596335|3692713|P2|NOT COMPLETED|Overall Study||9
1509390|NCT01596335|3692714|P1|NOT COMPLETED|Overall Study||5
1509391|NCT01596335|3692713|P2|COMPLETED|Overall Study||6
1509392|NCT01596335|3692714|P1|COMPLETED|Overall Study||11
1509393|NCT01596335|3692713|P2|STARTED|Overall Study||15
1509394|NCT01596335|3692714|P1|STARTED|Overall Study||16
1509395|NCT01596283|3692726|P2|NOT COMPLETED|Overall Study||0
1509396|NCT01596283|3692727|P1|NOT COMPLETED|Overall Study||0
1509397|NCT01596283|3692726|P2|COMPLETED|Overall Study||66
1509398|NCT01596283|3692727|P1|COMPLETED|Overall Study||69
1509399|NCT01596283|3692726|P2|STARTED|Overall Study||66
1509400|NCT01596283|3692727|P1|STARTED|Overall Study||69
1509401|NCT01596231|3692743|P2|NOT COMPLETED|Overall Study||0
1509402|NCT01596231|3692744|P1|NOT COMPLETED|Overall Study||0
1509403|NCT01596231|3692743|P2|COMPLETED|Overall Study||10
1509404|NCT01596231|3692744|P1|COMPLETED|Overall Study||10
1509405|NCT01596231|3692743|P2|STARTED|Overall Study||10
1509406|NCT01596231|3692744|P1|STARTED|Overall Study||10
1509407|NCT01596127|3692750|P1|NOT COMPLETED|Overall Study||1
1509408|NCT01596127|3692750|P1|COMPLETED|Overall Study||3
1509409|NCT01596127|3692750|P1|STARTED|Overall Study||4
1509410|NCT01596088|3692755|P1|NOT COMPLETED|Overall Study||0
1509411|NCT01596088|3692755|P1|COMPLETED|Overall Study||2
1509412|NCT01596088|3692755|P1|STARTED|Overall Study||2
1509413|NCT01596062|3692762|P3|NOT COMPLETED|Overall Study||3
1509414|NCT01596062|3692763|P2|NOT COMPLETED|Overall Study||0
1509415|NCT01596062|3692764|P1|NOT COMPLETED|Overall Study||1
1509416|NCT01596062|3692762|P3|COMPLETED|Overall Study||4
1509417|NCT01596062|3692763|P2|COMPLETED|Overall Study||6
1509418|NCT01596062|3692764|P1|COMPLETED|Overall Study||2
1509419|NCT01596062|3692762|P3|STARTED|Overall Study||7
1509420|NCT01596062|3692763|P2|STARTED|Overall Study||6
1509421|NCT01596062|3692764|P1|STARTED|Overall Study||3
1509422|NCT01595854|3692801|P5|NOT COMPLETED|Overall Study||0
1509423|NCT01595854|3692802|P4|NOT COMPLETED|Overall Study||0
1509424|NCT01595854|3692803|P3|NOT COMPLETED|Overall Study||0
1509425|NCT01595854|3692804|P2|NOT COMPLETED|Overall Study||0
1509426|NCT01595854|3692805|P1|NOT COMPLETED|Overall Study||0
1509427|NCT01595854|3692801|P5|COMPLETED|Overall Study||12
1509428|NCT01595854|3692802|P4|COMPLETED|Overall Study||4
1509429|NCT01595854|3692803|P3|COMPLETED|Overall Study||8
1509430|NCT01595854|3692804|P2|COMPLETED|Overall Study||4
1509431|NCT01595854|3692805|P1|COMPLETED|Overall Study||8
1509432|NCT01595854|3692801|P5|STARTED|Overall Study||12
1509433|NCT01595854|3692802|P4|STARTED|Overall Study||4
1509434|NCT01595854|3692803|P3|STARTED|Overall Study||8
1509435|NCT01595854|3692804|P2|STARTED|Overall Study||4
1509436|NCT01595854|3692805|P1|STARTED|Overall Study||8
1509437|NCT01595646|3692828|P3|NOT COMPLETED|Overall Study||0
1509438|NCT01595646|3692829|P2|NOT COMPLETED|Overall Study||0
1509439|NCT01595646|3692830|P1|NOT COMPLETED|Overall Study||1
1509440|NCT01595646|3692828|P3|COMPLETED|Overall Study||12
1509441|NCT01595646|3692829|P2|COMPLETED|Overall Study||12
1509442|NCT01595646|3692830|P1|COMPLETED|Overall Study||12
1509443|NCT01595646|3692828|P3|STARTED|Overall Study||12
1509444|NCT01595646|3692829|P2|STARTED|Overall Study||12
1509445|NCT01595646|3692830|P1|STARTED|Overall Study||13
1509446|NCT01595438|3692852|P2|NOT COMPLETED|Overall Study||41
1509447|NCT01595438|3692853|P1|NOT COMPLETED|Overall Study||43
1509448|NCT01595438|3692852|P2|COMPLETED|Overall Study||476
1509449|NCT01595438|3692853|P1|COMPLETED|Overall Study||473
1509450|NCT01595438|3692852|P2|STARTED|Overall Study||517
1509451|NCT01595438|3692853|P1|STARTED|Overall Study||516
1509452|NCT01595386|3692979|P2|NOT COMPLETED|Overall Study||0
1509453|NCT01595386|3692980|P1|NOT COMPLETED|Overall Study||0
1509454|NCT01595386|3692979|P2|COMPLETED|Overall Study||19
1509455|NCT01595386|3692980|P1|COMPLETED|Overall Study||21
1509456|NCT01595386|3692979|P2|STARTED|Overall Study||19
1509457|NCT01595386|3692980|P1|STARTED|Overall Study||21
1509458|NCT01595282|3693008|P2|NOT COMPLETED|Overall Study||0
1509459|NCT01595282|3693009|P1|NOT COMPLETED|Overall Study||0
1509460|NCT01595282|3693008|P2|COMPLETED|Overall Study||47
1509461|NCT01595282|3693009|P1|COMPLETED|Overall Study||47
1509462|NCT01595282|3693008|P2|STARTED|Overall Study||47
1509463|NCT01595282|3693009|P1|STARTED|Overall Study||47
1509464|NCT01595009|3693021|P4|NOT COMPLETED|Extension||11
1509465|NCT01595009|3693022|P3|NOT COMPLETED|Extension||4
1509466|NCT01595009|3693023|P2|NOT COMPLETED|Extension||0
1509467|NCT01595009|3693024|P1|NOT COMPLETED|Extension||0
1509468|NCT01595009|3693021|P4|COMPLETED|Extension||0
1509469|NCT01595009|3693022|P3|COMPLETED|Extension||0
1509470|NCT01595009|3693023|P2|COMPLETED|Extension||0
1509471|NCT01595009|3693024|P1|COMPLETED|Extension||0
1509472|NCT01595009|3693021|P4|STARTED|Extension||11
1509473|NCT01595009|3693022|P3|STARTED|Extension||4
1509474|NCT01595009|3693023|P2|STARTED|Extension||0
1509475|NCT01595009|3693024|P1|STARTED|Extension||0
1509476|NCT01595009|3693021|P4|NOT COMPLETED|Core||0
1509477|NCT01595009|3693022|P3|NOT COMPLETED|Core||0
1509478|NCT01595009|3693023|P2|NOT COMPLETED|Core||120
1509479|NCT01595009|3693024|P1|NOT COMPLETED|Core||126
1509480|NCT01595009|3693021|P4|COMPLETED|Core||0
1509481|NCT01595009|3693022|P3|COMPLETED|Core||0
1509482|NCT01595009|3693023|P2|COMPLETED|Core||0
1509483|NCT01595009|3693024|P1|COMPLETED|Core||0
1509484|NCT01595009|3693021|P4|STARTED|Core||0
1509485|NCT01595009|3693022|P3|STARTED|Core||0
1509486|NCT01595009|3693023|P2|STARTED|Core||120
1509487|NCT01595009|3693024|P1|STARTED|Core||126
1509488|NCT01594970|3693059|P3|NOT COMPLETED|Overall Study||66
1509489|NCT01594970|3693060|P2|NOT COMPLETED|Overall Study||82
1509490|NCT01594970|3693061|P1|NOT COMPLETED|Overall Study||75
1509491|NCT01594970|3693059|P3|COMPLETED|Overall Study||191
1509492|NCT01594970|3693060|P2|COMPLETED|Overall Study||166
1509493|NCT01594970|3693061|P1|COMPLETED|Overall Study||220
1509494|NCT01594970|3693059|P3|STARTED|Overall Study||257
1509495|NCT01594970|3693060|P2|STARTED|Overall Study||248
1509496|NCT01594970|3693061|P1|STARTED|Overall Study||295
1509497|NCT01594853|3693080|P2|NOT COMPLETED|Overall Study||3
1509498|NCT01594853|3693081|P1|NOT COMPLETED|Overall Study||2
1509499|NCT01594853|3693080|P2|COMPLETED|Overall Study||12
1509500|NCT01594853|3693081|P1|COMPLETED|Overall Study||14
1509501|NCT01594853|3693080|P2|STARTED|Overall Study||15
1509502|NCT01594853|3693081|P1|STARTED|Overall Study||16
1509503|NCT01594827|3693089|P2|NOT COMPLETED|Overall Study||0
1509504|NCT01594827|3693090|P1|NOT COMPLETED|Overall Study||4
1509505|NCT01594827|3693089|P2|COMPLETED|Overall Study||15
1509506|NCT01594827|3693090|P1|COMPLETED|Overall Study||10
1509507|NCT01594827|3693089|P2|STARTED|Overall Study||15
1509508|NCT01594827|3693090|P1|STARTED|Overall Study||14
1509509|NCT01594762|3693102|P2|NOT COMPLETED|Overall Study||10
1509510|NCT01594762|3693103|P1|NOT COMPLETED|Overall Study||11
1509511|NCT01594762|3693102|P2|COMPLETED|Overall Study||93
1509512|NCT01594762|3693103|P1|COMPLETED|Overall Study||86
1509513|NCT01594762|3693102|P2|STARTED|Overall Study||103
1509514|NCT01594762|3693103|P1|STARTED|Overall Study||97
1509515|NCT01594749|3693115|P2|NOT COMPLETED|Overall Study||18
1509516|NCT01594749|3693116|P1|NOT COMPLETED|Overall Study||22
1509517|NCT01594749|3693115|P2|COMPLETED|Overall Study||490
1509518|NCT01594749|3693116|P1|COMPLETED|Overall Study||485
1509519|NCT01594749|3693115|P2|Treated|Overall Study||498
1509520|NCT01594749|3693116|P1|Treated|Overall Study||503
1509521|NCT01594749|3693115|P2|STARTED|Overall Study||508
1509522|NCT01594749|3693116|P1|STARTED|Overall Study||507
1509523|NCT01594515|3693142|P10|NOT COMPLETED|Overall Study||0
1509524|NCT01594515|3693143|P9|NOT COMPLETED|Overall Study||0
1509525|NCT01594515|3693144|P8|NOT COMPLETED|Overall Study||0
1509526|NCT01594515|3693145|P7|NOT COMPLETED|Overall Study||0
1509527|NCT01594515|3693146|P6|NOT COMPLETED|Overall Study||0
1509528|NCT01594515|3693147|P5|NOT COMPLETED|Overall Study||0
1509529|NCT01594515|3693148|P4|NOT COMPLETED|Overall Study||0
1509530|NCT01594515|3693149|P3|NOT COMPLETED|Overall Study||0
1509531|NCT01594515|3693150|P2|NOT COMPLETED|Overall Study||0
1509532|NCT01594515|3693151|P1|NOT COMPLETED|Overall Study||0
1509533|NCT01594515|3693142|P10|COMPLETED|Overall Study||16
1509534|NCT01594515|3693143|P9|COMPLETED|Overall Study||6
1509535|NCT01594515|3693144|P8|COMPLETED|Overall Study||6
1509536|NCT01594515|3693145|P7|COMPLETED|Overall Study||6
1509537|NCT01594515|3693146|P6|COMPLETED|Overall Study||6
1509538|NCT01594515|3693147|P5|COMPLETED|Overall Study||6
1509539|NCT01594515|3693148|P4|COMPLETED|Overall Study||6
1509540|NCT01594515|3693149|P3|COMPLETED|Overall Study||6
1509541|NCT01594515|3693150|P2|COMPLETED|Overall Study||6
1509542|NCT01594515|3693151|P1|COMPLETED|Overall Study||6
1509543|NCT01594515|3693142|P10|STARTED|Overall Study||16
1509544|NCT01594515|3693143|P9|STARTED|Overall Study||6
1509545|NCT01594515|3693144|P8|STARTED|Overall Study||6
1509546|NCT01594515|3693145|P7|STARTED|Overall Study||6
1509547|NCT01594515|3693146|P6|STARTED|Overall Study||6
1509548|NCT01594515|3693147|P5|STARTED|Overall Study||6
1509549|NCT01594515|3693148|P4|STARTED|Overall Study||6
1509550|NCT01594515|3693149|P3|STARTED|Overall Study||6
1509551|NCT01594515|3693150|P2|STARTED|Overall Study||6
1509552|NCT01594515|3693151|P1|STARTED|Overall Study||6
1509553|NCT01594424|3693241|P1|NOT COMPLETED|Overall Study||2
1509554|NCT01594424|3693241|P1|COMPLETED|Overall Study||8
1509555|NCT01594424|3693241|P1|STARTED|Overall Study||10
1509556|NCT01594411|3693245|P1|NOT COMPLETED|Overall Study||2
1509557|NCT01594411|3693245|P1|COMPLETED|Overall Study||249
1509558|NCT01594411|3693245|P1|STARTED|Overall Study||251
1509559|NCT01594385|3693254|P2|NOT COMPLETED|Overall Study||0
1509560|NCT01594385|3693255|P1|NOT COMPLETED|Overall Study||0
1509561|NCT01594385|3693254|P2|COMPLETED|Overall Study||13
1509562|NCT01594385|3693255|P1|COMPLETED|Overall Study||17
1509563|NCT01594385|3693254|P2|STARTED|Overall Study||13
1509564|NCT01594385|3693255|P1|STARTED|Overall Study||17
1509565|NCT01594294|3693279|P2|NOT COMPLETED|Overall Study||4
1509566|NCT01594294|3693280|P1|NOT COMPLETED|Overall Study||3
1509567|NCT01594294|3693279|P2|COMPLETED|Overall Study||36
1509568|NCT01594294|3693280|P1|COMPLETED|Overall Study||36
1509569|NCT01594294|3693279|P2|STARTED|Overall Study||40
1509570|NCT01594294|3693280|P1|STARTED|Overall Study||39
1509571|NCT01594125|3693299|P5|NOT COMPLETED|Overall Study||7
1509572|NCT01594125|3693300|P4|NOT COMPLETED|Overall Study||4
1509573|NCT01594125|3693301|P3|NOT COMPLETED|Overall Study||3
1509574|NCT01594125|3693302|P2|NOT COMPLETED|Overall Study||12
1509575|NCT01594125|3693303|P1|NOT COMPLETED|Overall Study||4
1509576|NCT01594125|3693299|P5|COMPLETED|Overall Study||0
1509577|NCT01594125|3693300|P4|COMPLETED|Overall Study||0
1509578|NCT01594125|3693301|P3|COMPLETED|Overall Study||0
1509579|NCT01594125|3693302|P2|COMPLETED|Overall Study||0
1509580|NCT01594125|3693303|P1|COMPLETED|Overall Study||0
1509581|NCT01594125|3693299|P5|STARTED|Overall Study||7
1509582|NCT01594125|3693300|P4|STARTED|Overall Study||4
1509583|NCT01594125|3693301|P3|STARTED|Overall Study||3
1509584|NCT01594125|3693302|P2|STARTED|Overall Study||12
1509585|NCT01594125|3693303|P1|STARTED|Overall Study||4
1509586|NCT01593852|3693337|P2|NOT COMPLETED|Overall Study||0
1509587|NCT01593852|3693338|P1|NOT COMPLETED|Overall Study||0
1509588|NCT01593852|3693337|P2|COMPLETED|Overall Study||68
1509589|NCT01593852|3693338|P1|COMPLETED|Overall Study||68
1509590|NCT01593852|3693337|P2|STARTED|Overall Study||68
1509591|NCT01593852|3693338|P1|STARTED|Overall Study||68
1509592|NCT01593787|3693363|P3|NOT COMPLETED|Overall Study||0
1509593|NCT01593787|3693364|P2|NOT COMPLETED|Overall Study||0
1509594|NCT01593787|3693365|P1|NOT COMPLETED|Overall Study||1
1509595|NCT01593787|3693363|P3|COMPLETED|Overall Study||18
1509596|NCT01593787|3693364|P2|COMPLETED|Overall Study||8
1509597|NCT01593787|3693365|P1|COMPLETED|Overall Study||5
1509598|NCT01593787|3693363|P3|STARTED|Overall Study||18
1509599|NCT01593787|3693364|P2|STARTED|Overall Study||8
1509600|NCT01593787|3693365|P1|STARTED|Overall Study||6
1509601|NCT01593722|3693405|P2|NOT COMPLETED|Overall Study||0
1509602|NCT01593722|3693406|P1|NOT COMPLETED|Overall Study||0
1509603|NCT01593722|3693405|P2|COMPLETED|Overall Study||6
1509604|NCT01593722|3693406|P1|COMPLETED|Overall Study||6
1509605|NCT01593722|3693405|P2|STARTED|Overall Study||6
1509606|NCT01593722|3693406|P1|STARTED|Overall Study||6
1509607|NCT01593670|3693420|P1|NOT COMPLETED|Overall Study||0
1509608|NCT01593670|3693420|P1|COMPLETED|Overall Study||9
1509609|NCT01593670|3693420|P1|STARTED|Overall Study||9
1509610|NCT01593592|3693430|P2|NOT COMPLETED|Overall Study||0
1509611|NCT01593592|3693431|P1|NOT COMPLETED|Overall Study||0
1509612|NCT01593592|3693430|P2|COMPLETED|Overall Study||35
1509613|NCT01593592|3693431|P1|COMPLETED|Overall Study||35
1509614|NCT01593592|3693430|P2|STARTED|Overall Study||35
1509615|NCT01593592|3693431|P1|STARTED|Overall Study||35
1509616|NCT01593215|3693443|P2|NOT COMPLETED|Overall Study||0
1509617|NCT01593215|3693444|P1|NOT COMPLETED|Overall Study||1
1509618|NCT01593215|3693443|P2|COMPLETED|Overall Study||25
1509619|NCT01593215|3693444|P1|COMPLETED|Overall Study||24
1509620|NCT01593215|3693443|P2|STARTED|Overall Study||25
1509621|NCT01593215|3693444|P1|STARTED|Overall Study||25
1509622|NCT01592864|3693452|P2|NOT COMPLETED|Overall Study||1
1509623|NCT01592864|3693453|P1|NOT COMPLETED|Overall Study||0
1509624|NCT01592864|3693452|P2|COMPLETED|Overall Study||57
1509625|NCT01592864|3693453|P1|COMPLETED|Overall Study||60
1509626|NCT01592864|3693452|P2|STARTED|Overall Study||58
1509627|NCT01592864|3693453|P1|STARTED|Overall Study||60
1509628|NCT01592851|3693467|P2|NOT COMPLETED|Overall Study||0
1509629|NCT01592851|3693468|P1|NOT COMPLETED|Overall Study||0
1509630|NCT01592851|3693467|P2|COMPLETED|Overall Study||57
1509631|NCT01592851|3693468|P1|COMPLETED|Overall Study||56
1509632|NCT01592851|3693467|P2|STARTED|Overall Study||57
1509633|NCT01592851|3693468|P1|STARTED|Overall Study||56
1509634|NCT01592799|3693484|P1|NOT COMPLETED|Overall Study||0
1509635|NCT01592799|3693484|P1|COMPLETED|Overall Study||501
1509636|NCT01592799|3693484|P1|STARTED|Overall Study||501
1509637|NCT01592786|3693514|P1|NOT COMPLETED|Overall Study||138
1509638|NCT01592786|3693514|P1|COMPLETED|Overall Study||765
1509639|NCT01592786|3693514|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
1509640|NCT01592773|3693518|P1|NOT COMPLETED|Overall Study||666
1509641|NCT01592773|3693518|P1|COMPLETED|Overall Study||81
1509642|NCT01592773|3693518|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
1509643|NCT01592760|3693525|P3|NOT COMPLETED|24-hour Follow-Up||2
1509644|NCT01592760|3693526|P2|NOT COMPLETED|24-hour Follow-Up||3
1509645|NCT01592760|3693527|P1|NOT COMPLETED|24-hour Follow-Up||4
1509646|NCT01592760|3693525|P3|COMPLETED|24-hour Follow-Up||43
1509647|NCT01592760|3693526|P2|COMPLETED|24-hour Follow-Up||87
1509648|NCT01592760|3693527|P1|COMPLETED|24-hour Follow-Up||86
1509649|NCT01592760|3693525|P3|STARTED|24-hour Follow-Up||45
1509650|NCT01592760|3693526|P2|STARTED|24-hour Follow-Up||90
1509651|NCT01592760|3693527|P1|STARTED|24-hour Follow-Up||90
1509652|NCT01592760|3693525|P3|NOT COMPLETED|Perioperative to Discharge||0
1509653|NCT01592760|3693526|P2|NOT COMPLETED|Perioperative to Discharge||0
1509654|NCT01592760|3693527|P1|NOT COMPLETED|Perioperative to Discharge||0
1509655|NCT01592760|3693525|P3|COMPLETED|Perioperative to Discharge||45
1509656|NCT01592760|3693526|P2|COMPLETED|Perioperative to Discharge||90
1509657|NCT01592760|3693527|P1|COMPLETED|Perioperative to Discharge||90
1509658|NCT01592760|3693525|P3|STARTED|Perioperative to Discharge||45
1509659|NCT01592760|3693526|P2|STARTED|Perioperative to Discharge||90
1509660|NCT01592760|3693527|P1|STARTED|Perioperative to Discharge||90
1509661|NCT01592708|3693570|P2|NOT COMPLETED|Overall Study||0
1509662|NCT01592708|3693571|P1|NOT COMPLETED|Overall Study||3
1509663|NCT01592708|3693570|P2|COMPLETED|Overall Study||137
1509664|NCT01592708|3693571|P1|COMPLETED|Overall Study||93
1509665|NCT01592708|3693570|P2|STARTED|Overall Study||137
1509666|NCT01592708|3693571|P1|STARTED|Overall Study||96
1509667|NCT01592695|3693587|P2|NOT COMPLETED|Overall Study||4
1509668|NCT01592695|3693588|P1|NOT COMPLETED|Overall Study||8
1509669|NCT01592695|3693587|P2|COMPLETED|Overall Study||28
1509670|NCT01592695|3693588|P1|COMPLETED|Overall Study||23
1509671|NCT01592695|3693587|P2|STARTED|Overall Study||32
1509672|NCT01592695|3693588|P1|STARTED|Overall Study||31
1509673|NCT01592435|3693606|P1|NOT COMPLETED|Overall Study||0
1509674|NCT01592435|3693606|P1|COMPLETED|Overall Study||76
1509675|NCT01592435|3693606|P1|STARTED|Overall Study||76
1509676|NCT01592396|3693614|P2|NOT COMPLETED|Overall Study||0
1509677|NCT01592396|3693615|P1|NOT COMPLETED|Overall Study||0
1509678|NCT01592396|3693614|P2|COMPLETED|Overall Study||10
1509679|NCT01592396|3693615|P1|COMPLETED|Overall Study||10
1509680|NCT01592396|3693614|P2|STARTED|Overall Study||10
1509681|NCT01592396|3693615|P1|STARTED|Overall Study||10
1509682|NCT01592383|3693630|P1|NOT COMPLETED|Overall Study||1
1509683|NCT01592383|3693630|P1|COMPLETED|Overall Study||1
1509684|NCT01592383|3693630|P1|STARTED|Overall Study||2
1509685|NCT01592344|3693641|P2|NOT COMPLETED|Overall Study||5
1509686|NCT01592344|3693642|P1|NOT COMPLETED|Overall Study||4
1509687|NCT01592344|3693641|P2|COMPLETED|Overall Study||44
1509688|NCT01592344|3693642|P1|COMPLETED|Overall Study||41
1509689|NCT01592344|3693641|P2|STARTED|Overall Study||49
1509690|NCT01592344|3693642|P1|STARTED|Overall Study||45
1509691|NCT01592292|3693656|P4|NOT COMPLETED|Overall Study||1
1509692|NCT01592292|3693657|P3|NOT COMPLETED|Overall Study||3
1509693|NCT01592292|3693658|P2|NOT COMPLETED|Overall Study||5
1509694|NCT01592292|3693659|P1|NOT COMPLETED|Overall Study||6
1509695|NCT01592292|3693656|P4|COMPLETED|Overall Study||10
1509696|NCT01592292|3693657|P3|COMPLETED|Overall Study||10
1509697|NCT01592292|3693658|P2|COMPLETED|Overall Study||15
1509698|NCT01592292|3693659|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
1509699|NCT01592292|3693656|P4|Standard Population Set (SPS)|Overall Study||7
1509700|NCT01592292|3693657|P3|Standard Population Set (SPS)|Overall Study||7
1509701|NCT01592292|3693658|P2|Standard Population Set (SPS)|Overall Study||10
1509702|NCT01592292|3693659|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
1509703|NCT01592292|3693656|P4|Intention to Treat (ITT) Set|Overall Study||8
1509704|NCT01592292|3693657|P3|Intention to Treat (ITT) Set|Overall Study||10
1509705|NCT01592292|3693658|P2|Intention to Treat (ITT) Set|Overall Study||13
1509706|NCT01592292|3693659|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
1509707|NCT01592292|3693656|P4|STARTED|Overall Study||11
1509708|NCT01592292|3693657|P3|STARTED|Overall Study||13
1509709|NCT01592292|3693658|P2|STARTED|Overall Study||20
1509710|NCT01592292|3693659|P1|STARTED|Overall Study||46
1509711|NCT01592240|3693698|P7|NOT COMPLETED|Overall Study||3
1509712|NCT01592240|3693699|P6|NOT COMPLETED|Overall Study||3
1509713|NCT01592240|3693700|P5|NOT COMPLETED|Overall Study||7
1509714|NCT01592240|3693701|P4|NOT COMPLETED|Overall Study||3
1509715|NCT01592240|3693702|P3|NOT COMPLETED|Overall Study||7
1509716|NCT01592240|3693703|P2|NOT COMPLETED|Overall Study||11
1509717|NCT01592240|3693704|P1|NOT COMPLETED|Overall Study||3
1509718|NCT01592240|3693698|P7|COMPLETED|Overall Study||48
1509719|NCT01592240|3693699|P6|COMPLETED|Overall Study||47
1509720|NCT01592240|3693700|P5|COMPLETED|Overall Study||44
1509721|NCT01592240|3693701|P4|COMPLETED|Overall Study||47
1509722|NCT01592240|3693702|P3|COMPLETED|Overall Study||45
1509723|NCT01592240|3693703|P2|COMPLETED|Overall Study||39
1509724|NCT01592240|3693704|P1|COMPLETED|Overall Study||47
1509725|NCT01592240|3693698|P7|STARTED|Overall Study||51
1509726|NCT01592240|3693699|P6|STARTED|Overall Study||50
1509727|NCT01592240|3693700|P5|STARTED|Overall Study||51
1509728|NCT01592240|3693701|P4|STARTED|Overall Study||50
1509729|NCT01592240|3693702|P3|STARTED|Overall Study||52
1509730|NCT01592240|3693703|P2|STARTED|Overall Study||50
1509731|NCT01592240|3693704|P1|STARTED|Overall Study||50
1509732|NCT01592071|3693884|P1|NOT COMPLETED|Overall Study||0
1509733|NCT01592071|3693884|P1|COMPLETED|Overall Study||120
1509734|NCT01592071|3693884|P1|STARTED|Overall Study||120
1509735|NCT01592045|3693897|P2|NOT COMPLETED|Overall Study||2
1509736|NCT01592045|3693898|P1|NOT COMPLETED|Overall Study||5
1509737|NCT01592045|3693897|P2|COMPLETED|Overall Study||12
1509738|NCT01592045|3693898|P1|COMPLETED|Overall Study||9
1509739|NCT01592045|3693897|P2|Completed Course 5|Overall Study||12
1509740|NCT01592045|3693898|P1|Completed Course 5|Overall Study||9
1509741|NCT01592045|3693897|P2|Completed Course 4|Overall Study||12
1509742|NCT01592045|3693898|P1|Completed Course 4|Overall Study||11
1509743|NCT01592045|3693897|P2|Completed Course 3|Overall Study||13
1509744|NCT01592045|3693898|P1|Completed Course 3|Overall Study||11
1509745|NCT01592045|3693897|P2|Completed Course 2|Overall Study||13
1509746|NCT01592045|3693898|P1|Completed Course 2|Overall Study||13
1509747|NCT01592045|3693897|P2|Completed Course 1|Overall Study||14
1509748|NCT01592045|3693898|P1|Completed Course 1|Overall Study||13
1509749|NCT01592045|3693897|P2|STARTED|Overall Study||14
1509750|NCT01592045|3693898|P1|STARTED|Overall Study||14
1509751|NCT01592006|3693906|P1|NOT COMPLETED|Overall Study||0
1509752|NCT01592006|3693906|P1|COMPLETED|Overall Study||3
1509753|NCT01592006|3693906|P1|STARTED|Overall Study||3
1509754|NCT01591954|3693911|P1|NOT COMPLETED|Overall Study||0
1509755|NCT01591954|3693911|P1|COMPLETED|Overall Study||1
1509756|NCT01591954|3693911|P1|STARTED|Overall Study||1
1509757|NCT01591863|3693916|P1|NOT COMPLETED|Overall Study||14
1509758|NCT01591863|3693916|P1|COMPLETED|Overall Study||24
1509759|NCT01591863|3693916|P1|STARTED|Overall Study||38
1509760|NCT01591837|3693928|P2|NOT COMPLETED|Overall Study||0
1509761|NCT01591837|3693929|P1|NOT COMPLETED|Overall Study||0
1509762|NCT01591837|3693928|P2|COMPLETED|Overall Study||60
1509763|NCT01591837|3693929|P1|COMPLETED|Overall Study||60
1509764|NCT01591837|3693928|P2|STARTED|Overall Study||60
1509765|NCT01591837|3693929|P1|STARTED|Overall Study||60
1509766|NCT01591733|3693943|P1|NOT COMPLETED|Overall Study||0
1509767|NCT01591733|3693943|P1|COMPLETED|Overall Study||48
1509768|NCT01591733|3693943|P1|STARTED|Overall Study||48
1509769|NCT01591681|3693954|P1|NOT COMPLETED|Overall Study||4
1509770|NCT01591681|3693954|P1|COMPLETED|Overall Study||45
1509771|NCT01591681|3693954|P1|STARTED|Overall Study||49
1509772|NCT01591616|3693980|P1|NOT COMPLETED|Overall Study||1
1509773|NCT01591616|3693980|P1|COMPLETED|Overall Study||15
1509774|NCT01591616|3693980|P1|STARTED|Overall Study||16
1509775|NCT01591499|3694121|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
1509776|NCT01591499|3694122|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
1509777|NCT01591499|3694123|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
1509778|NCT01591499|3694124|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
1509779|NCT01591499|3694121|P4|COMPLETED|Second Intervention (up to 24 Days)||34
1509780|NCT01591499|3694122|P3|COMPLETED|Second Intervention (up to 24 Days)||28
1509781|NCT01591499|3694123|P2|COMPLETED|Second Intervention (up to 24 Days)||34
1509782|NCT01591499|3694124|P1|COMPLETED|Second Intervention (up to 24 Days)||27
1509783|NCT01591499|3694121|P4|STARTED|Second Intervention (up to 24 Days)||37
1509784|NCT01591499|3694122|P3|STARTED|Second Intervention (up to 24 Days)||31
1509785|NCT01591499|3694123|P2|STARTED|Second Intervention (up to 24 Days)||37
1509786|NCT01591499|3694124|P1|STARTED|Second Intervention (up to 24 Days)||33
1509787|NCT01591499|3694121|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
1509788|NCT01591499|3694122|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
1509789|NCT01591499|3694123|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
1509790|NCT01591499|3694124|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
1509791|NCT01591499|3694121|P4|COMPLETED|First Intervention (up to 24 Days)||37
1509792|NCT01591499|3694122|P3|COMPLETED|First Intervention (up to 24 Days)||31
1509793|NCT01591499|3694123|P2|COMPLETED|First Intervention (up to 24 Days)||37
1509794|NCT01591499|3694124|P1|COMPLETED|First Intervention (up to 24 Days)||33
1509795|NCT01591499|3694121|P4|STARTED|First Intervention (up to 24 Days)||37
1509796|NCT01591499|3694122|P3|STARTED|First Intervention (up to 24 Days)||31
1509797|NCT01591499|3694123|P2|STARTED|First Intervention (up to 24 Days)||37
1509798|NCT01591499|3694124|P1|STARTED|First Intervention (up to 24 Days)||33
1509799|NCT01591499|3694121|P4|NOT COMPLETED|Baseline Visit||2
1509800|NCT01591499|3694122|P3|NOT COMPLETED|Baseline Visit||0
1509801|NCT01591499|3694123|P2|NOT COMPLETED|Baseline Visit||2
1509802|NCT01591499|3694124|P1|NOT COMPLETED|Baseline Visit||0
1509803|NCT01591499|3694121|P4|COMPLETED|Baseline Visit||37
1509804|NCT01591499|3694122|P3|COMPLETED|Baseline Visit||31
1509805|NCT01591499|3694123|P2|COMPLETED|Baseline Visit||37
1509806|NCT01591499|3694124|P1|COMPLETED|Baseline Visit||33
1509807|NCT01591499|3694121|P4|STARTED|Baseline Visit||39
1509808|NCT01591499|3694122|P3|STARTED|Baseline Visit||31
1509809|NCT01591499|3694123|P2|STARTED|Baseline Visit||39
1509810|NCT01591499|3694124|P1|STARTED|Baseline Visit||33
1509811|NCT01591460|3694190|P1|NOT COMPLETED|Overall Study||26
1509812|NCT01591460|3694190|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
1509813|NCT01591460|3694190|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
1509814|NCT01591408|3694272|P2|NOT COMPLETED|Overall Study||8
1509815|NCT01591408|3694273|P1|NOT COMPLETED|Overall Study||12
1509816|NCT01591408|3694272|P2|COMPLETED|Overall Study||24
1509817|NCT01591408|3694273|P1|COMPLETED|Overall Study||24
1509818|NCT01591408|3694272|P2|STARTED|Overall Study||32
1509819|NCT01591408|3694273|P1|STARTED|Overall Study||36
1509820|NCT01591382|3694281|P2|NOT COMPLETED|Overall Study||2
1509821|NCT01591382|3694282|P1|NOT COMPLETED|Overall Study||3
1509822|NCT01591382|3694281|P2|COMPLETED|Overall Study||30
1509823|NCT01591382|3694282|P1|COMPLETED|Overall Study||29
1509824|NCT01591382|3694281|P2|STARTED|Overall Study||32
1509825|NCT01591382|3694282|P1|STARTED|Overall Study||32
1509826|NCT01591317|3694299|P3|NOT COMPLETED|Overall Study||0
1509827|NCT01591317|3694300|P2|NOT COMPLETED|Overall Study||0
1509828|NCT01591317|3694301|P1|NOT COMPLETED|Overall Study||0
1509829|NCT01591317|3694299|P3|COMPLETED|Overall Study||10
1509830|NCT01591317|3694300|P2|COMPLETED|Overall Study||10
1509831|NCT01591317|3694301|P1|COMPLETED|Overall Study||10
1509832|NCT01591317|3694299|P3|STARTED|Overall Study||10
1509833|NCT01591317|3694300|P2|STARTED|Overall Study||10
1509834|NCT01591317|3694301|P1|STARTED|Overall Study||10
1509835|NCT01591096|3694327|P1|NOT COMPLETED|Overall Study||1
1509836|NCT01591096|3694327|P1|COMPLETED|Overall Study||0
1509837|NCT01591096|3694327|P1|STARTED|Overall Study||1
1509838|NCT01591044|3694336|P3|NOT COMPLETED|Overall Study||4
1509839|NCT01591044|3694337|P2|NOT COMPLETED|Overall Study||9
1509840|NCT01591044|3694338|P1|NOT COMPLETED|Overall Study||7
1509841|NCT01591044|3694336|P3|COMPLETED|Overall Study||96
1509842|NCT01591044|3694337|P2|COMPLETED|Overall Study||91
1509843|NCT01591044|3694338|P1|COMPLETED|Overall Study||94
1509844|NCT01591044|3694336|P3|STARTED|Overall Study||100
1509845|NCT01591044|3694337|P2|STARTED|Overall Study||100
1509846|NCT01591044|3694338|P1|STARTED|Overall Study||101
1509847|NCT01591018|3694348|P2|NOT COMPLETED|Overall Study||0
1509848|NCT01591018|3694349|P1|NOT COMPLETED|Overall Study||0
1509849|NCT01591018|3694348|P2|COMPLETED|Overall Study||60
1509850|NCT01591018|3694349|P1|COMPLETED|Overall Study||60
1509851|NCT01591018|3694348|P2|STARTED|Overall Study||60
1509852|NCT01591018|3694349|P1|STARTED|Overall Study||60
1509853|NCT01591005|3694363|P4|NOT COMPLETED|Overall Study||0
1509854|NCT01591005|3694364|P3|NOT COMPLETED|Overall Study||0
1509855|NCT01591005|3694365|P2|NOT COMPLETED|Overall Study||0
1509856|NCT01591005|3694366|P1|NOT COMPLETED|Overall Study||0
1509857|NCT01591005|3694363|P4|COMPLETED|Overall Study||68
1509858|NCT01591005|3694364|P3|COMPLETED|Overall Study||68
1509859|NCT01591005|3694365|P2|COMPLETED|Overall Study||53
1509860|NCT01591005|3694366|P1|COMPLETED|Overall Study||53
1509861|NCT01591005|3694363|P4|STARTED|Overall Study||68
1509862|NCT01591005|3694364|P3|STARTED|Overall Study||68
1509863|NCT01591005|3694365|P2|STARTED|Overall Study||53
1509864|NCT01591005|3694366|P1|STARTED|Overall Study||53
1509865|NCT01590979|3694402|P2|NOT COMPLETED|Overall Study||0
1509866|NCT01590979|3694403|P1|NOT COMPLETED|Overall Study||0
1509867|NCT01590979|3694402|P2|COMPLETED|Overall Study||27
1509868|NCT01590979|3694403|P1|COMPLETED|Overall Study||27
1509869|NCT01590979|3694402|P2|STARTED|Overall Study||27
1509870|NCT01590979|3694403|P1|STARTED|Overall Study||27
1509871|NCT01590888|3694412|P3|NOT COMPLETED|Overall Study||1
1509872|NCT01590888|3694413|P2|NOT COMPLETED|Overall Study||0
1509873|NCT01590888|3694414|P1|NOT COMPLETED|Overall Study||4
1509874|NCT01590888|3694412|P3|COMPLETED|Overall Study||34
1509875|NCT01590888|3694413|P2|COMPLETED|Overall Study||38
1509876|NCT01590888|3694414|P1|COMPLETED|Overall Study||32
1509877|NCT01590888|3694412|P3|STARTED|Overall Study||35
1509878|NCT01590888|3694413|P2|STARTED|Overall Study||38
1509879|NCT01590888|3694414|P1|STARTED|Overall Study||36
1509880|NCT01590875|3694460|P2|NOT COMPLETED|Overall Study||0
1509881|NCT01590875|3694461|P1|NOT COMPLETED|Overall Study||0
1509882|NCT01590875|3694460|P2|COMPLETED|Overall Study||10
1509883|NCT01590875|3694461|P1|COMPLETED|Overall Study||10
1509884|NCT01590875|3694460|P2|STARTED|Overall Study||10
1509885|NCT01590875|3694461|P1|STARTED|Overall Study||10
1509886|NCT01590810|3694474|P5|NOT COMPLETED|Overall Study||0
1509887|NCT01590810|3694475|P4|NOT COMPLETED|Overall Study||0
1509888|NCT01590810|3694476|P3|NOT COMPLETED|Overall Study||1
1509889|NCT01590810|3694477|P2|NOT COMPLETED|Overall Study||1
1509890|NCT01590810|3694478|P1|NOT COMPLETED|Overall Study||0
1509891|NCT01590810|3694474|P5|COMPLETED|Overall Study||2
1509892|NCT01590810|3694475|P4|COMPLETED|Overall Study||8
1509893|NCT01590810|3694476|P3|COMPLETED|Overall Study||7
1509894|NCT01590810|3694477|P2|COMPLETED|Overall Study||7
1509895|NCT01590810|3694478|P1|COMPLETED|Overall Study||8
1509896|NCT01590810|3694474|P5|STARTED|Overall Study||2
1509897|NCT01590810|3694475|P4|STARTED|Overall Study||8
1509898|NCT01590810|3694476|P3|STARTED|Overall Study||8
1509899|NCT01590810|3694477|P2|STARTED|Overall Study||8
1509900|NCT01590810|3694478|P1|STARTED|Overall Study||8
1509901|NCT01590797|3694623|P2|NOT COMPLETED|Overall Study||16
1509902|NCT01590797|3694624|P1|NOT COMPLETED|Overall Study||17
1509903|NCT01590797|3694623|P2|COMPLETED|Overall Study||217
1509904|NCT01590797|3694624|P1|COMPLETED|Overall Study||217
1509905|NCT01590797|3694623|P2|STARTED|Overall Study||233
1509906|NCT01590797|3694624|P1|STARTED|Overall Study||234
1509907|NCT01590771|3694640|P2|NOT COMPLETED|Overall Study||39
1509908|NCT01590771|3694641|P1|NOT COMPLETED|Overall Study||19
1509909|NCT01590771|3694640|P2|COMPLETED|Overall Study||210
1509910|NCT01590771|3694641|P1|COMPLETED|Overall Study||230
1509911|NCT01590771|3694640|P2|STARTED|Overall Study||249
1509912|NCT01590771|3694641|P1|STARTED|Overall Study||249
1509913|NCT01590758|3694669|P2|NOT COMPLETED|Overall Study||7
1509914|NCT01590758|3694670|P1|NOT COMPLETED|Overall Study||5
1509915|NCT01590758|3694669|P2|COMPLETED|Overall Study||97
1509916|NCT01590758|3694670|P1|COMPLETED|Overall Study||80
1509917|NCT01590758|3694669|P2|STARTED|Overall Study||104
1509918|NCT01590758|3694670|P1|STARTED|Overall Study||85
1509919|NCT01590563|3694680|P1|NOT COMPLETED|Overall Study||1
1509920|NCT01590563|3694680|P1|COMPLETED|Overall Study||14
1509921|NCT01590563|3694680|P1|STARTED|Overall Study||15
1509922|NCT01590550|3694686|P1|NOT COMPLETED|Overall Study||0
1509923|NCT01590550|3694686|P1|COMPLETED|Overall Study||18
1509924|NCT01590550|3694686|P1|STARTED|Overall Study||18
1509925|NCT01590394|3694692|P1|NOT COMPLETED|Overall Study||0
1509926|NCT01590394|3694692|P1|COMPLETED|Overall Study||3
1509927|NCT01590394|3694692|P1|STARTED|Overall Study||3
1509928|NCT01590264|3694696|P1|NOT COMPLETED|Overall Study||0
1509929|NCT01590264|3694696|P1|COMPLETED|Overall Study||5
1509930|NCT01590264|3694696|P1|STARTED|Overall Study||5
1509931|NCT01590238|3694701|P1|NOT COMPLETED|Overall Study||2
1509932|NCT01590238|3694701|P1|COMPLETED|Overall Study||13
1509933|NCT01590238|3694701|P1|STARTED|Overall Study||15
1509934|NCT01590212|3694708|P3|NOT COMPLETED|Overall Study||5
1509935|NCT01590212|3694709|P2|NOT COMPLETED|Overall Study||4
1509936|NCT01590212|3694710|P1|NOT COMPLETED|Overall Study||3
1509937|NCT01590212|3694708|P3|COMPLETED|Overall Study||9
1509938|NCT01590212|3694709|P2|COMPLETED|Overall Study||5
1509939|NCT01590212|3694710|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
1509940|NCT01590212|3694708|P3|Post-intervention|Overall Study|failed contact=1|10
1509941|NCT01590212|3694709|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
1509942|NCT01590212|3694710|P1|Post-intervention|Overall Study|failed contact=3|7
1509943|NCT01590212|3694708|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
1509944|NCT01590212|3694709|P2|Baseline (Pre-intervention)|Overall Study||9
1509945|NCT01590212|3694710|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
1509946|NCT01590212|3694708|P3|STARTED|Overall Study||14
1509947|NCT01590212|3694709|P2|STARTED|Overall Study||9
1509948|NCT01590212|3694710|P1|STARTED|Overall Study||12
1509949|NCT01589978|3694727|P1|NOT COMPLETED|Overall Study||0
1509950|NCT01589978|3694727|P1|COMPLETED|Overall Study||2681
1509951|NCT01589978|3694727|P1|STARTED|Overall Study||2681
1509952|NCT01589926|3694753|P2|NOT COMPLETED|Overall Study||0
1509953|NCT01589926|3694754|P1|NOT COMPLETED|Overall Study||0
1509954|NCT01589926|3694753|P2|COMPLETED|Overall Study||0
1509955|NCT01589926|3694754|P1|COMPLETED|Overall Study||0
1509956|NCT01589926|3694753|P2|STARTED|Overall Study||0
1509957|NCT01589926|3694754|P1|STARTED|Overall Study||0
1509958|NCT01589822|3694775|P3|NOT COMPLETED|Overall Study||1
1509959|NCT01589822|3694776|P2|NOT COMPLETED|Overall Study||3
1509960|NCT01589822|3694777|P1|NOT COMPLETED|Overall Study||4
1509961|NCT01589822|3694775|P3|COMPLETED|Overall Study||40
1509962|NCT01589822|3694776|P2|COMPLETED|Overall Study||86
1509963|NCT01589822|3694777|P1|COMPLETED|Overall Study||80
1509964|NCT01589822|3694775|P3|STARTED|Overall Study||41
1509965|NCT01589822|3694776|P2|STARTED|Overall Study||89
1509966|NCT01589822|3694777|P1|STARTED|Overall Study||84
1509967|NCT01589653|3694796|P2|NOT COMPLETED|Overall Study||11
1509968|NCT01589653|3694797|P1|NOT COMPLETED|Overall Study||7
1509969|NCT01589653|3694796|P2|COMPLETED|Overall Study||68
1509970|NCT01589653|3694797|P1|COMPLETED|Overall Study||69
1509971|NCT01589653|3694796|P2|Exposed|Overall Study||78
1509972|NCT01589653|3694797|P1|Exposed|Overall Study||76
1509973|NCT01589653|3694796|P2|STARTED|Overall Study||79
1509974|NCT01589653|3694797|P1|STARTED|Overall Study||76
1509975|NCT01589601|3694813|P2|NOT COMPLETED|Overall Study||49
1509976|NCT01589601|3694814|P1|NOT COMPLETED|Overall Study||47
1509977|NCT01589601|3694813|P2|COMPLETED|Overall Study||26
1509978|NCT01589601|3694814|P1|COMPLETED|Overall Study||28
1509979|NCT01589601|3694813|P2|STARTED|Overall Study||75
1509980|NCT01589601|3694814|P1|STARTED|Overall Study||75
1509981|NCT01589510|3694830|P1|NOT COMPLETED|Overall Study||33
1509982|NCT01589510|3694830|P1|COMPLETED|Overall Study||386
1509983|NCT01589510|3694830|P1|STARTED|Overall Study||419
1509984|NCT01589497|3694845|P4|NOT COMPLETED|Overall Study||1
1509985|NCT01589497|3694846|P3|NOT COMPLETED|Overall Study||1
1509986|NCT01589497|3694847|P2|NOT COMPLETED|Overall Study||1
1509987|NCT01589497|3694848|P1|NOT COMPLETED|Overall Study||1
1509988|NCT01589497|3694845|P4|COMPLETED|Overall Study||17
1509989|NCT01589497|3694846|P3|COMPLETED|Overall Study||15
1509990|NCT01589497|3694847|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
1509991|NCT01589497|3694848|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
1509992|NCT01589497|3694845|P4|STARTED|Overall Study||18
1509993|NCT01589497|3694846|P3|STARTED|Overall Study||16
1509994|NCT01589497|3694847|P2|STARTED|Overall Study||17
1509995|NCT01589497|3694848|P1|STARTED|Overall Study||18
1509996|NCT01589484|3694949|P1|NOT COMPLETED|Overall Study||4
1509997|NCT01589484|3694949|P1|COMPLETED|Overall Study||100
1509998|NCT01589484|3694949|P1|STARTED|Overall Study||104
1509999|NCT01589445|3694954|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
1510000|NCT01589445|3694954|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
1510001|NCT01589445|3694954|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
1510002|NCT01589445|3694954|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
1510003|NCT01589445|3694954|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
1510004|NCT01589445|3694954|P1|STARTED|001 (Pioglitazone) -3 Months||77
1510005|NCT01589237|3694974|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
1510006|NCT01589237|3694975|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
1510007|NCT01589237|3694976|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
1510008|NCT01589237|3694977|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
1510009|NCT01589237|3694974|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
1510010|NCT01589237|3694975|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
1510011|NCT01589237|3694976|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
1510012|NCT01589237|3694977|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
1510013|NCT01589237|3694974|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
1510014|NCT01589237|3694975|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
1510015|NCT01589237|3694976|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
1510016|NCT01589237|3694977|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
1510017|NCT01589237|3694974|P4|NOT COMPLETED|Part A (52 Weeks)||0
1510018|NCT01589237|3694975|P3|NOT COMPLETED|Part A (52 Weeks)||2
1510019|NCT01589237|3694976|P2|NOT COMPLETED|Part A (52 Weeks)||3
1510020|NCT01589237|3694977|P1|NOT COMPLETED|Part A (52 Weeks)||2
1510021|NCT01589237|3694974|P4|COMPLETED|Part A (52 Weeks)||5
1510022|NCT01589237|3694975|P3|COMPLETED|Part A (52 Weeks)||8
1510023|NCT01589237|3694976|P2|COMPLETED|Part A (52 Weeks)||9
1510024|NCT01589237|3694977|P1|COMPLETED|Part A (52 Weeks)||9
1510025|NCT01589237|3694974|P4|STARTED|Part A (52 Weeks)||5
1510026|NCT01589237|3694975|P3|STARTED|Part A (52 Weeks)||10
1510027|NCT01589237|3694976|P2|STARTED|Part A (52 Weeks)||12
1510028|NCT01589237|3694977|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
1510029|NCT01588951|3695026|P3|NOT COMPLETED|Overall Study||1
1510030|NCT01588951|3695027|P2|NOT COMPLETED|Overall Study||0
1510031|NCT01588951|3695028|P1|NOT COMPLETED|Overall Study||0
1510032|NCT01588951|3695026|P3|COMPLETED|Overall Study||5
1510033|NCT01588951|3695027|P2|COMPLETED|Overall Study||2
1510034|NCT01588951|3695028|P1|COMPLETED|Overall Study||2
1510035|NCT01588951|3695026|P3|STARTED|Overall Study||6
1510036|NCT01588951|3695027|P2|STARTED|Overall Study||2
1510037|NCT01588951|3695028|P1|STARTED|Overall Study||2
1510038|NCT01588821|3695036|P1|NOT COMPLETED|Overall Study||0
1510039|NCT01588821|3695036|P1|COMPLETED|Overall Study||37
1510040|NCT01588821|3695036|P1|STARTED|Overall Study||37
1510041|NCT01588561|3695041|P2|NOT COMPLETED|Overall Study||0
1510042|NCT01588561|3695042|P1|NOT COMPLETED|Overall Study||0
1510043|NCT01588561|3695041|P2|COMPLETED|Overall Study||1
1510044|NCT01588561|3695042|P1|COMPLETED|Overall Study||14
1510045|NCT01588561|3695041|P2|Second Injection (Visit 2)|Overall Study||1
1510046|NCT01588561|3695042|P1|Second Injection (Visit 2)|Overall Study||14
1510047|NCT01588561|3695041|P2|Rest Period|Overall Study||1
1510048|NCT01588561|3695042|P1|Rest Period|Overall Study||14
1510049|NCT01588561|3695041|P2|First Injection (Visit 1)|Overall Study||1
1510050|NCT01588561|3695042|P1|First Injection (Visit 1)|Overall Study||14
1510051|NCT01588561|3695041|P2|STARTED|Overall Study||1
1510052|NCT01588561|3695042|P1|STARTED|Overall Study||14
1510053|NCT01588548|3695059|P6|NOT COMPLETED|Overall Study||6
1510054|NCT01588548|3695060|P5|NOT COMPLETED|Overall Study||6
1510055|NCT01588548|3695061|P4|NOT COMPLETED|Overall Study||7
1510056|NCT01588548|3695062|P3|NOT COMPLETED|Overall Study||6
1510057|NCT01588548|3695063|P2|NOT COMPLETED|Overall Study||7
1510058|NCT01588548|3695064|P1|NOT COMPLETED|Overall Study||3
1510059|NCT01588548|3695059|P6|COMPLETED|Overall Study||0
1510060|NCT01588548|3695060|P5|COMPLETED|Overall Study||0
1510061|NCT01588548|3695061|P4|COMPLETED|Overall Study||0
1510062|NCT01588548|3695062|P3|COMPLETED|Overall Study||0
1510063|NCT01588548|3695063|P2|COMPLETED|Overall Study||0
1510064|NCT01588548|3695064|P1|COMPLETED|Overall Study||0
1510065|NCT01588548|3695059|P6|Cycle 1 Day 21|Overall Study||3
1510066|NCT01588548|3695060|P5|Cycle 1 Day 21|Overall Study||3
1510067|NCT01588548|3695061|P4|Cycle 1 Day 21|Overall Study||5
1510068|NCT01588548|3695062|P3|Cycle 1 Day 21|Overall Study||2
1510069|NCT01588548|3695063|P2|Cycle 1 Day 21|Overall Study||5
1510070|NCT01588548|3695064|P1|Cycle 1 Day 21|Overall Study||3
1510071|NCT01588548|3695059|P6|STARTED|Overall Study||6
1510072|NCT01588548|3695060|P5|STARTED|Overall Study||6
1510073|NCT01588548|3695061|P4|STARTED|Overall Study||7
1510074|NCT01588548|3695062|P3|STARTED|Overall Study||6
1510075|NCT01588548|3695063|P2|STARTED|Overall Study||7
1510076|NCT01588548|3695064|P1|STARTED|Overall Study||3
1510077|NCT01588496|3695081|P3|NOT COMPLETED|Overall Study||0
1510078|NCT01588496|3695082|P2|NOT COMPLETED|Overall Study||1
1510079|NCT01588496|3695083|P1|NOT COMPLETED|Overall Study||0
1510080|NCT01588496|3695081|P3|COMPLETED|Overall Study||33
1510081|NCT01588496|3695082|P2|COMPLETED|Overall Study||16
1510082|NCT01588496|3695083|P1|COMPLETED|Overall Study||8
1510083|NCT01588496|3695081|P3|Received Treatment|Overall Study||33
1510084|NCT01588496|3695082|P2|Received Treatment|Overall Study||16
1510085|NCT01588496|3695083|P1|Received Treatment|Overall Study||8
1510086|NCT01588496|3695081|P3|STARTED|Overall Study||33
1510087|NCT01588496|3695082|P2|STARTED|Overall Study||17
1510088|NCT01588496|3695083|P1|STARTED|Overall Study||8
1510089|NCT01588470|3695108|P1|NOT COMPLETED|Overall Study||80
1510090|NCT01588470|3695108|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
1510091|NCT01588470|3695108|P1|STARTED|Overall Study|First enrolled April 2007|130
1510092|NCT01588444|3695119|P2|NOT COMPLETED|Overall Study||0
1510093|NCT01588444|3695120|P1|NOT COMPLETED|Overall Study||0
1510094|NCT01588444|3695119|P2|COMPLETED|Overall Study||20
1510095|NCT01588444|3695120|P1|COMPLETED|Overall Study||20
1510096|NCT01588444|3695119|P2|STARTED|Overall Study||20
1510097|NCT01588444|3695120|P1|STARTED|Overall Study||20
1510098|NCT01588418|3695126|P2|NOT COMPLETED|Overall Study||0
1510099|NCT01588418|3695127|P1|NOT COMPLETED|Overall Study||0
1510100|NCT01588418|3695126|P2|COMPLETED|Overall Study||4
1510101|NCT01588418|3695127|P1|COMPLETED|Overall Study||11
1510102|NCT01588418|3695126|P2|STARTED|Overall Study||4
1510103|NCT01588418|3695127|P1|STARTED|Overall Study||11
1510104|NCT01588405|3695133|P1|NOT COMPLETED|Overall Study||2
1510105|NCT01588405|3695133|P1|COMPLETED|Overall Study||31
1510106|NCT01588405|3695133|P1|STARTED|Overall Study||33
1510107|NCT01588353|3695160|P3|NOT COMPLETED|Step3||2
1510108|NCT01588353|3695161|P2|NOT COMPLETED|Step3||0
1510109|NCT01588353|3695162|P1|NOT COMPLETED|Step3||0
1510110|NCT01588353|3695160|P3|COMPLETED|Step3||23
1510111|NCT01588353|3695161|P2|COMPLETED|Step3||0
1510112|NCT01588353|3695162|P1|COMPLETED|Step3||0
1510113|NCT01588353|3695160|P3|STARTED|Step3||25
1510114|NCT01588353|3695161|P2|STARTED|Step3||0
1510115|NCT01588353|3695162|P1|STARTED|Step3||0
1510116|NCT01588353|3695160|P3|NOT COMPLETED|Step2||0
1510117|NCT01588353|3695161|P2|NOT COMPLETED|Step2||1
1510118|NCT01588353|3695162|P1|NOT COMPLETED|Step2||0
1510119|NCT01588353|3695160|P3|COMPLETED|Step2||0
1510120|NCT01588353|3695161|P2|COMPLETED|Step2||70
1510121|NCT01588353|3695162|P1|COMPLETED|Step2||0
1510122|NCT01588353|3695160|P3|STARTED|Step2||0
1510123|NCT01588353|3695161|P2|STARTED|Step2||71
1510124|NCT01588353|3695162|P1|STARTED|Step2||0
1510125|NCT01588353|3695160|P3|NOT COMPLETED|Step1||0
1510126|NCT01588353|3695161|P2|NOT COMPLETED|Step1||0
1510127|NCT01588353|3695162|P1|NOT COMPLETED|Step1||0
1510128|NCT01588353|3695160|P3|COMPLETED|Step1||0
1510129|NCT01588353|3695161|P2|COMPLETED|Step1||0
1510130|NCT01588353|3695162|P1|COMPLETED|Step1||6
1510131|NCT01588353|3695160|P3|STARTED|Step1||0
1510132|NCT01588353|3695161|P2|STARTED|Step1||0
1510133|NCT01588353|3695162|P1|STARTED|Step1||6
1510134|NCT01588158|3695180|P2|NOT COMPLETED|Overall Study||0
1510135|NCT01588158|3695181|P1|NOT COMPLETED|Overall Study||0
1510136|NCT01588158|3695180|P2|COMPLETED|Overall Study||3
1510137|NCT01588158|3695181|P1|COMPLETED|Overall Study||4
1510138|NCT01588158|3695180|P2|STARTED|Overall Study||3
1510139|NCT01588158|3695181|P1|STARTED|Overall Study||4
1510140|NCT01588106|3695205|P2|NOT COMPLETED|Overall Study||4
1510141|NCT01588106|3695206|P1|NOT COMPLETED|Overall Study||5
1510142|NCT01588106|3695205|P2|COMPLETED|Overall Study||72
1510143|NCT01588106|3695206|P1|COMPLETED|Overall Study||73
1510144|NCT01588106|3695205|P2|STARTED|Overall Study||76
1510145|NCT01588106|3695206|P1|STARTED|Overall Study||78
1510146|NCT01587989|3695214|P3|NOT COMPLETED|Randomized Study Treatment||1
1510147|NCT01587989|3695215|P2|NOT COMPLETED|Randomized Study Treatment||2
1510148|NCT01587989|3695216|P1|NOT COMPLETED|Randomized Study Treatment||0
1510149|NCT01587989|3695214|P3|COMPLETED|Randomized Study Treatment||32
1510150|NCT01587989|3695215|P2|COMPLETED|Randomized Study Treatment||30
1510151|NCT01587989|3695216|P1|COMPLETED|Randomized Study Treatment||0
1510152|NCT01587989|3695214|P3|STARTED|Randomized Study Treatment||33
1510153|NCT01587989|3695215|P2|STARTED|Randomized Study Treatment||32
1510154|NCT01587989|3695216|P1|STARTED|Randomized Study Treatment||0
1510155|NCT01587989|3695214|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
1510156|NCT01587989|3695215|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
1510157|NCT01587989|3695216|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
1510158|NCT01587989|3695214|P3|COMPLETED|12-Week Open-Label Run-In Period||0
1510159|NCT01587989|3695215|P2|COMPLETED|12-Week Open-Label Run-In Period||0
1510160|NCT01587989|3695216|P1|COMPLETED|12-Week Open-Label Run-In Period||65
1510161|NCT01587989|3695214|P3|STARTED|12-Week Open-Label Run-In Period||0
1510162|NCT01587989|3695215|P2|STARTED|12-Week Open-Label Run-In Period||0
1510163|NCT01587989|3695216|P1|STARTED|12-Week Open-Label Run-In Period||77
1510164|NCT01587963|3695240|P2|NOT COMPLETED|Overall Study||0
1510165|NCT01587963|3695241|P1|NOT COMPLETED|Overall Study||1
1510166|NCT01587963|3695240|P2|COMPLETED|Overall Study||4
1510167|NCT01587963|3695241|P1|COMPLETED|Overall Study||6
1510168|NCT01587963|3695240|P2|STARTED|Overall Study||4
1510169|NCT01587963|3695241|P1|STARTED|Overall Study||7
1510170|NCT01587950|3695247|P1|NOT COMPLETED|Period 3||0
1510171|NCT01587950|3695247|P1|COMPLETED|Period 3||12
1510172|NCT01587950|3695247|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
1510173|NCT01587950|3695247|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
1510174|NCT01587950|3695247|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
1510175|NCT01587950|3695247|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
1510176|NCT01587950|3695247|P1|Received Sterile Water (5 Minutes)|Period 3||5
1510177|NCT01587950|3695247|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
1510178|NCT01587950|3695247|P1|Received Sterile Water (2 Minutes)|Period 3||2
1510179|NCT01587950|3695247|P1|Received Sterile Water (10 Minutes)|Period 3||5
1510180|NCT01587950|3695247|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
1510181|NCT01587950|3695247|P1|STARTED|Period 3||12
1510182|NCT01587950|3695247|P1|NOT COMPLETED|Washout 2||0
1510183|NCT01587950|3695247|P1|COMPLETED|Washout 2||12
1510184|NCT01587950|3695247|P1|STARTED|Washout 2||12
1510185|NCT01587950|3695247|P1|NOT COMPLETED|Period 2||0
1510186|NCT01587950|3695247|P1|COMPLETED|Period 2||12
1510187|NCT01587950|3695247|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
1510188|NCT01587950|3695247|P1|Received Sterile Water (10 Minutes)|Period 2||2
1510189|NCT01587950|3695247|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
1510190|NCT01587950|3695247|P1|Received Sterile Water (5 Minutes)|Period 2||2
1510191|NCT01587950|3695247|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
1510192|NCT01587950|3695247|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
1510193|NCT01587950|3695247|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
1510194|NCT01587950|3695247|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
1510195|NCT01587950|3695247|P1|Received Sterile Water (2 Minutes)|Period 2||8
1510196|NCT01587950|3695247|P1|STARTED|Period 2||12
1510197|NCT01587950|3695247|P1|NOT COMPLETED|Washout 1||0
1510198|NCT01587950|3695247|P1|COMPLETED|Washout 1||12
1510199|NCT01587950|3695247|P1|STARTED|Washout 1||12
1510200|NCT01587950|3695247|P1|NOT COMPLETED|Period 1||0
1510201|NCT01587950|3695247|P1|COMPLETED|Period 1||12
1510202|NCT01587950|3695247|P1|Received Sterile Water (5 Minutes)|Period 1||5
1510203|NCT01587950|3695247|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
1510204|NCT01587950|3695247|P1|Received Sterile Water (10 Minutes)|Period 1||5
1510205|NCT01587950|3695247|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
1510206|NCT01587950|3695247|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
1510207|NCT01587950|3695247|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
1510208|NCT01587950|3695247|P1|Received Sterile Water (2 Minutes)|Period 1||2
1510209|NCT01587950|3695247|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
1510210|NCT01587950|3695247|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
1510211|NCT01587950|3695247|P1|STARTED|Period 1||12
1510212|NCT01587924|3695281|P4|NOT COMPLETED|Overall Study||1
1510213|NCT01587924|3695282|P3|NOT COMPLETED|Overall Study||4
1510214|NCT01587924|3695283|P2|NOT COMPLETED|Overall Study||4
1510215|NCT01587924|3695284|P1|NOT COMPLETED|Overall Study||4
1510216|NCT01587924|3695281|P4|COMPLETED|Overall Study||19
1510217|NCT01587924|3695282|P3|COMPLETED|Overall Study||17
1510218|NCT01587924|3695283|P2|COMPLETED|Overall Study||17
1510219|NCT01587924|3695284|P1|COMPLETED|Overall Study||17
1510220|NCT01587924|3695281|P4|STARTED|Overall Study||20
1510221|NCT01587924|3695282|P3|STARTED|Overall Study||21
1510222|NCT01587924|3695283|P2|STARTED|Overall Study||21
1510223|NCT01587924|3695284|P1|STARTED|Overall Study||21
1510224|NCT01587898|3695385|P4|NOT COMPLETED|Overall Study||2
1510225|NCT01587898|3695386|P3|NOT COMPLETED|Overall Study||2
1510226|NCT01587898|3695387|P2|NOT COMPLETED|Overall Study||5
1510227|NCT01587898|3695388|P1|NOT COMPLETED|Overall Study||4
1510228|NCT01587898|3695385|P4|COMPLETED|Overall Study||17
1510229|NCT01587898|3695386|P3|COMPLETED|Overall Study||16
1510230|NCT01587898|3695387|P2|COMPLETED|Overall Study||12
1510231|NCT01587898|3695388|P1|COMPLETED|Overall Study||14
1510232|NCT01587898|3695385|P4|STARTED|Overall Study||19
1510233|NCT01587898|3695386|P3|STARTED|Overall Study||18
1510234|NCT01587898|3695387|P2|STARTED|Overall Study||17
1510235|NCT01587898|3695388|P1|STARTED|Overall Study||18
1510236|NCT01587885|3695564|P2|NOT COMPLETED|Treatment Period 2||0
1510237|NCT01587885|3695565|P1|NOT COMPLETED|Treatment Period 2||0
1510238|NCT01587885|3695564|P2|COMPLETED|Treatment Period 2||19
1510239|NCT01587885|3695565|P1|COMPLETED|Treatment Period 2||26
1510240|NCT01587885|3695564|P2|STARTED|Treatment Period 2||19
1510241|NCT01587885|3695565|P1|STARTED|Treatment Period 2||26
1510242|NCT01587885|3695564|P2|NOT COMPLETED|Treatment Period 1||3
1510243|NCT01587885|3695565|P1|NOT COMPLETED|Treatment Period 1||0
1510244|NCT01587885|3695564|P2|COMPLETED|Treatment Period 1||19
1510245|NCT01587885|3695565|P1|COMPLETED|Treatment Period 1||26
1510246|NCT01587885|3695564|P2|STARTED|Treatment Period 1||22
1510247|NCT01587885|3695565|P1|STARTED|Treatment Period 1||26
1510248|NCT01587651|3695581|P3|NOT COMPLETED|Overall Study||1
1510249|NCT01587651|3695582|P2|NOT COMPLETED|Overall Study||3
1510250|NCT01587651|3695583|P1|NOT COMPLETED|Overall Study||0
1510251|NCT01587651|3695581|P3|COMPLETED|Overall Study||34
1510252|NCT01587651|3695582|P2|COMPLETED|Overall Study||38
1510253|NCT01587651|3695583|P1|COMPLETED|Overall Study||34
1510254|NCT01587651|3695581|P3|STARTED|Overall Study||35
1510255|NCT01587651|3695582|P2|STARTED|Overall Study||41
1510256|NCT01587651|3695583|P1|STARTED|Overall Study||34
1510257|NCT01587274|3695613|P3|NOT COMPLETED|Overall Study||3
1510258|NCT01587274|3695614|P2|NOT COMPLETED|Overall Study||5
1510259|NCT01587274|3695615|P1|NOT COMPLETED|Overall Study||4
1510260|NCT01587274|3695613|P3|COMPLETED|Overall Study||104
1510261|NCT01587274|3695614|P2|COMPLETED|Overall Study||103
1510262|NCT01587274|3695615|P1|COMPLETED|Overall Study||104
1510263|NCT01587274|3695613|P3|STARTED|Overall Study||107
1510264|NCT01587274|3695614|P2|STARTED|Overall Study||108
1510265|NCT01587274|3695615|P1|STARTED|Overall Study||108
1510266|NCT01587118|3695623|P1|NOT COMPLETED|Overall Study||7
1510267|NCT01587118|3695623|P1|COMPLETED|Overall Study||11
1510268|NCT01587118|3695623|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
1510269|NCT01587105|3695630|P2|NOT COMPLETED|Overall Study||43
1510270|NCT01587105|3695631|P1|NOT COMPLETED|Overall Study||6
1510271|NCT01587105|3695630|P2|COMPLETED|Overall Study||138
1510272|NCT01587105|3695631|P1|COMPLETED|Overall Study||144
1510273|NCT01587105|3695630|P2|STARTED|Overall Study||181
1510274|NCT01587105|3695631|P1|STARTED|Overall Study||150
1510275|NCT01587079|3695647|P1|NOT COMPLETED|Overall Study||39
1510276|NCT01587079|3695647|P1|COMPLETED|Overall Study||120
1510277|NCT01587079|3695647|P1|STARTED|Overall Study||159
1510278|NCT01587027|3695771|P2|NOT COMPLETED|Discharge (1 Day)||0
1510279|NCT01587027|3695772|P1|NOT COMPLETED|Discharge (1 Day)||0
1510280|NCT01587027|3695771|P2|COMPLETED|Discharge (1 Day)||8
1510281|NCT01587027|3695772|P1|COMPLETED|Discharge (1 Day)||8
1510282|NCT01587027|3695771|P2|STARTED|Discharge (1 Day)||8
1510283|NCT01587027|3695772|P1|STARTED|Discharge (1 Day)||8
1510284|NCT01587027|3695771|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1510285|NCT01587027|3695772|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1510286|NCT01587027|3695771|P2|COMPLETED|Third Intervention (1 Day)||8
1510287|NCT01587027|3695772|P1|COMPLETED|Third Intervention (1 Day)||8
1510288|NCT01587027|3695771|P2|STARTED|Third Intervention (1 Day)||8
1510289|NCT01587027|3695772|P1|STARTED|Third Intervention (1 Day)||8
1510290|NCT01587027|3695771|P2|NOT COMPLETED|Washout (1 Day)||0
1510291|NCT01587027|3695772|P1|NOT COMPLETED|Washout (1 Day)||0
1510292|NCT01587027|3695771|P2|COMPLETED|Washout (1 Day)||8
1510293|NCT01587027|3695772|P1|COMPLETED|Washout (1 Day)||8
1510294|NCT01587027|3695771|P2|STARTED|Washout (1 Day)||8
1510295|NCT01587027|3695772|P1|STARTED|Washout (1 Day)||8
1510296|NCT01587027|3695771|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1510297|NCT01587027|3695772|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1510298|NCT01587027|3695771|P2|COMPLETED|Second Intervention (1 Day)||8
1510299|NCT01587027|3695772|P1|COMPLETED|Second Intervention (1 Day)||8
1510300|NCT01587027|3695771|P2|STARTED|Second Intervention (1 Day)||8
1510301|NCT01587027|3695772|P1|STARTED|Second Intervention (1 Day)||8
1510302|NCT01587027|3695771|P2|NOT COMPLETED|Washout (1 Day)||0
1510303|NCT01587027|3695772|P1|NOT COMPLETED|Washout (1 Day)||0
1510304|NCT01587027|3695771|P2|COMPLETED|Washout (1 Day)||8
1510305|NCT01587027|3695772|P1|COMPLETED|Washout (1 Day)||8
1510306|NCT01587027|3695771|P2|STARTED|Washout (1 Day)||8
1510307|NCT01587027|3695772|P1|STARTED|Washout (1 Day)||8
1510308|NCT01587027|3695771|P2|NOT COMPLETED|First Intervention (1 Day)||0
1510309|NCT01587027|3695772|P1|NOT COMPLETED|First Intervention (1 Day)||0
1510310|NCT01587027|3695771|P2|COMPLETED|First Intervention (1 Day)||8
1510311|NCT01587027|3695772|P1|COMPLETED|First Intervention (1 Day)||8
1510312|NCT01587027|3695771|P2|STARTED|First Intervention (1 Day)||8
1510313|NCT01587027|3695772|P1|STARTED|First Intervention (1 Day)||8
1510314|NCT01587014|3695778|P1|NOT COMPLETED|Overall Study||2
1510315|NCT01587014|3695778|P1|COMPLETED|Overall Study||24
1510316|NCT01587014|3695778|P1|STARTED|Overall Study||26
1510317|NCT01587001|3695785|P2|NOT COMPLETED|Overall Study||1
1510318|NCT01587001|3695786|P1|NOT COMPLETED|Overall Study||6
1510319|NCT01587001|3695785|P2|COMPLETED|Overall Study||2
1510320|NCT01587001|3695786|P1|COMPLETED|Overall Study||8
1510321|NCT01587001|3695785|P2|STARTED|Overall Study||3
1510322|NCT01587001|3695786|P1|STARTED|Overall Study||14
1510323|NCT01586975|3695797|P3|NOT COMPLETED|Overall Study||0
1510324|NCT01586975|3695798|P2|NOT COMPLETED|Overall Study||0
1510325|NCT01586975|3695799|P1|NOT COMPLETED|Overall Study||0
1510326|NCT01586975|3695797|P3|COMPLETED|Overall Study||46
1510327|NCT01586975|3695798|P2|COMPLETED|Overall Study||32
1510328|NCT01586975|3695799|P1|COMPLETED|Overall Study||15
1510329|NCT01586975|3695797|P3|STARTED|Overall Study||46
1510330|NCT01586975|3695798|P2|STARTED|Overall Study||32
1510331|NCT01586975|3695799|P1|STARTED|Overall Study||15
1510332|NCT01586962|3695807|P1|NOT COMPLETED|Overall Study||0
1510333|NCT01586962|3695807|P1|COMPLETED|Overall Study||56
1510334|NCT01586962|3695807|P1|STARTED|Overall Study||56
1510335|NCT01586897|3695815|P2|NOT COMPLETED|Overall Study||0
1510336|NCT01586897|3695816|P1|NOT COMPLETED|Overall Study||0
1510337|NCT01586897|3695815|P2|COMPLETED|Overall Study||26
1510338|NCT01586897|3695816|P1|COMPLETED|Overall Study||26
1510339|NCT01586897|3695815|P2|STARTED|Overall Study||26
1510340|NCT01586897|3695816|P1|STARTED|Overall Study||26
1510341|NCT01586819|3695834|P2|NOT COMPLETED|Overall Study||0
1510342|NCT01586819|3695835|P1|NOT COMPLETED|Overall Study||1
1510343|NCT01586819|3695834|P2|COMPLETED|Overall Study||14
1510344|NCT01586819|3695835|P1|COMPLETED|Overall Study||11
1510345|NCT01586819|3695834|P2|STARTED|Overall Study||14
1510346|NCT01586819|3695835|P1|STARTED|Overall Study||12
1510347|NCT01586806|3695846|P3|NOT COMPLETED|Overall Study||2
1510348|NCT01586806|3695847|P2|NOT COMPLETED|Overall Study||4
1510349|NCT01586806|3695848|P1|NOT COMPLETED|Overall Study||3
1510350|NCT01586806|3695846|P3|COMPLETED|Overall Study||63
1510351|NCT01586806|3695847|P2|COMPLETED|Overall Study||61
1510352|NCT01586806|3695848|P1|COMPLETED|Overall Study||62
1510353|NCT01586806|3695846|P3|STARTED|Overall Study||65
1510354|NCT01586806|3695847|P2|STARTED|Overall Study||65
1510355|NCT01586806|3695848|P1|STARTED|Overall Study||65
1510356|NCT01586364|3695868|P1|NOT COMPLETED|Overall Study||117
1510357|NCT01586364|3695868|P1|COMPLETED|Overall Study||184
1510358|NCT01586364|3695868|P1|STARTED|Overall Study||301
1510359|NCT01586338|3695921|P1|NOT COMPLETED|Overall Study||8
1510360|NCT01586338|3695921|P1|COMPLETED|Overall Study||229
1510361|NCT01586338|3695921|P1|STARTED|Overall Study||237
1510362|NCT01586312|3695933|P2|NOT COMPLETED|Overall Study||0
1510363|NCT01586312|3695934|P1|NOT COMPLETED|Overall Study||0
1510364|NCT01586312|3695933|P2|COMPLETED|Overall Study||15
1510365|NCT01586312|3695934|P1|COMPLETED|Overall Study||15
1510366|NCT01586312|3695933|P2|STARTED|Overall Study||15
1510367|NCT01586312|3695934|P1|STARTED|Overall Study||15
1510368|NCT01586195|3695944|P1|NOT COMPLETED|Overall Study||26
1510369|NCT01586195|3695944|P1|COMPLETED|Overall Study||5
1510370|NCT01586195|3695944|P1|STARTED|Overall Study||31
1510371|NCT01586156|3695958|P3|NOT COMPLETED|Overall Study||0
1510372|NCT01586156|3695959|P2|NOT COMPLETED|Overall Study||1
1510373|NCT01586156|3695960|P1|NOT COMPLETED|Overall Study||0
1510374|NCT01586156|3695958|P3|COMPLETED|Overall Study||10
1510375|NCT01586156|3695959|P2|COMPLETED|Overall Study||9
1510376|NCT01586156|3695960|P1|COMPLETED|Overall Study||10
1510377|NCT01586156|3695958|P3|STARTED|Overall Study||10
1510378|NCT01586156|3695959|P2|STARTED|Overall Study||10
1510379|NCT01586156|3695960|P1|STARTED|Overall Study||10
1510380|NCT01586026|3695986|P3|NOT COMPLETED|Overall Study||0
1510381|NCT01586026|3695987|P2|NOT COMPLETED|Overall Study||0
1510382|NCT01586026|3695988|P1|NOT COMPLETED|Overall Study||0
1510383|NCT01586026|3695986|P3|COMPLETED|Overall Study||271
1510384|NCT01586026|3695987|P2|COMPLETED|Overall Study||414
1510385|NCT01586026|3695988|P1|COMPLETED|Overall Study||350
1510386|NCT01586026|3695986|P3|STARTED|Overall Study||271
1510387|NCT01586026|3695987|P2|STARTED|Overall Study||414
1510388|NCT01586026|3695988|P1|STARTED|Overall Study||350
1510389|NCT01585987|3695998|P2|NOT COMPLETED|Treated||49
1510390|NCT01585987|3695999|P1|NOT COMPLETED|Treated||54
1510391|NCT01585987|3695998|P2|COMPLETED|Treated||2
1510392|NCT01585987|3695999|P1|COMPLETED|Treated||3
1510393|NCT01585987|3695998|P2|STARTED|Treated||51
1510394|NCT01585987|3695999|P1|STARTED|Treated||57
1510395|NCT01585987|3695998|P2|NOT COMPLETED|Randomized||6
1510396|NCT01585987|3695999|P1|NOT COMPLETED|Randomized||0
1510397|NCT01585987|3695998|P2|COMPLETED|Randomized||51
1510398|NCT01585987|3695999|P1|COMPLETED|Randomized||57
1510399|NCT01585987|3695998|P2|STARTED|Randomized||57
1510400|NCT01585987|3695999|P1|STARTED|Randomized||57
1510401|NCT01585961|3696014|P1|NOT COMPLETED|Overall Study||33
1510402|NCT01585961|3696014|P1|COMPLETED|Overall Study||478
1510403|NCT01585961|3696014|P1|Safety|Overall Study|Patients ablated with study catheter|508
1510404|NCT01585961|3696014|P1|STARTED|Overall Study||511
1510405|NCT01585779|3696031|P2|NOT COMPLETED|Overall Study||7
1510406|NCT01585779|3696032|P1|NOT COMPLETED|Overall Study||10
1510407|NCT01585779|3696031|P2|COMPLETED|Overall Study||21
1510408|NCT01585779|3696032|P1|COMPLETED|Overall Study||26
1510409|NCT01585779|3696031|P2|STARTED|Overall Study||28
1510410|NCT01585779|3696032|P1|STARTED|Overall Study||36
1510411|NCT01585766|3696092|P6|NOT COMPLETED|Overall Study||0
1510412|NCT01585766|3696093|P5|NOT COMPLETED|Overall Study||0
1510413|NCT01585766|3696094|P4|NOT COMPLETED|Overall Study||0
1510414|NCT01585766|3696095|P3|NOT COMPLETED|Overall Study||2
1510415|NCT01585766|3696096|P2|NOT COMPLETED|Overall Study||2
1510416|NCT01585766|3696097|P1|NOT COMPLETED|Overall Study||0
1510417|NCT01585766|3696092|P6|COMPLETED|Overall Study||6
1510418|NCT01585766|3696093|P5|COMPLETED|Overall Study||3
1510419|NCT01585766|3696094|P4|COMPLETED|Overall Study||4
1510420|NCT01585766|3696095|P3|COMPLETED|Overall Study||1
1510421|NCT01585766|3696096|P2|COMPLETED|Overall Study||3
1510422|NCT01585766|3696097|P1|COMPLETED|Overall Study||7
1510423|NCT01585766|3696092|P6|STARTED|Overall Study||6
1510424|NCT01585766|3696093|P5|STARTED|Overall Study||3
1510425|NCT01585766|3696094|P4|STARTED|Overall Study||4
1510426|NCT01585766|3696095|P3|STARTED|Overall Study||3
1510427|NCT01585766|3696096|P2|STARTED|Overall Study||5
1510428|NCT01585766|3696097|P1|STARTED|Overall Study||7
1510429|NCT01585597|3696196|P1|NOT COMPLETED|Overall Study||0
1510430|NCT01585597|3696196|P1|COMPLETED|Overall Study||20
1510431|NCT01585597|3696196|P1|STARTED|Overall Study||20
1510432|NCT01585584|3696201|P1|NOT COMPLETED|Overall Study||4
1510433|NCT01585584|3696201|P1|COMPLETED|Overall Study||6
1510434|NCT01585584|3696201|P1|STARTED|Overall Study||10
1510435|NCT01585558|3696208|P3|NOT COMPLETED|Overall Study||15
1510436|NCT01585558|3696209|P2|NOT COMPLETED|Overall Study||12
1510437|NCT01585558|3696210|P1|NOT COMPLETED|Overall Study||13
1510438|NCT01585558|3696208|P3|COMPLETED|Overall Study||34
1510439|NCT01585558|3696209|P2|COMPLETED|Overall Study||57
1510440|NCT01585558|3696210|P1|COMPLETED|Overall Study||49
1510441|NCT01585558|3696208|P3|STARTED|Overall Study||49
1510442|NCT01585558|3696209|P2|STARTED|Overall Study||69
1510443|NCT01585558|3696210|P1|STARTED|Overall Study||62
1510444|NCT01585441|3696391|P2|NOT COMPLETED|Overall Study||0
1510445|NCT01585441|3696392|P1|NOT COMPLETED|Overall Study||0
1510446|NCT01585441|3696391|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
1510447|NCT01585441|3696392|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
1510448|NCT01585441|3696391|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
1510449|NCT01585441|3696392|P1|Final Study Safety Visit|Overall Study||3
1510450|NCT01585441|3696391|P2|Received Finasteride at Month 3|Overall Study||2
1510451|NCT01585441|3696392|P1|Received Finasteride at Month 3|Overall Study||2
1510452|NCT01585441|3696391|P2|Month 3|Overall Study||3
1510453|NCT01585441|3696392|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
1510454|NCT01585441|3696391|P2|STARTED|Overall Study||3
1510455|NCT01585441|3696392|P1|STARTED|Overall Study||3
1510456|NCT01585428|3696444|P2|NOT COMPLETED|Overall Study||0
1510457|NCT01585428|3696445|P1|NOT COMPLETED|Overall Study||1
1510458|NCT01585428|3696444|P2|COMPLETED|Overall Study||11
1510459|NCT01585428|3696445|P1|COMPLETED|Overall Study||17
1510460|NCT01585428|3696444|P2|STARTED|Overall Study||11
1510461|NCT01585428|3696445|P1|STARTED|Overall Study||18
1510462|NCT01585324|3696453|P1|NOT COMPLETED|Overall Study||0
1510463|NCT01585324|3696453|P1|COMPLETED|Overall Study||30
1510464|NCT01585324|3696453|P1|STARTED|Overall Study||30
1510465|NCT01585272|3696469|P1|NOT COMPLETED|Overall Study||39
1510466|NCT01585272|3696469|P1|COMPLETED|Overall Study||82
1510467|NCT01585272|3696469|P1|Exelon Patch 10 cm2|Overall Study||96
1510468|NCT01585272|3696469|P1|Exelon Patch 5 cm2|Overall Study||114
1510469|NCT01585272|3696469|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
1510470|NCT01585272|3696469|P1|STARTED|Overall Study||121
1510471|NCT01585246|3696482|P5|NOT COMPLETED|Overall Study||2
1510472|NCT01585246|3696483|P4|NOT COMPLETED|Overall Study||4
1510473|NCT01585246|3696484|P3|NOT COMPLETED|Overall Study||4
1510474|NCT01585246|3696485|P2|NOT COMPLETED|Overall Study||1
1510475|NCT01585246|3696486|P1|NOT COMPLETED|Overall Study||0
1510476|NCT01585246|3696482|P5|COMPLETED|Overall Study||9
1510477|NCT01585246|3696483|P4|COMPLETED|Overall Study||6
1510478|NCT01585246|3696484|P3|COMPLETED|Overall Study||16
1510479|NCT01585246|3696485|P2|COMPLETED|Overall Study||3
1510480|NCT01585246|3696486|P1|COMPLETED|Overall Study||3
1510481|NCT01585246|3696482|P5|STARTED|Overall Study||11
1510482|NCT01585246|3696483|P4|STARTED|Overall Study||10
1510483|NCT01585246|3696484|P3|STARTED|Overall Study||20
1510484|NCT01585246|3696485|P2|STARTED|Overall Study||4
1510485|NCT01585246|3696486|P1|STARTED|Overall Study||3
1510486|NCT01585207|3696501|P1|NOT COMPLETED|Overall Study||0
1510487|NCT01585207|3696501|P1|COMPLETED|Overall Study||4
1510488|NCT01585207|3696501|P1|STARTED|Overall Study||4
1510489|NCT01585168|3696507|P4|NOT COMPLETED|Overall Study||1
1510490|NCT01585168|3696508|P3|NOT COMPLETED|Overall Study||1
1510491|NCT01585168|3696509|P2|NOT COMPLETED|Overall Study||1
1510492|NCT01585168|3696510|P1|NOT COMPLETED|Overall Study||3
1510493|NCT01585168|3696507|P4|COMPLETED|Overall Study||18
1510494|NCT01585168|3696508|P3|COMPLETED|Overall Study||15
1510495|NCT01585168|3696509|P2|COMPLETED|Overall Study||17
1510496|NCT01585168|3696510|P1|COMPLETED|Overall Study||15
1510497|NCT01585168|3696507|P4|STARTED|Overall Study||19
1510498|NCT01585168|3696508|P3|STARTED|Overall Study||16
1510499|NCT01585168|3696509|P2|STARTED|Overall Study||18
1510500|NCT01585168|3696510|P1|STARTED|Overall Study||18
1510501|NCT01585129|3696532|P2|NOT COMPLETED|Overall Study||0
1510502|NCT01585129|3696533|P1|NOT COMPLETED|Overall Study||0
1510503|NCT01585129|3696532|P2|COMPLETED|Overall Study||39
1510504|NCT01585129|3696533|P1|COMPLETED|Overall Study||41
1510505|NCT01585129|3696532|P2|STARTED|Overall Study||39
1510506|NCT01585129|3696533|P1|STARTED|Overall Study||41
1510507|NCT01585038|3696545|P2|NOT COMPLETED|Overall Study||2
1510508|NCT01585038|3696546|P1|NOT COMPLETED|Overall Study||2
1510509|NCT01585038|3696545|P2|COMPLETED|Overall Study||18
1510510|NCT01585038|3696546|P1|COMPLETED|Overall Study||18
1510511|NCT01585038|3696545|P2|STARTED|Overall Study||20
1510512|NCT01585038|3696546|P1|STARTED|Overall Study||20
1510513|NCT01584843|3696562|P6|NOT COMPLETED|Second Treatment Period||1
1510514|NCT01584843|3696563|P5|NOT COMPLETED|Second Treatment Period||0
1510515|NCT01584843|3696564|P4|NOT COMPLETED|Second Treatment Period||0
1510516|NCT01584843|3696565|P3|NOT COMPLETED|Second Treatment Period||0
1510517|NCT01584843|3696566|P2|NOT COMPLETED|Second Treatment Period||0
1510518|NCT01584843|3696567|P1|NOT COMPLETED|Second Treatment Period||0
1510519|NCT01584843|3696562|P6|COMPLETED|Second Treatment Period||0
1510520|NCT01584843|3696563|P5|COMPLETED|Second Treatment Period||3
1510521|NCT01584843|3696564|P4|COMPLETED|Second Treatment Period||6
1510522|NCT01584843|3696565|P3|COMPLETED|Second Treatment Period||2
1510523|NCT01584843|3696566|P2|COMPLETED|Second Treatment Period||1
1510524|NCT01584843|3696567|P1|COMPLETED|Second Treatment Period||2
1510525|NCT01584843|3696562|P6|STARTED|Second Treatment Period||1
1510526|NCT01584843|3696563|P5|STARTED|Second Treatment Period||3
1510527|NCT01584843|3696564|P4|STARTED|Second Treatment Period||6
1510528|NCT01584843|3696565|P3|STARTED|Second Treatment Period||2
1510529|NCT01584843|3696566|P2|STARTED|Second Treatment Period||1
1510530|NCT01584843|3696567|P1|STARTED|Second Treatment Period||2
1510531|NCT01584843|3696562|P6|NOT COMPLETED|First Treatment Period||2
1510532|NCT01584843|3696563|P5|NOT COMPLETED|First Treatment Period||0
1510533|NCT01584843|3696564|P4|NOT COMPLETED|First Treatment Period||0
1510534|NCT01584843|3696565|P3|NOT COMPLETED|First Treatment Period||1
1510535|NCT01584843|3696566|P2|NOT COMPLETED|First Treatment Period||0
1510536|NCT01584843|3696567|P1|NOT COMPLETED|First Treatment Period||0
1510537|NCT01584843|3696562|P6|COMPLETED|First Treatment Period||9
1510538|NCT01584843|3696563|P5|COMPLETED|First Treatment Period||10
1510539|NCT01584843|3696564|P4|COMPLETED|First Treatment Period||10
1510540|NCT01584843|3696565|P3|COMPLETED|First Treatment Period||2
1510541|NCT01584843|3696566|P2|COMPLETED|First Treatment Period||4
1510542|NCT01584843|3696567|P1|COMPLETED|First Treatment Period||3
1510543|NCT01584843|3696562|P6|STARTED|First Treatment Period||11
1510544|NCT01584843|3696563|P5|STARTED|First Treatment Period||10
1510545|NCT01584843|3696564|P4|STARTED|First Treatment Period||10
1510546|NCT01584843|3696565|P3|STARTED|First Treatment Period||3
1510547|NCT01584843|3696566|P2|STARTED|First Treatment Period||4
1510548|NCT01584843|3696567|P1|STARTED|First Treatment Period||3
1510549|NCT01584648|3696678|P2|NOT COMPLETED|Overall Study||212
1510550|NCT01584648|3696679|P1|NOT COMPLETED|Overall Study||211
1510551|NCT01584648|3696678|P2|COMPLETED|Overall Study||0
1510552|NCT01584648|3696679|P1|COMPLETED|Overall Study||0
1510553|NCT01584648|3696678|P2|Ongoing|Overall Study||147
1510554|NCT01584648|3696679|P1|Ongoing|Overall Study||154
1510555|NCT01584648|3696678|P2|STARTED|Overall Study||212
1510556|NCT01584648|3696679|P1|STARTED|Overall Study||211
1510557|NCT01584609|3696719|P2|NOT COMPLETED|Overall Study||4
1510558|NCT01584609|3696720|P1|NOT COMPLETED|Overall Study||12
1510559|NCT01584609|3696719|P2|COMPLETED|Overall Study||96
1510560|NCT01584609|3696720|P1|COMPLETED|Overall Study||86
1510561|NCT01584609|3696719|P2|STARTED|Overall Study||100
1510562|NCT01584609|3696720|P1|STARTED|Overall Study||98
1510563|NCT01584544|3696745|P5|NOT COMPLETED|Overall Study||0
1510564|NCT01584544|3696746|P4|NOT COMPLETED|Overall Study||0
1510565|NCT01584544|3696747|P3|NOT COMPLETED|Overall Study||0
1510566|NCT01584544|3696748|P2|NOT COMPLETED|Overall Study||0
1510567|NCT01584544|3696749|P1|NOT COMPLETED|Overall Study||0
1510568|NCT01584544|3696745|P5|COMPLETED|Overall Study||6
1510569|NCT01584544|3696746|P4|COMPLETED|Overall Study||3
1510570|NCT01584544|3696747|P3|COMPLETED|Overall Study||6
1510571|NCT01584544|3696748|P2|COMPLETED|Overall Study||6
1510572|NCT01584544|3696749|P1|COMPLETED|Overall Study||3
1510573|NCT01584544|3696745|P5|STARTED|Overall Study||6
1510574|NCT01584544|3696746|P4|STARTED|Overall Study||3
1510575|NCT01584544|3696747|P3|STARTED|Overall Study||6
1510576|NCT01584544|3696748|P2|STARTED|Overall Study||6
1510577|NCT01584544|3696749|P1|STARTED|Overall Study||3
1510578|NCT01584518|3696763|P2|NOT COMPLETED|Overall Study||0
1510579|NCT01584518|3696764|P1|NOT COMPLETED|Overall Study||0
1510580|NCT01584518|3696763|P2|COMPLETED|Overall Study||25
1510581|NCT01584518|3696764|P1|COMPLETED|Overall Study||25
1510582|NCT01584518|3696763|P2|STARTED|Overall Study||25
1510583|NCT01584518|3696764|P1|STARTED|Overall Study||25
1510584|NCT01584479|3696774|P4|NOT COMPLETED|Overall Study||0
1510585|NCT01584479|3696775|P3|NOT COMPLETED|Overall Study||0
1510586|NCT01584479|3696776|P2|NOT COMPLETED|Overall Study||0
1510587|NCT01584479|3696777|P1|NOT COMPLETED|Overall Study||0
1510588|NCT01584479|3696774|P4|COMPLETED|Overall Study||1847
1510589|NCT01584479|3696775|P3|COMPLETED|Overall Study||852
1510590|NCT01584479|3696776|P2|COMPLETED|Overall Study||1686
1510591|NCT01584479|3696777|P1|COMPLETED|Overall Study||732
1510592|NCT01584479|3696774|P4|STARTED|Overall Study||1847
1510593|NCT01584479|3696775|P3|STARTED|Overall Study||852
1510594|NCT01584479|3696776|P2|STARTED|Overall Study||1686
1510595|NCT01584479|3696777|P1|STARTED|Overall Study||732
1510596|NCT01584388|3696787|P1|NOT COMPLETED|Overall Study||0
1510597|NCT01584388|3696787|P1|COMPLETED|Overall Study||30
1510598|NCT01584388|3696787|P1|STARTED|Overall Study||30
1510599|NCT01584232|3696807|P2|NOT COMPLETED|Overall Study||3
1510600|NCT01584232|3696808|P1|NOT COMPLETED|Overall Study||8
1510601|NCT01584232|3696807|P2|COMPLETED|Overall Study||177
1510602|NCT01584232|3696808|P1|COMPLETED|Overall Study||173
1510603|NCT01584232|3696807|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
1510604|NCT01584232|3696808|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
1510605|NCT01584232|3696807|P2|STARTED|Overall Study||180
1510606|NCT01584232|3696808|P1|STARTED|Overall Study||181
1510607|NCT01583894|3696824|P1|NOT COMPLETED|Overall Study||15
1510608|NCT01583894|3696824|P1|COMPLETED|Overall Study||813
1510609|NCT01583894|3696824|P1|STARTED|Overall Study||828
1510610|NCT01583647|3696828|P2|NOT COMPLETED|Overall Study||0
1510611|NCT01583647|3696829|P1|NOT COMPLETED|Overall Study||0
1510612|NCT01583647|3696828|P2|COMPLETED|Overall Study||0
1510613|NCT01583647|3696829|P1|COMPLETED|Overall Study||10
1510614|NCT01583647|3696828|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
1510615|NCT01583647|3696829|P1|STARTED|Overall Study||10
1510616|NCT01583543|3696841|P1|NOT COMPLETED|Overall Study||0
1510617|NCT01583543|3696841|P1|COMPLETED|Overall Study||12
1510618|NCT01583543|3696841|P1|STARTED|Overall Study||12
1510619|NCT01583530|3696854|P6|NOT COMPLETED|Overall Study||3
1510620|NCT01583530|3696855|P5|NOT COMPLETED|Overall Study||5
1510621|NCT01583530|3696856|P4|NOT COMPLETED|Overall Study||1
1510622|NCT01583530|3696857|P3|NOT COMPLETED|Overall Study||0
1510623|NCT01583530|3696858|P2|NOT COMPLETED|Overall Study||3
1510624|NCT01583530|3696859|P1|NOT COMPLETED|Overall Study||0
1510625|NCT01583530|3696854|P6|COMPLETED|Overall Study||17
1510626|NCT01583530|3696855|P5|COMPLETED|Overall Study||15
1510627|NCT01583530|3696856|P4|COMPLETED|Overall Study||18
1510628|NCT01583530|3696857|P3|COMPLETED|Overall Study||20
1510629|NCT01583530|3696858|P2|COMPLETED|Overall Study||17
1510630|NCT01583530|3696859|P1|COMPLETED|Overall Study||19
1510631|NCT01583530|3696854|P6|STARTED|Overall Study||20
1510632|NCT01583530|3696855|P5|STARTED|Overall Study||20
1510633|NCT01583530|3696856|P4|STARTED|Overall Study||19
1510634|NCT01583530|3696857|P3|STARTED|Overall Study||20
1510635|NCT01583530|3696858|P2|STARTED|Overall Study||20
1510636|NCT01583530|3696859|P1|STARTED|Overall Study||19
1510637|NCT01583452|3696905|P2|NOT COMPLETED|Overall Study||0
1510638|NCT01583452|3696906|P1|NOT COMPLETED|Overall Study||0
1510639|NCT01583452|3696905|P2|COMPLETED|Overall Study||20
1510640|NCT01583452|3696906|P1|COMPLETED|Overall Study||21
1510641|NCT01583452|3696905|P2|STARTED|Overall Study||20
1510642|NCT01583452|3696906|P1|STARTED|Overall Study||21
1510643|NCT01583374|3696921|P3|NOT COMPLETED|Overall Study||25
1510644|NCT01583374|3696922|P2|NOT COMPLETED|Overall Study||16
1510645|NCT01583374|3696923|P1|NOT COMPLETED|Overall Study||19
1510646|NCT01583374|3696921|P3|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|138
1510647|NCT01583374|3696922|P2|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|147
1510648|NCT01583374|3696923|P1|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|145
1510649|NCT01583374|3696921|P3|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|49
1510650|NCT01583374|3696922|P2|Early Escape at Week 16|Overall Study||49
1510651|NCT01583374|3696923|P1|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|51
1510652|NCT01583374|3696921|P3|Completed Week 16|Overall Study||144
1510653|NCT01583374|3696922|P2|Completed Week 16|Overall Study||151
1510654|NCT01583374|3696923|P1|Completed Week 16|Overall Study||150
1510655|NCT01583374|3696921|P3|Received Treatment|Overall Study||163
1510656|NCT01583374|3696922|P2|Received Treatment|Overall Study||163
1510657|NCT01583374|3696923|P1|Received Treatment|Overall Study||164
1510658|NCT01583374|3696921|P3|STARTED|Overall Study||163
1510659|NCT01583374|3696922|P2|STARTED|Overall Study||163
1510660|NCT01583374|3696923|P1|STARTED|Overall Study||164
1510661|NCT01583218|3696935|P2|NOT COMPLETED|Overall Study||283
1510662|NCT01583218|3696936|P1|NOT COMPLETED|Overall Study||289
1510663|NCT01583218|3696935|P2|COMPLETED|Overall Study||3471
1510664|NCT01583218|3696936|P1|COMPLETED|Overall Study||3470
1510665|NCT01583218|3696935|P2|STARTED|Overall Study||3754
1510666|NCT01583218|3696936|P1|STARTED|Overall Study||3759
1510667|NCT01583166|3696956|P2|NOT COMPLETED|Overall Study||6
1510668|NCT01583166|3696957|P1|NOT COMPLETED|Overall Study||4
1510669|NCT01583166|3696956|P2|COMPLETED|Overall Study||39
1510670|NCT01583166|3696957|P1|COMPLETED|Overall Study||41
1510671|NCT01583166|3696956|P2|STARTED|Overall Study||45
1510672|NCT01583166|3696957|P1|STARTED|Overall Study||45
1510673|NCT01583101|3696971|P2|NOT COMPLETED|Overall Study||0
1510674|NCT01583101|3696972|P1|NOT COMPLETED|Overall Study||0
1510675|NCT01583101|3696971|P2|COMPLETED|Overall Study||1161
1510676|NCT01583101|3696972|P1|COMPLETED|Overall Study||1076
1510677|NCT01583101|3696971|P2|STARTED|Overall Study||1161
1510678|NCT01583101|3696972|P1|STARTED|Overall Study||1076
1510679|NCT01582971|3696980|P2|NOT COMPLETED|Overall Study||37
1510680|NCT01582971|3696981|P1|NOT COMPLETED|Overall Study||39
1510681|NCT01582971|3696980|P2|COMPLETED|Overall Study||91
1510682|NCT01582971|3696981|P1|COMPLETED|Overall Study||89
1510683|NCT01582971|3696980|P2|STARTED|Overall Study||128
1510684|NCT01582971|3696981|P1|STARTED|Overall Study||128
1510685|NCT01582945|3696999|P1|NOT COMPLETED|Overall Study||2
1510686|NCT01582945|3696999|P1|COMPLETED|Overall Study||12
1510687|NCT01582945|3696999|P1|STARTED|Overall Study||14
1510688|NCT01582880|3697003|P1|NOT COMPLETED|Overall Study||0
1510689|NCT01582880|3697003|P1|COMPLETED|Overall Study||1
1510690|NCT01582880|3697003|P1|STARTED|Overall Study||1
1510691|NCT01582854|3697013|P2|NOT COMPLETED|Overall Study||34
1510692|NCT01582854|3697014|P1|NOT COMPLETED|Overall Study||36
1510693|NCT01582854|3697013|P2|COMPLETED|Overall Study||221
1510694|NCT01582854|3697014|P1|COMPLETED|Overall Study||212
1510695|NCT01582854|3697013|P2|STARTED|Overall Study||255
1510696|NCT01582854|3697014|P1|STARTED|Overall Study||248
1510697|NCT01582789|3697042|P2|NOT COMPLETED|Second Intervention (14 Days)||0
1510698|NCT01582789|3697043|P1|NOT COMPLETED|Second Intervention (14 Days)||1
1510699|NCT01582789|3697042|P2|COMPLETED|Second Intervention (14 Days)||27
1510700|NCT01582789|3697043|P1|COMPLETED|Second Intervention (14 Days)||33
1510701|NCT01582789|3697042|P2|STARTED|Second Intervention (14 Days)||27
1510702|NCT01582789|3697043|P1|STARTED|Second Intervention (14 Days)||34
1510703|NCT01582789|3697042|P2|NOT COMPLETED|First Intervention (14 Days)||0
1510704|NCT01582789|3697043|P1|NOT COMPLETED|First Intervention (14 Days)||0
1510705|NCT01582789|3697042|P2|COMPLETED|First Intervention (14 Days)||27
1510706|NCT01582789|3697043|P1|COMPLETED|First Intervention (14 Days)||34
1510707|NCT01582789|3697042|P2|STARTED|First Intervention (14 Days)||27
1510708|NCT01582789|3697043|P1|STARTED|First Intervention (14 Days)||34
1510709|NCT01582490|3697061|P2|NOT COMPLETED|Overall Study||1
1510710|NCT01582490|3697062|P1|NOT COMPLETED|Overall Study||1
1510711|NCT01582490|3697061|P2|COMPLETED|Overall Study||9
1510712|NCT01582490|3697062|P1|COMPLETED|Overall Study||8
1510713|NCT01582490|3697061|P2|STARTED|Overall Study||10
1510714|NCT01582490|3697062|P1|STARTED|Overall Study||9
1510715|NCT01582477|3697084|P2|NOT COMPLETED|Overall Study||0
1510716|NCT01582477|3697085|P1|NOT COMPLETED|Overall Study||0
1510717|NCT01582477|3697084|P2|COMPLETED|Overall Study||12
1510718|NCT01582477|3697085|P1|COMPLETED|Overall Study||12
1510719|NCT01582477|3697084|P2|STARTED|Overall Study||12
1510720|NCT01582477|3697085|P1|STARTED|Overall Study||12
1510721|NCT01582451|3697103|P2|NOT COMPLETED|Overall Study||20
1510722|NCT01582451|3697104|P1|NOT COMPLETED|Overall Study||32
1510723|NCT01582451|3697103|P2|COMPLETED|Overall Study||139
1510724|NCT01582451|3697104|P1|COMPLETED|Overall Study||275
1510725|NCT01582451|3697103|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
1510726|NCT01582451|3697104|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
1510727|NCT01582451|3697103|P2|STARTED|Overall Study||159
1510728|NCT01582451|3697104|P1|STARTED|Overall Study||307
1510729|NCT01582308|3697146|P10|NOT COMPLETED|Period 5||0
1510730|NCT01582308|3697147|P9|NOT COMPLETED|Period 5||0
1510731|NCT01582308|3697148|P8|NOT COMPLETED|Period 5||0
1510732|NCT01582308|3697149|P7|NOT COMPLETED|Period 5||0
1510733|NCT01582308|3697150|P6|NOT COMPLETED|Period 5||0
1510734|NCT01582308|3697151|P5|NOT COMPLETED|Period 5||0
1510735|NCT01582308|3697152|P4|NOT COMPLETED|Period 5||0
1510736|NCT01582308|3697153|P3|NOT COMPLETED|Period 5||0
1510737|NCT01582308|3697154|P2|NOT COMPLETED|Period 5||0
1510738|NCT01582308|3697155|P1|NOT COMPLETED|Period 5||0
1510739|NCT01582308|3697146|P10|COMPLETED|Period 5||1
1510740|NCT01582308|3697147|P9|COMPLETED|Period 5||2
1510741|NCT01582308|3697148|P8|COMPLETED|Period 5||2
1510742|NCT01582308|3697149|P7|COMPLETED|Period 5||2
1510743|NCT01582308|3697150|P6|COMPLETED|Period 5||1
1510744|NCT01582308|3697151|P5|COMPLETED|Period 5||2
1510745|NCT01582308|3697152|P4|COMPLETED|Period 5||2
1510746|NCT01582308|3697153|P3|COMPLETED|Period 5||2
1510747|NCT01582308|3697154|P2|COMPLETED|Period 5||2
1510748|NCT01582308|3697155|P1|COMPLETED|Period 5||1
1510749|NCT01582308|3697146|P10|STARTED|Period 5||1
1510750|NCT01582308|3697147|P9|STARTED|Period 5||2
1510751|NCT01582308|3697148|P8|STARTED|Period 5||2
1510752|NCT01582308|3697149|P7|STARTED|Period 5||2
1510753|NCT01582308|3697150|P6|STARTED|Period 5||1
1510754|NCT01582308|3697151|P5|STARTED|Period 5||2
1510755|NCT01582308|3697152|P4|STARTED|Period 5||2
1510756|NCT01582308|3697153|P3|STARTED|Period 5||2
1510757|NCT01582308|3697154|P2|STARTED|Period 5||2
1510758|NCT01582308|3697155|P1|STARTED|Period 5||1
1510759|NCT01582308|3697146|P10|NOT COMPLETED|10-day Washout Following Period 4||0
1510760|NCT01582308|3697147|P9|NOT COMPLETED|10-day Washout Following Period 4||0
1510761|NCT01582308|3697148|P8|NOT COMPLETED|10-day Washout Following Period 4||0
1510762|NCT01582308|3697149|P7|NOT COMPLETED|10-day Washout Following Period 4||0
1510763|NCT01582308|3697150|P6|NOT COMPLETED|10-day Washout Following Period 4||0
1510764|NCT01582308|3697151|P5|NOT COMPLETED|10-day Washout Following Period 4||0
1510765|NCT01582308|3697152|P4|NOT COMPLETED|10-day Washout Following Period 4||0
1510766|NCT01582308|3697153|P3|NOT COMPLETED|10-day Washout Following Period 4||0
1510767|NCT01582308|3697154|P2|NOT COMPLETED|10-day Washout Following Period 4||0
1510768|NCT01582308|3697155|P1|NOT COMPLETED|10-day Washout Following Period 4||0
1510769|NCT01582308|3697146|P10|COMPLETED|10-day Washout Following Period 4||1
1510770|NCT01582308|3697147|P9|COMPLETED|10-day Washout Following Period 4||2
1510771|NCT01582308|3697148|P8|COMPLETED|10-day Washout Following Period 4||2
1510772|NCT01582308|3697149|P7|COMPLETED|10-day Washout Following Period 4||2
1510773|NCT01582308|3697150|P6|COMPLETED|10-day Washout Following Period 4||1
1510774|NCT01582308|3697151|P5|COMPLETED|10-day Washout Following Period 4||2
1510775|NCT01582308|3697152|P4|COMPLETED|10-day Washout Following Period 4||2
1510776|NCT01582308|3697153|P3|COMPLETED|10-day Washout Following Period 4||2
1510777|NCT01582308|3697154|P2|COMPLETED|10-day Washout Following Period 4||2
1510778|NCT01582308|3697155|P1|COMPLETED|10-day Washout Following Period 4||1
1510779|NCT01582308|3697146|P10|STARTED|10-day Washout Following Period 4||1
1510780|NCT01582308|3697147|P9|STARTED|10-day Washout Following Period 4||2
1510781|NCT01582308|3697148|P8|STARTED|10-day Washout Following Period 4||2
1510782|NCT01582308|3697149|P7|STARTED|10-day Washout Following Period 4||2
1510783|NCT01582308|3697150|P6|STARTED|10-day Washout Following Period 4||1
1510784|NCT01582308|3697151|P5|STARTED|10-day Washout Following Period 4||2
1510785|NCT01582308|3697152|P4|STARTED|10-day Washout Following Period 4||2
1510786|NCT01582308|3697153|P3|STARTED|10-day Washout Following Period 4||2
1510787|NCT01582308|3697154|P2|STARTED|10-day Washout Following Period 4||2
1510788|NCT01582308|3697155|P1|STARTED|10-day Washout Following Period 4||1
1510789|NCT01582308|3697146|P10|NOT COMPLETED|Period 4||1
1510790|NCT01582308|3697147|P9|NOT COMPLETED|Period 4||0
1510791|NCT01582308|3697148|P8|NOT COMPLETED|Period 4||0
1510792|NCT01582308|3697149|P7|NOT COMPLETED|Period 4||0
1510793|NCT01582308|3697150|P6|NOT COMPLETED|Period 4||1
1510794|NCT01582308|3697151|P5|NOT COMPLETED|Period 4||0
1510795|NCT01582308|3697152|P4|NOT COMPLETED|Period 4||0
1510796|NCT01582308|3697153|P3|NOT COMPLETED|Period 4||0
1510797|NCT01582308|3697154|P2|NOT COMPLETED|Period 4||0
1510798|NCT01582308|3697155|P1|NOT COMPLETED|Period 4||1
1510799|NCT01582308|3697146|P10|COMPLETED|Period 4||1
1510800|NCT01582308|3697147|P9|COMPLETED|Period 4||2
1510801|NCT01582308|3697148|P8|COMPLETED|Period 4||2
1510802|NCT01582308|3697149|P7|COMPLETED|Period 4||2
1510803|NCT01582308|3697150|P6|COMPLETED|Period 4||1
1510804|NCT01582308|3697151|P5|COMPLETED|Period 4||2
1510805|NCT01582308|3697152|P4|COMPLETED|Period 4||2
1510806|NCT01582308|3697153|P3|COMPLETED|Period 4||2
1510807|NCT01582308|3697154|P2|COMPLETED|Period 4||2
1510808|NCT01582308|3697155|P1|COMPLETED|Period 4||1
1510809|NCT01582308|3697146|P10|STARTED|Period 4||2
1510810|NCT01582308|3697147|P9|STARTED|Period 4||2
1510811|NCT01582308|3697148|P8|STARTED|Period 4||2
1510812|NCT01582308|3697149|P7|STARTED|Period 4||2
1510813|NCT01582308|3697150|P6|STARTED|Period 4||2
1510814|NCT01582308|3697151|P5|STARTED|Period 4||2
1510815|NCT01582308|3697152|P4|STARTED|Period 4||2
1510816|NCT01582308|3697153|P3|STARTED|Period 4||2
1510817|NCT01582308|3697154|P2|STARTED|Period 4||2
1510818|NCT01582308|3697155|P1|STARTED|Period 4||2
1510819|NCT01582308|3697146|P10|NOT COMPLETED|10-day Washout Following Period 3||0
1510820|NCT01582308|3697147|P9|NOT COMPLETED|10-day Washout Following Period 3||0
1510821|NCT01582308|3697148|P8|NOT COMPLETED|10-day Washout Following Period 3||0
1510822|NCT01582308|3697149|P7|NOT COMPLETED|10-day Washout Following Period 3||0
1510823|NCT01582308|3697150|P6|NOT COMPLETED|10-day Washout Following Period 3||0
1510824|NCT01582308|3697151|P5|NOT COMPLETED|10-day Washout Following Period 3||0
1510825|NCT01582308|3697152|P4|NOT COMPLETED|10-day Washout Following Period 3||0
1510826|NCT01582308|3697153|P3|NOT COMPLETED|10-day Washout Following Period 3||0
1510827|NCT01582308|3697154|P2|NOT COMPLETED|10-day Washout Following Period 3||0
1510828|NCT01582308|3697155|P1|NOT COMPLETED|10-day Washout Following Period 3||0
1510829|NCT01582308|3697146|P10|COMPLETED|10-day Washout Following Period 3||2
1510830|NCT01582308|3697147|P9|COMPLETED|10-day Washout Following Period 3||2
1510831|NCT01582308|3697148|P8|COMPLETED|10-day Washout Following Period 3||2
1510832|NCT01582308|3697149|P7|COMPLETED|10-day Washout Following Period 3||2
1510833|NCT01582308|3697150|P6|COMPLETED|10-day Washout Following Period 3||2
1510834|NCT01582308|3697151|P5|COMPLETED|10-day Washout Following Period 3||2
1510835|NCT01582308|3697152|P4|COMPLETED|10-day Washout Following Period 3||2
1510836|NCT01582308|3697153|P3|COMPLETED|10-day Washout Following Period 3||2
1510837|NCT01582308|3697154|P2|COMPLETED|10-day Washout Following Period 3||2
1510838|NCT01582308|3697155|P1|COMPLETED|10-day Washout Following Period 3||2
1510839|NCT01582308|3697146|P10|STARTED|10-day Washout Following Period 3||2
1510840|NCT01582308|3697147|P9|STARTED|10-day Washout Following Period 3||2
1510841|NCT01582308|3697148|P8|STARTED|10-day Washout Following Period 3||2
1510842|NCT01582308|3697149|P7|STARTED|10-day Washout Following Period 3||2
1510843|NCT01582308|3697150|P6|STARTED|10-day Washout Following Period 3||2
1510844|NCT01582308|3697151|P5|STARTED|10-day Washout Following Period 3||2
1510845|NCT01582308|3697152|P4|STARTED|10-day Washout Following Period 3||2
1510846|NCT01582308|3697153|P3|STARTED|10-day Washout Following Period 3||2
1510847|NCT01582308|3697154|P2|STARTED|10-day Washout Following Period 3||2
1510848|NCT01582308|3697155|P1|STARTED|10-day Washout Following Period 3||2
1510849|NCT01582308|3697146|P10|NOT COMPLETED|Period 3||0
1510850|NCT01582308|3697147|P9|NOT COMPLETED|Period 3||0
1510851|NCT01582308|3697148|P8|NOT COMPLETED|Period 3||0
1510852|NCT01582308|3697149|P7|NOT COMPLETED|Period 3||0
1510853|NCT01582308|3697150|P6|NOT COMPLETED|Period 3||0
1510854|NCT01582308|3697151|P5|NOT COMPLETED|Period 3||0
1510855|NCT01582308|3697152|P4|NOT COMPLETED|Period 3||0
1510856|NCT01582308|3697153|P3|NOT COMPLETED|Period 3||0
1510857|NCT01582308|3697154|P2|NOT COMPLETED|Period 3||0
1510858|NCT01582308|3697155|P1|NOT COMPLETED|Period 3||0
1510859|NCT01582308|3697146|P10|COMPLETED|Period 3||2
1510860|NCT01582308|3697147|P9|COMPLETED|Period 3||2
1510861|NCT01582308|3697148|P8|COMPLETED|Period 3||2
1510862|NCT01582308|3697149|P7|COMPLETED|Period 3||2
1510863|NCT01582308|3697150|P6|COMPLETED|Period 3||2
1510864|NCT01582308|3697151|P5|COMPLETED|Period 3||2
1510865|NCT01582308|3697152|P4|COMPLETED|Period 3||2
1510866|NCT01582308|3697153|P3|COMPLETED|Period 3||2
1510867|NCT01582308|3697154|P2|COMPLETED|Period 3||2
1510868|NCT01582308|3697155|P1|COMPLETED|Period 3||2
1510869|NCT01582308|3697146|P10|STARTED|Period 3||2
1510870|NCT01582308|3697147|P9|STARTED|Period 3||2
1510871|NCT01582308|3697148|P8|STARTED|Period 3||2
1510872|NCT01582308|3697149|P7|STARTED|Period 3||2
1510873|NCT01582308|3697150|P6|STARTED|Period 3||2
1510874|NCT01582308|3697151|P5|STARTED|Period 3||2
1510875|NCT01582308|3697152|P4|STARTED|Period 3||2
1510876|NCT01582308|3697153|P3|STARTED|Period 3||2
1510877|NCT01582308|3697154|P2|STARTED|Period 3||2
1510878|NCT01582308|3697155|P1|STARTED|Period 3||2
1510879|NCT01582308|3697146|P10|NOT COMPLETED|10-day Washout Following Period 2||0
1510880|NCT01582308|3697147|P9|NOT COMPLETED|10-day Washout Following Period 2||0
1510881|NCT01582308|3697148|P8|NOT COMPLETED|10-day Washout Following Period 2||0
1510882|NCT01582308|3697149|P7|NOT COMPLETED|10-day Washout Following Period 2||0
1510883|NCT01582308|3697150|P6|NOT COMPLETED|10-day Washout Following Period 2||0
1510884|NCT01582308|3697151|P5|NOT COMPLETED|10-day Washout Following Period 2||0
1510885|NCT01582308|3697152|P4|NOT COMPLETED|10-day Washout Following Period 2||0
1510886|NCT01582308|3697153|P3|NOT COMPLETED|10-day Washout Following Period 2||0
1510887|NCT01582308|3697154|P2|NOT COMPLETED|10-day Washout Following Period 2||0
1510888|NCT01582308|3697155|P1|NOT COMPLETED|10-day Washout Following Period 2||0
1510889|NCT01582308|3697146|P10|COMPLETED|10-day Washout Following Period 2||2
1510890|NCT01582308|3697147|P9|COMPLETED|10-day Washout Following Period 2||2
1510891|NCT01582308|3697148|P8|COMPLETED|10-day Washout Following Period 2||2
1510892|NCT01582308|3697149|P7|COMPLETED|10-day Washout Following Period 2||2
1510893|NCT01582308|3697150|P6|COMPLETED|10-day Washout Following Period 2||2
1510894|NCT01582308|3697151|P5|COMPLETED|10-day Washout Following Period 2||2
1510895|NCT01582308|3697152|P4|COMPLETED|10-day Washout Following Period 2||2
1510896|NCT01582308|3697153|P3|COMPLETED|10-day Washout Following Period 2||2
1510897|NCT01582308|3697154|P2|COMPLETED|10-day Washout Following Period 2||2
1510898|NCT01582308|3697155|P1|COMPLETED|10-day Washout Following Period 2||2
1510899|NCT01582308|3697146|P10|STARTED|10-day Washout Following Period 2||2
1510900|NCT01582308|3697147|P9|STARTED|10-day Washout Following Period 2||2
1510901|NCT01582308|3697148|P8|STARTED|10-day Washout Following Period 2||2
1510902|NCT01582308|3697149|P7|STARTED|10-day Washout Following Period 2||2
1510903|NCT01582308|3697150|P6|STARTED|10-day Washout Following Period 2||2
1510904|NCT01582308|3697151|P5|STARTED|10-day Washout Following Period 2||2
1510905|NCT01582308|3697152|P4|STARTED|10-day Washout Following Period 2||2
1510906|NCT01582308|3697153|P3|STARTED|10-day Washout Following Period 2||2
1510907|NCT01582308|3697154|P2|STARTED|10-day Washout Following Period 2||2
1510908|NCT01582308|3697155|P1|STARTED|10-day Washout Following Period 2||2
1510909|NCT01582308|3697146|P10|NOT COMPLETED|Period 2||0
1510910|NCT01582308|3697147|P9|NOT COMPLETED|Period 2||0
1510911|NCT01582308|3697148|P8|NOT COMPLETED|Period 2||0
1510912|NCT01582308|3697149|P7|NOT COMPLETED|Period 2||0
1510913|NCT01582308|3697150|P6|NOT COMPLETED|Period 2||0
1510914|NCT01582308|3697151|P5|NOT COMPLETED|Period 2||0
1510915|NCT01582308|3697152|P4|NOT COMPLETED|Period 2||0
1510916|NCT01582308|3697153|P3|NOT COMPLETED|Period 2||0
1510917|NCT01582308|3697154|P2|NOT COMPLETED|Period 2||0
1510918|NCT01582308|3697155|P1|NOT COMPLETED|Period 2||0
1510919|NCT01582308|3697146|P10|COMPLETED|Period 2||2
1510920|NCT01582308|3697147|P9|COMPLETED|Period 2||2
1510921|NCT01582308|3697148|P8|COMPLETED|Period 2||2
1510922|NCT01582308|3697149|P7|COMPLETED|Period 2||2
1510923|NCT01582308|3697150|P6|COMPLETED|Period 2||2
1510924|NCT01582308|3697151|P5|COMPLETED|Period 2||2
1510925|NCT01582308|3697152|P4|COMPLETED|Period 2||2
1510926|NCT01582308|3697153|P3|COMPLETED|Period 2||2
1510927|NCT01582308|3697154|P2|COMPLETED|Period 2||2
1510928|NCT01582308|3697155|P1|COMPLETED|Period 2||2
1510929|NCT01582308|3697146|P10|STARTED|Period 2||2
1510930|NCT01582308|3697147|P9|STARTED|Period 2||2
1510931|NCT01582308|3697148|P8|STARTED|Period 2||2
1510932|NCT01582308|3697149|P7|STARTED|Period 2||2
1510933|NCT01582308|3697150|P6|STARTED|Period 2||2
1510934|NCT01582308|3697151|P5|STARTED|Period 2||2
1510935|NCT01582308|3697152|P4|STARTED|Period 2||2
1510936|NCT01582308|3697153|P3|STARTED|Period 2||2
1510937|NCT01582308|3697154|P2|STARTED|Period 2||2
1510938|NCT01582308|3697155|P1|STARTED|Period 2||2
1510939|NCT01582308|3697146|P10|NOT COMPLETED|10-day Washout Following Period 1||0
1510940|NCT01582308|3697147|P9|NOT COMPLETED|10-day Washout Following Period 1||0
1510941|NCT01582308|3697148|P8|NOT COMPLETED|10-day Washout Following Period 1||0
1510942|NCT01582308|3697149|P7|NOT COMPLETED|10-day Washout Following Period 1||0
1510943|NCT01582308|3697150|P6|NOT COMPLETED|10-day Washout Following Period 1||0
1510944|NCT01582308|3697151|P5|NOT COMPLETED|10-day Washout Following Period 1||1
1510945|NCT01582308|3697152|P4|NOT COMPLETED|10-day Washout Following Period 1||0
1510946|NCT01582308|3697153|P3|NOT COMPLETED|10-day Washout Following Period 1||0
1510947|NCT01582308|3697154|P2|NOT COMPLETED|10-day Washout Following Period 1||0
1510948|NCT01582308|3697155|P1|NOT COMPLETED|10-day Washout Following Period 1||0
1510949|NCT01582308|3697146|P10|COMPLETED|10-day Washout Following Period 1||2
1510950|NCT01582308|3697147|P9|COMPLETED|10-day Washout Following Period 1||2
1510951|NCT01582308|3697148|P8|COMPLETED|10-day Washout Following Period 1||2
1510952|NCT01582308|3697149|P7|COMPLETED|10-day Washout Following Period 1||2
1510953|NCT01582308|3697150|P6|COMPLETED|10-day Washout Following Period 1||2
1510954|NCT01582308|3697151|P5|COMPLETED|10-day Washout Following Period 1||2
1510955|NCT01582308|3697152|P4|COMPLETED|10-day Washout Following Period 1||2
1510956|NCT01582308|3697153|P3|COMPLETED|10-day Washout Following Period 1||2
1510957|NCT01582308|3697154|P2|COMPLETED|10-day Washout Following Period 1||2
1510958|NCT01582308|3697155|P1|COMPLETED|10-day Washout Following Period 1||2
1510959|NCT01582308|3697146|P10|STARTED|10-day Washout Following Period 1||2
1510960|NCT01582308|3697147|P9|STARTED|10-day Washout Following Period 1||2
1510961|NCT01582308|3697148|P8|STARTED|10-day Washout Following Period 1||2
1510962|NCT01582308|3697149|P7|STARTED|10-day Washout Following Period 1||2
1510963|NCT01582308|3697150|P6|STARTED|10-day Washout Following Period 1||2
1510964|NCT01582308|3697151|P5|STARTED|10-day Washout Following Period 1||3
1510965|NCT01582308|3697152|P4|STARTED|10-day Washout Following Period 1||2
1510966|NCT01582308|3697153|P3|STARTED|10-day Washout Following Period 1||2
1510967|NCT01582308|3697154|P2|STARTED|10-day Washout Following Period 1||2
1510968|NCT01582308|3697155|P1|STARTED|10-day Washout Following Period 1||2
1510969|NCT01582308|3697146|P10|NOT COMPLETED|Period 1||0
1510970|NCT01582308|3697147|P9|NOT COMPLETED|Period 1||0
1510971|NCT01582308|3697148|P8|NOT COMPLETED|Period 1||0
1510972|NCT01582308|3697149|P7|NOT COMPLETED|Period 1||1
1510973|NCT01582308|3697150|P6|NOT COMPLETED|Period 1||0
1510974|NCT01582308|3697151|P5|NOT COMPLETED|Period 1||0
1510975|NCT01582308|3697152|P4|NOT COMPLETED|Period 1||0
1510976|NCT01582308|3697153|P3|NOT COMPLETED|Period 1||0
1510977|NCT01582308|3697154|P2|NOT COMPLETED|Period 1||0
1510978|NCT01582308|3697155|P1|NOT COMPLETED|Period 1||0
1510979|NCT01582308|3697146|P10|COMPLETED|Period 1||2
1510980|NCT01582308|3697147|P9|COMPLETED|Period 1||2
1510981|NCT01582308|3697148|P8|COMPLETED|Period 1||2
1510982|NCT01582308|3697149|P7|COMPLETED|Period 1||2
1510983|NCT01582308|3697150|P6|COMPLETED|Period 1||2
1510984|NCT01582308|3697151|P5|COMPLETED|Period 1||3
1510985|NCT01582308|3697152|P4|COMPLETED|Period 1||2
1510986|NCT01582308|3697153|P3|COMPLETED|Period 1||2
1510987|NCT01582308|3697154|P2|COMPLETED|Period 1||2
1510988|NCT01582308|3697155|P1|COMPLETED|Period 1||2
1510989|NCT01582308|3697146|P10|STARTED|Period 1||2
1510990|NCT01582308|3697147|P9|STARTED|Period 1||2
1510991|NCT01582308|3697148|P8|STARTED|Period 1||2
1510992|NCT01582308|3697149|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
1510993|NCT01582308|3697150|P6|STARTED|Period 1||2
1510994|NCT01582308|3697151|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
1510995|NCT01582308|3697152|P4|STARTED|Period 1||2
1510996|NCT01582308|3697153|P3|STARTED|Period 1||2
1510997|NCT01582308|3697154|P2|STARTED|Period 1||2
1510998|NCT01582308|3697155|P1|STARTED|Period 1||2
1510999|NCT01582282|3697183|P3|NOT COMPLETED|Overall Study||0
1511000|NCT01582282|3697184|P2|NOT COMPLETED|Overall Study||2
1511001|NCT01582282|3697185|P1|NOT COMPLETED|Overall Study||2
1511002|NCT01582282|3697183|P3|COMPLETED|Overall Study||8
1511003|NCT01582282|3697184|P2|COMPLETED|Overall Study||12
1511004|NCT01582282|3697185|P1|COMPLETED|Overall Study||13
1511005|NCT01582282|3697183|P3|STARTED|Overall Study||8
1511006|NCT01582282|3697184|P2|STARTED|Overall Study||14
1511007|NCT01582282|3697185|P1|STARTED|Overall Study||15
1511008|NCT01582243|3697208|P1|NOT COMPLETED|Overall Study||3
1511009|NCT01582243|3697208|P1|COMPLETED|Overall Study||37
1511010|NCT01582243|3697208|P1|STARTED|Overall Study||40
1511011|NCT01582178|3697219|P2|NOT COMPLETED|Overall Study||5
1511012|NCT01582178|3697220|P1|NOT COMPLETED|Overall Study||6
1511013|NCT01582178|3697219|P2|COMPLETED|Overall Study||101
1511014|NCT01582178|3697220|P1|COMPLETED|Overall Study||100
1511015|NCT01582178|3697219|P2|STARTED|Overall Study||106
1511016|NCT01582178|3697220|P1|STARTED|Overall Study||106
1511017|NCT01582139|3697228|P2|NOT COMPLETED|Overall Study||0
1511018|NCT01582139|3697229|P1|NOT COMPLETED|Overall Study||0
1511019|NCT01582139|3697228|P2|COMPLETED|Overall Study||6
1511020|NCT01582139|3697229|P1|COMPLETED|Overall Study||6
1511021|NCT01582139|3697228|P2|STARTED|Overall Study||6
1511022|NCT01582139|3697229|P1|STARTED|Overall Study||6
1511023|NCT01582100|3697241|P1|NOT COMPLETED|Overall Study||2
1511024|NCT01582100|3697241|P1|COMPLETED|Overall Study||0
1511025|NCT01582100|3697241|P1|STARTED|Overall Study||2
1511026|NCT01582061|3697247|P2|NOT COMPLETED|Overall Study||36
1511027|NCT01582061|3697248|P1|NOT COMPLETED|Overall Study||28
1511028|NCT01582061|3697247|P2|COMPLETED|Overall Study||19
1511029|NCT01582061|3697248|P1|COMPLETED|Overall Study||21
1511030|NCT01582061|3697247|P2|STARTED|Overall Study||55
1511031|NCT01582061|3697248|P1|STARTED|Overall Study||49
1511032|NCT01582009|3697298|P1|NOT COMPLETED|Overall Study||2
1511033|NCT01582009|3697298|P1|COMPLETED|Overall Study||24
1511034|NCT01582009|3697298|P1|STARTED|Overall Study||26
1511035|NCT01581931|3697306|P2|NOT COMPLETED|Second Period||0
1511036|NCT01581931|3697307|P1|NOT COMPLETED|Second Period||0
1511037|NCT01581931|3697306|P2|COMPLETED|Second Period||15
1511038|NCT01581931|3697307|P1|COMPLETED|Second Period||16
1511039|NCT01581931|3697306|P2|STARTED|Second Period||15
1511040|NCT01581931|3697307|P1|STARTED|Second Period||16
1511041|NCT01581931|3697306|P2|NOT COMPLETED|Washout||1
1511042|NCT01581931|3697307|P1|NOT COMPLETED|Washout||0
1511043|NCT01581931|3697306|P2|COMPLETED|Washout||15
1511044|NCT01581931|3697307|P1|COMPLETED|Washout||16
1511045|NCT01581931|3697306|P2|STARTED|Washout||16
1511046|NCT01581931|3697307|P1|STARTED|Washout||16
1511047|NCT01581931|3697306|P2|NOT COMPLETED|First Period||0
1511048|NCT01581931|3697307|P1|NOT COMPLETED|First Period||0
1511049|NCT01581931|3697306|P2|COMPLETED|First Period||16
1511050|NCT01581931|3697307|P1|COMPLETED|First Period||16
1511051|NCT01581931|3697306|P2|STARTED|First Period||16
1511052|NCT01581931|3697307|P1|STARTED|First Period||16
1511053|NCT01581710|3697321|P2|NOT COMPLETED|Second Intervention (14days)||2
1511054|NCT01581710|3697322|P1|NOT COMPLETED|Second Intervention (14days)||0
1511055|NCT01581710|3697321|P2|COMPLETED|Second Intervention (14days)||12
1511056|NCT01581710|3697322|P1|COMPLETED|Second Intervention (14days)||18
1511057|NCT01581710|3697321|P2|STARTED|Second Intervention (14days)||14
1511058|NCT01581710|3697322|P1|STARTED|Second Intervention (14days)||18
1511059|NCT01581710|3697321|P2|NOT COMPLETED|Washout Period (14days)||0
1511060|NCT01581710|3697322|P1|NOT COMPLETED|Washout Period (14days)||0
1511061|NCT01581710|3697321|P2|COMPLETED|Washout Period (14days)||14
1511062|NCT01581710|3697322|P1|COMPLETED|Washout Period (14days)||18
1511063|NCT01581710|3697321|P2|STARTED|Washout Period (14days)||14
1511064|NCT01581710|3697322|P1|STARTED|Washout Period (14days)||18
1511065|NCT01581710|3697321|P2|NOT COMPLETED|First Intervention (14days)||0
1511066|NCT01581710|3697322|P1|NOT COMPLETED|First Intervention (14days)||0
1511067|NCT01581710|3697321|P2|COMPLETED|First Intervention (14days)||14
1511068|NCT01581710|3697322|P1|COMPLETED|First Intervention (14days)||18
1511069|NCT01581710|3697321|P2|STARTED|First Intervention (14days)||14
1511070|NCT01581710|3697322|P1|STARTED|First Intervention (14days)||18
1511071|NCT01581684|3697360|P10|NOT COMPLETED|Overall Study||0
1511072|NCT01581684|3697361|P9|NOT COMPLETED|Overall Study||1
1511073|NCT01581684|3697362|P8|NOT COMPLETED|Overall Study||0
1511074|NCT01581684|3697363|P7|NOT COMPLETED|Overall Study||0
1511075|NCT01581684|3697364|P6|NOT COMPLETED|Overall Study||0
1511076|NCT01581684|3697365|P5|NOT COMPLETED|Overall Study||0
1511077|NCT01581684|3697366|P4|NOT COMPLETED|Overall Study||0
1511078|NCT01581684|3697367|P3|NOT COMPLETED|Overall Study||0
1511079|NCT01581684|3697368|P2|NOT COMPLETED|Overall Study||0
1511080|NCT01581684|3697369|P1|NOT COMPLETED|Overall Study||0
1511081|NCT01581684|3697360|P10|COMPLETED|Overall Study||5
1511082|NCT01581684|3697361|P9|COMPLETED|Overall Study||0
1511083|NCT01581684|3697362|P8|COMPLETED|Overall Study||6
1511084|NCT01581684|3697363|P7|COMPLETED|Overall Study||6
1511085|NCT01581684|3697364|P6|COMPLETED|Overall Study||6
1511086|NCT01581684|3697365|P5|COMPLETED|Overall Study||6
1511087|NCT01581684|3697366|P4|COMPLETED|Overall Study||6
1511088|NCT01581684|3697367|P3|COMPLETED|Overall Study||6
1511089|NCT01581684|3697368|P2|COMPLETED|Overall Study||6
1511090|NCT01581684|3697369|P1|COMPLETED|Overall Study||14
1511091|NCT01581684|3697360|P10|STARTED|Overall Study||5
1511092|NCT01581684|3697361|P9|STARTED|Overall Study||1
1511093|NCT01581684|3697362|P8|STARTED|Overall Study||6
1511094|NCT01581684|3697363|P7|STARTED|Overall Study||6
1511095|NCT01581684|3697364|P6|STARTED|Overall Study||6
1511096|NCT01581684|3697365|P5|STARTED|Overall Study||6
1511097|NCT01581684|3697366|P4|STARTED|Overall Study||6
1511098|NCT01581684|3697367|P3|STARTED|Overall Study||6
1511099|NCT01581684|3697368|P2|STARTED|Overall Study||6
1511100|NCT01581684|3697369|P1|STARTED|Overall Study||14
1511101|NCT01581658|3697444|P4|NOT COMPLETED|Overall Study||0
1511102|NCT01581658|3697445|P3|NOT COMPLETED|Overall Study||0
1511103|NCT01581658|3697446|P2|NOT COMPLETED|Overall Study||0
1511104|NCT01581658|3697447|P1|NOT COMPLETED|Overall Study||0
1511105|NCT01581658|3697444|P4|COMPLETED|Overall Study||8
1511106|NCT01581658|3697445|P3|COMPLETED|Overall Study||8
1511107|NCT01581658|3697446|P2|COMPLETED|Overall Study||8
1511108|NCT01581658|3697447|P1|COMPLETED|Overall Study||8
1511109|NCT01581658|3697444|P4|STARTED|Overall Study||8
1511110|NCT01581658|3697445|P3|STARTED|Overall Study||8
1511111|NCT01581658|3697446|P2|STARTED|Overall Study||8
1511112|NCT01581658|3697447|P1|STARTED|Overall Study||8
1511113|NCT01581619|3697465|P1|NOT COMPLETED|Overall Study||2
1511114|NCT01581619|3697465|P1|COMPLETED|Overall Study||52
1511115|NCT01581619|3697465|P1|STARTED|Overall Study||54
1511116|NCT01581541|3697473|P11|NOT COMPLETED|Overall Study||0
1511117|NCT01581541|3697474|P10|NOT COMPLETED|Overall Study||0
1511118|NCT01581541|3697475|P9|NOT COMPLETED|Overall Study||0
1511119|NCT01581541|3697476|P8|NOT COMPLETED|Overall Study||0
1511120|NCT01581541|3697477|P7|NOT COMPLETED|Overall Study||0
1511121|NCT01581541|3697478|P6|NOT COMPLETED|Overall Study||0
1511122|NCT01581541|3697479|P5|NOT COMPLETED|Overall Study||0
1511123|NCT01581541|3697480|P4|NOT COMPLETED|Overall Study||0
1511124|NCT01581541|3697481|P3|NOT COMPLETED|Overall Study||0
1511125|NCT01581541|3697482|P2|NOT COMPLETED|Overall Study||0
1511126|NCT01581541|3697483|P1|NOT COMPLETED|Overall Study||0
1511127|NCT01581541|3697473|P11|COMPLETED|Overall Study||1
1511128|NCT01581541|3697474|P10|COMPLETED|Overall Study||3
1511129|NCT01581541|3697475|P9|COMPLETED|Overall Study||1
1511130|NCT01581541|3697476|P8|COMPLETED|Overall Study||2
1511131|NCT01581541|3697477|P7|COMPLETED|Overall Study||1
1511132|NCT01581541|3697478|P6|COMPLETED|Overall Study||3
1511133|NCT01581541|3697479|P5|COMPLETED|Overall Study||2
1511134|NCT01581541|3697480|P4|COMPLETED|Overall Study||1
1511135|NCT01581541|3697481|P3|COMPLETED|Overall Study||1
1511136|NCT01581541|3697482|P2|COMPLETED|Overall Study||1
1511137|NCT01581541|3697483|P1|COMPLETED|Overall Study||1
1511138|NCT01581541|3697473|P11|STARTED|Overall Study||1
1511139|NCT01581541|3697474|P10|STARTED|Overall Study||3
1511140|NCT01581541|3697475|P9|STARTED|Overall Study||1
1511141|NCT01581541|3697476|P8|STARTED|Overall Study||2
1511142|NCT01581541|3697477|P7|STARTED|Overall Study||1
1511143|NCT01581541|3697478|P6|STARTED|Overall Study||3
1511144|NCT01581541|3697479|P5|STARTED|Overall Study||2
1511145|NCT01581541|3697480|P4|STARTED|Overall Study||1
1511146|NCT01581541|3697481|P3|STARTED|Overall Study||1
1511147|NCT01581541|3697482|P2|STARTED|Overall Study||1
1511148|NCT01581541|3697483|P1|STARTED|Overall Study||1
1511149|NCT01581437|3697607|P1|NOT COMPLETED|Overall Study||0
1511150|NCT01581437|3697607|P1|COMPLETED|Overall Study||78
1511151|NCT01581437|3697607|P1|STARTED|Overall Study||78
1511152|NCT01581307|3697618|P1|NOT COMPLETED|Overall Study||1
1511153|NCT01581307|3697618|P1|COMPLETED|Overall Study||8
1511154|NCT01581307|3697618|P1|STARTED|Overall Study||9
1511155|NCT01581281|3697627|P3|NOT COMPLETED|Overall Study||12
1511156|NCT01581281|3697628|P2|NOT COMPLETED|Overall Study||6
1511157|NCT01581281|3697629|P1|NOT COMPLETED|Overall Study||15
1511158|NCT01581281|3697627|P3|COMPLETED|Overall Study||132
1511159|NCT01581281|3697628|P2|COMPLETED|Overall Study||66
1511160|NCT01581281|3697629|P1|COMPLETED|Overall Study||130
1511161|NCT01581281|3697627|P3|STARTED|Overall Study||144
1511162|NCT01581281|3697628|P2|STARTED|Overall Study||72
1511163|NCT01581281|3697629|P1|STARTED|Overall Study||145
1511164|NCT01581021|3697651|P2|NOT COMPLETED|Overall Study||11
1511165|NCT01581021|3697652|P1|NOT COMPLETED|Overall Study||10
1511166|NCT01581021|3697651|P2|COMPLETED|Overall Study||18
1511167|NCT01581021|3697652|P1|COMPLETED|Overall Study||19
1511168|NCT01581021|3697651|P2|STARTED|Overall Study||29
1511169|NCT01581021|3697652|P1|STARTED|Overall Study||29
1511170|NCT01581008|3697666|P2|NOT COMPLETED|Overall Study||6
1511171|NCT01581008|3697667|P1|NOT COMPLETED|Overall Study||1
1511172|NCT01581008|3697666|P2|COMPLETED|Overall Study||7
1511173|NCT01581008|3697667|P1|COMPLETED|Overall Study||16
1511174|NCT01581008|3697666|P2|STARTED|Overall Study||13
1511175|NCT01581008|3697667|P1|STARTED|Overall Study||17
1511176|NCT01580995|3697679|P2|NOT COMPLETED|Overall Study||2
1511177|NCT01580995|3697680|P1|NOT COMPLETED|Overall Study||2
1511178|NCT01580995|3697679|P2|COMPLETED|Overall Study||7
1511179|NCT01580995|3697680|P1|COMPLETED|Overall Study||8
1511180|NCT01580995|3697679|P2|STARTED|Overall Study||9
1511181|NCT01580995|3697680|P1|STARTED|Overall Study||10
1511182|NCT01580904|3697688|P2|NOT COMPLETED|Overall Study||7
1511183|NCT01580904|3697689|P1|NOT COMPLETED|Overall Study||4
1511184|NCT01580904|3697688|P2|COMPLETED|Overall Study||42
1511185|NCT01580904|3697689|P1|COMPLETED|Overall Study||47
1511186|NCT01580904|3697688|P2|STARTED|Overall Study||49
1511187|NCT01580904|3697689|P1|STARTED|Overall Study||51
1511188|NCT01580618|3697703|P2|NOT COMPLETED|Overall Study||0
1511189|NCT01580618|3697704|P1|NOT COMPLETED|Overall Study||1
1511190|NCT01580618|3697703|P2|COMPLETED|Overall Study||12
1511191|NCT01580618|3697704|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
1511192|NCT01580618|3697703|P2|STARTED|Overall Study||12
1511193|NCT01580618|3697704|P1|STARTED|Overall Study||8
1511194|NCT01580592|3697720|P3|NOT COMPLETED|Overall Study||0
1511195|NCT01580592|3697721|P2|NOT COMPLETED|Overall Study||0
1511196|NCT01580592|3697722|P1|NOT COMPLETED|Overall Study||0
1511197|NCT01580592|3697720|P3|COMPLETED|Overall Study||12
1511198|NCT01580592|3697721|P2|COMPLETED|Overall Study||9
1511199|NCT01580592|3697722|P1|COMPLETED|Overall Study||10
1511200|NCT01580592|3697720|P3|STARTED|Overall Study||12
1511201|NCT01580592|3697721|P2|STARTED|Overall Study||9
1511202|NCT01580592|3697722|P1|STARTED|Overall Study||10
1511203|NCT01580488|3697733|P1|NOT COMPLETED|Overall Study||1
1511204|NCT01580488|3697733|P1|COMPLETED|Overall Study||23
1511205|NCT01580488|3697733|P1|STARTED|Overall Study||24
1511206|NCT01580423|3697777|P2|NOT COMPLETED|Second Intervention||0
1511207|NCT01580423|3697778|P1|NOT COMPLETED|Second Intervention||0
1511208|NCT01580423|3697777|P2|COMPLETED|Second Intervention||8
1511209|NCT01580423|3697778|P1|COMPLETED|Second Intervention||8
1511210|NCT01580423|3697777|P2|STARTED|Second Intervention||8
1511211|NCT01580423|3697778|P1|STARTED|Second Intervention||8
1511212|NCT01580423|3697777|P2|NOT COMPLETED|First Intervention||0
1511213|NCT01580423|3697778|P1|NOT COMPLETED|First Intervention||0
1511214|NCT01580423|3697777|P2|COMPLETED|First Intervention||8
1511215|NCT01580423|3697778|P1|COMPLETED|First Intervention||8
1511216|NCT01580423|3697777|P2|STARTED|First Intervention||8
1511217|NCT01580423|3697778|P1|STARTED|First Intervention||8
1511218|NCT01580410|3697790|P2|NOT COMPLETED|Overall Study||8
1511219|NCT01580410|3697791|P1|NOT COMPLETED|Overall Study||11
1511220|NCT01580410|3697790|P2|COMPLETED|Overall Study||60
1511221|NCT01580410|3697791|P1|COMPLETED|Overall Study||57
1511222|NCT01580410|3697790|P2|STARTED|Overall Study||68
1511223|NCT01580410|3697791|P1|STARTED|Overall Study||68
1511224|NCT01580306|3697807|P4|NOT COMPLETED|Overall Study||0
1511225|NCT01580306|3697808|P3|NOT COMPLETED|Overall Study||0
1511226|NCT01580306|3697809|P2|NOT COMPLETED|Overall Study||0
1511227|NCT01580306|3697810|P1|NOT COMPLETED|Overall Study||0
1511228|NCT01580306|3697807|P4|COMPLETED|Overall Study||8
1511229|NCT01580306|3697808|P3|COMPLETED|Overall Study||8
1511230|NCT01580306|3697809|P2|COMPLETED|Overall Study||8
1511231|NCT01580306|3697810|P1|COMPLETED|Overall Study||8
1511232|NCT01580306|3697807|P4|STARTED|Overall Study||8
1511233|NCT01580306|3697808|P3|STARTED|Overall Study||8
1511234|NCT01580306|3697809|P2|STARTED|Overall Study||8
1511235|NCT01580306|3697810|P1|STARTED|Overall Study||8
1511236|NCT01580293|3697839|P3|NOT COMPLETED|Part B||3
1511237|NCT01580293|3697840|P2|NOT COMPLETED|Part B||0
1511238|NCT01580293|3697841|P1|NOT COMPLETED|Part B||0
1511239|NCT01580293|3697839|P3|COMPLETED|Part B||16
1511240|NCT01580293|3697840|P2|COMPLETED|Part B||0
1511241|NCT01580293|3697841|P1|COMPLETED|Part B||0
1511242|NCT01580293|3697839|P3|Part B Ongoing|Part B||1
1511243|NCT01580293|3697840|P2|Part B Ongoing|Part B||0
1511244|NCT01580293|3697841|P1|Part B Ongoing|Part B||0
1511245|NCT01580293|3697839|P3|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
1511246|NCT01580293|3697840|P2|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
1511247|NCT01580293|3697841|P1|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
1511248|NCT01580293|3697839|P3|NOT COMPLETED|Part A_Extension||0
1511249|NCT01580293|3697840|P2|NOT COMPLETED|Part A_Extension||75
1511250|NCT01580293|3697841|P1|NOT COMPLETED|Part A_Extension||9
1511251|NCT01580293|3697839|P3|COMPLETED|Part A_Extension||0
1511252|NCT01580293|3697840|P2|COMPLETED|Part A_Extension||32
1511253|NCT01580293|3697841|P1|COMPLETED|Part A_Extension||5
1511254|NCT01580293|3697839|P3|Extension Ongoing|Part A_Extension||0
1511255|NCT01580293|3697840|P2|Extension Ongoing|Part A_Extension||69
1511256|NCT01580293|3697841|P1|Extension Ongoing|Part A_Extension||9
1511257|NCT01580293|3697839|P3|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
1511258|NCT01580293|3697840|P2|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
1511259|NCT01580293|3697841|P1|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
1511260|NCT01580293|3697839|P3|NOT COMPLETED|Part A_Main Trial||0
1511261|NCT01580293|3697840|P2|NOT COMPLETED|Part A_Main Trial||6
1511262|NCT01580293|3697841|P1|NOT COMPLETED|Part A_Main Trial||2
1511263|NCT01580293|3697839|P3|COMPLETED|Part A_Main Trial||0
1511264|NCT01580293|3697840|P2|COMPLETED|Part A_Main Trial||108
1511265|NCT01580293|3697841|P1|COMPLETED|Part A_Main Trial||18
1511266|NCT01580293|3697839|P3|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
1511267|NCT01580293|3697840|P2|STARTED|Part A_Main Trial||114
1511268|NCT01580293|3697841|P1|STARTED|Part A_Main Trial||20
1511269|NCT01580098|3697926|P3|NOT COMPLETED|Overall Study||3
1511270|NCT01580098|3697927|P2|NOT COMPLETED|Overall Study||13
1511271|NCT01580098|3697928|P1|NOT COMPLETED|Overall Study||15
1511272|NCT01580098|3697926|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
1511273|NCT01580098|3697927|P2|COMPLETED|Overall Study||101
1511274|NCT01580098|3697928|P1|COMPLETED|Overall Study||61
1511275|NCT01580098|3697926|P3|STARTED|Overall Study||3
1511276|NCT01580098|3697927|P2|STARTED|Overall Study||114
1511277|NCT01580098|3697928|P1|STARTED|Overall Study||76
1511278|NCT01580072|3697951|P3|NOT COMPLETED|Overall Study||0
1511279|NCT01580072|3697952|P2|NOT COMPLETED|Overall Study||9
1511280|NCT01580072|3697953|P1|NOT COMPLETED|Overall Study||12
1511281|NCT01580072|3697951|P3|COMPLETED|Overall Study||0
1511282|NCT01580072|3697952|P2|COMPLETED|Overall Study||28
1511283|NCT01580072|3697953|P1|COMPLETED|Overall Study||16
1511284|NCT01580072|3697951|P3|STARTED|Overall Study||0
1511285|NCT01580072|3697952|P2|STARTED|Overall Study||37
1511286|NCT01580072|3697953|P1|STARTED|Overall Study||28
1511287|NCT01580020|3697981|P4|NOT COMPLETED|Overall Study||2
1511288|NCT01580020|3697982|P3|NOT COMPLETED|Overall Study||4
1511289|NCT01580020|3697983|P2|NOT COMPLETED|Overall Study||7
1511290|NCT01580020|3697984|P1|NOT COMPLETED|Overall Study||1
1511291|NCT01580020|3697981|P4|COMPLETED|Overall Study||20
1511292|NCT01580020|3697982|P3|COMPLETED|Overall Study||57
1511293|NCT01580020|3697983|P2|COMPLETED|Overall Study||33
1511294|NCT01580020|3697984|P1|COMPLETED|Overall Study||51
1511295|NCT01580020|3697981|P4|STARTED|Overall Study||22
1511296|NCT01580020|3697982|P3|STARTED|Overall Study||61
1511297|NCT01580020|3697983|P2|STARTED|Overall Study||40
1511298|NCT01580020|3697984|P1|STARTED|Overall Study||52
1511299|NCT01579916|3698028|P2|NOT COMPLETED|Overall Study||2
1511300|NCT01579916|3698029|P1|NOT COMPLETED|Overall Study||8
1511301|NCT01579916|3698028|P2|COMPLETED|Overall Study||59
1511302|NCT01579916|3698029|P1|COMPLETED|Overall Study||234
1511303|NCT01579916|3698028|P2|STARTED|Overall Study||61
1511304|NCT01579916|3698029|P1|STARTED|Overall Study||242
1511305|NCT01579812|3698055|P1|NOT COMPLETED|Overall Study||52
1511306|NCT01579812|3698055|P1|COMPLETED|Overall Study||38
1511307|NCT01579812|3698055|P1|STARTED|Overall Study||90
1511308|NCT01579747|3698065|P2|NOT COMPLETED|Overall Study||0
1511309|NCT01579747|3698066|P1|NOT COMPLETED|Overall Study||0
1511310|NCT01579747|3698065|P2|COMPLETED|Overall Study||12
1511311|NCT01579747|3698066|P1|COMPLETED|Overall Study||12
1511312|NCT01579747|3698065|P2|STARTED|Overall Study||12
1511313|NCT01579747|3698066|P1|STARTED|Overall Study||12
1511314|NCT01579669|3698076|P2|NOT COMPLETED|Overall Study||0
1511315|NCT01579669|3698077|P1|NOT COMPLETED|Overall Study||36
1511316|NCT01579669|3698076|P2|COMPLETED|Overall Study||41
1511317|NCT01579669|3698077|P1|COMPLETED|Overall Study||134
1511318|NCT01579669|3698076|P2|STARTED|Overall Study||41
1511319|NCT01579669|3698077|P1|STARTED|Overall Study||170
1511320|NCT01579578|3698089|P2|NOT COMPLETED|Overall Study||12
1511321|NCT01579578|3698090|P1|NOT COMPLETED|Overall Study||13
1511322|NCT01579578|3698089|P2|COMPLETED|Overall Study||0
1511323|NCT01579578|3698090|P1|COMPLETED|Overall Study||0
1511324|NCT01579578|3698089|P2|Ongoing|Overall Study||0
1511325|NCT01579578|3698090|P1|Ongoing|Overall Study||3
1511326|NCT01579578|3698089|P2|STARTED|Overall Study||12
1511327|NCT01579578|3698090|P1|STARTED|Overall Study||13
1511328|NCT01579565|3698102|P2|NOT COMPLETED|Treated||3
1511329|NCT01579565|3698103|P1|NOT COMPLETED|Treated||2
1511330|NCT01579565|3698102|P2|COMPLETED|Treated||201
1511331|NCT01579565|3698103|P1|COMPLETED|Treated||200
1511332|NCT01579565|3698102|P2|STARTED|Treated||204
1511333|NCT01579565|3698103|P1|STARTED|Treated||202
1511334|NCT01579565|3698102|P2|NOT COMPLETED|Randomized||5
1511335|NCT01579565|3698103|P1|NOT COMPLETED|Randomized||5
1511336|NCT01579565|3698102|P2|COMPLETED|Randomized||204
1511337|NCT01579565|3698103|P1|COMPLETED|Randomized||202
1511338|NCT01579565|3698102|P2|STARTED|Randomized||209
1511339|NCT01579565|3698103|P1|STARTED|Randomized||207
1511340|NCT01579474|3698137|P6|NOT COMPLETED|Overall Study||1
1511341|NCT01579474|3698138|P5|NOT COMPLETED|Overall Study||1
1511342|NCT01579474|3698139|P4|NOT COMPLETED|Overall Study||0
1511343|NCT01579474|3698140|P3|NOT COMPLETED|Overall Study||2
1511344|NCT01579474|3698141|P2|NOT COMPLETED|Overall Study||13
1511345|NCT01579474|3698142|P1|NOT COMPLETED|Overall Study||3
1511346|NCT01579474|3698137|P6|COMPLETED|Overall Study||1
1511347|NCT01579474|3698138|P5|COMPLETED|Overall Study||9
1511348|NCT01579474|3698139|P4|COMPLETED|Overall Study||3
1511349|NCT01579474|3698140|P3|COMPLETED|Overall Study||27
1511350|NCT01579474|3698141|P2|COMPLETED|Overall Study||30
1511351|NCT01579474|3698142|P1|COMPLETED|Overall Study||41
1511352|NCT01579474|3698137|P6|STARTED|Overall Study||2
1511353|NCT01579474|3698138|P5|STARTED|Overall Study||10
1511354|NCT01579474|3698139|P4|STARTED|Overall Study||3
1511355|NCT01579474|3698140|P3|STARTED|Overall Study||29
1511356|NCT01579474|3698141|P2|STARTED|Overall Study||43
1511357|NCT01579474|3698142|P1|STARTED|Overall Study||44
1511358|NCT01579318|3698216|P1|NOT COMPLETED|Overall Study||1
1511359|NCT01579318|3698216|P1|COMPLETED|Overall Study||1
1511360|NCT01579318|3698216|P1|STARTED|Overall Study||2
1511361|NCT01579305|3698229|P2|NOT COMPLETED|Overall Study||27
1511362|NCT01579305|3698230|P1|NOT COMPLETED|Overall Study||21
1511363|NCT01579305|3698229|P2|COMPLETED|Overall Study||115
1511364|NCT01579305|3698230|P1|COMPLETED|Overall Study||118
1511365|NCT01579305|3698229|P2|Continued After Treatment|Overall Study||141
1511366|NCT01579305|3698230|P1|Continued After Treatment|Overall Study||139
1511367|NCT01579305|3698229|P2|Discontinued Before Treatment|Overall Study||1
1511368|NCT01579305|3698230|P1|Discontinued Before Treatment|Overall Study||0
1511369|NCT01579305|3698229|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
1511370|NCT01579305|3698230|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
1511371|NCT01579214|3698238|P2|NOT COMPLETED|Overall Study||0
1511372|NCT01579214|3698239|P1|NOT COMPLETED|Overall Study||0
1511373|NCT01579214|3698238|P2|COMPLETED|Overall Study||138
1511374|NCT01579214|3698239|P1|COMPLETED|Overall Study||45
1511375|NCT01579214|3698238|P2|STARTED|Overall Study||138
1511376|NCT01579214|3698239|P1|STARTED|Overall Study||45
1511377|NCT01579084|3698257|P10|NOT COMPLETED|Overall Study||0
1511378|NCT01579084|3698258|P9|NOT COMPLETED|Overall Study||0
1511379|NCT01579084|3698259|P8|NOT COMPLETED|Overall Study||0
1511380|NCT01579084|3698260|P7|NOT COMPLETED|Overall Study||0
1511381|NCT01579084|3698261|P6|NOT COMPLETED|Overall Study||0
1511382|NCT01579084|3698262|P5|NOT COMPLETED|Overall Study||0
1511383|NCT01579084|3698263|P4|NOT COMPLETED|Overall Study||0
1511384|NCT01579084|3698264|P3|NOT COMPLETED|Overall Study||0
1511385|NCT01579084|3698265|P2|NOT COMPLETED|Overall Study||0
1511386|NCT01579084|3698266|P1|NOT COMPLETED|Overall Study||0
1511387|NCT01579084|3698257|P10|COMPLETED|Overall Study||4
1511388|NCT01579084|3698258|P9|COMPLETED|Overall Study||4
1511389|NCT01579084|3698259|P8|COMPLETED|Overall Study||4
1511390|NCT01579084|3698260|P7|COMPLETED|Overall Study||4
1511391|NCT01579084|3698261|P6|COMPLETED|Overall Study||8
1511392|NCT01579084|3698262|P5|COMPLETED|Overall Study||8
1511393|NCT01579084|3698263|P4|COMPLETED|Overall Study||8
1511394|NCT01579084|3698264|P3|COMPLETED|Overall Study||8
1511395|NCT01579084|3698265|P2|COMPLETED|Overall Study||8
1511396|NCT01579084|3698266|P1|COMPLETED|Overall Study||8
1511397|NCT01579084|3698257|P10|STARTED|Overall Study||4
1511398|NCT01579084|3698258|P9|STARTED|Overall Study||4
1511399|NCT01579084|3698259|P8|STARTED|Overall Study||4
1511400|NCT01579084|3698260|P7|STARTED|Overall Study||4
1511401|NCT01579084|3698261|P6|STARTED|Overall Study||8
1511402|NCT01579084|3698262|P5|STARTED|Overall Study||8
1511403|NCT01579084|3698263|P4|STARTED|Overall Study||8
1511404|NCT01579084|3698264|P3|STARTED|Overall Study||8
1511405|NCT01579084|3698265|P2|STARTED|Overall Study||8
1511406|NCT01579084|3698266|P1|STARTED|Overall Study||8
1511407|NCT01579045|3698294|P1|NOT COMPLETED|Overall Study||0
1511408|NCT01579045|3698294|P1|COMPLETED|Overall Study||24
1511409|NCT01579045|3698294|P1|STARTED|Overall Study||24
1511410|NCT01579006|3698311|P1|NOT COMPLETED|Overall Study||33
1511411|NCT01579006|3698311|P1|COMPLETED|Overall Study||151
1511412|NCT01579006|3698311|P1|STARTED|Overall Study||184
1511413|NCT01578993|3698350|P1|NOT COMPLETED|Overall Study||0
1511414|NCT01578993|3698350|P1|COMPLETED|Overall Study||101
1511415|NCT01578993|3698350|P1|STARTED|Overall Study||101
1511416|NCT01578980|3698354|P1|NOT COMPLETED|Overall Study||0
1511417|NCT01578980|3698354|P1|COMPLETED|Overall Study||20
1511418|NCT01578980|3698354|P1|STARTED|Overall Study||20
1511419|NCT01578967|3698359|P1|NOT COMPLETED|Overall Study||0
1511420|NCT01578967|3698359|P1|COMPLETED|Overall Study||41
1511421|NCT01578967|3698359|P1|STARTED|Overall Study||41
1511422|NCT01578850|3698370|P3|NOT COMPLETED|Period 2||14
1511423|NCT01578850|3698371|P2|NOT COMPLETED|Period 2||13
1511424|NCT01578850|3698372|P1|NOT COMPLETED|Period 2||0
1511425|NCT01578850|3698370|P3|COMPLETED|Period 2||162
1511426|NCT01578850|3698371|P2|COMPLETED|Period 2||154
1511427|NCT01578850|3698372|P1|COMPLETED|Period 2||0
1511428|NCT01578850|3698370|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
1511429|NCT01578850|3698371|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
1511430|NCT01578850|3698372|P1|STARTED|Period 2||0
1511431|NCT01578850|3698370|P3|NOT COMPLETED|Period 1||0
1511432|NCT01578850|3698371|P2|NOT COMPLETED|Period 1||0
1511433|NCT01578850|3698372|P1|NOT COMPLETED|Period 1||37
1511434|NCT01578850|3698370|P3|COMPLETED|Period 1||0
1511435|NCT01578850|3698371|P2|COMPLETED|Period 1||0
1511436|NCT01578850|3698372|P1|COMPLETED|Period 1||452
1511437|NCT01578850|3698370|P3|STARTED|Period 1||0
1511438|NCT01578850|3698371|P2|STARTED|Period 1||0
1511439|NCT01578850|3698372|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
1511440|NCT01578785|3698424|P2|NOT COMPLETED|Overall Study||119
1511441|NCT01578785|3698425|P1|NOT COMPLETED|Overall Study||59
1511442|NCT01578785|3698424|P2|COMPLETED|Overall Study||0
1511443|NCT01578785|3698425|P1|COMPLETED|Overall Study||0
1511444|NCT01578785|3698424|P2|STARTED|Overall Study||119
1511445|NCT01578785|3698425|P1|STARTED|Overall Study||59
1511446|NCT01578772|3698437|P1|NOT COMPLETED|Overall Study||0
1511447|NCT01578772|3698437|P1|COMPLETED|Overall Study||17
1511448|NCT01578772|3698437|P1|STARTED|Overall Study||17
1511449|NCT01578707|3698446|P2|NOT COMPLETED|Overall Study||0
1511450|NCT01578707|3698447|P1|NOT COMPLETED|Overall Study||0
1511451|NCT01578707|3698446|P2|COMPLETED|Overall Study||195
1511452|NCT01578707|3698447|P1|COMPLETED|Overall Study||196
1511453|NCT01578707|3698446|P2|STARTED|Overall Study||195
1511454|NCT01578707|3698447|P1|STARTED|Overall Study||196
1511455|NCT01578551|3698457|P2|NOT COMPLETED|Overall Study||0
1511456|NCT01578551|3698458|P1|NOT COMPLETED|Overall Study||1
1511457|NCT01578551|3698457|P2|COMPLETED|Overall Study||6
1511458|NCT01578551|3698458|P1|COMPLETED|Overall Study||18
1511459|NCT01578551|3698457|P2|STARTED|Overall Study||6
1511460|NCT01578551|3698458|P1|STARTED|Overall Study||19
1511461|NCT01578499|3698470|P2|NOT COMPLETED|Overall Study||65
1511462|NCT01578499|3698471|P1|NOT COMPLETED|Overall Study||66
1511463|NCT01578499|3698470|P2|COMPLETED|Overall Study||0
1511464|NCT01578499|3698471|P1|COMPLETED|Overall Study||0
1511465|NCT01578499|3698470|P2|Intent to Treat Population: CD30+|Overall Study||64
1511466|NCT01578499|3698471|P1|Intent to Treat Population: CD30+|Overall Study||64
1511467|NCT01578499|3698470|P2|Safety Population: Treated|Overall Study||62
1511468|NCT01578499|3698471|P1|Safety Population: Treated|Overall Study||66
1511469|NCT01578499|3698470|P2|STARTED|Overall Study||65
1511470|NCT01578499|3698471|P1|STARTED|Overall Study||66
1511471|NCT01578486|3698505|P1|NOT COMPLETED|Overall Study||5
1511472|NCT01578486|3698505|P1|COMPLETED|Overall Study||8
1511473|NCT01578486|3698505|P1|STARTED|Overall Study||13
1511474|NCT01578330|3698516|P1|NOT COMPLETED|Overall Study||7
1511475|NCT01578330|3698516|P1|COMPLETED|Overall Study||35
1511476|NCT01578330|3698516|P1|Per Protocol Population|Overall Study||35
1511477|NCT01578330|3698516|P1|STARTED|Overall Study||42
1511478|NCT01578239|3698525|P2|NOT COMPLETED|Overall Study||25
1511479|NCT01578239|3698526|P1|NOT COMPLETED|Overall Study||22
1511480|NCT01578239|3698525|P2|COMPLETED|Overall Study||88
1511481|NCT01578239|3698526|P1|COMPLETED|Overall Study||94
1511482|NCT01578239|3698525|P2|STARTED|Overall Study||113
1511483|NCT01578239|3698526|P1|STARTED|Overall Study||116
1511484|NCT01578187|3698532|P1|NOT COMPLETED|Usability Phase||1
1511485|NCT01578187|3698532|P1|COMPLETED|Usability Phase||47
1511486|NCT01578187|3698532|P1|STARTED|Usability Phase||48
1511487|NCT01578187|3698532|P1|NOT COMPLETED|Label Comprehension Phase||0
1511488|NCT01578187|3698532|P1|COMPLETED|Label Comprehension Phase||63
1511489|NCT01578187|3698532|P1|STARTED|Label Comprehension Phase||63
1511490|NCT01578044|3698540|P2|NOT COMPLETED|Overall Study||0
1511491|NCT01578044|3698541|P1|NOT COMPLETED|Overall Study||0
1511492|NCT01578044|3698540|P2|COMPLETED|Overall Study||6
1511493|NCT01578044|3698541|P1|COMPLETED|Overall Study||6
1511494|NCT01578044|3698540|P2|STARTED|Overall Study||6
1511495|NCT01578044|3698541|P1|STARTED|Overall Study||6
1511496|NCT01578031|3698551|P4|NOT COMPLETED|Overall Study||0
1511497|NCT01578031|3698552|P3|NOT COMPLETED|Overall Study||0
1511498|NCT01578031|3698553|P2|NOT COMPLETED|Overall Study||34
1511499|NCT01578031|3698554|P1|NOT COMPLETED|Overall Study||62
1511500|NCT01578031|3698551|P4|COMPLETED|Overall Study|Only baseline data collected|30
1511501|NCT01578031|3698552|P3|COMPLETED|Overall Study|Only baseline data collected|12
1511502|NCT01578031|3698553|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
1511503|NCT01578031|3698554|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
1511504|NCT01578031|3698551|P4|STARTED|Overall Study||30
1511505|NCT01578031|3698552|P3|STARTED|Overall Study||12
1511506|NCT01578031|3698553|P2|STARTED|Overall Study||69
1511507|NCT01578031|3698554|P1|STARTED|Overall Study||129
1511508|NCT01577966|3698562|P1|NOT COMPLETED|Overall Study||0
1511509|NCT01577966|3698562|P1|COMPLETED|Overall Study||9
1511510|NCT01577966|3698562|P1|STARTED|Overall Study||9
1511511|NCT01577758|3698566|P8|NOT COMPLETED|mCRC Expansion Phase||25
1511512|NCT01577758|3698567|P7|NOT COMPLETED|mCRC Expansion Phase||0
1511513|NCT01577758|3698568|P6|NOT COMPLETED|mCRC Expansion Phase||0
1511514|NCT01577758|3698569|P5|NOT COMPLETED|mCRC Expansion Phase||0
1511515|NCT01577758|3698570|P4|NOT COMPLETED|mCRC Expansion Phase||0
1511516|NCT01577758|3698571|P3|NOT COMPLETED|mCRC Expansion Phase||0
1511517|NCT01577758|3698572|P2|NOT COMPLETED|mCRC Expansion Phase||0
1511518|NCT01577758|3698573|P1|NOT COMPLETED|mCRC Expansion Phase||0
1511519|NCT01577758|3698566|P8|COMPLETED|mCRC Expansion Phase||0
1511520|NCT01577758|3698567|P7|COMPLETED|mCRC Expansion Phase||0
1511521|NCT01577758|3698568|P6|COMPLETED|mCRC Expansion Phase||0
1511522|NCT01577758|3698569|P5|COMPLETED|mCRC Expansion Phase||0
1511523|NCT01577758|3698570|P4|COMPLETED|mCRC Expansion Phase||0
1511524|NCT01577758|3698571|P3|COMPLETED|mCRC Expansion Phase||0
1511525|NCT01577758|3698572|P2|COMPLETED|mCRC Expansion Phase||0
1511526|NCT01577758|3698573|P1|COMPLETED|mCRC Expansion Phase||0
1511527|NCT01577758|3698566|P8|STARTED|mCRC Expansion Phase||25
1511528|NCT01577758|3698567|P7|STARTED|mCRC Expansion Phase||0
1511529|NCT01577758|3698568|P6|STARTED|mCRC Expansion Phase||0
1511530|NCT01577758|3698569|P5|STARTED|mCRC Expansion Phase||0
1511531|NCT01577758|3698570|P4|STARTED|mCRC Expansion Phase||0
1511532|NCT01577758|3698571|P3|STARTED|mCRC Expansion Phase||0
1511533|NCT01577758|3698572|P2|STARTED|mCRC Expansion Phase||0
1511534|NCT01577758|3698573|P1|STARTED|mCRC Expansion Phase||0
1511535|NCT01577758|3698566|P8|NOT COMPLETED|Dose Escalation Phase||0
1511536|NCT01577758|3698567|P7|NOT COMPLETED|Dose Escalation Phase||1
1511537|NCT01577758|3698568|P6|NOT COMPLETED|Dose Escalation Phase||4
1511538|NCT01577758|3698569|P5|NOT COMPLETED|Dose Escalation Phase||6
1511539|NCT01577758|3698570|P4|NOT COMPLETED|Dose Escalation Phase||2
1511540|NCT01577758|3698571|P3|NOT COMPLETED|Dose Escalation Phase||2
1511541|NCT01577758|3698572|P2|NOT COMPLETED|Dose Escalation Phase||2
1511542|NCT01577758|3698573|P1|NOT COMPLETED|Dose Escalation Phase||2
1511543|NCT01577758|3698566|P8|COMPLETED|Dose Escalation Phase||0
1511544|NCT01577758|3698567|P7|COMPLETED|Dose Escalation Phase||0
1511545|NCT01577758|3698568|P6|COMPLETED|Dose Escalation Phase||0
1511546|NCT01577758|3698569|P5|COMPLETED|Dose Escalation Phase||0
1511547|NCT01577758|3698570|P4|COMPLETED|Dose Escalation Phase||0
1511548|NCT01577758|3698571|P3|COMPLETED|Dose Escalation Phase||0
1511549|NCT01577758|3698572|P2|COMPLETED|Dose Escalation Phase||0
1511550|NCT01577758|3698573|P1|COMPLETED|Dose Escalation Phase||0
1511551|NCT01577758|3698566|P8|STARTED|Dose Escalation Phase||0
1511552|NCT01577758|3698567|P7|STARTED|Dose Escalation Phase||1
1511553|NCT01577758|3698568|P6|STARTED|Dose Escalation Phase||4
1511554|NCT01577758|3698569|P5|STARTED|Dose Escalation Phase||6
1511555|NCT01577758|3698570|P4|STARTED|Dose Escalation Phase||2
1511556|NCT01577758|3698571|P3|STARTED|Dose Escalation Phase||2
1511557|NCT01577758|3698572|P2|STARTED|Dose Escalation Phase||2
1511558|NCT01577758|3698573|P1|STARTED|Dose Escalation Phase||2
1511559|NCT01577745|3698612|P6|NOT COMPLETED|Overall Study||4
1511560|NCT01577745|3698613|P5|NOT COMPLETED|Overall Study||5
1511561|NCT01577745|3698614|P4|NOT COMPLETED|Overall Study||6
1511562|NCT01577745|3698615|P3|NOT COMPLETED|Overall Study||2
1511563|NCT01577745|3698616|P2|NOT COMPLETED|Overall Study||3
1511564|NCT01577745|3698617|P1|NOT COMPLETED|Overall Study||3
1511565|NCT01577745|3698612|P6|COMPLETED|Overall Study||1
1511566|NCT01577745|3698613|P5|COMPLETED|Overall Study||0
1511567|NCT01577745|3698614|P4|COMPLETED|Overall Study||0
1511568|NCT01577745|3698615|P3|COMPLETED|Overall Study||1
1511569|NCT01577745|3698616|P2|COMPLETED|Overall Study||0
1511570|NCT01577745|3698617|P1|COMPLETED|Overall Study||0
1511571|NCT01577745|3698612|P6|STARTED|Overall Study||5
1511572|NCT01577745|3698613|P5|STARTED|Overall Study||5
1511573|NCT01577745|3698614|P4|STARTED|Overall Study||6
1511574|NCT01577745|3698615|P3|STARTED|Overall Study||3
1511575|NCT01577745|3698616|P2|STARTED|Overall Study||3
1511576|NCT01577745|3698617|P1|STARTED|Overall Study||3
1511577|NCT01577732|3698734|P1|NOT COMPLETED|Overall Study||0
1511578|NCT01577732|3698734|P1|COMPLETED|Overall Study||300
1511579|NCT01577732|3698734|P1|STARTED|Overall Study||300
1511580|NCT01577706|3698741|P3|NOT COMPLETED|Third Intervention (1 Day)||0
1511581|NCT01577706|3698742|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1511582|NCT01577706|3698743|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1511583|NCT01577706|3698741|P3|COMPLETED|Third Intervention (1 Day)||3
1511584|NCT01577706|3698742|P2|COMPLETED|Third Intervention (1 Day)||1
1511585|NCT01577706|3698743|P1|COMPLETED|Third Intervention (1 Day)||3
1511586|NCT01577706|3698741|P3|STARTED|Third Intervention (1 Day)||3
1511587|NCT01577706|3698742|P2|STARTED|Third Intervention (1 Day)||1
1511588|NCT01577706|3698743|P1|STARTED|Third Intervention (1 Day)||3
1511589|NCT01577706|3698741|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
1511590|NCT01577706|3698742|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
1511591|NCT01577706|3698743|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
1511592|NCT01577706|3698741|P3|COMPLETED|Washout (at Least 1 Week)||3
1511593|NCT01577706|3698742|P2|COMPLETED|Washout (at Least 1 Week)||1
1511594|NCT01577706|3698743|P1|COMPLETED|Washout (at Least 1 Week)||3
1511595|NCT01577706|3698741|P3|STARTED|Washout (at Least 1 Week)||3
1511596|NCT01577706|3698742|P2|STARTED|Washout (at Least 1 Week)||1
1511597|NCT01577706|3698743|P1|STARTED|Washout (at Least 1 Week)||3
1511598|NCT01577706|3698741|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1511599|NCT01577706|3698742|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1511600|NCT01577706|3698743|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1511601|NCT01577706|3698741|P3|COMPLETED|Second Intervention (1 Day)||3
1511602|NCT01577706|3698742|P2|COMPLETED|Second Intervention (1 Day)||1
1511603|NCT01577706|3698743|P1|COMPLETED|Second Intervention (1 Day)||3
1511604|NCT01577706|3698741|P3|STARTED|Second Intervention (1 Day)||3
1511605|NCT01577706|3698742|P2|STARTED|Second Intervention (1 Day)||1
1511606|NCT01577706|3698743|P1|STARTED|Second Intervention (1 Day)||3
1511607|NCT01577706|3698741|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
1511608|NCT01577706|3698742|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
1511609|NCT01577706|3698743|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
1511610|NCT01577706|3698741|P3|COMPLETED|Washout (at Least 1 Week)||3
1511611|NCT01577706|3698742|P2|COMPLETED|Washout (at Least 1 Week)||1
1511612|NCT01577706|3698743|P1|COMPLETED|Washout (at Least 1 Week)||3
1511613|NCT01577706|3698741|P3|STARTED|Washout (at Least 1 Week)||3
1511614|NCT01577706|3698742|P2|STARTED|Washout (at Least 1 Week)||1
1511615|NCT01577706|3698743|P1|STARTED|Washout (at Least 1 Week)||3
1511616|NCT01577706|3698741|P3|NOT COMPLETED|First Intervention (1 Day)||0
1511617|NCT01577706|3698742|P2|NOT COMPLETED|First Intervention (1 Day)||0
1511618|NCT01577706|3698743|P1|NOT COMPLETED|First Intervention (1 Day)||0
1511619|NCT01577706|3698741|P3|COMPLETED|First Intervention (1 Day)||3
1511620|NCT01577706|3698742|P2|COMPLETED|First Intervention (1 Day)||1
1511621|NCT01577706|3698743|P1|COMPLETED|First Intervention (1 Day)||3
1511622|NCT01577706|3698741|P3|STARTED|First Intervention (1 Day)||3
1511623|NCT01577706|3698742|P2|STARTED|First Intervention (1 Day)||1
1511624|NCT01577706|3698743|P1|STARTED|First Intervention (1 Day)||3
1511625|NCT01577628|3698771|P3|NOT COMPLETED|Overall Study||2
1511626|NCT01577628|3698772|P2|NOT COMPLETED|Overall Study||0
1511627|NCT01577628|3698773|P1|NOT COMPLETED|Overall Study||0
1511628|NCT01577628|3698771|P3|COMPLETED|Overall Study||0
1511629|NCT01577628|3698772|P2|COMPLETED|Overall Study||0
1511630|NCT01577628|3698773|P1|COMPLETED|Overall Study||0
1511631|NCT01577628|3698771|P3|STARTED|Overall Study||2
1511632|NCT01577628|3698772|P2|STARTED|Overall Study||0
1511633|NCT01577628|3698773|P1|STARTED|Overall Study||0
1511634|NCT01577381|3698801|P4|NOT COMPLETED|Overall Study||2
1511635|NCT01577381|3698802|P3|NOT COMPLETED|Overall Study||3
1511636|NCT01577381|3698803|P2|NOT COMPLETED|Overall Study||3
1511637|NCT01577381|3698804|P1|NOT COMPLETED|Overall Study||2
1511638|NCT01577381|3698801|P4|COMPLETED|Overall Study||0
1511639|NCT01577381|3698802|P3|COMPLETED|Overall Study||0
1511640|NCT01577381|3698803|P2|COMPLETED|Overall Study||0
1511641|NCT01577381|3698804|P1|COMPLETED|Overall Study||0
1511642|NCT01577381|3698801|P4|STARTED|Overall Study||2
1511643|NCT01577381|3698802|P3|STARTED|Overall Study||3
1511644|NCT01577381|3698803|P2|STARTED|Overall Study||3
1511645|NCT01577381|3698804|P1|STARTED|Overall Study||2
1511646|NCT01577329|3698935|P2|NOT COMPLETED|Overall Study||0
1511647|NCT01577329|3698936|P1|NOT COMPLETED|Overall Study||3
1511648|NCT01577329|3698935|P2|COMPLETED|Overall Study||22
1511649|NCT01577329|3698936|P1|COMPLETED|Overall Study||16
1511650|NCT01577329|3698935|P2|STARTED|Overall Study||22
1511651|NCT01577329|3698936|P1|STARTED|Overall Study||19
1511652|NCT01577186|3698942|P1|NOT COMPLETED|Overall Study||130
1511653|NCT01577186|3698942|P1|COMPLETED|Overall Study||350
1511654|NCT01577186|3698942|P1|STARTED|Overall Study||480
1511655|NCT01577160|3698950|P1|NOT COMPLETED|Overall Study||98
1511656|NCT01577160|3698950|P1|COMPLETED|Overall Study||255
1511657|NCT01577160|3698950|P1|STARTED|Overall Study||353
1511658|NCT01577108|3698960|P2|NOT COMPLETED|Overall Study||6
1511659|NCT01577108|3698961|P1|NOT COMPLETED|Overall Study||5
1511660|NCT01577108|3698960|P2|COMPLETED|Overall Study||50
1511661|NCT01577108|3698961|P1|COMPLETED|Overall Study||49
1511662|NCT01577108|3698960|P2|STARTED|Overall Study||56
1511663|NCT01577108|3698961|P1|STARTED|Overall Study||54
1511664|NCT01576952|3698969|P2|NOT COMPLETED|Overall Study||55
1511665|NCT01576952|3698970|P1|NOT COMPLETED|Overall Study||41
1511666|NCT01576952|3698969|P2|COMPLETED|Overall Study||33
1511667|NCT01576952|3698970|P1|COMPLETED|Overall Study||139
1511668|NCT01576952|3698969|P2|mITT Population|Overall Study||85
1511669|NCT01576952|3698970|P1|mITT Population|Overall Study||168
1511670|NCT01576952|3698969|P2|Safety Population|Overall Study||85
1511671|NCT01576952|3698970|P1|Safety Population|Overall Study||169
1511672|NCT01576952|3698969|P2|STARTED|Overall Study||88
1511673|NCT01576952|3698970|P1|STARTED|Overall Study||180
1511674|NCT01576939|3698976|P1|NOT COMPLETED|Overall Study||0
1511675|NCT01576939|3698976|P1|COMPLETED|Overall Study||30
1511676|NCT01576939|3698976|P1|STARTED|Overall Study||30
1511677|NCT01576874|3698986|P2|NOT COMPLETED|Overall Study||0
1511678|NCT01576874|3698987|P1|NOT COMPLETED|Overall Study||0
1511679|NCT01576874|3698986|P2|COMPLETED|Overall Study||72
1511680|NCT01576874|3698987|P1|COMPLETED|Overall Study||72
1511681|NCT01576874|3698986|P2|STARTED|Overall Study||72
1511682|NCT01576874|3698987|P1|STARTED|Overall Study||72
1511683|NCT01576809|3698997|P1|NOT COMPLETED|Overall Study||0
1511684|NCT01576809|3698997|P1|COMPLETED|Overall Study||51
1511685|NCT01576809|3698997|P1|STARTED|Overall Study||51
1511686|NCT01576718|3699009|P7|NOT COMPLETED|Treatment Period||30
1511687|NCT01576718|3699010|P6|NOT COMPLETED|Treatment Period||48
1511688|NCT01576718|3699011|P5|NOT COMPLETED|Treatment Period||27
1511689|NCT01576718|3699012|P4|NOT COMPLETED|Treatment Period||31
1511690|NCT01576718|3699013|P3|NOT COMPLETED|Treatment Period||20
1511691|NCT01576718|3699014|P2|NOT COMPLETED|Treatment Period||25
1511692|NCT01576718|3699015|P1|NOT COMPLETED|Treatment Period||0
1511693|NCT01576718|3699009|P7|COMPLETED|Treatment Period||77
1511694|NCT01576718|3699010|P6|COMPLETED|Treatment Period||58
1511695|NCT01576718|3699011|P5|COMPLETED|Treatment Period||80
1511696|NCT01576718|3699012|P4|COMPLETED|Treatment Period||75
1511697|NCT01576718|3699013|P3|COMPLETED|Treatment Period||87
1511698|NCT01576718|3699014|P2|COMPLETED|Treatment Period||82
1511699|NCT01576718|3699015|P1|COMPLETED|Treatment Period||0
1511700|NCT01576718|3699009|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
1511701|NCT01576718|3699010|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
1511702|NCT01576718|3699011|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
1511703|NCT01576718|3699012|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
1511704|NCT01576718|3699013|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
1511705|NCT01576718|3699014|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
1511706|NCT01576718|3699015|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
1511707|NCT01576718|3699009|P7|Safety Population|Treatment Period||106
1511708|NCT01576718|3699010|P6|Safety Population|Treatment Period||106
1511709|NCT01576718|3699011|P5|Safety Population|Treatment Period||107
1511710|NCT01576718|3699012|P4|Safety Population|Treatment Period||106
1511711|NCT01576718|3699013|P3|Safety Population|Treatment Period||107
1511712|NCT01576718|3699014|P2|Safety Population|Treatment Period||107
1511713|NCT01576718|3699015|P1|Safety Population|Treatment Period||0
1511714|NCT01576718|3699009|P7|STARTED|Treatment Period||107
1511715|NCT01576718|3699010|P6|STARTED|Treatment Period||106
1511716|NCT01576718|3699011|P5|STARTED|Treatment Period||107
1511717|NCT01576718|3699012|P4|STARTED|Treatment Period||106
1511718|NCT01576718|3699013|P3|STARTED|Treatment Period||107
1511719|NCT01576718|3699014|P2|STARTED|Treatment Period||107
1511720|NCT01576718|3699015|P1|STARTED|Treatment Period||0
1511721|NCT01576718|3699009|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511722|NCT01576718|3699010|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511723|NCT01576718|3699011|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511724|NCT01576718|3699012|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511725|NCT01576718|3699013|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511726|NCT01576718|3699014|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511727|NCT01576718|3699015|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
1511728|NCT01576718|3699009|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511729|NCT01576718|3699010|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511730|NCT01576718|3699011|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511731|NCT01576718|3699012|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511732|NCT01576718|3699013|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511733|NCT01576718|3699014|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1511734|NCT01576718|3699015|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
1511735|NCT01576718|3699009|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1511736|NCT01576718|3699010|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1511737|NCT01576718|3699011|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1511738|NCT01576718|3699012|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1511739|NCT01576718|3699013|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1511740|NCT01576718|3699014|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1511741|NCT01576718|3699015|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
1511742|NCT01576549|3699107|P1|NOT COMPLETED|Overall Study||2
1511743|NCT01576549|3699107|P1|COMPLETED|Overall Study||0
1511744|NCT01576549|3699107|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
1511745|NCT01576549|3699107|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
1511746|NCT01576549|3699107|P1|STARTED|Overall Study||2
1511747|NCT01576471|3699117|P2|NOT COMPLETED|Overall Study||9
1511748|NCT01576471|3699118|P1|NOT COMPLETED|Overall Study||8
1511749|NCT01576471|3699117|P2|COMPLETED|Overall Study||116
1511750|NCT01576471|3699118|P1|COMPLETED|Overall Study||117
1511751|NCT01576471|3699117|P2|STARTED|Overall Study||125
1511752|NCT01576471|3699118|P1|STARTED|Overall Study||125
1511753|NCT01576406|3699130|P6|NOT COMPLETED|Overall Study||12
1511754|NCT01576406|3699131|P5|NOT COMPLETED|Overall Study||8
1511755|NCT01576406|3699132|P4|NOT COMPLETED|Overall Study||9
1511756|NCT01576406|3699133|P3|NOT COMPLETED|Overall Study||16
1511757|NCT01576406|3699134|P2|NOT COMPLETED|Overall Study||8
1511758|NCT01576406|3699135|P1|NOT COMPLETED|Overall Study||6
1511759|NCT01576406|3699130|P6|COMPLETED|Overall Study||4
1511760|NCT01576406|3699131|P5|COMPLETED|Overall Study||8
1511761|NCT01576406|3699132|P4|COMPLETED|Overall Study||1
1511762|NCT01576406|3699133|P3|COMPLETED|Overall Study||4
1511763|NCT01576406|3699134|P2|COMPLETED|Overall Study||7
1511764|NCT01576406|3699135|P1|COMPLETED|Overall Study||5
1511765|NCT01576406|3699130|P6|STARTED|Overall Study||16
1511766|NCT01576406|3699131|P5|STARTED|Overall Study||16
1511767|NCT01576406|3699132|P4|STARTED|Overall Study||10
1511768|NCT01576406|3699133|P3|STARTED|Overall Study||20
1511769|NCT01576406|3699134|P2|STARTED|Overall Study||15
1511770|NCT01576406|3699135|P1|STARTED|Overall Study||11
1511771|NCT01576367|3699383|P1|NOT COMPLETED|Overall Study||3
1511772|NCT01576367|3699383|P1|COMPLETED|Overall Study||14
1511773|NCT01576367|3699383|P1|STARTED|Overall Study||17
1511774|NCT01576341|3699391|P1|NOT COMPLETED|Overall Study||93
1511775|NCT01576341|3699391|P1|COMPLETED|Overall Study||324
1511776|NCT01576341|3699391|P1|STARTED|Overall Study||417
1511777|NCT01576276|3699400|P2|NOT COMPLETED|Overall Study||11
1511778|NCT01576276|3699401|P1|NOT COMPLETED|Overall Study||8
1511779|NCT01576276|3699400|P2|COMPLETED|Overall Study||18
1511780|NCT01576276|3699401|P1|COMPLETED|Overall Study||14
1511781|NCT01576276|3699400|P2|STARTED|Overall Study||29
1511782|NCT01576276|3699401|P1|STARTED|Overall Study||22
1511783|NCT01576159|3699412|P4|NOT COMPLETED|Overall Study||1
1511784|NCT01576159|3699413|P3|NOT COMPLETED|Overall Study||1
1511785|NCT01576159|3699414|P2|NOT COMPLETED|Overall Study||1
1511786|NCT01576159|3699415|P1|NOT COMPLETED|Overall Study||1
1511787|NCT01576159|3699412|P4|COMPLETED|Overall Study||11
1511788|NCT01576159|3699413|P3|COMPLETED|Overall Study||11
1511789|NCT01576159|3699414|P2|COMPLETED|Overall Study||11
1511790|NCT01576159|3699415|P1|COMPLETED|Overall Study||11
1511791|NCT01576159|3699412|P4|STARTED|Overall Study||12
1511792|NCT01576159|3699413|P3|STARTED|Overall Study||12
1511793|NCT01576159|3699414|P2|STARTED|Overall Study||12
1511794|NCT01576159|3699415|P1|STARTED|Overall Study||12
1511795|NCT01576146|3699433|P1|NOT COMPLETED|Extension Period 2||17
1511796|NCT01576146|3699433|P1|COMPLETED|Extension Period 2||0
1511797|NCT01576146|3699433|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
1511798|NCT01576146|3699433|P1|NOT COMPLETED|Extension Period 1||10
1511799|NCT01576146|3699433|P1|COMPLETED|Extension Period 1||20
1511800|NCT01576146|3699433|P1|STARTED|Extension Period 1||30
1511801|NCT01576120|3699442|P2|NOT COMPLETED|Overall Study||0
1511802|NCT01576120|3699443|P1|NOT COMPLETED|Overall Study||0
1511803|NCT01576120|3699442|P2|COMPLETED|Overall Study||19
1511804|NCT01576120|3699443|P1|COMPLETED|Overall Study||21
1511805|NCT01576120|3699442|P2|STARTED|Overall Study||19
1511806|NCT01576120|3699443|P1|STARTED|Overall Study||21
1511807|NCT01576055|3699451|P2|NOT COMPLETED|Overall Study||6
1511808|NCT01576055|3699452|P1|NOT COMPLETED|Overall Study||19
1511809|NCT01576055|3699451|P2|COMPLETED|Overall Study||64
1511810|NCT01576055|3699452|P1|COMPLETED|Overall Study||178
1511811|NCT01576055|3699451|P2|STARTED|Overall Study||70
1511812|NCT01576055|3699452|P1|STARTED|Overall Study||197
1511813|NCT01576042|3699466|P2|NOT COMPLETED|Overall Study||0
1511814|NCT01576042|3699467|P1|NOT COMPLETED|Overall Study||2
1511815|NCT01576042|3699466|P2|COMPLETED|Overall Study||14
1511816|NCT01576042|3699467|P1|COMPLETED|Overall Study||11
1511817|NCT01576042|3699466|P2|Switched to the Other Arm|Overall Study||1
1511818|NCT01576042|3699467|P1|Switched to the Other Arm|Overall Study||5
1511819|NCT01576042|3699466|P2|STARTED|Overall Study||14
1511820|NCT01576042|3699467|P1|STARTED|Overall Study||13
1511821|NCT01575912|3699490|P3|NOT COMPLETED|Overall Study||0
1511822|NCT01575912|3699491|P2|NOT COMPLETED|Overall Study||0
1511823|NCT01575912|3699492|P1|NOT COMPLETED|Overall Study||0
1511824|NCT01575912|3699490|P3|COMPLETED|Overall Study||30
1511825|NCT01575912|3699491|P2|COMPLETED|Overall Study||32
1511826|NCT01575912|3699492|P1|COMPLETED|Overall Study||30
1511827|NCT01575912|3699490|P3|STARTED|Overall Study||30
1511828|NCT01575912|3699491|P2|STARTED|Overall Study||32
1511829|NCT01575912|3699492|P1|STARTED|Overall Study||30
1511830|NCT01575899|3699503|P3|NOT COMPLETED|Overall Study||2
1511831|NCT01575899|3699504|P2|NOT COMPLETED|Overall Study||5
1511832|NCT01575899|3699505|P1|NOT COMPLETED|Overall Study||5
1511833|NCT01575899|3699503|P3|COMPLETED|Overall Study||60
1511834|NCT01575899|3699504|P2|COMPLETED|Overall Study||68
1511835|NCT01575899|3699505|P1|COMPLETED|Overall Study||68
1511836|NCT01575899|3699503|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
1511837|NCT01575899|3699504|P2|STARTED|Overall Study||73
1511838|NCT01575899|3699505|P1|STARTED|Overall Study||73
1511839|NCT01575873|3699519|P4|NOT COMPLETED|Overall Study||67
1511840|NCT01575873|3699520|P3|NOT COMPLETED|Overall Study||74
1511841|NCT01575873|3699521|P2|NOT COMPLETED|Overall Study||36
1511842|NCT01575873|3699522|P1|NOT COMPLETED|Overall Study||28
1511843|NCT01575873|3699519|P4|COMPLETED|Overall Study||186
1511844|NCT01575873|3699520|P3|COMPLETED|Overall Study||178
1511845|NCT01575873|3699521|P2|COMPLETED|Overall Study||109
1511846|NCT01575873|3699522|P1|COMPLETED|Overall Study||117
1511847|NCT01575873|3699519|P4|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
1511848|NCT01575873|3699520|P3|Received Study Drug|Overall Study|Participants who received oral risedronate|246
1511849|NCT01575873|3699521|P2|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
1511850|NCT01575873|3699522|P1|Received Study Drug|Overall Study|Participants who received oral risedronate|140
1511851|NCT01575873|3699519|P4|STARTED|Overall Study||253
1511852|NCT01575873|3699520|P3|STARTED|Overall Study||252
1511853|NCT01575873|3699521|P2|STARTED|Overall Study||145
1511854|NCT01575873|3699522|P1|STARTED|Overall Study||145
1511855|NCT01575834|3699548|P2|NOT COMPLETED|Overall Study||738
1511856|NCT01575834|3699549|P1|NOT COMPLETED|Overall Study||699
1511857|NCT01575834|3699548|P2|COMPLETED|Overall Study|Completed 36-month study period|2851
1511858|NCT01575834|3699549|P1|COMPLETED|Overall Study|Completed 36-month study period|2892
1511859|NCT01575834|3699548|P2|Completed 24-month Study Period|Overall Study||2994
1511860|NCT01575834|3699549|P1|Completed 24-month Study Period|Overall Study||3032
1511861|NCT01575834|3699548|P2|Completed Double-blind Period|Overall Study||3185
1511862|NCT01575834|3699549|P1|Completed Double-blind Period|Overall Study||3205
1511863|NCT01575834|3699548|P2|Received Double-blind Treatment|Overall Study||3575
1511864|NCT01575834|3699549|P1|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
1511865|NCT01575834|3699548|P2|STARTED|Overall Study||3589
1511866|NCT01575834|3699549|P1|STARTED|Overall Study||3591
1511867|NCT01575808|3699601|P2|NOT COMPLETED|Overall Study||0
1511868|NCT01575808|3699602|P1|NOT COMPLETED|Overall Study||3
1511869|NCT01575808|3699601|P2|COMPLETED|Overall Study||68
1511870|NCT01575808|3699602|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
1511871|NCT01575808|3699601|P2|STARTED|Overall Study||68
1511872|NCT01575808|3699602|P1|STARTED|Overall Study||103
1511873|NCT01575769|3699649|P1|NOT COMPLETED|Overall Study||41
1511874|NCT01575769|3699649|P1|COMPLETED|Overall Study||0
1511875|NCT01575769|3699649|P1|STARTED|Overall Study||41
1511876|NCT01575756|3699675|P2|NOT COMPLETED|Treatment Period 2||0
1511877|NCT01575756|3699676|P1|NOT COMPLETED|Treatment Period 2||0
1511878|NCT01575756|3699675|P2|COMPLETED|Treatment Period 2||11
1511879|NCT01575756|3699676|P1|COMPLETED|Treatment Period 2||11
1511880|NCT01575756|3699675|P2|STARTED|Treatment Period 2||11
1511881|NCT01575756|3699676|P1|STARTED|Treatment Period 2||11
1511882|NCT01575756|3699675|P2|NOT COMPLETED|Treatment Period 1||0
1511883|NCT01575756|3699676|P1|NOT COMPLETED|Treatment Period 1||0
1511884|NCT01575756|3699675|P2|COMPLETED|Treatment Period 1||11
1511885|NCT01575756|3699676|P1|COMPLETED|Treatment Period 1||11
1511886|NCT01575756|3699675|P2|STARTED|Treatment Period 1||11
1511887|NCT01575756|3699676|P1|STARTED|Treatment Period 1||11
1511888|NCT01575561|3699707|P1|NOT COMPLETED|Overall Study||39
1511889|NCT01575561|3699707|P1|COMPLETED|Overall Study||338
1511890|NCT01575561|3699707|P1|STARTED|Overall Study||377
1511891|NCT01575522|3699719|P1|NOT COMPLETED|Overall Study||0
1511892|NCT01575522|3699719|P1|COMPLETED|Overall Study||22
1511893|NCT01575522|3699719|P1|STARTED|Overall Study||22
1511894|NCT01575275|3699727|P1|NOT COMPLETED|Overall Study||0
1511895|NCT01575275|3699727|P1|COMPLETED|Overall Study||8
1511896|NCT01575275|3699727|P1|STARTED|Overall Study||8
1511897|NCT01575197|3699737|P3|NOT COMPLETED|Overall Study||6
1511898|NCT01575197|3699738|P2|NOT COMPLETED|Overall Study||9
1511899|NCT01575197|3699739|P1|NOT COMPLETED|Overall Study||3
1511900|NCT01575197|3699737|P3|COMPLETED|Overall Study||146
1511901|NCT01575197|3699738|P2|COMPLETED|Overall Study||143
1511902|NCT01575197|3699739|P1|COMPLETED|Overall Study||149
1511903|NCT01575197|3699737|P3|STARTED|Overall Study||152
1511904|NCT01575197|3699738|P2|STARTED|Overall Study||152
1511905|NCT01575197|3699739|P1|STARTED|Overall Study||152
1511906|NCT01575106|3699752|P1|NOT COMPLETED|Overall Study||14
1511907|NCT01575106|3699752|P1|COMPLETED|Overall Study||24
1511908|NCT01575106|3699752|P1|STARTED|Overall Study||38
1511909|NCT01575080|3699758|P1|NOT COMPLETED|Overall Study||0
1511910|NCT01575080|3699758|P1|COMPLETED|Overall Study||102
1511911|NCT01575080|3699758|P1|STARTED|Overall Study||102
1511912|NCT01575054|3699767|P2|NOT COMPLETED|Overall Study||26
1511913|NCT01575054|3699768|P1|NOT COMPLETED|Overall Study||29
1511914|NCT01575054|3699767|P2|COMPLETED|Overall Study||209
1511915|NCT01575054|3699768|P1|COMPLETED|Overall Study||204
1511916|NCT01575054|3699767|P2|STARTED|Overall Study||235
1511917|NCT01575054|3699768|P1|STARTED|Overall Study||233
1511918|NCT01575028|3699784|P2|NOT COMPLETED|Overall Study||1
1511919|NCT01575028|3699785|P1|NOT COMPLETED|Overall Study||0
1511920|NCT01575028|3699784|P2|COMPLETED|Overall Study||0
1511921|NCT01575028|3699785|P1|COMPLETED|Overall Study||2
1511922|NCT01575028|3699784|P2|STARTED|Overall Study||1
1511923|NCT01575028|3699785|P1|STARTED|Overall Study||2
1511924|NCT01574703|3699795|P4|NOT COMPLETED|Overall Study||114
1511925|NCT01574703|3699796|P3|NOT COMPLETED|Overall Study||105
1511926|NCT01574703|3699797|P2|NOT COMPLETED|Overall Study||112
1511927|NCT01574703|3699798|P1|NOT COMPLETED|Overall Study||125
1511928|NCT01574703|3699795|P4|COMPLETED|Overall Study||1007
1511929|NCT01574703|3699796|P3|COMPLETED|Overall Study||1011
1511930|NCT01574703|3699797|P2|COMPLETED|Overall Study||1054
1511931|NCT01574703|3699798|P1|COMPLETED|Overall Study||1067
1511932|NCT01574703|3699795|P4|STARTED|Overall Study||1121
1511933|NCT01574703|3699796|P3|STARTED|Overall Study||1116
1511934|NCT01574703|3699797|P2|STARTED|Overall Study||1166
1511935|NCT01574703|3699798|P1|STARTED|Overall Study||1192
1511936|NCT01574651|3699842|P2|NOT COMPLETED|Overall Study||52
1511937|NCT01574651|3699843|P1|NOT COMPLETED|Overall Study||61
1511938|NCT01574651|3699842|P2|COMPLETED|Overall Study||406
1511939|NCT01574651|3699843|P1|COMPLETED|Overall Study||415
1511940|NCT01574651|3699842|P2|Per Protocol Set (PPS)|Overall Study||374
1511941|NCT01574651|3699843|P1|Per Protocol Set (PPS)|Overall Study||373
1511942|NCT01574651|3699842|P2|Full Analysis Set (FAS)|Overall Study||458
1511943|NCT01574651|3699843|P1|Full Analysis Set (FAS)|Overall Study||476
1511944|NCT01574651|3699842|P2|STARTED|Overall Study||458
1511945|NCT01574651|3699843|P1|STARTED|Overall Study||476
1511946|NCT01574612|3699865|P1|NOT COMPLETED|Overall Study||8
1511947|NCT01574612|3699865|P1|COMPLETED|Overall Study||46
1511948|NCT01574612|3699865|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
1511949|NCT01574326|3699871|P2|NOT COMPLETED|Overall Study||19
1511950|NCT01574326|3699872|P1|NOT COMPLETED|Overall Study||16
1511951|NCT01574326|3699871|P2|COMPLETED|Overall Study||31
1511952|NCT01574326|3699872|P1|COMPLETED|Overall Study||35
1511953|NCT01574326|3699871|P2|Treated|Overall Study||49
1511954|NCT01574326|3699872|P1|Treated|Overall Study||51
1511955|NCT01574326|3699871|P2|STARTED|Overall Study||50
1511956|NCT01574326|3699872|P1|STARTED|Overall Study||51
1511957|NCT01574248|3699885|P2|NOT COMPLETED|Overall Study||0
1511958|NCT01574248|3699886|P1|NOT COMPLETED|Overall Study||3
1511959|NCT01574248|3699885|P2|COMPLETED|Overall Study||18
1511960|NCT01574248|3699886|P1|COMPLETED|Overall Study||12
1511961|NCT01574248|3699885|P2|STARTED|Overall Study||18
1511962|NCT01574248|3699886|P1|STARTED|Overall Study||15
1511963|NCT01574183|3699906|P2|NOT COMPLETED|Overall Study||18
1511964|NCT01574183|3699907|P1|NOT COMPLETED|Overall Study||27
1511965|NCT01574183|3699906|P2|COMPLETED|Overall Study||17
1511966|NCT01574183|3699907|P1|COMPLETED|Overall Study||14
1511967|NCT01574183|3699906|P2|STARTED|Overall Study||35
1511968|NCT01574183|3699907|P1|STARTED|Overall Study||41
1511969|NCT01574144|3699917|P1|NOT COMPLETED|Overall Study||0
1511970|NCT01574144|3699917|P1|COMPLETED|Overall Study||70
1511971|NCT01574144|3699917|P1|STARTED|Overall Study||70
1511972|NCT01574105|3699924|P2|NOT COMPLETED|Overall Study||0
1511973|NCT01574105|3699925|P1|NOT COMPLETED|Overall Study||0
1511974|NCT01574105|3699924|P2|COMPLETED|Overall Study||37
1511975|NCT01574105|3699925|P1|COMPLETED|Overall Study||29
1511976|NCT01574105|3699924|P2|STARTED|Overall Study||37
1511977|NCT01574105|3699925|P1|STARTED|Overall Study||29
1511978|NCT01574079|3699935|P2|NOT COMPLETED|Overall Study||2
1511979|NCT01574079|3699936|P1|NOT COMPLETED|Overall Study||1
1511980|NCT01574079|3699935|P2|COMPLETED|Overall Study||13
1511981|NCT01574079|3699936|P1|COMPLETED|Overall Study||17
1511982|NCT01574079|3699935|P2|STARTED|Overall Study||15
1511983|NCT01574079|3699936|P1|STARTED|Overall Study||18
1511984|NCT01573910|3699948|P2|NOT COMPLETED|Overall Study||17
1511985|NCT01573910|3699949|P1|NOT COMPLETED|Overall Study||20
1511986|NCT01573910|3699948|P2|COMPLETED|Overall Study||476
1511987|NCT01573910|3699949|P1|COMPLETED|Overall Study||469
1511988|NCT01573910|3699948|P2|STARTED|Overall Study||493
1511989|NCT01573910|3699949|P1|STARTED|Overall Study||489
1511990|NCT01573767|3699961|P4|NOT COMPLETED|Overall Study||24
1511991|NCT01573767|3699962|P3|NOT COMPLETED|Overall Study||14
1511992|NCT01573767|3699963|P2|NOT COMPLETED|Overall Study||21
1511993|NCT01573767|3699964|P1|NOT COMPLETED|Overall Study||22
1511994|NCT01573767|3699961|P4|COMPLETED|Overall Study||90
1511995|NCT01573767|3699962|P3|COMPLETED|Overall Study||99
1511996|NCT01573767|3699963|P2|COMPLETED|Overall Study||93
1511997|NCT01573767|3699964|P1|COMPLETED|Overall Study||93
1511998|NCT01573767|3699961|P4|STARTED|Overall Study||114
1511999|NCT01573767|3699962|P3|STARTED|Overall Study||113
1512000|NCT01573767|3699963|P2|STARTED|Overall Study||114
1512001|NCT01573767|3699964|P1|STARTED|Overall Study||115
1512002|NCT01573624|3699998|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
1512003|NCT01573624|3699999|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
1512004|NCT01573624|3700000|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
1512005|NCT01573624|3700001|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
1512006|NCT01573624|3700002|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
1512007|NCT01573624|3700003|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
1512008|NCT01573624|3700004|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
1512009|NCT01573624|3699998|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
1512010|NCT01573624|3699999|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
1512011|NCT01573624|3700000|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
1512012|NCT01573624|3700001|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
1512013|NCT01573624|3700002|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
1512014|NCT01573624|3700003|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
1512015|NCT01573624|3700004|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
1512016|NCT01573624|3699998|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
1512017|NCT01573624|3699999|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
1512018|NCT01573624|3700000|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
1512019|NCT01573624|3700001|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
1512020|NCT01573624|3700002|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
1512021|NCT01573624|3700003|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
1512022|NCT01573624|3700004|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
1512023|NCT01573624|3699998|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
1512024|NCT01573624|3699999|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
1512025|NCT01573624|3700000|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
1512026|NCT01573624|3700001|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
1512027|NCT01573624|3700002|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
1512028|NCT01573624|3700003|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
1512029|NCT01573624|3700004|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
1512030|NCT01573624|3699998|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
1512031|NCT01573624|3699999|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
1512032|NCT01573624|3700000|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
1512033|NCT01573624|3700001|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
1512034|NCT01573624|3700002|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
1512035|NCT01573624|3700003|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
1512036|NCT01573624|3700004|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
1512037|NCT01573624|3699998|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
1512038|NCT01573624|3699999|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
1512039|NCT01573624|3700000|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
1512040|NCT01573624|3700001|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
1512041|NCT01573624|3700002|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
1512042|NCT01573624|3700003|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
1512043|NCT01573624|3700004|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
1512044|NCT01573624|3699998|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
1512045|NCT01573624|3699999|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
1512046|NCT01573624|3700000|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
1512047|NCT01573624|3700001|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
1512048|NCT01573624|3700002|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
1512049|NCT01573624|3700003|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
1512050|NCT01573624|3700004|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
1512051|NCT01573624|3699998|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
1512052|NCT01573624|3699999|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
1512053|NCT01573624|3700000|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
1512054|NCT01573624|3700001|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
1512055|NCT01573624|3700002|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
1512056|NCT01573624|3700003|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
1512057|NCT01573624|3700004|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
1512058|NCT01573624|3699998|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
1512059|NCT01573624|3699999|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
1512060|NCT01573624|3700000|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
1512061|NCT01573624|3700001|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
1512062|NCT01573624|3700002|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
1512063|NCT01573624|3700003|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
1512064|NCT01573624|3700004|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
1512065|NCT01573624|3699998|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
1512066|NCT01573624|3699999|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
1512067|NCT01573624|3700000|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
1512068|NCT01573624|3700001|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
1512069|NCT01573624|3700002|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
1512070|NCT01573624|3700003|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
1512071|NCT01573624|3700004|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
1512072|NCT01573624|3699998|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
1512073|NCT01573624|3699999|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
1512074|NCT01573624|3700000|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
1512075|NCT01573624|3700001|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
1512076|NCT01573624|3700002|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
1512077|NCT01573624|3700003|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
1512078|NCT01573624|3700004|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
1512079|NCT01573624|3699998|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
1512080|NCT01573624|3699999|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
1512081|NCT01573624|3700000|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
1512082|NCT01573624|3700001|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
1512083|NCT01573624|3700002|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
1512084|NCT01573624|3700003|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
1512085|NCT01573624|3700004|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
1512086|NCT01573624|3699998|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
1512087|NCT01573624|3699999|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
1512088|NCT01573624|3700000|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
1512089|NCT01573624|3700001|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
1512090|NCT01573624|3700002|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
1512091|NCT01573624|3700003|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
1512092|NCT01573624|3700004|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
1512093|NCT01573624|3699998|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
1512094|NCT01573624|3699999|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
1512095|NCT01573624|3700000|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
1512096|NCT01573624|3700001|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
1512097|NCT01573624|3700002|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
1512098|NCT01573624|3700003|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
1512099|NCT01573624|3700004|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
1512100|NCT01573624|3699998|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
1512101|NCT01573624|3699999|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
1512102|NCT01573624|3700000|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
1512103|NCT01573624|3700001|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
1512104|NCT01573624|3700002|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
1512105|NCT01573624|3700003|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
1512106|NCT01573624|3700004|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
1512107|NCT01573624|3699998|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
1512108|NCT01573624|3699999|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
1512109|NCT01573624|3700000|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
1512110|NCT01573624|3700001|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
1512111|NCT01573624|3700002|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
1512112|NCT01573624|3700003|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
1512113|NCT01573624|3700004|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
1512114|NCT01573624|3699998|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
1512115|NCT01573624|3699999|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
1512116|NCT01573624|3700000|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
1512117|NCT01573624|3700001|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
1512118|NCT01573624|3700002|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
1512119|NCT01573624|3700003|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
1512120|NCT01573624|3700004|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
1512121|NCT01573624|3699998|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
1512122|NCT01573624|3699999|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
1512123|NCT01573624|3700000|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
1512124|NCT01573624|3700001|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
1512125|NCT01573624|3700002|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
1512126|NCT01573624|3700003|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
1512127|NCT01573624|3700004|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
1512128|NCT01573325|3700051|P1|NOT COMPLETED|Overall Study||0
1512129|NCT01573325|3700051|P1|COMPLETED|Overall Study||50
1512130|NCT01573325|3700051|P1|STARTED|Overall Study||50
1512131|NCT01573260|3700058|P2|NOT COMPLETED|Overall Study||0
1512132|NCT01573260|3700059|P1|NOT COMPLETED|Overall Study||0
1512133|NCT01573260|3700058|P2|COMPLETED|Overall Study||15
1512134|NCT01573260|3700059|P1|COMPLETED|Overall Study||18
1512135|NCT01573260|3700058|P2|STARTED|Overall Study||15
1512136|NCT01573260|3700059|P1|STARTED|Overall Study||18
1512137|NCT01573000|3700093|P2|NOT COMPLETED|Long-Term Follow-Up||1
1512138|NCT01573000|3700094|P1|NOT COMPLETED|Long-Term Follow-Up||3
1512139|NCT01573000|3700093|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
1512140|NCT01573000|3700094|P1|COMPLETED|Long-Term Follow-Up||11
1512141|NCT01573000|3700093|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
1512142|NCT01573000|3700094|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
1512143|NCT01573000|3700093|P2|NOT COMPLETED|Crossover Phase||18
1512144|NCT01573000|3700094|P1|NOT COMPLETED|Crossover Phase||0
1512145|NCT01573000|3700093|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
1512146|NCT01573000|3700094|P1|COMPLETED|Crossover Phase||0
1512147|NCT01573000|3700093|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
1512148|NCT01573000|3700094|P1|STARTED|Crossover Phase||0
1512149|NCT01573000|3700093|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
1512150|NCT01573000|3700094|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
1512151|NCT01573000|3700093|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
1512152|NCT01573000|3700094|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
1512153|NCT01573000|3700093|P2|STARTED|Dosimetric and Therapeutic Treatment||36
1512154|NCT01573000|3700094|P1|STARTED|Dosimetric and Therapeutic Treatment||42
1512155|NCT01572948|3700190|P2|NOT COMPLETED|Overall Study||1
1512156|NCT01572948|3700191|P1|NOT COMPLETED|Overall Study||1
1512157|NCT01572948|3700190|P2|COMPLETED|Overall Study||15
1512158|NCT01572948|3700191|P1|COMPLETED|Overall Study||10
1512159|NCT01572948|3700190|P2|STARTED|Overall Study||16
1512160|NCT01572948|3700191|P1|STARTED|Overall Study||11
1512161|NCT01572844|3700207|P2|NOT COMPLETED|Overall Study||1
1512162|NCT01572844|3700208|P1|NOT COMPLETED|Overall Study||1
1512163|NCT01572844|3700207|P2|COMPLETED|Overall Study||2
1512164|NCT01572844|3700208|P1|COMPLETED|Overall Study||2
1512165|NCT01572844|3700207|P2|STARTED|Overall Study||3
1512166|NCT01572844|3700208|P1|STARTED|Overall Study||3
1512167|NCT01572792|3700226|P5|NOT COMPLETED|Extension Study||32
1512168|NCT01572792|3700227|P4|NOT COMPLETED|Extension Study||29
1512169|NCT01572792|3700228|P3|NOT COMPLETED|Extension Study||26
1512170|NCT01572792|3700229|P2|NOT COMPLETED|Extension Study||29
1512171|NCT01572792|3700230|P1|NOT COMPLETED|Extension Study||25
1512172|NCT01572792|3700226|P5|COMPLETED|Extension Study||160
1512173|NCT01572792|3700227|P4|COMPLETED|Extension Study||165
1512174|NCT01572792|3700228|P3|COMPLETED|Extension Study||179
1512175|NCT01572792|3700229|P2|COMPLETED|Extension Study||155
1512176|NCT01572792|3700230|P1|COMPLETED|Extension Study||121
1512177|NCT01572792|3700226|P5|STARTED|Extension Study||192
1512178|NCT01572792|3700227|P4|STARTED|Extension Study||194
1512179|NCT01572792|3700228|P3|STARTED|Extension Study||205
1512180|NCT01572792|3700229|P2|STARTED|Extension Study||184
1512181|NCT01572792|3700230|P1|STARTED|Extension Study||146
1512182|NCT01572792|3700226|P5|NOT COMPLETED|Lead-in Study||69
1512183|NCT01572792|3700227|P4|NOT COMPLETED|Lead-in Study||72
1512184|NCT01572792|3700228|P3|NOT COMPLETED|Lead-in Study||62
1512185|NCT01572792|3700229|P2|NOT COMPLETED|Lead-in Study||66
1512186|NCT01572792|3700230|P1|NOT COMPLETED|Lead-in Study||101
1512187|NCT01572792|3700226|P5|COMPLETED|Lead-in Study||270
1512188|NCT01572792|3700227|P4|COMPLETED|Lead-in Study||268
1512189|NCT01572792|3700228|P3|COMPLETED|Lead-in Study||276
1512190|NCT01572792|3700229|P2|COMPLETED|Lead-in Study||272
1512191|NCT01572792|3700230|P1|COMPLETED|Lead-in Study||236
1512192|NCT01572792|3700226|P5|STARTED|Lead-in Study||339
1512193|NCT01572792|3700227|P4|STARTED|Lead-in Study||340
1512194|NCT01572792|3700228|P3|STARTED|Lead-in Study||338
1512195|NCT01572792|3700229|P2|STARTED|Lead-in Study||338
1512196|NCT01572792|3700230|P1|STARTED|Lead-in Study||337
1512197|NCT01572740|3700279|P2|NOT COMPLETED|Overall Study||5
1512198|NCT01572740|3700280|P1|NOT COMPLETED|Overall Study||6
1512199|NCT01572740|3700279|P2|COMPLETED|Overall Study||125
1512200|NCT01572740|3700280|P1|COMPLETED|Overall Study||121
1512201|NCT01572740|3700279|P2|STARTED|Overall Study||130
1512202|NCT01572740|3700280|P1|STARTED|Overall Study||127
1512203|NCT01572727|3700310|P2|NOT COMPLETED|Overall Study||209
1512204|NCT01572727|3700311|P1|NOT COMPLETED|Overall Study||207
1512205|NCT01572727|3700310|P2|COMPLETED|Overall Study||0
1512206|NCT01572727|3700311|P1|COMPLETED|Overall Study||0
1512207|NCT01572727|3700310|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
1512208|NCT01572727|3700311|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
1512209|NCT01572727|3700310|P2|STARTED|Overall Study||209
1512210|NCT01572727|3700311|P1|STARTED|Overall Study||207
1512211|NCT01572675|3700333|P2|NOT COMPLETED|Overall Study||223
1512212|NCT01572675|3700334|P1|NOT COMPLETED|Overall Study||237
1512213|NCT01572675|3700333|P2|COMPLETED|Overall Study||56
1512214|NCT01572675|3700334|P1|COMPLETED|Overall Study||31
1512215|NCT01572675|3700333|P2|STARTED|Overall Study||279
1512216|NCT01572675|3700334|P1|STARTED|Overall Study||268
1512217|NCT01572389|3700433|P2|NOT COMPLETED|Overall Study||21
1512218|NCT01572389|3700434|P1|NOT COMPLETED|Overall Study||46
1512219|NCT01572389|3700433|P2|COMPLETED|Overall Study||68
1512220|NCT01572389|3700434|P1|COMPLETED|Overall Study||90
1512221|NCT01572389|3700433|P2|STARTED|Overall Study||89
1512222|NCT01572389|3700434|P1|STARTED|Overall Study||136
1512223|NCT01572298|3700444|P2|NOT COMPLETED|Overall Study||1
1512224|NCT01572298|3700445|P1|NOT COMPLETED|Overall Study||2
1512225|NCT01572298|3700444|P2|COMPLETED|Overall Study||12
1512226|NCT01572298|3700445|P1|COMPLETED|Overall Study||12
1512227|NCT01572298|3700444|P2|STARTED|Overall Study||13
1512228|NCT01572298|3700445|P1|STARTED|Overall Study||14
1512229|NCT01572207|3700455|P2|NOT COMPLETED|Overall Study||3
1512230|NCT01572207|3700456|P1|NOT COMPLETED|Overall Study||2
1512231|NCT01572207|3700455|P2|COMPLETED|Overall Study||13
1512232|NCT01572207|3700456|P1|COMPLETED|Overall Study||12
1512233|NCT01572207|3700455|P2|STARTED|Overall Study||16
1512234|NCT01572207|3700456|P1|STARTED|Overall Study||14
1512235|NCT01571557|3700466|P1|NOT COMPLETED|Overall Study||0
1512236|NCT01571557|3700466|P1|COMPLETED|Overall Study||573
1512237|NCT01571557|3700466|P1|STARTED|Overall Study||573
1512238|NCT01571453|3700475|P2|NOT COMPLETED|Overall Study||62
1512239|NCT01571453|3700476|P1|NOT COMPLETED|Overall Study||38
1512240|NCT01571453|3700475|P2|COMPLETED|Overall Study||164
1512241|NCT01571453|3700476|P1|COMPLETED|Overall Study||173
1512242|NCT01571453|3700475|P2|STARTED|Overall Study||226
1512243|NCT01571453|3700476|P1|STARTED|Overall Study||211
1512244|NCT01571362|3700492|P3|NOT COMPLETED|Double-Blind Treatment Period||39
1512245|NCT01571362|3700493|P2|NOT COMPLETED|Double-Blind Treatment Period||53
1512246|NCT01571362|3700494|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1512247|NCT01571362|3700492|P3|COMPLETED|Double-Blind Treatment Period||107
1512248|NCT01571362|3700493|P2|COMPLETED|Double-Blind Treatment Period||81
1512249|NCT01571362|3700494|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
1512250|NCT01571362|3700492|P3|STARTED|Double-Blind Treatment Period||146
1512251|NCT01571362|3700493|P2|STARTED|Double-Blind Treatment Period||134
1512252|NCT01571362|3700494|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
1512253|NCT01571362|3700492|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
1512254|NCT01571362|3700493|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
1512255|NCT01571362|3700494|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
1512256|NCT01571362|3700492|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
1512257|NCT01571362|3700493|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
1512258|NCT01571362|3700494|P1|COMPLETED|Open-Label Conversion + Titration Period||281
1512259|NCT01571362|3700492|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
1512260|NCT01571362|3700493|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
1512261|NCT01571362|3700494|P1|STARTED|Open-Label Conversion + Titration Period||410
1512262|NCT01571284|3700664|P1|NOT COMPLETED|Overall Study||169
1512263|NCT01571284|3700664|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
1512264|NCT01571284|3700664|P1|Safety Population|Overall Study||779
1512265|NCT01571284|3700664|P1|STARTED|Overall Study||781
1512266|NCT01571232|3700687|P2|NOT COMPLETED|Overall Study||1
1512267|NCT01571232|3700688|P1|NOT COMPLETED|Overall Study||1
1512268|NCT01571232|3700687|P2|COMPLETED|Overall Study||9
1512269|NCT01571232|3700688|P1|COMPLETED|Overall Study||9
1512270|NCT01571232|3700687|P2|STARTED|Overall Study||10
1512271|NCT01571232|3700688|P1|STARTED|Overall Study||10
1512272|NCT01570751|3700700|P2|NOT COMPLETED|Period B (16 Weeks)||1
1512273|NCT01570751|3700701|P1|NOT COMPLETED|Period B (16 Weeks)||1
1512274|NCT01570751|3700700|P2|COMPLETED|Period B (16 Weeks)||66
1512275|NCT01570751|3700701|P1|COMPLETED|Period B (16 Weeks)||69
1512276|NCT01570751|3700700|P2|Exposed|Period B (16 Weeks)||67
1512277|NCT01570751|3700701|P1|Exposed|Period B (16 Weeks)||70
1512278|NCT01570751|3700700|P2|STARTED|Period B (16 Weeks)||67
1512279|NCT01570751|3700701|P1|STARTED|Period B (16 Weeks)||70
1512280|NCT01570751|3700700|P2|NOT COMPLETED|Period A (16 Weeks)||5
1512281|NCT01570751|3700701|P1|NOT COMPLETED|Period A (16 Weeks)||3
1512282|NCT01570751|3700700|P2|COMPLETED|Period A (16 Weeks)||67
1512283|NCT01570751|3700701|P1|COMPLETED|Period A (16 Weeks)||70
1512284|NCT01570751|3700700|P2|Exposed|Period A (16 Weeks)||72
1512285|NCT01570751|3700701|P1|Exposed|Period A (16 Weeks)||73
1512286|NCT01570751|3700700|P2|STARTED|Period A (16 Weeks)||72
1512287|NCT01570751|3700701|P1|STARTED|Period A (16 Weeks)||73
1512288|NCT01570686|3700719|P2|NOT COMPLETED|Overall Study||16
1512289|NCT01570686|3700720|P1|NOT COMPLETED|Overall Study||22
1512290|NCT01570686|3700719|P2|COMPLETED|Overall Study||278
1512291|NCT01570686|3700720|P1|COMPLETED|Overall Study||274
1512292|NCT01570686|3700719|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
1512293|NCT01570686|3700720|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
1512294|NCT01570686|3700719|P2|STARTED|Overall Study||294
1512295|NCT01570686|3700720|P1|STARTED|Overall Study||296
1512296|NCT01570634|3700746|P1|NOT COMPLETED|Overall Study||0
1512297|NCT01570634|3700746|P1|COMPLETED|Overall Study||2
1512298|NCT01570634|3700746|P1|STARTED|Overall Study||2
1512299|NCT01570309|3700756|P2|NOT COMPLETED|Overall Study||3
1512300|NCT01570309|3700757|P1|NOT COMPLETED|Overall Study||3
1512301|NCT01570309|3700756|P2|COMPLETED|Overall Study||45
1512302|NCT01570309|3700757|P1|COMPLETED|Overall Study||45
1512303|NCT01570309|3700756|P2|STARTED|Overall Study||48
1512304|NCT01570309|3700757|P1|STARTED|Overall Study||48
1512305|NCT01570244|3700771|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
1512306|NCT01570244|3700771|P1|COMPLETED|Microgynon+Faldaprevir||15
1512307|NCT01570244|3700771|P1|STARTED|Microgynon+Faldaprevir||16
1512308|NCT01570244|3700771|P1|NOT COMPLETED|Microgynon||0
1512309|NCT01570244|3700771|P1|COMPLETED|Microgynon||16
1512310|NCT01570244|3700771|P1|STARTED|Microgynon||16
1512311|NCT01570192|3700793|P2|NOT COMPLETED|Overall Study||13
1512312|NCT01570192|3700794|P1|NOT COMPLETED|Overall Study||7
1512313|NCT01570192|3700793|P2|COMPLETED|Overall Study||17
1512314|NCT01570192|3700794|P1|COMPLETED|Overall Study||6
1512315|NCT01570192|3700793|P2|STARTED|Overall Study||30
1512316|NCT01570192|3700794|P1|STARTED|Overall Study||13
1512317|NCT01569841|3700832|P2|NOT COMPLETED|Period B (6 Weeks)||0
1512318|NCT01569841|3700833|P1|NOT COMPLETED|Period B (6 Weeks)||0
1512319|NCT01569841|3700832|P2|COMPLETED|Period B (6 Weeks)||11
1512320|NCT01569841|3700833|P1|COMPLETED|Period B (6 Weeks)||12
1512321|NCT01569841|3700832|P2|Exposed|Period B (6 Weeks)||11
1512322|NCT01569841|3700833|P1|Exposed|Period B (6 Weeks)||12
1512323|NCT01569841|3700832|P2|STARTED|Period B (6 Weeks)||11
1512324|NCT01569841|3700833|P1|STARTED|Period B (6 Weeks)||12
1512325|NCT01569841|3700832|P2|NOT COMPLETED|Period A (6 Weeks)||1
1512326|NCT01569841|3700833|P1|NOT COMPLETED|Period A (6 Weeks)||0
1512327|NCT01569841|3700832|P2|COMPLETED|Period A (6 Weeks)||11
1512328|NCT01569841|3700833|P1|COMPLETED|Period A (6 Weeks)||12
1512329|NCT01569841|3700832|P2|Exposed|Period A (6 Weeks)||12
1512330|NCT01569841|3700833|P1|Exposed|Period A (6 Weeks)||12
1512331|NCT01569841|3700832|P2|STARTED|Period A (6 Weeks)||12
1512332|NCT01569841|3700833|P1|STARTED|Period A (6 Weeks)||12
1512333|NCT01569828|3700851|P2|NOT COMPLETED|Overall Study||0
1512334|NCT01569828|3700852|P1|NOT COMPLETED|Overall Study||0
1512335|NCT01569828|3700851|P2|COMPLETED|Overall Study||6
1512336|NCT01569828|3700852|P1|COMPLETED|Overall Study||6
1512337|NCT01569828|3700851|P2|STARTED|Overall Study||6
1512338|NCT01569828|3700852|P1|STARTED|Overall Study||6
1512339|NCT01569815|3700874|P4|NOT COMPLETED|Overall Study||0
1512340|NCT01569815|3700875|P3|NOT COMPLETED|Overall Study||0
1512341|NCT01569815|3700876|P2|NOT COMPLETED|Overall Study||0
1512342|NCT01569815|3700877|P1|NOT COMPLETED|Overall Study||0
1512343|NCT01569815|3700874|P4|COMPLETED|Overall Study||8
1512344|NCT01569815|3700875|P3|COMPLETED|Overall Study||8
1512345|NCT01569815|3700876|P2|COMPLETED|Overall Study||8
1512346|NCT01569815|3700877|P1|COMPLETED|Overall Study||8
1512347|NCT01569815|3700874|P4|STARTED|Overall Study||8
1512348|NCT01569815|3700875|P3|STARTED|Overall Study||8
1512349|NCT01569815|3700876|P2|STARTED|Overall Study||8
1512350|NCT01569815|3700877|P1|STARTED|Overall Study||8
1512351|NCT01569763|3700922|P2|NOT COMPLETED|Overall Study||7
1512352|NCT01569763|3700923|P1|NOT COMPLETED|Overall Study||3
1512353|NCT01569763|3700922|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
1512354|NCT01569763|3700923|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
1512355|NCT01569763|3700922|P2|Treated|Overall Study||51
1512356|NCT01569763|3700923|P1|Treated|Overall Study||102
1512357|NCT01569763|3700922|P2|STARTED|Overall Study||51
1512358|NCT01569763|3700923|P1|STARTED|Overall Study||102
1512359|NCT01569607|3700935|P2|NOT COMPLETED|Overall Study||1
1512360|NCT01569607|3700936|P1|NOT COMPLETED|Overall Study||1
1512361|NCT01569607|3700935|P2|COMPLETED|Overall Study||10
1512362|NCT01569607|3700936|P1|COMPLETED|Overall Study||10
1512363|NCT01569607|3700935|P2|STARTED|Overall Study||11
1512364|NCT01569607|3700936|P1|STARTED|Overall Study||11
1512365|NCT01569568|3700960|P2|NOT COMPLETED|Overall Study||2
1512366|NCT01569568|3700961|P1|NOT COMPLETED|Overall Study||0
1512367|NCT01569568|3700960|P2|COMPLETED|Overall Study||27
1512368|NCT01569568|3700961|P1|COMPLETED|Overall Study||20
1512369|NCT01569568|3700960|P2|STARTED|Overall Study||29
1512370|NCT01569568|3700961|P1|STARTED|Overall Study||20
1512371|NCT01569529|3700975|P2|NOT COMPLETED|Overall Study||0
1512372|NCT01569529|3700976|P1|NOT COMPLETED|Overall Study||0
1512373|NCT01569529|3700975|P2|COMPLETED|Overall Study||394
1512374|NCT01569529|3700976|P1|COMPLETED|Overall Study||2676
1512375|NCT01569529|3700975|P2|STARTED|Overall Study||394
1512376|NCT01569529|3700976|P1|STARTED|Overall Study||2676
1512377|NCT01569464|3700984|P2|NOT COMPLETED|Overall Study||5
1512378|NCT01569464|3700985|P1|NOT COMPLETED|Overall Study||10
1512379|NCT01569464|3700984|P2|COMPLETED|Overall Study||44
1512380|NCT01569464|3700985|P1|COMPLETED|Overall Study||91
1512381|NCT01569464|3700984|P2|STARTED|Overall Study||49
1512382|NCT01569464|3700985|P1|STARTED|Overall Study||101
1512383|NCT01569451|3701023|P2|NOT COMPLETED|Overall Study||13
1512384|NCT01569451|3701024|P1|NOT COMPLETED|Overall Study||14
1512385|NCT01569451|3701023|P2|COMPLETED|Overall Study||14
1512386|NCT01569451|3701024|P1|COMPLETED|Overall Study||12
1512387|NCT01569451|3701023|P2|STARTED|Overall Study||27
1512388|NCT01569451|3701024|P1|STARTED|Overall Study||26
1512389|NCT01569438|3701052|P2|NOT COMPLETED|Overall Study||9
1512390|NCT01569438|3701053|P1|NOT COMPLETED|Overall Study||2
1512391|NCT01569438|3701052|P2|COMPLETED|Overall Study||27
1512392|NCT01569438|3701053|P1|COMPLETED|Overall Study||36
1512393|NCT01569438|3701052|P2|STARTED|Overall Study||36
1512394|NCT01569438|3701053|P1|STARTED|Overall Study||38
1512395|NCT01569295|3701067|P2|NOT COMPLETED|Overall Study||67
1512396|NCT01569295|3701068|P1|NOT COMPLETED|Overall Study||134
1512397|NCT01569295|3701067|P2|COMPLETED|Overall Study||142
1512398|NCT01569295|3701068|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint (progressive disease or death)|73
1512399|NCT01569295|3701067|P2|STARTED|Overall Study||209
1512400|NCT01569295|3701068|P1|STARTED|Overall Study||207
1512401|NCT01569191|3701084|P2|NOT COMPLETED|Overall Study||0
1512402|NCT01569191|3701085|P1|NOT COMPLETED|Overall Study||0
1512403|NCT01569191|3701084|P2|COMPLETED|Overall Study||7
1512404|NCT01569191|3701085|P1|COMPLETED|Overall Study||11
1512405|NCT01569191|3701084|P2|STARTED|Overall Study||7
1512406|NCT01569191|3701085|P1|STARTED|Overall Study||11
1512407|NCT01569152|3701105|P3|NOT COMPLETED|Safety Extension, Period 3||55
1512408|NCT01569152|3701106|P2|NOT COMPLETED|Safety Extension, Period 3||0
1512409|NCT01569152|3701107|P1|NOT COMPLETED|Safety Extension, Period 3||0
1512410|NCT01569152|3701105|P3|COMPLETED|Safety Extension, Period 3||0
1512411|NCT01569152|3701106|P2|COMPLETED|Safety Extension, Period 3||0
1512412|NCT01569152|3701107|P1|COMPLETED|Safety Extension, Period 3||0
1512413|NCT01569152|3701105|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
1512414|NCT01569152|3701106|P2|STARTED|Safety Extension, Period 3||0
1512415|NCT01569152|3701107|P1|STARTED|Safety Extension, Period 3||0
1512416|NCT01569152|3701105|P3|NOT COMPLETED|Phase IIa, Period 1||0
1512417|NCT01569152|3701106|P2|NOT COMPLETED|Phase IIa, Period 1||32
1512418|NCT01569152|3701107|P1|NOT COMPLETED|Phase IIa, Period 1||21
1512419|NCT01569152|3701105|P3|COMPLETED|Phase IIa, Period 1||0
1512420|NCT01569152|3701106|P2|COMPLETED|Phase IIa, Period 1||9
1512421|NCT01569152|3701107|P1|COMPLETED|Phase IIa, Period 1||20
1512422|NCT01569152|3701105|P3|STARTED|Phase IIa, Period 1||0
1512423|NCT01569152|3701106|P2|STARTED|Phase IIa, Period 1||41
1512424|NCT01569152|3701107|P1|STARTED|Phase IIa, Period 1||41
1512425|NCT01569126|3701170|P6|NOT COMPLETED|Overall Study||0
1512426|NCT01569126|3701171|P5|NOT COMPLETED|Overall Study||0
1512427|NCT01569126|3701172|P4|NOT COMPLETED|Overall Study||0
1512428|NCT01569126|3701173|P3|NOT COMPLETED|Overall Study||0
1512429|NCT01569126|3701174|P2|NOT COMPLETED|Overall Study||0
1512430|NCT01569126|3701175|P1|NOT COMPLETED|Overall Study||0
1512431|NCT01569126|3701170|P6|COMPLETED|Overall Study||12
1512432|NCT01569126|3701171|P5|COMPLETED|Overall Study||12
1512433|NCT01569126|3701172|P4|COMPLETED|Overall Study||8
1512434|NCT01569126|3701173|P3|COMPLETED|Overall Study||8
1512435|NCT01569126|3701174|P2|COMPLETED|Overall Study||8
1512436|NCT01569126|3701175|P1|COMPLETED|Overall Study||8
1512437|NCT01569126|3701170|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
1512438|NCT01569126|3701171|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
1512439|NCT01569126|3701172|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
1512440|NCT01569126|3701173|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
1512441|NCT01569126|3701174|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
1512442|NCT01569126|3701175|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
1512443|NCT01569126|3701170|P6|STARTED|Overall Study||12
1512444|NCT01569126|3701171|P5|STARTED|Overall Study||12
1512445|NCT01569126|3701172|P4|STARTED|Overall Study||8
1512446|NCT01569126|3701173|P3|STARTED|Overall Study||8
1512447|NCT01569126|3701174|P2|STARTED|Overall Study||8
1512448|NCT01569126|3701175|P1|STARTED|Overall Study||8
1512449|NCT01569087|3701213|P3|NOT COMPLETED|Overall Study||1
1512450|NCT01569087|3701214|P2|NOT COMPLETED|Overall Study||0
1512451|NCT01569087|3701215|P1|NOT COMPLETED|Overall Study||1
1512452|NCT01569087|3701213|P3|COMPLETED|Overall Study||18
1512453|NCT01569087|3701214|P2|COMPLETED|Overall Study||20
1512454|NCT01569087|3701215|P1|COMPLETED|Overall Study||20
1512455|NCT01569087|3701213|P3|STARTED|Overall Study||19
1512456|NCT01569087|3701214|P2|STARTED|Overall Study||20
1512457|NCT01569087|3701215|P1|STARTED|Overall Study||21
1512458|NCT01569074|3701243|P5|NOT COMPLETED|Overall Study||8
1512459|NCT01569074|3701244|P4|NOT COMPLETED|Overall Study||8
1512460|NCT01569074|3701245|P3|NOT COMPLETED|Overall Study||12
1512461|NCT01569074|3701246|P2|NOT COMPLETED|Overall Study||9
1512462|NCT01569074|3701247|P1|NOT COMPLETED|Overall Study||7
1512463|NCT01569074|3701243|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
1512464|NCT01569074|3701244|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
1512465|NCT01569074|3701245|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
1512466|NCT01569074|3701246|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
1512467|NCT01569074|3701247|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
1512468|NCT01569074|3701243|P5|Randomised But Did Not Receive Treatment|Overall Study||0
1512469|NCT01569074|3701244|P4|Randomised But Did Not Receive Treatment|Overall Study||0
1512470|NCT01569074|3701245|P3|Randomised But Did Not Receive Treatment|Overall Study||0
1512471|NCT01569074|3701246|P2|Randomised But Did Not Receive Treatment|Overall Study||0
1512472|NCT01569074|3701247|P1|Randomised But Did Not Receive Treatment|Overall Study||0
1512473|NCT01569074|3701243|P5|STARTED|Overall Study|Patients who received treatment|33
1512474|NCT01569074|3701244|P4|STARTED|Overall Study|Patients who received treatment|33
1512475|NCT01569074|3701245|P3|STARTED|Overall Study|Patients who received treatment|33
1512476|NCT01569074|3701246|P2|STARTED|Overall Study|Patients who received treatment|33
1512477|NCT01569074|3701247|P1|STARTED|Overall Study|Patients who received treatment|31
1512478|NCT01569022|3701303|P2|NOT COMPLETED|Second Intervention||2
1512479|NCT01569022|3701304|P1|NOT COMPLETED|Second Intervention||2
1512480|NCT01569022|3701303|P2|COMPLETED|Second Intervention||18
1512481|NCT01569022|3701304|P1|COMPLETED|Second Intervention||17
1512482|NCT01569022|3701303|P2|STARTED|Second Intervention||20
1512483|NCT01569022|3701304|P1|STARTED|Second Intervention||19
1512484|NCT01569022|3701303|P2|NOT COMPLETED|First Intervention||1
1512485|NCT01569022|3701304|P1|NOT COMPLETED|First Intervention||2
1512486|NCT01569022|3701303|P2|COMPLETED|First Intervention||20
1512487|NCT01569022|3701304|P1|COMPLETED|First Intervention||19
1512488|NCT01569022|3701303|P2|STARTED|First Intervention||21
1512489|NCT01569022|3701304|P1|STARTED|First Intervention||21
1512490|NCT01568905|3701319|P3|NOT COMPLETED|Overall Study||0
1512491|NCT01568905|3701320|P2|NOT COMPLETED|Overall Study||0
1512492|NCT01568905|3701321|P1|NOT COMPLETED|Overall Study||1
1512493|NCT01568905|3701319|P3|COMPLETED|Overall Study||12
1512494|NCT01568905|3701320|P2|COMPLETED|Overall Study||11
1512495|NCT01568905|3701321|P1|COMPLETED|Overall Study||12
1512496|NCT01568905|3701319|P3|STARTED|Overall Study||12
1512497|NCT01568905|3701320|P2|STARTED|Overall Study||11
1512498|NCT01568905|3701321|P1|STARTED|Overall Study||13
1512499|NCT01568892|3701340|P2|NOT COMPLETED|Open-label Phase||3
1512500|NCT01568892|3701341|P1|NOT COMPLETED|Open-label Phase||6
1512501|NCT01568892|3701340|P2|COMPLETED|Open-label Phase||13
1512502|NCT01568892|3701341|P1|COMPLETED|Open-label Phase||7
1512503|NCT01568892|3701340|P2|STARTED|Open-label Phase||16
1512504|NCT01568892|3701341|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
1512505|NCT01568892|3701340|P2|NOT COMPLETED|Double-blind Phase||0
1512506|NCT01568892|3701341|P1|NOT COMPLETED|Double-blind Phase||0
1512507|NCT01568892|3701340|P2|COMPLETED|Double-blind Phase||16
1512508|NCT01568892|3701341|P1|COMPLETED|Double-blind Phase||14
1512509|NCT01568892|3701340|P2|STARTED|Double-blind Phase||16
1512510|NCT01568892|3701341|P1|STARTED|Double-blind Phase||14
1512511|NCT01568866|3701411|P2|NOT COMPLETED|Overall Study||416
1512512|NCT01568866|3701412|P1|NOT COMPLETED|Overall Study||438
1512513|NCT01568866|3701411|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
1512514|NCT01568866|3701412|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
1512515|NCT01568866|3701411|P2|Received Treatment|Overall Study||463
1512516|NCT01568866|3701412|P1|Received Treatment|Overall Study||456
1512517|NCT01568866|3701411|P2|STARTED|Overall Study||464
1512518|NCT01568866|3701412|P1|STARTED|Overall Study||465
1512519|NCT01568827|3701434|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
1512520|NCT01568827|3701435|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
1512521|NCT01568827|3701434|P2|COMPLETED|Intervention 2 (5 Days)||5
1512522|NCT01568827|3701435|P1|COMPLETED|Intervention 2 (5 Days)||5
1512523|NCT01568827|3701434|P2|STARTED|Intervention 2 (5 Days)||5
1512524|NCT01568827|3701435|P1|STARTED|Intervention 2 (5 Days)||5
1512525|NCT01568827|3701434|P2|NOT COMPLETED|Washout (2 Days)||0
1512526|NCT01568827|3701435|P1|NOT COMPLETED|Washout (2 Days)||0
1512527|NCT01568827|3701434|P2|COMPLETED|Washout (2 Days)||5
1512528|NCT01568827|3701435|P1|COMPLETED|Washout (2 Days)||5
1512529|NCT01568827|3701434|P2|STARTED|Washout (2 Days)||5
1512530|NCT01568827|3701435|P1|STARTED|Washout (2 Days)||5
1512531|NCT01568827|3701434|P2|NOT COMPLETED|First Intervention (6 Days)||0
1512532|NCT01568827|3701435|P1|NOT COMPLETED|First Intervention (6 Days)||0
1512533|NCT01568827|3701434|P2|COMPLETED|First Intervention (6 Days)||5
1512534|NCT01568827|3701435|P1|COMPLETED|First Intervention (6 Days)||5
1512535|NCT01568827|3701434|P2|STARTED|First Intervention (6 Days)||5
1512536|NCT01568827|3701435|P1|STARTED|First Intervention (6 Days)||5
1512537|NCT01568593|3701443|P2|NOT COMPLETED|Overall Study||3
1512538|NCT01568593|3701444|P1|NOT COMPLETED|Overall Study||7
1512539|NCT01568593|3701443|P2|COMPLETED|Overall Study||42
1512540|NCT01568593|3701444|P1|COMPLETED|Overall Study||41
1512541|NCT01568593|3701443|P2|STARTED|Overall Study||45
1512542|NCT01568593|3701444|P1|STARTED|Overall Study||48
1512543|NCT01568424|3701450|P1|NOT COMPLETED|Overall Study||0
1512544|NCT01568424|3701450|P1|COMPLETED|Overall Study||25
1512545|NCT01568424|3701450|P1|STARTED|Overall Study||25
1512546|NCT01568112|3701464|P4|NOT COMPLETED|Overall Study||12
1512547|NCT01568112|3701465|P3|NOT COMPLETED|Overall Study||7
1512548|NCT01568112|3701466|P2|NOT COMPLETED|Overall Study||8
1512549|NCT01568112|3701467|P1|NOT COMPLETED|Overall Study||5
1512550|NCT01568112|3701464|P4|COMPLETED|Overall Study||30
1512551|NCT01568112|3701465|P3|COMPLETED|Overall Study||36
1512552|NCT01568112|3701466|P2|COMPLETED|Overall Study||36
1512553|NCT01568112|3701467|P1|COMPLETED|Overall Study||39
1512554|NCT01568112|3701464|P4|STARTED|Overall Study||42
1512555|NCT01568112|3701465|P3|STARTED|Overall Study||43
1512556|NCT01568112|3701466|P2|STARTED|Overall Study||44
1512557|NCT01568112|3701467|P1|STARTED|Overall Study||44
1512558|NCT01568073|3701590|P5|NOT COMPLETED|Overall Study||9
1512559|NCT01568073|3701591|P4|NOT COMPLETED|Overall Study||11
1512560|NCT01568073|3701592|P3|NOT COMPLETED|Overall Study||12
1512561|NCT01568073|3701593|P2|NOT COMPLETED|Overall Study||15
1512562|NCT01568073|3701594|P1|NOT COMPLETED|Overall Study||11
1512563|NCT01568073|3701590|P5|COMPLETED|Overall Study||107
1512564|NCT01568073|3701591|P4|COMPLETED|Overall Study||108
1512565|NCT01568073|3701592|P3|COMPLETED|Overall Study||110
1512566|NCT01568073|3701593|P2|COMPLETED|Overall Study||107
1512567|NCT01568073|3701594|P1|COMPLETED|Overall Study||110
1512568|NCT01568073|3701590|P5|STARTED|Overall Study||116
1512569|NCT01568073|3701591|P4|STARTED|Overall Study||119
1512570|NCT01568073|3701592|P3|STARTED|Overall Study||122
1512571|NCT01568073|3701593|P2|STARTED|Overall Study||122
1512572|NCT01568073|3701594|P1|STARTED|Overall Study||121
1512573|NCT01568047|3701625|P4|NOT COMPLETED|Overall Study||1
1512574|NCT01568047|3701626|P3|NOT COMPLETED|Overall Study||1
1512575|NCT01568047|3701627|P2|NOT COMPLETED|Overall Study||1
1512576|NCT01568047|3701628|P1|NOT COMPLETED|Overall Study||1
1512577|NCT01568047|3701625|P4|COMPLETED|Overall Study||9
1512578|NCT01568047|3701626|P3|COMPLETED|Overall Study||9
1512579|NCT01568047|3701627|P2|COMPLETED|Overall Study||9
1512580|NCT01568047|3701628|P1|COMPLETED|Overall Study||9
1512581|NCT01568047|3701625|P4|STARTED|Overall Study||10
1512582|NCT01568047|3701626|P3|STARTED|Overall Study||10
1512583|NCT01568047|3701627|P2|STARTED|Overall Study||10
1512584|NCT01568047|3701628|P1|STARTED|Overall Study||10
1512585|NCT01568034|3701646|P4|NOT COMPLETED|Overall Study||0
1512586|NCT01568034|3701647|P3|NOT COMPLETED|Overall Study||0
1512587|NCT01568034|3701648|P2|NOT COMPLETED|Overall Study||0
1512588|NCT01568034|3701649|P1|NOT COMPLETED|Overall Study||1
1512589|NCT01568034|3701646|P4|COMPLETED|Overall Study||3
1512590|NCT01568034|3701647|P3|COMPLETED|Overall Study||3
1512591|NCT01568034|3701648|P2|COMPLETED|Overall Study||2
1512592|NCT01568034|3701649|P1|COMPLETED|Overall Study||1
1512593|NCT01568034|3701646|P4|Placebo|Overall Study||3
1512594|NCT01568034|3701647|P3|Placebo|Overall Study||3
1512595|NCT01568034|3701648|P2|Placebo|Overall Study||2
1512596|NCT01568034|3701649|P1|Placebo|Overall Study||1
1512597|NCT01568034|3701646|P4|100 mg BIA 9-1067|Overall Study||3
1512598|NCT01568034|3701647|P3|100 mg BIA 9-1067|Overall Study||3
1512599|NCT01568034|3701648|P2|100 mg BIA 9-1067|Overall Study||2
1512600|NCT01568034|3701649|P1|100 mg BIA 9-1067|Overall Study||2
1512601|NCT01568034|3701646|P4|50 mg BIA 9-1067|Overall Study||3
1512602|NCT01568034|3701647|P3|50 mg BIA 9-1067|Overall Study||3
1512603|NCT01568034|3701648|P2|50 mg BIA 9-1067|Overall Study||2
1512604|NCT01568034|3701649|P1|50 mg BIA 9-1067|Overall Study||2
1512605|NCT01568034|3701646|P4|25 mg BIA 9-1067|Overall Study||3
1512606|NCT01568034|3701647|P3|25 mg BIA 9-1067|Overall Study||3
1512607|NCT01568034|3701648|P2|25 mg BIA 9-1067|Overall Study||2
1512608|NCT01568034|3701649|P1|25 mg BIA 9-1067|Overall Study||2
1512609|NCT01568034|3701646|P4|STARTED|Overall Study||3
1512610|NCT01568034|3701647|P3|STARTED|Overall Study||3
1512611|NCT01568034|3701648|P2|STARTED|Overall Study||2
1512612|NCT01568034|3701649|P1|STARTED|Overall Study||2
1512613|NCT01568021|3701667|P1|NOT COMPLETED|Overall Study||16
1512614|NCT01568021|3701667|P1|COMPLETED|Overall Study||83
1512615|NCT01568021|3701667|P1|STARTED|Overall Study||99
1512616|NCT01568008|3701673|P1|NOT COMPLETED|Overall Study||234
1512617|NCT01568008|3701673|P1|COMPLETED|Overall Study||699
1512618|NCT01568008|3701673|P1|STARTED|Overall Study||933
1512619|NCT01567943|3701684|P3|NOT COMPLETED|Overall Study||0
1512620|NCT01567943|3701685|P2|NOT COMPLETED|Overall Study||10
1512621|NCT01567943|3701686|P1|NOT COMPLETED|Overall Study||14
1512622|NCT01567943|3701684|P3|COMPLETED|Overall Study||44
1512623|NCT01567943|3701685|P2|COMPLETED|Overall Study||29
1512624|NCT01567943|3701686|P1|COMPLETED|Overall Study||26
1512625|NCT01567943|3701684|P3|STARTED|Overall Study||44
1512626|NCT01567943|3701685|P2|STARTED|Overall Study||39
1512627|NCT01567943|3701686|P1|STARTED|Overall Study||40
1512628|NCT01567865|3701698|P4|NOT COMPLETED|Evaluated for Immunogenicity||30
1512629|NCT01567865|3701699|P3|NOT COMPLETED|Evaluated for Immunogenicity||19
1512630|NCT01567865|3701700|P2|NOT COMPLETED|Evaluated for Immunogenicity||25
1512631|NCT01567865|3701701|P1|NOT COMPLETED|Evaluated for Immunogenicity||17
1512632|NCT01567865|3701698|P4|COMPLETED|Evaluated for Immunogenicity||194
1512633|NCT01567865|3701699|P3|COMPLETED|Evaluated for Immunogenicity||192
1512634|NCT01567865|3701700|P2|COMPLETED|Evaluated for Immunogenicity||195
1512635|NCT01567865|3701701|P1|COMPLETED|Evaluated for Immunogenicity||146
1512636|NCT01567865|3701698|P4|STARTED|Evaluated for Immunogenicity||224
1512637|NCT01567865|3701699|P3|STARTED|Evaluated for Immunogenicity||211
1512638|NCT01567865|3701700|P2|STARTED|Evaluated for Immunogenicity||220
1512639|NCT01567865|3701701|P1|STARTED|Evaluated for Immunogenicity||163
1512640|NCT01567865|3701698|P4|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
1512641|NCT01567865|3701699|P3|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
1512642|NCT01567865|3701700|P2|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
1512643|NCT01567865|3701701|P1|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
1512644|NCT01567865|3701698|P4|COMPLETED|Enrolled and Vaccinated (Day 0)||224
1512645|NCT01567865|3701699|P3|COMPLETED|Enrolled and Vaccinated (Day 0)||211
1512646|NCT01567865|3701700|P2|COMPLETED|Enrolled and Vaccinated (Day 0)||220
1512647|NCT01567865|3701701|P1|COMPLETED|Enrolled and Vaccinated (Day 0)||163
1512648|NCT01567865|3701698|P4|STARTED|Enrolled and Vaccinated (Day 0)||224
1512649|NCT01567865|3701699|P3|STARTED|Enrolled and Vaccinated (Day 0)||211
1512650|NCT01567865|3701700|P2|STARTED|Enrolled and Vaccinated (Day 0)||220
1512651|NCT01567865|3701701|P1|STARTED|Enrolled and Vaccinated (Day 0)||163
1512652|NCT01567852|3701731|P2|NOT COMPLETED|Overall Study||7
1512653|NCT01567852|3701732|P1|NOT COMPLETED|Overall Study||4
1512654|NCT01567852|3701731|P2|COMPLETED|Overall Study||5
1512655|NCT01567852|3701732|P1|COMPLETED|Overall Study||4
1512656|NCT01567852|3701731|P2|STARTED|Overall Study||12
1512657|NCT01567852|3701732|P1|STARTED|Overall Study||8
1512658|NCT01567839|3701740|P1|NOT COMPLETED|Overall Study||0
1512659|NCT01567839|3701740|P1|COMPLETED|Overall Study||60
1512660|NCT01567839|3701740|P1|STARTED|Overall Study||60
1512661|NCT01567826|3701750|P2|NOT COMPLETED|Overall Study||2
1512662|NCT01567826|3701751|P1|NOT COMPLETED|Overall Study||3
1512663|NCT01567826|3701750|P2|COMPLETED|Overall Study||42
1512664|NCT01567826|3701751|P1|COMPLETED|Overall Study||40
1512665|NCT01567826|3701750|P2|STARTED|Overall Study||44
1512666|NCT01567826|3701751|P1|STARTED|Overall Study||43
1512667|NCT01567527|3701777|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
1512668|NCT01567527|3701778|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
1512669|NCT01567527|3701779|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1512670|NCT01567527|3701780|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1512671|NCT01567527|3701781|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
1512672|NCT01567527|3701777|P5|COMPLETED|Double-blind, Placebo-controlled Phase||38
1512673|NCT01567527|3701778|P4|COMPLETED|Double-blind, Placebo-controlled Phase||64
1512674|NCT01567527|3701779|P3|COMPLETED|Double-blind, Placebo-controlled Phase||0
1512675|NCT01567527|3701780|P2|COMPLETED|Double-blind, Placebo-controlled Phase||0
1512676|NCT01567527|3701781|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
1512677|NCT01567527|3701777|P5|STARTED|Double-blind, Placebo-controlled Phase||133
1512678|NCT01567527|3701778|P4|STARTED|Double-blind, Placebo-controlled Phase||133
1512679|NCT01567527|3701779|P3|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
1512680|NCT01567527|3701780|P2|STARTED|Double-blind, Placebo-controlled Phase||0
1512681|NCT01567527|3701781|P1|STARTED|Double-blind, Placebo-controlled Phase||0
1512682|NCT01567527|3701777|P5|NOT COMPLETED|IM Depot Stabilization.||0
1512683|NCT01567527|3701778|P4|NOT COMPLETED|IM Depot Stabilization.||0
1512684|NCT01567527|3701779|P3|NOT COMPLETED|IM Depot Stabilization.||159
1512685|NCT01567527|3701780|P2|NOT COMPLETED|IM Depot Stabilization.||0
1512686|NCT01567527|3701781|P1|NOT COMPLETED|IM Depot Stabilization.||0
1512687|NCT01567527|3701777|P5|COMPLETED|IM Depot Stabilization.||0
1512688|NCT01567527|3701778|P4|COMPLETED|IM Depot Stabilization.||0
1512689|NCT01567527|3701779|P3|COMPLETED|IM Depot Stabilization.||266
1512690|NCT01567527|3701780|P2|COMPLETED|IM Depot Stabilization.||0
1512691|NCT01567527|3701781|P1|COMPLETED|IM Depot Stabilization.||0
1512692|NCT01567527|3701777|P5|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
1512693|NCT01567527|3701778|P4|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
1512694|NCT01567527|3701779|P3|STARTED|IM Depot Stabilization.||425
1512695|NCT01567527|3701780|P2|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
1512696|NCT01567527|3701781|P1|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
1512697|NCT01567527|3701777|P5|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1512698|NCT01567527|3701778|P4|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1512699|NCT01567527|3701779|P3|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1512700|NCT01567527|3701780|P2|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
1512701|NCT01567527|3701781|P1|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1512702|NCT01567527|3701777|P5|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1512703|NCT01567527|3701778|P4|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1512704|NCT01567527|3701779|P3|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1512705|NCT01567527|3701780|P2|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
1512706|NCT01567527|3701781|P1|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
1512707|NCT01567527|3701777|P5|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
1512708|NCT01567527|3701778|P4|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
1512709|NCT01567527|3701779|P3|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
1512710|NCT01567527|3701780|P2|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
1512711|NCT01567527|3701781|P1|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
1512712|NCT01567527|3701777|P5|NOT COMPLETED|Conversion Phase.||0
1512713|NCT01567527|3701778|P4|NOT COMPLETED|Conversion Phase.||0
1512714|NCT01567527|3701779|P3|NOT COMPLETED|Conversion Phase.||0
1512715|NCT01567527|3701780|P2|NOT COMPLETED|Conversion Phase.||0
1512716|NCT01567527|3701781|P1|NOT COMPLETED|Conversion Phase.||99
1512717|NCT01567527|3701777|P5|COMPLETED|Conversion Phase.||0
1512718|NCT01567527|3701778|P4|COMPLETED|Conversion Phase.||0
1512719|NCT01567527|3701779|P3|COMPLETED|Conversion Phase.||0
1512720|NCT01567527|3701780|P2|COMPLETED|Conversion Phase.||0
1512721|NCT01567527|3701781|P1|COMPLETED|Conversion Phase.||367
1512722|NCT01567527|3701777|P5|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
1512723|NCT01567527|3701778|P4|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
1512724|NCT01567527|3701779|P3|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
1512725|NCT01567527|3701780|P2|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
1512726|NCT01567527|3701781|P1|STARTED|Conversion Phase.||466
1512727|NCT01567462|3701798|P2|NOT COMPLETED|Overall Study||7
1512728|NCT01567462|3701799|P1|NOT COMPLETED|Overall Study||4
1512729|NCT01567462|3701798|P2|COMPLETED|Overall Study||38
1512730|NCT01567462|3701799|P1|COMPLETED|Overall Study||41
1512731|NCT01567462|3701798|P2|STARTED|Overall Study||45
1512732|NCT01567462|3701799|P1|STARTED|Overall Study||45
1512733|NCT01567371|3701811|P1|NOT COMPLETED|Overall Study||0
1512734|NCT01567371|3701811|P1|COMPLETED|Overall Study||30
1512735|NCT01567371|3701811|P1|STARTED|Overall Study||30
1512736|NCT01567163|3701816|P1|NOT COMPLETED|Overall Study||4
1512737|NCT01567163|3701816|P1|COMPLETED|Overall Study||18
1512738|NCT01567163|3701816|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
1512739|NCT01567163|3701816|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
1512740|NCT01567163|3701816|P1|STARTED|Overall Study||22
1512741|NCT01567150|3701828|P2|NOT COMPLETED|Overall Study||2
1512742|NCT01567150|3701829|P1|NOT COMPLETED|Overall Study||2
1512743|NCT01567150|3701828|P2|COMPLETED|Overall Study||16
1512744|NCT01567150|3701829|P1|COMPLETED|Overall Study||19
1512745|NCT01567150|3701828|P2|STARTED|Overall Study||18
1512746|NCT01567150|3701829|P1|STARTED|Overall Study||21
1512747|NCT01567020|3701841|P4|NOT COMPLETED|Overall Study||1
1512748|NCT01567020|3701842|P3|NOT COMPLETED|Overall Study||2
1512749|NCT01567020|3701843|P2|NOT COMPLETED|Overall Study||5
1512750|NCT01567020|3701844|P1|NOT COMPLETED|Overall Study||7
1512751|NCT01567020|3701841|P4|COMPLETED|Overall Study||10
1512752|NCT01567020|3701842|P3|COMPLETED|Overall Study||18
1512753|NCT01567020|3701843|P2|COMPLETED|Overall Study||41
1512754|NCT01567020|3701844|P1|COMPLETED|Overall Study||21
1512755|NCT01567020|3701841|P4|STARTED|Overall Study||11
1512756|NCT01567020|3701842|P3|STARTED|Overall Study||20
1512757|NCT01567020|3701843|P2|STARTED|Overall Study||46
1512758|NCT01567020|3701844|P1|STARTED|Overall Study||28
1512759|NCT01566981|3701856|P2|NOT COMPLETED|Overall Study||8
1512760|NCT01566981|3701857|P1|NOT COMPLETED|Overall Study||5
1512761|NCT01566981|3701856|P2|COMPLETED|Overall Study||54
1512762|NCT01566981|3701857|P1|COMPLETED|Overall Study||53
1512763|NCT01566981|3701856|P2|STARTED|Overall Study||62
1512764|NCT01566981|3701857|P1|STARTED|Overall Study||58
1512765|NCT01566838|3701869|P2|NOT COMPLETED|Overall Study||0
1512766|NCT01566838|3701870|P1|NOT COMPLETED|Overall Study||3
1512767|NCT01566838|3701869|P2|COMPLETED|Overall Study||42
1512768|NCT01566838|3701870|P1|COMPLETED|Overall Study||38
1512769|NCT01566838|3701869|P2|STARTED|Overall Study||42
1512770|NCT01566838|3701870|P1|STARTED|Overall Study||41
1512771|NCT01566773|3701886|P1|NOT COMPLETED|Overall Study||30
1512772|NCT01566773|3701886|P1|COMPLETED|Overall Study||110
1512773|NCT01566773|3701886|P1|Spiriva® Handihaler®|Overall Study||62
1512774|NCT01566773|3701886|P1|Placebo MDI|Overall Study||62
1512775|NCT01566773|3701886|P1|GP MDI 0.6 µg BID|Overall Study||59
1512776|NCT01566773|3701886|P1|GP MDI 1.2 µg BID|Overall Study||57
1512777|NCT01566773|3701886|P1|GP MDI 2.4 µg BID|Overall Study||64
1512778|NCT01566773|3701886|P1|GP MDI 4.6 µg BID|Overall Study||62
1512779|NCT01566773|3701886|P1|GP MDI 9 µg BID|Overall Study||64
1512780|NCT01566773|3701886|P1|GP MDI 18 µg BID|Overall Study||64
1512781|NCT01566773|3701886|P1|STARTED|Overall Study||140
1512782|NCT01566721|3702095|P2|NOT COMPLETED|Overall Study||710
1512783|NCT01566721|3702096|P1|NOT COMPLETED|Overall Study||1867
1512784|NCT01566721|3702095|P2|COMPLETED|Overall Study||0
1512785|NCT01566721|3702096|P1|COMPLETED|Overall Study||0
1512786|NCT01566721|3702095|P2|Received Treatment|Overall Study||709
1512787|NCT01566721|3702096|P1|Received Treatment|Overall Study||1864
1512788|NCT01566721|3702095|P2|STARTED|Overall Study||710
1512789|NCT01566721|3702096|P1|STARTED|Overall Study||1867
1512790|NCT01566630|3702121|P2|NOT COMPLETED|Overall Study||0
1512791|NCT01566630|3702122|P1|NOT COMPLETED|Overall Study||0
1512792|NCT01566630|3702121|P2|COMPLETED|Overall Study||1
1512793|NCT01566630|3702122|P1|COMPLETED|Overall Study||2
1512794|NCT01566630|3702121|P2|STARTED|Overall Study||1
1512795|NCT01566630|3702122|P1|STARTED|Overall Study||2
1512796|NCT01566604|3702178|P2|NOT COMPLETED|Overall Study||11
1512797|NCT01566604|3702179|P1|NOT COMPLETED|Overall Study||24
1512798|NCT01566604|3702178|P2|COMPLETED|Overall Study||143
1512799|NCT01566604|3702179|P1|COMPLETED|Overall Study||282
1512800|NCT01566604|3702178|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
1512801|NCT01566604|3702179|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
1512802|NCT01566604|3702178|P2|Full Analysis Set (FAS)|Overall Study||154
1512803|NCT01566604|3702179|P1|Full Analysis Set (FAS)|Overall Study||305
1512804|NCT01566604|3702178|P2|Safety Set|Overall Study||154
1512805|NCT01566604|3702179|P1|Safety Set|Overall Study||305
1512806|NCT01566604|3702178|P2|STARTED|Overall Study||154
1512807|NCT01566604|3702179|P1|STARTED|Overall Study||306
1512808|NCT01566539|3702213|P9|NOT COMPLETED|Within Subject Group||0
1512809|NCT01566539|3702214|P8|NOT COMPLETED|Within Subject Group||0
1512810|NCT01566539|3702215|P7|NOT COMPLETED|Within Subject Group||0
1512811|NCT01566539|3702216|P6|NOT COMPLETED|Within Subject Group||0
1512812|NCT01566539|3702217|P5|NOT COMPLETED|Within Subject Group||0
1512813|NCT01566539|3702218|P4|NOT COMPLETED|Within Subject Group||3
1512814|NCT01566539|3702219|P3|NOT COMPLETED|Within Subject Group||0
1512815|NCT01566539|3702220|P2|NOT COMPLETED|Within Subject Group||0
1512816|NCT01566539|3702221|P1|NOT COMPLETED|Within Subject Group||0
1512817|NCT01566539|3702213|P9|COMPLETED|Within Subject Group||0
1512818|NCT01566539|3702214|P8|COMPLETED|Within Subject Group||0
1512819|NCT01566539|3702215|P7|COMPLETED|Within Subject Group||0
1512820|NCT01566539|3702216|P6|COMPLETED|Within Subject Group||0
1512821|NCT01566539|3702217|P5|COMPLETED|Within Subject Group||0
1512822|NCT01566539|3702218|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
1512823|NCT01566539|3702219|P3|COMPLETED|Within Subject Group||0
1512824|NCT01566539|3702220|P2|COMPLETED|Within Subject Group||0
1512825|NCT01566539|3702221|P1|COMPLETED|Within Subject Group||0
1512826|NCT01566539|3702213|P9|STARTED|Within Subject Group||0
1512827|NCT01566539|3702214|P8|STARTED|Within Subject Group||0
1512828|NCT01566539|3702215|P7|STARTED|Within Subject Group||0
1512829|NCT01566539|3702216|P6|STARTED|Within Subject Group||0
1512830|NCT01566539|3702217|P5|STARTED|Within Subject Group||0
1512831|NCT01566539|3702218|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
1512832|NCT01566539|3702219|P3|STARTED|Within Subject Group||0
1512833|NCT01566539|3702220|P2|STARTED|Within Subject Group||0
1512834|NCT01566539|3702221|P1|STARTED|Within Subject Group||0
1512835|NCT01566539|3702213|P9|NOT COMPLETED|Main Study Period||0
1512836|NCT01566539|3702214|P8|NOT COMPLETED|Main Study Period||0
1512837|NCT01566539|3702215|P7|NOT COMPLETED|Main Study Period||0
1512838|NCT01566539|3702216|P6|NOT COMPLETED|Main Study Period||3
1512839|NCT01566539|3702217|P5|NOT COMPLETED|Main Study Period||0
1512840|NCT01566539|3702218|P4|NOT COMPLETED|Main Study Period||0
1512841|NCT01566539|3702219|P3|NOT COMPLETED|Main Study Period||0
1512842|NCT01566539|3702220|P2|NOT COMPLETED|Main Study Period||0
1512843|NCT01566539|3702221|P1|NOT COMPLETED|Main Study Period||1
1512844|NCT01566539|3702213|P9|COMPLETED|Main Study Period||1
1512845|NCT01566539|3702214|P8|COMPLETED|Main Study Period||30
1512846|NCT01566539|3702215|P7|COMPLETED|Main Study Period||30
1512847|NCT01566539|3702216|P6|COMPLETED|Main Study Period||40
1512848|NCT01566539|3702217|P5|COMPLETED|Main Study Period||40
1512849|NCT01566539|3702218|P4|COMPLETED|Main Study Period||0
1512850|NCT01566539|3702219|P3|COMPLETED|Main Study Period||104
1512851|NCT01566539|3702220|P2|COMPLETED|Main Study Period||100
1512852|NCT01566539|3702221|P1|COMPLETED|Main Study Period||100
1512853|NCT01566539|3702213|P9|STARTED|Main Study Period||1
1512854|NCT01566539|3702214|P8|STARTED|Main Study Period||30
1512855|NCT01566539|3702215|P7|STARTED|Main Study Period||30
1512856|NCT01566539|3702216|P6|STARTED|Main Study Period||43
1512857|NCT01566539|3702217|P5|STARTED|Main Study Period||40
1512858|NCT01566539|3702218|P4|STARTED|Main Study Period||0
1512859|NCT01566539|3702219|P3|STARTED|Main Study Period||104
1512860|NCT01566539|3702220|P2|STARTED|Main Study Period||100
1512861|NCT01566539|3702221|P1|STARTED|Main Study Period||101
1512862|NCT01566526|3702274|P1|NOT COMPLETED|Overall Study||0
1512863|NCT01566526|3702274|P1|COMPLETED|Overall Study||26
1512864|NCT01566526|3702274|P1|STARTED|Overall Study||26
1512865|NCT01566500|3702284|P1|NOT COMPLETED|Overall Study||0
1512866|NCT01566500|3702284|P1|COMPLETED|Overall Study||140
1512867|NCT01566500|3702284|P1|STARTED|Overall Study||140
1512868|NCT01566461|3702290|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
1512869|NCT01566461|3702291|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
1512870|NCT01566461|3702290|P2|COMPLETED|IN.PACT SFA II Phase||55
1512871|NCT01566461|3702291|P1|COMPLETED|IN.PACT SFA II Phase||109
1512872|NCT01566461|3702290|P2|STARTED|IN.PACT SFA II Phase||60
1512873|NCT01566461|3702291|P1|STARTED|IN.PACT SFA II Phase||121
1512874|NCT01566461|3702290|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
1512875|NCT01566461|3702291|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
1512876|NCT01566461|3702290|P2|COMPLETED|IN.PACT SFA I Phase||49
1512877|NCT01566461|3702291|P1|COMPLETED|IN.PACT SFA I Phase||88
1512878|NCT01566461|3702290|P2|STARTED|IN.PACT SFA I Phase||51
1512879|NCT01566461|3702291|P1|STARTED|IN.PACT SFA I Phase||99
1512880|NCT01566435|3702335|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
1512881|NCT01566435|3702335|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
1512882|NCT01566435|3702335|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
1512883|NCT01566435|3702335|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
1512884|NCT01566435|3702335|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
1512885|NCT01566435|3702335|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
1512886|NCT01566435|3702335|P1|NOT COMPLETED|ACF Induction Therapy||0
1512887|NCT01566435|3702335|P1|COMPLETED|ACF Induction Therapy||30
1512888|NCT01566435|3702335|P1|STARTED|ACF Induction Therapy||30
1512889|NCT01566409|3702351|P2|NOT COMPLETED|Overall Study||5
1512890|NCT01566409|3702352|P1|NOT COMPLETED|Overall Study||2
1512891|NCT01566409|3702351|P2|COMPLETED|Overall Study||48
1512892|NCT01566409|3702352|P1|COMPLETED|Overall Study||47
1512893|NCT01566409|3702351|P2|STARTED|Overall Study||53
1512894|NCT01566409|3702352|P1|STARTED|Overall Study||49
1512895|NCT01566370|3702360|P2|NOT COMPLETED|Overall Study||1
1512896|NCT01566370|3702361|P1|NOT COMPLETED|Overall Study||2
1512897|NCT01566370|3702360|P2|COMPLETED|Overall Study||0
1512898|NCT01566370|3702361|P1|COMPLETED|Overall Study||0
1512899|NCT01566370|3702360|P2|STARTED|Overall Study||1
1512900|NCT01566370|3702361|P1|STARTED|Overall Study||2
1512901|NCT01566331|3702387|P2|NOT COMPLETED|Overall Study||0
1512902|NCT01566331|3702388|P1|NOT COMPLETED|Overall Study||0
1512903|NCT01566331|3702387|P2|COMPLETED|Overall Study||40
1512904|NCT01566331|3702388|P1|COMPLETED|Overall Study||40
1512905|NCT01566331|3702387|P2|STARTED|Overall Study||40
1512906|NCT01566331|3702388|P1|STARTED|Overall Study||40
1512907|NCT01566214|3702396|P2|NOT COMPLETED|Overall Study||0
1512908|NCT01566214|3702397|P1|NOT COMPLETED|Overall Study||3
1512909|NCT01566214|3702396|P2|COMPLETED|Overall Study||6
1512910|NCT01566214|3702397|P1|COMPLETED|Overall Study||3
1512911|NCT01566214|3702396|P2|STARTED|Overall Study||6
1512912|NCT01566214|3702397|P1|STARTED|Overall Study||6
1512913|NCT01566162|3702427|P1|NOT COMPLETED|Overall Study||36
1512914|NCT01566162|3702427|P1|COMPLETED|Overall Study||155
1512915|NCT01566162|3702427|P1|STARTED|Overall Study||191
1512916|NCT01566149|3702441|P2|NOT COMPLETED|Overall Study||2
1512917|NCT01566149|3702442|P1|NOT COMPLETED|Overall Study||3
1512918|NCT01566149|3702441|P2|COMPLETED|Overall Study||23
1512919|NCT01566149|3702442|P1|COMPLETED|Overall Study||21
1512920|NCT01566149|3702441|P2|STARTED|Overall Study||25
1512921|NCT01566149|3702442|P1|STARTED|Overall Study||24
1512922|NCT01566084|3702458|P2|NOT COMPLETED|Overall Study||0
1512923|NCT01566084|3702459|P1|NOT COMPLETED|Overall Study||0
1512924|NCT01566084|3702458|P2|COMPLETED|Overall Study||10
1512925|NCT01566084|3702459|P1|COMPLETED|Overall Study||7
1512926|NCT01566084|3702458|P2|STARTED|Overall Study||10
1512927|NCT01566084|3702459|P1|STARTED|Overall Study||7
1512928|NCT01565993|3702475|P2|NOT COMPLETED|Overall Study||3
1512929|NCT01565993|3702476|P1|NOT COMPLETED|Overall Study||0
1512930|NCT01565993|3702475|P2|COMPLETED|Overall Study||39
1512931|NCT01565993|3702476|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
1512932|NCT01565993|3702475|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
1512933|NCT01565993|3702476|P1|STARTED|Overall Study||66
1512934|NCT01565980|3702484|P2|NOT COMPLETED|Overall Study||4
1512935|NCT01565980|3702485|P1|NOT COMPLETED|Overall Study||4
1512936|NCT01565980|3702484|P2|COMPLETED|Overall Study||16
1512937|NCT01565980|3702485|P1|COMPLETED|Overall Study||16
1512938|NCT01565980|3702484|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
1512939|NCT01565980|3702485|P1|STARTED|Overall Study||20
1512940|NCT01565941|3702505|P2|NOT COMPLETED|Overall Study||4
1512941|NCT01565941|3702506|P1|NOT COMPLETED|Overall Study||11
1512942|NCT01565941|3702505|P2|COMPLETED|Overall Study||349
1512943|NCT01565941|3702506|P1|COMPLETED|Overall Study||349
1512944|NCT01565941|3702505|P2|STARTED|Overall Study||353
1512945|NCT01565941|3702506|P1|STARTED|Overall Study||360
1512946|NCT01565902|3702548|P4|NOT COMPLETED|Overall Study||0
1512947|NCT01565902|3702549|P3|NOT COMPLETED|Overall Study||0
1512948|NCT01565902|3702550|P2|NOT COMPLETED|Overall Study||0
1512949|NCT01565902|3702551|P1|NOT COMPLETED|Overall Study||0
1512950|NCT01565902|3702548|P4|COMPLETED|Overall Study||16
1512951|NCT01565902|3702549|P3|COMPLETED|Overall Study||8
1512952|NCT01565902|3702550|P2|COMPLETED|Overall Study||8
1512953|NCT01565902|3702551|P1|COMPLETED|Overall Study||8
1512954|NCT01565902|3702548|P4|STARTED|Overall Study||16
1512955|NCT01565902|3702549|P3|STARTED|Overall Study||8
1512956|NCT01565902|3702550|P2|STARTED|Overall Study||8
1512957|NCT01565902|3702551|P1|STARTED|Overall Study||8
1512958|NCT01565889|3702585|P6|NOT COMPLETED|Part B||4
1512959|NCT01565889|3702586|P5|NOT COMPLETED|Part B||0
1512960|NCT01565889|3702587|P4|NOT COMPLETED|Part B||0
1512961|NCT01565889|3702588|P3|NOT COMPLETED|Part B||0
1512962|NCT01565889|3702589|P2|NOT COMPLETED|Part B||0
1512963|NCT01565889|3702590|P1|NOT COMPLETED|Part B||0
1512964|NCT01565889|3702585|P6|COMPLETED|Part B||19
1512965|NCT01565889|3702586|P5|COMPLETED|Part B||0
1512966|NCT01565889|3702587|P4|COMPLETED|Part B||0
1512967|NCT01565889|3702588|P3|COMPLETED|Part B||0
1512968|NCT01565889|3702589|P2|COMPLETED|Part B||0
1512969|NCT01565889|3702590|P1|COMPLETED|Part B||0
1512970|NCT01565889|3702585|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
1512971|NCT01565889|3702586|P5|STARTED|Part B||0
1512972|NCT01565889|3702587|P4|STARTED|Part B||0
1512973|NCT01565889|3702588|P3|STARTED|Part B||0
1512974|NCT01565889|3702589|P2|STARTED|Part B||0
1512975|NCT01565889|3702590|P1|STARTED|Part B||0
1512976|NCT01565889|3702585|P6|NOT COMPLETED|Part A||0
1512977|NCT01565889|3702586|P5|NOT COMPLETED|Part A||0
1512978|NCT01565889|3702587|P4|NOT COMPLETED|Part A||0
1512979|NCT01565889|3702588|P3|NOT COMPLETED|Part A||0
1512980|NCT01565889|3702589|P2|NOT COMPLETED|Part A||0
1512981|NCT01565889|3702590|P1|NOT COMPLETED|Part A||1
1512982|NCT01565889|3702585|P6|COMPLETED|Part A||0
1512983|NCT01565889|3702586|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
1512984|NCT01565889|3702587|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
1512985|NCT01565889|3702588|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
1512986|NCT01565889|3702589|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
1512987|NCT01565889|3702590|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
1512988|NCT01565889|3702585|P6|STARTED|Part A||0
1512989|NCT01565889|3702586|P5|STARTED|Part A||7
1512990|NCT01565889|3702587|P4|STARTED|Part A||7
1512991|NCT01565889|3702588|P3|STARTED|Part A||8
1512992|NCT01565889|3702589|P2|STARTED|Part A||4
1512993|NCT01565889|3702590|P1|STARTED|Part A||12
1512994|NCT01565850|3702621|P2|NOT COMPLETED|Overall Study||8
1512995|NCT01565850|3702622|P1|NOT COMPLETED|Overall Study||20
1512996|NCT01565850|3702621|P2|COMPLETED|Overall Study||42
1512997|NCT01565850|3702622|P1|COMPLETED|Overall Study||83
1512998|NCT01565850|3702621|P2|STARTED|Overall Study||50
1512999|NCT01565850|3702622|P1|STARTED|Overall Study||103
1513000|NCT01565707|3702642|P4|NOT COMPLETED|Overall Study||5
1513001|NCT01565707|3702643|P3|NOT COMPLETED|Overall Study||3
1513002|NCT01565707|3702644|P2|NOT COMPLETED|Overall Study||8
1513003|NCT01565707|3702645|P1|NOT COMPLETED|Overall Study||9
1513004|NCT01565707|3702642|P4|COMPLETED|Overall Study||17
1513005|NCT01565707|3702643|P3|COMPLETED|Overall Study||16
1513006|NCT01565707|3702644|P2|COMPLETED|Overall Study||65
1513007|NCT01565707|3702645|P1|COMPLETED|Overall Study||66
1513008|NCT01565707|3702642|P4|Treated|Overall Study||22
1513009|NCT01565707|3702643|P3|Treated|Overall Study||19
1513010|NCT01565707|3702644|P2|Treated|Overall Study||73
1513011|NCT01565707|3702645|P1|Treated|Overall Study||73
1513012|NCT01565707|3702642|P4|STARTED|Overall Study||22
1513013|NCT01565707|3702643|P3|STARTED|Overall Study||19
1513014|NCT01565707|3702644|P2|STARTED|Overall Study||73
1513015|NCT01565707|3702645|P1|STARTED|Overall Study||75
1513016|NCT01565642|3702738|P2|NOT COMPLETED|Overall Study||1
1513017|NCT01565642|3702739|P1|NOT COMPLETED|Overall Study||2
1513018|NCT01565642|3702738|P2|COMPLETED|Overall Study||150
1513019|NCT01565642|3702739|P1|COMPLETED|Overall Study||149
1513020|NCT01565642|3702738|P2|STARTED|Overall Study||151
1513021|NCT01565642|3702739|P1|STARTED|Overall Study||151
1513022|NCT01565616|3702761|P1|NOT COMPLETED|Overall Study||0
1513023|NCT01565616|3702761|P1|COMPLETED|Overall Study||22
1513024|NCT01565616|3702761|P1|Second Component: Related or Unrelated|Overall Study||17
1513025|NCT01565616|3702761|P1|First Component: 5 Related Donors|Overall Study||5
1513026|NCT01565616|3702761|P1|STARTED|Overall Study||22
1513027|NCT01565564|3702774|P2|NOT COMPLETED|Overall Study||1
1513028|NCT01565564|3702775|P1|NOT COMPLETED|Overall Study||5
1513029|NCT01565564|3702774|P2|COMPLETED|Overall Study||361
1513030|NCT01565564|3702775|P1|COMPLETED|Overall Study||339
1513031|NCT01565564|3702774|P2|STARTED|Overall Study||362
1513032|NCT01565564|3702775|P1|STARTED|Overall Study||344
1513033|NCT01565551|3702785|P2|NOT COMPLETED|Overall Study||0
1513034|NCT01565551|3702786|P1|NOT COMPLETED|Overall Study||0
1513035|NCT01565551|3702785|P2|COMPLETED|Overall Study||51
1513036|NCT01565551|3702786|P1|COMPLETED|Overall Study||586
1513037|NCT01565551|3702785|P2|6-Month Outcomes|Overall Study||30
1513038|NCT01565551|3702786|P1|6-Month Outcomes|Overall Study||412
1513039|NCT01565551|3702785|P2|Neuroimaging|Overall Study||25
1513040|NCT01565551|3702786|P1|Neuroimaging|Overall Study||233
1513041|NCT01565551|3702785|P2|Biospecimens/Biomarkers|Overall Study||22
1513042|NCT01565551|3702786|P1|Biospecimens/Biomarkers|Overall Study||479
1513043|NCT01565551|3702785|P2|Clinical/Demographics|Overall Study||51
1513044|NCT01565551|3702786|P1|Clinical/Demographics|Overall Study||586
1513045|NCT01565551|3702785|P2|STARTED|Overall Study||51
1513046|NCT01565551|3702786|P1|STARTED|Overall Study||586
1513047|NCT01565538|3702794|P2|NOT COMPLETED|Overall Study||0
1513048|NCT01565538|3702795|P1|NOT COMPLETED|Overall Study||0
1513049|NCT01565538|3702794|P2|COMPLETED|Overall Study||62
1513050|NCT01565538|3702795|P1|COMPLETED|Overall Study||61
1513051|NCT01565538|3702794|P2|STARTED|Overall Study||62
1513052|NCT01565538|3702795|P1|STARTED|Overall Study||61
1513053|NCT01565382|3702805|P2|NOT COMPLETED|Overall Study||0
1513054|NCT01565382|3702806|P1|NOT COMPLETED|Overall Study||0
1513055|NCT01565382|3702805|P2|COMPLETED|Overall Study||7
1513056|NCT01565382|3702806|P1|COMPLETED|Overall Study||40
1513057|NCT01565382|3702805|P2|STARTED|Overall Study||7
1513058|NCT01565382|3702806|P1|STARTED|Overall Study||40
1513059|NCT01565369|3702811|P1|NOT COMPLETED|Overall Study||0
1513060|NCT01565369|3702811|P1|COMPLETED|Overall Study||35
1513061|NCT01565369|3702811|P1|STARTED|Overall Study||35
1513062|NCT01565356|3702817|P1|NOT COMPLETED|Overall Study||0
1513063|NCT01565356|3702817|P1|COMPLETED|Overall Study||41
1513064|NCT01565356|3702817|P1|STARTED|Overall Study||41
1513065|NCT01565343|3702825|P3|NOT COMPLETED|Overall Study||0
1513066|NCT01565343|3702826|P2|NOT COMPLETED|Overall Study||0
1513067|NCT01565343|3702827|P1|NOT COMPLETED|Overall Study||1
1513068|NCT01565343|3702825|P3|COMPLETED|Overall Study||10
1513069|NCT01565343|3702826|P2|COMPLETED|Overall Study||4
1513070|NCT01565343|3702827|P1|COMPLETED|Overall Study||10
1513071|NCT01565343|3702825|P3|STARTED|Overall Study||10
1513072|NCT01565343|3702826|P2|STARTED|Overall Study||4
1513073|NCT01565343|3702827|P1|STARTED|Overall Study||11
1513074|NCT01565330|3702838|P4|NOT COMPLETED|Overall Study||0
1513075|NCT01565330|3702839|P3|NOT COMPLETED|Overall Study||0
1513076|NCT01565330|3702840|P2|NOT COMPLETED|Overall Study||0
1513077|NCT01565330|3702841|P1|NOT COMPLETED|Overall Study||0
1513078|NCT01565330|3702838|P4|COMPLETED|Overall Study||7
1513079|NCT01565330|3702839|P3|COMPLETED|Overall Study||4
1513080|NCT01565330|3702840|P2|COMPLETED|Overall Study||4
1513081|NCT01565330|3702841|P1|COMPLETED|Overall Study||5
1513082|NCT01565330|3702838|P4|STARTED|Overall Study||7
1513083|NCT01565330|3702839|P3|STARTED|Overall Study||4
1513084|NCT01565330|3702840|P2|STARTED|Overall Study||4
1513085|NCT01565330|3702841|P1|STARTED|Overall Study||5
1513086|NCT01565291|3702857|P2|NOT COMPLETED|Overall Study||0
1513087|NCT01565291|3702858|P1|NOT COMPLETED|Overall Study||1
1513088|NCT01565291|3702857|P2|COMPLETED|Overall Study||16
1513089|NCT01565291|3702858|P1|COMPLETED|Overall Study||15
1513090|NCT01565291|3702857|P2|STARTED|Overall Study||16
1513091|NCT01565291|3702858|P1|STARTED|Overall Study||16
1513092|NCT01565148|3702870|P4|NOT COMPLETED|Overall Study||13
1513093|NCT01565148|3702871|P3|NOT COMPLETED|Overall Study||7
1513094|NCT01565148|3702872|P2|NOT COMPLETED|Overall Study||15
1513095|NCT01565148|3702873|P1|NOT COMPLETED|Overall Study||15
1513096|NCT01565148|3702870|P4|COMPLETED|Overall Study||32
1513097|NCT01565148|3702871|P3|COMPLETED|Overall Study||40
1513098|NCT01565148|3702872|P2|COMPLETED|Overall Study||31
1513099|NCT01565148|3702873|P1|COMPLETED|Overall Study||32
1513100|NCT01565148|3702870|P4|STARTED|Overall Study||45
1513101|NCT01565148|3702871|P3|STARTED|Overall Study||47
1513102|NCT01565148|3702872|P2|STARTED|Overall Study||46
1513103|NCT01565148|3702873|P1|STARTED|Overall Study||47
1513104|NCT01565083|3702909|P2|NOT COMPLETED|Overall Study||39
1513105|NCT01565083|3702910|P1|NOT COMPLETED|Overall Study||33
1513106|NCT01565083|3702909|P2|COMPLETED|Overall Study||68
1513107|NCT01565083|3702910|P1|COMPLETED|Overall Study||73
1513108|NCT01565083|3702909|P2|STARTED|Overall Study||107
1513109|NCT01565083|3702910|P1|STARTED|Overall Study||106
1513110|NCT01564953|3702936|P1|NOT COMPLETED|Overall Study||0
1513111|NCT01564953|3702936|P1|COMPLETED|Overall Study||143
1513112|NCT01564953|3702936|P1|STARTED|Overall Study||143
1513113|NCT01564862|3702947|P3|NOT COMPLETED|Overall Study||30
1513114|NCT01564862|3702948|P2|NOT COMPLETED|Overall Study||34
1513115|NCT01564862|3702949|P1|NOT COMPLETED|Overall Study||30
1513116|NCT01564862|3702947|P3|COMPLETED|Overall Study||164
1513117|NCT01564862|3702948|P2|COMPLETED|Overall Study||176
1513118|NCT01564862|3702949|P1|COMPLETED|Overall Study||168
1513119|NCT01564862|3702947|P3|Received Treatment|Overall Study||191
1513120|NCT01564862|3702948|P2|Received Treatment|Overall Study||207
1513121|NCT01564862|3702949|P1|Received Treatment|Overall Study||196
1513122|NCT01564862|3702947|P3|STARTED|Overall Study||194
1513123|NCT01564862|3702948|P2|STARTED|Overall Study||210
1513124|NCT01564862|3702949|P1|STARTED|Overall Study||198
1513125|NCT01564784|3703000|P2|NOT COMPLETED|Overall Study||133
1513126|NCT01564784|3703001|P1|NOT COMPLETED|Overall Study||134
1513127|NCT01564784|3703000|P2|COMPLETED|Overall Study||10
1513128|NCT01564784|3703001|P1|COMPLETED|Overall Study||30
1513129|NCT01564784|3703000|P2|STARTED|Overall Study|Treated (162 randomized)|143
1513130|NCT01564784|3703001|P1|STARTED|Overall Study|Treated (164 randomized)|164
1513131|NCT01564758|3703028|P1|NOT COMPLETED|Overall Study||14
1513132|NCT01564758|3703028|P1|COMPLETED|Overall Study||85
1513133|NCT01564758|3703028|P1|STARTED|Overall Study||99
1513134|NCT01564732|3703035|P2|NOT COMPLETED|Overall Study||5
1513135|NCT01564732|3703036|P1|NOT COMPLETED|Overall Study||6
1513136|NCT01564732|3703035|P2|COMPLETED|Overall Study||0
1513137|NCT01564732|3703036|P1|COMPLETED|Overall Study||0
1513138|NCT01564732|3703035|P2|STARTED|Overall Study||5
1513139|NCT01564732|3703036|P1|STARTED|Overall Study||6
1513140|NCT01564706|3703052|P1|NOT COMPLETED|Overall Study||0
1513141|NCT01564706|3703052|P1|COMPLETED|Overall Study||9
1513142|NCT01564706|3703052|P1|STARTED|Overall Study||9
1513143|NCT01564693|3703059|P3|NOT COMPLETED|Overall Study||0
1513144|NCT01564693|3703060|P2|NOT COMPLETED|Overall Study||0
1513145|NCT01564693|3703061|P1|NOT COMPLETED|Overall Study||0
1513146|NCT01564693|3703059|P3|COMPLETED|Overall Study||2
1513147|NCT01564693|3703060|P2|COMPLETED|Overall Study||4
1513148|NCT01564693|3703061|P1|COMPLETED|Overall Study||9
1513149|NCT01564693|3703059|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
1513150|NCT01564693|3703060|P2|STARTED|Overall Study||4
1513151|NCT01564693|3703061|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
1513152|NCT01564537|3703071|P2|NOT COMPLETED|Overall Study||6
1513153|NCT01564537|3703072|P1|NOT COMPLETED|Overall Study||6
1513154|NCT01564537|3703071|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
1513155|NCT01564537|3703072|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
1513156|NCT01564537|3703071|P2|Safety Population: Received Study Drug|Overall Study||360
1513157|NCT01564537|3703072|P1|Safety Population: Received Study Drug|Overall Study||360
1513158|NCT01564537|3703071|P2|STARTED|Overall Study||362
1513159|NCT01564537|3703072|P1|STARTED|Overall Study||360
1513160|NCT01564459|3703095|P3|NOT COMPLETED|Double-blind Treatment||1
1513161|NCT01564459|3703096|P2|NOT COMPLETED|Double-blind Treatment||0
1513162|NCT01564459|3703097|P1|NOT COMPLETED|Double-blind Treatment||0
1513163|NCT01564459|3703095|P3|COMPLETED|Double-blind Treatment||82
1513164|NCT01564459|3703096|P2|COMPLETED|Double-blind Treatment||87
1513165|NCT01564459|3703097|P1|COMPLETED|Double-blind Treatment||0
1513166|NCT01564459|3703095|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
1513167|NCT01564459|3703096|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
1513168|NCT01564459|3703097|P1|STARTED|Double-blind Treatment||0
1513169|NCT01564459|3703095|P3|NOT COMPLETED|Run-In||0
1513170|NCT01564459|3703096|P2|NOT COMPLETED|Run-In||0
1513171|NCT01564459|3703097|P1|NOT COMPLETED|Run-In||12
1513172|NCT01564459|3703095|P3|COMPLETED|Run-In||83
1513173|NCT01564459|3703096|P2|COMPLETED|Run-In||87
1513174|NCT01564459|3703097|P1|COMPLETED|Run-In||0
1513175|NCT01564459|3703095|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
1513176|NCT01564459|3703096|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
1513177|NCT01564459|3703097|P1|STARTED|Run-In||12
1513178|NCT01564407|3703121|P5|NOT COMPLETED|Overall Study||0
1513179|NCT01564407|3703122|P4|NOT COMPLETED|Overall Study||1
1513180|NCT01564407|3703123|P3|NOT COMPLETED|Overall Study||0
1513181|NCT01564407|3703124|P2|NOT COMPLETED|Overall Study||2
1513182|NCT01564407|3703125|P1|NOT COMPLETED|Overall Study||0
1513183|NCT01564407|3703121|P5|COMPLETED|Overall Study||0
1513184|NCT01564407|3703122|P4|COMPLETED|Overall Study||1
1513185|NCT01564407|3703123|P3|COMPLETED|Overall Study||4
1513186|NCT01564407|3703124|P2|COMPLETED|Overall Study||3
1513187|NCT01564407|3703125|P1|COMPLETED|Overall Study||4
1513188|NCT01564407|3703121|P5|STARTED|Overall Study||0
1513189|NCT01564407|3703122|P4|STARTED|Overall Study||2
1513190|NCT01564407|3703123|P3|STARTED|Overall Study||4
1513191|NCT01564407|3703124|P2|STARTED|Overall Study||5
1513192|NCT01564407|3703125|P1|STARTED|Overall Study||4
1513193|NCT01564394|3703166|P2|NOT COMPLETED|Overall Study||10
1513194|NCT01564394|3703167|P1|NOT COMPLETED|Overall Study||6
1513195|NCT01564394|3703166|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
1513196|NCT01564394|3703167|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
1513197|NCT01564394|3703166|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
1513198|NCT01564394|3703167|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
1513199|NCT01564277|3703181|P2|NOT COMPLETED|Overall Study||1
1513200|NCT01564277|3703182|P1|NOT COMPLETED|Overall Study||1
1513201|NCT01564277|3703181|P2|COMPLETED|Overall Study||11
1513202|NCT01564277|3703182|P1|COMPLETED|Overall Study||11
1513203|NCT01564277|3703181|P2|STARTED|Overall Study||12
1513204|NCT01564277|3703182|P1|STARTED|Overall Study||12
1513205|NCT01563978|3703200|P2|NOT COMPLETED|Overall Study||2
1513206|NCT01563978|3703201|P1|NOT COMPLETED|Overall Study||4
1513207|NCT01563978|3703200|P2|COMPLETED|Overall Study||65
1513208|NCT01563978|3703201|P1|COMPLETED|Overall Study||64
1513209|NCT01563978|3703200|P2|Randomised But Did Not Receive Treatment|Overall Study||0
1513210|NCT01563978|3703201|P1|Randomised But Did Not Receive Treatment|Overall Study||0
1513211|NCT01563978|3703200|P2|STARTED|Overall Study|Patients who received treatment.|67
1513212|NCT01563978|3703201|P1|STARTED|Overall Study|Patients who received treatment.|68
1513213|NCT01563913|3703227|P2|NOT COMPLETED|Overall Study||0
1513214|NCT01563913|3703228|P1|NOT COMPLETED|Overall Study||2
1513215|NCT01563913|3703227|P2|COMPLETED|Overall Study||15
1513216|NCT01563913|3703228|P1|COMPLETED|Overall Study||13
1513217|NCT01563913|3703227|P2|STARTED|Overall Study||15
1513218|NCT01563913|3703228|P1|STARTED|Overall Study||15
1513219|NCT01563536|3703240|P2|NOT COMPLETED|Overall Study||2
1513220|NCT01563536|3703241|P1|NOT COMPLETED|Overall Study||1
1513221|NCT01563536|3703240|P2|COMPLETED|Overall Study||4
1513222|NCT01563536|3703241|P1|COMPLETED|Overall Study||5
1513223|NCT01563536|3703240|P2|STARTED|Overall Study||6
1513224|NCT01563536|3703241|P1|STARTED|Overall Study||6
1513225|NCT01563406|3703273|P4|NOT COMPLETED|Overall Study||0
1513226|NCT01563406|3703274|P3|NOT COMPLETED|Overall Study||0
1513227|NCT01563406|3703275|P2|NOT COMPLETED|Overall Study||0
1513228|NCT01563406|3703276|P1|NOT COMPLETED|Overall Study||0
1513229|NCT01563406|3703273|P4|COMPLETED|Overall Study|112 hubs|29
1513230|NCT01563406|3703274|P3|COMPLETED|Overall Study|101 hubs|30
1513231|NCT01563406|3703275|P2|COMPLETED|Overall Study|102 hubs|30
1513232|NCT01563406|3703276|P1|COMPLETED|Overall Study|194 hubs|60
1513233|NCT01563406|3703273|P4|STARTED|Overall Study|112 hubs|29
1513234|NCT01563406|3703274|P3|STARTED|Overall Study|101 hubs|30
1513235|NCT01563406|3703275|P2|STARTED|Overall Study|102 hubs|30
1513236|NCT01563406|3703276|P1|STARTED|Overall Study|194 hubs|60
1513237|NCT01563198|3703294|P1|NOT COMPLETED|After Training||0
1513238|NCT01563198|3703294|P1|COMPLETED|After Training||47979
1513239|NCT01563198|3703294|P1|STARTED|After Training||47979
1513240|NCT01563198|3703294|P1|NOT COMPLETED|Baseline||0
1513241|NCT01563198|3703294|P1|COMPLETED|Baseline||49733
1513242|NCT01563198|3703294|P1|STARTED|Baseline||49733
1513243|NCT01563185|3703300|P1|NOT COMPLETED|Overall Study||2
1513244|NCT01563185|3703300|P1|COMPLETED|Overall Study||10
1513245|NCT01563185|3703300|P1|STARTED|Overall Study||12
1513246|NCT01563172|3703314|P1|NOT COMPLETED|Overall Study||13
1513247|NCT01563172|3703314|P1|COMPLETED|Overall Study||52
1513248|NCT01563172|3703314|P1|Control Dentifrice|Overall Study||60
1513249|NCT01563172|3703314|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
1513250|NCT01563172|3703314|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
1513251|NCT01563172|3703314|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
1513252|NCT01563172|3703314|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
1513253|NCT01563172|3703314|P1|STARTED|Overall Study||65
1513254|NCT01563081|3703343|P2|NOT COMPLETED|Overall Study||0
1513255|NCT01563081|3703344|P1|NOT COMPLETED|Overall Study||0
1513256|NCT01563081|3703343|P2|COMPLETED|Overall Study||30
1513257|NCT01563081|3703344|P1|COMPLETED|Overall Study||30
1513258|NCT01563081|3703343|P2|STARTED|Overall Study||30
1513259|NCT01563081|3703344|P1|STARTED|Overall Study||30
1513260|NCT01563055|3703357|P1|NOT COMPLETED|Overall Study||0
1513261|NCT01563055|3703357|P1|COMPLETED|Overall Study||10
1513262|NCT01563055|3703357|P1|STARTED|Overall Study||10
1513263|NCT01563029|3703420|P5|NOT COMPLETED|Overall Study||29
1513264|NCT01563029|3703421|P4|NOT COMPLETED|Overall Study||33
1513265|NCT01563029|3703422|P3|NOT COMPLETED|Overall Study||33
1513266|NCT01563029|3703423|P2|NOT COMPLETED|Overall Study||24
1513267|NCT01563029|3703424|P1|NOT COMPLETED|Overall Study||53
1513268|NCT01563029|3703420|P5|COMPLETED|Overall Study||89
1513269|NCT01563029|3703421|P4|COMPLETED|Overall Study||85
1513270|NCT01563029|3703422|P3|COMPLETED|Overall Study||87
1513271|NCT01563029|3703423|P2|COMPLETED|Overall Study||94
1513272|NCT01563029|3703424|P1|COMPLETED|Overall Study||66
1513273|NCT01563029|3703420|P5|STARTED|Overall Study||118
1513274|NCT01563029|3703421|P4|STARTED|Overall Study||118
1513275|NCT01563029|3703422|P3|STARTED|Overall Study||120
1513276|NCT01563029|3703423|P2|STARTED|Overall Study||118
1513277|NCT01563029|3703424|P1|STARTED|Overall Study||119
1513278|NCT01563003|3703474|P2|NOT COMPLETED|Overall Study||0
1513279|NCT01563003|3703475|P1|NOT COMPLETED|Overall Study||0
1513280|NCT01563003|3703474|P2|COMPLETED|Overall Study||15
1513281|NCT01563003|3703475|P1|COMPLETED|Overall Study||16
1513282|NCT01563003|3703474|P2|STARTED|Overall Study||15
1513283|NCT01563003|3703475|P1|STARTED|Overall Study||16
1513284|NCT01562886|3703485|P1|NOT COMPLETED|Overall Study||1
1513285|NCT01562886|3703485|P1|COMPLETED|Overall Study||13
1513286|NCT01562886|3703485|P1|STARTED|Overall Study||14
1513287|NCT01562873|3703490|P2|NOT COMPLETED|Overall Study||0
1513288|NCT01562873|3703491|P1|NOT COMPLETED|Overall Study||21
1513289|NCT01562873|3703490|P2|COMPLETED|Overall Study||0
1513290|NCT01562873|3703491|P1|COMPLETED|Overall Study||0
1513291|NCT01562873|3703490|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
1513292|NCT01562873|3703491|P1|STARTED|Overall Study||21
1513293|NCT01562756|3703498|P1|NOT COMPLETED|Overall Study||0
1513294|NCT01562756|3703498|P1|COMPLETED|Overall Study||6
1513295|NCT01562756|3703498|P1|STARTED|Overall Study||6
1513296|NCT01562743|3703503|P1|NOT COMPLETED|Overall Study||52
1513297|NCT01562743|3703503|P1|COMPLETED|Overall Study||133
1513298|NCT01562743|3703503|P1|STARTED|Overall Study||185
1513299|NCT01562678|3703515|P2|NOT COMPLETED|Overall Study||2
1513300|NCT01562678|3703516|P1|NOT COMPLETED|Overall Study||6
1513301|NCT01562678|3703515|P2|COMPLETED|Overall Study||12
1513302|NCT01562678|3703516|P1|COMPLETED|Overall Study||8
1513303|NCT01562678|3703515|P2|STARTED|Overall Study||14
1513304|NCT01562678|3703516|P1|STARTED|Overall Study||14
1513305|NCT01562613|3703522|P1|NOT COMPLETED|Overall Study||4
1513306|NCT01562613|3703522|P1|COMPLETED|Overall Study||529
1513307|NCT01562613|3703522|P1|STARTED|Overall Study||533
1513308|NCT01562548|3703532|P4|NOT COMPLETED|Overall Study||0
1513309|NCT01562548|3703533|P3|NOT COMPLETED|Overall Study||1
1513310|NCT01562548|3703534|P2|NOT COMPLETED|Overall Study||0
1513311|NCT01562548|3703535|P1|NOT COMPLETED|Overall Study||0
1513312|NCT01562548|3703532|P4|COMPLETED|Overall Study||14
1513313|NCT01562548|3703533|P3|COMPLETED|Overall Study||24
1513314|NCT01562548|3703534|P2|COMPLETED|Overall Study||15
1513315|NCT01562548|3703535|P1|COMPLETED|Overall Study||25
1513316|NCT01562548|3703532|P4|STARTED|Overall Study||14
1513317|NCT01562548|3703533|P3|STARTED|Overall Study||25
1513318|NCT01562548|3703534|P2|STARTED|Overall Study||15
1513319|NCT01562548|3703535|P1|STARTED|Overall Study||25
1513320|NCT01562444|3703588|P3|NOT COMPLETED|Overall Study||7
1513321|NCT01562444|3703589|P2|NOT COMPLETED|Overall Study||2
1513322|NCT01562444|3703590|P1|NOT COMPLETED|Overall Study||5
1513323|NCT01562444|3703588|P3|COMPLETED|Overall Study||99
1513324|NCT01562444|3703589|P2|COMPLETED|Overall Study||49
1513325|NCT01562444|3703590|P1|COMPLETED|Overall Study||43
1513326|NCT01562444|3703588|P3|STARTED|Overall Study||106
1513327|NCT01562444|3703589|P2|STARTED|Overall Study||51
1513328|NCT01562444|3703590|P1|STARTED|Overall Study||48
1513329|NCT01562379|3703840|P5|NOT COMPLETED|Overall Study||40
1513330|NCT01562379|3703841|P4|NOT COMPLETED|Overall Study||57
1513331|NCT01562379|3703842|P3|NOT COMPLETED|Overall Study||62
1513332|NCT01562379|3703843|P2|NOT COMPLETED|Overall Study||97
1513333|NCT01562379|3703844|P1|NOT COMPLETED|Overall Study||126
1513334|NCT01562379|3703840|P5|COMPLETED|Overall Study||785
1513335|NCT01562379|3703841|P4|COMPLETED|Overall Study||786
1513336|NCT01562379|3703842|P3|COMPLETED|Overall Study||789
1513337|NCT01562379|3703843|P2|COMPLETED|Overall Study||1395
1513338|NCT01562379|3703844|P1|COMPLETED|Overall Study||1312
1513339|NCT01562379|3703840|P5|STARTED|Overall Study||825
1513340|NCT01562379|3703841|P4|STARTED|Overall Study||843
1513341|NCT01562379|3703842|P3|STARTED|Overall Study||851
1513342|NCT01562379|3703843|P2|STARTED|Overall Study||1492
1513343|NCT01562379|3703844|P1|STARTED|Overall Study||1438
1513344|NCT01562327|3703856|P1|NOT COMPLETED|Overall Study||8
1513345|NCT01562327|3703856|P1|COMPLETED|Overall Study||42
1513346|NCT01562327|3703856|P1|STARTED|Overall Study||50
1513347|NCT01562314|3703886|P2|NOT COMPLETED|Overall Study||8
1513348|NCT01562314|3703887|P1|NOT COMPLETED|Overall Study||13
1513349|NCT01562314|3703886|P2|COMPLETED|Overall Study||23
1513350|NCT01562314|3703887|P1|COMPLETED|Overall Study||16
1513351|NCT01562314|3703886|P2|Per Protocol (PP) Analysis Set|Overall Study||27
1513352|NCT01562314|3703887|P1|Per Protocol (PP) Analysis Set|Overall Study||17
1513353|NCT01562314|3703886|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
1513354|NCT01562314|3703887|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
1513355|NCT01562314|3703886|P2|Received at Least 1 Dose of Study Drug|Overall Study||31
1513356|NCT01562314|3703887|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
1513357|NCT01562314|3703886|P2|STARTED|Overall Study||31
1513358|NCT01562314|3703887|P1|STARTED|Overall Study||29
1513359|NCT01562275|3703944|P13|NOT COMPLETED|Stage 2||5
1513360|NCT01562275|3703945|P12|NOT COMPLETED|Stage 2||14
1513361|NCT01562275|3703946|P11|NOT COMPLETED|Stage 2||0
1513362|NCT01562275|3703947|P10|NOT COMPLETED|Stage 2||0
1513363|NCT01562275|3703948|P9|NOT COMPLETED|Stage 2||0
1513364|NCT01562275|3703949|P8|NOT COMPLETED|Stage 2||0
1513365|NCT01562275|3703950|P7|NOT COMPLETED|Stage 2||0
1513366|NCT01562275|3703951|P6|NOT COMPLETED|Stage 2||0
1513367|NCT01562275|3703952|P5|NOT COMPLETED|Stage 2||0
1513368|NCT01562275|3703953|P4|NOT COMPLETED|Stage 2||0
1513369|NCT01562275|3703954|P3|NOT COMPLETED|Stage 2||0
1513370|NCT01562275|3703955|P2|NOT COMPLETED|Stage 2||0
1513371|NCT01562275|3703956|P1|NOT COMPLETED|Stage 2||0
1513372|NCT01562275|3703944|P13|COMPLETED|Stage 2||0
1513373|NCT01562275|3703945|P12|COMPLETED|Stage 2||0
1513374|NCT01562275|3703946|P11|COMPLETED|Stage 2||0
1513375|NCT01562275|3703947|P10|COMPLETED|Stage 2||0
1513376|NCT01562275|3703948|P9|COMPLETED|Stage 2||0
1513377|NCT01562275|3703949|P8|COMPLETED|Stage 2||0
1513378|NCT01562275|3703950|P7|COMPLETED|Stage 2||0
1513379|NCT01562275|3703951|P6|COMPLETED|Stage 2||0
1513380|NCT01562275|3703952|P5|COMPLETED|Stage 2||0
1513381|NCT01562275|3703953|P4|COMPLETED|Stage 2||0
1513382|NCT01562275|3703954|P3|COMPLETED|Stage 2||0
1513383|NCT01562275|3703955|P2|COMPLETED|Stage 2||0
1513384|NCT01562275|3703956|P1|COMPLETED|Stage 2||0
1513385|NCT01562275|3703944|P13|STARTED|Stage 2||5
1513386|NCT01562275|3703945|P12|STARTED|Stage 2||14
1513387|NCT01562275|3703946|P11|STARTED|Stage 2||0
1513388|NCT01562275|3703947|P10|STARTED|Stage 2||0
1513389|NCT01562275|3703948|P9|STARTED|Stage 2||0
1513390|NCT01562275|3703949|P8|STARTED|Stage 2||0
1513391|NCT01562275|3703950|P7|STARTED|Stage 2||0
1513392|NCT01562275|3703951|P6|STARTED|Stage 2||0
1513393|NCT01562275|3703952|P5|STARTED|Stage 2||0
1513394|NCT01562275|3703953|P4|STARTED|Stage 2||0
1513395|NCT01562275|3703954|P3|STARTED|Stage 2||0
1513396|NCT01562275|3703955|P2|STARTED|Stage 2||0
1513397|NCT01562275|3703956|P1|STARTED|Stage 2||0
1513398|NCT01562275|3703944|P13|NOT COMPLETED|Stage 1||0
1513399|NCT01562275|3703945|P12|NOT COMPLETED|Stage 1||0
1513400|NCT01562275|3703946|P11|NOT COMPLETED|Stage 1||3
1513401|NCT01562275|3703947|P10|NOT COMPLETED|Stage 1||7
1513402|NCT01562275|3703948|P9|NOT COMPLETED|Stage 1||3
1513403|NCT01562275|3703949|P8|NOT COMPLETED|Stage 1||7
1513404|NCT01562275|3703950|P7|NOT COMPLETED|Stage 1||3
1513405|NCT01562275|3703951|P6|NOT COMPLETED|Stage 1||4
1513406|NCT01562275|3703952|P5|NOT COMPLETED|Stage 1||4
1513407|NCT01562275|3703953|P4|NOT COMPLETED|Stage 1||4
1513408|NCT01562275|3703954|P3|NOT COMPLETED|Stage 1||3
1513409|NCT01562275|3703955|P2|NOT COMPLETED|Stage 1||7
1513410|NCT01562275|3703956|P1|NOT COMPLETED|Stage 1||3
1513411|NCT01562275|3703944|P13|COMPLETED|Stage 1||0
1513412|NCT01562275|3703945|P12|COMPLETED|Stage 1||0
1513413|NCT01562275|3703946|P11|COMPLETED|Stage 1||0
1513414|NCT01562275|3703947|P10|COMPLETED|Stage 1||0
1513415|NCT01562275|3703948|P9|COMPLETED|Stage 1||0
1513416|NCT01562275|3703949|P8|COMPLETED|Stage 1||0
1513417|NCT01562275|3703950|P7|COMPLETED|Stage 1||0
1513418|NCT01562275|3703951|P6|COMPLETED|Stage 1||0
1513419|NCT01562275|3703952|P5|COMPLETED|Stage 1||0
1513420|NCT01562275|3703953|P4|COMPLETED|Stage 1||0
1513421|NCT01562275|3703954|P3|COMPLETED|Stage 1||0
1513422|NCT01562275|3703955|P2|COMPLETED|Stage 1||0
1513423|NCT01562275|3703956|P1|COMPLETED|Stage 1||0
1513424|NCT01562275|3703944|P13|STARTED|Stage 1||0
1513425|NCT01562275|3703945|P12|STARTED|Stage 1||0
1513426|NCT01562275|3703946|P11|STARTED|Stage 1||3
1513427|NCT01562275|3703947|P10|STARTED|Stage 1||7
1513428|NCT01562275|3703948|P9|STARTED|Stage 1||3
1513429|NCT01562275|3703949|P8|STARTED|Stage 1||7
1513430|NCT01562275|3703950|P7|STARTED|Stage 1||3
1513431|NCT01562275|3703951|P6|STARTED|Stage 1||4
1513432|NCT01562275|3703952|P5|STARTED|Stage 1||4
1513433|NCT01562275|3703953|P4|STARTED|Stage 1||4
1513434|NCT01562275|3703954|P3|STARTED|Stage 1||3
1513435|NCT01562275|3703955|P2|STARTED|Stage 1||7
1513436|NCT01562275|3703956|P1|STARTED|Stage 1||3
1513437|NCT01562132|3704088|P2|NOT COMPLETED|Overall Study||0
1513438|NCT01562132|3704089|P1|NOT COMPLETED|Overall Study||0
1513439|NCT01562132|3704088|P2|COMPLETED|Overall Study||3
1513440|NCT01562132|3704089|P1|COMPLETED|Overall Study||3
1513441|NCT01562132|3704088|P2|STARTED|Overall Study||3
1513442|NCT01562132|3704089|P1|STARTED|Overall Study||3
1513443|NCT01561976|3704101|P6|NOT COMPLETED|Period 3||0
1513444|NCT01561976|3704102|P5|NOT COMPLETED|Period 3||0
1513445|NCT01561976|3704103|P4|NOT COMPLETED|Period 3||0
1513446|NCT01561976|3704104|P3|NOT COMPLETED|Period 3||0
1513447|NCT01561976|3704105|P2|NOT COMPLETED|Period 3||0
1513448|NCT01561976|3704106|P1|NOT COMPLETED|Period 3||0
1513449|NCT01561976|3704101|P6|COMPLETED|Period 3||4
1513450|NCT01561976|3704102|P5|COMPLETED|Period 3||5
1513451|NCT01561976|3704103|P4|COMPLETED|Period 3||4
1513452|NCT01561976|3704104|P3|COMPLETED|Period 3||3
1513453|NCT01561976|3704105|P2|COMPLETED|Period 3||5
1513454|NCT01561976|3704106|P1|COMPLETED|Period 3||4
1513455|NCT01561976|3704101|P6|STARTED|Period 3||4
1513456|NCT01561976|3704102|P5|STARTED|Period 3||5
1513457|NCT01561976|3704103|P4|STARTED|Period 3||4
1513458|NCT01561976|3704104|P3|STARTED|Period 3||3
1513459|NCT01561976|3704105|P2|STARTED|Period 3||5
1513460|NCT01561976|3704106|P1|STARTED|Period 3||4
1513461|NCT01561976|3704101|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1513462|NCT01561976|3704102|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1513463|NCT01561976|3704103|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1513464|NCT01561976|3704104|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
1513465|NCT01561976|3704105|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1513466|NCT01561976|3704106|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
1513467|NCT01561976|3704101|P6|COMPLETED|Washout Period 2 (7 Days)||4
1513468|NCT01561976|3704102|P5|COMPLETED|Washout Period 2 (7 Days)||5
1513469|NCT01561976|3704103|P4|COMPLETED|Washout Period 2 (7 Days)||4
1513470|NCT01561976|3704104|P3|COMPLETED|Washout Period 2 (7 Days)||3
1513471|NCT01561976|3704105|P2|COMPLETED|Washout Period 2 (7 Days)||5
1513472|NCT01561976|3704106|P1|COMPLETED|Washout Period 2 (7 Days)||4
1513473|NCT01561976|3704101|P6|STARTED|Washout Period 2 (7 Days)||4
1513474|NCT01561976|3704102|P5|STARTED|Washout Period 2 (7 Days)||5
1513475|NCT01561976|3704103|P4|STARTED|Washout Period 2 (7 Days)||4
1513476|NCT01561976|3704104|P3|STARTED|Washout Period 2 (7 Days)||4
1513477|NCT01561976|3704105|P2|STARTED|Washout Period 2 (7 Days)||5
1513478|NCT01561976|3704106|P1|STARTED|Washout Period 2 (7 Days)||5
1513479|NCT01561976|3704101|P6|NOT COMPLETED|Period 2||0
1513480|NCT01561976|3704102|P5|NOT COMPLETED|Period 2||0
1513481|NCT01561976|3704103|P4|NOT COMPLETED|Period 2||0
1513482|NCT01561976|3704104|P3|NOT COMPLETED|Period 2||0
1513483|NCT01561976|3704105|P2|NOT COMPLETED|Period 2||0
1513484|NCT01561976|3704106|P1|NOT COMPLETED|Period 2||0
1513485|NCT01561976|3704101|P6|COMPLETED|Period 2||4
1513486|NCT01561976|3704102|P5|COMPLETED|Period 2||5
1513487|NCT01561976|3704103|P4|COMPLETED|Period 2||4
1513488|NCT01561976|3704104|P3|COMPLETED|Period 2||4
1513489|NCT01561976|3704105|P2|COMPLETED|Period 2||5
1513490|NCT01561976|3704106|P1|COMPLETED|Period 2||5
1513491|NCT01561976|3704101|P6|STARTED|Period 2||4
1513492|NCT01561976|3704102|P5|STARTED|Period 2||5
1513493|NCT01561976|3704103|P4|STARTED|Period 2||4
1513494|NCT01561976|3704104|P3|STARTED|Period 2||4
1513495|NCT01561976|3704105|P2|STARTED|Period 2||5
1513496|NCT01561976|3704106|P1|STARTED|Period 2||5
1513497|NCT01561976|3704101|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
1513498|NCT01561976|3704102|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1513499|NCT01561976|3704103|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
1513500|NCT01561976|3704104|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1513501|NCT01561976|3704105|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1513502|NCT01561976|3704106|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1513503|NCT01561976|3704101|P6|COMPLETED|Washout Period 1 (7 Days)||4
1513504|NCT01561976|3704102|P5|COMPLETED|Washout Period 1 (7 Days)||5
1513505|NCT01561976|3704103|P4|COMPLETED|Washout Period 1 (7 Days)||4
1513506|NCT01561976|3704104|P3|COMPLETED|Washout Period 1 (7 Days)||4
1513507|NCT01561976|3704105|P2|COMPLETED|Washout Period 1 (7 Days)||5
1513508|NCT01561976|3704106|P1|COMPLETED|Washout Period 1 (7 Days)||5
1513509|NCT01561976|3704101|P6|STARTED|Washout Period 1 (7 Days)||5
1513510|NCT01561976|3704102|P5|STARTED|Washout Period 1 (7 Days)||5
1513511|NCT01561976|3704103|P4|STARTED|Washout Period 1 (7 Days)||5
1513512|NCT01561976|3704104|P3|STARTED|Washout Period 1 (7 Days)||4
1513513|NCT01561976|3704105|P2|STARTED|Washout Period 1 (7 Days)||5
1513514|NCT01561976|3704106|P1|STARTED|Washout Period 1 (7 Days)||5
1513515|NCT01561976|3704101|P6|NOT COMPLETED|Period 1||0
1513516|NCT01561976|3704102|P5|NOT COMPLETED|Period 1||0
1513517|NCT01561976|3704103|P4|NOT COMPLETED|Period 1||0
1513518|NCT01561976|3704104|P3|NOT COMPLETED|Period 1||1
1513519|NCT01561976|3704105|P2|NOT COMPLETED|Period 1||0
1513520|NCT01561976|3704106|P1|NOT COMPLETED|Period 1||0
1513521|NCT01561976|3704101|P6|COMPLETED|Period 1||5
1513522|NCT01561976|3704102|P5|COMPLETED|Period 1||5
1513523|NCT01561976|3704103|P4|COMPLETED|Period 1||5
1513524|NCT01561976|3704104|P3|COMPLETED|Period 1||4
1513525|NCT01561976|3704105|P2|COMPLETED|Period 1||5
1513526|NCT01561976|3704106|P1|COMPLETED|Period 1||5
1513527|NCT01561976|3704101|P6|STARTED|Period 1||5
1513528|NCT01561976|3704102|P5|STARTED|Period 1||5
1513529|NCT01561976|3704103|P4|STARTED|Period 1||5
1513530|NCT01561976|3704104|P3|STARTED|Period 1||5
1513531|NCT01561976|3704105|P2|STARTED|Period 1||5
1513532|NCT01561976|3704106|P1|STARTED|Period 1||5
1513533|NCT01561898|3704139|P4|NOT COMPLETED|Overall Study||20
1513534|NCT01561898|3704140|P3|NOT COMPLETED|Overall Study||44
1513535|NCT01561898|3704141|P2|NOT COMPLETED|Overall Study||41
1513536|NCT01561898|3704142|P1|NOT COMPLETED|Overall Study||2
1513537|NCT01561898|3704139|P4|COMPLETED|Overall Study||12
1513538|NCT01561898|3704140|P3|COMPLETED|Overall Study||53
1513539|NCT01561898|3704141|P2|COMPLETED|Overall Study||51
1513540|NCT01561898|3704142|P1|COMPLETED|Overall Study||5
1513541|NCT01561898|3704139|P4|STARTED|Overall Study||32
1513542|NCT01561898|3704140|P3|STARTED|Overall Study||97
1513543|NCT01561898|3704141|P2|STARTED|Overall Study||92
1513544|NCT01561898|3704142|P1|STARTED|Overall Study||7
1513545|NCT01561755|3704156|P2|NOT COMPLETED|Overall Study||1
1513546|NCT01561755|3704157|P1|NOT COMPLETED|Overall Study||0
1513547|NCT01561755|3704156|P2|COMPLETED|Overall Study||5
1513548|NCT01561755|3704157|P1|COMPLETED|Overall Study||6
1513549|NCT01561755|3704156|P2|STARTED|Overall Study||6
1513550|NCT01561755|3704157|P1|STARTED|Overall Study||6
1513551|NCT01561716|3704181|P6|NOT COMPLETED|Overall Study||0
1513552|NCT01561716|3704182|P5|NOT COMPLETED|Overall Study||0
1513553|NCT01561716|3704183|P4|NOT COMPLETED|Overall Study||0
1513554|NCT01561716|3704184|P3|NOT COMPLETED|Overall Study||0
1513555|NCT01561716|3704185|P2|NOT COMPLETED|Overall Study||0
1513556|NCT01561716|3704186|P1|NOT COMPLETED|Overall Study||0
1513557|NCT01561716|3704181|P6|COMPLETED|Overall Study||5
1513558|NCT01561716|3704182|P5|COMPLETED|Overall Study||5
1513559|NCT01561716|3704183|P4|COMPLETED|Overall Study||5
1513560|NCT01561716|3704184|P3|COMPLETED|Overall Study||5
1513561|NCT01561716|3704185|P2|COMPLETED|Overall Study||5
1513562|NCT01561716|3704186|P1|COMPLETED|Overall Study||5
1513563|NCT01561716|3704181|P6|STARTED|Overall Study||5
1513564|NCT01561716|3704182|P5|STARTED|Overall Study||5
1513565|NCT01561716|3704183|P4|STARTED|Overall Study||5
1513566|NCT01561716|3704184|P3|STARTED|Overall Study||5
1513567|NCT01561716|3704185|P2|STARTED|Overall Study||5
1513568|NCT01561716|3704186|P1|STARTED|Overall Study||5
1513569|NCT01561703|3704202|P2|NOT COMPLETED|Overall Study||6
1513570|NCT01561703|3704203|P1|NOT COMPLETED|Overall Study||8
1513571|NCT01561703|3704202|P2|COMPLETED|Overall Study||24
1513572|NCT01561703|3704203|P1|COMPLETED|Overall Study||20
1513573|NCT01561703|3704202|P2|STARTED|Overall Study||30
1513574|NCT01561703|3704203|P1|STARTED|Overall Study||28
1513575|NCT01561560|3704209|P2|NOT COMPLETED|Second Two Weeks of Wear||1
1513576|NCT01561560|3704210|P1|NOT COMPLETED|Second Two Weeks of Wear||0
1513577|NCT01561560|3704209|P2|COMPLETED|Second Two Weeks of Wear||58
1513578|NCT01561560|3704210|P1|COMPLETED|Second Two Weeks of Wear||60
1513579|NCT01561560|3704209|P2|STARTED|Second Two Weeks of Wear||59
1513580|NCT01561560|3704210|P1|STARTED|Second Two Weeks of Wear||60
1513581|NCT01561560|3704209|P2|NOT COMPLETED|First Two Weeks of Wear||2
1513582|NCT01561560|3704210|P1|NOT COMPLETED|First Two Weeks of Wear||0
1513583|NCT01561560|3704209|P2|COMPLETED|First Two Weeks of Wear||59
1513584|NCT01561560|3704210|P1|COMPLETED|First Two Weeks of Wear||60
1513585|NCT01561560|3704209|P2|STARTED|First Two Weeks of Wear||61
1513586|NCT01561560|3704210|P1|STARTED|First Two Weeks of Wear||60
1513587|NCT01561469|3704218|P2|NOT COMPLETED|Overall Study||0
1513588|NCT01561469|3704219|P1|NOT COMPLETED|Overall Study||0
1513589|NCT01561469|3704218|P2|COMPLETED|Overall Study||87
1513590|NCT01561469|3704219|P1|COMPLETED|Overall Study||101
1513591|NCT01561469|3704218|P2|STARTED|Overall Study||87
1513592|NCT01561469|3704219|P1|STARTED|Overall Study||101
1513593|NCT01561430|3704241|P4|NOT COMPLETED|Overall Study||13
1513594|NCT01561430|3704242|P3|NOT COMPLETED|Overall Study||17
1513595|NCT01561430|3704243|P2|NOT COMPLETED|Overall Study||15
1513596|NCT01561430|3704244|P1|NOT COMPLETED|Overall Study||1
1513597|NCT01561430|3704241|P4|COMPLETED|Overall Study||7
1513598|NCT01561430|3704242|P3|COMPLETED|Overall Study||1
1513599|NCT01561430|3704243|P2|COMPLETED|Overall Study||8
1513600|NCT01561430|3704244|P1|COMPLETED|Overall Study||8
1513601|NCT01561430|3704241|P4|Received at Least One Dose of Study Drug|Overall Study||20
1513602|NCT01561430|3704242|P3|Received at Least One Dose of Study Drug|Overall Study||18
1513603|NCT01561430|3704243|P2|Received at Least One Dose of Study Drug|Overall Study||23
1513604|NCT01561430|3704244|P1|Received at Least One Dose of Study Drug|Overall Study||9
1513605|NCT01561430|3704241|P4|STARTED|Overall Study||20
1513606|NCT01561430|3704242|P3|STARTED|Overall Study||18
1513607|NCT01561430|3704243|P2|STARTED|Overall Study||23
1513608|NCT01561430|3704244|P1|STARTED|Overall Study||9
1513609|NCT01561313|3704284|P2|NOT COMPLETED|Overall Study||0
1513610|NCT01561313|3704285|P1|NOT COMPLETED|Overall Study||2
1513611|NCT01561313|3704284|P2|COMPLETED|Overall Study||31
1513612|NCT01561313|3704285|P1|COMPLETED|Overall Study||31
1513613|NCT01561313|3704284|P2|STARTED|Overall Study||31
1513614|NCT01561313|3704285|P1|STARTED|Overall Study||33
1513615|NCT01561300|3704303|P2|NOT COMPLETED|Second Intervention||0
1513616|NCT01561300|3704304|P1|NOT COMPLETED|Second Intervention||0
1513617|NCT01561300|3704303|P2|COMPLETED|Second Intervention||15
1513618|NCT01561300|3704304|P1|COMPLETED|Second Intervention||14
1513619|NCT01561300|3704303|P2|STARTED|Second Intervention||15
1513620|NCT01561300|3704304|P1|STARTED|Second Intervention||14
1513621|NCT01561300|3704303|P2|NOT COMPLETED|Washout on Placebo||0
1513622|NCT01561300|3704304|P1|NOT COMPLETED|Washout on Placebo||0
1513623|NCT01561300|3704303|P2|COMPLETED|Washout on Placebo||15
1513624|NCT01561300|3704304|P1|COMPLETED|Washout on Placebo||14
1513625|NCT01561300|3704303|P2|STARTED|Washout on Placebo||15
1513626|NCT01561300|3704304|P1|STARTED|Washout on Placebo||14
1513627|NCT01561300|3704303|P2|NOT COMPLETED|First Intervention||0
1513628|NCT01561300|3704304|P1|NOT COMPLETED|First Intervention||0
1513629|NCT01561300|3704303|P2|COMPLETED|First Intervention||15
1513630|NCT01561300|3704304|P1|COMPLETED|First Intervention||14
1513631|NCT01561300|3704303|P2|STARTED|First Intervention||15
1513632|NCT01561300|3704304|P1|STARTED|First Intervention||14
1513633|NCT01561300|3704303|P2|NOT COMPLETED|Run in on Placebo||0
1513634|NCT01561300|3704304|P1|NOT COMPLETED|Run in on Placebo||1
1513635|NCT01561300|3704303|P2|COMPLETED|Run in on Placebo||15
1513636|NCT01561300|3704304|P1|COMPLETED|Run in on Placebo||14
1513637|NCT01561300|3704303|P2|STARTED|Run in on Placebo||15
1513638|NCT01561300|3704304|P1|STARTED|Run in on Placebo||15
1513639|NCT01561079|3704315|P1|NOT COMPLETED|Overall Study||78
1513640|NCT01561079|3704315|P1|COMPLETED|Overall Study||49
1513641|NCT01561079|3704315|P1|STARTED|Overall Study||127
1513642|NCT01560988|3704358|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
1513643|NCT01560988|3704359|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
1513644|NCT01560988|3704358|P2|COMPLETED|Second Intervention (Six Weeks)||22
1513645|NCT01560988|3704359|P1|COMPLETED|Second Intervention (Six Weeks)||18
1513646|NCT01560988|3704358|P2|STARTED|Second Intervention (Six Weeks)||24
1513647|NCT01560988|3704359|P1|STARTED|Second Intervention (Six Weeks)||20
1513648|NCT01560988|3704358|P2|NOT COMPLETED|Washout (Six Weeks)||2
1513649|NCT01560988|3704359|P1|NOT COMPLETED|Washout (Six Weeks)||2
1513650|NCT01560988|3704358|P2|COMPLETED|Washout (Six Weeks)||24
1513651|NCT01560988|3704359|P1|COMPLETED|Washout (Six Weeks)||20
1513652|NCT01560988|3704358|P2|STARTED|Washout (Six Weeks)||26
1513653|NCT01560988|3704359|P1|STARTED|Washout (Six Weeks)||22
1513654|NCT01560988|3704358|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
1513655|NCT01560988|3704359|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
1513656|NCT01560988|3704358|P2|COMPLETED|First Intervention (Six Weeks)||26
1513657|NCT01560988|3704359|P1|COMPLETED|First Intervention (Six Weeks)||22
1513658|NCT01560988|3704358|P2|STARTED|First Intervention (Six Weeks)||30
1513659|NCT01560988|3704359|P1|STARTED|First Intervention (Six Weeks)||32
1513660|NCT01560975|3704382|P1|NOT COMPLETED|Overall Study||0
1513661|NCT01560975|3704382|P1|COMPLETED|Overall Study||10
1513662|NCT01560975|3704382|P1|STARTED|Overall Study||10
1513663|NCT01560819|3704397|P2|NOT COMPLETED|Overall Study||0
1513664|NCT01560819|3704398|P1|NOT COMPLETED|Overall Study||1
1513665|NCT01560819|3704397|P2|COMPLETED|Overall Study||10
1513666|NCT01560819|3704398|P1|COMPLETED|Overall Study||9
1513667|NCT01560819|3704397|P2|STARTED|Overall Study||10
1513668|NCT01560819|3704398|P1|STARTED|Overall Study||10
1513669|NCT01560507|3704405|P3|NOT COMPLETED|Overall Study||2
1513670|NCT01560507|3704406|P2|NOT COMPLETED|Overall Study||2
1513671|NCT01560507|3704407|P1|NOT COMPLETED|Overall Study||4
1513672|NCT01560507|3704405|P3|COMPLETED|Overall Study||0
1513673|NCT01560507|3704406|P2|COMPLETED|Overall Study||0
1513674|NCT01560507|3704407|P1|COMPLETED|Overall Study||1
1513675|NCT01560507|3704405|P3|STARTED|Overall Study||2
1513676|NCT01560507|3704406|P2|STARTED|Overall Study||2
1513677|NCT01560507|3704407|P1|STARTED|Overall Study||5
1513678|NCT01560429|3704420|P2|NOT COMPLETED|Overall Study||6
1513679|NCT01560429|3704421|P1|NOT COMPLETED|Overall Study||3
1513680|NCT01560429|3704420|P2|COMPLETED|Overall Study||20
1513681|NCT01560429|3704421|P1|COMPLETED|Overall Study||23
1513682|NCT01560429|3704420|P2|STARTED|Overall Study||26
1513683|NCT01560429|3704421|P1|STARTED|Overall Study||26
1513684|NCT01560403|3704431|P2|NOT COMPLETED|Overall Study||1
1513685|NCT01560403|3704432|P1|NOT COMPLETED|Overall Study||0
1513686|NCT01560403|3704431|P2|COMPLETED|Overall Study||8
1513687|NCT01560403|3704432|P1|COMPLETED|Overall Study||5
1513688|NCT01560403|3704431|P2|STARTED|Overall Study||9
1513689|NCT01560403|3704432|P1|STARTED|Overall Study||5
1513690|NCT01560377|3704438|P1|NOT COMPLETED|Overall Study||0
1513691|NCT01560377|3704438|P1|COMPLETED|Overall Study||147
1513692|NCT01560377|3704438|P1|Eligible for Analysis|Overall Study||139
1513693|NCT01560377|3704438|P1|STARTED|Overall Study||147
1513694|NCT01560260|3704443|P1|NOT COMPLETED|Overall Study||0
1513695|NCT01560260|3704443|P1|COMPLETED|Overall Study||20
1513696|NCT01560260|3704443|P1|STARTED|Overall Study||20
1513697|NCT01560234|3704467|P8|NOT COMPLETED|Overall Study||2
1513698|NCT01560234|3704468|P7|NOT COMPLETED|Overall Study||0
1513699|NCT01560234|3704469|P6|NOT COMPLETED|Overall Study||2
1513700|NCT01560234|3704470|P5|NOT COMPLETED|Overall Study||0
1513701|NCT01560234|3704471|P4|NOT COMPLETED|Overall Study||0
1513702|NCT01560234|3704472|P3|NOT COMPLETED|Overall Study||1
1513703|NCT01560234|3704473|P2|NOT COMPLETED|Overall Study||0
1513704|NCT01560234|3704474|P1|NOT COMPLETED|Overall Study||3
1513705|NCT01560234|3704467|P8|COMPLETED|Overall Study||6
1513706|NCT01560234|3704468|P7|COMPLETED|Overall Study||4
1513707|NCT01560234|3704469|P6|COMPLETED|Overall Study||2
1513708|NCT01560234|3704470|P5|COMPLETED|Overall Study||4
1513709|NCT01560234|3704471|P4|COMPLETED|Overall Study||3
1513710|NCT01560234|3704472|P3|COMPLETED|Overall Study||3
1513711|NCT01560234|3704473|P2|COMPLETED|Overall Study||4
1513712|NCT01560234|3704474|P1|COMPLETED|Overall Study||13
1513713|NCT01560234|3704467|P8|STARTED|Overall Study||8
1513714|NCT01560234|3704468|P7|STARTED|Overall Study||4
1513715|NCT01560234|3704469|P6|STARTED|Overall Study||4
1513716|NCT01560234|3704470|P5|STARTED|Overall Study||4
1513717|NCT01560234|3704471|P4|STARTED|Overall Study||3
1513718|NCT01560234|3704472|P3|STARTED|Overall Study||4
1513719|NCT01560234|3704473|P2|STARTED|Overall Study||4
1513720|NCT01560234|3704474|P1|STARTED|Overall Study||16
1513721|NCT01560143|3704548|P1|NOT COMPLETED|Overall Study||0
1513722|NCT01560143|3704548|P1|COMPLETED|Overall Study||12
1513723|NCT01560143|3704548|P1|STARTED|Overall Study||12
1513724|NCT01559935|3704552|P1|NOT COMPLETED|Maintenance Phase||54
1513725|NCT01559935|3704552|P1|COMPLETED|Maintenance Phase||0
1513726|NCT01559935|3704552|P1|STARTED|Maintenance Phase||54
1513727|NCT01559935|3704552|P1|NOT COMPLETED|BiRD Phase||4
1513728|NCT01559935|3704552|P1|COMPLETED|BiRD Phase||54
1513729|NCT01559935|3704552|P1|STARTED|BiRD Phase||58
1513730|NCT01559935|3704552|P1|NOT COMPLETED|Car Phase||14
1513731|NCT01559935|3704552|P1|COMPLETED|Car Phase||58
1513732|NCT01559935|3704552|P1|STARTED|Car Phase||72
1513733|NCT01559922|3704562|P2|NOT COMPLETED|Overall Study||10
1513734|NCT01559922|3704563|P1|NOT COMPLETED|Overall Study||4
1513735|NCT01559922|3704562|P2|COMPLETED|Overall Study||87
1513736|NCT01559922|3704563|P1|COMPLETED|Overall Study||46
1513737|NCT01559922|3704562|P2|STARTED|Overall Study||97
1513738|NCT01559922|3704563|P1|STARTED|Overall Study||50
1513739|NCT01559857|3704571|P2|NOT COMPLETED|Overall Study||0
1513740|NCT01559857|3704572|P1|NOT COMPLETED|Overall Study||0
1513741|NCT01559857|3704571|P2|COMPLETED|Overall Study||18
1513742|NCT01559857|3704572|P1|COMPLETED|Overall Study||19
1513743|NCT01559857|3704571|P2|STARTED|Overall Study||18
1513744|NCT01559857|3704572|P1|STARTED|Overall Study||19
1513745|NCT01559844|3704588|P1|NOT COMPLETED|Overall Study||25
1513746|NCT01559844|3704588|P1|COMPLETED|Overall Study||36
1513747|NCT01559844|3704588|P1|STARTED|Overall Study||61
1513748|NCT01559675|3704601|P2|NOT COMPLETED|Overall Study||14
1513749|NCT01559675|3704602|P1|NOT COMPLETED|Overall Study||15
1513750|NCT01559675|3704601|P2|COMPLETED|Overall Study||49
1513751|NCT01559675|3704602|P1|COMPLETED|Overall Study||43
1513752|NCT01559675|3704601|P2|STARTED|Overall Study||63
1513753|NCT01559675|3704602|P1|STARTED|Overall Study||58
1513754|NCT01559649|3704610|P2|NOT COMPLETED|Overall Study||6
1513755|NCT01559649|3704611|P1|NOT COMPLETED|Overall Study||19
1513756|NCT01559649|3704610|P2|COMPLETED|Overall Study||9
1513757|NCT01559649|3704611|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
1513758|NCT01559649|3704610|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
1513759|NCT01559649|3704611|P1|STARTED|Overall Study||269
1513760|NCT01559506|3704624|P2|NOT COMPLETED|Overall Study||3
1513761|NCT01559506|3704625|P1|NOT COMPLETED|Overall Study||0
1513762|NCT01559506|3704624|P2|COMPLETED|Overall Study||18
1513763|NCT01559506|3704625|P1|COMPLETED|Overall Study||20
1513764|NCT01559506|3704624|P2|STARTED|Overall Study||21
1513765|NCT01559506|3704625|P1|STARTED|Overall Study||20
1513766|NCT01559454|3704633|P2|NOT COMPLETED|Overall Study||6
1513767|NCT01559454|3704634|P1|NOT COMPLETED|Overall Study||3
1513768|NCT01559454|3704633|P2|COMPLETED|Overall Study||4
1513769|NCT01559454|3704634|P1|COMPLETED|Overall Study||6
1513770|NCT01559454|3704633|P2|STARTED|Overall Study||10
1513771|NCT01559454|3704634|P1|STARTED|Overall Study||9
1513772|NCT01559311|3704653|P3|NOT COMPLETED|Overall Study||8
1513773|NCT01559311|3704654|P2|NOT COMPLETED|Overall Study||6
1513774|NCT01559311|3704655|P1|NOT COMPLETED|Overall Study||3
1513775|NCT01559311|3704653|P3|COMPLETED|Overall Study|12-Month|26
1513776|NCT01559311|3704654|P2|COMPLETED|Overall Study|12-Month|28
1513777|NCT01559311|3704655|P1|COMPLETED|Overall Study|12-Month|27
1513778|NCT01559311|3704653|P3|6-Month|Overall Study||28
1513779|NCT01559311|3704654|P2|6-Month|Overall Study||33
1513780|NCT01559311|3704655|P1|6-Month|Overall Study||27
1513781|NCT01559311|3704653|P3|3-Month|Overall Study||29
1513782|NCT01559311|3704654|P2|3-Month|Overall Study||34
1513783|NCT01559311|3704655|P1|3-Month|Overall Study||27
1513784|NCT01559311|3704653|P3|1-Month|Overall Study||29
1513785|NCT01559311|3704654|P2|1-Month|Overall Study||34
1513786|NCT01559311|3704655|P1|1-Month|Overall Study||27
1513787|NCT01559311|3704653|P3|Implant|Overall Study||32
1513788|NCT01559311|3704654|P2|Implant|Overall Study||34
1513789|NCT01559311|3704655|P1|Implant|Overall Study||28
1513790|NCT01559311|3704653|P3|STARTED|Overall Study|Enrollment & Baseline|34
1513791|NCT01559311|3704654|P2|STARTED|Overall Study|Enrollment & Baseline|34
1513792|NCT01559311|3704655|P1|STARTED|Overall Study|Enrollment & Baseline|30
1513793|NCT01559116|3704666|P1|NOT COMPLETED|Overall Study||26
1513794|NCT01559116|3704666|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
1513795|NCT01559116|3704666|P1|STARTED|Overall Study|Randomised|219
1513796|NCT01559064|3704737|P3|NOT COMPLETED|Overall Study||2
1513797|NCT01559064|3704738|P2|NOT COMPLETED|Overall Study||1
1513798|NCT01559064|3704739|P1|NOT COMPLETED|Overall Study||1
1513799|NCT01559064|3704737|P3|COMPLETED|Overall Study||57
1513800|NCT01559064|3704738|P2|COMPLETED|Overall Study||39
1513801|NCT01559064|3704739|P1|COMPLETED|Overall Study||15
1513802|NCT01559064|3704737|P3|STARTED|Overall Study||59
1513803|NCT01559064|3704738|P2|STARTED|Overall Study||40
1513804|NCT01559064|3704739|P1|STARTED|Overall Study||16
1513805|NCT01559012|3704749|P2|NOT COMPLETED|Overall Study||1
1513806|NCT01559012|3704750|P1|NOT COMPLETED|Overall Study||0
1513807|NCT01559012|3704749|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
1513808|NCT01559012|3704750|P1|COMPLETED|Overall Study||6
1513809|NCT01559012|3704749|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
1513810|NCT01559012|3704750|P1|STARTED|Overall Study||6
1513811|NCT01558791|3704775|P2|NOT COMPLETED|Overall Study||0
1513812|NCT01558791|3704776|P1|NOT COMPLETED|Overall Study||0
1513813|NCT01558791|3704775|P2|COMPLETED|Overall Study||629
1513814|NCT01558791|3704776|P1|COMPLETED|Overall Study||607
1513815|NCT01558791|3704775|P2|STARTED|Overall Study||629
1513816|NCT01558791|3704776|P1|STARTED|Overall Study||607
1513817|NCT01558739|3704786|P1|NOT COMPLETED|Overall Study||17
1513818|NCT01558739|3704786|P1|COMPLETED|Overall Study||31
1513819|NCT01558739|3704786|P1|STARTED|Overall Study||48
1513820|NCT01558700|3704800|P2|NOT COMPLETED|Overall Study||0
1513821|NCT01558700|3704801|P1|NOT COMPLETED|Overall Study||0
1513822|NCT01558700|3704800|P2|COMPLETED|Overall Study||21
1513823|NCT01558700|3704801|P1|COMPLETED|Overall Study||19
1513824|NCT01558700|3704800|P2|STARTED|Overall Study||21
1513825|NCT01558700|3704801|P1|STARTED|Overall Study||19
1513826|NCT01558674|3704811|P2|NOT COMPLETED|Part 2||0
1513827|NCT01558674|3704812|P1|NOT COMPLETED|Part 2||0
1513828|NCT01558674|3704811|P2|COMPLETED|Part 2||0
1513829|NCT01558674|3704812|P1|COMPLETED|Part 2||0
1513830|NCT01558674|3704811|P2|STARTED|Part 2||0
1513831|NCT01558674|3704812|P1|STARTED|Part 2||0
1513832|NCT01558674|3704811|P2|NOT COMPLETED|Part 1||0
1513833|NCT01558674|3704812|P1|NOT COMPLETED|Part 1||11
1513834|NCT01558674|3704811|P2|COMPLETED|Part 1||0
1513835|NCT01558674|3704812|P1|COMPLETED|Part 1||0
1513836|NCT01558674|3704811|P2|STARTED|Part 1||0
1513837|NCT01558674|3704812|P1|STARTED|Part 1||11
1513838|NCT01558661|3704856|P1|NOT COMPLETED|Overall Study||0
1513839|NCT01558661|3704856|P1|COMPLETED|Overall Study||33
1513840|NCT01558661|3704856|P1|Second Stage|Overall Study||15
1513841|NCT01558661|3704856|P1|First Stage|Overall Study||18
1513842|NCT01558661|3704856|P1|STARTED|Overall Study||33
1513843|NCT01558596|3704865|P2|NOT COMPLETED|Overall Study||1
1513844|NCT01558596|3704866|P1|NOT COMPLETED|Overall Study||3
1513845|NCT01558596|3704865|P2|COMPLETED|Overall Study||100
1513846|NCT01558596|3704866|P1|COMPLETED|Overall Study||101
1513847|NCT01558596|3704865|P2|STARTED|Overall Study||101
1513848|NCT01558596|3704866|P1|STARTED|Overall Study||104
1513849|NCT01558492|3704872|P1|NOT COMPLETED|Overall Study||0
1513850|NCT01558492|3704872|P1|COMPLETED|Overall Study||3
1513851|NCT01558492|3704872|P1|STARTED|Overall Study||3
1513852|NCT01558297|3704881|P3|NOT COMPLETED|Overall Study||1
1513853|NCT01558297|3704882|P2|NOT COMPLETED|Overall Study||2
1513854|NCT01558297|3704883|P1|NOT COMPLETED|Overall Study||2
1513855|NCT01558297|3704881|P3|COMPLETED|Overall Study||29
1513856|NCT01558297|3704882|P2|COMPLETED|Overall Study||27
1513857|NCT01558297|3704883|P1|COMPLETED|Overall Study||28
1513858|NCT01558297|3704881|P3|STARTED|Overall Study||30
1513859|NCT01558297|3704882|P2|STARTED|Overall Study||29
1513860|NCT01558297|3704883|P1|STARTED|Overall Study||30
1513861|NCT01558271|3704900|P3|NOT COMPLETED|Overall Study||17
1513862|NCT01558271|3704901|P2|NOT COMPLETED|Overall Study||11
1513863|NCT01558271|3704902|P1|NOT COMPLETED|Overall Study||18
1513864|NCT01558271|3704900|P3|COMPLETED|Overall Study||124
1513865|NCT01558271|3704901|P2|COMPLETED|Overall Study||59
1513866|NCT01558271|3704902|P1|COMPLETED|Overall Study||263
1513867|NCT01558271|3704900|P3|Completed 26 Weeks|Overall Study||128
1513868|NCT01558271|3704901|P2|Completed 26 Weeks|Overall Study||63
1513869|NCT01558271|3704902|P1|Completed 26 Weeks|Overall Study||271
1513870|NCT01558271|3704900|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
1513871|NCT01558271|3704901|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
1513872|NCT01558271|3704902|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
1513873|NCT01558271|3704900|P3|STARTED|Overall Study||141
1513874|NCT01558271|3704901|P2|STARTED|Overall Study||70
1513875|NCT01558271|3704902|P1|STARTED|Overall Study||281
1513876|NCT01558128|3704964|P1|NOT COMPLETED|Overall Study||0
1513877|NCT01558128|3704964|P1|COMPLETED|Overall Study||1
1513878|NCT01558128|3704964|P1|STARTED|Overall Study||1
1513879|NCT01558089|3704968|P1|NOT COMPLETED|Overall Study||13
1513880|NCT01558089|3704968|P1|COMPLETED|Overall Study||63
1513881|NCT01558089|3704968|P1|STARTED|Overall Study||76
1513882|NCT01557959|3704979|P1|NOT COMPLETED|Overall Study||0
1513883|NCT01557959|3704979|P1|COMPLETED|Overall Study||45
1513884|NCT01557959|3704979|P1|STARTED|Overall Study||45
1513885|NCT01557946|3704989|P2|NOT COMPLETED|Overall Study||0
1513886|NCT01557946|3704990|P1|NOT COMPLETED|Overall Study||3
1513887|NCT01557946|3704989|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
1513888|NCT01557946|3704990|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
1513889|NCT01557946|3704989|P2|STARTED|Overall Study||12
1513890|NCT01557946|3704990|P1|STARTED|Overall Study||20
1513891|NCT01557920|3704996|P2|NOT COMPLETED|Overall Study||3
1513892|NCT01557920|3704997|P1|NOT COMPLETED|Overall Study||3
1513893|NCT01557920|3704996|P2|COMPLETED|Overall Study||6
1513894|NCT01557920|3704997|P1|COMPLETED|Overall Study||6
1513895|NCT01557920|3704996|P2|STARTED|Overall Study||9
1513896|NCT01557920|3704997|P1|STARTED|Overall Study||9
1513897|NCT01557894|3705032|P2|NOT COMPLETED|Overall Study||5
1513898|NCT01557894|3705033|P1|NOT COMPLETED|Overall Study||3
1513899|NCT01557894|3705032|P2|COMPLETED|Overall Study||33
1513900|NCT01557894|3705033|P1|COMPLETED|Overall Study||35
1513901|NCT01557894|3705032|P2|STARTED|Overall Study||38
1513902|NCT01557894|3705033|P1|STARTED|Overall Study||38
1513903|NCT01557868|3705049|P2|NOT COMPLETED|Overall Study||30
1513904|NCT01557868|3705050|P1|NOT COMPLETED|Overall Study||27
1513905|NCT01557868|3705049|P2|COMPLETED|Overall Study||65
1513906|NCT01557868|3705050|P1|COMPLETED|Overall Study||76
1513907|NCT01557868|3705049|P2|STARTED|Overall Study||95
1513908|NCT01557868|3705050|P1|STARTED|Overall Study||103
1513909|NCT01557842|3705060|P2|NOT COMPLETED|Overall Study||6
1513910|NCT01557842|3705061|P1|NOT COMPLETED|Overall Study||9
1513911|NCT01557842|3705060|P2|COMPLETED|Overall Study||0
1513912|NCT01557842|3705061|P1|COMPLETED|Overall Study||0
1513913|NCT01557842|3705060|P2|STARTED|Overall Study||6
1513914|NCT01557842|3705061|P1|STARTED|Overall Study||9
1513915|NCT01557751|3705069|P1|NOT COMPLETED|Overall Study||3
1513916|NCT01557751|3705069|P1|COMPLETED|Overall Study||153
1513917|NCT01557751|3705069|P1|STARTED|Overall Study||156
1513918|NCT01557699|3705076|P3|NOT COMPLETED|Overall Study||0
1513919|NCT01557699|3705077|P2|NOT COMPLETED|Overall Study||0
1513920|NCT01557699|3705078|P1|NOT COMPLETED|Overall Study||0
1513921|NCT01557699|3705076|P3|COMPLETED|Overall Study||20
1513922|NCT01557699|3705077|P2|COMPLETED|Overall Study||20
1513923|NCT01557699|3705078|P1|COMPLETED|Overall Study||20
1513924|NCT01557699|3705076|P3|STARTED|Overall Study||20
1513925|NCT01557699|3705077|P2|STARTED|Overall Study||20
1513926|NCT01557699|3705078|P1|STARTED|Overall Study||20
1513927|NCT01557595|3705110|P1|NOT COMPLETED|Overall Study||8
1513928|NCT01557595|3705110|P1|COMPLETED|Overall Study||14
1513929|NCT01557595|3705110|P1|STARTED|Overall Study||22
1513930|NCT01557582|3705114|P1|NOT COMPLETED|Overall Study||6
1513931|NCT01557582|3705114|P1|COMPLETED|Overall Study||97
1513932|NCT01557582|3705114|P1|STARTED|Overall Study||103
1513933|NCT01557569|3705122|P2|NOT COMPLETED|Overall Study||7
1513934|NCT01557569|3705123|P1|NOT COMPLETED|Overall Study||5
1513935|NCT01557569|3705122|P2|COMPLETED|Overall Study||0
1513936|NCT01557569|3705123|P1|COMPLETED|Overall Study||1
1513937|NCT01557569|3705122|P2|Completed 2-wk Residential Stay|Overall Study||1
1513938|NCT01557569|3705123|P1|Completed 2-wk Residential Stay|Overall Study||3
1513939|NCT01557569|3705122|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
1513940|NCT01557569|3705123|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
1513941|NCT01557504|3705131|P2|NOT COMPLETED|Overall Study||0
1513942|NCT01557504|3705132|P1|NOT COMPLETED|Overall Study||1
1513943|NCT01557504|3705131|P2|COMPLETED|Overall Study||12
1513944|NCT01557504|3705132|P1|COMPLETED|Overall Study||12
1513945|NCT01557504|3705131|P2|STARTED|Overall Study||12
1513946|NCT01557504|3705132|P1|STARTED|Overall Study||13
1513947|NCT01557348|3705157|P2|NOT COMPLETED|Overall Study||90
1513948|NCT01557348|3705158|P1|NOT COMPLETED|Overall Study||80
1513949|NCT01557348|3705157|P2|COMPLETED|Overall Study||417
1513950|NCT01557348|3705158|P1|COMPLETED|Overall Study||524
1513951|NCT01557348|3705157|P2|Safety Population|Overall Study||507
1513952|NCT01557348|3705158|P1|Safety Population|Overall Study||604
1513953|NCT01557348|3705157|P2|STARTED|Overall Study||507
1513954|NCT01557348|3705158|P1|STARTED|Overall Study||604
1513955|NCT01557322|3705200|P2|NOT COMPLETED|Overall Study||0
1513956|NCT01557322|3705201|P1|NOT COMPLETED|Overall Study||0
1513957|NCT01557322|3705200|P2|COMPLETED|Overall Study||1543
1513958|NCT01557322|3705201|P1|COMPLETED|Overall Study||211
1513959|NCT01557322|3705200|P2|STARTED|Overall Study||1543
1513960|NCT01557322|3705201|P1|STARTED|Overall Study||211
1513961|NCT01557283|3705275|P1|NOT COMPLETED|Overall Study||44
1513962|NCT01557283|3705275|P1|COMPLETED|Overall Study||96
1513963|NCT01557283|3705275|P1|STARTED|Overall Study||140
1513964|NCT01557166|3705287|P2|NOT COMPLETED|Overall Study||37
1513965|NCT01557166|3705288|P1|NOT COMPLETED|Overall Study||46
1513966|NCT01557166|3705287|P2|COMPLETED|Overall Study||142
1513967|NCT01557166|3705288|P1|COMPLETED|Overall Study||134
1513968|NCT01557166|3705287|P2|Exposed|Overall Study||179
1513969|NCT01557166|3705288|P1|Exposed|Overall Study||176
1513970|NCT01557166|3705287|P2|STARTED|Overall Study||179
1513971|NCT01557166|3705288|P1|STARTED|Overall Study||180
1513972|NCT01556997|3705303|P3|NOT COMPLETED|Overall Study||32
1513973|NCT01556997|3705304|P2|NOT COMPLETED|Overall Study||28
1513974|NCT01556997|3705305|P1|NOT COMPLETED|Overall Study||26
1513975|NCT01556997|3705303|P3|COMPLETED|Overall Study||246
1513976|NCT01556997|3705304|P2|COMPLETED|Overall Study||252
1513977|NCT01556997|3705305|P1|COMPLETED|Overall Study||253
1513978|NCT01556997|3705303|P3|STARTED|Overall Study||278
1513979|NCT01556997|3705304|P2|STARTED|Overall Study||280
1513980|NCT01556997|3705305|P1|STARTED|Overall Study||279
1513981|NCT01556932|3705316|P2|NOT COMPLETED|Second Treament||0
1513982|NCT01556932|3705317|P1|NOT COMPLETED|Second Treament||0
1513983|NCT01556932|3705316|P2|COMPLETED|Second Treament||8
1513984|NCT01556932|3705317|P1|COMPLETED|Second Treament||12
1513985|NCT01556932|3705316|P2|Recieved|Second Treament||8
1513986|NCT01556932|3705317|P1|Recieved|Second Treament||12
1513987|NCT01556932|3705316|P2|STARTED|Second Treament||8
1513988|NCT01556932|3705317|P1|STARTED|Second Treament||12
1513989|NCT01556932|3705316|P2|NOT COMPLETED|Time Point 60 Minutes||1
1513990|NCT01556932|3705317|P1|NOT COMPLETED|Time Point 60 Minutes||1
1513991|NCT01556932|3705316|P2|COMPLETED|Time Point 60 Minutes||8
1513992|NCT01556932|3705317|P1|COMPLETED|Time Point 60 Minutes||12
1513993|NCT01556932|3705316|P2|Recieved|Time Point 60 Minutes||8
1513994|NCT01556932|3705317|P1|Recieved|Time Point 60 Minutes||12
1513995|NCT01556932|3705316|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
1513996|NCT01556932|3705317|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
1513997|NCT01556932|3705316|P2|NOT COMPLETED|Baseline First Treatment||0
1513998|NCT01556932|3705317|P1|NOT COMPLETED|Baseline First Treatment||0
1513999|NCT01556932|3705316|P2|COMPLETED|Baseline First Treatment||9
1514000|NCT01556932|3705317|P1|COMPLETED|Baseline First Treatment||13
1514001|NCT01556932|3705316|P2|Recieved|Baseline First Treatment||9
1514002|NCT01556932|3705317|P1|Recieved|Baseline First Treatment||13
1514003|NCT01556932|3705316|P2|STARTED|Baseline First Treatment||9
1514004|NCT01556932|3705317|P1|STARTED|Baseline First Treatment||13
1514005|NCT01556906|3705322|P1|NOT COMPLETED|Overall Study||0
1514006|NCT01556906|3705322|P1|COMPLETED|Overall Study||6
1514007|NCT01556906|3705322|P1|STARTED|Overall Study||6
1514008|NCT01556763|3705343|P3|NOT COMPLETED|Overall Study||0
1514009|NCT01556763|3705344|P2|NOT COMPLETED|Overall Study||1
1514010|NCT01556763|3705345|P1|NOT COMPLETED|Overall Study||0
1514011|NCT01556763|3705343|P3|COMPLETED|Overall Study||8
1514012|NCT01556763|3705344|P2|COMPLETED|Overall Study||8
1514013|NCT01556763|3705345|P1|COMPLETED|Overall Study||4
1514014|NCT01556763|3705343|P3|STARTED|Overall Study||8
1514015|NCT01556763|3705344|P2|STARTED|Overall Study||9
1514016|NCT01556763|3705345|P1|STARTED|Overall Study||4
1514017|NCT01556724|3705383|P2|NOT COMPLETED|Overall Study||0
1514018|NCT01556724|3705384|P1|NOT COMPLETED|Overall Study||0
1514019|NCT01556724|3705383|P2|COMPLETED|Overall Study||14
1514020|NCT01556724|3705384|P1|COMPLETED|Overall Study||16
1514021|NCT01556724|3705383|P2|STARTED|Overall Study||14
1514022|NCT01556724|3705384|P1|STARTED|Overall Study||16
1514023|NCT01556633|3705400|P2|NOT COMPLETED|Overall Study||0
1514024|NCT01556633|3705401|P1|NOT COMPLETED|Overall Study||0
1514025|NCT01556633|3705400|P2|COMPLETED|Overall Study||6
1514026|NCT01556633|3705401|P1|COMPLETED|Overall Study||10
1514027|NCT01556633|3705400|P2|STARTED|Overall Study||6
1514028|NCT01556633|3705401|P1|STARTED|Overall Study||10
1514029|NCT01556594|3705426|P3|NOT COMPLETED|Overall Study||0
1514030|NCT01556594|3705427|P2|NOT COMPLETED|Overall Study||0
1514031|NCT01556594|3705428|P1|NOT COMPLETED|Overall Study||0
1514032|NCT01556594|3705426|P3|COMPLETED|Overall Study||6
1514033|NCT01556594|3705427|P2|COMPLETED|Overall Study||2
1514034|NCT01556594|3705428|P1|COMPLETED|Overall Study||10
1514035|NCT01556594|3705426|P3|STARTED|Overall Study||6
1514036|NCT01556594|3705427|P2|STARTED|Overall Study||2
1514037|NCT01556594|3705428|P1|STARTED|Overall Study||10
1514038|NCT01556451|3705462|P1|NOT COMPLETED|Overall Study||0
1514039|NCT01556451|3705462|P1|COMPLETED|Overall Study||180
1514040|NCT01556451|3705462|P1|STARTED|Overall Study||180
1514041|NCT01556425|3705473|P4|NOT COMPLETED|Overall Study||0
1514042|NCT01556425|3705474|P3|NOT COMPLETED|Overall Study||0
1514043|NCT01556425|3705475|P2|NOT COMPLETED|Overall Study||0
1514044|NCT01556425|3705476|P1|NOT COMPLETED|Overall Study||0
1514045|NCT01556425|3705473|P4|COMPLETED|Overall Study||18
1514046|NCT01556425|3705474|P3|COMPLETED|Overall Study||18
1514047|NCT01556425|3705475|P2|COMPLETED|Overall Study||23
1514048|NCT01556425|3705476|P1|COMPLETED|Overall Study||25
1514049|NCT01556425|3705473|P4|STARTED|Overall Study||18
1514050|NCT01556425|3705474|P3|STARTED|Overall Study||18
1514051|NCT01556425|3705475|P2|STARTED|Overall Study||23
1514052|NCT01556425|3705476|P1|STARTED|Overall Study||25
1514053|NCT01556347|3705490|P1|NOT COMPLETED|Recovery Phase||0
1514054|NCT01556347|3705490|P1|COMPLETED|Recovery Phase||2
1514055|NCT01556347|3705490|P1|STARTED|Recovery Phase||2
1514056|NCT01556347|3705490|P1|NOT COMPLETED|Bortezomib Treatment Phase||0
1514057|NCT01556347|3705490|P1|COMPLETED|Bortezomib Treatment Phase||2
1514058|NCT01556347|3705490|P1|STARTED|Bortezomib Treatment Phase||2
1514059|NCT01556347|3705490|P1|NOT COMPLETED|Induction Immunotherapy||0
1514060|NCT01556347|3705490|P1|COMPLETED|Induction Immunotherapy||2
1514061|NCT01556347|3705490|P1|STARTED|Induction Immunotherapy||2
1514062|NCT01556204|3705520|P2|NOT COMPLETED|Overall Study||0
1514063|NCT01556204|3705521|P1|NOT COMPLETED|Overall Study||0
1514064|NCT01556204|3705520|P2|COMPLETED|Overall Study||38
1514065|NCT01556204|3705521|P1|COMPLETED|Overall Study||35
1514066|NCT01556204|3705520|P2|STARTED|Overall Study||38
1514067|NCT01556204|3705521|P1|STARTED|Overall Study||35
1514068|NCT01556165|3705531|P2|NOT COMPLETED|Overall Study||7
1514069|NCT01556165|3705532|P1|NOT COMPLETED|Overall Study||12
1514070|NCT01556165|3705531|P2|COMPLETED|Overall Study||58
1514071|NCT01556165|3705532|P1|COMPLETED|Overall Study||53
1514072|NCT01556165|3705531|P2|STARTED|Overall Study||65
1514073|NCT01556165|3705532|P1|STARTED|Overall Study||65
1514074|NCT01556100|3705544|P1|NOT COMPLETED|Overall Study||6
1514075|NCT01556100|3705544|P1|COMPLETED|Overall Study||34
1514076|NCT01556100|3705544|P1|STARTED|Overall Study||40
1514077|NCT01556061|3705551|P2|NOT COMPLETED|Overall Study||0
1514078|NCT01556061|3705552|P1|NOT COMPLETED|Overall Study||0
1514079|NCT01556061|3705551|P2|COMPLETED|Overall Study||25
1514080|NCT01556061|3705552|P1|COMPLETED|Overall Study||25
1514081|NCT01556061|3705551|P2|STARTED|Overall Study||25
1514082|NCT01556061|3705552|P1|STARTED|Overall Study||25
1514083|NCT01555983|3705562|P6|NOT COMPLETED|Overall Study||1
1514084|NCT01555983|3705563|P5|NOT COMPLETED|Overall Study||1
1514085|NCT01555983|3705564|P4|NOT COMPLETED|Overall Study||0
1514086|NCT01555983|3705565|P3|NOT COMPLETED|Overall Study||0
1514087|NCT01555983|3705566|P2|NOT COMPLETED|Overall Study||0
1514088|NCT01555983|3705567|P1|NOT COMPLETED|Overall Study||1
1514089|NCT01555983|3705562|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
1514090|NCT01555983|3705563|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
1514091|NCT01555983|3705564|P4|COMPLETED|Overall Study||7
1514092|NCT01555983|3705565|P3|COMPLETED|Overall Study||7
1514093|NCT01555983|3705566|P2|COMPLETED|Overall Study||7
1514094|NCT01555983|3705567|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
1514095|NCT01555983|3705562|P6|STARTED|Overall Study||7
1514096|NCT01555983|3705563|P5|STARTED|Overall Study||5
1514097|NCT01555983|3705564|P4|STARTED|Overall Study||7
1514098|NCT01555983|3705565|P3|STARTED|Overall Study||7
1514099|NCT01555983|3705566|P2|STARTED|Overall Study||7
1514100|NCT01555983|3705567|P1|STARTED|Overall Study||9
1514101|NCT01555931|3705577|P2|NOT COMPLETED|Overall Study||5
1514102|NCT01555931|3705578|P1|NOT COMPLETED|Overall Study||2
1514103|NCT01555931|3705577|P2|COMPLETED|Overall Study||13
1514104|NCT01555931|3705578|P1|COMPLETED|Overall Study||15
1514105|NCT01555931|3705577|P2|STARTED|Overall Study||18
1514106|NCT01555931|3705578|P1|STARTED|Overall Study||17
1514107|NCT01555567|3705590|P4|NOT COMPLETED|Return to Activity||1
1514108|NCT01555567|3705591|P3|NOT COMPLETED|Return to Activity||0
1514109|NCT01555567|3705592|P2|NOT COMPLETED|Return to Activity||2
1514110|NCT01555567|3705593|P1|NOT COMPLETED|Return to Activity||1
1514111|NCT01555567|3705590|P4|COMPLETED|Return to Activity||8
1514112|NCT01555567|3705591|P3|COMPLETED|Return to Activity||8
1514113|NCT01555567|3705592|P2|COMPLETED|Return to Activity||10
1514114|NCT01555567|3705593|P1|COMPLETED|Return to Activity||10
1514115|NCT01555567|3705590|P4|STARTED|Return to Activity||9
1514116|NCT01555567|3705591|P3|STARTED|Return to Activity||8
1514117|NCT01555567|3705592|P2|STARTED|Return to Activity||12
1514118|NCT01555567|3705593|P1|STARTED|Return to Activity||11
1514119|NCT01555567|3705590|P4|NOT COMPLETED|12 Week||0
1514120|NCT01555567|3705591|P3|NOT COMPLETED|12 Week||1
1514121|NCT01555567|3705592|P2|NOT COMPLETED|12 Week||1
1514122|NCT01555567|3705593|P1|NOT COMPLETED|12 Week||1
1514123|NCT01555567|3705590|P4|COMPLETED|12 Week||9
1514124|NCT01555567|3705591|P3|COMPLETED|12 Week||8
1514125|NCT01555567|3705592|P2|COMPLETED|12 Week||12
1514126|NCT01555567|3705593|P1|COMPLETED|12 Week||11
1514127|NCT01555567|3705590|P4|STARTED|12 Week||9
1514128|NCT01555567|3705591|P3|STARTED|12 Week||9
1514129|NCT01555567|3705592|P2|STARTED|12 Week||13
1514130|NCT01555567|3705593|P1|STARTED|12 Week||12
1514131|NCT01555489|3705607|P1|NOT COMPLETED|Overall Study||0
1514132|NCT01555489|3705607|P1|COMPLETED|Overall Study||11
1514133|NCT01555489|3705607|P1|STARTED|Overall Study||11
1514134|NCT01555463|3705614|P2|NOT COMPLETED|Follow up||45
1514135|NCT01555463|3705615|P1|NOT COMPLETED|Follow up||38
1514136|NCT01555463|3705614|P2|COMPLETED|Follow up||394
1514137|NCT01555463|3705615|P1|COMPLETED|Follow up||409
1514138|NCT01555463|3705614|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
1514139|NCT01555463|3705615|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
1514140|NCT01555463|3705614|P2|NOT COMPLETED|Treatment||79
1514141|NCT01555463|3705615|P1|NOT COMPLETED|Treatment||64
1514142|NCT01555463|3705614|P2|COMPLETED|Treatment||399
1514143|NCT01555463|3705615|P1|COMPLETED|Treatment||419
1514144|NCT01555463|3705614|P2|STARTED|Treatment||478
1514145|NCT01555463|3705615|P1|STARTED|Treatment||483
1514146|NCT01555164|3705657|P2|NOT COMPLETED|Overall Study||35
1514147|NCT01555164|3705658|P1|NOT COMPLETED|Overall Study||40
1514148|NCT01555164|3705657|P2|COMPLETED|Overall Study||185
1514149|NCT01555164|3705658|P1|COMPLETED|Overall Study||182
1514150|NCT01555164|3705657|P2|STARTED|Overall Study||220
1514151|NCT01555164|3705658|P1|STARTED|Overall Study||222
1514152|NCT01555151|3705672|P4|NOT COMPLETED|Overall Study||10
1514153|NCT01555151|3705673|P3|NOT COMPLETED|Overall Study||6
1514154|NCT01555151|3705674|P2|NOT COMPLETED|Overall Study||8
1514155|NCT01555151|3705675|P1|NOT COMPLETED|Overall Study||13
1514156|NCT01555151|3705672|P4|COMPLETED|Overall Study||176
1514157|NCT01555151|3705673|P3|COMPLETED|Overall Study||178
1514158|NCT01555151|3705674|P2|COMPLETED|Overall Study||173
1514159|NCT01555151|3705675|P1|COMPLETED|Overall Study||175
1514160|NCT01555151|3705672|P4|Safety Set (SAF)|Overall Study||186
1514161|NCT01555151|3705673|P3|Safety Set (SAF)|Overall Study||183
1514162|NCT01555151|3705674|P2|Safety Set (SAF)|Overall Study||180
1514163|NCT01555151|3705675|P1|Safety Set (SAF)|Overall Study||186
1514164|NCT01555151|3705672|P4|STARTED|Overall Study||186
1514165|NCT01555151|3705673|P3|STARTED|Overall Study||184
1514166|NCT01555151|3705674|P2|STARTED|Overall Study||181
1514167|NCT01555151|3705675|P1|STARTED|Overall Study||188
1514168|NCT01555138|3705728|P2|NOT COMPLETED|Overall Study||38
1514169|NCT01555138|3705729|P1|NOT COMPLETED|Overall Study||47
1514170|NCT01555138|3705728|P2|COMPLETED|Overall Study||250
1514171|NCT01555138|3705729|P1|COMPLETED|Overall Study||246
1514172|NCT01555138|3705728|P2|STARTED|Overall Study||288
1514173|NCT01555138|3705729|P1|STARTED|Overall Study||293
1514174|NCT01555125|3705758|P5|NOT COMPLETED|Follow-Up Period||0
1514175|NCT01555125|3705759|P4|NOT COMPLETED|Follow-Up Period||1
1514176|NCT01555125|3705760|P3|NOT COMPLETED|Follow-Up Period||1
1514177|NCT01555125|3705761|P2|NOT COMPLETED|Follow-Up Period||1
1514178|NCT01555125|3705762|P1|NOT COMPLETED|Follow-Up Period||4
1514179|NCT01555125|3705758|P5|COMPLETED|Follow-Up Period||0
1514180|NCT01555125|3705759|P4|COMPLETED|Follow-Up Period||17
1514181|NCT01555125|3705760|P3|COMPLETED|Follow-Up Period||18
1514182|NCT01555125|3705761|P2|COMPLETED|Follow-Up Period||30
1514183|NCT01555125|3705762|P1|COMPLETED|Follow-Up Period||32
1514184|NCT01555125|3705758|P5|STARTED|Follow-Up Period||0
1514185|NCT01555125|3705759|P4|STARTED|Follow-Up Period||18
1514186|NCT01555125|3705760|P3|STARTED|Follow-Up Period||19
1514187|NCT01555125|3705761|P2|STARTED|Follow-Up Period||31
1514188|NCT01555125|3705762|P1|STARTED|Follow-Up Period||36
1514189|NCT01555125|3705758|P5|NOT COMPLETED|Extension||0
1514190|NCT01555125|3705759|P4|NOT COMPLETED|Extension||22
1514191|NCT01555125|3705760|P3|NOT COMPLETED|Extension||23
1514192|NCT01555125|3705761|P2|NOT COMPLETED|Extension||51
1514193|NCT01555125|3705762|P1|NOT COMPLETED|Extension||45
1514194|NCT01555125|3705758|P5|COMPLETED|Extension||0
1514195|NCT01555125|3705759|P4|COMPLETED|Extension||1
1514196|NCT01555125|3705760|P3|COMPLETED|Extension||0
1514197|NCT01555125|3705761|P2|COMPLETED|Extension||0
1514198|NCT01555125|3705762|P1|COMPLETED|Extension||1
1514199|NCT01555125|3705758|P5|STARTED|Extension||0
1514200|NCT01555125|3705759|P4|STARTED|Extension||23
1514201|NCT01555125|3705760|P3|STARTED|Extension||23
1514202|NCT01555125|3705761|P2|STARTED|Extension||51
1514203|NCT01555125|3705762|P1|STARTED|Extension||46
1514204|NCT01555125|3705758|P5|NOT COMPLETED|Maintenance Period||0
1514205|NCT01555125|3705759|P4|NOT COMPLETED|Maintenance Period||2
1514206|NCT01555125|3705760|P3|NOT COMPLETED|Maintenance Period||4
1514207|NCT01555125|3705761|P2|NOT COMPLETED|Maintenance Period||4
1514208|NCT01555125|3705762|P1|NOT COMPLETED|Maintenance Period||10
1514209|NCT01555125|3705758|P5|COMPLETED|Maintenance Period||0
1514210|NCT01555125|3705759|P4|COMPLETED|Maintenance Period||25
1514211|NCT01555125|3705760|P3|COMPLETED|Maintenance Period||25
1514212|NCT01555125|3705761|P2|COMPLETED|Maintenance Period||52
1514213|NCT01555125|3705762|P1|COMPLETED|Maintenance Period||48
1514214|NCT01555125|3705758|P5|STARTED|Maintenance Period||0
1514215|NCT01555125|3705759|P4|STARTED|Maintenance Period||27
1514216|NCT01555125|3705760|P3|STARTED|Maintenance Period||29
1514217|NCT01555125|3705761|P2|STARTED|Maintenance Period||56
1514218|NCT01555125|3705762|P1|STARTED|Maintenance Period||58
1514219|NCT01555125|3705758|P5|NOT COMPLETED|Induction Period||3
1514220|NCT01555125|3705759|P4|NOT COMPLETED|Induction Period||0
1514221|NCT01555125|3705760|P3|NOT COMPLETED|Induction Period||0
1514222|NCT01555125|3705761|P2|NOT COMPLETED|Induction Period||3
1514223|NCT01555125|3705762|P1|NOT COMPLETED|Induction Period||1
1514224|NCT01555125|3705758|P5|COMPLETED|Induction Period||56
1514225|NCT01555125|3705759|P4|COMPLETED|Induction Period||0
1514226|NCT01555125|3705760|P3|COMPLETED|Induction Period||0
1514227|NCT01555125|3705761|P2|COMPLETED|Induction Period||56
1514228|NCT01555125|3705762|P1|COMPLETED|Induction Period||58
1514229|NCT01555125|3705758|P5|STARTED|Induction Period||59
1514230|NCT01555125|3705759|P4|STARTED|Induction Period||0
1514231|NCT01555125|3705760|P3|STARTED|Induction Period||0
1514232|NCT01555125|3705761|P2|STARTED|Induction Period||59
1514233|NCT01555125|3705762|P1|STARTED|Induction Period||59
1514234|NCT01555073|3705855|P4|NOT COMPLETED|Overall Study||5
1514235|NCT01555073|3705856|P3|NOT COMPLETED|Overall Study||0
1514236|NCT01555073|3705857|P2|NOT COMPLETED|Overall Study||2
1514237|NCT01555073|3705858|P1|NOT COMPLETED|Overall Study||1
1514238|NCT01555073|3705855|P4|COMPLETED|Overall Study||1
1514239|NCT01555073|3705856|P3|COMPLETED|Overall Study||7
1514240|NCT01555073|3705857|P2|COMPLETED|Overall Study||1
1514241|NCT01555073|3705858|P1|COMPLETED|Overall Study||6
1514242|NCT01555073|3705855|P4|STARTED|Overall Study||6
1514243|NCT01555073|3705856|P3|STARTED|Overall Study||7
1514244|NCT01555073|3705857|P2|STARTED|Overall Study||3
1514245|NCT01555073|3705858|P1|STARTED|Overall Study||7
1514246|NCT01555021|3705874|P2|NOT COMPLETED|Overall Study||2
1514247|NCT01555021|3705875|P1|NOT COMPLETED|Overall Study||1
1514248|NCT01555021|3705874|P2|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
1514249|NCT01555021|3705875|P1|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
1514250|NCT01555021|3705874|P2|STARTED|Overall Study||2
1514251|NCT01555021|3705875|P1|STARTED|Overall Study||2
1514252|NCT01554982|3705887|P1|NOT COMPLETED|Overall Study||43
1514253|NCT01554982|3705887|P1|COMPLETED|Overall Study||125
1514254|NCT01554982|3705887|P1|Received Drug|Overall Study||166
1514255|NCT01554982|3705887|P1|STARTED|Overall Study||168
1514256|NCT01554904|3705900|P1|NOT COMPLETED|Overall Study||4
1514257|NCT01554904|3705900|P1|COMPLETED|Overall Study||14
1514258|NCT01554904|3705900|P1|Home Sleep Study 2|Overall Study||14
1514259|NCT01554904|3705900|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
1514260|NCT01554904|3705900|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
1514261|NCT01554904|3705900|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
1514262|NCT01554904|3705900|P1|STARTED|Overall Study||18
1514263|NCT01554891|3705908|P3|NOT COMPLETED|Overall Study||2
1514264|NCT01554891|3705909|P2|NOT COMPLETED|Overall Study||5
1514265|NCT01554891|3705910|P1|NOT COMPLETED|Overall Study||7
1514266|NCT01554891|3705908|P3|COMPLETED|Overall Study||55
1514267|NCT01554891|3705909|P2|COMPLETED|Overall Study||115
1514268|NCT01554891|3705910|P1|COMPLETED|Overall Study||98
1514269|NCT01554891|3705908|P3|STARTED|Overall Study||57
1514270|NCT01554891|3705909|P2|STARTED|Overall Study||120
1514271|NCT01554891|3705910|P1|STARTED|Overall Study||105
1514272|NCT01554579|3705920|P2|NOT COMPLETED|Overall Study||27
1514273|NCT01554579|3705921|P1|NOT COMPLETED|Overall Study||10
1514274|NCT01554579|3705920|P2|COMPLETED|Overall Study||58
1514275|NCT01554579|3705921|P1|COMPLETED|Overall Study||76
1514276|NCT01554579|3705920|P2|STARTED|Overall Study||85
1514277|NCT01554579|3705921|P1|STARTED|Overall Study||86
1514278|NCT01554241|3705935|P4|NOT COMPLETED|Overall Study||1
1514279|NCT01554241|3705936|P3|NOT COMPLETED|Overall Study||4
1514280|NCT01554241|3705937|P2|NOT COMPLETED|Overall Study||1
1514281|NCT01554241|3705938|P1|NOT COMPLETED|Overall Study||3
1514282|NCT01554241|3705935|P4|COMPLETED|Overall Study||13
1514283|NCT01554241|3705936|P3|COMPLETED|Overall Study||20
1514284|NCT01554241|3705937|P2|COMPLETED|Overall Study||19
1514285|NCT01554241|3705938|P1|COMPLETED|Overall Study||20
1514286|NCT01554241|3705935|P4|STARTED|Overall Study||14
1514287|NCT01554241|3705936|P3|STARTED|Overall Study||24
1514288|NCT01554241|3705937|P2|STARTED|Overall Study||20
1514289|NCT01554241|3705938|P1|STARTED|Overall Study||23
1514290|NCT01554176|3705954|P5|NOT COMPLETED|Run-out Phase||0
1514291|NCT01554176|3705955|P4|NOT COMPLETED|Run-out Phase||1
1514292|NCT01554176|3705956|P3|NOT COMPLETED|Run-out Phase||0
1514293|NCT01554176|3705957|P2|NOT COMPLETED|Run-out Phase||0
1514294|NCT01554176|3705958|P1|NOT COMPLETED|Run-out Phase||0
1514295|NCT01554176|3705954|P5|COMPLETED|Run-out Phase||59
1514296|NCT01554176|3705955|P4|COMPLETED|Run-out Phase||27
1514297|NCT01554176|3705956|P3|COMPLETED|Run-out Phase||29
1514298|NCT01554176|3705957|P2|COMPLETED|Run-out Phase||0
1514299|NCT01554176|3705958|P1|COMPLETED|Run-out Phase||0
1514300|NCT01554176|3705954|P5|Treated|Run-out Phase||59
1514301|NCT01554176|3705955|P4|Treated|Run-out Phase||28
1514302|NCT01554176|3705956|P3|Treated|Run-out Phase||29
1514303|NCT01554176|3705957|P2|Treated|Run-out Phase||0
1514304|NCT01554176|3705958|P1|Treated|Run-out Phase||0
1514305|NCT01554176|3705954|P5|STARTED|Run-out Phase||59
1514306|NCT01554176|3705955|P4|STARTED|Run-out Phase||28
1514307|NCT01554176|3705956|P3|STARTED|Run-out Phase||29
1514308|NCT01554176|3705957|P2|STARTED|Run-out Phase||0
1514309|NCT01554176|3705958|P1|STARTED|Run-out Phase||0
1514310|NCT01554176|3705954|P5|NOT COMPLETED|Treatment Phase||0
1514311|NCT01554176|3705955|P4|NOT COMPLETED|Treatment Phase||0
1514312|NCT01554176|3705956|P3|NOT COMPLETED|Treatment Phase||0
1514313|NCT01554176|3705957|P2|NOT COMPLETED|Treatment Phase||5
1514314|NCT01554176|3705958|P1|NOT COMPLETED|Treatment Phase||8
1514315|NCT01554176|3705954|P5|COMPLETED|Treatment Phase||0
1514316|NCT01554176|3705955|P4|COMPLETED|Treatment Phase||0
1514317|NCT01554176|3705956|P3|COMPLETED|Treatment Phase||0
1514318|NCT01554176|3705957|P2|COMPLETED|Treatment Phase||59
1514319|NCT01554176|3705958|P1|COMPLETED|Treatment Phase||57
1514320|NCT01554176|3705954|P5|Treated|Treatment Phase||0
1514321|NCT01554176|3705955|P4|Treated|Treatment Phase||0
1514322|NCT01554176|3705956|P3|Treated|Treatment Phase||0
1514323|NCT01554176|3705957|P2|Treated|Treatment Phase||64
1514324|NCT01554176|3705958|P1|Treated|Treatment Phase||64
1514325|NCT01554176|3705954|P5|STARTED|Treatment Phase||0
1514326|NCT01554176|3705955|P4|STARTED|Treatment Phase||0
1514327|NCT01554176|3705956|P3|STARTED|Treatment Phase||0
1514328|NCT01554176|3705957|P2|STARTED|Treatment Phase||64
1514329|NCT01554176|3705958|P1|STARTED|Treatment Phase||65
1514330|NCT01554163|3705985|P2|NOT COMPLETED|Overall Study||10
1514331|NCT01554163|3705986|P1|NOT COMPLETED|Overall Study||8
1514332|NCT01554163|3705985|P2|COMPLETED|Overall Study||109
1514333|NCT01554163|3705986|P1|COMPLETED|Overall Study||112
1514334|NCT01554163|3705985|P2|Number Treated|Overall Study||119
1514335|NCT01554163|3705986|P1|Number Treated|Overall Study||119
1514336|NCT01554163|3705985|P2|STARTED|Overall Study||119
1514337|NCT01554163|3705986|P1|STARTED|Overall Study||120
1514338|NCT01553916|3706004|P1|NOT COMPLETED|Overall Study||3
1514339|NCT01553916|3706004|P1|COMPLETED|Overall Study||16
1514340|NCT01553916|3706004|P1|STARTED|Overall Study||19
1514341|NCT01553851|3706021|P1|NOT COMPLETED|Overall Study||3
1514342|NCT01553851|3706021|P1|COMPLETED|Overall Study||17
1514343|NCT01553851|3706021|P1|STARTED|Overall Study||20
1514344|NCT01553747|3706036|P3|NOT COMPLETED|Overall Study||109
1514345|NCT01553747|3706037|P2|NOT COMPLETED|Overall Study||119
1514346|NCT01553747|3706038|P1|NOT COMPLETED|Overall Study||131
1514347|NCT01553747|3706036|P3|COMPLETED|Overall Study||273
1514348|NCT01553747|3706037|P2|COMPLETED|Overall Study||264
1514349|NCT01553747|3706038|P1|COMPLETED|Overall Study||250
1514350|NCT01553747|3706036|P3|Participated in Blinded-Placebo Period|Overall Study||272
1514351|NCT01553747|3706037|P2|Participated in Blinded-Placebo Period|Overall Study||253
1514352|NCT01553747|3706038|P1|Participated in Blinded-Placebo Period|Overall Study||246
1514353|NCT01553747|3706036|P3|Attended Week 26 Visit|Overall Study||278
1514354|NCT01553747|3706037|P2|Attended Week 26 Visit|Overall Study||271
1514355|NCT01553747|3706038|P1|Attended Week 26 Visit|Overall Study||259
1514356|NCT01553747|3706036|P3|Attended Week 12 Visit|Overall Study||312
1514357|NCT01553747|3706037|P2|Attended Week 12 Visit|Overall Study||301
1514358|NCT01553747|3706038|P1|Attended Week 12 Visit|Overall Study||296
1514359|NCT01553747|3706036|P3|STARTED|Overall Study||382
1514360|NCT01553747|3706037|P2|STARTED|Overall Study||383
1514361|NCT01553747|3706038|P1|STARTED|Overall Study||381
1514362|NCT01553708|3706090|P2|NOT COMPLETED|Overall Study||0
1514363|NCT01553708|3706091|P1|NOT COMPLETED|Overall Study||0
1514364|NCT01553708|3706090|P2|COMPLETED|Overall Study||17
1514365|NCT01553708|3706091|P1|COMPLETED|Overall Study||17
1514366|NCT01553708|3706090|P2|STARTED|Overall Study||17
1514367|NCT01553708|3706091|P1|STARTED|Overall Study||17
1514368|NCT01553591|3706100|P3|NOT COMPLETED|Overall Study||158
1514369|NCT01553591|3706101|P2|NOT COMPLETED|Overall Study||169
1514370|NCT01553591|3706102|P1|NOT COMPLETED|Overall Study||172
1514371|NCT01553591|3706100|P3|COMPLETED|Overall Study||269
1514372|NCT01553591|3706101|P2|COMPLETED|Overall Study||257
1514373|NCT01553591|3706102|P1|COMPLETED|Overall Study||257
1514374|NCT01553591|3706100|P3|Attended Week 26 Visit|Overall Study||290
1514375|NCT01553591|3706101|P2|Attended Week 26 Visit|Overall Study||291
1514376|NCT01553591|3706102|P1|Attended Week 26 Visit|Overall Study||289
1514377|NCT01553591|3706100|P3|Attended Week 12 Visit|Overall Study||342
1514378|NCT01553591|3706101|P2|Attended Week 12 Visit|Overall Study||330
1514379|NCT01553591|3706102|P1|Attended Week 12 Visit|Overall Study||341
1514380|NCT01553591|3706100|P3|STARTED|Overall Study||427
1514381|NCT01553591|3706101|P2|STARTED|Overall Study||426
1514382|NCT01553591|3706102|P1|STARTED|Overall Study||429
1514383|NCT01553539|3706152|P1|NOT COMPLETED|Overall Study||0
1514384|NCT01553539|3706152|P1|COMPLETED|Overall Study||20
1514385|NCT01553539|3706152|P1|STARTED|Overall Study||20
1514386|NCT01553318|3706162|P2|NOT COMPLETED|Overall Study||2
1514387|NCT01553318|3706163|P1|NOT COMPLETED|Overall Study||3
1514388|NCT01553318|3706162|P2|COMPLETED|Overall Study||25
1514389|NCT01553318|3706163|P1|COMPLETED|Overall Study||21
1514390|NCT01553318|3706162|P2|STARTED|Overall Study||27
1514391|NCT01553318|3706163|P1|STARTED|Overall Study||24
1514392|NCT01553292|3706175|P1|NOT COMPLETED|Overall Study||0
1514393|NCT01553292|3706175|P1|COMPLETED|Overall Study||21
1514394|NCT01553292|3706175|P1|STARTED|Overall Study||21
1514395|NCT01553240|3706191|P1|NOT COMPLETED|Overall Study||0
1514396|NCT01553240|3706191|P1|COMPLETED|Overall Study||0
1514397|NCT01553240|3706191|P1|STARTED|Overall Study||0
1514398|NCT01553188|3706200|P4|NOT COMPLETED|Overall Study||0
1514399|NCT01553188|3706201|P3|NOT COMPLETED|Overall Study||2
1514400|NCT01553188|3706202|P2|NOT COMPLETED|Overall Study||1
1514401|NCT01553188|3706203|P1|NOT COMPLETED|Overall Study||1
1514402|NCT01553188|3706200|P4|COMPLETED|Overall Study||11
1514403|NCT01553188|3706201|P3|COMPLETED|Overall Study||14
1514404|NCT01553188|3706202|P2|COMPLETED|Overall Study||5
1514405|NCT01553188|3706203|P1|COMPLETED|Overall Study||2
1514406|NCT01553188|3706200|P4|STARTED|Overall Study||11
1514407|NCT01553188|3706201|P3|STARTED|Overall Study||16
1514408|NCT01553188|3706202|P2|STARTED|Overall Study||6
1514409|NCT01553188|3706203|P1|STARTED|Overall Study||3
1514410|NCT01553136|3706230|P2|NOT COMPLETED|Overall Study||22
1514411|NCT01553136|3706231|P1|NOT COMPLETED|Overall Study||16
1514412|NCT01553136|3706230|P2|COMPLETED|Overall Study||45
1514413|NCT01553136|3706231|P1|COMPLETED|Overall Study||48
1514414|NCT01553136|3706230|P2|Completed Treatment|Overall Study||52
1514415|NCT01553136|3706231|P1|Completed Treatment|Overall Study||55
1514416|NCT01553136|3706230|P2|STARTED|Overall Study||67
1514417|NCT01553136|3706231|P1|STARTED|Overall Study||64
1514418|NCT01553058|3706248|P3|NOT COMPLETED|Overall Study||3
1514419|NCT01553058|3706249|P2|NOT COMPLETED|Overall Study||1
1514420|NCT01553058|3706250|P1|NOT COMPLETED|Overall Study||1
1514421|NCT01553058|3706248|P3|COMPLETED|Overall Study||30
1514422|NCT01553058|3706249|P2|COMPLETED|Overall Study||30
1514423|NCT01553058|3706250|P1|COMPLETED|Overall Study||32
1514424|NCT01553058|3706248|P3|STARTED|Overall Study||33
1514425|NCT01553058|3706249|P2|STARTED|Overall Study||31
1514426|NCT01553058|3706250|P1|STARTED|Overall Study||33
1514427|NCT01552954|3706311|P2|NOT COMPLETED|Overall Study||6
1514428|NCT01552954|3706312|P1|NOT COMPLETED|Overall Study||5
1514429|NCT01552954|3706311|P2|COMPLETED|Overall Study||119
1514430|NCT01552954|3706312|P1|COMPLETED|Overall Study||126
1514431|NCT01552954|3706311|P2|STARTED|Overall Study||125
1514432|NCT01552954|3706312|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
1514433|NCT01552928|3706328|P4|NOT COMPLETED|Period 4||0
1514434|NCT01552928|3706329|P3|NOT COMPLETED|Period 4||0
1514435|NCT01552928|3706330|P2|NOT COMPLETED|Period 4||0
1514436|NCT01552928|3706331|P1|NOT COMPLETED|Period 4||0
1514437|NCT01552928|3706328|P4|COMPLETED|Period 4||16
1514438|NCT01552928|3706329|P3|COMPLETED|Period 4||14
1514439|NCT01552928|3706330|P2|COMPLETED|Period 4||15
1514440|NCT01552928|3706331|P1|COMPLETED|Period 4||14
1514441|NCT01552928|3706328|P4|STARTED|Period 4||16
1514442|NCT01552928|3706329|P3|STARTED|Period 4||14
1514443|NCT01552928|3706330|P2|STARTED|Period 4||15
1514444|NCT01552928|3706331|P1|STARTED|Period 4||14
1514445|NCT01552928|3706328|P4|NOT COMPLETED|Period 3||0
1514446|NCT01552928|3706329|P3|NOT COMPLETED|Period 3||1
1514447|NCT01552928|3706330|P2|NOT COMPLETED|Period 3||0
1514448|NCT01552928|3706331|P1|NOT COMPLETED|Period 3||0
1514449|NCT01552928|3706328|P4|COMPLETED|Period 3||16
1514450|NCT01552928|3706329|P3|COMPLETED|Period 3||14
1514451|NCT01552928|3706330|P2|COMPLETED|Period 3||15
1514452|NCT01552928|3706331|P1|COMPLETED|Period 3||14
1514453|NCT01552928|3706328|P4|STARTED|Period 3||16
1514454|NCT01552928|3706329|P3|STARTED|Period 3||15
1514455|NCT01552928|3706330|P2|STARTED|Period 3||15
1514456|NCT01552928|3706331|P1|STARTED|Period 3||14
1514457|NCT01552928|3706328|P4|NOT COMPLETED|Period 2||0
1514458|NCT01552928|3706329|P3|NOT COMPLETED|Period 2||0
1514459|NCT01552928|3706330|P2|NOT COMPLETED|Period 2||0
1514460|NCT01552928|3706331|P1|NOT COMPLETED|Period 2||0
1514461|NCT01552928|3706328|P4|COMPLETED|Period 2||16
1514462|NCT01552928|3706329|P3|COMPLETED|Period 2||15
1514463|NCT01552928|3706330|P2|COMPLETED|Period 2||15
1514464|NCT01552928|3706331|P1|COMPLETED|Period 2||14
1514465|NCT01552928|3706328|P4|STARTED|Period 2||16
1514466|NCT01552928|3706329|P3|STARTED|Period 2||15
1514467|NCT01552928|3706330|P2|STARTED|Period 2||15
1514468|NCT01552928|3706331|P1|STARTED|Period 2||14
1514469|NCT01552928|3706328|P4|NOT COMPLETED|Period 1||0
1514470|NCT01552928|3706329|P3|NOT COMPLETED|Period 1||0
1514471|NCT01552928|3706330|P2|NOT COMPLETED|Period 1||0
1514472|NCT01552928|3706331|P1|NOT COMPLETED|Period 1||0
1514473|NCT01552928|3706328|P4|COMPLETED|Period 1||16
1514474|NCT01552928|3706329|P3|COMPLETED|Period 1||15
1514475|NCT01552928|3706330|P2|COMPLETED|Period 1||15
1514476|NCT01552928|3706331|P1|COMPLETED|Period 1||14
1514477|NCT01552928|3706328|P4|STARTED|Period 1||16
1514478|NCT01552928|3706329|P3|STARTED|Period 1||15
1514479|NCT01552928|3706330|P2|STARTED|Period 1||15
1514480|NCT01552928|3706331|P1|STARTED|Period 1||14
1514481|NCT01552915|3706378|P3|NOT COMPLETED|Overall Study||27
1514482|NCT01552915|3706379|P2|NOT COMPLETED|Overall Study||29
1514483|NCT01552915|3706380|P1|NOT COMPLETED|Overall Study||23
1514484|NCT01552915|3706378|P3|COMPLETED|Overall Study||157
1514485|NCT01552915|3706379|P2|COMPLETED|Overall Study||155
1514486|NCT01552915|3706380|P1|COMPLETED|Overall Study||68
1514487|NCT01552915|3706378|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
1514488|NCT01552915|3706379|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
1514489|NCT01552915|3706380|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
1514490|NCT01552902|3706403|P3|NOT COMPLETED|Overall Study||33
1514491|NCT01552902|3706404|P2|NOT COMPLETED|Overall Study||37
1514492|NCT01552902|3706405|P1|NOT COMPLETED|Overall Study||13
1514493|NCT01552902|3706403|P3|COMPLETED|Overall Study||186
1514494|NCT01552902|3706404|P2|COMPLETED|Overall Study||181
1514495|NCT01552902|3706405|P1|COMPLETED|Overall Study||97
1514496|NCT01552902|3706403|P3|STARTED|Overall Study||219
1514497|NCT01552902|3706404|P2|STARTED|Overall Study||218
1514498|NCT01552902|3706405|P1|STARTED|Overall Study||110
1514499|NCT01552889|3706427|P2|NOT COMPLETED|Overall Study||5
1514500|NCT01552889|3706428|P1|NOT COMPLETED|Overall Study||11
1514501|NCT01552889|3706427|P2|COMPLETED|Overall Study||95
1514502|NCT01552889|3706428|P1|COMPLETED|Overall Study||90
1514503|NCT01552889|3706427|P2|STARTED|Overall Study||100
1514504|NCT01552889|3706428|P1|STARTED|Overall Study||101
1514505|NCT01552876|3706438|P2|NOT COMPLETED|Overall Study||0
1514506|NCT01552876|3706439|P1|NOT COMPLETED|Overall Study||0
1514507|NCT01552876|3706438|P2|COMPLETED|Overall Study||20
1514508|NCT01552876|3706439|P1|COMPLETED|Overall Study||20
1514509|NCT01552876|3706438|P2|STARTED|Overall Study||20
1514510|NCT01552876|3706439|P1|STARTED|Overall Study||20
1514511|NCT01552772|3706455|P1|NOT COMPLETED|Overall Study||4
1514512|NCT01552772|3706455|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
1514513|NCT01552772|3706455|P1|STARTED|Overall Study||60
1514514|NCT01552694|3706471|P2|NOT COMPLETED|Overall Study||2
1514515|NCT01552694|3706472|P1|NOT COMPLETED|Overall Study||0
1514516|NCT01552694|3706471|P2|COMPLETED|Overall Study||18
1514517|NCT01552694|3706472|P1|COMPLETED|Overall Study||18
1514518|NCT01552694|3706471|P2|STARTED|Overall Study||20
1514519|NCT01552694|3706472|P1|STARTED|Overall Study||18
1514520|NCT01552681|3706488|P2|NOT COMPLETED|Overall Study||1
1514521|NCT01552681|3706489|P1|NOT COMPLETED|Overall Study||5
1514522|NCT01552681|3706488|P2|COMPLETED|Overall Study||18
1514523|NCT01552681|3706489|P1|COMPLETED|Overall Study||28
1514524|NCT01552681|3706488|P2|STARTED|Overall Study||19
1514525|NCT01552681|3706489|P1|STARTED|Overall Study||33
1514526|NCT01552603|3706537|P1|NOT COMPLETED|Overall Study||1
1514527|NCT01552603|3706537|P1|COMPLETED|Overall Study||13
1514528|NCT01552603|3706537|P1|STARTED|Overall Study||14
1514529|NCT01552408|3706544|P2|NOT COMPLETED|Overall Study||2
1514530|NCT01552408|3706545|P1|NOT COMPLETED|Overall Study||4
1514531|NCT01552408|3706544|P2|COMPLETED|Overall Study||18
1514532|NCT01552408|3706545|P1|COMPLETED|Overall Study||16
1514533|NCT01552408|3706544|P2|STARTED|Overall Study||20
1514534|NCT01552408|3706545|P1|STARTED|Overall Study||20
1514535|NCT01552343|3706567|P2|NOT COMPLETED|Overall Study||0
1514536|NCT01552343|3706568|P1|NOT COMPLETED|Overall Study||0
1514537|NCT01552343|3706567|P2|COMPLETED|Overall Study||27
1514538|NCT01552343|3706568|P1|COMPLETED|Overall Study||29
1514539|NCT01552343|3706567|P2|STARTED|Overall Study||27
1514540|NCT01552343|3706568|P1|STARTED|Overall Study||29
1514541|NCT01552057|3706591|P2|NOT COMPLETED|Overall Study||48
1514542|NCT01552057|3706592|P1|NOT COMPLETED|Overall Study||30
1514543|NCT01552057|3706591|P2|COMPLETED|Overall Study||149
1514544|NCT01552057|3706592|P1|COMPLETED|Overall Study||166
1514545|NCT01552057|3706591|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
1514546|NCT01552057|3706592|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
1514547|NCT01552057|3706591|P2|STARTED|Overall Study||197
1514548|NCT01552057|3706592|P1|STARTED|Overall Study||196
1514549|NCT01551979|3706626|P2|NOT COMPLETED|Overall Study||2
1514550|NCT01551979|3706627|P1|NOT COMPLETED|Overall Study||2
1514551|NCT01551979|3706626|P2|COMPLETED|Overall Study||5
1514552|NCT01551979|3706627|P1|COMPLETED|Overall Study||8
1514553|NCT01551979|3706626|P2|1 Week Post Treatment|Overall Study||6
1514554|NCT01551979|3706627|P1|1 Week Post Treatment|Overall Study||10
1514555|NCT01551979|3706626|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
1514556|NCT01551979|3706627|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
1514557|NCT01551979|3706626|P2|STARTED|Overall Study||7
1514558|NCT01551979|3706627|P1|STARTED|Overall Study||10
1514559|NCT01551888|3706643|P2|NOT COMPLETED|Period 2||0
1514560|NCT01551888|3706644|P1|NOT COMPLETED|Period 2||0
1514561|NCT01551888|3706643|P2|COMPLETED|Period 2||12
1514562|NCT01551888|3706644|P1|COMPLETED|Period 2||12
1514563|NCT01551888|3706643|P2|STARTED|Period 2||12
1514564|NCT01551888|3706644|P1|STARTED|Period 2||12
1514565|NCT01551888|3706643|P2|NOT COMPLETED|Period 1||0
1514566|NCT01551888|3706644|P1|NOT COMPLETED|Period 1||0
1514567|NCT01551888|3706643|P2|COMPLETED|Period 1||12
1514568|NCT01551888|3706644|P1|COMPLETED|Period 1||12
1514569|NCT01551888|3706643|P2|STARTED|Period 1||12
1514570|NCT01551888|3706644|P1|STARTED|Period 1||12
1514571|NCT01551758|3706658|P2|NOT COMPLETED|Overall Study||105
1514572|NCT01551758|3706659|P1|NOT COMPLETED|Overall Study||94
1514573|NCT01551758|3706658|P2|COMPLETED|Overall Study||1291
1514574|NCT01551758|3706659|P1|COMPLETED|Overall Study||1309
1514575|NCT01551758|3706658|P2|STARTED|Overall Study||1396
1514576|NCT01551758|3706659|P1|STARTED|Overall Study||1403
1514577|NCT01551745|3706697|P1|NOT COMPLETED|Overall Study||3
1514578|NCT01551745|3706697|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
1514579|NCT01551745|3706697|P1|STARTED|Overall Study||5
1514580|NCT01551693|3706706|P2|NOT COMPLETED|Overall Study||2
1514581|NCT01551693|3706707|P1|NOT COMPLETED|Overall Study||1
1514582|NCT01551693|3706706|P2|COMPLETED|Overall Study||0
1514583|NCT01551693|3706707|P1|COMPLETED|Overall Study||0
1514584|NCT01551693|3706706|P2|STARTED|Overall Study||2
1514585|NCT01551693|3706707|P1|STARTED|Overall Study||1
1514586|NCT01551355|3706723|P6|NOT COMPLETED|Overall Study||6
1514587|NCT01551355|3706724|P5|NOT COMPLETED|Overall Study||9
1514588|NCT01551355|3706725|P4|NOT COMPLETED|Overall Study||24
1514589|NCT01551355|3706726|P3|NOT COMPLETED|Overall Study||34
1514590|NCT01551355|3706727|P2|NOT COMPLETED|Overall Study||49
1514591|NCT01551355|3706728|P1|NOT COMPLETED|Overall Study||51
1514592|NCT01551355|3706723|P6|COMPLETED|Overall Study||65
1514593|NCT01551355|3706724|P5|COMPLETED|Overall Study||55
1514594|NCT01551355|3706725|P4|COMPLETED|Overall Study||411
1514595|NCT01551355|3706726|P3|COMPLETED|Overall Study||459
1514596|NCT01551355|3706727|P2|COMPLETED|Overall Study||545
1514597|NCT01551355|3706728|P1|COMPLETED|Overall Study||571
1514598|NCT01551355|3706723|P6|STARTED|Overall Study||71
1514599|NCT01551355|3706724|P5|STARTED|Overall Study||64
1514600|NCT01551355|3706725|P4|STARTED|Overall Study||435
1514601|NCT01551355|3706726|P3|STARTED|Overall Study||493
1514602|NCT01551355|3706727|P2|STARTED|Overall Study||594
1514603|NCT01551355|3706728|P1|STARTED|Overall Study||622
1514604|NCT01551303|3706742|P2|NOT COMPLETED|Overall Study||7
1514605|NCT01551303|3706743|P1|NOT COMPLETED|Overall Study||4
1514606|NCT01551303|3706742|P2|COMPLETED|Overall Study||15
1514607|NCT01551303|3706743|P1|COMPLETED|Overall Study||21
1514608|NCT01551303|3706742|P2|STARTED|Overall Study||22
1514609|NCT01551303|3706743|P1|STARTED|Overall Study||25
1514610|NCT01551199|3706749|P1|NOT COMPLETED|Overall Study||5
1514611|NCT01551199|3706749|P1|COMPLETED|Overall Study||2
1514612|NCT01551199|3706749|P1|STARTED|Overall Study||7
1514613|NCT01551186|3706757|P2|NOT COMPLETED|Overall Study||13
1514614|NCT01551186|3706758|P1|NOT COMPLETED|Overall Study||20
1514615|NCT01551186|3706757|P2|COMPLETED|Overall Study||40
1514616|NCT01551186|3706758|P1|COMPLETED|Overall Study||30
1514617|NCT01551186|3706757|P2|STARTED|Overall Study||53
1514618|NCT01551186|3706758|P1|STARTED|Overall Study||50
1514619|NCT01551173|3706766|P2|NOT COMPLETED|Overall Study||32
1514620|NCT01551173|3706767|P1|NOT COMPLETED|Overall Study||28
1514621|NCT01551173|3706766|P2|COMPLETED|Overall Study||186
1514622|NCT01551173|3706767|P1|COMPLETED|Overall Study||190
1514623|NCT01551173|3706766|P2|Full Analysis Set (FAS)|Overall Study||214
1514624|NCT01551173|3706767|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
1514625|NCT01551173|3706766|P2|STARTED|Overall Study||218
1514626|NCT01551173|3706767|P1|STARTED|Overall Study|"Started indicates randomized"|218
1514627|NCT01551095|3706778|P1|NOT COMPLETED|Overall Study||0
1514628|NCT01551095|3706778|P1|COMPLETED|Overall Study||7
1514629|NCT01551095|3706778|P1|STARTED|Overall Study||7
1514630|NCT01551082|3706783|P1|NOT COMPLETED|Overall Study||0
1514631|NCT01551082|3706783|P1|COMPLETED|Overall Study||12
1514632|NCT01551082|3706783|P1|STARTED|Overall Study||12
1514633|NCT01551056|3706789|P2|NOT COMPLETED|Overall Study||0
1514634|NCT01551056|3706790|P1|NOT COMPLETED|Overall Study||2
1514635|NCT01551056|3706789|P2|COMPLETED|Overall Study||45
1514636|NCT01551056|3706790|P1|COMPLETED|Overall Study||44
1514637|NCT01551056|3706789|P2|STARTED|Overall Study||45
1514638|NCT01551056|3706790|P1|STARTED|Overall Study||46
1514639|NCT01550965|3706844|P1|NOT COMPLETED|Overall Study||110
1514640|NCT01550965|3706844|P1|COMPLETED|Overall Study||353
1514641|NCT01550965|3706844|P1|STARTED|Overall Study||463
1514642|NCT01550952|3706863|P1|NOT COMPLETED|Overall Study||0
1514643|NCT01550952|3706863|P1|COMPLETED|Overall Study||10
1514644|NCT01550952|3706863|P1|STARTED|Overall Study||10
1514645|NCT01550809|3706873|P2|NOT COMPLETED|Overall Study||0
1514646|NCT01550809|3706874|P1|NOT COMPLETED|Overall Study||0
1514647|NCT01550809|3706873|P2|COMPLETED|Overall Study||6
1514648|NCT01550809|3706874|P1|COMPLETED|Overall Study||6
1514649|NCT01550809|3706873|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
1514650|NCT01550809|3706874|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
1514651|NCT01550757|3706888|P4|NOT COMPLETED|Overall Study||54
1514652|NCT01550757|3706889|P3|NOT COMPLETED|Overall Study||45
1514653|NCT01550757|3706890|P2|NOT COMPLETED|Overall Study||14
1514654|NCT01550757|3706891|P1|NOT COMPLETED|Overall Study||23
1514655|NCT01550757|3706888|P4|COMPLETED|Overall Study||90
1514656|NCT01550757|3706889|P3|COMPLETED|Overall Study||85
1514657|NCT01550757|3706890|P2|COMPLETED|Overall Study||38
1514658|NCT01550757|3706891|P1|COMPLETED|Overall Study||33
1514659|NCT01550757|3706888|P4|STARTED|Overall Study||144
1514660|NCT01550757|3706889|P3|STARTED|Overall Study||130
1514661|NCT01550757|3706890|P2|STARTED|Overall Study||52
1514662|NCT01550757|3706891|P1|STARTED|Overall Study||56
1514663|NCT01550744|3706901|P3|NOT COMPLETED|Double-Blind||67
1514664|NCT01550744|3706902|P2|NOT COMPLETED|Double-Blind||17
1514665|NCT01550744|3706903|P1|NOT COMPLETED|Double-Blind||0
1514666|NCT01550744|3706901|P3|COMPLETED|Double-Blind||235
1514667|NCT01550744|3706902|P2|COMPLETED|Double-Blind||59
1514668|NCT01550744|3706903|P1|COMPLETED|Double-Blind||0
1514669|NCT01550744|3706901|P3|STARTED|Double-Blind||302
1514670|NCT01550744|3706902|P2|STARTED|Double-Blind||76
1514671|NCT01550744|3706903|P1|STARTED|Double-Blind||0
1514672|NCT01550744|3706901|P3|NOT COMPLETED|Open-Label||0
1514673|NCT01550744|3706902|P2|NOT COMPLETED|Open-Label||0
1514674|NCT01550744|3706903|P1|NOT COMPLETED|Open-Label||100
1514675|NCT01550744|3706901|P3|COMPLETED|Open-Label||0
1514676|NCT01550744|3706902|P2|COMPLETED|Open-Label||0
1514677|NCT01550744|3706903|P1|COMPLETED|Open-Label||378
1514678|NCT01550744|3706901|P3|STARTED|Open-Label||0
1514679|NCT01550744|3706902|P2|STARTED|Open-Label||0
1514680|NCT01550744|3706903|P1|STARTED|Open-Label||478
1514681|NCT01550705|3706916|P1|NOT COMPLETED|Overall Study||1
1514682|NCT01550705|3706916|P1|COMPLETED|Overall Study||10
1514683|NCT01550705|3706916|P1|STARTED|Overall Study||11
1514684|NCT01550549|3706921|P1|NOT COMPLETED|Overall Study||0
1514685|NCT01550549|3706921|P1|COMPLETED|Overall Study||151
1514686|NCT01550549|3706921|P1|STARTED|Overall Study||151
1514687|NCT01550510|3706933|P1|NOT COMPLETED|Overall Study||0
1514688|NCT01550510|3706933|P1|COMPLETED|Overall Study||4
1514689|NCT01550510|3706933|P1|STARTED|Overall Study||4
1514690|NCT01550302|3706940|P2|NOT COMPLETED|Overall Study||0
1514691|NCT01550302|3706941|P1|NOT COMPLETED|Overall Study||0
1514692|NCT01550302|3706940|P2|COMPLETED|Overall Study||5
1514693|NCT01550302|3706941|P1|COMPLETED|Overall Study||5
1514694|NCT01550302|3706940|P2|STARTED|Overall Study||5
1514695|NCT01550302|3706941|P1|STARTED|Overall Study||5
1514696|NCT01550289|3706961|P2|NOT COMPLETED|Overall Study||4
1514697|NCT01550289|3706962|P1|NOT COMPLETED|Overall Study||13
1514698|NCT01550289|3706961|P2|COMPLETED|Overall Study||57
1514699|NCT01550289|3706962|P1|COMPLETED|Overall Study||115
1514700|NCT01550289|3706961|P2|STARTED|Overall Study||61
1514701|NCT01550289|3706962|P1|STARTED|Overall Study||128
1514702|NCT01550224|3706994|P2|NOT COMPLETED|Overall Study||0
1514703|NCT01550224|3706995|P1|NOT COMPLETED|Overall Study||0
1514704|NCT01550224|3706994|P2|COMPLETED|Overall Study||20
1514705|NCT01550224|3706995|P1|COMPLETED|Overall Study||3
1514706|NCT01550224|3706994|P2|STARTED|Overall Study||20
1514707|NCT01550224|3706995|P1|STARTED|Overall Study||3
1514708|NCT01549977|3707019|P2|NOT COMPLETED|Overall Study||0
1514709|NCT01549977|3707020|P1|NOT COMPLETED|Overall Study||0
1514710|NCT01549977|3707019|P2|COMPLETED|Overall Study||0
1514711|NCT01549977|3707020|P1|COMPLETED|Overall Study||1
1514712|NCT01549977|3707019|P2|STARTED|Overall Study||0
1514713|NCT01549977|3707020|P1|STARTED|Overall Study||1
1514714|NCT01549964|3707038|P4|NOT COMPLETED|80-Week Extension Period||137
1514715|NCT01549964|3707039|P3|NOT COMPLETED|80-Week Extension Period||140
1514716|NCT01549964|3707040|P2|NOT COMPLETED|80-Week Extension Period||138
1514717|NCT01549964|3707041|P1|NOT COMPLETED|80-Week Extension Period||66
1514718|NCT01549964|3707038|P4|COMPLETED|80-Week Extension Period||0
1514719|NCT01549964|3707039|P3|COMPLETED|80-Week Extension Period||0
1514720|NCT01549964|3707040|P2|COMPLETED|80-Week Extension Period||0
1514721|NCT01549964|3707041|P1|COMPLETED|80-Week Extension Period||0
1514722|NCT01549964|3707038|P4|STARTED|80-Week Extension Period||137
1514723|NCT01549964|3707039|P3|STARTED|80-Week Extension Period||140
1514724|NCT01549964|3707040|P2|STARTED|80-Week Extension Period||138
1514725|NCT01549964|3707041|P1|STARTED|80-Week Extension Period||66
1514726|NCT01549964|3707038|P4|NOT COMPLETED|24-Week Treatment Period||121
1514727|NCT01549964|3707039|P3|NOT COMPLETED|24-Week Treatment Period||116
1514728|NCT01549964|3707040|P2|NOT COMPLETED|24-Week Treatment Period||111
1514729|NCT01549964|3707041|P1|NOT COMPLETED|24-Week Treatment Period||61
1514730|NCT01549964|3707038|P4|COMPLETED|24-Week Treatment Period||140
1514731|NCT01549964|3707039|P3|COMPLETED|24-Week Treatment Period||147
1514732|NCT01549964|3707040|P2|COMPLETED|24-Week Treatment Period||149
1514733|NCT01549964|3707041|P1|COMPLETED|24-Week Treatment Period||71
1514734|NCT01549964|3707038|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
1514735|NCT01549964|3707039|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
1514736|NCT01549964|3707040|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
1514737|NCT01549964|3707041|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
1514738|NCT01549964|3707038|P4|STARTED|24-Week Treatment Period||261
1514739|NCT01549964|3707039|P3|STARTED|24-Week Treatment Period||263
1514740|NCT01549964|3707040|P2|STARTED|24-Week Treatment Period||260
1514741|NCT01549964|3707041|P1|STARTED|24-Week Treatment Period||132
1514742|NCT01549951|3707059|P1|NOT COMPLETED|Overall Study||50
1514743|NCT01549951|3707059|P1|COMPLETED|Overall Study||0
1514744|NCT01549951|3707059|P1|Primary Reason Off Study Treatment|Overall Study||50
1514745|NCT01549951|3707059|P1|STARTED|Overall Study||50
1514746|NCT01549925|3707077|P2|NOT COMPLETED|Overall Study||0
1514747|NCT01549925|3707078|P1|NOT COMPLETED|Overall Study||0
1514748|NCT01549925|3707077|P2|COMPLETED|Overall Study||25
1514749|NCT01549925|3707078|P1|COMPLETED|Overall Study||25
1514750|NCT01549925|3707077|P2|STARTED|Overall Study||25
1514751|NCT01549925|3707078|P1|STARTED|Overall Study||25
1514752|NCT01549873|3707086|P2|NOT COMPLETED|Overall Study||1
1514753|NCT01549873|3707087|P1|NOT COMPLETED|Overall Study||0
1514754|NCT01549873|3707086|P2|COMPLETED|Overall Study||14
1514755|NCT01549873|3707087|P1|COMPLETED|Overall Study||15
1514756|NCT01549873|3707086|P2|STARTED|Overall Study||15
1514757|NCT01549873|3707087|P1|STARTED|Overall Study||15
1514758|NCT01549860|3707099|P2|NOT COMPLETED|Overall Study||1
1514759|NCT01549860|3707100|P1|NOT COMPLETED|Overall Study||2
1514760|NCT01549860|3707099|P2|COMPLETED|Overall Study||40
1514761|NCT01549860|3707100|P1|COMPLETED|Overall Study||38
1514762|NCT01549860|3707099|P2|STARTED|Overall Study||41
1514763|NCT01549860|3707100|P1|STARTED|Overall Study||40
1514764|NCT01549613|3707112|P2|NOT COMPLETED|Overall Study||11
1514765|NCT01549613|3707113|P1|NOT COMPLETED|Overall Study||11
1514766|NCT01549613|3707112|P2|COMPLETED|Overall Study||39
1514767|NCT01549613|3707113|P1|COMPLETED|Overall Study||39
1514768|NCT01549613|3707112|P2|STARTED|Overall Study||50
1514769|NCT01549613|3707113|P1|STARTED|Overall Study||50
1514770|NCT01549405|3707121|P2|NOT COMPLETED|Overall Study||0
1514771|NCT01549405|3707122|P1|NOT COMPLETED|Overall Study||0
1514772|NCT01549405|3707121|P2|COMPLETED|Overall Study||20
1514773|NCT01549405|3707122|P1|COMPLETED|Overall Study||20
1514774|NCT01549405|3707121|P2|STARTED|Overall Study||20
1514775|NCT01549405|3707122|P1|STARTED|Overall Study||20
1514776|NCT01549392|3707132|P2|NOT COMPLETED|Overall Study||0
1514777|NCT01549392|3707133|P1|NOT COMPLETED|Overall Study||1
1514778|NCT01549392|3707132|P2|COMPLETED|Overall Study||0
1514779|NCT01549392|3707133|P1|COMPLETED|Overall Study||2
1514780|NCT01549392|3707132|P2|STARTED|Overall Study||0
1514781|NCT01549392|3707133|P1|STARTED|Overall Study||3
1514782|NCT01549340|3707139|P1|NOT COMPLETED|Overall Study||8405
1514783|NCT01549340|3707139|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
1514784|NCT01549340|3707139|P1|Started AIT|Overall Study||3182
1514785|NCT01549340|3707139|P1|STARTED|Overall Study|Advised to receive AIT|8790
1514786|NCT01549275|3707152|P2|NOT COMPLETED|Overall Study||0
1514787|NCT01549275|3707153|P1|NOT COMPLETED|Overall Study||1
1514788|NCT01549275|3707152|P2|COMPLETED|Overall Study||29
1514789|NCT01549275|3707153|P1|COMPLETED|Overall Study||75
1514790|NCT01549275|3707152|P2|STARTED|Overall Study||29
1514791|NCT01549275|3707153|P1|STARTED|Overall Study||76
1514792|NCT01549223|3707165|P2|NOT COMPLETED|Overall Study||0
1514793|NCT01549223|3707166|P1|NOT COMPLETED|Overall Study||0
1514794|NCT01549223|3707165|P2|COMPLETED|Overall Study||30
1514795|NCT01549223|3707166|P1|COMPLETED|Overall Study||30
1514796|NCT01549223|3707165|P2|STARTED|Overall Study||30
1514797|NCT01549223|3707166|P1|STARTED|Overall Study||30
1514798|NCT01549041|3707176|P2|NOT COMPLETED|Overall Study||8
1514799|NCT01549041|3707177|P1|NOT COMPLETED|Overall Study||2
1514800|NCT01549041|3707176|P2|COMPLETED|Overall Study||10
1514801|NCT01549041|3707177|P1|COMPLETED|Overall Study||10
1514802|NCT01549041|3707176|P2|STARTED|Overall Study||18
1514803|NCT01549041|3707177|P1|STARTED|Overall Study||12
1514804|NCT01549002|3707187|P2|NOT COMPLETED|Overall Study||4
1514805|NCT01549002|3707188|P1|NOT COMPLETED|Overall Study||0
1514806|NCT01549002|3707187|P2|COMPLETED|Overall Study||6
1514807|NCT01549002|3707188|P1|COMPLETED|Overall Study||10
1514808|NCT01549002|3707187|P2|STARTED|Overall Study||10
1514809|NCT01549002|3707188|P1|STARTED|Overall Study||10
1514810|NCT01548885|3707198|P1|NOT COMPLETED|Overall Study||0
1514811|NCT01548885|3707198|P1|COMPLETED|Overall Study||146
1514812|NCT01548885|3707198|P1|STARTED|Overall Study||146
1514813|NCT01548833|3707203|P1|NOT COMPLETED|Overall Study||0
1514814|NCT01548833|3707203|P1|COMPLETED|Overall Study||39
1514815|NCT01548833|3707203|P1|STARTED|Overall Study||39
1514816|NCT01548742|3707213|P2|NOT COMPLETED|Overall Study||4
1514817|NCT01548742|3707214|P1|NOT COMPLETED|Overall Study||13
1514818|NCT01548742|3707213|P2|COMPLETED|Overall Study||54
1514819|NCT01548742|3707214|P1|COMPLETED|Overall Study||45
1514820|NCT01548742|3707213|P2|STARTED|Overall Study||58
1514821|NCT01548742|3707214|P1|STARTED|Overall Study||58
1514822|NCT01548690|3707232|P4|NOT COMPLETED|Overall Study||5
1514823|NCT01548690|3707233|P3|NOT COMPLETED|Overall Study||5
1514824|NCT01548690|3707234|P2|NOT COMPLETED|Overall Study||3
1514825|NCT01548690|3707235|P1|NOT COMPLETED|Overall Study||0
1514826|NCT01548690|3707232|P4|COMPLETED|Overall Study||10
1514827|NCT01548690|3707233|P3|COMPLETED|Overall Study||8
1514828|NCT01548690|3707234|P2|COMPLETED|Overall Study||7
1514829|NCT01548690|3707235|P1|COMPLETED|Overall Study||9
1514830|NCT01548690|3707232|P4|Evaluable (72 Hours on Infusion)|Overall Study||12
1514831|NCT01548690|3707233|P3|Evaluable (72 Hours on Infusion)|Overall Study||12
1514832|NCT01548690|3707234|P2|Evaluable (72 Hours on Infusion)|Overall Study||6
1514833|NCT01548690|3707235|P1|Evaluable (72 Hours on Infusion)|Overall Study||6
1514834|NCT01548690|3707232|P4|STARTED|Overall Study||15
1514835|NCT01548690|3707233|P3|STARTED|Overall Study||13
1514836|NCT01548690|3707234|P2|STARTED|Overall Study||10
1514837|NCT01548690|3707235|P1|STARTED|Overall Study||9
1514838|NCT01548638|3707261|P1|NOT COMPLETED|Overall Study||4
1514839|NCT01548638|3707261|P1|COMPLETED|Overall Study||9
1514840|NCT01548638|3707261|P1|STARTED|Overall Study||13
1514841|NCT01548573|3707271|P1|NOT COMPLETED|Overall Study||5
1514842|NCT01548573|3707271|P1|COMPLETED|Overall Study||14
1514843|NCT01548573|3707271|P1|STARTED|Overall Study||19
1514844|NCT01548417|3707280|P2|NOT COMPLETED|Overall Study||2
1514845|NCT01548417|3707281|P1|NOT COMPLETED|Overall Study||0
1514846|NCT01548417|3707280|P2|COMPLETED|Overall Study||26
1514847|NCT01548417|3707281|P1|COMPLETED|Overall Study||28
1514848|NCT01548417|3707280|P2|STARTED|Overall Study||28
1514849|NCT01548417|3707281|P1|STARTED|Overall Study||28
1514850|NCT01548404|3707291|P2|NOT COMPLETED|Overall Study||14
1514851|NCT01548404|3707292|P1|NOT COMPLETED|Overall Study||30
1514852|NCT01548404|3707291|P2|COMPLETED|Overall Study||41
1514853|NCT01548404|3707292|P1|COMPLETED|Overall Study||24
1514854|NCT01548404|3707291|P2|STARTED|Overall Study||55
1514855|NCT01548404|3707292|P1|STARTED|Overall Study||54
1514856|NCT01548287|3707318|P5|NOT COMPLETED|Randomized Period||0
1514857|NCT01548287|3707319|P4|NOT COMPLETED|Randomized Period||0
1514858|NCT01548287|3707320|P3|NOT COMPLETED|Randomized Period||7
1514859|NCT01548287|3707321|P2|NOT COMPLETED|Randomized Period||2
1514860|NCT01548287|3707322|P1|NOT COMPLETED|Randomized Period||0
1514861|NCT01548287|3707318|P5|COMPLETED|Randomized Period||0
1514862|NCT01548287|3707319|P4|COMPLETED|Randomized Period||20
1514863|NCT01548287|3707320|P3|COMPLETED|Randomized Period||13
1514864|NCT01548287|3707321|P2|COMPLETED|Randomized Period||20
1514865|NCT01548287|3707322|P1|COMPLETED|Randomized Period||19
1514866|NCT01548287|3707318|P5|STARTED|Randomized Period||0
1514867|NCT01548287|3707319|P4|STARTED|Randomized Period||20
1514868|NCT01548287|3707320|P3|STARTED|Randomized Period||20
1514869|NCT01548287|3707321|P2|STARTED|Randomized Period||22
1514870|NCT01548287|3707322|P1|STARTED|Randomized Period||19
1514871|NCT01548287|3707318|P5|NOT COMPLETED|Screening||83
1514872|NCT01548287|3707319|P4|NOT COMPLETED|Screening||0
1514873|NCT01548287|3707320|P3|NOT COMPLETED|Screening||0
1514874|NCT01548287|3707321|P2|NOT COMPLETED|Screening||0
1514875|NCT01548287|3707322|P1|NOT COMPLETED|Screening||0
1514876|NCT01548287|3707318|P5|COMPLETED|Screening||0
1514877|NCT01548287|3707319|P4|COMPLETED|Screening||20
1514878|NCT01548287|3707320|P3|COMPLETED|Screening||20
1514879|NCT01548287|3707321|P2|COMPLETED|Screening||22
1514880|NCT01548287|3707322|P1|COMPLETED|Screening||19
1514881|NCT01548287|3707318|P5|STARTED|Screening||83
1514882|NCT01548287|3707319|P4|STARTED|Screening||20
1514883|NCT01548287|3707320|P3|STARTED|Screening||20
1514884|NCT01548287|3707321|P2|STARTED|Screening||22
1514885|NCT01548287|3707322|P1|STARTED|Screening||19
1514886|NCT01548040|3707354|P2|NOT COMPLETED|Overall Study||10
1514887|NCT01548040|3707355|P1|NOT COMPLETED|Overall Study||13
1514888|NCT01548040|3707354|P2|COMPLETED|Overall Study||45
1514889|NCT01548040|3707355|P1|COMPLETED|Overall Study||43
1514890|NCT01548040|3707354|P2|STARTED|Overall Study||55
1514891|NCT01548040|3707355|P1|STARTED|Overall Study||56
1514892|NCT01547806|3707363|P1|NOT COMPLETED|Overall Study||0
1514893|NCT01547806|3707363|P1|COMPLETED|Overall Study||49
1514894|NCT01547806|3707363|P1|STARTED|Overall Study||49
1514895|NCT01547728|3707379|P1|NOT COMPLETED|Overall Study||41
1514896|NCT01547728|3707379|P1|COMPLETED|Overall Study||1
1514897|NCT01547728|3707379|P1|STARTED|Overall Study||42
1514898|NCT01547715|3707386|P3|NOT COMPLETED|Overall Study||0
1514899|NCT01547715|3707387|P2|NOT COMPLETED|Overall Study||0
1514900|NCT01547715|3707388|P1|NOT COMPLETED|Overall Study||0
1514901|NCT01547715|3707386|P3|COMPLETED|Overall Study||60
1514902|NCT01547715|3707387|P2|COMPLETED|Overall Study||60
1514903|NCT01547715|3707388|P1|COMPLETED|Overall Study||60
1514904|NCT01547715|3707386|P3|STARTED|Overall Study||60
1514905|NCT01547715|3707387|P2|STARTED|Overall Study||60
1514906|NCT01547715|3707388|P1|STARTED|Overall Study||60
1514907|NCT01547598|3707488|P2|NOT COMPLETED|Overall Study||5
1514908|NCT01547598|3707489|P1|NOT COMPLETED|Overall Study||6
1514909|NCT01547598|3707488|P2|COMPLETED|Overall Study||63
1514910|NCT01547598|3707489|P1|COMPLETED|Overall Study||61
1514911|NCT01547598|3707488|P2|STARTED|Overall Study||68
1514912|NCT01547598|3707489|P1|STARTED|Overall Study||67
1514913|NCT01547390|3707506|P2|NOT COMPLETED|Overall Study||10
1514914|NCT01547390|3707507|P1|NOT COMPLETED|Overall Study||13
1514915|NCT01547390|3707506|P2|COMPLETED|Overall Study||16
1514916|NCT01547390|3707507|P1|COMPLETED|Overall Study||14
1514917|NCT01547390|3707506|P2|STARTED|Overall Study||26
1514918|NCT01547390|3707507|P1|STARTED|Overall Study||27
1514919|NCT01547299|3707517|P2|NOT COMPLETED|Overall Study||2
1514920|NCT01547299|3707518|P1|NOT COMPLETED|Overall Study||2
1514921|NCT01547299|3707517|P2|COMPLETED|Overall Study||25
1514922|NCT01547299|3707518|P1|COMPLETED|Overall Study||23
1514923|NCT01547299|3707517|P2|STARTED|Overall Study||27
1514924|NCT01547299|3707518|P1|STARTED|Overall Study||25
1514925|NCT01547286|3707584|P1|NOT COMPLETED|Overall Study||2
1514926|NCT01547286|3707584|P1|COMPLETED|Overall Study||5
1514927|NCT01547286|3707584|P1|STARTED|Overall Study||7
1514928|NCT01547247|3707593|P2|NOT COMPLETED|Overall Study||6
1514929|NCT01547247|3707594|P1|NOT COMPLETED|Overall Study||6
1514930|NCT01547247|3707593|P2|COMPLETED|Overall Study||98
1514931|NCT01547247|3707594|P1|COMPLETED|Overall Study||98
1514932|NCT01547247|3707593|P2|STARTED|Overall Study||104
1514933|NCT01547247|3707594|P1|STARTED|Overall Study||104
1514934|NCT01547130|3707604|P2|NOT COMPLETED|Overall Study||5
1514935|NCT01547130|3707605|P1|NOT COMPLETED|Overall Study||9
1514936|NCT01547130|3707604|P2|COMPLETED|Overall Study||68
1514937|NCT01547130|3707605|P1|COMPLETED|Overall Study||65
1514938|NCT01547130|3707604|P2|STARTED|Overall Study||73
1514939|NCT01547130|3707605|P1|STARTED|Overall Study||74
1514940|NCT01547000|3707621|P2|NOT COMPLETED|Overall Study||0
1514941|NCT01547000|3707622|P1|NOT COMPLETED|Overall Study||0
1514942|NCT01547000|3707621|P2|COMPLETED|Overall Study||16
1514943|NCT01547000|3707622|P1|COMPLETED|Overall Study||18
1514944|NCT01547000|3707621|P2|STARTED|Overall Study||16
1514945|NCT01547000|3707622|P1|STARTED|Overall Study||18
1514946|NCT01546922|3707628|P2|NOT COMPLETED|Second Period of 10 Weeks||3
1514947|NCT01546922|3707629|P1|NOT COMPLETED|Second Period of 10 Weeks||3
1514948|NCT01546922|3707628|P2|COMPLETED|Second Period of 10 Weeks||25
1514949|NCT01546922|3707629|P1|COMPLETED|Second Period of 10 Weeks||22
1514950|NCT01546922|3707628|P2|STARTED|Second Period of 10 Weeks||28
1514951|NCT01546922|3707629|P1|STARTED|Second Period of 10 Weeks||25
1514952|NCT01546922|3707628|P2|NOT COMPLETED|First Period of 10 Weeks||2
1514953|NCT01546922|3707629|P1|NOT COMPLETED|First Period of 10 Weeks||5
1514954|NCT01546922|3707628|P2|COMPLETED|First Period of 10 Weeks||28
1514955|NCT01546922|3707629|P1|COMPLETED|First Period of 10 Weeks||25
1514956|NCT01546922|3707628|P2|STARTED|First Period of 10 Weeks||30
1514957|NCT01546922|3707629|P1|STARTED|First Period of 10 Weeks||30
1514958|NCT01546883|3707635|P1|NOT COMPLETED|Overall Study||12
1514959|NCT01546883|3707635|P1|COMPLETED|Overall Study||2
1514960|NCT01546883|3707635|P1|STARTED|Overall Study||14
1514961|NCT01546688|3707641|P2|NOT COMPLETED|Overall Study||5
1514962|NCT01546688|3707642|P1|NOT COMPLETED|Overall Study||3
1514963|NCT01546688|3707641|P2|COMPLETED|Overall Study||28
1514964|NCT01546688|3707642|P1|COMPLETED|Overall Study||15
1514965|NCT01546688|3707641|P2|STARTED|Overall Study||33
1514966|NCT01546688|3707642|P1|STARTED|Overall Study||18
1514967|NCT01546675|3707656|P2|NOT COMPLETED|Overall Study||0
1514968|NCT01546675|3707657|P1|NOT COMPLETED|Overall Study||0
1514969|NCT01546675|3707656|P2|COMPLETED|Overall Study||1
1514970|NCT01546675|3707657|P1|COMPLETED|Overall Study||1
1514971|NCT01546675|3707656|P2|STARTED|Overall Study||1
1514972|NCT01546675|3707657|P1|STARTED|Overall Study||1
1514973|NCT01546649|3707674|P2|NOT COMPLETED|Overall Study||9
1514974|NCT01546649|3707675|P1|NOT COMPLETED|Overall Study||8
1514975|NCT01546649|3707674|P2|COMPLETED|Overall Study||75
1514976|NCT01546649|3707675|P1|COMPLETED|Overall Study||75
1514977|NCT01546649|3707674|P2|STARTED|Overall Study||84
1514978|NCT01546649|3707675|P1|STARTED|Overall Study||83
1514979|NCT01546636|3707697|P2|NOT COMPLETED|Overall Study||0
1514980|NCT01546636|3707698|P1|NOT COMPLETED|Overall Study||0
1514981|NCT01546636|3707697|P2|COMPLETED|Overall Study||34
1514982|NCT01546636|3707698|P1|COMPLETED|Overall Study||36
1514983|NCT01546636|3707697|P2|STARTED|Overall Study||34
1514984|NCT01546636|3707698|P1|STARTED|Overall Study||36
1514985|NCT01546623|3707710|P2|NOT COMPLETED|Overall Study||6
1514986|NCT01546623|3707711|P1|NOT COMPLETED|Overall Study||6
1514987|NCT01546623|3707710|P2|COMPLETED|Overall Study||74
1514988|NCT01546623|3707711|P1|COMPLETED|Overall Study||76
1514989|NCT01546623|3707710|P2|Received Study Drug|Overall Study||79
1514990|NCT01546623|3707711|P1|Received Study Drug|Overall Study||81
1514991|NCT01546623|3707710|P2|STARTED|Overall Study||80
1514992|NCT01546623|3707711|P1|STARTED|Overall Study||82
1514993|NCT01546519|3707741|P4|NOT COMPLETED|Overall Study||6
1514994|NCT01546519|3707742|P3|NOT COMPLETED|Overall Study||8
1514995|NCT01546519|3707743|P2|NOT COMPLETED|Overall Study||8
1514996|NCT01546519|3707744|P1|NOT COMPLETED|Overall Study||9
1514997|NCT01546519|3707741|P4|COMPLETED|Overall Study||0
1514998|NCT01546519|3707742|P3|COMPLETED|Overall Study||0
1514999|NCT01546519|3707743|P2|COMPLETED|Overall Study||0
1515000|NCT01546519|3707744|P1|COMPLETED|Overall Study||0
1515001|NCT01546519|3707741|P4|Safety-Evaluable Participants|Overall Study||6
1515002|NCT01546519|3707742|P3|Safety-Evaluable Participants|Overall Study||8
1515003|NCT01546519|3707743|P2|Safety-Evaluable Participants|Overall Study||8
1515004|NCT01546519|3707744|P1|Safety-Evaluable Participants|Overall Study||9
1515005|NCT01546519|3707741|P4|STARTED|Overall Study||6
1515006|NCT01546519|3707742|P3|STARTED|Overall Study||8
1515007|NCT01546519|3707743|P2|STARTED|Overall Study||8
1515008|NCT01546519|3707744|P1|STARTED|Overall Study||9
1515009|NCT01546454|3707786|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
1515010|NCT01546454|3707786|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
1515011|NCT01546454|3707786|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
1515012|NCT01546454|3707786|P1|NOT COMPLETED|Eligard Treatment||0
1515013|NCT01546454|3707786|P1|COMPLETED|Eligard Treatment||4
1515014|NCT01546454|3707786|P1|STARTED|Eligard Treatment||4
1515015|NCT01546454|3707786|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
1515016|NCT01546454|3707786|P1|COMPLETED|Oral Contraceptive Cycle||4
1515017|NCT01546454|3707786|P1|STARTED|Oral Contraceptive Cycle||4
1515018|NCT01546454|3707786|P1|NOT COMPLETED|Natural Menstrual Cycle||0
1515019|NCT01546454|3707786|P1|COMPLETED|Natural Menstrual Cycle||4
1515020|NCT01546454|3707786|P1|STARTED|Natural Menstrual Cycle||4
1515021|NCT01546402|3707794|P2|NOT COMPLETED|Overall Study||0
1515022|NCT01546402|3707795|P1|NOT COMPLETED|Overall Study||0
1515023|NCT01546402|3707794|P2|COMPLETED|Overall Study||10
1515024|NCT01546402|3707795|P1|COMPLETED|Overall Study||10
1515025|NCT01546402|3707794|P2|STARTED|Overall Study||10
1515026|NCT01546402|3707795|P1|STARTED|Overall Study||10
1515027|NCT01546285|3707803|P1|NOT COMPLETED|Overall Study||0
1515028|NCT01546285|3707803|P1|COMPLETED|Overall Study||66
1515029|NCT01546285|3707803|P1|STARTED|Overall Study||66
1515030|NCT01546207|3707809|P1|NOT COMPLETED|Overall Study||1
1515031|NCT01546207|3707809|P1|COMPLETED|Overall Study||3
1515032|NCT01546207|3707809|P1|STARTED|Overall Study||4
1515033|NCT01546194|3707815|P2|NOT COMPLETED|Overall Study||35
1515034|NCT01546194|3707816|P1|NOT COMPLETED|Overall Study||36
1515035|NCT01546194|3707815|P2|COMPLETED|Overall Study||65
1515036|NCT01546194|3707816|P1|COMPLETED|Overall Study||64
1515037|NCT01546194|3707815|P2|STARTED|Overall Study||100
1515038|NCT01546194|3707816|P1|STARTED|Overall Study||100
1515039|NCT01546168|3707824|P2|NOT COMPLETED|Overall Study||0
1515040|NCT01546168|3707825|P1|NOT COMPLETED|Overall Study||4
1515041|NCT01546168|3707824|P2|COMPLETED|Overall Study||33
1515042|NCT01546168|3707825|P1|COMPLETED|Overall Study||51
1515043|NCT01546168|3707824|P2|STARTED|Overall Study||33
1515044|NCT01546168|3707825|P1|STARTED|Overall Study||55
1515045|NCT01546155|3707837|P1|NOT COMPLETED|Overall Study||3
1515046|NCT01546155|3707837|P1|COMPLETED|Overall Study||8
1515047|NCT01546155|3707837|P1|STARTED|Overall Study||11
1515048|NCT01546142|3707843|P2|NOT COMPLETED|Overall Study||34
1515049|NCT01546142|3707844|P1|NOT COMPLETED|Overall Study||44
1515050|NCT01546142|3707843|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
1515051|NCT01546142|3707844|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
1515052|NCT01546142|3707843|P2|Received Treatment|Overall Study||257
1515053|NCT01546142|3707844|P1|Received Treatment|Overall Study||257
1515054|NCT01546142|3707843|P2|STARTED|Overall Study||258
1515055|NCT01546142|3707844|P1|STARTED|Overall Study||258
1515056|NCT01546038|3707862|P9|NOT COMPLETED|Overall Study||44
1515057|NCT01546038|3707863|P8|NOT COMPLETED|Overall Study||88
1515058|NCT01546038|3707864|P7|NOT COMPLETED|Overall Study||71
1515059|NCT01546038|3707865|P6|NOT COMPLETED|Overall Study||6
1515060|NCT01546038|3707866|P5|NOT COMPLETED|Overall Study||16
1515061|NCT01546038|3707867|P4|NOT COMPLETED|Overall Study||3
1515062|NCT01546038|3707868|P3|NOT COMPLETED|Overall Study||4
1515063|NCT01546038|3707869|P2|NOT COMPLETED|Overall Study||6
1515064|NCT01546038|3707870|P1|NOT COMPLETED|Overall Study||17
1515065|NCT01546038|3707862|P9|COMPLETED|Overall Study||0
1515066|NCT01546038|3707863|P8|COMPLETED|Overall Study||0
1515067|NCT01546038|3707864|P7|COMPLETED|Overall Study||0
1515068|NCT01546038|3707865|P6|COMPLETED|Overall Study||0
1515069|NCT01546038|3707866|P5|COMPLETED|Overall Study||0
1515070|NCT01546038|3707867|P4|COMPLETED|Overall Study||0
1515071|NCT01546038|3707868|P3|COMPLETED|Overall Study||0
1515072|NCT01546038|3707869|P2|COMPLETED|Overall Study||0
1515073|NCT01546038|3707870|P1|COMPLETED|Overall Study||0
1515074|NCT01546038|3707862|P9|Received Treatment|Overall Study||41
1515075|NCT01546038|3707863|P8|Received Treatment|Overall Study||84
1515076|NCT01546038|3707864|P7|Received Treatment|Overall Study||69
1515077|NCT01546038|3707865|P6|Received Treatment|Overall Study||6
1515078|NCT01546038|3707866|P5|Received Treatment|Overall Study||16
1515079|NCT01546038|3707867|P4|Received Treatment|Overall Study||3
1515080|NCT01546038|3707868|P3|Received Treatment|Overall Study||4
1515081|NCT01546038|3707869|P2|Received Treatment|Overall Study||6
1515082|NCT01546038|3707870|P1|Received Treatment|Overall Study||17
1515083|NCT01546038|3707862|P9|STARTED|Overall Study||44
1515084|NCT01546038|3707863|P8|STARTED|Overall Study||88
1515085|NCT01546038|3707864|P7|STARTED|Overall Study||71
1515086|NCT01546038|3707865|P6|STARTED|Overall Study||6
1515087|NCT01546038|3707866|P5|STARTED|Overall Study||16
1515088|NCT01546038|3707867|P4|STARTED|Overall Study||3
1515089|NCT01546038|3707868|P3|STARTED|Overall Study||4
1515090|NCT01546038|3707869|P2|STARTED|Overall Study||6
1515091|NCT01546038|3707870|P1|STARTED|Overall Study||17
1515092|NCT01545843|3708033|P3|NOT COMPLETED|Overall Study||4
1515093|NCT01545843|3708034|P2|NOT COMPLETED|Overall Study||7
1515094|NCT01545843|3708035|P1|NOT COMPLETED|Overall Study||3
1515095|NCT01545843|3708033|P3|COMPLETED|Overall Study||21
1515096|NCT01545843|3708034|P2|COMPLETED|Overall Study||17
1515097|NCT01545843|3708035|P1|COMPLETED|Overall Study||16
1515098|NCT01545843|3708033|P3|STARTED|Overall Study||25
1515099|NCT01545843|3708034|P2|STARTED|Overall Study||24
1515100|NCT01545843|3708035|P1|STARTED|Overall Study||19
1515101|NCT01545765|3708064|P1|NOT COMPLETED|Overall Study||0
1515102|NCT01545765|3708064|P1|COMPLETED|Overall Study||31
1515103|NCT01545765|3708064|P1|STARTED|Overall Study||31
1515104|NCT01545700|3708081|P6|NOT COMPLETED|Overall Study||0
1515105|NCT01545700|3708082|P5|NOT COMPLETED|Overall Study||1
1515106|NCT01545700|3708083|P4|NOT COMPLETED|Overall Study||0
1515107|NCT01545700|3708084|P3|NOT COMPLETED|Overall Study||2
1515108|NCT01545700|3708085|P2|NOT COMPLETED|Overall Study||1
1515109|NCT01545700|3708086|P1|NOT COMPLETED|Overall Study||1
1515110|NCT01545700|3708081|P6|COMPLETED|Overall Study||33
1515111|NCT01545700|3708082|P5|COMPLETED|Overall Study||32
1515112|NCT01545700|3708083|P4|COMPLETED|Overall Study||34
1515113|NCT01545700|3708084|P3|COMPLETED|Overall Study||31
1515114|NCT01545700|3708085|P2|COMPLETED|Overall Study||32
1515115|NCT01545700|3708086|P1|COMPLETED|Overall Study||33
1515116|NCT01545700|3708081|P6|STARTED|Overall Study||33
1515117|NCT01545700|3708082|P5|STARTED|Overall Study||33
1515118|NCT01545700|3708083|P4|STARTED|Overall Study||34
1515119|NCT01545700|3708084|P3|STARTED|Overall Study||33
1515120|NCT01545700|3708085|P2|STARTED|Overall Study||33
1515121|NCT01545700|3708086|P1|STARTED|Overall Study||34
1515122|NCT01545583|3708129|P9|NOT COMPLETED|Overall Study||0
1515123|NCT01545583|3708130|P8|NOT COMPLETED|Overall Study||0
1515124|NCT01545583|3708131|P7|NOT COMPLETED|Overall Study||0
1515125|NCT01545583|3708132|P6|NOT COMPLETED|Overall Study||0
1515126|NCT01545583|3708133|P5|NOT COMPLETED|Overall Study||0
1515127|NCT01545583|3708134|P4|NOT COMPLETED|Overall Study||0
1515128|NCT01545583|3708135|P3|NOT COMPLETED|Overall Study||0
1515129|NCT01545583|3708136|P2|NOT COMPLETED|Overall Study||0
1515130|NCT01545583|3708137|P1|NOT COMPLETED|Overall Study||0
1515131|NCT01545583|3708129|P9|COMPLETED|Overall Study||6
1515132|NCT01545583|3708130|P8|COMPLETED|Overall Study||6
1515133|NCT01545583|3708131|P7|COMPLETED|Overall Study||6
1515134|NCT01545583|3708132|P6|COMPLETED|Overall Study||6
1515135|NCT01545583|3708133|P5|COMPLETED|Overall Study||6
1515136|NCT01545583|3708134|P4|COMPLETED|Overall Study||6
1515137|NCT01545583|3708135|P3|COMPLETED|Overall Study||6
1515138|NCT01545583|3708136|P2|COMPLETED|Overall Study||2
1515139|NCT01545583|3708137|P1|COMPLETED|Overall Study||12
1515140|NCT01545583|3708129|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
1515141|NCT01545583|3708130|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
1515142|NCT01545583|3708131|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
1515143|NCT01545583|3708132|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
1515144|NCT01545583|3708133|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
1515145|NCT01545583|3708134|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
1515146|NCT01545583|3708135|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1515147|NCT01545583|3708136|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
1515148|NCT01545583|3708137|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
1515149|NCT01545583|3708129|P9|STARTED|Overall Study||6
1515150|NCT01545583|3708130|P8|STARTED|Overall Study||6
1515151|NCT01545583|3708131|P7|STARTED|Overall Study||6
1515152|NCT01545583|3708132|P6|STARTED|Overall Study||6
1515153|NCT01545583|3708133|P5|STARTED|Overall Study||6
1515154|NCT01545583|3708134|P4|STARTED|Overall Study||6
1515155|NCT01545583|3708135|P3|STARTED|Overall Study||6
1515156|NCT01545583|3708136|P2|STARTED|Overall Study||2
1515157|NCT01545583|3708137|P1|STARTED|Overall Study||12
1515158|NCT01545518|3708189|P1|NOT COMPLETED|Overall Study||0
1515159|NCT01545518|3708189|P1|COMPLETED|Overall Study||20
1515160|NCT01545518|3708189|P1|STARTED|Overall Study||20
1515161|NCT01545388|3708196|P3|NOT COMPLETED|Overall Study||8
1515162|NCT01545388|3708197|P2|NOT COMPLETED|Overall Study||11
1515163|NCT01545388|3708198|P1|NOT COMPLETED|Overall Study||8
1515164|NCT01545388|3708196|P3|COMPLETED|Overall Study||58
1515165|NCT01545388|3708197|P2|COMPLETED|Overall Study||122
1515166|NCT01545388|3708198|P1|COMPLETED|Overall Study||130
1515167|NCT01545388|3708196|P3|STARTED|Overall Study||66
1515168|NCT01545388|3708197|P2|STARTED|Overall Study||133
1515169|NCT01545388|3708198|P1|STARTED|Overall Study||138
1515170|NCT01545375|3708217|P2|NOT COMPLETED|Overall Study||90
1515171|NCT01545375|3708218|P1|NOT COMPLETED|Overall Study||97
1515172|NCT01545375|3708217|P2|COMPLETED|Overall Study||813
1515173|NCT01545375|3708218|P1|COMPLETED|Overall Study||803
1515174|NCT01545375|3708217|P2|STARTED|Overall Study||903
1515175|NCT01545375|3708218|P1|STARTED|Overall Study||900
1515176|NCT01545336|3708268|P2|NOT COMPLETED|Overall Study||0
1515177|NCT01545336|3708269|P1|NOT COMPLETED|Overall Study||0
1515178|NCT01545336|3708268|P2|COMPLETED|Overall Study||6
1515179|NCT01545336|3708269|P1|COMPLETED|Overall Study||12
1515180|NCT01545336|3708268|P2|STARTED|Overall Study||6
1515181|NCT01545336|3708269|P1|STARTED|Overall Study||12
1515182|NCT01545232|3708281|P2|NOT COMPLETED|Overall Study||0
1515183|NCT01545232|3708282|P1|NOT COMPLETED|Overall Study||0
1515184|NCT01545232|3708281|P2|COMPLETED|Overall Study||342
1515185|NCT01545232|3708282|P1|COMPLETED|Overall Study||338
1515186|NCT01545232|3708281|P2|STARTED|Overall Study||342
1515187|NCT01545232|3708282|P1|STARTED|Overall Study||338
1515188|NCT01545193|3708312|P2|NOT COMPLETED|Overall Study||1
1515189|NCT01545193|3708313|P1|NOT COMPLETED|Overall Study||0
1515190|NCT01545193|3708312|P2|COMPLETED|Overall Study||149
1515191|NCT01545193|3708313|P1|COMPLETED|Overall Study||150
1515192|NCT01545193|3708312|P2|STARTED|Overall Study||150
1515193|NCT01545193|3708313|P1|STARTED|Overall Study||150
1515194|NCT01545076|3708325|P5|NOT COMPLETED|IgPro10 Rescue Period||0
1515195|NCT01545076|3708326|P4|NOT COMPLETED|IgPro10 Rescue Period||0
1515196|NCT01545076|3708327|P3|NOT COMPLETED|IgPro10 Rescue Period||0
1515197|NCT01545076|3708328|P2|NOT COMPLETED|IgPro10 Rescue Period||0
1515198|NCT01545076|3708329|P1|NOT COMPLETED|IgPro10 Rescue Period||0
1515199|NCT01545076|3708325|P5|COMPLETED|IgPro10 Rescue Period||60
1515200|NCT01545076|3708326|P4|COMPLETED|IgPro10 Rescue Period||0
1515201|NCT01545076|3708327|P3|COMPLETED|IgPro10 Rescue Period||0
1515202|NCT01545076|3708328|P2|COMPLETED|IgPro10 Rescue Period||0
1515203|NCT01545076|3708329|P1|COMPLETED|IgPro10 Rescue Period||0
1515204|NCT01545076|3708325|P5|STARTED|IgPro10 Rescue Period||60
1515205|NCT01545076|3708326|P4|STARTED|IgPro10 Rescue Period||0
1515206|NCT01545076|3708327|P3|STARTED|IgPro10 Rescue Period||0
1515207|NCT01545076|3708328|P2|STARTED|IgPro10 Rescue Period||0
1515208|NCT01545076|3708329|P1|STARTED|IgPro10 Rescue Period||0
1515209|NCT01545076|3708325|P5|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
1515210|NCT01545076|3708326|P4|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
1515211|NCT01545076|3708327|P3|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
1515212|NCT01545076|3708328|P2|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
1515213|NCT01545076|3708329|P1|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
1515214|NCT01545076|3708325|P5|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
1515215|NCT01545076|3708326|P4|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
1515216|NCT01545076|3708327|P3|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
1515217|NCT01545076|3708328|P2|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
1515218|NCT01545076|3708329|P1|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
1515219|NCT01545076|3708325|P5|STARTED|IgPro20 Subcutaneous Treatment Period||0
1515220|NCT01545076|3708326|P4|STARTED|IgPro20 Subcutaneous Treatment Period||57
1515221|NCT01545076|3708327|P3|STARTED|IgPro20 Subcutaneous Treatment Period||57
1515222|NCT01545076|3708328|P2|STARTED|IgPro20 Subcutaneous Treatment Period||58
1515223|NCT01545076|3708329|P1|STARTED|IgPro20 Subcutaneous Treatment Period||0
1515224|NCT01545076|3708325|P5|NOT COMPLETED|IgPro10 Restabilization Period||0
1515225|NCT01545076|3708326|P4|NOT COMPLETED|IgPro10 Restabilization Period||0
1515226|NCT01545076|3708327|P3|NOT COMPLETED|IgPro10 Restabilization Period||0
1515227|NCT01545076|3708328|P2|NOT COMPLETED|IgPro10 Restabilization Period||0
1515228|NCT01545076|3708329|P1|NOT COMPLETED|IgPro10 Restabilization Period||36
1515229|NCT01545076|3708325|P5|COMPLETED|IgPro10 Restabilization Period||0
1515230|NCT01545076|3708326|P4|COMPLETED|IgPro10 Restabilization Period||0
1515231|NCT01545076|3708327|P3|COMPLETED|IgPro10 Restabilization Period||0
1515232|NCT01545076|3708328|P2|COMPLETED|IgPro10 Restabilization Period||0
1515233|NCT01545076|3708329|P1|COMPLETED|IgPro10 Restabilization Period||172
1515234|NCT01545076|3708325|P5|STARTED|IgPro10 Restabilization Period||0
1515235|NCT01545076|3708326|P4|STARTED|IgPro10 Restabilization Period||0
1515236|NCT01545076|3708327|P3|STARTED|IgPro10 Restabilization Period||0
1515237|NCT01545076|3708328|P2|STARTED|IgPro10 Restabilization Period||0
1515238|NCT01545076|3708329|P1|STARTED|IgPro10 Restabilization Period||208
1515239|NCT01544998|3708379|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
1515240|NCT01544998|3708380|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
1515241|NCT01544998|3708379|P2|COMPLETED|Second Intervention (3 Hours)||15
1515242|NCT01544998|3708380|P1|COMPLETED|Second Intervention (3 Hours)||26
1515243|NCT01544998|3708379|P2|STARTED|Second Intervention (3 Hours)||15
1515244|NCT01544998|3708380|P1|STARTED|Second Intervention (3 Hours)||26
1515245|NCT01544998|3708379|P2|NOT COMPLETED|Washout (1 Week)||0
1515246|NCT01544998|3708380|P1|NOT COMPLETED|Washout (1 Week)||0
1515247|NCT01544998|3708379|P2|COMPLETED|Washout (1 Week)||15
1515248|NCT01544998|3708380|P1|COMPLETED|Washout (1 Week)||26
1515249|NCT01544998|3708379|P2|STARTED|Washout (1 Week)||15
1515250|NCT01544998|3708380|P1|STARTED|Washout (1 Week)||26
1515251|NCT01544998|3708379|P2|NOT COMPLETED|First Intervention (3 Hours)||0
1515252|NCT01544998|3708380|P1|NOT COMPLETED|First Intervention (3 Hours)||0
1515253|NCT01544998|3708379|P2|COMPLETED|First Intervention (3 Hours)||15
1515254|NCT01544998|3708380|P1|COMPLETED|First Intervention (3 Hours)||26
1515255|NCT01544998|3708379|P2|STARTED|First Intervention (3 Hours)||15
1515256|NCT01544998|3708380|P1|STARTED|First Intervention (3 Hours)||26
1515257|NCT01544920|3708400|P2|NOT COMPLETED|Overall Study||23
1515258|NCT01544920|3708401|P1|NOT COMPLETED|Overall Study||19
1515259|NCT01544920|3708400|P2|COMPLETED|Overall Study||346
1515260|NCT01544920|3708401|P1|COMPLETED|Overall Study||349
1515261|NCT01544920|3708400|P2|STARTED|Overall Study||369
1515262|NCT01544920|3708401|P1|STARTED|Overall Study||368
1515263|NCT01544595|3708415|P6|NOT COMPLETED|Status at Week 156||15
1515264|NCT01544595|3708416|P5|NOT COMPLETED|Status at Week 156||38
1515265|NCT01544595|3708417|P4|NOT COMPLETED|Status at Week 156||166
1515266|NCT01544595|3708418|P3|NOT COMPLETED|Status at Week 156||140
1515267|NCT01544595|3708419|P2|NOT COMPLETED|Status at Week 156||78
1515268|NCT01544595|3708420|P1|NOT COMPLETED|Status at Week 156||117
1515269|NCT01544595|3708415|P6|COMPLETED|Status at Week 156||38
1515270|NCT01544595|3708416|P5|COMPLETED|Status at Week 156||60
1515271|NCT01544595|3708417|P4|COMPLETED|Status at Week 156||15
1515272|NCT01544595|3708418|P3|COMPLETED|Status at Week 156||10
1515273|NCT01544595|3708419|P2|COMPLETED|Status at Week 156||285
1515274|NCT01544595|3708420|P1|COMPLETED|Status at Week 156||184
1515275|NCT01544595|3708415|P6|STARTED|Status at Week 156||53
1515276|NCT01544595|3708416|P5|STARTED|Status at Week 156||98
1515277|NCT01544595|3708417|P4|STARTED|Status at Week 156||181
1515278|NCT01544595|3708418|P3|STARTED|Status at Week 156||150
1515279|NCT01544595|3708419|P2|STARTED|Status at Week 156||363
1515280|NCT01544595|3708420|P1|STARTED|Status at Week 156||301
1515281|NCT01544595|3708415|P6|NOT COMPLETED|Status at Week 68||0
1515282|NCT01544595|3708416|P5|NOT COMPLETED|Status at Week 68||0
1515283|NCT01544595|3708417|P4|NOT COMPLETED|Status at Week 68||51
1515284|NCT01544595|3708418|P3|NOT COMPLETED|Status at Week 68||63
1515285|NCT01544595|3708419|P2|NOT COMPLETED|Status at Week 68||17
1515286|NCT01544595|3708420|P1|NOT COMPLETED|Status at Week 68||39
1515287|NCT01544595|3708415|P6|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
1515288|NCT01544595|3708416|P5|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
1515289|NCT01544595|3708417|P4|COMPLETED|Status at Week 68||130
1515290|NCT01544595|3708418|P3|COMPLETED|Status at Week 68||87
1515291|NCT01544595|3708419|P2|COMPLETED|Status at Week 68||346
1515292|NCT01544595|3708420|P1|COMPLETED|Status at Week 68||262
1515293|NCT01544595|3708415|P6|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
1515294|NCT01544595|3708416|P5|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
1515295|NCT01544595|3708417|P4|STARTED|Status at Week 68||181
1515296|NCT01544595|3708418|P3|STARTED|Status at Week 68||150
1515297|NCT01544595|3708419|P2|STARTED|Status at Week 68||363
1515298|NCT01544595|3708420|P1|STARTED|Status at Week 68||301
1515299|NCT01544582|3708496|P4|NOT COMPLETED|Analysis Population||39
1515300|NCT01544582|3708497|P3|NOT COMPLETED|Analysis Population||102
1515301|NCT01544582|3708498|P2|NOT COMPLETED|Analysis Population||118
1515302|NCT01544582|3708499|P1|NOT COMPLETED|Analysis Population||0
1515303|NCT01544582|3708496|P4|COMPLETED|Analysis Population||35
1515304|NCT01544582|3708497|P3|COMPLETED|Analysis Population||205
1515305|NCT01544582|3708498|P2|COMPLETED|Analysis Population||180
1515306|NCT01544582|3708499|P1|COMPLETED|Analysis Population||0
1515307|NCT01544582|3708496|P4|STARTED|Analysis Population||74
1515308|NCT01544582|3708497|P3|STARTED|Analysis Population||307
1515309|NCT01544582|3708498|P2|STARTED|Analysis Population||298
1515402|NCT01544153|3708785|P1|NOT COMPLETED|Overall Study||0
1515310|NCT01544582|3708499|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
1515311|NCT01544582|3708496|P4|NOT COMPLETED|Screening/Eligibility||0
1515312|NCT01544582|3708497|P3|NOT COMPLETED|Screening/Eligibility||0
1515313|NCT01544582|3708498|P2|NOT COMPLETED|Screening/Eligibility||0
1515314|NCT01544582|3708499|P1|NOT COMPLETED|Screening/Eligibility||34
1515315|NCT01544582|3708496|P4|COMPLETED|Screening/Eligibility||0
1515316|NCT01544582|3708497|P3|COMPLETED|Screening/Eligibility||0
1515317|NCT01544582|3708498|P2|COMPLETED|Screening/Eligibility||0
1515318|NCT01544582|3708499|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
1515319|NCT01544582|3708496|P4|Analysis Population|Screening/Eligibility||0
1515320|NCT01544582|3708497|P3|Analysis Population|Screening/Eligibility||0
1515321|NCT01544582|3708498|P2|Analysis Population|Screening/Eligibility||0
1515322|NCT01544582|3708499|P1|Analysis Population|Screening/Eligibility||679
1515323|NCT01544582|3708496|P4|STARTED|Screening/Eligibility||0
1515324|NCT01544582|3708497|P3|STARTED|Screening/Eligibility||0
1515325|NCT01544582|3708498|P2|STARTED|Screening/Eligibility||0
1515326|NCT01544582|3708499|P1|STARTED|Screening/Eligibility||713
1515327|NCT01544478|3708557|P1|NOT COMPLETED|Overall Study||118
1515328|NCT01544478|3708557|P1|COMPLETED|Overall Study||912
1515329|NCT01544478|3708557|P1|Vaccination 3|Overall Study||1019
1515330|NCT01544478|3708557|P1|Vaccination 2|Overall Study||1026
1515331|NCT01544478|3708557|P1|Vaccination 1|Overall Study||1030
1515332|NCT01544478|3708557|P1|STARTED|Overall Study||1030
1515333|NCT01544361|3708566|P5|NOT COMPLETED|Overall Study||0
1515334|NCT01544361|3708567|P4|NOT COMPLETED|Overall Study||0
1515335|NCT01544361|3708568|P3|NOT COMPLETED|Overall Study||0
1515336|NCT01544361|3708569|P2|NOT COMPLETED|Overall Study||0
1515337|NCT01544361|3708570|P1|NOT COMPLETED|Overall Study||0
1515338|NCT01544361|3708566|P5|COMPLETED|Overall Study||6
1515339|NCT01544361|3708567|P4|COMPLETED|Overall Study||6
1515340|NCT01544361|3708568|P3|COMPLETED|Overall Study||6
1515341|NCT01544361|3708569|P2|COMPLETED|Overall Study||6
1515342|NCT01544361|3708570|P1|COMPLETED|Overall Study||8
1515343|NCT01544361|3708566|P5|STARTED|Overall Study||6
1515344|NCT01544361|3708567|P4|STARTED|Overall Study||6
1515345|NCT01544361|3708568|P3|STARTED|Overall Study||6
1515346|NCT01544361|3708569|P2|STARTED|Overall Study||6
1515347|NCT01544361|3708570|P1|STARTED|Overall Study||8
1515348|NCT01544348|3708600|P8|NOT COMPLETED|Overall Study||0
1515349|NCT01544348|3708601|P7|NOT COMPLETED|Overall Study||2
1515350|NCT01544348|3708602|P6|NOT COMPLETED|Overall Study||3
1515351|NCT01544348|3708603|P5|NOT COMPLETED|Overall Study||1
1515352|NCT01544348|3708604|P4|NOT COMPLETED|Overall Study||0
1515353|NCT01544348|3708605|P3|NOT COMPLETED|Overall Study||0
1515354|NCT01544348|3708606|P2|NOT COMPLETED|Overall Study||0
1515355|NCT01544348|3708607|P1|NOT COMPLETED|Overall Study||2
1515356|NCT01544348|3708600|P8|COMPLETED|Overall Study||8
1515357|NCT01544348|3708601|P7|COMPLETED|Overall Study||12
1515358|NCT01544348|3708602|P6|COMPLETED|Overall Study||16
1515359|NCT01544348|3708603|P5|COMPLETED|Overall Study||15
1515360|NCT01544348|3708604|P4|COMPLETED|Overall Study||3
1515361|NCT01544348|3708605|P3|COMPLETED|Overall Study||3
1515362|NCT01544348|3708606|P2|COMPLETED|Overall Study||6
1515363|NCT01544348|3708607|P1|COMPLETED|Overall Study||15
1515364|NCT01544348|3708600|P8|Treated|Overall Study||8
1515365|NCT01544348|3708601|P7|Treated|Overall Study||14
1515366|NCT01544348|3708602|P6|Treated|Overall Study||18
1515367|NCT01544348|3708603|P5|Treated|Overall Study||15
1515368|NCT01544348|3708604|P4|Treated|Overall Study||3
1515369|NCT01544348|3708605|P3|Treated|Overall Study||3
1515370|NCT01544348|3708606|P2|Treated|Overall Study||6
1515371|NCT01544348|3708607|P1|Treated|Overall Study||17
1515372|NCT01544348|3708600|P8|STARTED|Overall Study||8
1515373|NCT01544348|3708601|P7|STARTED|Overall Study||14
1515374|NCT01544348|3708602|P6|STARTED|Overall Study||19
1515375|NCT01544348|3708603|P5|STARTED|Overall Study||16
1515376|NCT01544348|3708604|P4|STARTED|Overall Study||3
1515377|NCT01544348|3708605|P3|STARTED|Overall Study||3
1515378|NCT01544348|3708606|P2|STARTED|Overall Study||6
1515379|NCT01544348|3708607|P1|STARTED|Overall Study||17
1515380|NCT01544309|3708649|P2|NOT COMPLETED|Overall Study||11
1515381|NCT01544309|3708650|P1|NOT COMPLETED|Overall Study||20
1515382|NCT01544309|3708649|P2|COMPLETED|Overall Study||514
1515383|NCT01544309|3708650|P1|COMPLETED|Overall Study||504
1515384|NCT01544309|3708649|P2|STARTED|Overall Study||525
1515385|NCT01544309|3708650|P1|STARTED|Overall Study||524
1515386|NCT01544179|3708688|P2|NOT COMPLETED|Overall Study||46
1515387|NCT01544179|3708689|P1|NOT COMPLETED|Overall Study||63
1515388|NCT01544179|3708688|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
1515389|NCT01544179|3708689|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
1515390|NCT01544179|3708688|P2|Did Not Receive Treatment|Overall Study||0
1515391|NCT01544179|3708689|P1|Did Not Receive Treatment|Overall Study||1
1515392|NCT01544179|3708688|P2|Received Treatment|Overall Study||132
1515393|NCT01544179|3708689|P1|Received Treatment|Overall Study||132
1515394|NCT01544179|3708688|P2|STARTED|Overall Study||132
1515395|NCT01544179|3708689|P1|STARTED|Overall Study||133
1515396|NCT01544166|3708717|P1|NOT COMPLETED|Overall Study||0
1515397|NCT01544166|3708717|P1|COMPLETED|Overall Study||44
1515398|NCT01544166|3708717|P1|STARTED|Overall Study||44
1515399|NCT01544153|3708782|P4|NOT COMPLETED|Overall Study||0
1515400|NCT01544153|3708783|P3|NOT COMPLETED|Overall Study||1
1515401|NCT01544153|3708784|P2|NOT COMPLETED|Overall Study||1
1515403|NCT01544153|3708782|P4|COMPLETED|Overall Study||1317
1515404|NCT01544153|3708783|P3|COMPLETED|Overall Study||1313
1515405|NCT01544153|3708784|P2|COMPLETED|Overall Study||1323
1515406|NCT01544153|3708785|P1|COMPLETED|Overall Study||1337
1515407|NCT01544153|3708782|P4|STARTED|Overall Study||1317
1515408|NCT01544153|3708783|P3|STARTED|Overall Study||1314
1515409|NCT01544153|3708784|P2|STARTED|Overall Study||1324
1515410|NCT01544153|3708785|P1|STARTED|Overall Study||1337
1515411|NCT01544114|3708802|P3|NOT COMPLETED|Overall Study||5
1515412|NCT01544114|3708803|P2|NOT COMPLETED|Overall Study||4
1515413|NCT01544114|3708804|P1|NOT COMPLETED|Overall Study||1
1515414|NCT01544114|3708802|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
1515415|NCT01544114|3708803|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
1515416|NCT01544114|3708804|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
1515417|NCT01544114|3708802|P3|STARTED|Overall Study||22
1515418|NCT01544114|3708803|P2|STARTED|Overall Study||20
1515419|NCT01544114|3708804|P1|STARTED|Overall Study||4
1515420|NCT01544062|3708835|P2|NOT COMPLETED|Overall Study||0
1515421|NCT01544062|3708836|P1|NOT COMPLETED|Overall Study||0
1515422|NCT01544062|3708835|P2|COMPLETED|Overall Study||35
1515423|NCT01544062|3708836|P1|COMPLETED|Overall Study||33
1515424|NCT01544062|3708835|P2|STARTED|Overall Study||35
1515425|NCT01544062|3708836|P1|STARTED|Overall Study||33
1515426|NCT01544023|3708882|P1|NOT COMPLETED|Overall Study||0
1515427|NCT01544023|3708882|P1|COMPLETED|Overall Study||207
1515428|NCT01544023|3708882|P1|STARTED|Overall Study|retrospective|207
1515429|NCT01543958|3708887|P1|NOT COMPLETED|Overall Study||4
1515430|NCT01543958|3708887|P1|COMPLETED|Overall Study||36
1515431|NCT01543958|3708887|P1|STARTED|Overall Study||40
1515432|NCT01543828|3708942|P2|NOT COMPLETED|Treatment 2||0
1515433|NCT01543828|3708943|P1|NOT COMPLETED|Treatment 2||1
1515434|NCT01543828|3708942|P2|COMPLETED|Treatment 2||19
1515435|NCT01543828|3708943|P1|COMPLETED|Treatment 2||19
1515436|NCT01543828|3708942|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
1515437|NCT01543828|3708943|P1|STARTED|Treatment 2||20
1515438|NCT01543828|3708942|P2|NOT COMPLETED|Treatment 1||0
1515439|NCT01543828|3708943|P1|NOT COMPLETED|Treatment 1||0
1515440|NCT01543828|3708942|P2|COMPLETED|Treatment 1||20
1515441|NCT01543828|3708943|P1|COMPLETED|Treatment 1||20
1515442|NCT01543828|3708942|P2|STARTED|Treatment 1||20
1515443|NCT01543828|3708943|P1|STARTED|Treatment 1||20
1515444|NCT01543685|3708956|P5|NOT COMPLETED|Overall Study||4
1515445|NCT01543685|3708957|P4|NOT COMPLETED|Overall Study||0
1515446|NCT01543685|3708958|P3|NOT COMPLETED|Overall Study||2
1515447|NCT01543685|3708959|P2|NOT COMPLETED|Overall Study||3
1515448|NCT01543685|3708960|P1|NOT COMPLETED|Overall Study||3
1515449|NCT01543685|3708956|P5|COMPLETED|Overall Study||90
1515450|NCT01543685|3708957|P4|COMPLETED|Overall Study||93
1515451|NCT01543685|3708958|P3|COMPLETED|Overall Study||89
1515452|NCT01543685|3708959|P2|COMPLETED|Overall Study||88
1515453|NCT01543685|3708960|P1|COMPLETED|Overall Study||90
1515454|NCT01543685|3708956|P5|STARTED|Overall Study||94
1515455|NCT01543685|3708957|P4|STARTED|Overall Study||93
1515456|NCT01543685|3708958|P3|STARTED|Overall Study||91
1515457|NCT01543685|3708959|P2|STARTED|Overall Study||91
1515458|NCT01543685|3708960|P1|STARTED|Overall Study||93
1515459|NCT01543607|3709007|P1|NOT COMPLETED|Overall Study||0
1515460|NCT01543607|3709007|P1|COMPLETED|Overall Study||1
1515461|NCT01543607|3709007|P1|STARTED|Overall Study||1
1515462|NCT01543581|3709013|P2|NOT COMPLETED|Overall Study||0
1515463|NCT01543581|3709014|P1|NOT COMPLETED|Overall Study||0
1515464|NCT01543581|3709013|P2|COMPLETED|Overall Study||0
1515465|NCT01543581|3709014|P1|COMPLETED|Overall Study||1
1515466|NCT01543581|3709013|P2|STARTED|Overall Study||0
1515467|NCT01543581|3709014|P1|STARTED|Overall Study||1
1515468|NCT01543568|3709020|P1|NOT COMPLETED|Overall Study||1
1515469|NCT01543568|3709020|P1|COMPLETED|Overall Study||45
1515470|NCT01543568|3709020|P1|STARTED|Overall Study||46
1515471|NCT01543503|3709032|P2|NOT COMPLETED|Overall Study||87
1515472|NCT01543503|3709033|P1|NOT COMPLETED|Overall Study||76
1515473|NCT01543503|3709032|P2|COMPLETED|Overall Study||711
1515474|NCT01543503|3709033|P1|COMPLETED|Overall Study||350
1515475|NCT01543503|3709032|P2|STARTED|Overall Study||798
1515476|NCT01543503|3709033|P1|STARTED|Overall Study||426
1515477|NCT01543204|3709077|P1|NOT COMPLETED|Overall Study||8
1515478|NCT01543204|3709077|P1|COMPLETED|Overall Study||56
1515479|NCT01543204|3709077|P1|STARTED|Overall Study||64
1515480|NCT01543178|3709124|P3|NOT COMPLETED|Double-blind Period||37
1515481|NCT01543178|3709125|P2|NOT COMPLETED|Double-blind Period||44
1515482|NCT01543178|3709126|P1|NOT COMPLETED|Double-blind Period||0
1515483|NCT01543178|3709124|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
1515484|NCT01543178|3709125|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
1515485|NCT01543178|3709126|P1|COMPLETED|Double-blind Period||0
1515486|NCT01543178|3709124|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
1515487|NCT01543178|3709125|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
1515488|NCT01543178|3709126|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
1515489|NCT01543178|3709124|P3|NOT COMPLETED|Open-label Period||0
1515490|NCT01543178|3709125|P2|NOT COMPLETED|Open-label Period||0
1515491|NCT01543178|3709126|P1|NOT COMPLETED|Open-label Period||1947
1515492|NCT01543178|3709124|P3|COMPLETED|Open-label Period||0
1515493|NCT01543178|3709125|P2|COMPLETED|Open-label Period||0
1515494|NCT01543178|3709126|P1|COMPLETED|Open-label Period||636
1515495|NCT01543178|3709124|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
1515496|NCT01543178|3709125|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
1515497|NCT01543178|3709126|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
1515498|NCT01543074|3709137|P4|NOT COMPLETED|Overall Study||0
1515499|NCT01543074|3709138|P3|NOT COMPLETED|Overall Study||0
1515500|NCT01543074|3709139|P2|NOT COMPLETED|Overall Study||0
1515501|NCT01543074|3709140|P1|NOT COMPLETED|Overall Study||0
1515502|NCT01543074|3709137|P4|COMPLETED|Overall Study||6
1515503|NCT01543074|3709138|P3|COMPLETED|Overall Study||5
1515504|NCT01543074|3709139|P2|COMPLETED|Overall Study||7
1515505|NCT01543074|3709140|P1|COMPLETED|Overall Study||5
1515506|NCT01543074|3709137|P4|STARTED|Overall Study||6
1515507|NCT01543074|3709138|P3|STARTED|Overall Study||5
1515508|NCT01543074|3709139|P2|STARTED|Overall Study||7
1515509|NCT01543074|3709140|P1|STARTED|Overall Study||5
1515510|NCT01542957|3709156|P2|NOT COMPLETED|12-month Follow-up||13
1515511|NCT01542957|3709157|P1|NOT COMPLETED|12-month Follow-up||16
1515512|NCT01542957|3709156|P2|COMPLETED|12-month Follow-up||40
1515513|NCT01542957|3709157|P1|COMPLETED|12-month Follow-up||37
1515514|NCT01542957|3709156|P2|STARTED|12-month Follow-up||53
1515515|NCT01542957|3709157|P1|STARTED|12-month Follow-up||53
1515516|NCT01542957|3709156|P2|NOT COMPLETED|3-month Follow-up||8
1515517|NCT01542957|3709157|P1|NOT COMPLETED|3-month Follow-up||3
1515518|NCT01542957|3709156|P2|COMPLETED|3-month Follow-up||45
1515519|NCT01542957|3709157|P1|COMPLETED|3-month Follow-up||50
1515520|NCT01542957|3709156|P2|STARTED|3-month Follow-up||53
1515521|NCT01542957|3709157|P1|STARTED|3-month Follow-up||53
1515522|NCT01542957|3709156|P2|NOT COMPLETED|End of Therapy||10
1515523|NCT01542957|3709157|P1|NOT COMPLETED|End of Therapy||12
1515524|NCT01542957|3709156|P2|COMPLETED|End of Therapy||53
1515525|NCT01542957|3709157|P1|COMPLETED|End of Therapy||53
1515526|NCT01542957|3709156|P2|STARTED|End of Therapy||63
1515527|NCT01542957|3709157|P1|STARTED|End of Therapy||65
1515528|NCT01542788|3709169|P2|NOT COMPLETED|Overall Study||71
1515529|NCT01542788|3709170|P1|NOT COMPLETED|Overall Study||55
1515530|NCT01542788|3709169|P2|COMPLETED|Overall Study||0
1515531|NCT01542788|3709170|P1|COMPLETED|Overall Study||154
1515532|NCT01542788|3709169|P2|Randomized and Treated|Overall Study||71
1515533|NCT01542788|3709170|P1|Randomized and Treated|Overall Study||207
1515534|NCT01542788|3709169|P2|STARTED|Overall Study||71
1515535|NCT01542788|3709170|P1|STARTED|Overall Study||209
1515536|NCT01542684|3709186|P1|NOT COMPLETED|Overall Study||0
1515537|NCT01542684|3709186|P1|COMPLETED|Overall Study||8
1515538|NCT01542684|3709186|P1|STARTED|Overall Study||8
1515539|NCT01542645|3709192|P2|NOT COMPLETED|Overall Study||3
1515540|NCT01542645|3709193|P1|NOT COMPLETED|Overall Study||5
1515541|NCT01542645|3709192|P2|COMPLETED|Overall Study||79
1515542|NCT01542645|3709193|P1|COMPLETED|Overall Study||77
1515543|NCT01542645|3709192|P2|STARTED|Overall Study||82
1515544|NCT01542645|3709193|P1|STARTED|Overall Study||82
1515545|NCT01542632|3709209|P6|NOT COMPLETED|Overall Study||0
1515546|NCT01542632|3709210|P5|NOT COMPLETED|Overall Study||4
1515547|NCT01542632|3709211|P4|NOT COMPLETED|Overall Study||2
1515548|NCT01542632|3709212|P3|NOT COMPLETED|Overall Study||1
1515549|NCT01542632|3709213|P2|NOT COMPLETED|Overall Study||1
1515550|NCT01542632|3709214|P1|NOT COMPLETED|Overall Study||0
1515551|NCT01542632|3709209|P6|COMPLETED|Overall Study||24
1515552|NCT01542632|3709210|P5|COMPLETED|Overall Study||17
1515553|NCT01542632|3709211|P4|COMPLETED|Overall Study||19
1515554|NCT01542632|3709212|P3|COMPLETED|Overall Study||23
1515555|NCT01542632|3709213|P2|COMPLETED|Overall Study||24
1515556|NCT01542632|3709214|P1|COMPLETED|Overall Study||25
1515557|NCT01542632|3709209|P6|STARTED|Overall Study||24
1515558|NCT01542632|3709210|P5|STARTED|Overall Study||21
1515559|NCT01542632|3709211|P4|STARTED|Overall Study||21
1515560|NCT01542632|3709212|P3|STARTED|Overall Study||24
1515561|NCT01542632|3709213|P2|STARTED|Overall Study||25
1515562|NCT01542632|3709214|P1|STARTED|Overall Study||25
1515563|NCT01542541|3709260|P2|NOT COMPLETED|Overall Study||0
1515564|NCT01542541|3709261|P1|NOT COMPLETED|Overall Study||8
1515565|NCT01542541|3709260|P2|COMPLETED|Overall Study||30
1515566|NCT01542541|3709261|P1|COMPLETED|Overall Study||30
1515567|NCT01542541|3709260|P2|STARTED|Overall Study||30
1515568|NCT01542541|3709261|P1|STARTED|Overall Study||38
1515569|NCT01542528|3709271|P2|NOT COMPLETED|Overall Study||7
1515570|NCT01542528|3709272|P1|NOT COMPLETED|Overall Study||12
1515571|NCT01542528|3709271|P2|COMPLETED|Overall Study||49
1515572|NCT01542528|3709272|P1|COMPLETED|Overall Study||49
1515573|NCT01542528|3709271|P2|STARTED|Overall Study||56
1515574|NCT01542528|3709272|P1|STARTED|Overall Study||61
1515575|NCT01542502|3709280|P2|NOT COMPLETED|Overall Study||0
1515576|NCT01542502|3709281|P1|NOT COMPLETED|Overall Study||0
1515577|NCT01542502|3709280|P2|COMPLETED|Overall Study||6
1515578|NCT01542502|3709281|P1|COMPLETED|Overall Study||6
1515579|NCT01542502|3709280|P2|STARTED|Overall Study||6
1515580|NCT01542502|3709281|P1|STARTED|Overall Study||6
1515581|NCT01542398|3709291|P2|NOT COMPLETED|Overall Study||13
1515582|NCT01542398|3709292|P1|NOT COMPLETED|Overall Study||8
1515583|NCT01542398|3709291|P2|COMPLETED|Overall Study||67
1515584|NCT01542398|3709292|P1|COMPLETED|Overall Study||71
1515585|NCT01542398|3709291|P2|Post-Intervention Assessment|Overall Study||80
1515586|NCT01542398|3709292|P1|Post-Intervention Assessment|Overall Study||78
1515587|NCT01542398|3709291|P2|STARTED|Overall Study||80
1515588|NCT01542398|3709292|P1|STARTED|Overall Study||79
1515589|NCT01542372|3709300|P2|NOT COMPLETED|Overall Study||0
1515590|NCT01542372|3709301|P1|NOT COMPLETED|Overall Study||0
1515591|NCT01542372|3709300|P2|COMPLETED|Overall Study||11
1515592|NCT01542372|3709301|P1|COMPLETED|Overall Study||11
1515593|NCT01542372|3709300|P2|STARTED|Overall Study||11
1515594|NCT01542372|3709301|P1|STARTED|Overall Study||11
1515595|NCT01542307|3709316|P2|NOT COMPLETED|Overall Study||0
1515596|NCT01542307|3709317|P1|NOT COMPLETED|Overall Study||0
1515597|NCT01542307|3709316|P2|COMPLETED|Overall Study||22
1515598|NCT01542307|3709317|P1|COMPLETED|Overall Study||22
1515599|NCT01542307|3709316|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
1515600|NCT01542307|3709317|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
1515601|NCT01542255|3709337|P1|NOT COMPLETED|Overall Study||0
1515602|NCT01542255|3709337|P1|COMPLETED|Overall Study||7
1515603|NCT01542255|3709337|P1|Analyzed for Time to Progression|Overall Study||7
1515604|NCT01542255|3709337|P1|STARTED|Overall Study||7
1515605|NCT01542125|3709343|P2|NOT COMPLETED|Overall Study||0
1515606|NCT01542125|3709344|P1|NOT COMPLETED|Overall Study||0
1515607|NCT01542125|3709343|P2|COMPLETED|Overall Study||141
1515608|NCT01542125|3709344|P1|COMPLETED|Overall Study||140
1515609|NCT01542125|3709343|P2|STARTED|Overall Study||141
1515610|NCT01542125|3709344|P1|STARTED|Overall Study||140
1515611|NCT01542034|3709352|P2|NOT COMPLETED|Overall Study||23
1515612|NCT01542034|3709353|P1|NOT COMPLETED|Overall Study||30
1515613|NCT01542034|3709352|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
1515614|NCT01542034|3709353|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
1515615|NCT01542034|3709352|P2|Received Treatment|Overall Study||249
1515616|NCT01542034|3709353|P1|Received Treatment|Overall Study||256
1515617|NCT01542034|3709352|P2|STARTED|Overall Study||250
1515618|NCT01542034|3709353|P1|STARTED|Overall Study||256
1515619|NCT01541969|3709367|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
1515620|NCT01541969|3709368|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
1515621|NCT01541969|3709367|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
1515622|NCT01541969|3709368|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
1515623|NCT01541969|3709367|P2|STARTED|Open Label Extension (12-36 Weeks)||48
1515624|NCT01541969|3709368|P1|STARTED|Open Label Extension (12-36 Weeks)||44
1515625|NCT01541969|3709367|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
1515626|NCT01541969|3709368|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
1515627|NCT01541969|3709367|P2|COMPLETED|Double-blind (0-12 Weeks)||48
1515628|NCT01541969|3709368|P1|COMPLETED|Double-blind (0-12 Weeks)||44
1515629|NCT01541969|3709367|P2|STARTED|Double-blind (0-12 Weeks)||50
1515630|NCT01541969|3709368|P1|STARTED|Double-blind (0-12 Weeks)||50
1515631|NCT01541930|3709384|P1|NOT COMPLETED|Overall Study||1
1515632|NCT01541930|3709384|P1|COMPLETED|Overall Study||20
1515633|NCT01541930|3709384|P1|STARTED|Overall Study||21
1515634|NCT01541917|3709406|P2|NOT COMPLETED|Overall Study||9
1515635|NCT01541917|3709407|P1|NOT COMPLETED|Overall Study||15
1515636|NCT01541917|3709406|P2|COMPLETED|Overall Study||136
1515637|NCT01541917|3709407|P1|COMPLETED|Overall Study||129
1515638|NCT01541917|3709406|P2|STARTED|Overall Study||145
1515639|NCT01541917|3709407|P1|STARTED|Overall Study||144
1515640|NCT01541891|3709425|P2|NOT COMPLETED|Overall Study||1
1515641|NCT01541891|3709426|P1|NOT COMPLETED|Overall Study||1
1515642|NCT01541891|3709425|P2|COMPLETED|Overall Study||14
1515643|NCT01541891|3709426|P1|COMPLETED|Overall Study||14
1515644|NCT01541891|3709425|P2|STARTED|Overall Study||15
1515645|NCT01541891|3709426|P1|STARTED|Overall Study||15
1515646|NCT01541865|3709436|P1|NOT COMPLETED|Overall Study||22
1515647|NCT01541865|3709436|P1|COMPLETED|Overall Study||124
1515648|NCT01541865|3709436|P1|STARTED|Overall Study||146
1515649|NCT01541826|3709454|P3|NOT COMPLETED|Overall Study||0
1515650|NCT01541826|3709455|P2|NOT COMPLETED|Overall Study||3
1515651|NCT01541826|3709456|P1|NOT COMPLETED|Overall Study||4
1515652|NCT01541826|3709454|P3|COMPLETED|Overall Study||6
1515653|NCT01541826|3709455|P2|COMPLETED|Overall Study||25
1515654|NCT01541826|3709456|P1|COMPLETED|Overall Study||24
1515655|NCT01541826|3709454|P3|STARTED|Overall Study||6
1515656|NCT01541826|3709455|P2|STARTED|Overall Study||28
1515657|NCT01541826|3709456|P1|STARTED|Overall Study||28
1515658|NCT01541735|3709525|P2|NOT COMPLETED|Overall Study||0
1515659|NCT01541735|3709526|P1|NOT COMPLETED|Overall Study||0
1515660|NCT01541735|3709525|P2|COMPLETED|Overall Study||7
1515661|NCT01541735|3709526|P1|COMPLETED|Overall Study||7
1515662|NCT01541735|3709525|P2|STARTED|Overall Study||7
1515663|NCT01541735|3709526|P1|STARTED|Overall Study||7
1515664|NCT01541644|3709538|P1|NOT COMPLETED|Overall Study||3
1515665|NCT01541644|3709538|P1|COMPLETED|Overall Study||24
1515666|NCT01541644|3709538|P1|STARTED|Overall Study||27
1515667|NCT01541553|3709544|P2|NOT COMPLETED|Overall Study||14
1515668|NCT01541553|3709545|P1|NOT COMPLETED|Overall Study||12
1515669|NCT01541553|3709544|P2|COMPLETED|Overall Study||148
1515670|NCT01541553|3709545|P1|COMPLETED|Overall Study||155
1515671|NCT01541553|3709544|P2|STARTED|Overall Study||162
1515672|NCT01541553|3709545|P1|STARTED|Overall Study||167
1515673|NCT01541397|3709557|P2|NOT COMPLETED|Overall Study||2
1515674|NCT01541397|3709558|P1|NOT COMPLETED|Overall Study||4
1515675|NCT01541397|3709557|P2|COMPLETED|Overall Study||0
1515676|NCT01541397|3709558|P1|COMPLETED|Overall Study||0
1515677|NCT01541397|3709557|P2|STARTED|Overall Study||2
1515678|NCT01541397|3709558|P1|STARTED|Overall Study||4
1515679|NCT01541384|3709573|P3|NOT COMPLETED|Overall Study||2
1515680|NCT01541384|3709574|P2|NOT COMPLETED|Overall Study||1
1515681|NCT01541384|3709575|P1|NOT COMPLETED|Overall Study||0
1515682|NCT01541384|3709573|P3|COMPLETED|Overall Study||38
1515683|NCT01541384|3709574|P2|COMPLETED|Overall Study||39
1515684|NCT01541384|3709575|P1|COMPLETED|Overall Study||40
1515685|NCT01541384|3709573|P3|STARTED|Overall Study||40
1515686|NCT01541384|3709574|P2|STARTED|Overall Study||40
1515687|NCT01541384|3709575|P1|STARTED|Overall Study||40
1515688|NCT01541371|3709583|P1|NOT COMPLETED|Overall Study||77
1515689|NCT01541371|3709583|P1|COMPLETED|Overall Study||326
1515690|NCT01541371|3709583|P1|Full Analysis Set|Overall Study||394
1515691|NCT01541371|3709583|P1|STARTED|Overall Study||403
1515692|NCT01541358|3709606|P1|NOT COMPLETED|Overall Study||0
1515693|NCT01541358|3709606|P1|COMPLETED|Overall Study||2
1515694|NCT01541358|3709606|P1|STARTED|Overall Study||2
1515695|NCT01541254|3709612|P1|NOT COMPLETED|Overall Study||6
1515696|NCT01541254|3709612|P1|COMPLETED|Overall Study||30
1515697|NCT01541254|3709612|P1|STARTED|Overall Study||36
1515698|NCT01541215|3709619|P2|NOT COMPLETED|Overall Study||16
1515699|NCT01541215|3709620|P1|NOT COMPLETED|Overall Study||10
1515700|NCT01541215|3709619|P2|COMPLETED|Overall Study||53
1515701|NCT01541215|3709620|P1|COMPLETED|Overall Study||56
1515702|NCT01541215|3709619|P2|Exposed|Overall Study||68
1515703|NCT01541215|3709620|P1|Exposed|Overall Study||66
1515704|NCT01541215|3709619|P2|STARTED|Overall Study||69
1515705|NCT01541215|3709620|P1|STARTED|Overall Study||66
1515706|NCT01540981|3709758|P2|NOT COMPLETED|Overall Study||0
1515707|NCT01540981|3709759|P1|NOT COMPLETED|Overall Study||1
1515708|NCT01540981|3709758|P2|COMPLETED|Overall Study||6
1515709|NCT01540981|3709759|P1|COMPLETED|Overall Study||5
1515710|NCT01540981|3709758|P2|STARTED|Overall Study||6
1515711|NCT01540981|3709759|P1|STARTED|Overall Study||6
1515712|NCT01540851|3709769|P2|NOT COMPLETED|Overall Study||18
1515713|NCT01540851|3709770|P1|NOT COMPLETED|Overall Study||21
1515714|NCT01540851|3709769|P2|COMPLETED|Overall Study||136
1515715|NCT01540851|3709770|P1|COMPLETED|Overall Study||133
1515716|NCT01540851|3709769|P2|STARTED|Overall Study||154
1515717|NCT01540851|3709770|P1|STARTED|Overall Study||154
1515718|NCT01540825|3709791|P11|NOT COMPLETED|Overall Study||0
1515719|NCT01540825|3709792|P10|NOT COMPLETED|Overall Study||0
1515720|NCT01540825|3709793|P9|NOT COMPLETED|Overall Study||0
1515721|NCT01540825|3709794|P8|NOT COMPLETED|Overall Study||0
1515722|NCT01540825|3709795|P7|NOT COMPLETED|Overall Study||0
1515723|NCT01540825|3709796|P6|NOT COMPLETED|Overall Study||0
1515724|NCT01540825|3709797|P5|NOT COMPLETED|Overall Study||0
1515725|NCT01540825|3709798|P4|NOT COMPLETED|Overall Study||0
1515726|NCT01540825|3709799|P3|NOT COMPLETED|Overall Study||0
1515727|NCT01540825|3709800|P2|NOT COMPLETED|Overall Study||0
1515728|NCT01540825|3709801|P1|NOT COMPLETED|Overall Study||0
1515729|NCT01540825|3709791|P11|COMPLETED|Overall Study||6
1515730|NCT01540825|3709792|P10|COMPLETED|Overall Study||6
1515731|NCT01540825|3709793|P9|COMPLETED|Overall Study||6
1515732|NCT01540825|3709794|P8|COMPLETED|Overall Study||6
1515733|NCT01540825|3709795|P7|COMPLETED|Overall Study||6
1515734|NCT01540825|3709796|P6|COMPLETED|Overall Study||6
1515735|NCT01540825|3709797|P5|COMPLETED|Overall Study||6
1515736|NCT01540825|3709798|P4|COMPLETED|Overall Study||6
1515737|NCT01540825|3709799|P3|COMPLETED|Overall Study||6
1515738|NCT01540825|3709800|P2|COMPLETED|Overall Study||6
1515739|NCT01540825|3709801|P1|COMPLETED|Overall Study||20
1515740|NCT01540825|3709791|P11|STARTED|Overall Study||6
1515741|NCT01540825|3709792|P10|STARTED|Overall Study||6
1515742|NCT01540825|3709793|P9|STARTED|Overall Study||6
1515743|NCT01540825|3709794|P8|STARTED|Overall Study||6
1515744|NCT01540825|3709795|P7|STARTED|Overall Study||6
1515745|NCT01540825|3709796|P6|STARTED|Overall Study||6
1515746|NCT01540825|3709797|P5|STARTED|Overall Study||6
1515747|NCT01540825|3709798|P4|STARTED|Overall Study||6
1515748|NCT01540825|3709799|P3|STARTED|Overall Study||6
1515749|NCT01540825|3709800|P2|STARTED|Overall Study||6
1515750|NCT01540825|3709801|P1|STARTED|Overall Study||20
1515751|NCT01540773|3709897|P2|NOT COMPLETED|Second Intervention||0
1515752|NCT01540773|3709898|P1|NOT COMPLETED|Second Intervention||0
1515753|NCT01540773|3709897|P2|COMPLETED|Second Intervention||8
1515754|NCT01540773|3709898|P1|COMPLETED|Second Intervention||8
1515755|NCT01540773|3709897|P2|STARTED|Second Intervention||8
1515756|NCT01540773|3709898|P1|STARTED|Second Intervention||8
1515757|NCT01540773|3709897|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
1515758|NCT01540773|3709898|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
1515759|NCT01540773|3709897|P2|COMPLETED|Wash Out Period of 1 Week||8
1515760|NCT01540773|3709898|P1|COMPLETED|Wash Out Period of 1 Week||8
1515761|NCT01540773|3709897|P2|STARTED|Wash Out Period of 1 Week||8
1515762|NCT01540773|3709898|P1|STARTED|Wash Out Period of 1 Week||8
1515763|NCT01540773|3709897|P2|NOT COMPLETED|First Intervention||0
1515764|NCT01540773|3709898|P1|NOT COMPLETED|First Intervention||0
1515765|NCT01540773|3709897|P2|COMPLETED|First Intervention||8
1515766|NCT01540773|3709898|P1|COMPLETED|First Intervention||8
1515767|NCT01540773|3709897|P2|STARTED|First Intervention||8
1515768|NCT01540773|3709898|P1|STARTED|First Intervention||8
1515769|NCT01540513|3709908|P1|NOT COMPLETED|Overall Study||0
1515770|NCT01540513|3709908|P1|COMPLETED|Overall Study||12
1515771|NCT01540513|3709908|P1|STARTED|Overall Study||12
1515772|NCT01540487|3709917|P2|NOT COMPLETED|Overall Study||0
1515773|NCT01540487|3709918|P1|NOT COMPLETED|Overall Study||1
1515774|NCT01540487|3709917|P2|COMPLETED|Overall Study||24
1515775|NCT01540487|3709918|P1|COMPLETED|Overall Study||23
1515776|NCT01540487|3709917|P2|STARTED|Overall Study||24
1515777|NCT01540487|3709918|P1|STARTED|Overall Study||24
1515778|NCT01540370|3709952|P1|NOT COMPLETED|Overall Study||2
1515779|NCT01540370|3709952|P1|COMPLETED|Overall Study||100
1515780|NCT01540370|3709952|P1|STARTED|Overall Study||102
1515781|NCT01540266|3709963|P6|NOT COMPLETED|Overall Study||0
1515782|NCT01540266|3709964|P5|NOT COMPLETED|Overall Study||0
1515783|NCT01540266|3709965|P4|NOT COMPLETED|Overall Study||0
1515784|NCT01540266|3709966|P3|NOT COMPLETED|Overall Study||1
1515785|NCT01540266|3709967|P2|NOT COMPLETED|Overall Study||1
1515786|NCT01540266|3709968|P1|NOT COMPLETED|Overall Study||6
1515787|NCT01540266|3709963|P6|COMPLETED|Overall Study||19
1515788|NCT01540266|3709964|P5|COMPLETED|Overall Study||20
1515789|NCT01540266|3709965|P4|COMPLETED|Overall Study||38
1515790|NCT01540266|3709966|P3|COMPLETED|Overall Study||59
1515791|NCT01540266|3709967|P2|COMPLETED|Overall Study||41
1515792|NCT01540266|3709968|P1|COMPLETED|Overall Study||57
1515793|NCT01540266|3709963|P6|STARTED|Overall Study||19
1515794|NCT01540266|3709964|P5|STARTED|Overall Study||20
1515795|NCT01540266|3709965|P4|STARTED|Overall Study||38
1515796|NCT01540266|3709966|P3|STARTED|Overall Study||60
1515797|NCT01540266|3709967|P2|STARTED|Overall Study||42
1515798|NCT01540266|3709968|P1|STARTED|Overall Study||63
1515799|NCT01540162|3709984|P2|NOT COMPLETED|Overall Study||0
1515800|NCT01540162|3709985|P1|NOT COMPLETED|Overall Study||0
1515801|NCT01540162|3709984|P2|COMPLETED|Overall Study||32
1515802|NCT01540162|3709985|P1|COMPLETED|Overall Study||30
1515803|NCT01540162|3709984|P2|STARTED|Overall Study||32
1515804|NCT01540162|3709985|P1|STARTED|Overall Study||30
1515805|NCT01540045|3709995|P1|NOT COMPLETED|Overall Study||0
1515806|NCT01540045|3709995|P1|COMPLETED|Overall Study||40
1515807|NCT01540045|3709995|P1|STARTED|Overall Study||40
1515808|NCT01539980|3710034|P1|NOT COMPLETED|Overall Study||0
1515809|NCT01539980|3710034|P1|COMPLETED|Overall Study||30
1515810|NCT01539980|3710034|P1|STARTED|Overall Study||30
1515811|NCT01539811|3710044|P2|NOT COMPLETED|Overall Study||0
1515812|NCT01539811|3710045|P1|NOT COMPLETED|Overall Study||0
1515813|NCT01539811|3710044|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
1515814|NCT01539811|3710045|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
1515815|NCT01539811|3710044|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
1515816|NCT01539811|3710045|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
1515817|NCT01539759|3710053|P2|NOT COMPLETED|Overall Study||8
1515818|NCT01539759|3710054|P1|NOT COMPLETED|Overall Study||6
1515819|NCT01539759|3710053|P2|COMPLETED|Overall Study||48
1515820|NCT01539759|3710054|P1|COMPLETED|Overall Study||50
1515821|NCT01539759|3710053|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
1515822|NCT01539759|3710054|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
1515823|NCT01539759|3710053|P2|IUD Removal|Overall Study||7
1515824|NCT01539759|3710054|P1|IUD Removal|Overall Study||2
1515825|NCT01539759|3710053|P2|IUD Expulsion|Overall Study||4
1515826|NCT01539759|3710054|P1|IUD Expulsion|Overall Study||1
1515827|NCT01539759|3710053|P2|Had Successful IUD Placement|Overall Study||53
1515828|NCT01539759|3710054|P1|Had Successful IUD Placement|Overall Study||34
1515829|NCT01539759|3710053|P2|STARTED|Overall Study||56
1515830|NCT01539759|3710054|P1|STARTED|Overall Study||56
1515831|NCT01539642|3710066|P2|NOT COMPLETED|Overall Study||31
1515832|NCT01539642|3710067|P1|NOT COMPLETED|Overall Study||36
1515833|NCT01539642|3710066|P2|COMPLETED|Overall Study||27
1515834|NCT01539642|3710067|P1|COMPLETED|Overall Study||78
1515835|NCT01539642|3710066|P2|STARTED|Overall Study||58
1515836|NCT01539642|3710067|P1|STARTED|Overall Study||114
1515837|NCT01539590|3710075|P2|NOT COMPLETED|Overall Study||0
1515838|NCT01539590|3710076|P1|NOT COMPLETED|Overall Study||3
1515839|NCT01539590|3710075|P2|COMPLETED|Overall Study||2
1515840|NCT01539590|3710076|P1|COMPLETED|Overall Study||0
1515841|NCT01539590|3710075|P2|Complete Study Treatment|Overall Study||2
1515842|NCT01539590|3710076|P1|Complete Study Treatment|Overall Study||1
1515843|NCT01539590|3710075|P2|STARTED|Overall Study||2
1515844|NCT01539590|3710076|P1|STARTED|Overall Study||3
1515845|NCT01539538|3710084|P2|NOT COMPLETED|Overall Study||44
1515846|NCT01539538|3710085|P1|NOT COMPLETED|Overall Study||31
1515847|NCT01539538|3710084|P2|COMPLETED|Overall Study||136
1515848|NCT01539538|3710085|P1|COMPLETED|Overall Study||146
1515849|NCT01539538|3710084|P2|STARTED|Overall Study||180
1515850|NCT01539538|3710085|P1|STARTED|Overall Study||177
1515851|NCT01539525|3710094|P3|NOT COMPLETED|Overall Study||17
1515852|NCT01539525|3710095|P2|NOT COMPLETED|Overall Study||16
1515853|NCT01539525|3710096|P1|NOT COMPLETED|Overall Study||20
1515854|NCT01539525|3710094|P3|COMPLETED|Overall Study||134
1515855|NCT01539525|3710095|P2|COMPLETED|Overall Study||127
1515856|NCT01539525|3710096|P1|COMPLETED|Overall Study||125
1515857|NCT01539525|3710094|P3|STARTED|Overall Study||151
1515858|NCT01539525|3710095|P2|STARTED|Overall Study||143
1515859|NCT01539525|3710096|P1|STARTED|Overall Study||145
1515860|NCT01539512|3710115|P2|NOT COMPLETED|Overall Study||13
1515861|NCT01539512|3710116|P1|NOT COMPLETED|Overall Study||23
1515862|NCT01539512|3710115|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
1515863|NCT01539512|3710116|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
1515864|NCT01539512|3710115|P2|STARTED|Overall Study||110
1515865|NCT01539512|3710116|P1|STARTED|Overall Study||110
1515866|NCT01539317|3710132|P2|NOT COMPLETED|Overall Study||0
1515867|NCT01539317|3710133|P1|NOT COMPLETED|Overall Study||1
1515868|NCT01539317|3710132|P2|COMPLETED|Overall Study||25
1515869|NCT01539317|3710133|P1|COMPLETED|Overall Study||24
1515870|NCT01539317|3710132|P2|STARTED|Overall Study||25
1515871|NCT01539317|3710133|P1|STARTED|Overall Study||25
1515872|NCT01539135|3710150|P2|NOT COMPLETED|Overall Study||0
1515873|NCT01539135|3710151|P1|NOT COMPLETED|Overall Study||0
1515874|NCT01539135|3710150|P2|COMPLETED|Overall Study||37
1515875|NCT01539135|3710151|P1|COMPLETED|Overall Study||43
1515876|NCT01539135|3710150|P2|STARTED|Overall Study||37
1515877|NCT01539135|3710151|P1|STARTED|Overall Study||43
1515878|NCT01539083|3710163|P3|NOT COMPLETED|After Randomization (TP and VTP)||23
1515879|NCT01539083|3710164|P2|NOT COMPLETED|After Randomization (TP and VTP)||21
1515880|NCT01539083|3710165|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
1515881|NCT01539083|3710163|P3|COMPLETED|After Randomization (TP and VTP)||80
1515882|NCT01539083|3710164|P2|COMPLETED|After Randomization (TP and VTP)||79
1515883|NCT01539083|3710165|P1|COMPLETED|After Randomization (TP and VTP)||0
1515884|NCT01539083|3710163|P3|Safety Population|After Randomization (TP and VTP)||103
1515885|NCT01539083|3710164|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
1515886|NCT01539083|3710165|P1|Safety Population|After Randomization (TP and VTP)||0
1515887|NCT01539083|3710163|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
1515888|NCT01539083|3710164|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
1515889|NCT01539083|3710165|P1|STARTED|After Randomization (TP and VTP)||0
1515890|NCT01539083|3710163|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
1515891|NCT01539083|3710164|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
1515892|NCT01539083|3710165|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
1515893|NCT01539083|3710163|P3|COMPLETED|Before Randomization (VCD Induction)||0
1515894|NCT01539083|3710164|P2|COMPLETED|Before Randomization (VCD Induction)||0
1515895|NCT01539083|3710165|P1|COMPLETED|Before Randomization (VCD Induction)||203
1515896|NCT01539083|3710163|P3|Treated|Before Randomization (VCD Induction)||0
1515897|NCT01539083|3710164|P2|Treated|Before Randomization (VCD Induction)||0
1515898|NCT01539083|3710165|P1|Treated|Before Randomization (VCD Induction)||254
1515899|NCT01539083|3710163|P3|STARTED|Before Randomization (VCD Induction)||0
1515900|NCT01539083|3710164|P2|STARTED|Before Randomization (VCD Induction)||0
1515901|NCT01539083|3710165|P1|STARTED|Before Randomization (VCD Induction)||256
1515902|NCT01539070|3710188|P2|NOT COMPLETED|Overall Study||39
1515903|NCT01539070|3710189|P1|NOT COMPLETED|Overall Study||59
1515904|NCT01539070|3710188|P2|COMPLETED|Overall Study||99
1515905|NCT01539070|3710189|P1|COMPLETED|Overall Study||109
1515906|NCT01539070|3710188|P2|STARTED|Overall Study||138
1515907|NCT01539070|3710189|P1|STARTED|Overall Study||168
1515908|NCT01538862|3710201|P1|NOT COMPLETED|Overall Study||0
1515909|NCT01538862|3710201|P1|COMPLETED|Overall Study||7
1515910|NCT01538862|3710201|P1|STARTED|Overall Study||7
1515911|NCT01538719|3710209|P2|NOT COMPLETED|Overall Study||0
1515912|NCT01538719|3710210|P1|NOT COMPLETED|Overall Study||2
1515913|NCT01538719|3710209|P2|COMPLETED|Overall Study||12
1515914|NCT01538719|3710210|P1|COMPLETED|Overall Study||5
1515915|NCT01538719|3710209|P2|STARTED|Overall Study||12
1515916|NCT01538719|3710210|P1|STARTED|Overall Study||7
1515917|NCT01538615|3710220|P2|NOT COMPLETED|Overall Study||12
1515918|NCT01538615|3710221|P1|NOT COMPLETED|Overall Study||22
1515919|NCT01538615|3710220|P2|COMPLETED|Overall Study||146
1515920|NCT01538615|3710221|P1|COMPLETED|Overall Study||140
1515921|NCT01538615|3710220|P2|STARTED|Overall Study||158
1515922|NCT01538615|3710221|P1|STARTED|Overall Study||162
1515923|NCT01538472|3710233|P1|NOT COMPLETED|Overall Study||4
1515924|NCT01538472|3710233|P1|COMPLETED|Overall Study||36
1515925|NCT01538472|3710233|P1|STARTED|Overall Study||40
1515926|NCT01538199|3710244|P4|NOT COMPLETED|Overall Study||2
1515927|NCT01538199|3710245|P3|NOT COMPLETED|Overall Study||1
1515928|NCT01538199|3710246|P2|NOT COMPLETED|Overall Study||3
1515929|NCT01538199|3710247|P1|NOT COMPLETED|Overall Study||2
1515930|NCT01538199|3710244|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
1515931|NCT01538199|3710245|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
1515932|NCT01538199|3710246|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
1515933|NCT01538199|3710247|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
1515934|NCT01538199|3710244|P4|STARTED|Overall Study||3
1515935|NCT01538199|3710245|P3|STARTED|Overall Study||4
1515936|NCT01538199|3710246|P2|STARTED|Overall Study||11
1515937|NCT01538199|3710247|P1|STARTED|Overall Study||10
1515938|NCT01537900|3710270|P1|NOT COMPLETED|Overall Study||0
1515939|NCT01537900|3710270|P1|COMPLETED|Overall Study||4
1515940|NCT01537900|3710270|P1|STARTED|Overall Study||4
1515941|NCT01537835|3710284|P3|NOT COMPLETED|Overall Study||0
1515942|NCT01537835|3710285|P2|NOT COMPLETED|Overall Study||0
1515943|NCT01537835|3710286|P1|NOT COMPLETED|Overall Study||0
1515944|NCT01537835|3710284|P3|COMPLETED|Overall Study||35
1515945|NCT01537835|3710285|P2|COMPLETED|Overall Study||37
1515946|NCT01537835|3710286|P1|COMPLETED|Overall Study||37
1515947|NCT01537835|3710284|P3|STARTED|Overall Study||35
1515948|NCT01537835|3710285|P2|STARTED|Overall Study||37
1515949|NCT01537835|3710286|P1|STARTED|Overall Study||37
1515950|NCT01537783|3710299|P2|NOT COMPLETED|Overall Study||2
1515951|NCT01537783|3710300|P1|NOT COMPLETED|Overall Study||11
1515952|NCT01537783|3710299|P2|COMPLETED|Overall Study||23
1515953|NCT01537783|3710300|P1|COMPLETED|Overall Study||14
1515954|NCT01537783|3710299|P2|STARTED|Overall Study||25
1515955|NCT01537783|3710300|P1|STARTED|Overall Study||25
1515956|NCT01537666|3710310|P4|NOT COMPLETED|Overall Study||0
1515957|NCT01537666|3710311|P3|NOT COMPLETED|Overall Study||0
1515958|NCT01537666|3710312|P2|NOT COMPLETED|Overall Study||0
1515959|NCT01537666|3710313|P1|NOT COMPLETED|Overall Study||0
1515960|NCT01537666|3710310|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
1515961|NCT01537666|3710311|P3|COMPLETED|Overall Study||6
1515962|NCT01537666|3710312|P2|COMPLETED|Overall Study||6
1515963|NCT01537666|3710313|P1|COMPLETED|Overall Study||6
1515964|NCT01537666|3710310|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
1515965|NCT01537666|3710311|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
1515966|NCT01537666|3710312|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
1515967|NCT01537666|3710313|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
1515968|NCT01537549|3710351|P1|NOT COMPLETED|Overall Study||3
1515969|NCT01537549|3710351|P1|COMPLETED|Overall Study||8
1515970|NCT01537549|3710351|P1|STARTED|Overall Study||11
1515971|NCT01537432|3710359|P2|NOT COMPLETED|Overall Study||2
1515972|NCT01537432|3710360|P1|NOT COMPLETED|Overall Study||6
1515973|NCT01537432|3710359|P2|COMPLETED|Overall Study||10
1515974|NCT01537432|3710360|P1|COMPLETED|Overall Study||18
1515975|NCT01537432|3710359|P2|STARTED|Overall Study||12
1515976|NCT01537432|3710360|P1|STARTED|Overall Study||24
1515977|NCT01537419|3710370|P2|NOT COMPLETED|Overall Study||12
1515978|NCT01537419|3710371|P1|NOT COMPLETED|Overall Study||11
1515979|NCT01537419|3710370|P2|COMPLETED|Overall Study||54
1515980|NCT01537419|3710371|P1|COMPLETED|Overall Study||52
1515981|NCT01537419|3710370|P2|STARTED|Overall Study||66
1515982|NCT01537419|3710371|P1|STARTED|Overall Study||63
1515983|NCT01537393|3710383|P2|NOT COMPLETED|Overall Study||191
1515984|NCT01537393|3710384|P1|NOT COMPLETED|Overall Study||154
1515985|NCT01537393|3710383|P2|COMPLETED|Overall Study||507
1515986|NCT01537393|3710384|P1|COMPLETED|Overall Study||553
1515987|NCT01537393|3710383|P2|STARTED|Overall Study||698
1515988|NCT01537393|3710384|P1|STARTED|Overall Study||707
1515989|NCT01537367|3710395|P3|NOT COMPLETED|Overall Study||0
1515990|NCT01537367|3710396|P2|NOT COMPLETED|Overall Study||0
1515991|NCT01537367|3710397|P1|NOT COMPLETED|Overall Study||0
1515992|NCT01537367|3710395|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
1515993|NCT01537367|3710396|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
1515994|NCT01537367|3710397|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
1515995|NCT01537367|3710395|P3|STARTED|Overall Study||613
1515996|NCT01537367|3710396|P2|STARTED|Overall Study||610
1515997|NCT01537367|3710397|P1|STARTED|Overall Study||615
1515998|NCT01537315|3710413|P2|NOT COMPLETED|Overall Study||0
1515999|NCT01537315|3710414|P1|NOT COMPLETED|Overall Study||0
1516000|NCT01537315|3710413|P2|COMPLETED|Overall Study||7
1516001|NCT01537315|3710414|P1|COMPLETED|Overall Study||1
1516002|NCT01537315|3710413|P2|STARTED|Overall Study||7
1516003|NCT01537315|3710414|P1|STARTED|Overall Study||1
1516004|NCT01537302|3710420|P1|NOT COMPLETED|Overall Study||2
1516005|NCT01537302|3710420|P1|COMPLETED|Overall Study||199
1516006|NCT01537302|3710420|P1|STARTED|Overall Study||201
1516007|NCT01537198|3710427|P1|NOT COMPLETED|Overall Study||154
1516008|NCT01537198|3710427|P1|COMPLETED|Overall Study||463
1516009|NCT01537198|3710427|P1|STARTED|Overall Study||617
1516010|NCT01537185|3710435|P4|NOT COMPLETED|Overall Study||2
1516011|NCT01537185|3710436|P3|NOT COMPLETED|Overall Study||6
1516012|NCT01537185|3710437|P2|NOT COMPLETED|Overall Study||6
1516013|NCT01537185|3710438|P1|NOT COMPLETED|Overall Study||3
1516014|NCT01537185|3710435|P4|COMPLETED|Overall Study||8
1516015|NCT01537185|3710436|P3|COMPLETED|Overall Study||4
1516016|NCT01537185|3710437|P2|COMPLETED|Overall Study||6
1516017|NCT01537185|3710438|P1|COMPLETED|Overall Study||7
1516018|NCT01537185|3710435|P4|STARTED|Overall Study||10
1516019|NCT01537185|3710436|P3|STARTED|Overall Study||10
1516020|NCT01537185|3710437|P2|STARTED|Overall Study||12
1516021|NCT01537185|3710438|P1|STARTED|Overall Study||10
1516022|NCT01537133|3710456|P4|NOT COMPLETED|Overall Study||0
1516023|NCT01537133|3710457|P3|NOT COMPLETED|Overall Study||0
1516024|NCT01537133|3710458|P2|NOT COMPLETED|Overall Study||0
1516025|NCT01537133|3710459|P1|NOT COMPLETED|Overall Study||3
1516026|NCT01537133|3710456|P4|COMPLETED|Overall Study||21
1516027|NCT01537133|3710457|P3|COMPLETED|Overall Study||21
1516028|NCT01537133|3710458|P2|COMPLETED|Overall Study||14
1516029|NCT01537133|3710459|P1|COMPLETED|Overall Study||25
1516030|NCT01537133|3710456|P4|STARTED|Overall Study||21
1516031|NCT01537133|3710457|P3|STARTED|Overall Study||21
1516032|NCT01537133|3710458|P2|STARTED|Overall Study||14
1516033|NCT01537133|3710459|P1|STARTED|Overall Study||28
1516034|NCT01537120|3710475|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
1516035|NCT01537120|3710475|P1|COMPLETED|12 Weeks Vildagliptin||23
1516036|NCT01537120|3710475|P1|STARTED|12 Weeks Vildagliptin||23
1516037|NCT01537120|3710475|P1|NOT COMPLETED|3 Weeks Placebo||1
1516038|NCT01537120|3710475|P1|COMPLETED|3 Weeks Placebo||23
1516039|NCT01537120|3710475|P1|STARTED|3 Weeks Placebo||24
1516040|NCT01537120|3710475|P1|NOT COMPLETED|8 Weeks Washout||1
1516041|NCT01537120|3710475|P1|COMPLETED|8 Weeks Washout||24
1516042|NCT01537120|3710475|P1|STARTED|8 Weeks Washout||25
1516043|NCT01537120|3710475|P1|NOT COMPLETED|Enrolled||0
1516044|NCT01537120|3710475|P1|COMPLETED|Enrolled||25
1516045|NCT01537120|3710475|P1|STARTED|Enrolled||25
1516046|NCT01537081|3710488|P3|NOT COMPLETED|Overall Study||16
1516047|NCT01537081|3710489|P2|NOT COMPLETED|Overall Study||38
1516048|NCT01537081|3710490|P1|NOT COMPLETED|Overall Study||39
1516049|NCT01537081|3710488|P3|COMPLETED|Overall Study||547
1516050|NCT01537081|3710489|P2|COMPLETED|Overall Study||1086
1516051|NCT01537081|3710490|P1|COMPLETED|Overall Study||1084
1516052|NCT01537081|3710488|P3|Modified Intent to Treat Population|Overall Study||556
1516053|NCT01537081|3710489|P2|Modified Intent to Treat Population|Overall Study||1109
1516054|NCT01537081|3710490|P1|Modified Intent to Treat Population|Overall Study||1106
1516055|NCT01537081|3710488|P3|Safety Population|Overall Study||561
1516056|NCT01537081|3710489|P2|Safety Population|Overall Study||1122
1516057|NCT01537081|3710490|P1|Safety Population|Overall Study||1122
1516058|NCT01537081|3710488|P3|STARTED|Overall Study||563
1516059|NCT01537081|3710489|P2|STARTED|Overall Study||1124
1516060|NCT01537081|3710490|P1|STARTED|Overall Study||1123
1516061|NCT01537068|3710503|P2|NOT COMPLETED|Overall Study||3
1516062|NCT01537068|3710504|P1|NOT COMPLETED|Overall Study||4
1516063|NCT01537068|3710503|P2|COMPLETED|Overall Study||26
1516064|NCT01537068|3710504|P1|COMPLETED|Overall Study||26
1516065|NCT01537068|3710503|P2|STARTED|Overall Study||29
1516066|NCT01537068|3710504|P1|STARTED|Overall Study||30
1516067|NCT01537042|3710516|P2|NOT COMPLETED|Overall Study||5
1516068|NCT01537042|3710517|P1|NOT COMPLETED|Overall Study||0
1516069|NCT01537042|3710516|P2|COMPLETED|Overall Study||15
1516070|NCT01537042|3710517|P1|COMPLETED|Overall Study||10
1516071|NCT01537042|3710516|P2|STARTED|Overall Study||20
1516072|NCT01537042|3710517|P1|STARTED|Overall Study||10
1516073|NCT01537029|3710553|P1|NOT COMPLETED|Overall Study||0
1516074|NCT01537029|3710553|P1|COMPLETED|Overall Study||15
1516075|NCT01537029|3710553|P1|STARTED|Overall Study||15
1516076|NCT01536951|3710559|P9|NOT COMPLETED|Third Intervention||0
1516077|NCT01536951|3710560|P8|NOT COMPLETED|Third Intervention||0
1516078|NCT01536951|3710561|P7|NOT COMPLETED|Third Intervention||0
1516079|NCT01536951|3710562|P6|NOT COMPLETED|Third Intervention||0
1516080|NCT01536951|3710563|P5|NOT COMPLETED|Third Intervention||0
1516081|NCT01536951|3710564|P4|NOT COMPLETED|Third Intervention||0
1516082|NCT01536951|3710565|P3|NOT COMPLETED|Third Intervention||0
1516083|NCT01536951|3710566|P2|NOT COMPLETED|Third Intervention||0
1516084|NCT01536951|3710567|P1|NOT COMPLETED|Third Intervention||0
1516085|NCT01536951|3710559|P9|COMPLETED|Third Intervention||9
1516086|NCT01536951|3710560|P8|COMPLETED|Third Intervention||8
1516087|NCT01536951|3710561|P7|COMPLETED|Third Intervention||9
1516088|NCT01536951|3710562|P6|COMPLETED|Third Intervention||9
1516089|NCT01536951|3710563|P5|COMPLETED|Third Intervention||9
1516090|NCT01536951|3710564|P4|COMPLETED|Third Intervention||8
1516091|NCT01536951|3710565|P3|COMPLETED|Third Intervention||2
1516092|NCT01536951|3710566|P2|COMPLETED|Third Intervention||3
1516093|NCT01536951|3710567|P1|COMPLETED|Third Intervention||3
1516094|NCT01536951|3710559|P9|STARTED|Third Intervention||9
1516095|NCT01536951|3710560|P8|STARTED|Third Intervention||8
1516096|NCT01536951|3710561|P7|STARTED|Third Intervention||9
1516097|NCT01536951|3710562|P6|STARTED|Third Intervention||9
1516098|NCT01536951|3710563|P5|STARTED|Third Intervention||9
1516099|NCT01536951|3710564|P4|STARTED|Third Intervention||8
1516100|NCT01536951|3710565|P3|STARTED|Third Intervention||2
1516101|NCT01536951|3710566|P2|STARTED|Third Intervention||3
1516102|NCT01536951|3710567|P1|STARTED|Third Intervention||3
1516103|NCT01536951|3710559|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
1516104|NCT01536951|3710560|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
1516105|NCT01536951|3710561|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
1516106|NCT01536951|3710562|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
1516107|NCT01536951|3710563|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
1516108|NCT01536951|3710564|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
1516109|NCT01536951|3710565|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
1516110|NCT01536951|3710566|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
1516111|NCT01536951|3710567|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
1516112|NCT01536951|3710559|P9|COMPLETED|Second Intervention and Washout Period 2||9
1516113|NCT01536951|3710560|P8|COMPLETED|Second Intervention and Washout Period 2||8
1516114|NCT01536951|3710561|P7|COMPLETED|Second Intervention and Washout Period 2||9
1516115|NCT01536951|3710562|P6|COMPLETED|Second Intervention and Washout Period 2||9
1516116|NCT01536951|3710563|P5|COMPLETED|Second Intervention and Washout Period 2||9
1516117|NCT01536951|3710564|P4|COMPLETED|Second Intervention and Washout Period 2||8
1516118|NCT01536951|3710565|P3|COMPLETED|Second Intervention and Washout Period 2||2
1516119|NCT01536951|3710566|P2|COMPLETED|Second Intervention and Washout Period 2||3
1516120|NCT01536951|3710567|P1|COMPLETED|Second Intervention and Washout Period 2||3
1516121|NCT01536951|3710559|P9|STARTED|Second Intervention and Washout Period 2||9
1516122|NCT01536951|3710560|P8|STARTED|Second Intervention and Washout Period 2||9
1516123|NCT01536951|3710561|P7|STARTED|Second Intervention and Washout Period 2||9
1516124|NCT01536951|3710562|P6|STARTED|Second Intervention and Washout Period 2||9
1516125|NCT01536951|3710563|P5|STARTED|Second Intervention and Washout Period 2||9
1516126|NCT01536951|3710564|P4|STARTED|Second Intervention and Washout Period 2||8
1516127|NCT01536951|3710565|P3|STARTED|Second Intervention and Washout Period 2||2
1516128|NCT01536951|3710566|P2|STARTED|Second Intervention and Washout Period 2||3
1516129|NCT01536951|3710567|P1|STARTED|Second Intervention and Washout Period 2||3
1516130|NCT01536951|3710559|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
1516131|NCT01536951|3710560|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
1516132|NCT01536951|3710561|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
1516133|NCT01536951|3710562|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
1516134|NCT01536951|3710563|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
1516135|NCT01536951|3710564|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
1516136|NCT01536951|3710565|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
1516137|NCT01536951|3710566|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
1516138|NCT01536951|3710567|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
1516139|NCT01536951|3710559|P9|COMPLETED|First Intervention and Washout Period 1||9
1516140|NCT01536951|3710560|P8|COMPLETED|First Intervention and Washout Period 1||9
1516141|NCT01536951|3710561|P7|COMPLETED|First Intervention and Washout Period 1||9
1516142|NCT01536951|3710562|P6|COMPLETED|First Intervention and Washout Period 1||9
1516143|NCT01536951|3710563|P5|COMPLETED|First Intervention and Washout Period 1||9
1516144|NCT01536951|3710564|P4|COMPLETED|First Intervention and Washout Period 1||8
1516145|NCT01536951|3710565|P3|COMPLETED|First Intervention and Washout Period 1||2
1516146|NCT01536951|3710566|P2|COMPLETED|First Intervention and Washout Period 1||3
1516147|NCT01536951|3710567|P1|COMPLETED|First Intervention and Washout Period 1||3
1516148|NCT01536951|3710559|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1516149|NCT01536951|3710560|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1516150|NCT01536951|3710561|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1516151|NCT01536951|3710562|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1516152|NCT01536951|3710563|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
1516153|NCT01536951|3710564|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
1516154|NCT01536951|3710565|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
1516155|NCT01536951|3710566|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
1516156|NCT01536951|3710567|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
1516157|NCT01536951|3710559|P9|STARTED|First Intervention and Washout Period 1||9
1516158|NCT01536951|3710560|P8|STARTED|First Intervention and Washout Period 1||9
1516159|NCT01536951|3710561|P7|STARTED|First Intervention and Washout Period 1||9
1516160|NCT01536951|3710562|P6|STARTED|First Intervention and Washout Period 1||9
1516161|NCT01536951|3710563|P5|STARTED|First Intervention and Washout Period 1||9
1516162|NCT01536951|3710564|P4|STARTED|First Intervention and Washout Period 1||8
1516163|NCT01536951|3710565|P3|STARTED|First Intervention and Washout Period 1||3
1516164|NCT01536951|3710566|P2|STARTED|First Intervention and Washout Period 1||3
1516165|NCT01536951|3710567|P1|STARTED|First Intervention and Washout Period 1||3
1516166|NCT01536938|3710597|P3|NOT COMPLETED|Overall Study||8
1516167|NCT01536938|3710598|P2|NOT COMPLETED|Overall Study||7
1516168|NCT01536938|3710599|P1|NOT COMPLETED|Overall Study||6
1516169|NCT01536938|3710597|P3|COMPLETED|Overall Study||93
1516170|NCT01536938|3710598|P2|COMPLETED|Overall Study||94
1516171|NCT01536938|3710599|P1|COMPLETED|Overall Study||94
1516172|NCT01536938|3710597|P3|STARTED|Overall Study||101
1516173|NCT01536938|3710598|P2|STARTED|Overall Study||101
1516174|NCT01536938|3710599|P1|STARTED|Overall Study||100
1516175|NCT01536886|3710611|P4|NOT COMPLETED|Overall Study||3
1516176|NCT01536886|3710612|P3|NOT COMPLETED|Overall Study||2
1516177|NCT01536886|3710613|P2|NOT COMPLETED|Overall Study||8
1516178|NCT01536886|3710614|P1|NOT COMPLETED|Overall Study||5
1516179|NCT01536886|3710611|P4|COMPLETED|Overall Study||48
1516180|NCT01536886|3710612|P3|COMPLETED|Overall Study||47
1516181|NCT01536886|3710613|P2|COMPLETED|Overall Study||127
1516182|NCT01536886|3710614|P1|COMPLETED|Overall Study||136
1516183|NCT01536886|3710611|P4|STARTED|Overall Study||51
1516184|NCT01536886|3710612|P3|STARTED|Overall Study||49
1516185|NCT01536886|3710613|P2|STARTED|Overall Study||135
1516186|NCT01536886|3710614|P1|STARTED|Overall Study||141
1516187|NCT01536860|3710624|P3|NOT COMPLETED|Third Intervention (1 Day)||0
1516188|NCT01536860|3710625|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1516189|NCT01536860|3710626|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1516190|NCT01536860|3710624|P3|COMPLETED|Third Intervention (1 Day)||4
1516191|NCT01536860|3710625|P2|COMPLETED|Third Intervention (1 Day)||4
1516192|NCT01536860|3710626|P1|COMPLETED|Third Intervention (1 Day)||3
1516193|NCT01536860|3710624|P3|STARTED|Third Intervention (1 Day)||4
1516194|NCT01536860|3710625|P2|STARTED|Third Intervention (1 Day)||4
1516195|NCT01536860|3710626|P1|STARTED|Third Intervention (1 Day)||3
1516196|NCT01536860|3710624|P3|NOT COMPLETED|Washout Period (3 Days)||0
1516197|NCT01536860|3710625|P2|NOT COMPLETED|Washout Period (3 Days)||0
1516198|NCT01536860|3710626|P1|NOT COMPLETED|Washout Period (3 Days)||1
1516199|NCT01536860|3710624|P3|COMPLETED|Washout Period (3 Days)||4
1516200|NCT01536860|3710625|P2|COMPLETED|Washout Period (3 Days)||4
1516201|NCT01536860|3710626|P1|COMPLETED|Washout Period (3 Days)||3
1516202|NCT01536860|3710624|P3|STARTED|Washout Period (3 Days)||4
1516203|NCT01536860|3710625|P2|STARTED|Washout Period (3 Days)||4
1516204|NCT01536860|3710626|P1|STARTED|Washout Period (3 Days)||4
1516205|NCT01536860|3710624|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1516206|NCT01536860|3710625|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1516207|NCT01536860|3710626|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1516208|NCT01536860|3710624|P3|COMPLETED|Second Intervention (1 Day)||4
1516209|NCT01536860|3710625|P2|COMPLETED|Second Intervention (1 Day)||4
1516210|NCT01536860|3710626|P1|COMPLETED|Second Intervention (1 Day)||4
1516211|NCT01536860|3710624|P3|STARTED|Second Intervention (1 Day)||4
1516212|NCT01536860|3710625|P2|STARTED|Second Intervention (1 Day)||4
1516213|NCT01536860|3710626|P1|STARTED|Second Intervention (1 Day)||4
1516214|NCT01536860|3710624|P3|NOT COMPLETED|Washout Period (3 Days)||0
1516215|NCT01536860|3710625|P2|NOT COMPLETED|Washout Period (3 Days)||0
1516216|NCT01536860|3710626|P1|NOT COMPLETED|Washout Period (3 Days)||0
1516217|NCT01536860|3710624|P3|COMPLETED|Washout Period (3 Days)||4
1516218|NCT01536860|3710625|P2|COMPLETED|Washout Period (3 Days)||4
1516219|NCT01536860|3710626|P1|COMPLETED|Washout Period (3 Days)||4
1516220|NCT01536860|3710624|P3|STARTED|Washout Period (3 Days)||4
1516221|NCT01536860|3710625|P2|STARTED|Washout Period (3 Days)||4
1516222|NCT01536860|3710626|P1|STARTED|Washout Period (3 Days)||4
1516223|NCT01536860|3710624|P3|NOT COMPLETED|First Intervention (1 Day)||0
1516224|NCT01536860|3710625|P2|NOT COMPLETED|First Intervention (1 Day)||0
1516225|NCT01536860|3710626|P1|NOT COMPLETED|First Intervention (1 Day)||0
1516226|NCT01536860|3710624|P3|COMPLETED|First Intervention (1 Day)||4
1516227|NCT01536860|3710625|P2|COMPLETED|First Intervention (1 Day)||4
1516228|NCT01536860|3710626|P1|COMPLETED|First Intervention (1 Day)||4
1516229|NCT01536860|3710624|P3|STARTED|First Intervention (1 Day)||4
1516230|NCT01536860|3710625|P2|STARTED|First Intervention (1 Day)||4
1516231|NCT01536860|3710626|P1|STARTED|First Intervention (1 Day)||4
1516232|NCT01536704|3710634|P4|NOT COMPLETED|Period 4||0
1516233|NCT01536704|3710635|P3|NOT COMPLETED|Period 4||0
1516234|NCT01536704|3710636|P2|NOT COMPLETED|Period 4||0
1516235|NCT01536704|3710637|P1|NOT COMPLETED|Period 4||0
1516236|NCT01536704|3710634|P4|COMPLETED|Period 4||10
1516237|NCT01536704|3710635|P3|COMPLETED|Period 4||10
1516238|NCT01536704|3710636|P2|COMPLETED|Period 4||11
1516239|NCT01536704|3710637|P1|COMPLETED|Period 4||12
1516240|NCT01536704|3710634|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1516241|NCT01536704|3710635|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1516242|NCT01536704|3710636|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
1516243|NCT01536704|3710637|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
1516244|NCT01536704|3710634|P4|NOT COMPLETED|Washout Period 3||0
1516245|NCT01536704|3710635|P3|NOT COMPLETED|Washout Period 3||1
1516246|NCT01536704|3710636|P2|NOT COMPLETED|Washout Period 3||0
1516247|NCT01536704|3710637|P1|NOT COMPLETED|Washout Period 3||0
1516248|NCT01536704|3710634|P4|COMPLETED|Washout Period 3||10
1516249|NCT01536704|3710635|P3|COMPLETED|Washout Period 3||11
1516250|NCT01536704|3710636|P2|COMPLETED|Washout Period 3||12
1516251|NCT01536704|3710637|P1|COMPLETED|Washout Period 3||10
1516252|NCT01536704|3710634|P4|STARTED|Washout Period 3||10
1516253|NCT01536704|3710635|P3|STARTED|Washout Period 3||12
1516254|NCT01536704|3710636|P2|STARTED|Washout Period 3||12
1516255|NCT01536704|3710637|P1|STARTED|Washout Period 3||10
1516256|NCT01536704|3710634|P4|NOT COMPLETED|Period 3||1
1516257|NCT01536704|3710635|P3|NOT COMPLETED|Period 3||0
1516258|NCT01536704|3710636|P2|NOT COMPLETED|Period 3||0
1516259|NCT01536704|3710637|P1|NOT COMPLETED|Period 3||0
1516260|NCT01536704|3710634|P4|COMPLETED|Period 3||10
1516261|NCT01536704|3710635|P3|COMPLETED|Period 3||12
1516262|NCT01536704|3710636|P2|COMPLETED|Period 3||12
1516263|NCT01536704|3710637|P1|COMPLETED|Period 3||10
1516264|NCT01536704|3710634|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
1516265|NCT01536704|3710635|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1516266|NCT01536704|3710636|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1516267|NCT01536704|3710637|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
1516268|NCT01536704|3710634|P4|NOT COMPLETED|Washout Period 2||1
1516269|NCT01536704|3710635|P3|NOT COMPLETED|Washout Period 2||0
1516270|NCT01536704|3710636|P2|NOT COMPLETED|Washout Period 2||0
1516271|NCT01536704|3710637|P1|NOT COMPLETED|Washout Period 2||1
1516272|NCT01536704|3710634|P4|COMPLETED|Washout Period 2||12
1516273|NCT01536704|3710635|P3|COMPLETED|Washout Period 2||10
1516274|NCT01536704|3710636|P2|COMPLETED|Washout Period 2||11
1516275|NCT01536704|3710637|P1|COMPLETED|Washout Period 2||12
1516276|NCT01536704|3710634|P4|STARTED|Washout Period 2||13
1516277|NCT01536704|3710635|P3|STARTED|Washout Period 2||10
1516278|NCT01536704|3710636|P2|STARTED|Washout Period 2||11
1516279|NCT01536704|3710637|P1|STARTED|Washout Period 2||13
1516280|NCT01536704|3710634|P4|NOT COMPLETED|Period 2||0
1516281|NCT01536704|3710635|P3|NOT COMPLETED|Period 2||0
1516282|NCT01536704|3710636|P2|NOT COMPLETED|Period 2||0
1516283|NCT01536704|3710637|P1|NOT COMPLETED|Period 2||0
1516284|NCT01536704|3710634|P4|COMPLETED|Period 2||13
1516285|NCT01536704|3710635|P3|COMPLETED|Period 2||10
1516286|NCT01536704|3710636|P2|COMPLETED|Period 2||11
1516287|NCT01536704|3710637|P1|COMPLETED|Period 2||13
1516288|NCT01536704|3710634|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1516289|NCT01536704|3710635|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
1516290|NCT01536704|3710636|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
1516291|NCT01536704|3710637|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1516292|NCT01536704|3710634|P4|NOT COMPLETED|Washout Period 1||0
1516293|NCT01536704|3710635|P3|NOT COMPLETED|Washout Period 1||0
1516294|NCT01536704|3710636|P2|NOT COMPLETED|Washout Period 1||2
1516295|NCT01536704|3710637|P1|NOT COMPLETED|Washout Period 1||1
1516296|NCT01536704|3710634|P4|COMPLETED|Washout Period 1||13
1516297|NCT01536704|3710635|P3|COMPLETED|Washout Period 1||13
1516298|NCT01536704|3710636|P2|COMPLETED|Washout Period 1||10
1516299|NCT01536704|3710637|P1|COMPLETED|Washout Period 1||11
1516300|NCT01536704|3710634|P4|STARTED|Washout Period 1||13
1516301|NCT01536704|3710635|P3|STARTED|Washout Period 1||13
1516302|NCT01536704|3710636|P2|STARTED|Washout Period 1||12
1516303|NCT01536704|3710637|P1|STARTED|Washout Period 1||12
1516304|NCT01536704|3710634|P4|NOT COMPLETED|Period 1||0
1516305|NCT01536704|3710635|P3|NOT COMPLETED|Period 1||0
1516306|NCT01536704|3710636|P2|NOT COMPLETED|Period 1||0
1516307|NCT01536704|3710637|P1|NOT COMPLETED|Period 1||0
1516308|NCT01536704|3710634|P4|COMPLETED|Period 1||13
1516309|NCT01536704|3710635|P3|COMPLETED|Period 1||13
1516310|NCT01536704|3710636|P2|COMPLETED|Period 1||12
1516311|NCT01536704|3710637|P1|COMPLETED|Period 1||12
1516312|NCT01536704|3710634|P4|STARTED|Period 1||13
1516313|NCT01536704|3710635|P3|STARTED|Period 1||13
1516314|NCT01536704|3710636|P2|STARTED|Period 1||12
1516315|NCT01536704|3710637|P1|STARTED|Period 1||12
1516316|NCT01536587|3710667|P1|NOT COMPLETED|Overall Study||2
1516317|NCT01536587|3710667|P1|COMPLETED|Overall Study||30
1516318|NCT01536587|3710667|P1|STARTED|Overall Study||32
1516319|NCT01536574|3710706|P2|NOT COMPLETED|Overall Study||7
1516320|NCT01536574|3710707|P1|NOT COMPLETED|Overall Study||6
1516321|NCT01536574|3710706|P2|COMPLETED|Overall Study||126
1516322|NCT01536574|3710707|P1|COMPLETED|Overall Study||156
1516323|NCT01536574|3710706|P2|STARTED|Overall Study||133
1516324|NCT01536574|3710707|P1|STARTED|Overall Study||162
1516325|NCT01536561|3710725|P1|NOT COMPLETED|Long-Term Follow-Up||0
1516326|NCT01536561|3710725|P1|COMPLETED|Long-Term Follow-Up||13
1516327|NCT01536561|3710725|P1|STARTED|Long-Term Follow-Up||13
1516328|NCT01536561|3710725|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
1516329|NCT01536561|3710725|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
1516330|NCT01536561|3710725|P1|STARTED|Dosimetric and Therapeutic Treatment||59
1516331|NCT01536496|3710765|P2|NOT COMPLETED|Overall Study||1
1516332|NCT01536496|3710766|P1|NOT COMPLETED|Overall Study||2
1516333|NCT01536496|3710765|P2|COMPLETED|Overall Study||56
1516334|NCT01536496|3710766|P1|COMPLETED|Overall Study||55
1516335|NCT01536496|3710765|P2|STARTED|Overall Study||57
1516336|NCT01536496|3710766|P1|STARTED|Overall Study||57
1516337|NCT01536418|3710802|P2|NOT COMPLETED|Overall Study||66
1516338|NCT01536418|3710803|P1|NOT COMPLETED|Overall Study||69
1516339|NCT01536418|3710802|P2|COMPLETED|Overall Study||60
1516340|NCT01536418|3710803|P1|COMPLETED|Overall Study||58
1516341|NCT01536418|3710802|P2|STARTED|Overall Study||126
1516342|NCT01536418|3710803|P1|STARTED|Overall Study||127
1516343|NCT01536405|3710823|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
1516344|NCT01536405|3710824|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
1516345|NCT01536405|3710823|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
1516346|NCT01536405|3710824|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
1516347|NCT01536405|3710823|P2|STARTED|Visit 4 to Extended Study Follow-up||618
1516348|NCT01536405|3710824|P1|STARTED|Visit 4 to Extended Study Follow-up||615
1516349|NCT01536405|3710823|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
1516350|NCT01536405|3710824|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
1516351|NCT01536405|3710823|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
1516352|NCT01536405|3710824|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
1516353|NCT01536405|3710823|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
1516354|NCT01536405|3710824|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
1516355|NCT01536405|3710823|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
1516356|NCT01536405|3710824|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
1516357|NCT01536405|3710823|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
1516358|NCT01536405|3710824|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
1516359|NCT01536405|3710823|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
1516360|NCT01536405|3710824|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
1516361|NCT01536405|3710823|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
1516362|NCT01536405|3710824|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
1516363|NCT01536405|3710823|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
1516364|NCT01536405|3710824|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
1516365|NCT01536405|3710823|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
1516366|NCT01536405|3710824|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
1516367|NCT01536405|3710823|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
1516368|NCT01536405|3710824|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
1516369|NCT01536405|3710823|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
1516370|NCT01536405|3710824|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
1516371|NCT01536405|3710823|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
1516372|NCT01536405|3710824|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
1516373|NCT01536405|3710823|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
1516374|NCT01536405|3710824|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
1516375|NCT01536405|3710823|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
1516376|NCT01536405|3710824|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
1516377|NCT01536379|3710862|P2|NOT COMPLETED|Overall Study||3
1516378|NCT01536379|3710863|P1|NOT COMPLETED|Overall Study||2
1516379|NCT01536379|3710862|P2|COMPLETED|Overall Study||9
1516380|NCT01536379|3710863|P1|COMPLETED|Overall Study||11
1516381|NCT01536379|3710862|P2|STARTED|Overall Study||12
1516382|NCT01536379|3710863|P1|STARTED|Overall Study||13
1516383|NCT01536366|3710939|P2|NOT COMPLETED|Overall Study||4
1516384|NCT01536366|3710940|P1|NOT COMPLETED|Overall Study||13
1516385|NCT01536366|3710939|P2|COMPLETED|Overall Study||9
1516386|NCT01536366|3710940|P1|COMPLETED|Overall Study||1
1516387|NCT01536366|3710939|P2|Follow-up|Overall Study||9
1516388|NCT01536366|3710940|P1|Follow-up|Overall Study||13
1516389|NCT01536366|3710939|P2|Repaglinide|Overall Study||13
1516390|NCT01536366|3710940|P1|Repaglinide|Overall Study||14
1516391|NCT01536366|3710939|P2|BIA 9-1067 + Repaglinide|Overall Study||10
1516392|NCT01536366|3710940|P1|BIA 9-1067 + Repaglinide|Overall Study||14
1516393|NCT01536366|3710939|P2|STARTED|Overall Study||13
1516394|NCT01536366|3710940|P1|STARTED|Overall Study||14
1516395|NCT01536262|3710955|P3|NOT COMPLETED|Overall Study||2
1516396|NCT01536262|3710956|P2|NOT COMPLETED|Overall Study||2
1516397|NCT01536262|3710957|P1|NOT COMPLETED|Overall Study||8
1516398|NCT01536262|3710955|P3|COMPLETED|Overall Study||39
1516399|NCT01536262|3710956|P2|COMPLETED|Overall Study||38
1516400|NCT01536262|3710957|P1|COMPLETED|Overall Study||33
1516401|NCT01536262|3710955|P3|STARTED|Overall Study||41
1516402|NCT01536262|3710956|P2|STARTED|Overall Study||40
1516403|NCT01536262|3710957|P1|STARTED|Overall Study||41
1516404|NCT01536197|3710973|P2|NOT COMPLETED|Overall Study||0
1516405|NCT01536197|3710974|P1|NOT COMPLETED|Overall Study||0
1516406|NCT01536197|3710973|P2|COMPLETED|Overall Study||10
1516407|NCT01536197|3710974|P1|COMPLETED|Overall Study||23
1516408|NCT01536197|3710973|P2|STARTED|Overall Study||10
1516409|NCT01536197|3710974|P1|STARTED|Overall Study||23
1516410|NCT01536184|3710984|P2|NOT COMPLETED|Overall Study||0
1516411|NCT01536184|3710985|P1|NOT COMPLETED|Overall Study||0
1516412|NCT01536184|3710984|P2|COMPLETED|Overall Study||4
1516413|NCT01536184|3710985|P1|COMPLETED|Overall Study||8
1516414|NCT01536184|3710984|P2|STARTED|Overall Study||4
1516415|NCT01536184|3710985|P1|STARTED|Overall Study||8
1516416|NCT01536171|3710999|P1|NOT COMPLETED|Overall Study||1
1516417|NCT01536171|3710999|P1|COMPLETED|Overall Study||21
1516418|NCT01536171|3710999|P1|STARTED|Overall Study||22
1516419|NCT01536145|3711004|P11|NOT COMPLETED|Overall Study||10
1516420|NCT01536145|3711005|P10|NOT COMPLETED|Overall Study||6
1516421|NCT01536145|3711006|P9|NOT COMPLETED|Overall Study||3
1516422|NCT01536145|3711007|P8|NOT COMPLETED|Overall Study||4
1516423|NCT01536145|3711008|P7|NOT COMPLETED|Overall Study||2
1516424|NCT01536145|3711009|P6|NOT COMPLETED|Overall Study||3
1516425|NCT01536145|3711010|P5|NOT COMPLETED|Overall Study||2
1516426|NCT01536145|3711011|P4|NOT COMPLETED|Overall Study||2
1516427|NCT01536145|3711012|P3|NOT COMPLETED|Overall Study||2
1516428|NCT01536145|3711013|P2|NOT COMPLETED|Overall Study||4
1516429|NCT01536145|3711014|P1|NOT COMPLETED|Overall Study||3
1516430|NCT01536145|3711004|P11|COMPLETED|Overall Study||0
1516431|NCT01536145|3711005|P10|COMPLETED|Overall Study||1
1516432|NCT01536145|3711006|P9|COMPLETED|Overall Study||0
1516433|NCT01536145|3711007|P8|COMPLETED|Overall Study||0
1516434|NCT01536145|3711008|P7|COMPLETED|Overall Study||1
1516435|NCT01536145|3711009|P6|COMPLETED|Overall Study||0
1516436|NCT01536145|3711010|P5|COMPLETED|Overall Study||2
1516437|NCT01536145|3711011|P4|COMPLETED|Overall Study||1
1516438|NCT01536145|3711012|P3|COMPLETED|Overall Study||1
1516439|NCT01536145|3711013|P2|COMPLETED|Overall Study||0
1516440|NCT01536145|3711014|P1|COMPLETED|Overall Study||0
1516441|NCT01536145|3711004|P11|STARTED|Overall Study||10
1516442|NCT01536145|3711005|P10|STARTED|Overall Study||7
1516443|NCT01536145|3711006|P9|STARTED|Overall Study||3
1516444|NCT01536145|3711007|P8|STARTED|Overall Study||4
1516445|NCT01536145|3711008|P7|STARTED|Overall Study||3
1516446|NCT01536145|3711009|P6|STARTED|Overall Study||3
1516447|NCT01536145|3711010|P5|STARTED|Overall Study||4
1516448|NCT01536145|3711011|P4|STARTED|Overall Study||3
1516449|NCT01536145|3711012|P3|STARTED|Overall Study||3
1516450|NCT01536145|3711013|P2|STARTED|Overall Study||4
1516451|NCT01536145|3711014|P1|STARTED|Overall Study||3
1516452|NCT01536119|3711121|P2|NOT COMPLETED|Overall Study||14
1516453|NCT01536119|3711122|P1|NOT COMPLETED|Overall Study||17
1516542|NCT01535638|3711267|P4|COMPLETED|Treatment 1 (Single Dose)||3
1516454|NCT01536119|3711121|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
1516455|NCT01536119|3711122|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
1516456|NCT01536119|3711121|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
1516457|NCT01536119|3711122|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
1516458|NCT01536093|3711148|P2|NOT COMPLETED|Overall Study||3
1516459|NCT01536093|3711149|P1|NOT COMPLETED|Overall Study||3
1516460|NCT01536093|3711148|P2|COMPLETED|Overall Study||21
1516461|NCT01536093|3711149|P1|COMPLETED|Overall Study||21
1516462|NCT01536093|3711148|P2|STARTED|Overall Study||24
1516463|NCT01536093|3711149|P1|STARTED|Overall Study||24
1516464|NCT01536067|3711165|P1|NOT COMPLETED|Overall Study||1
1516465|NCT01536067|3711165|P1|COMPLETED|Overall Study||2
1516466|NCT01536067|3711165|P1|STARTED|Overall Study||3
1516467|NCT01536015|3711178|P2|NOT COMPLETED|Overall Study||10
1516468|NCT01536015|3711179|P1|NOT COMPLETED|Overall Study||8
1516469|NCT01536015|3711178|P2|COMPLETED|Overall Study||3
1516470|NCT01536015|3711179|P1|COMPLETED|Overall Study||4
1516471|NCT01536015|3711178|P2|STARTED|Overall Study||13
1516472|NCT01536015|3711179|P1|STARTED|Overall Study||12
1516473|NCT01535976|3711197|P2|NOT COMPLETED|Overall Study||1
1516474|NCT01535976|3711198|P1|NOT COMPLETED|Overall Study||1
1516475|NCT01535976|3711197|P2|COMPLETED|Overall Study||26
1516476|NCT01535976|3711198|P1|COMPLETED|Overall Study||26
1516477|NCT01535976|3711197|P2|STARTED|Overall Study||27
1516478|NCT01535976|3711198|P1|STARTED|Overall Study||27
1516479|NCT01535937|3711206|P2|NOT COMPLETED|Overall Study||0
1516480|NCT01535937|3711207|P1|NOT COMPLETED|Overall Study||0
1516481|NCT01535937|3711206|P2|COMPLETED|Overall Study||28
1516482|NCT01535937|3711207|P1|COMPLETED|Overall Study||27
1516483|NCT01535937|3711206|P2|STARTED|Overall Study||28
1516484|NCT01535937|3711207|P1|STARTED|Overall Study||27
1516485|NCT01535807|3711217|P2|NOT COMPLETED|Overall Study||2
1516486|NCT01535807|3711218|P1|NOT COMPLETED|Overall Study||2
1516487|NCT01535807|3711217|P2|COMPLETED|Overall Study||20
1516488|NCT01535807|3711218|P1|COMPLETED|Overall Study||20
1516489|NCT01535807|3711217|P2|STARTED|Overall Study||22
1516490|NCT01535807|3711218|P1|STARTED|Overall Study||22
1516491|NCT01535729|3711224|P1|NOT COMPLETED|Overall Study||416
1516492|NCT01535729|3711224|P1|COMPLETED|Overall Study||49
1516493|NCT01535729|3711224|P1|Treated|Overall Study||385
1516494|NCT01535729|3711224|P1|STARTED|Overall Study||465
1516495|NCT01535664|3711251|P1|NOT COMPLETED|Overall Study||0
1516496|NCT01535664|3711251|P1|COMPLETED|Overall Study||20
1516497|NCT01535664|3711251|P1|STARTED|Overall Study||20
1516498|NCT01535638|3711265|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
1516499|NCT01535638|3711266|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
1516500|NCT01535638|3711267|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
1516501|NCT01535638|3711268|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
1516502|NCT01535638|3711269|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
1516503|NCT01535638|3711270|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
1516504|NCT01535638|3711265|P6|COMPLETED|Treatment 3 (Single Dose)||2
1516505|NCT01535638|3711266|P5|COMPLETED|Treatment 3 (Single Dose)||3
1516506|NCT01535638|3711267|P4|COMPLETED|Treatment 3 (Single Dose)||2
1516507|NCT01535638|3711268|P3|COMPLETED|Treatment 3 (Single Dose)||3
1516508|NCT01535638|3711269|P2|COMPLETED|Treatment 3 (Single Dose)||3
1516509|NCT01535638|3711270|P1|COMPLETED|Treatment 3 (Single Dose)||3
1516510|NCT01535638|3711265|P6|STARTED|Treatment 3 (Single Dose)||2
1516511|NCT01535638|3711266|P5|STARTED|Treatment 3 (Single Dose)||3
1516512|NCT01535638|3711267|P4|STARTED|Treatment 3 (Single Dose)||3
1516513|NCT01535638|3711268|P3|STARTED|Treatment 3 (Single Dose)||3
1516514|NCT01535638|3711269|P2|STARTED|Treatment 3 (Single Dose)||3
1516515|NCT01535638|3711270|P1|STARTED|Treatment 3 (Single Dose)||3
1516516|NCT01535638|3711265|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
1516517|NCT01535638|3711266|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
1516518|NCT01535638|3711267|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
1516519|NCT01535638|3711268|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
1516520|NCT01535638|3711269|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
1516521|NCT01535638|3711270|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
1516522|NCT01535638|3711265|P6|COMPLETED|Treatment 2 (Single Dose)||2
1516523|NCT01535638|3711266|P5|COMPLETED|Treatment 2 (Single Dose)||3
1516524|NCT01535638|3711267|P4|COMPLETED|Treatment 2 (Single Dose)||3
1516525|NCT01535638|3711268|P3|COMPLETED|Treatment 2 (Single Dose)||3
1516526|NCT01535638|3711269|P2|COMPLETED|Treatment 2 (Single Dose)||3
1516527|NCT01535638|3711270|P1|COMPLETED|Treatment 2 (Single Dose)||3
1516528|NCT01535638|3711265|P6|STARTED|Treatment 2 (Single Dose)||2
1516529|NCT01535638|3711266|P5|STARTED|Treatment 2 (Single Dose)||3
1516530|NCT01535638|3711267|P4|STARTED|Treatment 2 (Single Dose)||3
1516531|NCT01535638|3711268|P3|STARTED|Treatment 2 (Single Dose)||3
1516532|NCT01535638|3711269|P2|STARTED|Treatment 2 (Single Dose)||3
1516533|NCT01535638|3711270|P1|STARTED|Treatment 2 (Single Dose)||3
1516534|NCT01535638|3711265|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
1516535|NCT01535638|3711266|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
1516536|NCT01535638|3711267|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
1516537|NCT01535638|3711268|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
1516538|NCT01535638|3711269|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
1516539|NCT01535638|3711270|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
1516540|NCT01535638|3711265|P6|COMPLETED|Treatment 1 (Single Dose)||2
1516541|NCT01535638|3711266|P5|COMPLETED|Treatment 1 (Single Dose)||3
1516543|NCT01535638|3711268|P3|COMPLETED|Treatment 1 (Single Dose)||3
1516544|NCT01535638|3711269|P2|COMPLETED|Treatment 1 (Single Dose)||3
1516545|NCT01535638|3711270|P1|COMPLETED|Treatment 1 (Single Dose)||3
1516546|NCT01535638|3711265|P6|STARTED|Treatment 1 (Single Dose)||3
1516547|NCT01535638|3711266|P5|STARTED|Treatment 1 (Single Dose)||3
1516548|NCT01535638|3711267|P4|STARTED|Treatment 1 (Single Dose)||3
1516549|NCT01535638|3711268|P3|STARTED|Treatment 1 (Single Dose)||3
1516550|NCT01535638|3711269|P2|STARTED|Treatment 1 (Single Dose)||3
1516551|NCT01535638|3711270|P1|STARTED|Treatment 1 (Single Dose)||3
1516552|NCT01535599|3711284|P2|NOT COMPLETED|Overall Study||96
1516553|NCT01535599|3711285|P1|NOT COMPLETED|Overall Study||50
1516554|NCT01535599|3711284|P2|COMPLETED|Overall Study||250
1516555|NCT01535599|3711285|P1|COMPLETED|Overall Study||297
1516556|NCT01535599|3711284|P2|STARTED|Overall Study||346
1516557|NCT01535599|3711285|P1|STARTED|Overall Study||347
1516558|NCT01535560|3711297|P2|NOT COMPLETED|Overall Study||96
1516559|NCT01535560|3711298|P1|NOT COMPLETED|Overall Study||37
1516560|NCT01535560|3711297|P2|COMPLETED|Overall Study||179
1516561|NCT01535560|3711298|P1|COMPLETED|Overall Study||237
1516562|NCT01535560|3711297|P2|STARTED|Overall Study||275
1516563|NCT01535560|3711298|P1|STARTED|Overall Study||274
1516564|NCT01535365|3711310|P2|NOT COMPLETED|Overall Study||0
1516565|NCT01535365|3711311|P1|NOT COMPLETED|Overall Study||0
1516566|NCT01535365|3711310|P2|COMPLETED|Overall Study||29
1516567|NCT01535365|3711311|P1|COMPLETED|Overall Study||31
1516568|NCT01535365|3711310|P2|STARTED|Overall Study||29
1516569|NCT01535365|3711311|P1|STARTED|Overall Study||31
1516570|NCT01535326|3711322|P3|NOT COMPLETED|Overall Study||0
1516571|NCT01535326|3711323|P2|NOT COMPLETED|Overall Study||0
1516572|NCT01535326|3711324|P1|NOT COMPLETED|Overall Study||0
1516573|NCT01535326|3711322|P3|COMPLETED|Overall Study||90
1516574|NCT01535326|3711323|P2|COMPLETED|Overall Study||90
1516575|NCT01535326|3711324|P1|COMPLETED|Overall Study||90
1516576|NCT01535326|3711322|P3|STARTED|Overall Study||90
1516577|NCT01535326|3711323|P2|STARTED|Overall Study||90
1516578|NCT01535326|3711324|P1|STARTED|Overall Study||90
1516579|NCT01535287|3711343|P2|NOT COMPLETED|Overall Study||6
1516580|NCT01535287|3711344|P1|NOT COMPLETED|Overall Study||5
1516581|NCT01535287|3711343|P2|COMPLETED|Overall Study||64
1516582|NCT01535287|3711344|P1|COMPLETED|Overall Study||65
1516583|NCT01535287|3711343|P2|STARTED|Overall Study||70
1516584|NCT01535287|3711344|P1|STARTED|Overall Study||70
1516585|NCT01535261|3711360|P1|NOT COMPLETED|Overall Study||50
1516586|NCT01535261|3711360|P1|COMPLETED|Overall Study||307
1516587|NCT01535261|3711360|P1|STARTED|Overall Study||357
1516588|NCT01535235|3711373|P2|NOT COMPLETED|Overall Study||0
1516589|NCT01535235|3711374|P1|NOT COMPLETED|Overall Study||1
1516590|NCT01535235|3711373|P2|COMPLETED|Overall Study||15
1516591|NCT01535235|3711374|P1|COMPLETED|Overall Study||15
1516592|NCT01535235|3711373|P2|STARTED|Overall Study||15
1516593|NCT01535235|3711374|P1|STARTED|Overall Study||16
1516594|NCT01535222|3711388|P6|NOT COMPLETED|Overall Study||0
1516595|NCT01535222|3711389|P5|NOT COMPLETED|Overall Study||0
1516596|NCT01535222|3711390|P4|NOT COMPLETED|Overall Study||0
1516597|NCT01535222|3711391|P3|NOT COMPLETED|Overall Study||1
1516598|NCT01535222|3711392|P2|NOT COMPLETED|Overall Study||0
1516599|NCT01535222|3711393|P1|NOT COMPLETED|Overall Study||0
1516600|NCT01535222|3711388|P6|COMPLETED|Overall Study||8
1516601|NCT01535222|3711389|P5|COMPLETED|Overall Study||6
1516602|NCT01535222|3711390|P4|COMPLETED|Overall Study||6
1516603|NCT01535222|3711391|P3|COMPLETED|Overall Study||6
1516604|NCT01535222|3711392|P2|COMPLETED|Overall Study||3
1516605|NCT01535222|3711393|P1|COMPLETED|Overall Study||3
1516606|NCT01535222|3711388|P6|STARTED|Overall Study||8
1516607|NCT01535222|3711389|P5|STARTED|Overall Study||6
1516608|NCT01535222|3711390|P4|STARTED|Overall Study||6
1516609|NCT01535222|3711391|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
1516610|NCT01535222|3711392|P2|STARTED|Overall Study||3
1516611|NCT01535222|3711393|P1|STARTED|Overall Study||3
1516612|NCT01535118|3711413|P1|NOT COMPLETED|Overall Study||0
1516613|NCT01535118|3711413|P1|COMPLETED|Overall Study||2765
1516614|NCT01535118|3711413|P1|STARTED|Overall Study||2765
1516615|NCT01535040|3711424|P2|NOT COMPLETED|Overall Study||21
1516616|NCT01535040|3711425|P1|NOT COMPLETED|Overall Study||30
1516617|NCT01535040|3711424|P2|COMPLETED|Overall Study||44
1516618|NCT01535040|3711425|P1|COMPLETED|Overall Study||35
1516619|NCT01535040|3711424|P2|STARTED|Overall Study||65
1516620|NCT01535040|3711425|P1|STARTED|Overall Study||65
1516621|NCT01535014|3711441|P4|NOT COMPLETED|Overall Study||0
1516622|NCT01535014|3711442|P3|NOT COMPLETED|Overall Study||1
1516623|NCT01535014|3711443|P2|NOT COMPLETED|Overall Study||6
1516624|NCT01535014|3711444|P1|NOT COMPLETED|Overall Study||2
1516625|NCT01535014|3711441|P4|COMPLETED|Overall Study||33
1516626|NCT01535014|3711442|P3|COMPLETED|Overall Study||49
1516627|NCT01535014|3711443|P2|COMPLETED|Overall Study||194
1516628|NCT01535014|3711444|P1|COMPLETED|Overall Study||208
1516629|NCT01535014|3711441|P4|STARTED|Overall Study||33
1516630|NCT01535014|3711442|P3|STARTED|Overall Study||50
1516631|NCT01535014|3711443|P2|STARTED|Overall Study||200
1516632|NCT01535014|3711444|P1|STARTED|Overall Study||210
1516633|NCT01535001|3711478|P2|NOT COMPLETED|Overall Study||6
1516634|NCT01535001|3711479|P1|NOT COMPLETED|Overall Study||3
1516635|NCT01535001|3711478|P2|COMPLETED|Overall Study||44
1516636|NCT01535001|3711479|P1|COMPLETED|Overall Study||47
1516637|NCT01535001|3711478|P2|STARTED|Overall Study||50
1516638|NCT01535001|3711479|P1|STARTED|Overall Study||50
1516639|NCT01534975|3711505|P4|NOT COMPLETED|Overall Study||0
1516640|NCT01534975|3711506|P3|NOT COMPLETED|Overall Study||0
1516641|NCT01534975|3711507|P2|NOT COMPLETED|Overall Study||0
1516642|NCT01534975|3711508|P1|NOT COMPLETED|Overall Study||0
1516643|NCT01534975|3711505|P4|COMPLETED|Overall Study||84
1516644|NCT01534975|3711506|P3|COMPLETED|Overall Study||160
1516645|NCT01534975|3711507|P2|COMPLETED|Overall Study||133
1516646|NCT01534975|3711508|P1|COMPLETED|Overall Study||136
1516647|NCT01534975|3711505|P4|STARTED|Overall Study||84
1516648|NCT01534975|3711506|P3|STARTED|Overall Study||160
1516649|NCT01534975|3711507|P2|STARTED|Overall Study||133
1516650|NCT01534975|3711508|P1|STARTED|Overall Study||136
1516651|NCT01534962|3711522|P4|NOT COMPLETED|Overall Study||32
1516652|NCT01534962|3711523|P3|NOT COMPLETED|Overall Study||24
1516653|NCT01534962|3711524|P2|NOT COMPLETED|Overall Study||26
1516654|NCT01534962|3711525|P1|NOT COMPLETED|Overall Study||37
1516655|NCT01534962|3711522|P4|COMPLETED|Overall Study||24
1516656|NCT01534962|3711523|P3|COMPLETED|Overall Study||34
1516657|NCT01534962|3711524|P2|COMPLETED|Overall Study||34
1516658|NCT01534962|3711525|P1|COMPLETED|Overall Study||30
1516659|NCT01534962|3711522|P4|STARTED|Overall Study||56
1516660|NCT01534962|3711523|P3|STARTED|Overall Study||58
1516661|NCT01534962|3711524|P2|STARTED|Overall Study||60
1516662|NCT01534962|3711525|P1|STARTED|Overall Study||67
1516663|NCT01534910|3711557|P2|NOT COMPLETED|Overall Study||4
1516664|NCT01534910|3711558|P1|NOT COMPLETED|Overall Study||4
1516665|NCT01534910|3711557|P2|COMPLETED|Overall Study||28
1516666|NCT01534910|3711558|P1|COMPLETED|Overall Study||29
1516667|NCT01534910|3711557|P2|STARTED|Overall Study||32
1516668|NCT01534910|3711558|P1|STARTED|Overall Study||33
1516669|NCT01534897|3711566|P1|NOT COMPLETED|Overall Study||0
1516670|NCT01534897|3711566|P1|COMPLETED|Overall Study||10
1516671|NCT01534897|3711566|P1|Day 37 Iodine-131 Treatment|Overall Study||6
1516672|NCT01534897|3711566|P1|Day 25 Iodine-131 Scan|Overall Study||10
1516673|NCT01534897|3711566|P1|STARTED|Overall Study||10
1516674|NCT01534689|3711574|P1|NOT COMPLETED|Overall Study||0
1516675|NCT01534689|3711574|P1|COMPLETED|Overall Study||105
1516676|NCT01534689|3711574|P1|STARTED|Overall Study||105
1516677|NCT01534676|3711582|P2|NOT COMPLETED|Overall Study||1
1516678|NCT01534676|3711583|P1|NOT COMPLETED|Overall Study||2
1516679|NCT01534676|3711582|P2|COMPLETED|Overall Study||0
1516680|NCT01534676|3711583|P1|COMPLETED|Overall Study||0
1516681|NCT01534676|3711582|P2|STARTED|Overall Study||1
1516682|NCT01534676|3711583|P1|STARTED|Overall Study||2
1516683|NCT01534637|3711589|P1|NOT COMPLETED|Overall Study||9
1516684|NCT01534637|3711589|P1|COMPLETED|Overall Study||13
1516685|NCT01534637|3711589|P1|STARTED|Overall Study||22
1516686|NCT01534533|3711599|P4|NOT COMPLETED|Overall Study||4
1516687|NCT01534533|3711600|P3|NOT COMPLETED|Overall Study||8
1516688|NCT01534533|3711601|P2|NOT COMPLETED|Overall Study||3
1516689|NCT01534533|3711602|P1|NOT COMPLETED|Overall Study||8
1516690|NCT01534533|3711599|P4|COMPLETED|Overall Study||44
1516691|NCT01534533|3711600|P3|COMPLETED|Overall Study||40
1516692|NCT01534533|3711601|P2|COMPLETED|Overall Study||45
1516693|NCT01534533|3711602|P1|COMPLETED|Overall Study||40
1516694|NCT01534533|3711599|P4|STARTED|Overall Study||48
1516695|NCT01534533|3711600|P3|STARTED|Overall Study||48
1516696|NCT01534533|3711601|P2|STARTED|Overall Study||48
1516697|NCT01534533|3711602|P1|STARTED|Overall Study||48
1516698|NCT01534520|3711630|P2|NOT COMPLETED|Overall Study||1
1516699|NCT01534520|3711631|P1|NOT COMPLETED|Overall Study||0
1516700|NCT01534520|3711630|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
1516701|NCT01534520|3711631|P1|COMPLETED|Overall Study||30
1516702|NCT01534520|3711630|P2|STARTED|Overall Study||29
1516703|NCT01534520|3711631|P1|STARTED|Overall Study||30
1516704|NCT01534416|3711645|P2|NOT COMPLETED|Overall Study||0
1516705|NCT01534416|3711646|P1|NOT COMPLETED|Overall Study||0
1516706|NCT01534416|3711645|P2|COMPLETED|Overall Study||64
1516707|NCT01534416|3711646|P1|COMPLETED|Overall Study||68
1516708|NCT01534416|3711645|P2|STARTED|Overall Study||64
1516709|NCT01534416|3711646|P1|STARTED|Overall Study||68
1516710|NCT01534351|3711665|P3|NOT COMPLETED|Overall Study||0
1516711|NCT01534351|3711666|P2|NOT COMPLETED|Overall Study||0
1516712|NCT01534351|3711667|P1|NOT COMPLETED|Overall Study||1
1516713|NCT01534351|3711665|P3|COMPLETED|Overall Study||0
1516714|NCT01534351|3711666|P2|COMPLETED|Overall Study||0
1516715|NCT01534351|3711667|P1|COMPLETED|Overall Study||0
1516716|NCT01534351|3711665|P3|STARTED|Overall Study||0
1516717|NCT01534351|3711666|P2|STARTED|Overall Study||0
1516718|NCT01534351|3711667|P1|STARTED|Overall Study||1
1516719|NCT01534260|3711686|P2|NOT COMPLETED|Overall Study||20
1516720|NCT01534260|3711687|P1|NOT COMPLETED|Overall Study||16
1516721|NCT01534260|3711686|P2|COMPLETED|Overall Study||0
1516722|NCT01534260|3711687|P1|COMPLETED|Overall Study||1
1516723|NCT01534260|3711686|P2|STARTED|Overall Study||20
1516724|NCT01534260|3711687|P1|STARTED|Overall Study||17
1516725|NCT01534208|3711697|P2|NOT COMPLETED|Overall Study||49
1516726|NCT01534208|3711698|P1|NOT COMPLETED|Overall Study||57
1516727|NCT01534208|3711697|P2|COMPLETED|Overall Study||234
1516728|NCT01534208|3711698|P1|COMPLETED|Overall Study||159
1516729|NCT01534208|3711697|P2|STARTED|Overall Study||283
1516730|NCT01534208|3711698|P1|STARTED|Overall Study||216
1516731|NCT01534182|3711716|P2|NOT COMPLETED|Overall Study||10
1516732|NCT01534182|3711717|P1|NOT COMPLETED|Overall Study||12
1516733|NCT01534182|3711716|P2|COMPLETED|Overall Study||58
1516734|NCT01534182|3711717|P1|COMPLETED|Overall Study||218
1516735|NCT01534182|3711716|P2|Full Analysis Set|Overall Study||62
1516736|NCT01534182|3711717|P1|Full Analysis Set|Overall Study||229
1516737|NCT01534182|3711716|P2|Safety Set|Overall Study||64
1516738|NCT01534182|3711717|P1|Safety Set|Overall Study||230
1516739|NCT01534182|3711716|P2|STARTED|Overall Study||68
1516740|NCT01534182|3711717|P1|STARTED|Overall Study||230
1516741|NCT01534143|3711732|P1|NOT COMPLETED|Overall Study||0
1516742|NCT01534143|3711732|P1|COMPLETED|Overall Study||1
1516743|NCT01534143|3711732|P1|STARTED|Overall Study||1
1516744|NCT01534078|3711748|P1|NOT COMPLETED|Overall Study||2
1516745|NCT01534078|3711748|P1|COMPLETED|Overall Study||32
1516746|NCT01534078|3711748|P1|STARTED|Overall Study||34
1516747|NCT01534052|3711755|P1|NOT COMPLETED|Overall Study||0
1516748|NCT01534052|3711755|P1|COMPLETED|Overall Study||52
1516749|NCT01534052|3711755|P1|Treatment Received|Overall Study||52
1516750|NCT01534052|3711755|P1|STARTED|Overall Study||52
1516751|NCT01533974|3711761|P2|NOT COMPLETED|Overall Study||50
1516752|NCT01533974|3711762|P1|NOT COMPLETED|Overall Study||51
1516753|NCT01533974|3711761|P2|COMPLETED|Overall Study||176
1516754|NCT01533974|3711762|P1|COMPLETED|Overall Study||173
1516755|NCT01533974|3711761|P2|STARTED|Overall Study||226
1516756|NCT01533974|3711762|P1|STARTED|Overall Study||224
1516757|NCT01533948|3711768|P1|NOT COMPLETED|Overall Study||0
1516758|NCT01533948|3711768|P1|COMPLETED|Overall Study||25
1516759|NCT01533948|3711768|P1|STARTED|Overall Study||25
1516760|NCT01533935|3711776|P5|NOT COMPLETED|Overall Study||8
1516761|NCT01533935|3711777|P4|NOT COMPLETED|Overall Study||7
1516762|NCT01533935|3711778|P3|NOT COMPLETED|Overall Study||8
1516763|NCT01533935|3711779|P2|NOT COMPLETED|Overall Study||13
1516764|NCT01533935|3711780|P1|NOT COMPLETED|Overall Study||6
1516765|NCT01533935|3711776|P5|COMPLETED|Overall Study|All treatment periods|50
1516766|NCT01533935|3711777|P4|COMPLETED|Overall Study|All treatment periods|52
1516767|NCT01533935|3711778|P3|COMPLETED|Overall Study|All treatment periods|50
1516768|NCT01533935|3711779|P2|COMPLETED|Overall Study|All treatment periods|45
1516769|NCT01533935|3711780|P1|COMPLETED|Overall Study|All treatment periods|52
1516770|NCT01533935|3711776|P5|Received Tio+Olo 5/5|Overall Study||55
1516771|NCT01533935|3711777|P4|Received Tio+Olo 5/5|Overall Study||54
1516772|NCT01533935|3711778|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
1516773|NCT01533935|3711779|P2|Received Tio+Olo 5/5|Overall Study||58
1516774|NCT01533935|3711780|P1|Received Tio+Olo 5/5|Overall Study||56
1516775|NCT01533935|3711776|P5|Received Tio+Olo 2.5/5|Overall Study||56
1516776|NCT01533935|3711777|P4|Received Tio+Olo 2.5/5|Overall Study||56
1516777|NCT01533935|3711778|P3|Received Tio+Olo 2.5/5|Overall Study||49
1516778|NCT01533935|3711779|P2|Received Tio+Olo 2.5/5|Overall Study||0
1516779|NCT01533935|3711780|P1|Received Tio+Olo 2.5/5|Overall Study||58
1516780|NCT01533935|3711776|P5|Received Tio 5|Overall Study||52
1516781|NCT01533935|3711777|P4|Received Tio 5|Overall Study||0
1516782|NCT01533935|3711778|P3|Received Tio 5|Overall Study||58
1516783|NCT01533935|3711779|P2|Received Tio 5|Overall Study||54
1516784|NCT01533935|3711780|P1|Received Tio 5|Overall Study||54
1516785|NCT01533935|3711776|P5|Received Olo 5|Overall Study||0
1516786|NCT01533935|3711777|P4|Received Olo 5|Overall Study||59
1516787|NCT01533935|3711778|P3|Received Olo 5|Overall Study||55
1516788|NCT01533935|3711779|P2|Received Olo 5|Overall Study||52
1516789|NCT01533935|3711780|P1|Received Olo 5|Overall Study||52
1516790|NCT01533935|3711776|P5|Received Placebo|Overall Study||58
1516791|NCT01533935|3711777|P4|Received Placebo|Overall Study||57
1516792|NCT01533935|3711778|P3|Received Placebo|Overall Study||52
1516793|NCT01533935|3711779|P2|Received Placebo|Overall Study||47
1516794|NCT01533935|3711780|P1|Received Placebo|Overall Study||0
1516795|NCT01533935|3711776|P5|STARTED|Overall Study||58
1516796|NCT01533935|3711777|P4|STARTED|Overall Study||59
1516797|NCT01533935|3711778|P3|STARTED|Overall Study||58
1516798|NCT01533935|3711779|P2|STARTED|Overall Study||58
1516799|NCT01533935|3711780|P1|STARTED|Overall Study||58
1516800|NCT01533922|3711807|P5|NOT COMPLETED|Overall Study||6
1516801|NCT01533922|3711808|P4|NOT COMPLETED|Overall Study||5
1516802|NCT01533922|3711809|P3|NOT COMPLETED|Overall Study||10
1516803|NCT01533922|3711810|P2|NOT COMPLETED|Overall Study||12
1516804|NCT01533922|3711811|P1|NOT COMPLETED|Overall Study||10
1516805|NCT01533922|3711807|P5|COMPLETED|Overall Study|Completed all treatment arms|53
1516806|NCT01533922|3711808|P4|COMPLETED|Overall Study|Completed all treatment arms|53
1516807|NCT01533922|3711809|P3|COMPLETED|Overall Study|Completed all treatment arms|50
1516808|NCT01533922|3711810|P2|COMPLETED|Overall Study|Completed all treatment arms|47
1516809|NCT01533922|3711811|P1|COMPLETED|Overall Study|Completed all treatment arms|49
1516810|NCT01533922|3711807|P5|Received Tio+Olo 5/5|Overall Study||56
1516811|NCT01533922|3711808|P4|Received Tio+Olo 5/5|Overall Study||53
1516812|NCT01533922|3711809|P3|Received Tio+Olo 5/5|Overall Study||0
1516813|NCT01533922|3711810|P2|Received Tio+Olo 5/5|Overall Study||59
1516814|NCT01533922|3711811|P1|Received Tio+Olo 5/5|Overall Study||58
1516815|NCT01533922|3711807|P5|Received Tio+Olo 2.5/5|Overall Study||56
1516816|NCT01533922|3711808|P4|Received Tio+Olo 2.5/5|Overall Study||55
1516817|NCT01533922|3711809|P3|Received Tio+Olo 2.5/5|Overall Study||52
1516818|NCT01533922|3711810|P2|Received Tio+Olo 2.5/5|Overall Study||0
1516819|NCT01533922|3711811|P1|Received Tio+Olo 2.5/5|Overall Study||59
1516820|NCT01533922|3711807|P5|Received Tio 5|Overall Study||54
1516821|NCT01533922|3711808|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
1516822|NCT01533922|3711809|P3|Received Tio 5|Overall Study||59
1516823|NCT01533922|3711810|P2|Received Tio 5|Overall Study||58
1516824|NCT01533922|3711811|P1|Received Tio 5|Overall Study||54
1516825|NCT01533922|3711807|P5|Received Olo 5|Overall Study||0
1516826|NCT01533922|3711808|P4|Received Olo 5|Overall Study||57
1516827|NCT01533922|3711809|P3|Received Olo 5|Overall Study||57
1516828|NCT01533922|3711810|P2|Received Olo 5|Overall Study||52
1516829|NCT01533922|3711811|P1|Received Olo 5|Overall Study||51
1516830|NCT01533922|3711807|P5|Received Placebo|Overall Study||59
1516831|NCT01533922|3711808|P4|Received Placebo|Overall Study||57
1516832|NCT01533922|3711809|P3|Received Placebo|Overall Study||57
1516833|NCT01533922|3711810|P2|Received Placebo|Overall Study||49
1516834|NCT01533922|3711811|P1|Received Placebo|Overall Study||0
1516835|NCT01533922|3711807|P5|STARTED|Overall Study||59
1516836|NCT01533922|3711808|P4|STARTED|Overall Study||58
1516837|NCT01533922|3711809|P3|STARTED|Overall Study||60
1516838|NCT01533922|3711810|P2|STARTED|Overall Study||59
1516839|NCT01533922|3711811|P1|STARTED|Overall Study||59
1516840|NCT01533753|3711840|P2|NOT COMPLETED|Overall Study||0
1516841|NCT01533753|3711841|P1|NOT COMPLETED|Overall Study||0
1516842|NCT01533753|3711840|P2|COMPLETED|Overall Study||3
1516843|NCT01533753|3711841|P1|COMPLETED|Overall Study||2
1516844|NCT01533753|3711840|P2|STARTED|Overall Study||3
1516845|NCT01533753|3711841|P1|STARTED|Overall Study||2
1516846|NCT01533688|3711856|P3|NOT COMPLETED|Overall Study||8
1516847|NCT01533688|3711857|P2|NOT COMPLETED|Overall Study||10
1516848|NCT01533688|3711858|P1|NOT COMPLETED|Overall Study||8
1516849|NCT01533688|3711856|P3|COMPLETED|Overall Study||63
1516850|NCT01533688|3711857|P2|COMPLETED|Overall Study||60
1516851|NCT01533688|3711858|P1|COMPLETED|Overall Study||63
1516852|NCT01533688|3711856|P3|STARTED|Overall Study||71
1516853|NCT01533688|3711857|P2|STARTED|Overall Study||70
1516854|NCT01533688|3711858|P1|STARTED|Overall Study||71
1516855|NCT01533597|3711871|P2|NOT COMPLETED|Overall Study||10
1516856|NCT01533597|3711872|P1|NOT COMPLETED|Overall Study||6
1516857|NCT01533597|3711871|P2|COMPLETED|Overall Study||25
1516858|NCT01533597|3711872|P1|COMPLETED|Overall Study||29
1516859|NCT01533597|3711871|P2|STARTED|Overall Study||35
1516860|NCT01533597|3711872|P1|STARTED|Overall Study||35
1516861|NCT01533493|3711890|P2|NOT COMPLETED|Overall Study||3
1516862|NCT01533493|3711891|P1|NOT COMPLETED|Overall Study||5
1516863|NCT01533493|3711890|P2|COMPLETED|Overall Study||11
1516864|NCT01533493|3711891|P1|COMPLETED|Overall Study||7
1516865|NCT01533493|3711890|P2|STARTED|Overall Study||14
1516866|NCT01533493|3711891|P1|STARTED|Overall Study||12
1516867|NCT01533428|3711899|P2|NOT COMPLETED|Overall Study||8
1516868|NCT01533428|3711900|P1|NOT COMPLETED|Overall Study||9
1516869|NCT01533428|3711899|P2|COMPLETED|Overall Study||175
1516870|NCT01533428|3711900|P1|COMPLETED|Overall Study||177
1516871|NCT01533428|3711899|P2|STARTED|Overall Study||183
1516872|NCT01533428|3711900|P1|STARTED|Overall Study||186
1516873|NCT01533259|3711940|P1|NOT COMPLETED|Overall Study||0
1516874|NCT01533259|3711940|P1|COMPLETED|Overall Study||48
1516875|NCT01533259|3711940|P1|STARTED|Overall Study||48
1516876|NCT01533246|3711946|P1|NOT COMPLETED|Overall Study||2
1516877|NCT01533246|3711946|P1|COMPLETED|Overall Study||15
1516878|NCT01533246|3711946|P1|STARTED|Overall Study||17
1516879|NCT01533181|3711957|P2|NOT COMPLETED|Overall Study||1
1516880|NCT01533181|3711958|P1|NOT COMPLETED|Overall Study||1
1516881|NCT01533181|3711957|P2|COMPLETED|Overall Study||28
1516882|NCT01533181|3711958|P1|COMPLETED|Overall Study||14
1516883|NCT01533181|3711957|P2|STARTED|Overall Study||29
1516884|NCT01533181|3711958|P1|STARTED|Overall Study||15
1516885|NCT01533116|3711974|P4|NOT COMPLETED|Overall Study||0
1516886|NCT01533116|3711975|P3|NOT COMPLETED|Overall Study||1
1516887|NCT01533116|3711976|P2|NOT COMPLETED|Overall Study||1
1516888|NCT01533116|3711977|P1|NOT COMPLETED|Overall Study||2
1516889|NCT01533116|3711974|P4|COMPLETED|Overall Study||12
1516890|NCT01533116|3711975|P3|COMPLETED|Overall Study||12
1516891|NCT01533116|3711976|P2|COMPLETED|Overall Study||12
1516892|NCT01533116|3711977|P1|COMPLETED|Overall Study||12
1516893|NCT01533116|3711974|P4|STARTED|Overall Study||12
1516894|NCT01533116|3711975|P3|STARTED|Overall Study||13
1516895|NCT01533116|3711976|P2|STARTED|Overall Study||13
1516896|NCT01533116|3711977|P1|STARTED|Overall Study||14
1516897|NCT01533077|3712007|P4|NOT COMPLETED|Overall Study||0
1516898|NCT01533077|3712008|P3|NOT COMPLETED|Overall Study||0
1516899|NCT01533077|3712009|P2|NOT COMPLETED|Overall Study||1
1516900|NCT01533077|3712010|P1|NOT COMPLETED|Overall Study||1
1516901|NCT01533077|3712007|P4|COMPLETED|Overall Study||4
1516902|NCT01533077|3712008|P3|COMPLETED|Overall Study||4
1516903|NCT01533077|3712009|P2|COMPLETED|Overall Study||4
1516904|NCT01533077|3712010|P1|COMPLETED|Overall Study||4
1516905|NCT01533077|3712007|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
1516906|NCT01533077|3712008|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
1516907|NCT01533077|3712009|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
1516908|NCT01533077|3712010|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
1516909|NCT01533077|3712007|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
1516910|NCT01533077|3712008|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
1516911|NCT01533077|3712009|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
1516912|NCT01533077|3712010|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
1516913|NCT01533077|3712007|P4|Sinemet® 100/25|Overall Study||4
1516914|NCT01533077|3712008|P3|Sinemet® 100/25|Overall Study||4
1516915|NCT01533077|3712009|P2|Sinemet® 100/25|Overall Study||5
1516916|NCT01533077|3712010|P1|Sinemet® 100/25|Overall Study||4
1516917|NCT01533077|3712007|P4|BIA 9-1067 50 mg|Overall Study||4
1516918|NCT01533077|3712008|P3|BIA 9-1067 50 mg|Overall Study||4
1516919|NCT01533077|3712009|P2|BIA 9-1067 50 mg|Overall Study||5
1516920|NCT01533077|3712010|P1|BIA 9-1067 50 mg|Overall Study||5
1516921|NCT01533077|3712007|P4|STARTED|Overall Study||4
1516922|NCT01533077|3712008|P3|STARTED|Overall Study||4
1516923|NCT01533077|3712009|P2|STARTED|Overall Study||5
1516924|NCT01533077|3712010|P1|STARTED|Overall Study||5
1516925|NCT01533038|3712066|P2|NOT COMPLETED|Overall Study||1
1516926|NCT01533038|3712067|P1|NOT COMPLETED|Overall Study||0
1516927|NCT01533038|3712066|P2|COMPLETED|Overall Study||34
1516928|NCT01533038|3712067|P1|COMPLETED|Overall Study||45
1516929|NCT01533038|3712066|P2|STARTED|Overall Study||35
1516930|NCT01533038|3712067|P1|STARTED|Overall Study||45
1516931|NCT01532999|3712075|P2|NOT COMPLETED|Overall Study||18
1516932|NCT01532999|3712076|P1|NOT COMPLETED|Overall Study||31
1516933|NCT01532999|3712075|P2|COMPLETED|Overall Study||77
1516934|NCT01532999|3712076|P1|COMPLETED|Overall Study||65
1516935|NCT01532999|3712075|P2|STARTED|Overall Study||95
1516936|NCT01532999|3712076|P1|STARTED|Overall Study||96
1516937|NCT01532973|3712107|P10|NOT COMPLETED|Part 3||0
1516938|NCT01532973|3712108|P9|NOT COMPLETED|Part 3||0
1516939|NCT01532973|3712109|P8|NOT COMPLETED|Part 3||0
1516940|NCT01532973|3712110|P7|NOT COMPLETED|Part 3||0
1516941|NCT01532973|3712111|P6|NOT COMPLETED|Part 3||0
1516942|NCT01532973|3712112|P5|NOT COMPLETED|Part 3||0
1516943|NCT01532973|3712113|P4|NOT COMPLETED|Part 3||0
1516944|NCT01532973|3712114|P3|NOT COMPLETED|Part 3||0
1516945|NCT01532973|3712115|P2|NOT COMPLETED|Part 3||0
1516946|NCT01532973|3712116|P1|NOT COMPLETED|Part 3||0
1516947|NCT01532973|3712107|P10|COMPLETED|Part 3||6
1516948|NCT01532973|3712108|P9|COMPLETED|Part 3||6
1516949|NCT01532973|3712109|P8|COMPLETED|Part 3||0
1516950|NCT01532973|3712110|P7|COMPLETED|Part 3||0
1516951|NCT01532973|3712111|P6|COMPLETED|Part 3||0
1516952|NCT01532973|3712112|P5|COMPLETED|Part 3||0
1516953|NCT01532973|3712113|P4|COMPLETED|Part 3||0
1516954|NCT01532973|3712114|P3|COMPLETED|Part 3||0
1516955|NCT01532973|3712115|P2|COMPLETED|Part 3||0
1516956|NCT01532973|3712116|P1|COMPLETED|Part 3||0
1516957|NCT01532973|3712107|P10|STARTED|Part 3||6
1516958|NCT01532973|3712108|P9|STARTED|Part 3||6
1516959|NCT01532973|3712109|P8|STARTED|Part 3||0
1516960|NCT01532973|3712110|P7|STARTED|Part 3||0
1516961|NCT01532973|3712111|P6|STARTED|Part 3||0
1516962|NCT01532973|3712112|P5|STARTED|Part 3||0
1516963|NCT01532973|3712113|P4|STARTED|Part 3||0
1516964|NCT01532973|3712114|P3|STARTED|Part 3||0
1516965|NCT01532973|3712115|P2|STARTED|Part 3||0
1516966|NCT01532973|3712116|P1|STARTED|Part 3||0
1516967|NCT01532973|3712107|P10|NOT COMPLETED|Part 2||0
1516968|NCT01532973|3712108|P9|NOT COMPLETED|Part 2||0
1516969|NCT01532973|3712109|P8|NOT COMPLETED|Part 2||0
1516970|NCT01532973|3712110|P7|NOT COMPLETED|Part 2||0
1516971|NCT01532973|3712111|P6|NOT COMPLETED|Part 2||0
1516972|NCT01532973|3712112|P5|NOT COMPLETED|Part 2||0
1516973|NCT01532973|3712113|P4|NOT COMPLETED|Part 2||0
1516974|NCT01532973|3712114|P3|NOT COMPLETED|Part 2||0
1516975|NCT01532973|3712115|P2|NOT COMPLETED|Part 2||0
1516976|NCT01532973|3712116|P1|NOT COMPLETED|Part 2||0
1516977|NCT01532973|3712107|P10|COMPLETED|Part 2||0
1516978|NCT01532973|3712108|P9|COMPLETED|Part 2||0
1516979|NCT01532973|3712109|P8|COMPLETED|Part 2||0
1516980|NCT01532973|3712110|P7|COMPLETED|Part 2||6
1516981|NCT01532973|3712111|P6|COMPLETED|Part 2||6
1516982|NCT01532973|3712112|P5|COMPLETED|Part 2||6
1516983|NCT01532973|3712113|P4|COMPLETED|Part 2||0
1516984|NCT01532973|3712114|P3|COMPLETED|Part 2||0
1516985|NCT01532973|3712115|P2|COMPLETED|Part 2||0
1516986|NCT01532973|3712116|P1|COMPLETED|Part 2||0
1516987|NCT01532973|3712107|P10|STARTED|Part 2||0
1516988|NCT01532973|3712108|P9|STARTED|Part 2||0
1516989|NCT01532973|3712109|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
1516990|NCT01532973|3712110|P7|STARTED|Part 2||6
1516991|NCT01532973|3712111|P6|STARTED|Part 2||6
1516992|NCT01532973|3712112|P5|STARTED|Part 2||6
1516993|NCT01532973|3712113|P4|STARTED|Part 2||0
1516994|NCT01532973|3712114|P3|STARTED|Part 2||0
1516995|NCT01532973|3712115|P2|STARTED|Part 2||0
1516996|NCT01532973|3712116|P1|STARTED|Part 2||0
1516997|NCT01532973|3712107|P10|NOT COMPLETED|Part 1||0
1516998|NCT01532973|3712108|P9|NOT COMPLETED|Part 1||0
1516999|NCT01532973|3712109|P8|NOT COMPLETED|Part 1||0
1517000|NCT01532973|3712110|P7|NOT COMPLETED|Part 1||0
1517001|NCT01532973|3712111|P6|NOT COMPLETED|Part 1||0
1517002|NCT01532973|3712112|P5|NOT COMPLETED|Part 1||0
1517003|NCT01532973|3712113|P4|NOT COMPLETED|Part 1||0
1517004|NCT01532973|3712114|P3|NOT COMPLETED|Part 1||0
1517005|NCT01532973|3712115|P2|NOT COMPLETED|Part 1||0
1517006|NCT01532973|3712116|P1|NOT COMPLETED|Part 1||0
1517007|NCT01532973|3712107|P10|COMPLETED|Part 1||0
1517008|NCT01532973|3712108|P9|COMPLETED|Part 1||0
1517009|NCT01532973|3712109|P8|COMPLETED|Part 1||0
1517010|NCT01532973|3712110|P7|COMPLETED|Part 1||0
1517011|NCT01532973|3712111|P6|COMPLETED|Part 1||0
1517012|NCT01532973|3712112|P5|COMPLETED|Part 1||0
1517013|NCT01532973|3712113|P4|COMPLETED|Part 1||0
1517014|NCT01532973|3712114|P3|COMPLETED|Part 1||6
1517015|NCT01532973|3712115|P2|COMPLETED|Part 1||6
1517016|NCT01532973|3712116|P1|COMPLETED|Part 1||6
1517017|NCT01532973|3712107|P10|STARTED|Part 1||0
1517018|NCT01532973|3712108|P9|STARTED|Part 1||0
1517019|NCT01532973|3712109|P8|STARTED|Part 1||0
1517020|NCT01532973|3712110|P7|STARTED|Part 1||0
1517021|NCT01532973|3712111|P6|STARTED|Part 1||0
1517022|NCT01532973|3712112|P5|STARTED|Part 1||0
1517023|NCT01532973|3712113|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
1517024|NCT01532973|3712114|P3|STARTED|Part 1||6
1517025|NCT01532973|3712115|P2|STARTED|Part 1||6
1517026|NCT01532973|3712116|P1|STARTED|Part 1||6
1517027|NCT01532934|3712158|P2|NOT COMPLETED|Overall Study||13
1517028|NCT01532934|3712159|P1|NOT COMPLETED|Overall Study||14
1517029|NCT01532934|3712158|P2|COMPLETED|Overall Study||39
1517030|NCT01532934|3712159|P1|COMPLETED|Overall Study||39
1517031|NCT01532934|3712158|P2|STARTED|Overall Study||52
1517032|NCT01532934|3712159|P1|STARTED|Overall Study||53
1517033|NCT01532921|3712169|P1|NOT COMPLETED|Overall Study||16
1517034|NCT01532921|3712169|P1|COMPLETED|Overall Study||69
1517035|NCT01532921|3712169|P1|6 Months Follow Up|Overall Study||68
1517036|NCT01532921|3712169|P1|Discharge|Overall Study||75
1517037|NCT01532921|3712169|P1|Implantation Procedure|Overall Study||76
1517038|NCT01532921|3712169|P1|STARTED|Overall Study||85
1517039|NCT01532869|3712191|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
1517040|NCT01532869|3712192|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
1517041|NCT01532869|3712191|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
1517042|NCT01532869|3712192|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
1517043|NCT01532869|3712191|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
1517044|NCT01532869|3712192|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
1517045|NCT01532869|3712191|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
1517046|NCT01532869|3712192|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
1517047|NCT01532869|3712191|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
1517048|NCT01532869|3712192|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
1517049|NCT01532869|3712191|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
1517050|NCT01532869|3712192|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
1517051|NCT01532869|3712191|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
1517052|NCT01532869|3712192|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
1517053|NCT01532869|3712191|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
1517054|NCT01532869|3712192|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
1517055|NCT01532869|3712191|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
1517056|NCT01532869|3712192|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
1517057|NCT01532830|3712229|P1|NOT COMPLETED|Overall Study||4
1517058|NCT01532830|3712229|P1|COMPLETED|Overall Study||26
1517059|NCT01532830|3712229|P1|STARTED|Overall Study||30
1517060|NCT01532817|3712238|P1|NOT COMPLETED|Overall Study||0
1517061|NCT01532817|3712238|P1|COMPLETED|Overall Study||30
1517062|NCT01532817|3712238|P1|STARTED|Overall Study||30
1517063|NCT01532635|3712242|P1|NOT COMPLETED|Overall Study||0
1517064|NCT01532635|3712242|P1|COMPLETED|Overall Study||4
1517065|NCT01532635|3712242|P1|STARTED|Overall Study||4
1517066|NCT01532570|3712258|P4|NOT COMPLETED|Overall Study||0
1517067|NCT01532570|3712259|P3|NOT COMPLETED|Overall Study||0
1517068|NCT01532570|3712260|P2|NOT COMPLETED|Overall Study||1
1517069|NCT01532570|3712261|P1|NOT COMPLETED|Overall Study||1
1517070|NCT01532570|3712258|P4|COMPLETED|Overall Study||4
1517071|NCT01532570|3712259|P3|COMPLETED|Overall Study||1
1517072|NCT01532570|3712260|P2|COMPLETED|Overall Study||1
1517073|NCT01532570|3712261|P1|COMPLETED|Overall Study||10
1517074|NCT01532570|3712258|P4|STARTED|Overall Study||4
1517075|NCT01532570|3712259|P3|STARTED|Overall Study||1
1517076|NCT01532570|3712260|P2|STARTED|Overall Study||2
1517077|NCT01532570|3712261|P1|STARTED|Overall Study||11
1517078|NCT01532453|3712294|P2|NOT COMPLETED|Overall Study||70
1517079|NCT01532453|3712295|P1|NOT COMPLETED|Overall Study||27
1517080|NCT01532453|3712294|P2|COMPLETED|Overall Study||90
1517081|NCT01532453|3712295|P1|COMPLETED|Overall Study||54
1517082|NCT01532453|3712294|P2|STARTED|Overall Study||160
1517083|NCT01532453|3712295|P1|STARTED|Overall Study||81
1517084|NCT01532414|3712306|P3|NOT COMPLETED|Overall Study||3
1517085|NCT01532414|3712307|P2|NOT COMPLETED|Overall Study||2
1517086|NCT01532414|3712308|P1|NOT COMPLETED|Overall Study||7
1517087|NCT01532414|3712306|P3|COMPLETED|Overall Study||35
1517088|NCT01532414|3712307|P2|COMPLETED|Overall Study||19
1517089|NCT01532414|3712308|P1|COMPLETED|Overall Study||85
1517090|NCT01532414|3712306|P3|STARTED|Overall Study||38
1517091|NCT01532414|3712307|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
1517092|NCT01532414|3712308|P1|STARTED|Overall Study||92
1517093|NCT01532362|3712318|P2|NOT COMPLETED|Overall Study||0
1517094|NCT01532362|3712319|P1|NOT COMPLETED|Overall Study||0
1517095|NCT01532362|3712318|P2|COMPLETED|Overall Study||0
1517096|NCT01532362|3712319|P1|COMPLETED|Overall Study||1
1517097|NCT01532362|3712318|P2|STARTED|Overall Study||0
1517098|NCT01532362|3712319|P1|STARTED|Overall Study||1
1517099|NCT01532349|3712327|P2|NOT COMPLETED|Overall Study||5
1517100|NCT01532349|3712328|P1|NOT COMPLETED|Overall Study||2
1517101|NCT01532349|3712327|P2|COMPLETED|Overall Study||12
1517102|NCT01532349|3712328|P1|COMPLETED|Overall Study||15
1517103|NCT01532349|3712327|P2|STARTED|Overall Study||17
1517104|NCT01532349|3712328|P1|STARTED|Overall Study||17
1517105|NCT01532141|3712337|P3|NOT COMPLETED|Overall Study||0
1517106|NCT01532141|3712338|P2|NOT COMPLETED|Overall Study||0
1517107|NCT01532141|3712339|P1|NOT COMPLETED|Overall Study||1
1517108|NCT01532141|3712337|P3|COMPLETED|Overall Study||8
1517109|NCT01532141|3712338|P2|COMPLETED|Overall Study||8
1517110|NCT01532141|3712339|P1|COMPLETED|Overall Study||8
1517111|NCT01532141|3712337|P3|Period 3|Overall Study||8
1517112|NCT01532141|3712338|P2|Period 3|Overall Study||8
1517113|NCT01532141|3712339|P1|Period 3|Overall Study||8
1517114|NCT01532141|3712337|P3|Period 2|Overall Study||8
1517115|NCT01532141|3712338|P2|Period 2|Overall Study||8
1517116|NCT01532141|3712339|P1|Period 2|Overall Study||8
1517117|NCT01532141|3712337|P3|Period 1|Overall Study||8
1517118|NCT01532141|3712338|P2|Period 1|Overall Study||8
1517119|NCT01532141|3712339|P1|Period 1|Overall Study||9
1517120|NCT01532141|3712337|P3|STARTED|Overall Study||8
1517121|NCT01532141|3712338|P2|STARTED|Overall Study||8
1517122|NCT01532141|3712339|P1|STARTED|Overall Study||9
1517123|NCT01532128|3712357|P3|NOT COMPLETED|Overall Study||0
1517124|NCT01532128|3712358|P2|NOT COMPLETED|Overall Study||0
1517125|NCT01532128|3712359|P1|NOT COMPLETED|Overall Study||0
1517126|NCT01532128|3712357|P3|COMPLETED|Overall Study||8
1517127|NCT01532128|3712358|P2|COMPLETED|Overall Study||8
1517128|NCT01532128|3712359|P1|COMPLETED|Overall Study||8
1517129|NCT01532128|3712357|P3|STARTED|Overall Study||8
1517130|NCT01532128|3712358|P2|STARTED|Overall Study||8
1517131|NCT01532128|3712359|P1|STARTED|Overall Study||8
1517132|NCT01531998|3712374|P1|NOT COMPLETED|Overall Study||3
1517133|NCT01531998|3712374|P1|COMPLETED|Overall Study||8
1517134|NCT01531998|3712374|P1|STARTED|Overall Study||11
1517135|NCT01531725|3712379|P1|NOT COMPLETED|Overall Study||5
1517136|NCT01531725|3712379|P1|COMPLETED|Overall Study||197
1517137|NCT01531725|3712379|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
1517138|NCT01531673|3712397|P13|NOT COMPLETED|Overall Study||0
1517139|NCT01531673|3712398|P12|NOT COMPLETED|Overall Study||0
1517140|NCT01531673|3712399|P11|NOT COMPLETED|Overall Study||0
1517141|NCT01531673|3712400|P10|NOT COMPLETED|Overall Study||1
1517142|NCT01531673|3712401|P9|NOT COMPLETED|Overall Study||0
1517143|NCT01531673|3712402|P8|NOT COMPLETED|Overall Study||0
1517144|NCT01531673|3712403|P7|NOT COMPLETED|Overall Study||0
1517145|NCT01531673|3712404|P6|NOT COMPLETED|Overall Study||1
1517146|NCT01531673|3712405|P5|NOT COMPLETED|Overall Study||1
1517147|NCT01531673|3712406|P4|NOT COMPLETED|Overall Study||1
1517148|NCT01531673|3712407|P3|NOT COMPLETED|Overall Study||0
1517149|NCT01531673|3712408|P2|NOT COMPLETED|Overall Study||1
1517150|NCT01531673|3712409|P1|NOT COMPLETED|Overall Study||0
1517151|NCT01531673|3712397|P13|COMPLETED|Overall Study||14
1517152|NCT01531673|3712398|P12|COMPLETED|Overall Study||4
1517153|NCT01531673|3712399|P11|COMPLETED|Overall Study||16
1517154|NCT01531673|3712400|P10|COMPLETED|Overall Study||18
1517155|NCT01531673|3712401|P9|COMPLETED|Overall Study||17
1517156|NCT01531673|3712402|P8|COMPLETED|Overall Study||9
1517157|NCT01531673|3712403|P7|COMPLETED|Overall Study||17
1517158|NCT01531673|3712404|P6|COMPLETED|Overall Study||18
1517159|NCT01531673|3712405|P5|COMPLETED|Overall Study||7
1517160|NCT01531673|3712406|P4|COMPLETED|Overall Study||17
1517161|NCT01531673|3712407|P3|COMPLETED|Overall Study||8
1517162|NCT01531673|3712408|P2|COMPLETED|Overall Study||7
1517163|NCT01531673|3712409|P1|COMPLETED|Overall Study||33
1517164|NCT01531673|3712397|P13|STARTED|Overall Study||14
1517165|NCT01531673|3712398|P12|STARTED|Overall Study||4
1517166|NCT01531673|3712399|P11|STARTED|Overall Study||16
1517167|NCT01531673|3712400|P10|STARTED|Overall Study||19
1517168|NCT01531673|3712401|P9|STARTED|Overall Study||17
1517169|NCT01531673|3712402|P8|STARTED|Overall Study||9
1517170|NCT01531673|3712403|P7|STARTED|Overall Study||17
1517171|NCT01531673|3712404|P6|STARTED|Overall Study||19
1517172|NCT01531673|3712405|P5|STARTED|Overall Study||8
1517173|NCT01531673|3712406|P4|STARTED|Overall Study||18
1517174|NCT01531673|3712407|P3|STARTED|Overall Study||8
1517175|NCT01531673|3712408|P2|STARTED|Overall Study||8
1517176|NCT01531673|3712409|P1|STARTED|Overall Study||33
1517177|NCT01531387|3712520|P2|NOT COMPLETED|Overall Study||11
1517178|NCT01531387|3712521|P1|NOT COMPLETED|Overall Study||11
1517179|NCT01531387|3712520|P2|COMPLETED|Overall Study||0
1517180|NCT01531387|3712521|P1|COMPLETED|Overall Study||0
1517181|NCT01531387|3712520|P2|STARTED|Overall Study||11
1517182|NCT01531387|3712521|P1|STARTED|Overall Study||11
1517183|NCT01531374|3712538|P3|NOT COMPLETED|Overall Study||283
1517184|NCT01531374|3712539|P2|NOT COMPLETED|Overall Study||142
1517185|NCT01531374|3712540|P1|NOT COMPLETED|Overall Study||364
1517186|NCT01531374|3712538|P3|COMPLETED|Overall Study||836
1517187|NCT01531374|3712539|P2|COMPLETED|Overall Study||231
1517188|NCT01531374|3712540|P1|COMPLETED|Overall Study||921
1517189|NCT01531374|3712538|P3|STARTED|Overall Study||1119
1517190|NCT01531374|3712539|P2|STARTED|Overall Study||373
1517191|NCT01531374|3712540|P1|STARTED|Overall Study||1285
1517192|NCT01531335|3712604|P2|NOT COMPLETED|Overall Study||0
1517193|NCT01531335|3712605|P1|NOT COMPLETED|Overall Study||0
1517194|NCT01531335|3712604|P2|COMPLETED|Overall Study||40
1517195|NCT01531335|3712605|P1|COMPLETED|Overall Study||40
1517196|NCT01531335|3712604|P2|STARTED|Overall Study||40
1517197|NCT01531335|3712605|P1|STARTED|Overall Study||40
1517198|NCT01531205|3712613|P1|NOT COMPLETED|Overall Study||1
1517199|NCT01531205|3712613|P1|COMPLETED|Overall Study||1
1517200|NCT01531205|3712613|P1|STARTED|Overall Study||2
1517201|NCT01531153|3712625|P3|NOT COMPLETED|Overall Study||15
1517202|NCT01531153|3712626|P2|NOT COMPLETED|Overall Study||9
1517203|NCT01531153|3712627|P1|NOT COMPLETED|Overall Study||10
1517204|NCT01531153|3712625|P3|COMPLETED|Overall Study||15
1517205|NCT01531153|3712626|P2|COMPLETED|Overall Study||22
1517206|NCT01531153|3712627|P1|COMPLETED|Overall Study||22
1517207|NCT01531153|3712625|P3|STARTED|Overall Study||30
1517208|NCT01531153|3712626|P2|STARTED|Overall Study||31
1517209|NCT01531153|3712627|P1|STARTED|Overall Study||32
1517210|NCT01530997|3712683|P1|NOT COMPLETED|Overall Study||2
1517211|NCT01530997|3712683|P1|COMPLETED|Overall Study||43
1517212|NCT01530997|3712683|P1|STARTED|Overall Study||45
1517213|NCT01530880|3712703|P1|NOT COMPLETED|Overall Study||0
1517214|NCT01530880|3712703|P1|COMPLETED|Overall Study||35
1517215|NCT01530880|3712703|P1|STARTED|Overall Study||35
1517216|NCT01530477|3712717|P3|NOT COMPLETED|Overall Study||0
1517217|NCT01530477|3712718|P2|NOT COMPLETED|Overall Study||0
1517218|NCT01530477|3712719|P1|NOT COMPLETED|Overall Study||0
1517219|NCT01530477|3712717|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
1517220|NCT01530477|3712718|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
1517221|NCT01530477|3712719|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
1517222|NCT01530477|3712717|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
1517223|NCT01530477|3712718|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
1517224|NCT01530477|3712719|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
1517225|NCT01530464|3712727|P2|NOT COMPLETED|Washout (24h)||1
1517226|NCT01530464|3712728|P1|NOT COMPLETED|Washout (24h)||0
1517227|NCT01530464|3712727|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
1517228|NCT01530464|3712728|P1|COMPLETED|Washout (24h)||9
1517229|NCT01530464|3712727|P2|STARTED|Washout (24h)||8
1517230|NCT01530464|3712728|P1|STARTED|Washout (24h)||9
1517231|NCT01530464|3712727|P2|NOT COMPLETED|Third Intervention (24h)||0
1517232|NCT01530464|3712728|P1|NOT COMPLETED|Third Intervention (24h)||0
1517233|NCT01530464|3712727|P2|COMPLETED|Third Intervention (24h)||8
1517234|NCT01530464|3712728|P1|COMPLETED|Third Intervention (24h)||9
1517235|NCT01530464|3712727|P2|STARTED|Third Intervention (24h)||8
1517236|NCT01530464|3712728|P1|STARTED|Third Intervention (24h)||9
1517237|NCT01530464|3712727|P2|NOT COMPLETED|Washout (24h)||0
1517238|NCT01530464|3712728|P1|NOT COMPLETED|Washout (24h)||1
1517239|NCT01530464|3712727|P2|COMPLETED|Washout (24h)||8
1517240|NCT01530464|3712728|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
1517241|NCT01530464|3712727|P2|STARTED|Washout (24h)||8
1517242|NCT01530464|3712728|P1|STARTED|Washout (24h)||10
1517243|NCT01530464|3712727|P2|NOT COMPLETED|Second Intervention (24h)||0
1517244|NCT01530464|3712728|P1|NOT COMPLETED|Second Intervention (24h)||0
1517245|NCT01530464|3712727|P2|COMPLETED|Second Intervention (24h)||8
1517246|NCT01530464|3712728|P1|COMPLETED|Second Intervention (24h)||10
1517247|NCT01530464|3712727|P2|STARTED|Second Intervention (24h)||8
1517248|NCT01530464|3712728|P1|STARTED|Second Intervention (24h)||10
1517249|NCT01530464|3712727|P2|NOT COMPLETED|Washout (24h)||0
1517250|NCT01530464|3712728|P1|NOT COMPLETED|Washout (24h)||0
1517251|NCT01530464|3712727|P2|COMPLETED|Washout (24h)||8
1517252|NCT01530464|3712728|P1|COMPLETED|Washout (24h)||10
1517253|NCT01530464|3712727|P2|STARTED|Washout (24h)||8
1517254|NCT01530464|3712728|P1|STARTED|Washout (24h)||10
1517255|NCT01530464|3712727|P2|NOT COMPLETED|First Intervention (24h)||0
1517256|NCT01530464|3712728|P1|NOT COMPLETED|First Intervention (24h)||0
1517257|NCT01530464|3712727|P2|COMPLETED|First Intervention (24h)||8
1517258|NCT01530464|3712728|P1|COMPLETED|First Intervention (24h)||10
1517259|NCT01530464|3712727|P2|STARTED|First Intervention (24h)||8
1517260|NCT01530464|3712728|P1|STARTED|First Intervention (24h)||10
1517261|NCT01530399|3712761|P6|NOT COMPLETED|Overall Study||1
1517262|NCT01530399|3712762|P5|NOT COMPLETED|Overall Study||0
1517263|NCT01530399|3712763|P4|NOT COMPLETED|Overall Study||0
1517264|NCT01530399|3712764|P3|NOT COMPLETED|Overall Study||1
1517265|NCT01530399|3712765|P2|NOT COMPLETED|Overall Study||2
1517266|NCT01530399|3712766|P1|NOT COMPLETED|Overall Study||1
1517267|NCT01530399|3712761|P6|COMPLETED|Overall Study||6
1517268|NCT01530399|3712762|P5|COMPLETED|Overall Study||6
1517269|NCT01530399|3712763|P4|COMPLETED|Overall Study||10
1517270|NCT01530399|3712764|P3|COMPLETED|Overall Study||7
1517271|NCT01530399|3712765|P2|COMPLETED|Overall Study||8
1517272|NCT01530399|3712766|P1|COMPLETED|Overall Study||7
1517273|NCT01530399|3712761|P6|STARTED|Overall Study||7
1517274|NCT01530399|3712762|P5|STARTED|Overall Study||6
1517275|NCT01530399|3712763|P4|STARTED|Overall Study||10
1517276|NCT01530399|3712764|P3|STARTED|Overall Study||8
1517277|NCT01530399|3712765|P2|STARTED|Overall Study||10
1517278|NCT01530399|3712766|P1|STARTED|Overall Study||8
1517279|NCT01530334|3712780|P1|NOT COMPLETED|Overall Study||51
1517280|NCT01530334|3712780|P1|COMPLETED|Overall Study||10
1517281|NCT01530334|3712780|P1|STARTED|Overall Study||61
1517282|NCT01530243|3712793|P4|NOT COMPLETED|Overall Study||2
1517283|NCT01530243|3712794|P3|NOT COMPLETED|Overall Study||3
1517284|NCT01530243|3712795|P2|NOT COMPLETED|Overall Study||3
1517285|NCT01530243|3712796|P1|NOT COMPLETED|Overall Study||2
1517286|NCT01530243|3712793|P4|COMPLETED|Overall Study||24
1517287|NCT01530243|3712794|P3|COMPLETED|Overall Study||23
1517288|NCT01530243|3712795|P2|COMPLETED|Overall Study||23
1517289|NCT01530243|3712796|P1|COMPLETED|Overall Study||24
1517290|NCT01530243|3712793|P4|STARTED|Overall Study||26
1517291|NCT01530243|3712794|P3|STARTED|Overall Study||26
1517292|NCT01530243|3712795|P2|STARTED|Overall Study||26
1517293|NCT01530243|3712796|P1|STARTED|Overall Study||26
1517294|NCT01530178|3712816|P2|NOT COMPLETED|Overall Study||0
1517295|NCT01530178|3712817|P1|NOT COMPLETED|Overall Study||0
1517296|NCT01530178|3712816|P2|COMPLETED|Overall Study||6
1517297|NCT01530178|3712817|P1|COMPLETED|Overall Study||2
1517298|NCT01530178|3712816|P2|STARTED|Overall Study||6
1517299|NCT01530178|3712817|P1|STARTED|Overall Study||2
1517300|NCT01530087|3712827|P1|NOT COMPLETED|Overall Study||2
1517301|NCT01530087|3712827|P1|COMPLETED|Overall Study||1
1517302|NCT01530087|3712827|P1|STARTED|Overall Study||3
1517303|NCT01529827|3712832|P1|NOT COMPLETED|Overall Study||0
1517304|NCT01529827|3712832|P1|COMPLETED|Overall Study||94
1517305|NCT01529827|3712832|P1|STARTED|Overall Study||94
1517306|NCT01529645|3712849|P10|NOT COMPLETED|Overall Study||0
1517307|NCT01529645|3712850|P9|NOT COMPLETED|Overall Study||1
1517308|NCT01529645|3712851|P8|NOT COMPLETED|Overall Study||0
1517309|NCT01529645|3712852|P7|NOT COMPLETED|Overall Study||2
1517310|NCT01529645|3712853|P6|NOT COMPLETED|Overall Study||1
1517311|NCT01529645|3712854|P5|NOT COMPLETED|Overall Study||2
1517312|NCT01529645|3712855|P4|NOT COMPLETED|Overall Study||2
1517313|NCT01529645|3712856|P3|NOT COMPLETED|Overall Study||2
1517314|NCT01529645|3712857|P2|NOT COMPLETED|Overall Study||1
1517315|NCT01529645|3712858|P1|NOT COMPLETED|Overall Study||2
1517316|NCT01529645|3712849|P10|COMPLETED|Overall Study||42
1517317|NCT01529645|3712850|P9|COMPLETED|Overall Study||41
1517318|NCT01529645|3712851|P8|COMPLETED|Overall Study||42
1517319|NCT01529645|3712852|P7|COMPLETED|Overall Study||40
1517320|NCT01529645|3712853|P6|COMPLETED|Overall Study||41
1517321|NCT01529645|3712854|P5|COMPLETED|Overall Study||40
1517322|NCT01529645|3712855|P4|COMPLETED|Overall Study||40
1517323|NCT01529645|3712856|P3|COMPLETED|Overall Study||40
1517324|NCT01529645|3712857|P2|COMPLETED|Overall Study||41
1517325|NCT01529645|3712858|P1|COMPLETED|Overall Study||40
1517326|NCT01529645|3712849|P10|STARTED|Overall Study||42
1517327|NCT01529645|3712850|P9|STARTED|Overall Study||42
1517328|NCT01529645|3712851|P8|STARTED|Overall Study||42
1517329|NCT01529645|3712852|P7|STARTED|Overall Study||42
1517330|NCT01529645|3712853|P6|STARTED|Overall Study||42
1517331|NCT01529645|3712854|P5|STARTED|Overall Study||42
1517332|NCT01529645|3712855|P4|STARTED|Overall Study||42
1517333|NCT01529645|3712856|P3|STARTED|Overall Study||42
1517334|NCT01529645|3712857|P2|STARTED|Overall Study||42
1517335|NCT01529645|3712858|P1|STARTED|Overall Study||42
1517336|NCT01529632|3712956|P2|NOT COMPLETED|Overall Study||3
1517337|NCT01529632|3712957|P1|NOT COMPLETED|Overall Study||3
1517338|NCT01529632|3712956|P2|COMPLETED|Overall Study||100
1517339|NCT01529632|3712957|P1|COMPLETED|Overall Study||87
1517340|NCT01529632|3712956|P2|STARTED|Overall Study||103
1517341|NCT01529632|3712957|P1|STARTED|Overall Study||90
1517342|NCT01529515|3712977|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
1517343|NCT01529515|3712978|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
1517344|NCT01529515|3712979|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
1517345|NCT01529515|3712980|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
1517346|NCT01529515|3712977|P4|COMPLETED|DOUBLE BLIND PHASE||148
1517347|NCT01529515|3712978|P3|COMPLETED|DOUBLE BLIND PHASE||122
1517348|NCT01529515|3712979|P2|COMPLETED|DOUBLE BLIND PHASE||0
1517349|NCT01529515|3712980|P1|COMPLETED|DOUBLE BLIND PHASE||0
1517350|NCT01529515|3712977|P4|STARTED|DOUBLE BLIND PHASE||160
1517351|NCT01529515|3712978|P3|STARTED|DOUBLE BLIND PHASE||145
1517352|NCT01529515|3712979|P2|STARTED|DOUBLE BLIND PHASE||0
1517353|NCT01529515|3712980|P1|STARTED|DOUBLE BLIND PHASE||0
1517354|NCT01529515|3712977|P4|NOT COMPLETED|MAINTENANCE PHASE||0
1517355|NCT01529515|3712978|P3|NOT COMPLETED|MAINTENANCE PHASE||0
1517356|NCT01529515|3712979|P2|NOT COMPLETED|MAINTENANCE PHASE||74
1517357|NCT01529515|3712980|P1|NOT COMPLETED|MAINTENANCE PHASE||0
1517358|NCT01529515|3712977|P4|COMPLETED|MAINTENANCE PHASE||0
1517359|NCT01529515|3712978|P3|COMPLETED|MAINTENANCE PHASE||0
1517360|NCT01529515|3712979|P2|COMPLETED|MAINTENANCE PHASE||305
1517361|NCT01529515|3712980|P1|COMPLETED|MAINTENANCE PHASE||0
1517362|NCT01529515|3712977|P4|STARTED|MAINTENANCE PHASE||0
1517363|NCT01529515|3712978|P3|STARTED|MAINTENANCE PHASE||0
1517364|NCT01529515|3712979|P2|STARTED|MAINTENANCE PHASE||379
1517365|NCT01529515|3712980|P1|STARTED|MAINTENANCE PHASE||0
1517366|NCT01529515|3712977|P4|NOT COMPLETED|TRANSITION PHASE||0
1517367|NCT01529515|3712978|P3|NOT COMPLETED|TRANSITION PHASE||0
1517368|NCT01529515|3712979|P2|NOT COMPLETED|TRANSITION PHASE||0
1517369|NCT01529515|3712980|P1|NOT COMPLETED|TRANSITION PHASE||127
1517370|NCT01529515|3712977|P4|COMPLETED|TRANSITION PHASE||0
1517371|NCT01529515|3712978|P3|COMPLETED|TRANSITION PHASE||0
1517372|NCT01529515|3712979|P2|COMPLETED|TRANSITION PHASE||0
1517373|NCT01529515|3712980|P1|COMPLETED|TRANSITION PHASE||379
1517374|NCT01529515|3712977|P4|STARTED|TRANSITION PHASE||0
1517375|NCT01529515|3712978|P3|STARTED|TRANSITION PHASE||0
1517376|NCT01529515|3712979|P2|STARTED|TRANSITION PHASE||0
1517377|NCT01529515|3712980|P1|STARTED|TRANSITION PHASE||506
1517378|NCT01529502|3712999|P6|NOT COMPLETED|Overall Study||0
1517379|NCT01529502|3713000|P5|NOT COMPLETED|Overall Study||0
1517380|NCT01529502|3713001|P4|NOT COMPLETED|Overall Study||2
1517381|NCT01529502|3713002|P3|NOT COMPLETED|Overall Study||0
1517382|NCT01529502|3713003|P2|NOT COMPLETED|Overall Study||0
1517383|NCT01529502|3713004|P1|NOT COMPLETED|Overall Study||0
1517384|NCT01529502|3712999|P6|COMPLETED|Overall Study||2
1517385|NCT01529502|3713000|P5|COMPLETED|Overall Study||2
1517386|NCT01529502|3713001|P4|COMPLETED|Overall Study||1
1517387|NCT01529502|3713002|P3|COMPLETED|Overall Study||2
1517388|NCT01529502|3713003|P2|COMPLETED|Overall Study||3
1517389|NCT01529502|3713004|P1|COMPLETED|Overall Study||2
1517390|NCT01529502|3712999|P6|STARTED|Overall Study||2
1517391|NCT01529502|3713000|P5|STARTED|Overall Study||2
1517392|NCT01529502|3713001|P4|STARTED|Overall Study||3
1517393|NCT01529502|3713002|P3|STARTED|Overall Study||2
1517394|NCT01529502|3713003|P2|STARTED|Overall Study||3
1517395|NCT01529502|3713004|P1|STARTED|Overall Study||2
1517396|NCT01529450|3713017|P2|NOT COMPLETED|Overall Study||2
1517397|NCT01529450|3713018|P1|NOT COMPLETED|Overall Study||0
1517398|NCT01529450|3713017|P2|COMPLETED|Overall Study||6
1517399|NCT01529450|3713018|P1|COMPLETED|Overall Study||3
1517400|NCT01529450|3713017|P2|STARTED|Overall Study||8
1517401|NCT01529450|3713018|P1|STARTED|Overall Study||3
1517402|NCT01529385|3713027|P2|NOT COMPLETED|Overall Study||1
1517403|NCT01529385|3713028|P1|NOT COMPLETED|Overall Study||2
1517404|NCT01529385|3713027|P2|COMPLETED|Overall Study||39
1517405|NCT01529385|3713028|P1|COMPLETED|Overall Study||38
1517406|NCT01529385|3713027|P2|Received Intervention|Overall Study||40
1517407|NCT01529385|3713028|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
1517408|NCT01529385|3713027|P2|STARTED|Overall Study||40
1517409|NCT01529385|3713028|P1|STARTED|Overall Study||40
1517410|NCT01529346|3713057|P5|NOT COMPLETED|Overall Study||0
1517411|NCT01529346|3713058|P4|NOT COMPLETED|Overall Study||0
1517412|NCT01529346|3713059|P3|NOT COMPLETED|Overall Study||2
1517413|NCT01529346|3713060|P2|NOT COMPLETED|Overall Study||1
1517414|NCT01529346|3713061|P1|NOT COMPLETED|Overall Study||2
1517415|NCT01529346|3713057|P5|COMPLETED|Overall Study||36
1517416|NCT01529346|3713058|P4|COMPLETED|Overall Study||36
1517417|NCT01529346|3713059|P3|COMPLETED|Overall Study||52
1517418|NCT01529346|3713060|P2|COMPLETED|Overall Study||53
1517419|NCT01529346|3713061|P1|COMPLETED|Overall Study||53
1517420|NCT01529346|3713057|P5|STARTED|Overall Study||36
1517421|NCT01529346|3713058|P4|STARTED|Overall Study||36
1517422|NCT01529346|3713059|P3|STARTED|Overall Study||54
1517423|NCT01529346|3713060|P2|STARTED|Overall Study||54
1517424|NCT01529346|3713061|P1|STARTED|Overall Study||55
1517425|NCT01529268|3713149|P2|NOT COMPLETED|Overall Study||3
1517426|NCT01529268|3713150|P1|NOT COMPLETED|Overall Study||12
1517427|NCT01529268|3713149|P2|COMPLETED|Overall Study||78
1517428|NCT01529268|3713150|P1|COMPLETED|Overall Study||76
1517429|NCT01529268|3713149|P2|Completed 52-week Biopsy|Overall Study||75
1517430|NCT01529268|3713150|P1|Completed 52-week Biopsy|Overall Study||71
1517431|NCT01529268|3713149|P2|STARTED|Overall Study||81
1517432|NCT01529268|3713150|P1|STARTED|Overall Study||88
1517433|NCT01529203|3713204|P1|NOT COMPLETED|Overall Study||3
1517434|NCT01529203|3713204|P1|COMPLETED|Overall Study||57
1517435|NCT01529203|3713204|P1|STARTED|Overall Study||60
1517436|NCT01529112|3713212|P2|NOT COMPLETED|Overall Study||41
1517437|NCT01529112|3713213|P1|NOT COMPLETED|Overall Study||69
1517438|NCT01529112|3713212|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
1517439|NCT01529112|3713213|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
1517440|NCT01529112|3713212|P2|STARTED|Overall Study||46
1517441|NCT01529112|3713213|P1|STARTED|Overall Study||89
1517442|NCT01528969|3713240|P2|NOT COMPLETED|Overall Study||0
1517443|NCT01528969|3713241|P1|NOT COMPLETED|Overall Study||2
1517444|NCT01528969|3713240|P2|COMPLETED|Overall Study||38
1517445|NCT01528969|3713241|P1|COMPLETED|Overall Study||35
1517446|NCT01528969|3713240|P2|STARTED|Overall Study||38
1517447|NCT01528969|3713241|P1|STARTED|Overall Study||37
1517448|NCT01528891|3713249|P2|NOT COMPLETED|Overall Study||0
1517449|NCT01528891|3713250|P1|NOT COMPLETED|Overall Study||0
1517450|NCT01528891|3713249|P2|COMPLETED|Overall Study||200
1517451|NCT01528891|3713250|P1|COMPLETED|Overall Study||200
1517452|NCT01528891|3713249|P2|STARTED|Overall Study||200
1517453|NCT01528891|3713250|P1|STARTED|Overall Study||200
1517454|NCT01528878|3713262|P1|NOT COMPLETED|Overall Study||0
1517455|NCT01528878|3713262|P1|COMPLETED|Overall Study||30
1517456|NCT01528878|3713262|P1|STARTED|Overall Study||30
1517457|NCT01528787|3713274|P4|NOT COMPLETED|Overall Study||1
1517458|NCT01528787|3713275|P3|NOT COMPLETED|Overall Study||1
1517459|NCT01528787|3713276|P2|NOT COMPLETED|Overall Study||0
1517460|NCT01528787|3713277|P1|NOT COMPLETED|Overall Study||0
1517461|NCT01528787|3713274|P4|COMPLETED|Overall Study||22
1517462|NCT01528787|3713275|P3|COMPLETED|Overall Study||18
1517463|NCT01528787|3713276|P2|COMPLETED|Overall Study||21
1517464|NCT01528787|3713277|P1|COMPLETED|Overall Study||22
1517465|NCT01528787|3713274|P4|STARTED|Overall Study||23
1517466|NCT01528787|3713275|P3|STARTED|Overall Study||19
1517467|NCT01528787|3713276|P2|STARTED|Overall Study||21
1517468|NCT01528787|3713277|P1|STARTED|Overall Study||22
1517469|NCT01528735|3713289|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
1517470|NCT01528735|3713290|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
1517471|NCT01528735|3713289|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
1517472|NCT01528735|3713290|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
1517473|NCT01528735|3713289|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
1517474|NCT01528735|3713290|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
1517475|NCT01528735|3713289|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
1517476|NCT01528735|3713290|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
1517477|NCT01528735|3713289|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
1517478|NCT01528735|3713290|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
1517479|NCT01528735|3713289|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
1517480|NCT01528735|3713290|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
1517481|NCT01528709|3713392|P2|NOT COMPLETED|Overall Study||15
1517482|NCT01528709|3713393|P1|NOT COMPLETED|Overall Study||13
1517483|NCT01528709|3713392|P2|COMPLETED|Overall Study||72
1517484|NCT01528709|3713393|P1|COMPLETED|Overall Study||73
1517485|NCT01528709|3713392|P2|STARTED|Overall Study||87
1517486|NCT01528709|3713393|P1|STARTED|Overall Study||86
1517487|NCT01528696|3713403|P2|NOT COMPLETED|Overall Study||19
1517488|NCT01528696|3713404|P1|NOT COMPLETED|Overall Study||18
1517489|NCT01528696|3713403|P2|COMPLETED|Overall Study||0
1517490|NCT01528696|3713404|P1|COMPLETED|Overall Study||0
1517491|NCT01528696|3713403|P2|Hospital Stay (2-5 Days)|Overall Study||19
1517492|NCT01528696|3713404|P1|Hospital Stay (2-5 Days)|Overall Study||18
1517493|NCT01528696|3713403|P2|STARTED|Overall Study||19
1517494|NCT01528696|3713404|P1|STARTED|Overall Study||18
1517495|NCT01528605|3713420|P6|NOT COMPLETED|Overall Study||0
1517496|NCT01528605|3713421|P5|NOT COMPLETED|Overall Study||0
1517497|NCT01528605|3713422|P4|NOT COMPLETED|Overall Study||1
1517498|NCT01528605|3713423|P3|NOT COMPLETED|Overall Study||1
1517499|NCT01528605|3713424|P2|NOT COMPLETED|Overall Study||0
1517500|NCT01528605|3713425|P1|NOT COMPLETED|Overall Study||2
1517501|NCT01528605|3713420|P6|COMPLETED|Overall Study||28
1517502|NCT01528605|3713421|P5|COMPLETED|Overall Study||28
1517503|NCT01528605|3713422|P4|COMPLETED|Overall Study||27
1517504|NCT01528605|3713423|P3|COMPLETED|Overall Study||27
1517505|NCT01528605|3713424|P2|COMPLETED|Overall Study||28
1517506|NCT01528605|3713425|P1|COMPLETED|Overall Study||26
1517507|NCT01528605|3713420|P6|STARTED|Overall Study||28
1517508|NCT01528605|3713421|P5|STARTED|Overall Study||28
1517509|NCT01528605|3713422|P4|STARTED|Overall Study||28
1517510|NCT01528605|3713423|P3|STARTED|Overall Study||28
1517511|NCT01528605|3713424|P2|STARTED|Overall Study||28
1517512|NCT01528605|3713425|P1|STARTED|Overall Study||28
1517513|NCT01528592|3713449|P1|NOT COMPLETED|Overall Study||0
1517514|NCT01528592|3713449|P1|COMPLETED|Overall Study||18
1517515|NCT01528592|3713449|P1|STARTED|Overall Study||18
1517516|NCT01528345|3713455|P2|NOT COMPLETED|Overall Study||50
1517517|NCT01528345|3713456|P1|NOT COMPLETED|Overall Study||47
1517518|NCT01528345|3713455|P2|COMPLETED|Overall Study||0
1517519|NCT01528345|3713456|P1|COMPLETED|Overall Study||0
1517520|NCT01528345|3713455|P2|STARTED|Overall Study||50
1517521|NCT01528345|3713456|P1|STARTED|Overall Study||47
1517522|NCT01528332|3713474|P2|NOT COMPLETED|Overall Study||2
1517523|NCT01528332|3713475|P1|NOT COMPLETED|Overall Study||4
1517524|NCT01528332|3713474|P2|COMPLETED|Overall Study||84
1517525|NCT01528332|3713475|P1|COMPLETED|Overall Study||81
1517526|NCT01528332|3713474|P2|STARTED|Overall Study||86
1517527|NCT01528332|3713475|P1|STARTED|Overall Study||85
1517528|NCT01528319|3713481|P1|NOT COMPLETED|Overall Study||1
1517529|NCT01528319|3713481|P1|COMPLETED|Overall Study||23
1517530|NCT01528319|3713481|P1|12 Weeks After Surgery|Overall Study||24
1517531|NCT01528319|3713481|P1|STARTED|Overall Study||24
1517532|NCT01528293|3713492|P2|NOT COMPLETED|Overall Study||0
1517533|NCT01528293|3713493|P1|NOT COMPLETED|Overall Study||1
1517534|NCT01528293|3713492|P2|COMPLETED|Overall Study||1
1517535|NCT01528293|3713493|P1|COMPLETED|Overall Study||0
1517536|NCT01528293|3713492|P2|STARTED|Overall Study||1
1517537|NCT01528293|3713493|P1|STARTED|Overall Study||1
1517538|NCT01528215|3713507|P2|NOT COMPLETED|Overall Study||1
1517539|NCT01528215|3713508|P1|NOT COMPLETED|Overall Study||4
1517540|NCT01528215|3713507|P2|COMPLETED|Overall Study||60
1517541|NCT01528215|3713508|P1|COMPLETED|Overall Study||55
1517542|NCT01528215|3713507|P2|STARTED|Overall Study||61
1517543|NCT01528215|3713508|P1|STARTED|Overall Study||59
1517544|NCT01528150|3713514|P1|NOT COMPLETED|Overall Study||44
1517545|NCT01528150|3713514|P1|COMPLETED|Overall Study||422
1517546|NCT01528150|3713514|P1|STARTED|Overall Study||466
1517547|NCT01528124|3713525|P7|NOT COMPLETED|Overall Study||0
1517548|NCT01528124|3713526|P6|NOT COMPLETED|Overall Study||0
1517549|NCT01528124|3713527|P5|NOT COMPLETED|Overall Study||0
1517550|NCT01528124|3713528|P4|NOT COMPLETED|Overall Study||0
1517551|NCT01528124|3713529|P3|NOT COMPLETED|Overall Study||0
1517552|NCT01528124|3713530|P2|NOT COMPLETED|Overall Study||0
1517553|NCT01528124|3713531|P1|NOT COMPLETED|Overall Study||0
1517554|NCT01528124|3713525|P7|COMPLETED|Overall Study||6
1517555|NCT01528124|3713526|P6|COMPLETED|Overall Study||6
1517556|NCT01528124|3713527|P5|COMPLETED|Overall Study||5
1517557|NCT01528124|3713528|P4|COMPLETED|Overall Study||6
1517558|NCT01528124|3713529|P3|COMPLETED|Overall Study||6
1517559|NCT01528124|3713530|P2|COMPLETED|Overall Study||6
1517560|NCT01528124|3713531|P1|COMPLETED|Overall Study||6
1517561|NCT01528124|3713525|P7|Received Study Drug|Overall Study||6
1517562|NCT01528124|3713526|P6|Received Study Drug|Overall Study||6
1517563|NCT01528124|3713527|P5|Received Study Drug|Overall Study||5
1517564|NCT01528124|3713528|P4|Received Study Drug|Overall Study||6
1517565|NCT01528124|3713529|P3|Received Study Drug|Overall Study||6
1517566|NCT01528124|3713530|P2|Received Study Drug|Overall Study||6
1517567|NCT01528124|3713531|P1|Received Study Drug|Overall Study||6
1517568|NCT01528124|3713525|P7|STARTED|Overall Study||6
1517569|NCT01528124|3713526|P6|STARTED|Overall Study||6
1517570|NCT01528124|3713527|P5|STARTED|Overall Study||5
1517571|NCT01528124|3713528|P4|STARTED|Overall Study||6
1517572|NCT01528124|3713529|P3|STARTED|Overall Study||6
1517573|NCT01528124|3713530|P2|STARTED|Overall Study||6
1517574|NCT01528124|3713531|P1|STARTED|Overall Study||6
1517575|NCT01527942|3713567|P2|NOT COMPLETED|Overall Study||0
1517576|NCT01527942|3713568|P1|NOT COMPLETED|Overall Study||0
1517577|NCT01527942|3713567|P2|COMPLETED|Overall Study||18
1517578|NCT01527942|3713568|P1|COMPLETED|Overall Study||16
1517579|NCT01527942|3713567|P2|STARTED|Overall Study||18
1517580|NCT01527942|3713568|P1|STARTED|Overall Study||16
1517581|NCT01527513|3713580|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
1517582|NCT01527513|3713581|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
1517583|NCT01527513|3713580|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
1517584|NCT01527513|3713581|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
1517585|NCT01527513|3713580|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
1517586|NCT01527513|3713581|P1|STARTED|Eligible for 1-Year Open Label Period||0
1517587|NCT01527513|3713580|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
1517588|NCT01527513|3713581|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
1517589|NCT01527513|3713580|P2|COMPLETED|Double Blind Period (DB) - Part I||75
1517590|NCT01527513|3713581|P1|COMPLETED|Double Blind Period (DB) - Part I||37
1517591|NCT01527513|3713580|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
1517592|NCT01527513|3713581|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
1517593|NCT01527513|3713580|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
1517594|NCT01527513|3713581|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
1517595|NCT01527513|3713580|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
1517596|NCT01527513|3713581|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
1517597|NCT01527513|3713580|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
1517598|NCT01527513|3713581|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
1517599|NCT01527513|3713580|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
1517600|NCT01527513|3713581|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
1517601|NCT01527513|3713580|P2|Safety Population|Double Blind Period (DB) - Part I||83
1517602|NCT01527513|3713581|P1|Safety Population|Double Blind Period (DB) - Part I||40
1517603|NCT01527513|3713580|P2|Randomized|Double Blind Period (DB) - Part I||83
1517604|NCT01527513|3713581|P1|Randomized|Double Blind Period (DB) - Part I||40
1517605|NCT01527513|3713580|P2|STARTED|Double Blind Period (DB) - Part I||83
1517606|NCT01527513|3713581|P1|STARTED|Double Blind Period (DB) - Part I||40
1517607|NCT01527500|3713595|P2|NOT COMPLETED|Part B||0
1517608|NCT01527500|3713596|P1|NOT COMPLETED|Part B||1
1517609|NCT01527500|3713595|P2|COMPLETED|Part B||1
1517610|NCT01527500|3713596|P1|COMPLETED|Part B||6
1517611|NCT01527500|3713595|P2|STARTED|Part B||1
1517612|NCT01527500|3713596|P1|STARTED|Part B||7
1517613|NCT01527500|3713595|P2|NOT COMPLETED|Part A||13
1517614|NCT01527500|3713596|P1|NOT COMPLETED|Part A||30
1517615|NCT01527500|3713595|P2|COMPLETED|Part A||38
1517616|NCT01527500|3713596|P1|COMPLETED|Part A||69
1517617|NCT01527500|3713595|P2|STARTED|Part A||51
1517618|NCT01527500|3713596|P1|STARTED|Part A||99
1517619|NCT01527487|3713626|P2|NOT COMPLETED|Overall Study||7
1517620|NCT01527487|3713627|P1|NOT COMPLETED|Overall Study||8
1517621|NCT01527487|3713626|P2|COMPLETED|Overall Study||15
1517622|NCT01527487|3713627|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
1517623|NCT01527487|3713626|P2|STARTED|Overall Study||22
1517624|NCT01527487|3713627|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
1517625|NCT01527370|3713639|P1|NOT COMPLETED|Overall Study||6
1517626|NCT01527370|3713639|P1|COMPLETED|Overall Study||244
1517627|NCT01527370|3713639|P1|STARTED|Overall Study||250
1517628|NCT01527162|3713645|P2|NOT COMPLETED|Overall Study||0
1517629|NCT01527162|3713646|P1|NOT COMPLETED|Overall Study||0
1517630|NCT01527162|3713645|P2|COMPLETED|Overall Study||5
1517631|NCT01527162|3713646|P1|COMPLETED|Overall Study||6
1517632|NCT01527162|3713645|P2|STARTED|Overall Study||5
1517633|NCT01527162|3713646|P1|STARTED|Overall Study||6
1517634|NCT01527110|3713656|P1|NOT COMPLETED|Overall Study||1
1517635|NCT01527110|3713656|P1|COMPLETED|Overall Study||20
1517636|NCT01527110|3713656|P1|STARTED|Overall Study||21
1517637|NCT01527006|3713703|P2|NOT COMPLETED|Extension Phase||8
1517638|NCT01527006|3713704|P1|NOT COMPLETED|Extension Phase||6
1517639|NCT01527006|3713703|P2|COMPLETED|Extension Phase||14
1517640|NCT01527006|3713704|P1|COMPLETED|Extension Phase||13
1517641|NCT01527006|3713703|P2|STARTED|Extension Phase||22
1517642|NCT01527006|3713704|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
1517643|NCT01527006|3713703|P2|NOT COMPLETED|Core Study||6
1517644|NCT01527006|3713704|P1|NOT COMPLETED|Core Study||2
1517645|NCT01527006|3713703|P2|COMPLETED|Core Study||22
1517646|NCT01527006|3713704|P1|COMPLETED|Core Study||20
1517647|NCT01527006|3713703|P2|STARTED|Core Study||28
1517648|NCT01527006|3713704|P1|STARTED|Core Study||22
1517649|NCT01526902|3713754|P2|NOT COMPLETED|Overall Study||0
1517650|NCT01526902|3713755|P1|NOT COMPLETED|Overall Study||0
1517651|NCT01526902|3713754|P2|COMPLETED|Overall Study||24
1517652|NCT01526902|3713755|P1|COMPLETED|Overall Study||25
1517653|NCT01526902|3713754|P2|STARTED|Overall Study||24
1517654|NCT01526902|3713755|P1|STARTED|Overall Study||25
1517655|NCT01526889|3713773|P2|NOT COMPLETED|Treatment Extension Period||0
1517656|NCT01526889|3713774|P1|NOT COMPLETED|Treatment Extension Period||1
1517657|NCT01526889|3713773|P2|COMPLETED|Treatment Extension Period||0
1517658|NCT01526889|3713774|P1|COMPLETED|Treatment Extension Period||4
1517659|NCT01526889|3713773|P2|STARTED|Treatment Extension Period||0
1517660|NCT01526889|3713774|P1|STARTED|Treatment Extension Period||5
1517661|NCT01526889|3713773|P2|NOT COMPLETED|Treatment Period||0
1517662|NCT01526889|3713774|P1|NOT COMPLETED|Treatment Period||2
1517663|NCT01526889|3713773|P2|COMPLETED|Treatment Period||7
1517664|NCT01526889|3713774|P1|COMPLETED|Treatment Period||16
1517665|NCT01526889|3713773|P2|STARTED|Treatment Period||7
1517666|NCT01526889|3713774|P1|STARTED|Treatment Period||18
1517667|NCT01526785|3713795|P1|NOT COMPLETED|Overall Study||13
1517668|NCT01526785|3713795|P1|COMPLETED|Overall Study||100
1517669|NCT01526785|3713795|P1|STARTED|Overall Study||113
1517670|NCT01526733|3713805|P2|NOT COMPLETED|Phase 2||0
1517671|NCT01526733|3713806|P1|NOT COMPLETED|Phase 2||0
1517672|NCT01526733|3713805|P2|COMPLETED|Phase 2||12
1517673|NCT01526733|3713806|P1|COMPLETED|Phase 2||10
1517674|NCT01526733|3713805|P2|STARTED|Phase 2||12
1517675|NCT01526733|3713806|P1|STARTED|Phase 2||10
1517676|NCT01526733|3713805|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
1517677|NCT01526733|3713806|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
1517678|NCT01526733|3713805|P2|COMPLETED|Washout Period of 5 to 21 Days||12
1517679|NCT01526733|3713806|P1|COMPLETED|Washout Period of 5 to 21 Days||10
1517680|NCT01526733|3713805|P2|STARTED|Washout Period of 5 to 21 Days||12
1517681|NCT01526733|3713806|P1|STARTED|Washout Period of 5 to 21 Days||10
1517682|NCT01526733|3713805|P2|NOT COMPLETED|Phase 1||1
1517683|NCT01526733|3713806|P1|NOT COMPLETED|Phase 1||2
1517684|NCT01526733|3713805|P2|COMPLETED|Phase 1||12
1517685|NCT01526733|3713806|P1|COMPLETED|Phase 1||10
1517686|NCT01526733|3713805|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
1517687|NCT01526733|3713806|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
1517688|NCT01526733|3713805|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
1517689|NCT01526733|3713806|P1|STARTED|Phase 1||12
1517690|NCT01526629|3713824|P1|NOT COMPLETED|Overall Study||46
1517691|NCT01526629|3713824|P1|COMPLETED|Overall Study||308
1517692|NCT01526629|3713824|P1|STARTED|Overall Study||354
1517693|NCT01526577|3713833|P5|NOT COMPLETED|Overall Study||2
1517694|NCT01526577|3713834|P4|NOT COMPLETED|Overall Study||1
1517695|NCT01526577|3713835|P3|NOT COMPLETED|Overall Study||1
1517696|NCT01526577|3713836|P2|NOT COMPLETED|Overall Study||0
1517697|NCT01526577|3713837|P1|NOT COMPLETED|Overall Study||1
1517698|NCT01526577|3713833|P5|COMPLETED|Overall Study||8
1517699|NCT01526577|3713834|P4|COMPLETED|Overall Study||8
1517700|NCT01526577|3713835|P3|COMPLETED|Overall Study||32
1517701|NCT01526577|3713836|P2|COMPLETED|Overall Study||12
1517702|NCT01526577|3713837|P1|COMPLETED|Overall Study||48
1517703|NCT01526577|3713833|P5|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
1517704|NCT01526577|3713834|P4|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
1517705|NCT01526577|3713835|P3|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
1517706|NCT01526577|3713836|P2|STARTED|Overall Study||12
1517707|NCT01526577|3713837|P1|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
1517708|NCT01526551|3713845|P1|NOT COMPLETED|Overall Study||424
1517709|NCT01526551|3713845|P1|COMPLETED|Overall Study||511
1517710|NCT01526551|3713845|P1|STARTED|Overall Study||935
1517711|NCT01526538|3713852|P2|NOT COMPLETED|Overall Study||4
1517712|NCT01526538|3713853|P1|NOT COMPLETED|Overall Study||9
1517713|NCT01526538|3713852|P2|COMPLETED|Overall Study||18
1517714|NCT01526538|3713853|P1|COMPLETED|Overall Study||21
1517715|NCT01526538|3713852|P2|STARTED|Overall Study||22
1517716|NCT01526538|3713853|P1|STARTED|Overall Study||30
1517717|NCT01526343|3713863|P1|NOT COMPLETED|Overall Study||0
1517718|NCT01526343|3713863|P1|COMPLETED|Overall Study||47
1517719|NCT01526343|3713863|P1|STARTED|Overall Study||47
1517720|NCT01526213|3713874|P6|NOT COMPLETED|Period 3 (5 Days)||0
1517721|NCT01526213|3713875|P5|NOT COMPLETED|Period 3 (5 Days)||0
1517722|NCT01526213|3713876|P4|NOT COMPLETED|Period 3 (5 Days)||0
1517723|NCT01526213|3713877|P3|NOT COMPLETED|Period 3 (5 Days)||0
1517724|NCT01526213|3713878|P2|NOT COMPLETED|Period 3 (5 Days)||0
1517725|NCT01526213|3713879|P1|NOT COMPLETED|Period 3 (5 Days)||0
1517726|NCT01526213|3713874|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517727|NCT01526213|3713875|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517728|NCT01526213|3713876|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517729|NCT01526213|3713877|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517730|NCT01526213|3713878|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517731|NCT01526213|3713879|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517732|NCT01526213|3713874|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517733|NCT01526213|3713875|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517734|NCT01526213|3713876|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517735|NCT01526213|3713877|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517736|NCT01526213|3713878|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517737|NCT01526213|3713879|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517738|NCT01526213|3713874|P6|NOT COMPLETED|Washout 2 (10 Days)||0
1517739|NCT01526213|3713875|P5|NOT COMPLETED|Washout 2 (10 Days)||0
1517740|NCT01526213|3713876|P4|NOT COMPLETED|Washout 2 (10 Days)||0
1517741|NCT01526213|3713877|P3|NOT COMPLETED|Washout 2 (10 Days)||0
1517742|NCT01526213|3713878|P2|NOT COMPLETED|Washout 2 (10 Days)||0
1517743|NCT01526213|3713879|P1|NOT COMPLETED|Washout 2 (10 Days)||0
1517744|NCT01526213|3713874|P6|COMPLETED|Washout 2 (10 Days)||3
1517745|NCT01526213|3713875|P5|COMPLETED|Washout 2 (10 Days)||3
1517746|NCT01526213|3713876|P4|COMPLETED|Washout 2 (10 Days)||3
1517747|NCT01526213|3713877|P3|COMPLETED|Washout 2 (10 Days)||3
1517748|NCT01526213|3713878|P2|COMPLETED|Washout 2 (10 Days)||3
1517749|NCT01526213|3713879|P1|COMPLETED|Washout 2 (10 Days)||3
1517750|NCT01526213|3713874|P6|STARTED|Washout 2 (10 Days)||3
1517751|NCT01526213|3713875|P5|STARTED|Washout 2 (10 Days)||3
1517752|NCT01526213|3713876|P4|STARTED|Washout 2 (10 Days)||3
1517753|NCT01526213|3713877|P3|STARTED|Washout 2 (10 Days)||3
1517754|NCT01526213|3713878|P2|STARTED|Washout 2 (10 Days)||3
1517755|NCT01526213|3713879|P1|STARTED|Washout 2 (10 Days)||3
1517756|NCT01526213|3713874|P6|NOT COMPLETED|Period 2 (5 Days)||0
1517757|NCT01526213|3713875|P5|NOT COMPLETED|Period 2 (5 Days)||0
1517758|NCT01526213|3713876|P4|NOT COMPLETED|Period 2 (5 Days)||0
1517759|NCT01526213|3713877|P3|NOT COMPLETED|Period 2 (5 Days)||0
1517760|NCT01526213|3713878|P2|NOT COMPLETED|Period 2 (5 Days)||0
1517761|NCT01526213|3713879|P1|NOT COMPLETED|Period 2 (5 Days)||0
1517762|NCT01526213|3713874|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
1517763|NCT01526213|3713875|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
1517764|NCT01526213|3713876|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
1517765|NCT01526213|3713877|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
1517766|NCT01526213|3713878|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517767|NCT01526213|3713879|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517768|NCT01526213|3713874|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517769|NCT01526213|3713875|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517770|NCT01526213|3713876|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517771|NCT01526213|3713877|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517772|NCT01526213|3713878|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517773|NCT01526213|3713879|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517774|NCT01526213|3713874|P6|NOT COMPLETED|Washout 1 (10 Days)||0
1517775|NCT01526213|3713875|P5|NOT COMPLETED|Washout 1 (10 Days)||0
1517776|NCT01526213|3713876|P4|NOT COMPLETED|Washout 1 (10 Days)||0
1517777|NCT01526213|3713877|P3|NOT COMPLETED|Washout 1 (10 Days)||0
1517778|NCT01526213|3713878|P2|NOT COMPLETED|Washout 1 (10 Days)||0
1517779|NCT01526213|3713879|P1|NOT COMPLETED|Washout 1 (10 Days)||0
1517780|NCT01526213|3713874|P6|COMPLETED|Washout 1 (10 Days)||3
1517781|NCT01526213|3713875|P5|COMPLETED|Washout 1 (10 Days)||3
1517782|NCT01526213|3713876|P4|COMPLETED|Washout 1 (10 Days)||3
1517783|NCT01526213|3713877|P3|COMPLETED|Washout 1 (10 Days)||3
1517784|NCT01526213|3713878|P2|COMPLETED|Washout 1 (10 Days)||3
1517785|NCT01526213|3713879|P1|COMPLETED|Washout 1 (10 Days)||3
1517786|NCT01526213|3713874|P6|STARTED|Washout 1 (10 Days)||3
1517787|NCT01526213|3713875|P5|STARTED|Washout 1 (10 Days)||3
1517788|NCT01526213|3713876|P4|STARTED|Washout 1 (10 Days)||3
1517789|NCT01526213|3713877|P3|STARTED|Washout 1 (10 Days)||3
1517790|NCT01526213|3713878|P2|STARTED|Washout 1 (10 Days)||3
1517791|NCT01526213|3713879|P1|STARTED|Washout 1 (10 Days)||3
1517792|NCT01526213|3713874|P6|NOT COMPLETED|Period 1 (5 Days)||0
1517793|NCT01526213|3713875|P5|NOT COMPLETED|Period 1 (5 Days)||0
1517794|NCT01526213|3713876|P4|NOT COMPLETED|Period 1 (5 Days)||0
1517795|NCT01526213|3713877|P3|NOT COMPLETED|Period 1 (5 Days)||0
1517796|NCT01526213|3713878|P2|NOT COMPLETED|Period 1 (5 Days)||0
1517797|NCT01526213|3713879|P1|NOT COMPLETED|Period 1 (5 Days)||0
1517798|NCT01526213|3713874|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517799|NCT01526213|3713875|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517800|NCT01526213|3713876|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517885|NCT01525420|3714181|P1|COMPLETED|Overall Study||43
1517801|NCT01526213|3713877|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517802|NCT01526213|3713878|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517803|NCT01526213|3713879|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
1517804|NCT01526213|3713874|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
1517805|NCT01526213|3713875|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517806|NCT01526213|3713876|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517807|NCT01526213|3713877|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517808|NCT01526213|3713878|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517809|NCT01526213|3713879|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
1517810|NCT01526148|3713892|P2|NOT COMPLETED|Overall Study||13
1517811|NCT01526148|3713893|P1|NOT COMPLETED|Overall Study||14
1517812|NCT01526148|3713892|P2|COMPLETED|Overall Study||11
1517813|NCT01526148|3713893|P1|COMPLETED|Overall Study||4
1517814|NCT01526148|3713892|P2|STARTED|Overall Study||24
1517815|NCT01526148|3713893|P1|STARTED|Overall Study||18
1517816|NCT01525927|3713903|P1|NOT COMPLETED|Overall Study||0
1517817|NCT01525927|3713903|P1|COMPLETED|Overall Study||0
1517818|NCT01525927|3713903|P1|STARTED|Overall Study||0
1517819|NCT01525849|3713917|P2|NOT COMPLETED|Overall Study||16
1517820|NCT01525849|3713918|P1|NOT COMPLETED|Overall Study||5
1517821|NCT01525849|3713917|P2|COMPLETED|Overall Study||59
1517822|NCT01525849|3713918|P1|COMPLETED|Overall Study||71
1517823|NCT01525849|3713917|P2|6-Months|Overall Study||60
1517824|NCT01525849|3713918|P1|6-Months|Overall Study||73
1517825|NCT01525849|3713917|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
1517826|NCT01525849|3713918|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
1517827|NCT01525849|3713917|P2|STARTED|Overall Study||75
1517828|NCT01525849|3713918|P1|STARTED|Overall Study||76
1517829|NCT01525745|3713934|P2|NOT COMPLETED|Overall Study||1
1517830|NCT01525745|3713935|P1|NOT COMPLETED|Overall Study||1
1517831|NCT01525745|3713934|P2|COMPLETED|Overall Study||1
1517832|NCT01525745|3713935|P1|COMPLETED|Overall Study||3
1517833|NCT01525745|3713934|P2|STARTED|Overall Study||2
1517834|NCT01525745|3713935|P1|STARTED|Overall Study||4
1517835|NCT01525667|3713952|P3|NOT COMPLETED|Overall Study||0
1517836|NCT01525667|3713953|P2|NOT COMPLETED|Overall Study||0
1517837|NCT01525667|3713954|P1|NOT COMPLETED|Overall Study||0
1517838|NCT01525667|3713952|P3|COMPLETED|Overall Study||7
1517839|NCT01525667|3713953|P2|COMPLETED|Overall Study||6
1517840|NCT01525667|3713954|P1|COMPLETED|Overall Study||7
1517841|NCT01525667|3713952|P3|STARTED|Overall Study||7
1517842|NCT01525667|3713953|P2|STARTED|Overall Study||6
1517843|NCT01525667|3713954|P1|STARTED|Overall Study||7
1517844|NCT01525641|3713974|P1|NOT COMPLETED|Overall Study||180
1517845|NCT01525641|3713974|P1|COMPLETED|Overall Study||435
1517846|NCT01525641|3713974|P1|STARTED|Overall Study||615
1517847|NCT01525628|3713988|P5|NOT COMPLETED|Overall Study||3
1517848|NCT01525628|3713989|P4|NOT COMPLETED|Overall Study||4
1517849|NCT01525628|3713990|P3|NOT COMPLETED|Overall Study||5
1517850|NCT01525628|3713991|P2|NOT COMPLETED|Overall Study||5
1517851|NCT01525628|3713992|P1|NOT COMPLETED|Overall Study||2
1517852|NCT01525628|3713988|P5|COMPLETED|Overall Study||4
1517853|NCT01525628|3713989|P4|COMPLETED|Overall Study||10
1517854|NCT01525628|3713990|P3|COMPLETED|Overall Study||11
1517855|NCT01525628|3713991|P2|COMPLETED|Overall Study||14
1517856|NCT01525628|3713992|P1|COMPLETED|Overall Study||14
1517857|NCT01525628|3713988|P5|STARTED|Overall Study||7
1517858|NCT01525628|3713989|P4|STARTED|Overall Study||14
1517859|NCT01525628|3713990|P3|STARTED|Overall Study||16
1517860|NCT01525628|3713991|P2|STARTED|Overall Study||19
1517861|NCT01525628|3713992|P1|STARTED|Overall Study||16
1517862|NCT01525615|3714059|P3|NOT COMPLETED|Overall Study||6
1517863|NCT01525615|3714060|P2|NOT COMPLETED|Overall Study||7
1517864|NCT01525615|3714061|P1|NOT COMPLETED|Overall Study||14
1517865|NCT01525615|3714059|P3|COMPLETED|Overall Study||133
1517866|NCT01525615|3714060|P2|COMPLETED|Overall Study||126
1517867|NCT01525615|3714061|P1|COMPLETED|Overall Study||118
1517868|NCT01525615|3714059|P3|STARTED|Overall Study||139
1517869|NCT01525615|3714060|P2|STARTED|Overall Study||133
1517870|NCT01525615|3714061|P1|STARTED|Overall Study||132
1517871|NCT01525563|3714105|P1|NOT COMPLETED|Overall Study||212
1517872|NCT01525563|3714105|P1|COMPLETED|Overall Study|6 Months Follow-up|788
1517873|NCT01525563|3714105|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
1517874|NCT01525563|3714105|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
1517875|NCT01525563|3714105|P1|STARTED|Overall Study||1000
1517876|NCT01525550|3714117|P2|NOT COMPLETED|Overall Study||45
1517877|NCT01525550|3714118|P1|NOT COMPLETED|Overall Study||61
1517878|NCT01525550|3714117|P2|COMPLETED|Overall Study||0
1517879|NCT01525550|3714118|P1|COMPLETED|Overall Study||0
1517880|NCT01525550|3714117|P2|STARTED|Overall Study||45
1517881|NCT01525550|3714118|P1|STARTED|Overall Study||61
1517882|NCT01525420|3714180|P2|NOT COMPLETED|Overall Study||24
1517883|NCT01525420|3714181|P1|NOT COMPLETED|Overall Study||16
1517884|NCT01525420|3714180|P2|COMPLETED|Overall Study||38
1517886|NCT01525420|3714180|P2|STARTED|Overall Study||62
1517887|NCT01525420|3714181|P1|STARTED|Overall Study||59
1517888|NCT01525407|3714189|P2|NOT COMPLETED|Overall Study||4
1517889|NCT01525407|3714190|P1|NOT COMPLETED|Overall Study||3
1517890|NCT01525407|3714189|P2|COMPLETED|Overall Study||38
1517891|NCT01525407|3714190|P1|COMPLETED|Overall Study||38
1517892|NCT01525407|3714189|P2|STARTED|Overall Study||42
1517893|NCT01525407|3714190|P1|STARTED|Overall Study||41
1517894|NCT01525329|3714206|P2|NOT COMPLETED|Overall Study||0
1517895|NCT01525329|3714207|P1|NOT COMPLETED|Overall Study||0
1517896|NCT01525329|3714206|P2|COMPLETED|Overall Study||14
1517897|NCT01525329|3714207|P1|COMPLETED|Overall Study||4
1517898|NCT01525329|3714206|P2|STARTED|Overall Study||14
1517899|NCT01525329|3714207|P1|STARTED|Overall Study||4
1517900|NCT01525238|3714222|P3|NOT COMPLETED|Overall Study||0
1517901|NCT01525238|3714223|P2|NOT COMPLETED|Overall Study||0
1517902|NCT01525238|3714224|P1|NOT COMPLETED|Overall Study||1
1517903|NCT01525238|3714222|P3|COMPLETED|Overall Study||8
1517904|NCT01525238|3714223|P2|COMPLETED|Overall Study||8
1517905|NCT01525238|3714224|P1|COMPLETED|Overall Study||7
1517906|NCT01525238|3714222|P3|STARTED|Overall Study||8
1517907|NCT01525238|3714223|P2|STARTED|Overall Study||8
1517908|NCT01525238|3714224|P1|STARTED|Overall Study||8
1517909|NCT01525225|3714289|P1|NOT COMPLETED|Treated||0
1517910|NCT01525225|3714289|P1|COMPLETED|Treated||2
1517911|NCT01525225|3714289|P1|STARTED|Treated||2
1517912|NCT01525225|3714289|P1|NOT COMPLETED|Enrollment||2
1517913|NCT01525225|3714289|P1|COMPLETED|Enrollment||2
1517914|NCT01525225|3714289|P1|STARTED|Enrollment||4
1517915|NCT01525173|3714296|P2|NOT COMPLETED|Overall Study||5
1517916|NCT01525173|3714297|P1|NOT COMPLETED|Overall Study||7
1517917|NCT01525173|3714296|P2|COMPLETED|Overall Study||62
1517918|NCT01525173|3714297|P1|COMPLETED|Overall Study||63
1517919|NCT01525173|3714296|P2|STARTED|Overall Study||67
1517920|NCT01525173|3714297|P1|STARTED|Overall Study||70
1517921|NCT01524978|3714314|P11|NOT COMPLETED|Overall Study||28
1517922|NCT01524978|3714315|P10|NOT COMPLETED|Overall Study||9
1517923|NCT01524978|3714316|P9|NOT COMPLETED|Overall Study||12
1517924|NCT01524978|3714317|P8|NOT COMPLETED|Overall Study||12
1517925|NCT01524978|3714318|P7|NOT COMPLETED|Overall Study||26
1517926|NCT01524978|3714319|P6|NOT COMPLETED|Overall Study||9
1517927|NCT01524978|3714320|P5|NOT COMPLETED|Overall Study||9
1517928|NCT01524978|3714321|P4|NOT COMPLETED|Overall Study||27
1517929|NCT01524978|3714322|P3|NOT COMPLETED|Overall Study||10
1517930|NCT01524978|3714323|P2|NOT COMPLETED|Overall Study||4
1517931|NCT01524978|3714324|P1|NOT COMPLETED|Overall Study||62
1517932|NCT01524978|3714314|P11|COMPLETED|Overall Study||0
1517933|NCT01524978|3714315|P10|COMPLETED|Overall Study||0
1517934|NCT01524978|3714316|P9|COMPLETED|Overall Study||0
1517935|NCT01524978|3714317|P8|COMPLETED|Overall Study||0
1517936|NCT01524978|3714318|P7|COMPLETED|Overall Study||0
1517937|NCT01524978|3714319|P6|COMPLETED|Overall Study||0
1517938|NCT01524978|3714320|P5|COMPLETED|Overall Study||0
1517939|NCT01524978|3714321|P4|COMPLETED|Overall Study||0
1517940|NCT01524978|3714322|P3|COMPLETED|Overall Study||0
1517941|NCT01524978|3714323|P2|COMPLETED|Overall Study||0
1517942|NCT01524978|3714324|P1|COMPLETED|Overall Study||0
1517943|NCT01524978|3714314|P11|STARTED|Overall Study||28
1517944|NCT01524978|3714315|P10|STARTED|Overall Study||9
1517945|NCT01524978|3714316|P9|STARTED|Overall Study||12
1517946|NCT01524978|3714317|P8|STARTED|Overall Study||12
1517947|NCT01524978|3714318|P7|STARTED|Overall Study||26
1517948|NCT01524978|3714319|P6|STARTED|Overall Study||9
1517949|NCT01524978|3714320|P5|STARTED|Overall Study||9
1517950|NCT01524978|3714321|P4|STARTED|Overall Study||27
1517951|NCT01524978|3714322|P3|STARTED|Overall Study||10
1517952|NCT01524978|3714323|P2|STARTED|Overall Study||4
1517953|NCT01524978|3714324|P1|STARTED|Overall Study||62
1517954|NCT01524913|3714452|P3|NOT COMPLETED|Overall Study||0
1517955|NCT01524913|3714453|P2|NOT COMPLETED|Overall Study||0
1517956|NCT01524913|3714454|P1|NOT COMPLETED|Overall Study||4
1517957|NCT01524913|3714452|P3|COMPLETED|Overall Study||31
1517958|NCT01524913|3714453|P2|COMPLETED|Overall Study||36
1517959|NCT01524913|3714454|P1|COMPLETED|Overall Study||31
1517960|NCT01524913|3714452|P3|STARTED|Overall Study||31
1517961|NCT01524913|3714453|P2|STARTED|Overall Study||36
1517962|NCT01524913|3714454|P1|STARTED|Overall Study||35
1517963|NCT01524900|3714476|P5|NOT COMPLETED|Overall Study||0
1517964|NCT01524900|3714477|P4|NOT COMPLETED|Overall Study||1
1517965|NCT01524900|3714478|P3|NOT COMPLETED|Overall Study||1
1517966|NCT01524900|3714479|P2|NOT COMPLETED|Overall Study||14
1517967|NCT01524900|3714480|P1|NOT COMPLETED|Overall Study||6
1517968|NCT01524900|3714476|P5|COMPLETED|Overall Study||40
1517969|NCT01524900|3714477|P4|COMPLETED|Overall Study||21
1517970|NCT01524900|3714478|P3|COMPLETED|Overall Study||29
1517971|NCT01524900|3714479|P2|COMPLETED|Overall Study||232
1517972|NCT01524900|3714480|P1|COMPLETED|Overall Study||43
1517973|NCT01524900|3714476|P5|STARTED|Overall Study||40
1517974|NCT01524900|3714477|P4|STARTED|Overall Study||22
1517975|NCT01524900|3714478|P3|STARTED|Overall Study||30
1517976|NCT01524900|3714479|P2|STARTED|Overall Study||246
1517977|NCT01524900|3714480|P1|STARTED|Overall Study||49
1517978|NCT01524887|3714525|P3|NOT COMPLETED|Overall Study||86
1517979|NCT01524887|3714526|P2|NOT COMPLETED|Overall Study||90
1517980|NCT01524887|3714527|P1|NOT COMPLETED|Overall Study||85
1517981|NCT01524887|3714525|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
1517982|NCT01524887|3714526|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
1517983|NCT01524887|3714527|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
1517984|NCT01524887|3714525|P3|Received Treatment|Overall Study||83
1517985|NCT01524887|3714526|P2|Received Treatment|Overall Study||85
1517986|NCT01524887|3714527|P1|Received Treatment|Overall Study||83
1517987|NCT01524887|3714525|P3|STARTED|Overall Study||86
1517988|NCT01524887|3714526|P2|STARTED|Overall Study||90
1517989|NCT01524887|3714527|P1|STARTED|Overall Study||85
1517990|NCT01524796|3714571|P1|NOT COMPLETED|Overall Study||28
1517991|NCT01524796|3714571|P1|COMPLETED|Overall Study||100
1517992|NCT01524796|3714571|P1|STARTED|Overall Study||128
1517993|NCT01524783|3714586|P2|NOT COMPLETED|Randomized and Treated||84
1517994|NCT01524783|3714587|P1|NOT COMPLETED|Randomized and Treated||155
1517995|NCT01524783|3714586|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
1517996|NCT01524783|3714587|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
1517997|NCT01524783|3714586|P2|STARTED|Randomized and Treated||97
1517998|NCT01524783|3714587|P1|STARTED|Randomized and Treated||203
1517999|NCT01524783|3714586|P2|NOT COMPLETED|Randomized But Not Treated||0
1518000|NCT01524783|3714587|P1|NOT COMPLETED|Randomized But Not Treated||2
1518001|NCT01524783|3714586|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
1518002|NCT01524783|3714587|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
1518003|NCT01524783|3714586|P2|STARTED|Randomized But Not Treated||97
1518004|NCT01524783|3714587|P1|STARTED|Randomized But Not Treated||205
1518005|NCT01524770|3714595|P2|NOT COMPLETED|Second Intervention||0
1518006|NCT01524770|3714596|P1|NOT COMPLETED|Second Intervention||0
1518007|NCT01524770|3714595|P2|COMPLETED|Second Intervention||23
1518008|NCT01524770|3714596|P1|COMPLETED|Second Intervention||23
1518009|NCT01524770|3714595|P2|STARTED|Second Intervention||23
1518010|NCT01524770|3714596|P1|STARTED|Second Intervention||23
1518011|NCT01524770|3714595|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
1518012|NCT01524770|3714596|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
1518013|NCT01524770|3714595|P2|COMPLETED|Washout Period of at Least 28 Days||23
1518014|NCT01524770|3714596|P1|COMPLETED|Washout Period of at Least 28 Days||23
1518015|NCT01524770|3714595|P2|STARTED|Washout Period of at Least 28 Days||23
1518016|NCT01524770|3714596|P1|STARTED|Washout Period of at Least 28 Days||23
1518017|NCT01524770|3714595|P2|NOT COMPLETED|First Intervention||1
1518018|NCT01524770|3714596|P1|NOT COMPLETED|First Intervention||3
1518019|NCT01524770|3714595|P2|COMPLETED|First Intervention||23
1518020|NCT01524770|3714596|P1|COMPLETED|First Intervention||23
1518021|NCT01524770|3714595|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
1518022|NCT01524770|3714596|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
1518023|NCT01524770|3714595|P2|STARTED|First Intervention||24
1518024|NCT01524770|3714596|P1|STARTED|First Intervention||26
1518025|NCT01524692|3714606|P1|NOT COMPLETED|Overall Study||3
1518026|NCT01524692|3714606|P1|COMPLETED|Overall Study||32
1518027|NCT01524692|3714606|P1|STARTED|Overall Study||35
1518028|NCT01524627|3714616|P2|NOT COMPLETED|Overall Study||2
1518029|NCT01524627|3714617|P1|NOT COMPLETED|Overall Study||1
1518030|NCT01524627|3714616|P2|COMPLETED|Overall Study||19
1518031|NCT01524627|3714617|P1|COMPLETED|Overall Study||21
1518032|NCT01524627|3714616|P2|STARTED|Overall Study||21
1518033|NCT01524627|3714617|P1|STARTED|Overall Study||22
1518034|NCT01524302|3714625|P2|NOT COMPLETED|Overall Study||0
1518035|NCT01524302|3714626|P1|NOT COMPLETED|Overall Study||0
1518036|NCT01524302|3714625|P2|COMPLETED|Overall Study||6
1518037|NCT01524302|3714626|P1|COMPLETED|Overall Study||6
1518038|NCT01524302|3714625|P2|STARTED|Overall Study||6
1518039|NCT01524302|3714626|P1|STARTED|Overall Study||6
1518040|NCT01524198|3714644|P2|NOT COMPLETED|Overall Study||16
1518041|NCT01524198|3714645|P1|NOT COMPLETED|Overall Study||23
1518042|NCT01524198|3714644|P2|COMPLETED|Overall Study||458
1518043|NCT01524198|3714645|P1|COMPLETED|Overall Study||448
1518044|NCT01524198|3714644|P2|STARTED|Overall Study||474
1518045|NCT01524198|3714645|P1|STARTED|Overall Study||471
1518046|NCT01524133|3714656|P3|NOT COMPLETED|Overall Study 52 Weeks||27
1518047|NCT01524133|3714657|P2|NOT COMPLETED|Overall Study 52 Weeks||20
1518048|NCT01524133|3714658|P1|NOT COMPLETED|Overall Study 52 Weeks||21
1518049|NCT01524133|3714656|P3|COMPLETED|Overall Study 52 Weeks||40
1518050|NCT01524133|3714657|P2|COMPLETED|Overall Study 52 Weeks||49
1518051|NCT01524133|3714658|P1|COMPLETED|Overall Study 52 Weeks||50
1518052|NCT01524133|3714656|P3|STARTED|Overall Study 52 Weeks||67
1518053|NCT01524133|3714657|P2|STARTED|Overall Study 52 Weeks||69
1518054|NCT01524133|3714658|P1|STARTED|Overall Study 52 Weeks||71
1518055|NCT01524133|3714656|P3|NOT COMPLETED|Treatment Phase||36
1518056|NCT01524133|3714657|P2|NOT COMPLETED|Treatment Phase||32
1518057|NCT01524133|3714658|P1|NOT COMPLETED|Treatment Phase||19
1518058|NCT01524133|3714656|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
1518059|NCT01524133|3714657|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
1518060|NCT01524133|3714658|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
1518061|NCT01524133|3714656|P3|STARTED|Treatment Phase||67
1518062|NCT01524133|3714657|P2|STARTED|Treatment Phase||69
1518063|NCT01524133|3714658|P1|STARTED|Treatment Phase||71
1518064|NCT01523964|3714673|P4|NOT COMPLETED|Overall Study||0
1518065|NCT01523964|3714674|P3|NOT COMPLETED|Overall Study||0
1518066|NCT01523964|3714675|P2|NOT COMPLETED|Overall Study||0
1518067|NCT01523964|3714676|P1|NOT COMPLETED|Overall Study||0
1518068|NCT01523964|3714673|P4|COMPLETED|Overall Study||15
1518069|NCT01523964|3714674|P3|COMPLETED|Overall Study||16
1518070|NCT01523964|3714675|P2|COMPLETED|Overall Study||30
1518071|NCT01523964|3714676|P1|COMPLETED|Overall Study||31
1518072|NCT01523964|3714673|P4|STARTED|Overall Study||15
1518073|NCT01523964|3714674|P3|STARTED|Overall Study||16
1518074|NCT01523964|3714675|P2|STARTED|Overall Study||30
1518075|NCT01523964|3714676|P1|STARTED|Overall Study||31
1518076|NCT01523899|3714688|P2|NOT COMPLETED|Overall Study||0
1518077|NCT01523899|3714689|P1|NOT COMPLETED|Overall Study||0
1518078|NCT01523899|3714688|P2|COMPLETED|Overall Study||126
1518079|NCT01523899|3714689|P1|COMPLETED|Overall Study||126
1518080|NCT01523899|3714688|P2|STARTED|Overall Study||126
1518081|NCT01523899|3714689|P1|STARTED|Overall Study||126
1518082|NCT01523886|3714701|P2|NOT COMPLETED|Overall Study||1
1518083|NCT01523886|3714702|P1|NOT COMPLETED|Overall Study||0
1518084|NCT01523886|3714701|P2|COMPLETED|Overall Study||23
1518085|NCT01523886|3714702|P1|COMPLETED|Overall Study||25
1518086|NCT01523886|3714701|P2|STARTED|Overall Study||24
1518087|NCT01523886|3714702|P1|STARTED|Overall Study||25
1518088|NCT01523873|3714708|P1|NOT COMPLETED|Overall Study||422
1518089|NCT01523873|3714708|P1|COMPLETED|Overall Study||35499
1518090|NCT01523873|3714708|P1|Administered With Dotarem|Overall Study||35474
1518091|NCT01523873|3714708|P1|STARTED|Overall Study||35921
1518092|NCT01523821|3714718|P3|NOT COMPLETED|Overall Study||0
1518093|NCT01523821|3714719|P2|NOT COMPLETED|Overall Study||0
1518094|NCT01523821|3714720|P1|NOT COMPLETED|Overall Study||0
1518095|NCT01523821|3714718|P3|COMPLETED|Overall Study||6
1518096|NCT01523821|3714719|P2|COMPLETED|Overall Study||6
1518097|NCT01523821|3714720|P1|COMPLETED|Overall Study||8
1518098|NCT01523821|3714718|P3|STARTED|Overall Study||6
1518099|NCT01523821|3714719|P2|STARTED|Overall Study||6
1518100|NCT01523821|3714720|P1|STARTED|Overall Study||8
1518101|NCT01523782|3714746|P3|NOT COMPLETED|Overall Study||5
1518102|NCT01523782|3714747|P2|NOT COMPLETED|Overall Study||0
1518103|NCT01523782|3714748|P1|NOT COMPLETED|Overall Study||1
1518104|NCT01523782|3714746|P3|COMPLETED|Overall Study||9
1518105|NCT01523782|3714747|P2|COMPLETED|Overall Study||13
1518106|NCT01523782|3714748|P1|COMPLETED|Overall Study||2
1518107|NCT01523782|3714746|P3|STARTED|Overall Study||14
1518108|NCT01523782|3714747|P2|STARTED|Overall Study||13
1518109|NCT01523782|3714748|P1|STARTED|Overall Study||3
1518110|NCT01523756|3714795|P2|NOT COMPLETED|Test Period 2||1
1518111|NCT01523756|3714796|P1|NOT COMPLETED|Test Period 2||0
1518112|NCT01523756|3714795|P2|COMPLETED|Test Period 2||7
1518113|NCT01523756|3714796|P1|COMPLETED|Test Period 2||10
1518114|NCT01523756|3714795|P2|STARTED|Test Period 2||8
1518115|NCT01523756|3714796|P1|STARTED|Test Period 2||10
1518116|NCT01523756|3714795|P2|NOT COMPLETED|Test Period 1||0
1518117|NCT01523756|3714796|P1|NOT COMPLETED|Test Period 1||1
1518118|NCT01523756|3714795|P2|COMPLETED|Test Period 1||8
1518119|NCT01523756|3714796|P1|COMPLETED|Test Period 1||10
1518120|NCT01523756|3714795|P2|STARTED|Test Period 1||8
1518121|NCT01523756|3714796|P1|STARTED|Test Period 1||11
1518122|NCT01523756|3714795|P2|NOT COMPLETED|Baseline Period||1
1518123|NCT01523756|3714796|P1|NOT COMPLETED|Baseline Period||0
1518124|NCT01523756|3714795|P2|COMPLETED|Baseline Period||8
1518125|NCT01523756|3714796|P1|COMPLETED|Baseline Period||11
1518126|NCT01523756|3714795|P2|STARTED|Baseline Period||9
1518127|NCT01523756|3714796|P1|STARTED|Baseline Period||11
1518128|NCT01523743|3714804|P2|NOT COMPLETED|Period 2||2
1518129|NCT01523743|3714805|P1|NOT COMPLETED|Period 2||1
1518130|NCT01523743|3714804|P2|COMPLETED|Period 2||58
1518131|NCT01523743|3714805|P1|COMPLETED|Period 2||52
1518132|NCT01523743|3714804|P2|STARTED|Period 2||60
1518133|NCT01523743|3714805|P1|STARTED|Period 2||53
1518134|NCT01523743|3714804|P2|NOT COMPLETED|Period 1||2
1518135|NCT01523743|3714805|P1|NOT COMPLETED|Period 1||10
1518136|NCT01523743|3714804|P2|COMPLETED|Period 1||60
1518137|NCT01523743|3714805|P1|COMPLETED|Period 1||53
1518138|NCT01523743|3714804|P2|STARTED|Period 1||62
1518139|NCT01523743|3714805|P1|STARTED|Period 1||63
1518140|NCT01523613|3714814|P3|NOT COMPLETED|Overall Study||12
1518141|NCT01523613|3714815|P2|NOT COMPLETED|Overall Study||5
1518142|NCT01523613|3714816|P1|NOT COMPLETED|Overall Study||7
1518143|NCT01523613|3714814|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
1518144|NCT01523613|3714815|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
1518145|NCT01523613|3714816|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
1518146|NCT01523613|3714814|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
1518147|NCT01523613|3714815|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
1518148|NCT01523613|3714816|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
1518149|NCT01523587|3714828|P2|NOT COMPLETED|Overall Study||54
1518150|NCT01523587|3714829|P1|NOT COMPLETED|Overall Study||87
1518151|NCT01523587|3714828|P2|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|280
1518152|NCT01523587|3714829|P1|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|248
1518153|NCT01523587|3714828|P2|STARTED|Overall Study||334
1518154|NCT01523587|3714829|P1|STARTED|Overall Study||335
1518155|NCT01523496|3714851|P4|NOT COMPLETED|Overall Study||3
1518156|NCT01523496|3714852|P3|NOT COMPLETED|Overall Study||12
1518157|NCT01523496|3714853|P2|NOT COMPLETED|Overall Study||4
1518158|NCT01523496|3714854|P1|NOT COMPLETED|Overall Study||10
1518159|NCT01523496|3714851|P4|COMPLETED|Overall Study||27
1518160|NCT01523496|3714852|P3|COMPLETED|Overall Study||46
1518161|NCT01523496|3714853|P2|COMPLETED|Overall Study||32
1518162|NCT01523496|3714854|P1|COMPLETED|Overall Study||56
1518163|NCT01523496|3714851|P4|STARTED|Overall Study||30
1518164|NCT01523496|3714852|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
1518165|NCT01523496|3714853|P2|STARTED|Overall Study||36
1518166|NCT01523496|3714854|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
1518167|NCT01523457|3714870|P2|NOT COMPLETED|Overall Study||2
1518168|NCT01523457|3714871|P1|NOT COMPLETED|Overall Study||7
1518169|NCT01523457|3714870|P2|COMPLETED|Overall Study||29
1518170|NCT01523457|3714871|P1|COMPLETED|Overall Study||37
1518171|NCT01523457|3714870|P2|STARTED|Overall Study||31
1518172|NCT01523457|3714871|P1|STARTED|Overall Study||44
1518173|NCT01523392|3714889|P2|NOT COMPLETED|Treatment Period 2||0
1518174|NCT01523392|3714890|P1|NOT COMPLETED|Treatment Period 2||0
1518175|NCT01523392|3714889|P2|COMPLETED|Treatment Period 2||14
1518176|NCT01523392|3714890|P1|COMPLETED|Treatment Period 2||17
1518177|NCT01523392|3714889|P2|STARTED|Treatment Period 2||14
1518178|NCT01523392|3714890|P1|STARTED|Treatment Period 2||17
1518179|NCT01523392|3714889|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
1518180|NCT01523392|3714890|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
1518181|NCT01523392|3714889|P2|COMPLETED|Washout Period - 10 to 14 Days||14
1518182|NCT01523392|3714890|P1|COMPLETED|Washout Period - 10 to 14 Days||17
1518183|NCT01523392|3714889|P2|STARTED|Washout Period - 10 to 14 Days||14
1518184|NCT01523392|3714890|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
1518185|NCT01523392|3714889|P2|NOT COMPLETED|Treatment Period 1||0
1518186|NCT01523392|3714890|P1|NOT COMPLETED|Treatment Period 1||3
1518187|NCT01523392|3714889|P2|COMPLETED|Treatment Period 1||14
1518188|NCT01523392|3714890|P1|COMPLETED|Treatment Period 1||17
1518189|NCT01523392|3714889|P2|STARTED|Treatment Period 1||14
1518190|NCT01523392|3714890|P1|STARTED|Treatment Period 1||20
1518191|NCT01523366|3714906|P2|NOT COMPLETED|Treatment Period 2||0
1518192|NCT01523366|3714907|P1|NOT COMPLETED|Treatment Period 2||1
1518193|NCT01523366|3714906|P2|COMPLETED|Treatment Period 2||20
1518194|NCT01523366|3714907|P1|COMPLETED|Treatment Period 2||18
1518195|NCT01523366|3714906|P2|STARTED|Treatment Period 2||20
1518196|NCT01523366|3714907|P1|STARTED|Treatment Period 2||19
1518197|NCT01523366|3714906|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
1518198|NCT01523366|3714907|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
1518199|NCT01523366|3714906|P2|COMPLETED|Washout Period - 10-14 Days||20
1518200|NCT01523366|3714907|P1|COMPLETED|Washout Period - 10-14 Days||19
1518201|NCT01523366|3714906|P2|STARTED|Washout Period - 10-14 Days||20
1518202|NCT01523366|3714907|P1|STARTED|Washout Period - 10-14 Days||19
1518203|NCT01523366|3714906|P2|NOT COMPLETED|Treatment Period 1||0
1518204|NCT01523366|3714907|P1|NOT COMPLETED|Treatment Period 1||1
1518205|NCT01523366|3714906|P2|COMPLETED|Treatment Period 1||20
1518206|NCT01523366|3714907|P1|COMPLETED|Treatment Period 1||19
1518207|NCT01523366|3714906|P2|STARTED|Treatment Period 1||20
1518208|NCT01523366|3714907|P1|STARTED|Treatment Period 1||20
1518209|NCT01523301|3714923|P2|NOT COMPLETED|Overall Study||32
1518210|NCT01523301|3714924|P1|NOT COMPLETED|Overall Study||35
1518211|NCT01523301|3714923|P2|COMPLETED|Overall Study||164
1518212|NCT01523301|3714924|P1|COMPLETED|Overall Study||149
1518213|NCT01523301|3714923|P2|STARTED|Overall Study||196
1518214|NCT01523301|3714924|P1|STARTED|Overall Study||184
1518215|NCT01522976|3714945|P3|NOT COMPLETED|Overall Study||93
1518216|NCT01522976|3714946|P2|NOT COMPLETED|Overall Study||92
1518217|NCT01522976|3714947|P1|NOT COMPLETED|Overall Study||97
1518218|NCT01522976|3714945|P3|COMPLETED|Overall Study||0
1518219|NCT01522976|3714946|P2|COMPLETED|Overall Study||0
1518220|NCT01522976|3714947|P1|COMPLETED|Overall Study||0
1518221|NCT01522976|3714945|P3|STARTED|Overall Study||93
1518222|NCT01522976|3714946|P2|STARTED|Overall Study||92
1518223|NCT01522976|3714947|P1|STARTED|Overall Study||97
1518224|NCT01522963|3714974|P4|NOT COMPLETED|Overall Study||6
1518225|NCT01522963|3714975|P3|NOT COMPLETED|Overall Study||3
1518226|NCT01522963|3714976|P2|NOT COMPLETED|Overall Study||3
1518227|NCT01522963|3714977|P1|NOT COMPLETED|Overall Study||2
1518228|NCT01522963|3714974|P4|COMPLETED|Overall Study||18
1518229|NCT01522963|3714975|P3|COMPLETED|Overall Study||22
1518230|NCT01522963|3714976|P2|COMPLETED|Overall Study||22
1518231|NCT01522963|3714977|P1|COMPLETED|Overall Study||22
1518232|NCT01522963|3714974|P4|STARTED|Overall Study||24
1518233|NCT01522963|3714975|P3|STARTED|Overall Study||25
1518234|NCT01522963|3714976|P2|STARTED|Overall Study||25
1518235|NCT01522963|3714977|P1|STARTED|Overall Study||24
1518236|NCT01522937|3714989|P1|NOT COMPLETED|Overall Study||0
1518237|NCT01522937|3714989|P1|COMPLETED|Overall Study||146
1518238|NCT01522937|3714989|P1|STARTED|Overall Study||146
1518239|NCT01522924|3714999|P2|NOT COMPLETED|Overall Study||0
1518240|NCT01522924|3715000|P1|NOT COMPLETED|Overall Study||0
1518241|NCT01522924|3714999|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
1518242|NCT01522924|3715000|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
1518243|NCT01522924|3714999|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
1518244|NCT01522924|3715000|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
1518245|NCT01522703|3715020|P2|NOT COMPLETED|Overall Study||6
1518246|NCT01522703|3715021|P1|NOT COMPLETED|Overall Study||5
1518247|NCT01522703|3715020|P2|COMPLETED|Overall Study||20
1518248|NCT01522703|3715021|P1|COMPLETED|Overall Study||20
1518249|NCT01522703|3715020|P2|STARTED|Overall Study||26
1518250|NCT01522703|3715021|P1|STARTED|Overall Study||25
1518251|NCT01522456|3715027|P1|NOT COMPLETED|Overall Study||8
1518252|NCT01522456|3715027|P1|COMPLETED|Overall Study||65
1518253|NCT01522456|3715027|P1|STARTED|Overall Study||73
1518254|NCT01522443|3715090|P2|NOT COMPLETED|Overall Study||55
1518255|NCT01522443|3715091|P1|NOT COMPLETED|Overall Study||53
1518256|NCT01522443|3715090|P2|COMPLETED|Overall Study||3
1518257|NCT01522443|3715091|P1|COMPLETED|Overall Study||8
1518258|NCT01522443|3715090|P2|STARTED|Overall Study||58
1518259|NCT01522443|3715091|P1|STARTED|Overall Study||61
1518260|NCT01522404|3715103|P2|NOT COMPLETED|Second Intervention (up to Week 58)||0
1518261|NCT01522404|3715104|P1|NOT COMPLETED|Second Intervention (up to Week 58)||1
1518262|NCT01522404|3715103|P2|COMPLETED|Second Intervention (up to Week 58)||19
1518263|NCT01522404|3715104|P1|COMPLETED|Second Intervention (up to Week 58)||17
1518264|NCT01522404|3715103|P2|STARTED|Second Intervention (up to Week 58)||19
1518265|NCT01522404|3715104|P1|STARTED|Second Intervention (up to Week 58)||18
1518266|NCT01522404|3715103|P2|NOT COMPLETED|First Intervention (up to Week 29)||0
1518267|NCT01522404|3715104|P1|NOT COMPLETED|First Intervention (up to Week 29)||2
1518268|NCT01522404|3715103|P2|COMPLETED|First Intervention (up to Week 29)||19
1518269|NCT01522404|3715104|P1|COMPLETED|First Intervention (up to Week 29)||18
1518270|NCT01522404|3715103|P2|STARTED|First Intervention (up to Week 29)||19
1518271|NCT01522404|3715104|P1|STARTED|First Intervention (up to Week 29)||20
1518272|NCT01522391|3715118|P2|NOT COMPLETED|Overall Study||1
1518273|NCT01522391|3715119|P1|NOT COMPLETED|Overall Study||1
1518274|NCT01522391|3715118|P2|COMPLETED|Overall Study||20
1518275|NCT01522391|3715119|P1|COMPLETED|Overall Study||19
1518276|NCT01522391|3715118|P2|STARTED|Overall Study||21
1518277|NCT01522391|3715119|P1|STARTED|Overall Study||20
1518278|NCT01522339|3715179|P1|NOT COMPLETED|Overall Study||0
1518279|NCT01522339|3715179|P1|COMPLETED|Overall Study||15
1518280|NCT01522339|3715179|P1|STARTED|Overall Study||15
1518281|NCT01522235|3715186|P2|NOT COMPLETED|Overall Study||1
1518282|NCT01522235|3715187|P1|NOT COMPLETED|Overall Study||1
1518283|NCT01522235|3715186|P2|COMPLETED|Overall Study||2
1518284|NCT01522235|3715187|P1|COMPLETED|Overall Study||2
1518285|NCT01522235|3715186|P2|Randomized|Overall Study||3
1518286|NCT01522235|3715187|P1|Randomized|Overall Study||2
1518287|NCT01522235|3715186|P2|STARTED|Overall Study||3
1518288|NCT01522235|3715187|P1|STARTED|Overall Study||3
1518289|NCT01522131|3715205|P2|NOT COMPLETED|Overall Study||0
1518290|NCT01522131|3715206|P1|NOT COMPLETED|Overall Study||2
1518291|NCT01522131|3715205|P2|COMPLETED|Overall Study||17
1518292|NCT01522131|3715206|P1|COMPLETED|Overall Study||14
1518293|NCT01522131|3715205|P2|STARTED|Overall Study||17
1518294|NCT01522131|3715206|P1|STARTED|Overall Study||16
1518295|NCT01521949|3715214|P1|NOT COMPLETED|Overall Study||0
1518296|NCT01521949|3715214|P1|COMPLETED|Overall Study||21
1518297|NCT01521949|3715214|P1|STARTED|Overall Study||21
1518298|NCT01521923|3715223|P4|NOT COMPLETED|Overall Study||13
1518299|NCT01521923|3715224|P3|NOT COMPLETED|Overall Study||15
1518300|NCT01521923|3715225|P2|NOT COMPLETED|Overall Study||9
1518301|NCT01521923|3715226|P1|NOT COMPLETED|Overall Study||7
1518302|NCT01521923|3715223|P4|COMPLETED|Overall Study||70
1518303|NCT01521923|3715224|P3|COMPLETED|Overall Study||112
1518304|NCT01521923|3715225|P2|COMPLETED|Overall Study||72
1518305|NCT01521923|3715226|P1|COMPLETED|Overall Study||59
1518306|NCT01521923|3715223|P4|STARTED|Overall Study||83
1518307|NCT01521923|3715224|P3|STARTED|Overall Study||127
1518308|NCT01521923|3715225|P2|STARTED|Overall Study||81
1518309|NCT01521923|3715226|P1|STARTED|Overall Study||66
1518310|NCT01521897|3715346|P1|NOT COMPLETED|Overall Study||23
1518311|NCT01521897|3715346|P1|COMPLETED|Overall Study||1120
1518312|NCT01521897|3715346|P1|STARTED|Overall Study||1143
1518313|NCT01521884|3715358|P1|NOT COMPLETED|Overall Study||27
1518314|NCT01521884|3715358|P1|COMPLETED|Overall Study||35
1518315|NCT01521884|3715358|P1|STARTED|Overall Study||62
1518316|NCT01521871|3715377|P2|NOT COMPLETED|Overall Study||0
1518317|NCT01521871|3715378|P1|NOT COMPLETED|Overall Study||0
1518318|NCT01521871|3715377|P2|COMPLETED|Overall Study||32
1518319|NCT01521871|3715378|P1|COMPLETED|Overall Study||32
1518320|NCT01521871|3715377|P2|STARTED|Overall Study||32
1518321|NCT01521871|3715378|P1|STARTED|Overall Study||32
1518322|NCT01521845|3715418|P2|NOT COMPLETED|Overall Study||5
1518323|NCT01521845|3715419|P1|NOT COMPLETED|Overall Study||9
1518324|NCT01521845|3715418|P2|COMPLETED|Overall Study||47
1518325|NCT01521845|3715419|P1|COMPLETED|Overall Study||43
1518326|NCT01521845|3715418|P2|STARTED|Overall Study||52
1518327|NCT01521845|3715419|P1|STARTED|Overall Study||52
1518328|NCT01521780|3715429|P3|NOT COMPLETED|Overall Study||0
1518329|NCT01521780|3715430|P2|NOT COMPLETED|Overall Study||0
1518330|NCT01521780|3715431|P1|NOT COMPLETED|Overall Study||0
1518331|NCT01521780|3715429|P3|COMPLETED|Overall Study||2
1518332|NCT01521780|3715430|P2|COMPLETED|Overall Study||1
1518333|NCT01521780|3715431|P1|COMPLETED|Overall Study||9
1518334|NCT01521780|3715429|P3|STARTED|Overall Study||2
1518335|NCT01521780|3715430|P2|STARTED|Overall Study||1
1518336|NCT01521780|3715431|P1|STARTED|Overall Study||9
1518337|NCT01521559|3715455|P2|NOT COMPLETED|Overall Study||18
1518338|NCT01521559|3715456|P1|NOT COMPLETED|Overall Study||15
1518339|NCT01521559|3715455|P2|COMPLETED|Overall Study||73
1518340|NCT01521559|3715456|P1|COMPLETED|Overall Study||77
1518341|NCT01521559|3715455|P2|Completed Week 52|Overall Study||73
1518342|NCT01521559|3715456|P1|Completed Week 52|Overall Study||77
1518343|NCT01521559|3715455|P2|Completed Week 24|Overall Study||85
1518344|NCT01521559|3715456|P1|Completed Week 24|Overall Study||83
1518345|NCT01521559|3715455|P2|STARTED|Overall Study||91
1518346|NCT01521559|3715456|P1|STARTED|Overall Study||92
1518347|NCT01521546|3715470|P2|NOT COMPLETED|Overall Study||0
1518348|NCT01521546|3715471|P1|NOT COMPLETED|Overall Study||2
1518349|NCT01521546|3715470|P2|COMPLETED|Overall Study||20
1518350|NCT01521546|3715471|P1|COMPLETED|Overall Study||20
1518351|NCT01521546|3715470|P2|STARTED|Overall Study||20
1518352|NCT01521546|3715471|P1|STARTED|Overall Study||22
1518353|NCT01521507|3715479|P2|NOT COMPLETED|Stage 2: Observational Design||2
1518354|NCT01521507|3715480|P1|NOT COMPLETED|Stage 2: Observational Design||4
1518355|NCT01521507|3715479|P2|COMPLETED|Stage 2: Observational Design||92
1518356|NCT01521507|3715480|P1|COMPLETED|Stage 2: Observational Design||94
1518357|NCT01521507|3715479|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
1518358|NCT01521507|3715480|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
1518359|NCT01521507|3715479|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
1518360|NCT01521507|3715480|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
1518361|NCT01521507|3715479|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
1518362|NCT01521507|3715480|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
1518363|NCT01521507|3715479|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
1518364|NCT01521507|3715480|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
1518365|NCT01521507|3715479|P2|STARTED|Stage 2: Observational Design||94
1518366|NCT01521507|3715480|P1|STARTED|Stage 2: Observational Design||98
1518367|NCT01521507|3715479|P2|NOT COMPLETED|Stage 1: Randomized Design||5
1518368|NCT01521507|3715480|P1|NOT COMPLETED|Stage 1: Randomized Design||3
1518369|NCT01521507|3715479|P2|COMPLETED|Stage 1: Randomized Design||94
1518370|NCT01521507|3715480|P1|COMPLETED|Stage 1: Randomized Design||98
1518371|NCT01521507|3715479|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
1518372|NCT01521507|3715480|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
1518373|NCT01521507|3715479|P2|STARTED|Stage 1: Randomized Design||99
1518374|NCT01521507|3715480|P1|STARTED|Stage 1: Randomized Design||101
1518375|NCT01521494|3715502|P5|NOT COMPLETED|Overall Study||7
1518376|NCT01521494|3715503|P4|NOT COMPLETED|Overall Study||21
1518377|NCT01521494|3715504|P3|NOT COMPLETED|Overall Study||12
1518378|NCT01521494|3715505|P2|NOT COMPLETED|Overall Study||5
1518379|NCT01521494|3715506|P1|NOT COMPLETED|Overall Study||2
1518380|NCT01521494|3715502|P5|COMPLETED|Overall Study||30
1518381|NCT01521494|3715503|P4|COMPLETED|Overall Study||15
1518382|NCT01521494|3715504|P3|COMPLETED|Overall Study||23
1518383|NCT01521494|3715505|P2|COMPLETED|Overall Study||31
1518384|NCT01521494|3715506|P1|COMPLETED|Overall Study||37
1518385|NCT01521494|3715502|P5|STARTED|Overall Study||37
1518386|NCT01521494|3715503|P4|STARTED|Overall Study||36
1518387|NCT01521494|3715504|P3|STARTED|Overall Study||35
1518388|NCT01521494|3715505|P2|STARTED|Overall Study||36
1518389|NCT01521494|3715506|P1|STARTED|Overall Study||39
1518390|NCT01521364|3715528|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
1518391|NCT01521364|3715528|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
1518392|NCT01521364|3715528|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
1518393|NCT01521364|3715528|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
1518394|NCT01521364|3715528|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
1518395|NCT01521364|3715528|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
1518396|NCT01521364|3715528|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
1518397|NCT01521364|3715528|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
1518398|NCT01521364|3715528|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
1518399|NCT01521260|3715541|P2|NOT COMPLETED|Overall Study||0
1518400|NCT01521260|3715542|P1|NOT COMPLETED|Overall Study||0
1518401|NCT01521260|3715541|P2|COMPLETED|Overall Study||15
1518402|NCT01521260|3715542|P1|COMPLETED|Overall Study||15
1518403|NCT01521260|3715541|P2|STARTED|Overall Study||15
1518404|NCT01521260|3715542|P1|STARTED|Overall Study||15
1518405|NCT01521143|3715552|P4|NOT COMPLETED|Overall Study||7
1518406|NCT01521143|3715553|P3|NOT COMPLETED|Overall Study||8
1518407|NCT01521143|3715554|P2|NOT COMPLETED|Overall Study||26
1518408|NCT01521143|3715555|P1|NOT COMPLETED|Overall Study||29
1518409|NCT01521143|3715552|P4|COMPLETED|Overall Study||0
1518410|NCT01521143|3715553|P3|COMPLETED|Overall Study||0
1518411|NCT01521143|3715554|P2|COMPLETED|Overall Study||10
1518412|NCT01521143|3715555|P1|COMPLETED|Overall Study||11
1518413|NCT01521143|3715552|P4|Received Treatment|Overall Study||4
1518414|NCT01521143|3715553|P3|Received Treatment|Overall Study||3
1518415|NCT01521143|3715554|P2|Received Treatment|Overall Study||20
1518416|NCT01521143|3715555|P1|Received Treatment|Overall Study||20
1518417|NCT01521143|3715552|P4|STARTED|Overall Study||7
1518418|NCT01521143|3715553|P3|STARTED|Overall Study||8
1518419|NCT01521143|3715554|P2|STARTED|Overall Study||36
1518420|NCT01521143|3715555|P1|STARTED|Overall Study||40
1518421|NCT01521026|3715587|P2|NOT COMPLETED|Overall Study||3
1518422|NCT01521026|3715588|P1|NOT COMPLETED|Overall Study||15
1518423|NCT01521026|3715587|P2|COMPLETED|Overall Study||28
1518424|NCT01521026|3715588|P1|COMPLETED|Overall Study||23
1518425|NCT01521026|3715587|P2|STARTED|Overall Study||31
1518426|NCT01521026|3715588|P1|STARTED|Overall Study||38
1518427|NCT01520987|3715604|P8|NOT COMPLETED|Overall Study||0
1518428|NCT01520987|3715605|P7|NOT COMPLETED|Overall Study||0
1518429|NCT01520987|3715606|P6|NOT COMPLETED|Overall Study||1
1518430|NCT01520987|3715607|P5|NOT COMPLETED|Overall Study||0
1518431|NCT01520987|3715608|P4|NOT COMPLETED|Overall Study||0
1518432|NCT01520987|3715609|P3|NOT COMPLETED|Overall Study||0
1518433|NCT01520987|3715610|P2|NOT COMPLETED|Overall Study||0
1518434|NCT01520987|3715611|P1|NOT COMPLETED|Overall Study||1
1518435|NCT01520987|3715604|P8|COMPLETED|Overall Study||14
1518436|NCT01520987|3715605|P7|COMPLETED|Overall Study||12
1518437|NCT01520987|3715606|P6|COMPLETED|Overall Study||13
1518438|NCT01520987|3715607|P5|COMPLETED|Overall Study||14
1518439|NCT01520987|3715608|P4|COMPLETED|Overall Study||15
1518440|NCT01520987|3715609|P3|COMPLETED|Overall Study||11
1518441|NCT01520987|3715610|P2|COMPLETED|Overall Study||12
1518442|NCT01520987|3715611|P1|COMPLETED|Overall Study||12
1518443|NCT01520987|3715604|P8|Dosed|Overall Study||14
1518444|NCT01520987|3715605|P7|Dosed|Overall Study||12
1518445|NCT01520987|3715606|P6|Dosed|Overall Study||14
1518446|NCT01520987|3715607|P5|Dosed|Overall Study||14
1518447|NCT01520987|3715608|P4|Dosed|Overall Study||15
1518448|NCT01520987|3715609|P3|Dosed|Overall Study||11
1518449|NCT01520987|3715610|P2|Dosed|Overall Study||12
1518450|NCT01520987|3715611|P1|Dosed|Overall Study||13
1518451|NCT01520987|3715604|P8|STARTED|Overall Study||14
1518452|NCT01520987|3715605|P7|STARTED|Overall Study||12
1518453|NCT01520987|3715606|P6|STARTED|Overall Study||14
1518454|NCT01520987|3715607|P5|STARTED|Overall Study||14
1518455|NCT01520987|3715608|P4|STARTED|Overall Study||15
1518456|NCT01520987|3715609|P3|STARTED|Overall Study||11
1518457|NCT01520987|3715610|P2|STARTED|Overall Study||12
1518458|NCT01520987|3715611|P1|STARTED|Overall Study||13
1518459|NCT01520922|3715671|P2|NOT COMPLETED|Survival Follow-up||0
1518460|NCT01520922|3715672|P1|NOT COMPLETED|Survival Follow-up||1
1518461|NCT01520922|3715671|P2|COMPLETED|Survival Follow-up||40
1518462|NCT01520922|3715672|P1|COMPLETED|Survival Follow-up||20
1518463|NCT01520922|3715671|P2|STARTED|Survival Follow-up||40
1518464|NCT01520922|3715672|P1|STARTED|Survival Follow-up||21
1518465|NCT01520922|3715671|P2|NOT COMPLETED|Follow up||1
1518466|NCT01520922|3715672|P1|NOT COMPLETED|Follow up||0
1518467|NCT01520922|3715671|P2|COMPLETED|Follow up||44
1518468|NCT01520922|3715672|P1|COMPLETED|Follow up||44
1518469|NCT01520922|3715671|P2|STARTED|Follow up||45
1518470|NCT01520922|3715672|P1|STARTED|Follow up||44
1518471|NCT01520922|3715671|P2|NOT COMPLETED|Treatment Phase||8
1518472|NCT01520922|3715672|P1|NOT COMPLETED|Treatment Phase||5
1518473|NCT01520922|3715671|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
1518474|NCT01520922|3715672|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
1518475|NCT01520922|3715671|P2|STARTED|Treatment Phase||53
1518476|NCT01520922|3715672|P1|STARTED|Treatment Phase||44
1518477|NCT01520909|3715734|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
1518478|NCT01520909|3715735|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
1518479|NCT01520909|3715736|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
1518480|NCT01520909|3715734|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
1518481|NCT01520909|3715735|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
1518482|NCT01520909|3715736|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
1518483|NCT01520909|3715734|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
1518484|NCT01520909|3715735|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
1518485|NCT01520909|3715736|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
1518486|NCT01520909|3715734|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
1518487|NCT01520909|3715735|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
1518488|NCT01520909|3715736|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
1518489|NCT01520909|3715734|P3|COMPLETED|Part 1 (Randomized Period)||0
1518490|NCT01520909|3715735|P2|COMPLETED|Part 1 (Randomized Period)||61
1518491|NCT01520909|3715736|P1|COMPLETED|Part 1 (Randomized Period)||28
1518492|NCT01520909|3715734|P3|STARTED|Part 1 (Randomized Period)||0
1518493|NCT01520909|3715735|P2|STARTED|Part 1 (Randomized Period)||63
1518494|NCT01520909|3715736|P1|STARTED|Part 1 (Randomized Period)||29
1518495|NCT01520727|3715807|P9|NOT COMPLETED|Overall Study||0
1518496|NCT01520727|3715808|P8|NOT COMPLETED|Overall Study||0
1518497|NCT01520727|3715809|P7|NOT COMPLETED|Overall Study||0
1518498|NCT01520727|3715810|P6|NOT COMPLETED|Overall Study||0
1518499|NCT01520727|3715811|P5|NOT COMPLETED|Overall Study||0
1518500|NCT01520727|3715812|P4|NOT COMPLETED|Overall Study||0
1518501|NCT01520727|3715813|P3|NOT COMPLETED|Overall Study||0
1518502|NCT01520727|3715814|P2|NOT COMPLETED|Overall Study||0
1518503|NCT01520727|3715815|P1|NOT COMPLETED|Overall Study||0
1518504|NCT01520727|3715807|P9|COMPLETED|Overall Study||16
1518505|NCT01520727|3715808|P8|COMPLETED|Overall Study||6
1518506|NCT01520727|3715809|P7|COMPLETED|Overall Study||6
1518507|NCT01520727|3715810|P6|COMPLETED|Overall Study||6
1518508|NCT01520727|3715811|P5|COMPLETED|Overall Study||6
1518509|NCT01520727|3715812|P4|COMPLETED|Overall Study||6
1518510|NCT01520727|3715813|P3|COMPLETED|Overall Study||6
1518511|NCT01520727|3715814|P2|COMPLETED|Overall Study||6
1518512|NCT01520727|3715815|P1|COMPLETED|Overall Study||6
1518513|NCT01520727|3715807|P9|STARTED|Overall Study||16
1518514|NCT01520727|3715808|P8|STARTED|Overall Study||6
1518515|NCT01520727|3715809|P7|STARTED|Overall Study||6
1518516|NCT01520727|3715810|P6|STARTED|Overall Study||6
1518517|NCT01520727|3715811|P5|STARTED|Overall Study||6
1518518|NCT01520727|3715812|P4|STARTED|Overall Study||6
1518519|NCT01520727|3715813|P3|STARTED|Overall Study||6
1518520|NCT01520727|3715814|P2|STARTED|Overall Study||6
1518521|NCT01520727|3715815|P1|STARTED|Overall Study||6
1518522|NCT01520714|3715853|P2|NOT COMPLETED|Overall Study||6
1518523|NCT01520714|3715854|P1|NOT COMPLETED|Overall Study||0
1518524|NCT01520714|3715853|P2|COMPLETED|Overall Study||5
1518525|NCT01520714|3715854|P1|COMPLETED|Overall Study||0
1518526|NCT01520714|3715853|P2|STARTED|Overall Study||11
1518527|NCT01520714|3715854|P1|STARTED|Overall Study||0
1518528|NCT01520558|3715863|P3|NOT COMPLETED|Overall Study||3
1518529|NCT01520558|3715864|P2|NOT COMPLETED|Overall Study||2
1518530|NCT01520558|3715865|P1|NOT COMPLETED|Overall Study||2
1518531|NCT01520558|3715863|P3|COMPLETED|Overall Study||3
1518532|NCT01520558|3715864|P2|COMPLETED|Overall Study||1
1518533|NCT01520558|3715865|P1|COMPLETED|Overall Study||1
1518534|NCT01520558|3715863|P3|STARTED|Overall Study||6
1518535|NCT01520558|3715864|P2|STARTED|Overall Study||3
1518536|NCT01520558|3715865|P1|STARTED|Overall Study||3
1518537|NCT01520532|3715873|P1|NOT COMPLETED|Overall Study||0
1518538|NCT01520532|3715873|P1|COMPLETED|Overall Study||60
1518539|NCT01520532|3715873|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
1518540|NCT01520506|3715879|P1|NOT COMPLETED|Overall Study||6
1518541|NCT01520506|3715879|P1|COMPLETED|Overall Study||44
1518542|NCT01520506|3715879|P1|STARTED|Overall Study||50
1518543|NCT01520454|3715889|P4|NOT COMPLETED|Overall Study||0
1518544|NCT01520454|3715890|P3|NOT COMPLETED|Overall Study||0
1518545|NCT01520454|3715891|P2|NOT COMPLETED|Overall Study||0
1518546|NCT01520454|3715892|P1|NOT COMPLETED|Overall Study||0
1518547|NCT01520454|3715889|P4|COMPLETED|Overall Study||6
1518548|NCT01520454|3715890|P3|COMPLETED|Overall Study||5
1518549|NCT01520454|3715891|P2|COMPLETED|Overall Study||6
1518550|NCT01520454|3715892|P1|COMPLETED|Overall Study||9
1518551|NCT01520454|3715889|P4|STARTED|Overall Study||6
1518552|NCT01520454|3715890|P3|STARTED|Overall Study||5
1518553|NCT01520454|3715891|P2|STARTED|Overall Study||6
1518554|NCT01520454|3715892|P1|STARTED|Overall Study||9
1518555|NCT01520402|3715934|P1|NOT COMPLETED|Overall Study||5
1518556|NCT01520402|3715934|P1|COMPLETED|Overall Study||30
1518557|NCT01520402|3715934|P1|STARTED|Overall Study||35
1518558|NCT01520363|3715947|P2|NOT COMPLETED|Overall Study||0
1518559|NCT01520363|3715948|P1|NOT COMPLETED|Overall Study||2
1518560|NCT01520363|3715947|P2|COMPLETED|Overall Study||26
1518561|NCT01520363|3715948|P1|COMPLETED|Overall Study||24
1518562|NCT01520363|3715947|P2|STARTED|Overall Study||26
1518563|NCT01520363|3715948|P1|STARTED|Overall Study||26
1518564|NCT01520207|3716024|P2|NOT COMPLETED|Overall Study||0
1518565|NCT01520207|3716025|P1|NOT COMPLETED|Overall Study||2
1518566|NCT01520207|3716024|P2|COMPLETED|Overall Study||25
1518567|NCT01520207|3716025|P1|COMPLETED|Overall Study||25
1518568|NCT01520207|3716024|P2|STARTED|Overall Study||25
1518569|NCT01520207|3716025|P1|STARTED|Overall Study||27
1518570|NCT01519960|3716034|P3|NOT COMPLETED|Overall Study||10
1518571|NCT01519960|3716035|P2|NOT COMPLETED|Overall Study||50
1518572|NCT01519960|3716036|P1|NOT COMPLETED|Overall Study||101
1518573|NCT01519960|3716034|P3|COMPLETED|Overall Study||0
1518574|NCT01519960|3716035|P2|COMPLETED|Overall Study||0
1518575|NCT01519960|3716036|P1|COMPLETED|Overall Study||0
1518576|NCT01519960|3716034|P3|Completed FU Week 24|Overall Study||10
1518577|NCT01519960|3716035|P2|Completed FU Week 24|Overall Study||15
1518578|NCT01519960|3716036|P1|Completed FU Week 24|Overall Study||101
1518579|NCT01519960|3716034|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
1518580|NCT01519960|3716035|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
1518581|NCT01519960|3716036|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
1518582|NCT01519960|3716034|P3|Completed Week 48|Overall Study||10
1518583|NCT01519960|3716035|P2|Completed Week 48|Overall Study||47
1518584|NCT01519960|3716036|P1|Completed Week 48|Overall Study||99
1518585|NCT01519960|3716034|P3|STARTED|Overall Study||10
1518586|NCT01519960|3716035|P2|STARTED|Overall Study||50
1518587|NCT01519960|3716036|P1|STARTED|Overall Study||101
1518588|NCT01519947|3716146|P4|NOT COMPLETED|Overall Study||8
1518589|NCT01519947|3716147|P3|NOT COMPLETED|Overall Study||7
1518590|NCT01519947|3716148|P2|NOT COMPLETED|Overall Study||4
1518591|NCT01519947|3716149|P1|NOT COMPLETED|Overall Study||2
1518592|NCT01519947|3716146|P4|COMPLETED|Overall Study||34
1518593|NCT01519947|3716147|P3|COMPLETED|Overall Study||8
1518594|NCT01519947|3716148|P2|COMPLETED|Overall Study||7
1518595|NCT01519947|3716149|P1|COMPLETED|Overall Study||17
1518596|NCT01519947|3716146|P4|STARTED|Overall Study||42
1518597|NCT01519947|3716147|P3|STARTED|Overall Study||15
1518598|NCT01519947|3716148|P2|STARTED|Overall Study||11
1518599|NCT01519947|3716149|P1|STARTED|Overall Study||19
1518600|NCT01519934|3716179|P1|NOT COMPLETED|Overall Study||3
1518601|NCT01519934|3716179|P1|COMPLETED|Overall Study||45
1518602|NCT01519934|3716179|P1|STARTED|Overall Study||48
1518603|NCT01519921|3716188|P2|NOT COMPLETED|Overall Study||15
1518604|NCT01519921|3716189|P1|NOT COMPLETED|Overall Study||21
1518605|NCT01519921|3716188|P2|COMPLETED|Overall Study||49
1518606|NCT01519921|3716189|P1|COMPLETED|Overall Study||65
1518607|NCT01519921|3716188|P2|STARTED|Overall Study||64
1518608|NCT01519921|3716189|P1|STARTED|Overall Study||86
1518609|NCT01519882|3716213|P2|NOT COMPLETED|Overall Study||0
1518610|NCT01519882|3716214|P1|NOT COMPLETED|Overall Study||0
1518611|NCT01519882|3716213|P2|COMPLETED|Overall Study||0
1518612|NCT01519882|3716214|P1|COMPLETED|Overall Study||1
1518613|NCT01519882|3716213|P2|STARTED|Overall Study||0
1518614|NCT01519882|3716214|P1|STARTED|Overall Study||1
1518615|NCT01519817|3716238|P4|NOT COMPLETED|Overall Study||1
1518616|NCT01519817|3716239|P3|NOT COMPLETED|Overall Study||0
1518617|NCT01519817|3716240|P2|NOT COMPLETED|Overall Study||0
1518618|NCT01519817|3716241|P1|NOT COMPLETED|Overall Study||1
1518619|NCT01519817|3716238|P4|COMPLETED|Overall Study||10
1518620|NCT01519817|3716239|P3|COMPLETED|Overall Study||16
1518621|NCT01519817|3716240|P2|COMPLETED|Overall Study||3
1518622|NCT01519817|3716241|P1|COMPLETED|Overall Study||3
1518623|NCT01519817|3716238|P4|STARTED|Overall Study||11
1518624|NCT01519817|3716239|P3|STARTED|Overall Study||16
1518625|NCT01519817|3716240|P2|STARTED|Overall Study||3
1518626|NCT01519817|3716241|P1|STARTED|Overall Study||4
1518627|NCT01519791|3716281|P2|NOT COMPLETED|Overall Study||368
1518628|NCT01519791|3716282|P1|NOT COMPLETED|Overall Study||152
1518629|NCT01519791|3716281|P2|COMPLETED|Overall Study||292
1518630|NCT01519791|3716282|P1|COMPLETED|Overall Study||67
1518631|NCT01519791|3716281|P2|Completed Week 52|Overall Study||500
1518632|NCT01519791|3716282|P1|Completed Week 52|Overall Study||143
1518633|NCT01519791|3716281|P2|STARTED|Overall Study||660
1518634|NCT01519791|3716282|P1|STARTED|Overall Study||219
1518635|NCT01519778|3716346|P1|NOT COMPLETED|Overall Study||14
1518636|NCT01519778|3716346|P1|COMPLETED|Overall Study||186
1518637|NCT01519778|3716346|P1|STARTED|Overall Study||200
1518638|NCT01519765|3716352|P2|NOT COMPLETED|Overall Study||2
1518639|NCT01519765|3716353|P1|NOT COMPLETED|Overall Study||3
1518640|NCT01519765|3716352|P2|COMPLETED|Overall Study||34
1518641|NCT01519765|3716353|P1|COMPLETED|Overall Study||34
1518642|NCT01519765|3716352|P2|STARTED|Overall Study||36
1518643|NCT01519765|3716353|P1|STARTED|Overall Study||37
1518644|NCT01519713|3716402|P3|NOT COMPLETED|Overall Study||0
1518645|NCT01519713|3716403|P2|NOT COMPLETED|Overall Study||0
1518646|NCT01519713|3716404|P1|NOT COMPLETED|Overall Study||0
1518647|NCT01519713|3716402|P3|COMPLETED|Overall Study||4
1518648|NCT01519713|3716403|P2|COMPLETED|Overall Study||2
1518649|NCT01519713|3716404|P1|COMPLETED|Overall Study||194
1518650|NCT01519713|3716402|P3|STARTED|Overall Study||4
1518651|NCT01519713|3716403|P2|STARTED|Overall Study||2
1518652|NCT01519713|3716404|P1|STARTED|Overall Study||194
1518653|NCT01519700|3716431|P4|NOT COMPLETED|Overall Study||7
1518654|NCT01519700|3716432|P3|NOT COMPLETED|Overall Study||7
1518655|NCT01519700|3716433|P2|NOT COMPLETED|Overall Study||6
1518656|NCT01519700|3716434|P1|NOT COMPLETED|Overall Study||9
1518657|NCT01519700|3716431|P4|COMPLETED|Overall Study||47
1518658|NCT01519700|3716432|P3|COMPLETED|Overall Study||48
1518659|NCT01519700|3716433|P2|COMPLETED|Overall Study||49
1518660|NCT01519700|3716434|P1|COMPLETED|Overall Study||45
1518661|NCT01519700|3716431|P4|Treated Cycle 6 Neupogen|Overall Study||49
1518662|NCT01519700|3716432|P3|Treated Cycle 6 Neupogen|Overall Study||0
1518663|NCT01519700|3716433|P2|Treated Cycle 6 Neupogen|Overall Study||49
1518664|NCT01519700|3716434|P1|Treated Cycle 6 Neupogen|Overall Study||0
1518665|NCT01519700|3716431|P4|Treated Cycle 6 EP2006|Overall Study||0
1518666|NCT01519700|3716432|P3|Treated Cycle 6 EP2006|Overall Study||48
1518667|NCT01519700|3716433|P2|Treated Cycle 6 EP2006|Overall Study||0
1518668|NCT01519700|3716434|P1|Treated Cycle 6 EP2006|Overall Study||45
1518669|NCT01519700|3716431|P4|Treated Cycle 5 Neupogen|Overall Study||50
1518670|NCT01519700|3716432|P3|Treated Cycle 5 Neupogen|Overall Study||48
1518671|NCT01519700|3716433|P2|Treated Cycle 5 Neupogen|Overall Study||0
1518672|NCT01519700|3716434|P1|Treated Cycle 5 Neupogen|Overall Study||0
1518673|NCT01519700|3716431|P4|Treated Cycle 5 EP2006|Overall Study||0
1518674|NCT01519700|3716432|P3|Treated Cycle 5 EP2006|Overall Study||0
1518675|NCT01519700|3716433|P2|Treated Cycle 5 EP2006|Overall Study||49
1518676|NCT01519700|3716434|P1|Treated Cycle 5 EP2006|Overall Study||46
1518677|NCT01519700|3716431|P4|Treated Cycle 4 Neupogen|Overall Study||50
1518678|NCT01519700|3716432|P3|Treated Cycle 4 Neupogen|Overall Study||0
1518679|NCT01519700|3716433|P2|Treated Cycle 4 Neupogen|Overall Study||51
1518680|NCT01519700|3716434|P1|Treated Cycle 4 Neupogen|Overall Study||0
1518681|NCT01519700|3716431|P4|Treated Cycle 4 EP2006|Overall Study||0
1518682|NCT01519700|3716432|P3|Treated Cycle 4 EP2006|Overall Study||50
1518683|NCT01519700|3716433|P2|Treated Cycle 4 EP2006|Overall Study||0
1518684|NCT01519700|3716434|P1|Treated Cycle 4 EP2006|Overall Study||51
1518685|NCT01519700|3716431|P4|Treated Cycle 3 Neupogen|Overall Study||51
1518686|NCT01519700|3716432|P3|Treated Cycle 3 Neupogen|Overall Study||54
1518687|NCT01519700|3716433|P2|Treated Cycle 3 Neupogen|Overall Study||0
1518688|NCT01519700|3716434|P1|Treated Cycle 3 Neupogen|Overall Study||0
1518689|NCT01519700|3716431|P4|Treated Cycle 3 EP2006|Overall Study||0
1518690|NCT01519700|3716432|P3|Treated Cycle 3 EP2006|Overall Study||0
1518691|NCT01519700|3716433|P2|Treated Cycle 3 EP2006|Overall Study||51
1518692|NCT01519700|3716434|P1|Treated Cycle 3 EP2006|Overall Study||51
1518693|NCT01519700|3716431|P4|Treated Cycle 2 Neupogen|Overall Study||51
1518694|NCT01519700|3716432|P3|Treated Cycle 2 Neupogen|Overall Study||0
1518695|NCT01519700|3716433|P2|Treated Cycle 2 Neupogen|Overall Study||52
1518696|NCT01519700|3716434|P1|Treated Cycle 2 Neupogen|Overall Study||0
1518697|NCT01519700|3716431|P4|Treated Cycle 2 EP2006|Overall Study||0
1518698|NCT01519700|3716432|P3|Treated Cycle 2 EP2006|Overall Study||55
1518699|NCT01519700|3716433|P2|Treated Cycle 2 EP2006|Overall Study||0
1518700|NCT01519700|3716434|P1|Treated Cycle 2 EP2006|Overall Study||52
1518701|NCT01519700|3716431|P4|Treated Cycle 1 Neupogen|Overall Study||52
1518702|NCT01519700|3716432|P3|Treated Cycle 1 Neupogen|Overall Study||55
1518703|NCT01519700|3716433|P2|Treated Cycle 1 Neupogen|Overall Study||0
1518704|NCT01519700|3716434|P1|Treated Cycle 1 Neupogen|Overall Study||0
1518705|NCT01519700|3716431|P4|Treated Cycle 1 EP2006|Overall Study||0
1518706|NCT01519700|3716432|P3|Treated Cycle 1 EP2006|Overall Study||0
1518707|NCT01519700|3716433|P2|Treated Cycle 1 EP2006|Overall Study||54
1518708|NCT01519700|3716434|P1|Treated Cycle 1 EP2006|Overall Study||53
1518709|NCT01519700|3716431|P4|STARTED|Overall Study||54
1518710|NCT01519700|3716432|P3|STARTED|Overall Study||55
1518711|NCT01519700|3716433|P2|STARTED|Overall Study||55
1518712|NCT01519700|3716434|P1|STARTED|Overall Study||54
1518713|NCT01519674|3716469|P3|NOT COMPLETED|Overall Study||12
1518714|NCT01519674|3716470|P2|NOT COMPLETED|Overall Study||13
1518715|NCT01519674|3716471|P1|NOT COMPLETED|Overall Study||21
1518716|NCT01519674|3716469|P3|COMPLETED|Overall Study||181
1518717|NCT01519674|3716470|P2|COMPLETED|Overall Study||182
1518718|NCT01519674|3716471|P1|COMPLETED|Overall Study||173
1518719|NCT01519674|3716469|P3|Exposed|Overall Study||190
1518720|NCT01519674|3716470|P2|Exposed|Overall Study||193
1518721|NCT01519674|3716471|P1|Exposed|Overall Study||192
1518722|NCT01519674|3716469|P3|STARTED|Overall Study||193
1518723|NCT01519674|3716470|P2|STARTED|Overall Study||195
1518724|NCT01519674|3716471|P1|STARTED|Overall Study||194
1518725|NCT01519661|3716509|P1|NOT COMPLETED|Overall Study||61
1518726|NCT01519661|3716509|P1|COMPLETED|Overall Study||96
1518727|NCT01519661|3716509|P1|STARTED|Overall Study||157
1518728|NCT01519648|3716526|P2|NOT COMPLETED|Overall Study||0
1518729|NCT01519648|3716527|P1|NOT COMPLETED|Overall Study||0
1518730|NCT01519648|3716526|P2|COMPLETED|Overall Study||306
1518731|NCT01519648|3716527|P1|COMPLETED|Overall Study||502
1518732|NCT01519648|3716526|P2|STARTED|Overall Study||306
1518733|NCT01519648|3716527|P1|STARTED|Overall Study||502
1518734|NCT01519518|3716535|P2|NOT COMPLETED|Overall Study||10
1518735|NCT01519518|3716536|P1|NOT COMPLETED|Overall Study||7
1518736|NCT01519518|3716535|P2|COMPLETED|Overall Study||905
1518737|NCT01519518|3716536|P1|COMPLETED|Overall Study||907
1518738|NCT01519518|3716535|P2|STARTED|Overall Study||915
1518739|NCT01519518|3716536|P1|STARTED|Overall Study||914
1518740|NCT01519466|3716550|P2|NOT COMPLETED|Overall Study||0
1518741|NCT01519466|3716551|P1|NOT COMPLETED|Overall Study||0
1518742|NCT01519466|3716550|P2|COMPLETED|Overall Study||16
1518743|NCT01519466|3716551|P1|COMPLETED|Overall Study||33
1518744|NCT01519466|3716550|P2|STARTED|Overall Study||16
1518745|NCT01519466|3716551|P1|STARTED|Overall Study||33
1518746|NCT01519427|3716561|P1|NOT COMPLETED|Overall Study||2
1518747|NCT01519427|3716561|P1|COMPLETED|Overall Study||0
1518748|NCT01519427|3716561|P1|STARTED|Overall Study||2
1518749|NCT01519414|3716570|P3|NOT COMPLETED|Post Cross-over||0
1518750|NCT01519414|3716571|P2|NOT COMPLETED|Post Cross-over||0
1518751|NCT01519414|3716572|P1|NOT COMPLETED|Post Cross-over||0
1518752|NCT01519414|3716570|P3|COMPLETED|Post Cross-over||12
1518753|NCT01519414|3716571|P2|COMPLETED|Post Cross-over||14
1518754|NCT01519414|3716572|P1|COMPLETED|Post Cross-over||52
1518755|NCT01519414|3716570|P3|STARTED|Post Cross-over||12
1518756|NCT01519414|3716571|P2|STARTED|Post Cross-over||14
1518757|NCT01519414|3716572|P1|STARTED|Post Cross-over||52
1518758|NCT01519414|3716570|P3|NOT COMPLETED|Pre Cross-over||0
1518759|NCT01519414|3716571|P2|NOT COMPLETED|Pre Cross-over||0
1518760|NCT01519414|3716572|P1|NOT COMPLETED|Pre Cross-over||0
1518761|NCT01519414|3716570|P3|COMPLETED|Pre Cross-over||0
1518762|NCT01519414|3716571|P2|COMPLETED|Pre Cross-over||26
1518763|NCT01519414|3716572|P1|COMPLETED|Pre Cross-over||52
1518764|NCT01519414|3716570|P3|STARTED|Pre Cross-over||0
1518765|NCT01519414|3716571|P2|STARTED|Pre Cross-over||26
1518766|NCT01519414|3716572|P1|STARTED|Pre Cross-over||52
1518767|NCT01519323|3716593|P2|NOT COMPLETED|Overall Study||3
1518768|NCT01519323|3716594|P1|NOT COMPLETED|Overall Study||3
1518769|NCT01519323|3716593|P2|COMPLETED|Overall Study||0
1518770|NCT01519323|3716594|P1|COMPLETED|Overall Study||0
1518771|NCT01519323|3716593|P2|STARTED|Overall Study||3
1518772|NCT01519323|3716594|P1|STARTED|Overall Study||3
1518773|NCT01519284|3716610|P5|NOT COMPLETED|Overall Study||0
1518774|NCT01519284|3716611|P4|NOT COMPLETED|Overall Study||0
1518775|NCT01519284|3716612|P3|NOT COMPLETED|Overall Study||2
1518776|NCT01519284|3716613|P2|NOT COMPLETED|Overall Study||0
1518777|NCT01519284|3716614|P1|NOT COMPLETED|Overall Study||0
1518778|NCT01519284|3716610|P5|COMPLETED|Overall Study||16
1518779|NCT01519284|3716611|P4|COMPLETED|Overall Study||16
1518780|NCT01519284|3716612|P3|COMPLETED|Overall Study||16
1518781|NCT01519284|3716613|P2|COMPLETED|Overall Study||16
1518782|NCT01519284|3716614|P1|COMPLETED|Overall Study||16
1518783|NCT01519284|3716610|P5|STARTED|Overall Study||16
1518784|NCT01519284|3716611|P4|STARTED|Overall Study||16
1518785|NCT01519284|3716612|P3|STARTED|Overall Study||18
1518786|NCT01519284|3716613|P2|STARTED|Overall Study||16
1518787|NCT01519284|3716614|P1|STARTED|Overall Study||16
1518788|NCT01519271|3716643|P2|NOT COMPLETED|Phase 2||0
1518789|NCT01519271|3716644|P1|NOT COMPLETED|Phase 2||0
1518790|NCT01519271|3716643|P2|COMPLETED|Phase 2||14
1518791|NCT01519271|3716644|P1|COMPLETED|Phase 2||12
1518792|NCT01519271|3716643|P2|STARTED|Phase 2||14
1518793|NCT01519271|3716644|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
1518794|NCT01519271|3716643|P2|NOT COMPLETED|Phase 1||1
1518795|NCT01519271|3716644|P1|NOT COMPLETED|Phase 1||0
1518796|NCT01519271|3716643|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
1518797|NCT01519271|3716644|P1|COMPLETED|Phase 1||14
1518798|NCT01519271|3716643|P2|STARTED|Phase 1||14
1518799|NCT01519271|3716644|P1|STARTED|Phase 1||14
1518800|NCT01519245|3716654|P2|NOT COMPLETED|Overall Study||2
1518801|NCT01519245|3716655|P1|NOT COMPLETED|Overall Study||1
1518802|NCT01519245|3716654|P2|COMPLETED|Overall Study||18
1518803|NCT01519245|3716655|P1|COMPLETED|Overall Study||23
1518804|NCT01519245|3716654|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
1518805|NCT01519245|3716655|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
1518806|NCT01519245|3716654|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
1518807|NCT01519245|3716655|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
1518808|NCT01519245|3716654|P2|STARTED|Overall Study||20
1518809|NCT01519245|3716655|P1|STARTED|Overall Study||24
1518810|NCT01519206|3716667|P1|NOT COMPLETED|Overall Study||5
1518811|NCT01519206|3716667|P1|COMPLETED|Overall Study||27
1518812|NCT01519206|3716667|P1|STARTED|Overall Study||32
1518813|NCT01519167|3716681|P2|NOT COMPLETED|Overall Study||8
1518814|NCT01519167|3716682|P1|NOT COMPLETED|Overall Study||0
1518815|NCT01519167|3716681|P2|COMPLETED|Overall Study||81
1518816|NCT01519167|3716682|P1|COMPLETED|Overall Study||1
1518817|NCT01519167|3716681|P2|STARTED|Overall Study||89
1518818|NCT01519167|3716682|P1|STARTED|Overall Study||1
1518819|NCT01519089|3716708|P2|NOT COMPLETED|Overall Study||15
1518820|NCT01519089|3716709|P1|NOT COMPLETED|Overall Study||7
1518821|NCT01519089|3716708|P2|COMPLETED|Overall Study||33
1518822|NCT01519089|3716709|P1|COMPLETED|Overall Study||40
1518823|NCT01519089|3716708|P2|Received Treatment|Overall Study||47
1518824|NCT01519089|3716709|P1|Received Treatment|Overall Study||47
1518825|NCT01519089|3716708|P2|STARTED|Overall Study||48
1518826|NCT01519089|3716709|P1|STARTED|Overall Study||47
1518827|NCT01518946|3716830|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
1518828|NCT01518946|3716831|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
1518829|NCT01518946|3716832|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
1518830|NCT01518946|3716830|P3|COMPLETED|Randomized Phase (Second Intervention)||10
1518831|NCT01518946|3716831|P2|COMPLETED|Randomized Phase (Second Intervention)||9
1518832|NCT01518946|3716832|P1|COMPLETED|Randomized Phase (Second Intervention)||0
1518833|NCT01518946|3716830|P3|STARTED|Randomized Phase (Second Intervention)||10
1518834|NCT01518946|3716831|P2|STARTED|Randomized Phase (Second Intervention)||9
1518835|NCT01518946|3716832|P1|STARTED|Randomized Phase (Second Intervention)||0
1518836|NCT01518946|3716830|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
1518837|NCT01518946|3716831|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
1518838|NCT01518946|3716832|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
1518839|NCT01518946|3716830|P3|COMPLETED|Randomized Phase (First Intervention)||10
1518840|NCT01518946|3716831|P2|COMPLETED|Randomized Phase (First Intervention)||9
1518841|NCT01518946|3716832|P1|COMPLETED|Randomized Phase (First Intervention)||0
1518842|NCT01518946|3716830|P3|STARTED|Randomized Phase (First Intervention)||10
1518843|NCT01518946|3716831|P2|STARTED|Randomized Phase (First Intervention)||10
1518844|NCT01518946|3716832|P1|STARTED|Randomized Phase (First Intervention)||0
1518845|NCT01518946|3716830|P3|NOT COMPLETED|Open-label Phase||0
1518846|NCT01518946|3716831|P2|NOT COMPLETED|Open-label Phase||0
1518847|NCT01518946|3716832|P1|NOT COMPLETED|Open-label Phase||4
1518848|NCT01518946|3716830|P3|COMPLETED|Open-label Phase||0
1518849|NCT01518946|3716831|P2|COMPLETED|Open-label Phase||0
1518850|NCT01518946|3716832|P1|COMPLETED|Open-label Phase||20
1518851|NCT01518946|3716830|P3|STARTED|Open-label Phase||0
1518852|NCT01518946|3716831|P2|STARTED|Open-label Phase||0
1518853|NCT01518946|3716832|P1|STARTED|Open-label Phase||24
1518854|NCT01518530|3716839|P1|NOT COMPLETED|Post-Treatment Follow-up||0
1518855|NCT01518530|3716839|P1|COMPLETED|Post-Treatment Follow-up||9
1518856|NCT01518530|3716839|P1|STARTED|Post-Treatment Follow-up||9
1518857|NCT01518530|3716839|P1|NOT COMPLETED|Active Treatment Period||1
1518858|NCT01518530|3716839|P1|COMPLETED|Active Treatment Period||9
1518859|NCT01518530|3716839|P1|STARTED|Active Treatment Period||10
1518860|NCT01518374|3716843|P1|NOT COMPLETED|Overall Study||7
1518861|NCT01518374|3716843|P1|COMPLETED|Overall Study||1761
1518862|NCT01518374|3716843|P1|STARTED|Overall Study||1768
1518863|NCT01518322|3716847|P1|NOT COMPLETED|Overall Study||13
1518864|NCT01518322|3716847|P1|COMPLETED|Overall Study||222
1518865|NCT01518322|3716847|P1|STARTED|Overall Study||235
1518866|NCT01518270|3716860|P1|NOT COMPLETED|Overall Study||0
1518867|NCT01518270|3716860|P1|COMPLETED|Overall Study||179
1518868|NCT01518270|3716860|P1|STARTED|Overall Study||179
1518869|NCT01518257|3716868|P2|NOT COMPLETED|Overall Study||0
1518870|NCT01518257|3716869|P1|NOT COMPLETED|Overall Study||2
1518871|NCT01518257|3716868|P2|COMPLETED|Overall Study||60
1518872|NCT01518257|3716869|P1|COMPLETED|Overall Study||59
1518873|NCT01518257|3716868|P2|STARTED|Overall Study||60
1518874|NCT01518257|3716869|P1|STARTED|Overall Study||61
1518875|NCT01518244|3716891|P1|NOT COMPLETED|Overall Study||3
1518876|NCT01518244|3716891|P1|COMPLETED|Overall Study||47
1518877|NCT01518244|3716891|P1|STARTED|Overall Study||50
1518878|NCT01518192|3716899|P3|NOT COMPLETED|Overall Study||35
1518879|NCT01518192|3716900|P2|NOT COMPLETED|Overall Study||26
1518880|NCT01518192|3716901|P1|NOT COMPLETED|Overall Study||29
1518881|NCT01518192|3716899|P3|COMPLETED|Overall Study||224
1518882|NCT01518192|3716900|P2|COMPLETED|Overall Study||114
1518883|NCT01518192|3716901|P1|COMPLETED|Overall Study||116
1518884|NCT01518192|3716899|P3|STARTED|Overall Study||259
1518885|NCT01518192|3716900|P2|STARTED|Overall Study||140
1518886|NCT01518192|3716901|P1|STARTED|Overall Study||145
1518887|NCT01518153|3716922|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
1518888|NCT01518153|3716923|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
1518889|NCT01518153|3716924|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
1518890|NCT01518153|3716922|P3|COMPLETED|Donor Lymphocyte Infusion||3
1518891|NCT01518153|3716923|P2|COMPLETED|Donor Lymphocyte Infusion||1
1518892|NCT01518153|3716924|P1|COMPLETED|Donor Lymphocyte Infusion||0
1518893|NCT01518153|3716922|P3|STARTED|Donor Lymphocyte Infusion||4
1518894|NCT01518153|3716923|P2|STARTED|Donor Lymphocyte Infusion||3
1518895|NCT01518153|3716924|P1|STARTED|Donor Lymphocyte Infusion||0
1518896|NCT01518153|3716922|P3|NOT COMPLETED|Stem Cell Transplant||0
1518897|NCT01518153|3716923|P2|NOT COMPLETED|Stem Cell Transplant||0
1518898|NCT01518153|3716924|P1|NOT COMPLETED|Stem Cell Transplant||9
1518899|NCT01518153|3716922|P3|COMPLETED|Stem Cell Transplant||0
1518900|NCT01518153|3716923|P2|COMPLETED|Stem Cell Transplant||0
1518901|NCT01518153|3716924|P1|COMPLETED|Stem Cell Transplant||7
1518902|NCT01518153|3716922|P3|STARTED|Stem Cell Transplant||0
1518903|NCT01518153|3716923|P2|STARTED|Stem Cell Transplant||0
1518904|NCT01518153|3716924|P1|STARTED|Stem Cell Transplant||16
1518905|NCT01517984|3716935|P4|NOT COMPLETED|Overall Study||1
1518906|NCT01517984|3716936|P3|NOT COMPLETED|Overall Study||4
1518907|NCT01517984|3716937|P2|NOT COMPLETED|Overall Study||23
1518908|NCT01517984|3716938|P1|NOT COMPLETED|Overall Study||5
1518909|NCT01517984|3716935|P4|COMPLETED|Overall Study||6
1518910|NCT01517984|3716936|P3|COMPLETED|Overall Study||10
1518911|NCT01517984|3716937|P2|COMPLETED|Overall Study||3
1518912|NCT01517984|3716938|P1|COMPLETED|Overall Study||0
1518913|NCT01517984|3716935|P4|STARTED|Overall Study||7
1518914|NCT01517984|3716936|P3|STARTED|Overall Study||14
1518915|NCT01517984|3716937|P2|STARTED|Overall Study||26
1518916|NCT01517984|3716938|P1|STARTED|Overall Study||5
1518917|NCT01517893|3716964|P2|NOT COMPLETED|Overall Study||0
1518918|NCT01517893|3716965|P1|NOT COMPLETED|Overall Study||3
1518919|NCT01517893|3716964|P2|COMPLETED|Overall Study||7
1518920|NCT01517893|3716965|P1|COMPLETED|Overall Study||5
1518921|NCT01517893|3716964|P2|STARTED|Overall Study||7
1518922|NCT01517893|3716965|P1|STARTED|Overall Study||8
1518923|NCT01517867|3716987|P2|NOT COMPLETED|Overall Study||65
1518924|NCT01517867|3716988|P1|NOT COMPLETED|Overall Study||63
1518925|NCT01517867|3716987|P2|COMPLETED|Overall Study||15
1518926|NCT01517867|3716988|P1|COMPLETED|Overall Study||18
1518927|NCT01517867|3716987|P2|STARTED|Overall Study||80
1518928|NCT01517867|3716988|P1|STARTED|Overall Study||81
1518929|NCT01517750|3717000|P4|NOT COMPLETED|Overall Study||1
1518930|NCT01517750|3717001|P3|NOT COMPLETED|Overall Study||4
1518931|NCT01517750|3717002|P2|NOT COMPLETED|Overall Study||2
1518932|NCT01517750|3717003|P1|NOT COMPLETED|Overall Study||1
1518933|NCT01517750|3717000|P4|COMPLETED|Overall Study||18
1518934|NCT01517750|3717001|P3|COMPLETED|Overall Study||17
1518935|NCT01517750|3717002|P2|COMPLETED|Overall Study||17
1518936|NCT01517750|3717003|P1|COMPLETED|Overall Study||20
1518937|NCT01517750|3717000|P4|STARTED|Overall Study||19
1518938|NCT01517750|3717001|P3|STARTED|Overall Study||21
1518939|NCT01517750|3717002|P2|STARTED|Overall Study||19
1518940|NCT01517750|3717003|P1|STARTED|Overall Study||21
1518941|NCT01517529|3717033|P1|NOT COMPLETED|Overall Study||0
1518942|NCT01517529|3717033|P1|COMPLETED|Overall Study||10
1518943|NCT01517529|3717033|P1|STARTED|Overall Study||10
1518944|NCT01517412|3717040|P2|NOT COMPLETED|Overall Study||24
1518945|NCT01517412|3717041|P1|NOT COMPLETED|Overall Study||36
1518946|NCT01517412|3717040|P2|COMPLETED|Overall Study||202
1518947|NCT01517412|3717041|P1|COMPLETED|Overall Study||189
1518948|NCT01517412|3717040|P2|STARTED|Overall Study||226
1518949|NCT01517412|3717041|P1|STARTED|Overall Study||225
1518950|NCT01517373|3717070|P6|NOT COMPLETED|Treatment Period||7
1518951|NCT01517373|3717071|P5|NOT COMPLETED|Treatment Period||6
1518952|NCT01517373|3717072|P4|NOT COMPLETED|Treatment Period||7
1518953|NCT01517373|3717073|P3|NOT COMPLETED|Treatment Period||6
1518954|NCT01517373|3717074|P2|NOT COMPLETED|Treatment Period||4
1518955|NCT01517373|3717075|P1|NOT COMPLETED|Treatment Period||0
1518956|NCT01517373|3717070|P6|COMPLETED|Treatment Period||54
1518957|NCT01517373|3717071|P5|COMPLETED|Treatment Period||55
1518958|NCT01517373|3717072|P4|COMPLETED|Treatment Period||54
1518959|NCT01517373|3717073|P3|COMPLETED|Treatment Period||54
1518960|NCT01517373|3717074|P2|COMPLETED|Treatment Period||57
1518961|NCT01517373|3717075|P1|COMPLETED|Treatment Period||0
1518962|NCT01517373|3717070|P6|STARTED|Treatment Period||61
1518963|NCT01517373|3717071|P5|STARTED|Treatment Period||61
1518964|NCT01517373|3717072|P4|STARTED|Treatment Period||61
1518965|NCT01517373|3717073|P3|STARTED|Treatment Period||60
1518966|NCT01517373|3717074|P2|STARTED|Treatment Period||61
1518967|NCT01517373|3717075|P1|STARTED|Treatment Period||0
1518968|NCT01517373|3717070|P6|NOT COMPLETED|Run-in Period||0
1518969|NCT01517373|3717071|P5|NOT COMPLETED|Run-in Period||0
1518970|NCT01517373|3717072|P4|NOT COMPLETED|Run-in Period||0
1518971|NCT01517373|3717073|P3|NOT COMPLETED|Run-in Period||0
1518972|NCT01517373|3717074|P2|NOT COMPLETED|Run-in Period||0
1518973|NCT01517373|3717075|P1|NOT COMPLETED|Run-in Period||57
1518974|NCT01517373|3717070|P6|COMPLETED|Run-in Period||0
1518975|NCT01517373|3717071|P5|COMPLETED|Run-in Period||0
1518976|NCT01517373|3717072|P4|COMPLETED|Run-in Period||0
1518977|NCT01517373|3717073|P3|COMPLETED|Run-in Period||0
1518978|NCT01517373|3717074|P2|COMPLETED|Run-in Period||0
1518979|NCT01517373|3717075|P1|COMPLETED|Run-in Period||304
1518980|NCT01517373|3717070|P6|STARTED|Run-in Period||0
1518981|NCT01517373|3717071|P5|STARTED|Run-in Period||0
1518982|NCT01517373|3717072|P4|STARTED|Run-in Period||0
1518983|NCT01517373|3717073|P3|STARTED|Run-in Period||0
1518984|NCT01517373|3717074|P2|STARTED|Run-in Period||0
1518985|NCT01517373|3717075|P1|STARTED|Run-in Period||361
1518986|NCT01517295|3717145|P2|NOT COMPLETED|Overall Study||0
1518987|NCT01517295|3717146|P1|NOT COMPLETED|Overall Study||1
1518988|NCT01517295|3717145|P2|COMPLETED|Overall Study||14
1518989|NCT01517295|3717146|P1|COMPLETED|Overall Study||15
1518990|NCT01517295|3717145|P2|STARTED|Overall Study||14
1518991|NCT01517295|3717146|P1|STARTED|Overall Study||16
1518992|NCT01517282|3717160|P4|NOT COMPLETED|Overall Study||1
1518993|NCT01517282|3717161|P3|NOT COMPLETED|Overall Study||1
1518994|NCT01517282|3717162|P2|NOT COMPLETED|Overall Study||1
1518995|NCT01517282|3717163|P1|NOT COMPLETED|Overall Study||1
1518996|NCT01517282|3717160|P4|COMPLETED|Overall Study||5
1518997|NCT01517282|3717161|P3|COMPLETED|Overall Study||8
1518998|NCT01517282|3717162|P2|COMPLETED|Overall Study||7
1518999|NCT01517282|3717163|P1|COMPLETED|Overall Study||8
1519000|NCT01517282|3717160|P4|STARTED|Overall Study||6
1519001|NCT01517282|3717161|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
1519002|NCT01517282|3717162|P2|STARTED|Overall Study||8
1519003|NCT01517282|3717163|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
1519004|NCT01517178|3717197|P2|NOT COMPLETED|Period 2||2
1519005|NCT01517178|3717198|P1|NOT COMPLETED|Period 2||6
1519006|NCT01517178|3717197|P2|COMPLETED|Period 2||4
1519007|NCT01517178|3717198|P1|COMPLETED|Period 2||5
1519008|NCT01517178|3717197|P2|STARTED|Period 2||6
1519009|NCT01517178|3717198|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
1519010|NCT01517178|3717197|P2|NOT COMPLETED|Period 1||5
1519011|NCT01517178|3717198|P1|NOT COMPLETED|Period 1||4
1519012|NCT01517178|3717197|P2|COMPLETED|Period 1||6
1519013|NCT01517178|3717198|P1|COMPLETED|Period 1||12
1519014|NCT01517178|3717197|P2|STARTED|Period 1||11
1519015|NCT01517178|3717198|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
1519016|NCT01517074|3717204|P1|NOT COMPLETED|Overall Study||0
1519017|NCT01517074|3717204|P1|COMPLETED|Overall Study||5
1519018|NCT01517074|3717204|P1|STARTED|Overall Study||5
1519019|NCT01516970|3717217|P2|NOT COMPLETED|Overall Study||21
1519020|NCT01516970|3717218|P1|NOT COMPLETED|Overall Study||18
1519021|NCT01516970|3717217|P2|COMPLETED|Overall Study||132
1519022|NCT01516970|3717218|P1|COMPLETED|Overall Study||141
1519023|NCT01516970|3717217|P2|STARTED|Overall Study||153
1519024|NCT01516970|3717218|P1|STARTED|Overall Study||159
1519025|NCT01516892|3717230|P1|NOT COMPLETED|Overall Study||343
1519026|NCT01516892|3717230|P1|COMPLETED|Overall Study||373
1519027|NCT01516892|3717230|P1|STARTED|Overall Study||716
1519028|NCT01516879|3717238|P2|NOT COMPLETED|Overall Study||34
1519029|NCT01516879|3717239|P1|NOT COMPLETED|Overall Study||16
1519030|NCT01516879|3717238|P2|COMPLETED|Overall Study||568
1519031|NCT01516879|3717239|P1|COMPLETED|Overall Study||287
1519032|NCT01516879|3717238|P2|Received Treatment|Overall Study||599
1519033|NCT01516879|3717239|P1|Received Treatment|Overall Study||302
1519034|NCT01516879|3717238|P2|STARTED|Overall Study||602
1519035|NCT01516879|3717239|P1|STARTED|Overall Study||303
1519036|NCT01516749|3717273|P1|NOT COMPLETED|Follow-up Off Therapy||1
1519037|NCT01516749|3717273|P1|COMPLETED|Follow-up Off Therapy||4
1519038|NCT01516749|3717273|P1|STARTED|Follow-up Off Therapy||5
1519039|NCT01516749|3717273|P1|NOT COMPLETED|Active Therapy||1
1519040|NCT01516749|3717273|P1|COMPLETED|Active Therapy||5
1519041|NCT01516749|3717273|P1|STARTED|Active Therapy||6
1519042|NCT01516736|3717282|P2|NOT COMPLETED|Overall Study||13
1519043|NCT01516736|3717283|P1|NOT COMPLETED|Overall Study||20
1519044|NCT01516736|3717282|P2|COMPLETED|Overall Study||140
1519045|NCT01516736|3717283|P1|COMPLETED|Overall Study||135
1519046|NCT01516736|3717282|P2|STARTED|Overall Study||153
1519047|NCT01516736|3717283|P1|STARTED|Overall Study||155
1519048|NCT01516632|3717305|P2|NOT COMPLETED|Overall Study||15
1519049|NCT01516632|3717306|P1|NOT COMPLETED|Overall Study||24
1519050|NCT01516632|3717305|P2|COMPLETED|Overall Study||48
1519051|NCT01516632|3717306|P1|COMPLETED|Overall Study||77
1519052|NCT01516632|3717305|P2|STARTED|Overall Study||63
1519053|NCT01516632|3717306|P1|STARTED|Overall Study||101
1519054|NCT01516437|3717320|P4|NOT COMPLETED|Overall Study||1
1519055|NCT01516437|3717321|P3|NOT COMPLETED|Overall Study||1
1519056|NCT01516437|3717322|P2|NOT COMPLETED|Overall Study||0
1519057|NCT01516437|3717323|P1|NOT COMPLETED|Overall Study||0
1519058|NCT01516437|3717320|P4|COMPLETED|Overall Study||6
1519059|NCT01516437|3717321|P3|COMPLETED|Overall Study||14
1519060|NCT01516437|3717322|P2|COMPLETED|Overall Study||24
1519061|NCT01516437|3717323|P1|COMPLETED|Overall Study||24
1519062|NCT01516437|3717320|P4|STARTED|Overall Study||7
1519063|NCT01516437|3717321|P3|STARTED|Overall Study||15
1519064|NCT01516437|3717322|P2|STARTED|Overall Study||24
1519065|NCT01516437|3717323|P1|STARTED|Overall Study||24
1519066|NCT01516424|3717379|P2|NOT COMPLETED|Overall Study||22
1519067|NCT01516424|3717380|P1|NOT COMPLETED|Overall Study||35
1519068|NCT01516424|3717379|P2|COMPLETED|Overall Study||114
1519069|NCT01516424|3717380|P1|COMPLETED|Overall Study||96
1519070|NCT01516424|3717379|P2|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
1519071|NCT01516424|3717380|P1|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
1519072|NCT01516268|3717388|P2|NOT COMPLETED|Overall Study||0
1519073|NCT01516268|3717389|P1|NOT COMPLETED|Overall Study||0
1519074|NCT01516268|3717388|P2|COMPLETED|Overall Study||25
1519075|NCT01516268|3717389|P1|COMPLETED|Overall Study||25
1519076|NCT01516268|3717388|P2|STARTED|Overall Study||25
1519077|NCT01516268|3717389|P1|STARTED|Overall Study||25
1519078|NCT01516034|3717395|P1|NOT COMPLETED|Overall Study||8
1519079|NCT01516034|3717395|P1|COMPLETED|Overall Study||0
1519080|NCT01516034|3717395|P1|STARTED|Overall Study||8
1519081|NCT01516008|3717402|P3|NOT COMPLETED|Overall Study||18
1519082|NCT01516008|3717403|P2|NOT COMPLETED|Overall Study||16
1519083|NCT01516008|3717404|P1|NOT COMPLETED|Overall Study||45
1519084|NCT01516008|3717402|P3|COMPLETED|Overall Study||99
1519085|NCT01516008|3717403|P2|COMPLETED|Overall Study||105
1519086|NCT01516008|3717404|P1|COMPLETED|Overall Study||69
1519087|NCT01516008|3717402|P3|STARTED|Overall Study||117
1519088|NCT01516008|3717403|P2|STARTED|Overall Study||121
1519089|NCT01516008|3717404|P1|STARTED|Overall Study||114
1519090|NCT01515956|3717436|P1|NOT COMPLETED|Overall Study||0
1519091|NCT01515956|3717436|P1|COMPLETED|Overall Study||15
1519092|NCT01515956|3717436|P1|STARTED|Overall Study||15
1519093|NCT01515943|3717445|P3|NOT COMPLETED|Overall Study||13
1519094|NCT01515943|3717446|P2|NOT COMPLETED|Overall Study||16
1519095|NCT01515943|3717447|P1|NOT COMPLETED|Overall Study||6
1519096|NCT01515943|3717445|P3|COMPLETED|Overall Study||31
1519097|NCT01515943|3717446|P2|COMPLETED|Overall Study||69
1519098|NCT01515943|3717447|P1|COMPLETED|Overall Study||69
1519099|NCT01515943|3717445|P3|STARTED|Overall Study||44
1519100|NCT01515943|3717446|P2|STARTED|Overall Study||85
1519101|NCT01515943|3717447|P1|STARTED|Overall Study||75
1519102|NCT01515891|3717493|P1|NOT COMPLETED|Overall Study||0
1519103|NCT01515891|3717493|P1|COMPLETED|Overall Study||4
1519104|NCT01515891|3717493|P1|STARTED|Overall Study||4
1519105|NCT01515865|3717500|P3|NOT COMPLETED|Part C (Randomized)||0
1519106|NCT01515865|3717501|P2|NOT COMPLETED|Part C (Randomized)||0
1519107|NCT01515865|3717502|P1|NOT COMPLETED|Part C (Randomized)||0
1519108|NCT01515865|3717500|P3|COMPLETED|Part C (Randomized)||34
1519109|NCT01515865|3717501|P2|COMPLETED|Part C (Randomized)||33
1519110|NCT01515865|3717502|P1|COMPLETED|Part C (Randomized)||0
1519111|NCT01515865|3717500|P3|STARTED|Part C (Randomized)||34
1519112|NCT01515865|3717501|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
1519113|NCT01515865|3717502|P1|STARTED|Part C (Randomized)||0
1519114|NCT01515865|3717500|P3|NOT COMPLETED|Part B (Open-label)||0
1519115|NCT01515865|3717501|P2|NOT COMPLETED|Part B (Open-label)||0
1519116|NCT01515865|3717502|P1|NOT COMPLETED|Part B (Open-label)||2
1519117|NCT01515865|3717500|P3|COMPLETED|Part B (Open-label)||0
1519118|NCT01515865|3717501|P2|COMPLETED|Part B (Open-label)||0
1519119|NCT01515865|3717502|P1|COMPLETED|Part B (Open-label)||69
1519120|NCT01515865|3717500|P3|STARTED|Part B (Open-label)||0
1519121|NCT01515865|3717501|P2|STARTED|Part B (Open-label)||0
1519122|NCT01515865|3717502|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
1519123|NCT01515865|3717500|P3|NOT COMPLETED|Part A (Open-label)||0
1519124|NCT01515865|3717501|P2|NOT COMPLETED|Part A (Open-label)||0
1519125|NCT01515865|3717502|P1|NOT COMPLETED|Part A (Open-label)||3
1519126|NCT01515865|3717500|P3|COMPLETED|Part A (Open-label)||0
1519127|NCT01515865|3717501|P2|COMPLETED|Part A (Open-label)||0
1519128|NCT01515865|3717502|P1|COMPLETED|Part A (Open-label)||95
1519129|NCT01515865|3717500|P3|STARTED|Part A (Open-label)||0
1519130|NCT01515865|3717501|P2|STARTED|Part A (Open-label)||0
1519131|NCT01515865|3717502|P1|STARTED|Part A (Open-label)||98
1519132|NCT01515696|3717512|P2|NOT COMPLETED|Overall Study||10
1519133|NCT01515696|3717513|P1|NOT COMPLETED|Overall Study||8
1519134|NCT01515696|3717512|P2|COMPLETED|Overall Study||39
1519135|NCT01515696|3717513|P1|COMPLETED|Overall Study||39
1519136|NCT01515696|3717512|P2|STARTED|Overall Study||49
1519137|NCT01515696|3717513|P1|STARTED|Overall Study||47
1519138|NCT01515657|3717523|P3|NOT COMPLETED|Third Intervention||0
1519139|NCT01515657|3717524|P2|NOT COMPLETED|Third Intervention||0
1519140|NCT01515657|3717525|P1|NOT COMPLETED|Third Intervention||1
1519141|NCT01515657|3717523|P3|COMPLETED|Third Intervention||13
1519142|NCT01515657|3717524|P2|COMPLETED|Third Intervention||11
1519143|NCT01515657|3717525|P1|COMPLETED|Third Intervention||13
1519144|NCT01515657|3717523|P3|STARTED|Third Intervention||13
1519145|NCT01515657|3717524|P2|STARTED|Third Intervention||11
1519146|NCT01515657|3717525|P1|STARTED|Third Intervention||14
1519147|NCT01515657|3717523|P3|NOT COMPLETED|Second Intervention||0
1519148|NCT01515657|3717524|P2|NOT COMPLETED|Second Intervention||1
1519149|NCT01515657|3717525|P1|NOT COMPLETED|Second Intervention||0
1519150|NCT01515657|3717523|P3|COMPLETED|Second Intervention||13
1519151|NCT01515657|3717524|P2|COMPLETED|Second Intervention||11
1519152|NCT01515657|3717525|P1|COMPLETED|Second Intervention||14
1519153|NCT01515657|3717523|P3|STARTED|Second Intervention||13
1519154|NCT01515657|3717524|P2|STARTED|Second Intervention||12
1519155|NCT01515657|3717525|P1|STARTED|Second Intervention||14
1519156|NCT01515657|3717523|P3|NOT COMPLETED|First Intervention||0
1519157|NCT01515657|3717524|P2|NOT COMPLETED|First Intervention||1
1519158|NCT01515657|3717525|P1|NOT COMPLETED|First Intervention||0
1519159|NCT01515657|3717523|P3|COMPLETED|First Intervention||13
1519160|NCT01515657|3717524|P2|COMPLETED|First Intervention||12
1519161|NCT01515657|3717525|P1|COMPLETED|First Intervention||14
1519162|NCT01515657|3717523|P3|STARTED|First Intervention||13
1519163|NCT01515657|3717524|P2|STARTED|First Intervention||13
1519164|NCT01515657|3717525|P1|STARTED|First Intervention||14
1519165|NCT01515566|3717535|P2|NOT COMPLETED|Overall Study||0
1519166|NCT01515566|3717536|P1|NOT COMPLETED|Overall Study||0
1519167|NCT01515566|3717535|P2|COMPLETED|Overall Study||10
1519168|NCT01515566|3717536|P1|COMPLETED|Overall Study||10
1519169|NCT01515566|3717535|P2|STARTED|Overall Study||10
1519170|NCT01515566|3717536|P1|STARTED|Overall Study||10
1519171|NCT01515540|3717548|P2|NOT COMPLETED|Overall Study||3
1519172|NCT01515540|3717549|P1|NOT COMPLETED|Overall Study||5
1519173|NCT01515540|3717548|P2|COMPLETED|Overall Study||15
1519174|NCT01515540|3717549|P1|COMPLETED|Overall Study||15
1519175|NCT01515540|3717548|P2|STARTED|Overall Study||18
1519176|NCT01515540|3717549|P1|STARTED|Overall Study||20
1519177|NCT01515488|3717557|P2|NOT COMPLETED|Overall Study||0
1519178|NCT01515488|3717558|P1|NOT COMPLETED|Overall Study||0
1519179|NCT01515488|3717557|P2|COMPLETED|Overall Study||200
1519180|NCT01515488|3717558|P1|COMPLETED|Overall Study||200
1519181|NCT01515488|3717557|P2|STARTED|Overall Study||200
1519182|NCT01515488|3717558|P1|STARTED|Overall Study||200
1519183|NCT01515423|3717570|P3|NOT COMPLETED|DOUBLE BLIND||92
1519184|NCT01515423|3717571|P2|NOT COMPLETED|DOUBLE BLIND||82
1519185|NCT01515423|3717572|P1|NOT COMPLETED|DOUBLE BLIND||0
1519186|NCT01515423|3717570|P3|COMPLETED|DOUBLE BLIND||420
1519187|NCT01515423|3717571|P2|COMPLETED|DOUBLE BLIND||422
1519188|NCT01515423|3717572|P1|COMPLETED|DOUBLE BLIND||0
1519189|NCT01515423|3717570|P3|STARTED|DOUBLE BLIND||512
1519190|NCT01515423|3717571|P2|STARTED|DOUBLE BLIND||504
1519191|NCT01515423|3717572|P1|STARTED|DOUBLE BLIND||0
1519192|NCT01515423|3717570|P3|NOT COMPLETED|Open Label Phase||0
1519193|NCT01515423|3717571|P2|NOT COMPLETED|Open Label Phase||0
1519194|NCT01515423|3717572|P1|NOT COMPLETED|Open Label Phase||413
1519195|NCT01515423|3717570|P3|COMPLETED|Open Label Phase||0
1519196|NCT01515423|3717571|P2|COMPLETED|Open Label Phase||0
1519197|NCT01515423|3717572|P1|COMPLETED|Open Label Phase||1016
1519198|NCT01515423|3717570|P3|STARTED|Open Label Phase||0
1519199|NCT01515423|3717571|P2|STARTED|Open Label Phase||0
1519200|NCT01515423|3717572|P1|STARTED|Open Label Phase||1429
1519201|NCT01515410|3717591|P2|NOT COMPLETED|Overall Study||0
1519202|NCT01515410|3717592|P1|NOT COMPLETED|Overall Study||0
1519203|NCT01515410|3717591|P2|COMPLETED|Overall Study||15
1519204|NCT01515410|3717592|P1|COMPLETED|Overall Study||19
1519205|NCT01515410|3717591|P2|STARTED|Overall Study||15
1519206|NCT01515410|3717592|P1|STARTED|Overall Study||19
1519207|NCT01515345|3717600|P2|NOT COMPLETED|Overall Study||0
1519208|NCT01515345|3717601|P1|NOT COMPLETED|Overall Study||1
1519209|NCT01515345|3717600|P2|COMPLETED|Overall Study||343
1519210|NCT01515345|3717601|P1|COMPLETED|Overall Study||664
1519211|NCT01515345|3717600|P2|STARTED|Overall Study||343
1519212|NCT01515345|3717601|P1|STARTED|Overall Study||665
1519213|NCT01515306|3717613|P2|NOT COMPLETED|Overall Study||14
1519214|NCT01515306|3717614|P1|NOT COMPLETED|Overall Study||12
1519215|NCT01515306|3717613|P2|COMPLETED|Overall Study||2
1519216|NCT01515306|3717614|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
1519217|NCT01515306|3717613|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
1519218|NCT01515306|3717614|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
1519219|NCT01515306|3717613|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
1519220|NCT01515306|3717614|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
1519221|NCT01515306|3717613|P2|STARTED|Overall Study||16
1519222|NCT01515306|3717614|P1|STARTED|Overall Study||24
1519223|NCT01515189|3717627|P2|NOT COMPLETED|First Re-Induction Phase||15
1519224|NCT01515189|3717628|P1|NOT COMPLETED|First Re-Induction Phase||14
1519225|NCT01515189|3717627|P2|COMPLETED|First Re-Induction Phase||17
1519226|NCT01515189|3717628|P1|COMPLETED|First Re-Induction Phase||9
1519227|NCT01515189|3717627|P2|STARTED|First Re-Induction Phase||32
1519228|NCT01515189|3717628|P1|STARTED|First Re-Induction Phase||23
1519229|NCT01515189|3717627|P2|NOT COMPLETED|Induction||232
1519230|NCT01515189|3717628|P1|NOT COMPLETED|Induction||237
1519231|NCT01515189|3717627|P2|COMPLETED|Induction||130
1519232|NCT01515189|3717628|P1|COMPLETED|Induction||128
1519233|NCT01515189|3717627|P2|STARTED|Induction||362
1519234|NCT01515189|3717628|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
1519235|NCT01515176|3717650|P2|NOT COMPLETED|Overall Study||0
1519236|NCT01515176|3717651|P1|NOT COMPLETED|Overall Study||0
1519237|NCT01515176|3717650|P2|COMPLETED|Overall Study||32
1519238|NCT01515176|3717651|P1|COMPLETED|Overall Study||4
1519239|NCT01515176|3717650|P2|STARTED|Overall Study||32
1519240|NCT01515176|3717651|P1|STARTED|Overall Study||4
1519241|NCT01515072|3717665|P2|NOT COMPLETED|Overall Study||0
1519242|NCT01515072|3717666|P1|NOT COMPLETED|Overall Study||0
1519243|NCT01515072|3717665|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
1519244|NCT01515072|3717666|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
1519245|NCT01515072|3717665|P2|STARTED|Overall Study||155
1519246|NCT01515072|3717666|P1|STARTED|Overall Study||166
1519247|NCT01515046|3717706|P1|NOT COMPLETED|Overall Study||0
1519248|NCT01515046|3717706|P1|COMPLETED|Overall Study||1
1519249|NCT01515046|3717706|P1|STARTED|Overall Study||1
1519250|NCT01514864|3717716|P2|NOT COMPLETED|Overall Study||5
1519251|NCT01514864|3717717|P1|NOT COMPLETED|Overall Study||9
1519252|NCT01514864|3717716|P2|COMPLETED|Overall Study||0
1519253|NCT01514864|3717717|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
1519254|NCT01514864|3717716|P2|STARTED|Overall Study||5
1519255|NCT01514864|3717717|P1|STARTED|Overall Study||9
1519256|NCT01514786|3717735|P2|NOT COMPLETED|Overall Study||0
1519257|NCT01514786|3717736|P1|NOT COMPLETED|Overall Study||0
1519258|NCT01514786|3717735|P2|COMPLETED|Overall Study||284
1519259|NCT01514786|3717736|P1|COMPLETED|Overall Study||286
1519260|NCT01514786|3717735|P2|STARTED|Overall Study||284
1519261|NCT01514786|3717736|P1|STARTED|Overall Study||286
1519262|NCT01514760|3717742|P1|NOT COMPLETED|Overall Study||2
1519263|NCT01514760|3717742|P1|COMPLETED|Overall Study||20
1519264|NCT01514760|3717742|P1|STARTED|Overall Study||22
1519265|NCT01514734|3717749|P1|NOT COMPLETED|Overall Study||0
1519266|NCT01514734|3717749|P1|COMPLETED|Overall Study||9
1519267|NCT01514734|3717749|P1|STARTED|Overall Study||9
1519268|NCT01514682|3717755|P2|NOT COMPLETED|Overall Study||6
1519269|NCT01514682|3717756|P1|NOT COMPLETED|Overall Study||6
1519270|NCT01514682|3717755|P2|COMPLETED|Overall Study||14
1519271|NCT01514682|3717756|P1|COMPLETED|Overall Study||13
1519272|NCT01514682|3717755|P2|STARTED|Overall Study||20
1519273|NCT01514682|3717756|P1|STARTED|Overall Study||19
1519274|NCT01514630|3717772|P1|NOT COMPLETED|Overall Study||3
1519275|NCT01514630|3717772|P1|COMPLETED|Overall Study||11
1519276|NCT01514630|3717772|P1|STARTED|Overall Study||14
1519277|NCT01514513|3717778|P2|NOT COMPLETED|Overall Study||1
1519278|NCT01514513|3717779|P1|NOT COMPLETED|Overall Study||1
1519279|NCT01514513|3717778|P2|COMPLETED|Overall Study||20
1519280|NCT01514513|3717779|P1|COMPLETED|Overall Study||20
1519281|NCT01514513|3717778|P2|STARTED|Overall Study||21
1519282|NCT01514513|3717779|P1|STARTED|Overall Study||21
1519283|NCT01514461|3717790|P3|NOT COMPLETED|Overall Study||4
1519284|NCT01514461|3717791|P2|NOT COMPLETED|Overall Study||3
1519285|NCT01514461|3717792|P1|NOT COMPLETED|Overall Study||5
1519286|NCT01514461|3717790|P3|COMPLETED|Overall Study||11
1519287|NCT01514461|3717791|P2|COMPLETED|Overall Study||12
1519288|NCT01514461|3717792|P1|COMPLETED|Overall Study||10
1519289|NCT01514461|3717790|P3|STARTED|Overall Study||15
1519290|NCT01514461|3717791|P2|STARTED|Overall Study||15
1519291|NCT01514461|3717792|P1|STARTED|Overall Study||15
1519292|NCT01514448|3717831|P2|NOT COMPLETED|Overall Study||8
1519293|NCT01514448|3717832|P1|NOT COMPLETED|Overall Study||12
1519294|NCT01514448|3717831|P2|COMPLETED|Overall Study||5
1519295|NCT01514448|3717832|P1|COMPLETED|Overall Study||4
1519296|NCT01514448|3717831|P2|Full Analysis Set (FAS)|Overall Study||13
1519297|NCT01514448|3717832|P1|Full Analysis Set (FAS)|Overall Study||12
1519298|NCT01514448|3717831|P2|STARTED|Overall Study||13
1519299|NCT01514448|3717832|P1|STARTED|Overall Study||16
1519300|NCT01514422|3717847|P1|NOT COMPLETED|Overall Study||1
1519301|NCT01514422|3717847|P1|COMPLETED|Overall Study||19
1519302|NCT01514422|3717847|P1|STARTED|Overall Study||20
1519303|NCT01514396|3717853|P1|NOT COMPLETED|Overall Study||0
1519304|NCT01514396|3717853|P1|COMPLETED|Overall Study||8
1519305|NCT01514396|3717853|P1|STARTED|Overall Study||8
1519306|NCT01514357|3717860|P2|NOT COMPLETED|Overall Study||0
1519307|NCT01514357|3717861|P1|NOT COMPLETED|Overall Study||4
1519308|NCT01514357|3717860|P2|COMPLETED|Overall Study||0
1519309|NCT01514357|3717861|P1|COMPLETED|Overall Study||8
1519310|NCT01514357|3717860|P2|STARTED|Overall Study||0
1519311|NCT01514357|3717861|P1|STARTED|Overall Study||12
1519312|NCT01514318|3717867|P1|NOT COMPLETED|Overall Study||0
1519313|NCT01514318|3717867|P1|COMPLETED|Overall Study||8
1519314|NCT01514318|3717867|P1|STARTED|Overall Study||8
1519315|NCT01514292|3717873|P1|NOT COMPLETED|Overall Study||0
1519316|NCT01514292|3717873|P1|COMPLETED|Overall Study||72
1519317|NCT01514292|3717873|P1|STARTED|Overall Study||72
1519318|NCT01514240|3717879|P2|NOT COMPLETED|Overall Study||11
1519319|NCT01514240|3717880|P1|NOT COMPLETED|Overall Study||6
1519320|NCT01514240|3717879|P2|COMPLETED|Overall Study||45
1519321|NCT01514240|3717880|P1|COMPLETED|Overall Study||50
1519322|NCT01514240|3717879|P2|STARTED|Overall Study||56
1519323|NCT01514240|3717880|P1|STARTED|Overall Study||56
1519324|NCT01514162|3717954|P1|NOT COMPLETED|Overall Study||85
1519325|NCT01514162|3717954|P1|COMPLETED|Overall Study||160
1519326|NCT01514162|3717954|P1|STARTED|Overall Study||245
1519327|NCT01514149|3717965|P5|NOT COMPLETED|Overall Study||1
1519328|NCT01514149|3717966|P4|NOT COMPLETED|Overall Study||1
1519329|NCT01514149|3717967|P3|NOT COMPLETED|Overall Study||3
1519330|NCT01514149|3717968|P2|NOT COMPLETED|Overall Study||1
1519331|NCT01514149|3717969|P1|NOT COMPLETED|Overall Study||3
1519332|NCT01514149|3717965|P5|COMPLETED|Overall Study||14
1519333|NCT01514149|3717966|P4|COMPLETED|Overall Study||13
1519334|NCT01514149|3717967|P3|COMPLETED|Overall Study||11
1519335|NCT01514149|3717968|P2|COMPLETED|Overall Study||14
1519336|NCT01514149|3717969|P1|COMPLETED|Overall Study||12
1519337|NCT01514149|3717965|P5|STARTED|Overall Study||15
1519338|NCT01514149|3717966|P4|STARTED|Overall Study||14
1519339|NCT01514149|3717967|P3|STARTED|Overall Study||14
1519340|NCT01514149|3717968|P2|STARTED|Overall Study||15
1519341|NCT01514149|3717969|P1|STARTED|Overall Study||15
1519342|NCT01514136|3717993|P8|NOT COMPLETED|Test Period; Test D*||0
1519343|NCT01514136|3717994|P7|NOT COMPLETED|Test Period; Test D*||0
1519344|NCT01514136|3717995|P6|NOT COMPLETED|Test Period; Test D*||0
1519345|NCT01514136|3717996|P5|NOT COMPLETED|Test Period; Test D*||0
1519346|NCT01514136|3717997|P4|NOT COMPLETED|Test Period; Test D*||0
1519347|NCT01514136|3717998|P3|NOT COMPLETED|Test Period; Test D*||0
1519348|NCT01514136|3717999|P2|NOT COMPLETED|Test Period; Test D*||0
1519349|NCT01514136|3718000|P1|NOT COMPLETED|Test Period; Test D*||0
1519350|NCT01514136|3717993|P8|COMPLETED|Test Period; Test D*||23
1519351|NCT01514136|3717994|P7|COMPLETED|Test Period; Test D*||0
1519352|NCT01514136|3717995|P6|COMPLETED|Test Period; Test D*||0
1519353|NCT01514136|3717996|P5|COMPLETED|Test Period; Test D*||0
1519354|NCT01514136|3717997|P4|COMPLETED|Test Period; Test D*||0
1519355|NCT01514136|3717998|P3|COMPLETED|Test Period; Test D*||0
1519356|NCT01514136|3717999|P2|COMPLETED|Test Period; Test D*||0
1519357|NCT01514136|3718000|P1|COMPLETED|Test Period; Test D*||0
1519358|NCT01514136|3717993|P8|STARTED|Test Period; Test D*||23
1519359|NCT01514136|3717994|P7|STARTED|Test Period; Test D*||0
1519360|NCT01514136|3717995|P6|STARTED|Test Period; Test D*||0
1519361|NCT01514136|3717996|P5|STARTED|Test Period; Test D*||0
1519362|NCT01514136|3717997|P4|STARTED|Test Period; Test D*||0
1519363|NCT01514136|3717998|P3|STARTED|Test Period; Test D*||0
1519364|NCT01514136|3717999|P2|STARTED|Test Period; Test D*||0
1519365|NCT01514136|3718000|P1|STARTED|Test Period; Test D*||0
1519366|NCT01514136|3717993|P8|NOT COMPLETED|Test Period 2; Test C*||0
1519367|NCT01514136|3717994|P7|NOT COMPLETED|Test Period 2; Test C*||3
1519368|NCT01514136|3717995|P6|NOT COMPLETED|Test Period 2; Test C*||0
1519369|NCT01514136|3717996|P5|NOT COMPLETED|Test Period 2; Test C*||0
1519370|NCT01514136|3717997|P4|NOT COMPLETED|Test Period 2; Test C*||0
1519371|NCT01514136|3717998|P3|NOT COMPLETED|Test Period 2; Test C*||0
1519372|NCT01514136|3717999|P2|NOT COMPLETED|Test Period 2; Test C*||0
1519373|NCT01514136|3718000|P1|NOT COMPLETED|Test Period 2; Test C*||0
1519374|NCT01514136|3717993|P8|COMPLETED|Test Period 2; Test C*||0
1519375|NCT01514136|3717994|P7|COMPLETED|Test Period 2; Test C*||23
1519376|NCT01514136|3717995|P6|COMPLETED|Test Period 2; Test C*||0
1519377|NCT01514136|3717996|P5|COMPLETED|Test Period 2; Test C*||0
1519378|NCT01514136|3717997|P4|COMPLETED|Test Period 2; Test C*||0
1519379|NCT01514136|3717998|P3|COMPLETED|Test Period 2; Test C*||0
1519380|NCT01514136|3717999|P2|COMPLETED|Test Period 2; Test C*||0
1519381|NCT01514136|3718000|P1|COMPLETED|Test Period 2; Test C*||0
1519382|NCT01514136|3717993|P8|STARTED|Test Period 2; Test C*||0
1519383|NCT01514136|3717994|P7|STARTED|Test Period 2; Test C*||26
1519384|NCT01514136|3717995|P6|STARTED|Test Period 2; Test C*||0
1519385|NCT01514136|3717996|P5|STARTED|Test Period 2; Test C*||0
1519386|NCT01514136|3717997|P4|STARTED|Test Period 2; Test C*||0
1519387|NCT01514136|3717998|P3|STARTED|Test Period 2; Test C*||0
1519388|NCT01514136|3717999|P2|STARTED|Test Period 2; Test C*||0
1519389|NCT01514136|3718000|P1|STARTED|Test Period 2; Test C*||0
1519390|NCT01514136|3717993|P8|NOT COMPLETED|Test Period 2; Test B*||0
1519391|NCT01514136|3717994|P7|NOT COMPLETED|Test Period 2; Test B*||0
1519392|NCT01514136|3717995|P6|NOT COMPLETED|Test Period 2; Test B*||2
1519393|NCT01514136|3717996|P5|NOT COMPLETED|Test Period 2; Test B*||0
1519394|NCT01514136|3717997|P4|NOT COMPLETED|Test Period 2; Test B*||0
1519395|NCT01514136|3717998|P3|NOT COMPLETED|Test Period 2; Test B*||0
1519396|NCT01514136|3717999|P2|NOT COMPLETED|Test Period 2; Test B*||0
1519397|NCT01514136|3718000|P1|NOT COMPLETED|Test Period 2; Test B*||0
1519398|NCT01514136|3717993|P8|COMPLETED|Test Period 2; Test B*||0
1519399|NCT01514136|3717994|P7|COMPLETED|Test Period 2; Test B*||0
1519400|NCT01514136|3717995|P6|COMPLETED|Test Period 2; Test B*||26
1519401|NCT01514136|3717996|P5|COMPLETED|Test Period 2; Test B*||0
1519402|NCT01514136|3717997|P4|COMPLETED|Test Period 2; Test B*||0
1519403|NCT01514136|3717998|P3|COMPLETED|Test Period 2; Test B*||0
1519404|NCT01514136|3717999|P2|COMPLETED|Test Period 2; Test B*||0
1519405|NCT01514136|3718000|P1|COMPLETED|Test Period 2; Test B*||0
1519406|NCT01514136|3717993|P8|STARTED|Test Period 2; Test B*||0
1519407|NCT01514136|3717994|P7|STARTED|Test Period 2; Test B*||0
1519408|NCT01514136|3717995|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
1519409|NCT01514136|3717996|P5|STARTED|Test Period 2; Test B*||0
1519410|NCT01514136|3717997|P4|STARTED|Test Period 2; Test B*||0
1519411|NCT01514136|3717998|P3|STARTED|Test Period 2; Test B*||0
1519412|NCT01514136|3717999|P2|STARTED|Test Period 2; Test B*||0
1519413|NCT01514136|3718000|P1|STARTED|Test Period 2; Test B*||0
1519414|NCT01514136|3717993|P8|NOT COMPLETED|Test Period 2; Test A*||0
1519415|NCT01514136|3717994|P7|NOT COMPLETED|Test Period 2; Test A*||0
1519416|NCT01514136|3717995|P6|NOT COMPLETED|Test Period 2; Test A*||0
1519417|NCT01514136|3717996|P5|NOT COMPLETED|Test Period 2; Test A*||2
1519418|NCT01514136|3717997|P4|NOT COMPLETED|Test Period 2; Test A*||0
1519419|NCT01514136|3717998|P3|NOT COMPLETED|Test Period 2; Test A*||0
1519420|NCT01514136|3717999|P2|NOT COMPLETED|Test Period 2; Test A*||0
1519421|NCT01514136|3718000|P1|NOT COMPLETED|Test Period 2; Test A*||0
1519422|NCT01514136|3717993|P8|COMPLETED|Test Period 2; Test A*||0
1519423|NCT01514136|3717994|P7|COMPLETED|Test Period 2; Test A*||0
1519424|NCT01514136|3717995|P6|COMPLETED|Test Period 2; Test A*||0
1519425|NCT01514136|3717996|P5|COMPLETED|Test Period 2; Test A*||26
1519426|NCT01514136|3717997|P4|COMPLETED|Test Period 2; Test A*||0
1519427|NCT01514136|3717998|P3|COMPLETED|Test Period 2; Test A*||0
1519428|NCT01514136|3717999|P2|COMPLETED|Test Period 2; Test A*||0
1519429|NCT01514136|3718000|P1|COMPLETED|Test Period 2; Test A*||0
1519430|NCT01514136|3717993|P8|STARTED|Test Period 2; Test A*||0
1519431|NCT01514136|3717994|P7|STARTED|Test Period 2; Test A*||0
1519432|NCT01514136|3717995|P6|STARTED|Test Period 2; Test A*||0
1519433|NCT01514136|3717996|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
1519434|NCT01514136|3717997|P4|STARTED|Test Period 2; Test A*||0
1519435|NCT01514136|3717998|P3|STARTED|Test Period 2; Test A*||0
1519436|NCT01514136|3717999|P2|STARTED|Test Period 2; Test A*||0
1519437|NCT01514136|3718000|P1|STARTED|Test Period 2; Test A*||0
1519438|NCT01514136|3717993|P8|NOT COMPLETED|Test Period 1; Test D||0
1519439|NCT01514136|3717994|P7|NOT COMPLETED|Test Period 1; Test D||0
1519440|NCT01514136|3717995|P6|NOT COMPLETED|Test Period 1; Test D||0
1519441|NCT01514136|3717996|P5|NOT COMPLETED|Test Period 1; Test D||0
1519442|NCT01514136|3717997|P4|NOT COMPLETED|Test Period 1; Test D||2
1519443|NCT01514136|3717998|P3|NOT COMPLETED|Test Period 1; Test D||0
1519444|NCT01514136|3717999|P2|NOT COMPLETED|Test Period 1; Test D||0
1519445|NCT01514136|3718000|P1|NOT COMPLETED|Test Period 1; Test D||0
1519446|NCT01514136|3717993|P8|COMPLETED|Test Period 1; Test D||0
1519447|NCT01514136|3717994|P7|COMPLETED|Test Period 1; Test D||0
1519448|NCT01514136|3717995|P6|COMPLETED|Test Period 1; Test D||0
1519449|NCT01514136|3717996|P5|COMPLETED|Test Period 1; Test D||0
1519450|NCT01514136|3717997|P4|COMPLETED|Test Period 1; Test D||24
1519451|NCT01514136|3717998|P3|COMPLETED|Test Period 1; Test D||0
1519452|NCT01514136|3717999|P2|COMPLETED|Test Period 1; Test D||0
1519453|NCT01514136|3718000|P1|COMPLETED|Test Period 1; Test D||0
1519454|NCT01514136|3717993|P8|STARTED|Test Period 1; Test D||0
1519455|NCT01514136|3717994|P7|STARTED|Test Period 1; Test D||0
1519456|NCT01514136|3717995|P6|STARTED|Test Period 1; Test D||0
1519457|NCT01514136|3717996|P5|STARTED|Test Period 1; Test D||0
1519458|NCT01514136|3717997|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
1519459|NCT01514136|3717998|P3|STARTED|Test Period 1; Test D||0
1519460|NCT01514136|3717999|P2|STARTED|Test Period 1; Test D||0
1519461|NCT01514136|3718000|P1|STARTED|Test Period 1; Test D||0
1519462|NCT01514136|3717993|P8|NOT COMPLETED|Test Period 1; Test C||0
1519463|NCT01514136|3717994|P7|NOT COMPLETED|Test Period 1; Test C||0
1519464|NCT01514136|3717995|P6|NOT COMPLETED|Test Period 1; Test C||0
1519465|NCT01514136|3717996|P5|NOT COMPLETED|Test Period 1; Test C||0
1519466|NCT01514136|3717997|P4|NOT COMPLETED|Test Period 1; Test C||0
1519467|NCT01514136|3717998|P3|NOT COMPLETED|Test Period 1; Test C||0
1519468|NCT01514136|3717999|P2|NOT COMPLETED|Test Period 1; Test C||0
1519469|NCT01514136|3718000|P1|NOT COMPLETED|Test Period 1; Test C||0
1519470|NCT01514136|3717993|P8|COMPLETED|Test Period 1; Test C||0
1519471|NCT01514136|3717994|P7|COMPLETED|Test Period 1; Test C||0
1519472|NCT01514136|3717995|P6|COMPLETED|Test Period 1; Test C||0
1519473|NCT01514136|3717996|P5|COMPLETED|Test Period 1; Test C||0
1519474|NCT01514136|3717997|P4|COMPLETED|Test Period 1; Test C||0
1519475|NCT01514136|3717998|P3|COMPLETED|Test Period 1; Test C||24
1519476|NCT01514136|3717999|P2|COMPLETED|Test Period 1; Test C||0
1519477|NCT01514136|3718000|P1|COMPLETED|Test Period 1; Test C||0
1519478|NCT01514136|3717993|P8|STARTED|Test Period 1; Test C||0
1519479|NCT01514136|3717994|P7|STARTED|Test Period 1; Test C||0
1519480|NCT01514136|3717995|P6|STARTED|Test Period 1; Test C||0
1519481|NCT01514136|3717996|P5|STARTED|Test Period 1; Test C||0
1519482|NCT01514136|3717997|P4|STARTED|Test Period 1; Test C||0
1519483|NCT01514136|3717998|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
1519484|NCT01514136|3717999|P2|STARTED|Test Period 1; Test C||0
1519485|NCT01514136|3718000|P1|STARTED|Test Period 1; Test C||0
1519486|NCT01514136|3717993|P8|NOT COMPLETED|Test Period 1; Test B||0
1519487|NCT01514136|3717994|P7|NOT COMPLETED|Test Period 1; Test B||0
1519488|NCT01514136|3717995|P6|NOT COMPLETED|Test Period 1; Test B||0
1519489|NCT01514136|3717996|P5|NOT COMPLETED|Test Period 1; Test B||0
1519490|NCT01514136|3717997|P4|NOT COMPLETED|Test Period 1; Test B||0
1519491|NCT01514136|3717998|P3|NOT COMPLETED|Test Period 1; Test B||0
1519492|NCT01514136|3717999|P2|NOT COMPLETED|Test Period 1; Test B||1
1519493|NCT01514136|3718000|P1|NOT COMPLETED|Test Period 1; Test B||0
1519494|NCT01514136|3717993|P8|COMPLETED|Test Period 1; Test B||0
1519495|NCT01514136|3717994|P7|COMPLETED|Test Period 1; Test B||0
1519496|NCT01514136|3717995|P6|COMPLETED|Test Period 1; Test B||0
1519497|NCT01514136|3717996|P5|COMPLETED|Test Period 1; Test B||0
1519498|NCT01514136|3717997|P4|COMPLETED|Test Period 1; Test B||0
1519499|NCT01514136|3717998|P3|COMPLETED|Test Period 1; Test B||0
1519500|NCT01514136|3717999|P2|COMPLETED|Test Period 1; Test B||23
1519501|NCT01514136|3718000|P1|COMPLETED|Test Period 1; Test B||0
1519502|NCT01514136|3717993|P8|STARTED|Test Period 1; Test B||0
1519503|NCT01514136|3717994|P7|STARTED|Test Period 1; Test B||0
1519504|NCT01514136|3717995|P6|STARTED|Test Period 1; Test B||0
1519505|NCT01514136|3717996|P5|STARTED|Test Period 1; Test B||0
1519506|NCT01514136|3717997|P4|STARTED|Test Period 1; Test B||0
1519507|NCT01514136|3717998|P3|STARTED|Test Period 1; Test B||0
1519508|NCT01514136|3717999|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
1519509|NCT01514136|3718000|P1|STARTED|Test Period 1; Test B||0
1519510|NCT01514136|3717993|P8|NOT COMPLETED|Test Period 1; Test A||0
1519511|NCT01514136|3717994|P7|NOT COMPLETED|Test Period 1; Test A||0
1519512|NCT01514136|3717995|P6|NOT COMPLETED|Test Period 1; Test A||0
1519513|NCT01514136|3717996|P5|NOT COMPLETED|Test Period 1; Test A||0
1519514|NCT01514136|3717997|P4|NOT COMPLETED|Test Period 1; Test A||0
1519515|NCT01514136|3717998|P3|NOT COMPLETED|Test Period 1; Test A||0
1519516|NCT01514136|3717999|P2|NOT COMPLETED|Test Period 1; Test A||0
1519517|NCT01514136|3718000|P1|NOT COMPLETED|Test Period 1; Test A||3
1519518|NCT01514136|3717993|P8|COMPLETED|Test Period 1; Test A||0
1519519|NCT01514136|3717994|P7|COMPLETED|Test Period 1; Test A||0
1519520|NCT01514136|3717995|P6|COMPLETED|Test Period 1; Test A||0
1519521|NCT01514136|3717996|P5|COMPLETED|Test Period 1; Test A||0
1519522|NCT01514136|3717997|P4|COMPLETED|Test Period 1; Test A||0
1519523|NCT01514136|3717998|P3|COMPLETED|Test Period 1; Test A||0
1519524|NCT01514136|3717999|P2|COMPLETED|Test Period 1; Test A||0
1519525|NCT01514136|3718000|P1|COMPLETED|Test Period 1; Test A||22
1519526|NCT01514136|3717993|P8|STARTED|Test Period 1; Test A||0
1519527|NCT01514136|3717994|P7|STARTED|Test Period 1; Test A||0
1519528|NCT01514136|3717995|P6|STARTED|Test Period 1; Test A||0
1519529|NCT01514136|3717996|P5|STARTED|Test Period 1; Test A||0
1519530|NCT01514136|3717997|P4|STARTED|Test Period 1; Test A||0
1519531|NCT01514136|3717998|P3|STARTED|Test Period 1; Test A||0
1519532|NCT01514136|3717999|P2|STARTED|Test Period 1; Test A||0
1519533|NCT01514136|3718000|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
1519534|NCT01513902|3718029|P3|NOT COMPLETED|Overall Study||0
1519535|NCT01513902|3718030|P2|NOT COMPLETED|Overall Study||0
1519536|NCT01513902|3718031|P1|NOT COMPLETED|Overall Study||0
1519537|NCT01513902|3718029|P3|COMPLETED|Overall Study||9
1519538|NCT01513902|3718030|P2|COMPLETED|Overall Study||9
1519539|NCT01513902|3718031|P1|COMPLETED|Overall Study||8
1519540|NCT01513902|3718029|P3|STARTED|Overall Study||9
1519541|NCT01513902|3718030|P2|STARTED|Overall Study||9
1519542|NCT01513902|3718031|P1|STARTED|Overall Study||8
1519543|NCT01513590|3718068|P2|NOT COMPLETED|Overall Study||13
1519544|NCT01513590|3718069|P1|NOT COMPLETED|Overall Study||10
1519545|NCT01513590|3718068|P2|COMPLETED|Overall Study||184
1519546|NCT01513590|3718069|P1|COMPLETED|Overall Study||187
1519547|NCT01513590|3718068|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
1519548|NCT01513590|3718069|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
1519549|NCT01513590|3718068|P2|STARTED|Overall Study||197
1519550|NCT01513590|3718069|P1|STARTED|Overall Study||197
1519551|NCT01513551|3718090|P3|NOT COMPLETED|Overall Study||5
1519552|NCT01513551|3718091|P2|NOT COMPLETED|Overall Study||6
1519553|NCT01513551|3718092|P1|NOT COMPLETED|Overall Study||4
1519554|NCT01513551|3718090|P3|COMPLETED|Overall Study||226
1519555|NCT01513551|3718091|P2|COMPLETED|Overall Study||225
1519556|NCT01513551|3718092|P1|COMPLETED|Overall Study||226
1519557|NCT01513551|3718090|P3|Vaccinated|Overall Study||230
1519558|NCT01513551|3718091|P2|Vaccinated|Overall Study||231
1519559|NCT01513551|3718092|P1|Vaccinated|Overall Study||230
1519560|NCT01513551|3718090|P3|STARTED|Overall Study||231
1519561|NCT01513551|3718091|P2|STARTED|Overall Study||231
1519562|NCT01513551|3718092|P1|STARTED|Overall Study||230
1519563|NCT01513538|3718118|P1|NOT COMPLETED|Overall Study||5
1519564|NCT01513538|3718118|P1|COMPLETED|Overall Study||573
1519565|NCT01513538|3718118|P1|STARTED|Overall Study||578
1519566|NCT01513473|3718124|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
1519567|NCT01513473|3718125|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
1519568|NCT01513473|3718124|P2|COMPLETED|Extension Trial (26 Weeks)||122
1519569|NCT01513473|3718125|P1|COMPLETED|Extension Trial (26 Weeks)||151
1519570|NCT01513473|3718124|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
1519571|NCT01513473|3718125|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
1519572|NCT01513473|3718124|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
1519573|NCT01513473|3718125|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
1519574|NCT01513473|3718124|P2|COMPLETED|Main Trial (26 Weeks)||165
1519575|NCT01513473|3718125|P1|COMPLETED|Main Trial (26 Weeks)||170
1519576|NCT01513473|3718124|P2|Exposed|Main Trial (26 Weeks)||175
1519577|NCT01513473|3718125|P1|Exposed|Main Trial (26 Weeks)||174
1519578|NCT01513473|3718124|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
1519579|NCT01513473|3718125|P1|STARTED|Main Trial (26 Weeks)||174
1519580|NCT01513460|3718152|P3|NOT COMPLETED|Overall Study||56
1519581|NCT01513460|3718153|P2|NOT COMPLETED|Overall Study||32
1519582|NCT01513460|3718154|P1|NOT COMPLETED|Overall Study||29
1519583|NCT01513460|3718152|P3|COMPLETED|Overall Study||201
1519584|NCT01513460|3718153|P2|COMPLETED|Overall Study||226
1519585|NCT01513460|3718154|P1|COMPLETED|Overall Study||229
1519586|NCT01513460|3718152|P3|Per-protocol Set|Overall Study||166
1519587|NCT01513460|3718153|P2|Per-protocol Set|Overall Study||186
1519588|NCT01513460|3718154|P1|Per-protocol Set|Overall Study||196
1519589|NCT01513460|3718152|P3|Full Analysis Set|Overall Study||257
1519590|NCT01513460|3718153|P2|Full Analysis Set|Overall Study||258
1519591|NCT01513460|3718154|P1|Full Analysis Set|Overall Study||257
1519592|NCT01513460|3718152|P3|STARTED|Overall Study||257
1519593|NCT01513460|3718153|P2|STARTED|Overall Study||258
1519594|NCT01513460|3718154|P1|STARTED|Overall Study||258
1519595|NCT01513447|3718180|P2|NOT COMPLETED|Overall Study||0
1519596|NCT01513447|3718181|P1|NOT COMPLETED|Overall Study||0
1519597|NCT01513447|3718180|P2|COMPLETED|Overall Study||5
1519598|NCT01513447|3718181|P1|COMPLETED|Overall Study||3
1519599|NCT01513447|3718180|P2|STARTED|Overall Study||5
1519600|NCT01513447|3718181|P1|STARTED|Overall Study||3
1519601|NCT01513330|3718189|P2|NOT COMPLETED|Standard Care First,||4
1519602|NCT01513330|3718190|P1|NOT COMPLETED|Standard Care First,||4
1519603|NCT01513330|3718189|P2|COMPLETED|Standard Care First,||52
1519604|NCT01513330|3718190|P1|COMPLETED|Standard Care First,||56
1519605|NCT01513330|3718189|P2|STARTED|Standard Care First,||56
1519606|NCT01513330|3718190|P1|STARTED|Standard Care First,||60
1519607|NCT01513330|3718189|P2|NOT COMPLETED|SenSura Mio First,||2
1519608|NCT01513330|3718190|P1|NOT COMPLETED|SenSura Mio First,||4
1519609|NCT01513330|3718189|P2|COMPLETED|SenSura Mio First,||56
1519610|NCT01513330|3718190|P1|COMPLETED|SenSura Mio First,||60
1519611|NCT01513330|3718189|P2|STARTED|SenSura Mio First,||58
1519612|NCT01513330|3718190|P1|STARTED|SenSura Mio First,||64
1519613|NCT01513317|3718198|P2|NOT COMPLETED|Overall Study||24
1519614|NCT01513317|3718199|P1|NOT COMPLETED|Overall Study||34
1519615|NCT01513317|3718198|P2|COMPLETED|Overall Study||2
1519616|NCT01513317|3718199|P1|COMPLETED|Overall Study||16
1519617|NCT01513317|3718198|P2|STARTED|Overall Study||26
1519618|NCT01513317|3718199|P1|STARTED|Overall Study||50
1519619|NCT01513291|3718217|P5|NOT COMPLETED|Run-out Period||0
1519620|NCT01513291|3718218|P4|NOT COMPLETED|Run-out Period||2
1519621|NCT01513291|3718219|P3|NOT COMPLETED|Run-out Period||0
1519622|NCT01513291|3718220|P2|NOT COMPLETED|Run-out Period||0
1519623|NCT01513291|3718221|P1|NOT COMPLETED|Run-out Period||0
1519624|NCT01513291|3718217|P5|COMPLETED|Run-out Period||101
1519625|NCT01513291|3718218|P4|COMPLETED|Run-out Period||45
1519626|NCT01513291|3718219|P3|COMPLETED|Run-out Period||50
1519627|NCT01513291|3718220|P2|COMPLETED|Run-out Period||0
1519628|NCT01513291|3718221|P1|COMPLETED|Run-out Period||0
1519629|NCT01513291|3718217|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
1519630|NCT01513291|3718218|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
1519631|NCT01513291|3718219|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
1519632|NCT01513291|3718220|P2|STARTED|Run-out Period||0
1519633|NCT01513291|3718221|P1|STARTED|Run-out Period||0
1519634|NCT01513291|3718217|P5|NOT COMPLETED|Treatment Period||0
1519635|NCT01513291|3718218|P4|NOT COMPLETED|Treatment Period||0
1519636|NCT01513291|3718219|P3|NOT COMPLETED|Treatment Period||0
1519637|NCT01513291|3718220|P2|NOT COMPLETED|Treatment Period||16
1519638|NCT01513291|3718221|P1|NOT COMPLETED|Treatment Period||23
1519639|NCT01513291|3718217|P5|COMPLETED|Treatment Period||0
1519640|NCT01513291|3718218|P4|COMPLETED|Treatment Period||0
1519641|NCT01513291|3718219|P3|COMPLETED|Treatment Period||0
1519642|NCT01513291|3718220|P2|COMPLETED|Treatment Period||101
1519643|NCT01513291|3718221|P1|COMPLETED|Treatment Period||97
1519644|NCT01513291|3718217|P5|Treated|Treatment Period||0
1519645|NCT01513291|3718218|P4|Treated|Treatment Period||0
1519646|NCT01513291|3718219|P3|Treated|Treatment Period||0
1519647|NCT01513291|3718220|P2|Treated|Treatment Period||115
1519648|NCT01513291|3718221|P1|Treated|Treatment Period||120
1519649|NCT01513291|3718217|P5|STARTED|Treatment Period||0
1519650|NCT01513291|3718218|P4|STARTED|Treatment Period||0
1519651|NCT01513291|3718219|P3|STARTED|Treatment Period||0
1519652|NCT01513291|3718220|P2|STARTED|Treatment Period||117
1519653|NCT01513291|3718221|P1|STARTED|Treatment Period||120
1519654|NCT01513239|3718249|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
1519655|NCT01513239|3718250|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
1519656|NCT01513239|3718251|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
1519657|NCT01513239|3718252|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
1519658|NCT01513239|3718253|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
1519659|NCT01513239|3718254|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
1519660|NCT01513239|3718249|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
1519661|NCT01513239|3718250|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
1519662|NCT01513239|3718251|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
1519663|NCT01513239|3718252|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
1519664|NCT01513239|3718253|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
1519665|NCT01513239|3718254|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
1519666|NCT01513239|3718249|P6|STARTED|Period 2: 9 Month Extension Phase||83
1519667|NCT01513239|3718250|P5|STARTED|Period 2: 9 Month Extension Phase||100
1519668|NCT01513239|3718251|P4|STARTED|Period 2: 9 Month Extension Phase||112
1519669|NCT01513239|3718252|P3|STARTED|Period 2: 9 Month Extension Phase||0
1519670|NCT01513239|3718253|P2|STARTED|Period 2: 9 Month Extension Phase||0
1519671|NCT01513239|3718254|P1|STARTED|Period 2: 9 Month Extension Phase||0
1519672|NCT01513239|3718249|P6|NOT COMPLETED|Period 1: Main Phase||0
1519673|NCT01513239|3718250|P5|NOT COMPLETED|Period 1: Main Phase||0
1519674|NCT01513239|3718251|P4|NOT COMPLETED|Period 1: Main Phase||0
1519675|NCT01513239|3718252|P3|NOT COMPLETED|Period 1: Main Phase||88
1519676|NCT01513239|3718253|P2|NOT COMPLETED|Period 1: Main Phase||70
1519677|NCT01513239|3718254|P1|NOT COMPLETED|Period 1: Main Phase||75
1519678|NCT01513239|3718249|P6|COMPLETED|Period 1: Main Phase||0
1519679|NCT01513239|3718250|P5|COMPLETED|Period 1: Main Phase||0
1519680|NCT01513239|3718251|P4|COMPLETED|Period 1: Main Phase||0
1519681|NCT01513239|3718252|P3|COMPLETED|Period 1: Main Phase||311
1519682|NCT01513239|3718253|P2|COMPLETED|Period 1: Main Phase||337
1519683|NCT01513239|3718254|P1|COMPLETED|Period 1: Main Phase||322
1519684|NCT01513239|3718249|P6|All Participants as Treated|Period 1: Main Phase||0
1519685|NCT01513239|3718250|P5|All Participants as Treated|Period 1: Main Phase||0
1519686|NCT01513239|3718251|P4|All Participants as Treated|Period 1: Main Phase||0
1519687|NCT01513239|3718252|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
1519688|NCT01513239|3718253|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
1519689|NCT01513239|3718254|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
1519690|NCT01513239|3718249|P6|Treated|Period 1: Main Phase||0
1519691|NCT01513239|3718250|P5|Treated|Period 1: Main Phase||0
1519692|NCT01513239|3718251|P4|Treated|Period 1: Main Phase||0
1519693|NCT01513239|3718252|P3|Treated|Period 1: Main Phase|Treated participants|381
1519694|NCT01513239|3718253|P2|Treated|Period 1: Main Phase|Treated participants|396
1519695|NCT01513239|3718254|P1|Treated|Period 1: Main Phase|Treated participants|391
1519696|NCT01513239|3718249|P6|STARTED|Period 1: Main Phase||0
1519697|NCT01513239|3718250|P5|STARTED|Period 1: Main Phase||0
1519698|NCT01513239|3718251|P4|STARTED|Period 1: Main Phase||0
1519699|NCT01513239|3718252|P3|STARTED|Period 1: Main Phase|Randomized participants|399
1519700|NCT01513239|3718253|P2|STARTED|Period 1: Main Phase|Randomized participants|407
1519701|NCT01513239|3718254|P1|STARTED|Period 1: Main Phase|Randomized participants|397
1519702|NCT01513148|3718307|P2|NOT COMPLETED|Overall Study||2
1519703|NCT01513148|3718308|P1|NOT COMPLETED|Overall Study||2
1519704|NCT01513148|3718307|P2|COMPLETED|Overall Study||14
1519705|NCT01513148|3718308|P1|COMPLETED|Overall Study||14
1519706|NCT01513148|3718307|P2|STARTED|Overall Study||16
1519707|NCT01513148|3718308|P1|STARTED|Overall Study||16
1519708|NCT01513122|3718356|P2|NOT COMPLETED|Overall Study||3
1519709|NCT01513122|3718357|P1|NOT COMPLETED|Overall Study||11
1519710|NCT01513122|3718356|P2|COMPLETED|Overall Study||105
1519711|NCT01513122|3718357|P1|COMPLETED|Overall Study||91
1519712|NCT01513122|3718356|P2|STARTED|Overall Study||108
1519713|NCT01513122|3718357|P1|STARTED|Overall Study||102
1519714|NCT01512979|3718375|P2|NOT COMPLETED|Overall Study||22
1519715|NCT01512979|3718376|P1|NOT COMPLETED|Overall Study||19
1519716|NCT01512979|3718375|P2|COMPLETED|Overall Study||135
1519717|NCT01512979|3718376|P1|COMPLETED|Overall Study||140
1519718|NCT01512979|3718375|P2|STARTED|Overall Study|Randomised and treated|157
1519719|NCT01512979|3718376|P1|STARTED|Overall Study|Randomised and treated|159
1519720|NCT01512849|3718396|P4|NOT COMPLETED|Crossover Period 2||0
1519721|NCT01512849|3718397|P3|NOT COMPLETED|Crossover Period 2||0
1519722|NCT01512849|3718398|P2|NOT COMPLETED|Crossover Period 2||0
1519723|NCT01512849|3718399|P1|NOT COMPLETED|Crossover Period 2||0
1519724|NCT01512849|3718396|P4|COMPLETED|Crossover Period 2||6
1519725|NCT01512849|3718397|P3|COMPLETED|Crossover Period 2||6
1519726|NCT01512849|3718398|P2|COMPLETED|Crossover Period 2||6
1519727|NCT01512849|3718399|P1|COMPLETED|Crossover Period 2||6
1519728|NCT01512849|3718396|P4|STARTED|Crossover Period 2||6
1519729|NCT01512849|3718397|P3|STARTED|Crossover Period 2||6
1519730|NCT01512849|3718398|P2|STARTED|Crossover Period 2||6
1519731|NCT01512849|3718399|P1|STARTED|Crossover Period 2||6
1519732|NCT01512849|3718396|P4|NOT COMPLETED|Crossover Period 1||0
1519733|NCT01512849|3718397|P3|NOT COMPLETED|Crossover Period 1||0
1519734|NCT01512849|3718398|P2|NOT COMPLETED|Crossover Period 1||0
1519735|NCT01512849|3718399|P1|NOT COMPLETED|Crossover Period 1||0
1519736|NCT01512849|3718396|P4|COMPLETED|Crossover Period 1||6
1519737|NCT01512849|3718397|P3|COMPLETED|Crossover Period 1||6
1519738|NCT01512849|3718398|P2|COMPLETED|Crossover Period 1||6
1519739|NCT01512849|3718399|P1|COMPLETED|Crossover Period 1||6
1519740|NCT01512849|3718396|P4|STARTED|Crossover Period 1||6
1519741|NCT01512849|3718397|P3|STARTED|Crossover Period 1||6
1519742|NCT01512849|3718398|P2|STARTED|Crossover Period 1||6
1519743|NCT01512849|3718399|P1|STARTED|Crossover Period 1||6
1519744|NCT01512797|3718423|P2|NOT COMPLETED|Overall Study||0
1519745|NCT01512797|3718424|P1|NOT COMPLETED|Overall Study||0
1519746|NCT01512797|3718423|P2|COMPLETED|Overall Study||16
1519747|NCT01512797|3718424|P1|COMPLETED|Overall Study||16
1519748|NCT01512797|3718423|P2|STARTED|Overall Study||16
1519749|NCT01512797|3718424|P1|STARTED|Overall Study||16
1519750|NCT01512745|3718440|P2|NOT COMPLETED|Overall Study||20
1519751|NCT01512745|3718441|P1|NOT COMPLETED|Overall Study||40
1519752|NCT01512745|3718440|P2|COMPLETED|Overall Study||71
1519753|NCT01512745|3718441|P1|COMPLETED|Overall Study||136
1519754|NCT01512745|3718440|P2|STARTED|Overall Study||91
1519755|NCT01512745|3718441|P1|STARTED|Overall Study||176
1519756|NCT01512693|3718457|P2|NOT COMPLETED|Overall Study||1
1519757|NCT01512693|3718458|P1|NOT COMPLETED|Overall Study||0
1519758|NCT01512693|3718457|P2|COMPLETED|Overall Study||8
1519759|NCT01512693|3718458|P1|COMPLETED|Overall Study||8
1519760|NCT01512693|3718457|P2|STARTED|Overall Study||9
1519761|NCT01512693|3718458|P1|STARTED|Overall Study||8
1519762|NCT01512667|3718472|P2|NOT COMPLETED|Overall Study||0
1519763|NCT01512667|3718473|P1|NOT COMPLETED|Overall Study||0
1519764|NCT01512667|3718472|P2|COMPLETED|Overall Study||12
1519765|NCT01512667|3718473|P1|COMPLETED|Overall Study||13
1519766|NCT01512667|3718472|P2|Unmatched Participants|Overall Study||0
1519767|NCT01512667|3718473|P1|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
1519768|NCT01512667|3718472|P2|Matched Participants|Overall Study||12
1519769|NCT01512667|3718473|P1|Matched Participants|Overall Study||12
1519770|NCT01512667|3718472|P2|STARTED|Overall Study||12
1519771|NCT01512667|3718473|P1|STARTED|Overall Study||13
1519772|NCT01512368|3718485|P1|NOT COMPLETED|Overall Study||3
1519773|NCT01512368|3718485|P1|COMPLETED|Overall Study||60
1519774|NCT01512368|3718485|P1|STARTED|Overall Study||63
1519775|NCT01512251|3718496|P2|NOT COMPLETED|Phase II||0
1519776|NCT01512251|3718497|P1|NOT COMPLETED|Phase II||0
1519777|NCT01512251|3718496|P2|COMPLETED|Phase II||0
1519778|NCT01512251|3718497|P1|COMPLETED|Phase II||0
1519779|NCT01512251|3718496|P2|STARTED|Phase II||0
1519780|NCT01512251|3718497|P1|STARTED|Phase II||0
1519781|NCT01512251|3718496|P2|NOT COMPLETED|Phase I, Dose 4||0
1519782|NCT01512251|3718497|P1|NOT COMPLETED|Phase I, Dose 4||0
1519783|NCT01512251|3718496|P2|COMPLETED|Phase I, Dose 4||0
1519784|NCT01512251|3718497|P1|COMPLETED|Phase I, Dose 4||0
1519785|NCT01512251|3718496|P2|STARTED|Phase I, Dose 4||0
1519786|NCT01512251|3718497|P1|STARTED|Phase I, Dose 4||0
1519787|NCT01512251|3718496|P2|NOT COMPLETED|Phase I, Dose 3||0
1519788|NCT01512251|3718497|P1|NOT COMPLETED|Phase I, Dose 3||0
1519789|NCT01512251|3718496|P2|COMPLETED|Phase I, Dose 3||0
1519790|NCT01512251|3718497|P1|COMPLETED|Phase I, Dose 3||0
1519791|NCT01512251|3718496|P2|STARTED|Phase I, Dose 3||0
1519792|NCT01512251|3718497|P1|STARTED|Phase I, Dose 3||0
1519793|NCT01512251|3718496|P2|NOT COMPLETED|Phase I, Dose 2||0
1519794|NCT01512251|3718497|P1|NOT COMPLETED|Phase I, Dose 2||0
1519795|NCT01512251|3718496|P2|COMPLETED|Phase I, Dose 2||0
1519796|NCT01512251|3718497|P1|COMPLETED|Phase I, Dose 2||0
1519797|NCT01512251|3718496|P2|STARTED|Phase I, Dose 2||0
1519798|NCT01512251|3718497|P1|STARTED|Phase I, Dose 2||0
1519799|NCT01512251|3718496|P2|NOT COMPLETED|Phase I, Dose 1||5
1519800|NCT01512251|3718497|P1|NOT COMPLETED|Phase I, Dose 1||3
1519801|NCT01512251|3718496|P2|COMPLETED|Phase I, Dose 1||0
1519802|NCT01512251|3718497|P1|COMPLETED|Phase I, Dose 1||0
1519803|NCT01512251|3718496|P2|STARTED|Phase I, Dose 1||5
1519804|NCT01512251|3718497|P1|STARTED|Phase I, Dose 1||3
1519805|NCT01512251|3718496|P2|NOT COMPLETED|Dose Level -1||0
1519806|NCT01512251|3718497|P1|NOT COMPLETED|Dose Level -1||0
1519807|NCT01512251|3718496|P2|COMPLETED|Dose Level -1||5
1519808|NCT01512251|3718497|P1|COMPLETED|Dose Level -1||3
1519809|NCT01512251|3718496|P2|STARTED|Dose Level -1||5
1519810|NCT01512251|3718497|P1|STARTED|Dose Level -1||3
1519811|NCT01512225|3718518|P2|NOT COMPLETED|Overall Study||0
1519812|NCT01512225|3718519|P1|NOT COMPLETED|Overall Study||0
1519813|NCT01512225|3718518|P2|COMPLETED|Overall Study||45
1519814|NCT01512225|3718519|P1|COMPLETED|Overall Study||45
1519815|NCT01512225|3718518|P2|Provided Day 14 Volume|Overall Study||40
1519816|NCT01512225|3718519|P1|Provided Day 14 Volume|Overall Study||45
1519817|NCT01512225|3718518|P2|STARTED|Overall Study||45
1519818|NCT01512225|3718519|P1|STARTED|Overall Study||45
1519819|NCT01512160|3718543|P4|NOT COMPLETED|Overall Study||1
1519820|NCT01512160|3718544|P3|NOT COMPLETED|Overall Study||0
1519821|NCT01512160|3718545|P2|NOT COMPLETED|Overall Study||0
1519822|NCT01512160|3718546|P1|NOT COMPLETED|Overall Study||2
1519823|NCT01512160|3718543|P4|COMPLETED|Overall Study||22
1519824|NCT01512160|3718544|P3|COMPLETED|Overall Study||22
1519825|NCT01512160|3718545|P2|COMPLETED|Overall Study||23
1519826|NCT01512160|3718546|P1|COMPLETED|Overall Study||20
1519827|NCT01512160|3718543|P4|STARTED|Overall Study||23
1519828|NCT01512160|3718544|P3|STARTED|Overall Study||22
1519829|NCT01512160|3718545|P2|STARTED|Overall Study||23
1519830|NCT01512160|3718546|P1|STARTED|Overall Study||22
1519831|NCT01512108|3718638|P2|NOT COMPLETED|Overall Study||9
1519832|NCT01512108|3718639|P1|NOT COMPLETED|Overall Study||22
1519833|NCT01512108|3718638|P2|COMPLETED|Overall Study||111
1519834|NCT01512108|3718639|P1|COMPLETED|Overall Study||221
1519835|NCT01512108|3718638|P2|Exposed|Overall Study||120
1519836|NCT01512108|3718639|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
1519837|NCT01512108|3718638|P2|STARTED|Overall Study||120
1519838|NCT01512108|3718639|P1|STARTED|Overall Study||243
1519839|NCT01511978|3718653|P2|NOT COMPLETED|Overall Study||0
1519840|NCT01511978|3718654|P1|NOT COMPLETED|Overall Study||0
1519841|NCT01511978|3718653|P2|COMPLETED|Overall Study||18
1519842|NCT01511978|3718654|P1|COMPLETED|Overall Study||14
1519843|NCT01511978|3718653|P2|STARTED|Overall Study||18
1519844|NCT01511978|3718654|P1|STARTED|Overall Study||14
1519845|NCT01511939|3718665|P3|NOT COMPLETED|Overall Study||0
1519846|NCT01511939|3718666|P2|NOT COMPLETED|Overall Study||1
1519847|NCT01511939|3718667|P1|NOT COMPLETED|Overall Study||2
1519848|NCT01511939|3718665|P3|COMPLETED|Overall Study||8
1519849|NCT01511939|3718666|P2|COMPLETED|Overall Study||4
1519850|NCT01511939|3718667|P1|COMPLETED|Overall Study||7
1519851|NCT01511939|3718665|P3|STARTED|Overall Study||8
1519852|NCT01511939|3718666|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
1519853|NCT01511939|3718667|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
1519854|NCT01511809|3718686|P2|NOT COMPLETED|Overall Study||7
1519855|NCT01511809|3718687|P1|NOT COMPLETED|Overall Study||7
1519856|NCT01511809|3718686|P2|COMPLETED|Overall Study||52
1519857|NCT01511809|3718687|P1|COMPLETED|Overall Study||51
1519858|NCT01511809|3718686|P2|STARTED|Overall Study||59
1519859|NCT01511809|3718687|P1|STARTED|Overall Study||58
1519860|NCT01511536|3718696|P3|NOT COMPLETED|Phase 2||9
1519861|NCT01511536|3718697|P2|NOT COMPLETED|Phase 2||0
1519862|NCT01511536|3718698|P1|NOT COMPLETED|Phase 2||0
1519863|NCT01511536|3718696|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
1519864|NCT01511536|3718697|P2|COMPLETED|Phase 2||0
1519865|NCT01511536|3718698|P1|COMPLETED|Phase 2||0
1519866|NCT01511536|3718696|P3|STARTED|Phase 2||27
1519867|NCT01511536|3718697|P2|STARTED|Phase 2||0
1519868|NCT01511536|3718698|P1|STARTED|Phase 2||0
1519869|NCT01511536|3718696|P3|NOT COMPLETED|Phase 1||0
1519870|NCT01511536|3718697|P2|NOT COMPLETED|Phase 1||1
1519871|NCT01511536|3718698|P1|NOT COMPLETED|Phase 1||0
1519872|NCT01511536|3718696|P3|COMPLETED|Phase 1||0
1519873|NCT01511536|3718697|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
1519874|NCT01511536|3718698|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
1519875|NCT01511536|3718696|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
1519876|NCT01511536|3718697|P2|STARTED|Phase 1||7
1519877|NCT01511536|3718698|P1|STARTED|Phase 1||3
1519878|NCT01511445|3718720|P2|NOT COMPLETED|Overall Study||4
1519879|NCT01511445|3718721|P1|NOT COMPLETED|Overall Study||5
1519880|NCT01511445|3718720|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
1519881|NCT01511445|3718721|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
1519882|NCT01511445|3718720|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
1519883|NCT01511445|3718721|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
1519884|NCT01511445|3718720|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
1519885|NCT01511445|3718721|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
1519886|NCT01511445|3718720|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
1519887|NCT01511445|3718721|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
1519888|NCT01511445|3718720|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
1519889|NCT01511445|3718721|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
1519890|NCT01511315|3718729|P1|NOT COMPLETED|Overall Study||4
1519891|NCT01511315|3718729|P1|COMPLETED|Overall Study||32
1519892|NCT01511315|3718729|P1|STARTED|Overall Study||36
1519893|NCT01511250|3718749|P10|NOT COMPLETED|Overall Study||5
1519894|NCT01511250|3718750|P9|NOT COMPLETED|Overall Study||14
1519895|NCT01511250|3718751|P8|NOT COMPLETED|Overall Study||4
1519896|NCT01511250|3718752|P7|NOT COMPLETED|Overall Study||2
1519897|NCT01511250|3718753|P6|NOT COMPLETED|Overall Study||0
1519898|NCT01511250|3718754|P5|NOT COMPLETED|Overall Study||0
1519899|NCT01511250|3718755|P4|NOT COMPLETED|Overall Study||3
1519900|NCT01511250|3718756|P3|NOT COMPLETED|Overall Study||4
1519901|NCT01511250|3718757|P2|NOT COMPLETED|Overall Study||5
1519902|NCT01511250|3718758|P1|NOT COMPLETED|Overall Study||9
1519903|NCT01511250|3718749|P10|COMPLETED|Overall Study||48
1519904|NCT01511250|3718750|P9|COMPLETED|Overall Study||145
1519905|NCT01511250|3718751|P8|COMPLETED|Overall Study||9
1519906|NCT01511250|3718752|P7|COMPLETED|Overall Study||21
1519907|NCT01511250|3718753|P6|COMPLETED|Overall Study||17
1519908|NCT01511250|3718754|P5|COMPLETED|Overall Study||21
1519909|NCT01511250|3718755|P4|COMPLETED|Overall Study||11
1519910|NCT01511250|3718756|P3|COMPLETED|Overall Study||18
1519911|NCT01511250|3718757|P2|COMPLETED|Overall Study||9
1519912|NCT01511250|3718758|P1|COMPLETED|Overall Study||15
1519913|NCT01511250|3718749|P10|STARTED|Overall Study||53
1519914|NCT01511250|3718750|P9|STARTED|Overall Study||159
1519915|NCT01511250|3718751|P8|STARTED|Overall Study||13
1519916|NCT01511250|3718752|P7|STARTED|Overall Study||23
1519917|NCT01511250|3718753|P6|STARTED|Overall Study||17
1519918|NCT01511250|3718754|P5|STARTED|Overall Study||21
1519919|NCT01511250|3718755|P4|STARTED|Overall Study||14
1519920|NCT01511250|3718756|P3|STARTED|Overall Study||22
1519921|NCT01511250|3718757|P2|STARTED|Overall Study||14
1519922|NCT01511250|3718758|P1|STARTED|Overall Study||24
1519923|NCT01511107|3718906|P2|NOT COMPLETED|Overall Study||41
1519924|NCT01511107|3718907|P1|NOT COMPLETED|Overall Study||22
1519925|NCT01511107|3718906|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
1519926|NCT01511107|3718907|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
1519927|NCT01511107|3718906|P2|STARTED|Overall Study|Randomized to the treatment group.|260
1519928|NCT01511107|3718907|P1|STARTED|Overall Study|Randomized to the treatment group.|260
1519929|NCT01511081|3718957|P2|NOT COMPLETED|Overall Study||0
1519930|NCT01511081|3718958|P1|NOT COMPLETED|Overall Study||0
1519931|NCT01511081|3718957|P2|COMPLETED|Overall Study||9
1519932|NCT01511081|3718958|P1|COMPLETED|Overall Study||8
1519933|NCT01511081|3718957|P2|STARTED|Overall Study||9
1519934|NCT01511081|3718958|P1|STARTED|Overall Study||8
1519935|NCT01511016|3718968|P2|NOT COMPLETED|Overall Study||2
1519936|NCT01511016|3718969|P1|NOT COMPLETED|Overall Study||2
1519937|NCT01511016|3718968|P2|COMPLETED|Overall Study||7
1519938|NCT01511016|3718969|P1|COMPLETED|Overall Study||6
1519939|NCT01511016|3718968|P2|STARTED|Overall Study||9
1519940|NCT01511016|3718969|P1|STARTED|Overall Study||8
1519941|NCT01510912|3718985|P1|NOT COMPLETED|Overall Study||242
1519942|NCT01510912|3718985|P1|COMPLETED|Overall Study||360
1519943|NCT01510912|3718985|P1|STARTED|Overall Study||602
1519944|NCT01510834|3718991|P1|NOT COMPLETED|Overall Study||33
1519945|NCT01510834|3718991|P1|COMPLETED|Overall Study||57
1519946|NCT01510834|3718991|P1|STARTED|Overall Study||90
1519947|NCT01510769|3719001|P3|NOT COMPLETED|Overall Study||22
1519948|NCT01510769|3719002|P2|NOT COMPLETED|Overall Study||25
1519949|NCT01510769|3719003|P1|NOT COMPLETED|Overall Study||27
1519950|NCT01510769|3719001|P3|COMPLETED|Overall Study||87
1519951|NCT01510769|3719002|P2|COMPLETED|Overall Study||84
1519952|NCT01510769|3719003|P1|COMPLETED|Overall Study||79
1519953|NCT01510769|3719001|P3|STARTED|Overall Study||109
1519954|NCT01510769|3719002|P2|STARTED|Overall Study||109
1519955|NCT01510769|3719003|P1|STARTED|Overall Study||106
1519956|NCT01510756|3719020|P1|NOT COMPLETED|Overall Study||4
1519957|NCT01510756|3719020|P1|COMPLETED|Overall Study||0
1519958|NCT01510756|3719020|P1|STARTED|Overall Study||4
1519959|NCT01510717|3719028|P2|NOT COMPLETED|Overall Study||5
1519960|NCT01510717|3719029|P1|NOT COMPLETED|Overall Study||2
1519961|NCT01510717|3719028|P2|COMPLETED|Overall Study||160
1519962|NCT01510717|3719029|P1|COMPLETED|Overall Study||153
1519963|NCT01510717|3719028|P2|STARTED|Overall Study||165
1519964|NCT01510717|3719029|P1|STARTED|Overall Study||155
1519965|NCT01510704|3719057|P4|NOT COMPLETED|Overall Study||0
1519966|NCT01510704|3719058|P3|NOT COMPLETED|Overall Study||0
1519967|NCT01510704|3719059|P2|NOT COMPLETED|Overall Study||0
1519968|NCT01510704|3719060|P1|NOT COMPLETED|Overall Study||0
1519969|NCT01510704|3719057|P4|COMPLETED|Overall Study||53
1519970|NCT01510704|3719058|P3|COMPLETED|Overall Study||50
1519971|NCT01510704|3719059|P2|COMPLETED|Overall Study||58
1519972|NCT01510704|3719060|P1|COMPLETED|Overall Study||54
1519973|NCT01510704|3719057|P4|STARTED|Overall Study||53
1519974|NCT01510704|3719058|P3|STARTED|Overall Study||50
1519975|NCT01510704|3719059|P2|STARTED|Overall Study||58
1519976|NCT01510704|3719060|P1|STARTED|Overall Study||54
1519977|NCT01510652|3719072|P2|NOT COMPLETED|Overall Study||67
1519978|NCT01510652|3719073|P1|NOT COMPLETED|Overall Study||92
1519979|NCT01510652|3719072|P2|COMPLETED|Overall Study||288
1519980|NCT01510652|3719073|P1|COMPLETED|Overall Study||627
1519981|NCT01510652|3719072|P2|Baseline|Overall Study||348
1519982|NCT01510652|3719073|P1|Baseline|Overall Study||718
1519983|NCT01510652|3719072|P2|STARTED|Overall Study||355
1519984|NCT01510652|3719073|P1|STARTED|Overall Study||719
1519985|NCT01510457|3719085|P2|NOT COMPLETED|Overall Study||3
1519986|NCT01510457|3719086|P1|NOT COMPLETED|Overall Study||5
1519987|NCT01510457|3719085|P2|COMPLETED|Overall Study||26
1519988|NCT01510457|3719086|P1|COMPLETED|Overall Study||12
1519989|NCT01510457|3719085|P2|STARTED|Overall Study||29
1519990|NCT01510457|3719086|P1|STARTED|Overall Study||17
1519991|NCT01510379|3719106|P2|NOT COMPLETED|Overall Study||0
1519992|NCT01510379|3719107|P1|NOT COMPLETED|Overall Study||0
1519993|NCT01510379|3719106|P2|COMPLETED|Overall Study||51
1519994|NCT01510379|3719107|P1|COMPLETED|Overall Study||49
1519995|NCT01510379|3719106|P2|STARTED|Overall Study||51
1519996|NCT01510379|3719107|P1|STARTED|Overall Study||49
1519997|NCT01510327|3719115|P1|NOT COMPLETED|Overall Study||0
1519998|NCT01510327|3719115|P1|COMPLETED|Overall Study||22
1519999|NCT01510327|3719115|P1|STARTED|Overall Study||22
1520000|NCT01510158|3719149|P3|NOT COMPLETED|Overall Study||50
1520001|NCT01510158|3719150|P2|NOT COMPLETED|Overall Study||53
1520002|NCT01510158|3719151|P1|NOT COMPLETED|Overall Study||51
1520003|NCT01510158|3719149|P3|COMPLETED|Overall Study||152
1520004|NCT01510158|3719150|P2|COMPLETED|Overall Study||150
1520005|NCT01510158|3719151|P1|COMPLETED|Overall Study||151
1520006|NCT01510158|3719149|P3|STARTED|Overall Study||202
1520007|NCT01510158|3719150|P2|STARTED|Overall Study||203
1520008|NCT01510158|3719151|P1|STARTED|Overall Study||202
1520009|NCT01510145|3719165|P1|NOT COMPLETED|Overall Study||18
1520010|NCT01510145|3719165|P1|COMPLETED|Overall Study||173
1520011|NCT01510145|3719165|P1|STARTED|Overall Study||191
1520012|NCT01510028|3719174|P4|NOT COMPLETED|Overall Study||0
1520013|NCT01510028|3719175|P3|NOT COMPLETED|Overall Study||0
1520014|NCT01510028|3719176|P2|NOT COMPLETED|Overall Study||0
1520015|NCT01510028|3719177|P1|NOT COMPLETED|Overall Study||1
1520016|NCT01510028|3719174|P4|COMPLETED|Overall Study||6
1520017|NCT01510028|3719175|P3|COMPLETED|Overall Study||6
1520018|NCT01510028|3719176|P2|COMPLETED|Overall Study||6
1520019|NCT01510028|3719177|P1|COMPLETED|Overall Study||5
1520020|NCT01510028|3719174|P4|STARTED|Overall Study||6
1520021|NCT01510028|3719175|P3|STARTED|Overall Study||6
1520022|NCT01510028|3719176|P2|STARTED|Overall Study||6
1520023|NCT01510028|3719177|P1|STARTED|Overall Study||6
1520024|NCT01509807|3719293|P2|NOT COMPLETED|Overall Study||1
1520025|NCT01509807|3719294|P1|NOT COMPLETED|Overall Study||1
1520026|NCT01509807|3719293|P2|COMPLETED|Overall Study||16
1520027|NCT01509807|3719294|P1|COMPLETED|Overall Study||15
1520028|NCT01509807|3719293|P2|STARTED|Overall Study||17
1520029|NCT01509807|3719294|P1|STARTED|Overall Study||16
1520030|NCT01509664|3719320|P2|NOT COMPLETED|Overall Study||21
1520031|NCT01509664|3719321|P1|NOT COMPLETED|Overall Study||15
1520032|NCT01509664|3719320|P2|COMPLETED|Overall Study||28
1520033|NCT01509664|3719321|P1|COMPLETED|Overall Study||34
1520034|NCT01509664|3719320|P2|T3 Follow-up|Overall Study||33
1520035|NCT01509664|3719321|P1|T3 Follow-up|Overall Study||40
1520036|NCT01509664|3719320|P2|T2 Follow-up|Overall Study||38
1520037|NCT01509664|3719321|P1|T2 Follow-up|Overall Study||45
1520038|NCT01509664|3719320|P2|STARTED|Overall Study||49
1520039|NCT01509664|3719321|P1|STARTED|Overall Study||49
1520040|NCT01509638|3719329|P2|NOT COMPLETED|Overall Study||2
1520041|NCT01509638|3719330|P1|NOT COMPLETED|Overall Study||3
1520042|NCT01509638|3719329|P2|COMPLETED|Overall Study||24
1520043|NCT01509638|3719330|P1|COMPLETED|Overall Study||20
1520044|NCT01509638|3719329|P2|STARTED|Overall Study||26
1520045|NCT01509638|3719330|P1|STARTED|Overall Study||23
1520046|NCT01509625|3719354|P1|NOT COMPLETED|Overall Study||9
1520047|NCT01509625|3719354|P1|COMPLETED|Overall Study||263
1520048|NCT01509625|3719354|P1|STARTED|Overall Study||272
1520049|NCT01509586|3719372|P2|NOT COMPLETED|Overall Study||0
1520050|NCT01509586|3719373|P1|NOT COMPLETED|Overall Study||0
1520051|NCT01509586|3719372|P2|COMPLETED|Overall Study|final intent to treat sample|610
1520052|NCT01509586|3719373|P1|COMPLETED|Overall Study|final intent to treat sample|626
1520053|NCT01509586|3719372|P2|Week 58 (Month 12)|Overall Study||499
1520054|NCT01509586|3719373|P1|Week 58 (Month 12)|Overall Study||492
1520055|NCT01509586|3719372|P2|Week 46|Overall Study||494
1520056|NCT01509586|3719373|P1|Week 46|Overall Study||483
1520057|NCT01509586|3719372|P2|Week 32 (Month 6)|Overall Study||523
1520058|NCT01509586|3719373|P1|Week 32 (Month 6)|Overall Study||504
1520059|NCT01509586|3719372|P2|Week18|Overall Study||555
1520060|NCT01509586|3719373|P1|Week18|Overall Study||529
1520061|NCT01509586|3719372|P2|Week 14|Overall Study||566
1520062|NCT01509586|3719373|P1|Week 14|Overall Study||528
1520063|NCT01509586|3719372|P2|Week 10|Overall Study||574
1520064|NCT01509586|3719373|P1|Week 10|Overall Study||537
1520065|NCT01509586|3719372|P2|Week 6|Overall Study||585
1520066|NCT01509586|3719373|P1|Week 6|Overall Study||551
1520067|NCT01509586|3719372|P2|Week 3|Overall Study||585
1520068|NCT01509586|3719373|P1|Week 3|Overall Study||574
1520069|NCT01509586|3719372|P2|STARTED|Overall Study|Week 0|610
1520070|NCT01509586|3719373|P1|STARTED|Overall Study|Week 0|626
1520071|NCT01509404|3719383|P2|NOT COMPLETED|Overall Study||0
1520072|NCT01509404|3719384|P1|NOT COMPLETED|Overall Study||0
1520073|NCT01509404|3719383|P2|COMPLETED|Overall Study||20
1520074|NCT01509404|3719384|P1|COMPLETED|Overall Study||20
1520075|NCT01509404|3719383|P2|STARTED|Overall Study||20
1520076|NCT01509404|3719384|P1|STARTED|Overall Study||20
1520077|NCT01509183|3719406|P2|NOT COMPLETED|Overall Study||111
1520078|NCT01509183|3719407|P1|NOT COMPLETED|Overall Study||109
1520079|NCT01509183|3719406|P2|COMPLETED|Overall Study||134
1520080|NCT01509183|3719407|P1|COMPLETED|Overall Study||141
1520081|NCT01509183|3719406|P2|STARTED|Overall Study||245
1520082|NCT01509183|3719407|P1|STARTED|Overall Study||250
1520083|NCT01509105|3719415|P1|NOT COMPLETED|Overall Study||0
1520084|NCT01509105|3719415|P1|COMPLETED|Overall Study||649
1520085|NCT01509105|3719415|P1|STARTED|Overall Study||649
1520086|NCT01509079|3719432|P2|NOT COMPLETED|Overall Study||3
1520087|NCT01509079|3719433|P1|NOT COMPLETED|Overall Study||0
1520088|NCT01509079|3719432|P2|COMPLETED|Overall Study||56
1520089|NCT01509079|3719433|P1|COMPLETED|Overall Study||57
1520090|NCT01509079|3719432|P2|STARTED|Overall Study||59
1520091|NCT01509079|3719433|P1|STARTED|Overall Study||57
1520092|NCT01509053|3719449|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
1520093|NCT01509053|3719449|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
1520094|NCT01509053|3719449|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
1520095|NCT01509053|3719449|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
1520096|NCT01509053|3719449|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
1520097|NCT01509053|3719449|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
1520098|NCT01509053|3719449|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
1520099|NCT01509053|3719449|P1|COMPLETED|Oral Aripirazole (Phase A)||8
1520100|NCT01509053|3719449|P1|STARTED|Oral Aripirazole (Phase A)||19
1520101|NCT01509040|3719463|P3|NOT COMPLETED|Overall Study||0
1520102|NCT01509040|3719464|P2|NOT COMPLETED|Overall Study||1
1520103|NCT01509040|3719465|P1|NOT COMPLETED|Overall Study||0
1520104|NCT01509040|3719463|P3|COMPLETED|Overall Study||0
1520105|NCT01509040|3719464|P2|COMPLETED|Overall Study||1
1520106|NCT01509040|3719465|P1|COMPLETED|Overall Study||0
1520107|NCT01509040|3719463|P3|STARTED|Overall Study||0
1520108|NCT01509040|3719464|P2|STARTED|Overall Study||2
1520109|NCT01509040|3719465|P1|STARTED|Overall Study||0
1520110|NCT01508936|3719511|P2|NOT COMPLETED|Overall Study||79
1520111|NCT01508936|3719512|P1|NOT COMPLETED|Overall Study||23
1520112|NCT01508936|3719511|P2|COMPLETED|Overall Study||330
1520113|NCT01508936|3719512|P1|COMPLETED|Overall Study||79
1520114|NCT01508936|3719511|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
1520115|NCT01508936|3719512|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
1520116|NCT01508936|3719511|P2|Full Analysis Set|Overall Study||395
1520117|NCT01508936|3719512|P1|Full Analysis Set|Overall Study||97
1520118|NCT01508936|3719511|P2|Safety Analysis Set|Overall Study||395
1520119|NCT01508936|3719512|P1|Safety Analysis Set|Overall Study||97
1520120|NCT01508936|3719511|P2|Randomized, Not Treated|Overall Study||3
1520121|NCT01508936|3719512|P1|Randomized, Not Treated|Overall Study||1
1520122|NCT01508936|3719511|P2|Randomized|Overall Study||398
1520123|NCT01508936|3719512|P1|Randomized|Overall Study||98
1520124|NCT01508936|3719511|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
1520125|NCT01508936|3719512|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
1520126|NCT01508936|3719511|P2|STARTED|Overall Study||409
1520127|NCT01508936|3719512|P1|STARTED|Overall Study||102
1520128|NCT01508910|3719551|P4|NOT COMPLETED|Treatment||3
1520129|NCT01508910|3719552|P3|NOT COMPLETED|Treatment||10
1520130|NCT01508910|3719553|P2|NOT COMPLETED|Treatment||4
1520131|NCT01508910|3719554|P1|NOT COMPLETED|Treatment||2
1520132|NCT01508910|3719551|P4|COMPLETED|Treatment||3
1520133|NCT01508910|3719552|P3|COMPLETED|Treatment||18
1520134|NCT01508910|3719553|P2|COMPLETED|Treatment||24
1520135|NCT01508910|3719554|P1|COMPLETED|Treatment||48
1520136|NCT01508910|3719551|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
1520137|NCT01508910|3719552|P3|STARTED|Treatment||28
1520138|NCT01508910|3719553|P2|STARTED|Treatment||28
1520139|NCT01508910|3719554|P1|STARTED|Treatment||50
1520140|NCT01508910|3719551|P4|NOT COMPLETED|Randomization||0
1520141|NCT01508910|3719552|P3|NOT COMPLETED|Randomization||0
1520142|NCT01508910|3719553|P2|NOT COMPLETED|Randomization||0
1520143|NCT01508910|3719554|P1|NOT COMPLETED|Randomization||0
1520144|NCT01508910|3719551|P4|COMPLETED|Randomization||0
1520145|NCT01508910|3719552|P3|COMPLETED|Randomization||28
1520146|NCT01508910|3719553|P2|COMPLETED|Randomization||27
1520147|NCT01508910|3719554|P1|COMPLETED|Randomization||57
1520148|NCT01508910|3719551|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
1520149|NCT01508910|3719552|P3|STARTED|Randomization||28
1520150|NCT01508910|3719553|P2|STARTED|Randomization||27
1520151|NCT01508910|3719554|P1|STARTED|Randomization||57
1520152|NCT01508832|3719578|P2|NOT COMPLETED|Overall Study||0
1520153|NCT01508832|3719579|P1|NOT COMPLETED|Overall Study||0
1520154|NCT01508832|3719578|P2|COMPLETED|Overall Study||6
1520155|NCT01508832|3719579|P1|COMPLETED|Overall Study||6
1520156|NCT01508832|3719578|P2|STARTED|Overall Study||6
1520157|NCT01508832|3719579|P1|STARTED|Overall Study||6
1520158|NCT01508702|3719587|P2|NOT COMPLETED|Overall Study||13
1520159|NCT01508702|3719588|P1|NOT COMPLETED|Overall Study||23
1520160|NCT01508702|3719587|P2|COMPLETED|Overall Study||94
1520161|NCT01508702|3719588|P1|COMPLETED|Overall Study||84
1520162|NCT01508702|3719587|P2|STARTED|Overall Study||107
1520163|NCT01508702|3719588|P1|STARTED|Overall Study||107
1520164|NCT01508676|3719596|P2|NOT COMPLETED|Phase II (2 Weeks)||1
1520165|NCT01508676|3719597|P1|NOT COMPLETED|Phase II (2 Weeks)||1
1520166|NCT01508676|3719596|P2|COMPLETED|Phase II (2 Weeks)||13
1520167|NCT01508676|3719597|P1|COMPLETED|Phase II (2 Weeks)||15
1520168|NCT01508676|3719596|P2|STARTED|Phase II (2 Weeks)||14
1520169|NCT01508676|3719597|P1|STARTED|Phase II (2 Weeks)||16
1520170|NCT01508676|3719596|P2|NOT COMPLETED|Washout Period (1 Week)||0
1520171|NCT01508676|3719597|P1|NOT COMPLETED|Washout Period (1 Week)||0
1520172|NCT01508676|3719596|P2|COMPLETED|Washout Period (1 Week)||14
1520173|NCT01508676|3719597|P1|COMPLETED|Washout Period (1 Week)||16
1520174|NCT01508676|3719596|P2|STARTED|Washout Period (1 Week)||14
1520175|NCT01508676|3719597|P1|STARTED|Washout Period (1 Week)||16
1520176|NCT01508676|3719596|P2|NOT COMPLETED|Phase I (2 Weeks)||3
1520177|NCT01508676|3719597|P1|NOT COMPLETED|Phase I (2 Weeks)||2
1520178|NCT01508676|3719596|P2|COMPLETED|Phase I (2 Weeks)||14
1520179|NCT01508676|3719597|P1|COMPLETED|Phase I (2 Weeks)||16
1520180|NCT01508676|3719596|P2|STARTED|Phase I (2 Weeks)||17
1520181|NCT01508676|3719597|P1|STARTED|Phase I (2 Weeks)||18
1520182|NCT01508455|3719607|P1|NOT COMPLETED|Overall Study||0
1520183|NCT01508455|3719607|P1|COMPLETED|Overall Study||6
1520184|NCT01508455|3719607|P1|STARTED|Overall Study||6
1520185|NCT01508325|3719618|P2|NOT COMPLETED|Overall Study||21
1520186|NCT01508325|3719619|P1|NOT COMPLETED|Overall Study||18
1520187|NCT01508325|3719618|P2|COMPLETED|Overall Study||72
1520188|NCT01508325|3719619|P1|COMPLETED|Overall Study||75
1520189|NCT01508325|3719618|P2|STARTED|Overall Study||93
1520190|NCT01508325|3719619|P1|STARTED|Overall Study||93
1520191|NCT01508169|3719649|P2|NOT COMPLETED|Overall Study||2
1520192|NCT01508169|3719650|P1|NOT COMPLETED|Overall Study||3
1520193|NCT01508169|3719649|P2|COMPLETED|Overall Study||45
1520194|NCT01508169|3719650|P1|COMPLETED|Overall Study||44
1520195|NCT01508169|3719649|P2|STARTED|Overall Study||47
1520196|NCT01508169|3719650|P1|STARTED|Overall Study||47
1520197|NCT01508130|3719664|P2|NOT COMPLETED|Overall Study||69
1520198|NCT01508130|3719665|P1|NOT COMPLETED|Overall Study||227
1520199|NCT01508130|3719664|P2|COMPLETED|Overall Study||73
1520200|NCT01508130|3719665|P1|COMPLETED|Overall Study||266
1520201|NCT01508130|3719664|P2|mTRT|Overall Study||142
1520202|NCT01508130|3719665|P1|mTRT|Overall Study||493
1520203|NCT01508130|3719664|P2|STARTED|Overall Study||142
1520204|NCT01508130|3719665|P1|STARTED|Overall Study||493
1520205|NCT01508117|3719707|P1|NOT COMPLETED|Overall Study||0
1520206|NCT01508117|3719707|P1|COMPLETED|Overall Study||1
1520207|NCT01508117|3719707|P1|STARTED|Overall Study||1
1520208|NCT01508052|3719713|P2|NOT COMPLETED|Overall Study||0
1520209|NCT01508052|3719714|P1|NOT COMPLETED|Overall Study||0
1520210|NCT01508052|3719713|P2|COMPLETED|Overall Study||20
1520211|NCT01508052|3719714|P1|COMPLETED|Overall Study||20
1520212|NCT01508052|3719713|P2|STARTED|Overall Study||20
1520213|NCT01508052|3719714|P1|STARTED|Overall Study||20
1520214|NCT01508013|3719722|P2|NOT COMPLETED|Overall Study||23
1520215|NCT01508013|3719723|P1|NOT COMPLETED|Overall Study||32
1520216|NCT01508013|3719722|P2|COMPLETED|Overall Study||206
1520217|NCT01508013|3719723|P1|COMPLETED|Overall Study||182
1520218|NCT01508013|3719722|P2|STARTED|Overall Study||229
1520219|NCT01508013|3719723|P1|STARTED|Overall Study||214
1520220|NCT01507896|3719733|P1|NOT COMPLETED|Overall Study||2
1520221|NCT01507896|3719733|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
1520222|NCT01507896|3719733|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
1520223|NCT01507831|3719776|P2|NOT COMPLETED|Overall Study||440
1520224|NCT01507831|3719777|P1|NOT COMPLETED|Overall Study||193
1520225|NCT01507831|3719776|P2|COMPLETED|Overall Study||1113
1520226|NCT01507831|3719777|P1|COMPLETED|Overall Study||595
1520227|NCT01507831|3719776|P2|Treated|Overall Study||1550
1520228|NCT01507831|3719777|P1|Treated|Overall Study||788
1520229|NCT01507831|3719776|P2|STARTED|Overall Study|Randomized|1553
1520230|NCT01507831|3719777|P1|STARTED|Overall Study|Randomized|788
1520231|NCT01507662|3719847|P2|NOT COMPLETED|Overall Study||831
1520232|NCT01507662|3719848|P1|NOT COMPLETED|Overall Study||816
1520233|NCT01507662|3719847|P2|COMPLETED|Overall Study||3020
1520234|NCT01507662|3719848|P1|COMPLETED|Overall Study||3082
1520235|NCT01507662|3719847|P2|STARTED|Overall Study||3851
1520236|NCT01507662|3719848|P1|STARTED|Overall Study||3898
1520237|NCT01507493|3719856|P2|NOT COMPLETED|Overall Study||0
1520238|NCT01507493|3719857|P1|NOT COMPLETED|Overall Study||0
1520239|NCT01507493|3719856|P2|COMPLETED|Overall Study||178
1520240|NCT01507493|3719857|P1|COMPLETED|Overall Study||22
1520241|NCT01507493|3719856|P2|STARTED|Overall Study||178
1520242|NCT01507493|3719857|P1|STARTED|Overall Study||22
1520243|NCT01507246|3719873|P2|NOT COMPLETED|Overall Study||1
1520244|NCT01507246|3719874|P1|NOT COMPLETED|Overall Study||2
1520245|NCT01507246|3719873|P2|COMPLETED|Overall Study||21
1520246|NCT01507246|3719874|P1|COMPLETED|Overall Study||18
1520247|NCT01507246|3719873|P2|STARTED|Overall Study||22
1520248|NCT01507246|3719874|P1|STARTED|Overall Study||20
1520249|NCT01507233|3719888|P2|NOT COMPLETED|Overall Study||0
1520250|NCT01507233|3719889|P1|NOT COMPLETED|Overall Study||0
1520251|NCT01507233|3719888|P2|COMPLETED|Overall Study||0
1520252|NCT01507233|3719889|P1|COMPLETED|Overall Study||5
1520253|NCT01507233|3719888|P2|STARTED|Overall Study||0
1520254|NCT01507233|3719889|P1|STARTED|Overall Study||5
1520255|NCT01507220|3719901|P2|NOT COMPLETED|Overall Study||0
1520256|NCT01507220|3719902|P1|NOT COMPLETED|Overall Study||0
1520257|NCT01507220|3719901|P2|COMPLETED|Overall Study||0
1520258|NCT01507220|3719902|P1|COMPLETED|Overall Study||2
1520259|NCT01507220|3719901|P2|STARTED|Overall Study||0
1520260|NCT01507220|3719902|P1|STARTED|Overall Study||2
1520261|NCT01507181|3719916|P2|NOT COMPLETED|Overall Study||0
1520262|NCT01507181|3719917|P1|NOT COMPLETED|Overall Study||0
1520263|NCT01507181|3719916|P2|COMPLETED|Overall Study||12
1520264|NCT01507181|3719917|P1|COMPLETED|Overall Study||12
1520265|NCT01507181|3719916|P2|STARTED|Overall Study||12
1520266|NCT01507181|3719917|P1|STARTED|Overall Study||12
1520267|NCT01507155|3719937|P2|NOT COMPLETED|Overall Study||0
1520268|NCT01507155|3719938|P1|NOT COMPLETED|Overall Study||0
1520269|NCT01507155|3719937|P2|COMPLETED|Overall Study||60
1520270|NCT01507155|3719938|P1|COMPLETED|Overall Study||625
1520271|NCT01507155|3719937|P2|STARTED|Overall Study||60
1520272|NCT01507155|3719938|P1|STARTED|Overall Study||625
1520273|NCT01507103|3719947|P3|NOT COMPLETED|Overall Study||0
1520274|NCT01507103|3719948|P2|NOT COMPLETED|Overall Study||0
1520275|NCT01507103|3719949|P1|NOT COMPLETED|Overall Study||0
1520276|NCT01507103|3719947|P3|COMPLETED|Overall Study||42
1520277|NCT01507103|3719948|P2|COMPLETED|Overall Study||41
1520278|NCT01507103|3719949|P1|COMPLETED|Overall Study||41
1520279|NCT01507103|3719947|P3|STARTED|Overall Study||42
1520280|NCT01507103|3719948|P2|STARTED|Overall Study||41
1520281|NCT01507103|3719949|P1|STARTED|Overall Study||41
1520282|NCT01507090|3719972|P1|NOT COMPLETED|Overall Study||18
1520283|NCT01507090|3719972|P1|COMPLETED|Overall Study||624
1520284|NCT01507090|3719972|P1|STARTED|Overall Study||642
1520285|NCT01507051|3720011|P4|NOT COMPLETED|Overall Study||7
1520286|NCT01507051|3720012|P3|NOT COMPLETED|Overall Study||1
1520287|NCT01507051|3720013|P2|NOT COMPLETED|Overall Study||3
1520288|NCT01507051|3720014|P1|NOT COMPLETED|Overall Study||2
1520289|NCT01507051|3720011|P4|COMPLETED|Overall Study||0
1520290|NCT01507051|3720012|P3|COMPLETED|Overall Study||28
1520291|NCT01507051|3720013|P2|COMPLETED|Overall Study||28
1520292|NCT01507051|3720014|P1|COMPLETED|Overall Study||27
1520293|NCT01507051|3720011|P4|Received Placebo or Rivaroxaban|Overall Study||0
1520294|NCT01507051|3720012|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
1520295|NCT01507051|3720013|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
1520296|NCT01507051|3720014|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
1520297|NCT01507051|3720011|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
1520298|NCT01507051|3720012|P3|Warfarin run-in Phase|Overall Study||0
1520299|NCT01507051|3720013|P2|Warfarin run-in Phase|Overall Study||28
1520300|NCT01507051|3720014|P1|Warfarin run-in Phase|Overall Study||28
1520301|NCT01507051|3720011|P4|STARTED|Overall Study||7
1520302|NCT01507051|3720012|P3|STARTED|Overall Study||29
1520303|NCT01507051|3720013|P2|STARTED|Overall Study||31
1520304|NCT01507051|3720014|P1|STARTED|Overall Study||29
1520305|NCT01506960|3720132|P1|NOT COMPLETED|Overall Study||47
1520306|NCT01506960|3720132|P1|COMPLETED|Overall Study||17
1520307|NCT01506960|3720132|P1|STARTED|Overall Study||64
1520308|NCT01506947|3720138|P1|NOT COMPLETED|Overall Study||16
1520309|NCT01506947|3720138|P1|COMPLETED|Overall Study||49
1520310|NCT01506947|3720138|P1|STARTED|Overall Study||65
1520311|NCT01506908|3720156|P2|NOT COMPLETED|Overall Study||0
1520312|NCT01506908|3720157|P1|NOT COMPLETED|Overall Study||1
1520313|NCT01506908|3720156|P2|COMPLETED|Overall Study||161
1520314|NCT01506908|3720157|P1|COMPLETED|Overall Study||161
1520315|NCT01506908|3720156|P2|STARTED|Overall Study||161
1520316|NCT01506908|3720157|P1|STARTED|Overall Study||162
1520317|NCT01506882|3720175|P2|NOT COMPLETED|Overall Study||7
1520318|NCT01506882|3720176|P1|NOT COMPLETED|Overall Study||22
1520319|NCT01506882|3720175|P2|COMPLETED|Overall Study||3
1520320|NCT01506882|3720176|P1|COMPLETED|Overall Study||39
1520321|NCT01506882|3720175|P2|STARTED|Overall Study||10
1520322|NCT01506882|3720176|P1|STARTED|Overall Study||61
1520323|NCT01506726|3720190|P2|NOT COMPLETED|Overall Study||2
1520324|NCT01506726|3720191|P1|NOT COMPLETED|Overall Study||1
1520325|NCT01506726|3720190|P2|COMPLETED|Overall Study||3
1520326|NCT01506726|3720191|P1|COMPLETED|Overall Study||5
1520327|NCT01506726|3720190|P2|STARTED|Overall Study||5
1520328|NCT01506726|3720191|P1|STARTED|Overall Study||6
1520329|NCT01506596|3720231|P1|NOT COMPLETED|Overall Study||1
1520330|NCT01506596|3720231|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
1520331|NCT01506596|3720231|P1|STARTED|Overall Study||42
1520332|NCT01506479|3720242|P3|NOT COMPLETED|Overall Study||3
1520333|NCT01506479|3720243|P2|NOT COMPLETED|Overall Study||5
1520334|NCT01506479|3720244|P1|NOT COMPLETED|Overall Study||3
1520335|NCT01506479|3720242|P3|COMPLETED|Overall Study||42
1520336|NCT01506479|3720243|P2|COMPLETED|Overall Study||38
1520337|NCT01506479|3720244|P1|COMPLETED|Overall Study||37
1520338|NCT01506479|3720242|P3|STARTED|Overall Study||45
1520339|NCT01506479|3720243|P2|STARTED|Overall Study||43
1520340|NCT01506479|3720244|P1|STARTED|Overall Study||40
1520341|NCT01506362|3720256|P1|NOT COMPLETED|Overall Study||6
1520342|NCT01506362|3720256|P1|COMPLETED|Overall Study||16
1520343|NCT01506362|3720256|P1|STARTED|Overall Study||22
1520344|NCT01506323|3720262|P2|NOT COMPLETED|Overall Study||13
1520345|NCT01506323|3720263|P1|NOT COMPLETED|Overall Study||24
1520346|NCT01506323|3720262|P2|COMPLETED|Overall Study||71
1520347|NCT01506323|3720263|P1|COMPLETED|Overall Study||65
1520348|NCT01506323|3720262|P2|Post-treatment Completed CAPS|Overall Study||72
1520349|NCT01506323|3720263|P1|Post-treatment Completed CAPS|Overall Study||68
1520350|NCT01506323|3720262|P2|Post-treatment Completers|Overall Study||72
1520351|NCT01506323|3720263|P1|Post-treatment Completers|Overall Study||69
1520352|NCT01506323|3720262|P2|STARTED|Overall Study||84
1520353|NCT01506323|3720263|P1|STARTED|Overall Study||89
1520354|NCT01506193|3720292|P3|NOT COMPLETED|Overall Study||14
1520355|NCT01506193|3720293|P2|NOT COMPLETED|Overall Study||4
1520356|NCT01506193|3720294|P1|NOT COMPLETED|Overall Study||14
1520357|NCT01506193|3720292|P3|COMPLETED|Overall Study||168
1520358|NCT01506193|3720293|P2|COMPLETED|Overall Study||179
1520359|NCT01506193|3720294|P1|COMPLETED|Overall Study||337
1520360|NCT01506193|3720292|P3|STARTED|Overall Study||182
1520361|NCT01506193|3720293|P2|STARTED|Overall Study||183
1520362|NCT01506193|3720294|P1|STARTED|Overall Study||351
1520363|NCT01505881|3720327|P2|NOT COMPLETED|Overall Study||1
1520364|NCT01505881|3720328|P1|NOT COMPLETED|Overall Study||4
1520365|NCT01505881|3720327|P2|COMPLETED|Overall Study||58
1520366|NCT01505881|3720328|P1|COMPLETED|Overall Study||95
1520367|NCT01505881|3720327|P2|STARTED|Overall Study||59
1520368|NCT01505881|3720328|P1|STARTED|Overall Study||99
1520369|NCT01505764|3720342|P2|NOT COMPLETED|Overall Study||1
1520370|NCT01505764|3720343|P1|NOT COMPLETED|Overall Study||3
1520371|NCT01505764|3720342|P2|COMPLETED|Overall Study||2
1520372|NCT01505764|3720343|P1|COMPLETED|Overall Study||3
1520373|NCT01505764|3720342|P2|STARTED|Overall Study||3
1520374|NCT01505764|3720343|P1|STARTED|Overall Study||6
1520375|NCT01505673|3720373|P2|NOT COMPLETED|Overall Study||2
1520376|NCT01505673|3720374|P1|NOT COMPLETED|Overall Study||3
1520377|NCT01505673|3720373|P2|COMPLETED|Overall Study||34
1520378|NCT01505673|3720374|P1|COMPLETED|Overall Study||32
1520379|NCT01505673|3720373|P2|STARTED|Overall Study||36
1520380|NCT01505673|3720374|P1|STARTED|Overall Study||35
1520381|NCT01505647|3720434|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
1520382|NCT01505647|3720435|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
1520383|NCT01505647|3720434|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
1520384|NCT01505647|3720435|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
1520385|NCT01505647|3720434|P2|STARTED|Day 43 Through Day 182 Follow-up||166
1520386|NCT01505647|3720435|P1|STARTED|Day 43 Through Day 182 Follow-up||329
1520387|NCT01505647|3720434|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
1520388|NCT01505647|3720435|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
1520389|NCT01505647|3720434|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
1520390|NCT01505647|3720435|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
1520391|NCT01505647|3720434|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
1520392|NCT01505647|3720435|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
1520393|NCT01505647|3720434|P2|STARTED|Day 1 Through Day 42 Follow-up||166
1520394|NCT01505647|3720435|P1|STARTED|Day 1 Through Day 42 Follow-up||332
1520395|NCT01505608|3720451|P2|NOT COMPLETED|Phase II||2
1520396|NCT01505608|3720452|P1|NOT COMPLETED|Phase II||2
1520397|NCT01505608|3720451|P2|COMPLETED|Phase II||2
1520398|NCT01505608|3720452|P1|COMPLETED|Phase II||0
1520399|NCT01505608|3720451|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
1520400|NCT01505608|3720452|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
1520401|NCT01505608|3720451|P2|NOT COMPLETED|Phase I||6
1520402|NCT01505608|3720452|P1|NOT COMPLETED|Phase I||0
1520403|NCT01505608|3720451|P2|COMPLETED|Phase I||2
1520404|NCT01505608|3720452|P1|COMPLETED|Phase I||0
1520405|NCT01505608|3720451|P2|STARTED|Phase I||8
1520406|NCT01505608|3720452|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
1520407|NCT01505530|3720471|P3|NOT COMPLETED|Overall Study||41
1520408|NCT01505530|3720472|P2|NOT COMPLETED|Overall Study||43
1520409|NCT01505530|3720473|P1|NOT COMPLETED|Overall Study||41
1520410|NCT01505530|3720471|P3|COMPLETED|Overall Study||0
1520411|NCT01505530|3720472|P2|COMPLETED|Overall Study||0
1520412|NCT01505530|3720473|P1|COMPLETED|Overall Study||0
1520413|NCT01505530|3720471|P3|Completed One Cycle of Study Drug|Overall Study||31
1520414|NCT01505530|3720472|P2|Completed One Cycle of Study Drug|Overall Study||27
1520415|NCT01505530|3720473|P1|Completed One Cycle of Study Drug|Overall Study||29
1520416|NCT01505530|3720471|P3|Received At Least One Dose of Study Drug|Overall Study||41
1520417|NCT01505530|3720472|P2|Received At Least One Dose of Study Drug|Overall Study||42
1520418|NCT01505530|3720473|P1|Received At Least One Dose of Study Drug|Overall Study||41
1520419|NCT01505530|3720471|P3|STARTED|Overall Study||41
1520420|NCT01505530|3720472|P2|STARTED|Overall Study||43
1520421|NCT01505530|3720473|P1|STARTED|Overall Study||41
1520422|NCT01505465|3720516|P2|NOT COMPLETED|Overall Study||7
1520423|NCT01505465|3720517|P1|NOT COMPLETED|Overall Study||6
1520424|NCT01505465|3720516|P2|COMPLETED|Overall Study||18
1520425|NCT01505465|3720517|P1|COMPLETED|Overall Study||19
1520426|NCT01505465|3720516|P2|STARTED|Overall Study||25
1520427|NCT01505465|3720517|P1|STARTED|Overall Study||25
1520428|NCT01505387|3720533|P2|NOT COMPLETED|Overall Study||1
1520429|NCT01505387|3720534|P1|NOT COMPLETED|Overall Study||2
1520430|NCT01505387|3720533|P2|COMPLETED|Overall Study||24
1520431|NCT01505387|3720534|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
1520432|NCT01505387|3720533|P2|Treated|Overall Study||24
1520433|NCT01505387|3720534|P1|Treated|Overall Study||24
1520434|NCT01505387|3720533|P2|STARTED|Overall Study||25
1520435|NCT01505387|3720534|P1|STARTED|Overall Study||25
1520436|NCT01505374|3720540|P2|NOT COMPLETED|Overall Study||0
1520437|NCT01505374|3720541|P1|NOT COMPLETED|Overall Study||1
1520438|NCT01505374|3720540|P2|COMPLETED|Overall Study||30
1520439|NCT01505374|3720541|P1|COMPLETED|Overall Study||29
1520440|NCT01505374|3720540|P2|STARTED|Overall Study||30
1520441|NCT01505374|3720541|P1|STARTED|Overall Study||30
1520442|NCT01505166|3720558|P3|NOT COMPLETED|Overall Study||0
1520443|NCT01505166|3720559|P2|NOT COMPLETED|Overall Study||0
1520444|NCT01505166|3720560|P1|NOT COMPLETED|Overall Study||0
1520445|NCT01505166|3720558|P3|COMPLETED|Overall Study||0
1520446|NCT01505166|3720559|P2|COMPLETED|Overall Study||0
1520447|NCT01505166|3720560|P1|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
1520448|NCT01505166|3720558|P3|STARTED|Overall Study||0
1520449|NCT01505166|3720559|P2|STARTED|Overall Study||0
1520450|NCT01505166|3720560|P1|STARTED|Overall Study||3
1520451|NCT01505114|3720576|P4|NOT COMPLETED|Overall Study||23
1520452|NCT01505114|3720577|P3|NOT COMPLETED|Overall Study||18
1520453|NCT01505114|3720578|P2|NOT COMPLETED|Overall Study||13
1520454|NCT01505114|3720579|P1|NOT COMPLETED|Overall Study||25
1520455|NCT01505114|3720576|P4|COMPLETED|Overall Study||128
1520456|NCT01505114|3720577|P3|COMPLETED|Overall Study||129
1520457|NCT01505114|3720578|P2|COMPLETED|Overall Study||135
1520458|NCT01505114|3720579|P1|COMPLETED|Overall Study||123
1520459|NCT01505114|3720576|P4|STARTED|Overall Study||151
1520460|NCT01505114|3720577|P3|STARTED|Overall Study||147
1520461|NCT01505114|3720578|P2|STARTED|Overall Study||148
1520462|NCT01505114|3720579|P1|STARTED|Overall Study||148
1520463|NCT01504997|3720589|P1|NOT COMPLETED|Overall Study||0
1520464|NCT01504997|3720589|P1|COMPLETED|Overall Study||18
1520465|NCT01504997|3720589|P1|STARTED|Overall Study||18
1520466|NCT01504971|3720593|P1|NOT COMPLETED|Overall Study||13
1520467|NCT01504971|3720593|P1|COMPLETED|Overall Study||82
1520468|NCT01504971|3720593|P1|STARTED|Overall Study||95
1520469|NCT01504958|3720604|P3|NOT COMPLETED|Overall Study||0
1520470|NCT01504958|3720605|P2|NOT COMPLETED|Overall Study||0
1520471|NCT01504958|3720606|P1|NOT COMPLETED|Overall Study||0
1520472|NCT01504958|3720604|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
1520473|NCT01504958|3720605|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
1520474|NCT01504958|3720606|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
1520475|NCT01504958|3720604|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
1520476|NCT01504958|3720605|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
1520477|NCT01504958|3720606|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
1520478|NCT01504867|3720622|P2|NOT COMPLETED|Overall Study||3
1520479|NCT01504867|3720623|P1|NOT COMPLETED|Overall Study||7
1520480|NCT01504867|3720622|P2|COMPLETED|Overall Study||195
1520481|NCT01504867|3720623|P1|COMPLETED|Overall Study||195
1520482|NCT01504867|3720622|P2|STARTED|Overall Study||198
1520483|NCT01504867|3720623|P1|STARTED|Overall Study||202
1520484|NCT01504854|3720643|P2|NOT COMPLETED|Overall Study||7
1520485|NCT01504854|3720644|P1|NOT COMPLETED|Overall Study||8
1520486|NCT01504854|3720643|P2|COMPLETED|Overall Study||48
1520487|NCT01504854|3720644|P1|COMPLETED|Overall Study||56
1520488|NCT01504854|3720643|P2|STARTED|Overall Study||55
1520489|NCT01504854|3720644|P1|STARTED|Overall Study||64
1520490|NCT01504204|3720660|P2|NOT COMPLETED|Overall Study||1
1520491|NCT01504204|3720661|P1|NOT COMPLETED|Overall Study||1
1520492|NCT01504204|3720660|P2|COMPLETED|Overall Study||9
1520493|NCT01504204|3720661|P1|COMPLETED|Overall Study||9
1520494|NCT01504204|3720660|P2|STARTED|Overall Study||10
1520495|NCT01504204|3720661|P1|STARTED|Overall Study||10
1520496|NCT01503749|3720674|P3|NOT COMPLETED|Overall Study||0
1520497|NCT01503749|3720675|P2|NOT COMPLETED|Overall Study||0
1520498|NCT01503749|3720676|P1|NOT COMPLETED|Overall Study||0
1520499|NCT01503749|3720674|P3|COMPLETED|Overall Study||3
1520500|NCT01503749|3720675|P2|COMPLETED|Overall Study||3
1520501|NCT01503749|3720676|P1|COMPLETED|Overall Study||3
1520502|NCT01503749|3720674|P3|STARTED|Overall Study||3
1520503|NCT01503749|3720675|P2|STARTED|Overall Study||3
1520504|NCT01503749|3720676|P1|STARTED|Overall Study||3
1520505|NCT01503333|3720689|P2|NOT COMPLETED|Overall Study||305
1520506|NCT01503333|3720690|P1|NOT COMPLETED|Overall Study||340
1520507|NCT01503333|3720689|P2|COMPLETED|Overall Study||461
1520508|NCT01503333|3720690|P1|COMPLETED|Overall Study||437
1520509|NCT01503333|3720689|P2|Completed Post-intervention|Overall Study||706
1520510|NCT01503333|3720690|P1|Completed Post-intervention|Overall Study||680
1520511|NCT01503333|3720689|P2|Completed Baseline|Overall Study||753
1520512|NCT01503333|3720690|P1|Completed Baseline|Overall Study||766
1520513|NCT01503333|3720689|P2|STARTED|Overall Study||766
1520514|NCT01503333|3720690|P1|STARTED|Overall Study||777
1520515|NCT01503164|3720718|P2|NOT COMPLETED|Overall Study||1
1520516|NCT01503164|3720719|P1|NOT COMPLETED|Overall Study||2
1520517|NCT01503164|3720718|P2|COMPLETED|Overall Study||55
1520518|NCT01503164|3720719|P1|COMPLETED|Overall Study||53
1520519|NCT01503164|3720718|P2|STARTED|Overall Study||56
1520520|NCT01503164|3720719|P1|STARTED|Overall Study||55
1520521|NCT01503021|3720749|P2|NOT COMPLETED|Overall Study||26
1520522|NCT01503021|3720750|P1|NOT COMPLETED|Overall Study||27
1520523|NCT01503021|3720749|P2|COMPLETED|Overall Study||332
1520524|NCT01503021|3720750|P1|COMPLETED|Overall Study||333
1520525|NCT01503021|3720749|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
1520526|NCT01503021|3720750|P1|Completed Treatment|Overall Study||333
1520527|NCT01503021|3720749|P2|Dosed|Overall Study||352
1520528|NCT01503021|3720750|P1|Dosed|Overall Study||351
1520529|NCT01503021|3720749|P2|STARTED|Overall Study||358
1520530|NCT01503021|3720750|P1|STARTED|Overall Study||360
1520531|NCT01502956|3720799|P2|NOT COMPLETED|Overall Study||26
1520532|NCT01502956|3720800|P1|NOT COMPLETED|Overall Study||24
1520533|NCT01502956|3720799|P2|COMPLETED|Overall Study||168
1520534|NCT01502956|3720800|P1|COMPLETED|Overall Study||168
1520535|NCT01502956|3720799|P2|STARTED|Overall Study||194
1520536|NCT01502956|3720800|P1|STARTED|Overall Study||192
1520537|NCT01502787|3720824|P2|NOT COMPLETED|Overall Study||0
1520538|NCT01502787|3720825|P1|NOT COMPLETED|Overall Study||0
1520539|NCT01502787|3720824|P2|COMPLETED|Overall Study||10
1520540|NCT01502787|3720825|P1|COMPLETED|Overall Study||11
1520541|NCT01502787|3720824|P2|STARTED|Overall Study||10
1520542|NCT01502787|3720825|P1|STARTED|Overall Study||11
1520543|NCT01502761|3720839|P4|NOT COMPLETED|Overall Study||0
1520544|NCT01502761|3720840|P3|NOT COMPLETED|Overall Study||0
1520545|NCT01502761|3720841|P2|NOT COMPLETED|Overall Study||0
1520546|NCT01502761|3720842|P1|NOT COMPLETED|Overall Study||0
1520547|NCT01502761|3720839|P4|COMPLETED|Overall Study||0
1520548|NCT01502761|3720840|P3|COMPLETED|Overall Study||0
1520549|NCT01502761|3720841|P2|COMPLETED|Overall Study||0
1520550|NCT01502761|3720842|P1|COMPLETED|Overall Study||4
1520551|NCT01502761|3720839|P4|STARTED|Overall Study||0
1520552|NCT01502761|3720840|P3|STARTED|Overall Study||0
1520553|NCT01502761|3720841|P2|STARTED|Overall Study||0
1520554|NCT01502761|3720842|P1|STARTED|Overall Study||4
1520555|NCT01502709|3720858|P2|NOT COMPLETED|Overall Study||0
1520556|NCT01502709|3720859|P1|NOT COMPLETED|Overall Study||4
1520557|NCT01502709|3720858|P2|COMPLETED|Overall Study||0
1520558|NCT01502709|3720859|P1|COMPLETED|Overall Study||1
1520559|NCT01502709|3720858|P2|STARTED|Overall Study||0
1520560|NCT01502709|3720859|P1|STARTED|Overall Study||5
1520561|NCT01502644|3720872|P4|NOT COMPLETED|Assigned to NA Groups||8
1520562|NCT01502644|3720873|P3|NOT COMPLETED|Assigned to NA Groups||3
1520563|NCT01502644|3720874|P2|NOT COMPLETED|Assigned to NA Groups||6
1520564|NCT01502644|3720875|P1|NOT COMPLETED|Assigned to NA Groups||0
1520565|NCT01502644|3720872|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
1520566|NCT01502644|3720873|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
1520567|NCT01502644|3720874|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
1520568|NCT01502644|3720875|P1|COMPLETED|Assigned to NA Groups||0
1520569|NCT01502644|3720872|P4|STARTED|Assigned to NA Groups||32
1520570|NCT01502644|3720873|P3|STARTED|Assigned to NA Groups||10
1520571|NCT01502644|3720874|P2|STARTED|Assigned to NA Groups||30
1520572|NCT01502644|3720875|P1|STARTED|Assigned to NA Groups||0
1520573|NCT01502644|3720872|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1520574|NCT01502644|3720873|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1520575|NCT01502644|3720874|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1520576|NCT01502644|3720875|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
1520577|NCT01502644|3720872|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1520578|NCT01502644|3720873|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1520579|NCT01502644|3720874|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
1520580|NCT01502644|3720875|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
1520581|NCT01502644|3720872|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
1520582|NCT01502644|3720873|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
1520583|NCT01502644|3720874|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
1520584|NCT01502644|3720875|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
1520585|NCT01502423|3720885|P2|NOT COMPLETED|Overall Study||1
1520586|NCT01502423|3720886|P1|NOT COMPLETED|Overall Study||0
1520587|NCT01502423|3720885|P2|COMPLETED|Overall Study||29
1520588|NCT01502423|3720886|P1|COMPLETED|Overall Study||31
1520589|NCT01502423|3720885|P2|STARTED|Overall Study||30
1520590|NCT01502423|3720886|P1|STARTED|Overall Study||31
1520591|NCT01502410|3720908|P4|NOT COMPLETED|Overall Study||0
1520592|NCT01502410|3720909|P3|NOT COMPLETED|Overall Study||0
1520593|NCT01502410|3720910|P2|NOT COMPLETED|Overall Study||10
1520594|NCT01502410|3720911|P1|NOT COMPLETED|Overall Study||10
1520595|NCT01502410|3720908|P4|COMPLETED|Overall Study||0
1520596|NCT01502410|3720909|P3|COMPLETED|Overall Study||0
1520597|NCT01502410|3720910|P2|COMPLETED|Overall Study||0
1520598|NCT01502410|3720911|P1|COMPLETED|Overall Study||0
1520599|NCT01502410|3720908|P4|STARTED|Overall Study||0
1520600|NCT01502410|3720909|P3|STARTED|Overall Study||0
1520601|NCT01502410|3720910|P2|STARTED|Overall Study||10
1520602|NCT01502410|3720911|P1|STARTED|Overall Study||10
1520603|NCT01502371|3720929|P5|NOT COMPLETED|Overall Study||52
1520604|NCT01502371|3720930|P4|NOT COMPLETED|Overall Study||37
1520605|NCT01502371|3720931|P3|NOT COMPLETED|Overall Study||25
1520606|NCT01502371|3720932|P2|NOT COMPLETED|Overall Study||32
1520607|NCT01502371|3720933|P1|NOT COMPLETED|Overall Study||41
1520608|NCT01502371|3720929|P5|COMPLETED|Overall Study||60
1520609|NCT01502371|3720930|P4|COMPLETED|Overall Study||88
1520610|NCT01502371|3720931|P3|COMPLETED|Overall Study||83
1520611|NCT01502371|3720932|P2|COMPLETED|Overall Study||81
1520612|NCT01502371|3720933|P1|COMPLETED|Overall Study||79
1520613|NCT01502371|3720929|P5|STARTED|Overall Study||112
1520614|NCT01502371|3720930|P4|STARTED|Overall Study||125
1520615|NCT01502371|3720931|P3|STARTED|Overall Study||108
1520616|NCT01502371|3720932|P2|STARTED|Overall Study||113
1520617|NCT01502371|3720933|P1|STARTED|Overall Study||120
1520618|NCT01502332|3720958|P2|NOT COMPLETED|Overall Study||0
1520619|NCT01502332|3720959|P1|NOT COMPLETED|Overall Study||0
1520620|NCT01502332|3720958|P2|COMPLETED|Overall Study||163
1520621|NCT01502332|3720959|P1|COMPLETED|Overall Study||157
1520622|NCT01502332|3720958|P2|STARTED|Overall Study||163
1520623|NCT01502332|3720959|P1|STARTED|Overall Study||157
1520624|NCT01502228|3720973|P1|NOT COMPLETED|Overall Study||1
1520625|NCT01502228|3720973|P1|COMPLETED|Overall Study||13
1520626|NCT01502228|3720973|P1|STARTED|Overall Study||14
1520627|NCT01502033|3720978|P1|NOT COMPLETED|Overall Study||3
1520628|NCT01502033|3720978|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
1520629|NCT01502033|3720978|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
1520630|NCT01501955|3720986|P2|NOT COMPLETED|Overall Study||3
1520631|NCT01501955|3720987|P1|NOT COMPLETED|Overall Study||2
1520632|NCT01501955|3720986|P2|COMPLETED|Overall Study||6
1520633|NCT01501955|3720987|P1|COMPLETED|Overall Study||9
1520634|NCT01501955|3720986|P2|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
1520635|NCT01501955|3720987|P1|2 Years Postop|Overall Study||9
1520636|NCT01501955|3720986|P2|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
1520637|NCT01501955|3720987|P1|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
1520638|NCT01501955|3720986|P2|6 Weeks Postop|Overall Study||9
1520639|NCT01501955|3720987|P1|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
1520640|NCT01501955|3720986|P2|Surgery|Overall Study||9
1520641|NCT01501955|3720987|P1|Surgery|Overall Study||11
1520642|NCT01501955|3720986|P2|STARTED|Overall Study||9
1520643|NCT01501955|3720987|P1|STARTED|Overall Study||11
1520644|NCT01501929|3721029|P2|NOT COMPLETED|Second Intervention||0
1520645|NCT01501929|3721030|P1|NOT COMPLETED|Second Intervention||0
1520646|NCT01501929|3721029|P2|COMPLETED|Second Intervention||17
1520647|NCT01501929|3721030|P1|COMPLETED|Second Intervention||8
1520648|NCT01501929|3721029|P2|STARTED|Second Intervention||17
1520649|NCT01501929|3721030|P1|STARTED|Second Intervention||8
1520650|NCT01501929|3721029|P2|NOT COMPLETED|First Intervention||0
1520651|NCT01501929|3721030|P1|NOT COMPLETED|First Intervention||0
1520652|NCT01501929|3721029|P2|COMPLETED|First Intervention||17
1520653|NCT01501929|3721030|P1|COMPLETED|First Intervention||8
1520654|NCT01501929|3721029|P2|STARTED|First Intervention||17
1520655|NCT01501929|3721030|P1|STARTED|First Intervention||8
1520656|NCT01501162|3721040|P2|NOT COMPLETED|Overall Study||5
1520657|NCT01501162|3721041|P1|NOT COMPLETED|Overall Study||8
1520658|NCT01501162|3721040|P2|COMPLETED|Overall Study||60
1520659|NCT01501162|3721041|P1|COMPLETED|Overall Study||57
1520660|NCT01501162|3721040|P2|STARTED|Overall Study||65
1520661|NCT01501162|3721041|P1|STARTED|Overall Study||65
1520662|NCT01501110|3721051|P2|NOT COMPLETED|Overall Study||1
1520663|NCT01501110|3721052|P1|NOT COMPLETED|Overall Study||0
1520664|NCT01501110|3721051|P2|COMPLETED|Overall Study||33
1520665|NCT01501110|3721052|P1|COMPLETED|Overall Study||34
1520666|NCT01501110|3721051|P2|STARTED|Overall Study||34
1520667|NCT01501110|3721052|P1|STARTED|Overall Study||34
1520668|NCT01500772|3721058|P1|NOT COMPLETED|Overall Study||6
1520669|NCT01500772|3721058|P1|COMPLETED|Overall Study||0
1520670|NCT01500772|3721058|P1|STARTED|Overall Study||6
1520671|NCT01500746|3721067|P2|NOT COMPLETED|Overall Study||0
1520672|NCT01500746|3721068|P1|NOT COMPLETED|Overall Study||0
1520673|NCT01500746|3721067|P2|COMPLETED|Overall Study||4
1520674|NCT01500746|3721068|P1|COMPLETED|Overall Study||4
1520675|NCT01500746|3721067|P2|STARTED|Overall Study||4
1520676|NCT01500746|3721068|P1|STARTED|Overall Study||4
1520677|NCT01500733|3721076|P2|NOT COMPLETED|Overall Study||3
1520678|NCT01500733|3721077|P1|NOT COMPLETED|Overall Study||2
1520679|NCT01500733|3721076|P2|COMPLETED|Overall Study||48
1520680|NCT01500733|3721077|P1|COMPLETED|Overall Study||33
1520681|NCT01500733|3721076|P2|STARTED|Overall Study||51
1520682|NCT01500733|3721077|P1|STARTED|Overall Study||35
1520683|NCT01500720|3721085|P2|NOT COMPLETED|Overall Study||9
1520684|NCT01500720|3721086|P1|NOT COMPLETED|Overall Study||5
1520685|NCT01500720|3721085|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
1520686|NCT01500720|3721086|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
1520687|NCT01500720|3721085|P2|Treated|Overall Study||88
1520688|NCT01500720|3721086|P1|Treated|Overall Study||89
1520689|NCT01500720|3721085|P2|STARTED|Overall Study|Randomized|89
1520690|NCT01500720|3721086|P1|STARTED|Overall Study|Randomized|90
1520691|NCT01500694|3721100|P2|NOT COMPLETED|Overall Study||29
1520692|NCT01500694|3721101|P1|NOT COMPLETED|Overall Study||52
1520693|NCT01500694|3721100|P2|COMPLETED|Overall Study||54
1520694|NCT01500694|3721101|P1|COMPLETED|Overall Study||79
1520695|NCT01500694|3721100|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
1520696|NCT01500694|3721101|P1|STARTED|Overall Study||131
1520697|NCT01500629|3721127|P2|NOT COMPLETED|Period 2 (Single Dose)||0
1520698|NCT01500629|3721128|P1|NOT COMPLETED|Period 2 (Single Dose)||0
1520699|NCT01500629|3721127|P2|COMPLETED|Period 2 (Single Dose)||10
1520700|NCT01500629|3721128|P1|COMPLETED|Period 2 (Single Dose)||10
1520701|NCT01500629|3721127|P2|STARTED|Period 2 (Single Dose)||10
1520702|NCT01500629|3721128|P1|STARTED|Period 2 (Single Dose)||10
1520703|NCT01500629|3721127|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
1520704|NCT01500629|3721128|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
1520705|NCT01500629|3721127|P2|COMPLETED|Washout Period of 14 to 30 Days||10
1520706|NCT01500629|3721128|P1|COMPLETED|Washout Period of 14 to 30 Days||10
1520707|NCT01500629|3721127|P2|STARTED|Washout Period of 14 to 30 Days||10
1520708|NCT01500629|3721128|P1|STARTED|Washout Period of 14 to 30 Days||11
1520709|NCT01500629|3721127|P2|NOT COMPLETED|Period 1 (Single Dose)||0
1520710|NCT01500629|3721128|P1|NOT COMPLETED|Period 1 (Single Dose)||0
1520711|NCT01500629|3721127|P2|COMPLETED|Period 1 (Single Dose)||10
1520712|NCT01500629|3721128|P1|COMPLETED|Period 1 (Single Dose)||11
1520713|NCT01500629|3721127|P2|STARTED|Period 1 (Single Dose)||10
1520714|NCT01500629|3721128|P1|STARTED|Period 1 (Single Dose)||11
1520715|NCT01500434|3721212|P1|NOT COMPLETED|Overall Study||7
1520716|NCT01500434|3721212|P1|COMPLETED|Overall Study||95
1520717|NCT01500434|3721212|P1|STARTED|Overall Study||102
1520718|NCT01500382|3721245|P4|NOT COMPLETED|Treatment Period 2||0
1520719|NCT01500382|3721246|P3|NOT COMPLETED|Treatment Period 2||0
1520720|NCT01500382|3721247|P2|NOT COMPLETED|Treatment Period 2||0
1520721|NCT01500382|3721248|P1|NOT COMPLETED|Treatment Period 2||0
1520722|NCT01500382|3721245|P4|COMPLETED|Treatment Period 2||1
1520723|NCT01500382|3721246|P3|COMPLETED|Treatment Period 2||0
1520724|NCT01500382|3721247|P2|COMPLETED|Treatment Period 2||1
1520725|NCT01500382|3721248|P1|COMPLETED|Treatment Period 2||1
1520726|NCT01500382|3721245|P4|STARTED|Treatment Period 2||1
1520727|NCT01500382|3721246|P3|STARTED|Treatment Period 2||0
1520728|NCT01500382|3721247|P2|STARTED|Treatment Period 2||1
1520729|NCT01500382|3721248|P1|STARTED|Treatment Period 2||1
1520730|NCT01500382|3721245|P4|NOT COMPLETED|Washout Period||0
1520731|NCT01500382|3721246|P3|NOT COMPLETED|Washout Period||1
1520732|NCT01500382|3721247|P2|NOT COMPLETED|Washout Period||0
1520733|NCT01500382|3721248|P1|NOT COMPLETED|Washout Period||0
1520734|NCT01500382|3721245|P4|COMPLETED|Washout Period||1
1520735|NCT01500382|3721246|P3|COMPLETED|Washout Period||0
1520736|NCT01500382|3721247|P2|COMPLETED|Washout Period||1
1520737|NCT01500382|3721248|P1|COMPLETED|Washout Period||1
1520738|NCT01500382|3721245|P4|STARTED|Washout Period||1
1520739|NCT01500382|3721246|P3|STARTED|Washout Period||1
1520740|NCT01500382|3721247|P2|STARTED|Washout Period||1
1520741|NCT01500382|3721248|P1|STARTED|Washout Period||1
1520742|NCT01500382|3721245|P4|NOT COMPLETED|Treatment Period 1||0
1520743|NCT01500382|3721246|P3|NOT COMPLETED|Treatment Period 1||0
1520744|NCT01500382|3721247|P2|NOT COMPLETED|Treatment Period 1||0
1520745|NCT01500382|3721248|P1|NOT COMPLETED|Treatment Period 1||0
1520746|NCT01500382|3721245|P4|COMPLETED|Treatment Period 1||1
1520747|NCT01500382|3721246|P3|COMPLETED|Treatment Period 1||1
1520748|NCT01500382|3721247|P2|COMPLETED|Treatment Period 1||1
1520749|NCT01500382|3721248|P1|COMPLETED|Treatment Period 1||1
1520750|NCT01500382|3721245|P4|STARTED|Treatment Period 1||1
1520751|NCT01500382|3721246|P3|STARTED|Treatment Period 1||1
1520752|NCT01500382|3721247|P2|STARTED|Treatment Period 1||1
1520753|NCT01500382|3721248|P1|STARTED|Treatment Period 1||1
1520754|NCT01500317|3721273|P3|NOT COMPLETED|Overall Study||0
1520755|NCT01500317|3721274|P2|NOT COMPLETED|Overall Study||2
1520756|NCT01500317|3721275|P1|NOT COMPLETED|Overall Study||3
1520757|NCT01500317|3721273|P3|COMPLETED|Overall Study||13
1520758|NCT01500317|3721274|P2|COMPLETED|Overall Study||10
1520759|NCT01500317|3721275|P1|COMPLETED|Overall Study||10
1520760|NCT01500317|3721273|P3|STARTED|Overall Study||13
1520761|NCT01500317|3721274|P2|STARTED|Overall Study||12
1520762|NCT01500317|3721275|P1|STARTED|Overall Study||13
1520763|NCT01500278|3721297|P2|NOT COMPLETED|Week 13 - Week 104||126
1520764|NCT01500278|3721298|P1|NOT COMPLETED|Week 13 - Week 104||139
1520765|NCT01500278|3721297|P2|COMPLETED|Week 13 - Week 104||302
1520766|NCT01500278|3721298|P1|COMPLETED|Week 13 - Week 104||287
1520767|NCT01500278|3721297|P2|STARTED|Week 13 - Week 104||428
1520768|NCT01500278|3721298|P1|STARTED|Week 13 - Week 104||426
1520769|NCT01500278|3721297|P2|NOT COMPLETED|Week 0 - Week 12||30
1520770|NCT01500278|3721298|P1|NOT COMPLETED|Week 0 - Week 12||31
1520771|NCT01500278|3721297|P2|COMPLETED|Week 0 - Week 12||428
1520772|NCT01500278|3721298|P1|COMPLETED|Week 0 - Week 12||426
1520773|NCT01500278|3721297|P2|STARTED|Week 0 - Week 12||458
1520774|NCT01500278|3721298|P1|STARTED|Week 0 - Week 12||457
1520775|NCT01500252|3721322|P2|NOT COMPLETED|Overall Study||6
1520776|NCT01500252|3721323|P1|NOT COMPLETED|Overall Study||9
1520777|NCT01500252|3721322|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
1520778|NCT01500252|3721323|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
1520779|NCT01500252|3721322|P2|Ten Years|Overall Study||11
1520780|NCT01500252|3721323|P1|Ten Years|Overall Study||12
1520781|NCT01500252|3721322|P2|Five Years|Overall Study||13
1520782|NCT01500252|3721323|P1|Five Years|Overall Study||17
1520783|NCT01500252|3721322|P2|One Years|Overall Study||16
1520784|NCT01500252|3721323|P1|One Years|Overall Study||20
1520785|NCT01500252|3721322|P2|STARTED|Overall Study||17
1520786|NCT01500252|3721323|P1|STARTED|Overall Study||21
1520787|NCT01500226|3721349|P2|NOT COMPLETED|Overall Study||494
1520788|NCT01500226|3721350|P1|NOT COMPLETED|Overall Study||499
1520789|NCT01500226|3721349|P2|COMPLETED|Overall Study||191
1520790|NCT01500226|3721350|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
1520791|NCT01500226|3721349|P2|STARTED|Overall Study||685
1520792|NCT01500226|3721350|P1|STARTED|Overall Study|Number of randomized patients|684
1520793|NCT01500213|3721362|P2|NOT COMPLETED|Overall Study||224
1520794|NCT01500213|3721363|P1|NOT COMPLETED|Overall Study||217
1520795|NCT01500213|3721362|P2|COMPLETED|Overall Study||53
1520796|NCT01500213|3721363|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
1520797|NCT01500213|3721362|P2|STARTED|Overall Study||277
1520798|NCT01500213|3721363|P1|STARTED|Overall Study|Number of randomized patients|278
1520799|NCT01500135|3721375|P2|NOT COMPLETED|Overall Study||11
1520800|NCT01500135|3721376|P1|NOT COMPLETED|Overall Study||17
1520801|NCT01500135|3721375|P2|COMPLETED|Overall Study||39
1520802|NCT01500135|3721376|P1|COMPLETED|Overall Study||83
1520803|NCT01500135|3721375|P2|STARTED|Overall Study||50
1520804|NCT01500135|3721376|P1|STARTED|Overall Study||100
1520805|NCT01500109|3721389|P3|NOT COMPLETED|Overall Study||0
1520806|NCT01500109|3721390|P2|NOT COMPLETED|Overall Study||0
1520807|NCT01500109|3721391|P1|NOT COMPLETED|Overall Study||0
1520808|NCT01500109|3721389|P3|COMPLETED|Overall Study||16
1520809|NCT01500109|3721390|P2|COMPLETED|Overall Study||14
1520810|NCT01500109|3721391|P1|COMPLETED|Overall Study||15
1520811|NCT01500109|3721389|P3|STARTED|Overall Study||16
1520812|NCT01500109|3721390|P2|STARTED|Overall Study||14
1520813|NCT01500109|3721391|P1|STARTED|Overall Study||15
1520814|NCT01500096|3721403|P4|NOT COMPLETED|Overall Study||2
1520815|NCT01500096|3721404|P3|NOT COMPLETED|Overall Study||0
1520816|NCT01500096|3721405|P2|NOT COMPLETED|Overall Study||0
1520817|NCT01500096|3721406|P1|NOT COMPLETED|Overall Study||1
1520818|NCT01500096|3721403|P4|COMPLETED|Overall Study||14
1520819|NCT01500096|3721404|P3|COMPLETED|Overall Study||31
1520820|NCT01500096|3721405|P2|COMPLETED|Overall Study||17
1520821|NCT01500096|3721406|P1|COMPLETED|Overall Study||31
1520822|NCT01500096|3721403|P4|STARTED|Overall Study||16
1520823|NCT01500096|3721404|P3|STARTED|Overall Study||31
1520824|NCT01500096|3721405|P2|STARTED|Overall Study||17
1520825|NCT01500096|3721406|P1|STARTED|Overall Study||32
1520826|NCT01500083|3721462|P2|NOT COMPLETED|Overall Study||43
1520827|NCT01500083|3721463|P1|NOT COMPLETED|Overall Study||12
1520828|NCT01500083|3721462|P2|COMPLETED|Overall Study||31
1520829|NCT01500083|3721463|P1|COMPLETED|Overall Study||4
1520830|NCT01500083|3721462|P2|STARTED|Overall Study||74
1520831|NCT01500083|3721463|P1|STARTED|Overall Study||16
1520832|NCT01500057|3721471|P2|NOT COMPLETED|Overall Study||4
1520833|NCT01500057|3721472|P1|NOT COMPLETED|Overall Study||6
1520834|NCT01500057|3721471|P2|COMPLETED|Overall Study||31
1520835|NCT01500057|3721472|P1|COMPLETED|Overall Study||25
1520836|NCT01500057|3721471|P2|STARTED|Overall Study||35
1520837|NCT01500057|3721472|P1|STARTED|Overall Study||31
1520838|NCT01500031|3721482|P1|NOT COMPLETED|Overall Study||5
1520839|NCT01500031|3721482|P1|COMPLETED|Overall Study||87
1520840|NCT01500031|3721482|P1|STARTED|Overall Study||92
1520841|NCT01499862|3721497|P1|NOT COMPLETED|Overall Study||0
1520842|NCT01499862|3721497|P1|COMPLETED|Overall Study||3
1520843|NCT01499862|3721497|P1|STARTED|Overall Study||3
1520844|NCT01499849|3721517|P2|NOT COMPLETED|Overall Study||226
1520845|NCT01499849|3721518|P1|NOT COMPLETED|Overall Study||224
1520846|NCT01499849|3721517|P2|COMPLETED|Overall Study||40
1520847|NCT01499849|3721518|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
1520848|NCT01499849|3721517|P2|STARTED|Overall Study||266
1520849|NCT01499849|3721518|P1|STARTED|Overall Study|Number of randomized patients|266
1520850|NCT01499810|3721528|P1|NOT COMPLETED|Overall Study||12
1520851|NCT01499810|3721528|P1|COMPLETED|Overall Study||41
1520852|NCT01499810|3721528|P1|STARTED|Overall Study||53
1520853|NCT01499667|3721578|P3|NOT COMPLETED|Overall Study||10
1520854|NCT01499667|3721579|P2|NOT COMPLETED|Overall Study||11
1520855|NCT01499667|3721580|P1|NOT COMPLETED|Overall Study||9
1520856|NCT01499667|3721578|P3|COMPLETED|Overall Study||40
1520857|NCT01499667|3721579|P2|COMPLETED|Overall Study||31
1520858|NCT01499667|3721580|P1|COMPLETED|Overall Study||41
1520859|NCT01499667|3721578|P3|Modified Full Analysis Set|Overall Study||39
1520860|NCT01499667|3721579|P2|Modified Full Analysis Set|Overall Study||29
1520861|NCT01499667|3721580|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
1520862|NCT01499667|3721578|P3|Full Analysis Set (FAS)|Overall Study||50
1520863|NCT01499667|3721579|P2|Full Analysis Set (FAS)|Overall Study||42
1520864|NCT01499667|3721580|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
1520865|NCT01499667|3721578|P3|STARTED|Overall Study||50
1520866|NCT01499667|3721579|P2|STARTED|Overall Study||42
1520867|NCT01499667|3721580|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
1520868|NCT01499654|3721609|P1|NOT COMPLETED|Overall Study||0
1520869|NCT01499654|3721609|P1|COMPLETED|Overall Study||64
1520870|NCT01499654|3721609|P1|STARTED|Overall Study||64
1520871|NCT01499576|3721628|P1|NOT COMPLETED|Overall Study||21
1520872|NCT01499576|3721628|P1|COMPLETED|Overall Study||105
1520873|NCT01499576|3721628|P1|STARTED|Overall Study||126
1520874|NCT01499498|3721634|P1|NOT COMPLETED|Overall Study||0
1520875|NCT01499498|3721634|P1|COMPLETED|Overall Study||13
1520876|NCT01499498|3721634|P1|STARTED|Overall Study||13
1520877|NCT01499355|3721642|P4|NOT COMPLETED|Double-Blind Period||23
1520878|NCT01499355|3721643|P3|NOT COMPLETED|Double-Blind Period||25
1520879|NCT01499355|3721644|P2|NOT COMPLETED|Double-Blind Period||23
1520880|NCT01499355|3721645|P1|NOT COMPLETED|Double-Blind Period||0
1520881|NCT01499355|3721642|P4|COMPLETED|Double-Blind Period||39
1520882|NCT01499355|3721643|P3|COMPLETED|Double-Blind Period||38
1520883|NCT01499355|3721644|P2|COMPLETED|Double-Blind Period||40
1520884|NCT01499355|3721645|P1|COMPLETED|Double-Blind Period||0
1520885|NCT01499355|3721642|P4|STARTED|Double-Blind Period||62
1520886|NCT01499355|3721643|P3|STARTED|Double-Blind Period||63
1520887|NCT01499355|3721644|P2|STARTED|Double-Blind Period||63
1520888|NCT01499355|3721645|P1|STARTED|Double-Blind Period||0
1520889|NCT01499355|3721642|P4|NOT COMPLETED|Run-In Period||0
1520890|NCT01499355|3721643|P3|NOT COMPLETED|Run-In Period||0
1520891|NCT01499355|3721644|P2|NOT COMPLETED|Run-In Period||0
1520892|NCT01499355|3721645|P1|NOT COMPLETED|Run-In Period||31
1520893|NCT01499355|3721642|P4|COMPLETED|Run-In Period||0
1520894|NCT01499355|3721643|P3|COMPLETED|Run-In Period||0
1520895|NCT01499355|3721644|P2|COMPLETED|Run-In Period||0
1520896|NCT01499355|3721645|P1|COMPLETED|Run-In Period||245
1520897|NCT01499355|3721642|P4|STARTED|Run-In Period||0
1520898|NCT01499355|3721643|P3|STARTED|Run-In Period||0
1520899|NCT01499355|3721644|P2|STARTED|Run-In Period||0
1520900|NCT01499355|3721645|P1|STARTED|Run-In Period||276
1520901|NCT01499303|3721678|P2|NOT COMPLETED|Overall Study||7
1520902|NCT01499303|3721679|P1|NOT COMPLETED|Overall Study||3
1520903|NCT01499303|3721678|P2|COMPLETED|Overall Study||40
1520904|NCT01499303|3721679|P1|COMPLETED|Overall Study||18
1520905|NCT01499303|3721678|P2|STARTED|Overall Study||47
1520906|NCT01499303|3721679|P1|STARTED|Overall Study||21
1520907|NCT01499290|3721687|P2|NOT COMPLETED|Overall Study||35
1520908|NCT01499290|3721688|P1|NOT COMPLETED|Overall Study||55
1520909|NCT01499290|3721687|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
1520910|NCT01499290|3721688|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
1520911|NCT01499290|3721687|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
1520912|NCT01499290|3721688|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
1520913|NCT01499277|3721738|P2|NOT COMPLETED|Overall Study||32
1520914|NCT01499277|3721739|P1|NOT COMPLETED|Overall Study||47
1520915|NCT01499277|3721738|P2|COMPLETED|Overall Study||223
1520916|NCT01499277|3721739|P1|COMPLETED|Overall Study||459
1520917|NCT01499277|3721738|P2|STARTED|Overall Study||255
1520918|NCT01499277|3721739|P1|STARTED|Overall Study||506
1520919|NCT01499199|3721761|P1|NOT COMPLETED|Overall Study||2
1520920|NCT01499199|3721761|P1|COMPLETED|Overall Study||11
1520921|NCT01499199|3721761|P1|STARTED|Overall Study||13
1520922|NCT01499173|3721780|P1|NOT COMPLETED|Overall Study||37
1520923|NCT01499173|3721780|P1|COMPLETED|Overall Study||64
1520924|NCT01499173|3721780|P1|STARTED|Overall Study||101
1520925|NCT01499160|3721790|P1|NOT COMPLETED|Overall Study||2
1520926|NCT01499160|3721790|P1|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
1520927|NCT01499160|3721790|P1|STARTED|Overall Study||7
1520928|NCT01499147|3721797|P2|NOT COMPLETED|Overall Study||5
1520929|NCT01499147|3721798|P1|NOT COMPLETED|Overall Study||15
1520930|NCT01499147|3721797|P2|COMPLETED|Overall Study||12
1520931|NCT01499147|3721798|P1|COMPLETED|Overall Study||18
1520932|NCT01499147|3721797|P2|STARTED|Overall Study||17
1520933|NCT01499147|3721798|P1|STARTED|Overall Study||33
1520934|NCT01499134|3721813|P2|NOT COMPLETED|Overall Study||1
1520935|NCT01499134|3721814|P1|NOT COMPLETED|Overall Study||0
1520936|NCT01499134|3721813|P2|COMPLETED|Overall Study||7
1520937|NCT01499134|3721814|P1|COMPLETED|Overall Study||9
1520938|NCT01499134|3721813|P2|STARTED|Overall Study||8
1520939|NCT01499134|3721814|P1|STARTED|Overall Study||9
1520940|NCT01499095|3721836|P2|NOT COMPLETED|Overall Study||93
1520941|NCT01499095|3721837|P1|NOT COMPLETED|Overall Study||89
1520942|NCT01499095|3721836|P2|COMPLETED|Overall Study||314
1520943|NCT01499095|3721837|P1|COMPLETED|Overall Study||315
1520944|NCT01499095|3721836|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
1521030|NCT01498419|3722073|P1|NOT COMPLETED|Overall Study||18
1521031|NCT01498419|3722070|P4|COMPLETED|Overall Study||7
1520945|NCT01499095|3721837|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
1520946|NCT01499095|3721836|P2|Participated in Substudy|Overall Study||0
1520947|NCT01499095|3721837|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
1520948|NCT01499095|3721836|P2|Treated|Overall Study||406
1520949|NCT01499095|3721837|P1|Treated|Overall Study||403
1520950|NCT01499095|3721836|P2|STARTED|Overall Study||407
1520951|NCT01499095|3721837|P1|STARTED|Overall Study||404
1520952|NCT01499082|3721867|P2|NOT COMPLETED|Overall Study||48
1520953|NCT01499082|3721868|P1|NOT COMPLETED|Overall Study||45
1520954|NCT01499082|3721867|P2|COMPLETED|Overall Study||355
1520955|NCT01499082|3721868|P1|COMPLETED|Overall Study||359
1520956|NCT01499082|3721867|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
1520957|NCT01499082|3721868|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
1520958|NCT01499082|3721867|P2|Participated in Substudy|Overall Study||0
1520959|NCT01499082|3721868|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
1520960|NCT01499082|3721867|P2|Treated|Overall Study||402
1520961|NCT01499082|3721868|P1|Treated|Overall Study||404
1520962|NCT01499082|3721867|P2|STARTED|Overall Study||403
1520963|NCT01499082|3721868|P1|STARTED|Overall Study||404
1520964|NCT01498978|3721896|P1|NOT COMPLETED|Overall Study||2
1520965|NCT01498978|3721896|P1|COMPLETED|Overall Study||8
1520966|NCT01498978|3721896|P1|STARTED|Overall Study||10
1520967|NCT01498822|3721918|P2|NOT COMPLETED|Overall Study||56
1520968|NCT01498822|3721919|P1|NOT COMPLETED|Overall Study||54
1520969|NCT01498822|3721918|P2|COMPLETED|Overall Study||122
1520970|NCT01498822|3721919|P1|COMPLETED|Overall Study||121
1520971|NCT01498822|3721918|P2|STARTED|Overall Study||178
1520972|NCT01498822|3721919|P1|STARTED|Overall Study||175
1520973|NCT01498744|3721933|P2|NOT COMPLETED|Overall Study||0
1520974|NCT01498744|3721934|P1|NOT COMPLETED|Overall Study||0
1520975|NCT01498744|3721933|P2|COMPLETED|Overall Study||31
1520976|NCT01498744|3721934|P1|COMPLETED|Overall Study||22
1520977|NCT01498744|3721933|P2|STARTED|Overall Study||31
1520978|NCT01498744|3721934|P1|STARTED|Overall Study||22
1520979|NCT01498692|3721946|P1|NOT COMPLETED|Overall Study||8
1520980|NCT01498692|3721946|P1|COMPLETED|Overall Study||86
1520981|NCT01498692|3721946|P1|STARTED|Overall Study||94
1520982|NCT01498679|3721977|P2|NOT COMPLETED|Overall Study||22
1520983|NCT01498679|3721978|P1|NOT COMPLETED|Overall Study||89
1520984|NCT01498679|3721977|P2|COMPLETED|Overall Study||131
1520985|NCT01498679|3721978|P1|COMPLETED|Overall Study||65
1520986|NCT01498679|3721977|P2|STARTED|Overall Study||153
1520987|NCT01498679|3721978|P1|STARTED|Overall Study||154
1520988|NCT01498653|3721994|P2|NOT COMPLETED|Overall Study||35
1520989|NCT01498653|3721995|P1|NOT COMPLETED|Overall Study||19
1520990|NCT01498653|3721994|P2|COMPLETED|Overall Study||119
1520991|NCT01498653|3721995|P1|COMPLETED|Overall Study||136
1520992|NCT01498653|3721994|P2|STARTED|Overall Study||154
1520993|NCT01498653|3721995|P1|STARTED|Overall Study||155
1520994|NCT01498640|3722009|P1|NOT COMPLETED|Overall Study||5
1520995|NCT01498640|3722009|P1|COMPLETED|Overall Study||47
1520996|NCT01498640|3722009|P1|STARTED|Overall Study||52
1520997|NCT01498601|3722025|P2|NOT COMPLETED|Overall Study||0
1520998|NCT01498601|3722026|P1|NOT COMPLETED|Overall Study||0
1520999|NCT01498601|3722025|P2|COMPLETED|Overall Study||32
1521000|NCT01498601|3722026|P1|COMPLETED|Overall Study||51
1521001|NCT01498601|3722025|P2|STARTED|Overall Study||32
1521002|NCT01498601|3722026|P1|STARTED|Overall Study||51
1521003|NCT01498588|3722032|P1|NOT COMPLETED|Overall Study||0
1521004|NCT01498588|3722032|P1|COMPLETED|Overall Study||7
1521005|NCT01498588|3722032|P1|STARTED|Overall Study||7
1521006|NCT01498575|3722039|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
1521007|NCT01498575|3722040|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
1521008|NCT01498575|3722039|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
1521009|NCT01498575|3722040|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
1521010|NCT01498575|3722039|P2|STARTED|On the Road Driving Assessment (ODA)||89
1521011|NCT01498575|3722040|P1|STARTED|On the Road Driving Assessment (ODA)||128
1521012|NCT01498575|3722039|P2|NOT COMPLETED|Overall Sample||14
1521013|NCT01498575|3722040|P1|NOT COMPLETED|Overall Sample||60
1521014|NCT01498575|3722039|P2|COMPLETED|Overall Sample||400
1521015|NCT01498575|3722040|P1|COMPLETED|Overall Sample||550
1521016|NCT01498575|3722039|P2|STARTED|Overall Sample||414
1521017|NCT01498575|3722040|P1|STARTED|Overall Sample||610
1521018|NCT01498549|3722046|P1|NOT COMPLETED|Overall Study||4
1521019|NCT01498549|3722046|P1|COMPLETED|Overall Study||35
1521020|NCT01498549|3722046|P1|Sugar Pill 0 mg|Overall Study||36
1521021|NCT01498549|3722046|P1|Atomoxetine 80 mg|Overall Study||37
1521022|NCT01498549|3722046|P1|Atomoxetine 40 mg|Overall Study||39
1521023|NCT01498549|3722046|P1|STARTED|Overall Study||39
1521024|NCT01498458|3722057|P1|NOT COMPLETED|Overall Study||7
1521025|NCT01498458|3722057|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
1521026|NCT01498458|3722057|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
1521027|NCT01498419|3722070|P4|NOT COMPLETED|Overall Study||19
1521028|NCT01498419|3722071|P3|NOT COMPLETED|Overall Study||18
1521029|NCT01498419|3722072|P2|NOT COMPLETED|Overall Study||23
1521032|NCT01498419|3722071|P3|COMPLETED|Overall Study||41
1521033|NCT01498419|3722072|P2|COMPLETED|Overall Study||39
1521034|NCT01498419|3722073|P1|COMPLETED|Overall Study||42
1521035|NCT01498419|3722070|P4|STARTED|Overall Study||26
1521036|NCT01498419|3722071|P3|STARTED|Overall Study||59
1521037|NCT01498419|3722072|P2|STARTED|Overall Study||62
1521038|NCT01498419|3722073|P1|STARTED|Overall Study||60
1521039|NCT01498185|3722112|P5|NOT COMPLETED|Overall Study||3
1521040|NCT01498185|3722113|P4|NOT COMPLETED|Overall Study||3
1521041|NCT01498185|3722114|P3|NOT COMPLETED|Overall Study||0
1521042|NCT01498185|3722115|P2|NOT COMPLETED|Overall Study||1
1521043|NCT01498185|3722116|P1|NOT COMPLETED|Overall Study||1
1521044|NCT01498185|3722112|P5|COMPLETED|Overall Study||12
1521045|NCT01498185|3722113|P4|COMPLETED|Overall Study||11
1521046|NCT01498185|3722114|P3|COMPLETED|Overall Study||15
1521047|NCT01498185|3722115|P2|COMPLETED|Overall Study||12
1521048|NCT01498185|3722116|P1|COMPLETED|Overall Study||12
1521049|NCT01498185|3722112|P5|STARTED|Overall Study||15
1521050|NCT01498185|3722113|P4|STARTED|Overall Study||14
1521051|NCT01498185|3722114|P3|STARTED|Overall Study||15
1521052|NCT01498185|3722115|P2|STARTED|Overall Study||13
1521053|NCT01498185|3722116|P1|STARTED|Overall Study||13
1521054|NCT01498120|3722156|P1|NOT COMPLETED|Overall Study||13
1521055|NCT01498120|3722156|P1|COMPLETED|Overall Study||1
1521056|NCT01498120|3722156|P1|STARTED|Overall Study||14
1521057|NCT01498068|3722163|P2|NOT COMPLETED|Overall Study||1
1521058|NCT01498068|3722164|P1|NOT COMPLETED|Overall Study||1
1521059|NCT01498068|3722163|P2|COMPLETED|Overall Study||19
1521060|NCT01498068|3722164|P1|COMPLETED|Overall Study||15
1521061|NCT01498068|3722163|P2|STARTED|Overall Study||20
1521062|NCT01498068|3722164|P1|STARTED|Overall Study||16
1521063|NCT01497938|3722182|P2|NOT COMPLETED|Overall Study||2
1521064|NCT01497938|3722183|P1|NOT COMPLETED|Overall Study||5
1521065|NCT01497938|3722182|P2|COMPLETED|Overall Study||124
1521066|NCT01497938|3722183|P1|COMPLETED|Overall Study||116
1521067|NCT01497938|3722182|P2|STARTED|Overall Study||126
1521068|NCT01497938|3722183|P1|STARTED|Overall Study||121
1521069|NCT01497899|3722195|P4|NOT COMPLETED|Open-Label Extension Phase||5
1521070|NCT01497899|3722196|P3|NOT COMPLETED|Open-Label Extension Phase||9
1521071|NCT01497899|3722197|P2|NOT COMPLETED|Open-Label Extension Phase||7
1521072|NCT01497899|3722198|P1|NOT COMPLETED|Open-Label Extension Phase||19
1521073|NCT01497899|3722195|P4|COMPLETED|Open-Label Extension Phase||33
1521074|NCT01497899|3722196|P3|COMPLETED|Open-Label Extension Phase||61
1521075|NCT01497899|3722197|P2|COMPLETED|Open-Label Extension Phase||46
1521076|NCT01497899|3722198|P1|COMPLETED|Open-Label Extension Phase||86
1521077|NCT01497899|3722195|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
1521078|NCT01497899|3722196|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
1521079|NCT01497899|3722197|P2|STARTED|Open-Label Extension Phase||53
1521080|NCT01497899|3722198|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
1521081|NCT01497899|3722195|P4|NOT COMPLETED|Double-Blind Phase||0
1521082|NCT01497899|3722196|P3|NOT COMPLETED|Double-Blind Phase||0
1521083|NCT01497899|3722197|P2|NOT COMPLETED|Double-Blind Phase||5
1521084|NCT01497899|3722198|P1|NOT COMPLETED|Double-Blind Phase||6
1521085|NCT01497899|3722195|P4|COMPLETED|Double-Blind Phase||0
1521086|NCT01497899|3722196|P3|COMPLETED|Double-Blind Phase||0
1521087|NCT01497899|3722197|P2|COMPLETED|Double-Blind Phase||53
1521088|NCT01497899|3722198|P1|COMPLETED|Double-Blind Phase||107
1521089|NCT01497899|3722195|P4|STARTED|Double-Blind Phase||0
1521090|NCT01497899|3722196|P3|STARTED|Double-Blind Phase||0
1521091|NCT01497899|3722197|P2|STARTED|Double-Blind Phase||58
1521092|NCT01497899|3722198|P1|STARTED|Double-Blind Phase||113
1521093|NCT01497756|3722211|P1|NOT COMPLETED|Overall Study||0
1521094|NCT01497756|3722211|P1|COMPLETED|Overall Study||10
1521095|NCT01497756|3722211|P1|STARTED|Overall Study||10
1521096|NCT01497665|3722216|P1|NOT COMPLETED|Overall Study||0
1521097|NCT01497665|3722216|P1|COMPLETED|Overall Study||16
1521098|NCT01497665|3722216|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
1521099|NCT01497665|3722216|P1|STARTED|Overall Study||16
1521100|NCT01497613|3722226|P2|NOT COMPLETED|Overall Study||19
1521101|NCT01497613|3722227|P1|NOT COMPLETED|Overall Study||37
1521102|NCT01497613|3722226|P2|COMPLETED|Overall Study||131
1521103|NCT01497613|3722227|P1|COMPLETED|Overall Study||113
1521104|NCT01497613|3722226|P2|STARTED|Overall Study||150
1521105|NCT01497613|3722227|P1|STARTED|Overall Study||150
1521106|NCT01497366|3722265|P2|NOT COMPLETED|Overall Study||88
1521107|NCT01497366|3722266|P1|NOT COMPLETED|Overall Study||39
1521108|NCT01497366|3722265|P2|COMPLETED|Overall Study||176
1521109|NCT01497366|3722266|P1|COMPLETED|Overall Study||224
1521110|NCT01497366|3722265|P2|Randomized But Not Treated|Overall Study||21
1521111|NCT01497366|3722266|P1|Randomized But Not Treated|Overall Study||7
1521112|NCT01497366|3722265|P2|STARTED|Overall Study||264
1521113|NCT01497366|3722266|P1|STARTED|Overall Study||263
1521114|NCT01497275|3722284|P1|NOT COMPLETED|Overall Study||2
1521115|NCT01497275|3722284|P1|COMPLETED|Overall Study||3
1521116|NCT01497275|3722284|P1|STARTED|Overall Study||5
1521117|NCT01497262|3722291|P1|NOT COMPLETED|Overall Study||11
1521118|NCT01497262|3722291|P1|COMPLETED|Overall Study||151
1521119|NCT01497262|3722291|P1|STARTED|Overall Study||162
1521120|NCT01497197|3722298|P2|NOT COMPLETED|Overall Study||15
1521121|NCT01497197|3722299|P1|NOT COMPLETED|Overall Study||17
1521122|NCT01497197|3722298|P2|COMPLETED|Overall Study||70
1521123|NCT01497197|3722299|P1|COMPLETED|Overall Study||72
1521124|NCT01497197|3722298|P2|STARTED|Overall Study||85
1521125|NCT01497197|3722299|P1|STARTED|Overall Study||89
1521126|NCT01497171|3722327|P2|NOT COMPLETED|Overall Study||0
1521127|NCT01497171|3722328|P1|NOT COMPLETED|Overall Study||0
1521128|NCT01497171|3722327|P2|COMPLETED|Overall Study||3
1521129|NCT01497171|3722328|P1|COMPLETED|Overall Study||2
1521130|NCT01497171|3722327|P2|STARTED|Overall Study||3
1521131|NCT01497171|3722328|P1|STARTED|Overall Study||2
1521132|NCT01496846|3722340|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
1521133|NCT01496846|3722341|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
1521134|NCT01496846|3722342|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
1521135|NCT01496846|3722343|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
1521136|NCT01496846|3722344|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
1521137|NCT01496846|3722345|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
1521138|NCT01496846|3722340|P6|COMPLETED|Supplemental Buccal Infiltration||38
1521139|NCT01496846|3722341|P5|COMPLETED|Supplemental Buccal Infiltration||35
1521140|NCT01496846|3722342|P4|COMPLETED|Supplemental Buccal Infiltration||40
1521141|NCT01496846|3722343|P3|COMPLETED|Supplemental Buccal Infiltration||36
1521142|NCT01496846|3722344|P2|COMPLETED|Supplemental Buccal Infiltration||0
1521143|NCT01496846|3722345|P1|COMPLETED|Supplemental Buccal Infiltration||0
1521144|NCT01496846|3722340|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
1521145|NCT01496846|3722341|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
1521146|NCT01496846|3722342|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
1521147|NCT01496846|3722343|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
1521148|NCT01496846|3722344|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
1521149|NCT01496846|3722345|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
1521150|NCT01496846|3722340|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
1521151|NCT01496846|3722341|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
1521152|NCT01496846|3722342|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
1521153|NCT01496846|3722343|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
1521154|NCT01496846|3722344|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
1521155|NCT01496846|3722345|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
1521156|NCT01496846|3722340|P6|COMPLETED|IANB Articaine (All Participants)||38
1521157|NCT01496846|3722341|P5|COMPLETED|IANB Articaine (All Participants)||35
1521158|NCT01496846|3722342|P4|COMPLETED|IANB Articaine (All Participants)||40
1521159|NCT01496846|3722343|P3|COMPLETED|IANB Articaine (All Participants)||36
1521160|NCT01496846|3722344|P2|COMPLETED|IANB Articaine (All Participants)||23
1521161|NCT01496846|3722345|P1|COMPLETED|IANB Articaine (All Participants)||27
1521162|NCT01496846|3722340|P6|STARTED|IANB Articaine (All Participants)||38
1521163|NCT01496846|3722341|P5|STARTED|IANB Articaine (All Participants)||35
1521164|NCT01496846|3722342|P4|STARTED|IANB Articaine (All Participants)||40
1521165|NCT01496846|3722343|P3|STARTED|IANB Articaine (All Participants)||36
1521166|NCT01496846|3722344|P2|STARTED|IANB Articaine (All Participants)||24
1521167|NCT01496846|3722345|P1|STARTED|IANB Articaine (All Participants)||28
1521168|NCT01496807|3722356|P1|NOT COMPLETED|Overall Study||30
1521169|NCT01496807|3722356|P1|COMPLETED|Overall Study||1
1521170|NCT01496807|3722356|P1|STARTED|Overall Study||31
1521171|NCT01496469|3722368|P2|NOT COMPLETED|Overall Study||8
1521172|NCT01496469|3722369|P1|NOT COMPLETED|Overall Study||10
1521173|NCT01496469|3722368|P2|COMPLETED|Overall Study||53
1521174|NCT01496469|3722369|P1|COMPLETED|Overall Study||50
1521175|NCT01496469|3722368|P2|STARTED|Overall Study||61
1521176|NCT01496469|3722369|P1|STARTED|Overall Study||60
1521177|NCT01496456|3722379|P1|NOT COMPLETED|Overall Study||8
1521178|NCT01496456|3722379|P1|COMPLETED|Overall Study||9
1521179|NCT01496456|3722379|P1|3-yr Final Recall|Overall Study||9
1521180|NCT01496456|3722379|P1|2-yr Recall|Overall Study||10
1521181|NCT01496456|3722379|P1|1-yr Recall|Overall Study||12
1521182|NCT01496456|3722379|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
1521183|NCT01496456|3722379|P1|STARTED|Overall Study||17
1521184|NCT01496430|3722392|P3|NOT COMPLETED|Overall Study||10
1521185|NCT01496430|3722393|P2|NOT COMPLETED|Overall Study||5
1521186|NCT01496430|3722394|P1|NOT COMPLETED|Overall Study||6
1521187|NCT01496430|3722392|P3|COMPLETED|Overall Study||25
1521188|NCT01496430|3722393|P2|COMPLETED|Overall Study||30
1521189|NCT01496430|3722394|P1|COMPLETED|Overall Study||29
1521190|NCT01496430|3722392|P3|STARTED|Overall Study||35
1521191|NCT01496430|3722393|P2|STARTED|Overall Study||35
1521192|NCT01496430|3722394|P1|STARTED|Overall Study||35
1521193|NCT01496352|3722470|P2|NOT COMPLETED|Overall Study||0
1521194|NCT01496352|3722471|P1|NOT COMPLETED|Overall Study||0
1521195|NCT01496352|3722470|P2|COMPLETED|Overall Study||6
1521196|NCT01496352|3722471|P1|COMPLETED|Overall Study||24
1521197|NCT01496352|3722470|P2|STARTED|Overall Study||6
1521198|NCT01496352|3722471|P1|STARTED|Overall Study||24
1521199|NCT01496313|3722489|P2|NOT COMPLETED|Overall Study||15
1521200|NCT01496313|3722490|P1|NOT COMPLETED|Overall Study||5
1521201|NCT01496313|3722489|P2|COMPLETED|Overall Study||26
1521202|NCT01496313|3722490|P1|COMPLETED|Overall Study||35
1521203|NCT01496313|3722489|P2|STARTED|Overall Study||41
1521204|NCT01496313|3722490|P1|STARTED|Overall Study||40
1521205|NCT01496287|3722506|P1|NOT COMPLETED|Overall Study||6
1521206|NCT01496287|3722506|P1|COMPLETED|Overall Study||64
1521207|NCT01496287|3722506|P1|STARTED|Overall Study||70
1521208|NCT01496274|3722516|P2|NOT COMPLETED|Overall Study||5
1521209|NCT01496274|3722517|P1|NOT COMPLETED|Overall Study||3
1521210|NCT01496274|3722516|P2|COMPLETED|Overall Study||18
1521211|NCT01496274|3722517|P1|COMPLETED|Overall Study||37
1521212|NCT01496274|3722516|P2|STARTED|Overall Study||23
1521213|NCT01496274|3722517|P1|STARTED|Overall Study||40
1521214|NCT01496248|3722549|P1|NOT COMPLETED|Overall Study||10
1521215|NCT01496248|3722549|P1|COMPLETED|Overall Study||25
1521216|NCT01496248|3722549|P1|STARTED|Overall Study||35
1521217|NCT01496183|3722562|P2|NOT COMPLETED|Overall Study||2
1521218|NCT01496183|3722563|P1|NOT COMPLETED|Overall Study||3
1521219|NCT01496183|3722562|P2|COMPLETED|Overall Study||13
1521220|NCT01496183|3722563|P1|COMPLETED|Overall Study||6
1521221|NCT01496183|3722562|P2|STARTED|Overall Study||15
1521222|NCT01496183|3722563|P1|STARTED|Overall Study||9
1521223|NCT01496157|3722593|P1|NOT COMPLETED|Overall Study||0
1521224|NCT01496157|3722593|P1|COMPLETED|Overall Study||13
1521225|NCT01496157|3722593|P1|STARTED|Overall Study||13
1521226|NCT01496131|3722600|P2|NOT COMPLETED|Overall Study||0
1521227|NCT01496131|3722601|P1|NOT COMPLETED|Overall Study||0
1521228|NCT01496131|3722600|P2|COMPLETED|Overall Study||14
1521229|NCT01496131|3722601|P1|COMPLETED|Overall Study||14
1521230|NCT01496131|3722600|P2|STARTED|Overall Study||14
1521231|NCT01496131|3722601|P1|STARTED|Overall Study||14
1521232|NCT01496066|3722615|P2|NOT COMPLETED|Overall Study||9
1521233|NCT01496066|3722616|P1|NOT COMPLETED|Overall Study||12
1521234|NCT01496066|3722615|P2|COMPLETED|Overall Study||188
1521235|NCT01496066|3722616|P1|COMPLETED|Overall Study||391
1521236|NCT01496066|3722615|P2|STARTED|Overall Study||197
1521237|NCT01496066|3722616|P1|STARTED|Overall Study||403
1521238|NCT01495988|3722639|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521239|NCT01495988|3722640|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521240|NCT01495988|3722641|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521241|NCT01495988|3722642|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521242|NCT01495988|3722639|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521243|NCT01495988|3722640|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521244|NCT01495988|3722641|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
1521245|NCT01495988|3722642|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521246|NCT01495988|3722639|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521247|NCT01495988|3722640|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521248|NCT01495988|3722641|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
1521249|NCT01495988|3722642|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1521250|NCT01495988|3722639|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1521251|NCT01495988|3722640|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1521252|NCT01495988|3722641|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1521253|NCT01495988|3722642|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1521254|NCT01495988|3722639|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
1521255|NCT01495988|3722640|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
1521256|NCT01495988|3722641|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1521257|NCT01495988|3722642|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1521258|NCT01495988|3722639|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
1521259|NCT01495988|3722640|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
1521260|NCT01495988|3722641|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
1521261|NCT01495988|3722642|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
1521262|NCT01495975|3722678|P2|NOT COMPLETED|Overall Study||0
1521263|NCT01495975|3722679|P1|NOT COMPLETED|Overall Study||1
1521264|NCT01495975|3722678|P2|COMPLETED|Overall Study||14
1521265|NCT01495975|3722679|P1|COMPLETED|Overall Study||14
1521266|NCT01495975|3722678|P2|STARTED|Overall Study||14
1521267|NCT01495975|3722679|P1|STARTED|Overall Study||15
1521268|NCT01495923|3722687|P2|NOT COMPLETED|Overall Study||0
1521269|NCT01495923|3722688|P1|NOT COMPLETED|Overall Study||0
1521270|NCT01495923|3722687|P2|COMPLETED|Overall Study||72
1521271|NCT01495923|3722688|P1|COMPLETED|Overall Study||73
1521272|NCT01495923|3722687|P2|STARTED|Overall Study||72
1521273|NCT01495923|3722688|P1|STARTED|Overall Study||73
1521274|NCT01495858|3722721|P3|NOT COMPLETED|Overall Study||0
1521275|NCT01495858|3722722|P2|NOT COMPLETED|Overall Study||0
1521276|NCT01495858|3722723|P1|NOT COMPLETED|Overall Study||0
1521277|NCT01495858|3722721|P3|COMPLETED|Overall Study||54
1521278|NCT01495858|3722722|P2|COMPLETED|Overall Study||106
1521279|NCT01495858|3722723|P1|COMPLETED|Overall Study||107
1521280|NCT01495858|3722721|P3|STARTED|Overall Study||54
1521281|NCT01495858|3722722|P2|STARTED|Overall Study||106
1521282|NCT01495858|3722723|P1|STARTED|Overall Study||107
1521283|NCT01495793|3722803|P1|NOT COMPLETED|Overall Study||2
1521284|NCT01495793|3722803|P1|COMPLETED|Overall Study||22
1521285|NCT01495793|3722803|P1|STARTED|Overall Study||24
1521286|NCT01495702|3722816|P2|NOT COMPLETED|Extension Phase||0
1521287|NCT01495702|3722817|P1|NOT COMPLETED|Extension Phase||0
1521288|NCT01495702|3722816|P2|COMPLETED|Extension Phase||2
1521289|NCT01495702|3722817|P1|COMPLETED|Extension Phase||26
1521290|NCT01495702|3722816|P2|STARTED|Extension Phase||2
1521291|NCT01495702|3722817|P1|STARTED|Extension Phase||26
1521292|NCT01495702|3722816|P2|NOT COMPLETED|Randomized Phase||28
1521293|NCT01495702|3722817|P1|NOT COMPLETED|Randomized Phase||26
1521294|NCT01495702|3722816|P2|COMPLETED|Randomized Phase||119
1521295|NCT01495702|3722817|P1|COMPLETED|Randomized Phase||266
1521296|NCT01495702|3722816|P2|STARTED|Randomized Phase||147
1521297|NCT01495702|3722817|P1|STARTED|Randomized Phase||292
1521298|NCT01495689|3722832|P2|NOT COMPLETED|Overall Study||7
1521299|NCT01495689|3722833|P1|NOT COMPLETED|Overall Study||10
1521300|NCT01495689|3722832|P2|COMPLETED|Overall Study||16
1521301|NCT01495689|3722833|P1|COMPLETED|Overall Study||16
1521302|NCT01495689|3722832|P2|STARTED|Overall Study||23
1521303|NCT01495689|3722833|P1|STARTED|Overall Study||26
1521304|NCT01495585|3722842|P3|NOT COMPLETED|Overall Study||0
1521305|NCT01495585|3722843|P2|NOT COMPLETED|Overall Study||0
1521306|NCT01495585|3722844|P1|NOT COMPLETED|Overall Study||0
1521307|NCT01495585|3722842|P3|COMPLETED|Overall Study||4
1521308|NCT01495585|3722843|P2|COMPLETED|Overall Study||6
1521309|NCT01495585|3722844|P1|COMPLETED|Overall Study||4
1521310|NCT01495585|3722842|P3|Open Label Lonafarnib 200 mg|Overall Study||0
1521311|NCT01495585|3722843|P2|Open Label Lonafarnib 200 mg|Overall Study||0
1521312|NCT01495585|3722844|P1|Open Label Lonafarnib 200 mg|Overall Study||2
1521313|NCT01495585|3722842|P3|STARTED|Overall Study||4
1521314|NCT01495585|3722843|P2|STARTED|Overall Study||6
1521315|NCT01495585|3722844|P1|STARTED|Overall Study||4
1521316|NCT01495572|3722857|P2|NOT COMPLETED|Overall Study||0
1521317|NCT01495572|3722858|P1|NOT COMPLETED|Overall Study||0
1521318|NCT01495572|3722857|P2|COMPLETED|Overall Study||5
1521319|NCT01495572|3722858|P1|COMPLETED|Overall Study||0
1521320|NCT01495572|3722857|P2|STARTED|Overall Study||5
1521321|NCT01495572|3722858|P1|STARTED|Overall Study||0
1521322|NCT01495481|3722866|P1|NOT COMPLETED|Dexmedetomidine||0
1521323|NCT01495481|3722866|P1|COMPLETED|Dexmedetomidine||22
1521324|NCT01495481|3722866|P1|STARTED|Dexmedetomidine||22
1521325|NCT01495481|3722866|P1|NOT COMPLETED|Washout||0
1521326|NCT01495481|3722866|P1|COMPLETED|Washout||22
1521327|NCT01495481|3722866|P1|STARTED|Washout||22
1521328|NCT01495481|3722866|P1|NOT COMPLETED|Adenosine||0
1521329|NCT01495481|3722866|P1|COMPLETED|Adenosine||22
1521330|NCT01495481|3722866|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
1521331|NCT01495286|3722878|P1|NOT COMPLETED|Overall Study||0
1521332|NCT01495286|3722878|P1|COMPLETED|Overall Study||30
1521333|NCT01495286|3722878|P1|STARTED|Overall Study||30
1521334|NCT01495221|3722886|P1|NOT COMPLETED|Overall Study||0
1521335|NCT01495221|3722886|P1|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
1521336|NCT01495221|3722886|P1|STARTED|Overall Study|First Patient enrolled December 2011.|9
1521337|NCT01495000|3722895|P2|NOT COMPLETED|Overall Study||12
1521338|NCT01495000|3722896|P1|NOT COMPLETED|Overall Study||13
1521339|NCT01495000|3722895|P2|COMPLETED|Overall Study||114
1521340|NCT01495000|3722896|P1|COMPLETED|Overall Study||111
1521341|NCT01495000|3722895|P2|STARTED|Overall Study||126
1521342|NCT01495000|3722896|P1|STARTED|Overall Study||124
1521343|NCT01494987|3722938|P2|NOT COMPLETED|Overall Study||28
1521344|NCT01494987|3722939|P1|NOT COMPLETED|Overall Study||28
1521345|NCT01494987|3722938|P2|COMPLETED|Overall Study||187
1521346|NCT01494987|3722939|P1|COMPLETED|Overall Study||188
1521347|NCT01494987|3722938|P2|STARTED|Overall Study||215
1521348|NCT01494987|3722939|P1|STARTED|Overall Study||216
1521349|NCT01494818|3722953|P2|NOT COMPLETED|Overall Study||2
1521350|NCT01494818|3722954|P1|NOT COMPLETED|Overall Study||2
1521351|NCT01494818|3722953|P2|COMPLETED|Overall Study||37
1521352|NCT01494818|3722954|P1|COMPLETED|Overall Study||37
1521353|NCT01494818|3722953|P2|STARTED|Overall Study||39
1521354|NCT01494818|3722954|P1|STARTED|Overall Study||39
1521355|NCT01494753|3722976|P2|NOT COMPLETED|Day42-Day84||0
1521356|NCT01494753|3722977|P1|NOT COMPLETED|Day42-Day84||0
1521357|NCT01494753|3722976|P2|COMPLETED|Day42-Day84||15
1521358|NCT01494753|3722977|P1|COMPLETED|Day42-Day84||15
1521359|NCT01494753|3722976|P2|STARTED|Day42-Day84||15
1521360|NCT01494753|3722977|P1|STARTED|Day42-Day84||15
1521361|NCT01494753|3722976|P2|NOT COMPLETED|Day0-Day42||0
1521362|NCT01494753|3722977|P1|NOT COMPLETED|Day0-Day42||0
1521363|NCT01494753|3722976|P2|COMPLETED|Day0-Day42||15
1521364|NCT01494753|3722977|P1|COMPLETED|Day0-Day42||15
1521365|NCT01494753|3722976|P2|STARTED|Day0-Day42||15
1521366|NCT01494753|3722977|P1|STARTED|Day0-Day42||15
1521367|NCT01494649|3722985|P2|NOT COMPLETED|Overall Study||1
1521368|NCT01494649|3722986|P1|NOT COMPLETED|Overall Study||0
1521369|NCT01494649|3722985|P2|COMPLETED|Overall Study||58
1521370|NCT01494649|3722986|P1|COMPLETED|Overall Study||59
1521371|NCT01494649|3722985|P2|STARTED|Overall Study||59
1521372|NCT01494649|3722986|P1|STARTED|Overall Study||59
1521373|NCT01494610|3723002|P2|NOT COMPLETED|Period 4||0
1521374|NCT01494610|3723003|P1|NOT COMPLETED|Period 4||1
1521375|NCT01494610|3723002|P2|COMPLETED|Period 4||28
1521376|NCT01494610|3723003|P1|COMPLETED|Period 4||27
1521377|NCT01494610|3723002|P2|STARTED|Period 4||28
1521378|NCT01494610|3723003|P1|STARTED|Period 4||28
1521379|NCT01494610|3723002|P2|NOT COMPLETED|Period 3||0
1521380|NCT01494610|3723003|P1|NOT COMPLETED|Period 3||2
1521381|NCT01494610|3723002|P2|COMPLETED|Period 3||28
1521382|NCT01494610|3723003|P1|COMPLETED|Period 3||28
1521383|NCT01494610|3723002|P2|STARTED|Period 3||28
1521384|NCT01494610|3723003|P1|STARTED|Period 3||30
1521385|NCT01494610|3723002|P2|NOT COMPLETED|Period 2||0
1521386|NCT01494610|3723003|P1|NOT COMPLETED|Period 2||0
1521387|NCT01494610|3723002|P2|COMPLETED|Period 2||28
1521388|NCT01494610|3723003|P1|COMPLETED|Period 2||30
1521389|NCT01494610|3723002|P2|STARTED|Period 2||28
1521390|NCT01494610|3723003|P1|STARTED|Period 2||30
1521391|NCT01494610|3723002|P2|NOT COMPLETED|Period 1||1
1521392|NCT01494610|3723003|P1|NOT COMPLETED|Period 1||1
1521393|NCT01494610|3723002|P2|COMPLETED|Period 1||28
1521394|NCT01494610|3723003|P1|COMPLETED|Period 1||30
1521395|NCT01494610|3723002|P2|STARTED|Period 1||29
1521396|NCT01494610|3723003|P1|STARTED|Period 1||31
1521397|NCT01494584|3723071|P1|NOT COMPLETED|Overall Study||1
1521398|NCT01494584|3723071|P1|COMPLETED|Overall Study||4
1521399|NCT01494584|3723071|P1|STARTED|Overall Study||5
1521400|NCT01494545|3723160|P1|NOT COMPLETED|Overall Study||10
1521401|NCT01494545|3723160|P1|COMPLETED|Overall Study||92
1521402|NCT01494545|3723160|P1|STARTED|Overall Study||102
1521403|NCT01494532|3723203|P6|NOT COMPLETED|Overall Study||0
1521404|NCT01494532|3723204|P5|NOT COMPLETED|Overall Study||12
1521405|NCT01494532|3723205|P4|NOT COMPLETED|Overall Study||15
1521406|NCT01494532|3723206|P3|NOT COMPLETED|Overall Study||17
1521407|NCT01494532|3723207|P2|NOT COMPLETED|Overall Study||4
1521408|NCT01494532|3723208|P1|NOT COMPLETED|Overall Study||10
1521409|NCT01494532|3723203|P6|COMPLETED|Overall Study||25
1521410|NCT01494532|3723204|P5|COMPLETED|Overall Study||64
1521411|NCT01494532|3723205|P4|COMPLETED|Overall Study||60
1521412|NCT01494532|3723206|P3|COMPLETED|Overall Study||59
1521413|NCT01494532|3723207|P2|COMPLETED|Overall Study||21
1521414|NCT01494532|3723208|P1|COMPLETED|Overall Study||65
1521415|NCT01494532|3723203|P6|STARTED|Overall Study||25
1521416|NCT01494532|3723204|P5|STARTED|Overall Study||76
1521417|NCT01494532|3723205|P4|STARTED|Overall Study||75
1521418|NCT01494532|3723206|P3|STARTED|Overall Study||76
1521419|NCT01494532|3723207|P2|STARTED|Overall Study||25
1521420|NCT01494532|3723208|P1|STARTED|Overall Study||75
1521421|NCT01494506|3723363|P3|NOT COMPLETED|Overall Study||103
1521422|NCT01494506|3723364|P2|NOT COMPLETED|Overall Study||143
1521423|NCT01494506|3723365|P1|NOT COMPLETED|Overall Study||148
1521424|NCT01494506|3723363|P3|COMPLETED|Overall Study||14
1521425|NCT01494506|3723364|P2|COMPLETED|Overall Study||6
1521426|NCT01494506|3723365|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
1521427|NCT01494506|3723363|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
1521428|NCT01494506|3723364|P2|Treated Population|Overall Study||134
1521429|NCT01494506|3723365|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
1521430|NCT01494506|3723363|P3|STARTED|Overall Study||117
1521431|NCT01494506|3723364|P2|STARTED|Overall Study||149
1521432|NCT01494506|3723365|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
1521433|NCT01494467|3723402|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
1521434|NCT01494467|3723403|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
1521435|NCT01494467|3723402|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
1521436|NCT01494467|3723403|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
1521437|NCT01494467|3723402|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
1521438|NCT01494467|3723403|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
1521439|NCT01494467|3723402|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
1521440|NCT01494467|3723403|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
1521441|NCT01494467|3723402|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
1521442|NCT01494467|3723403|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
1521443|NCT01494467|3723402|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
1521444|NCT01494467|3723403|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
1521445|NCT01494467|3723402|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
1521446|NCT01494467|3723403|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
1521447|NCT01494467|3723402|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
1521448|NCT01494467|3723403|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
1521449|NCT01494467|3723402|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
1521450|NCT01494467|3723403|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
1521451|NCT01494350|3723419|P1|NOT COMPLETED|Overall Study||1
1521452|NCT01494350|3723419|P1|COMPLETED|Overall Study||49
1521453|NCT01494350|3723419|P1|STARTED|Overall Study||50
1521454|NCT01494298|3723429|P2|NOT COMPLETED|Overall Study||8
1521455|NCT01494298|3723430|P1|NOT COMPLETED|Overall Study||2
1521456|NCT01494298|3723429|P2|COMPLETED|Overall Study||47
1521457|NCT01494298|3723430|P1|COMPLETED|Overall Study||54
1521458|NCT01494298|3723429|P2|STARTED|Overall Study||55
1521459|NCT01494298|3723430|P1|STARTED|Overall Study||56
1521460|NCT01494038|3723442|P2|NOT COMPLETED|Overall Study||83
1521461|NCT01494038|3723443|P1|NOT COMPLETED|Overall Study||88
1521462|NCT01494038|3723442|P2|COMPLETED|Overall Study||396
1521463|NCT01494038|3723443|P1|COMPLETED|Overall Study||389
1521464|NCT01494038|3723442|P2|STARTED|Overall Study||479
1521465|NCT01494038|3723443|P1|STARTED|Overall Study||477
1521466|NCT01493960|3723531|P2|NOT COMPLETED|Overall Study||18
1521467|NCT01493960|3723532|P1|NOT COMPLETED|Overall Study||32
1521468|NCT01493960|3723531|P2|COMPLETED|Overall Study||26
1521469|NCT01493960|3723532|P1|COMPLETED|Overall Study||55
1521470|NCT01493960|3723531|P2|Received Study Drug|Overall Study||43
1521471|NCT01493960|3723532|P1|Received Study Drug|Overall Study||87
1521472|NCT01493960|3723531|P2|STARTED|Overall Study||44
1521473|NCT01493960|3723532|P1|STARTED|Overall Study||87
1521474|NCT01493947|3723552|P2|NOT COMPLETED|Period B Extension Period||32
1521475|NCT01493947|3723553|P1|NOT COMPLETED|Period B Extension Period||33
1521476|NCT01493947|3723552|P2|COMPLETED|Period B Extension Period||326
1521477|NCT01493947|3723553|P1|COMPLETED|Period B Extension Period||366
1521478|NCT01493947|3723552|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
1521479|NCT01493947|3723553|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
1521480|NCT01493947|3723552|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
1521481|NCT01493947|3723553|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
1521482|NCT01493947|3723552|P2|COMPLETED|Period A Efficacy and Safety Data||456
1521483|NCT01493947|3723553|P1|COMPLETED|Period A Efficacy and Safety Data||446
1521484|NCT01493947|3723552|P2|STARTED|Period A Efficacy and Safety Data||484
1521485|NCT01493947|3723553|P1|STARTED|Period A Efficacy and Safety Data||478
1521486|NCT01493778|3723563|P1|NOT COMPLETED|Overall Study||3
1521487|NCT01493778|3723563|P1|COMPLETED|Overall Study||56
1521488|NCT01493778|3723563|P1|STARTED|Overall Study||59
1521489|NCT01493687|3723591|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
1521490|NCT01493687|3723592|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
1521491|NCT01493687|3723591|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
1521492|NCT01493687|3723592|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
1521493|NCT01493687|3723591|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
1521494|NCT01493687|3723592|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
1521495|NCT01493687|3723591|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
1521496|NCT01493687|3723592|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
1521497|NCT01493687|3723591|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
1521498|NCT01493687|3723592|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
1521499|NCT01493687|3723591|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
1521500|NCT01493687|3723592|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
1521501|NCT01493687|3723591|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
1521502|NCT01493687|3723592|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
1521503|NCT01493687|3723591|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
1521504|NCT01493687|3723592|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
1521505|NCT01493687|3723591|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
1521506|NCT01493687|3723592|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
1521507|NCT01493557|3723611|P3|NOT COMPLETED|Adding the Second Strategy||0
1521508|NCT01493557|3723612|P2|NOT COMPLETED|Adding the Second Strategy||4
1521509|NCT01493557|3723613|P1|NOT COMPLETED|Adding the Second Strategy||2
1521510|NCT01493557|3723611|P3|COMPLETED|Adding the Second Strategy||0
1521511|NCT01493557|3723612|P2|COMPLETED|Adding the Second Strategy||11
1521512|NCT01493557|3723613|P1|COMPLETED|Adding the Second Strategy||12
1521513|NCT01493557|3723611|P3|STARTED|Adding the Second Strategy||0
1521514|NCT01493557|3723612|P2|STARTED|Adding the Second Strategy||15
1521515|NCT01493557|3723613|P1|STARTED|Adding the Second Strategy||14
1521516|NCT01493557|3723611|P3|NOT COMPLETED|Randomized to Management Strategies||0
1521517|NCT01493557|3723612|P2|NOT COMPLETED|Randomized to Management Strategies||11
1521518|NCT01493557|3723613|P1|NOT COMPLETED|Randomized to Management Strategies||15
1521519|NCT01493557|3723611|P3|COMPLETED|Randomized to Management Strategies||0
1521520|NCT01493557|3723612|P2|COMPLETED|Randomized to Management Strategies||47
1521521|NCT01493557|3723613|P1|COMPLETED|Randomized to Management Strategies||44
1521522|NCT01493557|3723611|P3|STARTED|Randomized to Management Strategies||0
1521523|NCT01493557|3723612|P2|STARTED|Randomized to Management Strategies||58
1521524|NCT01493557|3723613|P1|STARTED|Randomized to Management Strategies||59
1521525|NCT01493557|3723611|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
1521526|NCT01493557|3723612|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
1521527|NCT01493557|3723613|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
1521528|NCT01493557|3723611|P3|COMPLETED|Not Randomized to Management Strategies||816
1521529|NCT01493557|3723612|P2|COMPLETED|Not Randomized to Management Strategies||0
1521530|NCT01493557|3723613|P1|COMPLETED|Not Randomized to Management Strategies||0
1521531|NCT01493557|3723611|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
1521532|NCT01493557|3723612|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
1521533|NCT01493557|3723613|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
1521534|NCT01493557|3723611|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
1521535|NCT01493557|3723612|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
1521536|NCT01493557|3723613|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
1521537|NCT01493557|3723611|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
1521538|NCT01493557|3723612|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
1521539|NCT01493557|3723613|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
1521540|NCT01493557|3723611|P3|STARTED|Not Randomized to Management Strategies||950
1521541|NCT01493557|3723612|P2|STARTED|Not Randomized to Management Strategies||0
1521542|NCT01493557|3723613|P1|STARTED|Not Randomized to Management Strategies||0
1521543|NCT01493531|3723641|P3|NOT COMPLETED|Overall Study||48
1521544|NCT01493531|3723642|P2|NOT COMPLETED|Overall Study||50
1521545|NCT01493531|3723643|P1|NOT COMPLETED|Overall Study||41
1521546|NCT01493531|3723641|P3|COMPLETED|Overall Study||158
1521547|NCT01493531|3723642|P2|COMPLETED|Overall Study||150
1521548|NCT01493531|3723643|P1|COMPLETED|Overall Study||163
1521549|NCT01493531|3723641|P3|STARTED|Overall Study||206
1521550|NCT01493531|3723642|P2|STARTED|Overall Study||200
1521551|NCT01493531|3723643|P1|STARTED|Overall Study||204
1521552|NCT01493427|3723657|P1|NOT COMPLETED|Overall Study||20
1521553|NCT01493427|3723657|P1|COMPLETED|Overall Study||179
1521554|NCT01493427|3723657|P1|STARTED|Overall Study||199
1521555|NCT01493284|3723662|P1|NOT COMPLETED|Overall Study||61
1521556|NCT01493284|3723662|P1|COMPLETED|Overall Study||161
1521557|NCT01493284|3723662|P1|STARTED|Overall Study||222
1521558|NCT01493180|3723671|P2|NOT COMPLETED|Overall Study||2
1521559|NCT01493180|3723672|P1|NOT COMPLETED|Overall Study||3
1521560|NCT01493180|3723671|P2|COMPLETED|Overall Study||49
1521561|NCT01493180|3723672|P1|COMPLETED|Overall Study||48
1521562|NCT01493180|3723671|P2|STARTED|Overall Study||51
1521563|NCT01493180|3723672|P1|STARTED|Overall Study||51
1521564|NCT01493167|3723678|P1|NOT COMPLETED|Overall Study||0
1521565|NCT01493167|3723678|P1|COMPLETED|Overall Study||97
1521566|NCT01493167|3723678|P1|STARTED|Overall Study||97
1521567|NCT01493089|3723684|P2|NOT COMPLETED|Overall Study||3
1521568|NCT01493089|3723685|P1|NOT COMPLETED|Overall Study||3
1521569|NCT01493089|3723684|P2|COMPLETED|Overall Study||114
1521570|NCT01493089|3723685|P1|COMPLETED|Overall Study||119
1521571|NCT01493089|3723684|P2|STARTED|Overall Study||117
1521572|NCT01493089|3723685|P1|STARTED|Overall Study||122
1521573|NCT01493024|3723705|P4|NOT COMPLETED|Overall Study||0
1521574|NCT01493024|3723706|P3|NOT COMPLETED|Overall Study||0
1521575|NCT01493024|3723707|P2|NOT COMPLETED|Overall Study||0
1521576|NCT01493024|3723708|P1|NOT COMPLETED|Overall Study||0
1521577|NCT01493024|3723705|P4|COMPLETED|Overall Study||24
1521578|NCT01493024|3723706|P3|COMPLETED|Overall Study||24
1521579|NCT01493024|3723707|P2|COMPLETED|Overall Study||12
1521580|NCT01493024|3723708|P1|COMPLETED|Overall Study||30
1521581|NCT01493024|3723705|P4|STARTED|Overall Study||24
1521582|NCT01493024|3723706|P3|STARTED|Overall Study||24
1521583|NCT01493024|3723707|P2|STARTED|Overall Study||12
1521584|NCT01493024|3723708|P1|STARTED|Overall Study||30
1521585|NCT01492686|3723784|P2|NOT COMPLETED|Open-label Phase||18
1521586|NCT01492686|3723785|P1|NOT COMPLETED|Open-label Phase||12
1521587|NCT01492686|3723784|P2|COMPLETED|Open-label Phase||40
1521588|NCT01492686|3723785|P1|COMPLETED|Open-label Phase||53
1521589|NCT01492686|3723784|P2|STARTED|Open-label Phase||58
1521590|NCT01492686|3723785|P1|STARTED|Open-label Phase||65
1521591|NCT01492686|3723784|P2|NOT COMPLETED|Double-blind Phase||8
1521592|NCT01492686|3723785|P1|NOT COMPLETED|Double-blind Phase||2
1521593|NCT01492686|3723784|P2|COMPLETED|Double-blind Phase||60
1521594|NCT01492686|3723785|P1|COMPLETED|Double-blind Phase||67
1521595|NCT01492686|3723784|P2|STARTED|Double-blind Phase||68
1521596|NCT01492686|3723785|P1|STARTED|Double-blind Phase||69
1521597|NCT01492439|3723811|P2|NOT COMPLETED|Overall Study||9
1521598|NCT01492439|3723812|P1|NOT COMPLETED|Overall Study||4
1521599|NCT01492439|3723811|P2|COMPLETED|Overall Study||9
1521600|NCT01492439|3723812|P1|COMPLETED|Overall Study||15
1521601|NCT01492439|3723811|P2|Post-intervention|Overall Study||13
1521602|NCT01492439|3723812|P1|Post-intervention|Overall Study||18
1521603|NCT01492439|3723811|P2|STARTED|Overall Study||18
1521604|NCT01492439|3723812|P1|STARTED|Overall Study||19
1521605|NCT01492426|3723860|P2|NOT COMPLETED|Follow-Up||10
1521606|NCT01492426|3723861|P1|NOT COMPLETED|Follow-Up||25
1521607|NCT01492426|3723860|P2|COMPLETED|Follow-Up||181
1521608|NCT01492426|3723861|P1|COMPLETED|Follow-Up||359
1521609|NCT01492426|3723860|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
1521610|NCT01492426|3723861|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
1521611|NCT01492426|3723860|P2|NOT COMPLETED|Treatment||40
1521612|NCT01492426|3723861|P1|NOT COMPLETED|Treatment||83
1521613|NCT01492426|3723860|P2|COMPLETED|Treatment||160
1521614|NCT01492426|3723861|P1|COMPLETED|Treatment||319
1521615|NCT01492426|3723860|P2|STARTED|Treatment||200
1521616|NCT01492426|3723861|P1|STARTED|Treatment||402
1521617|NCT01492400|3723879|P2|NOT COMPLETED|Overall Study||16
1521618|NCT01492400|3723880|P1|NOT COMPLETED|Overall Study||16
1521619|NCT01492400|3723879|P2|COMPLETED|Overall Study||166
1521620|NCT01492400|3723880|P1|COMPLETED|Overall Study||165
1521621|NCT01492400|3723879|P2|STARTED|Overall Study||182
1521622|NCT01492400|3723880|P1|STARTED|Overall Study||181
1521623|NCT01492309|3723892|P2|NOT COMPLETED|Overall Study||0
1521624|NCT01492309|3723893|P1|NOT COMPLETED|Overall Study||0
1521625|NCT01492309|3723892|P2|COMPLETED|Overall Study||11
1521626|NCT01492309|3723893|P1|COMPLETED|Overall Study||11
1521627|NCT01492309|3723892|P2|STARTED|Overall Study||11
1521628|NCT01492309|3723893|P1|STARTED|Overall Study||11
1521629|NCT01492088|3723904|P3|NOT COMPLETED|Overall Study||14
1521630|NCT01492088|3723905|P2|NOT COMPLETED|Overall Study||14
1521631|NCT01492088|3723906|P1|NOT COMPLETED|Overall Study||3
1521632|NCT01492088|3723904|P3|COMPLETED|Overall Study||3
1521633|NCT01492088|3723905|P2|COMPLETED|Overall Study||2
1521634|NCT01492088|3723906|P1|COMPLETED|Overall Study||0
1521635|NCT01492088|3723904|P3|STARTED|Overall Study||17
1521636|NCT01492088|3723905|P2|STARTED|Overall Study||16
1521637|NCT01492088|3723906|P1|STARTED|Overall Study||3
1521638|NCT01491984|3723966|P2|NOT COMPLETED|Overall Study||1
1521639|NCT01491984|3723967|P1|NOT COMPLETED|Overall Study||2
1521640|NCT01491984|3723966|P2|COMPLETED|Overall Study||44
1521641|NCT01491984|3723967|P1|COMPLETED|Overall Study||47
1521642|NCT01491984|3723966|P2|STARTED|Overall Study||45
1521643|NCT01491984|3723967|P1|STARTED|Overall Study||49
1521644|NCT01491958|3723975|P2|NOT COMPLETED|Overall Study||0
1521645|NCT01491958|3723976|P1|NOT COMPLETED|Overall Study||0
1521646|NCT01491958|3723975|P2|COMPLETED|Overall Study||40
1521647|NCT01491958|3723976|P1|COMPLETED|Overall Study||40
1521648|NCT01491958|3723975|P2|STARTED|Overall Study||40
1521649|NCT01491958|3723976|P1|STARTED|Overall Study||40
1521650|NCT01491919|3723987|P3|NOT COMPLETED|Overall Study||1
1521651|NCT01491919|3723988|P2|NOT COMPLETED|Overall Study||2
1521652|NCT01491919|3723989|P1|NOT COMPLETED|Overall Study||1
1521653|NCT01491919|3723987|P3|COMPLETED|Overall Study||2
1521654|NCT01491919|3723988|P2|COMPLETED|Overall Study||8
1521655|NCT01491919|3723989|P1|COMPLETED|Overall Study||12
1521656|NCT01491919|3723987|P3|STARTED|Overall Study||3
1521657|NCT01491919|3723988|P2|STARTED|Overall Study||10
1521658|NCT01491919|3723989|P1|STARTED|Overall Study||13
1521659|NCT01491893|3724035|P10|NOT COMPLETED|Overall Study||0
1521660|NCT01491893|3724036|P9|NOT COMPLETED|Overall Study||0
1521661|NCT01491893|3724037|P8|NOT COMPLETED|Overall Study||0
1521662|NCT01491893|3724038|P7|NOT COMPLETED|Overall Study||0
1521663|NCT01491893|3724039|P6|NOT COMPLETED|Overall Study||0
1521664|NCT01491893|3724040|P5|NOT COMPLETED|Overall Study||0
1521665|NCT01491893|3724041|P4|NOT COMPLETED|Overall Study||0
1521666|NCT01491893|3724042|P3|NOT COMPLETED|Overall Study||0
1521667|NCT01491893|3724043|P2|NOT COMPLETED|Overall Study||0
1521668|NCT01491893|3724044|P1|NOT COMPLETED|Overall Study||0
1521669|NCT01491893|3724035|P10|COMPLETED|Overall Study||7
1521670|NCT01491893|3724036|P9|COMPLETED|Overall Study||15
1521671|NCT01491893|3724037|P8|COMPLETED|Overall Study||24
1521672|NCT01491893|3724038|P7|COMPLETED|Overall Study||6
1521673|NCT01491893|3724039|P6|COMPLETED|Overall Study||1
1521674|NCT01491893|3724040|P5|COMPLETED|Overall Study||4
1521675|NCT01491893|3724041|P4|COMPLETED|Overall Study||1
1521676|NCT01491893|3724042|P3|COMPLETED|Overall Study||1
1521677|NCT01491893|3724043|P2|COMPLETED|Overall Study||1
1521678|NCT01491893|3724044|P1|COMPLETED|Overall Study||1
1521679|NCT01491893|3724035|P10|STARTED|Overall Study||7
1521680|NCT01491893|3724036|P9|STARTED|Overall Study||15
1521681|NCT01491893|3724037|P8|STARTED|Overall Study||24
1521682|NCT01491893|3724038|P7|STARTED|Overall Study||6
1521683|NCT01491893|3724039|P6|STARTED|Overall Study||1
1521684|NCT01491893|3724040|P5|STARTED|Overall Study||4
1521685|NCT01491893|3724041|P4|STARTED|Overall Study||1
1521686|NCT01491893|3724042|P3|STARTED|Overall Study||1
1521687|NCT01491893|3724043|P2|STARTED|Overall Study||1
1521688|NCT01491893|3724044|P1|STARTED|Overall Study||1
1521689|NCT01491802|3724060|P2|NOT COMPLETED|Overall Study||2
1521690|NCT01491802|3724061|P1|NOT COMPLETED|Overall Study||1
1521691|NCT01491802|3724060|P2|COMPLETED|Overall Study||6
1521692|NCT01491802|3724061|P1|COMPLETED|Overall Study||8
1521693|NCT01491802|3724060|P2|STARTED|Overall Study||8
1521694|NCT01491802|3724061|P1|STARTED|Overall Study||9
1521695|NCT01491737|3724088|P2|NOT COMPLETED|Overall Study||50
1521696|NCT01491737|3724089|P1|NOT COMPLETED|Overall Study||49
1521697|NCT01491737|3724088|P2|COMPLETED|Overall Study||79
1521698|NCT01491737|3724089|P1|COMPLETED|Overall Study||80
1521699|NCT01491737|3724088|P2|STARTED|Overall Study||129
1521700|NCT01491737|3724089|P1|STARTED|Overall Study||129
1521701|NCT01491672|3724112|P3|NOT COMPLETED|Overall Study||11
1521702|NCT01491672|3724113|P2|NOT COMPLETED|Overall Study||60
1521703|NCT01491672|3724114|P1|NOT COMPLETED|Overall Study||56
1521704|NCT01491672|3724112|P3|COMPLETED|Overall Study||3
1521705|NCT01491672|3724113|P2|COMPLETED|Overall Study||2
1521706|NCT01491672|3724114|P1|COMPLETED|Overall Study||2
1521707|NCT01491672|3724112|P3|Safety Set|Overall Study||14
1521708|NCT01491672|3724113|P2|Safety Set|Overall Study||61
1521709|NCT01491672|3724114|P1|Safety Set|Overall Study||58
1521710|NCT01491672|3724112|P3|STARTED|Overall Study||14
1521711|NCT01491672|3724113|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
1521712|NCT01491672|3724114|P1|STARTED|Overall Study||58
1521713|NCT01491633|3724139|P1|NOT COMPLETED|Overall Study||5
1521714|NCT01491633|3724139|P1|COMPLETED|Overall Study||0
1521715|NCT01491633|3724139|P1|STARTED|Overall Study||5
1521716|NCT01491607|3724151|P1|NOT COMPLETED|Overall Study||10
1521717|NCT01491607|3724151|P1|COMPLETED|Overall Study||190
1521718|NCT01491607|3724151|P1|STARTED|Overall Study||200
1521719|NCT01491490|3724249|P2|NOT COMPLETED|Overall Study||0
1521720|NCT01491490|3724250|P1|NOT COMPLETED|Overall Study||0
1521721|NCT01491490|3724249|P2|COMPLETED|Overall Study||1
1521722|NCT01491490|3724250|P1|COMPLETED|Overall Study||1
1521723|NCT01491490|3724249|P2|STARTED|Overall Study||1
1521724|NCT01491490|3724250|P1|STARTED|Overall Study||1
1521725|NCT01491178|3724256|P1|NOT COMPLETED|Overall Study||2794
1521726|NCT01491178|3724256|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
1521727|NCT01491178|3724256|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
1521728|NCT01491113|3724266|P5|NOT COMPLETED|Overall Study||0
1521729|NCT01491113|3724267|P4|NOT COMPLETED|Overall Study||0
1521730|NCT01491113|3724268|P3|NOT COMPLETED|Overall Study||0
1521731|NCT01491113|3724269|P2|NOT COMPLETED|Overall Study||0
1521732|NCT01491113|3724270|P1|NOT COMPLETED|Overall Study||0
1521733|NCT01491113|3724266|P5|COMPLETED|Overall Study||6
1521734|NCT01491113|3724267|P4|COMPLETED|Overall Study||6
1521735|NCT01491113|3724268|P3|COMPLETED|Overall Study||6
1521736|NCT01491113|3724269|P2|COMPLETED|Overall Study||6
1521737|NCT01491113|3724270|P1|COMPLETED|Overall Study||6
1521738|NCT01491113|3724266|P5|STARTED|Overall Study||6
1521739|NCT01491113|3724267|P4|STARTED|Overall Study||6
1521740|NCT01491113|3724268|P3|STARTED|Overall Study||6
1521741|NCT01491113|3724269|P2|STARTED|Overall Study||6
1521742|NCT01491113|3724270|P1|STARTED|Overall Study||6
1521743|NCT01491035|3724365|P8|NOT COMPLETED|Overall Study||0
1521744|NCT01491035|3724366|P7|NOT COMPLETED|Overall Study||0
1521745|NCT01491035|3724367|P6|NOT COMPLETED|Overall Study||0
1521746|NCT01491035|3724368|P5|NOT COMPLETED|Overall Study||1
1521747|NCT01491035|3724369|P4|NOT COMPLETED|Overall Study||0
1521748|NCT01491035|3724370|P3|NOT COMPLETED|Overall Study||0
1521749|NCT01491035|3724371|P2|NOT COMPLETED|Overall Study||0
1521750|NCT01491035|3724372|P1|NOT COMPLETED|Overall Study||0
1521751|NCT01491035|3724365|P8|COMPLETED|Overall Study||6
1521752|NCT01491035|3724366|P7|COMPLETED|Overall Study||6
1521753|NCT01491035|3724367|P6|COMPLETED|Overall Study||6
1521754|NCT01491035|3724368|P5|COMPLETED|Overall Study||5
1521755|NCT01491035|3724369|P4|COMPLETED|Overall Study||6
1521756|NCT01491035|3724370|P3|COMPLETED|Overall Study||6
1521757|NCT01491035|3724371|P2|COMPLETED|Overall Study||6
1521758|NCT01491035|3724372|P1|COMPLETED|Overall Study||6
1521759|NCT01491035|3724365|P8|STARTED|Overall Study||6
1521760|NCT01491035|3724366|P7|STARTED|Overall Study||6
1521761|NCT01491035|3724367|P6|STARTED|Overall Study||6
1521762|NCT01491035|3724368|P5|STARTED|Overall Study||6
1521763|NCT01491035|3724369|P4|STARTED|Overall Study||6
1521764|NCT01491035|3724370|P3|STARTED|Overall Study||6
1521765|NCT01491035|3724371|P2|STARTED|Overall Study||6
1521766|NCT01491035|3724372|P1|STARTED|Overall Study||6
1521767|NCT01491022|3724440|P2|NOT COMPLETED|Intervention 2||0
1521768|NCT01491022|3724441|P1|NOT COMPLETED|Intervention 2||1
1521769|NCT01491022|3724440|P2|COMPLETED|Intervention 2||11
1521770|NCT01491022|3724441|P1|COMPLETED|Intervention 2||8
1521771|NCT01491022|3724440|P2|STARTED|Intervention 2||11
1521772|NCT01491022|3724441|P1|STARTED|Intervention 2||9
1521773|NCT01491022|3724440|P2|NOT COMPLETED|2 Week Washout||0
1521774|NCT01491022|3724441|P1|NOT COMPLETED|2 Week Washout||0
1521775|NCT01491022|3724440|P2|COMPLETED|2 Week Washout||11
1521776|NCT01491022|3724441|P1|COMPLETED|2 Week Washout||9
1521777|NCT01491022|3724440|P2|STARTED|2 Week Washout||11
1521778|NCT01491022|3724441|P1|STARTED|2 Week Washout||9
1521779|NCT01491022|3724440|P2|NOT COMPLETED|Intervention 1||1
1521780|NCT01491022|3724441|P1|NOT COMPLETED|Intervention 1||1
1521781|NCT01491022|3724440|P2|COMPLETED|Intervention 1||11
1521782|NCT01491022|3724441|P1|COMPLETED|Intervention 1||9
1521783|NCT01491022|3724440|P2|STARTED|Intervention 1||12
1521784|NCT01491022|3724441|P1|STARTED|Intervention 1||10
1521785|NCT01490931|3724457|P1|NOT COMPLETED|Overall Study||0
1521786|NCT01490931|3724457|P1|COMPLETED|Overall Study||25
1521787|NCT01490931|3724457|P1|STARTED|Overall Study||25
1521788|NCT01490866|3724473|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
1521789|NCT01490866|3724473|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
1521790|NCT01490866|3724473|P1|STARTED|Axitinib Maintenance Therapy||49
1521791|NCT01490866|3724473|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
1521792|NCT01490866|3724473|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
1521793|NCT01490866|3724473|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
1521794|NCT01490840|3724484|P2|NOT COMPLETED|Phase 2||6
1521795|NCT01490840|3724485|P1|NOT COMPLETED|Phase 2||6
1521796|NCT01490840|3724484|P2|COMPLETED|Phase 2||68
1521797|NCT01490840|3724485|P1|COMPLETED|Phase 2||75
1521798|NCT01490840|3724484|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
1521799|NCT01490840|3724485|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
1521800|NCT01490840|3724484|P2|NOT COMPLETED|Phase 1||6
1521801|NCT01490840|3724485|P1|NOT COMPLETED|Phase 1||10
1521802|NCT01490840|3724484|P2|COMPLETED|Phase 1||78
1521803|NCT01490840|3724485|P1|COMPLETED|Phase 1||84
1521804|NCT01490840|3724484|P2|Modified Full Analysis Set|Phase 1||83
1521805|NCT01490840|3724485|P1|Modified Full Analysis Set|Phase 1||56
1521806|NCT01490840|3724484|P2|STARTED|Phase 1||84
1521807|NCT01490840|3724485|P1|STARTED|Phase 1||94
1521808|NCT01490814|3724509|P2|NOT COMPLETED|Overall Study||8
1521809|NCT01490814|3724510|P1|NOT COMPLETED|Overall Study||4
1521810|NCT01490814|3724509|P2|COMPLETED|Overall Study|376 received ablation|376
1521811|NCT01490814|3724510|P1|COMPLETED|Overall Study|374 received ablation|374
1521812|NCT01490814|3724509|P2|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
1521813|NCT01490814|3724510|P1|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
1521814|NCT01490788|3724530|P6|NOT COMPLETED|Overall Study||0
1521815|NCT01490788|3724531|P5|NOT COMPLETED|Overall Study||0
1521816|NCT01490788|3724532|P4|NOT COMPLETED|Overall Study||0
1521817|NCT01490788|3724533|P3|NOT COMPLETED|Overall Study||0
1521818|NCT01490788|3724534|P2|NOT COMPLETED|Overall Study||0
1521819|NCT01490788|3724535|P1|NOT COMPLETED|Overall Study||1
1521820|NCT01490788|3724530|P6|COMPLETED|Overall Study||5
1521821|NCT01490788|3724531|P5|COMPLETED|Overall Study||5
1521822|NCT01490788|3724532|P4|COMPLETED|Overall Study||5
1521823|NCT01490788|3724533|P3|COMPLETED|Overall Study||5
1521824|NCT01490788|3724534|P2|COMPLETED|Overall Study||5
1521825|NCT01490788|3724535|P1|COMPLETED|Overall Study||4
1521826|NCT01490788|3724530|P6|STARTED|Overall Study||5
1521827|NCT01490788|3724531|P5|STARTED|Overall Study||5
1521828|NCT01490788|3724532|P4|STARTED|Overall Study||5
1521829|NCT01490788|3724533|P3|STARTED|Overall Study||5
1521830|NCT01490788|3724534|P2|STARTED|Overall Study||5
1521831|NCT01490788|3724535|P1|STARTED|Overall Study||5
1521832|NCT01490697|3724548|P2|NOT COMPLETED|Overall Study||2
1521833|NCT01490697|3724549|P1|NOT COMPLETED|Overall Study||1
1521834|NCT01490697|3724548|P2|COMPLETED|Overall Study||16
1521835|NCT01490697|3724549|P1|COMPLETED|Overall Study||15
1521836|NCT01490697|3724548|P2|STARTED|Overall Study||18
1521837|NCT01490697|3724549|P1|STARTED|Overall Study||16
1521838|NCT01490684|3724557|P1|NOT COMPLETED|Overall Study||0
1521839|NCT01490684|3724557|P1|COMPLETED|Overall Study||162
1521840|NCT01490684|3724557|P1|STARTED|Overall Study||162
1521841|NCT01490632|3724569|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
1521842|NCT01490632|3724570|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
1521843|NCT01490632|3724571|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
1521844|NCT01490632|3724572|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
1521845|NCT01490632|3724573|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
1521846|NCT01490632|3724574|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
1521847|NCT01490632|3724575|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
1521848|NCT01490632|3724576|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
1521849|NCT01490632|3724577|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
1521850|NCT01490632|3724578|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
1521851|NCT01490632|3724579|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
1521852|NCT01490632|3724580|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
1521853|NCT01490632|3724581|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
1521854|NCT01490632|3724582|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
1521855|NCT01490632|3724583|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
1521856|NCT01490632|3724584|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
1521857|NCT01490632|3724585|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
1521858|NCT01490632|3724586|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
1521859|NCT01490632|3724587|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
1521860|NCT01490632|3724588|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
1521861|NCT01490632|3724569|P20|COMPLETED|Part D: Re-Treatment Period||30
1521862|NCT01490632|3724570|P19|COMPLETED|Part D: Re-Treatment Period||12
1521863|NCT01490632|3724571|P18|COMPLETED|Part D: Re-Treatment Period||8
1521864|NCT01490632|3724572|P17|COMPLETED|Part D: Re-Treatment Period||3
1521865|NCT01490632|3724573|P16|COMPLETED|Part D: Re-Treatment Period||0
1521866|NCT01490632|3724574|P15|COMPLETED|Part D: Re-Treatment Period||0
1521867|NCT01490632|3724575|P14|COMPLETED|Part D: Re-Treatment Period||0
1521868|NCT01490632|3724576|P13|COMPLETED|Part D: Re-Treatment Period||0
1521869|NCT01490632|3724577|P12|COMPLETED|Part D: Re-Treatment Period||0
1521870|NCT01490632|3724578|P11|COMPLETED|Part D: Re-Treatment Period||0
1521871|NCT01490632|3724579|P10|COMPLETED|Part D: Re-Treatment Period||0
1521872|NCT01490632|3724580|P9|COMPLETED|Part D: Re-Treatment Period||0
1521873|NCT01490632|3724581|P8|COMPLETED|Part D: Re-Treatment Period||0
1521874|NCT01490632|3724582|P7|COMPLETED|Part D: Re-Treatment Period||0
1521875|NCT01490632|3724583|P6|COMPLETED|Part D: Re-Treatment Period||0
1521876|NCT01490632|3724584|P5|COMPLETED|Part D: Re-Treatment Period||0
1521877|NCT01490632|3724585|P4|COMPLETED|Part D: Re-Treatment Period||0
1521878|NCT01490632|3724586|P3|COMPLETED|Part D: Re-Treatment Period||0
1521879|NCT01490632|3724587|P2|COMPLETED|Part D: Re-Treatment Period||0
1521880|NCT01490632|3724588|P1|COMPLETED|Part D: Re-Treatment Period||0
1521881|NCT01490632|3724569|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
1521882|NCT01490632|3724570|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
1521883|NCT01490632|3724571|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
1521884|NCT01490632|3724572|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
1521885|NCT01490632|3724573|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
1521886|NCT01490632|3724574|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
1521887|NCT01490632|3724575|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
1521888|NCT01490632|3724576|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
1521889|NCT01490632|3724577|P12|STARTED|Part D: Re-Treatment Period||0
1521890|NCT01490632|3724578|P11|STARTED|Part D: Re-Treatment Period||0
1521891|NCT01490632|3724579|P10|STARTED|Part D: Re-Treatment Period||0
1521892|NCT01490632|3724580|P9|STARTED|Part D: Re-Treatment Period||0
1521893|NCT01490632|3724581|P8|STARTED|Part D: Re-Treatment Period||0
1521894|NCT01490632|3724582|P7|STARTED|Part D: Re-Treatment Period||0
1521895|NCT01490632|3724583|P6|STARTED|Part D: Re-Treatment Period||0
1521896|NCT01490632|3724584|P5|STARTED|Part D: Re-Treatment Period||0
1521897|NCT01490632|3724585|P4|STARTED|Part D: Re-Treatment Period||0
1521898|NCT01490632|3724586|P3|STARTED|Part D: Re-Treatment Period||0
1521899|NCT01490632|3724587|P2|STARTED|Part D: Re-Treatment Period||0
1521900|NCT01490632|3724588|P1|STARTED|Part D: Re-Treatment Period||0
1521901|NCT01490632|3724569|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521902|NCT01490632|3724570|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521903|NCT01490632|3724571|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521904|NCT01490632|3724572|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521905|NCT01490632|3724573|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
1521906|NCT01490632|3724574|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
1521907|NCT01490632|3724575|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
1521908|NCT01490632|3724576|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
1521909|NCT01490632|3724577|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521910|NCT01490632|3724578|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521911|NCT01490632|3724579|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521912|NCT01490632|3724580|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521913|NCT01490632|3724581|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521914|NCT01490632|3724582|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521915|NCT01490632|3724583|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521916|NCT01490632|3724584|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521917|NCT01490632|3724585|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521918|NCT01490632|3724586|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521919|NCT01490632|3724587|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521920|NCT01490632|3724588|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
1521921|NCT01490632|3724569|P20|COMPLETED|Part C: Washout or Step-Down Period||0
1521922|NCT01490632|3724570|P19|COMPLETED|Part C: Washout or Step-Down Period||0
1521923|NCT01490632|3724571|P18|COMPLETED|Part C: Washout or Step-Down Period||0
1521924|NCT01490632|3724572|P17|COMPLETED|Part C: Washout or Step-Down Period||0
1521925|NCT01490632|3724573|P16|COMPLETED|Part C: Washout or Step-Down Period||18
1521926|NCT01490632|3724574|P15|COMPLETED|Part C: Washout or Step-Down Period||37
1521927|NCT01490632|3724575|P14|COMPLETED|Part C: Washout or Step-Down Period||6
1521928|NCT01490632|3724576|P13|COMPLETED|Part C: Washout or Step-Down Period||10
1521929|NCT01490632|3724577|P12|COMPLETED|Part C: Washout or Step-Down Period||0
1521930|NCT01490632|3724578|P11|COMPLETED|Part C: Washout or Step-Down Period||0
1521931|NCT01490632|3724579|P10|COMPLETED|Part C: Washout or Step-Down Period||0
1521932|NCT01490632|3724580|P9|COMPLETED|Part C: Washout or Step-Down Period||0
1521933|NCT01490632|3724581|P8|COMPLETED|Part C: Washout or Step-Down Period||0
1521934|NCT01490632|3724582|P7|COMPLETED|Part C: Washout or Step-Down Period||0
1521935|NCT01490632|3724583|P6|COMPLETED|Part C: Washout or Step-Down Period||0
1521936|NCT01490632|3724584|P5|COMPLETED|Part C: Washout or Step-Down Period||0
1521937|NCT01490632|3724585|P4|COMPLETED|Part C: Washout or Step-Down Period||0
1521938|NCT01490632|3724586|P3|COMPLETED|Part C: Washout or Step-Down Period||0
1521939|NCT01490632|3724587|P2|COMPLETED|Part C: Washout or Step-Down Period||0
1521940|NCT01490632|3724588|P1|COMPLETED|Part C: Washout or Step-Down Period||0
1521941|NCT01490632|3724569|P20|STARTED|Part C: Washout or Step-Down Period||0
1521942|NCT01490632|3724570|P19|STARTED|Part C: Washout or Step-Down Period||0
1521943|NCT01490632|3724571|P18|STARTED|Part C: Washout or Step-Down Period||0
1521944|NCT01490632|3724572|P17|STARTED|Part C: Washout or Step-Down Period||0
1521945|NCT01490632|3724573|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
1521946|NCT01490632|3724574|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
1521947|NCT01490632|3724575|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
1521948|NCT01490632|3724576|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
1521949|NCT01490632|3724577|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
1521950|NCT01490632|3724578|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
1521951|NCT01490632|3724579|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
1521952|NCT01490632|3724580|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
1521953|NCT01490632|3724581|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
1521954|NCT01490632|3724582|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
1521955|NCT01490632|3724583|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
1521956|NCT01490632|3724584|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
1521957|NCT01490632|3724585|P4|STARTED|Part C: Washout or Step-Down Period||0
1521958|NCT01490632|3724586|P3|STARTED|Part C: Washout or Step-Down Period||0
1521959|NCT01490632|3724587|P2|STARTED|Part C: Washout or Step-Down Period||0
1521960|NCT01490632|3724588|P1|STARTED|Part C: Washout or Step-Down Period||0
1521961|NCT01490632|3724569|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521962|NCT01490632|3724570|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521963|NCT01490632|3724571|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521964|NCT01490632|3724572|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521965|NCT01490632|3724573|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521966|NCT01490632|3724574|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521967|NCT01490632|3724575|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521968|NCT01490632|3724576|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521969|NCT01490632|3724577|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
1521970|NCT01490632|3724578|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
1521971|NCT01490632|3724579|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
1521972|NCT01490632|3724580|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
1521973|NCT01490632|3724581|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
1521974|NCT01490632|3724582|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
1521975|NCT01490632|3724583|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
1521976|NCT01490632|3724584|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521977|NCT01490632|3724585|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521978|NCT01490632|3724586|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521979|NCT01490632|3724587|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521980|NCT01490632|3724588|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
1521981|NCT01490632|3724569|P20|COMPLETED|Part B: Extension or Step-Up Period||0
1521982|NCT01490632|3724570|P19|COMPLETED|Part B: Extension or Step-Up Period||0
1521983|NCT01490632|3724571|P18|COMPLETED|Part B: Extension or Step-Up Period||0
1521984|NCT01490632|3724572|P17|COMPLETED|Part B: Extension or Step-Up Period||0
1521985|NCT01490632|3724573|P16|COMPLETED|Part B: Extension or Step-Up Period||0
1521986|NCT01490632|3724574|P15|COMPLETED|Part B: Extension or Step-Up Period||0
1521987|NCT01490632|3724575|P14|COMPLETED|Part B: Extension or Step-Up Period||0
1521988|NCT01490632|3724576|P13|COMPLETED|Part B: Extension or Step-Up Period||0
1521989|NCT01490632|3724577|P12|COMPLETED|Part B: Extension or Step-Up Period||0
1521990|NCT01490632|3724578|P11|COMPLETED|Part B: Extension or Step-Up Period||22
1521991|NCT01490632|3724579|P10|COMPLETED|Part B: Extension or Step-Up Period||25
1521992|NCT01490632|3724580|P9|COMPLETED|Part B: Extension or Step-Up Period||6
1521993|NCT01490632|3724581|P8|COMPLETED|Part B: Extension or Step-Up Period||13
1521994|NCT01490632|3724582|P7|COMPLETED|Part B: Extension or Step-Up Period||51
1521995|NCT01490632|3724583|P6|COMPLETED|Part B: Extension or Step-Up Period||25
1521996|NCT01490632|3724584|P5|COMPLETED|Part B: Extension or Step-Up Period||0
1521997|NCT01490632|3724585|P4|COMPLETED|Part B: Extension or Step-Up Period||0
1521998|NCT01490632|3724586|P3|COMPLETED|Part B: Extension or Step-Up Period||0
1521999|NCT01490632|3724587|P2|COMPLETED|Part B: Extension or Step-Up Period||0
1522000|NCT01490632|3724588|P1|COMPLETED|Part B: Extension or Step-Up Period||0
1522001|NCT01490632|3724569|P20|STARTED|Part B: Extension or Step-Up Period||0
1522002|NCT01490632|3724570|P19|STARTED|Part B: Extension or Step-Up Period||0
1522003|NCT01490632|3724571|P18|STARTED|Part B: Extension or Step-Up Period||0
1522004|NCT01490632|3724572|P17|STARTED|Part B: Extension or Step-Up Period||0
1522005|NCT01490632|3724573|P16|STARTED|Part B: Extension or Step-Up Period||0
1522006|NCT01490632|3724574|P15|STARTED|Part B: Extension or Step-Up Period||0
1522007|NCT01490632|3724575|P14|STARTED|Part B: Extension or Step-Up Period||0
1522008|NCT01490632|3724576|P13|STARTED|Part B: Extension or Step-Up Period||0
1522009|NCT01490632|3724577|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
1522010|NCT01490632|3724578|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
1522011|NCT01490632|3724579|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
1522012|NCT01490632|3724580|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
1522013|NCT01490632|3724581|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
1522014|NCT01490632|3724582|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
1522015|NCT01490632|3724583|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
1522016|NCT01490632|3724584|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1522017|NCT01490632|3724585|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1522018|NCT01490632|3724586|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1522019|NCT01490632|3724587|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1522020|NCT01490632|3724588|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
1522021|NCT01490632|3724569|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
1522022|NCT01490632|3724570|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
1522023|NCT01490632|3724571|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
1522024|NCT01490632|3724572|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
1522025|NCT01490632|3724573|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
1522026|NCT01490632|3724574|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
1522027|NCT01490632|3724575|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
1522028|NCT01490632|3724576|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
1522029|NCT01490632|3724577|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
1522030|NCT01490632|3724578|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
1522031|NCT01490632|3724579|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
1522032|NCT01490632|3724580|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
1522033|NCT01490632|3724581|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
1522034|NCT01490632|3724582|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
1522035|NCT01490632|3724583|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
1522036|NCT01490632|3724584|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
1522037|NCT01490632|3724585|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
1522038|NCT01490632|3724586|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
1522039|NCT01490632|3724587|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
1522040|NCT01490632|3724588|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
1522041|NCT01490632|3724569|P20|COMPLETED|Part A: Initial Treatment Period||0
1522042|NCT01490632|3724570|P19|COMPLETED|Part A: Initial Treatment Period||0
1522043|NCT01490632|3724571|P18|COMPLETED|Part A: Initial Treatment Period||0
1522044|NCT01490632|3724572|P17|COMPLETED|Part A: Initial Treatment Period||0
1522045|NCT01490632|3724573|P16|COMPLETED|Part A: Initial Treatment Period||0
1522046|NCT01490632|3724574|P15|COMPLETED|Part A: Initial Treatment Period||0
1522047|NCT01490632|3724575|P14|COMPLETED|Part A: Initial Treatment Period||0
1522048|NCT01490632|3724576|P13|COMPLETED|Part A: Initial Treatment Period||0
1522049|NCT01490632|3724577|P12|COMPLETED|Part A: Initial Treatment Period||0
1522050|NCT01490632|3724578|P11|COMPLETED|Part A: Initial Treatment Period||0
1522051|NCT01490632|3724579|P10|COMPLETED|Part A: Initial Treatment Period||0
1522052|NCT01490632|3724580|P9|COMPLETED|Part A: Initial Treatment Period||0
1522053|NCT01490632|3724581|P8|COMPLETED|Part A: Initial Treatment Period||0
1522054|NCT01490632|3724582|P7|COMPLETED|Part A: Initial Treatment Period||0
1522055|NCT01490632|3724583|P6|COMPLETED|Part A: Initial Treatment Period||0
1522056|NCT01490632|3724584|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
1522057|NCT01490632|3724585|P4|COMPLETED|Part A: Initial Treatment Period||55
1522058|NCT01490632|3724586|P3|COMPLETED|Part A: Initial Treatment Period||67
1522059|NCT01490632|3724587|P2|COMPLETED|Part A: Initial Treatment Period||28
1522060|NCT01490632|3724588|P1|COMPLETED|Part A: Initial Treatment Period||27
1522061|NCT01490632|3724569|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522062|NCT01490632|3724570|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522063|NCT01490632|3724571|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522064|NCT01490632|3724572|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522065|NCT01490632|3724573|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522066|NCT01490632|3724574|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522067|NCT01490632|3724575|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522068|NCT01490632|3724576|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522069|NCT01490632|3724577|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522070|NCT01490632|3724578|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522071|NCT01490632|3724579|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522072|NCT01490632|3724580|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522073|NCT01490632|3724581|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522074|NCT01490632|3724582|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522075|NCT01490632|3724583|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
1522076|NCT01490632|3724584|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
1522077|NCT01490632|3724585|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
1522078|NCT01490632|3724586|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
1522079|NCT01490632|3724587|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
1522080|NCT01490632|3724588|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
1522081|NCT01490632|3724569|P20|STARTED|Part A: Initial Treatment Period||0
1522082|NCT01490632|3724570|P19|STARTED|Part A: Initial Treatment Period||0
1522083|NCT01490632|3724571|P18|STARTED|Part A: Initial Treatment Period||0
1522084|NCT01490632|3724572|P17|STARTED|Part A: Initial Treatment Period||0
1522085|NCT01490632|3724573|P16|STARTED|Part A: Initial Treatment Period||0
1522086|NCT01490632|3724574|P15|STARTED|Part A: Initial Treatment Period||0
1522087|NCT01490632|3724575|P14|STARTED|Part A: Initial Treatment Period||0
1522088|NCT01490632|3724576|P13|STARTED|Part A: Initial Treatment Period||0
1522089|NCT01490632|3724577|P12|STARTED|Part A: Initial Treatment Period||0
1522090|NCT01490632|3724578|P11|STARTED|Part A: Initial Treatment Period||0
1522091|NCT01490632|3724579|P10|STARTED|Part A: Initial Treatment Period||0
1522092|NCT01490632|3724580|P9|STARTED|Part A: Initial Treatment Period||0
1522093|NCT01490632|3724581|P8|STARTED|Part A: Initial Treatment Period||0
1522094|NCT01490632|3724582|P7|STARTED|Part A: Initial Treatment Period||0
1522095|NCT01490632|3724583|P6|STARTED|Part A: Initial Treatment Period||0
1522096|NCT01490632|3724584|P5|STARTED|Part A: Initial Treatment Period||69
1522097|NCT01490632|3724585|P4|STARTED|Part A: Initial Treatment Period||64
1522098|NCT01490632|3724586|P3|STARTED|Part A: Initial Treatment Period||72
1522099|NCT01490632|3724587|P2|STARTED|Part A: Initial Treatment Period||32
1522100|NCT01490632|3724588|P1|STARTED|Part A: Initial Treatment Period||34
1522101|NCT01490359|3724718|P2|NOT COMPLETED|Overall Study||17
1522102|NCT01490359|3724719|P1|NOT COMPLETED|Overall Study||24
1522103|NCT01490359|3724718|P2|COMPLETED|Overall Study||555
1522104|NCT01490359|3724719|P1|COMPLETED|Overall Study||585
1522105|NCT01490359|3724718|P2|Followed-up at 12 mo|Overall Study||537
1522106|NCT01490359|3724719|P1|Followed-up at 12 mo|Overall Study||569
1522107|NCT01490359|3724718|P2|Followed-up at 6 mo|Overall Study||535
1522108|NCT01490359|3724719|P1|Followed-up at 6 mo|Overall Study||558
1522109|NCT01490359|3724718|P2|STARTED|Overall Study||572
1522110|NCT01490359|3724719|P1|STARTED|Overall Study||609
1522111|NCT01490294|3724743|P4|NOT COMPLETED|Overall Study||1
1522112|NCT01490294|3724744|P3|NOT COMPLETED|Overall Study||1
1522113|NCT01490294|3724745|P2|NOT COMPLETED|Overall Study||0
1522114|NCT01490294|3724746|P1|NOT COMPLETED|Overall Study||5
1522115|NCT01490294|3724743|P4|COMPLETED|Overall Study||54
1522116|NCT01490294|3724744|P3|COMPLETED|Overall Study||58
1522117|NCT01490294|3724745|P2|COMPLETED|Overall Study||60
1522118|NCT01490294|3724746|P1|COMPLETED|Overall Study||53
1522119|NCT01490294|3724743|P4|Participant Received Treatment|Overall Study||54
1522120|NCT01490294|3724744|P3|Participant Received Treatment|Overall Study||58
1522121|NCT01490294|3724745|P2|Participant Received Treatment|Overall Study||60
1522122|NCT01490294|3724746|P1|Participant Received Treatment|Overall Study||54
1522123|NCT01490294|3724743|P4|STARTED|Overall Study||55
1522124|NCT01490294|3724744|P3|STARTED|Overall Study||59
1522125|NCT01490294|3724745|P2|STARTED|Overall Study||60
1522126|NCT01490294|3724746|P1|STARTED|Overall Study||58
1522127|NCT01490190|3724980|P1|NOT COMPLETED|Overall Study||48
1522128|NCT01490190|3724980|P1|COMPLETED|Overall Study||204
1522129|NCT01490190|3724980|P1|STARTED|Overall Study||252
1522130|NCT01490151|3725001|P1|NOT COMPLETED|Overall Study||0
1522131|NCT01490151|3725001|P1|COMPLETED|Overall Study||22
1522132|NCT01490151|3725001|P1|STARTED|Overall Study||22
1522133|NCT01490125|3725007|P6|NOT COMPLETED|Period III||0
1522134|NCT01490125|3725008|P5|NOT COMPLETED|Period III||1
1522135|NCT01490125|3725009|P4|NOT COMPLETED|Period III||2
1522136|NCT01490125|3725010|P3|NOT COMPLETED|Period III||0
1522137|NCT01490125|3725011|P2|NOT COMPLETED|Period III||1
1522138|NCT01490125|3725012|P1|NOT COMPLETED|Period III||3
1522139|NCT01490125|3725007|P6|COMPLETED|Period III||35
1522140|NCT01490125|3725008|P5|COMPLETED|Period III||31
1522141|NCT01490125|3725009|P4|COMPLETED|Period III||28
1522142|NCT01490125|3725010|P3|COMPLETED|Period III||34
1522143|NCT01490125|3725011|P2|COMPLETED|Period III||32
1522144|NCT01490125|3725012|P1|COMPLETED|Period III||31
1522145|NCT01490125|3725007|P6|STARTED|Period III||35
1522146|NCT01490125|3725008|P5|STARTED|Period III||32
1522147|NCT01490125|3725009|P4|STARTED|Period III||30
1522148|NCT01490125|3725010|P3|STARTED|Period III||34
1522149|NCT01490125|3725011|P2|STARTED|Period III||33
1522150|NCT01490125|3725012|P1|STARTED|Period III||34
1522151|NCT01490125|3725007|P6|NOT COMPLETED|Period II||2
1522152|NCT01490125|3725008|P5|NOT COMPLETED|Period II||4
1522153|NCT01490125|3725009|P4|NOT COMPLETED|Period II||3
1522154|NCT01490125|3725010|P3|NOT COMPLETED|Period II||3
1522155|NCT01490125|3725011|P2|NOT COMPLETED|Period II||4
1522156|NCT01490125|3725012|P1|NOT COMPLETED|Period II||3
1522157|NCT01490125|3725007|P6|COMPLETED|Period II||35
1522158|NCT01490125|3725008|P5|COMPLETED|Period II||32
1522159|NCT01490125|3725009|P4|COMPLETED|Period II||30
1522160|NCT01490125|3725010|P3|COMPLETED|Period II||34
1522161|NCT01490125|3725011|P2|COMPLETED|Period II||33
1522162|NCT01490125|3725012|P1|COMPLETED|Period II||34
1522163|NCT01490125|3725007|P6|STARTED|Period II||37
1522164|NCT01490125|3725008|P5|STARTED|Period II||36
1522165|NCT01490125|3725009|P4|STARTED|Period II||33
1522166|NCT01490125|3725010|P3|STARTED|Period II||37
1522167|NCT01490125|3725011|P2|STARTED|Period II||37
1522168|NCT01490125|3725012|P1|STARTED|Period II||37
1522169|NCT01490125|3725007|P6|NOT COMPLETED|Period I||5
1522170|NCT01490125|3725008|P5|NOT COMPLETED|Period I||4
1522171|NCT01490125|3725009|P4|NOT COMPLETED|Period I||5
1522172|NCT01490125|3725010|P3|NOT COMPLETED|Period I||4
1522173|NCT01490125|3725011|P2|NOT COMPLETED|Period I||5
1522174|NCT01490125|3725012|P1|NOT COMPLETED|Period I||6
1522175|NCT01490125|3725007|P6|COMPLETED|Period I||37
1522176|NCT01490125|3725008|P5|COMPLETED|Period I||36
1522177|NCT01490125|3725009|P4|COMPLETED|Period I||33
1522178|NCT01490125|3725010|P3|COMPLETED|Period I||37
1522179|NCT01490125|3725011|P2|COMPLETED|Period I||37
1522180|NCT01490125|3725012|P1|COMPLETED|Period I||37
1522181|NCT01490125|3725007|P6|STARTED|Period I||42
1522182|NCT01490125|3725008|P5|STARTED|Period I||40
1522183|NCT01490125|3725009|P4|STARTED|Period I||38
1522184|NCT01490125|3725010|P3|STARTED|Period I||41
1522185|NCT01490125|3725011|P2|STARTED|Period I||42
1522186|NCT01490125|3725012|P1|STARTED|Period I||43
1522187|NCT01490086|3725040|P5|NOT COMPLETED|Overall Study||11
1522188|NCT01490086|3725041|P4|NOT COMPLETED|Overall Study||7
1522189|NCT01490086|3725042|P3|NOT COMPLETED|Overall Study||7
1522190|NCT01490086|3725043|P2|NOT COMPLETED|Overall Study||15
1522191|NCT01490086|3725044|P1|NOT COMPLETED|Overall Study||8
1522192|NCT01490086|3725040|P5|COMPLETED|Overall Study||28
1522193|NCT01490086|3725041|P4|COMPLETED|Overall Study||13
1522194|NCT01490086|3725042|P3|COMPLETED|Overall Study||51
1522195|NCT01490086|3725043|P2|COMPLETED|Overall Study||44
1522196|NCT01490086|3725044|P1|COMPLETED|Overall Study||50
1522197|NCT01490086|3725040|P5|STARTED|Overall Study||39
1522198|NCT01490086|3725041|P4|STARTED|Overall Study||20
1522199|NCT01490086|3725042|P3|STARTED|Overall Study||58
1522200|NCT01490086|3725043|P2|STARTED|Overall Study||59
1522201|NCT01490086|3725044|P1|STARTED|Overall Study||58
1522202|NCT01490060|3725078|P4|NOT COMPLETED|Cycle 2||0
1522203|NCT01490060|3725079|P3|NOT COMPLETED|Cycle 2||1
1522204|NCT01490060|3725080|P2|NOT COMPLETED|Cycle 2||1
1522205|NCT01490060|3725081|P1|NOT COMPLETED|Cycle 2||2
1522206|NCT01490060|3725078|P4|COMPLETED|Cycle 2||8
1522207|NCT01490060|3725079|P3|COMPLETED|Cycle 2||8
1522208|NCT01490060|3725080|P2|COMPLETED|Cycle 2||11
1522209|NCT01490060|3725081|P1|COMPLETED|Cycle 2||9
1522210|NCT01490060|3725078|P4|STARTED|Cycle 2||8
1522211|NCT01490060|3725079|P3|STARTED|Cycle 2||9
1522212|NCT01490060|3725080|P2|STARTED|Cycle 2||12
1522213|NCT01490060|3725081|P1|STARTED|Cycle 2||11
1522214|NCT01490060|3725078|P4|NOT COMPLETED|Cycle 1||3
1522215|NCT01490060|3725079|P3|NOT COMPLETED|Cycle 1||3
1522216|NCT01490060|3725080|P2|NOT COMPLETED|Cycle 1||1
1522217|NCT01490060|3725081|P1|NOT COMPLETED|Cycle 1||0
1522218|NCT01490060|3725078|P4|COMPLETED|Cycle 1||8
1522219|NCT01490060|3725079|P3|COMPLETED|Cycle 1||9
1522220|NCT01490060|3725080|P2|COMPLETED|Cycle 1||12
1522221|NCT01490060|3725081|P1|COMPLETED|Cycle 1||11
1522222|NCT01490060|3725078|P4|STARTED|Cycle 1||11
1522223|NCT01490060|3725079|P3|STARTED|Cycle 1||12
1522224|NCT01490060|3725080|P2|STARTED|Cycle 1||13
1522225|NCT01490060|3725081|P1|STARTED|Cycle 1||11
1522226|NCT01489969|3725092|P3|NOT COMPLETED|Overall Study||1
1522227|NCT01489969|3725093|P2|NOT COMPLETED|Overall Study||4
1522228|NCT01489969|3725094|P1|NOT COMPLETED|Overall Study||5
1522229|NCT01489969|3725092|P3|COMPLETED|Overall Study||44
1522230|NCT01489969|3725093|P2|COMPLETED|Overall Study||43
1522231|NCT01489969|3725094|P1|COMPLETED|Overall Study||40
1522232|NCT01489969|3725092|P3|STARTED|Overall Study||45
1522233|NCT01489969|3725093|P2|STARTED|Overall Study||47
1522234|NCT01489969|3725094|P1|STARTED|Overall Study||45
1522235|NCT01489956|3725110|P3|NOT COMPLETED|Overall Study||1
1522236|NCT01489956|3725111|P2|NOT COMPLETED|Overall Study||0
1522237|NCT01489956|3725112|P1|NOT COMPLETED|Overall Study||1
1522238|NCT01489956|3725110|P3|COMPLETED|Overall Study||5
1522239|NCT01489956|3725111|P2|COMPLETED|Overall Study||0
1522240|NCT01489956|3725112|P1|COMPLETED|Overall Study||12
1522241|NCT01489956|3725110|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
1522242|NCT01489956|3725111|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
1522243|NCT01489956|3725112|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
1522244|NCT01489891|3725149|P2|NOT COMPLETED|Overall Study||0
1522245|NCT01489891|3725150|P1|NOT COMPLETED|Overall Study||1
1522246|NCT01489891|3725149|P2|COMPLETED|Overall Study||60
1522247|NCT01489891|3725150|P1|COMPLETED|Overall Study||59
1522248|NCT01489891|3725149|P2|STARTED|Overall Study||60
1522249|NCT01489891|3725150|P1|STARTED|Overall Study||60
1522250|NCT01489826|3725171|P9|NOT COMPLETED|Overall Study||0
1522251|NCT01489826|3725172|P8|NOT COMPLETED|Overall Study||0
1522252|NCT01489826|3725173|P7|NOT COMPLETED|Overall Study||0
1522253|NCT01489826|3725174|P6|NOT COMPLETED|Overall Study||0
1522254|NCT01489826|3725175|P5|NOT COMPLETED|Overall Study||0
1522255|NCT01489826|3725176|P4|NOT COMPLETED|Overall Study||0
1522256|NCT01489826|3725177|P3|NOT COMPLETED|Overall Study||0
1522257|NCT01489826|3725178|P2|NOT COMPLETED|Overall Study||0
1522258|NCT01489826|3725179|P1|NOT COMPLETED|Overall Study||0
1522259|NCT01489826|3725171|P9|COMPLETED|Overall Study||6
1522260|NCT01489826|3725172|P8|COMPLETED|Overall Study||3
1522261|NCT01489826|3725173|P7|COMPLETED|Overall Study||9
1522262|NCT01489826|3725174|P6|COMPLETED|Overall Study||3
1522263|NCT01489826|3725175|P5|COMPLETED|Overall Study||3
1522264|NCT01489826|3725176|P4|COMPLETED|Overall Study||7
1522265|NCT01489826|3725177|P3|COMPLETED|Overall Study||3
1522266|NCT01489826|3725178|P2|COMPLETED|Overall Study||3
1522267|NCT01489826|3725179|P1|COMPLETED|Overall Study||3
1522268|NCT01489826|3725171|P9|STARTED|Overall Study||6
1522269|NCT01489826|3725172|P8|STARTED|Overall Study||3
1522270|NCT01489826|3725173|P7|STARTED|Overall Study||9
1522271|NCT01489826|3725174|P6|STARTED|Overall Study||3
1522272|NCT01489826|3725175|P5|STARTED|Overall Study||3
1522273|NCT01489826|3725176|P4|STARTED|Overall Study||7
1522274|NCT01489826|3725177|P3|STARTED|Overall Study||3
1522275|NCT01489826|3725178|P2|STARTED|Overall Study||3
1522276|NCT01489826|3725179|P1|STARTED|Overall Study||3
1522277|NCT01489670|3725276|P1|NOT COMPLETED|Overall Study||53
1522278|NCT01489670|3725276|P1|COMPLETED|Overall Study||334
1522279|NCT01489670|3725276|P1|STARTED|Overall Study||387
1522280|NCT01489527|3725288|P2|NOT COMPLETED|Overall Study||26
1522281|NCT01489527|3725289|P1|NOT COMPLETED|Overall Study||22
1522282|NCT01489527|3725288|P2|COMPLETED|Overall Study||175
1522283|NCT01489527|3725289|P1|COMPLETED|Overall Study||183
1522284|NCT01489527|3725288|P2|STARTED|Overall Study||201
1522285|NCT01489527|3725289|P1|STARTED|Overall Study||205
1522286|NCT01489358|3725306|P3|NOT COMPLETED|Overall Study||2
1522287|NCT01489358|3725307|P2|NOT COMPLETED|Overall Study||0
1522288|NCT01489358|3725308|P1|NOT COMPLETED|Overall Study||0
1522289|NCT01489358|3725306|P3|COMPLETED|Overall Study||8
1522290|NCT01489358|3725307|P2|COMPLETED|Overall Study||10
1522291|NCT01489358|3725308|P1|COMPLETED|Overall Study||5
1522292|NCT01489358|3725306|P3|STARTED|Overall Study||10
1522293|NCT01489358|3725307|P2|STARTED|Overall Study||10
1522294|NCT01489358|3725308|P1|STARTED|Overall Study||5
1522295|NCT01489254|3725358|P4|NOT COMPLETED|Open-label Extension Part||58
1522296|NCT01489254|3725359|P3|NOT COMPLETED|Open-label Extension Part||0
1522297|NCT01489254|3725360|P2|NOT COMPLETED|Open-label Extension Part||0
1522298|NCT01489254|3725361|P1|NOT COMPLETED|Open-label Extension Part||0
1522299|NCT01489254|3725358|P4|COMPLETED|Open-label Extension Part||670
1522300|NCT01489254|3725359|P3|COMPLETED|Open-label Extension Part||0
1522301|NCT01489254|3725360|P2|COMPLETED|Open-label Extension Part||0
1522302|NCT01489254|3725361|P1|COMPLETED|Open-label Extension Part||0
1522303|NCT01489254|3725358|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
1522304|NCT01489254|3725359|P3|STARTED|Open-label Extension Part||0
1522305|NCT01489254|3725360|P2|STARTED|Open-label Extension Part||0
1522306|NCT01489254|3725361|P1|STARTED|Open-label Extension Part||0
1522307|NCT01489254|3725358|P4|NOT COMPLETED|Double-blind Part||0
1522308|NCT01489254|3725359|P3|NOT COMPLETED|Double-blind Part||3
1522309|NCT01489254|3725360|P2|NOT COMPLETED|Double-blind Part||33
1522310|NCT01489254|3725361|P1|NOT COMPLETED|Double-blind Part||25
1522311|NCT01489254|3725358|P4|COMPLETED|Double-blind Part||0
1522312|NCT01489254|3725359|P3|COMPLETED|Double-blind Part||81
1522313|NCT01489254|3725360|P2|COMPLETED|Double-blind Part||324
1522314|NCT01489254|3725361|P1|COMPLETED|Double-blind Part||330
1522315|NCT01489254|3725358|P4|STARTED|Double-blind Part||0
1522316|NCT01489254|3725359|P3|STARTED|Double-blind Part||84
1522317|NCT01489254|3725360|P2|STARTED|Double-blind Part||357
1522318|NCT01489254|3725361|P1|STARTED|Double-blind Part||355
1522319|NCT01489189|3725372|P2|NOT COMPLETED|Overall Study||35
1522320|NCT01489189|3725373|P1|NOT COMPLETED|Overall Study||31
1522321|NCT01489189|3725372|P2|COMPLETED|Overall Study|Number of Eyes|168
1522322|NCT01489189|3725373|P1|COMPLETED|Overall Study|Number of Eyes|160
1522323|NCT01489189|3725372|P2|STARTED|Overall Study|Number of Eyes|203
1522324|NCT01489189|3725373|P1|STARTED|Overall Study|Number of Eyes|191
1522325|NCT01488994|3725400|P2|NOT COMPLETED|Overall Study||1
1522326|NCT01488994|3725401|P1|NOT COMPLETED|Overall Study||0
1522327|NCT01488994|3725400|P2|COMPLETED|Overall Study||11
1522328|NCT01488994|3725401|P1|COMPLETED|Overall Study||11
1522329|NCT01488994|3725400|P2|STARTED|Overall Study||12
1522330|NCT01488994|3725401|P1|STARTED|Overall Study||11
1522331|NCT01488877|3725488|P3|NOT COMPLETED|Re-randomization||0
1522332|NCT01488877|3725489|P2|NOT COMPLETED|Re-randomization||0
1522333|NCT01488877|3725490|P1|NOT COMPLETED|Re-randomization||0
1522334|NCT01488877|3725488|P3|COMPLETED|Re-randomization||3
1522335|NCT01488877|3725489|P2|COMPLETED|Re-randomization||0
1522336|NCT01488877|3725490|P1|COMPLETED|Re-randomization||0
1522337|NCT01488877|3725488|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
1522338|NCT01488877|3725489|P2|STARTED|Re-randomization||0
1522339|NCT01488877|3725490|P1|STARTED|Re-randomization||0
1522340|NCT01488877|3725488|P3|NOT COMPLETED|Initial Randomization||0
1522341|NCT01488877|3725489|P2|NOT COMPLETED|Initial Randomization||0
1522342|NCT01488877|3725490|P1|NOT COMPLETED|Initial Randomization||0
1522343|NCT01488877|3725488|P3|COMPLETED|Initial Randomization||0
1522344|NCT01488877|3725489|P2|COMPLETED|Initial Randomization||5
1522345|NCT01488877|3725490|P1|COMPLETED|Initial Randomization||1
1522346|NCT01488877|3725488|P3|STARTED|Initial Randomization||0
1522347|NCT01488877|3725489|P2|STARTED|Initial Randomization||5
1522348|NCT01488877|3725490|P1|STARTED|Initial Randomization||1
1522349|NCT01488708|3725507|P2|NOT COMPLETED|Overall Study||578
1522350|NCT01488708|3725508|P1|NOT COMPLETED|Overall Study||940
1522351|NCT01488708|3725507|P2|COMPLETED|Overall Study||0
1522352|NCT01488708|3725508|P1|COMPLETED|Overall Study||0
1522353|NCT01488708|3725507|P2|Participated in Follow Up|Overall Study||526
1522354|NCT01488708|3725508|P1|Participated in Follow Up|Overall Study||810
1522355|NCT01488708|3725507|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
1522356|NCT01488708|3725508|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
1522357|NCT01488708|3725507|P2|STARTED|Overall Study||578
1522358|NCT01488708|3725508|P1|STARTED|Overall Study||940
1522359|NCT01488578|3725528|P1|NOT COMPLETED|Overall Study||1836
1522360|NCT01488578|3725528|P1|COMPLETED|Overall Study||9321
1522361|NCT01488578|3725528|P1|STARTED|Overall Study||11157
1522362|NCT01488487|3725562|P1|NOT COMPLETED|Overall Study||9
1522363|NCT01488487|3725562|P1|COMPLETED|Overall Study||15
1522364|NCT01488487|3725562|P1|Received Treatment|Overall Study||24
1522365|NCT01488487|3725562|P1|STARTED|Overall Study||24
1522366|NCT01488448|3725571|P2|NOT COMPLETED|Overall Study||17
1522367|NCT01488448|3725572|P1|NOT COMPLETED|Overall Study||20
1522368|NCT01488448|3725571|P2|COMPLETED|Overall Study||97
1522369|NCT01488448|3725572|P1|COMPLETED|Overall Study||93
1522370|NCT01488448|3725571|P2|STARTED|Overall Study||114
1522371|NCT01488448|3725572|P1|STARTED|Overall Study||113
1522372|NCT01488409|3725596|P2|NOT COMPLETED|Overall Study||4
1522373|NCT01488409|3725597|P1|NOT COMPLETED|Overall Study||4
1522374|NCT01488409|3725596|P2|COMPLETED|Overall Study||15
1522375|NCT01488409|3725597|P1|COMPLETED|Overall Study||16
1522376|NCT01488409|3725596|P2|STARTED|Overall Study||19
1522377|NCT01488409|3725597|P1|STARTED|Overall Study||20
1522378|NCT01488370|3725614|P3|NOT COMPLETED|Overall Study||1
1522379|NCT01488370|3725615|P2|NOT COMPLETED|Overall Study||1
1522380|NCT01488370|3725616|P1|NOT COMPLETED|Overall Study||0
1522381|NCT01488370|3725614|P3|COMPLETED|Overall Study||19
1522382|NCT01488370|3725615|P2|COMPLETED|Overall Study||22
1522383|NCT01488370|3725616|P1|COMPLETED|Overall Study||22
1522384|NCT01488370|3725614|P3|STARTED|Overall Study||20
1522385|NCT01488370|3725615|P2|STARTED|Overall Study||23
1522386|NCT01488370|3725616|P1|STARTED|Overall Study||22
1522387|NCT01488318|3725636|P1|NOT COMPLETED|Overall Study||0
1522388|NCT01488318|3725636|P1|COMPLETED|Overall Study||14
1522389|NCT01488318|3725636|P1|STARTED|Overall Study||14
1522390|NCT01488279|3725645|P2|NOT COMPLETED|Overall Study||0
1522391|NCT01488279|3725646|P1|NOT COMPLETED|Overall Study||0
1522392|NCT01488279|3725645|P2|COMPLETED|Overall Study||5
1522393|NCT01488279|3725646|P1|COMPLETED|Overall Study||5
1522394|NCT01488279|3725645|P2|STARTED|Overall Study||5
1522395|NCT01488279|3725646|P1|STARTED|Overall Study||5
1522396|NCT01488188|3725662|P2|NOT COMPLETED|Overall Study||0
1522397|NCT01488188|3725663|P1|NOT COMPLETED|Overall Study||0
1522398|NCT01488188|3725662|P2|COMPLETED|Overall Study||20
1522399|NCT01488188|3725663|P1|COMPLETED|Overall Study||20
1522400|NCT01488188|3725662|P2|STARTED|Overall Study||20
1522401|NCT01488188|3725663|P1|STARTED|Overall Study||20
1522402|NCT01488097|3725675|P1|NOT COMPLETED|Overall Study||1
1522403|NCT01488097|3725675|P1|COMPLETED|Overall Study||7
1522404|NCT01488097|3725675|P1|Received Study Drug in Extension Study|Overall Study||8
1522405|NCT01488097|3725675|P1|STARTED|Overall Study||8
1522406|NCT01488071|3725688|P2|NOT COMPLETED|Overall Study||63
1522407|NCT01488071|3725689|P1|NOT COMPLETED|Overall Study||53
1522408|NCT01488071|3725688|P2|COMPLETED|Overall Study||179
1522409|NCT01488071|3725689|P1|COMPLETED|Overall Study||200
1522410|NCT01488071|3725688|P2|STARTED|Overall Study|APTS|242
1522411|NCT01488071|3725689|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
1522412|NCT01488019|3725723|P2|NOT COMPLETED|Overall Study||304
1522413|NCT01488019|3725724|P1|NOT COMPLETED|Overall Study||247
1522414|NCT01488019|3725723|P2|COMPLETED|Overall Study||226
1522415|NCT01488019|3725724|P1|COMPLETED|Overall Study||294
1522416|NCT01488019|3725723|P2|STARTED|Overall Study||530
1522417|NCT01488019|3725724|P1|STARTED|Overall Study||541
1522418|NCT01487954|3725758|P2|NOT COMPLETED|Overall Study||0
1522419|NCT01487954|3725759|P1|NOT COMPLETED|Overall Study||0
1522420|NCT01487954|3725758|P2|COMPLETED|Overall Study||16
1522421|NCT01487954|3725759|P1|COMPLETED|Overall Study||29
1522422|NCT01487954|3725758|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
1522423|NCT01487954|3725759|P1|Safety lead-in|Overall Study||10
1522424|NCT01487954|3725758|P2|STARTED|Overall Study||16
1522425|NCT01487954|3725759|P1|STARTED|Overall Study||29
1522426|NCT01487863|3725769|P2|NOT COMPLETED|Overall Study||19
1522427|NCT01487863|3725770|P1|NOT COMPLETED|Overall Study||19
1522428|NCT01487863|3725769|P2|COMPLETED|Overall Study||15
1522429|NCT01487863|3725770|P1|COMPLETED|Overall Study||16
1522430|NCT01487863|3725769|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
1522431|NCT01487863|3725770|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
1522432|NCT01487863|3725769|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
1522433|NCT01487863|3725770|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
1522434|NCT01487863|3725769|P2|STARTED|Overall Study||34
1522435|NCT01487863|3725770|P1|STARTED|Overall Study||35
1522436|NCT01487668|3725778|P2|NOT COMPLETED|Overall Study||17
1522437|NCT01487668|3725779|P1|NOT COMPLETED|Overall Study||25
1522438|NCT01487668|3725778|P2|COMPLETED|Overall Study||124
1522439|NCT01487668|3725779|P1|COMPLETED|Overall Study||121
1522440|NCT01487668|3725778|P2|STARTED|Overall Study||141
1522441|NCT01487668|3725779|P1|STARTED|Overall Study||146
1522442|NCT01487577|3725787|P1|NOT COMPLETED|Overall Study||1
1522443|NCT01487577|3725787|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
1522444|NCT01487577|3725787|P1|STARTED|Overall Study||19
1522445|NCT01487525|3725801|P2|NOT COMPLETED|Overall Study||1
1522446|NCT01487525|3725802|P1|NOT COMPLETED|Overall Study||0
1522447|NCT01487525|3725801|P2|COMPLETED|Overall Study||19
1522448|NCT01487525|3725802|P1|COMPLETED|Overall Study||22
1522449|NCT01487525|3725801|P2|STARTED|Overall Study||20
1522450|NCT01487525|3725802|P1|STARTED|Overall Study||22
1522451|NCT01487499|3725812|P1|NOT COMPLETED|Overall Study||0
1522452|NCT01487499|3725812|P1|COMPLETED|Overall Study||4
1522453|NCT01487499|3725812|P1|STARTED|Overall Study||4
1522454|NCT01487265|3725818|P1|NOT COMPLETED|Overall Study||37
1522455|NCT01487265|3725818|P1|COMPLETED|Overall Study||0
1522456|NCT01487265|3725818|P1|STARTED|Overall Study||37
1522457|NCT01487161|3725830|P4|NOT COMPLETED|Overall Study||2
1522458|NCT01487161|3725831|P3|NOT COMPLETED|Overall Study||1
1522459|NCT01487161|3725832|P2|NOT COMPLETED|Overall Study||2
1522460|NCT01487161|3725833|P1|NOT COMPLETED|Overall Study||2
1522461|NCT01487161|3725830|P4|COMPLETED|Overall Study||50
1522462|NCT01487161|3725831|P3|COMPLETED|Overall Study||59
1522463|NCT01487161|3725832|P2|COMPLETED|Overall Study||57
1522464|NCT01487161|3725833|P1|COMPLETED|Overall Study||56
1522465|NCT01487161|3725830|P4|STARTED|Overall Study||52
1522466|NCT01487161|3725831|P3|STARTED|Overall Study||60
1522467|NCT01487161|3725832|P2|STARTED|Overall Study||59
1522468|NCT01487161|3725833|P1|STARTED|Overall Study||58
1522469|NCT01486966|3725898|P2|NOT COMPLETED|Overall Study||2
1522470|NCT01486966|3725899|P1|NOT COMPLETED|Overall Study||0
1522471|NCT01486966|3725898|P2|COMPLETED|Overall Study||27
1522472|NCT01486966|3725899|P1|COMPLETED|Overall Study||29
1522473|NCT01486966|3725898|P2|STARTED|Overall Study||29
1522474|NCT01486966|3725899|P1|STARTED|Overall Study||29
1522475|NCT01486927|3725923|P1|NOT COMPLETED|Overall Study||13
1522476|NCT01486927|3725923|P1|COMPLETED|Overall Study||161
1522477|NCT01486927|3725923|P1|STARTED|Overall Study||174
1522478|NCT01486810|3725954|P1|NOT COMPLETED|Overall Study||8
1522479|NCT01486810|3725954|P1|COMPLETED|Overall Study||9
1522480|NCT01486810|3725954|P1|STARTED|Overall Study||17
1522481|NCT01486758|3725961|P2|NOT COMPLETED|Overall Study||1
1522482|NCT01486758|3725962|P1|NOT COMPLETED|Overall Study||0
1522483|NCT01486758|3725961|P2|COMPLETED|Overall Study||19
1522484|NCT01486758|3725962|P1|COMPLETED|Overall Study||20
1522485|NCT01486758|3725961|P2|STARTED|Overall Study||20
1522486|NCT01486758|3725962|P1|STARTED|Overall Study||20
1522487|NCT01486615|3725986|P4|NOT COMPLETED|Overall Study||2
1522488|NCT01486615|3725987|P3|NOT COMPLETED|Overall Study||2
1522489|NCT01486615|3725988|P2|NOT COMPLETED|Overall Study||1
1522490|NCT01486615|3725989|P1|NOT COMPLETED|Overall Study||0
1522491|NCT01486615|3725986|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
1522492|NCT01486615|3725987|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
1522577|NCT01485536|3726148|P1|COMPLETED|Overall Study||17
1522493|NCT01486615|3725988|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
1522494|NCT01486615|3725989|P1|COMPLETED|Overall Study||20
1522495|NCT01486615|3725986|P4|STARTED|Overall Study||20
1522496|NCT01486615|3725987|P3|STARTED|Overall Study||20
1522497|NCT01486615|3725988|P2|STARTED|Overall Study||20
1522498|NCT01486615|3725989|P1|STARTED|Overall Study||20
1522499|NCT01486446|3726029|P2|NOT COMPLETED|Overall Study||0
1522500|NCT01486446|3726030|P1|NOT COMPLETED|Overall Study||1
1522501|NCT01486446|3726029|P2|COMPLETED|Overall Study||1
1522502|NCT01486446|3726030|P1|COMPLETED|Overall Study||6
1522503|NCT01486446|3726029|P2|STARTED|Overall Study||1
1522504|NCT01486446|3726030|P1|STARTED|Overall Study||7
1522505|NCT01486316|3726053|P4|NOT COMPLETED|Overall Study||2
1522506|NCT01486316|3726054|P3|NOT COMPLETED|Overall Study||5
1522507|NCT01486316|3726055|P2|NOT COMPLETED|Overall Study||3
1522508|NCT01486316|3726056|P1|NOT COMPLETED|Overall Study||4
1522509|NCT01486316|3726053|P4|COMPLETED|Overall Study||0
1522510|NCT01486316|3726054|P3|COMPLETED|Overall Study||0
1522511|NCT01486316|3726055|P2|COMPLETED|Overall Study||7
1522512|NCT01486316|3726056|P1|COMPLETED|Overall Study||3
1522513|NCT01486316|3726053|P4|STARTED|Overall Study|Exited prior to 6 month visit|2
1522514|NCT01486316|3726054|P3|STARTED|Overall Study|Exited prior to implant|5
1522515|NCT01486316|3726055|P2|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
1522516|NCT01486316|3726056|P1|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
1522517|NCT01486238|3726068|P2|NOT COMPLETED|Overall Study||6
1522518|NCT01486238|3726069|P1|NOT COMPLETED|Overall Study||2
1522519|NCT01486238|3726068|P2|COMPLETED|Overall Study||43
1522520|NCT01486238|3726069|P1|COMPLETED|Overall Study||21
1522521|NCT01486238|3726068|P2|STARTED|Overall Study||49
1522522|NCT01486238|3726069|P1|STARTED|Overall Study||23
1522523|NCT01486199|3726077|P2|NOT COMPLETED|Study Day at t= 2 Years||0
1522524|NCT01486199|3726078|P1|NOT COMPLETED|Study Day at t= 2 Years||0
1522525|NCT01486199|3726077|P2|COMPLETED|Study Day at t= 2 Years||0
1522526|NCT01486199|3726078|P1|COMPLETED|Study Day at t= 2 Years||9
1522527|NCT01486199|3726077|P2|STARTED|Study Day at t= 2 Years||0
1522528|NCT01486199|3726078|P1|STARTED|Study Day at t= 2 Years||9
1522529|NCT01486199|3726077|P2|NOT COMPLETED|Two Year Period Between Study Days||0
1522530|NCT01486199|3726078|P1|NOT COMPLETED|Two Year Period Between Study Days||1
1522531|NCT01486199|3726077|P2|COMPLETED|Two Year Period Between Study Days||0
1522532|NCT01486199|3726078|P1|COMPLETED|Two Year Period Between Study Days||9
1522533|NCT01486199|3726077|P2|STARTED|Two Year Period Between Study Days||0
1522534|NCT01486199|3726078|P1|STARTED|Two Year Period Between Study Days||10
1522535|NCT01486199|3726077|P2|NOT COMPLETED|Baseline Study Day||1
1522536|NCT01486199|3726078|P1|NOT COMPLETED|Baseline Study Day||0
1522537|NCT01486199|3726077|P2|COMPLETED|Baseline Study Day||9
1522538|NCT01486199|3726078|P1|COMPLETED|Baseline Study Day||10
1522539|NCT01486199|3726077|P2|STARTED|Baseline Study Day||10
1522540|NCT01486199|3726078|P1|STARTED|Baseline Study Day||10
1522541|NCT01486043|3726090|P1|NOT COMPLETED|Overall Study||2
1522542|NCT01486043|3726090|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
1522543|NCT01486043|3726090|P1|STARTED|Overall Study||4
1522544|NCT01485991|3726098|P2|NOT COMPLETED|Overall Study||36
1522545|NCT01485991|3726099|P1|NOT COMPLETED|Overall Study||32
1522546|NCT01485991|3726098|P2|COMPLETED|Overall Study||350
1522547|NCT01485991|3726099|P1|COMPLETED|Overall Study||353
1522548|NCT01485991|3726098|P2|Treated|Overall Study||384
1522549|NCT01485991|3726099|P1|Treated|Overall Study||379
1522550|NCT01485991|3726098|P2|STARTED|Overall Study||386
1522551|NCT01485991|3726099|P1|STARTED|Overall Study||385
1522552|NCT01485887|3726109|P1|NOT COMPLETED|Overall Study||12
1522553|NCT01485887|3726109|P1|COMPLETED|Overall Study||38
1522554|NCT01485887|3726109|P1|STARTED|Overall Study||50
1522555|NCT01485796|3726121|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
1522556|NCT01485796|3726121|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
1522557|NCT01485796|3726121|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
1522558|NCT01485796|3726121|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
1522559|NCT01485796|3726121|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
1522560|NCT01485796|3726121|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
1522561|NCT01485796|3726121|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
1522562|NCT01485796|3726121|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
1522563|NCT01485796|3726121|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
1522564|NCT01485796|3726121|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
1522565|NCT01485796|3726121|P1|NOT COMPLETED|Period 2: Epoch 2||35
1522566|NCT01485796|3726121|P1|COMPLETED|Period 2: Epoch 2||1
1522567|NCT01485796|3726121|P1|Treated in Epoch 2|Period 2: Epoch 2||36
1522568|NCT01485796|3726121|P1|STARTED|Period 2: Epoch 2||36
1522569|NCT01485796|3726121|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
1522570|NCT01485796|3726121|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
1522571|NCT01485796|3726121|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
1522572|NCT01485796|3726121|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
1522573|NCT01485640|3726143|P1|NOT COMPLETED|Overall Study||122
1522574|NCT01485640|3726143|P1|COMPLETED|Overall Study||40
1522575|NCT01485640|3726143|P1|STARTED|Overall Study||162
1522576|NCT01485536|3726148|P1|NOT COMPLETED|Overall Study||4
1522578|NCT01485536|3726148|P1|STARTED|Overall Study||21
1522579|NCT01485380|3726153|P1|NOT COMPLETED|Overall Study||3
1522580|NCT01485380|3726153|P1|COMPLETED|Overall Study||17
1522581|NCT01485380|3726153|P1|STARTED|Overall Study||20
1522582|NCT01485354|3726157|P1|NOT COMPLETED|Overall Study||5
1522583|NCT01485354|3726157|P1|COMPLETED|Overall Study||12
1522584|NCT01485354|3726157|P1|STARTED|Overall Study||17
1522585|NCT01485172|3726171|P6|NOT COMPLETED|Overall Study||4
1522586|NCT01485172|3726172|P5|NOT COMPLETED|Overall Study||5
1522587|NCT01485172|3726173|P4|NOT COMPLETED|Overall Study||8
1522588|NCT01485172|3726174|P3|NOT COMPLETED|Overall Study||7
1522589|NCT01485172|3726175|P2|NOT COMPLETED|Overall Study||1
1522590|NCT01485172|3726176|P1|NOT COMPLETED|Overall Study||7
1522591|NCT01485172|3726171|P6|COMPLETED|Overall Study||9
1522592|NCT01485172|3726172|P5|COMPLETED|Overall Study||34
1522593|NCT01485172|3726173|P4|COMPLETED|Overall Study||32
1522594|NCT01485172|3726174|P3|COMPLETED|Overall Study||34
1522595|NCT01485172|3726175|P2|COMPLETED|Overall Study||12
1522596|NCT01485172|3726176|P1|COMPLETED|Overall Study||33
1522597|NCT01485172|3726171|P6|STARTED|Overall Study||13
1522598|NCT01485172|3726172|P5|STARTED|Overall Study||39
1522599|NCT01485172|3726173|P4|STARTED|Overall Study||40
1522600|NCT01485172|3726174|P3|STARTED|Overall Study||41
1522601|NCT01485172|3726175|P2|STARTED|Overall Study||13
1522602|NCT01485172|3726176|P1|STARTED|Overall Study||40
1522603|NCT01485094|3726253|P3|NOT COMPLETED|Overall Study||1
1522604|NCT01485094|3726254|P2|NOT COMPLETED|Overall Study||2
1522605|NCT01485094|3726255|P1|NOT COMPLETED|Overall Study||3
1522606|NCT01485094|3726253|P3|COMPLETED|Overall Study||18
1522607|NCT01485094|3726254|P2|COMPLETED|Overall Study||18
1522608|NCT01485094|3726255|P1|COMPLETED|Overall Study||17
1522609|NCT01485094|3726253|P3|STARTED|Overall Study||19
1522610|NCT01485094|3726254|P2|STARTED|Overall Study||20
1522611|NCT01485094|3726255|P1|STARTED|Overall Study||20
1522612|NCT01484977|3726296|P1|NOT COMPLETED|Overall Study||27
1522613|NCT01484977|3726296|P1|COMPLETED|Overall Study||93
1522614|NCT01484977|3726296|P1|STARTED|Overall Study||120
1522615|NCT01484951|3726300|P1|NOT COMPLETED|Overall Study||5
1522616|NCT01484951|3726300|P1|COMPLETED|Overall Study||69
1522617|NCT01484951|3726300|P1|STARTED|Overall Study||74
1522618|NCT01484938|3726305|P1|NOT COMPLETED|Overall Study||4
1522619|NCT01484938|3726305|P1|COMPLETED|Overall Study||171
1522620|NCT01484938|3726305|P1|STARTED|Overall Study||175
1522621|NCT01484912|3726312|P2|NOT COMPLETED|Overall Study||1
1522622|NCT01484912|3726313|P1|NOT COMPLETED|Overall Study||1
1522623|NCT01484912|3726312|P2|COMPLETED|Overall Study||39
1522624|NCT01484912|3726313|P1|COMPLETED|Overall Study||38
1522625|NCT01484912|3726312|P2|STARTED|Overall Study||40
1522626|NCT01484912|3726313|P1|STARTED|Overall Study||39
1522627|NCT01484873|3726323|P1|NOT COMPLETED|Overall Study||2
1522628|NCT01484873|3726323|P1|COMPLETED|Overall Study||8
1522629|NCT01484873|3726323|P1|STARTED|Overall Study||10
1522630|NCT01484834|3726335|P4|NOT COMPLETED|Overall Study||4
1522631|NCT01484834|3726336|P3|NOT COMPLETED|Overall Study||1
1522632|NCT01484834|3726337|P2|NOT COMPLETED|Overall Study||8
1522633|NCT01484834|3726338|P1|NOT COMPLETED|Overall Study||5
1522634|NCT01484834|3726335|P4|COMPLETED|Overall Study||20
1522635|NCT01484834|3726336|P3|COMPLETED|Overall Study||38
1522636|NCT01484834|3726337|P2|COMPLETED|Overall Study||54
1522637|NCT01484834|3726338|P1|COMPLETED|Overall Study||60
1522638|NCT01484834|3726335|P4|STARTED|Overall Study||24
1522639|NCT01484834|3726336|P3|STARTED|Overall Study||39
1522640|NCT01484834|3726337|P2|STARTED|Overall Study||62
1522641|NCT01484834|3726338|P1|STARTED|Overall Study||65
1522642|NCT01484652|3726366|P2|NOT COMPLETED|Overall Study||21
1522643|NCT01484652|3726367|P1|NOT COMPLETED|Overall Study||15
1522644|NCT01484652|3726366|P2|COMPLETED|Overall Study||142
1522645|NCT01484652|3726367|P1|COMPLETED|Overall Study||151
1522646|NCT01484652|3726366|P2|STARTED|Overall Study||163
1522647|NCT01484652|3726367|P1|STARTED|Overall Study||166
1522648|NCT01484626|3726373|P1|NOT COMPLETED|Overall Study||0
1522649|NCT01484626|3726373|P1|COMPLETED|Overall Study||3
1522650|NCT01484626|3726373|P1|STARTED|Overall Study||3
1522651|NCT01484561|3726379|P2|NOT COMPLETED|Overall Study||6
1522652|NCT01484561|3726380|P1|NOT COMPLETED|Overall Study||9
1522653|NCT01484561|3726379|P2|COMPLETED|Overall Study||45
1522654|NCT01484561|3726380|P1|COMPLETED|Overall Study||88
1522655|NCT01484561|3726379|P2|STARTED|Overall Study||51
1522656|NCT01484561|3726380|P1|STARTED|Overall Study||97
1522657|NCT01484496|3726470|P4|NOT COMPLETED|Period 2||22
1522658|NCT01484496|3726471|P3|NOT COMPLETED|Period 2||15
1522659|NCT01484496|3726472|P2|NOT COMPLETED|Period 2||0
1522660|NCT01484496|3726473|P1|NOT COMPLETED|Period 2||0
1522661|NCT01484496|3726470|P4|COMPLETED|Period 2||434
1522662|NCT01484496|3726471|P3|COMPLETED|Period 2||191
1522663|NCT01484496|3726472|P2|COMPLETED|Period 2||0
1522664|NCT01484496|3726473|P1|COMPLETED|Period 2||0
1522665|NCT01484496|3726470|P4|STARTED|Period 2||456
1522666|NCT01484496|3726471|P3|STARTED|Period 2||206
1522667|NCT01484496|3726472|P2|STARTED|Period 2||0
1522668|NCT01484496|3726473|P1|STARTED|Period 2||0
1522669|NCT01484496|3726470|P4|NOT COMPLETED|Period 1||0
1522670|NCT01484496|3726471|P3|NOT COMPLETED|Period 1||0
1522671|NCT01484496|3726472|P2|NOT COMPLETED|Period 1||93
1522672|NCT01484496|3726473|P1|NOT COMPLETED|Period 1||66
1522673|NCT01484496|3726470|P4|COMPLETED|Period 1||0
1522674|NCT01484496|3726471|P3|COMPLETED|Period 1||0
1522675|NCT01484496|3726472|P2|COMPLETED|Period 1||463
1522676|NCT01484496|3726473|P1|COMPLETED|Period 1||214
1522677|NCT01484496|3726470|P4|STARTED|Period 1||0
1522678|NCT01484496|3726471|P3|STARTED|Period 1||0
1522679|NCT01484496|3726472|P2|STARTED|Period 1||556
1522680|NCT01484496|3726473|P1|STARTED|Period 1||280
1522681|NCT01484340|3726487|P2|NOT COMPLETED|Overall Study||0
1522682|NCT01484340|3726488|P1|NOT COMPLETED|Overall Study||0
1522683|NCT01484340|3726487|P2|COMPLETED|Overall Study||279
1522684|NCT01484340|3726488|P1|COMPLETED|Overall Study||281
1522685|NCT01484340|3726487|P2|STARTED|Overall Study||279
1522686|NCT01484340|3726488|P1|STARTED|Overall Study||281
1522687|NCT01484314|3726500|P1|NOT COMPLETED|Overall Study||0
1522688|NCT01484314|3726500|P1|COMPLETED|Overall Study||1
1522689|NCT01484314|3726500|P1|STARTED|Overall Study||1
1522690|NCT01484197|3726506|P4|NOT COMPLETED|Treatment Period 4||0
1522691|NCT01484197|3726507|P3|NOT COMPLETED|Treatment Period 4||0
1522692|NCT01484197|3726508|P2|NOT COMPLETED|Treatment Period 4||0
1522693|NCT01484197|3726509|P1|NOT COMPLETED|Treatment Period 4||0
1522694|NCT01484197|3726506|P4|COMPLETED|Treatment Period 4||6
1522695|NCT01484197|3726507|P3|COMPLETED|Treatment Period 4||9
1522696|NCT01484197|3726508|P2|COMPLETED|Treatment Period 4||8
1522697|NCT01484197|3726509|P1|COMPLETED|Treatment Period 4||7
1522698|NCT01484197|3726506|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
1522699|NCT01484197|3726507|P3|STARTED|Treatment Period 4||9
1522700|NCT01484197|3726508|P2|STARTED|Treatment Period 4||8
1522701|NCT01484197|3726509|P1|STARTED|Treatment Period 4||7
1522702|NCT01484197|3726506|P4|NOT COMPLETED|Treatment Period 3||0
1522703|NCT01484197|3726507|P3|NOT COMPLETED|Treatment Period 3||0
1522704|NCT01484197|3726508|P2|NOT COMPLETED|Treatment Period 3||0
1522705|NCT01484197|3726509|P1|NOT COMPLETED|Treatment Period 3||0
1522706|NCT01484197|3726506|P4|COMPLETED|Treatment Period 3||8
1522707|NCT01484197|3726507|P3|COMPLETED|Treatment Period 3||9
1522708|NCT01484197|3726508|P2|COMPLETED|Treatment Period 3||8
1522709|NCT01484197|3726509|P1|COMPLETED|Treatment Period 3||7
1522710|NCT01484197|3726506|P4|STARTED|Treatment Period 3||8
1522711|NCT01484197|3726507|P3|STARTED|Treatment Period 3||9
1522712|NCT01484197|3726508|P2|STARTED|Treatment Period 3||8
1522713|NCT01484197|3726509|P1|STARTED|Treatment Period 3||7
1522714|NCT01484197|3726506|P4|NOT COMPLETED|Treatment Period 2||1
1522715|NCT01484197|3726507|P3|NOT COMPLETED|Treatment Period 2||0
1522716|NCT01484197|3726508|P2|NOT COMPLETED|Treatment Period 2||0
1522717|NCT01484197|3726509|P1|NOT COMPLETED|Treatment Period 2||0
1522718|NCT01484197|3726506|P4|COMPLETED|Treatment Period 2||8
1522719|NCT01484197|3726507|P3|COMPLETED|Treatment Period 2||9
1522720|NCT01484197|3726508|P2|COMPLETED|Treatment Period 2||8
1522721|NCT01484197|3726509|P1|COMPLETED|Treatment Period 2||7
1522722|NCT01484197|3726506|P4|STARTED|Treatment Period 2||9
1522723|NCT01484197|3726507|P3|STARTED|Treatment Period 2||9
1522724|NCT01484197|3726508|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
1522725|NCT01484197|3726509|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
1522726|NCT01484197|3726506|P4|NOT COMPLETED|Treatment Period 1||0
1522727|NCT01484197|3726507|P3|NOT COMPLETED|Treatment Period 1||0
1522728|NCT01484197|3726508|P2|NOT COMPLETED|Treatment Period 1||0
1522729|NCT01484197|3726509|P1|NOT COMPLETED|Treatment Period 1||1
1522730|NCT01484197|3726506|P4|COMPLETED|Treatment Period 1||9
1522731|NCT01484197|3726507|P3|COMPLETED|Treatment Period 1||9
1522732|NCT01484197|3726508|P2|COMPLETED|Treatment Period 1||9
1522733|NCT01484197|3726509|P1|COMPLETED|Treatment Period 1||8
1522734|NCT01484197|3726506|P4|STARTED|Treatment Period 1||9
1522735|NCT01484197|3726507|P3|STARTED|Treatment Period 1||9
1522736|NCT01484197|3726508|P2|STARTED|Treatment Period 1||9
1522737|NCT01484197|3726509|P1|STARTED|Treatment Period 1||9
1522738|NCT01484132|3726592|P1|NOT COMPLETED|Overall Study||22
1522739|NCT01484132|3726592|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
1522740|NCT01484132|3726592|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
1522741|NCT01484132|3726592|P1|STARTED|Overall Study||113
1522742|NCT01484054|3726600|P2|NOT COMPLETED|Period 2||0
1522743|NCT01484054|3726601|P1|NOT COMPLETED|Period 2||0
1522744|NCT01484054|3726600|P2|COMPLETED|Period 2||49
1522745|NCT01484054|3726601|P1|COMPLETED|Period 2||50
1522746|NCT01484054|3726600|P2|STARTED|Period 2||49
1522747|NCT01484054|3726601|P1|STARTED|Period 2||50
1522748|NCT01484054|3726600|P2|NOT COMPLETED|Period 1||1
1522749|NCT01484054|3726601|P1|NOT COMPLETED|Period 1||0
1522750|NCT01484054|3726600|P2|COMPLETED|Period 1||49
1522751|NCT01484054|3726601|P1|COMPLETED|Period 1||50
1522752|NCT01484054|3726600|P2|STARTED|Period 1||50
1522753|NCT01484054|3726601|P1|STARTED|Period 1||50
1522754|NCT01484041|3726611|P1|NOT COMPLETED|Overall Study||0
1522755|NCT01484041|3726611|P1|COMPLETED|Overall Study||12
1522756|NCT01484041|3726611|P1|STARTED|Overall Study||12
1522757|NCT01484028|3726619|P4|NOT COMPLETED|Period 2||0
1522758|NCT01484028|3726620|P3|NOT COMPLETED|Period 2||0
1522759|NCT01484028|3726621|P2|NOT COMPLETED|Period 2||0
1522760|NCT01484028|3726622|P1|NOT COMPLETED|Period 2||0
1522761|NCT01484028|3726619|P4|COMPLETED|Period 2||66
1522762|NCT01484028|3726620|P3|COMPLETED|Period 2||64
1522763|NCT01484028|3726621|P2|COMPLETED|Period 2||67
1522764|NCT01484028|3726622|P1|COMPLETED|Period 2||66
1522765|NCT01484028|3726619|P4|STARTED|Period 2||66
1522766|NCT01484028|3726620|P3|STARTED|Period 2||64
1522767|NCT01484028|3726621|P2|STARTED|Period 2||67
1522768|NCT01484028|3726622|P1|STARTED|Period 2||66
1522769|NCT01484028|3726619|P4|NOT COMPLETED|Period 1||1
1522770|NCT01484028|3726620|P3|NOT COMPLETED|Period 1||0
1522771|NCT01484028|3726621|P2|NOT COMPLETED|Period 1||3
1522772|NCT01484028|3726622|P1|NOT COMPLETED|Period 1||0
1522773|NCT01484028|3726619|P4|COMPLETED|Period 1||66
1522774|NCT01484028|3726620|P3|COMPLETED|Period 1||64
1522775|NCT01484028|3726621|P2|COMPLETED|Period 1||67
1522776|NCT01484028|3726622|P1|COMPLETED|Period 1||66
1522777|NCT01484028|3726619|P4|STARTED|Period 1||67
1522778|NCT01484028|3726620|P3|STARTED|Period 1||64
1522779|NCT01484028|3726621|P2|STARTED|Period 1||70
1522780|NCT01484028|3726622|P1|STARTED|Period 1||66
1522781|NCT01483963|3726637|P5|NOT COMPLETED|Overall Study||0
1522782|NCT01483963|3726638|P4|NOT COMPLETED|Overall Study||0
1522783|NCT01483963|3726639|P3|NOT COMPLETED|Overall Study||0
1522784|NCT01483963|3726640|P2|NOT COMPLETED|Overall Study||0
1522785|NCT01483963|3726641|P1|NOT COMPLETED|Overall Study||0
1522786|NCT01483963|3726637|P5|COMPLETED|Overall Study||10
1522787|NCT01483963|3726638|P4|COMPLETED|Overall Study||10
1522788|NCT01483963|3726639|P3|COMPLETED|Overall Study||10
1522789|NCT01483963|3726640|P2|COMPLETED|Overall Study||10
1522790|NCT01483963|3726641|P1|COMPLETED|Overall Study||10
1522791|NCT01483963|3726637|P5|STARTED|Overall Study||10
1522792|NCT01483963|3726638|P4|STARTED|Overall Study||10
1522793|NCT01483963|3726639|P3|STARTED|Overall Study||10
1522794|NCT01483963|3726640|P2|STARTED|Overall Study||10
1522795|NCT01483963|3726641|P1|STARTED|Overall Study||10
1522796|NCT01483937|3726715|P2|NOT COMPLETED|Overall Study||3
1522797|NCT01483937|3726716|P1|NOT COMPLETED|Overall Study||4
1522798|NCT01483937|3726715|P2|COMPLETED|Overall Study||14
1522799|NCT01483937|3726716|P1|COMPLETED|Overall Study||11
1522800|NCT01483937|3726715|P2|STARTED|Overall Study||17
1522801|NCT01483937|3726716|P1|STARTED|Overall Study||15
1522802|NCT01483924|3726743|P5|NOT COMPLETED|Overall Study||2
1522803|NCT01483924|3726744|P4|NOT COMPLETED|Overall Study||4
1522804|NCT01483924|3726745|P3|NOT COMPLETED|Overall Study||1
1522805|NCT01483924|3726746|P2|NOT COMPLETED|Overall Study||0
1522806|NCT01483924|3726747|P1|NOT COMPLETED|Overall Study||2
1522807|NCT01483924|3726743|P5|COMPLETED|Overall Study||10
1522808|NCT01483924|3726744|P4|COMPLETED|Overall Study||8
1522809|NCT01483924|3726745|P3|COMPLETED|Overall Study||11
1522810|NCT01483924|3726746|P2|COMPLETED|Overall Study||12
1522811|NCT01483924|3726747|P1|COMPLETED|Overall Study||10
1522812|NCT01483924|3726743|P5|STARTED|Overall Study||12
1522813|NCT01483924|3726744|P4|STARTED|Overall Study||12
1522814|NCT01483924|3726745|P3|STARTED|Overall Study||12
1522815|NCT01483924|3726746|P2|STARTED|Overall Study||12
1522816|NCT01483924|3726747|P1|STARTED|Overall Study||12
1522817|NCT01483820|3726795|P1|NOT COMPLETED|Overall Study||8
1522818|NCT01483820|3726795|P1|COMPLETED|Overall Study||0
1522819|NCT01483820|3726795|P1|STARTED|Overall Study||8
1522820|NCT01483651|3726804|P6|NOT COMPLETED|Overall Study||1
1522821|NCT01483651|3726805|P5|NOT COMPLETED|Overall Study||0
1522822|NCT01483651|3726806|P4|NOT COMPLETED|Overall Study||0
1522823|NCT01483651|3726807|P3|NOT COMPLETED|Overall Study||1
1522824|NCT01483651|3726808|P2|NOT COMPLETED|Overall Study||1
1522825|NCT01483651|3726809|P1|NOT COMPLETED|Overall Study||0
1522826|NCT01483651|3726804|P6|COMPLETED|Overall Study||1
1522827|NCT01483651|3726805|P5|COMPLETED|Overall Study||2
1522828|NCT01483651|3726806|P4|COMPLETED|Overall Study||1
1522829|NCT01483651|3726807|P3|COMPLETED|Overall Study||1
1522830|NCT01483651|3726808|P2|COMPLETED|Overall Study||2
1522831|NCT01483651|3726809|P1|COMPLETED|Overall Study||1
1522832|NCT01483651|3726804|P6|STARTED|Overall Study||2
1522833|NCT01483651|3726805|P5|STARTED|Overall Study||2
1522834|NCT01483651|3726806|P4|STARTED|Overall Study||1
1522835|NCT01483651|3726807|P3|STARTED|Overall Study||2
1522836|NCT01483651|3726808|P2|STARTED|Overall Study||3
1522837|NCT01483651|3726809|P1|STARTED|Overall Study||1
1522838|NCT01483625|3726819|P2|NOT COMPLETED|Overall Study||2
1522839|NCT01483625|3726820|P1|NOT COMPLETED|Overall Study||4
1522840|NCT01483625|3726819|P2|COMPLETED|Overall Study||66
1522841|NCT01483625|3726820|P1|COMPLETED|Overall Study||68
1522842|NCT01483625|3726819|P2|STARTED|Overall Study||68
1522843|NCT01483625|3726820|P1|STARTED|Overall Study||72
1522844|NCT01483599|3726843|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
1522845|NCT01483599|3726844|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
1522846|NCT01483599|3726845|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
1522847|NCT01483599|3726846|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
1522848|NCT01483599|3726847|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
1522849|NCT01483599|3726848|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
1522850|NCT01483599|3726849|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
1522851|NCT01483599|3726850|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522852|NCT01483599|3726851|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522853|NCT01483599|3726852|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522854|NCT01483599|3726853|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522855|NCT01483599|3726854|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522856|NCT01483599|3726855|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522857|NCT01483599|3726856|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522858|NCT01483599|3726843|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
1522859|NCT01483599|3726844|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
1522860|NCT01483599|3726845|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
1522861|NCT01483599|3726846|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
1522862|NCT01483599|3726847|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
1522863|NCT01483599|3726848|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
1522864|NCT01483599|3726849|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
1522865|NCT01483599|3726850|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522866|NCT01483599|3726851|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522867|NCT01483599|3726852|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522868|NCT01483599|3726853|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522869|NCT01483599|3726854|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522870|NCT01483599|3726855|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522871|NCT01483599|3726856|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
1522872|NCT01483599|3726843|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
1522873|NCT01483599|3726844|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
1522874|NCT01483599|3726845|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
1522875|NCT01483599|3726846|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
1522876|NCT01483599|3726847|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
1522877|NCT01483599|3726848|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
1522878|NCT01483599|3726849|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
1522879|NCT01483599|3726850|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
1522880|NCT01483599|3726851|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
1522881|NCT01483599|3726852|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
1522882|NCT01483599|3726853|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
1522883|NCT01483599|3726854|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
1522884|NCT01483599|3726855|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
1522885|NCT01483599|3726856|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
1522886|NCT01483599|3726843|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522887|NCT01483599|3726844|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522888|NCT01483599|3726845|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522889|NCT01483599|3726846|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522890|NCT01483599|3726847|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522891|NCT01483599|3726848|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522892|NCT01483599|3726849|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522893|NCT01483599|3726850|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
1522894|NCT01483599|3726851|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
1522895|NCT01483599|3726852|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
1522896|NCT01483599|3726853|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
1522897|NCT01483599|3726854|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522898|NCT01483599|3726855|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
1522899|NCT01483599|3726856|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
1522900|NCT01483599|3726843|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522901|NCT01483599|3726844|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522902|NCT01483599|3726845|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522903|NCT01483599|3726846|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522904|NCT01483599|3726847|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522905|NCT01483599|3726848|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522906|NCT01483599|3726849|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
1522907|NCT01483599|3726850|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
1522908|NCT01483599|3726851|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
1522909|NCT01483599|3726852|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
1522910|NCT01483599|3726853|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
1522911|NCT01483599|3726854|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
1522912|NCT01483599|3726855|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
1522913|NCT01483599|3726856|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
1522914|NCT01483599|3726843|P14|Treated|Controlled Period (CP) (up to Week 16)||0
1522915|NCT01483599|3726844|P13|Treated|Controlled Period (CP) (up to Week 16)||0
1522916|NCT01483599|3726845|P12|Treated|Controlled Period (CP) (up to Week 16)||0
1522917|NCT01483599|3726846|P11|Treated|Controlled Period (CP) (up to Week 16)||0
1522918|NCT01483599|3726847|P10|Treated|Controlled Period (CP) (up to Week 16)||0
1522919|NCT01483599|3726848|P9|Treated|Controlled Period (CP) (up to Week 16)||0
1522920|NCT01483599|3726849|P8|Treated|Controlled Period (CP) (up to Week 16)||0
1522921|NCT01483599|3726850|P7|Treated|Controlled Period (CP) (up to Week 16)||43
1522922|NCT01483599|3726851|P6|Treated|Controlled Period (CP) (up to Week 16)||41
1522923|NCT01483599|3726852|P5|Treated|Controlled Period (CP) (up to Week 16)||42
1522924|NCT01483599|3726853|P4|Treated|Controlled Period (CP) (up to Week 16)||42
1522925|NCT01483599|3726854|P3|Treated|Controlled Period (CP) (up to Week 16)||41
1522926|NCT01483599|3726855|P2|Treated|Controlled Period (CP) (up to Week 16)||41
1522927|NCT01483599|3726856|P1|Treated|Controlled Period (CP) (up to Week 16)||42
1522928|NCT01483599|3726843|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
1522929|NCT01483599|3726844|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
1522930|NCT01483599|3726845|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
1522931|NCT01483599|3726846|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
1522932|NCT01483599|3726847|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
1522933|NCT01483599|3726848|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
1522934|NCT01483599|3726849|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
1522935|NCT01483599|3726850|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
1522936|NCT01483599|3726851|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
1522937|NCT01483599|3726852|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
1522938|NCT01483599|3726853|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
1522939|NCT01483599|3726854|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
1522940|NCT01483599|3726855|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
1522941|NCT01483599|3726856|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
1522942|NCT01483378|3726905|P2|NOT COMPLETED|Overall Study||0
1522943|NCT01483378|3726906|P1|NOT COMPLETED|Overall Study||0
1522944|NCT01483378|3726905|P2|COMPLETED|Overall Study||66
1522945|NCT01483378|3726906|P1|COMPLETED|Overall Study||100
1522946|NCT01483378|3726905|P2|STARTED|Overall Study||66
1522947|NCT01483378|3726906|P1|STARTED|Overall Study||100
1522948|NCT01483352|3726912|P1|NOT COMPLETED|Overall Study||0
1522949|NCT01483352|3726912|P1|COMPLETED|Overall Study||12
1522950|NCT01483352|3726912|P1|STARTED|Overall Study||12
1522951|NCT01483209|3726931|P1|NOT COMPLETED|Overall Study||1
1522952|NCT01483209|3726931|P1|COMPLETED|Overall Study||1
1522953|NCT01483209|3726931|P1|STARTED|Overall Study||2
1522954|NCT01483183|3726946|P10|NOT COMPLETED|Overall Study||1
1522955|NCT01483183|3726947|P9|NOT COMPLETED|Overall Study||0
1522956|NCT01483183|3726948|P8|NOT COMPLETED|Overall Study||0
1522957|NCT01483183|3726949|P7|NOT COMPLETED|Overall Study||2
1522958|NCT01483183|3726950|P6|NOT COMPLETED|Overall Study||0
1522959|NCT01483183|3726951|P5|NOT COMPLETED|Overall Study||0
1522960|NCT01483183|3726952|P4|NOT COMPLETED|Overall Study||0
1522961|NCT01483183|3726953|P3|NOT COMPLETED|Overall Study||0
1522962|NCT01483183|3726954|P2|NOT COMPLETED|Overall Study||0
1522963|NCT01483183|3726955|P1|NOT COMPLETED|Overall Study||0
1522964|NCT01483183|3726946|P10|COMPLETED|Overall Study||4
1522965|NCT01483183|3726947|P9|COMPLETED|Overall Study||4
1522966|NCT01483183|3726948|P8|COMPLETED|Overall Study||4
1522967|NCT01483183|3726949|P7|COMPLETED|Overall Study||4
1522968|NCT01483183|3726950|P6|COMPLETED|Overall Study||4
1522969|NCT01483183|3726951|P5|COMPLETED|Overall Study||4
1522970|NCT01483183|3726952|P4|COMPLETED|Overall Study||3
1522971|NCT01483183|3726953|P3|COMPLETED|Overall Study||5
1522972|NCT01483183|3726954|P2|COMPLETED|Overall Study||1
1522973|NCT01483183|3726955|P1|COMPLETED|Overall Study||4
1522974|NCT01483183|3726946|P10|STARTED|Overall Study||5
1522975|NCT01483183|3726947|P9|STARTED|Overall Study||4
1522976|NCT01483183|3726948|P8|STARTED|Overall Study||4
1522977|NCT01483183|3726949|P7|STARTED|Overall Study||6
1522978|NCT01483183|3726950|P6|STARTED|Overall Study||4
1522979|NCT01483183|3726951|P5|STARTED|Overall Study||4
1522980|NCT01483183|3726952|P4|STARTED|Overall Study||3
1522981|NCT01483183|3726953|P3|STARTED|Overall Study||5
1522982|NCT01483183|3726954|P2|STARTED|Overall Study||1
1522983|NCT01483183|3726955|P1|STARTED|Overall Study||4
1522984|NCT01483118|3727025|P2|NOT COMPLETED|Overall Study||16
1522985|NCT01483118|3727026|P1|NOT COMPLETED|Overall Study||12
1522986|NCT01483118|3727025|P2|COMPLETED|Overall Study||6
1522987|NCT01483118|3727026|P1|COMPLETED|Overall Study||11
1522988|NCT01483118|3727025|P2|Completed 3 Months|Overall Study||11
1522989|NCT01483118|3727026|P1|Completed 3 Months|Overall Study||15
1522990|NCT01483118|3727025|P2|STARTED|Overall Study||22
1522991|NCT01483118|3727026|P1|STARTED|Overall Study||23
1522992|NCT01482962|3727038|P2|NOT COMPLETED|Overall Study||133
1522993|NCT01482962|3727039|P1|NOT COMPLETED|Overall Study||138
1522994|NCT01482962|3727038|P2|COMPLETED|Overall Study||0
1522995|NCT01482962|3727039|P1|COMPLETED|Overall Study||0
1522996|NCT01482962|3727038|P2|Safety Population: Received Study Drug|Overall Study||127
1522997|NCT01482962|3727039|P1|Safety Population: Received Study Drug|Overall Study||137
1522998|NCT01482962|3727038|P2|STARTED|Overall Study||133
1522999|NCT01482962|3727039|P1|STARTED|Overall Study||138
1523000|NCT01482910|3727072|P2|NOT COMPLETED|Overall Study||9
1523001|NCT01482910|3727073|P1|NOT COMPLETED|Overall Study||15
1523002|NCT01482910|3727072|P2|COMPLETED|Overall Study||67
1523003|NCT01482910|3727073|P1|COMPLETED|Overall Study||213
1523004|NCT01482910|3727072|P2|Completed Week 28|Overall Study||71
1523005|NCT01482910|3727073|P1|Completed Week 28|Overall Study||216
1523006|NCT01482910|3727072|P2|STARTED|Overall Study||76
1523007|NCT01482910|3727073|P1|STARTED|Overall Study||228
1523008|NCT01482884|3727085|P2|NOT COMPLETED|Overall Study||18
1523009|NCT01482884|3727086|P1|NOT COMPLETED|Overall Study||13
1523010|NCT01482884|3727085|P2|COMPLETED|Overall Study||37
1523011|NCT01482884|3727086|P1|COMPLETED|Overall Study||43
1523012|NCT01482884|3727085|P2|STARTED|Overall Study||55
1523013|NCT01482884|3727086|P1|STARTED|Overall Study|One participant did not receive study treatment|56
1523014|NCT01482819|3727112|P1|NOT COMPLETED|Overall Study||2
1523015|NCT01482819|3727112|P1|COMPLETED|Overall Study||19
1523016|NCT01482819|3727112|P1|STARTED|Overall Study||21
1523017|NCT01482767|3727132|P2|NOT COMPLETED|Overall Study||49
1523018|NCT01482767|3727133|P1|NOT COMPLETED|Overall Study||54
1523019|NCT01482767|3727132|P2|COMPLETED|Overall Study||78
1523020|NCT01482767|3727133|P1|COMPLETED|Overall Study||81
1523021|NCT01482767|3727132|P2|STARTED|Overall Study||127
1523022|NCT01482767|3727133|P1|STARTED|Overall Study||135
1523023|NCT01482429|3727155|P2|NOT COMPLETED|Protocol||0
1523024|NCT01482429|3727156|P1|NOT COMPLETED|Protocol||275
1523025|NCT01482429|3727155|P2|COMPLETED|Protocol||0
1523026|NCT01482429|3727156|P1|COMPLETED|Protocol||139
1523027|NCT01482429|3727155|P2|STARTED|Protocol||0
1523028|NCT01482429|3727156|P1|STARTED|Protocol||414
1523029|NCT01482429|3727155|P2|NOT COMPLETED|Care Usual||173
1523030|NCT01482429|3727156|P1|NOT COMPLETED|Care Usual||0
1523031|NCT01482429|3727155|P2|COMPLETED|Care Usual||96
1523032|NCT01482429|3727156|P1|COMPLETED|Care Usual||0
1523033|NCT01482429|3727155|P2|STARTED|Care Usual||269
1523034|NCT01482429|3727156|P1|STARTED|Care Usual||0
1523035|NCT01482325|3727164|P1|NOT COMPLETED|Overall Study||0
1523036|NCT01482325|3727164|P1|COMPLETED|Overall Study||31
1523037|NCT01482325|3727164|P1|STARTED|Overall Study||31
1523038|NCT01482312|3727168|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
1523039|NCT01482312|3727169|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
1523040|NCT01482312|3727170|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
1523041|NCT01482312|3727168|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
1523042|NCT01482312|3727169|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
1523043|NCT01482312|3727170|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
1523044|NCT01482312|3727168|P3|STARTED|Period 3, 90 Minutes of Wear||9
1523045|NCT01482312|3727169|P2|STARTED|Period 3, 90 Minutes of Wear||9
1523046|NCT01482312|3727170|P1|STARTED|Period 3, 90 Minutes of Wear||8
1523047|NCT01482312|3727168|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
1523048|NCT01482312|3727169|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
1523049|NCT01482312|3727170|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
1523050|NCT01482312|3727168|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
1523051|NCT01482312|3727169|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
1523052|NCT01482312|3727170|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
1523053|NCT01482312|3727168|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
1523054|NCT01482312|3727169|P2|STARTED|Period 2, 90 Minutes of Wear||9
1523055|NCT01482312|3727170|P1|STARTED|Period 2, 90 Minutes of Wear||9
1523056|NCT01482312|3727168|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
1523057|NCT01482312|3727169|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
1523058|NCT01482312|3727170|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
1523059|NCT01482312|3727168|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
1523060|NCT01482312|3727169|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
1523061|NCT01482312|3727170|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
1523062|NCT01482312|3727168|P3|STARTED|Period 1, 90 Minutes of Wear||10
1523063|NCT01482312|3727169|P2|STARTED|Period 1, 90 Minutes of Wear||9
1523064|NCT01482312|3727170|P1|STARTED|Period 1, 90 Minutes of Wear||10
1523065|NCT01482221|3727184|P3|NOT COMPLETED|Overall Study||23
1523066|NCT01482221|3727185|P2|NOT COMPLETED|Overall Study||20
1523067|NCT01482221|3727186|P1|NOT COMPLETED|Overall Study||21
1523068|NCT01482221|3727184|P3|COMPLETED|Overall Study||77
1523069|NCT01482221|3727185|P2|COMPLETED|Overall Study||81
1523070|NCT01482221|3727186|P1|COMPLETED|Overall Study||80
1523071|NCT01482221|3727184|P3|STARTED|Overall Study||100
1523072|NCT01482221|3727185|P2|STARTED|Overall Study||101
1523073|NCT01482221|3727186|P1|STARTED|Overall Study||101
1523074|NCT01482169|3727227|P1|NOT COMPLETED|Overall Study||2
1523075|NCT01482169|3727227|P1|COMPLETED|Overall Study||46
1523076|NCT01482169|3727227|P1|STARTED|Overall Study||48
1523077|NCT01482091|3727236|P2|NOT COMPLETED|Overall Study||0
1523078|NCT01482091|3727237|P1|NOT COMPLETED|Overall Study||0
1523079|NCT01482091|3727236|P2|COMPLETED|Overall Study||24
1523080|NCT01482091|3727237|P1|COMPLETED|Overall Study||25
1523081|NCT01482091|3727236|P2|STARTED|Overall Study||24
1523082|NCT01482091|3727237|P1|STARTED|Overall Study||25
1523083|NCT01482065|3727269|P2|NOT COMPLETED|Overall Study||1
1523084|NCT01482065|3727270|P1|NOT COMPLETED|Overall Study||0
1523085|NCT01482065|3727269|P2|COMPLETED|Overall Study||4
1523086|NCT01482065|3727270|P1|COMPLETED|Overall Study||4
1523087|NCT01482065|3727269|P2|STARTED|Overall Study||5
1523088|NCT01482065|3727270|P1|STARTED|Overall Study||4
1523089|NCT01481935|3727284|P2|NOT COMPLETED|Overall Study||0
1523090|NCT01481935|3727285|P1|NOT COMPLETED|Overall Study||0
1523091|NCT01481935|3727284|P2|COMPLETED|Overall Study||93
1523092|NCT01481935|3727285|P1|COMPLETED|Overall Study||97
1523093|NCT01481935|3727284|P2|STARTED|Overall Study||93
1523094|NCT01481935|3727285|P1|STARTED|Overall Study||97
1523095|NCT01481896|3727291|P1|NOT COMPLETED|Overall Study||12
1523096|NCT01481896|3727291|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
1523097|NCT01481896|3727291|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
1523098|NCT01481896|3727291|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
1523099|NCT01481779|3727307|P2|NOT COMPLETED|Overall Study||28
1523100|NCT01481779|3727308|P1|NOT COMPLETED|Overall Study||70
1523101|NCT01481779|3727307|P2|COMPLETED|Overall Study||132
1523102|NCT01481779|3727308|P1|COMPLETED|Overall Study||225
1523103|NCT01481779|3727307|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
1523104|NCT01481779|3727308|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
1523105|NCT01481779|3727307|P2|STARTED|Overall Study||160
1523106|NCT01481779|3727308|P1|STARTED|Overall Study||295
1523107|NCT01481740|3727356|P2|NOT COMPLETED|Overall Study||7
1523108|NCT01481740|3727357|P1|NOT COMPLETED|Overall Study||11
1523109|NCT01481740|3727356|P2|COMPLETED|Overall Study||81
1523110|NCT01481740|3727357|P1|COMPLETED|Overall Study||79
1523111|NCT01481740|3727356|P2|STARTED|Overall Study||88
1523112|NCT01481740|3727357|P1|STARTED|Overall Study||90
1523113|NCT01481558|3727375|P2|NOT COMPLETED|Overall Study||0
1523114|NCT01481558|3727376|P1|NOT COMPLETED|Overall Study||0
1523115|NCT01481558|3727375|P2|COMPLETED|Overall Study||20
1523116|NCT01481558|3727376|P1|COMPLETED|Overall Study||20
1523117|NCT01481558|3727375|P2|STARTED|Overall Study||20
1523118|NCT01481558|3727376|P1|STARTED|Overall Study||20
1523119|NCT01481376|3727382|P1|NOT COMPLETED|Overall Study||31
1523120|NCT01481376|3727382|P1|COMPLETED|Overall Study||169
1523121|NCT01481376|3727382|P1|STARTED|Overall Study||200
1523122|NCT01481324|3727393|P3|NOT COMPLETED|Overall Study||2
1523123|NCT01481324|3727394|P2|NOT COMPLETED|Overall Study||2
1523124|NCT01481324|3727395|P1|NOT COMPLETED|Overall Study||0
1523125|NCT01481324|3727393|P3|COMPLETED|Overall Study||20
1523126|NCT01481324|3727394|P2|COMPLETED|Overall Study||22
1523127|NCT01481324|3727395|P1|COMPLETED|Overall Study||21
1523128|NCT01481324|3727393|P3|Month 3-Wear Rate Data|Overall Study||6
1523129|NCT01481324|3727394|P2|Month 3-Wear Rate Data|Overall Study||11
1523130|NCT01481324|3727395|P1|Month 3-Wear Rate Data|Overall Study||7
1523131|NCT01481324|3727393|P3|Month 2-Wear Rate Data|Overall Study||7
1523132|NCT01481324|3727394|P2|Month 2-Wear Rate Data|Overall Study||13
1523133|NCT01481324|3727395|P1|Month 2-Wear Rate Data|Overall Study||9
1523134|NCT01481324|3727393|P3|Month 1-Wear Rate Data|Overall Study||8
1523135|NCT01481324|3727394|P2|Month 1-Wear Rate Data|Overall Study||16
1523136|NCT01481324|3727395|P1|Month 1-Wear Rate Data|Overall Study||15
1523137|NCT01481324|3727393|P3|STARTED|Overall Study||22
1523138|NCT01481324|3727394|P2|STARTED|Overall Study||24
1523139|NCT01481324|3727395|P1|STARTED|Overall Study||21
1523140|NCT01481129|3727403|P1|NOT COMPLETED|Overall Study||0
1523141|NCT01481129|3727403|P1|COMPLETED|Overall Study||22
1523142|NCT01481129|3727403|P1|STARTED|Overall Study||22
1523143|NCT01481116|3727414|P3|NOT COMPLETED|Overall Study||813
1523144|NCT01481116|3727415|P2|NOT COMPLETED|Overall Study||817
1523145|NCT01481116|3727416|P1|NOT COMPLETED|Overall Study||824
1523146|NCT01481116|3727414|P3|COMPLETED|Overall Study||0
1523147|NCT01481116|3727415|P2|COMPLETED|Overall Study||0
1523148|NCT01481116|3727416|P1|COMPLETED|Overall Study||0
1523149|NCT01481116|3727414|P3|Treated|Overall Study||813
1523150|NCT01481116|3727415|P2|Treated|Overall Study||816
1523151|NCT01481116|3727416|P1|Treated|Overall Study||822
1523152|NCT01481116|3727414|P3|STARTED|Overall Study||813
1523153|NCT01481116|3727415|P2|STARTED|Overall Study||817
1523154|NCT01481116|3727416|P1|STARTED|Overall Study||824
1523155|NCT01480843|3727442|P1|NOT COMPLETED|Overall Study||5
1523156|NCT01480843|3727442|P1|COMPLETED|Overall Study||60
1523157|NCT01480843|3727442|P1|STARTED|Overall Study||65
1523158|NCT01480674|3727447|P1|NOT COMPLETED|Overall Study||35
1523159|NCT01480674|3727447|P1|COMPLETED|Overall Study||125
1523160|NCT01480674|3727447|P1|Analysed Set|Overall Study||128
1523161|NCT01480674|3727447|P1|Safety Set|Overall Study||154
1523162|NCT01480674|3727447|P1|STARTED|Overall Study||160
1523163|NCT01480596|3727461|P2|NOT COMPLETED|Overall Study||2
1523164|NCT01480596|3727462|P1|NOT COMPLETED|Overall Study||5
1523165|NCT01480596|3727461|P2|COMPLETED|Overall Study||16
1523166|NCT01480596|3727462|P1|COMPLETED|Overall Study||17
1523167|NCT01480596|3727461|P2|STARTED|Overall Study||18
1523168|NCT01480596|3727462|P1|STARTED|Overall Study||22
1523169|NCT01480297|3727504|P1|NOT COMPLETED|Overall Study||0
1523170|NCT01480297|3727504|P1|COMPLETED|Overall Study||8
1523171|NCT01480297|3727504|P1|STARTED|Overall Study||8
1523172|NCT01480284|3727510|P2|NOT COMPLETED|Overall Study||0
1523173|NCT01480284|3727511|P1|NOT COMPLETED|Overall Study||8
1523174|NCT01480284|3727510|P2|COMPLETED|Overall Study||56
1523175|NCT01480284|3727511|P1|COMPLETED|Overall Study||102
1523176|NCT01480284|3727510|P2|STARTED|Overall Study||56
1523177|NCT01480284|3727511|P1|STARTED|Overall Study||110
1523178|NCT01480232|3727543|P4|NOT COMPLETED|Overall Study||19
1523179|NCT01480232|3727544|P3|NOT COMPLETED|Overall Study||17
1523180|NCT01480232|3727545|P2|NOT COMPLETED|Overall Study||22
1523181|NCT01480232|3727546|P1|NOT COMPLETED|Overall Study||18
1523182|NCT01480232|3727543|P4|COMPLETED|Overall Study||22
1523183|NCT01480232|3727544|P3|COMPLETED|Overall Study||21
1523184|NCT01480232|3727545|P2|COMPLETED|Overall Study||19
1523185|NCT01480232|3727546|P1|COMPLETED|Overall Study||22
1523186|NCT01480232|3727543|P4|STARTED|Overall Study||41
1523187|NCT01480232|3727544|P3|STARTED|Overall Study||38
1523188|NCT01480232|3727545|P2|STARTED|Overall Study||41
1523189|NCT01480232|3727546|P1|STARTED|Overall Study||40
1523190|NCT01480219|3727574|P2|NOT COMPLETED|Overall Study||0
1523191|NCT01480219|3727575|P1|NOT COMPLETED|Overall Study||0
1523192|NCT01480219|3727574|P2|COMPLETED|Overall Study||142
1523193|NCT01480219|3727575|P1|COMPLETED|Overall Study||325
1523194|NCT01480219|3727574|P2|STARTED|Overall Study||142
1523195|NCT01480219|3727575|P1|STARTED|Overall Study||325
1523196|NCT01480089|3727583|P2|NOT COMPLETED|Overall Study||0
1523197|NCT01480089|3727584|P1|NOT COMPLETED|Overall Study||0
1523198|NCT01480089|3727583|P2|COMPLETED|Overall Study||30
1523199|NCT01480089|3727584|P1|COMPLETED|Overall Study||25
1523200|NCT01480089|3727583|P2|STARTED|Overall Study||30
1523201|NCT01480089|3727584|P1|STARTED|Overall Study||25
1523202|NCT01480076|3727594|P1|NOT COMPLETED|Overall Study||290
1523203|NCT01480076|3727594|P1|COMPLETED|Overall Study||611
1523204|NCT01480076|3727594|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
1523205|NCT01480076|3727594|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
1523206|NCT01479985|3727715|P2|NOT COMPLETED|Overall Study||0
1523207|NCT01479985|3727716|P1|NOT COMPLETED|Overall Study||0
1523208|NCT01479985|3727715|P2|COMPLETED|Overall Study||80
1523209|NCT01479985|3727716|P1|COMPLETED|Overall Study||161
1523210|NCT01479985|3727715|P2|STARTED|Overall Study||80
1523211|NCT01479985|3727716|P1|STARTED|Overall Study||161
1523212|NCT01479868|3727724|P1|NOT COMPLETED|Overall Study||9
1523213|NCT01479868|3727724|P1|COMPLETED|Overall Study||97
1523214|NCT01479868|3727724|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
1523215|NCT01479777|3727739|P1|NOT COMPLETED|Overall Study||2
1523216|NCT01479777|3727739|P1|COMPLETED|Overall Study||10
1523217|NCT01479777|3727739|P1|STARTED|Overall Study||12
1523218|NCT01479764|3727751|P2|NOT COMPLETED|Treated||2
1523219|NCT01479764|3727752|P1|NOT COMPLETED|Treated||0
1523220|NCT01479764|3727751|P2|COMPLETED|Treated||75
1523221|NCT01479764|3727752|P1|COMPLETED|Treated||74
1523222|NCT01479764|3727751|P2|STARTED|Treated||77
1523223|NCT01479764|3727752|P1|STARTED|Treated||74
1523224|NCT01479764|3727751|P2|NOT COMPLETED|Randomized||1
1523225|NCT01479764|3727752|P1|NOT COMPLETED|Randomized||2
1523226|NCT01479764|3727751|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
1523227|NCT01479764|3727752|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
1523228|NCT01479764|3727751|P2|STARTED|Randomized||78
1523229|NCT01479764|3727752|P1|STARTED|Randomized||76
1523230|NCT01479725|3727762|P2|NOT COMPLETED|Overall Study||1
1523231|NCT01479725|3727763|P1|NOT COMPLETED|Overall Study||2
1523232|NCT01479725|3727762|P2|COMPLETED|Overall Study||1
1523233|NCT01479725|3727763|P1|COMPLETED|Overall Study||4
1523234|NCT01479725|3727762|P2|STARTED|Overall Study||2
1523235|NCT01479725|3727763|P1|STARTED|Overall Study||6
1523236|NCT01479621|3727775|P7|NOT COMPLETED|Treatment Period||20
1523237|NCT01479621|3727776|P6|NOT COMPLETED|Treatment Period||41
1523238|NCT01479621|3727777|P5|NOT COMPLETED|Treatment Period||21
1523239|NCT01479621|3727778|P4|NOT COMPLETED|Treatment Period||12
1523240|NCT01479621|3727779|P3|NOT COMPLETED|Treatment Period||21
1523241|NCT01479621|3727780|P2|NOT COMPLETED|Treatment Period||24
1523242|NCT01479621|3727781|P1|NOT COMPLETED|Treatment Period||0
1523243|NCT01479621|3727775|P7|COMPLETED|Treatment Period||84
1523244|NCT01479621|3727776|P6|COMPLETED|Treatment Period||63
1523245|NCT01479621|3727777|P5|COMPLETED|Treatment Period||82
1523246|NCT01479621|3727778|P4|COMPLETED|Treatment Period||92
1523247|NCT01479621|3727779|P3|COMPLETED|Treatment Period||83
1523248|NCT01479621|3727780|P2|COMPLETED|Treatment Period||79
1523249|NCT01479621|3727781|P1|COMPLETED|Treatment Period||0
1523250|NCT01479621|3727775|P7|Full Analysis Set|Treatment Period||102
1523251|NCT01479621|3727776|P6|Full Analysis Set|Treatment Period||102
1523252|NCT01479621|3727777|P5|Full Analysis Set|Treatment Period||102
1523253|NCT01479621|3727778|P4|Full Analysis Set|Treatment Period||102
1523254|NCT01479621|3727779|P3|Full Analysis Set|Treatment Period||101
1523255|NCT01479621|3727780|P2|Full Analysis Set|Treatment Period||102
1523256|NCT01479621|3727781|P1|Full Analysis Set|Treatment Period||0
1523257|NCT01479621|3727775|P7|Safety Population|Treatment Period||104
1523258|NCT01479621|3727776|P6|Safety Population|Treatment Period||104
1523259|NCT01479621|3727777|P5|Safety Population|Treatment Period||103
1523260|NCT01479621|3727778|P4|Safety Population|Treatment Period||104
1523261|NCT01479621|3727779|P3|Safety Population|Treatment Period||104
1523262|NCT01479621|3727780|P2|Safety Population|Treatment Period||103
1523263|NCT01479621|3727781|P1|Safety Population|Treatment Period||0
1523264|NCT01479621|3727775|P7|STARTED|Treatment Period||104
1523265|NCT01479621|3727776|P6|STARTED|Treatment Period||104
1523266|NCT01479621|3727777|P5|STARTED|Treatment Period||103
1523267|NCT01479621|3727778|P4|STARTED|Treatment Period||104
1523268|NCT01479621|3727779|P3|STARTED|Treatment Period||104
1523269|NCT01479621|3727780|P2|STARTED|Treatment Period||103
1523270|NCT01479621|3727781|P1|STARTED|Treatment Period||0
1523271|NCT01479621|3727775|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523272|NCT01479621|3727776|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523273|NCT01479621|3727777|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523274|NCT01479621|3727778|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523275|NCT01479621|3727779|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523276|NCT01479621|3727780|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523277|NCT01479621|3727781|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
1523278|NCT01479621|3727775|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523279|NCT01479621|3727776|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523280|NCT01479621|3727777|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523281|NCT01479621|3727778|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523282|NCT01479621|3727779|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523283|NCT01479621|3727780|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
1523284|NCT01479621|3727781|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
1523285|NCT01479621|3727775|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1523286|NCT01479621|3727776|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1523287|NCT01479621|3727777|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1523288|NCT01479621|3727778|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1523289|NCT01479621|3727779|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1523290|NCT01479621|3727780|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
1523291|NCT01479621|3727781|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
1523292|NCT01479595|3727869|P2|NOT COMPLETED|Overall Study||2
1523293|NCT01479595|3727870|P1|NOT COMPLETED|Overall Study||2
1523294|NCT01479595|3727869|P2|COMPLETED|Overall Study||19
1523295|NCT01479595|3727870|P1|COMPLETED|Overall Study||42
1523296|NCT01479595|3727869|P2|Per Protocol Analysis Set|Overall Study||20
1523297|NCT01479595|3727870|P1|Per Protocol Analysis Set|Overall Study||41
1523298|NCT01479595|3727869|P2|PK Analysis Set|Overall Study||0
1523299|NCT01479595|3727870|P1|PK Analysis Set|Overall Study||42
1523300|NCT01479595|3727869|P2|STARTED|Overall Study||21
1523301|NCT01479595|3727870|P1|STARTED|Overall Study||44
1523302|NCT01479543|3727897|P5|NOT COMPLETED|Overall Study||1
1523303|NCT01479543|3727898|P4|NOT COMPLETED|Overall Study||0
1523304|NCT01479543|3727899|P3|NOT COMPLETED|Overall Study||1
1523305|NCT01479543|3727900|P2|NOT COMPLETED|Overall Study||0
1523306|NCT01479543|3727901|P1|NOT COMPLETED|Overall Study||1
1523307|NCT01479543|3727897|P5|COMPLETED|Overall Study||20
1523308|NCT01479543|3727898|P4|COMPLETED|Overall Study||20
1523309|NCT01479543|3727899|P3|COMPLETED|Overall Study||20
1523310|NCT01479543|3727900|P2|COMPLETED|Overall Study||20
1523311|NCT01479543|3727901|P1|COMPLETED|Overall Study||20
1523312|NCT01479543|3727897|P5|STARTED|Overall Study||21
1523313|NCT01479543|3727898|P4|STARTED|Overall Study||20
1523314|NCT01479543|3727899|P3|STARTED|Overall Study||21
1523315|NCT01479543|3727900|P2|STARTED|Overall Study||20
1523316|NCT01479543|3727901|P1|STARTED|Overall Study||21
1523317|NCT01479530|3727915|P2|NOT COMPLETED|Overall Study||12
1523318|NCT01479530|3727916|P1|NOT COMPLETED|Overall Study||10
1523319|NCT01479530|3727915|P2|COMPLETED|Overall Study||151
1523320|NCT01479530|3727916|P1|COMPLETED|Overall Study||148
1523321|NCT01479530|3727915|P2|STARTED|Overall Study||163
1523322|NCT01479530|3727916|P1|STARTED|Overall Study||158
1523323|NCT01479517|3727931|P3|NOT COMPLETED|Overall Study||0
1523324|NCT01479517|3727932|P2|NOT COMPLETED|Overall Study||0
1523325|NCT01479517|3727933|P1|NOT COMPLETED|Overall Study||0
1523326|NCT01479517|3727931|P3|COMPLETED|Overall Study||10
1523327|NCT01479517|3727932|P2|COMPLETED|Overall Study||10
1523328|NCT01479517|3727933|P1|COMPLETED|Overall Study||10
1523329|NCT01479517|3727931|P3|STARTED|Overall Study||10
1523330|NCT01479517|3727932|P2|STARTED|Overall Study||10
1523331|NCT01479517|3727933|P1|STARTED|Overall Study||10
1523332|NCT01479478|3727952|P2|NOT COMPLETED|Overall Study||0
1523333|NCT01479478|3727953|P1|NOT COMPLETED|Overall Study||0
1523334|NCT01479478|3727952|P2|COMPLETED|Overall Study||126
1523335|NCT01479478|3727953|P1|COMPLETED|Overall Study||125
1523336|NCT01479478|3727952|P2|STARTED|Overall Study||126
1523337|NCT01479478|3727953|P1|STARTED|Overall Study||125
1523338|NCT01479374|3727996|P3|NOT COMPLETED|Overall Study||5
1523339|NCT01479374|3727997|P2|NOT COMPLETED|Overall Study||8
1523340|NCT01479374|3727998|P1|NOT COMPLETED|Overall Study||3
1523341|NCT01479374|3727996|P3|COMPLETED|Overall Study||63
1523342|NCT01479374|3727997|P2|COMPLETED|Overall Study||60
1523343|NCT01479374|3727998|P1|COMPLETED|Overall Study||63
1523344|NCT01479374|3727996|P3|STARTED|Overall Study||68
1523345|NCT01479374|3727997|P2|STARTED|Overall Study||68
1523346|NCT01479374|3727998|P1|STARTED|Overall Study||66
1523347|NCT01479270|3728026|P2|NOT COMPLETED|Overall Study||0
1523348|NCT01479270|3728027|P1|NOT COMPLETED|Overall Study||0
1523349|NCT01479270|3728026|P2|COMPLETED|Overall Study||28
1523350|NCT01479270|3728027|P1|COMPLETED|Overall Study||28
1523351|NCT01479270|3728026|P2|STARTED|Overall Study||28
1523352|NCT01479270|3728027|P1|STARTED|Overall Study||28
1523353|NCT01479127|3728039|P1|NOT COMPLETED|Overall Study||3
1523354|NCT01479127|3728039|P1|COMPLETED|Overall Study||5
1523355|NCT01479127|3728039|P1|Started LCIG|Overall Study||6
1523356|NCT01479127|3728039|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
1523357|NCT01479010|3728073|P1|NOT COMPLETED|Overall Study||1
1523358|NCT01479010|3728073|P1|COMPLETED|Overall Study||1
1523359|NCT01479010|3728073|P1|STARTED|Overall Study||2
1523360|NCT01478971|3728084|P1|NOT COMPLETED|Peginesatide Treatment Period||14
1523361|NCT01478971|3728084|P1|COMPLETED|Peginesatide Treatment Period||143
1523362|NCT01478971|3728084|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
1523363|NCT01478971|3728084|P1|NOT COMPLETED|Standard of Care Period||25
1523364|NCT01478971|3728084|P1|COMPLETED|Standard of Care Period||159
1523365|NCT01478971|3728084|P1|Received Treatment|Standard of Care Period||178
1523366|NCT01478971|3728084|P1|STARTED|Standard of Care Period||184
1523367|NCT01478958|3728101|P3|NOT COMPLETED|Overall Study||3
1523368|NCT01478958|3728102|P2|NOT COMPLETED|Overall Study||2
1523369|NCT01478958|3728103|P1|NOT COMPLETED|Overall Study||2
1523370|NCT01478958|3728101|P3|COMPLETED|Overall Study||66
1523371|NCT01478958|3728102|P2|COMPLETED|Overall Study||64
1523372|NCT01478958|3728103|P1|COMPLETED|Overall Study||65
1523373|NCT01478958|3728101|P3|STARTED|Overall Study||69
1523374|NCT01478958|3728102|P2|STARTED|Overall Study||66
1523375|NCT01478958|3728103|P1|STARTED|Overall Study||67
1523376|NCT01478828|3728111|P1|NOT COMPLETED|Overall Study||1
1523377|NCT01478828|3728111|P1|COMPLETED|Overall Study||1
1523378|NCT01478828|3728111|P1|STARTED|Overall Study||2
1523379|NCT01478620|3728116|P1|NOT COMPLETED|Overall Study||6
1523380|NCT01478620|3728116|P1|COMPLETED|Overall Study||119
1523381|NCT01478620|3728116|P1|STARTED|Overall Study||125
1523382|NCT01478594|3728122|P2|NOT COMPLETED|Overall Study||28
1523383|NCT01478594|3728123|P1|NOT COMPLETED|Overall Study||65
1523384|NCT01478594|3728122|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
1523385|NCT01478594|3728123|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
1523386|NCT01478594|3728122|P2|Treated|Overall Study||87
1523387|NCT01478594|3728123|P1|Treated|Overall Study||177
1523388|NCT01478594|3728122|P2|STARTED|Overall Study||88
1523389|NCT01478594|3728123|P1|STARTED|Overall Study||177
1523390|NCT01478581|3728199|P4|NOT COMPLETED|Overall Study||0
1523391|NCT01478581|3728200|P3|NOT COMPLETED|Overall Study||0
1523392|NCT01478581|3728201|P2|NOT COMPLETED|Overall Study||0
1523393|NCT01478581|3728202|P1|NOT COMPLETED|Overall Study||0
1523394|NCT01478581|3728199|P4|COMPLETED|Overall Study||43
1523395|NCT01478581|3728200|P3|COMPLETED|Overall Study||18
1523396|NCT01478581|3728201|P2|COMPLETED|Overall Study||18
1523397|NCT01478581|3728202|P1|COMPLETED|Overall Study||13
1523398|NCT01478581|3728199|P4|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
1523399|NCT01478581|3728200|P3|STARTED|Overall Study||18
1523400|NCT01478581|3728201|P2|STARTED|Overall Study||18
1523401|NCT01478581|3728202|P1|STARTED|Overall Study||13
1523402|NCT01478373|3728248|P1|NOT COMPLETED|Survival Phase||38
1523403|NCT01478373|3728248|P1|COMPLETED|Survival Phase||0
1523404|NCT01478373|3728248|P1|STARTED|Survival Phase||38
1523405|NCT01478373|3728248|P1|NOT COMPLETED|Treatment Phase||1
1523406|NCT01478373|3728248|P1|COMPLETED|Treatment Phase||38
1523407|NCT01478373|3728248|P1|STARTED|Treatment Phase||39
1523408|NCT01478360|3728261|P2|NOT COMPLETED|Overall Study||3
1523409|NCT01478360|3728262|P1|NOT COMPLETED|Overall Study||2
1523410|NCT01478360|3728261|P2|COMPLETED|Overall Study||12
1523411|NCT01478360|3728262|P1|COMPLETED|Overall Study||29
1523412|NCT01478360|3728261|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
1523413|NCT01478360|3728262|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
1523414|NCT01478360|3728261|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
1523415|NCT01478360|3728262|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
1523416|NCT01478360|3728261|P2|STARTED|Overall Study||15
1523417|NCT01478360|3728262|P1|STARTED|Overall Study||31
1523418|NCT01478347|3728268|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
1523419|NCT01478347|3728268|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
1523420|NCT01478347|3728268|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
1523421|NCT01478347|3728268|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
1523422|NCT01478347|3728268|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
1523423|NCT01478347|3728268|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
1523424|NCT01478256|3728275|P2|NOT COMPLETED|Overall Study||0
1523425|NCT01478256|3728276|P1|NOT COMPLETED|Overall Study||0
1523426|NCT01478256|3728275|P2|COMPLETED|Overall Study||15
1523427|NCT01478256|3728276|P1|COMPLETED|Overall Study||15
1523428|NCT01478256|3728275|P2|STARTED|Overall Study||15
1523429|NCT01478256|3728276|P1|STARTED|Overall Study||15
1523430|NCT01478113|3728286|P2|NOT COMPLETED|Overall Study||1
1523431|NCT01478113|3728287|P1|NOT COMPLETED|Overall Study||1
1523432|NCT01478113|3728286|P2|COMPLETED|Overall Study||1
1523433|NCT01478113|3728287|P1|COMPLETED|Overall Study||1
1523434|NCT01478113|3728286|P2|STARTED|Overall Study||2
1523435|NCT01478113|3728287|P1|STARTED|Overall Study||2
1523436|NCT01478087|3728305|P1|NOT COMPLETED|Overall Study||1
1523437|NCT01478087|3728305|P1|COMPLETED|Overall Study||2
1523438|NCT01478087|3728305|P1|STARTED|Overall Study||3
1523439|NCT01478048|3728312|P2|NOT COMPLETED|Overall Study||75
1523440|NCT01478048|3728313|P1|NOT COMPLETED|Overall Study||77
1523441|NCT01478048|3728312|P2|COMPLETED|Overall Study||0
1523442|NCT01478048|3728313|P1|COMPLETED|Overall Study||0
1523443|NCT01478048|3728312|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
1523444|NCT01478048|3728313|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
1523445|NCT01478048|3728312|P2|STARTED|Overall Study||75
1523446|NCT01478048|3728313|P1|STARTED|Overall Study||77
1523447|NCT01478009|3728331|P2|NOT COMPLETED|Overall Study||1
1523448|NCT01478009|3728332|P1|NOT COMPLETED|Overall Study||1
1523449|NCT01478009|3728331|P2|COMPLETED|Overall Study||49
1523450|NCT01478009|3728332|P1|COMPLETED|Overall Study||49
1523451|NCT01478009|3728331|P2|STARTED|Overall Study||50
1523452|NCT01478009|3728332|P1|STARTED|Overall Study||50
1523453|NCT01477892|3728342|P2|NOT COMPLETED|Overall Study||2
1523454|NCT01477892|3728343|P1|NOT COMPLETED|Overall Study||0
1523455|NCT01477892|3728342|P2|COMPLETED|Overall Study||5
1523456|NCT01477892|3728343|P1|COMPLETED|Overall Study||7
1523457|NCT01477892|3728342|P2|STARTED|Overall Study||7
1523458|NCT01477892|3728343|P1|STARTED|Overall Study||7
1523459|NCT01477853|3728354|P3|NOT COMPLETED|Phase B||11
1523460|NCT01477853|3728355|P2|NOT COMPLETED|Phase B||11
1523461|NCT01477853|3728356|P1|NOT COMPLETED|Phase B||12
1523462|NCT01477853|3728354|P3|COMPLETED|Phase B||0
1523463|NCT01477853|3728355|P2|COMPLETED|Phase B||0
1523464|NCT01477853|3728356|P1|COMPLETED|Phase B||0
1523465|NCT01477853|3728354|P3|STARTED|Phase B||11
1523466|NCT01477853|3728355|P2|STARTED|Phase B||11
1523467|NCT01477853|3728356|P1|STARTED|Phase B||12
1523468|NCT01477853|3728354|P3|NOT COMPLETED|Phase A||44
1523469|NCT01477853|3728355|P2|NOT COMPLETED|Phase A||45
1523470|NCT01477853|3728356|P1|NOT COMPLETED|Phase A||43
1523471|NCT01477853|3728354|P3|COMPLETED|Phase A||11
1523472|NCT01477853|3728355|P2|COMPLETED|Phase A||11
1523473|NCT01477853|3728356|P1|COMPLETED|Phase A||12
1523474|NCT01477853|3728354|P3|STARTED|Phase A||55
1523475|NCT01477853|3728355|P2|STARTED|Phase A||56
1523476|NCT01477853|3728356|P1|STARTED|Phase A||55
1523477|NCT01477762|3728398|P4|NOT COMPLETED|Overall Study||2
1523478|NCT01477762|3728399|P3|NOT COMPLETED|Overall Study||4
1523479|NCT01477762|3728400|P2|NOT COMPLETED|Overall Study||13
1523480|NCT01477762|3728401|P1|NOT COMPLETED|Overall Study||9
1523481|NCT01477762|3728398|P4|COMPLETED|Overall Study||11
1523482|NCT01477762|3728399|P3|COMPLETED|Overall Study||16
1523483|NCT01477762|3728400|P2|COMPLETED|Overall Study||20
1523484|NCT01477762|3728401|P1|COMPLETED|Overall Study||16
1523485|NCT01477762|3728398|P4|STARTED|Overall Study||13
1523486|NCT01477762|3728399|P3|STARTED|Overall Study||20
1523487|NCT01477762|3728400|P2|STARTED|Overall Study||33
1523488|NCT01477762|3728401|P1|STARTED|Overall Study||25
1523489|NCT01477749|3728423|P1|NOT COMPLETED|Overall Study||4
1523490|NCT01477749|3728423|P1|COMPLETED|Overall Study||43
1523491|NCT01477749|3728423|P1|STARTED|Overall Study||47
1523492|NCT01477710|3728430|P1|NOT COMPLETED|Overall Study||0
1523493|NCT01477710|3728430|P1|COMPLETED|Overall Study||30
1523494|NCT01477710|3728430|P1|STARTED|Overall Study||30
1523495|NCT01477567|3728445|P7|NOT COMPLETED|Overall Study||0
1523496|NCT01477567|3728446|P6|NOT COMPLETED|Overall Study||0
1523497|NCT01477567|3728447|P5|NOT COMPLETED|Overall Study||0
1523498|NCT01477567|3728448|P4|NOT COMPLETED|Overall Study||0
1523499|NCT01477567|3728449|P3|NOT COMPLETED|Overall Study||0
1523500|NCT01477567|3728450|P2|NOT COMPLETED|Overall Study||0
1523501|NCT01477567|3728451|P1|NOT COMPLETED|Overall Study||0
1523502|NCT01477567|3728445|P7|COMPLETED|Overall Study||6
1523503|NCT01477567|3728446|P6|COMPLETED|Overall Study||5
1523504|NCT01477567|3728447|P5|COMPLETED|Overall Study||6
1523505|NCT01477567|3728448|P4|COMPLETED|Overall Study||6
1523506|NCT01477567|3728449|P3|COMPLETED|Overall Study||6
1523507|NCT01477567|3728450|P2|COMPLETED|Overall Study||6
1523508|NCT01477567|3728451|P1|COMPLETED|Overall Study||5
1523509|NCT01477567|3728445|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
1523510|NCT01477567|3728446|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
1523511|NCT01477567|3728447|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
1523512|NCT01477567|3728448|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
1523513|NCT01477567|3728449|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1523514|NCT01477567|3728450|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1523515|NCT01477567|3728451|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
1523516|NCT01477567|3728445|P7|STARTED|Overall Study||6
1523517|NCT01477567|3728446|P6|STARTED|Overall Study||5
1523518|NCT01477567|3728447|P5|STARTED|Overall Study||6
1523519|NCT01477567|3728448|P4|STARTED|Overall Study||6
1523520|NCT01477567|3728449|P3|STARTED|Overall Study||6
1523521|NCT01477567|3728450|P2|STARTED|Overall Study||6
1523522|NCT01477567|3728451|P1|STARTED|Overall Study||5
1523523|NCT01477463|3728507|P2|NOT COMPLETED|Overall Study||0
1523524|NCT01477463|3728508|P1|NOT COMPLETED|Overall Study||0
1523525|NCT01477463|3728507|P2|COMPLETED|Overall Study||6
1523526|NCT01477463|3728508|P1|COMPLETED|Overall Study||18
1523527|NCT01477463|3728507|P2|STARTED|Overall Study||6
1523528|NCT01477463|3728508|P1|STARTED|Overall Study||18
1523529|NCT01477450|3728521|P3|NOT COMPLETED|Overall Study||0
1523530|NCT01477450|3728522|P2|NOT COMPLETED|Overall Study||0
1523531|NCT01477450|3728523|P1|NOT COMPLETED|Overall Study||0
1523532|NCT01477450|3728521|P3|COMPLETED|Overall Study||10
1523533|NCT01477450|3728522|P2|COMPLETED|Overall Study||10
1523534|NCT01477450|3728523|P1|COMPLETED|Overall Study||10
1523535|NCT01477450|3728521|P3|STARTED|Overall Study||10
1523536|NCT01477450|3728522|P2|STARTED|Overall Study||10
1523537|NCT01477450|3728523|P1|STARTED|Overall Study||10
1523538|NCT01477333|3728531|P1|NOT COMPLETED|Overall Study||3
1523539|NCT01477333|3728531|P1|COMPLETED|Overall Study||15
1523540|NCT01477333|3728531|P1|STARTED|Overall Study||18
1523541|NCT01477320|3728549|P2|NOT COMPLETED|Overall Study||15
1523542|NCT01477320|3728550|P1|NOT COMPLETED|Overall Study||7
1523543|NCT01477320|3728549|P2|COMPLETED|Overall Study||47
1523544|NCT01477320|3728550|P1|COMPLETED|Overall Study||55
1523545|NCT01477320|3728549|P2|STARTED|Overall Study||62
1523546|NCT01477320|3728550|P1|STARTED|Overall Study||62
1523547|NCT01476748|3728561|P3|NOT COMPLETED|Overall Study||0
1523548|NCT01476748|3728562|P2|NOT COMPLETED|Overall Study||0
1523549|NCT01476748|3728563|P1|NOT COMPLETED|Overall Study||0
1523550|NCT01476748|3728561|P3|COMPLETED|Overall Study||5
1523551|NCT01476748|3728562|P2|COMPLETED|Overall Study||5
1523552|NCT01476748|3728563|P1|COMPLETED|Overall Study||5
1523553|NCT01476748|3728561|P3|STARTED|Overall Study||5
1523554|NCT01476748|3728562|P2|STARTED|Overall Study||5
1523555|NCT01476748|3728563|P1|STARTED|Overall Study||5
1523556|NCT01476722|3728574|P1|NOT COMPLETED|Overall Study||1
1523557|NCT01476722|3728574|P1|COMPLETED|Overall Study||124
1523558|NCT01476722|3728574|P1|STARTED|Overall Study||125
1523559|NCT01476696|3728581|P3|NOT COMPLETED|Overall Study||0
1523560|NCT01476696|3728582|P2|NOT COMPLETED|Overall Study||1
1523561|NCT01476696|3728583|P1|NOT COMPLETED|Overall Study||3
1523562|NCT01476696|3728581|P3|COMPLETED|Overall Study||9
1523563|NCT01476696|3728582|P2|COMPLETED|Overall Study||8
1523564|NCT01476696|3728583|P1|COMPLETED|Overall Study||12
1523565|NCT01476696|3728581|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
1523566|NCT01476696|3728582|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
1523567|NCT01476696|3728583|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
1523568|NCT01476696|3728581|P3|STARTED|Overall Study||9
1523569|NCT01476696|3728582|P2|STARTED|Overall Study||9
1523570|NCT01476696|3728583|P1|STARTED|Overall Study||15
1523571|NCT01476475|3728599|P2|NOT COMPLETED|Overall Study||3
1523572|NCT01476475|3728600|P1|NOT COMPLETED|Overall Study||11
1523573|NCT01476475|3728599|P2|COMPLETED|Overall Study||159
1523574|NCT01476475|3728600|P1|COMPLETED|Overall Study||150
1523575|NCT01476475|3728599|P2|STARTED|Overall Study||162
1523576|NCT01476475|3728600|P1|STARTED|Overall Study||161
1523577|NCT01476345|3728632|P2|NOT COMPLETED|Period 4||0
1523578|NCT01476345|3728633|P1|NOT COMPLETED|Period 4||0
1523579|NCT01476345|3728632|P2|COMPLETED|Period 4||39
1523580|NCT01476345|3728633|P1|COMPLETED|Period 4||39
1523581|NCT01476345|3728632|P2|STARTED|Period 4||39
1523582|NCT01476345|3728633|P1|STARTED|Period 4||39
1523583|NCT01476345|3728632|P2|NOT COMPLETED|Period 3||0
1523584|NCT01476345|3728633|P1|NOT COMPLETED|Period 3||0
1523585|NCT01476345|3728632|P2|COMPLETED|Period 3||39
1523586|NCT01476345|3728633|P1|COMPLETED|Period 3||39
1523587|NCT01476345|3728632|P2|STARTED|Period 3||39
1523588|NCT01476345|3728633|P1|STARTED|Period 3||39
1523589|NCT01476345|3728632|P2|NOT COMPLETED|Period 2||0
1523590|NCT01476345|3728633|P1|NOT COMPLETED|Period 2||0
1523591|NCT01476345|3728632|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
1523592|NCT01476345|3728633|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
1523593|NCT01476345|3728632|P2|STARTED|Period 2||40
1523594|NCT01476345|3728633|P1|STARTED|Period 2||40
1523595|NCT01476345|3728632|P2|NOT COMPLETED|Period 1||0
1523596|NCT01476345|3728633|P1|NOT COMPLETED|Period 1||0
1523597|NCT01476345|3728632|P2|COMPLETED|Period 1||40
1523598|NCT01476345|3728633|P1|COMPLETED|Period 1||40
1523599|NCT01476345|3728632|P2|Received at Least 1 Dose of Study Drug|Period 1||40
1523600|NCT01476345|3728633|P1|Received at Least 1 Dose of Study Drug|Period 1||40
1523601|NCT01476345|3728632|P2|STARTED|Period 1||40
1523602|NCT01476345|3728633|P1|STARTED|Period 1||40
1523603|NCT01476202|3728648|P3|NOT COMPLETED|Overall Study||0
1523604|NCT01476202|3728649|P2|NOT COMPLETED|Overall Study||0
1523605|NCT01476202|3728650|P1|NOT COMPLETED|Overall Study||0
1523606|NCT01476202|3728648|P3|COMPLETED|Overall Study||40
1523607|NCT01476202|3728649|P2|COMPLETED|Overall Study||40
1523608|NCT01476202|3728650|P1|COMPLETED|Overall Study||40
1523609|NCT01476202|3728648|P3|STARTED|Overall Study||40
1523610|NCT01476202|3728649|P2|STARTED|Overall Study||40
1523611|NCT01476202|3728650|P1|STARTED|Overall Study||40
1523612|NCT01475955|3728666|P5|NOT COMPLETED|Overall Study||0
1523613|NCT01475955|3728667|P4|NOT COMPLETED|Overall Study||0
1523614|NCT01475955|3728668|P3|NOT COMPLETED|Overall Study||3
1523615|NCT01475955|3728669|P2|NOT COMPLETED|Overall Study||0
1523616|NCT01475955|3728670|P1|NOT COMPLETED|Overall Study||1
1523617|NCT01475955|3728666|P5|COMPLETED|Overall Study||46
1523618|NCT01475955|3728667|P4|COMPLETED|Overall Study||46
1523619|NCT01475955|3728668|P3|COMPLETED|Overall Study||44
1523620|NCT01475955|3728669|P2|COMPLETED|Overall Study||48
1523621|NCT01475955|3728670|P1|COMPLETED|Overall Study||47
1523622|NCT01475955|3728666|P5|STARTED|Overall Study||46
1523623|NCT01475955|3728667|P4|STARTED|Overall Study||46
1523624|NCT01475955|3728668|P3|STARTED|Overall Study||47
1523625|NCT01475955|3728669|P2|STARTED|Overall Study||48
1523626|NCT01475955|3728670|P1|STARTED|Overall Study||48
1523627|NCT01475851|3729029|P2|NOT COMPLETED|Overall Study||0
1523628|NCT01475851|3729030|P1|NOT COMPLETED|Overall Study||1
1523629|NCT01475851|3729029|P2|COMPLETED|Overall Study||21
1523630|NCT01475851|3729030|P1|COMPLETED|Overall Study||12
1523631|NCT01475851|3729029|P2|STARTED|Overall Study||21
1523632|NCT01475851|3729030|P1|STARTED|Overall Study||13
1523633|NCT01475838|3729058|P2|NOT COMPLETED|Extension Phase||0
1523634|NCT01475838|3729059|P1|NOT COMPLETED|Extension Phase||1
1523635|NCT01475838|3729058|P2|COMPLETED|Extension Phase||20
1523636|NCT01475838|3729059|P1|COMPLETED|Extension Phase||41
1523637|NCT01475838|3729058|P2|STARTED|Extension Phase||20
1523638|NCT01475838|3729059|P1|STARTED|Extension Phase||42
1523639|NCT01475838|3729058|P2|NOT COMPLETED|Randomized Phase||36
1523640|NCT01475838|3729059|P1|NOT COMPLETED|Randomized Phase||30
1523641|NCT01475838|3729058|P2|COMPLETED|Randomized Phase||109
1523642|NCT01475838|3729059|P1|COMPLETED|Randomized Phase||263
1523643|NCT01475838|3729058|P2|STARTED|Randomized Phase||145
1523644|NCT01475838|3729059|P1|STARTED|Randomized Phase||293
1523645|NCT01475734|3729074|P2|NOT COMPLETED|Overall Study||1
1523646|NCT01475734|3729075|P1|NOT COMPLETED|Overall Study||2
1523647|NCT01475734|3729074|P2|COMPLETED|Overall Study||21
1523648|NCT01475734|3729075|P1|COMPLETED|Overall Study||20
1523649|NCT01475734|3729074|P2|STARTED|Overall Study||22
1523650|NCT01475734|3729075|P1|STARTED|Overall Study||22
1523651|NCT01475721|3729103|P2|NOT COMPLETED|Overall Study||14
1523652|NCT01475721|3729104|P1|NOT COMPLETED|Overall Study||11
1523653|NCT01475721|3729103|P2|COMPLETED|Overall Study||5831
1523654|NCT01475721|3729104|P1|COMPLETED|Overall Study||5823
1523655|NCT01475721|3729103|P2|STARTED|Overall Study||5845
1523656|NCT01475721|3729104|P1|STARTED|Overall Study||5834
1523657|NCT01475513|3729120|P2|NOT COMPLETED|Overall Study||10
1523658|NCT01475513|3729121|P1|NOT COMPLETED|Overall Study||3
1523659|NCT01475513|3729120|P2|COMPLETED|Overall Study||16
1523660|NCT01475513|3729121|P1|COMPLETED|Overall Study||17
1523661|NCT01475513|3729120|P2|STARTED|Overall Study||26
1523662|NCT01475513|3729121|P1|STARTED|Overall Study||20
1523663|NCT01475487|3729159|P2|NOT COMPLETED|Overall Study||1
1523664|NCT01475487|3729160|P1|NOT COMPLETED|Overall Study||2
1523665|NCT01475487|3729159|P2|COMPLETED|Overall Study||24
1523666|NCT01475487|3729160|P1|COMPLETED|Overall Study||23
1523667|NCT01475487|3729159|P2|STARTED|Overall Study||25
1523668|NCT01475487|3729160|P1|STARTED|Overall Study||25
1523669|NCT01475474|3729172|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
1523670|NCT01475474|3729172|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
1523671|NCT01475474|3729172|P1|STARTED|Return to Baseline Period - 4 Weeks||73
1523672|NCT01475474|3729172|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
1523673|NCT01475474|3729172|P1|COMPLETED|Treatment Period - 12 Weeks||73
1523674|NCT01475474|3729172|P1|STARTED|Treatment Period - 12 Weeks||91
1523675|NCT01475474|3729172|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
1523676|NCT01475474|3729172|P1|COMPLETED|Baseline Period - 4 Weeks||91
1523677|NCT01475474|3729172|P1|STARTED|Baseline Period - 4 Weeks||97
1523678|NCT01475461|3729183|P7|NOT COMPLETED|Treatment Period||2
1523679|NCT01475461|3729184|P6|NOT COMPLETED|Treatment Period||5
1523680|NCT01475461|3729185|P5|NOT COMPLETED|Treatment Period||4
1523681|NCT01475461|3729186|P4|NOT COMPLETED|Treatment Period||8
1523682|NCT01475461|3729187|P3|NOT COMPLETED|Treatment Period||4
1523683|NCT01475461|3729188|P2|NOT COMPLETED|Treatment Period||9
1523684|NCT01475461|3729189|P1|NOT COMPLETED|Treatment Period||0
1523685|NCT01475461|3729183|P7|COMPLETED|Treatment Period||53
1523686|NCT01475461|3729184|P6|COMPLETED|Treatment Period||51
1523687|NCT01475461|3729185|P5|COMPLETED|Treatment Period||52
1523688|NCT01475461|3729186|P4|COMPLETED|Treatment Period||46
1523689|NCT01475461|3729187|P3|COMPLETED|Treatment Period||53
1523690|NCT01475461|3729188|P2|COMPLETED|Treatment Period||48
1523691|NCT01475461|3729189|P1|COMPLETED|Treatment Period||0
1523692|NCT01475461|3729183|P7|STARTED|Treatment Period||55
1523693|NCT01475461|3729184|P6|STARTED|Treatment Period||56
1523694|NCT01475461|3729185|P5|STARTED|Treatment Period||56
1523695|NCT01475461|3729186|P4|STARTED|Treatment Period||54
1523696|NCT01475461|3729187|P3|STARTED|Treatment Period||57
1523697|NCT01475461|3729188|P2|STARTED|Treatment Period||57
1523698|NCT01475461|3729189|P1|STARTED|Treatment Period||0
1523699|NCT01475461|3729183|P7|NOT COMPLETED|Run-in Period||0
1523700|NCT01475461|3729184|P6|NOT COMPLETED|Run-in Period||0
1523701|NCT01475461|3729185|P5|NOT COMPLETED|Run-in Period||0
1523702|NCT01475461|3729186|P4|NOT COMPLETED|Run-in Period||0
1523703|NCT01475461|3729187|P3|NOT COMPLETED|Run-in Period||0
1523704|NCT01475461|3729188|P2|NOT COMPLETED|Run-in Period||0
1523705|NCT01475461|3729189|P1|NOT COMPLETED|Run-in Period||41
1523706|NCT01475461|3729183|P7|COMPLETED|Run-in Period||0
1523707|NCT01475461|3729184|P6|COMPLETED|Run-in Period||0
1523708|NCT01475461|3729185|P5|COMPLETED|Run-in Period||0
1523709|NCT01475461|3729186|P4|COMPLETED|Run-in Period||0
1523710|NCT01475461|3729187|P3|COMPLETED|Run-in Period||0
1523711|NCT01475461|3729188|P2|COMPLETED|Run-in Period||0
1523712|NCT01475461|3729189|P1|COMPLETED|Run-in Period||335
1523713|NCT01475461|3729183|P7|STARTED|Run-in Period||0
1523714|NCT01475461|3729184|P6|STARTED|Run-in Period||0
1523715|NCT01475461|3729185|P5|STARTED|Run-in Period||0
1523716|NCT01475461|3729186|P4|STARTED|Run-in Period||0
1523717|NCT01475461|3729187|P3|STARTED|Run-in Period||0
1523718|NCT01475461|3729188|P2|STARTED|Run-in Period||0
1523719|NCT01475461|3729189|P1|STARTED|Run-in Period||376
1523720|NCT01475331|3729269|P2|NOT COMPLETED|Overall Study||2
1523721|NCT01475331|3729270|P1|NOT COMPLETED|Overall Study||5
1523722|NCT01475331|3729269|P2|COMPLETED|Overall Study||21
1523723|NCT01475331|3729270|P1|COMPLETED|Overall Study||18
1523724|NCT01475331|3729269|P2|STARTED|Overall Study||23
1523725|NCT01475331|3729270|P1|STARTED|Overall Study||23
1523726|NCT01475305|3729278|P2|NOT COMPLETED|Overall Study||0
1523727|NCT01475305|3729279|P1|NOT COMPLETED|Overall Study||0
1523728|NCT01475305|3729278|P2|COMPLETED|Overall Study||3
1523729|NCT01475305|3729279|P1|COMPLETED|Overall Study||4
1523730|NCT01475305|3729278|P2|End of Quarantine, Day 15|Overall Study||3
1523731|NCT01475305|3729279|P1|End of Quarantine, Day 15|Overall Study||4
1523732|NCT01475305|3729278|P2|STARTED|Overall Study||3
1523733|NCT01475305|3729279|P1|STARTED|Overall Study||4
1523734|NCT01475253|3729322|P4|NOT COMPLETED|Open Label Extension||0
1523735|NCT01475253|3729323|P3|NOT COMPLETED|Open Label Extension||0
1523736|NCT01475253|3729324|P2|NOT COMPLETED|Open Label Extension||0
1523737|NCT01475253|3729325|P1|NOT COMPLETED|Open Label Extension||0
1523738|NCT01475253|3729322|P4|COMPLETED|Open Label Extension||56
1523739|NCT01475253|3729323|P3|COMPLETED|Open Label Extension||0
1523740|NCT01475253|3729324|P2|COMPLETED|Open Label Extension||0
1523741|NCT01475253|3729325|P1|COMPLETED|Open Label Extension||0
1523742|NCT01475253|3729322|P4|STARTED|Open Label Extension||56
1523743|NCT01475253|3729323|P3|STARTED|Open Label Extension||0
1523744|NCT01475253|3729324|P2|STARTED|Open Label Extension||0
1523745|NCT01475253|3729325|P1|STARTED|Open Label Extension||0
1523746|NCT01475253|3729322|P4|NOT COMPLETED|Randomized, Blinded Study||0
1523747|NCT01475253|3729323|P3|NOT COMPLETED|Randomized, Blinded Study||0
1523748|NCT01475253|3729324|P2|NOT COMPLETED|Randomized, Blinded Study||1
1523749|NCT01475253|3729325|P1|NOT COMPLETED|Randomized, Blinded Study||2
1523750|NCT01475253|3729322|P4|COMPLETED|Randomized, Blinded Study||0
1523751|NCT01475253|3729323|P3|COMPLETED|Randomized, Blinded Study||11
1523752|NCT01475253|3729324|P2|COMPLETED|Randomized, Blinded Study||45
1523753|NCT01475253|3729325|P1|COMPLETED|Randomized, Blinded Study||45
1523754|NCT01475253|3729322|P4|STARTED|Randomized, Blinded Study||0
1523755|NCT01475253|3729323|P3|STARTED|Randomized, Blinded Study||11
1523756|NCT01475253|3729324|P2|STARTED|Randomized, Blinded Study||46
1523757|NCT01475253|3729325|P1|STARTED|Randomized, Blinded Study||47
1523758|NCT01475214|3729354|P3|NOT COMPLETED|Overall Study||2
1523759|NCT01475214|3729355|P2|NOT COMPLETED|Overall Study||4
1523760|NCT01475214|3729356|P1|NOT COMPLETED|Overall Study||5
1523761|NCT01475214|3729354|P3|COMPLETED|Overall Study||79
1523762|NCT01475214|3729355|P2|COMPLETED|Overall Study||75
1523763|NCT01475214|3729356|P1|COMPLETED|Overall Study||79
1523764|NCT01475214|3729354|P3|STARTED|Overall Study||81
1523765|NCT01475214|3729355|P2|STARTED|Overall Study||79
1523766|NCT01475214|3729356|P1|STARTED|Overall Study||84
1523767|NCT01475175|3729367|P1|NOT COMPLETED|Overall Study||0
1523768|NCT01475175|3729367|P1|COMPLETED|Overall Study||12
1523769|NCT01475175|3729367|P1|STARTED|Overall Study||12
1523770|NCT01475097|3729381|P2|NOT COMPLETED|Overall Study||1
1523771|NCT01475097|3729382|P1|NOT COMPLETED|Overall Study||1
1523772|NCT01475097|3729381|P2|COMPLETED|Overall Study||126
1523773|NCT01475097|3729382|P1|COMPLETED|Overall Study||127
1523774|NCT01475097|3729381|P2|STARTED|Overall Study||127
1523775|NCT01475097|3729382|P1|STARTED|Overall Study||128
1523776|NCT01475071|3729390|P1|NOT COMPLETED|Overall Study||8
1523777|NCT01475071|3729390|P1|COMPLETED|Overall Study||92
1523778|NCT01475071|3729390|P1|STARTED|Overall Study||100
1523779|NCT01474993|3729400|P2|NOT COMPLETED|Overall Study||3
1523780|NCT01474993|3729401|P1|NOT COMPLETED|Overall Study||1
1523781|NCT01474993|3729400|P2|COMPLETED|Overall Study||26
1523782|NCT01474993|3729401|P1|COMPLETED|Overall Study||14
1523783|NCT01474993|3729400|P2|STARTED|Overall Study||29
1523784|NCT01474993|3729401|P1|STARTED|Overall Study||15
1523785|NCT01474915|3729431|P2|NOT COMPLETED|Overall Study||10
1523786|NCT01474915|3729432|P1|NOT COMPLETED|Overall Study||10
1523787|NCT01474915|3729431|P2|COMPLETED|Overall Study||51
1523788|NCT01474915|3729432|P1|COMPLETED|Overall Study||50
1523789|NCT01474915|3729431|P2|STARTED|Overall Study||61
1523790|NCT01474915|3729432|P1|STARTED|Overall Study||60
1523791|NCT01474876|3729443|P3|NOT COMPLETED|Overall Study||0
1523792|NCT01474876|3729444|P2|NOT COMPLETED|Overall Study||23
1523793|NCT01474876|3729445|P1|NOT COMPLETED|Overall Study||66
1523794|NCT01474876|3729443|P3|COMPLETED|Overall Study||1
1523795|NCT01474876|3729444|P2|COMPLETED|Overall Study||128
1523796|NCT01474876|3729445|P1|COMPLETED|Overall Study||337
1523797|NCT01474876|3729443|P3|STARTED|Overall Study||1
1523798|NCT01474876|3729444|P2|STARTED|Overall Study||151
1523799|NCT01474876|3729445|P1|STARTED|Overall Study||403
1523800|NCT01474863|3729479|P3|NOT COMPLETED|Overall Study||0
1523801|NCT01474863|3729480|P2|NOT COMPLETED|Overall Study||0
1523802|NCT01474863|3729481|P1|NOT COMPLETED|Overall Study||0
1523803|NCT01474863|3729479|P3|COMPLETED|Overall Study||24
1523804|NCT01474863|3729480|P2|COMPLETED|Overall Study||22
1523805|NCT01474863|3729481|P1|COMPLETED|Overall Study||26
1523806|NCT01474863|3729479|P3|STARTED|Overall Study||24
1523807|NCT01474863|3729480|P2|STARTED|Overall Study||22
1523808|NCT01474863|3729481|P1|STARTED|Overall Study||26
1523809|NCT01474772|3729491|P2|NOT COMPLETED|Follow-up||1
1523810|NCT01474772|3729492|P1|NOT COMPLETED|Follow-up||0
1523811|NCT01474772|3729491|P2|COMPLETED|Follow-up||86
1523812|NCT01474772|3729492|P1|COMPLETED|Follow-up||77
1523813|NCT01474772|3729491|P2|STARTED|Follow-up||87
1523814|NCT01474772|3729492|P1|STARTED|Follow-up||77
1523815|NCT01474772|3729491|P2|NOT COMPLETED|Period 2||10
1523816|NCT01474772|3729492|P1|NOT COMPLETED|Period 2||9
1523817|NCT01474772|3729491|P2|COMPLETED|Period 2||87
1523818|NCT01474772|3729492|P1|COMPLETED|Period 2||77
1523819|NCT01474772|3729491|P2|STARTED|Period 2||97
1523820|NCT01474772|3729492|P1|STARTED|Period 2||86
1523821|NCT01474772|3729491|P2|NOT COMPLETED|Washout||2
1523822|NCT01474772|3729492|P1|NOT COMPLETED|Washout||3
1523823|NCT01474772|3729491|P2|COMPLETED|Washout||97
1523824|NCT01474772|3729492|P1|COMPLETED|Washout||86
1523825|NCT01474772|3729491|P2|STARTED|Washout||99
1523826|NCT01474772|3729492|P1|STARTED|Washout||89
1523827|NCT01474772|3729491|P2|NOT COMPLETED|Period 1||3
1523828|NCT01474772|3729492|P1|NOT COMPLETED|Period 1||12
1523829|NCT01474772|3729491|P2|COMPLETED|Period 1||99
1523830|NCT01474772|3729492|P1|COMPLETED|Period 1||89
1523831|NCT01474772|3729491|P2|STARTED|Period 1|STARTED=treated|102
1523832|NCT01474772|3729492|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
1523833|NCT01474746|3729542|P2|NOT COMPLETED|Overall Study||2
1523834|NCT01474746|3729543|P1|NOT COMPLETED|Overall Study||3
1523835|NCT01474746|3729542|P2|COMPLETED|Overall Study||25
1523836|NCT01474746|3729543|P1|COMPLETED|Overall Study||27
1523837|NCT01474746|3729542|P2|STARTED|Overall Study||27
1523838|NCT01474746|3729543|P1|STARTED|Overall Study||30
1523839|NCT01474681|3729607|P4|NOT COMPLETED|Overall Study||6
1523840|NCT01474681|3729608|P3|NOT COMPLETED|Overall Study||2
1523841|NCT01474681|3729609|P2|NOT COMPLETED|Overall Study||3
1523842|NCT01474681|3729610|P1|NOT COMPLETED|Overall Study||0
1523843|NCT01474681|3729607|P4|COMPLETED|Overall Study||9
1523844|NCT01474681|3729608|P3|COMPLETED|Overall Study||1
1523845|NCT01474681|3729609|P2|COMPLETED|Overall Study||5
1523846|NCT01474681|3729610|P1|COMPLETED|Overall Study||1
1523847|NCT01474681|3729607|P4|STARTED|Overall Study||15
1523848|NCT01474681|3729608|P3|STARTED|Overall Study||3
1523849|NCT01474681|3729609|P2|STARTED|Overall Study||8
1523850|NCT01474681|3729610|P1|STARTED|Overall Study||1
1523851|NCT01474590|3729654|P2|NOT COMPLETED|Overall Study||17
1523852|NCT01474590|3729655|P1|NOT COMPLETED|Overall Study||28
1523853|NCT01474590|3729654|P2|COMPLETED|Overall Study||116
1523854|NCT01474590|3729655|P1|COMPLETED|Overall Study||105
1523855|NCT01474590|3729654|P2|STARTED|Overall Study||133
1523856|NCT01474590|3729655|P1|STARTED|Overall Study||133
1523857|NCT01474551|3729661|P1|NOT COMPLETED|Overall Study||1
1523858|NCT01474551|3729661|P1|COMPLETED|Overall Study||1
1523859|NCT01474551|3729661|P1|STARTED|Overall Study||2
1523860|NCT01474538|3729667|P2|NOT COMPLETED|Treatment Period 2||2
1523861|NCT01474538|3729668|P1|NOT COMPLETED|Treatment Period 2||6
1523862|NCT01474538|3729667|P2|COMPLETED|Treatment Period 2||56
1523863|NCT01474538|3729668|P1|COMPLETED|Treatment Period 2||51
1523864|NCT01474538|3729667|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
1523865|NCT01474538|3729668|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
1523866|NCT01474538|3729667|P2|STARTED|Treatment Period 2||58
1523867|NCT01474538|3729668|P1|STARTED|Treatment Period 2||57
1523868|NCT01474538|3729667|P2|NOT COMPLETED|Treatment Period 1||4
1523869|NCT01474538|3729668|P1|NOT COMPLETED|Treatment Period 1||3
1523870|NCT01474538|3729667|P2|COMPLETED|Treatment Period 1||58
1523871|NCT01474538|3729668|P1|COMPLETED|Treatment Period 1||57
1523872|NCT01474538|3729667|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
1523873|NCT01474538|3729668|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
1523874|NCT01474538|3729667|P2|STARTED|Treatment Period 1||62
1523875|NCT01474538|3729668|P1|STARTED|Treatment Period 1||60
1523876|NCT01474512|3729685|P10|NOT COMPLETED|Maintenance Period||18
1523877|NCT01474512|3729686|P9|NOT COMPLETED|Maintenance Period||16
1523878|NCT01474512|3729687|P8|NOT COMPLETED|Maintenance Period||41
1523879|NCT01474512|3729688|P7|NOT COMPLETED|Maintenance Period||10
1523880|NCT01474512|3729689|P6|NOT COMPLETED|Maintenance Period||52
1523881|NCT01474512|3729690|P5|NOT COMPLETED|Maintenance Period||119
1523882|NCT01474512|3729691|P4|NOT COMPLETED|Maintenance Period||202
1523883|NCT01474512|3729692|P3|NOT COMPLETED|Maintenance Period||0
1523884|NCT01474512|3729693|P2|NOT COMPLETED|Maintenance Period||0
1523885|NCT01474512|3729694|P1|NOT COMPLETED|Maintenance Period||0
1523886|NCT01474512|3729685|P10|COMPLETED|Maintenance Period||44
1523887|NCT01474512|3729686|P9|COMPLETED|Maintenance Period||62
1523888|NCT01474512|3729687|P8|COMPLETED|Maintenance Period||350
1523889|NCT01474512|3729688|P7|COMPLETED|Maintenance Period||6
1523890|NCT01474512|3729689|P6|COMPLETED|Maintenance Period||177
1523891|NCT01474512|3729690|P5|COMPLETED|Maintenance Period||108
1523892|NCT01474512|3729691|P4|COMPLETED|Maintenance Period||24
1523893|NCT01474512|3729692|P3|COMPLETED|Maintenance Period||0
1523894|NCT01474512|3729693|P2|COMPLETED|Maintenance Period||0
1523895|NCT01474512|3729694|P1|COMPLETED|Maintenance Period||0
1523896|NCT01474512|3729685|P10|Received Study Drug|Maintenance Period||62
1523897|NCT01474512|3729686|P9|Received Study Drug|Maintenance Period||78
1523898|NCT01474512|3729687|P8|Received Study Drug|Maintenance Period||391
1523899|NCT01474512|3729688|P7|Received Study Drug|Maintenance Period||16
1523900|NCT01474512|3729689|P6|Received Study Drug|Maintenance Period||229
1523901|NCT01474512|3729690|P5|Received Study Drug|Maintenance Period||227
1523902|NCT01474512|3729691|P4|Received Study Drug|Maintenance Period||226
1523903|NCT01474512|3729692|P3|Received Study Drug|Maintenance Period||0
1523904|NCT01474512|3729693|P2|Received Study Drug|Maintenance Period||0
1523905|NCT01474512|3729694|P1|Received Study Drug|Maintenance Period||0
1523906|NCT01474512|3729685|P10|STARTED|Maintenance Period||62
1523907|NCT01474512|3729686|P9|STARTED|Maintenance Period||78
1523908|NCT01474512|3729687|P8|STARTED|Maintenance Period||391
1523909|NCT01474512|3729688|P7|STARTED|Maintenance Period||16
1523910|NCT01474512|3729689|P6|STARTED|Maintenance Period||229
1523911|NCT01474512|3729690|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
1523912|NCT01474512|3729691|P4|STARTED|Maintenance Period||226
1523913|NCT01474512|3729692|P3|STARTED|Maintenance Period||0
1523914|NCT01474512|3729693|P2|STARTED|Maintenance Period||0
1523915|NCT01474512|3729694|P1|STARTED|Maintenance Period||0
1523916|NCT01474512|3729685|P10|NOT COMPLETED|Induction Period||0
1523917|NCT01474512|3729686|P9|NOT COMPLETED|Induction Period||0
1523918|NCT01474512|3729687|P8|NOT COMPLETED|Induction Period||0
1523919|NCT01474512|3729688|P7|NOT COMPLETED|Induction Period||0
1523920|NCT01474512|3729689|P6|NOT COMPLETED|Induction Period||0
1523921|NCT01474512|3729690|P5|NOT COMPLETED|Induction Period||0
1523922|NCT01474512|3729691|P4|NOT COMPLETED|Induction Period||0
1523923|NCT01474512|3729692|P3|NOT COMPLETED|Induction Period||18
1523924|NCT01474512|3729693|P2|NOT COMPLETED|Induction Period||24
1523925|NCT01474512|3729694|P1|NOT COMPLETED|Induction Period||24
1523926|NCT01474512|3729685|P10|COMPLETED|Induction Period||0
1523927|NCT01474512|3729686|P9|COMPLETED|Induction Period||0
1523928|NCT01474512|3729687|P8|COMPLETED|Induction Period||0
1523929|NCT01474512|3729688|P7|COMPLETED|Induction Period||0
1523930|NCT01474512|3729689|P6|COMPLETED|Induction Period||0
1523931|NCT01474512|3729690|P5|COMPLETED|Induction Period||0
1523932|NCT01474512|3729691|P4|COMPLETED|Induction Period||0
1523933|NCT01474512|3729692|P3|COMPLETED|Induction Period||415
1523934|NCT01474512|3729693|P2|COMPLETED|Induction Period||408
1523935|NCT01474512|3729694|P1|COMPLETED|Induction Period||407
1523936|NCT01474512|3729685|P10|Received Study Drug|Induction Period||0
1523937|NCT01474512|3729686|P9|Received Study Drug|Induction Period||0
1523938|NCT01474512|3729687|P8|Received Study Drug|Induction Period||0
1523939|NCT01474512|3729688|P7|Received Study Drug|Induction Period||0
1523940|NCT01474512|3729689|P6|Received Study Drug|Induction Period||0
1523941|NCT01474512|3729690|P5|Received Study Drug|Induction Period||0
1523942|NCT01474512|3729691|P4|Received Study Drug|Induction Period||0
1523943|NCT01474512|3729692|P3|Received Study Drug|Induction Period||433
1523944|NCT01474512|3729693|P2|Received Study Drug|Induction Period||432
1523945|NCT01474512|3729694|P1|Received Study Drug|Induction Period||431
1523946|NCT01474512|3729685|P10|STARTED|Induction Period||0
1523947|NCT01474512|3729686|P9|STARTED|Induction Period||0
1523948|NCT01474512|3729687|P8|STARTED|Induction Period||0
1523949|NCT01474512|3729688|P7|STARTED|Induction Period||0
1523950|NCT01474512|3729689|P6|STARTED|Induction Period||0
1523951|NCT01474512|3729690|P5|STARTED|Induction Period||0
1523952|NCT01474512|3729691|P4|STARTED|Induction Period||0
1523953|NCT01474512|3729692|P3|STARTED|Induction Period||433
1523954|NCT01474512|3729693|P2|STARTED|Induction Period||432
1523955|NCT01474512|3729694|P1|STARTED|Induction Period||431
1523956|NCT01474434|3729763|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
1523957|NCT01474434|3729764|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
1523958|NCT01474434|3729765|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
1523959|NCT01474434|3729766|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
1523960|NCT01474434|3729763|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
1523961|NCT01474434|3729764|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
1523962|NCT01474434|3729765|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
1523963|NCT01474434|3729766|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
1523964|NCT01474434|3729763|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
1523965|NCT01474434|3729764|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
1523966|NCT01474434|3729765|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
1523967|NCT01474434|3729766|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
1523968|NCT01474434|3729763|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
1523969|NCT01474434|3729764|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
1523970|NCT01474434|3729765|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
1523971|NCT01474434|3729766|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
1523972|NCT01474434|3729763|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
1523973|NCT01474434|3729764|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
1523974|NCT01474434|3729765|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
1523975|NCT01474434|3729766|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
1523976|NCT01474434|3729763|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
1523977|NCT01474434|3729764|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
1523978|NCT01474434|3729765|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
1523979|NCT01474434|3729766|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
1523980|NCT01474317|3729808|P1|NOT COMPLETED|Overall Study||2
1523981|NCT01474317|3729808|P1|COMPLETED|Overall Study||224
1523982|NCT01474317|3729808|P1|STARTED|Overall Study||226
1523983|NCT01474291|3729817|P1|NOT COMPLETED|Overall Study||220
1523984|NCT01474291|3729817|P1|COMPLETED|Overall Study||383
1523985|NCT01474291|3729817|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
1523986|NCT01474291|3729817|P1|STARTED|Overall Study||603
1523987|NCT01474239|3729861|P2|NOT COMPLETED|Overall Study||32
1523988|NCT01474239|3729862|P1|NOT COMPLETED|Overall Study||59
1523989|NCT01474239|3729861|P2|COMPLETED|Overall Study||0
1523990|NCT01474239|3729862|P1|COMPLETED|Overall Study||0
1523991|NCT01474239|3729861|P2|STARTED|Overall Study||32
1523992|NCT01474239|3729862|P1|STARTED|Overall Study||59
1523993|NCT01474213|3729900|P2|NOT COMPLETED|Overall Study||0
1523994|NCT01474213|3729901|P1|NOT COMPLETED|Overall Study||0
1523995|NCT01474213|3729900|P2|COMPLETED|Overall Study||20
1523996|NCT01474213|3729901|P1|COMPLETED|Overall Study||20
1523997|NCT01474213|3729900|P2|STARTED|Overall Study||20
1523998|NCT01474213|3729901|P1|STARTED|Overall Study||20
1523999|NCT01474200|3729925|P2|NOT COMPLETED|Overall Study||30
1524000|NCT01474200|3729926|P1|NOT COMPLETED|Overall Study||29
1524001|NCT01474200|3729925|P2|COMPLETED|Overall Study||84
1524002|NCT01474200|3729926|P1|COMPLETED|Overall Study||81
1524003|NCT01474200|3729925|P2|STARTED|Overall Study||114
1524004|NCT01474200|3729926|P1|STARTED|Overall Study||110
1524005|NCT01474122|3729979|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
1524006|NCT01474122|3729980|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
1524007|NCT01474122|3729981|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
1524008|NCT01474122|3729979|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
1524009|NCT01474122|3729980|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
1524010|NCT01474122|3729981|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
1524011|NCT01474122|3729979|P3|STARTED|Period 2: Week 16 to End of Study||88
1524012|NCT01474122|3729980|P2|STARTED|Period 2: Week 16 to End of Study||86
1524013|NCT01474122|3729981|P1|STARTED|Period 2: Week 16 to End of Study||87
1524014|NCT01474122|3729979|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
1524015|NCT01474122|3729980|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
1524016|NCT01474122|3729981|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
1524017|NCT01474122|3729979|P3|COMPLETED|Period 1: Baseline to Week 16||88
1524018|NCT01474122|3729980|P2|COMPLETED|Period 1: Baseline to Week 16||86
1524019|NCT01474122|3729981|P1|COMPLETED|Period 1: Baseline to Week 16||87
1524020|NCT01474122|3729979|P3|STARTED|Period 1: Baseline to Week 16||89
1524204|NCT01472939|3730652|P4|NOT COMPLETED|Overall Study||20
1524021|NCT01474122|3729980|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
1524022|NCT01474122|3729981|P1|STARTED|Period 1: Baseline to Week 16||88
1524023|NCT01474109|3730007|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
1524024|NCT01474109|3730008|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
1524025|NCT01474109|3730009|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
1524026|NCT01474109|3730007|P3|COMPLETED|Period 2: Week 16 to End of Study||83
1524027|NCT01474109|3730008|P2|COMPLETED|Period 2: Week 16 to End of Study||73
1524028|NCT01474109|3730009|P1|COMPLETED|Period 2: Week 16 to End of Study||70
1524029|NCT01474109|3730007|P3|STARTED|Period 2: Week 16 to End of Study||95
1524030|NCT01474109|3730008|P2|STARTED|Period 2: Week 16 to End of Study||91
1524031|NCT01474109|3730009|P1|STARTED|Period 2: Week 16 to End of Study||88
1524032|NCT01474109|3730007|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
1524033|NCT01474109|3730008|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
1524034|NCT01474109|3730009|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
1524035|NCT01474109|3730007|P3|COMPLETED|Period 1: Baseline to Week 16||95
1524036|NCT01474109|3730008|P2|COMPLETED|Period 1: Baseline to Week 16||91
1524037|NCT01474109|3730009|P1|COMPLETED|Period 1: Baseline to Week 16||88
1524038|NCT01474109|3730007|P3|STARTED|Period 1: Baseline to Week 16||97
1524039|NCT01474109|3730008|P2|STARTED|Period 1: Baseline to Week 16||97
1524040|NCT01474109|3730009|P1|STARTED|Period 1: Baseline to Week 16||95
1524041|NCT01473992|3730034|P3|NOT COMPLETED|Overall Study||0
1524042|NCT01473992|3730035|P2|NOT COMPLETED|Overall Study||0
1524043|NCT01473992|3730036|P1|NOT COMPLETED|Overall Study||0
1524044|NCT01473992|3730034|P3|COMPLETED|Overall Study||5
1524045|NCT01473992|3730035|P2|COMPLETED|Overall Study||10
1524046|NCT01473992|3730036|P1|COMPLETED|Overall Study||10
1524047|NCT01473992|3730034|P3|STARTED|Overall Study||5
1524048|NCT01473992|3730035|P2|STARTED|Overall Study||10
1524049|NCT01473992|3730036|P1|STARTED|Overall Study||10
1524050|NCT01473953|3730056|P5|NOT COMPLETED|Overall Study||0
1524051|NCT01473953|3730057|P4|NOT COMPLETED|Overall Study||0
1524052|NCT01473953|3730058|P3|NOT COMPLETED|Overall Study||0
1524053|NCT01473953|3730059|P2|NOT COMPLETED|Overall Study||0
1524054|NCT01473953|3730060|P1|NOT COMPLETED|Overall Study||1
1524055|NCT01473953|3730056|P5|COMPLETED|Overall Study||8
1524056|NCT01473953|3730057|P4|COMPLETED|Overall Study||5
1524057|NCT01473953|3730058|P3|COMPLETED|Overall Study||6
1524058|NCT01473953|3730059|P2|COMPLETED|Overall Study||6
1524059|NCT01473953|3730060|P1|COMPLETED|Overall Study||5
1524060|NCT01473953|3730056|P5|STARTED|Overall Study||8
1524061|NCT01473953|3730057|P4|STARTED|Overall Study||5
1524062|NCT01473953|3730058|P3|STARTED|Overall Study||6
1524063|NCT01473953|3730059|P2|STARTED|Overall Study||6
1524064|NCT01473953|3730060|P1|STARTED|Overall Study||6
1524065|NCT01473836|3730102|P1|NOT COMPLETED|Overall Study||6
1524066|NCT01473836|3730102|P1|COMPLETED|Overall Study||32
1524067|NCT01473836|3730102|P1|STARTED|Overall Study||38
1524068|NCT01473758|3730113|P4|NOT COMPLETED|Cycle 2||0
1524069|NCT01473758|3730114|P3|NOT COMPLETED|Cycle 2||5
1524070|NCT01473758|3730115|P2|NOT COMPLETED|Cycle 2||0
1524071|NCT01473758|3730116|P1|NOT COMPLETED|Cycle 2||0
1524072|NCT01473758|3730113|P4|COMPLETED|Cycle 2||4
1524073|NCT01473758|3730114|P3|COMPLETED|Cycle 2||5
1524074|NCT01473758|3730115|P2|COMPLETED|Cycle 2||0
1524075|NCT01473758|3730116|P1|COMPLETED|Cycle 2||0
1524076|NCT01473758|3730113|P4|STARTED|Cycle 2||4
1524077|NCT01473758|3730114|P3|STARTED|Cycle 2||10
1524078|NCT01473758|3730115|P2|STARTED|Cycle 2||0
1524079|NCT01473758|3730116|P1|STARTED|Cycle 2||0
1524080|NCT01473758|3730113|P4|NOT COMPLETED|Cycle 1||0
1524081|NCT01473758|3730114|P3|NOT COMPLETED|Cycle 1||0
1524082|NCT01473758|3730115|P2|NOT COMPLETED|Cycle 1||3
1524083|NCT01473758|3730116|P1|NOT COMPLETED|Cycle 1||11
1524084|NCT01473758|3730113|P4|COMPLETED|Cycle 1||0
1524085|NCT01473758|3730114|P3|COMPLETED|Cycle 1||0
1524086|NCT01473758|3730115|P2|COMPLETED|Cycle 1||40
1524087|NCT01473758|3730116|P1|COMPLETED|Cycle 1||27
1524088|NCT01473758|3730113|P4|STARTED|Cycle 1||0
1524089|NCT01473758|3730114|P3|STARTED|Cycle 1||0
1524090|NCT01473758|3730115|P2|STARTED|Cycle 1||43
1524091|NCT01473758|3730116|P1|STARTED|Cycle 1||38
1524092|NCT01473745|3730240|P2|NOT COMPLETED|Overall Study||0
1524093|NCT01473745|3730241|P1|NOT COMPLETED|Overall Study||0
1524094|NCT01473745|3730240|P2|COMPLETED|Overall Study||24
1524095|NCT01473745|3730241|P1|COMPLETED|Overall Study||24
1524096|NCT01473745|3730240|P2|STARTED|Overall Study||24
1524097|NCT01473745|3730241|P1|STARTED|Overall Study||24
1524098|NCT01473732|3730253|P2|NOT COMPLETED|Overall Study||0
1524099|NCT01473732|3730254|P1|NOT COMPLETED|Overall Study||2
1524100|NCT01473732|3730253|P2|COMPLETED|Overall Study||0
1524101|NCT01473732|3730254|P1|COMPLETED|Overall Study||0
1524102|NCT01473732|3730253|P2|STARTED|Overall Study||0
1524103|NCT01473732|3730254|P1|STARTED|Overall Study||2
1524104|NCT01473602|3730262|P2|NOT COMPLETED|Overall Study||8
1524105|NCT01473602|3730263|P1|NOT COMPLETED|Overall Study||8
1524106|NCT01473602|3730262|P2|COMPLETED|Overall Study||13
1524107|NCT01473602|3730263|P1|COMPLETED|Overall Study||10
1524108|NCT01473602|3730262|P2|Completed 12 Months|Overall Study||13
1524109|NCT01473602|3730263|P1|Completed 12 Months|Overall Study||10
1524110|NCT01473602|3730262|P2|Completed 6 Months|Overall Study||15
1524111|NCT01473602|3730263|P1|Completed 6 Months|Overall Study||12
1524112|NCT01473602|3730262|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
1524205|NCT01472939|3730653|P3|NOT COMPLETED|Overall Study||11
1524113|NCT01473602|3730263|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
1524114|NCT01473602|3730262|P2|STARTED|Overall Study||21
1524115|NCT01473602|3730263|P1|STARTED|Overall Study||18
1524116|NCT01473589|3730299|P2|NOT COMPLETED|Overall Study||16
1524117|NCT01473589|3730300|P1|NOT COMPLETED|Overall Study||11
1524118|NCT01473589|3730299|P2|COMPLETED|Overall Study||46
1524119|NCT01473589|3730300|P1|COMPLETED|Overall Study||49
1524120|NCT01473589|3730299|P2|Completed 12 Months|Overall Study||48
1524121|NCT01473589|3730300|P1|Completed 12 Months|Overall Study||49
1524122|NCT01473589|3730299|P2|Completed 6 Months|Overall Study||54
1524123|NCT01473589|3730300|P1|Completed 6 Months|Overall Study||51
1524124|NCT01473589|3730299|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
1524125|NCT01473589|3730300|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
1524126|NCT01473589|3730299|P2|STARTED|Overall Study||62
1524127|NCT01473589|3730300|P1|STARTED|Overall Study||60
1524128|NCT01473563|3730334|P1|NOT COMPLETED|Overall Study||1
1524129|NCT01473563|3730334|P1|COMPLETED|Overall Study||51
1524130|NCT01473563|3730334|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
1524131|NCT01473563|3730334|P1|STARTED|Overall Study||52
1524132|NCT01473524|3730356|P3|NOT COMPLETED|Overall Study||3
1524133|NCT01473524|3730357|P2|NOT COMPLETED|Overall Study||9
1524134|NCT01473524|3730358|P1|NOT COMPLETED|Overall Study||7
1524135|NCT01473524|3730356|P3|COMPLETED|Overall Study||70
1524136|NCT01473524|3730357|P2|COMPLETED|Overall Study||64
1524137|NCT01473524|3730358|P1|COMPLETED|Overall Study||64
1524138|NCT01473524|3730356|P3|STARTED|Overall Study||73
1524139|NCT01473524|3730357|P2|STARTED|Overall Study||73
1524140|NCT01473524|3730358|P1|STARTED|Overall Study||71
1524141|NCT01473420|3730391|P2|NOT COMPLETED|Maintenance Period (16 Weeks)||17
1524142|NCT01473420|3730392|P1|NOT COMPLETED|Maintenance Period (16 Weeks)||18
1524143|NCT01473420|3730391|P2|COMPLETED|Maintenance Period (16 Weeks)||105
1524144|NCT01473420|3730392|P1|COMPLETED|Maintenance Period (16 Weeks)||106
1524145|NCT01473420|3730391|P2|STARTED|Maintenance Period (16 Weeks)||122
1524146|NCT01473420|3730392|P1|STARTED|Maintenance Period (16 Weeks)||124
1524147|NCT01473420|3730391|P2|NOT COMPLETED|Titration Period (18 Weeks)||38
1524148|NCT01473420|3730392|P1|NOT COMPLETED|Titration Period (18 Weeks)||36
1524149|NCT01473420|3730391|P2|COMPLETED|Titration Period (18 Weeks)||122
1524150|NCT01473420|3730392|P1|COMPLETED|Titration Period (18 Weeks)||124
1524151|NCT01473420|3730391|P2|Treated|Titration Period (18 Weeks)||86
1524152|NCT01473420|3730392|P1|Treated|Titration Period (18 Weeks)||80
1524153|NCT01473420|3730391|P2|STARTED|Titration Period (18 Weeks)||160
1524154|NCT01473420|3730392|P1|STARTED|Titration Period (18 Weeks)||160
1524155|NCT01473407|3730476|P2|NOT COMPLETED|Overall Study||47
1524156|NCT01473407|3730477|P1|NOT COMPLETED|Overall Study||54
1524157|NCT01473407|3730476|P2|COMPLETED|Overall Study||259
1524158|NCT01473407|3730477|P1|COMPLETED|Overall Study||252
1524159|NCT01473407|3730476|P2|STARTED|Overall Study||306
1524160|NCT01473407|3730477|P1|STARTED|Overall Study||306
1524161|NCT01473394|3730531|P2|NOT COMPLETED|Overall Study||43
1524162|NCT01473394|3730532|P1|NOT COMPLETED|Overall Study||45
1524163|NCT01473394|3730531|P2|COMPLETED|Overall Study||212
1524164|NCT01473394|3730532|P1|COMPLETED|Overall Study||208
1524165|NCT01473394|3730531|P2|STARTED|Overall Study||255
1524166|NCT01473394|3730532|P1|STARTED|Overall Study||253
1524167|NCT01473381|3730546|P4|NOT COMPLETED|Overall Study||89
1524168|NCT01473381|3730547|P3|NOT COMPLETED|Overall Study||102
1524169|NCT01473381|3730548|P2|NOT COMPLETED|Overall Study||93
1524170|NCT01473381|3730549|P1|NOT COMPLETED|Overall Study||80
1524171|NCT01473381|3730546|P4|COMPLETED|Overall Study||200
1524172|NCT01473381|3730547|P3|COMPLETED|Overall Study||189
1524173|NCT01473381|3730548|P2|COMPLETED|Overall Study||199
1524174|NCT01473381|3730549|P1|COMPLETED|Overall Study||210
1524175|NCT01473381|3730546|P4|Safety Population|Overall Study||282
1524176|NCT01473381|3730547|P3|Safety Population|Overall Study||287
1524177|NCT01473381|3730548|P2|Safety Population|Overall Study||288
1524178|NCT01473381|3730549|P1|Safety Population|Overall Study||281
1524179|NCT01473381|3730546|P4|STARTED|Overall Study||289
1524180|NCT01473381|3730547|P3|STARTED|Overall Study||291
1524181|NCT01473381|3730548|P2|STARTED|Overall Study||292
1524182|NCT01473381|3730549|P1|STARTED|Overall Study||290
1524183|NCT01473368|3730571|P4|NOT COMPLETED|Overall Study||0
1524184|NCT01473368|3730572|P3|NOT COMPLETED|Overall Study||3
1524185|NCT01473368|3730573|P2|NOT COMPLETED|Overall Study||0
1524186|NCT01473368|3730574|P1|NOT COMPLETED|Overall Study||1
1524187|NCT01473368|3730571|P4|COMPLETED|Overall Study||12
1524188|NCT01473368|3730572|P3|COMPLETED|Overall Study||12
1524189|NCT01473368|3730573|P2|COMPLETED|Overall Study||12
1524190|NCT01473368|3730574|P1|COMPLETED|Overall Study||13
1524191|NCT01473368|3730571|P4|STARTED|Overall Study||12
1524192|NCT01473368|3730572|P3|STARTED|Overall Study||15
1524193|NCT01473368|3730573|P2|STARTED|Overall Study||12
1524194|NCT01473368|3730574|P1|STARTED|Overall Study||14
1524195|NCT01473160|3730611|P1|NOT COMPLETED|Overall Study||0
1524196|NCT01473160|3730611|P1|COMPLETED|Overall Study||9
1524197|NCT01473160|3730611|P1|STARTED|Overall Study||9
1524198|NCT01472965|3730631|P2|NOT COMPLETED|Overall Study||0
1524199|NCT01472965|3730632|P1|NOT COMPLETED|Overall Study||1
1524200|NCT01472965|3730631|P2|COMPLETED|Overall Study||46
1524201|NCT01472965|3730632|P1|COMPLETED|Overall Study||48
1524202|NCT01472965|3730631|P2|STARTED|Overall Study||46
1524203|NCT01472965|3730632|P1|STARTED|Overall Study||49
1524206|NCT01472939|3730654|P2|NOT COMPLETED|Overall Study||14
1524207|NCT01472939|3730655|P1|NOT COMPLETED|Overall Study||20
1524208|NCT01472939|3730652|P4|COMPLETED|Overall Study||99
1524209|NCT01472939|3730653|P3|COMPLETED|Overall Study||108
1524210|NCT01472939|3730654|P2|COMPLETED|Overall Study||105
1524211|NCT01472939|3730655|P1|COMPLETED|Overall Study||103
1524212|NCT01472939|3730652|P4|STARTED|Overall Study||119
1524213|NCT01472939|3730653|P3|STARTED|Overall Study||119
1524214|NCT01472939|3730654|P2|STARTED|Overall Study||119
1524215|NCT01472939|3730655|P1|STARTED|Overall Study||123
1524216|NCT01472874|3730682|P1|NOT COMPLETED|Overall Study||0
1524217|NCT01472874|3730682|P1|COMPLETED|Overall Study||8
1524218|NCT01472874|3730682|P1|STARTED|Overall Study||8
1524219|NCT01472835|3730699|P2|NOT COMPLETED|Overall Study||0
1524220|NCT01472835|3730700|P1|NOT COMPLETED|Overall Study||2
1524221|NCT01472835|3730699|P2|COMPLETED|Overall Study||36
1524222|NCT01472835|3730700|P1|COMPLETED|Overall Study||35
1524223|NCT01472835|3730699|P2|STARTED|Overall Study||36
1524224|NCT01472835|3730700|P1|STARTED|Overall Study||37
1524225|NCT01472822|3730716|P2|NOT COMPLETED|Overall Study||2
1524226|NCT01472822|3730717|P1|NOT COMPLETED|Overall Study||2
1524227|NCT01472822|3730716|P2|COMPLETED|Overall Study||28
1524228|NCT01472822|3730717|P1|COMPLETED|Overall Study||28
1524229|NCT01472822|3730716|P2|STARTED|Overall Study||30
1524230|NCT01472822|3730717|P1|STARTED|Overall Study||30
1524231|NCT01472562|3730731|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
1524232|NCT01472562|3730731|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
1524233|NCT01472562|3730731|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
1524234|NCT01472562|3730731|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
1524235|NCT01472562|3730731|P1|COMPLETED|Induction Phase (Week 1- 48)||27
1524236|NCT01472562|3730731|P1|STARTED|Induction Phase (Week 1- 48)||38
1524237|NCT01472549|3730738|P2|NOT COMPLETED|Overall Study||0
1524238|NCT01472549|3730739|P1|NOT COMPLETED|Overall Study||0
1524239|NCT01472549|3730738|P2|COMPLETED|Overall Study||575
1524240|NCT01472549|3730739|P1|COMPLETED|Overall Study||572
1524241|NCT01472549|3730738|P2|STARTED|Overall Study||575
1524242|NCT01472549|3730739|P1|STARTED|Overall Study||572
1524243|NCT01472432|3730761|P2|NOT COMPLETED|Overall Study||0
1524244|NCT01472432|3730762|P1|NOT COMPLETED|Overall Study||0
1524245|NCT01472432|3730761|P2|COMPLETED|Overall Study||53
1524246|NCT01472432|3730762|P1|COMPLETED|Overall Study||53
1524247|NCT01472432|3730761|P2|Ulcer Reduction|Overall Study||33
1524248|NCT01472432|3730762|P1|Ulcer Reduction|Overall Study||13
1524249|NCT01472432|3730761|P2|STARTED|Overall Study||53
1524250|NCT01472432|3730762|P1|STARTED|Overall Study||53
1524251|NCT01472380|3730778|P1|NOT COMPLETED|Efavirenz and FFA||0
1524252|NCT01472380|3730778|P1|COMPLETED|Efavirenz and FFA||28
1524253|NCT01472380|3730778|P1|STARTED|Efavirenz and FFA||28
1524254|NCT01472380|3730778|P1|NOT COMPLETED|1 Day Period Between Dosing||1
1524255|NCT01472380|3730778|P1|COMPLETED|1 Day Period Between Dosing||28
1524256|NCT01472380|3730778|P1|STARTED|1 Day Period Between Dosing||29
1524257|NCT01472380|3730778|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
1524258|NCT01472380|3730778|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
1524259|NCT01472380|3730778|P1|STARTED|Fenofibric Acid (FFA) Alone||29
1524260|NCT01472380|3730778|P1|NOT COMPLETED|Efavirenz Alone||1
1524261|NCT01472380|3730778|P1|COMPLETED|Efavirenz Alone||29
1524262|NCT01472380|3730778|P1|STARTED|Efavirenz Alone||30
1524263|NCT01472341|3730789|P1|NOT COMPLETED|Overall Study||272
1524264|NCT01472341|3730789|P1|COMPLETED|Overall Study||235
1524265|NCT01472341|3730789|P1|STARTED|Overall Study||507
1524266|NCT01472289|3730795|P1|NOT COMPLETED|Overall Study||2
1524267|NCT01472289|3730795|P1|COMPLETED|Overall Study||15
1524268|NCT01472289|3730795|P1|STARTED|Overall Study||17
1524269|NCT01472185|3730807|P2|NOT COMPLETED|Overall Study||34
1524270|NCT01472185|3730808|P1|NOT COMPLETED|Overall Study||34
1524271|NCT01472185|3730807|P2|COMPLETED|Overall Study||199
1524272|NCT01472185|3730808|P1|COMPLETED|Overall Study||198
1524273|NCT01472185|3730807|P2|STARTED|Overall Study||233
1524274|NCT01472185|3730808|P1|STARTED|Overall Study||232
1524275|NCT01471782|3730828|P6|NOT COMPLETED|Overall Study||41
1524276|NCT01471782|3730829|P5|NOT COMPLETED|Overall Study||26
1524277|NCT01471782|3730830|P4|NOT COMPLETED|Overall Study||5
1524278|NCT01471782|3730831|P3|NOT COMPLETED|Overall Study||5
1524279|NCT01471782|3730832|P2|NOT COMPLETED|Overall Study||6
1524280|NCT01471782|3730833|P1|NOT COMPLETED|Overall Study||5
1524281|NCT01471782|3730828|P6|COMPLETED|Overall Study|Completed 5 cycles|3
1524282|NCT01471782|3730829|P5|COMPLETED|Overall Study|Completed 5 cycles|0
1524283|NCT01471782|3730830|P4|COMPLETED|Overall Study|Completed 5 cycles|1
1524284|NCT01471782|3730831|P3|COMPLETED|Overall Study|Completed 5 cycles|0
1524285|NCT01471782|3730832|P2|COMPLETED|Overall Study|Completed 5 cycles|1
1524286|NCT01471782|3730833|P1|COMPLETED|Overall Study|Completed 5 cycles|0
1524287|NCT01471782|3730828|P6|STARTED|Overall Study||44
1524288|NCT01471782|3730829|P5|STARTED|Overall Study||26
1524289|NCT01471782|3730830|P4|STARTED|Overall Study||6
1524290|NCT01471782|3730831|P3|STARTED|Overall Study||5
1524291|NCT01471782|3730832|P2|STARTED|Overall Study||7
1524292|NCT01471782|3730833|P1|STARTED|Overall Study||5
1524293|NCT01471691|3730887|P2|NOT COMPLETED|Overall Study||1
1524294|NCT01471691|3730888|P1|NOT COMPLETED|Overall Study||0
1524295|NCT01471691|3730887|P2|COMPLETED|Overall Study||5
1524296|NCT01471691|3730888|P1|COMPLETED|Overall Study||8
1524297|NCT01471691|3730887|P2|STARTED|Overall Study||6
1524298|NCT01471691|3730888|P1|STARTED|Overall Study||8
1524299|NCT01471379|3730897|P3|NOT COMPLETED|Overall Study||0
1524300|NCT01471379|3730898|P2|NOT COMPLETED|Overall Study||1
1524301|NCT01471379|3730899|P1|NOT COMPLETED|Overall Study||1
1524302|NCT01471379|3730897|P3|COMPLETED|Overall Study||0
1524303|NCT01471379|3730898|P2|COMPLETED|Overall Study||0
1524304|NCT01471379|3730899|P1|COMPLETED|Overall Study||0
1524305|NCT01471379|3730897|P3|STARTED|Overall Study||0
1524306|NCT01471379|3730898|P2|STARTED|Overall Study||1
1524307|NCT01471379|3730899|P1|STARTED|Overall Study||1
1524308|NCT01471353|3730919|P1|NOT COMPLETED|Overall Study||3
1524309|NCT01471353|3730919|P1|COMPLETED|Overall Study||39
1524310|NCT01471353|3730919|P1|STARTED|Overall Study||42
1524311|NCT01471340|3730930|P2|NOT COMPLETED|Overall Study||6
1524312|NCT01471340|3730931|P1|NOT COMPLETED|Overall Study||6
1524313|NCT01471340|3730930|P2|COMPLETED|Overall Study||5855
1524314|NCT01471340|3730931|P1|COMPLETED|Overall Study||5862
1524315|NCT01471340|3730930|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
1524316|NCT01471340|3730931|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
1524317|NCT01471639|3730941|P1|NOT COMPLETED|Overall Study||0
1524318|NCT01471639|3730941|P1|COMPLETED|Overall Study||37
1524319|NCT01471639|3730941|P1|STARTED|Overall Study||37
1524320|NCT01471626|3730946|P1|NOT COMPLETED|Overall Study||0
1524321|NCT01471626|3730946|P1|COMPLETED|Overall Study||21
1524322|NCT01471626|3730946|P1|STARTED|Overall Study||21
1524323|NCT01471574|3730954|P4|NOT COMPLETED|Follow-up Period||3
1524324|NCT01471574|3730955|P3|NOT COMPLETED|Follow-up Period||7
1524325|NCT01471574|3730956|P2|NOT COMPLETED|Follow-up Period||2
1524326|NCT01471574|3730957|P1|NOT COMPLETED|Follow-up Period||7
1524327|NCT01471574|3730954|P4|COMPLETED|Follow-up Period||21
1524328|NCT01471574|3730955|P3|COMPLETED|Follow-up Period||95
1524329|NCT01471574|3730956|P2|COMPLETED|Follow-up Period||32
1524330|NCT01471574|3730957|P1|COMPLETED|Follow-up Period||114
1524331|NCT01471574|3730954|P4|STARTED|Follow-up Period||24
1524332|NCT01471574|3730955|P3|STARTED|Follow-up Period||102
1524333|NCT01471574|3730956|P2|STARTED|Follow-up Period||34
1524334|NCT01471574|3730957|P1|STARTED|Follow-up Period||121
1524335|NCT01471574|3730954|P4|NOT COMPLETED|Treatment Period||3
1524336|NCT01471574|3730955|P3|NOT COMPLETED|Treatment Period||24
1524337|NCT01471574|3730956|P2|NOT COMPLETED|Treatment Period||10
1524338|NCT01471574|3730957|P1|NOT COMPLETED|Treatment Period||31
1524339|NCT01471574|3730954|P4|COMPLETED|Treatment Period||21
1524340|NCT01471574|3730955|P3|COMPLETED|Treatment Period||82
1524341|NCT01471574|3730956|P2|COMPLETED|Treatment Period||29
1524342|NCT01471574|3730957|P1|COMPLETED|Treatment Period||101
1524343|NCT01471574|3730954|P4|STARTED|Treatment Period||24
1524344|NCT01471574|3730955|P3|STARTED|Treatment Period||106
1524345|NCT01471574|3730956|P2|STARTED|Treatment Period||39
1524346|NCT01471574|3730957|P1|STARTED|Treatment Period||132
1524347|NCT01471197|3730988|P2|NOT COMPLETED|Overall Study||2
1524348|NCT01471197|3730989|P1|NOT COMPLETED|Overall Study||6
1524349|NCT01471197|3730988|P2|COMPLETED|Overall Study||0
1524350|NCT01471197|3730989|P1|COMPLETED|Overall Study||0
1524351|NCT01471197|3730988|P2|STARTED|Overall Study||2
1524352|NCT01471197|3730989|P1|STARTED|Overall Study||6
1524353|NCT01471171|3730999|P2|NOT COMPLETED|Treatment Period 2||0
1524354|NCT01471171|3731000|P1|NOT COMPLETED|Treatment Period 2||1
1524355|NCT01471171|3730999|P2|COMPLETED|Treatment Period 2||54
1524356|NCT01471171|3731000|P1|COMPLETED|Treatment Period 2||52
1524357|NCT01471171|3730999|P2|STARTED|Treatment Period 2||54
1524358|NCT01471171|3731000|P1|STARTED|Treatment Period 2||53
1524359|NCT01471171|3730999|P2|NOT COMPLETED|Treatment Period 1||1
1524360|NCT01471171|3731000|P1|NOT COMPLETED|Treatment Period 1||4
1524361|NCT01471171|3730999|P2|COMPLETED|Treatment Period 1||54
1524362|NCT01471171|3731000|P1|COMPLETED|Treatment Period 1||53
1524363|NCT01471171|3730999|P2|STARTED|Treatment Period 1||55
1524364|NCT01471171|3731000|P1|STARTED|Treatment Period 1||57
1524365|NCT01471041|3731010|P1|NOT COMPLETED|Overall Study||7
1524366|NCT01471041|3731010|P1|COMPLETED|Overall Study||47
1524367|NCT01471041|3731010|P1|STARTED|Overall Study||54
1524368|NCT01471015|3731018|P3|NOT COMPLETED|Overall Study||1
1524369|NCT01471015|3731019|P2|NOT COMPLETED|Overall Study||1
1524370|NCT01471015|3731020|P1|NOT COMPLETED|Overall Study||0
1524371|NCT01471015|3731018|P3|COMPLETED|Overall Study||9
1524372|NCT01471015|3731019|P2|COMPLETED|Overall Study||9
1524373|NCT01471015|3731020|P1|COMPLETED|Overall Study||10
1524374|NCT01471015|3731018|P3|STARTED|Overall Study||10
1524375|NCT01471015|3731019|P2|STARTED|Overall Study||10
1524376|NCT01471015|3731020|P1|STARTED|Overall Study||10
1524377|NCT01470859|3731034|P2|NOT COMPLETED|Overall Study||0
1524378|NCT01470859|3731035|P1|NOT COMPLETED|Overall Study||1
1524379|NCT01470859|3731034|P2|COMPLETED|Overall Study||15
1524380|NCT01470859|3731035|P1|COMPLETED|Overall Study||14
1524381|NCT01470859|3731034|P2|STARTED|Overall Study||15
1524382|NCT01470859|3731035|P1|STARTED|Overall Study||15
1524383|NCT01470651|3731051|P2|NOT COMPLETED|Overall Study||3
1524384|NCT01470651|3731052|P1|NOT COMPLETED|Overall Study||7
1524385|NCT01470651|3731051|P2|COMPLETED|Overall Study||10
1524386|NCT01470651|3731052|P1|COMPLETED|Overall Study||6
1524387|NCT01470651|3731051|P2|STARTED|Overall Study||13
1524388|NCT01470651|3731052|P1|STARTED|Overall Study||13
1524389|NCT01470599|3731062|P2|NOT COMPLETED|Overall Study||43
1524390|NCT01470599|3731063|P1|NOT COMPLETED|Overall Study||19
1524391|NCT01470599|3731062|P2|COMPLETED|Overall Study||45
1524392|NCT01470599|3731063|P1|COMPLETED|Overall Study||43
1524393|NCT01470599|3731062|P2|STARTED|Overall Study||88
1524394|NCT01470599|3731063|P1|STARTED|Overall Study||62
1524395|NCT01470469|3731127|P2|NOT COMPLETED|Overall Study||24
1524396|NCT01470469|3731128|P1|NOT COMPLETED|Overall Study||10
1524397|NCT01470469|3731127|P2|COMPLETED|Overall Study||38
1524398|NCT01470469|3731128|P1|COMPLETED|Overall Study||11
1524399|NCT01470469|3731127|P2|STARTED|Overall Study||62
1524400|NCT01470469|3731128|P1|STARTED|Overall Study||21
1524401|NCT01470417|3731148|P2|NOT COMPLETED|Overall Study||2
1524402|NCT01470417|3731149|P1|NOT COMPLETED|Overall Study||0
1524403|NCT01470417|3731148|P2|COMPLETED|Overall Study||5
1524404|NCT01470417|3731149|P1|COMPLETED|Overall Study||3
1524405|NCT01470417|3731148|P2|STARTED|Overall Study||7
1524406|NCT01470417|3731149|P1|STARTED|Overall Study||3
1524407|NCT01470326|3731161|P1|NOT COMPLETED|Overall Study||153
1524408|NCT01470326|3731161|P1|COMPLETED|Overall Study||3034
1524409|NCT01470326|3731161|P1|STARTED|Overall Study||3187
1524410|NCT01470248|3731172|P1|NOT COMPLETED|Overall Study||1
1524411|NCT01470248|3731172|P1|COMPLETED|Overall Study||19
1524412|NCT01470248|3731172|P1|STARTED|Overall Study||20
1524413|NCT01470196|3731179|P1|NOT COMPLETED|Overall Study||0
1524414|NCT01470196|3731179|P1|COMPLETED|Overall Study||31
1524415|NCT01470196|3731179|P1|STARTED|Overall Study||31
1524416|NCT01470170|3731192|P5|NOT COMPLETED|Overall Study||0
1524417|NCT01470170|3731193|P4|NOT COMPLETED|Overall Study||0
1524418|NCT01470170|3731194|P3|NOT COMPLETED|Overall Study||0
1524419|NCT01470170|3731195|P2|NOT COMPLETED|Overall Study||0
1524420|NCT01470170|3731196|P1|NOT COMPLETED|Overall Study||0
1524421|NCT01470170|3731192|P5|COMPLETED|Overall Study||34
1524422|NCT01470170|3731193|P4|COMPLETED|Overall Study||36
1524423|NCT01470170|3731194|P3|COMPLETED|Overall Study||34
1524424|NCT01470170|3731195|P2|COMPLETED|Overall Study||35
1524425|NCT01470170|3731196|P1|COMPLETED|Overall Study||34
1524426|NCT01470170|3731192|P5|STARTED|Overall Study||34
1524427|NCT01470170|3731193|P4|STARTED|Overall Study||36
1524428|NCT01470170|3731194|P3|STARTED|Overall Study||34
1524429|NCT01470170|3731195|P2|STARTED|Overall Study||35
1524430|NCT01470170|3731196|P1|STARTED|Overall Study||34
1524431|NCT01470144|3731228|P1|NOT COMPLETED|Overall Study||10
1524432|NCT01470144|3731228|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
1524433|NCT01470144|3731228|P1|STARTED|Overall Study||41
1524434|NCT01470118|3731236|P3|NOT COMPLETED|Overall Study||2
1524435|NCT01470118|3731237|P2|NOT COMPLETED|Overall Study||5
1524436|NCT01470118|3731238|P1|NOT COMPLETED|Overall Study||5
1524437|NCT01470118|3731236|P3|COMPLETED|Overall Study||39
1524438|NCT01470118|3731237|P2|COMPLETED|Overall Study||38
1524439|NCT01470118|3731238|P1|COMPLETED|Overall Study||38
1524440|NCT01470118|3731236|P3|STARTED|Overall Study||41
1524441|NCT01470118|3731237|P2|STARTED|Overall Study||43
1524442|NCT01470118|3731238|P1|STARTED|Overall Study||43
1524443|NCT01470027|3731273|P3|NOT COMPLETED|Overall Study||1
1524444|NCT01470027|3731274|P2|NOT COMPLETED|Overall Study||1
1524445|NCT01470027|3731275|P1|NOT COMPLETED|Overall Study||1
1524446|NCT01470027|3731273|P3|COMPLETED|Overall Study||15
1524447|NCT01470027|3731274|P2|COMPLETED|Overall Study||14
1524448|NCT01470027|3731275|P1|COMPLETED|Overall Study||15
1524449|NCT01470027|3731273|P3|STARTED|Overall Study||16
1524450|NCT01470027|3731274|P2|STARTED|Overall Study||15
1524451|NCT01470027|3731275|P1|STARTED|Overall Study||16
1524452|NCT01470001|3731333|P2|NOT COMPLETED|Overall Study||2
1524453|NCT01470001|3731334|P1|NOT COMPLETED|Overall Study||5
1524454|NCT01470001|3731333|P2|COMPLETED|Overall Study||58
1524455|NCT01470001|3731334|P1|COMPLETED|Overall Study||53
1524456|NCT01470001|3731333|P2|STARTED|Overall Study||60
1524457|NCT01470001|3731334|P1|STARTED|Overall Study||58
1524458|NCT01469819|3731344|P1|NOT COMPLETED|Overall Study||8
1524459|NCT01469819|3731344|P1|COMPLETED|Overall Study||29
1524460|NCT01469819|3731344|P1|STARTED|Overall Study||37
1524461|NCT01469767|3731354|P1|NOT COMPLETED|Overall Study||0
1524462|NCT01469767|3731354|P1|COMPLETED|Overall Study||10
1524463|NCT01469767|3731354|P1|STARTED|Overall Study||10
1524464|NCT01469715|3731362|P1|NOT COMPLETED|Overall Study||0
1524465|NCT01469715|3731362|P1|COMPLETED|Overall Study||16
1524466|NCT01469715|3731362|P1|STARTED|Overall Study||16
1524467|NCT01469637|3731368|P2|NOT COMPLETED|Second Intervention||0
1524468|NCT01469637|3731369|P1|NOT COMPLETED|Second Intervention||1
1524469|NCT01469637|3731368|P2|COMPLETED|Second Intervention||21
1524470|NCT01469637|3731369|P1|COMPLETED|Second Intervention||21
1524471|NCT01469637|3731368|P2|STARTED|Second Intervention||21
1524472|NCT01469637|3731369|P1|STARTED|Second Intervention||22
1524473|NCT01469637|3731368|P2|NOT COMPLETED|First Intervention||1
1524474|NCT01469637|3731369|P1|NOT COMPLETED|First Intervention||0
1524475|NCT01469637|3731368|P2|COMPLETED|First Intervention||21
1524476|NCT01469637|3731369|P1|COMPLETED|First Intervention||22
1524477|NCT01469637|3731368|P2|STARTED|First Intervention||22
1524478|NCT01469637|3731369|P1|STARTED|First Intervention||22
1524479|NCT01469546|3731377|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
1524480|NCT01469546|3731377|P1|COMPLETED|Dose Escalation to 10 mg||19
1524481|NCT01469546|3731377|P1|STARTED|Dose Escalation to 10 mg||19
1524482|NCT01469546|3731377|P1|NOT COMPLETED|Received 5 mg Dose||23
1524483|NCT01469546|3731377|P1|COMPLETED|Received 5 mg Dose||19
1524484|NCT01469546|3731377|P1|Completed First Cycle|Received 5 mg Dose||30
1524485|NCT01469546|3731377|P1|STARTED|Received 5 mg Dose||42
1524486|NCT01469377|3731387|P3|NOT COMPLETED|Overall Study||66
1524487|NCT01469377|3731388|P2|NOT COMPLETED|Overall Study||48
1524488|NCT01469377|3731389|P1|NOT COMPLETED|Overall Study||35
1524489|NCT01469377|3731387|P3|COMPLETED|Overall Study||210
1524490|NCT01469377|3731388|P2|COMPLETED|Overall Study||226
1524491|NCT01469377|3731389|P1|COMPLETED|Overall Study||234
1524492|NCT01469377|3731387|P3|STARTED|Overall Study||276
1524493|NCT01469377|3731388|P2|STARTED|Overall Study||274
1524494|NCT01469377|3731389|P1|STARTED|Overall Study||269
1524495|NCT01469364|3731400|P1|NOT COMPLETED|Overall Study||2
1524496|NCT01469364|3731400|P1|COMPLETED|Overall Study||28
1524497|NCT01469364|3731400|P1|STARTED|Overall Study||30
1524498|NCT01469234|3731418|P3|NOT COMPLETED|Overall Study||0
1524499|NCT01469234|3731419|P2|NOT COMPLETED|Overall Study||0
1524500|NCT01469234|3731420|P1|NOT COMPLETED|Overall Study||0
1524501|NCT01469234|3731418|P3|COMPLETED|Overall Study||85
1524502|NCT01469234|3731419|P2|COMPLETED|Overall Study||85
1524503|NCT01469234|3731420|P1|COMPLETED|Overall Study||85
1524504|NCT01469234|3731418|P3|STARTED|Overall Study||85
1524505|NCT01469234|3731419|P2|STARTED|Overall Study||85
1524506|NCT01469234|3731420|P1|STARTED|Overall Study||85
1524507|NCT01469221|3731451|P3|NOT COMPLETED|Double Blind Phase||0
1524508|NCT01469221|3731452|P2|NOT COMPLETED|Double Blind Phase||17
1524509|NCT01469221|3731453|P1|NOT COMPLETED|Double Blind Phase||14
1524510|NCT01469221|3731451|P3|COMPLETED|Double Blind Phase||0
1524511|NCT01469221|3731452|P2|COMPLETED|Double Blind Phase||0
1524512|NCT01469221|3731453|P1|COMPLETED|Double Blind Phase||0
1524513|NCT01469221|3731451|P3|STARTED|Double Blind Phase||0
1524514|NCT01469221|3731452|P2|STARTED|Double Blind Phase||17
1524515|NCT01469221|3731453|P1|STARTED|Double Blind Phase||14
1524516|NCT01469221|3731451|P3|NOT COMPLETED|Open Label Phase||3
1524517|NCT01469221|3731452|P2|NOT COMPLETED|Open Label Phase||0
1524518|NCT01469221|3731453|P1|NOT COMPLETED|Open Label Phase||0
1524519|NCT01469221|3731451|P3|COMPLETED|Open Label Phase||44
1524520|NCT01469221|3731452|P2|COMPLETED|Open Label Phase||0
1524521|NCT01469221|3731453|P1|COMPLETED|Open Label Phase||0
1524522|NCT01469221|3731451|P3|STARTED|Open Label Phase||47
1524523|NCT01469221|3731452|P2|STARTED|Open Label Phase||0
1524524|NCT01469221|3731453|P1|STARTED|Open Label Phase||0
1524525|NCT01469182|3731464|P2|NOT COMPLETED|Overall Study||6
1524526|NCT01469182|3731465|P1|NOT COMPLETED|Overall Study||35
1524527|NCT01469182|3731464|P2|COMPLETED|Overall Study||298
1524528|NCT01469182|3731465|P1|COMPLETED|Overall Study||575
1524529|NCT01469182|3731464|P2|Treated|Overall Study||304
1524530|NCT01469182|3731465|P1|Treated|Overall Study||609
1524531|NCT01469182|3731464|P2|STARTED|Overall Study||304
1524532|NCT01469182|3731465|P1|STARTED|Overall Study||610
1524533|NCT01469065|3731492|P5|NOT COMPLETED|Overall Study||1
1524534|NCT01469065|3731493|P4|NOT COMPLETED|Overall Study||0
1524535|NCT01469065|3731494|P3|NOT COMPLETED|Overall Study||0
1524536|NCT01469065|3731495|P2|NOT COMPLETED|Overall Study||1
1524537|NCT01469065|3731496|P1|NOT COMPLETED|Overall Study||0
1524538|NCT01469065|3731492|P5|COMPLETED|Overall Study||16
1524539|NCT01469065|3731493|P4|COMPLETED|Overall Study||16
1524540|NCT01469065|3731494|P3|COMPLETED|Overall Study||16
1524541|NCT01469065|3731495|P2|COMPLETED|Overall Study||16
1524542|NCT01469065|3731496|P1|COMPLETED|Overall Study||16
1524543|NCT01469065|3731492|P5|STARTED|Overall Study||17
1524544|NCT01469065|3731493|P4|STARTED|Overall Study||16
1524545|NCT01469065|3731494|P3|STARTED|Overall Study||16
1524546|NCT01469065|3731495|P2|STARTED|Overall Study||17
1524547|NCT01469065|3731496|P1|STARTED|Overall Study||16
1524548|NCT01469052|3731592|P6|NOT COMPLETED|Overall Study||6
1524549|NCT01469052|3731593|P5|NOT COMPLETED|Overall Study||8
1524550|NCT01469052|3731594|P4|NOT COMPLETED|Overall Study||5
1524551|NCT01469052|3731595|P3|NOT COMPLETED|Overall Study||6
1524552|NCT01469052|3731596|P2|NOT COMPLETED|Overall Study||4
1524553|NCT01469052|3731597|P1|NOT COMPLETED|Overall Study||6
1524554|NCT01469052|3731592|P6|COMPLETED|Overall Study||0
1524555|NCT01469052|3731593|P5|COMPLETED|Overall Study||0
1524556|NCT01469052|3731594|P4|COMPLETED|Overall Study||1
1524557|NCT01469052|3731595|P3|COMPLETED|Overall Study||0
1524558|NCT01469052|3731596|P2|COMPLETED|Overall Study||0
1524559|NCT01469052|3731597|P1|COMPLETED|Overall Study||0
1524560|NCT01469052|3731592|P6|STARTED|Overall Study||6
1524561|NCT01469052|3731593|P5|STARTED|Overall Study||8
1524562|NCT01469052|3731594|P4|STARTED|Overall Study||6
1524563|NCT01469052|3731595|P3|STARTED|Overall Study||6
1524564|NCT01469052|3731596|P2|STARTED|Overall Study||4
1524565|NCT01469052|3731597|P1|STARTED|Overall Study||6
1524566|NCT01469039|3731644|P3|NOT COMPLETED|Overall Study||113
1524567|NCT01469039|3731645|P2|NOT COMPLETED|Overall Study||73
1524568|NCT01469039|3731646|P1|NOT COMPLETED|Overall Study||77
1524569|NCT01469039|3731644|P3|COMPLETED|Overall Study||95
1524570|NCT01469039|3731645|P2|COMPLETED|Overall Study||135
1524571|NCT01469039|3731646|P1|COMPLETED|Overall Study||130
1524572|NCT01469039|3731644|P3|STARTED|Overall Study||208
1524573|NCT01469039|3731645|P2|STARTED|Overall Study||208
1524574|NCT01469039|3731646|P1|STARTED|Overall Study||207
1524575|NCT01469013|3731662|P13|NOT COMPLETED|Part B (Extension Period)||6
1524576|NCT01469013|3731663|P12|NOT COMPLETED|Part B (Extension Period)||6
1524577|NCT01469013|3731664|P11|NOT COMPLETED|Part B (Extension Period)||2
1524578|NCT01469013|3731665|P10|NOT COMPLETED|Part B (Extension Period)||3
1524579|NCT01469013|3731666|P9|NOT COMPLETED|Part B (Extension Period)||4
1524580|NCT01469013|3731667|P8|NOT COMPLETED|Part B (Extension Period)||5
1524581|NCT01469013|3731668|P7|NOT COMPLETED|Part B (Extension Period)||5
1524582|NCT01469013|3731669|P6|NOT COMPLETED|Part B (Extension Period)||2
1524583|NCT01469013|3731670|P5|NOT COMPLETED|Part B (Extension Period)||0
1524584|NCT01469013|3731671|P4|NOT COMPLETED|Part B (Extension Period)||0
1524585|NCT01469013|3731672|P3|NOT COMPLETED|Part B (Extension Period)||0
1524586|NCT01469013|3731673|P2|NOT COMPLETED|Part B (Extension Period)||0
1524587|NCT01469013|3731674|P1|NOT COMPLETED|Part B (Extension Period)||0
1524588|NCT01469013|3731662|P13|COMPLETED|Part B (Extension Period)||18
1524589|NCT01469013|3731663|P12|COMPLETED|Part B (Extension Period)||18
1524590|NCT01469013|3731664|P11|COMPLETED|Part B (Extension Period)||10
1524591|NCT01469013|3731665|P10|COMPLETED|Part B (Extension Period)||8
1524592|NCT01469013|3731666|P9|COMPLETED|Part B (Extension Period)||20
1524593|NCT01469013|3731667|P8|COMPLETED|Part B (Extension Period)||18
1524594|NCT01469013|3731668|P7|COMPLETED|Part B (Extension Period)||7
1524595|NCT01469013|3731669|P6|COMPLETED|Part B (Extension Period)||10
1524596|NCT01469013|3731670|P5|COMPLETED|Part B (Extension Period)||0
1524597|NCT01469013|3731671|P4|COMPLETED|Part B (Extension Period)||0
1524598|NCT01469013|3731672|P3|COMPLETED|Part B (Extension Period)||0
1524599|NCT01469013|3731673|P2|COMPLETED|Part B (Extension Period)||0
1524600|NCT01469013|3731674|P1|COMPLETED|Part B (Extension Period)||0
1524601|NCT01469013|3731662|P13|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
1524602|NCT01469013|3731663|P12|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
1524603|NCT01469013|3731664|P11|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
1524604|NCT01469013|3731665|P10|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
1524605|NCT01469013|3731666|P9|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
1524606|NCT01469013|3731667|P8|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
1524607|NCT01469013|3731668|P7|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
1524608|NCT01469013|3731669|P6|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
1524609|NCT01469013|3731670|P5|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1524610|NCT01469013|3731671|P4|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1524611|NCT01469013|3731672|P3|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1524612|NCT01469013|3731673|P2|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1524613|NCT01469013|3731674|P1|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
1524614|NCT01469013|3731662|P13|STARTED|Part B (Extension Period)||24
1524615|NCT01469013|3731663|P12|STARTED|Part B (Extension Period)||24
1524616|NCT01469013|3731664|P11|STARTED|Part B (Extension Period)||12
1524617|NCT01469013|3731665|P10|STARTED|Part B (Extension Period)||11
1524618|NCT01469013|3731666|P9|STARTED|Part B (Extension Period)||24
1524619|NCT01469013|3731667|P8|STARTED|Part B (Extension Period)||23
1524620|NCT01469013|3731668|P7|STARTED|Part B (Extension Period)||12
1524621|NCT01469013|3731669|P6|STARTED|Part B (Extension Period)||12
1524622|NCT01469013|3731670|P5|STARTED|Part B (Extension Period)||0
1524623|NCT01469013|3731671|P4|STARTED|Part B (Extension Period)||0
1524624|NCT01469013|3731672|P3|STARTED|Part B (Extension Period)||0
1524625|NCT01469013|3731673|P2|STARTED|Part B (Extension Period)||0
1524626|NCT01469013|3731674|P1|STARTED|Part B (Extension Period)||0
1524627|NCT01469013|3731662|P13|NOT COMPLETED|Part A (Treatment Period)||0
1524628|NCT01469013|3731663|P12|NOT COMPLETED|Part A (Treatment Period)||0
1524629|NCT01469013|3731664|P11|NOT COMPLETED|Part A (Treatment Period)||0
1524630|NCT01469013|3731665|P10|NOT COMPLETED|Part A (Treatment Period)||0
1524631|NCT01469013|3731666|P9|NOT COMPLETED|Part A (Treatment Period)||0
1524632|NCT01469013|3731667|P8|NOT COMPLETED|Part A (Treatment Period)||0
1524633|NCT01469013|3731668|P7|NOT COMPLETED|Part A (Treatment Period)||0
1524634|NCT01469013|3731669|P6|NOT COMPLETED|Part A (Treatment Period)||0
1524635|NCT01469013|3731670|P5|NOT COMPLETED|Part A (Treatment Period)||1
1524636|NCT01469013|3731671|P4|NOT COMPLETED|Part A (Treatment Period)||0
1524637|NCT01469013|3731672|P3|NOT COMPLETED|Part A (Treatment Period)||1
1524638|NCT01469013|3731673|P2|NOT COMPLETED|Part A (Treatment Period)||0
1524639|NCT01469013|3731674|P1|NOT COMPLETED|Part A (Treatment Period)||1
1524640|NCT01469013|3731662|P13|COMPLETED|Part A (Treatment Period)||0
1524641|NCT01469013|3731663|P12|COMPLETED|Part A (Treatment Period)||0
1524642|NCT01469013|3731664|P11|COMPLETED|Part A (Treatment Period)||0
1524643|NCT01469013|3731665|P10|COMPLETED|Part A (Treatment Period)||0
1524644|NCT01469013|3731666|P9|COMPLETED|Part A (Treatment Period)||0
1524645|NCT01469013|3731667|P8|COMPLETED|Part A (Treatment Period)||0
1524646|NCT01469013|3731668|P7|COMPLETED|Part A (Treatment Period)||0
1524647|NCT01469013|3731669|P6|COMPLETED|Part A (Treatment Period)||0
1524648|NCT01469013|3731670|P5|COMPLETED|Part A (Treatment Period)||48
1524649|NCT01469013|3731671|P4|COMPLETED|Part A (Treatment Period)||24
1524650|NCT01469013|3731672|P3|COMPLETED|Part A (Treatment Period)||23
1524651|NCT01469013|3731673|P2|COMPLETED|Part A (Treatment Period)||24
1524652|NCT01469013|3731674|P1|COMPLETED|Part A (Treatment Period)||23
1524653|NCT01469013|3731662|P13|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1524654|NCT01469013|3731663|P12|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1524655|NCT01469013|3731664|P11|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1524656|NCT01469013|3731665|P10|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1524657|NCT01469013|3731666|P9|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1524658|NCT01469013|3731667|P8|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1524834|NCT01468181|3731968|P4|COMPLETED|Overall Study||63
1524659|NCT01469013|3731668|P7|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1524660|NCT01469013|3731669|P6|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
1524661|NCT01469013|3731670|P5|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
1524662|NCT01469013|3731671|P4|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
1524663|NCT01469013|3731672|P3|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
1524664|NCT01469013|3731673|P2|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
1524665|NCT01469013|3731674|P1|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
1524666|NCT01469013|3731662|P13|STARTED|Part A (Treatment Period)||0
1524667|NCT01469013|3731663|P12|STARTED|Part A (Treatment Period)||0
1524668|NCT01469013|3731664|P11|STARTED|Part A (Treatment Period)||0
1524669|NCT01469013|3731665|P10|STARTED|Part A (Treatment Period)||0
1524670|NCT01469013|3731666|P9|STARTED|Part A (Treatment Period)||0
1524671|NCT01469013|3731667|P8|STARTED|Part A (Treatment Period)||0
1524672|NCT01469013|3731668|P7|STARTED|Part A (Treatment Period)||0
1524673|NCT01469013|3731669|P6|STARTED|Part A (Treatment Period)||0
1524674|NCT01469013|3731670|P5|STARTED|Part A (Treatment Period)||49
1524675|NCT01469013|3731671|P4|STARTED|Part A (Treatment Period)||24
1524676|NCT01469013|3731672|P3|STARTED|Part A (Treatment Period)||24
1524677|NCT01469013|3731673|P2|STARTED|Part A (Treatment Period)||24
1524678|NCT01469013|3731674|P1|STARTED|Part A (Treatment Period)||24
1524679|NCT01469000|3731759|P2|NOT COMPLETED|Overall Study||9
1524680|NCT01469000|3731760|P1|NOT COMPLETED|Overall Study||33
1524681|NCT01469000|3731759|P2|COMPLETED|Overall Study||57
1524682|NCT01469000|3731760|P1|COMPLETED|Overall Study||96
1524683|NCT01469000|3731759|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
1524684|NCT01469000|3731760|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
1524685|NCT01469000|3731759|P2|STARTED|Overall Study||66
1524686|NCT01469000|3731760|P1|STARTED|Overall Study||129
1524687|NCT01468987|3731776|P2|NOT COMPLETED|Overall Study||60
1524688|NCT01468987|3731777|P1|NOT COMPLETED|Overall Study||71
1524689|NCT01468987|3731776|P2|COMPLETED|Overall Study||618
1524690|NCT01468987|3731777|P1|COMPLETED|Overall Study||620
1524691|NCT01468987|3731776|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
1524692|NCT01468987|3731777|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
1524693|NCT01468987|3731776|P2|STARTED|Overall Study||678
1524694|NCT01468987|3731777|P1|STARTED|Overall Study||691
1524695|NCT01468896|3731823|P2|NOT COMPLETED|Overall Study||0
1524696|NCT01468896|3731824|P1|NOT COMPLETED|Overall Study||0
1524697|NCT01468896|3731823|P2|COMPLETED|Overall Study||17
1524698|NCT01468896|3731824|P1|COMPLETED|Overall Study||6
1524699|NCT01468896|3731823|P2|STARTED|Overall Study||17
1524700|NCT01468896|3731824|P1|STARTED|Overall Study||6
1524701|NCT01468818|3731840|P1|NOT COMPLETED|Overall Study||2
1524702|NCT01468818|3731840|P1|COMPLETED|Overall Study||16
1524703|NCT01468818|3731840|P1|STARTED|Overall Study||18
1524704|NCT01468675|3731847|P2|NOT COMPLETED|Overall Study||1372
1524705|NCT01468675|3731848|P1|NOT COMPLETED|Overall Study||1000
1524706|NCT01468675|3731847|P2|COMPLETED|Overall Study||2004
1524707|NCT01468675|3731848|P1|COMPLETED|Overall Study||1699
1524708|NCT01468675|3731847|P2|STARTED|Overall Study||3376
1524709|NCT01468675|3731848|P1|STARTED|Overall Study||2699
1524710|NCT01468584|3731854|P1|NOT COMPLETED|Overall Study||0
1524711|NCT01468584|3731854|P1|COMPLETED|Overall Study||10
1524712|NCT01468584|3731854|P1|STARTED|Overall Study||10
1524713|NCT01468558|3731858|P1|NOT COMPLETED|Overall Study||2
1524714|NCT01468558|3731858|P1|COMPLETED|Overall Study||22
1524715|NCT01468558|3731858|P1|STARTED|Overall Study||24
1524716|NCT01468350|3731873|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
1524717|NCT01468350|3731874|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
1524718|NCT01468350|3731875|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
1524719|NCT01468350|3731876|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
1524720|NCT01468350|3731873|P4|COMPLETED|(PART B) Day 1, Day 15||12
1524721|NCT01468350|3731874|P3|COMPLETED|(PART B) Day 1, Day 15||12
1524722|NCT01468350|3731875|P2|COMPLETED|(PART B) Day 1, Day 15||0
1524723|NCT01468350|3731876|P1|COMPLETED|(PART B) Day 1, Day 15||0
1524724|NCT01468350|3731873|P4|STARTED|(PART B) Day 1, Day 15||12
1524725|NCT01468350|3731874|P3|STARTED|(PART B) Day 1, Day 15||12
1524726|NCT01468350|3731875|P2|STARTED|(PART B) Day 1, Day 15||0
1524727|NCT01468350|3731876|P1|STARTED|(PART B) Day 1, Day 15||0
1524728|NCT01468350|3731873|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
1524729|NCT01468350|3731874|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
1524730|NCT01468350|3731875|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
1524731|NCT01468350|3731876|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
1524732|NCT01468350|3731873|P4|COMPLETED|(PART A) Day 1, Day 3||0
1524733|NCT01468350|3731874|P3|COMPLETED|(PART A) Day 1, Day 3||0
1524734|NCT01468350|3731875|P2|COMPLETED|(PART A) Day 1, Day 3||5
1524735|NCT01468350|3731876|P1|COMPLETED|(PART A) Day 1, Day 3||6
1524736|NCT01468350|3731873|P4|STARTED|(PART A) Day 1, Day 3||0
1524737|NCT01468350|3731874|P3|STARTED|(PART A) Day 1, Day 3||0
1524738|NCT01468350|3731875|P2|STARTED|(PART A) Day 1, Day 3||5
1524739|NCT01468350|3731876|P1|STARTED|(PART A) Day 1, Day 3||6
1524740|NCT01468337|3731886|P1|NOT COMPLETED|Overall Study||0
1524741|NCT01468337|3731886|P1|COMPLETED|Overall Study||5
1524742|NCT01468337|3731886|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
1524743|NCT01468337|3731886|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
1524835|NCT01468181|3731969|P3|COMPLETED|Overall Study||57
1524744|NCT01468337|3731886|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
1524745|NCT01468337|3731886|P1|Week 2|Overall Study||5
1524746|NCT01468337|3731886|P1|STARTED|Overall Study||5
1524747|NCT01468311|3731898|P1|NOT COMPLETED|Overall Study||2
1524748|NCT01468311|3731898|P1|COMPLETED|Overall Study||4
1524749|NCT01468311|3731898|P1|STARTED|Overall Study||6
1524750|NCT01468233|3731910|P6|NOT COMPLETED|Treatment Period 2||23
1524751|NCT01468233|3731911|P5|NOT COMPLETED|Treatment Period 2||28
1524752|NCT01468233|3731912|P4|NOT COMPLETED|Treatment Period 2||28
1524753|NCT01468233|3731913|P3|NOT COMPLETED|Treatment Period 2||111
1524754|NCT01468233|3731914|P2|NOT COMPLETED|Treatment Period 2||0
1524755|NCT01468233|3731915|P1|NOT COMPLETED|Treatment Period 2||0
1524756|NCT01468233|3731910|P6|COMPLETED|Treatment Period 2||28
1524757|NCT01468233|3731911|P5|COMPLETED|Treatment Period 2||25
1524758|NCT01468233|3731912|P4|COMPLETED|Treatment Period 2||23
1524759|NCT01468233|3731913|P3|COMPLETED|Treatment Period 2||40
1524760|NCT01468233|3731914|P2|COMPLETED|Treatment Period 2||0
1524761|NCT01468233|3731915|P1|COMPLETED|Treatment Period 2||0
1524762|NCT01468233|3731910|P6|STARTED|Treatment Period 2||51
1524763|NCT01468233|3731911|P5|STARTED|Treatment Period 2||53
1524764|NCT01468233|3731912|P4|STARTED|Treatment Period 2||51
1524765|NCT01468233|3731913|P3|STARTED|Treatment Period 2||151
1524766|NCT01468233|3731914|P2|STARTED|Treatment Period 2||0
1524767|NCT01468233|3731915|P1|STARTED|Treatment Period 2||0
1524768|NCT01468233|3731910|P6|NOT COMPLETED|Treatment Period 1||0
1524769|NCT01468233|3731911|P5|NOT COMPLETED|Treatment Period 1||0
1524770|NCT01468233|3731912|P4|NOT COMPLETED|Treatment Period 1||0
1524771|NCT01468233|3731913|P3|NOT COMPLETED|Treatment Period 1||0
1524772|NCT01468233|3731914|P2|NOT COMPLETED|Treatment Period 1||8
1524773|NCT01468233|3731915|P1|NOT COMPLETED|Treatment Period 1||12
1524774|NCT01468233|3731910|P6|COMPLETED|Treatment Period 1||0
1524775|NCT01468233|3731911|P5|COMPLETED|Treatment Period 1||0
1524776|NCT01468233|3731912|P4|COMPLETED|Treatment Period 1||0
1524777|NCT01468233|3731913|P3|COMPLETED|Treatment Period 1||0
1524778|NCT01468233|3731914|P2|COMPLETED|Treatment Period 1||155
1524779|NCT01468233|3731915|P1|COMPLETED|Treatment Period 1||151
1524780|NCT01468233|3731910|P6|STARTED|Treatment Period 1||0
1524781|NCT01468233|3731911|P5|STARTED|Treatment Period 1||0
1524782|NCT01468233|3731912|P4|STARTED|Treatment Period 1||0
1524783|NCT01468233|3731913|P3|STARTED|Treatment Period 1||0
1524784|NCT01468233|3731914|P2|STARTED|Treatment Period 1||163
1524785|NCT01468233|3731915|P1|STARTED|Treatment Period 1||163
1524786|NCT01468207|3731937|P6|NOT COMPLETED|Treatment Period 2||20
1524787|NCT01468207|3731938|P5|NOT COMPLETED|Treatment Period 2||21
1524788|NCT01468207|3731939|P4|NOT COMPLETED|Treatment Period 2||27
1524789|NCT01468207|3731940|P3|NOT COMPLETED|Treatment Period 2||52
1524790|NCT01468207|3731941|P2|NOT COMPLETED|Treatment Period 2||0
1524791|NCT01468207|3731942|P1|NOT COMPLETED|Treatment Period 2||0
1524792|NCT01468207|3731937|P6|COMPLETED|Treatment Period 2||28
1524793|NCT01468207|3731938|P5|COMPLETED|Treatment Period 2||27
1524794|NCT01468207|3731939|P4|COMPLETED|Treatment Period 2||22
1524795|NCT01468207|3731940|P3|COMPLETED|Treatment Period 2||93
1524796|NCT01468207|3731941|P2|COMPLETED|Treatment Period 2||0
1524797|NCT01468207|3731942|P1|COMPLETED|Treatment Period 2||0
1524798|NCT01468207|3731937|P6|STARTED|Treatment Period 2||48
1524799|NCT01468207|3731938|P5|STARTED|Treatment Period 2||48
1524800|NCT01468207|3731939|P4|STARTED|Treatment Period 2||49
1524801|NCT01468207|3731940|P3|STARTED|Treatment Period 2||145
1524802|NCT01468207|3731941|P2|STARTED|Treatment Period 2||0
1524803|NCT01468207|3731942|P1|STARTED|Treatment Period 2||0
1524804|NCT01468207|3731937|P6|NOT COMPLETED|Treatment Period 1||0
1524805|NCT01468207|3731938|P5|NOT COMPLETED|Treatment Period 1||0
1524806|NCT01468207|3731939|P4|NOT COMPLETED|Treatment Period 1||0
1524807|NCT01468207|3731940|P3|NOT COMPLETED|Treatment Period 1||0
1524808|NCT01468207|3731941|P2|NOT COMPLETED|Treatment Period 1||8
1524809|NCT01468207|3731942|P1|NOT COMPLETED|Treatment Period 1||9
1524810|NCT01468207|3731937|P6|COMPLETED|Treatment Period 1||0
1524811|NCT01468207|3731938|P5|COMPLETED|Treatment Period 1||0
1524812|NCT01468207|3731939|P4|COMPLETED|Treatment Period 1||0
1524813|NCT01468207|3731940|P3|COMPLETED|Treatment Period 1||0
1524814|NCT01468207|3731941|P2|COMPLETED|Treatment Period 1||145
1524815|NCT01468207|3731942|P1|COMPLETED|Treatment Period 1||145
1524816|NCT01468207|3731937|P6|Received Study Drug|Treatment Period 1||0
1524817|NCT01468207|3731938|P5|Received Study Drug|Treatment Period 1||0
1524818|NCT01468207|3731939|P4|Received Study Drug|Treatment Period 1||0
1524819|NCT01468207|3731940|P3|Received Study Drug|Treatment Period 1||0
1524820|NCT01468207|3731941|P2|Received Study Drug|Treatment Period 1||153
1524821|NCT01468207|3731942|P1|Received Study Drug|Treatment Period 1||152
1524822|NCT01468207|3731937|P6|STARTED|Treatment Period 1||0
1524823|NCT01468207|3731938|P5|STARTED|Treatment Period 1||0
1524824|NCT01468207|3731939|P4|STARTED|Treatment Period 1||0
1524825|NCT01468207|3731940|P3|STARTED|Treatment Period 1||0
1524826|NCT01468207|3731941|P2|STARTED|Treatment Period 1||153
1524827|NCT01468207|3731942|P1|STARTED|Treatment Period 1||154
1524828|NCT01468181|3731967|P5|NOT COMPLETED|Overall Study||5
1524829|NCT01468181|3731968|P4|NOT COMPLETED|Overall Study||3
1524830|NCT01468181|3731969|P3|NOT COMPLETED|Overall Study||8
1524831|NCT01468181|3731970|P2|NOT COMPLETED|Overall Study||2
1524832|NCT01468181|3731971|P1|NOT COMPLETED|Overall Study||10
1524833|NCT01468181|3731967|P5|COMPLETED|Overall Study||66
1524836|NCT01468181|3731970|P2|COMPLETED|Overall Study||59
1524837|NCT01468181|3731971|P1|COMPLETED|Overall Study||121
1524838|NCT01468181|3731967|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
1524839|NCT01468181|3731968|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
1524840|NCT01468181|3731969|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
1524841|NCT01468181|3731970|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
1524842|NCT01468181|3731971|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
1524843|NCT01468181|3731967|P5|STARTED|Overall Study||71
1524844|NCT01468181|3731968|P4|STARTED|Overall Study||66
1524845|NCT01468181|3731969|P3|STARTED|Overall Study||65
1524846|NCT01468181|3731970|P2|STARTED|Overall Study||61
1524847|NCT01468181|3731971|P1|STARTED|Overall Study||131
1524848|NCT01468077|3732020|P2|NOT COMPLETED|Overall Study||3
1524849|NCT01468077|3732021|P1|NOT COMPLETED|Overall Study||4
1524850|NCT01468077|3732020|P2|COMPLETED|Overall Study||22
1524851|NCT01468077|3732021|P1|COMPLETED|Overall Study||18
1524852|NCT01468077|3732020|P2|STARTED|Overall Study||25
1524853|NCT01468077|3732021|P1|STARTED|Overall Study||22
1524854|NCT01468012|3732060|P3|NOT COMPLETED|Overall Study||4
1524855|NCT01468012|3732061|P2|NOT COMPLETED|Overall Study||1
1524856|NCT01468012|3732062|P1|NOT COMPLETED|Overall Study||2
1524857|NCT01468012|3732060|P3|COMPLETED|Overall Study||0
1524858|NCT01468012|3732061|P2|COMPLETED|Overall Study||9
1524859|NCT01468012|3732062|P1|COMPLETED|Overall Study||7
1524860|NCT01468012|3732060|P3|STARTED|Overall Study||4
1524861|NCT01468012|3732061|P2|STARTED|Overall Study||10
1524862|NCT01468012|3732062|P1|STARTED|Overall Study||9
1524863|NCT01467999|3732073|P1|NOT COMPLETED|Overall Study||13
1524864|NCT01467999|3732073|P1|COMPLETED|Overall Study||9
1524865|NCT01467999|3732073|P1|STARTED|Overall Study||22
1524866|NCT01467960|3732083|P6|NOT COMPLETED|Overall Study||30
1524867|NCT01467960|3732084|P5|NOT COMPLETED|Overall Study||30
1524868|NCT01467960|3732085|P4|NOT COMPLETED|Overall Study||30
1524869|NCT01467960|3732086|P3|NOT COMPLETED|Overall Study||0
1524870|NCT01467960|3732087|P2|NOT COMPLETED|Overall Study||0
1524871|NCT01467960|3732088|P1|NOT COMPLETED|Overall Study||0
1524872|NCT01467960|3732083|P6|COMPLETED|Overall Study||0
1524873|NCT01467960|3732084|P5|COMPLETED|Overall Study||0
1524874|NCT01467960|3732085|P4|COMPLETED|Overall Study||0
1524875|NCT01467960|3732086|P3|COMPLETED|Overall Study||30
1524876|NCT01467960|3732087|P2|COMPLETED|Overall Study||30
1524877|NCT01467960|3732088|P1|COMPLETED|Overall Study||30
1524878|NCT01467960|3732083|P6|STARTED|Overall Study||30
1524879|NCT01467960|3732084|P5|STARTED|Overall Study||30
1524880|NCT01467960|3732085|P4|STARTED|Overall Study||30
1524881|NCT01467960|3732086|P3|STARTED|Overall Study||30
1524882|NCT01467960|3732087|P2|STARTED|Overall Study||30
1524883|NCT01467960|3732088|P1|STARTED|Overall Study||30
1524884|NCT01467947|3732102|P1|NOT COMPLETED|Overall Study||0
1524885|NCT01467947|3732102|P1|COMPLETED|Overall Study||46
1524886|NCT01467947|3732102|P1|STARTED|Overall Study||46
1524887|NCT01467934|3732110|P3|NOT COMPLETED|Overall Study||0
1524888|NCT01467934|3732111|P2|NOT COMPLETED|Overall Study||0
1524889|NCT01467934|3732112|P1|NOT COMPLETED|Overall Study||0
1524890|NCT01467934|3732110|P3|COMPLETED|Overall Study||110
1524891|NCT01467934|3732111|P2|COMPLETED|Overall Study||212
1524892|NCT01467934|3732112|P1|COMPLETED|Overall Study||208
1524893|NCT01467934|3732110|P3|STARTED|Overall Study||110
1524894|NCT01467934|3732111|P2|STARTED|Overall Study||212
1524895|NCT01467934|3732112|P1|STARTED|Overall Study||208
1524896|NCT01467882|3732120|P1|NOT COMPLETED|Overall Study||0
1524897|NCT01467882|3732120|P1|COMPLETED|Overall Study||44
1524898|NCT01467882|3732120|P1|STARTED|Overall Study||44
1524899|NCT01467713|3732147|P4|NOT COMPLETED|Overall Study||109
1524900|NCT01467713|3732148|P3|NOT COMPLETED|Overall Study||102
1524901|NCT01467713|3732149|P2|NOT COMPLETED|Overall Study||104
1524902|NCT01467713|3732150|P1|NOT COMPLETED|Overall Study||102
1524903|NCT01467713|3732147|P4|COMPLETED|Overall Study||45
1524904|NCT01467713|3732148|P3|COMPLETED|Overall Study||58
1524905|NCT01467713|3732149|P2|COMPLETED|Overall Study||60
1524906|NCT01467713|3732150|P1|COMPLETED|Overall Study||62
1524907|NCT01467713|3732147|P4|Safety Analysis Set: Received Treatment|Overall Study||154
1524908|NCT01467713|3732148|P3|Safety Analysis Set: Received Treatment|Overall Study||159
1524909|NCT01467713|3732149|P2|Safety Analysis Set: Received Treatment|Overall Study||164
1524910|NCT01467713|3732150|P1|Safety Analysis Set: Received Treatment|Overall Study||163
1524911|NCT01467713|3732147|P4|STARTED|Overall Study||154
1524912|NCT01467713|3732148|P3|STARTED|Overall Study||160
1524913|NCT01467713|3732149|P2|STARTED|Overall Study||164
1524914|NCT01467713|3732150|P1|STARTED|Overall Study||164
1524915|NCT01467700|3732204|P4|NOT COMPLETED|Overall Study||27
1524916|NCT01467700|3732205|P3|NOT COMPLETED|Overall Study||27
1524917|NCT01467700|3732206|P2|NOT COMPLETED|Overall Study||28
1524918|NCT01467700|3732207|P1|NOT COMPLETED|Overall Study||29
1524919|NCT01467700|3732204|P4|COMPLETED|Overall Study||96
1524920|NCT01467700|3732205|P3|COMPLETED|Overall Study||97
1524921|NCT01467700|3732206|P2|COMPLETED|Overall Study||100
1524922|NCT01467700|3732207|P1|COMPLETED|Overall Study||86
1524923|NCT01467700|3732204|P4|Safety Set - Received Treatment|Overall Study||123
1524924|NCT01467700|3732205|P3|Safety Set - Received Treatment|Overall Study||124
1524925|NCT01467700|3732206|P2|Safety Set - Received Treatment|Overall Study||127
1524926|NCT01467700|3732207|P1|Safety Set - Received Treatment|Overall Study||115
1524927|NCT01467700|3732204|P4|STARTED|Overall Study||123
1524928|NCT01467700|3732205|P3|STARTED|Overall Study||124
1524929|NCT01467700|3732206|P2|STARTED|Overall Study||128
1524930|NCT01467700|3732207|P1|STARTED|Overall Study||115
1524931|NCT01467661|3732249|P1|NOT COMPLETED|Overall Study||21
1524932|NCT01467661|3732249|P1|COMPLETED|Overall Study|Completed study SPD422-309 (NCT01467661)|32
1524933|NCT01467661|3732249|P1|Started Post Marketing Trial|Overall Study||33
1524934|NCT01467661|3732249|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
1524935|NCT01467661|3732249|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
1524936|NCT01467661|3732249|P1|STARTED|Overall Study|Started Study SPD422-308 (NCT01214915)|53
1524937|NCT01467583|3732269|P3|NOT COMPLETED|Overall Study||2
1524938|NCT01467583|3732270|P2|NOT COMPLETED|Overall Study||1
1524939|NCT01467583|3732271|P1|NOT COMPLETED|Overall Study||2
1524940|NCT01467583|3732269|P3|COMPLETED|Overall Study||10
1524941|NCT01467583|3732270|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
1524942|NCT01467583|3732271|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
1524943|NCT01467583|3732269|P3|STARTED|Overall Study||12
1524944|NCT01467583|3732270|P2|STARTED|Overall Study||4
1524945|NCT01467583|3732271|P1|STARTED|Overall Study||16
1524946|NCT01467570|3732284|P2|NOT COMPLETED|Overall Study||9
1524947|NCT01467570|3732285|P1|NOT COMPLETED|Overall Study||8
1524948|NCT01467570|3732284|P2|COMPLETED|Overall Study||63
1524949|NCT01467570|3732285|P1|COMPLETED|Overall Study||67
1524950|NCT01467570|3732284|P2|STARTED|Overall Study||72
1524951|NCT01467570|3732285|P1|STARTED|Overall Study||75
1524952|NCT01467557|3732311|P2|NOT COMPLETED|Overall Study||107
1524953|NCT01467557|3732312|P1|NOT COMPLETED|Overall Study||99
1524954|NCT01467557|3732311|P2|COMPLETED|Overall Study||463
1524955|NCT01467557|3732312|P1|COMPLETED|Overall Study||502
1524956|NCT01467557|3732311|P2|12 Month Survey Completed|Overall Study||463
1524957|NCT01467557|3732312|P1|12 Month Survey Completed|Overall Study||502
1524958|NCT01467557|3732311|P2|4 Month Survey Completed|Overall Study||493
1524959|NCT01467557|3732312|P1|4 Month Survey Completed|Overall Study||533
1524960|NCT01467557|3732311|P2|2 Week Survey Completed|Overall Study||522
1524961|NCT01467557|3732312|P1|2 Week Survey Completed|Overall Study||551
1524962|NCT01467557|3732311|P2|STARTED|Overall Study||570
1524963|NCT01467557|3732312|P1|STARTED|Overall Study||601
1524964|NCT01467505|3732322|P2|NOT COMPLETED|Overall Study||3
1524965|NCT01467505|3732323|P1|NOT COMPLETED|Overall Study||33
1524966|NCT01467505|3732322|P2|COMPLETED|Overall Study||7
1524967|NCT01467505|3732323|P1|COMPLETED|Overall Study||18
1524968|NCT01467505|3732322|P2|STARTED|Overall Study||10
1524969|NCT01467505|3732323|P1|STARTED|Overall Study||51
1524970|NCT01467492|3732355|P2|NOT COMPLETED|Overall Study||13
1524971|NCT01467492|3732356|P1|NOT COMPLETED|Overall Study||22
1524972|NCT01467492|3732355|P2|COMPLETED|Overall Study||25
1524973|NCT01467492|3732356|P1|COMPLETED|Overall Study||61
1524974|NCT01467492|3732355|P2|STARTED|Overall Study||38
1524975|NCT01467492|3732356|P1|STARTED|Overall Study||83
1524976|NCT01467479|3732380|P3|NOT COMPLETED|Overall Study||16
1524977|NCT01467479|3732381|P2|NOT COMPLETED|Overall Study||17
1524978|NCT01467479|3732382|P1|NOT COMPLETED|Overall Study||9
1524979|NCT01467479|3732380|P3|COMPLETED|Overall Study||45
1524980|NCT01467479|3732381|P2|COMPLETED|Overall Study||52
1524981|NCT01467479|3732382|P1|COMPLETED|Overall Study||46
1524982|NCT01467479|3732380|P3|Treated|Overall Study||59
1524983|NCT01467479|3732381|P2|Treated|Overall Study||69
1524984|NCT01467479|3732382|P1|Treated|Overall Study||54
1524985|NCT01467479|3732380|P3|STARTED|Overall Study||61
1524986|NCT01467479|3732381|P2|STARTED|Overall Study||69
1524987|NCT01467479|3732382|P1|STARTED|Overall Study||55
1524988|NCT01467466|3732413|P4|NOT COMPLETED|Overall Study||88
1524989|NCT01467466|3732414|P3|NOT COMPLETED|Overall Study||104
1524990|NCT01467466|3732415|P2|NOT COMPLETED|Overall Study||104
1524991|NCT01467466|3732416|P1|NOT COMPLETED|Overall Study||109
1524992|NCT01467466|3732413|P4|COMPLETED|Overall Study||1203
1524993|NCT01467466|3732414|P3|COMPLETED|Overall Study||1190
1524994|NCT01467466|3732415|P2|COMPLETED|Overall Study||1188
1524995|NCT01467466|3732416|P1|COMPLETED|Overall Study||1191
1524996|NCT01467466|3732413|P4|STARTED|Overall Study||1291
1524997|NCT01467466|3732414|P3|STARTED|Overall Study||1294
1524998|NCT01467466|3732415|P2|STARTED|Overall Study||1292
1524999|NCT01467466|3732416|P1|STARTED|Overall Study||1300
1525000|NCT01467427|3732428|P2|NOT COMPLETED|Overall Study||13
1525001|NCT01467427|3732429|P1|NOT COMPLETED|Overall Study||12
1525002|NCT01467427|3732428|P2|COMPLETED|Overall Study||0
1525003|NCT01467427|3732429|P1|COMPLETED|Overall Study||0
1525004|NCT01467427|3732428|P2|Completed Main Phase|Overall Study||13
1525005|NCT01467427|3732429|P1|Completed Main Phase|Overall Study||11
1525006|NCT01467427|3732428|P2|STARTED|Overall Study||13
1525007|NCT01467427|3732429|P1|STARTED|Overall Study||12
1525008|NCT01467076|3732450|P3|NOT COMPLETED|Overall Study||0
1525009|NCT01467076|3732451|P2|NOT COMPLETED|Overall Study||0
1525010|NCT01467076|3732452|P1|NOT COMPLETED|Overall Study||1
1525011|NCT01467076|3732450|P3|COMPLETED|Overall Study||2
1525012|NCT01467076|3732451|P2|COMPLETED|Overall Study||2
1525013|NCT01467076|3732452|P1|COMPLETED|Overall Study||2
1525014|NCT01467076|3732450|P3|STARTED|Overall Study||2
1525015|NCT01467076|3732451|P2|STARTED|Overall Study||2
1525016|NCT01467076|3732452|P1|STARTED|Overall Study||3
1525017|NCT01467037|3732462|P1|NOT COMPLETED|Overall Study||0
1525018|NCT01467037|3732462|P1|COMPLETED|Overall Study||374
1525019|NCT01467037|3732462|P1|STARTED|Overall Study||374
1525020|NCT01466881|3732469|P1|NOT COMPLETED|Overall Study||40
1525021|NCT01466881|3732469|P1|COMPLETED|Overall Study||2
1525022|NCT01466881|3732469|P1|Eligible and Treated|Overall Study||37
1525023|NCT01466881|3732469|P1|STARTED|Overall Study||42
1525024|NCT01466790|3732486|P8|NOT COMPLETED|Overall Study||1
1525025|NCT01466790|3732487|P7|NOT COMPLETED|Overall Study||1
1525026|NCT01466790|3732488|P6|NOT COMPLETED|Overall Study||0
1525027|NCT01466790|3732489|P5|NOT COMPLETED|Overall Study||3
1525028|NCT01466790|3732490|P4|NOT COMPLETED|Overall Study||0
1525029|NCT01466790|3732491|P3|NOT COMPLETED|Overall Study||0
1525030|NCT01466790|3732492|P2|NOT COMPLETED|Overall Study||1
1525031|NCT01466790|3732493|P1|NOT COMPLETED|Overall Study||4
1525032|NCT01466790|3732486|P8|COMPLETED|Overall Study||13
1525033|NCT01466790|3732487|P7|COMPLETED|Overall Study||26
1525034|NCT01466790|3732488|P6|COMPLETED|Overall Study||16
1525035|NCT01466790|3732489|P5|COMPLETED|Overall Study||27
1525036|NCT01466790|3732490|P4|COMPLETED|Overall Study||14
1525037|NCT01466790|3732491|P3|COMPLETED|Overall Study||27
1525038|NCT01466790|3732492|P2|COMPLETED|Overall Study||14
1525039|NCT01466790|3732493|P1|COMPLETED|Overall Study||20
1525040|NCT01466790|3732486|P8|STARTED|Overall Study||14
1525041|NCT01466790|3732487|P7|STARTED|Overall Study||27
1525042|NCT01466790|3732488|P6|STARTED|Overall Study||16
1525043|NCT01466790|3732489|P5|STARTED|Overall Study||30
1525044|NCT01466790|3732490|P4|STARTED|Overall Study||14
1525045|NCT01466790|3732491|P3|STARTED|Overall Study||27
1525046|NCT01466790|3732492|P2|STARTED|Overall Study||15
1525047|NCT01466790|3732493|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
1525048|NCT01466764|3732557|P2|NOT COMPLETED|Overall Study||0
1525049|NCT01466764|3732558|P1|NOT COMPLETED|Overall Study||0
1525050|NCT01466764|3732557|P2|COMPLETED|Overall Study||5
1525051|NCT01466764|3732558|P1|COMPLETED|Overall Study||5
1525052|NCT01466764|3732557|P2|STARTED|Overall Study||5
1525053|NCT01466764|3732558|P1|STARTED|Overall Study||5
1525054|NCT01466673|3732578|P2|NOT COMPLETED|Overall Study||6
1525055|NCT01466673|3732579|P1|NOT COMPLETED|Overall Study||7
1525056|NCT01466673|3732578|P2|COMPLETED|Overall Study||95
1525057|NCT01466673|3732579|P1|COMPLETED|Overall Study||93
1525058|NCT01466673|3732578|P2|STARTED|Overall Study||101
1525059|NCT01466673|3732579|P1|STARTED|Overall Study||100
1525060|NCT01466660|3732605|P2|NOT COMPLETED|Overall Study||151
1525061|NCT01466660|3732606|P1|NOT COMPLETED|Overall Study||146
1525062|NCT01466660|3732605|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|8
1525063|NCT01466660|3732606|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|14
1525064|NCT01466660|3732605|P2|STARTED|Overall Study||159
1525065|NCT01466660|3732606|P1|STARTED|Overall Study||160
1525066|NCT01466595|3732632|P2|NOT COMPLETED|Overall Study||1
1525067|NCT01466595|3732633|P1|NOT COMPLETED|Overall Study||0
1525068|NCT01466595|3732632|P2|COMPLETED|Overall Study||23
1525069|NCT01466595|3732633|P1|COMPLETED|Overall Study||49
1525070|NCT01466595|3732632|P2|STARTED|Overall Study||24
1525071|NCT01466595|3732633|P1|STARTED|Overall Study||49
1525072|NCT01466491|3732727|P4|NOT COMPLETED|Overall Study||0
1525073|NCT01466491|3732728|P3|NOT COMPLETED|Overall Study||3
1525074|NCT01466491|3732729|P2|NOT COMPLETED|Overall Study||3
1525075|NCT01466491|3732730|P1|NOT COMPLETED|Overall Study||0
1525076|NCT01466491|3732727|P4|COMPLETED|Overall Study||83
1525077|NCT01466491|3732728|P3|COMPLETED|Overall Study||80
1525078|NCT01466491|3732729|P2|COMPLETED|Overall Study||80
1525079|NCT01466491|3732730|P1|COMPLETED|Overall Study||83
1525080|NCT01466491|3732727|P4|STARTED|Overall Study||83
1525081|NCT01466491|3732728|P3|STARTED|Overall Study||83
1525082|NCT01466491|3732729|P2|STARTED|Overall Study||83
1525083|NCT01466491|3732730|P1|STARTED|Overall Study||83
1525084|NCT01466387|3732750|P6|NOT COMPLETED|Overall Study||1
1525085|NCT01466387|3732751|P5|NOT COMPLETED|Overall Study||0
1525086|NCT01466387|3732752|P4|NOT COMPLETED|Overall Study||2
1525087|NCT01466387|3732753|P3|NOT COMPLETED|Overall Study||1
1525088|NCT01466387|3732754|P2|NOT COMPLETED|Overall Study||0
1525089|NCT01466387|3732755|P1|NOT COMPLETED|Overall Study||1
1525090|NCT01466387|3732750|P6|COMPLETED|Overall Study||99
1525091|NCT01466387|3732751|P5|COMPLETED|Overall Study||51
1525092|NCT01466387|3732752|P4|COMPLETED|Overall Study||99
1525093|NCT01466387|3732753|P3|COMPLETED|Overall Study||98
1525094|NCT01466387|3732754|P2|COMPLETED|Overall Study||100
1525095|NCT01466387|3732755|P1|COMPLETED|Overall Study||100
1525096|NCT01466387|3732750|P6|STARTED|Overall Study||100
1525097|NCT01466387|3732751|P5|STARTED|Overall Study||51
1525098|NCT01466387|3732752|P4|STARTED|Overall Study||101
1525099|NCT01466387|3732753|P3|STARTED|Overall Study||99
1525100|NCT01466387|3732754|P2|STARTED|Overall Study||100
1525101|NCT01466387|3732755|P1|STARTED|Overall Study||101
1525102|NCT01466361|3732797|P4|NOT COMPLETED|Overall Study||0
1525103|NCT01466361|3732798|P3|NOT COMPLETED|Overall Study||0
1525104|NCT01466361|3732799|P2|NOT COMPLETED|Overall Study||0
1525105|NCT01466361|3732800|P1|NOT COMPLETED|Overall Study||0
1525106|NCT01466361|3732797|P4|COMPLETED|Overall Study||41
1525107|NCT01466361|3732798|P3|COMPLETED|Overall Study||60
1525108|NCT01466361|3732799|P2|COMPLETED|Overall Study||34
1525109|NCT01466361|3732800|P1|COMPLETED|Overall Study||52
1525110|NCT01466361|3732797|P4|STARTED|Overall Study||41
1525111|NCT01466361|3732798|P3|STARTED|Overall Study||60
1525112|NCT01466361|3732799|P2|STARTED|Overall Study||34
1525113|NCT01466361|3732800|P1|STARTED|Overall Study||52
1525114|NCT01466348|3732816|P2|NOT COMPLETED|Period II - Second Intervention||0
1525115|NCT01466348|3732817|P1|NOT COMPLETED|Period II - Second Intervention||0
1525116|NCT01466348|3732816|P2|COMPLETED|Period II - Second Intervention||36
1525117|NCT01466348|3732817|P1|COMPLETED|Period II - Second Intervention||35
1525118|NCT01466348|3732816|P2|STARTED|Period II - Second Intervention||36
1525119|NCT01466348|3732817|P1|STARTED|Period II - Second Intervention||35
1525120|NCT01466348|3732816|P2|NOT COMPLETED|Period I - First Intervention||1
1525121|NCT01466348|3732817|P1|NOT COMPLETED|Period I - First Intervention||0
1525122|NCT01466348|3732816|P2|COMPLETED|Period I - First Intervention||35
1525123|NCT01466348|3732817|P1|COMPLETED|Period I - First Intervention||36
1525124|NCT01466348|3732816|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
1525125|NCT01466348|3732817|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
1525126|NCT01466348|3732816|P2|STARTED|Period I - First Intervention||36
1525127|NCT01466348|3732817|P1|STARTED|Period I - First Intervention||36
1525128|NCT01466270|3732845|P2|NOT COMPLETED|Overall Study||6
1525129|NCT01466270|3732846|P1|NOT COMPLETED|Overall Study||12
1525130|NCT01466270|3732845|P2|COMPLETED|Overall Study||25
1525131|NCT01466270|3732846|P1|COMPLETED|Overall Study||19
1525132|NCT01466270|3732845|P2|STARTED|Overall Study||31
1525133|NCT01466270|3732846|P1|STARTED|Overall Study||31
1525134|NCT01466192|3732858|P1|NOT COMPLETED|Overall Study||4
1525135|NCT01466192|3732858|P1|COMPLETED|Overall Study||104
1525136|NCT01466192|3732858|P1|STARTED|Overall Study||108
1525137|NCT01466179|3732862|P1|NOT COMPLETED|Overall Study||179
1525138|NCT01466179|3732862|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
1525139|NCT01466179|3732862|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
1525140|NCT01466153|3732885|P3|NOT COMPLETED|Overall Study||25
1525141|NCT01466153|3732886|P2|NOT COMPLETED|Overall Study||24
1525142|NCT01466153|3732887|P1|NOT COMPLETED|Overall Study||29
1525143|NCT01466153|3732885|P3|COMPLETED|Overall Study||36
1525144|NCT01466153|3732886|P2|COMPLETED|Overall Study||12
1525145|NCT01466153|3732887|P1|COMPLETED|Overall Study||33
1525146|NCT01466153|3732885|P3|STARTED|Overall Study||61
1525147|NCT01466153|3732886|P2|STARTED|Overall Study||36
1525148|NCT01466153|3732887|P1|STARTED|Overall Study||62
1525149|NCT01466127|3732928|P2|NOT COMPLETED|Overall Study||16
1525150|NCT01466127|3732929|P1|NOT COMPLETED|Overall Study||14
1525151|NCT01466127|3732928|P2|COMPLETED|Overall Study||14
1525152|NCT01466127|3732929|P1|COMPLETED|Overall Study||16
1525153|NCT01466127|3732928|P2|STARTED|Overall Study||30
1525154|NCT01466127|3732929|P1|STARTED|Overall Study||30
1525155|NCT01466075|3732935|P1|NOT COMPLETED|Overall Study||0
1525156|NCT01466075|3732935|P1|COMPLETED|Overall Study||207
1525157|NCT01466075|3732935|P1|STARTED|Overall Study||207
1525158|NCT01466062|3732942|P1|NOT COMPLETED|Overall Study||2
1525159|NCT01466062|3732942|P1|COMPLETED|Overall Study||26
1525160|NCT01466062|3732942|P1|STARTED|Overall Study||28
1525161|NCT01465997|3732965|P2|NOT COMPLETED|Overall Study||89
1525162|NCT01465997|3732966|P1|NOT COMPLETED|Overall Study||68
1525163|NCT01465997|3732965|P2|COMPLETED|Overall Study||180
1525164|NCT01465997|3732966|P1|COMPLETED|Overall Study||211
1525165|NCT01465997|3732965|P2|STARTED|Overall Study||269
1525166|NCT01465997|3732966|P1|STARTED|Overall Study||279
1525167|NCT01465958|3732976|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
1525168|NCT01465958|3732977|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
1525169|NCT01465958|3732976|P2|COMPLETED|Subcutaneous (SC) Phase||10
1525170|NCT01465958|3732977|P1|COMPLETED|Subcutaneous (SC) Phase||0
1525171|NCT01465958|3732976|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
1525172|NCT01465958|3732977|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
1525173|NCT01465958|3732976|P2|NOT COMPLETED|Intravenous (IV) Phase||0
1525174|NCT01465958|3732977|P1|NOT COMPLETED|Intravenous (IV) Phase||0
1525175|NCT01465958|3732976|P2|COMPLETED|Intravenous (IV) Phase||0
1525176|NCT01465958|3732977|P1|COMPLETED|Intravenous (IV) Phase||11
1525177|NCT01465958|3732976|P2|STARTED|Intravenous (IV) Phase||0
1525178|NCT01465958|3732977|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
1525179|NCT01465958|3732976|P2|NOT COMPLETED|Run-in Phase||0
1525180|NCT01465958|3732977|P1|NOT COMPLETED|Run-in Phase||1
1525181|NCT01465958|3732976|P2|COMPLETED|Run-in Phase||0
1525182|NCT01465958|3732977|P1|COMPLETED|Run-in Phase||10
1525183|NCT01465958|3732976|P2|STARTED|Run-in Phase||0
1525184|NCT01465958|3732977|P1|STARTED|Run-in Phase||11
1525185|NCT01465802|3732990|P5|NOT COMPLETED|Overall Study||12
1525186|NCT01465802|3732991|P4|NOT COMPLETED|Overall Study||29
1525187|NCT01465802|3732992|P3|NOT COMPLETED|Overall Study||0
1525188|NCT01465802|3732993|P2|NOT COMPLETED|Overall Study||24
1525189|NCT01465802|3732994|P1|NOT COMPLETED|Overall Study||33
1525190|NCT01465802|3732990|P5|COMPLETED|Overall Study||13
1525191|NCT01465802|3732991|P4|COMPLETED|Overall Study||38
1525192|NCT01465802|3732992|P3|COMPLETED|Overall Study||7
1525193|NCT01465802|3732993|P2|COMPLETED|Overall Study||42
1525194|NCT01465802|3732994|P1|COMPLETED|Overall Study||33
1525195|NCT01465802|3732990|P5|STARTED|Overall Study||25
1525196|NCT01465802|3732991|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
1525197|NCT01465802|3732992|P3|STARTED|Overall Study||7
1525198|NCT01465802|3732993|P2|STARTED|Overall Study||66
1525199|NCT01465802|3732994|P1|STARTED|Overall Study||66
1525200|NCT01465763|3733046|P3|NOT COMPLETED|Overall Study||4
1525201|NCT01465763|3733047|P2|NOT COMPLETED|Overall Study||1
1525202|NCT01465763|3733048|P1|NOT COMPLETED|Overall Study||31
1525203|NCT01465763|3733046|P3|COMPLETED|Overall Study||118
1525204|NCT01465763|3733047|P2|COMPLETED|Overall Study||15
1525205|NCT01465763|3733048|P1|COMPLETED|Overall Study||445
1525206|NCT01465763|3733046|P3|STARTED|Overall Study||122
1525207|NCT01465763|3733047|P2|STARTED|Overall Study||16
1525208|NCT01465763|3733048|P1|STARTED|Overall Study||476
1525209|NCT01465412|3733077|P4|NOT COMPLETED|Overall Study||0
1525210|NCT01465412|3733078|P3|NOT COMPLETED|Overall Study||0
1525211|NCT01465412|3733079|P2|NOT COMPLETED|Overall Study||0
1525212|NCT01465412|3733080|P1|NOT COMPLETED|Overall Study||0
1525213|NCT01465412|3733077|P4|COMPLETED|Overall Study||9
1525214|NCT01465412|3733078|P3|COMPLETED|Overall Study||9
1525215|NCT01465412|3733079|P2|COMPLETED|Overall Study||12
1525216|NCT01465412|3733080|P1|COMPLETED|Overall Study||12
1525217|NCT01465412|3733077|P4|STARTED|Overall Study||9
1525218|NCT01465412|3733078|P3|STARTED|Overall Study||9
1525219|NCT01465412|3733079|P2|STARTED|Overall Study||12
1525220|NCT01465412|3733080|P1|STARTED|Overall Study||12
1525221|NCT01465386|3733118|P1|NOT COMPLETED|Overall Study||4
1525222|NCT01465386|3733118|P1|COMPLETED|Overall Study||2
1525223|NCT01465386|3733118|P1|STARTED|Overall Study||6
1525224|NCT01465347|3733122|P2|NOT COMPLETED|Overall Study||3
1525225|NCT01465347|3733123|P1|NOT COMPLETED|Overall Study||1
1525226|NCT01465347|3733122|P2|COMPLETED|Overall Study||53
1525227|NCT01465347|3733123|P1|COMPLETED|Overall Study||2
1525228|NCT01465347|3733122|P2|STARTED|Overall Study||56
1525229|NCT01465347|3733123|P1|STARTED|Overall Study||3
1525230|NCT01465230|3733133|P1|NOT COMPLETED|Overall Study||2
1525231|NCT01465230|3733133|P1|COMPLETED|Overall Study||0
1525232|NCT01465230|3733133|P1|STARTED|Overall Study||2
1525233|NCT01465178|3733139|P2|NOT COMPLETED|Overall Study||0
1525234|NCT01465178|3733140|P1|NOT COMPLETED|Overall Study||1
1525235|NCT01465178|3733139|P2|COMPLETED|Overall Study||31
1525236|NCT01465178|3733140|P1|COMPLETED|Overall Study||30
1525237|NCT01465178|3733139|P2|STARTED|Overall Study||31
1525238|NCT01465178|3733140|P1|STARTED|Overall Study||31
1525239|NCT01465048|3733151|P3|NOT COMPLETED|Overall Study||0
1525240|NCT01465048|3733152|P2|NOT COMPLETED|Overall Study||0
1525241|NCT01465048|3733153|P1|NOT COMPLETED|Overall Study||0
1525242|NCT01465048|3733151|P3|COMPLETED|Overall Study||6
1525243|NCT01465048|3733152|P2|COMPLETED|Overall Study||6
1525244|NCT01465048|3733153|P1|COMPLETED|Overall Study||6
1525245|NCT01465048|3733151|P3|STARTED|Overall Study||6
1525246|NCT01465048|3733152|P2|STARTED|Overall Study||6
1525247|NCT01465048|3733153|P1|STARTED|Overall Study||6
1525248|NCT01465022|3733164|P3|NOT COMPLETED|Overall Study||70
1525249|NCT01465022|3733165|P2|NOT COMPLETED|Overall Study||23
1525250|NCT01465022|3733166|P1|NOT COMPLETED|Overall Study||23
1525251|NCT01465022|3733164|P3|COMPLETED|Overall Study||0
1525252|NCT01465022|3733165|P2|COMPLETED|Overall Study||40
1525253|NCT01465022|3733166|P1|COMPLETED|Overall Study||41
1525254|NCT01465022|3733164|P3|STARTED|Overall Study||70
1525255|NCT01465022|3733165|P2|STARTED|Overall Study||63
1525256|NCT01465022|3733166|P1|STARTED|Overall Study||64
1525257|NCT01464996|3733180|P1|NOT COMPLETED|Overall Study||0
1525258|NCT01464996|3733180|P1|COMPLETED|Overall Study||24
1525259|NCT01464996|3733180|P1|OptiBond FL|Overall Study||24
1525260|NCT01464996|3733180|P1|OptiBond XTR|Overall Study||23
1525261|NCT01464996|3733180|P1|STARTED|Overall Study||24
1525262|NCT01464931|3733200|P2|NOT COMPLETED|Overall Study||0
1525263|NCT01464931|3733201|P1|NOT COMPLETED|Overall Study||1
1525264|NCT01464931|3733200|P2|COMPLETED|Overall Study||16
1525265|NCT01464931|3733201|P1|COMPLETED|Overall Study||15
1525266|NCT01464931|3733200|P2|STARTED|Overall Study||16
1525267|NCT01464931|3733201|P1|STARTED|Overall Study||16
1525268|NCT01464879|3733238|P1|NOT COMPLETED|Overall Study||2
1525269|NCT01464879|3733238|P1|COMPLETED|Overall Study||18
1525270|NCT01464879|3733238|P1|Applicator Application (3.75 mL)|Overall Study||18
1525271|NCT01464879|3733238|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
1525272|NCT01464879|3733238|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
1525273|NCT01464879|3733238|P1|Washout Period|Overall Study||20
1525274|NCT01464879|3733238|P1|Hand Application (2.50 mL)|Overall Study||20
1525275|NCT01464879|3733238|P1|STARTED|Overall Study||20
1525276|NCT01464840|3733275|P3|NOT COMPLETED|Overall Study||0
1525277|NCT01464840|3733276|P2|NOT COMPLETED|Overall Study||0
1525278|NCT01464840|3733277|P1|NOT COMPLETED|Overall Study||0
1525279|NCT01464840|3733275|P3|COMPLETED|Overall Study||10
1525280|NCT01464840|3733276|P2|COMPLETED|Overall Study||10
1525281|NCT01464840|3733277|P1|COMPLETED|Overall Study||10
1525282|NCT01464840|3733275|P3|STARTED|Overall Study||10
1525283|NCT01464840|3733276|P2|STARTED|Overall Study||10
1525284|NCT01464840|3733277|P1|STARTED|Overall Study||10
1525285|NCT01464827|3733299|P14|NOT COMPLETED|Overall Study||3
1525286|NCT01464827|3733300|P13|NOT COMPLETED|Overall Study||2
1525287|NCT01464827|3733301|P12|NOT COMPLETED|Overall Study||2
1525288|NCT01464827|3733302|P11|NOT COMPLETED|Overall Study||2
1525289|NCT01464827|3733303|P10|NOT COMPLETED|Overall Study||3
1525290|NCT01464827|3733304|P9|NOT COMPLETED|Overall Study||3
1525291|NCT01464827|3733305|P8|NOT COMPLETED|Overall Study||3
1525292|NCT01464827|3733306|P7|NOT COMPLETED|Overall Study||4
1525293|NCT01464827|3733307|P6|NOT COMPLETED|Overall Study||1
1525294|NCT01464827|3733308|P5|NOT COMPLETED|Overall Study||8
1525295|NCT01464827|3733309|P4|NOT COMPLETED|Overall Study||4
1525296|NCT01464827|3733310|P3|NOT COMPLETED|Overall Study||0
1525297|NCT01464827|3733311|P2|NOT COMPLETED|Overall Study||7
1525298|NCT01464827|3733312|P1|NOT COMPLETED|Overall Study||3
1525299|NCT01464827|3733299|P14|COMPLETED|Overall Study||19
1525300|NCT01464827|3733300|P13|COMPLETED|Overall Study||21
1525301|NCT01464827|3733301|P12|COMPLETED|Overall Study||21
1525302|NCT01464827|3733302|P11|COMPLETED|Overall Study||21
1525303|NCT01464827|3733303|P10|COMPLETED|Overall Study||44
1525304|NCT01464827|3733304|P9|COMPLETED|Overall Study||37
1525305|NCT01464827|3733305|P8|COMPLETED|Overall Study||37
1525306|NCT01464827|3733306|P7|COMPLETED|Overall Study||37
1525307|NCT01464827|3733307|P6|COMPLETED|Overall Study||38
1525308|NCT01464827|3733308|P5|COMPLETED|Overall Study||72
1525309|NCT01464827|3733309|P4|COMPLETED|Overall Study||36
1525310|NCT01464827|3733310|P3|COMPLETED|Overall Study||39
1525311|NCT01464827|3733311|P2|COMPLETED|Overall Study||36
1525312|NCT01464827|3733312|P1|COMPLETED|Overall Study||77
1525313|NCT01464827|3733299|P14|Treated|Overall Study||20
1525314|NCT01464827|3733300|P13|Treated|Overall Study||23
1525315|NCT01464827|3733301|P12|Treated|Overall Study||22
1525316|NCT01464827|3733302|P11|Treated|Overall Study||23
1525317|NCT01464827|3733303|P10|Treated|Overall Study||45
1525318|NCT01464827|3733304|P9|Treated|Overall Study||40
1525319|NCT01464827|3733305|P8|Treated|Overall Study||40
1525320|NCT01464827|3733306|P7|Treated|Overall Study||40
1525321|NCT01464827|3733307|P6|Treated|Overall Study||39
1525322|NCT01464827|3733308|P5|Treated|Overall Study||79
1525323|NCT01464827|3733309|P4|Treated|Overall Study||40
1525324|NCT01464827|3733310|P3|Treated|Overall Study||39
1525325|NCT01464827|3733311|P2|Treated|Overall Study||41
1525326|NCT01464827|3733312|P1|Treated|Overall Study||80
1525327|NCT01464827|3733299|P14|STARTED|Overall Study||22
1525328|NCT01464827|3733300|P13|STARTED|Overall Study||23
1525329|NCT01464827|3733301|P12|STARTED|Overall Study||23
1525330|NCT01464827|3733302|P11|STARTED|Overall Study||23
1525331|NCT01464827|3733303|P10|STARTED|Overall Study||47
1525332|NCT01464827|3733304|P9|STARTED|Overall Study||40
1525333|NCT01464827|3733305|P8|STARTED|Overall Study||40
1525334|NCT01464827|3733306|P7|STARTED|Overall Study||41
1525335|NCT01464827|3733307|P6|STARTED|Overall Study||39
1525336|NCT01464827|3733308|P5|STARTED|Overall Study||80
1525337|NCT01464827|3733309|P4|STARTED|Overall Study||40
1525338|NCT01464827|3733310|P3|STARTED|Overall Study||39
1525339|NCT01464827|3733311|P2|STARTED|Overall Study||43
1525340|NCT01464827|3733312|P1|STARTED|Overall Study||80
1525341|NCT01464788|3733359|P3|NOT COMPLETED|Overall Study||0
1525342|NCT01464788|3733360|P2|NOT COMPLETED|Overall Study||2
1525343|NCT01464788|3733361|P1|NOT COMPLETED|Overall Study||0
1525344|NCT01464788|3733359|P3|COMPLETED|Overall Study||29
1525345|NCT01464788|3733360|P2|COMPLETED|Overall Study||29
1525346|NCT01464788|3733361|P1|COMPLETED|Overall Study||30
1525347|NCT01464788|3733359|P3|STARTED|Overall Study||29
1525348|NCT01464788|3733360|P2|STARTED|Overall Study||31
1525349|NCT01464788|3733361|P1|STARTED|Overall Study||30
1525350|NCT01464619|3733374|P2|NOT COMPLETED|Overall Study||4
1525351|NCT01464619|3733375|P1|NOT COMPLETED|Overall Study||3
1525352|NCT01464619|3733374|P2|COMPLETED|Overall Study||25
1525353|NCT01464619|3733375|P1|COMPLETED|Overall Study||29
1525354|NCT01464619|3733374|P2|STARTED|Overall Study||29
1525355|NCT01464619|3733375|P1|STARTED|Overall Study||32
1525356|NCT01464424|3733395|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
1525357|NCT01464424|3733396|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
1525358|NCT01464424|3733395|P2|COMPLETED|Period 2, Second 6 Weeks||41
1525359|NCT01464424|3733396|P1|COMPLETED|Period 2, Second 6 Weeks||42
1525360|NCT01464424|3733395|P2|STARTED|Period 2, Second 6 Weeks||41
1525361|NCT01464424|3733396|P1|STARTED|Period 2, Second 6 Weeks||42
1525362|NCT01464424|3733395|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
1525363|NCT01464424|3733396|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
1525364|NCT01464424|3733395|P2|COMPLETED|Period 1, First 6 Weeks||41
1525365|NCT01464424|3733396|P1|COMPLETED|Period 1, First 6 Weeks||42
1525366|NCT01464424|3733395|P2|STARTED|Period 1, First 6 Weeks||42
1525367|NCT01464424|3733396|P1|STARTED|Period 1, First 6 Weeks||42
1525368|NCT01464359|3733404|P1|NOT COMPLETED|Overall Study||0
1525369|NCT01464359|3733404|P1|COMPLETED|Overall Study||3
1525370|NCT01464359|3733404|P1|STARTED|Overall Study||3
1525371|NCT01464346|3733416|P3|NOT COMPLETED|Overall Study||1
1525372|NCT01464346|3733417|P2|NOT COMPLETED|Overall Study||0
1525373|NCT01464346|3733418|P1|NOT COMPLETED|Overall Study||0
1525374|NCT01464346|3733416|P3|COMPLETED|Overall Study||28
1525375|NCT01464346|3733417|P2|COMPLETED|Overall Study||32
1525376|NCT01464346|3733418|P1|COMPLETED|Overall Study||29
1525377|NCT01464346|3733416|P3|STARTED|Overall Study||29
1525378|NCT01464346|3733417|P2|STARTED|Overall Study||32
1525379|NCT01464346|3733418|P1|STARTED|Overall Study||29
1525380|NCT01464307|3733429|P2|NOT COMPLETED|Open-Label Extension Period||0
1525381|NCT01464307|3733430|P1|NOT COMPLETED|Open-Label Extension Period||51
1525382|NCT01464307|3733429|P2|COMPLETED|Open-Label Extension Period||0
1525383|NCT01464307|3733430|P1|COMPLETED|Open-Label Extension Period||218
1525384|NCT01464307|3733429|P2|Treated|Open-Label Extension Period||0
1525385|NCT01464307|3733430|P1|Treated|Open-Label Extension Period||269
1525386|NCT01464307|3733429|P2|STARTED|Open-Label Extension Period||0
1525387|NCT01464307|3733430|P1|STARTED|Open-Label Extension Period||269
1525388|NCT01464307|3733429|P2|NOT COMPLETED|Main Period||5
1525389|NCT01464307|3733430|P1|NOT COMPLETED|Main Period||15
1525390|NCT01464307|3733429|P2|COMPLETED|Main Period||140
1525391|NCT01464307|3733430|P1|COMPLETED|Main Period||129
1525392|NCT01464307|3733429|P2|Treated|Main Period||145
1525393|NCT01464307|3733430|P1|Treated|Main Period||144
1525394|NCT01464307|3733429|P2|STARTED|Main Period||145
1525395|NCT01464307|3733430|P1|STARTED|Main Period||144
1525396|NCT01464255|3733445|P2|NOT COMPLETED|Overall Study||1
1525397|NCT01464255|3733446|P1|NOT COMPLETED|Overall Study||0
1525398|NCT01464255|3733445|P2|COMPLETED|Overall Study||24
1525399|NCT01464255|3733446|P1|COMPLETED|Overall Study||25
1525400|NCT01464255|3733445|P2|STARTED|Overall Study||25
1525401|NCT01464255|3733446|P1|STARTED|Overall Study||25
1525402|NCT01464229|3733471|P2|NOT COMPLETED|Overall Study||2
1525403|NCT01464229|3733472|P1|NOT COMPLETED|Overall Study||5
1525404|NCT01464229|3733471|P2|COMPLETED|Overall Study||8
1525405|NCT01464229|3733472|P1|COMPLETED|Overall Study||5
1525406|NCT01464229|3733471|P2|STARTED|Overall Study||10
1525407|NCT01464229|3733472|P1|STARTED|Overall Study||10
1525408|NCT01464190|3733480|P2|NOT COMPLETED|Overall Study||41
1525409|NCT01464190|3733481|P1|NOT COMPLETED|Overall Study||69
1525410|NCT01464190|3733480|P2|COMPLETED|Overall Study||227
1525411|NCT01464190|3733481|P1|COMPLETED|Overall Study||322
1525412|NCT01464190|3733480|P2|STARTED|Overall Study||268
1525413|NCT01464190|3733481|P1|STARTED|Overall Study||391
1525414|NCT01464021|3733491|P1|NOT COMPLETED|Overall Study||26
1525415|NCT01464021|3733491|P1|COMPLETED|Overall Study||0
1525416|NCT01464021|3733491|P1|STARTED|Overall Study||26
1525417|NCT01463982|3733507|P4|NOT COMPLETED|Overall Study||0
1525418|NCT01463982|3733508|P3|NOT COMPLETED|Overall Study||2
1525419|NCT01463982|3733509|P2|NOT COMPLETED|Overall Study||1
1525420|NCT01463982|3733510|P1|NOT COMPLETED|Overall Study||0
1525421|NCT01463982|3733507|P4|COMPLETED|Overall Study||6
1525422|NCT01463982|3733508|P3|COMPLETED|Overall Study||2
1525423|NCT01463982|3733509|P2|COMPLETED|Overall Study||7
1525424|NCT01463982|3733510|P1|COMPLETED|Overall Study||3
1525425|NCT01463982|3733507|P4|STARTED|Overall Study||6
1525426|NCT01463982|3733508|P3|STARTED|Overall Study||4
1525427|NCT01463982|3733509|P2|STARTED|Overall Study||8
1525428|NCT01463982|3733510|P1|STARTED|Overall Study||3
1525429|NCT01463878|3733526|P2|NOT COMPLETED|Overall Study||2
1525430|NCT01463878|3733527|P1|NOT COMPLETED|Overall Study||2
1525431|NCT01463878|3733526|P2|COMPLETED|Overall Study||7
1525432|NCT01463878|3733527|P1|COMPLETED|Overall Study||7
1525433|NCT01463878|3733526|P2|STARTED|Overall Study||9
1525434|NCT01463878|3733527|P1|STARTED|Overall Study||9
1525435|NCT01463696|3733541|P8|NOT COMPLETED|Overall Study||4
1525436|NCT01463696|3733542|P7|NOT COMPLETED|Overall Study||10
1525437|NCT01463696|3733543|P6|NOT COMPLETED|Overall Study||3
1525438|NCT01463696|3733544|P5|NOT COMPLETED|Overall Study||1
1525439|NCT01463696|3733545|P4|NOT COMPLETED|Overall Study||4
1525440|NCT01463696|3733546|P3|NOT COMPLETED|Overall Study||1
1525441|NCT01463696|3733547|P2|NOT COMPLETED|Overall Study||2
1525442|NCT01463696|3733548|P1|NOT COMPLETED|Overall Study||0
1525443|NCT01463696|3733541|P8|COMPLETED|Overall Study||2
1525444|NCT01463696|3733542|P7|COMPLETED|Overall Study||6
1525445|NCT01463696|3733543|P6|COMPLETED|Overall Study||3
1525446|NCT01463696|3733544|P5|COMPLETED|Overall Study||2
1525447|NCT01463696|3733545|P4|COMPLETED|Overall Study||3
1525448|NCT01463696|3733546|P3|COMPLETED|Overall Study||2
1525449|NCT01463696|3733547|P2|COMPLETED|Overall Study||4
1525450|NCT01463696|3733548|P1|COMPLETED|Overall Study||1
1525451|NCT01463696|3733541|P8|Treated|Overall Study||6
1525452|NCT01463696|3733542|P7|Treated|Overall Study||15
1525453|NCT01463696|3733543|P6|Treated|Overall Study||6
1525454|NCT01463696|3733544|P5|Treated|Overall Study||3
1525455|NCT01463696|3733545|P4|Treated|Overall Study||7
1525456|NCT01463696|3733546|P3|Treated|Overall Study||3
1525457|NCT01463696|3733547|P2|Treated|Overall Study||6
1525458|NCT01463696|3733548|P1|Treated|Overall Study||1
1525459|NCT01463696|3733541|P8|STARTED|Overall Study||6
1525460|NCT01463696|3733542|P7|STARTED|Overall Study||16
1525461|NCT01463696|3733543|P6|STARTED|Overall Study||6
1525462|NCT01463696|3733544|P5|STARTED|Overall Study||3
1525463|NCT01463696|3733545|P4|STARTED|Overall Study||7
1525464|NCT01463696|3733546|P3|STARTED|Overall Study||3
1525465|NCT01463696|3733547|P2|STARTED|Overall Study||6
1525466|NCT01463696|3733548|P1|STARTED|Overall Study||1
1525467|NCT01463683|3733601|P3|NOT COMPLETED|Overall Study||11
1525468|NCT01463683|3733602|P2|NOT COMPLETED|Overall Study||31
1525469|NCT01463683|3733603|P1|NOT COMPLETED|Overall Study||19
1525470|NCT01463683|3733601|P3|COMPLETED|Overall Study||93
1525471|NCT01463683|3733602|P2|COMPLETED|Overall Study||278
1525472|NCT01463683|3733603|P1|COMPLETED|Overall Study||290
1525473|NCT01463683|3733601|P3|Received Vaccination 3 (Month 6)|Overall Study||93
1525474|NCT01463683|3733602|P2|Received Vaccination 3 (Month 6)|Overall Study||281
1525475|NCT01463683|3733603|P1|Received Vaccination 3 (Month 6)|Overall Study||290
1525476|NCT01463683|3733601|P3|Received Vaccination 2 (Month 1)|Overall Study||103
1525477|NCT01463683|3733602|P2|Received Vaccination 2 (Month 1)|Overall Study||300
1525478|NCT01463683|3733603|P1|Received Vaccination 2 (Month 1)|Overall Study||302
1525479|NCT01463683|3733601|P3|Received Vaccination 1 (Day 1)|Overall Study||104
1525480|NCT01463683|3733602|P2|Received Vaccination 1 (Day 1)|Overall Study||308
1525481|NCT01463683|3733603|P1|Received Vaccination 1 (Day 1)|Overall Study||309
1525482|NCT01463683|3733601|P3|STARTED|Overall Study||104
1525483|NCT01463683|3733602|P2|STARTED|Overall Study||309
1525484|NCT01463683|3733603|P1|STARTED|Overall Study||309
1525485|NCT01463631|3733620|P4|NOT COMPLETED|Overall Study||6
1525486|NCT01463631|3733621|P3|NOT COMPLETED|Overall Study||1
1525487|NCT01463631|3733622|P2|NOT COMPLETED|Overall Study||0
1525488|NCT01463631|3733623|P1|NOT COMPLETED|Overall Study||0
1525489|NCT01463631|3733620|P4|COMPLETED|Overall Study||9
1525490|NCT01463631|3733621|P3|COMPLETED|Overall Study||4
1525491|NCT01463631|3733622|P2|COMPLETED|Overall Study||4
1525492|NCT01463631|3733623|P1|COMPLETED|Overall Study||3
1525493|NCT01463631|3733620|P4|Received at Least One Dose of Study Drug|Overall Study||15
1525494|NCT01463631|3733621|P3|Received at Least One Dose of Study Drug|Overall Study||5
1525495|NCT01463631|3733622|P2|Received at Least One Dose of Study Drug|Overall Study||4
1525496|NCT01463631|3733623|P1|Received at Least One Dose of Study Drug|Overall Study||3
1525497|NCT01463631|3733620|P4|STARTED|Overall Study||15
1525498|NCT01463631|3733621|P3|STARTED|Overall Study||5
1525499|NCT01463631|3733622|P2|STARTED|Overall Study||4
1525500|NCT01463631|3733623|P1|STARTED|Overall Study||3
1525501|NCT01463527|3733645|P2|NOT COMPLETED|Overall Study||7
1525502|NCT01463527|3733646|P1|NOT COMPLETED|Overall Study||6
1525503|NCT01463527|3733645|P2|COMPLETED|Overall Study||77
1525504|NCT01463527|3733646|P1|COMPLETED|Overall Study||77
1525505|NCT01463527|3733645|P2|STARTED|Overall Study||84
1525506|NCT01463527|3733646|P1|STARTED|Overall Study||83
1525507|NCT01463384|3733654|P1|NOT COMPLETED|Overall Study||0
1525508|NCT01463384|3733654|P1|COMPLETED|Overall Study||13
1525509|NCT01463384|3733654|P1|STARTED|Overall Study||13
1525510|NCT01463293|3733669|P3|NOT COMPLETED|Overall Study||12
1525511|NCT01463293|3733670|P2|NOT COMPLETED|Overall Study||16
1525512|NCT01463293|3733671|P1|NOT COMPLETED|Overall Study||6
1525513|NCT01463293|3733669|P3|COMPLETED|Overall Study||59
1525514|NCT01463293|3733670|P2|COMPLETED|Overall Study||63
1525515|NCT01463293|3733671|P1|COMPLETED|Overall Study||68
1525516|NCT01463293|3733669|P3|STARTED|Overall Study||71
1525517|NCT01463293|3733670|P2|STARTED|Overall Study||79
1525518|NCT01463293|3733671|P1|STARTED|Overall Study||74
1525519|NCT01463202|3733681|P2|NOT COMPLETED|Overall Study||0
1525520|NCT01463202|3733682|P1|NOT COMPLETED|Overall Study||0
1525521|NCT01463202|3733681|P2|COMPLETED|Overall Study||78
1525522|NCT01463202|3733682|P1|COMPLETED|Overall Study||79
1525523|NCT01463202|3733681|P2|STARTED|Overall Study||78
1525524|NCT01463202|3733682|P1|STARTED|Overall Study||79
1525525|NCT01463111|3733694|P1|NOT COMPLETED|Overall Study||9
1525526|NCT01463111|3733694|P1|COMPLETED|Overall Study||17
1525527|NCT01463111|3733694|P1|STARTED|Overall Study||26
1525528|NCT01463033|3733704|P2|NOT COMPLETED|Overall Study||6
1525529|NCT01463033|3733705|P1|NOT COMPLETED|Overall Study||7
1525530|NCT01463033|3733704|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
1525531|NCT01463033|3733705|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
1525532|NCT01463033|3733704|P2|STARTED|Overall Study||60
1525533|NCT01463033|3733705|P1|STARTED|Overall Study||66
1525534|NCT01463007|3733712|P1|NOT COMPLETED|Overall Study||1
1525535|NCT01463007|3733712|P1|COMPLETED|Overall Study||40
1525536|NCT01463007|3733712|P1|STARTED|Overall Study||41
1525537|NCT01462942|3733723|P5|NOT COMPLETED|Overall Study||45
1525538|NCT01462942|3733724|P4|NOT COMPLETED|Overall Study||50
1525539|NCT01462942|3733725|P3|NOT COMPLETED|Overall Study||40
1525540|NCT01462942|3733726|P2|NOT COMPLETED|Overall Study||34
1525541|NCT01462942|3733727|P1|NOT COMPLETED|Overall Study||34
1525542|NCT01462942|3733723|P5|COMPLETED|Overall Study||339
1525543|NCT01462942|3733724|P4|COMPLETED|Overall Study||335
1525544|NCT01462942|3733725|P3|COMPLETED|Overall Study||341
1525545|NCT01462942|3733726|P2|COMPLETED|Overall Study||351
1525546|NCT01462942|3733727|P1|COMPLETED|Overall Study||160
1525547|NCT01462942|3733723|P5|STARTED|Overall Study||384
1525548|NCT01462942|3733724|P4|STARTED|Overall Study||385
1525549|NCT01462942|3733725|P3|STARTED|Overall Study||381
1525550|NCT01462942|3733726|P2|STARTED|Overall Study||385
1525551|NCT01462942|3733727|P1|STARTED|Overall Study||194
1525552|NCT01462929|3733757|P3|NOT COMPLETED|Overall Study||5
1525553|NCT01462929|3733758|P2|NOT COMPLETED|Overall Study||4
1525554|NCT01462929|3733759|P1|NOT COMPLETED|Overall Study||5
1525555|NCT01462929|3733757|P3|COMPLETED|Overall Study||80
1525556|NCT01462929|3733758|P2|COMPLETED|Overall Study||154
1525557|NCT01462929|3733759|P1|COMPLETED|Overall Study||166
1525558|NCT01462929|3733757|P3|STARTED|Overall Study||85
1525559|NCT01462929|3733758|P2|STARTED|Overall Study||158
1525560|NCT01462929|3733759|P1|STARTED|Overall Study||171
1525561|NCT01462877|3733770|P1|NOT COMPLETED|Overall Study||71
1525562|NCT01462877|3733770|P1|COMPLETED|Overall Study||435
1525563|NCT01462877|3733770|P1|Per-protocol Set|Overall Study||364
1525564|NCT01462877|3733770|P1|Full Analysis Set|Overall Study||468
1525565|NCT01462877|3733770|P1|Safety Set|Overall Study||492
1525566|NCT01462877|3733770|P1|STARTED|Overall Study||506
1525567|NCT01462812|3733786|P2|NOT COMPLETED|Overall Study||1
1525568|NCT01462812|3733787|P1|NOT COMPLETED|Overall Study||0
1525569|NCT01462812|3733786|P2|COMPLETED|Overall Study||111
1525570|NCT01462812|3733787|P1|COMPLETED|Overall Study||111
1525571|NCT01462812|3733786|P2|STARTED|Overall Study||112
1525572|NCT01462812|3733787|P1|STARTED|Overall Study||111
1525573|NCT01462773|3733793|P1|NOT COMPLETED|Overall Study||0
1525574|NCT01462773|3733793|P1|COMPLETED|Overall Study||16
1525575|NCT01462773|3733793|P1|STARTED|Overall Study||16
1525576|NCT01462695|3733800|P2|NOT COMPLETED|Overall Study||13
1525577|NCT01462695|3733801|P1|NOT COMPLETED|Overall Study||17
1525578|NCT01462695|3733800|P2|COMPLETED|Overall Study||0
1525579|NCT01462695|3733801|P1|COMPLETED|Overall Study||0
1525580|NCT01462695|3733800|P2|STARTED|Overall Study||13
1525581|NCT01462695|3733801|P1|STARTED|Overall Study||17
1525582|NCT01462565|3733807|P1|NOT COMPLETED|Overall Study||0
1525583|NCT01462565|3733807|P1|COMPLETED|Overall Study||16
1525584|NCT01462565|3733807|P1|STARTED|Overall Study||16
1525585|NCT01462435|3733829|P4|NOT COMPLETED|Overall Study||5
1525586|NCT01462435|3733830|P3|NOT COMPLETED|Overall Study||1
1525587|NCT01462435|3733831|P2|NOT COMPLETED|Overall Study||0
1525588|NCT01462435|3733832|P1|NOT COMPLETED|Overall Study||1
1525589|NCT01462435|3733829|P4|COMPLETED|Overall Study||101
1525590|NCT01462435|3733830|P3|COMPLETED|Overall Study||106
1525591|NCT01462435|3733831|P2|COMPLETED|Overall Study||109
1525592|NCT01462435|3733832|P1|COMPLETED|Overall Study||105
1525593|NCT01462435|3733829|P4|STARTED|Overall Study||106
1525594|NCT01462435|3733830|P3|STARTED|Overall Study||107
1525595|NCT01462435|3733831|P2|STARTED|Overall Study||109
1525596|NCT01462435|3733832|P1|STARTED|Overall Study||106
1525597|NCT01462370|3733870|P2|NOT COMPLETED|Overall Study||5
1525598|NCT01462370|3733871|P1|NOT COMPLETED|Overall Study||1
1525599|NCT01462370|3733870|P2|COMPLETED|Overall Study||65
1525600|NCT01462370|3733871|P1|COMPLETED|Overall Study||68
1525601|NCT01462370|3733870|P2|STARTED|Overall Study||70
1525602|NCT01462370|3733871|P1|STARTED|Overall Study||69
1525603|NCT01462357|3733906|P3|NOT COMPLETED|Month 36||0
1525604|NCT01462357|3733907|P2|NOT COMPLETED|Month 36||0
1525605|NCT01462357|3733908|P1|NOT COMPLETED|Month 36||0
1525606|NCT01462357|3733906|P3|COMPLETED|Month 36||346
1525607|NCT01462357|3733907|P2|COMPLETED|Month 36||339
1525608|NCT01462357|3733908|P1|COMPLETED|Month 36||351
1525609|NCT01462357|3733906|P3|STARTED|Month 36||346
1525610|NCT01462357|3733907|P2|STARTED|Month 36||339
1525611|NCT01462357|3733908|P1|STARTED|Month 36||351
1525612|NCT01462357|3733906|P3|NOT COMPLETED|Month 24||9
1525613|NCT01462357|3733907|P2|NOT COMPLETED|Month 24||14
1525614|NCT01462357|3733908|P1|NOT COMPLETED|Month 24||4
1525615|NCT01462357|3733906|P3|COMPLETED|Month 24||349
1525616|NCT01462357|3733907|P2|COMPLETED|Month 24||344
1525617|NCT01462357|3733908|P1|COMPLETED|Month 24||355
1525618|NCT01462357|3733906|P3|STARTED|Month 24||358
1525619|NCT01462357|3733907|P2|STARTED|Month 24||358
1525620|NCT01462357|3733908|P1|STARTED|Month 24||359
1525621|NCT01462357|3733906|P3|NOT COMPLETED|Month 18||9
1525622|NCT01462357|3733907|P2|NOT COMPLETED|Month 18||11
1525623|NCT01462357|3733908|P1|NOT COMPLETED|Month 18||3
1525624|NCT01462357|3733906|P3|COMPLETED|Month 18||349
1525625|NCT01462357|3733907|P2|COMPLETED|Month 18||347
1525626|NCT01462357|3733908|P1|COMPLETED|Month 18||356
1525627|NCT01462357|3733906|P3|STARTED|Month 18||358
1525628|NCT01462357|3733907|P2|STARTED|Month 18||358
1525629|NCT01462357|3733908|P1|STARTED|Month 18||359
1525630|NCT01462357|3733906|P3|NOT COMPLETED|Month 12||8
1525631|NCT01462357|3733907|P2|NOT COMPLETED|Month 12||10
1525632|NCT01462357|3733908|P1|NOT COMPLETED|Month 12||3
1525633|NCT01462357|3733906|P3|COMPLETED|Month 12||350
1525634|NCT01462357|3733907|P2|COMPLETED|Month 12||348
1525635|NCT01462357|3733908|P1|COMPLETED|Month 12||356
1525636|NCT01462357|3733906|P3|STARTED|Month 12||358
1525637|NCT01462357|3733907|P2|STARTED|Month 12||358
1525638|NCT01462357|3733908|P1|STARTED|Month 12||359
1525639|NCT01462357|3733906|P3|NOT COMPLETED|Month 7||6
1525640|NCT01462357|3733907|P2|NOT COMPLETED|Month 7||5
1525641|NCT01462357|3733908|P1|NOT COMPLETED|Month 7||1
1525642|NCT01462357|3733906|P3|COMPLETED|Month 7||352
1525643|NCT01462357|3733907|P2|COMPLETED|Month 7||353
1525644|NCT01462357|3733908|P1|COMPLETED|Month 7||358
1525645|NCT01462357|3733906|P3|STARTED|Month 7||358
1525646|NCT01462357|3733907|P2|STARTED|Month 7||358
1525647|NCT01462357|3733908|P1|STARTED|Month 7||359
1525648|NCT01462344|3733981|P2|NOT COMPLETED|Overall Study||350
1525649|NCT01462344|3733982|P1|NOT COMPLETED|Overall Study||383
1525650|NCT01462344|3733981|P2|COMPLETED|Overall Study||2751
1525651|NCT01462344|3733982|P1|COMPLETED|Overall Study||2724
1525652|NCT01462344|3733981|P2|STARTED|Overall Study||3101
1525653|NCT01462344|3733982|P1|STARTED|Overall Study||3107
1525654|NCT01462318|3734004|P3|NOT COMPLETED|Extension Phase||45
1525655|NCT01462318|3734005|P2|NOT COMPLETED|Extension Phase||0
1525656|NCT01462318|3734006|P1|NOT COMPLETED|Extension Phase||0
1525657|NCT01462318|3734004|P3|COMPLETED|Extension Phase||70
1525658|NCT01462318|3734005|P2|COMPLETED|Extension Phase||0
1525659|NCT01462318|3734006|P1|COMPLETED|Extension Phase||0
1525660|NCT01462318|3734004|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
1525661|NCT01462318|3734005|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
1525662|NCT01462318|3734006|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
1525663|NCT01462318|3734004|P3|NOT COMPLETED|Main Study / TP-DI Study||0
1525664|NCT01462318|3734005|P2|NOT COMPLETED|Main Study / TP-DI Study||0
1525665|NCT01462318|3734006|P1|NOT COMPLETED|Main Study / TP-DI Study||8
1525666|NCT01462318|3734004|P3|COMPLETED|Main Study / TP-DI Study||0
1525667|NCT01462318|3734005|P2|COMPLETED|Main Study / TP-DI Study||20
1525668|NCT01462318|3734006|P1|COMPLETED|Main Study / TP-DI Study||105
1525669|NCT01462318|3734004|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
1525670|NCT01462318|3734005|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
1525671|NCT01462318|3734006|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
1525672|NCT01462318|3734004|P3|STARTED|Main Study / TP-DI Study||0
1525673|NCT01462318|3734005|P2|STARTED|Main Study / TP-DI Study||20
1525674|NCT01462318|3734006|P1|STARTED|Main Study / TP-DI Study||113
1525675|NCT01462292|3734026|P3|NOT COMPLETED|Overall Study||0
1525676|NCT01462292|3734027|P2|NOT COMPLETED|Overall Study||0
1525677|NCT01462292|3734028|P1|NOT COMPLETED|Overall Study||0
1525678|NCT01462292|3734026|P3|COMPLETED|Overall Study||18
1525679|NCT01462292|3734027|P2|COMPLETED|Overall Study||17
1525680|NCT01462292|3734028|P1|COMPLETED|Overall Study||16
1525681|NCT01462292|3734026|P3|STARTED|Overall Study||18
1525682|NCT01462292|3734027|P2|STARTED|Overall Study||17
1525683|NCT01462292|3734028|P1|STARTED|Overall Study||16
1525684|NCT01462279|3734087|P1|NOT COMPLETED|Overall Study||3
1525685|NCT01462279|3734087|P1|COMPLETED|Overall Study||17
1525686|NCT01462279|3734087|P1|STARTED|Overall Study||20
1525687|NCT01462266|3734094|P2|NOT COMPLETED|Overall Study||27
1525688|NCT01462266|3734095|P1|NOT COMPLETED|Overall Study||35
1525689|NCT01462266|3734094|P2|COMPLETED|Overall Study||303
1525690|NCT01462266|3734095|P1|COMPLETED|Overall Study||295
1525691|NCT01462266|3734094|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
1525692|NCT01462266|3734095|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
1525693|NCT01462266|3734094|P2|STARTED|Overall Study||330
1525694|NCT01462266|3734095|P1|STARTED|Overall Study||330
1525695|NCT01462227|3734111|P4|NOT COMPLETED|Second Assignment||0
1525696|NCT01462227|3734112|P3|NOT COMPLETED|Second Assignment||1
1525697|NCT01462227|3734113|P2|NOT COMPLETED|Second Assignment||1
1525698|NCT01462227|3734114|P1|NOT COMPLETED|Second Assignment||1
1525699|NCT01462227|3734111|P4|COMPLETED|Second Assignment||5
1525700|NCT01462227|3734112|P3|COMPLETED|Second Assignment||5
1525701|NCT01462227|3734113|P2|COMPLETED|Second Assignment||1
1525702|NCT01462227|3734114|P1|COMPLETED|Second Assignment||3
1525703|NCT01462227|3734111|P4|STARTED|Second Assignment||5
1525704|NCT01462227|3734112|P3|STARTED|Second Assignment||6
1525705|NCT01462227|3734113|P2|STARTED|Second Assignment||2
1525706|NCT01462227|3734114|P1|STARTED|Second Assignment||4
1525707|NCT01462227|3734111|P4|NOT COMPLETED|First Assignment||0
1525708|NCT01462227|3734112|P3|NOT COMPLETED|First Assignment||0
1525709|NCT01462227|3734113|P2|NOT COMPLETED|First Assignment||0
1525710|NCT01462227|3734114|P1|NOT COMPLETED|First Assignment||0
1525711|NCT01462227|3734111|P4|COMPLETED|First Assignment||5
1525712|NCT01462227|3734112|P3|COMPLETED|First Assignment||6
1525713|NCT01462227|3734113|P2|COMPLETED|First Assignment||2
1525714|NCT01462227|3734114|P1|COMPLETED|First Assignment||4
1525715|NCT01462227|3734111|P4|STARTED|First Assignment||5
1525716|NCT01462227|3734112|P3|STARTED|First Assignment||6
1525717|NCT01462227|3734113|P2|STARTED|First Assignment||2
1525718|NCT01462227|3734114|P1|STARTED|First Assignment||4
1525719|NCT01462162|3734132|P1|NOT COMPLETED|Overall Study||12
1525720|NCT01462162|3734132|P1|COMPLETED|Overall Study||108
1525721|NCT01462162|3734132|P1|STARTED|Overall Study||120
1525722|NCT01462084|3734157|P2|NOT COMPLETED|Overall Study||1
1525723|NCT01462084|3734158|P1|NOT COMPLETED|Overall Study||2
1525724|NCT01462084|3734157|P2|COMPLETED|Overall Study||9
1525725|NCT01462084|3734158|P1|COMPLETED|Overall Study||9
1525726|NCT01462084|3734157|P2|Included for Analysis|Overall Study||9
1525727|NCT01462084|3734158|P1|Included for Analysis|Overall Study||9
1525728|NCT01462084|3734157|P2|STARTED|Overall Study||10
1525729|NCT01462084|3734158|P1|STARTED|Overall Study||11
1525730|NCT01462045|3734169|P3|NOT COMPLETED|Overall Study||0
1525731|NCT01462045|3734170|P2|NOT COMPLETED|Overall Study||1
1525732|NCT01462045|3734171|P1|NOT COMPLETED|Overall Study||0
1525733|NCT01462045|3734169|P3|COMPLETED|Overall Study||7
1525734|NCT01462045|3734170|P2|COMPLETED|Overall Study||10
1525735|NCT01462045|3734171|P1|COMPLETED|Overall Study||11
1525736|NCT01462045|3734169|P3|STARTED|Overall Study||7
1525737|NCT01462045|3734170|P2|STARTED|Overall Study||11
1525738|NCT01462045|3734171|P1|STARTED|Overall Study||11
1525739|NCT01461993|3734185|P3|NOT COMPLETED|Overall Study||64
1525740|NCT01461993|3734186|P2|NOT COMPLETED|Overall Study||157
1525741|NCT01461993|3734187|P1|NOT COMPLETED|Overall Study||151
1525742|NCT01461993|3734185|P3|COMPLETED|Overall Study||438
1525743|NCT01461993|3734186|P2|COMPLETED|Overall Study||841
1525744|NCT01461993|3734187|P1|COMPLETED|Overall Study||848
1525745|NCT01461993|3734185|P3|STARTED|Overall Study||502
1525746|NCT01461993|3734186|P2|STARTED|Overall Study||998
1525747|NCT01461993|3734187|P1|STARTED|Overall Study||999
1525748|NCT01461980|3734212|P3|NOT COMPLETED|Overall Study||165
1525749|NCT01461980|3734213|P2|NOT COMPLETED|Overall Study||145
1525750|NCT01461980|3734214|P1|NOT COMPLETED|Overall Study||166
1525751|NCT01461980|3734212|P3|COMPLETED|Overall Study||717
1525752|NCT01461980|3734213|P2|COMPLETED|Overall Study||733
1525753|NCT01461980|3734214|P1|COMPLETED|Overall Study||722
1525754|NCT01461980|3734212|P3|Vaccination 3|Overall Study||748
1525755|NCT01461980|3734213|P2|Vaccination 3|Overall Study||777
1525756|NCT01461980|3734214|P1|Vaccination 3|Overall Study||757
1525757|NCT01461980|3734212|P3|Vaccination 2|Overall Study||799
1525758|NCT01461980|3734213|P2|Vaccination 2|Overall Study||819
1525759|NCT01461980|3734214|P1|Vaccination 2|Overall Study||802
1525760|NCT01461980|3734212|P3|Vaccination 1|Overall Study||875
1525761|NCT01461980|3734213|P2|Vaccination 1|Overall Study||870
1525762|NCT01461980|3734214|P1|Vaccination 1|Overall Study||884
1525763|NCT01461980|3734212|P3|STARTED|Overall Study||882
1525764|NCT01461980|3734213|P2|STARTED|Overall Study||878
1525765|NCT01461980|3734214|P1|STARTED|Overall Study||888
1525766|NCT01461863|3734246|P2|NOT COMPLETED|Overall Study||0
1525767|NCT01461863|3734247|P1|NOT COMPLETED|Overall Study||0
1525768|NCT01461863|3734246|P2|COMPLETED|Overall Study||48
1525769|NCT01461863|3734247|P1|COMPLETED|Overall Study||48
1525770|NCT01461863|3734246|P2|STARTED|Overall Study||48
1525771|NCT01461863|3734247|P1|STARTED|Overall Study||48
1525772|NCT01461824|3734258|P3|NOT COMPLETED|Overall Study||3
1525773|NCT01461824|3734259|P2|NOT COMPLETED|Overall Study||4
1525774|NCT01461824|3734260|P1|NOT COMPLETED|Overall Study||2
1525775|NCT01461824|3734258|P3|COMPLETED|Overall Study||8
1525776|NCT01461824|3734259|P2|COMPLETED|Overall Study||7
1525777|NCT01461824|3734260|P1|COMPLETED|Overall Study||10
1525778|NCT01461824|3734258|P3|STARTED|Overall Study||11
1525779|NCT01461824|3734259|P2|STARTED|Overall Study||11
1525780|NCT01461824|3734260|P1|STARTED|Overall Study||12
1525781|NCT01461811|3734276|P2|NOT COMPLETED|Overall Study||3
1525782|NCT01461811|3734277|P1|NOT COMPLETED|Overall Study||4
1525783|NCT01461811|3734276|P2|COMPLETED|Overall Study||46
1525784|NCT01461811|3734277|P1|COMPLETED|Overall Study||91
1525785|NCT01461811|3734276|P2|STARTED|Overall Study||49
1525786|NCT01461811|3734277|P1|STARTED|Overall Study||95
1525787|NCT01461733|3734307|P2|NOT COMPLETED|Overall Study||4
1525788|NCT01461733|3734308|P1|NOT COMPLETED|Overall Study||4
1525789|NCT01461733|3734307|P2|COMPLETED|Overall Study||8
1525790|NCT01461733|3734308|P1|COMPLETED|Overall Study||8
1525791|NCT01461733|3734307|P2|STARTED|Overall Study||12
1525792|NCT01461733|3734308|P1|STARTED|Overall Study||12
1525793|NCT01461707|3734316|P2|NOT COMPLETED|Overall Study||0
1525794|NCT01461707|3734317|P1|NOT COMPLETED|Overall Study||1
1525795|NCT01461707|3734316|P2|COMPLETED|Overall Study||15
1525796|NCT01461707|3734317|P1|COMPLETED|Overall Study||14
1525797|NCT01461707|3734316|P2|STARTED|Overall Study||15
1525798|NCT01461707|3734317|P1|STARTED|Overall Study||15
1525799|NCT01461668|3734327|P2|NOT COMPLETED|Overall Study||1
1525800|NCT01461668|3734328|P1|NOT COMPLETED|Overall Study||2
1525801|NCT01461668|3734327|P2|COMPLETED|Overall Study||25
1525802|NCT01461668|3734328|P1|COMPLETED|Overall Study||25
1525803|NCT01461668|3734327|P2|STARTED|Overall Study||26
1525804|NCT01461668|3734328|P1|STARTED|Overall Study||27
1525805|NCT01461655|3734334|P1|NOT COMPLETED|Overall Study||0
1525806|NCT01461655|3734334|P1|COMPLETED|Overall Study||40
1525807|NCT01461655|3734334|P1|STARTED|Overall Study||40
1525808|NCT01461551|3734354|P3|NOT COMPLETED|Overall Study||2
1525809|NCT01461551|3734355|P2|NOT COMPLETED|Overall Study||1
1525810|NCT01461551|3734356|P1|NOT COMPLETED|Overall Study||2
1525811|NCT01461551|3734354|P3|COMPLETED|Overall Study||33
1525812|NCT01461551|3734355|P2|COMPLETED|Overall Study||34
1525813|NCT01461551|3734356|P1|COMPLETED|Overall Study||33
1525814|NCT01461551|3734354|P3|STARTED|Overall Study||35
1525815|NCT01461551|3734355|P2|STARTED|Overall Study||35
1525816|NCT01461551|3734356|P1|STARTED|Overall Study||35
1525817|NCT01461538|3734367|P3|NOT COMPLETED|Overall Study||2
1525818|NCT01461538|3734368|P2|NOT COMPLETED|Overall Study||8
1525819|NCT01461538|3734369|P1|NOT COMPLETED|Overall Study||18
1525820|NCT01461538|3734367|P3|COMPLETED|Overall Study||7
1525821|NCT01461538|3734368|P2|COMPLETED|Overall Study||20
1525822|NCT01461538|3734369|P1|COMPLETED|Overall Study||28
1525823|NCT01461538|3734367|P3|STARTED|Overall Study||9
1525824|NCT01461538|3734368|P2|STARTED|Overall Study||28
1525825|NCT01461538|3734369|P1|STARTED|Overall Study||46
1525826|NCT01461499|3734407|P2|NOT COMPLETED|Overall Study||4
1525827|NCT01461499|3734408|P1|NOT COMPLETED|Overall Study||8
1525828|NCT01461499|3734407|P2|COMPLETED|Overall Study||114
1525829|NCT01461499|3734408|P1|COMPLETED|Overall Study||111
1525830|NCT01461499|3734407|P2|STARTED|Overall Study||118
1525831|NCT01461499|3734408|P1|STARTED|Overall Study||119
1525832|NCT01461473|3734418|P2|NOT COMPLETED|Overall Study||4
1525833|NCT01461473|3734419|P1|NOT COMPLETED|Overall Study||5
1525834|NCT01461473|3734418|P2|COMPLETED|Overall Study||55
1525835|NCT01461473|3734419|P1|COMPLETED|Overall Study||67
1525836|NCT01461473|3734418|P2|STARTED|Overall Study||59
1525837|NCT01461473|3734419|P1|STARTED|Overall Study||72
1525838|NCT01461369|3734438|P3|NOT COMPLETED|Overall Study||17
1525839|NCT01461369|3734439|P2|NOT COMPLETED|Overall Study||17
1525840|NCT01461369|3734440|P1|NOT COMPLETED|Overall Study||13
1525841|NCT01461369|3734438|P3|COMPLETED|Overall Study||86
1525842|NCT01461369|3734439|P2|COMPLETED|Overall Study||81
1525843|NCT01461369|3734440|P1|COMPLETED|Overall Study||91
1525844|NCT01461369|3734438|P3|STARTED|Overall Study||103
1525845|NCT01461369|3734439|P2|STARTED|Overall Study||98
1525846|NCT01461369|3734440|P1|STARTED|Overall Study||104
1525847|NCT01461096|3734465|P2|NOT COMPLETED|Overall Study||61
1525848|NCT01461096|3734466|P1|NOT COMPLETED|Overall Study||62
1525849|NCT01461096|3734465|P2|COMPLETED|Overall Study||226
1525850|NCT01461096|3734466|P1|COMPLETED|Overall Study||226
1525851|NCT01461096|3734465|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
1525852|NCT01461096|3734466|P1|Did Not Start Treatment|Overall Study||0
1525853|NCT01461096|3734465|P2|STARTED|Overall Study||287
1525854|NCT01461096|3734466|P1|STARTED|Overall Study||288
1525855|NCT01461057|3734482|P2|NOT COMPLETED|Overall Study||15
1525856|NCT01461057|3734483|P1|NOT COMPLETED|Overall Study||15
1525857|NCT01461057|3734482|P2|COMPLETED|Overall Study||0
1525858|NCT01461057|3734483|P1|COMPLETED|Overall Study||0
1525859|NCT01461057|3734482|P2|STARTED|Overall Study||15
1525860|NCT01461057|3734483|P1|STARTED|Overall Study||15
1525861|NCT01461044|3734493|P2|NOT COMPLETED|Overall Study||40
1525862|NCT01461044|3734494|P1|NOT COMPLETED|Overall Study||70
1525863|NCT01461044|3734493|P2|COMPLETED|Overall Study||37
1525864|NCT01461044|3734494|P1|COMPLETED|Overall Study||80
1525865|NCT01461044|3734493|P2|Participants Alive at Inclusion|Overall Study||58
1525866|NCT01461044|3734494|P1|Participants Alive at Inclusion|Overall Study||127
1525867|NCT01461044|3734493|P2|STARTED|Overall Study||77
1525868|NCT01461044|3734494|P1|STARTED|Overall Study||150
1525869|NCT01460940|3734567|P1|NOT COMPLETED|Overall Study||0
1525870|NCT01460940|3734567|P1|COMPLETED|Overall Study||24
1525871|NCT01460940|3734567|P1|STARTED|Overall Study||24
1525872|NCT01460927|3734573|P1|NOT COMPLETED|Overall Study||0
1525873|NCT01460927|3734573|P1|COMPLETED|Overall Study||25
1525874|NCT01460927|3734573|P1|STARTED|Overall Study||25
1525875|NCT01460875|3734581|P1|NOT COMPLETED|Overall Study||0
1525876|NCT01460875|3734581|P1|COMPLETED|Overall Study||34
1525877|NCT01460875|3734581|P1|STARTED|Overall Study||34
1525878|NCT01460732|3734592|P1|NOT COMPLETED|Overall Study||0
1525879|NCT01460732|3734592|P1|COMPLETED|Overall Study||81
1525880|NCT01460732|3734592|P1|STARTED|Overall Study||81
1525881|NCT01460628|3734605|P1|NOT COMPLETED|Overall Study||5
1525882|NCT01460628|3734605|P1|COMPLETED|Overall Study||20
1525883|NCT01460628|3734605|P1|STARTED|Overall Study||25
1525884|NCT01460446|3734617|P2|NOT COMPLETED|Overall Study||20
1525885|NCT01460446|3734618|P1|NOT COMPLETED|Overall Study||5
1525886|NCT01460446|3734617|P2|COMPLETED|Overall Study||93
1525887|NCT01460446|3734618|P1|COMPLETED|Overall Study||100
1525888|NCT01460446|3734617|P2|STARTED|Overall Study||113
1525889|NCT01460446|3734618|P1|STARTED|Overall Study||105
1525890|NCT01460407|3734645|P2|NOT COMPLETED|Period 2: Day 6 to Day 14||1
1525891|NCT01460407|3734646|P1|NOT COMPLETED|Period 2: Day 6 to Day 14||0
1525892|NCT01460407|3734645|P2|COMPLETED|Period 2: Day 6 to Day 14||13
1525893|NCT01460407|3734646|P1|COMPLETED|Period 2: Day 6 to Day 14||0
1525894|NCT01460407|3734645|P2|STARTED|Period 2: Day 6 to Day 14||14
1525895|NCT01460407|3734646|P1|STARTED|Period 2: Day 6 to Day 14||0
1525896|NCT01460407|3734645|P2|NOT COMPLETED|Period 1: Day 1 to Day 5||0
1525897|NCT01460407|3734646|P1|NOT COMPLETED|Period 1: Day 1 to Day 5||0
1525898|NCT01460407|3734645|P2|COMPLETED|Period 1: Day 1 to Day 5||0
1525899|NCT01460407|3734646|P1|COMPLETED|Period 1: Day 1 to Day 5||14
1525900|NCT01460407|3734645|P2|STARTED|Period 1: Day 1 to Day 5||0
1525901|NCT01460407|3734646|P1|STARTED|Period 1: Day 1 to Day 5||14
1525902|NCT01460381|3734659|P2|NOT COMPLETED|Period 2 (Days 8-15)||0
1525903|NCT01460381|3734660|P1|NOT COMPLETED|Period 2 (Days 8-15)||1
1525904|NCT01460381|3734659|P2|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
1525905|NCT01460381|3734660|P1|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
1525906|NCT01460381|3734659|P2|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
1525907|NCT01460381|3734660|P1|STARTED|Period 2 (Days 8-15)||7
1525908|NCT01460381|3734659|P2|NOT COMPLETED|Period 1 (Days 1-7)||0
1525909|NCT01460381|3734660|P1|NOT COMPLETED|Period 1 (Days 1-7)||0
1525910|NCT01460381|3734659|P2|COMPLETED|Period 1 (Days 1-7)||11
1525911|NCT01460381|3734660|P1|COMPLETED|Period 1 (Days 1-7)||7
1525912|NCT01460381|3734659|P2|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
1525913|NCT01460381|3734660|P1|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
1525914|NCT01460381|3734659|P2|STARTED|Period 1 (Days 1-7)||11
1525915|NCT01460381|3734660|P1|STARTED|Period 1 (Days 1-7)||7
1525916|NCT01460368|3734676|P7|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
1525917|NCT01460368|3734677|P6|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
1525918|NCT01460368|3734678|P5|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
1525919|NCT01460368|3734679|P4|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
1525920|NCT01460368|3734680|P3|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
1525921|NCT01460368|3734681|P2|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
1525922|NCT01460368|3734682|P1|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
1525923|NCT01460368|3734676|P7|COMPLETED|Part B: Third Interventions (Period 3)||9
1525924|NCT01460368|3734677|P6|COMPLETED|Part B: Third Interventions (Period 3)||9
1525925|NCT01460368|3734678|P5|COMPLETED|Part B: Third Interventions (Period 3)||9
1525926|NCT01460368|3734679|P4|COMPLETED|Part B: Third Interventions (Period 3)||9
1525927|NCT01460368|3734680|P3|COMPLETED|Part B: Third Interventions (Period 3)||8
1525928|NCT01460368|3734681|P2|COMPLETED|Part B: Third Interventions (Period 3)||8
1525929|NCT01460368|3734682|P1|COMPLETED|Part B: Third Interventions (Period 3)||0
1525930|NCT01460368|3734676|P7|STARTED|Part B: Third Interventions (Period 3)||9
1525931|NCT01460368|3734677|P6|STARTED|Part B: Third Interventions (Period 3)||10
1525932|NCT01460368|3734678|P5|STARTED|Part B: Third Interventions (Period 3)||9
1525933|NCT01460368|3734679|P4|STARTED|Part B: Third Interventions (Period 3)||10
1525934|NCT01460368|3734680|P3|STARTED|Part B: Third Interventions (Period 3)||9
1525935|NCT01460368|3734681|P2|STARTED|Part B: Third Interventions (Period 3)||8
1525936|NCT01460368|3734682|P1|STARTED|Part B: Third Interventions (Period 3)||0
1525937|NCT01460368|3734676|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525938|NCT01460368|3734677|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525939|NCT01460368|3734678|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525940|NCT01460368|3734679|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525941|NCT01460368|3734680|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
1525942|NCT01460368|3734681|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525943|NCT01460368|3734682|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525944|NCT01460368|3734676|P7|COMPLETED|Part B: Washout (up to 15 Days)||9
1525945|NCT01460368|3734677|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
1525946|NCT01460368|3734678|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
1525947|NCT01460368|3734679|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
1525948|NCT01460368|3734680|P3|COMPLETED|Part B: Washout (up to 15 Days)||9
1525949|NCT01460368|3734681|P2|COMPLETED|Part B: Washout (up to 15 Days)||8
1525950|NCT01460368|3734682|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
1525951|NCT01460368|3734676|P7|STARTED|Part B: Washout (up to 15 Days)||9
1525952|NCT01460368|3734677|P6|STARTED|Part B: Washout (up to 15 Days)||10
1525953|NCT01460368|3734678|P5|STARTED|Part B: Washout (up to 15 Days)||9
1525954|NCT01460368|3734679|P4|STARTED|Part B: Washout (up to 15 Days)||10
1525955|NCT01460368|3734680|P3|STARTED|Part B: Washout (up to 15 Days)||10
1525956|NCT01460368|3734681|P2|STARTED|Part B: Washout (up to 15 Days)||8
1525957|NCT01460368|3734682|P1|STARTED|Part B: Washout (up to 15 Days)||0
1525958|NCT01460368|3734676|P7|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
1525959|NCT01460368|3734677|P6|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1525960|NCT01460368|3734678|P5|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1525961|NCT01460368|3734679|P4|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1525962|NCT01460368|3734680|P3|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1525963|NCT01460368|3734681|P2|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
1525964|NCT01460368|3734682|P1|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
1525965|NCT01460368|3734676|P7|COMPLETED|Part B: Second Intervention (Period 2)||9
1525966|NCT01460368|3734677|P6|COMPLETED|Part B: Second Intervention (Period 2)||10
1525967|NCT01460368|3734678|P5|COMPLETED|Part B: Second Intervention (Period 2)||9
1525968|NCT01460368|3734679|P4|COMPLETED|Part B: Second Intervention (Period 2)||10
1525969|NCT01460368|3734680|P3|COMPLETED|Part B: Second Intervention (Period 2)||10
1525970|NCT01460368|3734681|P2|COMPLETED|Part B: Second Intervention (Period 2)||8
1525971|NCT01460368|3734682|P1|COMPLETED|Part B: Second Intervention (Period 2)||0
1525972|NCT01460368|3734676|P7|STARTED|Part B: Second Intervention (Period 2)||10
1525973|NCT01460368|3734677|P6|STARTED|Part B: Second Intervention (Period 2)||10
1525974|NCT01460368|3734678|P5|STARTED|Part B: Second Intervention (Period 2)||9
1525975|NCT01460368|3734679|P4|STARTED|Part B: Second Intervention (Period 2)||10
1525976|NCT01460368|3734680|P3|STARTED|Part B: Second Intervention (Period 2)||10
1525977|NCT01460368|3734681|P2|STARTED|Part B: Second Intervention (Period 2)||10
1525978|NCT01460368|3734682|P1|STARTED|Part B: Second Intervention (Period 2)||0
1525979|NCT01460368|3734676|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525980|NCT01460368|3734677|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525981|NCT01460368|3734678|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525982|NCT01460368|3734679|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525983|NCT01460368|3734680|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525984|NCT01460368|3734681|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525985|NCT01460368|3734682|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
1525986|NCT01460368|3734676|P7|COMPLETED|Part B: Washout (up to 15 Days)||10
1525987|NCT01460368|3734677|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
1525988|NCT01460368|3734678|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
1525989|NCT01460368|3734679|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
1525990|NCT01460368|3734680|P3|COMPLETED|Part B: Washout (up to 15 Days)||10
1525991|NCT01460368|3734681|P2|COMPLETED|Part B: Washout (up to 15 Days)||10
1525992|NCT01460368|3734682|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
1525993|NCT01460368|3734676|P7|STARTED|Part B: Washout (up to 15 Days)||10
1525994|NCT01460368|3734677|P6|STARTED|Part B: Washout (up to 15 Days)||10
1525995|NCT01460368|3734678|P5|STARTED|Part B: Washout (up to 15 Days)||9
1525996|NCT01460368|3734679|P4|STARTED|Part B: Washout (up to 15 Days)||10
1525997|NCT01460368|3734680|P3|STARTED|Part B: Washout (up to 15 Days)||10
1525998|NCT01460368|3734681|P2|STARTED|Part B: Washout (up to 15 Days)||10
1525999|NCT01460368|3734682|P1|STARTED|Part B: Washout (up to 15 Days)||0
1526000|NCT01460368|3734676|P7|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1526001|NCT01460368|3734677|P6|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1526002|NCT01460368|3734678|P5|NOT COMPLETED|Part B: First Intervention (Period 1)||1
1526003|NCT01460368|3734679|P4|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1526004|NCT01460368|3734680|P3|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1526005|NCT01460368|3734681|P2|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1526006|NCT01460368|3734682|P1|NOT COMPLETED|Part B: First Intervention (Period 1)||0
1526007|NCT01460368|3734676|P7|COMPLETED|Part B: First Intervention (Period 1)||10
1526008|NCT01460368|3734677|P6|COMPLETED|Part B: First Intervention (Period 1)||10
1526009|NCT01460368|3734678|P5|COMPLETED|Part B: First Intervention (Period 1)||9
1526010|NCT01460368|3734679|P4|COMPLETED|Part B: First Intervention (Period 1)||10
1526011|NCT01460368|3734680|P3|COMPLETED|Part B: First Intervention (Period 1)||10
1526012|NCT01460368|3734681|P2|COMPLETED|Part B: First Intervention (Period 1)||10
1526013|NCT01460368|3734682|P1|COMPLETED|Part B: First Intervention (Period 1)||0
1526014|NCT01460368|3734676|P7|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1526015|NCT01460368|3734677|P6|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1526016|NCT01460368|3734678|P5|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1526017|NCT01460368|3734679|P4|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1526018|NCT01460368|3734680|P3|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1526019|NCT01460368|3734681|P2|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
1526020|NCT01460368|3734682|P1|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
1526021|NCT01460368|3734676|P7|STARTED|Part B: First Intervention (Period 1)||10
1526022|NCT01460368|3734677|P6|STARTED|Part B: First Intervention (Period 1)||10
1526023|NCT01460368|3734678|P5|STARTED|Part B: First Intervention (Period 1)||10
1526024|NCT01460368|3734679|P4|STARTED|Part B: First Intervention (Period 1)||10
1526025|NCT01460368|3734680|P3|STARTED|Part B: First Intervention (Period 1)||10
1526026|NCT01460368|3734681|P2|STARTED|Part B: First Intervention (Period 1)||10
1526027|NCT01460368|3734682|P1|STARTED|Part B: First Intervention (Period 1)||0
1526028|NCT01460368|3734676|P7|NOT COMPLETED|Part A||0
1526029|NCT01460368|3734677|P6|NOT COMPLETED|Part A||0
1526030|NCT01460368|3734678|P5|NOT COMPLETED|Part A||0
1526031|NCT01460368|3734679|P4|NOT COMPLETED|Part A||0
1526032|NCT01460368|3734680|P3|NOT COMPLETED|Part A||0
1526033|NCT01460368|3734681|P2|NOT COMPLETED|Part A||0
1526034|NCT01460368|3734682|P1|NOT COMPLETED|Part A||0
1526035|NCT01460368|3734676|P7|COMPLETED|Part A||0
1526036|NCT01460368|3734677|P6|COMPLETED|Part A||0
1526037|NCT01460368|3734678|P5|COMPLETED|Part A||0
1526038|NCT01460368|3734679|P4|COMPLETED|Part A||0
1526039|NCT01460368|3734680|P3|COMPLETED|Part A||0
1526040|NCT01460368|3734681|P2|COMPLETED|Part A||0
1526041|NCT01460368|3734682|P1|COMPLETED|Part A||7
1526042|NCT01460368|3734676|P7|Received at Least One Dose of Study Drug|Part A||0
1526043|NCT01460368|3734677|P6|Received at Least One Dose of Study Drug|Part A||0
1526044|NCT01460368|3734678|P5|Received at Least One Dose of Study Drug|Part A||0
1526045|NCT01460368|3734679|P4|Received at Least One Dose of Study Drug|Part A||0
1526046|NCT01460368|3734680|P3|Received at Least One Dose of Study Drug|Part A||0
1526047|NCT01460368|3734681|P2|Received at Least One Dose of Study Drug|Part A||0
1526048|NCT01460368|3734682|P1|Received at Least One Dose of Study Drug|Part A||7
1526049|NCT01460368|3734676|P7|STARTED|Part A||0
1526050|NCT01460368|3734677|P6|STARTED|Part A||0
1526051|NCT01460368|3734678|P5|STARTED|Part A||0
1526052|NCT01460368|3734679|P4|STARTED|Part A||0
1526053|NCT01460368|3734680|P3|STARTED|Part A||0
1526054|NCT01460368|3734681|P2|STARTED|Part A||0
1526055|NCT01460368|3734682|P1|STARTED|Part A||7
1526056|NCT01460342|3734694|P2|NOT COMPLETED|Overall Study||14
1526057|NCT01460342|3734695|P1|NOT COMPLETED|Overall Study||11
1526058|NCT01460342|3734694|P2|COMPLETED|Overall Study||292
1526059|NCT01460342|3734695|P1|COMPLETED|Overall Study||293
1526060|NCT01460342|3734694|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
1526061|NCT01460342|3734695|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
1526062|NCT01460342|3734694|P2|STARTED|Overall Study||306
1526063|NCT01460342|3734695|P1|STARTED|Overall Study||304
1526064|NCT01460303|3734717|P2|NOT COMPLETED|Overall Study||0
1526065|NCT01460303|3734718|P1|NOT COMPLETED|Overall Study||0
1526066|NCT01460303|3734717|P2|COMPLETED|Overall Study||24
1526067|NCT01460303|3734718|P1|COMPLETED|Overall Study||25
1526068|NCT01460303|3734717|P2|STARTED|Overall Study||24
1526069|NCT01460303|3734718|P1|STARTED|Overall Study||25
1526070|NCT01460290|3734726|P1|NOT COMPLETED|Overall Study||4
1526071|NCT01460290|3734726|P1|COMPLETED|Overall Study||11
1526072|NCT01460290|3734726|P1|STARTED|Overall Study||15
1526073|NCT01460225|3734746|P1|NOT COMPLETED|Overall Study||0
1526074|NCT01460225|3734746|P1|COMPLETED|Overall Study|November 2010|19
1526075|NCT01460225|3734746|P1|STARTED|Overall Study|January 2009.|19
1526076|NCT01460160|3734753|P2|NOT COMPLETED|Follow-up||2
1526077|NCT01460160|3734754|P1|NOT COMPLETED|Follow-up||11
1526078|NCT01460160|3734753|P2|COMPLETED|Follow-up||20
1526079|NCT01460160|3734754|P1|COMPLETED|Follow-up||67
1526080|NCT01460160|3734753|P2|STARTED|Follow-up||22
1526081|NCT01460160|3734754|P1|STARTED|Follow-up||78
1526082|NCT01460160|3734753|P2|NOT COMPLETED|Treatment||5
1526083|NCT01460160|3734754|P1|NOT COMPLETED|Treatment||23
1526084|NCT01460160|3734753|P2|COMPLETED|Treatment||19
1526085|NCT01460160|3734754|P1|COMPLETED|Treatment||59
1526086|NCT01460160|3734753|P2|STARTED|Treatment||24
1526087|NCT01460160|3734754|P1|STARTED|Treatment||82
1526088|NCT01459913|3734795|P4|NOT COMPLETED|Overall Study||33
1526089|NCT01459913|3734796|P3|NOT COMPLETED|Overall Study||13
1526090|NCT01459913|3734797|P2|NOT COMPLETED|Overall Study||20
1526091|NCT01459913|3734798|P1|NOT COMPLETED|Overall Study||41
1526092|NCT01459913|3734795|P4|COMPLETED|Overall Study||29
1526093|NCT01459913|3734796|P3|COMPLETED|Overall Study||6
1526094|NCT01459913|3734797|P2|COMPLETED|Overall Study||32
1526095|NCT01459913|3734798|P1|COMPLETED|Overall Study||65
1526096|NCT01459913|3734795|P4|STARTED|Overall Study||62
1526097|NCT01459913|3734796|P3|STARTED|Overall Study||19
1526098|NCT01459913|3734797|P2|STARTED|Overall Study||52
1526099|NCT01459913|3734798|P1|STARTED|Overall Study||106
1526100|NCT01459796|3734829|P2|NOT COMPLETED|Overall Study||126
1526101|NCT01459796|3734830|P1|NOT COMPLETED|Overall Study||94
1526102|NCT01459796|3734829|P2|COMPLETED|Overall Study||0
1526103|NCT01459796|3734830|P1|COMPLETED|Overall Study||0
1526104|NCT01459796|3734829|P2|STARTED|Overall Study||126
1526105|NCT01459796|3734830|P1|STARTED|Overall Study||94
1526106|NCT01459783|3734848|P2|NOT COMPLETED|6 Months to 12 Months||30
1526107|NCT01459783|3734849|P1|NOT COMPLETED|6 Months to 12 Months||19
1526108|NCT01459783|3734848|P2|COMPLETED|6 Months to 12 Months||23
1526109|NCT01459783|3734849|P1|COMPLETED|6 Months to 12 Months||20
1526110|NCT01459783|3734848|P2|STARTED|6 Months to 12 Months||53
1526111|NCT01459783|3734849|P1|STARTED|6 Months to 12 Months||39
1526112|NCT01459783|3734848|P2|NOT COMPLETED|Baseline to 6 Months||20
1526113|NCT01459783|3734849|P1|NOT COMPLETED|Baseline to 6 Months||32
1526114|NCT01459783|3734848|P2|COMPLETED|Baseline to 6 Months||53
1526115|NCT01459783|3734849|P1|COMPLETED|Baseline to 6 Months||39
1526116|NCT01459783|3734848|P2|STARTED|Baseline to 6 Months||73
1526117|NCT01459783|3734849|P1|STARTED|Baseline to 6 Months||71
1526118|NCT01459705|3734860|P3|NOT COMPLETED|Overall Study||7
1526119|NCT01459705|3734861|P2|NOT COMPLETED|Overall Study||24
1526120|NCT01459705|3734862|P1|NOT COMPLETED|Overall Study||22
1526121|NCT01459705|3734860|P3|COMPLETED|Overall Study||47
1526122|NCT01459705|3734861|P2|COMPLETED|Overall Study||30
1526123|NCT01459705|3734862|P1|COMPLETED|Overall Study||32
1526124|NCT01459705|3734860|P3|STARTED|Overall Study||54
1526125|NCT01459705|3734861|P2|STARTED|Overall Study||54
1526126|NCT01459705|3734862|P1|STARTED|Overall Study||54
1526127|NCT01459653|3734880|P1|NOT COMPLETED|Overall Study||668
1526128|NCT01459653|3734880|P1|COMPLETED|Overall Study||828
1526129|NCT01459653|3734880|P1|STARTED|Overall Study||1496
1526130|NCT01459588|3735030|P4|NOT COMPLETED|Overall Study||1
1526131|NCT01459588|3735031|P3|NOT COMPLETED|Overall Study||1
1526132|NCT01459588|3735032|P2|NOT COMPLETED|Overall Study||2
1526133|NCT01459588|3735033|P1|NOT COMPLETED|Overall Study||1
1526134|NCT01459588|3735030|P4|COMPLETED|Overall Study||55
1526135|NCT01459588|3735031|P3|COMPLETED|Overall Study||102
1526136|NCT01459588|3735032|P2|COMPLETED|Overall Study||49
1526137|NCT01459588|3735033|P1|COMPLETED|Overall Study||104
1526138|NCT01459588|3735030|P4|STARTED|Overall Study||56
1526139|NCT01459588|3735031|P3|STARTED|Overall Study||103
1526140|NCT01459588|3735032|P2|STARTED|Overall Study||51
1526141|NCT01459588|3735033|P1|STARTED|Overall Study||105
1526142|NCT01459068|3735061|P2|NOT COMPLETED|Overall Study||34
1526143|NCT01459068|3735062|P1|NOT COMPLETED|Overall Study||39
1526144|NCT01459068|3735061|P2|COMPLETED|Overall Study||148
1526145|NCT01459068|3735062|P1|COMPLETED|Overall Study||126
1526146|NCT01459068|3735061|P2|STARTED|Overall Study||182
1526147|NCT01459068|3735062|P1|STARTED|Overall Study||165
1526148|NCT01459016|3735078|P1|NOT COMPLETED|Overall Study||15
1526149|NCT01459016|3735078|P1|COMPLETED|Overall Study||41
1526150|NCT01459016|3735078|P1|STARTED|Overall Study||56
1526151|NCT01458990|3735094|P2|NOT COMPLETED|Overall Study||0
1526152|NCT01458990|3735095|P1|NOT COMPLETED|Overall Study||0
1526153|NCT01458990|3735094|P2|COMPLETED|Overall Study||15
1526154|NCT01458990|3735095|P1|COMPLETED|Overall Study||45
1526155|NCT01458990|3735094|P2|STARTED|Overall Study||15
1526156|NCT01458990|3735095|P1|STARTED|Overall Study||45
1526157|NCT01458951|3735106|P3|NOT COMPLETED|Overall Study||15
1526158|NCT01458951|3735107|P2|NOT COMPLETED|Overall Study||1
1526159|NCT01458951|3735108|P1|NOT COMPLETED|Overall Study||32
1526160|NCT01458951|3735106|P3|COMPLETED|Overall Study||97
1526161|NCT01458951|3735107|P2|COMPLETED|Overall Study||5
1526162|NCT01458951|3735108|P1|COMPLETED|Overall Study||397
1526163|NCT01458951|3735106|P3|STARTED|Overall Study||112
1526164|NCT01458951|3735107|P2|STARTED|Overall Study||6
1526165|NCT01458951|3735108|P1|STARTED|Overall Study||429
1526166|NCT01458639|3735133|P1|NOT COMPLETED|Overall Study||6
1526167|NCT01458639|3735133|P1|COMPLETED|Overall Study||12
1526168|NCT01458639|3735133|P1|STARTED|Overall Study||18
1526169|NCT01458587|3735145|P2|NOT COMPLETED|Overall Study||0
1526170|NCT01458587|3735146|P1|NOT COMPLETED|Overall Study||1
1526171|NCT01458587|3735145|P2|COMPLETED|Overall Study||35
1526172|NCT01458587|3735146|P1|COMPLETED|Overall Study||34
1526173|NCT01458587|3735145|P2|STARTED|Overall Study||35
1526174|NCT01458587|3735146|P1|STARTED|Overall Study||35
1526175|NCT01458574|3735309|P3|NOT COMPLETED|Overall Study||145
1526176|NCT01458574|3735310|P2|NOT COMPLETED|Overall Study||71
1526177|NCT01458574|3735311|P1|NOT COMPLETED|Overall Study||87
1526178|NCT01458574|3735309|P3|COMPLETED|Overall Study||53
1526179|NCT01458574|3735310|P2|COMPLETED|Overall Study||126
1526180|NCT01458574|3735311|P1|COMPLETED|Overall Study||111
1526181|NCT01458574|3735309|P3|Treated|Overall Study||198
1526182|NCT01458574|3735310|P2|Treated|Overall Study||196
1526183|NCT01458574|3735311|P1|Treated|Overall Study||198
1526184|NCT01458574|3735309|P3|STARTED|Overall Study||198
1526185|NCT01458574|3735310|P2|STARTED|Overall Study||197
1526186|NCT01458574|3735311|P1|STARTED|Overall Study||198
1526187|NCT01458561|3735396|P2|NOT COMPLETED|Overall Study||0
1526188|NCT01458561|3735397|P1|NOT COMPLETED|Overall Study||0
1526189|NCT01458561|3735396|P2|COMPLETED|Overall Study||1
1526190|NCT01458561|3735397|P1|COMPLETED|Overall Study||0
1526191|NCT01458561|3735396|P2|STARTED|Overall Study||1
1526192|NCT01458561|3735397|P1|STARTED|Overall Study||0
1526193|NCT01458535|3735441|P6|NOT COMPLETED|Overall Study||4
1526194|NCT01458535|3735442|P5|NOT COMPLETED|Overall Study||4
1526195|NCT01458535|3735443|P4|NOT COMPLETED|Overall Study||4
1526196|NCT01458535|3735444|P3|NOT COMPLETED|Overall Study||2
1526197|NCT01458535|3735445|P2|NOT COMPLETED|Overall Study||2
1526198|NCT01458535|3735446|P1|NOT COMPLETED|Overall Study||0
1526199|NCT01458535|3735441|P6|COMPLETED|Overall Study||7
1526200|NCT01458535|3735442|P5|COMPLETED|Overall Study||6
1526201|NCT01458535|3735443|P4|COMPLETED|Overall Study||6
1526202|NCT01458535|3735444|P3|COMPLETED|Overall Study||8
1526203|NCT01458535|3735445|P2|COMPLETED|Overall Study||8
1526204|NCT01458535|3735446|P1|COMPLETED|Overall Study||10
1526205|NCT01458535|3735441|P6|STARTED|Overall Study||11
1526206|NCT01458535|3735442|P5|STARTED|Overall Study||10
1526207|NCT01458535|3735443|P4|STARTED|Overall Study||10
1526208|NCT01458535|3735444|P3|STARTED|Overall Study||10
1526209|NCT01458535|3735445|P2|STARTED|Overall Study||10
1526210|NCT01458535|3735446|P1|STARTED|Overall Study||10
1526211|NCT01458522|3735498|P2|NOT COMPLETED|Overall Study||11
1526212|NCT01458522|3735499|P1|NOT COMPLETED|Overall Study||3
1526213|NCT01458522|3735498|P2|COMPLETED|Overall Study||26
1526214|NCT01458522|3735499|P1|COMPLETED|Overall Study||34
1526215|NCT01458522|3735498|P2|Crossover to Second Drug|Overall Study||10
1526216|NCT01458522|3735499|P1|Crossover to Second Drug|Overall Study||15
1526217|NCT01458522|3735498|P2|Received First Drug|Overall Study||35
1526218|NCT01458522|3735499|P1|Received First Drug|Overall Study||35
1526219|NCT01458522|3735498|P2|STARTED|Overall Study||37
1526220|NCT01458522|3735499|P1|STARTED|Overall Study||37
1526221|NCT01458392|3735528|P3|NOT COMPLETED|Overall Study||31
1526222|NCT01458392|3735529|P2|NOT COMPLETED|Overall Study||13
1526223|NCT01458392|3735530|P1|NOT COMPLETED|Overall Study||2
1526224|NCT01458392|3735528|P3|COMPLETED|Overall Study||0
1526225|NCT01458392|3735529|P2|COMPLETED|Overall Study||0
1526226|NCT01458392|3735530|P1|COMPLETED|Overall Study||0
1526227|NCT01458392|3735528|P3|STARTED|Overall Study||31
1526228|NCT01458392|3735529|P2|STARTED|Overall Study||13
1526229|NCT01458392|3735530|P1|STARTED|Overall Study||2
1526230|NCT01458288|3735550|P1|NOT COMPLETED|Overall Study||0
1526231|NCT01458288|3735550|P1|COMPLETED|Overall Study||12
1526232|NCT01458288|3735550|P1|STARTED|Overall Study||12
1526233|NCT01458275|3735562|P3|NOT COMPLETED|Overall Study||9
1526234|NCT01458275|3735563|P2|NOT COMPLETED|Overall Study||13
1526235|NCT01458275|3735564|P1|NOT COMPLETED|Overall Study||14
1526236|NCT01458275|3735562|P3|COMPLETED|Overall Study||273
1526237|NCT01458275|3735563|P2|COMPLETED|Overall Study||269
1526238|NCT01458275|3735564|P1|COMPLETED|Overall Study||269
1526239|NCT01458275|3735562|P3|STARTED|Overall Study||282
1526240|NCT01458275|3735563|P2|STARTED|Overall Study||282
1526241|NCT01458275|3735564|P1|STARTED|Overall Study||283
1526242|NCT01458249|3735606|P1|NOT COMPLETED|Overall Study||8
1526243|NCT01458249|3735606|P1|COMPLETED|Overall Study||44
1526244|NCT01458249|3735606|P1|Participants Treated|Overall Study||51
1526245|NCT01458249|3735606|P1|STARTED|Overall Study||52
1526246|NCT01458210|3735625|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
1526247|NCT01458210|3735625|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
1526248|NCT01458210|3735625|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
1526249|NCT01458210|3735625|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
1526250|NCT01458210|3735625|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
1526251|NCT01458210|3735625|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
1526252|NCT01458210|3735625|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
1526253|NCT01458210|3735625|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
1526254|NCT01458210|3735625|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
1526255|NCT01458210|3735625|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
1526256|NCT01458171|3735642|P1|NOT COMPLETED|Overall Study||1
1526257|NCT01458171|3735642|P1|COMPLETED|Overall Study||22
1526258|NCT01458171|3735642|P1|STARTED|Overall Study||23
1526259|NCT01458119|3735663|P1|NOT COMPLETED|Overall Study||20
1526260|NCT01458119|3735663|P1|COMPLETED|Overall Study||65
1526261|NCT01458119|3735663|P1|ITT-Amenable Population|Overall Study||68
1526262|NCT01458119|3735663|P1|Intent to Treat (ITT) Population|Overall Study||85
1526263|NCT01458119|3735663|P1|Safety Population|Overall Study||85
1526264|NCT01458119|3735663|P1|Received at Least 1 Dose of Study Drug|Overall Study||85
1526265|NCT01458119|3735663|P1|STARTED|Overall Study||85
1526266|NCT01458106|3735670|P2|NOT COMPLETED|Overall Study||1
1526267|NCT01458106|3735671|P1|NOT COMPLETED|Overall Study||3
1526268|NCT01458106|3735670|P2|COMPLETED|Overall Study||34
1526269|NCT01458106|3735671|P1|COMPLETED|Overall Study||33
1526270|NCT01458106|3735670|P2|Non-PK Subgroup|Overall Study||0
1526271|NCT01458106|3735671|P1|Non-PK Subgroup|Overall Study||11
1526272|NCT01458106|3735670|P2|PK Subgroup|Overall Study||35
1526273|NCT01458106|3735671|P1|PK Subgroup|Overall Study||25
1526274|NCT01458106|3735670|P2|STARTED|Overall Study||35
1526275|NCT01458106|3735671|P1|STARTED|Overall Study||36
1526276|NCT01457950|3735748|P4|NOT COMPLETED|Open-Label Phase||2
1526277|NCT01457950|3735749|P3|NOT COMPLETED|Open-Label Phase||2
1526278|NCT01457950|3735750|P2|NOT COMPLETED|Open-Label Phase||0
1526279|NCT01457950|3735751|P1|NOT COMPLETED|Open-Label Phase||0
1526280|NCT01457950|3735748|P4|COMPLETED|Open-Label Phase||61
1526281|NCT01457950|3735749|P3|COMPLETED|Open-Label Phase||58
1526282|NCT01457950|3735750|P2|COMPLETED|Open-Label Phase||0
1526283|NCT01457950|3735751|P1|COMPLETED|Open-Label Phase||0
1526284|NCT01457950|3735748|P4|STARTED|Open-Label Phase||63
1526285|NCT01457950|3735749|P3|STARTED|Open-Label Phase||60
1526286|NCT01457950|3735750|P2|STARTED|Open-Label Phase||0
1526287|NCT01457950|3735751|P1|STARTED|Open-Label Phase||0
1526288|NCT01457950|3735748|P4|NOT COMPLETED|Double-Blind Phase||0
1526289|NCT01457950|3735749|P3|NOT COMPLETED|Double-Blind Phase||0
1526290|NCT01457950|3735750|P2|NOT COMPLETED|Double-Blind Phase||3
1526291|NCT01457950|3735751|P1|NOT COMPLETED|Double-Blind Phase||9
1526292|NCT01457950|3735748|P4|COMPLETED|Double-Blind Phase||0
1526293|NCT01457950|3735749|P3|COMPLETED|Double-Blind Phase||0
1526294|NCT01457950|3735750|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
1526378|NCT01457521|3735952|P2|NOT COMPLETED|Overall Study||10
1526295|NCT01457950|3735751|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
1526296|NCT01457950|3735748|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
1526297|NCT01457950|3735749|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
1526298|NCT01457950|3735750|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
1526299|NCT01457950|3735751|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
1526300|NCT01457950|3735748|P4|STARTED|Double-Blind Phase||0
1526301|NCT01457950|3735749|P3|STARTED|Double-Blind Phase||0
1526302|NCT01457950|3735750|P2|STARTED|Double-Blind Phase||66
1526303|NCT01457950|3735751|P1|STARTED|Double-Blind Phase||69
1526304|NCT01457924|3735830|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
1526305|NCT01457924|3735831|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
1526306|NCT01457924|3735832|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
1526307|NCT01457924|3735833|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
1526308|NCT01457924|3735834|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
1526309|NCT01457924|3735830|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
1526310|NCT01457924|3735831|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
1526311|NCT01457924|3735832|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
1526312|NCT01457924|3735833|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
1526313|NCT01457924|3735834|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
1526314|NCT01457924|3735830|P5|STARTED|Individualized FUP (Weeks 48+)||42
1526315|NCT01457924|3735831|P4|STARTED|Individualized FUP (Weeks 48+)||20
1526316|NCT01457924|3735832|P3|STARTED|Individualized FUP (Weeks 48+)||16
1526317|NCT01457924|3735833|P2|STARTED|Individualized FUP (Weeks 48+)||18
1526318|NCT01457924|3735834|P1|STARTED|Individualized FUP (Weeks 48+)||16
1526319|NCT01457924|3735830|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
1526320|NCT01457924|3735831|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
1526321|NCT01457924|3735832|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
1526322|NCT01457924|3735833|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
1526323|NCT01457924|3735834|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
1526324|NCT01457924|3735830|P5|COMPLETED|FUP (Weeks 24-48)||57
1526325|NCT01457924|3735831|P4|COMPLETED|FUP (Weeks 24-48)||32
1526326|NCT01457924|3735832|P3|COMPLETED|FUP (Weeks 24-48)||30
1526327|NCT01457924|3735833|P2|COMPLETED|FUP (Weeks 24-48)||30
1526328|NCT01457924|3735834|P1|COMPLETED|FUP (Weeks 24-48)||63
1526329|NCT01457924|3735830|P5|STARTED|FUP (Weeks 24-48)||59
1526330|NCT01457924|3735831|P4|STARTED|FUP (Weeks 24-48)||33
1526331|NCT01457924|3735832|P3|STARTED|FUP (Weeks 24-48)||32
1526332|NCT01457924|3735833|P2|STARTED|FUP (Weeks 24-48)||31
1526333|NCT01457924|3735834|P1|STARTED|FUP (Weeks 24-48)||66
1526334|NCT01457924|3735830|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
1526335|NCT01457924|3735831|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
1526336|NCT01457924|3735832|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
1526337|NCT01457924|3735833|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
1526338|NCT01457924|3735834|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
1526339|NCT01457924|3735830|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
1526340|NCT01457924|3735831|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
1526341|NCT01457924|3735832|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
1526342|NCT01457924|3735833|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
1526343|NCT01457924|3735834|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
1526344|NCT01457924|3735830|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
1526345|NCT01457924|3735831|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
1526346|NCT01457924|3735832|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
1526347|NCT01457924|3735833|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
1526348|NCT01457924|3735834|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
1526349|NCT01457924|3735830|P5|STARTED|Treatment Phase (Weeks 0-24)||64
1526350|NCT01457924|3735831|P4|STARTED|Treatment Phase (Weeks 0-24)||34
1526351|NCT01457924|3735832|P3|STARTED|Treatment Phase (Weeks 0-24)||32
1526352|NCT01457924|3735833|P2|STARTED|Treatment Phase (Weeks 0-24)||34
1526353|NCT01457924|3735834|P1|STARTED|Treatment Phase (Weeks 0-24)||67
1526354|NCT01457885|3735896|P1|NOT COMPLETED|Overall Study||0
1526355|NCT01457885|3735896|P1|COMPLETED|Overall Study||74
1526356|NCT01457885|3735896|P1|STARTED|Overall Study||74
1526357|NCT01457846|3735904|P2|NOT COMPLETED|Overall Study||30
1526358|NCT01457846|3735905|P1|NOT COMPLETED|Overall Study||41
1526359|NCT01457846|3735904|P2|COMPLETED|Overall Study||0
1526360|NCT01457846|3735905|P1|COMPLETED|Overall Study||0
1526361|NCT01457846|3735904|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
1526362|NCT01457846|3735905|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
1526363|NCT01457846|3735904|P2|Did Not Receive Treatment|Overall Study||3
1526364|NCT01457846|3735905|P1|Did Not Receive Treatment|Overall Study||1
1526365|NCT01457846|3735904|P2|Received Treatment|Overall Study||27
1526366|NCT01457846|3735905|P1|Received Treatment|Overall Study||40
1526367|NCT01457846|3735904|P2|STARTED|Overall Study||30
1526368|NCT01457846|3735905|P1|STARTED|Overall Study||41
1526369|NCT01457703|3735921|P2|NOT COMPLETED|Overall Study||11
1526370|NCT01457703|3735922|P1|NOT COMPLETED|Overall Study||6
1526371|NCT01457703|3735921|P2|COMPLETED|Overall Study||22
1526372|NCT01457703|3735922|P1|COMPLETED|Overall Study||23
1526373|NCT01457703|3735921|P2|STARTED|Overall Study||33
1526374|NCT01457703|3735922|P1|STARTED|Overall Study||29
1526375|NCT01457573|3735936|P1|NOT COMPLETED|Overall Study||0
1526376|NCT01457573|3735936|P1|COMPLETED|Overall Study||10
1526377|NCT01457573|3735936|P1|STARTED|Overall Study||10
1526379|NCT01457521|3735953|P1|NOT COMPLETED|Overall Study||12
1526380|NCT01457521|3735952|P2|COMPLETED|Overall Study||117
1526381|NCT01457521|3735953|P1|COMPLETED|Overall Study||111
1526382|NCT01457521|3735952|P2|STARTED|Overall Study||127
1526383|NCT01457521|3735953|P1|STARTED|Overall Study||123
1526384|NCT01457430|3735959|P1|NOT COMPLETED|Overall Study||0
1526385|NCT01457430|3735959|P1|COMPLETED|Overall Study||19
1526386|NCT01457430|3735959|P1|STARTED|Overall Study||19
1526387|NCT01457417|3735971|P5|NOT COMPLETED|Overall Study||0
1526388|NCT01457417|3735972|P4|NOT COMPLETED|Overall Study||0
1526389|NCT01457417|3735973|P3|NOT COMPLETED|Overall Study||0
1526390|NCT01457417|3735974|P2|NOT COMPLETED|Overall Study||0
1526391|NCT01457417|3735975|P1|NOT COMPLETED|Overall Study||0
1526392|NCT01457417|3735971|P5|COMPLETED|Overall Study||19
1526393|NCT01457417|3735972|P4|COMPLETED|Overall Study||3
1526394|NCT01457417|3735973|P3|COMPLETED|Overall Study||4
1526395|NCT01457417|3735974|P2|COMPLETED|Overall Study||3
1526396|NCT01457417|3735975|P1|COMPLETED|Overall Study||3
1526397|NCT01457417|3735971|P5|STARTED|Overall Study||19
1526398|NCT01457417|3735972|P4|STARTED|Overall Study||3
1526399|NCT01457417|3735973|P3|STARTED|Overall Study||4
1526400|NCT01457417|3735974|P2|STARTED|Overall Study||3
1526401|NCT01457417|3735975|P1|STARTED|Overall Study||3
1526402|NCT01457339|3736033|P2|NOT COMPLETED|Period 6 (250 mg)||1
1526403|NCT01457339|3736034|P1|NOT COMPLETED|Period 6 (250 mg)||1
1526404|NCT01457339|3736033|P2|COMPLETED|Period 6 (250 mg)||21
1526405|NCT01457339|3736034|P1|COMPLETED|Period 6 (250 mg)||6
1526406|NCT01457339|3736033|P2|STARTED|Period 6 (250 mg)||22
1526407|NCT01457339|3736034|P1|STARTED|Period 6 (250 mg)||7
1526408|NCT01457339|3736033|P2|NOT COMPLETED|Period 5 (200 mg)||1
1526409|NCT01457339|3736034|P1|NOT COMPLETED|Period 5 (200 mg)||0
1526410|NCT01457339|3736033|P2|COMPLETED|Period 5 (200 mg)||22
1526411|NCT01457339|3736034|P1|COMPLETED|Period 5 (200 mg)||7
1526412|NCT01457339|3736033|P2|STARTED|Period 5 (200 mg)||23
1526413|NCT01457339|3736034|P1|STARTED|Period 5 (200 mg)||7
1526414|NCT01457339|3736033|P2|NOT COMPLETED|Period 4 (150 mg)||0
1526415|NCT01457339|3736034|P1|NOT COMPLETED|Period 4 (150 mg)||0
1526416|NCT01457339|3736033|P2|COMPLETED|Period 4 (150 mg)||23
1526417|NCT01457339|3736034|P1|COMPLETED|Period 4 (150 mg)||7
1526418|NCT01457339|3736033|P2|STARTED|Period 4 (150 mg)||23
1526419|NCT01457339|3736034|P1|STARTED|Period 4 (150 mg)||7
1526420|NCT01457339|3736033|P2|NOT COMPLETED|Period 3 (100 mg)||1
1526421|NCT01457339|3736034|P1|NOT COMPLETED|Period 3 (100 mg)||0
1526422|NCT01457339|3736033|P2|COMPLETED|Period 3 (100 mg)||23
1526423|NCT01457339|3736034|P1|COMPLETED|Period 3 (100 mg)||7
1526424|NCT01457339|3736033|P2|STARTED|Period 3 (100 mg)||24
1526425|NCT01457339|3736034|P1|STARTED|Period 3 (100 mg)||7
1526426|NCT01457339|3736033|P2|NOT COMPLETED|Period 2 (70 mg)||0
1526427|NCT01457339|3736034|P1|NOT COMPLETED|Period 2 (70 mg)||0
1526428|NCT01457339|3736033|P2|COMPLETED|Period 2 (70 mg)||24
1526429|NCT01457339|3736034|P1|COMPLETED|Period 2 (70 mg)||7
1526430|NCT01457339|3736033|P2|STARTED|Period 2 (70 mg)||24
1526431|NCT01457339|3736034|P1|STARTED|Period 2 (70 mg)||7
1526432|NCT01457339|3736033|P2|NOT COMPLETED|Period 1 (50 mg)||0
1526433|NCT01457339|3736034|P1|NOT COMPLETED|Period 1 (50 mg)||0
1526434|NCT01457339|3736033|P2|COMPLETED|Period 1 (50 mg)||24
1526435|NCT01457339|3736034|P1|COMPLETED|Period 1 (50 mg)||7
1526436|NCT01457339|3736033|P2|STARTED|Period 1 (50 mg)||24
1526437|NCT01457339|3736034|P1|STARTED|Period 1 (50 mg)||7
1526438|NCT01457053|3736200|P2|NOT COMPLETED|Overall Study||1
1526439|NCT01457053|3736201|P1|NOT COMPLETED|Overall Study||1
1526440|NCT01457053|3736200|P2|COMPLETED|Overall Study||1
1526441|NCT01457053|3736201|P1|COMPLETED|Overall Study||1
1526442|NCT01457053|3736200|P2|STARTED|Overall Study||2
1526443|NCT01457053|3736201|P1|STARTED|Overall Study||2
1526444|NCT01457014|3736207|P4|NOT COMPLETED|Fourth Night||0
1526445|NCT01457014|3736208|P3|NOT COMPLETED|Fourth Night||0
1526446|NCT01457014|3736209|P2|NOT COMPLETED|Fourth Night||0
1526447|NCT01457014|3736210|P1|NOT COMPLETED|Fourth Night||0
1526448|NCT01457014|3736207|P4|COMPLETED|Fourth Night||11
1526449|NCT01457014|3736208|P3|COMPLETED|Fourth Night||12
1526450|NCT01457014|3736209|P2|COMPLETED|Fourth Night||11
1526451|NCT01457014|3736210|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
1526452|NCT01457014|3736207|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1526453|NCT01457014|3736208|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
1526454|NCT01457014|3736209|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1526455|NCT01457014|3736210|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
1526456|NCT01457014|3736207|P4|NOT COMPLETED|Third Night||0
1526457|NCT01457014|3736208|P3|NOT COMPLETED|Third Night||0
1526458|NCT01457014|3736209|P2|NOT COMPLETED|Third Night||0
1526459|NCT01457014|3736210|P1|NOT COMPLETED|Third Night||0
1526460|NCT01457014|3736207|P4|COMPLETED|Third Night||12
1526461|NCT01457014|3736208|P3|COMPLETED|Third Night||11
1526462|NCT01457014|3736209|P2|COMPLETED|Third Night||11
1526463|NCT01457014|3736210|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
1526464|NCT01457014|3736207|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
1526465|NCT01457014|3736208|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1526553|NCT01456130|3736469|P1|NOT COMPLETED|Overall Study||10
1526466|NCT01457014|3736209|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1526467|NCT01457014|3736210|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
1526468|NCT01457014|3736207|P4|NOT COMPLETED|Second Night||0
1526469|NCT01457014|3736208|P3|NOT COMPLETED|Second Night||0
1526470|NCT01457014|3736209|P2|NOT COMPLETED|Second Night||0
1526471|NCT01457014|3736210|P1|NOT COMPLETED|Second Night||0
1526472|NCT01457014|3736207|P4|COMPLETED|Second Night||11
1526473|NCT01457014|3736208|P3|COMPLETED|Second Night||11
1526474|NCT01457014|3736209|P2|COMPLETED|Second Night||12
1526475|NCT01457014|3736210|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
1526476|NCT01457014|3736207|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1526477|NCT01457014|3736208|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
1526478|NCT01457014|3736209|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
1526479|NCT01457014|3736210|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
1526480|NCT01457014|3736207|P4|NOT COMPLETED|First Night||0
1526481|NCT01457014|3736208|P3|NOT COMPLETED|First Night||0
1526482|NCT01457014|3736209|P2|NOT COMPLETED|First Night||0
1526483|NCT01457014|3736210|P1|NOT COMPLETED|First Night||40
1526484|NCT01457014|3736207|P4|COMPLETED|First Night||0
1526485|NCT01457014|3736208|P3|COMPLETED|First Night||0
1526486|NCT01457014|3736209|P2|COMPLETED|First Night||0
1526487|NCT01457014|3736210|P1|COMPLETED|First Night||34
1526488|NCT01457014|3736207|P4|STARTED|First Night||0
1526489|NCT01457014|3736208|P3|STARTED|First Night||0
1526490|NCT01457014|3736209|P2|STARTED|First Night||0
1526491|NCT01457014|3736210|P1|STARTED|First Night||74
1526492|NCT01456962|3736227|P2|NOT COMPLETED|Overall Study||1
1526493|NCT01456962|3736228|P1|NOT COMPLETED|Overall Study||2
1526494|NCT01456962|3736227|P2|COMPLETED|Overall Study||19
1526495|NCT01456962|3736228|P1|COMPLETED|Overall Study||14
1526496|NCT01456962|3736227|P2|STARTED|Overall Study||20
1526497|NCT01456962|3736228|P1|STARTED|Overall Study||16
1526498|NCT01456936|3736238|P4|NOT COMPLETED|Overall Study||483
1526499|NCT01456936|3736239|P3|NOT COMPLETED|Overall Study||481
1526500|NCT01456936|3736240|P2|NOT COMPLETED|Overall Study||448
1526501|NCT01456936|3736241|P1|NOT COMPLETED|Overall Study||439
1526502|NCT01456936|3736238|P4|COMPLETED|Overall Study||1552
1526503|NCT01456936|3736239|P3|COMPLETED|Overall Study||1557
1526504|NCT01456936|3736240|P2|COMPLETED|Overall Study||1586
1526505|NCT01456936|3736241|P1|COMPLETED|Overall Study||1598
1526506|NCT01456936|3736238|P4|Randomized and Treated|Overall Study||2014
1526507|NCT01456936|3736239|P3|Randomized and Treated|Overall Study||2022
1526508|NCT01456936|3736240|P2|Randomized and Treated|Overall Study||2006
1526509|NCT01456936|3736241|P1|Randomized and Treated|Overall Study||2016
1526510|NCT01456936|3736238|P4|STARTED|Overall Study||2035
1526511|NCT01456936|3736239|P3|STARTED|Overall Study||2038
1526512|NCT01456936|3736240|P2|STARTED|Overall Study||2034
1526513|NCT01456936|3736241|P1|STARTED|Overall Study||2037
1526514|NCT01456780|3736350|P3|NOT COMPLETED|Overall Study||0
1526515|NCT01456780|3736351|P2|NOT COMPLETED|Overall Study||3
1526516|NCT01456780|3736352|P1|NOT COMPLETED|Overall Study||3
1526517|NCT01456780|3736350|P3|COMPLETED|Overall Study||20
1526518|NCT01456780|3736351|P2|COMPLETED|Overall Study||17
1526519|NCT01456780|3736352|P1|COMPLETED|Overall Study||17
1526520|NCT01456780|3736350|P3|STARTED|Overall Study||20
1526521|NCT01456780|3736351|P2|STARTED|Overall Study||20
1526522|NCT01456780|3736352|P1|STARTED|Overall Study||20
1526523|NCT01456299|3736372|P3|NOT COMPLETED|Overall Study||1
1526524|NCT01456299|3736373|P2|NOT COMPLETED|Overall Study||1
1526525|NCT01456299|3736374|P1|NOT COMPLETED|Overall Study||0
1526526|NCT01456299|3736372|P3|COMPLETED|Overall Study||33
1526527|NCT01456299|3736373|P2|COMPLETED|Overall Study||33
1526528|NCT01456299|3736374|P1|COMPLETED|Overall Study||34
1526529|NCT01456299|3736372|P3|STARTED|Overall Study||34
1526530|NCT01456299|3736373|P2|STARTED|Overall Study||34
1526531|NCT01456299|3736374|P1|STARTED|Overall Study||34
1526532|NCT01456195|3736385|P3|NOT COMPLETED|Overall Study||14
1526533|NCT01456195|3736386|P2|NOT COMPLETED|Overall Study||10
1526534|NCT01456195|3736387|P1|NOT COMPLETED|Overall Study||11
1526535|NCT01456195|3736385|P3|COMPLETED|Overall Study||127
1526536|NCT01456195|3736386|P2|COMPLETED|Overall Study||127
1526537|NCT01456195|3736387|P1|COMPLETED|Overall Study||132
1526538|NCT01456195|3736385|P3|STARTED|Overall Study||141
1526539|NCT01456195|3736386|P2|STARTED|Overall Study||137
1526540|NCT01456195|3736387|P1|STARTED|Overall Study||143
1526541|NCT01456169|3736407|P3|NOT COMPLETED|Overall Study||12
1526542|NCT01456169|3736408|P2|NOT COMPLETED|Overall Study||5
1526543|NCT01456169|3736409|P1|NOT COMPLETED|Overall Study||10
1526544|NCT01456169|3736407|P3|COMPLETED|Overall Study||123
1526545|NCT01456169|3736408|P2|COMPLETED|Overall Study||122
1526546|NCT01456169|3736409|P1|COMPLETED|Overall Study||123
1526547|NCT01456169|3736407|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
1526548|NCT01456169|3736408|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
1526549|NCT01456169|3736409|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
1526550|NCT01456143|3736460|P1|NOT COMPLETED|Overall Study||0
1526551|NCT01456143|3736460|P1|COMPLETED|Overall Study||33
1526552|NCT01456143|3736460|P1|STARTED|Overall Study||33
1526554|NCT01456130|3736469|P1|COMPLETED|Overall Study||57
1526555|NCT01456130|3736469|P1|STARTED|Overall Study||67
1526556|NCT01456052|3736479|P3|NOT COMPLETED|Overall Study||5
1526557|NCT01456052|3736480|P2|NOT COMPLETED|Overall Study||5
1526558|NCT01456052|3736481|P1|NOT COMPLETED|Overall Study||2
1526559|NCT01456052|3736479|P3|COMPLETED|Overall Study||19
1526560|NCT01456052|3736480|P2|COMPLETED|Overall Study||20
1526561|NCT01456052|3736481|P1|COMPLETED|Overall Study||8
1526562|NCT01456052|3736479|P3|STARTED|Overall Study||24
1526563|NCT01456052|3736480|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
1526564|NCT01456052|3736481|P1|STARTED|Overall Study||10
1526565|NCT01456039|3736501|P3|NOT COMPLETED|Phase 2 (Second Step)||33
1526566|NCT01456039|3736502|P2|NOT COMPLETED|Phase 2 (Second Step)||0
1526567|NCT01456039|3736503|P1|NOT COMPLETED|Phase 2 (Second Step)||0
1526568|NCT01456039|3736501|P3|COMPLETED|Phase 2 (Second Step)||7
1526569|NCT01456039|3736502|P2|COMPLETED|Phase 2 (Second Step)||0
1526570|NCT01456039|3736503|P1|COMPLETED|Phase 2 (Second Step)||0
1526571|NCT01456039|3736501|P3|STARTED|Phase 2 (Second Step)||40
1526572|NCT01456039|3736502|P2|STARTED|Phase 2 (Second Step)||0
1526573|NCT01456039|3736503|P1|STARTED|Phase 2 (Second Step)||0
1526574|NCT01456039|3736501|P3|NOT COMPLETED|Phase 1 (First Step)||0
1526575|NCT01456039|3736502|P2|NOT COMPLETED|Phase 1 (First Step)||7
1526576|NCT01456039|3736503|P1|NOT COMPLETED|Phase 1 (First Step)||2
1526577|NCT01456039|3736501|P3|COMPLETED|Phase 1 (First Step)||0
1526578|NCT01456039|3736502|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
1526579|NCT01456039|3736503|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
1526580|NCT01456039|3736501|P3|STARTED|Phase 1 (First Step)||0
1526581|NCT01456039|3736502|P2|STARTED|Phase 1 (First Step)||8
1526582|NCT01456039|3736503|P1|STARTED|Phase 1 (First Step)||3
1526583|NCT01456000|3736575|P2|NOT COMPLETED|Overall Study||3
1526584|NCT01456000|3736576|P1|NOT COMPLETED|Overall Study||8
1526585|NCT01456000|3736575|P2|COMPLETED|Overall Study||172
1526586|NCT01456000|3736576|P1|COMPLETED|Overall Study||170
1526587|NCT01456000|3736575|P2|STARTED|Overall Study||175
1526588|NCT01456000|3736576|P1|STARTED|Overall Study||178
1526589|NCT01455545|3736582|P2|NOT COMPLETED|Overall Study||0
1526590|NCT01455545|3736583|P1|NOT COMPLETED|Overall Study||0
1526591|NCT01455545|3736582|P2|COMPLETED|Overall Study||45
1526592|NCT01455545|3736583|P1|COMPLETED|Overall Study||55
1526593|NCT01455545|3736582|P2|STARTED|Overall Study||45
1526594|NCT01455545|3736583|P1|STARTED|Overall Study||55
1526595|NCT01455519|3736613|P2|NOT COMPLETED|Overall Study||5
1526596|NCT01455519|3736614|P1|NOT COMPLETED|Overall Study||4
1526597|NCT01455519|3736613|P2|COMPLETED|Overall Study||18
1526598|NCT01455519|3736614|P1|COMPLETED|Overall Study||8
1526599|NCT01455519|3736613|P2|STARTED|Overall Study||23
1526600|NCT01455519|3736614|P1|STARTED|Overall Study||12
1526601|NCT01455428|3736646|P2|NOT COMPLETED|Overall Study||18
1526602|NCT01455428|3736647|P1|NOT COMPLETED|Overall Study||14
1526603|NCT01455428|3736646|P2|COMPLETED|Overall Study||92
1526604|NCT01455428|3736647|P1|COMPLETED|Overall Study||98
1526605|NCT01455428|3736646|P2|Treated|Overall Study||109
1526606|NCT01455428|3736647|P1|Treated|Overall Study||111
1526607|NCT01455428|3736646|P2|STARTED|Overall Study||110
1526608|NCT01455428|3736647|P1|STARTED|Overall Study||112
1526609|NCT01455415|3736703|P2|NOT COMPLETED|Follow-up||2
1526610|NCT01455415|3736704|P1|NOT COMPLETED|Follow-up||3
1526611|NCT01455415|3736703|P2|COMPLETED|Follow-up||104
1526612|NCT01455415|3736704|P1|COMPLETED|Follow-up||111
1526613|NCT01455415|3736703|P2|STARTED|Follow-up||106
1526614|NCT01455415|3736704|P1|STARTED|Follow-up||114
1526615|NCT01455415|3736703|P2|NOT COMPLETED|Period 2||10
1526616|NCT01455415|3736704|P1|NOT COMPLETED|Period 2||13
1526617|NCT01455415|3736703|P2|COMPLETED|Period 2||106
1526618|NCT01455415|3736704|P1|COMPLETED|Period 2||114
1526619|NCT01455415|3736703|P2|STARTED|Period 2||116
1526620|NCT01455415|3736704|P1|STARTED|Period 2||127
1526621|NCT01455415|3736703|P2|NOT COMPLETED|Washout||7
1526622|NCT01455415|3736704|P1|NOT COMPLETED|Washout||8
1526623|NCT01455415|3736703|P2|COMPLETED|Washout||116
1526624|NCT01455415|3736704|P1|COMPLETED|Washout||127
1526625|NCT01455415|3736703|P2|STARTED|Washout||123
1526626|NCT01455415|3736704|P1|STARTED|Washout||135
1526627|NCT01455415|3736703|P2|NOT COMPLETED|Period 1||24
1526628|NCT01455415|3736704|P1|NOT COMPLETED|Period 1||19
1526629|NCT01455415|3736703|P2|COMPLETED|Period 1||123
1526630|NCT01455415|3736704|P1|COMPLETED|Period 1||135
1526631|NCT01455415|3736703|P2|STARTED|Period 1|Started=Treated|147
1526632|NCT01455415|3736704|P1|STARTED|Period 1|Started=Treated|154
1526633|NCT01455220|3736754|P1|NOT COMPLETED|Overall Study||30
1526634|NCT01455220|3736754|P1|COMPLETED|Overall Study||15
1526635|NCT01455220|3736754|P1|STARTED|Overall Study||45
1526636|NCT01455194|3736764|P4|NOT COMPLETED|Overall Study||28
1526637|NCT01455194|3736765|P3|NOT COMPLETED|Overall Study||30
1526638|NCT01455194|3736766|P2|NOT COMPLETED|Overall Study||31
1526639|NCT01455194|3736767|P1|NOT COMPLETED|Overall Study||153
1526640|NCT01455194|3736764|P4|COMPLETED|Overall Study||97
1526641|NCT01455194|3736765|P3|COMPLETED|Overall Study||92
1526642|NCT01455194|3736766|P2|COMPLETED|Overall Study||89
1526643|NCT01455194|3736767|P1|COMPLETED|Overall Study||0
1526644|NCT01455194|3736764|P4|STARTED|Overall Study||125
1526645|NCT01455194|3736765|P3|STARTED|Overall Study||122
1526646|NCT01455194|3736766|P2|STARTED|Overall Study||120
1526647|NCT01455194|3736767|P1|STARTED|Overall Study||153
1526648|NCT01455181|3736816|P1|NOT COMPLETED|Overall Study||0
1526649|NCT01455181|3736816|P1|COMPLETED|Overall Study||24
1526650|NCT01455181|3736816|P1|STARTED|Overall Study||24
1526651|NCT01455064|3736824|P1|NOT COMPLETED|Overall Study||1
1526652|NCT01455064|3736824|P1|COMPLETED|Overall Study||30
1526653|NCT01455064|3736824|P1|STARTED|Overall Study||31
1526654|NCT01455012|3736830|P2|NOT COMPLETED|Overall Study||4
1526655|NCT01455012|3736831|P1|NOT COMPLETED|Overall Study||11
1526656|NCT01455012|3736830|P2|COMPLETED|Overall Study||36
1526657|NCT01455012|3736831|P1|COMPLETED|Overall Study||30
1526658|NCT01455012|3736830|P2|STARTED|Overall Study||40
1526659|NCT01455012|3736831|P1|STARTED|Overall Study||41
1526660|NCT01454947|3736871|P8|NOT COMPLETED|Overall Study||5
1526661|NCT01454947|3736872|P7|NOT COMPLETED|Overall Study||1
1526662|NCT01454947|3736873|P6|NOT COMPLETED|Overall Study||3
1526663|NCT01454947|3736874|P5|NOT COMPLETED|Overall Study||1
1526664|NCT01454947|3736875|P4|NOT COMPLETED|Overall Study||1
1526665|NCT01454947|3736876|P3|NOT COMPLETED|Overall Study||3
1526666|NCT01454947|3736877|P2|NOT COMPLETED|Overall Study||4
1526667|NCT01454947|3736878|P1|NOT COMPLETED|Overall Study||3
1526668|NCT01454947|3736871|P8|COMPLETED|Overall Study||23
1526669|NCT01454947|3736872|P7|COMPLETED|Overall Study||26
1526670|NCT01454947|3736873|P6|COMPLETED|Overall Study||32
1526671|NCT01454947|3736874|P5|COMPLETED|Overall Study||33
1526672|NCT01454947|3736875|P4|COMPLETED|Overall Study||19
1526673|NCT01454947|3736876|P3|COMPLETED|Overall Study||32
1526674|NCT01454947|3736877|P2|COMPLETED|Overall Study||38
1526675|NCT01454947|3736878|P1|COMPLETED|Overall Study||24
1526676|NCT01454947|3736871|P8|STARTED|Overall Study||28
1526677|NCT01454947|3736872|P7|STARTED|Overall Study||27
1526678|NCT01454947|3736873|P6|STARTED|Overall Study||35
1526679|NCT01454947|3736874|P5|STARTED|Overall Study||34
1526680|NCT01454947|3736875|P4|STARTED|Overall Study||20
1526681|NCT01454947|3736876|P3|STARTED|Overall Study||35
1526682|NCT01454947|3736877|P2|STARTED|Overall Study||42
1526683|NCT01454947|3736878|P1|STARTED|Overall Study||27
1526684|NCT01454934|3736898|P2|NOT COMPLETED|Overall Study||270
1526685|NCT01454934|3736899|P1|NOT COMPLETED|Overall Study||270
1526686|NCT01454934|3736898|P2|COMPLETED|Overall Study||0
1526687|NCT01454934|3736899|P1|COMPLETED|Overall Study||0
1526688|NCT01454934|3736898|P2|STARTED|Overall Study||270
1526689|NCT01454934|3736899|P1|STARTED|Overall Study||270
1526690|NCT01454830|3736911|P2|NOT COMPLETED|Overall Study||27
1526691|NCT01454830|3736912|P1|NOT COMPLETED|Overall Study||31
1526692|NCT01454830|3736911|P2|COMPLETED|Overall Study||30
1526693|NCT01454830|3736912|P1|COMPLETED|Overall Study||30
1526694|NCT01454830|3736911|P2|STARTED|Overall Study||57
1526695|NCT01454830|3736912|P1|STARTED|Overall Study||61
1526696|NCT01454791|3736932|P2|NOT COMPLETED|Overall Study||0
1526697|NCT01454791|3736933|P1|NOT COMPLETED|Overall Study||0
1526698|NCT01454791|3736932|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
1526699|NCT01454791|3736933|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
1526700|NCT01454791|3736932|P2|STARTED|Overall Study||20
1526701|NCT01454791|3736933|P1|STARTED|Overall Study||20
1526702|NCT01454778|3736943|P1|NOT COMPLETED|Overall Study||3
1526703|NCT01454778|3736943|P1|COMPLETED|Overall Study||47
1526704|NCT01454778|3736943|P1|STARTED|Overall Study||50
1526705|NCT01454739|3736954|P2|NOT COMPLETED|Overall Study||21
1526706|NCT01454739|3736955|P1|NOT COMPLETED|Overall Study||7
1526707|NCT01454739|3736954|P2|COMPLETED|Overall Study||158
1526708|NCT01454739|3736955|P1|COMPLETED|Overall Study||54
1526709|NCT01454739|3736954|P2|Surgery Subgroup|Overall Study||26
1526710|NCT01454739|3736955|P1|Surgery Subgroup|Overall Study||2
1526711|NCT01454739|3736954|P2|Episodic|Overall Study||13
1526712|NCT01454739|3736955|P1|Episodic|Overall Study||0
1526713|NCT01454739|3736954|P2|Personalized Prophylaxis|Overall Study||23
1526714|NCT01454739|3736955|P1|Personalized Prophylaxis|Overall Study||3
1526715|NCT01454739|3736954|P2|Weekly Prophylaxis|Overall Study||34
1526716|NCT01454739|3736955|P1|Weekly Prophylaxis|Overall Study||0
1526717|NCT01454739|3736954|P2|Tailored Prophylaxis|Overall Study||131
1526718|NCT01454739|3736955|P1|Tailored Prophylaxis|Overall Study||59
1526719|NCT01454739|3736954|P2|STARTED|Overall Study||179
1526720|NCT01454739|3736955|P1|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
1526721|NCT01454726|3736984|P2|NOT COMPLETED|Overall Study||1
1526722|NCT01454726|3736985|P1|NOT COMPLETED|Overall Study||0
1526723|NCT01454726|3736984|P2|COMPLETED|Overall Study||10
1526724|NCT01454726|3736985|P1|COMPLETED|Overall Study||16
1526725|NCT01454726|3736984|P2|STARTED|Overall Study||11
1526726|NCT01454726|3736985|P1|STARTED|Overall Study||16
1526727|NCT01454583|3736994|P3|NOT COMPLETED|3rd Year||297
1526728|NCT01454583|3736995|P2|NOT COMPLETED|3rd Year||512
1526729|NCT01454583|3736996|P1|NOT COMPLETED|3rd Year||1959
1526730|NCT01454583|3736994|P3|COMPLETED|3rd Year||285
1526731|NCT01454583|3736995|P2|COMPLETED|3rd Year||470
1526732|NCT01454583|3736996|P1|COMPLETED|3rd Year||1832
1526733|NCT01454583|3736994|P3|STARTED|3rd Year||582
1526734|NCT01454583|3736995|P2|STARTED|3rd Year||982
1526735|NCT01454583|3736996|P1|STARTED|3rd Year||3791
1526736|NCT01454583|3736994|P3|NOT COMPLETED|2nd Year||737
1526737|NCT01454583|3736995|P2|NOT COMPLETED|2nd Year||1049
1526738|NCT01454583|3736996|P1|NOT COMPLETED|2nd Year||3965
1526739|NCT01454583|3736994|P3|COMPLETED|2nd Year||1376
1526740|NCT01454583|3736995|P2|COMPLETED|2nd Year||1647
1526741|NCT01454583|3736996|P1|COMPLETED|2nd Year||6212
1526742|NCT01454583|3736994|P3|STARTED|2nd Year||2113
1526743|NCT01454583|3736995|P2|STARTED|2nd Year||2696
1526744|NCT01454583|3736996|P1|STARTED|2nd Year||10177
1526745|NCT01454583|3736994|P3|NOT COMPLETED|1st Year||180
1526746|NCT01454583|3736995|P2|NOT COMPLETED|1st Year||318
1526747|NCT01454583|3736996|P1|NOT COMPLETED|1st Year||1057
1526748|NCT01454583|3736994|P3|COMPLETED|1st Year||1933
1526749|NCT01454583|3736995|P2|COMPLETED|1st Year||2378
1526750|NCT01454583|3736996|P1|COMPLETED|1st Year||9120
1526751|NCT01454583|3736994|P3|STARTED|1st Year||2113
1526752|NCT01454583|3736995|P2|STARTED|1st Year||2696
1526753|NCT01454583|3736996|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
1526754|NCT01454531|3737064|P1|NOT COMPLETED|Overall Study||23
1526755|NCT01454531|3737064|P1|COMPLETED|Overall Study||173
1526756|NCT01454531|3737064|P1|Subjects Treated|Overall Study||192
1526757|NCT01454531|3737064|P1|STARTED|Overall Study||196
1526758|NCT01454505|3737076|P4|NOT COMPLETED|Overall Study||0
1526759|NCT01454505|3737077|P3|NOT COMPLETED|Overall Study||0
1526760|NCT01454505|3737078|P2|NOT COMPLETED|Overall Study||0
1526761|NCT01454505|3737079|P1|NOT COMPLETED|Overall Study||0
1526762|NCT01454505|3737076|P4|COMPLETED|Overall Study||20
1526763|NCT01454505|3737077|P3|COMPLETED|Overall Study||40
1526764|NCT01454505|3737078|P2|COMPLETED|Overall Study||15
1526765|NCT01454505|3737079|P1|COMPLETED|Overall Study||35
1526766|NCT01454505|3737076|P4|STARTED|Overall Study||20
1526767|NCT01454505|3737077|P3|STARTED|Overall Study||40
1526768|NCT01454505|3737078|P2|STARTED|Overall Study||15
1526769|NCT01454505|3737079|P1|STARTED|Overall Study||35
1526770|NCT01454414|3737093|P2|NOT COMPLETED|Overall Study||16
1526771|NCT01454414|3737094|P1|NOT COMPLETED|Overall Study||13
1526772|NCT01454414|3737093|P2|COMPLETED|Overall Study||64
1526773|NCT01454414|3737094|P1|COMPLETED|Overall Study||66
1526774|NCT01454414|3737093|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
1526775|NCT01454414|3737094|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
1526776|NCT01454414|3737093|P2|STARTED|Overall Study||80
1526777|NCT01454414|3737094|P1|STARTED|Overall Study||79
1526778|NCT01454401|3737100|P1|NOT COMPLETED|Overall Study||5
1526779|NCT01454401|3737100|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
1526780|NCT01454401|3737100|P1|STARTED|Overall Study|ITT|44
1526781|NCT01454284|3737107|P2|NOT COMPLETED|Overall Study||73
1526782|NCT01454284|3737108|P1|NOT COMPLETED|Overall Study||116
1526783|NCT01454284|3737107|P2|COMPLETED|Overall Study||377
1526784|NCT01454284|3737108|P1|COMPLETED|Overall Study||548
1526785|NCT01454284|3737107|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
1526786|NCT01454284|3737108|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
1526787|NCT01454284|3737107|P2|STARTED|Overall Study||450
1526788|NCT01454284|3737108|P1|STARTED|Overall Study||664
1526789|NCT01454258|3737156|P1|NOT COMPLETED|Overall Study||997
1526790|NCT01454258|3737156|P1|COMPLETED|Overall Study||9103
1526791|NCT01454258|3737156|P1|STARTED|Overall Study||10100
1526792|NCT01454076|3737167|P5|NOT COMPLETED|Overall Study||6
1526793|NCT01454076|3737168|P4|NOT COMPLETED|Overall Study||2
1526794|NCT01454076|3737169|P3|NOT COMPLETED|Overall Study||9
1526795|NCT01454076|3737170|P2|NOT COMPLETED|Overall Study||6
1526796|NCT01454076|3737171|P1|NOT COMPLETED|Overall Study||13
1526797|NCT01454076|3737167|P5|COMPLETED|Overall Study||15
1526798|NCT01454076|3737168|P4|COMPLETED|Overall Study||16
1526799|NCT01454076|3737169|P3|COMPLETED|Overall Study||15
1526800|NCT01454076|3737170|P2|COMPLETED|Overall Study||14
1526801|NCT01454076|3737171|P1|COMPLETED|Overall Study||16
1526802|NCT01454076|3737167|P5|STARTED|Overall Study||21
1526803|NCT01454076|3737168|P4|STARTED|Overall Study||18
1526804|NCT01454076|3737169|P3|STARTED|Overall Study||24
1526805|NCT01454076|3737170|P2|STARTED|Overall Study||20
1526806|NCT01454076|3737171|P1|STARTED|Overall Study||29
1526807|NCT01454063|3737224|P2|NOT COMPLETED|Treated||0
1526808|NCT01454063|3737225|P1|NOT COMPLETED|Treated||2
1526809|NCT01454063|3737224|P2|COMPLETED|Treated||201
1526810|NCT01454063|3737225|P1|COMPLETED|Treated||199
1526811|NCT01454063|3737224|P2|STARTED|Treated||201
1526812|NCT01454063|3737225|P1|STARTED|Treated||201
1526813|NCT01454063|3737224|P2|NOT COMPLETED|Randomized||2
1526814|NCT01454063|3737225|P1|NOT COMPLETED|Randomized||1
1526815|NCT01454063|3737224|P2|COMPLETED|Randomized||201
1526816|NCT01454063|3737225|P1|COMPLETED|Randomized||201
1526817|NCT01454063|3737224|P2|STARTED|Randomized||203
1526818|NCT01454063|3737225|P1|STARTED|Randomized||202
1526819|NCT01453998|3737246|P3|NOT COMPLETED|After Protocol Amendment 2.||0
1526820|NCT01453998|3737247|P2|NOT COMPLETED|After Protocol Amendment 2.||0
1526821|NCT01453998|3737248|P1|NOT COMPLETED|After Protocol Amendment 2.||1
1526822|NCT01453998|3737246|P3|COMPLETED|After Protocol Amendment 2.||183
1526823|NCT01453998|3737247|P2|COMPLETED|After Protocol Amendment 2.||99
1526824|NCT01453998|3737248|P1|COMPLETED|After Protocol Amendment 2.||102
1526825|NCT01453998|3737246|P3|STARTED|After Protocol Amendment 2.||183
1526826|NCT01453998|3737247|P2|STARTED|After Protocol Amendment 2.||99
1526827|NCT01453998|3737248|P1|STARTED|After Protocol Amendment 2.||103
1526828|NCT01453998|3737246|P3|NOT COMPLETED|Before Protocol Amendment 2||0
1526829|NCT01453998|3737247|P2|NOT COMPLETED|Before Protocol Amendment 2||0
1526830|NCT01453998|3737248|P1|NOT COMPLETED|Before Protocol Amendment 2||0
1526831|NCT01453998|3737246|P3|COMPLETED|Before Protocol Amendment 2||99
1526832|NCT01453998|3737247|P2|COMPLETED|Before Protocol Amendment 2||88
1526833|NCT01453998|3737248|P1|COMPLETED|Before Protocol Amendment 2||85
1526834|NCT01453998|3737246|P3|STARTED|Before Protocol Amendment 2||99
1526835|NCT01453998|3737247|P2|STARTED|Before Protocol Amendment 2||88
1526836|NCT01453998|3737248|P1|STARTED|Before Protocol Amendment 2||85
1526837|NCT01453946|3737313|P1|NOT COMPLETED|Overall Study||9
1526838|NCT01453946|3737313|P1|COMPLETED|Overall Study||41
1526839|NCT01453946|3737313|P1|STARTED|Overall Study||50
1526840|NCT01453894|3737321|P2|NOT COMPLETED|Overall Study||0
1526841|NCT01453894|3737322|P1|NOT COMPLETED|Overall Study||0
1526842|NCT01453894|3737321|P2|COMPLETED|Overall Study||225
1526843|NCT01453894|3737322|P1|COMPLETED|Overall Study||225
1526844|NCT01453894|3737321|P2|STARTED|Overall Study||225
1526845|NCT01453894|3737322|P1|STARTED|Overall Study||225
1526846|NCT01453855|3737330|P2|NOT COMPLETED|Overall Study||14
1526847|NCT01453855|3737331|P1|NOT COMPLETED|Overall Study||10
1526848|NCT01453855|3737330|P2|COMPLETED|Overall Study||408
1526849|NCT01453855|3737331|P1|COMPLETED|Overall Study||432
1526850|NCT01453855|3737330|P2|STARTED|Overall Study||422
1526851|NCT01453855|3737331|P1|STARTED|Overall Study||442
1526852|NCT01453725|3737339|P2|NOT COMPLETED|Overall Study||11
1526853|NCT01453725|3737340|P1|NOT COMPLETED|Overall Study||13
1526854|NCT01453725|3737339|P2|COMPLETED|Overall Study||89
1526855|NCT01453725|3737340|P1|COMPLETED|Overall Study||85
1526856|NCT01453725|3737339|P2|STARTED|Overall Study||100
1526857|NCT01453725|3737340|P1|STARTED|Overall Study||98
1526858|NCT01453595|3737363|P3|NOT COMPLETED|Overall Study||2
1526859|NCT01453595|3737364|P2|NOT COMPLETED|Overall Study||1
1526860|NCT01453595|3737365|P1|NOT COMPLETED|Overall Study||2
1526861|NCT01453595|3737363|P3|COMPLETED|Overall Study||0
1526862|NCT01453595|3737364|P2|COMPLETED|Overall Study||5
1526863|NCT01453595|3737365|P1|COMPLETED|Overall Study||0
1526864|NCT01453595|3737363|P3|STARTED|Overall Study||2
1526865|NCT01453595|3737364|P2|STARTED|Overall Study||6
1526866|NCT01453595|3737365|P1|STARTED|Overall Study||2
1526867|NCT01453569|3737374|P3|NOT COMPLETED|Overall Study||7
1526868|NCT01453569|3737375|P2|NOT COMPLETED|Overall Study||14
1526869|NCT01453569|3737376|P1|NOT COMPLETED|Overall Study||11
1526870|NCT01453569|3737374|P3|COMPLETED|Overall Study||78
1526871|NCT01453569|3737375|P2|COMPLETED|Overall Study||70
1526872|NCT01453569|3737376|P1|COMPLETED|Overall Study||75
1526873|NCT01453569|3737374|P3|STARTED|Overall Study||85
1526874|NCT01453569|3737375|P2|STARTED|Overall Study||84
1526875|NCT01453569|3737376|P1|STARTED|Overall Study||86
1526876|NCT01453413|3737393|P1|NOT COMPLETED|Overall Study||0
1526877|NCT01453413|3737393|P1|COMPLETED|Overall Study||297
1526878|NCT01453413|3737393|P1|STARTED|Overall Study||297
1526879|NCT01453387|3737400|P2|NOT COMPLETED|Overall Study||0
1526880|NCT01453387|3737401|P1|NOT COMPLETED|Overall Study||0
1526881|NCT01453387|3737400|P2|COMPLETED|Overall Study||7
1526882|NCT01453387|3737401|P1|COMPLETED|Overall Study||21
1526883|NCT01453387|3737400|P2|STARTED|Overall Study||7
1526884|NCT01453387|3737401|P1|STARTED|Overall Study||21
1526885|NCT01453374|3737484|P1|NOT COMPLETED|Overall Study||18
1526886|NCT01453374|3737484|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
1526887|NCT01453374|3737484|P1|STARTED|Overall Study||27
1526888|NCT01453361|3737500|P1|NOT COMPLETED|Overall Study||16
1526889|NCT01453361|3737500|P1|COMPLETED|Overall Study||2
1526890|NCT01453361|3737500|P1|STARTED|Overall Study||18
1526891|NCT01453348|3737508|P3|NOT COMPLETED|Overall Study||1
1526892|NCT01453348|3737509|P2|NOT COMPLETED|Overall Study||1
1526893|NCT01453348|3737510|P1|NOT COMPLETED|Overall Study||1
1526894|NCT01453348|3737508|P3|COMPLETED|Overall Study||83
1526895|NCT01453348|3737509|P2|COMPLETED|Overall Study||83
1526896|NCT01453348|3737510|P1|COMPLETED|Overall Study||83
1526897|NCT01453348|3737508|P3|STARTED|Overall Study||84
1526898|NCT01453348|3737509|P2|STARTED|Overall Study||84
1526899|NCT01453348|3737510|P1|STARTED|Overall Study||84
1526900|NCT01453296|3737526|P2|NOT COMPLETED|Treatment Period 2||0
1526901|NCT01453296|3737527|P1|NOT COMPLETED|Treatment Period 2||2
1526902|NCT01453296|3737526|P2|COMPLETED|Treatment Period 2||13
1526903|NCT01453296|3737527|P1|COMPLETED|Treatment Period 2||11
1526904|NCT01453296|3737526|P2|STARTED|Treatment Period 2||13
1526905|NCT01453296|3737527|P1|STARTED|Treatment Period 2||13
1526906|NCT01453296|3737526|P2|NOT COMPLETED|Washout Period||0
1526907|NCT01453296|3737527|P1|NOT COMPLETED|Washout Period||0
1526908|NCT01453296|3737526|P2|COMPLETED|Washout Period||13
1526909|NCT01453296|3737527|P1|COMPLETED|Washout Period||13
1526910|NCT01453296|3737526|P2|STARTED|Washout Period||13
1526911|NCT01453296|3737527|P1|STARTED|Washout Period||13
1526912|NCT01453296|3737526|P2|NOT COMPLETED|Treatment Period 1||1
1526913|NCT01453296|3737527|P1|NOT COMPLETED|Treatment Period 1||1
1526914|NCT01453296|3737526|P2|COMPLETED|Treatment Period 1||13
1526915|NCT01453296|3737527|P1|COMPLETED|Treatment Period 1||13
1526916|NCT01453296|3737526|P2|STARTED|Treatment Period 1||14
1526917|NCT01453296|3737527|P1|STARTED|Treatment Period 1||14
1526918|NCT01453205|3737594|P3|NOT COMPLETED|Overall Study||54
1526919|NCT01453205|3737595|P2|NOT COMPLETED|Overall Study||52
1526920|NCT01453205|3737596|P1|NOT COMPLETED|Overall Study||80
1526921|NCT01453205|3737594|P3|COMPLETED|Overall Study||1
1526922|NCT01453205|3737595|P2|COMPLETED|Overall Study||0
1526923|NCT01453205|3737596|P1|COMPLETED|Overall Study||0
1526924|NCT01453205|3737594|P3|STARTED|Overall Study||55
1526925|NCT01453205|3737595|P2|STARTED|Overall Study||52
1526926|NCT01453205|3737596|P1|STARTED|Overall Study||80
1526927|NCT01453166|3737647|P3|NOT COMPLETED|Overall Study||1
1526928|NCT01453166|3737648|P2|NOT COMPLETED|Overall Study||2
1526929|NCT01453166|3737649|P1|NOT COMPLETED|Overall Study||2
1526930|NCT01453166|3737647|P3|COMPLETED|Overall Study||38
1526931|NCT01453166|3737648|P2|COMPLETED|Overall Study||39
1526932|NCT01453166|3737649|P1|COMPLETED|Overall Study||40
1526933|NCT01453166|3737647|P3|STARTED|Overall Study||39
1526934|NCT01453166|3737648|P2|STARTED|Overall Study||41
1526935|NCT01453166|3737649|P1|STARTED|Overall Study||42
1526936|NCT01453153|3737672|P3|NOT COMPLETED|Overall Study||20
1526937|NCT01453153|3737673|P2|NOT COMPLETED|Overall Study||4
1526938|NCT01453153|3737674|P1|NOT COMPLETED|Overall Study||4
1526939|NCT01453153|3737672|P3|COMPLETED|Overall Study||0
1526940|NCT01453153|3737673|P2|COMPLETED|Overall Study||0
1526941|NCT01453153|3737674|P1|COMPLETED|Overall Study||0
1526942|NCT01453153|3737672|P3|STARTED|Overall Study||20
1526943|NCT01453153|3737673|P2|STARTED|Overall Study||4
1526944|NCT01453153|3737674|P1|STARTED|Overall Study||4
1526945|NCT01453075|3737747|P2|NOT COMPLETED|Overall Study||1
1526946|NCT01453075|3737748|P1|NOT COMPLETED|Overall Study||5
1526947|NCT01453075|3737747|P2|COMPLETED|Overall Study||14
1526948|NCT01453075|3737748|P1|COMPLETED|Overall Study||11
1526949|NCT01453075|3737747|P2|STARTED|Overall Study||15
1526950|NCT01453075|3737748|P1|STARTED|Overall Study||16
1526951|NCT01453049|3737756|P2|NOT COMPLETED|Overall Study||42
1526952|NCT01453049|3737757|P1|NOT COMPLETED|Overall Study||41
1526953|NCT01453049|3737756|P2|COMPLETED|Overall Study||2
1526954|NCT01453049|3737757|P1|COMPLETED|Overall Study||1
1526955|NCT01453049|3737756|P2|STARTED|Overall Study||44
1526956|NCT01453049|3737757|P1|STARTED|Overall Study||42
1526957|NCT01453036|3737830|P3|NOT COMPLETED|Overall Study||31
1526958|NCT01453036|3737831|P2|NOT COMPLETED|Overall Study||115
1526959|NCT01453036|3737832|P1|NOT COMPLETED|Overall Study||26
1526960|NCT01453036|3737830|P3|COMPLETED|Overall Study||277
1526961|NCT01453036|3737831|P2|COMPLETED|Overall Study||193
1526962|NCT01453036|3737832|P1|COMPLETED|Overall Study||282
1526963|NCT01453036|3737830|P3|STARTED|Overall Study||308
1526964|NCT01453036|3737831|P2|STARTED|Overall Study||308
1526965|NCT01453036|3737832|P1|STARTED|Overall Study||308
1526966|NCT01453023|3737840|P2|NOT COMPLETED|Treatment Period 2||1
1526967|NCT01453023|3737841|P1|NOT COMPLETED|Treatment Period 2||0
1526968|NCT01453023|3737840|P2|COMPLETED|Treatment Period 2||11
1526969|NCT01453023|3737841|P1|COMPLETED|Treatment Period 2||12
1526970|NCT01453023|3737840|P2|STARTED|Treatment Period 2||12
1526971|NCT01453023|3737841|P1|STARTED|Treatment Period 2||12
1526972|NCT01453023|3737840|P2|NOT COMPLETED|Washout Period||0
1526973|NCT01453023|3737841|P1|NOT COMPLETED|Washout Period||0
1526974|NCT01453023|3737840|P2|COMPLETED|Washout Period||12
1526975|NCT01453023|3737841|P1|COMPLETED|Washout Period||12
1526976|NCT01453023|3737840|P2|STARTED|Washout Period||12
1526977|NCT01453023|3737841|P1|STARTED|Washout Period||12
1526978|NCT01453023|3737840|P2|NOT COMPLETED|Treatment Period (TP) 1||1
1526979|NCT01453023|3737841|P1|NOT COMPLETED|Treatment Period (TP) 1||1
1526980|NCT01453023|3737840|P2|COMPLETED|Treatment Period (TP) 1||12
1526981|NCT01453023|3737841|P1|COMPLETED|Treatment Period (TP) 1||12
1526982|NCT01453023|3737840|P2|STARTED|Treatment Period (TP) 1||13
1526983|NCT01453023|3737841|P1|STARTED|Treatment Period (TP) 1||13
1526984|NCT01452854|3737909|P1|NOT COMPLETED|Overall Study||0
1526985|NCT01452854|3737909|P1|COMPLETED|Overall Study||2
1526986|NCT01452854|3737909|P1|STARTED|Overall Study||2
1526987|NCT01452529|3737915|P3|NOT COMPLETED|Double-blind (DB) Period||82
1526988|NCT01452529|3737916|P2|NOT COMPLETED|Double-blind (DB) Period||67
1526989|NCT01452529|3737917|P1|NOT COMPLETED|Double-blind (DB) Period||0
1526990|NCT01452529|3737915|P3|COMPLETED|Double-blind (DB) Period||210
1526991|NCT01452529|3737916|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
1526992|NCT01452529|3737917|P1|COMPLETED|Double-blind (DB) Period||0
1526993|NCT01452529|3737915|P3|STARTED|Double-blind (DB) Period||292
1526994|NCT01452529|3737916|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
1526995|NCT01452529|3737917|P1|STARTED|Double-blind (DB) Period||0
1526996|NCT01452529|3737915|P3|NOT COMPLETED|Run-in Period||0
1526997|NCT01452529|3737916|P2|NOT COMPLETED|Run-in Period||0
1526998|NCT01452529|3737917|P1|NOT COMPLETED|Run-in Period||313
1526999|NCT01452529|3737915|P3|COMPLETED|Run-in Period||0
1527000|NCT01452529|3737916|P2|COMPLETED|Run-in Period||0
1527001|NCT01452529|3737917|P1|COMPLETED|Run-in Period||592
1527002|NCT01452529|3737915|P3|STARTED|Run-in Period||0
1527003|NCT01452529|3737916|P2|STARTED|Run-in Period||0
1527004|NCT01452529|3737917|P1|STARTED|Run-in Period||905
1527005|NCT01452425|3737932|P1|NOT COMPLETED|Overall Study||0
1527006|NCT01452425|3737932|P1|COMPLETED|Overall Study||10
1527007|NCT01452425|3737932|P1|STARTED|Overall Study||10
1527008|NCT01452347|3737939|P2|NOT COMPLETED|Overall Study||7
1527009|NCT01452347|3737940|P1|NOT COMPLETED|Overall Study||17
1527010|NCT01452347|3737939|P2|COMPLETED|Overall Study||77
1527011|NCT01452347|3737940|P1|COMPLETED|Overall Study||151
1527012|NCT01452347|3737939|P2|STARTED|Overall Study||84
1527013|NCT01452347|3737940|P1|STARTED|Overall Study||168
1527014|NCT01452269|3737958|P2|NOT COMPLETED|Overall Study||5
1527015|NCT01452269|3737959|P1|NOT COMPLETED|Overall Study||1
1527016|NCT01452269|3737958|P2|COMPLETED|Overall Study||51
1527017|NCT01452269|3737959|P1|COMPLETED|Overall Study||47
1527018|NCT01452269|3737958|P2|STARTED|Overall Study||56
1527019|NCT01452269|3737959|P1|STARTED|Overall Study||48
1527020|NCT01452152|3737972|P3|NOT COMPLETED|Overall Study||4
1527021|NCT01452152|3737973|P2|NOT COMPLETED|Overall Study||0
1527022|NCT01452152|3737974|P1|NOT COMPLETED|Overall Study||5
1527023|NCT01452152|3737972|P3|COMPLETED|Overall Study||0
1527024|NCT01452152|3737973|P2|COMPLETED|Overall Study||0
1527025|NCT01452152|3737974|P1|COMPLETED|Overall Study||0
1527026|NCT01452152|3737972|P3|STARTED|Overall Study||4
1527027|NCT01452152|3737973|P2|STARTED|Overall Study||0
1527028|NCT01452152|3737974|P1|STARTED|Overall Study||5
1527029|NCT01452126|3737997|P1|NOT COMPLETED|Overall Study||0
1527030|NCT01452126|3737997|P1|COMPLETED|Overall Study||49
1527031|NCT01452126|3737997|P1|STARTED|Overall Study||49
1527032|NCT01451996|3738009|P4|NOT COMPLETED|Overall Study||0
1527033|NCT01451996|3738010|P3|NOT COMPLETED|Overall Study||0
1527034|NCT01451996|3738011|P2|NOT COMPLETED|Overall Study||0
1527035|NCT01451996|3738012|P1|NOT COMPLETED|Overall Study||0
1527036|NCT01451996|3738009|P4|COMPLETED|Overall Study||85
1527037|NCT01451996|3738010|P3|COMPLETED|Overall Study||85
1527038|NCT01451996|3738011|P2|COMPLETED|Overall Study||87
1527039|NCT01451996|3738012|P1|COMPLETED|Overall Study||83
1527040|NCT01451996|3738009|P4|STARTED|Overall Study||85
1527041|NCT01451996|3738010|P3|STARTED|Overall Study||85
1527042|NCT01451996|3738011|P2|STARTED|Overall Study||87
1527043|NCT01451996|3738012|P1|STARTED|Overall Study||83
1527044|NCT01451983|3738030|P4|NOT COMPLETED|Overall Study||0
1527045|NCT01451983|3738031|P3|NOT COMPLETED|Overall Study||0
1527046|NCT01451983|3738032|P2|NOT COMPLETED|Overall Study||0
1527047|NCT01451983|3738033|P1|NOT COMPLETED|Overall Study||0
1527048|NCT01451983|3738030|P4|COMPLETED|Overall Study||24
1527049|NCT01451983|3738031|P3|COMPLETED|Overall Study||61
1527050|NCT01451983|3738032|P2|COMPLETED|Overall Study||27
1527051|NCT01451983|3738033|P1|COMPLETED|Overall Study||26
1527052|NCT01451983|3738030|P4|STARTED|Overall Study||24
1527053|NCT01451983|3738031|P3|STARTED|Overall Study||61
1527054|NCT01451983|3738032|P2|STARTED|Overall Study||27
1527055|NCT01451983|3738033|P1|STARTED|Overall Study||26
1527056|NCT01451931|3738046|P3|NOT COMPLETED|Overall Study||43
1527057|NCT01451931|3738047|P2|NOT COMPLETED|Overall Study||58
1527058|NCT01451931|3738048|P1|NOT COMPLETED|Overall Study||33
1527059|NCT01451931|3738046|P3|COMPLETED|Overall Study||923
1527060|NCT01451931|3738047|P2|COMPLETED|Overall Study||843
1527061|NCT01451931|3738048|P1|COMPLETED|Overall Study||876
1527062|NCT01451931|3738046|P3|6-month Follow up|Overall Study||923
1527063|NCT01451931|3738047|P2|6-month Follow up|Overall Study||843
1527064|NCT01451931|3738048|P1|6-month Follow up|Overall Study||876
1527065|NCT01451931|3738046|P3|Baseline Data Collection|Overall Study||958
1527066|NCT01451931|3738047|P2|Baseline Data Collection|Overall Study||893
1527067|NCT01451931|3738048|P1|Baseline Data Collection|Overall Study||908
1527068|NCT01451931|3738046|P3|STARTED|Overall Study||966
1527069|NCT01451931|3738047|P2|STARTED|Overall Study||901
1527070|NCT01451931|3738048|P1|STARTED|Overall Study||909
1527071|NCT01451827|3738072|P4|NOT COMPLETED|Overall Study||4
1527072|NCT01451827|3738073|P3|NOT COMPLETED|Overall Study||2
1527073|NCT01451827|3738074|P2|NOT COMPLETED|Overall Study||5
1527074|NCT01451827|3738075|P1|NOT COMPLETED|Overall Study||3
1527075|NCT01451827|3738072|P4|COMPLETED|Overall Study||39
1527076|NCT01451827|3738073|P3|COMPLETED|Overall Study||42
1527077|NCT01451827|3738074|P2|COMPLETED|Overall Study||40
1527078|NCT01451827|3738075|P1|COMPLETED|Overall Study||42
1527079|NCT01451827|3738072|P4|STARTED|Overall Study||43
1527080|NCT01451827|3738073|P3|STARTED|Overall Study||44
1527081|NCT01451827|3738074|P2|STARTED|Overall Study||45
1527082|NCT01451827|3738075|P1|STARTED|Overall Study||45
1527083|NCT01451814|3738095|P2|NOT COMPLETED|Overall Study||5
1527084|NCT01451814|3738096|P1|NOT COMPLETED|Overall Study||6
1527085|NCT01451814|3738095|P2|COMPLETED|Overall Study||26
1527086|NCT01451814|3738096|P1|COMPLETED|Overall Study||29
1527087|NCT01451814|3738095|P2|Attended a Session|Overall Study||31
1527088|NCT01451814|3738096|P1|Attended a Session|Overall Study||35
1527089|NCT01451814|3738095|P2|STARTED|Overall Study||31
1527090|NCT01451814|3738096|P1|STARTED|Overall Study||35
1527091|NCT01451775|3738106|P6|NOT COMPLETED|Overall Study||0
1527092|NCT01451775|3738107|P5|NOT COMPLETED|Overall Study||0
1527093|NCT01451775|3738108|P4|NOT COMPLETED|Overall Study||0
1527094|NCT01451775|3738109|P3|NOT COMPLETED|Overall Study||0
1527095|NCT01451775|3738110|P2|NOT COMPLETED|Overall Study||0
1527096|NCT01451775|3738111|P1|NOT COMPLETED|Overall Study||0
1527097|NCT01451775|3738106|P6|COMPLETED|Overall Study||3
1527098|NCT01451775|3738107|P5|COMPLETED|Overall Study||3
1527099|NCT01451775|3738108|P4|COMPLETED|Overall Study||3
1527100|NCT01451775|3738109|P3|COMPLETED|Overall Study||3
1527101|NCT01451775|3738110|P2|COMPLETED|Overall Study||3
1527102|NCT01451775|3738111|P1|COMPLETED|Overall Study||3
1527103|NCT01451775|3738106|P6|STARTED|Overall Study||3
1527104|NCT01451775|3738107|P5|STARTED|Overall Study||3
1527105|NCT01451775|3738108|P4|STARTED|Overall Study||3
1527106|NCT01451775|3738109|P3|STARTED|Overall Study||3
1527107|NCT01451775|3738110|P2|STARTED|Overall Study||3
1527108|NCT01451775|3738111|P1|STARTED|Overall Study||3
1527109|NCT01451762|3738128|P3|NOT COMPLETED|Overall Study||6
1527110|NCT01451762|3738129|P2|NOT COMPLETED|Overall Study||6
1527111|NCT01451762|3738130|P1|NOT COMPLETED|Overall Study||3
1527112|NCT01451762|3738128|P3|COMPLETED|Overall Study||24
1527113|NCT01451762|3738129|P2|COMPLETED|Overall Study||24
1527114|NCT01451762|3738130|P1|COMPLETED|Overall Study||27
1527115|NCT01451762|3738128|P3|STARTED|Overall Study||30
1527116|NCT01451762|3738129|P2|STARTED|Overall Study||30
1527117|NCT01451762|3738130|P1|STARTED|Overall Study||30
1527118|NCT01451749|3738140|P2|NOT COMPLETED|Overall Study||14
1527119|NCT01451749|3738141|P1|NOT COMPLETED|Overall Study||32
1527120|NCT01451749|3738140|P2|COMPLETED|Overall Study||94
1527121|NCT01451749|3738141|P1|COMPLETED|Overall Study||184
1527122|NCT01451749|3738140|P2|STARTED|Overall Study||108
1527123|NCT01451749|3738141|P1|STARTED|Overall Study||216
1527124|NCT01451723|3738153|P2|NOT COMPLETED|Overall Study||5
1527125|NCT01451723|3738154|P1|NOT COMPLETED|Overall Study||6
1527126|NCT01451723|3738153|P2|COMPLETED|Overall Study||0
1527127|NCT01451723|3738154|P1|COMPLETED|Overall Study||0
1527128|NCT01451723|3738153|P2|STARTED|Overall Study||5
1527129|NCT01451723|3738154|P1|STARTED|Overall Study||6
1527130|NCT01451645|3738164|P2|NOT COMPLETED|Overall Study||8
1527131|NCT01451645|3738165|P1|NOT COMPLETED|Overall Study||9
1527132|NCT01451645|3738164|P2|COMPLETED|Overall Study||33
1527133|NCT01451645|3738165|P1|COMPLETED|Overall Study||32
1527134|NCT01451645|3738164|P2|STARTED|Overall Study||41
1527135|NCT01451645|3738165|P1|STARTED|Overall Study||41
1527136|NCT01451632|3738179|P10|NOT COMPLETED|Overall Study||0
1527137|NCT01451632|3738180|P9|NOT COMPLETED|Overall Study||0
1527138|NCT01451632|3738181|P8|NOT COMPLETED|Overall Study||0
1527139|NCT01451632|3738182|P7|NOT COMPLETED|Overall Study||0
1527140|NCT01451632|3738183|P6|NOT COMPLETED|Overall Study||0
1527141|NCT01451632|3738184|P5|NOT COMPLETED|Overall Study||0
1527142|NCT01451632|3738185|P4|NOT COMPLETED|Overall Study||0
1527143|NCT01451632|3738186|P3|NOT COMPLETED|Overall Study||0
1527144|NCT01451632|3738187|P2|NOT COMPLETED|Overall Study||0
1527145|NCT01451632|3738188|P1|NOT COMPLETED|Overall Study||0
1527146|NCT01451632|3738179|P10|COMPLETED|Overall Study||4
1527147|NCT01451632|3738180|P9|COMPLETED|Overall Study||4
1527148|NCT01451632|3738181|P8|COMPLETED|Overall Study||6
1527149|NCT01451632|3738182|P7|COMPLETED|Overall Study||8
1527150|NCT01451632|3738183|P6|COMPLETED|Overall Study||4
1527151|NCT01451632|3738184|P5|COMPLETED|Overall Study||4
1527152|NCT01451632|3738185|P4|COMPLETED|Overall Study||3
1527153|NCT01451632|3738186|P3|COMPLETED|Overall Study||3
1527154|NCT01451632|3738187|P2|COMPLETED|Overall Study||4
1527155|NCT01451632|3738188|P1|COMPLETED|Overall Study||8
1527156|NCT01451632|3738179|P10|STARTED|Overall Study||4
1527157|NCT01451632|3738180|P9|STARTED|Overall Study||4
1527158|NCT01451632|3738181|P8|STARTED|Overall Study||6
1527159|NCT01451632|3738182|P7|STARTED|Overall Study||8
1527160|NCT01451632|3738183|P6|STARTED|Overall Study||4
1527161|NCT01451632|3738184|P5|STARTED|Overall Study||4
1527162|NCT01451632|3738185|P4|STARTED|Overall Study||3
1527163|NCT01451632|3738186|P3|STARTED|Overall Study||3
1527164|NCT01451632|3738187|P2|STARTED|Overall Study||4
1527165|NCT01451632|3738188|P1|STARTED|Overall Study||8
1527166|NCT01451606|3738236|P2|NOT COMPLETED|Overall Study||3
1527167|NCT01451606|3738237|P1|NOT COMPLETED|Overall Study||4
1527168|NCT01451606|3738236|P2|COMPLETED|Overall Study||15
1527169|NCT01451606|3738237|P1|COMPLETED|Overall Study||12
1527170|NCT01451606|3738236|P2|STARTED|Overall Study||18
1527171|NCT01451606|3738237|P1|STARTED|Overall Study||16
1527172|NCT01451554|3738247|P2|NOT COMPLETED|Overall Study||9
1527173|NCT01451554|3738248|P1|NOT COMPLETED|Overall Study||14
1527174|NCT01451554|3738247|P2|COMPLETED|Overall Study||23
1527175|NCT01451554|3738248|P1|COMPLETED|Overall Study||19
1527176|NCT01451554|3738247|P2|STARTED|Overall Study||32
1527177|NCT01451554|3738248|P1|STARTED|Overall Study||33
1527178|NCT01451541|3738259|P3|NOT COMPLETED|Overall Study||27
1527179|NCT01451541|3738260|P2|NOT COMPLETED|Overall Study||25
1527180|NCT01451541|3738261|P1|NOT COMPLETED|Overall Study||36
1527181|NCT01451541|3738259|P3|COMPLETED|Overall Study||254
1527182|NCT01451541|3738260|P2|COMPLETED|Overall Study||257
1527183|NCT01451541|3738261|P1|COMPLETED|Overall Study||247
1527184|NCT01451541|3738259|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
1527185|NCT01451541|3738260|P2|STARTED|Overall Study||282
1527186|NCT01451541|3738261|P1|STARTED|Overall Study||283
1527187|NCT01451463|3738301|P1|NOT COMPLETED|Overall Study||0
1527188|NCT01451463|3738301|P1|COMPLETED|Overall Study||11
1527189|NCT01451463|3738301|P1|STARTED|Overall Study||11
1527190|NCT01451437|3738319|P9|NOT COMPLETED|Overall Study||4
1527191|NCT01451437|3738320|P8|NOT COMPLETED|Overall Study||3
1527192|NCT01451437|3738321|P7|NOT COMPLETED|Overall Study||6
1527193|NCT01451437|3738322|P6|NOT COMPLETED|Overall Study||3
1527194|NCT01451437|3738323|P5|NOT COMPLETED|Overall Study||4
1527195|NCT01451437|3738324|P4|NOT COMPLETED|Overall Study||1
1527196|NCT01451437|3738325|P3|NOT COMPLETED|Overall Study||3
1527197|NCT01451437|3738326|P2|NOT COMPLETED|Overall Study||1
1527198|NCT01451437|3738327|P1|NOT COMPLETED|Overall Study||1
1527199|NCT01451437|3738319|P9|COMPLETED|Overall Study||0
1527200|NCT01451437|3738320|P8|COMPLETED|Overall Study||0
1527201|NCT01451437|3738321|P7|COMPLETED|Overall Study||0
1527202|NCT01451437|3738322|P6|COMPLETED|Overall Study||0
1527203|NCT01451437|3738323|P5|COMPLETED|Overall Study||0
1527204|NCT01451437|3738324|P4|COMPLETED|Overall Study||0
1527205|NCT01451437|3738325|P3|COMPLETED|Overall Study||0
1527206|NCT01451437|3738326|P2|COMPLETED|Overall Study||0
1527207|NCT01451437|3738327|P1|COMPLETED|Overall Study||0
1527208|NCT01451437|3738319|P9|STARTED|Overall Study||4
1527209|NCT01451437|3738320|P8|STARTED|Overall Study||3
1527210|NCT01451437|3738321|P7|STARTED|Overall Study||6
1527211|NCT01451437|3738322|P6|STARTED|Overall Study||3
1527212|NCT01451437|3738323|P5|STARTED|Overall Study||4
1527213|NCT01451437|3738324|P4|STARTED|Overall Study||1
1527214|NCT01451437|3738325|P3|STARTED|Overall Study||3
1527215|NCT01451437|3738326|P2|STARTED|Overall Study||1
1527216|NCT01451437|3738327|P1|STARTED|Overall Study||1
1527217|NCT01451424|3738459|P4|NOT COMPLETED|Overall Study||5
1527218|NCT01451424|3738460|P3|NOT COMPLETED|Overall Study||1
1527219|NCT01451424|3738461|P2|NOT COMPLETED|Overall Study||2
1527220|NCT01451424|3738462|P1|NOT COMPLETED|Overall Study||1
1527221|NCT01451424|3738459|P4|COMPLETED|Overall Study||5
1527222|NCT01451424|3738460|P3|COMPLETED|Overall Study||11
1527223|NCT01451424|3738461|P2|COMPLETED|Overall Study||7
1527224|NCT01451424|3738462|P1|COMPLETED|Overall Study||8
1527225|NCT01451424|3738459|P4|STARTED|Overall Study||10
1527226|NCT01451424|3738460|P3|STARTED|Overall Study||12
1527227|NCT01451424|3738461|P2|STARTED|Overall Study||9
1527228|NCT01451424|3738462|P1|STARTED|Overall Study||9
1527229|NCT01451411|3738495|P2|NOT COMPLETED|Overall Study||0
1527230|NCT01451411|3738496|P1|NOT COMPLETED|Overall Study||0
1527231|NCT01451411|3738495|P2|COMPLETED|Overall Study||1
1527232|NCT01451411|3738496|P1|COMPLETED|Overall Study||3
1527233|NCT01451411|3738495|P2|STARTED|Overall Study||1
1527234|NCT01451411|3738496|P1|STARTED|Overall Study||3
1527235|NCT01451398|3738520|P2|NOT COMPLETED|Overall Study||37
1527236|NCT01451398|3738521|P1|NOT COMPLETED|Overall Study||27
1527237|NCT01451398|3738520|P2|COMPLETED|Overall Study||139
1527238|NCT01451398|3738521|P1|COMPLETED|Overall Study||150
1527239|NCT01451398|3738520|P2|STARTED|Overall Study||176
1527240|NCT01451398|3738521|P1|STARTED|Overall Study||177
1527241|NCT01451203|3738555|P2|NOT COMPLETED|Post-treatment Period||34
1527242|NCT01451203|3738556|P1|NOT COMPLETED|Post-treatment Period||14
1527243|NCT01451203|3738555|P2|COMPLETED|Post-treatment Period||74
1527244|NCT01451203|3738556|P1|COMPLETED|Post-treatment Period||57
1527245|NCT01451203|3738555|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
1527246|NCT01451203|3738556|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
1527247|NCT01451203|3738555|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
1527248|NCT01451203|3738556|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
1527249|NCT01451203|3738555|P2|NOT COMPLETED|Double-blind Treatment Period||50
1527250|NCT01451203|3738556|P1|NOT COMPLETED|Double-blind Treatment Period||85
1527251|NCT01451203|3738555|P2|COMPLETED|Double-blind Treatment Period||111
1527252|NCT01451203|3738556|P1|COMPLETED|Double-blind Treatment Period||73
1527253|NCT01451203|3738555|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
1527254|NCT01451203|3738556|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
1527255|NCT01451203|3738555|P2|Received Treatment|Double-blind Treatment Period||159
1527256|NCT01451203|3738556|P1|Received Treatment|Double-blind Treatment Period||157
1527257|NCT01451203|3738555|P2|STARTED|Double-blind Treatment Period||161
1527258|NCT01451203|3738556|P1|STARTED|Double-blind Treatment Period||158
1527259|NCT01450826|3738572|P2|NOT COMPLETED|Overall Study||0
1527260|NCT01450826|3738573|P1|NOT COMPLETED|Overall Study||0
1527261|NCT01450826|3738572|P2|COMPLETED|Overall Study||66
1527262|NCT01450826|3738573|P1|COMPLETED|Overall Study||70
1527263|NCT01450826|3738572|P2|STARTED|Overall Study||66
1527264|NCT01450826|3738573|P1|STARTED|Overall Study||70
1527265|NCT01450813|3738589|P4|NOT COMPLETED|Overall Study||3
1527266|NCT01450813|3738590|P3|NOT COMPLETED|Overall Study||0
1527267|NCT01450813|3738591|P2|NOT COMPLETED|Overall Study||1
1527268|NCT01450813|3738592|P1|NOT COMPLETED|Overall Study||1
1527269|NCT01450813|3738589|P4|COMPLETED|Overall Study||17
1527270|NCT01450813|3738590|P3|COMPLETED|Overall Study||20
1527271|NCT01450813|3738591|P2|COMPLETED|Overall Study||19
1527272|NCT01450813|3738592|P1|COMPLETED|Overall Study||19
1527273|NCT01450813|3738589|P4|STARTED|Overall Study||20
1527274|NCT01450813|3738590|P3|STARTED|Overall Study||20
1527275|NCT01450813|3738591|P2|STARTED|Overall Study||20
1527276|NCT01450813|3738592|P1|STARTED|Overall Study||20
1527277|NCT01450800|3738606|P2|NOT COMPLETED|Overall Study||3
1527278|NCT01450800|3738607|P1|NOT COMPLETED|Overall Study||1
1527279|NCT01450800|3738606|P2|COMPLETED|Overall Study||78
1527280|NCT01450800|3738607|P1|COMPLETED|Overall Study||81
1527281|NCT01450800|3738606|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
1527282|NCT01450800|3738607|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
1527283|NCT01450787|3738623|P2|NOT COMPLETED|Overall Study||0
1527284|NCT01450787|3738624|P1|NOT COMPLETED|Overall Study||0
1527285|NCT01450787|3738623|P2|COMPLETED|Overall Study||25
1527286|NCT01450787|3738624|P1|COMPLETED|Overall Study||38
1527287|NCT01450787|3738623|P2|STARTED|Overall Study||25
1527288|NCT01450787|3738624|P1|STARTED|Overall Study||38
1527289|NCT01450761|3738642|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||476
1527290|NCT01450761|3738643|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||478
1527291|NCT01450761|3738642|P2|COMPLETED|Treatment With Blinded Study Therapy||0
1527292|NCT01450761|3738643|P1|COMPLETED|Treatment With Blinded Study Therapy||0
1527293|NCT01450761|3738642|P2|STARTED|Treatment With Blinded Study Therapy||476
1527294|NCT01450761|3738643|P1|STARTED|Treatment With Blinded Study Therapy||478
1527295|NCT01450761|3738642|P2|NOT COMPLETED|Lead-in Chemotherapy||85
1527296|NCT01450761|3738643|P1|NOT COMPLETED|Lead-in Chemotherapy||84
1527297|NCT01450761|3738642|P2|COMPLETED|Lead-in Chemotherapy||476
1527298|NCT01450761|3738643|P1|COMPLETED|Lead-in Chemotherapy||478
1527299|NCT01450761|3738642|P2|STARTED|Lead-in Chemotherapy||561
1527300|NCT01450761|3738643|P1|STARTED|Lead-in Chemotherapy||562
1527301|NCT01450761|3738642|P2|NOT COMPLETED|Randomization||5
1527302|NCT01450761|3738643|P1|NOT COMPLETED|Randomization||4
1527303|NCT01450761|3738642|P2|COMPLETED|Randomization||561
1527304|NCT01450761|3738643|P1|COMPLETED|Randomization||562
1527305|NCT01450761|3738642|P2|STARTED|Randomization||566
1527306|NCT01450761|3738643|P1|STARTED|Randomization||566
1527307|NCT01450696|3738655|P2|NOT COMPLETED|Overall Study||148
1527308|NCT01450696|3738656|P1|NOT COMPLETED|Overall Study||148
1527309|NCT01450696|3738655|P2|COMPLETED|Overall Study||0
1527310|NCT01450696|3738656|P1|COMPLETED|Overall Study||0
1527311|NCT01450696|3738655|P2|Treated (Safety Population)|Overall Study||147
1527312|NCT01450696|3738656|P1|Treated (Safety Population)|Overall Study||147
1527313|NCT01450696|3738655|P2|STARTED|Overall Study||148
1527314|NCT01450696|3738656|P1|STARTED|Overall Study||148
1527315|NCT01450683|3738678|P1|NOT COMPLETED|Overall Study||2
1527316|NCT01450683|3738678|P1|COMPLETED|Overall Study||2
1527317|NCT01450683|3738678|P1|STARTED|Overall Study||4
1527318|NCT01450631|3738684|P2|NOT COMPLETED|Overall Study||4
1527319|NCT01450631|3738685|P1|NOT COMPLETED|Overall Study||3
1527320|NCT01450631|3738684|P2|COMPLETED|Overall Study||42
1527321|NCT01450631|3738685|P1|COMPLETED|Overall Study||43
1527322|NCT01450631|3738684|P2|STARTED|Overall Study||46
1527323|NCT01450631|3738685|P1|STARTED|Overall Study||46
1527324|NCT01450397|3738693|P1|NOT COMPLETED|Overall Study||0
1527325|NCT01450397|3738693|P1|COMPLETED|Overall Study||5
1527326|NCT01450397|3738693|P1|STARTED|Overall Study||5
1527327|NCT01450319|3738697|P1|NOT COMPLETED|Overall Study||0
1527328|NCT01450319|3738697|P1|COMPLETED|Overall Study||70
1527329|NCT01450319|3738697|P1|STARTED|Overall Study||70
1527330|NCT01450306|3738710|P2|NOT COMPLETED|Overall Study||0
1527331|NCT01450306|3738711|P1|NOT COMPLETED|Overall Study||0
1527332|NCT01450306|3738710|P2|COMPLETED|Overall Study||10
1527333|NCT01450306|3738711|P1|COMPLETED|Overall Study||10
1527334|NCT01450306|3738710|P2|STARTED|Overall Study||10
1527335|NCT01450306|3738711|P1|STARTED|Overall Study||10
1527336|NCT01450189|3738724|P3|NOT COMPLETED|Overall Study||0
1527337|NCT01450189|3738725|P2|NOT COMPLETED|Overall Study||0
1527338|NCT01450189|3738726|P1|NOT COMPLETED|Overall Study||0
1527339|NCT01450189|3738724|P3|COMPLETED|Overall Study||19
1527340|NCT01450189|3738725|P2|COMPLETED|Overall Study||18
1527341|NCT01450189|3738726|P1|COMPLETED|Overall Study||9
1527342|NCT01450189|3738724|P3|STARTED|Overall Study||19
1527343|NCT01450189|3738725|P2|STARTED|Overall Study||18
1527344|NCT01450189|3738726|P1|STARTED|Overall Study||9
1527345|NCT01450098|3738815|P2|NOT COMPLETED|Period 3||3
1527346|NCT01450098|3738816|P1|NOT COMPLETED|Period 3||0
1527347|NCT01450098|3738815|P2|COMPLETED|Period 3||28
1527348|NCT01450098|3738816|P1|COMPLETED|Period 3||8
1527349|NCT01450098|3738815|P2|Received at Least 1 Dose of Study Drug|Period 3||30
1527350|NCT01450098|3738816|P1|Received at Least 1 Dose of Study Drug|Period 3||8
1527351|NCT01450098|3738815|P2|STARTED|Period 3||31
1527352|NCT01450098|3738816|P1|STARTED|Period 3||8
1527353|NCT01450098|3738815|P2|NOT COMPLETED|Washout of at Least 14 Days||0
1527354|NCT01450098|3738816|P1|NOT COMPLETED|Washout of at Least 14 Days||0
1527355|NCT01450098|3738815|P2|COMPLETED|Washout of at Least 14 Days||31
1527356|NCT01450098|3738816|P1|COMPLETED|Washout of at Least 14 Days||8
1527357|NCT01450098|3738815|P2|STARTED|Washout of at Least 14 Days||31
1527358|NCT01450098|3738816|P1|STARTED|Washout of at Least 14 Days||8
1527359|NCT01450098|3738815|P2|NOT COMPLETED|Period 2||0
1527360|NCT01450098|3738816|P1|NOT COMPLETED|Period 2||0
1527361|NCT01450098|3738815|P2|COMPLETED|Period 2||31
1527362|NCT01450098|3738816|P1|COMPLETED|Period 2||8
1527363|NCT01450098|3738815|P2|Received at Least 1 Dose of Study Drug|Period 2||31
1527364|NCT01450098|3738816|P1|Received at Least 1 Dose of Study Drug|Period 2||8
1527365|NCT01450098|3738815|P2|STARTED|Period 2||31
1527366|NCT01450098|3738816|P1|STARTED|Period 2||8
1527367|NCT01450098|3738815|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
1527368|NCT01450098|3738816|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
1527369|NCT01450098|3738815|P2|COMPLETED|Washout Period of at Least 14 Days||31
1527370|NCT01450098|3738816|P1|COMPLETED|Washout Period of at Least 14 Days||8
1527371|NCT01450098|3738815|P2|STARTED|Washout Period of at Least 14 Days||31
1527372|NCT01450098|3738816|P1|STARTED|Washout Period of at Least 14 Days||8
1527373|NCT01450098|3738815|P2|NOT COMPLETED|Period 1||0
1527374|NCT01450098|3738816|P1|NOT COMPLETED|Period 1||0
1527375|NCT01450098|3738815|P2|COMPLETED|Period 1||31
1527376|NCT01450098|3738816|P1|COMPLETED|Period 1||8
1527377|NCT01450098|3738815|P2|Received at Least 1 Dose of Study Drug|Period 1||31
1527378|NCT01450098|3738816|P1|Received at Least 1 Dose of Study Drug|Period 1||8
1527379|NCT01450098|3738815|P2|STARTED|Period 1||31
1527380|NCT01450098|3738816|P1|STARTED|Period 1||8
1527381|NCT01450007|3738835|P3|NOT COMPLETED|Overall Study||3
1527382|NCT01450007|3738836|P2|NOT COMPLETED|Overall Study||5
1527383|NCT01450007|3738837|P1|NOT COMPLETED|Overall Study||2
1527384|NCT01450007|3738835|P3|COMPLETED|Overall Study||41
1527385|NCT01450007|3738836|P2|COMPLETED|Overall Study||37
1527386|NCT01450007|3738837|P1|COMPLETED|Overall Study||42
1527387|NCT01450007|3738835|P3|STARTED|Overall Study||44
1527388|NCT01450007|3738836|P2|STARTED|Overall Study||42
1527389|NCT01450007|3738837|P1|STARTED|Overall Study||44
1527390|NCT01449955|3738856|P2|NOT COMPLETED|Overall Study||2
1527391|NCT01449955|3738857|P1|NOT COMPLETED|Overall Study||1
1527392|NCT01449955|3738856|P2|COMPLETED|Overall Study||24
1527393|NCT01449955|3738857|P1|COMPLETED|Overall Study||27
1527394|NCT01449955|3738856|P2|STARTED|Overall Study||26
1527395|NCT01449955|3738857|P1|STARTED|Overall Study||28
1527396|NCT01449929|3738885|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
1527397|NCT01449929|3738886|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
1527398|NCT01449929|3738887|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
1527399|NCT01449929|3738885|P3|COMPLETED|Extension Phase Approximately 3 Years||115
1527400|NCT01449929|3738886|P2|COMPLETED|Extension Phase Approximately 3 Years||0
1527401|NCT01449929|3738887|P1|COMPLETED|Extension Phase Approximately 3 Years||0
1527402|NCT01449929|3738885|P3|STARTED|Extension Phase Approximately 3 Years||123
1527403|NCT01449929|3738886|P2|STARTED|Extension Phase Approximately 3 Years||0
1527404|NCT01449929|3738887|P1|STARTED|Extension Phase Approximately 3 Years||0
1527405|NCT01449929|3738885|P3|NOT COMPLETED|Randomization Phase 96 Week||0
1527406|NCT01449929|3738886|P2|NOT COMPLETED|Randomization Phase 96 Week||53
1527407|NCT01449929|3738887|P1|NOT COMPLETED|Randomization Phase 96 Week||33
1527408|NCT01449929|3738885|P3|COMPLETED|Randomization Phase 96 Week||0
1527409|NCT01449929|3738886|P2|COMPLETED|Randomization Phase 96 Week||189
1527410|NCT01449929|3738887|P1|COMPLETED|Randomization Phase 96 Week||209
1527411|NCT01449929|3738885|P3|STARTED|Randomization Phase 96 Week||0
1527412|NCT01449929|3738886|P2|STARTED|Randomization Phase 96 Week||242
1527413|NCT01449929|3738887|P1|STARTED|Randomization Phase 96 Week||242
1527414|NCT01449812|3738927|P3|NOT COMPLETED|Overall Study||1
1527415|NCT01449812|3738928|P2|NOT COMPLETED|Overall Study||0
1527416|NCT01449812|3738929|P1|NOT COMPLETED|Overall Study||2
1527417|NCT01449812|3738927|P3|COMPLETED|Overall Study||279
1527418|NCT01449812|3738928|P2|COMPLETED|Overall Study||273
1527419|NCT01449812|3738929|P1|COMPLETED|Overall Study||270
1527420|NCT01449812|3738927|P3|STARTED|Overall Study||280
1527421|NCT01449812|3738928|P2|STARTED|Overall Study||273
1527422|NCT01449812|3738929|P1|STARTED|Overall Study||272
1527423|NCT01449747|3739023|P2|NOT COMPLETED|Overall Study||0
1527424|NCT01449747|3739024|P1|NOT COMPLETED|Overall Study||0
1527425|NCT01449747|3739023|P2|COMPLETED|Overall Study||12
1527426|NCT01449747|3739024|P1|COMPLETED|Overall Study||12
1527427|NCT01449747|3739023|P2|STARTED|Overall Study||12
1527428|NCT01449747|3739024|P1|STARTED|Overall Study||12
1527429|NCT01449734|3739038|P1|NOT COMPLETED|Overall Study||0
1527430|NCT01449734|3739038|P1|COMPLETED|Overall Study||215
1527431|NCT01449734|3739038|P1|STARTED|Overall Study||215
1527432|NCT01449721|3739044|P2|NOT COMPLETED|Overall Study||2
1527433|NCT01449721|3739045|P1|NOT COMPLETED|Overall Study||0
1527434|NCT01449721|3739044|P2|COMPLETED|Overall Study||28
1527435|NCT01449721|3739045|P1|COMPLETED|Overall Study||112
1527436|NCT01449721|3739044|P2|STARTED|Overall Study||30
1527437|NCT01449721|3739045|P1|STARTED|Overall Study||112
1527438|NCT01449708|3739057|P2|NOT COMPLETED|Overall Study||3
1527439|NCT01449708|3739058|P1|NOT COMPLETED|Overall Study||2
1527440|NCT01449708|3739057|P2|COMPLETED|Overall Study||60
1527441|NCT01449708|3739058|P1|COMPLETED|Overall Study||59
1527442|NCT01449708|3739057|P2|STARTED|Overall Study||63
1527443|NCT01449708|3739058|P1|STARTED|Overall Study||61
1527444|NCT01449682|3739069|P2|NOT COMPLETED|Overall Study||1
1527445|NCT01449682|3739070|P1|NOT COMPLETED|Overall Study||1
1527446|NCT01449682|3739069|P2|COMPLETED|Overall Study||4
1527447|NCT01449682|3739070|P1|COMPLETED|Overall Study||4
1527448|NCT01449682|3739069|P2|STARTED|Overall Study||5
1527449|NCT01449682|3739070|P1|STARTED|Overall Study||5
1527450|NCT01449539|3739082|P1|NOT COMPLETED|Overall Study||4
1527451|NCT01449539|3739082|P1|COMPLETED|Overall Study||4
1527452|NCT01449539|3739082|P1|STARTED|Overall Study||8
1527453|NCT01449526|3739088|P2|NOT COMPLETED|Overall Study||6
1527454|NCT01449526|3739089|P1|NOT COMPLETED|Overall Study||2
1527455|NCT01449526|3739088|P2|COMPLETED|Overall Study||77
1527456|NCT01449526|3739089|P1|COMPLETED|Overall Study||81
1527457|NCT01449526|3739088|P2|STARTED|Overall Study||83
1527458|NCT01449526|3739089|P1|STARTED|Overall Study||83
1527459|NCT01449513|3739099|P2|NOT COMPLETED|Overall Study||0
1527460|NCT01449513|3739100|P1|NOT COMPLETED|Overall Study||0
1527461|NCT01449513|3739099|P2|COMPLETED|Overall Study||8
1527462|NCT01449513|3739100|P1|COMPLETED|Overall Study||16
1527463|NCT01449513|3739099|P2|STARTED|Overall Study||8
1527464|NCT01449513|3739100|P1|STARTED|Overall Study||16
1527465|NCT01449461|3739158|P6|NOT COMPLETED|Overall Study||15
1527466|NCT01449461|3739159|P5|NOT COMPLETED|Overall Study||48
1527467|NCT01449461|3739160|P4|NOT COMPLETED|Overall Study||32
1527468|NCT01449461|3739161|P3|NOT COMPLETED|Overall Study||18
1527469|NCT01449461|3739162|P2|NOT COMPLETED|Overall Study||18
1527470|NCT01449461|3739163|P1|NOT COMPLETED|Overall Study||6
1527471|NCT01449461|3739158|P6|COMPLETED|Overall Study||0
1527472|NCT01449461|3739159|P5|COMPLETED|Overall Study||0
1527473|NCT01449461|3739160|P4|COMPLETED|Overall Study||0
1527474|NCT01449461|3739161|P3|COMPLETED|Overall Study||0
1527475|NCT01449461|3739162|P2|COMPLETED|Overall Study||0
1527476|NCT01449461|3739163|P1|COMPLETED|Overall Study||0
1527477|NCT01449461|3739158|P6|STARTED|Overall Study||15
1527478|NCT01449461|3739159|P5|STARTED|Overall Study||48
1527479|NCT01449461|3739160|P4|STARTED|Overall Study||32
1527480|NCT01449461|3739161|P3|STARTED|Overall Study||18
1527481|NCT01449461|3739162|P2|STARTED|Overall Study||18
1527482|NCT01449461|3739163|P1|STARTED|Overall Study||6
1527483|NCT01449370|3739300|P25|NOT COMPLETED|Overall Study||8
1527484|NCT01449370|3739301|P24|NOT COMPLETED|Overall Study||10
1527485|NCT01449370|3739302|P23|NOT COMPLETED|Overall Study||4
1527486|NCT01449370|3739303|P22|NOT COMPLETED|Overall Study||4
1527487|NCT01449370|3739304|P21|NOT COMPLETED|Overall Study||6
1527488|NCT01449370|3739305|P20|NOT COMPLETED|Overall Study||3
1527489|NCT01449370|3739306|P19|NOT COMPLETED|Overall Study||3
1527490|NCT01449370|3739307|P18|NOT COMPLETED|Overall Study||3
1527491|NCT01449370|3739308|P17|NOT COMPLETED|Overall Study||7
1527492|NCT01449370|3739309|P16|NOT COMPLETED|Overall Study||3
1527493|NCT01449370|3739310|P15|NOT COMPLETED|Overall Study||3
1527494|NCT01449370|3739311|P14|NOT COMPLETED|Overall Study||11
1527495|NCT01449370|3739312|P13|NOT COMPLETED|Overall Study||3
1527496|NCT01449370|3739313|P12|NOT COMPLETED|Overall Study||3
1527497|NCT01449370|3739314|P11|NOT COMPLETED|Overall Study||3
1527498|NCT01449370|3739315|P10|NOT COMPLETED|Overall Study||3
1527499|NCT01449370|3739316|P9|NOT COMPLETED|Overall Study||12
1527500|NCT01449370|3739317|P8|NOT COMPLETED|Overall Study||3
1527501|NCT01449370|3739318|P7|NOT COMPLETED|Overall Study||3
1527502|NCT01449370|3739319|P6|NOT COMPLETED|Overall Study||3
1527503|NCT01449370|3739320|P5|NOT COMPLETED|Overall Study||3
1527504|NCT01449370|3739321|P4|NOT COMPLETED|Overall Study||4
1527505|NCT01449370|3739322|P3|NOT COMPLETED|Overall Study||8
1527506|NCT01449370|3739323|P2|NOT COMPLETED|Overall Study||6
1527507|NCT01449370|3739324|P1|NOT COMPLETED|Overall Study||6
1527508|NCT01449370|3739300|P25|COMPLETED|Overall Study||0
1527509|NCT01449370|3739301|P24|COMPLETED|Overall Study||0
1527510|NCT01449370|3739302|P23|COMPLETED|Overall Study||0
1527511|NCT01449370|3739303|P22|COMPLETED|Overall Study||0
1527512|NCT01449370|3739304|P21|COMPLETED|Overall Study||0
1527513|NCT01449370|3739305|P20|COMPLETED|Overall Study||0
1527514|NCT01449370|3739306|P19|COMPLETED|Overall Study||0
1527515|NCT01449370|3739307|P18|COMPLETED|Overall Study||0
1527516|NCT01449370|3739308|P17|COMPLETED|Overall Study||0
1527517|NCT01449370|3739309|P16|COMPLETED|Overall Study||0
1527518|NCT01449370|3739310|P15|COMPLETED|Overall Study||0
1527519|NCT01449370|3739311|P14|COMPLETED|Overall Study||0
1527520|NCT01449370|3739312|P13|COMPLETED|Overall Study||0
1527521|NCT01449370|3739313|P12|COMPLETED|Overall Study||0
1527522|NCT01449370|3739314|P11|COMPLETED|Overall Study||0
1527523|NCT01449370|3739315|P10|COMPLETED|Overall Study||0
1527524|NCT01449370|3739316|P9|COMPLETED|Overall Study||0
1527525|NCT01449370|3739317|P8|COMPLETED|Overall Study||0
1527526|NCT01449370|3739318|P7|COMPLETED|Overall Study||0
1527527|NCT01449370|3739319|P6|COMPLETED|Overall Study||0
1527528|NCT01449370|3739320|P5|COMPLETED|Overall Study||0
1527529|NCT01449370|3739321|P4|COMPLETED|Overall Study||0
1527530|NCT01449370|3739322|P3|COMPLETED|Overall Study||0
1527531|NCT01449370|3739323|P2|COMPLETED|Overall Study||0
1527532|NCT01449370|3739324|P1|COMPLETED|Overall Study||0
1527533|NCT01449370|3739300|P25|STARTED|Overall Study||8
1527534|NCT01449370|3739301|P24|STARTED|Overall Study||10
1527535|NCT01449370|3739302|P23|STARTED|Overall Study||4
1527536|NCT01449370|3739303|P22|STARTED|Overall Study||4
1527537|NCT01449370|3739304|P21|STARTED|Overall Study||6
1527538|NCT01449370|3739305|P20|STARTED|Overall Study||3
1527539|NCT01449370|3739306|P19|STARTED|Overall Study||3
1527540|NCT01449370|3739307|P18|STARTED|Overall Study||3
1527541|NCT01449370|3739308|P17|STARTED|Overall Study||7
1527542|NCT01449370|3739309|P16|STARTED|Overall Study||3
1527543|NCT01449370|3739310|P15|STARTED|Overall Study||3
1527544|NCT01449370|3739311|P14|STARTED|Overall Study||11
1527545|NCT01449370|3739312|P13|STARTED|Overall Study||3
1527546|NCT01449370|3739313|P12|STARTED|Overall Study||3
1527547|NCT01449370|3739314|P11|STARTED|Overall Study||3
1527548|NCT01449370|3739315|P10|STARTED|Overall Study||3
1527549|NCT01449370|3739316|P9|STARTED|Overall Study||12
1527550|NCT01449370|3739317|P8|STARTED|Overall Study||3
1527551|NCT01449370|3739318|P7|STARTED|Overall Study||3
1527552|NCT01449370|3739319|P6|STARTED|Overall Study||3
1527553|NCT01449370|3739320|P5|STARTED|Overall Study||3
1527554|NCT01449370|3739321|P4|STARTED|Overall Study||4
1527555|NCT01449370|3739322|P3|STARTED|Overall Study||8
1527556|NCT01449370|3739323|P2|STARTED|Overall Study||6
1527557|NCT01449370|3739324|P1|STARTED|Overall Study||6
1527558|NCT01449305|3739697|P1|NOT COMPLETED|Overall Study||2
1527559|NCT01449305|3739697|P1|COMPLETED|Overall Study||42
1527560|NCT01449305|3739697|P1|STARTED|Overall Study||44
1527561|NCT01449279|3739702|P1|NOT COMPLETED|Overall Study||7
1527562|NCT01449279|3739702|P1|COMPLETED|Overall Study||15
1527563|NCT01449279|3739702|P1|STARTED|Overall Study||22
1527564|NCT01449266|3739713|P1|NOT COMPLETED|Overall Study||0
1527565|NCT01449266|3739713|P1|COMPLETED|Overall Study||10
1527566|NCT01449266|3739713|P1|STARTED|Overall Study||10
1527567|NCT01449240|3739720|P1|NOT COMPLETED|Overall Study||0
1527568|NCT01449240|3739720|P1|COMPLETED|Overall Study||10
1527569|NCT01449240|3739720|P1|STARTED|Overall Study||10
1527570|NCT01449006|3739727|P2|NOT COMPLETED|Overall Study||0
1527571|NCT01449006|3739728|P1|NOT COMPLETED|Overall Study||3
1527572|NCT01449006|3739727|P2|COMPLETED|Overall Study||9
1527573|NCT01449006|3739728|P1|COMPLETED|Overall Study||5
1527574|NCT01449006|3739727|P2|STARTED|Overall Study||9
1527575|NCT01449006|3739728|P1|STARTED|Overall Study||8
1527576|NCT01448850|3739742|P2|NOT COMPLETED|Overall Study||40
1527577|NCT01448850|3739743|P1|NOT COMPLETED|Overall Study||34
1527578|NCT01448850|3739742|P2|COMPLETED|Overall Study||120
1527579|NCT01448850|3739743|P1|COMPLETED|Overall Study||130
1527580|NCT01448850|3739742|P2|STARTED|Overall Study||160
1527581|NCT01448850|3739743|P1|STARTED|Overall Study||164
1527582|NCT01448707|3739768|P2|NOT COMPLETED|Overall Study||18
1527583|NCT01448707|3739769|P1|NOT COMPLETED|Overall Study||18
1527584|NCT01448707|3739768|P2|COMPLETED|Overall Study||118
1527585|NCT01448707|3739769|P1|COMPLETED|Overall Study||119
1527586|NCT01448707|3739768|P2|STARTED|Overall Study||136
1527587|NCT01448707|3739769|P1|STARTED|Overall Study||137
1527588|NCT01448616|3739790|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
1527589|NCT01448616|3739791|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
1527590|NCT01448616|3739792|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
1527591|NCT01448616|3739793|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
1527592|NCT01448616|3739790|P4|COMPLETED|Study Drug (Treatment Phase)||9
1527593|NCT01448616|3739791|P3|COMPLETED|Study Drug (Treatment Phase)||23
1527594|NCT01448616|3739792|P2|COMPLETED|Study Drug (Treatment Phase)||22
1527595|NCT01448616|3739793|P1|COMPLETED|Study Drug (Treatment Phase)||0
1527596|NCT01448616|3739790|P4|STARTED|Study Drug (Treatment Phase)||13
1527597|NCT01448616|3739791|P3|STARTED|Study Drug (Treatment Phase)||27
1527598|NCT01448616|3739792|P2|STARTED|Study Drug (Treatment Phase)||24
1527599|NCT01448616|3739793|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
1527600|NCT01448616|3739790|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
1527601|NCT01448616|3739791|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
1527602|NCT01448616|3739792|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
1527603|NCT01448616|3739793|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
1527604|NCT01448616|3739790|P4|COMPLETED|Lead-In (Observational Phase)||0
1527605|NCT01448616|3739791|P3|COMPLETED|Lead-In (Observational Phase)||0
1527606|NCT01448616|3739792|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
1527607|NCT01448616|3739793|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
1527608|NCT01448616|3739790|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
1527609|NCT01448616|3739791|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
1527610|NCT01448616|3739792|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
1527611|NCT01448616|3739793|P1|STARTED|Lead-In (Observational Phase)||73
1527612|NCT01448525|3739813|P2|NOT COMPLETED|Overall Study||2
1527613|NCT01448525|3739814|P1|NOT COMPLETED|Overall Study||1
1527614|NCT01448525|3739813|P2|COMPLETED|Overall Study||42
1527615|NCT01448525|3739814|P1|COMPLETED|Overall Study||43
1527616|NCT01448525|3739813|P2|STARTED|Overall Study||44
1527617|NCT01448525|3739814|P1|STARTED|Overall Study||44
1527618|NCT01448486|3739824|P2|NOT COMPLETED|Overall Study||0
1527619|NCT01448486|3739825|P1|NOT COMPLETED|Overall Study||0
1527620|NCT01448486|3739824|P2|COMPLETED|Overall Study||3
1527621|NCT01448486|3739825|P1|COMPLETED|Overall Study||3
1527622|NCT01448486|3739824|P2|STARTED|Overall Study||3
1527623|NCT01448486|3739825|P1|STARTED|Overall Study||3
1527624|NCT01448356|3739833|P1|NOT COMPLETED|Overall Study||0
1527625|NCT01448356|3739833|P1|COMPLETED|Overall Study|cross-over|10
1527626|NCT01448356|3739833|P1|STARTED|Overall Study||10
1527627|NCT01448213|3739840|P2|NOT COMPLETED|Overall Study||22
1527628|NCT01448213|3739841|P1|NOT COMPLETED|Overall Study||17
1527629|NCT01448213|3739840|P2|COMPLETED|Overall Study||112
1527630|NCT01448213|3739841|P1|COMPLETED|Overall Study||113
1527631|NCT01448213|3739840|P2|STARTED|Overall Study||134
1527632|NCT01448213|3739841|P1|STARTED|Overall Study||130
1527633|NCT01448057|3739851|P2|NOT COMPLETED|Overall Study||4
1527634|NCT01448057|3739852|P1|NOT COMPLETED|Overall Study||8
1527635|NCT01448057|3739851|P2|COMPLETED|Overall Study||167
1527636|NCT01448057|3739852|P1|COMPLETED|Overall Study||162
1527637|NCT01448057|3739851|P2|STARTED|Overall Study||171
1527638|NCT01448057|3739852|P1|STARTED|Overall Study||170
1527639|NCT01448044|3739862|P2|NOT COMPLETED|Follow Up Period||14
1527640|NCT01448044|3739863|P1|NOT COMPLETED|Follow Up Period||12
1527641|NCT01448044|3739862|P2|COMPLETED|Follow Up Period||26
1527642|NCT01448044|3739863|P1|COMPLETED|Follow Up Period||65
1527643|NCT01448044|3739862|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
1527644|NCT01448044|3739863|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
1527645|NCT01448044|3739862|P2|NOT COMPLETED|Treatment Period||16
1527646|NCT01448044|3739863|P1|NOT COMPLETED|Treatment Period||23
1527647|NCT01448044|3739862|P2|COMPLETED|Treatment Period||26
1527648|NCT01448044|3739863|P1|COMPLETED|Treatment Period||59
1527649|NCT01448044|3739862|P2|STARTED|Treatment Period||42
1527650|NCT01448044|3739863|P1|STARTED|Treatment Period||82
1527651|NCT01447927|3739879|P2|NOT COMPLETED|Overall Study||3
1527652|NCT01447927|3739880|P1|NOT COMPLETED|Overall Study||5
1527653|NCT01447927|3739879|P2|COMPLETED|Overall Study||33
1527654|NCT01447927|3739880|P1|COMPLETED|Overall Study||33
1527655|NCT01447927|3739879|P2|STARTED|Overall Study||36
1527656|NCT01447927|3739880|P1|STARTED|Overall Study||38
1527657|NCT01447914|3739888|P1|NOT COMPLETED|Overall Study||0
1527658|NCT01447914|3739888|P1|COMPLETED|Overall Study||16
1527659|NCT01447914|3739888|P1|STARTED|Overall Study||16
1527660|NCT01447849|3739897|P4|NOT COMPLETED|Second Intervention||0
1527661|NCT01447849|3739898|P3|NOT COMPLETED|Second Intervention||0
1527662|NCT01447849|3739899|P2|NOT COMPLETED|Second Intervention||0
1527663|NCT01447849|3739900|P1|NOT COMPLETED|Second Intervention||0
1527664|NCT01447849|3739897|P4|COMPLETED|Second Intervention||10
1527665|NCT01447849|3739898|P3|COMPLETED|Second Intervention||10
1527666|NCT01447849|3739899|P2|COMPLETED|Second Intervention||10
1527667|NCT01447849|3739900|P1|COMPLETED|Second Intervention||10
1527668|NCT01447849|3739897|P4|STARTED|Second Intervention||10
1527669|NCT01447849|3739898|P3|STARTED|Second Intervention||10
1527670|NCT01447849|3739899|P2|STARTED|Second Intervention||10
1527671|NCT01447849|3739900|P1|STARTED|Second Intervention||10
1527672|NCT01447849|3739897|P4|NOT COMPLETED|Washout Period for 1 Week||0
1527673|NCT01447849|3739898|P3|NOT COMPLETED|Washout Period for 1 Week||0
1527674|NCT01447849|3739899|P2|NOT COMPLETED|Washout Period for 1 Week||0
1527675|NCT01447849|3739900|P1|NOT COMPLETED|Washout Period for 1 Week||0
1527676|NCT01447849|3739897|P4|COMPLETED|Washout Period for 1 Week||10
1527677|NCT01447849|3739898|P3|COMPLETED|Washout Period for 1 Week||10
1527678|NCT01447849|3739899|P2|COMPLETED|Washout Period for 1 Week||10
1527679|NCT01447849|3739900|P1|COMPLETED|Washout Period for 1 Week||10
1527680|NCT01447849|3739897|P4|STARTED|Washout Period for 1 Week||10
1527681|NCT01447849|3739898|P3|STARTED|Washout Period for 1 Week||10
1527682|NCT01447849|3739899|P2|STARTED|Washout Period for 1 Week||10
1527683|NCT01447849|3739900|P1|STARTED|Washout Period for 1 Week||10
1527684|NCT01447849|3739897|P4|NOT COMPLETED|First Intervention||0
1527685|NCT01447849|3739898|P3|NOT COMPLETED|First Intervention||0
1527686|NCT01447849|3739899|P2|NOT COMPLETED|First Intervention||0
1527687|NCT01447849|3739900|P1|NOT COMPLETED|First Intervention||0
1527688|NCT01447849|3739897|P4|COMPLETED|First Intervention||10
1527689|NCT01447849|3739898|P3|COMPLETED|First Intervention||10
1527690|NCT01447849|3739899|P2|COMPLETED|First Intervention||10
1527691|NCT01447849|3739900|P1|COMPLETED|First Intervention||10
1527692|NCT01447849|3739897|P4|STARTED|First Intervention||10
1527693|NCT01447849|3739898|P3|STARTED|First Intervention||10
1527694|NCT01447849|3739899|P2|STARTED|First Intervention||10
1527695|NCT01447849|3739900|P1|STARTED|First Intervention||10
1527696|NCT01447719|3739910|P1|NOT COMPLETED|Overall Study||93
1527697|NCT01447719|3739910|P1|COMPLETED|Overall Study||59
1527698|NCT01447719|3739910|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
1527699|NCT01447719|3739910|P1|Valid AV-45 Scan Acquired|Overall Study||147
1527700|NCT01447719|3739910|P1|STARTED|Overall Study||152
1527701|NCT01447706|3739923|P2|NOT COMPLETED|Overall Study||3
1527702|NCT01447706|3739924|P1|NOT COMPLETED|Overall Study||0
1527703|NCT01447706|3739923|P2|COMPLETED|Overall Study||80
1527704|NCT01447706|3739924|P1|COMPLETED|Overall Study||140
1527705|NCT01447706|3739923|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
1527706|NCT01447706|3739924|P1|STARTED|Overall Study||140
1527707|NCT01447576|3739936|P1|NOT COMPLETED|Overall Study||476
1527708|NCT01447576|3739936|P1|COMPLETED|Overall Study||560
1527709|NCT01447576|3739936|P1|STARTED|Overall Study||1036
1527710|NCT01447511|3739947|P5|NOT COMPLETED|Rifampin Period||0
1527711|NCT01447511|3739948|P4|NOT COMPLETED|Rifampin Period||1
1527712|NCT01447511|3739949|P3|NOT COMPLETED|Rifampin Period||0
1527713|NCT01447511|3739950|P2|NOT COMPLETED|Rifampin Period||0
1527714|NCT01447511|3739951|P1|NOT COMPLETED|Rifampin Period||0
1527715|NCT01447511|3739947|P5|COMPLETED|Rifampin Period||4
1527716|NCT01447511|3739948|P4|COMPLETED|Rifampin Period||2
1527717|NCT01447511|3739949|P3|COMPLETED|Rifampin Period||8
1527718|NCT01447511|3739950|P2|COMPLETED|Rifampin Period||5
1527719|NCT01447511|3739951|P1|COMPLETED|Rifampin Period||8
1527720|NCT01447511|3739947|P5|STARTED|Rifampin Period||4
1527721|NCT01447511|3739948|P4|STARTED|Rifampin Period||3
1527722|NCT01447511|3739949|P3|STARTED|Rifampin Period||8
1527723|NCT01447511|3739950|P2|STARTED|Rifampin Period||5
1527724|NCT01447511|3739951|P1|STARTED|Rifampin Period||8
1527725|NCT01447511|3739947|P5|NOT COMPLETED|Fluconazole Period||0
1527726|NCT01447511|3739948|P4|NOT COMPLETED|Fluconazole Period||0
1527727|NCT01447511|3739949|P3|NOT COMPLETED|Fluconazole Period||1
1527728|NCT01447511|3739950|P2|NOT COMPLETED|Fluconazole Period||0
1527729|NCT01447511|3739951|P1|NOT COMPLETED|Fluconazole Period||0
1527730|NCT01447511|3739947|P5|COMPLETED|Fluconazole Period||4
1527731|NCT01447511|3739948|P4|COMPLETED|Fluconazole Period||3
1527732|NCT01447511|3739949|P3|COMPLETED|Fluconazole Period||8
1527733|NCT01447511|3739950|P2|COMPLETED|Fluconazole Period||0
1527734|NCT01447511|3739951|P1|COMPLETED|Fluconazole Period||8
1527735|NCT01447511|3739947|P5|STARTED|Fluconazole Period||4
1527736|NCT01447511|3739948|P4|STARTED|Fluconazole Period||3
1527737|NCT01447511|3739949|P3|STARTED|Fluconazole Period||9
1527738|NCT01447511|3739950|P2|STARTED|Fluconazole Period||0
1527739|NCT01447511|3739951|P1|STARTED|Fluconazole Period||8
1527740|NCT01447511|3739947|P5|NOT COMPLETED|Control Period||0
1527741|NCT01447511|3739948|P4|NOT COMPLETED|Control Period||0
1527742|NCT01447511|3739949|P3|NOT COMPLETED|Control Period||0
1527743|NCT01447511|3739950|P2|NOT COMPLETED|Control Period||0
1527744|NCT01447511|3739951|P1|NOT COMPLETED|Control Period||0
1527745|NCT01447511|3739947|P5|COMPLETED|Control Period||4
1527746|NCT01447511|3739948|P4|COMPLETED|Control Period||3
1527747|NCT01447511|3739949|P3|COMPLETED|Control Period||9
1527748|NCT01447511|3739950|P2|COMPLETED|Control Period||5
1527749|NCT01447511|3739951|P1|COMPLETED|Control Period||8
1527750|NCT01447511|3739947|P5|STARTED|Control Period||4
1527751|NCT01447511|3739948|P4|STARTED|Control Period||3
1527752|NCT01447511|3739949|P3|STARTED|Control Period||9
1527753|NCT01447511|3739950|P2|STARTED|Control Period||5
1527754|NCT01447511|3739951|P1|STARTED|Control Period||8
1527755|NCT01447446|3739969|P6|NOT COMPLETED|Overall Study||32
1527756|NCT01447446|3739970|P5|NOT COMPLETED|Overall Study||211
1527757|NCT01447446|3739971|P4|NOT COMPLETED|Overall Study||33
1527758|NCT01447446|3739972|P3|NOT COMPLETED|Overall Study||100
1527759|NCT01447446|3739973|P2|NOT COMPLETED|Overall Study||165
1527760|NCT01447446|3739974|P1|NOT COMPLETED|Overall Study||722
1527761|NCT01447446|3739969|P6|COMPLETED|Overall Study||54
1527762|NCT01447446|3739970|P5|COMPLETED|Overall Study||610
1527763|NCT01447446|3739971|P4|COMPLETED|Overall Study||60
1527764|NCT01447446|3739972|P3|COMPLETED|Overall Study||192
1527765|NCT01447446|3739973|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
1527766|NCT01447446|3739974|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
1527767|NCT01447446|3739969|P6|STARTED|Overall Study||86
1527768|NCT01447446|3739970|P5|STARTED|Overall Study||821
1527769|NCT01447446|3739971|P4|STARTED|Overall Study||93
1527770|NCT01447446|3739972|P3|STARTED|Overall Study||292
1527771|NCT01447446|3739973|P2|STARTED|Overall Study||496
1527772|NCT01447446|3739974|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
1527773|NCT01447433|3740064|P2|NOT COMPLETED|Overall Study||6
1527774|NCT01447433|3740065|P1|NOT COMPLETED|Overall Study||4
1527775|NCT01447433|3740064|P2|COMPLETED|Overall Study||21
1527776|NCT01447433|3740065|P1|COMPLETED|Overall Study||22
1527777|NCT01447433|3740064|P2|STARTED|Overall Study||27
1527778|NCT01447433|3740065|P1|STARTED|Overall Study||26
1527779|NCT01447420|3740092|P3|NOT COMPLETED|Overall Study||10
1527780|NCT01447420|3740093|P2|NOT COMPLETED|Overall Study||27
1527781|NCT01447420|3740094|P1|NOT COMPLETED|Overall Study||10
1527782|NCT01447420|3740092|P3|COMPLETED|Overall Study||8
1527783|NCT01447420|3740093|P2|COMPLETED|Overall Study||45
1527784|NCT01447420|3740094|P1|COMPLETED|Overall Study||29
1527785|NCT01447420|3740092|P3|STARTED|Overall Study||18
1527786|NCT01447420|3740093|P2|STARTED|Overall Study||72
1527787|NCT01447420|3740094|P1|STARTED|Overall Study||39
1527788|NCT01447225|3740114|P10|NOT COMPLETED|Overall Study||0
1527789|NCT01447225|3740115|P9|NOT COMPLETED|Overall Study||0
1527790|NCT01447225|3740116|P8|NOT COMPLETED|Overall Study||0
1527791|NCT01447225|3740117|P7|NOT COMPLETED|Overall Study||0
1527792|NCT01447225|3740118|P6|NOT COMPLETED|Overall Study||0
1527793|NCT01447225|3740119|P5|NOT COMPLETED|Overall Study||0
1527794|NCT01447225|3740120|P4|NOT COMPLETED|Overall Study||0
1527795|NCT01447225|3740121|P3|NOT COMPLETED|Overall Study||0
1527796|NCT01447225|3740122|P2|NOT COMPLETED|Overall Study||0
1527797|NCT01447225|3740123|P1|NOT COMPLETED|Overall Study||0
1527798|NCT01447225|3740114|P10|COMPLETED|Overall Study||4
1527799|NCT01447225|3740115|P9|COMPLETED|Overall Study||3
1527800|NCT01447225|3740116|P8|COMPLETED|Overall Study||4
1527801|NCT01447225|3740117|P7|COMPLETED|Overall Study||7
1527802|NCT01447225|3740118|P6|COMPLETED|Overall Study||3
1527803|NCT01447225|3740119|P5|COMPLETED|Overall Study||3
1527804|NCT01447225|3740120|P4|COMPLETED|Overall Study||3
1527805|NCT01447225|3740121|P3|COMPLETED|Overall Study||5
1527806|NCT01447225|3740122|P2|COMPLETED|Overall Study||8
1527807|NCT01447225|3740123|P1|COMPLETED|Overall Study||3
1527808|NCT01447225|3740114|P10|STARTED|Overall Study||4
1527809|NCT01447225|3740115|P9|STARTED|Overall Study||3
1527810|NCT01447225|3740116|P8|STARTED|Overall Study||4
1527811|NCT01447225|3740117|P7|STARTED|Overall Study||7
1527812|NCT01447225|3740118|P6|STARTED|Overall Study||3
1527813|NCT01447225|3740119|P5|STARTED|Overall Study||3
1527814|NCT01447225|3740120|P4|STARTED|Overall Study||3
1527815|NCT01447225|3740121|P3|STARTED|Overall Study||5
1527816|NCT01447225|3740122|P2|STARTED|Overall Study||8
1527817|NCT01447225|3740123|P1|STARTED|Overall Study||3
1527818|NCT01447121|3740193|P1|NOT COMPLETED|Overall Study||0
1527819|NCT01447121|3740193|P1|COMPLETED|Overall Study||118
1527820|NCT01447121|3740193|P1|STARTED|Overall Study||118
1527821|NCT01447017|3740200|P2|NOT COMPLETED|Overall Study||10
1527822|NCT01447017|3740201|P1|NOT COMPLETED|Overall Study||10
1527823|NCT01447017|3740200|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
1527824|NCT01447017|3740201|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
1527825|NCT01447017|3740200|P2|Performed Visit 2|Overall Study||24
1527826|NCT01447017|3740201|P1|Performed Visit 2|Overall Study||43
1527827|NCT01447017|3740200|P2|STARTED|Overall Study||24
1527828|NCT01447017|3740201|P1|STARTED|Overall Study||45
1527829|NCT01446874|3740210|P3|NOT COMPLETED|Overall Study||18
1527830|NCT01446874|3740211|P2|NOT COMPLETED|Overall Study||4
1527831|NCT01446874|3740212|P1|NOT COMPLETED|Overall Study||2
1527832|NCT01446874|3740210|P3|COMPLETED|Overall Study||62
1527833|NCT01446874|3740211|P2|COMPLETED|Overall Study||46
1527834|NCT01446874|3740212|P1|COMPLETED|Overall Study||18
1527835|NCT01446874|3740210|P3|STARTED|Overall Study||80
1527836|NCT01446874|3740211|P2|STARTED|Overall Study||50
1527837|NCT01446874|3740212|P1|STARTED|Overall Study||20
1527838|NCT01446796|3740238|P2|NOT COMPLETED|Overall Study||0
1527839|NCT01446796|3740239|P1|NOT COMPLETED|Overall Study||1
1527840|NCT01446796|3740238|P2|COMPLETED|Overall Study|Study terminated early|0
1527841|NCT01446796|3740239|P1|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
1527842|NCT01446796|3740238|P2|STARTED|Overall Study||0
1527843|NCT01446796|3740239|P1|STARTED|Overall Study||3
1527844|NCT01446705|3740253|P2|NOT COMPLETED|Overall Study||0
1527845|NCT01446705|3740254|P1|NOT COMPLETED|Overall Study||0
1527846|NCT01446705|3740253|P2|COMPLETED|Overall Study||6627
1527847|NCT01446705|3740254|P1|COMPLETED|Overall Study||50446
1527848|NCT01446705|3740253|P2|STARTED|Overall Study||6627
1527849|NCT01446705|3740254|P1|STARTED|Overall Study||50446
1527850|NCT01446419|3740264|P2|NOT COMPLETED|Overall Study||1
1527851|NCT01446419|3740265|P1|NOT COMPLETED|Overall Study||5
1527852|NCT01446419|3740264|P2|COMPLETED|Overall Study||77
1527853|NCT01446419|3740265|P1|COMPLETED|Overall Study||142
1527854|NCT01446419|3740264|P2|12 Month Follow-up|Overall Study||77
1527855|NCT01446419|3740265|P1|12 Month Follow-up|Overall Study||142
1527856|NCT01446419|3740264|P2|6 Month Follow-up|Overall Study||77
1527857|NCT01446419|3740265|P1|6 Month Follow-up|Overall Study||144
1527858|NCT01446419|3740264|P2|3 Month Follow-up|Overall Study||77
1527859|NCT01446419|3740265|P1|3 Month Follow-up|Overall Study||146
1527860|NCT01446419|3740264|P2|STARTED|Overall Study||78
1527861|NCT01446419|3740265|P1|STARTED|Overall Study||147
1527862|NCT01446289|3740279|P4|NOT COMPLETED|Overall Study||0
1527863|NCT01446289|3740280|P3|NOT COMPLETED|Overall Study||1
1527864|NCT01446289|3740281|P2|NOT COMPLETED|Overall Study||0
1527865|NCT01446289|3740282|P1|NOT COMPLETED|Overall Study||1
1527866|NCT01446289|3740279|P4|COMPLETED|Overall Study||35
1527867|NCT01446289|3740280|P3|COMPLETED|Overall Study||50
1527868|NCT01446289|3740281|P2|COMPLETED|Overall Study||35
1527869|NCT01446289|3740282|P1|COMPLETED|Overall Study||50
1527870|NCT01446289|3740279|P4|STARTED|Overall Study||35
1527871|NCT01446289|3740280|P3|STARTED|Overall Study||51
1527872|NCT01446289|3740281|P2|STARTED|Overall Study||35
1527873|NCT01446289|3740282|P1|STARTED|Overall Study||51
1527874|NCT01446250|3740310|P4|NOT COMPLETED|Follow-up||6
1527875|NCT01446250|3740311|P3|NOT COMPLETED|Follow-up||0
1527876|NCT01446250|3740312|P2|NOT COMPLETED|Follow-up||0
1527877|NCT01446250|3740313|P1|NOT COMPLETED|Follow-up||0
1527878|NCT01446250|3740310|P4|COMPLETED|Follow-up||0
1527879|NCT01446250|3740311|P3|COMPLETED|Follow-up||0
1527880|NCT01446250|3740312|P2|COMPLETED|Follow-up||0
1527881|NCT01446250|3740313|P1|COMPLETED|Follow-up||0
1527882|NCT01446250|3740310|P4|STARTED|Follow-up||6
1527883|NCT01446250|3740311|P3|STARTED|Follow-up||0
1527884|NCT01446250|3740312|P2|STARTED|Follow-up||0
1527885|NCT01446250|3740313|P1|STARTED|Follow-up||0
1527886|NCT01446250|3740310|P4|NOT COMPLETED|Treatment Period 2||0
1527887|NCT01446250|3740311|P3|NOT COMPLETED|Treatment Period 2||0
1527888|NCT01446250|3740312|P2|NOT COMPLETED|Treatment Period 2||1
1527889|NCT01446250|3740313|P1|NOT COMPLETED|Treatment Period 2||0
1527890|NCT01446250|3740310|P4|COMPLETED|Treatment Period 2||0
1527891|NCT01446250|3740311|P3|COMPLETED|Treatment Period 2||0
1527892|NCT01446250|3740312|P2|COMPLETED|Treatment Period 2||6
1527893|NCT01446250|3740313|P1|COMPLETED|Treatment Period 2||0
1527894|NCT01446250|3740310|P4|STARTED|Treatment Period 2||0
1527895|NCT01446250|3740311|P3|STARTED|Treatment Period 2||0
1527896|NCT01446250|3740312|P2|STARTED|Treatment Period 2||7
1527897|NCT01446250|3740313|P1|STARTED|Treatment Period 2||0
1527898|NCT01446250|3740310|P4|NOT COMPLETED|Clinical Hold||0
1527899|NCT01446250|3740311|P3|NOT COMPLETED|Clinical Hold||0
1527900|NCT01446250|3740312|P2|NOT COMPLETED|Clinical Hold||0
1527901|NCT01446250|3740313|P1|NOT COMPLETED|Clinical Hold||0
1527902|NCT01446250|3740310|P4|COMPLETED|Clinical Hold||0
1527903|NCT01446250|3740311|P3|COMPLETED|Clinical Hold||5
1527904|NCT01446250|3740312|P2|COMPLETED|Clinical Hold||2
1527905|NCT01446250|3740313|P1|COMPLETED|Clinical Hold||0
1527906|NCT01446250|3740310|P4|STARTED|Clinical Hold||0
1527907|NCT01446250|3740311|P3|STARTED|Clinical Hold||5
1527908|NCT01446250|3740312|P2|STARTED|Clinical Hold||2
1527909|NCT01446250|3740313|P1|STARTED|Clinical Hold||0
1527910|NCT01446250|3740310|P4|NOT COMPLETED|Treatment Period 1||0
1527911|NCT01446250|3740311|P3|NOT COMPLETED|Treatment Period 1||0
1527912|NCT01446250|3740312|P2|NOT COMPLETED|Treatment Period 1||1
1527913|NCT01446250|3740313|P1|NOT COMPLETED|Treatment Period 1||0
1527914|NCT01446250|3740310|P4|COMPLETED|Treatment Period 1||0
1527915|NCT01446250|3740311|P3|COMPLETED|Treatment Period 1||0
1527916|NCT01446250|3740312|P2|COMPLETED|Treatment Period 1||2
1527917|NCT01446250|3740313|P1|COMPLETED|Treatment Period 1||5
1527918|NCT01446250|3740310|P4|STARTED|Treatment Period 1||0
1527919|NCT01446250|3740311|P3|STARTED|Treatment Period 1||0
1527920|NCT01446250|3740312|P2|STARTED|Treatment Period 1||3
1527921|NCT01446250|3740313|P1|STARTED|Treatment Period 1||5
1527922|NCT01446237|3740325|P1|NOT COMPLETED|Overall Study||10
1527923|NCT01446237|3740325|P1|COMPLETED|Overall Study||115
1527924|NCT01446237|3740325|P1|STARTED|Overall Study||125
1527925|NCT01446159|3740337|P4|NOT COMPLETED|Overall Study||62
1527926|NCT01446159|3740338|P3|NOT COMPLETED|Overall Study||72
1527927|NCT01446159|3740339|P2|NOT COMPLETED|Overall Study||3
1527928|NCT01446159|3740340|P1|NOT COMPLETED|Overall Study||3
1527929|NCT01446159|3740337|P4|COMPLETED|Overall Study||23
1527930|NCT01446159|3740338|P3|COMPLETED|Overall Study||20
1527931|NCT01446159|3740339|P2|COMPLETED|Overall Study||0
1527932|NCT01446159|3740340|P1|COMPLETED|Overall Study||0
1527933|NCT01446159|3740337|P4|STARTED|Overall Study||85
1527934|NCT01446159|3740338|P3|STARTED|Overall Study||92
1527935|NCT01446159|3740339|P2|STARTED|Overall Study||3
1527936|NCT01446159|3740340|P1|STARTED|Overall Study||3
1527937|NCT01446042|3740415|P3|NOT COMPLETED|Overall Study||9
1527938|NCT01446042|3740416|P2|NOT COMPLETED|Overall Study||3
1527939|NCT01446042|3740417|P1|NOT COMPLETED|Overall Study||20
1527940|NCT01446042|3740415|P3|COMPLETED|Overall Study||69
1527941|NCT01446042|3740416|P2|COMPLETED|Overall Study||83
1527942|NCT01446042|3740417|P1|COMPLETED|Overall Study||122
1527943|NCT01446042|3740415|P3|STARTED|Overall Study||78
1527944|NCT01446042|3740416|P2|STARTED|Overall Study||86
1527945|NCT01446042|3740417|P1|STARTED|Overall Study||142
1527946|NCT01446003|3740428|P2|NOT COMPLETED|Period 2||0
1527947|NCT01446003|3740429|P1|NOT COMPLETED|Period 2||1
1527948|NCT01446003|3740428|P2|COMPLETED|Period 2||15
1527949|NCT01446003|3740429|P1|COMPLETED|Period 2||13
1527950|NCT01446003|3740428|P2|STARTED|Period 2||15
1527951|NCT01446003|3740429|P1|STARTED|Period 2||14
1527952|NCT01446003|3740428|P2|NOT COMPLETED|Period 1||0
1527953|NCT01446003|3740429|P1|NOT COMPLETED|Period 1||2
1527954|NCT01446003|3740428|P2|COMPLETED|Period 1||15
1527955|NCT01446003|3740429|P1|COMPLETED|Period 1||14
1527956|NCT01446003|3740428|P2|STARTED|Period 1||15
1527957|NCT01446003|3740429|P1|STARTED|Period 1||16
1527958|NCT01445951|3740450|P3|NOT COMPLETED|Overall Study||19
1527959|NCT01445951|3740451|P2|NOT COMPLETED|Overall Study||36
1527960|NCT01445951|3740452|P1|NOT COMPLETED|Overall Study||44
1527961|NCT01445951|3740450|P3|COMPLETED|Overall Study||151
1527962|NCT01445951|3740451|P2|COMPLETED|Overall Study||138
1527963|NCT01445951|3740452|P1|COMPLETED|Overall Study||130
1527964|NCT01445951|3740450|P3|STARTED|Overall Study||170
1527965|NCT01445951|3740451|P2|STARTED|Overall Study||174
1527966|NCT01445951|3740452|P1|STARTED|Overall Study||174
1527967|NCT01445873|3740490|P1|NOT COMPLETED|Overall Study||0
1527968|NCT01445873|3740490|P1|COMPLETED|Overall Study||36
1527969|NCT01445873|3740490|P1|STARTED|Overall Study||36
1527970|NCT01445847|3740520|P2|NOT COMPLETED|Overall Study||14
1527971|NCT01445847|3740521|P1|NOT COMPLETED|Overall Study||14
1527972|NCT01445847|3740520|P2|COMPLETED|Overall Study||36
1527973|NCT01445847|3740521|P1|COMPLETED|Overall Study||36
1527974|NCT01445847|3740520|P2|STARTED|Overall Study||50
1527975|NCT01445847|3740521|P1|STARTED|Overall Study||50
1527976|NCT01445769|3740527|P1|NOT COMPLETED|Overall Study||8
1527977|NCT01445769|3740527|P1|COMPLETED|Overall Study||37
1527978|NCT01445769|3740527|P1|STARTED|Overall Study||45
1527979|NCT01445678|3740547|P2|NOT COMPLETED|Overall Study||21
1527980|NCT01445678|3740548|P1|NOT COMPLETED|Overall Study||30
1527981|NCT01445678|3740547|P2|COMPLETED|Overall Study||476
1527982|NCT01445678|3740548|P1|COMPLETED|Overall Study||452
1527983|NCT01445678|3740547|P2|STARTED|Overall Study||497
1527984|NCT01445678|3740548|P1|STARTED|Overall Study||482
1527985|NCT01445652|3740566|P2|NOT COMPLETED|Overall Study||3
1527986|NCT01445652|3740567|P1|NOT COMPLETED|Overall Study||10
1527987|NCT01445652|3740566|P2|COMPLETED|Overall Study||50
1527988|NCT01445652|3740567|P1|COMPLETED|Overall Study||47
1527989|NCT01445652|3740566|P2|STARTED|Overall Study||53
1527990|NCT01445652|3740567|P1|STARTED|Overall Study||57
1527991|NCT01445626|3740575|P1|NOT COMPLETED|Overall Study||0
1527992|NCT01445626|3740575|P1|COMPLETED|Overall Study||87
1527993|NCT01445626|3740575|P1|STARTED|Overall Study||87
1527994|NCT01445613|3740585|P1|NOT COMPLETED|1-year Follow-up||77
1527995|NCT01445613|3740585|P1|COMPLETED|1-year Follow-up||1088
1527996|NCT01445613|3740585|P1|STARTED|1-year Follow-up||1165
1527997|NCT01445613|3740585|P1|NOT COMPLETED|30-day Follow-up||35
1527998|NCT01445613|3740585|P1|COMPLETED|30-day Follow-up||1165
1527999|NCT01445613|3740585|P1|STARTED|30-day Follow-up||1200
1528000|NCT01445548|3740603|P1|NOT COMPLETED|Overall Study||1
1528001|NCT01445548|3740603|P1|COMPLETED|Overall Study||5
1528002|NCT01445548|3740603|P1|STARTED|Overall Study||6
1528003|NCT01445301|3740627|P3|NOT COMPLETED|Overall Study||9
1528004|NCT01445301|3740628|P2|NOT COMPLETED|Overall Study||35
1528005|NCT01445301|3740629|P1|NOT COMPLETED|Overall Study||21
1528006|NCT01445301|3740627|P3|COMPLETED|Overall Study||290
1528007|NCT01445301|3740628|P2|COMPLETED|Overall Study||262
1528008|NCT01445301|3740629|P1|COMPLETED|Overall Study||183
1528009|NCT01445301|3740627|P3|STARTED|Overall Study||299
1528010|NCT01445301|3740628|P2|STARTED|Overall Study||297
1528011|NCT01445301|3740629|P1|STARTED|Overall Study||204
1528012|NCT01445028|3740666|P2|NOT COMPLETED|Overall Study||3
1528013|NCT01445028|3740667|P1|NOT COMPLETED|Overall Study||0
1528014|NCT01445028|3740666|P2|COMPLETED|Overall Study||51
1528015|NCT01445028|3740667|P1|COMPLETED|Overall Study||58
1528016|NCT01445028|3740666|P2|STARTED|Overall Study||54
1528017|NCT01445028|3740667|P1|STARTED|Overall Study||58
1528018|NCT01444924|3740675|P2|NOT COMPLETED|Overall Study||0
1528019|NCT01444924|3740676|P1|NOT COMPLETED|Overall Study||0
1528020|NCT01444924|3740675|P2|COMPLETED|Overall Study||33
1528021|NCT01444924|3740676|P1|COMPLETED|Overall Study||31
1528022|NCT01444924|3740675|P2|STARTED|Overall Study||33
1528023|NCT01444924|3740676|P1|STARTED|Overall Study||31
1528024|NCT01444911|3740686|P2|NOT COMPLETED|Overall Study||0
1528025|NCT01444911|3740687|P1|NOT COMPLETED|Overall Study||8
1528026|NCT01444911|3740686|P2|COMPLETED|Overall Study||13
1528027|NCT01444911|3740687|P1|COMPLETED|Overall Study||8
1528028|NCT01444911|3740686|P2|STARTED|Overall Study||13
1528029|NCT01444911|3740687|P1|STARTED|Overall Study||16
1528030|NCT01444898|3740699|P1|NOT COMPLETED|Overall Study||1
1528031|NCT01444898|3740699|P1|COMPLETED|Overall Study||9
1528032|NCT01444898|3740699|P1|STARTED|Overall Study||10
1528033|NCT01444781|3740714|P3|NOT COMPLETED|Overall Study||3
1528034|NCT01444781|3740715|P2|NOT COMPLETED|Overall Study||4
1528035|NCT01444781|3740716|P1|NOT COMPLETED|Overall Study||3
1528036|NCT01444781|3740714|P3|COMPLETED|Overall Study||272
1528037|NCT01444781|3740715|P2|COMPLETED|Overall Study||411
1528038|NCT01444781|3740716|P1|COMPLETED|Overall Study||413
1528039|NCT01444781|3740714|P3|STARTED|Overall Study||275
1528040|NCT01444781|3740715|P2|STARTED|Overall Study||415
1528041|NCT01444781|3740716|P1|STARTED|Overall Study||416
1528042|NCT01444742|3740754|P1|NOT COMPLETED|Overall Study||1
1528043|NCT01444742|3740754|P1|COMPLETED|Overall Study||80
1528044|NCT01444742|3740754|P1|STARTED|Overall Study||81
1528045|NCT01444651|3740761|P2|NOT COMPLETED|Overall Study||9
1528046|NCT01444651|3740762|P1|NOT COMPLETED|Overall Study||11
1528047|NCT01444651|3740761|P2|COMPLETED|Overall Study||28
1528048|NCT01444651|3740762|P1|COMPLETED|Overall Study||25
1528049|NCT01444651|3740761|P2|STARTED|Overall Study||37
1528050|NCT01444651|3740762|P1|STARTED|Overall Study||36
1528051|NCT01444456|3740778|P1|NOT COMPLETED|Overall Study||285
1528052|NCT01444456|3740778|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
1528053|NCT01444456|3740778|P1|Received Darbepoetin Alfa|Overall Study||1134
1528054|NCT01444456|3740778|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
1528055|NCT01444456|3740778|P1|STARTED|Overall Study||1262
1528056|NCT01444430|3740789|P2|NOT COMPLETED|Overall Study||81
1528057|NCT01444430|3740790|P1|NOT COMPLETED|Overall Study||61
1528058|NCT01444430|3740789|P2|COMPLETED|Overall Study||5766
1528059|NCT01444430|3740790|P1|COMPLETED|Overall Study||5785
1528060|NCT01444430|3740789|P2|STARTED|Overall Study||5847
1528061|NCT01444430|3740790|P1|STARTED|Overall Study||5846
1528062|NCT01444417|3740812|P2|NOT COMPLETED|Overall Study||1
1528063|NCT01444417|3740813|P1|NOT COMPLETED|Overall Study||2
1528064|NCT01444417|3740812|P2|COMPLETED|Overall Study||41
1528065|NCT01444417|3740813|P1|COMPLETED|Overall Study||18
1528066|NCT01444417|3740812|P2|Received Treatment|Overall Study||42
1528067|NCT01444417|3740813|P1|Received Treatment|Overall Study||19
1528068|NCT01444417|3740812|P2|STARTED|Overall Study||42
1528069|NCT01444417|3740813|P1|STARTED|Overall Study||20
1528070|NCT01444391|3740829|P1|NOT COMPLETED|Overall Study||1
1528071|NCT01444391|3740829|P1|COMPLETED|Overall Study||41
1528072|NCT01444391|3740829|P1|STARTED|Overall Study||42
1528073|NCT01444378|3740837|P1|NOT COMPLETED|Overall Study||17
1528074|NCT01444378|3740837|P1|COMPLETED|Overall Study||124
1528075|NCT01444378|3740837|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
1528076|NCT01444300|3740949|P2|NOT COMPLETED|Overall Study||0
1528077|NCT01444300|3740950|P1|NOT COMPLETED|Overall Study||4
1528078|NCT01444300|3740949|P2|COMPLETED|Overall Study||12
1528079|NCT01444300|3740950|P1|COMPLETED|Overall Study||8
1528080|NCT01444300|3740949|P2|STARTED|Overall Study||12
1528081|NCT01444300|3740950|P1|STARTED|Overall Study||12
1528082|NCT01444287|3740960|P1|NOT COMPLETED|Period 4||0
1528083|NCT01444287|3740960|P1|COMPLETED|Period 4||22
1528084|NCT01444287|3740960|P1|STARTED|Period 4||22
1528085|NCT01444287|3740960|P1|NOT COMPLETED|Period 3||0
1528086|NCT01444287|3740960|P1|COMPLETED|Period 3||22
1528087|NCT01444287|3740960|P1|STARTED|Period 3||22
1528088|NCT01444287|3740960|P1|NOT COMPLETED|Period 2||0
1528089|NCT01444287|3740960|P1|COMPLETED|Period 2||22
1528090|NCT01444287|3740960|P1|STARTED|Period 2||22
1528091|NCT01444287|3740960|P1|NOT COMPLETED|Period 1||0
1528092|NCT01444287|3740960|P1|COMPLETED|Period 1||22
1528093|NCT01444287|3740960|P1|STARTED|Period 1||22
1528094|NCT01444092|3740982|P1|NOT COMPLETED|Overall Study||17
1528095|NCT01444092|3740982|P1|COMPLETED|Overall Study||91
1528096|NCT01444092|3740982|P1|INFORMED CONSENT OBTAINED|Overall Study||108
1528097|NCT01444092|3740982|P1|STARTED|Overall Study||108
1528098|NCT01444027|3740991|P3|NOT COMPLETED|Overall Study||38
1528099|NCT01444027|3740992|P2|NOT COMPLETED|Overall Study||30
1528100|NCT01444027|3740993|P1|NOT COMPLETED|Overall Study||30
1528101|NCT01444027|3740991|P3|COMPLETED|Overall Study||133
1528102|NCT01444027|3740992|P2|COMPLETED|Overall Study||141
1528103|NCT01444027|3740993|P1|COMPLETED|Overall Study||142
1528104|NCT01444027|3740991|P3|3 Month Follow-up|Overall Study||133
1528105|NCT01444027|3740992|P2|3 Month Follow-up|Overall Study||141
1528106|NCT01444027|3740993|P1|3 Month Follow-up|Overall Study||142
1528107|NCT01444027|3740991|P3|1 Month Follow-up|Overall Study||141
1528108|NCT01444027|3740992|P2|1 Month Follow-up|Overall Study||159
1528109|NCT01444027|3740993|P1|1 Month Follow-up|Overall Study||160
1528110|NCT01444027|3740991|P3|Received Intervention as Assigned|Overall Study||147
1528111|NCT01444027|3740992|P2|Received Intervention as Assigned|Overall Study||161
1528112|NCT01444027|3740993|P1|Received Intervention as Assigned|Overall Study||168
1528113|NCT01444027|3740991|P3|STARTED|Overall Study||171
1528114|NCT01444027|3740992|P2|STARTED|Overall Study||171
1528115|NCT01444027|3740993|P1|STARTED|Overall Study||172
1528116|NCT01443923|3741015|P2|NOT COMPLETED|Overall Study||0
1528117|NCT01443923|3741016|P1|NOT COMPLETED|Overall Study||1
1528118|NCT01443923|3741015|P2|COMPLETED|Overall Study||1
1528119|NCT01443923|3741016|P1|COMPLETED|Overall Study||2
1528120|NCT01443923|3741015|P2|STARTED|Overall Study||1
1528121|NCT01443923|3741016|P1|STARTED|Overall Study||3
1528122|NCT01443858|3741033|P3|NOT COMPLETED|Overall Study||7
1528123|NCT01443858|3741034|P2|NOT COMPLETED|Overall Study||13
1528124|NCT01443858|3741035|P1|NOT COMPLETED|Overall Study||15
1528125|NCT01443858|3741033|P3|COMPLETED|Overall Study||18
1528126|NCT01443858|3741034|P2|COMPLETED|Overall Study||12
1528127|NCT01443858|3741035|P1|COMPLETED|Overall Study||10
1528128|NCT01443858|3741033|P3|STARTED|Overall Study||25
1528129|NCT01443858|3741034|P2|STARTED|Overall Study||25
1528130|NCT01443858|3741035|P1|STARTED|Overall Study||25
1528131|NCT01443845|3741057|P2|NOT COMPLETED|Overall Study||337
1528132|NCT01443845|3741058|P1|NOT COMPLETED|Overall Study||254
1528133|NCT01443845|3741057|P2|COMPLETED|Overall Study||841
1528134|NCT01443845|3741058|P1|COMPLETED|Overall Study||922
1528135|NCT01443845|3741057|P2|STARTED|Overall Study||1178
1528136|NCT01443845|3741058|P1|STARTED|Overall Study||1176
1528137|NCT01443494|3741070|P1|NOT COMPLETED|Overall Study||0
1528138|NCT01443494|3741070|P1|COMPLETED|Overall Study||19
1528139|NCT01443494|3741070|P1|STARTED|Overall Study||19
1528140|NCT01443403|3741079|P4|NOT COMPLETED|Overall Study||9
1528141|NCT01443403|3741080|P3|NOT COMPLETED|Overall Study||7
1528142|NCT01443403|3741081|P2|NOT COMPLETED|Overall Study||6
1528143|NCT01443403|3741082|P1|NOT COMPLETED|Overall Study||6
1528144|NCT01443403|3741079|P4|COMPLETED|Overall Study||52
1528145|NCT01443403|3741080|P3|COMPLETED|Overall Study||54
1528146|NCT01443403|3741081|P2|COMPLETED|Overall Study||55
1528147|NCT01443403|3741082|P1|COMPLETED|Overall Study||55
1528148|NCT01443403|3741079|P4|Received Treatment|Overall Study||61
1528149|NCT01443403|3741080|P3|Received Treatment|Overall Study||60
1528150|NCT01443403|3741081|P2|Received Treatment|Overall Study||61
1528151|NCT01443403|3741082|P1|Received Treatment|Overall Study||61
1528152|NCT01443403|3741079|P4|STARTED|Overall Study||61
1528153|NCT01443403|3741080|P3|STARTED|Overall Study||61
1528154|NCT01443403|3741081|P2|STARTED|Overall Study||61
1528155|NCT01443403|3741082|P1|STARTED|Overall Study||61
1528156|NCT01443364|3741229|P1|NOT COMPLETED|Overall Study||41
1528157|NCT01443364|3741229|P1|COMPLETED|Overall Study||91
1528158|NCT01443364|3741229|P1|STARTED|Overall Study||132
1528159|NCT01443130|3741358|P6|NOT COMPLETED|Overall Study||34
1528160|NCT01443130|3741359|P5|NOT COMPLETED|Overall Study||44
1528161|NCT01443130|3741360|P4|NOT COMPLETED|Overall Study||39
1528162|NCT01443130|3741361|P3|NOT COMPLETED|Overall Study||77
1528163|NCT01443130|3741362|P2|NOT COMPLETED|Overall Study||69
1528164|NCT01443130|3741363|P1|NOT COMPLETED|Overall Study||68
1528165|NCT01443130|3741358|P6|COMPLETED|Overall Study||225
1528166|NCT01443130|3741359|P5|COMPLETED|Overall Study||230
1528167|NCT01443130|3741360|P4|COMPLETED|Overall Study||231
1528168|NCT01443130|3741361|P3|COMPLETED|Overall Study||223
1528169|NCT01443130|3741362|P2|COMPLETED|Overall Study||231
1528170|NCT01443130|3741363|P1|COMPLETED|Overall Study||232
1528171|NCT01443130|3741358|P6|STARTED|Overall Study||259
1528172|NCT01443130|3741359|P5|STARTED|Overall Study||274
1528173|NCT01443130|3741360|P4|STARTED|Overall Study||270
1528174|NCT01443130|3741361|P3|STARTED|Overall Study||300
1528175|NCT01443130|3741362|P2|STARTED|Overall Study||300
1528176|NCT01443130|3741363|P1|STARTED|Overall Study||300
1528177|NCT01443078|3741413|P1|NOT COMPLETED|Overall Study||29
1528178|NCT01443078|3741413|P1|COMPLETED|Overall Study||13
1528179|NCT01443078|3741413|P1|STARTED|Overall Study||42
1528180|NCT01443026|3741420|P2|NOT COMPLETED|Overall Study||5
1528181|NCT01443026|3741421|P1|NOT COMPLETED|Overall Study||3
1528182|NCT01443026|3741420|P2|COMPLETED|Overall Study||32
1528183|NCT01443026|3741421|P1|COMPLETED|Overall Study||26
1528184|NCT01443026|3741420|P2|STARTED|Overall Study||37
1528185|NCT01443026|3741421|P1|STARTED|Overall Study||29
1528186|NCT01442844|3741429|P2|NOT COMPLETED|Overall Study||0
1528187|NCT01442844|3741430|P1|NOT COMPLETED|Overall Study||0
1528188|NCT01442844|3741429|P2|COMPLETED|Overall Study||2
1528189|NCT01442844|3741430|P1|COMPLETED|Overall Study||1
1528190|NCT01442844|3741429|P2|STARTED|Overall Study||2
1528191|NCT01442844|3741430|P1|STARTED|Overall Study||1
1528192|NCT01442779|3741436|P1|NOT COMPLETED|Overall Study||7
1528193|NCT01442779|3741436|P1|COMPLETED|Overall Study||11
1528194|NCT01442779|3741436|P1|STARTED|Overall Study||18
1528195|NCT01442714|3741442|P1|NOT COMPLETED|Overall Study||12
1528196|NCT01442714|3741442|P1|COMPLETED|Overall Study||21
1528197|NCT01442714|3741442|P1|STARTED|Overall Study||33
1528198|NCT01442688|3741450|P2|NOT COMPLETED|Second Intervention||0
1528199|NCT01442688|3741451|P1|NOT COMPLETED|Second Intervention||1
1528200|NCT01442688|3741450|P2|COMPLETED|Second Intervention||31
1528201|NCT01442688|3741451|P1|COMPLETED|Second Intervention||28
1528202|NCT01442688|3741450|P2|STARTED|Second Intervention||31
1528203|NCT01442688|3741451|P1|STARTED|Second Intervention||29
1528204|NCT01442688|3741450|P2|NOT COMPLETED|First Intervention||0
1528205|NCT01442688|3741451|P1|NOT COMPLETED|First Intervention||2
1528206|NCT01442688|3741450|P2|COMPLETED|First Intervention||31
1528207|NCT01442688|3741451|P1|COMPLETED|First Intervention||29
1528208|NCT01442688|3741450|P2|STARTED|First Intervention||31
1528209|NCT01442688|3741451|P1|STARTED|First Intervention||31
1528210|NCT01442675|3741459|P1|NOT COMPLETED|Overall Study||12
1528211|NCT01442675|3741459|P1|COMPLETED|Overall Study||822
1528212|NCT01442675|3741459|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
1528213|NCT01442675|3741459|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
1528214|NCT01442675|3741459|P1|STARTED|Overall Study||834
1528215|NCT01442493|3741471|P2|NOT COMPLETED|Overall Study||2
1528216|NCT01442493|3741472|P1|NOT COMPLETED|Overall Study||3
1528217|NCT01442493|3741471|P2|COMPLETED|Overall Study||149
1528218|NCT01442493|3741472|P1|COMPLETED|Overall Study||146
1528219|NCT01442493|3741471|P2|STARTED|Overall Study||151
1528220|NCT01442493|3741472|P1|STARTED|Overall Study||149
1528221|NCT01442376|3741493|P3|NOT COMPLETED|Overall Study||5
1528222|NCT01442376|3741494|P2|NOT COMPLETED|Overall Study||9
1528223|NCT01442376|3741495|P1|NOT COMPLETED|Overall Study||3
1528224|NCT01442376|3741493|P3|COMPLETED|Overall Study||159
1528225|NCT01442376|3741494|P2|COMPLETED|Overall Study||160
1528226|NCT01442376|3741495|P1|COMPLETED|Overall Study||166
1528227|NCT01442376|3741493|P3|STARTED|Overall Study|Randomized patients|164
1528228|NCT01442376|3741494|P2|STARTED|Overall Study|Randomized patients|169
1528229|NCT01442376|3741495|P1|STARTED|Overall Study|Randomized patients|169
1528230|NCT01442181|3741508|P2|NOT COMPLETED|Overall Study||3
1528231|NCT01442181|3741509|P1|NOT COMPLETED|Overall Study||4
1528232|NCT01442181|3741508|P2|COMPLETED|Overall Study||8
1528233|NCT01442181|3741509|P1|COMPLETED|Overall Study||10
1528234|NCT01442181|3741508|P2|STARTED|Overall Study||11
1528235|NCT01442181|3741509|P1|STARTED|Overall Study||14
1528236|NCT01442155|3741533|P1|NOT COMPLETED|Overall Study||65
1528237|NCT01442155|3741533|P1|COMPLETED|Overall Study||9
1528238|NCT01442155|3741533|P1|STARTED|Overall Study||74
1528239|NCT01442129|3741540|P2|NOT COMPLETED|Overall Study||0
1528240|NCT01442129|3741541|P1|NOT COMPLETED|Overall Study||0
1528241|NCT01442129|3741540|P2|COMPLETED|Overall Study||10
1528242|NCT01442129|3741541|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
1528243|NCT01442129|3741540|P2|STARTED|Overall Study||10
1528244|NCT01442129|3741541|P1|STARTED|Overall Study||20
1528245|NCT01442103|3741549|P1|NOT COMPLETED|Overall Study||2
1528246|NCT01442103|3741549|P1|COMPLETED|Overall Study||8
1528247|NCT01442103|3741549|P1|STARTED|Overall Study||10
1528248|NCT01442064|3741559|P6|NOT COMPLETED|Overall Study||99
1528249|NCT01442064|3741560|P5|NOT COMPLETED|Overall Study||106
1528250|NCT01442064|3741561|P4|NOT COMPLETED|Overall Study||98
1528251|NCT01442064|3741562|P3|NOT COMPLETED|Overall Study||104
1528252|NCT01442064|3741563|P2|NOT COMPLETED|Overall Study||101
1528253|NCT01442064|3741564|P1|NOT COMPLETED|Overall Study||97
1528254|NCT01442064|3741559|P6|COMPLETED|Overall Study||0
1528255|NCT01442064|3741560|P5|COMPLETED|Overall Study||1
1528256|NCT01442064|3741561|P4|COMPLETED|Overall Study||0
1528257|NCT01442064|3741562|P3|COMPLETED|Overall Study||0
1528258|NCT01442064|3741563|P2|COMPLETED|Overall Study||2
1528259|NCT01442064|3741564|P1|COMPLETED|Overall Study||0
1528260|NCT01442064|3741559|P6|Received Study Drug in Extension Study|Overall Study||81
1528261|NCT01442064|3741560|P5|Received Study Drug in Extension Study|Overall Study||89
1528262|NCT01442064|3741561|P4|Received Study Drug in Extension Study|Overall Study||70
1528263|NCT01442064|3741562|P3|Received Study Drug in Extension Study|Overall Study||60
1528264|NCT01442064|3741563|P2|Received Study Drug in Extension Study|Overall Study||70
1528265|NCT01442064|3741564|P1|Received Study Drug in Extension Study|Overall Study||61
1528266|NCT01442064|3741559|P6|Ranibizumab-Treated Subjects|Overall Study||99
1528267|NCT01442064|3741560|P5|Ranibizumab-Treated Subjects|Overall Study||107
1528268|NCT01442064|3741561|P4|Ranibizumab-Treated Subjects|Overall Study||96
1528269|NCT01442064|3741562|P3|Ranibizumab-Treated Subjects|Overall Study||104
1528270|NCT01442064|3741563|P2|Ranibizumab-Treated Subjects|Overall Study||103
1528271|NCT01442064|3741564|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
1528272|NCT01442064|3741559|P6|STARTED|Overall Study||99
1528273|NCT01442064|3741560|P5|STARTED|Overall Study||107
1528274|NCT01442064|3741561|P4|STARTED|Overall Study||98
1528275|NCT01442064|3741562|P3|STARTED|Overall Study||104
1528276|NCT01442064|3741563|P2|STARTED|Overall Study||103
1528277|NCT01442064|3741564|P1|STARTED|Overall Study||97
1528278|NCT01442038|3741601|P2|NOT COMPLETED|Overall Study||279
1528279|NCT01442038|3741602|P1|NOT COMPLETED|Overall Study||303
1528280|NCT01442038|3741601|P2|COMPLETED|Overall Study||1040
1528281|NCT01442038|3741602|P1|COMPLETED|Overall Study||1029
1528282|NCT01442038|3741601|P2|STARTED|Overall Study||1319
1528283|NCT01442038|3741602|P1|STARTED|Overall Study||1332
1528284|NCT01441973|3741616|P2|NOT COMPLETED|Overall Study||16
1528285|NCT01441973|3741617|P1|NOT COMPLETED|Overall Study||15
1528286|NCT01441973|3741616|P2|COMPLETED|Overall Study|Still receiving treatment|0
1528287|NCT01441973|3741617|P1|COMPLETED|Overall Study|Still receiving treatment|0
1528288|NCT01441973|3741616|P2|STARTED|Overall Study||16
1528289|NCT01441973|3741617|P1|STARTED|Overall Study||15
1528290|NCT01441960|3741639|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
1528291|NCT01441960|3741640|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
1528292|NCT01441960|3741639|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
1528293|NCT01441960|3741640|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
1528294|NCT01441960|3741639|P2|STARTED|Second Neuromuscular Blocking Agent||13
1528295|NCT01441960|3741640|P1|STARTED|Second Neuromuscular Blocking Agent||18
1528296|NCT01441960|3741639|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
1528297|NCT01441960|3741640|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
1528298|NCT01441960|3741639|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
1528299|NCT01441960|3741640|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
1528300|NCT01441960|3741639|P2|STARTED|First Neuromuscular Blocking Agent:||19
1528301|NCT01441960|3741640|P1|STARTED|First Neuromuscular Blocking Agent:||26
1528302|NCT01441882|3741650|P1|NOT COMPLETED|Overall Study||6
1528303|NCT01441882|3741650|P1|COMPLETED|Overall Study||13
1528304|NCT01441882|3741650|P1|STARTED|Overall Study||19
1528305|NCT01441843|3741656|P2|NOT COMPLETED|Overall Study||5
1528306|NCT01441843|3741657|P1|NOT COMPLETED|Overall Study||12
1528307|NCT01441843|3741656|P2|COMPLETED|Overall Study||195
1528308|NCT01441843|3741657|P1|COMPLETED|Overall Study||188
1528309|NCT01441843|3741656|P2|STARTED|Overall Study||200
1528310|NCT01441843|3741657|P1|STARTED|Overall Study||200
1528311|NCT01441765|3741665|P2|NOT COMPLETED|Overall Study||0
1528312|NCT01441765|3741666|P1|NOT COMPLETED|Overall Study||1
1528313|NCT01441765|3741665|P2|COMPLETED|Overall Study|not opened|0
1528314|NCT01441765|3741666|P1|COMPLETED|Overall Study||10
1528315|NCT01441765|3741665|P2|STARTED|Overall Study|not opened|0
1528316|NCT01441765|3741666|P1|STARTED|Overall Study||11
1528317|NCT01441596|3741683|P3|NOT COMPLETED|Overall Study||4
1528318|NCT01441596|3741684|P2|NOT COMPLETED|Overall Study||3
1528319|NCT01441596|3741685|P1|NOT COMPLETED|Overall Study||4
1528320|NCT01441596|3741683|P3|COMPLETED|Overall Study||39
1528321|NCT01441596|3741684|P2|COMPLETED|Overall Study||35
1528322|NCT01441596|3741685|P1|COMPLETED|Overall Study||36
1528323|NCT01441596|3741683|P3|STARTED|Overall Study||43
1528324|NCT01441596|3741684|P2|STARTED|Overall Study||38
1528325|NCT01441596|3741685|P1|STARTED|Overall Study||40
1528326|NCT01441570|3741701|P2|NOT COMPLETED|Overall Study||0
1528327|NCT01441570|3741702|P1|NOT COMPLETED|Overall Study||0
1528328|NCT01441570|3741701|P2|COMPLETED|Overall Study||5
1528329|NCT01441570|3741702|P1|COMPLETED|Overall Study||6
1528330|NCT01441570|3741701|P2|STARTED|Overall Study||5
1528331|NCT01441570|3741702|P1|STARTED|Overall Study||6
1528332|NCT01441466|3741712|P2|NOT COMPLETED|Overall Study||0
1528333|NCT01441466|3741713|P1|NOT COMPLETED|Overall Study||0
1528334|NCT01441466|3741712|P2|COMPLETED|Overall Study||11
1528335|NCT01441466|3741713|P1|COMPLETED|Overall Study||37
1528336|NCT01441466|3741712|P2|STARTED|Overall Study||11
1528337|NCT01441466|3741713|P1|STARTED|Overall Study||37
1528338|NCT01441440|3741732|P3|NOT COMPLETED|Overall Study||22
1528339|NCT01441440|3741733|P2|NOT COMPLETED|Overall Study||23
1528340|NCT01441440|3741734|P1|NOT COMPLETED|Overall Study||17
1528341|NCT01441440|3741732|P3|COMPLETED|Overall Study||158
1528342|NCT01441440|3741733|P2|COMPLETED|Overall Study||151
1528343|NCT01441440|3741734|P1|COMPLETED|Overall Study||166
1528344|NCT01441440|3741732|P3|STARTED|Overall Study|Safety analysis set|180
1528345|NCT01441440|3741733|P2|STARTED|Overall Study|Safety analysis set|174
1528346|NCT01441440|3741734|P1|STARTED|Overall Study|Safety analysis set|183
1528347|NCT01441414|3741757|P1|NOT COMPLETED|Overall Study||15
1528348|NCT01441414|3741757|P1|COMPLETED|Overall Study||3
1528349|NCT01441414|3741757|P1|STARTED|Overall Study||18
1528350|NCT01441401|3741782|P1|NOT COMPLETED|Overall Study||0
1528351|NCT01441401|3741782|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
1528352|NCT01441401|3741782|P1|STARTED|Overall Study||82
1528353|NCT01441245|3741810|P2|NOT COMPLETED|Overall Study||0
1528354|NCT01441245|3741811|P1|NOT COMPLETED|Overall Study||0
1528355|NCT01441245|3741810|P2|COMPLETED|Overall Study||27
1528356|NCT01441245|3741811|P1|COMPLETED|Overall Study||30
1528357|NCT01441245|3741810|P2|STARTED|Overall Study||27
1528358|NCT01441245|3741811|P1|STARTED|Overall Study||30
1528359|NCT01441180|3741836|P3|NOT COMPLETED|Overall Study||3
1528360|NCT01441180|3741837|P2|NOT COMPLETED|Overall Study||1
1528361|NCT01441180|3741838|P1|NOT COMPLETED|Overall Study||1
1528362|NCT01441180|3741836|P3|COMPLETED|Overall Study||22
1528363|NCT01441180|3741837|P2|COMPLETED|Overall Study||24
1528364|NCT01441180|3741838|P1|COMPLETED|Overall Study||9
1528365|NCT01441180|3741836|P3|STARTED|Overall Study||25
1528366|NCT01441180|3741837|P2|STARTED|Overall Study||25
1528367|NCT01441180|3741838|P1|STARTED|Overall Study||10
1528368|NCT01441102|3741849|P1|NOT COMPLETED|Overall Study||3
1528369|NCT01441102|3741849|P1|COMPLETED|Overall Study||4
1528370|NCT01441102|3741849|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
1528371|NCT01441076|3741869|P1|NOT COMPLETED|Overall Study||2
1528372|NCT01441076|3741869|P1|COMPLETED|Overall Study||4
1528373|NCT01441076|3741869|P1|STARTED|Overall Study||6
1528374|NCT01441037|3741887|P1|NOT COMPLETED|Overall Study||0
1528375|NCT01441037|3741887|P1|COMPLETED|Overall Study||27
1528376|NCT01441037|3741887|P1|STARTED|Overall Study||27
1528377|NCT01440972|3741893|P2|NOT COMPLETED|Overall Study||2
1528378|NCT01440972|3741894|P1|NOT COMPLETED|Overall Study||3
1528379|NCT01440972|3741893|P2|COMPLETED|Overall Study||19
1528380|NCT01440972|3741894|P1|COMPLETED|Overall Study||21
1528381|NCT01440972|3741893|P2|STARTED|Overall Study||21
1528382|NCT01440972|3741894|P1|STARTED|Overall Study||24
1528383|NCT01440959|3741908|P1|NOT COMPLETED|Overall Study||0
1528384|NCT01440959|3741908|P1|COMPLETED|Overall Study||30
1528385|NCT01440959|3741908|P1|STARTED|Overall Study||30
1528386|NCT01440946|3741918|P2|NOT COMPLETED|Overall Study||1
1528387|NCT01440946|3741919|P1|NOT COMPLETED|Overall Study||2
1528388|NCT01440946|3741918|P2|COMPLETED|Overall Study||14
1528389|NCT01440946|3741919|P1|COMPLETED|Overall Study||13
1528390|NCT01440946|3741918|P2|STARTED|Overall Study||15
1528391|NCT01440946|3741919|P1|STARTED|Overall Study||15
1528392|NCT01440881|3741958|P2|NOT COMPLETED|Overall Study||1
1528393|NCT01440881|3741959|P1|NOT COMPLETED|Overall Study||0
1528394|NCT01440881|3741958|P2|COMPLETED|Overall Study||14
1528395|NCT01440881|3741959|P1|COMPLETED|Overall Study||14
1528396|NCT01440881|3741958|P2|STARTED|Overall Study||15
1528397|NCT01440881|3741959|P1|STARTED|Overall Study||14
1528398|NCT01440816|3741973|P2|NOT COMPLETED|Overall Study||11
1528399|NCT01440816|3741974|P1|NOT COMPLETED|Overall Study||1
1528400|NCT01440816|3741973|P2|COMPLETED|Overall Study||1
1528401|NCT01440816|3741974|P1|COMPLETED|Overall Study||2
1528402|NCT01440816|3741973|P2|STARTED|Overall Study||12
1528403|NCT01440816|3741974|P1|STARTED|Overall Study||3
1528404|NCT01440764|3741990|P7|NOT COMPLETED|Test Day 3||0
1528405|NCT01440764|3741991|P6|NOT COMPLETED|Test Day 3||0
1528406|NCT01440764|3741992|P5|NOT COMPLETED|Test Day 3||0
1528407|NCT01440764|3741993|P4|NOT COMPLETED|Test Day 3||0
1528408|NCT01440764|3741994|P3|NOT COMPLETED|Test Day 3||0
1528409|NCT01440764|3741995|P2|NOT COMPLETED|Test Day 3||0
1528410|NCT01440764|3741996|P1|NOT COMPLETED|Test Day 3||0
1528411|NCT01440764|3741990|P7|COMPLETED|Test Day 3||3
1528412|NCT01440764|3741991|P6|COMPLETED|Test Day 3||5
1528413|NCT01440764|3741992|P5|COMPLETED|Test Day 3||3
1528414|NCT01440764|3741993|P4|COMPLETED|Test Day 3||1
1528415|NCT01440764|3741994|P3|COMPLETED|Test Day 3||6
1528416|NCT01440764|3741995|P2|COMPLETED|Test Day 3||2
1528417|NCT01440764|3741996|P1|COMPLETED|Test Day 3||3
1528418|NCT01440764|3741990|P7|STARTED|Test Day 3||3
1528419|NCT01440764|3741991|P6|STARTED|Test Day 3||5
1528420|NCT01440764|3741992|P5|STARTED|Test Day 3||3
1528421|NCT01440764|3741993|P4|STARTED|Test Day 3||1
1528422|NCT01440764|3741994|P3|STARTED|Test Day 3||6
1528423|NCT01440764|3741995|P2|STARTED|Test Day 3||2
1528424|NCT01440764|3741996|P1|STARTED|Test Day 3||3
1528425|NCT01440764|3741990|P7|NOT COMPLETED|Test Day 2||0
1528426|NCT01440764|3741991|P6|NOT COMPLETED|Test Day 2||0
1528427|NCT01440764|3741992|P5|NOT COMPLETED|Test Day 2||0
1528428|NCT01440764|3741993|P4|NOT COMPLETED|Test Day 2||0
1528429|NCT01440764|3741994|P3|NOT COMPLETED|Test Day 2||0
1528430|NCT01440764|3741995|P2|NOT COMPLETED|Test Day 2||0
1528431|NCT01440764|3741996|P1|NOT COMPLETED|Test Day 2||0
1528432|NCT01440764|3741990|P7|COMPLETED|Test Day 2||3
1528433|NCT01440764|3741991|P6|COMPLETED|Test Day 2||5
1528434|NCT01440764|3741992|P5|COMPLETED|Test Day 2||3
1528435|NCT01440764|3741993|P4|COMPLETED|Test Day 2||1
1528436|NCT01440764|3741994|P3|COMPLETED|Test Day 2||6
1528437|NCT01440764|3741995|P2|COMPLETED|Test Day 2||2
1528438|NCT01440764|3741996|P1|COMPLETED|Test Day 2||3
1528439|NCT01440764|3741990|P7|STARTED|Test Day 2||3
1528440|NCT01440764|3741991|P6|STARTED|Test Day 2||5
1528441|NCT01440764|3741992|P5|STARTED|Test Day 2||3
1528442|NCT01440764|3741993|P4|STARTED|Test Day 2||1
1528443|NCT01440764|3741994|P3|STARTED|Test Day 2||6
1528444|NCT01440764|3741995|P2|STARTED|Test Day 2||2
1528445|NCT01440764|3741996|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
1528446|NCT01440764|3741990|P7|NOT COMPLETED|Test Day 1||0
1528447|NCT01440764|3741991|P6|NOT COMPLETED|Test Day 1||0
1528448|NCT01440764|3741992|P5|NOT COMPLETED|Test Day 1||0
1528449|NCT01440764|3741993|P4|NOT COMPLETED|Test Day 1||0
1528450|NCT01440764|3741994|P3|NOT COMPLETED|Test Day 1||0
1528451|NCT01440764|3741995|P2|NOT COMPLETED|Test Day 1||0
1528452|NCT01440764|3741996|P1|NOT COMPLETED|Test Day 1||0
1528453|NCT01440764|3741990|P7|COMPLETED|Test Day 1||3
1528454|NCT01440764|3741991|P6|COMPLETED|Test Day 1||5
1528455|NCT01440764|3741992|P5|COMPLETED|Test Day 1||3
1528456|NCT01440764|3741993|P4|COMPLETED|Test Day 1||1
1528457|NCT01440764|3741994|P3|COMPLETED|Test Day 1||6
1528458|NCT01440764|3741995|P2|COMPLETED|Test Day 1||2
1528459|NCT01440764|3741996|P1|COMPLETED|Test Day 1||4
1528460|NCT01440764|3741990|P7|STARTED|Test Day 1||3
1528461|NCT01440764|3741991|P6|STARTED|Test Day 1||5
1528462|NCT01440764|3741992|P5|STARTED|Test Day 1||3
1528463|NCT01440764|3741993|P4|STARTED|Test Day 1||1
1528464|NCT01440764|3741994|P3|STARTED|Test Day 1||6
1528465|NCT01440764|3741995|P2|STARTED|Test Day 1||2
1528466|NCT01440764|3741996|P1|STARTED|Test Day 1||4
1528467|NCT01440647|3742017|P2|NOT COMPLETED|Overall Study||3
1528468|NCT01440647|3742018|P1|NOT COMPLETED|Overall Study||2
1528469|NCT01440647|3742017|P2|COMPLETED|Overall Study||15
1528470|NCT01440647|3742018|P1|COMPLETED|Overall Study||14
1528471|NCT01440647|3742017|P2|STARTED|Overall Study||18
1528472|NCT01440647|3742018|P1|STARTED|Overall Study||16
1528473|NCT01440634|3742028|P2|NOT COMPLETED|Randomization Phase||10
1528474|NCT01440634|3742029|P1|NOT COMPLETED|Randomization Phase||6
1528475|NCT01440634|3742028|P2|COMPLETED|Randomization Phase||14
1528476|NCT01440634|3742029|P1|COMPLETED|Randomization Phase||24
1528477|NCT01440634|3742028|P2|STARTED|Randomization Phase||24
1528478|NCT01440634|3742029|P1|STARTED|Randomization Phase||30
1528479|NCT01440634|3742028|P2|NOT COMPLETED|Cross Sectional Phase||0
1528480|NCT01440634|3742029|P1|NOT COMPLETED|Cross Sectional Phase||0
1528481|NCT01440634|3742028|P2|COMPLETED|Cross Sectional Phase||347
1528482|NCT01440634|3742029|P1|COMPLETED|Cross Sectional Phase||0
1528483|NCT01440634|3742028|P2|STARTED|Cross Sectional Phase||347
1528484|NCT01440634|3742029|P1|STARTED|Cross Sectional Phase||0
1528485|NCT01440595|3742037|P3|NOT COMPLETED|Overall Study||1
1528486|NCT01440595|3742038|P2|NOT COMPLETED|Overall Study||3
1528487|NCT01440595|3742039|P1|NOT COMPLETED|Overall Study||1
1528488|NCT01440595|3742037|P3|COMPLETED|Overall Study||0
1528489|NCT01440595|3742038|P2|COMPLETED|Overall Study||0
1528490|NCT01440595|3742039|P1|COMPLETED|Overall Study||0
1528491|NCT01440595|3742037|P3|STARTED|Overall Study||1
1528492|NCT01440595|3742038|P2|STARTED|Overall Study||3
1528493|NCT01440595|3742039|P1|STARTED|Overall Study||1
1528494|NCT01440569|3742059|P2|NOT COMPLETED|Open-Label Rollover Phase||6
1528495|NCT01440569|3742060|P1|NOT COMPLETED|Open-Label Rollover Phase||47
1528496|NCT01440569|3742059|P2|COMPLETED|Open-Label Rollover Phase||7
1528497|NCT01440569|3742060|P1|COMPLETED|Open-Label Rollover Phase||204
1528498|NCT01440569|3742059|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
1528499|NCT01440569|3742060|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
1528500|NCT01440569|3742059|P2|NOT COMPLETED|Main Study||4
1528501|NCT01440569|3742060|P1|NOT COMPLETED|Main Study||36
1528502|NCT01440569|3742059|P2|COMPLETED|Main Study||14
1528503|NCT01440569|3742060|P1|COMPLETED|Main Study||260
1528504|NCT01440569|3742059|P2|Enrolled and Treated|Main Study||18
1528505|NCT01440569|3742060|P1|Enrolled and Treated|Main Study||295
1528506|NCT01440569|3742059|P2|STARTED|Main Study||18
1528507|NCT01440569|3742060|P1|STARTED|Main Study||296
1528508|NCT01440543|3742082|P4|NOT COMPLETED|Overall Study||6
1528509|NCT01440543|3742083|P3|NOT COMPLETED|Overall Study||2
1528510|NCT01440543|3742084|P2|NOT COMPLETED|Overall Study||4
1528511|NCT01440543|3742085|P1|NOT COMPLETED|Overall Study||4
1528512|NCT01440543|3742082|P4|COMPLETED|Overall Study||101
1528513|NCT01440543|3742083|P3|COMPLETED|Overall Study||100
1528514|NCT01440543|3742084|P2|COMPLETED|Overall Study||101
1528515|NCT01440543|3742085|P1|COMPLETED|Overall Study||102
1528516|NCT01440543|3742082|P4|STARTED|Overall Study||107
1528517|NCT01440543|3742083|P3|STARTED|Overall Study||102
1528518|NCT01440543|3742084|P2|STARTED|Overall Study||105
1528519|NCT01440543|3742085|P1|STARTED|Overall Study||106
1528520|NCT01440517|3742095|P1|NOT COMPLETED|Overall Study||1
1528521|NCT01440517|3742095|P1|COMPLETED|Overall Study||4
1528522|NCT01440517|3742095|P1|STARTED|Overall Study||5
1528523|NCT01440387|3742102|P2|NOT COMPLETED|Overall Study||0
1528524|NCT01440387|3742103|P1|NOT COMPLETED|Overall Study||0
1528525|NCT01440387|3742102|P2|COMPLETED|Overall Study||56
1528526|NCT01440387|3742103|P1|COMPLETED|Overall Study||56
1528527|NCT01440387|3742102|P2|STARTED|Overall Study||56
1528528|NCT01440387|3742103|P1|STARTED|Overall Study||56
1528529|NCT01440374|3742126|P4|NOT COMPLETED|Part 3: Extension||32
1528530|NCT01440374|3742127|P3|NOT COMPLETED|Part 3: Extension||0
1528531|NCT01440374|3742128|P2|NOT COMPLETED|Part 3: Extension||0
1528532|NCT01440374|3742129|P1|NOT COMPLETED|Part 3: Extension||0
1528533|NCT01440374|3742126|P4|COMPLETED|Part 3: Extension||27
1528534|NCT01440374|3742127|P3|COMPLETED|Part 3: Extension||0
1528535|NCT01440374|3742128|P2|COMPLETED|Part 3: Extension||0
1528536|NCT01440374|3742129|P1|COMPLETED|Part 3: Extension||0
1528537|NCT01440374|3742126|P4|STARTED|Part 3: Extension||59
1528538|NCT01440374|3742127|P3|STARTED|Part 3: Extension||0
1528539|NCT01440374|3742128|P2|STARTED|Part 3: Extension||0
1528540|NCT01440374|3742129|P1|STARTED|Part 3: Extension||0
1528541|NCT01440374|3742126|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
1528542|NCT01440374|3742127|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
1528543|NCT01440374|3742128|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
1528544|NCT01440374|3742129|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
1528545|NCT01440374|3742126|P4|COMPLETED|Part 2; Double-blind Phase||0
1528546|NCT01440374|3742127|P3|COMPLETED|Part 2; Double-blind Phase||43
1528547|NCT01440374|3742128|P2|COMPLETED|Part 2; Double-blind Phase||27
1528548|NCT01440374|3742129|P1|COMPLETED|Part 2; Double-blind Phase||0
1528549|NCT01440374|3742126|P4|STARTED|Part 2; Double-blind Phase||0
1528550|NCT01440374|3742127|P3|STARTED|Part 2; Double-blind Phase||98
1528551|NCT01440374|3742128|P2|STARTED|Part 2; Double-blind Phase||47
1528552|NCT01440374|3742129|P1|STARTED|Part 2; Double-blind Phase||0
1528553|NCT01440374|3742126|P4|NOT COMPLETED|Part 1: Open-label Phase||0
1528554|NCT01440374|3742127|P3|NOT COMPLETED|Part 1: Open-label Phase||0
1528555|NCT01440374|3742128|P2|NOT COMPLETED|Part 1: Open-label Phase||0
1528556|NCT01440374|3742129|P1|NOT COMPLETED|Part 1: Open-label Phase||6
1528557|NCT01440374|3742126|P4|COMPLETED|Part 1: Open-label Phase||0
1528558|NCT01440374|3742127|P3|COMPLETED|Part 1: Open-label Phase||0
1528559|NCT01440374|3742128|P2|COMPLETED|Part 1: Open-label Phase||0
1528560|NCT01440374|3742129|P1|COMPLETED|Part 1: Open-label Phase||11
1528561|NCT01440374|3742126|P4|STARTED|Part 1: Open-label Phase||0
1528562|NCT01440374|3742127|P3|STARTED|Part 1: Open-label Phase||0
1528563|NCT01440374|3742128|P2|STARTED|Part 1: Open-label Phase||0
1528564|NCT01440374|3742129|P1|STARTED|Part 1: Open-label Phase||17
1528565|NCT01440322|3742164|P2|NOT COMPLETED|Overall Study||1
1528566|NCT01440322|3742165|P1|NOT COMPLETED|Overall Study||7
1528567|NCT01440322|3742164|P2|COMPLETED|Overall Study||49
1528568|NCT01440322|3742165|P1|COMPLETED|Overall Study||90
1528569|NCT01440322|3742164|P2|STARTED|Overall Study||50
1528570|NCT01440322|3742165|P1|STARTED|Overall Study||97
1528571|NCT01440283|3742187|P1|NOT COMPLETED|Overall Study||10
1528572|NCT01440283|3742187|P1|COMPLETED|Overall Study||4
1528573|NCT01440283|3742187|P1|STARTED|Overall Study||14
1528574|NCT01440101|3742202|P3|NOT COMPLETED|Overall Study||1
1528575|NCT01440101|3742203|P2|NOT COMPLETED|Overall Study||4
1528576|NCT01440101|3742204|P1|NOT COMPLETED|Overall Study||2
1528577|NCT01440101|3742202|P3|COMPLETED|Overall Study||46
1528578|NCT01440101|3742203|P2|COMPLETED|Overall Study||43
1528579|NCT01440101|3742204|P1|COMPLETED|Overall Study||10
1528580|NCT01440101|3742202|P3|STARTED|Overall Study||47
1528581|NCT01440101|3742203|P2|STARTED|Overall Study||47
1528582|NCT01440101|3742204|P1|STARTED|Overall Study||12
1528583|NCT01440049|3742237|P1|NOT COMPLETED|Overall Study||5
1528584|NCT01440049|3742237|P1|COMPLETED|Overall Study||155
1528585|NCT01440049|3742237|P1|STARTED|Overall Study||160
1528586|NCT01439971|3742269|P5|NOT COMPLETED|Overall Study||1
1528587|NCT01439971|3742270|P4|NOT COMPLETED|Overall Study||0
1528588|NCT01439971|3742271|P3|NOT COMPLETED|Overall Study||2
1528589|NCT01439971|3742272|P2|NOT COMPLETED|Overall Study||1
1528590|NCT01439971|3742273|P1|NOT COMPLETED|Overall Study||0
1528591|NCT01439971|3742269|P5|COMPLETED|Overall Study||6
1528592|NCT01439971|3742270|P4|COMPLETED|Overall Study||6
1528593|NCT01439971|3742271|P3|COMPLETED|Overall Study||6
1528594|NCT01439971|3742272|P2|COMPLETED|Overall Study||6
1528595|NCT01439971|3742273|P1|COMPLETED|Overall Study||1
1528596|NCT01439971|3742269|P5|Received Treatment|Overall Study||6
1528597|NCT01439971|3742270|P4|Received Treatment|Overall Study||6
1528598|NCT01439971|3742271|P3|Received Treatment|Overall Study||6
1528599|NCT01439971|3742272|P2|Received Treatment|Overall Study||6
1528600|NCT01439971|3742273|P1|Received Treatment|Overall Study||1
1528601|NCT01439971|3742269|P5|STARTED|Overall Study||7
1528602|NCT01439971|3742270|P4|STARTED|Overall Study||6
1528603|NCT01439971|3742271|P3|STARTED|Overall Study||8
1528604|NCT01439971|3742272|P2|STARTED|Overall Study||7
1528605|NCT01439971|3742273|P1|STARTED|Overall Study||1
1528606|NCT01439945|3742453|P4|NOT COMPLETED|Optional Continuation Phase||0
1528607|NCT01439945|3742454|P3|NOT COMPLETED|Optional Continuation Phase||0
1528608|NCT01439945|3742455|P2|NOT COMPLETED|Optional Continuation Phase||0
1528609|NCT01439945|3742456|P1|NOT COMPLETED|Optional Continuation Phase||0
1528610|NCT01439945|3742453|P4|COMPLETED|Optional Continuation Phase||0
1528611|NCT01439945|3742454|P3|COMPLETED|Optional Continuation Phase||0
1528612|NCT01439945|3742455|P2|COMPLETED|Optional Continuation Phase||44
1528613|NCT01439945|3742456|P1|COMPLETED|Optional Continuation Phase||72
1528614|NCT01439945|3742453|P4|STARTED|Optional Continuation Phase||0
1528615|NCT01439945|3742454|P3|STARTED|Optional Continuation Phase||0
1528616|NCT01439945|3742455|P2|STARTED|Optional Continuation Phase||44
1528617|NCT01439945|3742456|P1|STARTED|Optional Continuation Phase||72
1528618|NCT01439945|3742453|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
1528619|NCT01439945|3742454|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
1528620|NCT01439945|3742455|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
1528621|NCT01439945|3742456|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
1528622|NCT01439945|3742453|P4|COMPLETED|Double-Blind Treatment Phase||46
1528623|NCT01439945|3742454|P3|COMPLETED|Double-Blind Treatment Phase||45
1528624|NCT01439945|3742455|P2|COMPLETED|Double-Blind Treatment Phase||91
1528625|NCT01439945|3742456|P1|COMPLETED|Double-Blind Treatment Phase||93
1528626|NCT01439945|3742453|P4|STARTED|Double-Blind Treatment Phase||48
1528627|NCT01439945|3742454|P3|STARTED|Double-Blind Treatment Phase||48
1528628|NCT01439945|3742455|P2|STARTED|Double-Blind Treatment Phase||96
1528629|NCT01439945|3742456|P1|STARTED|Double-Blind Treatment Phase||97
1528630|NCT01439867|3742481|P2|NOT COMPLETED|Overall Study||8
1528631|NCT01439867|3742482|P1|NOT COMPLETED|Overall Study||6
1528632|NCT01439867|3742481|P2|COMPLETED|Overall Study||2
1528633|NCT01439867|3742482|P1|COMPLETED|Overall Study||2
1528634|NCT01439867|3742481|P2|Received Treatment|Overall Study||10
1528635|NCT01439867|3742482|P1|Received Treatment|Overall Study||7
1528636|NCT01439867|3742481|P2|STARTED|Overall Study||10
1528637|NCT01439867|3742482|P1|STARTED|Overall Study||8
1528638|NCT01439724|3742523|P2|NOT COMPLETED|Overall Study||8
1528639|NCT01439724|3742524|P1|NOT COMPLETED|Overall Study||9
1528640|NCT01439724|3742523|P2|COMPLETED|Overall Study||39
1528641|NCT01439724|3742524|P1|COMPLETED|Overall Study||38
1528642|NCT01439724|3742523|P2|STARTED|Overall Study||47
1528643|NCT01439724|3742524|P1|STARTED|Overall Study||47
1528644|NCT01439711|3742530|P1|NOT COMPLETED|Overall Study||40
1528645|NCT01439711|3742530|P1|COMPLETED|Overall Study||68
1528646|NCT01439711|3742530|P1|STARTED|Overall Study||108
1528647|NCT01439672|3742541|P1|NOT COMPLETED|Overall Study||24
1528648|NCT01439672|3742541|P1|COMPLETED|Overall Study||11
1528649|NCT01439672|3742541|P1|STARTED|Overall Study||35
1528650|NCT01439633|3742545|P1|NOT COMPLETED|Overall Study||0
1528651|NCT01439633|3742545|P1|COMPLETED|Overall Study||22
1528652|NCT01439633|3742545|P1|STARTED|Overall Study||22
1528653|NCT01439620|3742549|P1|NOT COMPLETED|Overall Study||0
1528654|NCT01439620|3742549|P1|COMPLETED|Overall Study||7
1528655|NCT01439620|3742549|P1|STARTED|Overall Study||7
1528656|NCT01439581|3742555|P2|NOT COMPLETED|Overall Study||0
1528657|NCT01439581|3742556|P1|NOT COMPLETED|Overall Study||0
1528658|NCT01439581|3742555|P2|COMPLETED|Overall Study||212
1528659|NCT01439581|3742556|P1|COMPLETED|Overall Study||216
1528660|NCT01439581|3742555|P2|STARTED|Overall Study||212
1528661|NCT01439581|3742556|P1|STARTED|Overall Study||216
1528662|NCT01439373|3742564|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
1528663|NCT01439373|3742565|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
1528664|NCT01439373|3742564|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
1528665|NCT01439373|3742565|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
1528666|NCT01439373|3742564|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
1528667|NCT01439373|3742565|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
1528668|NCT01439373|3742564|P2|NOT COMPLETED|Monotherapy (Day 1)||1
1528669|NCT01439373|3742565|P1|NOT COMPLETED|Monotherapy (Day 1)||0
1528670|NCT01439373|3742564|P2|COMPLETED|Monotherapy (Day 1)||4
1528671|NCT01439373|3742565|P1|COMPLETED|Monotherapy (Day 1)||11
1528672|NCT01439373|3742564|P2|STARTED|Monotherapy (Day 1)||5
1528673|NCT01439373|3742565|P1|STARTED|Monotherapy (Day 1)||11
1528674|NCT01439360|3742608|P2|NOT COMPLETED|Overall Study||208
1528675|NCT01439360|3742609|P1|NOT COMPLETED|Overall Study||198
1528676|NCT01439360|3742608|P2|COMPLETED|Overall Study||5804
1528677|NCT01439360|3742609|P1|COMPLETED|Overall Study||5808
1528678|NCT01439360|3742608|P2|STARTED|Overall Study||6012
1528679|NCT01439360|3742609|P1|STARTED|Overall Study||6006
1528680|NCT01439282|3742659|P2|NOT COMPLETED|Overall Study||1
1528681|NCT01439282|3742660|P1|NOT COMPLETED|Overall Study||8
1528682|NCT01439282|3742659|P2|COMPLETED|Overall Study||9
1528683|NCT01439282|3742660|P1|COMPLETED|Overall Study||59
1528684|NCT01439282|3742659|P2|STARTED|Overall Study||10
1528685|NCT01439282|3742660|P1|STARTED|Overall Study||67
1528686|NCT01439204|3742670|P2|NOT COMPLETED|Overall Study||3
1528687|NCT01439204|3742671|P1|NOT COMPLETED|Overall Study||4
1528688|NCT01439204|3742670|P2|COMPLETED|Overall Study||33
1528689|NCT01439204|3742671|P1|COMPLETED|Overall Study||32
1528690|NCT01439204|3742670|P2|STARTED|Overall Study||36
1528691|NCT01439204|3742671|P1|STARTED|Overall Study||36
1528692|NCT01439165|3742705|P2|NOT COMPLETED|Overall Study||2
1528693|NCT01439165|3742706|P1|NOT COMPLETED|Overall Study||21
1528694|NCT01439165|3742705|P2|COMPLETED|Overall Study||326
1528695|NCT01439165|3742706|P1|COMPLETED|Overall Study||981
1528696|NCT01439165|3742705|P2|STARTED|Overall Study||328
1528697|NCT01439165|3742706|P1|STARTED|Overall Study||1002
1528698|NCT01439126|3742720|P2|NOT COMPLETED|Overall Study||42
1528699|NCT01439126|3742721|P1|NOT COMPLETED|Overall Study||31
1528700|NCT01439126|3742720|P2|COMPLETED|Overall Study||25
1528701|NCT01439126|3742721|P1|COMPLETED|Overall Study||37
1528702|NCT01439126|3742720|P2|STARTED|Overall Study||67
1528703|NCT01439126|3742721|P1|STARTED|Overall Study||68
1528704|NCT01439074|3742743|P2|NOT COMPLETED|Overall Study||13
1528705|NCT01439074|3742744|P1|NOT COMPLETED|Overall Study||9
1528706|NCT01439074|3742743|P2|COMPLETED|Overall Study||74
1528707|NCT01439074|3742744|P1|COMPLETED|Overall Study||66
1528708|NCT01439074|3742743|P2|STARTED|Overall Study||87
1528709|NCT01439074|3742744|P1|STARTED|Overall Study||75
1528710|NCT01439035|3742756|P1|NOT COMPLETED|Overall Study||0
1528711|NCT01439035|3742756|P1|COMPLETED|Overall Study||6
1528712|NCT01439035|3742756|P1|STARTED|Overall Study||6
1528713|NCT01438996|3742763|P3|NOT COMPLETED|Overall Study||0
1528714|NCT01438996|3742764|P2|NOT COMPLETED|Overall Study||1
1528715|NCT01438996|3742765|P1|NOT COMPLETED|Overall Study||4
1528716|NCT01438996|3742763|P3|COMPLETED|Overall Study||20
1528717|NCT01438996|3742764|P2|COMPLETED|Overall Study||12
1528718|NCT01438996|3742765|P1|COMPLETED|Overall Study||14
1528719|NCT01438996|3742763|P3|STARTED|Overall Study||20
1528720|NCT01438996|3742764|P2|STARTED|Overall Study||13
1528721|NCT01438996|3742765|P1|STARTED|Overall Study||18
1528722|NCT01438840|3742799|P3|NOT COMPLETED|Extension Phase||10
1528723|NCT01438840|3742800|P2|NOT COMPLETED|Extension Phase||0
1528724|NCT01438840|3742801|P1|NOT COMPLETED|Extension Phase||0
1528725|NCT01438840|3742799|P3|COMPLETED|Extension Phase||29
1528726|NCT01438840|3742800|P2|COMPLETED|Extension Phase||0
1528727|NCT01438840|3742801|P1|COMPLETED|Extension Phase||0
1528728|NCT01438840|3742799|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
1528729|NCT01438840|3742800|P2|STARTED|Extension Phase||0
1528730|NCT01438840|3742801|P1|STARTED|Extension Phase||0
1528731|NCT01438840|3742799|P3|NOT COMPLETED|Core Study||0
1528732|NCT01438840|3742800|P2|NOT COMPLETED|Core Study||10
1528733|NCT01438840|3742801|P1|NOT COMPLETED|Core Study||16
1528734|NCT01438840|3742799|P3|COMPLETED|Core Study||0
1528735|NCT01438840|3742800|P2|COMPLETED|Core Study||22
1528736|NCT01438840|3742801|P1|COMPLETED|Core Study||1
1528737|NCT01438840|3742799|P3|STARTED|Core Study||0
1528738|NCT01438840|3742800|P2|STARTED|Core Study||32
1528739|NCT01438840|3742801|P1|STARTED|Core Study||17
1528740|NCT01438814|3742814|P2|NOT COMPLETED|Overall Study||14
1528741|NCT01438814|3742815|P1|NOT COMPLETED|Overall Study||14
1528742|NCT01438814|3742814|P2|COMPLETED|Overall Study||331
1528743|NCT01438814|3742815|P1|COMPLETED|Overall Study||330
1528744|NCT01438814|3742814|P2|STARTED|Overall Study||345
1528745|NCT01438814|3742815|P1|STARTED|Overall Study||344
1528746|NCT01438710|3742845|P2|NOT COMPLETED|Second Week of Treatment||0
1528747|NCT01438710|3742846|P1|NOT COMPLETED|Second Week of Treatment||1
1528748|NCT01438710|3742845|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
1528749|NCT01438710|3742846|P1|COMPLETED|Second Week of Treatment||40
1528750|NCT01438710|3742845|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
1528751|NCT01438710|3742846|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
1528752|NCT01438710|3742845|P2|NOT COMPLETED|First Week of Treatment||3
1528753|NCT01438710|3742846|P1|NOT COMPLETED|First Week of Treatment||0
1528754|NCT01438710|3742845|P2|COMPLETED|First Week of Treatment||41
1528755|NCT01438710|3742846|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
1528756|NCT01438710|3742845|P2|STARTED|First Week of Treatment||44
1528757|NCT01438710|3742846|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
1528758|NCT01438541|3742851|P1|NOT COMPLETED|Overall Study||7
1528759|NCT01438541|3742851|P1|COMPLETED|Overall Study||22
1528760|NCT01438541|3742851|P1|STARTED|Overall Study||29
1528761|NCT01438489|3742860|P3|NOT COMPLETED|Overall Study||19
1528762|NCT01438489|3742861|P2|NOT COMPLETED|Overall Study||16
1528763|NCT01438489|3742862|P1|NOT COMPLETED|Overall Study||26
1528764|NCT01438489|3742860|P3|COMPLETED|Overall Study||85
1528765|NCT01438489|3742861|P2|COMPLETED|Overall Study||84
1528766|NCT01438489|3742862|P1|COMPLETED|Overall Study||77
1528767|NCT01438489|3742860|P3|STARTED|Overall Study||104
1528768|NCT01438489|3742861|P2|STARTED|Overall Study||100
1528769|NCT01438489|3742862|P1|STARTED|Overall Study||103
1528770|NCT01438424|3742905|P1|NOT COMPLETED|Overall Study||417
1528771|NCT01438424|3742905|P1|COMPLETED|Overall Study|Completed treatment|634
1528772|NCT01438424|3742905|P1|STARTED|Overall Study|Received treatment|1051
1528773|NCT01438307|3742943|P2|NOT COMPLETED|Overall Study||1
1528774|NCT01438307|3742944|P1|NOT COMPLETED|Overall Study||1
1528775|NCT01438307|3742943|P2|COMPLETED|Overall Study||13
1528776|NCT01438307|3742944|P1|COMPLETED|Overall Study||13
1528777|NCT01438307|3742943|P2|STARTED|Overall Study||14
1528778|NCT01438307|3742944|P1|STARTED|Overall Study||14
1528779|NCT01438294|3742958|P2|NOT COMPLETED|Overall Study||7
1528780|NCT01438294|3742959|P1|NOT COMPLETED|Overall Study||3
1528781|NCT01438294|3742958|P2|COMPLETED|Overall Study||13
1528782|NCT01438294|3742959|P1|COMPLETED|Overall Study||13
1528783|NCT01438294|3742958|P2|STARTED|Overall Study||20
1528784|NCT01438294|3742959|P1|STARTED|Overall Study||16
1528785|NCT01438229|3742969|P1|NOT COMPLETED|Overall Study||3
1528786|NCT01438229|3742969|P1|COMPLETED|Overall Study||44
1528787|NCT01438229|3742969|P1|Underwent Procedure|Overall Study||46
1528788|NCT01438229|3742969|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
1528789|NCT01438229|3742969|P1|STARTED|Overall Study||47
1528790|NCT01438177|3743002|P1|NOT COMPLETED|Overall Study||2
1528791|NCT01438177|3743002|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
1528792|NCT01438177|3743002|P1|STARTED|Overall Study||11
1528793|NCT01438151|3743008|P1|NOT COMPLETED|Overall Study||8
1528794|NCT01438151|3743008|P1|COMPLETED|Overall Study||3
1528795|NCT01438151|3743008|P1|STARTED|Overall Study||11
1528796|NCT01438060|3743014|P2|NOT COMPLETED|On Study Beyond Week 140||8
1528797|NCT01438060|3743015|P1|NOT COMPLETED|On Study Beyond Week 140||0
1528798|NCT01438060|3743014|P2|COMPLETED|On Study Beyond Week 140||1
1528799|NCT01438060|3743015|P1|COMPLETED|On Study Beyond Week 140||0
1528800|NCT01438060|3743014|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
1528801|NCT01438060|3743015|P1|STARTED|On Study Beyond Week 140||0
1528802|NCT01438060|3743014|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
1528803|NCT01438060|3743015|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
1528804|NCT01438060|3743014|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
1528805|NCT01438060|3743015|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
1528806|NCT01438060|3743014|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
1528807|NCT01438060|3743015|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
1528808|NCT01438060|3743014|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
1528809|NCT01438060|3743015|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
1528810|NCT01438060|3743014|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
1528811|NCT01438060|3743015|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
1528812|NCT01438060|3743014|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
1528813|NCT01438060|3743015|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
1528814|NCT01437995|3743096|P3|NOT COMPLETED|Overall Study||20
1528815|NCT01437995|3743097|P2|NOT COMPLETED|Overall Study||18
1528816|NCT01437995|3743098|P1|NOT COMPLETED|Overall Study||11
1528817|NCT01437995|3743096|P3|COMPLETED|Overall Study||135
1528818|NCT01437995|3743097|P2|COMPLETED|Overall Study||131
1528819|NCT01437995|3743098|P1|COMPLETED|Overall Study||140
1528820|NCT01437995|3743096|P3|Included in Treatment Failure Analysis|Overall Study||151
1528821|NCT01437995|3743097|P2|Included in Treatment Failure Analysis|Overall Study||146
1528822|NCT01437995|3743098|P1|Included in Treatment Failure Analysis|Overall Study||150
1528823|NCT01437995|3743096|P3|STARTED|Overall Study||155
1528824|NCT01437995|3743097|P2|STARTED|Overall Study||149
1528825|NCT01437995|3743098|P1|STARTED|Overall Study||151
1528826|NCT01437943|3743120|P2|NOT COMPLETED|Overall Study||2
1528827|NCT01437943|3743121|P1|NOT COMPLETED|Overall Study||7
1528828|NCT01437943|3743120|P2|COMPLETED|Overall Study||1
1528829|NCT01437943|3743121|P1|COMPLETED|Overall Study||0
1528830|NCT01437943|3743120|P2|STARTED|Overall Study||3
1528831|NCT01437943|3743121|P1|STARTED|Overall Study||7
1528832|NCT01437878|3743129|P2|NOT COMPLETED|Overall Study||0
1528833|NCT01437878|3743130|P1|NOT COMPLETED|Overall Study||1
1528834|NCT01437878|3743129|P2|COMPLETED|Overall Study||1
1528835|NCT01437878|3743130|P1|COMPLETED|Overall Study||0
1528836|NCT01437878|3743129|P2|STARTED|Overall Study||1
1528837|NCT01437878|3743130|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
1528838|NCT01437852|3743170|P1|NOT COMPLETED|Overall Study||0
1528839|NCT01437852|3743170|P1|COMPLETED|Overall Study||30
1528840|NCT01437852|3743170|P1|Received Autograft|Overall Study||30
1528841|NCT01437852|3743170|P1|Received StrataGraft Skin Tissue|Overall Study||30
1528842|NCT01437852|3743170|P1|STARTED|Overall Study||30
1528843|NCT01437540|3743178|P2|NOT COMPLETED|Overall Study||65
1528844|NCT01437540|3743179|P1|NOT COMPLETED|Overall Study||127
1528845|NCT01437540|3743178|P2|COMPLETED|Overall Study||133
1528846|NCT01437540|3743179|P1|COMPLETED|Overall Study||265
1528847|NCT01437540|3743178|P2|STARTED|Overall Study||198
1528848|NCT01437540|3743179|P1|STARTED|Overall Study||392
1528849|NCT01437501|3743193|P2|NOT COMPLETED|Overall Study||11
1528850|NCT01437501|3743194|P1|NOT COMPLETED|Overall Study||13
1528851|NCT01437501|3743193|P2|COMPLETED|Overall Study||132
1528852|NCT01437501|3743194|P1|COMPLETED|Overall Study||135
1528853|NCT01437501|3743193|P2|STARTED|Overall Study||143
1528854|NCT01437501|3743194|P1|STARTED|Overall Study||148
1528855|NCT01437488|3743202|P1|NOT COMPLETED|Overall Study||0
1528856|NCT01437488|3743202|P1|COMPLETED|Overall Study||14
1528857|NCT01437488|3743202|P1|STARTED|Overall Study||14
1528858|NCT01437423|3743209|P1|NOT COMPLETED|Overall Study||15
1528859|NCT01437423|3743209|P1|COMPLETED|Overall Study||647
1528860|NCT01437423|3743209|P1|STARTED|Overall Study||662
1528861|NCT01437397|3743221|P5|NOT COMPLETED|Overall Study||101
1528862|NCT01437397|3743222|P4|NOT COMPLETED|Overall Study||69
1528863|NCT01437397|3743223|P3|NOT COMPLETED|Overall Study||72
1528864|NCT01437397|3743224|P2|NOT COMPLETED|Overall Study||62
1528865|NCT01437397|3743225|P1|NOT COMPLETED|Overall Study||66
1528866|NCT01437397|3743221|P5|COMPLETED|Overall Study||236
1528867|NCT01437397|3743222|P4|COMPLETED|Overall Study||270
1528868|NCT01437397|3743223|P3|COMPLETED|Overall Study||268
1528869|NCT01437397|3743224|P2|COMPLETED|Overall Study||276
1528870|NCT01437397|3743225|P1|COMPLETED|Overall Study||272
1528871|NCT01437397|3743221|P5|STARTED|Overall Study||337
1528872|NCT01437397|3743222|P4|STARTED|Overall Study||339
1528873|NCT01437397|3743223|P3|STARTED|Overall Study||340
1528874|NCT01437397|3743224|P2|STARTED|Overall Study||338
1528875|NCT01437397|3743225|P1|STARTED|Overall Study||338
1528876|NCT01437319|3743252|P3|NOT COMPLETED|Phase II||37
1528877|NCT01437319|3743253|P2|NOT COMPLETED|Phase II||44
1528878|NCT01437319|3743254|P1|NOT COMPLETED|Phase II||0
1528879|NCT01437319|3743252|P3|COMPLETED|Phase II||75
1528880|NCT01437319|3743253|P2|COMPLETED|Phase II||71
1528881|NCT01437319|3743254|P1|COMPLETED|Phase II||0
1528882|NCT01437319|3743252|P3|STARTED|Phase II||112
1528883|NCT01437319|3743253|P2|STARTED|Phase II||115
1528884|NCT01437319|3743254|P1|STARTED|Phase II||0
1528885|NCT01437319|3743252|P3|NOT COMPLETED|Phase I||0
1528886|NCT01437319|3743253|P2|NOT COMPLETED|Phase I||0
1528887|NCT01437319|3743254|P1|NOT COMPLETED|Phase I||55
1528888|NCT01437319|3743252|P3|COMPLETED|Phase I||0
1528889|NCT01437319|3743253|P2|COMPLETED|Phase I||0
1528890|NCT01437319|3743254|P1|COMPLETED|Phase I||227
1528891|NCT01437319|3743252|P3|STARTED|Phase I||0
1528892|NCT01437319|3743253|P2|STARTED|Phase I||0
1528893|NCT01437319|3743254|P1|STARTED|Phase I||282
1528894|NCT01437267|3743269|P6|NOT COMPLETED|Overall Study||0
1528895|NCT01437267|3743270|P5|NOT COMPLETED|Overall Study||0
1528896|NCT01437267|3743271|P4|NOT COMPLETED|Overall Study||1
1528897|NCT01437267|3743272|P3|NOT COMPLETED|Overall Study||0
1528898|NCT01437267|3743273|P2|NOT COMPLETED|Overall Study||1
1528899|NCT01437267|3743274|P1|NOT COMPLETED|Overall Study||0
1528900|NCT01437267|3743269|P6|COMPLETED|Overall Study||20
1528901|NCT01437267|3743270|P5|COMPLETED|Overall Study||20
1528902|NCT01437267|3743271|P4|COMPLETED|Overall Study||19
1528903|NCT01437267|3743272|P3|COMPLETED|Overall Study||20
1528904|NCT01437267|3743273|P2|COMPLETED|Overall Study||19
1528905|NCT01437267|3743274|P1|COMPLETED|Overall Study||20
1528906|NCT01437267|3743269|P6|STARTED|Overall Study||20
1528907|NCT01437267|3743270|P5|STARTED|Overall Study||20
1528908|NCT01437267|3743271|P4|STARTED|Overall Study||20
1528909|NCT01437267|3743272|P3|STARTED|Overall Study||20
1528910|NCT01437267|3743273|P2|STARTED|Overall Study||20
1528911|NCT01437267|3743274|P1|STARTED|Overall Study||20
1528912|NCT01437124|3743312|P1|NOT COMPLETED|Overall Study||0
1528913|NCT01437124|3743312|P1|COMPLETED|Overall Study||83
1528914|NCT01437124|3743312|P1|STARTED|Overall Study||83
1528915|NCT01437111|3743317|P1|NOT COMPLETED|Overall Study||18
1528916|NCT01437111|3743317|P1|COMPLETED|Overall Study||182
1528917|NCT01437111|3743317|P1|Treated Participants|Overall Study||198
1528918|NCT01437111|3743317|P1|STARTED|Overall Study||200
1528919|NCT01437098|3743328|P1|NOT COMPLETED|Overall Study||13
1528920|NCT01437098|3743328|P1|COMPLETED|Overall Study||42
1528921|NCT01437098|3743328|P1|36 Months|Overall Study||36
1528922|NCT01437098|3743328|P1|24 Months|Overall Study||42
1528923|NCT01437098|3743328|P1|12 Months|Overall Study||45
1528924|NCT01437098|3743328|P1|6 Months|Overall Study||47
1528925|NCT01437098|3743328|P1|30 Days|Overall Study||51
1528926|NCT01437098|3743328|P1|STARTED|Overall Study||55
1528927|NCT01436799|3743385|P2|NOT COMPLETED|Overall Study||0
1528928|NCT01436799|3743386|P1|NOT COMPLETED|Overall Study||0
1528929|NCT01436799|3743385|P2|COMPLETED|Overall Study||20
1528930|NCT01436799|3743386|P1|COMPLETED|Overall Study||20
1528931|NCT01436799|3743385|P2|STARTED|Overall Study||20
1528932|NCT01436799|3743386|P1|STARTED|Overall Study||20
1528933|NCT01436643|3743395|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
1528934|NCT01436643|3743396|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
1528935|NCT01436643|3743397|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
1528936|NCT01436643|3743398|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
1528937|NCT01436643|3743395|P4|COMPLETED|Core Phase (16 Weeks)||0
1528938|NCT01436643|3743396|P3|COMPLETED|Core Phase (16 Weeks)||17
1528939|NCT01436643|3743397|P2|COMPLETED|Core Phase (16 Weeks)||11
1528940|NCT01436643|3743398|P1|COMPLETED|Core Phase (16 Weeks)||16
1528941|NCT01436643|3743395|P4|STARTED|Core Phase (16 Weeks)||0
1528942|NCT01436643|3743396|P3|STARTED|Core Phase (16 Weeks)||20
1528943|NCT01436643|3743397|P2|STARTED|Core Phase (16 Weeks)||15
1528944|NCT01436643|3743398|P1|STARTED|Core Phase (16 Weeks)||17
1528945|NCT01436643|3743395|P4|NOT COMPLETED|2-week Pre-treatment||10
1528946|NCT01436643|3743396|P3|NOT COMPLETED|2-week Pre-treatment||0
1528947|NCT01436643|3743397|P2|NOT COMPLETED|2-week Pre-treatment||0
1528948|NCT01436643|3743398|P1|NOT COMPLETED|2-week Pre-treatment||0
1528949|NCT01436643|3743395|P4|COMPLETED|2-week Pre-treatment||44
1528950|NCT01436643|3743396|P3|COMPLETED|2-week Pre-treatment||0
1528951|NCT01436643|3743397|P2|COMPLETED|2-week Pre-treatment||0
1528952|NCT01436643|3743398|P1|COMPLETED|2-week Pre-treatment||0
1528953|NCT01436643|3743395|P4|STARTED|2-week Pre-treatment||54
1528954|NCT01436643|3743396|P3|STARTED|2-week Pre-treatment||0
1528955|NCT01436643|3743397|P2|STARTED|2-week Pre-treatment||0
1528956|NCT01436643|3743398|P1|STARTED|2-week Pre-treatment||0
1528957|NCT01436526|3743410|P2|NOT COMPLETED|Period 2||0
1528958|NCT01436526|3743411|P1|NOT COMPLETED|Period 2||0
1528959|NCT01436526|3743410|P2|COMPLETED|Period 2||13
1528960|NCT01436526|3743411|P1|COMPLETED|Period 2||13
1528961|NCT01436526|3743410|P2|Participants Received Treatment|Period 2||13
1528962|NCT01436526|3743411|P1|Participants Received Treatment|Period 2||13
1528963|NCT01436526|3743410|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
1528964|NCT01436526|3743411|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
1528965|NCT01436526|3743410|P2|NOT COMPLETED|Period 1||0
1528966|NCT01436526|3743411|P1|NOT COMPLETED|Period 1||0
1528967|NCT01436526|3743410|P2|COMPLETED|Period 1||14
1528968|NCT01436526|3743411|P1|COMPLETED|Period 1||14
1528969|NCT01436526|3743410|P2|Participants Received Treatment|Period 1||14
1528970|NCT01436526|3743411|P1|Participants Received Treatment|Period 1||14
1528971|NCT01436526|3743410|P2|STARTED|Period 1||14
1528972|NCT01436526|3743411|P1|STARTED|Period 1||14
1528973|NCT01436500|3743433|P5|NOT COMPLETED|Overall Study||4
1528974|NCT01436500|3743434|P4|NOT COMPLETED|Overall Study||1
1528975|NCT01436500|3743435|P3|NOT COMPLETED|Overall Study||5
1528976|NCT01436500|3743436|P2|NOT COMPLETED|Overall Study||3
1528977|NCT01436500|3743437|P1|NOT COMPLETED|Overall Study||3
1528978|NCT01436500|3743433|P5|COMPLETED|Overall Study||9
1528979|NCT01436500|3743434|P4|COMPLETED|Overall Study||5
1528980|NCT01436500|3743435|P3|COMPLETED|Overall Study||7
1528981|NCT01436500|3743436|P2|COMPLETED|Overall Study||9
1528982|NCT01436500|3743437|P1|COMPLETED|Overall Study||9
1528983|NCT01436500|3743433|P5|STARTED|Overall Study||13
1528984|NCT01436500|3743434|P4|STARTED|Overall Study||6
1528985|NCT01436500|3743435|P3|STARTED|Overall Study||12
1528986|NCT01436500|3743436|P2|STARTED|Overall Study||12
1528987|NCT01436500|3743437|P1|STARTED|Overall Study||12
1528988|NCT01436435|3743470|P1|NOT COMPLETED|Overall Study||64
1528989|NCT01436435|3743470|P1|COMPLETED|Overall Study||177
1528990|NCT01436435|3743470|P1|STARTED|Overall Study||241
1528991|NCT01436370|3743487|P8|NOT COMPLETED|Overall Study||0
1528992|NCT01436370|3743488|P7|NOT COMPLETED|Overall Study||0
1528993|NCT01436370|3743489|P6|NOT COMPLETED|Overall Study||0
1528994|NCT01436370|3743490|P5|NOT COMPLETED|Overall Study||1
1528995|NCT01436370|3743491|P4|NOT COMPLETED|Overall Study||0
1528996|NCT01436370|3743492|P3|NOT COMPLETED|Overall Study||0
1528997|NCT01436370|3743493|P2|NOT COMPLETED|Overall Study||0
1528998|NCT01436370|3743494|P1|NOT COMPLETED|Overall Study||0
1528999|NCT01436370|3743487|P8|COMPLETED|Overall Study||16
1529000|NCT01436370|3743488|P7|COMPLETED|Overall Study||16
1529001|NCT01436370|3743489|P6|COMPLETED|Overall Study||19
1529002|NCT01436370|3743490|P5|COMPLETED|Overall Study||18
1529003|NCT01436370|3743491|P4|COMPLETED|Overall Study||10
1529004|NCT01436370|3743492|P3|COMPLETED|Overall Study||10
1529005|NCT01436370|3743493|P2|COMPLETED|Overall Study||6
1529006|NCT01436370|3743494|P1|COMPLETED|Overall Study||6
1529007|NCT01436370|3743487|P8|STARTED|Overall Study||16
1529008|NCT01436370|3743488|P7|STARTED|Overall Study||16
1529009|NCT01436370|3743489|P6|STARTED|Overall Study||19
1529010|NCT01436370|3743490|P5|STARTED|Overall Study||19
1529011|NCT01436370|3743491|P4|STARTED|Overall Study||10
1529012|NCT01436370|3743492|P3|STARTED|Overall Study||10
1529013|NCT01436370|3743493|P2|STARTED|Overall Study||6
1529014|NCT01436370|3743494|P1|STARTED|Overall Study||6
1529015|NCT01436305|3743575|P3|NOT COMPLETED|Overall Study||0
1529016|NCT01436305|3743576|P2|NOT COMPLETED|Overall Study||4
1529017|NCT01436305|3743577|P1|NOT COMPLETED|Overall Study||2
1529018|NCT01436305|3743575|P3|COMPLETED|Overall Study||7
1529019|NCT01436305|3743576|P2|COMPLETED|Overall Study||2
1529020|NCT01436305|3743577|P1|COMPLETED|Overall Study||4
1529021|NCT01436305|3743575|P3|STARTED|Overall Study||7
1529022|NCT01436305|3743576|P2|STARTED|Overall Study||6
1529023|NCT01436305|3743577|P1|STARTED|Overall Study||6
1529024|NCT01436279|3743674|P2|NOT COMPLETED|Overall Study||0
1529025|NCT01436279|3743675|P1|NOT COMPLETED|Overall Study||0
1529026|NCT01436279|3743674|P2|COMPLETED|Overall Study||20
1529027|NCT01436279|3743675|P1|COMPLETED|Overall Study||30
1529028|NCT01436279|3743674|P2|STARTED|Overall Study||20
1529029|NCT01436279|3743675|P1|STARTED|Overall Study||30
1529030|NCT01436266|3743697|P2|NOT COMPLETED|Overall Study||0
1529031|NCT01436266|3743698|P1|NOT COMPLETED|Overall Study||0
1529032|NCT01436266|3743697|P2|COMPLETED|Overall Study||1
1529033|NCT01436266|3743698|P1|COMPLETED|Overall Study||1
1529034|NCT01436266|3743697|P2|STARTED|Overall Study||1
1529035|NCT01436266|3743698|P1|STARTED|Overall Study||1
1529036|NCT01436253|3743704|P1|NOT COMPLETED|Overall Study||299
1529037|NCT01436253|3743704|P1|COMPLETED|Overall Study||1897
1529038|NCT01436253|3743704|P1|STARTED|Overall Study||2196
1529039|NCT01436201|3743709|P1|NOT COMPLETED|Overall Study||4
1529040|NCT01436201|3743709|P1|COMPLETED|Overall Study||20
1529041|NCT01436201|3743709|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
1529042|NCT01436201|3743709|P1|STARTED|Overall Study||24
1529043|NCT01436175|3743719|P1|NOT COMPLETED|Overall Study||1270
1529044|NCT01436175|3743719|P1|COMPLETED|Overall Study||300
1529045|NCT01436175|3743719|P1|STARTED|Overall Study||1570
1529046|NCT01436162|3743746|P3|NOT COMPLETED|Randomized Phase||25
1529047|NCT01436162|3743747|P2|NOT COMPLETED|Randomized Phase||31
1529048|NCT01436162|3743748|P1|NOT COMPLETED|Randomized Phase||44
1529049|NCT01436162|3743746|P3|COMPLETED|Randomized Phase||189
1529050|NCT01436162|3743747|P2|COMPLETED|Randomized Phase||181
1529051|NCT01436162|3743748|P1|COMPLETED|Randomized Phase||353
1529052|NCT01436162|3743746|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
1529053|NCT01436162|3743747|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
1529054|NCT01436162|3743748|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
1529055|NCT01436162|3743746|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
1529056|NCT01436162|3743747|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
1529057|NCT01436162|3743748|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
1529058|NCT01436162|3743746|P3|COMPLETED|Single-blind Lead-in Phase||0
1529059|NCT01436162|3743747|P2|COMPLETED|Single-blind Lead-in Phase||0
1529060|NCT01436162|3743748|P1|COMPLETED|Single-blind Lead-in Phase||823
1529061|NCT01436162|3743746|P3|STARTED|Single-blind Lead-in Phase||0
1529062|NCT01436162|3743747|P2|STARTED|Single-blind Lead-in Phase||0
1529063|NCT01436162|3743748|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
1529064|NCT01436149|3743782|P3|NOT COMPLETED|Randomized Phase||42
1529065|NCT01436149|3743783|P2|NOT COMPLETED|Randomized Phase||38
1529066|NCT01436149|3743784|P1|NOT COMPLETED|Randomized Phase||77
1529067|NCT01436149|3743782|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
1529068|NCT01436149|3743783|P2|COMPLETED|Randomized Phase||164
1529069|NCT01436149|3743784|P1|COMPLETED|Randomized Phase||415
1529070|NCT01436149|3743782|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
1529071|NCT01436149|3743783|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
1529072|NCT01436149|3743784|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
1529073|NCT01436149|3743782|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
1529074|NCT01436149|3743783|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
1529075|NCT01436149|3743784|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
1529076|NCT01436149|3743782|P3|COMPLETED|Antidepressant Lead-in Phase||0
1529077|NCT01436149|3743783|P2|COMPLETED|Antidepressant Lead-in Phase||0
1529078|NCT01436149|3743784|P1|COMPLETED|Antidepressant Lead-in Phase||896
1529079|NCT01436149|3743782|P3|STARTED|Antidepressant Lead-in Phase||0
1529080|NCT01436149|3743783|P2|STARTED|Antidepressant Lead-in Phase||0
1529081|NCT01436149|3743784|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
1529082|NCT01436110|3743815|P3|NOT COMPLETED|Overall Study||23
1529083|NCT01436110|3743816|P2|NOT COMPLETED|Overall Study||26
1529084|NCT01436110|3743817|P1|NOT COMPLETED|Overall Study||39
1529085|NCT01436110|3743815|P3|COMPLETED|Overall Study||95
1529086|NCT01436110|3743816|P2|COMPLETED|Overall Study||91
1529087|NCT01436110|3743817|P1|COMPLETED|Overall Study||77
1529088|NCT01436110|3743815|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
1529089|NCT01436110|3743816|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
1529090|NCT01436110|3743817|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
1529091|NCT01436110|3743815|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
1529092|NCT01436110|3743816|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
1529093|NCT01436110|3743817|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
1529094|NCT01436084|3743840|P1|NOT COMPLETED|Overall Study||4
1529095|NCT01436084|3743840|P1|COMPLETED|Overall Study||0
1529096|NCT01436084|3743840|P1|STARTED|Overall Study||4
1529097|NCT01436071|3743846|P2|NOT COMPLETED|Overall Study||14
1529098|NCT01436071|3743847|P1|NOT COMPLETED|Overall Study||26
1529099|NCT01436071|3743846|P2|COMPLETED|Overall Study||110
1529100|NCT01436071|3743847|P1|COMPLETED|Overall Study||98
1529101|NCT01436071|3743846|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
1529102|NCT01436071|3743847|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
1529103|NCT01436071|3743846|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
1529104|NCT01436071|3743847|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
1529105|NCT01436045|3743863|P2|NOT COMPLETED|Overall Study||0
1529106|NCT01436045|3743864|P1|NOT COMPLETED|Overall Study||0
1529107|NCT01436045|3743863|P2|COMPLETED|Overall Study||6
1529108|NCT01436045|3743864|P1|COMPLETED|Overall Study||6
1529109|NCT01436045|3743863|P2|STARTED|Overall Study||6
1529110|NCT01436045|3743864|P1|STARTED|Overall Study||6
1529111|NCT01436006|3743875|P1|NOT COMPLETED|Overall Study||37
1529112|NCT01436006|3743875|P1|COMPLETED|Overall Study||6663
1529113|NCT01436006|3743875|P1|STARTED|Overall Study||6700
1529114|NCT01435928|3743889|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
1529115|NCT01435928|3743890|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
1529116|NCT01435928|3743891|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
1529117|NCT01435928|3743889|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
1529118|NCT01435928|3743890|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
1529119|NCT01435928|3743891|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
1529120|NCT01435928|3743889|P3|STARTED|Double Blind Phase - 28 Weeks||141
1529121|NCT01435928|3743890|P2|STARTED|Double Blind Phase - 28 Weeks||144
1529122|NCT01435928|3743891|P1|STARTED|Double Blind Phase - 28 Weeks||0
1529123|NCT01435928|3743889|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
1529124|NCT01435928|3743890|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
1529125|NCT01435928|3743891|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
1529126|NCT01435928|3743889|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
1529127|NCT01435928|3743890|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
1529128|NCT01435928|3743891|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
1529129|NCT01435928|3743889|P3|STARTED|Open Label Phase - up to 24 Weeks||0
1529130|NCT01435928|3743890|P2|STARTED|Open Label Phase - up to 24 Weeks||0
1529131|NCT01435928|3743891|P1|STARTED|Open Label Phase - up to 24 Weeks||676
1529132|NCT01435798|3743918|P1|NOT COMPLETED|Overall Study||1
1529133|NCT01435798|3743918|P1|COMPLETED|Overall Study|Crossover design|25
1529134|NCT01435798|3743918|P1|100% MTD|Overall Study||25
1529135|NCT01435798|3743918|P1|50% MTD|Overall Study||25
1529136|NCT01435798|3743918|P1|25% MTD|Overall Study||26
1529137|NCT01435798|3743918|P1|0% MTD|Overall Study||25
1529138|NCT01435798|3743918|P1|STARTED|Overall Study|Crossover design|26
1529139|NCT01435772|3743935|P3|NOT COMPLETED|Overall Study||15
1529140|NCT01435772|3743936|P2|NOT COMPLETED|Overall Study||3
1529141|NCT01435772|3743937|P1|NOT COMPLETED|Overall Study||3
1529142|NCT01435772|3743935|P3|COMPLETED|Overall Study||0
1529143|NCT01435772|3743936|P2|COMPLETED|Overall Study||0
1529144|NCT01435772|3743937|P1|COMPLETED|Overall Study||0
1529145|NCT01435772|3743935|P3|STARTED|Overall Study||15
1529146|NCT01435772|3743936|P2|STARTED|Overall Study||3
1529147|NCT01435772|3743937|P1|STARTED|Overall Study||3
1529148|NCT01435759|3743987|P6|NOT COMPLETED|Double-blind Phase||9
1529149|NCT01435759|3743988|P5|NOT COMPLETED|Double-blind Phase||9
1529150|NCT01435759|3743989|P4|NOT COMPLETED|Double-blind Phase||9
1529151|NCT01435759|3743990|P3|NOT COMPLETED|Double-blind Phase||7
1529152|NCT01435759|3743991|P2|NOT COMPLETED|Double-blind Phase||7
1529153|NCT01435759|3743992|P1|NOT COMPLETED|Double-blind Phase||66
1529154|NCT01435759|3743987|P6|COMPLETED|Double-blind Phase||71
1529155|NCT01435759|3743988|P5|COMPLETED|Double-blind Phase||69
1529156|NCT01435759|3743989|P4|COMPLETED|Double-blind Phase||69
1529157|NCT01435759|3743990|P3|COMPLETED|Double-blind Phase||71
1529158|NCT01435759|3743991|P2|COMPLETED|Double-blind Phase||71
1529159|NCT01435759|3743992|P1|COMPLETED|Double-blind Phase||397
1529160|NCT01435759|3743987|P6|STARTED|Double-blind Phase||80
1529161|NCT01435759|3743988|P5|STARTED|Double-blind Phase||78
1529162|NCT01435759|3743989|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
1529163|NCT01435759|3743990|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
1529164|NCT01435759|3743991|P2|STARTED|Double-blind Phase||78
1529165|NCT01435759|3743992|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
1529166|NCT01435759|3743987|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
1529167|NCT01435759|3743988|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
1529168|NCT01435759|3743989|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
1529169|NCT01435759|3743990|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
1529170|NCT01435759|3743991|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
1529171|NCT01435759|3743992|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
1529172|NCT01435759|3743987|P6|COMPLETED|Antidepressant Lead-in Phase||0
1529173|NCT01435759|3743988|P5|COMPLETED|Antidepressant Lead-in Phase||0
1529174|NCT01435759|3743989|P4|COMPLETED|Antidepressant Lead-in Phase||0
1529175|NCT01435759|3743990|P3|COMPLETED|Antidepressant Lead-in Phase||0
1529176|NCT01435759|3743991|P2|COMPLETED|Antidepressant Lead-in Phase||0
1529177|NCT01435759|3743992|P1|COMPLETED|Antidepressant Lead-in Phase||855
1529178|NCT01435759|3743987|P6|STARTED|Antidepressant Lead-in Phase||0
1529179|NCT01435759|3743988|P5|STARTED|Antidepressant Lead-in Phase||0
1529180|NCT01435759|3743989|P4|STARTED|Antidepressant Lead-in Phase||0
1529181|NCT01435759|3743990|P3|STARTED|Antidepressant Lead-in Phase||0
1529182|NCT01435759|3743991|P2|STARTED|Antidepressant Lead-in Phase||0
1529183|NCT01435759|3743992|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
1529184|NCT01435655|3744019|P1|NOT COMPLETED|Overall Study||3
1529185|NCT01435655|3744019|P1|COMPLETED|Overall Study||7
1529186|NCT01435655|3744019|P1|STARTED|Overall Study||10
1529187|NCT01435616|3744033|P2|NOT COMPLETED|Overall Study||80
1529188|NCT01435616|3744034|P1|NOT COMPLETED|Overall Study||171
1529189|NCT01435616|3744033|P2|COMPLETED|Overall Study||455
1529190|NCT01435616|3744034|P1|COMPLETED|Overall Study||832
1529191|NCT01435616|3744033|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
1529192|NCT01435616|3744034|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
1529193|NCT01435616|3744033|P2|STARTED|Overall Study||535
1529194|NCT01435616|3744034|P1|STARTED|Overall Study||1003
1529195|NCT01435603|3744080|P2|NOT COMPLETED|Overall Study||35
1529196|NCT01435603|3744081|P1|NOT COMPLETED|Overall Study||39
1529197|NCT01435603|3744080|P2|COMPLETED|Overall Study||129
1529198|NCT01435603|3744081|P1|COMPLETED|Overall Study||128
1529199|NCT01435603|3744080|P2|STARTED|Overall Study||164
1529200|NCT01435603|3744081|P1|STARTED|Overall Study||167
1529201|NCT01435577|3744089|P2|NOT COMPLETED|Overall Study||52
1529202|NCT01435577|3744090|P1|NOT COMPLETED|Overall Study||17
1529203|NCT01435577|3744089|P2|COMPLETED|Overall Study||13
1529204|NCT01435577|3744090|P1|COMPLETED|Overall Study||47
1529205|NCT01435577|3744089|P2|STARTED|Overall Study||65
1529206|NCT01435577|3744090|P1|STARTED|Overall Study||64
1529207|NCT01435460|3744140|P2|NOT COMPLETED|Overall Study||6
1529208|NCT01435460|3744141|P1|NOT COMPLETED|Overall Study||11
1529209|NCT01435460|3744140|P2|COMPLETED|Overall Study||143
1529210|NCT01435460|3744141|P1|COMPLETED|Overall Study||140
1529211|NCT01435460|3744140|P2|STARTED|Overall Study||149
1529212|NCT01435460|3744141|P1|STARTED|Overall Study||151
1529213|NCT01435382|3744157|P4|NOT COMPLETED|Overall Study||1
1529214|NCT01435382|3744158|P3|NOT COMPLETED|Overall Study||1
1529215|NCT01435382|3744159|P2|NOT COMPLETED|Overall Study||2
1529216|NCT01435382|3744160|P1|NOT COMPLETED|Overall Study||1
1529217|NCT01435382|3744157|P4|COMPLETED|Overall Study||10
1529218|NCT01435382|3744158|P3|COMPLETED|Overall Study||12
1529219|NCT01435382|3744159|P2|COMPLETED|Overall Study||11
1529220|NCT01435382|3744160|P1|COMPLETED|Overall Study||11
1529221|NCT01435382|3744157|P4|STARTED|Overall Study||11
1529222|NCT01435382|3744158|P3|STARTED|Overall Study||13
1529223|NCT01435382|3744159|P2|STARTED|Overall Study||13
1529224|NCT01435382|3744160|P1|STARTED|Overall Study||12
1529225|NCT01435304|3744249|P2|NOT COMPLETED|Overall Study||0
1529226|NCT01435304|3744250|P1|NOT COMPLETED|Overall Study||0
1529227|NCT01435304|3744249|P2|COMPLETED|Overall Study||50
1529228|NCT01435304|3744250|P1|COMPLETED|Overall Study||50
1529229|NCT01435304|3744249|P2|STARTED|Overall Study||50
1529230|NCT01435304|3744250|P1|STARTED|Overall Study||50
1529231|NCT01435265|3744268|P2|NOT COMPLETED|Overall Study||1
1529232|NCT01435265|3744269|P1|NOT COMPLETED|Overall Study||0
1529233|NCT01435265|3744268|P2|COMPLETED|Overall Study||3
1529234|NCT01435265|3744269|P1|COMPLETED|Overall Study||3
1529235|NCT01435265|3744268|P2|STARTED|Overall Study||4
1529236|NCT01435265|3744269|P1|STARTED|Overall Study||3
1529237|NCT01435174|3744279|P1|NOT COMPLETED|Overall Study||9
1529238|NCT01435174|3744279|P1|COMPLETED|Overall Study||8
1529239|NCT01435174|3744279|P1|STARTED|Overall Study||17
1529240|NCT01435122|3744283|P1|NOT COMPLETED|Overall Study||8
1529241|NCT01435122|3744283|P1|COMPLETED|Overall Study||22
1529242|NCT01435122|3744283|P1|STARTED|Overall Study||30
1529243|NCT01435031|3744292|P1|NOT COMPLETED|ITT at 4 Years||7
1529244|NCT01435031|3744292|P1|COMPLETED|ITT at 4 Years||171
1529245|NCT01435031|3744292|P1|STARTED|ITT at 4 Years||178
1529246|NCT01435031|3744292|P1|NOT COMPLETED|ITT at 3 Years||11
1529247|NCT01435031|3744292|P1|COMPLETED|ITT at 3 Years||178
1529248|NCT01435031|3744292|P1|STARTED|ITT at 3 Years||189
1529249|NCT01435031|3744292|P1|NOT COMPLETED|ITT at 2 Years||13
1529250|NCT01435031|3744292|P1|COMPLETED|ITT at 2 Years||189
1529251|NCT01435031|3744292|P1|STARTED|ITT at 2 Years||202
1529252|NCT01435031|3744292|P1|NOT COMPLETED|ITT at 1 Year||9
1529253|NCT01435031|3744292|P1|COMPLETED|ITT at 1 Year||202
1529254|NCT01435031|3744292|P1|STARTED|ITT at 1 Year||211
1529255|NCT01435031|3744292|P1|NOT COMPLETED|ITT at 6 Months||5
1529256|NCT01435031|3744292|P1|COMPLETED|ITT at 6 Months||211
1529257|NCT01435031|3744292|P1|STARTED|ITT at 6 Months||216
1529258|NCT01435031|3744292|P1|NOT COMPLETED|ITT at 1 Month||6
1529259|NCT01435031|3744292|P1|COMPLETED|ITT at 1 Month||216
1529260|NCT01435031|3744292|P1|STARTED|ITT at 1 Month|ITT population|222
1529261|NCT01434823|3744392|P2|NOT COMPLETED|Overall Study||7
1529262|NCT01434823|3744393|P1|NOT COMPLETED|Overall Study||4
1529263|NCT01434823|3744392|P2|COMPLETED|Overall Study||778
1529264|NCT01434823|3744393|P1|COMPLETED|Overall Study||820
1529265|NCT01434823|3744392|P2|STARTED|Overall Study||785
1529266|NCT01434823|3744393|P1|STARTED|Overall Study||824
1529267|NCT01434693|3744413|P4|NOT COMPLETED|Overall Study||1
1529268|NCT01434693|3744414|P3|NOT COMPLETED|Overall Study||1
1529269|NCT01434693|3744415|P2|NOT COMPLETED|Overall Study||0
1529270|NCT01434693|3744416|P1|NOT COMPLETED|Overall Study||3
1529271|NCT01434693|3744413|P4|COMPLETED|Overall Study||8
1529272|NCT01434693|3744414|P3|COMPLETED|Overall Study||8
1529273|NCT01434693|3744415|P2|COMPLETED|Overall Study||9
1529274|NCT01434693|3744416|P1|COMPLETED|Overall Study||6
1529275|NCT01434693|3744413|P4|STARTED|Overall Study||9
1529276|NCT01434693|3744414|P3|STARTED|Overall Study||9
1529277|NCT01434693|3744415|P2|STARTED|Overall Study||9
1529278|NCT01434693|3744416|P1|STARTED|Overall Study||9
1529279|NCT01434680|3744430|P4|NOT COMPLETED|Overall Study||0
1529280|NCT01434680|3744431|P3|NOT COMPLETED|Overall Study||2
1529281|NCT01434680|3744432|P2|NOT COMPLETED|Overall Study||2
1529282|NCT01434680|3744433|P1|NOT COMPLETED|Overall Study||3
1529283|NCT01434680|3744430|P4|COMPLETED|Overall Study||119
1529284|NCT01434680|3744431|P3|COMPLETED|Overall Study||304
1529285|NCT01434680|3744432|P2|COMPLETED|Overall Study||266
1529286|NCT01434680|3744433|P1|COMPLETED|Overall Study||296
1529287|NCT01434680|3744430|P4|STARTED|Overall Study||119
1529288|NCT01434680|3744431|P3|STARTED|Overall Study||306
1529289|NCT01434680|3744432|P2|STARTED|Overall Study||268
1529290|NCT01434680|3744433|P1|STARTED|Overall Study||299
1529291|NCT01434667|3744450|P2|NOT COMPLETED|Overall Study||10
1529292|NCT01434667|3744451|P1|NOT COMPLETED|Overall Study||5
1529293|NCT01434667|3744450|P2|COMPLETED|Overall Study||65
1529294|NCT01434667|3744451|P1|COMPLETED|Overall Study||34
1529295|NCT01434667|3744450|P2|STARTED|Overall Study||75
1529296|NCT01434667|3744451|P1|STARTED|Overall Study||39
1529297|NCT01434654|3744477|P2|NOT COMPLETED|Overall Study||0
1529298|NCT01434654|3744478|P1|NOT COMPLETED|Overall Study||2
1529299|NCT01434654|3744477|P2|COMPLETED|Overall Study||12
1529300|NCT01434654|3744478|P1|COMPLETED|Overall Study||5
1529301|NCT01434654|3744477|P2|STARTED|Overall Study||12
1529302|NCT01434654|3744478|P1|STARTED|Overall Study||7
1529303|NCT01434641|3744490|P1|NOT COMPLETED|Overall Study||0
1529304|NCT01434641|3744490|P1|COMPLETED|Overall Study||102
1529305|NCT01434641|3744490|P1|STARTED|Overall Study||102
1529306|NCT01434511|3744495|P1|NOT COMPLETED|Overall Study||0
1529307|NCT01434511|3744495|P1|COMPLETED|Overall Study||1
1529308|NCT01434511|3744495|P1|STARTED|Overall Study||1
1529309|NCT01434342|3744514|P2|NOT COMPLETED|Overall Study||17
1529310|NCT01434342|3744515|P1|NOT COMPLETED|Overall Study||48
1529311|NCT01434342|3744514|P2|COMPLETED|Overall Study||31
1529312|NCT01434342|3744515|P1|COMPLETED|Overall Study||50
1529313|NCT01434342|3744514|P2|STARTED|Overall Study||48
1529314|NCT01434342|3744515|P1|STARTED|Overall Study||98
1529315|NCT01434290|3744525|P2|NOT COMPLETED|Overall Study||7
1529316|NCT01434290|3744526|P1|NOT COMPLETED|Overall Study||8
1529317|NCT01434290|3744525|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
1529318|NCT01434290|3744526|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
1529319|NCT01434290|3744525|P2|STARTED|Overall Study||128
1529320|NCT01434290|3744526|P1|STARTED|Overall Study||127
1529321|NCT01434186|3744554|P2|NOT COMPLETED|Overall Study||0
1529322|NCT01434186|3744555|P1|NOT COMPLETED|Overall Study||0
1529323|NCT01434186|3744554|P2|COMPLETED|Overall Study||4
1529324|NCT01434186|3744555|P1|COMPLETED|Overall Study||2
1529325|NCT01434186|3744554|P2|STARTED|Overall Study||4
1529326|NCT01434186|3744555|P1|STARTED|Overall Study||2
1529327|NCT01434121|3744564|P3|NOT COMPLETED|Overall Study||0
1529328|NCT01434121|3744565|P2|NOT COMPLETED|Overall Study||0
1529329|NCT01434121|3744566|P1|NOT COMPLETED|Overall Study||0
1529330|NCT01434121|3744564|P3|COMPLETED|Overall Study||8
1529331|NCT01434121|3744565|P2|COMPLETED|Overall Study||8
1529332|NCT01434121|3744566|P1|COMPLETED|Overall Study||8
1529333|NCT01434121|3744564|P3|STARTED|Overall Study||8
1529334|NCT01434121|3744565|P2|STARTED|Overall Study||8
1529335|NCT01434121|3744566|P1|STARTED|Overall Study||8
1529336|NCT01434030|3744592|P1|NOT COMPLETED|Overall Study||1
1529337|NCT01434030|3744592|P1|COMPLETED|Overall Study||56
1529338|NCT01434030|3744592|P1|STARTED|Overall Study||57
1529339|NCT01433978|3744599|P3|NOT COMPLETED|Extension Phase||6
1529340|NCT01433978|3744600|P2|NOT COMPLETED|Extension Phase||0
1529341|NCT01433978|3744601|P1|NOT COMPLETED|Extension Phase||0
1529342|NCT01433978|3744599|P3|COMPLETED|Extension Phase||0
1529343|NCT01433978|3744600|P2|COMPLETED|Extension Phase||0
1529344|NCT01433978|3744601|P1|COMPLETED|Extension Phase||0
1529345|NCT01433978|3744599|P3|STARTED|Extension Phase||6
1529346|NCT01433978|3744600|P2|STARTED|Extension Phase||0
1529347|NCT01433978|3744601|P1|STARTED|Extension Phase||0
1529348|NCT01433978|3744599|P3|NOT COMPLETED|Core Study||0
1529349|NCT01433978|3744600|P2|NOT COMPLETED|Core Study||11
1529350|NCT01433978|3744601|P1|NOT COMPLETED|Core Study||11
1529351|NCT01433978|3744599|P3|COMPLETED|Core Study||0
1529352|NCT01433978|3744600|P2|COMPLETED|Core Study||1
1529353|NCT01433978|3744601|P1|COMPLETED|Core Study||0
1529354|NCT01433978|3744599|P3|STARTED|Core Study||0
1529355|NCT01433978|3744600|P2|STARTED|Core Study||12
1529356|NCT01433978|3744601|P1|STARTED|Core Study||11
1529357|NCT01433913|3744610|P2|NOT COMPLETED|Overall Study||0
1529358|NCT01433913|3744611|P1|NOT COMPLETED|Overall Study||1
1529359|NCT01433913|3744610|P2|COMPLETED|Overall Study||10
1529360|NCT01433913|3744611|P1|COMPLETED|Overall Study||9
1529361|NCT01433913|3744610|P2|STARTED|Overall Study||10
1529362|NCT01433913|3744611|P1|STARTED|Overall Study||10
1529363|NCT01433731|3744647|P4|NOT COMPLETED|Overall Study||0
1529364|NCT01433731|3744648|P3|NOT COMPLETED|Overall Study||0
1529365|NCT01433731|3744649|P2|NOT COMPLETED|Overall Study||0
1529366|NCT01433731|3744650|P1|NOT COMPLETED|Overall Study||0
1529367|NCT01433731|3744647|P4|COMPLETED|Overall Study||5
1529368|NCT01433731|3744648|P3|COMPLETED|Overall Study||5
1529369|NCT01433731|3744649|P2|COMPLETED|Overall Study||5
1529370|NCT01433731|3744650|P1|COMPLETED|Overall Study||3
1529371|NCT01433731|3744647|P4|STARTED|Overall Study||5
1529372|NCT01433731|3744648|P3|STARTED|Overall Study||5
1529373|NCT01433731|3744649|P2|STARTED|Overall Study||5
1529374|NCT01433731|3744650|P1|STARTED|Overall Study||3
1529375|NCT01433549|3744658|P2|NOT COMPLETED|Phase 2: Second Study Product||1
1529376|NCT01433549|3744659|P1|NOT COMPLETED|Phase 2: Second Study Product||0
1529377|NCT01433549|3744658|P2|COMPLETED|Phase 2: Second Study Product||12
1529378|NCT01433549|3744659|P1|COMPLETED|Phase 2: Second Study Product||12
1529379|NCT01433549|3744658|P2|STARTED|Phase 2: Second Study Product||13
1529380|NCT01433549|3744659|P1|STARTED|Phase 2: Second Study Product||12
1529381|NCT01433549|3744658|P2|NOT COMPLETED|Phase 1: First Study Product||0
1529382|NCT01433549|3744659|P1|NOT COMPLETED|Phase 1: First Study Product||0
1529383|NCT01433549|3744658|P2|COMPLETED|Phase 1: First Study Product||13
1529384|NCT01433549|3744659|P1|COMPLETED|Phase 1: First Study Product||12
1529385|NCT01433549|3744658|P2|STARTED|Phase 1: First Study Product||13
1529386|NCT01433549|3744659|P1|STARTED|Phase 1: First Study Product||12
1529387|NCT01433471|3744669|P2|NOT COMPLETED|Overall Study||1
1529388|NCT01433471|3744670|P1|NOT COMPLETED|Overall Study||0
1529389|NCT01433471|3744669|P2|COMPLETED|Overall Study||1
1529390|NCT01433471|3744670|P1|COMPLETED|Overall Study||2
1529391|NCT01433471|3744669|P2|STARTED|Overall Study||2
1529392|NCT01433471|3744670|P1|STARTED|Overall Study||2
1529393|NCT01433354|3744686|P1|NOT COMPLETED|Overall Study||119
1529394|NCT01433354|3744686|P1|COMPLETED|Overall Study||0
1529395|NCT01433354|3744686|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
1529396|NCT01433263|3744702|P2|NOT COMPLETED|Overall Study||12
1529397|NCT01433263|3744703|P1|NOT COMPLETED|Overall Study||19
1529398|NCT01433263|3744702|P2|COMPLETED|Overall Study||16
1529399|NCT01433263|3744703|P1|COMPLETED|Overall Study||10
1529400|NCT01433263|3744702|P2|STARTED|Overall Study||28
1529401|NCT01433263|3744703|P1|STARTED|Overall Study||29
1529402|NCT01433250|3744732|P2|NOT COMPLETED|Overall Study||3
1529403|NCT01433250|3744733|P1|NOT COMPLETED|Overall Study||3
1529404|NCT01433250|3744732|P2|COMPLETED|Overall Study||14
1529405|NCT01433250|3744733|P1|COMPLETED|Overall Study||19
1529406|NCT01433250|3744732|P2|STARTED|Overall Study||17
1529407|NCT01433250|3744733|P1|STARTED|Overall Study||22
1529408|NCT01433172|3744752|P3|NOT COMPLETED|Overall Study||1
1529409|NCT01433172|3744753|P2|NOT COMPLETED|Overall Study||3
1529410|NCT01433172|3744754|P1|NOT COMPLETED|Overall Study||0
1529411|NCT01433172|3744752|P3|COMPLETED|Overall Study||32
1529412|NCT01433172|3744753|P2|COMPLETED|Overall Study||34
1529413|NCT01433172|3744754|P1|COMPLETED|Overall Study||3
1529414|NCT01433172|3744752|P3|STARTED|Overall Study||33
1529415|NCT01433172|3744753|P2|STARTED|Overall Study||37
1529416|NCT01433172|3744754|P1|STARTED|Overall Study||3
1529417|NCT01433159|3744766|P2|NOT COMPLETED|Overall Study||1
1529418|NCT01433159|3744767|P1|NOT COMPLETED|Overall Study||2
1529419|NCT01433159|3744766|P2|COMPLETED|Overall Study||9
1529420|NCT01433159|3744767|P1|COMPLETED|Overall Study||7
1529421|NCT01433159|3744766|P2|STARTED|Overall Study||10
1529422|NCT01433159|3744767|P1|STARTED|Overall Study||9
1529423|NCT01433107|3744775|P2|NOT COMPLETED|Overall Study||17
1529424|NCT01433107|3744776|P1|NOT COMPLETED|Overall Study||27
1529425|NCT01433107|3744775|P2|COMPLETED|Overall Study||128
1529426|NCT01433107|3744776|P1|COMPLETED|Overall Study||118
1529427|NCT01433107|3744775|P2|STARTED|Overall Study||145
1529428|NCT01433107|3744776|P1|STARTED|Overall Study||145
1529429|NCT01433081|3744788|P2|NOT COMPLETED|Overall Study||2
1529430|NCT01433081|3744789|P1|NOT COMPLETED|Overall Study||2
1529431|NCT01433081|3744788|P2|COMPLETED|Overall Study||23
1529432|NCT01433081|3744789|P1|COMPLETED|Overall Study||23
1529433|NCT01433081|3744788|P2|STARTED|Overall Study||25
1529434|NCT01433081|3744789|P1|STARTED|Overall Study||25
1529435|NCT01433055|3744799|P2|NOT COMPLETED|Overall Study||0
1529436|NCT01433055|3744800|P1|NOT COMPLETED|Overall Study||2
1529437|NCT01433055|3744799|P2|COMPLETED|Overall Study||23
1529438|NCT01433055|3744800|P1|COMPLETED|Overall Study||27
1529439|NCT01433055|3744799|P2|STARTED|Overall Study||23
1529440|NCT01433055|3744800|P1|STARTED|Overall Study||29
1529441|NCT01433042|3744814|P1|NOT COMPLETED|Overall Study||1
1529442|NCT01433042|3744814|P1|COMPLETED|Overall Study||224
1529443|NCT01433042|3744814|P1|STARTED|Overall Study||225
1529444|NCT01433016|3744818|P1|NOT COMPLETED|Overall Study||0
1529445|NCT01433016|3744818|P1|COMPLETED|Overall Study||20
1529446|NCT01433016|3744818|P1|STARTED|Overall Study||20
1529447|NCT01432938|3744822|P2|NOT COMPLETED|Second Intervention||0
1529448|NCT01432938|3744823|P1|NOT COMPLETED|Second Intervention||1
1529449|NCT01432938|3744822|P2|COMPLETED|Second Intervention||14
1529450|NCT01432938|3744823|P1|COMPLETED|Second Intervention||11
1529451|NCT01432938|3744822|P2|STARTED|Second Intervention||14
1529452|NCT01432938|3744823|P1|STARTED|Second Intervention||12
1529453|NCT01432938|3744822|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
1529454|NCT01432938|3744823|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
1529455|NCT01432938|3744822|P2|COMPLETED|Washout Period of at Least 24 Days||14
1529456|NCT01432938|3744823|P1|COMPLETED|Washout Period of at Least 24 Days||12
1529457|NCT01432938|3744822|P2|STARTED|Washout Period of at Least 24 Days||14
1529458|NCT01432938|3744823|P1|STARTED|Washout Period of at Least 24 Days||12
1529459|NCT01432938|3744822|P2|NOT COMPLETED|First Intervention||0
1529460|NCT01432938|3744823|P1|NOT COMPLETED|First Intervention||2
1529461|NCT01432938|3744822|P2|COMPLETED|First Intervention||14
1529462|NCT01432938|3744823|P1|COMPLETED|First Intervention||12
1529463|NCT01432938|3744822|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
1529464|NCT01432938|3744823|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
1529465|NCT01432938|3744822|P2|STARTED|First Intervention||14
1529466|NCT01432938|3744823|P1|STARTED|First Intervention||14
1529467|NCT01432886|3744840|P2|NOT COMPLETED|Overall Study||0
1529468|NCT01432886|3744841|P1|NOT COMPLETED|Overall Study||0
1529469|NCT01432886|3744840|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
1529470|NCT01432886|3744841|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
1529471|NCT01432886|3744840|P2|STARTED|Overall Study||6
1529472|NCT01432886|3744841|P1|STARTED|Overall Study||6
1529473|NCT01432756|3744853|P4|NOT COMPLETED|Overall Study||1
1529474|NCT01432756|3744854|P3|NOT COMPLETED|Overall Study||2
1529475|NCT01432756|3744855|P2|NOT COMPLETED|Overall Study||0
1529476|NCT01432756|3744856|P1|NOT COMPLETED|Overall Study||1
1529477|NCT01432756|3744853|P4|COMPLETED|Overall Study||33
1529478|NCT01432756|3744854|P3|COMPLETED|Overall Study||30
1529479|NCT01432756|3744855|P2|COMPLETED|Overall Study||34
1529480|NCT01432756|3744856|P1|COMPLETED|Overall Study||31
1529481|NCT01432756|3744853|P4|STARTED|Overall Study||34
1529482|NCT01432756|3744854|P3|STARTED|Overall Study||32
1529483|NCT01432756|3744855|P2|STARTED|Overall Study||34
1529484|NCT01432756|3744856|P1|STARTED|Overall Study||32
1529485|NCT01432626|3744864|P1|NOT COMPLETED|Overall Study||7
1529486|NCT01432626|3744864|P1|COMPLETED|Overall Study|Completed both images|3
1529487|NCT01432626|3744864|P1|STARTED|Overall Study||10
1529488|NCT01432600|3744871|P3|NOT COMPLETED|Overall Study||1
1529489|NCT01432600|3744872|P2|NOT COMPLETED|Overall Study||1
1529490|NCT01432600|3744873|P1|NOT COMPLETED|Overall Study||0
1529491|NCT01432600|3744871|P3|COMPLETED|Overall Study||33
1529492|NCT01432600|3744872|P2|COMPLETED|Overall Study||35
1529493|NCT01432600|3744873|P1|COMPLETED|Overall Study||10
1529494|NCT01432600|3744871|P3|STARTED|Overall Study||34
1529495|NCT01432600|3744872|P2|STARTED|Overall Study||36
1529496|NCT01432600|3744873|P1|STARTED|Overall Study||10
1529497|NCT01432574|3744889|P1|NOT COMPLETED|Overall Study||3
1529498|NCT01432574|3744889|P1|COMPLETED|Overall Study||147
1529499|NCT01432574|3744889|P1|STARTED|Overall Study||150
1529500|NCT01432561|3744895|P1|NOT COMPLETED|Overall Study||0
1529501|NCT01432561|3744895|P1|COMPLETED|Overall Study||8
1529502|NCT01432561|3744895|P1|STARTED|Overall Study||8
1529503|NCT01432535|3744904|P3|NOT COMPLETED|Overall Study||0
1529504|NCT01432535|3744905|P2|NOT COMPLETED|Overall Study||0
1529505|NCT01432535|3744906|P1|NOT COMPLETED|Overall Study||0
1529506|NCT01432535|3744904|P3|COMPLETED|Overall Study||6
1529507|NCT01432535|3744905|P2|COMPLETED|Overall Study||7
1529508|NCT01432535|3744906|P1|COMPLETED|Overall Study||12
1529509|NCT01432535|3744904|P3|STARTED|Overall Study||6
1529510|NCT01432535|3744905|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
1529511|NCT01432535|3744906|P1|STARTED|Overall Study||12
1529512|NCT01432457|3744935|P3|NOT COMPLETED|Overall Study||59
1529513|NCT01432457|3744936|P2|NOT COMPLETED|Overall Study||48
1529514|NCT01432457|3744937|P1|NOT COMPLETED|Overall Study||37
1529515|NCT01432457|3744935|P3|COMPLETED|Overall Study||253
1529516|NCT01432457|3744936|P2|COMPLETED|Overall Study||258
1529517|NCT01432457|3744937|P1|COMPLETED|Overall Study||269
1529518|NCT01432457|3744935|P3|STARTED|Overall Study||312
1529519|NCT01432457|3744936|P2|STARTED|Overall Study||306
1529520|NCT01432457|3744937|P1|STARTED|Overall Study||306
1529521|NCT01432444|3744966|P3|NOT COMPLETED|Extension Phase||192
1529522|NCT01432444|3744967|P2|NOT COMPLETED|Extension Phase||0
1529523|NCT01432444|3744968|P1|NOT COMPLETED|Extension Phase||0
1529524|NCT01432444|3744966|P3|COMPLETED|Extension Phase||0
1529525|NCT01432444|3744967|P2|COMPLETED|Extension Phase||0
1529526|NCT01432444|3744968|P1|COMPLETED|Extension Phase||0
1529527|NCT01432444|3744966|P3|STARTED|Extension Phase||192
1529528|NCT01432444|3744967|P2|STARTED|Extension Phase||0
1529529|NCT01432444|3744968|P1|STARTED|Extension Phase||0
1529530|NCT01432444|3744966|P3|NOT COMPLETED|Treatment Phase||0
1529531|NCT01432444|3744967|P2|NOT COMPLETED|Treatment Phase||140
1529532|NCT01432444|3744968|P1|NOT COMPLETED|Treatment Phase||0
1529533|NCT01432444|3744966|P3|COMPLETED|Treatment Phase||0
1529534|NCT01432444|3744967|P2|COMPLETED|Treatment Phase||293
1529535|NCT01432444|3744968|P1|COMPLETED|Treatment Phase||0
1529536|NCT01432444|3744966|P3|STARTED|Treatment Phase||0
1529537|NCT01432444|3744967|P2|STARTED|Treatment Phase||433
1529538|NCT01432444|3744968|P1|STARTED|Treatment Phase||0
1529539|NCT01432444|3744966|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
1529540|NCT01432444|3744967|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
1529541|NCT01432444|3744968|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
1529542|NCT01432444|3744966|P3|COMPLETED|Tolerability/Cross-titration Phase||0
1529543|NCT01432444|3744967|P2|COMPLETED|Tolerability/Cross-titration Phase||0
1529544|NCT01432444|3744968|P1|COMPLETED|Tolerability/Cross-titration Phase||265
1529545|NCT01432444|3744966|P3|STARTED|Tolerability/Cross-titration Phase||0
1529546|NCT01432444|3744967|P2|STARTED|Tolerability/Cross-titration Phase||0
1529547|NCT01432444|3744968|P1|STARTED|Tolerability/Cross-titration Phase||325
1529548|NCT01432405|3744980|P2|NOT COMPLETED|Overall Study||2
1529549|NCT01432405|3744981|P1|NOT COMPLETED|Overall Study||1
1529550|NCT01432405|3744980|P2|COMPLETED|Overall Study||10
1529551|NCT01432405|3744981|P1|COMPLETED|Overall Study||11
1529552|NCT01432405|3744980|P2|STARTED|Overall Study||12
1529553|NCT01432405|3744981|P1|STARTED|Overall Study||12
1529554|NCT01432379|3744989|P1|NOT COMPLETED|Overall Study||385
1529555|NCT01432379|3744989|P1|COMPLETED|Overall Study||783
1529556|NCT01432379|3744989|P1|STARTED|Overall Study||1168
1529557|NCT01432366|3744994|P1|NOT COMPLETED|Overall Study||68
1529558|NCT01432366|3744994|P1|COMPLETED|Overall Study||392
1529559|NCT01432366|3744994|P1|STARTED|Overall Study||460
1529560|NCT01432327|3745016|P4|NOT COMPLETED|Posttest 1 Year||23
1529561|NCT01432327|3745017|P3|NOT COMPLETED|Posttest 1 Year||20
1529562|NCT01432327|3745018|P2|NOT COMPLETED|Posttest 1 Year||28
1529563|NCT01432327|3745019|P1|NOT COMPLETED|Posttest 1 Year||24
1529564|NCT01432327|3745016|P4|COMPLETED|Posttest 1 Year||31
1529565|NCT01432327|3745017|P3|COMPLETED|Posttest 1 Year||30
1529566|NCT01432327|3745018|P2|COMPLETED|Posttest 1 Year||27
1529567|NCT01432327|3745019|P1|COMPLETED|Posttest 1 Year||28
1529568|NCT01432327|3745016|P4|STARTED|Posttest 1 Year||54
1529569|NCT01432327|3745017|P3|STARTED|Posttest 1 Year||50
1529570|NCT01432327|3745018|P2|STARTED|Posttest 1 Year||55
1529571|NCT01432327|3745019|P1|STARTED|Posttest 1 Year||52
1529572|NCT01432327|3745016|P4|NOT COMPLETED|Posttest 6 Months||2
1529573|NCT01432327|3745017|P3|NOT COMPLETED|Posttest 6 Months||5
1529574|NCT01432327|3745018|P2|NOT COMPLETED|Posttest 6 Months||0
1529575|NCT01432327|3745019|P1|NOT COMPLETED|Posttest 6 Months||0
1529576|NCT01432327|3745016|P4|COMPLETED|Posttest 6 Months||54
1529577|NCT01432327|3745017|P3|COMPLETED|Posttest 6 Months||50
1529578|NCT01432327|3745018|P2|COMPLETED|Posttest 6 Months||55
1529579|NCT01432327|3745019|P1|COMPLETED|Posttest 6 Months||52
1529580|NCT01432327|3745016|P4|STARTED|Posttest 6 Months||56
1529581|NCT01432327|3745017|P3|STARTED|Posttest 6 Months||55
1529582|NCT01432327|3745018|P2|STARTED|Posttest 6 Months||55
1529583|NCT01432327|3745019|P1|STARTED|Posttest 6 Months||52
1529584|NCT01432327|3745016|P4|NOT COMPLETED|Posttest 3 Months||1
1529585|NCT01432327|3745017|P3|NOT COMPLETED|Posttest 3 Months||2
1529586|NCT01432327|3745018|P2|NOT COMPLETED|Posttest 3 Months||2
1529587|NCT01432327|3745019|P1|NOT COMPLETED|Posttest 3 Months||4
1529588|NCT01432327|3745016|P4|COMPLETED|Posttest 3 Months||56
1529589|NCT01432327|3745017|P3|COMPLETED|Posttest 3 Months||55
1529590|NCT01432327|3745018|P2|COMPLETED|Posttest 3 Months||55
1529591|NCT01432327|3745019|P1|COMPLETED|Posttest 3 Months||52
1529592|NCT01432327|3745016|P4|STARTED|Posttest 3 Months||57
1529593|NCT01432327|3745017|P3|STARTED|Posttest 3 Months||57
1529594|NCT01432327|3745018|P2|STARTED|Posttest 3 Months||57
1529595|NCT01432327|3745019|P1|STARTED|Posttest 3 Months||56
1529596|NCT01432327|3745016|P4|NOT COMPLETED|Baseline||0
1529597|NCT01432327|3745017|P3|NOT COMPLETED|Baseline||0
1529598|NCT01432327|3745018|P2|NOT COMPLETED|Baseline||0
1529599|NCT01432327|3745019|P1|NOT COMPLETED|Baseline||0
1529600|NCT01432327|3745016|P4|COMPLETED|Baseline||57
1529601|NCT01432327|3745017|P3|COMPLETED|Baseline||57
1529602|NCT01432327|3745018|P2|COMPLETED|Baseline||57
1529603|NCT01432327|3745019|P1|COMPLETED|Baseline||56
1529604|NCT01432327|3745016|P4|STARTED|Baseline||57
1529605|NCT01432327|3745017|P3|STARTED|Baseline||57
1529606|NCT01432327|3745018|P2|STARTED|Baseline||57
1529607|NCT01432327|3745019|P1|STARTED|Baseline||56
1529608|NCT01432275|3745029|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
1529609|NCT01432275|3745030|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
1529610|NCT01432275|3745029|P2|COMPLETED|ADC With Calculator (10 Days)||79
1529611|NCT01432275|3745030|P1|COMPLETED|ADC With Calculator (10 Days)||85
1529612|NCT01432275|3745029|P2|STARTED|ADC With Calculator (10 Days)||81
1529613|NCT01432275|3745030|P1|STARTED|ADC With Calculator (10 Days)||88
1529614|NCT01432275|3745029|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
1529615|NCT01432275|3745030|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
1529616|NCT01432275|3745029|P2|COMPLETED|Second BG Meter System (7 Days)||81
1529617|NCT01432275|3745030|P1|COMPLETED|Second BG Meter System (7 Days)||88
1529618|NCT01432275|3745029|P2|STARTED|Second BG Meter System (7 Days)||84
1529619|NCT01432275|3745030|P1|STARTED|Second BG Meter System (7 Days)||90
1529620|NCT01432275|3745029|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
1529621|NCT01432275|3745030|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
1529622|NCT01432275|3745029|P2|COMPLETED|First BG Meter System (7 Days)||84
1529623|NCT01432275|3745030|P1|COMPLETED|First BG Meter System (7 Days)||90
1529624|NCT01432275|3745029|P2|STARTED|First BG Meter System (7 Days)||87
1529625|NCT01432275|3745030|P1|STARTED|First BG Meter System (7 Days)||90
1529626|NCT01432262|3745039|P2|NOT COMPLETED|Overall Study||1
1529627|NCT01432262|3745040|P1|NOT COMPLETED|Overall Study||2
1529628|NCT01432262|3745039|P2|COMPLETED|Overall Study||161
1529629|NCT01432262|3745040|P1|COMPLETED|Overall Study||160
1529630|NCT01432262|3745039|P2|Vaccinated|Overall Study||161
1529631|NCT01432262|3745040|P1|Vaccinated|Overall Study||162
1529632|NCT01432262|3745039|P2|STARTED|Overall Study||162
1529633|NCT01432262|3745040|P1|STARTED|Overall Study||162
1529634|NCT01432236|3745058|P2|NOT COMPLETED|Overall Study||18
1529635|NCT01432236|3745059|P1|NOT COMPLETED|Overall Study||26
1529636|NCT01432236|3745058|P2|COMPLETED|Overall Study||79
1529637|NCT01432236|3745059|P1|COMPLETED|Overall Study||70
1529638|NCT01432236|3745058|P2|STARTED|Overall Study||97
1529639|NCT01432236|3745059|P1|STARTED|Overall Study||96
1529640|NCT01432171|3745106|P2|NOT COMPLETED|Overall Study||11
1529641|NCT01432171|3745107|P1|NOT COMPLETED|Overall Study||14
1529642|NCT01432171|3745106|P2|COMPLETED|Overall Study||8
1529643|NCT01432171|3745107|P1|COMPLETED|Overall Study||4
1529644|NCT01432171|3745106|P2|STARTED|Overall Study||19
1529645|NCT01432171|3745107|P1|STARTED|Overall Study||18
1529646|NCT01432015|3745115|P2|NOT COMPLETED|Overall Study||0
1529647|NCT01432015|3745116|P1|NOT COMPLETED|Overall Study||0
1529648|NCT01432015|3745115|P2|COMPLETED|Overall Study||10
1529649|NCT01432015|3745116|P1|COMPLETED|Overall Study||10
1529650|NCT01432015|3745115|P2|STARTED|Overall Study||10
1529651|NCT01432015|3745116|P1|STARTED|Overall Study||10
1529652|NCT01431989|3745124|P2|NOT COMPLETED|Period 2||0
1529653|NCT01431989|3745125|P1|NOT COMPLETED|Period 2||0
1529654|NCT01431989|3745124|P2|COMPLETED|Period 2||14
1529655|NCT01431989|3745125|P1|COMPLETED|Period 2||14
1529656|NCT01431989|3745124|P2|STARTED|Period 2||14
1529657|NCT01431989|3745125|P1|STARTED|Period 2||14
1529658|NCT01431989|3745124|P2|NOT COMPLETED|14-Day Washout Period||0
1529659|NCT01431989|3745125|P1|NOT COMPLETED|14-Day Washout Period||0
1529660|NCT01431989|3745124|P2|COMPLETED|14-Day Washout Period||14
1529661|NCT01431989|3745125|P1|COMPLETED|14-Day Washout Period||14
1529662|NCT01431989|3745124|P2|STARTED|14-Day Washout Period||14
1529663|NCT01431989|3745125|P1|STARTED|14-Day Washout Period||14
1529664|NCT01431989|3745124|P2|NOT COMPLETED|Period 1||0
1529665|NCT01431989|3745125|P1|NOT COMPLETED|Period 1||0
1529666|NCT01431989|3745124|P2|COMPLETED|Period 1||14
1529667|NCT01431989|3745125|P1|COMPLETED|Period 1||14
1529668|NCT01431989|3745124|P2|STARTED|Period 1||14
1529669|NCT01431989|3745125|P1|STARTED|Period 1||14
1529670|NCT01431976|3745143|P1|NOT COMPLETED|Overall Study||14
1529671|NCT01431976|3745143|P1|COMPLETED|Overall Study||6
1529672|NCT01431976|3745143|P1|STARTED|Overall Study||20
1529673|NCT01431963|3745154|P1|NOT COMPLETED|Overall Study||35
1529674|NCT01431963|3745154|P1|COMPLETED|Overall Study||32
1529675|NCT01431963|3745154|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
1529676|NCT01431963|3745154|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
1529677|NCT01431963|3745154|P1|Complete MP (24 Weeks)|Overall Study||42
1529678|NCT01431963|3745154|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
1529679|NCT01431963|3745154|P1|Complete EP (6 Weeks)|Overall Study||52
1529680|NCT01431963|3745154|P1|Received Treatment|Overall Study||65
1529681|NCT01431963|3745154|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
1529682|NCT01431963|3745154|P1|STARTED|Overall Study||67
1529683|NCT01431950|3745162|P2|NOT COMPLETED|Overall Study||15
1529684|NCT01431950|3745163|P1|NOT COMPLETED|Overall Study||19
1529685|NCT01431950|3745162|P2|COMPLETED|Overall Study||104
1529686|NCT01431950|3745163|P1|COMPLETED|Overall Study||100
1529687|NCT01431950|3745162|P2|STARTED|Overall Study||119
1529688|NCT01431950|3745163|P1|STARTED|Overall Study||119
1529689|NCT01431846|3745180|P3|NOT COMPLETED|Overall Study||0
1529690|NCT01431846|3745181|P2|NOT COMPLETED|Overall Study||0
1529691|NCT01431846|3745182|P1|NOT COMPLETED|Overall Study||0
1529692|NCT01431846|3745180|P3|COMPLETED|Overall Study||8
1529693|NCT01431846|3745181|P2|COMPLETED|Overall Study||3
1529694|NCT01431846|3745182|P1|COMPLETED|Overall Study||8
1529695|NCT01431846|3745180|P3|STARTED|Overall Study||8
1529696|NCT01431846|3745181|P2|STARTED|Overall Study||3
1529697|NCT01431846|3745182|P1|STARTED|Overall Study||8
1529698|NCT01431755|3745190|P1|NOT COMPLETED|Overall Study||5
1529699|NCT01431755|3745190|P1|COMPLETED|Overall Study||49
1529700|NCT01431755|3745190|P1|STARTED|Overall Study||54
1529701|NCT01431716|3745201|P1|NOT COMPLETED|Overall Study||1
1529702|NCT01431716|3745201|P1|COMPLETED|Overall Study||41
1529703|NCT01431716|3745201|P1|STARTED|Overall Study||42
1529704|NCT01431703|3745218|P1|NOT COMPLETED|Overall Study||0
1529705|NCT01431703|3745218|P1|COMPLETED|Overall Study||326
1529706|NCT01431703|3745218|P1|STARTED|Overall Study||326
1529707|NCT01431521|3745226|P4|NOT COMPLETED|Overall Study||0
1529708|NCT01431521|3745227|P3|NOT COMPLETED|Overall Study||1
1529709|NCT01431521|3745228|P2|NOT COMPLETED|Overall Study||0
1529710|NCT01431521|3745229|P1|NOT COMPLETED|Overall Study||0
1529711|NCT01431521|3745226|P4|COMPLETED|Overall Study||5
1529712|NCT01431521|3745227|P3|COMPLETED|Overall Study||10
1529713|NCT01431521|3745228|P2|COMPLETED|Overall Study||5
1529714|NCT01431521|3745229|P1|COMPLETED|Overall Study||10
1529715|NCT01431521|3745226|P4|Treated|Overall Study||5
1529716|NCT01431521|3745227|P3|Treated|Overall Study||10
1529717|NCT01431521|3745228|P2|Treated|Overall Study||5
1529718|NCT01431521|3745229|P1|Treated|Overall Study||10
1529719|NCT01431521|3745226|P4|STARTED|Overall Study||5
1529720|NCT01431521|3745227|P3|STARTED|Overall Study||11
1529721|NCT01431521|3745228|P2|STARTED|Overall Study||5
1529722|NCT01431521|3745229|P1|STARTED|Overall Study||10
1529723|NCT01431508|3745250|P1|NOT COMPLETED|Overall Study||2
1529724|NCT01431508|3745250|P1|COMPLETED|Overall Study||13
1529725|NCT01431508|3745250|P1|STARTED|Overall Study||15
1529726|NCT01431391|3745256|P2|NOT COMPLETED|Overall Study||4
1529727|NCT01431391|3745257|P1|NOT COMPLETED|Overall Study||8
1529728|NCT01431391|3745256|P2|COMPLETED|Overall Study||30
1529729|NCT01431391|3745257|P1|COMPLETED|Overall Study||26
1529730|NCT01431391|3745256|P2|Received ≥1 Leaukapheresis|Overall Study||34
1529731|NCT01431391|3745257|P1|Received ≥1 Leaukapheresis|Overall Study||34
1529732|NCT01431391|3745256|P2|STARTED|Overall Study||34
1529733|NCT01431391|3745257|P1|STARTED|Overall Study||34
1529734|NCT01431339|3745267|P2|NOT COMPLETED|Overall Study||35
1529735|NCT01431339|3745268|P1|NOT COMPLETED|Overall Study||39
1529736|NCT01431339|3745267|P2|COMPLETED|Overall Study||333
1529737|NCT01431339|3745268|P1|COMPLETED|Overall Study||332
1529738|NCT01431339|3745267|P2|Safety Population|Overall Study||367
1529739|NCT01431339|3745268|P1|Safety Population|Overall Study||368
1529740|NCT01431339|3745267|P2|STARTED|Overall Study||368
1529741|NCT01431339|3745268|P1|STARTED|Overall Study||371
1529742|NCT01431300|3745283|P3|NOT COMPLETED|Overall Study||0
1529743|NCT01431300|3745284|P2|NOT COMPLETED|Overall Study||0
1529744|NCT01431300|3745285|P1|NOT COMPLETED|Overall Study||1
1529745|NCT01431300|3745283|P3|COMPLETED|Overall Study||10
1529746|NCT01431300|3745284|P2|COMPLETED|Overall Study||10
1529747|NCT01431300|3745285|P1|COMPLETED|Overall Study||10
1529748|NCT01431300|3745283|P3|STARTED|Overall Study||10
1529749|NCT01431300|3745284|P2|STARTED|Overall Study||10
1529750|NCT01431300|3745285|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
1529751|NCT01431287|3745301|P5|NOT COMPLETED|Overall Study||77
1529752|NCT01431287|3745302|P4|NOT COMPLETED|Overall Study||63
1529753|NCT01431287|3745303|P3|NOT COMPLETED|Overall Study||97
1529754|NCT01431287|3745304|P2|NOT COMPLETED|Overall Study||98
1529755|NCT01431287|3745305|P1|NOT COMPLETED|Overall Study||98
1529756|NCT01431287|3745301|P5|COMPLETED|Overall Study||430
1529757|NCT01431287|3745302|P4|COMPLETED|Overall Study||445
1529758|NCT01431287|3745303|P3|COMPLETED|Overall Study||410
1529759|NCT01431287|3745304|P2|COMPLETED|Overall Study||409
1529760|NCT01431287|3745305|P1|COMPLETED|Overall Study||412
1529761|NCT01431287|3745301|P5|STARTED|Overall Study||507
1529762|NCT01431287|3745302|P4|STARTED|Overall Study||508
1529763|NCT01431287|3745303|P3|STARTED|Overall Study||507
1529764|NCT01431287|3745304|P2|STARTED|Overall Study||507
1529765|NCT01431287|3745305|P1|STARTED|Overall Study|started are actually the randomized|510
1529766|NCT01431274|3745467|P5|NOT COMPLETED|Overall Study||56
1529767|NCT01431274|3745468|P4|NOT COMPLETED|Overall Study||60
1529768|NCT01431274|3745469|P3|NOT COMPLETED|Overall Study||72
1529769|NCT01431274|3745470|P2|NOT COMPLETED|Overall Study||77
1529770|NCT01431274|3745471|P1|NOT COMPLETED|Overall Study||97
1529771|NCT01431274|3745467|P5|COMPLETED|Overall Study||466
1529772|NCT01431274|3745468|P4|COMPLETED|Overall Study||462
1529773|NCT01431274|3745469|P3|COMPLETED|Overall Study||455
1529774|NCT01431274|3745470|P2|COMPLETED|Overall Study||448
1529775|NCT01431274|3745471|P1|COMPLETED|Overall Study||431
1529776|NCT01431274|3745467|P5|STARTED|Overall Study||522
1529777|NCT01431274|3745468|P4|STARTED|Overall Study||522
1529778|NCT01431274|3745469|P3|STARTED|Overall Study||527
1529779|NCT01431274|3745470|P2|STARTED|Overall Study||525
1529780|NCT01431274|3745471|P1|STARTED|Overall Study||528
1529781|NCT01431170|3745630|P2|NOT COMPLETED|Overall Study||1
1529782|NCT01431170|3745631|P1|NOT COMPLETED|Overall Study||3
1529783|NCT01431170|3745630|P2|COMPLETED|Overall Study||11
1529784|NCT01431170|3745631|P1|COMPLETED|Overall Study||9
1529785|NCT01431170|3745630|P2|STARTED|Overall Study||12
1529786|NCT01431170|3745631|P1|STARTED|Overall Study||12
1529787|NCT01431144|3745649|P2|NOT COMPLETED|Overall Study||0
1529788|NCT01431144|3745650|P1|NOT COMPLETED|Overall Study||2
1529789|NCT01431144|3745649|P2|COMPLETED|Overall Study||14
1529790|NCT01431144|3745650|P1|COMPLETED|Overall Study||11
1529791|NCT01431144|3745649|P2|STARTED|Overall Study||14
1529792|NCT01431144|3745650|P1|STARTED|Overall Study||13
1529793|NCT01431131|3745658|P2|NOT COMPLETED|Overall Study||0
1529794|NCT01431131|3745659|P1|NOT COMPLETED|Overall Study||0
1529795|NCT01431131|3745658|P2|COMPLETED|Overall Study||12
1529796|NCT01431131|3745659|P1|COMPLETED|Overall Study||12
1529797|NCT01431131|3745658|P2|STARTED|Overall Study||12
1529798|NCT01431131|3745659|P1|STARTED|Overall Study||12
1529799|NCT01431079|3745669|P2|NOT COMPLETED|Overall Study||39
1529800|NCT01431079|3745670|P1|NOT COMPLETED|Overall Study||35
1529801|NCT01431079|3745669|P2|COMPLETED|Overall Study||6
1529802|NCT01431079|3745670|P1|COMPLETED|Overall Study||10
1529803|NCT01431079|3745669|P2|Post-test|Overall Study||45
1529804|NCT01431079|3745670|P1|Post-test|Overall Study||45
1529805|NCT01431079|3745669|P2|STARTED|Overall Study||45
1529806|NCT01431079|3745670|P1|STARTED|Overall Study||45
1529807|NCT01431014|3745724|P2|NOT COMPLETED|Overall Study||9
1529808|NCT01431014|3745725|P1|NOT COMPLETED|Overall Study||3
1529809|NCT01431014|3745724|P2|COMPLETED|Overall Study||25
1529810|NCT01431014|3745725|P1|COMPLETED|Overall Study||31
1529811|NCT01431014|3745724|P2|STARTED|Overall Study||34
1529812|NCT01431014|3745725|P1|STARTED|Overall Study||34
1529813|NCT01430819|3745733|P2|NOT COMPLETED|Overall Study||0
1529814|NCT01430819|3745734|P1|NOT COMPLETED|Overall Study||0
1529815|NCT01430819|3745733|P2|COMPLETED|Overall Study||150
1529816|NCT01430819|3745734|P1|COMPLETED|Overall Study||150
1529817|NCT01430819|3745733|P2|STARTED|Overall Study||150
1529818|NCT01430819|3745734|P1|STARTED|Overall Study||150
1529819|NCT01430754|3745749|P2|NOT COMPLETED|Randomized Phase||0
1529820|NCT01430754|3745750|P1|NOT COMPLETED|Randomized Phase||0
1529821|NCT01430754|3745749|P2|COMPLETED|Randomized Phase||10
1529822|NCT01430754|3745750|P1|COMPLETED|Randomized Phase||10
1529823|NCT01430754|3745749|P2|STARTED|Randomized Phase||10
1529824|NCT01430754|3745750|P1|STARTED|Randomized Phase||10
1529825|NCT01430754|3745749|P2|NOT COMPLETED|Run-In Phase||0
1529826|NCT01430754|3745750|P1|NOT COMPLETED|Run-In Phase||37
1529827|NCT01430754|3745749|P2|COMPLETED|Run-In Phase||0
1529828|NCT01430754|3745750|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
1529829|NCT01430754|3745749|P2|Entrained - After Run-In Phase|Run-In Phase||0
1529830|NCT01430754|3745750|P1|Entrained - After Run-In Phase|Run-In Phase||24
1529831|NCT01430754|3745749|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
1529832|NCT01430754|3745750|P1|STARTED|Run-In Phase||57
1529833|NCT01430741|3745772|P4|NOT COMPLETED|Overall Study||0
1529834|NCT01430741|3745773|P3|NOT COMPLETED|Overall Study||10
1529835|NCT01430741|3745774|P2|NOT COMPLETED|Overall Study||0
1529836|NCT01430741|3745775|P1|NOT COMPLETED|Overall Study||0
1529837|NCT01430741|3745772|P4|COMPLETED|Overall Study||81
1529838|NCT01430741|3745773|P3|COMPLETED|Overall Study||37
1529839|NCT01430741|3745774|P2|COMPLETED|Overall Study||87
1529840|NCT01430741|3745775|P1|COMPLETED|Overall Study||22
1529841|NCT01430741|3745772|P4|STARTED|Overall Study||81
1529842|NCT01430741|3745773|P3|STARTED|Overall Study||47
1529843|NCT01430741|3745774|P2|STARTED|Overall Study||87
1529844|NCT01430741|3745775|P1|STARTED|Overall Study||22
1529845|NCT01430624|3745808|P3|NOT COMPLETED|Overall Study||29
1529846|NCT01430624|3745809|P2|NOT COMPLETED|Overall Study||34
1529847|NCT01430624|3745810|P1|NOT COMPLETED|Overall Study||28
1529848|NCT01430624|3745808|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
1529849|NCT01430624|3745809|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
1529850|NCT01430624|3745810|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
1529851|NCT01430624|3745808|P3|Eligible Baseline Completes|Overall Study||79
1529852|NCT01430624|3745809|P2|Eligible Baseline Completes|Overall Study||77
1529853|NCT01430624|3745810|P1|Eligible Baseline Completes|Overall Study||77
1529854|NCT01430624|3745808|P3|STARTED|Overall Study||81
1529855|NCT01430624|3745809|P2|STARTED|Overall Study||82
1529856|NCT01430624|3745810|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
1529857|NCT01430611|3745841|P2|NOT COMPLETED|Overall Study||15
1529858|NCT01430611|3745842|P1|NOT COMPLETED|Overall Study||17
1529859|NCT01430611|3745841|P2|COMPLETED|Overall Study||318
1529860|NCT01430611|3745842|P1|COMPLETED|Overall Study||315
1529861|NCT01430611|3745841|P2|STARTED|Overall Study||333
1529862|NCT01430611|3745842|P1|STARTED|Overall Study||332
1529863|NCT01430585|3745860|P1|NOT COMPLETED|Overall Study||14
1529864|NCT01430585|3745860|P1|COMPLETED|Overall Study||0
1529865|NCT01430585|3745860|P1|STARTED|Overall Study||14
1529866|NCT01430468|3745895|P2|NOT COMPLETED|Overall Study||2
1529867|NCT01430468|3745896|P1|NOT COMPLETED|Overall Study||3
1529868|NCT01430468|3745895|P2|COMPLETED|Overall Study||16
1529869|NCT01430468|3745896|P1|COMPLETED|Overall Study||15
1529870|NCT01430468|3745895|P2|STARTED|Overall Study||18
1529871|NCT01430468|3745896|P1|STARTED|Overall Study||18
1529872|NCT01430455|3745902|P1|NOT COMPLETED|Overall Study||2
1529873|NCT01430455|3745902|P1|COMPLETED|Overall Study||5
1529874|NCT01430455|3745902|P1|STARTED|Overall Study||7
1529875|NCT01430403|3745909|P3|NOT COMPLETED|Overall Study||8
1529876|NCT01430403|3745910|P2|NOT COMPLETED|Overall Study||9
1529877|NCT01430403|3745911|P1|NOT COMPLETED|Overall Study||17
1529878|NCT01430403|3745909|P3|COMPLETED|Overall Study||81
1529879|NCT01430403|3745910|P2|COMPLETED|Overall Study||121
1529880|NCT01430403|3745911|P1|COMPLETED|Overall Study||242
1529881|NCT01430403|3745909|P3|STARTED|Overall Study|Intent-to-treat|89
1529882|NCT01430403|3745910|P2|STARTED|Overall Study|Intent-to-treat|130
1529883|NCT01430403|3745911|P1|STARTED|Overall Study|Intent-to-treat|259
1529884|NCT01430325|3745964|P4|NOT COMPLETED|Overall Study||0
1529885|NCT01430325|3745965|P3|NOT COMPLETED|Overall Study||0
1529886|NCT01430325|3745966|P2|NOT COMPLETED|Overall Study||0
1529887|NCT01430325|3745967|P1|NOT COMPLETED|Overall Study||0
1529888|NCT01430325|3745964|P4|COMPLETED|Overall Study||12
1529889|NCT01430325|3745965|P3|COMPLETED|Overall Study||8
1529890|NCT01430325|3745966|P2|COMPLETED|Overall Study||12
1529891|NCT01430325|3745967|P1|COMPLETED|Overall Study||10
1529892|NCT01430325|3745964|P4|STARTED|Overall Study||12
1529893|NCT01430325|3745965|P3|STARTED|Overall Study||8
1529894|NCT01430325|3745966|P2|STARTED|Overall Study||12
1529895|NCT01430325|3745967|P1|STARTED|Overall Study||10
1529896|NCT01430299|3745987|P2|NOT COMPLETED|Overall Study||2
1529897|NCT01430299|3745988|P1|NOT COMPLETED|Overall Study||4
1529898|NCT01430299|3745987|P2|COMPLETED|Overall Study||21
1529899|NCT01430299|3745988|P1|COMPLETED|Overall Study||16
1529900|NCT01430299|3745987|P2|STARTED|Overall Study||23
1529901|NCT01430299|3745988|P1|STARTED|Overall Study||20
1529902|NCT01430182|3745996|P2|NOT COMPLETED|Overall Study||0
1529903|NCT01430182|3745997|P1|NOT COMPLETED|Overall Study||0
1529904|NCT01430182|3745996|P2|COMPLETED|Overall Study||8
1529905|NCT01430182|3745997|P1|COMPLETED|Overall Study||9
1529906|NCT01430182|3745996|P2|STARTED|Overall Study||8
1529907|NCT01430182|3745997|P1|STARTED|Overall Study||9
1529908|NCT01430169|3746003|P1|NOT COMPLETED|Overall Study||0
1529909|NCT01430169|3746003|P1|COMPLETED|Overall Study||20
1529910|NCT01430169|3746003|P1|STARTED|Overall Study||20
1529911|NCT01430130|3746018|P1|NOT COMPLETED|Overall Study||2
1529912|NCT01430130|3746018|P1|COMPLETED|Overall Study||10
1529913|NCT01430130|3746018|P1|STARTED|Overall Study||12
1529914|NCT01430104|3746024|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
1529915|NCT01430104|3746024|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
1529916|NCT01430104|3746024|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
1529917|NCT01430104|3746024|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
1529918|NCT01430104|3746024|P1|NOT COMPLETED|14-Day Lead-In Period||0
1529919|NCT01430104|3746024|P1|COMPLETED|14-Day Lead-In Period||30
1529920|NCT01430104|3746024|P1|STARTED|14-Day Lead-In Period||30
1529921|NCT01430091|3746036|P1|NOT COMPLETED|Overall Study||0
1529922|NCT01430091|3746036|P1|COMPLETED|Overall Study||18
1529923|NCT01430091|3746036|P1|STARTED|Overall Study||18
1529924|NCT01429987|3746062|P4|NOT COMPLETED|Overall Study||66
1529925|NCT01429987|3746063|P3|NOT COMPLETED|Overall Study||36
1529926|NCT01429987|3746064|P2|NOT COMPLETED|Overall Study||62
1529927|NCT01429987|3746065|P1|NOT COMPLETED|Overall Study||49
1529928|NCT01429987|3746062|P4|COMPLETED|Overall Study||171
1529929|NCT01429987|3746063|P3|COMPLETED|Overall Study||202
1529930|NCT01429987|3746064|P2|COMPLETED|Overall Study||176
1529931|NCT01429987|3746065|P1|COMPLETED|Overall Study||189
1529932|NCT01429987|3746062|P4|STARTED|Overall Study||237
1529933|NCT01429987|3746063|P3|STARTED|Overall Study||238
1529934|NCT01429987|3746064|P2|STARTED|Overall Study||238
1529935|NCT01429987|3746065|P1|STARTED|Overall Study||238
1529936|NCT01429792|3746091|P1|NOT COMPLETED|Overall Study||406
1529937|NCT01429792|3746091|P1|COMPLETED|Overall Study||607
1529938|NCT01429792|3746091|P1|Genotype 4|Overall Study||5
1529939|NCT01429792|3746091|P1|Genotype 2 & 3|Overall Study||305
1529940|NCT01429792|3746091|P1|Genotype 1|Overall Study||687
1529941|NCT01429792|3746091|P1|STARTED|Overall Study||1013
1529942|NCT01429623|3746105|P2|NOT COMPLETED|Overall Study||59
1529943|NCT01429623|3746106|P1|NOT COMPLETED|Overall Study||51
1529944|NCT01429623|3746105|P2|COMPLETED|Overall Study||48
1529945|NCT01429623|3746106|P1|COMPLETED|Overall Study||51
1529946|NCT01429623|3746105|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
1529947|NCT01429623|3746106|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
1529948|NCT01429623|3746105|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
1530037|NCT01428882|3746274|P2|COMPLETED|Overall Study||58
1529949|NCT01429623|3746106|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
1529950|NCT01429584|3746120|P2|NOT COMPLETED|Overall Study||1
1529951|NCT01429584|3746121|P1|NOT COMPLETED|Overall Study||1
1529952|NCT01429584|3746120|P2|COMPLETED|Overall Study||14
1529953|NCT01429584|3746121|P1|COMPLETED|Overall Study||14
1529954|NCT01429584|3746120|P2|STARTED|Overall Study||15
1529955|NCT01429584|3746121|P1|STARTED|Overall Study||15
1529956|NCT01429532|3746134|P3|NOT COMPLETED|Overall Study||0
1529957|NCT01429532|3746135|P2|NOT COMPLETED|Overall Study||0
1529958|NCT01429532|3746136|P1|NOT COMPLETED|Overall Study||0
1529959|NCT01429532|3746134|P3|COMPLETED|Overall Study||40
1529960|NCT01429532|3746135|P2|COMPLETED|Overall Study||40
1529961|NCT01429532|3746136|P1|COMPLETED|Overall Study||40
1529962|NCT01429532|3746134|P3|STARTED|Overall Study||40
1529963|NCT01429532|3746135|P2|STARTED|Overall Study||40
1529964|NCT01429532|3746136|P1|STARTED|Overall Study||40
1529965|NCT01429441|3746152|P2|NOT COMPLETED|Overall Study||23
1529966|NCT01429441|3746153|P1|NOT COMPLETED|Overall Study||38
1529967|NCT01429441|3746152|P2|COMPLETED|Overall Study||51
1529968|NCT01429441|3746153|P1|COMPLETED|Overall Study||108
1529969|NCT01429441|3746152|P2|STARTED|Overall Study||74
1529970|NCT01429441|3746153|P1|STARTED|Overall Study||146
1529971|NCT01429298|3746163|P2|NOT COMPLETED|Overall Study||6
1529972|NCT01429298|3746164|P1|NOT COMPLETED|Overall Study||4
1529973|NCT01429298|3746163|P2|COMPLETED|Overall Study||169
1529974|NCT01429298|3746164|P1|COMPLETED|Overall Study||171
1529975|NCT01429298|3746163|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
1529976|NCT01429298|3746164|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
1529977|NCT01429298|3746163|P2|STARTED|Overall Study||175
1529978|NCT01429298|3746164|P1|STARTED|Overall Study||175
1529979|NCT01429285|3746180|P2|NOT COMPLETED|Overall Study||9
1529980|NCT01429285|3746181|P1|NOT COMPLETED|Overall Study||22
1529981|NCT01429285|3746180|P2|COMPLETED|Overall Study||166
1529982|NCT01429285|3746181|P1|COMPLETED|Overall Study||153
1529983|NCT01429285|3746180|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
1529984|NCT01429285|3746181|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
1529985|NCT01429285|3746180|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
1529986|NCT01429285|3746181|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
1529987|NCT01429285|3746180|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
1529988|NCT01429285|3746181|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
1529989|NCT01429285|3746180|P2|STARTED|Overall Study||175
1529990|NCT01429285|3746181|P1|STARTED|Overall Study||175
1529991|NCT01429272|3746203|P4|NOT COMPLETED|Overall Study||5
1529992|NCT01429272|3746204|P3|NOT COMPLETED|Overall Study||4
1529993|NCT01429272|3746205|P2|NOT COMPLETED|Overall Study||9
1529994|NCT01429272|3746206|P1|NOT COMPLETED|Overall Study||6
1529995|NCT01429272|3746203|P4|COMPLETED|Overall Study||14
1529996|NCT01429272|3746204|P3|COMPLETED|Overall Study||15
1529997|NCT01429272|3746205|P2|COMPLETED|Overall Study||22
1529998|NCT01429272|3746206|P1|COMPLETED|Overall Study||24
1529999|NCT01429272|3746203|P4|STARTED|Overall Study||19
1530000|NCT01429272|3746204|P3|STARTED|Overall Study||19
1530001|NCT01429272|3746205|P2|STARTED|Overall Study||31
1530002|NCT01429272|3746206|P1|STARTED|Overall Study||30
1530003|NCT01429259|3746220|P1|NOT COMPLETED|Overall Study||0
1530004|NCT01429259|3746220|P1|COMPLETED|Overall Study||30
1530005|NCT01429259|3746220|P1|STARTED|Overall Study||30
1530006|NCT01429077|3746227|P2|NOT COMPLETED|Overall Study||3
1530007|NCT01429077|3746228|P1|NOT COMPLETED|Overall Study||0
1530008|NCT01429077|3746227|P2|COMPLETED|Overall Study||14
1530009|NCT01429077|3746228|P1|COMPLETED|Overall Study||19
1530010|NCT01429077|3746227|P2|Completed 6-week Intervention|Overall Study||17
1530011|NCT01429077|3746228|P1|Completed 6-week Intervention|Overall Study||19
1530012|NCT01429077|3746227|P2|STARTED|Overall Study||17
1530013|NCT01429077|3746228|P1|STARTED|Overall Study||19
1530014|NCT01429064|3746238|P4|NOT COMPLETED|Overall Study||0
1530015|NCT01429064|3746239|P3|NOT COMPLETED|Overall Study||0
1530016|NCT01429064|3746240|P2|NOT COMPLETED|Overall Study||0
1530017|NCT01429064|3746241|P1|NOT COMPLETED|Overall Study||0
1530018|NCT01429064|3746238|P4|COMPLETED|Overall Study||16
1530019|NCT01429064|3746239|P3|COMPLETED|Overall Study||19
1530020|NCT01429064|3746240|P2|COMPLETED|Overall Study||22
1530021|NCT01429064|3746241|P1|COMPLETED|Overall Study||19
1530022|NCT01429064|3746238|P4|STARTED|Overall Study||16
1530023|NCT01429064|3746239|P3|STARTED|Overall Study||19
1530024|NCT01429064|3746240|P2|STARTED|Overall Study||22
1530025|NCT01429064|3746241|P1|STARTED|Overall Study||19
1530026|NCT01429051|3746251|P1|NOT COMPLETED|Tolerability Phase||15
1530027|NCT01429051|3746251|P1|COMPLETED|Tolerability Phase||16
1530028|NCT01429051|3746251|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
1530029|NCT01429051|3746251|P1|NOT COMPLETED|Efficacy Phase||2
1530030|NCT01429051|3746251|P1|COMPLETED|Efficacy Phase||13
1530031|NCT01429051|3746251|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
1530032|NCT01429051|3746251|P1|NOT COMPLETED|Titration Phase||12
1530033|NCT01429051|3746251|P1|COMPLETED|Titration Phase||33
1530034|NCT01429051|3746251|P1|STARTED|Titration Phase||45
1530035|NCT01428882|3746274|P2|NOT COMPLETED|Overall Study||10
1530036|NCT01428882|3746275|P1|NOT COMPLETED|Overall Study||6
1530038|NCT01428882|3746275|P1|COMPLETED|Overall Study||61
1530039|NCT01428882|3746274|P2|STARTED|Overall Study||68
1530040|NCT01428882|3746275|P1|STARTED|Overall Study||67
1530041|NCT01428765|3746287|P1|NOT COMPLETED|Overall Study||0
1530042|NCT01428765|3746287|P1|COMPLETED|Overall Study||1063
1530043|NCT01428765|3746287|P1|STARTED|Overall Study||1063
1530044|NCT01428713|3746298|P2|NOT COMPLETED|Overall Study||5
1530045|NCT01428713|3746299|P1|NOT COMPLETED|Overall Study||3
1530046|NCT01428713|3746298|P2|COMPLETED|Overall Study||3
1530047|NCT01428713|3746299|P1|COMPLETED|Overall Study||6
1530048|NCT01428713|3746298|P2|STARTED|Overall Study||8
1530049|NCT01428713|3746299|P1|STARTED|Overall Study||9
1530050|NCT01428661|3746308|P3|NOT COMPLETED|Open Label Extension||320
1530051|NCT01428661|3746309|P2|NOT COMPLETED|Open Label Extension||0
1530052|NCT01428661|3746310|P1|NOT COMPLETED|Open Label Extension||0
1530053|NCT01428661|3746308|P3|COMPLETED|Open Label Extension||19
1530054|NCT01428661|3746309|P2|COMPLETED|Open Label Extension|Does not apply.|0
1530055|NCT01428661|3746310|P1|COMPLETED|Open Label Extension|Does not apply.|0
1530056|NCT01428661|3746308|P3|STARTED|Open Label Extension||339
1530057|NCT01428661|3746309|P2|STARTED|Open Label Extension|Does not apply.|0
1530058|NCT01428661|3746310|P1|STARTED|Open Label Extension|Does not apply.|0
1530059|NCT01428661|3746308|P3|NOT COMPLETED|Double-Masked Phase||0
1530060|NCT01428661|3746309|P2|NOT COMPLETED|Double-Masked Phase||49
1530061|NCT01428661|3746310|P1|NOT COMPLETED|Double-Masked Phase||57
1530062|NCT01428661|3746308|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
1530063|NCT01428661|3746309|P2|COMPLETED|Double-Masked Phase||204
1530064|NCT01428661|3746310|P1|COMPLETED|Double-Masked Phase||197
1530065|NCT01428661|3746308|P3|STARTED|Double-Masked Phase|Does not apply.|0
1530066|NCT01428661|3746309|P2|STARTED|Double-Masked Phase||253
1530067|NCT01428661|3746310|P1|STARTED|Double-Masked Phase||254
1530068|NCT01428583|3746318|P1|NOT COMPLETED|Overall Study||237
1530069|NCT01428583|3746318|P1|COMPLETED|Overall Study||158
1530070|NCT01428583|3746318|P1|STARTED|Overall Study||395
1530071|NCT01428453|3746342|P2|NOT COMPLETED|Overall Study||9
1530072|NCT01428453|3746343|P1|NOT COMPLETED|Overall Study||6
1530073|NCT01428453|3746342|P2|COMPLETED|Overall Study||52
1530074|NCT01428453|3746343|P1|COMPLETED|Overall Study||56
1530075|NCT01428453|3746342|P2|STARTED|Overall Study||61
1530076|NCT01428453|3746343|P1|STARTED|Overall Study||62
1530077|NCT01428336|3746369|P2|NOT COMPLETED|Overall Study||0
1530078|NCT01428336|3746370|P1|NOT COMPLETED|Overall Study||0
1530079|NCT01428336|3746369|P2|COMPLETED|Overall Study||12
1530080|NCT01428336|3746370|P1|COMPLETED|Overall Study||10
1530081|NCT01428336|3746369|P2|STARTED|Overall Study||12
1530082|NCT01428336|3746370|P1|STARTED|Overall Study||10
1530083|NCT01428258|3746382|P2|NOT COMPLETED|Intervention 2||0
1530084|NCT01428258|3746383|P1|NOT COMPLETED|Intervention 2||0
1530085|NCT01428258|3746382|P2|COMPLETED|Intervention 2||15
1530086|NCT01428258|3746383|P1|COMPLETED|Intervention 2||15
1530087|NCT01428258|3746382|P2|STARTED|Intervention 2||15
1530088|NCT01428258|3746383|P1|STARTED|Intervention 2||15
1530089|NCT01428258|3746382|P2|NOT COMPLETED|Intervention 1||0
1530090|NCT01428258|3746383|P1|NOT COMPLETED|Intervention 1||2
1530091|NCT01428258|3746382|P2|COMPLETED|Intervention 1||15
1530092|NCT01428258|3746383|P1|COMPLETED|Intervention 1||15
1530093|NCT01428258|3746382|P2|STARTED|Intervention 1||15
1530094|NCT01428258|3746383|P1|STARTED|Intervention 1||17
1530095|NCT01428219|3746401|P1|NOT COMPLETED|Overall Study||3
1530096|NCT01428219|3746401|P1|COMPLETED|Overall Study||22
1530097|NCT01428219|3746401|P1|STARTED|Overall Study||25
1530098|NCT01428193|3746412|P1|NOT COMPLETED|Overall Study||2
1530099|NCT01428193|3746412|P1|COMPLETED|Overall Study||2
1530100|NCT01428193|3746412|P1|STARTED|Overall Study||4
1530101|NCT01428128|3746416|P1|NOT COMPLETED|Overall Study||17
1530102|NCT01428128|3746416|P1|COMPLETED|Overall Study||33
1530103|NCT01428128|3746416|P1|STARTED|Overall Study||50
1530104|NCT01428115|3746421|P1|NOT COMPLETED|Overall Study||21
1530105|NCT01428115|3746421|P1|COMPLETED|Overall Study||62
1530106|NCT01428115|3746421|P1|STARTED|Overall Study||83
1530107|NCT01428076|3746436|P2|NOT COMPLETED|Overall Study||1
1530108|NCT01428076|3746437|P1|NOT COMPLETED|Overall Study||0
1530109|NCT01428076|3746436|P2|COMPLETED|Overall Study||11
1530110|NCT01428076|3746437|P1|COMPLETED|Overall Study||9
1530111|NCT01428076|3746436|P2|STARTED|Overall Study||12
1530112|NCT01428076|3746437|P1|STARTED|Overall Study||9
1530113|NCT01428063|3746448|P3|NOT COMPLETED|Overall Study||1
1530114|NCT01428063|3746449|P2|NOT COMPLETED|Overall Study||10
1530115|NCT01428063|3746450|P1|NOT COMPLETED|Overall Study||10
1530116|NCT01428063|3746448|P3|COMPLETED|Overall Study||5
1530117|NCT01428063|3746449|P2|COMPLETED|Overall Study||112
1530118|NCT01428063|3746450|P1|COMPLETED|Overall Study||89
1530119|NCT01428063|3746448|P3|STARTED|Overall Study||6
1530120|NCT01428063|3746449|P2|STARTED|Overall Study||122
1530121|NCT01428063|3746450|P1|STARTED|Overall Study||99
1530122|NCT01428024|3746521|P2|NOT COMPLETED|Overall Study||1
1530123|NCT01428024|3746522|P1|NOT COMPLETED|Overall Study||1
1530124|NCT01428024|3746521|P2|COMPLETED|Overall Study||29
1530125|NCT01428024|3746522|P1|COMPLETED|Overall Study||29
1530126|NCT01428024|3746521|P2|STARTED|Overall Study||30
1530127|NCT01428024|3746522|P1|STARTED|Overall Study||30
1530128|NCT01427933|3746541|P2|NOT COMPLETED|Overall Study||13
1530129|NCT01427933|3746542|P1|NOT COMPLETED|Overall Study||8
1530130|NCT01427933|3746541|P2|COMPLETED|Overall Study||57
1530131|NCT01427933|3746542|P1|COMPLETED|Overall Study||63
1530132|NCT01427933|3746541|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
1530133|NCT01427933|3746542|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
1530134|NCT01427933|3746541|P2|STARTED|Overall Study||70
1530135|NCT01427933|3746542|P1|STARTED|Overall Study||71
1530136|NCT01427920|3746562|P2|NOT COMPLETED|Overall Study||17
1530137|NCT01427920|3746563|P1|NOT COMPLETED|Overall Study||9
1530138|NCT01427920|3746562|P2|COMPLETED|Overall Study||157
1530139|NCT01427920|3746563|P1|COMPLETED|Overall Study||165
1530140|NCT01427920|3746562|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
1530141|NCT01427920|3746563|P1|Exposed|Overall Study||174
1530142|NCT01427920|3746562|P2|STARTED|Overall Study||174
1530143|NCT01427920|3746563|P1|STARTED|Overall Study||174
1530144|NCT01427907|3746583|P2|NOT COMPLETED|Overall Study||4
1530145|NCT01427907|3746584|P1|NOT COMPLETED|Overall Study||3
1530146|NCT01427907|3746583|P2|COMPLETED|Overall Study|Completed study|14
1530147|NCT01427907|3746584|P1|COMPLETED|Overall Study|Completed study|17
1530148|NCT01427907|3746583|P2|STARTED|Overall Study|Randomized|18
1530149|NCT01427907|3746584|P1|STARTED|Overall Study|Randomized|20
1530150|NCT01427881|3746590|P1|NOT COMPLETED|Overall Study||0
1530151|NCT01427881|3746590|P1|COMPLETED|Overall Study||43
1530152|NCT01427881|3746590|P1|STARTED|Overall Study||43
1530153|NCT01427803|3746605|P2|NOT COMPLETED|Overall Study||26
1530154|NCT01427803|3746606|P1|NOT COMPLETED|Overall Study||63
1530155|NCT01427803|3746605|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
1530156|NCT01427803|3746606|P1|COMPLETED|Overall Study||463
1530157|NCT01427803|3746605|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
1530158|NCT01427803|3746606|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
1530159|NCT01427803|3746605|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
1530160|NCT01427803|3746606|P1|Baseline Assessment|Overall Study||516
1530161|NCT01427803|3746605|P2|Purchased Product|Overall Study||252
1530162|NCT01427803|3746606|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
1530163|NCT01427803|3746605|P2|STARTED|Overall Study||252
1530164|NCT01427803|3746606|P1|STARTED|Overall Study||526
1530165|NCT01427751|3746620|P2|NOT COMPLETED|Overall Study||14
1530166|NCT01427751|3746621|P1|NOT COMPLETED|Overall Study||42
1530167|NCT01427751|3746620|P2|COMPLETED|Overall Study||139
1530168|NCT01427751|3746621|P1|COMPLETED|Overall Study||112
1530169|NCT01427751|3746620|P2|STARTED|Overall Study||153
1530170|NCT01427751|3746621|P1|STARTED|Overall Study||154
1530171|NCT01427738|3746641|P2|NOT COMPLETED|Overall Study||21
1530172|NCT01427738|3746642|P1|NOT COMPLETED|Overall Study||19
1530173|NCT01427738|3746641|P2|COMPLETED|Overall Study||90
1530174|NCT01427738|3746642|P1|COMPLETED|Overall Study||91
1530175|NCT01427738|3746641|P2|STARTED|Overall Study||111
1530176|NCT01427738|3746642|P1|STARTED|Overall Study||110
1530177|NCT01427517|3746663|P3|NOT COMPLETED|Overall Study||0
1530178|NCT01427517|3746664|P2|NOT COMPLETED|Overall Study||0
1530179|NCT01427517|3746665|P1|NOT COMPLETED|Overall Study||0
1530180|NCT01427517|3746663|P3|COMPLETED|Overall Study||3
1530181|NCT01427517|3746664|P2|COMPLETED|Overall Study||3
1530182|NCT01427517|3746665|P1|COMPLETED|Overall Study||3
1530183|NCT01427517|3746663|P3|STARTED|Overall Study||3
1530184|NCT01427517|3746664|P2|STARTED|Overall Study||3
1530185|NCT01427517|3746665|P1|STARTED|Overall Study||3
1530186|NCT01427504|3746679|P6|NOT COMPLETED|Overall Study||2
1530187|NCT01427504|3746680|P5|NOT COMPLETED|Overall Study||1
1530188|NCT01427504|3746681|P4|NOT COMPLETED|Overall Study||1
1530189|NCT01427504|3746682|P3|NOT COMPLETED|Overall Study||1
1530190|NCT01427504|3746683|P2|NOT COMPLETED|Overall Study||1
1530191|NCT01427504|3746684|P1|NOT COMPLETED|Overall Study||0
1530192|NCT01427504|3746679|P6|COMPLETED|Overall Study||4
1530193|NCT01427504|3746680|P5|COMPLETED|Overall Study||2
1530194|NCT01427504|3746681|P4|COMPLETED|Overall Study||5
1530195|NCT01427504|3746682|P3|COMPLETED|Overall Study||3
1530196|NCT01427504|3746683|P2|COMPLETED|Overall Study||2
1530197|NCT01427504|3746684|P1|COMPLETED|Overall Study||4
1530198|NCT01427504|3746679|P6|Received Combination|Overall Study||6
1530199|NCT01427504|3746680|P5|Received Combination|Overall Study||3
1530200|NCT01427504|3746681|P4|Received Combination|Overall Study||6
1530201|NCT01427504|3746682|P3|Received Combination|Overall Study||3
1530202|NCT01427504|3746683|P2|Received Combination|Overall Study||3
1530203|NCT01427504|3746684|P1|Received Combination|Overall Study||4
1530204|NCT01427504|3746679|P6|Received Etravirine|Overall Study||4
1530205|NCT01427504|3746680|P5|Received Etravirine|Overall Study||2
1530206|NCT01427504|3746681|P4|Received Etravirine|Overall Study||6
1530207|NCT01427504|3746682|P3|Received Etravirine|Overall Study||4
1530208|NCT01427504|3746683|P2|Received Etravirine|Overall Study||2
1530209|NCT01427504|3746684|P1|Received Etravirine|Overall Study||4
1530210|NCT01427504|3746679|P6|Received Boceprevir|Overall Study||4
1530211|NCT01427504|3746680|P5|Received Boceprevir|Overall Study||2
1530212|NCT01427504|3746681|P4|Received Boceprevir|Overall Study||5
1530213|NCT01427504|3746682|P3|Received Boceprevir|Overall Study||3
1530214|NCT01427504|3746683|P2|Received Boceprevir|Overall Study||3
1530215|NCT01427504|3746684|P1|Received Boceprevir|Overall Study||4
1530216|NCT01427504|3746679|P6|STARTED|Overall Study||6
1530217|NCT01427504|3746680|P5|STARTED|Overall Study||3
1530218|NCT01427504|3746681|P4|STARTED|Overall Study||6
1530219|NCT01427504|3746682|P3|STARTED|Overall Study||4
1530220|NCT01427504|3746683|P2|STARTED|Overall Study||3
1530221|NCT01427504|3746684|P1|STARTED|Overall Study||4
1530222|NCT01427309|3746705|P4|NOT COMPLETED|Overall Study||376
1530223|NCT01427309|3746706|P3|NOT COMPLETED|Overall Study||361
1530224|NCT01427309|3746707|P2|NOT COMPLETED|Overall Study||407
1530225|NCT01427309|3746708|P1|NOT COMPLETED|Overall Study||372
1530226|NCT01427309|3746705|P4|COMPLETED|Overall Study||8373
1530227|NCT01427309|3746706|P3|COMPLETED|Overall Study||8376
1530228|NCT01427309|3746707|P2|COMPLETED|Overall Study||6837
1530229|NCT01427309|3746708|P1|COMPLETED|Overall Study||6881
1530230|NCT01427309|3746705|P4|STARTED|Overall Study||8749
1530231|NCT01427309|3746706|P3|STARTED|Overall Study||8737
1530232|NCT01427309|3746707|P2|STARTED|Overall Study||7244
1530233|NCT01427309|3746708|P1|STARTED|Overall Study||7253
1530234|NCT01427296|3746748|P2|NOT COMPLETED|Overall Study||0
1530235|NCT01427296|3746749|P1|NOT COMPLETED|Overall Study||0
1530236|NCT01427296|3746748|P2|COMPLETED|Overall Study||1051
1530237|NCT01427296|3746749|P1|COMPLETED|Overall Study||1041
1530238|NCT01427296|3746748|P2|STARTED|Overall Study||1051
1530239|NCT01427296|3746749|P1|STARTED|Overall Study||1041
1530240|NCT01426958|3746755|P1|NOT COMPLETED|Overall Study||2
1530241|NCT01426958|3746755|P1|COMPLETED|Overall Study||22
1530242|NCT01426958|3746755|P1|STARTED|Overall Study||24
1530243|NCT01426867|3746772|P3|NOT COMPLETED|Overall Study||0
1530244|NCT01426867|3746773|P2|NOT COMPLETED|Overall Study||0
1530245|NCT01426867|3746774|P1|NOT COMPLETED|Overall Study||0
1530246|NCT01426867|3746772|P3|COMPLETED|Overall Study||34
1530247|NCT01426867|3746773|P2|COMPLETED|Overall Study||34
1530248|NCT01426867|3746774|P1|COMPLETED|Overall Study||33
1530249|NCT01426867|3746772|P3|STARTED|Overall Study||34
1530250|NCT01426867|3746773|P2|STARTED|Overall Study||34
1530251|NCT01426867|3746774|P1|STARTED|Overall Study||33
1530252|NCT01426854|3746784|P2|NOT COMPLETED|Overall Study||31
1530253|NCT01426854|3746785|P1|NOT COMPLETED|Overall Study||12
1530254|NCT01426854|3746784|P2|COMPLETED|Overall Study||98
1530255|NCT01426854|3746785|P1|COMPLETED|Overall Study||119
1530256|NCT01426854|3746784|P2|STARTED|Overall Study||129
1530257|NCT01426854|3746785|P1|STARTED|Overall Study||131
1530258|NCT01426789|3746795|P6|NOT COMPLETED|Part 2||0
1530259|NCT01426789|3746796|P5|NOT COMPLETED|Part 2||8
1530260|NCT01426789|3746797|P4|NOT COMPLETED|Part 2||1
1530261|NCT01426789|3746798|P3|NOT COMPLETED|Part 2||15
1530262|NCT01426789|3746799|P2|NOT COMPLETED|Part 2||0
1530263|NCT01426789|3746800|P1|NOT COMPLETED|Part 2||0
1530264|NCT01426789|3746795|P6|COMPLETED|Part 2||1
1530265|NCT01426789|3746796|P5|COMPLETED|Part 2||19
1530266|NCT01426789|3746797|P4|COMPLETED|Part 2||12
1530267|NCT01426789|3746798|P3|COMPLETED|Part 2||34
1530268|NCT01426789|3746799|P2|COMPLETED|Part 2||0
1530269|NCT01426789|3746800|P1|COMPLETED|Part 2||0
1530270|NCT01426789|3746795|P6|STARTED|Part 2||1
1530271|NCT01426789|3746796|P5|STARTED|Part 2||27
1530272|NCT01426789|3746797|P4|STARTED|Part 2||13
1530273|NCT01426789|3746798|P3|STARTED|Part 2||49
1530274|NCT01426789|3746799|P2|STARTED|Part 2||0
1530275|NCT01426789|3746800|P1|STARTED|Part 2||0
1530276|NCT01426789|3746795|P6|NOT COMPLETED|Part 1||0
1530277|NCT01426789|3746796|P5|NOT COMPLETED|Part 1||0
1530278|NCT01426789|3746797|P4|NOT COMPLETED|Part 1||0
1530279|NCT01426789|3746798|P3|NOT COMPLETED|Part 1||0
1530280|NCT01426789|3746799|P2|NOT COMPLETED|Part 1||4
1530281|NCT01426789|3746800|P1|NOT COMPLETED|Part 1||6
1530282|NCT01426789|3746795|P6|COMPLETED|Part 1||0
1530283|NCT01426789|3746796|P5|COMPLETED|Part 1||0
1530284|NCT01426789|3746797|P4|COMPLETED|Part 1||0
1530285|NCT01426789|3746798|P3|COMPLETED|Part 1||0
1530286|NCT01426789|3746799|P2|COMPLETED|Part 1||28
1530287|NCT01426789|3746800|P1|COMPLETED|Part 1||62
1530288|NCT01426789|3746795|P6|STARTED|Part 1||0
1530289|NCT01426789|3746796|P5|STARTED|Part 1||0
1530290|NCT01426789|3746797|P4|STARTED|Part 1||0
1530291|NCT01426789|3746798|P3|STARTED|Part 1||0
1530292|NCT01426789|3746799|P2|STARTED|Part 1||32
1530293|NCT01426789|3746800|P1|STARTED|Part 1||68
1530294|NCT01426763|3746816|P2|NOT COMPLETED|Overall Study||0
1530295|NCT01426763|3746817|P1|NOT COMPLETED|Overall Study||0
1530296|NCT01426763|3746816|P2|COMPLETED|Overall Study||6
1530297|NCT01426763|3746817|P1|COMPLETED|Overall Study||6
1530298|NCT01426763|3746816|P2|STARTED|Overall Study||6
1530299|NCT01426763|3746817|P1|STARTED|Overall Study||6
1530300|NCT01426555|3746825|P2|NOT COMPLETED|Overall Study||15
1530301|NCT01426555|3746826|P1|NOT COMPLETED|Overall Study||18
1530302|NCT01426555|3746825|P2|COMPLETED|Overall Study||20
1530303|NCT01426555|3746826|P1|COMPLETED|Overall Study||17
1530304|NCT01426555|3746825|P2|STARTED|Overall Study||35
1530305|NCT01426555|3746826|P1|STARTED|Overall Study||35
1530306|NCT01426516|3746836|P2|NOT COMPLETED|Overall Study||0
1530307|NCT01426516|3746837|P1|NOT COMPLETED|Overall Study||0
1530308|NCT01426516|3746836|P2|COMPLETED|Overall Study||17
1530309|NCT01426516|3746837|P1|COMPLETED|Overall Study||12
1530310|NCT01426516|3746836|P2|STARTED|Overall Study||17
1530311|NCT01426516|3746837|P1|STARTED|Overall Study||12
1530312|NCT01426438|3746845|P2|NOT COMPLETED|Overall Study||10
1530313|NCT01426438|3746846|P1|NOT COMPLETED|Overall Study||15
1530314|NCT01426438|3746845|P2|COMPLETED|Overall Study||39
1530315|NCT01426438|3746846|P1|COMPLETED|Overall Study||35
1530316|NCT01426438|3746845|P2|STARTED|Overall Study||49
1530317|NCT01426438|3746846|P1|STARTED|Overall Study||50
1530318|NCT01426425|3746878|P1|NOT COMPLETED|Overall Study||175
1530319|NCT01426425|3746878|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
1530320|NCT01426425|3746878|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
1530321|NCT01426425|3746878|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
1530322|NCT01426425|3746878|P1|STARTED|Overall Study||572
1530323|NCT01426386|3746890|P6|NOT COMPLETED|Overall Study||1
1530324|NCT01426386|3746891|P5|NOT COMPLETED|Overall Study||4
1530325|NCT01426386|3746892|P4|NOT COMPLETED|Overall Study||0
1530326|NCT01426386|3746893|P3|NOT COMPLETED|Overall Study||2
1530327|NCT01426386|3746894|P2|NOT COMPLETED|Overall Study||6
1530328|NCT01426386|3746895|P1|NOT COMPLETED|Overall Study||3
1530329|NCT01426386|3746890|P6|COMPLETED|Overall Study||42
1530330|NCT01426386|3746891|P5|COMPLETED|Overall Study||43
1530331|NCT01426386|3746892|P4|COMPLETED|Overall Study||44
1530332|NCT01426386|3746893|P3|COMPLETED|Overall Study||42
1530333|NCT01426386|3746894|P2|COMPLETED|Overall Study||39
1530334|NCT01426386|3746895|P1|COMPLETED|Overall Study||39
1530335|NCT01426386|3746890|P6|STARTED|Overall Study||43
1530336|NCT01426386|3746891|P5|STARTED|Overall Study||47
1530337|NCT01426386|3746892|P4|STARTED|Overall Study||44
1530338|NCT01426386|3746893|P3|STARTED|Overall Study||44
1530339|NCT01426386|3746894|P2|STARTED|Overall Study||45
1530340|NCT01426386|3746895|P1|STARTED|Overall Study||42
1530341|NCT01426373|3746951|P1|NOT COMPLETED|Overall Study||34
1530342|NCT01426373|3746951|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
1530343|NCT01426373|3746951|P1|STARTED|Overall Study||165
1530344|NCT01426360|3746969|P2|NOT COMPLETED|Overall Study||0
1530345|NCT01426360|3746970|P1|NOT COMPLETED|Overall Study||0
1530346|NCT01426360|3746969|P2|COMPLETED|Overall Study||41
1530347|NCT01426360|3746970|P1|COMPLETED|Overall Study||38
1530348|NCT01426360|3746969|P2|STARTED|Overall Study||41
1530349|NCT01426360|3746970|P1|STARTED|Overall Study||38
1530350|NCT01426347|3746984|P2|NOT COMPLETED|Overall Study||3
1530351|NCT01426347|3746985|P1|NOT COMPLETED|Overall Study||7
1530352|NCT01426347|3746984|P2|COMPLETED|Overall Study||39
1530353|NCT01426347|3746985|P1|COMPLETED|Overall Study||34
1530354|NCT01426347|3746984|P2|STARTED|Overall Study||42
1530355|NCT01426347|3746985|P1|STARTED|Overall Study||41
1530356|NCT01426269|3746993|P3|NOT COMPLETED|Period 2: 40 Weeks||47
1530357|NCT01426269|3746994|P2|NOT COMPLETED|Period 2: 40 Weeks||38
1530358|NCT01426269|3746995|P1|NOT COMPLETED|Period 2: 40 Weeks||0
1530359|NCT01426269|3746993|P3|COMPLETED|Period 2: 40 Weeks||18
1530360|NCT01426269|3746994|P2|COMPLETED|Period 2: 40 Weeks||27
1530361|NCT01426269|3746995|P1|COMPLETED|Period 2: 40 Weeks||0
1530362|NCT01426269|3746993|P3|STARTED|Period 2: 40 Weeks||65
1530363|NCT01426269|3746994|P2|STARTED|Period 2: 40 Weeks||65
1530364|NCT01426269|3746995|P1|STARTED|Period 2: 40 Weeks||0
1530365|NCT01426269|3746993|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
1530366|NCT01426269|3746994|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
1530367|NCT01426269|3746995|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
1530368|NCT01426269|3746993|P3|COMPLETED|Eligibility for Period 2, Randomization||0
1530369|NCT01426269|3746994|P2|COMPLETED|Eligibility for Period 2, Randomization||0
1530370|NCT01426269|3746995|P1|COMPLETED|Eligibility for Period 2, Randomization||130
1530371|NCT01426269|3746993|P3|STARTED|Eligibility for Period 2, Randomization||0
1530372|NCT01426269|3746994|P2|STARTED|Eligibility for Period 2, Randomization||0
1530373|NCT01426269|3746995|P1|STARTED|Eligibility for Period 2, Randomization||180
1530374|NCT01426269|3746993|P3|NOT COMPLETED|Period 1: 12 Weeks||0
1530375|NCT01426269|3746994|P2|NOT COMPLETED|Period 1: 12 Weeks||0
1530376|NCT01426269|3746995|P1|NOT COMPLETED|Period 1: 12 Weeks||55
1530377|NCT01426269|3746993|P3|COMPLETED|Period 1: 12 Weeks||0
1530378|NCT01426269|3746994|P2|COMPLETED|Period 1: 12 Weeks||0
1530379|NCT01426269|3746995|P1|COMPLETED|Period 1: 12 Weeks||180
1530380|NCT01426269|3746993|P3|STARTED|Period 1: 12 Weeks||0
1530381|NCT01426269|3746994|P2|STARTED|Period 1: 12 Weeks||0
1530382|NCT01426269|3746995|P1|STARTED|Period 1: 12 Weeks||235
1530383|NCT01426230|3747022|P2|NOT COMPLETED|Overall Study||27
1530384|NCT01426230|3747023|P1|NOT COMPLETED|Overall Study||31
1530385|NCT01426230|3747022|P2|COMPLETED|Overall Study||84
1530386|NCT01426230|3747023|P1|COMPLETED|Overall Study||55
1530387|NCT01426230|3747022|P2|STARTED|Overall Study||111
1530388|NCT01426230|3747023|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
1530389|NCT01426217|3747030|P2|NOT COMPLETED|Overall Study||14
1530390|NCT01426217|3747031|P1|NOT COMPLETED|Overall Study||8
1530391|NCT01426217|3747030|P2|COMPLETED|Overall Study||266
1530392|NCT01426217|3747031|P1|COMPLETED|Overall Study||306
1530393|NCT01426217|3747030|P2|STARTED|Overall Study||280
1530394|NCT01426217|3747031|P1|STARTED|Overall Study||314
1530395|NCT01426113|3747039|P2|NOT COMPLETED|Overall Study||2
1530396|NCT01426113|3747040|P1|NOT COMPLETED|Overall Study||1
1530397|NCT01426113|3747039|P2|COMPLETED|Overall Study||1
1530398|NCT01426113|3747040|P1|COMPLETED|Overall Study||2
1530399|NCT01426113|3747039|P2|STARTED|Overall Study||3
1530400|NCT01426113|3747040|P1|STARTED|Overall Study||3
1530401|NCT01426009|3747046|P1|NOT COMPLETED|Washout 4||1
1530402|NCT01426009|3747046|P1|COMPLETED|Washout 4||126
1530403|NCT01426009|3747046|P1|STARTED|Washout 4||127
1530404|NCT01426009|3747046|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
1530405|NCT01426009|3747046|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
1530406|NCT01426009|3747046|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
1530407|NCT01426009|3747046|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
1530408|NCT01426009|3747046|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
1530409|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
1530410|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
1530411|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
1530412|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
1530413|NCT01426009|3747046|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
1530414|NCT01426009|3747046|P1|NOT COMPLETED|Washout 3||1
1530415|NCT01426009|3747046|P1|COMPLETED|Washout 3||128
1530416|NCT01426009|3747046|P1|STARTED|Washout 3||129
1530417|NCT01426009|3747046|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
1530418|NCT01426009|3747046|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
1530419|NCT01426009|3747046|P1|Placebo|Period 3-Third Intervention (7 Days)||22
1530420|NCT01426009|3747046|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
1530421|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
1530422|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
1530423|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
1530424|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
1530425|NCT01426009|3747046|P1|STARTED|Period 3-Third Intervention (7 Days)||129
1530426|NCT01426009|3747046|P1|NOT COMPLETED|Washout 2||1
1530427|NCT01426009|3747046|P1|COMPLETED|Washout 2||129
1530428|NCT01426009|3747046|P1|STARTED|Washout 2||130
1530429|NCT01426009|3747046|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
1530430|NCT01426009|3747046|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
1530431|NCT01426009|3747046|P1|Placebo|Period 2-Second Intervention (7 Days)||21
1530432|NCT01426009|3747046|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
1530433|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
1530434|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
1530435|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
1530436|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
1530437|NCT01426009|3747046|P1|STARTED|Period 2-Second Intervention (7 Days)||135
1530438|NCT01426009|3747046|P1|NOT COMPLETED|Washout 1||2
1530439|NCT01426009|3747046|P1|COMPLETED|Washout 1||135
1530440|NCT01426009|3747046|P1|STARTED|Washout 1||137
1530441|NCT01426009|3747046|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
1530442|NCT01426009|3747046|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
1530443|NCT01426009|3747046|P1|Placebo|Period 1-First Intervention (7 Days)||24
1530444|NCT01426009|3747046|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
1530445|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
1530446|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
1530447|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
1530448|NCT01426009|3747046|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
1530449|NCT01426009|3747046|P1|STARTED|Period 1-First Intervention (7 Days)||139
1530450|NCT01425879|3747102|P1|NOT COMPLETED|Overall Study||0
1530451|NCT01425879|3747102|P1|COMPLETED|Overall Study||8
1530452|NCT01425879|3747102|P1|STARTED|Overall Study||8
1530453|NCT01425853|3747111|P2|NOT COMPLETED|Overall Study||77
1530454|NCT01425853|3747112|P1|NOT COMPLETED|Overall Study||64
1530455|NCT01425853|3747111|P2|COMPLETED|Overall Study||225
1530456|NCT01425853|3747112|P1|COMPLETED|Overall Study||240
1530457|NCT01425853|3747111|P2|Per Protocol (PP)|Overall Study||258
1530458|NCT01425853|3747112|P1|Per Protocol (PP)|Overall Study||264
1530459|NCT01425853|3747111|P2|Safety Population|Overall Study||299
1530460|NCT01425853|3747112|P1|Safety Population|Overall Study||304
1530461|NCT01425853|3747111|P2|STARTED|Overall Study||302
1530462|NCT01425853|3747112|P1|STARTED|Overall Study||304
1530463|NCT01425814|3747142|P6|NOT COMPLETED|Period 5||1
1530464|NCT01425814|3747143|P5|NOT COMPLETED|Period 5||0
1530465|NCT01425814|3747144|P4|NOT COMPLETED|Period 5||0
1530466|NCT01425814|3747145|P3|NOT COMPLETED|Period 5||1
1530467|NCT01425814|3747146|P2|NOT COMPLETED|Period 5||0
1530468|NCT01425814|3747147|P1|NOT COMPLETED|Period 5||0
1530469|NCT01425814|3747142|P6|COMPLETED|Period 5||11
1530470|NCT01425814|3747143|P5|COMPLETED|Period 5||12
1530471|NCT01425814|3747144|P4|COMPLETED|Period 5||10
1530472|NCT01425814|3747145|P3|COMPLETED|Period 5||10
1530473|NCT01425814|3747146|P2|COMPLETED|Period 5||9
1530474|NCT01425814|3747147|P1|COMPLETED|Period 5||11
1530475|NCT01425814|3747142|P6|STARTED|Period 5||12
1530476|NCT01425814|3747143|P5|STARTED|Period 5||12
1530477|NCT01425814|3747144|P4|STARTED|Period 5||10
1530478|NCT01425814|3747145|P3|STARTED|Period 5||11
1530479|NCT01425814|3747146|P2|STARTED|Period 5||9
1530480|NCT01425814|3747147|P1|STARTED|Period 5||11
1530481|NCT01425814|3747142|P6|NOT COMPLETED|Period 4||0
1530482|NCT01425814|3747143|P5|NOT COMPLETED|Period 4||0
1530483|NCT01425814|3747144|P4|NOT COMPLETED|Period 4||0
1530484|NCT01425814|3747145|P3|NOT COMPLETED|Period 4||1
1530485|NCT01425814|3747146|P2|NOT COMPLETED|Period 4||0
1530486|NCT01425814|3747147|P1|NOT COMPLETED|Period 4||1
1530487|NCT01425814|3747142|P6|COMPLETED|Period 4||12
1530488|NCT01425814|3747143|P5|COMPLETED|Period 4||12
1530489|NCT01425814|3747144|P4|COMPLETED|Period 4||10
1530490|NCT01425814|3747145|P3|COMPLETED|Period 4||11
1530491|NCT01425814|3747146|P2|COMPLETED|Period 4||9
1530492|NCT01425814|3747147|P1|COMPLETED|Period 4||11
1530493|NCT01425814|3747142|P6|STARTED|Period 4||12
1530494|NCT01425814|3747143|P5|STARTED|Period 4||12
1530495|NCT01425814|3747144|P4|STARTED|Period 4||10
1530496|NCT01425814|3747145|P3|STARTED|Period 4||12
1530497|NCT01425814|3747146|P2|STARTED|Period 4||9
1530498|NCT01425814|3747147|P1|STARTED|Period 4||12
1530499|NCT01425814|3747142|P6|NOT COMPLETED|Period 3||1
1530500|NCT01425814|3747143|P5|NOT COMPLETED|Period 3||0
1530501|NCT01425814|3747144|P4|NOT COMPLETED|Period 3||0
1530502|NCT01425814|3747145|P3|NOT COMPLETED|Period 3||0
1530503|NCT01425814|3747146|P2|NOT COMPLETED|Period 3||0
1530504|NCT01425814|3747147|P1|NOT COMPLETED|Period 3||0
1530505|NCT01425814|3747142|P6|COMPLETED|Period 3||12
1530506|NCT01425814|3747143|P5|COMPLETED|Period 3||12
1530507|NCT01425814|3747144|P4|COMPLETED|Period 3||10
1530508|NCT01425814|3747145|P3|COMPLETED|Period 3||12
1530509|NCT01425814|3747146|P2|COMPLETED|Period 3||9
1530510|NCT01425814|3747147|P1|COMPLETED|Period 3||12
1530511|NCT01425814|3747142|P6|STARTED|Period 3||13
1530512|NCT01425814|3747143|P5|STARTED|Period 3||12
1530513|NCT01425814|3747144|P4|STARTED|Period 3||10
1530514|NCT01425814|3747145|P3|STARTED|Period 3||12
1530515|NCT01425814|3747146|P2|STARTED|Period 3||9
1530516|NCT01425814|3747147|P1|STARTED|Period 3||12
1530517|NCT01425814|3747142|P6|NOT COMPLETED|Period 2||0
1530518|NCT01425814|3747143|P5|NOT COMPLETED|Period 2||0
1530519|NCT01425814|3747144|P4|NOT COMPLETED|Period 2||0
1530520|NCT01425814|3747145|P3|NOT COMPLETED|Period 2||0
1530521|NCT01425814|3747146|P2|NOT COMPLETED|Period 2||1
1530522|NCT01425814|3747147|P1|NOT COMPLETED|Period 2||0
1530523|NCT01425814|3747142|P6|COMPLETED|Period 2||13
1530524|NCT01425814|3747143|P5|COMPLETED|Period 2||12
1530525|NCT01425814|3747144|P4|COMPLETED|Period 2||10
1530526|NCT01425814|3747145|P3|COMPLETED|Period 2||12
1530527|NCT01425814|3747146|P2|COMPLETED|Period 2||9
1530528|NCT01425814|3747147|P1|COMPLETED|Period 2||12
1530529|NCT01425814|3747142|P6|STARTED|Period 2||13
1530530|NCT01425814|3747143|P5|STARTED|Period 2||12
1530531|NCT01425814|3747144|P4|STARTED|Period 2||10
1530532|NCT01425814|3747145|P3|STARTED|Period 2||12
1530533|NCT01425814|3747146|P2|STARTED|Period 2||10
1530534|NCT01425814|3747147|P1|STARTED|Period 2||12
1530535|NCT01425814|3747142|P6|NOT COMPLETED|Period 1||0
1530536|NCT01425814|3747143|P5|NOT COMPLETED|Period 1||0
1530537|NCT01425814|3747144|P4|NOT COMPLETED|Period 1||0
1530538|NCT01425814|3747145|P3|NOT COMPLETED|Period 1||0
1530539|NCT01425814|3747146|P2|NOT COMPLETED|Period 1||1
1530540|NCT01425814|3747147|P1|NOT COMPLETED|Period 1||0
1530541|NCT01425814|3747142|P6|COMPLETED|Period 1||13
1530542|NCT01425814|3747143|P5|COMPLETED|Period 1||12
1530543|NCT01425814|3747144|P4|COMPLETED|Period 1||10
1530544|NCT01425814|3747145|P3|COMPLETED|Period 1||12
1530545|NCT01425814|3747146|P2|COMPLETED|Period 1||10
1530546|NCT01425814|3747147|P1|COMPLETED|Period 1||12
1530547|NCT01425814|3747142|P6|STARTED|Period 1||13
1530548|NCT01425814|3747143|P5|STARTED|Period 1||12
1530549|NCT01425814|3747144|P4|STARTED|Period 1||10
1530550|NCT01425814|3747145|P3|STARTED|Period 1||12
1530551|NCT01425814|3747146|P2|STARTED|Period 1||11
1530552|NCT01425814|3747147|P1|STARTED|Period 1||12
1530553|NCT01425801|3747239|P6|NOT COMPLETED|Period 6||0
1530554|NCT01425801|3747240|P5|NOT COMPLETED|Period 6||0
1530555|NCT01425801|3747241|P4|NOT COMPLETED|Period 6||0
1530556|NCT01425801|3747242|P3|NOT COMPLETED|Period 6||0
1530557|NCT01425801|3747243|P2|NOT COMPLETED|Period 6||0
1530558|NCT01425801|3747244|P1|NOT COMPLETED|Period 6||0
1530559|NCT01425801|3747239|P6|COMPLETED|Period 6||10
1530560|NCT01425801|3747240|P5|COMPLETED|Period 6||11
1530561|NCT01425801|3747241|P4|COMPLETED|Period 6||12
1530562|NCT01425801|3747242|P3|COMPLETED|Period 6||7
1530563|NCT01425801|3747243|P2|COMPLETED|Period 6||9
1530564|NCT01425801|3747244|P1|COMPLETED|Period 6||9
1530565|NCT01425801|3747239|P6|STARTED|Period 6||10
1530566|NCT01425801|3747240|P5|STARTED|Period 6||11
1530567|NCT01425801|3747241|P4|STARTED|Period 6||12
1530568|NCT01425801|3747242|P3|STARTED|Period 6||7
1530569|NCT01425801|3747243|P2|STARTED|Period 6||9
1530570|NCT01425801|3747244|P1|STARTED|Period 6||9
1530571|NCT01425801|3747239|P6|NOT COMPLETED|Period 5||0
1530572|NCT01425801|3747240|P5|NOT COMPLETED|Period 5||0
1530573|NCT01425801|3747241|P4|NOT COMPLETED|Period 5||0
1530574|NCT01425801|3747242|P3|NOT COMPLETED|Period 5||0
1530575|NCT01425801|3747243|P2|NOT COMPLETED|Period 5||0
1530576|NCT01425801|3747244|P1|NOT COMPLETED|Period 5||0
1530577|NCT01425801|3747239|P6|COMPLETED|Period 5||10
1530578|NCT01425801|3747240|P5|COMPLETED|Period 5||11
1530579|NCT01425801|3747241|P4|COMPLETED|Period 5||12
1530580|NCT01425801|3747242|P3|COMPLETED|Period 5||7
1530581|NCT01425801|3747243|P2|COMPLETED|Period 5||9
1530582|NCT01425801|3747244|P1|COMPLETED|Period 5||9
1530583|NCT01425801|3747239|P6|STARTED|Period 5||10
1530584|NCT01425801|3747240|P5|STARTED|Period 5||11
1530585|NCT01425801|3747241|P4|STARTED|Period 5||12
1530586|NCT01425801|3747242|P3|STARTED|Period 5||7
1530587|NCT01425801|3747243|P2|STARTED|Period 5||9
1530588|NCT01425801|3747244|P1|STARTED|Period 5||9
1530589|NCT01425801|3747239|P6|NOT COMPLETED|Period 4||0
1530590|NCT01425801|3747240|P5|NOT COMPLETED|Period 4||0
1530591|NCT01425801|3747241|P4|NOT COMPLETED|Period 4||0
1530592|NCT01425801|3747242|P3|NOT COMPLETED|Period 4||1
1530593|NCT01425801|3747243|P2|NOT COMPLETED|Period 4||0
1530594|NCT01425801|3747244|P1|NOT COMPLETED|Period 4||0
1530595|NCT01425801|3747239|P6|COMPLETED|Period 4||10
1530596|NCT01425801|3747240|P5|COMPLETED|Period 4||11
1530597|NCT01425801|3747241|P4|COMPLETED|Period 4||12
1530598|NCT01425801|3747242|P3|COMPLETED|Period 4||7
1530599|NCT01425801|3747243|P2|COMPLETED|Period 4||9
1530600|NCT01425801|3747244|P1|COMPLETED|Period 4||9
1530601|NCT01425801|3747239|P6|STARTED|Period 4||10
1530602|NCT01425801|3747240|P5|STARTED|Period 4||11
1530603|NCT01425801|3747241|P4|STARTED|Period 4||12
1530604|NCT01425801|3747242|P3|STARTED|Period 4||8
1530605|NCT01425801|3747243|P2|STARTED|Period 4||9
1530606|NCT01425801|3747244|P1|STARTED|Period 4||9
1530607|NCT01425801|3747239|P6|NOT COMPLETED|Period 3||0
1530608|NCT01425801|3747240|P5|NOT COMPLETED|Period 3||0
1530609|NCT01425801|3747241|P4|NOT COMPLETED|Period 3||0
1530610|NCT01425801|3747242|P3|NOT COMPLETED|Period 3||1
1530611|NCT01425801|3747243|P2|NOT COMPLETED|Period 3||0
1530612|NCT01425801|3747244|P1|NOT COMPLETED|Period 3||0
1530613|NCT01425801|3747239|P6|COMPLETED|Period 3||10
1530614|NCT01425801|3747240|P5|COMPLETED|Period 3||11
1530615|NCT01425801|3747241|P4|COMPLETED|Period 3||12
1530616|NCT01425801|3747242|P3|COMPLETED|Period 3||8
1530617|NCT01425801|3747243|P2|COMPLETED|Period 3||9
1530618|NCT01425801|3747244|P1|COMPLETED|Period 3||9
1530619|NCT01425801|3747239|P6|STARTED|Period 3||10
1530620|NCT01425801|3747240|P5|STARTED|Period 3||11
1530621|NCT01425801|3747241|P4|STARTED|Period 3||12
1530622|NCT01425801|3747242|P3|STARTED|Period 3||9
1530623|NCT01425801|3747243|P2|STARTED|Period 3||9
1530624|NCT01425801|3747244|P1|STARTED|Period 3||9
1530625|NCT01425801|3747239|P6|NOT COMPLETED|Period 2||0
1530626|NCT01425801|3747240|P5|NOT COMPLETED|Period 2||1
1530627|NCT01425801|3747241|P4|NOT COMPLETED|Period 2||0
1530628|NCT01425801|3747242|P3|NOT COMPLETED|Period 2||0
1530629|NCT01425801|3747243|P2|NOT COMPLETED|Period 2||0
1530630|NCT01425801|3747244|P1|NOT COMPLETED|Period 2||0
1530631|NCT01425801|3747239|P6|COMPLETED|Period 2||10
1530632|NCT01425801|3747240|P5|COMPLETED|Period 2||11
1530633|NCT01425801|3747241|P4|COMPLETED|Period 2||12
1530634|NCT01425801|3747242|P3|COMPLETED|Period 2||9
1530635|NCT01425801|3747243|P2|COMPLETED|Period 2||9
1530636|NCT01425801|3747244|P1|COMPLETED|Period 2||9
1530637|NCT01425801|3747239|P6|STARTED|Period 2||10
1530638|NCT01425801|3747240|P5|STARTED|Period 2||12
1530639|NCT01425801|3747241|P4|STARTED|Period 2||12
1530640|NCT01425801|3747242|P3|STARTED|Period 2||9
1530641|NCT01425801|3747243|P2|STARTED|Period 2||9
1530642|NCT01425801|3747244|P1|STARTED|Period 2||9
1530643|NCT01425801|3747239|P6|NOT COMPLETED|Period 1||0
1530644|NCT01425801|3747240|P5|NOT COMPLETED|Period 1||1
1530645|NCT01425801|3747241|P4|NOT COMPLETED|Period 1||0
1530646|NCT01425801|3747242|P3|NOT COMPLETED|Period 1||0
1530647|NCT01425801|3747243|P2|NOT COMPLETED|Period 1||0
1530648|NCT01425801|3747244|P1|NOT COMPLETED|Period 1||0
1530649|NCT01425801|3747239|P6|COMPLETED|Period 1||10
1530650|NCT01425801|3747240|P5|COMPLETED|Period 1||12
1530651|NCT01425801|3747241|P4|COMPLETED|Period 1||12
1530652|NCT01425801|3747242|P3|COMPLETED|Period 1||9
1530653|NCT01425801|3747243|P2|COMPLETED|Period 1||9
1530654|NCT01425801|3747244|P1|COMPLETED|Period 1||9
1530655|NCT01425801|3747239|P6|STARTED|Period 1||10
1530656|NCT01425801|3747240|P5|STARTED|Period 1||13
1530657|NCT01425801|3747241|P4|STARTED|Period 1||12
1530658|NCT01425801|3747242|P3|STARTED|Period 1||9
1530659|NCT01425801|3747243|P2|STARTED|Period 1||9
1530660|NCT01425801|3747244|P1|STARTED|Period 1||9
1530661|NCT01425749|3747350|P2|NOT COMPLETED|Overall Study||1
1530662|NCT01425749|3747351|P1|NOT COMPLETED|Overall Study||0
1530663|NCT01425749|3747350|P2|COMPLETED|Overall Study||11
1530664|NCT01425749|3747351|P1|COMPLETED|Overall Study||13
1530665|NCT01425749|3747350|P2|STARTED|Overall Study||12
1530666|NCT01425749|3747351|P1|STARTED|Overall Study||13
1530667|NCT01425723|3747368|P2|NOT COMPLETED|Overall Study||18
1530668|NCT01425723|3747369|P1|NOT COMPLETED|Overall Study||4
1530669|NCT01425723|3747368|P2|COMPLETED|Overall Study||75
1530670|NCT01425723|3747369|P1|COMPLETED|Overall Study||23
1530671|NCT01425723|3747368|P2|Surgery Subgroup|Overall Study||15
1530672|NCT01425723|3747369|P1|Surgery Subgroup|Overall Study||1
1530673|NCT01425723|3747368|P2|Episodic|Overall Study||15
1530674|NCT01425723|3747369|P1|Episodic|Overall Study||0
1530675|NCT01425723|3747368|P2|Personalized Prophylaxis|Overall Study||17
1530676|NCT01425723|3747369|P1|Personalized Prophylaxis|Overall Study||2
1530677|NCT01425723|3747368|P2|Individualized Prophylaxis|Overall Study||31
1530678|NCT01425723|3747369|P1|Individualized Prophylaxis|Overall Study||5
1530679|NCT01425723|3747368|P2|Weekly Prophylaxis|Overall Study||51
1530680|NCT01425723|3747369|P1|Weekly Prophylaxis|Overall Study||23
1530681|NCT01425723|3747368|P2|STARTED|Overall Study||93
1530682|NCT01425723|3747369|P1|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
1530683|NCT01425632|3747399|P3|NOT COMPLETED|Overall Study||4
1530684|NCT01425632|3747400|P2|NOT COMPLETED|Overall Study||1
1530685|NCT01425632|3747401|P1|NOT COMPLETED|Overall Study||1
1530686|NCT01425632|3747399|P3|COMPLETED|Overall Study||159
1530687|NCT01425632|3747400|P2|COMPLETED|Overall Study||165
1530688|NCT01425632|3747401|P1|COMPLETED|Overall Study||160
1530689|NCT01425632|3747399|P3|STARTED|Overall Study||163
1530690|NCT01425632|3747400|P2|STARTED|Overall Study||166
1530691|NCT01425632|3747401|P1|STARTED|Overall Study||161
1530692|NCT01425528|3747411|P2|NOT COMPLETED|Overall Study||1
1530693|NCT01425528|3747412|P1|NOT COMPLETED|Overall Study||1
1530694|NCT01425528|3747411|P2|COMPLETED|Overall Study||5
1530695|NCT01425528|3747412|P1|COMPLETED|Overall Study||5
1530696|NCT01425528|3747411|P2|STARTED|Overall Study||6
1530697|NCT01425528|3747412|P1|STARTED|Overall Study||6
1530698|NCT01425463|3747420|P2|NOT COMPLETED|Overall Study||24
1530699|NCT01425463|3747421|P1|NOT COMPLETED|Overall Study||24
1530700|NCT01425463|3747420|P2|COMPLETED|Overall Study||102
1530701|NCT01425463|3747421|P1|COMPLETED|Overall Study||106
1530702|NCT01425463|3747420|P2|Full Analysis Set|Overall Study||116
1530703|NCT01425463|3747421|P1|Full Analysis Set|Overall Study||122
1530704|NCT01425463|3747420|P2|Safety Set|Overall Study||122
1530705|NCT01425463|3747421|P1|Safety Set|Overall Study||126
1530706|NCT01425463|3747420|P2|STARTED|Overall Study||126
1530707|NCT01425463|3747421|P1|STARTED|Overall Study||130
1530708|NCT01425359|3747437|P2|NOT COMPLETED|Overall Study||22
1530709|NCT01425359|3747438|P1|NOT COMPLETED|Overall Study||19
1530710|NCT01425359|3747437|P2|COMPLETED|Overall Study||451
1530711|NCT01425359|3747438|P1|COMPLETED|Overall Study||457
1530712|NCT01425359|3747437|P2|STARTED|Overall Study||473
1530713|NCT01425359|3747438|P1|STARTED|Overall Study||476
1530714|NCT01425307|3747456|P2|NOT COMPLETED|Overall Study||19
1530715|NCT01425307|3747457|P1|NOT COMPLETED|Overall Study||19
1530716|NCT01425307|3747456|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
1530717|NCT01425307|3747457|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
1530718|NCT01425307|3747456|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
1530719|NCT01425307|3747457|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
1530720|NCT01425268|3747469|P2|NOT COMPLETED|Overall Study||0
1530721|NCT01425268|3747470|P1|NOT COMPLETED|Overall Study||8
1530722|NCT01425268|3747469|P2|COMPLETED|Overall Study||52
1530723|NCT01425268|3747470|P1|COMPLETED|Overall Study||98
1530724|NCT01425268|3747469|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
1530725|NCT01425268|3747470|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
1530726|NCT01425229|3747478|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
1530727|NCT01425229|3747478|P1|COMPLETED|Bosentan During Clarithromycin||16
1530728|NCT01425229|3747478|P1|STARTED|Bosentan During Clarithromycin||16
1530729|NCT01425229|3747478|P1|NOT COMPLETED|Bosentan Steady-state||0
1530730|NCT01425229|3747478|P1|COMPLETED|Bosentan Steady-state||16
1530731|NCT01425229|3747478|P1|STARTED|Bosentan Steady-state||16
1530732|NCT01425229|3747478|P1|NOT COMPLETED|Bosentan Single Dose||0
1530733|NCT01425229|3747478|P1|COMPLETED|Bosentan Single Dose||16
1530734|NCT01425229|3747478|P1|STARTED|Bosentan Single Dose||16
1530735|NCT01425203|3747491|P3|NOT COMPLETED|Follow-up Phase||0
1530736|NCT01425203|3747492|P2|NOT COMPLETED|Follow-up Phase||0
1530737|NCT01425203|3747493|P1|NOT COMPLETED|Follow-up Phase||0
1530738|NCT01425203|3747491|P3|COMPLETED|Follow-up Phase||27
1530739|NCT01425203|3747492|P2|COMPLETED|Follow-up Phase||49
1530740|NCT01425203|3747493|P1|COMPLETED|Follow-up Phase||153
1530741|NCT01425203|3747491|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
1530742|NCT01425203|3747492|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
1530743|NCT01425203|3747493|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
1530744|NCT01425203|3747491|P3|NOT COMPLETED|Crossover Phase||6
1530745|NCT01425203|3747492|P2|NOT COMPLETED|Crossover Phase||0
1530746|NCT01425203|3747493|P1|NOT COMPLETED|Crossover Phase||0
1530747|NCT01425203|3747491|P3|COMPLETED|Crossover Phase||21
1530748|NCT01425203|3747492|P2|COMPLETED|Crossover Phase||0
1530749|NCT01425203|3747493|P1|COMPLETED|Crossover Phase||0
1530750|NCT01425203|3747491|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
1530751|NCT01425203|3747492|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
1530752|NCT01425203|3747493|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
1530753|NCT01425203|3747491|P3|NOT COMPLETED|Treatment Phase||0
1530754|NCT01425203|3747492|P2|NOT COMPLETED|Treatment Phase||37
1530755|NCT01425203|3747493|P1|NOT COMPLETED|Treatment Phase||27
1530756|NCT01425203|3747491|P3|COMPLETED|Treatment Phase||0
1530757|NCT01425203|3747492|P2|COMPLETED|Treatment Phase||42
1530758|NCT01425203|3747493|P1|COMPLETED|Treatment Phase||132
1530759|NCT01425203|3747491|P3|Treated (FAS)|Treatment Phase||0
1530760|NCT01425203|3747492|P2|Treated (FAS)|Treatment Phase||78
1530761|NCT01425203|3747493|P1|Treated (FAS)|Treatment Phase||159
1530762|NCT01425203|3747491|P3|STARTED|Treatment Phase||0
1530763|NCT01425203|3747492|P2|STARTED|Treatment Phase||79
1530764|NCT01425203|3747493|P1|STARTED|Treatment Phase||159
1530765|NCT01425190|3747510|P3|NOT COMPLETED|Overall Study||0
1530766|NCT01425190|3747511|P2|NOT COMPLETED|Overall Study||0
1530767|NCT01425190|3747512|P1|NOT COMPLETED|Overall Study||1
1530768|NCT01425190|3747510|P3|COMPLETED|Overall Study||0
1530769|NCT01425190|3747511|P2|COMPLETED|Overall Study||0
1530770|NCT01425190|3747512|P1|COMPLETED|Overall Study||15
1530771|NCT01425190|3747510|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
1530772|NCT01425190|3747511|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
1530773|NCT01425190|3747512|P1|STARTED|Overall Study||16
1530774|NCT01424943|3747531|P2|NOT COMPLETED|Overall Study||1
1530775|NCT01424943|3747532|P1|NOT COMPLETED|Overall Study||13
1530776|NCT01424943|3747531|P2|COMPLETED|Overall Study||23
1530777|NCT01424943|3747532|P1|COMPLETED|Overall Study||12
1530778|NCT01424943|3747531|P2|STARTED|Overall Study||24
1530779|NCT01424943|3747532|P1|STARTED|Overall Study||25
1530780|NCT01424930|3747548|P2|NOT COMPLETED|Overall Study||14
1530781|NCT01424930|3747549|P1|NOT COMPLETED|Overall Study||4
1530782|NCT01424930|3747548|P2|COMPLETED|Overall Study||4
1530783|NCT01424930|3747549|P1|COMPLETED|Overall Study||3
1530784|NCT01424930|3747548|P2|Completed Food Safety Evaluation|Overall Study||18
1530785|NCT01424930|3747549|P1|Completed Food Safety Evaluation|Overall Study||6
1530786|NCT01424930|3747548|P2|STARTED|Overall Study||18
1530787|NCT01424930|3747549|P1|STARTED|Overall Study||7
1530788|NCT01424813|3747563|P2|NOT COMPLETED|Overall Study||2
1530789|NCT01424813|3747564|P1|NOT COMPLETED|Overall Study||5
1530790|NCT01424813|3747563|P2|COMPLETED|Overall Study||77
1530791|NCT01424813|3747564|P1|COMPLETED|Overall Study||74
1530792|NCT01424813|3747563|P2|Treated|Overall Study|Safety set and full analysis set|78
1530793|NCT01424813|3747564|P1|Treated|Overall Study|Safety set and full analysis set|79
1530794|NCT01424813|3747563|P2|STARTED|Overall Study||79
1530795|NCT01424813|3747564|P1|STARTED|Overall Study||79
1530796|NCT01424644|3747584|P2|NOT COMPLETED|Overall Study||27
1530797|NCT01424644|3747585|P1|NOT COMPLETED|Overall Study||33
1530798|NCT01424644|3747584|P2|COMPLETED|Overall Study||372
1530799|NCT01424644|3747585|P1|COMPLETED|Overall Study||369
1530800|NCT01424644|3747584|P2|STARTED|Overall Study||399
1530801|NCT01424644|3747585|P1|STARTED|Overall Study||402
1530802|NCT01424566|3747599|P3|NOT COMPLETED|Double-blind Treatment||15
1530803|NCT01424566|3747600|P2|NOT COMPLETED|Double-blind Treatment||25
1530804|NCT01424566|3747601|P1|NOT COMPLETED|Double-blind Treatment||0
1530805|NCT01424566|3747599|P3|COMPLETED|Double-blind Treatment||88
1530806|NCT01424566|3747600|P2|COMPLETED|Double-blind Treatment||78
1530807|NCT01424566|3747601|P1|COMPLETED|Double-blind Treatment||0
1530808|NCT01424566|3747599|P3|ITT Population|Double-blind Treatment||103
1530809|NCT01424566|3747600|P2|ITT Population|Double-blind Treatment||103
1530810|NCT01424566|3747601|P1|ITT Population|Double-blind Treatment||0
1530811|NCT01424566|3747599|P3|Randomized Safety Population|Double-blind Treatment||103
1530812|NCT01424566|3747600|P2|Randomized Safety Population|Double-blind Treatment||103
1530813|NCT01424566|3747601|P1|Randomized Safety Population|Double-blind Treatment||0
1530814|NCT01424566|3747599|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
1530815|NCT01424566|3747600|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
1530816|NCT01424566|3747601|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
1530817|NCT01424566|3747599|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
1530818|NCT01424566|3747600|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
1530819|NCT01424566|3747601|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
1530820|NCT01424566|3747599|P3|NOT COMPLETED|Single-blind Treatment||0
1530821|NCT01424566|3747600|P2|NOT COMPLETED|Single-blind Treatment||0
1530822|NCT01424566|3747601|P1|NOT COMPLETED|Single-blind Treatment||200
1530823|NCT01424566|3747599|P3|COMPLETED|Single-blind Treatment||0
1530824|NCT01424566|3747600|P2|COMPLETED|Single-blind Treatment||0
1530825|NCT01424566|3747601|P1|COMPLETED|Single-blind Treatment||206
1530826|NCT01424566|3747599|P3|Met Randomization Criteria|Single-blind Treatment||0
1530827|NCT01424566|3747600|P2|Met Randomization Criteria|Single-blind Treatment||0
1530828|NCT01424566|3747601|P1|Met Randomization Criteria|Single-blind Treatment||206
1530829|NCT01424566|3747599|P3|Single-blind Safety Population|Single-blind Treatment||0
1530830|NCT01424566|3747600|P2|Single-blind Safety Population|Single-blind Treatment||0
1530831|NCT01424566|3747601|P1|Single-blind Safety Population|Single-blind Treatment||404
1530832|NCT01424566|3747599|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
1530833|NCT01424566|3747600|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
1530834|NCT01424566|3747601|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
1530835|NCT01424566|3747599|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
1530836|NCT01424566|3747600|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
1530837|NCT01424566|3747601|P1|STARTED|Single-blind Treatment||406
1530838|NCT01424514|3747628|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
1530839|NCT01424514|3747629|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
1530840|NCT01424514|3747628|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
1530841|NCT01424514|3747629|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
1530842|NCT01424514|3747628|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
1530843|NCT01424514|3747629|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
1530844|NCT01424514|3747628|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
1530845|NCT01424514|3747629|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
1530846|NCT01424514|3747628|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
1530847|NCT01424514|3747629|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
1530848|NCT01424514|3747628|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
1530849|NCT01424514|3747629|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
1530850|NCT01424514|3747628|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
1530851|NCT01424514|3747629|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
1530852|NCT01424514|3747628|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
1530853|NCT01424514|3747629|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
1530854|NCT01424514|3747628|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
1530855|NCT01424514|3747629|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
1530856|NCT01424501|3747674|P6|NOT COMPLETED|Overall Study||0
1530857|NCT01424501|3747675|P5|NOT COMPLETED|Overall Study||0
1530858|NCT01424501|3747676|P4|NOT COMPLETED|Overall Study||0
1530859|NCT01424501|3747677|P3|NOT COMPLETED|Overall Study||2
1530860|NCT01424501|3747678|P2|NOT COMPLETED|Overall Study||1
1530861|NCT01424501|3747679|P1|NOT COMPLETED|Overall Study||1
1530862|NCT01424501|3747674|P6|COMPLETED|Overall Study||40
1530863|NCT01424501|3747675|P5|COMPLETED|Overall Study||40
1530864|NCT01424501|3747676|P4|COMPLETED|Overall Study||25
1530865|NCT01424501|3747677|P3|COMPLETED|Overall Study||22
1530866|NCT01424501|3747678|P2|COMPLETED|Overall Study||5
1530867|NCT01424501|3747679|P1|COMPLETED|Overall Study||6
1530868|NCT01424501|3747674|P6|STARTED|Overall Study||40
1530869|NCT01424501|3747675|P5|STARTED|Overall Study||40
1530870|NCT01424501|3747676|P4|STARTED|Overall Study||25
1530871|NCT01424501|3747677|P3|STARTED|Overall Study||24
1530872|NCT01424501|3747678|P2|STARTED|Overall Study||6
1530873|NCT01424501|3747679|P1|STARTED|Overall Study||7
1530874|NCT01424306|3747843|P6|NOT COMPLETED|Overall Study||0
1530875|NCT01424306|3747844|P5|NOT COMPLETED|Overall Study||1
1530876|NCT01424306|3747845|P4|NOT COMPLETED|Overall Study||0
1530877|NCT01424306|3747846|P3|NOT COMPLETED|Overall Study||0
1530878|NCT01424306|3747847|P2|NOT COMPLETED|Overall Study||0
1530879|NCT01424306|3747848|P1|NOT COMPLETED|Overall Study||0
1530880|NCT01424306|3747843|P6|COMPLETED|Overall Study||6
1530881|NCT01424306|3747844|P5|COMPLETED|Overall Study||4
1530882|NCT01424306|3747845|P4|COMPLETED|Overall Study||3
1530883|NCT01424306|3747846|P3|COMPLETED|Overall Study||3
1530884|NCT01424306|3747847|P2|COMPLETED|Overall Study||4
1530885|NCT01424306|3747848|P1|COMPLETED|Overall Study||4
1530886|NCT01424306|3747843|P6|STARTED|Overall Study||6
1530887|NCT01424306|3747844|P5|STARTED|Overall Study||5
1530888|NCT01424306|3747845|P4|STARTED|Overall Study||3
1530889|NCT01424306|3747846|P3|STARTED|Overall Study||3
1530890|NCT01424306|3747847|P2|STARTED|Overall Study||4
1530891|NCT01424306|3747848|P1|STARTED|Overall Study||4
1530892|NCT01424228|3747897|P2|NOT COMPLETED|Overall Study||47
1530893|NCT01424228|3747898|P1|NOT COMPLETED|Overall Study||56
1530894|NCT01424228|3747897|P2|COMPLETED|Overall Study||135
1530895|NCT01424228|3747898|P1|COMPLETED|Overall Study||126
1530896|NCT01424228|3747897|P2|STARTED|Overall Study||182
1530897|NCT01424228|3747898|P1|STARTED|Overall Study||182
1530898|NCT01424189|3747938|P2|NOT COMPLETED|Overall Study||6
1530899|NCT01424189|3747939|P1|NOT COMPLETED|Overall Study||13
1530900|NCT01424189|3747938|P2|COMPLETED|Overall Study||182
1530901|NCT01424189|3747939|P1|COMPLETED|Overall Study||373
1530902|NCT01424189|3747938|P2|STARTED|Overall Study||188
1530903|NCT01424189|3747939|P1|STARTED|Overall Study||386
1530904|NCT01424072|3747954|P3|NOT COMPLETED|Overall Study||0
1530905|NCT01424072|3747955|P2|NOT COMPLETED|Overall Study||0
1530906|NCT01424072|3747956|P1|NOT COMPLETED|Overall Study||0
1530907|NCT01424072|3747954|P3|COMPLETED|Overall Study||22
1530908|NCT01424072|3747955|P2|COMPLETED|Overall Study||26
1530909|NCT01424072|3747956|P1|COMPLETED|Overall Study||27
1530910|NCT01424072|3747954|P3|STARTED|Overall Study||22
1530911|NCT01424072|3747955|P2|STARTED|Overall Study||26
1530912|NCT01424072|3747956|P1|STARTED|Overall Study||27
1530913|NCT01424033|3747973|P1|NOT COMPLETED|Overall Study||5
1530914|NCT01424033|3747973|P1|COMPLETED|Overall Study||0
1530915|NCT01424033|3747973|P1|STARTED|Overall Study||5
1530916|NCT01423916|3747980|P3|NOT COMPLETED|Overall Study||7
1530917|NCT01423916|3747981|P2|NOT COMPLETED|Overall Study||20
1530918|NCT01423916|3747982|P1|NOT COMPLETED|Overall Study||11
1530919|NCT01423916|3747980|P3|COMPLETED|Overall Study||64
1530920|NCT01423916|3747981|P2|COMPLETED|Overall Study||53
1530921|NCT01423916|3747982|P1|COMPLETED|Overall Study||63
1530922|NCT01423916|3747980|P3|STARTED|Overall Study||71
1530923|NCT01423916|3747981|P2|STARTED|Overall Study||73
1530924|NCT01423916|3747982|P1|STARTED|Overall Study||74
1530925|NCT01423812|3748038|P2|NOT COMPLETED|Overall Study||4
1530926|NCT01423812|3748039|P1|NOT COMPLETED|Overall Study||3
1530927|NCT01423812|3748038|P2|COMPLETED|Overall Study||26
1530928|NCT01423812|3748039|P1|COMPLETED|Overall Study||27
1530929|NCT01423812|3748038|P2|STARTED|Overall Study||30
1530930|NCT01423812|3748039|P1|STARTED|Overall Study||30
1530931|NCT01423773|3748047|P2|NOT COMPLETED|Period 2, 2 Days||0
1530932|NCT01423773|3748048|P1|NOT COMPLETED|Period 2, 2 Days||0
1530933|NCT01423773|3748047|P2|COMPLETED|Period 2, 2 Days||10
1530934|NCT01423773|3748048|P1|COMPLETED|Period 2, 2 Days||10
1530935|NCT01423773|3748047|P2|STARTED|Period 2, 2 Days||10
1530936|NCT01423773|3748048|P1|STARTED|Period 2, 2 Days||10
1530937|NCT01423773|3748047|P2|NOT COMPLETED|Period One, 2 Days||0
1530938|NCT01423773|3748048|P1|NOT COMPLETED|Period One, 2 Days||0
1530939|NCT01423773|3748047|P2|COMPLETED|Period One, 2 Days||10
1530940|NCT01423773|3748048|P1|COMPLETED|Period One, 2 Days||10
1530941|NCT01423773|3748047|P2|STARTED|Period One, 2 Days||10
1530942|NCT01423773|3748048|P1|STARTED|Period One, 2 Days||10
1530943|NCT01423760|3748056|P2|NOT COMPLETED|Overall Study||0
1530944|NCT01423760|3748057|P1|NOT COMPLETED|Overall Study||0
1530945|NCT01423760|3748056|P2|COMPLETED|Overall Study||13
1530946|NCT01423760|3748057|P1|COMPLETED|Overall Study||14
1530947|NCT01423760|3748056|P2|Safety Analysis Set|Overall Study||8
1530948|NCT01423760|3748057|P1|Safety Analysis Set|Overall Study||12
1530949|NCT01423760|3748056|P2|Number of Non-treatment Subjects|Overall Study||5
1530950|NCT01423760|3748057|P1|Number of Non-treatment Subjects|Overall Study||2
1530951|NCT01423760|3748056|P2|Number of Tecemotide Subjects|Overall Study||8
1530952|NCT01423760|3748057|P1|Number of Tecemotide Subjects|Overall Study||12
1530953|NCT01423760|3748056|P2|STARTED|Overall Study||13
1530954|NCT01423760|3748057|P1|STARTED|Overall Study||14
1530955|NCT01423617|3748067|P2|NOT COMPLETED|Overall Study||1
1530956|NCT01423617|3748068|P1|NOT COMPLETED|Overall Study||0
1530957|NCT01423617|3748067|P2|COMPLETED|Overall Study||45
1530958|NCT01423617|3748068|P1|COMPLETED|Overall Study||46
1530959|NCT01423617|3748067|P2|STARTED|Overall Study||46
1530960|NCT01423617|3748068|P1|STARTED|Overall Study||46
1530961|NCT01423604|3748085|P2|NOT COMPLETED|Randomized||63
1530962|NCT01423604|3748086|P1|NOT COMPLETED|Randomized||63
1530963|NCT01423604|3748085|P2|COMPLETED|Randomized||0
1530964|NCT01423604|3748086|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
1530965|NCT01423604|3748085|P2|STARTED|Randomized||63
1530966|NCT01423604|3748086|P1|STARTED|Randomized||64
1530967|NCT01423604|3748085|P2|NOT COMPLETED|Safety Run-In||0
1530968|NCT01423604|3748086|P1|NOT COMPLETED|Safety Run-In||9
1530969|NCT01423604|3748085|P2|COMPLETED|Safety Run-In||0
1530970|NCT01423604|3748086|P1|COMPLETED|Safety Run-In||0
1530971|NCT01423604|3748085|P2|STARTED|Safety Run-In||0
1530972|NCT01423604|3748086|P1|STARTED|Safety Run-In||9
1530973|NCT01423253|3748101|P1|NOT COMPLETED|Overall Study||9
1530974|NCT01423253|3748101|P1|COMPLETED|Overall Study||39
1530975|NCT01423253|3748101|P1|STARTED|Overall Study||48
1530976|NCT01423162|3748114|P2|NOT COMPLETED|Overall Study||0
1530977|NCT01423162|3748115|P1|NOT COMPLETED|Overall Study||0
1530978|NCT01423162|3748114|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
1530979|NCT01423162|3748115|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
1530980|NCT01423162|3748114|P2|STARTED|Overall Study||9
1530981|NCT01423162|3748115|P1|STARTED|Overall Study||11
1530982|NCT01423084|3748123|P2|NOT COMPLETED|Overall Study||4
1530983|NCT01423084|3748124|P1|NOT COMPLETED|Overall Study||2
1530984|NCT01423084|3748123|P2|COMPLETED|Overall Study||170
1530985|NCT01423084|3748124|P1|COMPLETED|Overall Study||168
1530986|NCT01423084|3748123|P2|STARTED|Overall Study||174
1530987|NCT01423084|3748124|P1|STARTED|Overall Study||170
1530988|NCT01422915|3748154|P1|NOT COMPLETED|Overall Study||1
1530989|NCT01422915|3748154|P1|COMPLETED|Overall Study||3
1530990|NCT01422915|3748154|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
1530991|NCT01422889|3748159|P1|NOT COMPLETED|Overall Study||9
1530992|NCT01422889|3748159|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
1530993|NCT01422889|3748159|P1|STARTED|Overall Study||1120
1530994|NCT01422876|3748174|P10|NOT COMPLETED|Week 52||17
1530995|NCT01422876|3748175|P9|NOT COMPLETED|Week 52||21
1530996|NCT01422876|3748176|P8|NOT COMPLETED|Week 52||23
1530997|NCT01422876|3748177|P7|NOT COMPLETED|Week 52||16
1530998|NCT01422876|3748178|P6|NOT COMPLETED|Week 52||17
1530999|NCT01422876|3748179|P5|NOT COMPLETED|Week 52||15
1531000|NCT01422876|3748180|P4|NOT COMPLETED|Week 52||18
1531001|NCT01422876|3748181|P3|NOT COMPLETED|Week 52||13
1531002|NCT01422876|3748182|P2|NOT COMPLETED|Week 52||10
1531003|NCT01422876|3748183|P1|NOT COMPLETED|Week 52||12
1531004|NCT01422876|3748174|P10|COMPLETED|Week 52||118
1531005|NCT01422876|3748175|P9|COMPLETED|Week 52||113
1531006|NCT01422876|3748176|P8|COMPLETED|Week 52||112
1531007|NCT01422876|3748177|P7|COMPLETED|Week 52||120
1531008|NCT01422876|3748178|P6|COMPLETED|Week 52||120
1531009|NCT01422876|3748179|P5|COMPLETED|Week 52||117
1531010|NCT01422876|3748180|P4|COMPLETED|Week 52||122
1531011|NCT01422876|3748181|P3|COMPLETED|Week 52||128
1531012|NCT01422876|3748182|P2|COMPLETED|Week 52||126
1531013|NCT01422876|3748183|P1|COMPLETED|Week 52||125
1531014|NCT01422876|3748174|P10|STARTED|Week 52||135
1531015|NCT01422876|3748175|P9|STARTED|Week 52||134
1531016|NCT01422876|3748176|P8|STARTED|Week 52||135
1531017|NCT01422876|3748177|P7|STARTED|Week 52||136
1531018|NCT01422876|3748178|P6|STARTED|Week 52||137
1531019|NCT01422876|3748179|P5|STARTED|Week 52||132
1531020|NCT01422876|3748180|P4|STARTED|Week 52||140
1531021|NCT01422876|3748181|P3|STARTED|Week 52||141
1531022|NCT01422876|3748182|P2|STARTED|Week 52||136
1531023|NCT01422876|3748183|P1|STARTED|Week 52||137
1531024|NCT01422876|3748174|P10|NOT COMPLETED|Week 24||10
1531025|NCT01422876|3748175|P9|NOT COMPLETED|Week 24||6
1531026|NCT01422876|3748176|P8|NOT COMPLETED|Week 24||7
1531027|NCT01422876|3748177|P7|NOT COMPLETED|Week 24||6
1531028|NCT01422876|3748178|P6|NOT COMPLETED|Week 24||6
1531029|NCT01422876|3748179|P5|NOT COMPLETED|Week 24||7
1531030|NCT01422876|3748180|P4|NOT COMPLETED|Week 24||8
1531031|NCT01422876|3748181|P3|NOT COMPLETED|Week 24||5
1531032|NCT01422876|3748182|P2|NOT COMPLETED|Week 24||3
1531033|NCT01422876|3748183|P1|NOT COMPLETED|Week 24||6
1531034|NCT01422876|3748174|P10|COMPLETED|Week 24||125
1531035|NCT01422876|3748175|P9|COMPLETED|Week 24||128
1531036|NCT01422876|3748176|P8|COMPLETED|Week 24||128
1531037|NCT01422876|3748177|P7|COMPLETED|Week 24||130
1531038|NCT01422876|3748178|P6|COMPLETED|Week 24||131
1531039|NCT01422876|3748179|P5|COMPLETED|Week 24||125
1531040|NCT01422876|3748180|P4|COMPLETED|Week 24||132
1531041|NCT01422876|3748181|P3|COMPLETED|Week 24||136
1531042|NCT01422876|3748182|P2|COMPLETED|Week 24||133
1531043|NCT01422876|3748183|P1|COMPLETED|Week 24||131
1531044|NCT01422876|3748174|P10|STARTED|Week 24||135
1531045|NCT01422876|3748175|P9|STARTED|Week 24||134
1531046|NCT01422876|3748176|P8|STARTED|Week 24||135
1531047|NCT01422876|3748177|P7|STARTED|Week 24||136
1531048|NCT01422876|3748178|P6|STARTED|Week 24||137
1531049|NCT01422876|3748179|P5|STARTED|Week 24||132
1531050|NCT01422876|3748180|P4|STARTED|Week 24||140
1531051|NCT01422876|3748181|P3|STARTED|Week 24||141
1531052|NCT01422876|3748182|P2|STARTED|Week 24||136
1531053|NCT01422876|3748183|P1|STARTED|Week 24||137
1531054|NCT01422850|3748230|P1|NOT COMPLETED|Overall Study||3
1531055|NCT01422850|3748230|P1|COMPLETED|Overall Study||18
1531056|NCT01422850|3748230|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
1531057|NCT01422850|3748230|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
1531058|NCT01422850|3748230|P1|Week 9 - Second Treatment|Overall Study||20
1531059|NCT01422850|3748230|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
1531060|NCT01422850|3748230|P1|Week 4 - First Treatment|Overall Study||21
1531061|NCT01422850|3748230|P1|STARTED|Overall Study||21
1531062|NCT01422824|3748236|P1|NOT COMPLETED|Overall Study||38
1531063|NCT01422824|3748236|P1|COMPLETED|Overall Study||147
1531064|NCT01422824|3748236|P1|Treated|Overall Study||184
1531065|NCT01422824|3748236|P1|STARTED|Overall Study||185
1531066|NCT01422720|3748241|P1|NOT COMPLETED|Overall Study||22
1531067|NCT01422720|3748241|P1|COMPLETED|Overall Study||50
1531068|NCT01422720|3748241|P1|Per-Protocol Set (PPS)|Overall Study||55
1531069|NCT01422720|3748241|P1|Full Analysis Set (FAS)|Overall Study||71
1531070|NCT01422720|3748241|P1|Safety Set|Overall Study||72
1531071|NCT01422720|3748241|P1|STARTED|Overall Study||72
1531072|NCT01422538|3748252|P3|NOT COMPLETED|Overall Study||2
1531073|NCT01422538|3748253|P2|NOT COMPLETED|Overall Study||2
1531074|NCT01422538|3748254|P1|NOT COMPLETED|Overall Study||0
1531075|NCT01422538|3748252|P3|COMPLETED|Overall Study||8
1531076|NCT01422538|3748253|P2|COMPLETED|Overall Study||8
1531077|NCT01422538|3748254|P1|COMPLETED|Overall Study||10
1531078|NCT01422538|3748252|P3|STARTED|Overall Study||10
1531079|NCT01422538|3748253|P2|STARTED|Overall Study||10
1531080|NCT01422538|3748254|P1|STARTED|Overall Study||10
1531081|NCT01422434|3748279|P3|NOT COMPLETED|Overall Study||6
1531082|NCT01422434|3748280|P2|NOT COMPLETED|Overall Study||5
1531083|NCT01422434|3748281|P1|NOT COMPLETED|Overall Study||11
1531084|NCT01422434|3748279|P3|COMPLETED|Overall Study||217
1531085|NCT01422434|3748280|P2|COMPLETED|Overall Study||221
1531086|NCT01422434|3748281|P1|COMPLETED|Overall Study||216
1531087|NCT01422434|3748279|P3|STARTED|Overall Study||223
1531088|NCT01422434|3748280|P2|STARTED|Overall Study||226
1531089|NCT01422434|3748281|P1|STARTED|Overall Study||227
1531090|NCT01422408|3748298|P1|NOT COMPLETED|Overall Study||4
1531091|NCT01422408|3748298|P1|COMPLETED|Overall Study||30
1531092|NCT01422408|3748298|P1|STARTED|Overall Study||34
1531093|NCT01422382|3748327|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
1531094|NCT01422382|3748327|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
1531095|NCT01422382|3748327|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
1531096|NCT01422382|3748327|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
1531097|NCT01422382|3748327|P1|COMPLETED|Diltiazem 240 mg QD||28
1531098|NCT01422382|3748327|P1|STARTED|Diltiazem 240 mg QD||28
1531099|NCT01422382|3748327|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
1531100|NCT01422382|3748327|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
1531101|NCT01422382|3748327|P1|STARTED|NK-104 4mg Once Daily (QD)||28
1531102|NCT01422369|3748332|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
1531103|NCT01422369|3748332|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
1531104|NCT01422369|3748332|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
1531105|NCT01422369|3748332|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
1531106|NCT01422369|3748332|P1|COMPLETED|Prezista 800mg/100mg QD||28
1531107|NCT01422369|3748332|P1|STARTED|Prezista 800mg/100mg QD||28
1531108|NCT01422369|3748332|P1|NOT COMPLETED|NK-104 4mg QD||0
1531109|NCT01422369|3748332|P1|COMPLETED|NK-104 4mg QD||28
1531110|NCT01422369|3748332|P1|STARTED|NK-104 4mg QD||28
1531111|NCT01422356|3748337|P1|NOT COMPLETED|Overall Study||31
1531112|NCT01422356|3748337|P1|COMPLETED|Overall Study||169
1531113|NCT01422356|3748337|P1|STARTED|Overall Study||200
1531114|NCT01422304|3748343|P2|NOT COMPLETED|Overall Study||37
1531115|NCT01422304|3748344|P1|NOT COMPLETED|Overall Study||24
1531116|NCT01422304|3748343|P2|COMPLETED|Overall Study||563
1531117|NCT01422304|3748344|P1|COMPLETED|Overall Study||574
1531118|NCT01422304|3748343|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
1531119|NCT01422304|3748344|P1|Treated|Overall Study||595
1531120|NCT01422304|3748343|P2|STARTED|Overall Study|Randomized|600
1531121|NCT01422304|3748344|P1|STARTED|Overall Study|Randomized|598
1531122|NCT01422239|3748376|P2|NOT COMPLETED|Overall Study||3
1531123|NCT01422239|3748377|P1|NOT COMPLETED|Overall Study||4
1531124|NCT01422239|3748376|P2|COMPLETED|Overall Study||3
1531125|NCT01422239|3748377|P1|COMPLETED|Overall Study||10
1531126|NCT01422239|3748376|P2|STARTED|Overall Study||6
1531127|NCT01422239|3748377|P1|STARTED|Overall Study||14
1531128|NCT01422226|3748389|P2|NOT COMPLETED|Overall Study||0
1531129|NCT01422226|3748390|P1|NOT COMPLETED|Overall Study||0
1531130|NCT01422226|3748389|P2|COMPLETED|Overall Study||2
1531131|NCT01422226|3748390|P1|COMPLETED|Overall Study||1
1531132|NCT01422226|3748389|P2|STARTED|Overall Study||2
1531133|NCT01422226|3748390|P1|STARTED|Overall Study||1
1531134|NCT01422213|3748399|P3|NOT COMPLETED|Overall Study||29
1531135|NCT01422213|3748400|P2|NOT COMPLETED|Overall Study||22
1531136|NCT01422213|3748401|P1|NOT COMPLETED|Overall Study||33
1531137|NCT01422213|3748399|P3|COMPLETED|Overall Study||178
1531138|NCT01422213|3748400|P2|COMPLETED|Overall Study||173
1531139|NCT01422213|3748401|P1|COMPLETED|Overall Study||163
1531140|NCT01422213|3748399|P3|STARTED|Overall Study||207
1531141|NCT01422213|3748400|P2|STARTED|Overall Study||195
1531142|NCT01422213|3748401|P1|STARTED|Overall Study||196
1531143|NCT01422187|3748462|P3|NOT COMPLETED|Overall Study||0
1531144|NCT01422187|3748463|P2|NOT COMPLETED|Overall Study||1
1531145|NCT01422187|3748464|P1|NOT COMPLETED|Overall Study||1
1531146|NCT01422187|3748462|P3|COMPLETED|Overall Study||2
1531147|NCT01422187|3748463|P2|COMPLETED|Overall Study||8
1531148|NCT01422187|3748464|P1|COMPLETED|Overall Study||7
1531149|NCT01422187|3748462|P3|STARTED|Overall Study||2
1531150|NCT01422187|3748463|P2|STARTED|Overall Study||9
1531151|NCT01422187|3748464|P1|STARTED|Overall Study||8
1531152|NCT01422135|3748481|P6|NOT COMPLETED|Overall Study||1
1531153|NCT01422135|3748482|P5|NOT COMPLETED|Overall Study||0
1531154|NCT01422135|3748483|P4|NOT COMPLETED|Overall Study||0
1531155|NCT01422135|3748484|P3|NOT COMPLETED|Overall Study||1
1531156|NCT01422135|3748485|P2|NOT COMPLETED|Overall Study||0
1531157|NCT01422135|3748486|P1|NOT COMPLETED|Overall Study||0
1531158|NCT01422135|3748481|P6|COMPLETED|Overall Study||3
1531159|NCT01422135|3748482|P5|COMPLETED|Overall Study||4
1531160|NCT01422135|3748483|P4|COMPLETED|Overall Study||4
1531161|NCT01422135|3748484|P3|COMPLETED|Overall Study||3
1531162|NCT01422135|3748485|P2|COMPLETED|Overall Study||4
1531163|NCT01422135|3748486|P1|COMPLETED|Overall Study||4
1531164|NCT01422135|3748481|P6|STARTED|Overall Study||4
1531165|NCT01422135|3748482|P5|STARTED|Overall Study||4
1531166|NCT01422135|3748483|P4|STARTED|Overall Study||4
1531167|NCT01422135|3748484|P3|STARTED|Overall Study||4
1531168|NCT01422135|3748485|P2|STARTED|Overall Study||4
1531169|NCT01422135|3748486|P1|STARTED|Overall Study||4
1531170|NCT01422070|3748497|P2|NOT COMPLETED|Overall Study||0
1531171|NCT01422070|3748498|P1|NOT COMPLETED|Overall Study||0
1531172|NCT01422070|3748497|P2|COMPLETED|Overall Study||803
1531173|NCT01422070|3748498|P1|COMPLETED|Overall Study||5031
1531174|NCT01422070|3748497|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
1531175|NCT01422070|3748498|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
1531176|NCT01421719|3748509|P1|NOT COMPLETED|Overall Study||4
1531177|NCT01421719|3748509|P1|COMPLETED|Overall Study||16
1531178|NCT01421719|3748509|P1|STARTED|Overall Study||20
1531179|NCT01421667|3748518|P4|NOT COMPLETED|Overall Study||1
1531180|NCT01421667|3748519|P3|NOT COMPLETED|Overall Study||2
1531181|NCT01421667|3748520|P2|NOT COMPLETED|Overall Study||2
1531182|NCT01421667|3748521|P1|NOT COMPLETED|Overall Study||0
1531183|NCT01421667|3748518|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
1531184|NCT01421667|3748519|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
1531185|NCT01421667|3748520|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
1531186|NCT01421667|3748521|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
1531187|NCT01421667|3748518|P4|STARTED|Overall Study||16
1531188|NCT01421667|3748519|P3|STARTED|Overall Study||53
1531189|NCT01421667|3748520|P2|STARTED|Overall Study||68
1531190|NCT01421667|3748521|P1|STARTED|Overall Study||35
1531191|NCT01421654|3748573|P2|NOT COMPLETED|Overall Study||0
1531192|NCT01421654|3748574|P1|NOT COMPLETED|Overall Study||0
1531193|NCT01421654|3748573|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
1531194|NCT01421654|3748574|P1|COMPLETED|Overall Study||11
1531195|NCT01421654|3748573|P2|STARTED|Overall Study||9
1531196|NCT01421654|3748574|P1|STARTED|Overall Study||11
1531197|NCT01421641|3748582|P2|NOT COMPLETED|Overall Study||2
1531198|NCT01421641|3748583|P1|NOT COMPLETED|Overall Study||2
1531199|NCT01421641|3748582|P2|COMPLETED|Overall Study||35
1531200|NCT01421641|3748583|P1|COMPLETED|Overall Study||35
1531201|NCT01421641|3748582|P2|STARTED|Overall Study||37
1531202|NCT01421641|3748583|P1|STARTED|Overall Study||37
1531203|NCT01421589|3748593|P1|NOT COMPLETED|Overall Study||0
1531204|NCT01421589|3748593|P1|COMPLETED|Overall Study||15
1531205|NCT01421589|3748593|P1|STARTED|Overall Study||15
1531206|NCT01421511|3748605|P2|NOT COMPLETED|Overall Study||28
1531207|NCT01421511|3748606|P1|NOT COMPLETED|Overall Study||19
1531208|NCT01421511|3748605|P2|COMPLETED|Overall Study||306
1531209|NCT01421511|3748606|P1|COMPLETED|Overall Study||313
1531210|NCT01421511|3748605|P2|STARTED|Overall Study||334
1531211|NCT01421511|3748606|P1|STARTED|Overall Study||332
1531212|NCT01421498|3748628|P2|NOT COMPLETED|Overall Study||11
1531213|NCT01421498|3748629|P1|NOT COMPLETED|Overall Study||12
1531214|NCT01421498|3748628|P2|COMPLETED|Overall Study||284
1531215|NCT01421498|3748629|P1|COMPLETED|Overall Study||281
1531216|NCT01421498|3748628|P2|STARTED|Overall Study||295
1531217|NCT01421498|3748629|P1|STARTED|Overall Study||293
1531218|NCT01421472|3748641|P4|NOT COMPLETED|Overall Study||0
1531219|NCT01421472|3748642|P3|NOT COMPLETED|Overall Study||0
1531220|NCT01421472|3748643|P2|NOT COMPLETED|Overall Study||0
1531221|NCT01421472|3748644|P1|NOT COMPLETED|Overall Study||0
1531222|NCT01421472|3748641|P4|COMPLETED|Overall Study||32
1531223|NCT01421472|3748642|P3|COMPLETED|Overall Study||64
1531224|NCT01421472|3748643|P2|COMPLETED|Overall Study||33
1531225|NCT01421472|3748644|P1|COMPLETED|Overall Study||67
1531226|NCT01421472|3748641|P4|STARTED|Overall Study||32
1531227|NCT01421472|3748642|P3|STARTED|Overall Study||64
1531228|NCT01421472|3748643|P2|STARTED|Overall Study||33
1531229|NCT01421472|3748644|P1|STARTED|Overall Study||67
1531230|NCT01421459|3748656|P2|NOT COMPLETED|Overall Study||52
1531231|NCT01421459|3748657|P1|NOT COMPLETED|Overall Study||45
1531232|NCT01421459|3748656|P2|COMPLETED|Overall Study||328
1531233|NCT01421459|3748657|P1|COMPLETED|Overall Study||334
1531234|NCT01421459|3748656|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
1531235|NCT01421459|3748657|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
1531236|NCT01421459|3748656|P2|STARTED|Overall Study||380
1531237|NCT01421459|3748657|P1|STARTED|Overall Study||379
1531238|NCT01421355|3748691|P1|NOT COMPLETED|Overall Study||6
1531239|NCT01421355|3748691|P1|COMPLETED|Overall Study||15
1531240|NCT01421355|3748691|P1|STARTED|Overall Study||21
1531241|NCT01421342|3748698|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
1531242|NCT01421342|3748699|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
1531243|NCT01421342|3748700|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
1531244|NCT01421342|3748698|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
1531245|NCT01421342|3748699|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
1531246|NCT01421342|3748700|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
1531247|NCT01421342|3748698|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
1531248|NCT01421342|3748699|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
1531249|NCT01421342|3748700|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
1531250|NCT01421342|3748698|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
1531251|NCT01421342|3748699|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
1531252|NCT01421342|3748700|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
1531253|NCT01421342|3748698|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
1531254|NCT01421342|3748699|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
1531255|NCT01421342|3748700|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
1531256|NCT01421342|3748698|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
1531257|NCT01421342|3748699|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
1531258|NCT01421342|3748700|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
1531259|NCT01421342|3748698|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
1531260|NCT01421342|3748699|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
1531261|NCT01421342|3748700|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
1531262|NCT01421342|3748698|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
1531263|NCT01421342|3748699|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
1531264|NCT01421342|3748700|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
1531265|NCT01421342|3748698|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
1531266|NCT01421342|3748699|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
1531267|NCT01421342|3748700|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
1531268|NCT01421303|3748717|P1|NOT COMPLETED|Overall Study||22
1531269|NCT01421303|3748717|P1|COMPLETED|Overall Study||58
1531270|NCT01421303|3748717|P1|STARTED|Overall Study||80
1531271|NCT01421277|3748744|P2|NOT COMPLETED|Overall Study||92
1531272|NCT01421277|3748745|P1|NOT COMPLETED|Overall Study||0
1531273|NCT01421277|3748744|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
1531274|NCT01421277|3748745|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
1531275|NCT01421277|3748744|P2|STARTED|Overall Study||191
1531276|NCT01421277|3748745|P1|STARTED|Overall Study||25
1531277|NCT01421225|3748757|P2|NOT COMPLETED|Overall Study||1
1531278|NCT01421225|3748758|P1|NOT COMPLETED|Overall Study||0
1531279|NCT01421225|3748757|P2|COMPLETED|Overall Study||5
1531280|NCT01421225|3748758|P1|COMPLETED|Overall Study||4
1531281|NCT01421225|3748757|P2|STARTED|Overall Study||6
1531282|NCT01421225|3748758|P1|STARTED|Overall Study||4
1531283|NCT01421147|3748772|P2|NOT COMPLETED|Extension Period||11
1531284|NCT01421147|3748773|P1|NOT COMPLETED|Extension Period||8
1531285|NCT01421147|3748772|P2|COMPLETED|Extension Period||245
1531286|NCT01421147|3748773|P1|COMPLETED|Extension Period||245
1531287|NCT01421147|3748772|P2|STARTED|Extension Period||256
1531288|NCT01421147|3748773|P1|STARTED|Extension Period||253
1531289|NCT01421147|3748772|P2|NOT COMPLETED|Treatment Period||11
1531290|NCT01421147|3748773|P1|NOT COMPLETED|Treatment Period||16
1531291|NCT01421147|3748772|P2|COMPLETED|Treatment Period||256
1531292|NCT01421147|3748773|P1|COMPLETED|Treatment Period||253
1531293|NCT01421147|3748772|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
1531294|NCT01421147|3748773|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
1531295|NCT01421147|3748772|P2|STARTED|Treatment Period||267
1531296|NCT01421147|3748773|P1|STARTED|Treatment Period||269
1531297|NCT01421134|3748805|P2|NOT COMPLETED|Overall Study||15
1531298|NCT01421134|3748806|P1|NOT COMPLETED|Overall Study||7
1531299|NCT01421134|3748805|P2|COMPLETED|Overall Study||87
1531300|NCT01421134|3748806|P1|COMPLETED|Overall Study||102
1531301|NCT01421134|3748805|P2|STARTED|Overall Study||102
1531302|NCT01421134|3748806|P1|STARTED|Overall Study||109
1531303|NCT01420926|3748826|P2|NOT COMPLETED|Overall Study||65
1531304|NCT01420926|3748827|P1|NOT COMPLETED|Overall Study||60
1531305|NCT01420926|3748826|P2|COMPLETED|Overall Study||16
1531306|NCT01420926|3748827|P1|COMPLETED|Overall Study||22
1531307|NCT01420926|3748826|P2|STARTED|Overall Study||81
1531308|NCT01420926|3748827|P1|STARTED|Overall Study||82
1531309|NCT01420848|3748844|P3|NOT COMPLETED|Overall Study||0
1531310|NCT01420848|3748845|P2|NOT COMPLETED|Overall Study||0
1531311|NCT01420848|3748846|P1|NOT COMPLETED|Overall Study||0
1531312|NCT01420848|3748844|P3|COMPLETED|Overall Study||22
1531313|NCT01420848|3748845|P2|COMPLETED|Overall Study||25
1531314|NCT01420848|3748846|P1|COMPLETED|Overall Study||24
1531315|NCT01420848|3748844|P3|STARTED|Overall Study||22
1531316|NCT01420848|3748845|P2|STARTED|Overall Study||25
1531317|NCT01420848|3748846|P1|STARTED|Overall Study||24
1531318|NCT01420653|3748861|P4|NOT COMPLETED|Overall Study||7
1531319|NCT01420653|3748862|P3|NOT COMPLETED|Overall Study||4
1531320|NCT01420653|3748863|P2|NOT COMPLETED|Overall Study||3
1531321|NCT01420653|3748864|P1|NOT COMPLETED|Overall Study||3
1531322|NCT01420653|3748861|P4|COMPLETED|Overall Study||68
1531323|NCT01420653|3748862|P3|COMPLETED|Overall Study||108
1531324|NCT01420653|3748863|P2|COMPLETED|Overall Study||108
1531325|NCT01420653|3748864|P1|COMPLETED|Overall Study||107
1531326|NCT01420653|3748861|P4|STARTED|Overall Study||75
1531327|NCT01420653|3748862|P3|STARTED|Overall Study||112
1531328|NCT01420653|3748863|P2|STARTED|Overall Study||111
1531329|NCT01420653|3748864|P1|STARTED|Overall Study||110
1531330|NCT01420289|3748876|P2|NOT COMPLETED|Overall Study||0
1531331|NCT01420289|3748877|P1|NOT COMPLETED|Overall Study||0
1531332|NCT01420289|3748876|P2|COMPLETED|Overall Study||16
1531333|NCT01420289|3748877|P1|COMPLETED|Overall Study||18
1531334|NCT01420289|3748876|P2|STARTED|Overall Study||16
1531335|NCT01420289|3748877|P1|STARTED|Overall Study||18
1531336|NCT01420146|3748889|P1|NOT COMPLETED|Overall Study||0
1531337|NCT01420146|3748889|P1|COMPLETED|Overall Study||20
1531338|NCT01420146|3748889|P1|STARTED|Overall Study||20
1531339|NCT01420081|3748902|P9|NOT COMPLETED|Overall Study||3
1531340|NCT01420081|3748903|P8|NOT COMPLETED|Overall Study||3
1531341|NCT01420081|3748904|P7|NOT COMPLETED|Overall Study||3
1531342|NCT01420081|3748905|P6|NOT COMPLETED|Overall Study||20
1531343|NCT01420081|3748906|P5|NOT COMPLETED|Overall Study||20
1531344|NCT01420081|3748907|P4|NOT COMPLETED|Overall Study||3
1531345|NCT01420081|3748908|P3|NOT COMPLETED|Overall Study||11
1531346|NCT01420081|3748909|P2|NOT COMPLETED|Overall Study||1
1531347|NCT01420081|3748910|P1|NOT COMPLETED|Overall Study||3
1531348|NCT01420081|3748902|P9|COMPLETED|Overall Study||0
1531349|NCT01420081|3748903|P8|COMPLETED|Overall Study||0
1531350|NCT01420081|3748904|P7|COMPLETED|Overall Study||0
1531351|NCT01420081|3748905|P6|COMPLETED|Overall Study||0
1531352|NCT01420081|3748906|P5|COMPLETED|Overall Study||0
1531353|NCT01420081|3748907|P4|COMPLETED|Overall Study||0
1531354|NCT01420081|3748908|P3|COMPLETED|Overall Study||0
1531355|NCT01420081|3748909|P2|COMPLETED|Overall Study||0
1531356|NCT01420081|3748910|P1|COMPLETED|Overall Study||0
1531357|NCT01420081|3748902|P9|STARTED|Overall Study||3
1531358|NCT01420081|3748903|P8|STARTED|Overall Study||3
1531359|NCT01420081|3748904|P7|STARTED|Overall Study||3
1531360|NCT01420081|3748905|P6|STARTED|Overall Study||20
1531361|NCT01420081|3748906|P5|STARTED|Overall Study||20
1531362|NCT01420081|3748907|P4|STARTED|Overall Study||3
1531363|NCT01420081|3748908|P3|STARTED|Overall Study||11
1531364|NCT01420081|3748909|P2|STARTED|Overall Study||1
1531365|NCT01420081|3748910|P1|STARTED|Overall Study||3
1531366|NCT01420016|3748991|P4|NOT COMPLETED|Safety Analysis||0
1531367|NCT01420016|3748992|P3|NOT COMPLETED|Safety Analysis||0
1531368|NCT01420016|3748993|P2|NOT COMPLETED|Safety Analysis||0
1531369|NCT01420016|3748994|P1|NOT COMPLETED|Safety Analysis||0
1531370|NCT01420016|3748991|P4|COMPLETED|Safety Analysis||5159
1531371|NCT01420016|3748992|P3|COMPLETED|Safety Analysis||6392
1531372|NCT01420016|3748993|P2|COMPLETED|Safety Analysis||0
1531373|NCT01420016|3748994|P1|COMPLETED|Safety Analysis||0
1531374|NCT01420016|3748991|P4|STARTED|Safety Analysis||5159
1531375|NCT01420016|3748992|P3|STARTED|Safety Analysis||6392
1531376|NCT01420016|3748993|P2|STARTED|Safety Analysis||0
1531377|NCT01420016|3748994|P1|STARTED|Safety Analysis||0
1531378|NCT01420016|3748991|P4|NOT COMPLETED|Primary Analysis||0
1531379|NCT01420016|3748992|P3|NOT COMPLETED|Primary Analysis||0
1531380|NCT01420016|3748993|P2|NOT COMPLETED|Primary Analysis||2540
1531381|NCT01420016|3748994|P1|NOT COMPLETED|Primary Analysis||2927
1531382|NCT01420016|3748991|P4|COMPLETED|Primary Analysis||0
1531383|NCT01420016|3748992|P3|COMPLETED|Primary Analysis||0
1531384|NCT01420016|3748993|P2|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
1531385|NCT01420016|3748994|P1|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
1531386|NCT01420016|3748991|P4|STARTED|Primary Analysis||0
1531387|NCT01420016|3748992|P3|STARTED|Primary Analysis||0
1531388|NCT01420016|3748993|P2|STARTED|Primary Analysis||6411
1531389|NCT01420016|3748994|P1|STARTED|Primary Analysis||6970
1531390|NCT01419977|3749002|P2|NOT COMPLETED|Overall Study||0
1531391|NCT01419977|3749003|P1|NOT COMPLETED|Overall Study||0
1531392|NCT01419977|3749002|P2|COMPLETED|Overall Study||13
1531393|NCT01419977|3749003|P1|COMPLETED|Overall Study||16
1531394|NCT01419977|3749002|P2|STARTED|Overall Study||13
1531395|NCT01419977|3749003|P1|STARTED|Overall Study||16
1531396|NCT01419795|3749017|P2|NOT COMPLETED|Overall Study||0
1531397|NCT01419795|3749018|P1|NOT COMPLETED|Overall Study||0
1531398|NCT01419795|3749017|P2|COMPLETED|Overall Study||0
1531399|NCT01419795|3749018|P1|COMPLETED|Overall Study||3
1531400|NCT01419795|3749017|P2|STARTED|Overall Study||0
1531401|NCT01419795|3749018|P1|STARTED|Overall Study||3
1531402|NCT01419769|3749040|P1|NOT COMPLETED|Overall Study||4
1531403|NCT01419769|3749040|P1|COMPLETED|Overall Study||29
1531404|NCT01419769|3749040|P1|STARTED|Overall Study||33
1531405|NCT01419639|3749053|P1|NOT COMPLETED|Overall Study||1
1531406|NCT01419639|3749053|P1|COMPLETED|Overall Study||9
1531407|NCT01419639|3749053|P1|STARTED|Overall Study||10
1531408|NCT01419314|3749061|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
1531409|NCT01419314|3749062|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
1531410|NCT01419314|3749061|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
1531411|NCT01419314|3749062|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
1531412|NCT01419314|3749061|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
1531413|NCT01419314|3749062|P1|STARTED|Follow-up at Week 6 of the Trial||17
1531414|NCT01419314|3749061|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
1531415|NCT01419314|3749062|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
1531416|NCT01419314|3749061|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
1531417|NCT01419314|3749062|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
1531418|NCT01419314|3749061|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
1531419|NCT01419314|3749062|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
1531420|NCT01419314|3749061|P2|NOT COMPLETED|Start of Study||0
1531421|NCT01419314|3749062|P1|NOT COMPLETED|Start of Study||0
1531422|NCT01419314|3749061|P2|COMPLETED|Start of Study||22
1531423|NCT01419314|3749062|P1|COMPLETED|Start of Study||23
1531424|NCT01419314|3749061|P2|STARTED|Start of Study|No comfort issues reported.|22
1531425|NCT01419314|3749062|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
1531426|NCT01419275|3749082|P1|NOT COMPLETED|Overall Study||0
1531427|NCT01419275|3749082|P1|COMPLETED|Overall Study||126
1531428|NCT01419275|3749082|P1|STARTED|Overall Study||126
1531429|NCT01419249|3749088|P2|NOT COMPLETED|Overall Study||0
1531430|NCT01419249|3749089|P1|NOT COMPLETED|Overall Study||0
1531431|NCT01419249|3749088|P2|COMPLETED|Overall Study||140
1531432|NCT01419249|3749089|P1|COMPLETED|Overall Study||318
1531433|NCT01419249|3749088|P2|STARTED|Overall Study||140
1531434|NCT01419249|3749089|P1|STARTED|Overall Study||318
1531435|NCT01419236|3749103|P2|NOT COMPLETED|Overall Study||5
1531436|NCT01419236|3749104|P1|NOT COMPLETED|Overall Study||5
1531437|NCT01419236|3749103|P2|COMPLETED|Overall Study||35
1531438|NCT01419236|3749104|P1|COMPLETED|Overall Study||31
1531439|NCT01419236|3749103|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
1531440|NCT01419236|3749104|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
1531441|NCT01419236|3749103|P2|STARTED|Overall Study||40
1531442|NCT01419236|3749104|P1|STARTED|Overall Study||36
1531443|NCT01419197|3749128|P2|NOT COMPLETED|Overall Study||198
1531444|NCT01419197|3749129|P1|NOT COMPLETED|Overall Study||404
1531445|NCT01419197|3749128|P2|COMPLETED|Overall Study||0
1531446|NCT01419197|3749129|P1|COMPLETED|Overall Study||0
1531447|NCT01419197|3749128|P2|Switched to Trastuzumab Emtansine|Overall Study||94
1531448|NCT01419197|3749129|P1|Switched to Trastuzumab Emtansine|Overall Study||0
1531449|NCT01419197|3749128|P2|STARTED|Overall Study||198
1531450|NCT01419197|3749129|P1|STARTED|Overall Study||404
1531451|NCT01419184|3749154|P2|NOT COMPLETED|Overall Study||15
1531452|NCT01419184|3749155|P1|NOT COMPLETED|Overall Study||10
1531453|NCT01419184|3749154|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
1531454|NCT01419184|3749155|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
1531455|NCT01419184|3749154|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
1531456|NCT01419184|3749155|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
1531457|NCT01419184|3749154|P2|STARTED|Overall Study||121
1531458|NCT01419184|3749155|P1|STARTED|Overall Study||128
1531459|NCT01419171|3749171|P1|NOT COMPLETED|Overall Study||0
1531460|NCT01419171|3749171|P1|COMPLETED|Overall Study||328
1531461|NCT01419171|3749171|P1|STARTED|Overall Study||328
1531462|NCT01419028|3749188|P1|NOT COMPLETED|Overall Study||0
1531463|NCT01419028|3749188|P1|COMPLETED|Overall Study||48
1531464|NCT01419028|3749188|P1|STARTED|Overall Study||48
1531465|NCT01418937|3749193|P1|NOT COMPLETED|Overall Study||8
1531466|NCT01418937|3749193|P1|COMPLETED|Overall Study||156
1531467|NCT01418937|3749193|P1|STARTED|Overall Study||164
1531468|NCT01418703|3749202|P4|NOT COMPLETED|Overall Study||0
1531469|NCT01418703|3749203|P3|NOT COMPLETED|Overall Study||0
1531470|NCT01418703|3749204|P2|NOT COMPLETED|Overall Study||0
1531471|NCT01418703|3749205|P1|NOT COMPLETED|Overall Study||0
1531472|NCT01418703|3749202|P4|COMPLETED|Overall Study||6
1531473|NCT01418703|3749203|P3|COMPLETED|Overall Study||6
1531474|NCT01418703|3749204|P2|COMPLETED|Overall Study||13
1531475|NCT01418703|3749205|P1|COMPLETED|Overall Study||13
1531476|NCT01418703|3749202|P4|STARTED|Overall Study||6
1531477|NCT01418703|3749203|P3|STARTED|Overall Study||6
1531478|NCT01418703|3749204|P2|STARTED|Overall Study||13
1531479|NCT01418703|3749205|P1|STARTED|Overall Study||13
1531480|NCT01418482|3749216|P1|NOT COMPLETED|Overall Study||0
1531481|NCT01418482|3749216|P1|COMPLETED|Overall Study||15
1531482|NCT01418482|3749216|P1|STARTED|Overall Study||15
1531483|NCT01418365|3749224|P2|NOT COMPLETED|Second Intervention||1
1531484|NCT01418365|3749225|P1|NOT COMPLETED|Second Intervention||0
1531485|NCT01418365|3749224|P2|COMPLETED|Second Intervention||13
1531486|NCT01418365|3749225|P1|COMPLETED|Second Intervention||14
1531487|NCT01418365|3749224|P2|STARTED|Second Intervention||14
1531488|NCT01418365|3749225|P1|STARTED|Second Intervention||14
1531489|NCT01418365|3749224|P2|NOT COMPLETED|First Intervention||1
1531490|NCT01418365|3749225|P1|NOT COMPLETED|First Intervention||1
1531491|NCT01418365|3749224|P2|COMPLETED|First Intervention||14
1531492|NCT01418365|3749225|P1|COMPLETED|First Intervention||14
1531493|NCT01418365|3749224|P2|STARTED|First Intervention||15
1531494|NCT01418365|3749225|P1|STARTED|First Intervention||15
1531495|NCT01418209|3749236|P3|NOT COMPLETED|Overall Study||4
1531496|NCT01418209|3749237|P2|NOT COMPLETED|Overall Study||3
1531497|NCT01418209|3749238|P1|NOT COMPLETED|Overall Study||2
1531498|NCT01418209|3749236|P3|COMPLETED|Overall Study||142
1531499|NCT01418209|3749237|P2|COMPLETED|Overall Study||93
1531500|NCT01418209|3749238|P1|COMPLETED|Overall Study||95
1531501|NCT01418209|3749236|P3|STARTED|Overall Study||146
1531502|NCT01418209|3749237|P2|STARTED|Overall Study||96
1531503|NCT01418209|3749238|P1|STARTED|Overall Study||97
1531504|NCT01418001|3749267|P1|NOT COMPLETED|Overall Study||0
1531505|NCT01418001|3749267|P1|COMPLETED|Overall Study||5
1531506|NCT01418001|3749267|P1|STARTED|Overall Study||5
1531507|NCT01417936|3749272|P1|NOT COMPLETED|Overall Study||0
1531508|NCT01417936|3749272|P1|COMPLETED|Overall Study||26
1531509|NCT01417936|3749272|P1|STARTED|Overall Study||26
1531510|NCT01417481|3749293|P2|NOT COMPLETED|Second Period (8 Weeks)||0
1531511|NCT01417481|3749294|P1|NOT COMPLETED|Second Period (8 Weeks)||0
1531512|NCT01417481|3749293|P2|COMPLETED|Second Period (8 Weeks)||5
1531513|NCT01417481|3749294|P1|COMPLETED|Second Period (8 Weeks)||8
1531514|NCT01417481|3749293|P2|STARTED|Second Period (8 Weeks)||5
1531515|NCT01417481|3749294|P1|STARTED|Second Period (8 Weeks)||8
1531516|NCT01417481|3749293|P2|NOT COMPLETED|Washout (2 Weeks)||0
1531517|NCT01417481|3749294|P1|NOT COMPLETED|Washout (2 Weeks)||0
1531518|NCT01417481|3749293|P2|COMPLETED|Washout (2 Weeks)||5
1531519|NCT01417481|3749294|P1|COMPLETED|Washout (2 Weeks)||8
1531520|NCT01417481|3749293|P2|STARTED|Washout (2 Weeks)||5
1531521|NCT01417481|3749294|P1|STARTED|Washout (2 Weeks)||8
1531522|NCT01417481|3749293|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
1531523|NCT01417481|3749294|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
1531524|NCT01417481|3749293|P2|COMPLETED|First Intervention (8 Weeks)||5
1531525|NCT01417481|3749294|P1|COMPLETED|First Intervention (8 Weeks)||8
1531526|NCT01417481|3749293|P2|STARTED|First Intervention (8 Weeks)||7
1531527|NCT01417481|3749294|P1|STARTED|First Intervention (8 Weeks)||8
1531528|NCT01417455|3749326|P8|NOT COMPLETED|Overall Study||0
1531529|NCT01417455|3749327|P7|NOT COMPLETED|Overall Study||0
1531530|NCT01417455|3749328|P6|NOT COMPLETED|Overall Study||0
1531531|NCT01417455|3749329|P5|NOT COMPLETED|Overall Study||0
1531532|NCT01417455|3749330|P4|NOT COMPLETED|Overall Study||0
1531533|NCT01417455|3749331|P3|NOT COMPLETED|Overall Study||0
1531534|NCT01417455|3749332|P2|NOT COMPLETED|Overall Study||0
1531535|NCT01417455|3749333|P1|NOT COMPLETED|Overall Study||0
1531536|NCT01417455|3749326|P8|COMPLETED|Overall Study||25
1531537|NCT01417455|3749327|P7|COMPLETED|Overall Study||13
1531538|NCT01417455|3749328|P6|COMPLETED|Overall Study||13
1531539|NCT01417455|3749329|P5|COMPLETED|Overall Study||30
1531540|NCT01417455|3749330|P4|COMPLETED|Overall Study||17
1531541|NCT01417455|3749331|P3|COMPLETED|Overall Study||17
1531542|NCT01417455|3749332|P2|COMPLETED|Overall Study||16
1531543|NCT01417455|3749333|P1|COMPLETED|Overall Study||16
1531544|NCT01417455|3749326|P8|STARTED|Overall Study||25
1531545|NCT01417455|3749327|P7|STARTED|Overall Study||13
1531546|NCT01417455|3749328|P6|STARTED|Overall Study||13
1531547|NCT01417455|3749329|P5|STARTED|Overall Study||30
1531548|NCT01417455|3749330|P4|STARTED|Overall Study||17
1531549|NCT01417455|3749331|P3|STARTED|Overall Study||17
1531550|NCT01417455|3749332|P2|STARTED|Overall Study||16
1531551|NCT01417455|3749333|P1|STARTED|Overall Study||16
1531552|NCT01417377|3749359|P1|NOT COMPLETED|Overall Study||13
1531553|NCT01417377|3749359|P1|COMPLETED|Overall Study||9
1531554|NCT01417377|3749359|P1|Treated|Overall Study||21
1531555|NCT01417377|3749359|P1|STARTED|Overall Study||22
1531556|NCT01417195|3749368|P2|NOT COMPLETED|Overall Study||1
1531557|NCT01417195|3749369|P1|NOT COMPLETED|Overall Study||3
1531558|NCT01417195|3749368|P2|COMPLETED|Overall Study||61
1531559|NCT01417195|3749369|P1|COMPLETED|Overall Study||57
1531560|NCT01417195|3749368|P2|STARTED|Overall Study||62
1531561|NCT01417195|3749369|P1|STARTED|Overall Study||60
1531562|NCT01417156|3749385|P1|NOT COMPLETED|Overall Study||14
1531563|NCT01417156|3749385|P1|COMPLETED|Overall Study||6
1531564|NCT01417156|3749385|P1|STARTED|Overall Study||20
1531565|NCT01417104|3749395|P2|NOT COMPLETED|Overall Study||2
1531566|NCT01417104|3749396|P1|NOT COMPLETED|Overall Study||6
1531567|NCT01417104|3749395|P2|COMPLETED|Overall Study||35
1531568|NCT01417104|3749396|P1|COMPLETED|Overall Study||28
1531569|NCT01417104|3749395|P2|STARTED|Overall Study||37
1531570|NCT01417104|3749396|P1|STARTED|Overall Study||34
1531571|NCT01417078|3749406|P1|NOT COMPLETED|Overall Study||1
1531572|NCT01417078|3749406|P1|COMPLETED|Overall Study||30
1531573|NCT01417078|3749406|P1|STARTED|Overall Study||31
1531574|NCT01417026|3749418|P2|NOT COMPLETED|Overall Study||0
1531575|NCT01417026|3749419|P1|NOT COMPLETED|Overall Study||2
1531576|NCT01417026|3749418|P2|COMPLETED|Overall Study||13
1531577|NCT01417026|3749419|P1|COMPLETED|Overall Study||14
1531578|NCT01417026|3749418|P2|STARTED|Overall Study||13
1531579|NCT01417026|3749419|P1|STARTED|Overall Study||16
1531580|NCT01417000|3749431|P2|NOT COMPLETED|Overall Study||29
1531581|NCT01417000|3749432|P1|NOT COMPLETED|Overall Study||61
1531582|NCT01417000|3749431|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
1531583|NCT01417000|3749432|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
1531584|NCT01417000|3749431|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
1531585|NCT01417000|3749432|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
1531586|NCT01416610|3749440|P1|NOT COMPLETED|Overall Study||43
1531587|NCT01416610|3749440|P1|COMPLETED|Overall Study||45
1531588|NCT01416610|3749440|P1|Completed Follow-up|Overall Study||45
1531589|NCT01416610|3749440|P1|Completed Treatment|Overall Study||47
1531590|NCT01416610|3749440|P1|Per Protocol|Overall Study||83
1531591|NCT01416610|3749440|P1|Safety Population|Overall Study||86
1531592|NCT01416610|3749440|P1|Intention to Treat|Overall Study||88
1531593|NCT01416610|3749440|P1|STARTED|Overall Study||88
1531594|NCT01416584|3749457|P3|NOT COMPLETED|Overall Study||1
1531595|NCT01416584|3749458|P2|NOT COMPLETED|Overall Study||2
1531596|NCT01416584|3749459|P1|NOT COMPLETED|Overall Study||3
1531597|NCT01416584|3749457|P3|COMPLETED|Overall Study||32
1531598|NCT01416584|3749458|P2|COMPLETED|Overall Study||33
1531599|NCT01416584|3749459|P1|COMPLETED|Overall Study||27
1531600|NCT01416584|3749457|P3|STARTED|Overall Study||33
1531601|NCT01416584|3749458|P2|STARTED|Overall Study||35
1531602|NCT01416584|3749459|P1|STARTED|Overall Study||30
1531603|NCT01416571|3749494|P1|NOT COMPLETED|Overall Study||2
1531604|NCT01416571|3749494|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
1531605|NCT01416571|3749494|P1|STARTED|Overall Study||78
1531606|NCT01416389|3749523|P2|NOT COMPLETED|Overall Study||0
1531607|NCT01416389|3749524|P1|NOT COMPLETED|Overall Study||3
1531608|NCT01416389|3749523|P2|COMPLETED|Overall Study||13
1531609|NCT01416389|3749524|P1|COMPLETED|Overall Study||23
1531610|NCT01416389|3749523|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
1531611|NCT01416389|3749524|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
1531612|NCT01416389|3749523|P2|STARTED|Overall Study||13
1531613|NCT01416389|3749524|P1|STARTED|Overall Study||26
1531614|NCT01416272|3749541|P1|NOT COMPLETED|Overall Study||4
1531615|NCT01416272|3749541|P1|COMPLETED|Overall Study||8
1531616|NCT01416272|3749541|P1|STARTED|Overall Study||12
1531617|NCT01416181|3749549|P2|NOT COMPLETED|Part 2||286
1531618|NCT01416181|3749550|P1|NOT COMPLETED|Part 2||271
1531619|NCT01416181|3749549|P2|COMPLETED|Part 2||6
1531620|NCT01416181|3749550|P1|COMPLETED|Part 2||3
1531621|NCT01416181|3749549|P2|Completed Treatment for > 96 Weeks|Part 2||0
1531622|NCT01416181|3749550|P1|Completed Treatment for > 96 Weeks|Part 2||1
1531623|NCT01416181|3749549|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
1531624|NCT01416181|3749550|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
1531625|NCT01416181|3749549|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
1531626|NCT01416181|3749550|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
1531627|NCT01416181|3749549|P2|STARTED|Part 2||292
1531628|NCT01416181|3749550|P1|STARTED|Part 2||274
1531629|NCT01416181|3749549|P2|NOT COMPLETED|Part 1||114
1531630|NCT01416181|3749550|P1|NOT COMPLETED|Part 1||137
1531631|NCT01416181|3749549|P2|COMPLETED|Part 1|Completed Study through Week 108|326
1531632|NCT01416181|3749550|P1|COMPLETED|Part 1|Completed Study through Week 108|312
1531633|NCT01416181|3749549|P2|Withdrew Prior to Dosing|Part 1||1
1531634|NCT01416181|3749550|P1|Withdrew Prior to Dosing|Part 1||0
1531635|NCT01416181|3749549|P2|STARTED|Part 1||440
1531636|NCT01416181|3749550|P1|STARTED|Part 1||449
1531637|NCT01416155|3749612|P1|NOT COMPLETED|Overall Study||58
1531638|NCT01416155|3749612|P1|COMPLETED|Overall Study||39
1531639|NCT01416155|3749612|P1|STARTED|Overall Study||97
1531640|NCT01416142|3749619|P3|NOT COMPLETED|PureVision2 HD||1
1531641|NCT01416142|3749620|P2|NOT COMPLETED|PureVision2 HD||0
1531642|NCT01416142|3749621|P1|NOT COMPLETED|PureVision2 HD||0
1531643|NCT01416142|3749619|P3|COMPLETED|PureVision2 HD||62
1531644|NCT01416142|3749620|P2|COMPLETED|PureVision2 HD||0
1531645|NCT01416142|3749621|P1|COMPLETED|PureVision2 HD||0
1531646|NCT01416142|3749619|P3|STARTED|PureVision2 HD||63
1531647|NCT01416142|3749620|P2|STARTED|PureVision2 HD||0
1531648|NCT01416142|3749621|P1|STARTED|PureVision2 HD||0
1531649|NCT01416142|3749619|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
1531650|NCT01416142|3749620|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
1531651|NCT01416142|3749621|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
1531652|NCT01416142|3749619|P3|COMPLETED|Cross Over at Movie Intermission||0
1531653|NCT01416142|3749620|P2|COMPLETED|Cross Over at Movie Intermission||31
1531654|NCT01416142|3749621|P1|COMPLETED|Cross Over at Movie Intermission||32
1531655|NCT01416142|3749619|P3|STARTED|Cross Over at Movie Intermission||0
1531656|NCT01416142|3749620|P2|STARTED|Cross Over at Movie Intermission||31
1531657|NCT01416142|3749621|P1|STARTED|Cross Over at Movie Intermission||32
1531658|NCT01416129|3749632|P2|NOT COMPLETED|Experimental Condition: Brimless||0
1531659|NCT01416129|3749633|P1|NOT COMPLETED|Experimental Condition: Brimless||0
1531660|NCT01416129|3749632|P2|COMPLETED|Experimental Condition: Brimless||5
1531661|NCT01416129|3749633|P1|COMPLETED|Experimental Condition: Brimless||5
1531662|NCT01416129|3749632|P2|STARTED|Experimental Condition: Brimless||5
1531663|NCT01416129|3749633|P1|STARTED|Experimental Condition: Brimless||5
1531664|NCT01416129|3749632|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
1531665|NCT01416129|3749633|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
1531666|NCT01416129|3749632|P2|COMPLETED|Control Condition: Ischial Containment||5
1531667|NCT01416129|3749633|P1|COMPLETED|Control Condition: Ischial Containment||5
1531668|NCT01416129|3749632|P2|STARTED|Control Condition: Ischial Containment||5
1531669|NCT01416129|3749633|P1|STARTED|Control Condition: Ischial Containment||5
1531670|NCT01416025|3749641|P2|NOT COMPLETED|Overall Study||0
1531671|NCT01416025|3749642|P1|NOT COMPLETED|Overall Study||0
1531672|NCT01416025|3749641|P2|COMPLETED|Overall Study||15
1531673|NCT01416025|3749642|P1|COMPLETED|Overall Study||14
1531674|NCT01416025|3749641|P2|STARTED|Overall Study||15
1531675|NCT01416025|3749642|P1|STARTED|Overall Study||14
1531676|NCT01415986|3749648|P1|NOT COMPLETED|Overall Study||1
1531677|NCT01415986|3749648|P1|COMPLETED|Overall Study|Study terminated|0
1531678|NCT01415986|3749648|P1|STARTED|Overall Study||1
1531679|NCT01415960|3749653|P1|NOT COMPLETED|Overall Study||12
1531680|NCT01415960|3749653|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
1531681|NCT01415960|3749653|P1|PK Subgroup|Overall Study||30
1531682|NCT01415960|3749653|P1|ITT|Overall Study||161
1531683|NCT01415960|3749653|P1|STARTED|Overall Study||163
1531684|NCT01415934|3749665|P2|NOT COMPLETED|Overall Study||7
1531685|NCT01415934|3749666|P1|NOT COMPLETED|Overall Study||3
1531686|NCT01415934|3749665|P2|COMPLETED|Overall Study||182
1531687|NCT01415934|3749666|P1|COMPLETED|Overall Study||189
1531688|NCT01415934|3749665|P2|STARTED|Overall Study||189
1531689|NCT01415934|3749666|P1|STARTED|Overall Study||192
1531690|NCT01415921|3749674|P2|NOT COMPLETED|Overall Study||3
1531691|NCT01415921|3749675|P1|NOT COMPLETED|Overall Study||3
1531692|NCT01415921|3749674|P2|COMPLETED|Overall Study||14
1531693|NCT01415921|3749675|P1|COMPLETED|Overall Study||13
1531694|NCT01415921|3749674|P2|STARTED|Overall Study||17
1531695|NCT01415921|3749675|P1|STARTED|Overall Study||16
1531696|NCT01415908|3749685|P2|NOT COMPLETED|Overall Study||0
1531697|NCT01415908|3749686|P1|NOT COMPLETED|Overall Study||1
1531698|NCT01415908|3749685|P2|COMPLETED|Overall Study||4
1531699|NCT01415908|3749686|P1|COMPLETED|Overall Study||10
1531700|NCT01415908|3749685|P2|STARTED|Overall Study||4
1531701|NCT01415908|3749686|P1|STARTED|Overall Study||11
1531702|NCT01415583|3749714|P2|NOT COMPLETED|Overall Study||0
1531703|NCT01415583|3749715|P1|NOT COMPLETED|Overall Study||0
1531704|NCT01415583|3749714|P2|COMPLETED|Overall Study||157
1531705|NCT01415583|3749715|P1|COMPLETED|Overall Study||157
1531706|NCT01415583|3749714|P2|STARTED|Overall Study||157
1531707|NCT01415583|3749715|P1|STARTED|Overall Study||157
1531708|NCT01415531|3749723|P2|NOT COMPLETED|Overall Study||37
1531709|NCT01415531|3749724|P1|NOT COMPLETED|Overall Study||25
1531710|NCT01415531|3749723|P2|COMPLETED|Overall Study||390
1531711|NCT01415531|3749724|P1|COMPLETED|Overall Study||189
1531712|NCT01415531|3749723|P2|STARTED|Overall Study||427
1531713|NCT01415531|3749724|P1|STARTED|Overall Study||214
1531714|NCT01415518|3749734|P2|NOT COMPLETED|Overall Study||31
1531715|NCT01415518|3749735|P1|NOT COMPLETED|Overall Study||16
1531716|NCT01415518|3749734|P2|COMPLETED|Overall Study||261
1531717|NCT01415518|3749735|P1|COMPLETED|Overall Study||276
1531718|NCT01415518|3749734|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
1531719|NCT01415518|3749735|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
1531720|NCT01415518|3749734|P2|Patients Who Received Study Treatment|Overall Study||292
1531721|NCT01415518|3749735|P1|Patients Who Received Study Treatment|Overall Study||290
1531722|NCT01415518|3749734|P2|STARTED|Overall Study||292
1531723|NCT01415518|3749735|P1|STARTED|Overall Study||292
1531724|NCT01415453|3749787|P1|NOT COMPLETED|Overall Study||0
1531725|NCT01415453|3749787|P1|COMPLETED|Overall Study||1
1531726|NCT01415453|3749787|P1|Imaging Study|Overall Study||1
1531727|NCT01415453|3749787|P1|STARTED|Overall Study||1
1531728|NCT01415427|3749795|P4|NOT COMPLETED|Overall Study||56
1531729|NCT01415427|3749796|P3|NOT COMPLETED|Overall Study||58
1531730|NCT01415427|3749797|P2|NOT COMPLETED|Overall Study||29
1531731|NCT01415427|3749798|P1|NOT COMPLETED|Overall Study||29
1531732|NCT01415427|3749795|P4|COMPLETED|Overall Study||0
1531733|NCT01415427|3749796|P3|COMPLETED|Overall Study||1
1531734|NCT01415427|3749797|P2|COMPLETED|Overall Study||0
1531735|NCT01415427|3749798|P1|COMPLETED|Overall Study||0
1531736|NCT01415427|3749795|P4|STARTED|Overall Study||56
1531737|NCT01415427|3749796|P3|STARTED|Overall Study||59
1531738|NCT01415427|3749797|P2|STARTED|Overall Study||29
1531739|NCT01415427|3749798|P1|STARTED|Overall Study||29
1531740|NCT01415401|3749835|P1|NOT COMPLETED|Overall Study||7
1531741|NCT01415401|3749835|P1|COMPLETED|Overall Study||47
1531742|NCT01415401|3749835|P1|STARTED|Overall Study||54
1531743|NCT01415349|3749840|P2|NOT COMPLETED|Treatment Period 2||0
1531744|NCT01415349|3749841|P1|NOT COMPLETED|Treatment Period 2||0
1531745|NCT01415349|3749840|P2|COMPLETED|Treatment Period 2||19
1531746|NCT01415349|3749841|P1|COMPLETED|Treatment Period 2||21
1531747|NCT01415349|3749840|P2|STARTED|Treatment Period 2||19
1531748|NCT01415349|3749841|P1|STARTED|Treatment Period 2||21
1531749|NCT01415349|3749840|P2|NOT COMPLETED|Treatment Period 1||2
1531750|NCT01415349|3749841|P1|NOT COMPLETED|Treatment Period 1||0
1531751|NCT01415349|3749840|P2|COMPLETED|Treatment Period 1||19
1531752|NCT01415349|3749841|P1|COMPLETED|Treatment Period 1||21
1531753|NCT01415349|3749840|P2|STARTED|Treatment Period 1||21
1531754|NCT01415349|3749841|P1|STARTED|Treatment Period 1||21
1531755|NCT01415232|3749849|P1|NOT COMPLETED|Overall Study||0
1531756|NCT01415232|3749849|P1|COMPLETED|Overall Study||160
1531757|NCT01415232|3749849|P1|STARTED|Overall Study||160
1531758|NCT01414855|3749853|P1|NOT COMPLETED|Overall Study||29
1531759|NCT01414855|3749853|P1|COMPLETED|Overall Study||71
1531760|NCT01414855|3749853|P1|STARTED|Overall Study||100
1531761|NCT01414634|3749869|P8|NOT COMPLETED|Overall Study||0
1531762|NCT01414634|3749870|P7|NOT COMPLETED|Overall Study||0
1531763|NCT01414634|3749871|P6|NOT COMPLETED|Overall Study||0
1531764|NCT01414634|3749872|P5|NOT COMPLETED|Overall Study||0
1531765|NCT01414634|3749873|P4|NOT COMPLETED|Overall Study||0
1531766|NCT01414634|3749874|P3|NOT COMPLETED|Overall Study||0
1531767|NCT01414634|3749875|P2|NOT COMPLETED|Overall Study||0
1531768|NCT01414634|3749876|P1|NOT COMPLETED|Overall Study||0
1531769|NCT01414634|3749869|P8|COMPLETED|Overall Study||1
1531770|NCT01414634|3749870|P7|COMPLETED|Overall Study||1
1531771|NCT01414634|3749871|P6|COMPLETED|Overall Study||2
1531772|NCT01414634|3749872|P5|COMPLETED|Overall Study||1
1531773|NCT01414634|3749873|P4|COMPLETED|Overall Study||1
1531774|NCT01414634|3749874|P3|COMPLETED|Overall Study||1
1531775|NCT01414634|3749875|P2|COMPLETED|Overall Study||1
1531776|NCT01414634|3749876|P1|COMPLETED|Overall Study||1
1531777|NCT01414634|3749869|P8|STARTED|Overall Study||1
1531778|NCT01414634|3749870|P7|STARTED|Overall Study||1
1531779|NCT01414634|3749871|P6|STARTED|Overall Study||2
1531780|NCT01414634|3749872|P5|STARTED|Overall Study||1
1531781|NCT01414634|3749873|P4|STARTED|Overall Study||1
1531782|NCT01414634|3749874|P3|STARTED|Overall Study||1
1531783|NCT01414634|3749875|P2|STARTED|Overall Study||1
1531784|NCT01414634|3749876|P1|STARTED|Overall Study||1
1531785|NCT01414413|3749889|P2|NOT COMPLETED|Overall Study||0
1531786|NCT01414413|3749890|P1|NOT COMPLETED|Overall Study||0
1531787|NCT01414413|3749889|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
1531788|NCT01414413|3749890|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
1531789|NCT01414413|3749889|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
1531790|NCT01414413|3749890|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
1531791|NCT01414257|3749902|P1|NOT COMPLETED|Overall Study||22
1531792|NCT01414257|3749902|P1|COMPLETED|Overall Study||2838
1531793|NCT01414257|3749902|P1|STARTED|Overall Study||2860
1531794|NCT01414244|3749915|P2|NOT COMPLETED|Overall Study||0
1531795|NCT01414244|3749916|P1|NOT COMPLETED|Overall Study||0
1531796|NCT01414244|3749915|P2|COMPLETED|Overall Study||52
1531797|NCT01414244|3749916|P1|COMPLETED|Overall Study||54
1531798|NCT01414244|3749915|P2|STARTED|Overall Study||52
1531799|NCT01414244|3749916|P1|STARTED|Overall Study||54
1531800|NCT01414205|3749930|P2|NOT COMPLETED|Overall Study||7
1531801|NCT01414205|3749931|P1|NOT COMPLETED|Overall Study||7
1531802|NCT01414205|3749930|P2|COMPLETED|Overall Study||32
1531803|NCT01414205|3749931|P1|COMPLETED|Overall Study||34
1531804|NCT01414205|3749930|P2|Received Study Drug|Overall Study||38
1531805|NCT01414205|3749931|P1|Received Study Drug|Overall Study||40
1531806|NCT01414205|3749930|P2|STARTED|Overall Study||39
1531807|NCT01414205|3749931|P1|STARTED|Overall Study||41
1531808|NCT01414192|3749967|P4|NOT COMPLETED|Overall Study||0
1531809|NCT01414192|3749968|P3|NOT COMPLETED|Overall Study||0
1531810|NCT01414192|3749969|P2|NOT COMPLETED|Overall Study||0
1531811|NCT01414192|3749970|P1|NOT COMPLETED|Overall Study||0
1531812|NCT01414192|3749967|P4|COMPLETED|Overall Study||1726
1531813|NCT01414192|3749968|P3|COMPLETED|Overall Study||424
1531814|NCT01414192|3749969|P2|COMPLETED|Overall Study||575
1531815|NCT01414192|3749970|P1|COMPLETED|Overall Study||490
1531816|NCT01414192|3749967|P4|STARTED|Overall Study||1726
1531817|NCT01414192|3749968|P3|STARTED|Overall Study||424
1531818|NCT01414192|3749969|P2|STARTED|Overall Study||575
1531819|NCT01414192|3749970|P1|STARTED|Overall Study||490
1531820|NCT01414166|3750000|P2|NOT COMPLETED|Overall Study||83
1531821|NCT01414166|3750001|P1|NOT COMPLETED|Overall Study||91
1531822|NCT01414166|3750000|P2|COMPLETED|Overall Study||39
1531823|NCT01414166|3750001|P1|COMPLETED|Overall Study||31
1531824|NCT01414166|3750000|P2|Treated|Overall Study||121
1531825|NCT01414166|3750001|P1|Treated|Overall Study||120
1531826|NCT01414166|3750000|P2|STARTED|Overall Study||122
1531827|NCT01414166|3750001|P1|STARTED|Overall Study||122
1531828|NCT01414153|3750027|P4|NOT COMPLETED|Overall Study||4
1531829|NCT01414153|3750028|P3|NOT COMPLETED|Overall Study||4
1531830|NCT01414153|3750029|P2|NOT COMPLETED|Overall Study||2
1531831|NCT01414153|3750030|P1|NOT COMPLETED|Overall Study||8
1531832|NCT01414153|3750027|P4|COMPLETED|Overall Study||37
1531833|NCT01414153|3750028|P3|COMPLETED|Overall Study||35
1531834|NCT01414153|3750029|P2|COMPLETED|Overall Study||38
1531835|NCT01414153|3750030|P1|COMPLETED|Overall Study||30
1531836|NCT01414153|3750027|P4|STARTED|Overall Study||41
1531837|NCT01414153|3750028|P3|STARTED|Overall Study||39
1531838|NCT01414153|3750029|P2|STARTED|Overall Study||40
1531839|NCT01414153|3750030|P1|STARTED|Overall Study||38
1531840|NCT01414114|3750064|P1|NOT COMPLETED|Overall Study||5
1531841|NCT01414114|3750064|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
1531842|NCT01414114|3750064|P1|STARTED|Overall Study||37
1531843|NCT01414036|3750084|P2|NOT COMPLETED|Completed 3 Month Survey||5
1531844|NCT01414036|3750085|P1|NOT COMPLETED|Completed 3 Month Survey||9
1531845|NCT01414036|3750084|P2|COMPLETED|Completed 3 Month Survey||19
1531846|NCT01414036|3750085|P1|COMPLETED|Completed 3 Month Survey||14
1531847|NCT01414036|3750084|P2|STARTED|Completed 3 Month Survey||24
1531848|NCT01414036|3750085|P1|STARTED|Completed 3 Month Survey||23
1531849|NCT01414036|3750084|P2|NOT COMPLETED|Received Allocated Intervention||13
1531850|NCT01414036|3750085|P1|NOT COMPLETED|Received Allocated Intervention||0
1531851|NCT01414036|3750084|P2|COMPLETED|Received Allocated Intervention||11
1531852|NCT01414036|3750085|P1|COMPLETED|Received Allocated Intervention||23
1531853|NCT01414036|3750084|P2|STARTED|Received Allocated Intervention||24
1531854|NCT01414036|3750085|P1|STARTED|Received Allocated Intervention||23
1531855|NCT01414010|3750099|P4|NOT COMPLETED|Overall Study||0
1531856|NCT01414010|3750100|P3|NOT COMPLETED|Overall Study||0
1531857|NCT01414010|3750101|P2|NOT COMPLETED|Overall Study||0
1531858|NCT01414010|3750102|P1|NOT COMPLETED|Overall Study||2
1531859|NCT01414010|3750099|P4|COMPLETED|Overall Study||8
1531860|NCT01414010|3750100|P3|COMPLETED|Overall Study||8
1531861|NCT01414010|3750101|P2|COMPLETED|Overall Study||8
1531862|NCT01414010|3750102|P1|COMPLETED|Overall Study||6
1531863|NCT01414010|3750099|P4|STARTED|Overall Study||8
1531864|NCT01414010|3750100|P3|STARTED|Overall Study||8
1531865|NCT01414010|3750101|P2|STARTED|Overall Study||8
1531866|NCT01414010|3750102|P1|STARTED|Overall Study||8
1531867|NCT01413958|3750120|P2|NOT COMPLETED|Overall Study||1
1531868|NCT01413958|3750121|P1|NOT COMPLETED|Overall Study||0
1531869|NCT01413958|3750120|P2|COMPLETED|Overall Study||286
1531870|NCT01413958|3750121|P1|COMPLETED|Overall Study||288
1531871|NCT01413958|3750120|P2|STARTED|Overall Study||287
1531872|NCT01413958|3750121|P1|STARTED|Overall Study||288
1531873|NCT01413750|3750156|P4|NOT COMPLETED|Overall Study||0
1531874|NCT01413750|3750157|P3|NOT COMPLETED|Overall Study||0
1531875|NCT01413750|3750158|P2|NOT COMPLETED|Overall Study||0
1531876|NCT01413750|3750159|P1|NOT COMPLETED|Overall Study||0
1531877|NCT01413750|3750156|P4|COMPLETED|Overall Study||7
1531878|NCT01413750|3750157|P3|COMPLETED|Overall Study||4
1531879|NCT01413750|3750158|P2|COMPLETED|Overall Study||6
1531880|NCT01413750|3750159|P1|COMPLETED|Overall Study||6
1531881|NCT01413750|3750156|P4|STARTED|Overall Study||7
1531882|NCT01413750|3750157|P3|STARTED|Overall Study||4
1531883|NCT01413750|3750158|P2|STARTED|Overall Study||6
1531884|NCT01413750|3750159|P1|STARTED|Overall Study||6
1531885|NCT01413542|3750172|P4|NOT COMPLETED|Overall Study||1
1531886|NCT01413542|3750173|P3|NOT COMPLETED|Overall Study||3
1531887|NCT01413542|3750174|P2|NOT COMPLETED|Overall Study||0
1531888|NCT01413542|3750175|P1|NOT COMPLETED|Overall Study||1
1531889|NCT01413542|3750172|P4|COMPLETED|Overall Study||7
1531890|NCT01413542|3750173|P3|COMPLETED|Overall Study||6
1531891|NCT01413542|3750174|P2|COMPLETED|Overall Study||6
1531892|NCT01413542|3750175|P1|COMPLETED|Overall Study||5
1531893|NCT01413542|3750172|P4|STARTED|Overall Study||8
1531894|NCT01413542|3750173|P3|STARTED|Overall Study||9
1531895|NCT01413542|3750174|P2|STARTED|Overall Study||6
1531896|NCT01413542|3750175|P1|STARTED|Overall Study||6
1531897|NCT01413516|3750190|P2|NOT COMPLETED|Overall Study||0
1531898|NCT01413516|3750191|P1|NOT COMPLETED|Overall Study||0
1531899|NCT01413516|3750190|P2|COMPLETED|Overall Study||9
1531900|NCT01413516|3750191|P1|COMPLETED|Overall Study||8
1531901|NCT01413516|3750190|P2|STARTED|Overall Study||9
1531902|NCT01413516|3750191|P1|STARTED|Overall Study||8
1531903|NCT01413503|3750197|P1|NOT COMPLETED|Overall Study||1
1531904|NCT01413503|3750197|P1|COMPLETED|Overall Study||49
1531905|NCT01413503|3750197|P1|STARTED|Overall Study||50
1531906|NCT01413360|3750201|P1|NOT COMPLETED|Overall Study||3
1531907|NCT01413360|3750201|P1|COMPLETED|Overall Study||7
1531908|NCT01413360|3750201|P1|STARTED|Overall Study||10
1531909|NCT01413204|3750209|P3|NOT COMPLETED|Overall Study||19
1531910|NCT01413204|3750210|P2|NOT COMPLETED|Overall Study||6
1531911|NCT01413204|3750211|P1|NOT COMPLETED|Overall Study||6
1531912|NCT01413204|3750209|P3|COMPLETED|Overall Study||74
1531913|NCT01413204|3750210|P2|COMPLETED|Overall Study||83
1531914|NCT01413204|3750211|P1|COMPLETED|Overall Study||84
1531915|NCT01413204|3750209|P3|STARTED|Overall Study||93
1531916|NCT01413204|3750210|P2|STARTED|Overall Study||89
1531917|NCT01413204|3750211|P1|STARTED|Overall Study||90
1531918|NCT01413191|3750219|P1|NOT COMPLETED|Overall Study||11
1531919|NCT01413191|3750219|P1|COMPLETED|Overall Study||7
1531920|NCT01413191|3750219|P1|STARTED|Overall Study||18
1531921|NCT01412983|3750223|P2|NOT COMPLETED|2nd Period||0
1531922|NCT01412983|3750224|P1|NOT COMPLETED|2nd Period||0
1531923|NCT01412983|3750223|P2|COMPLETED|2nd Period||46
1531924|NCT01412983|3750224|P1|COMPLETED|2nd Period||50
1531925|NCT01412983|3750223|P2|STARTED|2nd Period||46
1531926|NCT01412983|3750224|P1|STARTED|2nd Period||50
1531927|NCT01412983|3750223|P2|NOT COMPLETED|1st Period||4
1531928|NCT01412983|3750224|P1|NOT COMPLETED|1st Period||0
1531929|NCT01412983|3750223|P2|COMPLETED|1st Period||46
1531930|NCT01412983|3750224|P1|COMPLETED|1st Period||50
1531931|NCT01412983|3750223|P2|STARTED|1st Period||50
1531932|NCT01412983|3750224|P1|STARTED|1st Period||50
1531933|NCT01412957|3750234|P2|NOT COMPLETED|Overall Study||157
1531934|NCT01412957|3750235|P1|NOT COMPLETED|Overall Study||149
1531935|NCT01412957|3750234|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
1531936|NCT01412957|3750235|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
1531937|NCT01412957|3750234|P2|STARTED|Overall Study||188
1531938|NCT01412957|3750235|P1|STARTED|Overall Study||189
1531939|NCT01412944|3750257|P6|NOT COMPLETED|Follow-up||0
1531940|NCT01412944|3750258|P5|NOT COMPLETED|Follow-up||0
1531941|NCT01412944|3750259|P4|NOT COMPLETED|Follow-up||0
1531942|NCT01412944|3750260|P3|NOT COMPLETED|Follow-up||0
1531943|NCT01412944|3750261|P2|NOT COMPLETED|Follow-up||0
1531944|NCT01412944|3750262|P1|NOT COMPLETED|Follow-up||0
1531945|NCT01412944|3750257|P6|COMPLETED|Follow-up||0
1531946|NCT01412944|3750258|P5|COMPLETED|Follow-up||2
1531947|NCT01412944|3750259|P4|COMPLETED|Follow-up||1
1531948|NCT01412944|3750260|P3|COMPLETED|Follow-up||2
1531949|NCT01412944|3750261|P2|COMPLETED|Follow-up||0
1531950|NCT01412944|3750262|P1|COMPLETED|Follow-up||0
1531951|NCT01412944|3750257|P6|STARTED|Follow-up||0
1531952|NCT01412944|3750258|P5|STARTED|Follow-up||2
1531953|NCT01412944|3750259|P4|STARTED|Follow-up||1
1531954|NCT01412944|3750260|P3|STARTED|Follow-up||2
1531955|NCT01412944|3750261|P2|STARTED|Follow-up||0
1531956|NCT01412944|3750262|P1|STARTED|Follow-up||0
1531957|NCT01412944|3750257|P6|NOT COMPLETED|Entire: IV + Maintenance||0
1531958|NCT01412944|3750258|P5|NOT COMPLETED|Entire: IV + Maintenance||0
1531959|NCT01412944|3750259|P4|NOT COMPLETED|Entire: IV + Maintenance||0
1531960|NCT01412944|3750260|P3|NOT COMPLETED|Entire: IV + Maintenance||0
1531961|NCT01412944|3750261|P2|NOT COMPLETED|Entire: IV + Maintenance||5
1531962|NCT01412944|3750262|P1|NOT COMPLETED|Entire: IV + Maintenance||2
1531963|NCT01412944|3750257|P6|COMPLETED|Entire: IV + Maintenance||0
1531964|NCT01412944|3750258|P5|COMPLETED|Entire: IV + Maintenance||0
1531965|NCT01412944|3750259|P4|COMPLETED|Entire: IV + Maintenance||0
1531966|NCT01412944|3750260|P3|COMPLETED|Entire: IV + Maintenance||0
1531967|NCT01412944|3750261|P2|COMPLETED|Entire: IV + Maintenance||17
1531968|NCT01412944|3750262|P1|COMPLETED|Entire: IV + Maintenance||19
1531969|NCT01412944|3750257|P6|STARTED|Entire: IV + Maintenance||0
1531970|NCT01412944|3750258|P5|STARTED|Entire: IV + Maintenance||0
1531971|NCT01412944|3750259|P4|STARTED|Entire: IV + Maintenance||0
1531972|NCT01412944|3750260|P3|STARTED|Entire: IV + Maintenance||0
1531973|NCT01412944|3750261|P2|STARTED|Entire: IV + Maintenance||22
1531974|NCT01412944|3750262|P1|STARTED|Entire: IV + Maintenance||21
1531975|NCT01412944|3750257|P6|NOT COMPLETED|Entire: IV + Maintenance||2
1531976|NCT01412944|3750258|P5|NOT COMPLETED|Entire: IV + Maintenance||3
1531977|NCT01412944|3750259|P4|NOT COMPLETED|Entire: IV + Maintenance||1
1531978|NCT01412944|3750260|P3|NOT COMPLETED|Entire: IV + Maintenance||1
1531979|NCT01412944|3750261|P2|NOT COMPLETED|Entire: IV + Maintenance||0
1531980|NCT01412944|3750262|P1|NOT COMPLETED|Entire: IV + Maintenance||0
1531981|NCT01412944|3750257|P6|COMPLETED|Entire: IV + Maintenance||6
1531982|NCT01412944|3750258|P5|COMPLETED|Entire: IV + Maintenance||11
1531983|NCT01412944|3750259|P4|COMPLETED|Entire: IV + Maintenance||5
1531984|NCT01412944|3750260|P3|COMPLETED|Entire: IV + Maintenance||14
1531985|NCT01412944|3750261|P2|COMPLETED|Entire: IV + Maintenance||0
1531986|NCT01412944|3750262|P1|COMPLETED|Entire: IV + Maintenance||0
1531987|NCT01412944|3750257|P6|STARTED|Entire: IV + Maintenance||8
1531988|NCT01412944|3750258|P5|STARTED|Entire: IV + Maintenance||14
1531989|NCT01412944|3750259|P4|STARTED|Entire: IV + Maintenance||6
1531990|NCT01412944|3750260|P3|STARTED|Entire: IV + Maintenance||15
1531991|NCT01412944|3750261|P2|STARTED|Entire: IV + Maintenance||0
1531992|NCT01412944|3750262|P1|STARTED|Entire: IV + Maintenance||0
1531993|NCT01412944|3750257|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
1531994|NCT01412944|3750258|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
1531995|NCT01412944|3750259|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
1531996|NCT01412944|3750260|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
1531997|NCT01412944|3750261|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
1531998|NCT01412944|3750262|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
1531999|NCT01412944|3750257|P6|COMPLETED|IV: Per CAIN457A2307||0
1532000|NCT01412944|3750258|P5|COMPLETED|IV: Per CAIN457A2307||0
1532001|NCT01412944|3750259|P4|COMPLETED|IV: Per CAIN457A2307||0
1532002|NCT01412944|3750260|P3|COMPLETED|IV: Per CAIN457A2307||0
1532003|NCT01412944|3750261|P2|COMPLETED|IV: Per CAIN457A2307||20
1532004|NCT01412944|3750262|P1|COMPLETED|IV: Per CAIN457A2307||20
1532005|NCT01412944|3750257|P6|STARTED|IV: Per CAIN457A2307||0
1532006|NCT01412944|3750258|P5|STARTED|IV: Per CAIN457A2307||0
1532007|NCT01412944|3750259|P4|STARTED|IV: Per CAIN457A2307||0
1532008|NCT01412944|3750260|P3|STARTED|IV: Per CAIN457A2307||0
1532009|NCT01412944|3750261|P2|STARTED|IV: Per CAIN457A2307||22
1532010|NCT01412944|3750262|P1|STARTED|IV: Per CAIN457A2307||21
1532011|NCT01412944|3750257|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
1532012|NCT01412944|3750258|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1532013|NCT01412944|3750259|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1532014|NCT01412944|3750260|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
1532015|NCT01412944|3750261|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1532016|NCT01412944|3750262|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1532017|NCT01412944|3750257|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
1532018|NCT01412944|3750258|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
1532019|NCT01412944|3750259|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
1532020|NCT01412944|3750260|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
1532021|NCT01412944|3750261|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1532022|NCT01412944|3750262|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
1532023|NCT01412944|3750257|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
1532024|NCT01412944|3750258|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
1532025|NCT01412944|3750259|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
1532026|NCT01412944|3750260|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
1532027|NCT01412944|3750261|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
1532028|NCT01412944|3750262|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
1532029|NCT01412918|3750298|P2|NOT COMPLETED|Overall Study||0
1532030|NCT01412918|3750299|P1|NOT COMPLETED|Overall Study||0
1532031|NCT01412918|3750298|P2|COMPLETED|Overall Study||1
1532032|NCT01412918|3750299|P1|COMPLETED|Overall Study||20
1532033|NCT01412918|3750298|P2|STARTED|Overall Study||1
1532034|NCT01412918|3750299|P1|STARTED|Overall Study||20
1532035|NCT01412879|3750308|P3|NOT COMPLETED|Consolidation Therapy||0
1532036|NCT01412879|3750309|P2|NOT COMPLETED|Consolidation Therapy||0
1532037|NCT01412879|3750310|P1|NOT COMPLETED|Consolidation Therapy||0
1532038|NCT01412879|3750308|P3|COMPLETED|Consolidation Therapy||26
1532039|NCT01412879|3750309|P2|COMPLETED|Consolidation Therapy||0
1532040|NCT01412879|3750310|P1|COMPLETED|Consolidation Therapy||0
1532041|NCT01412879|3750308|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
1532042|NCT01412879|3750309|P2|STARTED|Consolidation Therapy||0
1532043|NCT01412879|3750310|P1|STARTED|Consolidation Therapy||0
1532044|NCT01412879|3750308|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
1532045|NCT01412879|3750309|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
1532046|NCT01412879|3750310|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
1532047|NCT01412879|3750308|P3|COMPLETED|Initial Registration (Induction Therapy)||0
1532048|NCT01412879|3750309|P2|COMPLETED|Initial Registration (Induction Therapy)||27
1532049|NCT01412879|3750310|P1|COMPLETED|Initial Registration (Induction Therapy)||5
1532050|NCT01412879|3750308|P3|Treatment Started|Initial Registration (Induction Therapy)||0
1532051|NCT01412879|3750309|P2|Treatment Started|Initial Registration (Induction Therapy)||35
1532052|NCT01412879|3750310|P1|Treatment Started|Initial Registration (Induction Therapy)||17
1532053|NCT01412879|3750308|P3|STARTED|Initial Registration (Induction Therapy)||0
1532054|NCT01412879|3750309|P2|STARTED|Initial Registration (Induction Therapy)||35
1532055|NCT01412879|3750310|P1|STARTED|Initial Registration (Induction Therapy)||18
1532056|NCT01412866|3750326|P2|NOT COMPLETED|Overall Study||2
1532057|NCT01412866|3750327|P1|NOT COMPLETED|Overall Study||1
1532058|NCT01412866|3750326|P2|COMPLETED|Overall Study||64
1532059|NCT01412866|3750327|P1|COMPLETED|Overall Study||57
1532060|NCT01412866|3750326|P2|STARTED|Overall Study||66
1532061|NCT01412866|3750327|P1|STARTED|Overall Study||58
1532062|NCT01412801|3750339|P6|NOT COMPLETED|Overall Study||3
1532063|NCT01412801|3750340|P5|NOT COMPLETED|Overall Study||3
1532064|NCT01412801|3750341|P4|NOT COMPLETED|Overall Study||4
1532065|NCT01412801|3750342|P3|NOT COMPLETED|Overall Study||7
1532066|NCT01412801|3750343|P2|NOT COMPLETED|Overall Study||5
1532067|NCT01412801|3750344|P1|NOT COMPLETED|Overall Study||4
1532068|NCT01412801|3750339|P6|COMPLETED|Overall Study||84
1532069|NCT01412801|3750340|P5|COMPLETED|Overall Study||85
1532070|NCT01412801|3750341|P4|COMPLETED|Overall Study||87
1532071|NCT01412801|3750342|P3|COMPLETED|Overall Study||83
1532072|NCT01412801|3750343|P2|COMPLETED|Overall Study||84
1532073|NCT01412801|3750344|P1|COMPLETED|Overall Study||87
1532074|NCT01412801|3750339|P6|STARTED|Overall Study||87
1532075|NCT01412801|3750340|P5|STARTED|Overall Study||88
1532076|NCT01412801|3750341|P4|STARTED|Overall Study||91
1532077|NCT01412801|3750342|P3|STARTED|Overall Study||90
1532078|NCT01412801|3750343|P2|STARTED|Overall Study||89
1532079|NCT01412801|3750344|P1|STARTED|Overall Study||91
1532080|NCT01412710|3750383|P2|NOT COMPLETED|Overall Study||5
1532081|NCT01412710|3750384|P1|NOT COMPLETED|Overall Study||4
1532082|NCT01412710|3750383|P2|COMPLETED|Overall Study||22
1532083|NCT01412710|3750384|P1|COMPLETED|Overall Study||46
1532084|NCT01412710|3750383|P2|STARTED|Overall Study||27
1532085|NCT01412710|3750384|P1|STARTED|Overall Study||50
1532086|NCT01412541|3750394|P2|NOT COMPLETED|Overall Study||20
1532087|NCT01412541|3750395|P1|NOT COMPLETED|Overall Study||36
1532088|NCT01412541|3750394|P2|COMPLETED|Overall Study||140
1532089|NCT01412541|3750395|P1|COMPLETED|Overall Study||280
1532090|NCT01412541|3750394|P2|STARTED|Overall Study||160
1532091|NCT01412541|3750395|P1|STARTED|Overall Study||316
1532092|NCT01412424|3750503|P1|NOT COMPLETED|Extension Treatment Period||6
1532093|NCT01412424|3750503|P1|COMPLETED|Extension Treatment Period||82
1532094|NCT01412424|3750503|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
1532095|NCT01412424|3750503|P1|NOT COMPLETED|Core Treatment Period||53
1532096|NCT01412424|3750503|P1|COMPLETED|Core Treatment Period||102
1532097|NCT01412424|3750503|P1|STARTED|Core Treatment Period||155
1532098|NCT01412333|3750521|P2|NOT COMPLETED|Overall Study||57
1532099|NCT01412333|3750522|P1|NOT COMPLETED|Overall Study||98
1532100|NCT01412333|3750521|P2|COMPLETED|Overall Study||360
1532101|NCT01412333|3750522|P1|COMPLETED|Overall Study||320
1532102|NCT01412333|3750521|P2|STARTED|Overall Study||417
1532103|NCT01412333|3750522|P1|STARTED|Overall Study||418
1532104|NCT01412281|3750557|P4|NOT COMPLETED|Overall Study||0
1532105|NCT01412281|3750558|P3|NOT COMPLETED|Overall Study||0
1532106|NCT01412281|3750559|P2|NOT COMPLETED|Overall Study||0
1532107|NCT01412281|3750560|P1|NOT COMPLETED|Overall Study||0
1532108|NCT01412281|3750557|P4|COMPLETED|Overall Study||110
1532109|NCT01412281|3750558|P3|COMPLETED|Overall Study||110
1532110|NCT01412281|3750559|P2|COMPLETED|Overall Study||110
1532111|NCT01412281|3750560|P1|COMPLETED|Overall Study||110
1532112|NCT01412281|3750557|P4|STARTED|Overall Study||110
1532113|NCT01412281|3750558|P3|STARTED|Overall Study||110
1532114|NCT01412281|3750559|P2|STARTED|Overall Study||110
1532115|NCT01412281|3750560|P1|STARTED|Overall Study||110
1532116|NCT01412229|3750582|P1|NOT COMPLETED|Overall Study||1
1532117|NCT01412229|3750582|P1|COMPLETED|Overall Study||38
1532118|NCT01412229|3750582|P1|STARTED|Overall Study||39
1532119|NCT01412164|3750594|P1|NOT COMPLETED|Overall Study||18
1532120|NCT01412164|3750594|P1|COMPLETED|Overall Study||712
1532121|NCT01412164|3750594|P1|STARTED|Overall Study||730
1532122|NCT01412151|3750598|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
1532123|NCT01412151|3750598|P1|COMPLETED|Week 306 - 310 - Washout Period||3
1532124|NCT01412151|3750598|P1|STARTED|Week 306 - 310 - Washout Period||5
1532125|NCT01412151|3750598|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
1532126|NCT01412151|3750598|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
1532127|NCT01412151|3750598|P1|STARTED|Week 0 - 306 - Treatment Period||10
1532128|NCT01412086|3750604|P1|NOT COMPLETED|Overall Study||0
1532129|NCT01412086|3750604|P1|COMPLETED|Overall Study||112
1532130|NCT01412086|3750604|P1|STARTED|Overall Study||112
1532131|NCT01412060|3750609|P3|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
1532132|NCT01412060|3750610|P2|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
1532133|NCT01412060|3750611|P1|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
1532134|NCT01412060|3750609|P3|COMPLETED|Double-blind Treatment Phase (DBP)||18
1532135|NCT01412060|3750610|P2|COMPLETED|Double-blind Treatment Phase (DBP)||16
1532136|NCT01412060|3750611|P1|COMPLETED|Double-blind Treatment Phase (DBP)||0
1532137|NCT01412060|3750609|P3|STARTED|Double-blind Treatment Phase (DBP)||101
1532138|NCT01412060|3750610|P2|STARTED|Double-blind Treatment Phase (DBP)||99
1532139|NCT01412060|3750611|P1|STARTED|Double-blind Treatment Phase (DBP)||0
1532140|NCT01412060|3750609|P3|NOT COMPLETED|Period Between SP and DBP||0
1532141|NCT01412060|3750610|P2|NOT COMPLETED|Period Between SP and DBP||0
1532142|NCT01412060|3750611|P1|NOT COMPLETED|Period Between SP and DBP||64
1532143|NCT01412060|3750609|P3|COMPLETED|Period Between SP and DBP||0
1532144|NCT01412060|3750610|P2|COMPLETED|Period Between SP and DBP||0
1532145|NCT01412060|3750611|P1|COMPLETED|Period Between SP and DBP||200
1532146|NCT01412060|3750609|P3|STARTED|Period Between SP and DBP||0
1532147|NCT01412060|3750610|P2|STARTED|Period Between SP and DBP||0
1532148|NCT01412060|3750611|P1|STARTED|Period Between SP and DBP||264
1532149|NCT01412060|3750609|P3|NOT COMPLETED|Open-label Stabilization Period (SP)||0
1532150|NCT01412060|3750610|P2|NOT COMPLETED|Open-label Stabilization Period (SP)||0
1532151|NCT01412060|3750611|P1|NOT COMPLETED|Open-label Stabilization Period (SP)||100
1532152|NCT01412060|3750609|P3|COMPLETED|Open-label Stabilization Period (SP)||0
1532153|NCT01412060|3750610|P2|COMPLETED|Open-label Stabilization Period (SP)||0
1532154|NCT01412060|3750611|P1|COMPLETED|Open-label Stabilization Period (SP)||264
1532155|NCT01412060|3750609|P3|STARTED|Open-label Stabilization Period (SP)||0
1532156|NCT01412060|3750610|P2|STARTED|Open-label Stabilization Period (SP)||0
1532157|NCT01412060|3750611|P1|STARTED|Open-label Stabilization Period (SP)||364
1532158|NCT01412060|3750609|P3|NOT COMPLETED|Period Between RIP and SP||0
1532159|NCT01412060|3750610|P2|NOT COMPLETED|Period Between RIP and SP||0
1532160|NCT01412060|3750611|P1|NOT COMPLETED|Period Between RIP and SP||54
1532161|NCT01412060|3750609|P3|COMPLETED|Period Between RIP and SP||0
1532162|NCT01412060|3750610|P2|COMPLETED|Period Between RIP and SP||0
1532163|NCT01412060|3750611|P1|COMPLETED|Period Between RIP and SP||364
1532164|NCT01412060|3750609|P3|STARTED|Period Between RIP and SP||0
1532165|NCT01412060|3750610|P2|STARTED|Period Between RIP and SP||0
1532166|NCT01412060|3750611|P1|STARTED|Period Between RIP and SP||418
1532167|NCT01412060|3750609|P3|NOT COMPLETED|Open-label Run-in Period (RIP)||0
1532168|NCT01412060|3750610|P2|NOT COMPLETED|Open-label Run-in Period (RIP)||0
1532169|NCT01412060|3750611|P1|NOT COMPLETED|Open-label Run-in Period (RIP)||347
1532170|NCT01412060|3750609|P3|COMPLETED|Open-label Run-in Period (RIP)||0
1532171|NCT01412060|3750610|P2|COMPLETED|Open-label Run-in Period (RIP)||0
1532172|NCT01412060|3750611|P1|COMPLETED|Open-label Run-in Period (RIP)||418
1532173|NCT01412060|3750609|P3|STARTED|Open-label Run-in Period (RIP)||0
1532174|NCT01412060|3750610|P2|STARTED|Open-label Run-in Period (RIP)||0
1532175|NCT01412060|3750611|P1|STARTED|Open-label Run-in Period (RIP)||765
1532176|NCT01411995|3750623|P2|NOT COMPLETED|Overall Study||1
1532177|NCT01411995|3750624|P1|NOT COMPLETED|Overall Study||0
1532178|NCT01411995|3750623|P2|COMPLETED|Overall Study||99
1532179|NCT01411995|3750624|P1|COMPLETED|Overall Study||100
1532180|NCT01411995|3750623|P2|STARTED|Overall Study||100
1532181|NCT01411995|3750624|P1|STARTED|Overall Study||100
1532182|NCT01411891|3750632|P2|NOT COMPLETED|Overall Study||2
1532183|NCT01411891|3750633|P1|NOT COMPLETED|Overall Study||3
1532184|NCT01411891|3750632|P2|COMPLETED|Overall Study||48
1532185|NCT01411891|3750633|P1|COMPLETED|Overall Study||47
1532186|NCT01411891|3750632|P2|STARTED|Overall Study||50
1532187|NCT01411891|3750633|P1|STARTED|Overall Study||50
1532188|NCT01411852|3750643|P2|NOT COMPLETED|Hospital Intervention Phase||18
1532189|NCT01411852|3750644|P1|NOT COMPLETED|Hospital Intervention Phase||24
1532190|NCT01411852|3750643|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
1532191|NCT01411852|3750644|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
1532192|NCT01411852|3750643|P2|STARTED|Hospital Intervention Phase||89
1532193|NCT01411852|3750644|P1|STARTED|Hospital Intervention Phase||83
1532194|NCT01411852|3750643|P2|NOT COMPLETED|Prehospital Intervention Phase||7
1532195|NCT01411852|3750644|P1|NOT COMPLETED|Prehospital Intervention Phase||12
1532196|NCT01411852|3750643|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
1532197|NCT01411852|3750644|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
1532198|NCT01411852|3750643|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
1532199|NCT01411852|3750644|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
1532200|NCT01411839|3750689|P2|NOT COMPLETED|Overall Study||3
1532201|NCT01411839|3750690|P1|NOT COMPLETED|Overall Study||4
1532202|NCT01411839|3750689|P2|COMPLETED|Overall Study||17
1532203|NCT01411839|3750690|P1|COMPLETED|Overall Study||16
1532204|NCT01411839|3750689|P2|STARTED|Overall Study||20
1532205|NCT01411839|3750690|P1|STARTED|Overall Study||20
1532206|NCT01411774|3750702|P2|NOT COMPLETED|Overall Study||3
1532207|NCT01411774|3750703|P1|NOT COMPLETED|Overall Study||0
1532208|NCT01411774|3750702|P2|COMPLETED|Overall Study||67
1532209|NCT01411774|3750703|P1|COMPLETED|Overall Study||72
1532210|NCT01411774|3750702|P2|STARTED|Overall Study||70
1532211|NCT01411774|3750703|P1|STARTED|Overall Study||72
1532212|NCT01411696|3750711|P1|NOT COMPLETED|Overall Study||0
1532213|NCT01411696|3750711|P1|COMPLETED|Overall Study||289
1532214|NCT01411696|3750711|P1|STARTED|Overall Study||289
1532215|NCT01411592|3750720|P2|NOT COMPLETED|Overall Study||0
1532216|NCT01411592|3750721|P1|NOT COMPLETED|Overall Study||0
1532217|NCT01411592|3750720|P2|COMPLETED|Overall Study||16
1532218|NCT01411592|3750721|P1|COMPLETED|Overall Study||14
1532219|NCT01411592|3750720|P2|5-Year Time Frame|Overall Study||16
1532220|NCT01411592|3750721|P1|5-Year Time Frame|Overall Study||14
1532221|NCT01411592|3750720|P2|STARTED|Overall Study||16
1532222|NCT01411592|3750721|P1|STARTED|Overall Study||14
1532223|NCT01411501|3750733|P4|NOT COMPLETED|Overall Study||7
1532224|NCT01411501|3750734|P3|NOT COMPLETED|Overall Study||6
1532225|NCT01411501|3750735|P2|NOT COMPLETED|Overall Study||6
1532226|NCT01411501|3750736|P1|NOT COMPLETED|Overall Study||10
1532227|NCT01411501|3750733|P4|COMPLETED|Overall Study||163
1532228|NCT01411501|3750734|P3|COMPLETED|Overall Study||159
1532229|NCT01411501|3750735|P2|COMPLETED|Overall Study||166
1532230|NCT01411501|3750736|P1|COMPLETED|Overall Study||158
1532231|NCT01411501|3750733|P4|STARTED|Overall Study||170
1532232|NCT01411501|3750734|P3|STARTED|Overall Study||165
1532233|NCT01411501|3750735|P2|STARTED|Overall Study||172
1532234|NCT01411501|3750736|P1|STARTED|Overall Study||168
1532235|NCT01411488|3750768|P2|NOT COMPLETED|Overall Study||5
1532236|NCT01411488|3750769|P1|NOT COMPLETED|Overall Study||6
1532237|NCT01411488|3750768|P2|COMPLETED|Overall Study||38
1532238|NCT01411488|3750769|P1|COMPLETED|Overall Study||41
1532239|NCT01411488|3750768|P2|STARTED|Overall Study||43
1532240|NCT01411488|3750769|P1|STARTED|Overall Study||47
1532241|NCT01411228|3750778|P3|NOT COMPLETED|Overall Study||1
1532242|NCT01411228|3750779|P2|NOT COMPLETED|Overall Study||0
1532243|NCT01411228|3750780|P1|NOT COMPLETED|Overall Study||1
1532244|NCT01411228|3750778|P3|COMPLETED|Overall Study||4
1532245|NCT01411228|3750779|P2|COMPLETED|Overall Study||5
1532246|NCT01411228|3750780|P1|COMPLETED|Overall Study||4
1532247|NCT01411228|3750778|P3|STARTED|Overall Study||5
1532248|NCT01411228|3750779|P2|STARTED|Overall Study||5
1532249|NCT01411228|3750780|P1|STARTED|Overall Study||5
1532250|NCT01411215|3750802|P2|NOT COMPLETED|Overall Study||84
1532251|NCT01411215|3750803|P1|NOT COMPLETED|Overall Study||66
1532252|NCT01411215|3750802|P2|COMPLETED|Overall Study||7
1532253|NCT01411215|3750803|P1|COMPLETED|Overall Study||3
1532254|NCT01411215|3750802|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
1532255|NCT01411215|3750803|P1|Treated|Overall Study||69
1532256|NCT01411215|3750802|P2|STARTED|Overall Study||91
1532257|NCT01411215|3750803|P1|STARTED|Overall Study||69
1532258|NCT01411137|3750836|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
1532259|NCT01411137|3750836|P1|COMPLETED|Part 3: Open-Label Extension||12
1532260|NCT01411137|3750836|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
1532261|NCT01411137|3750836|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
1532262|NCT01411137|3750836|P1|COMPLETED|Part 2: Open-Label Extension||25
1532263|NCT01411137|3750836|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
1532264|NCT01411137|3750836|P1|NOT COMPLETED|Part 1: Dose Conversion||10
1532265|NCT01411137|3750836|P1|COMPLETED|Part 1: Dose Conversion||33
1532266|NCT01411137|3750836|P1|STARTED|Part 1: Dose Conversion||43
1532267|NCT01411085|3750855|P1|NOT COMPLETED|Overall Study||3
1532268|NCT01411085|3750855|P1|COMPLETED|Overall Study||7
1532269|NCT01411085|3750855|P1|STARTED|Overall Study||10
1532270|NCT01410812|3750862|P3|NOT COMPLETED|Overall Study||0
1532271|NCT01410812|3750863|P2|NOT COMPLETED|Overall Study||0
1532272|NCT01410812|3750864|P1|NOT COMPLETED|Overall Study||0
1532273|NCT01410812|3750862|P3|COMPLETED|Overall Study||76
1532274|NCT01410812|3750863|P2|COMPLETED|Overall Study||75
1532275|NCT01410812|3750864|P1|COMPLETED|Overall Study||75
1532276|NCT01410812|3750862|P3|STARTED|Overall Study||76
1532277|NCT01410812|3750863|P2|STARTED|Overall Study||75
1532278|NCT01410812|3750864|P1|STARTED|Overall Study||75
1532279|NCT01410773|3750875|P1|NOT COMPLETED|Overall Study||0
1532280|NCT01410773|3750875|P1|COMPLETED|Overall Study||110
1532281|NCT01410773|3750875|P1|STARTED|Overall Study||110
1532282|NCT01410604|3750882|P2|NOT COMPLETED|Overall Study||2
1532283|NCT01410604|3750883|P1|NOT COMPLETED|Overall Study||3
1532284|NCT01410604|3750882|P2|COMPLETED|Overall Study||14
1532285|NCT01410604|3750883|P1|COMPLETED|Overall Study||12
1532286|NCT01410604|3750882|P2|STARTED|Overall Study||16
1532287|NCT01410604|3750883|P1|STARTED|Overall Study||15
1532288|NCT01410565|3750905|P3|NOT COMPLETED|Double Blind Phase||0
1532289|NCT01410565|3750906|P2|NOT COMPLETED|Double Blind Phase||15
1532290|NCT01410565|3750907|P1|NOT COMPLETED|Double Blind Phase||13
1532291|NCT01410565|3750905|P3|COMPLETED|Double Blind Phase||0
1532292|NCT01410565|3750906|P2|COMPLETED|Double Blind Phase||0
1532293|NCT01410565|3750907|P1|COMPLETED|Double Blind Phase||0
1532294|NCT01410565|3750905|P3|STARTED|Double Blind Phase||0
1532295|NCT01410565|3750906|P2|STARTED|Double Blind Phase||15
1532296|NCT01410565|3750907|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
1532297|NCT01410565|3750905|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
1532298|NCT01410565|3750906|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
1532299|NCT01410565|3750907|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
1532300|NCT01410565|3750905|P3|COMPLETED|Open Label Phase Apaziquone||58
1532301|NCT01410565|3750906|P2|COMPLETED|Open Label Phase Apaziquone||0
1532302|NCT01410565|3750907|P1|COMPLETED|Open Label Phase Apaziquone||0
1532303|NCT01410565|3750905|P3|STARTED|Open Label Phase Apaziquone||66
1532304|NCT01410565|3750906|P2|STARTED|Open Label Phase Apaziquone||0
1532305|NCT01410565|3750907|P1|STARTED|Open Label Phase Apaziquone||0
1532306|NCT01410552|3750917|P1|NOT COMPLETED|Overall Study||136
1532307|NCT01410552|3750917|P1|COMPLETED|Overall Study||877
1532308|NCT01410552|3750917|P1|STARTED|Overall Study||1013
1532309|NCT01410474|3750924|P2|NOT COMPLETED|Overall Study||1
1532310|NCT01410474|3750925|P1|NOT COMPLETED|Overall Study||0
1532311|NCT01410474|3750924|P2|COMPLETED|Overall Study||167
1532312|NCT01410474|3750925|P1|COMPLETED|Overall Study||173
1532313|NCT01410474|3750924|P2|STARTED|Overall Study||168
1532314|NCT01410474|3750925|P1|STARTED|Overall Study||173
1532315|NCT01410448|3750948|P2|NOT COMPLETED|Overall Study||35
1532316|NCT01410448|3750949|P1|NOT COMPLETED|Overall Study||12
1532317|NCT01410448|3750948|P2|COMPLETED|Overall Study||155
1532318|NCT01410448|3750949|P1|COMPLETED|Overall Study||181
1532319|NCT01410448|3750948|P2|Modified ITT Analysis Set|Overall Study||149
1532320|NCT01410448|3750949|P1|Modified ITT Analysis Set|Overall Study||161
1532321|NCT01410448|3750948|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
1532322|NCT01410448|3750949|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
1532323|NCT01410448|3750948|P2|STARTED|Overall Study||190
1532324|NCT01410448|3750949|P1|STARTED|Overall Study||193
1532325|NCT01410409|3750989|P2|NOT COMPLETED|Overall Study||4
1532326|NCT01410409|3750990|P1|NOT COMPLETED|Overall Study||1
1532327|NCT01410409|3750989|P2|COMPLETED|Overall Study||46
1532328|NCT01410409|3750990|P1|COMPLETED|Overall Study||49
1532329|NCT01410409|3750989|P2|STARTED|Overall Study||50
1532330|NCT01410409|3750990|P1|STARTED|Overall Study||50
1532331|NCT01410357|3751014|P2|NOT COMPLETED|Overall Study||24
1532332|NCT01410357|3751015|P1|NOT COMPLETED|Overall Study||26
1532333|NCT01410357|3751014|P2|COMPLETED|Overall Study||76
1532334|NCT01410357|3751015|P1|COMPLETED|Overall Study||74
1532335|NCT01410357|3751014|P2|STARTED|Overall Study||100
1532336|NCT01410357|3751015|P1|STARTED|Overall Study||100
1532337|NCT01410344|3751069|P1|NOT COMPLETED|Overall Study||3
1532338|NCT01410344|3751069|P1|COMPLETED|Overall Study||17
1532339|NCT01410344|3751069|P1|STARTED|Overall Study||20
1532340|NCT01410240|3751086|P3|NOT COMPLETED|Overall Study||2
1532341|NCT01410240|3751087|P2|NOT COMPLETED|Overall Study||1
1532342|NCT01410240|3751088|P1|NOT COMPLETED|Overall Study||1
1532343|NCT01410240|3751086|P3|COMPLETED|Overall Study||10
1532344|NCT01410240|3751087|P2|COMPLETED|Overall Study||52
1532345|NCT01410240|3751088|P1|COMPLETED|Overall Study||52
1532346|NCT01410240|3751086|P3|STARTED|Overall Study||12
1532347|NCT01410240|3751087|P2|STARTED|Overall Study||53
1532348|NCT01410240|3751088|P1|STARTED|Overall Study||53
1532349|NCT01410227|3751159|P4|NOT COMPLETED|Overall Study||1
1532350|NCT01410227|3751160|P3|NOT COMPLETED|Overall Study||2
1532351|NCT01410227|3751161|P2|NOT COMPLETED|Overall Study||0
1532352|NCT01410227|3751162|P1|NOT COMPLETED|Overall Study||4
1532353|NCT01410227|3751159|P4|COMPLETED|Overall Study||5
1532354|NCT01410227|3751160|P3|COMPLETED|Overall Study||13
1532355|NCT01410227|3751161|P2|COMPLETED|Overall Study||8
1532356|NCT01410227|3751162|P1|COMPLETED|Overall Study||4
1532357|NCT01410227|3751159|P4|STARTED|Overall Study||6
1532358|NCT01410227|3751160|P3|STARTED|Overall Study||15
1532359|NCT01410227|3751161|P2|STARTED|Overall Study||8
1532360|NCT01410227|3751162|P1|STARTED|Overall Study||8
1532361|NCT01410110|3751234|P2|NOT COMPLETED|Overall Study||2
1532362|NCT01410110|3751235|P1|NOT COMPLETED|Overall Study||4
1532363|NCT01410110|3751234|P2|COMPLETED|Overall Study||22
1532364|NCT01410110|3751235|P1|COMPLETED|Overall Study||20
1532365|NCT01410110|3751234|P2|6 Month Follow-up|Overall Study||22
1532366|NCT01410110|3751235|P1|6 Month Follow-up|Overall Study||20
1532367|NCT01410110|3751234|P2|3 Months (End of Intervention)|Overall Study||22
1532368|NCT01410110|3751235|P1|3 Months (End of Intervention)|Overall Study||20
1532369|NCT01410110|3751234|P2|Randomization|Overall Study||24
1532370|NCT01410110|3751235|P1|Randomization|Overall Study||24
1532371|NCT01410110|3751234|P2|STARTED|Overall Study||24
1532372|NCT01410110|3751235|P1|STARTED|Overall Study||24
1532373|NCT01410097|3751259|P2|NOT COMPLETED|Overall Study||3
1532374|NCT01410097|3751260|P1|NOT COMPLETED|Overall Study||5
1532375|NCT01410097|3751259|P2|COMPLETED|Overall Study||530
1532376|NCT01410097|3751260|P1|COMPLETED|Overall Study||551
1532377|NCT01410097|3751259|P2|STARTED|Overall Study||533
1532378|NCT01410097|3751260|P1|STARTED|Overall Study||556
1532379|NCT01409993|3751284|P4|NOT COMPLETED|Overall Study||5
1532380|NCT01409993|3751285|P3|NOT COMPLETED|Overall Study||3
1532381|NCT01409993|3751286|P2|NOT COMPLETED|Overall Study||5
1532382|NCT01409993|3751287|P1|NOT COMPLETED|Overall Study||4
1532383|NCT01409993|3751284|P4|COMPLETED|Overall Study||8
1532384|NCT01409993|3751285|P3|COMPLETED|Overall Study||11
1532385|NCT01409993|3751286|P2|COMPLETED|Overall Study||21
1532386|NCT01409993|3751287|P1|COMPLETED|Overall Study||21
1532387|NCT01409993|3751284|P4|STARTED|Overall Study||13
1532388|NCT01409993|3751285|P3|STARTED|Overall Study||14
1532389|NCT01409993|3751286|P2|STARTED|Overall Study||26
1532390|NCT01409993|3751287|P1|STARTED|Overall Study||25
1532391|NCT01409837|3751307|P2|NOT COMPLETED|Overall Study||2
1532392|NCT01409837|3751308|P1|NOT COMPLETED|Overall Study||3
1532393|NCT01409837|3751307|P2|COMPLETED|Overall Study||14
1532394|NCT01409837|3751308|P1|COMPLETED|Overall Study||14
1532395|NCT01409837|3751307|P2|282nd Week|Overall Study||14
1532396|NCT01409837|3751308|P1|282nd Week|Overall Study||14
1532397|NCT01409837|3751307|P2|186th Week|Overall Study||14
1532398|NCT01409837|3751308|P1|186th Week|Overall Study|Moved away to another location|14
1532399|NCT01409837|3751307|P2|138th Week|Overall Study||14
1532400|NCT01409837|3751308|P1|138th Week|Overall Study||15
1532401|NCT01409837|3751307|P2|114th Week|Overall Study||14
1532402|NCT01409837|3751308|P1|114th Week|Overall Study||15
1532403|NCT01409837|3751307|P2|102nd Week|Overall Study|Married another wife|14
1532404|NCT01409837|3751308|P1|102nd Week|Overall Study||15
1532405|NCT01409837|3751307|P2|96th Week|Overall Study||15
1532406|NCT01409837|3751308|P1|96th Week|Overall Study||15
1532407|NCT01409837|3751307|P2|48th Week|Overall Study||15
1532408|NCT01409837|3751308|P1|48th Week|Overall Study|Lost to follow-up|15
1532409|NCT01409837|3751307|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
1532410|NCT01409837|3751308|P1|24th Week|Overall Study||16
1532411|NCT01409837|3751307|P2|12th Week|Overall Study||16
1532412|NCT01409837|3751308|P1|12th Week|Overall Study|Moved away to another location|16
1532413|NCT01409837|3751307|P2|6th Week|Overall Study||16
1532414|NCT01409837|3751308|P1|6th Week|Overall Study||17
1532415|NCT01409837|3751307|P2|STARTED|Overall Study||16
1532416|NCT01409837|3751308|P1|STARTED|Overall Study||17
1532417|NCT01409707|3751333|P3|NOT COMPLETED|Overall Study||16
1532418|NCT01409707|3751334|P2|NOT COMPLETED|Overall Study||17
1532419|NCT01409707|3751335|P1|NOT COMPLETED|Overall Study||5
1532420|NCT01409707|3751333|P3|COMPLETED|Overall Study||24
1532421|NCT01409707|3751334|P2|COMPLETED|Overall Study||28
1532422|NCT01409707|3751335|P1|COMPLETED|Overall Study||36
1532423|NCT01409707|3751333|P3|STARTED|Overall Study||40
1532424|NCT01409707|3751334|P2|STARTED|Overall Study||45
1532425|NCT01409707|3751335|P1|STARTED|Overall Study||41
1532426|NCT01409564|3751347|P2|NOT COMPLETED|Overall Study||5
1532427|NCT01409564|3751348|P1|NOT COMPLETED|Overall Study||5
1532428|NCT01409564|3751347|P2|COMPLETED|Overall Study||18
1532429|NCT01409564|3751348|P1|COMPLETED|Overall Study||18
1532430|NCT01409564|3751347|P2|STARTED|Overall Study||23
1532431|NCT01409564|3751348|P1|STARTED|Overall Study||23
1532432|NCT01409434|3751366|P1|NOT COMPLETED|Overall Study||4
1532433|NCT01409434|3751366|P1|COMPLETED|Overall Study||40
1532434|NCT01409434|3751366|P1|STARTED|Overall Study||44
1532435|NCT01409382|3751376|P2|NOT COMPLETED|Overall Study||80
1532436|NCT01409382|3751377|P1|NOT COMPLETED|Overall Study||81
1532437|NCT01409382|3751376|P2|COMPLETED|Overall Study||160
1532438|NCT01409382|3751377|P1|COMPLETED|Overall Study||159
1532439|NCT01409382|3751376|P2|STARTED|Overall Study||240
1532440|NCT01409382|3751377|P1|STARTED|Overall Study||240
1532441|NCT01409291|3751391|P2|NOT COMPLETED|Overall Study||9
1532442|NCT01409291|3751392|P1|NOT COMPLETED|Overall Study||7
1532443|NCT01409291|3751391|P2|COMPLETED|Overall Study||19
1532444|NCT01409291|3751392|P1|COMPLETED|Overall Study||29
1532445|NCT01409291|3751391|P2|STARTED|Overall Study||28
1532446|NCT01409291|3751392|P1|STARTED|Overall Study||36
1532447|NCT01409239|3751402|P2|NOT COMPLETED|Overall Study||0
1532448|NCT01409239|3751403|P1|NOT COMPLETED|Overall Study||0
1532449|NCT01409239|3751402|P2|COMPLETED|Overall Study||17
1532450|NCT01409239|3751403|P1|COMPLETED|Overall Study||16
1532451|NCT01409239|3751402|P2|STARTED|Overall Study||17
1532452|NCT01409239|3751403|P1|STARTED|Overall Study||16
1532453|NCT01409213|3751409|P1|NOT COMPLETED|Overall Study||0
1532454|NCT01409213|3751409|P1|COMPLETED|Overall Study||1523
1532455|NCT01409213|3751409|P1|STARTED|Overall Study||1523
1532456|NCT01409096|3751416|P2|NOT COMPLETED|Overall Study||5
1532457|NCT01409096|3751417|P1|NOT COMPLETED|Overall Study||2
1532458|NCT01409096|3751416|P2|COMPLETED|Overall Study||35
1532459|NCT01409096|3751417|P1|COMPLETED|Overall Study||38
1532460|NCT01409096|3751416|P2|STARTED|Overall Study||40
1532461|NCT01409096|3751417|P1|STARTED|Overall Study||40
1532462|NCT01408992|3751429|P1|NOT COMPLETED|Overall Study||0
1532463|NCT01408992|3751429|P1|COMPLETED|Overall Study||558
1532464|NCT01408992|3751429|P1|STARTED|Overall Study||558
1532465|NCT01408914|3751444|P3|NOT COMPLETED|Overall Study||13
1532466|NCT01408914|3751445|P2|NOT COMPLETED|Overall Study||12
1532467|NCT01408914|3751446|P1|NOT COMPLETED|Overall Study||12
1532468|NCT01408914|3751444|P3|COMPLETED|Overall Study||47
1532469|NCT01408914|3751445|P2|COMPLETED|Overall Study||48
1532470|NCT01408914|3751446|P1|COMPLETED|Overall Study||48
1532471|NCT01408914|3751444|P3|STARTED|Overall Study||60
1532472|NCT01408914|3751445|P2|STARTED|Overall Study||60
1532473|NCT01408914|3751446|P1|STARTED|Overall Study||60
1532474|NCT01408888|3751460|P2|NOT COMPLETED|Second Intervention||0
1532475|NCT01408888|3751461|P1|NOT COMPLETED|Second Intervention||2
1532476|NCT01408888|3751460|P2|COMPLETED|Second Intervention||8
1532477|NCT01408888|3751461|P1|COMPLETED|Second Intervention||16
1532478|NCT01408888|3751460|P2|STARTED|Second Intervention||8
1532479|NCT01408888|3751461|P1|STARTED|Second Intervention||18
1532480|NCT01408888|3751460|P2|NOT COMPLETED|Washout of at Least 21 Days||0
1532481|NCT01408888|3751461|P1|NOT COMPLETED|Washout of at Least 21 Days||0
1532482|NCT01408888|3751460|P2|COMPLETED|Washout of at Least 21 Days||8
1532483|NCT01408888|3751461|P1|COMPLETED|Washout of at Least 21 Days||18
1532484|NCT01408888|3751460|P2|STARTED|Washout of at Least 21 Days||8
1532485|NCT01408888|3751461|P1|STARTED|Washout of at Least 21 Days||18
1532486|NCT01408888|3751460|P2|NOT COMPLETED|First Intervention||3
1532487|NCT01408888|3751461|P1|NOT COMPLETED|First Intervention||0
1532488|NCT01408888|3751460|P2|COMPLETED|First Intervention||8
1532489|NCT01408888|3751461|P1|COMPLETED|First Intervention||18
1532490|NCT01408888|3751460|P2|Received at Least 1 Dose of Drug|First Intervention||11
1532491|NCT01408888|3751461|P1|Received at Least 1 Dose of Drug|First Intervention||18
1532492|NCT01408888|3751460|P2|STARTED|First Intervention||11
1532493|NCT01408888|3751461|P1|STARTED|First Intervention||18
1532494|NCT01408862|3751484|P1|NOT COMPLETED|Overall Study||0
1532495|NCT01408862|3751484|P1|COMPLETED|Overall Study||20
1532496|NCT01408862|3751484|P1|STARTED|Overall Study||20
1532497|NCT01408732|3751489|P2|NOT COMPLETED|Overall Study||2
1532498|NCT01408732|3751490|P1|NOT COMPLETED|Overall Study||2
1532499|NCT01408732|3751489|P2|COMPLETED|Overall Study||7
1532500|NCT01408732|3751490|P1|COMPLETED|Overall Study||7
1532501|NCT01408732|3751489|P2|STARTED|Overall Study||9
1532502|NCT01408732|3751490|P1|STARTED|Overall Study||9
1532503|NCT01408719|3751516|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532504|NCT01408719|3751517|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532505|NCT01408719|3751518|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532506|NCT01408719|3751519|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532507|NCT01408719|3751520|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532508|NCT01408719|3751521|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532509|NCT01408719|3751522|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532510|NCT01408719|3751523|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532511|NCT01408719|3751524|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532512|NCT01408719|3751525|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532513|NCT01408719|3751526|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532514|NCT01408719|3751527|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532515|NCT01408719|3751528|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532516|NCT01408719|3751529|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532517|NCT01408719|3751530|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532518|NCT01408719|3751531|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532519|NCT01408719|3751532|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532520|NCT01408719|3751533|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532521|NCT01408719|3751534|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532522|NCT01408719|3751535|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
1532523|NCT01408719|3751516|P20|COMPLETED|Fourth Intervention (35 Days)||1
1532524|NCT01408719|3751517|P19|COMPLETED|Fourth Intervention (35 Days)||0
1532525|NCT01408719|3751518|P18|COMPLETED|Fourth Intervention (35 Days)||2
1532526|NCT01408719|3751519|P17|COMPLETED|Fourth Intervention (35 Days)||2
1532527|NCT01408719|3751520|P16|COMPLETED|Fourth Intervention (35 Days)||1
1532528|NCT01408719|3751521|P15|COMPLETED|Fourth Intervention (35 Days)||1
1532529|NCT01408719|3751522|P14|COMPLETED|Fourth Intervention (35 Days)||3
1532530|NCT01408719|3751523|P13|COMPLETED|Fourth Intervention (35 Days)||1
1532531|NCT01408719|3751524|P12|COMPLETED|Fourth Intervention (35 Days)||2
1532532|NCT01408719|3751525|P11|COMPLETED|Fourth Intervention (35 Days)||2
1532533|NCT01408719|3751526|P10|COMPLETED|Fourth Intervention (35 Days)||1
1532534|NCT01408719|3751527|P9|COMPLETED|Fourth Intervention (35 Days)||1
1532535|NCT01408719|3751528|P8|COMPLETED|Fourth Intervention (35 Days)||2
1532536|NCT01408719|3751529|P7|COMPLETED|Fourth Intervention (35 Days)||2
1532537|NCT01408719|3751530|P6|COMPLETED|Fourth Intervention (35 Days)||3
1532538|NCT01408719|3751531|P5|COMPLETED|Fourth Intervention (35 Days)||3
1532539|NCT01408719|3751532|P4|COMPLETED|Fourth Intervention (35 Days)||2
1532540|NCT01408719|3751533|P3|COMPLETED|Fourth Intervention (35 Days)||1
1532541|NCT01408719|3751534|P2|COMPLETED|Fourth Intervention (35 Days)||3
1532542|NCT01408719|3751535|P1|COMPLETED|Fourth Intervention (35 Days)||2
1532543|NCT01408719|3751516|P20|STARTED|Fourth Intervention (35 Days)||1
1532544|NCT01408719|3751517|P19|STARTED|Fourth Intervention (35 Days)||0
1532545|NCT01408719|3751518|P18|STARTED|Fourth Intervention (35 Days)||2
1532546|NCT01408719|3751519|P17|STARTED|Fourth Intervention (35 Days)||2
1532547|NCT01408719|3751520|P16|STARTED|Fourth Intervention (35 Days)||1
1532548|NCT01408719|3751521|P15|STARTED|Fourth Intervention (35 Days)||1
1532549|NCT01408719|3751522|P14|STARTED|Fourth Intervention (35 Days)||3
1532550|NCT01408719|3751523|P13|STARTED|Fourth Intervention (35 Days)||1
1532551|NCT01408719|3751524|P12|STARTED|Fourth Intervention (35 Days)||2
1532552|NCT01408719|3751525|P11|STARTED|Fourth Intervention (35 Days)||2
1532553|NCT01408719|3751526|P10|STARTED|Fourth Intervention (35 Days)||1
1532554|NCT01408719|3751527|P9|STARTED|Fourth Intervention (35 Days)||1
1532555|NCT01408719|3751528|P8|STARTED|Fourth Intervention (35 Days)||2
1532556|NCT01408719|3751529|P7|STARTED|Fourth Intervention (35 Days)||2
1532557|NCT01408719|3751530|P6|STARTED|Fourth Intervention (35 Days)||3
1532558|NCT01408719|3751531|P5|STARTED|Fourth Intervention (35 Days)||3
1532559|NCT01408719|3751532|P4|STARTED|Fourth Intervention (35 Days)||2
1532560|NCT01408719|3751533|P3|STARTED|Fourth Intervention (35 Days)||1
1532561|NCT01408719|3751534|P2|STARTED|Fourth Intervention (35 Days)||3
1532562|NCT01408719|3751535|P1|STARTED|Fourth Intervention (35 Days)||2
1532563|NCT01408719|3751516|P20|NOT COMPLETED|Washout Period (28 Days)||0
1532564|NCT01408719|3751517|P19|NOT COMPLETED|Washout Period (28 Days)||0
1532565|NCT01408719|3751518|P18|NOT COMPLETED|Washout Period (28 Days)||0
1532566|NCT01408719|3751519|P17|NOT COMPLETED|Washout Period (28 Days)||0
1532567|NCT01408719|3751520|P16|NOT COMPLETED|Washout Period (28 Days)||0
1532568|NCT01408719|3751521|P15|NOT COMPLETED|Washout Period (28 Days)||0
1532569|NCT01408719|3751522|P14|NOT COMPLETED|Washout Period (28 Days)||0
1532570|NCT01408719|3751523|P13|NOT COMPLETED|Washout Period (28 Days)||0
1532571|NCT01408719|3751524|P12|NOT COMPLETED|Washout Period (28 Days)||0
1532572|NCT01408719|3751525|P11|NOT COMPLETED|Washout Period (28 Days)||0
1532573|NCT01408719|3751526|P10|NOT COMPLETED|Washout Period (28 Days)||0
1532574|NCT01408719|3751527|P9|NOT COMPLETED|Washout Period (28 Days)||0
1532575|NCT01408719|3751528|P8|NOT COMPLETED|Washout Period (28 Days)||0
1532576|NCT01408719|3751529|P7|NOT COMPLETED|Washout Period (28 Days)||0
1532577|NCT01408719|3751530|P6|NOT COMPLETED|Washout Period (28 Days)||0
1532578|NCT01408719|3751531|P5|NOT COMPLETED|Washout Period (28 Days)||0
1532579|NCT01408719|3751532|P4|NOT COMPLETED|Washout Period (28 Days)||0
1532580|NCT01408719|3751533|P3|NOT COMPLETED|Washout Period (28 Days)||0
1532581|NCT01408719|3751534|P2|NOT COMPLETED|Washout Period (28 Days)||0
1532582|NCT01408719|3751535|P1|NOT COMPLETED|Washout Period (28 Days)||0
1532583|NCT01408719|3751516|P20|COMPLETED|Washout Period (28 Days)||1
1532584|NCT01408719|3751517|P19|COMPLETED|Washout Period (28 Days)||0
1532585|NCT01408719|3751518|P18|COMPLETED|Washout Period (28 Days)||2
1532586|NCT01408719|3751519|P17|COMPLETED|Washout Period (28 Days)||2
1532587|NCT01408719|3751520|P16|COMPLETED|Washout Period (28 Days)||1
1532588|NCT01408719|3751521|P15|COMPLETED|Washout Period (28 Days)||1
1532589|NCT01408719|3751522|P14|COMPLETED|Washout Period (28 Days)||3
1532590|NCT01408719|3751523|P13|COMPLETED|Washout Period (28 Days)||1
1532591|NCT01408719|3751524|P12|COMPLETED|Washout Period (28 Days)||2
1532592|NCT01408719|3751525|P11|COMPLETED|Washout Period (28 Days)||2
1532593|NCT01408719|3751526|P10|COMPLETED|Washout Period (28 Days)||1
1532594|NCT01408719|3751527|P9|COMPLETED|Washout Period (28 Days)||1
1532595|NCT01408719|3751528|P8|COMPLETED|Washout Period (28 Days)||2
1532596|NCT01408719|3751529|P7|COMPLETED|Washout Period (28 Days)||2
1532597|NCT01408719|3751530|P6|COMPLETED|Washout Period (28 Days)||3
1532598|NCT01408719|3751531|P5|COMPLETED|Washout Period (28 Days)||3
1532599|NCT01408719|3751532|P4|COMPLETED|Washout Period (28 Days)||2
1532600|NCT01408719|3751533|P3|COMPLETED|Washout Period (28 Days)||1
1532601|NCT01408719|3751534|P2|COMPLETED|Washout Period (28 Days)||3
1532602|NCT01408719|3751535|P1|COMPLETED|Washout Period (28 Days)||2
1532603|NCT01408719|3751516|P20|STARTED|Washout Period (28 Days)||1
1532604|NCT01408719|3751517|P19|STARTED|Washout Period (28 Days)||0
1532605|NCT01408719|3751518|P18|STARTED|Washout Period (28 Days)||2
1532606|NCT01408719|3751519|P17|STARTED|Washout Period (28 Days)||2
1532607|NCT01408719|3751520|P16|STARTED|Washout Period (28 Days)||1
1532608|NCT01408719|3751521|P15|STARTED|Washout Period (28 Days)||1
1532609|NCT01408719|3751522|P14|STARTED|Washout Period (28 Days)||3
1532610|NCT01408719|3751523|P13|STARTED|Washout Period (28 Days)||1
1532611|NCT01408719|3751524|P12|STARTED|Washout Period (28 Days)||2
1532612|NCT01408719|3751525|P11|STARTED|Washout Period (28 Days)||2
1532613|NCT01408719|3751526|P10|STARTED|Washout Period (28 Days)||1
1532614|NCT01408719|3751527|P9|STARTED|Washout Period (28 Days)||1
1532615|NCT01408719|3751528|P8|STARTED|Washout Period (28 Days)||2
1532616|NCT01408719|3751529|P7|STARTED|Washout Period (28 Days)||2
1532617|NCT01408719|3751530|P6|STARTED|Washout Period (28 Days)||3
1532618|NCT01408719|3751531|P5|STARTED|Washout Period (28 Days)||3
1532619|NCT01408719|3751532|P4|STARTED|Washout Period (28 Days)||2
1532620|NCT01408719|3751533|P3|STARTED|Washout Period (28 Days)||1
1532621|NCT01408719|3751534|P2|STARTED|Washout Period (28 Days)||3
1532622|NCT01408719|3751535|P1|STARTED|Washout Period (28 Days)||2
1532623|NCT01408719|3751516|P20|NOT COMPLETED|Third Intervention (35 Days)||0
1532624|NCT01408719|3751517|P19|NOT COMPLETED|Third Intervention (35 Days)||0
1532625|NCT01408719|3751518|P18|NOT COMPLETED|Third Intervention (35 Days)||0
1532626|NCT01408719|3751519|P17|NOT COMPLETED|Third Intervention (35 Days)||0
1532627|NCT01408719|3751520|P16|NOT COMPLETED|Third Intervention (35 Days)||0
1532628|NCT01408719|3751521|P15|NOT COMPLETED|Third Intervention (35 Days)||0
1532629|NCT01408719|3751522|P14|NOT COMPLETED|Third Intervention (35 Days)||0
1532630|NCT01408719|3751523|P13|NOT COMPLETED|Third Intervention (35 Days)||0
1532631|NCT01408719|3751524|P12|NOT COMPLETED|Third Intervention (35 Days)||0
1532632|NCT01408719|3751525|P11|NOT COMPLETED|Third Intervention (35 Days)||0
1532633|NCT01408719|3751526|P10|NOT COMPLETED|Third Intervention (35 Days)||0
1532634|NCT01408719|3751527|P9|NOT COMPLETED|Third Intervention (35 Days)||0
1532635|NCT01408719|3751528|P8|NOT COMPLETED|Third Intervention (35 Days)||1
1532636|NCT01408719|3751529|P7|NOT COMPLETED|Third Intervention (35 Days)||0
1532637|NCT01408719|3751530|P6|NOT COMPLETED|Third Intervention (35 Days)||0
1532638|NCT01408719|3751531|P5|NOT COMPLETED|Third Intervention (35 Days)||0
1532639|NCT01408719|3751532|P4|NOT COMPLETED|Third Intervention (35 Days)||0
1532640|NCT01408719|3751533|P3|NOT COMPLETED|Third Intervention (35 Days)||0
1532641|NCT01408719|3751534|P2|NOT COMPLETED|Third Intervention (35 Days)||0
1532642|NCT01408719|3751535|P1|NOT COMPLETED|Third Intervention (35 Days)||0
1532643|NCT01408719|3751516|P20|COMPLETED|Third Intervention (35 Days)||1
1532644|NCT01408719|3751517|P19|COMPLETED|Third Intervention (35 Days)||0
1532645|NCT01408719|3751518|P18|COMPLETED|Third Intervention (35 Days)||2
1532646|NCT01408719|3751519|P17|COMPLETED|Third Intervention (35 Days)||2
1532647|NCT01408719|3751520|P16|COMPLETED|Third Intervention (35 Days)||1
1532648|NCT01408719|3751521|P15|COMPLETED|Third Intervention (35 Days)||1
1532649|NCT01408719|3751522|P14|COMPLETED|Third Intervention (35 Days)||3
1532650|NCT01408719|3751523|P13|COMPLETED|Third Intervention (35 Days)||2
1532651|NCT01408719|3751524|P12|COMPLETED|Third Intervention (35 Days)||2
1532652|NCT01408719|3751525|P11|COMPLETED|Third Intervention (35 Days)||2
1532653|NCT01408719|3751526|P10|COMPLETED|Third Intervention (35 Days)||1
1532654|NCT01408719|3751527|P9|COMPLETED|Third Intervention (35 Days)||1
1532655|NCT01408719|3751528|P8|COMPLETED|Third Intervention (35 Days)||2
1532656|NCT01408719|3751529|P7|COMPLETED|Third Intervention (35 Days)||2
1532657|NCT01408719|3751530|P6|COMPLETED|Third Intervention (35 Days)||3
1532658|NCT01408719|3751531|P5|COMPLETED|Third Intervention (35 Days)||3
1532659|NCT01408719|3751532|P4|COMPLETED|Third Intervention (35 Days)||2
1532660|NCT01408719|3751533|P3|COMPLETED|Third Intervention (35 Days)||1
1532661|NCT01408719|3751534|P2|COMPLETED|Third Intervention (35 Days)||3
1532662|NCT01408719|3751535|P1|COMPLETED|Third Intervention (35 Days)||2
1532663|NCT01408719|3751516|P20|STARTED|Third Intervention (35 Days)||1
1532664|NCT01408719|3751517|P19|STARTED|Third Intervention (35 Days)||0
1532665|NCT01408719|3751518|P18|STARTED|Third Intervention (35 Days)||2
1532666|NCT01408719|3751519|P17|STARTED|Third Intervention (35 Days)||2
1532667|NCT01408719|3751520|P16|STARTED|Third Intervention (35 Days)||1
1532668|NCT01408719|3751521|P15|STARTED|Third Intervention (35 Days)||1
1532669|NCT01408719|3751522|P14|STARTED|Third Intervention (35 Days)||3
1532670|NCT01408719|3751523|P13|STARTED|Third Intervention (35 Days)||2
1532671|NCT01408719|3751524|P12|STARTED|Third Intervention (35 Days)||2
1532672|NCT01408719|3751525|P11|STARTED|Third Intervention (35 Days)||2
1532673|NCT01408719|3751526|P10|STARTED|Third Intervention (35 Days)||1
1532674|NCT01408719|3751527|P9|STARTED|Third Intervention (35 Days)||1
1532675|NCT01408719|3751528|P8|STARTED|Third Intervention (35 Days)||3
1532676|NCT01408719|3751529|P7|STARTED|Third Intervention (35 Days)||2
1532677|NCT01408719|3751530|P6|STARTED|Third Intervention (35 Days)||3
1532678|NCT01408719|3751531|P5|STARTED|Third Intervention (35 Days)||3
1532679|NCT01408719|3751532|P4|STARTED|Third Intervention (35 Days)||2
1532680|NCT01408719|3751533|P3|STARTED|Third Intervention (35 Days)||1
1532681|NCT01408719|3751534|P2|STARTED|Third Intervention (35 Days)||3
1532682|NCT01408719|3751535|P1|STARTED|Third Intervention (35 Days)||2
1532683|NCT01408719|3751516|P20|NOT COMPLETED|Washout Period (28 Days)||0
1532684|NCT01408719|3751517|P19|NOT COMPLETED|Washout Period (28 Days)||0
1532685|NCT01408719|3751518|P18|NOT COMPLETED|Washout Period (28 Days)||0
1532686|NCT01408719|3751519|P17|NOT COMPLETED|Washout Period (28 Days)||0
1532687|NCT01408719|3751520|P16|NOT COMPLETED|Washout Period (28 Days)||0
1532688|NCT01408719|3751521|P15|NOT COMPLETED|Washout Period (28 Days)||0
1532689|NCT01408719|3751522|P14|NOT COMPLETED|Washout Period (28 Days)||0
1532690|NCT01408719|3751523|P13|NOT COMPLETED|Washout Period (28 Days)||0
1532691|NCT01408719|3751524|P12|NOT COMPLETED|Washout Period (28 Days)||0
1532692|NCT01408719|3751525|P11|NOT COMPLETED|Washout Period (28 Days)||0
1532693|NCT01408719|3751526|P10|NOT COMPLETED|Washout Period (28 Days)||0
1532694|NCT01408719|3751527|P9|NOT COMPLETED|Washout Period (28 Days)||0
1532695|NCT01408719|3751528|P8|NOT COMPLETED|Washout Period (28 Days)||0
1532696|NCT01408719|3751529|P7|NOT COMPLETED|Washout Period (28 Days)||0
1532697|NCT01408719|3751530|P6|NOT COMPLETED|Washout Period (28 Days)||0
1532698|NCT01408719|3751531|P5|NOT COMPLETED|Washout Period (28 Days)||0
1532699|NCT01408719|3751532|P4|NOT COMPLETED|Washout Period (28 Days)||0
1532700|NCT01408719|3751533|P3|NOT COMPLETED|Washout Period (28 Days)||0
1532701|NCT01408719|3751534|P2|NOT COMPLETED|Washout Period (28 Days)||0
1532702|NCT01408719|3751535|P1|NOT COMPLETED|Washout Period (28 Days)||0
1532703|NCT01408719|3751516|P20|COMPLETED|Washout Period (28 Days)||1
1532704|NCT01408719|3751517|P19|COMPLETED|Washout Period (28 Days)||0
1532705|NCT01408719|3751518|P18|COMPLETED|Washout Period (28 Days)||2
1532706|NCT01408719|3751519|P17|COMPLETED|Washout Period (28 Days)||2
1532707|NCT01408719|3751520|P16|COMPLETED|Washout Period (28 Days)||1
1532708|NCT01408719|3751521|P15|COMPLETED|Washout Period (28 Days)||1
1532709|NCT01408719|3751522|P14|COMPLETED|Washout Period (28 Days)||3
1532710|NCT01408719|3751523|P13|COMPLETED|Washout Period (28 Days)||2
1532711|NCT01408719|3751524|P12|COMPLETED|Washout Period (28 Days)||2
1532712|NCT01408719|3751525|P11|COMPLETED|Washout Period (28 Days)||2
1532713|NCT01408719|3751526|P10|COMPLETED|Washout Period (28 Days)||1
1532714|NCT01408719|3751527|P9|COMPLETED|Washout Period (28 Days)||1
1532715|NCT01408719|3751528|P8|COMPLETED|Washout Period (28 Days)||3
1532716|NCT01408719|3751529|P7|COMPLETED|Washout Period (28 Days)||2
1532717|NCT01408719|3751530|P6|COMPLETED|Washout Period (28 Days)||3
1532718|NCT01408719|3751531|P5|COMPLETED|Washout Period (28 Days)||3
1532719|NCT01408719|3751532|P4|COMPLETED|Washout Period (28 Days)||2
1532720|NCT01408719|3751533|P3|COMPLETED|Washout Period (28 Days)||1
1532721|NCT01408719|3751534|P2|COMPLETED|Washout Period (28 Days)||3
1532722|NCT01408719|3751535|P1|COMPLETED|Washout Period (28 Days)||2
1532723|NCT01408719|3751516|P20|STARTED|Washout Period (28 Days)||1
1532724|NCT01408719|3751517|P19|STARTED|Washout Period (28 Days)||0
1532725|NCT01408719|3751518|P18|STARTED|Washout Period (28 Days)||2
1532726|NCT01408719|3751519|P17|STARTED|Washout Period (28 Days)||2
1532727|NCT01408719|3751520|P16|STARTED|Washout Period (28 Days)||1
1532728|NCT01408719|3751521|P15|STARTED|Washout Period (28 Days)||1
1532729|NCT01408719|3751522|P14|STARTED|Washout Period (28 Days)||3
1532730|NCT01408719|3751523|P13|STARTED|Washout Period (28 Days)||2
1532731|NCT01408719|3751524|P12|STARTED|Washout Period (28 Days)||2
1532732|NCT01408719|3751525|P11|STARTED|Washout Period (28 Days)||2
1532733|NCT01408719|3751526|P10|STARTED|Washout Period (28 Days)||1
1532734|NCT01408719|3751527|P9|STARTED|Washout Period (28 Days)||1
1532735|NCT01408719|3751528|P8|STARTED|Washout Period (28 Days)||3
1532736|NCT01408719|3751529|P7|STARTED|Washout Period (28 Days)||2
1532737|NCT01408719|3751530|P6|STARTED|Washout Period (28 Days)||3
1532738|NCT01408719|3751531|P5|STARTED|Washout Period (28 Days)||3
1532739|NCT01408719|3751532|P4|STARTED|Washout Period (28 Days)||2
1532740|NCT01408719|3751533|P3|STARTED|Washout Period (28 Days)||1
1532741|NCT01408719|3751534|P2|STARTED|Washout Period (28 Days)||3
1532742|NCT01408719|3751535|P1|STARTED|Washout Period (28 Days)||2
1532743|NCT01408719|3751516|P20|NOT COMPLETED|Second Intervention (35 Days)||0
1532744|NCT01408719|3751517|P19|NOT COMPLETED|Second Intervention (35 Days)||0
1532745|NCT01408719|3751518|P18|NOT COMPLETED|Second Intervention (35 Days)||0
1532746|NCT01408719|3751519|P17|NOT COMPLETED|Second Intervention (35 Days)||0
1532747|NCT01408719|3751520|P16|NOT COMPLETED|Second Intervention (35 Days)||0
1532748|NCT01408719|3751521|P15|NOT COMPLETED|Second Intervention (35 Days)||0
1532749|NCT01408719|3751522|P14|NOT COMPLETED|Second Intervention (35 Days)||1
1532750|NCT01408719|3751523|P13|NOT COMPLETED|Second Intervention (35 Days)||0
1532751|NCT01408719|3751524|P12|NOT COMPLETED|Second Intervention (35 Days)||0
1532752|NCT01408719|3751525|P11|NOT COMPLETED|Second Intervention (35 Days)||0
1532753|NCT01408719|3751526|P10|NOT COMPLETED|Second Intervention (35 Days)||0
1532754|NCT01408719|3751527|P9|NOT COMPLETED|Second Intervention (35 Days)||0
1532755|NCT01408719|3751528|P8|NOT COMPLETED|Second Intervention (35 Days)||0
1532756|NCT01408719|3751529|P7|NOT COMPLETED|Second Intervention (35 Days)||0
1532757|NCT01408719|3751530|P6|NOT COMPLETED|Second Intervention (35 Days)||0
1532758|NCT01408719|3751531|P5|NOT COMPLETED|Second Intervention (35 Days)||0
1532759|NCT01408719|3751532|P4|NOT COMPLETED|Second Intervention (35 Days)||0
1532760|NCT01408719|3751533|P3|NOT COMPLETED|Second Intervention (35 Days)||0
1532761|NCT01408719|3751534|P2|NOT COMPLETED|Second Intervention (35 Days)||0
1532762|NCT01408719|3751535|P1|NOT COMPLETED|Second Intervention (35 Days)||0
1532763|NCT01408719|3751516|P20|COMPLETED|Second Intervention (35 Days)||1
1532764|NCT01408719|3751517|P19|COMPLETED|Second Intervention (35 Days)||0
1532765|NCT01408719|3751518|P18|COMPLETED|Second Intervention (35 Days)||2
1532766|NCT01408719|3751519|P17|COMPLETED|Second Intervention (35 Days)||2
1532767|NCT01408719|3751520|P16|COMPLETED|Second Intervention (35 Days)||2
1532768|NCT01408719|3751521|P15|COMPLETED|Second Intervention (35 Days)||1
1532769|NCT01408719|3751522|P14|COMPLETED|Second Intervention (35 Days)||3
1532770|NCT01408719|3751523|P13|COMPLETED|Second Intervention (35 Days)||2
1532771|NCT01408719|3751524|P12|COMPLETED|Second Intervention (35 Days)||2
1532772|NCT01408719|3751525|P11|COMPLETED|Second Intervention (35 Days)||2
1532773|NCT01408719|3751526|P10|COMPLETED|Second Intervention (35 Days)||1
1532774|NCT01408719|3751527|P9|COMPLETED|Second Intervention (35 Days)||1
1532775|NCT01408719|3751528|P8|COMPLETED|Second Intervention (35 Days)||3
1532776|NCT01408719|3751529|P7|COMPLETED|Second Intervention (35 Days)||2
1532777|NCT01408719|3751530|P6|COMPLETED|Second Intervention (35 Days)||3
1532778|NCT01408719|3751531|P5|COMPLETED|Second Intervention (35 Days)||3
1532779|NCT01408719|3751532|P4|COMPLETED|Second Intervention (35 Days)||2
1532780|NCT01408719|3751533|P3|COMPLETED|Second Intervention (35 Days)||1
1532781|NCT01408719|3751534|P2|COMPLETED|Second Intervention (35 Days)||3
1532782|NCT01408719|3751535|P1|COMPLETED|Second Intervention (35 Days)||2
1532783|NCT01408719|3751516|P20|STARTED|Second Intervention (35 Days)||1
1532784|NCT01408719|3751517|P19|STARTED|Second Intervention (35 Days)||0
1532785|NCT01408719|3751518|P18|STARTED|Second Intervention (35 Days)||2
1532786|NCT01408719|3751519|P17|STARTED|Second Intervention (35 Days)||2
1532787|NCT01408719|3751520|P16|STARTED|Second Intervention (35 Days)||2
1532788|NCT01408719|3751521|P15|STARTED|Second Intervention (35 Days)||1
1532789|NCT01408719|3751522|P14|STARTED|Second Intervention (35 Days)||4
1532790|NCT01408719|3751523|P13|STARTED|Second Intervention (35 Days)||2
1532791|NCT01408719|3751524|P12|STARTED|Second Intervention (35 Days)||2
1532792|NCT01408719|3751525|P11|STARTED|Second Intervention (35 Days)||2
1532793|NCT01408719|3751526|P10|STARTED|Second Intervention (35 Days)||1
1532794|NCT01408719|3751527|P9|STARTED|Second Intervention (35 Days)||1
1532795|NCT01408719|3751528|P8|STARTED|Second Intervention (35 Days)||3
1532796|NCT01408719|3751529|P7|STARTED|Second Intervention (35 Days)||2
1532797|NCT01408719|3751530|P6|STARTED|Second Intervention (35 Days)||3
1532798|NCT01408719|3751531|P5|STARTED|Second Intervention (35 Days)||3
1532799|NCT01408719|3751532|P4|STARTED|Second Intervention (35 Days)||2
1532800|NCT01408719|3751533|P3|STARTED|Second Intervention (35 Days)||1
1532801|NCT01408719|3751534|P2|STARTED|Second Intervention (35 Days)||3
1532802|NCT01408719|3751535|P1|STARTED|Second Intervention (35 Days)||2
1532803|NCT01408719|3751516|P20|NOT COMPLETED|Washout Period (28 Days)||0
1532804|NCT01408719|3751517|P19|NOT COMPLETED|Washout Period (28 Days)||0
1532805|NCT01408719|3751518|P18|NOT COMPLETED|Washout Period (28 Days)||0
1532806|NCT01408719|3751519|P17|NOT COMPLETED|Washout Period (28 Days)||0
1532807|NCT01408719|3751520|P16|NOT COMPLETED|Washout Period (28 Days)||0
1532808|NCT01408719|3751521|P15|NOT COMPLETED|Washout Period (28 Days)||0
1532809|NCT01408719|3751522|P14|NOT COMPLETED|Washout Period (28 Days)||0
1532810|NCT01408719|3751523|P13|NOT COMPLETED|Washout Period (28 Days)||0
1532811|NCT01408719|3751524|P12|NOT COMPLETED|Washout Period (28 Days)||0
1532812|NCT01408719|3751525|P11|NOT COMPLETED|Washout Period (28 Days)||0
1532813|NCT01408719|3751526|P10|NOT COMPLETED|Washout Period (28 Days)||0
1532814|NCT01408719|3751527|P9|NOT COMPLETED|Washout Period (28 Days)||0
1532815|NCT01408719|3751528|P8|NOT COMPLETED|Washout Period (28 Days)||0
1532816|NCT01408719|3751529|P7|NOT COMPLETED|Washout Period (28 Days)||0
1532817|NCT01408719|3751530|P6|NOT COMPLETED|Washout Period (28 Days)||0
1532818|NCT01408719|3751531|P5|NOT COMPLETED|Washout Period (28 Days)||0
1532819|NCT01408719|3751532|P4|NOT COMPLETED|Washout Period (28 Days)||0
1532820|NCT01408719|3751533|P3|NOT COMPLETED|Washout Period (28 Days)||0
1532821|NCT01408719|3751534|P2|NOT COMPLETED|Washout Period (28 Days)||0
1532822|NCT01408719|3751535|P1|NOT COMPLETED|Washout Period (28 Days)||0
1532823|NCT01408719|3751516|P20|COMPLETED|Washout Period (28 Days)||1
1532824|NCT01408719|3751517|P19|COMPLETED|Washout Period (28 Days)||0
1532825|NCT01408719|3751518|P18|COMPLETED|Washout Period (28 Days)||2
1532826|NCT01408719|3751519|P17|COMPLETED|Washout Period (28 Days)||2
1532827|NCT01408719|3751520|P16|COMPLETED|Washout Period (28 Days)||2
1532828|NCT01408719|3751521|P15|COMPLETED|Washout Period (28 Days)||1
1532829|NCT01408719|3751522|P14|COMPLETED|Washout Period (28 Days)||4
1532830|NCT01408719|3751523|P13|COMPLETED|Washout Period (28 Days)||2
1532831|NCT01408719|3751524|P12|COMPLETED|Washout Period (28 Days)||2
1532832|NCT01408719|3751525|P11|COMPLETED|Washout Period (28 Days)||2
1532833|NCT01408719|3751526|P10|COMPLETED|Washout Period (28 Days)||1
1532834|NCT01408719|3751527|P9|COMPLETED|Washout Period (28 Days)||1
1532835|NCT01408719|3751528|P8|COMPLETED|Washout Period (28 Days)||3
1532836|NCT01408719|3751529|P7|COMPLETED|Washout Period (28 Days)||2
1532837|NCT01408719|3751530|P6|COMPLETED|Washout Period (28 Days)||3
1532838|NCT01408719|3751531|P5|COMPLETED|Washout Period (28 Days)||3
1532839|NCT01408719|3751532|P4|COMPLETED|Washout Period (28 Days)||2
1532840|NCT01408719|3751533|P3|COMPLETED|Washout Period (28 Days)||1
1532841|NCT01408719|3751534|P2|COMPLETED|Washout Period (28 Days)||3
1532842|NCT01408719|3751535|P1|COMPLETED|Washout Period (28 Days)||2
1532843|NCT01408719|3751516|P20|STARTED|Washout Period (28 Days)||1
1532844|NCT01408719|3751517|P19|STARTED|Washout Period (28 Days)||0
1532845|NCT01408719|3751518|P18|STARTED|Washout Period (28 Days)||2
1532846|NCT01408719|3751519|P17|STARTED|Washout Period (28 Days)||2
1532847|NCT01408719|3751520|P16|STARTED|Washout Period (28 Days)||2
1532848|NCT01408719|3751521|P15|STARTED|Washout Period (28 Days)||1
1532849|NCT01408719|3751522|P14|STARTED|Washout Period (28 Days)||4
1532850|NCT01408719|3751523|P13|STARTED|Washout Period (28 Days)||2
1532851|NCT01408719|3751524|P12|STARTED|Washout Period (28 Days)||2
1532852|NCT01408719|3751525|P11|STARTED|Washout Period (28 Days)||2
1532853|NCT01408719|3751526|P10|STARTED|Washout Period (28 Days)||1
1532854|NCT01408719|3751527|P9|STARTED|Washout Period (28 Days)||1
1532855|NCT01408719|3751528|P8|STARTED|Washout Period (28 Days)||3
1532856|NCT01408719|3751529|P7|STARTED|Washout Period (28 Days)||2
1532857|NCT01408719|3751530|P6|STARTED|Washout Period (28 Days)||3
1532858|NCT01408719|3751531|P5|STARTED|Washout Period (28 Days)||3
1532859|NCT01408719|3751532|P4|STARTED|Washout Period (28 Days)||2
1532860|NCT01408719|3751533|P3|STARTED|Washout Period (28 Days)||1
1532861|NCT01408719|3751534|P2|STARTED|Washout Period (28 Days)||3
1532862|NCT01408719|3751535|P1|STARTED|Washout Period (28 Days)||2
1532863|NCT01408719|3751516|P20|NOT COMPLETED|First Intervention (35 Days)||0
1532864|NCT01408719|3751517|P19|NOT COMPLETED|First Intervention (35 Days)||1
1532865|NCT01408719|3751518|P18|NOT COMPLETED|First Intervention (35 Days)||0
1532866|NCT01408719|3751519|P17|NOT COMPLETED|First Intervention (35 Days)||1
1532867|NCT01408719|3751520|P16|NOT COMPLETED|First Intervention (35 Days)||0
1532868|NCT01408719|3751521|P15|NOT COMPLETED|First Intervention (35 Days)||0
1532869|NCT01408719|3751522|P14|NOT COMPLETED|First Intervention (35 Days)||1
1532870|NCT01408719|3751523|P13|NOT COMPLETED|First Intervention (35 Days)||0
1532871|NCT01408719|3751524|P12|NOT COMPLETED|First Intervention (35 Days)||0
1532872|NCT01408719|3751525|P11|NOT COMPLETED|First Intervention (35 Days)||0
1532873|NCT01408719|3751526|P10|NOT COMPLETED|First Intervention (35 Days)||0
1532874|NCT01408719|3751527|P9|NOT COMPLETED|First Intervention (35 Days)||1
1532875|NCT01408719|3751528|P8|NOT COMPLETED|First Intervention (35 Days)||0
1532876|NCT01408719|3751529|P7|NOT COMPLETED|First Intervention (35 Days)||0
1532877|NCT01408719|3751530|P6|NOT COMPLETED|First Intervention (35 Days)||0
1532878|NCT01408719|3751531|P5|NOT COMPLETED|First Intervention (35 Days)||1
1532879|NCT01408719|3751532|P4|NOT COMPLETED|First Intervention (35 Days)||0
1532880|NCT01408719|3751533|P3|NOT COMPLETED|First Intervention (35 Days)||1
1532881|NCT01408719|3751534|P2|NOT COMPLETED|First Intervention (35 Days)||0
1532882|NCT01408719|3751535|P1|NOT COMPLETED|First Intervention (35 Days)||0
1532883|NCT01408719|3751516|P20|COMPLETED|First Intervention (35 Days)||1
1532884|NCT01408719|3751517|P19|COMPLETED|First Intervention (35 Days)||0
1532885|NCT01408719|3751518|P18|COMPLETED|First Intervention (35 Days)||2
1532886|NCT01408719|3751519|P17|COMPLETED|First Intervention (35 Days)||2
1532887|NCT01408719|3751520|P16|COMPLETED|First Intervention (35 Days)||2
1532888|NCT01408719|3751521|P15|COMPLETED|First Intervention (35 Days)||1
1532889|NCT01408719|3751522|P14|COMPLETED|First Intervention (35 Days)||4
1532890|NCT01408719|3751523|P13|COMPLETED|First Intervention (35 Days)||2
1532891|NCT01408719|3751524|P12|COMPLETED|First Intervention (35 Days)||2
1532892|NCT01408719|3751525|P11|COMPLETED|First Intervention (35 Days)||2
1532893|NCT01408719|3751526|P10|COMPLETED|First Intervention (35 Days)||1
1532894|NCT01408719|3751527|P9|COMPLETED|First Intervention (35 Days)||1
1532895|NCT01408719|3751528|P8|COMPLETED|First Intervention (35 Days)||3
1532896|NCT01408719|3751529|P7|COMPLETED|First Intervention (35 Days)||2
1532897|NCT01408719|3751530|P6|COMPLETED|First Intervention (35 Days)||3
1532898|NCT01408719|3751531|P5|COMPLETED|First Intervention (35 Days)||3
1532899|NCT01408719|3751532|P4|COMPLETED|First Intervention (35 Days)||2
1532900|NCT01408719|3751533|P3|COMPLETED|First Intervention (35 Days)||1
1532901|NCT01408719|3751534|P2|COMPLETED|First Intervention (35 Days)||3
1532902|NCT01408719|3751535|P1|COMPLETED|First Intervention (35 Days)||2
1532903|NCT01408719|3751516|P20|STARTED|First Intervention (35 Days)||1
1532904|NCT01408719|3751517|P19|STARTED|First Intervention (35 Days)||1
1532905|NCT01408719|3751518|P18|STARTED|First Intervention (35 Days)||2
1532906|NCT01408719|3751519|P17|STARTED|First Intervention (35 Days)||3
1532907|NCT01408719|3751520|P16|STARTED|First Intervention (35 Days)||2
1532908|NCT01408719|3751521|P15|STARTED|First Intervention (35 Days)||1
1532909|NCT01408719|3751522|P14|STARTED|First Intervention (35 Days)||5
1532910|NCT01408719|3751523|P13|STARTED|First Intervention (35 Days)||2
1532911|NCT01408719|3751524|P12|STARTED|First Intervention (35 Days)||2
1532912|NCT01408719|3751525|P11|STARTED|First Intervention (35 Days)||2
1532913|NCT01408719|3751526|P10|STARTED|First Intervention (35 Days)||1
1532914|NCT01408719|3751527|P9|STARTED|First Intervention (35 Days)||2
1532915|NCT01408719|3751528|P8|STARTED|First Intervention (35 Days)||3
1532916|NCT01408719|3751529|P7|STARTED|First Intervention (35 Days)||2
1532917|NCT01408719|3751530|P6|STARTED|First Intervention (35 Days)||3
1532918|NCT01408719|3751531|P5|STARTED|First Intervention (35 Days)||4
1532919|NCT01408719|3751532|P4|STARTED|First Intervention (35 Days)||2
1532920|NCT01408719|3751533|P3|STARTED|First Intervention (35 Days)||2
1532921|NCT01408719|3751534|P2|STARTED|First Intervention (35 Days)||3
1532922|NCT01408719|3751535|P1|STARTED|First Intervention (35 Days)||2
1532923|NCT01408706|3751547|P2|NOT COMPLETED|Overall Study||0
1532924|NCT01408706|3751548|P1|NOT COMPLETED|Overall Study||1
1532925|NCT01408706|3751547|P2|COMPLETED|Overall Study||30
1532926|NCT01408706|3751548|P1|COMPLETED|Overall Study||29
1532927|NCT01408706|3751547|P2|STARTED|Overall Study||30
1532928|NCT01408706|3751548|P1|STARTED|Overall Study||30
1532929|NCT01408641|3751560|P2|NOT COMPLETED|Overall Study||0
1532930|NCT01408641|3751561|P1|NOT COMPLETED|Overall Study||1
1532931|NCT01408641|3751560|P2|COMPLETED|Overall Study||0
1532932|NCT01408641|3751561|P1|COMPLETED|Overall Study||0
1532933|NCT01408641|3751560|P2|STARTED|Overall Study||0
1532934|NCT01408641|3751561|P1|STARTED|Overall Study||1
1532935|NCT01408628|3751569|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
1532936|NCT01408628|3751569|P1|COMPLETED|Completed 6 Month Follow-Up||25
1532937|NCT01408628|3751569|P1|STARTED|Completed 6 Month Follow-Up||39
1532938|NCT01408628|3751569|P1|NOT COMPLETED|Started Classes/Intervention||0
1532939|NCT01408628|3751569|P1|COMPLETED|Started Classes/Intervention||39
1532940|NCT01408628|3751569|P1|STARTED|Started Classes/Intervention||39
1532941|NCT01408628|3751569|P1|NOT COMPLETED|Consented||12
1532942|NCT01408628|3751569|P1|COMPLETED|Consented||39
1532943|NCT01408628|3751569|P1|STARTED|Consented||51
1532944|NCT01408576|3751578|P3|NOT COMPLETED|Overall Study||508
1532945|NCT01408576|3751579|P2|NOT COMPLETED|Overall Study||498
1532946|NCT01408576|3751580|P1|NOT COMPLETED|Overall Study||188
1532947|NCT01408576|3751578|P3|COMPLETED|Overall Study||0
1532948|NCT01408576|3751579|P2|COMPLETED|Overall Study||0
1532949|NCT01408576|3751580|P1|COMPLETED|Overall Study||56
1532950|NCT01408576|3751578|P3|STARTED|Overall Study||508
1532951|NCT01408576|3751579|P2|STARTED|Overall Study||498
1532952|NCT01408576|3751580|P1|STARTED|Overall Study||244
1532953|NCT01408563|3751627|P1|NOT COMPLETED|Overall Study||2
1532954|NCT01408563|3751627|P1|COMPLETED|Overall Study||31
1532955|NCT01408563|3751627|P1|Received Transplant|Overall Study||31
1532956|NCT01408563|3751627|P1|STARTED|Overall Study||33
1532957|NCT01408537|3751638|P1|NOT COMPLETED|Overall Study||8
1532958|NCT01408537|3751638|P1|COMPLETED|Overall Study||144
1532959|NCT01408537|3751638|P1|STARTED|Overall Study||152
1532960|NCT01408485|3751654|P1|NOT COMPLETED|Overall Study||21
1532961|NCT01408485|3751654|P1|COMPLETED|Overall Study||179
1532962|NCT01408485|3751654|P1|STARTED|Overall Study||200
1532963|NCT01408329|3751662|P2|NOT COMPLETED|Overall Study||4
1532964|NCT01408329|3751663|P1|NOT COMPLETED|Overall Study||3
1532965|NCT01408329|3751662|P2|COMPLETED|Overall Study||11
1532966|NCT01408329|3751663|P1|COMPLETED|Overall Study||10
1532967|NCT01408329|3751662|P2|STARTED|Overall Study||15
1532968|NCT01408329|3751663|P1|STARTED|Overall Study||13
1532969|NCT01408303|3751672|P3|NOT COMPLETED|Overall Study||6
1532970|NCT01408303|3751673|P2|NOT COMPLETED|Overall Study||12
1532971|NCT01408303|3751674|P1|NOT COMPLETED|Overall Study||6
1532972|NCT01408303|3751672|P3|COMPLETED|Overall Study||210
1532973|NCT01408303|3751673|P2|COMPLETED|Overall Study||204
1532974|NCT01408303|3751674|P1|COMPLETED|Overall Study||209
1532975|NCT01408303|3751672|P3|STARTED|Overall Study||216
1532976|NCT01408303|3751673|P2|STARTED|Overall Study||216
1532977|NCT01408303|3751674|P1|STARTED|Overall Study||215
1532978|NCT01408277|3751684|P2|NOT COMPLETED|Overall Study||4
1532979|NCT01408277|3751685|P1|NOT COMPLETED|Overall Study||8
1532980|NCT01408277|3751684|P2|COMPLETED|Overall Study||23
1532981|NCT01408277|3751685|P1|COMPLETED|Overall Study||20
1532982|NCT01408277|3751684|P2|STARTED|Overall Study||27
1532983|NCT01408277|3751685|P1|STARTED|Overall Study||28
1532984|NCT01408030|3751695|P4|NOT COMPLETED|Observation Phase (Off Drug)||4
1532985|NCT01408030|3751696|P3|NOT COMPLETED|Observation Phase (Off Drug)||6
1532986|NCT01408030|3751697|P2|NOT COMPLETED|Observation Phase (Off Drug)||6
1532987|NCT01408030|3751698|P1|NOT COMPLETED|Observation Phase (Off Drug)||4
1532988|NCT01408030|3751695|P4|COMPLETED|Observation Phase (Off Drug)||21
1532989|NCT01408030|3751696|P3|COMPLETED|Observation Phase (Off Drug)||26
1532990|NCT01408030|3751697|P2|COMPLETED|Observation Phase (Off Drug)||18
1532991|NCT01408030|3751698|P1|COMPLETED|Observation Phase (Off Drug)||22
1532992|NCT01408030|3751695|P4|STARTED|Observation Phase (Off Drug)||25
1532993|NCT01408030|3751696|P3|STARTED|Observation Phase (Off Drug)||32
1532994|NCT01408030|3751697|P2|STARTED|Observation Phase (Off Drug)||24
1532995|NCT01408030|3751698|P1|STARTED|Observation Phase (Off Drug)||26
1532996|NCT01408030|3751695|P4|NOT COMPLETED|Treatment Phase (on Drug)||3
1532997|NCT01408030|3751696|P3|NOT COMPLETED|Treatment Phase (on Drug)||1
1532998|NCT01408030|3751697|P2|NOT COMPLETED|Treatment Phase (on Drug)||7
1532999|NCT01408030|3751698|P1|NOT COMPLETED|Treatment Phase (on Drug)||3
1533000|NCT01408030|3751695|P4|COMPLETED|Treatment Phase (on Drug)||25
1533001|NCT01408030|3751696|P3|COMPLETED|Treatment Phase (on Drug)||32
1533002|NCT01408030|3751697|P2|COMPLETED|Treatment Phase (on Drug)||24
1533003|NCT01408030|3751698|P1|COMPLETED|Treatment Phase (on Drug)||26
1533004|NCT01408030|3751695|P4|STARTED|Treatment Phase (on Drug)||28
1533005|NCT01408030|3751696|P3|STARTED|Treatment Phase (on Drug)||33
1533006|NCT01408030|3751697|P2|STARTED|Treatment Phase (on Drug)||31
1533007|NCT01408030|3751698|P1|STARTED|Treatment Phase (on Drug)||29
1533008|NCT01407575|3751730|P2|NOT COMPLETED|Overall Study||1
1533009|NCT01407575|3751731|P1|NOT COMPLETED|Overall Study||2
1533010|NCT01407575|3751730|P2|COMPLETED|Overall Study||5
1533011|NCT01407575|3751731|P1|COMPLETED|Overall Study||5
1533012|NCT01407575|3751730|P2|STARTED|Overall Study||6
1533013|NCT01407575|3751731|P1|STARTED|Overall Study||7
1533014|NCT01407523|3751749|P1|NOT COMPLETED|Overall Study||0
1533015|NCT01407523|3751749|P1|COMPLETED|Overall Study||16
1533016|NCT01407523|3751749|P1|STARTED|Overall Study||16
1533017|NCT01407367|3751761|P2|NOT COMPLETED|Overall Study||78
1533018|NCT01407367|3751762|P1|NOT COMPLETED|Overall Study||40
1533019|NCT01407367|3751761|P2|COMPLETED|Overall Study||164
1533020|NCT01407367|3751762|P1|COMPLETED|Overall Study||68
1533021|NCT01407367|3751761|P2|STARTED|Overall Study||242
1533022|NCT01407367|3751762|P1|STARTED|Overall Study||108
1533023|NCT01407354|3751776|P2|NOT COMPLETED|Second Intervention||2
1533024|NCT01407354|3751777|P1|NOT COMPLETED|Second Intervention||0
1533025|NCT01407354|3751776|P2|COMPLETED|Second Intervention||13
1533026|NCT01407354|3751777|P1|COMPLETED|Second Intervention||18
1533027|NCT01407354|3751776|P2|STARTED|Second Intervention||15
1533028|NCT01407354|3751777|P1|STARTED|Second Intervention||18
1533029|NCT01407354|3751776|P2|NOT COMPLETED|First Intervention||2
1533030|NCT01407354|3751777|P1|NOT COMPLETED|First Intervention||2
1533031|NCT01407354|3751776|P2|COMPLETED|First Intervention||15
1533032|NCT01407354|3751777|P1|COMPLETED|First Intervention||18
1533033|NCT01407354|3751776|P2|STARTED|First Intervention||17
1533034|NCT01407354|3751777|P1|STARTED|First Intervention||20
1533035|NCT01407276|3751793|P8|NOT COMPLETED|Overall Study||1
1533036|NCT01407276|3751794|P7|NOT COMPLETED|Overall Study||0
1533037|NCT01407276|3751795|P6|NOT COMPLETED|Overall Study||0
1533038|NCT01407276|3751796|P5|NOT COMPLETED|Overall Study||0
1533039|NCT01407276|3751797|P4|NOT COMPLETED|Overall Study||0
1533040|NCT01407276|3751798|P3|NOT COMPLETED|Overall Study||0
1533041|NCT01407276|3751799|P2|NOT COMPLETED|Overall Study||0
1533042|NCT01407276|3751800|P1|NOT COMPLETED|Overall Study||0
1533043|NCT01407276|3751793|P8|COMPLETED|Overall Study||6
1533044|NCT01407276|3751794|P7|COMPLETED|Overall Study||6
1533045|NCT01407276|3751795|P6|COMPLETED|Overall Study||6
1533046|NCT01407276|3751796|P5|COMPLETED|Overall Study||6
1533047|NCT01407276|3751797|P4|COMPLETED|Overall Study||6
1533048|NCT01407276|3751798|P3|COMPLETED|Overall Study||6
1533049|NCT01407276|3751799|P2|COMPLETED|Overall Study||6
1533050|NCT01407276|3751800|P1|COMPLETED|Overall Study||6
1533051|NCT01407276|3751793|P8|STARTED|Overall Study||7
1533052|NCT01407276|3751794|P7|STARTED|Overall Study||6
1533053|NCT01407276|3751795|P6|STARTED|Overall Study||6
1533054|NCT01407276|3751796|P5|STARTED|Overall Study||6
1533055|NCT01407276|3751797|P4|STARTED|Overall Study||6
1533056|NCT01407276|3751798|P3|STARTED|Overall Study||6
1533057|NCT01407276|3751799|P2|STARTED|Overall Study||6
1533058|NCT01407276|3751800|P1|STARTED|Overall Study||6
1533059|NCT01407094|3751927|P3|NOT COMPLETED|Stage 2||15
1533060|NCT01407094|3751928|P2|NOT COMPLETED|Stage 2||11
1533061|NCT01407094|3751929|P1|NOT COMPLETED|Stage 2||21
1533062|NCT01407094|3751927|P3|COMPLETED|Stage 2||38
1533063|NCT01407094|3751928|P2|COMPLETED|Stage 2||35
1533064|NCT01407094|3751929|P1|COMPLETED|Stage 2||113
1533065|NCT01407094|3751927|P3|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
1533066|NCT01407094|3751928|P2|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
1533067|NCT01407094|3751929|P1|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
1533068|NCT01407094|3751927|P3|NOT COMPLETED|Stage 1||0
1533069|NCT01407094|3751928|P2|NOT COMPLETED|Stage 1||27
1533070|NCT01407094|3751929|P1|NOT COMPLETED|Stage 1||34
1533071|NCT01407094|3751927|P3|COMPLETED|Stage 1||0
1533072|NCT01407094|3751928|P2|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
1533073|NCT01407094|3751929|P1|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
1533074|NCT01407094|3751927|P3|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
1533075|NCT01407094|3751928|P2|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
1533076|NCT01407094|3751929|P1|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
1533077|NCT01407068|3751937|P1|NOT COMPLETED|Overall Study||0
1533078|NCT01407068|3751937|P1|COMPLETED|Overall Study||60
1533079|NCT01407068|3751937|P1|STARTED|Overall Study||60
1533080|NCT01406990|3751946|P1|NOT COMPLETED|Overall Study||0
1533081|NCT01406990|3751946|P1|COMPLETED|Overall Study||15
1533082|NCT01406990|3751946|P1|STARTED|Overall Study||15
1533083|NCT01406938|3751952|P6|NOT COMPLETED|Follow up||3
1533084|NCT01406938|3751953|P5|NOT COMPLETED|Follow up||9
1533085|NCT01406938|3751954|P4|NOT COMPLETED|Follow up||3
1533086|NCT01406938|3751955|P3|NOT COMPLETED|Follow up||8
1533087|NCT01406938|3751956|P2|NOT COMPLETED|Follow up||5
1533088|NCT01406938|3751957|P1|NOT COMPLETED|Follow up||8
1533089|NCT01406938|3751952|P6|COMPLETED|Follow up||32
1533090|NCT01406938|3751953|P5|COMPLETED|Follow up||31
1533091|NCT01406938|3751954|P4|COMPLETED|Follow up||36
1533092|NCT01406938|3751955|P3|COMPLETED|Follow up||32
1533093|NCT01406938|3751956|P2|COMPLETED|Follow up||18
1533094|NCT01406938|3751957|P1|COMPLETED|Follow up||18
1533095|NCT01406938|3751952|P6|STARTED|Follow up||35
1533096|NCT01406938|3751953|P5|STARTED|Follow up||40
1533097|NCT01406938|3751954|P4|STARTED|Follow up||39
1533098|NCT01406938|3751955|P3|STARTED|Follow up||40
1533099|NCT01406938|3751956|P2|STARTED|Follow up||23
1533100|NCT01406938|3751957|P1|STARTED|Follow up||26
1533101|NCT01406938|3751952|P6|NOT COMPLETED|Maintenance Period||16
1533102|NCT01406938|3751953|P5|NOT COMPLETED|Maintenance Period||25
1533103|NCT01406938|3751954|P4|NOT COMPLETED|Maintenance Period||18
1533104|NCT01406938|3751955|P3|NOT COMPLETED|Maintenance Period||17
1533105|NCT01406938|3751956|P2|NOT COMPLETED|Maintenance Period||0
1533106|NCT01406938|3751957|P1|NOT COMPLETED|Maintenance Period||0
1533107|NCT01406938|3751952|P6|COMPLETED|Maintenance Period||201
1533108|NCT01406938|3751953|P5|COMPLETED|Maintenance Period||181
1533109|NCT01406938|3751954|P4|COMPLETED|Maintenance Period||199
1533110|NCT01406938|3751955|P3|COMPLETED|Maintenance Period||186
1533111|NCT01406938|3751956|P2|COMPLETED|Maintenance Period||0
1533112|NCT01406938|3751957|P1|COMPLETED|Maintenance Period||0
1533113|NCT01406938|3751952|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
1533114|NCT01406938|3751953|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
1533115|NCT01406938|3751954|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
1533116|NCT01406938|3751955|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
1533117|NCT01406938|3751956|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
1533118|NCT01406938|3751957|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
1533119|NCT01406938|3751952|P6|STARTED|Maintenance Period||217
1533120|NCT01406938|3751953|P5|STARTED|Maintenance Period||206
1533121|NCT01406938|3751954|P4|STARTED|Maintenance Period||217
1533122|NCT01406938|3751955|P3|STARTED|Maintenance Period||203
1533123|NCT01406938|3751956|P2|STARTED|Maintenance Period||0
1533124|NCT01406938|3751957|P1|STARTED|Maintenance Period||0
1533125|NCT01406938|3751952|P6|NOT COMPLETED|Induction Period||0
1533126|NCT01406938|3751953|P5|NOT COMPLETED|Induction Period||0
1533127|NCT01406938|3751954|P4|NOT COMPLETED|Induction Period||0
1533128|NCT01406938|3751955|P3|NOT COMPLETED|Induction Period||0
1533129|NCT01406938|3751956|P2|NOT COMPLETED|Induction Period||20
1533130|NCT01406938|3751957|P1|NOT COMPLETED|Induction Period||18
1533131|NCT01406938|3751952|P6|COMPLETED|Induction Period||0
1533132|NCT01406938|3751953|P5|COMPLETED|Induction Period||0
1533133|NCT01406938|3751954|P4|COMPLETED|Induction Period||0
1533134|NCT01406938|3751955|P3|COMPLETED|Induction Period||0
1533135|NCT01406938|3751956|P2|COMPLETED|Induction Period||464
1533136|NCT01406938|3751957|P1|COMPLETED|Induction Period||464
1533137|NCT01406938|3751952|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
1533138|NCT01406938|3751953|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
1533139|NCT01406938|3751954|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
1533140|NCT01406938|3751955|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
1533141|NCT01406938|3751956|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
1533142|NCT01406938|3751957|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
1533143|NCT01406938|3751952|P6|STARTED|Induction Period||0
1533144|NCT01406938|3751953|P5|STARTED|Induction Period||0
1533145|NCT01406938|3751954|P4|STARTED|Induction Period||0
1533146|NCT01406938|3751955|P3|STARTED|Induction Period||0
1533147|NCT01406938|3751956|P2|STARTED|Induction Period||484
1533148|NCT01406938|3751957|P1|STARTED|Induction Period||482
1533149|NCT01406873|3752075|P2|NOT COMPLETED|Overall Study||1
1533150|NCT01406873|3752076|P1|NOT COMPLETED|Overall Study||1
1533151|NCT01406873|3752075|P2|COMPLETED|Overall Study||20
1533152|NCT01406873|3752076|P1|COMPLETED|Overall Study||20
1533153|NCT01406873|3752075|P2|STARTED|Overall Study||21
1533154|NCT01406873|3752076|P1|STARTED|Overall Study||21
1533155|NCT01406860|3752094|P2|NOT COMPLETED|Overall Study||0
1533156|NCT01406860|3752095|P1|NOT COMPLETED|Overall Study||0
1533157|NCT01406860|3752094|P2|COMPLETED|Overall Study||8
1533158|NCT01406860|3752095|P1|COMPLETED|Overall Study||11
1533159|NCT01406860|3752094|P2|STARTED|Overall Study||8
1533160|NCT01406860|3752095|P1|STARTED|Overall Study||11
1533161|NCT01406795|3752107|P1|NOT COMPLETED|Overall Study||1
1533162|NCT01406795|3752107|P1|COMPLETED|Overall Study||0
1533163|NCT01406795|3752107|P1|STARTED|Overall Study||1
1533164|NCT01406574|3752121|P4|NOT COMPLETED|Overall Study||4
1533165|NCT01406574|3752122|P3|NOT COMPLETED|Overall Study||1
1533166|NCT01406574|3752123|P2|NOT COMPLETED|Overall Study||1
1533167|NCT01406574|3752124|P1|NOT COMPLETED|Overall Study||1
1533168|NCT01406574|3752121|P4|COMPLETED|Overall Study||1
1533169|NCT01406574|3752122|P3|COMPLETED|Overall Study||6
1533170|NCT01406574|3752123|P2|COMPLETED|Overall Study||3
1533171|NCT01406574|3752124|P1|COMPLETED|Overall Study||6
1533172|NCT01406574|3752121|P4|STARTED|Overall Study||5
1533173|NCT01406574|3752122|P3|STARTED|Overall Study||7
1533174|NCT01406574|3752123|P2|STARTED|Overall Study||4
1533175|NCT01406574|3752124|P1|STARTED|Overall Study||7
1533176|NCT01406223|3752140|P4|NOT COMPLETED|Overall Study||16
1533177|NCT01406223|3752141|P3|NOT COMPLETED|Overall Study||18
1533178|NCT01406223|3752142|P2|NOT COMPLETED|Overall Study||12
1533179|NCT01406223|3752143|P1|NOT COMPLETED|Overall Study||12
1533180|NCT01406223|3752140|P4|COMPLETED|Overall Study||3
1533181|NCT01406223|3752141|P3|COMPLETED|Overall Study||2
1533182|NCT01406223|3752142|P2|COMPLETED|Overall Study||7
1533183|NCT01406223|3752143|P1|COMPLETED|Overall Study||6
1533184|NCT01406223|3752140|P4|STARTED|Overall Study||19
1533185|NCT01406223|3752141|P3|STARTED|Overall Study||20
1533186|NCT01406223|3752142|P2|STARTED|Overall Study||19
1533187|NCT01406223|3752143|P1|STARTED|Overall Study||18
1533188|NCT01406015|3752159|P2|NOT COMPLETED|Overall Study||3
1533189|NCT01406015|3752160|P1|NOT COMPLETED|Overall Study||3
1533190|NCT01406015|3752159|P2|COMPLETED|Overall Study||16
1533191|NCT01406015|3752160|P1|COMPLETED|Overall Study||16
1533192|NCT01406015|3752159|P2|STARTED|Overall Study||19
1533193|NCT01406015|3752160|P1|STARTED|Overall Study||19
1533194|NCT01405950|3752176|P4|NOT COMPLETED|Overall Study||0
1533195|NCT01405950|3752177|P3|NOT COMPLETED|Overall Study||0
1533196|NCT01405950|3752178|P2|NOT COMPLETED|Overall Study||0
1533197|NCT01405950|3752179|P1|NOT COMPLETED|Overall Study||1
1533198|NCT01405950|3752176|P4|COMPLETED|Overall Study||0
1533199|NCT01405950|3752177|P3|COMPLETED|Overall Study||0
1533200|NCT01405950|3752178|P2|COMPLETED|Overall Study||2
1533201|NCT01405950|3752179|P1|COMPLETED|Overall Study||7
1533202|NCT01405950|3752176|P4|STARTED|Overall Study||0
1533203|NCT01405950|3752177|P3|STARTED|Overall Study||0
1533204|NCT01405950|3752178|P2|STARTED|Overall Study||2
1533205|NCT01405950|3752179|P1|STARTED|Overall Study||8
1533206|NCT01405937|3752193|P2|NOT COMPLETED|Overall Study||0
1533207|NCT01405937|3752194|P1|NOT COMPLETED|Overall Study||0
1533208|NCT01405937|3752193|P2|COMPLETED|Overall Study||26
1533209|NCT01405937|3752194|P1|COMPLETED|Overall Study||25
1533210|NCT01405937|3752193|P2|STARTED|Overall Study||26
1533211|NCT01405937|3752194|P1|STARTED|Overall Study||25
1533212|NCT01405924|3752214|P1|NOT COMPLETED|Overall Study||10
1533213|NCT01405924|3752214|P1|COMPLETED|Overall Study||101
1533214|NCT01405924|3752214|P1|STARTED|Overall Study||111
1533215|NCT01405898|3752226|P2|NOT COMPLETED|Overall Study||2
1533216|NCT01405898|3752227|P1|NOT COMPLETED|Overall Study||2
1533217|NCT01405898|3752226|P2|COMPLETED|Overall Study||32
1533218|NCT01405898|3752227|P1|COMPLETED|Overall Study||32
1533219|NCT01405898|3752226|P2|STARTED|Overall Study||34
1533220|NCT01405898|3752227|P1|STARTED|Overall Study||34
1533221|NCT01405820|3752251|P6|NOT COMPLETED|Open-Label Treatment Period||2
1533222|NCT01405820|3752252|P5|NOT COMPLETED|Open-Label Treatment Period||2
1533223|NCT01405820|3752253|P4|NOT COMPLETED|Open-Label Treatment Period||5
1533224|NCT01405820|3752254|P3|NOT COMPLETED|Open-Label Treatment Period||3
1533225|NCT01405820|3752255|P2|NOT COMPLETED|Open-Label Treatment Period||2
1533226|NCT01405820|3752256|P1|NOT COMPLETED|Open-Label Treatment Period||4
1533227|NCT01405820|3752251|P6|COMPLETED|Open-Label Treatment Period||30
1533228|NCT01405820|3752252|P5|COMPLETED|Open-Label Treatment Period||40
1533229|NCT01405820|3752253|P4|COMPLETED|Open-Label Treatment Period||37
1533230|NCT01405820|3752254|P3|COMPLETED|Open-Label Treatment Period||39
1533231|NCT01405820|3752255|P2|COMPLETED|Open-Label Treatment Period||33
1533232|NCT01405820|3752256|P1|COMPLETED|Open-Label Treatment Period||40
1533233|NCT01405820|3752251|P6|STARTED|Open-Label Treatment Period||32
1533234|NCT01405820|3752252|P5|STARTED|Open-Label Treatment Period||42
1533235|NCT01405820|3752253|P4|STARTED|Open-Label Treatment Period||42
1533236|NCT01405820|3752254|P3|STARTED|Open-Label Treatment Period||42
1533237|NCT01405820|3752255|P2|STARTED|Open-Label Treatment Period||35
1533238|NCT01405820|3752256|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
1533239|NCT01405820|3752251|P6|NOT COMPLETED|Randomized Treatment Period||37
1533240|NCT01405820|3752252|P5|NOT COMPLETED|Randomized Treatment Period||45
1533241|NCT01405820|3752253|P4|NOT COMPLETED|Randomized Treatment Period||51
1533242|NCT01405820|3752254|P3|NOT COMPLETED|Randomized Treatment Period||43
1533243|NCT01405820|3752255|P2|NOT COMPLETED|Randomized Treatment Period||10
1533244|NCT01405820|3752256|P1|NOT COMPLETED|Randomized Treatment Period||11
1533245|NCT01405820|3752251|P6|COMPLETED|Randomized Treatment Period||1
1533246|NCT01405820|3752252|P5|COMPLETED|Randomized Treatment Period||2
1533247|NCT01405820|3752253|P4|COMPLETED|Randomized Treatment Period||3
1533248|NCT01405820|3752254|P3|COMPLETED|Randomized Treatment Period||9
1533249|NCT01405820|3752255|P2|COMPLETED|Randomized Treatment Period||35
1533250|NCT01405820|3752256|P1|COMPLETED|Randomized Treatment Period||43
1533251|NCT01405820|3752251|P6|Safety Population|Randomized Treatment Period||38
1533252|NCT01405820|3752252|P5|Safety Population|Randomized Treatment Period||47
1533253|NCT01405820|3752253|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
1533254|NCT01405820|3752254|P3|Safety Population|Randomized Treatment Period||52
1533255|NCT01405820|3752255|P2|Safety Population|Randomized Treatment Period||45
1533256|NCT01405820|3752256|P1|Safety Population|Randomized Treatment Period||54
1533257|NCT01405820|3752251|P6|STARTED|Randomized Treatment Period||38
1533258|NCT01405820|3752252|P5|STARTED|Randomized Treatment Period||47
1533259|NCT01405820|3752253|P4|STARTED|Randomized Treatment Period||54
1533260|NCT01405820|3752254|P3|STARTED|Randomized Treatment Period||52
1533261|NCT01405820|3752255|P2|STARTED|Randomized Treatment Period||45
1533262|NCT01405820|3752256|P1|STARTED|Randomized Treatment Period||54
1533263|NCT01405794|3752276|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
1533264|NCT01405794|3752276|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
1533265|NCT01405794|3752276|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
1533266|NCT01405794|3752276|P1|NOT COMPLETED|72 hr Washout||0
1533267|NCT01405794|3752276|P1|COMPLETED|72 hr Washout||12
1533268|NCT01405794|3752276|P1|STARTED|72 hr Washout||12
1533269|NCT01405794|3752276|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
1533270|NCT01405794|3752276|P1|COMPLETED|First Dose Placebo (14 Days)||12
1533271|NCT01405794|3752276|P1|STARTED|First Dose Placebo (14 Days)||12
1533272|NCT01405768|3752352|P2|NOT COMPLETED|Overall Study||0
1533273|NCT01405768|3752353|P1|NOT COMPLETED|Overall Study||4
1533274|NCT01405768|3752352|P2|COMPLETED|Overall Study||28
1533275|NCT01405768|3752353|P1|COMPLETED|Overall Study||24
1533276|NCT01405768|3752352|P2|STARTED|Overall Study||28
1533277|NCT01405768|3752353|P1|STARTED|Overall Study||28
1533278|NCT01405742|3752365|P2|NOT COMPLETED|Overall Study||0
1533279|NCT01405742|3752366|P1|NOT COMPLETED|Overall Study||1
1533280|NCT01405742|3752365|P2|COMPLETED|Overall Study||2
1533281|NCT01405742|3752366|P1|COMPLETED|Overall Study||1
1533282|NCT01405742|3752365|P2|STARTED|Overall Study||2
1533283|NCT01405742|3752366|P1|STARTED|Overall Study||2
1533284|NCT01405560|3752376|P1|NOT COMPLETED|Overall Study||1
1533285|NCT01405560|3752376|P1|COMPLETED|Overall Study||41
1533286|NCT01405560|3752376|P1|STARTED|Overall Study||42
1533287|NCT01405508|3752391|P4|NOT COMPLETED|Overall Study||0
1533288|NCT01405508|3752392|P3|NOT COMPLETED|Overall Study||0
1533289|NCT01405508|3752393|P2|NOT COMPLETED|Overall Study||1
1533290|NCT01405508|3752394|P1|NOT COMPLETED|Overall Study||1
1533291|NCT01405508|3752391|P4|COMPLETED|Overall Study||26
1533292|NCT01405508|3752392|P3|COMPLETED|Overall Study||27
1533293|NCT01405508|3752393|P2|COMPLETED|Overall Study||25
1533294|NCT01405508|3752394|P1|COMPLETED|Overall Study||25
1533295|NCT01405508|3752391|P4|STARTED|Overall Study||26
1533296|NCT01405508|3752392|P3|STARTED|Overall Study||27
1533297|NCT01405508|3752393|P2|STARTED|Overall Study||26
1533298|NCT01405508|3752394|P1|STARTED|Overall Study||26
1533299|NCT01405469|3752412|P1|NOT COMPLETED|Overall Study||0
1533300|NCT01405469|3752412|P1|COMPLETED|Overall Study||16
1533301|NCT01405469|3752412|P1|STARTED|Overall Study||16
1533302|NCT01405456|3752426|P2|NOT COMPLETED|Overall Study||1
1533303|NCT01405456|3752427|P1|NOT COMPLETED|Overall Study||3
1533304|NCT01405456|3752426|P2|COMPLETED|Overall Study||20
1533305|NCT01405456|3752427|P1|COMPLETED|Overall Study||22
1533306|NCT01405456|3752426|P2|STARTED|Overall Study||21
1533307|NCT01405456|3752427|P1|STARTED|Overall Study||25
1533308|NCT01405313|3752455|P1|NOT COMPLETED|Overall Study||0
1533309|NCT01405313|3752455|P1|COMPLETED|Overall Study||21
1533310|NCT01405313|3752455|P1|STARTED|Overall Study||21
1533311|NCT01405196|3752467|P4|NOT COMPLETED|Overall Study||9
1533312|NCT01405196|3752468|P3|NOT COMPLETED|Overall Study||23
1533313|NCT01405196|3752469|P2|NOT COMPLETED|Overall Study||12
1533314|NCT01405196|3752470|P1|NOT COMPLETED|Overall Study||11
1533315|NCT01405196|3752467|P4|COMPLETED|Overall Study||36
1533316|NCT01405196|3752468|P3|COMPLETED|Overall Study||23
1533317|NCT01405196|3752469|P2|COMPLETED|Overall Study||35
1533318|NCT01405196|3752470|P1|COMPLETED|Overall Study||34
1533319|NCT01405196|3752467|P4|STARTED|Overall Study||45
1533320|NCT01405196|3752468|P3|STARTED|Overall Study||46
1533321|NCT01405196|3752469|P2|STARTED|Overall Study||47
1533322|NCT01405196|3752470|P1|STARTED|Overall Study||45
1533323|NCT01405027|3752557|P2|NOT COMPLETED|Overall Study||51
1533324|NCT01405027|3752558|P1|NOT COMPLETED|Overall Study||32
1533325|NCT01405027|3752557|P2|COMPLETED|Overall Study||62
1533326|NCT01405027|3752558|P1|COMPLETED|Overall Study||52
1533327|NCT01405027|3752557|P2|STARTED|Overall Study||113
1533328|NCT01405027|3752558|P1|STARTED|Overall Study||84
1533329|NCT01404988|3752575|P3|NOT COMPLETED|Overall Study||3
1533330|NCT01404988|3752576|P2|NOT COMPLETED|Overall Study||4
1533331|NCT01404988|3752577|P1|NOT COMPLETED|Overall Study||6
1533332|NCT01404988|3752575|P3|COMPLETED|Overall Study||30
1533333|NCT01404988|3752576|P2|COMPLETED|Overall Study||29
1533334|NCT01404988|3752577|P1|COMPLETED|Overall Study||27
1533335|NCT01404988|3752575|P3|STARTED|Overall Study||33
1533336|NCT01404988|3752576|P2|STARTED|Overall Study||33
1533337|NCT01404988|3752577|P1|STARTED|Overall Study||33
1533338|NCT01404936|3752594|P1|NOT COMPLETED|Overall Study||0
1533339|NCT01404936|3752594|P1|COMPLETED|Overall Study||30
1533340|NCT01404936|3752594|P1|STARTED|Overall Study||30
1533341|NCT01404923|3752600|P2|NOT COMPLETED|Overall Study||17
1533342|NCT01404923|3752601|P1|NOT COMPLETED|Overall Study||23
1533343|NCT01404923|3752600|P2|COMPLETED|Overall Study||197
1533344|NCT01404923|3752601|P1|COMPLETED|Overall Study||199
1533345|NCT01404923|3752600|P2|STARTED|Overall Study||214
1533346|NCT01404923|3752601|P1|STARTED|Overall Study||222
1533347|NCT01404832|3752609|P1|NOT COMPLETED|Overall Study||0
1533348|NCT01404832|3752609|P1|COMPLETED|Overall Study||21
1533349|NCT01404832|3752609|P1|STARTED|Overall Study||21
1533350|NCT01404650|3752614|P1|NOT COMPLETED|Overall Study||0
1533351|NCT01404650|3752614|P1|COMPLETED|Overall Study||25
1533352|NCT01404650|3752614|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
1533353|NCT01404611|3752624|P3|NOT COMPLETED|Overall Study||5
1533354|NCT01404611|3752625|P2|NOT COMPLETED|Overall Study||19
1533355|NCT01404611|3752626|P1|NOT COMPLETED|Overall Study||8
1533356|NCT01404611|3752624|P3|COMPLETED|Overall Study||106
1533357|NCT01404611|3752625|P2|COMPLETED|Overall Study||89
1533358|NCT01404611|3752626|P1|COMPLETED|Overall Study||104
1533359|NCT01404611|3752624|P3|STARTED|Overall Study||111
1533360|NCT01404611|3752625|P2|STARTED|Overall Study||108
1533361|NCT01404611|3752626|P1|STARTED|Overall Study||112
1533362|NCT01404572|3752634|P3|NOT COMPLETED|Overall Study||0
1533363|NCT01404572|3752635|P2|NOT COMPLETED|Overall Study||0
1533364|NCT01404572|3752636|P1|NOT COMPLETED|Overall Study||0
1533365|NCT01404572|3752634|P3|COMPLETED|Overall Study||4
1533366|NCT01404572|3752635|P2|COMPLETED|Overall Study||4
1533367|NCT01404572|3752636|P1|COMPLETED|Overall Study||4
1533368|NCT01404572|3752634|P3|STARTED|Overall Study||4
1533369|NCT01404572|3752635|P2|STARTED|Overall Study||4
1533370|NCT01404572|3752636|P1|STARTED|Overall Study||4
1533371|NCT01404559|3752667|P4|NOT COMPLETED|Overall Study||0
1533372|NCT01404559|3752668|P3|NOT COMPLETED|Overall Study||0
1533373|NCT01404559|3752669|P2|NOT COMPLETED|Overall Study||0
1533374|NCT01404559|3752670|P1|NOT COMPLETED|Overall Study||0
1533375|NCT01404559|3752667|P4|COMPLETED|Overall Study||14
1533376|NCT01404559|3752668|P3|COMPLETED|Overall Study||4
1533377|NCT01404559|3752669|P2|COMPLETED|Overall Study||5
1533378|NCT01404559|3752670|P1|COMPLETED|Overall Study||5
1533379|NCT01404559|3752667|P4|STARTED|Overall Study||14
1533380|NCT01404559|3752668|P3|STARTED|Overall Study||4
1533381|NCT01404559|3752669|P2|STARTED|Overall Study||5
1533382|NCT01404559|3752670|P1|STARTED|Overall Study||5
1533383|NCT01404429|3752683|P2|NOT COMPLETED|Overall Study||7
1533384|NCT01404429|3752684|P1|NOT COMPLETED|Overall Study||9
1533385|NCT01404429|3752683|P2|COMPLETED|Overall Study||46
1533386|NCT01404429|3752684|P1|COMPLETED|Overall Study||38
1533387|NCT01404429|3752683|P2|STARTED|Overall Study||53
1533388|NCT01404429|3752684|P1|STARTED|Overall Study||47
1533389|NCT01404312|3752698|P2|NOT COMPLETED|Overall Study||311
1533390|NCT01404312|3752699|P1|NOT COMPLETED|Overall Study||298
1533391|NCT01404312|3752698|P2|COMPLETED|Overall Study||1193
1533392|NCT01404312|3752699|P1|COMPLETED|Overall Study||1198
1533393|NCT01404312|3752698|P2|STARTED|Overall Study||1504
1533394|NCT01404312|3752699|P1|STARTED|Overall Study||1496
1533395|NCT01404260|3752721|P2|NOT COMPLETED|Overall Study||9
1533396|NCT01404260|3752722|P1|NOT COMPLETED|Overall Study||3
1533397|NCT01404260|3752721|P2|COMPLETED|Overall Study||101
1533398|NCT01404260|3752722|P1|COMPLETED|Overall Study||106
1533399|NCT01404260|3752721|P2|STARTED|Overall Study||110
1533400|NCT01404260|3752722|P1|STARTED|Overall Study||109
1533401|NCT01404234|3752728|P1|NOT COMPLETED|Overall Study||2
1533402|NCT01404234|3752728|P1|COMPLETED|Overall Study||59
1533403|NCT01404234|3752728|P1|STARTED|Overall Study||61
1533404|NCT01404208|3752744|P2|NOT COMPLETED|Overall Study||0
1533405|NCT01404208|3752745|P1|NOT COMPLETED|Overall Study||3
1533406|NCT01404208|3752744|P2|COMPLETED|Overall Study||72
1533407|NCT01404208|3752745|P1|COMPLETED|Overall Study||67
1533408|NCT01404208|3752744|P2|STARTED|Overall Study||72
1533409|NCT01404208|3752745|P1|STARTED|Overall Study||70
1533410|NCT01404078|3752755|P2|NOT COMPLETED|Overall Study||20
1533411|NCT01404078|3752756|P1|NOT COMPLETED|Overall Study||18
1533412|NCT01404078|3752755|P2|COMPLETED|Overall Study||237
1533413|NCT01404078|3752756|P1|COMPLETED|Overall Study||243
1533414|NCT01404078|3752755|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
1533415|NCT01404078|3752756|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
1533416|NCT01404039|3752771|P13|NOT COMPLETED|Overall Study||0
1533417|NCT01404039|3752772|P12|NOT COMPLETED|Overall Study||0
1533418|NCT01404039|3752773|P11|NOT COMPLETED|Overall Study||1
1533419|NCT01404039|3752774|P10|NOT COMPLETED|Overall Study||1
1533420|NCT01404039|3752775|P9|NOT COMPLETED|Overall Study||0
1533421|NCT01404039|3752776|P8|NOT COMPLETED|Overall Study||0
1533422|NCT01404039|3752777|P7|NOT COMPLETED|Overall Study||0
1533423|NCT01404039|3752778|P6|NOT COMPLETED|Overall Study||0
1533424|NCT01404039|3752779|P5|NOT COMPLETED|Overall Study||0
1533425|NCT01404039|3752780|P4|NOT COMPLETED|Overall Study||0
1533426|NCT01404039|3752781|P3|NOT COMPLETED|Overall Study||0
1533427|NCT01404039|3752782|P2|NOT COMPLETED|Overall Study||0
1533428|NCT01404039|3752783|P1|NOT COMPLETED|Overall Study||1
1533429|NCT01404039|3752771|P13|COMPLETED|Overall Study||0
1533430|NCT01404039|3752772|P12|COMPLETED|Overall Study||0
1533431|NCT01404039|3752773|P11|COMPLETED|Overall Study||14
1533432|NCT01404039|3752774|P10|COMPLETED|Overall Study||14
1533433|NCT01404039|3752775|P9|COMPLETED|Overall Study||15
1533434|NCT01404039|3752776|P8|COMPLETED|Overall Study||15
1533435|NCT01404039|3752777|P7|COMPLETED|Overall Study||10
1533436|NCT01404039|3752778|P6|COMPLETED|Overall Study||10
1533437|NCT01404039|3752779|P5|COMPLETED|Overall Study||10
1533438|NCT01404039|3752780|P4|COMPLETED|Overall Study||10
1533439|NCT01404039|3752781|P3|COMPLETED|Overall Study||5
1533440|NCT01404039|3752782|P2|COMPLETED|Overall Study||5
1533441|NCT01404039|3752783|P1|COMPLETED|Overall Study||4
1533442|NCT01404039|3752771|P13|STARTED|Overall Study||0
1533443|NCT01404039|3752772|P12|STARTED|Overall Study||0
1533444|NCT01404039|3752773|P11|STARTED|Overall Study||15
1533445|NCT01404039|3752774|P10|STARTED|Overall Study||15
1533446|NCT01404039|3752775|P9|STARTED|Overall Study||15
1533447|NCT01404039|3752776|P8|STARTED|Overall Study||15
1533448|NCT01404039|3752777|P7|STARTED|Overall Study||10
1533449|NCT01404039|3752778|P6|STARTED|Overall Study||10
1533450|NCT01404039|3752779|P5|STARTED|Overall Study||10
1533451|NCT01404039|3752780|P4|STARTED|Overall Study||10
1533452|NCT01404039|3752781|P3|STARTED|Overall Study||5
1533453|NCT01404039|3752782|P2|STARTED|Overall Study||5
1533454|NCT01404039|3752783|P1|STARTED|Overall Study||5
1533455|NCT01403987|3752810|P3|NOT COMPLETED|Overall Study||18
1533456|NCT01403987|3752811|P2|NOT COMPLETED|Overall Study||17
1533457|NCT01403987|3752812|P1|NOT COMPLETED|Overall Study||18
1533458|NCT01403987|3752810|P3|COMPLETED|Overall Study||50
1533459|NCT01403987|3752811|P2|COMPLETED|Overall Study||17
1533460|NCT01403987|3752812|P1|COMPLETED|Overall Study||16
1533461|NCT01403987|3752810|P3|STARTED|Overall Study||68
1533462|NCT01403987|3752811|P2|STARTED|Overall Study||34
1533463|NCT01403987|3752812|P1|STARTED|Overall Study||34
1533464|NCT01403805|3752828|P2|NOT COMPLETED|Overall Study||7
1533465|NCT01403805|3752829|P1|NOT COMPLETED|Overall Study||0
1533466|NCT01403805|3752828|P2|COMPLETED|Overall Study||98
1533467|NCT01403805|3752829|P1|COMPLETED|Overall Study||94
1533468|NCT01403805|3752828|P2|Pneumonia Diagnosis|Overall Study||2
1533469|NCT01403805|3752829|P1|Pneumonia Diagnosis|Overall Study||21
1533470|NCT01403805|3752828|P2|STARTED|Overall Study||105
1533471|NCT01403805|3752829|P1|STARTED|Overall Study||94
1533472|NCT01403441|3752841|P1|NOT COMPLETED|Overall Study||0
1533473|NCT01403441|3752841|P1|COMPLETED|Overall Study||3
1533474|NCT01403441|3752841|P1|STARTED|Overall Study||3
1533475|NCT01403376|3752851|P3|NOT COMPLETED|Overall Study||0
1533476|NCT01403376|3752852|P2|NOT COMPLETED|Overall Study||0
1533477|NCT01403376|3752853|P1|NOT COMPLETED|Overall Study||0
1533478|NCT01403376|3752851|P3|COMPLETED|Overall Study||46
1533479|NCT01403376|3752852|P2|COMPLETED|Overall Study||41
1533480|NCT01403376|3752853|P1|COMPLETED|Overall Study||41
1533481|NCT01403376|3752851|P3|STARTED|Overall Study||46
1533482|NCT01403376|3752852|P2|STARTED|Overall Study||41
1533483|NCT01403376|3752853|P1|STARTED|Overall Study||41
1533484|NCT01403194|3752873|P1|NOT COMPLETED|Overall Study||10
1533485|NCT01403194|3752873|P1|COMPLETED|Overall Study||1
1533486|NCT01403194|3752873|P1|STARTED|Overall Study||11
1533487|NCT01403116|3752881|P2|NOT COMPLETED|Overall Study||27
1533488|NCT01403116|3752882|P1|NOT COMPLETED|Overall Study||32
1533489|NCT01403116|3752881|P2|COMPLETED|Overall Study||133
1533490|NCT01403116|3752882|P1|COMPLETED|Overall Study||129
1533491|NCT01403116|3752881|P2|Randomized in Error/ No Treatment Recvd|Overall Study||3
1533492|NCT01403116|3752882|P1|Randomized in Error/ No Treatment Recvd|Overall Study||1
1533493|NCT01403116|3752881|P2|Randomized|Overall Study||163
1533494|NCT01403116|3752882|P1|Randomized|Overall Study||162
1533495|NCT01403116|3752881|P2|STARTED|Overall Study||160
1533496|NCT01403116|3752882|P1|STARTED|Overall Study||161
1533497|NCT01403090|3752889|P1|NOT COMPLETED|Overall Study||0
1533498|NCT01403090|3752889|P1|COMPLETED|Overall Study||8
1533499|NCT01403090|3752889|P1|STARTED|Overall Study||8
1533500|NCT01403051|3752895|P2|NOT COMPLETED|Overall Study||6
1533501|NCT01403051|3752896|P1|NOT COMPLETED|Overall Study||10
1533502|NCT01403051|3752895|P2|COMPLETED|Overall Study||80
1533503|NCT01403051|3752896|P1|COMPLETED|Overall Study||71
1533504|NCT01403051|3752895|P2|Initiated Study Treatment|Overall Study||86
1533505|NCT01403051|3752896|P1|Initiated Study Treatment|Overall Study||81
1533506|NCT01403051|3752895|P2|STARTED|Overall Study||86
1533507|NCT01403051|3752896|P1|STARTED|Overall Study||81
1533508|NCT01402986|3752932|P4|NOT COMPLETED|Overall Study||22
1533509|NCT01402986|3752933|P3|NOT COMPLETED|Overall Study||8
1533510|NCT01402986|3752934|P2|NOT COMPLETED|Overall Study||15
1533511|NCT01402986|3752935|P1|NOT COMPLETED|Overall Study||9
1533512|NCT01402986|3752932|P4|COMPLETED|Overall Study||129
1533513|NCT01402986|3752933|P3|COMPLETED|Overall Study||67
1533514|NCT01402986|3752934|P2|COMPLETED|Overall Study||135
1533515|NCT01402986|3752935|P1|COMPLETED|Overall Study||67
1533516|NCT01402986|3752932|P4|STARTED|Overall Study||151
1533517|NCT01402986|3752933|P3|STARTED|Overall Study||75
1533518|NCT01402986|3752934|P2|STARTED|Overall Study||150
1533519|NCT01402986|3752935|P1|STARTED|Overall Study||76
1533520|NCT01402947|3753070|P2|NOT COMPLETED|Second Intervention||0
1533521|NCT01402947|3753071|P1|NOT COMPLETED|Second Intervention||0
1533522|NCT01402947|3753070|P2|COMPLETED|Second Intervention||14
1533523|NCT01402947|3753071|P1|COMPLETED|Second Intervention||15
1533524|NCT01402947|3753070|P2|STARTED|Second Intervention||14
1533525|NCT01402947|3753071|P1|STARTED|Second Intervention||15
1533526|NCT01402947|3753070|P2|NOT COMPLETED|First Intervention||1
1533527|NCT01402947|3753071|P1|NOT COMPLETED|First Intervention||0
1533528|NCT01402947|3753070|P2|COMPLETED|First Intervention||14
1533529|NCT01402947|3753071|P1|COMPLETED|First Intervention||15
1533530|NCT01402947|3753070|P2|STARTED|First Intervention||15
1533531|NCT01402947|3753071|P1|STARTED|First Intervention||15
1533532|NCT01402869|3753082|P3|NOT COMPLETED|Overall Study||1
1533533|NCT01402869|3753083|P2|NOT COMPLETED|Overall Study||0
1533534|NCT01402869|3753084|P1|NOT COMPLETED|Overall Study||0
1533535|NCT01402869|3753082|P3|COMPLETED|Overall Study||30
1533536|NCT01402869|3753083|P2|COMPLETED|Overall Study||30
1533537|NCT01402869|3753084|P1|COMPLETED|Overall Study||30
1533538|NCT01402869|3753082|P3|STARTED|Overall Study||31
1533539|NCT01402869|3753083|P2|STARTED|Overall Study||30
1533540|NCT01402869|3753084|P1|STARTED|Overall Study||30
1533541|NCT01402817|3753098|P1|NOT COMPLETED|Overall Study||11
1533542|NCT01402817|3753098|P1|COMPLETED|Overall Study||8
1533543|NCT01402817|3753098|P1|STARTED|Overall Study||19
1533544|NCT01402700|3753103|P1|NOT COMPLETED|Overall Study||7
1533545|NCT01402700|3753103|P1|COMPLETED|Overall Study||68
1533546|NCT01402700|3753103|P1|STARTED|Overall Study||75
1533547|NCT01402570|3753107|P1|NOT COMPLETED|Overall Study||1
1533548|NCT01402570|3753107|P1|COMPLETED|Overall Study||19
1533549|NCT01402570|3753107|P1|STARTED|Overall Study||20
1533550|NCT01402427|3753116|P2|NOT COMPLETED|Overall Study||0
1533551|NCT01402427|3753117|P1|NOT COMPLETED|Overall Study||0
1533552|NCT01402427|3753116|P2|COMPLETED|Overall Study||294
1533553|NCT01402427|3753117|P1|COMPLETED|Overall Study||297
1533554|NCT01402427|3753116|P2|STARTED|Overall Study||294
1533555|NCT01402427|3753117|P1|STARTED|Overall Study||297
1533556|NCT01402375|3753141|P6|NOT COMPLETED|Overall Study||0
1533557|NCT01402375|3753142|P5|NOT COMPLETED|Overall Study||0
1533558|NCT01402375|3753143|P4|NOT COMPLETED|Overall Study||0
1533559|NCT01402375|3753144|P3|NOT COMPLETED|Overall Study||0
1533560|NCT01402375|3753145|P2|NOT COMPLETED|Overall Study||0
1533561|NCT01402375|3753146|P1|NOT COMPLETED|Overall Study||0
1533562|NCT01402375|3753141|P6|COMPLETED|Overall Study||120
1533563|NCT01402375|3753142|P5|COMPLETED|Overall Study||120
1533564|NCT01402375|3753143|P4|COMPLETED|Overall Study||120
1533565|NCT01402375|3753144|P3|COMPLETED|Overall Study||120
1533566|NCT01402375|3753145|P2|COMPLETED|Overall Study||120
1533567|NCT01402375|3753146|P1|COMPLETED|Overall Study||120
1533568|NCT01402375|3753141|P6|STARTED|Overall Study||120
1533569|NCT01402375|3753142|P5|STARTED|Overall Study||120
1533570|NCT01402375|3753143|P4|STARTED|Overall Study||120
1533571|NCT01402375|3753144|P3|STARTED|Overall Study||120
1533572|NCT01402375|3753145|P2|STARTED|Overall Study||120
1533573|NCT01402375|3753146|P1|STARTED|Overall Study||120
1533574|NCT01402284|3753178|P1|NOT COMPLETED|Overall Study||15
1533575|NCT01402284|3753178|P1|COMPLETED|Overall Study||30
1533576|NCT01402284|3753178|P1|STARTED|Overall Study||45
1533577|NCT01402141|3753191|P2|NOT COMPLETED|Overall Study||2
1533578|NCT01402141|3753192|P1|NOT COMPLETED|Overall Study||1
1533579|NCT01402141|3753191|P2|COMPLETED|Overall Study||28
1533580|NCT01402141|3753192|P1|COMPLETED|Overall Study||29
1533581|NCT01402141|3753191|P2|STARTED|Overall Study||30
1533582|NCT01402141|3753192|P1|STARTED|Overall Study||30
1533583|NCT01402128|3753214|P2|NOT COMPLETED|Overall Study||0
1533584|NCT01402128|3753215|P1|NOT COMPLETED|Overall Study||1
1533585|NCT01402128|3753214|P2|COMPLETED|Overall Study||40
1533586|NCT01402128|3753215|P1|COMPLETED|Overall Study||39
1533587|NCT01402128|3753214|P2|STARTED|Overall Study||40
1533588|NCT01402128|3753215|P1|STARTED|Overall Study||40
1533589|NCT01402115|3753243|P2|NOT COMPLETED|Overall Study||1
1533590|NCT01402115|3753244|P1|NOT COMPLETED|Overall Study||1
1533591|NCT01402115|3753243|P2|COMPLETED|Overall Study||29
1533592|NCT01402115|3753244|P1|COMPLETED|Overall Study||29
1533593|NCT01402115|3753243|P2|STARTED|Overall Study||30
1533594|NCT01402115|3753244|P1|STARTED|Overall Study||30
1533595|NCT01402102|3753260|P2|NOT COMPLETED|Overall Study||3
1533596|NCT01402102|3753261|P1|NOT COMPLETED|Overall Study||2
1533597|NCT01402102|3753260|P2|COMPLETED|Overall Study||27
1533598|NCT01402102|3753261|P1|COMPLETED|Overall Study||28
1533599|NCT01402102|3753260|P2|STARTED|Overall Study||30
1533600|NCT01402102|3753261|P1|STARTED|Overall Study||30
1533601|NCT01402063|3753281|P2|NOT COMPLETED|Overall Study||3
1533602|NCT01402063|3753282|P1|NOT COMPLETED|Overall Study||3
1533603|NCT01402063|3753281|P2|COMPLETED|Overall Study||18
1533604|NCT01402063|3753282|P1|COMPLETED|Overall Study||39
1533605|NCT01402063|3753281|P2|STARTED|Overall Study||21
1533606|NCT01402063|3753282|P1|STARTED|Overall Study||42
1533607|NCT01402011|3753291|P3|NOT COMPLETED|Nine Month Follow-up||0
1533608|NCT01402011|3753292|P2|NOT COMPLETED|Nine Month Follow-up||1
1533609|NCT01402011|3753293|P1|NOT COMPLETED|Nine Month Follow-up||0
1533610|NCT01402011|3753291|P3|COMPLETED|Nine Month Follow-up||26
1533611|NCT01402011|3753292|P2|COMPLETED|Nine Month Follow-up||19
1533612|NCT01402011|3753293|P1|COMPLETED|Nine Month Follow-up||27
1533613|NCT01402011|3753291|P3|STARTED|Nine Month Follow-up||26
1533614|NCT01402011|3753292|P2|STARTED|Nine Month Follow-up||20
1533615|NCT01402011|3753293|P1|STARTED|Nine Month Follow-up||27
1533616|NCT01402011|3753291|P3|NOT COMPLETED|Active Treatment Period||0
1533617|NCT01402011|3753292|P2|NOT COMPLETED|Active Treatment Period||3
1533618|NCT01402011|3753293|P1|NOT COMPLETED|Active Treatment Period||1
1533619|NCT01402011|3753291|P3|COMPLETED|Active Treatment Period||26
1533620|NCT01402011|3753292|P2|COMPLETED|Active Treatment Period||20
1533621|NCT01402011|3753293|P1|COMPLETED|Active Treatment Period||27
1533622|NCT01402011|3753291|P3|STARTED|Active Treatment Period||26
1533623|NCT01402011|3753292|P2|STARTED|Active Treatment Period||23
1533624|NCT01402011|3753293|P1|STARTED|Active Treatment Period||28
1533625|NCT01402011|3753291|P3|NOT COMPLETED|Delayed Treatment Period||0
1533626|NCT01402011|3753292|P2|NOT COMPLETED|Delayed Treatment Period||0
1533627|NCT01402011|3753293|P1|NOT COMPLETED|Delayed Treatment Period||1
1533628|NCT01402011|3753291|P3|COMPLETED|Delayed Treatment Period||26
1533629|NCT01402011|3753292|P2|COMPLETED|Delayed Treatment Period||23
1533630|NCT01402011|3753293|P1|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
1533631|NCT01402011|3753291|P3|STARTED|Delayed Treatment Period||26
1533632|NCT01402011|3753292|P2|STARTED|Delayed Treatment Period||23
1533633|NCT01402011|3753293|P1|STARTED|Delayed Treatment Period||29
1533634|NCT01401959|3753322|P3|NOT COMPLETED|Treated||5
1533635|NCT01401959|3753323|P2|NOT COMPLETED|Treated||8
1533636|NCT01401959|3753324|P1|NOT COMPLETED|Treated||7
1533637|NCT01401959|3753322|P3|COMPLETED|Treated||26
1533638|NCT01401959|3753323|P2|COMPLETED|Treated||34
1533639|NCT01401959|3753324|P1|COMPLETED|Treated||46
1533640|NCT01401959|3753322|P3|STARTED|Treated||31
1533641|NCT01401959|3753323|P2|STARTED|Treated||42
1533642|NCT01401959|3753324|P1|STARTED|Treated||53
1533643|NCT01401959|3753322|P3|NOT COMPLETED|Enrolled||0
1533644|NCT01401959|3753323|P2|NOT COMPLETED|Enrolled||0
1533645|NCT01401959|3753324|P1|NOT COMPLETED|Enrolled||1
1533646|NCT01401959|3753322|P3|COMPLETED|Enrolled||31
1533647|NCT01401959|3753323|P2|COMPLETED|Enrolled||42
1533648|NCT01401959|3753324|P1|COMPLETED|Enrolled||53
1533649|NCT01401959|3753322|P3|STARTED|Enrolled||31
1533650|NCT01401959|3753323|P2|STARTED|Enrolled||42
1533651|NCT01401959|3753324|P1|STARTED|Enrolled||54
1533652|NCT01401907|3753340|P2|NOT COMPLETED|Overall Study||51
1533653|NCT01401907|3753341|P1|NOT COMPLETED|Overall Study||57
1533654|NCT01401907|3753340|P2|COMPLETED|Overall Study||124
1533655|NCT01401907|3753341|P1|COMPLETED|Overall Study||118
1533656|NCT01401907|3753340|P2|12 Week Outcomes|Overall Study||153
1533657|NCT01401907|3753341|P1|12 Week Outcomes|Overall Study||148
1533658|NCT01401907|3753340|P2|STARTED|Overall Study||175
1533659|NCT01401907|3753341|P1|STARTED|Overall Study||175
1533660|NCT01401842|3753361|P2|NOT COMPLETED|Overall Study||67
1533661|NCT01401842|3753362|P1|NOT COMPLETED|Overall Study||68
1533662|NCT01401842|3753361|P2|COMPLETED|Overall Study||217
1533663|NCT01401842|3753362|P1|COMPLETED|Overall Study||230
1533664|NCT01401842|3753361|P2|STARTED|Overall Study||284
1533665|NCT01401842|3753362|P1|STARTED|Overall Study||298
1533666|NCT01401699|3753372|P1|NOT COMPLETED|Overall Study||0
1533667|NCT01401699|3753372|P1|COMPLETED|Overall Study||110
1533668|NCT01401699|3753372|P1|STARTED|Overall Study||110
1533669|NCT01401647|3753379|P3|NOT COMPLETED|Overall Study||3
1533670|NCT01401647|3753380|P2|NOT COMPLETED|Overall Study||8
1533671|NCT01401647|3753381|P1|NOT COMPLETED|Overall Study||4
1533672|NCT01401647|3753379|P3|COMPLETED|Overall Study||1056
1533673|NCT01401647|3753380|P2|COMPLETED|Overall Study||985
1533674|NCT01401647|3753381|P1|COMPLETED|Overall Study||968
1533675|NCT01401647|3753379|P3|STARTED|Overall Study||1059
1533676|NCT01401647|3753380|P2|STARTED|Overall Study||993
1533677|NCT01401647|3753381|P1|STARTED|Overall Study||972
1533678|NCT01401595|3753394|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
1533679|NCT01401595|3753395|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
1533680|NCT01401595|3753394|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
1533681|NCT01401595|3753395|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
1533682|NCT01401595|3753394|P2|STARTED|Imaging and Treatment (for NE Arm)||10
1533683|NCT01401595|3753395|P1|STARTED|Imaging and Treatment (for NE Arm)||32
1533684|NCT01401595|3753394|P2|NOT COMPLETED|Recruitment and Screening||2
1533685|NCT01401595|3753395|P1|NOT COMPLETED|Recruitment and Screening||43
1533686|NCT01401595|3753394|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
1533687|NCT01401595|3753395|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
1533688|NCT01401595|3753394|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
1533689|NCT01401595|3753395|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
1533690|NCT01401582|3753406|P2|NOT COMPLETED|Overall Study||117
1533691|NCT01401582|3753407|P1|NOT COMPLETED|Overall Study||110
1533692|NCT01401582|3753406|P2|COMPLETED|Overall Study||291
1533693|NCT01401582|3753407|P1|COMPLETED|Overall Study||116
1533694|NCT01401582|3753406|P2|Baseline Completed|Overall Study||348
1533695|NCT01401582|3753407|P1|Baseline Completed|Overall Study||168
1533696|NCT01401582|3753406|P2|STARTED|Overall Study||408
1533697|NCT01401582|3753407|P1|STARTED|Overall Study||226
1533698|NCT01401530|3753426|P3|NOT COMPLETED|Overall Study||3
1533699|NCT01401530|3753427|P2|NOT COMPLETED|Overall Study||6
1533700|NCT01401530|3753428|P1|NOT COMPLETED|Overall Study||3
1533701|NCT01401530|3753426|P3|COMPLETED|Overall Study||0
1533702|NCT01401530|3753427|P2|COMPLETED|Overall Study||1
1533703|NCT01401530|3753428|P1|COMPLETED|Overall Study||0
1533704|NCT01401530|3753426|P3|STARTED|Overall Study||3
1533705|NCT01401530|3753427|P2|STARTED|Overall Study||7
1533706|NCT01401530|3753428|P1|STARTED|Overall Study||3
1533707|NCT01401517|3753468|P3|NOT COMPLETED|Overall Study||3
1533708|NCT01401517|3753469|P2|NOT COMPLETED|Overall Study||2
1533709|NCT01401517|3753470|P1|NOT COMPLETED|Overall Study||3
1533710|NCT01401517|3753468|P3|COMPLETED|Overall Study||15
1533711|NCT01401517|3753469|P2|COMPLETED|Overall Study||17
1533712|NCT01401517|3753470|P1|COMPLETED|Overall Study||15
1533713|NCT01401517|3753468|P3|STARTED|Overall Study||18
1533714|NCT01401517|3753469|P2|STARTED|Overall Study||19
1533715|NCT01401517|3753470|P1|STARTED|Overall Study||18
1533716|NCT01401478|3753478|P1|NOT COMPLETED|Overall Study||31
1533717|NCT01401478|3753478|P1|COMPLETED|Overall Study||55
1533718|NCT01401478|3753478|P1|STARTED|Overall Study||86
1533719|NCT01401465|3753491|P2|NOT COMPLETED|Treatment Period 2||2
1533720|NCT01401465|3753492|P1|NOT COMPLETED|Treatment Period 2||0
1533721|NCT01401465|3753491|P2|COMPLETED|Treatment Period 2||144
1533722|NCT01401465|3753492|P1|COMPLETED|Treatment Period 2||150
1533723|NCT01401465|3753491|P2|STARTED|Treatment Period 2||146
1533724|NCT01401465|3753492|P1|STARTED|Treatment Period 2||150
1533725|NCT01401465|3753491|P2|NOT COMPLETED|Washout||0
1533726|NCT01401465|3753492|P1|NOT COMPLETED|Washout||0
1533727|NCT01401465|3753491|P2|COMPLETED|Washout||146
1533728|NCT01401465|3753492|P1|COMPLETED|Washout||150
1533729|NCT01401465|3753491|P2|STARTED|Washout||146
1533730|NCT01401465|3753492|P1|STARTED|Washout||150
1533731|NCT01401465|3753491|P2|NOT COMPLETED|Treatment Period 1||16
1533732|NCT01401465|3753492|P1|NOT COMPLETED|Treatment Period 1||15
1533733|NCT01401465|3753491|P2|COMPLETED|Treatment Period 1||146
1533734|NCT01401465|3753492|P1|COMPLETED|Treatment Period 1||150
1533735|NCT01401465|3753491|P2|STARTED|Treatment Period 1||162
1533736|NCT01401465|3753492|P1|STARTED|Treatment Period 1||165
1533737|NCT01401452|3753555|P1|NOT COMPLETED|Overall Study||72
1533738|NCT01401452|3753555|P1|COMPLETED|Overall Study||174
1533739|NCT01401452|3753555|P1|Visit 5 (9 Months)|Overall Study||175
1533740|NCT01401452|3753555|P1|Visit 4 (6 Months)|Overall Study||172
1533741|NCT01401452|3753555|P1|Visit 3 (3 Months)|Overall Study||217
1533742|NCT01401452|3753555|P1|Visit 2 (1 Month)|Overall Study||225
1533743|NCT01401452|3753555|P1|Visit 1 (Baseline)|Overall Study||246
1533744|NCT01401452|3753555|P1|STARTED|Overall Study||246
1533745|NCT01401361|3753567|P1|NOT COMPLETED|Overall Study||28
1533746|NCT01401361|3753567|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
1533747|NCT01401361|3753567|P1|STARTED|Overall Study||150
1533748|NCT01401322|3753573|P1|NOT COMPLETED|Overall Study||2
1533749|NCT01401322|3753573|P1|COMPLETED|Overall Study||3
1533750|NCT01401322|3753573|P1|STARTED|Overall Study||5
1533751|NCT01401283|3753579|P2|NOT COMPLETED|Overall Study||10
1533752|NCT01401283|3753580|P1|NOT COMPLETED|Overall Study||10
1533753|NCT01401283|3753579|P2|COMPLETED|Overall Study||81
1533754|NCT01401283|3753580|P1|COMPLETED|Overall Study||79
1533755|NCT01401283|3753579|P2|STARTED|Overall Study||91
1533756|NCT01401283|3753580|P1|STARTED|Overall Study||89
1533757|NCT01401257|3753592|P4|NOT COMPLETED|Overall Study||2
1533758|NCT01401257|3753593|P3|NOT COMPLETED|Overall Study||3
1533759|NCT01401257|3753594|P2|NOT COMPLETED|Overall Study||2
1533760|NCT01401257|3753595|P1|NOT COMPLETED|Overall Study||0
1533761|NCT01401257|3753592|P4|COMPLETED|Overall Study||17
1533762|NCT01401257|3753593|P3|COMPLETED|Overall Study||16
1533763|NCT01401257|3753594|P2|COMPLETED|Overall Study||19
1533764|NCT01401257|3753595|P1|COMPLETED|Overall Study||21
1533765|NCT01401257|3753592|P4|STARTED|Overall Study||19
1533766|NCT01401257|3753593|P3|STARTED|Overall Study||19
1533767|NCT01401257|3753594|P2|STARTED|Overall Study||21
1533768|NCT01401257|3753595|P1|STARTED|Overall Study||21
1533769|NCT01401166|3753607|P4|NOT COMPLETED|Safety Follow-Up Period||19
1533770|NCT01401166|3753608|P3|NOT COMPLETED|Safety Follow-Up Period||17
1533771|NCT01401166|3753609|P2|NOT COMPLETED|Safety Follow-Up Period||18
1533772|NCT01401166|3753610|P1|NOT COMPLETED|Safety Follow-Up Period||25
1533773|NCT01401166|3753607|P4|COMPLETED|Safety Follow-Up Period||100
1533774|NCT01401166|3753608|P3|COMPLETED|Safety Follow-Up Period||104
1533775|NCT01401166|3753609|P2|COMPLETED|Safety Follow-Up Period||106
1533776|NCT01401166|3753610|P1|COMPLETED|Safety Follow-Up Period||99
1533777|NCT01401166|3753607|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
1533778|NCT01401166|3753608|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
1533779|NCT01401166|3753609|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
1533780|NCT01401166|3753610|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
1533781|NCT01401166|3753607|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
1533782|NCT01401166|3753608|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
1533783|NCT01401166|3753609|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
1533784|NCT01401166|3753610|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
1533785|NCT01401166|3753607|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
1533786|NCT01401166|3753608|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
1533787|NCT01401166|3753609|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
1533788|NCT01401166|3753610|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
1533789|NCT01401166|3753607|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
1533790|NCT01401166|3753608|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
1533791|NCT01401166|3753609|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
1533792|NCT01401166|3753610|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
1533793|NCT01401166|3753607|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
1533794|NCT01401166|3753608|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
1533795|NCT01401166|3753609|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
1533796|NCT01401166|3753610|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
1533797|NCT01401166|3753607|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
1533798|NCT01401166|3753608|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
1533799|NCT01401166|3753609|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
1533800|NCT01401166|3753610|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
1533801|NCT01401166|3753607|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
1533802|NCT01401166|3753608|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
1533803|NCT01401166|3753609|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
1533804|NCT01401166|3753610|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
1533805|NCT01401166|3753607|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
1533806|NCT01401166|3753608|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
1533807|NCT01401166|3753609|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
1533808|NCT01401166|3753610|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
1533809|NCT01401166|3753607|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
1533810|NCT01401166|3753608|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
1533811|NCT01401166|3753609|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
1533812|NCT01401166|3753610|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
1533813|NCT01401166|3753607|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
1533814|NCT01401166|3753608|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
1533815|NCT01401166|3753609|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
1533816|NCT01401166|3753610|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
1533817|NCT01401153|3753646|P2|NOT COMPLETED|Second Test Day||5
1533818|NCT01401153|3753647|P1|NOT COMPLETED|Second Test Day||0
1533819|NCT01401153|3753646|P2|COMPLETED|Second Test Day||60
1533820|NCT01401153|3753647|P1|COMPLETED|Second Test Day||45
1533821|NCT01401153|3753646|P2|STARTED|Second Test Day||65
1533822|NCT01401153|3753647|P1|STARTED|Second Test Day||45
1533823|NCT01401153|3753646|P2|NOT COMPLETED|First Test Day||10
1533824|NCT01401153|3753647|P1|NOT COMPLETED|First Test Day||1
1533825|NCT01401153|3753646|P2|COMPLETED|First Test Day||45
1533826|NCT01401153|3753647|P1|COMPLETED|First Test Day||65
1533827|NCT01401153|3753646|P2|STARTED|First Test Day||55
1533828|NCT01401153|3753647|P1|STARTED|First Test Day||66
1533829|NCT01401101|3753681|P2|NOT COMPLETED|Overall Study||27
1533830|NCT01401101|3753682|P1|NOT COMPLETED|Overall Study||22
1533831|NCT01401101|3753681|P2|COMPLETED|Overall Study||171
1533832|NCT01401101|3753682|P1|COMPLETED|Overall Study||184
1533833|NCT01401101|3753681|P2|STARTED|Overall Study||198
1533834|NCT01401101|3753682|P1|STARTED|Overall Study||206
1533835|NCT01401062|3753694|P2|NOT COMPLETED|Overall Study||8
1533836|NCT01401062|3753695|P1|NOT COMPLETED|Overall Study||11
1533837|NCT01401062|3753694|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
1533838|NCT01401062|3753695|P1|COMPLETED|Overall Study||0
1533839|NCT01401062|3753694|P2|STARTED|Overall Study||12
1533840|NCT01401062|3753695|P1|STARTED|Overall Study||11
1533841|NCT01401049|3753703|P2|NOT COMPLETED|Overall Study||0
1533842|NCT01401049|3753704|P1|NOT COMPLETED|Overall Study||0
1533843|NCT01401049|3753703|P2|COMPLETED|Overall Study||0
1533844|NCT01401049|3753704|P1|COMPLETED|Overall Study||0
1533845|NCT01401049|3753703|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
1533846|NCT01401049|3753704|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
1533847|NCT01401023|3753712|P1|NOT COMPLETED|Overall Study||0
1533848|NCT01401023|3753712|P1|COMPLETED|Overall Study||10
1533849|NCT01401023|3753712|P1|STARTED|Overall Study||10
1533850|NCT01401010|3753722|P2|NOT COMPLETED|Overall Study||0
1533851|NCT01401010|3753723|P1|NOT COMPLETED|Overall Study||1
1533852|NCT01401010|3753722|P2|COMPLETED|Overall Study||6
1533853|NCT01401010|3753723|P1|COMPLETED|Overall Study||5
1533854|NCT01401010|3753722|P2|STARTED|Overall Study||6
1533855|NCT01401010|3753723|P1|STARTED|Overall Study||6
1533856|NCT01400958|3753748|P2|NOT COMPLETED|Overall Study||2
1533857|NCT01400958|3753749|P1|NOT COMPLETED|Overall Study||1
1533858|NCT01400958|3753748|P2|COMPLETED|Overall Study||1
1533859|NCT01400958|3753749|P1|COMPLETED|Overall Study||2
1533860|NCT01400958|3753748|P2|STARTED|Overall Study||3
1533861|NCT01400958|3753749|P1|STARTED|Overall Study||3
1533862|NCT01400932|3753759|P2|NOT COMPLETED|Overall Study||15
1533863|NCT01400932|3753760|P1|NOT COMPLETED|Overall Study||14
1533864|NCT01400932|3753759|P2|COMPLETED|Overall Study||167
1533865|NCT01400932|3753760|P1|COMPLETED|Overall Study||164
1533866|NCT01400932|3753759|P2|STARTED|Overall Study||182
1533867|NCT01400932|3753760|P1|STARTED|Overall Study||178
1533868|NCT01400919|3753782|P1|NOT COMPLETED|Overall Study||8
1533869|NCT01400919|3753782|P1|COMPLETED|Overall Study||67
1533870|NCT01400919|3753782|P1|STARTED|Overall Study||75
1533871|NCT01400906|3753786|P6|NOT COMPLETED|Treatment Period 3||0
1533872|NCT01400906|3753787|P5|NOT COMPLETED|Treatment Period 3||0
1533873|NCT01400906|3753788|P4|NOT COMPLETED|Treatment Period 3||0
1533874|NCT01400906|3753789|P3|NOT COMPLETED|Treatment Period 3||0
1533875|NCT01400906|3753790|P2|NOT COMPLETED|Treatment Period 3||0
1533876|NCT01400906|3753791|P1|NOT COMPLETED|Treatment Period 3||0
1533877|NCT01400906|3753786|P6|COMPLETED|Treatment Period 3||5
1533878|NCT01400906|3753787|P5|COMPLETED|Treatment Period 3||6
1533879|NCT01400906|3753788|P4|COMPLETED|Treatment Period 3||6
1533880|NCT01400906|3753789|P3|COMPLETED|Treatment Period 3||6
1533881|NCT01400906|3753790|P2|COMPLETED|Treatment Period 3||6
1533882|NCT01400906|3753791|P1|COMPLETED|Treatment Period 3||6
1533883|NCT01400906|3753786|P6|STARTED|Treatment Period 3||5
1533884|NCT01400906|3753787|P5|STARTED|Treatment Period 3||6
1533885|NCT01400906|3753788|P4|STARTED|Treatment Period 3||6
1533886|NCT01400906|3753789|P3|STARTED|Treatment Period 3||6
1533887|NCT01400906|3753790|P2|STARTED|Treatment Period 3||6
1533888|NCT01400906|3753791|P1|STARTED|Treatment Period 3||6
1533889|NCT01400906|3753786|P6|NOT COMPLETED|Washout Period 2||0
1533890|NCT01400906|3753787|P5|NOT COMPLETED|Washout Period 2||0
1533891|NCT01400906|3753788|P4|NOT COMPLETED|Washout Period 2||0
1533892|NCT01400906|3753789|P3|NOT COMPLETED|Washout Period 2||0
1533893|NCT01400906|3753790|P2|NOT COMPLETED|Washout Period 2||0
1533894|NCT01400906|3753791|P1|NOT COMPLETED|Washout Period 2||0
1533895|NCT01400906|3753786|P6|COMPLETED|Washout Period 2||5
1533896|NCT01400906|3753787|P5|COMPLETED|Washout Period 2||6
1533897|NCT01400906|3753788|P4|COMPLETED|Washout Period 2||6
1533898|NCT01400906|3753789|P3|COMPLETED|Washout Period 2||6
1533899|NCT01400906|3753790|P2|COMPLETED|Washout Period 2||6
1533900|NCT01400906|3753791|P1|COMPLETED|Washout Period 2||6
1533901|NCT01400906|3753786|P6|STARTED|Washout Period 2||5
1533902|NCT01400906|3753787|P5|STARTED|Washout Period 2||6
1533903|NCT01400906|3753788|P4|STARTED|Washout Period 2||6
1533904|NCT01400906|3753789|P3|STARTED|Washout Period 2||6
1533905|NCT01400906|3753790|P2|STARTED|Washout Period 2||6
1533906|NCT01400906|3753791|P1|STARTED|Washout Period 2||6
1533907|NCT01400906|3753786|P6|NOT COMPLETED|Treatment Period 2||0
1533908|NCT01400906|3753787|P5|NOT COMPLETED|Treatment Period 2||0
1533909|NCT01400906|3753788|P4|NOT COMPLETED|Treatment Period 2||0
1533910|NCT01400906|3753789|P3|NOT COMPLETED|Treatment Period 2||0
1533911|NCT01400906|3753790|P2|NOT COMPLETED|Treatment Period 2||0
1533912|NCT01400906|3753791|P1|NOT COMPLETED|Treatment Period 2||0
1533913|NCT01400906|3753786|P6|COMPLETED|Treatment Period 2||5
1533914|NCT01400906|3753787|P5|COMPLETED|Treatment Period 2||6
1533915|NCT01400906|3753788|P4|COMPLETED|Treatment Period 2||6
1533916|NCT01400906|3753789|P3|COMPLETED|Treatment Period 2||6
1533917|NCT01400906|3753790|P2|COMPLETED|Treatment Period 2||6
1533918|NCT01400906|3753791|P1|COMPLETED|Treatment Period 2||6
1533919|NCT01400906|3753786|P6|STARTED|Treatment Period 2||5
1533920|NCT01400906|3753787|P5|STARTED|Treatment Period 2||6
1533921|NCT01400906|3753788|P4|STARTED|Treatment Period 2||6
1533922|NCT01400906|3753789|P3|STARTED|Treatment Period 2||6
1533923|NCT01400906|3753790|P2|STARTED|Treatment Period 2||6
1533924|NCT01400906|3753791|P1|STARTED|Treatment Period 2||6
1533925|NCT01400906|3753786|P6|NOT COMPLETED|Washout Period 1||0
1533926|NCT01400906|3753787|P5|NOT COMPLETED|Washout Period 1||0
1533927|NCT01400906|3753788|P4|NOT COMPLETED|Washout Period 1||0
1533928|NCT01400906|3753789|P3|NOT COMPLETED|Washout Period 1||0
1533929|NCT01400906|3753790|P2|NOT COMPLETED|Washout Period 1||0
1533930|NCT01400906|3753791|P1|NOT COMPLETED|Washout Period 1||0
1533931|NCT01400906|3753786|P6|COMPLETED|Washout Period 1||5
1533932|NCT01400906|3753787|P5|COMPLETED|Washout Period 1||6
1533933|NCT01400906|3753788|P4|COMPLETED|Washout Period 1||6
1533934|NCT01400906|3753789|P3|COMPLETED|Washout Period 1||6
1533935|NCT01400906|3753790|P2|COMPLETED|Washout Period 1||6
1533936|NCT01400906|3753791|P1|COMPLETED|Washout Period 1||6
1533937|NCT01400906|3753786|P6|STARTED|Washout Period 1||5
1533938|NCT01400906|3753787|P5|STARTED|Washout Period 1||6
1533939|NCT01400906|3753788|P4|STARTED|Washout Period 1||6
1533940|NCT01400906|3753789|P3|STARTED|Washout Period 1||6
1533941|NCT01400906|3753790|P2|STARTED|Washout Period 1||6
1533942|NCT01400906|3753791|P1|STARTED|Washout Period 1||6
1533943|NCT01400906|3753786|P6|NOT COMPLETED|Treatment Period 1||0
1533944|NCT01400906|3753787|P5|NOT COMPLETED|Treatment Period 1||0
1533945|NCT01400906|3753788|P4|NOT COMPLETED|Treatment Period 1||0
1533946|NCT01400906|3753789|P3|NOT COMPLETED|Treatment Period 1||0
1533947|NCT01400906|3753790|P2|NOT COMPLETED|Treatment Period 1||0
1533948|NCT01400906|3753791|P1|NOT COMPLETED|Treatment Period 1||0
1533949|NCT01400906|3753786|P6|COMPLETED|Treatment Period 1||5
1533950|NCT01400906|3753787|P5|COMPLETED|Treatment Period 1||6
1533951|NCT01400906|3753788|P4|COMPLETED|Treatment Period 1||6
1533952|NCT01400906|3753789|P3|COMPLETED|Treatment Period 1||6
1533953|NCT01400906|3753790|P2|COMPLETED|Treatment Period 1||6
1533954|NCT01400906|3753791|P1|COMPLETED|Treatment Period 1||6
1533955|NCT01400906|3753786|P6|STARTED|Treatment Period 1||5
1533956|NCT01400906|3753787|P5|STARTED|Treatment Period 1||6
1533957|NCT01400906|3753788|P4|STARTED|Treatment Period 1||6
1533958|NCT01400906|3753789|P3|STARTED|Treatment Period 1||6
1533959|NCT01400906|3753790|P2|STARTED|Treatment Period 1||6
1533960|NCT01400906|3753791|P1|STARTED|Treatment Period 1||6
1533961|NCT01400893|3753825|P2|NOT COMPLETED|Overall Study||27
1533962|NCT01400893|3753826|P1|NOT COMPLETED|Overall Study||27
1533963|NCT01400893|3753825|P2|COMPLETED|Overall Study||38
1533964|NCT01400893|3753826|P1|COMPLETED|Overall Study||42
1533965|NCT01400893|3753825|P2|STARTED|Overall Study||65
1533966|NCT01400893|3753826|P1|STARTED|Overall Study||69
1533967|NCT01400880|3753834|P1|NOT COMPLETED|Overall Study||2
1533968|NCT01400880|3753834|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
1533969|NCT01400880|3753834|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
1533970|NCT01400841|3753838|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
1533971|NCT01400841|3753838|P1|COMPLETED|Extended Study Phase (2 Years)||11
1533972|NCT01400841|3753838|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
1533973|NCT01400841|3753838|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
1533974|NCT01400841|3753838|P1|COMPLETED|Initial Study Phase (6 Months)||15
1533975|NCT01400841|3753838|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
1533976|NCT01400698|3753876|P6|NOT COMPLETED|Overall Study||6
1533977|NCT01400698|3753877|P5|NOT COMPLETED|Overall Study||7
1533978|NCT01400698|3753878|P4|NOT COMPLETED|Overall Study||8
1533979|NCT01400698|3753879|P3|NOT COMPLETED|Overall Study||2
1533980|NCT01400698|3753880|P2|NOT COMPLETED|Overall Study||11
1533981|NCT01400698|3753881|P1|NOT COMPLETED|Overall Study||15
1533982|NCT01400698|3753876|P6|COMPLETED|Overall Study||9
1533983|NCT01400698|3753877|P5|COMPLETED|Overall Study||7
1533984|NCT01400698|3753878|P4|COMPLETED|Overall Study||6
1533985|NCT01400698|3753879|P3|COMPLETED|Overall Study||0
1533986|NCT01400698|3753880|P2|COMPLETED|Overall Study||12
1533987|NCT01400698|3753881|P1|COMPLETED|Overall Study||8
1533988|NCT01400698|3753876|P6|STARTED|Overall Study||15
1533989|NCT01400698|3753877|P5|STARTED|Overall Study||14
1533990|NCT01400698|3753878|P4|STARTED|Overall Study||14
1533991|NCT01400698|3753879|P3|STARTED|Overall Study||2
1533992|NCT01400698|3753880|P2|STARTED|Overall Study||23
1533993|NCT01400698|3753881|P1|STARTED|Overall Study||23
1533994|NCT01400516|3753905|P2|NOT COMPLETED|Extension Trial||0
1533995|NCT01400516|3753906|P1|NOT COMPLETED|Extension Trial||0
1533996|NCT01400516|3753905|P2|COMPLETED|Extension Trial||7
1533997|NCT01400516|3753906|P1|COMPLETED|Extension Trial||6
1533998|NCT01400516|3753905|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
1533999|NCT01400516|3753906|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
1534000|NCT01400516|3753905|P2|NOT COMPLETED|Primary Trial||2
1534001|NCT01400516|3753906|P1|NOT COMPLETED|Primary Trial||0
1534002|NCT01400516|3753905|P2|COMPLETED|Primary Trial||12
1534003|NCT01400516|3753906|P1|COMPLETED|Primary Trial||12
1534004|NCT01400516|3753905|P2|STARTED|Primary Trial||14
1534005|NCT01400516|3753906|P1|STARTED|Primary Trial||12
1534006|NCT01400503|3753916|P1|NOT COMPLETED|Overall Study||60
1534007|NCT01400503|3753916|P1|COMPLETED|Overall Study||0
1534008|NCT01400503|3753916|P1|STARTED|Overall Study||60
1534009|NCT01400451|3753928|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
1534010|NCT01400451|3753929|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
1534011|NCT01400451|3753930|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
1534012|NCT01400451|3753928|P3|COMPLETED|Combination Treatment (or Intended)||0
1534013|NCT01400451|3753929|P2|COMPLETED|Combination Treatment (or Intended)||0
1534014|NCT01400451|3753930|P1|COMPLETED|Combination Treatment (or Intended)||0
1534015|NCT01400451|3753928|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
1534016|NCT01400451|3753929|P2|STARTED|Combination Treatment (or Intended)||4
1534017|NCT01400451|3753930|P1|STARTED|Combination Treatment (or Intended)||6
1534018|NCT01400451|3753928|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
1534019|NCT01400451|3753929|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
1534020|NCT01400451|3753930|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
1534021|NCT01400451|3753928|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
1534022|NCT01400451|3753929|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
1534023|NCT01400451|3753930|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
1534024|NCT01400451|3753928|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
1534025|NCT01400451|3753929|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
1534026|NCT01400451|3753930|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
1534027|NCT01400425|3753944|P1|NOT COMPLETED|Overall Study||10
1534028|NCT01400425|3753944|P1|COMPLETED|Overall Study||229
1534029|NCT01400425|3753944|P1|STARTED|Overall Study||239
1534030|NCT01400412|3753957|P2|NOT COMPLETED|Overall Study||17
1534031|NCT01400412|3753958|P1|NOT COMPLETED|Overall Study||10
1534032|NCT01400412|3753957|P2|COMPLETED|Overall Study||115
1534033|NCT01400412|3753958|P1|COMPLETED|Overall Study||120
1534034|NCT01400412|3753957|P2|STARTED|Overall Study||132
1534035|NCT01400412|3753958|P1|STARTED|Overall Study||130
1534036|NCT01400243|3754004|P2|NOT COMPLETED|Overall Study||11
1534037|NCT01400243|3754005|P1|NOT COMPLETED|Overall Study||8
1534038|NCT01400243|3754004|P2|COMPLETED|Overall Study||52
1534039|NCT01400243|3754005|P1|COMPLETED|Overall Study||56
1534040|NCT01400243|3754004|P2|STARTED|Overall Study||63
1534041|NCT01400243|3754005|P1|STARTED|Overall Study||64
1534042|NCT01400139|3754027|P1|NOT COMPLETED|HYD Extension Period||23
1534043|NCT01400139|3754027|P1|COMPLETED|HYD Extension Period||83
1534044|NCT01400139|3754027|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
1534045|NCT01400139|3754027|P1|NOT COMPLETED|HYD Core Study||512
1534046|NCT01400139|3754027|P1|COMPLETED|HYD Core Study||410
1534047|NCT01400139|3754027|P1|STARTED|HYD Core Study||922
1534048|NCT01400113|3754037|P2|NOT COMPLETED|Overall Study||1
1534049|NCT01400113|3754038|P1|NOT COMPLETED|Overall Study||1
1534050|NCT01400113|3754037|P2|COMPLETED|Overall Study||59
1534051|NCT01400113|3754038|P1|COMPLETED|Overall Study||59
1534052|NCT01400113|3754037|P2|STARTED|Overall Study||60
1534053|NCT01400113|3754038|P1|STARTED|Overall Study||60
1534054|NCT01399866|3754046|P2|NOT COMPLETED|Overall Study||2
1534055|NCT01399866|3754047|P1|NOT COMPLETED|Overall Study||4
1534056|NCT01399866|3754046|P2|COMPLETED|Overall Study||28
1534057|NCT01399866|3754047|P1|COMPLETED|Overall Study||28
1534058|NCT01399866|3754046|P2|STARTED|Overall Study||30
1534059|NCT01399866|3754047|P1|STARTED|Overall Study||32
1534060|NCT01399827|3754065|P2|NOT COMPLETED|Overall Study||0
1534061|NCT01399827|3754066|P1|NOT COMPLETED|Overall Study||0
1534062|NCT01399827|3754065|P2|COMPLETED|Overall Study||1
1534063|NCT01399827|3754066|P1|COMPLETED|Overall Study||1
1534064|NCT01399827|3754065|P2|STARTED|Overall Study||1
1534065|NCT01399827|3754066|P1|STARTED|Overall Study||1
1534066|NCT01399788|3754080|P2|NOT COMPLETED|Second Intervention Period||0
1534067|NCT01399788|3754081|P1|NOT COMPLETED|Second Intervention Period||0
1534068|NCT01399788|3754080|P2|COMPLETED|Second Intervention Period||18
1534069|NCT01399788|3754081|P1|COMPLETED|Second Intervention Period||17
1534070|NCT01399788|3754080|P2|STARTED|Second Intervention Period||18
1534071|NCT01399788|3754081|P1|STARTED|Second Intervention Period||17
1534072|NCT01399788|3754080|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
1534073|NCT01399788|3754081|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
1534074|NCT01399788|3754080|P2|COMPLETED|Washout Period (at Least 1 Week)||18
1534075|NCT01399788|3754081|P1|COMPLETED|Washout Period (at Least 1 Week)||17
1534076|NCT01399788|3754080|P2|STARTED|Washout Period (at Least 1 Week)||18
1534077|NCT01399788|3754081|P1|STARTED|Washout Period (at Least 1 Week)||17
1534078|NCT01399788|3754080|P2|NOT COMPLETED|First Intervention Period||0
1534079|NCT01399788|3754081|P1|NOT COMPLETED|First Intervention Period||1
1534080|NCT01399788|3754080|P2|COMPLETED|First Intervention Period||18
1534081|NCT01399788|3754081|P1|COMPLETED|First Intervention Period||17
1534082|NCT01399788|3754080|P2|STARTED|First Intervention Period||18
1534083|NCT01399788|3754081|P1|STARTED|First Intervention Period||18
1534084|NCT01399723|3754103|P2|NOT COMPLETED|Overall Study||1
1534085|NCT01399723|3754104|P1|NOT COMPLETED|Overall Study||0
1534086|NCT01399723|3754103|P2|COMPLETED|Overall Study||263
1534087|NCT01399723|3754104|P1|COMPLETED|Overall Study||263
1534088|NCT01399723|3754103|P2|STARTED|Overall Study||264
1534089|NCT01399723|3754104|P1|STARTED|Overall Study||263
1534090|NCT01399697|3754117|P3|NOT COMPLETED|Overall Study||4
1534091|NCT01399697|3754118|P2|NOT COMPLETED|Overall Study||3
1534092|NCT01399697|3754119|P1|NOT COMPLETED|Overall Study||41
1534093|NCT01399697|3754117|P3|COMPLETED|Overall Study||78
1534094|NCT01399697|3754118|P2|COMPLETED|Overall Study||80
1534095|NCT01399697|3754119|P1|COMPLETED|Overall Study||55
1534096|NCT01399697|3754117|P3|STARTED|Overall Study||82
1534097|NCT01399697|3754118|P2|STARTED|Overall Study||83
1534098|NCT01399697|3754119|P1|STARTED|Overall Study||96
1534099|NCT01399619|3754146|P4|NOT COMPLETED|Overall Study||17
1534100|NCT01399619|3754147|P3|NOT COMPLETED|Overall Study||12
1534101|NCT01399619|3754148|P2|NOT COMPLETED|Overall Study||0
1534102|NCT01399619|3754149|P1|NOT COMPLETED|Overall Study||25
1534103|NCT01399619|3754146|P4|COMPLETED|Overall Study||0
1534104|NCT01399619|3754147|P3|COMPLETED|Overall Study||74
1534105|NCT01399619|3754148|P2|COMPLETED|Overall Study||84
1534106|NCT01399619|3754149|P1|COMPLETED|Overall Study||98
1534107|NCT01399619|3754146|P4|STARTED|Overall Study||17
1534108|NCT01399619|3754147|P3|STARTED|Overall Study||86
1534109|NCT01399619|3754148|P2|STARTED|Overall Study||84
1534110|NCT01399619|3754149|P1|STARTED|Overall Study||123
1534111|NCT01399593|3754212|P2|NOT COMPLETED|Overall Study||2
1534112|NCT01399593|3754213|P1|NOT COMPLETED|Overall Study||3
1534113|NCT01399593|3754212|P2|COMPLETED|Overall Study||49
1534114|NCT01399593|3754213|P1|COMPLETED|Overall Study||48
1534115|NCT01399593|3754212|P2|STARTED|Overall Study||51
1534116|NCT01399593|3754213|P1|STARTED|Overall Study||51
1534117|NCT01399268|3754221|P2|NOT COMPLETED|Overall Study||0
1534118|NCT01399268|3754222|P1|NOT COMPLETED|Overall Study||0
1534119|NCT01399268|3754221|P2|COMPLETED|Overall Study||15
1534120|NCT01399268|3754222|P1|COMPLETED|Overall Study||15
1534121|NCT01399268|3754221|P2|STARTED|Overall Study||15
1534122|NCT01399268|3754222|P1|STARTED|Overall Study||15
1534123|NCT01399229|3754240|P3|NOT COMPLETED|Overall Study||0
1534124|NCT01399229|3754241|P2|NOT COMPLETED|Overall Study||0
1534125|NCT01399229|3754242|P1|NOT COMPLETED|Overall Study||0
1534126|NCT01399229|3754240|P3|COMPLETED|Overall Study||5
1534127|NCT01399229|3754241|P2|COMPLETED|Overall Study||5
1534128|NCT01399229|3754242|P1|COMPLETED|Overall Study||20
1534129|NCT01399229|3754240|P3|STARTED|Overall Study||5
1534130|NCT01399229|3754241|P2|STARTED|Overall Study||5
1534131|NCT01399229|3754242|P1|STARTED|Overall Study||20
1534132|NCT01399190|3754246|P1|NOT COMPLETED|Overall Study||20
1534133|NCT01399190|3754246|P1|COMPLETED|Overall Study||48
1534134|NCT01399190|3754246|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
1534135|NCT01399190|3754246|P1|Included in Final Analysis|Overall Study||63
1534136|NCT01399190|3754246|P1|STARTED|Overall Study||68
1534137|NCT01399125|3754254|P2|NOT COMPLETED|Overall Study||60
1534138|NCT01399125|3754255|P1|NOT COMPLETED|Overall Study||51
1534139|NCT01399125|3754254|P2|COMPLETED|Overall Study||193
1534140|NCT01399125|3754255|P1|COMPLETED|Overall Study||197
1534141|NCT01399125|3754254|P2|Per Protocol (PP) Population|Overall Study||188
1534142|NCT01399125|3754255|P1|Per Protocol (PP) Population|Overall Study||192
1534143|NCT01399125|3754254|P2|STARTED|Overall Study||253
1534144|NCT01399125|3754255|P1|STARTED|Overall Study||248
1534145|NCT01399099|3754269|P1|NOT COMPLETED|Overall Study||31
1534146|NCT01399099|3754269|P1|COMPLETED|Overall Study||36
1534147|NCT01399099|3754269|P1|6 Months|Overall Study||47
1534148|NCT01399099|3754269|P1|STARTED|Overall Study||67
1534149|NCT01399047|3754276|P2|NOT COMPLETED|Overall Study||1
1534150|NCT01399047|3754277|P1|NOT COMPLETED|Overall Study||0
1534151|NCT01399047|3754276|P2|COMPLETED|Overall Study||8
1534152|NCT01399047|3754277|P1|COMPLETED|Overall Study||10
1534153|NCT01399047|3754276|P2|STARTED|Overall Study||9
1534154|NCT01399047|3754277|P1|STARTED|Overall Study||10
1534155|NCT01399008|3754286|P3|NOT COMPLETED|Overall Study||2
1534156|NCT01399008|3754287|P2|NOT COMPLETED|Overall Study||5
1534157|NCT01399008|3754288|P1|NOT COMPLETED|Overall Study||3
1534158|NCT01399008|3754286|P3|COMPLETED|Overall Study||31
1534159|NCT01399008|3754287|P2|COMPLETED|Overall Study||27
1534160|NCT01399008|3754288|P1|COMPLETED|Overall Study||32
1534161|NCT01399008|3754286|P3|STARTED|Overall Study||33
1534162|NCT01399008|3754287|P2|STARTED|Overall Study||32
1534163|NCT01399008|3754288|P1|STARTED|Overall Study||35
1534164|NCT01398982|3754298|P2|NOT COMPLETED|Overall Study||2
1534165|NCT01398982|3754299|P1|NOT COMPLETED|Overall Study||6
1534166|NCT01398982|3754298|P2|COMPLETED|Overall Study||47
1534167|NCT01398982|3754299|P1|COMPLETED|Overall Study||38
1534168|NCT01398982|3754298|P2|STARTED|Overall Study||49
1534169|NCT01398982|3754299|P1|STARTED|Overall Study||44
1534170|NCT01398956|3754305|P1|NOT COMPLETED|Overall Study||10
1534171|NCT01398956|3754305|P1|COMPLETED|Overall Study||34
1534172|NCT01398956|3754305|P1|STARTED|Overall Study||44
1534173|NCT01398943|3754313|P4|NOT COMPLETED|Second Intervention (1 Day)||0
1534174|NCT01398943|3754314|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1534175|NCT01398943|3754315|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1534176|NCT01398943|3754316|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1534177|NCT01398943|3754313|P4|COMPLETED|Second Intervention (1 Day)||15
1534178|NCT01398943|3754314|P3|COMPLETED|Second Intervention (1 Day)||15
1534179|NCT01398943|3754315|P2|COMPLETED|Second Intervention (1 Day)||15
1534180|NCT01398943|3754316|P1|COMPLETED|Second Intervention (1 Day)||15
1534181|NCT01398943|3754313|P4|STARTED|Second Intervention (1 Day)||15
1534182|NCT01398943|3754314|P3|STARTED|Second Intervention (1 Day)||15
1534183|NCT01398943|3754315|P2|STARTED|Second Intervention (1 Day)||15
1534184|NCT01398943|3754316|P1|STARTED|Second Intervention (1 Day)||15
1534185|NCT01398943|3754313|P4|NOT COMPLETED|Washout (2-7 Days)||0
1534186|NCT01398943|3754314|P3|NOT COMPLETED|Washout (2-7 Days)||0
1534187|NCT01398943|3754315|P2|NOT COMPLETED|Washout (2-7 Days)||0
1534188|NCT01398943|3754316|P1|NOT COMPLETED|Washout (2-7 Days)||0
1534189|NCT01398943|3754313|P4|COMPLETED|Washout (2-7 Days)||15
1534190|NCT01398943|3754314|P3|COMPLETED|Washout (2-7 Days)||15
1534191|NCT01398943|3754315|P2|COMPLETED|Washout (2-7 Days)||15
1534192|NCT01398943|3754316|P1|COMPLETED|Washout (2-7 Days)||15
1534193|NCT01398943|3754313|P4|STARTED|Washout (2-7 Days)||15
1534194|NCT01398943|3754314|P3|STARTED|Washout (2-7 Days)||15
1534195|NCT01398943|3754315|P2|STARTED|Washout (2-7 Days)||15
1534196|NCT01398943|3754316|P1|STARTED|Washout (2-7 Days)||15
1534197|NCT01398943|3754313|P4|NOT COMPLETED|First Intervention (1 Day)||0
1534198|NCT01398943|3754314|P3|NOT COMPLETED|First Intervention (1 Day)||0
1534199|NCT01398943|3754315|P2|NOT COMPLETED|First Intervention (1 Day)||0
1534200|NCT01398943|3754316|P1|NOT COMPLETED|First Intervention (1 Day)||0
1534201|NCT01398943|3754313|P4|COMPLETED|First Intervention (1 Day)||15
1534202|NCT01398943|3754314|P3|COMPLETED|First Intervention (1 Day)||15
1534203|NCT01398943|3754315|P2|COMPLETED|First Intervention (1 Day)||15
1534204|NCT01398943|3754316|P1|COMPLETED|First Intervention (1 Day)||15
1534205|NCT01398943|3754313|P4|STARTED|First Intervention (1 Day)||15
1534206|NCT01398943|3754314|P3|STARTED|First Intervention (1 Day)||15
1534207|NCT01398943|3754315|P2|STARTED|First Intervention (1 Day)||15
1534208|NCT01398943|3754316|P1|STARTED|First Intervention (1 Day)||15
1534209|NCT01398852|3754324|P1|NOT COMPLETED|Overall Study||372
1534210|NCT01398852|3754324|P1|COMPLETED|Overall Study||0
1534211|NCT01398852|3754324|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
1534212|NCT01398839|3754330|P2|NOT COMPLETED|Overall Study||0
1534213|NCT01398839|3754331|P1|NOT COMPLETED|Overall Study||0
1534214|NCT01398839|3754330|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
1534215|NCT01398839|3754331|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
1534216|NCT01398839|3754330|P2|STARTED|Overall Study||37
1534217|NCT01398839|3754331|P1|STARTED|Overall Study||35
1534218|NCT01398787|3754337|P1|NOT COMPLETED|Overall Study||1
1534219|NCT01398787|3754337|P1|COMPLETED|Overall Study||197
1534220|NCT01398787|3754337|P1|STARTED|Overall Study||198
1534221|NCT01398514|3754355|P2|NOT COMPLETED|Overall Study||6
1534222|NCT01398514|3754356|P1|NOT COMPLETED|Overall Study||8
1534223|NCT01398514|3754355|P2|COMPLETED|Overall Study||20
1534224|NCT01398514|3754356|P1|COMPLETED|Overall Study||18
1534225|NCT01398514|3754355|P2|STARTED|Overall Study||26
1534226|NCT01398514|3754356|P1|STARTED|Overall Study||26
1534227|NCT01398475|3754368|P4|NOT COMPLETED|Overall Study||0
1534228|NCT01398475|3754369|P3|NOT COMPLETED|Overall Study||0
1534229|NCT01398475|3754370|P2|NOT COMPLETED|Overall Study||0
1534230|NCT01398475|3754371|P1|NOT COMPLETED|Overall Study||0
1534231|NCT01398475|3754368|P4|COMPLETED|Overall Study||4
1534232|NCT01398475|3754369|P3|COMPLETED|Overall Study||4
1534233|NCT01398475|3754370|P2|COMPLETED|Overall Study||3
1534234|NCT01398475|3754371|P1|COMPLETED|Overall Study||4
1534235|NCT01398475|3754368|P4|Received Fourth Intervention|Overall Study||4
1534236|NCT01398475|3754369|P3|Received Fourth Intervention|Overall Study||4
1534237|NCT01398475|3754370|P2|Received Fourth Intervention|Overall Study||3
1534238|NCT01398475|3754371|P1|Received Fourth Intervention|Overall Study||4
1534239|NCT01398475|3754368|P4|Received Third Intervention|Overall Study||4
1534240|NCT01398475|3754369|P3|Received Third Intervention|Overall Study||4
1534241|NCT01398475|3754370|P2|Received Third Intervention|Overall Study||3
1534242|NCT01398475|3754371|P1|Received Third Intervention|Overall Study||4
1534243|NCT01398475|3754368|P4|Received Second Intervention|Overall Study||4
1534244|NCT01398475|3754369|P3|Received Second Intervention|Overall Study||4
1534245|NCT01398475|3754370|P2|Received Second Intervention|Overall Study||3
1534246|NCT01398475|3754371|P1|Received Second Intervention|Overall Study||4
1534247|NCT01398475|3754368|P4|Received First Intervention|Overall Study||4
1534248|NCT01398475|3754369|P3|Received First Intervention|Overall Study||4
1534249|NCT01398475|3754370|P2|Received First Intervention|Overall Study||3
1534250|NCT01398475|3754371|P1|Received First Intervention|Overall Study||4
1534251|NCT01398475|3754368|P4|STARTED|Overall Study||4
1534252|NCT01398475|3754369|P3|STARTED|Overall Study||4
1534253|NCT01398475|3754370|P2|STARTED|Overall Study||3
1534254|NCT01398475|3754371|P1|STARTED|Overall Study||4
1534255|NCT01398410|3754391|P2|NOT COMPLETED|Overall Study||56
1534256|NCT01398410|3754392|P1|NOT COMPLETED|Overall Study||58
1534257|NCT01398410|3754391|P2|COMPLETED|Overall Study||148
1534258|NCT01398410|3754392|P1|COMPLETED|Overall Study||143
1534259|NCT01398410|3754391|P2|STARTED|Overall Study||204
1534260|NCT01398410|3754392|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
1534261|NCT01398358|3754403|P3|NOT COMPLETED|Overall Study||21
1534262|NCT01398358|3754404|P2|NOT COMPLETED|Overall Study||23
1534263|NCT01398358|3754405|P1|NOT COMPLETED|Overall Study||15
1534264|NCT01398358|3754403|P3|COMPLETED|Overall Study||234
1534265|NCT01398358|3754404|P2|COMPLETED|Overall Study||201
1534266|NCT01398358|3754405|P1|COMPLETED|Overall Study||203
1534267|NCT01398358|3754403|P3|STARTED|Overall Study||255
1534268|NCT01398358|3754404|P2|STARTED|Overall Study||224
1534269|NCT01398358|3754405|P1|STARTED|Overall Study||218
1534270|NCT01398176|3754418|P2|NOT COMPLETED|Overall Study||6
1534271|NCT01398176|3754419|P1|NOT COMPLETED|Overall Study||3
1534272|NCT01398176|3754418|P2|COMPLETED|Overall Study||19
1534273|NCT01398176|3754419|P1|COMPLETED|Overall Study||23
1534274|NCT01398176|3754418|P2|STARTED|Overall Study||25
1534275|NCT01398176|3754419|P1|STARTED|Overall Study||26
1534276|NCT01397890|3754427|P2|NOT COMPLETED|Overall Study||31
1534277|NCT01397890|3754428|P1|NOT COMPLETED|Overall Study||23
1534278|NCT01397890|3754427|P2|COMPLETED|Overall Study||260
1534279|NCT01397890|3754428|P1|COMPLETED|Overall Study||264
1534280|NCT01397890|3754427|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
1534281|NCT01397890|3754428|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
1534282|NCT01397890|3754427|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
1534283|NCT01397890|3754428|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
1534284|NCT01397890|3754427|P2|STARTED|Overall Study||291
1534285|NCT01397890|3754428|P1|STARTED|Overall Study||287
1534286|NCT01397851|3754482|P2|NOT COMPLETED|Overall Study||46
1534287|NCT01397851|3754483|P1|NOT COMPLETED|Overall Study||79
1534288|NCT01397851|3754482|P2|COMPLETED|Overall Study||39917
1534289|NCT01397851|3754483|P1|COMPLETED|Overall Study||41555
1534290|NCT01397851|3754482|P2|STARTED|Overall Study||39963
1534291|NCT01397851|3754483|P1|STARTED|Overall Study||41634
1534292|NCT01397825|3754499|P5|NOT COMPLETED|Overall Study||0
1534293|NCT01397825|3754500|P4|NOT COMPLETED|Overall Study||3
1534294|NCT01397825|3754501|P3|NOT COMPLETED|Overall Study||25
1534295|NCT01397825|3754502|P2|NOT COMPLETED|Overall Study||4
1534296|NCT01397825|3754503|P1|NOT COMPLETED|Overall Study||13
1534297|NCT01397825|3754499|P5|COMPLETED|Overall Study||0
1534298|NCT01397825|3754500|P4|COMPLETED|Overall Study||0
1534299|NCT01397825|3754501|P3|COMPLETED|Overall Study||0
1534300|NCT01397825|3754502|P2|COMPLETED|Overall Study||0
1534301|NCT01397825|3754503|P1|COMPLETED|Overall Study||0
1534302|NCT01397825|3754499|P5|STARTED|Overall Study||0
1534303|NCT01397825|3754500|P4|STARTED|Overall Study||3
1534304|NCT01397825|3754501|P3|STARTED|Overall Study||25
1534305|NCT01397825|3754502|P2|STARTED|Overall Study||4
1534306|NCT01397825|3754503|P1|STARTED|Overall Study||13
1534307|NCT01397786|3754573|P3|NOT COMPLETED|Phase B||138
1534308|NCT01397786|3754574|P2|NOT COMPLETED|Phase B||95
1534309|NCT01397786|3754575|P1|NOT COMPLETED|Phase B||303
1534310|NCT01397786|3754573|P3|COMPLETED|Phase B||91
1534311|NCT01397786|3754574|P2|COMPLETED|Phase B||109
1534312|NCT01397786|3754575|P1|COMPLETED|Phase B||308
1534313|NCT01397786|3754573|P3|STARTED|Phase B||229
1534314|NCT01397786|3754574|P2|STARTED|Phase B||204
1534315|NCT01397786|3754575|P1|STARTED|Phase B||611
1534316|NCT01397786|3754573|P3|NOT COMPLETED|Phase A||28
1534317|NCT01397786|3754574|P2|NOT COMPLETED|Phase A||0
1534318|NCT01397786|3754575|P1|NOT COMPLETED|Phase A||0
1534319|NCT01397786|3754573|P3|COMPLETED|Phase A||199
1534320|NCT01397786|3754574|P2|COMPLETED|Phase A||0
1534321|NCT01397786|3754575|P1|COMPLETED|Phase A||12
1534322|NCT01397786|3754573|P3|STARTED|Phase A||227
1534323|NCT01397786|3754574|P2|STARTED|Phase A||0
1534324|NCT01397786|3754575|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
1534325|NCT01397747|3754641|P1|NOT COMPLETED|Overall Study||1027
1534326|NCT01397747|3754641|P1|COMPLETED|Overall Study||9989
1534327|NCT01397747|3754641|P1|STARTED|Overall Study||11016
1534328|NCT01397656|3754648|P2|NOT COMPLETED|Overall Study||0
1534329|NCT01397656|3754649|P1|NOT COMPLETED|Overall Study||0
1534330|NCT01397656|3754648|P2|COMPLETED|Overall Study||30
1534331|NCT01397656|3754649|P1|COMPLETED|Overall Study||33
1534332|NCT01397656|3754648|P2|STARTED|Overall Study||30
1534333|NCT01397656|3754649|P1|STARTED|Overall Study||33
1534334|NCT01397617|3754664|P3|NOT COMPLETED|Overall Study||29
1534335|NCT01397617|3754665|P2|NOT COMPLETED|Overall Study||23
1534336|NCT01397617|3754666|P1|NOT COMPLETED|Overall Study||31
1534337|NCT01397617|3754664|P3|COMPLETED|Overall Study||31
1534338|NCT01397617|3754665|P2|COMPLETED|Overall Study||30
1534339|NCT01397617|3754666|P1|COMPLETED|Overall Study||33
1534340|NCT01397617|3754664|P3|STARTED|Overall Study||60
1534341|NCT01397617|3754665|P2|STARTED|Overall Study||53
1534342|NCT01397617|3754666|P1|STARTED|Overall Study||64
1534343|NCT01397591|3754677|P1|NOT COMPLETED|Overall Study||0
1534344|NCT01397591|3754677|P1|COMPLETED|Overall Study||2
1534345|NCT01397591|3754677|P1|STARTED|Overall Study||2
1534346|NCT01397552|3754687|P2|NOT COMPLETED|Overall Study||1
1534347|NCT01397552|3754688|P1|NOT COMPLETED|Overall Study||3
1534348|NCT01397552|3754687|P2|COMPLETED|Overall Study||3
1534349|NCT01397552|3754688|P1|COMPLETED|Overall Study||1
1534350|NCT01397552|3754687|P2|STARTED|Overall Study||4
1534351|NCT01397552|3754688|P1|STARTED|Overall Study||4
1534352|NCT01397461|3754697|P3|NOT COMPLETED|Overall Study||2
1534353|NCT01397461|3754698|P2|NOT COMPLETED|Overall Study||6
1534354|NCT01397461|3754699|P1|NOT COMPLETED|Overall Study||2
1534355|NCT01397461|3754697|P3|COMPLETED|Overall Study||152
1534356|NCT01397461|3754698|P2|COMPLETED|Overall Study||150
1534357|NCT01397461|3754699|P1|COMPLETED|Overall Study||153
1534358|NCT01397461|3754697|P3|STARTED|Overall Study||154
1534359|NCT01397461|3754698|P2|STARTED|Overall Study||156
1534360|NCT01397461|3754699|P1|STARTED|Overall Study||155
1534361|NCT01397448|3754710|P3|NOT COMPLETED|Overall Study||18
1534362|NCT01397448|3754711|P2|NOT COMPLETED|Overall Study||15
1534363|NCT01397448|3754712|P1|NOT COMPLETED|Overall Study||18
1534364|NCT01397448|3754710|P3|COMPLETED|Overall Study||140
1534365|NCT01397448|3754711|P2|COMPLETED|Overall Study||142
1534366|NCT01397448|3754712|P1|COMPLETED|Overall Study||138
1534367|NCT01397448|3754710|P3|STARTED|Overall Study||158
1534368|NCT01397448|3754711|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
1534369|NCT01397448|3754712|P1|STARTED|Overall Study||156
1534370|NCT01397422|3754727|P4|NOT COMPLETED|Overall Study||8
1534371|NCT01397422|3754728|P3|NOT COMPLETED|Overall Study||3
1534372|NCT01397422|3754729|P2|NOT COMPLETED|Overall Study||3
1534373|NCT01397422|3754730|P1|NOT COMPLETED|Overall Study||2
1534374|NCT01397422|3754727|P4|COMPLETED|Overall Study||12
1534375|NCT01397422|3754728|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
1534376|NCT01397422|3754729|P2|COMPLETED|Overall Study||17
1534377|NCT01397422|3754730|P1|COMPLETED|Overall Study||20
1534378|NCT01397422|3754727|P4|STARTED|Overall Study||20
1534379|NCT01397422|3754728|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
1534380|NCT01397422|3754729|P2|STARTED|Overall Study||20
1534381|NCT01397422|3754730|P1|STARTED|Overall Study||22
1534382|NCT01397409|3754770|P10|NOT COMPLETED|Stage 3||0
1534383|NCT01397409|3754771|P9|NOT COMPLETED|Stage 3||0
1534384|NCT01397409|3754772|P8|NOT COMPLETED|Stage 3||2
1534385|NCT01397409|3754773|P7|NOT COMPLETED|Stage 3||0
1534386|NCT01397409|3754774|P6|NOT COMPLETED|Stage 3||0
1534387|NCT01397409|3754775|P5|NOT COMPLETED|Stage 3||0
1534388|NCT01397409|3754776|P4|NOT COMPLETED|Stage 3||0
1534389|NCT01397409|3754777|P3|NOT COMPLETED|Stage 3||0
1534390|NCT01397409|3754778|P2|NOT COMPLETED|Stage 3||0
1534391|NCT01397409|3754779|P1|NOT COMPLETED|Stage 3||0
1534392|NCT01397409|3754770|P10|COMPLETED|Stage 3||16
1534393|NCT01397409|3754771|P9|COMPLETED|Stage 3||25
1534394|NCT01397409|3754772|P8|COMPLETED|Stage 3||21
1534395|NCT01397409|3754773|P7|COMPLETED|Stage 3||0
1534396|NCT01397409|3754774|P6|COMPLETED|Stage 3||0
1534397|NCT01397409|3754775|P5|COMPLETED|Stage 3||0
1534398|NCT01397409|3754776|P4|COMPLETED|Stage 3||0
1534399|NCT01397409|3754777|P3|COMPLETED|Stage 3||0
1534400|NCT01397409|3754778|P2|COMPLETED|Stage 3||0
1534401|NCT01397409|3754779|P1|COMPLETED|Stage 3||0
1534402|NCT01397409|3754770|P10|STARTED|Stage 3||16
1534403|NCT01397409|3754771|P9|STARTED|Stage 3||25
1534404|NCT01397409|3754772|P8|STARTED|Stage 3||23
1534405|NCT01397409|3754773|P7|STARTED|Stage 3||0
1534406|NCT01397409|3754774|P6|STARTED|Stage 3||0
1534407|NCT01397409|3754775|P5|STARTED|Stage 3||0
1534408|NCT01397409|3754776|P4|STARTED|Stage 3||0
1534409|NCT01397409|3754777|P3|STARTED|Stage 3||0
1534410|NCT01397409|3754778|P2|STARTED|Stage 3||0
1534411|NCT01397409|3754779|P1|STARTED|Stage 3||0
1534412|NCT01397409|3754770|P10|NOT COMPLETED|Stage 2||0
1534413|NCT01397409|3754771|P9|NOT COMPLETED|Stage 2||0
1534414|NCT01397409|3754772|P8|NOT COMPLETED|Stage 2||0
1534415|NCT01397409|3754773|P7|NOT COMPLETED|Stage 2||0
1534416|NCT01397409|3754774|P6|NOT COMPLETED|Stage 2||4
1534417|NCT01397409|3754775|P5|NOT COMPLETED|Stage 2||8
1534418|NCT01397409|3754776|P4|NOT COMPLETED|Stage 2||0
1534419|NCT01397409|3754777|P3|NOT COMPLETED|Stage 2||0
1534420|NCT01397409|3754778|P2|NOT COMPLETED|Stage 2||0
1534421|NCT01397409|3754779|P1|NOT COMPLETED|Stage 2||0
1534422|NCT01397409|3754770|P10|COMPLETED|Stage 2||0
1534423|NCT01397409|3754771|P9|COMPLETED|Stage 2||0
1534424|NCT01397409|3754772|P8|COMPLETED|Stage 2||0
1534425|NCT01397409|3754773|P7|COMPLETED|Stage 2||58
1534426|NCT01397409|3754774|P6|COMPLETED|Stage 2||54
1534427|NCT01397409|3754775|P5|COMPLETED|Stage 2||59
1534428|NCT01397409|3754776|P4|COMPLETED|Stage 2||0
1534429|NCT01397409|3754777|P3|COMPLETED|Stage 2||0
1534430|NCT01397409|3754778|P2|COMPLETED|Stage 2||0
1534431|NCT01397409|3754779|P1|COMPLETED|Stage 2||0
1534432|NCT01397409|3754770|P10|STARTED|Stage 2||0
1534433|NCT01397409|3754771|P9|STARTED|Stage 2||0
1534434|NCT01397409|3754772|P8|STARTED|Stage 2||0
1534435|NCT01397409|3754773|P7|STARTED|Stage 2||58
1534436|NCT01397409|3754774|P6|STARTED|Stage 2||58
1534437|NCT01397409|3754775|P5|STARTED|Stage 2||67
1534438|NCT01397409|3754776|P4|STARTED|Stage 2||0
1534439|NCT01397409|3754777|P3|STARTED|Stage 2||0
1534440|NCT01397409|3754778|P2|STARTED|Stage 2||0
1534441|NCT01397409|3754779|P1|STARTED|Stage 2||0
1534442|NCT01397409|3754770|P10|NOT COMPLETED|Stage 1||0
1534443|NCT01397409|3754771|P9|NOT COMPLETED|Stage 1||0
1534444|NCT01397409|3754772|P8|NOT COMPLETED|Stage 1||0
1534445|NCT01397409|3754773|P7|NOT COMPLETED|Stage 1||0
1534446|NCT01397409|3754774|P6|NOT COMPLETED|Stage 1||0
1534447|NCT01397409|3754775|P5|NOT COMPLETED|Stage 1||0
1534448|NCT01397409|3754776|P4|NOT COMPLETED|Stage 1||0
1534449|NCT01397409|3754777|P3|NOT COMPLETED|Stage 1||0
1534450|NCT01397409|3754778|P2|NOT COMPLETED|Stage 1||0
1534451|NCT01397409|3754779|P1|NOT COMPLETED|Stage 1||0
1534452|NCT01397409|3754770|P10|COMPLETED|Stage 1||0
1534453|NCT01397409|3754771|P9|COMPLETED|Stage 1||0
1534454|NCT01397409|3754772|P8|COMPLETED|Stage 1||0
1534455|NCT01397409|3754773|P7|COMPLETED|Stage 1||0
1534456|NCT01397409|3754774|P6|COMPLETED|Stage 1||0
1534457|NCT01397409|3754775|P5|COMPLETED|Stage 1||0
1534458|NCT01397409|3754776|P4|COMPLETED|Stage 1||3
1534459|NCT01397409|3754777|P3|COMPLETED|Stage 1||6
1534460|NCT01397409|3754778|P2|COMPLETED|Stage 1||6
1534461|NCT01397409|3754779|P1|COMPLETED|Stage 1||9
1534462|NCT01397409|3754770|P10|STARTED|Stage 1||0
1534463|NCT01397409|3754771|P9|STARTED|Stage 1||0
1534464|NCT01397409|3754772|P8|STARTED|Stage 1||0
1534465|NCT01397409|3754773|P7|STARTED|Stage 1||0
1534466|NCT01397409|3754774|P6|STARTED|Stage 1||0
1534467|NCT01397409|3754775|P5|STARTED|Stage 1||0
1534468|NCT01397409|3754776|P4|STARTED|Stage 1||3
1534469|NCT01397409|3754777|P3|STARTED|Stage 1||6
1534470|NCT01397409|3754778|P2|STARTED|Stage 1||6
1534471|NCT01397409|3754779|P1|STARTED|Stage 1||9
1534472|NCT01397253|3754819|P2|NOT COMPLETED|Overall Study||149
1534473|NCT01397253|3754820|P1|NOT COMPLETED|Overall Study||126
1534474|NCT01397253|3754819|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
1534475|NCT01397253|3754820|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
1534476|NCT01397253|3754819|P2|STARTED|Overall Study||392
1534477|NCT01397253|3754820|P1|STARTED|Overall Study||443
1534478|NCT01397084|3754826|P1|NOT COMPLETED|Overall Study||8
1534479|NCT01397084|3754826|P1|COMPLETED|Overall Study||100
1534480|NCT01397084|3754826|P1|STARTED|Overall Study||108
1534481|NCT01396525|3754833|P1|NOT COMPLETED|Overall Study||26
1534482|NCT01396525|3754833|P1|COMPLETED|Overall Study||127
1534483|NCT01396525|3754833|P1|STARTED|Overall Study||153
1534484|NCT01396512|3754933|P2|NOT COMPLETED|Overall Study||1
1534485|NCT01396512|3754934|P1|NOT COMPLETED|Overall Study||0
1534486|NCT01396512|3754933|P2|COMPLETED|Overall Study||136
1534487|NCT01396512|3754934|P1|COMPLETED|Overall Study||137
1534488|NCT01396512|3754933|P2|STARTED|Overall Study||137
1534489|NCT01396512|3754934|P1|STARTED|Overall Study||137
1534490|NCT01396447|3754950|P4|NOT COMPLETED|Overall Study||52
1534491|NCT01396447|3754951|P3|NOT COMPLETED|Overall Study||30
1534492|NCT01396447|3754952|P2|NOT COMPLETED|Overall Study||40
1534493|NCT01396447|3754953|P1|NOT COMPLETED|Overall Study||43
1534494|NCT01396447|3754950|P4|COMPLETED|Overall Study||94
1534495|NCT01396447|3754951|P3|COMPLETED|Overall Study||117
1534496|NCT01396447|3754952|P2|COMPLETED|Overall Study||103
1534497|NCT01396447|3754953|P1|COMPLETED|Overall Study||105
1534498|NCT01396447|3754950|P4|Received Treatment|Overall Study||146
1534499|NCT01396447|3754951|P3|Received Treatment|Overall Study||146
1534500|NCT01396447|3754952|P2|Received Treatment|Overall Study||141
1534501|NCT01396447|3754953|P1|Received Treatment|Overall Study||145
1534502|NCT01396447|3754950|P4|STARTED|Overall Study||146
1534503|NCT01396447|3754951|P3|STARTED|Overall Study||147
1534504|NCT01396447|3754952|P2|STARTED|Overall Study||143
1534505|NCT01396447|3754953|P1|STARTED|Overall Study||148
1534506|NCT01396434|3754970|P3|NOT COMPLETED|Overall Study||0
1534507|NCT01396434|3754971|P2|NOT COMPLETED|Overall Study||0
1534508|NCT01396434|3754972|P1|NOT COMPLETED|Overall Study||11
1534509|NCT01396434|3754970|P3|COMPLETED|Overall Study||14
1534510|NCT01396434|3754971|P2|COMPLETED|Overall Study||175
1534511|NCT01396434|3754972|P1|COMPLETED|Overall Study||2806
1534512|NCT01396434|3754970|P3|STARTED|Overall Study||14
1534513|NCT01396434|3754971|P2|STARTED|Overall Study||175
1534514|NCT01396434|3754972|P1|STARTED|Overall Study||2817
1534515|NCT01396421|3754984|P4|NOT COMPLETED|Overall Study||75
1534516|NCT01396421|3754985|P3|NOT COMPLETED|Overall Study||34
1534517|NCT01396421|3754986|P2|NOT COMPLETED|Overall Study||58
1534518|NCT01396421|3754987|P1|NOT COMPLETED|Overall Study||59
1534519|NCT01396421|3754984|P4|COMPLETED|Overall Study||109
1534520|NCT01396421|3754985|P3|COMPLETED|Overall Study||56
1534521|NCT01396421|3754986|P2|COMPLETED|Overall Study||124
1534522|NCT01396421|3754987|P1|COMPLETED|Overall Study||121
1534523|NCT01396421|3754984|P4|STARTED|Overall Study||184
1534524|NCT01396421|3754985|P3|STARTED|Overall Study||90
1534525|NCT01396421|3754986|P2|STARTED|Overall Study||182
1534526|NCT01396421|3754987|P1|STARTED|Overall Study||180
1534527|NCT01396395|3755059|P2|NOT COMPLETED|Overall Study||27
1534528|NCT01396395|3755060|P1|NOT COMPLETED|Overall Study||40
1534529|NCT01396395|3755059|P2|COMPLETED|Overall Study||175
1534530|NCT01396395|3755060|P1|COMPLETED|Overall Study||160
1534531|NCT01396395|3755059|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
1534532|NCT01396395|3755060|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
1534533|NCT01396395|3755059|P2|STARTED|Overall Study||202
1534534|NCT01396395|3755060|P1|STARTED|Overall Study||200
1534535|NCT01396382|3755095|P1|NOT COMPLETED|Overall Study||0
1534536|NCT01396382|3755095|P1|COMPLETED|Overall Study||97
1534537|NCT01396382|3755095|P1|STARTED|Overall Study||97
1534538|NCT01396317|3755102|P2|NOT COMPLETED|Overall Study||0
1534539|NCT01396317|3755103|P1|NOT COMPLETED|Overall Study||1
1534540|NCT01396317|3755102|P2|COMPLETED|Overall Study||10
1534541|NCT01396317|3755103|P1|COMPLETED|Overall Study||9
1534542|NCT01396317|3755102|P2|STARTED|Overall Study||10
1534543|NCT01396317|3755103|P1|STARTED|Overall Study||10
1534544|NCT01396265|3755117|P1|NOT COMPLETED|Rifa+Afatinib||1
1534545|NCT01396265|3755117|P1|COMPLETED|Rifa+Afatinib||21
1534546|NCT01396265|3755117|P1|STARTED|Rifa+Afatinib||22
1534547|NCT01396265|3755117|P1|NOT COMPLETED|Washout||0
1534548|NCT01396265|3755117|P1|COMPLETED|Washout||22
1534549|NCT01396265|3755117|P1|STARTED|Washout||22
1534550|NCT01396265|3755117|P1|NOT COMPLETED|Afatinib||0
1534551|NCT01396265|3755117|P1|COMPLETED|Afatinib||22
1534552|NCT01396265|3755117|P1|STARTED|Afatinib||22
1534553|NCT01396239|3755144|P4|NOT COMPLETED|Overall Study||0
1534554|NCT01396239|3755145|P3|NOT COMPLETED|Overall Study||0
1534555|NCT01396239|3755146|P2|NOT COMPLETED|Overall Study||0
1534556|NCT01396239|3755147|P1|NOT COMPLETED|Overall Study||0
1534557|NCT01396239|3755144|P4|COMPLETED|Overall Study||2
1534558|NCT01396239|3755145|P3|COMPLETED|Overall Study||4
1534559|NCT01396239|3755146|P2|COMPLETED|Overall Study||2
1534560|NCT01396239|3755147|P1|COMPLETED|Overall Study||4
1534561|NCT01396239|3755144|P4|STARTED|Overall Study||2
1534562|NCT01396239|3755145|P3|STARTED|Overall Study||4
1534563|NCT01396239|3755146|P2|STARTED|Overall Study||2
1534564|NCT01396239|3755147|P1|STARTED|Overall Study||4
1534565|NCT01396226|3755170|P2|NOT COMPLETED|Overall Study||0
1534566|NCT01396226|3755171|P1|NOT COMPLETED|Overall Study||0
1534567|NCT01396226|3755170|P2|COMPLETED|Overall Study||6
1534568|NCT01396226|3755171|P1|COMPLETED|Overall Study||12
1534569|NCT01396226|3755170|P2|Patients Who Completed Treatment|Overall Study||6
1534570|NCT01396226|3755171|P1|Patients Who Completed Treatment|Overall Study||12
1534571|NCT01396226|3755170|P2|Patients Who Received Treatment|Overall Study||6
1534572|NCT01396226|3755171|P1|Patients Who Received Treatment|Overall Study||12
1534573|NCT01396226|3755170|P2|STARTED|Overall Study||6
1534574|NCT01396226|3755171|P1|STARTED|Overall Study||12
1534575|NCT01396187|3755206|P5|NOT COMPLETED|Overall Study||1
1534576|NCT01396187|3755207|P4|NOT COMPLETED|Overall Study||0
1534577|NCT01396187|3755208|P3|NOT COMPLETED|Overall Study||1
1534578|NCT01396187|3755209|P2|NOT COMPLETED|Overall Study||3
1534579|NCT01396187|3755210|P1|NOT COMPLETED|Overall Study||1
1534580|NCT01396187|3755206|P5|COMPLETED|Overall Study||9
1534581|NCT01396187|3755207|P4|COMPLETED|Overall Study||10
1534582|NCT01396187|3755208|P3|COMPLETED|Overall Study||9
1534583|NCT01396187|3755209|P2|COMPLETED|Overall Study||9
1534584|NCT01396187|3755210|P1|COMPLETED|Overall Study||7
1534585|NCT01396187|3755206|P5|STARTED|Overall Study||10
1534586|NCT01396187|3755207|P4|STARTED|Overall Study||10
1534587|NCT01396187|3755208|P3|STARTED|Overall Study||10
1534588|NCT01396187|3755209|P2|STARTED|Overall Study||12
1534589|NCT01396187|3755210|P1|STARTED|Overall Study||8
1534590|NCT01396161|3755310|P7|NOT COMPLETED|Overall Study||1
1534591|NCT01396161|3755311|P6|NOT COMPLETED|Overall Study||0
1534592|NCT01396161|3755312|P5|NOT COMPLETED|Overall Study||1
1534593|NCT01396161|3755313|P4|NOT COMPLETED|Overall Study||0
1534594|NCT01396161|3755314|P3|NOT COMPLETED|Overall Study||0
1534595|NCT01396161|3755315|P2|NOT COMPLETED|Overall Study||0
1534596|NCT01396161|3755316|P1|NOT COMPLETED|Overall Study||0
1534597|NCT01396161|3755310|P7|COMPLETED|Overall Study||10
1534598|NCT01396161|3755311|P6|COMPLETED|Overall Study||9
1534599|NCT01396161|3755312|P5|COMPLETED|Overall Study||8
1534600|NCT01396161|3755313|P4|COMPLETED|Overall Study||9
1534601|NCT01396161|3755314|P3|COMPLETED|Overall Study||9
1534602|NCT01396161|3755315|P2|COMPLETED|Overall Study||5
1534603|NCT01396161|3755316|P1|COMPLETED|Overall Study||12
1534604|NCT01396161|3755310|P7|STARTED|Overall Study||11
1534605|NCT01396161|3755311|P6|STARTED|Overall Study||9
1534606|NCT01396161|3755312|P5|STARTED|Overall Study||9
1534607|NCT01396161|3755313|P4|STARTED|Overall Study||9
1534608|NCT01396161|3755314|P3|STARTED|Overall Study||9
1534609|NCT01396161|3755315|P2|STARTED|Overall Study||5
1534610|NCT01396161|3755316|P1|STARTED|Overall Study||12
1534611|NCT01396148|3755369|P1|NOT COMPLETED|Overall Study||1
1534612|NCT01396148|3755369|P1|COMPLETED|Overall Study||5
1534613|NCT01396148|3755369|P1|STARTED|Overall Study||6
1534614|NCT01396083|3755396|P2|NOT COMPLETED|Overall Study||47
1534615|NCT01396083|3755397|P1|NOT COMPLETED|Overall Study||11
1534616|NCT01396083|3755396|P2|COMPLETED|Overall Study||72
1534617|NCT01396083|3755397|P1|COMPLETED|Overall Study||113
1534618|NCT01396083|3755396|P2|STARTED|Overall Study||119
1534619|NCT01396083|3755397|P1|STARTED|Overall Study||124
1534620|NCT01396070|3755421|P1|NOT COMPLETED|Overall Study||19
1534621|NCT01396070|3755421|P1|COMPLETED|Overall Study||17
1534622|NCT01396070|3755421|P1|STARTED|Overall Study||36
1534623|NCT01396057|3755430|P2|NOT COMPLETED|Overall Study||18
1534624|NCT01396057|3755431|P1|NOT COMPLETED|Overall Study||11
1534625|NCT01396057|3755430|P2|COMPLETED|Overall Study||100
1534626|NCT01396057|3755431|P1|COMPLETED|Overall Study||115
1534627|NCT01396057|3755430|P2|STARTED|Overall Study||118
1534628|NCT01396057|3755431|P1|STARTED|Overall Study||126
1534629|NCT01396044|3755457|P2|NOT COMPLETED|Overall Study||0
1534630|NCT01396044|3755458|P1|NOT COMPLETED|Overall Study||0
1534631|NCT01396044|3755457|P2|COMPLETED|Overall Study||171
1534632|NCT01396044|3755458|P1|COMPLETED|Overall Study||125
1534633|NCT01396044|3755457|P2|STARTED|Overall Study||171
1534634|NCT01396044|3755458|P1|STARTED|Overall Study||125
1534635|NCT01396005|3755480|P2|NOT COMPLETED|Overall Study||2
1534636|NCT01396005|3755481|P1|NOT COMPLETED|Overall Study||0
1534637|NCT01396005|3755480|P2|COMPLETED|Overall Study||9
1534638|NCT01396005|3755481|P1|COMPLETED|Overall Study||10
1534639|NCT01396005|3755480|P2|STARTED|Overall Study||11
1534640|NCT01396005|3755481|P1|STARTED|Overall Study||10
1534641|NCT01395966|3755500|P3|NOT COMPLETED|Overall Study||8
1534642|NCT01395966|3755501|P2|NOT COMPLETED|Overall Study||19
1534643|NCT01395966|3755502|P1|NOT COMPLETED|Overall Study||10
1534644|NCT01395966|3755500|P3|COMPLETED|Overall Study||104
1534645|NCT01395966|3755501|P2|COMPLETED|Overall Study||91
1534646|NCT01395966|3755502|P1|COMPLETED|Overall Study||99
1534647|NCT01395966|3755500|P3|STARTED|Overall Study||112
1534648|NCT01395966|3755501|P2|STARTED|Overall Study||110
1534649|NCT01395966|3755502|P1|STARTED|Overall Study||109
1534650|NCT01395914|3755512|P2|NOT COMPLETED|Overall Study||37
1534651|NCT01395914|3755513|P1|NOT COMPLETED|Overall Study||72
1534652|NCT01395914|3755512|P2|COMPLETED|Overall Study||131
1534653|NCT01395914|3755513|P1|COMPLETED|Overall Study||273
1534654|NCT01395914|3755512|P2|Safety Population|Overall Study||167
1534655|NCT01395914|3755513|P1|Safety Population|Overall Study||343
1534656|NCT01395914|3755512|P2|ITT Population|Overall Study||168
1534657|NCT01395914|3755513|P1|ITT Population|Overall Study||345
1534658|NCT01395914|3755512|P2|STARTED|Overall Study||168
1534659|NCT01395914|3755513|P1|STARTED|Overall Study||345
1534660|NCT01395901|3755527|P2|NOT COMPLETED|Overall Study||5
1534661|NCT01395901|3755528|P1|NOT COMPLETED|Overall Study||10
1534662|NCT01395901|3755527|P2|COMPLETED|Overall Study|Treated patients completing the study|329
1534663|NCT01395901|3755528|P1|COMPLETED|Overall Study|Treated patients completing the study|326
1534664|NCT01395901|3755527|P2|STARTED|Overall Study|Randomized Population|334
1534665|NCT01395901|3755528|P1|STARTED|Overall Study|Randomized Population|336
1534666|NCT01395888|3755544|P3|NOT COMPLETED|Treatment Period (TP)||17
1534667|NCT01395888|3755545|P2|NOT COMPLETED|Treatment Period (TP)||15
1534668|NCT01395888|3755546|P1|NOT COMPLETED|Treatment Period (TP)||0
1534669|NCT01395888|3755544|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
1534670|NCT01395888|3755545|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
1534671|NCT01395888|3755546|P1|COMPLETED|Treatment Period (TP)||0
1534672|NCT01395888|3755544|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
1534673|NCT01395888|3755545|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
1534674|NCT01395888|3755546|P1|Completed the Treatment Period|Treatment Period (TP)||0
1534675|NCT01395888|3755544|P3|STARTED|Treatment Period (TP)||130
1534676|NCT01395888|3755545|P2|STARTED|Treatment Period (TP)||127
1534677|NCT01395888|3755546|P1|STARTED|Treatment Period (TP)||0
1534678|NCT01395888|3755544|P3|NOT COMPLETED|2-week Run-in Period||0
1534679|NCT01395888|3755545|P2|NOT COMPLETED|2-week Run-in Period||0
1534680|NCT01395888|3755546|P1|NOT COMPLETED|2-week Run-in Period||22
1534681|NCT01395888|3755544|P3|COMPLETED|2-week Run-in Period||0
1534682|NCT01395888|3755545|P2|COMPLETED|2-week Run-in Period||0
1534683|NCT01395888|3755546|P1|COMPLETED|2-week Run-in Period||257
1534684|NCT01395888|3755544|P3|STARTED|2-week Run-in Period||0
1534685|NCT01395888|3755545|P2|STARTED|2-week Run-in Period||0
1534686|NCT01395888|3755546|P1|STARTED|2-week Run-in Period||279
1534687|NCT01395823|3755554|P2|NOT COMPLETED|Overall Study||9
1534688|NCT01395823|3755555|P1|NOT COMPLETED|Overall Study||15
1534689|NCT01395823|3755554|P2|COMPLETED|Overall Study||130
1534690|NCT01395823|3755555|P1|COMPLETED|Overall Study||122
1534691|NCT01395823|3755554|P2|STARTED|Overall Study||139
1534692|NCT01395823|3755555|P1|STARTED|Overall Study||137
1534693|NCT01395810|3755565|P4|NOT COMPLETED|Overall Study||0
1534694|NCT01395810|3755566|P3|NOT COMPLETED|Overall Study||0
1534695|NCT01395810|3755567|P2|NOT COMPLETED|Overall Study||4
1534696|NCT01395810|3755568|P1|NOT COMPLETED|Overall Study||2
1534697|NCT01395810|3755565|P4|COMPLETED|Overall Study||5
1534698|NCT01395810|3755566|P3|COMPLETED|Overall Study||0
1534699|NCT01395810|3755567|P2|COMPLETED|Overall Study||44
1534700|NCT01395810|3755568|P1|COMPLETED|Overall Study||16
1534701|NCT01395810|3755565|P4|After Switching the Arms|Overall Study||5
1534702|NCT01395810|3755566|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
1534703|NCT01395810|3755567|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
1534795|NCT01395277|3755751|P1|STARTED|Overall Study||15
1534704|NCT01395810|3755568|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
1534705|NCT01395810|3755565|P4|STARTED|Overall Study||5
1534706|NCT01395810|3755566|P3|STARTED|Overall Study||0
1534707|NCT01395810|3755567|P2|STARTED|Overall Study||48
1534708|NCT01395810|3755568|P1|STARTED|Overall Study||18
1534709|NCT01395797|3755602|P6|NOT COMPLETED|Overall Study||3
1534710|NCT01395797|3755603|P5|NOT COMPLETED|Overall Study||2
1534711|NCT01395797|3755604|P4|NOT COMPLETED|Overall Study||2
1534712|NCT01395797|3755605|P3|NOT COMPLETED|Overall Study||4
1534713|NCT01395797|3755606|P2|NOT COMPLETED|Overall Study||1
1534714|NCT01395797|3755607|P1|NOT COMPLETED|Overall Study||3
1534715|NCT01395797|3755602|P6|COMPLETED|Overall Study||14
1534716|NCT01395797|3755603|P5|COMPLETED|Overall Study||7
1534717|NCT01395797|3755604|P4|COMPLETED|Overall Study||13
1534718|NCT01395797|3755605|P3|COMPLETED|Overall Study||14
1534719|NCT01395797|3755606|P2|COMPLETED|Overall Study||3
1534720|NCT01395797|3755607|P1|COMPLETED|Overall Study||16
1534721|NCT01395797|3755602|P6|STARTED|Overall Study||17
1534722|NCT01395797|3755603|P5|STARTED|Overall Study||9
1534723|NCT01395797|3755604|P4|STARTED|Overall Study||15
1534724|NCT01395797|3755605|P3|STARTED|Overall Study||18
1534725|NCT01395797|3755606|P2|STARTED|Overall Study||4
1534726|NCT01395797|3755607|P1|STARTED|Overall Study||19
1534727|NCT01395784|3755627|P1|NOT COMPLETED|Overall Study||15
1534728|NCT01395784|3755627|P1|COMPLETED|Overall Study||17
1534729|NCT01395784|3755627|P1|STARTED|Overall Study||32
1534730|NCT01395758|3755634|P3|NOT COMPLETED|Crossover Period||0
1534731|NCT01395758|3755635|P2|NOT COMPLETED|Crossover Period||0
1534732|NCT01395758|3755636|P1|NOT COMPLETED|Crossover Period||0
1534733|NCT01395758|3755634|P3|COMPLETED|Crossover Period||26
1534734|NCT01395758|3755635|P2|COMPLETED|Crossover Period||0
1534735|NCT01395758|3755636|P1|COMPLETED|Crossover Period||0
1534736|NCT01395758|3755634|P3|STARTED|Crossover Period||26
1534737|NCT01395758|3755635|P2|STARTED|Crossover Period||0
1534738|NCT01395758|3755636|P1|STARTED|Crossover Period||0
1534739|NCT01395758|3755634|P3|NOT COMPLETED|Open-label Treatment Period||0
1534740|NCT01395758|3755635|P2|NOT COMPLETED|Open-label Treatment Period||0
1534741|NCT01395758|3755636|P1|NOT COMPLETED|Open-label Treatment Period||4
1534742|NCT01395758|3755634|P3|COMPLETED|Open-label Treatment Period||0
1534743|NCT01395758|3755635|P2|COMPLETED|Open-label Treatment Period||45
1534744|NCT01395758|3755636|P1|COMPLETED|Open-label Treatment Period||47
1534745|NCT01395758|3755634|P3|STARTED|Open-label Treatment Period||0
1534746|NCT01395758|3755635|P2|STARTED|Open-label Treatment Period||45
1534747|NCT01395758|3755636|P1|STARTED|Open-label Treatment Period||51
1534748|NCT01395524|3755650|P3|NOT COMPLETED|Overall Study||17
1534749|NCT01395524|3755651|P2|NOT COMPLETED|Overall Study||16
1534750|NCT01395524|3755652|P1|NOT COMPLETED|Overall Study||18
1534751|NCT01395524|3755650|P3|COMPLETED|Overall Study||89
1534752|NCT01395524|3755651|P2|COMPLETED|Overall Study||83
1534753|NCT01395524|3755652|P1|COMPLETED|Overall Study||79
1534754|NCT01395524|3755650|P3|STARTED|Overall Study||106
1534755|NCT01395524|3755651|P2|STARTED|Overall Study||99
1534756|NCT01395524|3755652|P1|STARTED|Overall Study||97
1534757|NCT01395394|3755675|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
1534758|NCT01395394|3755676|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
1534759|NCT01395394|3755677|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
1534760|NCT01395394|3755675|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
1534761|NCT01395394|3755676|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
1534762|NCT01395394|3755677|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
1534763|NCT01395394|3755675|P3|STARTED|Study Visit 2 (Non-responders Only)||0
1534764|NCT01395394|3755676|P2|STARTED|Study Visit 2 (Non-responders Only)||0
1534765|NCT01395394|3755677|P1|STARTED|Study Visit 2 (Non-responders Only)||3
1534766|NCT01395394|3755675|P3|NOT COMPLETED|Baseline Study Visit||0
1534767|NCT01395394|3755676|P2|NOT COMPLETED|Baseline Study Visit||0
1534768|NCT01395394|3755677|P1|NOT COMPLETED|Baseline Study Visit||1
1534769|NCT01395394|3755675|P3|COMPLETED|Baseline Study Visit||5
1534770|NCT01395394|3755676|P2|COMPLETED|Baseline Study Visit||3
1534771|NCT01395394|3755677|P1|COMPLETED|Baseline Study Visit||3
1534772|NCT01395394|3755675|P3|STARTED|Baseline Study Visit||5
1534773|NCT01395394|3755676|P2|STARTED|Baseline Study Visit||3
1534774|NCT01395394|3755677|P1|STARTED|Baseline Study Visit||4
1534775|NCT01395368|3755688|P1|NOT COMPLETED|Overall Study||16
1534776|NCT01395368|3755688|P1|COMPLETED|Overall Study||92
1534777|NCT01395368|3755688|P1|STARTED|Overall Study||108
1534778|NCT01395329|3755695|P3|NOT COMPLETED|Overall Study||0
1534779|NCT01395329|3755696|P2|NOT COMPLETED|Overall Study||0
1534780|NCT01395329|3755697|P1|NOT COMPLETED|Overall Study||0
1534781|NCT01395329|3755695|P3|COMPLETED|Overall Study||14
1534782|NCT01395329|3755696|P2|COMPLETED|Overall Study||14
1534783|NCT01395329|3755697|P1|COMPLETED|Overall Study||14
1534784|NCT01395329|3755695|P3|STARTED|Overall Study||14
1534785|NCT01395329|3755696|P2|STARTED|Overall Study||14
1534786|NCT01395329|3755697|P1|STARTED|Overall Study||14
1534787|NCT01395316|3755744|P1|NOT COMPLETED|Overall Study||3
1534788|NCT01395316|3755744|P1|COMPLETED|Overall Study||5
1534789|NCT01395316|3755744|P1|STARTED|Overall Study||8
1534790|NCT01395277|3755750|P2|NOT COMPLETED|Overall Study||0
1534791|NCT01395277|3755751|P1|NOT COMPLETED|Overall Study||0
1534792|NCT01395277|3755750|P2|COMPLETED|Overall Study||15
1534793|NCT01395277|3755751|P1|COMPLETED|Overall Study||15
1534794|NCT01395277|3755750|P2|STARTED|Overall Study||15
1534796|NCT01395043|3755759|P1|NOT COMPLETED|Overall Study||0
1534797|NCT01395043|3755759|P1|COMPLETED|Overall Study||15
1534798|NCT01395043|3755759|P1|STARTED|Overall Study||15
1534799|NCT01395030|3755764|P1|NOT COMPLETED|Overall Study||7
1534800|NCT01395030|3755764|P1|COMPLETED|Overall Study||57
1534801|NCT01395030|3755764|P1|Adequate Tissue for Analysis|Overall Study||50
1534802|NCT01395030|3755764|P1|Complete FCH PET/CT|Overall Study||57
1534803|NCT01395030|3755764|P1|STARTED|Overall Study||64
1534804|NCT01395017|3755774|P2|NOT COMPLETED|Overall Study||102
1534805|NCT01395017|3755775|P1|NOT COMPLETED|Overall Study||100
1534806|NCT01395017|3755774|P2|COMPLETED|Overall Study||0
1534807|NCT01395017|3755775|P1|COMPLETED|Overall Study||0
1534808|NCT01395017|3755774|P2|Treated|Overall Study||101
1534809|NCT01395017|3755775|P1|Treated|Overall Study||98
1534810|NCT01395017|3755774|P2|STARTED|Overall Study||102
1534811|NCT01395017|3755775|P1|STARTED|Overall Study||100
1534812|NCT01394991|3755785|P2|NOT COMPLETED|Overall Study||72
1534813|NCT01394991|3755786|P1|NOT COMPLETED|Overall Study||59
1534814|NCT01394991|3755785|P2|COMPLETED|Overall Study||190
1534815|NCT01394991|3755786|P1|COMPLETED|Overall Study||183
1534816|NCT01394991|3755785|P2|STARTED|Overall Study||262
1534817|NCT01394991|3755786|P1|STARTED|Overall Study||242
1534818|NCT01394978|3755808|P2|NOT COMPLETED|Overall Study||31
1534819|NCT01394978|3755809|P1|NOT COMPLETED|Overall Study||21
1534820|NCT01394978|3755808|P2|COMPLETED|Overall Study||245
1534821|NCT01394978|3755809|P1|COMPLETED|Overall Study||147
1534822|NCT01394978|3755808|P2|STARTED|Overall Study||276
1534823|NCT01394978|3755809|P1|STARTED|Overall Study||168
1534824|NCT01394926|3755815|P1|NOT COMPLETED|Overall Study||0
1534825|NCT01394926|3755815|P1|COMPLETED|Overall Study||21
1534826|NCT01394926|3755815|P1|STARTED|Overall Study||21
1534827|NCT01394718|3755826|P2|NOT COMPLETED|Overall Study||1
1534828|NCT01394718|3755827|P1|NOT COMPLETED|Overall Study||2
1534829|NCT01394718|3755826|P2|COMPLETED|Overall Study||29
1534830|NCT01394718|3755827|P1|COMPLETED|Overall Study||28
1534831|NCT01394718|3755826|P2|STARTED|Overall Study||30
1534832|NCT01394718|3755827|P1|STARTED|Overall Study||30
1534833|NCT01394692|3755841|P2|NOT COMPLETED|Overall Study||0
1534834|NCT01394692|3755842|P1|NOT COMPLETED|Overall Study||0
1534835|NCT01394692|3755841|P2|COMPLETED|Overall Study||29
1534836|NCT01394692|3755842|P1|COMPLETED|Overall Study||29
1534837|NCT01394692|3755841|P2|STARTED|Overall Study||29
1534838|NCT01394692|3755842|P1|STARTED|Overall Study||29
1534839|NCT01394627|3755848|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1534840|NCT01394627|3755849|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1534841|NCT01394627|3755848|P2|COMPLETED|Second Intervention (1 Day)||12
1534842|NCT01394627|3755849|P1|COMPLETED|Second Intervention (1 Day)||7
1534843|NCT01394627|3755848|P2|STARTED|Second Intervention (1 Day)||12
1534844|NCT01394627|3755849|P1|STARTED|Second Intervention (1 Day)||7
1534845|NCT01394627|3755848|P2|NOT COMPLETED|Washout (1-3 Months)||0
1534846|NCT01394627|3755849|P1|NOT COMPLETED|Washout (1-3 Months)||1
1534847|NCT01394627|3755848|P2|COMPLETED|Washout (1-3 Months)||12
1534848|NCT01394627|3755849|P1|COMPLETED|Washout (1-3 Months)||7
1534849|NCT01394627|3755848|P2|STARTED|Washout (1-3 Months)||12
1534850|NCT01394627|3755849|P1|STARTED|Washout (1-3 Months)||8
1534851|NCT01394627|3755848|P2|NOT COMPLETED|First Intervention (1 Day)||1
1534852|NCT01394627|3755849|P1|NOT COMPLETED|First Intervention (1 Day)||0
1534853|NCT01394627|3755848|P2|COMPLETED|First Intervention (1 Day)||12
1534854|NCT01394627|3755849|P1|COMPLETED|First Intervention (1 Day)||8
1534855|NCT01394627|3755848|P2|STARTED|First Intervention (1 Day)||13
1534856|NCT01394627|3755849|P1|STARTED|First Intervention (1 Day)||8
1534857|NCT01394614|3755859|P2|NOT COMPLETED|Overall Study||0
1534858|NCT01394614|3755860|P1|NOT COMPLETED|Overall Study||0
1534859|NCT01394614|3755859|P2|COMPLETED|Overall Study||16
1534860|NCT01394614|3755860|P1|COMPLETED|Overall Study||8
1534861|NCT01394614|3755859|P2|STARTED|Overall Study||16
1534862|NCT01394614|3755860|P1|STARTED|Overall Study||8
1534863|NCT01394523|3755869|P3|NOT COMPLETED|Overall Study||0
1534864|NCT01394523|3755870|P2|NOT COMPLETED|Overall Study||0
1534865|NCT01394523|3755871|P1|NOT COMPLETED|Overall Study||1
1534866|NCT01394523|3755869|P3|COMPLETED|Overall Study||13
1534867|NCT01394523|3755870|P2|COMPLETED|Overall Study||13
1534868|NCT01394523|3755871|P1|COMPLETED|Overall Study||12
1534869|NCT01394523|3755869|P3|STARTED|Overall Study||13
1534870|NCT01394523|3755870|P2|STARTED|Overall Study||13
1534871|NCT01394523|3755871|P1|STARTED|Overall Study||13
1534872|NCT01394510|3755879|P1|NOT COMPLETED|Overall Study||0
1534873|NCT01394510|3755879|P1|COMPLETED|Overall Study||13
1534874|NCT01394510|3755879|P1|STARTED|Overall Study||13
1534875|NCT01394276|3755885|P1|NOT COMPLETED|Overall Study||62
1534876|NCT01394276|3755885|P1|COMPLETED|Overall Study||260
1534877|NCT01394276|3755885|P1|STARTED|Overall Study||322
1534878|NCT01394250|3755909|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
1534879|NCT01394250|3755910|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
1534880|NCT01394250|3755909|P2|COMPLETED|Successful IV Placement & Follow-Up||110
1534881|NCT01394250|3755910|P1|COMPLETED|Successful IV Placement & Follow-Up||114
1534882|NCT01394250|3755909|P2|STARTED|Successful IV Placement & Follow-Up||121
1534883|NCT01394250|3755910|P1|STARTED|Successful IV Placement & Follow-Up||120
1534884|NCT01394250|3755909|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
1534885|NCT01394250|3755910|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
1534886|NCT01394250|3755909|P2|COMPLETED|Randomization and IV Placement Attempt||121
1534887|NCT01394250|3755910|P1|COMPLETED|Randomization and IV Placement Attempt||120
1534888|NCT01394250|3755909|P2|STARTED|Randomization and IV Placement Attempt||134
1534889|NCT01394250|3755910|P1|STARTED|Randomization and IV Placement Attempt||134
1534890|NCT01394211|3755918|P1|NOT COMPLETED|Overall Study||2
1534891|NCT01394211|3755918|P1|COMPLETED|Overall Study||0
1534892|NCT01394211|3755918|P1|STARTED|Overall Study||2
1534893|NCT01394185|3755924|P6|NOT COMPLETED|Overall Study||1
1534894|NCT01394185|3755925|P5|NOT COMPLETED|Overall Study||4
1534895|NCT01394185|3755926|P4|NOT COMPLETED|Overall Study||1
1534896|NCT01394185|3755927|P3|NOT COMPLETED|Overall Study||0
1534897|NCT01394185|3755928|P2|NOT COMPLETED|Overall Study||0
1534898|NCT01394185|3755929|P1|NOT COMPLETED|Overall Study||6
1534899|NCT01394185|3755924|P6|COMPLETED|Overall Study||2
1534900|NCT01394185|3755925|P5|COMPLETED|Overall Study||2
1534901|NCT01394185|3755926|P4|COMPLETED|Overall Study||3
1534902|NCT01394185|3755927|P3|COMPLETED|Overall Study||2
1534903|NCT01394185|3755928|P2|COMPLETED|Overall Study||2
1534904|NCT01394185|3755929|P1|COMPLETED|Overall Study||2
1534905|NCT01394185|3755924|P6|STARTED|Overall Study||3
1534906|NCT01394185|3755925|P5|STARTED|Overall Study||6
1534907|NCT01394185|3755926|P4|STARTED|Overall Study||4
1534908|NCT01394185|3755927|P3|STARTED|Overall Study||2
1534909|NCT01394185|3755928|P2|STARTED|Overall Study||2
1534910|NCT01394185|3755929|P1|STARTED|Overall Study||8
1534911|NCT01394159|3755942|P2|NOT COMPLETED|Overall Study||0
1534912|NCT01394159|3755943|P1|NOT COMPLETED|Overall Study||0
1534913|NCT01394159|3755942|P2|COMPLETED|Overall Study||28
1534914|NCT01394159|3755943|P1|COMPLETED|Overall Study||28
1534915|NCT01394159|3755942|P2|STARTED|Overall Study||28
1534916|NCT01394159|3755943|P1|STARTED|Overall Study||28
1534917|NCT01394081|3755955|P2|NOT COMPLETED|Overall Study||0
1534918|NCT01394081|3755956|P1|NOT COMPLETED|Overall Study||0
1534919|NCT01394081|3755955|P2|COMPLETED|Overall Study||102
1534920|NCT01394081|3755956|P1|COMPLETED|Overall Study||101
1534921|NCT01394081|3755955|P2|STARTED|Overall Study||102
1534922|NCT01394081|3755956|P1|STARTED|Overall Study||101
1534923|NCT01393964|3755967|P3|NOT COMPLETED|Overall Study||9
1534924|NCT01393964|3755968|P2|NOT COMPLETED|Overall Study||9
1534925|NCT01393964|3755969|P1|NOT COMPLETED|Overall Study||8
1534926|NCT01393964|3755967|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
1534927|NCT01393964|3755968|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
1534928|NCT01393964|3755969|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
1534929|NCT01393964|3755967|P3|STARTED|Overall Study||9
1534930|NCT01393964|3755968|P2|STARTED|Overall Study||9
1534931|NCT01393964|3755969|P1|STARTED|Overall Study||8
1534932|NCT01393899|3756010|P3|NOT COMPLETED|Overall Study||23
1534933|NCT01393899|3756011|P2|NOT COMPLETED|Overall Study||28
1534934|NCT01393899|3756012|P1|NOT COMPLETED|Overall Study||32
1534935|NCT01393899|3756010|P3|COMPLETED|Overall Study||38
1534936|NCT01393899|3756011|P2|COMPLETED|Overall Study||32
1534937|NCT01393899|3756012|P1|COMPLETED|Overall Study||27
1534938|NCT01393899|3756010|P3|STARTED|Overall Study||61
1534939|NCT01393899|3756011|P2|STARTED|Overall Study||60
1534940|NCT01393899|3756012|P1|STARTED|Overall Study||59
1534941|NCT01393743|3756066|P3|NOT COMPLETED|Extension Phase||60
1534942|NCT01393743|3756067|P2|NOT COMPLETED|Extension Phase||0
1534943|NCT01393743|3756068|P1|NOT COMPLETED|Extension Phase||0
1534944|NCT01393743|3756066|P3|COMPLETED|Extension Phase||78
1534945|NCT01393743|3756067|P2|COMPLETED|Extension Phase||0
1534946|NCT01393743|3756068|P1|COMPLETED|Extension Phase||0
1534947|NCT01393743|3756066|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
1534948|NCT01393743|3756067|P2|STARTED|Extension Phase||0
1534949|NCT01393743|3756068|P1|STARTED|Extension Phase||0
1534950|NCT01393743|3756066|P3|NOT COMPLETED|Core Study||0
1534951|NCT01393743|3756067|P2|NOT COMPLETED|Core Study||13
1534952|NCT01393743|3756068|P1|NOT COMPLETED|Core Study||10
1534953|NCT01393743|3756066|P3|COMPLETED|Core Study||0
1534954|NCT01393743|3756067|P2|COMPLETED|Core Study||68
1534955|NCT01393743|3756068|P1|COMPLETED|Core Study||72
1534956|NCT01393743|3756066|P3|STARTED|Core Study||0
1534957|NCT01393743|3756067|P2|STARTED|Core Study|Treated|81
1534958|NCT01393743|3756068|P1|STARTED|Core Study|Treated|82
1534959|NCT01393730|3756091|P1|NOT COMPLETED|Overall Study||6
1534960|NCT01393730|3756091|P1|COMPLETED|Overall Study||34
1534961|NCT01393730|3756091|P1|Evaluable AR Mutation|Overall Study||14
1534962|NCT01393730|3756091|P1|Evaluable AR Amplification|Overall Study||21
1534963|NCT01393730|3756091|P1|Treated|Overall Study||38
1534964|NCT01393730|3756091|P1|STARTED|Overall Study||40
1534965|NCT01393717|3756103|P2|NOT COMPLETED|Overall Study||0
1534966|NCT01393717|3756104|P1|NOT COMPLETED|Overall Study||0
1534967|NCT01393717|3756103|P2|COMPLETED|Overall Study||20
1534968|NCT01393717|3756104|P1|COMPLETED|Overall Study||37
1534969|NCT01393717|3756103|P2|STARTED|Overall Study||20
1534970|NCT01393717|3756104|P1|STARTED|Overall Study||37
1534971|NCT01393704|3756118|P2|NOT COMPLETED|Overall Study||0
1534972|NCT01393704|3756119|P1|NOT COMPLETED|Overall Study||0
1534973|NCT01393704|3756118|P2|COMPLETED|Overall Study||76
1534974|NCT01393704|3756119|P1|COMPLETED|Overall Study||76
1534975|NCT01393704|3756118|P2|STARTED|Overall Study||76
1534976|NCT01393704|3756119|P1|STARTED|Overall Study||76
1534977|NCT01393626|3756137|P4|NOT COMPLETED|Overall Study||1
1534978|NCT01393626|3756138|P3|NOT COMPLETED|Overall Study||12
1534979|NCT01393626|3756139|P2|NOT COMPLETED|Overall Study||12
1534980|NCT01393626|3756140|P1|NOT COMPLETED|Overall Study||18
1534981|NCT01393626|3756137|P4|COMPLETED|Overall Study||15
1534982|NCT01393626|3756138|P3|COMPLETED|Overall Study||74
1534983|NCT01393626|3756139|P2|COMPLETED|Overall Study||74
1534984|NCT01393626|3756140|P1|COMPLETED|Overall Study||73
1534985|NCT01393626|3756137|P4|STARTED|Overall Study||16
1534986|NCT01393626|3756138|P3|STARTED|Overall Study||86
1534987|NCT01393626|3756139|P2|STARTED|Overall Study||86
1534988|NCT01393626|3756140|P1|STARTED|Overall Study||91
1534989|NCT01393613|3756220|P4|NOT COMPLETED|Overall Study||66
1534990|NCT01393613|3756221|P3|NOT COMPLETED|Overall Study||54
1534991|NCT01393613|3756222|P2|NOT COMPLETED|Overall Study||57
1534992|NCT01393613|3756223|P1|NOT COMPLETED|Overall Study||39
1534993|NCT01393613|3756220|P4|COMPLETED|Overall Study||118
1534994|NCT01393613|3756221|P3|COMPLETED|Overall Study||130
1534995|NCT01393613|3756222|P2|COMPLETED|Overall Study||129
1534996|NCT01393613|3756223|P1|COMPLETED|Overall Study||81
1534997|NCT01393613|3756220|P4|STARTED|Overall Study||184
1534998|NCT01393613|3756221|P3|STARTED|Overall Study||184
1534999|NCT01393613|3756222|P2|STARTED|Overall Study||186
1535000|NCT01393613|3756223|P1|STARTED|Overall Study||120
1535001|NCT01393600|3756285|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
1535002|NCT01393600|3756286|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
1535003|NCT01393600|3756287|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
1535004|NCT01393600|3756288|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
1535005|NCT01393600|3756285|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
1535006|NCT01393600|3756286|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
1535007|NCT01393600|3756287|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
1535008|NCT01393600|3756288|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
1535009|NCT01393600|3756285|P4|STARTED|Follow-up Period (Day 29 to 35)||8
1535010|NCT01393600|3756286|P3|STARTED|Follow-up Period (Day 29 to 35)||7
1535011|NCT01393600|3756287|P2|STARTED|Follow-up Period (Day 29 to 35)||7
1535012|NCT01393600|3756288|P1|STARTED|Follow-up Period (Day 29 to 35)||9
1535013|NCT01393600|3756285|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
1535014|NCT01393600|3756286|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
1535015|NCT01393600|3756287|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
1535016|NCT01393600|3756288|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
1535017|NCT01393600|3756285|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
1535018|NCT01393600|3756286|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
1535019|NCT01393600|3756287|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
1535020|NCT01393600|3756288|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
1535021|NCT01393600|3756285|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
1535022|NCT01393600|3756286|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
1535023|NCT01393600|3756287|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
1535024|NCT01393600|3756288|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
1535025|NCT01393600|3756285|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
1535026|NCT01393600|3756286|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
1535027|NCT01393600|3756287|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
1535028|NCT01393600|3756288|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
1535029|NCT01393600|3756285|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
1535030|NCT01393600|3756286|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
1535031|NCT01393600|3756287|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
1535032|NCT01393600|3756288|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
1535033|NCT01393600|3756285|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
1535034|NCT01393600|3756286|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
1535035|NCT01393600|3756287|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
1535036|NCT01393600|3756288|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
1535037|NCT01393457|3756307|P4|NOT COMPLETED|Overall Study||12
1535038|NCT01393457|3756308|P3|NOT COMPLETED|Overall Study||15
1535039|NCT01393457|3756309|P2|NOT COMPLETED|Overall Study||12
1535040|NCT01393457|3756310|P1|NOT COMPLETED|Overall Study||12
1535041|NCT01393457|3756307|P4|COMPLETED|Overall Study||15
1535042|NCT01393457|3756308|P3|COMPLETED|Overall Study||16
1535043|NCT01393457|3756309|P2|COMPLETED|Overall Study||14
1535044|NCT01393457|3756310|P1|COMPLETED|Overall Study||14
1535045|NCT01393457|3756307|P4|STARTED|Overall Study||27
1535046|NCT01393457|3756308|P3|STARTED|Overall Study||31
1535047|NCT01393457|3756309|P2|STARTED|Overall Study||26
1535048|NCT01393457|3756310|P1|STARTED|Overall Study||26
1535049|NCT01393444|3756324|P1|NOT COMPLETED|Overall Study||3
1535050|NCT01393444|3756324|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
1535051|NCT01393444|3756324|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
1535052|NCT01393444|3756324|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
1535053|NCT01393444|3756324|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
1535054|NCT01393444|3756324|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
1535055|NCT01393444|3756324|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
1535056|NCT01393444|3756324|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
1535057|NCT01393444|3756324|P1|STARTED|Overall Study||6
1535058|NCT01393405|3756329|P3|NOT COMPLETED|Maintenance Period Week||24
1535059|NCT01393405|3756330|P2|NOT COMPLETED|Maintenance Period Week||29
1535060|NCT01393405|3756331|P1|NOT COMPLETED|Maintenance Period Week||0
1535061|NCT01393405|3756329|P3|COMPLETED|Maintenance Period Week||16
1535062|NCT01393405|3756330|P2|COMPLETED|Maintenance Period Week||15
1535063|NCT01393405|3756331|P1|COMPLETED|Maintenance Period Week||0
1535064|NCT01393405|3756329|P3|STARTED|Maintenance Period Week||40
1535065|NCT01393405|3756330|P2|STARTED|Maintenance Period Week||44
1535066|NCT01393405|3756331|P1|STARTED|Maintenance Period Week||0
1535067|NCT01393405|3756329|P3|NOT COMPLETED|Induction Period (week1-16)||0
1535068|NCT01393405|3756330|P2|NOT COMPLETED|Induction Period (week1-16)||0
1535069|NCT01393405|3756331|P1|NOT COMPLETED|Induction Period (week1-16)||95
1535070|NCT01393405|3756329|P3|COMPLETED|Induction Period (week1-16)||0
1535071|NCT01393405|3756330|P2|COMPLETED|Induction Period (week1-16)||0
1535072|NCT01393405|3756331|P1|COMPLETED|Induction Period (week1-16)||84
1535073|NCT01393405|3756329|P3|STARTED|Induction Period (week1-16)||0
1535074|NCT01393405|3756330|P2|STARTED|Induction Period (week1-16)||0
1535075|NCT01393405|3756331|P1|STARTED|Induction Period (week1-16)||179
1535076|NCT01393392|3756350|P2|NOT COMPLETED|Overall Study||19
1535077|NCT01393392|3756351|P1|NOT COMPLETED|Overall Study||11
1535078|NCT01393392|3756350|P2|COMPLETED|Overall Study||24
1535079|NCT01393392|3756351|P1|COMPLETED|Overall Study||33
1535080|NCT01393392|3756350|P2|STARTED|Overall Study||43
1535081|NCT01393392|3756351|P1|STARTED|Overall Study||44
1535082|NCT01393132|3756369|P2|NOT COMPLETED|Overall Study||0
1535083|NCT01393132|3756370|P1|NOT COMPLETED|Overall Study||0
1535084|NCT01393132|3756369|P2|COMPLETED|Overall Study||3
1535085|NCT01393132|3756370|P1|COMPLETED|Overall Study||6
1535086|NCT01393132|3756369|P2|STARTED|Overall Study||3
1535087|NCT01393132|3756370|P1|STARTED|Overall Study||6
1535088|NCT01393106|3756382|P1|NOT COMPLETED|Overall Study||5
1535089|NCT01393106|3756382|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
1535090|NCT01393106|3756382|P1|STARTED|Overall Study||25
1535091|NCT01392963|3756401|P2|NOT COMPLETED|Week 24 Follow-up||0
1535092|NCT01392963|3756402|P1|NOT COMPLETED|Week 24 Follow-up||2
1535093|NCT01392963|3756401|P2|COMPLETED|Week 24 Follow-up||17
1535094|NCT01392963|3756402|P1|COMPLETED|Week 24 Follow-up||9
1535095|NCT01392963|3756401|P2|STARTED|Week 24 Follow-up||17
1535096|NCT01392963|3756402|P1|STARTED|Week 24 Follow-up||11
1535097|NCT01392963|3756401|P2|NOT COMPLETED|Week 12 (Second Intervention)||0
1535098|NCT01392963|3756402|P1|NOT COMPLETED|Week 12 (Second Intervention)||0
1535099|NCT01392963|3756401|P2|COMPLETED|Week 12 (Second Intervention)||17
1535100|NCT01392963|3756402|P1|COMPLETED|Week 12 (Second Intervention)||11
1535101|NCT01392963|3756401|P2|STARTED|Week 12 (Second Intervention)||17
1535102|NCT01392963|3756402|P1|STARTED|Week 12 (Second Intervention)||11
1535103|NCT01392963|3756401|P2|NOT COMPLETED|Week 0 (First Intervention)||2
1535104|NCT01392963|3756402|P1|NOT COMPLETED|Week 0 (First Intervention)||0
1535105|NCT01392963|3756401|P2|COMPLETED|Week 0 (First Intervention)||17
1535106|NCT01392963|3756402|P1|COMPLETED|Week 0 (First Intervention)||11
1535107|NCT01392963|3756401|P2|STARTED|Week 0 (First Intervention)||19
1535108|NCT01392963|3756402|P1|STARTED|Week 0 (First Intervention)||11
1535109|NCT01392742|3756410|P1|NOT COMPLETED|Overall Study||201
1535110|NCT01392742|3756410|P1|COMPLETED|Overall Study||242
1535111|NCT01392742|3756410|P1|STARTED|Overall Study||443
1535112|NCT01392703|3756425|P3|NOT COMPLETED|Day 9||0
1535113|NCT01392703|3756426|P2|NOT COMPLETED|Day 9||0
1535114|NCT01392703|3756427|P1|NOT COMPLETED|Day 9||0
1535115|NCT01392703|3756425|P3|COMPLETED|Day 9||25
1535116|NCT01392703|3756426|P2|COMPLETED|Day 9||26
1535117|NCT01392703|3756427|P1|COMPLETED|Day 9||26
1535118|NCT01392703|3756425|P3|STARTED|Day 9||25
1535119|NCT01392703|3756426|P2|STARTED|Day 9||26
1535120|NCT01392703|3756427|P1|STARTED|Day 9||26
1535121|NCT01392703|3756425|P3|NOT COMPLETED|Day 5||0
1535122|NCT01392703|3756426|P2|NOT COMPLETED|Day 5||0
1535123|NCT01392703|3756427|P1|NOT COMPLETED|Day 5||0
1535124|NCT01392703|3756425|P3|COMPLETED|Day 5||26
1535125|NCT01392703|3756426|P2|COMPLETED|Day 5||25
1535126|NCT01392703|3756427|P1|COMPLETED|Day 5||26
1535127|NCT01392703|3756425|P3|STARTED|Day 5||26
1535128|NCT01392703|3756426|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
1535129|NCT01392703|3756427|P1|STARTED|Day 5||26
1535130|NCT01392703|3756425|P3|NOT COMPLETED|Day 1||0
1535131|NCT01392703|3756426|P2|NOT COMPLETED|Day 1||0
1535132|NCT01392703|3756427|P1|NOT COMPLETED|Day 1||0
1535133|NCT01392703|3756425|P3|COMPLETED|Day 1||26
1535134|NCT01392703|3756426|P2|COMPLETED|Day 1||26
1535135|NCT01392703|3756427|P1|COMPLETED|Day 1||26
1535136|NCT01392703|3756425|P3|STARTED|Day 1||26
1535137|NCT01392703|3756426|P2|STARTED|Day 1||26
1535138|NCT01392703|3756427|P1|STARTED|Day 1||26
1535139|NCT01392677|3756456|P2|NOT COMPLETED|Overall Study||8
1535140|NCT01392677|3756457|P1|NOT COMPLETED|Overall Study||8
1535141|NCT01392677|3756456|P2|COMPLETED|Overall Study||101
1535142|NCT01392677|3756457|P1|COMPLETED|Overall Study||101
1535143|NCT01392677|3756456|P2|STARTED|Overall Study||109
1535144|NCT01392677|3756457|P1|STARTED|Overall Study||109
1535145|NCT01392625|3756473|P2|NOT COMPLETED|Overall Study||1
1535146|NCT01392625|3756474|P1|NOT COMPLETED|Overall Study||2
1535147|NCT01392625|3756473|P2|COMPLETED|Overall Study||18
1535148|NCT01392625|3756474|P1|COMPLETED|Overall Study||16
1535149|NCT01392625|3756473|P2|STARTED|Overall Study||19
1535150|NCT01392625|3756474|P1|STARTED|Overall Study||18
1535151|NCT01392573|3756492|P2|NOT COMPLETED|Overall Study||35
1535152|NCT01392573|3756493|P1|NOT COMPLETED|Overall Study||32
1535153|NCT01392573|3756492|P2|COMPLETED|Overall Study||171
1535154|NCT01392573|3756493|P1|COMPLETED|Overall Study||175
1535155|NCT01392573|3756492|P2|Exposed|Overall Study||206
1535156|NCT01392573|3756493|P1|Exposed|Overall Study||207
1535157|NCT01392573|3756492|P2|STARTED|Overall Study||206
1535158|NCT01392573|3756493|P1|STARTED|Overall Study||207
1535159|NCT01392560|3756501|P1|NOT COMPLETED|Overall Study||12
1535160|NCT01392560|3756501|P1|COMPLETED|Overall Study||40
1535161|NCT01392560|3756501|P1|STARTED|Overall Study||52
1535162|NCT01392547|3756507|P1|NOT COMPLETED|Overall Study||8
1535163|NCT01392547|3756507|P1|COMPLETED|Overall Study||64
1535164|NCT01392547|3756507|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
1535165|NCT01392495|3756521|P1|NOT COMPLETED|Overall Study||16
1535166|NCT01392495|3756521|P1|COMPLETED|Overall Study||1
1535167|NCT01392495|3756521|P1|Received 400 mg|Overall Study||13
1535168|NCT01392495|3756521|P1|Received 200 mg|Overall Study||4
1535169|NCT01392495|3756521|P1|STARTED|Overall Study||17
1535170|NCT01392378|3756538|P5|NOT COMPLETED|Toddler Dose||1
1535171|NCT01392378|3756539|P4|NOT COMPLETED|Toddler Dose||2
1535172|NCT01392378|3756540|P3|NOT COMPLETED|Toddler Dose||0
1535173|NCT01392378|3756541|P2|NOT COMPLETED|Toddler Dose||1
1535174|NCT01392378|3756542|P1|NOT COMPLETED|Toddler Dose||0
1535175|NCT01392378|3756538|P5|COMPLETED|Toddler Dose||208
1535176|NCT01392378|3756539|P4|COMPLETED|Toddler Dose||173
1535177|NCT01392378|3756540|P3|COMPLETED|Toddler Dose||170
1535178|NCT01392378|3756541|P2|COMPLETED|Toddler Dose||172
1535179|NCT01392378|3756542|P1|COMPLETED|Toddler Dose||169
1535180|NCT01392378|3756538|P5|STARTED|Toddler Dose||209
1535181|NCT01392378|3756539|P4|STARTED|Toddler Dose||175
1535182|NCT01392378|3756540|P3|STARTED|Toddler Dose||170
1535183|NCT01392378|3756541|P2|STARTED|Toddler Dose||173
1535184|NCT01392378|3756542|P1|STARTED|Toddler Dose||169
1535185|NCT01392378|3756538|P5|NOT COMPLETED|After Infant Series||1
1535186|NCT01392378|3756539|P4|NOT COMPLETED|After Infant Series||0
1535187|NCT01392378|3756540|P3|NOT COMPLETED|After Infant Series||2
1535188|NCT01392378|3756541|P2|NOT COMPLETED|After Infant Series||1
1535189|NCT01392378|3756542|P1|NOT COMPLETED|After Infant Series||0
1535190|NCT01392378|3756538|P5|COMPLETED|After Infant Series||209
1535191|NCT01392378|3756539|P4|COMPLETED|After Infant Series||175
1535192|NCT01392378|3756540|P3|COMPLETED|After Infant Series||170
1535193|NCT01392378|3756541|P2|COMPLETED|After Infant Series||173
1535194|NCT01392378|3756542|P1|COMPLETED|After Infant Series||169
1535195|NCT01392378|3756538|P5|STARTED|After Infant Series||210
1535196|NCT01392378|3756539|P4|STARTED|After Infant Series||175
1535197|NCT01392378|3756540|P3|STARTED|After Infant Series||172
1535198|NCT01392378|3756541|P2|STARTED|After Infant Series||174
1535199|NCT01392378|3756542|P1|STARTED|After Infant Series||169
1535200|NCT01392378|3756538|P5|NOT COMPLETED|Infant Series||0
1535201|NCT01392378|3756539|P4|NOT COMPLETED|Infant Series||2
1535202|NCT01392378|3756540|P3|NOT COMPLETED|Infant Series||0
1535203|NCT01392378|3756541|P2|NOT COMPLETED|Infant Series||2
1535204|NCT01392378|3756542|P1|NOT COMPLETED|Infant Series||4
1535205|NCT01392378|3756538|P5|COMPLETED|Infant Series||210
1535206|NCT01392378|3756539|P4|COMPLETED|Infant Series||175
1535207|NCT01392378|3756540|P3|COMPLETED|Infant Series||172
1535208|NCT01392378|3756541|P2|COMPLETED|Infant Series||174
1535209|NCT01392378|3756542|P1|COMPLETED|Infant Series||169
1535210|NCT01392378|3756538|P5|Vaccinated Dose 3|Infant Series||210
1535211|NCT01392378|3756539|P4|Vaccinated Dose 3|Infant Series||176
1535212|NCT01392378|3756540|P3|Vaccinated Dose 3|Infant Series||172
1535213|NCT01392378|3756541|P2|Vaccinated Dose 3|Infant Series||174
1535214|NCT01392378|3756542|P1|Vaccinated Dose 3|Infant Series||170
1535215|NCT01392378|3756538|P5|Vaccinated Dose 2|Infant Series||210
1535216|NCT01392378|3756539|P4|Vaccinated Dose 2|Infant Series||177
1535217|NCT01392378|3756540|P3|Vaccinated Dose 2|Infant Series||172
1535218|NCT01392378|3756541|P2|Vaccinated Dose 2|Infant Series||174
1535219|NCT01392378|3756542|P1|Vaccinated Dose 2|Infant Series||171
1535220|NCT01392378|3756538|P5|Vaccinated Dose 1|Infant Series||210
1535221|NCT01392378|3756539|P4|Vaccinated Dose 1|Infant Series||177
1535222|NCT01392378|3756540|P3|Vaccinated Dose 1|Infant Series||172
1535223|NCT01392378|3756541|P2|Vaccinated Dose 1|Infant Series||176
1535224|NCT01392378|3756542|P1|Vaccinated Dose 1|Infant Series||173
1535225|NCT01392378|3756538|P5|STARTED|Infant Series||210
1535226|NCT01392378|3756539|P4|STARTED|Infant Series||177
1535227|NCT01392378|3756540|P3|STARTED|Infant Series||172
1535228|NCT01392378|3756541|P2|STARTED|Infant Series||176
1535229|NCT01392378|3756542|P1|STARTED|Infant Series||173
1535230|NCT01392326|3756682|P3|NOT COMPLETED|Overall Study||48
1535231|NCT01392326|3756683|P2|NOT COMPLETED|Overall Study||35
1535232|NCT01392326|3756684|P1|NOT COMPLETED|Overall Study||47
1535233|NCT01392326|3756682|P3|COMPLETED|Overall Study||154
1535234|NCT01392326|3756683|P2|COMPLETED|Overall Study||167
1535235|NCT01392326|3756684|P1|COMPLETED|Overall Study||155
1535236|NCT01392326|3756682|P3|STARTED|Overall Study||202
1535237|NCT01392326|3756683|P2|STARTED|Overall Study||202
1535238|NCT01392326|3756684|P1|STARTED|Overall Study||202
1535239|NCT01392300|3756721|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
1535240|NCT01392300|3756722|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
1535241|NCT01392300|3756723|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
1535242|NCT01392300|3756721|P3|COMPLETED|Open Label Extension (OLEX) Period||248
1535243|NCT01392300|3756722|P2|COMPLETED|Open Label Extension (OLEX) Period||0
1535244|NCT01392300|3756723|P1|COMPLETED|Open Label Extension (OLEX) Period||0
1535245|NCT01392300|3756721|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
1535246|NCT01392300|3756722|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
1535247|NCT01392300|3756723|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
1535248|NCT01392300|3756721|P3|NOT COMPLETED|Main Period (MP)||0
1535249|NCT01392300|3756722|P2|NOT COMPLETED|Main Period (MP)||7
1535250|NCT01392300|3756723|P1|NOT COMPLETED|Main Period (MP)||11
1535251|NCT01392300|3756721|P3|COMPLETED|Main Period (MP)||0
1535252|NCT01392300|3756722|P2|COMPLETED|Main Period (MP)||100
1535253|NCT01392300|3756723|P1|COMPLETED|Main Period (MP)||199
1535254|NCT01392300|3756721|P3|STARTED|Main Period (MP)||0
1535255|NCT01392300|3756722|P2|STARTED|Main Period (MP)||107
1535256|NCT01392300|3756723|P1|STARTED|Main Period (MP)||210
1535257|NCT01392170|3756828|P1|NOT COMPLETED|Overall Study||2
1535258|NCT01392170|3756828|P1|COMPLETED|Overall Study||0
1535259|NCT01392170|3756828|P1|STARTED|Overall Study||2
1535260|NCT01392053|3756834|P2|NOT COMPLETED|Overall Study||0
1535261|NCT01392053|3756835|P1|NOT COMPLETED|Overall Study||0
1535262|NCT01392053|3756834|P2|COMPLETED|Overall Study||23
1535263|NCT01392053|3756835|P1|COMPLETED|Overall Study||23
1535264|NCT01392053|3756834|P2|STARTED|Overall Study||23
1535265|NCT01392053|3756835|P1|STARTED|Overall Study||23
1535266|NCT01391858|3756855|P2|NOT COMPLETED|Overall Study||0
1535267|NCT01391858|3756856|P1|NOT COMPLETED|Overall Study||2
1535268|NCT01391858|3756855|P2|COMPLETED|Overall Study||24
1535269|NCT01391858|3756856|P1|COMPLETED|Overall Study||23
1535270|NCT01391858|3756855|P2|STARTED|Overall Study||24
1535271|NCT01391858|3756856|P1|STARTED|Overall Study||25
1535272|NCT01391819|3756876|P1|NOT COMPLETED|Overall Study||402
1535273|NCT01391819|3756876|P1|COMPLETED|Overall Study||1714
1535274|NCT01391819|3756876|P1|STARTED|Overall Study||2116
1535275|NCT01391663|3756907|P4|NOT COMPLETED|Overall Study||0
1535276|NCT01391663|3756908|P3|NOT COMPLETED|Overall Study||1
1535277|NCT01391663|3756909|P2|NOT COMPLETED|Overall Study||0
1535278|NCT01391663|3756910|P1|NOT COMPLETED|Overall Study||0
1535279|NCT01391663|3756907|P4|COMPLETED|Overall Study||12
1535280|NCT01391663|3756908|P3|COMPLETED|Overall Study||11
1535281|NCT01391663|3756909|P2|COMPLETED|Overall Study||12
1535282|NCT01391663|3756910|P1|COMPLETED|Overall Study||12
1535283|NCT01391663|3756907|P4|STARTED|Overall Study||12
1535284|NCT01391663|3756908|P3|STARTED|Overall Study||12
1535285|NCT01391663|3756909|P2|STARTED|Overall Study||12
1535286|NCT01391663|3756910|P1|STARTED|Overall Study||12
1535287|NCT01391611|3756940|P1|NOT COMPLETED|Overall Study||22
1535288|NCT01391611|3756940|P1|COMPLETED|Overall Study||3
1535289|NCT01391611|3756940|P1|STARTED|Overall Study||25
1535290|NCT01391559|3756945|P2|NOT COMPLETED|Second Intervention||0
1535291|NCT01391559|3756946|P1|NOT COMPLETED|Second Intervention||0
1535292|NCT01391559|3756945|P2|COMPLETED|Second Intervention||10
1535293|NCT01391559|3756946|P1|COMPLETED|Second Intervention||10
1535294|NCT01391559|3756945|P2|STARTED|Second Intervention||10
1535295|NCT01391559|3756946|P1|STARTED|Second Intervention||10
1535296|NCT01391559|3756945|P2|NOT COMPLETED|First Intervention||0
1535297|NCT01391559|3756946|P1|NOT COMPLETED|First Intervention||0
1535298|NCT01391559|3756945|P2|COMPLETED|First Intervention||10
1535299|NCT01391559|3756946|P1|COMPLETED|First Intervention||10
1535300|NCT01391559|3756945|P2|STARTED|First Intervention||10
1535301|NCT01391559|3756946|P1|STARTED|First Intervention||10
1535302|NCT01391546|3756954|P2|NOT COMPLETED|Overall Study||0
1535303|NCT01391546|3756955|P1|NOT COMPLETED|Overall Study||1
1535304|NCT01391546|3756954|P2|COMPLETED|Overall Study||177
1535305|NCT01391546|3756955|P1|COMPLETED|Overall Study||176
1535306|NCT01391546|3756954|P2|Vaccinated|Overall Study||177
1535307|NCT01391546|3756955|P1|Vaccinated|Overall Study||176
1535308|NCT01391546|3756954|P2|STARTED|Overall Study||177
1535309|NCT01391546|3756955|P1|STARTED|Overall Study||177
1535310|NCT01391507|3756977|P4|NOT COMPLETED|Overall Study||7
1535311|NCT01391507|3756978|P3|NOT COMPLETED|Overall Study||4
1535312|NCT01391507|3756979|P2|NOT COMPLETED|Overall Study||4
1535313|NCT01391507|3756980|P1|NOT COMPLETED|Overall Study||4
1535314|NCT01391507|3756977|P4|COMPLETED|Overall Study||5
1535315|NCT01391507|3756978|P3|COMPLETED|Overall Study||2
1535316|NCT01391507|3756979|P2|COMPLETED|Overall Study||4
1535317|NCT01391507|3756980|P1|COMPLETED|Overall Study||6
1535318|NCT01391507|3756977|P4|STARTED|Overall Study||12
1535319|NCT01391507|3756978|P3|STARTED|Overall Study||6
1535320|NCT01391507|3756979|P2|STARTED|Overall Study||8
1535321|NCT01391507|3756980|P1|STARTED|Overall Study||10
1535322|NCT01391468|3757028|P2|NOT COMPLETED|Overall Study||2
1535323|NCT01391468|3757029|P1|NOT COMPLETED|Overall Study||6
1535324|NCT01391468|3757028|P2|COMPLETED|Overall Study||21
1535325|NCT01391468|3757029|P1|COMPLETED|Overall Study||18
1535326|NCT01391468|3757028|P2|STARTED|Overall Study||23
1535327|NCT01391468|3757029|P1|STARTED|Overall Study||24
1535328|NCT01391325|3757041|P1|NOT COMPLETED|Overall Study||494
1535329|NCT01391325|3757041|P1|COMPLETED|Overall Study||1238
1535330|NCT01391325|3757041|P1|STARTED|Overall Study||1732
1535331|NCT01391312|3757050|P2|NOT COMPLETED|Overall Study||1
1535332|NCT01391312|3757051|P1|NOT COMPLETED|Overall Study||2
1535333|NCT01391312|3757050|P2|COMPLETED|Overall Study||19
1535334|NCT01391312|3757051|P1|COMPLETED|Overall Study||18
1535335|NCT01391312|3757050|P2|STARTED|Overall Study||20
1535336|NCT01391312|3757051|P1|STARTED|Overall Study||20
1535337|NCT01391299|3757064|P3|NOT COMPLETED|Overall Study||2
1535338|NCT01391299|3757065|P2|NOT COMPLETED|Overall Study||1
1535339|NCT01391299|3757066|P1|NOT COMPLETED|Overall Study||0
1535340|NCT01391299|3757064|P3|COMPLETED|Overall Study||56
1535341|NCT01391299|3757065|P2|COMPLETED|Overall Study||59
1535342|NCT01391299|3757066|P1|COMPLETED|Overall Study||57
1535343|NCT01391299|3757064|P3|STARTED|Overall Study||58
1535344|NCT01391299|3757065|P2|STARTED|Overall Study||60
1535345|NCT01391299|3757066|P1|STARTED|Overall Study||57
1535346|NCT01391286|3757088|P2|NOT COMPLETED|Overall Study||0
1535347|NCT01391286|3757089|P1|NOT COMPLETED|Overall Study||0
1535348|NCT01391286|3757088|P2|COMPLETED|Overall Study||18
1535349|NCT01391286|3757089|P1|COMPLETED|Overall Study||18
1535350|NCT01391286|3757088|P2|STARTED|Overall Study||18
1535351|NCT01391286|3757089|P1|STARTED|Overall Study||18
1535352|NCT01391273|3757103|P2|NOT COMPLETED|Overall Study||2
1535353|NCT01391273|3757104|P1|NOT COMPLETED|Overall Study||4
1535354|NCT01391273|3757103|P2|COMPLETED|Overall Study||83
1535355|NCT01391273|3757104|P1|COMPLETED|Overall Study||84
1535356|NCT01391273|3757103|P2|STARTED|Overall Study||85
1535357|NCT01391273|3757104|P1|STARTED|Overall Study||88
1535358|NCT01391013|3757118|P2|NOT COMPLETED|Overall Study||0
1535359|NCT01391013|3757119|P1|NOT COMPLETED|Overall Study||0
1535360|NCT01391013|3757118|P2|COMPLETED|Overall Study||15
1535361|NCT01391013|3757119|P1|COMPLETED|Overall Study||15
1535362|NCT01391013|3757118|P2|STARTED|Overall Study||15
1535363|NCT01391013|3757119|P1|STARTED|Overall Study||15
1535364|NCT01391000|3757159|P2|NOT COMPLETED|Overall Study||0
1535365|NCT01391000|3757160|P1|NOT COMPLETED|Overall Study||2
1535366|NCT01391000|3757159|P2|COMPLETED|Overall Study||35
1535367|NCT01391000|3757160|P1|COMPLETED|Overall Study||33
1535368|NCT01391000|3757159|P2|STARTED|Overall Study||35
1535369|NCT01391000|3757160|P1|STARTED|Overall Study||35
1535370|NCT01390948|3757173|P3|NOT COMPLETED|Overall Study||3
1535371|NCT01390948|3757174|P2|NOT COMPLETED|Overall Study||62
1535372|NCT01390948|3757175|P1|NOT COMPLETED|Overall Study||59
1535373|NCT01390948|3757173|P3|COMPLETED|Overall Study||0
1535374|NCT01390948|3757174|P2|COMPLETED|Overall Study||0
1535375|NCT01390948|3757175|P1|COMPLETED|Overall Study||0
1535376|NCT01390948|3757173|P3|Treated|Overall Study||3
1535377|NCT01390948|3757174|P2|Treated|Overall Study||60
1535378|NCT01390948|3757175|P1|Treated|Overall Study||56
1535379|NCT01390948|3757173|P3|STARTED|Overall Study||3
1535380|NCT01390948|3757174|P2|STARTED|Overall Study||62
1535381|NCT01390948|3757175|P1|STARTED|Overall Study||59
1535382|NCT01390909|3757214|P6|NOT COMPLETED|Overall Study||0
1535383|NCT01390909|3757215|P5|NOT COMPLETED|Overall Study||0
1535384|NCT01390909|3757216|P4|NOT COMPLETED|Overall Study||0
1535385|NCT01390909|3757217|P3|NOT COMPLETED|Overall Study||0
1535386|NCT01390909|3757218|P2|NOT COMPLETED|Overall Study||0
1535387|NCT01390909|3757219|P1|NOT COMPLETED|Overall Study||0
1535388|NCT01390909|3757214|P6|COMPLETED|Overall Study||613
1535389|NCT01390909|3757215|P5|COMPLETED|Overall Study||613
1535390|NCT01390909|3757216|P4|COMPLETED|Overall Study||602
1535391|NCT01390909|3757217|P3|COMPLETED|Overall Study||3552
1535392|NCT01390909|3757218|P2|COMPLETED|Overall Study||3552
1535393|NCT01390909|3757219|P1|COMPLETED|Overall Study||3454
1535394|NCT01390909|3757214|P6|Participants in Subgroup|Overall Study||0
1535395|NCT01390909|3757215|P5|Participants in Subgroup|Overall Study||602
1535396|NCT01390909|3757216|P4|Participants in Subgroup|Overall Study||0
1535397|NCT01390909|3757217|P3|Participants in Subgroup|Overall Study||0
1535398|NCT01390909|3757218|P2|Participants in Subgroup|Overall Study||3454
1535399|NCT01390909|3757219|P1|Participants in Subgroup|Overall Study||0
1535400|NCT01390909|3757214|P6|STARTED|Overall Study||613
1535401|NCT01390909|3757215|P5|STARTED|Overall Study||613
1535402|NCT01390909|3757216|P4|STARTED|Overall Study||602
1535403|NCT01390909|3757217|P3|STARTED|Overall Study||3552
1535404|NCT01390909|3757218|P2|STARTED|Overall Study||3552
1535405|NCT01390909|3757219|P1|STARTED|Overall Study||3454
1535406|NCT01390870|3757237|P1|NOT COMPLETED|Overall Study||0
1535407|NCT01390870|3757237|P1|COMPLETED|Overall Study||400
1535408|NCT01390870|3757237|P1|STARTED|Overall Study||400
1535409|NCT01390857|3757241|P1|NOT COMPLETED|Overall Study||10
1535410|NCT01390857|3757241|P1|COMPLETED|Overall Study||369
1535411|NCT01390857|3757241|P1|STARTED|Overall Study||379
1535412|NCT01390844|3757252|P4|NOT COMPLETED|Follow-Up Phase||0
1535413|NCT01390844|3757253|P3|NOT COMPLETED|Follow-Up Phase||1
1535414|NCT01390844|3757254|P2|NOT COMPLETED|Follow-Up Phase||1
1535415|NCT01390844|3757255|P1|NOT COMPLETED|Follow-Up Phase||1
1535416|NCT01390844|3757252|P4|COMPLETED|Follow-Up Phase||8
1535417|NCT01390844|3757253|P3|COMPLETED|Follow-Up Phase||25
1535418|NCT01390844|3757254|P2|COMPLETED|Follow-Up Phase||36
1535419|NCT01390844|3757255|P1|COMPLETED|Follow-Up Phase||92
1535420|NCT01390844|3757252|P4|STARTED|Follow-Up Phase||8
1535421|NCT01390844|3757253|P3|STARTED|Follow-Up Phase||26
1535422|NCT01390844|3757254|P2|STARTED|Follow-Up Phase||37
1535423|NCT01390844|3757255|P1|STARTED|Follow-Up Phase||93
1535424|NCT01390844|3757252|P4|NOT COMPLETED|Treatment Phase||19
1535425|NCT01390844|3757253|P3|NOT COMPLETED|Treatment Phase||31
1535426|NCT01390844|3757254|P2|NOT COMPLETED|Treatment Phase||28
1535427|NCT01390844|3757255|P1|NOT COMPLETED|Treatment Phase||40
1535428|NCT01390844|3757252|P4|COMPLETED|Treatment Phase||8
1535429|NCT01390844|3757253|P3|COMPLETED|Treatment Phase||26
1535430|NCT01390844|3757254|P2|COMPLETED|Treatment Phase||37
1535431|NCT01390844|3757255|P1|COMPLETED|Treatment Phase||93
1535432|NCT01390844|3757252|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
1535433|NCT01390844|3757253|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
1535434|NCT01390844|3757254|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
1535435|NCT01390844|3757255|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
1535436|NCT01390844|3757252|P4|STARTED|Treatment Phase||27
1535437|NCT01390844|3757253|P3|STARTED|Treatment Phase||57
1535438|NCT01390844|3757254|P2|STARTED|Treatment Phase||65
1535439|NCT01390844|3757255|P1|STARTED|Treatment Phase||133
1535440|NCT01390818|3757296|P15|NOT COMPLETED|Overall Study||0
1535441|NCT01390818|3757297|P14|NOT COMPLETED|Overall Study||0
1535442|NCT01390818|3757298|P13|NOT COMPLETED|Overall Study||0
1535443|NCT01390818|3757299|P12|NOT COMPLETED|Overall Study||0
1535444|NCT01390818|3757300|P11|NOT COMPLETED|Overall Study||0
1535445|NCT01390818|3757301|P10|NOT COMPLETED|Overall Study||0
1535446|NCT01390818|3757302|P9|NOT COMPLETED|Overall Study||0
1535447|NCT01390818|3757303|P8|NOT COMPLETED|Overall Study||0
1535448|NCT01390818|3757304|P7|NOT COMPLETED|Overall Study||0
1535449|NCT01390818|3757305|P6|NOT COMPLETED|Overall Study||0
1535450|NCT01390818|3757306|P5|NOT COMPLETED|Overall Study||0
1535451|NCT01390818|3757307|P4|NOT COMPLETED|Overall Study||0
1535452|NCT01390818|3757308|P3|NOT COMPLETED|Overall Study||0
1535453|NCT01390818|3757309|P2|NOT COMPLETED|Overall Study||0
1535454|NCT01390818|3757310|P1|NOT COMPLETED|Overall Study||0
1535455|NCT01390818|3757296|P15|COMPLETED|Overall Study||15
1535456|NCT01390818|3757297|P14|COMPLETED|Overall Study||18
1535457|NCT01390818|3757298|P13|COMPLETED|Overall Study||24
1535458|NCT01390818|3757299|P12|COMPLETED|Overall Study||26
1535459|NCT01390818|3757300|P11|COMPLETED|Overall Study||4
1535460|NCT01390818|3757301|P10|COMPLETED|Overall Study||3
1535461|NCT01390818|3757302|P9|COMPLETED|Overall Study||3
1535462|NCT01390818|3757303|P8|COMPLETED|Overall Study||14
1535463|NCT01390818|3757304|P7|COMPLETED|Overall Study||19
1535464|NCT01390818|3757305|P6|COMPLETED|Overall Study||3
1535465|NCT01390818|3757306|P5|COMPLETED|Overall Study||4
1535466|NCT01390818|3757307|P4|COMPLETED|Overall Study||4
1535467|NCT01390818|3757308|P3|COMPLETED|Overall Study||3
1535468|NCT01390818|3757309|P2|COMPLETED|Overall Study||3
1535469|NCT01390818|3757310|P1|COMPLETED|Overall Study||3
1535470|NCT01390818|3757296|P15|STARTED|Overall Study||15
1535471|NCT01390818|3757297|P14|STARTED|Overall Study||18
1535472|NCT01390818|3757298|P13|STARTED|Overall Study||24
1535473|NCT01390818|3757299|P12|STARTED|Overall Study||26
1535474|NCT01390818|3757300|P11|STARTED|Overall Study||4
1535475|NCT01390818|3757301|P10|STARTED|Overall Study||3
1535476|NCT01390818|3757302|P9|STARTED|Overall Study||3
1535477|NCT01390818|3757303|P8|STARTED|Overall Study||14
1535478|NCT01390818|3757304|P7|STARTED|Overall Study||19
1535479|NCT01390818|3757305|P6|STARTED|Overall Study||3
1535480|NCT01390818|3757306|P5|STARTED|Overall Study||4
1535481|NCT01390818|3757307|P4|STARTED|Overall Study||4
1535482|NCT01390818|3757308|P3|STARTED|Overall Study||3
1535483|NCT01390818|3757309|P2|STARTED|Overall Study||3
1535484|NCT01390818|3757310|P1|STARTED|Overall Study||3
1535485|NCT01390779|3757582|P1|NOT COMPLETED|Overall Study||1
1535486|NCT01390779|3757582|P1|COMPLETED|Overall Study||32
1535487|NCT01390779|3757582|P1|STARTED|Overall Study||33
1535488|NCT01390649|3757587|P1|NOT COMPLETED|Overall Study||1
1535489|NCT01390649|3757587|P1|COMPLETED|Overall Study||56
1535490|NCT01390649|3757587|P1|STARTED|Overall Study|Subjects treated with Privigen|57
1535491|NCT01390441|3757597|P5|NOT COMPLETED|Extension Period||0
1535492|NCT01390441|3757598|P4|NOT COMPLETED|Extension Period||1
1535493|NCT01390441|3757599|P3|NOT COMPLETED|Extension Period||0
1535494|NCT01390441|3757600|P2|NOT COMPLETED|Extension Period||1
1535495|NCT01390441|3757601|P1|NOT COMPLETED|Extension Period||3
1535496|NCT01390441|3757597|P5|COMPLETED|Extension Period||3
1535497|NCT01390441|3757598|P4|COMPLETED|Extension Period||0
1535498|NCT01390441|3757599|P3|COMPLETED|Extension Period||1
1535499|NCT01390441|3757600|P2|COMPLETED|Extension Period||12
1535500|NCT01390441|3757601|P1|COMPLETED|Extension Period||12
1535501|NCT01390441|3757597|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
1535502|NCT01390441|3757598|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
1535503|NCT01390441|3757599|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
1535504|NCT01390441|3757600|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
1535505|NCT01390441|3757601|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
1535506|NCT01390441|3757597|P5|NOT COMPLETED|Treatment Period||11
1535507|NCT01390441|3757598|P4|NOT COMPLETED|Treatment Period||13
1535508|NCT01390441|3757599|P3|NOT COMPLETED|Treatment Period||10
1535509|NCT01390441|3757600|P2|NOT COMPLETED|Treatment Period||1
1535510|NCT01390441|3757601|P1|NOT COMPLETED|Treatment Period||1
1535511|NCT01390441|3757597|P5|COMPLETED|Treatment Period||7
1535512|NCT01390441|3757598|P4|COMPLETED|Treatment Period||6
1535513|NCT01390441|3757599|P3|COMPLETED|Treatment Period||8
1535514|NCT01390441|3757600|P2|COMPLETED|Treatment Period||21
1535515|NCT01390441|3757601|P1|COMPLETED|Treatment Period||22
1535516|NCT01390441|3757597|P5|STARTED|Treatment Period||18
1535517|NCT01390441|3757598|P4|STARTED|Treatment Period||19
1535518|NCT01390441|3757599|P3|STARTED|Treatment Period||18
1535519|NCT01390441|3757600|P2|STARTED|Treatment Period||22
1535520|NCT01390441|3757601|P1|STARTED|Treatment Period||23
1535521|NCT01390428|3757666|P6|NOT COMPLETED|Overall Study||0
1535522|NCT01390428|3757667|P5|NOT COMPLETED|Overall Study||1
1535523|NCT01390428|3757668|P4|NOT COMPLETED|Overall Study||0
1535524|NCT01390428|3757669|P3|NOT COMPLETED|Overall Study||1
1535525|NCT01390428|3757670|P2|NOT COMPLETED|Overall Study||0
1535526|NCT01390428|3757671|P1|NOT COMPLETED|Overall Study||0
1535527|NCT01390428|3757666|P6|COMPLETED|Overall Study||8
1535528|NCT01390428|3757667|P5|COMPLETED|Overall Study||7
1535529|NCT01390428|3757668|P4|COMPLETED|Overall Study||9
1535530|NCT01390428|3757669|P3|COMPLETED|Overall Study||8
1535531|NCT01390428|3757670|P2|COMPLETED|Overall Study||8
1535532|NCT01390428|3757671|P1|COMPLETED|Overall Study||8
1535533|NCT01390428|3757666|P6|STARTED|Overall Study||8
1535534|NCT01390428|3757667|P5|STARTED|Overall Study||8
1535535|NCT01390428|3757668|P4|STARTED|Overall Study||9
1535536|NCT01390428|3757669|P3|STARTED|Overall Study||9
1535537|NCT01390428|3757670|P2|STARTED|Overall Study||8
1535538|NCT01390428|3757671|P1|STARTED|Overall Study||8
1535539|NCT01390415|3757723|P2|NOT COMPLETED|Overall Study||0
1535540|NCT01390415|3757724|P1|NOT COMPLETED|Overall Study||0
1535541|NCT01390415|3757723|P2|COMPLETED|Overall Study||37
1535542|NCT01390415|3757724|P1|COMPLETED|Overall Study||99
1535543|NCT01390415|3757723|P2|STARTED|Overall Study||37
1535544|NCT01390415|3757724|P1|STARTED|Overall Study||99
1535545|NCT01390402|3757734|P1|NOT COMPLETED|Overall Study||5
1535546|NCT01390402|3757734|P1|COMPLETED|Overall Study||1
1535547|NCT01390402|3757734|P1|STARTED|Overall Study||6
1535548|NCT01390389|3757740|P2|NOT COMPLETED|Overall Study||1
1535549|NCT01390389|3757741|P1|NOT COMPLETED|Overall Study||4
1535550|NCT01390389|3757740|P2|COMPLETED|Overall Study||8
1535551|NCT01390389|3757741|P1|COMPLETED|Overall Study||6
1535552|NCT01390389|3757740|P2|STARTED|Overall Study||9
1535553|NCT01390389|3757741|P1|STARTED|Overall Study||10
1535554|NCT01390259|3757751|P2|NOT COMPLETED|Overall Study||0
1535555|NCT01390259|3757752|P1|NOT COMPLETED|Overall Study||0
1535556|NCT01390259|3757751|P2|COMPLETED|Overall Study||6
1535557|NCT01390259|3757752|P1|COMPLETED|Overall Study||5
1535558|NCT01390259|3757751|P2|STARTED|Overall Study||6
1535559|NCT01390259|3757752|P1|STARTED|Overall Study||5
1535560|NCT01390246|3757763|P2|NOT COMPLETED|Overall Study||25
1535561|NCT01390246|3757764|P1|NOT COMPLETED|Overall Study||20
1535562|NCT01390246|3757763|P2|COMPLETED|Overall Study||10
1535563|NCT01390246|3757764|P1|COMPLETED|Overall Study||10
1535564|NCT01390246|3757763|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
1535565|NCT01390246|3757764|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
1535566|NCT01390246|3757763|P2|Visit 6: End of Treatment|Overall Study||15
1535567|NCT01390246|3757764|P1|Visit 6: End of Treatment|Overall Study||15
1535568|NCT01390246|3757763|P2|Visit 2: Quit Day|Overall Study||24
1535569|NCT01390246|3757764|P1|Visit 2: Quit Day|Overall Study||24
1535570|NCT01390246|3757763|P2|STARTED|Overall Study||35
1535571|NCT01390246|3757764|P1|STARTED|Overall Study||30
1535572|NCT01390233|3757779|P3|NOT COMPLETED|Overall Study||6
1535573|NCT01390233|3757780|P2|NOT COMPLETED|Overall Study||2
1535574|NCT01390233|3757781|P1|NOT COMPLETED|Overall Study||5
1535575|NCT01390233|3757779|P3|COMPLETED|Overall Study||30
1535576|NCT01390233|3757780|P2|COMPLETED|Overall Study||29
1535577|NCT01390233|3757781|P1|COMPLETED|Overall Study||30
1535578|NCT01390233|3757779|P3|STARTED|Overall Study||36
1535579|NCT01390233|3757780|P2|STARTED|Overall Study||31
1535580|NCT01390233|3757781|P1|STARTED|Overall Study||35
1535581|NCT01390181|3757789|P1|NOT COMPLETED|Overall Study||4
1535582|NCT01390181|3757789|P1|COMPLETED|Overall Study||0
1535583|NCT01390181|3757789|P1|STARTED|Overall Study||4
1535584|NCT01390038|3757793|P1|NOT COMPLETED|Overall Study||8
1535585|NCT01390038|3757793|P1|COMPLETED|Overall Study||149
1535586|NCT01390038|3757793|P1|STARTED|Overall Study||157
1535587|NCT01389973|3757803|P1|NOT COMPLETED|Overall Study||20
1535588|NCT01389973|3757803|P1|COMPLETED|Overall Study||0
1535589|NCT01389973|3757803|P1|STARTED|Overall Study||20
1535590|NCT01389882|3757813|P2|NOT COMPLETED|Overall Study||4
1535591|NCT01389882|3757814|P1|NOT COMPLETED|Overall Study||1
1535592|NCT01389882|3757813|P2|COMPLETED|Overall Study||7
1535593|NCT01389882|3757814|P1|COMPLETED|Overall Study||12
1535594|NCT01389882|3757813|P2|STARTED|Overall Study||11
1535595|NCT01389882|3757814|P1|STARTED|Overall Study||13
1535596|NCT01389856|3757844|P2|NOT COMPLETED|Overall Study||0
1535597|NCT01389856|3757845|P1|NOT COMPLETED|Overall Study||0
1535598|NCT01389856|3757844|P2|COMPLETED|Overall Study||8
1535599|NCT01389856|3757845|P1|COMPLETED|Overall Study||13
1535600|NCT01389856|3757844|P2|STARTED|Overall Study|Randomized and treated.|8
1535601|NCT01389856|3757845|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
1535602|NCT01389817|3757902|P2|NOT COMPLETED|Overall Study||0
1535603|NCT01389817|3757903|P1|NOT COMPLETED|Overall Study||4
1535604|NCT01389817|3757902|P2|COMPLETED|Overall Study||0
1535605|NCT01389817|3757903|P1|COMPLETED|Overall Study||0
1535606|NCT01389817|3757902|P2|STARTED|Overall Study||0
1535607|NCT01389817|3757903|P1|STARTED|Overall Study||4
1535608|NCT01389765|3757909|P2|NOT COMPLETED|Second Intervention (Day 1)||0
1535609|NCT01389765|3757910|P1|NOT COMPLETED|Second Intervention (Day 1)||0
1535610|NCT01389765|3757909|P2|COMPLETED|Second Intervention (Day 1)||12
1535611|NCT01389765|3757910|P1|COMPLETED|Second Intervention (Day 1)||12
1535612|NCT01389765|3757909|P2|STARTED|Second Intervention (Day 1)||12
1535613|NCT01389765|3757910|P1|STARTED|Second Intervention (Day 1)||12
1535614|NCT01389765|3757909|P2|NOT COMPLETED|Washout Period (7 Days)||0
1535615|NCT01389765|3757910|P1|NOT COMPLETED|Washout Period (7 Days)||0
1535616|NCT01389765|3757909|P2|COMPLETED|Washout Period (7 Days)||12
1535617|NCT01389765|3757910|P1|COMPLETED|Washout Period (7 Days)||12
1535618|NCT01389765|3757909|P2|STARTED|Washout Period (7 Days)||12
1535619|NCT01389765|3757910|P1|STARTED|Washout Period (7 Days)||12
1535620|NCT01389765|3757909|P2|NOT COMPLETED|First Intervention (Day 1)||0
1535621|NCT01389765|3757910|P1|NOT COMPLETED|First Intervention (Day 1)||0
1535622|NCT01389765|3757909|P2|COMPLETED|First Intervention (Day 1)||12
1535623|NCT01389765|3757910|P1|COMPLETED|First Intervention (Day 1)||12
1535624|NCT01389765|3757909|P2|STARTED|First Intervention (Day 1)||12
1535625|NCT01389765|3757910|P1|STARTED|First Intervention (Day 1)||12
1535626|NCT01389752|3757920|P2|NOT COMPLETED|Study Period 2||0
1535627|NCT01389752|3757921|P1|NOT COMPLETED|Study Period 2||1
1535628|NCT01389752|3757920|P2|COMPLETED|Study Period 2||9
1535629|NCT01389752|3757921|P1|COMPLETED|Study Period 2||10
1535630|NCT01389752|3757920|P2|STARTED|Study Period 2||9
1535631|NCT01389752|3757921|P1|STARTED|Study Period 2||11
1535632|NCT01389752|3757920|P2|NOT COMPLETED|Study Period 1||2
1535633|NCT01389752|3757921|P1|NOT COMPLETED|Study Period 1||0
1535634|NCT01389752|3757920|P2|COMPLETED|Study Period 1||9
1535635|NCT01389752|3757921|P1|COMPLETED|Study Period 1||11
1535636|NCT01389752|3757920|P2|STARTED|Study Period 1||11
1535637|NCT01389752|3757921|P1|STARTED|Study Period 1||11
1535638|NCT01389596|3757934|P3|NOT COMPLETED|Overall Study||10
1535639|NCT01389596|3757935|P2|NOT COMPLETED|Overall Study||16
1535640|NCT01389596|3757936|P1|NOT COMPLETED|Overall Study||10
1535641|NCT01389596|3757934|P3|COMPLETED|Overall Study||84
1535642|NCT01389596|3757935|P2|COMPLETED|Overall Study||81
1535643|NCT01389596|3757936|P1|COMPLETED|Overall Study||94
1535644|NCT01389596|3757934|P3|STARTED|Overall Study||94
1535645|NCT01389596|3757935|P2|STARTED|Overall Study||97
1535646|NCT01389596|3757936|P1|STARTED|Overall Study||104
1535647|NCT01389323|3757995|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
1535648|NCT01389323|3757995|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
1535649|NCT01389323|3757995|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
1535650|NCT01389323|3757995|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
1535651|NCT01389323|3757995|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
1535652|NCT01389323|3757995|P1|STARTED|Treatment Period (up to 48 Weeks)||246
1535653|NCT01389284|3758018|P3|NOT COMPLETED|Overall Study||0
1535654|NCT01389284|3758019|P2|NOT COMPLETED|Overall Study||0
1535655|NCT01389284|3758020|P1|NOT COMPLETED|Overall Study||0
1535656|NCT01389284|3758018|P3|COMPLETED|Overall Study||60
1535657|NCT01389284|3758019|P2|COMPLETED|Overall Study||120
1535658|NCT01389284|3758020|P1|COMPLETED|Overall Study||120
1535659|NCT01389284|3758018|P3|STARTED|Overall Study||60
1535660|NCT01389284|3758019|P2|STARTED|Overall Study||120
1535661|NCT01389284|3758020|P1|STARTED|Overall Study||120
1535662|NCT01389102|3758058|P6|NOT COMPLETED|Overall Study||8
1535663|NCT01389102|3758059|P5|NOT COMPLETED|Overall Study||13
1535664|NCT01389102|3758060|P4|NOT COMPLETED|Overall Study||7
1535665|NCT01389102|3758061|P3|NOT COMPLETED|Overall Study||19
1535666|NCT01389102|3758062|P2|NOT COMPLETED|Overall Study||12
1535667|NCT01389102|3758063|P1|NOT COMPLETED|Overall Study||18
1535668|NCT01389102|3758058|P6|COMPLETED|Overall Study||68
1535669|NCT01389102|3758059|P5|COMPLETED|Overall Study||61
1535670|NCT01389102|3758060|P4|COMPLETED|Overall Study||69
1535671|NCT01389102|3758061|P3|COMPLETED|Overall Study||58
1535672|NCT01389102|3758062|P2|COMPLETED|Overall Study||64
1535673|NCT01389102|3758063|P1|COMPLETED|Overall Study||57
1535674|NCT01389102|3758058|P6|STARTED|Overall Study||76
1535675|NCT01389102|3758059|P5|STARTED|Overall Study||74
1535676|NCT01389102|3758060|P4|STARTED|Overall Study||76
1535677|NCT01389102|3758061|P3|STARTED|Overall Study||77
1535678|NCT01389102|3758062|P2|STARTED|Overall Study||76
1535679|NCT01389102|3758063|P1|STARTED|Overall Study||75
1535680|NCT01389076|3758083|P1|NOT COMPLETED|Overall Study||0
1535681|NCT01389076|3758083|P1|COMPLETED|Overall Study||22
1535682|NCT01389076|3758083|P1|STARTED|Overall Study||22
1535683|NCT01388946|3758093|P2|NOT COMPLETED|Overall Study||3
1535684|NCT01388946|3758094|P1|NOT COMPLETED|Overall Study||6
1535685|NCT01388946|3758093|P2|COMPLETED|Overall Study||52
1535686|NCT01388946|3758094|P1|COMPLETED|Overall Study||49
1535687|NCT01388946|3758093|P2|STARTED|Overall Study||55
1535688|NCT01388946|3758094|P1|STARTED|Overall Study||55
1535689|NCT01388920|3758129|P3|NOT COMPLETED|Overall Study||0
1535690|NCT01388920|3758130|P2|NOT COMPLETED|Overall Study||0
1535691|NCT01388920|3758131|P1|NOT COMPLETED|Overall Study||0
1535692|NCT01388920|3758129|P3|COMPLETED|Overall Study||0
1535693|NCT01388920|3758130|P2|COMPLETED|Overall Study||1
1535694|NCT01388920|3758131|P1|COMPLETED|Overall Study||1
1535695|NCT01388920|3758129|P3|STARTED|Overall Study||0
1535696|NCT01388920|3758130|P2|STARTED|Overall Study||1
1535697|NCT01388920|3758131|P1|STARTED|Overall Study||1
1535698|NCT01388907|3758141|P2|NOT COMPLETED|Overall Study||0
1535699|NCT01388907|3758142|P1|NOT COMPLETED|Overall Study||2
1535700|NCT01388907|3758141|P2|COMPLETED|Overall Study||28
1535701|NCT01388907|3758142|P1|COMPLETED|Overall Study||31
1535702|NCT01388907|3758141|P2|STARTED|Overall Study||28
1535703|NCT01388907|3758142|P1|STARTED|Overall Study||33
1535704|NCT01388816|3758158|P4|NOT COMPLETED|Overall Study||0
1535705|NCT01388816|3758159|P3|NOT COMPLETED|Overall Study||3
1535706|NCT01388816|3758160|P2|NOT COMPLETED|Overall Study||4
1535707|NCT01388816|3758161|P1|NOT COMPLETED|Overall Study||2
1535708|NCT01388816|3758158|P4|COMPLETED|Overall Study||44
1535709|NCT01388816|3758159|P3|COMPLETED|Overall Study||41
1535710|NCT01388816|3758160|P2|COMPLETED|Overall Study||39
1535711|NCT01388816|3758161|P1|COMPLETED|Overall Study||43
1535712|NCT01388816|3758158|P4|STARTED|Overall Study||44
1535713|NCT01388816|3758159|P3|STARTED|Overall Study||44
1535714|NCT01388816|3758160|P2|STARTED|Overall Study||43
1535715|NCT01388816|3758161|P1|STARTED|Overall Study||45
1535716|NCT01388790|3758190|P1|NOT COMPLETED|Overall Study||8
1535717|NCT01388790|3758190|P1|COMPLETED|Overall Study||32
1535718|NCT01388790|3758190|P1|STARTED|Overall Study||40
1535719|NCT01388777|3758195|P1|NOT COMPLETED|Overall Study||0
1535720|NCT01388777|3758195|P1|COMPLETED|Overall Study||1
1535721|NCT01388777|3758195|P1|Cryoablation|Overall Study||1
1535722|NCT01388777|3758195|P1|STARTED|Overall Study||1
1535723|NCT01388647|3758201|P2|NOT COMPLETED|Overall Study||2
1535724|NCT01388647|3758202|P1|NOT COMPLETED|Overall Study||1
1535725|NCT01388647|3758201|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
1535726|NCT01388647|3758202|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
1535727|NCT01388647|3758201|P2|STARTED|Overall Study||6
1535728|NCT01388647|3758202|P1|STARTED|Overall Study||6
1535729|NCT01388530|3758213|P1|NOT COMPLETED|Overall Study||5
1535730|NCT01388530|3758213|P1|COMPLETED|Overall Study||20
1535731|NCT01388530|3758213|P1|STARTED|Overall Study||25
1535732|NCT01388491|3758222|P2|NOT COMPLETED|Overall Study||29
1535733|NCT01388491|3758223|P1|NOT COMPLETED|Overall Study||34
1535734|NCT01388491|3758222|P2|COMPLETED|Overall Study||114
1535735|NCT01388491|3758223|P1|COMPLETED|Overall Study||116
1535736|NCT01388491|3758222|P2|Per Protocol (PP) Population|Overall Study||121
1535737|NCT01388491|3758223|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
1535738|NCT01388491|3758222|P2|Intent-to-Treat (ITT) Population|Overall Study||136
1535739|NCT01388491|3758223|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
1535740|NCT01388491|3758222|P2|Safety Population|Overall Study||142
1535741|NCT01388491|3758223|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
1535742|NCT01388491|3758222|P2|STARTED|Overall Study||143
1535743|NCT01388491|3758223|P1|STARTED|Overall Study|number randomized|150
1535744|NCT01388361|3758258|P3|NOT COMPLETED|Overall Study||14
1535745|NCT01388361|3758259|P2|NOT COMPLETED|Overall Study||12
1535746|NCT01388361|3758260|P1|NOT COMPLETED|Overall Study||12
1535747|NCT01388361|3758258|P3|COMPLETED|Overall Study||75
1535748|NCT01388361|3758259|P2|COMPLETED|Overall Study||76
1535749|NCT01388361|3758260|P1|COMPLETED|Overall Study||224
1535750|NCT01388361|3758258|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
1535751|NCT01388361|3758259|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
1535752|NCT01388361|3758260|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
1535753|NCT01388361|3758258|P3|STARTED|Overall Study||89
1535754|NCT01388361|3758259|P2|STARTED|Overall Study||88
1535755|NCT01388361|3758260|P1|STARTED|Overall Study||236
1535756|NCT01388166|3758277|P1|NOT COMPLETED|Overall Study||59
1535757|NCT01388166|3758277|P1|COMPLETED|Overall Study||1194
1535758|NCT01388166|3758277|P1|STARTED|Overall Study||1253
1535759|NCT01387789|3758283|P1|NOT COMPLETED|Overall Study||8
1535760|NCT01387789|3758283|P1|COMPLETED|Overall Study||63
1535761|NCT01387789|3758283|P1|STARTED|Overall Study||71
1535762|NCT01387737|3758297|P2|NOT COMPLETED|Overall Study||74
1535763|NCT01387737|3758298|P1|NOT COMPLETED|Overall Study||52
1535764|NCT01387737|3758297|P2|COMPLETED|Overall Study||641
1535765|NCT01387737|3758298|P1|COMPLETED|Overall Study||532
1535766|NCT01387737|3758297|P2|STARTED|Overall Study||715
1535767|NCT01387737|3758298|P1|STARTED|Overall Study||584
1535768|NCT01387672|3758310|P6|NOT COMPLETED|Overall Study||0
1535769|NCT01387672|3758311|P5|NOT COMPLETED|Overall Study||4
1535770|NCT01387672|3758312|P4|NOT COMPLETED|Overall Study||4
1535771|NCT01387672|3758313|P3|NOT COMPLETED|Overall Study||5
1535772|NCT01387672|3758314|P2|NOT COMPLETED|Overall Study||7
1535773|NCT01387672|3758315|P1|NOT COMPLETED|Overall Study||7
1535774|NCT01387672|3758310|P6|COMPLETED|Overall Study||37
1535775|NCT01387672|3758311|P5|COMPLETED|Overall Study||34
1535776|NCT01387672|3758312|P4|COMPLETED|Overall Study||35
1535777|NCT01387672|3758313|P3|COMPLETED|Overall Study||33
1535778|NCT01387672|3758314|P2|COMPLETED|Overall Study||31
1535779|NCT01387672|3758315|P1|COMPLETED|Overall Study||32
1535780|NCT01387672|3758310|P6|STARTED|Overall Study||37
1535781|NCT01387672|3758311|P5|STARTED|Overall Study||38
1535782|NCT01387672|3758312|P4|STARTED|Overall Study||39
1535783|NCT01387672|3758313|P3|STARTED|Overall Study||38
1535784|NCT01387672|3758314|P2|STARTED|Overall Study||38
1535785|NCT01387672|3758315|P1|STARTED|Overall Study||39
1535786|NCT01387607|3758332|P2|NOT COMPLETED|Overall Study||45
1535787|NCT01387607|3758333|P1|NOT COMPLETED|Overall Study||51
1535788|NCT01387607|3758332|P2|COMPLETED|Overall Study||125
1535789|NCT01387607|3758333|P1|COMPLETED|Overall Study||122
1535790|NCT01387607|3758332|P2|Received Treatment|Overall Study||164
1535791|NCT01387607|3758333|P1|Received Treatment|Overall Study||170
1535792|NCT01387607|3758332|P2|STARTED|Overall Study||170
1535793|NCT01387607|3758333|P1|STARTED|Overall Study||173
1535794|NCT01387594|3758387|P2|NOT COMPLETED|Overall Study||3
1535795|NCT01387594|3758388|P1|NOT COMPLETED|Overall Study||0
1535796|NCT01387594|3758387|P2|COMPLETED|Overall Study||36
1535797|NCT01387594|3758388|P1|COMPLETED|Overall Study||10
1535798|NCT01387594|3758387|P2|STARTED|Overall Study||39
1535799|NCT01387594|3758388|P1|STARTED|Overall Study||10
1535800|NCT01387581|3758403|P3|NOT COMPLETED|Overall Study||3
1535801|NCT01387581|3758404|P2|NOT COMPLETED|Overall Study||6
1535802|NCT01387581|3758405|P1|NOT COMPLETED|Overall Study||7
1535803|NCT01387581|3758403|P3|COMPLETED|Overall Study||9
1535804|NCT01387581|3758404|P2|COMPLETED|Overall Study||101
1535805|NCT01387581|3758405|P1|COMPLETED|Overall Study||101
1535806|NCT01387581|3758403|P3|STARTED|Overall Study||12
1535807|NCT01387581|3758404|P2|STARTED|Overall Study||107
1535808|NCT01387581|3758405|P1|STARTED|Overall Study||108
1535809|NCT01387542|3758416|P1|NOT COMPLETED|Overall Study||8
1535810|NCT01387542|3758416|P1|COMPLETED|Overall Study||32
1535811|NCT01387542|3758416|P1|Treated|Overall Study||38
1535812|NCT01387542|3758416|P1|STARTED|Overall Study||40
1535813|NCT01387464|3758425|P2|NOT COMPLETED|Overall Study||1
1535814|NCT01387464|3758426|P1|NOT COMPLETED|Overall Study||1
1535815|NCT01387464|3758425|P2|COMPLETED|Overall Study||29
1535816|NCT01387464|3758426|P1|COMPLETED|Overall Study||29
1535817|NCT01387464|3758425|P2|Per-Protocol Population|Overall Study||29
1535818|NCT01387464|3758426|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
1535819|NCT01387464|3758425|P2|Safety Population|Overall Study||29
1535820|NCT01387464|3758426|P1|Safety Population|Overall Study||30
1535821|NCT01387464|3758425|P2|STARTED|Overall Study||30
1535822|NCT01387464|3758426|P1|STARTED|Overall Study||30
1535823|NCT01387347|3758434|P2|NOT COMPLETED|Overall Study||1
1535824|NCT01387347|3758435|P1|NOT COMPLETED|Overall Study||2
1535825|NCT01387347|3758434|P2|COMPLETED|Overall Study||35
1535826|NCT01387347|3758435|P1|COMPLETED|Overall Study||34
1535827|NCT01387347|3758434|P2|STARTED|Overall Study||36
1535828|NCT01387347|3758435|P1|STARTED|Overall Study||36
1535829|NCT01387282|3758447|P2|NOT COMPLETED|Overall Study||47
1535830|NCT01387282|3758448|P1|NOT COMPLETED|Overall Study||97
1535831|NCT01387282|3758447|P2|COMPLETED|Overall Study||118
1535832|NCT01387282|3758448|P1|COMPLETED|Overall Study||233
1535833|NCT01387282|3758447|P2|Safety Population|Overall Study||161
1535834|NCT01387282|3758448|P1|Safety Population|Overall Study||330
1535835|NCT01387282|3758447|P2|MITT Population|Overall Study||136
1535836|NCT01387282|3758448|P1|MITT Population|Overall Study||268
1535837|NCT01387282|3758447|P2|ITT Population|Overall Study||165
1535838|NCT01387282|3758448|P1|ITT Population|Overall Study||330
1535839|NCT01387282|3758447|P2|STARTED|Overall Study||165
1535840|NCT01387282|3758448|P1|STARTED|Overall Study||330
1535841|NCT01387269|3758464|P2|NOT COMPLETED|Overall Study||40
1535842|NCT01387269|3758465|P1|NOT COMPLETED|Overall Study||92
1535843|NCT01387269|3758464|P2|COMPLETED|Overall Study||121
1535844|NCT01387269|3758465|P1|COMPLETED|Overall Study||231
1535845|NCT01387269|3758464|P2|Safety Population|Overall Study||161
1535846|NCT01387269|3758465|P1|Safety Population|Overall Study||320
1535847|NCT01387269|3758464|P2|MITT Population|Overall Study||141
1535848|NCT01387269|3758465|P1|MITT Population|Overall Study||284
1535849|NCT01387269|3758464|P2|ITT Population|Overall Study||161
1535850|NCT01387269|3758465|P1|ITT Population|Overall Study||323
1535851|NCT01387269|3758464|P2|STARTED|Overall Study||161
1535852|NCT01387269|3758465|P1|STARTED|Overall Study||323
1535853|NCT01387230|3758482|P3|NOT COMPLETED|Overall Study||13
1535854|NCT01387230|3758483|P2|NOT COMPLETED|Overall Study||7
1535855|NCT01387230|3758484|P1|NOT COMPLETED|Overall Study||18
1535856|NCT01387230|3758482|P3|COMPLETED|Overall Study||56
1535857|NCT01387230|3758483|P2|COMPLETED|Overall Study||62
1535858|NCT01387230|3758484|P1|COMPLETED|Overall Study||50
1535859|NCT01387230|3758482|P3|STARTED|Overall Study||69
1535860|NCT01387230|3758483|P2|STARTED|Overall Study||69
1535861|NCT01387230|3758484|P1|STARTED|Overall Study||68
1535862|NCT01387178|3758500|P2|NOT COMPLETED|Overall Study||0
1535863|NCT01387178|3758501|P1|NOT COMPLETED|Overall Study||0
1535864|NCT01387178|3758500|P2|COMPLETED|Overall Study||10641
1535865|NCT01387178|3758501|P1|COMPLETED|Overall Study||11582
1535866|NCT01387178|3758500|P2|STARTED|Overall Study||10641
1535867|NCT01387178|3758501|P1|STARTED|Overall Study||11582
1535868|NCT01387139|3758513|P2|NOT COMPLETED|Overall Study||0
1535869|NCT01387139|3758514|P1|NOT COMPLETED|Overall Study||0
1535870|NCT01387139|3758513|P2|COMPLETED|Overall Study||84
1535871|NCT01387139|3758514|P1|COMPLETED|Overall Study||99
1535872|NCT01387139|3758513|P2|STARTED|Overall Study||84
1535873|NCT01387139|3758514|P1|STARTED|Overall Study||99
1535874|NCT01387074|3758530|P1|NOT COMPLETED|Overall Study||8
1535875|NCT01387074|3758530|P1|COMPLETED|Overall Study||100
1535876|NCT01387074|3758530|P1|STARTED|Overall Study||108
1535877|NCT01387022|3758543|P2|NOT COMPLETED|Overall Study||4
1535878|NCT01387022|3758544|P1|NOT COMPLETED|Overall Study||1
1535879|NCT01387022|3758543|P2|COMPLETED|Overall Study||26
1535880|NCT01387022|3758544|P1|COMPLETED|Overall Study||28
1535881|NCT01387022|3758543|P2|STARTED|Overall Study||30
1535882|NCT01387022|3758544|P1|STARTED|Overall Study||29
1535883|NCT01386983|3758562|P2|NOT COMPLETED|Overall Study||0
1535884|NCT01386983|3758563|P1|NOT COMPLETED|Overall Study||0
1535885|NCT01386983|3758562|P2|COMPLETED|Overall Study||68
1535886|NCT01386983|3758563|P1|COMPLETED|Overall Study||264
1535887|NCT01386983|3758562|P2|STARTED|Overall Study||68
1535888|NCT01386983|3758563|P1|STARTED|Overall Study||264
1535889|NCT01386944|3758571|P1|NOT COMPLETED|Overall Study||56
1535890|NCT01386944|3758571|P1|COMPLETED|Overall Study||46
1535891|NCT01386944|3758571|P1|STARTED|Overall Study||102
1535892|NCT01386788|3758581|P1|NOT COMPLETED|Overall Study||2
1535893|NCT01386788|3758581|P1|COMPLETED|Overall Study||100
1535894|NCT01386788|3758581|P1|STARTED|Overall Study||102
1535895|NCT01386684|3758586|P1|NOT COMPLETED|Overall Study||293
1535896|NCT01386684|3758586|P1|COMPLETED|Overall Study||259
1535897|NCT01386684|3758586|P1|STARTED|Overall Study||552
1535898|NCT01386632|3758627|P2|NOT COMPLETED|Overall Study||4
1535899|NCT01386632|3758628|P1|NOT COMPLETED|Overall Study||5
1535900|NCT01386632|3758627|P2|COMPLETED|Overall Study||21
1535901|NCT01386632|3758628|P1|COMPLETED|Overall Study||20
1535902|NCT01386632|3758627|P2|STARTED|Overall Study||25
1535903|NCT01386632|3758628|P1|STARTED|Overall Study||25
1535904|NCT01386606|3758640|P4|NOT COMPLETED|Overall Study||1
1535905|NCT01386606|3758641|P3|NOT COMPLETED|Overall Study||3
1535906|NCT01386606|3758642|P2|NOT COMPLETED|Overall Study||4
1535907|NCT01386606|3758643|P1|NOT COMPLETED|Overall Study||4
1535908|NCT01386606|3758640|P4|COMPLETED|Overall Study||13
1535909|NCT01386606|3758641|P3|COMPLETED|Overall Study||13
1535910|NCT01386606|3758642|P2|COMPLETED|Overall Study||10
1535911|NCT01386606|3758643|P1|COMPLETED|Overall Study||12
1535912|NCT01386606|3758640|P4|STARTED|Overall Study||14
1535913|NCT01386606|3758641|P3|STARTED|Overall Study||16
1535914|NCT01386606|3758642|P2|STARTED|Overall Study||14
1535915|NCT01386606|3758643|P1|STARTED|Overall Study||16
1535916|NCT01386554|3758674|P3|NOT COMPLETED|Overall Study||6
1535917|NCT01386554|3758675|P2|NOT COMPLETED|Overall Study||9
1535918|NCT01386554|3758676|P1|NOT COMPLETED|Overall Study||3
1535919|NCT01386554|3758674|P3|COMPLETED|Overall Study||15
1535920|NCT01386554|3758675|P2|COMPLETED|Overall Study||26
1535921|NCT01386554|3758676|P1|COMPLETED|Overall Study||1
1535922|NCT01386554|3758674|P3|STARTED|Overall Study||21
1535923|NCT01386554|3758675|P2|STARTED|Overall Study||35
1535924|NCT01386554|3758676|P1|STARTED|Overall Study||4
1535925|NCT01386528|3758690|P1|NOT COMPLETED|Overall Study||0
1535926|NCT01386528|3758690|P1|COMPLETED|Overall Study||13
1535927|NCT01386528|3758690|P1|STARTED|Overall Study||13
1535928|NCT01386125|3758702|P2|NOT COMPLETED|Overall Study||37
1535929|NCT01386125|3758703|P1|NOT COMPLETED|Overall Study||25
1535930|NCT01386125|3758702|P2|COMPLETED|Overall Study||336
1535931|NCT01386125|3758703|P1|COMPLETED|Overall Study||350
1535932|NCT01386125|3758702|P2|STARTED|Overall Study||373
1535933|NCT01386125|3758703|P1|STARTED|Overall Study||375
1535934|NCT01386008|3758711|P1|NOT COMPLETED|Overall Study||20
1535935|NCT01386008|3758711|P1|COMPLETED|Overall Study||0
1535936|NCT01386008|3758711|P1|STARTED|Overall Study||20
1535937|NCT01385995|3758720|P2|NOT COMPLETED|Period 2, 2 Months||0
1535938|NCT01385995|3758721|P1|NOT COMPLETED|Period 2, 2 Months||0
1535939|NCT01385995|3758720|P2|COMPLETED|Period 2, 2 Months||25
1535940|NCT01385995|3758721|P1|COMPLETED|Period 2, 2 Months||24
1535941|NCT01385995|3758720|P2|STARTED|Period 2, 2 Months||25
1535942|NCT01385995|3758721|P1|STARTED|Period 2, 2 Months||24
1535943|NCT01385995|3758720|P2|NOT COMPLETED|Washout Period, 1 Month||0
1535944|NCT01385995|3758721|P1|NOT COMPLETED|Washout Period, 1 Month||0
1535945|NCT01385995|3758720|P2|COMPLETED|Washout Period, 1 Month||25
1535946|NCT01385995|3758721|P1|COMPLETED|Washout Period, 1 Month||24
1535947|NCT01385995|3758720|P2|STARTED|Washout Period, 1 Month||25
1535948|NCT01385995|3758721|P1|STARTED|Washout Period, 1 Month||24
1535949|NCT01385995|3758720|P2|NOT COMPLETED|Period 1, 2 Months||0
1535950|NCT01385995|3758721|P1|NOT COMPLETED|Period 1, 2 Months||1
1535951|NCT01385995|3758720|P2|COMPLETED|Period 1, 2 Months||25
1535952|NCT01385995|3758721|P1|COMPLETED|Period 1, 2 Months||24
1535953|NCT01385995|3758720|P2|STARTED|Period 1, 2 Months||25
1535954|NCT01385995|3758721|P1|STARTED|Period 1, 2 Months||25
1535955|NCT01385748|3758738|P3|NOT COMPLETED|Overall Study||13
1535956|NCT01385748|3758739|P2|NOT COMPLETED|Overall Study||14
1535957|NCT01385748|3758740|P1|NOT COMPLETED|Overall Study||15
1535958|NCT01385748|3758738|P3|COMPLETED|Overall Study||49
1535959|NCT01385748|3758739|P2|COMPLETED|Overall Study||51
1535960|NCT01385748|3758740|P1|COMPLETED|Overall Study||41
1535961|NCT01385748|3758738|P3|STARTED|Overall Study||62
1535962|NCT01385748|3758739|P2|STARTED|Overall Study||65
1535963|NCT01385748|3758740|P1|STARTED|Overall Study||56
1535964|NCT01385696|3758785|P2|NOT COMPLETED|Overall Study||0
1535965|NCT01385696|3758786|P1|NOT COMPLETED|Overall Study||0
1535966|NCT01385696|3758785|P2|COMPLETED|Overall Study||64
1535967|NCT01385696|3758786|P1|COMPLETED|Overall Study||66
1535968|NCT01385696|3758785|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
1535969|NCT01385696|3758786|P1|STARTED|Overall Study||66
1535970|NCT01385644|3758797|P2|NOT COMPLETED|Overall Study||0
1535971|NCT01385644|3758798|P1|NOT COMPLETED|Overall Study||0
1535972|NCT01385644|3758797|P2|COMPLETED|Overall Study||4
1535973|NCT01385644|3758798|P1|COMPLETED|Overall Study||4
1535974|NCT01385644|3758797|P2|STARTED|Overall Study||4
1535975|NCT01385644|3758798|P1|STARTED|Overall Study||4
1535976|NCT01385579|3758812|P2|NOT COMPLETED|Overall Study||0
1535977|NCT01385579|3758813|P1|NOT COMPLETED|Overall Study||0
1535978|NCT01385579|3758812|P2|COMPLETED|Overall Study||104
1535979|NCT01385579|3758813|P1|COMPLETED|Overall Study||98
1535980|NCT01385579|3758812|P2|STARTED|Overall Study||104
1535981|NCT01385579|3758813|P1|STARTED|Overall Study||98
1535982|NCT01385566|3758825|P6|NOT COMPLETED|Overall Study||0
1535983|NCT01385566|3758826|P5|NOT COMPLETED|Overall Study||0
1535984|NCT01385566|3758827|P4|NOT COMPLETED|Overall Study||1
1535985|NCT01385566|3758828|P3|NOT COMPLETED|Overall Study||0
1535986|NCT01385566|3758829|P2|NOT COMPLETED|Overall Study||0
1535987|NCT01385566|3758830|P1|NOT COMPLETED|Overall Study||1
1535988|NCT01385566|3758825|P6|COMPLETED|Overall Study||34
1535989|NCT01385566|3758826|P5|COMPLETED|Overall Study||34
1535990|NCT01385566|3758827|P4|COMPLETED|Overall Study||34
1535991|NCT01385566|3758828|P3|COMPLETED|Overall Study||34
1535992|NCT01385566|3758829|P2|COMPLETED|Overall Study||34
1535993|NCT01385566|3758830|P1|COMPLETED|Overall Study||51
1535994|NCT01385566|3758825|P6|STARTED|Overall Study||34
1535995|NCT01385566|3758826|P5|STARTED|Overall Study||34
1535996|NCT01385566|3758827|P4|STARTED|Overall Study||35
1535997|NCT01385566|3758828|P3|STARTED|Overall Study||34
1535998|NCT01385566|3758829|P2|STARTED|Overall Study||34
1535999|NCT01385566|3758830|P1|STARTED|Overall Study||52
1536000|NCT01385371|3758884|P2|NOT COMPLETED|Overall Study||97
1536001|NCT01385371|3758885|P1|NOT COMPLETED|Overall Study||149
1536002|NCT01385371|3758884|P2|COMPLETED|Overall Study||652
1536003|NCT01385371|3758885|P1|COMPLETED|Overall Study||603
1536004|NCT01385371|3758884|P2|STARTED|Overall Study||749
1536005|NCT01385371|3758885|P1|STARTED|Overall Study||752
1536006|NCT01385306|3758905|P1|NOT COMPLETED|Overall Study||0
1536007|NCT01385306|3758905|P1|COMPLETED|Overall Study||6
1536008|NCT01385306|3758905|P1|STARTED|Overall Study||6
1536009|NCT01385293|3758913|P1|NOT COMPLETED|Overall Study||0
1536010|NCT01385293|3758913|P1|COMPLETED|Overall Study||30
1536011|NCT01385293|3758913|P1|STARTED|Overall Study||30
1536012|NCT01385280|3758923|P1|NOT COMPLETED|Overall Study||0
1536013|NCT01385280|3758923|P1|COMPLETED|Overall Study||13
1536014|NCT01385280|3758923|P1|STARTED|Overall Study||13
1536015|NCT01385202|3758933|P1|NOT COMPLETED|Overall Study||18
1536016|NCT01385202|3758933|P1|COMPLETED|Overall Study||154
1536017|NCT01385202|3758933|P1|Undergoing Ablation|Overall Study||160
1536018|NCT01385202|3758933|P1|Study Catheter Inserted|Overall Study||161
1536019|NCT01385202|3758933|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
1536020|NCT01385189|3758945|P5|NOT COMPLETED|Overall Study||2
1536021|NCT01385189|3758946|P4|NOT COMPLETED|Overall Study||1
1536022|NCT01385189|3758947|P3|NOT COMPLETED|Overall Study||0
1536023|NCT01385189|3758948|P2|NOT COMPLETED|Overall Study||1
1536024|NCT01385189|3758949|P1|NOT COMPLETED|Overall Study||1
1536025|NCT01385189|3758945|P5|COMPLETED|Overall Study||6
1536026|NCT01385189|3758946|P4|COMPLETED|Overall Study||3
1536027|NCT01385189|3758947|P3|COMPLETED|Overall Study||4
1536028|NCT01385189|3758948|P2|COMPLETED|Overall Study||11
1536029|NCT01385189|3758949|P1|COMPLETED|Overall Study||11
1536030|NCT01385189|3758945|P5|STARTED|Overall Study||8
1536031|NCT01385189|3758946|P4|STARTED|Overall Study||4
1536032|NCT01385189|3758947|P3|STARTED|Overall Study||4
1536033|NCT01385189|3758948|P2|STARTED|Overall Study||12
1536034|NCT01385189|3758949|P1|STARTED|Overall Study||12
1536035|NCT01385137|3758970|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
1536036|NCT01385137|3758971|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
1536037|NCT01385137|3758970|P2|COMPLETED|Evaluable for Primary Endpoint||107
1536038|NCT01385137|3758971|P1|COMPLETED|Evaluable for Primary Endpoint||102
1536039|NCT01385137|3758970|P2|STARTED|Evaluable for Primary Endpoint||131
1536040|NCT01385137|3758971|P1|STARTED|Evaluable for Primary Endpoint||131
1536041|NCT01385137|3758970|P2|NOT COMPLETED|Evaluable at Baseline||4
1536042|NCT01385137|3758971|P1|NOT COMPLETED|Evaluable at Baseline||9
1536043|NCT01385137|3758970|P2|COMPLETED|Evaluable at Baseline||127
1536044|NCT01385137|3758971|P1|COMPLETED|Evaluable at Baseline||122
1536045|NCT01385137|3758970|P2|STARTED|Evaluable at Baseline||131
1536046|NCT01385137|3758971|P1|STARTED|Evaluable at Baseline||131
1536047|NCT01385098|3758985|P1|NOT COMPLETED|Overall Study||14
1536048|NCT01385098|3758985|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
1536049|NCT01385098|3758985|P1|STARTED|Overall Study||37
1536050|NCT01385033|3758993|P6|NOT COMPLETED|Part III||0
1536051|NCT01385033|3758994|P5|NOT COMPLETED|Part III||0
1536052|NCT01385033|3758995|P4|NOT COMPLETED|Part III||0
1536053|NCT01385033|3758996|P3|NOT COMPLETED|Part III||0
1536054|NCT01385033|3758997|P2|NOT COMPLETED|Part III||0
1536055|NCT01385033|3758998|P1|NOT COMPLETED|Part III||0
1536056|NCT01385033|3758993|P6|COMPLETED|Part III||0
1536057|NCT01385033|3758994|P5|COMPLETED|Part III||0
1536058|NCT01385033|3758995|P4|COMPLETED|Part III||0
1536059|NCT01385033|3758996|P3|COMPLETED|Part III||0
1536060|NCT01385033|3758997|P2|COMPLETED|Part III||0
1536061|NCT01385033|3758998|P1|COMPLETED|Part III||0
1536062|NCT01385033|3758993|P6|STARTED|Part III||0
1536063|NCT01385033|3758994|P5|STARTED|Part III||0
1536064|NCT01385033|3758995|P4|STARTED|Part III||0
1536065|NCT01385033|3758996|P3|STARTED|Part III||0
1536066|NCT01385033|3758997|P2|STARTED|Part III||0
1536067|NCT01385033|3758998|P1|STARTED|Part III||0
1536068|NCT01385033|3758993|P6|NOT COMPLETED|Part II||0
1536069|NCT01385033|3758994|P5|NOT COMPLETED|Part II||0
1536070|NCT01385033|3758995|P4|NOT COMPLETED|Part II||0
1536071|NCT01385033|3758996|P3|NOT COMPLETED|Part II||0
1536072|NCT01385033|3758997|P2|NOT COMPLETED|Part II||0
1536073|NCT01385033|3758998|P1|NOT COMPLETED|Part II||0
1536074|NCT01385033|3758993|P6|COMPLETED|Part II||0
1536075|NCT01385033|3758994|P5|COMPLETED|Part II||0
1536076|NCT01385033|3758995|P4|COMPLETED|Part II||0
1536077|NCT01385033|3758996|P3|COMPLETED|Part II||0
1536078|NCT01385033|3758997|P2|COMPLETED|Part II||0
1536079|NCT01385033|3758998|P1|COMPLETED|Part II||0
1536080|NCT01385033|3758993|P6|STARTED|Part II||0
1536081|NCT01385033|3758994|P5|STARTED|Part II||0
1536082|NCT01385033|3758995|P4|STARTED|Part II||0
1536083|NCT01385033|3758996|P3|STARTED|Part II||0
1536084|NCT01385033|3758997|P2|STARTED|Part II||0
1536085|NCT01385033|3758998|P1|STARTED|Part II||0
1536086|NCT01385033|3758993|P6|NOT COMPLETED|Part I||0
1536087|NCT01385033|3758994|P5|NOT COMPLETED|Part I||0
1536088|NCT01385033|3758995|P4|NOT COMPLETED|Part I||0
1536089|NCT01385033|3758996|P3|NOT COMPLETED|Part I||0
1536090|NCT01385033|3758997|P2|NOT COMPLETED|Part I||0
1536091|NCT01385033|3758998|P1|NOT COMPLETED|Part I||0
1536092|NCT01385033|3758993|P6|COMPLETED|Part I||0
1536093|NCT01385033|3758994|P5|COMPLETED|Part I||0
1536094|NCT01385033|3758995|P4|COMPLETED|Part I||0
1536095|NCT01385033|3758996|P3|COMPLETED|Part I||0
1536096|NCT01385033|3758997|P2|COMPLETED|Part I||14
1536097|NCT01385033|3758998|P1|COMPLETED|Part I||6
1536098|NCT01385033|3758993|P6|STARTED|Part I||0
1536099|NCT01385033|3758994|P5|STARTED|Part I||0
1536100|NCT01385033|3758995|P4|STARTED|Part I||0
1536101|NCT01385033|3758996|P3|STARTED|Part I||0
1536102|NCT01385033|3758997|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
1536103|NCT01385033|3758998|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
1536104|NCT01384760|3759007|P2|NOT COMPLETED|Overall Study||6
1536105|NCT01384760|3759008|P1|NOT COMPLETED|Overall Study||16
1536106|NCT01384760|3759007|P2|COMPLETED|Overall Study||37
1536107|NCT01384760|3759008|P1|COMPLETED|Overall Study||45
1536108|NCT01384760|3759007|P2|Randomized|Overall Study||43
1536109|NCT01384760|3759008|P1|Randomized|Overall Study||61
1536110|NCT01384760|3759007|P2|STARTED|Overall Study||43
1536111|NCT01384760|3759008|P1|STARTED|Overall Study||61
1536112|NCT01384734|3759021|P5|NOT COMPLETED|Overall Study||29
1536113|NCT01384734|3759022|P4|NOT COMPLETED|Overall Study||28
1536114|NCT01384734|3759023|P3|NOT COMPLETED|Overall Study||23
1536115|NCT01384734|3759024|P2|NOT COMPLETED|Overall Study||24
1536116|NCT01384734|3759025|P1|NOT COMPLETED|Overall Study||17
1536117|NCT01384734|3759021|P5|COMPLETED|Overall Study||22
1536118|NCT01384734|3759022|P4|COMPLETED|Overall Study||22
1536119|NCT01384734|3759023|P3|COMPLETED|Overall Study||28
1536120|NCT01384734|3759024|P2|COMPLETED|Overall Study||25
1536121|NCT01384734|3759025|P1|COMPLETED|Overall Study||33
1536122|NCT01384734|3759021|P5|STARTED|Overall Study||51
1536123|NCT01384734|3759022|P4|STARTED|Overall Study||50
1536124|NCT01384734|3759023|P3|STARTED|Overall Study||51
1536125|NCT01384734|3759024|P2|STARTED|Overall Study||49
1536126|NCT01384734|3759025|P1|STARTED|Overall Study||50
1536127|NCT01384591|3759108|P3|NOT COMPLETED|Overall Study||0
1536128|NCT01384591|3759109|P2|NOT COMPLETED|Overall Study||0
1536129|NCT01384591|3759110|P1|NOT COMPLETED|Overall Study||0
1536130|NCT01384591|3759108|P3|COMPLETED|Overall Study||2
1536131|NCT01384591|3759109|P2|COMPLETED|Overall Study||2
1536132|NCT01384591|3759110|P1|COMPLETED|Overall Study||2
1536133|NCT01384591|3759108|P3|STARTED|Overall Study||2
1536134|NCT01384591|3759109|P2|STARTED|Overall Study||2
1536135|NCT01384591|3759110|P1|STARTED|Overall Study||2
1536136|NCT01384539|3759240|P2|NOT COMPLETED|Overall Study||7
1536137|NCT01384539|3759241|P1|NOT COMPLETED|Overall Study||6
1536138|NCT01384539|3759240|P2|COMPLETED|Overall Study||57
1536139|NCT01384539|3759241|P1|COMPLETED|Overall Study||58
1536140|NCT01384539|3759240|P2|STARTED|Overall Study||64
1536141|NCT01384539|3759241|P1|STARTED|Overall Study||64
1536142|NCT01384292|3759254|P3|NOT COMPLETED|Part B||0
1536143|NCT01384292|3759255|P2|NOT COMPLETED|Part B||0
1536144|NCT01384292|3759256|P1|NOT COMPLETED|Part B||1
1536145|NCT01384292|3759254|P3|COMPLETED|Part B||0
1536146|NCT01384292|3759255|P2|COMPLETED|Part B||6
1536147|NCT01384292|3759256|P1|COMPLETED|Part B||2
1536148|NCT01384292|3759254|P3|STARTED|Part B||0
1536149|NCT01384292|3759255|P2|STARTED|Part B||6
1536150|NCT01384292|3759256|P1|STARTED|Part B||3
1536151|NCT01384292|3759254|P3|NOT COMPLETED|Part A||0
1536152|NCT01384292|3759255|P2|NOT COMPLETED|Part A||0
1536153|NCT01384292|3759256|P1|NOT COMPLETED|Part A||0
1536154|NCT01384292|3759254|P3|COMPLETED|Part A||4
1536155|NCT01384292|3759255|P2|COMPLETED|Part A||5
1536156|NCT01384292|3759256|P1|COMPLETED|Part A||5
1536157|NCT01384292|3759254|P3|STARTED|Part A||4
1536158|NCT01384292|3759255|P2|STARTED|Part A||5
1536159|NCT01384292|3759256|P1|STARTED|Part A||5
1536160|NCT01384019|3759268|P2|NOT COMPLETED|Overall Study||6
1536161|NCT01384019|3759269|P1|NOT COMPLETED|Overall Study||10
1536162|NCT01384019|3759268|P2|COMPLETED|Overall Study||55
1536163|NCT01384019|3759269|P1|COMPLETED|Overall Study||55
1536164|NCT01384019|3759268|P2|STARTED|Overall Study||61
1536165|NCT01384019|3759269|P1|STARTED|Overall Study||65
1536166|NCT01383993|3759278|P3|NOT COMPLETED|Overall Study||1
1536167|NCT01383993|3759279|P2|NOT COMPLETED|Overall Study||1
1536168|NCT01383993|3759280|P1|NOT COMPLETED|Overall Study||3
1536169|NCT01383993|3759278|P3|COMPLETED|Overall Study||1
1536170|NCT01383993|3759279|P2|COMPLETED|Overall Study||3
1536171|NCT01383993|3759280|P1|COMPLETED|Overall Study||12
1536172|NCT01383993|3759278|P3|STARTED|Overall Study||2
1536173|NCT01383993|3759279|P2|STARTED|Overall Study||4
1536174|NCT01383993|3759280|P1|STARTED|Overall Study||15
1536175|NCT01383954|3759327|P1|NOT COMPLETED|Overall Study||14
1536176|NCT01383954|3759327|P1|COMPLETED|Overall Study||38
1536177|NCT01383954|3759327|P1|Safety Population: Received Treatment|Overall Study||48
1536178|NCT01383954|3759327|P1|STARTED|Overall Study||52
1536179|NCT01383928|3759335|P3|NOT COMPLETED|Phase 2||40
1536180|NCT01383928|3759336|P2|NOT COMPLETED|Phase 2||0
1536181|NCT01383928|3759337|P1|NOT COMPLETED|Phase 2||0
1536182|NCT01383928|3759335|P3|COMPLETED|Phase 2||10
1536183|NCT01383928|3759336|P2|COMPLETED|Phase 2||0
1536184|NCT01383928|3759337|P1|COMPLETED|Phase 2||0
1536185|NCT01383928|3759335|P3|STARTED|Phase 2||50
1536186|NCT01383928|3759336|P2|STARTED|Phase 2||0
1536187|NCT01383928|3759337|P1|STARTED|Phase 2||0
1536188|NCT01383928|3759335|P3|NOT COMPLETED|Phase 1||0
1536189|NCT01383928|3759336|P2|NOT COMPLETED|Phase 1||7
1536190|NCT01383928|3759337|P1|NOT COMPLETED|Phase 1||5
1536191|NCT01383928|3759335|P3|COMPLETED|Phase 1||0
1536192|NCT01383928|3759336|P2|COMPLETED|Phase 1||0
1536193|NCT01383928|3759337|P1|COMPLETED|Phase 1||2
1536194|NCT01383928|3759335|P3|STARTED|Phase 1||0
1536195|NCT01383928|3759336|P2|STARTED|Phase 1||7
1536196|NCT01383928|3759337|P1|STARTED|Phase 1||7
1536197|NCT01383720|3759379|P1|NOT COMPLETED|Overall Study||0
1536198|NCT01383720|3759379|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
1536199|NCT01383720|3759379|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
1536200|NCT01383720|3759379|P1|STARTED|Overall Study||11
1536201|NCT01383707|3759401|P1|NOT COMPLETED|Overall Study||72
1536202|NCT01383707|3759401|P1|COMPLETED|Overall Study||5
1536203|NCT01383707|3759401|P1|STARTED|Overall Study||77
1536204|NCT01383681|3759410|P1|NOT COMPLETED|Overall Study||46
1536205|NCT01383681|3759410|P1|COMPLETED|Overall Study||189
1536206|NCT01383681|3759410|P1|STARTED|Overall Study||235
1536207|NCT01383616|3759417|P2|NOT COMPLETED|Overall Study||23
1536208|NCT01383616|3759418|P1|NOT COMPLETED|Overall Study||17
1536209|NCT01383616|3759417|P2|COMPLETED|Overall Study||21
1536210|NCT01383616|3759418|P1|COMPLETED|Overall Study||23
1536211|NCT01383616|3759417|P2|STARTED|Overall Study||44
1536212|NCT01383616|3759418|P1|STARTED|Overall Study||40
1536213|NCT01383499|3759441|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
1536214|NCT01383499|3759442|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
1536215|NCT01383499|3759443|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
1536216|NCT01383499|3759444|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
1536217|NCT01383499|3759441|P4|COMPLETED|Period 3 (4 Weeks)||25
1536218|NCT01383499|3759442|P3|COMPLETED|Period 3 (4 Weeks)||25
1536219|NCT01383499|3759443|P2|COMPLETED|Period 3 (4 Weeks)||24
1536220|NCT01383499|3759444|P1|COMPLETED|Period 3 (4 Weeks)||26
1536221|NCT01383499|3759441|P4|STARTED|Period 3 (4 Weeks)||25
1536222|NCT01383499|3759442|P3|STARTED|Period 3 (4 Weeks)||25
1536223|NCT01383499|3759443|P2|STARTED|Period 3 (4 Weeks)||24
1536224|NCT01383499|3759444|P1|STARTED|Period 3 (4 Weeks)||26
1536225|NCT01383499|3759441|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
1536226|NCT01383499|3759442|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
1536227|NCT01383499|3759443|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
1536228|NCT01383499|3759444|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
1536229|NCT01383499|3759441|P4|COMPLETED|Period 2 (4 Weeks)||25
1536230|NCT01383499|3759442|P3|COMPLETED|Period 2 (4 Weeks)||25
1536231|NCT01383499|3759443|P2|COMPLETED|Period 2 (4 Weeks)||24
1536232|NCT01383499|3759444|P1|COMPLETED|Period 2 (4 Weeks)||26
1536233|NCT01383499|3759441|P4|STARTED|Period 2 (4 Weeks)||25
1536234|NCT01383499|3759442|P3|STARTED|Period 2 (4 Weeks)||25
1536235|NCT01383499|3759443|P2|STARTED|Period 2 (4 Weeks)||24
1536236|NCT01383499|3759444|P1|STARTED|Period 2 (4 Weeks)||26
1536237|NCT01383499|3759441|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
1536238|NCT01383499|3759442|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
1536239|NCT01383499|3759443|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
1536240|NCT01383499|3759444|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
1536241|NCT01383499|3759441|P4|COMPLETED|Period 1 (4 Weeks)||25
1536242|NCT01383499|3759442|P3|COMPLETED|Period 1 (4 Weeks)||25
1536243|NCT01383499|3759443|P2|COMPLETED|Period 1 (4 Weeks)||24
1536244|NCT01383499|3759444|P1|COMPLETED|Period 1 (4 Weeks)||26
1536245|NCT01383499|3759441|P4|STARTED|Period 1 (4 Weeks)||25
1536246|NCT01383499|3759442|P3|STARTED|Period 1 (4 Weeks)||25
1536247|NCT01383499|3759443|P2|STARTED|Period 1 (4 Weeks)||24
1536248|NCT01383499|3759444|P1|STARTED|Period 1 (4 Weeks)||27
1536249|NCT01383486|3759494|P1|NOT COMPLETED|Overall Study||18
1536250|NCT01383486|3759494|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
1536251|NCT01383486|3759494|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
1536252|NCT01383486|3759494|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
1536253|NCT01383447|3759500|P1|NOT COMPLETED|Overall Study||2
1536254|NCT01383447|3759500|P1|COMPLETED|Overall Study||0
1536255|NCT01383447|3759500|P1|STARTED|Overall Study||2
1536256|NCT01383421|3759508|P1|NOT COMPLETED|Overall Study||346
1536257|NCT01383421|3759508|P1|COMPLETED|Overall Study||679
1536258|NCT01383421|3759508|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
1536259|NCT01383356|3759571|P2|NOT COMPLETED|Period 2||0
1536260|NCT01383356|3759572|P1|NOT COMPLETED|Period 2||0
1536261|NCT01383356|3759571|P2|COMPLETED|Period 2|Completed period 2.|23
1536262|NCT01383356|3759572|P1|COMPLETED|Period 2|Completed period 2.|21
1536263|NCT01383356|3759571|P2|STARTED|Period 2|Entered and treated.|23
1536264|NCT01383356|3759572|P1|STARTED|Period 2|Entered and treated.|21
1536265|NCT01383356|3759571|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
1536266|NCT01383356|3759572|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
1536267|NCT01383356|3759571|P2|COMPLETED|Washout Period (at Least 35 Days)||23
1536268|NCT01383356|3759572|P1|COMPLETED|Washout Period (at Least 35 Days)||21
1536269|NCT01383356|3759571|P2|STARTED|Washout Period (at Least 35 Days)||23
1536270|NCT01383356|3759572|P1|STARTED|Washout Period (at Least 35 Days)||21
1536271|NCT01383356|3759571|P2|NOT COMPLETED|Period 1||6
1536272|NCT01383356|3759572|P1|NOT COMPLETED|Period 1||8
1536273|NCT01383356|3759571|P2|COMPLETED|Period 1|Completed period 1.|23
1536274|NCT01383356|3759572|P1|COMPLETED|Period 1|Completed period 1.|21
1536275|NCT01383356|3759571|P2|STARTED|Period 1|Entered and treated.|29
1536276|NCT01383356|3759572|P1|STARTED|Period 1|Entered and treated.|29
1536277|NCT01383317|3759584|P2|NOT COMPLETED|Overall Study||2
1536278|NCT01383317|3759585|P1|NOT COMPLETED|Overall Study||3
1536279|NCT01383317|3759584|P2|COMPLETED|Overall Study||33
1536280|NCT01383317|3759585|P1|COMPLETED|Overall Study||26
1536281|NCT01383317|3759584|P2|STARTED|Overall Study||35
1536282|NCT01383317|3759585|P1|STARTED|Overall Study||29
1536283|NCT01383213|3759609|P2|NOT COMPLETED|Overall Study||0
1536284|NCT01383213|3759610|P1|NOT COMPLETED|Overall Study||0
1536285|NCT01383213|3759609|P2|COMPLETED|Overall Study||41
1536286|NCT01383213|3759610|P1|COMPLETED|Overall Study||40
1536287|NCT01383213|3759609|P2|STARTED|Overall Study||41
1536288|NCT01383213|3759610|P1|STARTED|Overall Study||40
1536289|NCT01383200|3759618|P2|NOT COMPLETED|Overall Study||0
1536290|NCT01383200|3759619|P1|NOT COMPLETED|Overall Study||0
1536291|NCT01383200|3759618|P2|COMPLETED|Overall Study||6
1536292|NCT01383200|3759619|P1|COMPLETED|Overall Study||5
1536293|NCT01383200|3759618|P2|STARTED|Overall Study||6
1536294|NCT01383200|3759619|P1|STARTED|Overall Study||5
1536295|NCT01383174|3759627|P2|NOT COMPLETED|6 Month Assessment||1
1536296|NCT01383174|3759628|P1|NOT COMPLETED|6 Month Assessment||5
1536297|NCT01383174|3759627|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
1536298|NCT01383174|3759628|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
1536299|NCT01383174|3759627|P2|STARTED|6 Month Assessment||74
1536300|NCT01383174|3759628|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
1536301|NCT01383174|3759627|P2|NOT COMPLETED|3 Month Assessment||1
1536302|NCT01383174|3759628|P1|NOT COMPLETED|3 Month Assessment||6
1536303|NCT01383174|3759627|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
1536304|NCT01383174|3759628|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
1536305|NCT01383174|3759627|P2|STARTED|3 Month Assessment||75
1536306|NCT01383174|3759628|P1|STARTED|3 Month Assessment||76
1536307|NCT01383174|3759627|P2|NOT COMPLETED|Baseline Assessment||0
1536308|NCT01383174|3759628|P1|NOT COMPLETED|Baseline Assessment||0
1536309|NCT01383174|3759627|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
1536310|NCT01383174|3759628|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
1536311|NCT01383174|3759627|P2|STARTED|Baseline Assessment||75
1536312|NCT01383174|3759628|P1|STARTED|Baseline Assessment||76
1536313|NCT01383161|3759654|P2|NOT COMPLETED|Overall Study||4
1536314|NCT01383161|3759655|P1|NOT COMPLETED|Overall Study||5
1536315|NCT01383161|3759654|P2|COMPLETED|Overall Study||17
1536316|NCT01383161|3759655|P1|COMPLETED|Overall Study||20
1536317|NCT01383161|3759654|P2|STARTED|Overall Study||21
1536318|NCT01383161|3759655|P1|STARTED|Overall Study||25
1536319|NCT01383096|3759674|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
1536320|NCT01383096|3759675|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
1536321|NCT01383096|3759676|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
1536322|NCT01383096|3759674|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1536323|NCT01383096|3759675|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
1536324|NCT01383096|3759676|P1|COMPLETED|Fifth Intervention (8 Days)||11
1536325|NCT01383096|3759674|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1536326|NCT01383096|3759675|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
1536327|NCT01383096|3759676|P1|STARTED|Fifth Intervention (8 Days)||13
1536328|NCT01383096|3759674|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
1536329|NCT01383096|3759675|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
1536330|NCT01383096|3759676|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
1536331|NCT01383096|3759674|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1536332|NCT01383096|3759675|P2|COMPLETED|Fourth Intervention (8 Days)||12
1536333|NCT01383096|3759676|P1|COMPLETED|Fourth Intervention (8 Days)||13
1536334|NCT01383096|3759674|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1536335|NCT01383096|3759675|P2|STARTED|Fourth Intervention (8 Days)||12
1536336|NCT01383096|3759676|P1|STARTED|Fourth Intervention (8 Days)||15
1536337|NCT01383096|3759674|P3|NOT COMPLETED|Third Intervention (8 Days)||0
1536338|NCT01383096|3759675|P2|NOT COMPLETED|Third Intervention (8 Days)||4
1536339|NCT01383096|3759676|P1|NOT COMPLETED|Third Intervention (8 Days)||4
1536340|NCT01383096|3759674|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1536341|NCT01383096|3759675|P2|COMPLETED|Third Intervention (8 Days)||12
1536342|NCT01383096|3759676|P1|COMPLETED|Third Intervention (8 Days)||15
1536343|NCT01383096|3759674|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
1536344|NCT01383096|3759675|P2|STARTED|Third Intervention (8 Days)||16
1536345|NCT01383096|3759676|P1|STARTED|Third Intervention (8 Days)||19
1536346|NCT01383096|3759674|P3|NOT COMPLETED|Second Intervention (8 Days)||2
1536347|NCT01383096|3759675|P2|NOT COMPLETED|Second Intervention (8 Days)||1
1536348|NCT01383096|3759676|P1|NOT COMPLETED|Second Intervention (8 Days)||0
1536349|NCT01383096|3759674|P3|COMPLETED|Second Intervention (8 Days)||14
1536350|NCT01383096|3759675|P2|COMPLETED|Second Intervention (8 Days)||16
1536351|NCT01383096|3759676|P1|COMPLETED|Second Intervention (8 Days)||19
1536352|NCT01383096|3759674|P3|STARTED|Second Intervention (8 Days)||16
1536353|NCT01383096|3759675|P2|STARTED|Second Intervention (8 Days)||17
1536354|NCT01383096|3759676|P1|STARTED|Second Intervention (8 Days)||19
1536355|NCT01383096|3759674|P3|NOT COMPLETED|First Intervention (8 Days)||0
1536356|NCT01383096|3759675|P2|NOT COMPLETED|First Intervention (8 Days)||0
1536357|NCT01383096|3759676|P1|NOT COMPLETED|First Intervention (8 Days)||0
1536358|NCT01383096|3759674|P3|COMPLETED|First Intervention (8 Days)||16
1536359|NCT01383096|3759675|P2|COMPLETED|First Intervention (8 Days)||17
1536360|NCT01383096|3759676|P1|COMPLETED|First Intervention (8 Days)||19
1536361|NCT01383096|3759674|P3|STARTED|First Intervention (8 Days)||16
1536362|NCT01383096|3759675|P2|STARTED|First Intervention (8 Days)||17
1536363|NCT01383096|3759676|P1|STARTED|First Intervention (8 Days)||19
1536364|NCT01383005|3759724|P2|NOT COMPLETED|Overall Study||0
1536365|NCT01383005|3759725|P1|NOT COMPLETED|Overall Study||0
1536366|NCT01383005|3759724|P2|COMPLETED|Overall Study||60
1536367|NCT01383005|3759725|P1|COMPLETED|Overall Study||34
1536368|NCT01383005|3759724|P2|STARTED|Overall Study||60
1536369|NCT01383005|3759725|P1|STARTED|Overall Study||34
1536370|NCT01382940|3759744|P1|NOT COMPLETED|Overall Study||73
1536371|NCT01382940|3759744|P1|COMPLETED|Overall Study||278
1536372|NCT01382940|3759744|P1|Received Day 182 Infusion|Overall Study||278
1536373|NCT01382940|3759744|P1|Received Day 168 Infusion|Overall Study||290
1536374|NCT01382940|3759744|P1|Received Day 15 Infusions|Overall Study||341
1536375|NCT01382940|3759744|P1|Received Day 1 Infusion|Overall Study||351
1536376|NCT01382940|3759744|P1|STARTED|Overall Study||351
1536377|NCT01382901|3759756|P2|NOT COMPLETED|Overall Study||14
1536378|NCT01382901|3759757|P1|NOT COMPLETED|Overall Study||17
1536379|NCT01382901|3759756|P2|COMPLETED|Overall Study||7
1536380|NCT01382901|3759757|P1|COMPLETED|Overall Study||7
1536381|NCT01382901|3759756|P2|STARTED|Overall Study||21
1536382|NCT01382901|3759757|P1|STARTED|Overall Study||24
1536383|NCT01382719|3759767|P4|NOT COMPLETED|Overall Study||33
1536384|NCT01382719|3759768|P3|NOT COMPLETED|Overall Study||34
1536385|NCT01382719|3759769|P2|NOT COMPLETED|Overall Study||19
1536386|NCT01382719|3759770|P1|NOT COMPLETED|Overall Study||18
1536387|NCT01382719|3759767|P4|COMPLETED|Overall Study||66
1536388|NCT01382719|3759768|P3|COMPLETED|Overall Study||66
1536389|NCT01382719|3759769|P2|COMPLETED|Overall Study||81
1536390|NCT01382719|3759770|P1|COMPLETED|Overall Study||80
1536391|NCT01382719|3759767|P4|Subjects Not Dosed|Overall Study||1
1536392|NCT01382719|3759768|P3|Subjects Not Dosed|Overall Study||1
1536393|NCT01382719|3759769|P2|Subjects Not Dosed|Overall Study||0
1536394|NCT01382719|3759770|P1|Subjects Not Dosed|Overall Study||1
1536395|NCT01382719|3759767|P4|STARTED|Overall Study||99
1536396|NCT01382719|3759768|P3|STARTED|Overall Study||100
1536397|NCT01382719|3759769|P2|STARTED|Overall Study||100
1536398|NCT01382719|3759770|P1|STARTED|Overall Study||98
1536399|NCT01382602|3759806|P2|NOT COMPLETED|Overall Study||4
1536400|NCT01382602|3759807|P1|NOT COMPLETED|Overall Study||0
1536401|NCT01382602|3759806|P2|COMPLETED|Overall Study||46
1536402|NCT01382602|3759807|P1|COMPLETED|Overall Study||93
1536403|NCT01382602|3759806|P2|STARTED|Overall Study||50
1536404|NCT01382602|3759807|P1|STARTED|Overall Study||93
1536405|NCT01382446|3759815|P2|NOT COMPLETED|Overall Study||4
1536406|NCT01382446|3759816|P1|NOT COMPLETED|Overall Study||3
1536407|NCT01382446|3759815|P2|COMPLETED|Overall Study||29
1536408|NCT01382446|3759816|P1|COMPLETED|Overall Study||30
1536409|NCT01382446|3759815|P2|STARTED|Overall Study||33
1536410|NCT01382446|3759816|P1|STARTED|Overall Study||33
1536411|NCT01382303|3759824|P2|NOT COMPLETED|Overall Study||17
1536412|NCT01382303|3759825|P1|NOT COMPLETED|Overall Study||35
1536413|NCT01382303|3759824|P2|COMPLETED|Overall Study||70
1536414|NCT01382303|3759825|P1|COMPLETED|Overall Study||52
1536415|NCT01382303|3759824|P2|STARTED|Overall Study||87
1536416|NCT01382303|3759825|P1|STARTED|Overall Study||87
1536417|NCT01382251|3759843|P2|NOT COMPLETED|Overall Study||21
1536418|NCT01382251|3759844|P1|NOT COMPLETED|Overall Study||21
1536419|NCT01382251|3759843|P2|COMPLETED|Overall Study||102
1536420|NCT01382251|3759844|P1|COMPLETED|Overall Study||102
1536421|NCT01382251|3759843|P2|STARTED|Overall Study||123
1536422|NCT01382251|3759844|P1|STARTED|Overall Study||123
1536423|NCT01382225|3759857|P2|NOT COMPLETED|Overall Study||7
1536424|NCT01382225|3759858|P1|NOT COMPLETED|Overall Study||14
1536425|NCT01382225|3759857|P2|COMPLETED|Overall Study||722
1536426|NCT01382225|3759858|P1|COMPLETED|Overall Study||711
1536427|NCT01382225|3759857|P2|STARTED|Overall Study||729
1536428|NCT01382225|3759858|P1|STARTED|Overall Study||725
1536429|NCT01382212|3759880|P1|NOT COMPLETED|Overall Study||2
1536430|NCT01382212|3759880|P1|COMPLETED|Overall Study||11
1536431|NCT01382212|3759880|P1|STARTED|Overall Study||13
1536432|NCT01382186|3759906|P2|NOT COMPLETED|Overall Study||0
1536433|NCT01382186|3759907|P1|NOT COMPLETED|Overall Study||1
1536434|NCT01382186|3759906|P2|COMPLETED|Overall Study||819
1536435|NCT01382186|3759907|P1|COMPLETED|Overall Study||32
1536436|NCT01382186|3759906|P2|STARTED|Overall Study||819
1536437|NCT01382186|3759907|P1|STARTED|Overall Study||33
1536438|NCT01382108|3759923|P2|NOT COMPLETED|Overall Study||0
1536439|NCT01382108|3759924|P1|NOT COMPLETED|Overall Study||0
1536440|NCT01382108|3759923|P2|COMPLETED|Overall Study||19
1536441|NCT01382108|3759924|P1|COMPLETED|Overall Study||20
1536442|NCT01382108|3759923|P2|STARTED|Overall Study||19
1536443|NCT01382108|3759924|P1|STARTED|Overall Study||20
1536444|NCT01381952|3759934|P1|NOT COMPLETED|Overall Study||0
1536445|NCT01381952|3759934|P1|COMPLETED|Overall Study||20
1536446|NCT01381952|3759934|P1|Collected Dose and Image Information|Overall Study||20
1536447|NCT01381952|3759934|P1|STARTED|Overall Study||20
1536448|NCT01381926|3759943|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
1536449|NCT01381926|3759944|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
1536450|NCT01381926|3759943|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
1536451|NCT01381926|3759944|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
1536452|NCT01381926|3759943|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
1536453|NCT01381926|3759944|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
1536454|NCT01381926|3759943|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
1536455|NCT01381926|3759944|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
1536456|NCT01381926|3759943|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
1536457|NCT01381926|3759944|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
1536458|NCT01381926|3759943|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
1536459|NCT01381926|3759944|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
1536460|NCT01381900|3759957|P3|NOT COMPLETED|Overall Study||12
1536461|NCT01381900|3759958|P2|NOT COMPLETED|Overall Study||9
1536462|NCT01381900|3759959|P1|NOT COMPLETED|Overall Study||9
1536463|NCT01381900|3759957|P3|COMPLETED|Overall Study||215
1536464|NCT01381900|3759958|P2|COMPLETED|Overall Study||214
1536465|NCT01381900|3759959|P1|COMPLETED|Overall Study||217
1536466|NCT01381900|3759957|P3|STARTED|Overall Study||227
1536467|NCT01381900|3759958|P2|STARTED|Overall Study||223
1536468|NCT01381900|3759959|P1|STARTED|Overall Study||226
1536469|NCT01381874|3759982|P3|NOT COMPLETED|Overall Study||76
1536470|NCT01381874|3759983|P2|NOT COMPLETED|Overall Study||63
1536471|NCT01381874|3759984|P1|NOT COMPLETED|Overall Study||77
1536472|NCT01381874|3759982|P3|COMPLETED|Overall Study||30
1536473|NCT01381874|3759983|P2|COMPLETED|Overall Study||26
1536474|NCT01381874|3759984|P1|COMPLETED|Overall Study||25
1536475|NCT01381874|3759982|P3|Treated|Overall Study||104
1536476|NCT01381874|3759983|P2|Treated|Overall Study||87
1536477|NCT01381874|3759984|P1|Treated|Overall Study||102
1536478|NCT01381874|3759982|P3|STARTED|Overall Study||106
1536479|NCT01381874|3759983|P2|STARTED|Overall Study||89
1536480|NCT01381874|3759984|P1|STARTED|Overall Study||102
1536481|NCT01381679|3760010|P1|NOT COMPLETED|Overall Study||888
1536482|NCT01381679|3760010|P1|COMPLETED|Overall Study||794
1536483|NCT01381679|3760010|P1|STARTED|Overall Study||1682
1536484|NCT01381575|3760025|P3|NOT COMPLETED|Overall Study||7
1536485|NCT01381575|3760026|P2|NOT COMPLETED|Overall Study||10
1536486|NCT01381575|3760027|P1|NOT COMPLETED|Overall Study||2
1536487|NCT01381575|3760025|P3|COMPLETED|Overall Study||408
1536488|NCT01381575|3760026|P2|COMPLETED|Overall Study||472
1536489|NCT01381575|3760027|P1|COMPLETED|Overall Study||548
1536490|NCT01381575|3760025|P3|STARTED|Overall Study||415
1536491|NCT01381575|3760026|P2|STARTED|Overall Study||482
1536492|NCT01381575|3760027|P1|STARTED|Overall Study||550
1536493|NCT01381562|3760084|P3|NOT COMPLETED|Overall Study||0
1536494|NCT01381562|3760085|P2|NOT COMPLETED|Overall Study||1
1536495|NCT01381562|3760086|P1|NOT COMPLETED|Overall Study||0
1536496|NCT01381562|3760084|P3|COMPLETED|Overall Study||5
1536497|NCT01381562|3760085|P2|COMPLETED|Overall Study||3
1536498|NCT01381562|3760086|P1|COMPLETED|Overall Study||5
1536499|NCT01381562|3760084|P3|STARTED|Overall Study||5
1536500|NCT01381562|3760085|P2|STARTED|Overall Study||4
1536501|NCT01381562|3760086|P1|STARTED|Overall Study||5
1536502|NCT01381549|3760154|P3|NOT COMPLETED|Overall Study||1
1536503|NCT01381549|3760155|P2|NOT COMPLETED|Overall Study||0
1536504|NCT01381549|3760156|P1|NOT COMPLETED|Overall Study||0
1536505|NCT01381549|3760154|P3|COMPLETED|Overall Study||5
1536506|NCT01381549|3760155|P2|COMPLETED|Overall Study||8
1536507|NCT01381549|3760156|P1|COMPLETED|Overall Study||6
1536508|NCT01381549|3760154|P3|STARTED|Overall Study||6
1536509|NCT01381549|3760155|P2|STARTED|Overall Study||8
1536510|NCT01381549|3760156|P1|STARTED|Overall Study||6
1536511|NCT01381471|3760251|P1|NOT COMPLETED|Overall Study||0
1536512|NCT01381471|3760251|P1|COMPLETED|Overall Study||11060
1536513|NCT01381471|3760251|P1|STARTED|Overall Study||11060
1536514|NCT01381406|3760258|P2|NOT COMPLETED|Overall Study||0
1536515|NCT01381406|3760259|P1|NOT COMPLETED|Overall Study||0
1536516|NCT01381406|3760258|P2|COMPLETED|Overall Study||852
1536517|NCT01381406|3760259|P1|COMPLETED|Overall Study||2481
1536518|NCT01381406|3760258|P2|STARTED|Overall Study||852
1536519|NCT01381406|3760259|P1|STARTED|Overall Study||2481
1536520|NCT01381120|3760271|P2|NOT COMPLETED|Overall Study||9
1536521|NCT01381120|3760272|P1|NOT COMPLETED|Overall Study||11
1536522|NCT01381120|3760271|P2|COMPLETED|Overall Study||18
1536523|NCT01381120|3760272|P1|COMPLETED|Overall Study||39
1536524|NCT01381120|3760271|P2|STARTED|Overall Study||27
1536525|NCT01381120|3760272|P1|STARTED|Overall Study||50
1536526|NCT01381016|3760282|P2|NOT COMPLETED|Overall Study||6
1536527|NCT01381016|3760283|P1|NOT COMPLETED|Overall Study||3
1536528|NCT01381016|3760282|P2|COMPLETED|Overall Study||11
1536529|NCT01381016|3760283|P1|COMPLETED|Overall Study||10
1536530|NCT01381016|3760282|P2|STARTED|Overall Study||17
1536531|NCT01381016|3760283|P1|STARTED|Overall Study||13
1536532|NCT01380834|3760293|P2|NOT COMPLETED|Overall Study||0
1536533|NCT01380834|3760294|P1|NOT COMPLETED|Overall Study||1
1536534|NCT01380834|3760293|P2|COMPLETED|Overall Study||42
1536535|NCT01380834|3760294|P1|COMPLETED|Overall Study||41
1536536|NCT01380834|3760293|P2|STARTED|Overall Study||42
1536537|NCT01380834|3760294|P1|STARTED|Overall Study||42
1536538|NCT01380782|3760306|P4|NOT COMPLETED|Overall Study||4
1536539|NCT01380782|3760307|P3|NOT COMPLETED|Overall Study||11
1536540|NCT01380782|3760308|P2|NOT COMPLETED|Overall Study||10
1536541|NCT01380782|3760309|P1|NOT COMPLETED|Overall Study||12
1536542|NCT01380782|3760306|P4|COMPLETED|Overall Study||0
1536543|NCT01380782|3760307|P3|COMPLETED|Overall Study||0
1536544|NCT01380782|3760308|P2|COMPLETED|Overall Study||0
1536545|NCT01380782|3760309|P1|COMPLETED|Overall Study||0
1536546|NCT01380782|3760306|P4|STARTED|Overall Study||4
1536547|NCT01380782|3760307|P3|STARTED|Overall Study||11
1536548|NCT01380782|3760308|P2|STARTED|Overall Study||10
1536549|NCT01380782|3760309|P1|STARTED|Overall Study||12
1536550|NCT01380769|3760332|P2|NOT COMPLETED|Overall Study||14
1536551|NCT01380769|3760333|P1|NOT COMPLETED|Overall Study||9
1536552|NCT01380769|3760332|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
1536553|NCT01380769|3760333|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
1536554|NCT01380769|3760332|P2|STARTED|Overall Study||57
1536555|NCT01380769|3760333|P1|STARTED|Overall Study||100
1536556|NCT01380743|3760345|P4|NOT COMPLETED|Overall Study||0
1536557|NCT01380743|3760346|P3|NOT COMPLETED|Overall Study||0
1536558|NCT01380743|3760347|P2|NOT COMPLETED|Overall Study||0
1536559|NCT01380743|3760348|P1|NOT COMPLETED|Overall Study||0
1536560|NCT01380743|3760345|P4|COMPLETED|Overall Study||7
1536561|NCT01380743|3760346|P3|COMPLETED|Overall Study||6
1536562|NCT01380743|3760347|P2|COMPLETED|Overall Study||6
1536563|NCT01380743|3760348|P1|COMPLETED|Overall Study||6
1536564|NCT01380743|3760345|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
1536565|NCT01380743|3760346|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1536566|NCT01380743|3760347|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1536567|NCT01380743|3760348|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
1536568|NCT01380743|3760345|P4|STARTED|Overall Study||7
1536569|NCT01380743|3760346|P3|STARTED|Overall Study||6
1536570|NCT01380743|3760347|P2|STARTED|Overall Study||6
1536571|NCT01380743|3760348|P1|STARTED|Overall Study||6
1536572|NCT01380730|3760394|P8|NOT COMPLETED|Overall Study||0
1536573|NCT01380730|3760395|P7|NOT COMPLETED|Overall Study||0
1536574|NCT01380730|3760396|P6|NOT COMPLETED|Overall Study||0
1536575|NCT01380730|3760397|P5|NOT COMPLETED|Overall Study||1
1536576|NCT01380730|3760398|P4|NOT COMPLETED|Overall Study||0
1536577|NCT01380730|3760399|P3|NOT COMPLETED|Overall Study||0
1536578|NCT01380730|3760400|P2|NOT COMPLETED|Overall Study||0
1536579|NCT01380730|3760401|P1|NOT COMPLETED|Overall Study||0
1536580|NCT01380730|3760394|P8|COMPLETED|Overall Study||80
1536581|NCT01380730|3760395|P7|COMPLETED|Overall Study||79
1536582|NCT01380730|3760396|P6|COMPLETED|Overall Study||79
1536583|NCT01380730|3760397|P5|COMPLETED|Overall Study||77
1536584|NCT01380730|3760398|P4|COMPLETED|Overall Study||79
1536585|NCT01380730|3760399|P3|COMPLETED|Overall Study||79
1536586|NCT01380730|3760400|P2|COMPLETED|Overall Study||79
1536587|NCT01380730|3760401|P1|COMPLETED|Overall Study||78
1536588|NCT01380730|3760394|P8|Received Treatment|Overall Study||80
1536589|NCT01380730|3760395|P7|Received Treatment|Overall Study||79
1536590|NCT01380730|3760396|P6|Received Treatment|Overall Study||79
1536591|NCT01380730|3760397|P5|Received Treatment|Overall Study||78
1536592|NCT01380730|3760398|P4|Received Treatment|Overall Study||79
1536593|NCT01380730|3760399|P3|Received Treatment|Overall Study||79
1536594|NCT01380730|3760400|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
1536595|NCT01380730|3760401|P1|Received Treatment|Overall Study||78
1536596|NCT01380730|3760394|P8|STARTED|Overall Study||80
1536597|NCT01380730|3760395|P7|STARTED|Overall Study||79
1536598|NCT01380730|3760396|P6|STARTED|Overall Study||79
1536599|NCT01380730|3760397|P5|STARTED|Overall Study||78
1536600|NCT01380730|3760398|P4|STARTED|Overall Study||79
1536601|NCT01380730|3760399|P3|STARTED|Overall Study||79
1536602|NCT01380730|3760400|P2|STARTED|Overall Study||79
1536603|NCT01380730|3760401|P1|STARTED|Overall Study||78
1536604|NCT01380639|3760461|P2|NOT COMPLETED|Overall Study||4
1536605|NCT01380639|3760462|P1|NOT COMPLETED|Overall Study||6
1536606|NCT01380639|3760461|P2|COMPLETED|Overall Study||36
1536607|NCT01380639|3760462|P1|COMPLETED|Overall Study||36
1536608|NCT01380639|3760461|P2|STARTED|Overall Study||40
1536609|NCT01380639|3760462|P1|STARTED|Overall Study||42
1536610|NCT01380379|3760468|P1|NOT COMPLETED|Overall Study||1
1536611|NCT01380379|3760468|P1|COMPLETED|Overall Study||8
1536612|NCT01380379|3760468|P1|STARTED|Overall Study||9
1536613|NCT01380366|3760473|P1|NOT COMPLETED|Overall Study||0
1536614|NCT01380366|3760473|P1|COMPLETED|Overall Study||15
1536615|NCT01380366|3760473|P1|STARTED|Overall Study||15
1536616|NCT01380327|3760481|P3|NOT COMPLETED|Overall Study||7
1536617|NCT01380327|3760482|P2|NOT COMPLETED|Overall Study||3
1536618|NCT01380327|3760483|P1|NOT COMPLETED|Overall Study||3
1536619|NCT01380327|3760481|P3|COMPLETED|Overall Study||21
1536620|NCT01380327|3760482|P2|COMPLETED|Overall Study||28
1536621|NCT01380327|3760483|P1|COMPLETED|Overall Study||27
1536622|NCT01380327|3760481|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
1536623|NCT01380327|3760482|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
1536624|NCT01380327|3760483|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
1536625|NCT01380197|3760505|P2|NOT COMPLETED|Overall Study||0
1536626|NCT01380197|3760506|P1|NOT COMPLETED|Overall Study||0
1536627|NCT01380197|3760505|P2|COMPLETED|Overall Study||20
1536628|NCT01380197|3760506|P1|COMPLETED|Overall Study||20
1536629|NCT01380197|3760505|P2|STARTED|Overall Study||20
1536630|NCT01380197|3760506|P1|STARTED|Overall Study||20
1536631|NCT01380145|3760514|P1|NOT COMPLETED|Overall Study||4
1536632|NCT01380145|3760514|P1|COMPLETED|Overall Study||9
1536633|NCT01380145|3760514|P1|STARTED|Overall Study||13
1536634|NCT01380093|3760522|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
1536635|NCT01380093|3760523|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
1536636|NCT01380093|3760524|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
1536637|NCT01380093|3760525|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
1536638|NCT01380093|3760526|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
1536639|NCT01380093|3760527|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
1536640|NCT01380093|3760528|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
1536641|NCT01380093|3760529|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
1536642|NCT01380093|3760530|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
1536643|NCT01380093|3760522|P9|COMPLETED|Treatment Phase: Third Intervention||4
1536644|NCT01380093|3760523|P8|COMPLETED|Treatment Phase: Third Intervention||6
1536645|NCT01380093|3760524|P7|COMPLETED|Treatment Phase: Third Intervention||6
1536646|NCT01380093|3760525|P6|COMPLETED|Treatment Phase: Third Intervention||6
1536647|NCT01380093|3760526|P5|COMPLETED|Treatment Phase: Third Intervention||6
1536648|NCT01380093|3760527|P4|COMPLETED|Treatment Phase: Third Intervention||5
1536649|NCT01380093|3760528|P3|COMPLETED|Treatment Phase: Third Intervention||0
1536650|NCT01380093|3760529|P2|COMPLETED|Treatment Phase: Third Intervention||0
1536651|NCT01380093|3760530|P1|COMPLETED|Treatment Phase: Third Intervention||0
1536652|NCT01380093|3760522|P9|STARTED|Treatment Phase: Third Intervention||6
1536653|NCT01380093|3760523|P8|STARTED|Treatment Phase: Third Intervention||6
1536654|NCT01380093|3760524|P7|STARTED|Treatment Phase: Third Intervention||6
1536655|NCT01380093|3760525|P6|STARTED|Treatment Phase: Third Intervention||6
1536656|NCT01380093|3760526|P5|STARTED|Treatment Phase: Third Intervention||6
1536657|NCT01380093|3760527|P4|STARTED|Treatment Phase: Third Intervention||5
1536658|NCT01380093|3760528|P3|STARTED|Treatment Phase: Third Intervention||0
1536659|NCT01380093|3760529|P2|STARTED|Treatment Phase: Third Intervention||0
1536660|NCT01380093|3760530|P1|STARTED|Treatment Phase: Third Intervention||0
1536661|NCT01380093|3760522|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
1536662|NCT01380093|3760523|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
1536663|NCT01380093|3760524|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
1536664|NCT01380093|3760525|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
1536665|NCT01380093|3760526|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
1536666|NCT01380093|3760527|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
1536667|NCT01380093|3760528|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
1536668|NCT01380093|3760529|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
1536669|NCT01380093|3760530|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
1536670|NCT01380093|3760522|P9|COMPLETED|Treatment Phase: Washout Period||6
1536671|NCT01380093|3760523|P8|COMPLETED|Treatment Phase: Washout Period||6
1536672|NCT01380093|3760524|P7|COMPLETED|Treatment Phase: Washout Period||6
1536673|NCT01380093|3760525|P6|COMPLETED|Treatment Phase: Washout Period||6
1536674|NCT01380093|3760526|P5|COMPLETED|Treatment Phase: Washout Period||6
1536675|NCT01380093|3760527|P4|COMPLETED|Treatment Phase: Washout Period||5
1536676|NCT01380093|3760528|P3|COMPLETED|Treatment Phase: Washout Period||0
1536677|NCT01380093|3760529|P2|COMPLETED|Treatment Phase: Washout Period||0
1536678|NCT01380093|3760530|P1|COMPLETED|Treatment Phase: Washout Period||0
1536679|NCT01380093|3760522|P9|STARTED|Treatment Phase: Washout Period||6
1536680|NCT01380093|3760523|P8|STARTED|Treatment Phase: Washout Period||6
1536681|NCT01380093|3760524|P7|STARTED|Treatment Phase: Washout Period||6
1536682|NCT01380093|3760525|P6|STARTED|Treatment Phase: Washout Period||6
1536683|NCT01380093|3760526|P5|STARTED|Treatment Phase: Washout Period||6
1536684|NCT01380093|3760527|P4|STARTED|Treatment Phase: Washout Period||5
1536685|NCT01380093|3760528|P3|STARTED|Treatment Phase: Washout Period||0
1536686|NCT01380093|3760529|P2|STARTED|Treatment Phase: Washout Period||0
1536687|NCT01380093|3760530|P1|STARTED|Treatment Phase: Washout Period||0
1536688|NCT01380093|3760522|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
1536689|NCT01380093|3760523|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
1536690|NCT01380093|3760524|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
1536691|NCT01380093|3760525|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
1536692|NCT01380093|3760526|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
1536693|NCT01380093|3760527|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
1536694|NCT01380093|3760528|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
1536695|NCT01380093|3760529|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
1536696|NCT01380093|3760530|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
1536697|NCT01380093|3760522|P9|COMPLETED|Treatment Phase: Second Intervention||6
1536698|NCT01380093|3760523|P8|COMPLETED|Treatment Phase: Second Intervention||6
1536699|NCT01380093|3760524|P7|COMPLETED|Treatment Phase: Second Intervention||6
1536700|NCT01380093|3760525|P6|COMPLETED|Treatment Phase: Second Intervention||6
1536701|NCT01380093|3760526|P5|COMPLETED|Treatment Phase: Second Intervention||6
1536702|NCT01380093|3760527|P4|COMPLETED|Treatment Phase: Second Intervention||5
1536703|NCT01380093|3760528|P3|COMPLETED|Treatment Phase: Second Intervention||0
1536704|NCT01380093|3760529|P2|COMPLETED|Treatment Phase: Second Intervention||0
1536705|NCT01380093|3760530|P1|COMPLETED|Treatment Phase: Second Intervention||0
1536706|NCT01380093|3760522|P9|STARTED|Treatment Phase: Second Intervention||6
1536707|NCT01380093|3760523|P8|STARTED|Treatment Phase: Second Intervention||6
1536708|NCT01380093|3760524|P7|STARTED|Treatment Phase: Second Intervention||6
1536709|NCT01380093|3760525|P6|STARTED|Treatment Phase: Second Intervention||6
1536710|NCT01380093|3760526|P5|STARTED|Treatment Phase: Second Intervention||6
1536711|NCT01380093|3760527|P4|STARTED|Treatment Phase: Second Intervention||6
1536712|NCT01380093|3760528|P3|STARTED|Treatment Phase: Second Intervention||0
1536713|NCT01380093|3760529|P2|STARTED|Treatment Phase: Second Intervention||0
1536714|NCT01380093|3760530|P1|STARTED|Treatment Phase: Second Intervention||0
1536715|NCT01380093|3760522|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
1536716|NCT01380093|3760523|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
1536717|NCT01380093|3760524|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
1536718|NCT01380093|3760525|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
1536719|NCT01380093|3760526|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
1536720|NCT01380093|3760527|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
1536721|NCT01380093|3760528|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
1536722|NCT01380093|3760529|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
1536723|NCT01380093|3760530|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
1536724|NCT01380093|3760522|P9|COMPLETED|Treatment Phase: Washout Period||6
1536725|NCT01380093|3760523|P8|COMPLETED|Treatment Phase: Washout Period||6
1536726|NCT01380093|3760524|P7|COMPLETED|Treatment Phase: Washout Period||6
1536727|NCT01380093|3760525|P6|COMPLETED|Treatment Phase: Washout Period||6
1536728|NCT01380093|3760526|P5|COMPLETED|Treatment Phase: Washout Period||6
1536729|NCT01380093|3760527|P4|COMPLETED|Treatment Phase: Washout Period||6
1536730|NCT01380093|3760528|P3|COMPLETED|Treatment Phase: Washout Period||0
1536731|NCT01380093|3760529|P2|COMPLETED|Treatment Phase: Washout Period||0
1536732|NCT01380093|3760530|P1|COMPLETED|Treatment Phase: Washout Period||0
1536733|NCT01380093|3760522|P9|STARTED|Treatment Phase: Washout Period||6
1536734|NCT01380093|3760523|P8|STARTED|Treatment Phase: Washout Period||6
1536735|NCT01380093|3760524|P7|STARTED|Treatment Phase: Washout Period||6
1536736|NCT01380093|3760525|P6|STARTED|Treatment Phase: Washout Period||6
1536737|NCT01380093|3760526|P5|STARTED|Treatment Phase: Washout Period||6
1536738|NCT01380093|3760527|P4|STARTED|Treatment Phase: Washout Period||6
1536739|NCT01380093|3760528|P3|STARTED|Treatment Phase: Washout Period||0
1536740|NCT01380093|3760529|P2|STARTED|Treatment Phase: Washout Period||0
1536741|NCT01380093|3760530|P1|STARTED|Treatment Phase: Washout Period||0
1536742|NCT01380093|3760522|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
1536743|NCT01380093|3760523|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
1536744|NCT01380093|3760524|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
1536745|NCT01380093|3760525|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
1536746|NCT01380093|3760526|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
1536747|NCT01380093|3760527|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
1536748|NCT01380093|3760528|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
1536749|NCT01380093|3760529|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
1536750|NCT01380093|3760530|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
1536751|NCT01380093|3760522|P9|COMPLETED|Treatment Phase: First Intervention||6
1536752|NCT01380093|3760523|P8|COMPLETED|Treatment Phase: First Intervention||6
1536753|NCT01380093|3760524|P7|COMPLETED|Treatment Phase: First Intervention||6
1536754|NCT01380093|3760525|P6|COMPLETED|Treatment Phase: First Intervention||6
1536755|NCT01380093|3760526|P5|COMPLETED|Treatment Phase: First Intervention||6
1536756|NCT01380093|3760527|P4|COMPLETED|Treatment Phase: First Intervention||6
1536757|NCT01380093|3760528|P3|COMPLETED|Treatment Phase: First Intervention||0
1536758|NCT01380093|3760529|P2|COMPLETED|Treatment Phase: First Intervention||0
1536759|NCT01380093|3760530|P1|COMPLETED|Treatment Phase: First Intervention||0
1536760|NCT01380093|3760522|P9|STARTED|Treatment Phase: First Intervention||6
1536761|NCT01380093|3760523|P8|STARTED|Treatment Phase: First Intervention||6
1536762|NCT01380093|3760524|P7|STARTED|Treatment Phase: First Intervention||6
1536763|NCT01380093|3760525|P6|STARTED|Treatment Phase: First Intervention||6
1536764|NCT01380093|3760526|P5|STARTED|Treatment Phase: First Intervention||6
1536765|NCT01380093|3760527|P4|STARTED|Treatment Phase: First Intervention||6
1536766|NCT01380093|3760528|P3|STARTED|Treatment Phase: First Intervention||0
1536767|NCT01380093|3760529|P2|STARTED|Treatment Phase: First Intervention||0
1536768|NCT01380093|3760530|P1|STARTED|Treatment Phase: First Intervention||0
1536769|NCT01380093|3760522|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1536770|NCT01380093|3760523|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1536771|NCT01380093|3760524|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1536772|NCT01380093|3760525|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1536773|NCT01380093|3760526|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1536774|NCT01380093|3760527|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1536775|NCT01380093|3760528|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
1536776|NCT01380093|3760529|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
1536777|NCT01380093|3760530|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
1536778|NCT01380093|3760522|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
1536779|NCT01380093|3760523|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
1536780|NCT01380093|3760524|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
1536781|NCT01380093|3760525|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
1536782|NCT01380093|3760526|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
1536783|NCT01380093|3760527|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
1536784|NCT01380093|3760528|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
1536785|NCT01380093|3760529|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
1536786|NCT01380093|3760530|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
1536787|NCT01380093|3760522|P9|STARTED|Drug Discrimination Phase: Day 2||0
1536788|NCT01380093|3760523|P8|STARTED|Drug Discrimination Phase: Day 2||0
1536789|NCT01380093|3760524|P7|STARTED|Drug Discrimination Phase: Day 2||0
1536790|NCT01380093|3760525|P6|STARTED|Drug Discrimination Phase: Day 2||0
1536791|NCT01380093|3760526|P5|STARTED|Drug Discrimination Phase: Day 2||0
1536792|NCT01380093|3760527|P4|STARTED|Drug Discrimination Phase: Day 2||0
1536793|NCT01380093|3760528|P3|STARTED|Drug Discrimination Phase: Day 2||29
1536794|NCT01380093|3760529|P2|STARTED|Drug Discrimination Phase: Day 2||29
1536795|NCT01380093|3760530|P1|STARTED|Drug Discrimination Phase: Day 2||0
1536796|NCT01380093|3760522|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1536797|NCT01380093|3760523|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1536798|NCT01380093|3760524|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1536799|NCT01380093|3760525|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1536800|NCT01380093|3760526|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1536801|NCT01380093|3760527|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1536802|NCT01380093|3760528|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1536803|NCT01380093|3760529|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
1536804|NCT01380093|3760530|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
1536805|NCT01380093|3760522|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
1536806|NCT01380093|3760523|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
1536807|NCT01380093|3760524|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
1536808|NCT01380093|3760525|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
1536809|NCT01380093|3760526|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
1536810|NCT01380093|3760527|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
1536811|NCT01380093|3760528|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
1536812|NCT01380093|3760529|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
1536813|NCT01380093|3760530|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
1536814|NCT01380093|3760522|P9|STARTED|Drug Discrimination Phase: Day 1||0
1536815|NCT01380093|3760523|P8|STARTED|Drug Discrimination Phase: Day 1||0
1536816|NCT01380093|3760524|P7|STARTED|Drug Discrimination Phase: Day 1||0
1536817|NCT01380093|3760525|P6|STARTED|Drug Discrimination Phase: Day 1||0
1536818|NCT01380093|3760526|P5|STARTED|Drug Discrimination Phase: Day 1||0
1536819|NCT01380093|3760527|P4|STARTED|Drug Discrimination Phase: Day 1||0
1536820|NCT01380093|3760528|P3|STARTED|Drug Discrimination Phase: Day 1||29
1536821|NCT01380093|3760529|P2|STARTED|Drug Discrimination Phase: Day 1||30
1536822|NCT01380093|3760530|P1|STARTED|Drug Discrimination Phase: Day 1||0
1536823|NCT01380093|3760522|P9|NOT COMPLETED|Naloxone Challenge Phase||0
1536824|NCT01380093|3760523|P8|NOT COMPLETED|Naloxone Challenge Phase||0
1536825|NCT01380093|3760524|P7|NOT COMPLETED|Naloxone Challenge Phase||0
1536826|NCT01380093|3760525|P6|NOT COMPLETED|Naloxone Challenge Phase||0
1536827|NCT01380093|3760526|P5|NOT COMPLETED|Naloxone Challenge Phase||0
1536828|NCT01380093|3760527|P4|NOT COMPLETED|Naloxone Challenge Phase||0
1536829|NCT01380093|3760528|P3|NOT COMPLETED|Naloxone Challenge Phase||0
1536830|NCT01380093|3760529|P2|NOT COMPLETED|Naloxone Challenge Phase||0
1536831|NCT01380093|3760530|P1|NOT COMPLETED|Naloxone Challenge Phase||21
1536832|NCT01380093|3760522|P9|COMPLETED|Naloxone Challenge Phase||0
1536833|NCT01380093|3760523|P8|COMPLETED|Naloxone Challenge Phase||0
1536834|NCT01380093|3760524|P7|COMPLETED|Naloxone Challenge Phase||0
1536835|NCT01380093|3760525|P6|COMPLETED|Naloxone Challenge Phase||0
1536836|NCT01380093|3760526|P5|COMPLETED|Naloxone Challenge Phase||0
1536837|NCT01380093|3760527|P4|COMPLETED|Naloxone Challenge Phase||0
1536838|NCT01380093|3760528|P3|COMPLETED|Naloxone Challenge Phase||0
1536839|NCT01380093|3760529|P2|COMPLETED|Naloxone Challenge Phase||0
1536840|NCT01380093|3760530|P1|COMPLETED|Naloxone Challenge Phase||59
1536841|NCT01380093|3760522|P9|TREATED|Naloxone Challenge Phase||0
1536842|NCT01380093|3760523|P8|TREATED|Naloxone Challenge Phase||0
1536843|NCT01380093|3760524|P7|TREATED|Naloxone Challenge Phase||0
1536844|NCT01380093|3760525|P6|TREATED|Naloxone Challenge Phase||0
1536845|NCT01380093|3760526|P5|TREATED|Naloxone Challenge Phase||0
1536846|NCT01380093|3760527|P4|TREATED|Naloxone Challenge Phase||0
1536847|NCT01380093|3760528|P3|TREATED|Naloxone Challenge Phase||0
1536848|NCT01380093|3760529|P2|TREATED|Naloxone Challenge Phase||0
1536849|NCT01380093|3760530|P1|TREATED|Naloxone Challenge Phase||59
1536850|NCT01380093|3760522|P9|STARTED|Naloxone Challenge Phase||0
1536851|NCT01380093|3760523|P8|STARTED|Naloxone Challenge Phase||0
1536852|NCT01380093|3760524|P7|STARTED|Naloxone Challenge Phase||0
1536853|NCT01380093|3760525|P6|STARTED|Naloxone Challenge Phase||0
1536854|NCT01380093|3760526|P5|STARTED|Naloxone Challenge Phase||0
1536855|NCT01380093|3760527|P4|STARTED|Naloxone Challenge Phase||0
1536856|NCT01380093|3760528|P3|STARTED|Naloxone Challenge Phase||0
1536857|NCT01380093|3760529|P2|STARTED|Naloxone Challenge Phase||0
1536858|NCT01380093|3760530|P1|STARTED|Naloxone Challenge Phase||80
1536859|NCT01380080|3760822|P2|NOT COMPLETED|Overall Study||23
1536860|NCT01380080|3760823|P1|NOT COMPLETED|Overall Study||33
1536861|NCT01380080|3760822|P2|COMPLETED|Overall Study||403
1536862|NCT01380080|3760823|P1|COMPLETED|Overall Study||391
1536863|NCT01380080|3760822|P2|STARTED|Overall Study||426
1536864|NCT01380080|3760823|P1|STARTED|Overall Study||424
1536865|NCT01379963|3760839|P1|NOT COMPLETED|Overall Study||0
1536866|NCT01379963|3760839|P1|COMPLETED|Overall Study||780
1536867|NCT01379963|3760839|P1|STARTED|Overall Study||780
1536868|NCT01379937|3760848|P4|NOT COMPLETED|Overall Study||1
1536869|NCT01379937|3760849|P3|NOT COMPLETED|Overall Study||2
1536870|NCT01379937|3760850|P2|NOT COMPLETED|Overall Study||3
1536871|NCT01379937|3760851|P1|NOT COMPLETED|Overall Study||1
1536872|NCT01379937|3760848|P4|COMPLETED|Overall Study||103
1536873|NCT01379937|3760849|P3|COMPLETED|Overall Study||102
1536874|NCT01379937|3760850|P2|COMPLETED|Overall Study||153
1536875|NCT01379937|3760851|P1|COMPLETED|Overall Study||155
1536876|NCT01379937|3760848|P4|STARTED|Overall Study||104
1536877|NCT01379937|3760849|P3|STARTED|Overall Study||104
1536878|NCT01379937|3760850|P2|STARTED|Overall Study||156
1536879|NCT01379937|3760851|P1|STARTED|Overall Study||156
1536880|NCT01379781|3760933|P2|NOT COMPLETED|Overall Study||8
1536881|NCT01379781|3760934|P1|NOT COMPLETED|Overall Study||11
1536882|NCT01379781|3760933|P2|COMPLETED|Overall Study||19
1536883|NCT01379781|3760934|P1|COMPLETED|Overall Study||16
1536884|NCT01379781|3760933|P2|STARTED|Overall Study||27
1536885|NCT01379781|3760934|P1|STARTED|Overall Study||27
1536886|NCT01379768|3760943|P3|NOT COMPLETED|Overall Study||0
1536887|NCT01379768|3760944|P2|NOT COMPLETED|Overall Study||1
1536888|NCT01379768|3760945|P1|NOT COMPLETED|Overall Study||3
1536889|NCT01379768|3760943|P3|COMPLETED|Overall Study||20
1536890|NCT01379768|3760944|P2|COMPLETED|Overall Study||21
1536891|NCT01379768|3760945|P1|COMPLETED|Overall Study||20
1536892|NCT01379768|3760943|P3|STARTED|Overall Study||20
1536893|NCT01379768|3760944|P2|STARTED|Overall Study||22
1536894|NCT01379768|3760945|P1|STARTED|Overall Study||23
1536895|NCT01379703|3760968|P3|NOT COMPLETED|9 Months Through 18 Months||0
1536896|NCT01379703|3760969|P2|NOT COMPLETED|9 Months Through 18 Months||230
1536897|NCT01379703|3760970|P1|NOT COMPLETED|9 Months Through 18 Months||0
1536898|NCT01379703|3760968|P3|COMPLETED|9 Months Through 18 Months||0
1536899|NCT01379703|3760969|P2|COMPLETED|9 Months Through 18 Months||854
1536900|NCT01379703|3760970|P1|COMPLETED|9 Months Through 18 Months||0
1536901|NCT01379703|3760968|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
1536902|NCT01379703|3760969|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
1536903|NCT01379703|3760970|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
1536904|NCT01379703|3760968|P3|NOT COMPLETED|Study Start Through 9 Months||143
1536905|NCT01379703|3760969|P2|NOT COMPLETED|Study Start Through 9 Months||122
1536906|NCT01379703|3760970|P1|NOT COMPLETED|Study Start Through 9 Months||4
1536907|NCT01379703|3760968|P3|COMPLETED|Study Start Through 9 Months||873
1536908|NCT01379703|3760969|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
1536909|NCT01379703|3760970|P1|COMPLETED|Study Start Through 9 Months||62
1536910|NCT01379703|3760968|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
1536911|NCT01379703|3760969|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
1536912|NCT01379703|3760970|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
1536913|NCT01379664|3761033|P2|NOT COMPLETED|Overall Study||0
1536914|NCT01379664|3761034|P1|NOT COMPLETED|Overall Study||0
1536915|NCT01379664|3761033|P2|COMPLETED|Overall Study||870
1536916|NCT01379664|3761034|P1|COMPLETED|Overall Study||714
1536917|NCT01379664|3761033|P2|STARTED|Overall Study||870
1536918|NCT01379664|3761034|P1|STARTED|Overall Study||714
1536919|NCT01379651|3761046|P2|NOT COMPLETED|Overall Study||0
1536920|NCT01379651|3761047|P1|NOT COMPLETED|Overall Study||0
1536921|NCT01379651|3761046|P2|COMPLETED|Overall Study||10
1536922|NCT01379651|3761047|P1|COMPLETED|Overall Study||10
1536923|NCT01379651|3761046|P2|STARTED|Overall Study||10
1536924|NCT01379651|3761047|P1|STARTED|Overall Study||10
1536925|NCT01379625|3761057|P2|NOT COMPLETED|Overall Study||0
1536926|NCT01379625|3761058|P1|NOT COMPLETED|Overall Study||0
1536927|NCT01379625|3761057|P2|COMPLETED|Overall Study||16
1536928|NCT01379625|3761058|P1|COMPLETED|Overall Study||16
1536929|NCT01379625|3761057|P2|STARTED|Overall Study||16
1536930|NCT01379625|3761058|P1|STARTED|Overall Study||16
1536931|NCT01379534|3761070|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
1536932|NCT01379534|3761071|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
1536933|NCT01379534|3761070|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
1536934|NCT01379534|3761071|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
1536935|NCT01379534|3761070|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
1536936|NCT01379534|3761071|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
1536937|NCT01379534|3761070|P2|NOT COMPLETED|Treatment Phase||31
1536938|NCT01379534|3761071|P1|NOT COMPLETED|Treatment Phase||22
1536939|NCT01379534|3761070|P2|COMPLETED|Treatment Phase||0
1536940|NCT01379534|3761071|P1|COMPLETED|Treatment Phase||0
1536941|NCT01379534|3761070|P2|STARTED|Treatment Phase||31
1536942|NCT01379534|3761071|P1|STARTED|Treatment Phase||22
1536943|NCT01379521|3761091|P2|NOT COMPLETED|Post-Treatment Evaluations||21
1536944|NCT01379521|3761092|P1|NOT COMPLETED|Post-Treatment Evaluations||25
1536945|NCT01379521|3761091|P2|COMPLETED|Post-Treatment Evaluations||0
1536946|NCT01379521|3761092|P1|COMPLETED|Post-Treatment Evaluations||0
1536947|NCT01379521|3761091|P2|STARTED|Post-Treatment Evaluations||21
1536948|NCT01379521|3761092|P1|STARTED|Post-Treatment Evaluations||25
1536949|NCT01379521|3761091|P2|NOT COMPLETED|Overall Study -Treatment Period||26
1536950|NCT01379521|3761092|P1|NOT COMPLETED|Overall Study -Treatment Period||33
1536951|NCT01379521|3761091|P2|COMPLETED|Overall Study -Treatment Period||0
1536952|NCT01379521|3761092|P1|COMPLETED|Overall Study -Treatment Period||0
1536953|NCT01379521|3761091|P2|STARTED|Overall Study -Treatment Period||26
1536954|NCT01379521|3761092|P1|STARTED|Overall Study -Treatment Period||33
1536955|NCT01379508|3761114|P4|NOT COMPLETED|Extension Period Weeks 109-156||0
1536956|NCT01379508|3761115|P3|NOT COMPLETED|Extension Period Weeks 109-156||14
1536957|NCT01379508|3761116|P2|NOT COMPLETED|Extension Period Weeks 109-156||3
1536958|NCT01379508|3761117|P1|NOT COMPLETED|Extension Period Weeks 109-156||19
1536959|NCT01379508|3761114|P4|COMPLETED|Extension Period Weeks 109-156||10
1536960|NCT01379508|3761115|P3|COMPLETED|Extension Period Weeks 109-156||65
1536961|NCT01379508|3761116|P2|COMPLETED|Extension Period Weeks 109-156||14
1536962|NCT01379508|3761117|P1|COMPLETED|Extension Period Weeks 109-156||45
1536963|NCT01379508|3761114|P4|STARTED|Extension Period Weeks 109-156||10
1536964|NCT01379508|3761115|P3|STARTED|Extension Period Weeks 109-156||79
1536965|NCT01379508|3761116|P2|STARTED|Extension Period Weeks 109-156||17
1536966|NCT01379508|3761117|P1|STARTED|Extension Period Weeks 109-156||64
1536967|NCT01379508|3761114|P4|NOT COMPLETED|Treatment to Week 104||0
1536968|NCT01379508|3761115|P3|NOT COMPLETED|Treatment to Week 104||13
1536969|NCT01379508|3761116|P2|NOT COMPLETED|Treatment to Week 104||3
1536970|NCT01379508|3761117|P1|NOT COMPLETED|Treatment to Week 104||19
1536971|NCT01379508|3761114|P4|COMPLETED|Treatment to Week 104||11
1536972|NCT01379508|3761115|P3|COMPLETED|Treatment to Week 104||96
1536973|NCT01379508|3761116|P2|COMPLETED|Treatment to Week 104||19
1536974|NCT01379508|3761117|P1|COMPLETED|Treatment to Week 104||80
1536975|NCT01379508|3761114|P4|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
1536976|NCT01379508|3761115|P3|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
1536977|NCT01379508|3761116|P2|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
1536978|NCT01379508|3761117|P1|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
1536979|NCT01379508|3761114|P4|Completed Wk 24|Treatment to Week 104||11
1536980|NCT01379508|3761115|P3|Completed Wk 24|Treatment to Week 104||107
1536981|NCT01379508|3761116|P2|Completed Wk 24|Treatment to Week 104||22
1536982|NCT01379508|3761117|P1|Completed Wk 24|Treatment to Week 104||93
1536983|NCT01379508|3761114|P4|STARTED|Treatment to Week 104||11
1536984|NCT01379508|3761115|P3|STARTED|Treatment to Week 104||109
1536985|NCT01379508|3761116|P2|STARTED|Treatment to Week 104||22
1536986|NCT01379508|3761117|P1|STARTED|Treatment to Week 104||99
1536987|NCT01379183|3761145|P2|NOT COMPLETED|Overall Study||0
1536988|NCT01379183|3761146|P1|NOT COMPLETED|Overall Study||0
1536989|NCT01379183|3761145|P2|COMPLETED|Overall Study||21
1536990|NCT01379183|3761146|P1|COMPLETED|Overall Study||19
1536991|NCT01379183|3761145|P2|STARTED|Overall Study||21
1536992|NCT01379183|3761146|P1|STARTED|Overall Study||19
1536993|NCT01378988|3761164|P2|NOT COMPLETED|Overall Study||0
1536994|NCT01378988|3761165|P1|NOT COMPLETED|Overall Study||0
1536995|NCT01378988|3761164|P2|COMPLETED|Overall Study||3
1536996|NCT01378988|3761165|P1|COMPLETED|Overall Study||2
1536997|NCT01378988|3761164|P2|STARTED|Overall Study||3
1536998|NCT01378988|3761165|P1|STARTED|Overall Study||2
1536999|NCT01378975|3761195|P2|NOT COMPLETED|Overall Study||50
1537000|NCT01378975|3761196|P1|NOT COMPLETED|Overall Study||86
1537001|NCT01378975|3761195|P2|COMPLETED|Overall Study||6
1537002|NCT01378975|3761196|P1|COMPLETED|Overall Study||4
1537003|NCT01378975|3761195|P2|STARTED|Overall Study||56
1537004|NCT01378975|3761196|P1|STARTED|Overall Study||90
1537005|NCT01378962|3761222|P1|NOT COMPLETED|Overall Study||17
1537006|NCT01378962|3761222|P1|COMPLETED|Overall Study||33
1537007|NCT01378962|3761222|P1|STARTED|Overall Study||50
1537008|NCT01378520|3761235|P2|NOT COMPLETED|Second Intervention (Day 4-6)||0
1537009|NCT01378520|3761236|P1|NOT COMPLETED|Second Intervention (Day 4-6)||0
1537010|NCT01378520|3761235|P2|COMPLETED|Second Intervention (Day 4-6)||10
1537011|NCT01378520|3761236|P1|COMPLETED|Second Intervention (Day 4-6)||10
1537012|NCT01378520|3761235|P2|STARTED|Second Intervention (Day 4-6)||10
1537013|NCT01378520|3761236|P1|STARTED|Second Intervention (Day 4-6)||10
1537014|NCT01378520|3761235|P2|NOT COMPLETED|First Intervention (Day 2-3)||0
1537015|NCT01378520|3761236|P1|NOT COMPLETED|First Intervention (Day 2-3)||0
1537016|NCT01378520|3761235|P2|COMPLETED|First Intervention (Day 2-3)||10
1537017|NCT01378520|3761236|P1|COMPLETED|First Intervention (Day 2-3)||10
1537018|NCT01378520|3761235|P2|STARTED|First Intervention (Day 2-3)||10
1537019|NCT01378520|3761236|P1|STARTED|First Intervention (Day 2-3)||10
1537020|NCT01378429|3761248|P2|NOT COMPLETED|Overall Study||0
1537021|NCT01378429|3761249|P1|NOT COMPLETED|Overall Study||1
1537022|NCT01378429|3761248|P2|COMPLETED|Overall Study||47
1537023|NCT01378429|3761249|P1|COMPLETED|Overall Study||41
1537024|NCT01378429|3761248|P2|STARTED|Overall Study||47
1537025|NCT01378429|3761249|P1|STARTED|Overall Study||42
1537026|NCT01378416|3761281|P1|NOT COMPLETED|Overall Study||0
1537027|NCT01378416|3761281|P1|COMPLETED|Overall Study||16
1537028|NCT01378416|3761281|P1|STARTED|Overall Study||16
1537029|NCT01378377|3761292|P3|NOT COMPLETED|Overall Study||0
1537030|NCT01378377|3761293|P2|NOT COMPLETED|Overall Study||0
1537031|NCT01378377|3761294|P1|NOT COMPLETED|Overall Study||0
1537032|NCT01378377|3761292|P3|COMPLETED|Overall Study||6
1537033|NCT01378377|3761293|P2|COMPLETED|Overall Study||23
1537034|NCT01378377|3761294|P1|COMPLETED|Overall Study||4
1537035|NCT01378377|3761292|P3|STARTED|Overall Study||6
1537036|NCT01378377|3761293|P2|STARTED|Overall Study||23
1537037|NCT01378377|3761294|P1|STARTED|Overall Study||4
1537038|NCT01378325|3761362|P2|NOT COMPLETED|Overall Study||1
1537039|NCT01378325|3761363|P1|NOT COMPLETED|Overall Study||0
1537040|NCT01378325|3761362|P2|COMPLETED|Overall Study||39
1537041|NCT01378325|3761363|P1|COMPLETED|Overall Study||40
1537042|NCT01378325|3761362|P2|STARTED|Overall Study||40
1537043|NCT01378325|3761363|P1|STARTED|Overall Study||40
1537044|NCT01378221|3761371|P2|NOT COMPLETED|Overall Study||9
1537045|NCT01378221|3761372|P1|NOT COMPLETED|Overall Study||7
1537046|NCT01378221|3761371|P2|COMPLETED|Overall Study||30
1537047|NCT01378221|3761372|P1|COMPLETED|Overall Study||29
1537048|NCT01378221|3761371|P2|STARTED|Overall Study||39
1537049|NCT01378221|3761372|P1|STARTED|Overall Study||36
1537050|NCT01378195|3761380|P2|NOT COMPLETED|Overall Study||18
1537051|NCT01378195|3761381|P1|NOT COMPLETED|Overall Study||29
1537052|NCT01378195|3761380|P2|COMPLETED|Overall Study||57
1537053|NCT01378195|3761381|P1|COMPLETED|Overall Study||46
1537054|NCT01378195|3761380|P2|STARTED|Overall Study||75
1537055|NCT01378195|3761381|P1|STARTED|Overall Study||75
1537056|NCT01378117|3761394|P3|NOT COMPLETED|Overall Study||3
1537057|NCT01378117|3761395|P2|NOT COMPLETED|Overall Study||1
1537058|NCT01378117|3761396|P1|NOT COMPLETED|Overall Study||4
1537059|NCT01378117|3761394|P3|COMPLETED|Overall Study||26
1537060|NCT01378117|3761395|P2|COMPLETED|Overall Study||29
1537061|NCT01378117|3761396|P1|COMPLETED|Overall Study||27
1537062|NCT01378117|3761394|P3|STARTED|Overall Study||29
1537063|NCT01378117|3761395|P2|STARTED|Overall Study||30
1537064|NCT01378117|3761396|P1|STARTED|Overall Study||31
1537065|NCT01378104|3761430|P2|NOT COMPLETED|Overall Study||26
1537066|NCT01378104|3761431|P1|NOT COMPLETED|Overall Study||27
1537067|NCT01378104|3761430|P2|COMPLETED|Overall Study||60
1537068|NCT01378104|3761431|P1|COMPLETED|Overall Study||65
1537069|NCT01378104|3761430|P2|STARTED|Overall Study||86
1537070|NCT01378104|3761431|P1|STARTED|Overall Study||92
1537071|NCT01378065|3761439|P1|NOT COMPLETED|Overall Study||0
1537072|NCT01378065|3761439|P1|COMPLETED|Overall Study||30
1537073|NCT01378065|3761439|P1|12 Months|Overall Study||30
1537074|NCT01378065|3761439|P1|6 Months|Overall Study||30
1537075|NCT01378065|3761439|P1|3 Months|Overall Study||30
1537076|NCT01378065|3761439|P1|6 Week|Overall Study||30
1537077|NCT01378065|3761439|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
1537078|NCT01377987|3761476|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1537079|NCT01377987|3761477|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1537080|NCT01377987|3761476|P2|COMPLETED|Second Intervention (7 Days)||14
1537081|NCT01377987|3761477|P1|COMPLETED|Second Intervention (7 Days)||13
1537082|NCT01377987|3761476|P2|STARTED|Second Intervention (7 Days)||14
1537083|NCT01377987|3761477|P1|STARTED|Second Intervention (7 Days)||13
1537084|NCT01377987|3761476|P2|NOT COMPLETED|Washout (7 Days)||1
1537085|NCT01377987|3761477|P1|NOT COMPLETED|Washout (7 Days)||1
1537086|NCT01377987|3761476|P2|COMPLETED|Washout (7 Days)||14
1537087|NCT01377987|3761477|P1|COMPLETED|Washout (7 Days)||13
1537088|NCT01377987|3761476|P2|STARTED|Washout (7 Days)||15
1537089|NCT01377987|3761477|P1|STARTED|Washout (7 Days)||14
1537090|NCT01377987|3761476|P2|NOT COMPLETED|First Intervention (7 Days)||0
1537091|NCT01377987|3761477|P1|NOT COMPLETED|First Intervention (7 Days)||0
1537092|NCT01377987|3761476|P2|COMPLETED|First Intervention (7 Days)||15
1537093|NCT01377987|3761477|P1|COMPLETED|First Intervention (7 Days)||14
1537094|NCT01377987|3761476|P2|STARTED|First Intervention (7 Days)||15
1537095|NCT01377987|3761477|P1|STARTED|First Intervention (7 Days)||14
1537096|NCT01377922|3761495|P2|NOT COMPLETED|Overall Study||0
1537097|NCT01377922|3761496|P1|NOT COMPLETED|Overall Study||1
1537098|NCT01377922|3761495|P2|COMPLETED|Overall Study||16
1537099|NCT01377922|3761496|P1|COMPLETED|Overall Study||21
1537100|NCT01377922|3761495|P2|STARTED|Overall Study||16
1537101|NCT01377922|3761496|P1|STARTED|Overall Study||22
1537102|NCT01377636|3761508|P1|NOT COMPLETED|Overall Study||0
1537103|NCT01377636|3761508|P1|COMPLETED|Overall Study||20
1537104|NCT01377636|3761508|P1|STARTED|Overall Study||20
1537105|NCT01377623|3761522|P2|NOT COMPLETED|Overall Study||5
1537106|NCT01377623|3761523|P1|NOT COMPLETED|Overall Study||7
1537107|NCT01377623|3761522|P2|COMPLETED|Overall Study||28
1537108|NCT01377623|3761523|P1|COMPLETED|Overall Study||26
1537109|NCT01377623|3761522|P2|STARTED|Overall Study||33
1537110|NCT01377623|3761523|P1|STARTED|Overall Study||33
1537111|NCT01377584|3761543|P6|NOT COMPLETED|Overall Study||3
1537112|NCT01377584|3761544|P5|NOT COMPLETED|Overall Study||3
1537113|NCT01377584|3761545|P4|NOT COMPLETED|Overall Study||4
1537114|NCT01377584|3761546|P3|NOT COMPLETED|Overall Study||4
1537115|NCT01377584|3761547|P2|NOT COMPLETED|Overall Study||3
1537116|NCT01377584|3761548|P1|NOT COMPLETED|Overall Study||3
1537117|NCT01377584|3761543|P6|COMPLETED|Overall Study||9
1537118|NCT01377584|3761544|P5|COMPLETED|Overall Study||9
1537119|NCT01377584|3761545|P4|COMPLETED|Overall Study||6
1537120|NCT01377584|3761546|P3|COMPLETED|Overall Study||6
1537121|NCT01377584|3761547|P2|COMPLETED|Overall Study||5
1537122|NCT01377584|3761548|P1|COMPLETED|Overall Study||5
1537123|NCT01377584|3761543|P6|STARTED|Overall Study||12
1537124|NCT01377584|3761544|P5|STARTED|Overall Study||12
1537125|NCT01377584|3761545|P4|STARTED|Overall Study||10
1537126|NCT01377584|3761546|P3|STARTED|Overall Study||10
1537127|NCT01377584|3761547|P2|STARTED|Overall Study||8
1537128|NCT01377584|3761548|P1|STARTED|Overall Study||8
1537129|NCT01377480|3761581|P4|NOT COMPLETED|Overall Study||11
1537130|NCT01377480|3761582|P3|NOT COMPLETED|Overall Study||10
1537131|NCT01377480|3761583|P2|NOT COMPLETED|Overall Study||1
1537132|NCT01377480|3761584|P1|NOT COMPLETED|Overall Study||0
1537133|NCT01377480|3761581|P4|COMPLETED|Overall Study||19
1537134|NCT01377480|3761582|P3|COMPLETED|Overall Study||18
1537135|NCT01377480|3761583|P2|COMPLETED|Overall Study||29
1537136|NCT01377480|3761584|P1|COMPLETED|Overall Study||32
1537137|NCT01377480|3761581|P4|STARTED|Overall Study||30
1537138|NCT01377480|3761582|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
1537139|NCT01377480|3761583|P2|STARTED|Overall Study||30
1537140|NCT01377480|3761584|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
1537141|NCT01377467|3761596|P2|NOT COMPLETED|Overall Study||0
1537142|NCT01377467|3761597|P1|NOT COMPLETED|Overall Study||0
1537143|NCT01377467|3761596|P2|COMPLETED|Overall Study||44
1537144|NCT01377467|3761597|P1|COMPLETED|Overall Study||46
1537145|NCT01377467|3761596|P2|STARTED|Overall Study||44
1537146|NCT01377467|3761597|P1|STARTED|Overall Study||46
1537147|NCT01377441|3761645|P2|NOT COMPLETED|Overall Study||0
1537148|NCT01377441|3761646|P1|NOT COMPLETED|Overall Study||0
1537149|NCT01377441|3761645|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
1537150|NCT01377441|3761646|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
1537151|NCT01377441|3761645|P2|STARTED|Overall Study||0
1537152|NCT01377441|3761646|P1|STARTED|Overall Study||0
1537153|NCT01377402|3761654|P1|NOT COMPLETED|Overall Study||0
1537154|NCT01377402|3761654|P1|COMPLETED|Overall Study||982
1537155|NCT01377402|3761654|P1|STARTED|Overall Study||982
1537156|NCT01377233|3761665|P5|NOT COMPLETED|Double-blind||2
1537157|NCT01377233|3761666|P4|NOT COMPLETED|Double-blind||4
1537158|NCT01377233|3761667|P3|NOT COMPLETED|Double-blind||2
1537159|NCT01377233|3761668|P2|NOT COMPLETED|Double-blind||1
1537160|NCT01377233|3761669|P1|NOT COMPLETED|Double-blind||0
1537161|NCT01377233|3761665|P5|COMPLETED|Double-blind||8
1537162|NCT01377233|3761666|P4|COMPLETED|Double-blind||7
1537163|NCT01377233|3761667|P3|COMPLETED|Double-blind||8
1537164|NCT01377233|3761668|P2|COMPLETED|Double-blind||10
1537165|NCT01377233|3761669|P1|COMPLETED|Double-blind||0
1537166|NCT01377233|3761665|P5|STARTED|Double-blind||10
1537167|NCT01377233|3761666|P4|STARTED|Double-blind||11
1537168|NCT01377233|3761667|P3|STARTED|Double-blind||10
1537169|NCT01377233|3761668|P2|STARTED|Double-blind||11
1537170|NCT01377233|3761669|P1|STARTED|Double-blind||0
1537171|NCT01377233|3761665|P5|NOT COMPLETED|Open-label||0
1537172|NCT01377233|3761666|P4|NOT COMPLETED|Open-label||0
1537173|NCT01377233|3761667|P3|NOT COMPLETED|Open-label||0
1537174|NCT01377233|3761668|P2|NOT COMPLETED|Open-label||0
1537175|NCT01377233|3761669|P1|NOT COMPLETED|Open-label||4
1537176|NCT01377233|3761665|P5|COMPLETED|Open-label||0
1537177|NCT01377233|3761666|P4|COMPLETED|Open-label||0
1537178|NCT01377233|3761667|P3|COMPLETED|Open-label||0
1537179|NCT01377233|3761668|P2|COMPLETED|Open-label||0
1537180|NCT01377233|3761669|P1|COMPLETED|Open-label||42
1537181|NCT01377233|3761665|P5|STARTED|Open-label||0
1537182|NCT01377233|3761666|P4|STARTED|Open-label||0
1537183|NCT01377233|3761667|P3|STARTED|Open-label||0
1537184|NCT01377233|3761668|P2|STARTED|Open-label||0
1537185|NCT01377233|3761669|P1|STARTED|Open-label||46
1537186|NCT01377194|3761696|P3|NOT COMPLETED|Overall Study||46
1537187|NCT01377194|3761697|P2|NOT COMPLETED|Overall Study||43
1537188|NCT01377194|3761698|P1|NOT COMPLETED|Overall Study||32
1537189|NCT01377194|3761696|P3|COMPLETED|Overall Study||142
1537190|NCT01377194|3761697|P2|COMPLETED|Overall Study||145
1537191|NCT01377194|3761698|P1|COMPLETED|Overall Study||154
1537192|NCT01377194|3761696|P3|STARTED|Overall Study||188
1537193|NCT01377194|3761697|P2|STARTED|Overall Study||188
1537194|NCT01377194|3761698|P1|STARTED|Overall Study||186
1537195|NCT01377012|3761712|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
1537196|NCT01377012|3761713|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
1537197|NCT01377012|3761714|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
1537198|NCT01377012|3761712|P3|COMPLETED|Extension Study, Weeks 104-260||0
1537199|NCT01377012|3761713|P2|COMPLETED|Extension Study, Weeks 104-260||0
1537200|NCT01377012|3761714|P1|COMPLETED|Extension Study, Weeks 104-260||0
1537201|NCT01377012|3761712|P3|STARTED|Extension Study, Weeks 104-260||68
1537202|NCT01377012|3761713|P2|STARTED|Extension Study, Weeks 104-260||71
1537203|NCT01377012|3761714|P1|STARTED|Extension Study, Weeks 104-260||57
1537204|NCT01377012|3761712|P3|NOT COMPLETED|Core Study||134
1537205|NCT01377012|3761713|P2|NOT COMPLETED|Core Study||132
1537206|NCT01377012|3761714|P1|NOT COMPLETED|Core Study||134
1537207|NCT01377012|3761712|P3|COMPLETED|Core Study||80
1537208|NCT01377012|3761713|P2|COMPLETED|Core Study||81
1537209|NCT01377012|3761714|P1|COMPLETED|Core Study||76
1537210|NCT01377012|3761712|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
1537211|NCT01377012|3761713|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
1537212|NCT01377012|3761714|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
1537213|NCT01377012|3761712|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
1537214|NCT01377012|3761713|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
1537215|NCT01377012|3761714|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
1537216|NCT01377012|3761712|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
1537217|NCT01377012|3761713|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
1537218|NCT01377012|3761714|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
1537219|NCT01377012|3761712|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
1537220|NCT01377012|3761713|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
1537221|NCT01377012|3761714|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
1537222|NCT01377012|3761712|P3|STARTED|Core Study||214
1537223|NCT01377012|3761713|P2|STARTED|Core Study||213
1537224|NCT01377012|3761714|P1|STARTED|Core Study||210
1537225|NCT01376908|3761751|P2|NOT COMPLETED|Overall Study||3
1537226|NCT01376908|3761752|P1|NOT COMPLETED|Overall Study||2
1537227|NCT01376908|3761751|P2|COMPLETED|Overall Study||26
1537228|NCT01376908|3761752|P1|COMPLETED|Overall Study||25
1537229|NCT01376908|3761751|P2|STARTED|Overall Study||29
1537230|NCT01376908|3761752|P1|STARTED|Overall Study||27
1537231|NCT01376804|3761785|P1|NOT COMPLETED|Follow-up Period||0
1537232|NCT01376804|3761785|P1|COMPLETED|Follow-up Period||55
1537233|NCT01376804|3761785|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
1537234|NCT01376804|3761785|P1|NOT COMPLETED|Treatment Period||8
1537235|NCT01376804|3761785|P1|COMPLETED|Treatment Period||49
1537236|NCT01376804|3761785|P1|Received Study Drug|Treatment Period||56
1537237|NCT01376804|3761785|P1|STARTED|Treatment Period||57
1537238|NCT01376700|3761796|P1|NOT COMPLETED|Overall Study||16
1537239|NCT01376700|3761796|P1|COMPLETED|Overall Study||3
1537240|NCT01376700|3761796|P1|STARTED|Overall Study||19
1537241|NCT01376557|3761817|P5|NOT COMPLETED|Overall Study||7
1537242|NCT01376557|3761818|P4|NOT COMPLETED|Overall Study||6
1537243|NCT01376557|3761819|P3|NOT COMPLETED|Overall Study||5
1537244|NCT01376557|3761820|P2|NOT COMPLETED|Overall Study||6
1537245|NCT01376557|3761821|P1|NOT COMPLETED|Overall Study||8
1537246|NCT01376557|3761817|P5|COMPLETED|Overall Study||53
1537247|NCT01376557|3761818|P4|COMPLETED|Overall Study||54
1537248|NCT01376557|3761819|P3|COMPLETED|Overall Study||55
1537249|NCT01376557|3761820|P2|COMPLETED|Overall Study||54
1537250|NCT01376557|3761821|P1|COMPLETED|Overall Study||51
1537251|NCT01376557|3761817|P5|STARTED|Overall Study||60
1537252|NCT01376557|3761818|P4|STARTED|Overall Study||60
1537253|NCT01376557|3761819|P3|STARTED|Overall Study||60
1537254|NCT01376557|3761820|P2|STARTED|Overall Study||60
1537255|NCT01376557|3761821|P1|STARTED|Overall Study||59
1537256|NCT01376388|3761858|P1|NOT COMPLETED|Overall Study||18
1537257|NCT01376388|3761858|P1|COMPLETED|Overall Study||112
1537258|NCT01376388|3761858|P1|STARTED|Overall Study||130
1537259|NCT01376362|3761873|P1|NOT COMPLETED|Overall Study||0
1537260|NCT01376362|3761873|P1|COMPLETED|Overall Study||5
1537261|NCT01376362|3761873|P1|STARTED|Overall Study||5
1537262|NCT01376349|3761896|P3|NOT COMPLETED|Optional Continuation Phase||0
1537263|NCT01376349|3761897|P2|NOT COMPLETED|Optional Continuation Phase||0
1537264|NCT01376349|3761898|P1|NOT COMPLETED|Optional Continuation Phase||0
1537265|NCT01376349|3761896|P3|COMPLETED|Optional Continuation Phase||94
1537266|NCT01376349|3761897|P2|COMPLETED|Optional Continuation Phase||0
1537267|NCT01376349|3761898|P1|COMPLETED|Optional Continuation Phase||0
1537268|NCT01376349|3761896|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
1537269|NCT01376349|3761897|P2|STARTED|Optional Continuation Phase||0
1537270|NCT01376349|3761898|P1|STARTED|Optional Continuation Phase||0
1537271|NCT01376349|3761896|P3|NOT COMPLETED|Raondomized Treatment||29
1537272|NCT01376349|3761897|P2|NOT COMPLETED|Raondomized Treatment||35
1537273|NCT01376349|3761898|P1|NOT COMPLETED|Raondomized Treatment||24
1537274|NCT01376349|3761896|P3|COMPLETED|Raondomized Treatment||118
1537275|NCT01376349|3761897|P2|COMPLETED|Raondomized Treatment||114
1537276|NCT01376349|3761898|P1|COMPLETED|Raondomized Treatment||123
1537277|NCT01376349|3761896|P3|STARTED|Raondomized Treatment||147
1537278|NCT01376349|3761897|P2|STARTED|Raondomized Treatment||149
1537279|NCT01376349|3761898|P1|STARTED|Raondomized Treatment||147
1537280|NCT01376323|3761912|P5|NOT COMPLETED|Overall Study||1
1537281|NCT01376323|3761913|P4|NOT COMPLETED|Overall Study||5
1537282|NCT01376323|3761914|P3|NOT COMPLETED|Overall Study||3
1537283|NCT01376323|3761915|P2|NOT COMPLETED|Overall Study||1
1537284|NCT01376323|3761916|P1|NOT COMPLETED|Overall Study||2
1537285|NCT01376323|3761912|P5|COMPLETED|Overall Study||17
1537286|NCT01376323|3761913|P4|COMPLETED|Overall Study||14
1537287|NCT01376323|3761914|P3|COMPLETED|Overall Study||16
1537288|NCT01376323|3761915|P2|COMPLETED|Overall Study||17
1537289|NCT01376323|3761916|P1|COMPLETED|Overall Study||18
1537290|NCT01376323|3761912|P5|STARTED|Overall Study||18
1537291|NCT01376323|3761913|P4|STARTED|Overall Study||19
1537292|NCT01376323|3761914|P3|STARTED|Overall Study||19
1537293|NCT01376323|3761915|P2|STARTED|Overall Study||18
1537294|NCT01376323|3761916|P1|STARTED|Overall Study||20
1537295|NCT01376297|3762000|P2|NOT COMPLETED|Overall Study||49
1537296|NCT01376297|3762001|P1|NOT COMPLETED|Overall Study||128
1537297|NCT01376297|3762000|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
1537298|NCT01376297|3762001|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
1537299|NCT01376297|3762000|P2|STARTED|Overall Study|number of randomised patients|104
1537300|NCT01376297|3762001|P1|STARTED|Overall Study|number of randomised patients|309
1537301|NCT01376245|3762011|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
1537302|NCT01376245|3762012|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
1537303|NCT01376245|3762013|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
1537304|NCT01376245|3762014|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
1537305|NCT01376245|3762015|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1537306|NCT01376245|3762011|P5|COMPLETED|24-week, Double-blind Treatment Period||134
1537307|NCT01376245|3762012|P4|COMPLETED|24-week, Double-blind Treatment Period||138
1537308|NCT01376245|3762013|P3|COMPLETED|24-week, Double-blind Treatment Period||135
1537309|NCT01376245|3762014|P2|COMPLETED|24-week, Double-blind Treatment Period||130
1537310|NCT01376245|3762015|P1|COMPLETED|24-week, Double-blind Treatment Period||0
1537311|NCT01376245|3762011|P5|STARTED|24-week, Double-blind Treatment Period||160
1537312|NCT01376245|3762012|P4|STARTED|24-week, Double-blind Treatment Period||161
1537313|NCT01376245|3762013|P3|STARTED|24-week, Double-blind Treatment Period||160
1537314|NCT01376245|3762014|P2|STARTED|24-week, Double-blind Treatment Period||162
1537315|NCT01376245|3762015|P1|STARTED|24-week, Double-blind Treatment Period||0
1537316|NCT01376245|3762011|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1537317|NCT01376245|3762012|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1537318|NCT01376245|3762013|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1537319|NCT01376245|3762014|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1537320|NCT01376245|3762015|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
1537321|NCT01376245|3762011|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1537322|NCT01376245|3762012|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1537323|NCT01376245|3762013|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1537324|NCT01376245|3762014|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
1537325|NCT01376245|3762015|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
1537326|NCT01376245|3762011|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
1537327|NCT01376245|3762012|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
1537328|NCT01376245|3762013|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
1537329|NCT01376245|3762014|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
1537330|NCT01376245|3762015|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
1537331|NCT01376167|3762032|P3|NOT COMPLETED|Overall Study||6
1537332|NCT01376167|3762033|P2|NOT COMPLETED|Overall Study||10
1537333|NCT01376167|3762034|P1|NOT COMPLETED|Overall Study||4
1537334|NCT01376167|3762032|P3|COMPLETED|Overall Study||123
1537335|NCT01376167|3762033|P2|COMPLETED|Overall Study||250
1537336|NCT01376167|3762034|P1|COMPLETED|Overall Study||129
1537337|NCT01376167|3762032|P3|STARTED|Overall Study||129
1537338|NCT01376167|3762033|P2|STARTED|Overall Study||260
1537339|NCT01376167|3762034|P1|STARTED|Overall Study||133
1537340|NCT01376089|3762105|P2|NOT COMPLETED|Overall Study||4
1537341|NCT01376089|3762106|P1|NOT COMPLETED|Overall Study||3
1537342|NCT01376089|3762105|P2|COMPLETED|Overall Study||144
1537343|NCT01376089|3762106|P1|COMPLETED|Overall Study||148
1537344|NCT01376089|3762105|P2|STARTED|Overall Study||148
1537345|NCT01376089|3762106|P1|STARTED|Overall Study||151
1537346|NCT01376050|3762118|P2|NOT COMPLETED|Overall Study||0
1537347|NCT01376050|3762119|P1|NOT COMPLETED|Overall Study||0
1537348|NCT01376050|3762118|P2|COMPLETED|Overall Study||11
1537349|NCT01376050|3762119|P1|COMPLETED|Overall Study||13
1537350|NCT01376050|3762118|P2|STARTED|Overall Study||11
1537351|NCT01376050|3762119|P1|STARTED|Overall Study||13
1537352|NCT01376037|3762129|P2|NOT COMPLETED|Overall Study||2
1537353|NCT01376037|3762130|P1|NOT COMPLETED|Overall Study||0
1537354|NCT01376037|3762129|P2|COMPLETED|Overall Study||29
1537355|NCT01376037|3762130|P1|COMPLETED|Overall Study||31
1537356|NCT01376037|3762129|P2|STARTED|Overall Study||31
1537357|NCT01376037|3762130|P1|STARTED|Overall Study||31
1537358|NCT01375946|3762136|P6|NOT COMPLETED|Overall Study||0
1537359|NCT01375946|3762137|P5|NOT COMPLETED|Overall Study||0
1537360|NCT01375946|3762138|P4|NOT COMPLETED|Overall Study||0
1537361|NCT01375946|3762139|P3|NOT COMPLETED|Overall Study||0
1537362|NCT01375946|3762140|P2|NOT COMPLETED|Overall Study||0
1537363|NCT01375946|3762141|P1|NOT COMPLETED|Overall Study||0
1537364|NCT01375946|3762136|P6|COMPLETED|Overall Study||4
1537365|NCT01375946|3762137|P5|COMPLETED|Overall Study||4
1537366|NCT01375946|3762138|P4|COMPLETED|Overall Study||4
1537367|NCT01375946|3762139|P3|COMPLETED|Overall Study||4
1537368|NCT01375946|3762140|P2|COMPLETED|Overall Study||4
1537369|NCT01375946|3762141|P1|COMPLETED|Overall Study||4
1537370|NCT01375946|3762136|P6|STARTED|Overall Study||4
1537371|NCT01375946|3762137|P5|STARTED|Overall Study||4
1537372|NCT01375946|3762138|P4|STARTED|Overall Study||4
1537373|NCT01375946|3762139|P3|STARTED|Overall Study||4
1537374|NCT01375946|3762140|P2|STARTED|Overall Study||4
1537375|NCT01375946|3762141|P1|STARTED|Overall Study||4
1537376|NCT01375777|3762158|P9|NOT COMPLETED|Overall Study||2
1537377|NCT01375777|3762159|P8|NOT COMPLETED|Overall Study||2
1537378|NCT01375777|3762160|P7|NOT COMPLETED|Overall Study||2
1537379|NCT01375777|3762161|P6|NOT COMPLETED|Overall Study||1
1537380|NCT01375777|3762162|P5|NOT COMPLETED|Overall Study||1
1537381|NCT01375777|3762163|P4|NOT COMPLETED|Overall Study||0
1537382|NCT01375777|3762164|P3|NOT COMPLETED|Overall Study||1
1537383|NCT01375777|3762165|P2|NOT COMPLETED|Overall Study||3
1537384|NCT01375777|3762166|P1|NOT COMPLETED|Overall Study||2
1537385|NCT01375777|3762158|P9|COMPLETED|Overall Study||44
1537386|NCT01375777|3762159|P8|COMPLETED|Overall Study||44
1537387|NCT01375777|3762160|P7|COMPLETED|Overall Study||44
1537388|NCT01375777|3762161|P6|COMPLETED|Overall Study||44
1537389|NCT01375777|3762162|P5|COMPLETED|Overall Study||45
1537390|NCT01375777|3762163|P4|COMPLETED|Overall Study||45
1537391|NCT01375777|3762164|P3|COMPLETED|Overall Study||45
1537392|NCT01375777|3762165|P2|COMPLETED|Overall Study||42
1537393|NCT01375777|3762166|P1|COMPLETED|Overall Study||44
1537394|NCT01375777|3762158|P9|Received Treatment|Overall Study||45
1537395|NCT01375777|3762159|P8|Received Treatment|Overall Study||45
1537396|NCT01375777|3762160|P7|Received Treatment|Overall Study||45
1537397|NCT01375777|3762161|P6|Received Treatment|Overall Study||45
1537398|NCT01375777|3762162|P5|Received Treatment|Overall Study||46
1537399|NCT01375777|3762163|P4|Received Treatment|Overall Study||45
1537400|NCT01375777|3762164|P3|Received Treatment|Overall Study||45
1537401|NCT01375777|3762165|P2|Received Treatment|Overall Study||45
1537402|NCT01375777|3762166|P1|Received Treatment|Overall Study||45
1537403|NCT01375777|3762158|P9|STARTED|Overall Study||46
1537404|NCT01375777|3762159|P8|STARTED|Overall Study||46
1537405|NCT01375777|3762160|P7|STARTED|Overall Study||46
1537406|NCT01375777|3762161|P6|STARTED|Overall Study||45
1537407|NCT01375777|3762162|P5|STARTED|Overall Study||46
1537408|NCT01375777|3762163|P4|STARTED|Overall Study||45
1537409|NCT01375777|3762164|P3|STARTED|Overall Study||46
1537410|NCT01375777|3762165|P2|STARTED|Overall Study||45
1537411|NCT01375777|3762166|P1|STARTED|Overall Study||46
1537412|NCT01375764|3762236|P5|NOT COMPLETED|Overall Study||1
1537413|NCT01375764|3762237|P4|NOT COMPLETED|Overall Study||1
1537414|NCT01375764|3762238|P3|NOT COMPLETED|Overall Study||0
1537415|NCT01375764|3762239|P2|NOT COMPLETED|Overall Study||1
1537416|NCT01375764|3762240|P1|NOT COMPLETED|Overall Study||2
1537417|NCT01375764|3762236|P5|COMPLETED|Overall Study||31
1537418|NCT01375764|3762237|P4|COMPLETED|Overall Study||31
1537419|NCT01375764|3762238|P3|COMPLETED|Overall Study||32
1537420|NCT01375764|3762239|P2|COMPLETED|Overall Study||30
1537421|NCT01375764|3762240|P1|COMPLETED|Overall Study||31
1537422|NCT01375764|3762236|P5|Received Treatment|Overall Study||32
1537423|NCT01375764|3762237|P4|Received Treatment|Overall Study||31
1537424|NCT01375764|3762238|P3|Received Treatment|Overall Study||32
1537425|NCT01375764|3762239|P2|Received Treatment|Overall Study||30
1537426|NCT01375764|3762240|P1|Received Treatment|Overall Study||32
1537427|NCT01375764|3762236|P5|STARTED|Overall Study||32
1537428|NCT01375764|3762237|P4|STARTED|Overall Study||32
1537429|NCT01375764|3762238|P3|STARTED|Overall Study||32
1537430|NCT01375764|3762239|P2|STARTED|Overall Study||31
1537431|NCT01375764|3762240|P1|STARTED|Overall Study||33
1537432|NCT01375751|3762286|P3|NOT COMPLETED|Overall Study||0
1537433|NCT01375751|3762287|P2|NOT COMPLETED|Overall Study||1
1537434|NCT01375751|3762288|P1|NOT COMPLETED|Overall Study||0
1537435|NCT01375751|3762286|P3|COMPLETED|Overall Study||56
1537436|NCT01375751|3762287|P2|COMPLETED|Overall Study||55
1537437|NCT01375751|3762288|P1|COMPLETED|Overall Study||56
1537438|NCT01375751|3762286|P3|Received Treatment|Overall Study||56
1537439|NCT01375751|3762287|P2|Received Treatment|Overall Study||55
1537440|NCT01375751|3762288|P1|Received Treatment|Overall Study||56
1537441|NCT01375751|3762286|P3|STARTED|Overall Study||56
1537442|NCT01375751|3762287|P2|STARTED|Overall Study||56
1537443|NCT01375751|3762288|P1|STARTED|Overall Study||56
1537444|NCT01375660|3762313|P2|NOT COMPLETED|Overall Study||16
1537445|NCT01375660|3762314|P1|NOT COMPLETED|Overall Study||16
1537446|NCT01375660|3762313|P2|COMPLETED|Overall Study||87
1537447|NCT01375660|3762314|P1|COMPLETED|Overall Study||86
1537448|NCT01375660|3762313|P2|STARTED|Overall Study||103
1537449|NCT01375660|3762314|P1|STARTED|Overall Study||102
1537450|NCT01375608|3762332|P1|NOT COMPLETED|Overall Study||2
1537451|NCT01375608|3762332|P1|COMPLETED|Overall Study||8
1537452|NCT01375608|3762332|P1|STARTED|Overall Study||10
1537453|NCT01375569|3762336|P1|NOT COMPLETED|Overall Study||0
1537454|NCT01375569|3762336|P1|COMPLETED|Overall Study||11
1537455|NCT01375569|3762336|P1|STARTED|Overall Study||11
1537456|NCT01375374|3762341|P1|NOT COMPLETED|Overall Study||1
1537457|NCT01375374|3762341|P1|COMPLETED|Overall Study||10
1537458|NCT01375374|3762341|P1|STARTED|Overall Study||11
1537459|NCT01375127|3762354|P6|NOT COMPLETED|Overall Study||0
1537460|NCT01375127|3762355|P5|NOT COMPLETED|Overall Study||0
1537461|NCT01375127|3762356|P4|NOT COMPLETED|Overall Study||0
1537462|NCT01375127|3762357|P3|NOT COMPLETED|Overall Study||0
1537463|NCT01375127|3762358|P2|NOT COMPLETED|Overall Study||0
1537464|NCT01375127|3762359|P1|NOT COMPLETED|Overall Study||0
1537465|NCT01375127|3762354|P6|COMPLETED|Overall Study||3
1537466|NCT01375127|3762355|P5|COMPLETED|Overall Study||5
1537467|NCT01375127|3762356|P4|COMPLETED|Overall Study||33
1537468|NCT01375127|3762357|P3|COMPLETED|Overall Study||40
1537469|NCT01375127|3762358|P2|COMPLETED|Overall Study||1
1537470|NCT01375127|3762359|P1|COMPLETED|Overall Study||1
1537471|NCT01375127|3762354|P6|STARTED|Overall Study||3
1537472|NCT01375127|3762355|P5|STARTED|Overall Study||5
1537473|NCT01375127|3762356|P4|STARTED|Overall Study||33
1537474|NCT01375127|3762357|P3|STARTED|Overall Study||40
1537475|NCT01375127|3762358|P2|STARTED|Overall Study||1
1537476|NCT01375127|3762359|P1|STARTED|Overall Study||1
1537477|NCT01375075|3762397|P6|NOT COMPLETED|Overall Study||3
1537478|NCT01375075|3762398|P5|NOT COMPLETED|Overall Study||0
1537479|NCT01375075|3762399|P4|NOT COMPLETED|Overall Study||1
1537480|NCT01375075|3762400|P3|NOT COMPLETED|Overall Study||3
1537481|NCT01375075|3762401|P2|NOT COMPLETED|Overall Study||1
1537482|NCT01375075|3762402|P1|NOT COMPLETED|Overall Study||1
1537483|NCT01375075|3762397|P6|COMPLETED|Overall Study||25
1537484|NCT01375075|3762398|P5|COMPLETED|Overall Study||27
1537485|NCT01375075|3762399|P4|COMPLETED|Overall Study||27
1537486|NCT01375075|3762400|P3|COMPLETED|Overall Study||24
1537487|NCT01375075|3762401|P2|COMPLETED|Overall Study||27
1537488|NCT01375075|3762402|P1|COMPLETED|Overall Study||26
1537489|NCT01375075|3762397|P6|Received at Least One Dose of Study Drug|Overall Study||28
1537490|NCT01375075|3762398|P5|Received at Least One Dose of Study Drug|Overall Study||27
1537491|NCT01375075|3762399|P4|Received at Least One Dose of Study Drug|Overall Study||28
1537492|NCT01375075|3762400|P3|Received at Least One Dose of Study Drug|Overall Study||27
1537493|NCT01375075|3762401|P2|Received at Least One Dose of Study Drug|Overall Study||28
1537494|NCT01375075|3762402|P1|Received at Least One Dose of Study Drug|Overall Study||27
1537495|NCT01375075|3762397|P6|STARTED|Overall Study||28
1537496|NCT01375075|3762398|P5|STARTED|Overall Study||27
1537497|NCT01375075|3762399|P4|STARTED|Overall Study||28
1537498|NCT01375075|3762400|P3|STARTED|Overall Study||27
1537499|NCT01375075|3762401|P2|STARTED|Overall Study||28
1537500|NCT01375075|3762402|P1|STARTED|Overall Study||27
1537501|NCT01375049|3762486|P1|NOT COMPLETED|Overall Study||50
1537502|NCT01375049|3762486|P1|COMPLETED|Overall Study||55
1537503|NCT01375049|3762486|P1|STARTED|Overall Study||105
1537504|NCT01374971|3762501|P1|NOT COMPLETED|Overall Study||1
1537505|NCT01374971|3762501|P1|COMPLETED|Overall Study||11
1537506|NCT01374971|3762501|P1|STARTED|Overall Study||12
1537507|NCT01374919|3762506|P1|NOT COMPLETED|Overall Study||2
1537508|NCT01374919|3762506|P1|COMPLETED|Overall Study||58
1537509|NCT01374919|3762506|P1|STARTED|Overall Study||60
1537510|NCT01374906|3762513|P2|NOT COMPLETED|Overall Study||48
1537511|NCT01374906|3762514|P1|NOT COMPLETED|Overall Study||40
1537512|NCT01374906|3762513|P2|COMPLETED|Overall Study||28
1537513|NCT01374906|3762514|P1|COMPLETED|Overall Study||34
1537514|NCT01374906|3762513|P2|Completed Extension Phase|Overall Study||15
1537515|NCT01374906|3762514|P1|Completed Extension Phase|Overall Study||24
1537516|NCT01374906|3762513|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
1537517|NCT01374906|3762514|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
1537518|NCT01374906|3762513|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
1537519|NCT01374906|3762514|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
1537520|NCT01374906|3762513|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
1537521|NCT01374906|3762514|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
1537522|NCT01374906|3762513|P2|Completed Core Phase|Overall Study||54
1537523|NCT01374906|3762514|P1|Completed Core Phase|Overall Study||50
1537524|NCT01374906|3762513|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
1537525|NCT01374906|3762514|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
1537526|NCT01374906|3762513|P2|STARTED|Overall Study||76
1537527|NCT01374906|3762514|P1|STARTED|Overall Study||74
1537528|NCT01374802|3762581|P1|NOT COMPLETED|Overall Study||0
1537529|NCT01374802|3762581|P1|COMPLETED|Overall Study||14
1537530|NCT01374802|3762581|P1|STARTED|Overall Study||14
1537531|NCT01374568|3762595|P2|NOT COMPLETED|Overall Study||2
1537532|NCT01374568|3762596|P1|NOT COMPLETED|Overall Study||0
1537533|NCT01374568|3762595|P2|COMPLETED|Overall Study||1
1537534|NCT01374568|3762596|P1|COMPLETED|Overall Study||2
1537535|NCT01374568|3762595|P2|STARTED|Overall Study||3
1537536|NCT01374568|3762596|P1|STARTED|Overall Study||2
1537537|NCT01374451|3762606|P2|NOT COMPLETED|Overall Study||0
1537538|NCT01374451|3762607|P1|NOT COMPLETED|Overall Study||1
1537539|NCT01374451|3762606|P2|COMPLETED|Overall Study||81
1537540|NCT01374451|3762607|P1|COMPLETED|Overall Study||78
1537541|NCT01374451|3762606|P2|STARTED|Overall Study||81
1537542|NCT01374451|3762607|P1|STARTED|Overall Study||79
1537543|NCT01374438|3762636|P2|NOT COMPLETED|Overall Study||0
1537544|NCT01374438|3762637|P1|NOT COMPLETED|Overall Study||0
1537545|NCT01374438|3762636|P2|COMPLETED|Overall Study||13
1537546|NCT01374438|3762637|P1|COMPLETED|Overall Study||16
1537547|NCT01374438|3762636|P2|STARTED|Overall Study||13
1537548|NCT01374438|3762637|P1|STARTED|Overall Study||16
1537549|NCT01374425|3762653|P2|NOT COMPLETED|Overall Study||188
1537550|NCT01374425|3762654|P1|NOT COMPLETED|Overall Study||188
1537551|NCT01374425|3762653|P2|COMPLETED|Overall Study||0
1537552|NCT01374425|3762654|P1|COMPLETED|Overall Study||0
1537553|NCT01374425|3762653|P2|STARTED|Overall Study||188
1537554|NCT01374425|3762654|P1|STARTED|Overall Study||188
1537555|NCT01374269|3762734|P2|NOT COMPLETED|Overall Study||5
1537556|NCT01374269|3762735|P1|NOT COMPLETED|Overall Study||6
1537557|NCT01374269|3762734|P2|COMPLETED|Overall Study||39
1537558|NCT01374269|3762735|P1|COMPLETED|Overall Study||40
1537559|NCT01374269|3762734|P2|STARTED|Overall Study||44
1537560|NCT01374269|3762735|P1|STARTED|Overall Study||46
1537561|NCT01374217|3762863|P1|NOT COMPLETED|Overall Study||13
1537562|NCT01374217|3762863|P1|COMPLETED|Overall Study||0
1537563|NCT01374217|3762863|P1|STARTED|Overall Study||13
1537564|NCT01374178|3762871|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
1537565|NCT01374178|3762872|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
1537566|NCT01374178|3762871|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
1537567|NCT01374178|3762872|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
1537568|NCT01374178|3762871|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
1537569|NCT01374178|3762872|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
1537570|NCT01374178|3762871|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
1537571|NCT01374178|3762872|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
1537572|NCT01374178|3762871|P2|COMPLETED|Washout Period of at Least 7 Days||5
1537573|NCT01374178|3762872|P1|COMPLETED|Washout Period of at Least 7 Days||10
1537574|NCT01374178|3762871|P2|STARTED|Washout Period of at Least 7 Days||5
1537575|NCT01374178|3762872|P1|STARTED|Washout Period of at Least 7 Days||11
1537576|NCT01374178|3762871|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
1537577|NCT01374178|3762872|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
1537578|NCT01374178|3762871|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
1537579|NCT01374178|3762872|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
1537580|NCT01374178|3762871|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
1537581|NCT01374178|3762872|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
1537582|NCT01374178|3762871|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
1537583|NCT01374178|3762872|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
1537584|NCT01374087|3762890|P2|NOT COMPLETED|Overall Study||16
1537585|NCT01374087|3762891|P1|NOT COMPLETED|Overall Study||15
1537586|NCT01374087|3762890|P2|COMPLETED|Overall Study||0
1537587|NCT01374087|3762891|P1|COMPLETED|Overall Study||0
1537588|NCT01374087|3762890|P2|STARTED|Overall Study||16
1537589|NCT01374087|3762891|P1|STARTED|Overall Study||15
1537590|NCT01373931|3762901|P2|NOT COMPLETED|Period 2||0
1537591|NCT01373931|3762902|P1|NOT COMPLETED|Period 2||0
1537592|NCT01373931|3762901|P2|COMPLETED|Period 2||8
1537593|NCT01373931|3762902|P1|COMPLETED|Period 2||6
1537594|NCT01373931|3762901|P2|STARTED|Period 2||8
1537595|NCT01373931|3762902|P1|STARTED|Period 2||6
1537596|NCT01373931|3762901|P2|NOT COMPLETED|Period 1||2
1537597|NCT01373931|3762902|P1|NOT COMPLETED|Period 1||2
1537598|NCT01373931|3762901|P2|COMPLETED|Period 1||8
1537599|NCT01373931|3762902|P1|COMPLETED|Period 1||6
1537600|NCT01373931|3762901|P2|STARTED|Period 1||10
1537601|NCT01373931|3762902|P1|STARTED|Period 1||8
1537602|NCT01373931|3762901|P2|NOT COMPLETED|Lead-in Period||0
1537603|NCT01373931|3762902|P1|NOT COMPLETED|Lead-in Period||2
1537604|NCT01373931|3762901|P2|COMPLETED|Lead-in Period||10
1537605|NCT01373931|3762902|P1|COMPLETED|Lead-in Period||8
1537606|NCT01373931|3762901|P2|Received at Least 1 Dose of Study Drug|Lead-in Period||10
1537607|NCT01373931|3762902|P1|Received at Least 1 Dose of Study Drug|Lead-in Period||8
1537608|NCT01373931|3762901|P2|STARTED|Lead-in Period||10
1537609|NCT01373931|3762902|P1|STARTED|Lead-in Period||10
1537610|NCT01373918|3762915|P2|NOT COMPLETED|Overall Study||1
1537611|NCT01373918|3762916|P1|NOT COMPLETED|Overall Study||0
1537612|NCT01373918|3762915|P2|COMPLETED|Overall Study||15
1537613|NCT01373918|3762916|P1|COMPLETED|Overall Study||20
1537614|NCT01373918|3762915|P2|STARTED|Overall Study||16
1537615|NCT01373918|3762916|P1|STARTED|Overall Study||20
1537616|NCT01373671|3762928|P1|NOT COMPLETED|Overall Study||92
1537617|NCT01373671|3762928|P1|COMPLETED|Overall Study||672
1537618|NCT01373671|3762928|P1|STARTED|Overall Study||764
1537619|NCT01373580|3762933|P1|NOT COMPLETED|Overall Study||56
1537620|NCT01373580|3762933|P1|COMPLETED|Overall Study||317
1537621|NCT01373580|3762933|P1|STARTED|Overall Study||373
1537622|NCT01373489|3762941|P2|NOT COMPLETED|Overall Study||13
1537623|NCT01373489|3762942|P1|NOT COMPLETED|Overall Study||15
1537624|NCT01373489|3762941|P2|COMPLETED|Overall Study||41
1537625|NCT01373489|3762942|P1|COMPLETED|Overall Study||44
1537626|NCT01373489|3762941|P2|STARTED|Overall Study||54
1537627|NCT01373489|3762942|P1|STARTED|Overall Study||59
1537628|NCT01373450|3762948|P6|NOT COMPLETED|Crossover Period 4||0
1537629|NCT01373450|3762949|P5|NOT COMPLETED|Crossover Period 4||0
1537630|NCT01373450|3762950|P4|NOT COMPLETED|Crossover Period 4||0
1537631|NCT01373450|3762951|P3|NOT COMPLETED|Crossover Period 4||0
1537632|NCT01373450|3762952|P2|NOT COMPLETED|Crossover Period 4||0
1537633|NCT01373450|3762953|P1|NOT COMPLETED|Crossover Period 4||0
1537634|NCT01373450|3762948|P6|COMPLETED|Crossover Period 4||2
1537635|NCT01373450|3762949|P5|COMPLETED|Crossover Period 4||2
1537636|NCT01373450|3762950|P4|COMPLETED|Crossover Period 4||2
1537637|NCT01373450|3762951|P3|COMPLETED|Crossover Period 4||2
1537638|NCT01373450|3762952|P2|COMPLETED|Crossover Period 4||2
1537639|NCT01373450|3762953|P1|COMPLETED|Crossover Period 4||2
1537640|NCT01373450|3762948|P6|STARTED|Crossover Period 4||2
1537641|NCT01373450|3762949|P5|STARTED|Crossover Period 4||2
1537642|NCT01373450|3762950|P4|STARTED|Crossover Period 4||2
1537643|NCT01373450|3762951|P3|STARTED|Crossover Period 4||2
1537644|NCT01373450|3762952|P2|STARTED|Crossover Period 4||2
1537645|NCT01373450|3762953|P1|STARTED|Crossover Period 4||2
1537646|NCT01373450|3762948|P6|NOT COMPLETED|7 Day Wash-out||0
1537647|NCT01373450|3762949|P5|NOT COMPLETED|7 Day Wash-out||0
1537648|NCT01373450|3762950|P4|NOT COMPLETED|7 Day Wash-out||0
1537649|NCT01373450|3762951|P3|NOT COMPLETED|7 Day Wash-out||0
1537650|NCT01373450|3762952|P2|NOT COMPLETED|7 Day Wash-out||0
1537651|NCT01373450|3762953|P1|NOT COMPLETED|7 Day Wash-out||0
1537652|NCT01373450|3762948|P6|COMPLETED|7 Day Wash-out||2
1537653|NCT01373450|3762949|P5|COMPLETED|7 Day Wash-out||2
1537654|NCT01373450|3762950|P4|COMPLETED|7 Day Wash-out||2
1537655|NCT01373450|3762951|P3|COMPLETED|7 Day Wash-out||2
1537656|NCT01373450|3762952|P2|COMPLETED|7 Day Wash-out||2
1537657|NCT01373450|3762953|P1|COMPLETED|7 Day Wash-out||2
1537658|NCT01373450|3762948|P6|STARTED|7 Day Wash-out||2
1537659|NCT01373450|3762949|P5|STARTED|7 Day Wash-out||2
1537660|NCT01373450|3762950|P4|STARTED|7 Day Wash-out||2
1537661|NCT01373450|3762951|P3|STARTED|7 Day Wash-out||2
1537662|NCT01373450|3762952|P2|STARTED|7 Day Wash-out||2
1537663|NCT01373450|3762953|P1|STARTED|7 Day Wash-out||2
1537664|NCT01373450|3762948|P6|NOT COMPLETED|Crossover Period 3||0
1537665|NCT01373450|3762949|P5|NOT COMPLETED|Crossover Period 3||0
1537666|NCT01373450|3762950|P4|NOT COMPLETED|Crossover Period 3||0
1537667|NCT01373450|3762951|P3|NOT COMPLETED|Crossover Period 3||0
1537668|NCT01373450|3762952|P2|NOT COMPLETED|Crossover Period 3||0
1537669|NCT01373450|3762953|P1|NOT COMPLETED|Crossover Period 3||0
1537670|NCT01373450|3762948|P6|COMPLETED|Crossover Period 3||2
1537671|NCT01373450|3762949|P5|COMPLETED|Crossover Period 3||2
1537672|NCT01373450|3762950|P4|COMPLETED|Crossover Period 3||2
1537673|NCT01373450|3762951|P3|COMPLETED|Crossover Period 3||2
1537674|NCT01373450|3762952|P2|COMPLETED|Crossover Period 3||2
1537675|NCT01373450|3762953|P1|COMPLETED|Crossover Period 3||2
1537676|NCT01373450|3762948|P6|STARTED|Crossover Period 3||2
1537677|NCT01373450|3762949|P5|STARTED|Crossover Period 3||2
1537678|NCT01373450|3762950|P4|STARTED|Crossover Period 3||2
1537679|NCT01373450|3762951|P3|STARTED|Crossover Period 3||2
1537680|NCT01373450|3762952|P2|STARTED|Crossover Period 3||2
1537681|NCT01373450|3762953|P1|STARTED|Crossover Period 3||2
1537682|NCT01373450|3762948|P6|NOT COMPLETED|7 Day Wash-out||0
1537683|NCT01373450|3762949|P5|NOT COMPLETED|7 Day Wash-out||0
1537684|NCT01373450|3762950|P4|NOT COMPLETED|7 Day Wash-out||0
1537685|NCT01373450|3762951|P3|NOT COMPLETED|7 Day Wash-out||0
1537686|NCT01373450|3762952|P2|NOT COMPLETED|7 Day Wash-out||0
1537687|NCT01373450|3762953|P1|NOT COMPLETED|7 Day Wash-out||0
1537688|NCT01373450|3762948|P6|COMPLETED|7 Day Wash-out||2
1537689|NCT01373450|3762949|P5|COMPLETED|7 Day Wash-out||2
1537690|NCT01373450|3762950|P4|COMPLETED|7 Day Wash-out||2
1537691|NCT01373450|3762951|P3|COMPLETED|7 Day Wash-out||2
1537692|NCT01373450|3762952|P2|COMPLETED|7 Day Wash-out||2
1537693|NCT01373450|3762953|P1|COMPLETED|7 Day Wash-out||2
1537694|NCT01373450|3762948|P6|STARTED|7 Day Wash-out||2
1537695|NCT01373450|3762949|P5|STARTED|7 Day Wash-out||2
1537696|NCT01373450|3762950|P4|STARTED|7 Day Wash-out||2
1537697|NCT01373450|3762951|P3|STARTED|7 Day Wash-out||2
1537698|NCT01373450|3762952|P2|STARTED|7 Day Wash-out||2
1537699|NCT01373450|3762953|P1|STARTED|7 Day Wash-out||2
1537700|NCT01373450|3762948|P6|NOT COMPLETED|Crossover Period 2||0
1537701|NCT01373450|3762949|P5|NOT COMPLETED|Crossover Period 2||0
1537702|NCT01373450|3762950|P4|NOT COMPLETED|Crossover Period 2||0
1537703|NCT01373450|3762951|P3|NOT COMPLETED|Crossover Period 2||0
1537704|NCT01373450|3762952|P2|NOT COMPLETED|Crossover Period 2||0
1537705|NCT01373450|3762953|P1|NOT COMPLETED|Crossover Period 2||0
1537706|NCT01373450|3762948|P6|COMPLETED|Crossover Period 2||2
1537707|NCT01373450|3762949|P5|COMPLETED|Crossover Period 2||2
1537708|NCT01373450|3762950|P4|COMPLETED|Crossover Period 2||2
1537709|NCT01373450|3762951|P3|COMPLETED|Crossover Period 2||2
1537710|NCT01373450|3762952|P2|COMPLETED|Crossover Period 2||2
1537711|NCT01373450|3762953|P1|COMPLETED|Crossover Period 2||2
1537712|NCT01373450|3762948|P6|STARTED|Crossover Period 2||2
1537713|NCT01373450|3762949|P5|STARTED|Crossover Period 2||2
1537714|NCT01373450|3762950|P4|STARTED|Crossover Period 2||2
1537715|NCT01373450|3762951|P3|STARTED|Crossover Period 2||2
1537716|NCT01373450|3762952|P2|STARTED|Crossover Period 2||2
1537717|NCT01373450|3762953|P1|STARTED|Crossover Period 2||2
1537718|NCT01373450|3762948|P6|NOT COMPLETED|7 Day Wash-out||0
1537719|NCT01373450|3762949|P5|NOT COMPLETED|7 Day Wash-out||0
1537720|NCT01373450|3762950|P4|NOT COMPLETED|7 Day Wash-out||0
1537721|NCT01373450|3762951|P3|NOT COMPLETED|7 Day Wash-out||0
1537722|NCT01373450|3762952|P2|NOT COMPLETED|7 Day Wash-out||0
1537723|NCT01373450|3762953|P1|NOT COMPLETED|7 Day Wash-out||0
1537724|NCT01373450|3762948|P6|COMPLETED|7 Day Wash-out||2
1537725|NCT01373450|3762949|P5|COMPLETED|7 Day Wash-out||2
1537726|NCT01373450|3762950|P4|COMPLETED|7 Day Wash-out||2
1537727|NCT01373450|3762951|P3|COMPLETED|7 Day Wash-out||2
1537728|NCT01373450|3762952|P2|COMPLETED|7 Day Wash-out||2
1537729|NCT01373450|3762953|P1|COMPLETED|7 Day Wash-out||2
1537730|NCT01373450|3762948|P6|STARTED|7 Day Wash-out||2
1537731|NCT01373450|3762949|P5|STARTED|7 Day Wash-out||2
1537732|NCT01373450|3762950|P4|STARTED|7 Day Wash-out||2
1537733|NCT01373450|3762951|P3|STARTED|7 Day Wash-out||2
1537734|NCT01373450|3762952|P2|STARTED|7 Day Wash-out||2
1537735|NCT01373450|3762953|P1|STARTED|7 Day Wash-out||2
1537736|NCT01373450|3762948|P6|NOT COMPLETED|Crossover Period 1||0
1537737|NCT01373450|3762949|P5|NOT COMPLETED|Crossover Period 1||0
1537738|NCT01373450|3762950|P4|NOT COMPLETED|Crossover Period 1||0
1537739|NCT01373450|3762951|P3|NOT COMPLETED|Crossover Period 1||0
1537740|NCT01373450|3762952|P2|NOT COMPLETED|Crossover Period 1||0
1537741|NCT01373450|3762953|P1|NOT COMPLETED|Crossover Period 1||0
1537742|NCT01373450|3762948|P6|COMPLETED|Crossover Period 1||2
1537743|NCT01373450|3762949|P5|COMPLETED|Crossover Period 1||2
1537744|NCT01373450|3762950|P4|COMPLETED|Crossover Period 1||2
1537745|NCT01373450|3762951|P3|COMPLETED|Crossover Period 1||2
1537746|NCT01373450|3762952|P2|COMPLETED|Crossover Period 1||2
1537747|NCT01373450|3762953|P1|COMPLETED|Crossover Period 1||2
1537748|NCT01373450|3762948|P6|STARTED|Crossover Period 1||2
1537749|NCT01373450|3762949|P5|STARTED|Crossover Period 1||2
1537750|NCT01373450|3762950|P4|STARTED|Crossover Period 1||2
1537751|NCT01373450|3762951|P3|STARTED|Crossover Period 1||2
1537752|NCT01373450|3762952|P2|STARTED|Crossover Period 1||2
1537753|NCT01373450|3762953|P1|STARTED|Crossover Period 1||2
1537754|NCT01373346|3762975|P1|NOT COMPLETED|Overall Study||1
1537755|NCT01373346|3762975|P1|COMPLETED|Overall Study||14
1537756|NCT01373346|3762975|P1|STARTED|Overall Study||15
1537757|NCT01373294|3762998|P2|NOT COMPLETED|Overall Study||0
1537758|NCT01373294|3762999|P1|NOT COMPLETED|Overall Study||1
1537759|NCT01373294|3762998|P2|COMPLETED|Overall Study||2
1537760|NCT01373294|3762999|P1|COMPLETED|Overall Study||14
1537761|NCT01373294|3762998|P2|STARTED|Overall Study||2
1537762|NCT01373294|3762999|P1|STARTED|Overall Study||15
1537763|NCT01373281|3763008|P2|NOT COMPLETED|Surveillance Expansion Period||118
1537764|NCT01373281|3763009|P1|NOT COMPLETED|Surveillance Expansion Period||202
1537765|NCT01373281|3763008|P2|COMPLETED|Surveillance Expansion Period||3279
1537766|NCT01373281|3763009|P1|COMPLETED|Surveillance Expansion Period||6595
1537767|NCT01373281|3763008|P2|STARTED|Surveillance Expansion Period||3397
1537768|NCT01373281|3763009|P1|STARTED|Surveillance Expansion Period||6797
1537769|NCT01373281|3763008|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
1537770|NCT01373281|3763009|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
1537771|NCT01373281|3763008|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
1537772|NCT01373281|3763009|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
1537773|NCT01373281|3763008|P2|STARTED|Vaccination Phase (Up to 25 Months)||3424
1537774|NCT01373281|3763009|P1|STARTED|Vaccination Phase (Up to 25 Months)||6851
1537775|NCT01373229|3763041|P1|NOT COMPLETED|Overall Study||6
1537776|NCT01373229|3763041|P1|COMPLETED|Overall Study||9
1537777|NCT01373229|3763041|P1|STARTED|Overall Study||15
1537778|NCT01373164|3763055|P5|NOT COMPLETED|Overall Study||2
1537779|NCT01373164|3763056|P4|NOT COMPLETED|Overall Study||12
1537780|NCT01373164|3763057|P3|NOT COMPLETED|Overall Study||1
1537781|NCT01373164|3763058|P2|NOT COMPLETED|Overall Study||1
1537782|NCT01373164|3763059|P1|NOT COMPLETED|Overall Study||0
1537783|NCT01373164|3763055|P5|COMPLETED|Overall Study||50
1537784|NCT01373164|3763056|P4|COMPLETED|Overall Study||92
1537785|NCT01373164|3763057|P3|COMPLETED|Overall Study||4
1537786|NCT01373164|3763058|P2|COMPLETED|Overall Study||3
1537787|NCT01373164|3763059|P1|COMPLETED|Overall Study||5
1537788|NCT01373164|3763055|P5|Received at Least One Dose|Overall Study||52
1537789|NCT01373164|3763056|P4|Received at Least One Dose|Overall Study||103
1537790|NCT01373164|3763057|P3|Received at Least One Dose|Overall Study||5
1537791|NCT01373164|3763058|P2|Received at Least One Dose|Overall Study||4
1537792|NCT01373164|3763059|P1|Received at Least One Dose|Overall Study||5
1537793|NCT01373164|3763055|P5|STARTED|Overall Study||52
1537794|NCT01373164|3763056|P4|STARTED|Overall Study||104
1537795|NCT01373164|3763057|P3|STARTED|Overall Study||5
1537796|NCT01373164|3763058|P2|STARTED|Overall Study||4
1537797|NCT01373164|3763059|P1|STARTED|Overall Study||5
1537798|NCT01372995|3763093|P3|NOT COMPLETED|Overall Study||1
1537799|NCT01372995|3763094|P2|NOT COMPLETED|Overall Study||1
1537800|NCT01372995|3763095|P1|NOT COMPLETED|Overall Study||0
1537801|NCT01372995|3763093|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
1537802|NCT01372995|3763094|P2|COMPLETED|Overall Study||9
1537803|NCT01372995|3763095|P1|COMPLETED|Overall Study||10
1537804|NCT01372995|3763093|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
1537805|NCT01372995|3763094|P2|STARTED|Overall Study||10
1537806|NCT01372995|3763095|P1|STARTED|Overall Study||10
1537807|NCT01372878|3763142|P1|NOT COMPLETED|Overall Study||184
1537808|NCT01372878|3763142|P1|COMPLETED|Overall Study||700
1537809|NCT01372878|3763142|P1|STARTED|Overall Study||884
1537810|NCT01372813|3763147|P1|NOT COMPLETED|Overall Study||0
1537811|NCT01372813|3763147|P1|COMPLETED|Overall Study||3
1537812|NCT01372813|3763147|P1|STARTED|Overall Study||3
1537813|NCT01372774|3763162|P2|NOT COMPLETED|Overall Study||5
1537814|NCT01372774|3763163|P1|NOT COMPLETED|Overall Study||4
1537815|NCT01372774|3763162|P2|COMPLETED|Overall Study||93
1537816|NCT01372774|3763163|P1|COMPLETED|Overall Study||92
1537817|NCT01372774|3763162|P2|STARTED|Overall Study||98
1537818|NCT01372774|3763163|P1|STARTED|Overall Study||96
1537819|NCT01372748|3763179|P2|NOT COMPLETED|Overall Study||39
1537820|NCT01372748|3763180|P1|NOT COMPLETED|Overall Study||23
1537821|NCT01372748|3763179|P2|COMPLETED|Overall Study|defined as having vital status|12603
1537822|NCT01372748|3763180|P1|COMPLETED|Overall Study|defined as having vital status|11022
1537823|NCT01372748|3763179|P2|STARTED|Overall Study||12642
1537824|NCT01372748|3763180|P1|STARTED|Overall Study||11045
1537825|NCT01372618|3763188|P1|NOT COMPLETED|Overall Study||9
1537826|NCT01372618|3763188|P1|COMPLETED|Overall Study||0
1537827|NCT01372618|3763188|P1|STARTED|Overall Study||9
1537828|NCT01372605|3763196|P2|NOT COMPLETED|Overall Study||10
1537829|NCT01372605|3763197|P1|NOT COMPLETED|Overall Study||12
1537830|NCT01372605|3763196|P2|COMPLETED|Overall Study||145
1537831|NCT01372605|3763197|P1|COMPLETED|Overall Study||137
1537832|NCT01372605|3763196|P2|STARTED|Overall Study||155
1537833|NCT01372605|3763197|P1|STARTED|Overall Study||149
1537834|NCT01372501|3763223|P1|NOT COMPLETED|Overall Study||5
1537835|NCT01372501|3763223|P1|COMPLETED|Overall Study||14
1537836|NCT01372501|3763223|P1|STARTED|Overall Study||19
1537837|NCT01372462|3763228|P1|NOT COMPLETED|No Treatment Control||0
1537838|NCT01372462|3763228|P1|COMPLETED|No Treatment Control||15
1537839|NCT01372462|3763228|P1|STARTED|No Treatment Control||15
1537840|NCT01372462|3763228|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
1537841|NCT01372462|3763228|P1|COMPLETED|Oxygen Nasal Cannula||15
1537842|NCT01372462|3763228|P1|STARTED|Oxygen Nasal Cannula||15
1537843|NCT01372462|3763228|P1|NOT COMPLETED|NIOV - Oxygen||0
1537844|NCT01372462|3763228|P1|COMPLETED|NIOV - Oxygen||15
1537845|NCT01372462|3763228|P1|STARTED|NIOV - Oxygen||15
1537846|NCT01372462|3763228|P1|NOT COMPLETED|NIOV - Room Air||0
1537847|NCT01372462|3763228|P1|COMPLETED|NIOV - Room Air||15
1537848|NCT01372462|3763228|P1|STARTED|NIOV - Room Air||15
1537849|NCT01372410|3763246|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1537850|NCT01372410|3763247|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1537851|NCT01372410|3763248|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
1537852|NCT01372410|3763249|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1537853|NCT01372410|3763250|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1537854|NCT01372410|3763251|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
1537855|NCT01372410|3763252|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1537856|NCT01372410|3763253|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
1537857|NCT01372410|3763246|P8|COMPLETED|Treatment Period 3 (7 Days)||18
1537858|NCT01372410|3763247|P7|COMPLETED|Treatment Period 3 (7 Days)||15
1537859|NCT01372410|3763248|P6|COMPLETED|Treatment Period 3 (7 Days)||18
1537860|NCT01372410|3763249|P5|COMPLETED|Treatment Period 3 (7 Days)||20
1537861|NCT01372410|3763250|P4|COMPLETED|Treatment Period 3 (7 Days)||22
1537862|NCT01372410|3763251|P3|COMPLETED|Treatment Period 3 (7 Days)||15
1537863|NCT01372410|3763252|P2|COMPLETED|Treatment Period 3 (7 Days)||18
1537864|NCT01372410|3763253|P1|COMPLETED|Treatment Period 3 (7 Days)||21
1537865|NCT01372410|3763246|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
1537866|NCT01372410|3763247|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
1537867|NCT01372410|3763248|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
1537868|NCT01372410|3763249|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
1537869|NCT01372410|3763250|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
1537870|NCT01372410|3763251|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
1537871|NCT01372410|3763252|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
1537872|NCT01372410|3763253|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
1537873|NCT01372410|3763246|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
1537874|NCT01372410|3763247|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
1537875|NCT01372410|3763248|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1537876|NCT01372410|3763249|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
1537877|NCT01372410|3763250|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1537878|NCT01372410|3763251|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1537879|NCT01372410|3763252|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1537880|NCT01372410|3763253|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
1537881|NCT01372410|3763246|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
1537882|NCT01372410|3763247|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
1537883|NCT01372410|3763248|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
1537884|NCT01372410|3763249|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
1537885|NCT01372410|3763250|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
1537886|NCT01372410|3763251|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
1537887|NCT01372410|3763252|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
1537888|NCT01372410|3763253|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
1537889|NCT01372410|3763246|P8|STARTED|Washout Period 2 (10-14 Days)||19
1537890|NCT01372410|3763247|P7|STARTED|Washout Period 2 (10-14 Days)||21
1537891|NCT01372410|3763248|P6|STARTED|Washout Period 2 (10-14 Days)||16
1537892|NCT01372410|3763249|P5|STARTED|Washout Period 2 (10-14 Days)||19
1537893|NCT01372410|3763250|P4|STARTED|Washout Period 2 (10-14 Days)||17
1537894|NCT01372410|3763251|P3|STARTED|Washout Period 2 (10-14 Days)||22
1537895|NCT01372410|3763252|P2|STARTED|Washout Period 2 (10-14 Days)||21
1537896|NCT01372410|3763253|P1|STARTED|Washout Period 2 (10-14 Days)||19
1537897|NCT01372410|3763246|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1537898|NCT01372410|3763247|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1537899|NCT01372410|3763248|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1537900|NCT01372410|3763249|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1537901|NCT01372410|3763250|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1537902|NCT01372410|3763251|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1537903|NCT01372410|3763252|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1537904|NCT01372410|3763253|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
1537905|NCT01372410|3763246|P8|COMPLETED|Treatment Period 2 (7 Days)||19
1537906|NCT01372410|3763247|P7|COMPLETED|Treatment Period 2 (7 Days)||21
1537907|NCT01372410|3763248|P6|COMPLETED|Treatment Period 2 (7 Days)||16
1537908|NCT01372410|3763249|P5|COMPLETED|Treatment Period 2 (7 Days)||19
1537909|NCT01372410|3763250|P4|COMPLETED|Treatment Period 2 (7 Days)||17
1537910|NCT01372410|3763251|P3|COMPLETED|Treatment Period 2 (7 Days)||22
1537911|NCT01372410|3763252|P2|COMPLETED|Treatment Period 2 (7 Days)||21
1537912|NCT01372410|3763253|P1|COMPLETED|Treatment Period 2 (7 Days)||19
1537913|NCT01372410|3763246|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
1537914|NCT01372410|3763247|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
1537915|NCT01372410|3763248|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
1537916|NCT01372410|3763249|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
1537917|NCT01372410|3763250|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
1537918|NCT01372410|3763251|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
1537919|NCT01372410|3763252|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
1537920|NCT01372410|3763253|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
1537921|NCT01372410|3763246|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
1537922|NCT01372410|3763247|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1537923|NCT01372410|3763248|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1537924|NCT01372410|3763249|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1537925|NCT01372410|3763250|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1537926|NCT01372410|3763251|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1537927|NCT01372410|3763252|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
1537928|NCT01372410|3763253|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
1537929|NCT01372410|3763246|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
1537930|NCT01372410|3763247|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
1537931|NCT01372410|3763248|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
1537932|NCT01372410|3763249|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
1537933|NCT01372410|3763250|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
1537934|NCT01372410|3763251|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
1537935|NCT01372410|3763252|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
1537936|NCT01372410|3763253|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
1537937|NCT01372410|3763246|P8|STARTED|Washout Period 1 (10-14 Days)||19
1537938|NCT01372410|3763247|P7|STARTED|Washout Period 1 (10-14 Days)||20
1537939|NCT01372410|3763248|P6|STARTED|Washout Period 1 (10-14 Days)||21
1537940|NCT01372410|3763249|P5|STARTED|Washout Period 1 (10-14 Days)||19
1537941|NCT01372410|3763250|P4|STARTED|Washout Period 1 (10-14 Days)||20
1537942|NCT01372410|3763251|P3|STARTED|Washout Period 1 (10-14 Days)||19
1537943|NCT01372410|3763252|P2|STARTED|Washout Period 1 (10-14 Days)||19
1537944|NCT01372410|3763253|P1|STARTED|Washout Period 1 (10-14 Days)||19
1537945|NCT01372410|3763246|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1537946|NCT01372410|3763247|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
1537947|NCT01372410|3763248|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1537948|NCT01372410|3763249|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
1537949|NCT01372410|3763250|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1537950|NCT01372410|3763251|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
1537951|NCT01372410|3763252|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
1537952|NCT01372410|3763253|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
1537953|NCT01372410|3763246|P8|COMPLETED|Treatment Period 1 (7 Days)||19
1537954|NCT01372410|3763247|P7|COMPLETED|Treatment Period 1 (7 Days)||20
1537955|NCT01372410|3763248|P6|COMPLETED|Treatment Period 1 (7 Days)||21
1537956|NCT01372410|3763249|P5|COMPLETED|Treatment Period 1 (7 Days)||19
1537957|NCT01372410|3763250|P4|COMPLETED|Treatment Period 1 (7 Days)||20
1537958|NCT01372410|3763251|P3|COMPLETED|Treatment Period 1 (7 Days)||19
1537959|NCT01372410|3763252|P2|COMPLETED|Treatment Period 1 (7 Days)||19
1537960|NCT01372410|3763253|P1|COMPLETED|Treatment Period 1 (7 Days)||19
1537961|NCT01372410|3763246|P8|STARTED|Treatment Period 1 (7 Days)||19
1537962|NCT01372410|3763247|P7|STARTED|Treatment Period 1 (7 Days)||22
1537963|NCT01372410|3763248|P6|STARTED|Treatment Period 1 (7 Days)||21
1537964|NCT01372410|3763249|P5|STARTED|Treatment Period 1 (7 Days)||21
1537965|NCT01372410|3763250|P4|STARTED|Treatment Period 1 (7 Days)||20
1537966|NCT01372410|3763251|P3|STARTED|Treatment Period 1 (7 Days)||19
1537967|NCT01372410|3763252|P2|STARTED|Treatment Period 1 (7 Days)||21
1537968|NCT01372410|3763253|P1|STARTED|Treatment Period 1 (7 Days)||20
1537969|NCT01372384|3763290|P1|NOT COMPLETED|Overall Study||3
1537970|NCT01372384|3763290|P1|COMPLETED|Overall Study||3
1537971|NCT01372384|3763290|P1|STARTED|Overall Study||6
1537972|NCT01372202|3763300|P3|NOT COMPLETED|Overall Study||0
1537973|NCT01372202|3763301|P2|NOT COMPLETED|Overall Study||0
1537974|NCT01372202|3763302|P1|NOT COMPLETED|Overall Study||0
1537975|NCT01372202|3763300|P3|COMPLETED|Overall Study||9
1537976|NCT01372202|3763301|P2|COMPLETED|Overall Study||9
1537977|NCT01372202|3763302|P1|COMPLETED|Overall Study||13
1537978|NCT01372202|3763300|P3|STARTED|Overall Study||9
1537979|NCT01372202|3763301|P2|STARTED|Overall Study||9
1537980|NCT01372202|3763302|P1|STARTED|Overall Study||13
1537981|NCT01372150|3763313|P3|NOT COMPLETED|Overall Study||16
1537982|NCT01372150|3763314|P2|NOT COMPLETED|Overall Study||14
1537983|NCT01372150|3763315|P1|NOT COMPLETED|Overall Study||13
1537984|NCT01372150|3763313|P3|COMPLETED|Overall Study||99
1537985|NCT01372150|3763314|P2|COMPLETED|Overall Study||99
1537986|NCT01372150|3763315|P1|COMPLETED|Overall Study||99
1537987|NCT01372150|3763313|P3|Treated|Overall Study||115
1537988|NCT01372150|3763314|P2|Treated|Overall Study||112
1537989|NCT01372150|3763315|P1|Treated|Overall Study||112
1537990|NCT01372150|3763313|P3|STARTED|Overall Study||115
1537991|NCT01372150|3763314|P2|STARTED|Overall Study||113
1537992|NCT01372150|3763315|P1|STARTED|Overall Study||112
1537993|NCT01371994|3763334|P2|NOT COMPLETED|Overall Study||42
1537994|NCT01371994|3763335|P1|NOT COMPLETED|Overall Study||57
1537995|NCT01371994|3763334|P2|COMPLETED|Overall Study||278
1537996|NCT01371994|3763335|P1|COMPLETED|Overall Study||263
1537997|NCT01371994|3763334|P2|Received Treatment|Overall Study||313
1537998|NCT01371994|3763335|P1|Received Treatment|Overall Study||310
1537999|NCT01371994|3763334|P2|STARTED|Overall Study||320
1538000|NCT01371994|3763335|P1|STARTED|Overall Study||320
1538001|NCT01371877|3763379|P2|NOT COMPLETED|Overall Study||4
1538002|NCT01371877|3763380|P1|NOT COMPLETED|Overall Study||0
1538003|NCT01371877|3763379|P2|COMPLETED|Overall Study||17
1538004|NCT01371877|3763380|P1|COMPLETED|Overall Study||21
1538005|NCT01371877|3763379|P2|STARTED|Overall Study||21
1538006|NCT01371877|3763380|P1|STARTED|Overall Study||21
1538007|NCT01371851|3763392|P2|NOT COMPLETED|Overall Study||9
1538008|NCT01371851|3763393|P1|NOT COMPLETED|Overall Study||8
1538009|NCT01371851|3763392|P2|COMPLETED|Overall Study||2
1538010|NCT01371851|3763393|P1|COMPLETED|Overall Study||3
1538011|NCT01371851|3763392|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
1538012|NCT01371851|3763393|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
1538013|NCT01371838|3763401|P2|NOT COMPLETED|Overall Study||66
1538014|NCT01371838|3763402|P1|NOT COMPLETED|Overall Study||49
1538015|NCT01371838|3763401|P2|COMPLETED|Overall Study||317
1538016|NCT01371838|3763402|P1|COMPLETED|Overall Study||332
1538017|NCT01371838|3763401|P2|STARTED|Overall Study||383
1538018|NCT01371838|3763402|P1|STARTED|Overall Study||381
1538019|NCT01371825|3763438|P1|NOT COMPLETED|Long-term Treatment Period||0
1538020|NCT01371825|3763438|P1|COMPLETED|Long-term Treatment Period|This period is currently ongoing.|6
1538021|NCT01371825|3763438|P1|STARTED|Long-term Treatment Period||6
1538022|NCT01371825|3763438|P1|NOT COMPLETED|Primary Efficacy Analysis Period||3
1538023|NCT01371825|3763438|P1|COMPLETED|Primary Efficacy Analysis Period||6
1538024|NCT01371825|3763438|P1|STARTED|Primary Efficacy Analysis Period||9
1538025|NCT01371786|3763452|P2|NOT COMPLETED|Overall Study||0
1538026|NCT01371786|3763453|P1|NOT COMPLETED|Overall Study||0
1538027|NCT01371786|3763452|P2|COMPLETED|Overall Study||7
1538028|NCT01371786|3763453|P1|COMPLETED|Overall Study||7
1538029|NCT01371786|3763452|P2|STARTED|Overall Study||7
1538030|NCT01371786|3763453|P1|STARTED|Overall Study||7
1538031|NCT01371747|3763473|P6|NOT COMPLETED|Overall Study||14
1538032|NCT01371747|3763474|P5|NOT COMPLETED|Overall Study||7
1538033|NCT01371747|3763475|P4|NOT COMPLETED|Overall Study||9
1538034|NCT01371747|3763476|P3|NOT COMPLETED|Overall Study||24
1538035|NCT01371747|3763477|P2|NOT COMPLETED|Overall Study||23
1538036|NCT01371747|3763478|P1|NOT COMPLETED|Overall Study||18
1538037|NCT01371747|3763473|P6|COMPLETED|Overall Study||16
1538038|NCT01371747|3763474|P5|COMPLETED|Overall Study||21
1538039|NCT01371747|3763475|P4|COMPLETED|Overall Study||17
1538040|NCT01371747|3763476|P3|COMPLETED|Overall Study||50
1538041|NCT01371747|3763477|P2|COMPLETED|Overall Study||51
1538042|NCT01371747|3763478|P1|COMPLETED|Overall Study||56
1538043|NCT01371747|3763473|P6|STARTED|Overall Study||30
1538044|NCT01371747|3763474|P5|STARTED|Overall Study||28
1538045|NCT01371747|3763475|P4|STARTED|Overall Study||26
1538046|NCT01371747|3763476|P3|STARTED|Overall Study||74
1538047|NCT01371747|3763477|P2|STARTED|Overall Study||74
1538048|NCT01371747|3763478|P1|STARTED|Overall Study||74
1538049|NCT01371734|3763543|P3|NOT COMPLETED|Overall Study||17
1538050|NCT01371734|3763544|P2|NOT COMPLETED|Overall Study||19
1538051|NCT01371734|3763545|P1|NOT COMPLETED|Overall Study||23
1538052|NCT01371734|3763543|P3|COMPLETED|Overall Study||104
1538053|NCT01371734|3763544|P2|COMPLETED|Overall Study||103
1538054|NCT01371734|3763545|P1|COMPLETED|Overall Study||97
1538055|NCT01371734|3763543|P3|STARTED|Overall Study||121
1538056|NCT01371734|3763544|P2|STARTED|Overall Study||122
1538057|NCT01371734|3763545|P1|STARTED|Overall Study||120
1538058|NCT01371721|3763565|P3|NOT COMPLETED|Overall Study||30
1538059|NCT01371721|3763566|P2|NOT COMPLETED|Overall Study||24
1538060|NCT01371721|3763567|P1|NOT COMPLETED|Overall Study||29
1538061|NCT01371721|3763565|P3|COMPLETED|Overall Study||62
1538062|NCT01371721|3763566|P2|COMPLETED|Overall Study||65
1538063|NCT01371721|3763567|P1|COMPLETED|Overall Study||59
1538064|NCT01371721|3763565|P3|Treated|Overall Study||92
1538065|NCT01371721|3763566|P2|Treated|Overall Study||89
1538066|NCT01371721|3763567|P1|Treated|Overall Study||87
1538067|NCT01371721|3763565|P3|STARTED|Overall Study||92
1538068|NCT01371721|3763566|P2|STARTED|Overall Study||89
1538069|NCT01371721|3763567|P1|STARTED|Overall Study||88
1538070|NCT01371708|3763600|P3|NOT COMPLETED|Overall Study||39
1538071|NCT01371708|3763601|P2|NOT COMPLETED|Overall Study||30
1538072|NCT01371708|3763602|P1|NOT COMPLETED|Overall Study||26
1538073|NCT01371708|3763600|P3|COMPLETED|Overall Study||59
1538074|NCT01371708|3763601|P2|COMPLETED|Overall Study||63
1538075|NCT01371708|3763602|P1|COMPLETED|Overall Study||66
1538076|NCT01371708|3763600|P3|Received Treatment|Overall Study||97
1538077|NCT01371708|3763601|P2|Received Treatment|Overall Study||93
1538078|NCT01371708|3763602|P1|Received Treatment|Overall Study||91
1538079|NCT01371708|3763600|P3|STARTED|Overall Study||98
1538080|NCT01371708|3763601|P2|STARTED|Overall Study||93
1538081|NCT01371708|3763602|P1|STARTED|Overall Study||92
1538082|NCT01371656|3763634|P2|NOT COMPLETED|Overall Study||14
1538083|NCT01371656|3763635|P1|NOT COMPLETED|Overall Study||64
1538084|NCT01371656|3763634|P2|COMPLETED|Overall Study||296
1538085|NCT01371656|3763635|P1|COMPLETED|Overall Study||250
1538086|NCT01371656|3763634|P2|STARTED|Overall Study||310
1538087|NCT01371656|3763635|P1|STARTED|Overall Study||314
1538088|NCT01371643|3763655|P2|NOT COMPLETED|Overall Study||0
1538089|NCT01371643|3763656|P1|NOT COMPLETED|Overall Study||3
1538090|NCT01371643|3763655|P2|COMPLETED|Overall Study||26
1538091|NCT01371643|3763656|P1|COMPLETED|Overall Study||12
1538092|NCT01371643|3763655|P2|STARTED|Overall Study||26
1538093|NCT01371643|3763656|P1|STARTED|Overall Study||15
1538094|NCT01371565|3763666|P1|NOT COMPLETED|Overall Study||3
1538095|NCT01371565|3763666|P1|COMPLETED|Overall Study||1
1538096|NCT01371565|3763666|P1|STARTED|Overall Study||4
1538097|NCT01371552|3763670|P6|NOT COMPLETED|Part 2, One Week||0
1538098|NCT01371552|3763671|P5|NOT COMPLETED|Part 2, One Week||0
1538099|NCT01371552|3763672|P4|NOT COMPLETED|Part 2, One Week||0
1538100|NCT01371552|3763673|P3|NOT COMPLETED|Part 2, One Week||0
1538101|NCT01371552|3763674|P2|NOT COMPLETED|Part 2, One Week||0
1538102|NCT01371552|3763675|P1|NOT COMPLETED|Part 2, One Week||0
1538103|NCT01371552|3763670|P6|COMPLETED|Part 2, One Week||18
1538104|NCT01371552|3763671|P5|COMPLETED|Part 2, One Week||15
1538105|NCT01371552|3763672|P4|COMPLETED|Part 2, One Week||20
1538106|NCT01371552|3763673|P3|COMPLETED|Part 2, One Week||18
1538107|NCT01371552|3763674|P2|COMPLETED|Part 2, One Week||17
1538108|NCT01371552|3763675|P1|COMPLETED|Part 2, One Week||18
1538109|NCT01371552|3763670|P6|STARTED|Part 2, One Week||18
1538110|NCT01371552|3763671|P5|STARTED|Part 2, One Week||15
1538111|NCT01371552|3763672|P4|STARTED|Part 2, One Week||20
1538112|NCT01371552|3763673|P3|STARTED|Part 2, One Week||18
1538113|NCT01371552|3763674|P2|STARTED|Part 2, One Week||17
1538114|NCT01371552|3763675|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
1538115|NCT01371552|3763670|P6|NOT COMPLETED|Part 1, Third 3 Days||1
1538116|NCT01371552|3763671|P5|NOT COMPLETED|Part 1, Third 3 Days||1
1538117|NCT01371552|3763672|P4|NOT COMPLETED|Part 1, Third 3 Days||0
1538118|NCT01371552|3763673|P3|NOT COMPLETED|Part 1, Third 3 Days||0
1538119|NCT01371552|3763674|P2|NOT COMPLETED|Part 1, Third 3 Days||0
1538120|NCT01371552|3763675|P1|NOT COMPLETED|Part 1, Third 3 Days||0
1538121|NCT01371552|3763670|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
1538122|NCT01371552|3763671|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
1538123|NCT01371552|3763672|P4|COMPLETED|Part 1, Third 3 Days||20
1538124|NCT01371552|3763673|P3|COMPLETED|Part 1, Third 3 Days||18
1538125|NCT01371552|3763674|P2|COMPLETED|Part 1, Third 3 Days||17
1538126|NCT01371552|3763675|P1|COMPLETED|Part 1, Third 3 Days||19
1538127|NCT01371552|3763670|P6|STARTED|Part 1, Third 3 Days||18
1538128|NCT01371552|3763671|P5|STARTED|Part 1, Third 3 Days||15
1538129|NCT01371552|3763672|P4|STARTED|Part 1, Third 3 Days||20
1538130|NCT01371552|3763673|P3|STARTED|Part 1, Third 3 Days||18
1538131|NCT01371552|3763674|P2|STARTED|Part 1, Third 3 Days||17
1538132|NCT01371552|3763675|P1|STARTED|Part 1, Third 3 Days||19
1538133|NCT01371552|3763670|P6|NOT COMPLETED|Part 1, Second 3 Days||0
1538134|NCT01371552|3763671|P5|NOT COMPLETED|Part 1, Second 3 Days||0
1538135|NCT01371552|3763672|P4|NOT COMPLETED|Part 1, Second 3 Days||0
1538136|NCT01371552|3763673|P3|NOT COMPLETED|Part 1, Second 3 Days||0
1538137|NCT01371552|3763674|P2|NOT COMPLETED|Part 1, Second 3 Days||0
1538138|NCT01371552|3763675|P1|NOT COMPLETED|Part 1, Second 3 Days||1
1538139|NCT01371552|3763670|P6|COMPLETED|Part 1, Second 3 Days||18
1538140|NCT01371552|3763671|P5|COMPLETED|Part 1, Second 3 Days||15
1538141|NCT01371552|3763672|P4|COMPLETED|Part 1, Second 3 Days||20
1538142|NCT01371552|3763673|P3|COMPLETED|Part 1, Second 3 Days||18
1538143|NCT01371552|3763674|P2|COMPLETED|Part 1, Second 3 Days||17
1538144|NCT01371552|3763675|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
1538145|NCT01371552|3763670|P6|STARTED|Part 1, Second 3 Days||18
1538146|NCT01371552|3763671|P5|STARTED|Part 1, Second 3 Days||15
1538147|NCT01371552|3763672|P4|STARTED|Part 1, Second 3 Days||20
1538148|NCT01371552|3763673|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
1538149|NCT01371552|3763674|P2|STARTED|Part 1, Second 3 Days||17
1538150|NCT01371552|3763675|P1|STARTED|Part 1, Second 3 Days||19
1538151|NCT01371552|3763670|P6|NOT COMPLETED|Part 1, First 3 Days||0
1538152|NCT01371552|3763671|P5|NOT COMPLETED|Part 1, First 3 Days||0
1538153|NCT01371552|3763672|P4|NOT COMPLETED|Part 1, First 3 Days||0
1538154|NCT01371552|3763673|P3|NOT COMPLETED|Part 1, First 3 Days||1
1538155|NCT01371552|3763674|P2|NOT COMPLETED|Part 1, First 3 Days||0
1538156|NCT01371552|3763675|P1|NOT COMPLETED|Part 1, First 3 Days||0
1538157|NCT01371552|3763670|P6|COMPLETED|Part 1, First 3 Days||18
1538158|NCT01371552|3763671|P5|COMPLETED|Part 1, First 3 Days||15
1538159|NCT01371552|3763672|P4|COMPLETED|Part 1, First 3 Days||20
1538160|NCT01371552|3763673|P3|COMPLETED|Part 1, First 3 Days||19
1538161|NCT01371552|3763674|P2|COMPLETED|Part 1, First 3 Days||17
1538162|NCT01371552|3763675|P1|COMPLETED|Part 1, First 3 Days||19
1538163|NCT01371552|3763670|P6|STARTED|Part 1, First 3 Days||18
1538164|NCT01371552|3763671|P5|STARTED|Part 1, First 3 Days||15
1538165|NCT01371552|3763672|P4|STARTED|Part 1, First 3 Days||20
1538166|NCT01371552|3763673|P3|STARTED|Part 1, First 3 Days||20
1538167|NCT01371552|3763674|P2|STARTED|Part 1, First 3 Days||17
1538168|NCT01371552|3763675|P1|STARTED|Part 1, First 3 Days||19
1538169|NCT01371539|3763702|P2|NOT COMPLETED|Period Two: One Week||3
1538170|NCT01371539|3763703|P1|NOT COMPLETED|Period Two: One Week||0
1538171|NCT01371539|3763702|P2|COMPLETED|Period Two: One Week||47
1538172|NCT01371539|3763703|P1|COMPLETED|Period Two: One Week||53
1538173|NCT01371539|3763702|P2|STARTED|Period Two: One Week||50
1538174|NCT01371539|3763703|P1|STARTED|Period Two: One Week||53
1538175|NCT01371539|3763702|P2|NOT COMPLETED|Period One: One Week||1
1538176|NCT01371539|3763703|P1|NOT COMPLETED|Period One: One Week||0
1538177|NCT01371539|3763702|P2|COMPLETED|Period One: One Week||50
1538178|NCT01371539|3763703|P1|COMPLETED|Period One: One Week||53
1538179|NCT01371539|3763702|P2|STARTED|Period One: One Week||51
1538180|NCT01371539|3763703|P1|STARTED|Period One: One Week||53
1538181|NCT01371110|3763713|P2|NOT COMPLETED|Overall Study||0
1538182|NCT01371110|3763714|P1|NOT COMPLETED|Overall Study||0
1538183|NCT01371110|3763713|P2|COMPLETED|Overall Study||2
1538184|NCT01371110|3763714|P1|COMPLETED|Overall Study||1
1538185|NCT01371110|3763713|P2|STARTED|Overall Study||2
1538186|NCT01371110|3763714|P1|STARTED|Overall Study||1
1538187|NCT01371006|3763724|P2|NOT COMPLETED|Overall Study||0
1538188|NCT01371006|3763725|P1|NOT COMPLETED|Overall Study||1
1538189|NCT01371006|3763724|P2|COMPLETED|Overall Study||15
1538190|NCT01371006|3763725|P1|COMPLETED|Overall Study||13
1538191|NCT01371006|3763724|P2|STARTED|Overall Study||15
1538192|NCT01371006|3763725|P1|STARTED|Overall Study||14
1538193|NCT01370863|3763766|P2|NOT COMPLETED|Overall Study||3
1538194|NCT01370863|3763767|P1|NOT COMPLETED|Overall Study||2
1538195|NCT01370863|3763766|P2|COMPLETED|Overall Study||30
1538196|NCT01370863|3763767|P1|COMPLETED|Overall Study||32
1538197|NCT01370863|3763766|P2|STARTED|Overall Study||33
1538198|NCT01370863|3763767|P1|STARTED|Overall Study||34
1538199|NCT01370837|3763780|P3|NOT COMPLETED|Overall Study||0
1538200|NCT01370837|3763781|P2|NOT COMPLETED|Overall Study||0
1538201|NCT01370837|3763782|P1|NOT COMPLETED|Overall Study||0
1538202|NCT01370837|3763780|P3|COMPLETED|Overall Study||17
1538203|NCT01370837|3763781|P2|COMPLETED|Overall Study||12
1538204|NCT01370837|3763782|P1|COMPLETED|Overall Study||12
1538205|NCT01370837|3763780|P3|STARTED|Overall Study||17
1538206|NCT01370837|3763781|P2|STARTED|Overall Study||12
1538207|NCT01370837|3763782|P1|STARTED|Overall Study||12
1538208|NCT01370733|3763792|P2|NOT COMPLETED|Overall Study||22
1538209|NCT01370733|3763793|P1|NOT COMPLETED|Overall Study||17
1538210|NCT01370733|3763792|P2|COMPLETED|Overall Study||77
1538211|NCT01370733|3763793|P1|COMPLETED|Overall Study||86
1538212|NCT01370733|3763792|P2|STARTED|Overall Study||99
1538213|NCT01370733|3763793|P1|STARTED|Overall Study||103
1538214|NCT01370694|3763815|P1|NOT COMPLETED|Overall Study||6
1538215|NCT01370694|3763815|P1|COMPLETED|Overall Study||1
1538216|NCT01370694|3763815|P1|STARTED|Overall Study||7
1538217|NCT01370655|3763837|P12|NOT COMPLETED|Period 2||0
1538218|NCT01370655|3763838|P11|NOT COMPLETED|Period 2||1
1538219|NCT01370655|3763839|P10|NOT COMPLETED|Period 2||0
1538220|NCT01370655|3763840|P9|NOT COMPLETED|Period 2||2
1538221|NCT01370655|3763841|P8|NOT COMPLETED|Period 2||1
1538222|NCT01370655|3763842|P7|NOT COMPLETED|Period 2||1
1538223|NCT01370655|3763843|P6|NOT COMPLETED|Period 2||0
1538224|NCT01370655|3763844|P5|NOT COMPLETED|Period 2||1
1538225|NCT01370655|3763845|P4|NOT COMPLETED|Period 2||0
1538226|NCT01370655|3763846|P3|NOT COMPLETED|Period 2||2
1538227|NCT01370655|3763847|P2|NOT COMPLETED|Period 2||0
1538228|NCT01370655|3763848|P1|NOT COMPLETED|Period 2||0
1538229|NCT01370655|3763837|P12|COMPLETED|Period 2||3
1538230|NCT01370655|3763838|P11|COMPLETED|Period 2||2
1538231|NCT01370655|3763839|P10|COMPLETED|Period 2||2
1538232|NCT01370655|3763840|P9|COMPLETED|Period 2||1
1538233|NCT01370655|3763841|P8|COMPLETED|Period 2||3
1538234|NCT01370655|3763842|P7|COMPLETED|Period 2||2
1538235|NCT01370655|3763843|P6|COMPLETED|Period 2||4
1538236|NCT01370655|3763844|P5|COMPLETED|Period 2||2
1538237|NCT01370655|3763845|P4|COMPLETED|Period 2||3
1538238|NCT01370655|3763846|P3|COMPLETED|Period 2||1
1538239|NCT01370655|3763847|P2|COMPLETED|Period 2||7
1538240|NCT01370655|3763848|P1|COMPLETED|Period 2||5
1538241|NCT01370655|3763837|P12|STARTED|Period 2||3
1538242|NCT01370655|3763838|P11|STARTED|Period 2||3
1538243|NCT01370655|3763839|P10|STARTED|Period 2||2
1538244|NCT01370655|3763840|P9|STARTED|Period 2||3
1538245|NCT01370655|3763841|P8|STARTED|Period 2||4
1538246|NCT01370655|3763842|P7|STARTED|Period 2||3
1538247|NCT01370655|3763843|P6|STARTED|Period 2||4
1538248|NCT01370655|3763844|P5|STARTED|Period 2||3
1538249|NCT01370655|3763845|P4|STARTED|Period 2||3
1538250|NCT01370655|3763846|P3|STARTED|Period 2||3
1538251|NCT01370655|3763847|P2|STARTED|Period 2||7
1538252|NCT01370655|3763848|P1|STARTED|Period 2||5
1538253|NCT01370655|3763837|P12|NOT COMPLETED|Period 1||0
1538254|NCT01370655|3763838|P11|NOT COMPLETED|Period 1||0
1538255|NCT01370655|3763839|P10|NOT COMPLETED|Period 1||0
1538256|NCT01370655|3763840|P9|NOT COMPLETED|Period 1||0
1538257|NCT01370655|3763841|P8|NOT COMPLETED|Period 1||0
1538258|NCT01370655|3763842|P7|NOT COMPLETED|Period 1||1
1538259|NCT01370655|3763843|P6|NOT COMPLETED|Period 1||0
1538260|NCT01370655|3763844|P5|NOT COMPLETED|Period 1||0
1538261|NCT01370655|3763845|P4|NOT COMPLETED|Period 1||0
1538262|NCT01370655|3763846|P3|NOT COMPLETED|Period 1||0
1538263|NCT01370655|3763847|P2|NOT COMPLETED|Period 1||0
1538264|NCT01370655|3763848|P1|NOT COMPLETED|Period 1||2
1538265|NCT01370655|3763837|P12|COMPLETED|Period 1||3
1538266|NCT01370655|3763838|P11|COMPLETED|Period 1||3
1538267|NCT01370655|3763839|P10|COMPLETED|Period 1||2
1538268|NCT01370655|3763840|P9|COMPLETED|Period 1||3
1538269|NCT01370655|3763841|P8|COMPLETED|Period 1||4
1538270|NCT01370655|3763842|P7|COMPLETED|Period 1||3
1538271|NCT01370655|3763843|P6|COMPLETED|Period 1||4
1538272|NCT01370655|3763844|P5|COMPLETED|Period 1||3
1538273|NCT01370655|3763845|P4|COMPLETED|Period 1||3
1538274|NCT01370655|3763846|P3|COMPLETED|Period 1||3
1538275|NCT01370655|3763847|P2|COMPLETED|Period 1||7
1538276|NCT01370655|3763848|P1|COMPLETED|Period 1||5
1538277|NCT01370655|3763837|P12|STARTED|Period 1||3
1538278|NCT01370655|3763838|P11|STARTED|Period 1||3
1538279|NCT01370655|3763839|P10|STARTED|Period 1||2
1538280|NCT01370655|3763840|P9|STARTED|Period 1||3
1538281|NCT01370655|3763841|P8|STARTED|Period 1||4
1538282|NCT01370655|3763842|P7|STARTED|Period 1||4
1538283|NCT01370655|3763843|P6|STARTED|Period 1||4
1538284|NCT01370655|3763844|P5|STARTED|Period 1||3
1538285|NCT01370655|3763845|P4|STARTED|Period 1||3
1538286|NCT01370655|3763846|P3|STARTED|Period 1||3
1538287|NCT01370655|3763847|P2|STARTED|Period 1||7
1538288|NCT01370655|3763848|P1|STARTED|Period 1||7
1538289|NCT01370642|3763885|P3|NOT COMPLETED|Overall Study||29
1538290|NCT01370642|3763886|P2|NOT COMPLETED|Overall Study||6
1538291|NCT01370642|3763887|P1|NOT COMPLETED|Overall Study||8
1538292|NCT01370642|3763885|P3|COMPLETED|Overall Study||69
1538293|NCT01370642|3763886|P2|COMPLETED|Overall Study||92
1538294|NCT01370642|3763887|P1|COMPLETED|Overall Study||90
1538295|NCT01370642|3763885|P3|FAS Population|Overall Study||98
1538296|NCT01370642|3763886|P2|FAS Population|Overall Study||97
1538297|NCT01370642|3763887|P1|FAS Population|Overall Study||98
1538298|NCT01370642|3763885|P3|STARTED|Overall Study||98
1538299|NCT01370642|3763886|P2|STARTED|Overall Study||98
1538300|NCT01370642|3763887|P1|STARTED|Overall Study||98
1538301|NCT01370616|3763918|P2|NOT COMPLETED|Overall Study||67
1538302|NCT01370616|3763919|P1|NOT COMPLETED|Overall Study||62
1538303|NCT01370616|3763918|P2|COMPLETED|Overall Study||216
1538304|NCT01370616|3763919|P1|COMPLETED|Overall Study||220
1538305|NCT01370616|3763918|P2|Treated|Overall Study||275
1538306|NCT01370616|3763919|P1|Treated|Overall Study||275
1538307|NCT01370616|3763918|P2|STARTED|Overall Study|Participants randomized|283
1538308|NCT01370616|3763919|P1|STARTED|Overall Study|Participants randomized|282
1538309|NCT01370603|3763943|P2|NOT COMPLETED|Period 2||4
1538310|NCT01370603|3763944|P1|NOT COMPLETED|Period 2||3
1538311|NCT01370603|3763943|P2|COMPLETED|Period 2||146
1538312|NCT01370603|3763944|P1|COMPLETED|Period 2||138
1538313|NCT01370603|3763943|P2|STARTED|Period 2||150
1538314|NCT01370603|3763944|P1|STARTED|Period 2||141
1538315|NCT01370603|3763943|P2|NOT COMPLETED|Crossover Washout||4
1538316|NCT01370603|3763944|P1|NOT COMPLETED|Crossover Washout||9
1538317|NCT01370603|3763943|P2|COMPLETED|Crossover Washout||150
1538318|NCT01370603|3763944|P1|COMPLETED|Crossover Washout||141
1538319|NCT01370603|3763943|P2|STARTED|Crossover Washout||154
1538320|NCT01370603|3763944|P1|STARTED|Crossover Washout||150
1538321|NCT01370603|3763943|P2|NOT COMPLETED|Period 1||10
1538322|NCT01370603|3763944|P1|NOT COMPLETED|Period 1||14
1538323|NCT01370603|3763943|P2|COMPLETED|Period 1||154
1538324|NCT01370603|3763944|P1|COMPLETED|Period 1||150
1538325|NCT01370603|3763943|P2|STARTED|Period 1||164
1538326|NCT01370603|3763944|P1|STARTED|Period 1||164
1538327|NCT01370590|3763962|P2|NOT COMPLETED|Period 2||2
1538328|NCT01370590|3763963|P1|NOT COMPLETED|Period 2||1
1538329|NCT01370590|3763962|P2|COMPLETED|Period 2||184
1538330|NCT01370590|3763963|P1|COMPLETED|Period 2||180
1538331|NCT01370590|3763962|P2|STARTED|Period 2||186
1538332|NCT01370590|3763963|P1|STARTED|Period 2||181
1538333|NCT01370590|3763962|P2|NOT COMPLETED|Crossover Washout Period||6
1538334|NCT01370590|3763963|P1|NOT COMPLETED|Crossover Washout Period||6
1538335|NCT01370590|3763962|P2|COMPLETED|Crossover Washout Period||186
1538336|NCT01370590|3763963|P1|COMPLETED|Crossover Washout Period||181
1538337|NCT01370590|3763962|P2|STARTED|Crossover Washout Period||192
1538338|NCT01370590|3763963|P1|STARTED|Crossover Washout Period||187
1538339|NCT01370590|3763962|P2|NOT COMPLETED|Period 1||11
1538340|NCT01370590|3763963|P1|NOT COMPLETED|Period 1||16
1538341|NCT01370590|3763962|P2|COMPLETED|Period 1||192
1538342|NCT01370590|3763963|P1|COMPLETED|Period 1||187
1538343|NCT01370590|3763962|P2|STARTED|Period 1||203
1538344|NCT01370590|3763963|P1|STARTED|Period 1||203
1538345|NCT01370564|3763979|P1|NOT COMPLETED|Overall Study||0
1538346|NCT01370564|3763979|P1|COMPLETED|Overall Study||21
1538347|NCT01370564|3763979|P1|STARTED|Overall Study||21
1538348|NCT01370538|3763991|P2|NOT COMPLETED|Overall Study||19
1538349|NCT01370538|3763992|P1|NOT COMPLETED|Overall Study||19
1538350|NCT01370538|3763991|P2|COMPLETED|Overall Study||152
1538351|NCT01370538|3763992|P1|COMPLETED|Overall Study||151
1538352|NCT01370538|3763991|P2|Patients Who Completed Treatment|Overall Study||152
1538353|NCT01370538|3763992|P1|Patients Who Completed Treatment|Overall Study||151
1538354|NCT01370538|3763991|P2|Patients Who Received Treatment|Overall Study||161
1538355|NCT01370538|3763992|P1|Patients Who Received Treatment|Overall Study||165
1538356|NCT01370538|3763991|P2|STARTED|Overall Study||171
1538357|NCT01370538|3763992|P1|STARTED|Overall Study||170
1538358|NCT01370525|3764008|P2|NOT COMPLETED|Overall Study||11
1538359|NCT01370525|3764009|P1|NOT COMPLETED|Overall Study||8
1538360|NCT01370525|3764008|P2|COMPLETED|Overall Study||158
1538361|NCT01370525|3764009|P1|COMPLETED|Overall Study||163
1538362|NCT01370525|3764008|P2|Patients Who Completed Treatment|Overall Study||158
1538363|NCT01370525|3764009|P1|Patients Who Completed Treatment|Overall Study||163
1538364|NCT01370525|3764008|P2|Patients Who Received Treatment|Overall Study||163
1538365|NCT01370525|3764009|P1|Patients Who Received Treatment|Overall Study||168
1538366|NCT01370525|3764008|P2|STARTED|Overall Study||169
1538367|NCT01370525|3764009|P1|STARTED|Overall Study||171
1538368|NCT01370499|3764025|P2|NOT COMPLETED|Overall Study||44
1538369|NCT01370499|3764026|P1|NOT COMPLETED|Overall Study||111
1538370|NCT01370499|3764025|P2|COMPLETED|Overall Study||49
1538371|NCT01370499|3764026|P1|COMPLETED|Overall Study||84
1538372|NCT01370499|3764025|P2|Received at Least 1 Dose of Study Drug|Overall Study||92
1538373|NCT01370499|3764026|P1|Received at Least 1 Dose of Study Drug|Overall Study||195
1538374|NCT01370499|3764025|P2|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
1538375|NCT01370499|3764026|P1|Entered Abrupt Discontinuation Phase|Overall Study||188
1538376|NCT01370499|3764025|P2|STARTED|Overall Study||93
1538377|NCT01370499|3764026|P1|STARTED|Overall Study||195
1538378|NCT01370460|3764060|P2|NOT COMPLETED|Overall Study||0
1538379|NCT01370460|3764061|P1|NOT COMPLETED|Overall Study||0
1538380|NCT01370460|3764060|P2|COMPLETED|Overall Study||51
1538381|NCT01370460|3764061|P1|COMPLETED|Overall Study||50
1538382|NCT01370460|3764060|P2|STARTED|Overall Study||51
1538383|NCT01370460|3764061|P1|STARTED|Overall Study||50
1538384|NCT01370408|3764068|P1|NOT COMPLETED|Overall Study||9
1538385|NCT01370408|3764068|P1|COMPLETED|Overall Study||76
1538386|NCT01370408|3764068|P1|STARTED|Overall Study||85
1538387|NCT01370369|3764079|P1|NOT COMPLETED|Overall Study||0
1538388|NCT01370369|3764079|P1|COMPLETED|Overall Study||20
1538389|NCT01370369|3764079|P1|STARTED|Overall Study||20
1538390|NCT01370356|3764128|P2|NOT COMPLETED|Overall Study||227
1538391|NCT01370356|3764129|P1|NOT COMPLETED|Overall Study||192
1538392|NCT01370356|3764128|P2|COMPLETED|Overall Study||515
1538393|NCT01370356|3764129|P1|COMPLETED|Overall Study||559
1538394|NCT01370356|3764128|P2|STARTED|Overall Study||742
1538395|NCT01370356|3764129|P1|STARTED|Overall Study||751
1538396|NCT01370265|3764143|P2|NOT COMPLETED|Second Intervention||0
1538397|NCT01370265|3764144|P1|NOT COMPLETED|Second Intervention||0
1538398|NCT01370265|3764143|P2|COMPLETED|Second Intervention||5
1538399|NCT01370265|3764144|P1|COMPLETED|Second Intervention||5
1538400|NCT01370265|3764143|P2|STARTED|Second Intervention||5
1538401|NCT01370265|3764144|P1|STARTED|Second Intervention||5
1538402|NCT01370265|3764143|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
1538403|NCT01370265|3764144|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
1538404|NCT01370265|3764143|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
1538405|NCT01370265|3764144|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
1538406|NCT01370265|3764143|P2|STARTED|Washout Period (50-minute Period Decay)||5
1538407|NCT01370265|3764144|P1|STARTED|Washout Period (50-minute Period Decay)||5
1538408|NCT01370265|3764143|P2|NOT COMPLETED|First Intervention||1
1538409|NCT01370265|3764144|P1|NOT COMPLETED|First Intervention||1
1538410|NCT01370265|3764143|P2|COMPLETED|First Intervention||5
1538411|NCT01370265|3764144|P1|COMPLETED|First Intervention||5
1538412|NCT01370265|3764143|P2|STARTED|First Intervention||6
1538413|NCT01370265|3764144|P1|STARTED|First Intervention||6
1538414|NCT01370265|3764143|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
1538415|NCT01370265|3764144|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
1538416|NCT01370265|3764143|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
1538417|NCT01370265|3764144|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
1538418|NCT01370265|3764143|P2|STARTED|Washout Period (50-minute Period Decay)||6
1538419|NCT01370265|3764144|P1|STARTED|Washout Period (50-minute Period Decay)||6
1538420|NCT01370265|3764143|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
1538421|NCT01370265|3764144|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
1538422|NCT01370265|3764143|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
1538423|NCT01370265|3764144|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
1538424|NCT01370265|3764143|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
1538425|NCT01370265|3764144|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
1538426|NCT01370083|3764163|P2|NOT COMPLETED|Overall Study||1
1538427|NCT01370083|3764164|P1|NOT COMPLETED|Overall Study||2
1538428|NCT01370083|3764163|P2|COMPLETED|Overall Study||6
1538429|NCT01370083|3764164|P1|COMPLETED|Overall Study||5
1538430|NCT01370083|3764163|P2|STARTED|Overall Study||7
1538431|NCT01370083|3764164|P1|STARTED|Overall Study||7
1538432|NCT01370005|3764177|P3|NOT COMPLETED|Overall Study||11
1538433|NCT01370005|3764178|P2|NOT COMPLETED|Overall Study||11
1538434|NCT01370005|3764179|P1|NOT COMPLETED|Overall Study||16
1538435|NCT01370005|3764177|P3|COMPLETED|Overall Study||266
1538436|NCT01370005|3764178|P2|COMPLETED|Overall Study||265
1538437|NCT01370005|3764179|P1|COMPLETED|Overall Study||256
1538438|NCT01370005|3764177|P3|STARTED|Overall Study||277
1538439|NCT01370005|3764178|P2|STARTED|Overall Study||276
1538440|NCT01370005|3764179|P1|STARTED|Overall Study||272
1538441|NCT01369888|3764236|P4|NOT COMPLETED|Overall Study||0
1538442|NCT01369888|3764237|P3|NOT COMPLETED|Overall Study||0
1538443|NCT01369888|3764238|P2|NOT COMPLETED|Overall Study||0
1538444|NCT01369888|3764239|P1|NOT COMPLETED|Overall Study||0
1538445|NCT01369888|3764236|P4|COMPLETED|Overall Study||0
1538446|NCT01369888|3764237|P3|COMPLETED|Overall Study||0
1538447|NCT01369888|3764238|P2|COMPLETED|Overall Study||2
1538448|NCT01369888|3764239|P1|COMPLETED|Overall Study||1
1538449|NCT01369888|3764236|P4|STARTED|Overall Study||0
1538450|NCT01369888|3764237|P3|STARTED|Overall Study||0
1538451|NCT01369888|3764238|P2|STARTED|Overall Study||2
1538452|NCT01369888|3764239|P1|STARTED|Overall Study||1
1538453|NCT01369875|3764249|P2|NOT COMPLETED|Overall Study||0
1538454|NCT01369875|3764250|P1|NOT COMPLETED|Overall Study||0
1538455|NCT01369875|3764249|P2|COMPLETED|Overall Study||1
1538456|NCT01369875|3764250|P1|COMPLETED|Overall Study||1
1538457|NCT01369875|3764249|P2|STARTED|Overall Study||1
1538458|NCT01369875|3764250|P1|STARTED|Overall Study||1
1538459|NCT01369849|3764261|P3|NOT COMPLETED|Overall Study||1
1538460|NCT01369849|3764262|P2|NOT COMPLETED|Overall Study||1
1538461|NCT01369849|3764263|P1|NOT COMPLETED|Overall Study||0
1538462|NCT01369849|3764261|P3|COMPLETED|Overall Study||4
1538463|NCT01369849|3764262|P2|COMPLETED|Overall Study||3
1538464|NCT01369849|3764263|P1|COMPLETED|Overall Study||6
1538465|NCT01369849|3764261|P3|STARTED|Overall Study||5
1538466|NCT01369849|3764262|P2|STARTED|Overall Study||4
1538467|NCT01369849|3764263|P1|STARTED|Overall Study||6
1538468|NCT01369784|3764285|P1|NOT COMPLETED|Overall Study||12
1538469|NCT01369784|3764285|P1|COMPLETED|Overall Study||146
1538470|NCT01369784|3764285|P1|STARTED|Overall Study||158
1538471|NCT01369758|3764310|P1|NOT COMPLETED|Overall Study||0
1538472|NCT01369758|3764310|P1|COMPLETED|Overall Study||290
1538473|NCT01369758|3764310|P1|STARTED|Overall Study||290
1538474|NCT01369745|3764320|P5|NOT COMPLETED|Overall Study||18
1538475|NCT01369745|3764321|P4|NOT COMPLETED|Overall Study||20
1538476|NCT01369745|3764322|P3|NOT COMPLETED|Overall Study||2
1538477|NCT01369745|3764323|P2|NOT COMPLETED|Overall Study||13
1538478|NCT01369745|3764324|P1|NOT COMPLETED|Overall Study||7
1538479|NCT01369745|3764320|P5|COMPLETED|Overall Study||65
1538480|NCT01369745|3764321|P4|COMPLETED|Overall Study||64
1538481|NCT01369745|3764322|P3|COMPLETED|Overall Study||16
1538482|NCT01369745|3764323|P2|COMPLETED|Overall Study||28
1538483|NCT01369745|3764324|P1|COMPLETED|Overall Study||25
1538484|NCT01369745|3764320|P5|STARTED|Overall Study||83
1538485|NCT01369745|3764321|P4|STARTED|Overall Study||84
1538486|NCT01369745|3764322|P3|STARTED|Overall Study||18
1538487|NCT01369745|3764323|P2|STARTED|Overall Study||41
1538488|NCT01369745|3764324|P1|STARTED|Overall Study||32
1538489|NCT01369732|3764358|P2|NOT COMPLETED|Overall Study||2
1538490|NCT01369732|3764359|P1|NOT COMPLETED|Overall Study||4
1538491|NCT01369732|3764358|P2|COMPLETED|Overall Study||31
1538492|NCT01369732|3764359|P1|COMPLETED|Overall Study||29
1538493|NCT01369732|3764358|P2|STARTED|Overall Study||33
1538494|NCT01369732|3764359|P1|STARTED|Overall Study||33
1538495|NCT01369706|3764365|P1|NOT COMPLETED|Overall Study||0
1538496|NCT01369706|3764365|P1|COMPLETED|Overall Study||388
1538497|NCT01369706|3764365|P1|STARTED|Overall Study||388
1538498|NCT01369680|3764373|P4|NOT COMPLETED|Overall Study||2
1538499|NCT01369680|3764374|P3|NOT COMPLETED|Overall Study||1
1538500|NCT01369680|3764375|P2|NOT COMPLETED|Overall Study||0
1538501|NCT01369680|3764376|P1|NOT COMPLETED|Overall Study||0
1538502|NCT01369680|3764373|P4|COMPLETED|Overall Study||1
1538503|NCT01369680|3764374|P3|COMPLETED|Overall Study||2
1538504|NCT01369680|3764375|P2|COMPLETED|Overall Study||3
1538505|NCT01369680|3764376|P1|COMPLETED|Overall Study||3
1538506|NCT01369680|3764373|P4|STARTED|Overall Study||3
1538507|NCT01369680|3764374|P3|STARTED|Overall Study||3
1538508|NCT01369680|3764375|P2|STARTED|Overall Study||3
1538509|NCT01369680|3764376|P1|STARTED|Overall Study||3
1538510|NCT01369641|3764397|P1|NOT COMPLETED|Overall Study||1
1538511|NCT01369641|3764397|P1|COMPLETED|Overall Study||0
1538512|NCT01369641|3764397|P1|STARTED|Overall Study||1
1538513|NCT01369615|3764403|P2|NOT COMPLETED|Overall Study||2
1538514|NCT01369615|3764404|P1|NOT COMPLETED|Overall Study||0
1538515|NCT01369615|3764403|P2|COMPLETED|Overall Study||12
1538516|NCT01369615|3764404|P1|COMPLETED|Overall Study||9
1538517|NCT01369615|3764403|P2|STARTED|Overall Study||14
1538518|NCT01369615|3764404|P1|STARTED|Overall Study||9
1538519|NCT01369511|3764414|P4|NOT COMPLETED|Overall Study||11
1538520|NCT01369511|3764415|P3|NOT COMPLETED|Overall Study||11
1538521|NCT01369511|3764416|P2|NOT COMPLETED|Overall Study||13
1538522|NCT01369511|3764417|P1|NOT COMPLETED|Overall Study||13
1538523|NCT01369511|3764414|P4|COMPLETED|Overall Study||89
1538524|NCT01369511|3764415|P3|COMPLETED|Overall Study||87
1538525|NCT01369511|3764416|P2|COMPLETED|Overall Study||91
1538526|NCT01369511|3764417|P1|COMPLETED|Overall Study||85
1538527|NCT01369511|3764414|P4|Received at Least 1 Dose of Study Drug|Overall Study||100
1538528|NCT01369511|3764415|P3|Received at Least 1 Dose of Study Drug|Overall Study||98
1538529|NCT01369511|3764416|P2|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
1538530|NCT01369511|3764417|P1|Received at Least 1 Dose of Study Drug|Overall Study||98
1538531|NCT01369511|3764414|P4|STARTED|Overall Study||100
1538532|NCT01369511|3764415|P3|STARTED|Overall Study||98
1538533|NCT01369511|3764416|P2|STARTED|Overall Study||104
1538534|NCT01369511|3764417|P1|STARTED|Overall Study||98
1538535|NCT01369485|3764433|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
1538536|NCT01369485|3764434|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
1538537|NCT01369485|3764433|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
1538538|NCT01369485|3764434|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
1538539|NCT01369485|3764433|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
1538540|NCT01369485|3764434|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
1538541|NCT01369485|3764433|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
1538542|NCT01369485|3764434|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
1538543|NCT01369485|3764433|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
1538544|NCT01369485|3764434|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
1538545|NCT01369485|3764433|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
1538546|NCT01369485|3764434|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
1538547|NCT01369355|3764480|P6|NOT COMPLETED|Overall Study||272
1538548|NCT01369355|3764481|P5|NOT COMPLETED|Overall Study||154
1538549|NCT01369355|3764482|P4|NOT COMPLETED|Overall Study||30
1538550|NCT01369355|3764483|P3|NOT COMPLETED|Overall Study||31
1538551|NCT01369355|3764484|P2|NOT COMPLETED|Overall Study||29
1538552|NCT01369355|3764485|P1|NOT COMPLETED|Overall Study||31
1538553|NCT01369355|3764480|P6|COMPLETED|Overall Study||204
1538554|NCT01369355|3764481|P5|COMPLETED|Overall Study||131
1538555|NCT01369355|3764482|P4|COMPLETED|Overall Study||93
1538556|NCT01369355|3764483|P3|COMPLETED|Overall Study||101
1538557|NCT01369355|3764484|P2|COMPLETED|Overall Study||103
1538558|NCT01369355|3764485|P1|COMPLETED|Overall Study||102
1538559|NCT01369355|3764480|P6|Treated|Overall Study||476
1538560|NCT01369355|3764481|P5|Treated|Overall Study||285
1538561|NCT01369355|3764482|P4|Treated|Overall Study||123
1538562|NCT01369355|3764483|P3|Treated|Overall Study||131
1538563|NCT01369355|3764484|P2|Treated|Overall Study||132
1538564|NCT01369355|3764485|P1|Treated|Overall Study||133
1538565|NCT01369355|3764480|P6|STARTED|Overall Study||476
1538566|NCT01369355|3764481|P5|STARTED|Overall Study||285
1538567|NCT01369355|3764482|P4|STARTED|Overall Study||123
1538568|NCT01369355|3764483|P3|STARTED|Overall Study||132
1538569|NCT01369355|3764484|P2|STARTED|Overall Study||132
1538570|NCT01369355|3764485|P1|STARTED|Overall Study||133
1538571|NCT01369342|3764514|P3|NOT COMPLETED|Overall Study||3
1538572|NCT01369342|3764515|P2|NOT COMPLETED|Overall Study||9
1538573|NCT01369342|3764516|P1|NOT COMPLETED|Overall Study||13
1538574|NCT01369342|3764514|P3|COMPLETED|Overall Study||210
1538575|NCT01369342|3764515|P2|COMPLETED|Overall Study||204
1538576|NCT01369342|3764516|P1|COMPLETED|Overall Study||201
1538577|NCT01369342|3764514|P3|STARTED|Overall Study||213
1538578|NCT01369342|3764515|P2|STARTED|Overall Study||213
1538579|NCT01369342|3764516|P1|STARTED|Overall Study||214
1538580|NCT01369329|3764539|P3|NOT COMPLETED|Overall Study||14
1538581|NCT01369329|3764540|P2|NOT COMPLETED|Overall Study||11
1538582|NCT01369329|3764541|P1|NOT COMPLETED|Overall Study||12
1538583|NCT01369329|3764539|P3|COMPLETED|Overall Study||245
1538584|NCT01369329|3764540|P2|COMPLETED|Overall Study||243
1538585|NCT01369329|3764541|P1|COMPLETED|Overall Study||244
1538586|NCT01369329|3764539|P3|STARTED|Overall Study||259
1538587|NCT01369329|3764540|P2|STARTED|Overall Study||254
1538588|NCT01369329|3764541|P1|STARTED|Overall Study||256
1538589|NCT01369225|3764567|P6|NOT COMPLETED|Overall Study||0
1538590|NCT01369225|3764568|P5|NOT COMPLETED|Overall Study||2
1538591|NCT01369225|3764569|P4|NOT COMPLETED|Overall Study||2
1538592|NCT01369225|3764570|P3|NOT COMPLETED|Overall Study||3
1538593|NCT01369225|3764571|P2|NOT COMPLETED|Overall Study||0
1538594|NCT01369225|3764572|P1|NOT COMPLETED|Overall Study||2
1538595|NCT01369225|3764567|P6|COMPLETED|Overall Study||9
1538596|NCT01369225|3764568|P5|COMPLETED|Overall Study||10
1538597|NCT01369225|3764569|P4|COMPLETED|Overall Study||8
1538598|NCT01369225|3764570|P3|COMPLETED|Overall Study||9
1538599|NCT01369225|3764571|P2|COMPLETED|Overall Study||3
1538600|NCT01369225|3764572|P1|COMPLETED|Overall Study||4
1538601|NCT01369225|3764567|P6|STARTED|Overall Study||9
1538602|NCT01369225|3764568|P5|STARTED|Overall Study||12
1538603|NCT01369225|3764569|P4|STARTED|Overall Study||10
1538604|NCT01369225|3764570|P3|STARTED|Overall Study||12
1538605|NCT01369225|3764571|P2|STARTED|Overall Study||3
1538606|NCT01369225|3764572|P1|STARTED|Overall Study||6
1538607|NCT01369199|3764664|P1|NOT COMPLETED|Overall Study||3
1538608|NCT01369199|3764664|P1|COMPLETED|Overall Study||25
1538609|NCT01369199|3764664|P1|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
1538610|NCT01369199|3764664|P1|STARTED|Overall Study||28
1538611|NCT01369108|3764686|P1|NOT COMPLETED|Overall Study||11
1538612|NCT01369108|3764686|P1|COMPLETED|Overall Study||49
1538613|NCT01369108|3764686|P1|STARTED|Overall Study|120 teeth|60
1538614|NCT01369030|3764693|P1|NOT COMPLETED|Overall Study||40
1538615|NCT01369030|3764693|P1|COMPLETED|Overall Study||554
1538616|NCT01369030|3764693|P1|STARTED|Overall Study||594
1538617|NCT01368965|3764699|P1|NOT COMPLETED|Overall Study||12
1538618|NCT01368965|3764699|P1|COMPLETED|Overall Study||40
1538619|NCT01368965|3764699|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
1538620|NCT01368965|3764699|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
1538621|NCT01368900|3764708|P1|NOT COMPLETED|Overall Study||7
1538622|NCT01368900|3764708|P1|COMPLETED|Overall Study||61
1538623|NCT01368900|3764708|P1|STARTED|Overall Study||68
1538624|NCT01368874|3764721|P3|NOT COMPLETED|Overall Study||1
1538625|NCT01368874|3764722|P2|NOT COMPLETED|Overall Study||0
1538626|NCT01368874|3764723|P1|NOT COMPLETED|Overall Study||3
1538627|NCT01368874|3764721|P3|COMPLETED|Overall Study||24
1538628|NCT01368874|3764722|P2|COMPLETED|Overall Study||5
1538629|NCT01368874|3764723|P1|COMPLETED|Overall Study||31
1538630|NCT01368874|3764721|P3|STARTED|Overall Study||25
1538631|NCT01368874|3764722|P2|STARTED|Overall Study||5
1538632|NCT01368874|3764723|P1|STARTED|Overall Study||34
1538633|NCT01368835|3764783|P1|NOT COMPLETED|Overall Study||33
1538634|NCT01368835|3764783|P1|COMPLETED|Overall Study||70
1538635|NCT01368835|3764783|P1|STARTED|Overall Study|103 Subjects Enrolled|103
1538636|NCT01368809|3764792|P2|NOT COMPLETED|Overall Study||0
1538637|NCT01368809|3764793|P1|NOT COMPLETED|Overall Study||0
1538638|NCT01368809|3764792|P2|COMPLETED|Overall Study||50
1538639|NCT01368809|3764793|P1|COMPLETED|Overall Study||50
1538640|NCT01368809|3764792|P2|STARTED|Overall Study||50
1538641|NCT01368809|3764793|P1|STARTED|Overall Study||50
1538642|NCT01368653|3764805|P2|NOT COMPLETED|Overall Study||9
1538643|NCT01368653|3764806|P1|NOT COMPLETED|Overall Study||6
1538644|NCT01368653|3764805|P2|COMPLETED|Overall Study||37
1538645|NCT01368653|3764806|P1|COMPLETED|Overall Study||41
1538646|NCT01368653|3764805|P2|Randomized to Advice Only in Phase 2|Overall Study||10
1538647|NCT01368653|3764806|P1|Randomized to Advice Only in Phase 2|Overall Study||10
1538648|NCT01368653|3764805|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
1538649|NCT01368653|3764806|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
1538650|NCT01368653|3764805|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
1538651|NCT01368653|3764806|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
1538652|NCT01368653|3764805|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
1538653|NCT01368653|3764806|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
1538654|NCT01368653|3764805|P2|Completed 4-week Follow-up|Overall Study||37
1538655|NCT01368653|3764806|P1|Completed 4-week Follow-up|Overall Study||44
1538656|NCT01368653|3764805|P2|STARTED|Overall Study||46
1538657|NCT01368653|3764806|P1|STARTED|Overall Study||47
1538658|NCT01368536|3764825|P3|NOT COMPLETED|Overall Study||59
1538659|NCT01368536|3764826|P2|NOT COMPLETED|Overall Study||59
1538660|NCT01368536|3764827|P1|NOT COMPLETED|Overall Study||51
1538661|NCT01368536|3764825|P3|COMPLETED|Overall Study||83
1538662|NCT01368536|3764826|P2|COMPLETED|Overall Study||78
1538663|NCT01368536|3764827|P1|COMPLETED|Overall Study||87
1538664|NCT01368536|3764825|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
1538665|NCT01368536|3764826|P2|Full Analysis Set|Overall Study||137
1538666|NCT01368536|3764827|P1|Full Analysis Set|Overall Study||138
1538667|NCT01368536|3764825|P3|STARTED|Overall Study||142
1538668|NCT01368536|3764826|P2|STARTED|Overall Study||137
1538669|NCT01368536|3764827|P1|STARTED|Overall Study||138
1538670|NCT01368497|3764848|P1|NOT COMPLETED|Overall Study||2
1538671|NCT01368497|3764848|P1|COMPLETED|Overall Study||58
1538672|NCT01368497|3764848|P1|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
1538673|NCT01368497|3764848|P1|STARTED|Overall Study||60
1538674|NCT01368432|3764876|P2|NOT COMPLETED|Overall Study||1
1538675|NCT01368432|3764877|P1|NOT COMPLETED|Overall Study||0
1538676|NCT01368432|3764876|P2|COMPLETED|Overall Study||7
1538677|NCT01368432|3764877|P1|COMPLETED|Overall Study||6
1538678|NCT01368432|3764876|P2|STARTED|Overall Study||8
1538679|NCT01368432|3764877|P1|STARTED|Overall Study||6
1538680|NCT01368406|3764911|P2|NOT COMPLETED|Overall Study||13
1538681|NCT01368406|3764912|P1|NOT COMPLETED|Overall Study||21
1538682|NCT01368406|3764911|P2|COMPLETED|Overall Study||66
1538683|NCT01368406|3764912|P1|COMPLETED|Overall Study||60
1538684|NCT01368406|3764911|P2|STARTED|Overall Study||79
1538685|NCT01368406|3764912|P1|STARTED|Overall Study||81
1538686|NCT01368276|3764920|P2|NOT COMPLETED|Overall Study||10
1538687|NCT01368276|3764921|P1|NOT COMPLETED|Overall Study||1
1538688|NCT01368276|3764920|P2|COMPLETED|Overall Study||18
1538689|NCT01368276|3764921|P1|COMPLETED|Overall Study||2
1538690|NCT01368276|3764920|P2|STARTED|Overall Study||28
1538691|NCT01368276|3764921|P1|STARTED|Overall Study||3
1538692|NCT01368263|3764934|P3|NOT COMPLETED|Overall Study||0
1538693|NCT01368263|3764935|P2|NOT COMPLETED|Overall Study||0
1538694|NCT01368263|3764936|P1|NOT COMPLETED|Overall Study||0
1538695|NCT01368263|3764934|P3|COMPLETED|Overall Study||1
1538696|NCT01368263|3764935|P2|COMPLETED|Overall Study||1
1538697|NCT01368263|3764936|P1|COMPLETED|Overall Study||6
1538698|NCT01368263|3764934|P3|STARTED|Overall Study||1
1538699|NCT01368263|3764935|P2|STARTED|Overall Study||1
1538700|NCT01368263|3764936|P1|STARTED|Overall Study||6
1538701|NCT01368211|3764958|P2|NOT COMPLETED|Second Platelets Transfusion||2
1538702|NCT01368211|3764959|P1|NOT COMPLETED|Second Platelets Transfusion||1
1538703|NCT01368211|3764958|P2|COMPLETED|Second Platelets Transfusion||5
1538704|NCT01368211|3764959|P1|COMPLETED|Second Platelets Transfusion||7
1538705|NCT01368211|3764958|P2|STARTED|Second Platelets Transfusion||7
1538706|NCT01368211|3764959|P1|STARTED|Second Platelets Transfusion||8
1538707|NCT01368211|3764958|P2|NOT COMPLETED|First Platelets Transfusion||0
1538708|NCT01368211|3764959|P1|NOT COMPLETED|First Platelets Transfusion||0
1538709|NCT01368211|3764958|P2|COMPLETED|First Platelets Transfusion||7
1538710|NCT01368211|3764959|P1|COMPLETED|First Platelets Transfusion||8
1538711|NCT01368211|3764958|P2|STARTED|First Platelets Transfusion||7
1538712|NCT01368211|3764959|P1|STARTED|First Platelets Transfusion||8
1538713|NCT01368185|3764967|P1|NOT COMPLETED|Overall Study||0
1538714|NCT01368185|3764967|P1|COMPLETED|Overall Study||1705
1538715|NCT01368185|3764967|P1|STARTED|Overall Study||1705
1538716|NCT01368081|3764987|P13|NOT COMPLETED|Overall Study||7
1538717|NCT01368081|3764988|P12|NOT COMPLETED|Overall Study||3
1538718|NCT01368081|3764989|P11|NOT COMPLETED|Overall Study||9
1538719|NCT01368081|3764990|P10|NOT COMPLETED|Overall Study||10
1538720|NCT01368081|3764991|P9|NOT COMPLETED|Overall Study||8
1538721|NCT01368081|3764992|P8|NOT COMPLETED|Overall Study||7
1538722|NCT01368081|3764993|P7|NOT COMPLETED|Overall Study||12
1538723|NCT01368081|3764994|P6|NOT COMPLETED|Overall Study||10
1538724|NCT01368081|3764995|P5|NOT COMPLETED|Overall Study||2
1538725|NCT01368081|3764996|P4|NOT COMPLETED|Overall Study||5
1538726|NCT01368081|3764997|P3|NOT COMPLETED|Overall Study||4
1538727|NCT01368081|3764998|P2|NOT COMPLETED|Overall Study||9
1538728|NCT01368081|3764999|P1|NOT COMPLETED|Overall Study||10
1538729|NCT01368081|3764987|P13|COMPLETED|Overall Study||63
1538730|NCT01368081|3764988|P12|COMPLETED|Overall Study||67
1538731|NCT01368081|3764989|P11|COMPLETED|Overall Study||62
1538732|NCT01368081|3764990|P10|COMPLETED|Overall Study||58
1538733|NCT01368081|3764991|P9|COMPLETED|Overall Study||62
1538734|NCT01368081|3764992|P8|COMPLETED|Overall Study||62
1538735|NCT01368081|3764993|P7|COMPLETED|Overall Study||124
1538736|NCT01368081|3764994|P6|COMPLETED|Overall Study||127
1538737|NCT01368081|3764995|P5|COMPLETED|Overall Study||63
1538738|NCT01368081|3764996|P4|COMPLETED|Overall Study||63
1538739|NCT01368081|3764997|P3|COMPLETED|Overall Study||59
1538740|NCT01368081|3764998|P2|COMPLETED|Overall Study||128
1538741|NCT01368081|3764999|P1|COMPLETED|Overall Study||126
1538742|NCT01368081|3764987|P13|STARTED|Overall Study||70
1538743|NCT01368081|3764988|P12|STARTED|Overall Study||70
1538744|NCT01368081|3764989|P11|STARTED|Overall Study||71
1538745|NCT01368081|3764990|P10|STARTED|Overall Study||68
1538746|NCT01368081|3764991|P9|STARTED|Overall Study||70
1538747|NCT01368081|3764992|P8|STARTED|Overall Study||69
1538748|NCT01368081|3764993|P7|STARTED|Overall Study||136
1538749|NCT01368081|3764994|P6|STARTED|Overall Study||137
1538750|NCT01368081|3764995|P5|STARTED|Overall Study||65
1538751|NCT01368081|3764996|P4|STARTED|Overall Study||68
1538752|NCT01368081|3764997|P3|STARTED|Overall Study||63
1538753|NCT01368081|3764998|P2|STARTED|Overall Study||137
1538754|NCT01368081|3764999|P1|STARTED|Overall Study||136
1538755|NCT01368042|3765053|P1|NOT COMPLETED|Overall Study||30
1538756|NCT01368042|3765053|P1|COMPLETED|Overall Study||235
1538757|NCT01368042|3765053|P1|STARTED|Overall Study||265
1538758|NCT01367886|3765073|P1|NOT COMPLETED|Overall Study||7
1538759|NCT01367886|3765073|P1|COMPLETED|Overall Study||14
1538760|NCT01367886|3765073|P1|STARTED|Overall Study||21
1538761|NCT01367860|3765082|P2|NOT COMPLETED|Overall Study||0
1538762|NCT01367860|3765083|P1|NOT COMPLETED|Overall Study||0
1538763|NCT01367860|3765082|P2|COMPLETED|Overall Study||20
1538764|NCT01367860|3765083|P1|COMPLETED|Overall Study||20
1538765|NCT01367860|3765082|P2|STARTED|Overall Study||20
1538766|NCT01367860|3765083|P1|STARTED|Overall Study||20
1538767|NCT01367847|3765123|P2|NOT COMPLETED|Overall Study||2
1538768|NCT01367847|3765124|P1|NOT COMPLETED|Overall Study||2
1538769|NCT01367847|3765123|P2|COMPLETED|Overall Study||7
1538770|NCT01367847|3765124|P1|COMPLETED|Overall Study||8
1538771|NCT01367847|3765123|P2|STARTED|Overall Study||9
1538772|NCT01367847|3765124|P1|STARTED|Overall Study||10
1538773|NCT01367834|3765140|P2|NOT COMPLETED|Overall Study||3
1538774|NCT01367834|3765141|P1|NOT COMPLETED|Overall Study||2
1538775|NCT01367834|3765140|P2|COMPLETED|Overall Study||3
1538776|NCT01367834|3765141|P1|COMPLETED|Overall Study||9
1538777|NCT01367834|3765140|P2|STARTED|Overall Study||6
1538778|NCT01367834|3765141|P1|STARTED|Overall Study||11
1538779|NCT01367704|3765165|P2|NOT COMPLETED|Overall Study||161
1538780|NCT01367704|3765166|P1|NOT COMPLETED|Overall Study||47
1538781|NCT01367704|3765165|P2|COMPLETED|Overall Study||847
1538782|NCT01367704|3765166|P1|COMPLETED|Overall Study||951
1538783|NCT01367704|3765165|P2|STARTED|Overall Study||1008
1538784|NCT01367704|3765166|P1|STARTED|Overall Study||998
1538785|NCT01367457|3765179|P3|NOT COMPLETED|Overall Study||0
1538786|NCT01367457|3765180|P2|NOT COMPLETED|Overall Study||0
1538787|NCT01367457|3765181|P1|NOT COMPLETED|Overall Study||188
1538788|NCT01367457|3765179|P3|COMPLETED|Overall Study||26
1538789|NCT01367457|3765180|P2|COMPLETED|Overall Study||23
1538790|NCT01367457|3765181|P1|COMPLETED|Overall Study||5
1538791|NCT01367457|3765179|P3|STARTED|Overall Study||26
1538792|NCT01367457|3765180|P2|STARTED|Overall Study||23
1538793|NCT01367457|3765181|P1|STARTED|Overall Study||193
1538794|NCT01367249|3765203|P2|NOT COMPLETED|Overall Study||16
1538795|NCT01367249|3765204|P1|NOT COMPLETED|Overall Study||9
1538796|NCT01367249|3765203|P2|COMPLETED|Overall Study||202
1538797|NCT01367249|3765204|P1|COMPLETED|Overall Study||213
1538798|NCT01367249|3765203|P2|STARTED|Overall Study||218
1538799|NCT01367249|3765204|P1|STARTED|Overall Study||222
1538800|NCT01367158|3765223|P11|NOT COMPLETED|Overall Study||1
1538801|NCT01367158|3765224|P10|NOT COMPLETED|Overall Study||0
1538802|NCT01367158|3765225|P9|NOT COMPLETED|Overall Study||0
1538803|NCT01367158|3765226|P8|NOT COMPLETED|Overall Study||2
1538804|NCT01367158|3765227|P7|NOT COMPLETED|Overall Study||0
1538805|NCT01367158|3765228|P6|NOT COMPLETED|Overall Study||2
1538806|NCT01367158|3765229|P5|NOT COMPLETED|Overall Study||2
1538807|NCT01367158|3765230|P4|NOT COMPLETED|Overall Study||1
1538808|NCT01367158|3765231|P3|NOT COMPLETED|Overall Study||1
1538809|NCT01367158|3765232|P2|NOT COMPLETED|Overall Study||3
1538810|NCT01367158|3765233|P1|NOT COMPLETED|Overall Study||0
1538811|NCT01367158|3765223|P11|COMPLETED|Overall Study||72
1538812|NCT01367158|3765224|P10|COMPLETED|Overall Study||50
1538813|NCT01367158|3765225|P9|COMPLETED|Overall Study||23
1538814|NCT01367158|3765226|P8|COMPLETED|Overall Study||47
1538815|NCT01367158|3765227|P7|COMPLETED|Overall Study||25
1538816|NCT01367158|3765228|P6|COMPLETED|Overall Study||46
1538817|NCT01367158|3765229|P5|COMPLETED|Overall Study||23
1538818|NCT01367158|3765230|P4|COMPLETED|Overall Study||48
1538819|NCT01367158|3765231|P3|COMPLETED|Overall Study||23
1538820|NCT01367158|3765232|P2|COMPLETED|Overall Study||46
1538821|NCT01367158|3765233|P1|COMPLETED|Overall Study||25
1538822|NCT01367158|3765223|P11|STARTED|Overall Study||73
1538823|NCT01367158|3765224|P10|STARTED|Overall Study||50
1538824|NCT01367158|3765225|P9|STARTED|Overall Study||23
1538825|NCT01367158|3765226|P8|STARTED|Overall Study||49
1538826|NCT01367158|3765227|P7|STARTED|Overall Study||25
1538827|NCT01367158|3765228|P6|STARTED|Overall Study||48
1538828|NCT01367158|3765229|P5|STARTED|Overall Study||25
1538829|NCT01367158|3765230|P4|STARTED|Overall Study||49
1538830|NCT01367158|3765231|P3|STARTED|Overall Study||24
1538831|NCT01367158|3765232|P2|STARTED|Overall Study||49
1538832|NCT01367158|3765233|P1|STARTED|Overall Study||25
1538833|NCT01367119|3765377|P2|NOT COMPLETED|Overall Study||1
1538834|NCT01367119|3765378|P1|NOT COMPLETED|Overall Study||2
1538835|NCT01367119|3765377|P2|COMPLETED|Overall Study||16
1538836|NCT01367119|3765378|P1|COMPLETED|Overall Study||19
1538837|NCT01367119|3765377|P2|STARTED|Overall Study||17
1538838|NCT01367119|3765378|P1|STARTED|Overall Study||21
1538839|NCT01367080|3765390|P2|NOT COMPLETED|2nd Administration||0
1538840|NCT01367080|3765391|P1|NOT COMPLETED|2nd Administration||0
1538841|NCT01367080|3765390|P2|COMPLETED|2nd Administration||6
1538842|NCT01367080|3765391|P1|COMPLETED|2nd Administration||6
1538843|NCT01367080|3765390|P2|STARTED|2nd Administration||6
1538844|NCT01367080|3765391|P1|STARTED|2nd Administration||6
1538845|NCT01367080|3765390|P2|NOT COMPLETED|1st Administration||0
1538846|NCT01367080|3765391|P1|NOT COMPLETED|1st Administration||0
1538847|NCT01367080|3765390|P2|COMPLETED|1st Administration||6
1538848|NCT01367080|3765391|P1|COMPLETED|1st Administration||6
1538849|NCT01367080|3765390|P2|STARTED|1st Administration||6
1538850|NCT01367080|3765391|P1|STARTED|1st Administration||6
1538851|NCT01366976|3765405|P2|NOT COMPLETED|Overall Study||0
1538852|NCT01366976|3765406|P1|NOT COMPLETED|Overall Study||0
1538853|NCT01366976|3765405|P2|COMPLETED|Overall Study||30
1538854|NCT01366976|3765406|P1|COMPLETED|Overall Study||30
1538855|NCT01366976|3765405|P2|STARTED|Overall Study||30
1538856|NCT01366976|3765406|P1|STARTED|Overall Study||30
1538857|NCT01366885|3765418|P1|NOT COMPLETED|Overall Study||1
1538858|NCT01366885|3765418|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
1538859|NCT01366885|3765418|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
1538860|NCT01366872|3765423|P1|NOT COMPLETED|Overall Study||0
1538861|NCT01366872|3765423|P1|COMPLETED|Overall Study||50
1538862|NCT01366872|3765423|P1|STARTED|Overall Study||50
1538863|NCT01366846|3765433|P4|NOT COMPLETED|Overall Study||1
1538864|NCT01366846|3765434|P3|NOT COMPLETED|Overall Study||1
1538865|NCT01366846|3765435|P2|NOT COMPLETED|Overall Study||4
1538866|NCT01366846|3765436|P1|NOT COMPLETED|Overall Study||3
1538867|NCT01366846|3765433|P4|COMPLETED|Overall Study||45
1538868|NCT01366846|3765434|P3|COMPLETED|Overall Study||46
1538869|NCT01366846|3765435|P2|COMPLETED|Overall Study||224
1538870|NCT01366846|3765436|P1|COMPLETED|Overall Study||232
1538871|NCT01366846|3765433|P4|STARTED|Overall Study||46
1538872|NCT01366846|3765434|P3|STARTED|Overall Study||47
1538873|NCT01366846|3765435|P2|STARTED|Overall Study||228
1538874|NCT01366846|3765436|P1|STARTED|Overall Study||235
1538875|NCT01366638|3765459|P3|NOT COMPLETED|Overall Study||6
1538876|NCT01366638|3765460|P2|NOT COMPLETED|Overall Study||0
1538877|NCT01366638|3765461|P1|NOT COMPLETED|Overall Study||1
1538878|NCT01366638|3765459|P3|COMPLETED|Overall Study||20
1538879|NCT01366638|3765460|P2|COMPLETED|Overall Study||29
1538880|NCT01366638|3765461|P1|COMPLETED|Overall Study||23
1538881|NCT01366638|3765459|P3|STARTED|Overall Study||26
1538882|NCT01366638|3765460|P2|STARTED|Overall Study||29
1538883|NCT01366638|3765461|P1|STARTED|Overall Study||24
1538884|NCT01366534|3765498|P3|NOT COMPLETED|Overall Study||0
1538885|NCT01366534|3765499|P2|NOT COMPLETED|Overall Study||2
1538886|NCT01366534|3765500|P1|NOT COMPLETED|Overall Study||2
1538887|NCT01366534|3765498|P3|COMPLETED|Overall Study||12
1538888|NCT01366534|3765499|P2|COMPLETED|Overall Study||25
1538889|NCT01366534|3765500|P1|COMPLETED|Overall Study||26
1538890|NCT01366534|3765498|P3|STARTED|Overall Study||12
1538891|NCT01366534|3765499|P2|STARTED|Overall Study||27
1538892|NCT01366534|3765500|P1|STARTED|Overall Study||28
1538893|NCT01366521|3765550|P4|NOT COMPLETED|Overall Study||0
1538894|NCT01366521|3765551|P3|NOT COMPLETED|Overall Study||2
1538895|NCT01366521|3765552|P2|NOT COMPLETED|Overall Study||1
1538896|NCT01366521|3765553|P1|NOT COMPLETED|Overall Study||1
1538897|NCT01366521|3765550|P4|COMPLETED|Overall Study||11
1538898|NCT01366521|3765551|P3|COMPLETED|Overall Study||21
1538899|NCT01366521|3765552|P2|COMPLETED|Overall Study||14
1538900|NCT01366521|3765553|P1|COMPLETED|Overall Study||20
1538901|NCT01366521|3765550|P4|STARTED|Overall Study||11
1538902|NCT01366521|3765551|P3|STARTED|Overall Study||23
1538903|NCT01366521|3765552|P2|STARTED|Overall Study||15
1538904|NCT01366521|3765553|P1|STARTED|Overall Study||21
1538905|NCT01366443|3765628|P1|NOT COMPLETED|Overall Study||3
1538906|NCT01366443|3765628|P1|COMPLETED|Overall Study||285
1538907|NCT01366443|3765628|P1|STARTED|Overall Study||288
1538908|NCT01366417|3765633|P1|NOT COMPLETED|Overall Study||18
1538909|NCT01366417|3765633|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
1538910|NCT01366417|3765633|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
1538911|NCT01366417|3765633|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
1538912|NCT01366417|3765633|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
1538913|NCT01366417|3765633|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
1538914|NCT01366417|3765633|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
1538915|NCT01366417|3765633|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
1538916|NCT01366417|3765633|P1|STARTED|Overall Study||43
1538917|NCT01366209|3765642|P2|NOT COMPLETED|Overall Study||36
1538918|NCT01366209|3765643|P1|NOT COMPLETED|Overall Study||35
1538919|NCT01366209|3765642|P2|COMPLETED|Overall Study||241
1538920|NCT01366209|3765643|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
1538921|NCT01366209|3765642|P2|STARTED|Overall Study||277
1538922|NCT01366209|3765643|P1|STARTED|Overall Study||278
1538923|NCT01366196|3765651|P2|NOT COMPLETED|Overall Study||0
1538924|NCT01366196|3765652|P1|NOT COMPLETED|Overall Study||0
1538925|NCT01366196|3765651|P2|COMPLETED|Overall Study||43
1538926|NCT01366196|3765652|P1|COMPLETED|Overall Study||43
1538927|NCT01366196|3765651|P2|STARTED|Overall Study||43
1538928|NCT01366196|3765652|P1|STARTED|Overall Study||43
1538929|NCT01366092|3765666|P1|NOT COMPLETED|Overall Study||4
1538930|NCT01366092|3765666|P1|COMPLETED|Overall Study||31
1538931|NCT01366092|3765666|P1|STARTED|Overall Study||35
1538932|NCT01365910|3765675|P1|NOT COMPLETED|Overall Study||30
1538933|NCT01365910|3765675|P1|COMPLETED|Overall Study||0
1538934|NCT01365910|3765675|P1|STARTED|Overall Study||30
1538935|NCT01365845|3765682|P3|NOT COMPLETED|Treatment Phase||0
1538936|NCT01365845|3765683|P2|NOT COMPLETED|Treatment Phase||0
1538937|NCT01365845|3765684|P1|NOT COMPLETED|Treatment Phase||0
1538938|NCT01365845|3765682|P3|COMPLETED|Treatment Phase||18
1538939|NCT01365845|3765683|P2|COMPLETED|Treatment Phase||0
1538940|NCT01365845|3765684|P1|COMPLETED|Treatment Phase||0
1538941|NCT01365845|3765682|P3|STARTED|Treatment Phase||18
1538942|NCT01365845|3765683|P2|STARTED|Treatment Phase||0
1538943|NCT01365845|3765684|P1|STARTED|Treatment Phase||0
1538944|NCT01365845|3765682|P3|NOT COMPLETED|Induction Phase||0
1538945|NCT01365845|3765683|P2|NOT COMPLETED|Induction Phase||0
1538946|NCT01365845|3765684|P1|NOT COMPLETED|Induction Phase||0
1538947|NCT01365845|3765682|P3|COMPLETED|Induction Phase||0
1538948|NCT01365845|3765683|P2|COMPLETED|Induction Phase||0
1538949|NCT01365845|3765684|P1|COMPLETED|Induction Phase||18
1538950|NCT01365845|3765682|P3|STARTED|Induction Phase||0
1538951|NCT01365845|3765683|P2|STARTED|Induction Phase||0
1538952|NCT01365845|3765684|P1|STARTED|Induction Phase||18
1538953|NCT01365819|3765691|P2|NOT COMPLETED|Overall Study||13
1538954|NCT01365819|3765692|P1|NOT COMPLETED|Overall Study||13
1538955|NCT01365819|3765691|P2|COMPLETED|Overall Study||14
1538956|NCT01365819|3765692|P1|COMPLETED|Overall Study||12
1538957|NCT01365819|3765691|P2|STARTED|Overall Study||27
1538958|NCT01365819|3765692|P1|STARTED|Overall Study||25
1538959|NCT01365793|3765710|P4|NOT COMPLETED|Overall Study||2
1538960|NCT01365793|3765711|P3|NOT COMPLETED|Overall Study||7
1538961|NCT01365793|3765712|P2|NOT COMPLETED|Overall Study||7
1538962|NCT01365793|3765713|P1|NOT COMPLETED|Overall Study||2
1538963|NCT01365793|3765710|P4|COMPLETED|Overall Study||347
1538964|NCT01365793|3765711|P3|COMPLETED|Overall Study||338
1538965|NCT01365793|3765712|P2|COMPLETED|Overall Study||344
1538966|NCT01365793|3765713|P1|COMPLETED|Overall Study||342
1538967|NCT01365793|3765710|P4|STARTED|Overall Study||349
1538968|NCT01365793|3765711|P3|STARTED|Overall Study||345
1538969|NCT01365793|3765712|P2|STARTED|Overall Study||351
1538970|NCT01365793|3765713|P1|STARTED|Overall Study||344
1538971|NCT01365650|3765739|P1|NOT COMPLETED|Treatment C||0
1538972|NCT01365650|3765739|P1|COMPLETED|Treatment C||24
1538973|NCT01365650|3765739|P1|STARTED|Treatment C||24
1538974|NCT01365650|3765739|P1|NOT COMPLETED|Treatment B||0
1538975|NCT01365650|3765739|P1|COMPLETED|Treatment B||24
1538976|NCT01365650|3765739|P1|STARTED|Treatment B||24
1538977|NCT01365650|3765739|P1|NOT COMPLETED|Treatment A||0
1538978|NCT01365650|3765739|P1|COMPLETED|Treatment A||24
1538979|NCT01365650|3765739|P1|STARTED|Treatment A||24
1538980|NCT01365624|3765764|P2|NOT COMPLETED|Overall Study||0
1538981|NCT01365624|3765765|P1|NOT COMPLETED|Overall Study||0
1538982|NCT01365624|3765764|P2|COMPLETED|Overall Study||15
1538983|NCT01365624|3765765|P1|COMPLETED|Overall Study||15
1538984|NCT01365624|3765764|P2|STARTED|Overall Study||15
1538985|NCT01365624|3765765|P1|STARTED|Overall Study||15
1538986|NCT01365611|3765781|P1|NOT COMPLETED|Overall Study||0
1538987|NCT01365611|3765781|P1|COMPLETED|Overall Study||36
1538988|NCT01365611|3765781|P1|STARTED|Overall Study||36
1538989|NCT01365585|3765797|P1|NOT COMPLETED|Overall Study||0
1538990|NCT01365585|3765797|P1|COMPLETED|Overall Study||227
1538991|NCT01365585|3765797|P1|STARTED|Overall Study||227
1538992|NCT01365546|3765811|P1|NOT COMPLETED|Overall Study||11
1538993|NCT01365546|3765811|P1|COMPLETED|Overall Study||30
1538994|NCT01365546|3765811|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
1538995|NCT01365507|3765821|P2|NOT COMPLETED|Overall Study||9
1538996|NCT01365507|3765822|P1|NOT COMPLETED|Overall Study||9
1538997|NCT01365507|3765821|P2|COMPLETED|Overall Study||131
1538998|NCT01365507|3765822|P1|COMPLETED|Overall Study||127
1538999|NCT01365507|3765821|P2|Exposed|Overall Study||140
1539000|NCT01365507|3765822|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
1539001|NCT01365507|3765821|P2|STARTED|Overall Study||140
1539002|NCT01365507|3765822|P1|STARTED|Overall Study||136
1539003|NCT01365494|3765838|P2|NOT COMPLETED|Overall Study||3
1539004|NCT01365494|3765839|P1|NOT COMPLETED|Overall Study||2
1539005|NCT01365494|3765838|P2|COMPLETED|Overall Study||121
1539006|NCT01365494|3765839|P1|COMPLETED|Overall Study||124
1539007|NCT01365494|3765838|P2|STARTED|Overall Study||124
1539008|NCT01365494|3765839|P1|STARTED|Overall Study||126
1539009|NCT01365481|3765855|P4|NOT COMPLETED|Overall Study||7
1539010|NCT01365481|3765856|P3|NOT COMPLETED|Overall Study||4
1539011|NCT01365481|3765857|P2|NOT COMPLETED|Overall Study||15
1539012|NCT01365481|3765858|P1|NOT COMPLETED|Overall Study||7
1539013|NCT01365481|3765855|P4|COMPLETED|Overall Study||50
1539014|NCT01365481|3765856|P3|COMPLETED|Overall Study||14
1539015|NCT01365481|3765857|P2|COMPLETED|Overall Study||37
1539016|NCT01365481|3765858|P1|COMPLETED|Overall Study||16
1539017|NCT01365481|3765855|P4|STARTED|Overall Study||57
1539018|NCT01365481|3765856|P3|STARTED|Overall Study||18
1539019|NCT01365481|3765857|P2|STARTED|Overall Study||52
1539020|NCT01365481|3765858|P1|STARTED|Overall Study||23
1539021|NCT01365468|3765878|P2|NOT COMPLETED|Overall Study||0
1539022|NCT01365468|3765879|P1|NOT COMPLETED|Overall Study||4
1539023|NCT01365468|3765878|P2|COMPLETED|Overall Study||5
1539024|NCT01365468|3765879|P1|COMPLETED|Overall Study||0
1539025|NCT01365468|3765878|P2|STARTED|Overall Study||5
1539026|NCT01365468|3765879|P1|STARTED|Overall Study||4
1539027|NCT01365455|3765894|P5|NOT COMPLETED|Follow-up Period||0
1539028|NCT01365455|3765895|P4|NOT COMPLETED|Follow-up Period||0
1539029|NCT01365455|3765896|P3|NOT COMPLETED|Follow-up Period||0
1539030|NCT01365455|3765897|P2|NOT COMPLETED|Follow-up Period||0
1539031|NCT01365455|3765898|P1|NOT COMPLETED|Follow-up Period||0
1539032|NCT01365455|3765894|P5|COMPLETED|Follow-up Period||0
1539033|NCT01365455|3765895|P4|COMPLETED|Follow-up Period||0
1539034|NCT01365455|3765896|P3|COMPLETED|Follow-up Period||18
1539035|NCT01365455|3765897|P2|COMPLETED|Follow-up Period||47
1539036|NCT01365455|3765898|P1|COMPLETED|Follow-up Period||58
1539037|NCT01365455|3765894|P5|STARTED|Follow-up Period||0
1539038|NCT01365455|3765895|P4|STARTED|Follow-up Period||0
1539039|NCT01365455|3765896|P3|STARTED|Follow-up Period||18
1539040|NCT01365455|3765897|P2|STARTED|Follow-up Period||47
1539041|NCT01365455|3765898|P1|STARTED|Follow-up Period||58
1539042|NCT01365455|3765894|P5|NOT COMPLETED|Maintenance Period||13
1539043|NCT01365455|3765895|P4|NOT COMPLETED|Maintenance Period||9
1539044|NCT01365455|3765896|P3|NOT COMPLETED|Maintenance Period||3
1539045|NCT01365455|3765897|P2|NOT COMPLETED|Maintenance Period||23
1539046|NCT01365455|3765898|P1|NOT COMPLETED|Maintenance Period||29
1539047|NCT01365455|3765894|P5|COMPLETED|Maintenance Period||92
1539048|NCT01365455|3765895|P4|COMPLETED|Maintenance Period||100
1539049|NCT01365455|3765896|P3|COMPLETED|Maintenance Period||15
1539050|NCT01365455|3765897|P2|COMPLETED|Maintenance Period||215
1539051|NCT01365455|3765898|P1|COMPLETED|Maintenance Period||201
1539052|NCT01365455|3765894|P5|STARTED|Maintenance Period||105
1539053|NCT01365455|3765895|P4|STARTED|Maintenance Period||109
1539054|NCT01365455|3765896|P3|STARTED|Maintenance Period||18
1539055|NCT01365455|3765897|P2|STARTED|Maintenance Period||238
1539056|NCT01365455|3765898|P1|STARTED|Maintenance Period||230
1539057|NCT01365455|3765894|P5|NOT COMPLETED|Induction Period||0
1539058|NCT01365455|3765895|P4|NOT COMPLETED|Induction Period||0
1539059|NCT01365455|3765896|P3|NOT COMPLETED|Induction Period||16
1539060|NCT01365455|3765897|P2|NOT COMPLETED|Induction Period||7
1539061|NCT01365455|3765898|P1|NOT COMPLETED|Induction Period||15
1539062|NCT01365455|3765894|P5|COMPLETED|Induction Period||0
1539063|NCT01365455|3765895|P4|COMPLETED|Induction Period||0
1539064|NCT01365455|3765896|P3|COMPLETED|Induction Period||232
1539065|NCT01365455|3765897|P2|COMPLETED|Induction Period||238
1539066|NCT01365455|3765898|P1|COMPLETED|Induction Period||230
1539067|NCT01365455|3765894|P5|STARTED|Induction Period||0
1539068|NCT01365455|3765895|P4|STARTED|Induction Period||0
1539069|NCT01365455|3765896|P3|STARTED|Induction Period||248
1539070|NCT01365455|3765897|P2|STARTED|Induction Period||245
1539071|NCT01365455|3765898|P1|STARTED|Induction Period||245
1539072|NCT01365273|3765988|P2|NOT COMPLETED|Overall Study||1
1539073|NCT01365273|3765989|P1|NOT COMPLETED|Overall Study||2
1539074|NCT01365273|3765988|P2|COMPLETED|Overall Study||20
1539075|NCT01365273|3765989|P1|COMPLETED|Overall Study||20
1539076|NCT01365273|3765988|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
1539077|NCT01365273|3765989|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
1539078|NCT01365273|3765988|P2|STARTED|Overall Study||21
1539079|NCT01365273|3765989|P1|STARTED|Overall Study||22
1539080|NCT01365130|3765999|P1|NOT COMPLETED|Overall Study||2
1539081|NCT01365130|3765999|P1|COMPLETED|Overall Study||13
1539082|NCT01365130|3765999|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
1539083|NCT01365091|3766008|P4|NOT COMPLETED|Period 2||0
1539084|NCT01365091|3766009|P3|NOT COMPLETED|Period 2||1
1539085|NCT01365091|3766010|P2|NOT COMPLETED|Period 2||0
1539086|NCT01365091|3766011|P1|NOT COMPLETED|Period 2||1
1539087|NCT01365091|3766008|P4|COMPLETED|Period 2||25
1539088|NCT01365091|3766009|P3|COMPLETED|Period 2||24
1539089|NCT01365091|3766010|P2|COMPLETED|Period 2||26
1539090|NCT01365091|3766011|P1|COMPLETED|Period 2||25
1539091|NCT01365091|3766008|P4|STARTED|Period 2||25
1539092|NCT01365091|3766009|P3|STARTED|Period 2||25
1539093|NCT01365091|3766010|P2|STARTED|Period 2||26
1539094|NCT01365091|3766011|P1|STARTED|Period 2||26
1539095|NCT01365091|3766008|P4|NOT COMPLETED|Period 1||3
1539096|NCT01365091|3766009|P3|NOT COMPLETED|Period 1||3
1539097|NCT01365091|3766010|P2|NOT COMPLETED|Period 1||2
1539098|NCT01365091|3766011|P1|NOT COMPLETED|Period 1||2
1539099|NCT01365091|3766008|P4|COMPLETED|Period 1||25
1539100|NCT01365091|3766009|P3|COMPLETED|Period 1||25
1539101|NCT01365091|3766010|P2|COMPLETED|Period 1||26
1539102|NCT01365091|3766011|P1|COMPLETED|Period 1||26
1539103|NCT01365091|3766008|P4|STARTED|Period 1||28
1539104|NCT01365091|3766009|P3|STARTED|Period 1||28
1539105|NCT01365091|3766010|P2|STARTED|Period 1||28
1539106|NCT01365091|3766011|P1|STARTED|Period 1||28
1539107|NCT01365052|3766039|P2|NOT COMPLETED|Overall Study||4
1539108|NCT01365052|3766040|P1|NOT COMPLETED|Overall Study||4
1539109|NCT01365052|3766039|P2|COMPLETED|Overall Study||105
1539110|NCT01365052|3766040|P1|COMPLETED|Overall Study||213
1539111|NCT01365052|3766039|P2|STARTED|Overall Study||109
1539112|NCT01365052|3766040|P1|STARTED|Overall Study||217
1539113|NCT01365039|3766056|P2|NOT COMPLETED|Overall Study||0
1539114|NCT01365039|3766057|P1|NOT COMPLETED|Overall Study||1
1539115|NCT01365039|3766056|P2|COMPLETED|Overall Study||87
1539116|NCT01365039|3766057|P1|COMPLETED|Overall Study||85
1539117|NCT01365039|3766056|P2|STARTED|Overall Study||87
1539118|NCT01365039|3766057|P1|STARTED|Overall Study||86
1539119|NCT01364922|3766068|P3|NOT COMPLETED|Double-Blind (DB) Period||5
1539120|NCT01364922|3766069|P2|NOT COMPLETED|Double-Blind (DB) Period||5
1539121|NCT01364922|3766070|P1|NOT COMPLETED|Double-Blind (DB) Period||0
1539122|NCT01364922|3766068|P3|COMPLETED|Double-Blind (DB) Period||42
1539123|NCT01364922|3766069|P2|COMPLETED|Double-Blind (DB) Period||94
1539124|NCT01364922|3766070|P1|COMPLETED|Double-Blind (DB) Period||0
1539125|NCT01364922|3766068|P3|STARTED|Double-Blind (DB) Period||47
1539126|NCT01364922|3766069|P2|STARTED|Double-Blind (DB) Period||99
1539127|NCT01364922|3766070|P1|STARTED|Double-Blind (DB) Period||0
1539128|NCT01364922|3766068|P3|NOT COMPLETED|Open-label (OL) Period||0
1539129|NCT01364922|3766069|P2|NOT COMPLETED|Open-label (OL) Period||0
1539130|NCT01364922|3766070|P1|NOT COMPLETED|Open-label (OL) Period||22
1539131|NCT01364922|3766068|P3|COMPLETED|Open-label (OL) Period||0
1539132|NCT01364922|3766069|P2|COMPLETED|Open-label (OL) Period||0
1539133|NCT01364922|3766070|P1|COMPLETED|Open-label (OL) Period||146
1539134|NCT01364922|3766068|P3|STARTED|Open-label (OL) Period||0
1539135|NCT01364922|3766069|P2|STARTED|Open-label (OL) Period||0
1539136|NCT01364922|3766070|P1|STARTED|Open-label (OL) Period||168
1539137|NCT01364896|3766081|P1|NOT COMPLETED|Overall Study||0
1539138|NCT01364896|3766081|P1|COMPLETED|Overall Study||46
1539139|NCT01364896|3766081|P1|STARTED|Overall Study||46
1539140|NCT01364870|3766092|P3|NOT COMPLETED|Overall Study||14
1539141|NCT01364870|3766093|P2|NOT COMPLETED|Overall Study||30
1539142|NCT01364870|3766094|P1|NOT COMPLETED|Overall Study||22
1539143|NCT01364870|3766092|P3|COMPLETED|Overall Study||58
1539144|NCT01364870|3766093|P2|COMPLETED|Overall Study||93
1539145|NCT01364870|3766094|P1|COMPLETED|Overall Study||100
1539146|NCT01364870|3766092|P3|STARTED|Overall Study||72
1539147|NCT01364870|3766093|P2|STARTED|Overall Study||123
1539148|NCT01364870|3766094|P1|STARTED|Overall Study||122
1539149|NCT01364740|3766105|P1|NOT COMPLETED|Overall Study||0
1539150|NCT01364740|3766105|P1|COMPLETED|Overall Study||10
1539151|NCT01364740|3766105|P1|STARTED|Overall Study||10
1539152|NCT01364727|3766113|P1|NOT COMPLETED|Overall Study||2
1539153|NCT01364727|3766113|P1|COMPLETED|Overall Study||33
1539154|NCT01364727|3766113|P1|STARTED|Overall Study||35
1539155|NCT01364649|3766121|P2|NOT COMPLETED|Overall Study||43
1539156|NCT01364649|3766122|P1|NOT COMPLETED|Overall Study||56
1539157|NCT01364649|3766121|P2|COMPLETED|Overall Study||179
1539158|NCT01364649|3766122|P1|COMPLETED|Overall Study||169
1539159|NCT01364649|3766121|P2|STARTED|Overall Study||222
1539160|NCT01364649|3766122|P1|STARTED|Overall Study||225
1539161|NCT01364584|3766134|P2|NOT COMPLETED|Overall Study||0
1539162|NCT01364584|3766135|P1|NOT COMPLETED|Overall Study||0
1539163|NCT01364584|3766134|P2|COMPLETED|Overall Study||12
1539164|NCT01364584|3766135|P1|COMPLETED|Overall Study||11
1539165|NCT01364584|3766134|P2|STARTED|Overall Study||12
1539166|NCT01364584|3766135|P1|STARTED|Overall Study||11
1539167|NCT01364558|3766169|P3|NOT COMPLETED|Dose Three||0
1539168|NCT01364558|3766170|P2|NOT COMPLETED|Dose Three||0
1539169|NCT01364558|3766171|P1|NOT COMPLETED|Dose Three||0
1539170|NCT01364558|3766169|P3|COMPLETED|Dose Three||8
1539171|NCT01364558|3766170|P2|COMPLETED|Dose Three||8
1539172|NCT01364558|3766171|P1|COMPLETED|Dose Three||8
1539173|NCT01364558|3766169|P3|STARTED|Dose Three||8
1539174|NCT01364558|3766170|P2|STARTED|Dose Three||8
1539175|NCT01364558|3766171|P1|STARTED|Dose Three||8
1539176|NCT01364558|3766169|P3|NOT COMPLETED|Dose Two||0
1539177|NCT01364558|3766170|P2|NOT COMPLETED|Dose Two||0
1539178|NCT01364558|3766171|P1|NOT COMPLETED|Dose Two||0
1539179|NCT01364558|3766169|P3|COMPLETED|Dose Two||8
1539180|NCT01364558|3766170|P2|COMPLETED|Dose Two||8
1539181|NCT01364558|3766171|P1|COMPLETED|Dose Two||8
1539182|NCT01364558|3766169|P3|STARTED|Dose Two||8
1539183|NCT01364558|3766170|P2|STARTED|Dose Two||8
1539184|NCT01364558|3766171|P1|STARTED|Dose Two||8
1539185|NCT01364558|3766169|P3|NOT COMPLETED|Dose One||0
1539186|NCT01364558|3766170|P2|NOT COMPLETED|Dose One||0
1539187|NCT01364558|3766171|P1|NOT COMPLETED|Dose One||0
1539188|NCT01364558|3766169|P3|COMPLETED|Dose One||8
1539189|NCT01364558|3766170|P2|COMPLETED|Dose One||8
1539190|NCT01364558|3766171|P1|COMPLETED|Dose One||8
1539191|NCT01364558|3766169|P3|STARTED|Dose One||8
1539192|NCT01364558|3766170|P2|STARTED|Dose One||8
1539193|NCT01364558|3766171|P1|STARTED|Dose One||8
1539194|NCT01364428|3766181|P2|NOT COMPLETED|Overall Study||15
1539195|NCT01364428|3766182|P1|NOT COMPLETED|Overall Study||20
1539196|NCT01364428|3766181|P2|COMPLETED|Overall Study||172
1539197|NCT01364428|3766182|P1|COMPLETED|Overall Study||166
1539198|NCT01364428|3766181|P2|Exposed|Overall Study||187
1539199|NCT01364428|3766182|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
1539200|NCT01364428|3766181|P2|STARTED|Overall Study||187
1539201|NCT01364428|3766182|P1|STARTED|Overall Study||186
1539202|NCT01364389|3766199|P3|NOT COMPLETED|Overall Study||1
1539203|NCT01364389|3766200|P2|NOT COMPLETED|Overall Study||1
1539204|NCT01364389|3766201|P1|NOT COMPLETED|Overall Study||2
1539205|NCT01364389|3766199|P3|COMPLETED|Overall Study||4
1539206|NCT01364389|3766200|P2|COMPLETED|Overall Study||5
1539207|NCT01364389|3766201|P1|COMPLETED|Overall Study||3
1539208|NCT01364389|3766199|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
1539209|NCT01364389|3766200|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
1539210|NCT01364389|3766201|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
1539211|NCT01364389|3766199|P3|STARTED|Overall Study||5
1539212|NCT01364389|3766200|P2|STARTED|Overall Study||6
1539213|NCT01364389|3766201|P1|STARTED|Overall Study||5
1539214|NCT01364298|3766220|P2|NOT COMPLETED|Overall Study||23
1539215|NCT01364298|3766221|P1|NOT COMPLETED|Overall Study||14
1539216|NCT01364298|3766220|P2|COMPLETED|Overall Study||154
1539217|NCT01364298|3766221|P1|COMPLETED|Overall Study||162
1539218|NCT01364298|3766220|P2|Treated|Overall Study||174
1539219|NCT01364298|3766221|P1|Treated|Overall Study||174
1539220|NCT01364298|3766220|P2|STARTED|Overall Study||177
1539221|NCT01364298|3766221|P1|STARTED|Overall Study||176
1539222|NCT01364259|3766245|P2|NOT COMPLETED|Overall Study||0
1539223|NCT01364259|3766246|P1|NOT COMPLETED|Overall Study||0
1539224|NCT01364259|3766245|P2|COMPLETED|Overall Study||8
1539225|NCT01364259|3766246|P1|COMPLETED|Overall Study||9
1539226|NCT01364259|3766245|P2|STARTED|Overall Study||8
1539227|NCT01364259|3766246|P1|STARTED|Overall Study||9
1539228|NCT01364233|3766254|P1|NOT COMPLETED|Overall Study||1
1539229|NCT01364233|3766254|P1|COMPLETED|Overall Study||9
1539230|NCT01364233|3766254|P1|STARTED|Overall Study||10
1539231|NCT01364207|3766258|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
1539232|NCT01364207|3766259|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
1539233|NCT01364207|3766258|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
1539234|NCT01364207|3766259|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
1539235|NCT01364207|3766258|P2|STARTED|Second Visit (~1.5-2 Hours)||54
1539236|NCT01364207|3766259|P1|STARTED|Second Visit (~1.5-2 Hours)||52
1539237|NCT01364207|3766258|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
1539238|NCT01364207|3766259|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
1539239|NCT01364207|3766258|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
1539240|NCT01364207|3766259|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
1539241|NCT01364207|3766258|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
1539242|NCT01364207|3766259|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
1539243|NCT01364207|3766258|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
1539244|NCT01364207|3766259|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
1539245|NCT01364207|3766258|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
1539246|NCT01364207|3766259|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
1539247|NCT01364207|3766258|P2|STARTED|First Visit (~1.5-2 Hours)||58
1539248|NCT01364207|3766259|P1|STARTED|First Visit (~1.5-2 Hours)||54
1539249|NCT01364090|3766270|P3|NOT COMPLETED|Overall Study||6
1539250|NCT01364090|3766271|P2|NOT COMPLETED|Overall Study||3
1539251|NCT01364090|3766272|P1|NOT COMPLETED|Overall Study||14
1539252|NCT01364090|3766270|P3|COMPLETED|Overall Study||0
1539253|NCT01364090|3766271|P2|COMPLETED|Overall Study||58
1539254|NCT01364090|3766272|P1|COMPLETED|Overall Study||12
1539255|NCT01364090|3766270|P3|STARTED|Overall Study||6
1539256|NCT01364090|3766271|P2|STARTED|Overall Study||61
1539257|NCT01364090|3766272|P1|STARTED|Overall Study||26
1539258|NCT01363986|3766280|P1|NOT COMPLETED|Overall Study||1
1539259|NCT01363986|3766280|P1|COMPLETED|Overall Study||2
1539260|NCT01363986|3766280|P1|STARTED|Overall Study||3
1539261|NCT01363908|3766290|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
1539262|NCT01363908|3766291|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
1539263|NCT01363908|3766290|P2|COMPLETED|Chronic Dosing (CD) Phase||10
1539264|NCT01363908|3766291|P1|COMPLETED|Chronic Dosing (CD) Phase||3
1539341|NCT01363440|3766415|P2|COMPLETED|Overall Study|Completed Week 100|125
1539265|NCT01363908|3766290|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
1539266|NCT01363908|3766291|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
1539267|NCT01363908|3766290|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
1539268|NCT01363908|3766291|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
1539269|NCT01363908|3766290|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
1539270|NCT01363908|3766291|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
1539271|NCT01363908|3766290|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
1539272|NCT01363908|3766291|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
1539273|NCT01363908|3766290|P2|NOT COMPLETED|Screening/Enrollment||0
1539274|NCT01363908|3766291|P1|NOT COMPLETED|Screening/Enrollment||1
1539275|NCT01363908|3766290|P2|COMPLETED|Screening/Enrollment||16
1539276|NCT01363908|3766291|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
1539277|NCT01363908|3766290|P2|STARTED|Screening/Enrollment||16
1539278|NCT01363908|3766291|P1|STARTED|Screening/Enrollment||14
1539279|NCT01363843|3766321|P1|NOT COMPLETED|Overall Study||1
1539280|NCT01363843|3766321|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
1539281|NCT01363843|3766321|P1|STARTED|Overall Study||39
1539282|NCT01363765|3766327|P2|NOT COMPLETED|Overall Study||4731
1539283|NCT01363765|3766328|P1|NOT COMPLETED|Overall Study||5800
1539284|NCT01363765|3766327|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
1539285|NCT01363765|3766328|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
1539286|NCT01363765|3766327|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
1539287|NCT01363765|3766328|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
1539288|NCT01363713|3766340|P1|NOT COMPLETED|Overall Study||6
1539289|NCT01363713|3766340|P1|COMPLETED|Overall Study|Analysed (n=130)|124
1539290|NCT01363713|3766340|P1|ALLOCATED|Overall Study||130
1539291|NCT01363713|3766340|P1|STARTED|Overall Study|Assessed for eligibility|130
1539292|NCT01363700|3766349|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1539293|NCT01363700|3766350|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1539294|NCT01363700|3766351|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1539295|NCT01363700|3766352|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1539296|NCT01363700|3766353|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
1539297|NCT01363700|3766349|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
1539298|NCT01363700|3766350|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
1539299|NCT01363700|3766351|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
1539300|NCT01363700|3766352|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
1539301|NCT01363700|3766353|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
1539302|NCT01363700|3766349|P5|STARTED|Epinastine vs Olopatadine Period2||43
1539303|NCT01363700|3766350|P4|STARTED|Epinastine vs Olopatadine Period2||43
1539304|NCT01363700|3766351|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
1539305|NCT01363700|3766352|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
1539306|NCT01363700|3766353|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
1539307|NCT01363700|3766349|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
1539308|NCT01363700|3766350|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
1539309|NCT01363700|3766351|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
1539310|NCT01363700|3766352|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
1539311|NCT01363700|3766353|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
1539312|NCT01363700|3766349|P5|COMPLETED|Epinastine vs Placebo Period1||0
1539313|NCT01363700|3766350|P4|COMPLETED|Epinastine vs Placebo Period1||0
1539314|NCT01363700|3766351|P3|COMPLETED|Epinastine vs Placebo Period1||22
1539315|NCT01363700|3766352|P2|COMPLETED|Epinastine vs Placebo Period1||21
1539316|NCT01363700|3766353|P1|COMPLETED|Epinastine vs Placebo Period1||43
1539317|NCT01363700|3766349|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
1539318|NCT01363700|3766350|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
1539319|NCT01363700|3766351|P3|STARTED|Epinastine vs Placebo Period1||22
1539320|NCT01363700|3766352|P2|STARTED|Epinastine vs Placebo Period1||22
1539321|NCT01363700|3766353|P1|STARTED|Epinastine vs Placebo Period1||43
1539322|NCT01363661|3766372|P2|NOT COMPLETED|Overall Study||4
1539323|NCT01363661|3766373|P1|NOT COMPLETED|Overall Study||14
1539324|NCT01363661|3766372|P2|COMPLETED|Overall Study||28
1539325|NCT01363661|3766373|P1|COMPLETED|Overall Study||18
1539326|NCT01363661|3766372|P2|STARTED|Overall Study||32
1539327|NCT01363661|3766373|P1|STARTED|Overall Study||32
1539328|NCT01363492|3766389|P1|NOT COMPLETED|Overall Study||0
1539329|NCT01363492|3766389|P1|COMPLETED|Overall Study||14
1539330|NCT01363492|3766389|P1|STARTED|Overall Study||14
1539331|NCT01363479|3766404|P2|NOT COMPLETED|Overall Study||21
1539332|NCT01363479|3766405|P1|NOT COMPLETED|Overall Study||12
1539333|NCT01363479|3766404|P2|COMPLETED|Overall Study||351
1539334|NCT01363479|3766405|P1|COMPLETED|Overall Study||359
1539335|NCT01363479|3766404|P2|STARTED|Overall Study|number of randomised patients|372
1539336|NCT01363479|3766405|P1|STARTED|Overall Study|number of randomised patients|371
1539337|NCT01363440|3766414|P3|NOT COMPLETED|Overall Study||27
1539338|NCT01363440|3766415|P2|NOT COMPLETED|Overall Study||31
1539339|NCT01363440|3766416|P1|NOT COMPLETED|Overall Study||23
1539340|NCT01363440|3766414|P3|COMPLETED|Overall Study|Completed Week 100|127
1539342|NCT01363440|3766416|P1|COMPLETED|Overall Study|Completed Week 100|133
1539343|NCT01363440|3766414|P3|Completed Week 100|Overall Study||127
1539344|NCT01363440|3766415|P2|Completed Week 100|Overall Study||125
1539345|NCT01363440|3766416|P1|Completed Week 100|Overall Study||133
1539346|NCT01363440|3766414|P3|Completed Week 52|Overall Study||144
1539347|NCT01363440|3766415|P2|Completed Week 52|Overall Study||146
1539348|NCT01363440|3766416|P1|Completed Week 52|Overall Study||145
1539349|NCT01363440|3766414|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
1539350|NCT01363440|3766415|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
1539351|NCT01363440|3766416|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
1539352|NCT01363440|3766414|P3|STARTED|Overall Study|randomized|154
1539353|NCT01363440|3766415|P2|STARTED|Overall Study|randomized|156
1539354|NCT01363440|3766416|P1|STARTED|Overall Study|randomized|156
1539355|NCT01363401|3766447|P2|NOT COMPLETED|Overall Study||4
1539356|NCT01363401|3766448|P1|NOT COMPLETED|Overall Study||2
1539357|NCT01363401|3766447|P2|COMPLETED|Overall Study||27
1539358|NCT01363401|3766448|P1|COMPLETED|Overall Study||39
1539359|NCT01363401|3766447|P2|STARTED|Overall Study||31
1539360|NCT01363401|3766448|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
1539361|NCT01363349|3766462|P2|NOT COMPLETED|Overall Study||70
1539362|NCT01363349|3766463|P1|NOT COMPLETED|Overall Study||67
1539363|NCT01363349|3766462|P2|COMPLETED|Overall Study||66
1539364|NCT01363349|3766463|P1|COMPLETED|Overall Study||66
1539365|NCT01363349|3766462|P2|Randomized|Overall Study||136
1539366|NCT01363349|3766463|P1|Randomized|Overall Study||133
1539367|NCT01363349|3766462|P2|STARTED|Overall Study||136
1539368|NCT01363349|3766463|P1|STARTED|Overall Study||133
1539369|NCT01363297|3766474|P5|NOT COMPLETED|Overall Study||31
1539370|NCT01363297|3766475|P4|NOT COMPLETED|Overall Study||10
1539371|NCT01363297|3766476|P3|NOT COMPLETED|Overall Study||6
1539372|NCT01363297|3766477|P2|NOT COMPLETED|Overall Study||6
1539373|NCT01363297|3766478|P1|NOT COMPLETED|Overall Study||3
1539374|NCT01363297|3766474|P5|COMPLETED|Overall Study||4
1539375|NCT01363297|3766475|P4|COMPLETED|Overall Study||3
1539376|NCT01363297|3766476|P3|COMPLETED|Overall Study||3
1539377|NCT01363297|3766477|P2|COMPLETED|Overall Study||6
1539378|NCT01363297|3766478|P1|COMPLETED|Overall Study||0
1539379|NCT01363297|3766474|P5|STARTED|Overall Study||35
1539380|NCT01363297|3766475|P4|STARTED|Overall Study||13
1539381|NCT01363297|3766476|P3|STARTED|Overall Study||9
1539382|NCT01363297|3766477|P2|STARTED|Overall Study||12
1539383|NCT01363297|3766478|P1|STARTED|Overall Study||3
1539384|NCT01363258|3766570|P2|NOT COMPLETED|Overall Study||0
1539385|NCT01363258|3766571|P1|NOT COMPLETED|Overall Study||0
1539386|NCT01363258|3766570|P2|COMPLETED|Overall Study||46
1539387|NCT01363258|3766571|P1|COMPLETED|Overall Study||54
1539388|NCT01363258|3766570|P2|STARTED|Overall Study||46
1539389|NCT01363258|3766571|P1|STARTED|Overall Study||54
1539390|NCT01363076|3766581|P2|NOT COMPLETED|Overall Study||1
1539391|NCT01363076|3766582|P1|NOT COMPLETED|Overall Study||0
1539392|NCT01363076|3766581|P2|COMPLETED|Overall Study||12
1539393|NCT01363076|3766582|P1|COMPLETED|Overall Study||7
1539394|NCT01363076|3766581|P2|STARTED|Overall Study||13
1539395|NCT01363076|3766582|P1|STARTED|Overall Study||7
1539396|NCT01363050|3766600|P1|NOT COMPLETED|Overall Study||0
1539397|NCT01363050|3766600|P1|COMPLETED|Overall Study||15
1539398|NCT01363050|3766600|P1|STARTED|Overall Study||15
1539399|NCT01363011|3766614|P2|NOT COMPLETED|Extension Phase||8
1539400|NCT01363011|3766615|P1|NOT COMPLETED|Extension Phase||5
1539401|NCT01363011|3766614|P2|COMPLETED|Extension Phase||41
1539402|NCT01363011|3766615|P1|COMPLETED|Extension Phase||13
1539403|NCT01363011|3766614|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
1539404|NCT01363011|3766615|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
1539405|NCT01363011|3766614|P2|NOT COMPLETED|Main Study||9
1539406|NCT01363011|3766615|P1|NOT COMPLETED|Main Study||4
1539407|NCT01363011|3766614|P2|COMPLETED|Main Study||64
1539408|NCT01363011|3766615|P1|COMPLETED|Main Study||29
1539409|NCT01363011|3766614|P2|STARTED|Main Study||73
1539410|NCT01363011|3766615|P1|STARTED|Main Study||33
1539411|NCT01362959|3766657|P2|NOT COMPLETED|Overall Study||0
1539412|NCT01362959|3766658|P1|NOT COMPLETED|Overall Study||0
1539413|NCT01362959|3766657|P2|COMPLETED|Overall Study||26
1539414|NCT01362959|3766658|P1|COMPLETED|Overall Study||21
1539415|NCT01362959|3766657|P2|STARTED|Overall Study||26
1539416|NCT01362959|3766658|P1|STARTED|Overall Study||21
1539417|NCT01362946|3766672|P2|NOT COMPLETED|Second Behavior Modification Block||0
1539418|NCT01362946|3766673|P1|NOT COMPLETED|Second Behavior Modification Block||0
1539419|NCT01362946|3766672|P2|COMPLETED|Second Behavior Modification Block||24
1539420|NCT01362946|3766673|P1|COMPLETED|Second Behavior Modification Block||23
1539421|NCT01362946|3766672|P2|STARTED|Second Behavior Modification Block||24
1539422|NCT01362946|3766673|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
1539423|NCT01362946|3766672|P2|NOT COMPLETED|First Behavior Modification Block||0
1539424|NCT01362946|3766673|P1|NOT COMPLETED|First Behavior Modification Block||0
1539425|NCT01362946|3766672|P2|COMPLETED|First Behavior Modification Block||24
1539426|NCT01362946|3766673|P1|COMPLETED|First Behavior Modification Block||24
1539427|NCT01362946|3766672|P2|STARTED|First Behavior Modification Block||24
1539428|NCT01362946|3766673|P1|STARTED|First Behavior Modification Block||24
1539429|NCT01362907|3766706|P2|NOT COMPLETED|Period 2, One Week||0
1539430|NCT01362907|3766707|P1|NOT COMPLETED|Period 2, One Week||0
1539431|NCT01362907|3766706|P2|COMPLETED|Period 2, One Week||20
1539432|NCT01362907|3766707|P1|COMPLETED|Period 2, One Week||20
1539433|NCT01362907|3766706|P2|STARTED|Period 2, One Week||20
1539434|NCT01362907|3766707|P1|STARTED|Period 2, One Week||20
1539435|NCT01362907|3766706|P2|NOT COMPLETED|Period 1, One Week||0
1539436|NCT01362907|3766707|P1|NOT COMPLETED|Period 1, One Week||0
1539437|NCT01362907|3766706|P2|COMPLETED|Period 1, One Week||20
1539438|NCT01362907|3766707|P1|COMPLETED|Period 1, One Week||20
1539439|NCT01362907|3766706|P2|STARTED|Period 1, One Week||20
1539440|NCT01362907|3766707|P1|STARTED|Period 1, One Week||20
1539441|NCT01362894|3766721|P2|NOT COMPLETED|Period Two, 1 Week||0
1539442|NCT01362894|3766722|P1|NOT COMPLETED|Period Two, 1 Week||0
1539443|NCT01362894|3766721|P2|COMPLETED|Period Two, 1 Week||115
1539444|NCT01362894|3766722|P1|COMPLETED|Period Two, 1 Week||118
1539445|NCT01362894|3766721|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
1539446|NCT01362894|3766722|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
1539447|NCT01362894|3766721|P2|NOT COMPLETED|Period One, 1 Week||0
1539448|NCT01362894|3766722|P1|NOT COMPLETED|Period One, 1 Week||0
1539449|NCT01362894|3766721|P2|COMPLETED|Period One, 1 Week||117
1539450|NCT01362894|3766722|P1|COMPLETED|Period One, 1 Week||119
1539451|NCT01362894|3766721|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
1539452|NCT01362894|3766722|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
1539453|NCT01362686|3766739|P3|NOT COMPLETED|Overall Study||10
1539454|NCT01362686|3766740|P2|NOT COMPLETED|Overall Study||12
1539455|NCT01362686|3766741|P1|NOT COMPLETED|Overall Study||8
1539456|NCT01362686|3766739|P3|COMPLETED|Overall Study||53
1539457|NCT01362686|3766740|P2|COMPLETED|Overall Study||54
1539458|NCT01362686|3766741|P1|COMPLETED|Overall Study||59
1539459|NCT01362686|3766739|P3|STARTED|Overall Study||63
1539460|NCT01362686|3766740|P2|STARTED|Overall Study||66
1539461|NCT01362686|3766741|P1|STARTED|Overall Study||67
1539462|NCT01362608|3766757|P2|NOT COMPLETED|Overall Study||8
1539463|NCT01362608|3766758|P1|NOT COMPLETED|Overall Study||4
1539464|NCT01362608|3766757|P2|COMPLETED|Overall Study||61
1539465|NCT01362608|3766758|P1|COMPLETED|Overall Study||63
1539466|NCT01362608|3766757|P2|STARTED|Overall Study||69
1539467|NCT01362608|3766758|P1|STARTED|Overall Study||67
1539468|NCT01362530|3766796|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
1539469|NCT01362530|3766797|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
1539470|NCT01362530|3766796|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
1539471|NCT01362530|3766797|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
1539472|NCT01362530|3766796|P2|STARTED|Optional Extension (Cycles 2-6)||0
1539473|NCT01362530|3766797|P1|STARTED|Optional Extension (Cycles 2-6)||171
1539474|NCT01362530|3766796|P2|NOT COMPLETED|Base Study (Cycle 1)||3
1539475|NCT01362530|3766797|P1|NOT COMPLETED|Base Study (Cycle 1)||5
1539476|NCT01362530|3766796|P2|COMPLETED|Base Study (Cycle 1)||149
1539477|NCT01362530|3766797|P1|COMPLETED|Base Study (Cycle 1)||150
1539478|NCT01362530|3766796|P2|Received Study Treatment|Base Study (Cycle 1)||150
1539479|NCT01362530|3766797|P1|Received Study Treatment|Base Study (Cycle 1)||152
1539480|NCT01362530|3766796|P2|STARTED|Base Study (Cycle 1)||152
1539481|NCT01362530|3766797|P1|STARTED|Base Study (Cycle 1)||155
1539482|NCT01362517|3766810|P1|NOT COMPLETED|Overall Study||2
1539483|NCT01362517|3766810|P1|COMPLETED|Overall Study||129
1539484|NCT01362517|3766810|P1|STARTED|Overall Study||131
1539485|NCT01362491|3766821|P3|NOT COMPLETED|Overall Study||0
1539486|NCT01362491|3766822|P2|NOT COMPLETED|Overall Study||0
1539487|NCT01362491|3766823|P1|NOT COMPLETED|Overall Study||1
1539488|NCT01362491|3766821|P3|COMPLETED|Overall Study||46
1539489|NCT01362491|3766822|P2|COMPLETED|Overall Study||89
1539490|NCT01362491|3766823|P1|COMPLETED|Overall Study||90
1539491|NCT01362491|3766821|P3|STARTED|Overall Study||46
1539492|NCT01362491|3766822|P2|STARTED|Overall Study||89
1539493|NCT01362491|3766823|P1|STARTED|Overall Study||91
1539494|NCT01362439|3766871|P1|NOT COMPLETED|Overall Study||15
1539495|NCT01362439|3766871|P1|COMPLETED|Overall Study||118
1539496|NCT01362439|3766871|P1|STARTED|Overall Study||133
1539497|NCT01362348|3766886|P1|NOT COMPLETED|Overall Study||14
1539498|NCT01362348|3766886|P1|COMPLETED|Overall Study||5
1539499|NCT01362348|3766886|P1|STARTED|Overall Study||19
1539500|NCT01362322|3766905|P2|NOT COMPLETED|Overall Study||7
1539501|NCT01362322|3766906|P1|NOT COMPLETED|Overall Study||5
1539502|NCT01362322|3766905|P2|COMPLETED|Overall Study||329
1539503|NCT01362322|3766906|P1|COMPLETED|Overall Study||330
1539504|NCT01362322|3766905|P2|STARTED|Overall Study||336
1539505|NCT01362322|3766906|P1|STARTED|Overall Study||335
1539506|NCT01362296|3766938|P4|NOT COMPLETED|Crossover Phase||2
1539507|NCT01362296|3766939|P3|NOT COMPLETED|Crossover Phase||23
1539508|NCT01362296|3766940|P2|NOT COMPLETED|Crossover Phase||0
1539509|NCT01362296|3766941|P1|NOT COMPLETED|Crossover Phase||0
1539510|NCT01362296|3766938|P4|COMPLETED|Crossover Phase||0
1539511|NCT01362296|3766939|P3|COMPLETED|Crossover Phase||0
1539512|NCT01362296|3766940|P2|COMPLETED|Crossover Phase||0
1539513|NCT01362296|3766941|P1|COMPLETED|Crossover Phase||0
1539514|NCT01362296|3766938|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
1539515|NCT01362296|3766939|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
1539516|NCT01362296|3766940|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
1539517|NCT01362296|3766941|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
1539518|NCT01362296|3766938|P4|NOT COMPLETED|Randomized Phase (RP)||0
1539519|NCT01362296|3766939|P3|NOT COMPLETED|Randomized Phase (RP)||0
1539520|NCT01362296|3766940|P2|NOT COMPLETED|Randomized Phase (RP)||43
1539521|NCT01362296|3766941|P1|NOT COMPLETED|Randomized Phase (RP)||87
1539522|NCT01362296|3766938|P4|COMPLETED|Randomized Phase (RP)||0
1539523|NCT01362296|3766939|P3|COMPLETED|Randomized Phase (RP)||0
1539524|NCT01362296|3766940|P2|COMPLETED|Randomized Phase (RP)||0
1539525|NCT01362296|3766941|P1|COMPLETED|Randomized Phase (RP)||0
1539526|NCT01362296|3766938|P4|STARTED|Randomized Phase (RP)||0
1539527|NCT01362296|3766939|P3|STARTED|Randomized Phase (RP)||0
1539528|NCT01362296|3766940|P2|STARTED|Randomized Phase (RP)||43
1539529|NCT01362296|3766941|P1|STARTED|Randomized Phase (RP)||87
1539530|NCT01362244|3766989|P2|NOT COMPLETED|Overall Study||32
1539531|NCT01362244|3766990|P1|NOT COMPLETED|Overall Study||32
1539532|NCT01362244|3766989|P2|COMPLETED|Overall Study||19
1539533|NCT01362244|3766990|P1|COMPLETED|Overall Study||22
1539534|NCT01362244|3766989|P2|STARTED|Overall Study||51
1539535|NCT01362244|3766990|P1|STARTED|Overall Study||54
1539536|NCT01362205|3767063|P2|NOT COMPLETED|Overall Study||0
1539537|NCT01362205|3767064|P1|NOT COMPLETED|Overall Study||0
1539538|NCT01362205|3767063|P2|COMPLETED|Overall Study||27
1539539|NCT01362205|3767064|P1|COMPLETED|Overall Study||22
1539540|NCT01362205|3767063|P2|STARTED|Overall Study||27
1539541|NCT01362205|3767064|P1|STARTED|Overall Study||22
1539542|NCT01362192|3767090|P1|NOT COMPLETED|Overall Study||4
1539543|NCT01362192|3767090|P1|COMPLETED|Overall Study||16
1539544|NCT01362192|3767090|P1|STARTED|Overall Study||20
1539545|NCT01362140|3767102|P2|NOT COMPLETED|Overall Study||11
1539546|NCT01362140|3767103|P1|NOT COMPLETED|Overall Study||10
1539547|NCT01362140|3767102|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
1539548|NCT01362140|3767103|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
1539549|NCT01362140|3767102|P2|Received Treatment|Overall Study||97
1539550|NCT01362140|3767103|P1|Received Treatment|Overall Study||49
1539551|NCT01362140|3767102|P2|STARTED|Overall Study||98
1539552|NCT01362140|3767103|P1|STARTED|Overall Study||49
1539553|NCT01362062|3767127|P2|NOT COMPLETED|Overall Study||0
1539554|NCT01362062|3767128|P1|NOT COMPLETED|Overall Study||26
1539555|NCT01362062|3767127|P2|COMPLETED|Overall Study||62
1539556|NCT01362062|3767128|P1|COMPLETED|Overall Study||22
1539557|NCT01362062|3767127|P2|STARTED|Overall Study||62
1539558|NCT01362062|3767128|P1|STARTED|Overall Study||48
1539559|NCT01362049|3767149|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
1539560|NCT01362049|3767150|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
1539561|NCT01362049|3767151|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
1539562|NCT01362049|3767152|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
1539563|NCT01362049|3767149|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
1539564|NCT01362049|3767150|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
1539565|NCT01362049|3767151|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
1539566|NCT01362049|3767152|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
1539567|NCT01362049|3767149|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
1539568|NCT01362049|3767150|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
1539569|NCT01362049|3767151|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
1539570|NCT01362049|3767152|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
1539571|NCT01362049|3767149|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
1539572|NCT01362049|3767150|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
1539573|NCT01362049|3767151|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
1539574|NCT01362049|3767152|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
1539575|NCT01362049|3767149|P4|COMPLETED|Follow-Up at 7 Weeks||24
1539576|NCT01362049|3767150|P3|COMPLETED|Follow-Up at 7 Weeks||30
1539577|NCT01362049|3767151|P2|COMPLETED|Follow-Up at 7 Weeks||16
1539578|NCT01362049|3767152|P1|COMPLETED|Follow-Up at 7 Weeks||23
1539579|NCT01362049|3767149|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
1539580|NCT01362049|3767150|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
1539581|NCT01362049|3767151|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
1539582|NCT01362049|3767152|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
1539583|NCT01362049|3767149|P4|STARTED|Follow-Up at 7 Weeks||25
1539584|NCT01362049|3767150|P3|STARTED|Follow-Up at 7 Weeks||32
1539585|NCT01362049|3767151|P2|STARTED|Follow-Up at 7 Weeks||19
1539586|NCT01362049|3767152|P1|STARTED|Follow-Up at 7 Weeks||26
1539587|NCT01361867|3767190|P1|NOT COMPLETED|Overall Study||0
1539588|NCT01361867|3767190|P1|COMPLETED|Overall Study||15
1539589|NCT01361867|3767190|P1|STARTED|Overall Study||15
1539590|NCT01361854|3767195|P2|NOT COMPLETED|Second Intervention||0
1539591|NCT01361854|3767196|P1|NOT COMPLETED|Second Intervention||0
1539592|NCT01361854|3767195|P2|COMPLETED|Second Intervention||48
1539593|NCT01361854|3767196|P1|COMPLETED|Second Intervention||47
1539594|NCT01361854|3767195|P2|STARTED|Second Intervention||48
1539595|NCT01361854|3767196|P1|STARTED|Second Intervention||47
1539596|NCT01361854|3767195|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
1539597|NCT01361854|3767196|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
1539598|NCT01361854|3767195|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
1539599|NCT01361854|3767196|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
1539600|NCT01361854|3767195|P2|STARTED|Wash-out, Maximum 2 Weeks||48
1539601|NCT01361854|3767196|P1|STARTED|Wash-out, Maximum 2 Weeks||47
1539602|NCT01361854|3767195|P2|NOT COMPLETED|Day 1||3
1539603|NCT01361854|3767196|P1|NOT COMPLETED|Day 1||4
1539604|NCT01361854|3767195|P2|COMPLETED|Day 1||48
1539605|NCT01361854|3767196|P1|COMPLETED|Day 1||47
1539606|NCT01361854|3767195|P2|STARTED|Day 1||51
1539607|NCT01361854|3767196|P1|STARTED|Day 1||51
1539608|NCT01361633|3767204|P2|NOT COMPLETED|Overall Study||3
1539609|NCT01361633|3767205|P1|NOT COMPLETED|Overall Study||6
1539610|NCT01361633|3767204|P2|COMPLETED|Overall Study||23
1539611|NCT01361633|3767205|P1|COMPLETED|Overall Study||19
1539612|NCT01361633|3767204|P2|STARTED|Overall Study||26
1539613|NCT01361633|3767205|P1|STARTED|Overall Study||25
1539614|NCT01361620|3767211|P1|NOT COMPLETED|Overall Study||0
1539615|NCT01361620|3767211|P1|COMPLETED|Overall Study||132
1539616|NCT01361620|3767211|P1|STARTED|Overall Study||132
1539617|NCT01361607|3767217|P2|NOT COMPLETED|Overall Study||41
1539618|NCT01361607|3767218|P1|NOT COMPLETED|Overall Study||64
1539619|NCT01361607|3767217|P2|COMPLETED|Overall Study||158
1539620|NCT01361607|3767218|P1|COMPLETED|Overall Study||136
1539621|NCT01361607|3767217|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
1539622|NCT01361607|3767218|P1|ITT Population|Overall Study||198
1539623|NCT01361607|3767217|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
1539624|NCT01361607|3767218|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
1539625|NCT01361607|3767217|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
1539626|NCT01361607|3767218|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
1539627|NCT01361607|3767217|P2|STARTED|Overall Study||199
1539628|NCT01361607|3767218|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
1539629|NCT01361594|3767246|P2|NOT COMPLETED|Overall Study||2
1539630|NCT01361594|3767247|P1|NOT COMPLETED|Overall Study||1
1539631|NCT01361594|3767246|P2|COMPLETED|Overall Study||151
1539632|NCT01361594|3767247|P1|COMPLETED|Overall Study||151
1539633|NCT01361594|3767246|P2|STARTED|Overall Study||153
1539634|NCT01361594|3767247|P1|STARTED|Overall Study||152
1539635|NCT01361568|3767261|P6|NOT COMPLETED|Overall Study||2
1539636|NCT01361568|3767262|P5|NOT COMPLETED|Overall Study||1
1539637|NCT01361568|3767263|P4|NOT COMPLETED|Overall Study||0
1539638|NCT01361568|3767264|P3|NOT COMPLETED|Overall Study||0
1539639|NCT01361568|3767265|P2|NOT COMPLETED|Overall Study||1
1539640|NCT01361568|3767266|P1|NOT COMPLETED|Overall Study||2
1539641|NCT01361568|3767261|P6|COMPLETED|Overall Study||11
1539642|NCT01361568|3767262|P5|COMPLETED|Overall Study||6
1539643|NCT01361568|3767263|P4|COMPLETED|Overall Study||21
1539644|NCT01361568|3767264|P3|COMPLETED|Overall Study||20
1539645|NCT01361568|3767265|P2|COMPLETED|Overall Study||70
1539646|NCT01361568|3767266|P1|COMPLETED|Overall Study||69
1539647|NCT01361568|3767261|P6|STARTED|Overall Study||13
1539648|NCT01361568|3767262|P5|STARTED|Overall Study||7
1539649|NCT01361568|3767263|P4|STARTED|Overall Study||21
1539650|NCT01361568|3767264|P3|STARTED|Overall Study||20
1539651|NCT01361568|3767265|P2|STARTED|Overall Study||71
1539652|NCT01361568|3767266|P1|STARTED|Overall Study||71
1539653|NCT01361464|3767296|P1|NOT COMPLETED|Overall Study||3
1539654|NCT01361464|3767296|P1|COMPLETED|Overall Study||18
1539655|NCT01361464|3767296|P1|STARTED|Overall Study||21
1539656|NCT01361308|3767305|P2|NOT COMPLETED|Overall Study||30
1539657|NCT01361308|3767306|P1|NOT COMPLETED|Overall Study||35
1539658|NCT01361308|3767305|P2|COMPLETED|Overall Study||278
1539659|NCT01361308|3767306|P1|COMPLETED|Overall Study||271
1539660|NCT01361308|3767305|P2|STARTED|Overall Study||308
1539661|NCT01361308|3767306|P1|STARTED|Overall Study||306
1539662|NCT01361217|3767346|P1|NOT COMPLETED|Overall Study||0
1539663|NCT01361217|3767346|P1|COMPLETED|Overall Study||10
1539664|NCT01361217|3767346|P1|STARTED|Overall Study||10
1539665|NCT01361178|3767354|P2|NOT COMPLETED|Overall Study||0
1539666|NCT01361178|3767355|P1|NOT COMPLETED|Overall Study||13
1539667|NCT01361178|3767354|P2|COMPLETED|Overall Study||11
1539668|NCT01361178|3767355|P1|COMPLETED|Overall Study||109
1539669|NCT01361178|3767354|P2|STARTED|Overall Study||11
1539670|NCT01361178|3767355|P1|STARTED|Overall Study||122
1539671|NCT01361126|3767363|P2|NOT COMPLETED|Overall Study||2
1539672|NCT01361126|3767364|P1|NOT COMPLETED|Overall Study||0
1539673|NCT01361126|3767363|P2|COMPLETED|Overall Study||2
1539674|NCT01361126|3767364|P1|COMPLETED|Overall Study||13
1539675|NCT01361126|3767363|P2|STARTED|Overall Study||4
1539676|NCT01361126|3767364|P1|STARTED|Overall Study||13
1539677|NCT01361113|3767379|P1|NOT COMPLETED|Overall Study||0
1539678|NCT01361113|3767379|P1|COMPLETED|Overall Study||21
1539679|NCT01361113|3767379|P1|STARTED|Overall Study||21
1539680|NCT01361048|3767390|P3|NOT COMPLETED|Overall Study||1
1539681|NCT01361048|3767391|P2|NOT COMPLETED|Overall Study||0
1539682|NCT01361048|3767392|P1|NOT COMPLETED|Overall Study||0
1539683|NCT01361048|3767390|P3|COMPLETED|Overall Study||9
1539684|NCT01361048|3767391|P2|COMPLETED|Overall Study||10
1539685|NCT01361048|3767392|P1|COMPLETED|Overall Study||20
1539686|NCT01361048|3767390|P3|STARTED|Overall Study||10
1539687|NCT01361048|3767391|P2|STARTED|Overall Study||10
1539688|NCT01361048|3767392|P1|STARTED|Overall Study||20
1539689|NCT01361009|3767403|P1|NOT COMPLETED|Overall Study||116
1539690|NCT01361009|3767403|P1|COMPLETED|Overall Study||1901
1539691|NCT01361009|3767403|P1|STARTED|Overall Study||2017
1539692|NCT01360996|3767413|P3|NOT COMPLETED|Overall Study||2
1539693|NCT01360996|3767414|P2|NOT COMPLETED|Overall Study||3
1539694|NCT01360996|3767415|P1|NOT COMPLETED|Overall Study||6
1539695|NCT01360996|3767413|P3|COMPLETED|Overall Study||21
1539696|NCT01360996|3767414|P2|COMPLETED|Overall Study||18
1539697|NCT01360996|3767415|P1|COMPLETED|Overall Study||14
1539698|NCT01360996|3767413|P3|STARTED|Overall Study||23
1539699|NCT01360996|3767414|P2|STARTED|Overall Study||21
1539700|NCT01360996|3767415|P1|STARTED|Overall Study||20
1539701|NCT01360866|3767438|P4|NOT COMPLETED|Overall Study||22
1539702|NCT01360866|3767439|P3|NOT COMPLETED|Overall Study||519
1539703|NCT01360866|3767440|P2|NOT COMPLETED|Overall Study||287
1539704|NCT01360866|3767441|P1|NOT COMPLETED|Overall Study||221
1539705|NCT01360866|3767438|P4|COMPLETED|Overall Study||54
1539706|NCT01360866|3767439|P3|COMPLETED|Overall Study||1126
1539707|NCT01360866|3767440|P2|COMPLETED|Overall Study||420
1539708|NCT01360866|3767441|P1|COMPLETED|Overall Study||295
1539709|NCT01360866|3767438|P4|STARTED|Overall Study||76
1539710|NCT01360866|3767439|P3|STARTED|Overall Study||1645
1539711|NCT01360866|3767440|P2|STARTED|Overall Study||707
1539712|NCT01360866|3767441|P1|STARTED|Overall Study||516
1539713|NCT01360840|3767470|P3|NOT COMPLETED|Overall Study||9
1539714|NCT01360840|3767471|P2|NOT COMPLETED|Overall Study||10
1539715|NCT01360840|3767472|P1|NOT COMPLETED|Overall Study||10
1539716|NCT01360840|3767470|P3|COMPLETED|Overall Study||51
1539717|NCT01360840|3767471|P2|COMPLETED|Overall Study||50
1539718|NCT01360840|3767472|P1|COMPLETED|Overall Study||50
1539719|NCT01360840|3767470|P3|STARTED|Overall Study||60
1539720|NCT01360840|3767471|P2|STARTED|Overall Study||60
1539721|NCT01360840|3767472|P1|STARTED|Overall Study||60
1539722|NCT01360645|3767524|P4|NOT COMPLETED|Phase A+||24
1539723|NCT01360645|3767525|P3|NOT COMPLETED|Phase A+||0
1539724|NCT01360645|3767526|P2|NOT COMPLETED|Phase A+||0
1539725|NCT01360645|3767527|P1|NOT COMPLETED|Phase A+||0
1539726|NCT01360645|3767524|P4|COMPLETED|Phase A+||307
1539727|NCT01360645|3767525|P3|COMPLETED|Phase A+||0
1539728|NCT01360645|3767526|P2|COMPLETED|Phase A+||0
1539729|NCT01360645|3767527|P1|COMPLETED|Phase A+||0
1539730|NCT01360645|3767524|P4|STARTED|Phase A+||331
1539731|NCT01360645|3767525|P3|STARTED|Phase A+||0
1539732|NCT01360645|3767526|P2|STARTED|Phase A+||0
1539733|NCT01360645|3767527|P1|STARTED|Phase A+||0
1539734|NCT01360645|3767524|P4|NOT COMPLETED|Phase B (6 Weeks)||0
1539735|NCT01360645|3767525|P3|NOT COMPLETED|Phase B (6 Weeks)||13
1539736|NCT01360645|3767526|P2|NOT COMPLETED|Phase B (6 Weeks)||14
1539737|NCT01360645|3767527|P1|NOT COMPLETED|Phase B (6 Weeks)||0
1539738|NCT01360645|3767524|P4|COMPLETED|Phase B (6 Weeks)||0
1539739|NCT01360645|3767525|P3|COMPLETED|Phase B (6 Weeks)||178
1539740|NCT01360645|3767526|P2|COMPLETED|Phase B (6 Weeks)||174
1539741|NCT01360645|3767527|P1|COMPLETED|Phase B (6 Weeks)||0
1539742|NCT01360645|3767524|P4|STARTED|Phase B (6 Weeks)||0
1539743|NCT01360645|3767525|P3|STARTED|Phase B (6 Weeks)||191
1539744|NCT01360645|3767526|P2|STARTED|Phase B (6 Weeks)||188
1539745|NCT01360645|3767527|P1|STARTED|Phase B (6 Weeks)||0
1539746|NCT01360645|3767524|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1539747|NCT01360645|3767525|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1539748|NCT01360645|3767526|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1539749|NCT01360645|3767527|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
1539750|NCT01360645|3767524|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1539751|NCT01360645|3767525|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1539752|NCT01360645|3767526|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1539753|NCT01360645|3767527|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
1539754|NCT01360645|3767524|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1539755|NCT01360645|3767525|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1539756|NCT01360645|3767526|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
1539757|NCT01360645|3767527|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
1539758|NCT01360632|3767582|P5|NOT COMPLETED|Phase A+||25
1539759|NCT01360632|3767583|P4|NOT COMPLETED|Phase A+||0
1539760|NCT01360632|3767584|P3|NOT COMPLETED|Phase A+||0
1539761|NCT01360632|3767585|P2|NOT COMPLETED|Phase A+||0
1539762|NCT01360632|3767586|P1|NOT COMPLETED|Phase A+||0
1539763|NCT01360632|3767582|P5|COMPLETED|Phase A+||575
1539764|NCT01360632|3767583|P4|COMPLETED|Phase A+||0
1539765|NCT01360632|3767584|P3|COMPLETED|Phase A+||0
1539766|NCT01360632|3767585|P2|COMPLETED|Phase A+||0
1539767|NCT01360632|3767586|P1|COMPLETED|Phase A+||0
1539768|NCT01360632|3767582|P5|STARTED|Phase A+||600
1539769|NCT01360632|3767583|P4|STARTED|Phase A+||0
1539770|NCT01360632|3767584|P3|STARTED|Phase A+||0
1539771|NCT01360632|3767585|P2|STARTED|Phase A+||0
1539772|NCT01360632|3767586|P1|STARTED|Phase A+||0
1539773|NCT01360632|3767582|P5|NOT COMPLETED|Phase B (6 Weeks)||0
1539774|NCT01360632|3767583|P4|NOT COMPLETED|Phase B (6 Weeks)||13
1539775|NCT01360632|3767584|P3|NOT COMPLETED|Phase B (6 Weeks)||20
1539776|NCT01360632|3767585|P2|NOT COMPLETED|Phase B (6 Weeks)||10
1539777|NCT01360632|3767586|P1|NOT COMPLETED|Phase B (6 Weeks)||0
1539778|NCT01360632|3767582|P5|COMPLETED|Phase B (6 Weeks)||0
1539779|NCT01360632|3767583|P4|COMPLETED|Phase B (6 Weeks)||208
1539780|NCT01360632|3767584|P3|COMPLETED|Phase B (6 Weeks)||210
1539781|NCT01360632|3767585|P2|COMPLETED|Phase B (6 Weeks)||216
1539782|NCT01360632|3767586|P1|COMPLETED|Phase B (6 Weeks)||0
1539783|NCT01360632|3767582|P5|STARTED|Phase B (6 Weeks)||0
1539784|NCT01360632|3767583|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
1539868|NCT01359748|3767816|P1|COMPLETED|Overall Study||48
1539785|NCT01360632|3767584|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
1539786|NCT01360632|3767585|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
1539787|NCT01360632|3767586|P1|STARTED|Phase B (6 Weeks)||0
1539788|NCT01360632|3767582|P5|NOT COMPLETED|Phase A (8 Weeks)||0
1539789|NCT01360632|3767583|P4|NOT COMPLETED|Phase A (8 Weeks)||0
1539790|NCT01360632|3767584|P3|NOT COMPLETED|Phase A (8 Weeks)||0
1539791|NCT01360632|3767585|P2|NOT COMPLETED|Phase A (8 Weeks)||0
1539792|NCT01360632|3767586|P1|NOT COMPLETED|Phase A (8 Weeks)||255
1539793|NCT01360632|3767582|P5|COMPLETED|Phase A (8 Weeks)||0
1539794|NCT01360632|3767583|P4|COMPLETED|Phase A (8 Weeks)||0
1539795|NCT01360632|3767584|P3|COMPLETED|Phase A (8 Weeks)||0
1539796|NCT01360632|3767585|P2|COMPLETED|Phase A (8 Weeks)||0
1539797|NCT01360632|3767586|P1|COMPLETED|Phase A (8 Weeks)||1277
1539798|NCT01360632|3767582|P5|STARTED|Phase A (8 Weeks)||0
1539799|NCT01360632|3767583|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
1539800|NCT01360632|3767584|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
1539801|NCT01360632|3767585|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
1539802|NCT01360632|3767586|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
1539803|NCT01360554|3767665|P2|NOT COMPLETED|Overall Study||439
1539804|NCT01360554|3767666|P1|NOT COMPLETED|Overall Study||439
1539805|NCT01360554|3767665|P2|COMPLETED|Overall Study||0
1539806|NCT01360554|3767666|P1|COMPLETED|Overall Study||0
1539807|NCT01360554|3767665|P2|Treated|Overall Study||436
1539808|NCT01360554|3767666|P1|Treated|Overall Study||436
1539809|NCT01360554|3767665|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
1539810|NCT01360554|3767666|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
1539811|NCT01360450|3767704|P2|NOT COMPLETED|Overall Study||0
1539812|NCT01360450|3767705|P1|NOT COMPLETED|Overall Study||0
1539813|NCT01360450|3767704|P2|COMPLETED|Overall Study||6
1539814|NCT01360450|3767705|P1|COMPLETED|Overall Study||6
1539815|NCT01360450|3767704|P2|Completed Treatment|Overall Study||6
1539816|NCT01360450|3767705|P1|Completed Treatment|Overall Study||6
1539817|NCT01360450|3767704|P2|STARTED|Overall Study||6
1539818|NCT01360450|3767705|P1|STARTED|Overall Study||6
1539819|NCT01360021|3767718|P3|NOT COMPLETED|Overall Study||7
1539820|NCT01360021|3767719|P2|NOT COMPLETED|Overall Study||4
1539821|NCT01360021|3767720|P1|NOT COMPLETED|Overall Study||8
1539822|NCT01360021|3767718|P3|COMPLETED|Overall Study|Patients who completed study|65
1539823|NCT01360021|3767719|P2|COMPLETED|Overall Study|Patients who completed study|67
1539824|NCT01360021|3767720|P1|COMPLETED|Overall Study|Patients who completed study|63
1539825|NCT01360021|3767718|P3|STARTED|Overall Study|Patients randomized|72
1539826|NCT01360021|3767719|P2|STARTED|Overall Study|Patients randomized|71
1539827|NCT01360021|3767720|P1|STARTED|Overall Study|Patients randomized|71
1539828|NCT01359943|3767746|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
1539829|NCT01359943|3767747|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
1539830|NCT01359943|3767748|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
1539831|NCT01359943|3767746|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
1539832|NCT01359943|3767747|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
1539833|NCT01359943|3767748|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
1539834|NCT01359943|3767746|P3|STARTED|Follow-up (Weeks 52 - 60)||44
1539835|NCT01359943|3767747|P2|STARTED|Follow-up (Weeks 52 - 60)||84
1539836|NCT01359943|3767748|P1|STARTED|Follow-up (Weeks 52 - 60)||86
1539837|NCT01359943|3767746|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
1539838|NCT01359943|3767747|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
1539839|NCT01359943|3767748|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
1539840|NCT01359943|3767746|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
1539841|NCT01359943|3767747|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
1539842|NCT01359943|3767748|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
1539843|NCT01359943|3767746|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
1539844|NCT01359943|3767747|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
1539845|NCT01359943|3767748|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
1539846|NCT01359943|3767746|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
1539847|NCT01359943|3767747|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
1539848|NCT01359943|3767748|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
1539849|NCT01359943|3767746|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
1539850|NCT01359943|3767747|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
1539851|NCT01359943|3767748|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
1539852|NCT01359943|3767746|P3|STARTED|Double-blind (Weeks 0 - 16)||44
1539853|NCT01359943|3767747|P2|STARTED|Double-blind (Weeks 0 - 16)||89
1539854|NCT01359943|3767748|P1|STARTED|Double-blind (Weeks 0 - 16)||88
1539855|NCT01359904|3767796|P2|NOT COMPLETED|Overall Study||0
1539856|NCT01359904|3767797|P1|NOT COMPLETED|Overall Study||1
1539857|NCT01359904|3767796|P2|COMPLETED|Overall Study||19
1539858|NCT01359904|3767797|P1|COMPLETED|Overall Study||14
1539859|NCT01359904|3767796|P2|STARTED|Overall Study||19
1539860|NCT01359904|3767797|P1|STARTED|Overall Study||15
1539861|NCT01359748|3767813|P4|NOT COMPLETED|Overall Study||0
1539862|NCT01359748|3767814|P3|NOT COMPLETED|Overall Study||0
1539863|NCT01359748|3767815|P2|NOT COMPLETED|Overall Study||0
1539864|NCT01359748|3767816|P1|NOT COMPLETED|Overall Study||0
1539865|NCT01359748|3767813|P4|COMPLETED|Overall Study||11
1539866|NCT01359748|3767814|P3|COMPLETED|Overall Study||10
1539867|NCT01359748|3767815|P2|COMPLETED|Overall Study||20
1539869|NCT01359748|3767813|P4|STARTED|Overall Study||11
1539870|NCT01359748|3767814|P3|STARTED|Overall Study||10
1539871|NCT01359748|3767815|P2|STARTED|Overall Study||20
1539872|NCT01359748|3767816|P1|STARTED|Overall Study||48
1539873|NCT01359735|3767826|P2|NOT COMPLETED|Overall Study||0
1539874|NCT01359735|3767827|P1|NOT COMPLETED|Overall Study||0
1539875|NCT01359735|3767826|P2|COMPLETED|Overall Study||4
1539876|NCT01359735|3767827|P1|COMPLETED|Overall Study||4
1539877|NCT01359735|3767826|P2|STARTED|Overall Study||4
1539878|NCT01359735|3767827|P1|STARTED|Overall Study||4
1539879|NCT01359644|3767851|P10|NOT COMPLETED|Follow-up Period||0
1539880|NCT01359644|3767852|P9|NOT COMPLETED|Follow-up Period||0
1539881|NCT01359644|3767853|P8|NOT COMPLETED|Follow-up Period||2
1539882|NCT01359644|3767854|P7|NOT COMPLETED|Follow-up Period||1
1539883|NCT01359644|3767855|P6|NOT COMPLETED|Follow-up Period||1
1539884|NCT01359644|3767856|P5|NOT COMPLETED|Follow-up Period||0
1539885|NCT01359644|3767857|P4|NOT COMPLETED|Follow-up Period||0
1539886|NCT01359644|3767858|P3|NOT COMPLETED|Follow-up Period||0
1539887|NCT01359644|3767859|P2|NOT COMPLETED|Follow-up Period||0
1539888|NCT01359644|3767860|P1|NOT COMPLETED|Follow-up Period||0
1539889|NCT01359644|3767851|P10|COMPLETED|Follow-up Period||20
1539890|NCT01359644|3767852|P9|COMPLETED|Follow-up Period||21
1539891|NCT01359644|3767853|P8|COMPLETED|Follow-up Period||39
1539892|NCT01359644|3767854|P7|COMPLETED|Follow-up Period||40
1539893|NCT01359644|3767855|P6|COMPLETED|Follow-up Period||12
1539894|NCT01359644|3767856|P5|COMPLETED|Follow-up Period||15
1539895|NCT01359644|3767857|P4|COMPLETED|Follow-up Period||14
1539896|NCT01359644|3767858|P3|COMPLETED|Follow-up Period||14
1539897|NCT01359644|3767859|P2|COMPLETED|Follow-up Period||16
1539898|NCT01359644|3767860|P1|COMPLETED|Follow-up Period||15
1539899|NCT01359644|3767851|P10|STARTED|Follow-up Period||20
1539900|NCT01359644|3767852|P9|STARTED|Follow-up Period||21
1539901|NCT01359644|3767853|P8|STARTED|Follow-up Period||41
1539902|NCT01359644|3767854|P7|STARTED|Follow-up Period||41
1539903|NCT01359644|3767855|P6|STARTED|Follow-up Period||13
1539904|NCT01359644|3767856|P5|STARTED|Follow-up Period||15
1539905|NCT01359644|3767857|P4|STARTED|Follow-up Period||14
1539906|NCT01359644|3767858|P3|STARTED|Follow-up Period||14
1539907|NCT01359644|3767859|P2|STARTED|Follow-up Period||16
1539908|NCT01359644|3767860|P1|STARTED|Follow-up Period||15
1539909|NCT01359644|3767851|P10|NOT COMPLETED|Treatment Period||0
1539910|NCT01359644|3767852|P9|NOT COMPLETED|Treatment Period||0
1539911|NCT01359644|3767853|P8|NOT COMPLETED|Treatment Period||0
1539912|NCT01359644|3767854|P7|NOT COMPLETED|Treatment Period||0
1539913|NCT01359644|3767855|P6|NOT COMPLETED|Treatment Period||2
1539914|NCT01359644|3767856|P5|NOT COMPLETED|Treatment Period||0
1539915|NCT01359644|3767857|P4|NOT COMPLETED|Treatment Period||0
1539916|NCT01359644|3767858|P3|NOT COMPLETED|Treatment Period||1
1539917|NCT01359644|3767859|P2|NOT COMPLETED|Treatment Period||1
1539918|NCT01359644|3767860|P1|NOT COMPLETED|Treatment Period||0
1539919|NCT01359644|3767851|P10|COMPLETED|Treatment Period||20
1539920|NCT01359644|3767852|P9|COMPLETED|Treatment Period||21
1539921|NCT01359644|3767853|P8|COMPLETED|Treatment Period||41
1539922|NCT01359644|3767854|P7|COMPLETED|Treatment Period||41
1539923|NCT01359644|3767855|P6|COMPLETED|Treatment Period||12
1539924|NCT01359644|3767856|P5|COMPLETED|Treatment Period||15
1539925|NCT01359644|3767857|P4|COMPLETED|Treatment Period||14
1539926|NCT01359644|3767858|P3|COMPLETED|Treatment Period||13
1539927|NCT01359644|3767859|P2|COMPLETED|Treatment Period||15
1539928|NCT01359644|3767860|P1|COMPLETED|Treatment Period||15
1539929|NCT01359644|3767851|P10|STARTED|Treatment Period||20
1539930|NCT01359644|3767852|P9|STARTED|Treatment Period||21
1539931|NCT01359644|3767853|P8|STARTED|Treatment Period||41
1539932|NCT01359644|3767854|P7|STARTED|Treatment Period||41
1539933|NCT01359644|3767855|P6|STARTED|Treatment Period||14
1539934|NCT01359644|3767856|P5|STARTED|Treatment Period||15
1539935|NCT01359644|3767857|P4|STARTED|Treatment Period||14
1539936|NCT01359644|3767858|P3|STARTED|Treatment Period||14
1539937|NCT01359644|3767859|P2|STARTED|Treatment Period||16
1539938|NCT01359644|3767860|P1|STARTED|Treatment Period||15
1539939|NCT01359449|3767904|P2|NOT COMPLETED|Overall Study||4
1539940|NCT01359449|3767905|P1|NOT COMPLETED|Overall Study||4
1539941|NCT01359449|3767904|P2|COMPLETED|Overall Study||58
1539942|NCT01359449|3767905|P1|COMPLETED|Overall Study||57
1539943|NCT01359449|3767904|P2|STARTED|Overall Study||62
1539944|NCT01359449|3767905|P1|STARTED|Overall Study||61
1539945|NCT01359410|3767929|P2|NOT COMPLETED|Overall Study||0
1539946|NCT01359410|3767930|P1|NOT COMPLETED|Overall Study||0
1539947|NCT01359410|3767929|P2|COMPLETED|Overall Study||46
1539948|NCT01359410|3767930|P1|COMPLETED|Overall Study||54
1539949|NCT01359410|3767929|P2|STARTED|Overall Study||46
1539950|NCT01359410|3767930|P1|STARTED|Overall Study||54
1539951|NCT01359371|3767944|P1|NOT COMPLETED|Overall Study||0
1539952|NCT01359371|3767944|P1|COMPLETED|Overall Study||41
1539953|NCT01359371|3767944|P1|STARTED|Overall Study||41
1539954|NCT01359254|3767951|P2|NOT COMPLETED|Overall Study||0
1539955|NCT01359254|3767952|P1|NOT COMPLETED|Overall Study||1
1539956|NCT01359254|3767951|P2|COMPLETED|Overall Study||0
1539957|NCT01359254|3767952|P1|COMPLETED|Overall Study||0
1539958|NCT01359254|3767951|P2|STARTED|Overall Study||0
1539959|NCT01359254|3767952|P1|STARTED|Overall Study||1
1539960|NCT01359150|3767962|P2|NOT COMPLETED|Overall Study||5
1539961|NCT01359150|3767963|P1|NOT COMPLETED|Overall Study||7
1539962|NCT01359150|3767962|P2|COMPLETED|Overall Study||106
1539963|NCT01359150|3767963|P1|COMPLETED|Overall Study||105
1539964|NCT01359150|3767962|P2|STARTED|Overall Study||111
1539965|NCT01359150|3767963|P1|STARTED|Overall Study||112
1539966|NCT01359111|3767985|P1|NOT COMPLETED|Overall Study||0
1539967|NCT01359111|3767985|P1|COMPLETED|Overall Study||20
1539968|NCT01359111|3767985|P1|STARTED|Overall Study||20
1539969|NCT01359007|3767992|P1|NOT COMPLETED|Overall Study||2
1539970|NCT01359007|3767992|P1|COMPLETED|Overall Study||3
1539971|NCT01359007|3767992|P1|STARTED|Overall Study||5
1539972|NCT01358968|3768000|P4|NOT COMPLETED|Continued Access Phase||7
1539973|NCT01358968|3768001|P3|NOT COMPLETED|Continued Access Phase||12
1539974|NCT01358968|3768002|P2|NOT COMPLETED|Continued Access Phase||0
1539975|NCT01358968|3768003|P1|NOT COMPLETED|Continued Access Phase||0
1539976|NCT01358968|3768000|P4|COMPLETED|Continued Access Phase||0
1539977|NCT01358968|3768001|P3|COMPLETED|Continued Access Phase||0
1539978|NCT01358968|3768002|P2|COMPLETED|Continued Access Phase||0
1539979|NCT01358968|3768003|P1|COMPLETED|Continued Access Phase||0
1539980|NCT01358968|3768000|P4|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
1539981|NCT01358968|3768001|P3|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
1539982|NCT01358968|3768002|P2|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
1539983|NCT01358968|3768003|P1|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
1539984|NCT01358968|3768000|P4|STARTED|Continued Access Phase||7
1539985|NCT01358968|3768001|P3|STARTED|Continued Access Phase||12
1539986|NCT01358968|3768002|P2|STARTED|Continued Access Phase||0
1539987|NCT01358968|3768003|P1|STARTED|Continued Access Phase||0
1539988|NCT01358968|3768000|P4|NOT COMPLETED|Period 2||0
1539989|NCT01358968|3768001|P3|NOT COMPLETED|Period 2||0
1539990|NCT01358968|3768002|P2|NOT COMPLETED|Period 2||1
1539991|NCT01358968|3768003|P1|NOT COMPLETED|Period 2||0
1539992|NCT01358968|3768000|P4|COMPLETED|Period 2||0
1539993|NCT01358968|3768001|P3|COMPLETED|Period 2||0
1539994|NCT01358968|3768002|P2|COMPLETED|Period 2||19
1539995|NCT01358968|3768003|P1|COMPLETED|Period 2||0
1539996|NCT01358968|3768000|P4|Received at Least 1 Dose of Study Drug|Period 2||0
1539997|NCT01358968|3768001|P3|Received at Least 1 Dose of Study Drug|Period 2||0
1539998|NCT01358968|3768002|P2|Received at Least 1 Dose of Study Drug|Period 2||19
1539999|NCT01358968|3768003|P1|Received at Least 1 Dose of Study Drug|Period 2||0
1540000|NCT01358968|3768000|P4|STARTED|Period 2||0
1540001|NCT01358968|3768001|P3|STARTED|Period 2||0
1540002|NCT01358968|3768002|P2|STARTED|Period 2||20
1540003|NCT01358968|3768003|P1|STARTED|Period 2||0
1540004|NCT01358968|3768000|P4|NOT COMPLETED|Period 1||0
1540005|NCT01358968|3768001|P3|NOT COMPLETED|Period 1||0
1540006|NCT01358968|3768002|P2|NOT COMPLETED|Period 1||0
1540007|NCT01358968|3768003|P1|NOT COMPLETED|Period 1||0
1540008|NCT01358968|3768000|P4|COMPLETED|Period 1||0
1540009|NCT01358968|3768001|P3|COMPLETED|Period 1||0
1540010|NCT01358968|3768002|P2|COMPLETED|Period 1||0
1540011|NCT01358968|3768003|P1|COMPLETED|Period 1||20
1540012|NCT01358968|3768000|P4|Received at Least 1 Dose of Study Drug|Period 1||0
1540013|NCT01358968|3768001|P3|Received at Least 1 Dose of Study Drug|Period 1||0
1540014|NCT01358968|3768002|P2|Received at Least 1 Dose of Study Drug|Period 1||0
1540015|NCT01358968|3768003|P1|Received at Least 1 Dose of Study Drug|Period 1||20
1540016|NCT01358968|3768000|P4|STARTED|Period 1||0
1540017|NCT01358968|3768001|P3|STARTED|Period 1||0
1540018|NCT01358968|3768002|P2|STARTED|Period 1||0
1540019|NCT01358968|3768003|P1|STARTED|Period 1||20
1540020|NCT01358877|3768019|P2|NOT COMPLETED|Overall Study||2404
1540021|NCT01358877|3768020|P1|NOT COMPLETED|Overall Study||2400
1540022|NCT01358877|3768019|P2|COMPLETED|Overall Study||0
1540023|NCT01358877|3768020|P1|COMPLETED|Overall Study||0
1540024|NCT01358877|3768019|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
1540025|NCT01358877|3768020|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
1540026|NCT01358877|3768019|P2|Did Not Receive Study Drug|Overall Study||13
1540027|NCT01358877|3768020|P1|Did Not Receive Study Drug|Overall Study||22
1540028|NCT01358877|3768019|P2|STARTED|Overall Study||2404
1540029|NCT01358877|3768020|P1|STARTED|Overall Study||2400
1540030|NCT01358864|3768090|P8|NOT COMPLETED|Overall Study||55
1540031|NCT01358864|3768091|P7|NOT COMPLETED|Overall Study||65
1540032|NCT01358864|3768092|P6|NOT COMPLETED|Overall Study||13
1540033|NCT01358864|3768093|P5|NOT COMPLETED|Overall Study||11
1540034|NCT01358864|3768094|P4|NOT COMPLETED|Overall Study||19
1540035|NCT01358864|3768095|P3|NOT COMPLETED|Overall Study||16
1540036|NCT01358864|3768096|P2|NOT COMPLETED|Overall Study||13
1540037|NCT01358864|3768097|P1|NOT COMPLETED|Overall Study||31
1540038|NCT01358864|3768090|P8|COMPLETED|Overall Study||85
1540039|NCT01358864|3768091|P7|COMPLETED|Overall Study||81
1540040|NCT01358864|3768092|P6|COMPLETED|Overall Study||42
1540041|NCT01358864|3768093|P5|COMPLETED|Overall Study||46
1540042|NCT01358864|3768094|P4|COMPLETED|Overall Study||10
1540043|NCT01358864|3768095|P3|COMPLETED|Overall Study||87
1540044|NCT01358864|3768096|P2|COMPLETED|Overall Study||86
1540045|NCT01358864|3768097|P1|COMPLETED|Overall Study||18
1540046|NCT01358864|3768090|P8|STARTED|Overall Study||140
1540047|NCT01358864|3768091|P7|STARTED|Overall Study||146
1540048|NCT01358864|3768092|P6|STARTED|Overall Study||55
1540049|NCT01358864|3768093|P5|STARTED|Overall Study||57
1540050|NCT01358864|3768094|P4|STARTED|Overall Study||29
1540051|NCT01358864|3768095|P3|STARTED|Overall Study||103
1540052|NCT01358864|3768096|P2|STARTED|Overall Study||99
1540053|NCT01358864|3768097|P1|STARTED|Overall Study||49
1540054|NCT01358825|3768188|P2|NOT COMPLETED|Overall Study||1
1540055|NCT01358825|3768189|P1|NOT COMPLETED|Overall Study||0
1540056|NCT01358825|3768188|P2|COMPLETED|Overall Study||45
1540057|NCT01358825|3768189|P1|COMPLETED|Overall Study||12
1540058|NCT01358825|3768188|P2|STARTED|Overall Study||46
1540059|NCT01358825|3768189|P1|STARTED|Overall Study||12
1540060|NCT01358760|3768213|P3|NOT COMPLETED|Overall Study||25
1540061|NCT01358760|3768214|P2|NOT COMPLETED|Overall Study||20
1540062|NCT01358760|3768215|P1|NOT COMPLETED|Overall Study||22
1540063|NCT01358760|3768213|P3|COMPLETED|Overall Study||125
1540064|NCT01358760|3768214|P2|COMPLETED|Overall Study||128
1540065|NCT01358760|3768215|P1|COMPLETED|Overall Study||130
1540066|NCT01358760|3768213|P3|ITT Population|Overall Study||134
1540067|NCT01358760|3768214|P2|ITT Population|Overall Study||134
1540068|NCT01358760|3768215|P1|ITT Population|Overall Study||139
1540069|NCT01358760|3768213|P3|Safety Population|Overall Study||148
1540070|NCT01358760|3768214|P2|Safety Population|Overall Study||143
1540071|NCT01358760|3768215|P1|Safety Population|Overall Study||150
1540072|NCT01358760|3768213|P3|STARTED|Overall Study||150
1540073|NCT01358760|3768214|P2|STARTED|Overall Study||148
1540074|NCT01358760|3768215|P1|STARTED|Overall Study||152
1540075|NCT01358734|3768250|P3|NOT COMPLETED|Overall Study||29
1540076|NCT01358734|3768251|P2|NOT COMPLETED|Overall Study||37
1540077|NCT01358734|3768252|P1|NOT COMPLETED|Overall Study||15
1540078|NCT01358734|3768250|P3|COMPLETED|Overall Study|Includes participants still receiving study treatment|5
1540079|NCT01358734|3768251|P2|COMPLETED|Overall Study|Includes participants still receiving study treatment|2
1540080|NCT01358734|3768252|P1|COMPLETED|Overall Study||0
1540081|NCT01358734|3768250|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
1540082|NCT01358734|3768251|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
1540083|NCT01358734|3768252|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
1540084|NCT01358734|3768250|P3|STARTED|Overall Study||34
1540085|NCT01358734|3768251|P2|STARTED|Overall Study||39
1540086|NCT01358734|3768252|P1|STARTED|Overall Study||15
1540087|NCT01358708|3768271|P2|NOT COMPLETED|Open-Label Treatment Phase||0
1540088|NCT01358708|3768272|P1|NOT COMPLETED|Open-Label Treatment Phase||0
1540089|NCT01358708|3768271|P2|COMPLETED|Open-Label Treatment Phase||12
1540090|NCT01358708|3768272|P1|COMPLETED|Open-Label Treatment Phase||5
1540091|NCT01358708|3768271|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
1540092|NCT01358708|3768272|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
1540093|NCT01358708|3768271|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
1540094|NCT01358708|3768272|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
1540095|NCT01358708|3768271|P2|COMPLETED|Double-Blind Treatment Phase||13
1540096|NCT01358708|3768272|P1|COMPLETED|Double-Blind Treatment Phase||10
1540097|NCT01358708|3768271|P2|Received Study Medication|Double-Blind Treatment Phase||13
1540098|NCT01358708|3768272|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
1540099|NCT01358708|3768271|P2|Randomized|Double-Blind Treatment Phase||13
1540100|NCT01358708|3768272|P1|Randomized|Double-Blind Treatment Phase||13
1540101|NCT01358708|3768271|P2|STARTED|Double-Blind Treatment Phase||13
1540102|NCT01358708|3768272|P1|STARTED|Double-Blind Treatment Phase||13
1540103|NCT01358578|3768295|P6|NOT COMPLETED|Follow-up Period||0
1540104|NCT01358578|3768296|P5|NOT COMPLETED|Follow-up Period||0
1540105|NCT01358578|3768297|P4|NOT COMPLETED|Follow-up Period||19
1540106|NCT01358578|3768298|P3|NOT COMPLETED|Follow-up Period||5
1540107|NCT01358578|3768299|P2|NOT COMPLETED|Follow-up Period||6
1540108|NCT01358578|3768300|P1|NOT COMPLETED|Follow-up Period||10
1540109|NCT01358578|3768295|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
1540110|NCT01358578|3768296|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
1540111|NCT01358578|3768297|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
1540112|NCT01358578|3768298|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
1540113|NCT01358578|3768299|P2|COMPLETED|Follow-up Period||119
1540114|NCT01358578|3768300|P1|COMPLETED|Follow-up Period||138
1540115|NCT01358578|3768295|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
1540116|NCT01358578|3768296|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
1540117|NCT01358578|3768297|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
1540118|NCT01358578|3768298|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
1540119|NCT01358578|3768299|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
1540120|NCT01358578|3768300|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
1540121|NCT01358578|3768295|P6|NOT COMPLETED|Maintenance Period||11
1540122|NCT01358578|3768296|P5|NOT COMPLETED|Maintenance Period||17
1540123|NCT01358578|3768297|P4|NOT COMPLETED|Maintenance Period||42
1540124|NCT01358578|3768298|P3|NOT COMPLETED|Maintenance Period||2
1540125|NCT01358578|3768299|P2|NOT COMPLETED|Maintenance Period||22
1540126|NCT01358578|3768300|P1|NOT COMPLETED|Maintenance Period||39
1540127|NCT01358578|3768295|P6|COMPLETED|Maintenance Period||131
1540128|NCT01358578|3768296|P5|COMPLETED|Maintenance Period||125
1540129|NCT01358578|3768297|P4|COMPLETED|Maintenance Period||263
1540130|NCT01358578|3768298|P3|COMPLETED|Maintenance Period||15
1540131|NCT01358578|3768299|P2|COMPLETED|Maintenance Period||290
1540132|NCT01358578|3768300|P1|COMPLETED|Maintenance Period||276
1540133|NCT01358578|3768295|P6|STARTED|Maintenance Period||142
1540134|NCT01358578|3768296|P5|STARTED|Maintenance Period||142
1540135|NCT01358578|3768297|P4|STARTED|Maintenance Period||305
1540136|NCT01358578|3768298|P3|STARTED|Maintenance Period||17
1540137|NCT01358578|3768299|P2|STARTED|Maintenance Period||312
1540138|NCT01358578|3768300|P1|STARTED|Maintenance Period||315
1540139|NCT01358578|3768295|P6|NOT COMPLETED|Induction Period||0
1540140|NCT01358578|3768296|P5|NOT COMPLETED|Induction Period||0
1540141|NCT01358578|3768297|P4|NOT COMPLETED|Induction Period||21
1540142|NCT01358578|3768298|P3|NOT COMPLETED|Induction Period||25
1540143|NCT01358578|3768299|P2|NOT COMPLETED|Induction Period||15
1540144|NCT01358578|3768300|P1|NOT COMPLETED|Induction Period||12
1540145|NCT01358578|3768295|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
1540146|NCT01358578|3768296|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
1540147|NCT01358578|3768297|P4|COMPLETED|Induction Period||305
1540148|NCT01358578|3768298|P3|COMPLETED|Induction Period||301
1540149|NCT01358578|3768299|P2|COMPLETED|Induction Period||312
1540150|NCT01358578|3768300|P1|COMPLETED|Induction Period||315
1540151|NCT01358578|3768295|P6|STARTED|Induction Period|These groups are populated after the induction period|0
1540152|NCT01358578|3768296|P5|STARTED|Induction Period|These groups are populated after the induction period|0
1540153|NCT01358578|3768297|P4|STARTED|Induction Period||326
1540154|NCT01358578|3768298|P3|STARTED|Induction Period||326
1540155|NCT01358578|3768299|P2|STARTED|Induction Period||327
1540156|NCT01358578|3768300|P1|STARTED|Induction Period||327
1540157|NCT01358526|3768352|P3|NOT COMPLETED|Double-blind Phase||121
1540158|NCT01358526|3768353|P2|NOT COMPLETED|Double-blind Phase||80
1540159|NCT01358526|3768354|P1|NOT COMPLETED|Double-blind Phase||0
1540160|NCT01358526|3768352|P3|COMPLETED|Double-blind Phase||181
1540161|NCT01358526|3768353|P2|COMPLETED|Double-blind Phase||218
1540162|NCT01358526|3768354|P1|COMPLETED|Double-blind Phase||0
1540163|NCT01358526|3768352|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
1540164|NCT01358526|3768353|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
1540165|NCT01358526|3768354|P1|STARTED|Double-blind Phase||0
1540166|NCT01358526|3768352|P3|NOT COMPLETED|Open-label Titration Period||0
1540167|NCT01358526|3768353|P2|NOT COMPLETED|Open-label Titration Period||0
1540168|NCT01358526|3768354|P1|NOT COMPLETED|Open-label Titration Period||494
1540169|NCT01358526|3768352|P3|COMPLETED|Open-label Titration Period||0
1540170|NCT01358526|3768353|P2|COMPLETED|Open-label Titration Period||0
1540171|NCT01358526|3768354|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
1540172|NCT01358526|3768352|P3|STARTED|Open-label Titration Period||0
1540173|NCT01358526|3768353|P2|STARTED|Open-label Titration Period||0
1540174|NCT01358526|3768354|P1|STARTED|Open-label Titration Period||1095
1540175|NCT01358357|3768371|P3|NOT COMPLETED|Double-Blind Phase||0
1540176|NCT01358357|3768372|P2|NOT COMPLETED|Double-Blind Phase||100
1540177|NCT01358357|3768373|P1|NOT COMPLETED|Double-Blind Phase||80
1540178|NCT01358357|3768371|P3|COMPLETED|Double-Blind Phase||0
1540179|NCT01358357|3768372|P2|COMPLETED|Double-Blind Phase||150
1540180|NCT01358357|3768373|P1|COMPLETED|Double-Blind Phase||166
1540181|NCT01358357|3768371|P3|STARTED|Double-Blind Phase||0
1540182|NCT01358357|3768372|P2|STARTED|Double-Blind Phase||250
1540183|NCT01358357|3768373|P1|STARTED|Double-Blind Phase||246
1540184|NCT01358357|3768371|P3|NOT COMPLETED|Open Label Phase||462
1540185|NCT01358357|3768372|P2|NOT COMPLETED|Open Label Phase||0
1540186|NCT01358357|3768373|P1|NOT COMPLETED|Open Label Phase||0
1540187|NCT01358357|3768371|P3|COMPLETED|Open Label Phase||503
1540188|NCT01358357|3768372|P2|COMPLETED|Open Label Phase||0
1540189|NCT01358357|3768373|P1|COMPLETED|Open Label Phase||0
1540190|NCT01358357|3768371|P3|STARTED|Open Label Phase||965
1540191|NCT01358357|3768372|P2|STARTED|Open Label Phase||0
1540192|NCT01358357|3768373|P1|STARTED|Open Label Phase||0
1540193|NCT01358175|3768409|P3|NOT COMPLETED|Overall Study||32
1540194|NCT01358175|3768410|P2|NOT COMPLETED|Overall Study||28
1540195|NCT01358175|3768411|P1|NOT COMPLETED|Overall Study||21
1540196|NCT01358175|3768409|P3|COMPLETED|Overall Study||90
1540197|NCT01358175|3768410|P2|COMPLETED|Overall Study||97
1540198|NCT01358175|3768411|P1|COMPLETED|Overall Study||103
1540199|NCT01358175|3768409|P3|STARTED|Overall Study||122
1540200|NCT01358175|3768410|P2|STARTED|Overall Study||125
1540201|NCT01358175|3768411|P1|STARTED|Overall Study||124
1540202|NCT01357980|3768448|P4|NOT COMPLETED|Overall Study||0
1540203|NCT01357980|3768449|P3|NOT COMPLETED|Overall Study||1
1540204|NCT01357980|3768450|P2|NOT COMPLETED|Overall Study||1
1540205|NCT01357980|3768451|P1|NOT COMPLETED|Overall Study||0
1540206|NCT01357980|3768448|P4|COMPLETED|Overall Study||7
1540207|NCT01357980|3768449|P3|COMPLETED|Overall Study||16
1540208|NCT01357980|3768450|P2|COMPLETED|Overall Study||6
1540209|NCT01357980|3768451|P1|COMPLETED|Overall Study||16
1540210|NCT01357980|3768448|P4|STARTED|Overall Study||7
1540211|NCT01357980|3768449|P3|STARTED|Overall Study||17
1540212|NCT01357980|3768450|P2|STARTED|Overall Study||7
1540213|NCT01357980|3768451|P1|STARTED|Overall Study||16
1540214|NCT01357915|3768495|P2|NOT COMPLETED|Overall Study||0
1540215|NCT01357915|3768496|P1|NOT COMPLETED|Overall Study||3
1540216|NCT01357915|3768495|P2|COMPLETED|Overall Study||17
1540217|NCT01357915|3768496|P1|COMPLETED|Overall Study||27
1540218|NCT01357915|3768495|P2|STARTED|Overall Study||17
1540219|NCT01357915|3768496|P1|STARTED|Overall Study||30
1540220|NCT01357889|3768511|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
1540221|NCT01357889|3768512|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
1540222|NCT01357889|3768511|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
1540223|NCT01357889|3768512|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
1540224|NCT01357889|3768511|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
1540225|NCT01357889|3768512|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
1540226|NCT01357889|3768511|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
1540227|NCT01357889|3768512|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
1540228|NCT01357889|3768511|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
1540229|NCT01357889|3768512|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
1540230|NCT01357889|3768511|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
1540231|NCT01357889|3768512|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
1540232|NCT01357889|3768511|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
1540233|NCT01357889|3768512|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
1540234|NCT01357889|3768511|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
1540235|NCT01357889|3768512|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
1540236|NCT01357889|3768511|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
1540237|NCT01357889|3768512|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
1540238|NCT01357850|3768556|P4|NOT COMPLETED|Overall Study||0
1540239|NCT01357850|3768557|P3|NOT COMPLETED|Overall Study||0
1540240|NCT01357850|3768558|P2|NOT COMPLETED|Overall Study||0
1540241|NCT01357850|3768559|P1|NOT COMPLETED|Overall Study||1
1540242|NCT01357850|3768556|P4|COMPLETED|Overall Study||27
1540243|NCT01357850|3768557|P3|COMPLETED|Overall Study||13
1540244|NCT01357850|3768558|P2|COMPLETED|Overall Study||12
1540245|NCT01357850|3768559|P1|COMPLETED|Overall Study||29
1540246|NCT01357850|3768556|P4|STARTED|Overall Study||27
1540247|NCT01357850|3768557|P3|STARTED|Overall Study||13
1540248|NCT01357850|3768558|P2|STARTED|Overall Study||12
1540249|NCT01357850|3768559|P1|STARTED|Overall Study||30
1540250|NCT01357720|3768633|P2|NOT COMPLETED|Overall Study||5
1540251|NCT01357720|3768634|P1|NOT COMPLETED|Overall Study||2
1540252|NCT01357720|3768633|P2|COMPLETED|Overall Study||195
1540253|NCT01357720|3768634|P1|COMPLETED|Overall Study||198
1540254|NCT01357720|3768633|P2|STARTED|Overall Study||200
1540255|NCT01357720|3768634|P1|STARTED|Overall Study||200
1540256|NCT01357655|3768650|P2|NOT COMPLETED|Overall Study||0
1540257|NCT01357655|3768651|P1|NOT COMPLETED|Overall Study||66
1540258|NCT01357655|3768650|P2|COMPLETED|Overall Study||0
1540259|NCT01357655|3768651|P1|COMPLETED|Overall Study||0
1540260|NCT01357655|3768650|P2|STARTED|Overall Study||0
1540261|NCT01357655|3768651|P1|STARTED|Overall Study||66
1540262|NCT01357616|3768668|P2|NOT COMPLETED|Overall Study||9
1540263|NCT01357616|3768669|P1|NOT COMPLETED|Overall Study||10
1540264|NCT01357616|3768668|P2|COMPLETED|Overall Study||153
1540265|NCT01357616|3768669|P1|COMPLETED|Overall Study||156
1540266|NCT01357616|3768668|P2|STARTED|Overall Study||162
1540267|NCT01357616|3768669|P1|STARTED|Overall Study||166
1540268|NCT01357551|3768683|P2|NOT COMPLETED|Overall Study||11
1540269|NCT01357551|3768684|P1|NOT COMPLETED|Overall Study||22
1540270|NCT01357551|3768683|P2|COMPLETED|Overall Study||101
1540271|NCT01357551|3768684|P1|COMPLETED|Overall Study||88
1540272|NCT01357551|3768683|P2|STARTED|Overall Study||112
1540273|NCT01357551|3768684|P1|STARTED|Overall Study||110
1540274|NCT01357512|3768698|P2|NOT COMPLETED|Overall Study||5
1540275|NCT01357512|3768699|P1|NOT COMPLETED|Overall Study||12
1540276|NCT01357512|3768698|P2|COMPLETED|Overall Study||60
1540277|NCT01357512|3768699|P1|COMPLETED|Overall Study||53
1540278|NCT01357512|3768698|P2|STARTED|Overall Study||65
1540279|NCT01357512|3768699|P1|STARTED|Overall Study||65
1540280|NCT01357239|3768711|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
1540281|NCT01357239|3768712|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
1540282|NCT01357239|3768713|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
1540283|NCT01357239|3768714|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
1540284|NCT01357239|3768711|P4|COMPLETED|Stratum II: Partially-Methylated||18
1540285|NCT01357239|3768712|P3|COMPLETED|Stratum II: Partially-Methylated||21
1540286|NCT01357239|3768713|P2|COMPLETED|Stratum II: Partially-Methylated||21
1540287|NCT01357239|3768714|P1|COMPLETED|Stratum II: Partially-Methylated||23
1540288|NCT01357239|3768711|P4|STARTED|Stratum II: Partially-Methylated||20
1540289|NCT01357239|3768712|P3|STARTED|Stratum II: Partially-Methylated||22
1540290|NCT01357239|3768713|P2|STARTED|Stratum II: Partially-Methylated||21
1540291|NCT01357239|3768714|P1|STARTED|Stratum II: Partially-Methylated||23
1540292|NCT01357239|3768711|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
1540293|NCT01357239|3768712|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
1540294|NCT01357239|3768713|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
1540295|NCT01357239|3768714|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
1540296|NCT01357239|3768711|P4|COMPLETED|Stratum I: Fully-Methylated||22
1540297|NCT01357239|3768712|P3|COMPLETED|Stratum I: Fully-Methylated||16
1540298|NCT01357239|3768713|P2|COMPLETED|Stratum I: Fully-Methylated||6
1540299|NCT01357239|3768714|P1|COMPLETED|Stratum I: Fully-Methylated||8
1540300|NCT01357239|3768711|P4|STARTED|Stratum I: Fully-Methylated||22
1540301|NCT01357239|3768712|P3|STARTED|Stratum I: Fully-Methylated||17
1540302|NCT01357239|3768713|P2|STARTED|Stratum I: Fully-Methylated||6
1540303|NCT01357239|3768714|P1|STARTED|Stratum I: Fully-Methylated||8
1540304|NCT01357239|3768711|P4|NOT COMPLETED|Stratum: All Patients||2
1540305|NCT01357239|3768712|P3|NOT COMPLETED|Stratum: All Patients||2
1540306|NCT01357239|3768713|P2|NOT COMPLETED|Stratum: All Patients||0
1540307|NCT01357239|3768714|P1|NOT COMPLETED|Stratum: All Patients||0
1540308|NCT01357239|3768711|P4|COMPLETED|Stratum: All Patients||40
1540309|NCT01357239|3768712|P3|COMPLETED|Stratum: All Patients||37
1540310|NCT01357239|3768713|P2|COMPLETED|Stratum: All Patients||27
1540311|NCT01357239|3768714|P1|COMPLETED|Stratum: All Patients||31
1540312|NCT01357239|3768711|P4|STARTED|Stratum: All Patients||42
1540313|NCT01357239|3768712|P3|STARTED|Stratum: All Patients||39
1540314|NCT01357239|3768713|P2|STARTED|Stratum: All Patients||27
1540315|NCT01357239|3768714|P1|STARTED|Stratum: All Patients||31
1540316|NCT01357161|3768772|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
1540317|NCT01357161|3768773|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
1540318|NCT01357161|3768774|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
1540319|NCT01357161|3768772|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
1540320|NCT01357161|3768773|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
1540321|NCT01357161|3768774|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
1540322|NCT01357161|3768772|P3|Treated|Part 2 (Double-Blind Comparison)||60
1540323|NCT01357161|3768773|P2|Treated|Part 2 (Double-Blind Comparison)||59
1540324|NCT01357161|3768774|P1|Treated|Part 2 (Double-Blind Comparison)||0
1540325|NCT01357161|3768772|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
1540326|NCT01357161|3768773|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
1540327|NCT01357161|3768774|P1|STARTED|Part 2 (Double-Blind Comparison)||0
1540328|NCT01357161|3768772|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
1540329|NCT01357161|3768773|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
1540330|NCT01357161|3768774|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
1540331|NCT01357161|3768772|P3|COMPLETED|Part 1 (Open Label Run-in)||0
1540332|NCT01357161|3768773|P2|COMPLETED|Part 1 (Open Label Run-in)||0
1540333|NCT01357161|3768774|P1|COMPLETED|Part 1 (Open Label Run-in)||0
1540334|NCT01357161|3768772|P3|STARTED|Part 1 (Open Label Run-in)||0
1540335|NCT01357161|3768773|P2|STARTED|Part 1 (Open Label Run-in)||0
1540336|NCT01357161|3768774|P1|STARTED|Part 1 (Open Label Run-in)||15
1540337|NCT01357148|3768803|P1|NOT COMPLETED|Overall Study||0
1540338|NCT01357148|3768803|P1|COMPLETED|Overall Study||143
1540339|NCT01357148|3768803|P1|STARTED|Overall Study||143
1540340|NCT01357135|3768813|P3|NOT COMPLETED|Overall Study||263
1540341|NCT01357135|3768814|P2|NOT COMPLETED|Overall Study||223
1540342|NCT01357135|3768815|P1|NOT COMPLETED|Overall Study||598
1540343|NCT01357135|3768813|P3|COMPLETED|Overall Study||583
1540344|NCT01357135|3768814|P2|COMPLETED|Overall Study||510
1540345|NCT01357135|3768815|P1|COMPLETED|Overall Study||1276
1540346|NCT01357135|3768813|P3|STARTED|Overall Study||846
1540347|NCT01357135|3768814|P2|STARTED|Overall Study||733
1540348|NCT01357135|3768815|P1|STARTED|Overall Study||1874
1540349|NCT01356966|3768826|P2|NOT COMPLETED|Overall Study||2
1540350|NCT01356966|3768827|P1|NOT COMPLETED|Overall Study||2
1540351|NCT01356966|3768826|P2|COMPLETED|Overall Study||12
1540352|NCT01356966|3768827|P1|COMPLETED|Overall Study||16
1540353|NCT01356966|3768826|P2|STARTED|Overall Study||14
1540354|NCT01356966|3768827|P1|STARTED|Overall Study||18
1540355|NCT01356940|3768839|P2|NOT COMPLETED|Second Intervention (28 Days)||0
1540356|NCT01356940|3768840|P1|NOT COMPLETED|Second Intervention (28 Days)||1
1540357|NCT01356940|3768839|P2|COMPLETED|Second Intervention (28 Days)||21
1540358|NCT01356940|3768840|P1|COMPLETED|Second Intervention (28 Days)||20
1540359|NCT01356940|3768839|P2|STARTED|Second Intervention (28 Days)||21
1540360|NCT01356940|3768840|P1|STARTED|Second Intervention (28 Days)||21
1540361|NCT01356940|3768839|P2|NOT COMPLETED|Washout (14 Days)||0
1540362|NCT01356940|3768840|P1|NOT COMPLETED|Washout (14 Days)||0
1540363|NCT01356940|3768839|P2|COMPLETED|Washout (14 Days)||21
1540364|NCT01356940|3768840|P1|COMPLETED|Washout (14 Days)||21
1540365|NCT01356940|3768839|P2|STARTED|Washout (14 Days)||21
1540366|NCT01356940|3768840|P1|STARTED|Washout (14 Days)||21
1540367|NCT01356940|3768839|P2|NOT COMPLETED|First Intervention (28 Days)||0
1540368|NCT01356940|3768840|P1|NOT COMPLETED|First Intervention (28 Days)||1
1540369|NCT01356940|3768839|P2|COMPLETED|First Intervention (28 Days)||21
1540370|NCT01356940|3768840|P1|COMPLETED|First Intervention (28 Days)||21
1540371|NCT01356940|3768839|P2|STARTED|First Intervention (28 Days)||21
1540372|NCT01356940|3768840|P1|STARTED|First Intervention (28 Days)||22
1540373|NCT01356667|3768850|P2|NOT COMPLETED|Overall Study||6
1540374|NCT01356667|3768851|P1|NOT COMPLETED|Overall Study||4
1540375|NCT01356667|3768850|P2|COMPLETED|Overall Study||0
1540376|NCT01356667|3768851|P1|COMPLETED|Overall Study||0
1540377|NCT01356667|3768850|P2|STARTED|Overall Study||6
1540378|NCT01356667|3768851|P1|STARTED|Overall Study||4
1540379|NCT01356628|3768861|P1|NOT COMPLETED|Overall Study||0
1540380|NCT01356628|3768861|P1|COMPLETED|Overall Study||23
1540381|NCT01356628|3768861|P1|STARTED|Overall Study||23
1540382|NCT01356602|3768869|P3|NOT COMPLETED|Overall Study||24
1540383|NCT01356602|3768870|P2|NOT COMPLETED|Overall Study||15
1540384|NCT01356602|3768871|P1|NOT COMPLETED|Overall Study||9
1540385|NCT01356602|3768869|P3|COMPLETED|Overall Study||108
1540386|NCT01356602|3768870|P2|COMPLETED|Overall Study||117
1540387|NCT01356602|3768871|P1|COMPLETED|Overall Study||124
1540388|NCT01356602|3768869|P3|Full Analysis Set|Overall Study||129
1540389|NCT01356602|3768870|P2|Full Analysis Set|Overall Study||129
1540390|NCT01356602|3768871|P1|Full Analysis Set|Overall Study||131
1540391|NCT01356602|3768869|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
1540392|NCT01356602|3768870|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
1540393|NCT01356602|3768871|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
1540394|NCT01356602|3768869|P3|STARTED|Overall Study||132
1540395|NCT01356602|3768870|P2|STARTED|Overall Study||132
1540396|NCT01356602|3768871|P1|STARTED|Overall Study||133
1540397|NCT01356589|3768930|P1|NOT COMPLETED|Overall Study||5
1540398|NCT01356589|3768930|P1|COMPLETED|Overall Study||1283
1540399|NCT01356589|3768930|P1|Treated|Overall Study||1285
1540400|NCT01356589|3768930|P1|STARTED|Overall Study||1288
1540401|NCT01356498|3768942|P6|NOT COMPLETED|Overall Study||14
1540402|NCT01356498|3768943|P5|NOT COMPLETED|Overall Study||20
1540403|NCT01356498|3768944|P4|NOT COMPLETED|Overall Study||14
1540404|NCT01356498|3768945|P3|NOT COMPLETED|Overall Study||12
1540405|NCT01356498|3768946|P2|NOT COMPLETED|Overall Study||8
1540406|NCT01356498|3768947|P1|NOT COMPLETED|Overall Study||11
1540407|NCT01356498|3768942|P6|COMPLETED|Overall Study||2
1540408|NCT01356498|3768943|P5|COMPLETED|Overall Study||8
1540409|NCT01356498|3768944|P4|COMPLETED|Overall Study||8
1540410|NCT01356498|3768945|P3|COMPLETED|Overall Study||11
1540411|NCT01356498|3768946|P2|COMPLETED|Overall Study||17
1540412|NCT01356498|3768947|P1|COMPLETED|Overall Study||24
1540413|NCT01356498|3768942|P6|STARTED|Overall Study||16
1540414|NCT01356498|3768943|P5|STARTED|Overall Study||28
1540415|NCT01356498|3768944|P4|STARTED|Overall Study||22
1540416|NCT01356498|3768945|P3|STARTED|Overall Study||23
1540417|NCT01356498|3768946|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
1540418|NCT01356498|3768947|P1|STARTED|Overall Study||35
1540419|NCT01356407|3768987|P2|NOT COMPLETED|Overall Study||4
1540420|NCT01356407|3768988|P1|NOT COMPLETED|Overall Study||6
1540421|NCT01356407|3768987|P2|COMPLETED|Overall Study||146
1540422|NCT01356407|3768988|P1|COMPLETED|Overall Study||144
1540423|NCT01356407|3768987|P2|STARTED|Overall Study||150
1540424|NCT01356407|3768988|P1|STARTED|Overall Study||150
1540425|NCT01356277|3769006|P2|NOT COMPLETED|Intervention Interval||7
1540426|NCT01356277|3769007|P1|NOT COMPLETED|Intervention Interval||10
1540427|NCT01356277|3769006|P2|COMPLETED|Intervention Interval||81
1540428|NCT01356277|3769007|P1|COMPLETED|Intervention Interval||66
1540429|NCT01356277|3769006|P2|STARTED|Intervention Interval||88
1540430|NCT01356277|3769007|P1|STARTED|Intervention Interval||76
1540431|NCT01356277|3769006|P2|NOT COMPLETED|Run-in||0
1540432|NCT01356277|3769007|P1|NOT COMPLETED|Run-in||5
1540433|NCT01356277|3769006|P2|COMPLETED|Run-in||88
1540434|NCT01356277|3769007|P1|COMPLETED|Run-in||76
1540435|NCT01356277|3769006|P2|STARTED|Run-in||88
1540436|NCT01356277|3769007|P1|STARTED|Run-in||81
1540437|NCT01356147|3769027|P2|NOT COMPLETED|Overall Study||0
1540438|NCT01356147|3769028|P1|NOT COMPLETED|Overall Study||0
1540439|NCT01356147|3769027|P2|COMPLETED|Overall Study||6
1540440|NCT01356147|3769028|P1|COMPLETED|Overall Study||5
1540441|NCT01356147|3769027|P2|STARTED|Overall Study||6
1540442|NCT01356147|3769028|P1|STARTED|Overall Study||5
1540443|NCT01355978|3769038|P1|NOT COMPLETED|Overall Study||4
1540444|NCT01355978|3769038|P1|COMPLETED|Overall Study||18
1540445|NCT01355978|3769038|P1|STARTED|Overall Study||22
1540446|NCT01355796|3769044|P2|NOT COMPLETED|Overall Study||0
1540447|NCT01355796|3769045|P1|NOT COMPLETED|Overall Study||0
1540448|NCT01355796|3769044|P2|COMPLETED|Overall Study||15
1540449|NCT01355796|3769045|P1|COMPLETED|Overall Study||15
1540450|NCT01355796|3769044|P2|Second Intervention for 14 Days|Overall Study||15
1540451|NCT01355796|3769045|P1|Second Intervention for 14 Days|Overall Study||15
1540452|NCT01355796|3769044|P2|Washout Period for 7 Days|Overall Study||15
1540453|NCT01355796|3769045|P1|Washout Period for 7 Days|Overall Study||15
1540454|NCT01355796|3769044|P2|First Intervention for 14 Days|Overall Study||15
1540455|NCT01355796|3769045|P1|First Intervention for 14 Days|Overall Study||15
1540456|NCT01355796|3769044|P2|STARTED|Overall Study||15
1540457|NCT01355796|3769045|P1|STARTED|Overall Study||15
1540458|NCT01355705|3769053|P1|NOT COMPLETED|Overall Study||0
1540459|NCT01355705|3769053|P1|COMPLETED|Overall Study||14
1540460|NCT01355705|3769053|P1|STARTED|Overall Study||14
1540461|NCT01355679|3769060|P1|NOT COMPLETED|Overall Study||2
1540462|NCT01355679|3769060|P1|COMPLETED|Overall Study||14
1540463|NCT01355679|3769060|P1|STARTED|Overall Study||16
1540464|NCT01355627|3769069|P2|NOT COMPLETED|Overall Study||38
1540465|NCT01355627|3769070|P1|NOT COMPLETED|Overall Study||33
1540466|NCT01355627|3769069|P2|COMPLETED|Overall Study||326
1540467|NCT01355627|3769070|P1|COMPLETED|Overall Study||329
1540468|NCT01355627|3769069|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
1540469|NCT01355627|3769070|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
1540470|NCT01355627|3769069|P2|Safety Analysis Set|Overall Study||364
1540471|NCT01355627|3769070|P1|Safety Analysis Set|Overall Study||362
1540472|NCT01355627|3769069|P2|STARTED|Overall Study||364
1540473|NCT01355627|3769070|P1|STARTED|Overall Study||362
1540474|NCT01355588|3769082|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
1540475|NCT01355588|3769083|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
1540476|NCT01355588|3769084|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
1540477|NCT01355588|3769085|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
1540478|NCT01355588|3769082|P4|COMPLETED|Fourth Intervention (After Washout)||4
1540479|NCT01355588|3769083|P3|COMPLETED|Fourth Intervention (After Washout)||4
1540480|NCT01355588|3769084|P2|COMPLETED|Fourth Intervention (After Washout)||4
1540481|NCT01355588|3769085|P1|COMPLETED|Fourth Intervention (After Washout)||4
1540482|NCT01355588|3769082|P4|STARTED|Fourth Intervention (After Washout)||4
1540483|NCT01355588|3769083|P3|STARTED|Fourth Intervention (After Washout)||4
1540484|NCT01355588|3769084|P2|STARTED|Fourth Intervention (After Washout)||4
1540485|NCT01355588|3769085|P1|STARTED|Fourth Intervention (After Washout)||4
1540486|NCT01355588|3769082|P4|NOT COMPLETED|Washout (3-7 Days)||0
1540487|NCT01355588|3769083|P3|NOT COMPLETED|Washout (3-7 Days)||0
1540488|NCT01355588|3769084|P2|NOT COMPLETED|Washout (3-7 Days)||0
1540489|NCT01355588|3769085|P1|NOT COMPLETED|Washout (3-7 Days)||0
1540490|NCT01355588|3769082|P4|COMPLETED|Washout (3-7 Days)||4
1540491|NCT01355588|3769083|P3|COMPLETED|Washout (3-7 Days)||4
1540492|NCT01355588|3769084|P2|COMPLETED|Washout (3-7 Days)||4
1540493|NCT01355588|3769085|P1|COMPLETED|Washout (3-7 Days)||4
1540494|NCT01355588|3769082|P4|STARTED|Washout (3-7 Days)||4
1540495|NCT01355588|3769083|P3|STARTED|Washout (3-7 Days)||4
1540496|NCT01355588|3769084|P2|STARTED|Washout (3-7 Days)||4
1540497|NCT01355588|3769085|P1|STARTED|Washout (3-7 Days)||4
1540498|NCT01355588|3769082|P4|NOT COMPLETED|Third Intervention (After Washout)||0
1540499|NCT01355588|3769083|P3|NOT COMPLETED|Third Intervention (After Washout)||0
1540500|NCT01355588|3769084|P2|NOT COMPLETED|Third Intervention (After Washout)||0
1540501|NCT01355588|3769085|P1|NOT COMPLETED|Third Intervention (After Washout)||0
1540502|NCT01355588|3769082|P4|COMPLETED|Third Intervention (After Washout)||4
1540503|NCT01355588|3769083|P3|COMPLETED|Third Intervention (After Washout)||4
1540504|NCT01355588|3769084|P2|COMPLETED|Third Intervention (After Washout)||4
1540505|NCT01355588|3769085|P1|COMPLETED|Third Intervention (After Washout)||4
1540506|NCT01355588|3769082|P4|STARTED|Third Intervention (After Washout)||4
1540507|NCT01355588|3769083|P3|STARTED|Third Intervention (After Washout)||4
1540508|NCT01355588|3769084|P2|STARTED|Third Intervention (After Washout)||4
1540509|NCT01355588|3769085|P1|STARTED|Third Intervention (After Washout)||4
1540510|NCT01355588|3769082|P4|NOT COMPLETED|Washout (3-7 Days)||0
1540511|NCT01355588|3769083|P3|NOT COMPLETED|Washout (3-7 Days)||0
1540512|NCT01355588|3769084|P2|NOT COMPLETED|Washout (3-7 Days)||0
1540513|NCT01355588|3769085|P1|NOT COMPLETED|Washout (3-7 Days)||0
1540514|NCT01355588|3769082|P4|COMPLETED|Washout (3-7 Days)||4
1540515|NCT01355588|3769083|P3|COMPLETED|Washout (3-7 Days)||4
1540516|NCT01355588|3769084|P2|COMPLETED|Washout (3-7 Days)||4
1540517|NCT01355588|3769085|P1|COMPLETED|Washout (3-7 Days)||4
1540518|NCT01355588|3769082|P4|STARTED|Washout (3-7 Days)||4
1540519|NCT01355588|3769083|P3|STARTED|Washout (3-7 Days)||4
1540520|NCT01355588|3769084|P2|STARTED|Washout (3-7 Days)||4
1540521|NCT01355588|3769085|P1|STARTED|Washout (3-7 Days)||4
1540522|NCT01355588|3769082|P4|NOT COMPLETED|Second Intervention (After Washout)||0
1540523|NCT01355588|3769083|P3|NOT COMPLETED|Second Intervention (After Washout)||0
1540524|NCT01355588|3769084|P2|NOT COMPLETED|Second Intervention (After Washout)||0
1540525|NCT01355588|3769085|P1|NOT COMPLETED|Second Intervention (After Washout)||0
1540526|NCT01355588|3769082|P4|COMPLETED|Second Intervention (After Washout)||4
1540527|NCT01355588|3769083|P3|COMPLETED|Second Intervention (After Washout)||4
1540528|NCT01355588|3769084|P2|COMPLETED|Second Intervention (After Washout)||4
1540529|NCT01355588|3769085|P1|COMPLETED|Second Intervention (After Washout)||4
1540530|NCT01355588|3769082|P4|STARTED|Second Intervention (After Washout)||4
1540531|NCT01355588|3769083|P3|STARTED|Second Intervention (After Washout)||4
1540532|NCT01355588|3769084|P2|STARTED|Second Intervention (After Washout)||4
1540533|NCT01355588|3769085|P1|STARTED|Second Intervention (After Washout)||4
1540534|NCT01355588|3769082|P4|NOT COMPLETED|Washout (3-7 Days)||0
1540535|NCT01355588|3769083|P3|NOT COMPLETED|Washout (3-7 Days)||0
1540536|NCT01355588|3769084|P2|NOT COMPLETED|Washout (3-7 Days)||0
1540537|NCT01355588|3769085|P1|NOT COMPLETED|Washout (3-7 Days)||0
1540538|NCT01355588|3769082|P4|COMPLETED|Washout (3-7 Days)||4
1540539|NCT01355588|3769083|P3|COMPLETED|Washout (3-7 Days)||4
1540540|NCT01355588|3769084|P2|COMPLETED|Washout (3-7 Days)||4
1540541|NCT01355588|3769085|P1|COMPLETED|Washout (3-7 Days)||4
1540542|NCT01355588|3769082|P4|STARTED|Washout (3-7 Days)||4
1540543|NCT01355588|3769083|P3|STARTED|Washout (3-7 Days)||4
1540544|NCT01355588|3769084|P2|STARTED|Washout (3-7 Days)||4
1540545|NCT01355588|3769085|P1|STARTED|Washout (3-7 Days)||4
1540546|NCT01355588|3769082|P4|NOT COMPLETED|First Intervention (Day 1)||0
1540547|NCT01355588|3769083|P3|NOT COMPLETED|First Intervention (Day 1)||0
1540548|NCT01355588|3769084|P2|NOT COMPLETED|First Intervention (Day 1)||0
1540549|NCT01355588|3769085|P1|NOT COMPLETED|First Intervention (Day 1)||0
1540550|NCT01355588|3769082|P4|COMPLETED|First Intervention (Day 1)||4
1540551|NCT01355588|3769083|P3|COMPLETED|First Intervention (Day 1)||4
1540552|NCT01355588|3769084|P2|COMPLETED|First Intervention (Day 1)||4
1540553|NCT01355588|3769085|P1|COMPLETED|First Intervention (Day 1)||4
1540554|NCT01355588|3769082|P4|STARTED|First Intervention (Day 1)||4
1540555|NCT01355588|3769083|P3|STARTED|First Intervention (Day 1)||4
1540556|NCT01355588|3769084|P2|STARTED|First Intervention (Day 1)||4
1540557|NCT01355588|3769085|P1|STARTED|First Intervention (Day 1)||4
1540558|NCT01355523|3769109|P2|NOT COMPLETED|Overall Study||10
1540559|NCT01355523|3769110|P1|NOT COMPLETED|Overall Study||1
1540560|NCT01355523|3769109|P2|COMPLETED|Overall Study||16
1540561|NCT01355523|3769110|P1|COMPLETED|Overall Study||27
1540562|NCT01355523|3769109|P2|STARTED|Overall Study||26
1540563|NCT01355523|3769110|P1|STARTED|Overall Study||28
1540564|NCT01355484|3769154|P2|NOT COMPLETED|Overall Study||54
1540565|NCT01355484|3769155|P1|NOT COMPLETED|Overall Study||51
1540566|NCT01355484|3769154|P2|COMPLETED|Overall Study||107
1540567|NCT01355484|3769155|P1|COMPLETED|Overall Study||109
1540568|NCT01355484|3769154|P2|STARTED|Overall Study||161
1540569|NCT01355484|3769155|P1|STARTED|Overall Study||160
1540570|NCT01355471|3769165|P2|NOT COMPLETED|Overall Study||3
1540571|NCT01355471|3769166|P1|NOT COMPLETED|Overall Study||7
1540572|NCT01355471|3769165|P2|COMPLETED|Overall Study||142
1540573|NCT01355471|3769166|P1|COMPLETED|Overall Study||141
1540574|NCT01355471|3769165|P2|STARTED|Overall Study||145
1540575|NCT01355471|3769166|P1|STARTED|Overall Study||148
1540576|NCT01355458|3769174|P2|NOT COMPLETED|Overall Study||4
1540577|NCT01355458|3769175|P1|NOT COMPLETED|Overall Study||2
1540578|NCT01355458|3769174|P2|COMPLETED|Overall Study||127
1540579|NCT01355458|3769175|P1|COMPLETED|Overall Study||127
1540580|NCT01355458|3769174|P2|STARTED|Overall Study||131
1540581|NCT01355458|3769175|P1|STARTED|Overall Study||129
1540582|NCT01355419|3769181|P1|NOT COMPLETED|Overall Study||8
1540583|NCT01355419|3769181|P1|COMPLETED|Overall Study||142
1540584|NCT01355419|3769181|P1|STARTED|Overall Study||150
1540585|NCT01355302|3769186|P3|NOT COMPLETED|Phase 2||0
1540586|NCT01355302|3769187|P2|NOT COMPLETED|Phase 2||0
1540587|NCT01355302|3769188|P1|NOT COMPLETED|Phase 2||0
1540588|NCT01355302|3769186|P3|COMPLETED|Phase 2||0
1540589|NCT01355302|3769187|P2|COMPLETED|Phase 2||0
1540590|NCT01355302|3769188|P1|COMPLETED|Phase 2||0
1540591|NCT01355302|3769186|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
1540592|NCT01355302|3769187|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
1540593|NCT01355302|3769188|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
1540594|NCT01355302|3769186|P3|NOT COMPLETED|Phase 1b||0
1540595|NCT01355302|3769187|P2|NOT COMPLETED|Phase 1b||0
1540596|NCT01355302|3769188|P1|NOT COMPLETED|Phase 1b||6
1540597|NCT01355302|3769186|P3|COMPLETED|Phase 1b||0
1540598|NCT01355302|3769187|P2|COMPLETED|Phase 1b||0
1540599|NCT01355302|3769188|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
1540600|NCT01355302|3769186|P3|STARTED|Phase 1b||0
1540601|NCT01355302|3769187|P2|STARTED|Phase 1b||0
1540602|NCT01355302|3769188|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
1540603|NCT01355289|3769203|P5|NOT COMPLETED|Open Label Extension||34
1540604|NCT01355289|3769204|P4|NOT COMPLETED|Open Label Extension||0
1540605|NCT01355289|3769205|P3|NOT COMPLETED|Open Label Extension||0
1540606|NCT01355289|3769206|P2|NOT COMPLETED|Open Label Extension||0
1540607|NCT01355289|3769207|P1|NOT COMPLETED|Open Label Extension||0
1540608|NCT01355289|3769203|P5|COMPLETED|Open Label Extension||28
1540609|NCT01355289|3769204|P4|COMPLETED|Open Label Extension||0
1540610|NCT01355289|3769205|P3|COMPLETED|Open Label Extension||0
1540611|NCT01355289|3769206|P2|COMPLETED|Open Label Extension||0
1540612|NCT01355289|3769207|P1|COMPLETED|Open Label Extension||0
1540613|NCT01355289|3769203|P5|STARTED|Open Label Extension||62
1540614|NCT01355289|3769204|P4|STARTED|Open Label Extension||0
1540615|NCT01355289|3769205|P3|STARTED|Open Label Extension||0
1540616|NCT01355289|3769206|P2|STARTED|Open Label Extension||0
1540617|NCT01355289|3769207|P1|STARTED|Open Label Extension||0
1540618|NCT01355289|3769203|P5|NOT COMPLETED|Core Study||0
1540619|NCT01355289|3769204|P4|NOT COMPLETED|Core Study||2
1540620|NCT01355289|3769205|P3|NOT COMPLETED|Core Study||0
1540621|NCT01355289|3769206|P2|NOT COMPLETED|Core Study||0
1540622|NCT01355289|3769207|P1|NOT COMPLETED|Core Study||1
1540623|NCT01355289|3769203|P5|COMPLETED|Core Study||0
1540624|NCT01355289|3769204|P4|COMPLETED|Core Study||12
1540625|NCT01355289|3769205|P3|COMPLETED|Core Study||18
1540626|NCT01355289|3769206|P2|COMPLETED|Core Study||16
1540627|NCT01355289|3769207|P1|COMPLETED|Core Study||16
1540628|NCT01355289|3769203|P5|STARTED|Core Study||0
1540629|NCT01355289|3769204|P4|STARTED|Core Study||14
1540630|NCT01355289|3769205|P3|STARTED|Core Study||18
1540631|NCT01355289|3769206|P2|STARTED|Core Study||16
1540632|NCT01355289|3769207|P1|STARTED|Core Study||17
1540633|NCT01355224|3769234|P4|NOT COMPLETED|Overall Study||29
1540634|NCT01355224|3769235|P3|NOT COMPLETED|Overall Study||19
1540635|NCT01355224|3769236|P2|NOT COMPLETED|Overall Study||23
1540636|NCT01355224|3769237|P1|NOT COMPLETED|Overall Study||31
1540637|NCT01355224|3769234|P4|COMPLETED|Overall Study||172
1540638|NCT01355224|3769235|P3|COMPLETED|Overall Study||177
1540639|NCT01355224|3769236|P2|COMPLETED|Overall Study||180
1540640|NCT01355224|3769237|P1|COMPLETED|Overall Study||167
1540641|NCT01355224|3769234|P4|Competed Baseline|Overall Study||193
1540642|NCT01355224|3769235|P3|Competed Baseline|Overall Study||193
1540643|NCT01355224|3769236|P2|Competed Baseline|Overall Study||200
1540644|NCT01355224|3769237|P1|Competed Baseline|Overall Study||191
1540645|NCT01355224|3769234|P4|STARTED|Overall Study||201
1540646|NCT01355224|3769235|P3|STARTED|Overall Study||196
1540647|NCT01355224|3769236|P2|STARTED|Overall Study||203
1540648|NCT01355224|3769237|P1|STARTED|Overall Study||198
1540649|NCT01355081|3769260|P3|NOT COMPLETED|Overall Study||11
1540650|NCT01355081|3769261|P2|NOT COMPLETED|Overall Study||10
1540651|NCT01355081|3769262|P1|NOT COMPLETED|Overall Study||7
1540652|NCT01355081|3769260|P3|COMPLETED|Overall Study||113
1540653|NCT01355081|3769261|P2|COMPLETED|Overall Study||113
1540654|NCT01355081|3769262|P1|COMPLETED|Overall Study||112
1540655|NCT01355081|3769260|P3|STARTED|Overall Study||124
1540656|NCT01355081|3769261|P2|STARTED|Overall Study||123
1540657|NCT01355081|3769262|P1|STARTED|Overall Study||119
1540658|NCT01355068|3769285|P2|NOT COMPLETED|Second Intervention Period||0
1540659|NCT01355068|3769286|P1|NOT COMPLETED|Second Intervention Period||0
1540660|NCT01355068|3769285|P2|COMPLETED|Second Intervention Period||11
1540661|NCT01355068|3769286|P1|COMPLETED|Second Intervention Period||13
1540662|NCT01355068|3769285|P2|STARTED|Second Intervention Period||11
1540663|NCT01355068|3769286|P1|STARTED|Second Intervention Period||13
1540664|NCT01355068|3769285|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1540665|NCT01355068|3769286|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1540666|NCT01355068|3769285|P2|COMPLETED|Washout Period (at Least 7 Days)||11
1540667|NCT01355068|3769286|P1|COMPLETED|Washout Period (at Least 7 Days)||13
1540668|NCT01355068|3769285|P2|STARTED|Washout Period (at Least 7 Days)||11
1540669|NCT01355068|3769286|P1|STARTED|Washout Period (at Least 7 Days)||13
1540670|NCT01355068|3769285|P2|NOT COMPLETED|First Intervention Period||2
1540671|NCT01355068|3769286|P1|NOT COMPLETED|First Intervention Period||0
1540672|NCT01355068|3769285|P2|COMPLETED|First Intervention Period||11
1540673|NCT01355068|3769286|P1|COMPLETED|First Intervention Period||13
1540674|NCT01355068|3769285|P2|STARTED|First Intervention Period||13
1540675|NCT01355068|3769286|P1|STARTED|First Intervention Period||13
1540676|NCT01354990|3769302|P1|NOT COMPLETED|Overall Study||0
1540677|NCT01354990|3769302|P1|COMPLETED|Overall Study||2974
1540678|NCT01354990|3769302|P1|STARTED|Overall Study||2974
1540679|NCT01354951|3769309|P1|NOT COMPLETED|Overall Study||2
1540680|NCT01354951|3769309|P1|COMPLETED|Overall Study||1
1540681|NCT01354951|3769309|P1|STARTED|Overall Study||3
1540682|NCT01354938|3769316|P1|NOT COMPLETED|Overall Study||1
1540683|NCT01354938|3769316|P1|COMPLETED|Overall Study||219
1540684|NCT01354938|3769316|P1|STARTED|Overall Study||220
1540685|NCT01354899|3769322|P1|NOT COMPLETED|Overall Study||3
1540686|NCT01354899|3769322|P1|COMPLETED|Overall Study||21
1540687|NCT01354899|3769322|P1|STARTED|Overall Study||24
1540688|NCT01354652|3769330|P3|NOT COMPLETED|Overall Study||0
1540689|NCT01354652|3769331|P2|NOT COMPLETED|Overall Study||2
1540690|NCT01354652|3769332|P1|NOT COMPLETED|Overall Study||3
1540691|NCT01354652|3769330|P3|COMPLETED|Overall Study||0
1540692|NCT01354652|3769331|P2|COMPLETED|Overall Study||0
1540693|NCT01354652|3769332|P1|COMPLETED|Overall Study||0
1540694|NCT01354652|3769330|P3|STARTED|Overall Study||0
1540695|NCT01354652|3769331|P2|STARTED|Overall Study||2
1540696|NCT01354652|3769332|P1|STARTED|Overall Study||3
1540697|NCT01354444|3769357|P2|NOT COMPLETED|Overall Study||4
1540698|NCT01354444|3769358|P1|NOT COMPLETED|Overall Study||8
1540699|NCT01354444|3769357|P2|COMPLETED|Overall Study||11
1540700|NCT01354444|3769358|P1|COMPLETED|Overall Study||6
1540701|NCT01354444|3769357|P2|STARTED|Overall Study||15
1540702|NCT01354444|3769358|P1|STARTED|Overall Study||14
1540703|NCT01354431|3769371|P3|NOT COMPLETED|Participants Treated||54
1540704|NCT01354431|3769372|P2|NOT COMPLETED|Participants Treated||54
1540705|NCT01354431|3769373|P1|NOT COMPLETED|Participants Treated||59
1540706|NCT01354431|3769371|P3|COMPLETED|Participants Treated||0
1540707|NCT01354431|3769372|P2|COMPLETED|Participants Treated||0
1540708|NCT01354431|3769373|P1|COMPLETED|Participants Treated||0
1540709|NCT01354431|3769371|P3|STARTED|Participants Treated||54
1540710|NCT01354431|3769372|P2|STARTED|Participants Treated||54
1540711|NCT01354431|3769373|P1|STARTED|Participants Treated||59
1540712|NCT01354431|3769371|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
1540713|NCT01354431|3769372|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
1540714|NCT01354431|3769373|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
1540715|NCT01354431|3769371|P3|COMPLETED|Randomized to Enter Treatment Period||54
1540716|NCT01354431|3769372|P2|COMPLETED|Randomized to Enter Treatment Period||54
1540717|NCT01354431|3769373|P1|COMPLETED|Randomized to Enter Treatment Period||59
1540718|NCT01354431|3769371|P3|STARTED|Randomized to Enter Treatment Period||54
1540719|NCT01354431|3769372|P2|STARTED|Randomized to Enter Treatment Period||54
1540720|NCT01354431|3769373|P1|STARTED|Randomized to Enter Treatment Period||60
1540721|NCT01354314|3769397|P4|NOT COMPLETED|Overall Study||6
1540722|NCT01354314|3769398|P3|NOT COMPLETED|Overall Study||8
1540723|NCT01354314|3769399|P2|NOT COMPLETED|Overall Study||3
1540724|NCT01354314|3769400|P1|NOT COMPLETED|Overall Study||6
1540725|NCT01354314|3769397|P4|COMPLETED|Overall Study||5
1540726|NCT01354314|3769398|P3|COMPLETED|Overall Study||3
1540727|NCT01354314|3769399|P2|COMPLETED|Overall Study||8
1540728|NCT01354314|3769400|P1|COMPLETED|Overall Study||6
1540729|NCT01354314|3769397|P4|Completed (ITT)|Overall Study||10
1540730|NCT01354314|3769398|P3|Completed (ITT)|Overall Study||9
1540731|NCT01354314|3769399|P2|Completed (ITT)|Overall Study||11
1540732|NCT01354314|3769400|P1|Completed (ITT)|Overall Study||11
1540733|NCT01354314|3769397|P4|STARTED|Overall Study||11
1540734|NCT01354314|3769398|P3|STARTED|Overall Study||11
1540735|NCT01354314|3769399|P2|STARTED|Overall Study||11
1540736|NCT01354314|3769400|P1|STARTED|Overall Study||12
1540737|NCT01354223|3769536|P2|NOT COMPLETED|Overall Study||1
1540738|NCT01354223|3769537|P1|NOT COMPLETED|Overall Study||3
1540739|NCT01354223|3769536|P2|COMPLETED|Overall Study||29
1540740|NCT01354223|3769537|P1|COMPLETED|Overall Study||57
1540741|NCT01354223|3769536|P2|STARTED|Overall Study||30
1540742|NCT01354223|3769537|P1|STARTED|Overall Study||60
1540743|NCT01354197|3769553|P1|NOT COMPLETED|Overall Study||0
1540744|NCT01354197|3769553|P1|COMPLETED|Overall Study||4652
1540745|NCT01354197|3769553|P1|STARTED|Overall Study||4652
1540746|NCT01354145|3769561|P2|NOT COMPLETED|Overall Study||34
1540747|NCT01354145|3769562|P1|NOT COMPLETED|Overall Study||39
1540748|NCT01354145|3769561|P2|COMPLETED|Overall Study||63
1540749|NCT01354145|3769562|P1|COMPLETED|Overall Study||58
1540750|NCT01354145|3769561|P2|STARTED|Overall Study||97
1540751|NCT01354145|3769562|P1|STARTED|Overall Study||97
1540752|NCT01354132|3769596|P2|NOT COMPLETED|1 Month Post Study Medication||3
1540753|NCT01354132|3769597|P1|NOT COMPLETED|1 Month Post Study Medication||1
1540754|NCT01354132|3769596|P2|COMPLETED|1 Month Post Study Medication||16
1540755|NCT01354132|3769597|P1|COMPLETED|1 Month Post Study Medication||21
1540756|NCT01354132|3769596|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
1540757|NCT01354132|3769597|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
1540758|NCT01354132|3769596|P2|STARTED|1 Month Post Study Medication||19
1540759|NCT01354132|3769597|P1|STARTED|1 Month Post Study Medication||22
1540760|NCT01354132|3769596|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
1540761|NCT01354132|3769597|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
1540762|NCT01354132|3769596|P2|COMPLETED|Double Blind (Visits 1-7)||19
1540763|NCT01354132|3769597|P1|COMPLETED|Double Blind (Visits 1-7)||22
1540764|NCT01354132|3769596|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
1540765|NCT01354132|3769597|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
1540766|NCT01354132|3769596|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
1540767|NCT01354132|3769597|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
1540768|NCT01354132|3769596|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
1540769|NCT01354132|3769597|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
1540770|NCT01354132|3769596|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
1540771|NCT01354132|3769597|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
1540772|NCT01354132|3769596|P2|NOT COMPLETED|Randomization||1
1540773|NCT01354132|3769597|P1|NOT COMPLETED|Randomization||1
1540774|NCT01354132|3769596|P2|COMPLETED|Randomization||30
1540775|NCT01354132|3769597|P1|COMPLETED|Randomization||31
1540776|NCT01354132|3769596|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
1540777|NCT01354132|3769597|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
1540778|NCT01354106|3769635|P1|NOT COMPLETED|Overall Study||2
1540779|NCT01354106|3769635|P1|COMPLETED|Overall Study||24
1540780|NCT01354106|3769635|P1|STARTED|Overall Study||26
1540781|NCT01354028|3769641|P2|NOT COMPLETED|Overall Study||5
1540782|NCT01354028|3769642|P1|NOT COMPLETED|Overall Study||2
1540783|NCT01354028|3769641|P2|COMPLETED|Overall Study||10
1540784|NCT01354028|3769642|P1|COMPLETED|Overall Study||13
1540785|NCT01354028|3769641|P2|STARTED|Overall Study||15
1540786|NCT01354028|3769642|P1|STARTED|Overall Study||15
1540787|NCT01354015|3769656|P2|NOT COMPLETED|Overall Study||5
1540788|NCT01354015|3769657|P1|NOT COMPLETED|Overall Study||6
1540789|NCT01354015|3769656|P2|COMPLETED|Overall Study||43
1540790|NCT01354015|3769657|P1|COMPLETED|Overall Study||44
1540791|NCT01354015|3769656|P2|STARTED|Overall Study||48
1540792|NCT01354015|3769657|P1|STARTED|Overall Study||50
1540793|NCT01353976|3769667|P2|NOT COMPLETED|Overall Study||51
1540794|NCT01353976|3769668|P1|NOT COMPLETED|Overall Study||48
1540795|NCT01353976|3769667|P2|COMPLETED|Overall Study||83
1540796|NCT01353976|3769668|P1|COMPLETED|Overall Study||82
1540797|NCT01353976|3769667|P2|STARTED|Overall Study||134
1540798|NCT01353976|3769668|P1|STARTED|Overall Study||130
1540799|NCT01353963|3769678|P1|NOT COMPLETED|Overall Study||2
1540800|NCT01353963|3769678|P1|COMPLETED|Overall Study||11
1540801|NCT01353963|3769678|P1|STARTED|Overall Study||13
1540802|NCT01353911|3769696|P8|NOT COMPLETED|Overall Study||15
1540803|NCT01353911|3769697|P7|NOT COMPLETED|Overall Study||6
1540804|NCT01353911|3769698|P6|NOT COMPLETED|Overall Study||7
1540805|NCT01353911|3769699|P5|NOT COMPLETED|Overall Study||6
1540806|NCT01353911|3769700|P4|NOT COMPLETED|Overall Study||2
1540807|NCT01353911|3769701|P3|NOT COMPLETED|Overall Study||9
1540808|NCT01353911|3769702|P2|NOT COMPLETED|Overall Study||9
1540809|NCT01353911|3769703|P1|NOT COMPLETED|Overall Study||8
1540810|NCT01353911|3769696|P8|COMPLETED|Overall Study||51
1540811|NCT01353911|3769697|P7|COMPLETED|Overall Study||30
1540812|NCT01353911|3769698|P6|COMPLETED|Overall Study||36
1540813|NCT01353911|3769699|P5|COMPLETED|Overall Study||23
1540814|NCT01353911|3769700|P4|COMPLETED|Overall Study||22
1540815|NCT01353911|3769701|P3|COMPLETED|Overall Study||59
1540816|NCT01353911|3769702|P2|COMPLETED|Overall Study||57
1540817|NCT01353911|3769703|P1|COMPLETED|Overall Study||28
1540818|NCT01353911|3769696|P8|STARTED|Overall Study||66
1540819|NCT01353911|3769697|P7|STARTED|Overall Study||36
1540820|NCT01353911|3769698|P6|STARTED|Overall Study||43
1540821|NCT01353911|3769699|P5|STARTED|Overall Study||29
1540822|NCT01353911|3769700|P4|STARTED|Overall Study||24
1540823|NCT01353911|3769701|P3|STARTED|Overall Study||68
1540824|NCT01353911|3769702|P2|STARTED|Overall Study||66
1540825|NCT01353911|3769703|P1|STARTED|Overall Study||36
1540826|NCT01353898|3769783|P6|NOT COMPLETED|Overall Study||1
1540827|NCT01353898|3769784|P5|NOT COMPLETED|Overall Study||0
1540828|NCT01353898|3769785|P4|NOT COMPLETED|Overall Study||0
1540829|NCT01353898|3769786|P3|NOT COMPLETED|Overall Study||0
1540830|NCT01353898|3769787|P2|NOT COMPLETED|Overall Study||0
1540831|NCT01353898|3769788|P1|NOT COMPLETED|Overall Study||0
1540832|NCT01353898|3769783|P6|COMPLETED|Overall Study||1
1540833|NCT01353898|3769784|P5|COMPLETED|Overall Study||2
1540834|NCT01353898|3769785|P4|COMPLETED|Overall Study||2
1540835|NCT01353898|3769786|P3|COMPLETED|Overall Study||2
1540836|NCT01353898|3769787|P2|COMPLETED|Overall Study||2
1540837|NCT01353898|3769788|P1|COMPLETED|Overall Study||2
1540838|NCT01353898|3769783|P6|STARTED|Overall Study||2
1540839|NCT01353898|3769784|P5|STARTED|Overall Study||2
1540840|NCT01353898|3769785|P4|STARTED|Overall Study||2
1540841|NCT01353898|3769786|P3|STARTED|Overall Study||2
1540842|NCT01353898|3769787|P2|STARTED|Overall Study||2
1540843|NCT01353898|3769788|P1|STARTED|Overall Study||2
1540844|NCT01353859|3769814|P1|NOT COMPLETED|Overall Study||4
1540845|NCT01353859|3769814|P1|COMPLETED|Overall Study||35
1540846|NCT01353859|3769814|P1|STARTED|Overall Study||39
1540847|NCT01353664|3769827|P1|NOT COMPLETED|Overall Study||19
1540848|NCT01353664|3769827|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
1540849|NCT01353664|3769827|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
1540850|NCT01353586|3769833|P2|NOT COMPLETED|Overall Study||2
1540851|NCT01353586|3769834|P1|NOT COMPLETED|Overall Study||7
1540852|NCT01353586|3769833|P2|COMPLETED|Overall Study||17
1540853|NCT01353586|3769834|P1|COMPLETED|Overall Study||160
1540854|NCT01353586|3769833|P2|Participated in SNA Substudy|Overall Study||19
1540855|NCT01353586|3769834|P1|Participated in SNA Substudy|Overall Study||19
1540856|NCT01353586|3769833|P2|Participated in Roll-in Phase|Overall Study||0
1540857|NCT01353586|3769834|P1|Participated in Roll-in Phase|Overall Study||22
1540858|NCT01353586|3769833|P2|Participated in Workflow Phase|Overall Study||0
1540859|NCT01353586|3769834|P1|Participated in Workflow Phase|Overall Study||20
1540860|NCT01353586|3769833|P2|STARTED|Overall Study||19
1540861|NCT01353586|3769834|P1|STARTED|Overall Study||167
1540862|NCT01353508|3769852|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
1540863|NCT01353508|3769853|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
1540864|NCT01353508|3769854|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
1540865|NCT01353508|3769855|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
1540866|NCT01353508|3769852|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
1540867|NCT01353508|3769853|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
1540868|NCT01353508|3769854|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
1540869|NCT01353508|3769855|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
1540870|NCT01353508|3769852|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
1540871|NCT01353508|3769853|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
1540872|NCT01353508|3769854|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
1540873|NCT01353508|3769855|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
1540874|NCT01353508|3769852|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
1540875|NCT01353508|3769853|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
1540876|NCT01353508|3769854|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
1540877|NCT01353508|3769855|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
1540878|NCT01353508|3769852|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
1540879|NCT01353508|3769853|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
1540880|NCT01353508|3769854|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
1540881|NCT01353508|3769855|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
1540882|NCT01353508|3769852|P4|STARTED|Period 1 - First Intervention (7 Days)||8
1540883|NCT01353508|3769853|P3|STARTED|Period 1 - First Intervention (7 Days)||8
1540884|NCT01353508|3769854|P2|STARTED|Period 1 - First Intervention (7 Days)||8
1540885|NCT01353508|3769855|P1|STARTED|Period 1 - First Intervention (7 Days)||8
1540886|NCT01353274|3769933|P1|NOT COMPLETED|Overall Study||28
1540887|NCT01353274|3769933|P1|COMPLETED|Overall Study||1129
1540888|NCT01353274|3769933|P1|STARTED|Overall Study||1157
1540889|NCT01353222|3769943|P2|NOT COMPLETED|Overall Study||72
1540890|NCT01353222|3769944|P1|NOT COMPLETED|Overall Study||70
1540891|NCT01353222|3769943|P2|COMPLETED|Overall Study||0
1540892|NCT01353222|3769944|P1|COMPLETED|Overall Study||0
1540893|NCT01353222|3769943|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
1540894|NCT01353222|3769944|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
1540895|NCT01353222|3769943|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
1540896|NCT01353222|3769944|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
1540897|NCT01353222|3769943|P2|STARTED|Overall Study||72
1540898|NCT01353222|3769944|P1|STARTED|Overall Study||70
1540899|NCT01353144|3769952|P2|NOT COMPLETED|Overall Study||8
1540900|NCT01353144|3769953|P1|NOT COMPLETED|Overall Study||9
1540901|NCT01353144|3769952|P2|COMPLETED|Overall Study||81
1540902|NCT01353144|3769953|P1|COMPLETED|Overall Study||80
1540903|NCT01353144|3769952|P2|STARTED|Overall Study||89
1540904|NCT01353144|3769953|P1|STARTED|Overall Study||89
1540905|NCT01353079|3769963|P2|NOT COMPLETED|Overall Study||21
1540906|NCT01353079|3769964|P1|NOT COMPLETED|Overall Study||27
1540907|NCT01353079|3769963|P2|COMPLETED|Overall Study||190
1540908|NCT01353079|3769964|P1|COMPLETED|Overall Study||191
1540909|NCT01353079|3769963|P2|STARTED|Overall Study||211
1540910|NCT01353079|3769964|P1|STARTED|Overall Study||218
1540911|NCT01352845|3769978|P2|NOT COMPLETED|Overall Study||203
1540912|NCT01352845|3769979|P1|NOT COMPLETED|Overall Study||671
1540913|NCT01352845|3769978|P2|COMPLETED|Overall Study||619
1540914|NCT01352845|3769979|P1|COMPLETED|Overall Study||1800
1540915|NCT01352845|3769978|P2|STARTED|Overall Study||822
1540916|NCT01352845|3769979|P1|STARTED|Overall Study||2471
1540917|NCT01352793|3770068|P2|NOT COMPLETED|Overall Study||245
1540918|NCT01352793|3770069|P1|NOT COMPLETED|Overall Study||585
1540919|NCT01352793|3770068|P2|COMPLETED|Overall Study||1663
1540920|NCT01352793|3770069|P1|COMPLETED|Overall Study||3219
1540921|NCT01352793|3770068|P2|Vaccination 3|Overall Study||1710
1540922|NCT01352793|3770069|P1|Vaccination 3|Overall Study||3314
1540923|NCT01352793|3770068|P2|Vaccination 2|Overall Study||1806
1540924|NCT01352793|3770069|P1|Vaccination 2|Overall Study||3530
1540925|NCT01352793|3770068|P2|Vaccination 1|Overall Study||1908
1540926|NCT01352793|3770069|P1|Vaccination 1|Overall Study||3796
1540927|NCT01352793|3770068|P2|STARTED|Overall Study||1908
1540928|NCT01352793|3770069|P1|STARTED|Overall Study||3804
1540929|NCT01352741|3770093|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
1540930|NCT01352741|3770094|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
1540931|NCT01352741|3770093|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
1540932|NCT01352741|3770094|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
1540933|NCT01352741|3770093|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
1540934|NCT01352741|3770094|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
1540935|NCT01352741|3770093|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
1540936|NCT01352741|3770094|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
1540937|NCT01352741|3770093|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
1540938|NCT01352741|3770094|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
1540939|NCT01352741|3770093|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
1540940|NCT01352741|3770094|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
1540941|NCT01352741|3770093|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
1540942|NCT01352741|3770094|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
1540943|NCT01352741|3770093|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
1540944|NCT01352741|3770094|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
1540945|NCT01352741|3770093|P2|NOT COMPLETED|Double-blind Comparative Period||26
1540946|NCT01352741|3770094|P1|NOT COMPLETED|Double-blind Comparative Period||28
1540947|NCT01352741|3770093|P2|COMPLETED|Double-blind Comparative Period||133
1540948|NCT01352741|3770094|P1|COMPLETED|Double-blind Comparative Period||126
1540949|NCT01352741|3770093|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
1540950|NCT01352741|3770094|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
1540951|NCT01352741|3770093|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
1540952|NCT01352741|3770094|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
1540953|NCT01352741|3770093|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
1540954|NCT01352741|3770094|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
1540955|NCT01352741|3770093|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
1540956|NCT01352741|3770094|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
1540957|NCT01352741|3770093|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
1540958|NCT01352741|3770094|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
1540959|NCT01352741|3770093|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
1540960|NCT01352741|3770094|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
1540961|NCT01352741|3770093|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
1540962|NCT01352741|3770094|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
1540963|NCT01352741|3770093|P2|Per Protocol Set|Double-blind Comparative Period||149
1540964|NCT01352741|3770094|P1|Per Protocol Set|Double-blind Comparative Period||139
1540965|NCT01352741|3770093|P2|Major Protocol Deviations|Double-blind Comparative Period||8
1540966|NCT01352741|3770094|P1|Major Protocol Deviations|Double-blind Comparative Period||13
1540967|NCT01352741|3770093|P2|Full Analysis Set|Double-blind Comparative Period||157
1540968|NCT01352741|3770094|P1|Full Analysis Set|Double-blind Comparative Period||152
1540969|NCT01352741|3770093|P2|No Pain Assessments Available|Double-blind Comparative Period||2
1540970|NCT01352741|3770094|P1|No Pain Assessments Available|Double-blind Comparative Period||2
1540971|NCT01352741|3770093|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
1540972|NCT01352741|3770094|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
1540973|NCT01352741|3770093|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
1540974|NCT01352741|3770094|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
1540975|NCT01352741|3770093|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
1540976|NCT01352741|3770094|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
1540977|NCT01352741|3770093|P2|COMPLETED|Open-label Tapentadol Titration Period||0
1540978|NCT01352741|3770094|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
1540979|NCT01352741|3770093|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
1540980|NCT01352741|3770094|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
1540981|NCT01352741|3770093|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
1540982|NCT01352741|3770094|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
1541160|NCT01350999|3770564|P2|Treated|Overall Study||171
1540983|NCT01352741|3770093|P2|STARTED|Open-label Tapentadol Titration Period||0
1540984|NCT01352741|3770094|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
1540985|NCT01352715|3770188|P2|NOT COMPLETED|Overall Study||46
1540986|NCT01352715|3770189|P1|NOT COMPLETED|Overall Study||45
1540987|NCT01352715|3770188|P2|COMPLETED|Overall Study||209
1540988|NCT01352715|3770189|P1|COMPLETED|Overall Study||215
1540989|NCT01352715|3770188|P2|STARTED|Overall Study||255
1540990|NCT01352715|3770189|P1|STARTED|Overall Study||260
1540991|NCT01352585|3770211|P1|NOT COMPLETED|Overall Study||11
1540992|NCT01352585|3770211|P1|COMPLETED|Overall Study||36
1540993|NCT01352585|3770211|P1|STARTED|Overall Study||47
1540994|NCT01352546|3770222|P1|NOT COMPLETED|Overall Study||0
1540995|NCT01352546|3770222|P1|COMPLETED|Overall Study||31
1540996|NCT01352546|3770222|P1|STARTED|Overall Study||31
1540997|NCT01352507|3770228|P2|NOT COMPLETED|Extension Phase||0
1540998|NCT01352507|3770229|P1|NOT COMPLETED|Extension Phase||0
1540999|NCT01352507|3770228|P2|COMPLETED|Extension Phase||173
1541000|NCT01352507|3770229|P1|COMPLETED|Extension Phase||164
1541001|NCT01352507|3770228|P2|STARTED|Extension Phase||173
1541002|NCT01352507|3770229|P1|STARTED|Extension Phase||164
1541003|NCT01352507|3770228|P2|NOT COMPLETED|Treatment Period 2||3
1541004|NCT01352507|3770229|P1|NOT COMPLETED|Treatment Period 2||6
1541005|NCT01352507|3770228|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
1541006|NCT01352507|3770229|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
1541007|NCT01352507|3770228|P2|Received Treatment|Treatment Period 2||181
1541008|NCT01352507|3770229|P1|Received Treatment|Treatment Period 2||173
1541009|NCT01352507|3770228|P2|STARTED|Treatment Period 2||183
1541010|NCT01352507|3770229|P1|STARTED|Treatment Period 2||176
1541011|NCT01352507|3770228|P2|NOT COMPLETED|Washout Period||1
1541012|NCT01352507|3770229|P1|NOT COMPLETED|Washout Period||0
1541013|NCT01352507|3770228|P2|COMPLETED|Washout Period||183
1541014|NCT01352507|3770229|P1|COMPLETED|Washout Period||176
1541015|NCT01352507|3770228|P2|STARTED|Washout Period||184
1541016|NCT01352507|3770229|P1|STARTED|Washout Period||176
1541017|NCT01352507|3770228|P2|NOT COMPLETED|Treatment Period 1||9
1541018|NCT01352507|3770229|P1|NOT COMPLETED|Treatment Period 1||14
1541019|NCT01352507|3770228|P2|COMPLETED|Treatment Period 1||184
1541020|NCT01352507|3770229|P1|COMPLETED|Treatment Period 1||176
1541021|NCT01352507|3770228|P2|Received Treatment|Treatment Period 1||188
1541022|NCT01352507|3770229|P1|Received Treatment|Treatment Period 1||182
1541023|NCT01352507|3770228|P2|STARTED|Treatment Period 1||193
1541024|NCT01352507|3770229|P1|STARTED|Treatment Period 1||190
1541025|NCT01352468|3770262|P2|NOT COMPLETED|Overall Study||4
1541026|NCT01352468|3770263|P1|NOT COMPLETED|Overall Study||5
1541027|NCT01352468|3770262|P2|COMPLETED|Overall Study||18
1541028|NCT01352468|3770263|P1|COMPLETED|Overall Study||17
1541029|NCT01352468|3770262|P2|STARTED|Overall Study||22
1541030|NCT01352468|3770263|P1|STARTED|Overall Study||22
1541031|NCT01352442|3770273|P1|NOT COMPLETED|Overall Study||12
1541032|NCT01352442|3770273|P1|COMPLETED|Overall Study||139
1541033|NCT01352442|3770273|P1|STARTED|Overall Study||151
1541034|NCT01352416|3770282|P4|NOT COMPLETED|Overall Study||1
1541035|NCT01352416|3770283|P3|NOT COMPLETED|Overall Study||2
1541036|NCT01352416|3770284|P2|NOT COMPLETED|Overall Study||2
1541037|NCT01352416|3770285|P1|NOT COMPLETED|Overall Study||1
1541038|NCT01352416|3770282|P4|COMPLETED|Overall Study||1
1541039|NCT01352416|3770283|P3|COMPLETED|Overall Study||0
1541040|NCT01352416|3770284|P2|COMPLETED|Overall Study||5
1541041|NCT01352416|3770285|P1|COMPLETED|Overall Study||3
1541042|NCT01352416|3770282|P4|STARTED|Overall Study||2
1541043|NCT01352416|3770283|P3|STARTED|Overall Study||2
1541044|NCT01352416|3770284|P2|STARTED|Overall Study||7
1541045|NCT01352416|3770285|P1|STARTED|Overall Study||4
1541046|NCT01352221|3770297|P4|NOT COMPLETED|Open-label Phase||11
1541047|NCT01352221|3770298|P3|NOT COMPLETED|Open-label Phase||13
1541048|NCT01352221|3770299|P2|NOT COMPLETED|Open-label Phase||0
1541049|NCT01352221|3770300|P1|NOT COMPLETED|Open-label Phase||0
1541050|NCT01352221|3770297|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
1541051|NCT01352221|3770298|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
1541052|NCT01352221|3770299|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1541053|NCT01352221|3770300|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1541054|NCT01352221|3770297|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
1541055|NCT01352221|3770298|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
1541056|NCT01352221|3770299|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1541057|NCT01352221|3770300|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1541058|NCT01352221|3770297|P4|NOT COMPLETED|Double-blind Phase||0
1541059|NCT01352221|3770298|P3|NOT COMPLETED|Double-blind Phase||0
1541060|NCT01352221|3770299|P2|NOT COMPLETED|Double-blind Phase||11
1541061|NCT01352221|3770300|P1|NOT COMPLETED|Double-blind Phase||9
1541062|NCT01352221|3770297|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1541063|NCT01352221|3770298|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1541064|NCT01352221|3770299|P2|COMPLETED|Double-blind Phase||53
1541065|NCT01352221|3770300|P1|COMPLETED|Double-blind Phase||55
1541066|NCT01352221|3770297|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1541067|NCT01352221|3770298|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1541068|NCT01352221|3770299|P2|STARTED|Double-blind Phase||64
1541069|NCT01352221|3770300|P1|STARTED|Double-blind Phase||64
1541070|NCT01352117|3770360|P2|NOT COMPLETED|Overall Study||96
1541071|NCT01352117|3770361|P1|NOT COMPLETED|Overall Study||68
1541072|NCT01352117|3770360|P2|COMPLETED|Overall Study||0
1541073|NCT01352117|3770361|P1|COMPLETED|Overall Study||28
1541074|NCT01352117|3770360|P2|Study Week 96 Data Potential|Overall Study||61
1541075|NCT01352117|3770361|P1|Study Week 96 Data Potential|Overall Study||58
1541076|NCT01352117|3770360|P2|Study Week 48 Data Potential|Overall Study||83
1541077|NCT01352117|3770361|P1|Study Week 48 Data Potential|Overall Study||80
1541078|NCT01352117|3770360|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
1541079|NCT01352117|3770361|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
1541080|NCT01352117|3770360|P2|STARTED|Overall Study||96
1541081|NCT01352117|3770361|P1|STARTED|Overall Study||96
1541082|NCT01351740|3770415|P2|NOT COMPLETED|Overall Study||6
1541083|NCT01351740|3770416|P1|NOT COMPLETED|Overall Study||2
1541084|NCT01351740|3770415|P2|COMPLETED|Overall Study||19
1541085|NCT01351740|3770416|P1|COMPLETED|Overall Study||23
1541086|NCT01351740|3770415|P2|STARTED|Overall Study||25
1541087|NCT01351740|3770416|P1|STARTED|Overall Study||25
1541088|NCT01351623|3770424|P1|NOT COMPLETED|Overall Study||9
1541089|NCT01351623|3770424|P1|COMPLETED|Overall Study||35
1541090|NCT01351623|3770424|P1|STARTED|Overall Study||44
1541091|NCT01351506|3770430|P1|NOT COMPLETED|Overall Study||137
1541092|NCT01351506|3770430|P1|COMPLETED|Overall Study||465
1541093|NCT01351506|3770430|P1|STARTED|Overall Study||602
1541094|NCT01351480|3770440|P1|NOT COMPLETED|Overall Study||8
1541095|NCT01351480|3770440|P1|COMPLETED|Overall Study||26
1541096|NCT01351480|3770440|P1|STARTED|Overall Study||34
1541097|NCT01351415|3770450|P2|NOT COMPLETED|Overall Study||240
1541098|NCT01351415|3770451|P1|NOT COMPLETED|Overall Study||245
1541099|NCT01351415|3770450|P2|COMPLETED|Overall Study||0
1541100|NCT01351415|3770451|P1|COMPLETED|Overall Study||0
1541101|NCT01351415|3770450|P2|Treated Participants|Overall Study||232
1541102|NCT01351415|3770451|P1|Treated Participants|Overall Study||243
1541103|NCT01351415|3770450|P2|STARTED|Overall Study||240
1541104|NCT01351415|3770451|P1|STARTED|Overall Study||245
1541105|NCT01351337|3770471|P1|NOT COMPLETED|Overall Study||0
1541106|NCT01351337|3770471|P1|COMPLETED|Overall Study||58
1541107|NCT01351337|3770471|P1|STARTED|Overall Study||58
1541108|NCT01351090|3770480|P3|NOT COMPLETED|Overall Study||6
1541109|NCT01351090|3770481|P2|NOT COMPLETED|Overall Study||11
1541110|NCT01351090|3770482|P1|NOT COMPLETED|Overall Study||11
1541111|NCT01351090|3770480|P3|COMPLETED|Overall Study||36
1541112|NCT01351090|3770481|P2|COMPLETED|Overall Study||31
1541113|NCT01351090|3770482|P1|COMPLETED|Overall Study||32
1541114|NCT01351090|3770480|P3|STARTED|Overall Study||42
1541115|NCT01351090|3770481|P2|STARTED|Overall Study||42
1541116|NCT01351090|3770482|P1|STARTED|Overall Study||43
1541117|NCT01351077|3770501|P2|NOT COMPLETED|Overall Study||0
1541118|NCT01351077|3770502|P1|NOT COMPLETED|Overall Study||0
1541119|NCT01351077|3770501|P2|COMPLETED|Overall Study||180
1541120|NCT01351077|3770502|P1|COMPLETED|Overall Study||180
1541121|NCT01351077|3770501|P2|STARTED|Overall Study||180
1541122|NCT01351077|3770502|P1|STARTED|Overall Study||180
1541123|NCT01351064|3770518|P2|NOT COMPLETED|Overall Study||0
1541124|NCT01351064|3770519|P1|NOT COMPLETED|Overall Study||0
1541125|NCT01351064|3770518|P2|COMPLETED|Overall Study||42
1541126|NCT01351064|3770519|P1|COMPLETED|Overall Study||42
1541127|NCT01351064|3770518|P2|STARTED|Overall Study||42
1541128|NCT01351064|3770519|P1|STARTED|Overall Study||42
1541129|NCT01351025|3770529|P2|NOT COMPLETED|Week 44 - 48||0
1541130|NCT01351025|3770530|P1|NOT COMPLETED|Week 44 - 48||0
1541131|NCT01351025|3770529|P2|COMPLETED|Week 44 - 48||43
1541132|NCT01351025|3770530|P1|COMPLETED|Week 44 - 48||42
1541133|NCT01351025|3770529|P2|STARTED|Week 44 - 48||43
1541134|NCT01351025|3770530|P1|STARTED|Week 44 - 48||42
1541135|NCT01351025|3770529|P2|NOT COMPLETED|Week 24 - 44||4
1541136|NCT01351025|3770530|P1|NOT COMPLETED|Week 24 - 44||1
1541137|NCT01351025|3770529|P2|COMPLETED|Week 24 - 44||43
1541138|NCT01351025|3770530|P1|COMPLETED|Week 24 - 44||42
1541139|NCT01351025|3770529|P2|STARTED|Week 24 - 44||47
1541140|NCT01351025|3770530|P1|STARTED|Week 24 - 44||43
1541141|NCT01351025|3770529|P2|NOT COMPLETED|Week 20 - 24||0
1541142|NCT01351025|3770530|P1|NOT COMPLETED|Week 20 - 24||0
1541143|NCT01351025|3770529|P2|COMPLETED|Week 20 - 24||47
1541144|NCT01351025|3770530|P1|COMPLETED|Week 20 - 24||43
1541145|NCT01351025|3770529|P2|STARTED|Week 20 - 24||47
1541146|NCT01351025|3770530|P1|STARTED|Week 20 - 24||43
1541147|NCT01351025|3770529|P2|NOT COMPLETED|Week 0 - 20||1
1541148|NCT01351025|3770530|P1|NOT COMPLETED|Week 0 - 20||3
1541149|NCT01351025|3770529|P2|COMPLETED|Week 0 - 20||47
1541150|NCT01351025|3770530|P1|COMPLETED|Week 0 - 20||43
1541151|NCT01351025|3770529|P2|STARTED|Week 0 - 20||48
1541152|NCT01351025|3770530|P1|STARTED|Week 0 - 20||46
1541153|NCT01350999|3770563|P3|NOT COMPLETED|Overall Study||21
1541154|NCT01350999|3770564|P2|NOT COMPLETED|Overall Study||14
1541155|NCT01350999|3770565|P1|NOT COMPLETED|Overall Study||8
1541156|NCT01350999|3770563|P3|COMPLETED|Overall Study||146
1541157|NCT01350999|3770564|P2|COMPLETED|Overall Study||157
1541158|NCT01350999|3770565|P1|COMPLETED|Overall Study||157
1541159|NCT01350999|3770563|P3|Treated|Overall Study||167
1541161|NCT01350999|3770565|P1|Treated|Overall Study||165
1541162|NCT01350999|3770563|P3|STARTED|Overall Study||167
1541163|NCT01350999|3770564|P2|STARTED|Overall Study||171
1541164|NCT01350999|3770565|P1|STARTED|Overall Study||165
1541165|NCT01350973|3770603|P3|NOT COMPLETED|Overall Study||8
1541166|NCT01350973|3770604|P2|NOT COMPLETED|Overall Study||8
1541167|NCT01350973|3770605|P1|NOT COMPLETED|Overall Study||6
1541168|NCT01350973|3770603|P3|COMPLETED|Overall Study||187
1541169|NCT01350973|3770604|P2|COMPLETED|Overall Study||202
1541170|NCT01350973|3770605|P1|COMPLETED|Overall Study||200
1541171|NCT01350973|3770603|P3|Received Treatment|Overall Study||195
1541172|NCT01350973|3770604|P2|Received Treatment|Overall Study||210
1541173|NCT01350973|3770605|P1|Received Treatment|Overall Study||205
1541174|NCT01350973|3770603|P3|STARTED|Overall Study||195
1541175|NCT01350973|3770604|P2|STARTED|Overall Study||210
1541176|NCT01350973|3770605|P1|STARTED|Overall Study||206
1541177|NCT01350947|3770640|P1|NOT COMPLETED|Overall Study||0
1541178|NCT01350947|3770640|P1|COMPLETED|Overall Study||11
1541179|NCT01350947|3770640|P1|STARTED|Overall Study||11
1541180|NCT01350934|3770646|P2|NOT COMPLETED|Extension Study||4
1541181|NCT01350934|3770647|P1|NOT COMPLETED|Extension Study||5
1541182|NCT01350934|3770646|P2|COMPLETED|Extension Study||101
1541183|NCT01350934|3770647|P1|COMPLETED|Extension Study||95
1541184|NCT01350934|3770646|P2|STARTED|Extension Study||105
1541185|NCT01350934|3770647|P1|STARTED|Extension Study||100
1541186|NCT01350934|3770646|P2|NOT COMPLETED|Base Study||3
1541187|NCT01350934|3770647|P1|NOT COMPLETED|Base Study||11
1541188|NCT01350934|3770646|P2|COMPLETED|Base Study||105
1541189|NCT01350934|3770647|P1|COMPLETED|Base Study||100
1541190|NCT01350934|3770646|P2|STARTED|Base Study||108
1541191|NCT01350934|3770647|P1|STARTED|Base Study||111
1541192|NCT01350804|3770669|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
1541193|NCT01350804|3770670|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
1541194|NCT01350804|3770671|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
1541195|NCT01350804|3770672|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
1541196|NCT01350804|3770669|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
1541197|NCT01350804|3770670|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
1541198|NCT01350804|3770671|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
1541199|NCT01350804|3770672|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
1541200|NCT01350804|3770669|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
1541201|NCT01350804|3770670|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
1541202|NCT01350804|3770671|P2|STARTED|Extension Study, Weeks 52 - 260||79
1541203|NCT01350804|3770672|P1|STARTED|Extension Study, Weeks 52 - 260||80
1541204|NCT01350804|3770669|P4|NOT COMPLETED|Core Study||26
1541205|NCT01350804|3770670|P3|NOT COMPLETED|Core Study||47
1541206|NCT01350804|3770671|P2|NOT COMPLETED|Core Study||47
1541207|NCT01350804|3770672|P1|NOT COMPLETED|Core Study||41
1541208|NCT01350804|3770669|P4|COMPLETED|Core Study||112
1541209|NCT01350804|3770670|P3|COMPLETED|Core Study||91
1541210|NCT01350804|3770671|P2|COMPLETED|Core Study||90
1541211|NCT01350804|3770672|P1|COMPLETED|Core Study||97
1541212|NCT01350804|3770669|P4|Full Analysis Set|Core Study||138
1541213|NCT01350804|3770670|P3|Full Analysis Set|Core Study||138
1541214|NCT01350804|3770671|P2|Full Analysis Set|Core Study||137
1541215|NCT01350804|3770672|P1|Full Analysis Set|Core Study||138
1541216|NCT01350804|3770669|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
1541217|NCT01350804|3770670|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
1541218|NCT01350804|3770671|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
1541219|NCT01350804|3770672|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
1541220|NCT01350804|3770669|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
1541221|NCT01350804|3770670|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
1541222|NCT01350804|3770671|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
1541223|NCT01350804|3770672|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
1541224|NCT01350804|3770669|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
1541225|NCT01350804|3770670|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
1541226|NCT01350804|3770671|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
1541227|NCT01350804|3770672|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
1541228|NCT01350804|3770669|P4|STARTED|Core Study||138
1541229|NCT01350804|3770670|P3|STARTED|Core Study||138
1541230|NCT01350804|3770671|P2|STARTED|Core Study||137
1541231|NCT01350804|3770672|P1|STARTED|Core Study||138
1541232|NCT01350583|3770761|P1|NOT COMPLETED|Overall Study||0
1541233|NCT01350583|3770761|P1|COMPLETED|Overall Study||2
1541234|NCT01350583|3770761|P1|STARTED|Overall Study||2
1541235|NCT01350544|3770769|P2|NOT COMPLETED|Overall Study||22
1541236|NCT01350544|3770770|P1|NOT COMPLETED|Overall Study||23
1541237|NCT01350544|3770769|P2|COMPLETED|Overall Study||86
1541238|NCT01350544|3770770|P1|COMPLETED|Overall Study||85
1541239|NCT01350544|3770769|P2|STARTED|Overall Study||108
1541240|NCT01350544|3770770|P1|STARTED|Overall Study||108
1541241|NCT01350479|3770778|P2|NOT COMPLETED|Overall Study||0
1541242|NCT01350479|3770779|P1|NOT COMPLETED|Overall Study||0
1541243|NCT01350479|3770778|P2|COMPLETED|Overall Study||106
1541244|NCT01350479|3770779|P1|COMPLETED|Overall Study||94
1541245|NCT01350479|3770778|P2|STARTED|Overall Study||106
1541246|NCT01350479|3770779|P1|STARTED|Overall Study||94
1541247|NCT01350414|3770785|P1|NOT COMPLETED|Overall Study||19
1541248|NCT01350414|3770785|P1|COMPLETED|Overall Study||162
1541249|NCT01350414|3770785|P1|Year 5|Overall Study||162
1541250|NCT01350414|3770785|P1|Year 4|Overall Study||159
1541251|NCT01350414|3770785|P1|Year 3|Overall Study||162
1541252|NCT01350414|3770785|P1|Year 2|Overall Study||165
1541253|NCT01350414|3770785|P1|STARTED|Overall Study||181
1541254|NCT01350401|3770802|P1|NOT COMPLETED|Overall Study||0
1541255|NCT01350401|3770802|P1|COMPLETED|Overall Study||4
1541256|NCT01350401|3770802|P1|STARTED|Overall Study||4
1541257|NCT01350388|3770814|P2|NOT COMPLETED|Overall Study||1
1541258|NCT01350388|3770815|P1|NOT COMPLETED|Overall Study||3
1541259|NCT01350388|3770814|P2|COMPLETED|Overall Study||39
1541260|NCT01350388|3770815|P1|COMPLETED|Overall Study||37
1541261|NCT01350388|3770814|P2|STARTED|Overall Study||40
1541262|NCT01350388|3770815|P1|STARTED|Overall Study||40
1541263|NCT01350271|3770834|P3|NOT COMPLETED|Overall Study||26
1541264|NCT01350271|3770835|P2|NOT COMPLETED|Overall Study||17
1541265|NCT01350271|3770836|P1|NOT COMPLETED|Overall Study||21
1541266|NCT01350271|3770834|P3|COMPLETED|Overall Study||48
1541267|NCT01350271|3770835|P2|COMPLETED|Overall Study||53
1541268|NCT01350271|3770836|P1|COMPLETED|Overall Study||49
1541269|NCT01350271|3770834|P3|STARTED|Overall Study||74
1541270|NCT01350271|3770835|P2|STARTED|Overall Study||70
1541271|NCT01350271|3770836|P1|STARTED|Overall Study||70
1541272|NCT01350258|3770850|P1|NOT COMPLETED|Overall Study||0
1541273|NCT01350258|3770850|P1|COMPLETED|Overall Study||8
1541274|NCT01350258|3770850|P1|STARTED|Overall Study||8
1541275|NCT01350245|3770859|P1|NOT COMPLETED|Overall Study||0
1541276|NCT01350245|3770859|P1|COMPLETED|Overall Study||28
1541277|NCT01350245|3770859|P1|STARTED|Overall Study||28
1541278|NCT01350232|3770864|P1|NOT COMPLETED|Overall Study||0
1541279|NCT01350232|3770864|P1|COMPLETED|Overall Study||2
1541280|NCT01350232|3770864|P1|STARTED|Overall Study||2
1541281|NCT01350141|3770878|P3|NOT COMPLETED|Overall Study||1
1541282|NCT01350141|3770879|P2|NOT COMPLETED|Overall Study||0
1541283|NCT01350141|3770880|P1|NOT COMPLETED|Overall Study||3
1541284|NCT01350141|3770878|P3|COMPLETED|Overall Study||15
1541285|NCT01350141|3770879|P2|COMPLETED|Overall Study||15
1541286|NCT01350141|3770880|P1|COMPLETED|Overall Study||12
1541287|NCT01350141|3770878|P3|Treated|Overall Study||16
1541288|NCT01350141|3770879|P2|Treated|Overall Study||15
1541289|NCT01350141|3770880|P1|Treated|Overall Study||14
1541290|NCT01350141|3770878|P3|STARTED|Overall Study||16
1541291|NCT01350141|3770879|P2|STARTED|Overall Study||15
1541292|NCT01350141|3770880|P1|STARTED|Overall Study||15
1541293|NCT01350128|3770914|P1|NOT COMPLETED|Overall Study||14
1541294|NCT01350128|3770914|P1|COMPLETED|Overall Study||89
1541295|NCT01350128|3770914|P1|Atrovent HFA 34 µg BID|Overall Study||48
1541296|NCT01350128|3770914|P1|Placebo MDI BID|Overall Study||48
1541297|NCT01350128|3770914|P1|GP MDI 4.6 µg BID|Overall Study||45
1541298|NCT01350128|3770914|P1|GP MDI 9 µg BID|Overall Study||49
1541299|NCT01350128|3770914|P1|GP MDI 18 µg BID|Overall Study||49
1541300|NCT01350128|3770914|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
1541301|NCT01350128|3770914|P1|STARTED|Overall Study||103
1541302|NCT01350115|3770978|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
1541303|NCT01350115|3770979|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
1541304|NCT01350115|3770978|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
1541305|NCT01350115|3770979|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
1541306|NCT01350115|3770978|P2|STARTED|Long Term Follow-Up (All Patients)||2
1541307|NCT01350115|3770979|P1|STARTED|Long Term Follow-Up (All Patients)||8
1541308|NCT01350115|3770978|P2|NOT COMPLETED|Core Study (All Patients)||0
1541309|NCT01350115|3770979|P1|NOT COMPLETED|Core Study (All Patients)||0
1541310|NCT01350115|3770978|P2|COMPLETED|Core Study (All Patients)||2
1541311|NCT01350115|3770979|P1|COMPLETED|Core Study (All Patients)||8
1541312|NCT01350115|3770978|P2|Pharmacodynamic Set|Core Study (All Patients)||2
1541313|NCT01350115|3770979|P1|Pharmacodynamic Set|Core Study (All Patients)||7
1541314|NCT01350115|3770978|P2|Safety Anlysis Set|Core Study (All Patients)||2
1541315|NCT01350115|3770979|P1|Safety Anlysis Set|Core Study (All Patients)||8
1541316|NCT01350115|3770978|P2|STARTED|Core Study (All Patients)||2
1541317|NCT01350115|3770979|P1|STARTED|Core Study (All Patients)||8
1541318|NCT01350102|3770995|P4|NOT COMPLETED|Overall Study||0
1541319|NCT01350102|3770996|P3|NOT COMPLETED|Overall Study||1
1541320|NCT01350102|3770997|P2|NOT COMPLETED|Overall Study||0
1541321|NCT01350102|3770998|P1|NOT COMPLETED|Overall Study||0
1541322|NCT01350102|3770995|P4|COMPLETED|Overall Study||0
1541323|NCT01350102|3770996|P3|COMPLETED|Overall Study||0
1541324|NCT01350102|3770997|P2|COMPLETED|Overall Study||1
1541325|NCT01350102|3770998|P1|COMPLETED|Overall Study||0
1541326|NCT01350102|3770995|P4|STARTED|Overall Study||0
1541327|NCT01350102|3770996|P3|STARTED|Overall Study||1
1541328|NCT01350102|3770997|P2|STARTED|Overall Study||1
1541329|NCT01350102|3770998|P1|STARTED|Overall Study||0
1541330|NCT01349972|3771018|P2|NOT COMPLETED|Overall Study||2
1541331|NCT01349972|3771019|P1|NOT COMPLETED|Overall Study||5
1541332|NCT01349972|3771018|P2|COMPLETED|Overall Study||56
1541333|NCT01349972|3771019|P1|COMPLETED|Overall Study||109
1541334|NCT01349972|3771018|P2|STARTED|Overall Study||58
1541335|NCT01349972|3771019|P1|STARTED|Overall Study||114
1541336|NCT01349959|3771035|P1|NOT COMPLETED|Overall Study||7
1541337|NCT01349959|3771035|P1|COMPLETED|Overall Study||33
1541338|NCT01349959|3771035|P1|STARTED|Overall Study|58 consented, 18 failed screening and did not receive study treatment|40
1541339|NCT01349933|3771041|P1|NOT COMPLETED|Overall Study||0
1541340|NCT01349933|3771041|P1|COMPLETED|Overall Study||21
1541341|NCT01349933|3771041|P1|STARTED|Overall Study||21
1541342|NCT01349920|3771051|P1|NOT COMPLETED|Overall Study||0
1541343|NCT01349920|3771051|P1|COMPLETED|Overall Study||15
1541344|NCT01349920|3771051|P1|STARTED|Overall Study||15
1541345|NCT01349907|3771071|P2|NOT COMPLETED|Overall Study||43
1541346|NCT01349907|3771072|P1|NOT COMPLETED|Overall Study||139
1541347|NCT01349907|3771071|P2|COMPLETED|Overall Study||38
1541348|NCT01349907|3771072|P1|COMPLETED|Overall Study||102
1541349|NCT01349907|3771071|P2|STARTED|Overall Study|Enrolled and Treated|81
1541350|NCT01349907|3771072|P1|STARTED|Overall Study|Enrolled and Treated|241
1541351|NCT01349829|3771110|P2|NOT COMPLETED|Overall Study||23
1541352|NCT01349829|3771111|P1|NOT COMPLETED|Overall Study||9
1541353|NCT01349829|3771110|P2|COMPLETED|Overall Study||102
1541354|NCT01349829|3771111|P1|COMPLETED|Overall Study||117
1541355|NCT01349829|3771110|P2|STARTED|Overall Study||125
1541356|NCT01349829|3771111|P1|STARTED|Overall Study||126
1541357|NCT01349816|3771129|P1|NOT COMPLETED|Overall Study||30
1541358|NCT01349816|3771129|P1|COMPLETED|Overall Study||155
1541359|NCT01349816|3771129|P1|FF MDI 9.6 µg|Overall Study||61
1541360|NCT01349816|3771129|P1|GFF MDI 9/9.6 µg|Overall Study||57
1541361|NCT01349816|3771129|P1|GFF MDI 18/9.6 µg|Overall Study||57
1541362|NCT01349816|3771129|P1|GFF MDI 36/9.6 µg|Overall Study||56
1541363|NCT01349816|3771129|P1|GFF MDI 36/7.2 µg|Overall Study||58
1541364|NCT01349816|3771129|P1|GP MDI 36 µg|Overall Study||61
1541365|NCT01349816|3771129|P1|STARTED|Overall Study||185
1541366|NCT01349803|3771195|P4|NOT COMPLETED|Overall Study||2
1541367|NCT01349803|3771196|P3|NOT COMPLETED|Overall Study||3
1541368|NCT01349803|3771197|P2|NOT COMPLETED|Overall Study||1
1541369|NCT01349803|3771198|P1|NOT COMPLETED|Overall Study||1
1541370|NCT01349803|3771195|P4|COMPLETED|Overall Study||57
1541371|NCT01349803|3771196|P3|COMPLETED|Overall Study||57
1541372|NCT01349803|3771197|P2|COMPLETED|Overall Study||57
1541373|NCT01349803|3771198|P1|COMPLETED|Overall Study||59
1541374|NCT01349803|3771195|P4|STARTED|Overall Study||59
1541375|NCT01349803|3771196|P3|STARTED|Overall Study||60
1541376|NCT01349803|3771197|P2|STARTED|Overall Study||58
1541377|NCT01349803|3771198|P1|STARTED|Overall Study||60
1541378|NCT01349790|3771268|P1|NOT COMPLETED|Overall Study||9
1541379|NCT01349790|3771268|P1|COMPLETED|Overall Study||31
1541380|NCT01349790|3771268|P1|STARTED|Overall Study||40
1541381|NCT01349660|3771290|P3|NOT COMPLETED|Overall Study||76
1541382|NCT01349660|3771291|P2|NOT COMPLETED|Overall Study||6
1541383|NCT01349660|3771292|P1|NOT COMPLETED|Overall Study||6
1541384|NCT01349660|3771290|P3|COMPLETED|Overall Study||0
1541385|NCT01349660|3771291|P2|COMPLETED|Overall Study||0
1541386|NCT01349660|3771292|P1|COMPLETED|Overall Study||0
1541387|NCT01349660|3771290|P3|STARTED|Overall Study||76
1541388|NCT01349660|3771291|P2|STARTED|Overall Study||6
1541389|NCT01349660|3771292|P1|STARTED|Overall Study||6
1541390|NCT01349595|3771310|P2|NOT COMPLETED|Overall Study||2
1541391|NCT01349595|3771311|P1|NOT COMPLETED|Overall Study||2
1541392|NCT01349595|3771310|P2|COMPLETED|Overall Study||0
1541393|NCT01349595|3771311|P1|COMPLETED|Overall Study||0
1541394|NCT01349595|3771310|P2|STARTED|Overall Study||2
1541395|NCT01349595|3771311|P1|STARTED|Overall Study||2
1541396|NCT01349491|3771319|P2|NOT COMPLETED|Overall Study||0
1541397|NCT01349491|3771320|P1|NOT COMPLETED|Overall Study||0
1541398|NCT01349491|3771319|P2|COMPLETED|Overall Study||5
1541399|NCT01349491|3771320|P1|COMPLETED|Overall Study||5
1541400|NCT01349491|3771319|P2|STARTED|Overall Study||5
1541401|NCT01349491|3771320|P1|STARTED|Overall Study||5
1541402|NCT01349465|3771328|P2|NOT COMPLETED|Overall Study||22
1541403|NCT01349465|3771329|P1|NOT COMPLETED|Overall Study||18
1541404|NCT01349465|3771328|P2|COMPLETED|Overall Study||27
1541405|NCT01349465|3771329|P1|COMPLETED|Overall Study||182
1541406|NCT01349465|3771328|P2|STARTED|Overall Study||49
1541407|NCT01349465|3771329|P1|STARTED|Overall Study||200
1541408|NCT01349231|3771341|P1|NOT COMPLETED|Overall Study||0
1541409|NCT01349231|3771341|P1|COMPLETED|Overall Study||10
1541410|NCT01349231|3771341|P1|STARTED|Overall Study||10
1541411|NCT01349192|3771350|P2|NOT COMPLETED|Overall Study||6
1541412|NCT01349192|3771351|P1|NOT COMPLETED|Overall Study||3
1541413|NCT01349192|3771350|P2|COMPLETED|Overall Study||17
1541414|NCT01349192|3771351|P1|COMPLETED|Overall Study||21
1541415|NCT01349192|3771350|P2|Withdrawals|Overall Study||6
1541416|NCT01349192|3771351|P1|Withdrawals|Overall Study||3
1541417|NCT01349192|3771350|P2|Evaluable for Primary Endpoint|Overall Study||19
1541418|NCT01349192|3771351|P1|Evaluable for Primary Endpoint|Overall Study||22
1541419|NCT01349192|3771350|P2|STARTED|Overall Study||23
1541420|NCT01349192|3771351|P1|STARTED|Overall Study||24
1541421|NCT01349114|3771365|P2|NOT COMPLETED|Overall Study||0
1541422|NCT01349114|3771366|P1|NOT COMPLETED|Overall Study||0
1541423|NCT01349114|3771365|P2|COMPLETED|Overall Study||11
1541424|NCT01349114|3771366|P1|COMPLETED|Overall Study||10
1541425|NCT01349114|3771365|P2|STARTED|Overall Study||11
1541426|NCT01349114|3771366|P1|STARTED|Overall Study||10
1541427|NCT01348854|3771376|P2|NOT COMPLETED|Overall Study||1
1541428|NCT01348854|3771377|P1|NOT COMPLETED|Overall Study||3
1541429|NCT01348854|3771376|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
1541430|NCT01348854|3771377|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
1541431|NCT01348854|3771376|P2|STARTED|Overall Study|10 eyes of 6 participants|6
1541432|NCT01348854|3771377|P1|STARTED|Overall Study|53 eyes of 34 participants|34
1541433|NCT01348789|3771385|P1|NOT COMPLETED|Overall Study||4
1541434|NCT01348789|3771385|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
1541435|NCT01348789|3771385|P1|STARTED|Overall Study||37
1541436|NCT01348776|3771396|P1|NOT COMPLETED|Overall Study||3
1541437|NCT01348776|3771396|P1|COMPLETED|Overall Study||84
1541438|NCT01348776|3771396|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
1541439|NCT01348698|3771409|P1|NOT COMPLETED|Overall Study||72
1541440|NCT01348698|3771409|P1|COMPLETED|Overall Study||2
1541441|NCT01348698|3771409|P1|STARTED|Overall Study||74
1541442|NCT01348607|3771419|P3|NOT COMPLETED|Overall Study||0
1541443|NCT01348607|3771420|P2|NOT COMPLETED|Overall Study||0
1541444|NCT01348607|3771421|P1|NOT COMPLETED|Overall Study||0
1541445|NCT01348607|3771419|P3|COMPLETED|Overall Study||0
1541446|NCT01348607|3771420|P2|COMPLETED|Overall Study||0
1541447|NCT01348607|3771421|P1|COMPLETED|Overall Study||1
1541448|NCT01348607|3771419|P3|STARTED|Overall Study||0
1541449|NCT01348607|3771420|P2|STARTED|Overall Study||0
1541450|NCT01348607|3771421|P1|STARTED|Overall Study||1
1541451|NCT01348425|3771434|P2|NOT COMPLETED|Overall Study||1
1541452|NCT01348425|3771435|P1|NOT COMPLETED|Overall Study||1
1541453|NCT01348425|3771434|P2|COMPLETED|Overall Study||13
1541454|NCT01348425|3771435|P1|COMPLETED|Overall Study||30
1541455|NCT01348425|3771434|P2|STARTED|Overall Study||14
1541456|NCT01348425|3771435|P1|STARTED|Overall Study||31
1541457|NCT01348347|3771443|P3|NOT COMPLETED|Overall Study||6
1541458|NCT01348347|3771444|P2|NOT COMPLETED|Overall Study||6
1541459|NCT01348347|3771445|P1|NOT COMPLETED|Overall Study||3
1541460|NCT01348347|3771443|P3|COMPLETED|Overall Study||0
1541461|NCT01348347|3771444|P2|COMPLETED|Overall Study||0
1541462|NCT01348347|3771445|P1|COMPLETED|Overall Study||0
1541463|NCT01348347|3771443|P3|STARTED|Overall Study||6
1541464|NCT01348347|3771444|P2|STARTED|Overall Study||6
1541465|NCT01348347|3771445|P1|STARTED|Overall Study||3
1541466|NCT01348165|3771476|P7|NOT COMPLETED|Overall Study||1
1541467|NCT01348165|3771477|P6|NOT COMPLETED|Overall Study||0
1541468|NCT01348165|3771478|P5|NOT COMPLETED|Overall Study||0
1541469|NCT01348165|3771479|P4|NOT COMPLETED|Overall Study||0
1541470|NCT01348165|3771480|P3|NOT COMPLETED|Overall Study||0
1541471|NCT01348165|3771481|P2|NOT COMPLETED|Overall Study||0
1541472|NCT01348165|3771482|P1|NOT COMPLETED|Overall Study||0
1541473|NCT01348165|3771476|P7|COMPLETED|Overall Study||5
1541474|NCT01348165|3771477|P6|COMPLETED|Overall Study||1
1541475|NCT01348165|3771478|P5|COMPLETED|Overall Study||6
1541476|NCT01348165|3771479|P4|COMPLETED|Overall Study||6
1541477|NCT01348165|3771480|P3|COMPLETED|Overall Study||6
1541478|NCT01348165|3771481|P2|COMPLETED|Overall Study||5
1541479|NCT01348165|3771482|P1|COMPLETED|Overall Study||10
1541480|NCT01348165|3771476|P7|STARTED|Overall Study||6
1541481|NCT01348165|3771477|P6|STARTED|Overall Study||1
1541482|NCT01348165|3771478|P5|STARTED|Overall Study||6
1541483|NCT01348165|3771479|P4|STARTED|Overall Study||6
1541484|NCT01348165|3771480|P3|STARTED|Overall Study||6
1541485|NCT01348165|3771481|P2|STARTED|Overall Study||5
1541486|NCT01348165|3771482|P1|STARTED|Overall Study||10
1541487|NCT01348139|3771611|P6|NOT COMPLETED|Period 6||0
1541488|NCT01348139|3771612|P5|NOT COMPLETED|Period 6||0
1541489|NCT01348139|3771613|P4|NOT COMPLETED|Period 6||0
1541490|NCT01348139|3771614|P3|NOT COMPLETED|Period 6||0
1541491|NCT01348139|3771615|P2|NOT COMPLETED|Period 6||0
1541492|NCT01348139|3771616|P1|NOT COMPLETED|Period 6||0
1541493|NCT01348139|3771611|P6|COMPLETED|Period 6||4
1541494|NCT01348139|3771612|P5|COMPLETED|Period 6||5
1541495|NCT01348139|3771613|P4|COMPLETED|Period 6||4
1541496|NCT01348139|3771614|P3|COMPLETED|Period 6||4
1541497|NCT01348139|3771615|P2|COMPLETED|Period 6||4
1541498|NCT01348139|3771616|P1|COMPLETED|Period 6||4
1541499|NCT01348139|3771611|P6|STARTED|Period 6||4
1541500|NCT01348139|3771612|P5|STARTED|Period 6||5
1541501|NCT01348139|3771613|P4|STARTED|Period 6||4
1541502|NCT01348139|3771614|P3|STARTED|Period 6||4
1541503|NCT01348139|3771615|P2|STARTED|Period 6||4
1541504|NCT01348139|3771616|P1|STARTED|Period 6||4
1541505|NCT01348139|3771611|P6|NOT COMPLETED|Period 5||0
1541506|NCT01348139|3771612|P5|NOT COMPLETED|Period 5||0
1541507|NCT01348139|3771613|P4|NOT COMPLETED|Period 5||0
1541508|NCT01348139|3771614|P3|NOT COMPLETED|Period 5||0
1541509|NCT01348139|3771615|P2|NOT COMPLETED|Period 5||0
1541510|NCT01348139|3771616|P1|NOT COMPLETED|Period 5||0
1541511|NCT01348139|3771611|P6|COMPLETED|Period 5||4
1541512|NCT01348139|3771612|P5|COMPLETED|Period 5||5
1541513|NCT01348139|3771613|P4|COMPLETED|Period 5||4
1541514|NCT01348139|3771614|P3|COMPLETED|Period 5||4
1541515|NCT01348139|3771615|P2|COMPLETED|Period 5||4
1541516|NCT01348139|3771616|P1|COMPLETED|Period 5||4
1541517|NCT01348139|3771611|P6|STARTED|Period 5||4
1541518|NCT01348139|3771612|P5|STARTED|Period 5||5
1541519|NCT01348139|3771613|P4|STARTED|Period 5||4
1541520|NCT01348139|3771614|P3|STARTED|Period 5||4
1541521|NCT01348139|3771615|P2|STARTED|Period 5||4
1541522|NCT01348139|3771616|P1|STARTED|Period 5||4
1541523|NCT01348139|3771611|P6|NOT COMPLETED|Period 4||0
1541524|NCT01348139|3771612|P5|NOT COMPLETED|Period 4||0
1541525|NCT01348139|3771613|P4|NOT COMPLETED|Period 4||0
1541526|NCT01348139|3771614|P3|NOT COMPLETED|Period 4||0
1541527|NCT01348139|3771615|P2|NOT COMPLETED|Period 4||0
1541528|NCT01348139|3771616|P1|NOT COMPLETED|Period 4||0
1541529|NCT01348139|3771611|P6|COMPLETED|Period 4||4
1541530|NCT01348139|3771612|P5|COMPLETED|Period 4||5
1541531|NCT01348139|3771613|P4|COMPLETED|Period 4||4
1541532|NCT01348139|3771614|P3|COMPLETED|Period 4||4
1541533|NCT01348139|3771615|P2|COMPLETED|Period 4||4
1541534|NCT01348139|3771616|P1|COMPLETED|Period 4||4
1541535|NCT01348139|3771611|P6|STARTED|Period 4||4
1541536|NCT01348139|3771612|P5|STARTED|Period 4||5
1541537|NCT01348139|3771613|P4|STARTED|Period 4||4
1541538|NCT01348139|3771614|P3|STARTED|Period 4||4
1541539|NCT01348139|3771615|P2|STARTED|Period 4||4
1541540|NCT01348139|3771616|P1|STARTED|Period 4||4
1541541|NCT01348139|3771611|P6|NOT COMPLETED|Period 3||0
1541542|NCT01348139|3771612|P5|NOT COMPLETED|Period 3||0
1541543|NCT01348139|3771613|P4|NOT COMPLETED|Period 3||0
1541544|NCT01348139|3771614|P3|NOT COMPLETED|Period 3||0
1541545|NCT01348139|3771615|P2|NOT COMPLETED|Period 3||0
1541546|NCT01348139|3771616|P1|NOT COMPLETED|Period 3||0
1541547|NCT01348139|3771611|P6|COMPLETED|Period 3||4
1541548|NCT01348139|3771612|P5|COMPLETED|Period 3||5
1541549|NCT01348139|3771613|P4|COMPLETED|Period 3||4
1541550|NCT01348139|3771614|P3|COMPLETED|Period 3||4
1541551|NCT01348139|3771615|P2|COMPLETED|Period 3||4
1541552|NCT01348139|3771616|P1|COMPLETED|Period 3||4
1541553|NCT01348139|3771611|P6|STARTED|Period 3||4
1541554|NCT01348139|3771612|P5|STARTED|Period 3||5
1541555|NCT01348139|3771613|P4|STARTED|Period 3||4
1541556|NCT01348139|3771614|P3|STARTED|Period 3||4
1541557|NCT01348139|3771615|P2|STARTED|Period 3||4
1541558|NCT01348139|3771616|P1|STARTED|Period 3||4
1541559|NCT01348139|3771611|P6|NOT COMPLETED|Period 2||0
1541560|NCT01348139|3771612|P5|NOT COMPLETED|Period 2||0
1541561|NCT01348139|3771613|P4|NOT COMPLETED|Period 2||0
1541562|NCT01348139|3771614|P3|NOT COMPLETED|Period 2||0
1541563|NCT01348139|3771615|P2|NOT COMPLETED|Period 2||0
1541564|NCT01348139|3771616|P1|NOT COMPLETED|Period 2||0
1541565|NCT01348139|3771611|P6|COMPLETED|Period 2||4
1541566|NCT01348139|3771612|P5|COMPLETED|Period 2||5
1541567|NCT01348139|3771613|P4|COMPLETED|Period 2||4
1541568|NCT01348139|3771614|P3|COMPLETED|Period 2||4
1541569|NCT01348139|3771615|P2|COMPLETED|Period 2||4
1541570|NCT01348139|3771616|P1|COMPLETED|Period 2||4
1541571|NCT01348139|3771611|P6|STARTED|Period 2||4
1541572|NCT01348139|3771612|P5|STARTED|Period 2||5
1541573|NCT01348139|3771613|P4|STARTED|Period 2||4
1541574|NCT01348139|3771614|P3|STARTED|Period 2||4
1541575|NCT01348139|3771615|P2|STARTED|Period 2||4
1541576|NCT01348139|3771616|P1|STARTED|Period 2||4
1541577|NCT01348139|3771611|P6|NOT COMPLETED|Period 1||0
1541578|NCT01348139|3771612|P5|NOT COMPLETED|Period 1||0
1541579|NCT01348139|3771613|P4|NOT COMPLETED|Period 1||0
1541580|NCT01348139|3771614|P3|NOT COMPLETED|Period 1||0
1541581|NCT01348139|3771615|P2|NOT COMPLETED|Period 1||0
1541582|NCT01348139|3771616|P1|NOT COMPLETED|Period 1||1
1541583|NCT01348139|3771611|P6|COMPLETED|Period 1||4
1541584|NCT01348139|3771612|P5|COMPLETED|Period 1||5
1541585|NCT01348139|3771613|P4|COMPLETED|Period 1||4
1541586|NCT01348139|3771614|P3|COMPLETED|Period 1||4
1541587|NCT01348139|3771615|P2|COMPLETED|Period 1||4
1541588|NCT01348139|3771616|P1|COMPLETED|Period 1||4
1541589|NCT01348139|3771611|P6|STARTED|Period 1||4
1541590|NCT01348139|3771612|P5|STARTED|Period 1||5
1541591|NCT01348139|3771613|P4|STARTED|Period 1||4
1541592|NCT01348139|3771614|P3|STARTED|Period 1||4
1541593|NCT01348139|3771615|P2|STARTED|Period 1||4
1541594|NCT01348139|3771616|P1|STARTED|Period 1||5
1541595|NCT01348100|3771697|P7|NOT COMPLETED|Overall Study||3
1541596|NCT01348100|3771698|P6|NOT COMPLETED|Overall Study||2
1541597|NCT01348100|3771699|P5|NOT COMPLETED|Overall Study||1
1541598|NCT01348100|3771700|P4|NOT COMPLETED|Overall Study||1
1541599|NCT01348100|3771701|P3|NOT COMPLETED|Overall Study||2
1541600|NCT01348100|3771702|P2|NOT COMPLETED|Overall Study||0
1541601|NCT01348100|3771703|P1|NOT COMPLETED|Overall Study||0
1541602|NCT01348100|3771697|P7|COMPLETED|Overall Study||13
1541603|NCT01348100|3771698|P6|COMPLETED|Overall Study||14
1541604|NCT01348100|3771699|P5|COMPLETED|Overall Study||14
1541605|NCT01348100|3771700|P4|COMPLETED|Overall Study||14
1541606|NCT01348100|3771701|P3|COMPLETED|Overall Study||13
1541607|NCT01348100|3771702|P2|COMPLETED|Overall Study||2
1541608|NCT01348100|3771703|P1|COMPLETED|Overall Study||2
1541609|NCT01348100|3771697|P7|STARTED|Overall Study||16
1541610|NCT01348100|3771698|P6|STARTED|Overall Study||16
1541611|NCT01348100|3771699|P5|STARTED|Overall Study||15
1541612|NCT01348100|3771700|P4|STARTED|Overall Study||15
1541613|NCT01348100|3771701|P3|STARTED|Overall Study||15
1541614|NCT01348100|3771702|P2|STARTED|Overall Study||2
1541615|NCT01348100|3771703|P1|STARTED|Overall Study||2
1541616|NCT01348087|3771748|P1|NOT COMPLETED|Overall Study||148
1541617|NCT01348087|3771748|P1|COMPLETED|Overall Study||0
1541618|NCT01348087|3771748|P1|STARTED|Overall Study||148
1541619|NCT01347931|3771762|P1|NOT COMPLETED|NIOV System||0
1541620|NCT01347931|3771762|P1|COMPLETED|NIOV System||29
1541621|NCT01347931|3771762|P1|STARTED|NIOV System||29
1541622|NCT01347931|3771762|P1|NOT COMPLETED|Standard Oxygen Therapy||1
1541623|NCT01347931|3771762|P1|COMPLETED|Standard Oxygen Therapy||29
1541624|NCT01347931|3771762|P1|STARTED|Standard Oxygen Therapy||30
1541625|NCT01347879|3771774|P2|NOT COMPLETED|Overall Study||17
1541626|NCT01347879|3771775|P1|NOT COMPLETED|Overall Study||7
1541627|NCT01347879|3771774|P2|COMPLETED|Overall Study||83
1541628|NCT01347879|3771775|P1|COMPLETED|Overall Study||46
1541629|NCT01347879|3771774|P2|STARTED|Overall Study||100
1541630|NCT01347879|3771775|P1|STARTED|Overall Study||53
1541631|NCT01347866|3771824|P17|NOT COMPLETED|Overall Study||2
1541632|NCT01347866|3771825|P16|NOT COMPLETED|Overall Study||4
1541633|NCT01347866|3771826|P15|NOT COMPLETED|Overall Study||3
1541634|NCT01347866|3771827|P14|NOT COMPLETED|Overall Study||7
1541635|NCT01347866|3771828|P13|NOT COMPLETED|Overall Study||7
1541636|NCT01347866|3771829|P12|NOT COMPLETED|Overall Study||4
1541637|NCT01347866|3771830|P11|NOT COMPLETED|Overall Study||3
1541638|NCT01347866|3771831|P10|NOT COMPLETED|Overall Study||7
1541639|NCT01347866|3771832|P9|NOT COMPLETED|Overall Study||31
1541640|NCT01347866|3771833|P8|NOT COMPLETED|Overall Study||4
1541641|NCT01347866|3771834|P7|NOT COMPLETED|Overall Study||6
1541642|NCT01347866|3771835|P6|NOT COMPLETED|Overall Study||3
1541643|NCT01347866|3771836|P5|NOT COMPLETED|Overall Study||7
1541644|NCT01347866|3771837|P4|NOT COMPLETED|Overall Study||7
1541645|NCT01347866|3771838|P3|NOT COMPLETED|Overall Study||1
1541646|NCT01347866|3771839|P2|NOT COMPLETED|Overall Study||1
1541647|NCT01347866|3771840|P1|NOT COMPLETED|Overall Study||5
1541648|NCT01347866|3771824|P17|COMPLETED|Overall Study||0
1541649|NCT01347866|3771825|P16|COMPLETED|Overall Study||0
1541650|NCT01347866|3771826|P15|COMPLETED|Overall Study||0
1541651|NCT01347866|3771827|P14|COMPLETED|Overall Study||0
1541652|NCT01347866|3771828|P13|COMPLETED|Overall Study||0
1541653|NCT01347866|3771829|P12|COMPLETED|Overall Study||0
1541654|NCT01347866|3771830|P11|COMPLETED|Overall Study||0
1541655|NCT01347866|3771831|P10|COMPLETED|Overall Study||0
1541656|NCT01347866|3771832|P9|COMPLETED|Overall Study||0
1541657|NCT01347866|3771833|P8|COMPLETED|Overall Study||0
1541658|NCT01347866|3771834|P7|COMPLETED|Overall Study||0
1541659|NCT01347866|3771835|P6|COMPLETED|Overall Study||0
1541660|NCT01347866|3771836|P5|COMPLETED|Overall Study||0
1541661|NCT01347866|3771837|P4|COMPLETED|Overall Study||0
1541662|NCT01347866|3771838|P3|COMPLETED|Overall Study||0
1541663|NCT01347866|3771839|P2|COMPLETED|Overall Study||0
1541664|NCT01347866|3771840|P1|COMPLETED|Overall Study||0
1541665|NCT01347866|3771824|P17|STARTED|Overall Study||2
1541666|NCT01347866|3771825|P16|STARTED|Overall Study||4
1541667|NCT01347866|3771826|P15|STARTED|Overall Study||3
1541668|NCT01347866|3771827|P14|STARTED|Overall Study||7
1541669|NCT01347866|3771828|P13|STARTED|Overall Study||7
1541670|NCT01347866|3771829|P12|STARTED|Overall Study||4
1541671|NCT01347866|3771830|P11|STARTED|Overall Study||3
1541672|NCT01347866|3771831|P10|STARTED|Overall Study||7
1541673|NCT01347866|3771832|P9|STARTED|Overall Study||31
1541674|NCT01347866|3771833|P8|STARTED|Overall Study||4
1541675|NCT01347866|3771834|P7|STARTED|Overall Study||6
1541676|NCT01347866|3771835|P6|STARTED|Overall Study||3
1541677|NCT01347866|3771836|P5|STARTED|Overall Study||7
1541678|NCT01347866|3771837|P4|STARTED|Overall Study||7
1541679|NCT01347866|3771838|P3|STARTED|Overall Study||1
1541680|NCT01347866|3771839|P2|STARTED|Overall Study||1
1541681|NCT01347866|3771840|P1|STARTED|Overall Study||5
1541682|NCT01347840|3772214|P1|NOT COMPLETED|Overall Study||1
1541683|NCT01347840|3772214|P1|COMPLETED|Overall Study||0
1541684|NCT01347840|3772214|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
1541685|NCT01347788|3772227|P3|NOT COMPLETED|Overall Study||0
1541686|NCT01347788|3772228|P2|NOT COMPLETED|Overall Study||0
1541687|NCT01347788|3772229|P1|NOT COMPLETED|Overall Study||0
1541688|NCT01347788|3772227|P3|COMPLETED|Overall Study||13
1541689|NCT01347788|3772228|P2|COMPLETED|Overall Study||10
1541690|NCT01347788|3772229|P1|COMPLETED|Overall Study||11
1541691|NCT01347788|3772227|P3|STARTED|Overall Study||13
1541692|NCT01347788|3772228|P2|STARTED|Overall Study||10
1541693|NCT01347788|3772229|P1|STARTED|Overall Study||11
1541694|NCT01347762|3772241|P4|NOT COMPLETED|Overall Study||8
1541695|NCT01347762|3772242|P3|NOT COMPLETED|Overall Study||9
1541696|NCT01347762|3772243|P2|NOT COMPLETED|Overall Study||2
1541697|NCT01347762|3772244|P1|NOT COMPLETED|Overall Study||4
1541698|NCT01347762|3772241|P4|COMPLETED|Overall Study||10
1541699|NCT01347762|3772242|P3|COMPLETED|Overall Study||7
1541700|NCT01347762|3772243|P2|COMPLETED|Overall Study||6
1541701|NCT01347762|3772244|P1|COMPLETED|Overall Study||6
1541702|NCT01347762|3772241|P4|STARTED|Overall Study||18
1541703|NCT01347762|3772242|P3|STARTED|Overall Study||16
1541704|NCT01347762|3772243|P2|STARTED|Overall Study||8
1541705|NCT01347762|3772244|P1|STARTED|Overall Study||10
1541706|NCT01347710|3772270|P1|NOT COMPLETED|Overall Study||31
1541707|NCT01347710|3772270|P1|COMPLETED|Overall Study||764
1541708|NCT01347710|3772270|P1|STARTED|Overall Study||795
1541709|NCT01347632|3772285|P1|NOT COMPLETED|Overall Study||2
1541710|NCT01347632|3772285|P1|COMPLETED|Overall Study||33
1541711|NCT01347632|3772285|P1|STARTED|Overall Study||35
1541712|NCT01347580|3772292|P2|NOT COMPLETED|Overall Study||56
1541713|NCT01347580|3772293|P1|NOT COMPLETED|Overall Study||65
1541714|NCT01347580|3772292|P2|COMPLETED|Overall Study|based on randomized treatment|897
1541715|NCT01347580|3772293|P1|COMPLETED|Overall Study|based on randomized treatment|844
1541716|NCT01347580|3772292|P2|Safety Population|Overall Study|based on actual treatment|950
1541717|NCT01347580|3772293|P1|Safety Population|Overall Study|based on actual treatment|908
1541718|NCT01347580|3772292|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
1541719|NCT01347580|3772293|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
1541720|NCT01347580|3772292|P2|STARTED|Overall Study|based on randomized treatment|953
1541721|NCT01347580|3772293|P1|STARTED|Overall Study|based on randomized treatment|909
1541722|NCT01347554|3772323|P2|NOT COMPLETED|Overall Study||11
1541723|NCT01347554|3772324|P1|NOT COMPLETED|Overall Study||7
1541724|NCT01347554|3772323|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
1541725|NCT01347554|3772324|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
1541726|NCT01347554|3772323|P2|STARTED|Overall Study||242
1541727|NCT01347554|3772324|P1|STARTED|Overall Study||237
1541728|NCT01347255|3772336|P1|NOT COMPLETED|Overall Study||0
1541729|NCT01347255|3772336|P1|COMPLETED|Overall Study||24
1541730|NCT01347255|3772336|P1|STARTED|Overall Study||24
1541731|NCT01347112|3772361|P2|NOT COMPLETED|Overall Study||12
1541732|NCT01347112|3772362|P1|NOT COMPLETED|Overall Study||4
1541733|NCT01347112|3772361|P2|COMPLETED|Overall Study||5
1541734|NCT01347112|3772362|P1|COMPLETED|Overall Study||12
1541735|NCT01347112|3772361|P2|STARTED|Overall Study||17
1541736|NCT01347112|3772362|P1|STARTED|Overall Study||16
1541737|NCT01347086|3772382|P10|NOT COMPLETED|Overall Study||1
1541738|NCT01347086|3772383|P9|NOT COMPLETED|Overall Study||0
1541739|NCT01347086|3772384|P8|NOT COMPLETED|Overall Study||1
1541740|NCT01347086|3772385|P7|NOT COMPLETED|Overall Study||1
1541741|NCT01347086|3772386|P6|NOT COMPLETED|Overall Study||0
1541742|NCT01347086|3772387|P5|NOT COMPLETED|Overall Study||0
1541743|NCT01347086|3772388|P4|NOT COMPLETED|Overall Study||0
1541744|NCT01347086|3772389|P3|NOT COMPLETED|Overall Study||1
1541745|NCT01347086|3772390|P2|NOT COMPLETED|Overall Study||0
1541746|NCT01347086|3772391|P1|NOT COMPLETED|Overall Study||0
1541747|NCT01347086|3772382|P10|COMPLETED|Overall Study||6
1541748|NCT01347086|3772383|P9|COMPLETED|Overall Study||6
1541749|NCT01347086|3772384|P8|COMPLETED|Overall Study||6
1541750|NCT01347086|3772385|P7|COMPLETED|Overall Study||6
1541751|NCT01347086|3772386|P6|COMPLETED|Overall Study||6
1541752|NCT01347086|3772387|P5|COMPLETED|Overall Study||6
1541753|NCT01347086|3772388|P4|COMPLETED|Overall Study||6
1541754|NCT01347086|3772389|P3|COMPLETED|Overall Study||6
1541755|NCT01347086|3772390|P2|COMPLETED|Overall Study||6
1541756|NCT01347086|3772391|P1|COMPLETED|Overall Study||2
1541757|NCT01347086|3772382|P10|STARTED|Overall Study|One subject was not treated.|7
1541758|NCT01347086|3772383|P9|STARTED|Overall Study||6
1541759|NCT01347086|3772384|P8|STARTED|Overall Study|One subject was not treated.|7
1541760|NCT01347086|3772385|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
1541761|NCT01347086|3772386|P6|STARTED|Overall Study||6
1541762|NCT01347086|3772387|P5|STARTED|Overall Study||6
1541763|NCT01347086|3772388|P4|STARTED|Overall Study||6
1541764|NCT01347086|3772389|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
1541765|NCT01347086|3772390|P2|STARTED|Overall Study||6
1541766|NCT01347086|3772391|P1|STARTED|Overall Study||2
1541767|NCT01347073|3772490|P1|NOT COMPLETED|Overall Study||2
1541768|NCT01347073|3772490|P1|COMPLETED|Overall Study||21
1541769|NCT01347073|3772490|P1|STARTED|Overall Study||23
1541770|NCT01347060|3772504|P2|NOT COMPLETED|Overall Study||0
1541771|NCT01347060|3772505|P1|NOT COMPLETED|Overall Study||0
1541772|NCT01347060|3772504|P2|COMPLETED|Overall Study||7580
1541773|NCT01347060|3772505|P1|COMPLETED|Overall Study||9868
1541774|NCT01347060|3772504|P2|STARTED|Overall Study||7580
1541775|NCT01347060|3772505|P1|STARTED|Overall Study||9868
1541776|NCT01347034|3772517|P2|NOT COMPLETED|Overall Study||0
1541777|NCT01347034|3772518|P1|NOT COMPLETED|Overall Study||0
1541778|NCT01347034|3772517|P2|COMPLETED|Overall Study||14
1541779|NCT01347034|3772518|P1|COMPLETED|Overall Study||6
1541780|NCT01347034|3772517|P2|STARTED|Overall Study||14
1541781|NCT01347034|3772518|P1|STARTED|Overall Study||6
1541782|NCT01347008|3772528|P2|NOT COMPLETED|Overall Study||0
1541783|NCT01347008|3772529|P1|NOT COMPLETED|Overall Study||0
1541784|NCT01347008|3772528|P2|COMPLETED|Overall Study||20
1541785|NCT01347008|3772529|P1|COMPLETED|Overall Study||21
1541786|NCT01347008|3772528|P2|STARTED|Overall Study||20
1541787|NCT01347008|3772529|P1|STARTED|Overall Study||21
1541788|NCT01346852|3772541|P2|NOT COMPLETED|Overall Study||0
1541789|NCT01346852|3772542|P1|NOT COMPLETED|Overall Study||0
1541790|NCT01346852|3772541|P2|COMPLETED|Overall Study||59684
1541791|NCT01346852|3772542|P1|COMPLETED|Overall Study||41753
1541792|NCT01346852|3772541|P2|STARTED|Overall Study||59684
1541793|NCT01346852|3772542|P1|STARTED|Overall Study||41753
1541794|NCT01346839|3772552|P2|NOT COMPLETED|Overall Study||209
1541795|NCT01346839|3772553|P1|NOT COMPLETED|Overall Study||314
1541796|NCT01346839|3772552|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
1541797|NCT01346839|3772553|P1|COMPLETED|Overall Study||369
1541798|NCT01346839|3772552|P2|STARTED|Overall Study||573
1541799|NCT01346839|3772553|P1|STARTED|Overall Study||683
1541800|NCT01346774|3772569|P2|NOT COMPLETED|Overall Study||17
1541801|NCT01346774|3772570|P1|NOT COMPLETED|Overall Study||13
1541802|NCT01346774|3772569|P2|COMPLETED|Overall Study||63
1541803|NCT01346774|3772570|P1|COMPLETED|Overall Study||67
1541804|NCT01346774|3772569|P2|STARTED|Overall Study||80
1541805|NCT01346774|3772570|P1|STARTED|Overall Study||80
1541806|NCT01346592|3772579|P3|NOT COMPLETED|Overall Study||78
1541807|NCT01346592|3772580|P2|NOT COMPLETED|Overall Study||89
1541808|NCT01346592|3772581|P1|NOT COMPLETED|Overall Study||153
1541809|NCT01346592|3772579|P3|COMPLETED|Overall Study||1408
1541810|NCT01346592|3772580|P2|COMPLETED|Overall Study||1389
1541811|NCT01346592|3772581|P1|COMPLETED|Overall Study||2983
1541812|NCT01346592|3772579|P3|STARTED|Overall Study||1486
1541813|NCT01346592|3772580|P2|STARTED|Overall Study||1478
1541814|NCT01346592|3772581|P1|STARTED|Overall Study||3136
1541815|NCT01346540|3772673|P2|NOT COMPLETED|Overall Study||12
1541816|NCT01346540|3772674|P1|NOT COMPLETED|Overall Study||3
1541817|NCT01346540|3772673|P2|COMPLETED|Overall Study||0
1541818|NCT01346540|3772674|P1|COMPLETED|Overall Study||1
1541819|NCT01346540|3772673|P2|STARTED|Overall Study||12
1541820|NCT01346540|3772674|P1|STARTED|Overall Study||4
1541821|NCT01346514|3772685|P2|NOT COMPLETED|Overall Study||37
1541822|NCT01346514|3772686|P1|NOT COMPLETED|Overall Study||29
1541823|NCT01346514|3772685|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
1541824|NCT01346514|3772686|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
1541825|NCT01346514|3772685|P2|12 Month Assessment|Overall Study||53
1541826|NCT01346514|3772686|P1|12 Month Assessment|Overall Study||62
1541827|NCT01346514|3772685|P2|9 Month Assessment|Overall Study||59
1541828|NCT01346514|3772686|P1|9 Month Assessment|Overall Study||67
1541829|NCT01346514|3772685|P2|6 Month Assessment|Overall Study||61
1541830|NCT01346514|3772686|P1|6 Month Assessment|Overall Study||74
1541831|NCT01346514|3772685|P2|3 Month Assessment|Overall Study||68
1541832|NCT01346514|3772686|P1|3 Month Assessment|Overall Study||83
1541833|NCT01346514|3772685|P2|STARTED|Overall Study||90
1541834|NCT01346514|3772686|P1|STARTED|Overall Study||91
1541835|NCT01346501|3772706|P2|NOT COMPLETED|Overall Study||13
1541836|NCT01346501|3772707|P1|NOT COMPLETED|Overall Study||11
1541837|NCT01346501|3772706|P2|COMPLETED|Overall Study||80
1541838|NCT01346501|3772707|P1|COMPLETED|Overall Study||68
1541839|NCT01346501|3772706|P2|STARTED|Overall Study||93
1541840|NCT01346501|3772707|P1|STARTED|Overall Study||79
1541841|NCT01346488|3772720|P1|NOT COMPLETED|Overall Study||706
1541842|NCT01346488|3772720|P1|COMPLETED|Overall Study||1262
1541843|NCT01346488|3772720|P1|STARTED|Overall Study||1968
1541844|NCT01346475|3772740|P2|NOT COMPLETED|Second Intervention||0
1541845|NCT01346475|3772741|P1|NOT COMPLETED|Second Intervention||0
1541846|NCT01346475|3772740|P2|COMPLETED|Second Intervention||25
1541847|NCT01346475|3772741|P1|COMPLETED|Second Intervention||18
1541848|NCT01346475|3772740|P2|STARTED|Second Intervention||25
1541849|NCT01346475|3772741|P1|STARTED|Second Intervention||18
1541850|NCT01346475|3772740|P2|NOT COMPLETED|First Intervention||3
1541851|NCT01346475|3772741|P1|NOT COMPLETED|First Intervention||4
1541852|NCT01346475|3772740|P2|COMPLETED|First Intervention||25
1541853|NCT01346475|3772741|P1|COMPLETED|First Intervention||18
1541854|NCT01346475|3772740|P2|STARTED|First Intervention||28
1541855|NCT01346475|3772741|P1|STARTED|First Intervention||22
1541856|NCT01346410|3772753|P1|NOT COMPLETED|Overall Study||1
1541857|NCT01346410|3772753|P1|COMPLETED|Overall Study||0
1541858|NCT01346410|3772753|P1|STARTED|Overall Study||1
1541859|NCT01346397|3772759|P2|NOT COMPLETED|Overall Study||0
1541860|NCT01346397|3772760|P1|NOT COMPLETED|Overall Study||0
1541861|NCT01346397|3772759|P2|COMPLETED|Overall Study||85
1541862|NCT01346397|3772760|P1|COMPLETED|Overall Study||85
1541863|NCT01346397|3772759|P2|STARTED|Overall Study||85
1541864|NCT01346397|3772760|P1|STARTED|Overall Study||85
1541865|NCT01346293|3772770|P2|NOT COMPLETED|Overall Study||21
1541866|NCT01346293|3772771|P1|NOT COMPLETED|Overall Study||67
1541867|NCT01346293|3772770|P2|COMPLETED|Overall Study||608
1541868|NCT01346293|3772771|P1|COMPLETED|Overall Study||2676
1541869|NCT01346293|3772770|P2|STARTED|Overall Study||629
1541870|NCT01346293|3772771|P1|STARTED|Overall Study||2743
1541871|NCT01346189|3772801|P4|NOT COMPLETED|Overall Study||11
1541872|NCT01346189|3772802|P3|NOT COMPLETED|Overall Study||14
1541873|NCT01346189|3772803|P2|NOT COMPLETED|Overall Study||17
1541874|NCT01346189|3772804|P1|NOT COMPLETED|Overall Study||16
1541875|NCT01346189|3772801|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
1541876|NCT01346189|3772802|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
1541877|NCT01346189|3772803|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
1541878|NCT01346189|3772804|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
1541879|NCT01346189|3772801|P4|STARTED|Overall Study||366
1541880|NCT01346189|3772802|P3|STARTED|Overall Study||346
1541881|NCT01346189|3772803|P2|STARTED|Overall Study||358
1541882|NCT01346189|3772804|P1|STARTED|Overall Study||433
1541883|NCT01346176|3772821|P3|NOT COMPLETED|Completed Satisfaction Survey||6
1541884|NCT01346176|3772822|P2|NOT COMPLETED|Completed Satisfaction Survey||4
1541885|NCT01346176|3772823|P1|NOT COMPLETED|Completed Satisfaction Survey||6
1541886|NCT01346176|3772821|P3|COMPLETED|Completed Satisfaction Survey||27
1541887|NCT01346176|3772822|P2|COMPLETED|Completed Satisfaction Survey||22
1541888|NCT01346176|3772823|P1|COMPLETED|Completed Satisfaction Survey||29
1541889|NCT01346176|3772821|P3|STARTED|Completed Satisfaction Survey||33
1541890|NCT01346176|3772822|P2|STARTED|Completed Satisfaction Survey||26
1541891|NCT01346176|3772823|P1|STARTED|Completed Satisfaction Survey||35
1541892|NCT01346176|3772821|P3|NOT COMPLETED|Completed Advance Directive||10
1541893|NCT01346176|3772822|P2|NOT COMPLETED|Completed Advance Directive||14
1541894|NCT01346176|3772823|P1|NOT COMPLETED|Completed Advance Directive||13
1541895|NCT01346176|3772821|P3|COMPLETED|Completed Advance Directive||33
1541896|NCT01346176|3772822|P2|COMPLETED|Completed Advance Directive||26
1541897|NCT01346176|3772823|P1|COMPLETED|Completed Advance Directive||35
1541898|NCT01346176|3772821|P3|STARTED|Completed Advance Directive||43
1541899|NCT01346176|3772822|P2|STARTED|Completed Advance Directive||40
1541900|NCT01346176|3772823|P1|STARTED|Completed Advance Directive||48
1541901|NCT01346176|3772821|P3|NOT COMPLETED|Recruited||0
1541902|NCT01346176|3772822|P2|NOT COMPLETED|Recruited||0
1541903|NCT01346176|3772823|P1|NOT COMPLETED|Recruited||1
1541904|NCT01346176|3772821|P3|COMPLETED|Recruited||43
1541905|NCT01346176|3772822|P2|COMPLETED|Recruited||40
1541906|NCT01346176|3772823|P1|COMPLETED|Recruited||48
1541907|NCT01346176|3772821|P3|STARTED|Recruited||43
1541908|NCT01346176|3772822|P2|STARTED|Recruited||40
1541909|NCT01346176|3772823|P1|STARTED|Recruited||49
1541910|NCT01346085|3772834|P1|NOT COMPLETED|Overall Study||0
1541911|NCT01346085|3772834|P1|COMPLETED|Overall Study||10
1541912|NCT01346085|3772834|P1|STARTED|Overall Study||10
1541913|NCT01346072|3772841|P2|NOT COMPLETED|Overall Study||0
1541914|NCT01346072|3772842|P1|NOT COMPLETED|Overall Study||0
1541915|NCT01346072|3772841|P2|COMPLETED|Overall Study||10
1541916|NCT01346072|3772842|P1|COMPLETED|Overall Study||11
1541917|NCT01346072|3772841|P2|STARTED|Overall Study||10
1541918|NCT01346072|3772842|P1|STARTED|Overall Study||11
1541919|NCT01346059|3772852|P2|NOT COMPLETED|Overall Study||0
1541920|NCT01346059|3772853|P1|NOT COMPLETED|Overall Study||1
1541921|NCT01346059|3772852|P2|COMPLETED|Overall Study||1
1541922|NCT01346059|3772853|P1|COMPLETED|Overall Study||0
1541923|NCT01346059|3772852|P2|STARTED|Overall Study||1
1541924|NCT01346059|3772853|P1|STARTED|Overall Study||1
1541925|NCT01345929|3772865|P2|NOT COMPLETED|Overall Study||19
1541926|NCT01345929|3772866|P1|NOT COMPLETED|Overall Study||21
1541927|NCT01345929|3772865|P2|COMPLETED|Overall Study||516
1541928|NCT01345929|3772866|P1|COMPLETED|Overall Study||512
1541929|NCT01345929|3772865|P2|STARTED|Overall Study||535
1541930|NCT01345929|3772866|P1|STARTED|Overall Study||533
1541931|NCT01345786|3772878|P4|NOT COMPLETED|Overall Study||3
1541932|NCT01345786|3772879|P3|NOT COMPLETED|Overall Study||5
1541933|NCT01345786|3772880|P2|NOT COMPLETED|Overall Study||8
1541934|NCT01345786|3772881|P1|NOT COMPLETED|Overall Study||6
1541935|NCT01345786|3772878|P4|COMPLETED|Overall Study||35
1541936|NCT01345786|3772879|P3|COMPLETED|Overall Study||33
1541937|NCT01345786|3772880|P2|COMPLETED|Overall Study||33
1541938|NCT01345786|3772881|P1|COMPLETED|Overall Study||35
1541939|NCT01345786|3772878|P4|Treated|Overall Study||37
1541940|NCT01345786|3772879|P3|Treated|Overall Study||37
1541941|NCT01345786|3772880|P2|Treated|Overall Study||41
1541942|NCT01345786|3772881|P1|Treated|Overall Study||41
1541943|NCT01345786|3772878|P4|STARTED|Overall Study|Number randomized|38
1541944|NCT01345786|3772879|P3|STARTED|Overall Study|Number randomized|38
1541945|NCT01345786|3772880|P2|STARTED|Overall Study|Number randomized|41
1541946|NCT01345786|3772881|P1|STARTED|Overall Study|Number randomized|41
1541947|NCT01345721|3772930|P3|NOT COMPLETED|Overall Study||0
1541948|NCT01345721|3772931|P2|NOT COMPLETED|Overall Study||0
1541949|NCT01345721|3772932|P1|NOT COMPLETED|Overall Study||0
1541950|NCT01345721|3772930|P3|COMPLETED|Overall Study||65
1541951|NCT01345721|3772931|P2|COMPLETED|Overall Study||66
1541952|NCT01345721|3772932|P1|COMPLETED|Overall Study||74
1541953|NCT01345721|3772930|P3|STARTED|Overall Study||65
1541954|NCT01345721|3772931|P2|STARTED|Overall Study||66
1541955|NCT01345721|3772932|P1|STARTED|Overall Study||74
1541956|NCT01345682|3772961|P2|NOT COMPLETED|Overall Study||161
1541957|NCT01345682|3772962|P1|NOT COMPLETED|Overall Study||322
1541958|NCT01345682|3772961|P2|COMPLETED|Overall Study||0
1541959|NCT01345682|3772962|P1|COMPLETED|Overall Study||0
1541960|NCT01345682|3772961|P2|STARTED|Overall Study|Randomised|161
1541961|NCT01345682|3772962|P1|STARTED|Overall Study|Randomised|322
1541962|NCT01345669|3772996|P2|NOT COMPLETED|Overall Study||119
1541963|NCT01345669|3772997|P1|NOT COMPLETED|Overall Study||287
1541964|NCT01345669|3772996|P2|COMPLETED|Overall Study||87
1541965|NCT01345669|3772997|P1|COMPLETED|Overall Study||124
1541966|NCT01345669|3772996|P2|STARTED|Overall Study||206
1541967|NCT01345669|3772997|P1|STARTED|Overall Study||411
1541968|NCT01345630|3773015|P2|NOT COMPLETED|Overall Study||359
1541969|NCT01345630|3773016|P1|NOT COMPLETED|Overall Study||361
1541970|NCT01345630|3773015|P2|COMPLETED|Overall Study||42
1541971|NCT01345630|3773016|P1|COMPLETED|Overall Study||35
1541972|NCT01345630|3773015|P2|STARTED|Overall Study||401
1541973|NCT01345630|3773016|P1|STARTED|Overall Study||396
1541974|NCT01345591|3773072|P1|NOT COMPLETED|Overall Study||1
1541975|NCT01345591|3773072|P1|COMPLETED|Overall Study||19
1541976|NCT01345591|3773072|P1|STARTED|Overall Study||20
1541977|NCT01345318|3773081|P1|NOT COMPLETED|Overall Study||80
1541978|NCT01345318|3773081|P1|COMPLETED|Overall Study||111
1541979|NCT01345318|3773081|P1|STARTED|Overall Study||191
1541980|NCT01345292|3773089|P3|NOT COMPLETED|Overall Study||1
1541981|NCT01345292|3773090|P2|NOT COMPLETED|Overall Study||0
1541982|NCT01345292|3773091|P1|NOT COMPLETED|Overall Study||2
1541983|NCT01345292|3773089|P3|COMPLETED|Overall Study||74
1541984|NCT01345292|3773090|P2|COMPLETED|Overall Study||76
1541985|NCT01345292|3773091|P1|COMPLETED|Overall Study||73
1541986|NCT01345292|3773089|P3|STARTED|Overall Study||75
1541987|NCT01345292|3773090|P2|STARTED|Overall Study||76
1541988|NCT01345292|3773091|P1|STARTED|Overall Study||75
1541989|NCT01345253|3773122|P2|NOT COMPLETED|Overall Study||79
1541990|NCT01345253|3773123|P1|NOT COMPLETED|Overall Study||56
1541991|NCT01345253|3773122|P2|COMPLETED|Overall Study||372
1541992|NCT01345253|3773123|P1|COMPLETED|Overall Study||170
1541993|NCT01345253|3773122|P2|STARTED|Overall Study||451
1541994|NCT01345253|3773123|P1|STARTED|Overall Study||226
1541995|NCT01345240|3773142|P5|NOT COMPLETED|Overall Study||7
1541996|NCT01345240|3773143|P4|NOT COMPLETED|Overall Study||10
1541997|NCT01345240|3773144|P3|NOT COMPLETED|Overall Study||10
1541998|NCT01345240|3773145|P2|NOT COMPLETED|Overall Study||14
1541999|NCT01345240|3773146|P1|NOT COMPLETED|Overall Study||2
1542000|NCT01345240|3773142|P5|COMPLETED|Overall Study||132
1542001|NCT01345240|3773143|P4|COMPLETED|Overall Study||131
1542002|NCT01345240|3773144|P3|COMPLETED|Overall Study||131
1542003|NCT01345240|3773145|P2|COMPLETED|Overall Study||128
1542004|NCT01345240|3773146|P1|COMPLETED|Overall Study||140
1542005|NCT01345240|3773142|P5|STARTED|Overall Study||139
1542006|NCT01345240|3773143|P4|STARTED|Overall Study||141
1542007|NCT01345240|3773144|P3|STARTED|Overall Study||141
1542008|NCT01345240|3773145|P2|STARTED|Overall Study||142
1542009|NCT01345240|3773146|P1|STARTED|Overall Study||142
1542010|NCT01345188|3773239|P1|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
1542011|NCT01345188|3773239|P1|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
1542012|NCT01345188|3773239|P1|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
1542013|NCT01345188|3773239|P1|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
1542014|NCT01345188|3773239|P1|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
1542015|NCT01345188|3773239|P1|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
1542016|NCT01345162|3773251|P2|NOT COMPLETED|Overall Study||4
1542017|NCT01345162|3773252|P1|NOT COMPLETED|Overall Study||2
1542018|NCT01345162|3773251|P2|COMPLETED|Overall Study||96
1542019|NCT01345162|3773252|P1|COMPLETED|Overall Study||98
1542020|NCT01345162|3773251|P2|STARTED|Overall Study||100
1542021|NCT01345162|3773252|P1|STARTED|Overall Study||100
1542022|NCT01345123|3773261|P3|NOT COMPLETED|Overall Study||88
1542023|NCT01345123|3773262|P2|NOT COMPLETED|Overall Study||85
1542024|NCT01345123|3773263|P1|NOT COMPLETED|Overall Study||79
1542025|NCT01345123|3773261|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
1542026|NCT01345123|3773262|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
1542027|NCT01345123|3773263|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
1542028|NCT01345123|3773261|P3|STARTED|Overall Study||3291
1542029|NCT01345123|3773262|P2|STARTED|Overall Study||3311
1542030|NCT01345123|3773263|P1|STARTED|Overall Study||3323
1542031|NCT01345058|3773285|P2|NOT COMPLETED|Overall Study||0
1542032|NCT01345058|3773286|P1|NOT COMPLETED|Overall Study||5
1542033|NCT01345058|3773285|P2|COMPLETED|Overall Study||36
1542034|NCT01345058|3773286|P1|COMPLETED|Overall Study||15
1542035|NCT01345058|3773285|P2|Received Lacosamide|Overall Study||0
1542036|NCT01345058|3773286|P1|Received Lacosamide|Overall Study||19
1542037|NCT01345058|3773285|P2|STARTED|Overall Study||36
1542038|NCT01345058|3773286|P1|STARTED|Overall Study||20
1542039|NCT01345019|3773302|P2|NOT COMPLETED|Overall Study||272
1542040|NCT01345019|3773303|P1|NOT COMPLETED|Overall Study||263
1542041|NCT01345019|3773302|P2|COMPLETED|Overall Study|Still on study as of the data cut-off date|587
1542042|NCT01345019|3773303|P1|COMPLETED|Overall Study|Still on study as of the data cut-off date|596
1542043|NCT01345019|3773302|P2|Received Treatment|Overall Study||850
1542044|NCT01345019|3773303|P1|Received Treatment|Overall Study||852
1542045|NCT01345019|3773302|P2|STARTED|Overall Study||859
1542046|NCT01345019|3773303|P1|STARTED|Overall Study||859
1542047|NCT01344876|3773323|P5|NOT COMPLETED|Overall Study||1
1542048|NCT01344876|3773324|P4|NOT COMPLETED|Overall Study||3
1542049|NCT01344876|3773325|P3|NOT COMPLETED|Overall Study||1
1542050|NCT01344876|3773326|P2|NOT COMPLETED|Overall Study||0
1542051|NCT01344876|3773327|P1|NOT COMPLETED|Overall Study||1
1542052|NCT01344876|3773323|P5|COMPLETED|Overall Study||2
1542053|NCT01344876|3773324|P4|COMPLETED|Overall Study||3
1542054|NCT01344876|3773325|P3|COMPLETED|Overall Study||3
1542055|NCT01344876|3773326|P2|COMPLETED|Overall Study||3
1542056|NCT01344876|3773327|P1|COMPLETED|Overall Study||3
1542057|NCT01344876|3773323|P5|STARTED|Overall Study||3
1542058|NCT01344876|3773324|P4|STARTED|Overall Study||6
1542059|NCT01344876|3773325|P3|STARTED|Overall Study||4
1542060|NCT01344876|3773326|P2|STARTED|Overall Study||3
1542061|NCT01344876|3773327|P1|STARTED|Overall Study||4
1542062|NCT01344824|3773341|P1|NOT COMPLETED|Overall Study||37
1542063|NCT01344824|3773341|P1|COMPLETED|Overall Study||1
1542064|NCT01344824|3773341|P1|STARTED|Overall Study||38
1542065|NCT01344759|3773349|P2|NOT COMPLETED|Overall Study||2
1542066|NCT01344759|3773350|P1|NOT COMPLETED|Overall Study||0
1542067|NCT01344759|3773349|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
1542068|NCT01344759|3773350|P1|COMPLETED|Overall Study||30
1542069|NCT01344759|3773349|P2|STARTED|Overall Study||30
1542070|NCT01344759|3773350|P1|STARTED|Overall Study||30
1542071|NCT01344629|3773382|P2|NOT COMPLETED|Crossover Period 4||0
1542072|NCT01344629|3773383|P1|NOT COMPLETED|Crossover Period 4||0
1542073|NCT01344629|3773382|P2|COMPLETED|Crossover Period 4||31
1542074|NCT01344629|3773383|P1|COMPLETED|Crossover Period 4||32
1542075|NCT01344629|3773382|P2|STARTED|Crossover Period 4||31
1542076|NCT01344629|3773383|P1|STARTED|Crossover Period 4||32
1542077|NCT01344629|3773382|P2|NOT COMPLETED|Crossover Period 3||0
1542078|NCT01344629|3773383|P1|NOT COMPLETED|Crossover Period 3||0
1542079|NCT01344629|3773382|P2|COMPLETED|Crossover Period 3||31
1542080|NCT01344629|3773383|P1|COMPLETED|Crossover Period 3||32
1542081|NCT01344629|3773382|P2|STARTED|Crossover Period 3||31
1542082|NCT01344629|3773383|P1|STARTED|Crossover Period 3||32
1542083|NCT01344629|3773382|P2|NOT COMPLETED|Crossover Period 2||1
1542084|NCT01344629|3773383|P1|NOT COMPLETED|Crossover Period 2||0
1542085|NCT01344629|3773382|P2|COMPLETED|Crossover Period 2||31
1542086|NCT01344629|3773383|P1|COMPLETED|Crossover Period 2||32
1542087|NCT01344629|3773382|P2|STARTED|Crossover Period 2||32
1542088|NCT01344629|3773383|P1|STARTED|Crossover Period 2||32
1542089|NCT01344629|3773382|P2|NOT COMPLETED|Crossover Period 1||0
1542090|NCT01344629|3773383|P1|NOT COMPLETED|Crossover Period 1||0
1542091|NCT01344629|3773382|P2|COMPLETED|Crossover Period 1||32
1542092|NCT01344629|3773383|P1|COMPLETED|Crossover Period 1||32
1542093|NCT01344629|3773382|P2|STARTED|Crossover Period 1||32
1542094|NCT01344629|3773383|P1|STARTED|Crossover Period 1||32
1542095|NCT01344616|3773403|P2|NOT COMPLETED|Overall Study||44
1542096|NCT01344616|3773404|P1|NOT COMPLETED|Overall Study||35
1542097|NCT01344616|3773403|P2|COMPLETED|Overall Study||194
1542098|NCT01344616|3773404|P1|COMPLETED|Overall Study||209
1542099|NCT01344616|3773403|P2|STARTED|Overall Study||238
1542100|NCT01344616|3773404|P1|STARTED|Overall Study||244
1542101|NCT01344538|3773412|P2|NOT COMPLETED|Overall Study||1
1542102|NCT01344538|3773413|P1|NOT COMPLETED|Overall Study||2
1542103|NCT01344538|3773412|P2|COMPLETED|Overall Study||16
1542104|NCT01344538|3773413|P1|COMPLETED|Overall Study||14
1542105|NCT01344538|3773412|P2|STARTED|Overall Study||17
1542106|NCT01344538|3773413|P1|STARTED|Overall Study||16
1542107|NCT01344460|3773419|P1|NOT COMPLETED|Overall Study||3
1542108|NCT01344460|3773419|P1|COMPLETED|Overall Study||312
1542109|NCT01344460|3773419|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
1542110|NCT01344460|3773419|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
1542111|NCT01344447|3773464|P1|NOT COMPLETED|Overall Study||8
1542112|NCT01344447|3773464|P1|COMPLETED|Overall Study||471
1542113|NCT01344447|3773464|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
1542114|NCT01344447|3773464|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
1542115|NCT01344369|3773508|P2|NOT COMPLETED|Second Intervention||1
1542116|NCT01344369|3773509|P1|NOT COMPLETED|Second Intervention||0
1542117|NCT01344369|3773508|P2|COMPLETED|Second Intervention||16
1542118|NCT01344369|3773509|P1|COMPLETED|Second Intervention||17
1542119|NCT01344369|3773508|P2|STARTED|Second Intervention||17
1542120|NCT01344369|3773509|P1|STARTED|Second Intervention||17
1542121|NCT01344369|3773508|P2|NOT COMPLETED|Washout of 28 Days||1
1542122|NCT01344369|3773509|P1|NOT COMPLETED|Washout of 28 Days||1
1542123|NCT01344369|3773508|P2|COMPLETED|Washout of 28 Days||17
1542124|NCT01344369|3773509|P1|COMPLETED|Washout of 28 Days||17
1542125|NCT01344369|3773508|P2|STARTED|Washout of 28 Days||18
1542126|NCT01344369|3773509|P1|STARTED|Washout of 28 Days||18
1542127|NCT01344369|3773508|P2|NOT COMPLETED|First Intervention||0
1542128|NCT01344369|3773509|P1|NOT COMPLETED|First Intervention||0
1542129|NCT01344369|3773508|P2|COMPLETED|First Intervention||18
1542130|NCT01344369|3773509|P1|COMPLETED|First Intervention||18
1542131|NCT01344369|3773508|P2|STARTED|First Intervention||18
1542132|NCT01344369|3773509|P1|STARTED|First Intervention||18
1542133|NCT01344226|3773525|P1|NOT COMPLETED|Overall Study||8
1542134|NCT01344226|3773525|P1|COMPLETED|Overall Study||41
1542135|NCT01344226|3773525|P1|STARTED|Overall Study||49
1542136|NCT01344161|3773534|P2|NOT COMPLETED|Overall Study||3
1542137|NCT01344161|3773535|P1|NOT COMPLETED|Overall Study||5
1542138|NCT01344161|3773534|P2|COMPLETED|Overall Study||39
1542139|NCT01344161|3773535|P1|COMPLETED|Overall Study||38
1542140|NCT01344161|3773534|P2|STARTED|Overall Study||42
1542141|NCT01344161|3773535|P1|STARTED|Overall Study||43
1542142|NCT01344057|3773547|P1|NOT COMPLETED|Overall Study||1
1542143|NCT01344057|3773547|P1|COMPLETED|Overall Study||62
1542144|NCT01344057|3773547|P1|STARTED|Overall Study||63
1542145|NCT01343901|3773554|P1|NOT COMPLETED|Overall Study||113
1542146|NCT01343901|3773554|P1|COMPLETED|Overall Study||97
1542147|NCT01343901|3773554|P1|Efficacy Population|Overall Study||205
1542148|NCT01343901|3773554|P1|STARTED|Overall Study||210
1542149|NCT01343888|3773578|P3|NOT COMPLETED|Overall Study||22
1542150|NCT01343888|3773579|P2|NOT COMPLETED|Overall Study||39
1542151|NCT01343888|3773580|P1|NOT COMPLETED|Overall Study||25
1542152|NCT01343888|3773578|P3|COMPLETED|Overall Study||110
1542153|NCT01343888|3773579|P2|COMPLETED|Overall Study||222
1542154|NCT01343888|3773580|P1|COMPLETED|Overall Study||234
1542155|NCT01343888|3773578|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
1542156|NCT01343888|3773579|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
1542157|NCT01343888|3773580|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
1542158|NCT01343823|3773622|P4|NOT COMPLETED|Overall Study||1
1542159|NCT01343823|3773623|P3|NOT COMPLETED|Overall Study||0
1542160|NCT01343823|3773624|P2|NOT COMPLETED|Overall Study||0
1542161|NCT01343823|3773625|P1|NOT COMPLETED|Overall Study||2
1542162|NCT01343823|3773622|P4|COMPLETED|Overall Study||19
1542163|NCT01343823|3773623|P3|COMPLETED|Overall Study||19
1542164|NCT01343823|3773624|P2|COMPLETED|Overall Study||20
1542165|NCT01343823|3773625|P1|COMPLETED|Overall Study||18
1542166|NCT01343823|3773622|P4|STARTED|Overall Study||20
1542167|NCT01343823|3773623|P3|STARTED|Overall Study||19
1542168|NCT01343823|3773624|P2|STARTED|Overall Study||20
1542169|NCT01343823|3773625|P1|STARTED|Overall Study||20
1542170|NCT01343667|3773641|P2|NOT COMPLETED|Overall Study||56
1542171|NCT01343667|3773642|P1|NOT COMPLETED|Overall Study||12
1542172|NCT01343667|3773641|P2|COMPLETED|Overall Study||916
1542173|NCT01343667|3773642|P1|COMPLETED|Overall Study||413
1542174|NCT01343667|3773641|P2|STARTED|Overall Study||972
1542175|NCT01343667|3773642|P1|STARTED|Overall Study||425
1542176|NCT01343485|3773650|P2|NOT COMPLETED|Overall Study||134
1542177|NCT01343485|3773651|P1|NOT COMPLETED|Overall Study||149
1542178|NCT01343485|3773650|P2|COMPLETED|Overall Study||46
1542179|NCT01343485|3773651|P1|COMPLETED|Overall Study||36
1542180|NCT01343485|3773650|P2|STARTED|Overall Study||180
1542181|NCT01343485|3773651|P1|STARTED|Overall Study||185
1542182|NCT01343368|3773659|P2|NOT COMPLETED|Overall Study||0
1542183|NCT01343368|3773660|P1|NOT COMPLETED|Overall Study||2
1542184|NCT01343368|3773659|P2|COMPLETED|Overall Study||10
1542185|NCT01343368|3773660|P1|COMPLETED|Overall Study||7
1542186|NCT01343368|3773659|P2|STARTED|Overall Study||10
1542187|NCT01343368|3773660|P1|STARTED|Overall Study||9
1542188|NCT01343277|3773696|P2|NOT COMPLETED|Overall Study||193
1542189|NCT01343277|3773697|P1|NOT COMPLETED|Overall Study||384
1542190|NCT01343277|3773696|P2|COMPLETED|Overall Study||0
1542191|NCT01343277|3773697|P1|COMPLETED|Overall Study||0
1542192|NCT01343277|3773696|P2|Treated|Overall Study||172
1542193|NCT01343277|3773697|P1|Treated|Overall Study||378
1542194|NCT01343277|3773696|P2|STARTED|Overall Study||193
1542195|NCT01343277|3773697|P1|STARTED|Overall Study||384
1542196|NCT01343251|3773715|P2|NOT COMPLETED|Overall Study||0
1542197|NCT01343251|3773716|P1|NOT COMPLETED|Overall Study||0
1542198|NCT01343251|3773715|P2|COMPLETED|Overall Study||17
1542199|NCT01343251|3773716|P1|COMPLETED|Overall Study||16
1542200|NCT01343251|3773715|P2|STARTED|Overall Study||17
1542201|NCT01343251|3773716|P1|STARTED|Overall Study||16
1542202|NCT01343095|3773733|P3|NOT COMPLETED|Overall Study||0
1542203|NCT01343095|3773734|P2|NOT COMPLETED|Overall Study||0
1542204|NCT01343095|3773735|P1|NOT COMPLETED|Overall Study||0
1542205|NCT01343095|3773733|P3|COMPLETED|Overall Study||3
1542206|NCT01343095|3773734|P2|COMPLETED|Overall Study||3
1542207|NCT01343095|3773735|P1|COMPLETED|Overall Study||2
1542208|NCT01343095|3773733|P3|STARTED|Overall Study||3
1542209|NCT01343095|3773734|P2|STARTED|Overall Study||3
1542210|NCT01343095|3773735|P1|STARTED|Overall Study||2
1542211|NCT01343082|3773758|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
1542212|NCT01343082|3773759|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
1542213|NCT01343082|3773760|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
1542214|NCT01343082|3773758|P3|COMPLETED|Treatment Period , Switched to DE-111||31
1542215|NCT01343082|3773759|P2|COMPLETED|Treatment Period , Switched to DE-111||36
1542216|NCT01343082|3773760|P1|COMPLETED|Treatment Period , Switched to DE-111||43
1542217|NCT01343082|3773758|P3|STARTED|Treatment Period , Switched to DE-111||43
1542218|NCT01343082|3773759|P2|STARTED|Treatment Period , Switched to DE-111||45
1542219|NCT01343082|3773760|P1|STARTED|Treatment Period , Switched to DE-111||48
1542220|NCT01343082|3773758|P3|NOT COMPLETED|The run-in Period||5
1542221|NCT01343082|3773759|P2|NOT COMPLETED|The run-in Period||4
1542222|NCT01343082|3773760|P1|NOT COMPLETED|The run-in Period||3
1542223|NCT01343082|3773758|P3|COMPLETED|The run-in Period||43
1542224|NCT01343082|3773759|P2|COMPLETED|The run-in Period||45
1542225|NCT01343082|3773760|P1|COMPLETED|The run-in Period||48
1542226|NCT01343082|3773758|P3|STARTED|The run-in Period||48
1542227|NCT01343082|3773759|P2|STARTED|The run-in Period||49
1542228|NCT01343082|3773760|P1|STARTED|The run-in Period||51
1542229|NCT01343056|3773768|P4|NOT COMPLETED|Overall Study||9
1542230|NCT01343056|3773769|P3|NOT COMPLETED|Overall Study||3
1542231|NCT01343056|3773770|P2|NOT COMPLETED|Overall Study||5
1542232|NCT01343056|3773771|P1|NOT COMPLETED|Overall Study||7
1542233|NCT01343056|3773768|P4|COMPLETED|Overall Study||29
1542234|NCT01343056|3773769|P3|COMPLETED|Overall Study||29
1542235|NCT01343056|3773770|P2|COMPLETED|Overall Study||31
1542236|NCT01343056|3773771|P1|COMPLETED|Overall Study||28
1542237|NCT01343056|3773768|P4|STARTED|Overall Study||38
1542238|NCT01343056|3773769|P3|STARTED|Overall Study||32
1542239|NCT01343056|3773770|P2|STARTED|Overall Study||36
1542240|NCT01343056|3773771|P1|STARTED|Overall Study||35
1542241|NCT01343004|3773812|P3|NOT COMPLETED|Overall Study||160
1542242|NCT01343004|3773813|P2|NOT COMPLETED|Overall Study||218
1542243|NCT01343004|3773814|P1|NOT COMPLETED|Overall Study||184
1542244|NCT01343004|3773812|P3|COMPLETED|Overall Study||658
1542245|NCT01343004|3773813|P2|COMPLETED|Overall Study||606
1542246|NCT01343004|3773814|P1|COMPLETED|Overall Study||637
1542247|NCT01343004|3773812|P3|STARTED|Overall Study||818
1542248|NCT01343004|3773813|P2|STARTED|Overall Study||824
1542249|NCT01343004|3773814|P1|STARTED|Overall Study||821
1542250|NCT01342965|3773839|P2|NOT COMPLETED|Overall Study||107
1542251|NCT01342965|3773840|P1|NOT COMPLETED|Overall Study||109
1542252|NCT01342965|3773839|P2|COMPLETED|Overall Study||0
1542253|NCT01342965|3773840|P1|COMPLETED|Overall Study||1
1542254|NCT01342965|3773839|P2|Received Treatment|Overall Study||104
1542255|NCT01342965|3773840|P1|Received Treatment|Overall Study||110
1542256|NCT01342965|3773839|P2|STARTED|Overall Study||107
1542257|NCT01342965|3773840|P1|STARTED|Overall Study||110
1542258|NCT01342926|3773858|P4|NOT COMPLETED|Overall Study||12
1542259|NCT01342926|3773859|P3|NOT COMPLETED|Overall Study||14
1542260|NCT01342926|3773860|P2|NOT COMPLETED|Overall Study||15
1542261|NCT01342926|3773861|P1|NOT COMPLETED|Overall Study||9
1542262|NCT01342926|3773858|P4|COMPLETED|Overall Study||39
1542263|NCT01342926|3773859|P3|COMPLETED|Overall Study||34
1542264|NCT01342926|3773860|P2|COMPLETED|Overall Study||31
1542265|NCT01342926|3773861|P1|COMPLETED|Overall Study||37
1542266|NCT01342926|3773858|P4|STARTED|Overall Study||51
1542267|NCT01342926|3773859|P3|STARTED|Overall Study||48
1542268|NCT01342926|3773860|P2|STARTED|Overall Study||46
1542269|NCT01342926|3773861|P1|STARTED|Overall Study||46
1542270|NCT01342913|3773941|P3|NOT COMPLETED|Double-Blind Treatment Period||23
1542271|NCT01342913|3773942|P2|NOT COMPLETED|Double-Blind Treatment Period||16
1542272|NCT01342913|3773943|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1542273|NCT01342913|3773941|P3|COMPLETED|Double-Blind Treatment Period||243
1542274|NCT01342913|3773942|P2|COMPLETED|Double-Blind Treatment Period||246
1542275|NCT01342913|3773943|P1|COMPLETED|Double-Blind Treatment Period||0
1542276|NCT01342913|3773941|P3|STARTED|Double-Blind Treatment Period||266
1542277|NCT01342913|3773942|P2|STARTED|Double-Blind Treatment Period||262
1542278|NCT01342913|3773943|P1|STARTED|Double-Blind Treatment Period||0
1542279|NCT01342913|3773941|P3|NOT COMPLETED|2-week Run-in Period||0
1542280|NCT01342913|3773942|P2|NOT COMPLETED|2-week Run-in Period||0
1542281|NCT01342913|3773943|P1|NOT COMPLETED|2-week Run-in Period||174
1542282|NCT01342913|3773941|P3|COMPLETED|2-week Run-in Period||0
1542283|NCT01342913|3773942|P2|COMPLETED|2-week Run-in Period||0
1542284|NCT01342913|3773943|P1|COMPLETED|2-week Run-in Period||528
1542285|NCT01342913|3773941|P3|STARTED|2-week Run-in Period||0
1542286|NCT01342913|3773942|P2|STARTED|2-week Run-in Period||0
1542287|NCT01342913|3773943|P1|STARTED|2-week Run-in Period||702
1542288|NCT01342887|3773953|P1|NOT COMPLETED|Overall Study||2
1542289|NCT01342887|3773953|P1|COMPLETED|Overall Study||4
1542290|NCT01342887|3773953|P1|STARTED|Overall Study||6
1542291|NCT01342770|3773960|P1|NOT COMPLETED|Overall Study||0
1542292|NCT01342770|3773960|P1|COMPLETED|Overall Study||6
1542293|NCT01342770|3773960|P1|STARTED|Overall Study||6
1542294|NCT01342757|3773978|P1|NOT COMPLETED|Overall Study||0
1542295|NCT01342757|3773978|P1|COMPLETED|Overall Study||12
1542296|NCT01342757|3773978|P1|STARTED|Overall Study||12
1542297|NCT01342666|3773987|P2|NOT COMPLETED|Overall Study||0
1542298|NCT01342666|3773988|P1|NOT COMPLETED|Overall Study||0
1542299|NCT01342666|3773987|P2|COMPLETED|Overall Study||24
1542300|NCT01342666|3773988|P1|COMPLETED|Overall Study||26
1542301|NCT01342666|3773987|P2|STARTED|Overall Study||24
1542302|NCT01342666|3773988|P1|STARTED|Overall Study||26
1542303|NCT01342640|3773994|P1|NOT COMPLETED|Overall Study||41
1542304|NCT01342640|3773994|P1|COMPLETED|Overall Study||29
1542305|NCT01342640|3773994|P1|STARTED|Overall Study||70
1542306|NCT01342549|3774002|P2|NOT COMPLETED|Overall Study||0
1542307|NCT01342549|3774003|P1|NOT COMPLETED|Overall Study||0
1542308|NCT01342549|3774002|P2|COMPLETED|Overall Study||31
1542309|NCT01342549|3774003|P1|COMPLETED|Overall Study||31
1542310|NCT01342549|3774002|P2|STARTED|Overall Study||31
1542311|NCT01342549|3774003|P1|STARTED|Overall Study||31
1542312|NCT01342523|3774041|P32|NOT COMPLETED|Overall Study||1
1542313|NCT01342523|3774042|P31|NOT COMPLETED|Overall Study||1
1542314|NCT01342523|3774043|P30|NOT COMPLETED|Overall Study||1
1542315|NCT01342523|3774044|P29|NOT COMPLETED|Overall Study||1
1542316|NCT01342523|3774045|P28|NOT COMPLETED|Overall Study||1
1542317|NCT01342523|3774046|P27|NOT COMPLETED|Overall Study||1
1542318|NCT01342523|3774047|P26|NOT COMPLETED|Overall Study||2
1542319|NCT01342523|3774048|P25|NOT COMPLETED|Overall Study||1
1542320|NCT01342523|3774049|P24|NOT COMPLETED|Overall Study||1
1542321|NCT01342523|3774050|P23|NOT COMPLETED|Overall Study||0
1542322|NCT01342523|3774051|P22|NOT COMPLETED|Overall Study||0
1542323|NCT01342523|3774052|P21|NOT COMPLETED|Overall Study||0
1542324|NCT01342523|3774053|P20|NOT COMPLETED|Overall Study||0
1542325|NCT01342523|3774054|P19|NOT COMPLETED|Overall Study||0
1542326|NCT01342523|3774055|P18|NOT COMPLETED|Overall Study||0
1542327|NCT01342523|3774056|P17|NOT COMPLETED|Overall Study||1
1542328|NCT01342523|3774057|P16|NOT COMPLETED|Overall Study||0
1542329|NCT01342523|3774058|P15|NOT COMPLETED|Overall Study||1
1542330|NCT01342523|3774059|P14|NOT COMPLETED|Overall Study||2
1542331|NCT01342523|3774060|P13|NOT COMPLETED|Overall Study||0
1542332|NCT01342523|3774061|P12|NOT COMPLETED|Overall Study||2
1542333|NCT01342523|3774062|P11|NOT COMPLETED|Overall Study||0
1542334|NCT01342523|3774063|P10|NOT COMPLETED|Overall Study||0
1542335|NCT01342523|3774064|P9|NOT COMPLETED|Overall Study||0
1542336|NCT01342523|3774065|P8|NOT COMPLETED|Overall Study||0
1542337|NCT01342523|3774066|P7|NOT COMPLETED|Overall Study||0
1542338|NCT01342523|3774067|P6|NOT COMPLETED|Overall Study||0
1542339|NCT01342523|3774068|P5|NOT COMPLETED|Overall Study||0
1542340|NCT01342523|3774069|P4|NOT COMPLETED|Overall Study||1
1542341|NCT01342523|3774070|P3|NOT COMPLETED|Overall Study||0
1542342|NCT01342523|3774071|P2|NOT COMPLETED|Overall Study||0
1542343|NCT01342523|3774072|P1|NOT COMPLETED|Overall Study||1
1542344|NCT01342523|3774041|P32|COMPLETED|Overall Study||27
1542345|NCT01342523|3774042|P31|COMPLETED|Overall Study||30
1542346|NCT01342523|3774043|P30|COMPLETED|Overall Study||28
1542347|NCT01342523|3774044|P29|COMPLETED|Overall Study||34
1542348|NCT01342523|3774045|P28|COMPLETED|Overall Study||30
1542349|NCT01342523|3774046|P27|COMPLETED|Overall Study||33
1542350|NCT01342523|3774047|P26|COMPLETED|Overall Study||36
1542351|NCT01342523|3774048|P25|COMPLETED|Overall Study||36
1542352|NCT01342523|3774049|P24|COMPLETED|Overall Study||35
1542353|NCT01342523|3774050|P23|COMPLETED|Overall Study||36
1542354|NCT01342523|3774051|P22|COMPLETED|Overall Study||30
1542355|NCT01342523|3774052|P21|COMPLETED|Overall Study||29
1542356|NCT01342523|3774053|P20|COMPLETED|Overall Study||27
1542357|NCT01342523|3774054|P19|COMPLETED|Overall Study||21
1542358|NCT01342523|3774055|P18|COMPLETED|Overall Study||27
1542359|NCT01342523|3774056|P17|COMPLETED|Overall Study||28
1542360|NCT01342523|3774057|P16|COMPLETED|Overall Study||32
1542361|NCT01342523|3774058|P15|COMPLETED|Overall Study||37
1542362|NCT01342523|3774059|P14|COMPLETED|Overall Study||36
1542363|NCT01342523|3774060|P13|COMPLETED|Overall Study||39
1542364|NCT01342523|3774061|P12|COMPLETED|Overall Study||36
1542365|NCT01342523|3774062|P11|COMPLETED|Overall Study||38
1542366|NCT01342523|3774063|P10|COMPLETED|Overall Study||28
1542367|NCT01342523|3774064|P9|COMPLETED|Overall Study||28
1542368|NCT01342523|3774065|P8|COMPLETED|Overall Study||27
1542369|NCT01342523|3774066|P7|COMPLETED|Overall Study||22
1542370|NCT01342523|3774067|P6|COMPLETED|Overall Study||36
1542371|NCT01342523|3774068|P5|COMPLETED|Overall Study||36
1542372|NCT01342523|3774069|P4|COMPLETED|Overall Study||32
1542373|NCT01342523|3774070|P3|COMPLETED|Overall Study||36
1542374|NCT01342523|3774071|P2|COMPLETED|Overall Study||32
1542375|NCT01342523|3774072|P1|COMPLETED|Overall Study||34
1542376|NCT01342523|3774041|P32|STARTED|Overall Study||28
1542377|NCT01342523|3774042|P31|STARTED|Overall Study||31
1542378|NCT01342523|3774043|P30|STARTED|Overall Study||29
1542379|NCT01342523|3774044|P29|STARTED|Overall Study||35
1542380|NCT01342523|3774045|P28|STARTED|Overall Study||31
1542381|NCT01342523|3774046|P27|STARTED|Overall Study||34
1542382|NCT01342523|3774047|P26|STARTED|Overall Study||38
1542383|NCT01342523|3774048|P25|STARTED|Overall Study||37
1542384|NCT01342523|3774049|P24|STARTED|Overall Study||36
1542385|NCT01342523|3774050|P23|STARTED|Overall Study||36
1542386|NCT01342523|3774051|P22|STARTED|Overall Study||30
1542387|NCT01342523|3774052|P21|STARTED|Overall Study||29
1542388|NCT01342523|3774053|P20|STARTED|Overall Study||27
1542389|NCT01342523|3774054|P19|STARTED|Overall Study||21
1542390|NCT01342523|3774055|P18|STARTED|Overall Study||27
1542391|NCT01342523|3774056|P17|STARTED|Overall Study||29
1542392|NCT01342523|3774057|P16|STARTED|Overall Study||32
1542393|NCT01342523|3774058|P15|STARTED|Overall Study||38
1542394|NCT01342523|3774059|P14|STARTED|Overall Study||38
1542395|NCT01342523|3774060|P13|STARTED|Overall Study||39
1542396|NCT01342523|3774061|P12|STARTED|Overall Study||38
1542397|NCT01342523|3774062|P11|STARTED|Overall Study||38
1542398|NCT01342523|3774063|P10|STARTED|Overall Study||28
1542399|NCT01342523|3774064|P9|STARTED|Overall Study||28
1542400|NCT01342523|3774065|P8|STARTED|Overall Study||27
1542401|NCT01342523|3774066|P7|STARTED|Overall Study||22
1542402|NCT01342523|3774067|P6|STARTED|Overall Study||36
1542403|NCT01342523|3774068|P5|STARTED|Overall Study||36
1542404|NCT01342523|3774069|P4|STARTED|Overall Study||33
1542405|NCT01342523|3774070|P3|STARTED|Overall Study||36
1542406|NCT01342523|3774071|P2|STARTED|Overall Study||32
1542407|NCT01342523|3774072|P1|STARTED|Overall Study||35
1542408|NCT01342510|3774089|P4|NOT COMPLETED|Overall Study||11
1542409|NCT01342510|3774090|P3|NOT COMPLETED|Overall Study||13
1542410|NCT01342510|3774091|P2|NOT COMPLETED|Overall Study||6
1542411|NCT01342510|3774092|P1|NOT COMPLETED|Overall Study||12
1542412|NCT01342510|3774089|P4|COMPLETED|Overall Study||39
1542413|NCT01342510|3774090|P3|COMPLETED|Overall Study||37
1542414|NCT01342510|3774091|P2|COMPLETED|Overall Study||44
1542415|NCT01342510|3774092|P1|COMPLETED|Overall Study||38
1542416|NCT01342510|3774089|P4|STARTED|Overall Study||50
1542417|NCT01342510|3774090|P3|STARTED|Overall Study||50
1542418|NCT01342510|3774091|P2|STARTED|Overall Study||50
1542419|NCT01342510|3774092|P1|STARTED|Overall Study||50
1542420|NCT01342484|3774105|P3|NOT COMPLETED|Overall Study||1
1542421|NCT01342484|3774106|P2|NOT COMPLETED|Overall Study||0
1542422|NCT01342484|3774107|P1|NOT COMPLETED|Overall Study||2
1542423|NCT01342484|3774105|P3|COMPLETED|Overall Study||13
1542424|NCT01342484|3774106|P2|COMPLETED|Overall Study||10
1542425|NCT01342484|3774107|P1|COMPLETED|Overall Study||13
1542426|NCT01342484|3774105|P3|STARTED|Overall Study||14
1542427|NCT01342484|3774106|P2|STARTED|Overall Study||10
1542428|NCT01342484|3774107|P1|STARTED|Overall Study||15
1542429|NCT01342471|3774123|P2|NOT COMPLETED|Overall Study||6
1542430|NCT01342471|3774124|P1|NOT COMPLETED|Overall Study||5
1542431|NCT01342471|3774123|P2|COMPLETED|Overall Study||23
1542432|NCT01342471|3774124|P1|COMPLETED|Overall Study||24
1542433|NCT01342471|3774123|P2|STARTED|Overall Study||29
1542434|NCT01342471|3774124|P1|STARTED|Overall Study||29
1542435|NCT01342458|3774140|P2|NOT COMPLETED|Overall Study||4
1542436|NCT01342458|3774141|P1|NOT COMPLETED|Overall Study||2
1542437|NCT01342458|3774140|P2|COMPLETED|Overall Study||24
1542438|NCT01342458|3774141|P1|COMPLETED|Overall Study||26
1542439|NCT01342458|3774140|P2|STARTED|Overall Study||28
1542440|NCT01342458|3774141|P1|STARTED|Overall Study||28
1542441|NCT01342445|3774163|P2|NOT COMPLETED|Overall Study||2
1542442|NCT01342445|3774164|P1|NOT COMPLETED|Overall Study||0
1542443|NCT01342445|3774163|P2|COMPLETED|Overall Study||22
1542444|NCT01342445|3774164|P1|COMPLETED|Overall Study||26
1542445|NCT01342445|3774163|P2|STARTED|Overall Study||24
1542446|NCT01342445|3774164|P1|STARTED|Overall Study||26
1542447|NCT01342341|3774180|P2|NOT COMPLETED|Overall Study||4
1542448|NCT01342341|3774181|P1|NOT COMPLETED|Overall Study||4
1542449|NCT01342341|3774180|P2|COMPLETED|Overall Study||20
1542450|NCT01342341|3774181|P1|COMPLETED|Overall Study||20
1542451|NCT01342341|3774180|P2|STARTED|Overall Study||24
1542452|NCT01342341|3774181|P1|STARTED|Overall Study||24
1542453|NCT01342211|3774192|P5|NOT COMPLETED|Overall Study||2
1542454|NCT01342211|3774193|P4|NOT COMPLETED|Overall Study||2
1542455|NCT01342211|3774194|P3|NOT COMPLETED|Overall Study||0
1542456|NCT01342211|3774195|P2|NOT COMPLETED|Overall Study||2
1542457|NCT01342211|3774196|P1|NOT COMPLETED|Overall Study||0
1542458|NCT01342211|3774192|P5|COMPLETED|Overall Study||16
1542459|NCT01342211|3774193|P4|COMPLETED|Overall Study||17
1542460|NCT01342211|3774194|P3|COMPLETED|Overall Study||18
1542461|NCT01342211|3774195|P2|COMPLETED|Overall Study||17
1542462|NCT01342211|3774196|P1|COMPLETED|Overall Study||19
1542463|NCT01342211|3774192|P5|Treated|Overall Study||17
1542464|NCT01342211|3774193|P4|Treated|Overall Study||19
1542465|NCT01342211|3774194|P3|Treated|Overall Study||18
1542466|NCT01342211|3774195|P2|Treated|Overall Study||17
1542467|NCT01342211|3774196|P1|Treated|Overall Study||19
1542468|NCT01342211|3774192|P5|STARTED|Overall Study||18
1542469|NCT01342211|3774193|P4|STARTED|Overall Study||19
1542470|NCT01342211|3774194|P3|STARTED|Overall Study||18
1542471|NCT01342211|3774195|P2|STARTED|Overall Study||19
1542472|NCT01342211|3774196|P1|STARTED|Overall Study||19
1542473|NCT01342172|3774262|P1|NOT COMPLETED|Overall Study||0
1542474|NCT01342172|3774262|P1|COMPLETED|Overall Study||9
1542475|NCT01342172|3774262|P1|STARTED|Overall Study||9
1542476|NCT01342107|3774268|P2|NOT COMPLETED|Overall Study||0
1542477|NCT01342107|3774269|P1|NOT COMPLETED|Overall Study||0
1542478|NCT01342107|3774268|P2|COMPLETED|Overall Study||32
1542479|NCT01342107|3774269|P1|COMPLETED|Overall Study||34
1542480|NCT01342107|3774268|P2|STARTED|Overall Study||32
1542481|NCT01342107|3774269|P1|STARTED|Overall Study||34
1542482|NCT01342094|3774277|P2|NOT COMPLETED|Overall Study||3
1542483|NCT01342094|3774278|P1|NOT COMPLETED|Overall Study||5
1542484|NCT01342094|3774277|P2|COMPLETED|Overall Study||81
1542485|NCT01342094|3774278|P1|COMPLETED|Overall Study||77
1542486|NCT01342094|3774277|P2|STARTED|Overall Study||84
1542487|NCT01342094|3774278|P1|STARTED|Overall Study||82
1542488|NCT01342081|3774287|P3|NOT COMPLETED|Overall Study||1
1542489|NCT01342081|3774288|P2|NOT COMPLETED|Overall Study||2
1542490|NCT01342081|3774289|P1|NOT COMPLETED|Overall Study||2
1542491|NCT01342081|3774287|P3|COMPLETED|Overall Study||163
1542492|NCT01342081|3774288|P2|COMPLETED|Overall Study||162
1542493|NCT01342081|3774289|P1|COMPLETED|Overall Study||159
1542494|NCT01342081|3774287|P3|STARTED|Overall Study||164
1542495|NCT01342081|3774288|P2|STARTED|Overall Study||164
1542496|NCT01342081|3774289|P1|STARTED|Overall Study||161
1542497|NCT01342029|3774297|P2|NOT COMPLETED|Period 2||0
1542498|NCT01342029|3774298|P1|NOT COMPLETED|Period 2||2
1542499|NCT01342029|3774297|P2|COMPLETED|Period 2||67
1542500|NCT01342029|3774298|P1|COMPLETED|Period 2||65
1542501|NCT01342029|3774297|P2|Dropout|Period 2||0
1542502|NCT01342029|3774298|P1|Dropout|Period 2||2
1542503|NCT01342029|3774297|P2|STARTED|Period 2||67
1542504|NCT01342029|3774298|P1|STARTED|Period 2||67
1542505|NCT01342029|3774297|P2|NOT COMPLETED|Washout||4
1542506|NCT01342029|3774298|P1|NOT COMPLETED|Washout||0
1542507|NCT01342029|3774297|P2|COMPLETED|Washout||67
1542508|NCT01342029|3774298|P1|COMPLETED|Washout||67
1542509|NCT01342029|3774297|P2|STARTED|Washout||71
1542510|NCT01342029|3774298|P1|STARTED|Washout||67
1542511|NCT01342029|3774297|P2|NOT COMPLETED|Period 1||1
1542512|NCT01342029|3774298|P1|NOT COMPLETED|Period 1||3
1542513|NCT01342029|3774297|P2|COMPLETED|Period 1||71
1542514|NCT01342029|3774298|P1|COMPLETED|Period 1||67
1542515|NCT01342029|3774297|P2|Dropout|Period 1||1
1542516|NCT01342029|3774298|P1|Dropout|Period 1||3
1542517|NCT01342029|3774297|P2|STARTED|Period 1||72
1542518|NCT01342029|3774298|P1|STARTED|Period 1||70
1542519|NCT01341990|3774308|P2|NOT COMPLETED|Overall Study||1
1542520|NCT01341990|3774309|P1|NOT COMPLETED|Overall Study||3
1542521|NCT01341990|3774308|P2|COMPLETED|Overall Study||32
1542522|NCT01341990|3774309|P1|COMPLETED|Overall Study||32
1542523|NCT01341990|3774308|P2|STARTED|Overall Study||33
1542524|NCT01341990|3774309|P1|STARTED|Overall Study||35
1542525|NCT01341977|3774319|P2|NOT COMPLETED|Overall Study||15
1542526|NCT01341977|3774320|P1|NOT COMPLETED|Overall Study||14
1542527|NCT01341977|3774319|P2|COMPLETED|Overall Study||270
1542528|NCT01341977|3774320|P1|COMPLETED|Overall Study||274
1542529|NCT01341977|3774319|P2|STARTED|Overall Study||285
1542530|NCT01341977|3774320|P1|STARTED|Overall Study||288
1542531|NCT01341912|3774326|P1|NOT COMPLETED|Overall Study||0
1542532|NCT01341912|3774326|P1|COMPLETED|Overall Study||3
1542533|NCT01341912|3774326|P1|STARTED|Overall Study||3
1542534|NCT01341782|3774333|P2|NOT COMPLETED|Overall Study||14
1542535|NCT01341782|3774334|P1|NOT COMPLETED|Overall Study||15
1542536|NCT01341782|3774333|P2|COMPLETED|Overall Study||114
1542537|NCT01341782|3774334|P1|COMPLETED|Overall Study||112
1542538|NCT01341782|3774333|P2|STARTED|Overall Study||128
1542539|NCT01341782|3774334|P1|STARTED|Overall Study||127
1542540|NCT01341600|3774353|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
1542541|NCT01341600|3774354|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
1542542|NCT01341600|3774355|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
1542543|NCT01341600|3774353|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
1542544|NCT01341600|3774354|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
1542545|NCT01341600|3774355|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
1542546|NCT01341600|3774353|P3|STARTED|Clopidogrel Plus Omeprazole||4
1542547|NCT01341600|3774354|P2|STARTED|Clopidogrel Plus Omeprazole||5
1542548|NCT01341600|3774355|P1|STARTED|Clopidogrel Plus Omeprazole||5
1542549|NCT01341600|3774353|P3|NOT COMPLETED|Clopidogrel 225 mg||0
1542550|NCT01341600|3774354|P2|NOT COMPLETED|Clopidogrel 225 mg||0
1542551|NCT01341600|3774355|P1|NOT COMPLETED|Clopidogrel 225 mg||0
1542552|NCT01341600|3774353|P3|COMPLETED|Clopidogrel 225 mg||6
1542553|NCT01341600|3774354|P2|COMPLETED|Clopidogrel 225 mg||6
1542554|NCT01341600|3774355|P1|COMPLETED|Clopidogrel 225 mg||6
1542555|NCT01341600|3774353|P3|STARTED|Clopidogrel 225 mg||6
1542556|NCT01341600|3774354|P2|STARTED|Clopidogrel 225 mg||6
1542557|NCT01341600|3774355|P1|STARTED|Clopidogrel 225 mg||6
1542558|NCT01341600|3774353|P3|NOT COMPLETED|Clopidogrel 150 mg||0
1542559|NCT01341600|3774354|P2|NOT COMPLETED|Clopidogrel 150 mg||0
1542560|NCT01341600|3774355|P1|NOT COMPLETED|Clopidogrel 150 mg||0
1542561|NCT01341600|3774353|P3|COMPLETED|Clopidogrel 150 mg||6
1542562|NCT01341600|3774354|P2|COMPLETED|Clopidogrel 150 mg||6
1542563|NCT01341600|3774355|P1|COMPLETED|Clopidogrel 150 mg||6
1542564|NCT01341600|3774353|P3|STARTED|Clopidogrel 150 mg||6
1542565|NCT01341600|3774354|P2|STARTED|Clopidogrel 150 mg||6
1542566|NCT01341600|3774355|P1|STARTED|Clopidogrel 150 mg||6
1542567|NCT01341600|3774353|P3|NOT COMPLETED|Clopidogrel 75 mg||0
1542568|NCT01341600|3774354|P2|NOT COMPLETED|Clopidogrel 75 mg||0
1542569|NCT01341600|3774355|P1|NOT COMPLETED|Clopidogrel 75 mg||0
1542570|NCT01341600|3774353|P3|COMPLETED|Clopidogrel 75 mg||6
1542571|NCT01341600|3774354|P2|COMPLETED|Clopidogrel 75 mg||6
1542572|NCT01341600|3774355|P1|COMPLETED|Clopidogrel 75 mg||6
1542573|NCT01341600|3774353|P3|STARTED|Clopidogrel 75 mg||6
1542574|NCT01341600|3774354|P2|STARTED|Clopidogrel 75 mg||6
1542575|NCT01341600|3774355|P1|STARTED|Clopidogrel 75 mg||6
1542576|NCT01341587|3774374|P2|NOT COMPLETED|Overall Study||10
1542577|NCT01341587|3774375|P1|NOT COMPLETED|Overall Study||4
1542578|NCT01341587|3774374|P2|COMPLETED|Overall Study||0
1542579|NCT01341587|3774375|P1|COMPLETED|Overall Study||0
1542580|NCT01341587|3774374|P2|STARTED|Overall Study||10
1542581|NCT01341587|3774375|P1|STARTED|Overall Study||4
1542582|NCT01341444|3774383|P2|NOT COMPLETED|Overall Study||3
1542583|NCT01341444|3774384|P1|NOT COMPLETED|Overall Study||5
1542584|NCT01341444|3774383|P2|COMPLETED|Overall Study||29
1542585|NCT01341444|3774384|P1|COMPLETED|Overall Study||26
1542586|NCT01341444|3774383|P2|STARTED|Overall Study||32
1542587|NCT01341444|3774384|P1|STARTED|Overall Study||31
1542588|NCT01341301|3774390|P1|NOT COMPLETED|Overall Study||0
1542589|NCT01341301|3774390|P1|COMPLETED|Overall Study||25
1542590|NCT01341301|3774390|P1|STARTED|Overall Study||25
1542591|NCT01341067|3774397|P1|NOT COMPLETED|Overall Study||4
1542592|NCT01341067|3774397|P1|COMPLETED|Overall Study||26
1542593|NCT01341067|3774397|P1|STARTED|Overall Study||30
1542594|NCT01340976|3774410|P6|NOT COMPLETED|Overall Study||1
1542595|NCT01340976|3774411|P5|NOT COMPLETED|Overall Study||2
1542596|NCT01340976|3774412|P4|NOT COMPLETED|Overall Study||3
1542597|NCT01340976|3774413|P3|NOT COMPLETED|Overall Study||3
1542598|NCT01340976|3774414|P2|NOT COMPLETED|Overall Study||2
1542599|NCT01340976|3774415|P1|NOT COMPLETED|Overall Study||4
1542600|NCT01340976|3774410|P6|COMPLETED|Overall Study||6
1542601|NCT01340976|3774411|P5|COMPLETED|Overall Study||5
1542602|NCT01340976|3774412|P4|COMPLETED|Overall Study||2
1542603|NCT01340976|3774413|P3|COMPLETED|Overall Study||4
1542604|NCT01340976|3774414|P2|COMPLETED|Overall Study||1
1542605|NCT01340976|3774415|P1|COMPLETED|Overall Study||0
1542606|NCT01340976|3774410|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
1542607|NCT01340976|3774411|P5|Received at Least 1 Dose of Study Drug|Overall Study||7
1542608|NCT01340976|3774412|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
1542609|NCT01340976|3774413|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
1542610|NCT01340976|3774414|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
1542611|NCT01340976|3774415|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
1542612|NCT01340976|3774410|P6|STARTED|Overall Study||7
1542613|NCT01340976|3774411|P5|STARTED|Overall Study||7
1542614|NCT01340976|3774412|P4|STARTED|Overall Study||5
1542615|NCT01340976|3774413|P3|STARTED|Overall Study||7
1542616|NCT01340976|3774414|P2|STARTED|Overall Study||3
1542617|NCT01340976|3774415|P1|STARTED|Overall Study||4
1542618|NCT01340937|3774453|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
1542619|NCT01340937|3774454|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
1542620|NCT01340937|3774455|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
1542621|NCT01340937|3774456|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
1542622|NCT01340937|3774453|P4|COMPLETED|Period 3: Toddler Vaccinations||319
1542623|NCT01340937|3774454|P3|COMPLETED|Period 3: Toddler Vaccinations||660
1542624|NCT01340937|3774455|P2|COMPLETED|Period 3: Toddler Vaccinations||641
1542625|NCT01340937|3774456|P1|COMPLETED|Period 3: Toddler Vaccinations||666
1542626|NCT01340937|3774453|P4|STARTED|Period 3: Toddler Vaccinations||329
1542627|NCT01340937|3774454|P3|STARTED|Period 3: Toddler Vaccinations||669
1542628|NCT01340937|3774455|P2|STARTED|Period 3: Toddler Vaccinations||658
1542629|NCT01340937|3774456|P1|STARTED|Period 3: Toddler Vaccinations||675
1542630|NCT01340937|3774453|P4|NOT COMPLETED|Period 2: Interim Period||41
1542631|NCT01340937|3774454|P3|NOT COMPLETED|Period 2: Interim Period||84
1542632|NCT01340937|3774455|P2|NOT COMPLETED|Period 2: Interim Period||79
1542633|NCT01340937|3774456|P1|NOT COMPLETED|Period 2: Interim Period||67
1542634|NCT01340937|3774453|P4|COMPLETED|Period 2: Interim Period||329
1542635|NCT01340937|3774454|P3|COMPLETED|Period 2: Interim Period||669
1542636|NCT01340937|3774455|P2|COMPLETED|Period 2: Interim Period||658
1542637|NCT01340937|3774456|P1|COMPLETED|Period 2: Interim Period||675
1542638|NCT01340937|3774453|P4|STARTED|Period 2: Interim Period||370
1542639|NCT01340937|3774454|P3|STARTED|Period 2: Interim Period||753
1542640|NCT01340937|3774455|P2|STARTED|Period 2: Interim Period||737
1542641|NCT01340937|3774456|P1|STARTED|Period 2: Interim Period||742
1542642|NCT01340937|3774453|P4|NOT COMPLETED|Period 1: Infant Series||32
1542643|NCT01340937|3774454|P3|NOT COMPLETED|Period 1: Infant Series||56
1542644|NCT01340937|3774455|P2|NOT COMPLETED|Period 1: Infant Series||60
1542645|NCT01340937|3774456|P1|NOT COMPLETED|Period 1: Infant Series||58
1542646|NCT01340937|3774453|P4|COMPLETED|Period 1: Infant Series||370
1542647|NCT01340937|3774454|P3|COMPLETED|Period 1: Infant Series||753
1542648|NCT01340937|3774455|P2|COMPLETED|Period 1: Infant Series||737
1542649|NCT01340937|3774456|P1|COMPLETED|Period 1: Infant Series||742
1542650|NCT01340937|3774453|P4|STARTED|Period 1: Infant Series||402
1542651|NCT01340937|3774454|P3|STARTED|Period 1: Infant Series||809
1542652|NCT01340937|3774455|P2|STARTED|Period 1: Infant Series||797
1542653|NCT01340937|3774456|P1|STARTED|Period 1: Infant Series||800
1542654|NCT01340872|3774615|P4|NOT COMPLETED|Open-label Phase||11
1542655|NCT01340872|3774616|P3|NOT COMPLETED|Open-label Phase||13
1542656|NCT01340872|3774617|P2|NOT COMPLETED|Open-label Phase||0
1542657|NCT01340872|3774618|P1|NOT COMPLETED|Open-label Phase||0
1542658|NCT01340872|3774615|P4|COMPLETED|Open-label Phase||36
1542659|NCT01340872|3774616|P3|COMPLETED|Open-label Phase||37
1542660|NCT01340872|3774617|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1542661|NCT01340872|3774618|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1542662|NCT01340872|3774615|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
1542663|NCT01340872|3774616|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
1542664|NCT01340872|3774617|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1542665|NCT01340872|3774618|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1542666|NCT01340872|3774615|P4|NOT COMPLETED|Double-blind Phase||0
1542667|NCT01340872|3774616|P3|NOT COMPLETED|Double-blind Phase||0
1542668|NCT01340872|3774617|P2|NOT COMPLETED|Double-blind Phase||11
1542669|NCT01340872|3774618|P1|NOT COMPLETED|Double-blind Phase||9
1542670|NCT01340872|3774615|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1542671|NCT01340872|3774616|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1542672|NCT01340872|3774617|P2|COMPLETED|Double-blind Phase||53
1542673|NCT01340872|3774618|P1|COMPLETED|Double-blind Phase||55
1542674|NCT01340872|3774615|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1542675|NCT01340872|3774616|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1542676|NCT01340872|3774617|P2|STARTED|Double-blind Phase||64
1542677|NCT01340872|3774618|P1|STARTED|Double-blind Phase||64
1542678|NCT01340794|3774678|P2|NOT COMPLETED|Overall Study||1
1542679|NCT01340794|3774679|P1|NOT COMPLETED|Overall Study||0
1542680|NCT01340794|3774678|P2|COMPLETED|Overall Study||4
1542681|NCT01340794|3774679|P1|COMPLETED|Overall Study||2
1542682|NCT01340794|3774678|P2|STARTED|Overall Study||5
1542683|NCT01340794|3774679|P1|STARTED|Overall Study||2
1542684|NCT01340768|3774695|P2|NOT COMPLETED|Overall Study||5
1542685|NCT01340768|3774696|P1|NOT COMPLETED|Overall Study||17
1542686|NCT01340768|3774695|P2|COMPLETED|Overall Study||429
1542687|NCT01340768|3774696|P1|COMPLETED|Overall Study||419
1542688|NCT01340768|3774695|P2|STARTED|Overall Study||434
1542689|NCT01340768|3774696|P1|STARTED|Overall Study||436
1542690|NCT01340664|3774707|P3|NOT COMPLETED|Overall Study||13
1542691|NCT01340664|3774708|P2|NOT COMPLETED|Overall Study||8
1542692|NCT01340664|3774709|P1|NOT COMPLETED|Overall Study||7
1542693|NCT01340664|3774707|P3|COMPLETED|Overall Study||80
1542694|NCT01340664|3774708|P2|COMPLETED|Overall Study||85
1542695|NCT01340664|3774709|P1|COMPLETED|Overall Study||86
1542696|NCT01340664|3774707|P3|STARTED|Overall Study||93
1542697|NCT01340664|3774708|P2|STARTED|Overall Study||93
1542698|NCT01340664|3774709|P1|STARTED|Overall Study||93
1542699|NCT01340651|3774726|P1|NOT COMPLETED|Overall Study||17
1542700|NCT01340651|3774726|P1|COMPLETED|Overall Study||24
1542701|NCT01340651|3774726|P1|STARTED|Overall Study||41
1542702|NCT01340625|3774742|P2|NOT COMPLETED|Second Intervention||0
1542703|NCT01340625|3774743|P1|NOT COMPLETED|Second Intervention||0
1542704|NCT01340625|3774742|P2|COMPLETED|Second Intervention||18
1542705|NCT01340625|3774743|P1|COMPLETED|Second Intervention||16
1542706|NCT01340625|3774742|P2|STARTED|Second Intervention||18
1542707|NCT01340625|3774743|P1|STARTED|Second Intervention||16
1542708|NCT01340625|3774742|P2|NOT COMPLETED|Washout Period of 28 Days||0
1542709|NCT01340625|3774743|P1|NOT COMPLETED|Washout Period of 28 Days||1
1542710|NCT01340625|3774742|P2|COMPLETED|Washout Period of 28 Days||18
1542711|NCT01340625|3774743|P1|COMPLETED|Washout Period of 28 Days||16
1542712|NCT01340625|3774742|P2|STARTED|Washout Period of 28 Days||18
1542713|NCT01340625|3774743|P1|STARTED|Washout Period of 28 Days||17
1542714|NCT01340625|3774742|P2|NOT COMPLETED|First Intervention||0
1542715|NCT01340625|3774743|P1|NOT COMPLETED|First Intervention||1
1542716|NCT01340625|3774742|P2|COMPLETED|First Intervention||18
1542717|NCT01340625|3774743|P1|COMPLETED|First Intervention||17
1542718|NCT01340625|3774742|P2|STARTED|First Intervention||18
1542719|NCT01340625|3774743|P1|STARTED|First Intervention||18
1542720|NCT01340586|3774761|P2|NOT COMPLETED|Overall Study||0
1542721|NCT01340586|3774762|P1|NOT COMPLETED|Overall Study||0
1542722|NCT01340586|3774761|P2|COMPLETED|Overall Study||8
1542723|NCT01340586|3774762|P1|COMPLETED|Overall Study||8
1542724|NCT01340586|3774761|P2|STARTED|Overall Study||8
1542725|NCT01340586|3774762|P1|STARTED|Overall Study||8
1542726|NCT01340573|3774827|P1|NOT COMPLETED|Overall Study||3
1542727|NCT01340573|3774827|P1|COMPLETED|Overall Study||0
1542728|NCT01340573|3774827|P1|STARTED|Overall Study||3
1542729|NCT01340495|3774848|P1|NOT COMPLETED|Overall Study||1
1542730|NCT01340495|3774848|P1|COMPLETED|Overall Study||69
1542731|NCT01340495|3774848|P1|STARTED|Overall Study||70
1542732|NCT01340300|3774859|P4|NOT COMPLETED|Overall Study||14
1542733|NCT01340300|3774860|P3|NOT COMPLETED|Overall Study||15
1542734|NCT01340300|3774861|P2|NOT COMPLETED|Overall Study||9
1542735|NCT01340300|3774862|P1|NOT COMPLETED|Overall Study||9
1542736|NCT01340300|3774859|P4|COMPLETED|Overall Study||20
1542737|NCT01340300|3774860|P3|COMPLETED|Overall Study||20
1542738|NCT01340300|3774861|P2|COMPLETED|Overall Study||26
1542739|NCT01340300|3774862|P1|COMPLETED|Overall Study||26
1542740|NCT01340300|3774859|P4|Follow-up Blood Sample|Overall Study||18
1542741|NCT01340300|3774860|P3|Follow-up Blood Sample|Overall Study||19
1542742|NCT01340300|3774861|P2|Follow-up Blood Sample|Overall Study||26
1542743|NCT01340300|3774862|P1|Follow-up Blood Sample|Overall Study||25
1542744|NCT01340300|3774859|P4|Baseline Blood Sample|Overall Study||29
1542745|NCT01340300|3774860|P3|Baseline Blood Sample|Overall Study||32
1542746|NCT01340300|3774861|P2|Baseline Blood Sample|Overall Study||34
1542747|NCT01340300|3774862|P1|Baseline Blood Sample|Overall Study||33
1542748|NCT01340300|3774859|P4|STARTED|Overall Study||34
1542749|NCT01340300|3774860|P3|STARTED|Overall Study||35
1542750|NCT01340300|3774861|P2|STARTED|Overall Study||35
1542751|NCT01340300|3774862|P1|STARTED|Overall Study||35
1542752|NCT01340209|3774895|P3|NOT COMPLETED|Overall Study||8
1542753|NCT01340209|3774896|P2|NOT COMPLETED|Overall Study||8
1542754|NCT01340209|3774897|P1|NOT COMPLETED|Overall Study||5
1542755|NCT01340209|3774895|P3|COMPLETED|Overall Study||106
1542756|NCT01340209|3774896|P2|COMPLETED|Overall Study||106
1542757|NCT01340209|3774897|P1|COMPLETED|Overall Study||52
1542758|NCT01340209|3774895|P3|STARTED|Overall Study||114
1542759|NCT01340209|3774896|P2|STARTED|Overall Study||114
1542760|NCT01340209|3774897|P1|STARTED|Overall Study||57
1542761|NCT01340196|3774932|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
1542762|NCT01340196|3774932|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
1542763|NCT01340196|3774932|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
1542764|NCT01340196|3774932|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
1542765|NCT01340196|3774932|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
1542766|NCT01340196|3774932|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
1542767|NCT01340196|3774932|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
1542768|NCT01340196|3774932|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
1542769|NCT01340196|3774932|P1|STARTED|Treat. Period 1 (Tenofovir)||16
1542770|NCT01340144|3774963|P2|NOT COMPLETED|Overall Study||58
1542771|NCT01340144|3774964|P1|NOT COMPLETED|Overall Study||72
1542772|NCT01340144|3774963|P2|COMPLETED|Overall Study||567
1542773|NCT01340144|3774964|P1|COMPLETED|Overall Study||553
1542774|NCT01340144|3774963|P2|STARTED|Overall Study||625
1542775|NCT01340144|3774964|P1|STARTED|Overall Study||625
1542776|NCT01340066|3774972|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
1542777|NCT01340066|3774973|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
1542778|NCT01340066|3774974|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
1542779|NCT01340066|3774972|P3|COMPLETED|5 Week Double Blind Randomization Period||31
1542780|NCT01340066|3774973|P2|COMPLETED|5 Week Double Blind Randomization Period||28
1542781|NCT01340066|3774974|P1|COMPLETED|5 Week Double Blind Randomization Period||0
1542782|NCT01340066|3774972|P3|STARTED|5 Week Double Blind Randomization Period||34
1542783|NCT01340066|3774973|P2|STARTED|5 Week Double Blind Randomization Period||33
1542784|NCT01340066|3774974|P1|STARTED|5 Week Double Blind Randomization Period||0
1542785|NCT01340066|3774972|P3|NOT COMPLETED|Placebo Run in Period||0
1542786|NCT01340066|3774973|P2|NOT COMPLETED|Placebo Run in Period||0
1542787|NCT01340066|3774974|P1|NOT COMPLETED|Placebo Run in Period||27
1542788|NCT01340066|3774972|P3|COMPLETED|Placebo Run in Period||0
1542789|NCT01340066|3774973|P2|COMPLETED|Placebo Run in Period||0
1542790|NCT01340066|3774974|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
1542791|NCT01340066|3774972|P3|STARTED|Placebo Run in Period||0
1542792|NCT01340066|3774973|P2|STARTED|Placebo Run in Period||0
1542793|NCT01340066|3774974|P1|STARTED|Placebo Run in Period||94
1542794|NCT01340027|3774993|P12|NOT COMPLETED|Overall Study||4
1542795|NCT01340027|3774994|P11|NOT COMPLETED|Overall Study||2
1542796|NCT01340027|3774995|P10|NOT COMPLETED|Overall Study||6
1542797|NCT01340027|3774996|P9|NOT COMPLETED|Overall Study||8
1542798|NCT01340027|3774997|P8|NOT COMPLETED|Overall Study||7
1542799|NCT01340027|3774998|P7|NOT COMPLETED|Overall Study||7
1542800|NCT01340027|3774999|P6|NOT COMPLETED|Overall Study||4
1542801|NCT01340027|3775000|P5|NOT COMPLETED|Overall Study||10
1542802|NCT01340027|3775001|P4|NOT COMPLETED|Overall Study||4
1542803|NCT01340027|3775002|P3|NOT COMPLETED|Overall Study||4
1542804|NCT01340027|3775003|P2|NOT COMPLETED|Overall Study||7
1542805|NCT01340027|3775004|P1|NOT COMPLETED|Overall Study||5
1542806|NCT01340027|3774993|P12|COMPLETED|Overall Study||77
1542807|NCT01340027|3774994|P11|COMPLETED|Overall Study||79
1542808|NCT01340027|3774995|P10|COMPLETED|Overall Study||146
1542809|NCT01340027|3774996|P9|COMPLETED|Overall Study||136
1542810|NCT01340027|3774997|P8|COMPLETED|Overall Study||142
1542811|NCT01340027|3774998|P7|COMPLETED|Overall Study||142
1542812|NCT01340027|3774999|P6|COMPLETED|Overall Study||74
1542813|NCT01340027|3775000|P5|COMPLETED|Overall Study||146
1542814|NCT01340027|3775001|P4|COMPLETED|Overall Study||75
1542815|NCT01340027|3775002|P3|COMPLETED|Overall Study||75
1542816|NCT01340027|3775003|P2|COMPLETED|Overall Study||71
1542817|NCT01340027|3775004|P1|COMPLETED|Overall Study||76
1542818|NCT01340027|3774993|P12|Received Treatment|Overall Study||81
1542819|NCT01340027|3774994|P11|Received Treatment|Overall Study||81
1542820|NCT01340027|3774995|P10|Received Treatment|Overall Study||152
1542821|NCT01340027|3774996|P9|Received Treatment|Overall Study||144
1542822|NCT01340027|3774997|P8|Received Treatment|Overall Study||149
1542823|NCT01340027|3774998|P7|Received Treatment|Overall Study||149
1542824|NCT01340027|3774999|P6|Received Treatment|Overall Study||78
1542825|NCT01340027|3775000|P5|Received Treatment|Overall Study||156
1542826|NCT01340027|3775001|P4|Received Treatment|Overall Study||79
1542827|NCT01340027|3775002|P3|Received Treatment|Overall Study||78
1542828|NCT01340027|3775003|P2|Received Treatment|Overall Study||78
1542829|NCT01340027|3775004|P1|Received Treatment|Overall Study||81
1542830|NCT01340027|3774993|P12|STARTED|Overall Study||81
1542831|NCT01340027|3774994|P11|STARTED|Overall Study||81
1542832|NCT01340027|3774995|P10|STARTED|Overall Study||152
1542833|NCT01340027|3774996|P9|STARTED|Overall Study||144
1542834|NCT01340027|3774997|P8|STARTED|Overall Study||149
1542835|NCT01340027|3774998|P7|STARTED|Overall Study||149
1542836|NCT01340027|3774999|P6|STARTED|Overall Study||78
1542837|NCT01340027|3775000|P5|STARTED|Overall Study||156
1542838|NCT01340027|3775001|P4|STARTED|Overall Study||79
1542839|NCT01340027|3775002|P3|STARTED|Overall Study||79
1542840|NCT01340027|3775003|P2|STARTED|Overall Study||78
1542841|NCT01340027|3775004|P1|STARTED|Overall Study||81
1542842|NCT01340014|3775380|P2|NOT COMPLETED|Period 2, Second 7 Days||1
1542843|NCT01340014|3775381|P1|NOT COMPLETED|Period 2, Second 7 Days||0
1542844|NCT01340014|3775380|P2|COMPLETED|Period 2, Second 7 Days||56
1542845|NCT01340014|3775381|P1|COMPLETED|Period 2, Second 7 Days||53
1542846|NCT01340014|3775380|P2|STARTED|Period 2, Second 7 Days||57
1542847|NCT01340014|3775381|P1|STARTED|Period 2, Second 7 Days||53
1542848|NCT01340014|3775380|P2|NOT COMPLETED|Period 1, First 7 Days||0
1542849|NCT01340014|3775381|P1|NOT COMPLETED|Period 1, First 7 Days||2
1542850|NCT01340014|3775380|P2|COMPLETED|Period 1, First 7 Days||57
1542851|NCT01340014|3775381|P1|COMPLETED|Period 1, First 7 Days||53
1542852|NCT01340014|3775380|P2|STARTED|Period 1, First 7 Days||57
1542853|NCT01340014|3775381|P1|STARTED|Period 1, First 7 Days||55
1542854|NCT01339936|3775389|P1|NOT COMPLETED|Overall Study||2
1542855|NCT01339936|3775389|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
1542856|NCT01339936|3775389|P1|STARTED|Overall Study|plus 2 screen failures|38
1542857|NCT01339923|3775402|P7|NOT COMPLETED|Overall Study||14
1542858|NCT01339923|3775403|P6|NOT COMPLETED|Overall Study||9
1542859|NCT01339923|3775404|P5|NOT COMPLETED|Overall Study||5
1542860|NCT01339923|3775405|P4|NOT COMPLETED|Overall Study||4
1542861|NCT01339923|3775406|P3|NOT COMPLETED|Overall Study||8
1542862|NCT01339923|3775407|P2|NOT COMPLETED|Overall Study||16
1542863|NCT01339923|3775408|P1|NOT COMPLETED|Overall Study||14
1542864|NCT01339923|3775402|P7|COMPLETED|Overall Study||111
1542865|NCT01339923|3775403|P6|COMPLETED|Overall Study||117
1542866|NCT01339923|3775404|P5|COMPLETED|Overall Study||295
1542867|NCT01339923|3775405|P4|COMPLETED|Overall Study||100
1542868|NCT01339923|3775406|P3|COMPLETED|Overall Study||243
1542869|NCT01339923|3775407|P2|COMPLETED|Overall Study||234
1542870|NCT01339923|3775408|P1|COMPLETED|Overall Study||239
1542871|NCT01339923|3775402|P7|STARTED|Overall Study||125
1542872|NCT01339923|3775403|P6|STARTED|Overall Study||126
1542873|NCT01339923|3775404|P5|STARTED|Overall Study||300
1542874|NCT01339923|3775405|P4|STARTED|Overall Study||104
1542875|NCT01339923|3775406|P3|STARTED|Overall Study||251
1542876|NCT01339923|3775407|P2|STARTED|Overall Study||250
1542877|NCT01339923|3775408|P1|STARTED|Overall Study||253
1542878|NCT01339910|3775479|P2|NOT COMPLETED|Overall Study||4
1542879|NCT01339910|3775480|P1|NOT COMPLETED|Overall Study||3
1542880|NCT01339910|3775479|P2|COMPLETED|Overall Study||133
1542881|NCT01339910|3775480|P1|COMPLETED|Overall Study||132
1542882|NCT01339910|3775479|P2|STARTED|Overall Study||137
1542883|NCT01339910|3775480|P1|STARTED|Overall Study||135
1542884|NCT01339897|3775518|P4|NOT COMPLETED|Overall Study||1
1542885|NCT01339897|3775519|P3|NOT COMPLETED|Overall Study||0
1542886|NCT01339897|3775520|P2|NOT COMPLETED|Overall Study||0
1542887|NCT01339897|3775521|P1|NOT COMPLETED|Overall Study||1
1542888|NCT01339897|3775518|P4|COMPLETED|Overall Study||5
1542889|NCT01339897|3775519|P3|COMPLETED|Overall Study||6
1542890|NCT01339897|3775520|P2|COMPLETED|Overall Study||6
1542891|NCT01339897|3775521|P1|COMPLETED|Overall Study||6
1542892|NCT01339897|3775518|P4|STARTED|Overall Study||6
1542893|NCT01339897|3775519|P3|STARTED|Overall Study||6
1542894|NCT01339897|3775520|P2|STARTED|Overall Study||6
1542895|NCT01339897|3775521|P1|STARTED|Overall Study||7
1542896|NCT01339832|3775547|P1|NOT COMPLETED|Overall Study||14
1542897|NCT01339832|3775547|P1|COMPLETED|Overall Study||37
1542898|NCT01339832|3775547|P1|STARTED|Overall Study||51
1542899|NCT01339429|3775558|P1|NOT COMPLETED|Overall Study||4
1542900|NCT01339429|3775558|P1|COMPLETED|Overall Study||37
1542901|NCT01339429|3775558|P1|STARTED|Overall Study||41
1542902|NCT01339416|3775563|P1|NOT COMPLETED|Overall Study||0
1542903|NCT01339416|3775563|P1|COMPLETED|Overall Study||8202
1542904|NCT01339416|3775563|P1|STARTED|Overall Study||8202
1542905|NCT01339403|3775575|P2|NOT COMPLETED|Overall Study||0
1542906|NCT01339403|3775576|P1|NOT COMPLETED|Overall Study||0
1542907|NCT01339403|3775575|P2|COMPLETED|Overall Study||257600
1542908|NCT01339403|3775576|P1|COMPLETED|Overall Study||24768
1542909|NCT01339403|3775575|P2|STARTED|Overall Study||257600
1542910|NCT01339403|3775576|P1|STARTED|Overall Study||24768
1542911|NCT01339390|3775598|P2|NOT COMPLETED|Overall Study||156
1542912|NCT01339390|3775599|P1|NOT COMPLETED|Overall Study||157
1542913|NCT01339390|3775598|P2|COMPLETED|Overall Study||1442
1542914|NCT01339390|3775599|P1|COMPLETED|Overall Study||1414
1542915|NCT01339390|3775598|P2|STARTED|Overall Study||1598
1542916|NCT01339390|3775599|P1|STARTED|Overall Study||1571
1542917|NCT01339299|3775607|P2|NOT COMPLETED|Overall Study||0
1542918|NCT01339299|3775608|P1|NOT COMPLETED|Overall Study||0
1542919|NCT01339299|3775607|P2|COMPLETED|Overall Study||50
1542920|NCT01339299|3775608|P1|COMPLETED|Overall Study||50
1542921|NCT01339299|3775607|P2|STARTED|Overall Study||50
1542922|NCT01339299|3775608|P1|STARTED|Overall Study||50
1542923|NCT01339260|3775616|P2|NOT COMPLETED|Multi-cycle Extension||193
1542924|NCT01339260|3775617|P1|NOT COMPLETED|Multi-cycle Extension||186
1542925|NCT01339260|3775616|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
1542926|NCT01339260|3775617|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
1542927|NCT01339260|3775616|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
1542928|NCT01339260|3775617|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
1542929|NCT01339260|3775616|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
1542930|NCT01339260|3775617|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
1542931|NCT01339260|3775616|P2|NOT COMPLETED|Cycle 1||10
1542932|NCT01339260|3775617|P1|NOT COMPLETED|Cycle 1||7
1542933|NCT01339260|3775616|P2|COMPLETED|Cycle 1||719
1542934|NCT01339260|3775617|P1|COMPLETED|Cycle 1||719
1542935|NCT01339260|3775616|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
1542936|NCT01339260|3775617|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
1542937|NCT01339260|3775616|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
1542938|NCT01339260|3775617|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
1542939|NCT01339260|3775616|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
1542940|NCT01339260|3775617|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
1542941|NCT01339247|3775629|P2|NOT COMPLETED|Period 2||0
1542942|NCT01339247|3775630|P1|NOT COMPLETED|Period 2||0
1542943|NCT01339247|3775629|P2|COMPLETED|Period 2||30
1542944|NCT01339247|3775630|P1|COMPLETED|Period 2||30
1542945|NCT01339247|3775629|P2|STARTED|Period 2||30
1542946|NCT01339247|3775630|P1|STARTED|Period 2||30
1542947|NCT01339247|3775629|P2|NOT COMPLETED|Period 1||0
1542948|NCT01339247|3775630|P1|NOT COMPLETED|Period 1||0
1542949|NCT01339247|3775629|P2|COMPLETED|Period 1||30
1542950|NCT01339247|3775630|P1|COMPLETED|Period 1||30
1542951|NCT01339247|3775629|P2|STARTED|Period 1||30
1542952|NCT01339247|3775630|P1|STARTED|Period 1||30
1542953|NCT01339091|3775642|P2|NOT COMPLETED|Overall Study||28
1542954|NCT01339091|3775643|P1|NOT COMPLETED|Overall Study||27
1542955|NCT01339091|3775642|P2|COMPLETED|Overall Study||257
1542956|NCT01339091|3775643|P1|COMPLETED|Overall Study||261
1542957|NCT01339091|3775642|P2|Safety Population|Overall Study||284
1542958|NCT01339091|3775643|P1|Safety Population|Overall Study||284
1542959|NCT01339091|3775642|P2|STARTED|Overall Study||285
1542960|NCT01339091|3775643|P1|STARTED|Overall Study||288
1542961|NCT01339052|3775657|P2|NOT COMPLETED|Overall Study||50
1542962|NCT01339052|3775658|P1|NOT COMPLETED|Overall Study||15
1542963|NCT01339052|3775657|P2|COMPLETED|Overall Study||0
1542964|NCT01339052|3775658|P1|COMPLETED|Overall Study||0
1542965|NCT01339052|3775657|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
1542966|NCT01339052|3775658|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
1542967|NCT01339052|3775657|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
1542968|NCT01339052|3775658|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
1542969|NCT01339052|3775657|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
1542970|NCT01339052|3775658|P1|Measurable Disease|Overall Study||11
1542971|NCT01339052|3775657|P2|STARTED|Overall Study||50
1542972|NCT01339052|3775658|P1|STARTED|Overall Study||15
1542973|NCT01339013|3775678|P1|NOT COMPLETED|Overall Study||0
1542974|NCT01339013|3775678|P1|COMPLETED|Overall Study||6
1542975|NCT01339013|3775678|P1|STARTED|Overall Study||6
1542976|NCT01339000|3775684|P2|NOT COMPLETED|Overall Study||0
1542977|NCT01339000|3775685|P1|NOT COMPLETED|Overall Study||1
1542978|NCT01339000|3775684|P2|COMPLETED|Overall Study||0
1542979|NCT01339000|3775685|P1|COMPLETED|Overall Study||0
1542980|NCT01339000|3775684|P2|STARTED|Overall Study||0
1542981|NCT01339000|3775685|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
1542982|NCT01338870|3775705|P6|NOT COMPLETED|Overall Study||6
1542983|NCT01338870|3775706|P5|NOT COMPLETED|Overall Study||6
1542984|NCT01338870|3775707|P4|NOT COMPLETED|Overall Study||9
1542985|NCT01338870|3775708|P3|NOT COMPLETED|Overall Study||11
1542986|NCT01338870|3775709|P2|NOT COMPLETED|Overall Study||12
1542987|NCT01338870|3775710|P1|NOT COMPLETED|Overall Study||9
1542988|NCT01338870|3775705|P6|COMPLETED|Overall Study||44
1542989|NCT01338870|3775706|P5|COMPLETED|Overall Study||46
1542990|NCT01338870|3775707|P4|COMPLETED|Overall Study||41
1542991|NCT01338870|3775708|P3|COMPLETED|Overall Study||39
1542992|NCT01338870|3775709|P2|COMPLETED|Overall Study||37
1542993|NCT01338870|3775710|P1|COMPLETED|Overall Study||41
1542994|NCT01338870|3775705|P6|STARTED|Overall Study||50
1542995|NCT01338870|3775706|P5|STARTED|Overall Study||52
1542996|NCT01338870|3775707|P4|STARTED|Overall Study||50
1542997|NCT01338870|3775708|P3|STARTED|Overall Study||50
1542998|NCT01338870|3775709|P2|STARTED|Overall Study||49
1542999|NCT01338870|3775710|P1|STARTED|Overall Study||50
1543000|NCT01338857|3775760|P1|NOT COMPLETED|Overall Study||11
1543001|NCT01338857|3775760|P1|COMPLETED|Overall Study||1
1543002|NCT01338857|3775760|P1|STARTED|Overall Study||12
1543003|NCT01338818|3775765|P1|NOT COMPLETED|Overall Study||36
1543004|NCT01338818|3775765|P1|COMPLETED|Overall Study||262
1543005|NCT01338818|3775765|P1|STARTED|Overall Study||298
1543006|NCT01338792|3775771|P1|NOT COMPLETED|Overall Study||4
1543007|NCT01338792|3775771|P1|COMPLETED|Overall Study||43
1543008|NCT01338792|3775771|P1|STARTED|Overall Study||47
1543009|NCT01338649|3775779|P2|NOT COMPLETED|Overall Study||0
1543010|NCT01338649|3775780|P1|NOT COMPLETED|Overall Study||0
1543011|NCT01338649|3775779|P2|COMPLETED|Overall Study||14
1543012|NCT01338649|3775780|P1|COMPLETED|Overall Study||13
1543013|NCT01338649|3775779|P2|STARTED|Overall Study||14
1543014|NCT01338649|3775780|P1|STARTED|Overall Study||13
1543015|NCT01338636|3775786|P1|NOT COMPLETED|Overall Study||8
1543016|NCT01338636|3775786|P1|COMPLETED|Overall Study||22
1543017|NCT01338636|3775786|P1|STARTED|Overall Study||30
1543018|NCT01338610|3775800|P3|NOT COMPLETED|Overall Study||1
1543019|NCT01338610|3775801|P2|NOT COMPLETED|Overall Study||1
1543020|NCT01338610|3775802|P1|NOT COMPLETED|Overall Study||5
1543021|NCT01338610|3775800|P3|COMPLETED|Overall Study||28
1543022|NCT01338610|3775801|P2|COMPLETED|Overall Study||55
1543023|NCT01338610|3775802|P1|COMPLETED|Overall Study||34
1543024|NCT01338610|3775800|P3|STARTED|Overall Study||29
1543025|NCT01338610|3775801|P2|STARTED|Overall Study||56
1543026|NCT01338610|3775802|P1|STARTED|Overall Study||39
1543027|NCT01338493|3775809|P1|NOT COMPLETED|24 Months Follow up||0
1543028|NCT01338493|3775809|P1|COMPLETED|24 Months Follow up||104
1543029|NCT01338493|3775809|P1|STARTED|24 Months Follow up||104
1543030|NCT01338493|3775809|P1|NOT COMPLETED|12 Months Follow up||9
1543031|NCT01338493|3775809|P1|COMPLETED|12 Months Follow up||104
1543032|NCT01338493|3775809|P1|STARTED|12 Months Follow up||113
1543033|NCT01338493|3775809|P1|NOT COMPLETED|6 Months Follow up||19
1543034|NCT01338493|3775809|P1|COMPLETED|6 Months Follow up||113
1543035|NCT01338493|3775809|P1|STARTED|6 Months Follow up||132
1543036|NCT01338493|3775809|P1|NOT COMPLETED|Discharge||2
1543037|NCT01338493|3775809|P1|COMPLETED|Discharge||132
1543038|NCT01338493|3775809|P1|STARTED|Discharge||134
1543039|NCT01338493|3775809|P1|NOT COMPLETED|Implant||0
1543040|NCT01338493|3775809|P1|COMPLETED|Implant||134
1543041|NCT01338493|3775809|P1|STARTED|Implant||134
1543042|NCT01338493|3775809|P1|NOT COMPLETED|Enrolled||5
1543043|NCT01338493|3775809|P1|COMPLETED|Enrolled||134
1543044|NCT01338493|3775809|P1|STARTED|Enrolled||139
1543045|NCT01338415|3775816|P2|NOT COMPLETED|Overall Study||9
1543046|NCT01338415|3775817|P1|NOT COMPLETED|Overall Study||10
1543047|NCT01338415|3775816|P2|COMPLETED|Overall Study||22
1543048|NCT01338415|3775817|P1|COMPLETED|Overall Study||23
1543049|NCT01338415|3775816|P2|Enrolled in FUTURE 3 Extension|Overall Study||27
1543050|NCT01338415|3775817|P1|Enrolled in FUTURE 3 Extension|Overall Study||31
1543051|NCT01338415|3775816|P2|STARTED|Overall Study||31
1543052|NCT01338415|3775817|P1|STARTED|Overall Study||33
1543053|NCT01338298|3775839|P2|NOT COMPLETED|Overall Study||3
1543054|NCT01338298|3775840|P1|NOT COMPLETED|Overall Study||4
1543055|NCT01338298|3775839|P2|COMPLETED|Overall Study||15
1543056|NCT01338298|3775840|P1|COMPLETED|Overall Study||20
1543057|NCT01338298|3775839|P2|STARTED|Overall Study||18
1543058|NCT01338298|3775840|P1|STARTED|Overall Study||24
1543059|NCT01338025|3775850|P2|NOT COMPLETED|Overall Study||11
1543060|NCT01338025|3775851|P1|NOT COMPLETED|Overall Study||11
1543061|NCT01338025|3775850|P2|COMPLETED|Overall Study||6
1543062|NCT01338025|3775851|P1|COMPLETED|Overall Study||5
1543063|NCT01338025|3775850|P2|STARTED|Overall Study||17
1543064|NCT01338025|3775851|P1|STARTED|Overall Study||16
1543065|NCT01338012|3775863|P1|NOT COMPLETED|Overall Study||8
1543066|NCT01338012|3775863|P1|COMPLETED|Overall Study||0
1543067|NCT01338012|3775863|P1|STARTED|Overall Study||8
1543068|NCT01337960|3775870|P3|NOT COMPLETED|Overall Study||0
1543069|NCT01337960|3775871|P2|NOT COMPLETED|Overall Study||0
1543070|NCT01337960|3775872|P1|NOT COMPLETED|Overall Study||2
1543071|NCT01337960|3775870|P3|COMPLETED|Overall Study||6
1543072|NCT01337960|3775871|P2|COMPLETED|Overall Study||14
1543073|NCT01337960|3775872|P1|COMPLETED|Overall Study||12
1543074|NCT01337960|3775870|P3|STARTED|Overall Study||6
1543075|NCT01337960|3775871|P2|STARTED|Overall Study||14
1543076|NCT01337960|3775872|P1|STARTED|Overall Study||14
1543077|NCT01337739|3775894|P2|NOT COMPLETED|Overall Study||0
1543078|NCT01337739|3775895|P1|NOT COMPLETED|Overall Study||0
1543079|NCT01337739|3775894|P2|COMPLETED|Overall Study||4
1543080|NCT01337739|3775895|P1|COMPLETED|Overall Study||6
1543081|NCT01337739|3775894|P2|STARTED|Overall Study||4
1543082|NCT01337739|3775895|P1|STARTED|Overall Study||6
1543083|NCT01337674|3775905|P4|NOT COMPLETED|Treatment Period 2||0
1543084|NCT01337674|3775906|P3|NOT COMPLETED|Treatment Period 2||1
1543085|NCT01337674|3775907|P2|NOT COMPLETED|Treatment Period 2||0
1543086|NCT01337674|3775908|P1|NOT COMPLETED|Treatment Period 2||0
1543087|NCT01337674|3775905|P4|COMPLETED|Treatment Period 2||6
1543088|NCT01337674|3775906|P3|COMPLETED|Treatment Period 2||5
1543089|NCT01337674|3775907|P2|COMPLETED|Treatment Period 2||6
1543090|NCT01337674|3775908|P1|COMPLETED|Treatment Period 2||6
1543091|NCT01337674|3775905|P4|STARTED|Treatment Period 2||6
1543092|NCT01337674|3775906|P3|STARTED|Treatment Period 2||6
1543093|NCT01337674|3775907|P2|STARTED|Treatment Period 2||6
1543094|NCT01337674|3775908|P1|STARTED|Treatment Period 2||6
1543095|NCT01337674|3775905|P4|NOT COMPLETED|Two-week Washout Period||0
1543096|NCT01337674|3775906|P3|NOT COMPLETED|Two-week Washout Period||0
1543097|NCT01337674|3775907|P2|NOT COMPLETED|Two-week Washout Period||0
1543098|NCT01337674|3775908|P1|NOT COMPLETED|Two-week Washout Period||0
1543099|NCT01337674|3775905|P4|COMPLETED|Two-week Washout Period||6
1543100|NCT01337674|3775906|P3|COMPLETED|Two-week Washout Period||6
1543101|NCT01337674|3775907|P2|COMPLETED|Two-week Washout Period||6
1543102|NCT01337674|3775908|P1|COMPLETED|Two-week Washout Period||6
1543103|NCT01337674|3775905|P4|STARTED|Two-week Washout Period||6
1543104|NCT01337674|3775906|P3|STARTED|Two-week Washout Period||6
1543105|NCT01337674|3775907|P2|STARTED|Two-week Washout Period||6
1543106|NCT01337674|3775908|P1|STARTED|Two-week Washout Period||6
1543107|NCT01337674|3775905|P4|NOT COMPLETED|Treatment Period 1||1
1543108|NCT01337674|3775906|P3|NOT COMPLETED|Treatment Period 1||0
1543109|NCT01337674|3775907|P2|NOT COMPLETED|Treatment Period 1||1
1543110|NCT01337674|3775908|P1|NOT COMPLETED|Treatment Period 1||0
1543111|NCT01337674|3775905|P4|COMPLETED|Treatment Period 1||6
1543112|NCT01337674|3775906|P3|COMPLETED|Treatment Period 1||6
1543113|NCT01337674|3775907|P2|COMPLETED|Treatment Period 1||6
1543114|NCT01337674|3775908|P1|COMPLETED|Treatment Period 1||6
1543115|NCT01337674|3775905|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
1543116|NCT01337674|3775906|P3|STARTED|Treatment Period 1||6
1543117|NCT01337674|3775907|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
1543118|NCT01337674|3775908|P1|STARTED|Treatment Period 1||6
1543119|NCT01337635|3775926|P2|NOT COMPLETED|Overall Study||1
1543120|NCT01337635|3775927|P1|NOT COMPLETED|Overall Study||0
1543121|NCT01337635|3775926|P2|COMPLETED|Overall Study||3
1543122|NCT01337635|3775927|P1|COMPLETED|Overall Study||3
1543123|NCT01337635|3775926|P2|STARTED|Overall Study||4
1543124|NCT01337635|3775927|P1|STARTED|Overall Study||3
1543125|NCT01337609|3775938|P3|NOT COMPLETED|Overall Study||0
1543126|NCT01337609|3775939|P2|NOT COMPLETED|Overall Study||0
1543127|NCT01337609|3775940|P1|NOT COMPLETED|Overall Study||1
1543128|NCT01337609|3775938|P3|COMPLETED|Overall Study||2
1543129|NCT01337609|3775939|P2|COMPLETED|Overall Study||2
1543130|NCT01337609|3775940|P1|COMPLETED|Overall Study||0
1543131|NCT01337609|3775938|P3|STARTED|Overall Study||2
1543132|NCT01337609|3775939|P2|STARTED|Overall Study||2
1543133|NCT01337609|3775940|P1|STARTED|Overall Study||1
1543134|NCT01337336|3775962|P2|NOT COMPLETED|Overall Study||0
1543135|NCT01337336|3775963|P1|NOT COMPLETED|Overall Study||0
1543136|NCT01337336|3775962|P2|COMPLETED|Overall Study||2923
1543137|NCT01337336|3775963|P1|COMPLETED|Overall Study||1078
1543138|NCT01337336|3775962|P2|STARTED|Overall Study||2923
1543139|NCT01337336|3775963|P1|STARTED|Overall Study||1078
1543140|NCT01337297|3775977|P2|NOT COMPLETED|Overall Study||6
1543141|NCT01337297|3775978|P1|NOT COMPLETED|Overall Study||5
1543142|NCT01337297|3775977|P2|COMPLETED|Overall Study||3
1543143|NCT01337297|3775978|P1|COMPLETED|Overall Study||6
1543144|NCT01337297|3775977|P2|STARTED|Overall Study||9
1543145|NCT01337297|3775978|P1|STARTED|Overall Study||11
1543146|NCT01337167|3775986|P2|NOT COMPLETED|Toddler Vaccinations||13
1543147|NCT01337167|3775987|P1|NOT COMPLETED|Toddler Vaccinations||14
1543148|NCT01337167|3775986|P2|COMPLETED|Toddler Vaccinations||407
1543149|NCT01337167|3775987|P1|COMPLETED|Toddler Vaccinations||829
1543150|NCT01337167|3775986|P2|STARTED|Toddler Vaccinations||420
1543151|NCT01337167|3775987|P1|STARTED|Toddler Vaccinations||843
1543152|NCT01337167|3775986|P2|NOT COMPLETED|Interim Period||40
1543153|NCT01337167|3775987|P1|NOT COMPLETED|Interim Period||81
1543154|NCT01337167|3775986|P2|COMPLETED|Interim Period||420
1543155|NCT01337167|3775987|P1|COMPLETED|Interim Period||843
1543156|NCT01337167|3775986|P2|STARTED|Interim Period||460
1543157|NCT01337167|3775987|P1|STARTED|Interim Period||924
1543158|NCT01337167|3775986|P2|NOT COMPLETED|Infant Series||27
1543159|NCT01337167|3775987|P1|NOT COMPLETED|Infant Series||62
1543160|NCT01337167|3775986|P2|COMPLETED|Infant Series||460
1543161|NCT01337167|3775987|P1|COMPLETED|Infant Series||924
1543162|NCT01337167|3775986|P2|STARTED|Infant Series||487
1543163|NCT01337167|3775987|P1|STARTED|Infant Series||986
1543164|NCT01337115|3776055|P2|NOT COMPLETED|Overall Study||0
1543165|NCT01337115|3776056|P1|NOT COMPLETED|Overall Study||2
1543166|NCT01337115|3776055|P2|COMPLETED|Overall Study||25
1543167|NCT01337115|3776056|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
1543168|NCT01337115|3776055|P2|STARTED|Overall Study||25
1543169|NCT01337115|3776056|P1|STARTED|Overall Study||25
1543170|NCT01337089|3776068|P1|NOT COMPLETED|Overall Study||404
1543171|NCT01337089|3776068|P1|COMPLETED|Overall Study||256
1543172|NCT01337089|3776068|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
1543173|NCT01337089|3776068|P1|Safety Population|Overall Study||660
1543174|NCT01337089|3776068|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
1543175|NCT01337089|3776068|P1|STARTED|Overall Study||660
1543176|NCT01337076|3776076|P1|NOT COMPLETED|Overall Study||2
1543177|NCT01337076|3776076|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
1543178|NCT01337076|3776076|P1|STARTED|Overall Study|subjects implanted|21
1543179|NCT01337050|3776083|P3|NOT COMPLETED|Overall Study||19
1543180|NCT01337050|3776084|P2|NOT COMPLETED|Overall Study||13
1543181|NCT01337050|3776085|P1|NOT COMPLETED|Overall Study||4
1543182|NCT01337050|3776083|P3|COMPLETED|Overall Study||0
1543183|NCT01337050|3776084|P2|COMPLETED|Overall Study||0
1543184|NCT01337050|3776085|P1|COMPLETED|Overall Study||0
1543185|NCT01337050|3776083|P3|STARTED|Overall Study||19
1543186|NCT01337050|3776084|P2|STARTED|Overall Study||13
1543187|NCT01337050|3776085|P1|STARTED|Overall Study||4
1543188|NCT01336972|3776146|P3|NOT COMPLETED|Overall Study||0
1543189|NCT01336972|3776147|P2|NOT COMPLETED|Overall Study||1
1543190|NCT01336972|3776148|P1|NOT COMPLETED|Overall Study||1
1543191|NCT01336972|3776146|P3|COMPLETED|Overall Study||9
1543192|NCT01336972|3776147|P2|COMPLETED|Overall Study||9
1543193|NCT01336972|3776148|P1|COMPLETED|Overall Study||9
1543194|NCT01336972|3776146|P3|STARTED|Overall Study||9
1543195|NCT01336972|3776147|P2|STARTED|Overall Study||10
1543196|NCT01336972|3776148|P1|STARTED|Overall Study||10
1543197|NCT01336959|3776186|P3|NOT COMPLETED|Overall Study||1
1543198|NCT01336959|3776187|P2|NOT COMPLETED|Overall Study||5
1543199|NCT01336959|3776188|P1|NOT COMPLETED|Overall Study||0
1543200|NCT01336959|3776186|P3|COMPLETED|Overall Study||40
1543201|NCT01336959|3776187|P2|COMPLETED|Overall Study||37
1543202|NCT01336959|3776188|P1|COMPLETED|Overall Study||8
1543203|NCT01336959|3776186|P3|STARTED|Overall Study||41
1543204|NCT01336959|3776187|P2|STARTED|Overall Study||42
1543205|NCT01336959|3776188|P1|STARTED|Overall Study||8
1543206|NCT01336933|3776199|P1|NOT COMPLETED|Overall Study||1
1543207|NCT01336933|3776199|P1|COMPLETED|Overall Study||33
1543208|NCT01336933|3776199|P1|STARTED|Overall Study||34
1543209|NCT01336894|3776210|P2|NOT COMPLETED|Follow-up||7
1543210|NCT01336894|3776211|P1|NOT COMPLETED|Follow-up||2
1543211|NCT01336894|3776210|P2|COMPLETED|Follow-up||0
1543212|NCT01336894|3776211|P1|COMPLETED|Follow-up||2
1543213|NCT01336894|3776210|P2|STARTED|Follow-up||7
1543214|NCT01336894|3776211|P1|STARTED|Follow-up||4
1543215|NCT01336894|3776210|P2|NOT COMPLETED|Protocol Interventions||0
1543216|NCT01336894|3776211|P1|NOT COMPLETED|Protocol Interventions||0
1543217|NCT01336894|3776210|P2|COMPLETED|Protocol Interventions||7
1543218|NCT01336894|3776211|P1|COMPLETED|Protocol Interventions||4
1543219|NCT01336894|3776210|P2|STARTED|Protocol Interventions||7
1543220|NCT01336894|3776211|P1|STARTED|Protocol Interventions||4
1543221|NCT01336764|3776231|P2|NOT COMPLETED|Overall Study||5
1543222|NCT01336764|3776232|P1|NOT COMPLETED|Overall Study||5
1543223|NCT01336764|3776231|P2|COMPLETED|Overall Study||5
1543224|NCT01336764|3776232|P1|COMPLETED|Overall Study||7
1543225|NCT01336764|3776231|P2|STARTED|Overall Study||10
1543226|NCT01336764|3776232|P1|STARTED|Overall Study||12
1543227|NCT01336738|3776243|P5|NOT COMPLETED|Overall Study||10
1543228|NCT01336738|3776244|P4|NOT COMPLETED|Overall Study||7
1543229|NCT01336738|3776245|P3|NOT COMPLETED|Overall Study||8
1543230|NCT01336738|3776246|P2|NOT COMPLETED|Overall Study||9
1543231|NCT01336738|3776247|P1|NOT COMPLETED|Overall Study||7
1543232|NCT01336738|3776243|P5|COMPLETED|Overall Study||43
1543233|NCT01336738|3776244|P4|COMPLETED|Overall Study||47
1543234|NCT01336738|3776245|P3|COMPLETED|Overall Study||45
1543235|NCT01336738|3776246|P2|COMPLETED|Overall Study||45
1543236|NCT01336738|3776247|P1|COMPLETED|Overall Study||45
1543237|NCT01336738|3776243|P5|STARTED|Overall Study||53
1543238|NCT01336738|3776244|P4|STARTED|Overall Study||54
1543239|NCT01336738|3776245|P3|STARTED|Overall Study||53
1543240|NCT01336738|3776246|P2|STARTED|Overall Study||54
1543241|NCT01336738|3776247|P1|STARTED|Overall Study||52
1543242|NCT01336712|3776289|P1|NOT COMPLETED|Overall Study||3
1543243|NCT01336712|3776289|P1|COMPLETED|Overall Study||27
1543244|NCT01336712|3776289|P1|STARTED|Overall Study||30
1543245|NCT01336647|3776302|P3|NOT COMPLETED|Overall Study||3
1543246|NCT01336647|3776303|P2|NOT COMPLETED|Overall Study||1
1543247|NCT01336647|3776304|P1|NOT COMPLETED|Overall Study||4
1543248|NCT01336647|3776302|P3|COMPLETED|Overall Study||44
1543249|NCT01336647|3776303|P2|COMPLETED|Overall Study||48
1543250|NCT01336647|3776304|P1|COMPLETED|Overall Study||42
1543251|NCT01336647|3776302|P3|STARTED|Overall Study||47
1543252|NCT01336647|3776303|P2|STARTED|Overall Study||49
1543253|NCT01336647|3776304|P1|STARTED|Overall Study||46
1543254|NCT01336634|3776318|P3|NOT COMPLETED|Overall Study||36
1543255|NCT01336634|3776319|P2|NOT COMPLETED|Overall Study||57
1543256|NCT01336634|3776320|P1|NOT COMPLETED|Overall Study||84
1543257|NCT01336634|3776318|P3|COMPLETED|Overall Study||0
1543258|NCT01336634|3776319|P2|COMPLETED|Overall Study||0
1543259|NCT01336634|3776320|P1|COMPLETED|Overall Study||0
1543260|NCT01336634|3776318|P3|STARTED|Overall Study||36
1543261|NCT01336634|3776319|P2|STARTED|Overall Study||57
1543262|NCT01336634|3776320|P1|STARTED|Overall Study||84
1543263|NCT01336621|3776361|P1|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
1543264|NCT01336621|3776361|P1|COMPLETED|SFUCP (up to 2.6 Years)||0
1543265|NCT01336621|3776361|P1|STARTED|SFUCP (up to 2.6 Years)||9
1543266|NCT01336621|3776361|P1|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
1543267|NCT01336621|3776361|P1|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
1543268|NCT01336621|3776361|P1|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
1543269|NCT01336608|3776411|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
1543270|NCT01336608|3776412|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
1543271|NCT01336608|3776413|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
1543272|NCT01336608|3776414|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1543273|NCT01336608|3776411|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
1543274|NCT01336608|3776412|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
1543275|NCT01336608|3776413|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
1543276|NCT01336608|3776414|P1|COMPLETED|24-week, Double-blind Treatment Period||0
1543277|NCT01336608|3776411|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
1543278|NCT01336608|3776412|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
1543279|NCT01336608|3776413|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
1543280|NCT01336608|3776414|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
1543281|NCT01336608|3776411|P4|STARTED|24-week, Double-blind Treatment Period||135
1543282|NCT01336608|3776412|P3|STARTED|24-week, Double-blind Treatment Period||154
1543283|NCT01336608|3776413|P2|STARTED|24-week, Double-blind Treatment Period||141
1543284|NCT01336608|3776414|P1|STARTED|24-week, Double-blind Treatment Period||0
1543285|NCT01336608|3776411|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1543286|NCT01336608|3776412|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1543287|NCT01336608|3776413|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1543288|NCT01336608|3776414|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
1543289|NCT01336608|3776411|P4|COMPLETED|2-week, Single-blind Run-In Period||0
1543290|NCT01336608|3776412|P3|COMPLETED|2-week, Single-blind Run-In Period||0
1543291|NCT01336608|3776413|P2|COMPLETED|2-week, Single-blind Run-In Period||0
1543292|NCT01336608|3776414|P1|COMPLETED|2-week, Single-blind Run-In Period||444
1543293|NCT01336608|3776411|P4|STARTED|2-week, Single-blind Run-In Period||0
1543294|NCT01336608|3776412|P3|STARTED|2-week, Single-blind Run-In Period||0
1543295|NCT01336608|3776413|P2|STARTED|2-week, Single-blind Run-In Period||0
1543296|NCT01336608|3776414|P1|STARTED|2-week, Single-blind Run-In Period||559
1543297|NCT01336569|3776428|P1|NOT COMPLETED|Overall Study||4
1543298|NCT01336569|3776428|P1|COMPLETED|Overall Study||45
1543299|NCT01336569|3776428|P1|STARTED|Overall Study||49
1543300|NCT01336413|3776434|P2|NOT COMPLETED|Overall Study||8
1543301|NCT01336413|3776435|P1|NOT COMPLETED|Overall Study||1
1543302|NCT01336413|3776434|P2|COMPLETED|Overall Study||18
1543303|NCT01336413|3776435|P1|COMPLETED|Overall Study||26
1543304|NCT01336413|3776434|P2|STARTED|Overall Study||26
1543305|NCT01336413|3776435|P1|STARTED|Overall Study||27
1543306|NCT01336296|3776453|P2|NOT COMPLETED|Overall Study||4
1543307|NCT01336296|3776454|P1|NOT COMPLETED|Overall Study||5
1543308|NCT01336296|3776453|P2|COMPLETED|Overall Study||17
1543309|NCT01336296|3776454|P1|COMPLETED|Overall Study||35
1543310|NCT01336296|3776453|P2|STARTED|Overall Study||21
1543311|NCT01336296|3776454|P1|STARTED|Overall Study||40
1543312|NCT01336205|3776470|P2|NOT COMPLETED|Overall Study||89
1543313|NCT01336205|3776471|P1|NOT COMPLETED|Overall Study||233
1543314|NCT01336205|3776470|P2|COMPLETED|Overall Study||192
1543315|NCT01336205|3776471|P1|COMPLETED|Overall Study||330
1543316|NCT01336205|3776470|P2|STARTED|Overall Study||281
1543317|NCT01336205|3776471|P1|STARTED|Overall Study||563
1543318|NCT01336140|3776483|P2|NOT COMPLETED|Overall Study||0
1543319|NCT01336140|3776484|P1|NOT COMPLETED|Overall Study||0
1543320|NCT01336140|3776483|P2|COMPLETED|Overall Study||150
1543321|NCT01336140|3776484|P1|COMPLETED|Overall Study||150
1543322|NCT01336140|3776483|P2|STARTED|Overall Study||150
1543323|NCT01336140|3776484|P1|STARTED|Overall Study||150
1543324|NCT01336023|3776499|P3|NOT COMPLETED|Week 27 to 52||28
1543325|NCT01336023|3776500|P2|NOT COMPLETED|Week 27 to 52||44
1543326|NCT01336023|3776501|P1|NOT COMPLETED|Week 27 to 52||28
1543327|NCT01336023|3776499|P3|COMPLETED|Week 27 to 52||285
1543328|NCT01336023|3776500|P2|COMPLETED|Week 27 to 52||621
1543329|NCT01336023|3776501|P1|COMPLETED|Week 27 to 52||305
1543330|NCT01336023|3776499|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
1543331|NCT01336023|3776500|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
1543332|NCT01336023|3776501|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
1543333|NCT01336023|3776499|P3|NOT COMPLETED|Week 0 to Week 26||73
1543334|NCT01336023|3776500|P2|NOT COMPLETED|Week 0 to Week 26||98
1543335|NCT01336023|3776501|P1|NOT COMPLETED|Week 0 to Week 26||48
1543336|NCT01336023|3776499|P3|COMPLETED|Week 0 to Week 26||342
1543337|NCT01336023|3776500|P2|COMPLETED|Week 0 to Week 26||736
1543338|NCT01336023|3776501|P1|COMPLETED|Week 0 to Week 26||366
1543339|NCT01336023|3776499|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
1543340|NCT01336023|3776500|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
1543341|NCT01336023|3776501|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
1543342|NCT01336023|3776499|P3|STARTED|Week 0 to Week 26||415
1543343|NCT01336023|3776500|P2|STARTED|Week 0 to Week 26||834
1543344|NCT01336023|3776501|P1|STARTED|Week 0 to Week 26||414
1543345|NCT01335997|3776522|P2|NOT COMPLETED|Period III||79
1543346|NCT01335997|3776523|P1|NOT COMPLETED|Period III||78
1543347|NCT01335997|3776522|P2|COMPLETED|Period III||4
1543348|NCT01335997|3776523|P1|COMPLETED|Period III||6
1543349|NCT01335997|3776522|P2|STARTED|Period III||83
1543350|NCT01335997|3776523|P1|STARTED|Period III||84
1543351|NCT01335997|3776522|P2|NOT COMPLETED|Period I and II||479
1543352|NCT01335997|3776523|P1|NOT COMPLETED|Period I and II||493
1543353|NCT01335997|3776522|P2|COMPLETED|Period I and II||83
1543354|NCT01335997|3776523|P1|COMPLETED|Period I and II||84
1543355|NCT01335997|3776522|P2|STARTED|Period I and II||562
1543356|NCT01335997|3776523|P1|STARTED|Period I and II||577
1543357|NCT01335971|3776536|P3|NOT COMPLETED|Overall Study||1
1543358|NCT01335971|3776537|P2|NOT COMPLETED|Overall Study||1
1543359|NCT01335971|3776538|P1|NOT COMPLETED|Overall Study||2
1543360|NCT01335971|3776536|P3|COMPLETED|Overall Study||28
1543361|NCT01335971|3776537|P2|COMPLETED|Overall Study||28
1543362|NCT01335971|3776538|P1|COMPLETED|Overall Study||29
1543363|NCT01335971|3776536|P3|STARTED|Overall Study||29
1543364|NCT01335971|3776537|P2|STARTED|Overall Study||29
1543365|NCT01335971|3776538|P1|STARTED|Overall Study||31
1543366|NCT01335932|3776575|P2|NOT COMPLETED|Overall Study||4
1543367|NCT01335932|3776576|P1|NOT COMPLETED|Overall Study||0
1543368|NCT01335932|3776575|P2|COMPLETED|Overall Study||72
1543369|NCT01335932|3776576|P1|COMPLETED|Overall Study||84
1543370|NCT01335932|3776575|P2|STARTED|Overall Study||76
1543371|NCT01335932|3776576|P1|STARTED|Overall Study||84
1543372|NCT01335867|3776716|P2|NOT COMPLETED|Overall Study||4
1543373|NCT01335867|3776717|P1|NOT COMPLETED|Overall Study||7
1543374|NCT01335867|3776716|P2|COMPLETED|Overall Study||12
1543375|NCT01335867|3776717|P1|COMPLETED|Overall Study||9
1543376|NCT01335867|3776716|P2|STARTED|Overall Study||16
1543377|NCT01335867|3776717|P1|STARTED|Overall Study||16
1543378|NCT01335789|3776727|P2|NOT COMPLETED|Overall Study||0
1543379|NCT01335789|3776728|P1|NOT COMPLETED|Overall Study||0
1543380|NCT01335789|3776727|P2|COMPLETED|Overall Study||8
1543381|NCT01335789|3776728|P1|COMPLETED|Overall Study||8
1543382|NCT01335789|3776727|P2|STARTED|Overall Study||8
1543383|NCT01335789|3776728|P1|STARTED|Overall Study||8
1543384|NCT01335750|3776738|P1|NOT COMPLETED|Overall Study||0
1543385|NCT01335750|3776738|P1|COMPLETED|Overall Study||32
1543386|NCT01335750|3776738|P1|STARTED|Overall Study||32
1543387|NCT01335724|3776759|P2|NOT COMPLETED|Overall Study||0
1543388|NCT01335724|3776760|P1|NOT COMPLETED|Overall Study||0
1543389|NCT01335724|3776759|P2|COMPLETED|Overall Study||36
1543390|NCT01335724|3776760|P1|COMPLETED|Overall Study||36
1543391|NCT01335724|3776759|P2|STARTED|Overall Study||36
1543392|NCT01335724|3776760|P1|STARTED|Overall Study||36
1543393|NCT01335698|3776775|P5|NOT COMPLETED|Treatment Stage 2||1
1543394|NCT01335698|3776776|P4|NOT COMPLETED|Treatment Stage 2||8
1543395|NCT01335698|3776777|P3|NOT COMPLETED|Treatment Stage 2||5
1543396|NCT01335698|3776778|P2|NOT COMPLETED|Treatment Stage 2||3
1543397|NCT01335698|3776779|P1|NOT COMPLETED|Treatment Stage 2||11
1543398|NCT01335698|3776775|P5|COMPLETED|Treatment Stage 2||5
1543399|NCT01335698|3776776|P4|COMPLETED|Treatment Stage 2||18
1543400|NCT01335698|3776777|P3|COMPLETED|Treatment Stage 2||11
1543401|NCT01335698|3776778|P2|COMPLETED|Treatment Stage 2||1
1543402|NCT01335698|3776779|P1|COMPLETED|Treatment Stage 2||4
1543403|NCT01335698|3776775|P5|STARTED|Treatment Stage 2||6
1543404|NCT01335698|3776776|P4|STARTED|Treatment Stage 2||26
1543405|NCT01335698|3776777|P3|STARTED|Treatment Stage 2||16
1543406|NCT01335698|3776778|P2|STARTED|Treatment Stage 2||4
1543407|NCT01335698|3776779|P1|STARTED|Treatment Stage 2||15
1543408|NCT01335698|3776775|P5|NOT COMPLETED|Treatment Stage 1||2
1543409|NCT01335698|3776776|P4|NOT COMPLETED|Treatment Stage 1||9
1543410|NCT01335698|3776777|P3|NOT COMPLETED|Treatment Stage 1||5
1543411|NCT01335698|3776778|P2|NOT COMPLETED|Treatment Stage 1||8
1543412|NCT01335698|3776779|P1|NOT COMPLETED|Treatment Stage 1||8
1543413|NCT01335698|3776775|P5|COMPLETED|Treatment Stage 1||6
1543414|NCT01335698|3776776|P4|COMPLETED|Treatment Stage 1||26
1543415|NCT01335698|3776777|P3|COMPLETED|Treatment Stage 1||16
1543416|NCT01335698|3776778|P2|COMPLETED|Treatment Stage 1||4
1543417|NCT01335698|3776779|P1|COMPLETED|Treatment Stage 1||15
1543418|NCT01335698|3776775|P5|STARTED|Treatment Stage 1||8
1543419|NCT01335698|3776776|P4|STARTED|Treatment Stage 1||35
1543420|NCT01335698|3776777|P3|STARTED|Treatment Stage 1||21
1543421|NCT01335698|3776778|P2|STARTED|Treatment Stage 1||12
1543422|NCT01335698|3776779|P1|STARTED|Treatment Stage 1||23
1543423|NCT01335685|3776844|P8|NOT COMPLETED|Overall Study||3
1543424|NCT01335685|3776845|P7|NOT COMPLETED|Overall Study||2
1543425|NCT01335685|3776846|P6|NOT COMPLETED|Overall Study||5
1543426|NCT01335685|3776847|P5|NOT COMPLETED|Overall Study||0
1543427|NCT01335685|3776848|P4|NOT COMPLETED|Overall Study||11
1543428|NCT01335685|3776849|P3|NOT COMPLETED|Overall Study||2
1543429|NCT01335685|3776850|P2|NOT COMPLETED|Overall Study||1
1543430|NCT01335685|3776851|P1|NOT COMPLETED|Overall Study||3
1543431|NCT01335685|3776844|P8|COMPLETED|Overall Study||3
1543432|NCT01335685|3776845|P7|COMPLETED|Overall Study||2
1543433|NCT01335685|3776846|P6|COMPLETED|Overall Study||1
1543434|NCT01335685|3776847|P5|COMPLETED|Overall Study||5
1543435|NCT01335685|3776848|P4|COMPLETED|Overall Study||15
1543436|NCT01335685|3776849|P3|COMPLETED|Overall Study||1
1543437|NCT01335685|3776850|P2|COMPLETED|Overall Study||3
1543438|NCT01335685|3776851|P1|COMPLETED|Overall Study||4
1543439|NCT01335685|3776844|P8|STARTED|Overall Study||6
1543440|NCT01335685|3776845|P7|STARTED|Overall Study||4
1543441|NCT01335685|3776846|P6|STARTED|Overall Study||6
1543442|NCT01335685|3776847|P5|STARTED|Overall Study||5
1543443|NCT01335685|3776848|P4|STARTED|Overall Study||26
1543444|NCT01335685|3776849|P3|STARTED|Overall Study||3
1543445|NCT01335685|3776850|P2|STARTED|Overall Study||4
1543446|NCT01335685|3776851|P1|STARTED|Overall Study||7
1543447|NCT01335542|3776955|P2|NOT COMPLETED|Overall Study||0
1543448|NCT01335542|3776956|P1|NOT COMPLETED|Overall Study||0
1543449|NCT01335542|3776955|P2|COMPLETED|Overall Study||45
1543450|NCT01335542|3776956|P1|COMPLETED|Overall Study||45
1543451|NCT01335542|3776955|P2|STARTED|Overall Study||45
1543452|NCT01335542|3776956|P1|STARTED|Overall Study||45
1543453|NCT01335477|3776964|P2|NOT COMPLETED|Overall Study||59
1543454|NCT01335477|3776965|P1|NOT COMPLETED|Overall Study||41
1543455|NCT01335477|3776964|P2|COMPLETED|Overall Study||272
1543456|NCT01335477|3776965|P1|COMPLETED|Overall Study||179
1543457|NCT01335477|3776964|P2|STARTED|Overall Study||331
1543458|NCT01335477|3776965|P1|STARTED|Overall Study||220
1543459|NCT01335464|3777029|P2|NOT COMPLETED|Overall Study||49
1543460|NCT01335464|3777030|P1|NOT COMPLETED|Overall Study||32
1543461|NCT01335464|3777029|P2|COMPLETED|Overall Study||260
1543462|NCT01335464|3777030|P1|COMPLETED|Overall Study||174
1543463|NCT01335464|3777029|P2|STARTED|Overall Study||309
1543464|NCT01335464|3777030|P1|STARTED|Overall Study||206
1543465|NCT01335308|3777095|P3|NOT COMPLETED|Overall Study||81
1543466|NCT01335308|3777096|P2|NOT COMPLETED|Overall Study||67
1543467|NCT01335308|3777097|P1|NOT COMPLETED|Overall Study||40
1543468|NCT01335308|3777095|P3|COMPLETED|Overall Study||154
1543469|NCT01335308|3777096|P2|COMPLETED|Overall Study||145
1543470|NCT01335308|3777097|P1|COMPLETED|Overall Study||158
1543471|NCT01335308|3777095|P3|STARTED|Overall Study||235
1543472|NCT01335308|3777096|P2|STARTED|Overall Study||212
1543473|NCT01335308|3777097|P1|STARTED|Overall Study||198
1543474|NCT01335230|3777118|P4|NOT COMPLETED|Overall Study||0
1543475|NCT01335230|3777119|P3|NOT COMPLETED|Overall Study||0
1543476|NCT01335230|3777120|P2|NOT COMPLETED|Overall Study||0
1543477|NCT01335230|3777121|P1|NOT COMPLETED|Overall Study||0
1543478|NCT01335230|3777118|P4|COMPLETED|Overall Study|subjects|10
1543479|NCT01335230|3777119|P3|COMPLETED|Overall Study|subjects|10
1543480|NCT01335230|3777120|P2|COMPLETED|Overall Study|subjects|10
1543481|NCT01335230|3777121|P1|COMPLETED|Overall Study|subjects|10
1543482|NCT01335230|3777118|P4|STARTED|Overall Study|subjects|10
1543483|NCT01335230|3777119|P3|STARTED|Overall Study|subjects|10
1543484|NCT01335230|3777120|P2|STARTED|Overall Study|subjects|10
1543485|NCT01335230|3777121|P1|STARTED|Overall Study|subjects|10
1543486|NCT01335204|3777131|P1|NOT COMPLETED|Overall Study||0
1543487|NCT01335204|3777131|P1|COMPLETED|Overall Study||4
1543488|NCT01335204|3777131|P1|STARTED|Overall Study||4
1543489|NCT01335191|3777142|P2|NOT COMPLETED|Overall Study||0
1543490|NCT01335191|3777143|P1|NOT COMPLETED|Overall Study||0
1543491|NCT01335191|3777142|P2|COMPLETED|Overall Study||11
1543492|NCT01335191|3777143|P1|COMPLETED|Overall Study||16
1543493|NCT01335191|3777142|P2|STARTED|Overall Study||11
1543494|NCT01335191|3777143|P1|STARTED|Overall Study||16
1543495|NCT01335061|3777149|P1|NOT COMPLETED|Overall Study||0
1543496|NCT01335061|3777149|P1|COMPLETED|Overall Study||25
1543497|NCT01335061|3777149|P1|STARTED|Overall Study||25
1543498|NCT01334957|3777164|P1|NOT COMPLETED|Overall Study||0
1543499|NCT01334957|3777164|P1|COMPLETED|Overall Study||300
1543500|NCT01334957|3777164|P1|Received Multiple Doses|Overall Study||48
1543501|NCT01334957|3777164|P1|Received Single Dose|Overall Study||252
1543502|NCT01334957|3777164|P1|STARTED|Overall Study||300
1543503|NCT01334944|3777172|P2|NOT COMPLETED|Overall Study||0
1543504|NCT01334944|3777173|P1|NOT COMPLETED|Overall Study||0
1543505|NCT01334944|3777172|P2|COMPLETED|Overall Study||139
1543506|NCT01334944|3777173|P1|COMPLETED|Overall Study||11
1543507|NCT01334944|3777172|P2|Received Multiple Doses|Overall Study||43
1543508|NCT01334944|3777173|P1|Received Multiple Doses|Overall Study||10
1543509|NCT01334944|3777172|P2|Received Singel Dose|Overall Study||96
1543510|NCT01334944|3777173|P1|Received Singel Dose|Overall Study||1
1543511|NCT01334944|3777172|P2|STARTED|Overall Study||139
1543512|NCT01334944|3777173|P1|STARTED|Overall Study||11
1543513|NCT01334918|3777199|P2|NOT COMPLETED|Overall Study||1
1543514|NCT01334918|3777200|P1|NOT COMPLETED|Overall Study||8
1543515|NCT01334918|3777199|P2|COMPLETED|Overall Study||60
1543516|NCT01334918|3777200|P1|COMPLETED|Overall Study||55
1543517|NCT01334918|3777199|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
1543518|NCT01334918|3777200|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
1543519|NCT01334918|3777199|P2|STARTED|Overall Study||61
1543520|NCT01334918|3777200|P1|STARTED|Overall Study||63
1543521|NCT01334866|3777226|P1|NOT COMPLETED|Overall Study||19
1543522|NCT01334866|3777226|P1|COMPLETED|Overall Study||72
1543523|NCT01334866|3777226|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
1543524|NCT01334723|3777236|P2|NOT COMPLETED|Overall Study||0
1543525|NCT01334723|3777237|P1|NOT COMPLETED|Overall Study||0
1543526|NCT01334723|3777236|P2|COMPLETED|Overall Study||17739
1543527|NCT01334723|3777237|P1|COMPLETED|Overall Study||17293
1543528|NCT01334723|3777236|P2|STARTED|Overall Study||17739
1543529|NCT01334723|3777237|P1|STARTED|Overall Study||17293
1543530|NCT01334710|3777263|P1|NOT COMPLETED|Overall Study||3
1543531|NCT01334710|3777263|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
1543532|NCT01334710|3777263|P1|STARTED|Overall Study||3
1543533|NCT01334606|3777268|P1|NOT COMPLETED|Overall Study||18
1543534|NCT01334606|3777268|P1|COMPLETED|Overall Study||3
1543535|NCT01334606|3777268|P1|STARTED|Overall Study||21
1543536|NCT01334554|3777276|P2|NOT COMPLETED|Overall Study||2
1543537|NCT01334554|3777277|P1|NOT COMPLETED|Overall Study||4
1543538|NCT01334554|3777276|P2|COMPLETED|Overall Study||21
1543539|NCT01334554|3777277|P1|COMPLETED|Overall Study||19
1543540|NCT01334554|3777276|P2|STARTED|Overall Study||23
1543541|NCT01334554|3777277|P1|STARTED|Overall Study||23
1543542|NCT01334515|3777287|P2|NOT COMPLETED|Overall Study||29
1543543|NCT01334515|3777288|P1|NOT COMPLETED|Overall Study||12
1543544|NCT01334515|3777287|P2|COMPLETED|Overall Study||7
1543545|NCT01334515|3777288|P1|COMPLETED|Overall Study||4
1543546|NCT01334515|3777287|P2|STARTED|Overall Study||36
1543547|NCT01334515|3777288|P1|STARTED|Overall Study||16
1543548|NCT01334229|3777298|P2|NOT COMPLETED|Overall Study||0
1543549|NCT01334229|3777299|P1|NOT COMPLETED|Overall Study||0
1543550|NCT01334229|3777298|P2|COMPLETED|Overall Study||11
1543551|NCT01334229|3777299|P1|COMPLETED|Overall Study||11
1543552|NCT01334229|3777298|P2|STARTED|Overall Study||11
1543553|NCT01334229|3777299|P1|STARTED|Overall Study||11
1543554|NCT01334216|3777317|P2|NOT COMPLETED|Overall Study||0
1543555|NCT01334216|3777318|P1|NOT COMPLETED|Overall Study||0
1543556|NCT01334216|3777317|P2|COMPLETED|Overall Study||194
1543557|NCT01334216|3777318|P1|COMPLETED|Overall Study||168
1543558|NCT01334216|3777317|P2|STARTED|Overall Study||194
1543559|NCT01334216|3777318|P1|STARTED|Overall Study||168
1543560|NCT01334125|3777326|P2|NOT COMPLETED|Overall Study||3
1543561|NCT01334125|3777327|P1|NOT COMPLETED|Overall Study||3
1543562|NCT01334125|3777326|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
1543563|NCT01334125|3777327|P1|COMPLETED|Overall Study|3 subjects move to another city|12
1543564|NCT01334125|3777326|P2|STARTED|Overall Study||13
1543565|NCT01334125|3777327|P1|STARTED|Overall Study||15
1543566|NCT01333956|3777343|P4|NOT COMPLETED|Overall Study||2
1543567|NCT01333956|3777344|P3|NOT COMPLETED|Overall Study||1
1543568|NCT01333956|3777345|P2|NOT COMPLETED|Overall Study||4
1543569|NCT01333956|3777346|P1|NOT COMPLETED|Overall Study||2
1543570|NCT01333956|3777343|P4|COMPLETED|Overall Study||28
1543571|NCT01333956|3777344|P3|COMPLETED|Overall Study||29
1543572|NCT01333956|3777345|P2|COMPLETED|Overall Study||26
1543573|NCT01333956|3777346|P1|COMPLETED|Overall Study||28
1543574|NCT01333956|3777343|P4|STARTED|Overall Study||30
1543575|NCT01333956|3777344|P3|STARTED|Overall Study||30
1543576|NCT01333956|3777345|P2|STARTED|Overall Study||30
1543577|NCT01333956|3777346|P1|STARTED|Overall Study||30
1543578|NCT01333943|3777382|P2|NOT COMPLETED|Overall Study||0
1543579|NCT01333943|3777383|P1|NOT COMPLETED|Overall Study||1
1543580|NCT01333943|3777382|P2|COMPLETED|Overall Study||47
1543581|NCT01333943|3777383|P1|COMPLETED|Overall Study||46
1543582|NCT01333943|3777382|P2|STARTED|Overall Study||47
1543583|NCT01333943|3777383|P1|STARTED|Overall Study||47
1543584|NCT01333865|3777399|P1|NOT COMPLETED|Overall Study||2
1543585|NCT01333865|3777399|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
1543586|NCT01333865|3777399|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
1543587|NCT01333813|3777404|P1|NOT COMPLETED|Overall Study||0
1543588|NCT01333813|3777404|P1|COMPLETED|Overall Study||297
1543589|NCT01333813|3777404|P1|STARTED|Overall Study||297
1543590|NCT01333722|3777419|P2|NOT COMPLETED|Overall Study||3
1543591|NCT01333722|3777420|P1|NOT COMPLETED|Overall Study||0
1543592|NCT01333722|3777419|P2|COMPLETED|Overall Study||46
1543593|NCT01333722|3777420|P1|COMPLETED|Overall Study||51
1543594|NCT01333722|3777419|P2|STARTED|Overall Study||49
1543595|NCT01333722|3777420|P1|STARTED|Overall Study||51
1543596|NCT01333592|3777434|P2|NOT COMPLETED|Overall Study||17
1543597|NCT01333592|3777435|P1|NOT COMPLETED|Overall Study||9
1543598|NCT01333592|3777434|P2|COMPLETED|Overall Study||52
1543599|NCT01333592|3777435|P1|COMPLETED|Overall Study||58
1543600|NCT01333592|3777434|P2|STARTED|Overall Study||69
1543601|NCT01333592|3777435|P1|STARTED|Overall Study||67
1543602|NCT01333501|3777445|P2|NOT COMPLETED|Overall Study||21
1543603|NCT01333501|3777446|P1|NOT COMPLETED|Overall Study||9
1543604|NCT01333501|3777445|P2|COMPLETED|Overall Study||30
1543605|NCT01333501|3777446|P1|COMPLETED|Overall Study||97
1543606|NCT01333501|3777445|P2|Safety Population|Overall Study||47
1543607|NCT01333501|3777446|P1|Safety Population|Overall Study||104
1543608|NCT01333501|3777445|P2|Full Analysis Set (FAS)|Overall Study||28
1543609|NCT01333501|3777446|P1|Full Analysis Set (FAS)|Overall Study||80
1543610|NCT01333501|3777445|P2|STARTED|Overall Study||51
1543611|NCT01333501|3777446|P1|STARTED|Overall Study||106
1543612|NCT01333488|3777495|P3|NOT COMPLETED|Overall Study||0
1543613|NCT01333488|3777496|P2|NOT COMPLETED|Overall Study||0
1543614|NCT01333488|3777497|P1|NOT COMPLETED|Overall Study||0
1543615|NCT01333488|3777495|P3|COMPLETED|Overall Study||3
1543616|NCT01333488|3777496|P2|COMPLETED|Overall Study||1
1543617|NCT01333488|3777497|P1|COMPLETED|Overall Study||2
1543618|NCT01333488|3777495|P3|STARTED|Overall Study||3
1543619|NCT01333488|3777496|P2|STARTED|Overall Study||1
1543620|NCT01333488|3777497|P1|STARTED|Overall Study||2
1543621|NCT01333475|3777513|P2|NOT COMPLETED|Overall Study||3
1543622|NCT01333475|3777514|P1|NOT COMPLETED|Overall Study||2
1543623|NCT01333475|3777513|P2|COMPLETED|Overall Study||6
1543624|NCT01333475|3777514|P1|COMPLETED|Overall Study||10
1543625|NCT01333475|3777513|P2|STARTED|Overall Study||9
1543626|NCT01333475|3777514|P1|STARTED|Overall Study||12
1543627|NCT01333436|3777524|P2|NOT COMPLETED|Overall Study||0
1543628|NCT01333436|3777525|P1|NOT COMPLETED|Overall Study||0
1543629|NCT01333436|3777524|P2|COMPLETED|Overall Study||50
1543630|NCT01333436|3777525|P1|COMPLETED|Overall Study||43
1543631|NCT01333436|3777524|P2|STARTED|Overall Study||50
1543632|NCT01333436|3777525|P1|STARTED|Overall Study||43
1543633|NCT01333397|3777540|P5|NOT COMPLETED|Overall Study||0
1543634|NCT01333397|3777541|P4|NOT COMPLETED|Overall Study||1
1543635|NCT01333397|3777542|P3|NOT COMPLETED|Overall Study||0
1543636|NCT01333397|3777543|P2|NOT COMPLETED|Overall Study||0
1543637|NCT01333397|3777544|P1|NOT COMPLETED|Overall Study||1
1543638|NCT01333397|3777540|P5|COMPLETED|Overall Study||35
1543639|NCT01333397|3777541|P4|COMPLETED|Overall Study||34
1543640|NCT01333397|3777542|P3|COMPLETED|Overall Study||35
1543641|NCT01333397|3777543|P2|COMPLETED|Overall Study||36
1543642|NCT01333397|3777544|P1|COMPLETED|Overall Study||34
1543643|NCT01333397|3777540|P5|STARTED|Overall Study||35
1543644|NCT01333397|3777541|P4|STARTED|Overall Study||35
1543645|NCT01333397|3777542|P3|STARTED|Overall Study||35
1543646|NCT01333397|3777543|P2|STARTED|Overall Study||36
1543647|NCT01333397|3777544|P1|STARTED|Overall Study||35
1543648|NCT01333189|3777618|P2|NOT COMPLETED|Overall Study||2
1543649|NCT01333189|3777619|P1|NOT COMPLETED|Overall Study||2
1543650|NCT01333189|3777618|P2|COMPLETED|Overall Study||11
1543651|NCT01333189|3777619|P1|COMPLETED|Overall Study||11
1543652|NCT01333189|3777618|P2|STARTED|Overall Study||13
1543653|NCT01333189|3777619|P1|STARTED|Overall Study||13
1543654|NCT01333111|3777650|P3|NOT COMPLETED|Overall Study||2
1543655|NCT01333111|3777651|P2|NOT COMPLETED|Overall Study||3
1543656|NCT01333111|3777652|P1|NOT COMPLETED|Overall Study||2
1543657|NCT01333111|3777650|P3|COMPLETED|Overall Study||13
1543658|NCT01333111|3777651|P2|COMPLETED|Overall Study||26
1543659|NCT01333111|3777652|P1|COMPLETED|Overall Study||28
1543660|NCT01333111|3777650|P3|STARTED|Overall Study||15
1543661|NCT01333111|3777651|P2|STARTED|Overall Study||29
1543662|NCT01333111|3777652|P1|STARTED|Overall Study||30
1543663|NCT01333072|3777678|P2|NOT COMPLETED|Overall Study||4
1543664|NCT01333072|3777679|P1|NOT COMPLETED|Overall Study||6
1543665|NCT01333072|3777678|P2|COMPLETED|Overall Study||27
1543666|NCT01333072|3777679|P1|COMPLETED|Overall Study||24
1543667|NCT01333072|3777678|P2|STARTED|Overall Study||31
1543668|NCT01333072|3777679|P1|STARTED|Overall Study||30
1543669|NCT01333059|3777687|P2|NOT COMPLETED|Overall Study||3
1543670|NCT01333059|3777688|P1|NOT COMPLETED|Overall Study||6
1543671|NCT01333059|3777687|P2|COMPLETED|Overall Study||8
1543672|NCT01333059|3777688|P1|COMPLETED|Overall Study||8
1543673|NCT01333059|3777687|P2|STARTED|Overall Study||11
1543674|NCT01333059|3777688|P1|STARTED|Overall Study||14
1543675|NCT01332994|3777698|P1|NOT COMPLETED|Overall Study||71
1543676|NCT01332994|3777698|P1|COMPLETED|Overall Study||448
1543677|NCT01332994|3777698|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
1543678|NCT01332994|3777698|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
1543679|NCT01332994|3777698|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
1543680|NCT01332994|3777698|P1|Completed Week 16|Overall Study||463
1543681|NCT01332994|3777698|P1|STARTED|Overall Study||519
1543682|NCT01332981|3777754|P1|NOT COMPLETED|Overall Study||0
1543683|NCT01332981|3777754|P1|COMPLETED|Overall Study||220
1543684|NCT01332981|3777754|P1|STARTED|Overall Study||220
1543685|NCT01332968|3777767|P8|NOT COMPLETED|Follow-Up Period||531
1543686|NCT01332968|3777768|P7|NOT COMPLETED|Follow-Up Period||542
1543687|NCT01332968|3777769|P6|NOT COMPLETED|Follow-Up Period||0
1543688|NCT01332968|3777770|P5|NOT COMPLETED|Follow-Up Period||0
1543689|NCT01332968|3777771|P4|NOT COMPLETED|Follow-Up Period||0
1543690|NCT01332968|3777772|P3|NOT COMPLETED|Follow-Up Period||0
1543691|NCT01332968|3777773|P2|NOT COMPLETED|Follow-Up Period||0
1543692|NCT01332968|3777774|P1|NOT COMPLETED|Follow-Up Period||0
1543693|NCT01332968|3777767|P8|COMPLETED|Follow-Up Period||0
1543694|NCT01332968|3777768|P7|COMPLETED|Follow-Up Period||0
1543695|NCT01332968|3777769|P6|COMPLETED|Follow-Up Period||0
1543696|NCT01332968|3777770|P5|COMPLETED|Follow-Up Period||0
1543697|NCT01332968|3777771|P4|COMPLETED|Follow-Up Period||0
1543698|NCT01332968|3777772|P3|COMPLETED|Follow-Up Period||0
1543699|NCT01332968|3777773|P2|COMPLETED|Follow-Up Period||0
1543700|NCT01332968|3777774|P1|COMPLETED|Follow-Up Period||0
1543701|NCT01332968|3777767|P8|STARTED|Follow-Up Period||531
1543702|NCT01332968|3777768|P7|STARTED|Follow-Up Period||542
1543703|NCT01332968|3777769|P6|STARTED|Follow-Up Period||0
1543704|NCT01332968|3777770|P5|STARTED|Follow-Up Period||0
1543705|NCT01332968|3777771|P4|STARTED|Follow-Up Period||0
1543706|NCT01332968|3777772|P3|STARTED|Follow-Up Period||0
1543707|NCT01332968|3777773|P2|STARTED|Follow-Up Period||0
1543708|NCT01332968|3777774|P1|STARTED|Follow-Up Period||0
1543709|NCT01332968|3777767|P8|NOT COMPLETED|Maintenance/Observation Period||0
1543710|NCT01332968|3777768|P7|NOT COMPLETED|Maintenance/Observation Period||0
1543711|NCT01332968|3777769|P6|NOT COMPLETED|Maintenance/Observation Period||9
1543712|NCT01332968|3777770|P5|NOT COMPLETED|Maintenance/Observation Period||10
1543713|NCT01332968|3777771|P4|NOT COMPLETED|Maintenance/Observation Period||207
1543714|NCT01332968|3777772|P3|NOT COMPLETED|Maintenance/Observation Period||213
1543715|NCT01332968|3777773|P2|NOT COMPLETED|Maintenance/Observation Period||0
1543716|NCT01332968|3777774|P1|NOT COMPLETED|Maintenance/Observation Period||0
1543717|NCT01332968|3777767|P8|COMPLETED|Maintenance/Observation Period||0
1543718|NCT01332968|3777768|P7|COMPLETED|Maintenance/Observation Period||0
1543719|NCT01332968|3777769|P6|COMPLETED|Maintenance/Observation Period||2
1543720|NCT01332968|3777770|P5|COMPLETED|Maintenance/Observation Period||2
1543721|NCT01332968|3777771|P4|COMPLETED|Maintenance/Observation Period||417
1543722|NCT01332968|3777772|P3|COMPLETED|Maintenance/Observation Period||399
1543723|NCT01332968|3777773|P2|COMPLETED|Maintenance/Observation Period||0
1543724|NCT01332968|3777774|P1|COMPLETED|Maintenance/Observation Period||0
1543725|NCT01332968|3777767|P8|STARTED|Maintenance/Observation Period||0
1543726|NCT01332968|3777768|P7|STARTED|Maintenance/Observation Period||0
1543727|NCT01332968|3777769|P6|STARTED|Maintenance/Observation Period||11
1543728|NCT01332968|3777770|P5|STARTED|Maintenance/Observation Period||12
1543729|NCT01332968|3777771|P4|STARTED|Maintenance/Observation Period||624
1543730|NCT01332968|3777772|P3|STARTED|Maintenance/Observation Period||612
1543731|NCT01332968|3777773|P2|STARTED|Maintenance/Observation Period||0
1543732|NCT01332968|3777774|P1|STARTED|Maintenance/Observation Period||0
1543733|NCT01332968|3777767|P8|NOT COMPLETED|Induction Period||0
1543734|NCT01332968|3777768|P7|NOT COMPLETED|Induction Period||0
1543735|NCT01332968|3777769|P6|NOT COMPLETED|Induction Period||0
1543736|NCT01332968|3777770|P5|NOT COMPLETED|Induction Period||0
1543737|NCT01332968|3777771|P4|NOT COMPLETED|Induction Period||0
1543738|NCT01332968|3777772|P3|NOT COMPLETED|Induction Period||0
1543739|NCT01332968|3777773|P2|NOT COMPLETED|Induction Period||56
1543740|NCT01332968|3777774|P1|NOT COMPLETED|Induction Period||58
1543741|NCT01332968|3777767|P8|COMPLETED|Induction Period||0
1543742|NCT01332968|3777768|P7|COMPLETED|Induction Period||0
1543743|NCT01332968|3777769|P6|COMPLETED|Induction Period||0
1543744|NCT01332968|3777770|P5|COMPLETED|Induction Period||0
1543745|NCT01332968|3777771|P4|COMPLETED|Induction Period||0
1543746|NCT01332968|3777772|P3|COMPLETED|Induction Period||0
1543747|NCT01332968|3777773|P2|COMPLETED|Induction Period||646
1543748|NCT01332968|3777774|P1|COMPLETED|Induction Period||641
1543749|NCT01332968|3777767|P8|STARTED|Induction Period||0
1543750|NCT01332968|3777768|P7|STARTED|Induction Period||0
1543751|NCT01332968|3777769|P6|STARTED|Induction Period||0
1543752|NCT01332968|3777770|P5|STARTED|Induction Period||0
1543753|NCT01332968|3777771|P4|STARTED|Induction Period||0
1543754|NCT01332968|3777772|P3|STARTED|Induction Period||0
1543755|NCT01332968|3777773|P2|STARTED|Induction Period||702
1543756|NCT01332968|3777774|P1|STARTED|Induction Period||699
1543757|NCT01332851|3777840|P2|NOT COMPLETED|Overall Study||13
1543758|NCT01332851|3777841|P1|NOT COMPLETED|Overall Study||11
1543759|NCT01332851|3777840|P2|COMPLETED|Overall Study||110
1543760|NCT01332851|3777841|P1|COMPLETED|Overall Study||113
1543761|NCT01332851|3777840|P2|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
1543762|NCT01332851|3777841|P1|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
1543763|NCT01332851|3777840|P2|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
1543764|NCT01332851|3777841|P1|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
1543765|NCT01332851|3777840|P2|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
1543766|NCT01332851|3777841|P1|Completed Follow up 1|Overall Study||116
1543767|NCT01332851|3777840|P2|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
1543768|NCT01332851|3777841|P1|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
1543769|NCT01332851|3777840|P2|STARTED|Overall Study||123
1543770|NCT01332851|3777841|P1|STARTED|Overall Study||124
1543771|NCT01332721|3777873|P1|NOT COMPLETED|Overall Study||0
1543772|NCT01332721|3777873|P1|COMPLETED|Overall Study||38
1543773|NCT01332721|3777873|P1|STARTED|Overall Study||38
1543774|NCT01332630|3777879|P1|NOT COMPLETED|Overall Study||3
1543775|NCT01332630|3777879|P1|COMPLETED|Overall Study||21
1543776|NCT01332630|3777879|P1|STARTED|Overall Study||24
1543777|NCT01332578|3777883|P2|NOT COMPLETED|Period II||0
1543778|NCT01332578|3777884|P1|NOT COMPLETED|Period II||0
1543779|NCT01332578|3777883|P2|COMPLETED|Period II||13
1543780|NCT01332578|3777884|P1|COMPLETED|Period II||12
1543781|NCT01332578|3777883|P2|STARTED|Period II||13
1543782|NCT01332578|3777884|P1|STARTED|Period II||12
1543783|NCT01332578|3777883|P2|NOT COMPLETED|Washout Period||0
1543784|NCT01332578|3777884|P1|NOT COMPLETED|Washout Period||0
1543785|NCT01332578|3777883|P2|COMPLETED|Washout Period||13
1543786|NCT01332578|3777884|P1|COMPLETED|Washout Period||12
1543787|NCT01332578|3777883|P2|STARTED|Washout Period||13
1543788|NCT01332578|3777884|P1|STARTED|Washout Period||12
1543789|NCT01332578|3777883|P2|NOT COMPLETED|Period I||0
1543790|NCT01332578|3777884|P1|NOT COMPLETED|Period I||0
1543791|NCT01332578|3777883|P2|COMPLETED|Period I||13
1543792|NCT01332578|3777884|P1|COMPLETED|Period I||12
1543793|NCT01332578|3777883|P2|STARTED|Period I||13
1543794|NCT01332578|3777884|P1|STARTED|Period I||12
1543795|NCT01332500|3777907|P4|NOT COMPLETED|Overall Study||0
1543796|NCT01332500|3777908|P3|NOT COMPLETED|Overall Study||0
1543797|NCT01332500|3777909|P2|NOT COMPLETED|Overall Study||0
1543798|NCT01332500|3777910|P1|NOT COMPLETED|Overall Study||0
1543799|NCT01332500|3777907|P4|COMPLETED|Overall Study||5806
1543800|NCT01332500|3777908|P3|COMPLETED|Overall Study||2903
1543801|NCT01332500|3777909|P2|COMPLETED|Overall Study||39771
1543802|NCT01332500|3777910|P1|COMPLETED|Overall Study||13257
1543803|NCT01332500|3777907|P4|STARTED|Overall Study||5806
1543804|NCT01332500|3777908|P3|STARTED|Overall Study||2903
1543805|NCT01332500|3777909|P2|STARTED|Overall Study||39771
1543806|NCT01332500|3777910|P1|STARTED|Overall Study||13257
1543807|NCT01332487|3777930|P2|NOT COMPLETED|Overall Study||0
1543808|NCT01332487|3777931|P1|NOT COMPLETED|Overall Study||0
1543809|NCT01332487|3777930|P2|COMPLETED|Overall Study||3063
1543810|NCT01332487|3777931|P1|COMPLETED|Overall Study||5554
1543811|NCT01332487|3777930|P2|STARTED|Overall Study||3063
1543812|NCT01332487|3777931|P1|STARTED|Overall Study||5554
1543813|NCT01332461|3777941|P2|NOT COMPLETED|Overall Study||0
1543814|NCT01332461|3777942|P1|NOT COMPLETED|Overall Study||0
1543815|NCT01332461|3777941|P2|COMPLETED|Overall Study||4386
1543816|NCT01332461|3777942|P1|COMPLETED|Overall Study||1291
1543817|NCT01332461|3777941|P2|STARTED|Overall Study||4386
1543818|NCT01332461|3777942|P1|STARTED|Overall Study||1291
1543819|NCT01332435|3777956|P4|NOT COMPLETED|Overall Study||0
1543820|NCT01332435|3777957|P3|NOT COMPLETED|Overall Study||0
1543821|NCT01332435|3777958|P2|NOT COMPLETED|Overall Study||0
1543822|NCT01332435|3777959|P1|NOT COMPLETED|Overall Study||0
1543823|NCT01332435|3777956|P4|COMPLETED|Overall Study||1656
1543824|NCT01332435|3777957|P3|COMPLETED|Overall Study||2604
1543825|NCT01332435|3777958|P2|COMPLETED|Overall Study||1064
1543826|NCT01332435|3777959|P1|COMPLETED|Overall Study||1572
1543827|NCT01332435|3777956|P4|STARTED|Overall Study||1656
1543828|NCT01332435|3777957|P3|STARTED|Overall Study||2604
1543829|NCT01332435|3777958|P2|STARTED|Overall Study||1064
1543830|NCT01332435|3777959|P1|STARTED|Overall Study||1572
1543831|NCT01332357|3777989|P1|NOT COMPLETED|Overall Study||0
1543832|NCT01332357|3777989|P1|COMPLETED|Overall Study||6139
1543833|NCT01332357|3777989|P1|STARTED|Overall Study||6139
1543834|NCT01332318|3777997|P4|NOT COMPLETED|Overall Study||2
1543835|NCT01332318|3777998|P3|NOT COMPLETED|Overall Study||1
1543836|NCT01332318|3777999|P2|NOT COMPLETED|Overall Study||4
1543837|NCT01332318|3778000|P1|NOT COMPLETED|Overall Study||2
1543838|NCT01332318|3777997|P4|COMPLETED|Overall Study||28
1543839|NCT01332318|3777998|P3|COMPLETED|Overall Study||33
1543840|NCT01332318|3777999|P2|COMPLETED|Overall Study||28
1543841|NCT01332318|3778000|P1|COMPLETED|Overall Study||32
1543842|NCT01332318|3777997|P4|STARTED|Overall Study||30
1543843|NCT01332318|3777998|P3|STARTED|Overall Study||34
1543844|NCT01332318|3777999|P2|STARTED|Overall Study||32
1543845|NCT01332318|3778000|P1|STARTED|Overall Study||34
1543846|NCT01332305|3778111|P5|NOT COMPLETED|Overall Study||12
1543847|NCT01332305|3778112|P4|NOT COMPLETED|Overall Study||8
1543848|NCT01332305|3778113|P3|NOT COMPLETED|Overall Study||14
1543849|NCT01332305|3778114|P2|NOT COMPLETED|Overall Study||14
1543850|NCT01332305|3778115|P1|NOT COMPLETED|Overall Study||10
1543851|NCT01332305|3778111|P5|COMPLETED|Overall Study||33
1543852|NCT01332305|3778112|P4|COMPLETED|Overall Study||30
1543853|NCT01332305|3778113|P3|COMPLETED|Overall Study||31
1543854|NCT01332305|3778114|P2|COMPLETED|Overall Study||34
1543855|NCT01332305|3778115|P1|COMPLETED|Overall Study||31
1543856|NCT01332305|3778111|P5|STARTED|Overall Study||45
1543857|NCT01332305|3778112|P4|STARTED|Overall Study||38
1543858|NCT01332305|3778113|P3|STARTED|Overall Study||45
1543859|NCT01332305|3778114|P2|STARTED|Overall Study||48
1543860|NCT01332305|3778115|P1|STARTED|Overall Study||41
1543861|NCT01332292|3778137|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1543862|NCT01332292|3778138|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1543863|NCT01332292|3778137|P2|COMPLETED|Treatment Period 2 (14 Days)||11
1543864|NCT01332292|3778138|P1|COMPLETED|Treatment Period 2 (14 Days)||11
1543865|NCT01332292|3778137|P2|STARTED|Treatment Period 2 (14 Days)||12
1543866|NCT01332292|3778138|P1|STARTED|Treatment Period 2 (14 Days)||12
1543867|NCT01332292|3778137|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
1543868|NCT01332292|3778138|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
1543869|NCT01332292|3778137|P2|COMPLETED|Washout Period (>=7 Days)||12
1543870|NCT01332292|3778138|P1|COMPLETED|Washout Period (>=7 Days)||12
1543871|NCT01332292|3778137|P2|STARTED|Washout Period (>=7 Days)||12
1543872|NCT01332292|3778138|P1|STARTED|Washout Period (>=7 Days)||12
1543873|NCT01332292|3778137|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1543874|NCT01332292|3778138|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1543875|NCT01332292|3778137|P2|COMPLETED|Treatment Period 1 (14 Days)||12
1543876|NCT01332292|3778138|P1|COMPLETED|Treatment Period 1 (14 Days)||12
1543877|NCT01332292|3778137|P2|STARTED|Treatment Period 1 (14 Days)||13
1543878|NCT01332292|3778138|P1|STARTED|Treatment Period 1 (14 Days)||14
1543879|NCT01332253|3778200|P2|NOT COMPLETED|Overall Study||0
1543880|NCT01332253|3778201|P1|NOT COMPLETED|Overall Study||0
1543881|NCT01332253|3778200|P2|COMPLETED|Overall Study||79
1543882|NCT01332253|3778201|P1|COMPLETED|Overall Study||82
1543883|NCT01332253|3778200|P2|STARTED|Overall Study||79
1543884|NCT01332253|3778201|P1|STARTED|Overall Study||82
1543885|NCT01332227|3778229|P2|NOT COMPLETED|Overall Study||5
1543886|NCT01332227|3778230|P1|NOT COMPLETED|Overall Study||16
1543887|NCT01332227|3778229|P2|COMPLETED|Overall Study||32
1543888|NCT01332227|3778230|P1|COMPLETED|Overall Study||56
1543889|NCT01332227|3778229|P2|STARTED|Overall Study|Participants who received treatment|37
1543890|NCT01332227|3778230|P1|STARTED|Overall Study|Participants who received treatment|72
1543891|NCT01332188|3778252|P4|NOT COMPLETED|Overall Study||0
1543892|NCT01332188|3778253|P3|NOT COMPLETED|Overall Study||4
1543893|NCT01332188|3778254|P2|NOT COMPLETED|Overall Study||1
1543894|NCT01332188|3778255|P1|NOT COMPLETED|Overall Study||2
1543895|NCT01332188|3778252|P4|COMPLETED|Overall Study||25
1543896|NCT01332188|3778253|P3|COMPLETED|Overall Study||21
1543897|NCT01332188|3778254|P2|COMPLETED|Overall Study||25
1543898|NCT01332188|3778255|P1|COMPLETED|Overall Study||23
1543899|NCT01332188|3778252|P4|STARTED|Overall Study||25
1543900|NCT01332188|3778253|P3|STARTED|Overall Study||25
1543901|NCT01332188|3778254|P2|STARTED|Overall Study||26
1543902|NCT01332188|3778255|P1|STARTED|Overall Study||25
1543903|NCT01332149|3778411|P2|NOT COMPLETED|Overall Study||38
1543904|NCT01332149|3778412|P1|NOT COMPLETED|Overall Study||30
1543905|NCT01332149|3778411|P2|COMPLETED|Overall Study||271
1543906|NCT01332149|3778412|P1|COMPLETED|Overall Study||284
1543907|NCT01332149|3778411|P2|Treated|Overall Study||307
1543908|NCT01332149|3778412|P1|Treated|Overall Study||313
1543909|NCT01332149|3778411|P2|STARTED|Overall Study|Assigned to study treatment.|309
1543910|NCT01332149|3778412|P1|STARTED|Overall Study|Assigned to study treatment.|314
1543911|NCT01332123|3778466|P1|NOT COMPLETED|Overall Study||0
1543912|NCT01332123|3778466|P1|COMPLETED|Overall Study||10
1543913|NCT01332123|3778466|P1|STARTED|Overall Study||10
1543914|NCT01332071|3778471|P2|NOT COMPLETED|Period 2||0
1543915|NCT01332071|3778472|P1|NOT COMPLETED|Period 2||0
1543916|NCT01332071|3778471|P2|COMPLETED|Period 2||13
1543917|NCT01332071|3778472|P1|COMPLETED|Period 2||13
1543918|NCT01332071|3778471|P2|STARTED|Period 2||13
1543919|NCT01332071|3778472|P1|STARTED|Period 2||13
1543920|NCT01332071|3778471|P2|NOT COMPLETED|7-Day Washout Period||0
1543921|NCT01332071|3778472|P1|NOT COMPLETED|7-Day Washout Period||0
1543922|NCT01332071|3778471|P2|COMPLETED|7-Day Washout Period||13
1543923|NCT01332071|3778472|P1|COMPLETED|7-Day Washout Period||13
1543924|NCT01332071|3778471|P2|STARTED|7-Day Washout Period||13
1543925|NCT01332071|3778472|P1|STARTED|7-Day Washout Period||13
1543926|NCT01332071|3778471|P2|NOT COMPLETED|Period 1||0
1543927|NCT01332071|3778472|P1|NOT COMPLETED|Period 1||0
1543928|NCT01332071|3778471|P2|COMPLETED|Period 1||13
1543929|NCT01332071|3778472|P1|COMPLETED|Period 1||13
1543930|NCT01332071|3778471|P2|STARTED|Period 1||13
1543931|NCT01332071|3778472|P1|STARTED|Period 1||13
1543932|NCT01332019|3778490|P2|NOT COMPLETED|Overall Study||122
1543933|NCT01332019|3778491|P1|NOT COMPLETED|Overall Study||113
1543934|NCT01332019|3778490|P2|COMPLETED|Overall Study||425
1543935|NCT01332019|3778491|P1|COMPLETED|Overall Study||417
1543936|NCT01332019|3778490|P2|STARTED|Overall Study||547
1543937|NCT01332019|3778491|P1|STARTED|Overall Study||530
1543938|NCT01331837|3778575|P2|NOT COMPLETED|Overall Study||67
1543939|NCT01331837|3778576|P1|NOT COMPLETED|Overall Study||56
1543940|NCT01331837|3778575|P2|COMPLETED|Overall Study||1475
1543941|NCT01331837|3778576|P1|COMPLETED|Overall Study||1482
1543942|NCT01331837|3778575|P2|STARTED|Overall Study||1542
1543943|NCT01331837|3778576|P1|STARTED|Overall Study||1538
1543944|NCT01331824|3778616|P1|NOT COMPLETED|Overall Study||13
1543945|NCT01331824|3778616|P1|COMPLETED|Overall Study||9
1543946|NCT01331824|3778616|P1|STARTED|Overall Study||22
1543947|NCT01331694|3778629|P6|NOT COMPLETED|Overall Study||0
1543948|NCT01331694|3778630|P5|NOT COMPLETED|Overall Study||0
1543949|NCT01331694|3778631|P4|NOT COMPLETED|Overall Study||0
1543950|NCT01331694|3778632|P3|NOT COMPLETED|Overall Study||0
1543951|NCT01331694|3778633|P2|NOT COMPLETED|Overall Study||0
1543952|NCT01331694|3778634|P1|NOT COMPLETED|Overall Study||0
1543953|NCT01331694|3778629|P6|COMPLETED|Overall Study||9126
1543954|NCT01331694|3778630|P5|COMPLETED|Overall Study||10617
1543955|NCT01331694|3778631|P4|COMPLETED|Overall Study||12595
1543956|NCT01331694|3778632|P3|COMPLETED|Overall Study||12659
1543957|NCT01331694|3778633|P2|COMPLETED|Overall Study||14449
1543958|NCT01331694|3778634|P1|COMPLETED|Overall Study||16684
1543959|NCT01331694|3778629|P6|STARTED|Overall Study||9126
1543960|NCT01331694|3778630|P5|STARTED|Overall Study||10617
1543961|NCT01331694|3778631|P4|STARTED|Overall Study||12595
1543962|NCT01331694|3778632|P3|STARTED|Overall Study||12659
1543963|NCT01331694|3778633|P2|STARTED|Overall Study||14449
1543964|NCT01331694|3778634|P1|STARTED|Overall Study||16684
1543965|NCT01331681|3778651|P3|NOT COMPLETED|Overall Study||35
1543966|NCT01331681|3778652|P2|NOT COMPLETED|Overall Study||34
1543967|NCT01331681|3778653|P1|NOT COMPLETED|Overall Study||35
1543968|NCT01331681|3778651|P3|COMPLETED|Overall Study|Completed Week 148|100
1543969|NCT01331681|3778652|P2|COMPLETED|Overall Study|Completed Week 148|101
1543970|NCT01331681|3778653|P1|COMPLETED|Overall Study|Completed Week 148|101
1543971|NCT01331681|3778651|P3|Completed Week 148|Overall Study||100
1543972|NCT01331681|3778652|P2|Completed Week 148|Overall Study||101
1543973|NCT01331681|3778653|P1|Completed Week 148|Overall Study||101
1543974|NCT01331681|3778651|P3|Completed Week 100|Overall Study||105
1543975|NCT01331681|3778652|P2|Completed Week 100|Overall Study||110
1543976|NCT01331681|3778653|P1|Completed Week 100|Overall Study||115
1543977|NCT01331681|3778651|P3|Completed Week 52|Overall Study||115
1543978|NCT01331681|3778652|P2|Completed Week 52|Overall Study||121
1543979|NCT01331681|3778653|P1|Completed Week 52|Overall Study||125
1543980|NCT01331681|3778651|P3|Participants Received Treatment|Overall Study|safety population|133
1543981|NCT01331681|3778652|P2|Participants Received Treatment|Overall Study|safety population|135
1543982|NCT01331681|3778653|P1|Participants Received Treatment|Overall Study|safety population|136
1543983|NCT01331681|3778651|P3|STARTED|Overall Study|randomized|135
1543984|NCT01331681|3778652|P2|STARTED|Overall Study|randomized|135
1543985|NCT01331681|3778653|P1|STARTED|Overall Study|randomized|136
1543986|NCT01331304|3778681|P2|NOT COMPLETED|Overall Study||60
1543987|NCT01331304|3778682|P1|NOT COMPLETED|Overall Study||58
1543988|NCT01331304|3778681|P2|COMPLETED|Overall Study||182
1543989|NCT01331304|3778682|P1|COMPLETED|Overall Study||182
1543990|NCT01331304|3778681|P2|STARTED|Overall Study||242
1543991|NCT01331304|3778682|P1|STARTED|Overall Study||240
1543992|NCT01331291|3778696|P2|NOT COMPLETED|Overall Study||9
1543993|NCT01331291|3778697|P1|NOT COMPLETED|Overall Study||2
1543994|NCT01331291|3778696|P2|COMPLETED|Overall Study||0
1543995|NCT01331291|3778697|P1|COMPLETED|Overall Study||0
1543996|NCT01331291|3778696|P2|STARTED|Overall Study||9
1543997|NCT01331291|3778697|P1|STARTED|Overall Study||2
1543998|NCT01331213|3778710|P2|NOT COMPLETED|Overall Study||0
1543999|NCT01331213|3778711|P1|NOT COMPLETED|Overall Study||0
1544000|NCT01331213|3778710|P2|COMPLETED|Overall Study||10
1544001|NCT01331213|3778711|P1|COMPLETED|Overall Study||8
1544002|NCT01331213|3778710|P2|STARTED|Overall Study||10
1544003|NCT01331213|3778711|P1|STARTED|Overall Study||8
1544004|NCT01331161|3778731|P2|NOT COMPLETED|Overall Study||2
1544005|NCT01331161|3778732|P1|NOT COMPLETED|Overall Study||1
1544006|NCT01331161|3778731|P2|COMPLETED|Overall Study||31
1544007|NCT01331161|3778732|P1|COMPLETED|Overall Study||43
1544008|NCT01331161|3778731|P2|STARTED|Overall Study||33
1544009|NCT01331161|3778732|P1|STARTED|Overall Study||44
1544010|NCT01331109|3778740|P1|NOT COMPLETED|Overall Study||57
1544011|NCT01331109|3778740|P1|COMPLETED|Overall Study||0
1544012|NCT01331109|3778740|P1|STARTED|Overall Study||57
1544013|NCT01331005|3778752|P2|NOT COMPLETED|Overall Study||4
1544014|NCT01331005|3778753|P1|NOT COMPLETED|Overall Study||4
1544015|NCT01331005|3778752|P2|COMPLETED|Overall Study||57
1544016|NCT01331005|3778753|P1|COMPLETED|Overall Study||60
1544017|NCT01331005|3778752|P2|STARTED|Overall Study||61
1544018|NCT01331005|3778753|P1|STARTED|Overall Study||64
1544019|NCT01330953|3778768|P5|NOT COMPLETED|Overall Study||0
1544020|NCT01330953|3778769|P4|NOT COMPLETED|Overall Study||0
1544021|NCT01330953|3778770|P3|NOT COMPLETED|Overall Study||0
1544022|NCT01330953|3778771|P2|NOT COMPLETED|Overall Study||0
1544023|NCT01330953|3778772|P1|NOT COMPLETED|Overall Study||0
1544024|NCT01330953|3778768|P5|COMPLETED|Overall Study||6
1544025|NCT01330953|3778769|P4|COMPLETED|Overall Study||6
1544026|NCT01330953|3778770|P3|COMPLETED|Overall Study||6
1544027|NCT01330953|3778771|P2|COMPLETED|Overall Study||6
1544028|NCT01330953|3778772|P1|COMPLETED|Overall Study||8
1544029|NCT01330953|3778768|P5|STARTED|Overall Study||6
1544030|NCT01330953|3778769|P4|STARTED|Overall Study||6
1544031|NCT01330953|3778770|P3|STARTED|Overall Study||6
1544032|NCT01330953|3778771|P2|STARTED|Overall Study||6
1544033|NCT01330953|3778772|P1|STARTED|Overall Study||8
1544034|NCT01330914|3778818|P1|NOT COMPLETED|Overall Study||7
1544035|NCT01330914|3778818|P1|COMPLETED|Overall Study||48
1544036|NCT01330914|3778818|P1|STARTED|Overall Study||55
1544037|NCT01330628|3778824|P2|NOT COMPLETED|Overall Study||40
1544038|NCT01330628|3778825|P1|NOT COMPLETED|Overall Study||70
1544039|NCT01330628|3778824|P2|COMPLETED|Overall Study||42
1544040|NCT01330628|3778825|P1|COMPLETED|Overall Study||100
1544041|NCT01330628|3778824|P2|6 Month Follow-up|Overall Study||60
1544042|NCT01330628|3778825|P1|6 Month Follow-up|Overall Study||135
1544043|NCT01330628|3778824|P2|30 Day Follow-up|Overall Study||73
1544044|NCT01330628|3778825|P1|30 Day Follow-up|Overall Study||165
1544045|NCT01330628|3778824|P2|STARTED|Overall Study||82
1544046|NCT01330628|3778825|P1|STARTED|Overall Study||170
1544047|NCT01330433|3778835|P2|NOT COMPLETED|Overall Study||3
1544048|NCT01330433|3778836|P1|NOT COMPLETED|Overall Study||2
1544049|NCT01330433|3778835|P2|COMPLETED|Overall Study||16
1544050|NCT01330433|3778836|P1|COMPLETED|Overall Study||14
1544051|NCT01330433|3778835|P2|STARTED|Overall Study||19
1544052|NCT01330433|3778836|P1|STARTED|Overall Study||16
1544053|NCT01330420|3778856|P1|NOT COMPLETED|Overall Study||4
1544054|NCT01330420|3778856|P1|COMPLETED|Overall Study||24
1544055|NCT01330420|3778856|P1|STARTED|Overall Study||28
1544056|NCT01330394|3778866|P2|NOT COMPLETED|Overall Study||0
1544057|NCT01330394|3778867|P1|NOT COMPLETED|Overall Study||0
1544058|NCT01330394|3778866|P2|COMPLETED|Overall Study||16
1544059|NCT01330394|3778867|P1|COMPLETED|Overall Study||17
1544060|NCT01330394|3778866|P2|STARTED|Overall Study||16
1544061|NCT01330394|3778867|P1|STARTED|Overall Study||17
1544062|NCT01330381|3778875|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
1544063|NCT01330381|3778876|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
1544064|NCT01330381|3778877|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
1544065|NCT01330381|3778875|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
1544066|NCT01330381|3778876|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
1544067|NCT01330381|3778877|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
1544068|NCT01330381|3778875|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
1544069|NCT01330381|3778876|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
1544070|NCT01330381|3778877|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
1544071|NCT01330381|3778875|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
1544072|NCT01330381|3778876|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
1544073|NCT01330381|3778877|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
1544074|NCT01330381|3778875|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
1544075|NCT01330381|3778876|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
1544076|NCT01330381|3778877|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
1544077|NCT01330381|3778875|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
1544078|NCT01330381|3778876|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
1544079|NCT01330381|3778877|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
1544080|NCT01330381|3778875|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
1544081|NCT01330381|3778876|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
1544082|NCT01330381|3778877|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
1544083|NCT01330355|3778923|P2|NOT COMPLETED|Overall Study||0
1544084|NCT01330355|3778924|P1|NOT COMPLETED|Overall Study||0
1544085|NCT01330355|3778923|P2|COMPLETED|Overall Study||17
1544086|NCT01330355|3778924|P1|COMPLETED|Overall Study||16
1544087|NCT01330355|3778923|P2|STARTED|Overall Study||17
1544088|NCT01330355|3778924|P1|STARTED|Overall Study||16
1544089|NCT01330316|3778938|P2|NOT COMPLETED|Overall Study||15
1544090|NCT01330316|3778939|P1|NOT COMPLETED|Overall Study||2
1544091|NCT01330316|3778938|P2|COMPLETED|Overall Study||60
1544092|NCT01330316|3778939|P1|COMPLETED|Overall Study||41
1544093|NCT01330316|3778938|P2|STARTED|Overall Study||75
1544094|NCT01330316|3778939|P1|STARTED|Overall Study||43
1544095|NCT01330303|3778975|P2|NOT COMPLETED|Period 2||0
1544096|NCT01330303|3778976|P1|NOT COMPLETED|Period 2||0
1544097|NCT01330303|3778975|P2|COMPLETED|Period 2||18
1544098|NCT01330303|3778976|P1|COMPLETED|Period 2||19
1544099|NCT01330303|3778975|P2|STARTED|Period 2||18
1544100|NCT01330303|3778976|P1|STARTED|Period 2||19
1544101|NCT01330303|3778975|P2|NOT COMPLETED|7-Day Washout Period||0
1544102|NCT01330303|3778976|P1|NOT COMPLETED|7-Day Washout Period||0
1544103|NCT01330303|3778975|P2|COMPLETED|7-Day Washout Period||18
1544104|NCT01330303|3778976|P1|COMPLETED|7-Day Washout Period||19
1544105|NCT01330303|3778975|P2|STARTED|7-Day Washout Period||18
1544106|NCT01330303|3778976|P1|STARTED|7-Day Washout Period||19
1544107|NCT01330303|3778975|P2|NOT COMPLETED|Period 1||2
1544108|NCT01330303|3778976|P1|NOT COMPLETED|Period 1||1
1544109|NCT01330303|3778975|P2|COMPLETED|Period 1||18
1544110|NCT01330303|3778976|P1|COMPLETED|Period 1||19
1544111|NCT01330303|3778975|P2|STARTED|Period 1||20
1544112|NCT01330303|3778976|P1|STARTED|Period 1||20
1544113|NCT01330290|3778986|P1|NOT COMPLETED|Overall Study||0
1544114|NCT01330290|3778986|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
1544115|NCT01330290|3778986|P1|STARTED|Overall Study||148
1544116|NCT01330134|3779012|P2|NOT COMPLETED|Overall Study||0
1544117|NCT01330134|3779013|P1|NOT COMPLETED|Overall Study||0
1544118|NCT01330134|3779012|P2|COMPLETED|Overall Study||237
1544119|NCT01330134|3779013|P1|COMPLETED|Overall Study||244
1544120|NCT01330134|3779012|P2|STARTED|Overall Study||237
1544121|NCT01330134|3779013|P1|STARTED|Overall Study||244
1544122|NCT01330108|3779023|P1|NOT COMPLETED|Overall Study||4
1544123|NCT01330108|3779023|P1|COMPLETED|Overall Study||28
1544124|NCT01330108|3779023|P1|STARTED|Overall Study||32
1544125|NCT01330043|3779030|P2|NOT COMPLETED|Overall Study||4
1544126|NCT01330043|3779031|P1|NOT COMPLETED|Overall Study||0
1544127|NCT01330043|3779030|P2|COMPLETED|Overall Study||108
1544128|NCT01330043|3779031|P1|COMPLETED|Overall Study||111
1544129|NCT01330043|3779030|P2|STARTED|Overall Study||112
1544130|NCT01330043|3779031|P1|STARTED|Overall Study||111
1544131|NCT01330030|3779041|P2|NOT COMPLETED|Overall Study||17
1544132|NCT01330030|3779042|P1|NOT COMPLETED|Overall Study||16
1544133|NCT01330030|3779041|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
1544134|NCT01330030|3779042|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
1544135|NCT01330030|3779041|P2|STARTED|Overall Study||122
1544136|NCT01330030|3779042|P1|STARTED|Overall Study||121
1544137|NCT01330017|3779053|P5|NOT COMPLETED|Overall Study||3
1544138|NCT01330017|3779054|P4|NOT COMPLETED|Overall Study||12
1544139|NCT01330017|3779055|P3|NOT COMPLETED|Overall Study||8
1544140|NCT01330017|3779056|P2|NOT COMPLETED|Overall Study||4
1544141|NCT01330017|3779057|P1|NOT COMPLETED|Overall Study||5
1544142|NCT01330017|3779053|P5|COMPLETED|Overall Study||100
1544143|NCT01330017|3779054|P4|COMPLETED|Overall Study||100
1544144|NCT01330017|3779055|P3|COMPLETED|Overall Study||99
1544145|NCT01330017|3779056|P2|COMPLETED|Overall Study||104
1544146|NCT01330017|3779057|P1|COMPLETED|Overall Study||104
1544147|NCT01330017|3779053|P5|STARTED|Overall Study||103
1544148|NCT01330017|3779054|P4|STARTED|Overall Study||112
1544149|NCT01330017|3779055|P3|STARTED|Overall Study||107
1544150|NCT01330017|3779056|P2|STARTED|Overall Study||108
1544151|NCT01330017|3779057|P1|STARTED|Overall Study||109
1544152|NCT01329978|3779106|P5|NOT COMPLETED|Rerandomization Treatment Period||4
1544153|NCT01329978|3779107|P4|NOT COMPLETED|Rerandomization Treatment Period||5
1544154|NCT01329978|3779108|P3|NOT COMPLETED|Rerandomization Treatment Period||0
1544155|NCT01329978|3779109|P2|NOT COMPLETED|Rerandomization Treatment Period||0
1544156|NCT01329978|3779110|P1|NOT COMPLETED|Rerandomization Treatment Period||0
1544157|NCT01329978|3779106|P5|COMPLETED|Rerandomization Treatment Period||71
1544158|NCT01329978|3779107|P4|COMPLETED|Rerandomization Treatment Period||70
1544159|NCT01329978|3779108|P3|COMPLETED|Rerandomization Treatment Period||0
1544160|NCT01329978|3779109|P2|COMPLETED|Rerandomization Treatment Period||0
1544161|NCT01329978|3779110|P1|COMPLETED|Rerandomization Treatment Period||0
1544162|NCT01329978|3779106|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
1544163|NCT01329978|3779107|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
1544164|NCT01329978|3779108|P3|STARTED|Rerandomization Treatment Period||0
1544165|NCT01329978|3779109|P2|STARTED|Rerandomization Treatment Period||0
1544166|NCT01329978|3779110|P1|STARTED|Rerandomization Treatment Period||0
1544167|NCT01329978|3779106|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1544168|NCT01329978|3779107|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1544169|NCT01329978|3779108|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
1544170|NCT01329978|3779109|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
1544171|NCT01329978|3779110|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
1544172|NCT01329978|3779106|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1544173|NCT01329978|3779107|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1544174|NCT01329978|3779108|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
1544175|NCT01329978|3779109|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
1544176|NCT01329978|3779110|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
1544177|NCT01329978|3779106|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
1544178|NCT01329978|3779107|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
1544179|NCT01329978|3779108|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
1544180|NCT01329978|3779109|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
1544181|NCT01329978|3779110|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
1544182|NCT01329939|3779184|P4|NOT COMPLETED|Overall Study||5
1544183|NCT01329939|3779185|P3|NOT COMPLETED|Overall Study||1
1544184|NCT01329939|3779186|P2|NOT COMPLETED|Overall Study||1
1544185|NCT01329939|3779187|P1|NOT COMPLETED|Overall Study||3
1544186|NCT01329939|3779184|P4|COMPLETED|Overall Study||4
1544187|NCT01329939|3779185|P3|COMPLETED|Overall Study||4
1544188|NCT01329939|3779186|P2|COMPLETED|Overall Study||4
1544189|NCT01329939|3779187|P1|COMPLETED|Overall Study||4
1544190|NCT01329939|3779184|P4|STARTED|Overall Study||9
1544191|NCT01329939|3779185|P3|STARTED|Overall Study||5
1544192|NCT01329939|3779186|P2|STARTED|Overall Study||5
1544193|NCT01329939|3779187|P1|STARTED|Overall Study||7
1544194|NCT01329848|3779225|P1|NOT COMPLETED|Overall Study||29
1544195|NCT01329848|3779225|P1|COMPLETED|Overall Study||54
1544196|NCT01329848|3779225|P1|STARTED|Overall Study||83
1544197|NCT01329679|3779230|P2|NOT COMPLETED|Overall Study||0
1544198|NCT01329679|3779231|P1|NOT COMPLETED|Overall Study||0
1544199|NCT01329679|3779230|P2|COMPLETED|Overall Study||13
1544200|NCT01329679|3779231|P1|COMPLETED|Overall Study||13
1544201|NCT01329679|3779230|P2|STARTED|Overall Study||13
1544202|NCT01329679|3779231|P1|STARTED|Overall Study||13
1544203|NCT01329562|3779251|P2|NOT COMPLETED|Overall Study||7
1544204|NCT01329562|3779252|P1|NOT COMPLETED|Overall Study||9
1544205|NCT01329562|3779251|P2|COMPLETED|Overall Study||14
1544206|NCT01329562|3779252|P1|COMPLETED|Overall Study||11
1544207|NCT01329562|3779251|P2|STARTED|Overall Study||21
1544208|NCT01329562|3779252|P1|STARTED|Overall Study||20
1544209|NCT01329549|3779301|P1|NOT COMPLETED|Overall Study||2
1544210|NCT01329549|3779301|P1|COMPLETED|Overall Study||0
1544211|NCT01329549|3779301|P1|STARTED|Overall Study||2
1544212|NCT01329419|3779312|P1|NOT COMPLETED|Overall Study||235
1544213|NCT01329419|3779312|P1|COMPLETED|Overall Study||4158
1544214|NCT01329419|3779312|P1|STARTED|Overall Study||4393
1544215|NCT01329263|3779320|P2|NOT COMPLETED|Overall Study||23
1544216|NCT01329263|3779321|P1|NOT COMPLETED|Overall Study||5
1544217|NCT01329263|3779320|P2|COMPLETED|Overall Study||22
1544218|NCT01329263|3779321|P1|COMPLETED|Overall Study||10
1544219|NCT01329263|3779320|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
1544220|NCT01329263|3779321|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
1544221|NCT01329263|3779320|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
1544222|NCT01329263|3779321|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
1544223|NCT01329263|3779320|P2|Completed Period 1 Own Menthol|Overall Study||45
1544224|NCT01329263|3779321|P1|Completed Period 1 Own Menthol|Overall Study||15
1544225|NCT01329263|3779320|P2|STARTED|Overall Study||45
1544226|NCT01329263|3779321|P1|STARTED|Overall Study||15
1544227|NCT01329198|3779335|P2|NOT COMPLETED|Overall Study||0
1544228|NCT01329198|3779336|P1|NOT COMPLETED|Overall Study||0
1544229|NCT01329198|3779335|P2|COMPLETED|Overall Study||2
1544230|NCT01329198|3779336|P1|COMPLETED|Overall Study||3
1544231|NCT01329198|3779335|P2|STARTED|Overall Study||2
1544232|NCT01329198|3779336|P1|STARTED|Overall Study||3
1544233|NCT01329185|3779349|P2|NOT COMPLETED|Overall Study||0
1544234|NCT01329185|3779350|P1|NOT COMPLETED|Overall Study||0
1544235|NCT01329185|3779349|P2|COMPLETED|Overall Study||7
1544236|NCT01329185|3779350|P1|COMPLETED|Overall Study||10
1544237|NCT01329185|3779349|P2|PTLD|Overall Study||0
1544238|NCT01329185|3779350|P1|PTLD|Overall Study||1
1544239|NCT01329185|3779349|P2|CMV Disease|Overall Study||0
1544240|NCT01329185|3779350|P1|CMV Disease|Overall Study||1
1544241|NCT01329185|3779349|P2|STARTED|Overall Study||7
1544242|NCT01329185|3779350|P1|STARTED|Overall Study||10
1544243|NCT01329029|3779358|P2|NOT COMPLETED|Overall Study||192
1544244|NCT01329029|3779359|P1|NOT COMPLETED|Overall Study||269
1544245|NCT01329029|3779358|P2|COMPLETED|Overall Study||780
1544246|NCT01329029|3779359|P1|COMPLETED|Overall Study||704
1544247|NCT01329029|3779358|P2|Safety Population|Overall Study||967
1544248|NCT01329029|3779359|P1|Safety Population|Overall Study||968
1544249|NCT01329029|3779358|P2|Full Analysis Set (FAS)|Overall Study||966
1544250|NCT01329029|3779359|P1|Full Analysis Set (FAS)|Overall Study||969
1544251|NCT01329029|3779358|P2|STARTED|Overall Study||972
1544252|NCT01329029|3779359|P1|STARTED|Overall Study||973
1544253|NCT01328964|3779432|P3|NOT COMPLETED|Overall Study||0
1544254|NCT01328964|3779433|P2|NOT COMPLETED|Overall Study||0
1544255|NCT01328964|3779434|P1|NOT COMPLETED|Overall Study||0
1544256|NCT01328964|3779432|P3|COMPLETED|Overall Study||4424
1544257|NCT01328964|3779433|P2|COMPLETED|Overall Study||3270
1544258|NCT01328964|3779434|P1|COMPLETED|Overall Study||2212
1544259|NCT01328964|3779432|P3|STARTED|Overall Study||4424
1544260|NCT01328964|3779433|P2|STARTED|Overall Study||3270
1544261|NCT01328964|3779434|P1|STARTED|Overall Study||2212
1544262|NCT01328951|3779449|P2|NOT COMPLETED|Overall Study||322
1544263|NCT01328951|3779450|P1|NOT COMPLETED|Overall Study||321
1544264|NCT01328951|3779449|P2|COMPLETED|Overall Study||0
1544265|NCT01328951|3779450|P1|COMPLETED|Overall Study||0
1544266|NCT01328951|3779449|P2|STARTED|Overall Study||322
1544267|NCT01328951|3779450|P1|STARTED|Overall Study||321
1544268|NCT01328873|3779474|P1|NOT COMPLETED|Overall Study||0
1544269|NCT01328873|3779474|P1|COMPLETED|Overall Study||49
1544270|NCT01328873|3779474|P1|STARTED|Overall Study||49
1544271|NCT01328782|3779486|P3|NOT COMPLETED|Overall Study||0
1544272|NCT01328782|3779487|P2|NOT COMPLETED|Overall Study||0
1544273|NCT01328782|3779488|P1|NOT COMPLETED|Overall Study||0
1544274|NCT01328782|3779486|P3|COMPLETED|Overall Study||39
1544275|NCT01328782|3779487|P2|COMPLETED|Overall Study||42
1544276|NCT01328782|3779488|P1|COMPLETED|Overall Study||43
1544277|NCT01328782|3779486|P3|STARTED|Overall Study||39
1544278|NCT01328782|3779487|P2|STARTED|Overall Study||42
1544279|NCT01328782|3779488|P1|STARTED|Overall Study||43
1544280|NCT01328769|3779510|P2|NOT COMPLETED|Overall Study||1
1544281|NCT01328769|3779511|P1|NOT COMPLETED|Overall Study||0
1544282|NCT01328769|3779510|P2|COMPLETED|Overall Study||23
1544283|NCT01328769|3779511|P1|COMPLETED|Overall Study||25
1544284|NCT01328769|3779510|P2|STARTED|Overall Study||24
1544285|NCT01328769|3779511|P1|STARTED|Overall Study||25
1544286|NCT01328756|3779519|P1|NOT COMPLETED|Overall Study||123
1544287|NCT01328756|3779519|P1|COMPLETED|Overall Study||191
1544288|NCT01328756|3779519|P1|STARTED|Overall Study||314
1544289|NCT01328717|3779536|P1|NOT COMPLETED|Overall Study||1
1544290|NCT01328717|3779536|P1|COMPLETED|Overall Study||77
1544291|NCT01328717|3779536|P1|STARTED|Overall Study||78
1544292|NCT01328574|3779541|P1|NOT COMPLETED|Overall Study||1
1544293|NCT01328574|3779541|P1|COMPLETED|Overall Study||12
1544294|NCT01328574|3779541|P1|STARTED|Overall Study||13
1544295|NCT01328548|3779555|P2|NOT COMPLETED|Overall Study||0
1544296|NCT01328548|3779556|P1|NOT COMPLETED|Overall Study||4
1544297|NCT01328548|3779555|P2|COMPLETED|Overall Study||50
1544298|NCT01328548|3779556|P1|COMPLETED|Overall Study||187
1544299|NCT01328548|3779555|P2|STARTED|Overall Study||50
1544300|NCT01328548|3779556|P1|STARTED|Overall Study||191
1544301|NCT01328535|3779574|P1|NOT COMPLETED|Overall Study||1
1544302|NCT01328535|3779574|P1|COMPLETED|Overall Study||24
1544303|NCT01328535|3779574|P1|STARTED|Overall Study||25
1544304|NCT01328496|3779585|P2|NOT COMPLETED|Overall Study||0
1544305|NCT01328496|3779586|P1|NOT COMPLETED|Overall Study||1
1544306|NCT01328496|3779585|P2|COMPLETED|Overall Study||4
1544307|NCT01328496|3779586|P1|COMPLETED|Overall Study||9
1544308|NCT01328496|3779585|P2|STARTED|Overall Study||4
1544309|NCT01328496|3779586|P1|STARTED|Overall Study||10
1544310|NCT01328444|3779604|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
1544311|NCT01328444|3779605|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
1544312|NCT01328444|3779606|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
1544313|NCT01328444|3779607|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
1544314|NCT01328444|3779608|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
1544315|NCT01328444|3779609|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
1544316|NCT01328444|3779604|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
1544317|NCT01328444|3779605|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
1544318|NCT01328444|3779606|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
1544319|NCT01328444|3779607|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
1544320|NCT01328444|3779608|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
1544321|NCT01328444|3779609|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
1544322|NCT01328444|3779604|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
1544323|NCT01328444|3779605|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
1544324|NCT01328444|3779606|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
1544325|NCT01328444|3779607|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
1544326|NCT01328444|3779608|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
1544327|NCT01328444|3779609|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
1544328|NCT01328444|3779604|P6|NOT COMPLETED|Washout Period (14 Days)||4
1544329|NCT01328444|3779605|P5|NOT COMPLETED|Washout Period (14 Days)||1
1544330|NCT01328444|3779606|P4|NOT COMPLETED|Washout Period (14 Days)||1
1544331|NCT01328444|3779607|P3|NOT COMPLETED|Washout Period (14 Days)||0
1544332|NCT01328444|3779608|P2|NOT COMPLETED|Washout Period (14 Days)||1
1544333|NCT01328444|3779609|P1|NOT COMPLETED|Washout Period (14 Days)||1
1544334|NCT01328444|3779604|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
1544335|NCT01328444|3779605|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
1544336|NCT01328444|3779606|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
1544337|NCT01328444|3779607|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
1544338|NCT01328444|3779608|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
1544339|NCT01328444|3779609|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
1544340|NCT01328444|3779604|P6|STARTED|Washout Period (14 Days)||72
1544341|NCT01328444|3779605|P5|STARTED|Washout Period (14 Days)||67
1544342|NCT01328444|3779606|P4|STARTED|Washout Period (14 Days)||33
1544343|NCT01328444|3779607|P3|STARTED|Washout Period (14 Days)||25
1544344|NCT01328444|3779608|P2|STARTED|Washout Period (14 Days)||21
1544345|NCT01328444|3779609|P1|STARTED|Washout Period (14 Days)||83
1544346|NCT01328444|3779604|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
1544347|NCT01328444|3779605|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
1544348|NCT01328444|3779606|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
1544349|NCT01328444|3779607|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
1544350|NCT01328444|3779608|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
1544351|NCT01328444|3779609|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
1544352|NCT01328444|3779604|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
1544353|NCT01328444|3779605|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
1544354|NCT01328444|3779606|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
1544355|NCT01328444|3779607|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
1544356|NCT01328444|3779608|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
1544357|NCT01328444|3779609|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
1544358|NCT01328444|3779604|P6|STARTED|Treatment Period 1 (12 Weeks)||78
1544359|NCT01328444|3779605|P5|STARTED|Treatment Period 1 (12 Weeks)||81
1544360|NCT01328444|3779606|P4|STARTED|Treatment Period 1 (12 Weeks)||41
1544361|NCT01328444|3779607|P3|STARTED|Treatment Period 1 (12 Weeks)||28
1544362|NCT01328444|3779608|P2|STARTED|Treatment Period 1 (12 Weeks)||26
1544363|NCT01328444|3779609|P1|STARTED|Treatment Period 1 (12 Weeks)||94
1544364|NCT01328431|3779655|P2|NOT COMPLETED|12 Month (12M)||97
1544365|NCT01328431|3779656|P1|NOT COMPLETED|12 Month (12M)||84
1544366|NCT01328431|3779655|P2|COMPLETED|12 Month (12M)||289
1544367|NCT01328431|3779656|P1|COMPLETED|12 Month (12M)||304
1544368|NCT01328431|3779655|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
1544369|NCT01328431|3779656|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
1544370|NCT01328431|3779655|P2|NOT COMPLETED|3 Month (3M)||72
1544371|NCT01328431|3779656|P1|NOT COMPLETED|3 Month (3M)||77
1544372|NCT01328431|3779655|P2|COMPLETED|3 Month (3M)||316
1544373|NCT01328431|3779656|P1|COMPLETED|3 Month (3M)||313
1544374|NCT01328431|3779655|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
1544375|NCT01328431|3779656|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
1544376|NCT01328431|3779655|P2|NOT COMPLETED|1 Month (1M)||58
1544377|NCT01328431|3779656|P1|NOT COMPLETED|1 Month (1M)||55
1544378|NCT01328431|3779655|P2|COMPLETED|1 Month (1M)||330
1544379|NCT01328431|3779656|P1|COMPLETED|1 Month (1M)||335
1544380|NCT01328431|3779655|P2|STARTED|1 Month (1M)||388
1544381|NCT01328431|3779656|P1|STARTED|1 Month (1M)||390
1544382|NCT01328431|3779655|P2|NOT COMPLETED|Baseline||2
1544383|NCT01328431|3779656|P1|NOT COMPLETED|Baseline||0
1544384|NCT01328431|3779655|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
1544385|NCT01328431|3779656|P1|COMPLETED|Baseline||390
1544386|NCT01328431|3779655|P2|STARTED|Baseline||390
1544387|NCT01328431|3779656|P1|STARTED|Baseline||390
1544388|NCT01328405|3779666|P2|NOT COMPLETED|Overall Study||0
1544389|NCT01328405|3779667|P1|NOT COMPLETED|Overall Study||0
1544390|NCT01328405|3779666|P2|COMPLETED|Overall Study||48
1544391|NCT01328405|3779667|P1|COMPLETED|Overall Study||52
1544392|NCT01328405|3779666|P2|STARTED|Overall Study||48
1544393|NCT01328405|3779667|P1|STARTED|Overall Study||52
1544394|NCT01328379|3779684|P3|NOT COMPLETED|Overall Study||0
1544395|NCT01328379|3779685|P2|NOT COMPLETED|Overall Study||0
1544396|NCT01328379|3779686|P1|NOT COMPLETED|Overall Study||1
1544397|NCT01328379|3779684|P3|COMPLETED|Overall Study||143
1544398|NCT01328379|3779685|P2|COMPLETED|Overall Study||144
1544399|NCT01328379|3779686|P1|COMPLETED|Overall Study||142
1544400|NCT01328379|3779684|P3|STARTED|Overall Study||143
1544401|NCT01328379|3779685|P2|STARTED|Overall Study||144
1544402|NCT01328379|3779686|P1|STARTED|Overall Study||143
1544403|NCT01328366|3779712|P1|NOT COMPLETED|Overall Study||10
1544404|NCT01328366|3779712|P1|COMPLETED|Overall Study||143
1544405|NCT01328366|3779712|P1|STARTED|Overall Study||153
1544406|NCT01328249|3779732|P2|NOT COMPLETED|Overall Study||3
1544407|NCT01328249|3779733|P1|NOT COMPLETED|Overall Study||7
1544408|NCT01328249|3779732|P2|COMPLETED|Overall Study||23
1544409|NCT01328249|3779733|P1|COMPLETED|Overall Study||48
1544410|NCT01328249|3779732|P2|STARTED|Overall Study||26
1544411|NCT01328249|3779733|P1|STARTED|Overall Study||55
1544412|NCT01328184|3779741|P1|NOT COMPLETED|Overall Study||0
1544413|NCT01328184|3779741|P1|COMPLETED|Overall Study||18
1544414|NCT01328184|3779741|P1|STARTED|Overall Study||18
1544415|NCT01328158|3779781|P1|NOT COMPLETED|Overall Study||0
1544416|NCT01328158|3779781|P1|COMPLETED|Overall Study||220
1544417|NCT01328158|3779781|P1|STARTED|Overall Study||220
1544418|NCT01328080|3779819|P1|NOT COMPLETED|Overall Study||5
1544419|NCT01328080|3779819|P1|COMPLETED|Overall Study||6
1544420|NCT01328080|3779819|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
1544421|NCT01328054|3779823|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
1544422|NCT01328054|3779824|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
1544423|NCT01328054|3779823|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
1544424|NCT01328054|3779824|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
1544425|NCT01328054|3779823|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
1544426|NCT01328054|3779824|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
1544427|NCT01328054|3779823|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
1544428|NCT01328054|3779824|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
1544429|NCT01328054|3779823|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
1544430|NCT01328054|3779824|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
1544431|NCT01328054|3779823|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
1544432|NCT01328054|3779824|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
1544433|NCT01328041|3779849|P1|NOT COMPLETED|Overall Study||57
1544434|NCT01328041|3779849|P1|COMPLETED|Overall Study||126
1544435|NCT01328041|3779849|P1|STARTED|Overall Study||183
1544436|NCT01327989|3779871|P1|NOT COMPLETED|Overall Study||14
1544437|NCT01327989|3779871|P1|COMPLETED|Overall Study||188
1544438|NCT01327989|3779871|P1|STARTED|Overall Study||202
1544439|NCT01327976|3779885|P2|NOT COMPLETED|Overall Study||7
1544440|NCT01327976|3779886|P1|NOT COMPLETED|Overall Study||8
1544441|NCT01327976|3779885|P2|COMPLETED|Overall Study||70
1544442|NCT01327976|3779886|P1|COMPLETED|Overall Study||154
1544443|NCT01327976|3779885|P2|STARTED|Overall Study||77
1544444|NCT01327976|3779886|P1|STARTED|Overall Study||162
1544445|NCT01327885|3779898|P2|NOT COMPLETED|Overall Study||224
1544446|NCT01327885|3779899|P1|NOT COMPLETED|Overall Study||228
1544447|NCT01327885|3779898|P2|COMPLETED|Overall Study||0
1544448|NCT01327885|3779899|P1|COMPLETED|Overall Study||0
1544449|NCT01327885|3779898|P2|STARTED|Overall Study||224
1544450|NCT01327885|3779899|P1|STARTED|Overall Study||228
1544451|NCT01327703|3779911|P2|NOT COMPLETED|Second Treatment Period||2
1544452|NCT01327703|3779912|P1|NOT COMPLETED|Second Treatment Period||1
1544453|NCT01327703|3779911|P2|COMPLETED|Second Treatment Period||42
1544454|NCT01327703|3779912|P1|COMPLETED|Second Treatment Period||39
1544455|NCT01327703|3779911|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
1544456|NCT01327703|3779912|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
1544457|NCT01327703|3779911|P2|NOT COMPLETED|First Treatment Period||0
1544458|NCT01327703|3779912|P1|NOT COMPLETED|First Treatment Period||0
1544459|NCT01327703|3779911|P2|COMPLETED|First Treatment Period||45
1544460|NCT01327703|3779912|P1|COMPLETED|First Treatment Period||42
1544461|NCT01327703|3779911|P2|STARTED|First Treatment Period||45
1544462|NCT01327703|3779912|P1|STARTED|First Treatment Period||42
1544463|NCT01327677|3779946|P2|NOT COMPLETED|Overall Study||13
1544464|NCT01327677|3779947|P1|NOT COMPLETED|Overall Study||20
1544465|NCT01327677|3779946|P2|COMPLETED|Overall Study||56
1544466|NCT01327677|3779947|P1|COMPLETED|Overall Study||48
1544467|NCT01327677|3779946|P2|STARTED|Overall Study||69
1544468|NCT01327677|3779947|P1|STARTED|Overall Study||68
1544469|NCT01327651|3779968|P9|NOT COMPLETED|Post Study Follow-up||2
1544470|NCT01327651|3779969|P8|NOT COMPLETED|Post Study Follow-up||1
1544471|NCT01327651|3779970|P7|NOT COMPLETED|Post Study Follow-up||4
1544472|NCT01327651|3779971|P6|NOT COMPLETED|Post Study Follow-up||0
1544473|NCT01327651|3779972|P5|NOT COMPLETED|Post Study Follow-up||0
1544474|NCT01327651|3779973|P4|NOT COMPLETED|Post Study Follow-up||0
1544475|NCT01327651|3779974|P3|NOT COMPLETED|Post Study Follow-up||1
1544476|NCT01327651|3779975|P2|NOT COMPLETED|Post Study Follow-up||1
1544477|NCT01327651|3779976|P1|NOT COMPLETED|Post Study Follow-up||0
1544478|NCT01327651|3779968|P9|COMPLETED|Post Study Follow-up||47
1544479|NCT01327651|3779969|P8|COMPLETED|Post Study Follow-up||49
1544480|NCT01327651|3779970|P7|COMPLETED|Post Study Follow-up||45
1544481|NCT01327651|3779971|P6|COMPLETED|Post Study Follow-up||59
1544482|NCT01327651|3779972|P5|COMPLETED|Post Study Follow-up||56
1544483|NCT01327651|3779973|P4|COMPLETED|Post Study Follow-up||57
1544484|NCT01327651|3779974|P3|COMPLETED|Post Study Follow-up||55
1544485|NCT01327651|3779975|P2|COMPLETED|Post Study Follow-up||55
1544486|NCT01327651|3779976|P1|COMPLETED|Post Study Follow-up||56
1544487|NCT01327651|3779968|P9|STARTED|Post Study Follow-up||49
1544488|NCT01327651|3779969|P8|STARTED|Post Study Follow-up||50
1544489|NCT01327651|3779970|P7|STARTED|Post Study Follow-up||49
1544490|NCT01327651|3779971|P6|STARTED|Post Study Follow-up||59
1544491|NCT01327651|3779972|P5|STARTED|Post Study Follow-up||56
1544492|NCT01327651|3779973|P4|STARTED|Post Study Follow-up||57
1544493|NCT01327651|3779974|P3|STARTED|Post Study Follow-up||56
1544494|NCT01327651|3779975|P2|STARTED|Post Study Follow-up||56
1544495|NCT01327651|3779976|P1|STARTED|Post Study Follow-up||56
1544496|NCT01327651|3779968|P9|NOT COMPLETED|Self-administered Dosing Period||11
1544497|NCT01327651|3779969|P8|NOT COMPLETED|Self-administered Dosing Period||10
1544498|NCT01327651|3779970|P7|NOT COMPLETED|Self-administered Dosing Period||10
1544499|NCT01327651|3779971|P6|NOT COMPLETED|Self-administered Dosing Period||0
1544500|NCT01327651|3779972|P5|NOT COMPLETED|Self-administered Dosing Period||3
1544501|NCT01327651|3779973|P4|NOT COMPLETED|Self-administered Dosing Period||3
1544502|NCT01327651|3779974|P3|NOT COMPLETED|Self-administered Dosing Period||4
1544503|NCT01327651|3779975|P2|NOT COMPLETED|Self-administered Dosing Period||3
1544504|NCT01327651|3779976|P1|NOT COMPLETED|Self-administered Dosing Period||4
1544505|NCT01327651|3779968|P9|COMPLETED|Self-administered Dosing Period||49
1544506|NCT01327651|3779969|P8|COMPLETED|Self-administered Dosing Period||50
1544507|NCT01327651|3779970|P7|COMPLETED|Self-administered Dosing Period||49
1544508|NCT01327651|3779971|P6|COMPLETED|Self-administered Dosing Period||59
1544509|NCT01327651|3779972|P5|COMPLETED|Self-administered Dosing Period||56
1544510|NCT01327651|3779973|P4|COMPLETED|Self-administered Dosing Period||57
1544511|NCT01327651|3779974|P3|COMPLETED|Self-administered Dosing Period||56
1544512|NCT01327651|3779975|P2|COMPLETED|Self-administered Dosing Period||56
1544513|NCT01327651|3779976|P1|COMPLETED|Self-administered Dosing Period||56
1544514|NCT01327651|3779968|P9|Week 26|Self-administered Dosing Period||49
1544515|NCT01327651|3779969|P8|Week 26|Self-administered Dosing Period||51
1544516|NCT01327651|3779970|P7|Week 26|Self-administered Dosing Period||50
1544517|NCT01327651|3779971|P6|Week 26|Self-administered Dosing Period||58
1544518|NCT01327651|3779972|P5|Week 26|Self-administered Dosing Period||56
1544519|NCT01327651|3779973|P4|Week 26|Self-administered Dosing Period||57
1544520|NCT01327651|3779974|P3|Week 26|Self-administered Dosing Period||53
1544521|NCT01327651|3779975|P2|Week 26|Self-administered Dosing Period||56
1544522|NCT01327651|3779976|P1|Week 26|Self-administered Dosing Period||58
1544523|NCT01327651|3779968|P9|Week 22|Self-administered Dosing Period||51
1544524|NCT01327651|3779969|P8|Week 22|Self-administered Dosing Period||50
1544525|NCT01327651|3779970|P7|Week 22|Self-administered Dosing Period||50
1544526|NCT01327651|3779971|P6|Week 22|Self-administered Dosing Period||59
1544527|NCT01327651|3779972|P5|Week 22|Self-administered Dosing Period||56
1544528|NCT01327651|3779973|P4|Week 22|Self-administered Dosing Period||58
1544529|NCT01327651|3779974|P3|Week 22|Self-administered Dosing Period||55
1544530|NCT01327651|3779975|P2|Week 22|Self-administered Dosing Period||56
1544531|NCT01327651|3779976|P1|Week 22|Self-administered Dosing Period||59
1544532|NCT01327651|3779968|P9|Week 18|Self-administered Dosing Period||53
1544533|NCT01327651|3779969|P8|Week 18|Self-administered Dosing Period||49
1544534|NCT01327651|3779970|P7|Week 18|Self-administered Dosing Period||53
1544535|NCT01327651|3779971|P6|Week 18|Self-administered Dosing Period||59
1544536|NCT01327651|3779972|P5|Week 18|Self-administered Dosing Period||57
1544537|NCT01327651|3779973|P4|Week 18|Self-administered Dosing Period||60
1544538|NCT01327651|3779974|P3|Week 18|Self-administered Dosing Period||56
1544539|NCT01327651|3779975|P2|Week 18|Self-administered Dosing Period||56
1544540|NCT01327651|3779976|P1|Week 18|Self-administered Dosing Period||57
1544541|NCT01327651|3779968|P9|Week 14|Self-administered Dosing Period||54
1544542|NCT01327651|3779969|P8|Week 14|Self-administered Dosing Period||51
1544543|NCT01327651|3779970|P7|Week 14|Self-administered Dosing Period||54
1544544|NCT01327651|3779971|P6|Week 14|Self-administered Dosing Period||59
1544545|NCT01327651|3779972|P5|Week 14|Self-administered Dosing Period||58
1544546|NCT01327651|3779973|P4|Week 14|Self-administered Dosing Period||60
1544547|NCT01327651|3779974|P3|Week 14|Self-administered Dosing Period||57
1544548|NCT01327651|3779975|P2|Week 14|Self-administered Dosing Period||55
1544549|NCT01327651|3779976|P1|Week 14|Self-administered Dosing Period||59
1544550|NCT01327651|3779968|P9|Week 10|Self-administered Dosing Period||56
1544551|NCT01327651|3779969|P8|Week 10|Self-administered Dosing Period||57
1544552|NCT01327651|3779970|P7|Week 10|Self-administered Dosing Period||57
1544553|NCT01327651|3779971|P6|Week 10|Self-administered Dosing Period||59
1544554|NCT01327651|3779972|P5|Week 10|Self-administered Dosing Period||59
1544555|NCT01327651|3779973|P4|Week 10|Self-administered Dosing Period||60
1544556|NCT01327651|3779974|P3|Week 10|Self-administered Dosing Period||60
1544557|NCT01327651|3779975|P2|Week 10|Self-administered Dosing Period||58
1544558|NCT01327651|3779976|P1|Week 10|Self-administered Dosing Period||59
1544559|NCT01327651|3779968|P9|STARTED|Self-administered Dosing Period||60
1544560|NCT01327651|3779969|P8|STARTED|Self-administered Dosing Period||60
1544561|NCT01327651|3779970|P7|STARTED|Self-administered Dosing Period||59
1544562|NCT01327651|3779971|P6|STARTED|Self-administered Dosing Period||59
1544563|NCT01327651|3779972|P5|STARTED|Self-administered Dosing Period||59
1544564|NCT01327651|3779973|P4|STARTED|Self-administered Dosing Period||60
1544565|NCT01327651|3779974|P3|STARTED|Self-administered Dosing Period||60
1544566|NCT01327651|3779975|P2|STARTED|Self-administered Dosing Period||59
1544567|NCT01327651|3779976|P1|STARTED|Self-administered Dosing Period||60
1544568|NCT01327599|3780095|P1|NOT COMPLETED|Overall Study||3
1544569|NCT01327599|3780095|P1|COMPLETED|Overall Study||57
1544570|NCT01327599|3780095|P1|STARTED|Overall Study||60
1544571|NCT01327547|3780105|P2|NOT COMPLETED|Overall Study||22
1544572|NCT01327547|3780106|P1|NOT COMPLETED|Overall Study||20
1544573|NCT01327547|3780105|P2|COMPLETED|Overall Study||45
1544574|NCT01327547|3780106|P1|COMPLETED|Overall Study||50
1544575|NCT01327547|3780105|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
1544576|NCT01327547|3780106|P1|Randomized and Not Treated|Overall Study||0
1544577|NCT01327547|3780105|P2|STARTED|Overall Study||67
1544578|NCT01327547|3780106|P1|STARTED|Overall Study||70
1544579|NCT01327508|3780159|P2|NOT COMPLETED|Overall Study||0
1544580|NCT01327508|3780160|P1|NOT COMPLETED|Overall Study||0
1544581|NCT01327508|3780159|P2|COMPLETED|Overall Study||30
1544582|NCT01327508|3780160|P1|COMPLETED|Overall Study||30
1544583|NCT01327508|3780159|P2|STARTED|Overall Study||30
1544584|NCT01327508|3780160|P1|STARTED|Overall Study||30
1544585|NCT01327495|3780174|P6|NOT COMPLETED|Overall Study||2
1544586|NCT01327495|3780175|P5|NOT COMPLETED|Overall Study||3
1544587|NCT01327495|3780176|P4|NOT COMPLETED|Overall Study||0
1544588|NCT01327495|3780177|P3|NOT COMPLETED|Overall Study||2
1544589|NCT01327495|3780178|P2|NOT COMPLETED|Overall Study||2
1544590|NCT01327495|3780179|P1|NOT COMPLETED|Overall Study||2
1544591|NCT01327495|3780174|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
1544592|NCT01327495|3780175|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
1544593|NCT01327495|3780176|P4|COMPLETED|Overall Study||9
1544594|NCT01327495|3780177|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
1544595|NCT01327495|3780178|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
1544596|NCT01327495|3780179|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
1544597|NCT01327495|3780174|P6|STARTED|Overall Study||11
1544598|NCT01327495|3780175|P5|STARTED|Overall Study||11
1544599|NCT01327495|3780176|P4|STARTED|Overall Study||9
1544600|NCT01327495|3780177|P3|STARTED|Overall Study||10
1544601|NCT01327495|3780178|P2|STARTED|Overall Study||11
1544602|NCT01327495|3780179|P1|STARTED|Overall Study||10
1544603|NCT01327482|3780271|P1|NOT COMPLETED|Overall Study||1
1544604|NCT01327482|3780271|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
1544605|NCT01327482|3780271|P1|STARTED|Overall Study||10
1544606|NCT01327339|3780276|P1|NOT COMPLETED|Overall Study||8
1544607|NCT01327339|3780276|P1|COMPLETED|Overall Study||747
1544608|NCT01327339|3780276|P1|STARTED|Overall Study||755
1544609|NCT01327313|3780286|P4|NOT COMPLETED|Overall Study||0
1544610|NCT01327313|3780287|P3|NOT COMPLETED|Overall Study||0
1544611|NCT01327313|3780288|P2|NOT COMPLETED|Overall Study||0
1544612|NCT01327313|3780289|P1|NOT COMPLETED|Overall Study||0
1544613|NCT01327313|3780286|P4|COMPLETED|Overall Study||7
1544614|NCT01327313|3780287|P3|COMPLETED|Overall Study||6
1544615|NCT01327313|3780288|P2|COMPLETED|Overall Study||6
1544616|NCT01327313|3780289|P1|COMPLETED|Overall Study||8
1544617|NCT01327313|3780286|P4|STARTED|Overall Study||7
1544618|NCT01327313|3780287|P3|STARTED|Overall Study||6
1544619|NCT01327313|3780288|P2|STARTED|Overall Study||6
1544620|NCT01327313|3780289|P1|STARTED|Overall Study||8
1544621|NCT01327300|3780411|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
1544622|NCT01327300|3780412|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
1544623|NCT01327300|3780411|P2|COMPLETED|Second Intervention (12 Weeks)||2
1544624|NCT01327300|3780412|P1|COMPLETED|Second Intervention (12 Weeks)||4
1544625|NCT01327300|3780411|P2|STARTED|Second Intervention (12 Weeks)||2
1544626|NCT01327300|3780412|P1|STARTED|Second Intervention (12 Weeks)||4
1544627|NCT01327300|3780411|P2|NOT COMPLETED|Washout (3 Weeks)||0
1544628|NCT01327300|3780412|P1|NOT COMPLETED|Washout (3 Weeks)||1
1544629|NCT01327300|3780411|P2|COMPLETED|Washout (3 Weeks)||2
1544630|NCT01327300|3780412|P1|COMPLETED|Washout (3 Weeks)||4
1544631|NCT01327300|3780411|P2|STARTED|Washout (3 Weeks)||2
1544632|NCT01327300|3780412|P1|STARTED|Washout (3 Weeks)||5
1544633|NCT01327300|3780411|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
1544634|NCT01327300|3780412|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
1544635|NCT01327300|3780411|P2|COMPLETED|First Intervention (12 Weeks)||2
1544636|NCT01327300|3780412|P1|COMPLETED|First Intervention (12 Weeks)||5
1544637|NCT01327300|3780411|P2|STARTED|First Intervention (12 Weeks)||2
1544638|NCT01327300|3780412|P1|STARTED|First Intervention (12 Weeks)||5
1544639|NCT01327274|3780428|P1|NOT COMPLETED|Overall Study||0
1544640|NCT01327274|3780428|P1|COMPLETED|Overall Study||15
1544641|NCT01327274|3780428|P1|STARTED|Overall Study||15
1544642|NCT01327157|3780437|P2|NOT COMPLETED|91-180||0
1544643|NCT01327157|3780438|P1|NOT COMPLETED|91-180||0
1544644|NCT01327157|3780437|P2|COMPLETED|91-180||0
1544645|NCT01327157|3780438|P1|COMPLETED|91-180||7
1544646|NCT01327157|3780437|P2|STARTED|91-180||0
1544647|NCT01327157|3780438|P1|STARTED|91-180||7
1544648|NCT01327157|3780437|P2|NOT COMPLETED|01-90||0
1544649|NCT01327157|3780438|P1|NOT COMPLETED|01-90||0
1544650|NCT01327157|3780437|P2|COMPLETED|01-90||7
1544651|NCT01327157|3780438|P1|COMPLETED|01-90||7
1544652|NCT01327157|3780437|P2|STARTED|01-90||7
1544653|NCT01327157|3780438|P1|STARTED|01-90||7
1544654|NCT01327053|3780452|P2|NOT COMPLETED|Overall Study||105
1544655|NCT01327053|3780453|P1|NOT COMPLETED|Overall Study||40
1544656|NCT01327053|3780452|P2|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|46
1544657|NCT01327053|3780453|P1|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|39
1544658|NCT01327053|3780452|P2|STARTED|Overall Study||151
1544659|NCT01327053|3780453|P1|STARTED|Overall Study||79
1544660|NCT01326962|3780481|P1|NOT COMPLETED|Overall Study||7
1544661|NCT01326962|3780481|P1|COMPLETED|Overall Study||21
1544662|NCT01326962|3780481|P1|STARTED|Overall Study||28
1544663|NCT01326910|3780499|P2|NOT COMPLETED|Overall Study||3
1544664|NCT01326910|3780500|P1|NOT COMPLETED|Overall Study||4
1544665|NCT01326910|3780499|P2|COMPLETED|Overall Study||42
1544666|NCT01326910|3780500|P1|COMPLETED|Overall Study||41
1544667|NCT01326910|3780499|P2|STARTED|Overall Study||45
1544668|NCT01326910|3780500|P1|STARTED|Overall Study||45
1544669|NCT01326845|3780514|P2|NOT COMPLETED|Overall Study||5
1544670|NCT01326845|3780515|P1|NOT COMPLETED|Overall Study||7
1544671|NCT01326845|3780514|P2|COMPLETED|Overall Study|Study terminated early|0
1544672|NCT01326845|3780515|P1|COMPLETED|Overall Study|Study terminated early|0
1544673|NCT01326845|3780514|P2|STARTED|Overall Study||5
1544674|NCT01326845|3780515|P1|STARTED|Overall Study||7
1544675|NCT01326780|3780541|P4|NOT COMPLETED|Overall Study||13
1544676|NCT01326780|3780542|P3|NOT COMPLETED|Overall Study||6
1544677|NCT01326780|3780543|P2|NOT COMPLETED|Overall Study||9
1544678|NCT01326780|3780544|P1|NOT COMPLETED|Overall Study||13
1544679|NCT01326780|3780541|P4|COMPLETED|Overall Study||94
1544680|NCT01326780|3780542|P3|COMPLETED|Overall Study||103
1544681|NCT01326780|3780543|P2|COMPLETED|Overall Study||100
1544682|NCT01326780|3780544|P1|COMPLETED|Overall Study||93
1544683|NCT01326780|3780541|P4|STARTED|Overall Study||107
1544684|NCT01326780|3780542|P3|STARTED|Overall Study||109
1544685|NCT01326780|3780543|P2|STARTED|Overall Study||109
1544686|NCT01326780|3780544|P1|STARTED|Overall Study||106
1544687|NCT01326728|3780576|P2|NOT COMPLETED|Overall Study||9
1544688|NCT01326728|3780577|P1|NOT COMPLETED|Overall Study||47
1544689|NCT01326728|3780576|P2|COMPLETED|Overall Study||0
1544690|NCT01326728|3780577|P1|COMPLETED|Overall Study||0
1544691|NCT01326728|3780576|P2|STARTED|Overall Study||9
1544692|NCT01326728|3780577|P1|STARTED|Overall Study||47
1544693|NCT01326533|3780596|P2|NOT COMPLETED|Overall Study||0
1544694|NCT01326533|3780597|P1|NOT COMPLETED|Overall Study||4
1544695|NCT01326533|3780596|P2|COMPLETED|Overall Study||15
1544696|NCT01326533|3780597|P1|COMPLETED|Overall Study||13
1544697|NCT01326533|3780596|P2|STARTED|Overall Study||15
1544698|NCT01326533|3780597|P1|STARTED|Overall Study||17
1544699|NCT01326026|3780607|P2|NOT COMPLETED|Overall Study||13
1544700|NCT01326026|3780608|P1|NOT COMPLETED|Overall Study||12
1544701|NCT01326026|3780607|P2|COMPLETED|Overall Study||98
1544702|NCT01326026|3780608|P1|COMPLETED|Overall Study||99
1544703|NCT01326026|3780607|P2|Exposed|Overall Study||111
1544704|NCT01326026|3780608|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
1544705|NCT01326026|3780607|P2|STARTED|Overall Study||111
1544706|NCT01326026|3780608|P1|STARTED|Overall Study||111
1544707|NCT01325870|3780625|P3|NOT COMPLETED|Overall Study||8
1544708|NCT01325870|3780626|P2|NOT COMPLETED|Overall Study||13
1544709|NCT01325870|3780627|P1|NOT COMPLETED|Overall Study||11
1544710|NCT01325870|3780625|P3|COMPLETED|Overall Study||6
1544711|NCT01325870|3780626|P2|COMPLETED|Overall Study||3
1544712|NCT01325870|3780627|P1|COMPLETED|Overall Study||7
1544713|NCT01325870|3780625|P3|STARTED|Overall Study||14
1544714|NCT01325870|3780626|P2|STARTED|Overall Study||16
1544715|NCT01325870|3780627|P1|STARTED|Overall Study||18
1544716|NCT01325792|3780641|P1|NOT COMPLETED|Overall Study||17
1544717|NCT01325792|3780641|P1|COMPLETED|Overall Study||87
1544718|NCT01325792|3780641|P1|STARTED|Overall Study||104
1544719|NCT01325714|3780648|P2|NOT COMPLETED|Overall Study||31
1544720|NCT01325714|3780649|P1|NOT COMPLETED|Overall Study||34
1544721|NCT01325714|3780648|P2|COMPLETED|Overall Study||71
1544722|NCT01325714|3780649|P1|COMPLETED|Overall Study||67
1544723|NCT01325714|3780648|P2|12 Month Assessment|Overall Study||71
1544724|NCT01325714|3780649|P1|12 Month Assessment|Overall Study||67
1544725|NCT01325714|3780648|P2|6 Month Asessment|Overall Study||82
1544726|NCT01325714|3780649|P1|6 Month Asessment|Overall Study||75
1544727|NCT01325714|3780648|P2|3 Month Assessment|Overall Study||86
1544728|NCT01325714|3780649|P1|3 Month Assessment|Overall Study||82
1544729|NCT01325714|3780648|P2|STARTED|Overall Study||102
1544730|NCT01325714|3780649|P1|STARTED|Overall Study||101
1544731|NCT01325701|3780673|P2|NOT COMPLETED|Overall Study||3
1544732|NCT01325701|3780674|P1|NOT COMPLETED|Overall Study||21
1544733|NCT01325701|3780673|P2|COMPLETED|Overall Study||5
1544734|NCT01325701|3780674|P1|COMPLETED|Overall Study||49
1544735|NCT01325701|3780673|P2|STARTED|Overall Study||8
1544736|NCT01325701|3780674|P1|STARTED|Overall Study||70
1544737|NCT01325623|3780684|P1|NOT COMPLETED|Overall Study||3
1544738|NCT01325623|3780684|P1|COMPLETED|Overall Study||28
1544739|NCT01325623|3780684|P1|STARTED|Overall Study||31
1544740|NCT01325584|3780726|P1|NOT COMPLETED|Overall Study||1
1544741|NCT01325584|3780726|P1|COMPLETED|Overall Study||11
1544742|NCT01325584|3780726|P1|STARTED|Overall Study||12
1544743|NCT01325532|3780736|P2|NOT COMPLETED|Overall Study||0
1544744|NCT01325532|3780737|P1|NOT COMPLETED|Overall Study||2
1544745|NCT01325532|3780736|P2|COMPLETED|Overall Study||13
1544746|NCT01325532|3780737|P1|COMPLETED|Overall Study||15
1544747|NCT01325532|3780736|P2|STARTED|Overall Study||13
1544748|NCT01325532|3780737|P1|STARTED|Overall Study||17
1544749|NCT01325493|3780749|P2|NOT COMPLETED|Overall Study||3
1544750|NCT01325493|3780750|P1|NOT COMPLETED|Overall Study||1
1544751|NCT01325493|3780749|P2|COMPLETED|Overall Study||21
1544752|NCT01325493|3780750|P1|COMPLETED|Overall Study||29
1544753|NCT01325493|3780749|P2|STARTED|Overall Study||24
1544754|NCT01325493|3780750|P1|STARTED|Overall Study||30
1544755|NCT01325428|3780762|P1|NOT COMPLETED|Part B||3
1544756|NCT01325428|3780762|P1|COMPLETED|Part B||7
1544757|NCT01325428|3780762|P1|STARTED|Part B||10
1544758|NCT01325428|3780762|P1|NOT COMPLETED|Part A||16
1544759|NCT01325428|3780762|P1|COMPLETED|Part A||10
1544760|NCT01325428|3780762|P1|STARTED|Part A||26
1544761|NCT01325350|3780782|P5|NOT COMPLETED|Overall Study||12
1544762|NCT01325350|3780783|P4|NOT COMPLETED|Overall Study||9
1544763|NCT01325350|3780784|P3|NOT COMPLETED|Overall Study||17
1544764|NCT01325350|3780785|P2|NOT COMPLETED|Overall Study||5
1544765|NCT01325350|3780786|P1|NOT COMPLETED|Overall Study||6
1544766|NCT01325350|3780782|P5|COMPLETED|Overall Study||50
1544767|NCT01325350|3780783|P4|COMPLETED|Overall Study||52
1544768|NCT01325350|3780784|P3|COMPLETED|Overall Study||44
1544769|NCT01325350|3780785|P2|COMPLETED|Overall Study||56
1544770|NCT01325350|3780786|P1|COMPLETED|Overall Study||55
1544771|NCT01325350|3780782|P5|STARTED|Overall Study||62
1544772|NCT01325350|3780783|P4|STARTED|Overall Study||61
1544773|NCT01325350|3780784|P3|STARTED|Overall Study||61
1544774|NCT01325350|3780785|P2|STARTED|Overall Study||61
1544775|NCT01325350|3780786|P1|STARTED|Overall Study||61
1544776|NCT01325337|3780828|P5|NOT COMPLETED|Overall Study||8
1544777|NCT01325337|3780829|P4|NOT COMPLETED|Overall Study||10
1544778|NCT01325337|3780830|P3|NOT COMPLETED|Overall Study||9
1544779|NCT01325337|3780831|P2|NOT COMPLETED|Overall Study||9
1544780|NCT01325337|3780832|P1|NOT COMPLETED|Overall Study||5
1544781|NCT01325337|3780828|P5|COMPLETED|Overall Study||53
1544782|NCT01325337|3780829|P4|COMPLETED|Overall Study||52
1544783|NCT01325337|3780830|P3|COMPLETED|Overall Study||53
1544784|NCT01325337|3780831|P2|COMPLETED|Overall Study||52
1544785|NCT01325337|3780832|P1|COMPLETED|Overall Study||56
1544786|NCT01325337|3780828|P5|STARTED|Overall Study||61
1544787|NCT01325337|3780829|P4|STARTED|Overall Study||62
1544788|NCT01325337|3780830|P3|STARTED|Overall Study||62
1544789|NCT01325337|3780831|P2|STARTED|Overall Study||61
1544790|NCT01325337|3780832|P1|STARTED|Overall Study||61
1544791|NCT01325311|3780871|P2|NOT COMPLETED|Overall Study||0
1544792|NCT01325311|3780872|P1|NOT COMPLETED|Overall Study||0
1544793|NCT01325311|3780871|P2|COMPLETED|Overall Study||7
1544794|NCT01325311|3780872|P1|COMPLETED|Overall Study||8
1544795|NCT01325311|3780871|P2|STARTED|Overall Study||7
1544796|NCT01325311|3780872|P1|STARTED|Overall Study||8
1544797|NCT01325181|3780908|P2|NOT COMPLETED|Overall Study||2
1544798|NCT01325181|3780909|P1|NOT COMPLETED|Overall Study||0
1544799|NCT01325181|3780908|P2|COMPLETED|Overall Study||14
1544800|NCT01325181|3780909|P1|COMPLETED|Overall Study||18
1544801|NCT01325181|3780908|P2|STARTED|Overall Study||16
1544802|NCT01325181|3780909|P1|STARTED|Overall Study||18
1544803|NCT01324999|3780915|P1|NOT COMPLETED|Overall Study||5
1544804|NCT01324999|3780915|P1|COMPLETED|Overall Study||7
1544805|NCT01324999|3780915|P1|STARTED|Overall Study||12
1544806|NCT01324947|3780926|P1|NOT COMPLETED|Overall Study||74
1544807|NCT01324947|3780926|P1|COMPLETED|Overall Study||0
1544808|NCT01324947|3780926|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
1544809|NCT01324947|3780926|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
1544810|NCT01324947|3780926|P1|STARTED|Overall Study||74
1544811|NCT01324882|3780939|P2|NOT COMPLETED|Overall Study||0
1544812|NCT01324882|3780940|P1|NOT COMPLETED|Overall Study||0
1544813|NCT01324882|3780939|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
1544814|NCT01324882|3780940|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
1544815|NCT01324882|3780939|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
1544816|NCT01324882|3780940|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
1544817|NCT01324830|3780967|P19|NOT COMPLETED|Overall Study||6
1544818|NCT01324830|3780968|P18|NOT COMPLETED|Overall Study||6
1544819|NCT01324830|3780969|P17|NOT COMPLETED|Overall Study||3
1544820|NCT01324830|3780970|P16|NOT COMPLETED|Overall Study||3
1544821|NCT01324830|3780971|P15|NOT COMPLETED|Overall Study||1
1544822|NCT01324830|3780972|P14|NOT COMPLETED|Overall Study||1
1544823|NCT01324830|3780973|P13|NOT COMPLETED|Overall Study||1
1544824|NCT01324830|3780974|P12|NOT COMPLETED|Overall Study||1
1544825|NCT01324830|3780975|P11|NOT COMPLETED|Overall Study||4
1544826|NCT01324830|3780976|P10|NOT COMPLETED|Overall Study||6
1544827|NCT01324830|3780977|P9|NOT COMPLETED|Overall Study||5
1544828|NCT01324830|3780978|P8|NOT COMPLETED|Overall Study||3
1544829|NCT01324830|3780979|P7|NOT COMPLETED|Overall Study||3
1544830|NCT01324830|3780980|P6|NOT COMPLETED|Overall Study||7
1544831|NCT01324830|3780981|P5|NOT COMPLETED|Overall Study||7
1544832|NCT01324830|3780982|P4|NOT COMPLETED|Overall Study||3
1544833|NCT01324830|3780983|P3|NOT COMPLETED|Overall Study||3
1544834|NCT01324830|3780984|P2|NOT COMPLETED|Overall Study||3
1544835|NCT01324830|3780985|P1|NOT COMPLETED|Overall Study||3
1544836|NCT01324830|3780967|P19|COMPLETED|Overall Study||0
1544837|NCT01324830|3780968|P18|COMPLETED|Overall Study||0
1544838|NCT01324830|3780969|P17|COMPLETED|Overall Study||0
1544839|NCT01324830|3780970|P16|COMPLETED|Overall Study||0
1544840|NCT01324830|3780971|P15|COMPLETED|Overall Study||0
1544841|NCT01324830|3780972|P14|COMPLETED|Overall Study||0
1544842|NCT01324830|3780973|P13|COMPLETED|Overall Study||0
1544843|NCT01324830|3780974|P12|COMPLETED|Overall Study||0
1544844|NCT01324830|3780975|P11|COMPLETED|Overall Study||0
1544845|NCT01324830|3780976|P10|COMPLETED|Overall Study||0
1544846|NCT01324830|3780977|P9|COMPLETED|Overall Study||0
1544847|NCT01324830|3780978|P8|COMPLETED|Overall Study||0
1544848|NCT01324830|3780979|P7|COMPLETED|Overall Study||0
1544849|NCT01324830|3780980|P6|COMPLETED|Overall Study||0
1544850|NCT01324830|3780981|P5|COMPLETED|Overall Study||0
1544851|NCT01324830|3780982|P4|COMPLETED|Overall Study||0
1544852|NCT01324830|3780983|P3|COMPLETED|Overall Study||0
1544853|NCT01324830|3780984|P2|COMPLETED|Overall Study||0
1544854|NCT01324830|3780985|P1|COMPLETED|Overall Study||0
1544855|NCT01324830|3780967|P19|STARTED|Overall Study||6
1544856|NCT01324830|3780968|P18|STARTED|Overall Study||6
1544857|NCT01324830|3780969|P17|STARTED|Overall Study||3
1544858|NCT01324830|3780970|P16|STARTED|Overall Study||3
1544859|NCT01324830|3780971|P15|STARTED|Overall Study||1
1544860|NCT01324830|3780972|P14|STARTED|Overall Study||1
1544861|NCT01324830|3780973|P13|STARTED|Overall Study||1
1544862|NCT01324830|3780974|P12|STARTED|Overall Study||1
1544863|NCT01324830|3780975|P11|STARTED|Overall Study||4
1544864|NCT01324830|3780976|P10|STARTED|Overall Study||6
1544865|NCT01324830|3780977|P9|STARTED|Overall Study||5
1544866|NCT01324830|3780978|P8|STARTED|Overall Study||3
1544867|NCT01324830|3780979|P7|STARTED|Overall Study||3
1544868|NCT01324830|3780980|P6|STARTED|Overall Study||7
1544869|NCT01324830|3780981|P5|STARTED|Overall Study||7
1544870|NCT01324830|3780982|P4|STARTED|Overall Study||3
1544871|NCT01324830|3780983|P3|STARTED|Overall Study||3
1544872|NCT01324830|3780984|P2|STARTED|Overall Study||3
1544873|NCT01324830|3780985|P1|STARTED|Overall Study||3
1544874|NCT01324700|3781101|P4|NOT COMPLETED|Overall Study||11
1544875|NCT01324700|3781102|P3|NOT COMPLETED|Overall Study||16
1544876|NCT01324700|3781103|P2|NOT COMPLETED|Overall Study||4
1544877|NCT01324700|3781104|P1|NOT COMPLETED|Overall Study||9
1544878|NCT01324700|3781101|P4|COMPLETED|Overall Study||37
1544879|NCT01324700|3781102|P3|COMPLETED|Overall Study||33
1544880|NCT01324700|3781103|P2|COMPLETED|Overall Study||16
1544881|NCT01324700|3781104|P1|COMPLETED|Overall Study||13
1544882|NCT01324700|3781101|P4|STARTED|Overall Study||48
1544883|NCT01324700|3781102|P3|STARTED|Overall Study||49
1544884|NCT01324700|3781103|P2|STARTED|Overall Study||20
1544885|NCT01324700|3781104|P1|STARTED|Overall Study||22
1544886|NCT01324687|3781120|P2|NOT COMPLETED|Overall Study||15
1544887|NCT01324687|3781121|P1|NOT COMPLETED|Overall Study||0
1544888|NCT01324687|3781120|P2|COMPLETED|Overall Study||479
1544889|NCT01324687|3781121|P1|COMPLETED|Overall Study||1058
1544890|NCT01324687|3781120|P2|STARTED|Overall Study||494
1544891|NCT01324687|3781121|P1|STARTED|Overall Study||1058
1544892|NCT01324622|3781131|P2|NOT COMPLETED|Overall Study||7
1544893|NCT01324622|3781132|P1|NOT COMPLETED|Overall Study||9
1544894|NCT01324622|3781131|P2|COMPLETED|Overall Study||4
1544895|NCT01324622|3781132|P1|COMPLETED|Overall Study||4
1544896|NCT01324622|3781131|P2|STARTED|Overall Study||11
1544897|NCT01324622|3781132|P1|STARTED|Overall Study||13
1544898|NCT01324570|3781162|P2|NOT COMPLETED|Overall Study||14
1544899|NCT01324570|3781163|P1|NOT COMPLETED|Overall Study||4
1544900|NCT01324570|3781162|P2|COMPLETED|Overall Study||21
1544901|NCT01324570|3781163|P1|COMPLETED|Overall Study||2
1544902|NCT01324570|3781162|P2|STARTED|Overall Study||35
1544903|NCT01324570|3781163|P1|STARTED|Overall Study||6
1544904|NCT01324453|3781177|P2|NOT COMPLETED|Overall Study||0
1544905|NCT01324453|3781178|P1|NOT COMPLETED|Overall Study||0
1544906|NCT01324453|3781177|P2|COMPLETED|Overall Study||49
1544907|NCT01324453|3781178|P1|COMPLETED|Overall Study||54
1544908|NCT01324453|3781177|P2|STARTED|Overall Study||49
1544909|NCT01324453|3781178|P1|STARTED|Overall Study||54
1544910|NCT01324440|3781200|P2|NOT COMPLETED|Overall Study||1
1544911|NCT01324440|3781201|P1|NOT COMPLETED|Overall Study||0
1544912|NCT01324440|3781200|P2|COMPLETED|Overall Study||31
1544913|NCT01324440|3781201|P1|COMPLETED|Overall Study||32
1544914|NCT01324440|3781200|P2|STARTED|Overall Study||32
1544915|NCT01324440|3781201|P1|STARTED|Overall Study||32
1544916|NCT01324401|3781215|P2|NOT COMPLETED|Overall Study||6
1544917|NCT01324401|3781216|P1|NOT COMPLETED|Overall Study||1
1544918|NCT01324401|3781215|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
1544919|NCT01324401|3781216|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
1544920|NCT01324401|3781215|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
1544921|NCT01324401|3781216|P1|STARTED|Overall Study||4
1544922|NCT01324388|3781227|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
1544923|NCT01324388|3781228|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
1544924|NCT01324388|3781229|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
1544925|NCT01324388|3781230|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
1544926|NCT01324388|3781227|P4|COMPLETED|Part 2 of Study: Second Intervention||9
1544927|NCT01324388|3781228|P3|COMPLETED|Part 2 of Study: Second Intervention||9
1544928|NCT01324388|3781229|P2|COMPLETED|Part 2 of Study: Second Intervention||0
1544929|NCT01324388|3781230|P1|COMPLETED|Part 2 of Study: Second Intervention||0
1544930|NCT01324388|3781227|P4|STARTED|Part 2 of Study: Second Intervention||9
1544931|NCT01324388|3781228|P3|STARTED|Part 2 of Study: Second Intervention||10
1544932|NCT01324388|3781229|P2|STARTED|Part 2 of Study: Second Intervention||0
1544933|NCT01324388|3781230|P1|STARTED|Part 2 of Study: Second Intervention||0
1544934|NCT01324388|3781227|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1544935|NCT01324388|3781228|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1544936|NCT01324388|3781229|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1544937|NCT01324388|3781230|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1544938|NCT01324388|3781227|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
1544939|NCT01324388|3781228|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
1544940|NCT01324388|3781229|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
1544941|NCT01324388|3781230|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
1544942|NCT01324388|3781227|P4|STARTED|Part 2: Washout of at Least 21 Days||9
1544943|NCT01324388|3781228|P3|STARTED|Part 2: Washout of at Least 21 Days||10
1544944|NCT01324388|3781229|P2|STARTED|Part 2: Washout of at Least 21 Days||0
1544945|NCT01324388|3781230|P1|STARTED|Part 2: Washout of at Least 21 Days||0
1544946|NCT01324388|3781227|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
1544947|NCT01324388|3781228|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
1544948|NCT01324388|3781229|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
1544949|NCT01324388|3781230|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
1544950|NCT01324388|3781227|P4|COMPLETED|Part 2 of Study: First Intervention||9
1544951|NCT01324388|3781228|P3|COMPLETED|Part 2 of Study: First Intervention||10
1544952|NCT01324388|3781229|P2|COMPLETED|Part 2 of Study: First Intervention||0
1544953|NCT01324388|3781230|P1|COMPLETED|Part 2 of Study: First Intervention||0
1544954|NCT01324388|3781227|P4|STARTED|Part 2 of Study: First Intervention||10
1544955|NCT01324388|3781228|P3|STARTED|Part 2 of Study: First Intervention||10
1544956|NCT01324388|3781229|P2|STARTED|Part 2 of Study: First Intervention||0
1544957|NCT01324388|3781230|P1|STARTED|Part 2 of Study: First Intervention||0
1544958|NCT01324388|3781227|P4|NOT COMPLETED|Part 1 of Study||0
1544959|NCT01324388|3781228|P3|NOT COMPLETED|Part 1 of Study||0
1544960|NCT01324388|3781229|P2|NOT COMPLETED|Part 1 of Study||2
1544961|NCT01324388|3781230|P1|NOT COMPLETED|Part 1 of Study||4
1544962|NCT01324388|3781227|P4|COMPLETED|Part 1 of Study||0
1544963|NCT01324388|3781228|P3|COMPLETED|Part 1 of Study||0
1544964|NCT01324388|3781229|P2|COMPLETED|Part 1 of Study||6
1544965|NCT01324388|3781230|P1|COMPLETED|Part 1 of Study||19
1544966|NCT01324388|3781227|P4|Received at Least 1 Dose|Part 1 of Study||0
1544967|NCT01324388|3781228|P3|Received at Least 1 Dose|Part 1 of Study||0
1544968|NCT01324388|3781229|P2|Received at Least 1 Dose|Part 1 of Study||8
1544969|NCT01324388|3781230|P1|Received at Least 1 Dose|Part 1 of Study||23
1544970|NCT01324388|3781227|P4|STARTED|Part 1 of Study||0
1544971|NCT01324388|3781228|P3|STARTED|Part 1 of Study||0
1544972|NCT01324388|3781229|P2|STARTED|Part 1 of Study||8
1544973|NCT01324388|3781230|P1|STARTED|Part 1 of Study||23
1544974|NCT01324349|3781251|P2|NOT COMPLETED|Overall Study||2
1544975|NCT01324349|3781252|P1|NOT COMPLETED|Overall Study||1
1544976|NCT01324349|3781251|P2|COMPLETED|Overall Study||16
1544977|NCT01324349|3781252|P1|COMPLETED|Overall Study||31
1544978|NCT01324349|3781251|P2|STARTED|Overall Study||18
1544979|NCT01324349|3781252|P1|STARTED|Overall Study||32
1544980|NCT01324323|3781262|P1|NOT COMPLETED|Overall Study||1
1544981|NCT01324323|3781262|P1|COMPLETED|Overall Study||13
1544982|NCT01324323|3781262|P1|STARTED|Overall Study||14
1544983|NCT01324310|3781282|P1|NOT COMPLETED|Overall Study||2
1544984|NCT01324310|3781282|P1|COMPLETED|Overall Study||13
1544985|NCT01324310|3781282|P1|STARTED|Overall Study||15
1544986|NCT01324271|3781302|P2|NOT COMPLETED|Overall Study||0
1544987|NCT01324271|3781303|P1|NOT COMPLETED|Overall Study||4
1544988|NCT01324271|3781302|P2|COMPLETED|Overall Study||28
1544989|NCT01324271|3781303|P1|COMPLETED|Overall Study||53
1544990|NCT01324271|3781302|P2|STARTED|Overall Study||28
1544991|NCT01324271|3781303|P1|STARTED|Overall Study||57
1544992|NCT01324128|3781311|P4|NOT COMPLETED|Stage 2||3
1544993|NCT01324128|3781312|P3|NOT COMPLETED|Stage 2||8
1544994|NCT01324128|3781313|P2|NOT COMPLETED|Stage 2||0
1544995|NCT01324128|3781314|P1|NOT COMPLETED|Stage 2||0
1544996|NCT01324128|3781311|P4|COMPLETED|Stage 2||46
1544997|NCT01324128|3781312|P3|COMPLETED|Stage 2||42
1544998|NCT01324128|3781313|P2|COMPLETED|Stage 2||0
1544999|NCT01324128|3781314|P1|COMPLETED|Stage 2||0
1545000|NCT01324128|3781311|P4|STARTED|Stage 2||49
1545001|NCT01324128|3781312|P3|STARTED|Stage 2||50
1545002|NCT01324128|3781313|P2|STARTED|Stage 2||0
1545003|NCT01324128|3781314|P1|STARTED|Stage 2||0
1545004|NCT01324128|3781311|P4|NOT COMPLETED|Stage 1||0
1545005|NCT01324128|3781312|P3|NOT COMPLETED|Stage 1||0
1545006|NCT01324128|3781313|P2|NOT COMPLETED|Stage 1||56
1545007|NCT01324128|3781314|P1|NOT COMPLETED|Stage 1||195
1545008|NCT01324128|3781311|P4|COMPLETED|Stage 1||0
1545009|NCT01324128|3781312|P3|COMPLETED|Stage 1||0
1545010|NCT01324128|3781313|P2|COMPLETED|Stage 1||293
1545011|NCT01324128|3781314|P1|COMPLETED|Stage 1||515
1545012|NCT01324128|3781311|P4|STARTED|Stage 1||0
1545013|NCT01324128|3781312|P3|STARTED|Stage 1||0
1545014|NCT01324128|3781313|P2|STARTED|Stage 1||349
1545015|NCT01324128|3781314|P1|STARTED|Stage 1||710
1545016|NCT01324102|3781326|P2|NOT COMPLETED|Overall Study||6
1545017|NCT01324102|3781327|P1|NOT COMPLETED|Overall Study||1
1545018|NCT01324102|3781326|P2|COMPLETED|Overall Study||6
1545019|NCT01324102|3781327|P1|COMPLETED|Overall Study||10
1545020|NCT01324102|3781326|P2|STARTED|Overall Study|Yoga group 4 and 6|12
1545021|NCT01324102|3781327|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
1545022|NCT01324024|3781334|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
1545023|NCT01324024|3781335|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
1545024|NCT01324024|3781334|P2|COMPLETED|Second Intervention (4 Weeks)||16
1545025|NCT01324024|3781335|P1|COMPLETED|Second Intervention (4 Weeks)||16
1545026|NCT01324024|3781334|P2|STARTED|Second Intervention (4 Weeks)||17
1545027|NCT01324024|3781335|P1|STARTED|Second Intervention (4 Weeks)||18
1545028|NCT01324024|3781334|P2|NOT COMPLETED|Washout (2 Weeks)||0
1545029|NCT01324024|3781335|P1|NOT COMPLETED|Washout (2 Weeks)||0
1545030|NCT01324024|3781334|P2|COMPLETED|Washout (2 Weeks)||17
1545031|NCT01324024|3781335|P1|COMPLETED|Washout (2 Weeks)||18
1545032|NCT01324024|3781334|P2|STARTED|Washout (2 Weeks)||17
1545033|NCT01324024|3781335|P1|STARTED|Washout (2 Weeks)||18
1545034|NCT01324024|3781334|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
1545035|NCT01324024|3781335|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
1545036|NCT01324024|3781334|P2|COMPLETED|First Intervention (4 Weeks)||17
1545037|NCT01324024|3781335|P1|COMPLETED|First Intervention (4 Weeks)||18
1545038|NCT01324024|3781334|P2|STARTED|First Intervention (4 Weeks)||17
1545039|NCT01324024|3781335|P1|STARTED|First Intervention (4 Weeks)||18
1545040|NCT01323998|3781353|P5|NOT COMPLETED|Overall Study||0
1545041|NCT01323998|3781354|P4|NOT COMPLETED|Overall Study||0
1545042|NCT01323998|3781355|P3|NOT COMPLETED|Overall Study||0
1545043|NCT01323998|3781356|P2|NOT COMPLETED|Overall Study||0
1545044|NCT01323998|3781357|P1|NOT COMPLETED|Overall Study||0
1545045|NCT01323998|3781353|P5|COMPLETED|Overall Study||6735
1545046|NCT01323998|3781354|P4|COMPLETED|Overall Study||12052
1545047|NCT01323998|3781355|P3|COMPLETED|Overall Study||10294
1545048|NCT01323998|3781356|P2|COMPLETED|Overall Study||18681
1545049|NCT01323998|3781357|P1|COMPLETED|Overall Study||200631
1545050|NCT01323998|3781353|P5|STARTED|Overall Study||6735
1545051|NCT01323998|3781354|P4|STARTED|Overall Study||12052
1545052|NCT01323998|3781355|P3|STARTED|Overall Study||10294
1545053|NCT01323998|3781356|P2|STARTED|Overall Study||18681
1545054|NCT01323998|3781357|P1|STARTED|Overall Study||200631
1545055|NCT01323972|3781373|P4|NOT COMPLETED|Overall Study||1
1545056|NCT01323972|3781374|P3|NOT COMPLETED|Overall Study||2
1545057|NCT01323972|3781375|P2|NOT COMPLETED|Overall Study||3
1545058|NCT01323972|3781376|P1|NOT COMPLETED|Overall Study||2
1545059|NCT01323972|3781373|P4|COMPLETED|Overall Study||79
1545060|NCT01323972|3781374|P3|COMPLETED|Overall Study||78
1545061|NCT01323972|3781375|P2|COMPLETED|Overall Study||76
1545062|NCT01323972|3781376|P1|COMPLETED|Overall Study||79
1545063|NCT01323972|3781373|P4|STARTED|Overall Study||80
1545064|NCT01323972|3781374|P3|STARTED|Overall Study||80
1545065|NCT01323972|3781375|P2|STARTED|Overall Study||79
1545066|NCT01323972|3781376|P1|STARTED|Overall Study||81
1545067|NCT01323959|3781411|P3|NOT COMPLETED|Overall Study||0
1545068|NCT01323959|3781412|P2|NOT COMPLETED|Overall Study||0
1545069|NCT01323959|3781413|P1|NOT COMPLETED|Overall Study||0
1545070|NCT01323959|3781411|P3|COMPLETED|Overall Study||72
1545071|NCT01323959|3781412|P2|COMPLETED|Overall Study||72
1545072|NCT01323959|3781413|P1|COMPLETED|Overall Study||67
1545073|NCT01323959|3781411|P3|STARTED|Overall Study||72
1545074|NCT01323959|3781412|P2|STARTED|Overall Study||72
1545075|NCT01323959|3781413|P1|STARTED|Overall Study||67
1545076|NCT01323920|3781469|P1|NOT COMPLETED|Overall Study||6
1545077|NCT01323920|3781469|P1|COMPLETED|Overall Study||29
1545078|NCT01323920|3781469|P1|STARTED|Overall Study||35
1545079|NCT01323855|3781481|P5|NOT COMPLETED|Overall Study||0
1545080|NCT01323855|3781482|P4|NOT COMPLETED|Overall Study||0
1545081|NCT01323855|3781483|P3|NOT COMPLETED|Overall Study||0
1545082|NCT01323855|3781484|P2|NOT COMPLETED|Overall Study||0
1545083|NCT01323855|3781485|P1|NOT COMPLETED|Overall Study||0
1545084|NCT01323855|3781481|P5|COMPLETED|Overall Study||11
1545085|NCT01323855|3781482|P4|COMPLETED|Overall Study||9
1545086|NCT01323855|3781483|P3|COMPLETED|Overall Study||8
1545087|NCT01323855|3781484|P2|COMPLETED|Overall Study||9
1545088|NCT01323855|3781485|P1|COMPLETED|Overall Study||9
1545089|NCT01323855|3781481|P5|STARTED|Overall Study||11
1545090|NCT01323855|3781482|P4|STARTED|Overall Study||9
1545091|NCT01323855|3781483|P3|STARTED|Overall Study||8
1545092|NCT01323855|3781484|P2|STARTED|Overall Study||9
1545093|NCT01323855|3781485|P1|STARTED|Overall Study||9
1545094|NCT01323790|3781510|P3|NOT COMPLETED|Overall Study||45
1545095|NCT01323790|3781511|P2|NOT COMPLETED|Overall Study||60
1545096|NCT01323790|3781512|P1|NOT COMPLETED|Overall Study||55
1545097|NCT01323790|3781510|P3|COMPLETED|Overall Study||188
1545098|NCT01323790|3781511|P2|COMPLETED|Overall Study||174
1545099|NCT01323790|3781512|P1|COMPLETED|Overall Study||178
1545100|NCT01323790|3781510|P3|STARTED|Overall Study||233
1545101|NCT01323790|3781511|P2|STARTED|Overall Study||234
1545102|NCT01323790|3781512|P1|STARTED|Overall Study||233
1545103|NCT01323777|3781550|P1|NOT COMPLETED|Overall Study||0
1545104|NCT01323777|3781550|P1|COMPLETED|Overall Study||65
1545105|NCT01323777|3781550|P1|STARTED|Overall Study||65
1545106|NCT01323673|3781563|P2|NOT COMPLETED|Overall Study||5
1545107|NCT01323673|3781564|P1|NOT COMPLETED|Overall Study||3
1545108|NCT01323673|3781563|P2|COMPLETED|Overall Study||58
1545109|NCT01323673|3781564|P1|COMPLETED|Overall Study||59
1545110|NCT01323673|3781563|P2|STARTED|Overall Study||63
1545111|NCT01323673|3781564|P1|STARTED|Overall Study||62
1545112|NCT01323660|3781584|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
1545113|NCT01323660|3781585|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
1545114|NCT01323660|3781586|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
1545115|NCT01323660|3781587|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
1545116|NCT01323660|3781588|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
1545117|NCT01323660|3781589|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
1545118|NCT01323660|3781584|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
1545119|NCT01323660|3781585|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
1545120|NCT01323660|3781586|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
1545121|NCT01323660|3781587|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
1545122|NCT01323660|3781588|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
1545123|NCT01323660|3781589|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
1545124|NCT01323660|3781584|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
1545125|NCT01323660|3781585|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
1545126|NCT01323660|3781586|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
1545127|NCT01323660|3781587|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
1545128|NCT01323660|3781588|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
1545129|NCT01323660|3781589|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
1545130|NCT01323660|3781584|P6|NOT COMPLETED|Washout Period (14 Days)||2
1545131|NCT01323660|3781585|P5|NOT COMPLETED|Washout Period (14 Days)||3
1545132|NCT01323660|3781586|P4|NOT COMPLETED|Washout Period (14 Days)||3
1545133|NCT01323660|3781587|P3|NOT COMPLETED|Washout Period (14 Days)||1
1545134|NCT01323660|3781588|P2|NOT COMPLETED|Washout Period (14 Days)||0
1545135|NCT01323660|3781589|P1|NOT COMPLETED|Washout Period (14 Days)||0
1545136|NCT01323660|3781584|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
1545137|NCT01323660|3781585|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
1545138|NCT01323660|3781586|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
1545139|NCT01323660|3781587|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
1545140|NCT01323660|3781588|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
1545141|NCT01323660|3781589|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
1545142|NCT01323660|3781584|P6|STARTED|Washout Period (14 Days)||61
1545143|NCT01323660|3781585|P5|STARTED|Washout Period (14 Days)||61
1545144|NCT01323660|3781586|P4|STARTED|Washout Period (14 Days)||31
1545145|NCT01323660|3781587|P3|STARTED|Washout Period (14 Days)||19
1545146|NCT01323660|3781588|P2|STARTED|Washout Period (14 Days)||21
1545147|NCT01323660|3781589|P1|STARTED|Washout Period (14 Days)||65
1545148|NCT01323660|3781584|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
1545149|NCT01323660|3781585|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
1545150|NCT01323660|3781586|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
1545151|NCT01323660|3781587|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
1545152|NCT01323660|3781588|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
1545153|NCT01323660|3781589|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
1545154|NCT01323660|3781584|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
1545155|NCT01323660|3781585|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
1545156|NCT01323660|3781586|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
1545157|NCT01323660|3781587|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
1545158|NCT01323660|3781588|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
1545159|NCT01323660|3781589|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
1545160|NCT01323660|3781584|P6|STARTED|Treatment Period 1 (12 Weeks)||70
1545161|NCT01323660|3781585|P5|STARTED|Treatment Period 1 (12 Weeks)||71
1545162|NCT01323660|3781586|P4|STARTED|Treatment Period 1 (12 Weeks)||36
1545163|NCT01323660|3781587|P3|STARTED|Treatment Period 1 (12 Weeks)||24
1545164|NCT01323660|3781588|P2|STARTED|Treatment Period 1 (12 Weeks)||22
1545165|NCT01323660|3781589|P1|STARTED|Treatment Period 1 (12 Weeks)||84
1545166|NCT01323647|3781635|P2|NOT COMPLETED|Overall Study||0
1545167|NCT01323647|3781636|P1|NOT COMPLETED|Overall Study||9
1545168|NCT01323647|3781635|P2|COMPLETED|Overall Study||487
1545169|NCT01323647|3781636|P1|COMPLETED|Overall Study||461
1545170|NCT01323647|3781635|P2|STARTED|Overall Study||487
1545171|NCT01323647|3781636|P1|STARTED|Overall Study||470
1545172|NCT01323634|3781653|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
1545173|NCT01323634|3781654|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
1545174|NCT01323634|3781655|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1545175|NCT01323634|3781653|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
1545176|NCT01323634|3781654|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
1545177|NCT01323634|3781655|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
1545178|NCT01323634|3781653|P3|STARTED|Double-Blind (DB) Treatment Period||261
1545179|NCT01323634|3781654|P2|STARTED|Double-Blind (DB) Treatment Period||260
1545180|NCT01323634|3781655|P1|STARTED|Double-Blind (DB) Treatment Period||0
1545181|NCT01323634|3781653|P3|NOT COMPLETED|2-week Run-in Period||0
1545182|NCT01323634|3781654|P2|NOT COMPLETED|2-week Run-in Period||0
1545183|NCT01323634|3781655|P1|NOT COMPLETED|2-week Run-in Period||212
1545184|NCT01323634|3781653|P3|COMPLETED|2-week Run-in Period||0
1545185|NCT01323634|3781654|P2|COMPLETED|2-week Run-in Period||0
1545186|NCT01323634|3781655|P1|COMPLETED|2-week Run-in Period||521
1545187|NCT01323634|3781653|P3|STARTED|2-week Run-in Period||0
1545188|NCT01323634|3781654|P2|STARTED|2-week Run-in Period||0
1545189|NCT01323634|3781655|P1|STARTED|2-week Run-in Period||733
1545190|NCT01323621|3781665|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
1545191|NCT01323621|3781666|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
1545192|NCT01323621|3781667|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
1545193|NCT01323621|3781665|P3|COMPLETED|12-week, Double-blind Treatment Period||239
1545194|NCT01323621|3781666|P2|COMPLETED|12-week, Double-blind Treatment Period||237
1545195|NCT01323621|3781667|P1|COMPLETED|12-week, Double-blind Treatment Period||0
1545196|NCT01323621|3781665|P3|STARTED|12-week, Double-blind Treatment Period||259
1545197|NCT01323621|3781666|P2|STARTED|12-week, Double-blind Treatment Period||252
1545198|NCT01323621|3781667|P1|STARTED|12-week, Double-blind Treatment Period||0
1545199|NCT01323621|3781665|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
1545200|NCT01323621|3781666|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
1545201|NCT01323621|3781667|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
1545202|NCT01323621|3781665|P3|COMPLETED|2-week, Single-blind Run In Period||0
1545203|NCT01323621|3781666|P2|COMPLETED|2-week, Single-blind Run In Period||0
1545204|NCT01323621|3781667|P1|COMPLETED|2-week, Single-blind Run In Period||511
1545205|NCT01323621|3781665|P3|STARTED|2-week, Single-blind Run In Period||0
1545206|NCT01323621|3781666|P2|STARTED|2-week, Single-blind Run In Period||0
1545207|NCT01323621|3781667|P1|STARTED|2-week, Single-blind Run In Period||739
1545208|NCT01323595|3781677|P2|NOT COMPLETED|Overall Study||21
1545209|NCT01323595|3781678|P1|NOT COMPLETED|Overall Study||23
1545210|NCT01323595|3781677|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
1545211|NCT01323595|3781678|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
1545212|NCT01323595|3781677|P2|STARTED|Overall Study||39
1545213|NCT01323595|3781678|P1|STARTED|Overall Study||39
1545214|NCT01323582|3781688|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
1545215|NCT01323582|3781689|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
1545216|NCT01323582|3781688|P2|COMPLETED|Weeks 8-11 (Period 2)||10
1545217|NCT01323582|3781689|P1|COMPLETED|Weeks 8-11 (Period 2)||10
1545218|NCT01323582|3781688|P2|STARTED|Weeks 8-11 (Period 2)||11
1545219|NCT01323582|3781689|P1|STARTED|Weeks 8-11 (Period 2)||10
1545220|NCT01323582|3781688|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
1545221|NCT01323582|3781689|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
1545222|NCT01323582|3781688|P2|COMPLETED|Weeks 5-7 (Washout)||11
1545223|NCT01323582|3781689|P1|COMPLETED|Weeks 5-7 (Washout)||10
1545224|NCT01323582|3781688|P2|STARTED|Weeks 5-7 (Washout)||12
1545225|NCT01323582|3781689|P1|STARTED|Weeks 5-7 (Washout)||10
1545226|NCT01323582|3781688|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
1545227|NCT01323582|3781689|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
1545228|NCT01323582|3781688|P2|COMPLETED|Weeks 1-4 (First Period)||12
1545229|NCT01323582|3781689|P1|COMPLETED|Weeks 1-4 (First Period)||10
1545230|NCT01323582|3781688|P2|STARTED|Weeks 1-4 (First Period)||14
1545231|NCT01323582|3781689|P1|STARTED|Weeks 1-4 (First Period)||12
1545232|NCT01323517|3781705|P1|NOT COMPLETED|Overall Study||0
1545233|NCT01323517|3781705|P1|COMPLETED|Overall Study||26
1545234|NCT01323517|3781705|P1|STARTED|Overall Study||26
1545235|NCT01323478|3781712|P1|NOT COMPLETED|Overall Study||24
1545236|NCT01323478|3781712|P1|COMPLETED|Overall Study||47
1545237|NCT01323478|3781712|P1|STARTED|Overall Study||71
1545238|NCT01323387|3781725|P1|NOT COMPLETED|Overall Study||84
1545239|NCT01323387|3781725|P1|COMPLETED|Overall Study||94
1545240|NCT01323387|3781725|P1|STARTED|Overall Study||178
1545241|NCT01323270|3781738|P2|NOT COMPLETED|Overall Study||29
1545242|NCT01323270|3781739|P1|NOT COMPLETED|Overall Study||43
1545243|NCT01323270|3781738|P2|COMPLETED|Overall Study||347
1545244|NCT01323270|3781739|P1|COMPLETED|Overall Study||330
1545245|NCT01323270|3781738|P2|STARTED|Overall Study||376
1545246|NCT01323270|3781739|P1|STARTED|Overall Study||373
1545247|NCT01323192|3781761|P2|NOT COMPLETED|Overall Study||6
1545248|NCT01323192|3781762|P1|NOT COMPLETED|Overall Study||9
1545249|NCT01323192|3781761|P2|COMPLETED|Overall Study||135
1545250|NCT01323192|3781762|P1|COMPLETED|Overall Study||134
1545251|NCT01323192|3781761|P2|STARTED|Overall Study||141
1545252|NCT01323192|3781762|P1|STARTED|Overall Study||143
1545253|NCT01323153|3781780|P2|NOT COMPLETED|Overall Study||8
1545254|NCT01323153|3781781|P1|NOT COMPLETED|Overall Study||17
1545255|NCT01323153|3781780|P2|COMPLETED|Overall Study||142
1545256|NCT01323153|3781781|P1|COMPLETED|Overall Study||133
1545257|NCT01323153|3781780|P2|STARTED|Overall Study||150
1545258|NCT01323153|3781781|P1|STARTED|Overall Study||150
1545259|NCT01323140|3781787|P1|NOT COMPLETED|Overall Study||2
1545260|NCT01323140|3781787|P1|COMPLETED|Overall Study||38
1545261|NCT01323140|3781787|P1|STARTED|Overall Study||40
1545262|NCT01323010|3781793|P2|NOT COMPLETED|Overall Study||0
1545263|NCT01323010|3781794|P1|NOT COMPLETED|Overall Study||0
1545264|NCT01323010|3781793|P2|COMPLETED|Overall Study||59
1545265|NCT01323010|3781794|P1|COMPLETED|Overall Study||60
1545266|NCT01323010|3781793|P2|STARTED|Overall Study||59
1545267|NCT01323010|3781794|P1|STARTED|Overall Study||60
1545268|NCT01322971|3781845|P2|NOT COMPLETED|Overall Study||1
1545269|NCT01322971|3781846|P1|NOT COMPLETED|Overall Study||1
1545270|NCT01322971|3781845|P2|COMPLETED|Overall Study||0
1545271|NCT01322971|3781846|P1|COMPLETED|Overall Study||0
1545272|NCT01322971|3781845|P2|STARTED|Overall Study||1
1545273|NCT01322971|3781846|P1|STARTED|Overall Study||1
1545274|NCT01322945|3781860|P2|NOT COMPLETED|Overall Study||0
1545275|NCT01322945|3781861|P1|NOT COMPLETED|Overall Study||0
1545276|NCT01322945|3781860|P2|COMPLETED|Overall Study||42
1545277|NCT01322945|3781861|P1|COMPLETED|Overall Study||52
1545278|NCT01322945|3781860|P2|STARTED|Overall Study||42
1545279|NCT01322945|3781861|P1|STARTED|Overall Study||52
1545280|NCT01322841|3781871|P2|NOT COMPLETED|Overall Study||0
1545281|NCT01322841|3781872|P1|NOT COMPLETED|Overall Study||0
1545282|NCT01322841|3781871|P2|COMPLETED|Overall Study||1123
1545283|NCT01322841|3781872|P1|COMPLETED|Overall Study||1116
1545284|NCT01322841|3781871|P2|STARTED|Overall Study||1123
1545285|NCT01322841|3781872|P1|STARTED|Overall Study||1116
1545286|NCT01322815|3781882|P2|NOT COMPLETED|Overall Study||0
1545287|NCT01322815|3781883|P1|NOT COMPLETED|Overall Study||0
1545288|NCT01322815|3781882|P2|COMPLETED|Overall Study||4
1545289|NCT01322815|3781883|P1|COMPLETED|Overall Study||7
1545290|NCT01322815|3781882|P2|STARTED|Overall Study||4
1545291|NCT01322815|3781883|P1|STARTED|Overall Study||7
1545292|NCT01322633|3781891|P2|NOT COMPLETED|Overall Study||0
1545293|NCT01322633|3781892|P1|NOT COMPLETED|Overall Study||0
1545294|NCT01322633|3781891|P2|COMPLETED|Overall Study||27686
1545295|NCT01322633|3781892|P1|COMPLETED|Overall Study||34178
1545296|NCT01322633|3781891|P2|STARTED|Overall Study||27686
1545297|NCT01322633|3781892|P1|STARTED|Overall Study||34178
1545298|NCT01322607|3781904|P2|NOT COMPLETED|Overall Study||0
1545299|NCT01322607|3781905|P1|NOT COMPLETED|Overall Study||1
1545300|NCT01322607|3781904|P2|COMPLETED|Overall Study||9
1545301|NCT01322607|3781905|P1|COMPLETED|Overall Study||10
1545302|NCT01322607|3781904|P2|STARTED|Overall Study||9
1545303|NCT01322607|3781905|P1|STARTED|Overall Study||11
1545304|NCT01322594|3781923|P6|NOT COMPLETED|Overall Study||0
1545305|NCT01322594|3781924|P5|NOT COMPLETED|Overall Study||0
1545306|NCT01322594|3781925|P4|NOT COMPLETED|Overall Study||0
1545307|NCT01322594|3781926|P3|NOT COMPLETED|Overall Study||0
1545308|NCT01322594|3781927|P2|NOT COMPLETED|Overall Study||0
1545309|NCT01322594|3781928|P1|NOT COMPLETED|Overall Study||0
1545310|NCT01322594|3781923|P6|COMPLETED|Overall Study||6
1545311|NCT01322594|3781924|P5|COMPLETED|Overall Study||7
1545312|NCT01322594|3781925|P4|COMPLETED|Overall Study||6
1545313|NCT01322594|3781926|P3|COMPLETED|Overall Study||3
1545314|NCT01322594|3781927|P2|COMPLETED|Overall Study||3
1545315|NCT01322594|3781928|P1|COMPLETED|Overall Study||6
1545316|NCT01322594|3781923|P6|STARTED|Overall Study||6
1545317|NCT01322594|3781924|P5|STARTED|Overall Study||7
1545318|NCT01322594|3781925|P4|STARTED|Overall Study||6
1545319|NCT01322594|3781926|P3|STARTED|Overall Study||3
1545320|NCT01322594|3781927|P2|STARTED|Overall Study||3
1545321|NCT01322594|3781928|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
1545322|NCT01322386|3782010|P2|NOT COMPLETED|Overall Study||2
1545323|NCT01322386|3782011|P1|NOT COMPLETED|Overall Study||0
1545324|NCT01322386|3782010|P2|COMPLETED|Overall Study||9
1545325|NCT01322386|3782011|P1|COMPLETED|Overall Study||10
1545326|NCT01322386|3782010|P2|STARTED|Overall Study||11
1545327|NCT01322386|3782011|P1|STARTED|Overall Study||10
1545328|NCT01322360|3782019|P1|NOT COMPLETED|Overall Study||0
1545329|NCT01322360|3782019|P1|COMPLETED|Overall Study||50
1545330|NCT01322360|3782019|P1|STARTED|Overall Study||50
1545331|NCT01322347|3782026|P2|NOT COMPLETED|Overall Study||35
1545332|NCT01322347|3782027|P1|NOT COMPLETED|Overall Study||51
1545333|NCT01322347|3782026|P2|COMPLETED|Overall Study||112
1545334|NCT01322347|3782027|P1|COMPLETED|Overall Study||96
1545335|NCT01322347|3782026|P2|Completed St 3|Overall Study||86
1545336|NCT01322347|3782027|P1|Completed St 3|Overall Study||82
1545337|NCT01322347|3782026|P2|Enrolled in St 3|Overall Study||113
1545338|NCT01322347|3782027|P1|Enrolled in St 3|Overall Study||101
1545339|NCT01322347|3782026|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
1545340|NCT01322347|3782027|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
1545341|NCT01322347|3782026|P2|Completed 48 Wks in St 2|Overall Study||22
1545342|NCT01322347|3782027|P1|Completed 48 Wks in St 2|Overall Study||28
1545343|NCT01322347|3782026|P2|STARTED|Overall Study||147
1545344|NCT01322347|3782027|P1|STARTED|Overall Study||147
1545345|NCT01322048|3782064|P2|NOT COMPLETED|Overall Study||0
1545346|NCT01322048|3782065|P1|NOT COMPLETED|Overall Study||0
1545347|NCT01322048|3782064|P2|COMPLETED|Overall Study||26
1545348|NCT01322048|3782065|P1|COMPLETED|Overall Study||21
1545349|NCT01322048|3782064|P2|STARTED|Overall Study||26
1545350|NCT01322048|3782065|P1|STARTED|Overall Study||21
1545351|NCT01322022|3782075|P2|NOT COMPLETED|Overall Study||2
1545352|NCT01322022|3782076|P1|NOT COMPLETED|Overall Study||5
1545353|NCT01322022|3782075|P2|COMPLETED|Overall Study||18
1545354|NCT01322022|3782076|P1|COMPLETED|Overall Study||15
1545355|NCT01322022|3782075|P2|Week 4|Overall Study||18
1545356|NCT01322022|3782076|P1|Week 4|Overall Study||15
1545357|NCT01322022|3782075|P2|STARTED|Overall Study||20
1545358|NCT01322022|3782076|P1|STARTED|Overall Study||20
1545359|NCT01322009|3782090|P2|NOT COMPLETED|Overall Study||3
1545360|NCT01322009|3782091|P1|NOT COMPLETED|Overall Study||0
1545361|NCT01322009|3782090|P2|COMPLETED|Overall Study||4
1545362|NCT01322009|3782091|P1|COMPLETED|Overall Study||7
1545363|NCT01322009|3782090|P2|STARTED|Overall Study||7
1545364|NCT01322009|3782091|P1|STARTED|Overall Study||7
1545365|NCT01321749|3782101|P2|NOT COMPLETED|Overall Study||22
1545366|NCT01321749|3782102|P1|NOT COMPLETED|Overall Study||13
1545367|NCT01321749|3782101|P2|COMPLETED|Overall Study||30
1545368|NCT01321749|3782102|P1|COMPLETED|Overall Study||38
1545369|NCT01321749|3782101|P2|STARTED|Overall Study||52
1545370|NCT01321749|3782102|P1|STARTED|Overall Study||51
1545371|NCT01321723|3782111|P3|NOT COMPLETED|Overall Study||4
1545372|NCT01321723|3782112|P2|NOT COMPLETED|Overall Study||5
1545373|NCT01321723|3782113|P1|NOT COMPLETED|Overall Study||5
1545374|NCT01321723|3782111|P3|COMPLETED|Overall Study||28
1545375|NCT01321723|3782112|P2|COMPLETED|Overall Study||28
1545376|NCT01321723|3782113|P1|COMPLETED|Overall Study||27
1545377|NCT01321723|3782111|P3|STARTED|Overall Study||32
1545378|NCT01321723|3782112|P2|STARTED|Overall Study||33
1545379|NCT01321723|3782113|P1|STARTED|Overall Study||32
1545380|NCT01321710|3782135|P3|NOT COMPLETED|Overall Study||0
1545381|NCT01321710|3782136|P2|NOT COMPLETED|Overall Study||5
1545382|NCT01321710|3782137|P1|NOT COMPLETED|Overall Study||4
1545383|NCT01321710|3782135|P3|COMPLETED|Overall Study||44
1545384|NCT01321710|3782136|P2|COMPLETED|Overall Study||53
1545385|NCT01321710|3782137|P1|COMPLETED|Overall Study||46
1545386|NCT01321710|3782135|P3|STARTED|Overall Study||44
1545387|NCT01321710|3782136|P2|STARTED|Overall Study||58
1545388|NCT01321710|3782137|P1|STARTED|Overall Study||50
1545389|NCT01321697|3782152|P1|NOT COMPLETED|Overall Study||7
1545390|NCT01321697|3782152|P1|COMPLETED|Overall Study||0
1545391|NCT01321697|3782152|P1|STARTED|Overall Study||7
1545392|NCT01321606|3782158|P4|NOT COMPLETED|Overall Study||1
1545393|NCT01321606|3782159|P3|NOT COMPLETED|Overall Study||0
1545394|NCT01321606|3782160|P2|NOT COMPLETED|Overall Study||0
1545395|NCT01321606|3782161|P1|NOT COMPLETED|Overall Study||0
1545396|NCT01321606|3782158|P4|COMPLETED|Overall Study||28
1545397|NCT01321606|3782159|P3|COMPLETED|Overall Study||34
1545398|NCT01321606|3782160|P2|COMPLETED|Overall Study||32
1545399|NCT01321606|3782161|P1|COMPLETED|Overall Study||18
1545400|NCT01321606|3782158|P4|STARTED|Overall Study||29
1545401|NCT01321606|3782159|P3|STARTED|Overall Study||34
1545402|NCT01321606|3782160|P2|STARTED|Overall Study||32
1545403|NCT01321606|3782161|P1|STARTED|Overall Study||18
1545404|NCT01321554|3782181|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||2
1545405|NCT01321554|3782182|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||28
1545406|NCT01321554|3782183|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
1545407|NCT01321554|3782184|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
1545408|NCT01321554|3782181|P4|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|25
1545409|NCT01321554|3782182|P3|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|54
1545410|NCT01321554|3782183|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
1545411|NCT01321554|3782184|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
1545412|NCT01321554|3782181|P4|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||3
1545413|NCT01321554|3782182|P3|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||18
1545414|NCT01321554|3782183|P2|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
1545415|NCT01321554|3782184|P1|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
1545416|NCT01321554|3782181|P4|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||22
1545417|NCT01321554|3782182|P3|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||36
1545418|NCT01321554|3782183|P2|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
1545419|NCT01321554|3782184|P1|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
1545420|NCT01321554|3782181|P4|STARTED|OOL Lenvatinib Treatment Period||27
1545421|NCT01321554|3782182|P3|STARTED|OOL Lenvatinib Treatment Period||82
1545422|NCT01321554|3782183|P2|STARTED|OOL Lenvatinib Treatment Period||0
1545423|NCT01321554|3782184|P1|STARTED|OOL Lenvatinib Treatment Period||0
1545424|NCT01321554|3782181|P4|NOT COMPLETED|Randomization Phase||0
1545425|NCT01321554|3782182|P3|NOT COMPLETED|Randomization Phase||0
1545426|NCT01321554|3782183|P2|NOT COMPLETED|Randomization Phase||4
1545427|NCT01321554|3782184|P1|NOT COMPLETED|Randomization Phase||45
1545428|NCT01321554|3782181|P4|COMPLETED|Randomization Phase||0
1545429|NCT01321554|3782182|P3|COMPLETED|Randomization Phase||0
1545430|NCT01321554|3782183|P2|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|127
1545431|NCT01321554|3782184|P1|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|216
1545432|NCT01321554|3782181|P4|Discontinued Due to Disease Progression|Randomization Phase||0
1545433|NCT01321554|3782182|P3|Discontinued Due to Disease Progression|Randomization Phase||0
1545434|NCT01321554|3782183|P2|Discontinued Due to Disease Progression|Randomization Phase||119
1545435|NCT01321554|3782184|P1|Discontinued Due to Disease Progression|Randomization Phase||94
1545436|NCT01321554|3782181|P4|Treatment Ongoing at Data Cutoff|Randomization Phase||0
1545437|NCT01321554|3782182|P3|Treatment Ongoing at Data Cutoff|Randomization Phase||0
1545438|NCT01321554|3782183|P2|Treatment Ongoing at Data Cutoff|Randomization Phase||8
1545439|NCT01321554|3782184|P1|Treatment Ongoing at Data Cutoff|Randomization Phase||122
1545440|NCT01321554|3782181|P4|STARTED|Randomization Phase||0
1545441|NCT01321554|3782182|P3|STARTED|Randomization Phase||0
1545442|NCT01321554|3782183|P2|STARTED|Randomization Phase||131
1545443|NCT01321554|3782184|P1|STARTED|Randomization Phase||261
1545444|NCT01321073|3782197|P1|NOT COMPLETED|Overall Study||7
1545445|NCT01321073|3782197|P1|COMPLETED|Overall Study||57
1545446|NCT01321073|3782197|P1|STARTED|Overall Study||64
1545447|NCT01321008|3782201|P1|NOT COMPLETED|Overall Study||1
1545448|NCT01321008|3782201|P1|COMPLETED|Overall Study||0
1545449|NCT01321008|3782201|P1|STARTED|Overall Study||1
1545450|NCT01320943|3782207|P2|NOT COMPLETED|Overall Study||2
1545451|NCT01320943|3782208|P1|NOT COMPLETED|Overall Study||1
1545452|NCT01320943|3782207|P2|COMPLETED|Overall Study||20
1545453|NCT01320943|3782208|P1|COMPLETED|Overall Study||20
1545454|NCT01320943|3782207|P2|STARTED|Overall Study||22
1545455|NCT01320943|3782208|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
1545456|NCT01320826|3782227|P1|NOT COMPLETED|Overall Study||0
1545457|NCT01320826|3782227|P1|COMPLETED|Overall Study||577
1545458|NCT01320826|3782227|P1|STARTED|Overall Study||577
1545459|NCT01320735|3782242|P1|NOT COMPLETED|Overall Study||106
1545460|NCT01320735|3782242|P1|COMPLETED|Overall Study||194
1545461|NCT01320735|3782242|P1|STARTED|Overall Study||300
1545462|NCT01320722|3782264|P5|NOT COMPLETED|Overall Study||8
1545463|NCT01320722|3782265|P4|NOT COMPLETED|Overall Study||14
1545464|NCT01320722|3782266|P3|NOT COMPLETED|Overall Study||7
1545465|NCT01320722|3782267|P2|NOT COMPLETED|Overall Study||6
1545466|NCT01320722|3782268|P1|NOT COMPLETED|Overall Study||3
1545467|NCT01320722|3782264|P5|COMPLETED|Overall Study||45
1545468|NCT01320722|3782265|P4|COMPLETED|Overall Study||35
1545469|NCT01320722|3782266|P3|COMPLETED|Overall Study||40
1545470|NCT01320722|3782267|P2|COMPLETED|Overall Study||41
1545471|NCT01320722|3782268|P1|COMPLETED|Overall Study||43
1545472|NCT01320722|3782264|P5|Received Intervention|Overall Study||51
1545473|NCT01320722|3782265|P4|Received Intervention|Overall Study||48
1545474|NCT01320722|3782266|P3|Received Intervention|Overall Study||46
1545475|NCT01320722|3782267|P2|Received Intervention|Overall Study||45
1545476|NCT01320722|3782268|P1|Received Intervention|Overall Study||43
1545477|NCT01320722|3782264|P5|STARTED|Overall Study||53
1545478|NCT01320722|3782265|P4|STARTED|Overall Study||49
1545479|NCT01320722|3782266|P3|STARTED|Overall Study||47
1545480|NCT01320722|3782267|P2|STARTED|Overall Study||47
1545481|NCT01320722|3782268|P1|STARTED|Overall Study||46
1545482|NCT01320683|3782305|P1|NOT COMPLETED|Overall Study||1
1545483|NCT01320683|3782305|P1|COMPLETED|Overall Study||0
1545484|NCT01320683|3782305|P1|STARTED|Overall Study||1
1545485|NCT01320553|3782314|P4|NOT COMPLETED|Overall Study||1
1545486|NCT01320553|3782315|P3|NOT COMPLETED|Overall Study||2
1545487|NCT01320553|3782316|P2|NOT COMPLETED|Overall Study||4
1545488|NCT01320553|3782317|P1|NOT COMPLETED|Overall Study||1
1545489|NCT01320553|3782314|P4|COMPLETED|Overall Study||29
1545490|NCT01320553|3782315|P3|COMPLETED|Overall Study||29
1545491|NCT01320553|3782316|P2|COMPLETED|Overall Study||26
1545492|NCT01320553|3782317|P1|COMPLETED|Overall Study||30
1545493|NCT01320553|3782314|P4|STARTED|Overall Study||30
1545494|NCT01320553|3782315|P3|STARTED|Overall Study||31
1545495|NCT01320553|3782316|P2|STARTED|Overall Study||30
1545496|NCT01320553|3782317|P1|STARTED|Overall Study||31
1545497|NCT01320293|3782331|P1|NOT COMPLETED|Overall Study||2
1545498|NCT01320293|3782331|P1|COMPLETED|Overall Study||16
1545499|NCT01320293|3782331|P1|STARTED|Overall Study||18
1545500|NCT01320202|3782339|P2|NOT COMPLETED|Overall Study||44
1545501|NCT01320202|3782340|P1|NOT COMPLETED|Overall Study||56
1545502|NCT01320202|3782339|P2|COMPLETED|Overall Study||109
1545503|NCT01320202|3782340|P1|COMPLETED|Overall Study||96
1545504|NCT01320202|3782339|P2|Completed St 3|Overall Study||82
1545505|NCT01320202|3782340|P1|Completed St 3|Overall Study||79
1545506|NCT01320202|3782339|P2|Enrolled in St 3|Overall Study||109
1545507|NCT01320202|3782340|P1|Enrolled in St 3|Overall Study||98
1545508|NCT01320202|3782339|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
1545509|NCT01320202|3782340|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
1545510|NCT01320202|3782339|P2|Comp 48 Wks in St 2|Overall Study||27
1545511|NCT01320202|3782340|P1|Comp 48 Wks in St 2|Overall Study||27
1545512|NCT01320202|3782339|P2|STARTED|Overall Study||153
1545513|NCT01320202|3782340|P1|STARTED|Overall Study||152
1545514|NCT01320137|3782377|P2|NOT COMPLETED|Overall Study||0
1545515|NCT01320137|3782378|P1|NOT COMPLETED|Overall Study||0
1545516|NCT01320137|3782377|P2|COMPLETED|Overall Study||40
1545517|NCT01320137|3782378|P1|COMPLETED|Overall Study||40
1545518|NCT01320137|3782377|P2|STARTED|Overall Study||40
1545519|NCT01320137|3782378|P1|STARTED|Overall Study||40
1545520|NCT01320072|3782392|P2|NOT COMPLETED|Overall Study||0
1545521|NCT01320072|3782393|P1|NOT COMPLETED|Overall Study||0
1545522|NCT01320072|3782392|P2|COMPLETED|Overall Study||13
1545523|NCT01320072|3782393|P1|COMPLETED|Overall Study||16
1545524|NCT01320072|3782392|P2|STARTED|Overall Study||13
1545525|NCT01320072|3782393|P1|STARTED|Overall Study||16
1545526|NCT01319877|3782404|P2|NOT COMPLETED|Overall Study||45
1545527|NCT01319877|3782405|P1|NOT COMPLETED|Overall Study||108
1545528|NCT01319877|3782404|P2|COMPLETED|Overall Study||108
1545529|NCT01319877|3782405|P1|COMPLETED|Overall Study||345
1545530|NCT01319877|3782404|P2|STARTED|Overall Study||153
1545531|NCT01319877|3782405|P1|STARTED|Overall Study||453
1545532|NCT01319851|3782440|P1|NOT COMPLETED|Overall Study||0
1545533|NCT01319851|3782440|P1|COMPLETED|Overall Study||3
1545534|NCT01319851|3782440|P1|STARTED|Overall Study||3
1545535|NCT01319812|3782452|P2|NOT COMPLETED|Overall Study||22
1545536|NCT01319812|3782453|P1|NOT COMPLETED|Overall Study||16
1545537|NCT01319812|3782452|P2|COMPLETED|Overall Study||280
1545538|NCT01319812|3782453|P1|COMPLETED|Overall Study||145
1545539|NCT01319812|3782452|P2|STARTED|Overall Study||302
1545540|NCT01319812|3782453|P1|STARTED|Overall Study||161
1545541|NCT01319799|3782525|P1|NOT COMPLETED|Overall Study||0
1545542|NCT01319799|3782525|P1|COMPLETED|Overall Study||10
1545543|NCT01319799|3782525|P1|STARTED|Overall Study||10
1545544|NCT01319773|3782535|P5|NOT COMPLETED|Overall Study||0
1545545|NCT01319773|3782536|P4|NOT COMPLETED|Overall Study||0
1545546|NCT01319773|3782537|P3|NOT COMPLETED|Overall Study||0
1545547|NCT01319773|3782538|P2|NOT COMPLETED|Overall Study||0
1545548|NCT01319773|3782539|P1|NOT COMPLETED|Overall Study||0
1545549|NCT01319773|3782535|P5|COMPLETED|Overall Study||8
1545550|NCT01319773|3782536|P4|COMPLETED|Overall Study||8
1545551|NCT01319773|3782537|P3|COMPLETED|Overall Study||8
1545552|NCT01319773|3782538|P2|COMPLETED|Overall Study||10
1545553|NCT01319773|3782539|P1|COMPLETED|Overall Study||10
1545554|NCT01319773|3782535|P5|STARTED|Overall Study||8
1545555|NCT01319773|3782536|P4|STARTED|Overall Study||8
1545556|NCT01319773|3782537|P3|STARTED|Overall Study||8
1545557|NCT01319773|3782538|P2|STARTED|Overall Study||10
1545558|NCT01319773|3782539|P1|STARTED|Overall Study||10
1545559|NCT01319721|3782555|P2|NOT COMPLETED|Overall Study||6
1545560|NCT01319721|3782556|P1|NOT COMPLETED|Overall Study||1
1545561|NCT01319721|3782555|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
1545562|NCT01319721|3782556|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
1545563|NCT01319721|3782555|P2|STARTED|Overall Study|The unit of measure is eyes.|48
1545564|NCT01319721|3782556|P1|STARTED|Overall Study|The unit of measure is eyes.|48
1545565|NCT01319617|3782570|P1|NOT COMPLETED|Overall Study||1
1545566|NCT01319617|3782570|P1|COMPLETED|Overall Study||40
1545567|NCT01319617|3782570|P1|STARTED|Overall Study||41
1545568|NCT01319552|3782574|P1|NOT COMPLETED|Overall Study||0
1545569|NCT01319552|3782574|P1|COMPLETED|Overall Study||14
1545570|NCT01319552|3782574|P1|STARTED|Overall Study||14
1545571|NCT01319539|3782579|P1|NOT COMPLETED|Overall Study||0
1545572|NCT01319539|3782579|P1|COMPLETED|Overall Study||12
1545573|NCT01319539|3782579|P1|STARTED|Overall Study||12
1545574|NCT01319500|3782589|P2|NOT COMPLETED|Overall Study||0
1545575|NCT01319500|3782590|P1|NOT COMPLETED|Overall Study||0
1545576|NCT01319500|3782589|P2|COMPLETED|Overall Study||2589
1545577|NCT01319500|3782590|P1|COMPLETED|Overall Study||1187
1545578|NCT01319500|3782589|P2|STARTED|Overall Study||2589
1545579|NCT01319500|3782590|P1|STARTED|Overall Study||1187
1545580|NCT01319422|3782609|P2|NOT COMPLETED|Overall Study||0
1545581|NCT01319422|3782610|P1|NOT COMPLETED|Overall Study||1
1545582|NCT01319422|3782609|P2|COMPLETED|Overall Study||20
1545583|NCT01319422|3782610|P1|COMPLETED|Overall Study||19
1545584|NCT01319422|3782609|P2|STARTED|Overall Study||20
1545585|NCT01319422|3782610|P1|STARTED|Overall Study||20
1545586|NCT01319396|3782624|P1|NOT COMPLETED|Overall Study||0
1545587|NCT01319396|3782624|P1|COMPLETED|Overall Study||24
1545588|NCT01319396|3782624|P1|STARTED|Overall Study||24
1545589|NCT01319383|3782628|P2|NOT COMPLETED|Overall Study||10
1545590|NCT01319383|3782629|P1|NOT COMPLETED|Overall Study||12
1545591|NCT01319383|3782628|P2|COMPLETED|Overall Study||3
1545592|NCT01319383|3782629|P1|COMPLETED|Overall Study||0
1545593|NCT01319383|3782628|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
1545594|NCT01319383|3782629|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
1545595|NCT01319383|3782628|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
1545596|NCT01319383|3782629|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
1545597|NCT01319383|3782628|P2|Step 2|Overall Study||0
1545598|NCT01319383|3782629|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
1545599|NCT01319383|3782628|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
1545600|NCT01319383|3782629|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
1545601|NCT01319383|3782628|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
1545602|NCT01319383|3782629|P1|Step 1|Overall Study||8
1545603|NCT01319383|3782628|P2|STARTED|Overall Study||13
1545604|NCT01319383|3782629|P1|STARTED|Overall Study||12
1545605|NCT01319318|3782646|P1|NOT COMPLETED|Overall Study||0
1545606|NCT01319318|3782646|P1|COMPLETED|Overall Study||25
1545607|NCT01319318|3782646|P1|STARTED|Overall Study||25
1545608|NCT01319110|3782652|P2|NOT COMPLETED|Overall Study||0
1545609|NCT01319110|3782653|P1|NOT COMPLETED|Overall Study||0
1545610|NCT01319110|3782652|P2|COMPLETED|Overall Study||5
1545611|NCT01319110|3782653|P1|COMPLETED|Overall Study||5
1545612|NCT01319110|3782652|P2|STARTED|Overall Study||5
1545613|NCT01319110|3782653|P1|STARTED|Overall Study||5
1545614|NCT01319045|3782661|P1|NOT COMPLETED|Overall Study||2
1545615|NCT01319045|3782661|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
1545616|NCT01319045|3782661|P1|STARTED|Overall Study||5
1545617|NCT01318993|3782668|P1|NOT COMPLETED|Overall Study||398
1545618|NCT01318993|3782668|P1|COMPLETED|Overall Study||0
1545619|NCT01318993|3782668|P1|STARTED|Overall Study||398
1545620|NCT01318967|3782684|P1|NOT COMPLETED|Overall Study||0
1545621|NCT01318967|3782684|P1|COMPLETED|Overall Study||10
1545622|NCT01318967|3782684|P1|STARTED|Overall Study||10
1545623|NCT01318915|3782689|P1|NOT COMPLETED|Overall Study||1
1545624|NCT01318915|3782689|P1|COMPLETED|Overall Study||9
1545625|NCT01318915|3782689|P1|STARTED|Overall Study||10
1545626|NCT01318876|3782714|P1|NOT COMPLETED|Day 29 Survey||1825
1545627|NCT01318876|3782714|P1|COMPLETED|Day 29 Survey||5724
1545628|NCT01318876|3782714|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
1545629|NCT01318876|3782714|P1|NOT COMPLETED|Day 8 Survey||1820
1545630|NCT01318876|3782714|P1|COMPLETED|Day 8 Survey||5825
1545631|NCT01318876|3782714|P1|STARTED|Day 8 Survey||7645
1545632|NCT01318733|3782719|P1|NOT COMPLETED|Overall Study||170
1545633|NCT01318733|3782719|P1|COMPLETED|Overall Study||279
1545634|NCT01318733|3782719|P1|STARTED|Overall Study||449
1545635|NCT01318694|3782727|P4|NOT COMPLETED|Overall Study||68
1545636|NCT01318694|3782728|P3|NOT COMPLETED|Overall Study||43
1545637|NCT01318694|3782729|P2|NOT COMPLETED|Overall Study||58
1545638|NCT01318694|3782730|P1|NOT COMPLETED|Overall Study||52
1545639|NCT01318694|3782727|P4|COMPLETED|Overall Study||200
1545640|NCT01318694|3782728|P3|COMPLETED|Overall Study||225
1545641|NCT01318694|3782729|P2|COMPLETED|Overall Study||212
1545642|NCT01318694|3782730|P1|COMPLETED|Overall Study||223
1545643|NCT01318694|3782727|P4|Safety Set|Overall Study||265
1545644|NCT01318694|3782728|P3|Safety Set|Overall Study||265
1545645|NCT01318694|3782729|P2|Safety Set|Overall Study||268
1545646|NCT01318694|3782730|P1|Safety Set|Overall Study||273
1545647|NCT01318694|3782727|P4|Full Analysis Set|Overall Study||268
1545648|NCT01318694|3782728|P3|Full Analysis Set|Overall Study||265
1545649|NCT01318694|3782729|P2|Full Analysis Set|Overall Study||270
1545650|NCT01318694|3782730|P1|Full Analysis Set|Overall Study||274
1545651|NCT01318694|3782727|P4|STARTED|Overall Study||268
1545652|NCT01318694|3782728|P3|STARTED|Overall Study||268
1545653|NCT01318694|3782729|P2|STARTED|Overall Study||270
1545654|NCT01318694|3782730|P1|STARTED|Overall Study||275
1545655|NCT01318538|3782786|P3|NOT COMPLETED|Overall Study||0
1545656|NCT01318538|3782787|P2|NOT COMPLETED|Overall Study||0
1545657|NCT01318538|3782788|P1|NOT COMPLETED|Overall Study||0
1545658|NCT01318538|3782786|P3|COMPLETED|Overall Study||8
1545659|NCT01318538|3782787|P2|COMPLETED|Overall Study||106
1545660|NCT01318538|3782788|P1|COMPLETED|Overall Study||52
1545661|NCT01318538|3782786|P3|STARTED|Overall Study||8
1545662|NCT01318538|3782787|P2|STARTED|Overall Study||106
1545663|NCT01318538|3782788|P1|STARTED|Overall Study||52
1545664|NCT01318512|3782812|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
1545665|NCT01318512|3782812|P1|COMPLETED|Maintenance Period (6 Months)||329
1545666|NCT01318512|3782812|P1|STARTED|Maintenance Period (6 Months)||340
1545667|NCT01318512|3782812|P1|NOT COMPLETED|Titration Period (4 Months)||0
1545668|NCT01318512|3782812|P1|COMPLETED|Titration Period (4 Months)||340
1545669|NCT01318512|3782812|P1|STARTED|Titration Period (4 Months)||340
1545670|NCT01318499|3782831|P3|NOT COMPLETED|Overall Study||147
1545671|NCT01318499|3782832|P2|NOT COMPLETED|Overall Study||76
1545672|NCT01318499|3782833|P1|NOT COMPLETED|Overall Study||65
1545673|NCT01318499|3782831|P3|COMPLETED|Overall Study||121
1545674|NCT01318499|3782832|P2|COMPLETED|Overall Study||458
1545675|NCT01318499|3782833|P1|COMPLETED|Overall Study||475
1545676|NCT01318499|3782831|P3|STARTED|Overall Study||268
1545677|NCT01318499|3782832|P2|STARTED|Overall Study||534
1545678|NCT01318499|3782833|P1|STARTED|Overall Study||540
1545679|NCT01318408|3782851|P1|NOT COMPLETED|Overall Study||8
1545680|NCT01318408|3782851|P1|COMPLETED|Overall Study||16
1545681|NCT01318408|3782851|P1|STARTED|Overall Study||24
1545682|NCT01318382|3782856|P1|NOT COMPLETED|Overall Study||13
1545683|NCT01318382|3782856|P1|COMPLETED|Overall Study||289
1545684|NCT01318382|3782856|P1|STARTED|Overall Study||302
1545685|NCT01318278|3782866|P3|NOT COMPLETED|Overall Study||0
1545686|NCT01318278|3782867|P2|NOT COMPLETED|Overall Study||0
1545687|NCT01318278|3782868|P1|NOT COMPLETED|Overall Study||0
1545688|NCT01318278|3782866|P3|COMPLETED|Overall Study||50
1545689|NCT01318278|3782867|P2|COMPLETED|Overall Study||10
1545690|NCT01318278|3782868|P1|COMPLETED|Overall Study||10
1545691|NCT01318278|3782866|P3|STARTED|Overall Study||50
1545692|NCT01318278|3782867|P2|STARTED|Overall Study||10
1545693|NCT01318278|3782868|P1|STARTED|Overall Study||10
1545694|NCT01318135|3782914|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
1545695|NCT01318135|3782915|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
1545696|NCT01318135|3782916|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
1545697|NCT01318135|3782917|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
1545698|NCT01318135|3782918|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
1545699|NCT01318135|3782919|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
1545700|NCT01318135|3782920|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
1545701|NCT01318135|3782921|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
1545702|NCT01318135|3782914|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
1545703|NCT01318135|3782915|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
1545704|NCT01318135|3782916|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
1545705|NCT01318135|3782917|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
1545706|NCT01318135|3782918|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
1545707|NCT01318135|3782919|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
1545708|NCT01318135|3782920|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
1545709|NCT01318135|3782921|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
1545710|NCT01318135|3782914|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
1545711|NCT01318135|3782915|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
1545712|NCT01318135|3782916|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
1545713|NCT01318135|3782917|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
1545714|NCT01318135|3782918|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
1545715|NCT01318135|3782919|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
1545716|NCT01318135|3782920|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
1545717|NCT01318135|3782921|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
1545718|NCT01318135|3782914|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1545719|NCT01318135|3782915|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1545720|NCT01318135|3782916|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1545721|NCT01318135|3782917|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1545722|NCT01318135|3782918|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1545723|NCT01318135|3782919|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1545724|NCT01318135|3782920|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1545725|NCT01318135|3782921|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
1545726|NCT01318135|3782914|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
1545727|NCT01318135|3782915|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
1545728|NCT01318135|3782916|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
1545729|NCT01318135|3782917|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
1545730|NCT01318135|3782918|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
1545731|NCT01318135|3782919|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
1545732|NCT01318135|3782920|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
1545733|NCT01318135|3782921|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
1545734|NCT01318135|3782914|P8|STARTED|Enrolled - Long-Term Extension Study||49
1545735|NCT01318135|3782915|P7|STARTED|Enrolled - Long-Term Extension Study||50
1545736|NCT01318135|3782916|P6|STARTED|Enrolled - Long-Term Extension Study||90
1545737|NCT01318135|3782917|P5|STARTED|Enrolled - Long-Term Extension Study||91
1545738|NCT01318135|3782918|P4|STARTED|Enrolled - Long-Term Extension Study||49
1545739|NCT01318135|3782919|P3|STARTED|Enrolled - Long-Term Extension Study||46
1545740|NCT01318135|3782920|P2|STARTED|Enrolled - Long-Term Extension Study||102
1545741|NCT01318135|3782921|P1|STARTED|Enrolled - Long-Term Extension Study||99
1545742|NCT01318122|3783053|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
1545743|NCT01318122|3783054|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
1545744|NCT01318122|3783055|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
1545745|NCT01318122|3783056|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
1545746|NCT01318122|3783053|P4|COMPLETED|Entered - Long-Term Extension Study||48
1545747|NCT01318122|3783054|P3|COMPLETED|Entered - Long-Term Extension Study||49
1545748|NCT01318122|3783055|P2|COMPLETED|Entered - Long-Term Extension Study||99
1545749|NCT01318122|3783056|P1|COMPLETED|Entered - Long-Term Extension Study||96
1545750|NCT01318122|3783053|P4|STARTED|Entered - Long-Term Extension Study||52
1545751|NCT01318122|3783054|P3|STARTED|Entered - Long-Term Extension Study||55
1545752|NCT01318122|3783055|P2|STARTED|Entered - Long-Term Extension Study||110
1545753|NCT01318122|3783056|P1|STARTED|Entered - Long-Term Extension Study||105
1545754|NCT01318122|3783053|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1545755|NCT01318122|3783054|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
1545756|NCT01318122|3783055|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1545757|NCT01318122|3783056|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1545758|NCT01318122|3783053|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
1545759|NCT01318122|3783054|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
1545760|NCT01318122|3783055|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
1545761|NCT01318122|3783056|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
1545762|NCT01318122|3783053|P4|STARTED|Enrolled - Long-Term Extension Study||53
1545763|NCT01318122|3783054|P3|STARTED|Enrolled - Long-Term Extension Study||57
1545764|NCT01318122|3783055|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
1545765|NCT01318122|3783056|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
1545766|NCT01318109|3783125|P3|NOT COMPLETED|Overall Study||0
1545767|NCT01318109|3783126|P2|NOT COMPLETED|Overall Study||3
1545768|NCT01318109|3783127|P1|NOT COMPLETED|Overall Study||1
1545769|NCT01318109|3783125|P3|COMPLETED|Overall Study||100
1545770|NCT01318109|3783126|P2|COMPLETED|Overall Study||93
1545771|NCT01318109|3783127|P1|COMPLETED|Overall Study||91
1545772|NCT01318109|3783125|P3|STARTED|Overall Study||100
1545773|NCT01318109|3783126|P2|STARTED|Overall Study||96
1545774|NCT01318109|3783127|P1|STARTED|Overall Study||92
1545775|NCT01318083|3783162|P3|NOT COMPLETED|Overall Study||5
1545776|NCT01318083|3783163|P2|NOT COMPLETED|Overall Study||2
1545777|NCT01318083|3783164|P1|NOT COMPLETED|Overall Study||6
1545778|NCT01318083|3783162|P3|COMPLETED|Overall Study||98
1545779|NCT01318083|3783163|P2|COMPLETED|Overall Study||102
1545780|NCT01318083|3783164|P1|COMPLETED|Overall Study||99
1545781|NCT01318083|3783162|P3|STARTED|Overall Study||103
1545782|NCT01318083|3783163|P2|STARTED|Overall Study||104
1545783|NCT01318083|3783164|P1|STARTED|Overall Study||105
1545784|NCT01318070|3783199|P3|NOT COMPLETED|Overall Study||7
1545785|NCT01318070|3783200|P2|NOT COMPLETED|Overall Study||2
1545786|NCT01318070|3783201|P1|NOT COMPLETED|Overall Study||2
1545787|NCT01318070|3783199|P3|COMPLETED|Overall Study||108
1545788|NCT01318070|3783200|P2|COMPLETED|Overall Study||111
1545789|NCT01318070|3783201|P1|COMPLETED|Overall Study||109
1545790|NCT01318070|3783199|P3|STARTED|Overall Study||115
1545791|NCT01318070|3783200|P2|STARTED|Overall Study||113
1545792|NCT01318070|3783201|P1|STARTED|Overall Study||111
1545793|NCT01318018|3783235|P2|NOT COMPLETED|Overall Study||0
1545794|NCT01318018|3783236|P1|NOT COMPLETED|Overall Study||0
1545795|NCT01318018|3783235|P2|COMPLETED|Overall Study||10
1545796|NCT01318018|3783236|P1|COMPLETED|Overall Study||10
1545797|NCT01318018|3783235|P2|STARTED|Overall Study||10
1545798|NCT01318018|3783236|P1|STARTED|Overall Study||10
1545799|NCT01317901|3783244|P2|NOT COMPLETED|Overall Study||0
1545800|NCT01317901|3783245|P1|NOT COMPLETED|Overall Study||0
1545801|NCT01317901|3783244|P2|COMPLETED|Overall Study||6
1545802|NCT01317901|3783245|P1|COMPLETED|Overall Study||6
1545803|NCT01317901|3783244|P2|STARTED|Overall Study||6
1545804|NCT01317901|3783245|P1|STARTED|Overall Study||6
1545805|NCT01317797|3783254|P3|NOT COMPLETED|Overall Study||1
1545806|NCT01317797|3783255|P2|NOT COMPLETED|Overall Study||1
1545807|NCT01317797|3783256|P1|NOT COMPLETED|Overall Study||0
1545808|NCT01317797|3783254|P3|COMPLETED|Overall Study||8
1545809|NCT01317797|3783255|P2|COMPLETED|Overall Study||6
1545810|NCT01317797|3783256|P1|COMPLETED|Overall Study||8
1545811|NCT01317797|3783254|P3|STARTED|Overall Study||9
1545812|NCT01317797|3783255|P2|STARTED|Overall Study||7
1545813|NCT01317797|3783256|P1|STARTED|Overall Study||8
1545814|NCT01317667|3783311|P3|NOT COMPLETED|Overall Study||0
1545815|NCT01317667|3783312|P2|NOT COMPLETED|Overall Study||0
1545816|NCT01317667|3783313|P1|NOT COMPLETED|Overall Study||0
1545817|NCT01317667|3783311|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
1545818|NCT01317667|3783312|P2|COMPLETED|Overall Study||10
1545819|NCT01317667|3783313|P1|COMPLETED|Overall Study||10
1545820|NCT01317667|3783311|P3|STARTED|Overall Study||10
1545821|NCT01317667|3783312|P2|STARTED|Overall Study||10
1545822|NCT01317667|3783313|P1|STARTED|Overall Study||10
1545823|NCT01317641|3783333|P9|NOT COMPLETED|Overall Study||5
1545824|NCT01317641|3783334|P8|NOT COMPLETED|Overall Study||5
1545825|NCT01317641|3783335|P7|NOT COMPLETED|Overall Study||3
1545826|NCT01317641|3783336|P6|NOT COMPLETED|Overall Study||0
1545827|NCT01317641|3783337|P5|NOT COMPLETED|Overall Study||0
1545828|NCT01317641|3783338|P4|NOT COMPLETED|Overall Study||1
1545829|NCT01317641|3783339|P3|NOT COMPLETED|Overall Study||0
1545830|NCT01317641|3783340|P2|NOT COMPLETED|Overall Study||1
1545831|NCT01317641|3783341|P1|NOT COMPLETED|Overall Study||1
1545832|NCT01317641|3783333|P9|COMPLETED|Overall Study||31
1545833|NCT01317641|3783334|P8|COMPLETED|Overall Study||33
1545834|NCT01317641|3783335|P7|COMPLETED|Overall Study||35
1545835|NCT01317641|3783336|P6|COMPLETED|Overall Study||3
1545836|NCT01317641|3783337|P5|COMPLETED|Overall Study||3
1545837|NCT01317641|3783338|P4|COMPLETED|Overall Study||3
1545838|NCT01317641|3783339|P3|COMPLETED|Overall Study||3
1545839|NCT01317641|3783340|P2|COMPLETED|Overall Study||6
1545840|NCT01317641|3783341|P1|COMPLETED|Overall Study||3
1545841|NCT01317641|3783333|P9|STARTED|Overall Study||36
1545842|NCT01317641|3783334|P8|STARTED|Overall Study||38
1545843|NCT01317641|3783335|P7|STARTED|Overall Study||38
1545844|NCT01317641|3783336|P6|STARTED|Overall Study||3
1545845|NCT01317641|3783337|P5|STARTED|Overall Study||3
1545846|NCT01317641|3783338|P4|STARTED|Overall Study||4
1545847|NCT01317641|3783339|P3|STARTED|Overall Study||3
1545848|NCT01317641|3783340|P2|STARTED|Overall Study||7
1545849|NCT01317641|3783341|P1|STARTED|Overall Study||4
1545850|NCT01317615|3783443|P1|NOT COMPLETED|Overall Study||49
1545851|NCT01317615|3783443|P1|COMPLETED|Overall Study||0
1545852|NCT01317615|3783443|P1|STARTED|Overall Study||49
1545853|NCT01317199|3783456|P4|NOT COMPLETED|Randomized Phase 2||17
1545854|NCT01317199|3783457|P3|NOT COMPLETED|Randomized Phase 2||21
1545855|NCT01317199|3783458|P2|NOT COMPLETED|Randomized Phase 2||11
1545856|NCT01317199|3783459|P1|NOT COMPLETED|Randomized Phase 2||0
1545857|NCT01317199|3783456|P4|COMPLETED|Randomized Phase 2||32
1545858|NCT01317199|3783457|P3|COMPLETED|Randomized Phase 2||35
1545859|NCT01317199|3783458|P2|COMPLETED|Randomized Phase 2||13
1545860|NCT01317199|3783459|P1|COMPLETED|Randomized Phase 2||0
1545861|NCT01317199|3783456|P4|STARTED|Randomized Phase 2||49
1545862|NCT01317199|3783457|P3|STARTED|Randomized Phase 2||56
1545863|NCT01317199|3783458|P2|STARTED|Randomized Phase 2||24
1545864|NCT01317199|3783459|P1|STARTED|Randomized Phase 2||0
1545865|NCT01317199|3783456|P4|NOT COMPLETED|Dose-escalation Phase 1||0
1545866|NCT01317199|3783457|P3|NOT COMPLETED|Dose-escalation Phase 1||0
1545867|NCT01317199|3783458|P2|NOT COMPLETED|Dose-escalation Phase 1||0
1545868|NCT01317199|3783459|P1|NOT COMPLETED|Dose-escalation Phase 1||7
1545869|NCT01317199|3783456|P4|COMPLETED|Dose-escalation Phase 1||0
1545870|NCT01317199|3783457|P3|COMPLETED|Dose-escalation Phase 1||0
1545871|NCT01317199|3783458|P2|COMPLETED|Dose-escalation Phase 1||0
1545872|NCT01317199|3783459|P1|COMPLETED|Dose-escalation Phase 1||7
1545873|NCT01317199|3783456|P4|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545874|NCT01317199|3783457|P3|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545875|NCT01317199|3783458|P2|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545876|NCT01317199|3783459|P1|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
1545877|NCT01317199|3783456|P4|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545878|NCT01317199|3783457|P3|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545879|NCT01317199|3783458|P2|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545880|NCT01317199|3783459|P1|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
1545881|NCT01317199|3783456|P4|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545882|NCT01317199|3783457|P3|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545883|NCT01317199|3783458|P2|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545884|NCT01317199|3783459|P1|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
1545885|NCT01317199|3783456|P4|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545886|NCT01317199|3783457|P3|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545887|NCT01317199|3783458|P2|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
1545888|NCT01317199|3783459|P1|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
1545889|NCT01317199|3783456|P4|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
1545890|NCT01317199|3783457|P3|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
1545891|NCT01317199|3783458|P2|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
1545892|NCT01317199|3783459|P1|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
1545893|NCT01317199|3783456|P4|STARTED|Dose-escalation Phase 1||0
1545894|NCT01317199|3783457|P3|STARTED|Dose-escalation Phase 1||0
1545895|NCT01317199|3783458|P2|STARTED|Dose-escalation Phase 1||0
1545896|NCT01317199|3783459|P1|STARTED|Dose-escalation Phase 1||14
1545897|NCT01317160|3783488|P2|NOT COMPLETED|Overall Study||6
1545898|NCT01317160|3783489|P1|NOT COMPLETED|Overall Study||4
1545899|NCT01317160|3783488|P2|COMPLETED|Overall Study||69
1545900|NCT01317160|3783489|P1|COMPLETED|Overall Study||71
1545901|NCT01317160|3783488|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
1545902|NCT01317160|3783489|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
1545903|NCT01317160|3783488|P2|STARTED|Overall Study||75
1545904|NCT01317160|3783489|P1|STARTED|Overall Study||75
1545905|NCT01317095|3783499|P2|NOT COMPLETED|Overall Study||0
1545906|NCT01317095|3783500|P1|NOT COMPLETED|Overall Study||0
1545907|NCT01317095|3783499|P2|COMPLETED|Overall Study||41
1545908|NCT01317095|3783500|P1|COMPLETED|Overall Study||39
1545909|NCT01317095|3783499|P2|STARTED|Overall Study||41
1545910|NCT01317095|3783500|P1|STARTED|Overall Study||39
1545911|NCT01317004|3783514|P2|NOT COMPLETED|Overall Study||9
1545912|NCT01317004|3783515|P1|NOT COMPLETED|Overall Study||4
1545913|NCT01317004|3783514|P2|COMPLETED|Overall Study||5
1545914|NCT01317004|3783515|P1|COMPLETED|Overall Study||47
1545915|NCT01317004|3783514|P2|Safety Set|Overall Study||11
1545916|NCT01317004|3783515|P1|Safety Set|Overall Study||50
1545917|NCT01317004|3783514|P2|STARTED|Overall Study||14
1545918|NCT01317004|3783515|P1|STARTED|Overall Study||51
1545919|NCT01316939|3783536|P3|NOT COMPLETED|Overall Study||69
1545920|NCT01316939|3783537|P2|NOT COMPLETED|Overall Study||68
1545921|NCT01316939|3783538|P1|NOT COMPLETED|Overall Study||63
1545922|NCT01316939|3783536|P3|COMPLETED|Overall Study||7
1545923|NCT01316939|3783537|P2|COMPLETED|Overall Study||9
1545924|NCT01316939|3783538|P1|COMPLETED|Overall Study||13
1545925|NCT01316939|3783536|P3|STARTED|Overall Study||76
1545926|NCT01316939|3783537|P2|STARTED|Overall Study||77
1545927|NCT01316939|3783538|P1|STARTED|Overall Study||76
1545928|NCT01316926|3783618|P2|NOT COMPLETED|Period 2||0
1545929|NCT01316926|3783619|P1|NOT COMPLETED|Period 2||0
1545930|NCT01316926|3783618|P2|COMPLETED|Period 2||30
1545931|NCT01316926|3783619|P1|COMPLETED|Period 2||29
1545932|NCT01316926|3783618|P2|STARTED|Period 2||30
1545933|NCT01316926|3783619|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
1545934|NCT01316926|3783618|P2|NOT COMPLETED|Period 1||0
1545935|NCT01316926|3783619|P1|NOT COMPLETED|Period 1||0
1545936|NCT01316926|3783618|P2|COMPLETED|Period 1||30
1545937|NCT01316926|3783619|P1|COMPLETED|Period 1||30
1545938|NCT01316926|3783618|P2|STARTED|Period 1||30
1545939|NCT01316926|3783619|P1|STARTED|Period 1||30
1545940|NCT01316913|3783633|P4|NOT COMPLETED|Overall Study||39
1545941|NCT01316913|3783634|P3|NOT COMPLETED|Overall Study||49
1545942|NCT01316913|3783635|P2|NOT COMPLETED|Overall Study||54
1545943|NCT01316913|3783636|P1|NOT COMPLETED|Overall Study||57
1545944|NCT01316913|3783633|P4|COMPLETED|Overall Study||176
1545945|NCT01316913|3783634|P3|COMPLETED|Overall Study||166
1545946|NCT01316913|3783635|P2|COMPLETED|Overall Study||163
1545947|NCT01316913|3783636|P1|COMPLETED|Overall Study||165
1545948|NCT01316913|3783633|P4|STARTED|Overall Study||215
1545949|NCT01316913|3783634|P3|STARTED|Overall Study||215
1545950|NCT01316913|3783635|P2|STARTED|Overall Study||217
1545951|NCT01316913|3783636|P1|STARTED|Overall Study||222
1545952|NCT01316900|3783658|P4|NOT COMPLETED|Overall Study||31
1545953|NCT01316900|3783659|P3|NOT COMPLETED|Overall Study||41
1545954|NCT01316900|3783660|P2|NOT COMPLETED|Overall Study||31
1545955|NCT01316900|3783661|P1|NOT COMPLETED|Overall Study||44
1545956|NCT01316900|3783658|P4|COMPLETED|Overall Study||177
1545957|NCT01316900|3783659|P3|COMPLETED|Overall Study||173
1545958|NCT01316900|3783660|P2|COMPLETED|Overall Study||181
1545959|NCT01316900|3783661|P1|COMPLETED|Overall Study||165
1545960|NCT01316900|3783658|P4|STARTED|Overall Study||208
1545961|NCT01316900|3783659|P3|STARTED|Overall Study||214
1545962|NCT01316900|3783660|P2|STARTED|Overall Study||212
1545963|NCT01316900|3783661|P1|STARTED|Overall Study||209
1545964|NCT01316887|3783682|P3|NOT COMPLETED|Overall Study||83
1545965|NCT01316887|3783683|P2|NOT COMPLETED|Overall Study||94
1545966|NCT01316887|3783684|P1|NOT COMPLETED|Overall Study||43
1545967|NCT01316887|3783682|P3|COMPLETED|Overall Study||143
1545968|NCT01316887|3783683|P2|COMPLETED|Overall Study||133
1545969|NCT01316887|3783684|P1|COMPLETED|Overall Study||66
1545970|NCT01316887|3783682|P3|STARTED|Overall Study||226
1545971|NCT01316887|3783683|P2|STARTED|Overall Study||227
1545972|NCT01316887|3783684|P1|STARTED|Overall Study||109
1545973|NCT01316770|3783746|P2|NOT COMPLETED|Overall Study||0
1545974|NCT01316770|3783747|P1|NOT COMPLETED|Overall Study||0
1545975|NCT01316770|3783746|P2|COMPLETED|Overall Study||9
1545976|NCT01316770|3783747|P1|COMPLETED|Overall Study||9
1545977|NCT01316770|3783746|P2|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
1545978|NCT01316770|3783747|P1|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
1545979|NCT01316692|3783809|P1|NOT COMPLETED|Overall Study||12
1545980|NCT01316692|3783809|P1|COMPLETED|Overall Study||0
1545981|NCT01316692|3783809|P1|STARTED|Overall Study||12
1545982|NCT01316614|3783818|P1|NOT COMPLETED|Overall Study||37
1545983|NCT01316614|3783818|P1|COMPLETED|Overall Study||100
1545984|NCT01316614|3783818|P1|STARTED|Overall Study||137
1545985|NCT01316575|3783835|P2|NOT COMPLETED|Overall Study||1
1545986|NCT01316575|3783836|P1|NOT COMPLETED|Overall Study||2
1545987|NCT01316575|3783835|P2|COMPLETED|Overall Study||19
1545988|NCT01316575|3783836|P1|COMPLETED|Overall Study||18
1545989|NCT01316575|3783835|P2|STARTED|Overall Study||20
1545990|NCT01316575|3783836|P1|STARTED|Overall Study||20
1545991|NCT01316510|3783850|P2|NOT COMPLETED|Overall Study||0
1545992|NCT01316510|3783851|P1|NOT COMPLETED|Overall Study||0
1545993|NCT01316510|3783850|P2|COMPLETED|Overall Study||12
1545994|NCT01316510|3783851|P1|COMPLETED|Overall Study||12
1545995|NCT01316510|3783850|P2|STARTED|Overall Study||12
1545996|NCT01316510|3783851|P1|STARTED|Overall Study||12
1545997|NCT01316419|3783859|P1|NOT COMPLETED|Overall Study||265
1545998|NCT01316419|3783859|P1|COMPLETED|Overall Study||1824
1545999|NCT01316419|3783859|P1|STARTED|Overall Study||2089
1546000|NCT01316380|3783885|P3|NOT COMPLETED|Overall Study||3
1546001|NCT01316380|3783886|P2|NOT COMPLETED|Overall Study||5
1546002|NCT01316380|3783887|P1|NOT COMPLETED|Overall Study||2
1546003|NCT01316380|3783885|P3|COMPLETED|Overall Study||152
1546004|NCT01316380|3783886|P2|COMPLETED|Overall Study||149
1546005|NCT01316380|3783887|P1|COMPLETED|Overall Study||154
1546006|NCT01316380|3783885|P3|STARTED|Overall Study||155
1546007|NCT01316380|3783886|P2|STARTED|Overall Study||154
1546008|NCT01316380|3783887|P1|STARTED|Overall Study||156
1546009|NCT01316341|3783928|P3|NOT COMPLETED|Overall Study||0
1546010|NCT01316341|3783929|P2|NOT COMPLETED|Overall Study||0
1546011|NCT01316341|3783930|P1|NOT COMPLETED|Overall Study||0
1546012|NCT01316341|3783928|P3|COMPLETED|Overall Study||9
1546013|NCT01316341|3783929|P2|COMPLETED|Overall Study||9
1546014|NCT01316341|3783930|P1|COMPLETED|Overall Study||6
1546015|NCT01316341|3783928|P3|STARTED|Overall Study||9
1546016|NCT01316341|3783929|P2|STARTED|Overall Study||9
1546017|NCT01316341|3783930|P1|STARTED|Overall Study||6
1546018|NCT01316315|3783998|P2|NOT COMPLETED|Sequence 2||0
1546019|NCT01316315|3783999|P1|NOT COMPLETED|Sequence 2||0
1546020|NCT01316315|3783998|P2|COMPLETED|Sequence 2||7
1546021|NCT01316315|3783999|P1|COMPLETED|Sequence 2||7
1546022|NCT01316315|3783998|P2|STARTED|Sequence 2||7
1546023|NCT01316315|3783999|P1|STARTED|Sequence 2||7
1546024|NCT01316315|3783998|P2|NOT COMPLETED|Sequence 1||0
1546025|NCT01316315|3783999|P1|NOT COMPLETED|Sequence 1||0
1546026|NCT01316315|3783998|P2|COMPLETED|Sequence 1||7
1546027|NCT01316315|3783999|P1|COMPLETED|Sequence 1||7
1546028|NCT01316315|3783998|P2|STARTED|Sequence 1||7
1546029|NCT01316315|3783999|P1|STARTED|Sequence 1||7
1546030|NCT01316302|3784013|P2|NOT COMPLETED|Overall Study||11
1546031|NCT01316302|3784014|P1|NOT COMPLETED|Overall Study||10
1546032|NCT01316302|3784013|P2|COMPLETED|Overall Study||22
1546033|NCT01316302|3784014|P1|COMPLETED|Overall Study||20
1546034|NCT01316302|3784013|P2|STARTED|Overall Study||33
1546035|NCT01316302|3784014|P1|STARTED|Overall Study||30
1546036|NCT01316263|3784026|P2|NOT COMPLETED|Overall Study||0
1546037|NCT01316263|3784027|P1|NOT COMPLETED|Overall Study||0
1546038|NCT01316263|3784026|P2|COMPLETED|Overall Study||14
1546039|NCT01316263|3784027|P1|COMPLETED|Overall Study||7
1546040|NCT01316263|3784026|P2|Received Any Study Drug|Overall Study||14
1546041|NCT01316263|3784027|P1|Received Any Study Drug|Overall Study||7
1546042|NCT01316263|3784026|P2|STARTED|Overall Study||14
1546043|NCT01316263|3784027|P1|STARTED|Overall Study||7
1546044|NCT01316224|3784053|P1|NOT COMPLETED|Overall Study||10
1546045|NCT01316224|3784053|P1|COMPLETED|Overall Study||42
1546046|NCT01316224|3784053|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
1546047|NCT01316224|3784053|P1|Completed Visit 4 to Dermatologist|Overall Study||42
1546048|NCT01316224|3784053|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
1546049|NCT01316224|3784053|P1|Completed Visit 3 to Dermatologist|Overall Study||48
1546050|NCT01316224|3784053|P1|Completed Visit 2 to Dermatologist|Overall Study||51
1546051|NCT01316224|3784053|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
1546052|NCT01316224|3784053|P1|Completed Visit 1 to Dermatologist|Overall Study||52
1546053|NCT01316224|3784053|P1|STARTED|Overall Study||52
1546054|NCT01316055|3784070|P3|NOT COMPLETED|Overall Study||0
1546055|NCT01316055|3784071|P2|NOT COMPLETED|Overall Study||0
1546056|NCT01316055|3784072|P1|NOT COMPLETED|Overall Study||1
1546057|NCT01316055|3784070|P3|COMPLETED|Overall Study||12
1546058|NCT01316055|3784071|P2|COMPLETED|Overall Study||17
1546059|NCT01316055|3784072|P1|COMPLETED|Overall Study||12
1546060|NCT01316055|3784070|P3|STARTED|Overall Study||12
1546061|NCT01316055|3784071|P2|STARTED|Overall Study||17
1546062|NCT01316055|3784072|P1|STARTED|Overall Study||13
1546063|NCT01316042|3784088|P2|NOT COMPLETED|Overall Study||1
1546064|NCT01316042|3784089|P1|NOT COMPLETED|Overall Study||0
1546065|NCT01316042|3784088|P2|COMPLETED|Overall Study||1
1546066|NCT01316042|3784089|P1|COMPLETED|Overall Study||2
1546067|NCT01316042|3784088|P2|STARTED|Overall Study||2
1546068|NCT01316042|3784089|P1|STARTED|Overall Study||2
1546069|NCT01315873|3784095|P1|NOT COMPLETED|Overall Study||0
1546070|NCT01315873|3784095|P1|COMPLETED|Overall Study||24
1546071|NCT01315873|3784095|P1|STARTED|Overall Study||24
1546072|NCT01315847|3784103|P2|NOT COMPLETED|Part III, Period 2||0
1546073|NCT01315847|3784104|P1|NOT COMPLETED|Part III, Period 2||0
1546074|NCT01315847|3784103|P2|COMPLETED|Part III, Period 2||3
1546075|NCT01315847|3784104|P1|COMPLETED|Part III, Period 2||0
1546076|NCT01315847|3784103|P2|Received [11C]MK-4232|Part III, Period 2||3
1546077|NCT01315847|3784104|P1|Received [11C]MK-4232|Part III, Period 2||0
1546078|NCT01315847|3784103|P2|Received Telcagepant|Part III, Period 2||3
1546079|NCT01315847|3784104|P1|Received Telcagepant|Part III, Period 2||0
1546080|NCT01315847|3784103|P2|STARTED|Part III, Period 2||3
1546081|NCT01315847|3784104|P1|STARTED|Part III, Period 2||0
1546082|NCT01315847|3784103|P2|NOT COMPLETED|Part III, Period 1||1
1546083|NCT01315847|3784104|P1|NOT COMPLETED|Part III, Period 1||0
1546084|NCT01315847|3784103|P2|COMPLETED|Part III, Period 1||3
1546085|NCT01315847|3784104|P1|COMPLETED|Part III, Period 1||0
1546176|NCT01314872|3784288|P5|NOT COMPLETED|Period 2||0
1546086|NCT01315847|3784103|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
1546087|NCT01315847|3784104|P1|Received [11C]MK-4232|Part III, Period 1||0
1546088|NCT01315847|3784103|P2|Received Telcagepant|Part III, Period 1||4
1546089|NCT01315847|3784104|P1|Received Telcagepant|Part III, Period 1||0
1546090|NCT01315847|3784103|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
1546091|NCT01315847|3784104|P1|STARTED|Part III, Period 1||0
1546092|NCT01315847|3784103|P2|NOT COMPLETED|Part I, Period 2||0
1546093|NCT01315847|3784104|P1|NOT COMPLETED|Part I, Period 2||0
1546094|NCT01315847|3784103|P2|COMPLETED|Part I, Period 2||0
1546095|NCT01315847|3784104|P1|COMPLETED|Part I, Period 2||3
1546096|NCT01315847|3784103|P2|Received [11C]MK-4232|Part I, Period 2||0
1546097|NCT01315847|3784104|P1|Received [11C]MK-4232|Part I, Period 2||3
1546098|NCT01315847|3784103|P2|Received Telcagepant|Part I, Period 2||0
1546099|NCT01315847|3784104|P1|Received Telcagepant|Part I, Period 2||3
1546100|NCT01315847|3784103|P2|STARTED|Part I, Period 2||0
1546101|NCT01315847|3784104|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
1546102|NCT01315847|3784103|P2|NOT COMPLETED|Part I, Period 1||0
1546103|NCT01315847|3784104|P1|NOT COMPLETED|Part I, Period 1||3
1546104|NCT01315847|3784103|P2|COMPLETED|Part I, Period 1||0
1546105|NCT01315847|3784104|P1|COMPLETED|Part I, Period 1||2
1546106|NCT01315847|3784103|P2|Received [11C]MK-4232|Part I, Period 1||0
1546107|NCT01315847|3784104|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
1546108|NCT01315847|3784103|P2|Received Telcagepant|Part I, Period 1||0
1546109|NCT01315847|3784104|P1|Received Telcagepant|Part I, Period 1||5
1546110|NCT01315847|3784103|P2|STARTED|Part I, Period 1||0
1546111|NCT01315847|3784104|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
1546112|NCT01315665|3784118|P2|NOT COMPLETED|Overall Study||0
1546113|NCT01315665|3784119|P1|NOT COMPLETED|Overall Study||0
1546114|NCT01315665|3784118|P2|COMPLETED|Overall Study||5
1546115|NCT01315665|3784119|P1|COMPLETED|Overall Study||10
1546116|NCT01315665|3784118|P2|STARTED|Overall Study||5
1546117|NCT01315665|3784119|P1|STARTED|Overall Study||10
1546118|NCT01315574|3784135|P2|NOT COMPLETED|Overall Study||0
1546119|NCT01315574|3784136|P1|NOT COMPLETED|Overall Study||0
1546120|NCT01315574|3784135|P2|COMPLETED|Overall Study||7
1546121|NCT01315574|3784136|P1|COMPLETED|Overall Study||7
1546122|NCT01315574|3784135|P2|STARTED|Overall Study||7
1546123|NCT01315574|3784136|P1|STARTED|Overall Study||7
1546124|NCT01315353|3784149|P3|NOT COMPLETED|Overall Study||13
1546125|NCT01315353|3784150|P2|NOT COMPLETED|Overall Study||23
1546126|NCT01315353|3784151|P1|NOT COMPLETED|Overall Study||29
1546127|NCT01315353|3784149|P3|COMPLETED|Overall Study||166
1546128|NCT01315353|3784150|P2|COMPLETED|Overall Study||120
1546129|NCT01315353|3784151|P1|COMPLETED|Overall Study||116
1546130|NCT01315353|3784149|P3|STARTED|Overall Study||179
1546131|NCT01315353|3784150|P2|STARTED|Overall Study||143
1546132|NCT01315353|3784151|P1|STARTED|Overall Study||145
1546133|NCT01315249|3784178|P2|NOT COMPLETED|Overall Study||47
1546134|NCT01315249|3784179|P1|NOT COMPLETED|Overall Study||44
1546135|NCT01315249|3784178|P2|COMPLETED|Overall Study||217
1546136|NCT01315249|3784179|P1|COMPLETED|Overall Study||215
1546137|NCT01315249|3784178|P2|STARTED|Overall Study||264
1546138|NCT01315249|3784179|P1|STARTED|Overall Study||259
1546139|NCT01315158|3784207|P2|NOT COMPLETED|Overall Study||0
1546140|NCT01315158|3784208|P1|NOT COMPLETED|Overall Study||0
1546141|NCT01315158|3784207|P2|COMPLETED|Overall Study||19
1546142|NCT01315158|3784208|P1|COMPLETED|Overall Study||17
1546143|NCT01315158|3784207|P2|STARTED|Overall Study||19
1546144|NCT01315158|3784208|P1|STARTED|Overall Study||17
1546145|NCT01315145|3784232|P2|NOT COMPLETED|Overall Study||5
1546146|NCT01315145|3784233|P1|NOT COMPLETED|Overall Study||17
1546147|NCT01315145|3784232|P2|COMPLETED|Overall Study||11
1546148|NCT01315145|3784233|P1|COMPLETED|Overall Study||105
1546149|NCT01315145|3784232|P2|STARTED|Overall Study||16
1546150|NCT01315145|3784233|P1|STARTED|Overall Study||122
1546151|NCT01315028|3784241|P2|NOT COMPLETED|Overall Study||1
1546152|NCT01315028|3784242|P1|NOT COMPLETED|Overall Study||1
1546153|NCT01315028|3784241|P2|COMPLETED|Overall Study||9
1546154|NCT01315028|3784242|P1|COMPLETED|Overall Study||9
1546155|NCT01315028|3784241|P2|STARTED|Overall Study||10
1546156|NCT01315028|3784242|P1|STARTED|Overall Study||10
1546157|NCT01315002|3784254|P2|NOT COMPLETED|Overall Study||5
1546158|NCT01315002|3784255|P1|NOT COMPLETED|Overall Study||5
1546159|NCT01315002|3784254|P2|COMPLETED|Overall Study||55
1546160|NCT01315002|3784255|P1|COMPLETED|Overall Study||56
1546161|NCT01315002|3784254|P2|STARTED|Overall Study||60
1546162|NCT01315002|3784255|P1|STARTED|Overall Study||61
1546163|NCT01314963|3784261|P1|NOT COMPLETED|Overall Study||0
1546164|NCT01314963|3784261|P1|COMPLETED|Overall Study||50
1546165|NCT01314963|3784261|P1|STARTED|Overall Study||50
1546166|NCT01314872|3784278|P15|NOT COMPLETED|Period 2||24
1546167|NCT01314872|3784279|P14|NOT COMPLETED|Period 2||53
1546168|NCT01314872|3784280|P13|NOT COMPLETED|Period 2||60
1546169|NCT01314872|3784281|P12|NOT COMPLETED|Period 2||48
1546170|NCT01314872|3784282|P11|NOT COMPLETED|Period 2||0
1546171|NCT01314872|3784283|P10|NOT COMPLETED|Period 2||0
1546172|NCT01314872|3784284|P9|NOT COMPLETED|Period 2||0
1546173|NCT01314872|3784285|P8|NOT COMPLETED|Period 2||0
1546174|NCT01314872|3784286|P7|NOT COMPLETED|Period 2||0
1546175|NCT01314872|3784287|P6|NOT COMPLETED|Period 2||0
1546177|NCT01314872|3784289|P4|NOT COMPLETED|Period 2||0
1546178|NCT01314872|3784290|P3|NOT COMPLETED|Period 2||0
1546179|NCT01314872|3784291|P2|NOT COMPLETED|Period 2||0
1546180|NCT01314872|3784292|P1|NOT COMPLETED|Period 2||0
1546181|NCT01314872|3784278|P15|COMPLETED|Period 2||110
1546182|NCT01314872|3784279|P14|COMPLETED|Period 2||187
1546183|NCT01314872|3784280|P13|COMPLETED|Period 2||188
1546184|NCT01314872|3784281|P12|COMPLETED|Period 2||175
1546185|NCT01314872|3784282|P11|COMPLETED|Period 2||0
1546186|NCT01314872|3784283|P10|COMPLETED|Period 2||0
1546187|NCT01314872|3784284|P9|COMPLETED|Period 2||0
1546188|NCT01314872|3784285|P8|COMPLETED|Period 2||0
1546189|NCT01314872|3784286|P7|COMPLETED|Period 2||0
1546190|NCT01314872|3784287|P6|COMPLETED|Period 2||0
1546191|NCT01314872|3784288|P5|COMPLETED|Period 2||0
1546192|NCT01314872|3784289|P4|COMPLETED|Period 2||0
1546193|NCT01314872|3784290|P3|COMPLETED|Period 2||0
1546194|NCT01314872|3784291|P2|COMPLETED|Period 2||0
1546195|NCT01314872|3784292|P1|COMPLETED|Period 2||0
1546196|NCT01314872|3784278|P15|STARTED|Period 2||134
1546197|NCT01314872|3784279|P14|STARTED|Period 2||240
1546198|NCT01314872|3784280|P13|STARTED|Period 2||248
1546199|NCT01314872|3784281|P12|STARTED|Period 2||223
1546200|NCT01314872|3784282|P11|STARTED|Period 2||0
1546201|NCT01314872|3784283|P10|STARTED|Period 2||0
1546202|NCT01314872|3784284|P9|STARTED|Period 2||0
1546203|NCT01314872|3784285|P8|STARTED|Period 2||0
1546204|NCT01314872|3784286|P7|STARTED|Period 2||0
1546205|NCT01314872|3784287|P6|STARTED|Period 2||0
1546206|NCT01314872|3784288|P5|STARTED|Period 2||0
1546207|NCT01314872|3784289|P4|STARTED|Period 2||0
1546208|NCT01314872|3784290|P3|STARTED|Period 2||0
1546209|NCT01314872|3784291|P2|STARTED|Period 2||0
1546210|NCT01314872|3784292|P1|STARTED|Period 2||0
1546211|NCT01314872|3784278|P15|NOT COMPLETED|Treatment Period 1||0
1546212|NCT01314872|3784279|P14|NOT COMPLETED|Treatment Period 1||0
1546213|NCT01314872|3784280|P13|NOT COMPLETED|Treatment Period 1||0
1546214|NCT01314872|3784281|P12|NOT COMPLETED|Treatment Period 1||0
1546215|NCT01314872|3784282|P11|NOT COMPLETED|Treatment Period 1||3
1546216|NCT01314872|3784283|P10|NOT COMPLETED|Treatment Period 1||4
1546217|NCT01314872|3784284|P9|NOT COMPLETED|Treatment Period 1||6
1546218|NCT01314872|3784285|P8|NOT COMPLETED|Treatment Period 1||7
1546219|NCT01314872|3784286|P7|NOT COMPLETED|Treatment Period 1||8
1546220|NCT01314872|3784287|P6|NOT COMPLETED|Treatment Period 1||7
1546221|NCT01314872|3784288|P5|NOT COMPLETED|Treatment Period 1||7
1546222|NCT01314872|3784289|P4|NOT COMPLETED|Treatment Period 1||7
1546223|NCT01314872|3784290|P3|NOT COMPLETED|Treatment Period 1||6
1546224|NCT01314872|3784291|P2|NOT COMPLETED|Treatment Period 1||6
1546225|NCT01314872|3784292|P1|NOT COMPLETED|Treatment Period 1||10
1546226|NCT01314872|3784278|P15|COMPLETED|Treatment Period 1||0
1546227|NCT01314872|3784279|P14|COMPLETED|Treatment Period 1||0
1546228|NCT01314872|3784280|P13|COMPLETED|Treatment Period 1||0
1546229|NCT01314872|3784281|P12|COMPLETED|Treatment Period 1||0
1546230|NCT01314872|3784282|P11|COMPLETED|Treatment Period 1||107
1546231|NCT01314872|3784283|P10|COMPLETED|Treatment Period 1||118
1546232|NCT01314872|3784284|P9|COMPLETED|Treatment Period 1||106
1546233|NCT01314872|3784285|P8|COMPLETED|Treatment Period 1||57
1546234|NCT01314872|3784286|P7|COMPLETED|Treatment Period 1||126
1546235|NCT01314872|3784287|P6|COMPLETED|Treatment Period 1||128
1546236|NCT01314872|3784288|P5|COMPLETED|Treatment Period 1||142
1546237|NCT01314872|3784289|P4|COMPLETED|Treatment Period 1||143
1546238|NCT01314872|3784290|P3|COMPLETED|Treatment Period 1||128
1546239|NCT01314872|3784291|P2|COMPLETED|Treatment Period 1||138
1546240|NCT01314872|3784292|P1|COMPLETED|Treatment Period 1||131
1546241|NCT01314872|3784278|P15|STARTED|Treatment Period 1||0
1546242|NCT01314872|3784279|P14|STARTED|Treatment Period 1||0
1546243|NCT01314872|3784280|P13|STARTED|Treatment Period 1||0
1546244|NCT01314872|3784281|P12|STARTED|Treatment Period 1||0
1546245|NCT01314872|3784282|P11|STARTED|Treatment Period 1||110
1546246|NCT01314872|3784283|P10|STARTED|Treatment Period 1||122
1546247|NCT01314872|3784284|P9|STARTED|Treatment Period 1||112
1546248|NCT01314872|3784285|P8|STARTED|Treatment Period 1||64
1546249|NCT01314872|3784286|P7|STARTED|Treatment Period 1||134
1546250|NCT01314872|3784287|P6|STARTED|Treatment Period 1||135
1546251|NCT01314872|3784288|P5|STARTED|Treatment Period 1||149
1546252|NCT01314872|3784289|P4|STARTED|Treatment Period 1||150
1546253|NCT01314872|3784290|P3|STARTED|Treatment Period 1||134
1546254|NCT01314872|3784291|P2|STARTED|Treatment Period 1||144
1546255|NCT01314872|3784292|P1|STARTED|Treatment Period 1||141
1546256|NCT01314742|3784385|P2|NOT COMPLETED|Overall Study||0
1546257|NCT01314742|3784386|P1|NOT COMPLETED|Overall Study||0
1546258|NCT01314742|3784385|P2|COMPLETED|Overall Study||21
1546259|NCT01314742|3784386|P1|COMPLETED|Overall Study||20
1546260|NCT01314742|3784385|P2|STARTED|Overall Study||21
1546261|NCT01314742|3784386|P1|STARTED|Overall Study||20
1546262|NCT01314716|3784396|P2|NOT COMPLETED|Open-Label Phase||12
1546263|NCT01314716|3784397|P1|NOT COMPLETED|Open-Label Phase||10
1546264|NCT01314716|3784396|P2|COMPLETED|Open-Label Phase||98
1546265|NCT01314716|3784397|P1|COMPLETED|Open-Label Phase||102
1546266|NCT01314716|3784396|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
1546267|NCT01314716|3784397|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
1546268|NCT01314716|3784396|P2|NOT COMPLETED|Double-Blind Phase||15
1546269|NCT01314716|3784397|P1|NOT COMPLETED|Double-Blind Phase||17
1546270|NCT01314716|3784396|P2|COMPLETED|Double-Blind Phase||123
1546271|NCT01314716|3784397|P1|COMPLETED|Double-Blind Phase||119
1546272|NCT01314716|3784396|P2|Randomized and Treated|Double-Blind Phase||137
1546273|NCT01314716|3784397|P1|Randomized and Treated|Double-Blind Phase||135
1546274|NCT01314716|3784396|P2|STARTED|Double-Blind Phase||138
1546275|NCT01314716|3784397|P1|STARTED|Double-Blind Phase||136
1546276|NCT01314703|3784409|P1|NOT COMPLETED|Overall Study||8
1546277|NCT01314703|3784409|P1|COMPLETED|Overall Study||27
1546278|NCT01314703|3784409|P1|Discontinued When Enrollment Completed|Overall Study||3
1546279|NCT01314703|3784409|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
1546280|NCT01314703|3784409|P1|Excluded Prior to Screening Baseline|Overall Study||2
1546281|NCT01314703|3784409|P1|Completed Study|Overall Study||27
1546282|NCT01314703|3784409|P1|Completed Treatment Visit|Overall Study||27
1546283|NCT01314703|3784409|P1|Completed Screen Visit|Overall Study||33
1546284|NCT01314703|3784409|P1|Signed Informed Consent|Overall Study||35
1546285|NCT01314703|3784409|P1|STARTED|Overall Study||35
1546286|NCT01314443|3784418|P4|NOT COMPLETED|Overall Study||2
1546287|NCT01314443|3784419|P3|NOT COMPLETED|Overall Study||2
1546288|NCT01314443|3784420|P2|NOT COMPLETED|Overall Study||3
1546289|NCT01314443|3784421|P1|NOT COMPLETED|Overall Study||4
1546290|NCT01314443|3784418|P4|COMPLETED|Overall Study||13
1546291|NCT01314443|3784419|P3|COMPLETED|Overall Study||13
1546292|NCT01314443|3784420|P2|COMPLETED|Overall Study||16
1546293|NCT01314443|3784421|P1|COMPLETED|Overall Study||14
1546294|NCT01314443|3784418|P4|STARTED|Overall Study||15
1546295|NCT01314443|3784419|P3|STARTED|Overall Study||15
1546296|NCT01314443|3784420|P2|STARTED|Overall Study||19
1546297|NCT01314443|3784421|P1|STARTED|Overall Study||18
1546298|NCT01314417|3784439|P1|NOT COMPLETED|Overall Study||0
1546299|NCT01314417|3784439|P1|COMPLETED|Overall Study||2
1546300|NCT01314417|3784439|P1|STARTED|Overall Study||2
1546301|NCT01314313|3784470|P2|NOT COMPLETED|Overall Study||311
1546302|NCT01314313|3784471|P1|NOT COMPLETED|Overall Study||227
1546303|NCT01314313|3784470|P2|COMPLETED|Overall Study||710
1546304|NCT01314313|3784471|P1|COMPLETED|Overall Study||784
1546305|NCT01314313|3784470|P2|Valve Implanted|Overall Study||936
1546306|NCT01314313|3784471|P1|Valve Implanted|Overall Study||974
1546307|NCT01314313|3784470|P2|As Treated|Overall Study||944
1546308|NCT01314313|3784471|P1|As Treated|Overall Study||994
1546309|NCT01314313|3784470|P2|STARTED|Overall Study||1021
1546310|NCT01314313|3784471|P1|STARTED|Overall Study||1011
1546311|NCT01314261|3784491|P4|NOT COMPLETED|Overall Study||3
1546312|NCT01314261|3784492|P3|NOT COMPLETED|Overall Study||3
1546313|NCT01314261|3784493|P2|NOT COMPLETED|Overall Study||4
1546314|NCT01314261|3784494|P1|NOT COMPLETED|Overall Study||2
1546315|NCT01314261|3784491|P4|COMPLETED|Overall Study||6
1546316|NCT01314261|3784492|P3|COMPLETED|Overall Study||7
1546317|NCT01314261|3784493|P2|COMPLETED|Overall Study||5
1546318|NCT01314261|3784494|P1|COMPLETED|Overall Study||7
1546319|NCT01314261|3784491|P4|Discontinued pegIFN/RBV|Overall Study||1
1546320|NCT01314261|3784492|P3|Discontinued pegIFN/RBV|Overall Study||5
1546321|NCT01314261|3784493|P2|Discontinued pegIFN/RBV|Overall Study||4
1546322|NCT01314261|3784494|P1|Discontinued pegIFN/RBV|Overall Study||1
1546323|NCT01314261|3784491|P4|Discontinued ABT-267 or Placebo|Overall Study||0
1546324|NCT01314261|3784492|P3|Discontinued ABT-267 or Placebo|Overall Study||1
1546325|NCT01314261|3784493|P2|Discontinued ABT-267 or Placebo|Overall Study||0
1546326|NCT01314261|3784494|P1|Discontinued ABT-267 or Placebo|Overall Study||1
1546327|NCT01314261|3784491|P4|STARTED|Overall Study||9
1546328|NCT01314261|3784492|P3|STARTED|Overall Study||10
1546329|NCT01314261|3784493|P2|STARTED|Overall Study||9
1546330|NCT01314261|3784494|P1|STARTED|Overall Study||9
1546331|NCT01314118|3784545|P1|NOT COMPLETED|Overall Study||131
1546332|NCT01314118|3784545|P1|COMPLETED|Overall Study||0
1546333|NCT01314118|3784545|P1|STARTED|Overall Study||131
1546334|NCT01314105|3784554|P2|NOT COMPLETED|Overall Study||12
1546335|NCT01314105|3784555|P1|NOT COMPLETED|Overall Study||7
1546336|NCT01314105|3784554|P2|COMPLETED|Overall Study||0
1546337|NCT01314105|3784555|P1|COMPLETED|Overall Study||0
1546338|NCT01314105|3784554|P2|STARTED|Overall Study||12
1546339|NCT01314105|3784555|P1|STARTED|Overall Study||7
1546340|NCT01314014|3784597|P1|NOT COMPLETED|Overall Study||0
1546341|NCT01314014|3784597|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
1546342|NCT01314014|3784597|P1|STARTED|Overall Study||22
1546343|NCT01314001|3784608|P6|NOT COMPLETED|Overall Study||71
1546344|NCT01314001|3784609|P5|NOT COMPLETED|Overall Study||72
1546345|NCT01314001|3784610|P4|NOT COMPLETED|Overall Study||69
1546346|NCT01314001|3784611|P3|NOT COMPLETED|Overall Study||69
1546347|NCT01314001|3784612|P2|NOT COMPLETED|Overall Study||69
1546348|NCT01314001|3784613|P1|NOT COMPLETED|Overall Study||75
1546349|NCT01314001|3784608|P6|COMPLETED|Overall Study||129
1546350|NCT01314001|3784609|P5|COMPLETED|Overall Study||148
1546351|NCT01314001|3784610|P4|COMPLETED|Overall Study||122
1546352|NCT01314001|3784611|P3|COMPLETED|Overall Study||158
1546353|NCT01314001|3784612|P2|COMPLETED|Overall Study||124
1546354|NCT01314001|3784613|P1|COMPLETED|Overall Study||140
1546355|NCT01314001|3784608|P6|6-Month Follow Up Survey|Overall Study||139
1546356|NCT01314001|3784609|P5|6-Month Follow Up Survey|Overall Study||157
1546357|NCT01314001|3784610|P4|6-Month Follow Up Survey|Overall Study||135
1546358|NCT01314001|3784611|P3|6-Month Follow Up Survey|Overall Study||165
1546359|NCT01314001|3784612|P2|6-Month Follow Up Survey|Overall Study||137
1546360|NCT01314001|3784613|P1|6-Month Follow Up Survey|Overall Study||146
1546361|NCT01314001|3784608|P6|End-of-Treatment Visit|Overall Study||160
1546362|NCT01314001|3784609|P5|End-of-Treatment Visit|Overall Study||174
1546363|NCT01314001|3784610|P4|End-of-Treatment Visit|Overall Study||146
1546364|NCT01314001|3784611|P3|End-of-Treatment Visit|Overall Study||179
1546365|NCT01314001|3784612|P2|End-of-Treatment Visit|Overall Study||141
1546366|NCT01314001|3784613|P1|End-of-Treatment Visit|Overall Study||156
1546367|NCT01314001|3784608|P6|STARTED|Overall Study||200
1546368|NCT01314001|3784609|P5|STARTED|Overall Study||220
1546369|NCT01314001|3784610|P4|STARTED|Overall Study||191
1546370|NCT01314001|3784611|P3|STARTED|Overall Study||227
1546371|NCT01314001|3784612|P2|STARTED|Overall Study||193
1546372|NCT01314001|3784613|P1|STARTED|Overall Study||215
1546373|NCT01313936|3784659|P2|NOT COMPLETED|Overall Study||0
1546374|NCT01313936|3784660|P1|NOT COMPLETED|Overall Study||0
1546375|NCT01313936|3784659|P2|COMPLETED|Overall Study||26
1546376|NCT01313936|3784660|P1|COMPLETED|Overall Study||6
1546377|NCT01313936|3784659|P2|STARTED|Overall Study||26
1546378|NCT01313936|3784660|P1|STARTED|Overall Study||6
1546379|NCT01313923|3784668|P1|NOT COMPLETED|Overall Study||3
1546380|NCT01313923|3784668|P1|COMPLETED|Overall Study||0
1546381|NCT01313923|3784668|P1|STARTED|Overall Study||3
1546382|NCT01313910|3784672|P1|NOT COMPLETED|Overall Study||0
1546383|NCT01313910|3784672|P1|COMPLETED|Overall Study||8
1546384|NCT01313910|3784672|P1|STARTED|Overall Study||8
1546385|NCT01313897|3784680|P1|NOT COMPLETED|Overall Study||2
1546386|NCT01313897|3784680|P1|COMPLETED|Overall Study||8
1546387|NCT01313897|3784680|P1|STARTED|Overall Study||10
1546388|NCT01313884|3784684|P1|NOT COMPLETED|Overall Study||1
1546389|NCT01313884|3784684|P1|COMPLETED|Overall Study||2
1546390|NCT01313884|3784684|P1|STARTED|Overall Study||3
1546391|NCT01313858|3784692|P3|NOT COMPLETED|Overall Study||238
1546392|NCT01313858|3784693|P2|NOT COMPLETED|Overall Study||270
1546393|NCT01313858|3784694|P1|NOT COMPLETED|Overall Study||286
1546394|NCT01313858|3784692|P3|COMPLETED|Overall Study||305
1546395|NCT01313858|3784693|P2|COMPLETED|Overall Study||276
1546396|NCT01313858|3784694|P1|COMPLETED|Overall Study||238
1546397|NCT01313858|3784692|P3|STARTED|Overall Study||543
1546398|NCT01313858|3784693|P2|STARTED|Overall Study||546
1546399|NCT01313858|3784694|P1|STARTED|Overall Study||524
1546400|NCT01313780|3784717|P2|NOT COMPLETED|Overall Study||28
1546401|NCT01313780|3784718|P1|NOT COMPLETED|Overall Study||25
1546402|NCT01313780|3784717|P2|COMPLETED|Overall Study|PPS|31
1546403|NCT01313780|3784718|P1|COMPLETED|Overall Study|PPS|33
1546404|NCT01313780|3784717|P2|STARTED|Overall Study|FAS|59
1546405|NCT01313780|3784718|P1|STARTED|Overall Study|FAS|58
1546406|NCT01313728|3784726|P1|NOT COMPLETED|Baseline to Completion||0
1546407|NCT01313728|3784726|P1|COMPLETED|Baseline to Completion||25
1546408|NCT01313728|3784726|P1|STARTED|Baseline to Completion||25
1546409|NCT01313728|3784726|P1|NOT COMPLETED|Informed Consent to Baseline||1
1546410|NCT01313728|3784726|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
1546411|NCT01313728|3784726|P1|STARTED|Informed Consent to Baseline||26
1546412|NCT01313689|3784746|P5|NOT COMPLETED|24-Week Randomization 2||15
1546413|NCT01313689|3784747|P4|NOT COMPLETED|24-Week Randomization 2||1
1546414|NCT01313689|3784748|P3|NOT COMPLETED|24-Week Randomization 2||3
1546415|NCT01313689|3784749|P2|NOT COMPLETED|24-Week Randomization 2||0
1546416|NCT01313689|3784750|P1|NOT COMPLETED|24-Week Randomization 2||0
1546417|NCT01313689|3784746|P5|COMPLETED|24-Week Randomization 2||27
1546418|NCT01313689|3784747|P4|COMPLETED|24-Week Randomization 2||12
1546419|NCT01313689|3784748|P3|COMPLETED|24-Week Randomization 2||21
1546420|NCT01313689|3784749|P2|COMPLETED|24-Week Randomization 2||0
1546421|NCT01313689|3784750|P1|COMPLETED|24-Week Randomization 2||0
1546422|NCT01313689|3784746|P5|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
1546423|NCT01313689|3784747|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
1546424|NCT01313689|3784748|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
1546425|NCT01313689|3784749|P2|STARTED|24-Week Randomization 2||0
1546426|NCT01313689|3784750|P1|STARTED|24-Week Randomization 2||0
1546427|NCT01313689|3784746|P5|NOT COMPLETED|24-Week Randomization 1||0
1546428|NCT01313689|3784747|P4|NOT COMPLETED|24-Week Randomization 1||0
1546429|NCT01313689|3784748|P3|NOT COMPLETED|24-Week Randomization 1||0
1546430|NCT01313689|3784749|P2|NOT COMPLETED|24-Week Randomization 1||10
1546431|NCT01313689|3784750|P1|NOT COMPLETED|24-Week Randomization 1||19
1546432|NCT01313689|3784746|P5|COMPLETED|24-Week Randomization 1||0
1546433|NCT01313689|3784747|P4|COMPLETED|24-Week Randomization 1||0
1546434|NCT01313689|3784748|P3|COMPLETED|24-Week Randomization 1||0
1546435|NCT01313689|3784749|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
1546436|NCT01313689|3784750|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
1546437|NCT01313689|3784746|P5|STARTED|24-Week Randomization 1||0
1546438|NCT01313689|3784747|P4|STARTED|24-Week Randomization 1||0
1546439|NCT01313689|3784748|P3|STARTED|24-Week Randomization 1||0
1546440|NCT01313689|3784749|P2|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
1546441|NCT01313689|3784750|P1|STARTED|24-Week Randomization 1||79
1546442|NCT01313676|3784829|P4|NOT COMPLETED|Overall Study||994
1546443|NCT01313676|3784830|P3|NOT COMPLETED|Overall Study||1088
1546444|NCT01313676|3784831|P2|NOT COMPLETED|Overall Study||1113
1546445|NCT01313676|3784832|P1|NOT COMPLETED|Overall Study||1250
1546446|NCT01313676|3784829|P4|COMPLETED|Overall Study||3146
1546447|NCT01313676|3784830|P3|COMPLETED|Overall Study||3052
1546448|NCT01313676|3784831|P2|COMPLETED|Overall Study||3044
1546449|NCT01313676|3784832|P1|COMPLETED|Overall Study||2881
1546450|NCT01313676|3784829|P4|STARTED|Overall Study||4140
1546451|NCT01313676|3784830|P3|STARTED|Overall Study||4140
1546452|NCT01313676|3784831|P2|STARTED|Overall Study||4157
1546453|NCT01313676|3784832|P1|STARTED|Overall Study||4131
1546454|NCT01313663|3784852|P2|NOT COMPLETED|Overall Study||8
1546455|NCT01313663|3784853|P1|NOT COMPLETED|Overall Study||4
1546456|NCT01313663|3784852|P2|COMPLETED|Overall Study||3
1546457|NCT01313663|3784853|P1|COMPLETED|Overall Study||5
1546458|NCT01313663|3784852|P2|STARTED|Overall Study||11
1546459|NCT01313663|3784853|P1|STARTED|Overall Study||9
1546460|NCT01313650|3784891|P4|NOT COMPLETED|Overall Study||81
1546461|NCT01313650|3784892|P3|NOT COMPLETED|Overall Study||103
1546462|NCT01313650|3784893|P2|NOT COMPLETED|Overall Study||94
1546463|NCT01313650|3784894|P1|NOT COMPLETED|Overall Study||76
1546464|NCT01313650|3784891|P4|COMPLETED|Overall Study||332
1546465|NCT01313650|3784892|P3|COMPLETED|Overall Study||318
1546466|NCT01313650|3784893|P2|COMPLETED|Overall Study||324
1546467|NCT01313650|3784894|P1|COMPLETED|Overall Study||204
1546468|NCT01313650|3784891|P4|STARTED|Overall Study||413
1546469|NCT01313650|3784892|P3|STARTED|Overall Study||421
1546470|NCT01313650|3784893|P2|STARTED|Overall Study||418
1546471|NCT01313650|3784894|P1|STARTED|Overall Study||280
1546472|NCT01313637|3784920|P4|NOT COMPLETED|Overall Study||78
1546473|NCT01313637|3784921|P3|NOT COMPLETED|Overall Study||106
1546474|NCT01313637|3784922|P2|NOT COMPLETED|Overall Study||95
1546475|NCT01313637|3784923|P1|NOT COMPLETED|Overall Study||92
1546476|NCT01313637|3784920|P4|COMPLETED|Overall Study||325
1546477|NCT01313637|3784921|P3|COMPLETED|Overall Study||298
1546478|NCT01313637|3784922|P2|COMPLETED|Overall Study||312
1546479|NCT01313637|3784923|P1|COMPLETED|Overall Study||183
1546480|NCT01313637|3784920|P4|STARTED|Overall Study||403
1546481|NCT01313637|3784921|P3|STARTED|Overall Study||404
1546482|NCT01313637|3784922|P2|STARTED|Overall Study||407
1546483|NCT01313637|3784923|P1|STARTED|Overall Study||275
1546484|NCT01313624|3784947|P2|NOT COMPLETED|Open-Label Phase||13
1546485|NCT01313624|3784948|P1|NOT COMPLETED|Open-Label Phase||4
1546486|NCT01313624|3784947|P2|COMPLETED|Open-Label Phase||109
1546487|NCT01313624|3784948|P1|COMPLETED|Open-Label Phase||92
1546488|NCT01313624|3784947|P2|STARTED|Open-Label Phase||122
1546489|NCT01313624|3784948|P1|STARTED|Open-Label Phase||96
1546490|NCT01313624|3784947|P2|NOT COMPLETED|Double-Blind Phase||10
1546491|NCT01313624|3784948|P1|NOT COMPLETED|Double-Blind Phase||38
1546492|NCT01313624|3784947|P2|COMPLETED|Double-Blind Phase||122
1546493|NCT01313624|3784948|P1|COMPLETED|Double-Blind Phase||96
1546494|NCT01313624|3784947|P2|STARTED|Double-Blind Phase||132
1546495|NCT01313624|3784948|P1|STARTED|Double-Blind Phase||134
1546496|NCT01313559|3784962|P2|NOT COMPLETED|Overall Study||2
1546497|NCT01313559|3784963|P1|NOT COMPLETED|Overall Study||4
1546498|NCT01313559|3784962|P2|COMPLETED|Overall Study||0
1546499|NCT01313559|3784963|P1|COMPLETED|Overall Study||0
1546500|NCT01313559|3784962|P2|STARTED|Overall Study||2
1546501|NCT01313559|3784963|P1|STARTED|Overall Study||4
1546502|NCT01313520|3784977|P2|NOT COMPLETED|Overall Study||0
1546503|NCT01313520|3784978|P1|NOT COMPLETED|Overall Study||0
1546504|NCT01313520|3784977|P2|COMPLETED|Overall Study||31
1546505|NCT01313520|3784978|P1|COMPLETED|Overall Study||30
1546506|NCT01313520|3784977|P2|STARTED|Overall Study||31
1546507|NCT01313520|3784978|P1|STARTED|Overall Study||30
1546508|NCT01313507|3784998|P1|NOT COMPLETED|Overall Study||0
1546509|NCT01313507|3784998|P1|COMPLETED|Overall Study||21
1546510|NCT01313507|3784998|P1|STARTED|Overall Study||21
1546511|NCT01313494|3785006|P2|NOT COMPLETED|Overall Study||50
1546512|NCT01313494|3785007|P1|NOT COMPLETED|Overall Study||67
1546513|NCT01313494|3785006|P2|COMPLETED|Overall Study||263
1546514|NCT01313494|3785007|P1|COMPLETED|Overall Study||246
1546515|NCT01313494|3785006|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
1546516|NCT01313494|3785007|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
1546517|NCT01313494|3785006|P2|STARTED|Overall Study||313
1546518|NCT01313494|3785007|P1|STARTED|Overall Study||313
1546519|NCT01313312|3785059|P1|NOT COMPLETED|Overall Study||36
1546520|NCT01313312|3785059|P1|COMPLETED|Overall Study||222
1546521|NCT01313312|3785059|P1|Cycle 5|Overall Study||11
1546522|NCT01313312|3785059|P1|Cycle 4|Overall Study||81
1546523|NCT01313312|3785059|P1|Cycle 3|Overall Study||175
1546524|NCT01313312|3785059|P1|Cycle 2|Overall Study||229
1546525|NCT01313312|3785059|P1|Cycle 1|Overall Study||254
1546526|NCT01313312|3785059|P1|STARTED|Overall Study||258
1546527|NCT01313299|3785106|P3|NOT COMPLETED|Overall Study||4
1546528|NCT01313299|3785107|P2|NOT COMPLETED|Overall Study||3
1546529|NCT01313299|3785108|P1|NOT COMPLETED|Overall Study||7
1546530|NCT01313299|3785106|P3|COMPLETED|Overall Study||77
1546531|NCT01313299|3785107|P2|COMPLETED|Overall Study||78
1546532|NCT01313299|3785108|P1|COMPLETED|Overall Study||74
1546533|NCT01313299|3785106|P3|STARTED|Overall Study||81
1546534|NCT01313299|3785107|P2|STARTED|Overall Study||81
1546535|NCT01313299|3785108|P1|STARTED|Overall Study||81
1546536|NCT01313286|3785122|P2|NOT COMPLETED|Period 2||0
1546537|NCT01313286|3785123|P1|NOT COMPLETED|Period 2||0
1546538|NCT01313286|3785122|P2|COMPLETED|Period 2||8
1546539|NCT01313286|3785123|P1|COMPLETED|Period 2||6
1546540|NCT01313286|3785122|P2|STARTED|Period 2||8
1546541|NCT01313286|3785123|P1|STARTED|Period 2||6
1546542|NCT01313286|3785122|P2|NOT COMPLETED|Period 1||0
1546543|NCT01313286|3785123|P1|NOT COMPLETED|Period 1||2
1546544|NCT01313286|3785122|P2|COMPLETED|Period 1||8
1546545|NCT01313286|3785123|P1|COMPLETED|Period 1||6
1546546|NCT01313286|3785122|P2|STARTED|Period 1||8
1546547|NCT01313286|3785123|P1|STARTED|Period 1||8
1546548|NCT01313273|3785133|P2|NOT COMPLETED|Overall Study||1
1546549|NCT01313273|3785134|P1|NOT COMPLETED|Overall Study||2
1546550|NCT01313273|3785133|P2|COMPLETED|Overall Study||0
1546551|NCT01313273|3785134|P1|COMPLETED|Overall Study||0
1546552|NCT01313273|3785133|P2|STARTED|Overall Study||1
1546553|NCT01313273|3785134|P1|STARTED|Overall Study||2
1546554|NCT01313221|3785149|P3|NOT COMPLETED|Overall Study||23
1546555|NCT01313221|3785150|P2|NOT COMPLETED|Overall Study||8
1546556|NCT01313221|3785151|P1|NOT COMPLETED|Overall Study||12
1546557|NCT01313221|3785149|P3|COMPLETED|Overall Study||0
1546558|NCT01313221|3785150|P2|COMPLETED|Overall Study||135
1546559|NCT01313221|3785151|P1|COMPLETED|Overall Study||132
1546560|NCT01313221|3785149|P3|Randomized|Overall Study||0
1546561|NCT01313221|3785150|P2|Randomized|Overall Study||143
1546562|NCT01313221|3785151|P1|Randomized|Overall Study||144
1546563|NCT01313221|3785149|P3|STARTED|Overall Study||23
1546564|NCT01313221|3785150|P2|STARTED|Overall Study||143
1546565|NCT01313221|3785151|P1|STARTED|Overall Study||144
1546566|NCT01313208|3785203|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
1546567|NCT01313208|3785204|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
1546568|NCT01313208|3785203|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
1546569|NCT01313208|3785204|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
1546570|NCT01313208|3785203|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
1546571|NCT01313208|3785204|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
1546572|NCT01313208|3785203|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
1546573|NCT01313208|3785204|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
1546574|NCT01313208|3785203|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
1546575|NCT01313208|3785204|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
1546576|NCT01313208|3785203|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
1546577|NCT01313208|3785204|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
1546578|NCT01313182|3785294|P2|NOT COMPLETED|Overall Study||92
1546579|NCT01313182|3785295|P1|NOT COMPLETED|Overall Study||66
1546580|NCT01313182|3785294|P2|COMPLETED|Overall Study||763
1546581|NCT01313182|3785295|P1|COMPLETED|Overall Study||776
1546582|NCT01313182|3785294|P2|STARTED|Overall Study||855
1546583|NCT01313182|3785295|P1|STARTED|Overall Study||842
1546584|NCT01313117|3785301|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
1546585|NCT01313117|3785301|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
1546586|NCT01313117|3785301|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
1546587|NCT01313117|3785301|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
1546588|NCT01313117|3785301|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
1546589|NCT01313117|3785301|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
1546590|NCT01313117|3785301|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
1546591|NCT01313117|3785301|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
1546592|NCT01313117|3785301|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
1546593|NCT01313117|3785301|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
1546594|NCT01313117|3785301|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
1546595|NCT01313117|3785301|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
1546596|NCT01313117|3785301|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
1546597|NCT01313117|3785301|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
1546598|NCT01313117|3785301|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
1546599|NCT01313078|3785308|P1|NOT COMPLETED|Overall Study||3
1546600|NCT01313078|3785308|P1|COMPLETED|Overall Study||1
1546601|NCT01313078|3785308|P1|STARTED|Overall Study||4
1546602|NCT01313039|3785313|P1|NOT COMPLETED|Overall Study||2
1546603|NCT01313039|3785313|P1|COMPLETED|Overall Study||2
1546604|NCT01313039|3785313|P1|STARTED|Overall Study||4
1546605|NCT01312961|3785319|P2|NOT COMPLETED|Overall Study||7
1546606|NCT01312961|3785320|P1|NOT COMPLETED|Overall Study||17
1546607|NCT01312961|3785319|P2|COMPLETED|Overall Study||45
1546608|NCT01312961|3785320|P1|COMPLETED|Overall Study||35
1546609|NCT01312961|3785319|P2|Treated|Overall Study||52
1546610|NCT01312961|3785320|P1|Treated|Overall Study||52
1546611|NCT01312961|3785319|P2|STARTED|Overall Study||52
1546612|NCT01312961|3785320|P1|STARTED|Overall Study||52
1546613|NCT01312948|3785346|P1|NOT COMPLETED|Overall Study||0
1546614|NCT01312948|3785346|P1|COMPLETED|Overall Study||6
1546615|NCT01312948|3785346|P1|STARTED|Overall Study||6
1546616|NCT01312909|3785356|P3|NOT COMPLETED|Overall Study||47
1546617|NCT01312909|3785357|P2|NOT COMPLETED|Overall Study||36
1546618|NCT01312909|3785358|P1|NOT COMPLETED|Overall Study||42
1546619|NCT01312909|3785356|P3|COMPLETED|Overall Study||53
1546620|NCT01312909|3785357|P2|COMPLETED|Overall Study||67
1546621|NCT01312909|3785358|P1|COMPLETED|Overall Study||67
1546622|NCT01312909|3785356|P3|Treated|Overall Study||99
1546623|NCT01312909|3785357|P2|Treated|Overall Study||100
1546624|NCT01312909|3785358|P1|Treated|Overall Study||108
1546625|NCT01312909|3785356|P3|STARTED|Overall Study||100
1546626|NCT01312909|3785357|P2|STARTED|Overall Study||103
1546627|NCT01312909|3785358|P1|STARTED|Overall Study||109
1546628|NCT01312844|3785407|P2|NOT COMPLETED|Overall Study||0
1546629|NCT01312844|3785408|P1|NOT COMPLETED|Overall Study||0
1546630|NCT01312844|3785407|P2|COMPLETED|Overall Study||3
1546631|NCT01312844|3785408|P1|COMPLETED|Overall Study||4
1546632|NCT01312844|3785407|P2|STARTED|Overall Study||3
1546633|NCT01312844|3785408|P1|STARTED|Overall Study||4
1546634|NCT01312818|3785430|P1|NOT COMPLETED|Overall Study||0
1546635|NCT01312818|3785430|P1|COMPLETED|Overall Study||2
1546636|NCT01312818|3785430|P1|STARTED|Overall Study||2
1546637|NCT01312805|3785438|P2|NOT COMPLETED|Overall Study||0
1546638|NCT01312805|3785439|P1|NOT COMPLETED|Overall Study||0
1546639|NCT01312805|3785438|P2|COMPLETED|Overall Study||1082
1546640|NCT01312805|3785439|P1|COMPLETED|Overall Study||1016
1546641|NCT01312805|3785438|P2|STARTED|Overall Study||1082
1546642|NCT01312805|3785439|P1|STARTED|Overall Study||1016
1546643|NCT01312766|3785447|P2|NOT COMPLETED|Overall Study||5
1546644|NCT01312766|3785448|P1|NOT COMPLETED|Overall Study||6
1546645|NCT01312766|3785447|P2|COMPLETED|Overall Study||130
1546646|NCT01312766|3785448|P1|COMPLETED|Overall Study||129
1546647|NCT01312766|3785447|P2|STARTED|Overall Study||135
1546648|NCT01312766|3785448|P1|STARTED|Overall Study||135
1546649|NCT01312675|3785480|P2|NOT COMPLETED|Overall Study||0
1546650|NCT01312675|3785481|P1|NOT COMPLETED|Overall Study||0
1546651|NCT01312675|3785480|P2|COMPLETED|Overall Study||7
1546652|NCT01312675|3785481|P1|COMPLETED|Overall Study||9
1546653|NCT01312675|3785480|P2|STARTED|Overall Study||7
1546654|NCT01312675|3785481|P1|STARTED|Overall Study||9
1546655|NCT01312519|3785489|P2|NOT COMPLETED|Overall Study||0
1546656|NCT01312519|3785490|P1|NOT COMPLETED|Overall Study||0
1546657|NCT01312519|3785489|P2|COMPLETED|Overall Study||24
1546658|NCT01312519|3785490|P1|COMPLETED|Overall Study||26
1546659|NCT01312519|3785489|P2|STARTED|Overall Study||24
1546660|NCT01312519|3785490|P1|STARTED|Overall Study||26
1546661|NCT01312467|3785498|P1|NOT COMPLETED|Overall Study||13
1546662|NCT01312467|3785498|P1|COMPLETED|Overall Study||32
1546663|NCT01312467|3785498|P1|STARTED|Overall Study||45
1546664|NCT01312428|3785507|P2|NOT COMPLETED|Overall Study||4
1546665|NCT01312428|3785508|P1|NOT COMPLETED|Overall Study||3
1546666|NCT01312428|3785507|P2|COMPLETED|Overall Study||0
1546667|NCT01312428|3785508|P1|COMPLETED|Overall Study||0
1546668|NCT01312428|3785507|P2|STARTED|Overall Study||4
1546669|NCT01312428|3785508|P1|STARTED|Overall Study||3
1546670|NCT01312272|3785518|P2|NOT COMPLETED|Overall Study||1
1546671|NCT01312272|3785519|P1|NOT COMPLETED|Overall Study||0
1546672|NCT01312272|3785518|P2|COMPLETED|Overall Study||11
1546673|NCT01312272|3785519|P1|COMPLETED|Overall Study||12
1546674|NCT01312272|3785518|P2|STARTED|Overall Study||12
1546675|NCT01312272|3785519|P1|STARTED|Overall Study||12
1546676|NCT01312181|3785538|P3|NOT COMPLETED|Overall Study||8
1546677|NCT01312181|3785539|P2|NOT COMPLETED|Overall Study||6
1546678|NCT01312181|3785540|P1|NOT COMPLETED|Overall Study||2
1546679|NCT01312181|3785538|P3|COMPLETED|Overall Study||75
1546680|NCT01312181|3785539|P2|COMPLETED|Overall Study||71
1546681|NCT01312181|3785540|P1|COMPLETED|Overall Study||78
1546682|NCT01312181|3785538|P3|STARTED|Overall Study||83
1546683|NCT01312181|3785539|P2|STARTED|Overall Study||77
1546684|NCT01312181|3785540|P1|STARTED|Overall Study||80
1546685|NCT01312129|3785553|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
1546686|NCT01312129|3785554|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
1546687|NCT01312129|3785553|P2|COMPLETED|Second Intervention (24 Hours)||6
1546688|NCT01312129|3785554|P1|COMPLETED|Second Intervention (24 Hours)||6
1546689|NCT01312129|3785553|P2|Alcohol Cue|Second Intervention (24 Hours)||6
1546690|NCT01312129|3785554|P1|Alcohol Cue|Second Intervention (24 Hours)||6
1546691|NCT01312129|3785553|P2|Control Cue|Second Intervention (24 Hours)||6
1546692|NCT01312129|3785554|P1|Control Cue|Second Intervention (24 Hours)||6
1546693|NCT01312129|3785553|P2|STARTED|Second Intervention (24 Hours)||7
1546694|NCT01312129|3785554|P1|STARTED|Second Intervention (24 Hours)||6
1546695|NCT01312129|3785553|P2|NOT COMPLETED|Washout (1 Week)||0
1546696|NCT01312129|3785554|P1|NOT COMPLETED|Washout (1 Week)||0
1546697|NCT01312129|3785553|P2|COMPLETED|Washout (1 Week)||7
1546698|NCT01312129|3785554|P1|COMPLETED|Washout (1 Week)||6
1546699|NCT01312129|3785553|P2|STARTED|Washout (1 Week)||7
1546700|NCT01312129|3785554|P1|STARTED|Washout (1 Week)||6
1546701|NCT01312129|3785553|P2|NOT COMPLETED|First Intervention (24 Hours)||0
1546702|NCT01312129|3785554|P1|NOT COMPLETED|First Intervention (24 Hours)||0
1546703|NCT01312129|3785553|P2|COMPLETED|First Intervention (24 Hours)||7
1546704|NCT01312129|3785554|P1|COMPLETED|First Intervention (24 Hours)||6
1546705|NCT01312129|3785553|P2|Alcohol Cue|First Intervention (24 Hours)||7
1546706|NCT01312129|3785554|P1|Alcohol Cue|First Intervention (24 Hours)||6
1546707|NCT01312129|3785553|P2|Control Cue|First Intervention (24 Hours)||7
1546708|NCT01312129|3785554|P1|Control Cue|First Intervention (24 Hours)||6
1546709|NCT01312129|3785553|P2|STARTED|First Intervention (24 Hours)||7
1546710|NCT01312129|3785554|P1|STARTED|First Intervention (24 Hours)||6
1546711|NCT01312038|3785562|P2|NOT COMPLETED|Overall Study||0
1546712|NCT01312038|3785563|P1|NOT COMPLETED|Overall Study||0
1546713|NCT01312038|3785562|P2|COMPLETED|Overall Study||12
1546714|NCT01312038|3785563|P1|COMPLETED|Overall Study||13
1546715|NCT01312038|3785562|P2|STARTED|Overall Study||12
1546716|NCT01312038|3785563|P1|STARTED|Overall Study||13
1546717|NCT01311895|3785571|P2|NOT COMPLETED|Overall Study||0
1546718|NCT01311895|3785572|P1|NOT COMPLETED|Overall Study||0
1546719|NCT01311895|3785571|P2|COMPLETED|Overall Study||175
1546720|NCT01311895|3785572|P1|COMPLETED|Overall Study||175
1546721|NCT01311895|3785571|P2|STARTED|Overall Study||175
1546722|NCT01311895|3785572|P1|STARTED|Overall Study||175
1546723|NCT01311687|3785584|P2|NOT COMPLETED|PFS Follow-up Phase||0
1546724|NCT01311687|3785585|P1|NOT COMPLETED|PFS Follow-up Phase||0
1546725|NCT01311687|3785584|P2|COMPLETED|PFS Follow-up Phase||8
1546726|NCT01311687|3785585|P1|COMPLETED|PFS Follow-up Phase||11
1546727|NCT01311687|3785584|P2|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
1546728|NCT01311687|3785585|P1|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
1546729|NCT01311687|3785584|P2|STARTED|PFS Follow-up Phase||8
1546730|NCT01311687|3785585|P1|STARTED|PFS Follow-up Phase||11
1546731|NCT01311687|3785584|P2|NOT COMPLETED|Treatment Phase||0
1546732|NCT01311687|3785585|P1|NOT COMPLETED|Treatment Phase||0
1546733|NCT01311687|3785584|P2|COMPLETED|Treatment Phase||153
1546734|NCT01311687|3785585|P1|COMPLETED|Treatment Phase||302
1546735|NCT01311687|3785584|P2|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
1546736|NCT01311687|3785585|P1|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
1546737|NCT01311687|3785584|P2|Received Study Drug|Treatment Phase||150
1546738|NCT01311687|3785585|P1|Received Study Drug|Treatment Phase||300
1546739|NCT01311687|3785584|P2|STARTED|Treatment Phase||153
1546740|NCT01311687|3785585|P1|STARTED|Treatment Phase||302
1546741|NCT01311661|3785639|P1|NOT COMPLETED|Overall Study||7
1546742|NCT01311661|3785639|P1|COMPLETED|Overall Study||199
1546743|NCT01311661|3785639|P1|Received Olo 10 mcg qd|Overall Study||102
1546744|NCT01311661|3785639|P1|Received Olo 5 mcg Bid|Overall Study||101
1546745|NCT01311661|3785639|P1|Received Olo 5 mcg qd|Overall Study||101
1546746|NCT01311661|3785639|P1|Received Olo 2.5 mcg Bid|Overall Study||101
1546747|NCT01311661|3785639|P1|Received Placebo|Overall Study||201
1546748|NCT01311661|3785639|P1|STARTED|Overall Study|Entered and treated|206
1546749|NCT01311557|3785783|P2|NOT COMPLETED|Overall Study||6
1546750|NCT01311557|3785784|P1|NOT COMPLETED|Overall Study||5
1546751|NCT01311557|3785783|P2|COMPLETED|Overall Study||645
1546752|NCT01311557|3785784|P1|COMPLETED|Overall Study||646
1546753|NCT01311557|3785783|P2|STARTED|Overall Study||651
1546754|NCT01311557|3785784|P1|STARTED|Overall Study||651
1546755|NCT01311505|3785800|P2|NOT COMPLETED|Second Intervention Period||0
1546756|NCT01311505|3785801|P1|NOT COMPLETED|Second Intervention Period||0
1546757|NCT01311505|3785800|P2|COMPLETED|Second Intervention Period||10
1546758|NCT01311505|3785801|P1|COMPLETED|Second Intervention Period||10
1546759|NCT01311505|3785800|P2|STARTED|Second Intervention Period||10
1546760|NCT01311505|3785801|P1|STARTED|Second Intervention Period||10
1546761|NCT01311505|3785800|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1546762|NCT01311505|3785801|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1546763|NCT01311505|3785800|P2|COMPLETED|Washout Period (at Least 7 Days)||10
1546764|NCT01311505|3785801|P1|COMPLETED|Washout Period (at Least 7 Days)||10
1546765|NCT01311505|3785800|P2|STARTED|Washout Period (at Least 7 Days)||10
1546766|NCT01311505|3785801|P1|STARTED|Washout Period (at Least 7 Days)||10
1546767|NCT01311505|3785800|P2|NOT COMPLETED|First Intervention Period||1
1546768|NCT01311505|3785801|P1|NOT COMPLETED|First Intervention Period||0
1546769|NCT01311505|3785800|P2|COMPLETED|First Intervention Period||10
1546770|NCT01311505|3785801|P1|COMPLETED|First Intervention Period||10
1546771|NCT01311505|3785800|P2|STARTED|First Intervention Period||11
1546772|NCT01311505|3785801|P1|STARTED|First Intervention Period||10
1546773|NCT01311362|3785829|P1|NOT COMPLETED|Ambrisentan and SJW||0
1546774|NCT01311362|3785829|P1|COMPLETED|Ambrisentan and SJW||20
1546775|NCT01311362|3785829|P1|STARTED|Ambrisentan and SJW||20
1546776|NCT01311362|3785829|P1|NOT COMPLETED|Ambrisentan Steady-state||0
1546777|NCT01311362|3785829|P1|COMPLETED|Ambrisentan Steady-state||20
1546778|NCT01311362|3785829|P1|STARTED|Ambrisentan Steady-state||20
1546779|NCT01311362|3785829|P1|NOT COMPLETED|Ambrisentan Single Dose||0
1546780|NCT01311362|3785829|P1|COMPLETED|Ambrisentan Single Dose||20
1546781|NCT01311362|3785829|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
1546782|NCT01311102|3785842|P2|NOT COMPLETED|Overall Study||0
1546783|NCT01311102|3785843|P1|NOT COMPLETED|Overall Study||0
1546784|NCT01311102|3785842|P2|COMPLETED|Overall Study||20
1546785|NCT01311102|3785843|P1|COMPLETED|Overall Study||20
1546786|NCT01311102|3785842|P2|STARTED|Overall Study||20
1546787|NCT01311102|3785843|P1|STARTED|Overall Study||20
1546788|NCT01311024|3785857|P2|NOT COMPLETED|Overall Study||22
1546789|NCT01311024|3785858|P1|NOT COMPLETED|Overall Study||35
1546790|NCT01311024|3785857|P2|COMPLETED|Overall Study||789
1546791|NCT01311024|3785858|P1|COMPLETED|Overall Study||1495
1546792|NCT01311024|3785857|P2|STARTED|Overall Study||811
1546793|NCT01311024|3785858|P1|STARTED|Overall Study||1530
1546794|NCT01310868|3785864|P1|NOT COMPLETED|Overall Study||13
1546795|NCT01310868|3785864|P1|COMPLETED|Overall Study||59
1546796|NCT01310868|3785864|P1|STARTED|Overall Study||72
1546797|NCT01310855|3785872|P2|NOT COMPLETED|Overall Study||0
1546798|NCT01310855|3785873|P1|NOT COMPLETED|Overall Study||0
1546799|NCT01310855|3785872|P2|COMPLETED|Overall Study||19
1546800|NCT01310855|3785873|P1|COMPLETED|Overall Study||19
1546801|NCT01310855|3785872|P2|STARTED|Overall Study||19
1546802|NCT01310855|3785873|P1|STARTED|Overall Study||19
1546803|NCT01310803|3785881|P2|NOT COMPLETED|Overall Study||0
1546804|NCT01310803|3785882|P1|NOT COMPLETED|Overall Study||1
1546805|NCT01310803|3785881|P2|COMPLETED|Overall Study||0
1546806|NCT01310803|3785882|P1|COMPLETED|Overall Study||0
1546807|NCT01310803|3785881|P2|STARTED|Overall Study||0
1546808|NCT01310803|3785882|P1|STARTED|Overall Study||1
1546809|NCT01310777|3785893|P3|NOT COMPLETED|Overall Study||30
1546810|NCT01310777|3785894|P2|NOT COMPLETED|Overall Study||14
1546811|NCT01310777|3785895|P1|NOT COMPLETED|Overall Study||33
1546812|NCT01310777|3785893|P3|COMPLETED|Overall Study||145
1546813|NCT01310777|3785894|P2|COMPLETED|Overall Study||178
1546814|NCT01310777|3785895|P1|COMPLETED|Overall Study||160
1546815|NCT01310777|3785893|P3|STARTED|Overall Study||175
1546816|NCT01310777|3785894|P2|STARTED|Overall Study||192
1546817|NCT01310777|3785895|P1|STARTED|Overall Study||193
1546818|NCT01310699|3785905|P2|NOT COMPLETED|Overall Study||6
1546819|NCT01310699|3785906|P1|NOT COMPLETED|Overall Study||4
1546820|NCT01310699|3785905|P2|COMPLETED|Overall Study||143
1546821|NCT01310699|3785906|P1|COMPLETED|Overall Study||128
1546822|NCT01310699|3785905|P2|STARTED|Overall Study||149
1546823|NCT01310699|3785906|P1|STARTED|Overall Study||132
1546824|NCT01310582|3785918|P2|NOT COMPLETED|Overall Study||0
1546825|NCT01310582|3785919|P1|NOT COMPLETED|Overall Study||0
1546826|NCT01310582|3785918|P2|COMPLETED|Overall Study||26
1546827|NCT01310582|3785919|P1|COMPLETED|Overall Study||31
1546828|NCT01310582|3785918|P2|STARTED|Overall Study||26
1546829|NCT01310582|3785919|P1|STARTED|Overall Study||31
1546830|NCT01310413|3785933|P7|NOT COMPLETED|From Day U0 to Day U385||3
1546831|NCT01310413|3785934|P6|NOT COMPLETED|From Day U0 to Day U385||0
1546832|NCT01310413|3785935|P5|NOT COMPLETED|From Day U0 to Day U385||0
1546833|NCT01310413|3785936|P4|NOT COMPLETED|From Day U0 to Day U385||0
1546834|NCT01310413|3785937|P3|NOT COMPLETED|From Day U0 to Day U385||0
1546835|NCT01310413|3785938|P2|NOT COMPLETED|From Day U0 to Day U385||0
1546836|NCT01310413|3785939|P1|NOT COMPLETED|From Day U0 to Day U385||0
1546837|NCT01310413|3785933|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
1546838|NCT01310413|3785934|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1546839|NCT01310413|3785935|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1546840|NCT01310413|3785936|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1546841|NCT01310413|3785937|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1546842|NCT01310413|3785938|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1546843|NCT01310413|3785939|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1546844|NCT01310413|3785933|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
1546845|NCT01310413|3785934|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1546846|NCT01310413|3785935|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1546847|NCT01310413|3785936|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1546848|NCT01310413|3785937|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1546849|NCT01310413|3785938|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1546850|NCT01310413|3785939|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1546851|NCT01310413|3785933|P7|NOT COMPLETED|Day 0 to Day 385||0
1546852|NCT01310413|3785934|P6|NOT COMPLETED|Day 0 to Day 385||3
1546853|NCT01310413|3785935|P5|NOT COMPLETED|Day 0 to Day 385||3
1546854|NCT01310413|3785936|P4|NOT COMPLETED|Day 0 to Day 385||8
1546855|NCT01310413|3785937|P3|NOT COMPLETED|Day 0 to Day 385||7
1546856|NCT01310413|3785938|P2|NOT COMPLETED|Day 0 to Day 385||8
1546857|NCT01310413|3785939|P1|NOT COMPLETED|Day 0 to Day 385||27
1546858|NCT01310413|3785933|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
1546859|NCT01310413|3785934|P6|COMPLETED|Day 0 to Day 385||77
1546860|NCT01310413|3785935|P5|COMPLETED|Day 0 to Day 385||73
1546861|NCT01310413|3785936|P4|COMPLETED|Day 0 to Day 385||67
1546862|NCT01310413|3785937|P3|COMPLETED|Day 0 to Day 385||203
1546863|NCT01310413|3785938|P2|COMPLETED|Day 0 to Day 385||190
1546864|NCT01310413|3785939|P1|COMPLETED|Day 0 to Day 385||172
1546865|NCT01310413|3785933|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
1546866|NCT01310413|3785934|P6|STARTED|Day 0 to Day 385||80
1546867|NCT01310413|3785935|P5|STARTED|Day 0 to Day 385||76
1546868|NCT01310413|3785936|P4|STARTED|Day 0 to Day 385||75
1546869|NCT01310413|3785937|P3|STARTED|Day 0 to Day 385||210
1546870|NCT01310413|3785938|P2|STARTED|Day 0 to Day 385||198
1546871|NCT01310413|3785939|P1|STARTED|Day 0 to Day 385||199
1546872|NCT01310400|3786095|P3|NOT COMPLETED|Overall Study||30
1546873|NCT01310400|3786096|P2|NOT COMPLETED|Overall Study||32
1546874|NCT01310400|3786097|P1|NOT COMPLETED|Overall Study||28
1546875|NCT01310400|3786095|P3|COMPLETED|Overall Study||422
1546876|NCT01310400|3786096|P2|COMPLETED|Overall Study||420
1546877|NCT01310400|3786097|P1|COMPLETED|Overall Study||424
1546878|NCT01310400|3786095|P3|STARTED|Overall Study||452
1546879|NCT01310400|3786096|P2|STARTED|Overall Study||452
1546880|NCT01310400|3786097|P1|STARTED|Overall Study||452
1546881|NCT01310179|3786114|P1|NOT COMPLETED|Overall Study||0
1546882|NCT01310179|3786114|P1|COMPLETED|Overall Study||12
1546883|NCT01310179|3786114|P1|STARTED|Overall Study||12
1546884|NCT01310127|3786121|P2|NOT COMPLETED|Overall Study||1
1546885|NCT01310127|3786122|P1|NOT COMPLETED|Overall Study||2
1546886|NCT01310127|3786121|P2|COMPLETED|Overall Study||10
1546887|NCT01310127|3786122|P1|COMPLETED|Overall Study||10
1546888|NCT01310127|3786121|P2|STARTED|Overall Study||11
1546889|NCT01310127|3786122|P1|STARTED|Overall Study||12
1546890|NCT01310036|3786134|P1|NOT COMPLETED|Overall Study||202
1546891|NCT01310036|3786134|P1|COMPLETED|Overall Study||6
1546892|NCT01310036|3786134|P1|STARTED|Overall Study||208
1546893|NCT01309997|3786147|P2|NOT COMPLETED|Overall Study||6
1546894|NCT01309997|3786148|P1|NOT COMPLETED|Overall Study||5
1546895|NCT01309997|3786147|P2|COMPLETED|Overall Study||31
1546896|NCT01309997|3786148|P1|COMPLETED|Overall Study||30
1546897|NCT01309997|3786147|P2|Crossed Over to Second Arm|Overall Study||23
1546898|NCT01309997|3786148|P1|Crossed Over to Second Arm|Overall Study||19
1546899|NCT01309997|3786147|P2|Remained on First Arm Only|Overall Study||14
1546900|NCT01309997|3786148|P1|Remained on First Arm Only|Overall Study||16
1546901|NCT01309997|3786147|P2|STARTED|Overall Study||37
1546902|NCT01309997|3786148|P1|STARTED|Overall Study||35
1546903|NCT01309919|3786172|P2|NOT COMPLETED|Overall Study||48
1546904|NCT01309919|3786173|P1|NOT COMPLETED|Overall Study||17
1546905|NCT01309919|3786172|P2|COMPLETED|Overall Study||27
1546906|NCT01309919|3786173|P1|COMPLETED|Overall Study||58
1546907|NCT01309919|3786172|P2|STARTED|Overall Study||75
1546908|NCT01309919|3786173|P1|STARTED|Overall Study||75
1546909|NCT01309893|3786185|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
1546910|NCT01309893|3786186|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
1546911|NCT01309893|3786185|P2|COMPLETED|Week 2 - Crossover Intervention||32
1546912|NCT01309893|3786186|P1|COMPLETED|Week 2 - Crossover Intervention||32
1546913|NCT01309893|3786185|P2|STARTED|Week 2 - Crossover Intervention||33
1546914|NCT01309893|3786186|P1|STARTED|Week 2 - Crossover Intervention||33
1546915|NCT01309893|3786185|P2|NOT COMPLETED|Week 1 - First Intervention||0
1546916|NCT01309893|3786186|P1|NOT COMPLETED|Week 1 - First Intervention||0
1546917|NCT01309893|3786185|P2|COMPLETED|Week 1 - First Intervention||33
1546918|NCT01309893|3786186|P1|COMPLETED|Week 1 - First Intervention||33
1546919|NCT01309893|3786185|P2|STARTED|Week 1 - First Intervention||33
1546920|NCT01309893|3786186|P1|STARTED|Week 1 - First Intervention||33
1546921|NCT01309880|3786196|P2|NOT COMPLETED|Overall Study||0
1546922|NCT01309880|3786197|P1|NOT COMPLETED|Overall Study||0
1546923|NCT01309880|3786196|P2|COMPLETED|Overall Study||33
1546924|NCT01309880|3786197|P1|COMPLETED|Overall Study||33
1546925|NCT01309880|3786196|P2|STARTED|Overall Study||33
1546926|NCT01309880|3786197|P1|STARTED|Overall Study||33
1546927|NCT01309841|3786210|P3|NOT COMPLETED|Overall Study||37
1546928|NCT01309841|3786211|P2|NOT COMPLETED|Overall Study||41
1546929|NCT01309841|3786212|P1|NOT COMPLETED|Overall Study||39
1546930|NCT01309841|3786210|P3|COMPLETED|Overall Study||180
1546931|NCT01309841|3786211|P2|COMPLETED|Overall Study||177
1546932|NCT01309841|3786212|P1|COMPLETED|Overall Study||178
1546933|NCT01309841|3786210|P3|STARTED|Overall Study||217
1546934|NCT01309841|3786211|P2|STARTED|Overall Study||218
1546935|NCT01309841|3786212|P1|STARTED|Overall Study||217
1546936|NCT01309828|3786252|P2|NOT COMPLETED|Overall Study||16
1546937|NCT01309828|3786253|P1|NOT COMPLETED|Overall Study||16
1546938|NCT01309828|3786252|P2|COMPLETED|Overall Study||60
1546939|NCT01309828|3786253|P1|COMPLETED|Overall Study||61
1546940|NCT01309828|3786252|P2|STARTED|Overall Study||76
1546941|NCT01309828|3786253|P1|STARTED|Overall Study||77
1546942|NCT01309802|3786267|P2|NOT COMPLETED|Overall Study||9
1546943|NCT01309802|3786268|P1|NOT COMPLETED|Overall Study||12
1546944|NCT01309802|3786267|P2|COMPLETED|Overall Study||14
1546945|NCT01309802|3786268|P1|COMPLETED|Overall Study||13
1546946|NCT01309802|3786267|P2|STARTED|Overall Study||23
1546947|NCT01309802|3786268|P1|STARTED|Overall Study||25
1546948|NCT01309737|3786287|P5|NOT COMPLETED|Week 16 to 52||33
1546949|NCT01309737|3786288|P4|NOT COMPLETED|Week 16 to 52||34
1546950|NCT01309737|3786289|P3|NOT COMPLETED|Week 16 to 52||0
1546951|NCT01309737|3786290|P2|NOT COMPLETED|Week 16 to 52||103
1546952|NCT01309737|3786291|P1|NOT COMPLETED|Week 16 to 52||133
1546953|NCT01309737|3786287|P5|COMPLETED|Week 16 to 52||44
1546954|NCT01309737|3786288|P4|COMPLETED|Week 16 to 52||41
1546955|NCT01309737|3786289|P3|COMPLETED|Week 16 to 52||0
1546956|NCT01309737|3786290|P2|COMPLETED|Week 16 to 52||238
1546957|NCT01309737|3786291|P1|COMPLETED|Week 16 to 52||198
1546958|NCT01309737|3786287|P5|STARTED|Week 16 to 52||77
1546959|NCT01309737|3786288|P4|STARTED|Week 16 to 52||75
1546960|NCT01309737|3786289|P3|STARTED|Week 16 to 52||0
1546961|NCT01309737|3786290|P2|STARTED|Week 16 to 52||341
1546962|NCT01309737|3786291|P1|STARTED|Week 16 to 52||331
1546963|NCT01309737|3786287|P5|NOT COMPLETED|Week 0 to 16||0
1546964|NCT01309737|3786288|P4|NOT COMPLETED|Week 0 to 16||0
1546965|NCT01309737|3786289|P3|NOT COMPLETED|Week 0 to 16||44
1546966|NCT01309737|3786290|P2|NOT COMPLETED|Week 0 to 16||40
1546967|NCT01309737|3786291|P1|NOT COMPLETED|Week 0 to 16||52
1546968|NCT01309737|3786287|P5|COMPLETED|Week 0 to 16||0
1546969|NCT01309737|3786288|P4|COMPLETED|Week 0 to 16||0
1546970|NCT01309737|3786289|P3|COMPLETED|Week 0 to 16||152
1546971|NCT01309737|3786290|P2|COMPLETED|Week 0 to 16||341
1546972|NCT01309737|3786291|P1|COMPLETED|Week 0 to 16||331
1546973|NCT01309737|3786287|P5|Treated|Week 0 to 16||0
1546974|NCT01309737|3786288|P4|Treated|Week 0 to 16||0
1546975|NCT01309737|3786289|P3|Treated|Week 0 to 16||196
1546976|NCT01309737|3786290|P2|Treated|Week 0 to 16||381
1546977|NCT01309737|3786291|P1|Treated|Week 0 to 16||382
1546978|NCT01309737|3786287|P5|STARTED|Week 0 to 16||0
1546979|NCT01309737|3786288|P4|STARTED|Week 0 to 16||0
1546980|NCT01309737|3786289|P3|STARTED|Week 0 to 16||196
1546981|NCT01309737|3786290|P2|STARTED|Week 0 to 16||381
1546982|NCT01309737|3786291|P1|STARTED|Week 0 to 16||383
1546983|NCT01309672|3786486|P1|NOT COMPLETED|Overall Study||37
1546984|NCT01309672|3786486|P1|COMPLETED|Overall Study||4
1546985|NCT01309672|3786486|P1|Received Protocol Treatment|Overall Study||40
1546986|NCT01309672|3786486|P1|STARTED|Overall Study||41
1546987|NCT01309659|3786496|P2|NOT COMPLETED|Overall Study||1
1546988|NCT01309659|3786497|P1|NOT COMPLETED|Overall Study||0
1546989|NCT01309659|3786496|P2|COMPLETED|Overall Study||9
1546990|NCT01309659|3786497|P1|COMPLETED|Overall Study||9
1546991|NCT01309659|3786496|P2|STARTED|Overall Study||10
1546992|NCT01309659|3786497|P1|STARTED|Overall Study||9
1546993|NCT01309646|3786539|P2|NOT COMPLETED|Overall Study||0
1546994|NCT01309646|3786540|P1|NOT COMPLETED|Overall Study||0
1546995|NCT01309646|3786539|P2|COMPLETED|Overall Study||227
1546996|NCT01309646|3786540|P1|COMPLETED|Overall Study||224
1546997|NCT01309646|3786539|P2|STARTED|Overall Study||227
1546998|NCT01309646|3786540|P1|STARTED|Overall Study||224
1546999|NCT01309581|3786580|P2|NOT COMPLETED|Overall Study||0
1547000|NCT01309581|3786581|P1|NOT COMPLETED|Overall Study||0
1547001|NCT01309581|3786580|P2|COMPLETED|Overall Study||1
1547002|NCT01309581|3786581|P1|COMPLETED|Overall Study||2
1547003|NCT01309581|3786580|P2|STARTED|Overall Study||1
1547004|NCT01309581|3786581|P1|STARTED|Overall Study||2
1547005|NCT01309451|3786591|P2|NOT COMPLETED|Overall Study||3
1547006|NCT01309451|3786592|P1|NOT COMPLETED|Overall Study||2
1547007|NCT01309451|3786591|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
1547008|NCT01309451|3786592|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
1547009|NCT01309451|3786591|P2|STARTED|Overall Study|unit of measure is number of eyes|21
1547010|NCT01309451|3786592|P1|STARTED|Overall Study|unit of measure is number of eyes|19
1547011|NCT01309386|3786602|P2|NOT COMPLETED|Overall Study||21
1547012|NCT01309386|3786603|P1|NOT COMPLETED|Overall Study||22
1547013|NCT01309386|3786602|P2|COMPLETED|Overall Study||29
1547014|NCT01309386|3786603|P1|COMPLETED|Overall Study||28
1547015|NCT01309386|3786602|P2|STARTED|Overall Study||50
1547016|NCT01309386|3786603|P1|STARTED|Overall Study||50
1547017|NCT01309360|3786624|P3|NOT COMPLETED|Overall Study||0
1547018|NCT01309360|3786625|P2|NOT COMPLETED|Overall Study||0
1547019|NCT01309360|3786626|P1|NOT COMPLETED|Overall Study||0
1547020|NCT01309360|3786624|P3|COMPLETED|Overall Study||40
1547021|NCT01309360|3786625|P2|COMPLETED|Overall Study||40
1547022|NCT01309360|3786626|P1|COMPLETED|Overall Study||40
1547023|NCT01309360|3786624|P3|STARTED|Overall Study||40
1547024|NCT01309360|3786625|P2|STARTED|Overall Study||40
1547025|NCT01309360|3786626|P1|STARTED|Overall Study||40
1547026|NCT01309308|3786651|P2|NOT COMPLETED|Overall Study||4
1547027|NCT01309308|3786652|P1|NOT COMPLETED|Overall Study||6
1547028|NCT01309308|3786651|P2|COMPLETED|Overall Study||71
1547029|NCT01309308|3786652|P1|COMPLETED|Overall Study||69
1547030|NCT01309308|3786651|P2|STARTED|Overall Study||75
1547031|NCT01309308|3786652|P1|STARTED|Overall Study||75
1547032|NCT01309282|3786660|P1|NOT COMPLETED|Overall Study||1
1547033|NCT01309282|3786660|P1|COMPLETED|Overall Study||8
1547034|NCT01309282|3786660|P1|STARTED|Overall Study||9
1547035|NCT01309269|3786677|P1|NOT COMPLETED|Overall Study||840
1547036|NCT01309269|3786677|P1|COMPLETED|Overall Study||245
1547037|NCT01309269|3786677|P1|Treated|Overall Study||978
1547038|NCT01309269|3786677|P1|STARTED|Overall Study||1085
1547039|NCT01309243|3786685|P2|NOT COMPLETED|Extension Phase||0
1547040|NCT01309243|3786686|P1|NOT COMPLETED|Extension Phase||6
1547041|NCT01309243|3786685|P2|COMPLETED|Extension Phase||117
1547042|NCT01309243|3786686|P1|COMPLETED|Extension Phase||34
1547043|NCT01309243|3786685|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
1547044|NCT01309243|3786686|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
1547045|NCT01309243|3786685|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
1547046|NCT01309243|3786686|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
1547047|NCT01309243|3786685|P2|COMPLETED|Randomized Phase Through Week 96||290
1547048|NCT01309243|3786686|P1|COMPLETED|Randomized Phase Through Week 96||316
1547049|NCT01309243|3786685|P2|Randomized and Treated|Randomized Phase Through Week 96||392
1547050|NCT01309243|3786686|P1|Randomized and Treated|Randomized Phase Through Week 96||394
1547051|NCT01309243|3786685|P2|STARTED|Randomized Phase Through Week 96||399
1547052|NCT01309243|3786686|P1|STARTED|Randomized Phase Through Week 96||400
1547053|NCT01309204|3786712|P2|NOT COMPLETED|Overall Study||75
1547054|NCT01309204|3786713|P1|NOT COMPLETED|Overall Study||67
1547055|NCT01309204|3786712|P2|COMPLETED|Overall Study||361
1547056|NCT01309204|3786713|P1|COMPLETED|Overall Study||385
1547057|NCT01309204|3786712|P2|STARTED|Overall Study||436
1547058|NCT01309204|3786713|P1|STARTED|Overall Study||452
1547059|NCT01309100|3786719|P1|NOT COMPLETED|Overall Study||2
1547060|NCT01309100|3786719|P1|COMPLETED|Overall Study||142
1547061|NCT01309100|3786719|P1|STARTED|Overall Study||144
1547062|NCT01308918|3786730|P1|NOT COMPLETED|Overall Study||0
1547063|NCT01308918|3786730|P1|COMPLETED|Overall Study||50
1547064|NCT01308918|3786730|P1|STARTED|Overall Study||50
1547065|NCT01308840|3786737|P1|NOT COMPLETED|Overall Study||0
1547066|NCT01308840|3786737|P1|COMPLETED|Overall Study||31
1547067|NCT01308840|3786737|P1|STARTED|Overall Study||31
1547068|NCT01308814|3786746|P2|NOT COMPLETED|Overall Study||23
1547069|NCT01308814|3786747|P1|NOT COMPLETED|Overall Study||17
1547070|NCT01308814|3786746|P2|COMPLETED|Overall Study||63
1547071|NCT01308814|3786747|P1|COMPLETED|Overall Study||69
1547072|NCT01308814|3786746|P2|STARTED|Overall Study||86
1547073|NCT01308814|3786747|P1|STARTED|Overall Study||86
1547074|NCT01308788|3786767|P2|NOT COMPLETED|2-year Treatment||11
1547075|NCT01308788|3786768|P1|NOT COMPLETED|2-year Treatment||4
1547076|NCT01308788|3786767|P2|COMPLETED|2-year Treatment||10
1547077|NCT01308788|3786768|P1|COMPLETED|2-year Treatment||10
1547078|NCT01308788|3786767|P2|STARTED|2-year Treatment||21
1547079|NCT01308788|3786768|P1|STARTED|2-year Treatment||14
1547080|NCT01308788|3786767|P2|NOT COMPLETED|6-month Treatment||0
1547081|NCT01308788|3786768|P1|NOT COMPLETED|6-month Treatment||0
1547082|NCT01308788|3786767|P2|COMPLETED|6-month Treatment||21
1547083|NCT01308788|3786768|P1|COMPLETED|6-month Treatment||14
1547084|NCT01308788|3786767|P2|STARTED|6-month Treatment||21
1547085|NCT01308788|3786768|P1|STARTED|6-month Treatment||14
1547086|NCT01308762|3786803|P3|NOT COMPLETED|Overall Study||0
1547087|NCT01308762|3786804|P2|NOT COMPLETED|Overall Study||1
1547088|NCT01308762|3786805|P1|NOT COMPLETED|Overall Study||0
1547089|NCT01308762|3786803|P3|COMPLETED|Overall Study||6
1547090|NCT01308762|3786804|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
1547091|NCT01308762|3786805|P1|COMPLETED|Overall Study||6
1547092|NCT01308762|3786803|P3|STARTED|Overall Study||6
1547093|NCT01308762|3786804|P2|STARTED|Overall Study||7
1547094|NCT01308762|3786805|P1|STARTED|Overall Study||6
1547095|NCT01308749|3786818|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
1547096|NCT01308749|3786819|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
1547097|NCT01308749|3786818|P2|COMPLETED|Period 2: Open Label Treatment||11
1547098|NCT01308749|3786819|P1|COMPLETED|Period 2: Open Label Treatment||11
1547099|NCT01308749|3786818|P2|STARTED|Period 2: Open Label Treatment||13
1547100|NCT01308749|3786819|P1|STARTED|Period 2: Open Label Treatment||11
1547101|NCT01308749|3786818|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
1547102|NCT01308749|3786819|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
1547103|NCT01308749|3786818|P2|COMPLETED|Period 1: Double Blind Treatment||13
1547104|NCT01308749|3786819|P1|COMPLETED|Period 1: Double Blind Treatment||11
1547105|NCT01308749|3786818|P2|STARTED|Period 1: Double Blind Treatment||13
1547106|NCT01308749|3786819|P1|STARTED|Period 1: Double Blind Treatment||12
1547107|NCT01308736|3786849|P2|NOT COMPLETED|Overall Study||5
1547108|NCT01308736|3786850|P1|NOT COMPLETED|Overall Study||6
1547109|NCT01308736|3786849|P2|COMPLETED|Overall Study||27
1547110|NCT01308736|3786850|P1|COMPLETED|Overall Study||25
1547111|NCT01308736|3786849|P2|STARTED|Overall Study||32
1547112|NCT01308736|3786850|P1|STARTED|Overall Study||31
1547113|NCT01308619|3786858|P2|NOT COMPLETED|Overall Study||3
1547114|NCT01308619|3786859|P1|NOT COMPLETED|Overall Study||7
1547115|NCT01308619|3786858|P2|COMPLETED|Overall Study||83
1547116|NCT01308619|3786859|P1|COMPLETED|Overall Study||77
1547117|NCT01308619|3786858|P2|STARTED|Overall Study||86
1547118|NCT01308619|3786859|P1|STARTED|Overall Study||84
1547119|NCT01308580|3786873|P2|NOT COMPLETED|Overall Study||7
1547120|NCT01308580|3786874|P1|NOT COMPLETED|Overall Study||12
1547121|NCT01308580|3786873|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
1547122|NCT01308580|3786874|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
1547123|NCT01308580|3786873|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
1547124|NCT01308580|3786874|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
1547125|NCT01308580|3786873|P2|STARTED|Overall Study||602
1547126|NCT01308580|3786874|P1|STARTED|Overall Study||598
1547127|NCT01308567|3786917|P3|NOT COMPLETED|Overall Study||4
1547128|NCT01308567|3786918|P2|NOT COMPLETED|Overall Study||4
1547129|NCT01308567|3786919|P1|NOT COMPLETED|Overall Study||2
1547130|NCT01308567|3786917|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
1547131|NCT01308567|3786918|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
1547132|NCT01308567|3786919|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
1547133|NCT01308567|3786917|P3|Ongoing Treatment at Data Cut-off|Overall Study||3
1547134|NCT01308567|3786918|P2|Ongoing Treatment at Data Cut-off|Overall Study||6
1547135|NCT01308567|3786919|P1|Ongoing Treatment at Data Cut-off|Overall Study||4
1547136|NCT01308567|3786917|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
1547137|NCT01308567|3786918|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
1547138|NCT01308567|3786919|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
1547139|NCT01308567|3786917|P3|STARTED|Overall Study|Randomized|388
1547140|NCT01308567|3786918|P2|STARTED|Overall Study|Randomized|389
1547141|NCT01308567|3786919|P1|STARTED|Overall Study|Randomized|391
1547142|NCT01308476|3786959|P2|NOT COMPLETED|Overall Study||2
1547143|NCT01308476|3786960|P1|NOT COMPLETED|Overall Study||3
1547144|NCT01308476|3786959|P2|COMPLETED|Overall Study||45
1547145|NCT01308476|3786960|P1|COMPLETED|Overall Study||45
1547146|NCT01308476|3786959|P2|STARTED|Overall Study|Entered and treated.|47
1547147|NCT01308476|3786960|P1|STARTED|Overall Study|Entered and treated.|48
1547148|NCT01308463|3786980|P1|NOT COMPLETED|Overall Study||29
1547149|NCT01308463|3786980|P1|COMPLETED|Overall Study||0
1547150|NCT01308463|3786980|P1|12 Years|Overall Study||2
1547151|NCT01308463|3786980|P1|11 Years|Overall Study||8
1547152|NCT01308463|3786980|P1|10 Years|Overall Study||8
1547153|NCT01308463|3786980|P1|9 Years|Overall Study||11
1547154|NCT01308463|3786980|P1|8 Years|Overall Study||14
1547155|NCT01308463|3786980|P1|7 Years|Overall Study||12
1547156|NCT01308463|3786980|P1|6 Years|Overall Study||11
1547157|NCT01308463|3786980|P1|5 Years|Overall Study||20
1547158|NCT01308463|3786980|P1|4 Years|Overall Study||20
1547159|NCT01308463|3786980|P1|3 Years|Overall Study||17
1547160|NCT01308463|3786980|P1|2 Years|Overall Study||18
1547161|NCT01308463|3786980|P1|1 Year|Overall Study||21
1547162|NCT01308463|3786980|P1|6 Months|Overall Study||23
1547163|NCT01308463|3786980|P1|STARTED|Overall Study||29
1547164|NCT01308450|3786987|P1|NOT COMPLETED|Overall Study||2
1547165|NCT01308450|3786987|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
1547166|NCT01308450|3786987|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
1547167|NCT01308424|3786993|P3|NOT COMPLETED|Randomization||2
1547168|NCT01308424|3786994|P2|NOT COMPLETED|Randomization||3
1547169|NCT01308424|3786995|P1|NOT COMPLETED|Randomization||0
1547170|NCT01308424|3786993|P3|COMPLETED|Randomization||82
1547171|NCT01308424|3786994|P2|COMPLETED|Randomization||84
1547172|NCT01308424|3786995|P1|COMPLETED|Randomization||0
1547173|NCT01308424|3786993|P3|STARTED|Randomization||84
1547174|NCT01308424|3786994|P2|STARTED|Randomization||87
1547175|NCT01308424|3786995|P1|STARTED|Randomization||0
1547176|NCT01308424|3786993|P3|NOT COMPLETED|Baseline Eligibility||0
1547177|NCT01308424|3786994|P2|NOT COMPLETED|Baseline Eligibility||0
1547178|NCT01308424|3786995|P1|NOT COMPLETED|Baseline Eligibility||71
1547179|NCT01308424|3786993|P3|COMPLETED|Baseline Eligibility||0
1547180|NCT01308424|3786994|P2|COMPLETED|Baseline Eligibility||0
1547181|NCT01308424|3786995|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
1547182|NCT01308424|3786993|P3|STARTED|Baseline Eligibility||0
1547183|NCT01308424|3786994|P2|STARTED|Baseline Eligibility||0
1547184|NCT01308424|3786995|P1|STARTED|Baseline Eligibility||242
1547185|NCT01308008|3787004|P2|NOT COMPLETED|12 Months||4
1547186|NCT01308008|3787005|P1|NOT COMPLETED|12 Months||8
1547187|NCT01308008|3787004|P2|COMPLETED|12 Months||58
1547188|NCT01308008|3787005|P1|COMPLETED|12 Months||46
1547189|NCT01308008|3787004|P2|STARTED|12 Months||62
1547190|NCT01308008|3787005|P1|STARTED|12 Months||54
1547191|NCT01308008|3787004|P2|NOT COMPLETED|6 Months||9
1547192|NCT01308008|3787005|P1|NOT COMPLETED|6 Months||8
1547193|NCT01308008|3787004|P2|COMPLETED|6 Months||62
1547194|NCT01308008|3787005|P1|COMPLETED|6 Months||54
1547195|NCT01308008|3787004|P2|STARTED|6 Months||71
1547196|NCT01308008|3787005|P1|STARTED|6 Months||62
1547197|NCT01308008|3787004|P2|NOT COMPLETED|4 Weeks||2
1547198|NCT01308008|3787005|P1|NOT COMPLETED|4 Weeks||9
1547199|NCT01308008|3787004|P2|COMPLETED|4 Weeks||71
1547200|NCT01308008|3787005|P1|COMPLETED|4 Weeks||62
1547201|NCT01308008|3787004|P2|STARTED|4 Weeks||73
1547202|NCT01308008|3787005|P1|STARTED|4 Weeks||71
1547203|NCT01307956|3787015|P1|NOT COMPLETED|Overall Study||0
1547204|NCT01307956|3787015|P1|COMPLETED|Overall Study||11
1547205|NCT01307956|3787015|P1|STARTED|Overall Study||11
1547206|NCT01307891|3787021|P2|NOT COMPLETED|Overall Study||1
1547207|NCT01307891|3787022|P1|NOT COMPLETED|Overall Study||3
1547208|NCT01307891|3787021|P2|COMPLETED|Overall Study||21
1547209|NCT01307891|3787022|P1|COMPLETED|Overall Study||39
1547210|NCT01307891|3787021|P2|STARTED|Overall Study||22
1547211|NCT01307891|3787022|P1|STARTED|Overall Study||42
1547212|NCT01307787|3787034|P2|NOT COMPLETED|Overall Study||0
1547213|NCT01307787|3787035|P1|NOT COMPLETED|Overall Study||2
1547214|NCT01307787|3787034|P2|COMPLETED|Overall Study||15
1547215|NCT01307787|3787035|P1|COMPLETED|Overall Study||17
1547216|NCT01307787|3787034|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
1547217|NCT01307787|3787035|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
1547218|NCT01307787|3787034|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
1547219|NCT01307787|3787035|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
1547220|NCT01307787|3787034|P2|STARTED|Overall Study||15
1547221|NCT01307787|3787035|P1|STARTED|Overall Study||19
1547222|NCT01307631|3787055|P2|NOT COMPLETED|Overall Study||0
1547223|NCT01307631|3787056|P1|NOT COMPLETED|Overall Study||0
1547224|NCT01307631|3787055|P2|COMPLETED|Overall Study||28
1547225|NCT01307631|3787056|P1|COMPLETED|Overall Study||9
1547226|NCT01307631|3787055|P2|STARTED|Overall Study||28
1547227|NCT01307631|3787056|P1|STARTED|Overall Study||9
1547228|NCT01307618|3787066|P2|NOT COMPLETED|Overall Study||0
1547229|NCT01307618|3787067|P1|NOT COMPLETED|Overall Study||0
1547230|NCT01307618|3787066|P2|COMPLETED|Overall Study||5
1547231|NCT01307618|3787067|P1|COMPLETED|Overall Study||5
1547232|NCT01307618|3787066|P2|STARTED|Overall Study||5
1547233|NCT01307618|3787067|P1|STARTED|Overall Study||5
1547234|NCT01307462|3787083|P1|NOT COMPLETED|Overall Study||1
1547235|NCT01307462|3787083|P1|COMPLETED|Overall Study||35
1547236|NCT01307462|3787083|P1|STARTED|Overall Study||36
1547237|NCT01307449|3787100|P4|NOT COMPLETED|Overall Study||0
1547238|NCT01307449|3787101|P3|NOT COMPLETED|Overall Study||0
1547239|NCT01307449|3787102|P2|NOT COMPLETED|Overall Study||0
1547240|NCT01307449|3787103|P1|NOT COMPLETED|Overall Study||1
1547241|NCT01307449|3787100|P4|COMPLETED|Overall Study||11
1547242|NCT01307449|3787101|P3|COMPLETED|Overall Study||11
1547243|NCT01307449|3787102|P2|COMPLETED|Overall Study||33
1547244|NCT01307449|3787103|P1|COMPLETED|Overall Study||32
1547245|NCT01307449|3787100|P4|STARTED|Overall Study||11
1547246|NCT01307449|3787101|P3|STARTED|Overall Study||11
1547247|NCT01307449|3787102|P2|STARTED|Overall Study||33
1547248|NCT01307449|3787103|P1|STARTED|Overall Study||33
1547249|NCT01307423|3787136|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
1547250|NCT01307423|3787137|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
1547251|NCT01307423|3787138|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1547252|NCT01307423|3787139|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1547253|NCT01307423|3787140|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1547254|NCT01307423|3787141|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1547255|NCT01307423|3787142|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
1547256|NCT01307423|3787143|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
1547257|NCT01307423|3787144|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1547258|NCT01307423|3787136|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
1547259|NCT01307423|3787137|P8|COMPLETED|Long-term Safety Phase (Year 5)||37
1547260|NCT01307423|3787138|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
1547261|NCT01307423|3787139|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
1547262|NCT01307423|3787140|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
1547263|NCT01307423|3787141|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
1547264|NCT01307423|3787142|P3|COMPLETED|Long-term Safety Phase (Year 5)||80
1547265|NCT01307423|3787143|P2|COMPLETED|Long-term Safety Phase (Year 5)||71
1547266|NCT01307423|3787144|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
1547267|NCT01307423|3787136|P9|STARTED|Long-term Safety Phase (Year 5)||44
1547268|NCT01307423|3787137|P8|STARTED|Long-term Safety Phase (Year 5)||38
1547269|NCT01307423|3787138|P7|STARTED|Long-term Safety Phase (Year 5)||0
1547270|NCT01307423|3787139|P6|STARTED|Long-term Safety Phase (Year 5)||0
1547271|NCT01307423|3787140|P5|STARTED|Long-term Safety Phase (Year 5)||0
1547272|NCT01307423|3787141|P4|STARTED|Long-term Safety Phase (Year 5)||0
1547273|NCT01307423|3787142|P3|STARTED|Long-term Safety Phase (Year 5)||86
1547274|NCT01307423|3787143|P2|STARTED|Long-term Safety Phase (Year 5)||81
1547275|NCT01307423|3787144|P1|STARTED|Long-term Safety Phase (Year 5)||0
1547276|NCT01307423|3787136|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
1547277|NCT01307423|3787137|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
1547278|NCT01307423|3787138|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1547279|NCT01307423|3787139|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1547280|NCT01307423|3787140|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1547281|NCT01307423|3787141|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1547282|NCT01307423|3787142|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
1547283|NCT01307423|3787143|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
1547284|NCT01307423|3787144|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1547285|NCT01307423|3787136|P9|COMPLETED|Long-term Safety Phase (Year 4)||44
1547286|NCT01307423|3787137|P8|COMPLETED|Long-term Safety Phase (Year 4)||38
1547287|NCT01307423|3787138|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
1547288|NCT01307423|3787139|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
1547289|NCT01307423|3787140|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
1547290|NCT01307423|3787141|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
1547291|NCT01307423|3787142|P3|COMPLETED|Long-term Safety Phase (Year 4)||86
1547292|NCT01307423|3787143|P2|COMPLETED|Long-term Safety Phase (Year 4)||81
1547293|NCT01307423|3787144|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
1547294|NCT01307423|3787136|P9|STARTED|Long-term Safety Phase (Year 4)||49
1547295|NCT01307423|3787137|P8|STARTED|Long-term Safety Phase (Year 4)||40
1547296|NCT01307423|3787138|P7|STARTED|Long-term Safety Phase (Year 4)||0
1547297|NCT01307423|3787139|P6|STARTED|Long-term Safety Phase (Year 4)||0
1547298|NCT01307423|3787140|P5|STARTED|Long-term Safety Phase (Year 4)||0
1547299|NCT01307423|3787141|P4|STARTED|Long-term Safety Phase (Year 4)||0
1547300|NCT01307423|3787142|P3|STARTED|Long-term Safety Phase (Year 4)||91
1547301|NCT01307423|3787143|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
1547302|NCT01307423|3787144|P1|STARTED|Long-term Safety Phase (Year 4)||0
1547303|NCT01307423|3787136|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
1547304|NCT01307423|3787137|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
1547305|NCT01307423|3787138|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1547306|NCT01307423|3787139|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1547307|NCT01307423|3787140|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1547308|NCT01307423|3787141|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1547309|NCT01307423|3787142|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
1547310|NCT01307423|3787143|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
1547311|NCT01307423|3787144|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1547312|NCT01307423|3787136|P9|COMPLETED|Long-term Safety Phase (Year 3)||49
1547313|NCT01307423|3787137|P8|COMPLETED|Long-term Safety Phase (Year 3)||40
1547314|NCT01307423|3787138|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
1547315|NCT01307423|3787139|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
1547316|NCT01307423|3787140|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
1547317|NCT01307423|3787141|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
1547318|NCT01307423|3787142|P3|COMPLETED|Long-term Safety Phase (Year 3)||91
1547319|NCT01307423|3787143|P2|COMPLETED|Long-term Safety Phase (Year 3)||90
1547320|NCT01307423|3787144|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
1547321|NCT01307423|3787136|P9|STARTED|Long-term Safety Phase (Year 3)||60
1547322|NCT01307423|3787137|P8|STARTED|Long-term Safety Phase (Year 3)||48
1547323|NCT01307423|3787138|P7|STARTED|Long-term Safety Phase (Year 3)||0
1547324|NCT01307423|3787139|P6|STARTED|Long-term Safety Phase (Year 3)||0
1547325|NCT01307423|3787140|P5|STARTED|Long-term Safety Phase (Year 3)||0
1547326|NCT01307423|3787141|P4|STARTED|Long-term Safety Phase (Year 3)||0
1547327|NCT01307423|3787142|P3|STARTED|Long-term Safety Phase (Year 3)||109
1547328|NCT01307423|3787143|P2|STARTED|Long-term Safety Phase (Year 3)||99
1547329|NCT01307423|3787144|P1|STARTED|Long-term Safety Phase (Year 3)||0
1547330|NCT01307423|3787136|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
1547331|NCT01307423|3787137|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
1547332|NCT01307423|3787138|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1547333|NCT01307423|3787139|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1547334|NCT01307423|3787140|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1547335|NCT01307423|3787141|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1547336|NCT01307423|3787142|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
1547337|NCT01307423|3787143|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
1547338|NCT01307423|3787144|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1547339|NCT01307423|3787136|P9|COMPLETED|Long-term Safety Phase (Year 2)||60
1547340|NCT01307423|3787137|P8|COMPLETED|Long-term Safety Phase (Year 2)||48
1547341|NCT01307423|3787138|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
1547342|NCT01307423|3787139|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
1547343|NCT01307423|3787140|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
1547344|NCT01307423|3787141|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
1547345|NCT01307423|3787142|P3|COMPLETED|Long-term Safety Phase (Year 2)||109
1547346|NCT01307423|3787143|P2|COMPLETED|Long-term Safety Phase (Year 2)||99
1547347|NCT01307423|3787144|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
1547348|NCT01307423|3787136|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
1547349|NCT01307423|3787137|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
1547350|NCT01307423|3787138|P7|STARTED|Long-term Safety Phase (Year 2)||0
1547351|NCT01307423|3787139|P6|STARTED|Long-term Safety Phase (Year 2)||0
1547352|NCT01307423|3787140|P5|STARTED|Long-term Safety Phase (Year 2)||0
1547353|NCT01307423|3787141|P4|STARTED|Long-term Safety Phase (Year 2)||0
1547354|NCT01307423|3787142|P3|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
1547355|NCT01307423|3787143|P2|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
1547356|NCT01307423|3787144|P1|STARTED|Long-term Safety Phase (Year 2)||0
1547357|NCT01307423|3787136|P9|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
1547358|NCT01307423|3787137|P8|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
1547359|NCT01307423|3787138|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
1547360|NCT01307423|3787139|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
1547361|NCT01307423|3787140|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
1547362|NCT01307423|3787141|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
1547363|NCT01307423|3787142|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
1547364|NCT01307423|3787143|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
1547365|NCT01307423|3787144|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
1547366|NCT01307423|3787136|P9|COMPLETED|Active Treatment Phase (Week 25-52)||0
1547367|NCT01307423|3787137|P8|COMPLETED|Active Treatment Phase (Week 25-52)||0
1547368|NCT01307423|3787138|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
1547369|NCT01307423|3787139|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
1547370|NCT01307423|3787140|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
1547371|NCT01307423|3787141|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
1547372|NCT01307423|3787142|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
1547373|NCT01307423|3787143|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
1547374|NCT01307423|3787144|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
1547375|NCT01307423|3787136|P9|STARTED|Active Treatment Phase (Week 25-52)||0
1547376|NCT01307423|3787137|P8|STARTED|Active Treatment Phase (Week 25-52)||0
1547377|NCT01307423|3787138|P7|STARTED|Active Treatment Phase (Week 25-52)||26
1547378|NCT01307423|3787139|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
1547379|NCT01307423|3787140|P5|STARTED|Active Treatment Phase (Week 25-52)||26
1547380|NCT01307423|3787141|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
1547381|NCT01307423|3787142|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
1547382|NCT01307423|3787143|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
1547383|NCT01307423|3787144|P1|STARTED|Active Treatment Phase (Week 25-52)||0
1547384|NCT01307423|3787136|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547385|NCT01307423|3787137|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547386|NCT01307423|3787138|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547387|NCT01307423|3787139|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547388|NCT01307423|3787140|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547389|NCT01307423|3787141|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547390|NCT01307423|3787142|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1547391|NCT01307423|3787143|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
1547392|NCT01307423|3787144|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
1547393|NCT01307423|3787136|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547394|NCT01307423|3787137|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547395|NCT01307423|3787138|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547396|NCT01307423|3787139|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547397|NCT01307423|3787140|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547398|NCT01307423|3787141|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1547399|NCT01307423|3787142|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
1547400|NCT01307423|3787143|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
1547401|NCT01307423|3787144|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
1547402|NCT01307423|3787136|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547403|NCT01307423|3787137|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547404|NCT01307423|3787138|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547405|NCT01307423|3787139|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547406|NCT01307423|3787140|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547407|NCT01307423|3787141|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547408|NCT01307423|3787142|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
1547409|NCT01307423|3787143|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
1547410|NCT01307423|3787144|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
1547411|NCT01307423|3787136|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547412|NCT01307423|3787137|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547413|NCT01307423|3787138|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547414|NCT01307423|3787139|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547415|NCT01307423|3787140|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547416|NCT01307423|3787141|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1547417|NCT01307423|3787142|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
1547418|NCT01307423|3787143|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
1547419|NCT01307423|3787144|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
1547420|NCT01307423|3787136|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1547421|NCT01307423|3787137|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1547422|NCT01307423|3787138|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1547423|NCT01307423|3787139|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1547424|NCT01307423|3787140|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1547425|NCT01307423|3787141|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1547426|NCT01307423|3787142|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
1547427|NCT01307423|3787143|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
1547428|NCT01307423|3787144|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
1547429|NCT01307423|3787136|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1547430|NCT01307423|3787137|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1547431|NCT01307423|3787138|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1547432|NCT01307423|3787139|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1547433|NCT01307423|3787140|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1547434|NCT01307423|3787141|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1547435|NCT01307423|3787142|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
1547436|NCT01307423|3787143|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
1547437|NCT01307423|3787144|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
1547438|NCT01307397|3787328|P1|NOT COMPLETED|Overall Study||0
1547439|NCT01307397|3787328|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
1547440|NCT01307397|3787328|P1|STARTED|Overall Study||3219
1547441|NCT01307319|3787350|P3|NOT COMPLETED|Overall Study||7
1547442|NCT01307319|3787351|P2|NOT COMPLETED|Overall Study||8
1547443|NCT01307319|3787352|P1|NOT COMPLETED|Overall Study||4
1547444|NCT01307319|3787350|P3|COMPLETED|Overall Study||227
1547445|NCT01307319|3787351|P2|COMPLETED|Overall Study||234
1547446|NCT01307319|3787352|P1|COMPLETED|Overall Study||235
1547447|NCT01307319|3787350|P3|ITT Population|Overall Study||234
1547448|NCT01307319|3787351|P2|ITT Population|Overall Study||241
1547449|NCT01307319|3787352|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
1547450|NCT01307319|3787350|P3|Safety Population|Overall Study||234
1547451|NCT01307319|3787351|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
1547452|NCT01307319|3787352|P1|Safety Population|Overall Study||239
1547453|NCT01307319|3787350|P3|STARTED|Overall Study|Randomized|234
1547454|NCT01307319|3787351|P2|STARTED|Overall Study|Randomized|242
1547455|NCT01307319|3787352|P1|STARTED|Overall Study|Randomized|239
1547456|NCT01307111|3787366|P2|NOT COMPLETED|1-2 Week IUD Check up||2
1547457|NCT01307111|3787367|P1|NOT COMPLETED|1-2 Week IUD Check up||2
1547458|NCT01307111|3787366|P2|COMPLETED|1-2 Week IUD Check up||38
1547459|NCT01307111|3787367|P1|COMPLETED|1-2 Week IUD Check up||38
1547460|NCT01307111|3787366|P2|STARTED|1-2 Week IUD Check up||40
1547461|NCT01307111|3787367|P1|STARTED|1-2 Week IUD Check up||40
1547462|NCT01307111|3787366|P2|NOT COMPLETED|IUD Insertion||0
1547463|NCT01307111|3787367|P1|NOT COMPLETED|IUD Insertion||2
1547464|NCT01307111|3787366|P2|COMPLETED|IUD Insertion||40
1547465|NCT01307111|3787367|P1|COMPLETED|IUD Insertion||40
1547466|NCT01307111|3787366|P2|STARTED|IUD Insertion||40
1547467|NCT01307111|3787367|P1|STARTED|IUD Insertion||42
1547468|NCT01307098|3787378|P3|NOT COMPLETED|Overall Study||0
1547469|NCT01307098|3787379|P2|NOT COMPLETED|Overall Study||0
1547470|NCT01307098|3787380|P1|NOT COMPLETED|Overall Study||0
1547471|NCT01307098|3787378|P3|COMPLETED|Overall Study||3
1547472|NCT01307098|3787379|P2|COMPLETED|Overall Study||3
1547473|NCT01307098|3787380|P1|COMPLETED|Overall Study||3
1547474|NCT01307098|3787378|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
1547475|NCT01307098|3787379|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
1547476|NCT01307098|3787380|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1547477|NCT01307098|3787378|P3|STARTED|Overall Study||3
1547478|NCT01307098|3787379|P2|STARTED|Overall Study||3
1547479|NCT01307098|3787380|P1|STARTED|Overall Study||3
1547480|NCT01307046|3787390|P2|NOT COMPLETED|Overall Study||11
1547481|NCT01307046|3787391|P1|NOT COMPLETED|Overall Study||12
1547482|NCT01307046|3787390|P2|COMPLETED|Overall Study||159
1547483|NCT01307046|3787391|P1|COMPLETED|Overall Study||154
1547484|NCT01307046|3787390|P2|STARTED|Overall Study||170
1547485|NCT01307046|3787391|P1|STARTED|Overall Study||166
1547486|NCT01307033|3787403|P4|NOT COMPLETED|44-week Open-label Extension||12
1547487|NCT01307033|3787404|P3|NOT COMPLETED|44-week Open-label Extension||11
1547488|NCT01307033|3787405|P2|NOT COMPLETED|44-week Open-label Extension||0
1547489|NCT01307033|3787406|P1|NOT COMPLETED|44-week Open-label Extension||0
1547490|NCT01307033|3787403|P4|COMPLETED|44-week Open-label Extension||115
1547491|NCT01307033|3787404|P3|COMPLETED|44-week Open-label Extension||120
1547492|NCT01307033|3787405|P2|COMPLETED|44-week Open-label Extension||0
1547493|NCT01307033|3787406|P1|COMPLETED|44-week Open-label Extension||0
1547494|NCT01307033|3787403|P4|STARTED|44-week Open-label Extension||127
1547495|NCT01307033|3787404|P3|STARTED|44-week Open-label Extension||131
1547496|NCT01307033|3787405|P2|STARTED|44-week Open-label Extension||0
1547497|NCT01307033|3787406|P1|STARTED|44-week Open-label Extension||0
1547498|NCT01307033|3787403|P4|NOT COMPLETED|8-week Double-blind Period||0
1547499|NCT01307033|3787404|P3|NOT COMPLETED|8-week Double-blind Period||0
1547500|NCT01307033|3787405|P2|NOT COMPLETED|8-week Double-blind Period||7
1547501|NCT01307033|3787406|P1|NOT COMPLETED|8-week Double-blind Period||13
1547502|NCT01307033|3787403|P4|COMPLETED|8-week Double-blind Period||0
1547503|NCT01307033|3787404|P3|COMPLETED|8-week Double-blind Period||0
1547504|NCT01307033|3787405|P2|COMPLETED|8-week Double-blind Period||127
1547505|NCT01307033|3787406|P1|COMPLETED|8-week Double-blind Period||131
1547506|NCT01307033|3787403|P4|STARTED|8-week Double-blind Period||0
1547507|NCT01307033|3787404|P3|STARTED|8-week Double-blind Period||0
1547508|NCT01307033|3787405|P2|STARTED|8-week Double-blind Period||134
1547509|NCT01307033|3787406|P1|STARTED|8-week Double-blind Period||144
1547510|NCT01307020|3787428|P10|NOT COMPLETED|Overall Study||0
1547511|NCT01307020|3787429|P9|NOT COMPLETED|Overall Study||0
1547512|NCT01307020|3787430|P8|NOT COMPLETED|Overall Study||0
1547513|NCT01307020|3787431|P7|NOT COMPLETED|Overall Study||1
1547514|NCT01307020|3787432|P6|NOT COMPLETED|Overall Study||0
1547515|NCT01307020|3787433|P5|NOT COMPLETED|Overall Study||0
1547516|NCT01307020|3787434|P4|NOT COMPLETED|Overall Study||1
1547517|NCT01307020|3787435|P3|NOT COMPLETED|Overall Study||1
1547518|NCT01307020|3787436|P2|NOT COMPLETED|Overall Study||1
1547519|NCT01307020|3787437|P1|NOT COMPLETED|Overall Study||0
1547520|NCT01307020|3787428|P10|COMPLETED|Overall Study||62
1547521|NCT01307020|3787429|P9|COMPLETED|Overall Study||61
1547522|NCT01307020|3787430|P8|COMPLETED|Overall Study||60
1547523|NCT01307020|3787431|P7|COMPLETED|Overall Study||58
1547524|NCT01307020|3787432|P6|COMPLETED|Overall Study||61
1547525|NCT01307020|3787433|P5|COMPLETED|Overall Study||60
1547526|NCT01307020|3787434|P4|COMPLETED|Overall Study||60
1547527|NCT01307020|3787435|P3|COMPLETED|Overall Study||62
1547528|NCT01307020|3787436|P2|COMPLETED|Overall Study||62
1547529|NCT01307020|3787437|P1|COMPLETED|Overall Study||61
1547530|NCT01307020|3787428|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
1547531|NCT01307020|3787429|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1547532|NCT01307020|3787430|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
1547533|NCT01307020|3787431|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
1547534|NCT01307020|3787432|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1547535|NCT01307020|3787433|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1547536|NCT01307020|3787434|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
1547537|NCT01307020|3787435|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
1547538|NCT01307020|3787436|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
1547539|NCT01307020|3787437|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1547540|NCT01307020|3787428|P10|Safety Population|Overall Study||62
1547541|NCT01307020|3787429|P9|Safety Population|Overall Study||61
1547542|NCT01307020|3787430|P8|Safety Population|Overall Study||60
1547543|NCT01307020|3787431|P7|Safety Population|Overall Study||59
1547544|NCT01307020|3787432|P6|Safety Population|Overall Study||61
1547545|NCT01307020|3787433|P5|Safety Population|Overall Study||60
1547546|NCT01307020|3787434|P4|Safety Population|Overall Study||61
1547547|NCT01307020|3787435|P3|Safety Population|Overall Study||63
1547548|NCT01307020|3787436|P2|Safety Population|Overall Study||63
1547549|NCT01307020|3787437|P1|Safety Population|Overall Study||61
1547550|NCT01307020|3787428|P10|STARTED|Overall Study||62
1547551|NCT01307020|3787429|P9|STARTED|Overall Study||61
1547552|NCT01307020|3787430|P8|STARTED|Overall Study||60
1547553|NCT01307020|3787431|P7|STARTED|Overall Study||59
1547554|NCT01307020|3787432|P6|STARTED|Overall Study||61
1547555|NCT01307020|3787433|P5|STARTED|Overall Study||60
1547556|NCT01307020|3787434|P4|STARTED|Overall Study||61
1547557|NCT01307020|3787435|P3|STARTED|Overall Study||63
1547558|NCT01307020|3787436|P2|STARTED|Overall Study||63
1547559|NCT01307020|3787437|P1|STARTED|Overall Study||61
1547560|NCT01307007|3787481|P2|NOT COMPLETED|Overall Study||0
1547561|NCT01307007|3787482|P1|NOT COMPLETED|Overall Study||0
1547562|NCT01307007|3787481|P2|COMPLETED|Overall Study||30
1547563|NCT01307007|3787482|P1|COMPLETED|Overall Study||25
1547564|NCT01307007|3787481|P2|STARTED|Overall Study||30
1547565|NCT01307007|3787482|P1|STARTED|Overall Study||25
1547566|NCT01306968|3787492|P4|NOT COMPLETED|Overall Study||4
1547567|NCT01306968|3787493|P3|NOT COMPLETED|Overall Study||1
1547568|NCT01306968|3787494|P2|NOT COMPLETED|Overall Study||3
1547569|NCT01306968|3787495|P1|NOT COMPLETED|Overall Study||1
1547570|NCT01306968|3787492|P4|COMPLETED|Overall Study||21
1547571|NCT01306968|3787493|P3|COMPLETED|Overall Study||23
1547572|NCT01306968|3787494|P2|COMPLETED|Overall Study||20
1547573|NCT01306968|3787495|P1|COMPLETED|Overall Study||6
1547574|NCT01306968|3787492|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
1547575|NCT01306968|3787493|P3|STARTED|Overall Study||24
1547576|NCT01306968|3787494|P2|STARTED|Overall Study||23
1547577|NCT01306968|3787495|P1|STARTED|Overall Study||7
1547578|NCT01306877|3787519|P2|NOT COMPLETED|Overall Study||4
1547579|NCT01306877|3787520|P1|NOT COMPLETED|Overall Study||3
1547580|NCT01306877|3787519|P2|COMPLETED|Overall Study||67
1547581|NCT01306877|3787520|P1|COMPLETED|Overall Study||75
1547582|NCT01306877|3787519|P2|STARTED|Overall Study||71
1547583|NCT01306877|3787520|P1|STARTED|Overall Study||78
1547584|NCT01306643|3787538|P1|NOT COMPLETED|Overall Study||13
1547585|NCT01306643|3787538|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
1547586|NCT01306643|3787538|P1|STARTED|Overall Study||18
1547587|NCT01306617|3787550|P3|NOT COMPLETED|Overall Study||5
1547588|NCT01306617|3787551|P2|NOT COMPLETED|Overall Study||1
1547589|NCT01306617|3787552|P1|NOT COMPLETED|Overall Study||1
1547590|NCT01306617|3787550|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
1547591|NCT01306617|3787551|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
1547592|NCT01306617|3787552|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
1547593|NCT01306617|3787550|P3|STARTED|Overall Study||17
1547594|NCT01306617|3787551|P2|STARTED|Overall Study||14
1547595|NCT01306617|3787552|P1|STARTED|Overall Study||19
1547596|NCT01306305|3787595|P2|NOT COMPLETED|Overall Study||0
1547597|NCT01306305|3787596|P1|NOT COMPLETED|Overall Study||2
1547598|NCT01306305|3787595|P2|COMPLETED|Overall Study||55
1547599|NCT01306305|3787596|P1|COMPLETED|Overall Study||53
1547600|NCT01306305|3787595|P2|STARTED|Overall Study||55
1547601|NCT01306305|3787596|P1|STARTED|Overall Study||55
1547602|NCT01306292|3787612|P4|NOT COMPLETED|Second Injection||0
1547603|NCT01306292|3787613|P3|NOT COMPLETED|Second Injection||1
1547604|NCT01306292|3787614|P2|NOT COMPLETED|Second Injection||0
1547605|NCT01306292|3787615|P1|NOT COMPLETED|Second Injection||0
1547606|NCT01306292|3787612|P4|COMPLETED|Second Injection||10
1547607|NCT01306292|3787613|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
1547608|NCT01306292|3787614|P2|COMPLETED|Second Injection||8
1547609|NCT01306292|3787615|P1|COMPLETED|Second Injection||10
1547610|NCT01306292|3787612|P4|STARTED|Second Injection||10
1547611|NCT01306292|3787613|P3|STARTED|Second Injection||8
1547612|NCT01306292|3787614|P2|STARTED|Second Injection||8
1547613|NCT01306292|3787615|P1|STARTED|Second Injection||10
1547614|NCT01306292|3787612|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1547615|NCT01306292|3787613|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1547616|NCT01306292|3787614|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1547617|NCT01306292|3787615|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1547618|NCT01306292|3787612|P4|COMPLETED|Washout (at Least 10 Minutes)||10
1547619|NCT01306292|3787613|P3|COMPLETED|Washout (at Least 10 Minutes)||8
1547620|NCT01306292|3787614|P2|COMPLETED|Washout (at Least 10 Minutes)||8
1547621|NCT01306292|3787615|P1|COMPLETED|Washout (at Least 10 Minutes)||10
1547622|NCT01306292|3787612|P4|STARTED|Washout (at Least 10 Minutes)||10
1547623|NCT01306292|3787613|P3|STARTED|Washout (at Least 10 Minutes)||8
1547624|NCT01306292|3787614|P2|STARTED|Washout (at Least 10 Minutes)||8
1547625|NCT01306292|3787615|P1|STARTED|Washout (at Least 10 Minutes)||10
1547626|NCT01306292|3787612|P4|NOT COMPLETED|First Injection||0
1547627|NCT01306292|3787613|P3|NOT COMPLETED|First Injection||0
1547628|NCT01306292|3787614|P2|NOT COMPLETED|First Injection||0
1547629|NCT01306292|3787615|P1|NOT COMPLETED|First Injection||0
1547630|NCT01306292|3787612|P4|COMPLETED|First Injection||10
1547631|NCT01306292|3787613|P3|COMPLETED|First Injection||8
1547632|NCT01306292|3787614|P2|COMPLETED|First Injection||8
1547633|NCT01306292|3787615|P1|COMPLETED|First Injection||10
1547634|NCT01306292|3787612|P4|STARTED|First Injection||10
1547635|NCT01306292|3787613|P3|STARTED|First Injection||8
1547636|NCT01306292|3787614|P2|STARTED|First Injection||8
1547637|NCT01306292|3787615|P1|STARTED|First Injection||10
1547638|NCT01306253|3787633|P2|NOT COMPLETED|Overall Study||1
1547639|NCT01306253|3787634|P1|NOT COMPLETED|Overall Study||1
1547640|NCT01306253|3787633|P2|COMPLETED|Overall Study||56
1547641|NCT01306253|3787634|P1|COMPLETED|Overall Study||56
1547642|NCT01306253|3787633|P2|STARTED|Overall Study||57
1547643|NCT01306253|3787634|P1|STARTED|Overall Study||57
1547644|NCT01306214|3787651|P3|NOT COMPLETED|Overall Study||22
1547645|NCT01306214|3787652|P2|NOT COMPLETED|Overall Study||28
1547646|NCT01306214|3787653|P1|NOT COMPLETED|Overall Study||28
1547647|NCT01306214|3787651|P3|COMPLETED|Overall Study||168
1547648|NCT01306214|3787652|P2|COMPLETED|Overall Study||159
1547649|NCT01306214|3787653|P1|COMPLETED|Overall Study||161
1547650|NCT01306214|3787651|P3|STARTED|Overall Study||190
1547651|NCT01306214|3787652|P2|STARTED|Overall Study||187
1547652|NCT01306214|3787653|P1|STARTED|Overall Study||189
1547653|NCT01306201|3787670|P1|NOT COMPLETED|Overall Study||10
1547654|NCT01306201|3787670|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
1547655|NCT01306201|3787670|P1|STARTED|Overall Study||63
1547656|NCT01306175|3787678|P1|NOT COMPLETED|Second Intervention||0
1547657|NCT01306175|3787678|P1|COMPLETED|Second Intervention||20
1547658|NCT01306175|3787678|P1|STARTED|Second Intervention||20
1547659|NCT01306175|3787678|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
1547660|NCT01306175|3787678|P1|COMPLETED|Washout Period of at Least 14 Days||20
1547661|NCT01306175|3787678|P1|STARTED|Washout Period of at Least 14 Days||20
1547662|NCT01306175|3787678|P1|NOT COMPLETED|First Intervention||0
1547663|NCT01306175|3787678|P1|COMPLETED|First Intervention||20
1547664|NCT01306175|3787678|P1|STARTED|First Intervention||20
1547665|NCT01306162|3787692|P4|NOT COMPLETED|Period 4||0
1547666|NCT01306162|3787693|P3|NOT COMPLETED|Period 4||0
1547667|NCT01306162|3787694|P2|NOT COMPLETED|Period 4||0
1547668|NCT01306162|3787695|P1|NOT COMPLETED|Period 4||0
1547669|NCT01306162|3787692|P4|COMPLETED|Period 4||8
1547670|NCT01306162|3787693|P3|COMPLETED|Period 4||9
1547671|NCT01306162|3787694|P2|COMPLETED|Period 4||8
1547672|NCT01306162|3787695|P1|COMPLETED|Period 4||9
1547673|NCT01306162|3787692|P4|STARTED|Period 4||8
1547674|NCT01306162|3787693|P3|STARTED|Period 4||9
1547675|NCT01306162|3787694|P2|STARTED|Period 4||8
1547676|NCT01306162|3787695|P1|STARTED|Period 4||9
1547677|NCT01306162|3787692|P4|NOT COMPLETED|Washout 2||0
1547678|NCT01306162|3787693|P3|NOT COMPLETED|Washout 2||0
1547679|NCT01306162|3787694|P2|NOT COMPLETED|Washout 2||0
1547680|NCT01306162|3787695|P1|NOT COMPLETED|Washout 2||0
1547681|NCT01306162|3787692|P4|COMPLETED|Washout 2||8
1547682|NCT01306162|3787693|P3|COMPLETED|Washout 2||9
1547683|NCT01306162|3787694|P2|COMPLETED|Washout 2||8
1547684|NCT01306162|3787695|P1|COMPLETED|Washout 2||9
1547685|NCT01306162|3787692|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
1547686|NCT01306162|3787693|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
1547687|NCT01306162|3787694|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
1547688|NCT01306162|3787695|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
1547689|NCT01306162|3787692|P4|NOT COMPLETED|Period 3||0
1547690|NCT01306162|3787693|P3|NOT COMPLETED|Period 3||0
1547691|NCT01306162|3787694|P2|NOT COMPLETED|Period 3||0
1547692|NCT01306162|3787695|P1|NOT COMPLETED|Period 3||0
1547693|NCT01306162|3787692|P4|COMPLETED|Period 3||8
1547694|NCT01306162|3787693|P3|COMPLETED|Period 3||9
1547695|NCT01306162|3787694|P2|COMPLETED|Period 3||8
1547696|NCT01306162|3787695|P1|COMPLETED|Period 3||9
1547697|NCT01306162|3787692|P4|STARTED|Period 3||8
1547698|NCT01306162|3787693|P3|STARTED|Period 3||9
1547699|NCT01306162|3787694|P2|STARTED|Period 3||8
1547700|NCT01306162|3787695|P1|STARTED|Period 3||9
1547701|NCT01306162|3787692|P4|NOT COMPLETED|Period 2||0
1547702|NCT01306162|3787693|P3|NOT COMPLETED|Period 2||0
1547703|NCT01306162|3787694|P2|NOT COMPLETED|Period 2||0
1547704|NCT01306162|3787695|P1|NOT COMPLETED|Period 2||0
1547705|NCT01306162|3787692|P4|COMPLETED|Period 2||8
1547706|NCT01306162|3787693|P3|COMPLETED|Period 2||9
1547707|NCT01306162|3787694|P2|COMPLETED|Period 2||8
1547708|NCT01306162|3787695|P1|COMPLETED|Period 2||9
1547709|NCT01306162|3787692|P4|STARTED|Period 2|No washout phase after Period 2.|8
1547710|NCT01306162|3787693|P3|STARTED|Period 2|No washout phase after Period 2.|9
1547711|NCT01306162|3787694|P2|STARTED|Period 2|No washout phase after Period 2.|8
1547712|NCT01306162|3787695|P1|STARTED|Period 2|No washout phase after Period 2.|9
1547713|NCT01306162|3787692|P4|NOT COMPLETED|Washout 1||0
1547714|NCT01306162|3787693|P3|NOT COMPLETED|Washout 1||0
1547715|NCT01306162|3787694|P2|NOT COMPLETED|Washout 1||1
1547716|NCT01306162|3787695|P1|NOT COMPLETED|Washout 1||0
1547717|NCT01306162|3787692|P4|COMPLETED|Washout 1||8
1547718|NCT01306162|3787693|P3|COMPLETED|Washout 1||9
1547719|NCT01306162|3787694|P2|COMPLETED|Washout 1||8
1547720|NCT01306162|3787695|P1|COMPLETED|Washout 1||9
1547721|NCT01306162|3787692|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
1547722|NCT01306162|3787693|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
1547723|NCT01306162|3787694|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
1547724|NCT01306162|3787695|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
1547725|NCT01306162|3787692|P4|NOT COMPLETED|Period 1||1
1547726|NCT01306162|3787693|P3|NOT COMPLETED|Period 1||0
1547727|NCT01306162|3787694|P2|NOT COMPLETED|Period 1||0
1547728|NCT01306162|3787695|P1|NOT COMPLETED|Period 1||0
1547729|NCT01306162|3787692|P4|COMPLETED|Period 1||8
1547730|NCT01306162|3787693|P3|COMPLETED|Period 1||9
1547731|NCT01306162|3787694|P2|COMPLETED|Period 1||9
1547732|NCT01306162|3787695|P1|COMPLETED|Period 1||9
1547733|NCT01306162|3787692|P4|STARTED|Period 1||9
1547734|NCT01306162|3787693|P3|STARTED|Period 1||9
1547735|NCT01306162|3787694|P2|STARTED|Period 1||9
1547736|NCT01306162|3787695|P1|STARTED|Period 1||9
1547737|NCT01306058|3787723|P1|NOT COMPLETED|Overall Study||2
1547738|NCT01306058|3787723|P1|COMPLETED|Overall Study||25
1547739|NCT01306058|3787723|P1|STARTED|Overall Study||27
1547740|NCT01306032|3787750|P6|NOT COMPLETED|Disease Progression/Crossover||0
1547741|NCT01306032|3787751|P5|NOT COMPLETED|Disease Progression/Crossover||0
1547742|NCT01306032|3787752|P4|NOT COMPLETED|Disease Progression/Crossover||3
1547743|NCT01306032|3787753|P3|NOT COMPLETED|Disease Progression/Crossover||0
1547744|NCT01306032|3787754|P2|NOT COMPLETED|Disease Progression/Crossover||2
1547745|NCT01306032|3787755|P1|NOT COMPLETED|Disease Progression/Crossover||0
1547746|NCT01306032|3787750|P6|COMPLETED|Disease Progression/Crossover||0
1547747|NCT01306032|3787751|P5|COMPLETED|Disease Progression/Crossover||0
1547748|NCT01306032|3787752|P4|COMPLETED|Disease Progression/Crossover||26
1547749|NCT01306032|3787753|P3|COMPLETED|Disease Progression/Crossover||0
1547750|NCT01306032|3787754|P2|COMPLETED|Disease Progression/Crossover||14
1547751|NCT01306032|3787755|P1|COMPLETED|Disease Progression/Crossover||0
1547752|NCT01306032|3787750|P6|STARTED|Disease Progression/Crossover||0
1547753|NCT01306032|3787751|P5|STARTED|Disease Progression/Crossover||0
1547754|NCT01306032|3787752|P4|STARTED|Disease Progression/Crossover||29
1547755|NCT01306032|3787753|P3|STARTED|Disease Progression/Crossover||0
1547756|NCT01306032|3787754|P2|STARTED|Disease Progression/Crossover||16
1547757|NCT01306032|3787755|P1|STARTED|Disease Progression/Crossover||0
1547758|NCT01306032|3787750|P6|NOT COMPLETED|First Intervention||2
1547759|NCT01306032|3787751|P5|NOT COMPLETED|First Intervention||2
1547760|NCT01306032|3787752|P4|NOT COMPLETED|First Intervention||1
1547761|NCT01306032|3787753|P3|NOT COMPLETED|First Intervention||2
1547762|NCT01306032|3787754|P2|NOT COMPLETED|First Intervention||2
1547763|NCT01306032|3787755|P1|NOT COMPLETED|First Intervention||1
1547764|NCT01306032|3787750|P6|COMPLETED|First Intervention||0
1547765|NCT01306032|3787751|P5|COMPLETED|First Intervention||0
1547766|NCT01306032|3787752|P4|COMPLETED|First Intervention||37
1547767|NCT01306032|3787753|P3|COMPLETED|First Intervention||35
1547768|NCT01306032|3787754|P2|COMPLETED|First Intervention||18
1547769|NCT01306032|3787755|P1|COMPLETED|First Intervention||21
1547770|NCT01306032|3787750|P6|STARTED|First Intervention||2
1547771|NCT01306032|3787751|P5|STARTED|First Intervention||2
1547772|NCT01306032|3787752|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
1547773|NCT01306032|3787753|P3|STARTED|First Intervention||37
1547774|NCT01306032|3787754|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
1547775|NCT01306032|3787755|P1|STARTED|First Intervention||22
1547776|NCT01305941|3787807|P1|NOT COMPLETED|Overall Study||10
1547777|NCT01305941|3787807|P1|COMPLETED|Overall Study||22
1547778|NCT01305941|3787807|P1|STARTED|Overall Study||32
1547779|NCT01305811|3787821|P2|NOT COMPLETED|Overall Study||11
1547780|NCT01305811|3787822|P1|NOT COMPLETED|Overall Study||8
1547781|NCT01305811|3787821|P2|COMPLETED|Overall Study||41
1547782|NCT01305811|3787822|P1|COMPLETED|Overall Study||44
1547783|NCT01305811|3787821|P2|STARTED|Overall Study||52
1547784|NCT01305811|3787822|P1|STARTED|Overall Study||52
1547785|NCT01305772|3787832|P2|NOT COMPLETED|Overall Study||0
1547786|NCT01305772|3787833|P1|NOT COMPLETED|Overall Study||0
1547787|NCT01305772|3787832|P2|COMPLETED|Overall Study||1
1547788|NCT01305772|3787833|P1|COMPLETED|Overall Study||5
1547789|NCT01305772|3787832|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
1547790|NCT01305772|3787833|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
1547791|NCT01305772|3787832|P2|Surgery/Biopsy #2|Overall Study||1
1547792|NCT01305772|3787833|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
1547793|NCT01305772|3787832|P2|Research PET/CT #2|Overall Study||1
1547794|NCT01305772|3787833|P1|Research PET/CT #2|Overall Study||5
1547795|NCT01305772|3787832|P2|Panitumumab Dose #1|Overall Study||1
1547796|NCT01305772|3787833|P1|Panitumumab Dose #1|Overall Study||5
1547797|NCT01305772|3787832|P2|Research PET/CT #1|Overall Study||1
1547798|NCT01305772|3787833|P1|Research PET/CT #1|Overall Study||5
1547799|NCT01305772|3787832|P2|Genomic Screening + Biopsy #1|Overall Study||1
1547800|NCT01305772|3787833|P1|Genomic Screening + Biopsy #1|Overall Study||5
1547801|NCT01305772|3787832|P2|STARTED|Overall Study||1
1547802|NCT01305772|3787833|P1|STARTED|Overall Study||5
1547803|NCT01305655|3787840|P1|NOT COMPLETED|Overall Study||0
1547804|NCT01305655|3787840|P1|COMPLETED|Overall Study|December 31, 2014|47
1547805|NCT01305655|3787840|P1|STARTED|Overall Study|July 2008|47
1547806|NCT01305577|3787847|P3|NOT COMPLETED|Overall Study||10
1547807|NCT01305577|3787848|P2|NOT COMPLETED|Overall Study||11
1547808|NCT01305577|3787849|P1|NOT COMPLETED|Overall Study||13
1547809|NCT01305577|3787847|P3|COMPLETED|Overall Study||112
1547810|NCT01305577|3787848|P2|COMPLETED|Overall Study||110
1547811|NCT01305577|3787849|P1|COMPLETED|Overall Study||107
1547812|NCT01305577|3787847|P3|Received Treatment|Overall Study||122
1547813|NCT01305577|3787848|P2|Received Treatment|Overall Study||121
1547814|NCT01305577|3787849|P1|Received Treatment|Overall Study||119
1547815|NCT01305577|3787847|P3|STARTED|Overall Study||122
1547816|NCT01305577|3787848|P2|STARTED|Overall Study||121
1547817|NCT01305577|3787849|P1|STARTED|Overall Study||120
1547818|NCT01305564|3787878|P1|NOT COMPLETED|Overall Study||37
1547819|NCT01305564|3787878|P1|COMPLETED|Overall Study||163
1547820|NCT01305564|3787878|P1|STARTED|Overall Study||200
1547821|NCT01305473|3787893|P1|NOT COMPLETED|Overall Study||0
1547822|NCT01305473|3787893|P1|COMPLETED|Overall Study||90
1547823|NCT01305473|3787893|P1|STARTED|Overall Study||90
1547824|NCT01305408|3787905|P2|NOT COMPLETED|Overall Study||31
1547825|NCT01305408|3787906|P1|NOT COMPLETED|Overall Study||32
1547826|NCT01305408|3787905|P2|COMPLETED|Overall Study||169
1547827|NCT01305408|3787906|P1|COMPLETED|Overall Study||167
1547828|NCT01305408|3787905|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
1547829|NCT01305408|3787906|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
1547830|NCT01305408|3787905|P2|Safety Population|Overall Study|Treated participants.|200
1547831|NCT01305408|3787906|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
1547832|NCT01305408|3787905|P2|STARTED|Overall Study||200
1547833|NCT01305408|3787906|P1|STARTED|Overall Study||199
1547834|NCT01305356|3787958|P2|NOT COMPLETED|Overall Study||0
1547835|NCT01305356|3787959|P1|NOT COMPLETED|Overall Study||0
1547836|NCT01305356|3787958|P2|COMPLETED|Overall Study||167
1547837|NCT01305356|3787959|P1|COMPLETED|Overall Study||132
1547838|NCT01305356|3787958|P2|STARTED|Overall Study||167
1547839|NCT01305356|3787959|P1|STARTED|Overall Study||132
1547840|NCT01305265|3787975|P2|NOT COMPLETED|Overall Study||6
1547841|NCT01305265|3787976|P1|NOT COMPLETED|Overall Study||2
1547842|NCT01305265|3787975|P2|COMPLETED|Overall Study||64
1547843|NCT01305265|3787976|P1|COMPLETED|Overall Study||69
1547844|NCT01305265|3787975|P2|STARTED|Overall Study||70
1547845|NCT01305265|3787976|P1|STARTED|Overall Study||71
1547846|NCT01305252|3787984|P2|NOT COMPLETED|Overall Study||0
1547847|NCT01305252|3787985|P1|NOT COMPLETED|Overall Study||1
1547848|NCT01305252|3787984|P2|COMPLETED|Overall Study||11
1547849|NCT01305252|3787985|P1|COMPLETED|Overall Study||9
1547850|NCT01305252|3787984|P2|STARTED|Overall Study||11
1547851|NCT01305252|3787985|P1|STARTED|Overall Study||10
1547852|NCT01305239|3787999|P1|NOT COMPLETED|Overall Study||23
1547853|NCT01305239|3787999|P1|COMPLETED|Overall Study||375
1547854|NCT01305239|3787999|P1|Intent to Treat Population|Overall Study||287
1547855|NCT01305239|3787999|P1|Safety Set|Overall Study||397
1547856|NCT01305239|3787999|P1|STARTED|Overall Study||398
1547857|NCT01305213|3788009|P2|NOT COMPLETED|Overall Study||0
1547858|NCT01305213|3788010|P1|NOT COMPLETED|Overall Study||0
1547859|NCT01305213|3788009|P2|COMPLETED|Overall Study||54
1547860|NCT01305213|3788010|P1|COMPLETED|Overall Study||53
1547861|NCT01305213|3788009|P2|STARTED|Overall Study||54
1547862|NCT01305213|3788010|P1|STARTED|Overall Study||53
1547863|NCT01305200|3788029|P3|NOT COMPLETED|Overall Study||3
1547864|NCT01305200|3788030|P2|NOT COMPLETED|Overall Study||31
1547865|NCT01305200|3788031|P1|NOT COMPLETED|Overall Study||29
1547866|NCT01305200|3788029|P3|COMPLETED|Overall Study||0
1547867|NCT01305200|3788030|P2|COMPLETED|Overall Study||81
1547868|NCT01305200|3788031|P1|COMPLETED|Overall Study||82
1547869|NCT01305200|3788029|P3|STARTED|Overall Study||3
1547870|NCT01305200|3788030|P2|STARTED|Overall Study||112
1547871|NCT01305200|3788031|P1|STARTED|Overall Study||111
1547872|NCT01305044|3788061|P2|NOT COMPLETED|Overall Study||6
1547873|NCT01305044|3788062|P1|NOT COMPLETED|Overall Study||3
1547874|NCT01305044|3788061|P2|COMPLETED|Overall Study||25
1547875|NCT01305044|3788062|P1|COMPLETED|Overall Study||29
1547876|NCT01305044|3788061|P2|STARTED|Overall Study||31
1547877|NCT01305044|3788062|P1|STARTED|Overall Study||32
1547878|NCT01304966|3788086|P1|NOT COMPLETED|Overall Study||0
1547879|NCT01304966|3788086|P1|COMPLETED|Overall Study||15
1547880|NCT01304966|3788086|P1|STARTED|Overall Study||15
1547881|NCT01304706|3788092|P1|NOT COMPLETED|Overall Study||17
1547882|NCT01304706|3788092|P1|COMPLETED|Overall Study||104
1547883|NCT01304706|3788092|P1|STARTED|Overall Study||121
1547884|NCT01304693|3788101|P5|NOT COMPLETED|Overall Study||1
1547885|NCT01304693|3788102|P4|NOT COMPLETED|Overall Study||1
1547886|NCT01304693|3788103|P3|NOT COMPLETED|Overall Study||1
1547887|NCT01304693|3788104|P2|NOT COMPLETED|Overall Study||0
1547888|NCT01304693|3788105|P1|NOT COMPLETED|Overall Study||0
1547889|NCT01304693|3788101|P5|COMPLETED|Overall Study||60
1547890|NCT01304693|3788102|P4|COMPLETED|Overall Study||39
1547891|NCT01304693|3788103|P3|COMPLETED|Overall Study||47
1547892|NCT01304693|3788104|P2|COMPLETED|Overall Study||35
1547893|NCT01304693|3788105|P1|COMPLETED|Overall Study||10
1547894|NCT01304693|3788101|P5|STARTED|Overall Study||61
1547895|NCT01304693|3788102|P4|STARTED|Overall Study||40
1547896|NCT01304693|3788103|P3|STARTED|Overall Study||48
1547897|NCT01304693|3788104|P2|STARTED|Overall Study||35
1547898|NCT01304693|3788105|P1|STARTED|Overall Study||10
1547899|NCT01304641|3788124|P2|NOT COMPLETED|Overall Study||0
1547900|NCT01304641|3788125|P1|NOT COMPLETED|Overall Study||0
1547901|NCT01304641|3788124|P2|COMPLETED|Overall Study||20132
1547902|NCT01304641|3788125|P1|COMPLETED|Overall Study||11470
1547903|NCT01304641|3788124|P2|STARTED|Overall Study||20132
1547904|NCT01304641|3788125|P1|STARTED|Overall Study||11470
1547905|NCT01304589|3788143|P1|NOT COMPLETED|Overall Study||13
1547906|NCT01304589|3788143|P1|COMPLETED|Overall Study||18
1547907|NCT01304589|3788143|P1|STARTED|Overall Study||31
1547908|NCT01304498|3788152|P2|NOT COMPLETED|Overall Study||5
1547909|NCT01304498|3788153|P1|NOT COMPLETED|Overall Study||6
1547910|NCT01304498|3788152|P2|COMPLETED|Overall Study||295
1547911|NCT01304498|3788153|P1|COMPLETED|Overall Study||294
1547912|NCT01304498|3788152|P2|Received ≥1 Dose|Overall Study||300
1547913|NCT01304498|3788153|P1|Received ≥1 Dose|Overall Study||300
1547914|NCT01304498|3788152|P2|STARTED|Overall Study||300
1547915|NCT01304498|3788153|P1|STARTED|Overall Study||300
1547916|NCT01304329|3788173|P6|NOT COMPLETED|Third Intervention (3 Days)||0
1547917|NCT01304329|3788174|P5|NOT COMPLETED|Third Intervention (3 Days)||0
1547918|NCT01304329|3788175|P4|NOT COMPLETED|Third Intervention (3 Days)||0
1547919|NCT01304329|3788176|P3|NOT COMPLETED|Third Intervention (3 Days)||0
1547920|NCT01304329|3788177|P2|NOT COMPLETED|Third Intervention (3 Days)||1
1547921|NCT01304329|3788178|P1|NOT COMPLETED|Third Intervention (3 Days)||0
1547922|NCT01304329|3788173|P6|COMPLETED|Third Intervention (3 Days)||3
1547923|NCT01304329|3788174|P5|COMPLETED|Third Intervention (3 Days)||3
1547924|NCT01304329|3788175|P4|COMPLETED|Third Intervention (3 Days)||3
1547925|NCT01304329|3788176|P3|COMPLETED|Third Intervention (3 Days)||3
1547926|NCT01304329|3788177|P2|COMPLETED|Third Intervention (3 Days)||2
1547927|NCT01304329|3788178|P1|COMPLETED|Third Intervention (3 Days)||3
1547928|NCT01304329|3788173|P6|STARTED|Third Intervention (3 Days)||3
1547929|NCT01304329|3788174|P5|STARTED|Third Intervention (3 Days)||3
1547930|NCT01304329|3788175|P4|STARTED|Third Intervention (3 Days)||3
1547931|NCT01304329|3788176|P3|STARTED|Third Intervention (3 Days)||3
1547932|NCT01304329|3788177|P2|STARTED|Third Intervention (3 Days)||3
1547933|NCT01304329|3788178|P1|STARTED|Third Intervention (3 Days)||3
1547934|NCT01304329|3788173|P6|NOT COMPLETED|Second Intervention (3 Days)||0
1547935|NCT01304329|3788174|P5|NOT COMPLETED|Second Intervention (3 Days)||0
1547936|NCT01304329|3788175|P4|NOT COMPLETED|Second Intervention (3 Days)||0
1547937|NCT01304329|3788176|P3|NOT COMPLETED|Second Intervention (3 Days)||0
1547938|NCT01304329|3788177|P2|NOT COMPLETED|Second Intervention (3 Days)||0
1547939|NCT01304329|3788178|P1|NOT COMPLETED|Second Intervention (3 Days)||0
1547940|NCT01304329|3788173|P6|COMPLETED|Second Intervention (3 Days)||3
1547941|NCT01304329|3788174|P5|COMPLETED|Second Intervention (3 Days)||3
1547942|NCT01304329|3788175|P4|COMPLETED|Second Intervention (3 Days)||3
1547943|NCT01304329|3788176|P3|COMPLETED|Second Intervention (3 Days)||3
1547944|NCT01304329|3788177|P2|COMPLETED|Second Intervention (3 Days)||3
1547945|NCT01304329|3788178|P1|COMPLETED|Second Intervention (3 Days)||3
1547946|NCT01304329|3788173|P6|STARTED|Second Intervention (3 Days)||3
1547947|NCT01304329|3788174|P5|STARTED|Second Intervention (3 Days)||3
1547948|NCT01304329|3788175|P4|STARTED|Second Intervention (3 Days)||3
1547949|NCT01304329|3788176|P3|STARTED|Second Intervention (3 Days)||3
1547950|NCT01304329|3788177|P2|STARTED|Second Intervention (3 Days)||3
1547951|NCT01304329|3788178|P1|STARTED|Second Intervention (3 Days)||3
1547952|NCT01304329|3788173|P6|NOT COMPLETED|First Intervention (3 Days)||0
1547953|NCT01304329|3788174|P5|NOT COMPLETED|First Intervention (3 Days)||0
1547954|NCT01304329|3788175|P4|NOT COMPLETED|First Intervention (3 Days)||0
1547955|NCT01304329|3788176|P3|NOT COMPLETED|First Intervention (3 Days)||0
1547956|NCT01304329|3788177|P2|NOT COMPLETED|First Intervention (3 Days)||0
1547957|NCT01304329|3788178|P1|NOT COMPLETED|First Intervention (3 Days)||0
1547958|NCT01304329|3788173|P6|COMPLETED|First Intervention (3 Days)||3
1547959|NCT01304329|3788174|P5|COMPLETED|First Intervention (3 Days)||3
1547960|NCT01304329|3788175|P4|COMPLETED|First Intervention (3 Days)||3
1547961|NCT01304329|3788176|P3|COMPLETED|First Intervention (3 Days)||3
1547962|NCT01304329|3788177|P2|COMPLETED|First Intervention (3 Days)||3
1547963|NCT01304329|3788178|P1|COMPLETED|First Intervention (3 Days)||3
1547964|NCT01304329|3788173|P6|STARTED|First Intervention (3 Days)||3
1547965|NCT01304329|3788174|P5|STARTED|First Intervention (3 Days)||3
1547966|NCT01304329|3788175|P4|STARTED|First Intervention (3 Days)||3
1547967|NCT01304329|3788176|P3|STARTED|First Intervention (3 Days)||3
1547968|NCT01304329|3788177|P2|STARTED|First Intervention (3 Days)||3
1547969|NCT01304329|3788178|P1|STARTED|First Intervention (3 Days)||3
1547970|NCT01304316|3788195|P1|NOT COMPLETED|Overall Study||0
1547971|NCT01304316|3788195|P1|COMPLETED|Overall Study||12
1547972|NCT01304316|3788195|P1|STARTED|Overall Study||12
1547973|NCT01304277|3788209|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
1547974|NCT01304277|3788209|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
1547975|NCT01304277|3788209|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
1547976|NCT01304277|3788209|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
1547977|NCT01304277|3788209|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
1547978|NCT01304277|3788209|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
1547979|NCT01304238|3788231|P10|NOT COMPLETED|Overall Study||0
1547980|NCT01304238|3788232|P9|NOT COMPLETED|Overall Study||0
1547981|NCT01304238|3788233|P8|NOT COMPLETED|Overall Study||0
1547982|NCT01304238|3788234|P7|NOT COMPLETED|Overall Study||0
1547983|NCT01304238|3788235|P6|NOT COMPLETED|Overall Study||0
1547984|NCT01304238|3788236|P5|NOT COMPLETED|Overall Study||0
1547985|NCT01304238|3788237|P4|NOT COMPLETED|Overall Study||0
1547986|NCT01304238|3788238|P3|NOT COMPLETED|Overall Study||0
1547987|NCT01304238|3788239|P2|NOT COMPLETED|Overall Study||0
1547988|NCT01304238|3788240|P1|NOT COMPLETED|Overall Study||0
1547989|NCT01304238|3788231|P10|COMPLETED|Overall Study||3
1547990|NCT01304238|3788232|P9|COMPLETED|Overall Study||1
1547991|NCT01304238|3788233|P8|COMPLETED|Overall Study||4
1547992|NCT01304238|3788234|P7|COMPLETED|Overall Study||5
1547993|NCT01304238|3788235|P6|COMPLETED|Overall Study||11
1547994|NCT01304238|3788236|P5|COMPLETED|Overall Study||11
1547995|NCT01304238|3788237|P4|COMPLETED|Overall Study||78
1547996|NCT01304238|3788238|P3|COMPLETED|Overall Study||46
1547997|NCT01304238|3788239|P2|COMPLETED|Overall Study||4
1547998|NCT01304238|3788240|P1|COMPLETED|Overall Study||32
1547999|NCT01304238|3788231|P10|STARTED|Overall Study||3
1548000|NCT01304238|3788232|P9|STARTED|Overall Study||1
1548001|NCT01304238|3788233|P8|STARTED|Overall Study||4
1548002|NCT01304238|3788234|P7|STARTED|Overall Study||5
1548003|NCT01304238|3788235|P6|STARTED|Overall Study||11
1548004|NCT01304238|3788236|P5|STARTED|Overall Study||11
1548005|NCT01304238|3788237|P4|STARTED|Overall Study||78
1548006|NCT01304238|3788238|P3|STARTED|Overall Study||46
1548007|NCT01304238|3788239|P2|STARTED|Overall Study||4
1548008|NCT01304238|3788240|P1|STARTED|Overall Study||32
1548009|NCT01304147|3788312|P2|NOT COMPLETED|Second Intervention (7days)||1
1548010|NCT01304147|3788313|P1|NOT COMPLETED|Second Intervention (7days)||1
1548011|NCT01304147|3788312|P2|COMPLETED|Second Intervention (7days)||9
1548012|NCT01304147|3788313|P1|COMPLETED|Second Intervention (7days)||9
1548013|NCT01304147|3788312|P2|STARTED|Second Intervention (7days)||10
1548014|NCT01304147|3788313|P1|STARTED|Second Intervention (7days)||10
1548015|NCT01304147|3788312|P2|NOT COMPLETED|Washout (1 Day)||0
1548016|NCT01304147|3788313|P1|NOT COMPLETED|Washout (1 Day)||0
1548017|NCT01304147|3788312|P2|COMPLETED|Washout (1 Day)||10
1548018|NCT01304147|3788313|P1|COMPLETED|Washout (1 Day)||10
1548019|NCT01304147|3788312|P2|STARTED|Washout (1 Day)||10
1548020|NCT01304147|3788313|P1|STARTED|Washout (1 Day)||10
1548021|NCT01304147|3788312|P2|NOT COMPLETED|First Intervention (7days)||0
1548022|NCT01304147|3788313|P1|NOT COMPLETED|First Intervention (7days)||0
1548023|NCT01304147|3788312|P2|COMPLETED|First Intervention (7days)||10
1548024|NCT01304147|3788313|P1|COMPLETED|First Intervention (7days)||10
1548025|NCT01304147|3788312|P2|STARTED|First Intervention (7days)||10
1548026|NCT01304147|3788313|P1|STARTED|First Intervention (7days)||10
1548027|NCT01304082|3788321|P5|NOT COMPLETED|Overall Study||0
1548028|NCT01304082|3788322|P4|NOT COMPLETED|Overall Study||0
1548029|NCT01304082|3788323|P3|NOT COMPLETED|Overall Study||0
1548030|NCT01304082|3788324|P2|NOT COMPLETED|Overall Study||0
1548031|NCT01304082|3788325|P1|NOT COMPLETED|Overall Study||0
1548032|NCT01304082|3788321|P5|COMPLETED|Overall Study||5
1548033|NCT01304082|3788322|P4|COMPLETED|Overall Study||8
1548034|NCT01304082|3788323|P3|COMPLETED|Overall Study||11
1548035|NCT01304082|3788324|P2|COMPLETED|Overall Study||2
1548036|NCT01304082|3788325|P1|COMPLETED|Overall Study||3
1548037|NCT01304082|3788321|P5|Third Intervention|Overall Study||5
1548038|NCT01304082|3788322|P4|Third Intervention|Overall Study||8
1548039|NCT01304082|3788323|P3|Third Intervention|Overall Study||11
1548040|NCT01304082|3788324|P2|Third Intervention|Overall Study||2
1548041|NCT01304082|3788325|P1|Third Intervention|Overall Study||3
1548042|NCT01304082|3788321|P5|Second Intervention|Overall Study||5
1548043|NCT01304082|3788322|P4|Second Intervention|Overall Study||8
1548044|NCT01304082|3788323|P3|Second Intervention|Overall Study||11
1548045|NCT01304082|3788324|P2|Second Intervention|Overall Study||2
1548046|NCT01304082|3788325|P1|Second Intervention|Overall Study||3
1548047|NCT01304082|3788321|P5|First Intervention|Overall Study||5
1548048|NCT01304082|3788322|P4|First Intervention|Overall Study||8
1548049|NCT01304082|3788323|P3|First Intervention|Overall Study||11
1548050|NCT01304082|3788324|P2|First Intervention|Overall Study||2
1548051|NCT01304082|3788325|P1|First Intervention|Overall Study||3
1548052|NCT01304082|3788321|P5|STARTED|Overall Study||5
1548053|NCT01304082|3788322|P4|STARTED|Overall Study||8
1548054|NCT01304082|3788323|P3|STARTED|Overall Study||11
1548055|NCT01304082|3788324|P2|STARTED|Overall Study||2
1548056|NCT01304082|3788325|P1|STARTED|Overall Study||3
1548057|NCT01303965|3788344|P2|NOT COMPLETED|Overall Study||10
1548058|NCT01303965|3788345|P1|NOT COMPLETED|Overall Study||3
1548059|NCT01303965|3788344|P2|COMPLETED|Overall Study||1
1548060|NCT01303965|3788345|P1|COMPLETED|Overall Study||0
1548061|NCT01303965|3788344|P2|STARTED|Overall Study||11
1548062|NCT01303965|3788345|P1|STARTED|Overall Study||3
1548063|NCT01303939|3788359|P2|NOT COMPLETED|Overall Study||0
1548064|NCT01303939|3788360|P1|NOT COMPLETED|Overall Study||7
1548065|NCT01303939|3788359|P2|COMPLETED|Overall Study||15
1548066|NCT01303939|3788360|P1|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
1548067|NCT01303939|3788359|P2|STARTED|Overall Study||15
1548068|NCT01303939|3788360|P1|STARTED|Overall Study||22
1548069|NCT01303861|3788373|P4|NOT COMPLETED|Overall Study||59
1548070|NCT01303861|3788374|P3|NOT COMPLETED|Overall Study||36
1548071|NCT01303861|3788375|P2|NOT COMPLETED|Overall Study||25
1548072|NCT01303861|3788376|P1|NOT COMPLETED|Overall Study||58
1548073|NCT01303861|3788373|P4|COMPLETED|Overall Study||54
1548074|NCT01303861|3788374|P3|COMPLETED|Overall Study||19
1548075|NCT01303861|3788375|P2|COMPLETED|Overall Study||25
1548076|NCT01303861|3788376|P1|COMPLETED|Overall Study||51
1548077|NCT01303861|3788373|P4|Finished Treatment Phase|Overall Study||72
1548078|NCT01303861|3788374|P3|Finished Treatment Phase|Overall Study||39
1548079|NCT01303861|3788375|P2|Finished Treatment Phase|Overall Study||34
1548080|NCT01303861|3788376|P1|Finished Treatment Phase|Overall Study||71
1548081|NCT01303861|3788373|P4|STARTED|Overall Study||113
1548082|NCT01303861|3788374|P3|STARTED|Overall Study||55
1548083|NCT01303861|3788375|P2|STARTED|Overall Study||50
1548084|NCT01303861|3788376|P1|STARTED|Overall Study||109
1548085|NCT01303835|3788397|P2|NOT COMPLETED|Overall Study||25
1548086|NCT01303835|3788398|P1|NOT COMPLETED|Overall Study||19
1548087|NCT01303835|3788397|P2|COMPLETED|Overall Study||31
1548088|NCT01303835|3788398|P1|COMPLETED|Overall Study||35
1548089|NCT01303835|3788397|P2|STARTED|Overall Study||56
1548090|NCT01303835|3788398|P1|STARTED|Overall Study||54
1548091|NCT01303744|3788412|P4|NOT COMPLETED|Overall Study||0
1548092|NCT01303744|3788413|P3|NOT COMPLETED|Overall Study||0
1548093|NCT01303744|3788414|P2|NOT COMPLETED|Overall Study||0
1548094|NCT01303744|3788415|P1|NOT COMPLETED|Overall Study||0
1548095|NCT01303744|3788412|P4|COMPLETED|Overall Study||24
1548096|NCT01303744|3788413|P3|COMPLETED|Overall Study||24
1548097|NCT01303744|3788414|P2|COMPLETED|Overall Study||24
1548098|NCT01303744|3788415|P1|COMPLETED|Overall Study||24
1548099|NCT01303744|3788412|P4|STARTED|Overall Study||24
1548100|NCT01303744|3788413|P3|STARTED|Overall Study||24
1548101|NCT01303744|3788414|P2|STARTED|Overall Study||24
1548102|NCT01303744|3788415|P1|STARTED|Overall Study||24
1548103|NCT01303627|3788435|P2|NOT COMPLETED|Overall Study||1
1548104|NCT01303627|3788436|P1|NOT COMPLETED|Overall Study||0
1548105|NCT01303627|3788435|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
1548106|NCT01303627|3788436|P1|COMPLETED|Overall Study||21
1548107|NCT01303627|3788435|P2|STARTED|Overall Study||21
1548108|NCT01303627|3788436|P1|STARTED|Overall Study||21
1548109|NCT01303510|3788444|P2|NOT COMPLETED|Overall Study||0
1548110|NCT01303510|3788445|P1|NOT COMPLETED|Overall Study||1
1548111|NCT01303510|3788444|P2|COMPLETED|Overall Study||56
1548112|NCT01303510|3788445|P1|COMPLETED|Overall Study||54
1548113|NCT01303510|3788444|P2|STARTED|Overall Study||56
1548114|NCT01303510|3788445|P1|STARTED|Overall Study||55
1548115|NCT01303445|3788459|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
1548116|NCT01303445|3788460|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
1548117|NCT01303445|3788459|P2|COMPLETED|Follow-up Period (14 Days)||25
1548118|NCT01303445|3788460|P1|COMPLETED|Follow-up Period (14 Days)||26
1548119|NCT01303445|3788459|P2|STARTED|Follow-up Period (14 Days)||26
1548120|NCT01303445|3788460|P1|STARTED|Follow-up Period (14 Days)||26
1548121|NCT01303445|3788459|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
1548122|NCT01303445|3788460|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
1548123|NCT01303445|3788459|P2|COMPLETED|Fourth Intervention (7 Days)||26
1548124|NCT01303445|3788460|P1|COMPLETED|Fourth Intervention (7 Days)||26
1548125|NCT01303445|3788459|P2|STARTED|Fourth Intervention (7 Days)||26
1548126|NCT01303445|3788460|P1|STARTED|Fourth Intervention (7 Days)||27
1548127|NCT01303445|3788459|P2|NOT COMPLETED|Third Intervention (7 Days)||0
1548128|NCT01303445|3788460|P1|NOT COMPLETED|Third Intervention (7 Days)||0
1548129|NCT01303445|3788459|P2|COMPLETED|Third Intervention (7 Days)||26
1548130|NCT01303445|3788460|P1|COMPLETED|Third Intervention (7 Days)||27
1548131|NCT01303445|3788459|P2|STARTED|Third Intervention (7 Days)||26
1548132|NCT01303445|3788460|P1|STARTED|Third Intervention (7 Days)||27
1548133|NCT01303445|3788459|P2|NOT COMPLETED|Washout (14 Days)||2
1548134|NCT01303445|3788460|P1|NOT COMPLETED|Washout (14 Days)||1
1548135|NCT01303445|3788459|P2|COMPLETED|Washout (14 Days)||26
1548136|NCT01303445|3788460|P1|COMPLETED|Washout (14 Days)||27
1548137|NCT01303445|3788459|P2|STARTED|Washout (14 Days)||28
1548138|NCT01303445|3788460|P1|STARTED|Washout (14 Days)||28
1548139|NCT01303445|3788459|P2|NOT COMPLETED|Second Intervention (7 Days)||2
1548140|NCT01303445|3788460|P1|NOT COMPLETED|Second Intervention (7 Days)||1
1548141|NCT01303445|3788459|P2|COMPLETED|Second Intervention (7 Days)||28
1548142|NCT01303445|3788460|P1|COMPLETED|Second Intervention (7 Days)||28
1548143|NCT01303445|3788459|P2|STARTED|Second Intervention (7 Days)||30
1548144|NCT01303445|3788460|P1|STARTED|Second Intervention (7 Days)||29
1548145|NCT01303445|3788459|P2|NOT COMPLETED|First Intervention (7 Days)||0
1548146|NCT01303445|3788460|P1|NOT COMPLETED|First Intervention (7 Days)||1
1548147|NCT01303445|3788459|P2|COMPLETED|First Intervention (7 Days)||30
1548148|NCT01303445|3788460|P1|COMPLETED|First Intervention (7 Days)||29
1548149|NCT01303445|3788459|P2|STARTED|First Intervention (7 Days)||30
1548150|NCT01303445|3788460|P1|STARTED|First Intervention (7 Days)||30
1548151|NCT01303406|3788492|P2|NOT COMPLETED|Overall Study||1
1548152|NCT01303406|3788493|P1|NOT COMPLETED|Overall Study||0
1548153|NCT01303406|3788492|P2|COMPLETED|Overall Study||15
1548154|NCT01303406|3788493|P1|COMPLETED|Overall Study||13
1548155|NCT01303406|3788492|P2|STARTED|Overall Study||16
1548156|NCT01303406|3788493|P1|STARTED|Overall Study||13
1548157|NCT01303380|3788501|P1|NOT COMPLETED|Overall Study||1
1548158|NCT01303380|3788501|P1|COMPLETED|Overall Study||8
1548159|NCT01303380|3788501|P1|STARTED|Overall Study||9
1548160|NCT01303224|3788531|P4|NOT COMPLETED|Overall Study||10
1548161|NCT01303224|3788532|P3|NOT COMPLETED|Overall Study||6
1548162|NCT01303224|3788533|P2|NOT COMPLETED|Overall Study||11
1548163|NCT01303224|3788534|P1|NOT COMPLETED|Overall Study||11
1548164|NCT01303224|3788531|P4|COMPLETED|Overall Study||133
1548165|NCT01303224|3788532|P3|COMPLETED|Overall Study||133
1548166|NCT01303224|3788533|P2|COMPLETED|Overall Study||131
1548167|NCT01303224|3788534|P1|COMPLETED|Overall Study||130
1548168|NCT01303224|3788531|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
1548169|NCT01303224|3788532|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
1548170|NCT01303224|3788533|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
1548171|NCT01303224|3788534|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
1548172|NCT01303224|3788531|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
1548173|NCT01303224|3788532|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
1548174|NCT01303224|3788533|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
1548175|NCT01303224|3788534|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
1548176|NCT01303159|3788560|P1|NOT COMPLETED|Overall Study||23
1548177|NCT01303159|3788560|P1|COMPLETED|Overall Study||6
1548178|NCT01303159|3788560|P1|STARTED|Overall Study||29
1548179|NCT01303003|3788567|P2|NOT COMPLETED|Overall Study||0
1548180|NCT01303003|3788568|P1|NOT COMPLETED|Overall Study||0
1548181|NCT01303003|3788567|P2|COMPLETED|Overall Study||0
1548182|NCT01303003|3788568|P1|COMPLETED|Overall Study||0
1548183|NCT01303003|3788567|P2|STARTED|Overall Study||0
1548184|NCT01303003|3788568|P1|STARTED|Overall Study||0
1548185|NCT01302964|3788578|P2|NOT COMPLETED|Overall Study||0
1548186|NCT01302964|3788579|P1|NOT COMPLETED|Overall Study||1
1548187|NCT01302964|3788578|P2|COMPLETED|Overall Study||10
1548188|NCT01302964|3788579|P1|COMPLETED|Overall Study||19
1548189|NCT01302964|3788578|P2|STARTED|Overall Study||10
1548190|NCT01302964|3788579|P1|STARTED|Overall Study||20
1548191|NCT01302938|3788589|P2|NOT COMPLETED|Overall Study||0
1548192|NCT01302938|3788590|P1|NOT COMPLETED|Overall Study||2
1548193|NCT01302938|3788589|P2|COMPLETED|Overall Study||6
1548194|NCT01302938|3788590|P1|COMPLETED|Overall Study||10
1548195|NCT01302938|3788589|P2|STARTED|Overall Study||6
1548196|NCT01302938|3788590|P1|STARTED|Overall Study||12
1548197|NCT01302899|3788635|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
1548198|NCT01302899|3788636|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
1548199|NCT01302899|3788635|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
1548200|NCT01302899|3788636|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
1548201|NCT01302899|3788635|P2|STARTED|Period 4 (Weeks 19 to 26)||3
1548202|NCT01302899|3788636|P1|STARTED|Period 4 (Weeks 19 to 26)||3
1548203|NCT01302899|3788635|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
1548204|NCT01302899|3788636|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
1548205|NCT01302899|3788635|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
1548206|NCT01302899|3788636|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
1548207|NCT01302899|3788635|P2|STARTED|Period 3 (Weeks 13 to 18)||3
1548208|NCT01302899|3788636|P1|STARTED|Period 3 (Weeks 13 to 18)||3
1548209|NCT01302899|3788635|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
1548210|NCT01302899|3788636|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
1548211|NCT01302899|3788635|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
1548212|NCT01302899|3788636|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
1548213|NCT01302899|3788635|P2|STARTED|Period 2 (Weeks 7 to 12)||4
1548214|NCT01302899|3788636|P1|STARTED|Period 2 (Weeks 7 to 12)||4
1548215|NCT01302899|3788635|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
1548216|NCT01302899|3788636|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
1548217|NCT01302899|3788635|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
1548218|NCT01302899|3788636|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
1548219|NCT01302899|3788635|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
1548220|NCT01302899|3788636|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
1548221|NCT01302860|3788686|P1|NOT COMPLETED|Overall Study||0
1548222|NCT01302860|3788686|P1|COMPLETED|Overall Study||17
1548223|NCT01302860|3788686|P1|STARTED|Overall Study||17
1548224|NCT01302743|3788701|P3|NOT COMPLETED|Overall Study||2
1548225|NCT01302743|3788702|P2|NOT COMPLETED|Overall Study||1
1548226|NCT01302743|3788703|P1|NOT COMPLETED|Overall Study||1
1548227|NCT01302743|3788701|P3|COMPLETED|Overall Study||8
1548228|NCT01302743|3788702|P2|COMPLETED|Overall Study||7
1548229|NCT01302743|3788703|P1|COMPLETED|Overall Study||6
1548230|NCT01302743|3788701|P3|STARTED|Overall Study||10
1548231|NCT01302743|3788702|P2|STARTED|Overall Study||8
1548232|NCT01302743|3788703|P1|STARTED|Overall Study||7
1548233|NCT01302691|3788716|P2|NOT COMPLETED|Overall Study||6
1548234|NCT01302691|3788717|P1|NOT COMPLETED|Overall Study||10
1548235|NCT01302691|3788716|P2|COMPLETED|Overall Study||157
1548236|NCT01302691|3788717|P1|COMPLETED|Overall Study||154
1548237|NCT01302691|3788716|P2|STARTED|Overall Study||163
1548238|NCT01302691|3788717|P1|STARTED|Overall Study||164
1548239|NCT01302548|3788737|P2|NOT COMPLETED|Overall Study||1
1548240|NCT01302548|3788738|P1|NOT COMPLETED|Overall Study||2
1548241|NCT01302548|3788737|P2|COMPLETED|Overall Study||18
1548242|NCT01302548|3788738|P1|COMPLETED|Overall Study||12
1548243|NCT01302548|3788737|P2|STARTED|Overall Study||19
1548244|NCT01302548|3788738|P1|STARTED|Overall Study||14
1548245|NCT01302483|3788750|P2|NOT COMPLETED|Overall Study||0
1548246|NCT01302483|3788751|P1|NOT COMPLETED|Overall Study||0
1548247|NCT01302483|3788750|P2|COMPLETED|Overall Study||15
1548248|NCT01302483|3788751|P1|COMPLETED|Overall Study||30
1548249|NCT01302483|3788750|P2|STARTED|Overall Study||15
1548250|NCT01302483|3788751|P1|STARTED|Overall Study||30
1548251|NCT01302444|3788767|P2|NOT COMPLETED|Overall Study||0
1548252|NCT01302444|3788768|P1|NOT COMPLETED|Overall Study||0
1548253|NCT01302444|3788767|P2|COMPLETED|Overall Study||0
1548254|NCT01302444|3788768|P1|COMPLETED|Overall Study||1
1548255|NCT01302444|3788767|P2|STARTED|Overall Study||0
1548256|NCT01302444|3788768|P1|STARTED|Overall Study||1
1548257|NCT01302418|3788788|P1|NOT COMPLETED|Overall Study||18
1548258|NCT01302418|3788788|P1|COMPLETED|Overall Study||254
1548259|NCT01302418|3788788|P1|STARTED|Overall Study||272
1548260|NCT01302392|3788794|P2|NOT COMPLETED|Overall Study||1
1548261|NCT01302392|3788795|P1|NOT COMPLETED|Overall Study||7
1548262|NCT01302392|3788794|P2|COMPLETED|Overall Study||156
1548263|NCT01302392|3788795|P1|COMPLETED|Overall Study||151
1548264|NCT01302392|3788794|P2|Treated|Overall Study||157
1548265|NCT01302392|3788795|P1|Treated|Overall Study||153
1548266|NCT01302392|3788794|P2|STARTED|Overall Study||157
1548267|NCT01302392|3788795|P1|STARTED|Overall Study||158
1548268|NCT01302366|3788815|P1|NOT COMPLETED|Overall Study||5
1548269|NCT01302366|3788815|P1|COMPLETED|Overall Study||15
1548270|NCT01302366|3788815|P1|STARTED|Overall Study||20
1548271|NCT01302119|3788823|P2|NOT COMPLETED|Overall Study||28
1548272|NCT01302119|3788824|P1|NOT COMPLETED|Overall Study||50
1548273|NCT01302119|3788823|P2|COMPLETED|Overall Study||177
1548274|NCT01302119|3788824|P1|COMPLETED|Overall Study||349
1548275|NCT01302119|3788823|P2|STARTED|Overall Study||205
1548276|NCT01302119|3788824|P1|STARTED|Overall Study||399
1548277|NCT01302067|3788839|P3|NOT COMPLETED|Overall Study||98
1548278|NCT01302067|3788840|P2|NOT COMPLETED|Overall Study||34
1548279|NCT01302067|3788841|P1|NOT COMPLETED|Overall Study||78
1548280|NCT01302067|3788839|P3|COMPLETED|Overall Study||681
1548281|NCT01302067|3788840|P2|COMPLETED|Overall Study||352
1548282|NCT01302067|3788841|P1|COMPLETED|Overall Study||712
1548283|NCT01302067|3788839|P3|STARTED|Overall Study||779
1548284|NCT01302067|3788840|P2|STARTED|Overall Study||386
1548285|NCT01302067|3788841|P1|STARTED|Overall Study||790
1548286|NCT01302054|3788912|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
1548287|NCT01302054|3788913|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
1548288|NCT01302054|3788914|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
1548289|NCT01302054|3788912|P3|COMPLETED|Double-Blind Treatment Phase||255
1548290|NCT01302054|3788913|P2|COMPLETED|Double-Blind Treatment Phase||281
1548291|NCT01302054|3788914|P1|COMPLETED|Double-Blind Treatment Phase||0
1548292|NCT01302054|3788912|P3|STARTED|Double-Blind Treatment Phase||301
1548293|NCT01302054|3788913|P2|STARTED|Double-Blind Treatment Phase||308
1548294|NCT01302054|3788914|P1|STARTED|Double-Blind Treatment Phase||0
1548295|NCT01302054|3788912|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
1548296|NCT01302054|3788913|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
1548297|NCT01302054|3788914|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
1548298|NCT01302054|3788912|P3|COMPLETED|Between Open-Label and Double Blind||0
1548299|NCT01302054|3788913|P2|COMPLETED|Between Open-Label and Double Blind||0
1548300|NCT01302054|3788914|P1|COMPLETED|Between Open-Label and Double Blind||609
1548301|NCT01302054|3788912|P3|STARTED|Between Open-Label and Double Blind||0
1548302|NCT01302054|3788913|P2|STARTED|Between Open-Label and Double Blind||0
1548303|NCT01302054|3788914|P1|STARTED|Between Open-Label and Double Blind||611
1548304|NCT01302054|3788912|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
1548305|NCT01302054|3788913|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
1548306|NCT01302054|3788914|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
1548307|NCT01302054|3788912|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
1548308|NCT01302054|3788913|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
1548309|NCT01302054|3788914|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
1548310|NCT01302054|3788912|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
1548311|NCT01302054|3788913|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
1548312|NCT01302054|3788914|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
1548313|NCT01302041|3788941|P1|NOT COMPLETED|Overall Study||40
1548314|NCT01302041|3788941|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
1548315|NCT01302041|3788941|P1|Treatment Received|Overall Study||67
1548316|NCT01302041|3788941|P1|STARTED|Overall Study||67
1548317|NCT01301963|3788972|P2|NOT COMPLETED|Overall Study||0
1548318|NCT01301963|3788973|P1|NOT COMPLETED|Overall Study||0
1548319|NCT01301963|3788972|P2|COMPLETED|Overall Study||4
1548320|NCT01301963|3788973|P1|COMPLETED|Overall Study||5
1548321|NCT01301963|3788972|P2|STARTED|Overall Study||4
1548322|NCT01301963|3788973|P1|STARTED|Overall Study||5
1548323|NCT01301950|3788983|P2|NOT COMPLETED|Overall Study||1
1548324|NCT01301950|3788984|P1|NOT COMPLETED|Overall Study||0
1548325|NCT01301950|3788983|P2|COMPLETED|Overall Study||14
1548326|NCT01301950|3788984|P1|COMPLETED|Overall Study||15
1548327|NCT01301950|3788983|P2|STARTED|Overall Study||15
1548328|NCT01301950|3788984|P1|STARTED|Overall Study||15
1548329|NCT01301833|3789002|P4|NOT COMPLETED|Overall Study||7
1548330|NCT01301833|3789003|P3|NOT COMPLETED|Overall Study||7
1548331|NCT01301833|3789004|P2|NOT COMPLETED|Overall Study||8
1548332|NCT01301833|3789005|P1|NOT COMPLETED|Overall Study||15
1548333|NCT01301833|3789002|P4|COMPLETED|Overall Study||68
1548334|NCT01301833|3789003|P3|COMPLETED|Overall Study||88
1548335|NCT01301833|3789004|P2|COMPLETED|Overall Study||72
1548336|NCT01301833|3789005|P1|COMPLETED|Overall Study||197
1548337|NCT01301833|3789002|P4|STARTED|Overall Study||75
1548338|NCT01301833|3789003|P3|STARTED|Overall Study||95
1548339|NCT01301833|3789004|P2|STARTED|Overall Study||80
1548340|NCT01301833|3789005|P1|STARTED|Overall Study||212
1548341|NCT01301742|3789031|P2|NOT COMPLETED|Second Intervention||0
1548342|NCT01301742|3789032|P1|NOT COMPLETED|Second Intervention||0
1548343|NCT01301742|3789031|P2|COMPLETED|Second Intervention||9
1548344|NCT01301742|3789032|P1|COMPLETED|Second Intervention||9
1548345|NCT01301742|3789031|P2|STARTED|Second Intervention||9
1548346|NCT01301742|3789032|P1|STARTED|Second Intervention||9
1548347|NCT01301742|3789031|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
1548348|NCT01301742|3789032|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
1548349|NCT01301742|3789031|P2|COMPLETED|Washout Period of at Least 7 Days||9
1548350|NCT01301742|3789032|P1|COMPLETED|Washout Period of at Least 7 Days||9
1548351|NCT01301742|3789031|P2|STARTED|Washout Period of at Least 7 Days||9
1548352|NCT01301742|3789032|P1|STARTED|Washout Period of at Least 7 Days||9
1548353|NCT01301742|3789031|P2|NOT COMPLETED|First Intervention||0
1548354|NCT01301742|3789032|P1|NOT COMPLETED|First Intervention||0
1548355|NCT01301742|3789031|P2|COMPLETED|First Intervention||9
1548356|NCT01301742|3789032|P1|COMPLETED|First Intervention||9
1548357|NCT01301742|3789031|P2|STARTED|First Intervention||9
1548358|NCT01301742|3789032|P1|STARTED|First Intervention||9
1548359|NCT01301729|3789043|P1|NOT COMPLETED|Overall Study||4
1548360|NCT01301729|3789043|P1|COMPLETED|Overall Study||28
1548361|NCT01301729|3789043|P1|STARTED|Overall Study||32
1548362|NCT01301625|3789054|P1|NOT COMPLETED|Overall Study||35
1548363|NCT01301625|3789054|P1|COMPLETED|Overall Study||43
1548364|NCT01301625|3789054|P1|STARTED|Overall Study||78
1548365|NCT01301508|3789126|P2|NOT COMPLETED|Overall Study||3
1548366|NCT01301508|3789127|P1|NOT COMPLETED|Overall Study||1
1548367|NCT01301508|3789126|P2|COMPLETED|Overall Study||22
1548368|NCT01301508|3789127|P1|COMPLETED|Overall Study||20
1548369|NCT01301508|3789126|P2|STARTED|Overall Study||25
1548370|NCT01301508|3789127|P1|STARTED|Overall Study||21
1548371|NCT01301456|3789157|P12|NOT COMPLETED|Stage 2||0
1548372|NCT01301456|3789158|P11|NOT COMPLETED|Stage 2||1
1548373|NCT01301456|3789159|P10|NOT COMPLETED|Stage 2||0
1548374|NCT01301456|3789160|P9|NOT COMPLETED|Stage 2||0
1548375|NCT01301456|3789161|P8|NOT COMPLETED|Stage 2||0
1548376|NCT01301456|3789162|P7|NOT COMPLETED|Stage 2||0
1548377|NCT01301456|3789163|P6|NOT COMPLETED|Stage 2||0
1548378|NCT01301456|3789164|P5|NOT COMPLETED|Stage 2||0
1548379|NCT01301456|3789165|P4|NOT COMPLETED|Stage 2||0
1548380|NCT01301456|3789166|P3|NOT COMPLETED|Stage 2||0
1548381|NCT01301456|3789167|P2|NOT COMPLETED|Stage 2||0
1548382|NCT01301456|3789168|P1|NOT COMPLETED|Stage 2||0
1548383|NCT01301456|3789157|P12|COMPLETED|Stage 2||6
1548384|NCT01301456|3789158|P11|COMPLETED|Stage 2||6
1548385|NCT01301456|3789159|P10|COMPLETED|Stage 2||7
1548386|NCT01301456|3789160|P9|COMPLETED|Stage 2||5
1548387|NCT01301456|3789161|P8|COMPLETED|Stage 2||7
1548388|NCT01301456|3789162|P7|COMPLETED|Stage 2||0
1548389|NCT01301456|3789163|P6|COMPLETED|Stage 2||0
1548390|NCT01301456|3789164|P5|COMPLETED|Stage 2||0
1548391|NCT01301456|3789165|P4|COMPLETED|Stage 2||0
1548392|NCT01301456|3789166|P3|COMPLETED|Stage 2||0
1548393|NCT01301456|3789167|P2|COMPLETED|Stage 2||0
1548394|NCT01301456|3789168|P1|COMPLETED|Stage 2||0
1548395|NCT01301456|3789157|P12|Received Treatment|Stage 2||6
1548396|NCT01301456|3789158|P11|Received Treatment|Stage 2||7
1548397|NCT01301456|3789159|P10|Received Treatment|Stage 2||7
1548398|NCT01301456|3789160|P9|Received Treatment|Stage 2||5
1548399|NCT01301456|3789161|P8|Received Treatment|Stage 2||7
1548400|NCT01301456|3789162|P7|Received Treatment|Stage 2||0
1548401|NCT01301456|3789163|P6|Received Treatment|Stage 2||0
1548402|NCT01301456|3789164|P5|Received Treatment|Stage 2||0
1548403|NCT01301456|3789165|P4|Received Treatment|Stage 2||0
1548404|NCT01301456|3789166|P3|Received Treatment|Stage 2||0
1548405|NCT01301456|3789167|P2|Received Treatment|Stage 2||0
1548406|NCT01301456|3789168|P1|Received Treatment|Stage 2||0
1548407|NCT01301456|3789157|P12|STARTED|Stage 2||6
1548408|NCT01301456|3789158|P11|STARTED|Stage 2||7
1548409|NCT01301456|3789159|P10|STARTED|Stage 2||7
1548410|NCT01301456|3789160|P9|STARTED|Stage 2||5
1548411|NCT01301456|3789161|P8|STARTED|Stage 2||7
1548412|NCT01301456|3789162|P7|STARTED|Stage 2||0
1548413|NCT01301456|3789163|P6|STARTED|Stage 2||0
1548414|NCT01301456|3789164|P5|STARTED|Stage 2||0
1548415|NCT01301456|3789165|P4|STARTED|Stage 2||0
1548416|NCT01301456|3789166|P3|STARTED|Stage 2||0
1548417|NCT01301456|3789167|P2|STARTED|Stage 2||0
1548418|NCT01301456|3789168|P1|STARTED|Stage 2||0
1548419|NCT01301456|3789157|P12|NOT COMPLETED|Stage 1||0
1548420|NCT01301456|3789158|P11|NOT COMPLETED|Stage 1||0
1548421|NCT01301456|3789159|P10|NOT COMPLETED|Stage 1||0
1548422|NCT01301456|3789160|P9|NOT COMPLETED|Stage 1||0
1548423|NCT01301456|3789161|P8|NOT COMPLETED|Stage 1||0
1548424|NCT01301456|3789162|P7|NOT COMPLETED|Stage 1||1
1548425|NCT01301456|3789163|P6|NOT COMPLETED|Stage 1||0
1548426|NCT01301456|3789164|P5|NOT COMPLETED|Stage 1||1
1548427|NCT01301456|3789165|P4|NOT COMPLETED|Stage 1||0
1548428|NCT01301456|3789166|P3|NOT COMPLETED|Stage 1||1
1548429|NCT01301456|3789167|P2|NOT COMPLETED|Stage 1||0
1548430|NCT01301456|3789168|P1|NOT COMPLETED|Stage 1||0
1548431|NCT01301456|3789157|P12|COMPLETED|Stage 1||0
1548432|NCT01301456|3789158|P11|COMPLETED|Stage 1||0
1548433|NCT01301456|3789159|P10|COMPLETED|Stage 1||0
1548434|NCT01301456|3789160|P9|COMPLETED|Stage 1||0
1548435|NCT01301456|3789161|P8|COMPLETED|Stage 1||0
1548436|NCT01301456|3789162|P7|COMPLETED|Stage 1||7
1548437|NCT01301456|3789163|P6|COMPLETED|Stage 1||5
1548438|NCT01301456|3789164|P5|COMPLETED|Stage 1||6
1548439|NCT01301456|3789165|P4|COMPLETED|Stage 1||6
1548440|NCT01301456|3789166|P3|COMPLETED|Stage 1||5
1548441|NCT01301456|3789167|P2|COMPLETED|Stage 1||5
1548442|NCT01301456|3789168|P1|COMPLETED|Stage 1||15
1548443|NCT01301456|3789157|P12|Received Treatment|Stage 1||0
1548444|NCT01301456|3789158|P11|Received Treatment|Stage 1||0
1548445|NCT01301456|3789159|P10|Received Treatment|Stage 1||0
1548446|NCT01301456|3789160|P9|Received Treatment|Stage 1||0
1548447|NCT01301456|3789161|P8|Received Treatment|Stage 1||0
1548448|NCT01301456|3789162|P7|Received Treatment|Stage 1||7
1548449|NCT01301456|3789163|P6|Received Treatment|Stage 1||5
1548450|NCT01301456|3789164|P5|Received Treatment|Stage 1||7
1548451|NCT01301456|3789165|P4|Received Treatment|Stage 1||6
1548452|NCT01301456|3789166|P3|Received Treatment|Stage 1||6
1548453|NCT01301456|3789167|P2|Received Treatment|Stage 1||5
1548454|NCT01301456|3789168|P1|Received Treatment|Stage 1||15
1548455|NCT01301456|3789157|P12|STARTED|Stage 1||0
1548456|NCT01301456|3789158|P11|STARTED|Stage 1||0
1548457|NCT01301456|3789159|P10|STARTED|Stage 1||0
1548458|NCT01301456|3789160|P9|STARTED|Stage 1||0
1548459|NCT01301456|3789161|P8|STARTED|Stage 1||0
1548460|NCT01301456|3789162|P7|STARTED|Stage 1||8
1548461|NCT01301456|3789163|P6|STARTED|Stage 1||5
1548462|NCT01301456|3789164|P5|STARTED|Stage 1||7
1548463|NCT01301456|3789165|P4|STARTED|Stage 1||6
1548464|NCT01301456|3789166|P3|STARTED|Stage 1||6
1548465|NCT01301456|3789167|P2|STARTED|Stage 1||5
1548466|NCT01301456|3789168|P1|STARTED|Stage 1||15
1548467|NCT01301391|3789394|P1|NOT COMPLETED|Overall Study||26
1548468|NCT01301391|3789394|P1|COMPLETED|Overall Study||4
1548469|NCT01301391|3789394|P1|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
1548470|NCT01301274|3789406|P2|NOT COMPLETED|Overall Study||1
1548471|NCT01301274|3789407|P1|NOT COMPLETED|Overall Study||2
1548472|NCT01301274|3789406|P2|COMPLETED|Overall Study||31
1548473|NCT01301274|3789407|P1|COMPLETED|Overall Study||32
1548474|NCT01301274|3789406|P2|STARTED|Overall Study||32
1548475|NCT01301274|3789407|P1|STARTED|Overall Study||34
1548476|NCT01301092|3789422|P3|NOT COMPLETED|Overall Study||1
1548477|NCT01301092|3789423|P2|NOT COMPLETED|Overall Study||0
1548478|NCT01301092|3789424|P1|NOT COMPLETED|Overall Study||0
1548479|NCT01301092|3789422|P3|COMPLETED|Overall Study||7
1548480|NCT01301092|3789423|P2|COMPLETED|Overall Study||16
1548481|NCT01301092|3789424|P1|COMPLETED|Overall Study||6
1548482|NCT01301092|3789422|P3|STARTED|Overall Study||8
1548483|NCT01301092|3789423|P2|STARTED|Overall Study||16
1548484|NCT01301092|3789424|P1|STARTED|Overall Study||6
1548485|NCT01301079|3789441|P2|NOT COMPLETED|Overall Study||2
1548486|NCT01301079|3789442|P1|NOT COMPLETED|Overall Study||2
1548487|NCT01301079|3789441|P2|COMPLETED|Overall Study||28
1548488|NCT01301079|3789442|P1|COMPLETED|Overall Study||28
1548489|NCT01301079|3789441|P2|STARTED|Overall Study||30
1548490|NCT01301079|3789442|P1|STARTED|Overall Study||30
1548491|NCT01301066|3789520|P2|NOT COMPLETED|Overall Study||35
1548492|NCT01301066|3789521|P1|NOT COMPLETED|Overall Study||27
1548493|NCT01301066|3789520|P2|COMPLETED|Overall Study||91
1548494|NCT01301066|3789521|P1|COMPLETED|Overall Study||99
1548495|NCT01301066|3789520|P2|STARTED|Overall Study||126
1548496|NCT01301066|3789521|P1|STARTED|Overall Study||126
1548497|NCT01301027|3789529|P2|NOT COMPLETED|Overall Study||10
1548498|NCT01301027|3789530|P1|NOT COMPLETED|Overall Study||8
1548499|NCT01301027|3789529|P2|COMPLETED|Overall Study||37
1548500|NCT01301027|3789530|P1|COMPLETED|Overall Study||40
1548501|NCT01301027|3789529|P2|STARTED|Overall Study||47
1548502|NCT01301027|3789530|P1|STARTED|Overall Study||48
1548503|NCT01301001|3789542|P2|NOT COMPLETED|Second Intervention||0
1548504|NCT01301001|3789543|P1|NOT COMPLETED|Second Intervention||4
1548505|NCT01301001|3789542|P2|COMPLETED|Second Intervention||36
1548506|NCT01301001|3789543|P1|COMPLETED|Second Intervention||30
1548507|NCT01301001|3789542|P2|STARTED|Second Intervention||36
1548508|NCT01301001|3789543|P1|STARTED|Second Intervention||34
1548509|NCT01301001|3789542|P2|NOT COMPLETED|Washout (2 Weeks)||0
1548510|NCT01301001|3789543|P1|NOT COMPLETED|Washout (2 Weeks)||0
1548511|NCT01301001|3789542|P2|COMPLETED|Washout (2 Weeks)||36
1548512|NCT01301001|3789543|P1|COMPLETED|Washout (2 Weeks)||34
1548513|NCT01301001|3789542|P2|STARTED|Washout (2 Weeks)||36
1548514|NCT01301001|3789543|P1|STARTED|Washout (2 Weeks)||34
1548515|NCT01301001|3789542|P2|NOT COMPLETED|First Intervention||9
1548516|NCT01301001|3789543|P1|NOT COMPLETED|First Intervention||10
1548517|NCT01301001|3789542|P2|COMPLETED|First Intervention||36
1548518|NCT01301001|3789543|P1|COMPLETED|First Intervention||34
1548519|NCT01301001|3789542|P2|STARTED|First Intervention||45
1548520|NCT01301001|3789543|P1|STARTED|First Intervention||44
1548521|NCT01300949|3789556|P3|NOT COMPLETED|Overall Study||0
1548522|NCT01300949|3789557|P2|NOT COMPLETED|Overall Study||0
1548523|NCT01300949|3789558|P1|NOT COMPLETED|Overall Study||0
1548524|NCT01300949|3789556|P3|COMPLETED|Overall Study||35
1548525|NCT01300949|3789557|P2|COMPLETED|Overall Study||125
1548526|NCT01300949|3789558|P1|COMPLETED|Overall Study||154
1548527|NCT01300949|3789556|P3|STARTED|Overall Study||35
1548528|NCT01300949|3789557|P2|STARTED|Overall Study||125
1548529|NCT01300949|3789558|P1|STARTED|Overall Study||154
1548530|NCT01300923|3789566|P2|NOT COMPLETED|Overall Study||2
1548531|NCT01300923|3789567|P1|NOT COMPLETED|Overall Study||0
1548532|NCT01300923|3789566|P2|COMPLETED|Overall Study||0
1548533|NCT01300923|3789567|P1|COMPLETED|Overall Study||12
1548534|NCT01300923|3789566|P2|STARTED|Overall Study||2
1548535|NCT01300923|3789567|P1|STARTED|Overall Study||12
1548536|NCT01300819|3789580|P2|NOT COMPLETED|Overall Study||44
1548537|NCT01300819|3789581|P1|NOT COMPLETED|Overall Study||22
1548538|NCT01300819|3789580|P2|COMPLETED|Overall Study||180
1548539|NCT01300819|3789581|P1|COMPLETED|Overall Study||103
1548540|NCT01300819|3789580|P2|STARTED|Overall Study||224
1548541|NCT01300819|3789581|P1|STARTED|Overall Study||125
1548542|NCT01300767|3789609|P1|NOT COMPLETED|Overall Study||4
1548543|NCT01300767|3789609|P1|COMPLETED|Overall Study||70
1548544|NCT01300767|3789609|P1|STARTED|Overall Study||74
1548545|NCT01300741|3789637|P1|NOT COMPLETED|Overall Study||3
1548546|NCT01300741|3789637|P1|COMPLETED|Overall Study||72
1548547|NCT01300741|3789637|P1|STARTED|Overall Study||75
1548548|NCT01300728|3789667|P2|NOT COMPLETED|Overall Study||1
1548549|NCT01300728|3789668|P1|NOT COMPLETED|Overall Study||2
1548550|NCT01300728|3789667|P2|COMPLETED|Overall Study||25
1548551|NCT01300728|3789668|P1|COMPLETED|Overall Study||24
1548552|NCT01300728|3789667|P2|STARTED|Overall Study||26
1548553|NCT01300728|3789668|P1|STARTED|Overall Study||26
1548554|NCT01300650|3789682|P1|NOT COMPLETED|Overall Study||1
1548555|NCT01300650|3789682|P1|COMPLETED|Overall Study||7
1548556|NCT01300650|3789682|P1|STARTED|Overall Study||8
1548557|NCT01300624|3789688|P1|NOT COMPLETED|Overall Study||0
1548558|NCT01300624|3789688|P1|COMPLETED|Overall Study||11
1548559|NCT01300624|3789688|P1|STARTED|Overall Study||11
1548560|NCT01300559|3789700|P2|NOT COMPLETED|Overall Study||0
1548561|NCT01300559|3789701|P1|NOT COMPLETED|Overall Study||0
1548562|NCT01300559|3789700|P2|COMPLETED|Overall Study||30
1548563|NCT01300559|3789701|P1|COMPLETED|Overall Study||30
1548564|NCT01300559|3789700|P2|STARTED|Overall Study||30
1548565|NCT01300559|3789701|P1|STARTED|Overall Study||30
1548566|NCT01300546|3789709|P2|NOT COMPLETED|Overall Study||6
1548567|NCT01300546|3789710|P1|NOT COMPLETED|Overall Study||1
1548568|NCT01300546|3789709|P2|COMPLETED|Overall Study||14
1548569|NCT01300546|3789710|P1|COMPLETED|Overall Study||18
1548570|NCT01300546|3789709|P2|STARTED|Overall Study||20
1548571|NCT01300546|3789710|P1|STARTED|Overall Study||19
1548572|NCT01300455|3789740|P2|NOT COMPLETED|Period 2||0
1548573|NCT01300455|3789741|P1|NOT COMPLETED|Period 2||0
1548574|NCT01300455|3789740|P2|COMPLETED|Period 2||13
1548575|NCT01300455|3789741|P1|COMPLETED|Period 2||12
1548576|NCT01300455|3789740|P2|STARTED|Period 2||13
1548577|NCT01300455|3789741|P1|STARTED|Period 2||12
1548578|NCT01300455|3789740|P2|NOT COMPLETED|Washout||0
1548579|NCT01300455|3789741|P1|NOT COMPLETED|Washout||1
1548580|NCT01300455|3789740|P2|COMPLETED|Washout||13
1548581|NCT01300455|3789741|P1|COMPLETED|Washout||12
1548582|NCT01300455|3789740|P2|STARTED|Washout||13
1548583|NCT01300455|3789741|P1|STARTED|Washout||13
1548584|NCT01300455|3789740|P2|NOT COMPLETED|Period 1||0
1548585|NCT01300455|3789741|P1|NOT COMPLETED|Period 1||0
1548586|NCT01300455|3789740|P2|COMPLETED|Period 1||13
1548587|NCT01300455|3789741|P1|COMPLETED|Period 1||13
1548588|NCT01300455|3789740|P2|STARTED|Period 1||13
1548589|NCT01300455|3789741|P1|STARTED|Period 1||13
1548590|NCT01300351|3789761|P2|NOT COMPLETED|Overall Study||38
1548591|NCT01300351|3789762|P1|NOT COMPLETED|Overall Study||36
1548592|NCT01300351|3789761|P2|COMPLETED|Overall Study||72
1548593|NCT01300351|3789762|P1|COMPLETED|Overall Study||75
1548594|NCT01300351|3789761|P2|Received Study Treatment|Overall Study||110
1548595|NCT01300351|3789762|P1|Received Study Treatment|Overall Study||109
1548596|NCT01300351|3789761|P2|STARTED|Overall Study||110
1548597|NCT01300351|3789762|P1|STARTED|Overall Study||111
1548598|NCT01300338|3789778|P2|NOT COMPLETED|Overall Study||0
1548599|NCT01300338|3789779|P1|NOT COMPLETED|Overall Study||5
1548600|NCT01300338|3789778|P2|COMPLETED|Overall Study||25
1548601|NCT01300338|3789779|P1|COMPLETED|Overall Study||20
1548602|NCT01300338|3789778|P2|STARTED|Overall Study||25
1548603|NCT01300338|3789779|P1|STARTED|Overall Study||25
1548604|NCT01300286|3789787|P1|NOT COMPLETED|Overall Study||1
1548605|NCT01300286|3789787|P1|COMPLETED|Overall Study||22
1548606|NCT01300286|3789787|P1|STARTED|Overall Study||23
1548607|NCT01300260|3789797|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
1548608|NCT01300260|3789798|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
1548609|NCT01300260|3789797|P2|COMPLETED|Period 2 of Study: Second Intervention||15
1548610|NCT01300260|3789798|P1|COMPLETED|Period 2 of Study: Second Intervention||14
1548611|NCT01300260|3789797|P2|STARTED|Period 2 of Study: Second Intervention||16
1548612|NCT01300260|3789798|P1|STARTED|Period 2 of Study: Second Intervention||14
1548613|NCT01300260|3789797|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
1548614|NCT01300260|3789798|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
1548615|NCT01300260|3789797|P2|COMPLETED|Washout Period of at Least 28 Days||16
1548616|NCT01300260|3789798|P1|COMPLETED|Washout Period of at Least 28 Days||14
1548617|NCT01300260|3789797|P2|STARTED|Washout Period of at Least 28 Days||16
1548618|NCT01300260|3789798|P1|STARTED|Washout Period of at Least 28 Days||14
1548619|NCT01300260|3789797|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
1548620|NCT01300260|3789798|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
1548621|NCT01300260|3789797|P2|COMPLETED|Period 1 of Study: First Intervention||16
1548622|NCT01300260|3789798|P1|COMPLETED|Period 1 of Study: First Intervention||14
1548623|NCT01300260|3789797|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
1548624|NCT01300260|3789798|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
1548625|NCT01300260|3789797|P2|STARTED|Period 1 of Study: First Intervention||17
1548626|NCT01300260|3789798|P1|STARTED|Period 1 of Study: First Intervention||15
1548627|NCT01300247|3789830|P2|NOT COMPLETED|Overall Study||2
1548628|NCT01300247|3789831|P1|NOT COMPLETED|Overall Study||4
1548629|NCT01300247|3789830|P2|COMPLETED|Overall Study||18
1548630|NCT01300247|3789831|P1|COMPLETED|Overall Study||17
1548631|NCT01300247|3789830|P2|STARTED|Overall Study||20
1548632|NCT01300247|3789831|P1|STARTED|Overall Study||21
1548633|NCT01300234|3789863|P2|NOT COMPLETED|Overall Study||27
1548634|NCT01300234|3789864|P1|NOT COMPLETED|Overall Study||28
1548635|NCT01300234|3789863|P2|COMPLETED|Overall Study||228
1548636|NCT01300234|3789864|P1|COMPLETED|Overall Study||229
1548637|NCT01300234|3789863|P2|STARTED|Overall Study||255
1548638|NCT01300234|3789864|P1|STARTED|Overall Study||257
1548639|NCT01300052|3789900|P2|NOT COMPLETED|Overall Study||3
1548640|NCT01300052|3789901|P1|NOT COMPLETED|Overall Study||6
1548641|NCT01300052|3789900|P2|COMPLETED|Overall Study||19
1548642|NCT01300052|3789901|P1|COMPLETED|Overall Study||40
1548643|NCT01300052|3789900|P2|STARTED|Overall Study||22
1548644|NCT01300052|3789901|P1|STARTED|Overall Study||46
1548645|NCT01299961|3789919|P1|NOT COMPLETED|Overall Study||6
1548646|NCT01299961|3789919|P1|COMPLETED|Overall Study||19
1548647|NCT01299961|3789919|P1|STARTED|Overall Study||25
1548648|NCT01299909|3789928|P3|NOT COMPLETED|Overall Study||17
1548649|NCT01299909|3789929|P2|NOT COMPLETED|Overall Study||18
1548650|NCT01299909|3789930|P1|NOT COMPLETED|Overall Study||22
1548651|NCT01299909|3789928|P3|COMPLETED|Overall Study||23
1548652|NCT01299909|3789929|P2|COMPLETED|Overall Study||49
1548653|NCT01299909|3789930|P1|COMPLETED|Overall Study||46
1548654|NCT01299909|3789928|P3|STARTED|Overall Study||40
1548655|NCT01299909|3789929|P2|STARTED|Overall Study||67
1548656|NCT01299909|3789930|P1|STARTED|Overall Study||68
1548657|NCT01299896|3789945|P2|NOT COMPLETED|Overall Study||18
1548658|NCT01299896|3789946|P1|NOT COMPLETED|Overall Study||1
1548659|NCT01299896|3789945|P2|COMPLETED|Overall Study||296
1548660|NCT01299896|3789946|P1|COMPLETED|Overall Study||318
1548661|NCT01299896|3789945|P2|STARTED|Overall Study||314
1548662|NCT01299896|3789946|P1|STARTED|Overall Study||319
1548663|NCT01299805|3789954|P2|NOT COMPLETED|Overall Study||0
1548664|NCT01299805|3789955|P1|NOT COMPLETED|Overall Study||2
1548665|NCT01299805|3789954|P2|COMPLETED|Overall Study||5
1548666|NCT01299805|3789955|P1|COMPLETED|Overall Study||10
1548667|NCT01299805|3789954|P2|STARTED|Overall Study||5
1548668|NCT01299805|3789955|P1|STARTED|Overall Study||12
1548669|NCT01299766|3789985|P2|NOT COMPLETED|Overall Study||23
1548670|NCT01299766|3789986|P1|NOT COMPLETED|Overall Study||34
1548671|NCT01299766|3789985|P2|COMPLETED|Overall Study||87
1548672|NCT01299766|3789986|P1|COMPLETED|Overall Study||77
1548673|NCT01299766|3789985|P2|STARTED|Overall Study||110
1548674|NCT01299766|3789986|P1|STARTED|Overall Study||111
1548675|NCT01299610|3789997|P3|NOT COMPLETED|Overall Study||0
1548676|NCT01299610|3789998|P2|NOT COMPLETED|Overall Study||0
1548677|NCT01299610|3789999|P1|NOT COMPLETED|Overall Study||0
1548678|NCT01299610|3789997|P3|COMPLETED|Overall Study||10
1548679|NCT01299610|3789998|P2|COMPLETED|Overall Study||5
1548680|NCT01299610|3789999|P1|COMPLETED|Overall Study||10
1548681|NCT01299610|3789997|P3|STARTED|Overall Study||10
1548682|NCT01299610|3789998|P2|STARTED|Overall Study||5
1548683|NCT01299610|3789999|P1|STARTED|Overall Study||10
1548684|NCT01299584|3790044|P1|NOT COMPLETED|Overall Study||9
1548685|NCT01299584|3790044|P1|COMPLETED|Overall Study||766
1548686|NCT01299584|3790044|P1|STARTED|Overall Study||775
1548687|NCT01299571|3790051|P1|NOT COMPLETED|Overall Study||107
1548688|NCT01299571|3790051|P1|COMPLETED|Overall Study||3870
1548689|NCT01299571|3790051|P1|STARTED|Overall Study||3977
1548690|NCT01299480|3790062|P5|NOT COMPLETED|Overall Study||20
1548691|NCT01299480|3790063|P4|NOT COMPLETED|Overall Study||25
1548692|NCT01299480|3790064|P3|NOT COMPLETED|Overall Study||41
1548693|NCT01299480|3790065|P2|NOT COMPLETED|Overall Study||35
1548694|NCT01299480|3790066|P1|NOT COMPLETED|Overall Study||42
1548695|NCT01299480|3790062|P5|COMPLETED|Overall Study||123
1548696|NCT01299480|3790063|P4|COMPLETED|Overall Study||261
1548697|NCT01299480|3790064|P3|COMPLETED|Overall Study||386
1548698|NCT01299480|3790065|P2|COMPLETED|Overall Study||395
1548699|NCT01299480|3790066|P1|COMPLETED|Overall Study||385
1548700|NCT01299480|3790062|P5|STARTED|Overall Study||143
1548701|NCT01299480|3790063|P4|STARTED|Overall Study||286
1548702|NCT01299480|3790064|P3|STARTED|Overall Study||427
1548703|NCT01299480|3790065|P2|STARTED|Overall Study||430
1548704|NCT01299480|3790066|P1|STARTED|Overall Study||427
1548705|NCT01299454|3790105|P4|NOT COMPLETED|Overall Study||0
1548706|NCT01299454|3790106|P3|NOT COMPLETED|Overall Study||0
1548707|NCT01299454|3790107|P2|NOT COMPLETED|Overall Study||0
1548708|NCT01299454|3790108|P1|NOT COMPLETED|Overall Study||0
1548709|NCT01299454|3790105|P4|COMPLETED|Overall Study||23
1548710|NCT01299454|3790106|P3|COMPLETED|Overall Study||6
1548711|NCT01299454|3790107|P2|COMPLETED|Overall Study||8
1548712|NCT01299454|3790108|P1|COMPLETED|Overall Study||8
1548713|NCT01299454|3790105|P4|STARTED|Overall Study||23
1548714|NCT01299454|3790106|P3|STARTED|Overall Study||6
1548715|NCT01299454|3790107|P2|STARTED|Overall Study||8
1548716|NCT01299454|3790108|P1|STARTED|Overall Study||8
1548717|NCT01299389|3790268|P4|NOT COMPLETED|Post-observational||6
1548718|NCT01299389|3790269|P3|NOT COMPLETED|Post-observational||12
1548719|NCT01299389|3790270|P2|NOT COMPLETED|Post-observational||0
1548720|NCT01299389|3790271|P1|NOT COMPLETED|Post-observational||0
1548721|NCT01299389|3790268|P4|COMPLETED|Post-observational||149
1548722|NCT01299389|3790269|P3|COMPLETED|Post-observational||144
1548723|NCT01299389|3790270|P2|COMPLETED|Post-observational||0
1548724|NCT01299389|3790271|P1|COMPLETED|Post-observational||0
1548725|NCT01299389|3790268|P4|STARTED|Post-observational||155
1548726|NCT01299389|3790269|P3|STARTED|Post-observational||156
1548727|NCT01299389|3790270|P2|STARTED|Post-observational||0
1548728|NCT01299389|3790271|P1|STARTED|Post-observational||0
1548729|NCT01299389|3790268|P4|NOT COMPLETED|Double-blind||0
1548730|NCT01299389|3790269|P3|NOT COMPLETED|Double-blind||0
1548731|NCT01299389|3790270|P2|NOT COMPLETED|Double-blind||64
1548732|NCT01299389|3790271|P1|NOT COMPLETED|Double-blind||109
1548733|NCT01299389|3790268|P4|COMPLETED|Double-blind||0
1548734|NCT01299389|3790269|P3|COMPLETED|Double-blind||0
1548735|NCT01299389|3790270|P2|COMPLETED|Double-blind||95
1548736|NCT01299389|3790271|P1|COMPLETED|Double-blind||55
1548737|NCT01299389|3790268|P4|STARTED|Double-blind||0
1548738|NCT01299389|3790269|P3|STARTED|Double-blind||0
1548739|NCT01299389|3790270|P2|STARTED|Double-blind||159
1548740|NCT01299389|3790271|P1|STARTED|Double-blind||164
1548741|NCT01299376|3790293|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
1548742|NCT01299376|3790294|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
1548743|NCT01299376|3790293|P2|COMPLETED|Extension (Weeks 9 to 52)||118
1548744|NCT01299376|3790294|P1|COMPLETED|Extension (Weeks 9 to 52)||124
1548745|NCT01299376|3790293|P2|STARTED|Extension (Weeks 9 to 52)||133
1548746|NCT01299376|3790294|P1|STARTED|Extension (Weeks 9 to 52)||134
1548747|NCT01299376|3790293|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
1548748|NCT01299376|3790294|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
1548749|NCT01299376|3790293|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
1548750|NCT01299376|3790294|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
1548751|NCT01299376|3790293|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
1548752|NCT01299376|3790294|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
1548753|NCT01299285|3790324|P1|NOT COMPLETED|Overall Study||0
1548754|NCT01299285|3790324|P1|COMPLETED|Overall Study||6
1548755|NCT01299285|3790324|P1|STARTED|Overall Study||6
1548756|NCT01299272|3790337|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
1548757|NCT01299272|3790338|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
1548758|NCT01299272|3790339|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
1548759|NCT01299272|3790340|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
1548760|NCT01299272|3790337|P4|COMPLETED|Double-blind (DB) Randomized Period||234
1548761|NCT01299272|3790338|P3|COMPLETED|Double-blind (DB) Randomized Period||224
1548762|NCT01299272|3790339|P2|COMPLETED|Double-blind (DB) Randomized Period||0
1548763|NCT01299272|3790340|P1|COMPLETED|Double-blind (DB) Randomized Period||0
1548764|NCT01299272|3790337|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
1548765|NCT01299272|3790338|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
1548766|NCT01299272|3790339|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
1548767|NCT01299272|3790340|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
1548768|NCT01299272|3790337|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
1548769|NCT01299272|3790338|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
1548770|NCT01299272|3790339|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
1548771|NCT01299272|3790340|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
1548772|NCT01299272|3790337|P4|STARTED|Double-blind (DB) Randomized Period||292
1548773|NCT01299272|3790338|P3|STARTED|Double-blind (DB) Randomized Period||294
1548774|NCT01299272|3790339|P2|STARTED|Double-blind (DB) Randomized Period||0
1548775|NCT01299272|3790340|P1|STARTED|Double-blind (DB) Randomized Period||0
1548776|NCT01299272|3790337|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
1548777|NCT01299272|3790338|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
1548778|NCT01299272|3790339|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
1548779|NCT01299272|3790340|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
1548780|NCT01299272|3790337|P4|COMPLETED|Stabilization Open-label (OL) Period||0
1548781|NCT01299272|3790338|P3|COMPLETED|Stabilization Open-label (OL) Period||0
1548782|NCT01299272|3790339|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
1548783|NCT01299272|3790340|P1|COMPLETED|Stabilization Open-label (OL) Period||0
1548784|NCT01299272|3790337|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
1548785|NCT01299272|3790338|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
1548786|NCT01299272|3790339|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
1548787|NCT01299272|3790340|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
1548788|NCT01299272|3790337|P4|STARTED|Stabilization Open-label (OL) Period||0
1548789|NCT01299272|3790338|P3|STARTED|Stabilization Open-label (OL) Period||0
1548790|NCT01299272|3790339|P2|STARTED|Stabilization Open-label (OL) Period||835
1548791|NCT01299272|3790340|P1|STARTED|Stabilization Open-label (OL) Period||0
1548792|NCT01299272|3790337|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
1548793|NCT01299272|3790338|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
1548794|NCT01299272|3790339|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
1548795|NCT01299272|3790340|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
1548796|NCT01299272|3790337|P4|COMPLETED|Acute Open-label (OL) Period||0
1548797|NCT01299272|3790338|P3|COMPLETED|Acute Open-label (OL) Period||0
1548798|NCT01299272|3790339|P2|COMPLETED|Acute Open-label (OL) Period||0
1548799|NCT01299272|3790340|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
1548800|NCT01299272|3790337|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
1548801|NCT01299272|3790338|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
1548802|NCT01299272|3790339|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
1548803|NCT01299272|3790340|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
1548804|NCT01299272|3790337|P4|STARTED|Acute Open-label (OL) Period||0
1548805|NCT01299272|3790338|P3|STARTED|Acute Open-label (OL) Period||0
1548806|NCT01299272|3790339|P2|STARTED|Acute Open-label (OL) Period||0
1548807|NCT01299272|3790340|P1|STARTED|Acute Open-label (OL) Period||1249
1548808|NCT01299116|3790395|P3|NOT COMPLETED|Overall Study||11
1548809|NCT01299116|3790396|P2|NOT COMPLETED|Overall Study||9
1548810|NCT01299116|3790397|P1|NOT COMPLETED|Overall Study||65
1548811|NCT01299116|3790395|P3|COMPLETED|Overall Study||184
1548812|NCT01299116|3790396|P2|COMPLETED|Overall Study||168
1548813|NCT01299116|3790397|P1|COMPLETED|Overall Study||457
1548814|NCT01299116|3790395|P3|STARTED|Overall Study||195
1548815|NCT01299116|3790396|P2|STARTED|Overall Study||177
1548816|NCT01299116|3790397|P1|STARTED|Overall Study||522
1548817|NCT01299103|3790414|P3|NOT COMPLETED|Overall Study||2
1548818|NCT01299103|3790415|P2|NOT COMPLETED|Overall Study||2
1548819|NCT01299103|3790416|P1|NOT COMPLETED|Overall Study||0
1548820|NCT01299103|3790414|P3|COMPLETED|Overall Study||8
1548821|NCT01299103|3790415|P2|COMPLETED|Overall Study||13
1548822|NCT01299103|3790416|P1|COMPLETED|Overall Study||15
1548823|NCT01299103|3790414|P3|STARTED|Overall Study||10
1548824|NCT01299103|3790415|P2|STARTED|Overall Study||15
1548825|NCT01299103|3790416|P1|STARTED|Overall Study||15
1548826|NCT01299090|3790427|P1|NOT COMPLETED|Overall Study||0
1548827|NCT01299090|3790427|P1|COMPLETED|Overall Study||49
1548828|NCT01299090|3790427|P1|STARTED|Overall Study||49
1548829|NCT01299077|3790432|P1|NOT COMPLETED|Overall Study||0
1548830|NCT01299077|3790432|P1|COMPLETED|Overall Study||478
1548831|NCT01299077|3790432|P1|STARTED|Overall Study||478
1548832|NCT01299025|3790442|P2|NOT COMPLETED|Overall Study||1
1548833|NCT01299025|3790443|P1|NOT COMPLETED|Overall Study||3
1548834|NCT01299025|3790442|P2|COMPLETED|Overall Study||41
1548835|NCT01299025|3790443|P1|COMPLETED|Overall Study||39
1548836|NCT01299025|3790442|P2|STARTED|Overall Study||42
1548837|NCT01299025|3790443|P1|STARTED|Overall Study||42
1548838|NCT01298778|3790457|P2|NOT COMPLETED|Overall Study||6
1548839|NCT01298778|3790458|P1|NOT COMPLETED|Overall Study||3
1548840|NCT01298778|3790457|P2|COMPLETED|Overall Study||30
1548841|NCT01298778|3790458|P1|COMPLETED|Overall Study||30
1548842|NCT01298778|3790457|P2|STARTED|Overall Study||36
1548843|NCT01298778|3790458|P1|STARTED|Overall Study||33
1548844|NCT01298765|3790478|P1|NOT COMPLETED|Long-Term Treatment Period||99
1548845|NCT01298765|3790478|P1|COMPLETED|Long-Term Treatment Period||127
1548846|NCT01298765|3790478|P1|STARTED|Long-Term Treatment Period||226
1548847|NCT01298765|3790478|P1|NOT COMPLETED|Titration Period||76
1548848|NCT01298765|3790478|P1|COMPLETED|Titration Period||226
1548849|NCT01298765|3790478|P1|STARTED|Titration Period||302
1548850|NCT01298700|3790488|P2|NOT COMPLETED|Overall Study||100
1548851|NCT01298700|3790489|P1|NOT COMPLETED|Overall Study||101
1548852|NCT01298700|3790488|P2|COMPLETED|Overall Study||303
1548853|NCT01298700|3790489|P1|COMPLETED|Overall Study||302
1548854|NCT01298700|3790488|P2|Safety Population: Received Study Drug|Overall Study||398
1548855|NCT01298700|3790489|P1|Safety Population: Received Study Drug|Overall Study||400
1548856|NCT01298700|3790488|P2|STARTED|Overall Study||403
1548857|NCT01298700|3790489|P1|STARTED|Overall Study||403
1548858|NCT01298661|3790500|P3|NOT COMPLETED|Overall Study||2
1548859|NCT01298661|3790501|P2|NOT COMPLETED|Overall Study||0
1548860|NCT01298661|3790502|P1|NOT COMPLETED|Overall Study||2
1548861|NCT01298661|3790500|P3|COMPLETED|Overall Study||32
1548862|NCT01298661|3790501|P2|COMPLETED|Overall Study||24
1548863|NCT01298661|3790502|P1|COMPLETED|Overall Study||31
1548864|NCT01298661|3790500|P3|STARTED|Overall Study||34
1548865|NCT01298661|3790501|P2|STARTED|Overall Study||24
1548866|NCT01298661|3790502|P1|STARTED|Overall Study||33
1548867|NCT01298648|3790580|P1|NOT COMPLETED|Overall Study||23
1548868|NCT01298648|3790580|P1|COMPLETED|Overall Study||1693
1548869|NCT01298648|3790580|P1|STARTED|Overall Study||1716
1548870|NCT01298570|3790591|P2|NOT COMPLETED|Overall Study||61
1548871|NCT01298570|3790592|P1|NOT COMPLETED|Overall Study||120
1548872|NCT01298570|3790591|P2|COMPLETED|Overall Study||0
1548873|NCT01298570|3790592|P1|COMPLETED|Overall Study||0
1548874|NCT01298570|3790591|P2|STARTED|Overall Study||61
1548875|NCT01298570|3790592|P1|STARTED|Overall Study||120
1548876|NCT01298544|3790608|P1|NOT COMPLETED|Overall Study||0
1548877|NCT01298544|3790608|P1|COMPLETED|Overall Study||335
1548878|NCT01298544|3790608|P1|STARTED|Overall Study||335
1548879|NCT01298531|3790619|P2|NOT COMPLETED|Overall Study||7
1548880|NCT01298531|3790620|P1|NOT COMPLETED|Overall Study||9
1548881|NCT01298531|3790619|P2|COMPLETED|Overall Study||41
1548882|NCT01298531|3790620|P1|COMPLETED|Overall Study||33
1548883|NCT01298531|3790619|P2|STARTED|Overall Study||48
1548884|NCT01298531|3790620|P1|STARTED|Overall Study||42
1548885|NCT01298518|3790749|P3|NOT COMPLETED|Overall Study||1
1548886|NCT01298518|3790750|P2|NOT COMPLETED|Overall Study||0
1548887|NCT01298518|3790751|P1|NOT COMPLETED|Overall Study||0
1548888|NCT01298518|3790749|P3|COMPLETED|Overall Study||15
1548889|NCT01298518|3790750|P2|COMPLETED|Overall Study||16
1548890|NCT01298518|3790751|P1|COMPLETED|Overall Study||16
1548891|NCT01298518|3790749|P3|STARTED|Overall Study||16
1548892|NCT01298518|3790750|P2|STARTED|Overall Study||16
1548893|NCT01298518|3790751|P1|STARTED|Overall Study||16
1548894|NCT01298492|3790803|P1|NOT COMPLETED|Overall Study||119
1548895|NCT01298492|3790803|P1|COMPLETED|Overall Study||149
1548896|NCT01298492|3790803|P1|STARTED|Overall Study||268
1548897|NCT01298362|3790811|P2|NOT COMPLETED|Overall Study||43
1548898|NCT01298362|3790812|P1|NOT COMPLETED|Overall Study||38
1548899|NCT01298362|3790811|P2|COMPLETED|Overall Study||123
1548900|NCT01298362|3790812|P1|COMPLETED|Overall Study||86
1548901|NCT01298362|3790811|P2|STARTED|Overall Study||166
1548902|NCT01298362|3790812|P1|STARTED|Overall Study||124
1548903|NCT01298323|3790832|P2|NOT COMPLETED|Overall Study||88
1548904|NCT01298323|3790833|P1|NOT COMPLETED|Overall Study||86
1548905|NCT01298323|3790832|P2|COMPLETED|Overall Study||15
1548906|NCT01298323|3790833|P1|COMPLETED|Overall Study||16
1548907|NCT01298323|3790832|P2|Ongoing|Overall Study||55
1548908|NCT01298323|3790833|P1|Ongoing|Overall Study||55
1548909|NCT01298323|3790832|P2|STARTED|Overall Study||103
1548910|NCT01298323|3790833|P1|STARTED|Overall Study||102
1548911|NCT01298167|3790841|P2|NOT COMPLETED|Overall Study||0
1548912|NCT01298167|3790842|P1|NOT COMPLETED|Overall Study||1
1548913|NCT01298167|3790841|P2|COMPLETED|Overall Study||8
1548914|NCT01298167|3790842|P1|COMPLETED|Overall Study||5
1548915|NCT01298167|3790841|P2|STARTED|Overall Study||8
1548916|NCT01298167|3790842|P1|STARTED|Overall Study||6
1548917|NCT01298128|3790850|P2|NOT COMPLETED|Overall Study||8
1548918|NCT01298128|3790851|P1|NOT COMPLETED|Overall Study||9
1548919|NCT01298128|3790850|P2|COMPLETED|Overall Study||27
1548920|NCT01298128|3790851|P1|COMPLETED|Overall Study||26
1548921|NCT01298128|3790850|P2|STARTED|Overall Study||35
1548922|NCT01298128|3790851|P1|STARTED|Overall Study||35
1548923|NCT01298063|3790862|P5|NOT COMPLETED|Overall Study||0
1548924|NCT01298063|3790863|P4|NOT COMPLETED|Overall Study||0
1548925|NCT01298063|3790864|P3|NOT COMPLETED|Overall Study||0
1548926|NCT01298063|3790865|P2|NOT COMPLETED|Overall Study||0
1548927|NCT01298063|3790866|P1|NOT COMPLETED|Overall Study||0
1548928|NCT01298063|3790862|P5|COMPLETED|Overall Study||8
1548929|NCT01298063|3790863|P4|COMPLETED|Overall Study||8
1548930|NCT01298063|3790864|P3|COMPLETED|Overall Study||8
1548931|NCT01298063|3790865|P2|COMPLETED|Overall Study||3
1548932|NCT01298063|3790866|P1|COMPLETED|Overall Study||8
1548933|NCT01298063|3790862|P5|STARTED|Overall Study||8
1548934|NCT01298063|3790863|P4|STARTED|Overall Study||8
1548935|NCT01298063|3790864|P3|STARTED|Overall Study||8
1548936|NCT01298063|3790865|P2|STARTED|Overall Study||3
1548937|NCT01298063|3790866|P1|STARTED|Overall Study||8
1548938|NCT01297920|3790896|P3|NOT COMPLETED|Overall Study||57
1548939|NCT01297920|3790897|P2|NOT COMPLETED|Overall Study||27
1548940|NCT01297920|3790898|P1|NOT COMPLETED|Overall Study||58
1548941|NCT01297920|3790896|P3|COMPLETED|Overall Study||178
1548942|NCT01297920|3790897|P2|COMPLETED|Overall Study||207
1548943|NCT01297920|3790898|P1|COMPLETED|Overall Study||163
1548944|NCT01297920|3790896|P3|STARTED|Overall Study||235
1548945|NCT01297920|3790897|P2|STARTED|Overall Study||234
1548946|NCT01297920|3790898|P1|STARTED|Overall Study||221
1548947|NCT01297595|3790906|P2|NOT COMPLETED|Second Intervention Period||0
1548948|NCT01297595|3790907|P1|NOT COMPLETED|Second Intervention Period||0
1548949|NCT01297595|3790906|P2|COMPLETED|Second Intervention Period||11
1548950|NCT01297595|3790907|P1|COMPLETED|Second Intervention Period||11
1548951|NCT01297595|3790906|P2|STARTED|Second Intervention Period||11
1548952|NCT01297595|3790907|P1|STARTED|Second Intervention Period||11
1548953|NCT01297595|3790906|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
1548954|NCT01297595|3790907|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
1548955|NCT01297595|3790906|P2|COMPLETED|Washout Period (At Least 14 Days)||11
1548956|NCT01297595|3790907|P1|COMPLETED|Washout Period (At Least 14 Days)||11
1548957|NCT01297595|3790906|P2|STARTED|Washout Period (At Least 14 Days)||11
1548958|NCT01297595|3790907|P1|STARTED|Washout Period (At Least 14 Days)||11
1548959|NCT01297595|3790906|P2|NOT COMPLETED|First Intervention Period||0
1548960|NCT01297595|3790907|P1|NOT COMPLETED|First Intervention Period||0
1548961|NCT01297595|3790906|P2|COMPLETED|First Intervention Period||11
1548962|NCT01297595|3790907|P1|COMPLETED|First Intervention Period||11
1548963|NCT01297595|3790906|P2|STARTED|First Intervention Period||11
1548964|NCT01297595|3790907|P1|STARTED|First Intervention Period||11
1548965|NCT01297517|3790942|P3|NOT COMPLETED|Overall Study||27
1548966|NCT01297517|3790943|P2|NOT COMPLETED|Overall Study||12
1548967|NCT01297517|3790944|P1|NOT COMPLETED|Overall Study||27
1548968|NCT01297517|3790942|P3|COMPLETED|Overall Study||193
1548969|NCT01297517|3790943|P2|COMPLETED|Overall Study||214
1548970|NCT01297517|3790944|P1|COMPLETED|Overall Study||187
1548971|NCT01297517|3790942|P3|STARTED|Overall Study||220
1548972|NCT01297517|3790943|P2|STARTED|Overall Study||226
1548973|NCT01297517|3790944|P1|STARTED|Overall Study||214
1548974|NCT01297504|3790952|P1|NOT COMPLETED|Overall Study||67
1548975|NCT01297504|3790952|P1|COMPLETED|Overall Study||397
1548976|NCT01297504|3790952|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
1548977|NCT01297504|3790952|P1|STARTED|Overall Study||464
1548978|NCT01297491|3790966|P2|NOT COMPLETED|Overall Study||33
1548979|NCT01297491|3790967|P1|NOT COMPLETED|Overall Study||30
1548980|NCT01297491|3790966|P2|COMPLETED|Overall Study||0
1548981|NCT01297491|3790967|P1|COMPLETED|Overall Study||0
1548982|NCT01297491|3790966|P2|STARTED|Overall Study||33
1548983|NCT01297491|3790967|P1|STARTED|Overall Study||30
1548984|NCT01297465|3790985|P2|NOT COMPLETED|Overall Study||10
1548985|NCT01297465|3790986|P1|NOT COMPLETED|Overall Study||8
1548986|NCT01297465|3790985|P2|COMPLETED|Overall Study||93
1548987|NCT01297465|3790986|P1|COMPLETED|Overall Study||91
1548988|NCT01297465|3790985|P2|STARTED|Overall Study||103
1548989|NCT01297465|3790986|P1|STARTED|Overall Study||99
1548990|NCT01297348|3791020|P2|NOT COMPLETED|Overall Study||0
1548991|NCT01297348|3791021|P1|NOT COMPLETED|Overall Study||0
1548992|NCT01297348|3791020|P2|COMPLETED|Overall Study||586401
1548993|NCT01297348|3791021|P1|COMPLETED|Overall Study||12281
1548994|NCT01297348|3791020|P2|STARTED|Overall Study||586401
1548995|NCT01297348|3791021|P1|STARTED|Overall Study||12281
1548996|NCT01297335|3791031|P1|NOT COMPLETED|Overall Study||0
1548997|NCT01297335|3791031|P1|COMPLETED|Overall Study||10
1548998|NCT01297335|3791031|P1|STARTED|Overall Study||10
1548999|NCT01297322|3791039|P2|NOT COMPLETED|Overall Study||1
1549000|NCT01297322|3791040|P1|NOT COMPLETED|Overall Study||1
1549001|NCT01297322|3791039|P2|COMPLETED|Overall Study||274
1549002|NCT01297322|3791040|P1|COMPLETED|Overall Study||141
1549003|NCT01297322|3791039|P2|STARTED|Overall Study||275
1549004|NCT01297322|3791040|P1|STARTED|Overall Study||142
1549005|NCT01297283|3791060|P1|NOT COMPLETED|Overall Study||19
1549006|NCT01297283|3791060|P1|COMPLETED|Overall Study||176
1549007|NCT01297283|3791060|P1|STARTED|Overall Study||195
1549008|NCT01297270|3791068|P3|NOT COMPLETED|Overall Study||29
1549009|NCT01297270|3791069|P2|NOT COMPLETED|Overall Study||72
1549010|NCT01297270|3791070|P1|NOT COMPLETED|Overall Study||45
1549011|NCT01297270|3791068|P3|COMPLETED|Overall Study||103
1549012|NCT01297270|3791069|P2|COMPLETED|Overall Study||192
1549013|NCT01297270|3791070|P1|COMPLETED|Overall Study||217
1549014|NCT01297270|3791068|P3|STARTED|Overall Study||132
1549015|NCT01297270|3791069|P2|STARTED|Overall Study||264
1549016|NCT01297270|3791070|P1|STARTED|Overall Study||262
1549017|NCT01297257|3791108|P1|NOT COMPLETED|Overall Study||0
1549018|NCT01297257|3791108|P1|COMPLETED|Overall Study||7740
1549019|NCT01297257|3791108|P1|STARTED|Overall Study||7740
1549020|NCT01297062|3791119|P7|NOT COMPLETED|Overall Study||8
1549021|NCT01297062|3791120|P6|NOT COMPLETED|Overall Study||1
1549022|NCT01297062|3791121|P5|NOT COMPLETED|Overall Study||2
1549023|NCT01297062|3791122|P4|NOT COMPLETED|Overall Study||1
1549024|NCT01297062|3791123|P3|NOT COMPLETED|Overall Study||2
1549025|NCT01297062|3791124|P2|NOT COMPLETED|Overall Study||1
1549026|NCT01297062|3791125|P1|NOT COMPLETED|Overall Study||4
1549027|NCT01297062|3791119|P7|COMPLETED|Overall Study||0
1549028|NCT01297062|3791120|P6|COMPLETED|Overall Study||13
1549029|NCT01297062|3791121|P5|COMPLETED|Overall Study||13
1549030|NCT01297062|3791122|P4|COMPLETED|Overall Study||13
1549031|NCT01297062|3791123|P3|COMPLETED|Overall Study||12
1549032|NCT01297062|3791124|P2|COMPLETED|Overall Study||13
1549033|NCT01297062|3791125|P1|COMPLETED|Overall Study||11
1549034|NCT01297062|3791119|P7|Evaluable Population|Overall Study||0
1549035|NCT01297062|3791120|P6|Evaluable Population|Overall Study||13
1549036|NCT01297062|3791121|P5|Evaluable Population|Overall Study||13
1549037|NCT01297062|3791122|P4|Evaluable Population|Overall Study||13
1549038|NCT01297062|3791123|P3|Evaluable Population|Overall Study||12
1549039|NCT01297062|3791124|P2|Evaluable Population|Overall Study||12
1549040|NCT01297062|3791125|P1|Evaluable Population|Overall Study||11
1549041|NCT01297062|3791119|P7|Intent to Treat (ITT)|Overall Study||0
1549042|NCT01297062|3791120|P6|Intent to Treat (ITT)|Overall Study||14
1549043|NCT01297062|3791121|P5|Intent to Treat (ITT)|Overall Study||15
1549044|NCT01297062|3791122|P4|Intent to Treat (ITT)|Overall Study||14
1549045|NCT01297062|3791123|P3|Intent to Treat (ITT)|Overall Study||14
1549046|NCT01297062|3791124|P2|Intent to Treat (ITT)|Overall Study||14
1549047|NCT01297062|3791125|P1|Intent to Treat (ITT)|Overall Study||15
1549048|NCT01297062|3791119|P7|STARTED|Overall Study||8
1549049|NCT01297062|3791120|P6|STARTED|Overall Study||14
1549050|NCT01297062|3791121|P5|STARTED|Overall Study||15
1549051|NCT01297062|3791122|P4|STARTED|Overall Study||14
1549052|NCT01297062|3791123|P3|STARTED|Overall Study||14
1549053|NCT01297062|3791124|P2|STARTED|Overall Study||14
1549054|NCT01297062|3791125|P1|STARTED|Overall Study||15
1549055|NCT01296841|3791149|P2|NOT COMPLETED|Overall Study||0
1549056|NCT01296841|3791150|P1|NOT COMPLETED|Overall Study||0
1549057|NCT01296841|3791149|P2|COMPLETED|Overall Study||15
1549058|NCT01296841|3791150|P1|COMPLETED|Overall Study||19
1549059|NCT01296841|3791149|P2|STARTED|Overall Study||15
1549060|NCT01296841|3791150|P1|STARTED|Overall Study||19
1549061|NCT01296815|3791162|P2|NOT COMPLETED|Overall Study||0
1549062|NCT01296815|3791163|P1|NOT COMPLETED|Overall Study||0
1549063|NCT01296815|3791162|P2|COMPLETED|Overall Study||7
1549064|NCT01296815|3791163|P1|COMPLETED|Overall Study||7
1549065|NCT01296815|3791162|P2|STARTED|Overall Study||7
1549066|NCT01296815|3791163|P1|STARTED|Overall Study||7
1549067|NCT01296763|3791172|P3|NOT COMPLETED|Overall Study||0
1549068|NCT01296763|3791173|P2|NOT COMPLETED|Overall Study||0
1549069|NCT01296763|3791174|P1|NOT COMPLETED|Overall Study||0
1549070|NCT01296763|3791172|P3|COMPLETED|Overall Study||6
1549071|NCT01296763|3791173|P2|COMPLETED|Overall Study||5
1549072|NCT01296763|3791174|P1|COMPLETED|Overall Study||7
1549073|NCT01296763|3791172|P3|STARTED|Overall Study||6
1549074|NCT01296763|3791173|P2|STARTED|Overall Study||5
1549075|NCT01296763|3791174|P1|STARTED|Overall Study||7
1549076|NCT01296698|3791187|P2|NOT COMPLETED|Overall Study||13
1549077|NCT01296698|3791188|P1|NOT COMPLETED|Overall Study||244
1549078|NCT01296698|3791187|P2|COMPLETED|Overall Study||0
1549079|NCT01296698|3791188|P1|COMPLETED|Overall Study||0
1549080|NCT01296698|3791187|P2|STARTED|Overall Study||13
1549081|NCT01296698|3791188|P1|STARTED|Overall Study||244
1549082|NCT01296672|3791242|P2|NOT COMPLETED|Overall Study||18
1549083|NCT01296672|3791243|P1|NOT COMPLETED|Overall Study||73
1549084|NCT01296672|3791242|P2|COMPLETED|Overall Study||59
1549085|NCT01296672|3791243|P1|COMPLETED|Overall Study||233
1549086|NCT01296672|3791242|P2|STARTED|Overall Study||77
1549087|NCT01296672|3791243|P1|STARTED|Overall Study||306
1549088|NCT01296646|3791255|P2|NOT COMPLETED|Overall Study||11
1549089|NCT01296646|3791256|P1|NOT COMPLETED|Overall Study||11
1549090|NCT01296646|3791255|P2|COMPLETED|Overall Study||29
1549091|NCT01296646|3791256|P1|COMPLETED|Overall Study||29
1549092|NCT01296646|3791255|P2|STARTED|Overall Study||40
1549093|NCT01296646|3791256|P1|STARTED|Overall Study||40
1549094|NCT01296568|3791264|P1|NOT COMPLETED|Continued Access Phase||3
1549095|NCT01296568|3791264|P1|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
1549096|NCT01296568|3791264|P1|STARTED|Continued Access Phase||3
1549097|NCT01296568|3791264|P1|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
1549098|NCT01296568|3791264|P1|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
1549099|NCT01296568|3791264|P1|STARTED|[^14C]LY2603618 Single Dose and Washout||3
1549100|NCT01296412|3791280|P2|NOT COMPLETED|Overall Study||70
1549101|NCT01296412|3791281|P1|NOT COMPLETED|Overall Study||51
1549102|NCT01296412|3791280|P2|COMPLETED|Overall Study||257
1549103|NCT01296412|3791281|P1|COMPLETED|Overall Study||275
1549104|NCT01296412|3791280|P2|STARTED|Overall Study||327
1549105|NCT01296412|3791281|P1|STARTED|Overall Study||326
1549106|NCT01296360|3791295|P2|NOT COMPLETED|Overall Study||8
1549107|NCT01296360|3791296|P1|NOT COMPLETED|Overall Study||6
1549108|NCT01296360|3791295|P2|COMPLETED|Overall Study||142
1549109|NCT01296360|3791296|P1|COMPLETED|Overall Study||144
1549110|NCT01296360|3791295|P2|Visit 2a (Month 13)|Overall Study||0
1549111|NCT01296360|3791296|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
1549112|NCT01296360|3791295|P2|Visit 2 (Month 12)|Overall Study||149
1549113|NCT01296360|3791296|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
1549114|NCT01296360|3791295|P2|STARTED|Overall Study||150
1549115|NCT01296360|3791296|P1|STARTED|Overall Study||150
1549116|NCT01296347|3791304|P2|NOT COMPLETED|Overall Study||5
1549117|NCT01296347|3791305|P1|NOT COMPLETED|Overall Study||0
1549118|NCT01296347|3791304|P2|COMPLETED|Overall Study||47
1549119|NCT01296347|3791305|P1|COMPLETED|Overall Study||52
1549120|NCT01296347|3791304|P2|6 Weeks Afer Surgery|Overall Study||47
1549121|NCT01296347|3791305|P1|6 Weeks Afer Surgery|Overall Study||52
1549122|NCT01296347|3791304|P2|STARTED|Overall Study||52
1549123|NCT01296347|3791305|P1|STARTED|Overall Study||52
1549124|NCT01296152|3791311|P1|NOT COMPLETED|Overall Study||1
1549125|NCT01296152|3791311|P1|COMPLETED|Overall Study||24
1549126|NCT01296152|3791311|P1|STARTED|Overall Study||25
1549127|NCT01296035|3791338|P1|NOT COMPLETED|Overall Study||1
1549128|NCT01296035|3791338|P1|COMPLETED|Overall Study||7
1549129|NCT01296035|3791338|P1|STARTED|Overall Study||8
1549130|NCT01295905|3791345|P2|NOT COMPLETED|Overall Study||0
1549131|NCT01295905|3791346|P1|NOT COMPLETED|Overall Study||2
1549132|NCT01295905|3791345|P2|COMPLETED|Overall Study||30
1549133|NCT01295905|3791346|P1|COMPLETED|Overall Study||58
1549134|NCT01295905|3791345|P2|STARTED|Overall Study||30
1549135|NCT01295905|3791346|P1|STARTED|Overall Study||60
1549136|NCT01295879|3791358|P1|NOT COMPLETED|Overall Study||0
1549137|NCT01295879|3791358|P1|COMPLETED|Overall Study||29
1549138|NCT01295879|3791358|P1|STARTED|Overall Study||29
1549139|NCT01295840|3791364|P1|NOT COMPLETED|Overall Study||1
1549140|NCT01295840|3791364|P1|COMPLETED|Overall Study||50
1549141|NCT01295840|3791364|P1|STARTED|Overall Study||51
1549142|NCT01295814|3791380|P2|NOT COMPLETED|Overall Study||2
1549143|NCT01295814|3791381|P1|NOT COMPLETED|Overall Study||2
1549144|NCT01295814|3791380|P2|COMPLETED|Overall Study||19
1549145|NCT01295814|3791381|P1|COMPLETED|Overall Study||20
1549146|NCT01295814|3791380|P2|STARTED|Overall Study||21
1549147|NCT01295814|3791381|P1|STARTED|Overall Study||22
1549148|NCT01295671|3791398|P3|NOT COMPLETED|Overall Study||3
1549149|NCT01295671|3791399|P2|NOT COMPLETED|Overall Study||7
1549150|NCT01295671|3791400|P1|NOT COMPLETED|Overall Study||7
1549151|NCT01295671|3791398|P3|COMPLETED|Overall Study||66
1549152|NCT01295671|3791399|P2|COMPLETED|Overall Study||60
1549153|NCT01295671|3791400|P1|COMPLETED|Overall Study||60
1549154|NCT01295671|3791398|P3|STARTED|Overall Study||69
1549155|NCT01295671|3791399|P2|STARTED|Overall Study||67
1549156|NCT01295671|3791400|P1|STARTED|Overall Study||67
1549157|NCT01295320|3791438|P1|NOT COMPLETED|Overall Study||10
1549158|NCT01295320|3791438|P1|COMPLETED|Overall Study||119
1549159|NCT01295320|3791438|P1|STARTED|Overall Study||129
1549160|NCT01295281|3791455|P2|NOT COMPLETED|Second Intervention (7days)||0
1549161|NCT01295281|3791456|P1|NOT COMPLETED|Second Intervention (7days)||0
1549162|NCT01295281|3791455|P2|COMPLETED|Second Intervention (7days)||51
1549163|NCT01295281|3791456|P1|COMPLETED|Second Intervention (7days)||53
1549164|NCT01295281|3791455|P2|STARTED|Second Intervention (7days)||51
1549165|NCT01295281|3791456|P1|STARTED|Second Intervention (7days)||53
1549166|NCT01295281|3791455|P2|NOT COMPLETED|First Intervention (7 Days)||1
1549167|NCT01295281|3791456|P1|NOT COMPLETED|First Intervention (7 Days)||0
1549168|NCT01295281|3791455|P2|COMPLETED|First Intervention (7 Days)||51
1549169|NCT01295281|3791456|P1|COMPLETED|First Intervention (7 Days)||53
1549170|NCT01295281|3791455|P2|STARTED|First Intervention (7 Days)||52
1549171|NCT01295281|3791456|P1|STARTED|First Intervention (7 Days)||53
1549172|NCT01295216|3791464|P2|NOT COMPLETED|Overall Study||34
1549173|NCT01295216|3791465|P1|NOT COMPLETED|Overall Study||50
1549174|NCT01295216|3791464|P2|COMPLETED|Overall Study||287
1549175|NCT01295216|3791465|P1|COMPLETED|Overall Study||266
1549176|NCT01295216|3791464|P2|STARTED|Overall Study||321
1549177|NCT01295216|3791465|P1|STARTED|Overall Study||316
1549178|NCT01295112|3791483|P2|NOT COMPLETED|Overall Study||0
1549179|NCT01295112|3791484|P1|NOT COMPLETED|Overall Study||0
1549180|NCT01295112|3791483|P2|COMPLETED|Overall Study||33
1549181|NCT01295112|3791484|P1|COMPLETED|Overall Study||35
1549182|NCT01295112|3791483|P2|STARTED|Overall Study||33
1549183|NCT01295112|3791484|P1|STARTED|Overall Study||35
1549184|NCT01295034|3791494|P2|NOT COMPLETED|Overall Study||5
1549185|NCT01295034|3791495|P1|NOT COMPLETED|Overall Study||5
1549186|NCT01295034|3791494|P2|COMPLETED|Overall Study||25
1549187|NCT01295034|3791495|P1|COMPLETED|Overall Study||27
1549188|NCT01295034|3791494|P2|STARTED|Overall Study||30
1549189|NCT01295034|3791495|P1|STARTED|Overall Study||32
1549190|NCT01294917|3791503|P1|NOT COMPLETED|Overall Study||6
1549191|NCT01294917|3791503|P1|COMPLETED|Overall Study||36
1549192|NCT01294917|3791503|P1|Received OptiFree RepleniSH MPS|Overall Study||36
1549193|NCT01294917|3791503|P1|Received Clear Care|Overall Study||36
1549194|NCT01294917|3791503|P1|Received Investigational MPS|Overall Study||36
1549195|NCT01294917|3791503|P1|STARTED|Overall Study||42
1549196|NCT01294800|3791513|P4|NOT COMPLETED|Overall Study||16
1549197|NCT01294800|3791514|P3|NOT COMPLETED|Overall Study||17
1549198|NCT01294800|3791515|P2|NOT COMPLETED|Overall Study||10
1549199|NCT01294800|3791516|P1|NOT COMPLETED|Overall Study||11
1549200|NCT01294800|3791513|P4|COMPLETED|Overall Study||97
1549201|NCT01294800|3791514|P3|COMPLETED|Overall Study||96
1549202|NCT01294800|3791515|P2|COMPLETED|Overall Study||103
1549203|NCT01294800|3791516|P1|COMPLETED|Overall Study||100
1549204|NCT01294800|3791513|P4|STARTED|Overall Study||113
1549205|NCT01294800|3791514|P3|STARTED|Overall Study||113
1549206|NCT01294800|3791515|P2|STARTED|Overall Study||113
1549207|NCT01294800|3791516|P1|STARTED|Overall Study||111
1549208|NCT01294787|3791542|P6|NOT COMPLETED|Period 3||0
1549209|NCT01294787|3791543|P5|NOT COMPLETED|Period 3||1
1549210|NCT01294787|3791544|P4|NOT COMPLETED|Period 3||0
1549211|NCT01294787|3791545|P3|NOT COMPLETED|Period 3||0
1549212|NCT01294787|3791546|P2|NOT COMPLETED|Period 3||0
1549213|NCT01294787|3791547|P1|NOT COMPLETED|Period 3||0
1549214|NCT01294787|3791542|P6|COMPLETED|Period 3||13
1549215|NCT01294787|3791543|P5|COMPLETED|Period 3||13
1549216|NCT01294787|3791544|P4|COMPLETED|Period 3||9
1549217|NCT01294787|3791545|P3|COMPLETED|Period 3||13
1549218|NCT01294787|3791546|P2|COMPLETED|Period 3||13
1549219|NCT01294787|3791547|P1|COMPLETED|Period 3||12
1549220|NCT01294787|3791542|P6|STARTED|Period 3||13
1549221|NCT01294787|3791543|P5|STARTED|Period 3||14
1549222|NCT01294787|3791544|P4|STARTED|Period 3||9
1549223|NCT01294787|3791545|P3|STARTED|Period 3||13
1549224|NCT01294787|3791546|P2|STARTED|Period 3||13
1549225|NCT01294787|3791547|P1|STARTED|Period 3||12
1549226|NCT01294787|3791542|P6|NOT COMPLETED|Period 2||0
1549227|NCT01294787|3791543|P5|NOT COMPLETED|Period 2||0
1549228|NCT01294787|3791544|P4|NOT COMPLETED|Period 2||2
1549229|NCT01294787|3791545|P3|NOT COMPLETED|Period 2||0
1549230|NCT01294787|3791546|P2|NOT COMPLETED|Period 2||3
1549231|NCT01294787|3791547|P1|NOT COMPLETED|Period 2||0
1549232|NCT01294787|3791542|P6|COMPLETED|Period 2||13
1549233|NCT01294787|3791543|P5|COMPLETED|Period 2||14
1549234|NCT01294787|3791544|P4|COMPLETED|Period 2||9
1549235|NCT01294787|3791545|P3|COMPLETED|Period 2||13
1549236|NCT01294787|3791546|P2|COMPLETED|Period 2||13
1549237|NCT01294787|3791547|P1|COMPLETED|Period 2||12
1549238|NCT01294787|3791542|P6|STARTED|Period 2||13
1549239|NCT01294787|3791543|P5|STARTED|Period 2||14
1549240|NCT01294787|3791544|P4|STARTED|Period 2||11
1549241|NCT01294787|3791545|P3|STARTED|Period 2||13
1549242|NCT01294787|3791546|P2|STARTED|Period 2||16
1549243|NCT01294787|3791547|P1|STARTED|Period 2||12
1549244|NCT01294787|3791542|P6|NOT COMPLETED|Period 1||2
1549245|NCT01294787|3791543|P5|NOT COMPLETED|Period 1||2
1549246|NCT01294787|3791544|P4|NOT COMPLETED|Period 1||1
1549247|NCT01294787|3791545|P3|NOT COMPLETED|Period 1||1
1549248|NCT01294787|3791546|P2|NOT COMPLETED|Period 1||0
1549249|NCT01294787|3791547|P1|NOT COMPLETED|Period 1||0
1549250|NCT01294787|3791542|P6|COMPLETED|Period 1||13
1549251|NCT01294787|3791543|P5|COMPLETED|Period 1||14
1549252|NCT01294787|3791544|P4|COMPLETED|Period 1||11
1549253|NCT01294787|3791545|P3|COMPLETED|Period 1||13
1549254|NCT01294787|3791546|P2|COMPLETED|Period 1||16
1549255|NCT01294787|3791547|P1|COMPLETED|Period 1||12
1549256|NCT01294787|3791542|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
1549257|NCT01294787|3791543|P5|STARTED|Period 1||16
1549258|NCT01294787|3791544|P4|STARTED|Period 1||12
1549259|NCT01294787|3791545|P3|STARTED|Period 1||14
1549260|NCT01294787|3791546|P2|STARTED|Period 1||16
1549261|NCT01294787|3791547|P1|STARTED|Period 1||12
1549262|NCT01294748|3791591|P2|NOT COMPLETED|Overall Study||2
1549263|NCT01294748|3791592|P1|NOT COMPLETED|Overall Study||5
1549264|NCT01294748|3791591|P2|COMPLETED|Overall Study|At 270 days|59
1549265|NCT01294748|3791592|P1|COMPLETED|Overall Study|At 270 days|118
1549266|NCT01294748|3791591|P2|STARTED|Overall Study||61
1549267|NCT01294748|3791592|P1|STARTED|Overall Study||123
1549268|NCT01294709|3791618|P2|NOT COMPLETED|Period 2||0
1549269|NCT01294709|3791619|P1|NOT COMPLETED|Period 2||1
1549270|NCT01294709|3791618|P2|COMPLETED|Period 2||31
1549271|NCT01294709|3791619|P1|COMPLETED|Period 2||28
1549272|NCT01294709|3791618|P2|STARTED|Period 2||31
1549273|NCT01294709|3791619|P1|STARTED|Period 2||29
1549274|NCT01294709|3791618|P2|NOT COMPLETED|Washout Period||1
1549275|NCT01294709|3791619|P1|NOT COMPLETED|Washout Period||1
1549276|NCT01294709|3791618|P2|COMPLETED|Washout Period||31
1549277|NCT01294709|3791619|P1|COMPLETED|Washout Period||29
1549278|NCT01294709|3791618|P2|STARTED|Washout Period||32
1549279|NCT01294709|3791619|P1|STARTED|Washout Period||30
1549280|NCT01294709|3791618|P2|NOT COMPLETED|Period 1||1
1549281|NCT01294709|3791619|P1|NOT COMPLETED|Period 1||1
1549282|NCT01294709|3791618|P2|COMPLETED|Period 1||32
1549283|NCT01294709|3791619|P1|COMPLETED|Period 1||30
1549284|NCT01294709|3791618|P2|STARTED|Period 1||33
1549285|NCT01294709|3791619|P1|STARTED|Period 1||31
1549286|NCT01294696|3791638|P1|NOT COMPLETED|Overall Study||74
1549287|NCT01294696|3791638|P1|COMPLETED|Overall Study||1187
1549288|NCT01294696|3791638|P1|STARTED|Overall Study||1261
1549289|NCT01294683|3791652|P2|NOT COMPLETED|Post Crossover (Period III)||32
1549290|NCT01294683|3791653|P1|NOT COMPLETED|Post Crossover (Period III)||33
1549291|NCT01294683|3791652|P2|COMPLETED|Post Crossover (Period III)||190
1549292|NCT01294683|3791653|P1|COMPLETED|Post Crossover (Period III)||199
1549293|NCT01294683|3791652|P2|STARTED|Post Crossover (Period III)||222
1549294|NCT01294683|3791653|P1|STARTED|Post Crossover (Period III)||232
1549295|NCT01294683|3791652|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
1549296|NCT01294683|3791653|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
1549297|NCT01294683|3791652|P2|COMPLETED|Precrossover (Periods I/II)||222
1549298|NCT01294683|3791653|P1|COMPLETED|Precrossover (Periods I/II)||232
1549299|NCT01294683|3791652|P2|Treated|Precrossover (Periods I/II)||486
1549300|NCT01294683|3791653|P1|Treated|Precrossover (Periods I/II)||486
1549301|NCT01294683|3791652|P2|STARTED|Precrossover (Periods I/II)||488
1549302|NCT01294683|3791653|P1|STARTED|Precrossover (Periods I/II)||489
1549303|NCT01294644|3791706|P3|NOT COMPLETED|Overall Study||14
1549304|NCT01294644|3791707|P2|NOT COMPLETED|Overall Study||10
1549305|NCT01294644|3791708|P1|NOT COMPLETED|Overall Study||10
1549306|NCT01294644|3791706|P3|COMPLETED|Overall Study||103
1549307|NCT01294644|3791707|P2|COMPLETED|Overall Study||112
1549308|NCT01294644|3791708|P1|COMPLETED|Overall Study||111
1549309|NCT01294644|3791706|P3|Received Treatment|Overall Study||114
1549310|NCT01294644|3791707|P2|Received Treatment|Overall Study||122
1549311|NCT01294644|3791708|P1|Received Treatment|Overall Study||118
1549312|NCT01294644|3791706|P3|STARTED|Overall Study||117
1549313|NCT01294644|3791707|P2|STARTED|Overall Study||122
1549314|NCT01294644|3791708|P1|STARTED|Overall Study||121
1549315|NCT01294592|3791739|P2|NOT COMPLETED|Overall Study||73
1549316|NCT01294592|3791740|P1|NOT COMPLETED|Overall Study||77
1549317|NCT01294592|3791739|P2|COMPLETED|Overall Study||300
1549318|NCT01294592|3791740|P1|COMPLETED|Overall Study||292
1549319|NCT01294592|3791739|P2|STARTED|Overall Study||373
1549320|NCT01294592|3791740|P1|STARTED|Overall Study||369
1549321|NCT01294579|3791768|P1|NOT COMPLETED|Overall Study||35
1549322|NCT01294579|3791768|P1|COMPLETED|Overall Study||14
1549323|NCT01294579|3791768|P1|STARTED|Overall Study||49
1549324|NCT01294553|3791778|P1|NOT COMPLETED|Overall Study||269
1549325|NCT01294553|3791778|P1|COMPLETED|Overall Study||713
1549326|NCT01294553|3791778|P1|STARTED|Overall Study||982
1549327|NCT01294514|3791784|P1|NOT COMPLETED|Overall Study||1
1549328|NCT01294514|3791784|P1|COMPLETED|Overall Study||26
1549329|NCT01294514|3791784|P1|STARTED|Overall Study||27
1549330|NCT01294462|3791794|P2|NOT COMPLETED|Overall Study||63
1549331|NCT01294462|3791795|P1|NOT COMPLETED|Overall Study||66
1549332|NCT01294462|3791794|P2|COMPLETED|Overall Study||337
1549333|NCT01294462|3791795|P1|COMPLETED|Overall Study||335
1549334|NCT01294462|3791794|P2|Received Randomized Treatment|Overall Study||380
1549335|NCT01294462|3791795|P1|Received Randomized Treatment|Overall Study||387
1549336|NCT01294462|3791794|P2|STARTED|Overall Study||400
1549337|NCT01294462|3791795|P1|STARTED|Overall Study||401
1549338|NCT01294449|3791809|P2|NOT COMPLETED|Overall Study||15
1549339|NCT01294449|3791810|P1|NOT COMPLETED|Overall Study||12
1549340|NCT01294449|3791809|P2|COMPLETED|Overall Study||237
1549341|NCT01294449|3791810|P1|COMPLETED|Overall Study||144
1549342|NCT01294449|3791809|P2|Consent to Registry|Overall Study||245
1549343|NCT01294449|3791810|P1|Consent to Registry|Overall Study||149
1549344|NCT01294449|3791809|P2|STARTED|Overall Study||252
1549345|NCT01294449|3791810|P1|STARTED|Overall Study||156
1549346|NCT01294436|3791818|P2|NOT COMPLETED|Overall Study||70
1549347|NCT01294436|3791819|P1|NOT COMPLETED|Overall Study||28
1549348|NCT01294436|3791818|P2|COMPLETED|Overall Study||409
1549349|NCT01294436|3791819|P1|COMPLETED|Overall Study||221
1549350|NCT01294436|3791818|P2|STARTED|Overall Study||479
1549351|NCT01294436|3791819|P1|STARTED|Overall Study||249
1549352|NCT01294423|3791854|P3|NOT COMPLETED|Overall Study||8
1549353|NCT01294423|3791855|P2|NOT COMPLETED|Overall Study||9
1549354|NCT01294423|3791856|P1|NOT COMPLETED|Overall Study||5
1549355|NCT01294423|3791854|P3|COMPLETED|Overall Study||79
1549356|NCT01294423|3791855|P2|COMPLETED|Overall Study||79
1549357|NCT01294423|3791856|P1|COMPLETED|Overall Study||81
1549358|NCT01294423|3791854|P3|STARTED|Overall Study||87
1549359|NCT01294423|3791855|P2|STARTED|Overall Study||88
1549360|NCT01294423|3791856|P1|STARTED|Overall Study||86
1549361|NCT01294397|3791870|P1|NOT COMPLETED|Overall Study||2
1549362|NCT01294397|3791870|P1|COMPLETED|Overall Study||17
1549363|NCT01294397|3791870|P1|STARTED|Overall Study||19
1549364|NCT01294384|3791883|P3|NOT COMPLETED|Overall Study||9
1549365|NCT01294384|3791884|P2|NOT COMPLETED|Overall Study||6
1549366|NCT01294384|3791885|P1|NOT COMPLETED|Overall Study||4
1549367|NCT01294384|3791883|P3|COMPLETED|Overall Study||95
1549368|NCT01294384|3791884|P2|COMPLETED|Overall Study||94
1549369|NCT01294384|3791885|P1|COMPLETED|Overall Study||97
1549370|NCT01294384|3791883|P3|STARTED|Overall Study||104
1549371|NCT01294384|3791884|P2|STARTED|Overall Study||100
1549372|NCT01294384|3791885|P1|STARTED|Overall Study||101
1549373|NCT01294371|3791914|P1|NOT COMPLETED|Overall Study||34
1549374|NCT01294371|3791914|P1|COMPLETED|Overall Study||357
1549375|NCT01294371|3791914|P1|Treated|Overall Study||390
1549376|NCT01294371|3791914|P1|STARTED|Overall Study||391
1549377|NCT01294358|3791922|P5|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
1549378|NCT01294358|3791923|P4|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1549379|NCT01294358|3791924|P3|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1549380|NCT01294358|3791925|P2|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1549381|NCT01294358|3791926|P1|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1549382|NCT01294358|3791922|P5|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1549383|NCT01294358|3791923|P4|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1549384|NCT01294358|3791924|P3|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1549385|NCT01294358|3791925|P2|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1549386|NCT01294358|3791926|P1|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
1549387|NCT01294358|3791922|P5|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
1549388|NCT01294358|3791923|P4|STARTED|Cohort 5: 3/8/12-3/9/12||0
1549389|NCT01294358|3791924|P3|STARTED|Cohort 5: 3/8/12-3/9/12||0
1549390|NCT01294358|3791925|P2|STARTED|Cohort 5: 3/8/12-3/9/12||0
1549391|NCT01294358|3791926|P1|STARTED|Cohort 5: 3/8/12-3/9/12||0
1549392|NCT01294358|3791922|P5|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1549393|NCT01294358|3791923|P4|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
1549394|NCT01294358|3791924|P3|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1549395|NCT01294358|3791925|P2|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1549396|NCT01294358|3791926|P1|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1549397|NCT01294358|3791922|P5|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1549398|NCT01294358|3791923|P4|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
1549399|NCT01294358|3791924|P3|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1549400|NCT01294358|3791925|P2|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1549401|NCT01294358|3791926|P1|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
1549402|NCT01294358|3791922|P5|STARTED|Cohort 4: 12/30/11-2/17/17||0
1549403|NCT01294358|3791923|P4|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
1549404|NCT01294358|3791924|P3|STARTED|Cohort 4: 12/30/11-2/17/17||0
1549405|NCT01294358|3791925|P2|STARTED|Cohort 4: 12/30/11-2/17/17||0
1549406|NCT01294358|3791926|P1|STARTED|Cohort 4: 12/30/11-2/17/17||0
1549407|NCT01294358|3791922|P5|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1549408|NCT01294358|3791923|P4|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1549409|NCT01294358|3791924|P3|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
1549410|NCT01294358|3791925|P2|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1549411|NCT01294358|3791926|P1|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1549412|NCT01294358|3791922|P5|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1549413|NCT01294358|3791923|P4|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1549414|NCT01294358|3791924|P3|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
1549415|NCT01294358|3791925|P2|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1549416|NCT01294358|3791926|P1|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
1549417|NCT01294358|3791922|P5|STARTED|Cohort 3: 12/1/11-10/6/12||0
1549418|NCT01294358|3791923|P4|STARTED|Cohort 3: 12/1/11-10/6/12||0
1549419|NCT01294358|3791924|P3|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
1549420|NCT01294358|3791925|P2|STARTED|Cohort 3: 12/1/11-10/6/12||0
1549421|NCT01294358|3791926|P1|STARTED|Cohort 3: 12/1/11-10/6/12||0
1549422|NCT01294358|3791922|P5|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1549423|NCT01294358|3791923|P4|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1549424|NCT01294358|3791924|P3|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1549425|NCT01294358|3791925|P2|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
1549426|NCT01294358|3791926|P1|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1549427|NCT01294358|3791922|P5|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1549428|NCT01294358|3791923|P4|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1549429|NCT01294358|3791924|P3|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1549430|NCT01294358|3791925|P2|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
1549431|NCT01294358|3791926|P1|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
1549432|NCT01294358|3791922|P5|STARTED|Cohort 2: 6/9/11-9/17/12||0
1549433|NCT01294358|3791923|P4|STARTED|Cohort 2: 6/9/11-9/17/12||0
1549434|NCT01294358|3791924|P3|STARTED|Cohort 2: 6/9/11-9/17/12||0
1549435|NCT01294358|3791925|P2|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
1549436|NCT01294358|3791926|P1|STARTED|Cohort 2: 6/9/11-9/17/12||0
1549437|NCT01294358|3791922|P5|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1549438|NCT01294358|3791923|P4|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1549439|NCT01294358|3791924|P3|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1549440|NCT01294358|3791925|P2|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1549441|NCT01294358|3791926|P1|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1549442|NCT01294358|3791922|P5|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1549443|NCT01294358|3791923|P4|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1549444|NCT01294358|3791924|P3|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1549445|NCT01294358|3791925|P2|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
1549446|NCT01294358|3791926|P1|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
1549447|NCT01294358|3791922|P5|STARTED|Cohort 1: 5/11/11-11/9/11||0
1549448|NCT01294358|3791923|P4|STARTED|Cohort 1: 5/11/11-11/9/11||0
1549449|NCT01294358|3791924|P3|STARTED|Cohort 1: 5/11/11-11/9/11||0
1549450|NCT01294358|3791925|P2|STARTED|Cohort 1: 5/11/11-11/9/11||0
1549451|NCT01294358|3791926|P1|STARTED|Cohort 1: 5/11/11-11/9/11||4
1549452|NCT01294319|3791988|P8|NOT COMPLETED|Overall Study||0
1549453|NCT01294319|3791989|P7|NOT COMPLETED|Overall Study||0
1549454|NCT01294319|3791990|P6|NOT COMPLETED|Overall Study||0
1549455|NCT01294319|3791991|P5|NOT COMPLETED|Overall Study||0
1549456|NCT01294319|3791992|P4|NOT COMPLETED|Overall Study||0
1549457|NCT01294319|3791993|P3|NOT COMPLETED|Overall Study||0
1549458|NCT01294319|3791994|P2|NOT COMPLETED|Overall Study||0
1549459|NCT01294319|3791995|P1|NOT COMPLETED|Overall Study||0
1549460|NCT01294319|3791988|P8|COMPLETED|Overall Study||5
1549461|NCT01294319|3791989|P7|COMPLETED|Overall Study||5
1549462|NCT01294319|3791990|P6|COMPLETED|Overall Study||4
1549463|NCT01294319|3791991|P5|COMPLETED|Overall Study||5
1549464|NCT01294319|3791992|P4|COMPLETED|Overall Study||5
1549465|NCT01294319|3791993|P3|COMPLETED|Overall Study||5
1549466|NCT01294319|3791994|P2|COMPLETED|Overall Study||6
1549467|NCT01294319|3791995|P1|COMPLETED|Overall Study||4
1549468|NCT01294319|3791988|P8|STARTED|Overall Study||5
1549469|NCT01294319|3791989|P7|STARTED|Overall Study||5
1549470|NCT01294319|3791990|P6|STARTED|Overall Study||4
1549471|NCT01294319|3791991|P5|STARTED|Overall Study||5
1549472|NCT01294319|3791992|P4|STARTED|Overall Study||5
1549473|NCT01294319|3791993|P3|STARTED|Overall Study||5
1549474|NCT01294319|3791994|P2|STARTED|Overall Study||6
1549475|NCT01294319|3791995|P1|STARTED|Overall Study||4
1549476|NCT01294306|3792005|P2|NOT COMPLETED|Overall Study||0
1549477|NCT01294306|3792006|P1|NOT COMPLETED|Overall Study||0
1549478|NCT01294306|3792005|P2|COMPLETED|Overall Study||35
1549479|NCT01294306|3792006|P1|COMPLETED|Overall Study||45
1549480|NCT01294306|3792005|P2|STARTED|Overall Study||35
1549481|NCT01294306|3792006|P1|STARTED|Overall Study||45
1549482|NCT01294267|3792020|P1|NOT COMPLETED|Overall Study||0
1549483|NCT01294267|3792020|P1|COMPLETED|Overall Study||20
1549484|NCT01294267|3792020|P1|STARTED|Overall Study||20
1549485|NCT01294241|3792026|P1|NOT COMPLETED|Overall Study||0
1549486|NCT01294241|3792026|P1|COMPLETED|Overall Study||10
1549487|NCT01294241|3792026|P1|STARTED|Overall Study||10
1549488|NCT01294228|3792034|P1|NOT COMPLETED|Overall Study||0
1549489|NCT01294228|3792034|P1|COMPLETED|Overall Study||1001
1549490|NCT01294228|3792034|P1|STARTED|Overall Study||1001
1549491|NCT01294163|3792041|P3|NOT COMPLETED|Overall Study||3
1549492|NCT01294163|3792042|P2|NOT COMPLETED|Overall Study||0
1549493|NCT01294163|3792043|P1|NOT COMPLETED|Overall Study||1
1549494|NCT01294163|3792041|P3|COMPLETED|Overall Study||163
1549495|NCT01294163|3792042|P2|COMPLETED|Overall Study||165
1549496|NCT01294163|3792043|P1|COMPLETED|Overall Study||177
1549497|NCT01294163|3792041|P3|STARTED|Overall Study||166
1549498|NCT01294163|3792042|P2|STARTED|Overall Study||165
1549499|NCT01294163|3792043|P1|STARTED|Overall Study||178
1549500|NCT01294150|3792054|P2|NOT COMPLETED|Overall Study||2
1549501|NCT01294150|3792055|P1|NOT COMPLETED|Overall Study||2
1549502|NCT01294150|3792054|P2|COMPLETED|Overall Study||64
1549503|NCT01294150|3792055|P1|COMPLETED|Overall Study||138
1549504|NCT01294150|3792054|P2|STARTED|Overall Study||66
1549505|NCT01294150|3792055|P1|STARTED|Overall Study||140
1549506|NCT01294098|3792068|P3|NOT COMPLETED|Overall Study||1
1549507|NCT01294098|3792069|P2|NOT COMPLETED|Overall Study||1
1549508|NCT01294098|3792070|P1|NOT COMPLETED|Overall Study||0
1549509|NCT01294098|3792068|P3|COMPLETED|Overall Study||0
1549510|NCT01294098|3792069|P2|COMPLETED|Overall Study||0
1549511|NCT01294098|3792070|P1|COMPLETED|Overall Study||0
1549512|NCT01294098|3792068|P3|STARTED|Overall Study||1
1549513|NCT01294098|3792069|P2|STARTED|Overall Study||1
1549514|NCT01294098|3792070|P1|STARTED|Overall Study||0
1549515|NCT01294046|3792084|P1|NOT COMPLETED|Overall Study||3
1549516|NCT01294046|3792084|P1|COMPLETED|Overall Study||0
1549517|NCT01294046|3792084|P1|STARTED|Overall Study||3
1549518|NCT01293968|3792099|P2|NOT COMPLETED|Overall Study||3
1549519|NCT01293968|3792100|P1|NOT COMPLETED|Overall Study||3
1549520|NCT01293968|3792099|P2|COMPLETED|Overall Study||14
1549521|NCT01293968|3792100|P1|COMPLETED|Overall Study||17
1549522|NCT01293968|3792099|P2|STARTED|Overall Study||17
1549523|NCT01293968|3792100|P1|STARTED|Overall Study||20
1549524|NCT01293825|3792106|P1|NOT COMPLETED|Overall Study||10
1549525|NCT01293825|3792106|P1|COMPLETED|Overall Study||20
1549526|NCT01293825|3792106|P1|STARTED|Overall Study||30
1549527|NCT01293695|3792120|P2|NOT COMPLETED|Overall Study||7
1549528|NCT01293695|3792121|P1|NOT COMPLETED|Overall Study||15
1549529|NCT01293695|3792120|P2|COMPLETED|Overall Study||87
1549530|NCT01293695|3792121|P1|COMPLETED|Overall Study||78
1549531|NCT01293695|3792120|P2|STARTED|Overall Study||94
1549532|NCT01293695|3792121|P1|STARTED|Overall Study||93
1549533|NCT01293539|3792135|P1|NOT COMPLETED|Overall Study||1
1549534|NCT01293539|3792135|P1|COMPLETED|Overall Study||9
1549535|NCT01293539|3792135|P1|STARTED|Overall Study||10
1549536|NCT01293240|3792139|P1|NOT COMPLETED|Overall Study||2
1549537|NCT01293240|3792139|P1|COMPLETED|Overall Study||115
1549538|NCT01293240|3792139|P1|STARTED|Overall Study||117
1549539|NCT01293084|3792154|P1|NOT COMPLETED|Overall Study||5
1549540|NCT01293084|3792154|P1|COMPLETED|Overall Study||12
1549541|NCT01293084|3792154|P1|STARTED|Overall Study||17
1549542|NCT01293032|3792166|P4|NOT COMPLETED|Treatment||1
1549543|NCT01293032|3792167|P3|NOT COMPLETED|Treatment||1
1549544|NCT01293032|3792168|P2|NOT COMPLETED|Treatment||5
1549545|NCT01293032|3792169|P1|NOT COMPLETED|Treatment||2
1549546|NCT01293032|3792166|P4|COMPLETED|Treatment||13
1549547|NCT01293032|3792167|P3|COMPLETED|Treatment||10
1549548|NCT01293032|3792168|P2|COMPLETED|Treatment||14
1549549|NCT01293032|3792169|P1|COMPLETED|Treatment||10
1549550|NCT01293032|3792166|P4|STARTED|Treatment||14
1549551|NCT01293032|3792167|P3|STARTED|Treatment||11
1549552|NCT01293032|3792168|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
1549553|NCT01293032|3792169|P1|STARTED|Treatment||12
1549554|NCT01293032|3792166|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
1549555|NCT01293032|3792167|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
1549556|NCT01293032|3792168|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
1549557|NCT01293032|3792169|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
1549558|NCT01293032|3792166|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
1549559|NCT01293032|3792167|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
1549560|NCT01293032|3792168|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
1549561|NCT01293032|3792169|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
1549562|NCT01293032|3792166|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
1549563|NCT01293032|3792167|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
1549564|NCT01293032|3792168|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
1549565|NCT01293032|3792169|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
1549566|NCT01293032|3792166|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
1549567|NCT01293032|3792167|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
1549568|NCT01293032|3792168|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
1549569|NCT01293032|3792169|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
1549570|NCT01293006|3792180|P4|NOT COMPLETED|Period 2||0
1549571|NCT01293006|3792181|P3|NOT COMPLETED|Period 2||0
1549572|NCT01293006|3792182|P2|NOT COMPLETED|Period 2||0
1549573|NCT01293006|3792183|P1|NOT COMPLETED|Period 2||1
1549574|NCT01293006|3792180|P4|COMPLETED|Period 2||3
1549575|NCT01293006|3792181|P3|COMPLETED|Period 2||9
1549576|NCT01293006|3792182|P2|COMPLETED|Period 2||2
1549577|NCT01293006|3792183|P1|COMPLETED|Period 2||10
1549578|NCT01293006|3792180|P4|STARTED|Period 2||3
1549579|NCT01293006|3792181|P3|STARTED|Period 2||9
1549580|NCT01293006|3792182|P2|STARTED|Period 2||2
1549581|NCT01293006|3792183|P1|STARTED|Period 2||11
1549582|NCT01293006|3792180|P4|NOT COMPLETED|Washout||0
1549583|NCT01293006|3792181|P3|NOT COMPLETED|Washout||0
1549584|NCT01293006|3792182|P2|NOT COMPLETED|Washout||0
1549585|NCT01293006|3792183|P1|NOT COMPLETED|Washout||0
1549586|NCT01293006|3792180|P4|COMPLETED|Washout||3
1549587|NCT01293006|3792181|P3|COMPLETED|Washout||9
1549588|NCT01293006|3792182|P2|COMPLETED|Washout||2
1549589|NCT01293006|3792183|P1|COMPLETED|Washout||11
1549590|NCT01293006|3792180|P4|STARTED|Washout||3
1549591|NCT01293006|3792181|P3|STARTED|Washout||9
1549592|NCT01293006|3792182|P2|STARTED|Washout||2
1549593|NCT01293006|3792183|P1|STARTED|Washout||11
1549594|NCT01293006|3792180|P4|NOT COMPLETED|Period 1||0
1549595|NCT01293006|3792181|P3|NOT COMPLETED|Period 1||0
1549596|NCT01293006|3792182|P2|NOT COMPLETED|Period 1||0
1549597|NCT01293006|3792183|P1|NOT COMPLETED|Period 1||0
1549598|NCT01293006|3792180|P4|COMPLETED|Period 1||3
1549599|NCT01293006|3792181|P3|COMPLETED|Period 1||9
1549600|NCT01293006|3792182|P2|COMPLETED|Period 1||2
1549601|NCT01293006|3792183|P1|COMPLETED|Period 1||11
1549602|NCT01293006|3792180|P4|STARTED|Period 1||3
1549603|NCT01293006|3792181|P3|STARTED|Period 1||9
1549604|NCT01293006|3792182|P2|STARTED|Period 1||2
1549605|NCT01293006|3792183|P1|STARTED|Period 1||11
1549606|NCT01292928|3792204|P1|NOT COMPLETED|Overall Study||24
1549607|NCT01292928|3792204|P1|COMPLETED|Overall Study||275
1549608|NCT01292928|3792204|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
1549609|NCT01292928|3792204|P1|STARTED|Overall Study||299
1549610|NCT01292876|3792221|P1|NOT COMPLETED|Overall Study||4
1549611|NCT01292876|3792221|P1|COMPLETED|Overall Study||13
1549612|NCT01292876|3792221|P1|STARTED|Overall Study||17
1549613|NCT01292837|3792227|P1|NOT COMPLETED|Overall Study||2
1549614|NCT01292837|3792227|P1|COMPLETED|Overall Study||11
1549615|NCT01292837|3792227|P1|STARTED|Overall Study||13
1549616|NCT01292798|3792236|P1|NOT COMPLETED|Overall Study||0
1549617|NCT01292798|3792236|P1|COMPLETED|Overall Study||43
1549618|NCT01292798|3792236|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
1549619|NCT01292798|3792236|P1|STARTED|Overall Study||43
1549620|NCT01292746|3792242|P1|NOT COMPLETED|Overall Study||0
1549621|NCT01292746|3792242|P1|COMPLETED|Overall Study||14
1549622|NCT01292746|3792242|P1|STARTED|Overall Study||14
1549623|NCT01292642|3792246|P1|NOT COMPLETED|Overall Study||5
1549624|NCT01292642|3792246|P1|COMPLETED|Overall Study||7
1549625|NCT01292642|3792246|P1|STARTED|Overall Study||12
1549626|NCT01292629|3792254|P1|NOT COMPLETED|Overall Study||0
1549627|NCT01292629|3792254|P1|COMPLETED|Overall Study||125
1549628|NCT01292629|3792254|P1|STARTED|Overall Study||125
1549629|NCT01292603|3792264|P6|NOT COMPLETED|Overall Survival Status||10
1549630|NCT01292603|3792265|P5|NOT COMPLETED|Overall Survival Status||16
1549631|NCT01292603|3792266|P4|NOT COMPLETED|Overall Survival Status||1
1549632|NCT01292603|3792267|P3|NOT COMPLETED|Overall Survival Status||3
1549633|NCT01292603|3792268|P2|NOT COMPLETED|Overall Survival Status||1
1549634|NCT01292603|3792269|P1|NOT COMPLETED|Overall Survival Status||3
1549635|NCT01292603|3792264|P6|COMPLETED|Overall Survival Status||78
1549636|NCT01292603|3792265|P5|COMPLETED|Overall Survival Status||72
1549637|NCT01292603|3792266|P4|COMPLETED|Overall Survival Status||7
1549638|NCT01292603|3792267|P3|COMPLETED|Overall Survival Status||20
1549639|NCT01292603|3792268|P2|COMPLETED|Overall Survival Status||16
1549640|NCT01292603|3792269|P1|COMPLETED|Overall Survival Status||13
1549641|NCT01292603|3792264|P6|STARTED|Overall Survival Status||88
1549642|NCT01292603|3792265|P5|STARTED|Overall Survival Status||88
1549643|NCT01292603|3792266|P4|STARTED|Overall Survival Status||8
1549644|NCT01292603|3792267|P3|STARTED|Overall Survival Status||23
1549645|NCT01292603|3792268|P2|STARTED|Overall Survival Status||17
1549646|NCT01292603|3792269|P1|STARTED|Overall Survival Status||16
1549647|NCT01292603|3792264|P6|NOT COMPLETED|Part 2: Regular Follow-Up||12
1549648|NCT01292603|3792265|P5|NOT COMPLETED|Part 2: Regular Follow-Up||19
1549649|NCT01292603|3792266|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
1549650|NCT01292603|3792267|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
1549651|NCT01292603|3792268|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
1549652|NCT01292603|3792269|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
1549653|NCT01292603|3792264|P6|COMPLETED|Part 2: Regular Follow-Up||75
1549654|NCT01292603|3792265|P5|COMPLETED|Part 2: Regular Follow-Up||68
1549655|NCT01292603|3792266|P4|COMPLETED|Part 2: Regular Follow-Up||0
1549656|NCT01292603|3792267|P3|COMPLETED|Part 2: Regular Follow-Up||0
1549657|NCT01292603|3792268|P2|COMPLETED|Part 2: Regular Follow-Up||0
1549658|NCT01292603|3792269|P1|COMPLETED|Part 2: Regular Follow-Up||0
1549659|NCT01292603|3792264|P6|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
1549660|NCT01292603|3792265|P5|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
1549661|NCT01292603|3792266|P4|STARTED|Part 2: Regular Follow-Up||0
1549662|NCT01292603|3792267|P3|STARTED|Part 2: Regular Follow-Up||0
1549663|NCT01292603|3792268|P2|STARTED|Part 2: Regular Follow-Up||0
1549664|NCT01292603|3792269|P1|STARTED|Part 2: Regular Follow-Up||0
1549665|NCT01292603|3792264|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
1549666|NCT01292603|3792265|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
1549667|NCT01292603|3792266|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1549668|NCT01292603|3792267|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1549669|NCT01292603|3792268|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1549670|NCT01292603|3792269|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1549671|NCT01292603|3792264|P6|COMPLETED|Part 2: Dose Confirmation Period||73
1549672|NCT01292603|3792265|P5|COMPLETED|Part 2: Dose Confirmation Period||72
1549673|NCT01292603|3792266|P4|COMPLETED|Part 2: Dose Confirmation Period||0
1549674|NCT01292603|3792267|P3|COMPLETED|Part 2: Dose Confirmation Period||0
1549675|NCT01292603|3792268|P2|COMPLETED|Part 2: Dose Confirmation Period||0
1549676|NCT01292603|3792269|P1|COMPLETED|Part 2: Dose Confirmation Period||0
1549677|NCT01292603|3792264|P6|STARTED|Part 2: Dose Confirmation Period||88
1549678|NCT01292603|3792265|P5|STARTED|Part 2: Dose Confirmation Period||88
1549679|NCT01292603|3792266|P4|STARTED|Part 2: Dose Confirmation Period||0
1549680|NCT01292603|3792267|P3|STARTED|Part 2: Dose Confirmation Period||0
1549681|NCT01292603|3792268|P2|STARTED|Part 2: Dose Confirmation Period||0
1549682|NCT01292603|3792269|P1|STARTED|Part 2: Dose Confirmation Period||0
1549683|NCT01292603|3792264|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
1549684|NCT01292603|3792265|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
1549685|NCT01292603|3792266|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
1549686|NCT01292603|3792267|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
1549687|NCT01292603|3792268|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
1549688|NCT01292603|3792269|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
1549689|NCT01292603|3792264|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
1549690|NCT01292603|3792265|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
1549691|NCT01292603|3792266|P4|COMPLETED|Part 1: Regular Follow-Up Period||7
1549692|NCT01292603|3792267|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
1549693|NCT01292603|3792268|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
1549694|NCT01292603|3792269|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
1549695|NCT01292603|3792264|P6|STARTED|Part 1: Regular Follow-Up Period||0
1549696|NCT01292603|3792265|P5|STARTED|Part 1: Regular Follow-Up Period||0
1549697|NCT01292603|3792266|P4|STARTED|Part 1: Regular Follow-Up Period||8
1549698|NCT01292603|3792267|P3|STARTED|Part 1: Regular Follow-Up Period||23
1549699|NCT01292603|3792268|P2|STARTED|Part 1: Regular Follow-Up Period||17
1549700|NCT01292603|3792269|P1|STARTED|Part 1: Regular Follow-Up Period||16
1549701|NCT01292603|3792264|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1549702|NCT01292603|3792265|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1549703|NCT01292603|3792266|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
1549704|NCT01292603|3792267|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1549705|NCT01292603|3792268|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1549706|NCT01292603|3792269|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1549707|NCT01292603|3792264|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
1549708|NCT01292603|3792265|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
1549709|NCT01292603|3792266|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
1549710|NCT01292603|3792267|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
1549711|NCT01292603|3792268|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
1549712|NCT01292603|3792269|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
1549713|NCT01292603|3792264|P6|STARTED|Part 1: Pilot Dose Selection Period||0
1549714|NCT01292603|3792265|P5|STARTED|Part 1: Pilot Dose Selection Period||0
1549715|NCT01292603|3792266|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
1549716|NCT01292603|3792267|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
1549717|NCT01292603|3792268|P2|STARTED|Part 1: Pilot Dose Selection Period||17
1549718|NCT01292603|3792269|P1|STARTED|Part 1: Pilot Dose Selection Period||16
1549719|NCT01292538|3792315|P2|NOT COMPLETED|Overall Study||0
1549720|NCT01292538|3792316|P1|NOT COMPLETED|Overall Study||0
1549721|NCT01292538|3792315|P2|COMPLETED|Overall Study||32
1549722|NCT01292538|3792316|P1|COMPLETED|Overall Study||35
1549723|NCT01292538|3792315|P2|STARTED|Overall Study||32
1549724|NCT01292538|3792316|P1|STARTED|Overall Study||35
1549725|NCT01292486|3792322|P1|NOT COMPLETED|Overall Study||6
1549726|NCT01292486|3792322|P1|COMPLETED|Overall Study||26
1549727|NCT01292486|3792322|P1|STARTED|Overall Study||32
1549728|NCT01292473|3792336|P4|NOT COMPLETED|Overall Study||12
1549729|NCT01292473|3792337|P3|NOT COMPLETED|Overall Study||9
1549730|NCT01292473|3792338|P2|NOT COMPLETED|Overall Study||7
1549731|NCT01292473|3792339|P1|NOT COMPLETED|Overall Study||5
1549732|NCT01292473|3792336|P4|COMPLETED|Overall Study||67
1549733|NCT01292473|3792337|P3|COMPLETED|Overall Study||74
1549734|NCT01292473|3792338|P2|COMPLETED|Overall Study||75
1549735|NCT01292473|3792339|P1|COMPLETED|Overall Study||74
1549736|NCT01292473|3792336|P4|STARTED|Overall Study||79
1549737|NCT01292473|3792337|P3|STARTED|Overall Study||83
1549738|NCT01292473|3792338|P2|STARTED|Overall Study||82
1549739|NCT01292473|3792339|P1|STARTED|Overall Study||79
1549740|NCT01292304|3792381|P1|NOT COMPLETED|Overall Study||0
1549741|NCT01292304|3792381|P1|COMPLETED|Overall Study||10
1549742|NCT01292304|3792381|P1|STARTED|Overall Study||10
1549743|NCT01292265|3792389|P1|NOT COMPLETED|Overall Study||0
1549744|NCT01292265|3792389|P1|COMPLETED|Overall Study||3
1549745|NCT01292265|3792389|P1|STARTED|Overall Study||3
1549746|NCT01292239|3792398|P2|NOT COMPLETED|Overall Study||7
1549747|NCT01292239|3792399|P1|NOT COMPLETED|Overall Study||4
1549748|NCT01292239|3792398|P2|COMPLETED|Overall Study||53
1549749|NCT01292239|3792399|P1|COMPLETED|Overall Study||119
1549750|NCT01292239|3792398|P2|STARTED|Overall Study||60
1549751|NCT01292239|3792399|P1|STARTED|Overall Study||123
1549752|NCT01292226|3792420|P1|NOT COMPLETED|Overall Study||13
1549753|NCT01292226|3792420|P1|COMPLETED|Overall Study||32
1549754|NCT01292226|3792420|P1|STARTED|Overall Study||45
1549755|NCT01292187|3792453|P2|NOT COMPLETED|Overall Study||13
1549756|NCT01292187|3792454|P1|NOT COMPLETED|Overall Study||17
1549757|NCT01292187|3792453|P2|COMPLETED|Overall Study||30
1549758|NCT01292187|3792454|P1|COMPLETED|Overall Study||69
1549759|NCT01292187|3792453|P2|STARTED|Overall Study||43
1549760|NCT01292187|3792454|P1|STARTED|Overall Study||86
1549761|NCT01292135|3792464|P2|NOT COMPLETED|Overall Study||9
1549762|NCT01292135|3792465|P1|NOT COMPLETED|Overall Study||0
1549763|NCT01292135|3792464|P2|COMPLETED|Overall Study||21
1549764|NCT01292135|3792465|P1|COMPLETED|Overall Study||3
1549765|NCT01292135|3792464|P2|STARTED|Overall Study||30
1549766|NCT01292135|3792465|P1|STARTED|Overall Study||3
1549767|NCT01292070|3792483|P1|NOT COMPLETED|Overall Study||0
1549768|NCT01292070|3792483|P1|COMPLETED|Overall Study||4
1549769|NCT01292070|3792483|P1|STARTED|Overall Study||4
1549770|NCT01292057|3792489|P2|NOT COMPLETED|Overall Study||2
1549771|NCT01292057|3792490|P1|NOT COMPLETED|Overall Study||2
1549772|NCT01292057|3792489|P2|COMPLETED|Overall Study||48
1549773|NCT01292057|3792490|P1|COMPLETED|Overall Study||47
1549774|NCT01292057|3792489|P2|STARTED|Overall Study||50
1549775|NCT01292057|3792490|P1|STARTED|Overall Study||49
1549776|NCT01292005|3792500|P2|NOT COMPLETED|Overall Study||0
1549777|NCT01292005|3792501|P1|NOT COMPLETED|Overall Study||0
1549778|NCT01292005|3792500|P2|COMPLETED|Overall Study||14
1549779|NCT01292005|3792501|P1|COMPLETED|Overall Study||14
1549780|NCT01292005|3792500|P2|STARTED|Overall Study||14
1549781|NCT01292005|3792501|P1|STARTED|Overall Study||14
1549782|NCT01291836|3792525|P2|NOT COMPLETED|Overall Study||0
1549783|NCT01291836|3792526|P1|NOT COMPLETED|Overall Study||0
1549784|NCT01291836|3792525|P2|COMPLETED|Overall Study||71
1549785|NCT01291836|3792526|P1|COMPLETED|Overall Study||930
1549786|NCT01291836|3792525|P2|STARTED|Overall Study||71
1549787|NCT01291836|3792526|P1|STARTED|Overall Study||930
1549788|NCT01291784|3792532|P3|NOT COMPLETED|Overall Study||0
1549789|NCT01291784|3792533|P2|NOT COMPLETED|Overall Study||1
1549790|NCT01291784|3792534|P1|NOT COMPLETED|Overall Study||0
1549791|NCT01291784|3792532|P3|COMPLETED|Overall Study||1
1549792|NCT01291784|3792533|P2|COMPLETED|Overall Study||0
1549793|NCT01291784|3792534|P1|COMPLETED|Overall Study||1
1549794|NCT01291784|3792532|P3|STARTED|Overall Study||1
1549795|NCT01291784|3792533|P2|STARTED|Overall Study||1
1549796|NCT01291784|3792534|P1|STARTED|Overall Study||1
1549797|NCT01291498|3792554|P1|NOT COMPLETED|Overall Study||1
1549798|NCT01291498|3792554|P1|COMPLETED|Overall Study||0
1549799|NCT01291498|3792554|P1|STARTED|Overall Study||1
1549800|NCT01291277|3792562|P2|NOT COMPLETED|Overall Study||3
1549801|NCT01291277|3792563|P1|NOT COMPLETED|Overall Study||5
1549802|NCT01291277|3792562|P2|COMPLETED|Overall Study||42
1549803|NCT01291277|3792563|P1|COMPLETED|Overall Study||40
1549804|NCT01291277|3792562|P2|STARTED|Overall Study||45
1549805|NCT01291277|3792563|P1|STARTED|Overall Study||45
1549806|NCT01291264|3792569|P1|NOT COMPLETED|Overall Study||0
1549807|NCT01291264|3792569|P1|COMPLETED|Overall Study||260
1549808|NCT01291264|3792569|P1|STARTED|Overall Study||260
1549809|NCT01291225|3792575|P2|NOT COMPLETED|Overall Study||39
1549810|NCT01291225|3792576|P1|NOT COMPLETED|Overall Study||85
1549811|NCT01291225|3792575|P2|COMPLETED|Overall Study||121
1549812|NCT01291225|3792576|P1|COMPLETED|Overall Study||66
1549813|NCT01291225|3792575|P2|STARTED|Overall Study||160
1549814|NCT01291225|3792576|P1|STARTED|Overall Study||151
1549815|NCT01291173|3792590|P4|NOT COMPLETED|Overall Study||13
1549816|NCT01291173|3792591|P3|NOT COMPLETED|Overall Study||13
1549817|NCT01291173|3792592|P2|NOT COMPLETED|Overall Study||15
1549818|NCT01291173|3792593|P1|NOT COMPLETED|Overall Study||17
1549819|NCT01291173|3792590|P4|COMPLETED|Overall Study||52
1549820|NCT01291173|3792591|P3|COMPLETED|Overall Study||52
1549821|NCT01291173|3792592|P2|COMPLETED|Overall Study||51
1549822|NCT01291173|3792593|P1|COMPLETED|Overall Study||47
1549823|NCT01291173|3792590|P4|STARTED|Overall Study||65
1549824|NCT01291173|3792591|P3|STARTED|Overall Study||65
1549825|NCT01291173|3792592|P2|STARTED|Overall Study||66
1549826|NCT01291173|3792593|P1|STARTED|Overall Study||64
1549827|NCT01291160|3792657|P2|NOT COMPLETED|Overall Study||16
1549828|NCT01291160|3792658|P1|NOT COMPLETED|Overall Study||18
1549829|NCT01291160|3792657|P2|COMPLETED|Overall Study||48
1549830|NCT01291160|3792658|P1|COMPLETED|Overall Study||48
1549831|NCT01291160|3792657|P2|STARTED|Overall Study||64
1549832|NCT01291160|3792658|P1|STARTED|Overall Study||66
1549833|NCT01291108|3792668|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
1549834|NCT01291108|3792669|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1549835|NCT01291108|3792670|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1549836|NCT01291108|3792671|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1549837|NCT01291108|3792672|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
1549838|NCT01291108|3792673|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1549839|NCT01291108|3792668|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
1549840|NCT01291108|3792669|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
1549841|NCT01291108|3792670|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
1549842|NCT01291108|3792671|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
1549843|NCT01291108|3792672|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
1549844|NCT01291108|3792673|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
1549845|NCT01291108|3792668|P6|STARTED|Month 2 (Adjunctive Therapy)||26
1549846|NCT01291108|3792669|P5|STARTED|Month 2 (Adjunctive Therapy)||34
1549847|NCT01291108|3792670|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
1549848|NCT01291108|3792671|P3|STARTED|Month 2 (Adjunctive Therapy)||24
1549849|NCT01291108|3792672|P2|STARTED|Month 2 (Adjunctive Therapy)||40
1549850|NCT01291108|3792673|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
1549851|NCT01291108|3792668|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
1549852|NCT01291108|3792669|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
1549853|NCT01291108|3792670|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
1549854|NCT01291108|3792671|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
1549855|NCT01291108|3792672|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
1549856|NCT01291108|3792673|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
1549857|NCT01291108|3792668|P6|COMPLETED|Month 1 (Monotherapy)||0
1549858|NCT01291108|3792669|P5|COMPLETED|Month 1 (Monotherapy)||0
1549859|NCT01291108|3792670|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
1549860|NCT01291108|3792671|P3|COMPLETED|Month 1 (Monotherapy)||0
1549861|NCT01291108|3792672|P2|COMPLETED|Month 1 (Monotherapy)||0
1549862|NCT01291108|3792673|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
1549863|NCT01291108|3792668|P6|STARTED|Month 1 (Monotherapy)||0
1549864|NCT01291108|3792669|P5|STARTED|Month 1 (Monotherapy)||0
1549865|NCT01291108|3792670|P4|STARTED|Month 1 (Monotherapy)||60
1549866|NCT01291108|3792671|P3|STARTED|Month 1 (Monotherapy)||0
1549867|NCT01291108|3792672|P2|STARTED|Month 1 (Monotherapy)||0
1549868|NCT01291108|3792673|P1|STARTED|Month 1 (Monotherapy)||65
1549869|NCT01291056|3792689|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
1549870|NCT01291056|3792690|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
1549871|NCT01291056|3792689|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
1549872|NCT01291056|3792690|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
1549873|NCT01291056|3792689|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
1549874|NCT01291056|3792690|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
1549875|NCT01291056|3792689|P2|NOT COMPLETED|Washout||0
1549876|NCT01291056|3792690|P1|NOT COMPLETED|Washout||0
1549877|NCT01291056|3792689|P2|COMPLETED|Washout||10
1549878|NCT01291056|3792690|P1|COMPLETED|Washout||10
1549879|NCT01291056|3792689|P2|STARTED|Washout||10
1549880|NCT01291056|3792690|P1|STARTED|Washout||10
1549881|NCT01291056|3792689|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
1549882|NCT01291056|3792690|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
1549883|NCT01291056|3792689|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
1549884|NCT01291056|3792690|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
1549885|NCT01291056|3792689|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
1549886|NCT01291056|3792690|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
1549887|NCT01291017|3792702|P1|NOT COMPLETED|Overall Study||5
1549888|NCT01291017|3792702|P1|COMPLETED|Overall Study||14
1549889|NCT01291017|3792702|P1|STARTED|Overall Study||19
1549890|NCT01290978|3792710|P1|NOT COMPLETED|Overall Study||0
1549891|NCT01290978|3792710|P1|COMPLETED|Overall Study||22
1549892|NCT01290978|3792710|P1|STARTED|Overall Study||22
1549893|NCT01290952|3792719|P2|NOT COMPLETED|Overall Study||14
1549894|NCT01290952|3792720|P1|NOT COMPLETED|Overall Study||12
1549895|NCT01290952|3792719|P2|COMPLETED|Overall Study||193
1549896|NCT01290952|3792720|P1|COMPLETED|Overall Study||192
1549897|NCT01290952|3792719|P2|STARTED|Overall Study||207
1549898|NCT01290952|3792720|P1|STARTED|Overall Study||204
1549899|NCT01290913|3792728|P1|NOT COMPLETED|Overall Study||1
1549900|NCT01290913|3792728|P1|COMPLETED|Overall Study||12
1549901|NCT01290913|3792728|P1|STARTED|Overall Study||13
1549902|NCT01290887|3792735|P2|NOT COMPLETED|Overall Study||536
1549903|NCT01290887|3792736|P1|NOT COMPLETED|Overall Study||466
1549904|NCT01290887|3792735|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
1549905|NCT01290887|3792736|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
1549906|NCT01290887|3792735|P2|Safety Analysis Set|Overall Study||571
1549907|NCT01290887|3792736|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
1549908|NCT01290887|3792735|P2|STARTED|Overall Study||571
1549909|NCT01290887|3792736|P1|STARTED|Overall Study||481
1549910|NCT01290874|3792776|P2|NOT COMPLETED|Overall Study||404
1549911|NCT01290874|3792777|P1|NOT COMPLETED|Overall Study||410
1549912|NCT01290874|3792776|P2|COMPLETED|Overall Study||134
1549913|NCT01290874|3792777|P1|COMPLETED|Overall Study||122
1549914|NCT01290874|3792776|P2|STARTED|Overall Study||538
1549915|NCT01290874|3792777|P1|STARTED|Overall Study||532
1549916|NCT01290822|3792797|P1|NOT COMPLETED|Overall Study||11
1549917|NCT01290822|3792797|P1|COMPLETED|Overall Study||1
1549918|NCT01290822|3792797|P1|STARTED|Overall Study||12
1549919|NCT01290796|3792806|P1|NOT COMPLETED|Overall Study||30
1549920|NCT01290796|3792806|P1|COMPLETED|Overall Study||123
1549921|NCT01290796|3792806|P1|STARTED|Overall Study||153
1549922|NCT01290757|3792822|P2|NOT COMPLETED|Overall Study||2
1549923|NCT01290757|3792823|P1|NOT COMPLETED|Overall Study||2
1549924|NCT01290757|3792822|P2|COMPLETED|Overall Study||88
1549925|NCT01290757|3792823|P1|COMPLETED|Overall Study||88
1549926|NCT01290757|3792822|P2|STARTED|Overall Study||90
1549927|NCT01290757|3792823|P1|STARTED|Overall Study||90
1549928|NCT01290731|3792839|P1|NOT COMPLETED|Overall Study||1
1549929|NCT01290731|3792839|P1|COMPLETED|Overall Study||48
1549930|NCT01290731|3792839|P1|STARTED|Overall Study||49
1549931|NCT01290718|3792851|P1|NOT COMPLETED|Overall Study||4
1549932|NCT01290718|3792851|P1|COMPLETED|Overall Study||0
1549933|NCT01290718|3792851|P1|STARTED|Overall Study||4
1549934|NCT01290679|3792860|P2|NOT COMPLETED|Overall Study||21
1549935|NCT01290679|3792861|P1|NOT COMPLETED|Overall Study||16
1549936|NCT01290679|3792860|P2|COMPLETED|Overall Study||113
1549937|NCT01290679|3792861|P1|COMPLETED|Overall Study||241
1549938|NCT01290679|3792860|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
1549939|NCT01290679|3792861|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
1549940|NCT01290666|3792930|P1|NOT COMPLETED|Overall Study||38
1549941|NCT01290666|3792930|P1|COMPLETED|Overall Study||55
1549942|NCT01290666|3792930|P1|STARTED|Overall Study||93
1549943|NCT01290640|3792936|P2|NOT COMPLETED|Overall Study||0
1549944|NCT01290640|3792937|P1|NOT COMPLETED|Overall Study||0
1549945|NCT01290640|3792936|P2|COMPLETED|Overall Study||10
1549946|NCT01290640|3792937|P1|COMPLETED|Overall Study||12
1549947|NCT01290640|3792936|P2|STARTED|Overall Study||10
1549948|NCT01290640|3792937|P1|STARTED|Overall Study||12
1549949|NCT01290627|3792948|P3|NOT COMPLETED|Overall Study||0
1549950|NCT01290627|3792949|P2|NOT COMPLETED|Overall Study||0
1549951|NCT01290627|3792950|P1|NOT COMPLETED|Overall Study||0
1549952|NCT01290627|3792948|P3|COMPLETED|Overall Study||10
1549953|NCT01290627|3792949|P2|COMPLETED|Overall Study||10
1549954|NCT01290627|3792950|P1|COMPLETED|Overall Study||10
1549955|NCT01290627|3792948|P3|STARTED|Overall Study||10
1549956|NCT01290627|3792949|P2|STARTED|Overall Study||10
1549957|NCT01290627|3792950|P1|STARTED|Overall Study||10
1549958|NCT01290614|3792972|P2|NOT COMPLETED|Overall Study||0
1549959|NCT01290614|3792973|P1|NOT COMPLETED|Overall Study||552
1549960|NCT01290614|3792972|P2|COMPLETED|Overall Study||1129
1549961|NCT01290614|3792973|P1|COMPLETED|Overall Study||518
1549962|NCT01290614|3792972|P2|STARTED|Overall Study||1129
1549963|NCT01290614|3792973|P1|STARTED|Overall Study||1070
1549964|NCT01290601|3792983|P4|NOT COMPLETED|Overall Study||0
1549965|NCT01290601|3792984|P3|NOT COMPLETED|Overall Study||0
1549966|NCT01290601|3792985|P2|NOT COMPLETED|Overall Study||5
1549967|NCT01290601|3792986|P1|NOT COMPLETED|Overall Study||11
1549968|NCT01290601|3792983|P4|COMPLETED|Overall Study||0
1549969|NCT01290601|3792984|P3|COMPLETED|Overall Study||0
1549970|NCT01290601|3792985|P2|COMPLETED|Overall Study||19
1549971|NCT01290601|3792986|P1|COMPLETED|Overall Study||35
1549972|NCT01290601|3792983|P4|STARTED|Overall Study||0
1549973|NCT01290601|3792984|P3|STARTED|Overall Study||0
1549974|NCT01290601|3792985|P2|STARTED|Overall Study||24
1549975|NCT01290601|3792986|P1|STARTED|Overall Study||46
1549976|NCT01290536|3793000|P1|NOT COMPLETED|Overall Study||0
1549977|NCT01290536|3793000|P1|COMPLETED|Overall Study||42
1549978|NCT01290536|3793000|P1|STARTED|Overall Study||42
1549979|NCT01290523|3793007|P1|NOT COMPLETED|Overall Study||0
1549980|NCT01290523|3793007|P1|COMPLETED|Overall Study||14
1549981|NCT01290523|3793007|P1|STARTED|Overall Study||14
1549982|NCT01290484|3793012|P1|NOT COMPLETED|Overall Study||0
1549983|NCT01290484|3793012|P1|COMPLETED|Overall Study||7
1549984|NCT01290484|3793012|P1|STARTED|Overall Study||7
1549985|NCT01290341|3793018|P2|NOT COMPLETED|Overall Study||29
1549986|NCT01290341|3793019|P1|NOT COMPLETED|Overall Study||92
1549987|NCT01290341|3793018|P2|COMPLETED|Overall Study||258
1549988|NCT01290341|3793019|P1|COMPLETED|Overall Study||481
1549989|NCT01290341|3793018|P2|STARTED|Overall Study||287
1549990|NCT01290341|3793019|P1|STARTED|Overall Study||573
1549991|NCT01290315|3793031|P4|NOT COMPLETED|Overall Study||5
1549992|NCT01290315|3793032|P3|NOT COMPLETED|Overall Study||0
1549993|NCT01290315|3793033|P2|NOT COMPLETED|Overall Study||3
1549994|NCT01290315|3793034|P1|NOT COMPLETED|Overall Study||3
1549995|NCT01290315|3793031|P4|COMPLETED|Overall Study||8
1549996|NCT01290315|3793032|P3|COMPLETED|Overall Study||10
1549997|NCT01290315|3793033|P2|COMPLETED|Overall Study||9
1549998|NCT01290315|3793034|P1|COMPLETED|Overall Study||11
1549999|NCT01290315|3793031|P4|STARTED|Overall Study||13
1550000|NCT01290315|3793032|P3|STARTED|Overall Study||10
1550001|NCT01290315|3793033|P2|STARTED|Overall Study||12
1550002|NCT01290315|3793034|P1|STARTED|Overall Study||14
1550003|NCT01290263|3793056|P5|NOT COMPLETED|Overall Study||37
1550004|NCT01290263|3793057|P4|NOT COMPLETED|Overall Study||27
1550005|NCT01290263|3793058|P3|NOT COMPLETED|Overall Study||7
1550006|NCT01290263|3793059|P2|NOT COMPLETED|Overall Study||3
1550007|NCT01290263|3793060|P1|NOT COMPLETED|Overall Study||11
1550008|NCT01290263|3793056|P5|COMPLETED|Overall Study||0
1550009|NCT01290263|3793057|P4|COMPLETED|Overall Study||0
1550010|NCT01290263|3793058|P3|COMPLETED|Overall Study||0
1550011|NCT01290263|3793059|P2|COMPLETED|Overall Study||0
1550012|NCT01290263|3793060|P1|COMPLETED|Overall Study||0
1550013|NCT01290263|3793056|P5|STARTED|Overall Study||37
1550014|NCT01290263|3793057|P4|STARTED|Overall Study||27
1550015|NCT01290263|3793058|P3|STARTED|Overall Study||7
1550016|NCT01290263|3793059|P2|STARTED|Overall Study||3
1550017|NCT01290263|3793060|P1|STARTED|Overall Study||11
1550018|NCT01290237|3793078|P2|NOT COMPLETED|Overall Study||2
1550019|NCT01290237|3793079|P1|NOT COMPLETED|Overall Study||11
1550020|NCT01290237|3793078|P2|COMPLETED|Overall Study||27
1550021|NCT01290237|3793079|P1|COMPLETED|Overall Study||19
1550022|NCT01290237|3793078|P2|STARTED|Overall Study||29
1550023|NCT01290237|3793079|P1|STARTED|Overall Study||30
1550024|NCT01290224|3793087|P1|NOT COMPLETED|Overall Study||5
1550025|NCT01290224|3793087|P1|COMPLETED|Overall Study||5
1550026|NCT01290224|3793087|P1|STARTED|Overall Study||10
1550027|NCT01290094|3793098|P1|NOT COMPLETED|Overall Study||6
1550028|NCT01290094|3793098|P1|COMPLETED|Overall Study||35
1550029|NCT01290094|3793098|P1|STARTED|Overall Study||41
1550030|NCT01290068|3793111|P2|NOT COMPLETED|Overall Study||6
1550031|NCT01290068|3793112|P1|NOT COMPLETED|Overall Study||7
1550032|NCT01290068|3793111|P2|COMPLETED|Overall Study||94
1550033|NCT01290068|3793112|P1|COMPLETED|Overall Study||101
1550034|NCT01290068|3793111|P2|Implanted|Overall Study||98
1550035|NCT01290068|3793112|P1|Implanted|Overall Study||108
1550036|NCT01290068|3793111|P2|STARTED|Overall Study||100
1550037|NCT01290068|3793112|P1|STARTED|Overall Study||108
1550038|NCT01290029|3793124|P1|NOT COMPLETED|Overall Study||2
1550039|NCT01290029|3793124|P1|COMPLETED|Overall Study||12
1550040|NCT01290029|3793124|P1|Received Study Treatment|Overall Study||12
1550041|NCT01290029|3793124|P1|STARTED|Overall Study||14
1550042|NCT01289990|3793150|P13|NOT COMPLETED|Overall Study||98
1550043|NCT01289990|3793151|P12|NOT COMPLETED|Overall Study||68
1550044|NCT01289990|3793152|P11|NOT COMPLETED|Overall Study||76
1550045|NCT01289990|3793153|P10|NOT COMPLETED|Overall Study||86
1550046|NCT01289990|3793154|P9|NOT COMPLETED|Overall Study||75
1550047|NCT01289990|3793155|P8|NOT COMPLETED|Overall Study||55
1550048|NCT01289990|3793156|P7|NOT COMPLETED|Overall Study||88
1550049|NCT01289990|3793157|P6|NOT COMPLETED|Overall Study||74
1550050|NCT01289990|3793158|P5|NOT COMPLETED|Overall Study||72
1550051|NCT01289990|3793159|P4|NOT COMPLETED|Overall Study||87
1550052|NCT01289990|3793160|P3|NOT COMPLETED|Overall Study||109
1550053|NCT01289990|3793161|P2|NOT COMPLETED|Overall Study||81
1550054|NCT01289990|3793162|P1|NOT COMPLETED|Overall Study||77
1550055|NCT01289990|3793150|P13|COMPLETED|Overall Study||127
1550056|NCT01289990|3793151|P12|COMPLETED|Overall Study||150
1550057|NCT01289990|3793152|P11|COMPLETED|Overall Study||150
1550058|NCT01289990|3793153|P10|COMPLETED|Overall Study||121
1550059|NCT01289990|3793154|P9|COMPLETED|Overall Study||139
1550060|NCT01289990|3793155|P8|COMPLETED|Overall Study||162
1550061|NCT01289990|3793156|P7|COMPLETED|Overall Study||78
1550062|NCT01289990|3793157|P6|COMPLETED|Overall Study||94
1550063|NCT01289990|3793158|P5|COMPLETED|Overall Study||93
1550064|NCT01289990|3793159|P4|COMPLETED|Overall Study||136
1550065|NCT01289990|3793160|P3|COMPLETED|Overall Study||119
1550066|NCT01289990|3793161|P2|COMPLETED|Overall Study||143
1550067|NCT01289990|3793162|P1|COMPLETED|Overall Study||147
1550068|NCT01289990|3793150|P13|STARTED|Overall Study||225
1550069|NCT01289990|3793151|P12|STARTED|Overall Study||218
1550070|NCT01289990|3793152|P11|STARTED|Overall Study||226
1550071|NCT01289990|3793153|P10|STARTED|Overall Study||207
1550072|NCT01289990|3793154|P9|STARTED|Overall Study||214
1550073|NCT01289990|3793155|P8|STARTED|Overall Study||217
1550074|NCT01289990|3793156|P7|STARTED|Overall Study||166
1550075|NCT01289990|3793157|P6|STARTED|Overall Study||168
1550076|NCT01289990|3793158|P5|STARTED|Overall Study||165
1550077|NCT01289990|3793159|P4|STARTED|Overall Study||223
1550078|NCT01289990|3793160|P3|STARTED|Overall Study||228
1550079|NCT01289990|3793161|P2|STARTED|Overall Study||224
1550080|NCT01289990|3793162|P1|STARTED|Overall Study||224
1550081|NCT01289912|3793348|P2|NOT COMPLETED|Overall Study||2
1550082|NCT01289912|3793349|P1|NOT COMPLETED|Overall Study||3
1550083|NCT01289912|3793348|P2|COMPLETED|Overall Study||13
1550084|NCT01289912|3793349|P1|COMPLETED|Overall Study||29
1550085|NCT01289912|3793348|P2|STARTED|Overall Study||15
1550086|NCT01289912|3793349|P1|STARTED|Overall Study||32
1550087|NCT01289847|3793379|P1|NOT COMPLETED|Overall Study||1
1550088|NCT01289847|3793379|P1|COMPLETED|Overall Study||24
1550089|NCT01289847|3793379|P1|STARTED|Overall Study||25
1550090|NCT01289821|3793388|P1|NOT COMPLETED|Survival Follow-up Period||18
1550091|NCT01289821|3793388|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
1550092|NCT01289821|3793388|P1|STARTED|Survival Follow-up Period||52
1550093|NCT01289821|3793388|P1|NOT COMPLETED|Safety Follow-up Period||5
1550094|NCT01289821|3793388|P1|COMPLETED|Safety Follow-up Period||49
1550095|NCT01289821|3793388|P1|STARTED|Safety Follow-up Period||54
1550096|NCT01289821|3793388|P1|NOT COMPLETED|Treatment Period||54
1550097|NCT01289821|3793388|P1|COMPLETED|Treatment Period||0
1550098|NCT01289821|3793388|P1|Participants Received Regorafenib|Treatment Period||54
1550099|NCT01289821|3793388|P1|STARTED|Treatment Period||54
1550100|NCT01289782|3793399|P2|NOT COMPLETED|Overall Study||12
1550101|NCT01289782|3793400|P1|NOT COMPLETED|Overall Study||25
1550102|NCT01289782|3793399|P2|COMPLETED|Overall Study||118
1550103|NCT01289782|3793400|P1|COMPLETED|Overall Study||239
1550104|NCT01289782|3793399|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
1550105|NCT01289782|3793400|P1|STARTED|Overall Study||264
1550106|NCT01289639|3793472|P3|NOT COMPLETED|Overall Study||0
1550107|NCT01289639|3793473|P2|NOT COMPLETED|Overall Study||0
1550108|NCT01289639|3793474|P1|NOT COMPLETED|Overall Study||1
1550109|NCT01289639|3793472|P3|COMPLETED|Overall Study||0
1550110|NCT01289639|3793473|P2|COMPLETED|Overall Study||6
1550111|NCT01289639|3793474|P1|COMPLETED|Overall Study||4
1550112|NCT01289639|3793472|P3|STARTED|Overall Study||0
1550113|NCT01289639|3793473|P2|STARTED|Overall Study||6
1550114|NCT01289639|3793474|P1|STARTED|Overall Study||5
1550115|NCT01289574|3793500|P3|NOT COMPLETED|Overall Study||3
1550116|NCT01289574|3793501|P2|NOT COMPLETED|Overall Study||3
1550117|NCT01289574|3793502|P1|NOT COMPLETED|Overall Study||7
1550118|NCT01289574|3793500|P3|COMPLETED|Overall Study||60
1550119|NCT01289574|3793501|P2|COMPLETED|Overall Study||57
1550120|NCT01289574|3793502|P1|COMPLETED|Overall Study||51
1550121|NCT01289574|3793500|P3|STARTED|Overall Study||63
1550122|NCT01289574|3793501|P2|STARTED|Overall Study||60
1550123|NCT01289574|3793502|P1|STARTED|Overall Study||58
1550124|NCT01289548|3793519|P3|NOT COMPLETED|Overall Study||0
1550125|NCT01289548|3793520|P2|NOT COMPLETED|Overall Study||0
1550126|NCT01289548|3793521|P1|NOT COMPLETED|Overall Study||0
1550127|NCT01289548|3793519|P3|COMPLETED|Overall Study||40
1550128|NCT01289548|3793520|P2|COMPLETED|Overall Study||40
1550129|NCT01289548|3793521|P1|COMPLETED|Overall Study||40
1550130|NCT01289548|3793519|P3|Recipients|Overall Study||20
1550131|NCT01289548|3793520|P2|Recipients|Overall Study||20
1550132|NCT01289548|3793521|P1|Recipients|Overall Study||20
1550133|NCT01289548|3793519|P3|Donors|Overall Study||20
1550134|NCT01289548|3793520|P2|Donors|Overall Study||20
1550135|NCT01289548|3793521|P1|Donors|Overall Study||20
1550136|NCT01289548|3793519|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
1550137|NCT01289548|3793520|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
1550138|NCT01289548|3793521|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
1550139|NCT01289522|3793565|P1|NOT COMPLETED|Overall Study||11
1550140|NCT01289522|3793565|P1|COMPLETED|Overall Study||43
1550141|NCT01289522|3793565|P1|STARTED|Overall Study||54
1550142|NCT01289418|3793574|P1|NOT COMPLETED|Day 29 Survey||2468
1550143|NCT01289418|3793574|P1|COMPLETED|Day 29 Survey||4057
1550144|NCT01289418|3793574|P1|STARTED|Day 29 Survey||6525
1550145|NCT01289418|3793574|P1|NOT COMPLETED|Day 8 Survey||2218
1550146|NCT01289418|3793574|P1|COMPLETED|Day 8 Survey||4307
1550147|NCT01289418|3793574|P1|STARTED|Day 8 Survey||6525
1550148|NCT01289392|3793583|P3|NOT COMPLETED|Overall Study||0
1550149|NCT01289392|3793584|P2|NOT COMPLETED|Overall Study||0
1550150|NCT01289392|3793585|P1|NOT COMPLETED|Overall Study||0
1550151|NCT01289392|3793583|P3|COMPLETED|Overall Study||7
1550152|NCT01289392|3793584|P2|COMPLETED|Overall Study||9
1550153|NCT01289392|3793585|P1|COMPLETED|Overall Study||9
1550154|NCT01289392|3793583|P3|STARTED|Overall Study||7
1550155|NCT01289392|3793584|P2|STARTED|Overall Study||9
1550156|NCT01289392|3793585|P1|STARTED|Overall Study||9
1550157|NCT01289275|3793597|P4|NOT COMPLETED|Overall Study||0
1550158|NCT01289275|3793598|P3|NOT COMPLETED|Overall Study||0
1550159|NCT01289275|3793599|P2|NOT COMPLETED|Overall Study||0
1550160|NCT01289275|3793600|P1|NOT COMPLETED|Overall Study||0
1550161|NCT01289275|3793597|P4|COMPLETED|Overall Study||316
1550162|NCT01289275|3793598|P3|COMPLETED|Overall Study||317
1550163|NCT01289275|3793599|P2|COMPLETED|Overall Study||320
1550164|NCT01289275|3793600|P1|COMPLETED|Overall Study||317
1550165|NCT01289275|3793597|P4|STARTED|Overall Study||316
1550166|NCT01289275|3793598|P3|STARTED|Overall Study||317
1550167|NCT01289275|3793599|P2|STARTED|Overall Study||320
1550168|NCT01289275|3793600|P1|STARTED|Overall Study||317
1550169|NCT01289210|3793610|P1|NOT COMPLETED|Overall Study||1
1550170|NCT01289210|3793610|P1|COMPLETED|Overall Study||1
1550171|NCT01289210|3793610|P1|STARTED|Overall Study||2
1550172|NCT01289119|3793620|P6|NOT COMPLETED|Overall Study||4
1550173|NCT01289119|3793621|P5|NOT COMPLETED|Overall Study||5
1550174|NCT01289119|3793622|P4|NOT COMPLETED|Overall Study||6
1550175|NCT01289119|3793623|P3|NOT COMPLETED|Overall Study||9
1550176|NCT01289119|3793624|P2|NOT COMPLETED|Overall Study||9
1550177|NCT01289119|3793625|P1|NOT COMPLETED|Overall Study||9
1550178|NCT01289119|3793620|P6|COMPLETED|Overall Study||57
1550179|NCT01289119|3793621|P5|COMPLETED|Overall Study||58
1550180|NCT01289119|3793622|P4|COMPLETED|Overall Study||93
1550181|NCT01289119|3793623|P3|COMPLETED|Overall Study||89
1550182|NCT01289119|3793624|P2|COMPLETED|Overall Study||83
1550183|NCT01289119|3793625|P1|COMPLETED|Overall Study||84
1550184|NCT01289119|3793620|P6|Treated|Overall Study||61
1550185|NCT01289119|3793621|P5|Treated|Overall Study||63
1550186|NCT01289119|3793622|P4|Treated|Overall Study||99
1550187|NCT01289119|3793623|P3|Treated|Overall Study||98
1550188|NCT01289119|3793624|P2|Treated|Overall Study||92
1550189|NCT01289119|3793625|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
1550190|NCT01289119|3793620|P6|STARTED|Overall Study||61
1550191|NCT01289119|3793621|P5|STARTED|Overall Study||63
1550192|NCT01289119|3793622|P4|STARTED|Overall Study||99
1550193|NCT01289119|3793623|P3|STARTED|Overall Study||98
1550194|NCT01289119|3793624|P2|STARTED|Overall Study||92
1550195|NCT01289119|3793625|P1|STARTED|Overall Study||93
1550196|NCT01289080|3793707|P2|NOT COMPLETED|Overall Study||0
1550197|NCT01289080|3793708|P1|NOT COMPLETED|Overall Study||0
1550198|NCT01289080|3793707|P2|COMPLETED|Overall Study||10
1550199|NCT01289080|3793708|P1|COMPLETED|Overall Study||9
1550200|NCT01289080|3793707|P2|STARTED|Overall Study||10
1550201|NCT01289080|3793708|P1|STARTED|Overall Study||9
1550202|NCT01289067|3793739|P1|NOT COMPLETED|Overall Study||0
1550203|NCT01289067|3793739|P1|COMPLETED|Overall Study||13
1550204|NCT01289067|3793739|P1|STARTED|Overall Study||13
1550205|NCT01289041|3793746|P1|NOT COMPLETED|Overall Study||70
1550206|NCT01289041|3793746|P1|COMPLETED|Overall Study||0
1550207|NCT01289041|3793746|P1|STARTED|Overall Study||70
1550208|NCT01289028|3793758|P1|NOT COMPLETED|Overall Study||83
1550209|NCT01289028|3793758|P1|COMPLETED|Overall Study||42
1550210|NCT01289028|3793758|P1|STARTED|Overall Study||125
1550211|NCT01289015|3793772|P2|NOT COMPLETED|Overall Study||54
1550212|NCT01289015|3793773|P1|NOT COMPLETED|Overall Study||99
1550213|NCT01289015|3793772|P2|COMPLETED|Overall Study||230
1550214|NCT01289015|3793773|P1|COMPLETED|Overall Study||472
1550215|NCT01289015|3793772|P2|STARTED|Overall Study||284
1550216|NCT01289015|3793773|P1|STARTED|Overall Study||571
1550217|NCT01288976|3793784|P3|NOT COMPLETED|Overall Study||20
1550218|NCT01288976|3793785|P2|NOT COMPLETED|Overall Study||27
1550219|NCT01288976|3793786|P1|NOT COMPLETED|Overall Study||178
1550220|NCT01288976|3793784|P3|COMPLETED|Overall Study||85
1550221|NCT01288976|3793785|P2|COMPLETED|Overall Study||22
1550222|NCT01288976|3793786|P1|COMPLETED|Overall Study||389
1550223|NCT01288976|3793784|P3|STARTED|Overall Study||105
1550224|NCT01288976|3793785|P2|STARTED|Overall Study||49
1550225|NCT01288976|3793786|P1|STARTED|Overall Study||567
1550226|NCT01288911|3793815|P2|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
1550227|NCT01288911|3793816|P1|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
1550228|NCT01288911|3793815|P2|COMPLETED|Open-label Period (All Enzalutamide)||0
1550229|NCT01288911|3793816|P1|COMPLETED|Open-label Period (All Enzalutamide)||0
1550230|NCT01288911|3793815|P2|Received Treatment|Open-label Period (All Enzalutamide)||9
1550231|NCT01288911|3793816|P1|Received Treatment|Open-label Period (All Enzalutamide)||42
1550232|NCT01288911|3793815|P2|STARTED|Open-label Period (All Enzalutamide)||9
1550233|NCT01288911|3793816|P1|STARTED|Open-label Period (All Enzalutamide)||42
1550234|NCT01288911|3793815|P2|NOT COMPLETED|Double-blind Period||182
1550235|NCT01288911|3793816|P1|NOT COMPLETED|Double-blind Period||142
1550236|NCT01288911|3793815|P2|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
1550237|NCT01288911|3793816|P1|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
1550238|NCT01288911|3793815|P2|Received Treatment|Double-blind Period||189
1550239|NCT01288911|3793816|P1|Received Treatment|Double-blind Period||183
1550240|NCT01288911|3793815|P2|STARTED|Double-blind Period||191
1550241|NCT01288911|3793816|P1|STARTED|Double-blind Period||184
1550242|NCT01288859|3793847|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550243|NCT01288859|3793848|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550244|NCT01288859|3793849|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550245|NCT01288859|3793850|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550246|NCT01288859|3793851|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550247|NCT01288859|3793852|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550248|NCT01288859|3793847|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550249|NCT01288859|3793848|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
1550250|NCT01288859|3793849|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
1550251|NCT01288859|3793850|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550252|NCT01288859|3793851|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550253|NCT01288859|3793852|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1550254|NCT01288859|3793847|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1550255|NCT01288859|3793848|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
1550256|NCT01288859|3793849|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
1550257|NCT01288859|3793850|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1550258|NCT01288859|3793851|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1550259|NCT01288859|3793852|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1550260|NCT01288859|3793847|P6|NOT COMPLETED|Washout Period of 1 Week||0
1550261|NCT01288859|3793848|P5|NOT COMPLETED|Washout Period of 1 Week||0
1550262|NCT01288859|3793849|P4|NOT COMPLETED|Washout Period of 1 Week||0
1550263|NCT01288859|3793850|P3|NOT COMPLETED|Washout Period of 1 Week||0
1550264|NCT01288859|3793851|P2|NOT COMPLETED|Washout Period of 1 Week||0
1550265|NCT01288859|3793852|P1|NOT COMPLETED|Washout Period of 1 Week||0
1550266|NCT01288859|3793847|P6|COMPLETED|Washout Period of 1 Week||0
1550267|NCT01288859|3793848|P5|COMPLETED|Washout Period of 1 Week||5
1550268|NCT01288859|3793849|P4|COMPLETED|Washout Period of 1 Week||5
1550269|NCT01288859|3793850|P3|COMPLETED|Washout Period of 1 Week||0
1550270|NCT01288859|3793851|P2|COMPLETED|Washout Period of 1 Week||0
1550271|NCT01288859|3793852|P1|COMPLETED|Washout Period of 1 Week||0
1550272|NCT01288859|3793847|P6|STARTED|Washout Period of 1 Week||0
1550273|NCT01288859|3793848|P5|STARTED|Washout Period of 1 Week||5
1550274|NCT01288859|3793849|P4|STARTED|Washout Period of 1 Week||5
1550275|NCT01288859|3793850|P3|STARTED|Washout Period of 1 Week||0
1550276|NCT01288859|3793851|P2|STARTED|Washout Period of 1 Week||0
1550277|NCT01288859|3793852|P1|STARTED|Washout Period of 1 Week||0
1550278|NCT01288859|3793847|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550279|NCT01288859|3793848|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550280|NCT01288859|3793849|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550281|NCT01288859|3793850|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550282|NCT01288859|3793851|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550283|NCT01288859|3793852|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550284|NCT01288859|3793847|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550285|NCT01288859|3793848|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
1550286|NCT01288859|3793849|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
1550287|NCT01288859|3793850|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550288|NCT01288859|3793851|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550289|NCT01288859|3793852|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1550290|NCT01288859|3793847|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1550291|NCT01288859|3793848|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
1550292|NCT01288859|3793849|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
1550293|NCT01288859|3793850|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1550294|NCT01288859|3793851|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1550295|NCT01288859|3793852|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1550296|NCT01288859|3793847|P6|NOT COMPLETED|Washout Period of 1 Week||0
1550297|NCT01288859|3793848|P5|NOT COMPLETED|Washout Period of 1 Week||0
1550298|NCT01288859|3793849|P4|NOT COMPLETED|Washout Period of 1 Week||0
1550299|NCT01288859|3793850|P3|NOT COMPLETED|Washout Period of 1 Week||0
1550300|NCT01288859|3793851|P2|NOT COMPLETED|Washout Period of 1 Week||0
1550301|NCT01288859|3793852|P1|NOT COMPLETED|Washout Period of 1 Week||0
1550302|NCT01288859|3793847|P6|COMPLETED|Washout Period of 1 Week||0
1550303|NCT01288859|3793848|P5|COMPLETED|Washout Period of 1 Week||5
1550304|NCT01288859|3793849|P4|COMPLETED|Washout Period of 1 Week||5
1550305|NCT01288859|3793850|P3|COMPLETED|Washout Period of 1 Week||0
1550306|NCT01288859|3793851|P2|COMPLETED|Washout Period of 1 Week||0
1550307|NCT01288859|3793852|P1|COMPLETED|Washout Period of 1 Week||0
1550308|NCT01288859|3793847|P6|STARTED|Washout Period of 1 Week||0
1550309|NCT01288859|3793848|P5|STARTED|Washout Period of 1 Week||5
1550310|NCT01288859|3793849|P4|STARTED|Washout Period of 1 Week||5
1550311|NCT01288859|3793850|P3|STARTED|Washout Period of 1 Week||0
1550312|NCT01288859|3793851|P2|STARTED|Washout Period of 1 Week||0
1550313|NCT01288859|3793852|P1|STARTED|Washout Period of 1 Week||0
1550314|NCT01288859|3793847|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550315|NCT01288859|3793848|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550316|NCT01288859|3793849|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550317|NCT01288859|3793850|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550318|NCT01288859|3793851|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550319|NCT01288859|3793852|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550320|NCT01288859|3793847|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550321|NCT01288859|3793848|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550322|NCT01288859|3793849|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550323|NCT01288859|3793850|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1550324|NCT01288859|3793851|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1550325|NCT01288859|3793852|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550326|NCT01288859|3793847|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550327|NCT01288859|3793848|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550328|NCT01288859|3793849|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550329|NCT01288859|3793850|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1550330|NCT01288859|3793851|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1550331|NCT01288859|3793852|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1550332|NCT01288859|3793847|P6|NOT COMPLETED|Washout Period of 1 Week||0
1550333|NCT01288859|3793848|P5|NOT COMPLETED|Washout Period of 1 Week||0
1550334|NCT01288859|3793849|P4|NOT COMPLETED|Washout Period of 1 Week||0
1550335|NCT01288859|3793850|P3|NOT COMPLETED|Washout Period of 1 Week||0
1550336|NCT01288859|3793851|P2|NOT COMPLETED|Washout Period of 1 Week||0
1550337|NCT01288859|3793852|P1|NOT COMPLETED|Washout Period of 1 Week||0
1550338|NCT01288859|3793847|P6|COMPLETED|Washout Period of 1 Week||0
1550339|NCT01288859|3793848|P5|COMPLETED|Washout Period of 1 Week||0
1550340|NCT01288859|3793849|P4|COMPLETED|Washout Period of 1 Week||0
1550341|NCT01288859|3793850|P3|COMPLETED|Washout Period of 1 Week||5
1550342|NCT01288859|3793851|P2|COMPLETED|Washout Period of 1 Week||5
1550343|NCT01288859|3793852|P1|COMPLETED|Washout Period of 1 Week||0
1550344|NCT01288859|3793847|P6|STARTED|Washout Period of 1 Week||0
1550345|NCT01288859|3793848|P5|STARTED|Washout Period of 1 Week||0
1550346|NCT01288859|3793849|P4|STARTED|Washout Period of 1 Week||0
1550347|NCT01288859|3793850|P3|STARTED|Washout Period of 1 Week||5
1550348|NCT01288859|3793851|P2|STARTED|Washout Period of 1 Week||5
1550349|NCT01288859|3793852|P1|STARTED|Washout Period of 1 Week||0
1550350|NCT01288859|3793847|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550351|NCT01288859|3793848|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550352|NCT01288859|3793849|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550353|NCT01288859|3793850|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550354|NCT01288859|3793851|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550355|NCT01288859|3793852|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550356|NCT01288859|3793847|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550357|NCT01288859|3793848|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550358|NCT01288859|3793849|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550359|NCT01288859|3793850|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1550360|NCT01288859|3793851|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1550361|NCT01288859|3793852|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550362|NCT01288859|3793847|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550363|NCT01288859|3793848|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550364|NCT01288859|3793849|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550365|NCT01288859|3793850|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1550366|NCT01288859|3793851|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1550367|NCT01288859|3793852|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1550368|NCT01288859|3793847|P6|NOT COMPLETED|Washout Period of 1 Week||0
1550369|NCT01288859|3793848|P5|NOT COMPLETED|Washout Period of 1 Week||0
1550370|NCT01288859|3793849|P4|NOT COMPLETED|Washout Period of 1 Week||0
1550371|NCT01288859|3793850|P3|NOT COMPLETED|Washout Period of 1 Week||0
1550372|NCT01288859|3793851|P2|NOT COMPLETED|Washout Period of 1 Week||0
1550373|NCT01288859|3793852|P1|NOT COMPLETED|Washout Period of 1 Week||0
1550374|NCT01288859|3793847|P6|COMPLETED|Washout Period of 1 Week||5
1550375|NCT01288859|3793848|P5|COMPLETED|Washout Period of 1 Week||0
1550376|NCT01288859|3793849|P4|COMPLETED|Washout Period of 1 Week||0
1550377|NCT01288859|3793850|P3|COMPLETED|Washout Period of 1 Week||0
1550378|NCT01288859|3793851|P2|COMPLETED|Washout Period of 1 Week||0
1550379|NCT01288859|3793852|P1|COMPLETED|Washout Period of 1 Week||5
1550380|NCT01288859|3793847|P6|STARTED|Washout Period of 1 Week||5
1550381|NCT01288859|3793848|P5|STARTED|Washout Period of 1 Week||0
1550382|NCT01288859|3793849|P4|STARTED|Washout Period of 1 Week||0
1550383|NCT01288859|3793850|P3|STARTED|Washout Period of 1 Week||0
1550384|NCT01288859|3793851|P2|STARTED|Washout Period of 1 Week||0
1550385|NCT01288859|3793852|P1|STARTED|Washout Period of 1 Week||5
1550386|NCT01288859|3793847|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550387|NCT01288859|3793848|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550388|NCT01288859|3793849|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550389|NCT01288859|3793850|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550390|NCT01288859|3793851|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550391|NCT01288859|3793852|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550392|NCT01288859|3793847|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
1550393|NCT01288859|3793848|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550394|NCT01288859|3793849|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550395|NCT01288859|3793850|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550396|NCT01288859|3793851|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1550397|NCT01288859|3793852|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
1550398|NCT01288859|3793847|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
1550399|NCT01288859|3793848|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1550400|NCT01288859|3793849|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1550401|NCT01288859|3793850|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1550402|NCT01288859|3793851|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1550403|NCT01288859|3793852|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
1550404|NCT01288859|3793847|P6|NOT COMPLETED|Washout Period of 1 Week||0
1550405|NCT01288859|3793848|P5|NOT COMPLETED|Washout Period of 1 Week||0
1550406|NCT01288859|3793849|P4|NOT COMPLETED|Washout Period of 1 Week||0
1550407|NCT01288859|3793850|P3|NOT COMPLETED|Washout Period of 1 Week||0
1550408|NCT01288859|3793851|P2|NOT COMPLETED|Washout Period of 1 Week||0
1550409|NCT01288859|3793852|P1|NOT COMPLETED|Washout Period of 1 Week||0
1550410|NCT01288859|3793847|P6|COMPLETED|Washout Period of 1 Week||5
1550411|NCT01288859|3793848|P5|COMPLETED|Washout Period of 1 Week||0
1550412|NCT01288859|3793849|P4|COMPLETED|Washout Period of 1 Week||0
1550413|NCT01288859|3793850|P3|COMPLETED|Washout Period of 1 Week||0
1550414|NCT01288859|3793851|P2|COMPLETED|Washout Period of 1 Week||0
1550415|NCT01288859|3793852|P1|COMPLETED|Washout Period of 1 Week||5
1550416|NCT01288859|3793847|P6|STARTED|Washout Period of 1 Week||5
1550417|NCT01288859|3793848|P5|STARTED|Washout Period of 1 Week||0
1550418|NCT01288859|3793849|P4|STARTED|Washout Period of 1 Week||0
1550419|NCT01288859|3793850|P3|STARTED|Washout Period of 1 Week||0
1550420|NCT01288859|3793851|P2|STARTED|Washout Period of 1 Week||0
1550421|NCT01288859|3793852|P1|STARTED|Washout Period of 1 Week||5
1550422|NCT01288859|3793847|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550423|NCT01288859|3793848|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550424|NCT01288859|3793849|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550425|NCT01288859|3793850|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550426|NCT01288859|3793851|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550427|NCT01288859|3793852|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550428|NCT01288859|3793847|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
1550429|NCT01288859|3793848|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550430|NCT01288859|3793849|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550431|NCT01288859|3793850|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550432|NCT01288859|3793851|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1550433|NCT01288859|3793852|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
1550434|NCT01288859|3793847|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
1550435|NCT01288859|3793848|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1550436|NCT01288859|3793849|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1550437|NCT01288859|3793850|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1550438|NCT01288859|3793851|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1550439|NCT01288859|3793852|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
1550440|NCT01288833|3793880|P2|NOT COMPLETED|Overall Study||0
1550441|NCT01288833|3793881|P1|NOT COMPLETED|Overall Study||0
1550442|NCT01288833|3793880|P2|COMPLETED|Overall Study||281
1550443|NCT01288833|3793881|P1|COMPLETED|Overall Study||277
1550444|NCT01288833|3793880|P2|STARTED|Overall Study||281
1550445|NCT01288833|3793881|P1|STARTED|Overall Study||277
1550446|NCT01288781|3793897|P2|NOT COMPLETED|Overall Study||0
1550447|NCT01288781|3793898|P1|NOT COMPLETED|Overall Study||0
1550448|NCT01288781|3793897|P2|COMPLETED|Overall Study||12
1550449|NCT01288781|3793898|P1|COMPLETED|Overall Study||11
1550450|NCT01288781|3793897|P2|STARTED|Overall Study||12
1550451|NCT01288781|3793898|P1|STARTED|Overall Study||11
1550452|NCT01288729|3793918|P2|NOT COMPLETED|Overall Study||0
1550453|NCT01288729|3793919|P1|NOT COMPLETED|Overall Study||1
1550454|NCT01288729|3793918|P2|COMPLETED|Overall Study||10
1550455|NCT01288729|3793919|P1|COMPLETED|Overall Study||9
1550456|NCT01288729|3793918|P2|STARTED|Overall Study||10
1550457|NCT01288729|3793919|P1|STARTED|Overall Study||10
1550458|NCT01288612|3793928|P3|NOT COMPLETED|Overall Study||82
1550459|NCT01288612|3793929|P2|NOT COMPLETED|Overall Study||82
1550460|NCT01288612|3793930|P1|NOT COMPLETED|Overall Study||89
1550461|NCT01288612|3793928|P3|COMPLETED|Overall Study||76
1550462|NCT01288612|3793929|P2|COMPLETED|Overall Study||69
1550463|NCT01288612|3793930|P1|COMPLETED|Overall Study||61
1550464|NCT01288612|3793928|P3|Agreed to Take Part|Overall Study||76
1550465|NCT01288612|3793929|P2|Agreed to Take Part|Overall Study||72
1550466|NCT01288612|3793930|P1|Agreed to Take Part|Overall Study||61
1550467|NCT01288612|3793928|P3|Contacted|Overall Study||138
1550468|NCT01288612|3793929|P2|Contacted|Overall Study||135
1550469|NCT01288612|3793930|P1|Contacted|Overall Study||139
1550470|NCT01288612|3793928|P3|STARTED|Overall Study||158
1550471|NCT01288612|3793929|P2|STARTED|Overall Study||151
1550472|NCT01288612|3793930|P1|STARTED|Overall Study||150
1550473|NCT01288534|3793959|P1|NOT COMPLETED|Overall Study||0
1550474|NCT01288534|3793959|P1|COMPLETED|Overall Study||68
1550475|NCT01288534|3793959|P1|STARTED|Overall Study||68
1550476|NCT01288521|3793969|P2|NOT COMPLETED|Overall Study||0
1550477|NCT01288521|3793970|P1|NOT COMPLETED|Overall Study||0
1550478|NCT01288521|3793969|P2|COMPLETED|Overall Study||5
1550479|NCT01288521|3793970|P1|COMPLETED|Overall Study||3
1550480|NCT01288521|3793969|P2|STARTED|Overall Study||5
1550481|NCT01288521|3793970|P1|STARTED|Overall Study||3
1550482|NCT01288469|3793979|P3|NOT COMPLETED|Overall Study||2
1550483|NCT01288469|3793980|P2|NOT COMPLETED|Overall Study||3
1550484|NCT01288469|3793981|P1|NOT COMPLETED|Overall Study||7
1550485|NCT01288469|3793979|P3|COMPLETED|Overall Study||28
1550486|NCT01288469|3793980|P2|COMPLETED|Overall Study||28
1550487|NCT01288469|3793981|P1|COMPLETED|Overall Study||24
1550488|NCT01288469|3793979|P3|Treated|Overall Study||30
1550489|NCT01288469|3793980|P2|Treated|Overall Study||31
1550490|NCT01288469|3793981|P1|Treated|Overall Study||31
1550491|NCT01288469|3793979|P3|STARTED|Overall Study|Randomized|30
1550492|NCT01288469|3793980|P2|STARTED|Overall Study|Randomized|31
1550493|NCT01288469|3793981|P1|STARTED|Overall Study|Randomized|31
1550494|NCT01288443|3794013|P6|NOT COMPLETED|Overall Study||5
1550495|NCT01288443|3794014|P5|NOT COMPLETED|Overall Study||7
1550496|NCT01288443|3794015|P4|NOT COMPLETED|Overall Study||4
1550497|NCT01288443|3794016|P3|NOT COMPLETED|Overall Study||1
1550498|NCT01288443|3794017|P2|NOT COMPLETED|Overall Study||1
1550499|NCT01288443|3794018|P1|NOT COMPLETED|Overall Study||0
1550500|NCT01288443|3794013|P6|COMPLETED|Overall Study||25
1550501|NCT01288443|3794014|P5|COMPLETED|Overall Study||23
1550502|NCT01288443|3794015|P4|COMPLETED|Overall Study||27
1550503|NCT01288443|3794016|P3|COMPLETED|Overall Study||30
1550504|NCT01288443|3794017|P2|COMPLETED|Overall Study||29
1550505|NCT01288443|3794018|P1|COMPLETED|Overall Study||31
1550506|NCT01288443|3794013|P6|Treated|Overall Study||30
1550507|NCT01288443|3794014|P5|Treated|Overall Study||29
1550508|NCT01288443|3794015|P4|Treated|Overall Study||31
1550509|NCT01288443|3794016|P3|Treated|Overall Study||31
1550510|NCT01288443|3794017|P2|Treated|Overall Study||30
1550511|NCT01288443|3794018|P1|Treated|Overall Study||31
1550512|NCT01288443|3794013|P6|STARTED|Overall Study|Randomized|30
1550513|NCT01288443|3794014|P5|STARTED|Overall Study|Randomized|30
1550514|NCT01288443|3794015|P4|STARTED|Overall Study|Randomized|31
1550515|NCT01288443|3794016|P3|STARTED|Overall Study|Randomized|31
1550516|NCT01288443|3794017|P2|STARTED|Overall Study|Randomized|30
1550517|NCT01288443|3794018|P1|STARTED|Overall Study|Randomized|31
1550518|NCT01288287|3794068|P1|NOT COMPLETED|Overall Study||46
1550519|NCT01288287|3794068|P1|COMPLETED|Overall Study||103
1550520|NCT01288287|3794068|P1|Full Analysis Set|Overall Study||111
1550521|NCT01288287|3794068|P1|Safety Set|Overall Study||147
1550522|NCT01288287|3794068|P1|STARTED|Overall Study||149
1550523|NCT01288209|3794083|P2|NOT COMPLETED|Overall Study||3
1550524|NCT01288209|3794084|P1|NOT COMPLETED|Overall Study||2
1550525|NCT01288209|3794083|P2|COMPLETED|Overall Study||50
1550526|NCT01288209|3794084|P1|COMPLETED|Overall Study||51
1550527|NCT01288209|3794083|P2|STARTED|Overall Study||53
1550528|NCT01288209|3794084|P1|STARTED|Overall Study||53
1550529|NCT01288079|3794114|P4|NOT COMPLETED|Overall Study||17
1550530|NCT01288079|3794115|P3|NOT COMPLETED|Overall Study||19
1550531|NCT01288079|3794116|P2|NOT COMPLETED|Overall Study||27
1550532|NCT01288079|3794117|P1|NOT COMPLETED|Overall Study||20
1550533|NCT01288079|3794114|P4|COMPLETED|Overall Study||18
1550534|NCT01288079|3794115|P3|COMPLETED|Overall Study||18
1550535|NCT01288079|3794116|P2|COMPLETED|Overall Study||9
1550536|NCT01288079|3794117|P1|COMPLETED|Overall Study||17
1550537|NCT01288079|3794114|P4|STARTED|Overall Study||35
1550538|NCT01288079|3794115|P3|STARTED|Overall Study||37
1550539|NCT01288079|3794116|P2|STARTED|Overall Study||36
1550540|NCT01288079|3794117|P1|STARTED|Overall Study||37
1550541|NCT01288053|3794127|P1|NOT COMPLETED|Overall Study||1
1550542|NCT01288053|3794127|P1|COMPLETED|Overall Study||8
1550543|NCT01288053|3794127|P1|STARTED|Overall Study||9
1550544|NCT01288027|3794131|P1|NOT COMPLETED|Overall Study||0
1550545|NCT01288027|3794131|P1|COMPLETED|Overall Study||16
1550546|NCT01288027|3794131|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
1550547|NCT01288027|3794131|P1|STARTED|Overall Study||16
1550548|NCT01287897|3794145|P4|NOT COMPLETED|Overall Study||7
1550549|NCT01287897|3794146|P3|NOT COMPLETED|Overall Study||12
1550550|NCT01287897|3794147|P2|NOT COMPLETED|Overall Study||11
1550551|NCT01287897|3794148|P1|NOT COMPLETED|Overall Study||11
1550552|NCT01287897|3794145|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
1550553|NCT01287897|3794146|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
1550554|NCT01287897|3794147|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
1550555|NCT01287897|3794148|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
1550556|NCT01287897|3794145|P4|Enrolled in NCT01345318|Overall Study||29
1550557|NCT01287897|3794146|P3|Enrolled in NCT01345318|Overall Study||56
1550558|NCT01287897|3794147|P2|Enrolled in NCT01345318|Overall Study||50
1550559|NCT01287897|3794148|P1|Enrolled in NCT01345318|Overall Study||56
1550560|NCT01287897|3794145|P4|Completed Follow-up Period|Overall Study||4
1550561|NCT01287897|3794146|P3|Completed Follow-up Period|Overall Study||3
1550562|NCT01287897|3794147|P2|Completed Follow-up Period|Overall Study||8
1550563|NCT01287897|3794148|P1|Completed Follow-up Period|Overall Study||3
1550564|NCT01287897|3794145|P4|Completed Treatment Period|Overall Study||29
1550565|NCT01287897|3794146|P3|Completed Treatment Period|Overall Study||58
1550566|NCT01287897|3794147|P2|Completed Treatment Period|Overall Study||52
1550567|NCT01287897|3794148|P1|Completed Treatment Period|Overall Study||58
1550568|NCT01287897|3794145|P4|Treated|Overall Study||40
1550569|NCT01287897|3794146|P3|Treated|Overall Study||71
1550570|NCT01287897|3794147|P2|Treated|Overall Study||67
1550571|NCT01287897|3794148|P1|Treated|Overall Study||69
1550572|NCT01287897|3794145|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
1550573|NCT01287897|3794146|P3|STARTED|Overall Study||71
1550574|NCT01287897|3794147|P2|STARTED|Overall Study||69
1550575|NCT01287897|3794148|P1|STARTED|Overall Study||70
1550576|NCT01287832|3794199|P2|NOT COMPLETED|Overall Study||1
1550577|NCT01287832|3794200|P1|NOT COMPLETED|Overall Study||1
1550578|NCT01287832|3794199|P2|COMPLETED|Overall Study||4
1550579|NCT01287832|3794200|P1|COMPLETED|Overall Study||5
1550580|NCT01287832|3794199|P2|STARTED|Overall Study||5
1550581|NCT01287832|3794200|P1|STARTED|Overall Study||6
1550582|NCT01287754|3794208|P2|NOT COMPLETED|Overall Study||21
1550583|NCT01287754|3794209|P1|NOT COMPLETED|Overall Study||3
1550584|NCT01287754|3794208|P2|COMPLETED|Overall Study||0
1550585|NCT01287754|3794209|P1|COMPLETED|Overall Study||0
1550586|NCT01287754|3794208|P2|STARTED|Overall Study||21
1550587|NCT01287754|3794209|P1|STARTED|Overall Study||3
1550588|NCT01287741|3794221|P2|NOT COMPLETED|Overall Study||706
1550589|NCT01287741|3794222|P1|NOT COMPLETED|Overall Study||712
1550590|NCT01287741|3794221|P2|COMPLETED|Overall Study||0
1550591|NCT01287741|3794222|P1|COMPLETED|Overall Study||0
1550592|NCT01287741|3794221|P2|STARTED|Overall Study||706
1550593|NCT01287741|3794222|P1|STARTED|Overall Study||712
1550594|NCT01287611|3794258|P2|NOT COMPLETED|Overall Study||19
1550595|NCT01287611|3794259|P1|NOT COMPLETED|Overall Study||33
1550596|NCT01287611|3794258|P2|COMPLETED|Overall Study||65
1550597|NCT01287611|3794259|P1|COMPLETED|Overall Study||51
1550680|NCT01287208|3794366|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
1550598|NCT01287611|3794258|P2|The Number of Patients Who Underwent C/S|Overall Study||84
1550599|NCT01287611|3794259|P1|The Number of Patients Who Underwent C/S|Overall Study||84
1550600|NCT01287611|3794258|P2|STARTED|Overall Study||84
1550601|NCT01287611|3794259|P1|STARTED|Overall Study||84
1550602|NCT01287416|3794269|P2|NOT COMPLETED|6 Month Follow-up||2
1550603|NCT01287416|3794270|P1|NOT COMPLETED|6 Month Follow-up||3
1550604|NCT01287416|3794269|P2|COMPLETED|6 Month Follow-up||22
1550605|NCT01287416|3794270|P1|COMPLETED|6 Month Follow-up||28
1550606|NCT01287416|3794269|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
1550607|NCT01287416|3794270|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
1550608|NCT01287416|3794269|P2|NOT COMPLETED|Pre-post Training||25
1550609|NCT01287416|3794270|P1|NOT COMPLETED|Pre-post Training||22
1550610|NCT01287416|3794269|P2|COMPLETED|Pre-post Training||23
1550611|NCT01287416|3794270|P1|COMPLETED|Pre-post Training||26
1550612|NCT01287416|3794269|P2|Post Training Questionnaire|Pre-post Training||23
1550613|NCT01287416|3794270|P1|Post Training Questionnaire|Pre-post Training||26
1550614|NCT01287416|3794269|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
1550615|NCT01287416|3794270|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
1550616|NCT01287416|3794269|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
1550617|NCT01287416|3794270|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
1550618|NCT01287403|3794306|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
1550619|NCT01287403|3794306|P1|COMPLETED|6th and Last Intervention (1 Day)||13
1550620|NCT01287403|3794306|P1|STARTED|6th and Last Intervention (1 Day)||13
1550621|NCT01287403|3794306|P1|NOT COMPLETED|Washout (7 Days)||0
1550622|NCT01287403|3794306|P1|COMPLETED|Washout (7 Days)||13
1550623|NCT01287403|3794306|P1|STARTED|Washout (7 Days)||13
1550624|NCT01287403|3794306|P1|NOT COMPLETED|5th Intervention (1 Day)||0
1550625|NCT01287403|3794306|P1|COMPLETED|5th Intervention (1 Day)||13
1550626|NCT01287403|3794306|P1|STARTED|5th Intervention (1 Day)||13
1550627|NCT01287403|3794306|P1|NOT COMPLETED|Washout (7 Days)||0
1550628|NCT01287403|3794306|P1|COMPLETED|Washout (7 Days)||13
1550629|NCT01287403|3794306|P1|STARTED|Washout (7 Days)||13
1550630|NCT01287403|3794306|P1|NOT COMPLETED|4th Intervention (1 Day)||0
1550631|NCT01287403|3794306|P1|COMPLETED|4th Intervention (1 Day)||13
1550632|NCT01287403|3794306|P1|STARTED|4th Intervention (1 Day)||13
1550633|NCT01287403|3794306|P1|NOT COMPLETED|Washout (7 Days)||0
1550634|NCT01287403|3794306|P1|COMPLETED|Washout (7 Days)||13
1550635|NCT01287403|3794306|P1|STARTED|Washout (7 Days)||13
1550636|NCT01287403|3794306|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
1550637|NCT01287403|3794306|P1|COMPLETED|3rd Intervention (1 Day)||13
1550638|NCT01287403|3794306|P1|STARTED|3rd Intervention (1 Day)||13
1550639|NCT01287403|3794306|P1|NOT COMPLETED|Washout (7 Days)||0
1550640|NCT01287403|3794306|P1|COMPLETED|Washout (7 Days)||13
1550641|NCT01287403|3794306|P1|STARTED|Washout (7 Days)||13
1550642|NCT01287403|3794306|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
1550643|NCT01287403|3794306|P1|COMPLETED|2nd Intervention (1 Day)||13
1550644|NCT01287403|3794306|P1|STARTED|2nd Intervention (1 Day)||13
1550645|NCT01287403|3794306|P1|NOT COMPLETED|Washout 7 Days||0
1550646|NCT01287403|3794306|P1|COMPLETED|Washout 7 Days||13
1550647|NCT01287403|3794306|P1|STARTED|Washout 7 Days||13
1550648|NCT01287403|3794306|P1|NOT COMPLETED|1st Intervention (1 Day)||1
1550649|NCT01287403|3794306|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
1550650|NCT01287403|3794306|P1|STARTED|1st Intervention (1 Day)||14
1550651|NCT01287403|3794306|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
1550652|NCT01287403|3794306|P1|COMPLETED|Diet Restriction (7 Days)||14
1550653|NCT01287403|3794306|P1|STARTED|Diet Restriction (7 Days)||14
1550654|NCT01287364|3794322|P2|NOT COMPLETED|Overall Study||10
1550655|NCT01287364|3794323|P1|NOT COMPLETED|Overall Study||9
1550656|NCT01287364|3794322|P2|COMPLETED|Overall Study||81
1550657|NCT01287364|3794323|P1|COMPLETED|Overall Study||85
1550658|NCT01287364|3794322|P2|STARTED|Overall Study||91
1550659|NCT01287364|3794323|P1|STARTED|Overall Study||94
1550660|NCT01287221|3794345|P2|NOT COMPLETED|Overall Study||5
1550661|NCT01287221|3794346|P1|NOT COMPLETED|Overall Study||4
1550662|NCT01287221|3794345|P2|COMPLETED|Overall Study||45
1550663|NCT01287221|3794346|P1|COMPLETED|Overall Study||46
1550664|NCT01287221|3794345|P2|Completed 12 Months Follow-up|Overall Study||39
1550665|NCT01287221|3794346|P1|Completed 12 Months Follow-up|Overall Study||40
1550666|NCT01287221|3794345|P2|Completed 9 Months Follow-up|Overall Study||40
1550667|NCT01287221|3794346|P1|Completed 9 Months Follow-up|Overall Study||42
1550668|NCT01287221|3794345|P2|Completed 6 Months Follow-up|Overall Study||43
1550669|NCT01287221|3794346|P1|Completed 6 Months Follow-up|Overall Study||47
1550670|NCT01287221|3794345|P2|Completed 3 Months Follow-up|Overall Study||50
1550671|NCT01287221|3794346|P1|Completed 3 Months Follow-up|Overall Study||49
1550672|NCT01287221|3794345|P2|STARTED|Overall Study||50
1550673|NCT01287221|3794346|P1|STARTED|Overall Study||50
1550674|NCT01287208|3794366|P2|NOT COMPLETED|Phase 2: Team Competition||0
1550675|NCT01287208|3794367|P1|NOT COMPLETED|Phase 2: Team Competition||0
1550676|NCT01287208|3794366|P2|COMPLETED|Phase 2: Team Competition||49
1550677|NCT01287208|3794367|P1|COMPLETED|Phase 2: Team Competition||50
1550678|NCT01287208|3794366|P2|STARTED|Phase 2: Team Competition||49
1550679|NCT01287208|3794367|P1|STARTED|Phase 2: Team Competition||50
1550681|NCT01287208|3794367|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
1550682|NCT01287208|3794366|P2|COMPLETED|Phase 1: Randomized Phase||49
1550683|NCT01287208|3794367|P1|COMPLETED|Phase 1: Randomized Phase||50
1550684|NCT01287208|3794366|P2|STARTED|Phase 1: Randomized Phase||52
1550685|NCT01287208|3794367|P1|STARTED|Phase 1: Randomized Phase||52
1550686|NCT01287195|3794381|P1|NOT COMPLETED|Overall Study||2
1550687|NCT01287195|3794381|P1|COMPLETED|Overall Study||4
1550688|NCT01287195|3794381|P1|STARTED|Overall Study||6
1550689|NCT01287117|3794396|P4|NOT COMPLETED|Overall Study||12
1550690|NCT01287117|3794397|P3|NOT COMPLETED|Overall Study||16
1550691|NCT01287117|3794398|P2|NOT COMPLETED|Overall Study||14
1550692|NCT01287117|3794399|P1|NOT COMPLETED|Overall Study||15
1550693|NCT01287117|3794396|P4|COMPLETED|Overall Study||69
1550694|NCT01287117|3794397|P3|COMPLETED|Overall Study||64
1550695|NCT01287117|3794398|P2|COMPLETED|Overall Study||64
1550696|NCT01287117|3794399|P1|COMPLETED|Overall Study||65
1550697|NCT01287117|3794396|P4|Received Treatment|Overall Study||81
1550698|NCT01287117|3794397|P3|Received Treatment|Overall Study||80
1550699|NCT01287117|3794398|P2|Received Treatment|Overall Study||77
1550700|NCT01287117|3794399|P1|Received Treatment|Overall Study||80
1550701|NCT01287117|3794396|P4|STARTED|Overall Study||81
1550702|NCT01287117|3794397|P3|STARTED|Overall Study||80
1550703|NCT01287117|3794398|P2|STARTED|Overall Study||78
1550704|NCT01287117|3794399|P1|STARTED|Overall Study||80
1550705|NCT01287065|3794445|P6|NOT COMPLETED|Treatment Period 3||0
1550706|NCT01287065|3794446|P5|NOT COMPLETED|Treatment Period 3||0
1550707|NCT01287065|3794447|P4|NOT COMPLETED|Treatment Period 3||0
1550708|NCT01287065|3794448|P3|NOT COMPLETED|Treatment Period 3||0
1550709|NCT01287065|3794449|P2|NOT COMPLETED|Treatment Period 3||0
1550710|NCT01287065|3794450|P1|NOT COMPLETED|Treatment Period 3||0
1550711|NCT01287065|3794445|P6|COMPLETED|Treatment Period 3||4
1550712|NCT01287065|3794446|P5|COMPLETED|Treatment Period 3||4
1550713|NCT01287065|3794447|P4|COMPLETED|Treatment Period 3||4
1550714|NCT01287065|3794448|P3|COMPLETED|Treatment Period 3||4
1550715|NCT01287065|3794449|P2|COMPLETED|Treatment Period 3||4
1550716|NCT01287065|3794450|P1|COMPLETED|Treatment Period 3||4
1550717|NCT01287065|3794445|P6|STARTED|Treatment Period 3||4
1550718|NCT01287065|3794446|P5|STARTED|Treatment Period 3||4
1550719|NCT01287065|3794447|P4|STARTED|Treatment Period 3||4
1550720|NCT01287065|3794448|P3|STARTED|Treatment Period 3||4
1550721|NCT01287065|3794449|P2|STARTED|Treatment Period 3||4
1550722|NCT01287065|3794450|P1|STARTED|Treatment Period 3||4
1550723|NCT01287065|3794445|P6|NOT COMPLETED|Washout Period 2||0
1550724|NCT01287065|3794446|P5|NOT COMPLETED|Washout Period 2||0
1550725|NCT01287065|3794447|P4|NOT COMPLETED|Washout Period 2||0
1550726|NCT01287065|3794448|P3|NOT COMPLETED|Washout Period 2||0
1550727|NCT01287065|3794449|P2|NOT COMPLETED|Washout Period 2||0
1550728|NCT01287065|3794450|P1|NOT COMPLETED|Washout Period 2||0
1550729|NCT01287065|3794445|P6|COMPLETED|Washout Period 2||4
1550730|NCT01287065|3794446|P5|COMPLETED|Washout Period 2||4
1550731|NCT01287065|3794447|P4|COMPLETED|Washout Period 2||4
1550732|NCT01287065|3794448|P3|COMPLETED|Washout Period 2||4
1550733|NCT01287065|3794449|P2|COMPLETED|Washout Period 2||4
1550734|NCT01287065|3794450|P1|COMPLETED|Washout Period 2||4
1550735|NCT01287065|3794445|P6|STARTED|Washout Period 2||4
1550736|NCT01287065|3794446|P5|STARTED|Washout Period 2||4
1550737|NCT01287065|3794447|P4|STARTED|Washout Period 2||4
1550738|NCT01287065|3794448|P3|STARTED|Washout Period 2||4
1550739|NCT01287065|3794449|P2|STARTED|Washout Period 2||4
1550740|NCT01287065|3794450|P1|STARTED|Washout Period 2||4
1550741|NCT01287065|3794445|P6|NOT COMPLETED|Treatment Period 2||0
1550742|NCT01287065|3794446|P5|NOT COMPLETED|Treatment Period 2||0
1550743|NCT01287065|3794447|P4|NOT COMPLETED|Treatment Period 2||0
1550744|NCT01287065|3794448|P3|NOT COMPLETED|Treatment Period 2||0
1550745|NCT01287065|3794449|P2|NOT COMPLETED|Treatment Period 2||0
1550746|NCT01287065|3794450|P1|NOT COMPLETED|Treatment Period 2||0
1550747|NCT01287065|3794445|P6|COMPLETED|Treatment Period 2||4
1550748|NCT01287065|3794446|P5|COMPLETED|Treatment Period 2||4
1550749|NCT01287065|3794447|P4|COMPLETED|Treatment Period 2||4
1550750|NCT01287065|3794448|P3|COMPLETED|Treatment Period 2||4
1550751|NCT01287065|3794449|P2|COMPLETED|Treatment Period 2||4
1550752|NCT01287065|3794450|P1|COMPLETED|Treatment Period 2||4
1550753|NCT01287065|3794445|P6|STARTED|Treatment Period 2||4
1550754|NCT01287065|3794446|P5|STARTED|Treatment Period 2||4
1550755|NCT01287065|3794447|P4|STARTED|Treatment Period 2||4
1550756|NCT01287065|3794448|P3|STARTED|Treatment Period 2||4
1550757|NCT01287065|3794449|P2|STARTED|Treatment Period 2||4
1550758|NCT01287065|3794450|P1|STARTED|Treatment Period 2||4
1550759|NCT01287065|3794445|P6|NOT COMPLETED|Washout Period 1||0
1550760|NCT01287065|3794446|P5|NOT COMPLETED|Washout Period 1||0
1550761|NCT01287065|3794447|P4|NOT COMPLETED|Washout Period 1||0
1550762|NCT01287065|3794448|P3|NOT COMPLETED|Washout Period 1||0
1550763|NCT01287065|3794449|P2|NOT COMPLETED|Washout Period 1||0
1550764|NCT01287065|3794450|P1|NOT COMPLETED|Washout Period 1||0
1550765|NCT01287065|3794445|P6|COMPLETED|Washout Period 1||4
1550766|NCT01287065|3794446|P5|COMPLETED|Washout Period 1||4
1550767|NCT01287065|3794447|P4|COMPLETED|Washout Period 1||4
1550768|NCT01287065|3794448|P3|COMPLETED|Washout Period 1||4
1550769|NCT01287065|3794449|P2|COMPLETED|Washout Period 1||4
1550770|NCT01287065|3794450|P1|COMPLETED|Washout Period 1||4
1550771|NCT01287065|3794445|P6|STARTED|Washout Period 1||4
1550772|NCT01287065|3794446|P5|STARTED|Washout Period 1||4
1550773|NCT01287065|3794447|P4|STARTED|Washout Period 1||4
1550774|NCT01287065|3794448|P3|STARTED|Washout Period 1||4
1550775|NCT01287065|3794449|P2|STARTED|Washout Period 1||4
1550776|NCT01287065|3794450|P1|STARTED|Washout Period 1||4
1550777|NCT01287065|3794445|P6|NOT COMPLETED|Treatment Period 1||1
1550778|NCT01287065|3794446|P5|NOT COMPLETED|Treatment Period 1||1
1550779|NCT01287065|3794447|P4|NOT COMPLETED|Treatment Period 1||0
1550780|NCT01287065|3794448|P3|NOT COMPLETED|Treatment Period 1||0
1550781|NCT01287065|3794449|P2|NOT COMPLETED|Treatment Period 1||0
1550782|NCT01287065|3794450|P1|NOT COMPLETED|Treatment Period 1||0
1550783|NCT01287065|3794445|P6|COMPLETED|Treatment Period 1||4
1550784|NCT01287065|3794446|P5|COMPLETED|Treatment Period 1||4
1550785|NCT01287065|3794447|P4|COMPLETED|Treatment Period 1||4
1550786|NCT01287065|3794448|P3|COMPLETED|Treatment Period 1||4
1550787|NCT01287065|3794449|P2|COMPLETED|Treatment Period 1||4
1550788|NCT01287065|3794450|P1|COMPLETED|Treatment Period 1||4
1550789|NCT01287065|3794445|P6|STARTED|Treatment Period 1||5
1550790|NCT01287065|3794446|P5|STARTED|Treatment Period 1||5
1550791|NCT01287065|3794447|P4|STARTED|Treatment Period 1||4
1550792|NCT01287065|3794448|P3|STARTED|Treatment Period 1||4
1550793|NCT01287065|3794449|P2|STARTED|Treatment Period 1||4
1550794|NCT01287065|3794450|P1|STARTED|Treatment Period 1||4
1550795|NCT01287039|3794469|P2|NOT COMPLETED|Overall Study||27
1550796|NCT01287039|3794470|P1|NOT COMPLETED|Overall Study||29
1550797|NCT01287039|3794469|P2|COMPLETED|Overall Study||218
1550798|NCT01287039|3794470|P1|COMPLETED|Overall Study||215
1550799|NCT01287039|3794469|P2|STARTED|Overall Study||245
1550800|NCT01287039|3794470|P1|STARTED|Overall Study||244
1550801|NCT01287013|3794503|P3|NOT COMPLETED|Overall Study||21
1550802|NCT01287013|3794504|P2|NOT COMPLETED|Overall Study||5
1550803|NCT01287013|3794505|P1|NOT COMPLETED|Overall Study||3
1550804|NCT01287013|3794503|P3|COMPLETED|Overall Study||0
1550805|NCT01287013|3794504|P2|COMPLETED|Overall Study||29
1550806|NCT01287013|3794505|P1|COMPLETED|Overall Study||29
1550807|NCT01287013|3794503|P3|STARTED|Overall Study||21
1550808|NCT01287013|3794504|P2|STARTED|Overall Study||34
1550809|NCT01287013|3794505|P1|STARTED|Overall Study||32
1550810|NCT01286818|3794520|P1|NOT COMPLETED|Overall Study||0
1550811|NCT01286818|3794520|P1|COMPLETED|Overall Study||6
1550812|NCT01286818|3794520|P1|Completed DLT Assessment Period|Overall Study||5
1550813|NCT01286818|3794520|P1|STARTED|Overall Study||6
1550814|NCT01286805|3794534|P2|NOT COMPLETED|Overall Study||1
1550815|NCT01286805|3794535|P1|NOT COMPLETED|Overall Study||0
1550816|NCT01286805|3794534|P2|COMPLETED|Overall Study||41
1550817|NCT01286805|3794535|P1|COMPLETED|Overall Study||41
1550818|NCT01286805|3794534|P2|STARTED|Overall Study||42
1550819|NCT01286805|3794535|P1|STARTED|Overall Study||41
1550820|NCT01286779|3794555|P1|NOT COMPLETED|Overall Study||19
1550821|NCT01286779|3794555|P1|COMPLETED|Overall Study||96
1550822|NCT01286779|3794555|P1|STARTED|Overall Study||115
1550823|NCT01286753|3794607|P2|NOT COMPLETED|Overall Study||25
1550824|NCT01286753|3794608|P1|NOT COMPLETED|Overall Study||26
1550825|NCT01286753|3794607|P2|COMPLETED|Overall Study||0
1550826|NCT01286753|3794608|P1|COMPLETED|Overall Study||0
1550827|NCT01286753|3794607|P2|STARTED|Overall Study||25
1550828|NCT01286753|3794608|P1|STARTED|Overall Study||26
1550829|NCT01286740|3794626|P1|NOT COMPLETED|Overall Study||2
1550830|NCT01286740|3794626|P1|COMPLETED|Overall Study||48
1550831|NCT01286740|3794626|P1|Week 12 (Primary Endpoint)|Overall Study||49
1550832|NCT01286740|3794626|P1|Enrolled and Treated|Overall Study||49
1550833|NCT01286740|3794626|P1|STARTED|Overall Study||50
1550834|NCT01286558|3794644|P2|NOT COMPLETED|Overall Study||2
1550835|NCT01286558|3794645|P1|NOT COMPLETED|Overall Study||1
1550836|NCT01286558|3794644|P2|COMPLETED|Overall Study||111
1550837|NCT01286558|3794645|P1|COMPLETED|Overall Study||111
1550838|NCT01286558|3794644|P2|STARTED|Overall Study||113
1550839|NCT01286558|3794645|P1|STARTED|Overall Study||112
1550840|NCT01286493|3794675|P1|NOT COMPLETED|Overall Study||3
1550841|NCT01286493|3794675|P1|COMPLETED|Overall Study||30
1550842|NCT01286493|3794675|P1|STARTED|Overall Study||33
1550843|NCT01286480|3794681|P2|NOT COMPLETED|Overall Study||3
1550844|NCT01286480|3794682|P1|NOT COMPLETED|Overall Study||5
1550845|NCT01286480|3794681|P2|COMPLETED|Overall Study||31
1550846|NCT01286480|3794682|P1|COMPLETED|Overall Study||27
1550847|NCT01286480|3794681|P2|STARTED|Overall Study||34
1550848|NCT01286480|3794682|P1|STARTED|Overall Study||32
1550849|NCT01286454|3794690|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550850|NCT01286454|3794691|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550851|NCT01286454|3794692|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550852|NCT01286454|3794693|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550853|NCT01286454|3794694|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550854|NCT01286454|3794695|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550855|NCT01286454|3794696|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550856|NCT01286454|3794697|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550857|NCT01286454|3794698|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550858|NCT01286454|3794699|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550859|NCT01286454|3794700|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
1550860|NCT01286454|3794690|P11|COMPLETED|Part II- Sixth Intervention Period||20
1550861|NCT01286454|3794691|P10|COMPLETED|Part II- Sixth Intervention Period||0
1550862|NCT01286454|3794692|P9|COMPLETED|Part II- Sixth Intervention Period||0
1550863|NCT01286454|3794693|P8|COMPLETED|Part II- Sixth Intervention Period||0
1550864|NCT01286454|3794694|P7|COMPLETED|Part II- Sixth Intervention Period||0
1550865|NCT01286454|3794695|P6|COMPLETED|Part II- Sixth Intervention Period||0
1550866|NCT01286454|3794696|P5|COMPLETED|Part II- Sixth Intervention Period||0
1550867|NCT01286454|3794697|P4|COMPLETED|Part II- Sixth Intervention Period||0
1550868|NCT01286454|3794698|P3|COMPLETED|Part II- Sixth Intervention Period||0
1550869|NCT01286454|3794699|P2|COMPLETED|Part II- Sixth Intervention Period||0
1550870|NCT01286454|3794700|P1|COMPLETED|Part II- Sixth Intervention Period||0
1550871|NCT01286454|3794690|P11|STARTED|Part II- Sixth Intervention Period||20
1550872|NCT01286454|3794691|P10|STARTED|Part II- Sixth Intervention Period||0
1550873|NCT01286454|3794692|P9|STARTED|Part II- Sixth Intervention Period||0
1550874|NCT01286454|3794693|P8|STARTED|Part II- Sixth Intervention Period||0
1550875|NCT01286454|3794694|P7|STARTED|Part II- Sixth Intervention Period||0
1550876|NCT01286454|3794695|P6|STARTED|Part II- Sixth Intervention Period||0
1550877|NCT01286454|3794696|P5|STARTED|Part II- Sixth Intervention Period||0
1550878|NCT01286454|3794697|P4|STARTED|Part II- Sixth Intervention Period||0
1550879|NCT01286454|3794698|P3|STARTED|Part II- Sixth Intervention Period||0
1550880|NCT01286454|3794699|P2|STARTED|Part II- Sixth Intervention Period||0
1550881|NCT01286454|3794700|P1|STARTED|Part II- Sixth Intervention Period||0
1550882|NCT01286454|3794690|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550883|NCT01286454|3794691|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550884|NCT01286454|3794692|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550885|NCT01286454|3794693|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550886|NCT01286454|3794694|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550887|NCT01286454|3794695|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550888|NCT01286454|3794696|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550889|NCT01286454|3794697|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550890|NCT01286454|3794698|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550891|NCT01286454|3794699|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550892|NCT01286454|3794700|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550893|NCT01286454|3794690|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
1550894|NCT01286454|3794691|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550895|NCT01286454|3794692|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550896|NCT01286454|3794693|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550897|NCT01286454|3794694|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550898|NCT01286454|3794695|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550899|NCT01286454|3794696|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550900|NCT01286454|3794697|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550901|NCT01286454|3794698|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550902|NCT01286454|3794699|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550903|NCT01286454|3794700|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1550904|NCT01286454|3794690|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
1550905|NCT01286454|3794691|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
1550906|NCT01286454|3794692|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
1550907|NCT01286454|3794693|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
1550908|NCT01286454|3794694|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
1550909|NCT01286454|3794695|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
1550910|NCT01286454|3794696|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
1550911|NCT01286454|3794697|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
1550912|NCT01286454|3794698|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
1550913|NCT01286454|3794699|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
1550914|NCT01286454|3794700|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
1550915|NCT01286454|3794690|P11|NOT COMPLETED|Fifth Intervention Period||0
1550916|NCT01286454|3794691|P10|NOT COMPLETED|Fifth Intervention Period||0
1550917|NCT01286454|3794692|P9|NOT COMPLETED|Fifth Intervention Period||0
1550918|NCT01286454|3794693|P8|NOT COMPLETED|Fifth Intervention Period||0
1550919|NCT01286454|3794694|P7|NOT COMPLETED|Fifth Intervention Period||0
1550920|NCT01286454|3794695|P6|NOT COMPLETED|Fifth Intervention Period||0
1550921|NCT01286454|3794696|P5|NOT COMPLETED|Fifth Intervention Period||0
1550922|NCT01286454|3794697|P4|NOT COMPLETED|Fifth Intervention Period||0
1550923|NCT01286454|3794698|P3|NOT COMPLETED|Fifth Intervention Period||0
1550924|NCT01286454|3794699|P2|NOT COMPLETED|Fifth Intervention Period||0
1550925|NCT01286454|3794700|P1|NOT COMPLETED|Fifth Intervention Period||0
1550926|NCT01286454|3794690|P11|COMPLETED|Fifth Intervention Period||0
1550927|NCT01286454|3794691|P10|COMPLETED|Fifth Intervention Period||2
1550928|NCT01286454|3794692|P9|COMPLETED|Fifth Intervention Period||2
1550929|NCT01286454|3794693|P8|COMPLETED|Fifth Intervention Period||2
1550930|NCT01286454|3794694|P7|COMPLETED|Fifth Intervention Period||2
1550931|NCT01286454|3794695|P6|COMPLETED|Fifth Intervention Period||2
1550932|NCT01286454|3794696|P5|COMPLETED|Fifth Intervention Period||2
1550933|NCT01286454|3794697|P4|COMPLETED|Fifth Intervention Period||2
1550934|NCT01286454|3794698|P3|COMPLETED|Fifth Intervention Period||2
1550935|NCT01286454|3794699|P2|COMPLETED|Fifth Intervention Period||2
1550936|NCT01286454|3794700|P1|COMPLETED|Fifth Intervention Period||2
1550937|NCT01286454|3794690|P11|STARTED|Fifth Intervention Period||0
1550938|NCT01286454|3794691|P10|STARTED|Fifth Intervention Period||2
1550939|NCT01286454|3794692|P9|STARTED|Fifth Intervention Period||2
1550940|NCT01286454|3794693|P8|STARTED|Fifth Intervention Period||2
1550941|NCT01286454|3794694|P7|STARTED|Fifth Intervention Period||2
1550942|NCT01286454|3794695|P6|STARTED|Fifth Intervention Period||2
1550943|NCT01286454|3794696|P5|STARTED|Fifth Intervention Period||2
1550944|NCT01286454|3794697|P4|STARTED|Fifth Intervention Period||2
1550945|NCT01286454|3794698|P3|STARTED|Fifth Intervention Period||2
1550946|NCT01286454|3794699|P2|STARTED|Fifth Intervention Period||2
1550947|NCT01286454|3794700|P1|STARTED|Fifth Intervention Period||2
1550948|NCT01286454|3794690|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550949|NCT01286454|3794691|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550950|NCT01286454|3794692|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550951|NCT01286454|3794693|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550952|NCT01286454|3794694|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550953|NCT01286454|3794695|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550954|NCT01286454|3794696|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550955|NCT01286454|3794697|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550956|NCT01286454|3794698|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550957|NCT01286454|3794699|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550958|NCT01286454|3794700|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1550959|NCT01286454|3794690|P11|COMPLETED|Washout Period (At Least 3 Days)||0
1550960|NCT01286454|3794691|P10|COMPLETED|Washout Period (At Least 3 Days)||2
1550961|NCT01286454|3794692|P9|COMPLETED|Washout Period (At Least 3 Days)||2
1550962|NCT01286454|3794693|P8|COMPLETED|Washout Period (At Least 3 Days)||2
1550963|NCT01286454|3794694|P7|COMPLETED|Washout Period (At Least 3 Days)||2
1550964|NCT01286454|3794695|P6|COMPLETED|Washout Period (At Least 3 Days)||2
1550965|NCT01286454|3794696|P5|COMPLETED|Washout Period (At Least 3 Days)||2
1550966|NCT01286454|3794697|P4|COMPLETED|Washout Period (At Least 3 Days)||2
1550967|NCT01286454|3794698|P3|COMPLETED|Washout Period (At Least 3 Days)||2
1550968|NCT01286454|3794699|P2|COMPLETED|Washout Period (At Least 3 Days)||2
1550969|NCT01286454|3794700|P1|COMPLETED|Washout Period (At Least 3 Days)||2
1550970|NCT01286454|3794690|P11|STARTED|Washout Period (At Least 3 Days)||0
1550971|NCT01286454|3794691|P10|STARTED|Washout Period (At Least 3 Days)||2
1550972|NCT01286454|3794692|P9|STARTED|Washout Period (At Least 3 Days)||2
1550973|NCT01286454|3794693|P8|STARTED|Washout Period (At Least 3 Days)||2
1550974|NCT01286454|3794694|P7|STARTED|Washout Period (At Least 3 Days)||2
1550975|NCT01286454|3794695|P6|STARTED|Washout Period (At Least 3 Days)||2
1550976|NCT01286454|3794696|P5|STARTED|Washout Period (At Least 3 Days)||2
1550977|NCT01286454|3794697|P4|STARTED|Washout Period (At Least 3 Days)||2
1550978|NCT01286454|3794698|P3|STARTED|Washout Period (At Least 3 Days)||2
1550979|NCT01286454|3794699|P2|STARTED|Washout Period (At Least 3 Days)||2
1550980|NCT01286454|3794700|P1|STARTED|Washout Period (At Least 3 Days)||2
1550981|NCT01286454|3794690|P11|NOT COMPLETED|Fourth Intervention Period||0
1550982|NCT01286454|3794691|P10|NOT COMPLETED|Fourth Intervention Period||0
1550983|NCT01286454|3794692|P9|NOT COMPLETED|Fourth Intervention Period||0
1550984|NCT01286454|3794693|P8|NOT COMPLETED|Fourth Intervention Period||0
1550985|NCT01286454|3794694|P7|NOT COMPLETED|Fourth Intervention Period||0
1550986|NCT01286454|3794695|P6|NOT COMPLETED|Fourth Intervention Period||0
1550987|NCT01286454|3794696|P5|NOT COMPLETED|Fourth Intervention Period||0
1550988|NCT01286454|3794697|P4|NOT COMPLETED|Fourth Intervention Period||0
1550989|NCT01286454|3794698|P3|NOT COMPLETED|Fourth Intervention Period||0
1550990|NCT01286454|3794699|P2|NOT COMPLETED|Fourth Intervention Period||0
1550991|NCT01286454|3794700|P1|NOT COMPLETED|Fourth Intervention Period||0
1550992|NCT01286454|3794690|P11|COMPLETED|Fourth Intervention Period||0
1550993|NCT01286454|3794691|P10|COMPLETED|Fourth Intervention Period||2
1550994|NCT01286454|3794692|P9|COMPLETED|Fourth Intervention Period||2
1550995|NCT01286454|3794693|P8|COMPLETED|Fourth Intervention Period||2
1550996|NCT01286454|3794694|P7|COMPLETED|Fourth Intervention Period||2
1550997|NCT01286454|3794695|P6|COMPLETED|Fourth Intervention Period||2
1550998|NCT01286454|3794696|P5|COMPLETED|Fourth Intervention Period||2
1550999|NCT01286454|3794697|P4|COMPLETED|Fourth Intervention Period||2
1551000|NCT01286454|3794698|P3|COMPLETED|Fourth Intervention Period||2
1551001|NCT01286454|3794699|P2|COMPLETED|Fourth Intervention Period||2
1551002|NCT01286454|3794700|P1|COMPLETED|Fourth Intervention Period||2
1551003|NCT01286454|3794690|P11|STARTED|Fourth Intervention Period||0
1551004|NCT01286454|3794691|P10|STARTED|Fourth Intervention Period||2
1551005|NCT01286454|3794692|P9|STARTED|Fourth Intervention Period||2
1551006|NCT01286454|3794693|P8|STARTED|Fourth Intervention Period||2
1551007|NCT01286454|3794694|P7|STARTED|Fourth Intervention Period||2
1551008|NCT01286454|3794695|P6|STARTED|Fourth Intervention Period||2
1551009|NCT01286454|3794696|P5|STARTED|Fourth Intervention Period||2
1551010|NCT01286454|3794697|P4|STARTED|Fourth Intervention Period||2
1551011|NCT01286454|3794698|P3|STARTED|Fourth Intervention Period||2
1551012|NCT01286454|3794699|P2|STARTED|Fourth Intervention Period||2
1551013|NCT01286454|3794700|P1|STARTED|Fourth Intervention Period||2
1551014|NCT01286454|3794690|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551015|NCT01286454|3794691|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551016|NCT01286454|3794692|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551017|NCT01286454|3794693|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551018|NCT01286454|3794694|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551019|NCT01286454|3794695|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551020|NCT01286454|3794696|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551021|NCT01286454|3794697|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551022|NCT01286454|3794698|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551023|NCT01286454|3794699|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551024|NCT01286454|3794700|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551025|NCT01286454|3794690|P11|COMPLETED|Washout Period (At Least 3 Days)||0
1551026|NCT01286454|3794691|P10|COMPLETED|Washout Period (At Least 3 Days)||2
1551027|NCT01286454|3794692|P9|COMPLETED|Washout Period (At Least 3 Days)||2
1551028|NCT01286454|3794693|P8|COMPLETED|Washout Period (At Least 3 Days)||2
1551029|NCT01286454|3794694|P7|COMPLETED|Washout Period (At Least 3 Days)||2
1551030|NCT01286454|3794695|P6|COMPLETED|Washout Period (At Least 3 Days)||2
1551031|NCT01286454|3794696|P5|COMPLETED|Washout Period (At Least 3 Days)||2
1551032|NCT01286454|3794697|P4|COMPLETED|Washout Period (At Least 3 Days)||2
1551033|NCT01286454|3794698|P3|COMPLETED|Washout Period (At Least 3 Days)||2
1551034|NCT01286454|3794699|P2|COMPLETED|Washout Period (At Least 3 Days)||2
1551035|NCT01286454|3794700|P1|COMPLETED|Washout Period (At Least 3 Days)||2
1551036|NCT01286454|3794690|P11|STARTED|Washout Period (At Least 3 Days)||0
1551037|NCT01286454|3794691|P10|STARTED|Washout Period (At Least 3 Days)||2
1551038|NCT01286454|3794692|P9|STARTED|Washout Period (At Least 3 Days)||2
1551039|NCT01286454|3794693|P8|STARTED|Washout Period (At Least 3 Days)||2
1551040|NCT01286454|3794694|P7|STARTED|Washout Period (At Least 3 Days)||2
1551041|NCT01286454|3794695|P6|STARTED|Washout Period (At Least 3 Days)||2
1551042|NCT01286454|3794696|P5|STARTED|Washout Period (At Least 3 Days)||2
1551043|NCT01286454|3794697|P4|STARTED|Washout Period (At Least 3 Days)||2
1551044|NCT01286454|3794698|P3|STARTED|Washout Period (At Least 3 Days)||2
1551045|NCT01286454|3794699|P2|STARTED|Washout Period (At Least 3 Days)||2
1551046|NCT01286454|3794700|P1|STARTED|Washout Period (At Least 3 Days)||2
1551047|NCT01286454|3794690|P11|NOT COMPLETED|Third Intervention Period||0
1551048|NCT01286454|3794691|P10|NOT COMPLETED|Third Intervention Period||0
1551049|NCT01286454|3794692|P9|NOT COMPLETED|Third Intervention Period||0
1551050|NCT01286454|3794693|P8|NOT COMPLETED|Third Intervention Period||0
1551051|NCT01286454|3794694|P7|NOT COMPLETED|Third Intervention Period||0
1551052|NCT01286454|3794695|P6|NOT COMPLETED|Third Intervention Period||0
1551053|NCT01286454|3794696|P5|NOT COMPLETED|Third Intervention Period||0
1551054|NCT01286454|3794697|P4|NOT COMPLETED|Third Intervention Period||0
1551055|NCT01286454|3794698|P3|NOT COMPLETED|Third Intervention Period||0
1551056|NCT01286454|3794699|P2|NOT COMPLETED|Third Intervention Period||0
1551057|NCT01286454|3794700|P1|NOT COMPLETED|Third Intervention Period||0
1551058|NCT01286454|3794690|P11|COMPLETED|Third Intervention Period||0
1551059|NCT01286454|3794691|P10|COMPLETED|Third Intervention Period||2
1551060|NCT01286454|3794692|P9|COMPLETED|Third Intervention Period||2
1551061|NCT01286454|3794693|P8|COMPLETED|Third Intervention Period||2
1551062|NCT01286454|3794694|P7|COMPLETED|Third Intervention Period||2
1551063|NCT01286454|3794695|P6|COMPLETED|Third Intervention Period||2
1551064|NCT01286454|3794696|P5|COMPLETED|Third Intervention Period||2
1551065|NCT01286454|3794697|P4|COMPLETED|Third Intervention Period||2
1551066|NCT01286454|3794698|P3|COMPLETED|Third Intervention Period||2
1551067|NCT01286454|3794699|P2|COMPLETED|Third Intervention Period||2
1551068|NCT01286454|3794700|P1|COMPLETED|Third Intervention Period||2
1551069|NCT01286454|3794690|P11|STARTED|Third Intervention Period||0
1551070|NCT01286454|3794691|P10|STARTED|Third Intervention Period||2
1551071|NCT01286454|3794692|P9|STARTED|Third Intervention Period||2
1551072|NCT01286454|3794693|P8|STARTED|Third Intervention Period||2
1551073|NCT01286454|3794694|P7|STARTED|Third Intervention Period||2
1551074|NCT01286454|3794695|P6|STARTED|Third Intervention Period||2
1551075|NCT01286454|3794696|P5|STARTED|Third Intervention Period||2
1551076|NCT01286454|3794697|P4|STARTED|Third Intervention Period||2
1551077|NCT01286454|3794698|P3|STARTED|Third Intervention Period||2
1551078|NCT01286454|3794699|P2|STARTED|Third Intervention Period||2
1551079|NCT01286454|3794700|P1|STARTED|Third Intervention Period||2
1551080|NCT01286454|3794690|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551081|NCT01286454|3794691|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551082|NCT01286454|3794692|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551083|NCT01286454|3794693|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551084|NCT01286454|3794694|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551085|NCT01286454|3794695|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551086|NCT01286454|3794696|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551087|NCT01286454|3794697|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551088|NCT01286454|3794698|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551089|NCT01286454|3794699|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551090|NCT01286454|3794700|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551091|NCT01286454|3794690|P11|COMPLETED|Washout Period (At Least 3 Days)||0
1551092|NCT01286454|3794691|P10|COMPLETED|Washout Period (At Least 3 Days)||2
1551093|NCT01286454|3794692|P9|COMPLETED|Washout Period (At Least 3 Days)||2
1551094|NCT01286454|3794693|P8|COMPLETED|Washout Period (At Least 3 Days)||2
1551095|NCT01286454|3794694|P7|COMPLETED|Washout Period (At Least 3 Days)||2
1551096|NCT01286454|3794695|P6|COMPLETED|Washout Period (At Least 3 Days)||2
1551097|NCT01286454|3794696|P5|COMPLETED|Washout Period (At Least 3 Days)||2
1551098|NCT01286454|3794697|P4|COMPLETED|Washout Period (At Least 3 Days)||2
1551099|NCT01286454|3794698|P3|COMPLETED|Washout Period (At Least 3 Days)||2
1551100|NCT01286454|3794699|P2|COMPLETED|Washout Period (At Least 3 Days)||2
1551101|NCT01286454|3794700|P1|COMPLETED|Washout Period (At Least 3 Days)||2
1551102|NCT01286454|3794690|P11|STARTED|Washout Period (At Least 3 Days)||0
1551103|NCT01286454|3794691|P10|STARTED|Washout Period (At Least 3 Days)||2
1551104|NCT01286454|3794692|P9|STARTED|Washout Period (At Least 3 Days)||2
1551105|NCT01286454|3794693|P8|STARTED|Washout Period (At Least 3 Days)||2
1551106|NCT01286454|3794694|P7|STARTED|Washout Period (At Least 3 Days)||2
1551107|NCT01286454|3794695|P6|STARTED|Washout Period (At Least 3 Days)||2
1551108|NCT01286454|3794696|P5|STARTED|Washout Period (At Least 3 Days)||2
1551109|NCT01286454|3794697|P4|STARTED|Washout Period (At Least 3 Days)||2
1551110|NCT01286454|3794698|P3|STARTED|Washout Period (At Least 3 Days)||2
1551111|NCT01286454|3794699|P2|STARTED|Washout Period (At Least 3 Days)||2
1551112|NCT01286454|3794700|P1|STARTED|Washout Period (At Least 3 Days)||2
1551113|NCT01286454|3794690|P11|NOT COMPLETED|Second Intervention Period||0
1551114|NCT01286454|3794691|P10|NOT COMPLETED|Second Intervention Period||0
1551115|NCT01286454|3794692|P9|NOT COMPLETED|Second Intervention Period||0
1551116|NCT01286454|3794693|P8|NOT COMPLETED|Second Intervention Period||0
1551117|NCT01286454|3794694|P7|NOT COMPLETED|Second Intervention Period||0
1551118|NCT01286454|3794695|P6|NOT COMPLETED|Second Intervention Period||0
1551119|NCT01286454|3794696|P5|NOT COMPLETED|Second Intervention Period||0
1551120|NCT01286454|3794697|P4|NOT COMPLETED|Second Intervention Period||0
1551121|NCT01286454|3794698|P3|NOT COMPLETED|Second Intervention Period||0
1551122|NCT01286454|3794699|P2|NOT COMPLETED|Second Intervention Period||0
1551123|NCT01286454|3794700|P1|NOT COMPLETED|Second Intervention Period||0
1551124|NCT01286454|3794690|P11|COMPLETED|Second Intervention Period||0
1551125|NCT01286454|3794691|P10|COMPLETED|Second Intervention Period||2
1551126|NCT01286454|3794692|P9|COMPLETED|Second Intervention Period||2
1551127|NCT01286454|3794693|P8|COMPLETED|Second Intervention Period||2
1551128|NCT01286454|3794694|P7|COMPLETED|Second Intervention Period||2
1551129|NCT01286454|3794695|P6|COMPLETED|Second Intervention Period||2
1551130|NCT01286454|3794696|P5|COMPLETED|Second Intervention Period||2
1551131|NCT01286454|3794697|P4|COMPLETED|Second Intervention Period||2
1551132|NCT01286454|3794698|P3|COMPLETED|Second Intervention Period||2
1551133|NCT01286454|3794699|P2|COMPLETED|Second Intervention Period||2
1551134|NCT01286454|3794700|P1|COMPLETED|Second Intervention Period||2
1551135|NCT01286454|3794690|P11|STARTED|Second Intervention Period||0
1551136|NCT01286454|3794691|P10|STARTED|Second Intervention Period||2
1551137|NCT01286454|3794692|P9|STARTED|Second Intervention Period||2
1551138|NCT01286454|3794693|P8|STARTED|Second Intervention Period||2
1551139|NCT01286454|3794694|P7|STARTED|Second Intervention Period||2
1551140|NCT01286454|3794695|P6|STARTED|Second Intervention Period||2
1551141|NCT01286454|3794696|P5|STARTED|Second Intervention Period||2
1551142|NCT01286454|3794697|P4|STARTED|Second Intervention Period||2
1551143|NCT01286454|3794698|P3|STARTED|Second Intervention Period||2
1551144|NCT01286454|3794699|P2|STARTED|Second Intervention Period||2
1551145|NCT01286454|3794700|P1|STARTED|Second Intervention Period||2
1551146|NCT01286454|3794690|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551147|NCT01286454|3794691|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551148|NCT01286454|3794692|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551149|NCT01286454|3794693|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551150|NCT01286454|3794694|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551151|NCT01286454|3794695|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551152|NCT01286454|3794696|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551153|NCT01286454|3794697|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551154|NCT01286454|3794698|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551155|NCT01286454|3794699|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551156|NCT01286454|3794700|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1551157|NCT01286454|3794690|P11|COMPLETED|Washout Period (At Least 3 Days)||0
1551158|NCT01286454|3794691|P10|COMPLETED|Washout Period (At Least 3 Days)||2
1551159|NCT01286454|3794692|P9|COMPLETED|Washout Period (At Least 3 Days)||2
1551160|NCT01286454|3794693|P8|COMPLETED|Washout Period (At Least 3 Days)||2
1551161|NCT01286454|3794694|P7|COMPLETED|Washout Period (At Least 3 Days)||2
1551162|NCT01286454|3794695|P6|COMPLETED|Washout Period (At Least 3 Days)||2
1551163|NCT01286454|3794696|P5|COMPLETED|Washout Period (At Least 3 Days)||2
1551164|NCT01286454|3794697|P4|COMPLETED|Washout Period (At Least 3 Days)||2
1551165|NCT01286454|3794698|P3|COMPLETED|Washout Period (At Least 3 Days)||2
1551166|NCT01286454|3794699|P2|COMPLETED|Washout Period (At Least 3 Days)||2
1551167|NCT01286454|3794700|P1|COMPLETED|Washout Period (At Least 3 Days)||2
1551168|NCT01286454|3794690|P11|STARTED|Washout Period (At Least 3 Days)||0
1551169|NCT01286454|3794691|P10|STARTED|Washout Period (At Least 3 Days)||2
1551170|NCT01286454|3794692|P9|STARTED|Washout Period (At Least 3 Days)||2
1551171|NCT01286454|3794693|P8|STARTED|Washout Period (At Least 3 Days)||2
1551172|NCT01286454|3794694|P7|STARTED|Washout Period (At Least 3 Days)||2
1551173|NCT01286454|3794695|P6|STARTED|Washout Period (At Least 3 Days)||2
1551174|NCT01286454|3794696|P5|STARTED|Washout Period (At Least 3 Days)||2
1551175|NCT01286454|3794697|P4|STARTED|Washout Period (At Least 3 Days)||2
1551176|NCT01286454|3794698|P3|STARTED|Washout Period (At Least 3 Days)||2
1551177|NCT01286454|3794699|P2|STARTED|Washout Period (At Least 3 Days)||2
1551178|NCT01286454|3794700|P1|STARTED|Washout Period (At Least 3 Days)||2
1551179|NCT01286454|3794690|P11|NOT COMPLETED|Part I- First Intervention Period||0
1551180|NCT01286454|3794691|P10|NOT COMPLETED|Part I- First Intervention Period||0
1551181|NCT01286454|3794692|P9|NOT COMPLETED|Part I- First Intervention Period||0
1551182|NCT01286454|3794693|P8|NOT COMPLETED|Part I- First Intervention Period||0
1551183|NCT01286454|3794694|P7|NOT COMPLETED|Part I- First Intervention Period||0
1551184|NCT01286454|3794695|P6|NOT COMPLETED|Part I- First Intervention Period||0
1551185|NCT01286454|3794696|P5|NOT COMPLETED|Part I- First Intervention Period||0
1551186|NCT01286454|3794697|P4|NOT COMPLETED|Part I- First Intervention Period||0
1551187|NCT01286454|3794698|P3|NOT COMPLETED|Part I- First Intervention Period||0
1551188|NCT01286454|3794699|P2|NOT COMPLETED|Part I- First Intervention Period||0
1551189|NCT01286454|3794700|P1|NOT COMPLETED|Part I- First Intervention Period||0
1551190|NCT01286454|3794690|P11|COMPLETED|Part I- First Intervention Period||0
1551191|NCT01286454|3794691|P10|COMPLETED|Part I- First Intervention Period||2
1551192|NCT01286454|3794692|P9|COMPLETED|Part I- First Intervention Period||2
1551193|NCT01286454|3794693|P8|COMPLETED|Part I- First Intervention Period||2
1551194|NCT01286454|3794694|P7|COMPLETED|Part I- First Intervention Period||2
1551195|NCT01286454|3794695|P6|COMPLETED|Part I- First Intervention Period||2
1551196|NCT01286454|3794696|P5|COMPLETED|Part I- First Intervention Period||2
1551197|NCT01286454|3794697|P4|COMPLETED|Part I- First Intervention Period||2
1551198|NCT01286454|3794698|P3|COMPLETED|Part I- First Intervention Period||2
1551199|NCT01286454|3794699|P2|COMPLETED|Part I- First Intervention Period||2
1551200|NCT01286454|3794700|P1|COMPLETED|Part I- First Intervention Period||2
1551201|NCT01286454|3794690|P11|STARTED|Part I- First Intervention Period||0
1551202|NCT01286454|3794691|P10|STARTED|Part I- First Intervention Period||2
1551203|NCT01286454|3794692|P9|STARTED|Part I- First Intervention Period||2
1551204|NCT01286454|3794693|P8|STARTED|Part I- First Intervention Period||2
1551205|NCT01286454|3794694|P7|STARTED|Part I- First Intervention Period||2
1551206|NCT01286454|3794695|P6|STARTED|Part I- First Intervention Period||2
1551207|NCT01286454|3794696|P5|STARTED|Part I- First Intervention Period||2
1551208|NCT01286454|3794697|P4|STARTED|Part I- First Intervention Period||2
1551209|NCT01286454|3794698|P3|STARTED|Part I- First Intervention Period||2
1551210|NCT01286454|3794699|P2|STARTED|Part I- First Intervention Period||2
1551211|NCT01286454|3794700|P1|STARTED|Part I- First Intervention Period||2
1551212|NCT01286402|3794740|P2|NOT COMPLETED|Overall Study||0
1551213|NCT01286402|3794741|P1|NOT COMPLETED|Overall Study||0
1551214|NCT01286402|3794740|P2|COMPLETED|Overall Study||6
1551215|NCT01286402|3794741|P1|COMPLETED|Overall Study||5
1551216|NCT01286402|3794740|P2|STARTED|Overall Study||6
1551217|NCT01286402|3794741|P1|STARTED|Overall Study||5
1551218|NCT01286324|3794749|P2|NOT COMPLETED|Overall Study||0
1551219|NCT01286324|3794750|P1|NOT COMPLETED|Overall Study||0
1551220|NCT01286324|3794749|P2|COMPLETED|Overall Study||17
1551221|NCT01286324|3794750|P1|COMPLETED|Overall Study||17
1551222|NCT01286324|3794749|P2|STARTED|Overall Study||17
1551223|NCT01286324|3794750|P1|STARTED|Overall Study||17
1551224|NCT01286311|3794768|P2|NOT COMPLETED|Overall Study||0
1551225|NCT01286311|3794769|P1|NOT COMPLETED|Overall Study||14
1551226|NCT01286311|3794768|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
1551227|NCT01286311|3794769|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
1551228|NCT01286311|3794768|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
1551229|NCT01286311|3794769|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
1551230|NCT01286207|3794786|P3|NOT COMPLETED|Overall Study||90
1551231|NCT01286207|3794787|P2|NOT COMPLETED|Overall Study||248
1551232|NCT01286207|3794788|P1|NOT COMPLETED|Overall Study||298
1551233|NCT01286207|3794786|P3|COMPLETED|Overall Study||261
1551234|NCT01286207|3794787|P2|COMPLETED|Overall Study||609
1551235|NCT01286207|3794788|P1|COMPLETED|Overall Study||453
1551236|NCT01286207|3794786|P3|STARTED|Overall Study||351
1551237|NCT01286207|3794787|P2|STARTED|Overall Study||857
1551238|NCT01286207|3794788|P1|STARTED|Overall Study||751
1551239|NCT01286168|3794808|P1|NOT COMPLETED|Overall Study||3
1551240|NCT01286168|3794808|P1|COMPLETED|Overall Study||101
1551241|NCT01286168|3794808|P1|STARTED|Overall Study||104
1551242|NCT01286129|3794822|P2|NOT COMPLETED|Overall Study||5
1551243|NCT01286129|3794823|P1|NOT COMPLETED|Overall Study||8
1551244|NCT01286129|3794822|P2|COMPLETED|Overall Study||13
1551245|NCT01286129|3794823|P1|COMPLETED|Overall Study||19
1551246|NCT01286129|3794822|P2|STARTED|Overall Study||18
1551247|NCT01286129|3794823|P1|STARTED|Overall Study||27
1551248|NCT01286077|3794833|P2|NOT COMPLETED|Overall Study||7
1551249|NCT01286077|3794834|P1|NOT COMPLETED|Overall Study||10
1551250|NCT01286077|3794833|P2|COMPLETED|Overall Study||46
1551251|NCT01286077|3794834|P1|COMPLETED|Overall Study||41
1551252|NCT01286077|3794833|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
1551253|NCT01286077|3794834|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
1551254|NCT01286012|3794870|P2|NOT COMPLETED|Overall Study||14
1551255|NCT01286012|3794871|P1|NOT COMPLETED|Overall Study||13
1551256|NCT01286012|3794870|P2|COMPLETED|Overall Study||40
1551257|NCT01286012|3794871|P1|COMPLETED|Overall Study||41
1551258|NCT01286012|3794870|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
1551259|NCT01286012|3794871|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
1551260|NCT01285947|3794887|P2|NOT COMPLETED|Overall Study||0
1551261|NCT01285947|3794888|P1|NOT COMPLETED|Overall Study||0
1551262|NCT01285947|3794887|P2|COMPLETED|Overall Study||10
1551263|NCT01285947|3794888|P1|COMPLETED|Overall Study||10
1551264|NCT01285947|3794887|P2|STARTED|Overall Study||10
1551265|NCT01285947|3794888|P1|STARTED|Overall Study||10
1551266|NCT01285908|3794894|P3|NOT COMPLETED|Treatment Crossover||0
1551267|NCT01285908|3794895|P2|NOT COMPLETED|Treatment Crossover||0
1551268|NCT01285908|3794896|P1|NOT COMPLETED|Treatment Crossover||0
1551269|NCT01285908|3794894|P3|COMPLETED|Treatment Crossover||2
1551270|NCT01285908|3794895|P2|COMPLETED|Treatment Crossover||2
1551271|NCT01285908|3794896|P1|COMPLETED|Treatment Crossover||0
1551272|NCT01285908|3794894|P3|STARTED|Treatment Crossover||2
1551273|NCT01285908|3794895|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
1551274|NCT01285908|3794896|P1|STARTED|Treatment Crossover||0
1551275|NCT01285908|3794894|P3|NOT COMPLETED|Baseline Measurement||0
1551276|NCT01285908|3794895|P2|NOT COMPLETED|Baseline Measurement||0
1551277|NCT01285908|3794896|P1|NOT COMPLETED|Baseline Measurement||3
1551278|NCT01285908|3794894|P3|COMPLETED|Baseline Measurement||0
1551279|NCT01285908|3794895|P2|COMPLETED|Baseline Measurement||0
1551280|NCT01285908|3794896|P1|COMPLETED|Baseline Measurement||3
1551281|NCT01285908|3794894|P3|STARTED|Baseline Measurement||0
1551282|NCT01285908|3794895|P2|STARTED|Baseline Measurement||0
1551283|NCT01285908|3794896|P1|STARTED|Baseline Measurement||6
1551284|NCT01285843|3794930|P2|NOT COMPLETED|Overall Study||2
1551285|NCT01285843|3794931|P1|NOT COMPLETED|Overall Study||2
1551286|NCT01285843|3794930|P2|COMPLETED|Overall Study||18
1551287|NCT01285843|3794931|P1|COMPLETED|Overall Study||18
1551288|NCT01285843|3794930|P2|STARTED|Overall Study||20
1551289|NCT01285843|3794931|P1|STARTED|Overall Study||20
1551290|NCT01285791|3794946|P3|NOT COMPLETED|Overall Study||0
1551291|NCT01285791|3794947|P2|NOT COMPLETED|Overall Study||0
1551292|NCT01285791|3794948|P1|NOT COMPLETED|Overall Study||0
1551293|NCT01285791|3794946|P3|COMPLETED|Overall Study||13
1551294|NCT01285791|3794947|P2|COMPLETED|Overall Study||15
1551295|NCT01285791|3794948|P1|COMPLETED|Overall Study||11
1551296|NCT01285791|3794946|P3|STARTED|Overall Study||13
1551297|NCT01285791|3794947|P2|STARTED|Overall Study||15
1551298|NCT01285791|3794948|P1|STARTED|Overall Study||11
1551299|NCT01285713|3794958|P2|NOT COMPLETED|Overall Study||0
1551300|NCT01285713|3794959|P1|NOT COMPLETED|Overall Study||0
1551301|NCT01285713|3794958|P2|COMPLETED|Overall Study||41
1551302|NCT01285713|3794959|P1|COMPLETED|Overall Study||42
1551303|NCT01285713|3794958|P2|STARTED|Overall Study||41
1551304|NCT01285713|3794959|P1|STARTED|Overall Study||42
1551305|NCT01285635|3794968|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
1551306|NCT01285635|3794969|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
1551307|NCT01285635|3794970|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
1551308|NCT01285635|3794968|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
1551309|NCT01285635|3794969|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
1551310|NCT01285635|3794970|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
1551311|NCT01285635|3794968|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
1551312|NCT01285635|3794969|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
1551313|NCT01285635|3794970|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
1551314|NCT01285635|3794968|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
1551315|NCT01285635|3794969|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
1551316|NCT01285635|3794970|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
1551317|NCT01285635|3794968|P3|COMPLETED|First Intervention (2 Weeks)||11
1551318|NCT01285635|3794969|P2|COMPLETED|First Intervention (2 Weeks)||11
1551319|NCT01285635|3794970|P1|COMPLETED|First Intervention (2 Weeks)||13
1551320|NCT01285635|3794968|P3|STARTED|First Intervention (2 Weeks)||11
1551321|NCT01285635|3794969|P2|STARTED|First Intervention (2 Weeks)||11
1551322|NCT01285635|3794970|P1|STARTED|First Intervention (2 Weeks)||13
1551323|NCT01285609|3794990|P2|NOT COMPLETED|Treated With Blinded Therapy||359
1551324|NCT01285609|3794991|P1|NOT COMPLETED|Treated With Blinded Therapy||387
1551325|NCT01285609|3794990|P2|COMPLETED|Treated With Blinded Therapy||2
1551326|NCT01285609|3794991|P1|COMPLETED|Treated With Blinded Therapy||1
1551327|NCT01285609|3794990|P2|STARTED|Treated With Blinded Therapy||361
1551328|NCT01285609|3794991|P1|STARTED|Treated With Blinded Therapy||388
1551329|NCT01285609|3794990|P2|NOT COMPLETED|Randomized||116
1551330|NCT01285609|3794991|P1|NOT COMPLETED|Randomized||91
1551331|NCT01285609|3794990|P2|COMPLETED|Randomized||361
1551332|NCT01285609|3794991|P1|COMPLETED|Randomized||388
1551333|NCT01285609|3794990|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
1551334|NCT01285609|3794991|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
1551335|NCT01285609|3794990|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
1551336|NCT01285609|3794991|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
1551337|NCT01285518|3795009|P8|NOT COMPLETED|Overall Study||0
1551338|NCT01285518|3795010|P7|NOT COMPLETED|Overall Study||0
1551339|NCT01285518|3795011|P6|NOT COMPLETED|Overall Study||1
1551340|NCT01285518|3795012|P5|NOT COMPLETED|Overall Study||0
1551341|NCT01285518|3795013|P4|NOT COMPLETED|Overall Study||0
1551342|NCT01285518|3795014|P3|NOT COMPLETED|Overall Study||0
1551343|NCT01285518|3795015|P2|NOT COMPLETED|Overall Study||0
1551344|NCT01285518|3795016|P1|NOT COMPLETED|Overall Study||0
1551345|NCT01285518|3795009|P8|COMPLETED|Overall Study||14
1551346|NCT01285518|3795010|P7|COMPLETED|Overall Study||10
1551347|NCT01285518|3795011|P6|COMPLETED|Overall Study||9
1551348|NCT01285518|3795012|P5|COMPLETED|Overall Study||10
1551349|NCT01285518|3795013|P4|COMPLETED|Overall Study||10
1551350|NCT01285518|3795014|P3|COMPLETED|Overall Study||10
1551351|NCT01285518|3795015|P2|COMPLETED|Overall Study||10
1551352|NCT01285518|3795016|P1|COMPLETED|Overall Study||10
1551353|NCT01285518|3795009|P8|STARTED|Overall Study||14
1551354|NCT01285518|3795010|P7|STARTED|Overall Study||10
1551355|NCT01285518|3795011|P6|STARTED|Overall Study||10
1551356|NCT01285518|3795012|P5|STARTED|Overall Study||10
1551357|NCT01285518|3795013|P4|STARTED|Overall Study||10
1551358|NCT01285518|3795014|P3|STARTED|Overall Study||10
1551359|NCT01285518|3795015|P2|STARTED|Overall Study||10
1551360|NCT01285518|3795016|P1|STARTED|Overall Study||10
1551361|NCT01285492|3795276|P2|NOT COMPLETED|Overall Study||1
1551362|NCT01285492|3795277|P1|NOT COMPLETED|Overall Study||17
1551363|NCT01285492|3795276|P2|COMPLETED|Overall Study||38
1551364|NCT01285492|3795277|P1|COMPLETED|Overall Study||104
1551365|NCT01285492|3795276|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
1551366|NCT01285492|3795277|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
1551367|NCT01285492|3795276|P2|STARTED|Overall Study|All patients randomized to this group|39
1551368|NCT01285492|3795277|P1|STARTED|Overall Study|All patients randomized to this group|121
1551369|NCT01285427|3795295|P1|NOT COMPLETED|Overall Study||1
1551370|NCT01285427|3795295|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
1551371|NCT01285427|3795295|P1|STARTED|Overall Study||300
1551372|NCT01285401|3795309|P2|NOT COMPLETED|Overall Study||29
1551373|NCT01285401|3795310|P1|NOT COMPLETED|Overall Study||17
1551374|NCT01285401|3795309|P2|COMPLETED|Overall Study||88
1551375|NCT01285401|3795310|P1|COMPLETED|Overall Study||98
1551376|NCT01285401|3795309|P2|Treated|Overall Study||116
1551377|NCT01285401|3795310|P1|Treated|Overall Study||113
1551378|NCT01285401|3795309|P2|STARTED|Overall Study||117
1551379|NCT01285401|3795310|P1|STARTED|Overall Study||115
1551380|NCT01285323|3795350|P2|NOT COMPLETED|Overall Study||30
1551381|NCT01285323|3795351|P1|NOT COMPLETED|Overall Study||33
1551382|NCT01285323|3795350|P2|COMPLETED|Overall Study||202
1551383|NCT01285323|3795351|P1|COMPLETED|Overall Study||199
1551384|NCT01285323|3795350|P2|Safety Analysis Set|Overall Study||232
1551385|NCT01285323|3795351|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
1551386|NCT01285323|3795350|P2|Full Analysis Set|Overall Study||232
1551387|NCT01285323|3795351|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
1551388|NCT01285323|3795350|P2|STARTED|Overall Study||232
1551389|NCT01285323|3795351|P1|STARTED|Overall Study||232
1551390|NCT01285310|3795386|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
1551391|NCT01285310|3795387|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
1551392|NCT01285310|3795388|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
1551393|NCT01285310|3795389|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
1551394|NCT01285310|3795390|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
1551395|NCT01285310|3795386|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
1551396|NCT01285310|3795387|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
1551397|NCT01285310|3795388|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
1551398|NCT01285310|3795389|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
1551399|NCT01285310|3795390|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
1551400|NCT01285310|3795386|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
1551401|NCT01285310|3795387|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
1551402|NCT01285310|3795388|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
1551403|NCT01285310|3795389|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
1551404|NCT01285310|3795390|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
1551405|NCT01285310|3795386|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1551406|NCT01285310|3795387|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1551407|NCT01285310|3795388|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
1551408|NCT01285310|3795389|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
1551409|NCT01285310|3795390|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
1551410|NCT01285310|3795386|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1551411|NCT01285310|3795387|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1551412|NCT01285310|3795388|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
1551413|NCT01285310|3795389|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
1551414|NCT01285310|3795390|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
1551415|NCT01285310|3795386|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
1551416|NCT01285310|3795387|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
1551417|NCT01285310|3795388|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
1551418|NCT01285310|3795389|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
1551419|NCT01285310|3795390|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
1551420|NCT01285076|3795623|P1|NOT COMPLETED|Overall Study||0
1551421|NCT01285076|3795623|P1|COMPLETED|Overall Study||834
1551422|NCT01285076|3795623|P1|STARTED|Overall Study||834
1551423|NCT01285050|3795636|P1|NOT COMPLETED|Overall Study||1
1551424|NCT01285050|3795636|P1|COMPLETED|Overall Study||19
1551425|NCT01285050|3795636|P1|STARTED|Overall Study||20
1551426|NCT01285024|3795643|P2|NOT COMPLETED|Overall Study||0
1551427|NCT01285024|3795644|P1|NOT COMPLETED|Overall Study||0
1551428|NCT01285024|3795643|P2|COMPLETED|Overall Study||60
1551429|NCT01285024|3795644|P1|COMPLETED|Overall Study||49
1551430|NCT01285024|3795643|P2|STARTED|Overall Study||60
1551431|NCT01285024|3795644|P1|STARTED|Overall Study||49
1551432|NCT01284959|3795655|P3|NOT COMPLETED|Overall Study||1
1551433|NCT01284959|3795656|P2|NOT COMPLETED|Overall Study||0
1551434|NCT01284959|3795657|P1|NOT COMPLETED|Overall Study||1
1551435|NCT01284959|3795655|P3|COMPLETED|Overall Study||10
1551436|NCT01284959|3795656|P2|COMPLETED|Overall Study||12
1551437|NCT01284959|3795657|P1|COMPLETED|Overall Study||10
1551438|NCT01284959|3795655|P3|STARTED|Overall Study||11
1551439|NCT01284959|3795656|P2|STARTED|Overall Study||12
1551440|NCT01284959|3795657|P1|STARTED|Overall Study||11
1551441|NCT01284634|3795687|P4|NOT COMPLETED|Overall Study||1
1551442|NCT01284634|3795688|P3|NOT COMPLETED|Overall Study||2
1551443|NCT01284634|3795689|P2|NOT COMPLETED|Overall Study||0
1551444|NCT01284634|3795690|P1|NOT COMPLETED|Overall Study||1
1551445|NCT01284634|3795687|P4|COMPLETED|Overall Study||4
1551446|NCT01284634|3795688|P3|COMPLETED|Overall Study||5
1551447|NCT01284634|3795689|P2|COMPLETED|Overall Study||6
1551448|NCT01284634|3795690|P1|COMPLETED|Overall Study||6
1551449|NCT01284634|3795687|P4|Intent to Treat (ITT) Analysis Set|Overall Study||5
1551450|NCT01284634|3795688|P3|Intent to Treat (ITT) Analysis Set|Overall Study||7
1551451|NCT01284634|3795689|P2|Intent to Treat (ITT) Analysis Set|Overall Study||6
1551452|NCT01284634|3795690|P1|Intent to Treat (ITT) Analysis Set|Overall Study||7
1551453|NCT01284634|3795687|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
1551454|NCT01284634|3795688|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
1551455|NCT01284634|3795689|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1551456|NCT01284634|3795690|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
1551457|NCT01284634|3795687|P4|STARTED|Overall Study||5
1551458|NCT01284634|3795688|P3|STARTED|Overall Study||7
1551459|NCT01284634|3795689|P2|STARTED|Overall Study||6
1551460|NCT01284634|3795690|P1|STARTED|Overall Study||7
1551461|NCT01284621|3795720|P6|NOT COMPLETED|Third Intervention (8 Days)||0
1551462|NCT01284621|3795721|P5|NOT COMPLETED|Third Intervention (8 Days)||0
1551463|NCT01284621|3795722|P4|NOT COMPLETED|Third Intervention (8 Days)||0
1551464|NCT01284621|3795723|P3|NOT COMPLETED|Third Intervention (8 Days)||0
1551465|NCT01284621|3795724|P2|NOT COMPLETED|Third Intervention (8 Days)||0
1551466|NCT01284621|3795725|P1|NOT COMPLETED|Third Intervention (8 Days)||0
1551467|NCT01284621|3795720|P6|COMPLETED|Third Intervention (8 Days)||4
1551468|NCT01284621|3795721|P5|COMPLETED|Third Intervention (8 Days)||3
1551469|NCT01284621|3795722|P4|COMPLETED|Third Intervention (8 Days)||4
1551470|NCT01284621|3795723|P3|COMPLETED|Third Intervention (8 Days)||4
1551471|NCT01284621|3795724|P2|COMPLETED|Third Intervention (8 Days)||4
1551472|NCT01284621|3795725|P1|COMPLETED|Third Intervention (8 Days)||3
1551473|NCT01284621|3795720|P6|STARTED|Third Intervention (8 Days)||4
1551474|NCT01284621|3795721|P5|STARTED|Third Intervention (8 Days)||3
1551475|NCT01284621|3795722|P4|STARTED|Third Intervention (8 Days)||4
1551476|NCT01284621|3795723|P3|STARTED|Third Intervention (8 Days)||4
1551477|NCT01284621|3795724|P2|STARTED|Third Intervention (8 Days)||4
1551478|NCT01284621|3795725|P1|STARTED|Third Intervention (8 Days)||3
1551479|NCT01284621|3795720|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1551480|NCT01284621|3795721|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1551481|NCT01284621|3795722|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1551482|NCT01284621|3795723|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1551483|NCT01284621|3795724|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1551484|NCT01284621|3795725|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1551485|NCT01284621|3795720|P6|COMPLETED|Washout Period 2 (7 Days)||4
1551486|NCT01284621|3795721|P5|COMPLETED|Washout Period 2 (7 Days)||3
1551487|NCT01284621|3795722|P4|COMPLETED|Washout Period 2 (7 Days)||4
1551488|NCT01284621|3795723|P3|COMPLETED|Washout Period 2 (7 Days)||4
1551489|NCT01284621|3795724|P2|COMPLETED|Washout Period 2 (7 Days)||4
1551490|NCT01284621|3795725|P1|COMPLETED|Washout Period 2 (7 Days)||3
1551491|NCT01284621|3795720|P6|STARTED|Washout Period 2 (7 Days)||4
1551492|NCT01284621|3795721|P5|STARTED|Washout Period 2 (7 Days)||3
1551493|NCT01284621|3795722|P4|STARTED|Washout Period 2 (7 Days)||4
1551494|NCT01284621|3795723|P3|STARTED|Washout Period 2 (7 Days)||4
1551495|NCT01284621|3795724|P2|STARTED|Washout Period 2 (7 Days)||4
1551496|NCT01284621|3795725|P1|STARTED|Washout Period 2 (7 Days)||3
1551497|NCT01284621|3795720|P6|NOT COMPLETED|Second Intervention (8 Days)||0
1551498|NCT01284621|3795721|P5|NOT COMPLETED|Second Intervention (8 Days)||0
1551499|NCT01284621|3795722|P4|NOT COMPLETED|Second Intervention (8 Days)||0
1551500|NCT01284621|3795723|P3|NOT COMPLETED|Second Intervention (8 Days)||0
1551501|NCT01284621|3795724|P2|NOT COMPLETED|Second Intervention (8 Days)||0
1551502|NCT01284621|3795725|P1|NOT COMPLETED|Second Intervention (8 Days)||0
1551503|NCT01284621|3795720|P6|COMPLETED|Second Intervention (8 Days)||4
1551504|NCT01284621|3795721|P5|COMPLETED|Second Intervention (8 Days)||3
1551505|NCT01284621|3795722|P4|COMPLETED|Second Intervention (8 Days)||4
1551506|NCT01284621|3795723|P3|COMPLETED|Second Intervention (8 Days)||4
1551507|NCT01284621|3795724|P2|COMPLETED|Second Intervention (8 Days)||4
1551508|NCT01284621|3795725|P1|COMPLETED|Second Intervention (8 Days)||3
1551509|NCT01284621|3795720|P6|STARTED|Second Intervention (8 Days)||4
1551510|NCT01284621|3795721|P5|STARTED|Second Intervention (8 Days)||3
1551511|NCT01284621|3795722|P4|STARTED|Second Intervention (8 Days)||4
1551512|NCT01284621|3795723|P3|STARTED|Second Intervention (8 Days)||4
1551513|NCT01284621|3795724|P2|STARTED|Second Intervention (8 Days)||4
1551514|NCT01284621|3795725|P1|STARTED|Second Intervention (8 Days)||3
1551515|NCT01284621|3795720|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1551516|NCT01284621|3795721|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
1551517|NCT01284621|3795722|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1551518|NCT01284621|3795723|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1551519|NCT01284621|3795724|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1551520|NCT01284621|3795725|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1551521|NCT01284621|3795720|P6|COMPLETED|Washout Period 1 (7 Days)||4
1551522|NCT01284621|3795721|P5|COMPLETED|Washout Period 1 (7 Days)||3
1551523|NCT01284621|3795722|P4|COMPLETED|Washout Period 1 (7 Days)||4
1551524|NCT01284621|3795723|P3|COMPLETED|Washout Period 1 (7 Days)||4
1551525|NCT01284621|3795724|P2|COMPLETED|Washout Period 1 (7 Days)||4
1551526|NCT01284621|3795725|P1|COMPLETED|Washout Period 1 (7 Days)||3
1551527|NCT01284621|3795720|P6|STARTED|Washout Period 1 (7 Days)||4
1551528|NCT01284621|3795721|P5|STARTED|Washout Period 1 (7 Days)||4
1551529|NCT01284621|3795722|P4|STARTED|Washout Period 1 (7 Days)||4
1551530|NCT01284621|3795723|P3|STARTED|Washout Period 1 (7 Days)||4
1551531|NCT01284621|3795724|P2|STARTED|Washout Period 1 (7 Days)||4
1551532|NCT01284621|3795725|P1|STARTED|Washout Period 1 (7 Days)||3
1551533|NCT01284621|3795720|P6|NOT COMPLETED|First Intervention (8 Days)||0
1551534|NCT01284621|3795721|P5|NOT COMPLETED|First Intervention (8 Days)||0
1551535|NCT01284621|3795722|P4|NOT COMPLETED|First Intervention (8 Days)||0
1551536|NCT01284621|3795723|P3|NOT COMPLETED|First Intervention (8 Days)||0
1551537|NCT01284621|3795724|P2|NOT COMPLETED|First Intervention (8 Days)||0
1551538|NCT01284621|3795725|P1|NOT COMPLETED|First Intervention (8 Days)||0
1551539|NCT01284621|3795720|P6|COMPLETED|First Intervention (8 Days)||4
1551540|NCT01284621|3795721|P5|COMPLETED|First Intervention (8 Days)||4
1551541|NCT01284621|3795722|P4|COMPLETED|First Intervention (8 Days)||4
1551542|NCT01284621|3795723|P3|COMPLETED|First Intervention (8 Days)||4
1551543|NCT01284621|3795724|P2|COMPLETED|First Intervention (8 Days)||4
1551544|NCT01284621|3795725|P1|COMPLETED|First Intervention (8 Days)||3
1551545|NCT01284621|3795720|P6|STARTED|First Intervention (8 Days)||4
1551546|NCT01284621|3795721|P5|STARTED|First Intervention (8 Days)||4
1551547|NCT01284621|3795722|P4|STARTED|First Intervention (8 Days)||4
1551548|NCT01284621|3795723|P3|STARTED|First Intervention (8 Days)||4
1551549|NCT01284621|3795724|P2|STARTED|First Intervention (8 Days)||4
1551550|NCT01284621|3795725|P1|STARTED|First Intervention (8 Days)||3
1551551|NCT01284517|3795769|P2|NOT COMPLETED|Overall Study||36
1551552|NCT01284517|3795770|P1|NOT COMPLETED|Overall Study||32
1551553|NCT01284517|3795769|P2|COMPLETED|Overall Study||140
1551554|NCT01284517|3795770|P1|COMPLETED|Overall Study||148
1551555|NCT01284517|3795769|P2|STARTED|Overall Study||176
1551556|NCT01284517|3795770|P1|STARTED|Overall Study||180
1551557|NCT01284504|3795782|P2|NOT COMPLETED|Overall Study||0
1551558|NCT01284504|3795783|P1|NOT COMPLETED|Overall Study||0
1551559|NCT01284504|3795782|P2|COMPLETED|Overall Study||0
1551560|NCT01284504|3795783|P1|COMPLETED|Overall Study||0
1551561|NCT01284504|3795782|P2|STARTED|Overall Study||0
1551562|NCT01284504|3795783|P1|STARTED|Overall Study||0
1551563|NCT01284491|3795793|P1|NOT COMPLETED|Overall Study||13
1551564|NCT01284491|3795793|P1|COMPLETED|Overall Study||0
1551565|NCT01284491|3795793|P1|STARTED|Overall Study||13
1551566|NCT01284426|3795799|P1|NOT COMPLETED|Overall Study||2
1551567|NCT01284426|3795799|P1|COMPLETED|Overall Study||92
1551568|NCT01284426|3795799|P1|STARTED|Overall Study||94
1551569|NCT01284361|3795803|P1|NOT COMPLETED|Overall Study||9
1551570|NCT01284361|3795803|P1|COMPLETED|Overall Study||82
1551571|NCT01284361|3795803|P1|STARTED|Overall Study||91
1551572|NCT01284335|3795823|P13|NOT COMPLETED|Overall Study||0
1551573|NCT01284335|3795824|P12|NOT COMPLETED|Overall Study||0
1551574|NCT01284335|3795825|P11|NOT COMPLETED|Overall Study||0
1551575|NCT01284335|3795826|P10|NOT COMPLETED|Overall Study||0
1551576|NCT01284335|3795827|P9|NOT COMPLETED|Overall Study||0
1551577|NCT01284335|3795828|P8|NOT COMPLETED|Overall Study||0
1551578|NCT01284335|3795829|P7|NOT COMPLETED|Overall Study||0
1551579|NCT01284335|3795830|P6|NOT COMPLETED|Overall Study||0
1551580|NCT01284335|3795831|P5|NOT COMPLETED|Overall Study||0
1551581|NCT01284335|3795832|P4|NOT COMPLETED|Overall Study||0
1551582|NCT01284335|3795833|P3|NOT COMPLETED|Overall Study||0
1551583|NCT01284335|3795834|P2|NOT COMPLETED|Overall Study||0
1551584|NCT01284335|3795835|P1|NOT COMPLETED|Overall Study||0
1551585|NCT01284335|3795823|P13|COMPLETED|Overall Study||12
1551586|NCT01284335|3795824|P12|COMPLETED|Overall Study||16
1551587|NCT01284335|3795825|P11|COMPLETED|Overall Study||45
1551588|NCT01284335|3795826|P10|COMPLETED|Overall Study||14
1551589|NCT01284335|3795827|P9|COMPLETED|Overall Study||4
1551590|NCT01284335|3795828|P8|COMPLETED|Overall Study||6
1551591|NCT01284335|3795829|P7|COMPLETED|Overall Study||19
1551592|NCT01284335|3795830|P6|COMPLETED|Overall Study||26
1551593|NCT01284335|3795831|P5|COMPLETED|Overall Study||24
1551594|NCT01284335|3795832|P4|COMPLETED|Overall Study||5
1551595|NCT01284335|3795833|P3|COMPLETED|Overall Study||5
1551596|NCT01284335|3795834|P2|COMPLETED|Overall Study||33
1551597|NCT01284335|3795835|P1|COMPLETED|Overall Study||25
1551598|NCT01284335|3795823|P13|Received at Least One Dose of Study Drug|Overall Study||12
1551599|NCT01284335|3795824|P12|Received at Least One Dose of Study Drug|Overall Study||16
1551600|NCT01284335|3795825|P11|Received at Least One Dose of Study Drug|Overall Study||45
1551601|NCT01284335|3795826|P10|Received at Least One Dose of Study Drug|Overall Study||14
1551602|NCT01284335|3795827|P9|Received at Least One Dose of Study Drug|Overall Study||4
1551603|NCT01284335|3795828|P8|Received at Least One Dose of Study Drug|Overall Study||6
1551604|NCT01284335|3795829|P7|Received at Least One Dose of Study Drug|Overall Study||19
1551605|NCT01284335|3795830|P6|Received at Least One Dose of Study Drug|Overall Study||26
1551606|NCT01284335|3795831|P5|Received at Least One Dose of Study Drug|Overall Study||24
1551607|NCT01284335|3795832|P4|Received at Least One Dose of Study Drug|Overall Study||5
1551608|NCT01284335|3795833|P3|Received at Least One Dose of Study Drug|Overall Study||5
1551609|NCT01284335|3795834|P2|Received at Least One Dose of Study Drug|Overall Study||33
1551610|NCT01284335|3795835|P1|Received at Least One Dose of Study Drug|Overall Study||25
1551611|NCT01284335|3795823|P13|STARTED|Overall Study||12
1551612|NCT01284335|3795824|P12|STARTED|Overall Study||16
1551613|NCT01284335|3795825|P11|STARTED|Overall Study||45
1551614|NCT01284335|3795826|P10|STARTED|Overall Study||14
1551615|NCT01284335|3795827|P9|STARTED|Overall Study||4
1551616|NCT01284335|3795828|P8|STARTED|Overall Study||6
1551617|NCT01284335|3795829|P7|STARTED|Overall Study||19
1551618|NCT01284335|3795830|P6|STARTED|Overall Study||26
1551619|NCT01284335|3795831|P5|STARTED|Overall Study||24
1551620|NCT01284335|3795832|P4|STARTED|Overall Study||5
1551621|NCT01284335|3795833|P3|STARTED|Overall Study||5
1551622|NCT01284335|3795834|P2|STARTED|Overall Study||33
1551623|NCT01284335|3795835|P1|STARTED|Overall Study||25
1551624|NCT01284296|3795883|P1|NOT COMPLETED|Overall Study||0
1551625|NCT01284296|3795883|P1|COMPLETED|Overall Study||20
1551626|NCT01284296|3795883|P1|STARTED|Overall Study||20
1551627|NCT01284244|3795890|P2|NOT COMPLETED|Overall Study||0
1551628|NCT01284244|3795891|P1|NOT COMPLETED|Overall Study||0
1551629|NCT01284244|3795890|P2|COMPLETED|Overall Study||18
1551630|NCT01284244|3795891|P1|COMPLETED|Overall Study||18
1551631|NCT01284244|3795890|P2|STARTED|Overall Study||18
1551632|NCT01284244|3795891|P1|STARTED|Overall Study||18
1551633|NCT01284140|3795899|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
1551634|NCT01284140|3795900|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
1551635|NCT01284140|3795899|P2|COMPLETED|Subjects With Paired 24hr Collections||5
1551636|NCT01284140|3795900|P1|COMPLETED|Subjects With Paired 24hr Collections||6
1551637|NCT01284140|3795899|P2|STARTED|Subjects With Paired 24hr Collections||11
1551638|NCT01284140|3795900|P1|STARTED|Subjects With Paired 24hr Collections||11
1551639|NCT01284140|3795899|P2|NOT COMPLETED|Randomization and Intervention||0
1551640|NCT01284140|3795900|P1|NOT COMPLETED|Randomization and Intervention||0
1551641|NCT01284140|3795899|P2|COMPLETED|Randomization and Intervention||11
1551642|NCT01284140|3795900|P1|COMPLETED|Randomization and Intervention||11
1551643|NCT01284140|3795899|P2|STARTED|Randomization and Intervention||11
1551644|NCT01284140|3795900|P1|STARTED|Randomization and Intervention||11
1551645|NCT01284114|3795914|P1|NOT COMPLETED|Overall Study||4
1551646|NCT01284114|3795914|P1|COMPLETED|Overall Study||19
1551647|NCT01284114|3795914|P1|STARTED|Overall Study||23
1551648|NCT01284062|3795926|P4|NOT COMPLETED|Overall Study||14
1551649|NCT01284062|3795927|P3|NOT COMPLETED|Overall Study||6
1551650|NCT01284062|3795928|P2|NOT COMPLETED|Overall Study||8
1551651|NCT01284062|3795929|P1|NOT COMPLETED|Overall Study||11
1551652|NCT01284062|3795926|P4|COMPLETED|Overall Study||7
1551653|NCT01284062|3795927|P3|COMPLETED|Overall Study||15
1551654|NCT01284062|3795928|P2|COMPLETED|Overall Study||13
1551655|NCT01284062|3795929|P1|COMPLETED|Overall Study||10
1551656|NCT01284062|3795926|P4|STARTED|Overall Study||21
1551657|NCT01284062|3795927|P3|STARTED|Overall Study||21
1551658|NCT01284062|3795928|P2|STARTED|Overall Study||21
1551659|NCT01284062|3795929|P1|STARTED|Overall Study||21
1551660|NCT01283971|3796003|P2|NOT COMPLETED|Overall Study||12
1551661|NCT01283971|3796004|P1|NOT COMPLETED|Overall Study||15
1551662|NCT01283971|3796003|P2|COMPLETED|Overall Study||36
1551663|NCT01283971|3796004|P1|COMPLETED|Overall Study||33
1551664|NCT01283971|3796003|P2|Intent to Treat Population|Overall Study||48
1551665|NCT01283971|3796004|P1|Intent to Treat Population|Overall Study||46
1551666|NCT01283971|3796003|P2|STARTED|Overall Study||48
1551667|NCT01283971|3796004|P1|STARTED|Overall Study||48
1551668|NCT01283581|3796051|P3|NOT COMPLETED|Overall Study||20
1551669|NCT01283581|3796052|P2|NOT COMPLETED|Overall Study||14
1551670|NCT01283581|3796053|P1|NOT COMPLETED|Overall Study||12
1551671|NCT01283581|3796051|P3|COMPLETED|Overall Study||78
1551672|NCT01283581|3796052|P2|COMPLETED|Overall Study||63
1551673|NCT01283581|3796053|P1|COMPLETED|Overall Study||69
1551674|NCT01283581|3796051|P3|STARTED|Overall Study||98
1551675|NCT01283581|3796052|P2|STARTED|Overall Study||77
1551676|NCT01283581|3796053|P1|STARTED|Overall Study||81
1551677|NCT01283555|3796064|P2|NOT COMPLETED|Second Intervention||0
1551678|NCT01283555|3796065|P1|NOT COMPLETED|Second Intervention||0
1551679|NCT01283555|3796064|P2|COMPLETED|Second Intervention||12
1551680|NCT01283555|3796065|P1|COMPLETED|Second Intervention||13
1551681|NCT01283555|3796064|P2|STARTED|Second Intervention||12
1551682|NCT01283555|3796065|P1|STARTED|Second Intervention||13
1551683|NCT01283555|3796064|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
1551684|NCT01283555|3796065|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
1551685|NCT01283555|3796064|P2|COMPLETED|Washout Period of at Least 21 Days||12
1551686|NCT01283555|3796065|P1|COMPLETED|Washout Period of at Least 21 Days||13
1551687|NCT01283555|3796064|P2|STARTED|Washout Period of at Least 21 Days||12
1551688|NCT01283555|3796065|P1|STARTED|Washout Period of at Least 21 Days||13
1551689|NCT01283555|3796064|P2|NOT COMPLETED|First Intervention||0
1551690|NCT01283555|3796065|P1|NOT COMPLETED|First Intervention||0
1551691|NCT01283555|3796064|P2|COMPLETED|First Intervention||12
1551692|NCT01283555|3796065|P1|COMPLETED|First Intervention||13
1551693|NCT01283555|3796064|P2|STARTED|First Intervention||12
1551694|NCT01283555|3796065|P1|STARTED|First Intervention||13
1551695|NCT01283516|3796117|P9|NOT COMPLETED|Overall Study||122
1551696|NCT01283516|3796118|P8|NOT COMPLETED|Overall Study||3
1551697|NCT01283516|3796119|P7|NOT COMPLETED|Overall Study||8
1551698|NCT01283516|3796120|P6|NOT COMPLETED|Overall Study||8
1551699|NCT01283516|3796121|P5|NOT COMPLETED|Overall Study||13
1551700|NCT01283516|3796122|P4|NOT COMPLETED|Overall Study||3
1551701|NCT01283516|3796123|P3|NOT COMPLETED|Overall Study||2
1551702|NCT01283516|3796124|P2|NOT COMPLETED|Overall Study||2
1551703|NCT01283516|3796125|P1|NOT COMPLETED|Overall Study||2
1551704|NCT01283516|3796117|P9|COMPLETED|Overall Study||133
1551705|NCT01283516|3796118|P8|COMPLETED|Overall Study||2
1551706|NCT01283516|3796119|P7|COMPLETED|Overall Study||2
1551707|NCT01283516|3796120|P6|COMPLETED|Overall Study||2
1551708|NCT01283516|3796121|P5|COMPLETED|Overall Study||1
1551709|NCT01283516|3796122|P4|COMPLETED|Overall Study||0
1551710|NCT01283516|3796123|P3|COMPLETED|Overall Study||1
1551711|NCT01283516|3796124|P2|COMPLETED|Overall Study||0
1551712|NCT01283516|3796125|P1|COMPLETED|Overall Study|Completed = Treatment Ongoing|0
1551713|NCT01283516|3796117|P9|Dose-Determining Set (DDS)|Overall Study||8
1551714|NCT01283516|3796118|P8|Dose-Determining Set (DDS)|Overall Study||5
1551715|NCT01283516|3796119|P7|Dose-Determining Set (DDS)|Overall Study||10
1551716|NCT01283516|3796120|P6|Dose-Determining Set (DDS)|Overall Study||8
1551717|NCT01283516|3796121|P5|Dose-Determining Set (DDS)|Overall Study||14
1551718|NCT01283516|3796122|P4|Dose-Determining Set (DDS)|Overall Study||3
1551719|NCT01283516|3796123|P3|Dose-Determining Set (DDS)|Overall Study||3
1551720|NCT01283516|3796124|P2|Dose-Determining Set (DDS)|Overall Study||1
1551721|NCT01283516|3796125|P1|Dose-Determining Set (DDS)|Overall Study||2
1551722|NCT01283516|3796117|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
1551723|NCT01283516|3796118|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
1551724|NCT01283516|3796119|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
1551725|NCT01283516|3796120|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
1551726|NCT01283516|3796121|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
1551727|NCT01283516|3796122|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
1551728|NCT01283516|3796123|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
1551729|NCT01283516|3796124|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
1551730|NCT01283516|3796125|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
1551731|NCT01283516|3796117|P9|STARTED|Overall Study||255
1551732|NCT01283516|3796118|P8|STARTED|Overall Study||5
1551733|NCT01283516|3796119|P7|STARTED|Overall Study||10
1551734|NCT01283516|3796120|P6|STARTED|Overall Study||10
1551735|NCT01283516|3796121|P5|STARTED|Overall Study||14
1551736|NCT01283516|3796122|P4|STARTED|Overall Study||3
1551737|NCT01283516|3796123|P3|STARTED|Overall Study||3
1551738|NCT01283516|3796124|P2|STARTED|Overall Study||2
1551739|NCT01283516|3796125|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
1551740|NCT01283464|3796149|P2|NOT COMPLETED|Overall Study||1
1551741|NCT01283464|3796150|P1|NOT COMPLETED|Overall Study||2
1551742|NCT01283464|3796149|P2|COMPLETED|Overall Study||11
1551743|NCT01283464|3796150|P1|COMPLETED|Overall Study||10
1551744|NCT01283464|3796149|P2|STARTED|Overall Study||12
1551745|NCT01283464|3796150|P1|STARTED|Overall Study||12
1551746|NCT01283334|3796156|P1|NOT COMPLETED|Overall Study||7
1551747|NCT01283334|3796156|P1|COMPLETED|Overall Study||13
1551748|NCT01283334|3796156|P1|STARTED|Overall Study||20
1551749|NCT01283321|3796164|P2|NOT COMPLETED|Overall Study||0
1551750|NCT01283321|3796165|P1|NOT COMPLETED|Overall Study||0
1551751|NCT01283321|3796164|P2|COMPLETED|Overall Study||10
1551752|NCT01283321|3796165|P1|COMPLETED|Overall Study||10
1551753|NCT01283321|3796164|P2|STARTED|Overall Study||10
1551754|NCT01283321|3796165|P1|STARTED|Overall Study||10
1551755|NCT01283282|3796179|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1551756|NCT01283282|3796180|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1551757|NCT01283282|3796179|P2|COMPLETED|Second Intervention (6 Weeks)||19
1551758|NCT01283282|3796180|P1|COMPLETED|Second Intervention (6 Weeks)||22
1551759|NCT01283282|3796179|P2|STARTED|Second Intervention (6 Weeks)||19
1551760|NCT01283282|3796180|P1|STARTED|Second Intervention (6 Weeks)||22
1551761|NCT01283282|3796179|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
1551762|NCT01283282|3796180|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
1551763|NCT01283282|3796179|P2|COMPLETED|First Intervention (6 Weeks)||19
1551764|NCT01283282|3796180|P1|COMPLETED|First Intervention (6 Weeks)||22
1551765|NCT01283282|3796179|P2|STARTED|First Intervention (6 Weeks)||23
1551766|NCT01283282|3796180|P1|STARTED|First Intervention (6 Weeks)||25
1551767|NCT01283152|3796200|P2|NOT COMPLETED|Overall Study||0
1551768|NCT01283152|3796201|P1|NOT COMPLETED|Overall Study||2
1551769|NCT01283152|3796200|P2|COMPLETED|Overall Study||25
1551770|NCT01283152|3796201|P1|COMPLETED|Overall Study||23
1551771|NCT01283152|3796200|P2|24-hr HESA Attempted|Overall Study||25
1551772|NCT01283152|3796201|P1|24-hr HESA Attempted|Overall Study||25
1551773|NCT01283152|3796200|P2|Study Treatment Received|Overall Study||25
1551774|NCT01283152|3796201|P1|Study Treatment Received|Overall Study||25
1551775|NCT01283152|3796200|P2|ITT Population|Overall Study||25
1551776|NCT01283152|3796201|P1|ITT Population|Overall Study||25
1551777|NCT01283152|3796200|P2|STARTED|Overall Study||25
1551778|NCT01283152|3796201|P1|STARTED|Overall Study||25
1551779|NCT01283139|3796215|P4|NOT COMPLETED|Overall Study||15
1551780|NCT01283139|3796216|P3|NOT COMPLETED|Overall Study||18
1551781|NCT01283139|3796217|P2|NOT COMPLETED|Overall Study||18
1551782|NCT01283139|3796218|P1|NOT COMPLETED|Overall Study||17
1551783|NCT01283139|3796215|P4|COMPLETED|Overall Study||92
1551784|NCT01283139|3796216|P3|COMPLETED|Overall Study||91
1551785|NCT01283139|3796217|P2|COMPLETED|Overall Study||90
1551786|NCT01283139|3796218|P1|COMPLETED|Overall Study||91
1551787|NCT01283139|3796215|P4|STARTED|Overall Study||107
1551788|NCT01283139|3796216|P3|STARTED|Overall Study||109
1551789|NCT01283139|3796217|P2|STARTED|Overall Study||108
1551790|NCT01283139|3796218|P1|STARTED|Overall Study||108
1551791|NCT01283035|3796260|P1|NOT COMPLETED|Overall Study||1
1551792|NCT01283035|3796260|P1|COMPLETED|Overall Study||5
1551793|NCT01283035|3796260|P1|STARTED|Overall Study||6
1551794|NCT01283022|3796269|P1|NOT COMPLETED|Overall Study||0
1551795|NCT01283022|3796269|P1|COMPLETED|Overall Study||24
1551796|NCT01283022|3796269|P1|STARTED|Overall Study||24
1551797|NCT01282866|3796275|P1|NOT COMPLETED|Overall Study||1
1551798|NCT01282866|3796275|P1|COMPLETED|Overall Study||34
1551799|NCT01282866|3796275|P1|STARTED|Overall Study||35
1551800|NCT01282814|3796283|P2|NOT COMPLETED|Second Intervention||0
1551801|NCT01282814|3796284|P1|NOT COMPLETED|Second Intervention||0
1551802|NCT01282814|3796283|P2|COMPLETED|Second Intervention||9
1551803|NCT01282814|3796284|P1|COMPLETED|Second Intervention||10
1551804|NCT01282814|3796283|P2|STARTED|Second Intervention||9
1551805|NCT01282814|3796284|P1|STARTED|Second Intervention||10
1551806|NCT01282814|3796283|P2|NOT COMPLETED|Washout of 7 Days||0
1551807|NCT01282814|3796284|P1|NOT COMPLETED|Washout of 7 Days||2
1551808|NCT01282814|3796283|P2|COMPLETED|Washout of 7 Days||9
1551809|NCT01282814|3796284|P1|COMPLETED|Washout of 7 Days||10
1551810|NCT01282814|3796283|P2|STARTED|Washout of 7 Days||9
1551811|NCT01282814|3796284|P1|STARTED|Washout of 7 Days||12
1551812|NCT01282814|3796283|P2|NOT COMPLETED|First Intervention||3
1551813|NCT01282814|3796284|P1|NOT COMPLETED|First Intervention||0
1551814|NCT01282814|3796283|P2|COMPLETED|First Intervention||9
1551815|NCT01282814|3796284|P1|COMPLETED|First Intervention||12
1551816|NCT01282814|3796283|P2|STARTED|First Intervention||12
1551817|NCT01282814|3796284|P1|STARTED|First Intervention||12
1551818|NCT01282801|3796296|P2|NOT COMPLETED|Second Intervention||1
1551819|NCT01282801|3796297|P1|NOT COMPLETED|Second Intervention||0
1551820|NCT01282801|3796296|P2|COMPLETED|Second Intervention||8
1551821|NCT01282801|3796297|P1|COMPLETED|Second Intervention||9
1551822|NCT01282801|3796296|P2|STARTED|Second Intervention||9
1551823|NCT01282801|3796297|P1|STARTED|Second Intervention||9
1551824|NCT01282801|3796296|P2|NOT COMPLETED|Washout of 7 Days||0
1551825|NCT01282801|3796297|P1|NOT COMPLETED|Washout of 7 Days||0
1551826|NCT01282801|3796296|P2|COMPLETED|Washout of 7 Days||9
1551827|NCT01282801|3796297|P1|COMPLETED|Washout of 7 Days||9
1551828|NCT01282801|3796296|P2|STARTED|Washout of 7 Days||9
1551829|NCT01282801|3796297|P1|STARTED|Washout of 7 Days||9
1551830|NCT01282801|3796296|P2|NOT COMPLETED|First Intervention||0
1551831|NCT01282801|3796297|P1|NOT COMPLETED|First Intervention||0
1551832|NCT01282801|3796296|P2|COMPLETED|First Intervention||9
1551833|NCT01282801|3796297|P1|COMPLETED|First Intervention||9
1551834|NCT01282801|3796296|P2|STARTED|First Intervention||9
1551835|NCT01282801|3796297|P1|STARTED|First Intervention||9
1551836|NCT01282723|3796313|P1|NOT COMPLETED|Overall Study||0
1551837|NCT01282723|3796313|P1|COMPLETED|Overall Study||20
1551838|NCT01282723|3796313|P1|STARTED|Overall Study||20
1551839|NCT01282710|3796317|P1|NOT COMPLETED|Overall Study||0
1551840|NCT01282710|3796317|P1|COMPLETED|Overall Study||20
1551841|NCT01282710|3796317|P1|STARTED|Overall Study||20
1551842|NCT01282476|3796321|P1|NOT COMPLETED|Overall Study||11
1551843|NCT01282476|3796321|P1|COMPLETED|Overall Study||7
1551844|NCT01282476|3796321|P1|STARTED|Overall Study||18
1551845|NCT01282424|3796327|P1|NOT COMPLETED|Overall Study||76
1551846|NCT01282424|3796327|P1|COMPLETED|Overall Study||49
1551847|NCT01282424|3796327|P1|Completed: Death|Overall Study||8
1551848|NCT01282424|3796327|P1|Completed: Disease Progression|Overall Study||41
1551849|NCT01282424|3796327|P1|STARTED|Overall Study||125
1551850|NCT01282372|3796344|P1|NOT COMPLETED|Overall Study||79
1551851|NCT01282372|3796344|P1|COMPLETED|Overall Study||421
1551852|NCT01282372|3796344|P1|STARTED|Overall Study||500
1551853|NCT01282294|3796372|P1|NOT COMPLETED|Overall Study||19
1551854|NCT01282294|3796372|P1|COMPLETED|Overall Study||81
1551855|NCT01282294|3796372|P1|12 Months|Overall Study||86
1551856|NCT01282294|3796372|P1|6 Months|Overall Study||94
1551857|NCT01282294|3796372|P1|3 Months|Overall Study||95
1551858|NCT01282294|3796372|P1|6 Weeks|Overall Study||95
1551859|NCT01282294|3796372|P1|Post-operative|Overall Study||99
1551860|NCT01282294|3796372|P1|Intra-operative|Overall Study||99
1551861|NCT01282294|3796372|P1|STARTED|Overall Study||100
1551862|NCT01282242|3796392|P2|NOT COMPLETED|Overall Study||0
1551863|NCT01282242|3796393|P1|NOT COMPLETED|Overall Study||0
1551864|NCT01282242|3796392|P2|COMPLETED|Overall Study||8
1551865|NCT01282242|3796393|P1|COMPLETED|Overall Study||80
1551866|NCT01282242|3796392|P2|STARTED|Overall Study||8
1551867|NCT01282242|3796393|P1|STARTED|Overall Study||80
1551868|NCT01282229|3796401|P1|NOT COMPLETED|Overall Study||2
1551869|NCT01282229|3796401|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
1551870|NCT01282229|3796401|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
1551871|NCT01282203|3796431|P1|NOT COMPLETED|Overall Study||1
1551872|NCT01282203|3796431|P1|COMPLETED|Overall Study||1121
1551873|NCT01282203|3796431|P1|STARTED|Overall Study||1122
1551874|NCT01282164|3796453|P2|NOT COMPLETED|Overall Study||0
1551875|NCT01282164|3796454|P1|NOT COMPLETED|Overall Study||1
1551876|NCT01282164|3796453|P2|COMPLETED|Overall Study||14
1551877|NCT01282164|3796454|P1|COMPLETED|Overall Study||28
1551878|NCT01282164|3796453|P2|STARTED|Overall Study||14
1551879|NCT01282164|3796454|P1|STARTED|Overall Study||29
1551880|NCT01282138|3796479|P2|NOT COMPLETED|CAPT||0
1551881|NCT01282138|3796480|P1|NOT COMPLETED|CAPT||0
1551882|NCT01282138|3796479|P2|COMPLETED|CAPT||7
1551883|NCT01282138|3796480|P1|COMPLETED|CAPT||6
1551884|NCT01282138|3796479|P2|STARTED|CAPT||7
1551885|NCT01282138|3796480|P1|STARTED|CAPT||6
1551886|NCT01282138|3796479|P2|NOT COMPLETED|EEC||0
1551887|NCT01282138|3796480|P1|NOT COMPLETED|EEC||0
1551888|NCT01282138|3796479|P2|COMPLETED|EEC||7
1551889|NCT01282138|3796480|P1|COMPLETED|EEC||6
1551890|NCT01282138|3796479|P2|STARTED|EEC||7
1551891|NCT01282138|3796480|P1|STARTED|EEC||6
1551892|NCT01282086|3796488|P1|NOT COMPLETED|Overall Study||0
1551893|NCT01282086|3796488|P1|COMPLETED|Overall Study||1365
1551894|NCT01282086|3796488|P1|STARTED|Overall Study||1365
1551895|NCT01281956|3796505|P2|NOT COMPLETED|2nd Intervention (3 Months)||0
1551896|NCT01281956|3796506|P1|NOT COMPLETED|2nd Intervention (3 Months)||1
1551897|NCT01281956|3796505|P2|COMPLETED|2nd Intervention (3 Months)||5
1551898|NCT01281956|3796506|P1|COMPLETED|2nd Intervention (3 Months)||4
1551899|NCT01281956|3796505|P2|STARTED|2nd Intervention (3 Months)||5
1551900|NCT01281956|3796506|P1|STARTED|2nd Intervention (3 Months)||5
1551901|NCT01281956|3796505|P2|NOT COMPLETED|1st Intervention (3 Months)||0
1551902|NCT01281956|3796506|P1|NOT COMPLETED|1st Intervention (3 Months)||0
1551903|NCT01281956|3796505|P2|COMPLETED|1st Intervention (3 Months)||5
1551904|NCT01281956|3796506|P1|COMPLETED|1st Intervention (3 Months)||5
1551905|NCT01281956|3796505|P2|STARTED|1st Intervention (3 Months)||5
1551906|NCT01281956|3796506|P1|STARTED|1st Intervention (3 Months)||5
1551907|NCT01281917|3796537|P1|NOT COMPLETED|Overall Study||1
1551908|NCT01281917|3796537|P1|COMPLETED|Overall Study||39
1551909|NCT01281917|3796537|P1|STARTED|Overall Study||40
1551910|NCT01281865|3796549|P2|NOT COMPLETED|Overall Study||1
1551911|NCT01281865|3796550|P1|NOT COMPLETED|Overall Study||3
1551912|NCT01281865|3796549|P2|COMPLETED|Overall Study||1
1551913|NCT01281865|3796550|P1|COMPLETED|Overall Study||9
1551914|NCT01281865|3796549|P2|STARTED|Overall Study||2
1551915|NCT01281865|3796550|P1|STARTED|Overall Study||12
1551916|NCT01281839|3796558|P2|NOT COMPLETED|Overall Study||14
1551917|NCT01281839|3796559|P1|NOT COMPLETED|Overall Study||10
1551918|NCT01281839|3796558|P2|COMPLETED|Overall Study||119
1551919|NCT01281839|3796559|P1|COMPLETED|Overall Study||250
1551920|NCT01281839|3796558|P2|STARTED|Overall Study||133
1551921|NCT01281839|3796559|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
1551922|NCT01281644|3796620|P1|NOT COMPLETED|Overall Study||5
1551923|NCT01281644|3796620|P1|COMPLETED|Overall Study||18
1551924|NCT01281644|3796620|P1|STARTED|Overall Study||23
1551925|NCT01281501|3796630|P2|NOT COMPLETED|Overall Study||0
1551926|NCT01281501|3796631|P1|NOT COMPLETED|Overall Study||0
1551927|NCT01281501|3796630|P2|COMPLETED|Overall Study||43
1551928|NCT01281501|3796631|P1|COMPLETED|Overall Study||44
1551929|NCT01281501|3796630|P2|STARTED|Overall Study||43
1551930|NCT01281501|3796631|P1|STARTED|Overall Study||44
1551931|NCT01281475|3796645|P2|NOT COMPLETED|Overall Study||8
1551932|NCT01281475|3796646|P1|NOT COMPLETED|Overall Study||4
1551933|NCT01281475|3796645|P2|COMPLETED|Overall Study||26
1551934|NCT01281475|3796646|P1|COMPLETED|Overall Study||29
1551935|NCT01281475|3796645|P2|STARTED|Overall Study||34
1551936|NCT01281475|3796646|P1|STARTED|Overall Study||33
1551937|NCT01281306|3796661|P7|NOT COMPLETED|Overall Study||7
1551938|NCT01281306|3796662|P6|NOT COMPLETED|Overall Study||7
1551939|NCT01281306|3796663|P5|NOT COMPLETED|Overall Study||9
1551940|NCT01281306|3796664|P4|NOT COMPLETED|Overall Study||11
1551941|NCT01281306|3796665|P3|NOT COMPLETED|Overall Study||8
1551942|NCT01281306|3796666|P2|NOT COMPLETED|Overall Study||4
1551943|NCT01281306|3796667|P1|NOT COMPLETED|Overall Study||8
1551944|NCT01281306|3796661|P7|COMPLETED|Overall Study||51
1551945|NCT01281306|3796662|P6|COMPLETED|Overall Study||135
1551946|NCT01281306|3796663|P5|COMPLETED|Overall Study||134
1551947|NCT01281306|3796664|P4|COMPLETED|Overall Study||123
1551948|NCT01281306|3796665|P3|COMPLETED|Overall Study||133
1551949|NCT01281306|3796666|P2|COMPLETED|Overall Study||141
1551950|NCT01281306|3796667|P1|COMPLETED|Overall Study||136
1551951|NCT01281306|3796661|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
1551952|NCT01281306|3796662|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
1551953|NCT01281306|3796663|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
1551954|NCT01281306|3796664|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
1551955|NCT01281306|3796665|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
1551956|NCT01281306|3796666|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
1551957|NCT01281306|3796667|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
1551958|NCT01281306|3796661|P7|Safety Set|Overall Study||58
1551959|NCT01281306|3796662|P6|Safety Set|Overall Study||142
1551960|NCT01281306|3796663|P5|Safety Set|Overall Study||143
1551961|NCT01281306|3796664|P4|Safety Set|Overall Study||133
1551962|NCT01281306|3796665|P3|Safety Set|Overall Study||141
1551963|NCT01281306|3796666|P2|Safety Set|Overall Study||145
1551964|NCT01281306|3796667|P1|Safety Set|Overall Study||143
1551965|NCT01281306|3796661|P7|Full Analysis Set|Overall Study||58
1551966|NCT01281306|3796662|P6|Full Analysis Set|Overall Study||142
1551967|NCT01281306|3796663|P5|Full Analysis Set|Overall Study||143
1551968|NCT01281306|3796664|P4|Full Analysis Set|Overall Study||133
1551969|NCT01281306|3796665|P3|Full Analysis Set|Overall Study||141
1551970|NCT01281306|3796666|P2|Full Analysis Set|Overall Study||145
1551971|NCT01281306|3796667|P1|Full Analysis Set|Overall Study||143
1551972|NCT01281306|3796661|P7|STARTED|Overall Study||58
1551973|NCT01281306|3796662|P6|STARTED|Overall Study||142
1551974|NCT01281306|3796663|P5|STARTED|Overall Study||143
1551975|NCT01281306|3796664|P4|STARTED|Overall Study||134
1551976|NCT01281306|3796665|P3|STARTED|Overall Study||141
1551977|NCT01281306|3796666|P2|STARTED|Overall Study||145
1551978|NCT01281306|3796667|P1|STARTED|Overall Study||144
1551979|NCT01281202|3796783|P2|NOT COMPLETED|Overall Study||36
1551980|NCT01281202|3796784|P1|NOT COMPLETED|Overall Study||28
1551981|NCT01281202|3796783|P2|COMPLETED|Overall Study||68
1551982|NCT01281202|3796784|P1|COMPLETED|Overall Study||75
1551983|NCT01281202|3796783|P2|STARTED|Overall Study||104
1551984|NCT01281202|3796784|P1|STARTED|Overall Study||103
1551985|NCT01281124|3796792|P1|NOT COMPLETED|Overall Study||1
1551986|NCT01281124|3796792|P1|COMPLETED|Overall Study||0
1551987|NCT01281124|3796792|P1|STARTED|Overall Study||1
1551988|NCT01281007|3796800|P2|NOT COMPLETED|Overall Study||8
1551989|NCT01281007|3796801|P1|NOT COMPLETED|Overall Study||4
1551990|NCT01281007|3796800|P2|COMPLETED|Overall Study||67
1551991|NCT01281007|3796801|P1|COMPLETED|Overall Study||71
1551992|NCT01281007|3796800|P2|STARTED|Overall Study||75
1551993|NCT01281007|3796801|P1|STARTED|Overall Study||75
1551994|NCT01280981|3796807|P1|NOT COMPLETED|Overall Study||92
1551995|NCT01280981|3796807|P1|COMPLETED|Overall Study||196
1551996|NCT01280981|3796807|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
1551997|NCT01280981|3796807|P1|STARTED|Overall Study||288
1551998|NCT01280968|3796818|P2|NOT COMPLETED|Overall Study||3
1551999|NCT01280968|3796819|P1|NOT COMPLETED|Overall Study||18
1552000|NCT01280968|3796818|P2|COMPLETED|Overall Study||4
1552001|NCT01280968|3796819|P1|COMPLETED|Overall Study||27
1552002|NCT01280968|3796818|P2|STARTED|Overall Study||7
1552003|NCT01280968|3796819|P1|STARTED|Overall Study||45
1552004|NCT01280955|3796835|P1|NOT COMPLETED|Overall Study||3
1552005|NCT01280955|3796835|P1|COMPLETED|Overall Study||27
1552006|NCT01280955|3796835|P1|STARTED|Overall Study||30
1552007|NCT01280942|3796868|P2|NOT COMPLETED|Overall Study||0
1552008|NCT01280942|3796869|P1|NOT COMPLETED|Overall Study||0
1552009|NCT01280942|3796868|P2|COMPLETED|Overall Study||9911
1552010|NCT01280942|3796869|P1|COMPLETED|Overall Study||10120
1552011|NCT01280942|3796868|P2|STARTED|Overall Study||9911
1552012|NCT01280942|3796869|P1|STARTED|Overall Study||10120
1552013|NCT01280903|3796879|P2|NOT COMPLETED|Overall Study||16
1552014|NCT01280903|3796880|P1|NOT COMPLETED|Overall Study||23
1552015|NCT01280903|3796879|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
1552016|NCT01280903|3796880|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
1552017|NCT01280903|3796879|P2|STARTED|Overall Study||91
1552018|NCT01280903|3796880|P1|STARTED|Overall Study||91
1552019|NCT01280695|3796949|P5|NOT COMPLETED|Overall Study||2
1552020|NCT01280695|3796950|P4|NOT COMPLETED|Overall Study||4
1552021|NCT01280695|3796951|P3|NOT COMPLETED|Overall Study||5
1552022|NCT01280695|3796952|P2|NOT COMPLETED|Overall Study||1
1552023|NCT01280695|3796953|P1|NOT COMPLETED|Overall Study||0
1552024|NCT01280695|3796949|P5|COMPLETED|Overall Study||24
1552025|NCT01280695|3796950|P4|COMPLETED|Overall Study||22
1552026|NCT01280695|3796951|P3|COMPLETED|Overall Study||21
1552027|NCT01280695|3796952|P2|COMPLETED|Overall Study||24
1552028|NCT01280695|3796953|P1|COMPLETED|Overall Study||26
1552029|NCT01280695|3796949|P5|STARTED|Overall Study||26
1552030|NCT01280695|3796950|P4|STARTED|Overall Study||26
1552031|NCT01280695|3796951|P3|STARTED|Overall Study||26
1552032|NCT01280695|3796952|P2|STARTED|Overall Study||25
1552033|NCT01280695|3796953|P1|STARTED|Overall Study||26
1552034|NCT01280656|3796993|P3|NOT COMPLETED|Overall Study||63
1552035|NCT01280656|3796994|P2|NOT COMPLETED|Overall Study||47
1552036|NCT01280656|3796995|P1|NOT COMPLETED|Overall Study||3
1552037|NCT01280656|3796993|P3|COMPLETED|Overall Study||223
1552038|NCT01280656|3796994|P2|COMPLETED|Overall Study||265
1552039|NCT01280656|3796995|P1|COMPLETED|Overall Study||59
1552040|NCT01280656|3796993|P3|STARTED|Overall Study||286
1552041|NCT01280656|3796994|P2|STARTED|Overall Study||312
1552042|NCT01280656|3796995|P1|STARTED|Overall Study||62
1552043|NCT01280604|3797041|P2|NOT COMPLETED|Overall Study||5
1552044|NCT01280604|3797042|P1|NOT COMPLETED|Overall Study||9
1552045|NCT01280604|3797041|P2|COMPLETED|Overall Study||28
1552046|NCT01280604|3797042|P1|COMPLETED|Overall Study||24
1552047|NCT01280604|3797041|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
1552048|NCT01280604|3797042|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
1552049|NCT01280604|3797041|P2|STARTED|Overall Study||33
1552050|NCT01280604|3797042|P1|STARTED|Overall Study||33
1552051|NCT01280591|3797062|P4|NOT COMPLETED|Overall Study||3
1552052|NCT01280591|3797063|P3|NOT COMPLETED|Overall Study||0
1552053|NCT01280591|3797064|P2|NOT COMPLETED|Overall Study||0
1552054|NCT01280591|3797065|P1|NOT COMPLETED|Overall Study||0
1552055|NCT01280591|3797062|P4|COMPLETED|Overall Study||99
1552056|NCT01280591|3797063|P3|COMPLETED|Overall Study||203
1552057|NCT01280591|3797064|P2|COMPLETED|Overall Study||204
1552058|NCT01280591|3797065|P1|COMPLETED|Overall Study||203
1552059|NCT01280591|3797062|P4|STARTED|Overall Study||102
1552060|NCT01280591|3797063|P3|STARTED|Overall Study||203
1552061|NCT01280591|3797064|P2|STARTED|Overall Study||204
1552062|NCT01280591|3797065|P1|STARTED|Overall Study||203
1552063|NCT01280552|3797157|P2|NOT COMPLETED|Overall Study||1
1552064|NCT01280552|3797158|P1|NOT COMPLETED|Overall Study||6
1552065|NCT01280552|3797157|P2|COMPLETED|Overall Study||42
1552159|NCT01279265|3797339|P1|COMPLETED|Overall Study||9
1552066|NCT01280552|3797158|P1|COMPLETED|Overall Study|Survival is still being assessed|75
1552067|NCT01280552|3797157|P2|STARTED|Overall Study||43
1552068|NCT01280552|3797158|P1|STARTED|Overall Study||81
1552069|NCT01280409|3797172|P2|NOT COMPLETED|Overall Study||19
1552070|NCT01280409|3797173|P1|NOT COMPLETED|Overall Study||16
1552071|NCT01280409|3797172|P2|COMPLETED|Overall Study||36
1552072|NCT01280409|3797173|P1|COMPLETED|Overall Study||43
1552073|NCT01280409|3797172|P2|STARTED|Overall Study||55
1552074|NCT01280409|3797173|P1|STARTED|Overall Study||59
1552075|NCT01280357|3797203|P1|NOT COMPLETED|Overall Study||26
1552076|NCT01280357|3797203|P1|COMPLETED|Overall Study||34
1552077|NCT01280357|3797203|P1|STARTED|Overall Study||60
1552078|NCT01280266|3797212|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
1552079|NCT01280266|3797213|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
1552080|NCT01280266|3797212|P2|COMPLETED|Second Intervention (Week 5-9)||12
1552081|NCT01280266|3797213|P1|COMPLETED|Second Intervention (Week 5-9)||14
1552082|NCT01280266|3797212|P2|STARTED|Second Intervention (Week 5-9)||12
1552083|NCT01280266|3797213|P1|STARTED|Second Intervention (Week 5-9)||14
1552084|NCT01280266|3797212|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
1552085|NCT01280266|3797213|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
1552086|NCT01280266|3797212|P2|COMPLETED|Washout Period (Week 4-5)||12
1552087|NCT01280266|3797213|P1|COMPLETED|Washout Period (Week 4-5)||14
1552088|NCT01280266|3797212|P2|STARTED|Washout Period (Week 4-5)||12
1552089|NCT01280266|3797213|P1|STARTED|Washout Period (Week 4-5)||14
1552090|NCT01280266|3797212|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
1552091|NCT01280266|3797213|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
1552092|NCT01280266|3797212|P2|COMPLETED|First Intervention (Week 1-4)||12
1552093|NCT01280266|3797213|P1|COMPLETED|First Intervention (Week 1-4)||14
1552094|NCT01280266|3797212|P2|STARTED|First Intervention (Week 1-4)||14
1552095|NCT01280266|3797213|P1|STARTED|First Intervention (Week 1-4)||15
1552096|NCT01280123|3797238|P3|NOT COMPLETED|Overall Study||1
1552097|NCT01280123|3797239|P2|NOT COMPLETED|Overall Study||4
1552098|NCT01280123|3797240|P1|NOT COMPLETED|Overall Study||1
1552099|NCT01280123|3797238|P3|COMPLETED|Overall Study||70
1552100|NCT01280123|3797239|P2|COMPLETED|Overall Study||63
1552101|NCT01280123|3797240|P1|COMPLETED|Overall Study||71
1552102|NCT01280123|3797238|P3|STARTED|Overall Study||71
1552103|NCT01280123|3797239|P2|STARTED|Overall Study||67
1552104|NCT01280123|3797240|P1|STARTED|Overall Study||72
1552105|NCT01280110|3797265|P2|NOT COMPLETED|Overall Study||0
1552106|NCT01280110|3797266|P1|NOT COMPLETED|Overall Study||0
1552107|NCT01280110|3797265|P2|COMPLETED|Overall Study||22
1552108|NCT01280110|3797266|P1|COMPLETED|Overall Study||22
1552109|NCT01280110|3797265|P2|STARTED|Overall Study||22
1552110|NCT01280110|3797266|P1|STARTED|Overall Study||22
1552111|NCT01280058|3797276|P2|NOT COMPLETED|Overall Study||0
1552112|NCT01280058|3797277|P1|NOT COMPLETED|Overall Study||0
1552113|NCT01280058|3797276|P2|COMPLETED|Overall Study||37
1552114|NCT01280058|3797277|P1|COMPLETED|Overall Study||36
1552115|NCT01280058|3797276|P2|STARTED|Overall Study||37
1552116|NCT01280058|3797277|P1|STARTED|Overall Study||36
1552117|NCT01279681|3797295|P2|NOT COMPLETED|Overall Study||17
1552118|NCT01279681|3797296|P1|NOT COMPLETED|Overall Study||15
1552119|NCT01279681|3797295|P2|COMPLETED|Overall Study||0
1552120|NCT01279681|3797296|P1|COMPLETED|Overall Study||0
1552121|NCT01279681|3797295|P2|STARTED|Overall Study||17
1552122|NCT01279681|3797296|P1|STARTED|Overall Study||15
1552123|NCT01279564|3797310|P2|NOT COMPLETED|Overall Study||0
1552124|NCT01279564|3797311|P1|NOT COMPLETED|Overall Study||0
1552125|NCT01279564|3797310|P2|COMPLETED|Overall Study||32
1552126|NCT01279564|3797311|P1|COMPLETED|Overall Study||40
1552127|NCT01279564|3797310|P2|STARTED|Overall Study||32
1552128|NCT01279564|3797311|P1|STARTED|Overall Study||40
1552129|NCT01279486|3797317|P1|NOT COMPLETED|Overall Study||1
1552130|NCT01279486|3797317|P1|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
1552131|NCT01279486|3797317|P1|STARTED|Overall Study||120
1552132|NCT01279447|3797323|P2|NOT COMPLETED|Overall Study||1
1552133|NCT01279447|3797324|P1|NOT COMPLETED|Overall Study||3
1552134|NCT01279447|3797323|P2|COMPLETED|Overall Study||33
1552135|NCT01279447|3797324|P1|COMPLETED|Overall Study||31
1552136|NCT01279447|3797323|P2|STARTED|Overall Study||34
1552137|NCT01279447|3797324|P1|STARTED|Overall Study||34
1552138|NCT01279317|3797330|P2|NOT COMPLETED|Period 2||0
1552139|NCT01279317|3797331|P1|NOT COMPLETED|Period 2||0
1552140|NCT01279317|3797330|P2|COMPLETED|Period 2||6
1552141|NCT01279317|3797331|P1|COMPLETED|Period 2||6
1552142|NCT01279317|3797330|P2|STARTED|Period 2||6
1552143|NCT01279317|3797331|P1|STARTED|Period 2||6
1552144|NCT01279317|3797330|P2|NOT COMPLETED|Washout||0
1552145|NCT01279317|3797331|P1|NOT COMPLETED|Washout||0
1552146|NCT01279317|3797330|P2|COMPLETED|Washout||6
1552147|NCT01279317|3797331|P1|COMPLETED|Washout||6
1552148|NCT01279317|3797330|P2|STARTED|Washout||6
1552149|NCT01279317|3797331|P1|STARTED|Washout||6
1552150|NCT01279317|3797330|P2|NOT COMPLETED|Period 1||0
1552151|NCT01279317|3797331|P1|NOT COMPLETED|Period 1||0
1552152|NCT01279317|3797330|P2|COMPLETED|Period 1||6
1552153|NCT01279317|3797331|P1|COMPLETED|Period 1||6
1552154|NCT01279317|3797330|P2|STARTED|Period 1||6
1552155|NCT01279317|3797331|P1|STARTED|Period 1||6
1552156|NCT01279265|3797338|P2|NOT COMPLETED|Overall Study||6
1552157|NCT01279265|3797339|P1|NOT COMPLETED|Overall Study||4
1552158|NCT01279265|3797338|P2|COMPLETED|Overall Study||11
1552160|NCT01279265|3797338|P2|STARTED|Overall Study||17
1552161|NCT01279265|3797339|P1|STARTED|Overall Study||13
1552162|NCT01279200|3797351|P2|NOT COMPLETED|Overall Study||7
1552163|NCT01279200|3797352|P1|NOT COMPLETED|Overall Study||2
1552164|NCT01279200|3797351|P2|COMPLETED|Overall Study||4
1552165|NCT01279200|3797352|P1|COMPLETED|Overall Study||8
1552166|NCT01279200|3797351|P2|STARTED|Overall Study||11
1552167|NCT01279200|3797352|P1|STARTED|Overall Study||10
1552168|NCT01279187|3797362|P2|NOT COMPLETED|Overall Study||0
1552169|NCT01279187|3797363|P1|NOT COMPLETED|Overall Study||0
1552170|NCT01279187|3797362|P2|COMPLETED|Overall Study||13
1552171|NCT01279187|3797363|P1|COMPLETED|Overall Study||14
1552172|NCT01279187|3797362|P2|STARTED|Overall Study||13
1552173|NCT01279187|3797363|P1|STARTED|Overall Study||14
1552174|NCT01279109|3797379|P2|NOT COMPLETED|Overall Study||12
1552175|NCT01279109|3797380|P1|NOT COMPLETED|Overall Study||13
1552176|NCT01279109|3797379|P2|COMPLETED|Overall Study||55
1552177|NCT01279109|3797380|P1|COMPLETED|Overall Study||55
1552178|NCT01279109|3797379|P2|STARTED|Overall Study||67
1552179|NCT01279109|3797380|P1|STARTED|Overall Study||68
1552180|NCT01279070|3797390|P2|NOT COMPLETED|Overall Study||4
1552181|NCT01279070|3797391|P1|NOT COMPLETED|Overall Study||5
1552182|NCT01279070|3797390|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
1552183|NCT01279070|3797391|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
1552184|NCT01279070|3797390|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
1552185|NCT01279070|3797391|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
1552186|NCT01279044|3797410|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
1552187|NCT01279044|3797411|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
1552188|NCT01279044|3797412|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
1552189|NCT01279044|3797410|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
1552190|NCT01279044|3797411|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
1552191|NCT01279044|3797412|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
1552192|NCT01279044|3797410|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
1552193|NCT01279044|3797411|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
1552194|NCT01279044|3797412|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
1552195|NCT01279044|3797410|P3|NOT COMPLETED|PHASE 1 - Formative||0
1552196|NCT01279044|3797411|P2|NOT COMPLETED|PHASE 1 - Formative||0
1552197|NCT01279044|3797412|P1|NOT COMPLETED|PHASE 1 - Formative||0
1552198|NCT01279044|3797410|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1552199|NCT01279044|3797411|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1552200|NCT01279044|3797412|P1|COMPLETED|PHASE 1 - Formative||59
1552201|NCT01279044|3797410|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1552202|NCT01279044|3797411|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1552203|NCT01279044|3797412|P1|STARTED|PHASE 1 - Formative||59
1552204|NCT01278953|3797432|P2|NOT COMPLETED|Overall Study||11
1552205|NCT01278953|3797433|P1|NOT COMPLETED|Overall Study||9
1552206|NCT01278953|3797432|P2|COMPLETED|Overall Study||134
1552207|NCT01278953|3797433|P1|COMPLETED|Overall Study||146
1552208|NCT01278953|3797432|P2|STARTED|Overall Study||145
1552209|NCT01278953|3797433|P1|STARTED|Overall Study||155
1552210|NCT01278927|3797445|P4|NOT COMPLETED|Overall Study||0
1552211|NCT01278927|3797446|P3|NOT COMPLETED|Overall Study||0
1552212|NCT01278927|3797447|P2|NOT COMPLETED|Overall Study||0
1552213|NCT01278927|3797448|P1|NOT COMPLETED|Overall Study||0
1552214|NCT01278927|3797445|P4|COMPLETED|Overall Study||175
1552215|NCT01278927|3797446|P3|COMPLETED|Overall Study||178
1552216|NCT01278927|3797447|P2|COMPLETED|Overall Study||178
1552217|NCT01278927|3797448|P1|COMPLETED|Overall Study||180
1552218|NCT01278927|3797445|P4|STARTED|Overall Study||175
1552219|NCT01278927|3797446|P3|STARTED|Overall Study||178
1552220|NCT01278927|3797447|P2|STARTED|Overall Study||178
1552221|NCT01278927|3797448|P1|STARTED|Overall Study||180
1552222|NCT01278862|3797488|P2|NOT COMPLETED|Overall Study||1
1552223|NCT01278862|3797489|P1|NOT COMPLETED|Overall Study||1
1552224|NCT01278862|3797488|P2|COMPLETED|Overall Study||42
1552225|NCT01278862|3797489|P1|COMPLETED|Overall Study||44
1552226|NCT01278862|3797488|P2|STARTED|Overall Study||43
1552227|NCT01278862|3797489|P1|STARTED|Overall Study||45
1552228|NCT01278797|3797497|P2|NOT COMPLETED|Period 2||0
1552229|NCT01278797|3797498|P1|NOT COMPLETED|Period 2||0
1552230|NCT01278797|3797497|P2|COMPLETED|Period 2||13
1552231|NCT01278797|3797498|P1|COMPLETED|Period 2||13
1552232|NCT01278797|3797497|P2|STARTED|Period 2||13
1552233|NCT01278797|3797498|P1|STARTED|Period 2||13
1552234|NCT01278797|3797497|P2|NOT COMPLETED|Washout Period of 21 Days||0
1552235|NCT01278797|3797498|P1|NOT COMPLETED|Washout Period of 21 Days||0
1552236|NCT01278797|3797497|P2|COMPLETED|Washout Period of 21 Days||13
1552237|NCT01278797|3797498|P1|COMPLETED|Washout Period of 21 Days||13
1552238|NCT01278797|3797497|P2|STARTED|Washout Period of 21 Days||13
1552239|NCT01278797|3797498|P1|STARTED|Washout Period of 21 Days||13
1552240|NCT01278797|3797497|P2|NOT COMPLETED|Period 1||1
1552241|NCT01278797|3797498|P1|NOT COMPLETED|Period 1||1
1552242|NCT01278797|3797497|P2|COMPLETED|Period 1||13
1552243|NCT01278797|3797498|P1|COMPLETED|Period 1||13
1552244|NCT01278797|3797497|P2|STARTED|Period 1||14
1552245|NCT01278797|3797498|P1|STARTED|Period 1||14
1552246|NCT01278745|3797510|P4|NOT COMPLETED|Overall Study||78
1552247|NCT01278745|3797511|P3|NOT COMPLETED|Overall Study||121
1552248|NCT01278745|3797512|P2|NOT COMPLETED|Overall Study||6
1552249|NCT01278745|3797513|P1|NOT COMPLETED|Overall Study||5
1552250|NCT01278745|3797510|P4|COMPLETED|Overall Study||0
1552251|NCT01278745|3797511|P3|COMPLETED|Overall Study||0
1552252|NCT01278745|3797512|P2|COMPLETED|Overall Study||68
1552253|NCT01278745|3797513|P1|COMPLETED|Overall Study||84
1552254|NCT01278745|3797510|P4|STARTED|Overall Study||78
1552255|NCT01278745|3797511|P3|STARTED|Overall Study||121
1552256|NCT01278745|3797512|P2|STARTED|Overall Study||74
1552257|NCT01278745|3797513|P1|STARTED|Overall Study||89
1552258|NCT01278615|3797545|P1|NOT COMPLETED|Overall Study||2
1552259|NCT01278615|3797545|P1|COMPLETED|Overall Study||14
1552260|NCT01278615|3797545|P1|STARTED|Overall Study||16
1552261|NCT01278485|3797555|P1|NOT COMPLETED|Overall Study||0
1552262|NCT01278485|3797555|P1|COMPLETED|Overall Study||719
1552263|NCT01278485|3797555|P1|STARTED|Overall Study||719
1552264|NCT01278407|3797571|P5|NOT COMPLETED|Extension Phase||30
1552265|NCT01278407|3797572|P4|NOT COMPLETED|Extension Phase||12
1552266|NCT01278407|3797573|P3|NOT COMPLETED|Extension Phase||0
1552267|NCT01278407|3797574|P2|NOT COMPLETED|Extension Phase||0
1552268|NCT01278407|3797575|P1|NOT COMPLETED|Extension Phase||0
1552269|NCT01278407|3797571|P5|COMPLETED|Extension Phase||66
1552270|NCT01278407|3797572|P4|COMPLETED|Extension Phase||34
1552271|NCT01278407|3797573|P3|COMPLETED|Extension Phase||0
1552272|NCT01278407|3797574|P2|COMPLETED|Extension Phase||0
1552273|NCT01278407|3797575|P1|COMPLETED|Extension Phase||0
1552274|NCT01278407|3797571|P5|STARTED|Extension Phase||96
1552275|NCT01278407|3797572|P4|STARTED|Extension Phase||46
1552276|NCT01278407|3797573|P3|STARTED|Extension Phase||0
1552277|NCT01278407|3797574|P2|STARTED|Extension Phase||0
1552278|NCT01278407|3797575|P1|STARTED|Extension Phase||0
1552279|NCT01278407|3797571|P5|NOT COMPLETED|Confirmatory Phase||0
1552280|NCT01278407|3797572|P4|NOT COMPLETED|Confirmatory Phase||0
1552281|NCT01278407|3797573|P3|NOT COMPLETED|Confirmatory Phase||6
1552282|NCT01278407|3797574|P2|NOT COMPLETED|Confirmatory Phase||16
1552283|NCT01278407|3797575|P1|NOT COMPLETED|Confirmatory Phase||9
1552284|NCT01278407|3797571|P5|COMPLETED|Confirmatory Phase||0
1552285|NCT01278407|3797572|P4|COMPLETED|Confirmatory Phase||0
1552286|NCT01278407|3797573|P3|COMPLETED|Confirmatory Phase||43
1552287|NCT01278407|3797574|P2|COMPLETED|Confirmatory Phase||31
1552288|NCT01278407|3797575|P1|COMPLETED|Confirmatory Phase||37
1552289|NCT01278407|3797571|P5|STARTED|Confirmatory Phase||0
1552290|NCT01278407|3797572|P4|STARTED|Confirmatory Phase||0
1552291|NCT01278407|3797573|P3|STARTED|Confirmatory Phase||49
1552292|NCT01278407|3797574|P2|STARTED|Confirmatory Phase||47
1552293|NCT01278407|3797575|P1|STARTED|Confirmatory Phase||46
1552294|NCT01278394|3797588|P1|NOT COMPLETED|Overall Study||1
1552295|NCT01278394|3797588|P1|COMPLETED|Overall Study||28
1552296|NCT01278394|3797588|P1|STARTED|Overall Study||29
1552297|NCT01278342|3797601|P3|NOT COMPLETED|Overall Study||0
1552298|NCT01278342|3797602|P2|NOT COMPLETED|Overall Study||1
1552299|NCT01278342|3797603|P1|NOT COMPLETED|Overall Study||4
1552300|NCT01278342|3797601|P3|COMPLETED|Overall Study||32
1552301|NCT01278342|3797602|P2|COMPLETED|Overall Study||30
1552302|NCT01278342|3797603|P1|COMPLETED|Overall Study||3
1552303|NCT01278342|3797601|P3|STARTED|Overall Study||32
1552304|NCT01278342|3797602|P2|STARTED|Overall Study||31
1552305|NCT01278342|3797603|P1|STARTED|Overall Study||7
1552306|NCT01278303|3797617|P1|NOT COMPLETED|Overall Study||0
1552307|NCT01278303|3797617|P1|COMPLETED|Overall Study||82
1552308|NCT01278303|3797617|P1|STARTED|Overall Study||82
1552309|NCT01278173|3797623|P1|NOT COMPLETED|Overall Study||27
1552310|NCT01278173|3797623|P1|COMPLETED|Overall Study||38
1552311|NCT01278173|3797623|P1|STARTED|Overall Study||65
1552312|NCT01278160|3797630|P2|NOT COMPLETED|Overall Study||6
1552313|NCT01278160|3797631|P1|NOT COMPLETED|Overall Study||5
1552314|NCT01278160|3797630|P2|COMPLETED|Overall Study||84
1552315|NCT01278160|3797631|P1|COMPLETED|Overall Study||84
1552316|NCT01278160|3797630|P2|STARTED|Overall Study||90
1552317|NCT01278160|3797631|P1|STARTED|Overall Study||89
1552318|NCT01278030|3797647|P2|NOT COMPLETED|Overall Study||4
1552319|NCT01278030|3797648|P1|NOT COMPLETED|Overall Study||8
1552320|NCT01278030|3797647|P2|COMPLETED|Overall Study||31
1552321|NCT01278030|3797648|P1|COMPLETED|Overall Study||35
1552322|NCT01278030|3797647|P2|STARTED|Overall Study||35
1552323|NCT01278030|3797648|P1|STARTED|Overall Study||43
1552324|NCT01277887|3797656|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
1552325|NCT01277887|3797657|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
1552326|NCT01277887|3797656|P2|COMPLETED|Post-Quit Treatment Phase||5
1552327|NCT01277887|3797657|P1|COMPLETED|Post-Quit Treatment Phase||3
1552328|NCT01277887|3797656|P2|STARTED|Post-Quit Treatment Phase||10
1552329|NCT01277887|3797657|P1|STARTED|Post-Quit Treatment Phase||6
1552330|NCT01277887|3797656|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
1552331|NCT01277887|3797657|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
1552332|NCT01277887|3797656|P2|COMPLETED|Pre-Quit Treatment Phase||10
1552333|NCT01277887|3797657|P1|COMPLETED|Pre-Quit Treatment Phase||6
1552334|NCT01277887|3797656|P2|Entered Study|Pre-Quit Treatment Phase||10
1552335|NCT01277887|3797657|P1|Entered Study|Pre-Quit Treatment Phase||7
1552336|NCT01277887|3797656|P2|STARTED|Pre-Quit Treatment Phase||10
1552337|NCT01277887|3797657|P1|STARTED|Pre-Quit Treatment Phase||9
1552338|NCT01277861|3797669|P2|NOT COMPLETED|Overall Study||2
1552339|NCT01277861|3797670|P1|NOT COMPLETED|Overall Study||2
1552340|NCT01277861|3797669|P2|COMPLETED|Overall Study||47
1552341|NCT01277861|3797670|P1|COMPLETED|Overall Study||49
1552342|NCT01277861|3797669|P2|STARTED|Overall Study||49
1552343|NCT01277861|3797670|P1|STARTED|Overall Study||51
1552344|NCT01277822|3797682|P2|NOT COMPLETED|Overall Study||11
1552345|NCT01277822|3797683|P1|NOT COMPLETED|Overall Study||15
1552346|NCT01277822|3797682|P2|COMPLETED|Overall Study||155
1552347|NCT01277822|3797683|P1|COMPLETED|Overall Study||153
1552348|NCT01277822|3797682|P2|STARTED|Overall Study||166
1552349|NCT01277822|3797683|P1|STARTED|Overall Study||168
1552350|NCT01277757|3797703|P1|NOT COMPLETED|Overall Study||2
1552351|NCT01277757|3797703|P1|COMPLETED|Overall Study||28
1552352|NCT01277757|3797703|P1|STARTED|Overall Study||30
1552353|NCT01277718|3797710|P2|NOT COMPLETED|Period 3 - Third Intervention||0
1552354|NCT01277718|3797711|P1|NOT COMPLETED|Period 3 - Third Intervention||0
1552355|NCT01277718|3797710|P2|COMPLETED|Period 3 - Third Intervention||7
1552356|NCT01277718|3797711|P1|COMPLETED|Period 3 - Third Intervention||10
1552357|NCT01277718|3797710|P2|STARTED|Period 3 - Third Intervention||7
1552358|NCT01277718|3797711|P1|STARTED|Period 3 - Third Intervention||10
1552359|NCT01277718|3797710|P2|NOT COMPLETED|Washout Period of 13 Days||0
1552360|NCT01277718|3797711|P1|NOT COMPLETED|Washout Period of 13 Days||0
1552361|NCT01277718|3797710|P2|COMPLETED|Washout Period of 13 Days||7
1552362|NCT01277718|3797711|P1|COMPLETED|Washout Period of 13 Days||10
1552363|NCT01277718|3797710|P2|STARTED|Washout Period of 13 Days||7
1552364|NCT01277718|3797711|P1|STARTED|Washout Period of 13 Days||10
1552365|NCT01277718|3797710|P2|NOT COMPLETED|Period 2 - Second Intervention||3
1552366|NCT01277718|3797711|P1|NOT COMPLETED|Period 2 - Second Intervention||0
1552367|NCT01277718|3797710|P2|COMPLETED|Period 2 - Second Intervention||7
1552368|NCT01277718|3797711|P1|COMPLETED|Period 2 - Second Intervention||10
1552369|NCT01277718|3797710|P2|STARTED|Period 2 - Second Intervention||10
1552370|NCT01277718|3797711|P1|STARTED|Period 2 - Second Intervention||10
1552371|NCT01277718|3797710|P2|NOT COMPLETED|Washout Period of 13 Days||0
1552372|NCT01277718|3797711|P1|NOT COMPLETED|Washout Period of 13 Days||0
1552373|NCT01277718|3797710|P2|COMPLETED|Washout Period of 13 Days||10
1552374|NCT01277718|3797711|P1|COMPLETED|Washout Period of 13 Days||10
1552375|NCT01277718|3797710|P2|STARTED|Washout Period of 13 Days||10
1552376|NCT01277718|3797711|P1|STARTED|Washout Period of 13 Days||10
1552377|NCT01277718|3797710|P2|NOT COMPLETED|Period 1 - First Intervention||0
1552378|NCT01277718|3797711|P1|NOT COMPLETED|Period 1 - First Intervention||0
1552379|NCT01277718|3797710|P2|COMPLETED|Period 1 - First Intervention||10
1552380|NCT01277718|3797711|P1|COMPLETED|Period 1 - First Intervention||10
1552381|NCT01277718|3797710|P2|STARTED|Period 1 - First Intervention||10
1552382|NCT01277718|3797711|P1|STARTED|Period 1 - First Intervention||10
1552383|NCT01277666|3797725|P3|NOT COMPLETED|Overall Study||49
1552384|NCT01277666|3797726|P2|NOT COMPLETED|Overall Study||59
1552385|NCT01277666|3797727|P1|NOT COMPLETED|Overall Study||45
1552386|NCT01277666|3797725|P3|COMPLETED|Overall Study||153
1552387|NCT01277666|3797726|P2|COMPLETED|Overall Study||144
1552388|NCT01277666|3797727|P1|COMPLETED|Overall Study||158
1552389|NCT01277666|3797725|P3|STARTED|Overall Study||202
1552390|NCT01277666|3797726|P2|STARTED|Overall Study||203
1552391|NCT01277666|3797727|P1|STARTED|Overall Study||203
1552392|NCT01277601|3797760|P4|NOT COMPLETED|Overall Study||36
1552393|NCT01277601|3797761|P3|NOT COMPLETED|Overall Study||27
1552394|NCT01277601|3797762|P2|NOT COMPLETED|Overall Study||48
1552395|NCT01277601|3797763|P1|NOT COMPLETED|Overall Study||37
1552396|NCT01277601|3797760|P4|COMPLETED|Overall Study||150
1552397|NCT01277601|3797761|P3|COMPLETED|Overall Study||163
1552398|NCT01277601|3797762|P2|COMPLETED|Overall Study||139
1552399|NCT01277601|3797763|P1|COMPLETED|Overall Study||151
1552400|NCT01277601|3797760|P4|STARTED|Overall Study||186
1552401|NCT01277601|3797761|P3|STARTED|Overall Study||190
1552402|NCT01277601|3797762|P2|STARTED|Overall Study||187
1552403|NCT01277601|3797763|P1|STARTED|Overall Study||188
1552404|NCT01277549|3797854|P2|NOT COMPLETED|Overall Study||14
1552405|NCT01277549|3797855|P1|NOT COMPLETED|Overall Study||26
1552406|NCT01277549|3797854|P2|COMPLETED|Overall Study||15
1552407|NCT01277549|3797855|P1|COMPLETED|Overall Study||15
1552408|NCT01277549|3797854|P2|STARTED|Overall Study||29
1552409|NCT01277549|3797855|P1|STARTED|Overall Study||41
1552410|NCT01277523|3797872|P3|NOT COMPLETED|Overall Study||0
1552411|NCT01277523|3797873|P2|NOT COMPLETED|Overall Study||1
1552412|NCT01277523|3797874|P1|NOT COMPLETED|Overall Study||3
1552413|NCT01277523|3797872|P3|COMPLETED|Overall Study||130
1552414|NCT01277523|3797873|P2|COMPLETED|Overall Study||126
1552415|NCT01277523|3797874|P1|COMPLETED|Overall Study||132
1552416|NCT01277523|3797872|P3|STARTED|Overall Study||130
1552417|NCT01277523|3797873|P2|STARTED|Overall Study||127
1552418|NCT01277523|3797874|P1|STARTED|Overall Study||135
1552419|NCT01277510|3797926|P2|NOT COMPLETED|Open-label Phase||3
1552420|NCT01277510|3797927|P1|NOT COMPLETED|Open-label Phase||7
1552421|NCT01277510|3797926|P2|COMPLETED|Open-label Phase|Completed investigational product|1
1552422|NCT01277510|3797927|P1|COMPLETED|Open-label Phase|Completed investigational product|1
1552423|NCT01277510|3797926|P2|Received Investigational Product|Open-label Phase||4
1552424|NCT01277510|3797927|P1|Received Investigational Product|Open-label Phase||6
1552425|NCT01277510|3797926|P2|STARTED|Open-label Phase||4
1552426|NCT01277510|3797927|P1|STARTED|Open-label Phase||8
1552427|NCT01277510|3797926|P2|NOT COMPLETED|Double-blind Phase||18
1552428|NCT01277510|3797927|P1|NOT COMPLETED|Double-blind Phase||13
1552429|NCT01277510|3797926|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
1552430|NCT01277510|3797927|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
1552431|NCT01277510|3797926|P2|Received Investigational Product|Double-blind Phase||22
1552432|NCT01277510|3797927|P1|Received Investigational Product|Double-blind Phase||21
1552433|NCT01277510|3797926|P2|STARTED|Double-blind Phase||22
1552434|NCT01277510|3797927|P1|STARTED|Double-blind Phase||21
1552435|NCT01277354|3797951|P2|NOT COMPLETED|Overall Study||0
1552436|NCT01277354|3797952|P1|NOT COMPLETED|Overall Study||0
1552437|NCT01277354|3797951|P2|COMPLETED|Overall Study||1
1552438|NCT01277354|3797952|P1|COMPLETED|Overall Study||1
1552439|NCT01277354|3797951|P2|STARTED|Overall Study||1
1552440|NCT01277354|3797952|P1|STARTED|Overall Study||1
1552441|NCT01277302|3797961|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
1552442|NCT01277302|3797962|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
1552443|NCT01277302|3797963|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
1552444|NCT01277302|3797961|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
1552445|NCT01277302|3797962|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
1552446|NCT01277302|3797963|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
1552447|NCT01277302|3797961|P3|STARTED|8-Month Alternate Dose Regimen Period||19
1552448|NCT01277302|3797962|P2|STARTED|8-Month Alternate Dose Regimen Period||86
1552449|NCT01277302|3797963|P1|STARTED|8-Month Alternate Dose Regimen Period||85
1552450|NCT01277302|3797961|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
1552451|NCT01277302|3797962|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
1552452|NCT01277302|3797963|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
1552453|NCT01277302|3797961|P3|COMPLETED|7-Month Fixed Treatment Period||19
1552454|NCT01277302|3797962|P2|COMPLETED|7-Month Fixed Treatment Period||86
1552455|NCT01277302|3797963|P1|COMPLETED|7-Month Fixed Treatment Period||85
1552456|NCT01277302|3797961|P3|STARTED|7-Month Fixed Treatment Period||31
1552457|NCT01277302|3797962|P2|STARTED|7-Month Fixed Treatment Period||86
1552458|NCT01277302|3797963|P1|STARTED|7-Month Fixed Treatment Period||85
1552459|NCT01277211|3797995|P2|NOT COMPLETED|Overall Study||63
1552460|NCT01277211|3797996|P1|NOT COMPLETED|Overall Study||150
1552461|NCT01277211|3797995|P2|COMPLETED|Overall Study||182
1552462|NCT01277211|3797996|P1|COMPLETED|Overall Study||588
1552463|NCT01277211|3797995|P2|Treated|Overall Study||232
1552464|NCT01277211|3797996|P1|Treated|Overall Study||714
1552465|NCT01277211|3797995|P2|STARTED|Overall Study||245
1552466|NCT01277211|3797996|P1|STARTED|Overall Study||738
1552467|NCT01277159|3798011|P5|NOT COMPLETED|Overall Study||5
1552468|NCT01277159|3798012|P4|NOT COMPLETED|Overall Study||3
1552469|NCT01277159|3798013|P3|NOT COMPLETED|Overall Study||3
1552470|NCT01277159|3798014|P2|NOT COMPLETED|Overall Study||1
1552471|NCT01277159|3798015|P1|NOT COMPLETED|Overall Study||4
1552472|NCT01277159|3798011|P5|COMPLETED|Overall Study||16
1552473|NCT01277159|3798012|P4|COMPLETED|Overall Study||19
1552474|NCT01277159|3798013|P3|COMPLETED|Overall Study||19
1552475|NCT01277159|3798014|P2|COMPLETED|Overall Study||21
1552476|NCT01277159|3798015|P1|COMPLETED|Overall Study||17
1552477|NCT01277159|3798011|P5|STARTED|Overall Study||21
1552478|NCT01277159|3798012|P4|STARTED|Overall Study||22
1552479|NCT01277159|3798013|P3|STARTED|Overall Study||22
1552480|NCT01277159|3798014|P2|STARTED|Overall Study||22
1552481|NCT01277159|3798015|P1|STARTED|Overall Study||21
1552482|NCT01277081|3798029|P2|NOT COMPLETED|Overall Study||0
1552483|NCT01277081|3798030|P1|NOT COMPLETED|Overall Study||0
1552484|NCT01277081|3798029|P2|COMPLETED|Overall Study||100
1552485|NCT01277081|3798030|P1|COMPLETED|Overall Study||100
1552486|NCT01277081|3798029|P2|STARTED|Overall Study||100
1552487|NCT01277081|3798030|P1|STARTED|Overall Study||100
1552488|NCT01277042|3798048|P2|NOT COMPLETED|Overall Study||5
1552489|NCT01277042|3798049|P1|NOT COMPLETED|Overall Study||8
1552490|NCT01277042|3798048|P2|COMPLETED|Overall Study||601
1552491|NCT01277042|3798049|P1|COMPLETED|Overall Study||598
1552492|NCT01277042|3798048|P2|STARTED|Overall Study||606
1552493|NCT01277042|3798049|P1|STARTED|Overall Study||606
1552494|NCT01276847|3798074|P3|NOT COMPLETED|Overall Study||0
1552495|NCT01276847|3798075|P2|NOT COMPLETED|Overall Study||0
1552496|NCT01276847|3798076|P1|NOT COMPLETED|Overall Study||1
1552497|NCT01276847|3798074|P3|COMPLETED|Overall Study||20
1552498|NCT01276847|3798075|P2|COMPLETED|Overall Study||10
1552499|NCT01276847|3798076|P1|COMPLETED|Overall Study||9
1552500|NCT01276847|3798074|P3|STARTED|Overall Study||20
1552501|NCT01276847|3798075|P2|STARTED|Overall Study||10
1552502|NCT01276847|3798076|P1|STARTED|Overall Study||10
1552503|NCT01276821|3798086|P2|NOT COMPLETED|Overall Study||1
1552504|NCT01276821|3798087|P1|NOT COMPLETED|Overall Study||0
1552505|NCT01276821|3798086|P2|COMPLETED|Overall Study||49
1552506|NCT01276821|3798087|P1|COMPLETED|Overall Study||50
1552507|NCT01276821|3798086|P2|STARTED|Overall Study||50
1552508|NCT01276821|3798087|P1|STARTED|Overall Study||50
1552509|NCT01276756|3798107|P2|NOT COMPLETED|Overall Study||2
1552510|NCT01276756|3798108|P1|NOT COMPLETED|Overall Study||5
1552511|NCT01276756|3798107|P2|COMPLETED|Overall Study||48
1552512|NCT01276756|3798108|P1|COMPLETED|Overall Study||45
1552513|NCT01276756|3798107|P2|STARTED|Overall Study||50
1552514|NCT01276756|3798108|P1|STARTED|Overall Study||50
1552515|NCT01276652|3798125|P3|NOT COMPLETED|Period 2: Observational||0
1552516|NCT01276652|3798126|P2|NOT COMPLETED|Period 2: Observational||0
1552517|NCT01276652|3798127|P1|NOT COMPLETED|Period 2: Observational||0
1552518|NCT01276652|3798125|P3|COMPLETED|Period 2: Observational||5
1552519|NCT01276652|3798126|P2|COMPLETED|Period 2: Observational||8
1552520|NCT01276652|3798127|P1|COMPLETED|Period 2: Observational||9
1552521|NCT01276652|3798125|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
1552522|NCT01276652|3798126|P2|STARTED|Period 2: Observational||8
1552523|NCT01276652|3798127|P1|STARTED|Period 2: Observational||9
1552524|NCT01276652|3798125|P3|NOT COMPLETED|Period 1: Randomization||0
1552525|NCT01276652|3798126|P2|NOT COMPLETED|Period 1: Randomization||0
1552526|NCT01276652|3798127|P1|NOT COMPLETED|Period 1: Randomization||0
1552527|NCT01276652|3798125|P3|COMPLETED|Period 1: Randomization||0
1552528|NCT01276652|3798126|P2|COMPLETED|Period 1: Randomization||8
1552529|NCT01276652|3798127|P1|COMPLETED|Period 1: Randomization||9
1552530|NCT01276652|3798125|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
1552531|NCT01276652|3798126|P2|STARTED|Period 1: Randomization||8
1552532|NCT01276652|3798127|P1|STARTED|Period 1: Randomization||9
1552533|NCT01276639|3798153|P5|NOT COMPLETED|Week 16 to 52||21
1552534|NCT01276639|3798154|P4|NOT COMPLETED|Week 16 to 52||16
1552535|NCT01276639|3798155|P3|NOT COMPLETED|Week 16 to 52||0
1552536|NCT01276639|3798156|P2|NOT COMPLETED|Week 16 to 52||101
1552537|NCT01276639|3798157|P1|NOT COMPLETED|Week 16 to 52||127
1552538|NCT01276639|3798153|P5|COMPLETED|Week 16 to 52||45
1552539|NCT01276639|3798154|P4|COMPLETED|Week 16 to 52||50
1552540|NCT01276639|3798155|P3|COMPLETED|Week 16 to 52||0
1552541|NCT01276639|3798156|P2|COMPLETED|Week 16 to 52||219
1552542|NCT01276639|3798157|P1|COMPLETED|Week 16 to 52||186
1552543|NCT01276639|3798153|P5|STARTED|Week 16 to 52||66
1552544|NCT01276639|3798154|P4|STARTED|Week 16 to 52||66
1552545|NCT01276639|3798155|P3|STARTED|Week 16 to 52||0
1552546|NCT01276639|3798156|P2|STARTED|Week 16 to 52||320
1552547|NCT01276639|3798157|P1|STARTED|Week 16 to 52||313
1552548|NCT01276639|3798153|P5|NOT COMPLETED|Week 0 to 16||0
1552549|NCT01276639|3798154|P4|NOT COMPLETED|Week 0 to 16||0
1552550|NCT01276639|3798155|P3|NOT COMPLETED|Week 0 to 16||45
1552551|NCT01276639|3798156|P2|NOT COMPLETED|Week 0 to 16||41
1552552|NCT01276639|3798157|P1|NOT COMPLETED|Week 0 to 16||50
1552553|NCT01276639|3798153|P5|COMPLETED|Week 0 to 16||0
1552554|NCT01276639|3798154|P4|COMPLETED|Week 0 to 16||0
1552555|NCT01276639|3798155|P3|COMPLETED|Week 0 to 16||132
1552556|NCT01276639|3798156|P2|COMPLETED|Week 0 to 16||320
1552557|NCT01276639|3798157|P1|COMPLETED|Week 0 to 16||313
1552558|NCT01276639|3798153|P5|Treated|Week 0 to 16||0
1552559|NCT01276639|3798154|P4|Treated|Week 0 to 16||0
1552560|NCT01276639|3798155|P3|Treated|Week 0 to 16||177
1552561|NCT01276639|3798156|P2|Treated|Week 0 to 16||360
1552562|NCT01276639|3798157|P1|Treated|Week 0 to 16||363
1552563|NCT01276639|3798153|P5|STARTED|Week 0 to 16||0
1552564|NCT01276639|3798154|P4|STARTED|Week 0 to 16||0
1552565|NCT01276639|3798155|P3|STARTED|Week 0 to 16||177
1552566|NCT01276639|3798156|P2|STARTED|Week 0 to 16||361
1552567|NCT01276639|3798157|P1|STARTED|Week 0 to 16||363
1552568|NCT01276535|3798352|P1|NOT COMPLETED|Overall Study||0
1552569|NCT01276535|3798352|P1|COMPLETED|Overall Study||12
1552570|NCT01276535|3798352|P1|STARTED|Overall Study||12
1552571|NCT01276509|3798362|P4|NOT COMPLETED|Overall Study||5
1552572|NCT01276509|3798363|P3|NOT COMPLETED|Overall Study||5
1552573|NCT01276509|3798364|P2|NOT COMPLETED|Overall Study||12
1552574|NCT01276509|3798365|P1|NOT COMPLETED|Overall Study||13
1552575|NCT01276509|3798362|P4|COMPLETED|Overall Study||58
1552576|NCT01276509|3798363|P3|COMPLETED|Overall Study||63
1552577|NCT01276509|3798364|P2|COMPLETED|Overall Study||53
1552578|NCT01276509|3798365|P1|COMPLETED|Overall Study||53
1552579|NCT01276509|3798362|P4|STARTED|Overall Study||63
1552580|NCT01276509|3798363|P3|STARTED|Overall Study||68
1552581|NCT01276509|3798364|P2|STARTED|Overall Study||65
1552582|NCT01276509|3798365|P1|STARTED|Overall Study||66
1552583|NCT01276457|3798418|P2|NOT COMPLETED|Extension Study||2
1552584|NCT01276457|3798419|P1|NOT COMPLETED|Extension Study||6
1552585|NCT01276457|3798418|P2|COMPLETED|Extension Study||110
1552586|NCT01276457|3798419|P1|COMPLETED|Extension Study||105
1552587|NCT01276457|3798418|P2|STARTED|Extension Study||112
1552588|NCT01276457|3798419|P1|STARTED|Extension Study||111
1552589|NCT01276457|3798418|P2|NOT COMPLETED|Core Study||20
1552590|NCT01276457|3798419|P1|NOT COMPLETED|Core Study||13
1552591|NCT01276457|3798418|P2|COMPLETED|Core Study||123
1552592|NCT01276457|3798419|P1|COMPLETED|Core Study||129
1552593|NCT01276457|3798418|P2|STARTED|Core Study||143
1552594|NCT01276457|3798419|P1|STARTED|Core Study||142
1552595|NCT01276353|3798433|P2|NOT COMPLETED|Extension||9
1552596|NCT01276353|3798434|P1|NOT COMPLETED|Extension||7
1552597|NCT01276353|3798433|P2|COMPLETED|Extension||14
1552598|NCT01276353|3798434|P1|COMPLETED|Extension||12
1552599|NCT01276353|3798433|P2|STARTED|Extension||23
1552600|NCT01276353|3798434|P1|STARTED|Extension||19
1552601|NCT01276353|3798433|P2|NOT COMPLETED|Double-blind||0
1552602|NCT01276353|3798434|P1|NOT COMPLETED|Double-blind||3
1552603|NCT01276353|3798433|P2|COMPLETED|Double-blind||23
1552604|NCT01276353|3798434|P1|COMPLETED|Double-blind||19
1552605|NCT01276353|3798433|P2|STARTED|Double-blind||23
1552606|NCT01276353|3798434|P1|STARTED|Double-blind||22
1552607|NCT01276327|3798446|P2|NOT COMPLETED|Overall Study||3
1552608|NCT01276327|3798447|P1|NOT COMPLETED|Overall Study||2
1552609|NCT01276327|3798446|P2|COMPLETED|Overall Study||29
1552610|NCT01276327|3798447|P1|COMPLETED|Overall Study||30
1552611|NCT01276327|3798446|P2|STARTED|Overall Study||32
1552612|NCT01276327|3798447|P1|STARTED|Overall Study||32
1552613|NCT01276314|3798473|P4|NOT COMPLETED|Overall Study||5
1552614|NCT01276314|3798474|P3|NOT COMPLETED|Overall Study||4
1552615|NCT01276314|3798475|P2|NOT COMPLETED|Overall Study||10
1552616|NCT01276314|3798476|P1|NOT COMPLETED|Overall Study||10
1552617|NCT01276314|3798473|P4|COMPLETED|Overall Study||17
1552618|NCT01276314|3798474|P3|COMPLETED|Overall Study||18
1552619|NCT01276314|3798475|P2|COMPLETED|Overall Study||33
1552620|NCT01276314|3798476|P1|COMPLETED|Overall Study||38
1552621|NCT01276314|3798473|P4|STARTED|Overall Study||22
1552622|NCT01276314|3798474|P3|STARTED|Overall Study||22
1552623|NCT01276314|3798475|P2|STARTED|Overall Study||43
1552624|NCT01276314|3798476|P1|STARTED|Overall Study||48
1552625|NCT01276301|3798486|P2|NOT COMPLETED|Second Intervention||0
1552626|NCT01276301|3798487|P1|NOT COMPLETED|Second Intervention||0
1552627|NCT01276301|3798486|P2|COMPLETED|Second Intervention||8
1552628|NCT01276301|3798487|P1|COMPLETED|Second Intervention||8
1552629|NCT01276301|3798486|P2|STARTED|Second Intervention||8
1552630|NCT01276301|3798487|P1|STARTED|Second Intervention||8
1552631|NCT01276301|3798486|P2|NOT COMPLETED|Washout Period of 7 Days||0
1552632|NCT01276301|3798487|P1|NOT COMPLETED|Washout Period of 7 Days||0
1552633|NCT01276301|3798486|P2|COMPLETED|Washout Period of 7 Days||8
1552634|NCT01276301|3798487|P1|COMPLETED|Washout Period of 7 Days||8
1552635|NCT01276301|3798486|P2|STARTED|Washout Period of 7 Days||8
1552636|NCT01276301|3798487|P1|STARTED|Washout Period of 7 Days||8
1552637|NCT01276301|3798486|P2|NOT COMPLETED|First Intervention||0
1552638|NCT01276301|3798487|P1|NOT COMPLETED|First Intervention||0
1552639|NCT01276301|3798486|P2|COMPLETED|First Intervention||8
1552640|NCT01276301|3798487|P1|COMPLETED|First Intervention||8
1552641|NCT01276301|3798486|P2|STARTED|First Intervention||8
1552642|NCT01276301|3798487|P1|STARTED|First Intervention||8
1552643|NCT01276288|3798514|P4|NOT COMPLETED|Overall Study||0
1552644|NCT01276288|3798515|P3|NOT COMPLETED|Overall Study||0
1552645|NCT01276288|3798516|P2|NOT COMPLETED|Overall Study||1
1552646|NCT01276288|3798517|P1|NOT COMPLETED|Overall Study||2
1552647|NCT01276288|3798514|P4|COMPLETED|Overall Study||5
1552648|NCT01276288|3798515|P3|COMPLETED|Overall Study||5
1552649|NCT01276288|3798516|P2|COMPLETED|Overall Study||5
1552650|NCT01276288|3798517|P1|COMPLETED|Overall Study||5
1552651|NCT01276288|3798514|P4|Received EMPA+TOR|Overall Study||5
1552652|NCT01276288|3798515|P3|Received EMPA+TOR|Overall Study||5
1552653|NCT01276288|3798516|P2|Received EMPA+TOR|Overall Study||0
1552654|NCT01276288|3798517|P1|Received EMPA+TOR|Overall Study||0
1552655|NCT01276288|3798514|P4|Received EMPA+HCT|Overall Study||0
1552656|NCT01276288|3798515|P3|Received EMPA+HCT|Overall Study||0
1552657|NCT01276288|3798516|P2|Received EMPA+HCT|Overall Study||5
1552658|NCT01276288|3798517|P1|Received EMPA+HCT|Overall Study||5
1552659|NCT01276288|3798514|P4|Received EMPA|Overall Study||5
1552660|NCT01276288|3798515|P3|Received EMPA|Overall Study||5
1552661|NCT01276288|3798516|P2|Received EMPA|Overall Study||5
1552662|NCT01276288|3798517|P1|Received EMPA|Overall Study||6
1552663|NCT01276288|3798514|P4|STARTED|Overall Study||5
1552664|NCT01276288|3798515|P3|STARTED|Overall Study||5
1552665|NCT01276288|3798516|P2|STARTED|Overall Study||6
1552666|NCT01276288|3798517|P1|STARTED|Overall Study||7
1552667|NCT01276223|3798644|P3|NOT COMPLETED|Overall Study||3
1552668|NCT01276223|3798645|P2|NOT COMPLETED|Overall Study||4
1552669|NCT01276223|3798646|P1|NOT COMPLETED|Overall Study||11
1552670|NCT01276223|3798644|P3|COMPLETED|Overall Study||101
1552671|NCT01276223|3798645|P2|COMPLETED|Overall Study||103
1552672|NCT01276223|3798646|P1|COMPLETED|Overall Study||67
1552673|NCT01276223|3798644|P3|STARTED|Overall Study||104
1552674|NCT01276223|3798645|P2|STARTED|Overall Study||107
1552675|NCT01276223|3798646|P1|STARTED|Overall Study||78
1552676|NCT01276197|3798655|P2|NOT COMPLETED|Overall Study||110
1552677|NCT01276197|3798656|P1|NOT COMPLETED|Overall Study||108
1552678|NCT01276197|3798655|P2|COMPLETED|Overall Study||200
1552679|NCT01276197|3798656|P1|COMPLETED|Overall Study||200
1552680|NCT01276197|3798655|P2|STARTED|Overall Study||310
1552681|NCT01276197|3798656|P1|STARTED|Overall Study||308
1552682|NCT01276171|3798667|P3|NOT COMPLETED|Overall Study||0
1552683|NCT01276171|3798668|P2|NOT COMPLETED|Overall Study||0
1552684|NCT01276171|3798669|P1|NOT COMPLETED|Overall Study||0
1552685|NCT01276171|3798667|P3|COMPLETED|Overall Study||256
1552686|NCT01276171|3798668|P2|COMPLETED|Overall Study||244
1552687|NCT01276171|3798669|P1|COMPLETED|Overall Study||249
1552688|NCT01276171|3798667|P3|STARTED|Overall Study||256
1552689|NCT01276171|3798668|P2|STARTED|Overall Study||244
1552690|NCT01276171|3798669|P1|STARTED|Overall Study||249
1552691|NCT01276106|3798687|P4|NOT COMPLETED|Overall Study||13
1552692|NCT01276106|3798688|P3|NOT COMPLETED|Overall Study||16
1552693|NCT01276106|3798689|P2|NOT COMPLETED|Overall Study||9
1552694|NCT01276106|3798690|P1|NOT COMPLETED|Overall Study||12
1552695|NCT01276106|3798687|P4|COMPLETED|Overall Study||52
1552696|NCT01276106|3798688|P3|COMPLETED|Overall Study||49
1552697|NCT01276106|3798689|P2|COMPLETED|Overall Study||55
1552698|NCT01276106|3798690|P1|COMPLETED|Overall Study||53
1552699|NCT01276106|3798687|P4|STARTED|Overall Study||65
1552700|NCT01276106|3798688|P3|STARTED|Overall Study||65
1552701|NCT01276106|3798689|P2|STARTED|Overall Study||64
1552702|NCT01276106|3798690|P1|STARTED|Overall Study||65
1552703|NCT01276054|3798702|P2|NOT COMPLETED|Overall Study||2
1552704|NCT01276054|3798703|P1|NOT COMPLETED|Overall Study||2
1552705|NCT01276054|3798702|P2|COMPLETED|Overall Study||0
1552706|NCT01276054|3798703|P1|COMPLETED|Overall Study||0
1552707|NCT01276054|3798702|P2|STARTED|Overall Study||2
1552708|NCT01276054|3798703|P1|STARTED|Overall Study||2
1552709|NCT01275833|3798711|P2|NOT COMPLETED|Overall Study||1
1552710|NCT01275833|3798712|P1|NOT COMPLETED|Overall Study||1
1552711|NCT01275833|3798711|P2|COMPLETED|Overall Study||0
1552712|NCT01275833|3798712|P1|COMPLETED|Overall Study||0
1552713|NCT01275833|3798711|P2|STARTED|Overall Study||1
1552714|NCT01275833|3798712|P1|STARTED|Overall Study||1
1552715|NCT01275755|3798720|P2|NOT COMPLETED|Run-out Placebo Period||0
1552716|NCT01275755|3798721|P1|NOT COMPLETED|Run-out Placebo Period||1
1552717|NCT01275755|3798720|P2|COMPLETED|Run-out Placebo Period||37
1552718|NCT01275755|3798721|P1|COMPLETED|Run-out Placebo Period||38
1552719|NCT01275755|3798720|P2|STARTED|Run-out Placebo Period||37
1552720|NCT01275755|3798721|P1|STARTED|Run-out Placebo Period||39
1552721|NCT01275755|3798720|P2|NOT COMPLETED|Double-blind Treatment Period||3
1552722|NCT01275755|3798721|P1|NOT COMPLETED|Double-blind Treatment Period||2
1552723|NCT01275755|3798720|P2|COMPLETED|Double-blind Treatment Period||37
1552724|NCT01275755|3798721|P1|COMPLETED|Double-blind Treatment Period||39
1552725|NCT01275755|3798720|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
1552726|NCT01275755|3798721|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
1552727|NCT01275755|3798720|P2|STARTED|Double-blind Treatment Period||40
1552728|NCT01275755|3798721|P1|STARTED|Double-blind Treatment Period||41
1552729|NCT01275755|3798720|P2|NOT COMPLETED|Run-in Placebo Period||0
1552730|NCT01275755|3798721|P1|NOT COMPLETED|Run-in Placebo Period||0
1552731|NCT01275755|3798720|P2|COMPLETED|Run-in Placebo Period||40
1552732|NCT01275755|3798721|P1|COMPLETED|Run-in Placebo Period||41
1552733|NCT01275755|3798720|P2|STARTED|Run-in Placebo Period||40
1552734|NCT01275755|3798721|P1|STARTED|Run-in Placebo Period||41
1552735|NCT01275664|3798727|P1|NOT COMPLETED|Overall Study||0
1552736|NCT01275664|3798727|P1|COMPLETED|Overall Study||4
1552737|NCT01275664|3798727|P1|STARTED|Overall Study||4
1552738|NCT01275625|3798735|P1|NOT COMPLETED|Overall Study||13
1552739|NCT01275625|3798735|P1|COMPLETED|Overall Study||64
1552740|NCT01275625|3798735|P1|Treated|Overall Study||77
1552741|NCT01275625|3798735|P1|STARTED|Overall Study||77
1552742|NCT01275586|3798749|P1|NOT COMPLETED|Overall Study||3
1552743|NCT01275586|3798749|P1|COMPLETED|Overall Study||3
1552744|NCT01275586|3798749|P1|STARTED|Overall Study||6
1552745|NCT01275430|3798753|P1|NOT COMPLETED|Overall Study||9
1552746|NCT01275430|3798753|P1|COMPLETED|Overall Study||18
1552747|NCT01275430|3798753|P1|STARTED|Overall Study||27
1552748|NCT01275365|3798765|P4|NOT COMPLETED|Overall Study||3
1552749|NCT01275365|3798766|P3|NOT COMPLETED|Overall Study||5
1552750|NCT01275365|3798767|P2|NOT COMPLETED|Overall Study||3
1552751|NCT01275365|3798768|P1|NOT COMPLETED|Overall Study||3
1552752|NCT01275365|3798765|P4|COMPLETED|Overall Study||19
1552753|NCT01275365|3798766|P3|COMPLETED|Overall Study||17
1552754|NCT01275365|3798767|P2|COMPLETED|Overall Study||21
1552755|NCT01275365|3798768|P1|COMPLETED|Overall Study||21
1552756|NCT01275365|3798765|P4|STARTED|Overall Study||22
1552757|NCT01275365|3798766|P3|STARTED|Overall Study||22
1552758|NCT01275365|3798767|P2|STARTED|Overall Study||24
1552759|NCT01275365|3798768|P1|STARTED|Overall Study||24
1552760|NCT01275313|3798816|P2|NOT COMPLETED|Overall Study||52
1552761|NCT01275313|3798817|P1|NOT COMPLETED|Overall Study||25
1552762|NCT01275313|3798816|P2|COMPLETED|Overall Study||79
1552763|NCT01275313|3798817|P1|COMPLETED|Overall Study||102
1552764|NCT01275313|3798816|P2|STARTED|Overall Study||131
1552765|NCT01275313|3798817|P1|STARTED|Overall Study||127
1552766|NCT01275196|3798825|P2|NOT COMPLETED|Overall Study||21
1552767|NCT01275196|3798826|P1|NOT COMPLETED|Overall Study||20
1552768|NCT01275196|3798825|P2|COMPLETED|Overall Study||113
1552769|NCT01275196|3798826|P1|COMPLETED|Overall Study||113
1552770|NCT01275196|3798825|P2|Intended to Continue Into Extension|Overall Study||113
1552771|NCT01275196|3798826|P1|Intended to Continue Into Extension|Overall Study||112
1552772|NCT01275196|3798825|P2|STARTED|Overall Study||134
1552773|NCT01275196|3798826|P1|STARTED|Overall Study||133
1552774|NCT01275131|3798869|P4|NOT COMPLETED|Period 2 (Crossover)||2
1552775|NCT01275131|3798870|P3|NOT COMPLETED|Period 2 (Crossover)||1
1552776|NCT01275131|3798871|P2|NOT COMPLETED|Period 2 (Crossover)||1
1552777|NCT01275131|3798872|P1|NOT COMPLETED|Period 2 (Crossover)||1
1552778|NCT01275131|3798869|P4|COMPLETED|Period 2 (Crossover)||8
1552779|NCT01275131|3798870|P3|COMPLETED|Period 2 (Crossover)||9
1552780|NCT01275131|3798871|P2|COMPLETED|Period 2 (Crossover)||8
1552781|NCT01275131|3798872|P1|COMPLETED|Period 2 (Crossover)||8
1552782|NCT01275131|3798869|P4|STARTED|Period 2 (Crossover)||10
1552783|NCT01275131|3798870|P3|STARTED|Period 2 (Crossover)||10
1552784|NCT01275131|3798871|P2|STARTED|Period 2 (Crossover)||9
1552785|NCT01275131|3798872|P1|STARTED|Period 2 (Crossover)||9
1552786|NCT01275131|3798869|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
1552787|NCT01275131|3798870|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
1552788|NCT01275131|3798871|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
1552789|NCT01275131|3798872|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
1552790|NCT01275131|3798869|P4|COMPLETED|5- to 14-Day Washout Period||10
1552791|NCT01275131|3798870|P3|COMPLETED|5- to 14-Day Washout Period||10
1552792|NCT01275131|3798871|P2|COMPLETED|5- to 14-Day Washout Period||9
1552793|NCT01275131|3798872|P1|COMPLETED|5- to 14-Day Washout Period||9
1552794|NCT01275131|3798869|P4|STARTED|5- to 14-Day Washout Period||10
1552795|NCT01275131|3798870|P3|STARTED|5- to 14-Day Washout Period||10
1552796|NCT01275131|3798871|P2|STARTED|5- to 14-Day Washout Period||9
1552797|NCT01275131|3798872|P1|STARTED|5- to 14-Day Washout Period||9
1552798|NCT01275131|3798869|P4|NOT COMPLETED|Period 1||2
1552799|NCT01275131|3798870|P3|NOT COMPLETED|Period 1||3
1552800|NCT01275131|3798871|P2|NOT COMPLETED|Period 1||0
1552801|NCT01275131|3798872|P1|NOT COMPLETED|Period 1||2
1552802|NCT01275131|3798869|P4|COMPLETED|Period 1||10
1552803|NCT01275131|3798870|P3|COMPLETED|Period 1||10
1552804|NCT01275131|3798871|P2|COMPLETED|Period 1||9
1552805|NCT01275131|3798872|P1|COMPLETED|Period 1||9
1552806|NCT01275131|3798869|P4|Received at Least One Dose of Study Drug|Period 1||12
1552807|NCT01275131|3798870|P3|Received at Least One Dose of Study Drug|Period 1||13
1552808|NCT01275131|3798871|P2|Received at Least One Dose of Study Drug|Period 1||9
1552809|NCT01275131|3798872|P1|Received at Least One Dose of Study Drug|Period 1||11
1552810|NCT01275131|3798869|P4|STARTED|Period 1||12
1552811|NCT01275131|3798870|P3|STARTED|Period 1||13
1552812|NCT01275131|3798871|P2|STARTED|Period 1||9
1552813|NCT01275131|3798872|P1|STARTED|Period 1||11
1552814|NCT01275092|3798906|P1|NOT COMPLETED|Overall Study||0
1552815|NCT01275092|3798906|P1|COMPLETED|Overall Study||164
1552816|NCT01275092|3798906|P1|STARTED|Overall Study||164
1552817|NCT01275066|3798915|P3|NOT COMPLETED|Overall Study||1
1552818|NCT01275066|3798916|P2|NOT COMPLETED|Overall Study||0
1552819|NCT01275066|3798917|P1|NOT COMPLETED|Overall Study||1
1552820|NCT01275066|3798915|P3|COMPLETED|Overall Study||57
1552821|NCT01275066|3798916|P2|COMPLETED|Overall Study||59
1552822|NCT01275066|3798917|P1|COMPLETED|Overall Study||59
1552823|NCT01275066|3798915|P3|Treated|Overall Study||58
1552824|NCT01275066|3798916|P2|Treated|Overall Study||59
1552825|NCT01275066|3798917|P1|Treated|Overall Study||59
1552826|NCT01275066|3798915|P3|STARTED|Overall Study||58
1552827|NCT01275066|3798916|P2|STARTED|Overall Study||59
1552828|NCT01275066|3798917|P1|STARTED|Overall Study||60
1552829|NCT01275053|3798931|P1|NOT COMPLETED|Overall Study||0
1552830|NCT01275053|3798931|P1|COMPLETED|Overall Study||12
1552831|NCT01275053|3798931|P1|STARTED|Overall Study||12
1552832|NCT01274897|3798937|P2|NOT COMPLETED|Overall Study||0
1552833|NCT01274897|3798938|P1|NOT COMPLETED|Overall Study||0
1552834|NCT01274897|3798937|P2|COMPLETED|Overall Study||153
1552835|NCT01274897|3798938|P1|COMPLETED|Overall Study||297
1552836|NCT01274897|3798937|P2|STARTED|Overall Study||153
1552837|NCT01274897|3798938|P1|STARTED|Overall Study||297
1552838|NCT01274715|3798950|P1|NOT COMPLETED|Overall Study||4
1552839|NCT01274715|3798950|P1|COMPLETED|Overall Study||8
1552840|NCT01274715|3798950|P1|Screened Out at Baseline|Overall Study||3
1552841|NCT01274715|3798950|P1|STARTED|Overall Study||12
1552842|NCT01274637|3798957|P2|NOT COMPLETED|Overall Study||2
1552843|NCT01274637|3798958|P1|NOT COMPLETED|Overall Study||0
1552844|NCT01274637|3798957|P2|COMPLETED|Overall Study||30
1552845|NCT01274637|3798958|P1|COMPLETED|Overall Study||30
1552846|NCT01274637|3798957|P2|STARTED|Overall Study||32
1552847|NCT01274637|3798958|P1|STARTED|Overall Study||30
1552848|NCT01274611|3798974|P1|NOT COMPLETED|Overall Study||0
1552849|NCT01274611|3798974|P1|COMPLETED|Overall Study||20
1552850|NCT01274611|3798974|P1|STARTED|Overall Study||20
1552851|NCT01274585|3798984|P2|NOT COMPLETED|Overall Study||0
1552852|NCT01274585|3798985|P1|NOT COMPLETED|Overall Study||0
1552853|NCT01274585|3798984|P2|COMPLETED|Overall Study||3
1552854|NCT01274585|3798985|P1|COMPLETED|Overall Study||2
1552855|NCT01274585|3798984|P2|STARTED|Overall Study||3
1552856|NCT01274585|3798985|P1|STARTED|Overall Study||2
1552857|NCT01274559|3798997|P2|NOT COMPLETED|Overall Study||145
1552858|NCT01274559|3798998|P1|NOT COMPLETED|Overall Study||197
1552859|NCT01274559|3798997|P2|COMPLETED|Overall Study||441
1552860|NCT01274559|3798998|P1|COMPLETED|Overall Study||390
1552861|NCT01274559|3798997|P2|Treated|Overall Study||572
1552862|NCT01274559|3798998|P1|Treated|Overall Study||572
1552863|NCT01274559|3798997|P2|STARTED|Overall Study||586
1552864|NCT01274559|3798998|P1|STARTED|Overall Study||587
1552865|NCT01274533|3799048|P1|NOT COMPLETED|Overall Study||4
1552866|NCT01274533|3799048|P1|COMPLETED|Overall Study||0
1552867|NCT01274533|3799048|P1|STARTED|Overall Study||4
1552868|NCT01274429|3799053|P1|NOT COMPLETED|Overall Study||5
1552869|NCT01274429|3799053|P1|COMPLETED|Overall Study||0
1552870|NCT01274429|3799053|P1|STARTED|Overall Study||5
1552871|NCT01274182|3799061|P3|NOT COMPLETED|Overall Study||12
1552872|NCT01274182|3799062|P2|NOT COMPLETED|Overall Study||18
1552873|NCT01274182|3799063|P1|NOT COMPLETED|Overall Study||21
1552874|NCT01274182|3799061|P3|COMPLETED|Overall Study||80
1552875|NCT01274182|3799062|P2|COMPLETED|Overall Study||69
1552876|NCT01274182|3799063|P1|COMPLETED|Overall Study||112
1552877|NCT01274182|3799061|P3|24 Weeks|Overall Study||84
1552878|NCT01274182|3799062|P2|24 Weeks|Overall Study||83
1552879|NCT01274182|3799063|P1|24 Weeks|Overall Study||123
1552880|NCT01274182|3799061|P3|STARTED|Overall Study||92
1552881|NCT01274182|3799062|P2|STARTED|Overall Study||87
1552882|NCT01274182|3799063|P1|STARTED|Overall Study||133
1552883|NCT01273896|3799100|P1|NOT COMPLETED|Overall Study||0
1552884|NCT01273896|3799100|P1|COMPLETED|Overall Study||22
1552885|NCT01273896|3799100|P1|STARTED|Overall Study||22
1552886|NCT01273883|3799104|P2|NOT COMPLETED|Second Intervention||1
1552887|NCT01273883|3799105|P1|NOT COMPLETED|Second Intervention||2
1552888|NCT01273883|3799104|P2|COMPLETED|Second Intervention||17
1552889|NCT01273883|3799105|P1|COMPLETED|Second Intervention||15
1552890|NCT01273883|3799104|P2|STARTED|Second Intervention||18
1552891|NCT01273883|3799105|P1|STARTED|Second Intervention||17
1552892|NCT01273883|3799104|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1552893|NCT01273883|3799105|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1552894|NCT01273883|3799104|P2|COMPLETED|Washout Period of 2 Weeks||18
1552895|NCT01273883|3799105|P1|COMPLETED|Washout Period of 2 Weeks||17
1552896|NCT01273883|3799104|P2|STARTED|Washout Period of 2 Weeks||18
1552897|NCT01273883|3799105|P1|STARTED|Washout Period of 2 Weeks||17
1552898|NCT01273883|3799104|P2|NOT COMPLETED|First Intervention||1
1552899|NCT01273883|3799105|P1|NOT COMPLETED|First Intervention||2
1552900|NCT01273883|3799104|P2|COMPLETED|First Intervention||18
1552901|NCT01273883|3799105|P1|COMPLETED|First Intervention||17
1552902|NCT01273883|3799104|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
1552903|NCT01273883|3799105|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
1552904|NCT01273857|3799119|P2|NOT COMPLETED|Overall Study||0
1552905|NCT01273857|3799120|P1|NOT COMPLETED|Overall Study||0
1552906|NCT01273857|3799119|P2|COMPLETED|Overall Study||7
1552907|NCT01273857|3799120|P1|COMPLETED|Overall Study||7
1552908|NCT01273857|3799119|P2|STARTED|Overall Study||7
1552909|NCT01273857|3799120|P1|STARTED|Overall Study||7
1552910|NCT01273818|3799131|P3|NOT COMPLETED|Overall Study||9
1552911|NCT01273818|3799132|P2|NOT COMPLETED|Overall Study||2
1552912|NCT01273818|3799133|P1|NOT COMPLETED|Overall Study||13
1552913|NCT01273818|3799131|P3|COMPLETED|Overall Study||91
1552914|NCT01273818|3799132|P2|COMPLETED|Overall Study||98
1552915|NCT01273818|3799133|P1|COMPLETED|Overall Study||87
1552916|NCT01273818|3799131|P3|STARTED|Overall Study||100
1552917|NCT01273818|3799132|P2|STARTED|Overall Study||100
1552918|NCT01273818|3799133|P1|STARTED|Overall Study||100
1552919|NCT01273805|3799143|P2|NOT COMPLETED|Overall Study||10
1552920|NCT01273805|3799144|P1|NOT COMPLETED|Overall Study||10
1552921|NCT01273805|3799143|P2|COMPLETED|Overall Study||0
1552922|NCT01273805|3799144|P1|COMPLETED|Overall Study||0
1552923|NCT01273805|3799143|P2|STARTED|Overall Study||10
1552924|NCT01273805|3799144|P1|STARTED|Overall Study||10
1552925|NCT01273766|3799163|P3|NOT COMPLETED|Overall Study||0
1552926|NCT01273766|3799164|P2|NOT COMPLETED|Overall Study||0
1552927|NCT01273766|3799165|P1|NOT COMPLETED|Overall Study||0
1552928|NCT01273766|3799163|P3|COMPLETED|Overall Study||5
1552929|NCT01273766|3799164|P2|COMPLETED|Overall Study||7
1552930|NCT01273766|3799165|P1|COMPLETED|Overall Study||4
1552931|NCT01273766|3799163|P3|STARTED|Overall Study||5
1552932|NCT01273766|3799164|P2|STARTED|Overall Study||7
1552933|NCT01273766|3799165|P1|STARTED|Overall Study||4
1552934|NCT01273623|3799175|P1|NOT COMPLETED|Overall Study||29
1552935|NCT01273623|3799175|P1|COMPLETED|Overall Study|met IVUS criteria|26
1552936|NCT01273623|3799175|P1|STARTED|Overall Study|met angiographic criteria|55
1552937|NCT01273597|3799182|P1|NOT COMPLETED|Overall Study||8
1552938|NCT01273597|3799182|P1|COMPLETED|Overall Study||52
1552939|NCT01273597|3799182|P1|STARTED|Overall Study||60
1552940|NCT01273519|3799197|P3|NOT COMPLETED|Overall Study||8
1552941|NCT01273519|3799198|P2|NOT COMPLETED|Overall Study||5
1552942|NCT01273519|3799199|P1|NOT COMPLETED|Overall Study||19
1552943|NCT01273519|3799197|P3|COMPLETED|Overall Study||39
1552944|NCT01273519|3799198|P2|COMPLETED|Overall Study||25
1552945|NCT01273519|3799199|P1|COMPLETED|Overall Study||59
1552946|NCT01273519|3799197|P3|STARTED|Overall Study||47
1552947|NCT01273519|3799198|P2|STARTED|Overall Study||30
1552948|NCT01273519|3799199|P1|STARTED|Overall Study||78
1552949|NCT01273181|3799236|P4|NOT COMPLETED|Phase 2, Dose 2||1
1552950|NCT01273181|3799237|P3|NOT COMPLETED|Phase 2, Dose 2||0
1552951|NCT01273181|3799238|P2|NOT COMPLETED|Phase 2, Dose 2||0
1552952|NCT01273181|3799239|P1|NOT COMPLETED|Phase 2, Dose 2||0
1552953|NCT01273181|3799236|P4|COMPLETED|Phase 2, Dose 2||0
1552954|NCT01273181|3799237|P3|COMPLETED|Phase 2, Dose 2||0
1552955|NCT01273181|3799238|P2|COMPLETED|Phase 2, Dose 2||0
1552956|NCT01273181|3799239|P1|COMPLETED|Phase 2, Dose 2||0
1552957|NCT01273181|3799236|P4|STARTED|Phase 2, Dose 2||1
1552958|NCT01273181|3799237|P3|STARTED|Phase 2, Dose 2||0
1552959|NCT01273181|3799238|P2|STARTED|Phase 2, Dose 2||0
1552960|NCT01273181|3799239|P1|STARTED|Phase 2, Dose 2||0
1552961|NCT01273181|3799236|P4|NOT COMPLETED|Phase 2, Dose 1||0
1552962|NCT01273181|3799237|P3|NOT COMPLETED|Phase 2, Dose 1||1
1552963|NCT01273181|3799238|P2|NOT COMPLETED|Phase 2, Dose 1||0
1552964|NCT01273181|3799239|P1|NOT COMPLETED|Phase 2, Dose 1||0
1552965|NCT01273181|3799236|P4|COMPLETED|Phase 2, Dose 1||0
1552966|NCT01273181|3799237|P3|COMPLETED|Phase 2, Dose 1||1
1552967|NCT01273181|3799238|P2|COMPLETED|Phase 2, Dose 1||0
1552968|NCT01273181|3799239|P1|COMPLETED|Phase 2, Dose 1||0
1552969|NCT01273181|3799236|P4|STARTED|Phase 2, Dose 1||0
1552970|NCT01273181|3799237|P3|STARTED|Phase 2, Dose 1||2
1552971|NCT01273181|3799238|P2|STARTED|Phase 2, Dose 1||0
1552972|NCT01273181|3799239|P1|STARTED|Phase 2, Dose 1||0
1552973|NCT01273181|3799236|P4|NOT COMPLETED|Phase I, Dose 2||0
1552974|NCT01273181|3799237|P3|NOT COMPLETED|Phase I, Dose 2||0
1552975|NCT01273181|3799238|P2|NOT COMPLETED|Phase I, Dose 2||1
1552976|NCT01273181|3799239|P1|NOT COMPLETED|Phase I, Dose 2||0
1552977|NCT01273181|3799236|P4|COMPLETED|Phase I, Dose 2||0
1552978|NCT01273181|3799237|P3|COMPLETED|Phase I, Dose 2||0
1552979|NCT01273181|3799238|P2|COMPLETED|Phase I, Dose 2||2
1552980|NCT01273181|3799239|P1|COMPLETED|Phase I, Dose 2||0
1552981|NCT01273181|3799236|P4|STARTED|Phase I, Dose 2||0
1552982|NCT01273181|3799237|P3|STARTED|Phase I, Dose 2||0
1552983|NCT01273181|3799238|P2|STARTED|Phase I, Dose 2||3
1552984|NCT01273181|3799239|P1|STARTED|Phase I, Dose 2||0
1552985|NCT01273181|3799236|P4|NOT COMPLETED|Phase I, Dose 1||0
1552986|NCT01273181|3799237|P3|NOT COMPLETED|Phase I, Dose 1||0
1552987|NCT01273181|3799238|P2|NOT COMPLETED|Phase I, Dose 1||0
1552988|NCT01273181|3799239|P1|NOT COMPLETED|Phase I, Dose 1||1
1552989|NCT01273181|3799236|P4|COMPLETED|Phase I, Dose 1||0
1552990|NCT01273181|3799237|P3|COMPLETED|Phase I, Dose 1||0
1552991|NCT01273181|3799238|P2|COMPLETED|Phase I, Dose 1||0
1552992|NCT01273181|3799239|P1|COMPLETED|Phase I, Dose 1||2
1552993|NCT01273181|3799236|P4|STARTED|Phase I, Dose 1||0
1552994|NCT01273181|3799237|P3|STARTED|Phase I, Dose 1||0
1552995|NCT01273181|3799238|P2|STARTED|Phase I, Dose 1||0
1552996|NCT01273181|3799239|P1|STARTED|Phase I, Dose 1||3
1552997|NCT01273064|3799258|P5|NOT COMPLETED|Overall Study||10
1552998|NCT01273064|3799259|P4|NOT COMPLETED|Overall Study||20
1552999|NCT01273064|3799260|P3|NOT COMPLETED|Overall Study||31
1553000|NCT01273064|3799261|P2|NOT COMPLETED|Overall Study||30
1553001|NCT01273064|3799262|P1|NOT COMPLETED|Overall Study||23
1553002|NCT01273064|3799258|P5|COMPLETED|Overall Study||0
1553003|NCT01273064|3799259|P4|COMPLETED|Overall Study||0
1553004|NCT01273064|3799260|P3|COMPLETED|Overall Study||0
1553005|NCT01273064|3799261|P2|COMPLETED|Overall Study||0
1553006|NCT01273064|3799262|P1|COMPLETED|Overall Study||0
1553007|NCT01273064|3799258|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
1553008|NCT01273064|3799259|P4|STARTED|Overall Study||20
1553009|NCT01273064|3799260|P3|STARTED|Overall Study||31
1553010|NCT01273064|3799261|P2|STARTED|Overall Study||30
1553011|NCT01273064|3799262|P1|STARTED|Overall Study||23
1553012|NCT01273038|3799281|P2|NOT COMPLETED|Second Intervention (14 Days)||2
1553013|NCT01273038|3799282|P1|NOT COMPLETED|Second Intervention (14 Days)||0
1553014|NCT01273038|3799281|P2|COMPLETED|Second Intervention (14 Days)||8
1553015|NCT01273038|3799282|P1|COMPLETED|Second Intervention (14 Days)||10
1553016|NCT01273038|3799281|P2|STARTED|Second Intervention (14 Days)||10
1553017|NCT01273038|3799282|P1|STARTED|Second Intervention (14 Days)||10
1553018|NCT01273038|3799281|P2|NOT COMPLETED|First Intervention (14 Days)||0
1553019|NCT01273038|3799282|P1|NOT COMPLETED|First Intervention (14 Days)||0
1553020|NCT01273038|3799281|P2|COMPLETED|First Intervention (14 Days)||10
1553021|NCT01273038|3799282|P1|COMPLETED|First Intervention (14 Days)||10
1553022|NCT01273038|3799281|P2|STARTED|First Intervention (14 Days)||10
1553023|NCT01273038|3799282|P1|STARTED|First Intervention (14 Days)||10
1553024|NCT01272960|3799290|P2|NOT COMPLETED|Overall Study||0
1553025|NCT01272960|3799291|P1|NOT COMPLETED|Overall Study||0
1553026|NCT01272960|3799290|P2|COMPLETED|Overall Study||15
1553027|NCT01272960|3799291|P1|COMPLETED|Overall Study||14
1553028|NCT01272960|3799290|P2|STARTED|Overall Study||15
1553029|NCT01272960|3799291|P1|STARTED|Overall Study||14
1553030|NCT01272947|3799305|P2|NOT COMPLETED|Overall Study||2
1553031|NCT01272947|3799306|P1|NOT COMPLETED|Overall Study||2
1553032|NCT01272947|3799305|P2|COMPLETED|Overall Study||98
1553033|NCT01272947|3799306|P1|COMPLETED|Overall Study||102
1553034|NCT01272947|3799305|P2|STARTED|Overall Study||100
1553035|NCT01272947|3799306|P1|STARTED|Overall Study||104
1553036|NCT01272934|3799316|P2|NOT COMPLETED|Overall Study||2
1553037|NCT01272934|3799317|P1|NOT COMPLETED|Overall Study||0
1553038|NCT01272934|3799316|P2|COMPLETED|Overall Study||101
1553039|NCT01272934|3799317|P1|COMPLETED|Overall Study||102
1553040|NCT01272934|3799316|P2|STARTED|Overall Study||103
1553041|NCT01272934|3799317|P1|STARTED|Overall Study||102
1553042|NCT01272921|3799327|P2|NOT COMPLETED|Overall Study||1
1553043|NCT01272921|3799328|P1|NOT COMPLETED|Overall Study||2
1553044|NCT01272921|3799327|P2|COMPLETED|Overall Study||70
1553045|NCT01272921|3799328|P1|COMPLETED|Overall Study||69
1553046|NCT01272921|3799327|P2|STARTED|Overall Study||71
1553047|NCT01272921|3799328|P1|STARTED|Overall Study||71
1553048|NCT01272908|3799336|P1|NOT COMPLETED|Re-Treatment Period||6
1553049|NCT01272908|3799336|P1|COMPLETED|Re-Treatment Period||71
1553050|NCT01272908|3799336|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
1553051|NCT01272908|3799336|P1|NOT COMPLETED|Initial Treatment Period||8
1553052|NCT01272908|3799336|P1|COMPLETED|Initial Treatment Period||112
1553053|NCT01272908|3799336|P1|STARTED|Initial Treatment Period||120
1553054|NCT01272882|3799370|P1|NOT COMPLETED|Overall Study||0
1553055|NCT01272882|3799370|P1|COMPLETED|Overall Study||13
1553056|NCT01272882|3799370|P1|STARTED|Overall Study||13
1553057|NCT01272869|3799376|P2|NOT COMPLETED|Period 2 (14 Days)||0
1553058|NCT01272869|3799377|P1|NOT COMPLETED|Period 2 (14 Days)||1
1553059|NCT01272869|3799376|P2|COMPLETED|Period 2 (14 Days)||10
1553060|NCT01272869|3799377|P1|COMPLETED|Period 2 (14 Days)||9
1553061|NCT01272869|3799376|P2|STARTED|Period 2 (14 Days)||10
1553062|NCT01272869|3799377|P1|STARTED|Period 2 (14 Days)||10
1553063|NCT01272869|3799376|P2|NOT COMPLETED|Period 1 (14 Days)||0
1553064|NCT01272869|3799377|P1|NOT COMPLETED|Period 1 (14 Days)||0
1553065|NCT01272869|3799376|P2|COMPLETED|Period 1 (14 Days)||10
1553066|NCT01272869|3799377|P1|COMPLETED|Period 1 (14 Days)||10
1553067|NCT01272869|3799376|P2|STARTED|Period 1 (14 Days)||10
1553068|NCT01272869|3799377|P1|STARTED|Period 1 (14 Days)||10
1553069|NCT01272830|3799385|P2|NOT COMPLETED|Overall Study||5
1553070|NCT01272830|3799386|P1|NOT COMPLETED|Overall Study||8
1553071|NCT01272830|3799385|P2|COMPLETED|Overall Study||21
1553072|NCT01272830|3799386|P1|COMPLETED|Overall Study||17
1553073|NCT01272830|3799385|P2|STARTED|Overall Study||26
1553074|NCT01272830|3799386|P1|STARTED|Overall Study||25
1553075|NCT01272804|3799404|P6|NOT COMPLETED|Overall Study||1
1553076|NCT01272804|3799405|P5|NOT COMPLETED|Overall Study||2
1553077|NCT01272804|3799406|P4|NOT COMPLETED|Overall Study||0
1553078|NCT01272804|3799407|P3|NOT COMPLETED|Overall Study||0
1553079|NCT01272804|3799408|P2|NOT COMPLETED|Overall Study||0
1553080|NCT01272804|3799409|P1|NOT COMPLETED|Overall Study||1
1553081|NCT01272804|3799404|P6|COMPLETED|Overall Study||15
1553082|NCT01272804|3799405|P5|COMPLETED|Overall Study||7
1553083|NCT01272804|3799406|P4|COMPLETED|Overall Study||9
1553084|NCT01272804|3799407|P3|COMPLETED|Overall Study||9
1553085|NCT01272804|3799408|P2|COMPLETED|Overall Study||9
1553086|NCT01272804|3799409|P1|COMPLETED|Overall Study||8
1553087|NCT01272804|3799404|P6|STARTED|Overall Study||16
1553088|NCT01272804|3799405|P5|STARTED|Overall Study||9
1553089|NCT01272804|3799406|P4|STARTED|Overall Study||9
1553090|NCT01272804|3799407|P3|STARTED|Overall Study||9
1553091|NCT01272804|3799408|P2|STARTED|Overall Study||9
1553092|NCT01272804|3799409|P1|STARTED|Overall Study||9
1553093|NCT01272661|3799567|P3|NOT COMPLETED|Overall Study||72
1553094|NCT01272661|3799568|P2|NOT COMPLETED|Overall Study||209
1553095|NCT01272661|3799569|P1|NOT COMPLETED|Overall Study||126
1553096|NCT01272661|3799567|P3|COMPLETED|Overall Study||314
1553097|NCT01272661|3799568|P2|COMPLETED|Overall Study||288
1553098|NCT01272661|3799569|P1|COMPLETED|Overall Study||287
1553099|NCT01272661|3799567|P3|STARTED|Overall Study||386
1553100|NCT01272661|3799568|P2|STARTED|Overall Study||497
1553101|NCT01272661|3799569|P1|STARTED|Overall Study||413
1553102|NCT01272635|3799594|P4|NOT COMPLETED|Overall Study||23
1553103|NCT01272635|3799595|P3|NOT COMPLETED|Overall Study||31
1553104|NCT01272635|3799596|P2|NOT COMPLETED|Overall Study||20
1553105|NCT01272635|3799597|P1|NOT COMPLETED|Overall Study||31
1553106|NCT01272635|3799594|P4|COMPLETED|Overall Study||129
1553107|NCT01272635|3799595|P3|COMPLETED|Overall Study||117
1553108|NCT01272635|3799596|P2|COMPLETED|Overall Study||134
1553109|NCT01272635|3799597|P1|COMPLETED|Overall Study||122
1553110|NCT01272635|3799594|P4|STARTED|Overall Study||152
1553111|NCT01272635|3799595|P3|STARTED|Overall Study||148
1553112|NCT01272635|3799596|P2|STARTED|Overall Study||154
1553113|NCT01272635|3799597|P1|STARTED|Overall Study||153
1553114|NCT01272583|3799615|P2|NOT COMPLETED|Overall Study||0
1553115|NCT01272583|3799616|P1|NOT COMPLETED|Overall Study||0
1553116|NCT01272583|3799615|P2|COMPLETED|Overall Study||8
1553117|NCT01272583|3799616|P1|COMPLETED|Overall Study||8
1553118|NCT01272583|3799615|P2|STARTED|Overall Study||8
1553119|NCT01272583|3799616|P1|STARTED|Overall Study||8
1553120|NCT01272388|3799647|P2|NOT COMPLETED|Overall Study||0
1553121|NCT01272388|3799648|P1|NOT COMPLETED|Overall Study||0
1553122|NCT01272388|3799647|P2|COMPLETED|Overall Study||0
1553123|NCT01272388|3799648|P1|COMPLETED|Overall Study||1
1553124|NCT01272388|3799647|P2|STARTED|Overall Study||0
1553125|NCT01272388|3799648|P1|STARTED|Overall Study||1
1553126|NCT01272284|3799656|P1|NOT COMPLETED|12-month Follow-up Visit||4
1553127|NCT01272284|3799656|P1|COMPLETED|12-month Follow-up Visit||105
1553128|NCT01272284|3799656|P1|STARTED|12-month Follow-up Visit||109
1553129|NCT01272284|3799656|P1|NOT COMPLETED|6-month Follow-up Visit||3
1553130|NCT01272284|3799656|P1|COMPLETED|6-month Follow-up Visit||109
1553131|NCT01272284|3799656|P1|STARTED|6-month Follow-up Visit||112
1553132|NCT01272284|3799656|P1|NOT COMPLETED|3-month Follow-up Visit||1
1553133|NCT01272284|3799656|P1|COMPLETED|3-month Follow-up Visit||112
1553134|NCT01272284|3799656|P1|STARTED|3-month Follow-up Visit||113
1553135|NCT01272245|3799670|P1|NOT COMPLETED|Overall Study||0
1553136|NCT01272245|3799670|P1|COMPLETED|Overall Study||36
1553137|NCT01272245|3799670|P1|STARTED|Overall Study||36
1553138|NCT01272232|3799681|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
1553139|NCT01272232|3799682|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
1553140|NCT01272232|3799683|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
1553141|NCT01272232|3799681|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
1553142|NCT01272232|3799682|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
1553143|NCT01272232|3799683|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
1553144|NCT01272232|3799681|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
1553145|NCT01272232|3799682|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
1553146|NCT01272232|3799683|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
1553147|NCT01272232|3799681|P3|NOT COMPLETED|Weeks 0-56||72
1553148|NCT01272232|3799682|P2|NOT COMPLETED|Weeks 0-56||47
1553149|NCT01272232|3799683|P1|NOT COMPLETED|Weeks 0-56||99
1553150|NCT01272232|3799681|P3|COMPLETED|Weeks 0-56||140
1553151|NCT01272232|3799682|P2|COMPLETED|Weeks 0-56||164
1553152|NCT01272232|3799683|P1|COMPLETED|Weeks 0-56||324
1553153|NCT01272232|3799681|P3|Exposed|Weeks 0-56||212
1553154|NCT01272232|3799682|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
1553155|NCT01272232|3799683|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
1553156|NCT01272232|3799681|P3|STARTED|Weeks 0-56||212
1553157|NCT01272232|3799682|P2|STARTED|Weeks 0-56||211
1553158|NCT01272232|3799683|P1|STARTED|Weeks 0-56||423
1553159|NCT01272219|3799728|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
1553160|NCT01272219|3799729|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
1553161|NCT01272219|3799730|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1553162|NCT01272219|3799731|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1553163|NCT01272219|3799732|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1553164|NCT01272219|3799733|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1553165|NCT01272219|3799728|P6|COMPLETED|Main + Extension Period: Week 0-172||327
1553166|NCT01272219|3799729|P5|COMPLETED|Main + Extension Period: Week 0-172||783
1553167|NCT01272219|3799730|P4|COMPLETED|Main + Extension Period: Week 0-172||0
1553168|NCT01272219|3799731|P3|COMPLETED|Main + Extension Period: Week 0-172||0
1553169|NCT01272219|3799732|P2|COMPLETED|Main + Extension Period: Week 0-172||0
1553170|NCT01272219|3799733|P1|COMPLETED|Main + Extension Period: Week 0-172||0
1553171|NCT01272219|3799728|P6|Exposed|Main + Extension Period: Week 0-172||747
1553172|NCT01272219|3799729|P5|Exposed|Main + Extension Period: Week 0-172||1501
1553173|NCT01272219|3799730|P4|Exposed|Main + Extension Period: Week 0-172||0
1553174|NCT01272219|3799731|P3|Exposed|Main + Extension Period: Week 0-172||0
1553175|NCT01272219|3799732|P2|Exposed|Main + Extension Period: Week 0-172||0
1553176|NCT01272219|3799733|P1|Exposed|Main + Extension Period: Week 0-172||0
1553177|NCT01272219|3799728|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
1553178|NCT01272219|3799729|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
1553179|NCT01272219|3799730|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
1553180|NCT01272219|3799731|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
1553181|NCT01272219|3799732|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
1553182|NCT01272219|3799733|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
1553183|NCT01272219|3799728|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1553184|NCT01272219|3799729|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1553185|NCT01272219|3799730|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
1553186|NCT01272219|3799731|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
1553187|NCT01272219|3799732|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
1553188|NCT01272219|3799733|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1553189|NCT01272219|3799728|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1553190|NCT01272219|3799729|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1553191|NCT01272219|3799730|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
1553192|NCT01272219|3799731|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
1553193|NCT01272219|3799732|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
1553194|NCT01272219|3799733|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1553195|NCT01272219|3799728|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
1553196|NCT01272219|3799729|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
1553197|NCT01272219|3799730|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
1553198|NCT01272219|3799731|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
1553199|NCT01272219|3799732|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
1553200|NCT01272219|3799733|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
1553201|NCT01272219|3799728|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
1553202|NCT01272219|3799729|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
1553203|NCT01272219|3799730|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
1553204|NCT01272219|3799731|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
1553205|NCT01272219|3799732|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
1553206|NCT01272219|3799733|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
1553207|NCT01272219|3799728|P6|COMPLETED|Main Period: Week 0 to Week 56||505
1553208|NCT01272219|3799729|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
1553209|NCT01272219|3799730|P4|COMPLETED|Main Period: Week 0 to Week 56||296
1553210|NCT01272219|3799731|P3|COMPLETED|Main Period: Week 0 to Week 56||0
1553211|NCT01272219|3799732|P2|COMPLETED|Main Period: Week 0 to Week 56||0
1553212|NCT01272219|3799733|P1|COMPLETED|Main Period: Week 0 to Week 56||679
1553213|NCT01272219|3799728|P6|Exposed|Main Period: Week 0 to Week 56||755
1553214|NCT01272219|3799729|P5|Exposed|Main Period: Week 0 to Week 56||1524
1553215|NCT01272219|3799730|P4|Exposed|Main Period: Week 0 to Week 56||487
1553216|NCT01272219|3799731|P3|Exposed|Main Period: Week 0 to Week 56||0
1553217|NCT01272219|3799732|P2|Exposed|Main Period: Week 0 to Week 56||0
1553218|NCT01272219|3799733|P1|Exposed|Main Period: Week 0 to Week 56||957
1553219|NCT01272219|3799728|P6|STARTED|Main Period: Week 0 to Week 56||757
1553220|NCT01272219|3799729|P5|STARTED|Main Period: Week 0 to Week 56||1528
1553221|NCT01272219|3799730|P4|STARTED|Main Period: Week 0 to Week 56||487
1553222|NCT01272219|3799731|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
1553223|NCT01272219|3799732|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
1553224|NCT01272219|3799733|P1|STARTED|Main Period: Week 0 to Week 56||959
1553225|NCT01272193|3799767|P2|NOT COMPLETED|Overall Study||12
1553226|NCT01272193|3799768|P1|NOT COMPLETED|Overall Study||10
1553227|NCT01272193|3799767|P2|COMPLETED|Overall Study||137
1553228|NCT01272193|3799768|P1|COMPLETED|Overall Study||137
1553229|NCT01272193|3799767|P2|STARTED|Overall Study||149
1553230|NCT01272193|3799768|P1|STARTED|Overall Study||147
1553231|NCT01272180|3799788|P4|NOT COMPLETED|Overall Study||14
1553232|NCT01272180|3799789|P3|NOT COMPLETED|Overall Study||13
1553233|NCT01272180|3799790|P2|NOT COMPLETED|Overall Study||21
1553234|NCT01272180|3799791|P1|NOT COMPLETED|Overall Study||17
1553235|NCT01272180|3799788|P4|COMPLETED|Overall Study||107
1553236|NCT01272180|3799789|P3|COMPLETED|Overall Study||109
1553237|NCT01272180|3799790|P2|COMPLETED|Overall Study||100
1553238|NCT01272180|3799791|P1|COMPLETED|Overall Study||103
1553239|NCT01272180|3799788|P4|STARTED|Overall Study||121
1553240|NCT01272180|3799789|P3|STARTED|Overall Study||122
1553241|NCT01272180|3799790|P2|STARTED|Overall Study||121
1553242|NCT01272180|3799791|P1|STARTED|Overall Study||120
1553243|NCT01272141|3799828|P1|NOT COMPLETED|Overall Study||0
1553244|NCT01272141|3799828|P1|COMPLETED|Overall Study||5
1553245|NCT01272141|3799828|P1|STARTED|Overall Study||5
1553246|NCT01272076|3799833|P1|NOT COMPLETED|Overall Study||0
1553247|NCT01272076|3799833|P1|COMPLETED|Overall Study||52
1553248|NCT01272076|3799833|P1|STARTED|Overall Study||52
1553249|NCT01272011|3799840|P3|NOT COMPLETED|Overall Study||0
1553250|NCT01272011|3799841|P2|NOT COMPLETED|Overall Study||2
1553251|NCT01272011|3799842|P1|NOT COMPLETED|Overall Study||0
1553252|NCT01272011|3799840|P3|COMPLETED|Overall Study||3
1553253|NCT01272011|3799841|P2|COMPLETED|Overall Study||8
1553254|NCT01272011|3799842|P1|COMPLETED|Overall Study||3
1553255|NCT01272011|3799840|P3|STARTED|Overall Study||3
1553256|NCT01272011|3799841|P2|STARTED|Overall Study||10
1553257|NCT01272011|3799842|P1|STARTED|Overall Study||3
1553258|NCT01271946|3799855|P2|NOT COMPLETED|Overall Study||0
1553259|NCT01271946|3799856|P1|NOT COMPLETED|Overall Study||0
1553260|NCT01271946|3799855|P2|COMPLETED|Overall Study||5
1553261|NCT01271946|3799856|P1|COMPLETED|Overall Study||346
1553262|NCT01271946|3799855|P2|STARTED|Overall Study||5
1553263|NCT01271946|3799856|P1|STARTED|Overall Study||346
1553264|NCT01271933|3799878|P3|NOT COMPLETED|Double-Blind Phase||12
1553265|NCT01271933|3799879|P2|NOT COMPLETED|Double-Blind Phase||17
1553266|NCT01271933|3799880|P1|NOT COMPLETED|Double-Blind Phase||0
1553267|NCT01271933|3799878|P3|COMPLETED|Double-Blind Phase||47
1553268|NCT01271933|3799879|P2|COMPLETED|Double-Blind Phase||46
1553269|NCT01271933|3799880|P1|COMPLETED|Double-Blind Phase||0
1553270|NCT01271933|3799878|P3|Treated|Double-Blind Phase||58
1553271|NCT01271933|3799879|P2|Treated|Double-Blind Phase||63
1553272|NCT01271933|3799880|P1|Treated|Double-Blind Phase||0
1553273|NCT01271933|3799878|P3|STARTED|Double-Blind Phase||59
1553274|NCT01271933|3799879|P2|STARTED|Double-Blind Phase||63
1553275|NCT01271933|3799880|P1|STARTED|Double-Blind Phase||0
1553276|NCT01271933|3799878|P3|NOT COMPLETED|Single-Blind Phase||0
1553277|NCT01271933|3799879|P2|NOT COMPLETED|Single-Blind Phase||0
1553278|NCT01271933|3799880|P1|NOT COMPLETED|Single-Blind Phase||121
1553279|NCT01271933|3799878|P3|COMPLETED|Single-Blind Phase||0
1553280|NCT01271933|3799879|P2|COMPLETED|Single-Blind Phase||0
1553281|NCT01271933|3799880|P1|COMPLETED|Single-Blind Phase||320
1553282|NCT01271933|3799878|P3|STARTED|Single-Blind Phase||0
1553283|NCT01271933|3799879|P2|STARTED|Single-Blind Phase||0
1553284|NCT01271933|3799880|P1|STARTED|Single-Blind Phase||441
1553285|NCT01271907|3799980|P3|NOT COMPLETED|Overall Study||0
1553286|NCT01271907|3799981|P2|NOT COMPLETED|Overall Study||0
1553287|NCT01271907|3799982|P1|NOT COMPLETED|Overall Study||0
1553288|NCT01271907|3799980|P3|COMPLETED|Overall Study||0
1553289|NCT01271907|3799981|P2|COMPLETED|Overall Study||0
1553290|NCT01271907|3799982|P1|COMPLETED|Overall Study||3
1553291|NCT01271907|3799980|P3|STARTED|Overall Study||0
1553292|NCT01271907|3799981|P2|STARTED|Overall Study||0
1553293|NCT01271907|3799982|P1|STARTED|Overall Study||3
1553294|NCT01271855|3799998|P2|NOT COMPLETED|Overall Study||0
1553295|NCT01271855|3799999|P1|NOT COMPLETED|Overall Study||0
1553296|NCT01271855|3799998|P2|COMPLETED|Overall Study||52
1553297|NCT01271855|3799999|P1|COMPLETED|Overall Study||48
1553298|NCT01271855|3799998|P2|STARTED|Overall Study||52
1553299|NCT01271855|3799999|P1|STARTED|Overall Study||48
1553300|NCT01271803|3800021|P12|NOT COMPLETED|Stage 2||39
1553301|NCT01271803|3800022|P11|NOT COMPLETED|Stage 2||27
1553302|NCT01271803|3800023|P10|NOT COMPLETED|Stage 2||0
1553303|NCT01271803|3800024|P9|NOT COMPLETED|Stage 2||0
1553304|NCT01271803|3800025|P8|NOT COMPLETED|Stage 2||0
1553305|NCT01271803|3800026|P7|NOT COMPLETED|Stage 2||0
1553306|NCT01271803|3800027|P6|NOT COMPLETED|Stage 2||0
1553307|NCT01271803|3800028|P5|NOT COMPLETED|Stage 2||0
1553308|NCT01271803|3800029|P4|NOT COMPLETED|Stage 2||0
1553309|NCT01271803|3800030|P3|NOT COMPLETED|Stage 2||0
1553310|NCT01271803|3800031|P2|NOT COMPLETED|Stage 2||0
1553311|NCT01271803|3800032|P1|NOT COMPLETED|Stage 2||0
1553312|NCT01271803|3800021|P12|COMPLETED|Stage 2||0
1553313|NCT01271803|3800022|P11|COMPLETED|Stage 2||0
1553314|NCT01271803|3800023|P10|COMPLETED|Stage 2||0
1553315|NCT01271803|3800024|P9|COMPLETED|Stage 2||0
1553316|NCT01271803|3800025|P8|COMPLETED|Stage 2||0
1553317|NCT01271803|3800026|P7|COMPLETED|Stage 2||0
1553318|NCT01271803|3800027|P6|COMPLETED|Stage 2||0
1553319|NCT01271803|3800028|P5|COMPLETED|Stage 2||0
1553320|NCT01271803|3800029|P4|COMPLETED|Stage 2||0
1553321|NCT01271803|3800030|P3|COMPLETED|Stage 2||0
1553322|NCT01271803|3800031|P2|COMPLETED|Stage 2||0
1553323|NCT01271803|3800032|P1|COMPLETED|Stage 2||0
1553324|NCT01271803|3800021|P12|STARTED|Stage 2||39
1553325|NCT01271803|3800022|P11|STARTED|Stage 2||27
1553326|NCT01271803|3800023|P10|STARTED|Stage 2||0
1553327|NCT01271803|3800024|P9|STARTED|Stage 2||0
1553328|NCT01271803|3800025|P8|STARTED|Stage 2||0
1553329|NCT01271803|3800026|P7|STARTED|Stage 2||0
1553330|NCT01271803|3800027|P6|STARTED|Stage 2||0
1553331|NCT01271803|3800028|P5|STARTED|Stage 2||0
1553332|NCT01271803|3800029|P4|STARTED|Stage 2||0
1553333|NCT01271803|3800030|P3|STARTED|Stage 2||0
1553334|NCT01271803|3800031|P2|STARTED|Stage 2||0
1553335|NCT01271803|3800032|P1|STARTED|Stage 2||0
1553336|NCT01271803|3800021|P12|NOT COMPLETED|Stage 1||0
1553337|NCT01271803|3800022|P11|NOT COMPLETED|Stage 1||0
1553338|NCT01271803|3800023|P10|NOT COMPLETED|Stage 1||2
1553339|NCT01271803|3800024|P9|NOT COMPLETED|Stage 1||5
1553340|NCT01271803|3800025|P8|NOT COMPLETED|Stage 1||3
1553341|NCT01271803|3800026|P7|NOT COMPLETED|Stage 1||4
1553342|NCT01271803|3800027|P6|NOT COMPLETED|Stage 1||4
1553343|NCT01271803|3800028|P5|NOT COMPLETED|Stage 1||4
1553344|NCT01271803|3800029|P4|NOT COMPLETED|Stage 1||3
1553345|NCT01271803|3800030|P3|NOT COMPLETED|Stage 1||27
1553346|NCT01271803|3800031|P2|NOT COMPLETED|Stage 1||8
1553347|NCT01271803|3800032|P1|NOT COMPLETED|Stage 1||5
1553348|NCT01271803|3800021|P12|COMPLETED|Stage 1||0
1553349|NCT01271803|3800022|P11|COMPLETED|Stage 1||0
1553350|NCT01271803|3800023|P10|COMPLETED|Stage 1||0
1553351|NCT01271803|3800024|P9|COMPLETED|Stage 1||0
1553352|NCT01271803|3800025|P8|COMPLETED|Stage 1||0
1553353|NCT01271803|3800026|P7|COMPLETED|Stage 1||0
1553354|NCT01271803|3800027|P6|COMPLETED|Stage 1||0
1553355|NCT01271803|3800028|P5|COMPLETED|Stage 1||0
1553356|NCT01271803|3800029|P4|COMPLETED|Stage 1||0
1553357|NCT01271803|3800030|P3|COMPLETED|Stage 1||0
1553358|NCT01271803|3800031|P2|COMPLETED|Stage 1||0
1553359|NCT01271803|3800032|P1|COMPLETED|Stage 1||0
1553360|NCT01271803|3800021|P12|STARTED|Stage 1||0
1553361|NCT01271803|3800022|P11|STARTED|Stage 1||0
1553362|NCT01271803|3800023|P10|STARTED|Stage 1||2
1553363|NCT01271803|3800024|P9|STARTED|Stage 1||5
1553364|NCT01271803|3800025|P8|STARTED|Stage 1||3
1553365|NCT01271803|3800026|P7|STARTED|Stage 1||4
1553366|NCT01271803|3800027|P6|STARTED|Stage 1||4
1553367|NCT01271803|3800028|P5|STARTED|Stage 1||4
1553368|NCT01271803|3800029|P4|STARTED|Stage 1||3
1553369|NCT01271803|3800030|P3|STARTED|Stage 1||27
1553370|NCT01271803|3800031|P2|STARTED|Stage 1||8
1553371|NCT01271803|3800032|P1|STARTED|Stage 1||5
1553372|NCT01271712|3800205|P2|NOT COMPLETED|Survival Follow-up||6
1553373|NCT01271712|3800206|P1|NOT COMPLETED|Survival Follow-up||15
1553374|NCT01271712|3800205|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
1553375|NCT01271712|3800206|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
1553376|NCT01271712|3800205|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
1553377|NCT01271712|3800206|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
1553378|NCT01271712|3800205|P2|NOT COMPLETED|Safety Follow-up||15
1553379|NCT01271712|3800206|P1|NOT COMPLETED|Safety Follow-up||21
1553380|NCT01271712|3800205|P2|COMPLETED|Safety Follow-up||37
1553381|NCT01271712|3800206|P1|COMPLETED|Safety Follow-up||97
1553382|NCT01271712|3800205|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
1553383|NCT01271712|3800206|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
1553384|NCT01271712|3800205|P2|NOT COMPLETED|Open Label Treatment||58
1553385|NCT01271712|3800206|P1|NOT COMPLETED|Open Label Treatment||91
1553386|NCT01271712|3800205|P2|COMPLETED|Open Label Treatment||0
1553387|NCT01271712|3800206|P1|COMPLETED|Open Label Treatment||0
1553388|NCT01271712|3800205|P2|STARTED|Open Label Treatment||58
1553389|NCT01271712|3800206|P1|STARTED|Open Label Treatment||91
1553390|NCT01271712|3800205|P2|NOT COMPLETED|Double Blind Treatment||8
1553391|NCT01271712|3800206|P1|NOT COMPLETED|Double Blind Treatment||42
1553392|NCT01271712|3800205|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
1553393|NCT01271712|3800206|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
1553394|NCT01271712|3800205|P2|Participants Received Treatment|Double Blind Treatment||66
1553395|NCT01271712|3800206|P1|Participants Received Treatment|Double Blind Treatment||132
1553396|NCT01271712|3800205|P2|STARTED|Double Blind Treatment||66
1553397|NCT01271712|3800206|P1|STARTED|Double Blind Treatment||133
1553398|NCT01271686|3800227|P1|NOT COMPLETED|Overall Study||0
1553399|NCT01271686|3800227|P1|COMPLETED|Overall Study||16
1553400|NCT01271686|3800227|P1|STARTED|Overall Study||16
1553401|NCT01271543|3800233|P2|NOT COMPLETED|Overall Study||1
1553402|NCT01271543|3800234|P1|NOT COMPLETED|Overall Study||1
1553403|NCT01271543|3800233|P2|COMPLETED|Overall Study||29
1553404|NCT01271543|3800234|P1|COMPLETED|Overall Study||29
1553405|NCT01271543|3800233|P2|STARTED|Overall Study||30
1553406|NCT01271543|3800234|P1|STARTED|Overall Study||30
1553407|NCT01271452|3800244|P2|NOT COMPLETED|Overall Study||8
1553408|NCT01271452|3800245|P1|NOT COMPLETED|Overall Study||7
1553409|NCT01271452|3800244|P2|COMPLETED|Overall Study||104
1553410|NCT01271452|3800245|P1|COMPLETED|Overall Study||105
1553411|NCT01271452|3800244|P2|STARTED|Overall Study||112
1553412|NCT01271452|3800245|P1|STARTED|Overall Study||112
1553413|NCT01271413|3800267|P2|NOT COMPLETED|Overall Study||8
1553414|NCT01271413|3800268|P1|NOT COMPLETED|Overall Study||9
1553415|NCT01271413|3800267|P2|COMPLETED|Overall Study||28
1553416|NCT01271413|3800268|P1|COMPLETED|Overall Study||28
1553417|NCT01271413|3800267|P2|STARTED|Overall Study||36
1553418|NCT01271413|3800268|P1|STARTED|Overall Study||37
1553419|NCT01271244|3800276|P2|NOT COMPLETED|Overall Study||3
1553420|NCT01271244|3800277|P1|NOT COMPLETED|Overall Study||7
1553421|NCT01271244|3800276|P2|COMPLETED|Overall Study||5
1553422|NCT01271244|3800277|P1|COMPLETED|Overall Study||11
1553423|NCT01271244|3800276|P2|STARTED|Overall Study||8
1553424|NCT01271244|3800277|P1|STARTED|Overall Study||18
1553425|NCT01271036|3800285|P2|NOT COMPLETED|Overall Study||0
1553426|NCT01271036|3800286|P1|NOT COMPLETED|Overall Study||0
1553427|NCT01271036|3800285|P2|COMPLETED|Overall Study||62
1553428|NCT01271036|3800286|P1|COMPLETED|Overall Study||62
1553429|NCT01271036|3800285|P2|STARTED|Overall Study||62
1553430|NCT01271036|3800286|P1|STARTED|Overall Study||62
1553431|NCT01271010|3800300|P1|NOT COMPLETED|Overall Study||61
1553432|NCT01271010|3800300|P1|COMPLETED|Overall Study||28
1553433|NCT01271010|3800300|P1|STARTED|Overall Study||89
1553434|NCT01270971|3800315|P2|NOT COMPLETED|Overall Study||23
1553435|NCT01270971|3800316|P1|NOT COMPLETED|Overall Study||52
1553436|NCT01270971|3800315|P2|COMPLETED|Overall Study||171
1553437|NCT01270971|3800316|P1|COMPLETED|Overall Study||348
1553438|NCT01270971|3800315|P2|STARTED|Overall Study||194
1553439|NCT01270971|3800316|P1|STARTED|Overall Study||400
1553440|NCT01270958|3800328|P1|NOT COMPLETED|Overall Study||4
1553441|NCT01270958|3800328|P1|COMPLETED|Overall Study||56
1553442|NCT01270958|3800328|P1|STARTED|Overall Study||60
1553443|NCT01270919|3800352|P1|NOT COMPLETED|Overall Study||0
1553444|NCT01270919|3800352|P1|COMPLETED|Overall Study||0
1553445|NCT01270919|3800352|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
1553446|NCT01270880|3800357|P1|NOT COMPLETED|Overall Study||1
1553447|NCT01270880|3800357|P1|COMPLETED|Overall Study||17
1553448|NCT01270880|3800357|P1|STARTED|Overall Study||18
1553449|NCT01270867|3800368|P2|NOT COMPLETED|Overall Study||0
1553450|NCT01270867|3800369|P1|NOT COMPLETED|Overall Study||1
1553451|NCT01270867|3800368|P2|COMPLETED|Overall Study||88
1553452|NCT01270867|3800369|P1|COMPLETED|Overall Study||89
1553453|NCT01270867|3800368|P2|STARTED|Overall Study||88
1553454|NCT01270867|3800369|P1|STARTED|Overall Study||90
1553455|NCT01270841|3800387|P4|NOT COMPLETED|Overall Study||13
1553456|NCT01270841|3800388|P3|NOT COMPLETED|Overall Study||11
1553457|NCT01270841|3800389|P2|NOT COMPLETED|Overall Study||14
1553458|NCT01270841|3800390|P1|NOT COMPLETED|Overall Study||13
1553459|NCT01270841|3800387|P4|COMPLETED|Overall Study||20
1553460|NCT01270841|3800388|P3|COMPLETED|Overall Study||18
1553461|NCT01270841|3800389|P2|COMPLETED|Overall Study||19
1553462|NCT01270841|3800390|P1|COMPLETED|Overall Study||16
1553463|NCT01270841|3800387|P4|STARTED|Overall Study||33
1553464|NCT01270841|3800388|P3|STARTED|Overall Study||29
1553465|NCT01270841|3800389|P2|STARTED|Overall Study||33
1553466|NCT01270841|3800390|P1|STARTED|Overall Study||29
1553467|NCT01270828|3800414|P3|NOT COMPLETED|Double Blind Phase||0
1553468|NCT01270828|3800415|P2|NOT COMPLETED|Double Blind Phase||45
1553469|NCT01270828|3800416|P1|NOT COMPLETED|Double Blind Phase||26
1553470|NCT01270828|3800414|P3|COMPLETED|Double Blind Phase||0
1553471|NCT01270828|3800415|P2|COMPLETED|Double Blind Phase||160
1553472|NCT01270828|3800416|P1|COMPLETED|Double Blind Phase||182
1553473|NCT01270828|3800414|P3|STARTED|Double Blind Phase||0
1553474|NCT01270828|3800415|P2|STARTED|Double Blind Phase||205
1553475|NCT01270828|3800416|P1|STARTED|Double Blind Phase||208
1553476|NCT01270828|3800414|P3|NOT COMPLETED|Pregabalin CR SB||146
1553477|NCT01270828|3800415|P2|NOT COMPLETED|Pregabalin CR SB||0
1553478|NCT01270828|3800416|P1|NOT COMPLETED|Pregabalin CR SB||0
1553479|NCT01270828|3800414|P3|COMPLETED|Pregabalin CR SB||660
1553480|NCT01270828|3800415|P2|COMPLETED|Pregabalin CR SB||0
1553481|NCT01270828|3800416|P1|COMPLETED|Pregabalin CR SB||0
1553482|NCT01270828|3800414|P3|STARTED|Pregabalin CR SB||806
1553483|NCT01270828|3800415|P2|STARTED|Pregabalin CR SB||0
1553484|NCT01270828|3800416|P1|STARTED|Pregabalin CR SB||0
1553485|NCT01270802|3800458|P2|NOT COMPLETED|Overall Study||1
1553486|NCT01270802|3800459|P1|NOT COMPLETED|Overall Study||2
1553487|NCT01270802|3800458|P2|COMPLETED|Overall Study||14
1553488|NCT01270802|3800459|P1|COMPLETED|Overall Study||13
1553489|NCT01270802|3800458|P2|STARTED|Overall Study||15
1553490|NCT01270802|3800459|P1|STARTED|Overall Study||15
1553491|NCT01270711|3800475|P8|NOT COMPLETED|Part 2: Effectiveness||0
1553492|NCT01270711|3800476|P7|NOT COMPLETED|Part 2: Effectiveness||0
1553493|NCT01270711|3800477|P6|NOT COMPLETED|Part 2: Effectiveness||0
1553494|NCT01270711|3800478|P5|NOT COMPLETED|Part 2: Effectiveness||0
1553495|NCT01270711|3800479|P4|NOT COMPLETED|Part 2: Effectiveness||0
1553496|NCT01270711|3800480|P3|NOT COMPLETED|Part 2: Effectiveness||0
1553497|NCT01270711|3800481|P2|NOT COMPLETED|Part 2: Effectiveness||0
1553498|NCT01270711|3800482|P1|NOT COMPLETED|Part 2: Effectiveness||0
1553499|NCT01270711|3800475|P8|COMPLETED|Part 2: Effectiveness||48
1553500|NCT01270711|3800476|P7|COMPLETED|Part 2: Effectiveness||2
1553501|NCT01270711|3800477|P6|COMPLETED|Part 2: Effectiveness||11
1553502|NCT01270711|3800478|P5|COMPLETED|Part 2: Effectiveness||0
1553503|NCT01270711|3800479|P4|COMPLETED|Part 2: Effectiveness||0
1553504|NCT01270711|3800480|P3|COMPLETED|Part 2: Effectiveness||0
1553505|NCT01270711|3800481|P2|COMPLETED|Part 2: Effectiveness||0
1553506|NCT01270711|3800482|P1|COMPLETED|Part 2: Effectiveness||0
1553507|NCT01270711|3800475|P8|STARTED|Part 2: Effectiveness||48
1553508|NCT01270711|3800476|P7|STARTED|Part 2: Effectiveness||2
1553509|NCT01270711|3800477|P6|STARTED|Part 2: Effectiveness||11
1553510|NCT01270711|3800478|P5|STARTED|Part 2: Effectiveness||0
1553511|NCT01270711|3800479|P4|STARTED|Part 2: Effectiveness||0
1553512|NCT01270711|3800480|P3|STARTED|Part 2: Effectiveness||0
1553513|NCT01270711|3800481|P2|STARTED|Part 2: Effectiveness||0
1553514|NCT01270711|3800482|P1|STARTED|Part 2: Effectiveness||0
1553515|NCT01270711|3800475|P8|NOT COMPLETED|Part 1: Compliance||0
1553516|NCT01270711|3800476|P7|NOT COMPLETED|Part 1: Compliance||0
1553517|NCT01270711|3800477|P6|NOT COMPLETED|Part 1: Compliance||0
1553518|NCT01270711|3800478|P5|NOT COMPLETED|Part 1: Compliance||0
1553519|NCT01270711|3800479|P4|NOT COMPLETED|Part 1: Compliance||0
1553520|NCT01270711|3800480|P3|NOT COMPLETED|Part 1: Compliance||0
1553521|NCT01270711|3800481|P2|NOT COMPLETED|Part 1: Compliance||0
1553522|NCT01270711|3800482|P1|NOT COMPLETED|Part 1: Compliance||0
1553523|NCT01270711|3800475|P8|COMPLETED|Part 1: Compliance||0
1553524|NCT01270711|3800476|P7|COMPLETED|Part 1: Compliance||0
1553525|NCT01270711|3800477|P6|COMPLETED|Part 1: Compliance||0
1553526|NCT01270711|3800478|P5|COMPLETED|Part 1: Compliance||2024
1553527|NCT01270711|3800479|P4|COMPLETED|Part 1: Compliance||5486
1553528|NCT01270711|3800480|P3|COMPLETED|Part 1: Compliance||326
1553529|NCT01270711|3800481|P2|COMPLETED|Part 1: Compliance||6580
1553530|NCT01270711|3800482|P1|COMPLETED|Part 1: Compliance||7537
1553531|NCT01270711|3800475|P8|STARTED|Part 1: Compliance||0
1553532|NCT01270711|3800476|P7|STARTED|Part 1: Compliance||0
1553533|NCT01270711|3800477|P6|STARTED|Part 1: Compliance||0
1553534|NCT01270711|3800478|P5|STARTED|Part 1: Compliance||2024
1553535|NCT01270711|3800479|P4|STARTED|Part 1: Compliance||5486
1553536|NCT01270711|3800480|P3|STARTED|Part 1: Compliance||326
1553537|NCT01270711|3800481|P2|STARTED|Part 1: Compliance||6580
1553538|NCT01270711|3800482|P1|STARTED|Part 1: Compliance||7537
1553539|NCT01270659|3800583|P4|NOT COMPLETED|Overall Study||0
1553540|NCT01270659|3800584|P3|NOT COMPLETED|Overall Study||0
1553541|NCT01270659|3800585|P2|NOT COMPLETED|Overall Study||0
1553542|NCT01270659|3800586|P1|NOT COMPLETED|Overall Study||0
1553543|NCT01270659|3800583|P4|COMPLETED|Overall Study||25
1553544|NCT01270659|3800584|P3|COMPLETED|Overall Study||4
1553545|NCT01270659|3800585|P2|COMPLETED|Overall Study||25
1553546|NCT01270659|3800586|P1|COMPLETED|Overall Study||6
1553547|NCT01270659|3800583|P4|STARTED|Overall Study||25
1553548|NCT01270659|3800584|P3|STARTED|Overall Study||4
1553549|NCT01270659|3800585|P2|STARTED|Overall Study||25
1553550|NCT01270659|3800586|P1|STARTED|Overall Study||6
1553551|NCT01270620|3800606|P2|NOT COMPLETED|Overall Study||3
1553552|NCT01270620|3800607|P1|NOT COMPLETED|Overall Study||1
1553553|NCT01270620|3800606|P2|COMPLETED|Overall Study||47
1553554|NCT01270620|3800607|P1|COMPLETED|Overall Study||49
1553555|NCT01270620|3800606|P2|STARTED|Overall Study||50
1553556|NCT01270620|3800607|P1|STARTED|Overall Study||50
1553557|NCT01270581|3800659|P2|NOT COMPLETED|Overall Study||0
1553558|NCT01270581|3800660|P1|NOT COMPLETED|Overall Study||1
1553559|NCT01270581|3800659|P2|COMPLETED|Overall Study||3
1553560|NCT01270581|3800660|P1|COMPLETED|Overall Study||3
1553561|NCT01270581|3800659|P2|STARTED|Overall Study||3
1553562|NCT01270581|3800660|P1|STARTED|Overall Study||4
1553563|NCT01270555|3800666|P1|NOT COMPLETED|Overall Study||13
1553564|NCT01270555|3800666|P1|COMPLETED|Overall Study||19
1553565|NCT01270555|3800666|P1|STARTED|Overall Study||32
1553566|NCT01270542|3800678|P2|NOT COMPLETED|Overall Study||1
1553567|NCT01270542|3800679|P1|NOT COMPLETED|Overall Study||1
1553568|NCT01270542|3800678|P2|COMPLETED|Overall Study||8
1553569|NCT01270542|3800679|P1|COMPLETED|Overall Study||9
1553570|NCT01270542|3800678|P2|STARTED|Overall Study||9
1553571|NCT01270542|3800679|P1|STARTED|Overall Study||10
1553572|NCT01270529|3800692|P3|NOT COMPLETED|Overall Study||0
1553573|NCT01270529|3800693|P2|NOT COMPLETED|Overall Study||0
1553574|NCT01270529|3800694|P1|NOT COMPLETED|Overall Study||0
1553575|NCT01270529|3800692|P3|COMPLETED|Overall Study||25
1553576|NCT01270529|3800693|P2|COMPLETED|Overall Study||7
1553577|NCT01270529|3800694|P1|COMPLETED|Overall Study||12
1553578|NCT01270529|3800692|P3|STARTED|Overall Study||25
1553579|NCT01270529|3800693|P2|STARTED|Overall Study||7
1553580|NCT01270529|3800694|P1|STARTED|Overall Study||12
1553581|NCT01270503|3800702|P1|NOT COMPLETED|Overall Study||1
1553582|NCT01270503|3800702|P1|COMPLETED|Overall Study||537
1553583|NCT01270503|3800702|P1|STARTED|Overall Study||538
1553584|NCT01270464|3800710|P3|NOT COMPLETED|Overall Study||18
1553585|NCT01270464|3800711|P2|NOT COMPLETED|Overall Study||12
1553586|NCT01270464|3800712|P1|NOT COMPLETED|Overall Study||20
1553587|NCT01270464|3800710|P3|COMPLETED|Overall Study||88
1553588|NCT01270464|3800711|P2|COMPLETED|Overall Study||92
1553589|NCT01270464|3800712|P1|COMPLETED|Overall Study||85
1553590|NCT01270464|3800710|P3|Pharmacokinetic Analysis Set|Overall Study||103
1553591|NCT01270464|3800711|P2|Pharmacokinetic Analysis Set|Overall Study||103
1553592|NCT01270464|3800712|P1|Pharmacokinetic Analysis Set|Overall Study||105
1553593|NCT01270464|3800710|P3|Full Analysis Set|Overall Study||103
1553594|NCT01270464|3800711|P2|Full Analysis Set|Overall Study||103
1553595|NCT01270464|3800712|P1|Full Analysis Set|Overall Study||105
1553596|NCT01270464|3800710|P3|Safety Analysis Set|Overall Study||103
1553597|NCT01270464|3800711|P2|Safety Analysis Set|Overall Study||103
1553598|NCT01270464|3800712|P1|Safety Analysis Set|Overall Study||105
1553599|NCT01270464|3800710|P3|STARTED|Overall Study||106
1553600|NCT01270464|3800711|P2|STARTED|Overall Study||104
1553601|NCT01270464|3800712|P1|STARTED|Overall Study||105
1553602|NCT01270256|3800761|P2|NOT COMPLETED|Overall Study||0
1553603|NCT01270256|3800762|P1|NOT COMPLETED|Overall Study||1
1553604|NCT01270256|3800761|P2|COMPLETED|Overall Study||20
1553605|NCT01270256|3800762|P1|COMPLETED|Overall Study||20
1553606|NCT01270256|3800761|P2|STARTED|Overall Study||20
1553607|NCT01270256|3800762|P1|STARTED|Overall Study||21
1553608|NCT01270139|3800771|P3|NOT COMPLETED|Overall Study||20
1553609|NCT01270139|3800772|P2|NOT COMPLETED|Overall Study||26
1553610|NCT01270139|3800773|P1|NOT COMPLETED|Overall Study||18
1553611|NCT01270139|3800771|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
1553612|NCT01270139|3800772|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
1553613|NCT01270139|3800773|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
1553614|NCT01270139|3800771|P3|STARTED|Overall Study|Intention-to-treat population|60
1553615|NCT01270139|3800772|P2|STARTED|Overall Study|Intention-to-treat population|60
1553616|NCT01270139|3800773|P1|STARTED|Overall Study|Intention-to-treat population|60
1553617|NCT01270126|3800833|P2|NOT COMPLETED|Overall Study||0
1553618|NCT01270126|3800834|P1|NOT COMPLETED|Overall Study||0
1553619|NCT01270126|3800833|P2|COMPLETED|Overall Study||10
1553620|NCT01270126|3800834|P1|COMPLETED|Overall Study||12
1553621|NCT01270126|3800833|P2|STARTED|Overall Study||10
1553622|NCT01270126|3800834|P1|STARTED|Overall Study||12
1553623|NCT01269918|3800842|P2|NOT COMPLETED|Overall Study||3
1553624|NCT01269918|3800843|P1|NOT COMPLETED|Overall Study||0
1553625|NCT01269918|3800842|P2|COMPLETED|Overall Study||68
1553626|NCT01269918|3800843|P1|COMPLETED|Overall Study||71
1553627|NCT01269918|3800842|P2|STARTED|Overall Study||71
1553628|NCT01269918|3800843|P1|STARTED|Overall Study||71
1553629|NCT01269801|3800877|P2|NOT COMPLETED|Overall Study||3
1553630|NCT01269801|3800878|P1|NOT COMPLETED|Overall Study||0
1553631|NCT01269801|3800877|P2|COMPLETED|Overall Study||77
1553632|NCT01269801|3800878|P1|COMPLETED|Overall Study||74
1553633|NCT01269801|3800877|P2|STARTED|Overall Study||80
1553634|NCT01269801|3800878|P1|STARTED|Overall Study||74
1553635|NCT01269749|3800886|P2|NOT COMPLETED|Overall Study||0
1553636|NCT01269749|3800887|P1|NOT COMPLETED|Overall Study||0
1553637|NCT01269749|3800886|P2|COMPLETED|Overall Study||3
1553638|NCT01269749|3800887|P1|COMPLETED|Overall Study||16
1553639|NCT01269749|3800886|P2|STARTED|Overall Study||3
1553640|NCT01269749|3800887|P1|STARTED|Overall Study||16
1553641|NCT01269736|3800897|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
1553642|NCT01269736|3800898|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
1553643|NCT01269736|3800897|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
1553644|NCT01269736|3800898|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
1553645|NCT01269736|3800897|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
1553646|NCT01269736|3800898|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
1553647|NCT01269736|3800897|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
1553648|NCT01269736|3800898|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
1553649|NCT01269736|3800897|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
1553650|NCT01269736|3800898|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
1553651|NCT01269736|3800897|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
1553652|NCT01269736|3800898|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
1553653|NCT01269736|3800897|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
1553654|NCT01269736|3800898|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
1553655|NCT01269736|3800897|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
1553656|NCT01269736|3800898|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
1553657|NCT01269736|3800897|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
1553658|NCT01269736|3800898|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
1553659|NCT01269736|3800897|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
1553660|NCT01269736|3800898|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
1553661|NCT01269736|3800897|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
1553662|NCT01269736|3800898|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
1553663|NCT01269736|3800897|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
1553664|NCT01269736|3800898|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
1553665|NCT01269736|3800897|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
1553666|NCT01269736|3800898|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
1553667|NCT01269736|3800897|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
1553668|NCT01269736|3800898|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
1553669|NCT01269736|3800897|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
1553670|NCT01269736|3800898|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
1553671|NCT01269736|3800897|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
1553672|NCT01269736|3800898|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
1553673|NCT01269736|3800897|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
1553674|NCT01269736|3800898|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
1553675|NCT01269736|3800897|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
1553676|NCT01269736|3800898|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
1553677|NCT01269710|3800910|P1|NOT COMPLETED|Overall Study||3
1553678|NCT01269710|3800910|P1|COMPLETED|Overall Study|This refers to Week 52.|1
1553679|NCT01269710|3800910|P1|Week 36|Overall Study||2
1553680|NCT01269710|3800910|P1|Week 12|Overall Study||3
1553681|NCT01269710|3800910|P1|STARTED|Overall Study||4
1553682|NCT01269346|3800918|P1|NOT COMPLETED|Extension Phase||43
1553683|NCT01269346|3800918|P1|COMPLETED|Extension Phase||0
1553684|NCT01269346|3800918|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
1553685|NCT01269346|3800918|P1|NOT COMPLETED|Treatment Phase||9
1553686|NCT01269346|3800918|P1|COMPLETED|Treatment Phase||43
1553687|NCT01269346|3800918|P1|Completed 6 Cycles|Treatment Phase||45
1553688|NCT01269346|3800918|P1|STARTED|Treatment Phase||52
1553689|NCT01269125|3800929|P3|NOT COMPLETED|Overall Study||0
1553690|NCT01269125|3800930|P2|NOT COMPLETED|Overall Study||5
1553691|NCT01269125|3800931|P1|NOT COMPLETED|Overall Study||7
1553692|NCT01269125|3800929|P3|COMPLETED|Overall Study||60
1553693|NCT01269125|3800930|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
1553694|NCT01269125|3800931|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
1553695|NCT01269125|3800929|P3|STARTED|Overall Study||60
1553696|NCT01269125|3800930|P2|STARTED|Overall Study||60
1553697|NCT01269125|3800931|P1|STARTED|Overall Study||60
1553698|NCT01269047|3800954|P3|NOT COMPLETED|Overall Study||1
1553699|NCT01269047|3800955|P2|NOT COMPLETED|Overall Study||2
1553700|NCT01269047|3800956|P1|NOT COMPLETED|Overall Study||1
1553701|NCT01269047|3800954|P3|COMPLETED|Overall Study||10
1553702|NCT01269047|3800955|P2|COMPLETED|Overall Study||11
1553703|NCT01269047|3800956|P1|COMPLETED|Overall Study||12
1553704|NCT01269047|3800954|P3|STARTED|Overall Study||11
1553705|NCT01269047|3800955|P2|STARTED|Overall Study||13
1553706|NCT01269047|3800956|P1|STARTED|Overall Study||13
1553707|NCT01268943|3800975|P4|NOT COMPLETED|Overall Study||0
1553708|NCT01268943|3800976|P3|NOT COMPLETED|Overall Study||0
1553709|NCT01268943|3800977|P2|NOT COMPLETED|Overall Study||0
1553710|NCT01268943|3800978|P1|NOT COMPLETED|Overall Study||0
1553711|NCT01268943|3800975|P4|COMPLETED|Overall Study||6
1553712|NCT01268943|3800976|P3|COMPLETED|Overall Study||3
1553713|NCT01268943|3800977|P2|COMPLETED|Overall Study||3
1553714|NCT01268943|3800978|P1|COMPLETED|Overall Study||6
1553715|NCT01268943|3800975|P4|STARTED|Overall Study||6
1553716|NCT01268943|3800976|P3|STARTED|Overall Study||3
1553717|NCT01268943|3800977|P2|STARTED|Overall Study||3
1553718|NCT01268943|3800978|P1|STARTED|Overall Study||6
1553719|NCT01268891|3800990|P2|NOT COMPLETED|Overall Study||8
1553720|NCT01268891|3800991|P1|NOT COMPLETED|Overall Study||8
1553721|NCT01268891|3800990|P2|COMPLETED|Overall Study||58
1553722|NCT01268891|3800991|P1|COMPLETED|Overall Study||58
1553723|NCT01268891|3800990|P2|STARTED|Overall Study||66
1553724|NCT01268891|3800991|P1|STARTED|Overall Study||66
1553725|NCT01268683|3801003|P1|NOT COMPLETED|Overall Study||0
1553726|NCT01268683|3801003|P1|COMPLETED|Overall Study||10
1553727|NCT01268683|3801003|P1|STARTED|Overall Study||10
1553728|NCT01268566|3801010|P1|NOT COMPLETED|Overall Study||43
1553729|NCT01268566|3801010|P1|COMPLETED|Overall Study||13
1553730|NCT01268566|3801010|P1|STARTED|Overall Study||56
1553731|NCT01268553|3801028|P1|NOT COMPLETED|Overall Study||0
1553732|NCT01268553|3801028|P1|COMPLETED|Overall Study||6
1553733|NCT01268553|3801028|P1|STARTED|Overall Study||6
1553734|NCT01268501|3801037|P1|NOT COMPLETED|Overall Study||9
1553735|NCT01268501|3801037|P1|COMPLETED|Overall Study||87
1553736|NCT01268501|3801037|P1|STARTED|Overall Study||96
1553737|NCT01268488|3801041|P1|NOT COMPLETED|Overall Study||5
1553738|NCT01268488|3801041|P1|COMPLETED|Overall Study||93
1553739|NCT01268488|3801041|P1|STARTED|Overall Study||98
1553740|NCT01268306|3801048|P1|NOT COMPLETED|Overall Study||1
1553741|NCT01268306|3801048|P1|COMPLETED|Overall Study||7
1553742|NCT01268306|3801048|P1|STARTED|Overall Study||8
1553743|NCT01268293|3801052|P1|NOT COMPLETED|Overall Study||9
1553744|NCT01268293|3801052|P1|COMPLETED|Overall Study||0
1553745|NCT01268293|3801052|P1|Completed Cycle 1|Overall Study||9
1553746|NCT01268293|3801052|P1|STARTED|Overall Study||9
1553747|NCT01268267|3801057|P1|NOT COMPLETED|Overall Study||1
1553748|NCT01268267|3801057|P1|COMPLETED|Overall Study||93
1553749|NCT01268267|3801057|P1|STARTED|Overall Study||94
1553750|NCT01268189|3801064|P1|NOT COMPLETED|Overall Study||3
1553751|NCT01268189|3801064|P1|COMPLETED|Overall Study||17
1553752|NCT01268189|3801064|P1|STARTED|Overall Study||20
1553753|NCT01268150|3801078|P1|NOT COMPLETED|Extension Phase||27
1553754|NCT01268150|3801078|P1|COMPLETED|Extension Phase||1
1553755|NCT01268150|3801078|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
1553756|NCT01268150|3801078|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
1553757|NCT01268150|3801078|P1|NOT COMPLETED|Treatment Phase||28
1553758|NCT01268150|3801078|P1|COMPLETED|Treatment Phase||28
1553759|NCT01268150|3801078|P1|STARTED|Treatment Phase||56
1553760|NCT01268111|3801088|P2|NOT COMPLETED|Overall Study||0
1553761|NCT01268111|3801089|P1|NOT COMPLETED|Overall Study||0
1553762|NCT01268111|3801088|P2|COMPLETED|Overall Study||6
1553763|NCT01268111|3801089|P1|COMPLETED|Overall Study||6
1553764|NCT01268111|3801088|P2|STARTED|Overall Study||6
1553765|NCT01268111|3801089|P1|STARTED|Overall Study||6
1553766|NCT01268098|3801097|P2|NOT COMPLETED|Overall Study||0
1553767|NCT01268098|3801098|P1|NOT COMPLETED|Overall Study||1
1553768|NCT01268098|3801097|P2|COMPLETED|Overall Study||23
1553769|NCT01268098|3801098|P1|COMPLETED|Overall Study||18
1553770|NCT01268098|3801097|P2|STARTED|Overall Study||23
1553771|NCT01268098|3801098|P1|STARTED|Overall Study||19
1553772|NCT01268046|3801110|P4|NOT COMPLETED|Overall Study||1
1553773|NCT01268046|3801111|P3|NOT COMPLETED|Overall Study||1
1553774|NCT01268046|3801112|P2|NOT COMPLETED|Overall Study||0
1553775|NCT01268046|3801113|P1|NOT COMPLETED|Overall Study||1
1553776|NCT01268046|3801110|P4|COMPLETED|Overall Study||7
1553777|NCT01268046|3801111|P3|COMPLETED|Overall Study||7
1553778|NCT01268046|3801112|P2|COMPLETED|Overall Study||9
1553779|NCT01268046|3801113|P1|COMPLETED|Overall Study||12
1553780|NCT01268046|3801110|P4|STARTED|Overall Study||8
1553781|NCT01268046|3801111|P3|STARTED|Overall Study||8
1553782|NCT01268046|3801112|P2|STARTED|Overall Study||9
1553783|NCT01268046|3801113|P1|STARTED|Overall Study||13
1553784|NCT01267994|3801123|P1|NOT COMPLETED|Overall Study||2
1553785|NCT01267994|3801123|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
1553786|NCT01267994|3801123|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
1553787|NCT01267929|3801130|P2|NOT COMPLETED|Overall Study||0
1553788|NCT01267929|3801131|P1|NOT COMPLETED|Overall Study||0
1553789|NCT01267929|3801130|P2|COMPLETED|Overall Study||15
1553790|NCT01267929|3801131|P1|COMPLETED|Overall Study||15
1553791|NCT01267929|3801130|P2|STARTED|Overall Study||15
1553792|NCT01267929|3801131|P1|STARTED|Overall Study||15
1553793|NCT01267864|3801140|P3|NOT COMPLETED|Overall Study||0
1553794|NCT01267864|3801141|P2|NOT COMPLETED|Overall Study||0
1553795|NCT01267864|3801142|P1|NOT COMPLETED|Overall Study||0
1553796|NCT01267864|3801140|P3|COMPLETED|Overall Study||110
1553797|NCT01267864|3801141|P2|COMPLETED|Overall Study||110
1553798|NCT01267864|3801142|P1|COMPLETED|Overall Study||110
1553799|NCT01267864|3801140|P3|STARTED|Overall Study||110
1553800|NCT01267864|3801141|P2|STARTED|Overall Study||110
1553801|NCT01267864|3801142|P1|STARTED|Overall Study||110
1553802|NCT01267825|3801161|P2|NOT COMPLETED|Overall Study||0
1553803|NCT01267825|3801162|P1|NOT COMPLETED|Overall Study||1
1553804|NCT01267825|3801161|P2|COMPLETED|Overall Study||0
1553805|NCT01267825|3801162|P1|COMPLETED|Overall Study||0
1553806|NCT01267825|3801161|P2|STARTED|Overall Study||0
1553807|NCT01267825|3801162|P1|STARTED|Overall Study||1
1553808|NCT01267422|3801172|P2|NOT COMPLETED|Safety and Efficacy Study||0
1553809|NCT01267422|3801173|P1|NOT COMPLETED|Safety and Efficacy Study||0
1553810|NCT01267422|3801172|P2|COMPLETED|Safety and Efficacy Study||4
1553811|NCT01267422|3801173|P1|COMPLETED|Safety and Efficacy Study||5
1553812|NCT01267422|3801172|P2|STARTED|Safety and Efficacy Study||4
1553813|NCT01267422|3801173|P1|STARTED|Safety and Efficacy Study||5
1553814|NCT01267422|3801172|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
1553815|NCT01267422|3801173|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
1553816|NCT01267422|3801172|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
1553817|NCT01267422|3801173|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
1553818|NCT01267422|3801172|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
1553819|NCT01267422|3801173|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
1553820|NCT01267292|3801193|P2|NOT COMPLETED|Overall Study||6
1553821|NCT01267292|3801194|P1|NOT COMPLETED|Overall Study||4
1553822|NCT01267292|3801193|P2|COMPLETED|Overall Study||20
1553823|NCT01267292|3801194|P1|COMPLETED|Overall Study||20
1553824|NCT01267292|3801193|P2|STARTED|Overall Study||26
1553825|NCT01267292|3801194|P1|STARTED|Overall Study||24
1553826|NCT01267279|3801230|P2|NOT COMPLETED|Overall Study||6
1553827|NCT01267279|3801231|P1|NOT COMPLETED|Overall Study||2
1553828|NCT01267279|3801230|P2|COMPLETED|Overall Study||21
1553829|NCT01267279|3801231|P1|COMPLETED|Overall Study||22
1553830|NCT01267279|3801230|P2|STARTED|Overall Study||27
1553831|NCT01267279|3801231|P1|STARTED|Overall Study||24
1553832|NCT01267266|3801237|P2|NOT COMPLETED|Randomized Phase||0
1553833|NCT01267266|3801238|P1|NOT COMPLETED|Randomized Phase||0
1553834|NCT01267266|3801237|P2|COMPLETED|Randomized Phase||5
1553835|NCT01267266|3801238|P1|COMPLETED|Randomized Phase||3
1553836|NCT01267266|3801237|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
1553837|NCT01267266|3801238|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
1553838|NCT01267266|3801237|P2|NOT COMPLETED|Lead-in Phase||0
1553839|NCT01267266|3801238|P1|NOT COMPLETED|Lead-in Phase||23
1553840|NCT01267266|3801237|P2|COMPLETED|Lead-in Phase||0
1553841|NCT01267266|3801238|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
1553842|NCT01267266|3801237|P2|STARTED|Lead-in Phase||0
1553843|NCT01267266|3801238|P1|STARTED|Lead-in Phase||31
1553844|NCT01267266|3801237|P2|NOT COMPLETED|Enrollment Phase||0
1553845|NCT01267266|3801238|P1|NOT COMPLETED|Enrollment Phase||2
1553846|NCT01267266|3801237|P2|COMPLETED|Enrollment Phase||0
1553847|NCT01267266|3801238|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
1553848|NCT01267266|3801237|P2|STARTED|Enrollment Phase||0
1553849|NCT01267266|3801238|P1|STARTED|Enrollment Phase||33
1553850|NCT01267253|3801251|P1|NOT COMPLETED|Overall Study||3
1553851|NCT01267253|3801251|P1|COMPLETED|Overall Study|Eligible and treated patients|28
1553852|NCT01267253|3801251|P1|STARTED|Overall Study||31
1553853|NCT01267240|3801259|P1|NOT COMPLETED|Overall Study||0
1553854|NCT01267240|3801259|P1|COMPLETED|Overall Study||25
1553855|NCT01267240|3801259|P1|STARTED|Overall Study||25
1553856|NCT01267227|3801269|P4|NOT COMPLETED|Overall Study||3
1553857|NCT01267227|3801270|P3|NOT COMPLETED|Overall Study||2
1553858|NCT01267227|3801271|P2|NOT COMPLETED|Overall Study||1
1553859|NCT01267227|3801272|P1|NOT COMPLETED|Overall Study||1
1553860|NCT01267227|3801269|P4|COMPLETED|Overall Study||17
1553861|NCT01267227|3801270|P3|COMPLETED|Overall Study||18
1553862|NCT01267227|3801271|P2|COMPLETED|Overall Study||19
1553863|NCT01267227|3801272|P1|COMPLETED|Overall Study||19
1553864|NCT01267227|3801269|P4|STARTED|Overall Study||20
1553865|NCT01267227|3801270|P3|STARTED|Overall Study||20
1553866|NCT01267227|3801271|P2|STARTED|Overall Study||20
1553867|NCT01267227|3801272|P1|STARTED|Overall Study||20
1553868|NCT01267201|3801290|P6|NOT COMPLETED|Third Intervention Period||0
1553869|NCT01267201|3801291|P5|NOT COMPLETED|Third Intervention Period||0
1553870|NCT01267201|3801292|P4|NOT COMPLETED|Third Intervention Period||0
1553871|NCT01267201|3801293|P3|NOT COMPLETED|Third Intervention Period||0
1553872|NCT01267201|3801294|P2|NOT COMPLETED|Third Intervention Period||0
1553873|NCT01267201|3801295|P1|NOT COMPLETED|Third Intervention Period||0
1553874|NCT01267201|3801290|P6|COMPLETED|Third Intervention Period||4
1553875|NCT01267201|3801291|P5|COMPLETED|Third Intervention Period||4
1553876|NCT01267201|3801292|P4|COMPLETED|Third Intervention Period||4
1553877|NCT01267201|3801293|P3|COMPLETED|Third Intervention Period||4
1553878|NCT01267201|3801294|P2|COMPLETED|Third Intervention Period||3
1553879|NCT01267201|3801295|P1|COMPLETED|Third Intervention Period||3
1553880|NCT01267201|3801290|P6|STARTED|Third Intervention Period||4
1553881|NCT01267201|3801291|P5|STARTED|Third Intervention Period||4
1553882|NCT01267201|3801292|P4|STARTED|Third Intervention Period||4
1553883|NCT01267201|3801293|P3|STARTED|Third Intervention Period||4
1553884|NCT01267201|3801294|P2|STARTED|Third Intervention Period||3
1553885|NCT01267201|3801295|P1|STARTED|Third Intervention Period||3
1553886|NCT01267201|3801290|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553887|NCT01267201|3801291|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553888|NCT01267201|3801292|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553889|NCT01267201|3801293|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553890|NCT01267201|3801294|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553891|NCT01267201|3801295|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553892|NCT01267201|3801290|P6|COMPLETED|Washout Period (At Least 2 Days)||4
1553893|NCT01267201|3801291|P5|COMPLETED|Washout Period (At Least 2 Days)||4
1553894|NCT01267201|3801292|P4|COMPLETED|Washout Period (At Least 2 Days)||4
1553895|NCT01267201|3801293|P3|COMPLETED|Washout Period (At Least 2 Days)||4
1553896|NCT01267201|3801294|P2|COMPLETED|Washout Period (At Least 2 Days)||3
1553897|NCT01267201|3801295|P1|COMPLETED|Washout Period (At Least 2 Days)||3
1553898|NCT01267201|3801290|P6|STARTED|Washout Period (At Least 2 Days)||4
1553899|NCT01267201|3801291|P5|STARTED|Washout Period (At Least 2 Days)||4
1553900|NCT01267201|3801292|P4|STARTED|Washout Period (At Least 2 Days)||4
1553901|NCT01267201|3801293|P3|STARTED|Washout Period (At Least 2 Days)||4
1553902|NCT01267201|3801294|P2|STARTED|Washout Period (At Least 2 Days)||3
1553903|NCT01267201|3801295|P1|STARTED|Washout Period (At Least 2 Days)||3
1553904|NCT01267201|3801290|P6|NOT COMPLETED|Second Intervention Period||0
1553905|NCT01267201|3801291|P5|NOT COMPLETED|Second Intervention Period||0
1553906|NCT01267201|3801292|P4|NOT COMPLETED|Second Intervention Period||0
1553907|NCT01267201|3801293|P3|NOT COMPLETED|Second Intervention Period||0
1553908|NCT01267201|3801294|P2|NOT COMPLETED|Second Intervention Period||1
1553909|NCT01267201|3801295|P1|NOT COMPLETED|Second Intervention Period||0
1553910|NCT01267201|3801290|P6|COMPLETED|Second Intervention Period||4
1553911|NCT01267201|3801291|P5|COMPLETED|Second Intervention Period||4
1553912|NCT01267201|3801292|P4|COMPLETED|Second Intervention Period||4
1553913|NCT01267201|3801293|P3|COMPLETED|Second Intervention Period||4
1553914|NCT01267201|3801294|P2|COMPLETED|Second Intervention Period||3
1553915|NCT01267201|3801295|P1|COMPLETED|Second Intervention Period||3
1553916|NCT01267201|3801290|P6|STARTED|Second Intervention Period||4
1553917|NCT01267201|3801291|P5|STARTED|Second Intervention Period||4
1553918|NCT01267201|3801292|P4|STARTED|Second Intervention Period||4
1553919|NCT01267201|3801293|P3|STARTED|Second Intervention Period||4
1553920|NCT01267201|3801294|P2|STARTED|Second Intervention Period||4
1553921|NCT01267201|3801295|P1|STARTED|Second Intervention Period||3
1553922|NCT01267201|3801290|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553923|NCT01267201|3801291|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553924|NCT01267201|3801292|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553925|NCT01267201|3801293|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553926|NCT01267201|3801294|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553927|NCT01267201|3801295|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1553928|NCT01267201|3801290|P6|COMPLETED|Washout Period (At Least 2 Days)||4
1553929|NCT01267201|3801291|P5|COMPLETED|Washout Period (At Least 2 Days)||4
1553930|NCT01267201|3801292|P4|COMPLETED|Washout Period (At Least 2 Days)||4
1553931|NCT01267201|3801293|P3|COMPLETED|Washout Period (At Least 2 Days)||4
1553932|NCT01267201|3801294|P2|COMPLETED|Washout Period (At Least 2 Days)||4
1553933|NCT01267201|3801295|P1|COMPLETED|Washout Period (At Least 2 Days)||3
1553934|NCT01267201|3801290|P6|STARTED|Washout Period (At Least 2 Days)||4
1553935|NCT01267201|3801291|P5|STARTED|Washout Period (At Least 2 Days)||4
1553936|NCT01267201|3801292|P4|STARTED|Washout Period (At Least 2 Days)||4
1553937|NCT01267201|3801293|P3|STARTED|Washout Period (At Least 2 Days)||4
1553938|NCT01267201|3801294|P2|STARTED|Washout Period (At Least 2 Days)||4
1553939|NCT01267201|3801295|P1|STARTED|Washout Period (At Least 2 Days)||3
1553940|NCT01267201|3801290|P6|NOT COMPLETED|First Intervention Period||0
1553941|NCT01267201|3801291|P5|NOT COMPLETED|First Intervention Period||0
1553942|NCT01267201|3801292|P4|NOT COMPLETED|First Intervention Period||0
1553943|NCT01267201|3801293|P3|NOT COMPLETED|First Intervention Period||0
1553944|NCT01267201|3801294|P2|NOT COMPLETED|First Intervention Period||0
1553945|NCT01267201|3801295|P1|NOT COMPLETED|First Intervention Period||1
1553946|NCT01267201|3801290|P6|COMPLETED|First Intervention Period||4
1553947|NCT01267201|3801291|P5|COMPLETED|First Intervention Period||4
1553948|NCT01267201|3801292|P4|COMPLETED|First Intervention Period||4
1553949|NCT01267201|3801293|P3|COMPLETED|First Intervention Period||4
1553950|NCT01267201|3801294|P2|COMPLETED|First Intervention Period||4
1553951|NCT01267201|3801295|P1|COMPLETED|First Intervention Period||3
1553952|NCT01267201|3801290|P6|STARTED|First Intervention Period||4
1553953|NCT01267201|3801291|P5|STARTED|First Intervention Period||4
1553954|NCT01267201|3801292|P4|STARTED|First Intervention Period||4
1553955|NCT01267201|3801293|P3|STARTED|First Intervention Period||4
1553956|NCT01267201|3801294|P2|STARTED|First Intervention Period||4
1553957|NCT01267201|3801295|P1|STARTED|First Intervention Period||4
1553958|NCT01267175|3801312|P1|NOT COMPLETED|Overall Study||2
1553959|NCT01267175|3801312|P1|COMPLETED|Overall Study||29
1553960|NCT01267175|3801312|P1|STARTED|Overall Study||31
1553961|NCT01267136|3801319|P2|NOT COMPLETED|Overall Study||6
1553962|NCT01267136|3801320|P1|NOT COMPLETED|Overall Study||4
1553963|NCT01267136|3801319|P2|COMPLETED|Overall Study||36
1553964|NCT01267136|3801320|P1|COMPLETED|Overall Study||38
1553965|NCT01267136|3801319|P2|STARTED|Overall Study||42
1553966|NCT01267136|3801320|P1|STARTED|Overall Study||42
1553967|NCT01267045|3801330|P2|NOT COMPLETED|6-month Outcome||3
1553968|NCT01267045|3801331|P1|NOT COMPLETED|6-month Outcome||0
1553969|NCT01267045|3801330|P2|COMPLETED|6-month Outcome||23
1553970|NCT01267045|3801331|P1|COMPLETED|6-month Outcome||22
1553971|NCT01267045|3801330|P2|STARTED|6-month Outcome||26
1553972|NCT01267045|3801331|P1|STARTED|6-month Outcome||22
1553973|NCT01267045|3801330|P2|NOT COMPLETED|2-month Outcomes||3
1553974|NCT01267045|3801331|P1|NOT COMPLETED|2-month Outcomes||4
1553975|NCT01267045|3801330|P2|COMPLETED|2-month Outcomes||26
1553976|NCT01267045|3801331|P1|COMPLETED|2-month Outcomes||22
1553977|NCT01267045|3801330|P2|STARTED|2-month Outcomes||29
1553978|NCT01267045|3801331|P1|STARTED|2-month Outcomes||26
1553979|NCT01267019|3801366|P3|NOT COMPLETED|Overall Study||6
1553980|NCT01267019|3801367|P2|NOT COMPLETED|Overall Study||6
1553981|NCT01267019|3801368|P1|NOT COMPLETED|Overall Study||6
1553982|NCT01267019|3801366|P3|COMPLETED|Overall Study||47
1553983|NCT01267019|3801367|P2|COMPLETED|Overall Study||47
1553984|NCT01267019|3801368|P1|COMPLETED|Overall Study||41
1553985|NCT01267019|3801366|P3|STARTED|Overall Study||53
1553986|NCT01267019|3801367|P2|STARTED|Overall Study||53
1553987|NCT01267019|3801368|P1|STARTED|Overall Study||47
1553988|NCT01266967|3801384|P2|NOT COMPLETED|Overall Study||83
1553989|NCT01266967|3801385|P1|NOT COMPLETED|Overall Study||89
1553990|NCT01266967|3801384|P2|COMPLETED|Overall Study||0
1553991|NCT01266967|3801385|P1|COMPLETED|Overall Study||0
1553992|NCT01266967|3801384|P2|STARTED|Overall Study||83
1553993|NCT01266967|3801385|P1|STARTED|Overall Study||89
1553994|NCT01266876|3801437|P5|NOT COMPLETED|Overall Study||0
1553995|NCT01266876|3801438|P4|NOT COMPLETED|Overall Study||1
1553996|NCT01266876|3801439|P3|NOT COMPLETED|Overall Study||0
1553997|NCT01266876|3801440|P2|NOT COMPLETED|Overall Study||0
1553998|NCT01266876|3801441|P1|NOT COMPLETED|Overall Study||0
1553999|NCT01266876|3801437|P5|COMPLETED|Overall Study||16
1554000|NCT01266876|3801438|P4|COMPLETED|Overall Study||14
1554001|NCT01266876|3801439|P3|COMPLETED|Overall Study||16
1554002|NCT01266876|3801440|P2|COMPLETED|Overall Study||15
1554003|NCT01266876|3801441|P1|COMPLETED|Overall Study||15
1554004|NCT01266876|3801437|P5|STARTED|Overall Study||16
1554005|NCT01266876|3801438|P4|STARTED|Overall Study||15
1554006|NCT01266876|3801439|P3|STARTED|Overall Study||16
1554007|NCT01266876|3801440|P2|STARTED|Overall Study||15
1554008|NCT01266876|3801441|P1|STARTED|Overall Study||15
1554009|NCT01266850|3801548|P5|NOT COMPLETED|Overall Study||30
1554010|NCT01266850|3801549|P4|NOT COMPLETED|Overall Study||28
1554011|NCT01266850|3801550|P3|NOT COMPLETED|Overall Study||24
1554012|NCT01266850|3801551|P2|NOT COMPLETED|Overall Study||36
1554013|NCT01266850|3801552|P1|NOT COMPLETED|Overall Study||30
1554014|NCT01266850|3801548|P5|COMPLETED|Overall Study||297
1554015|NCT01266850|3801549|P4|COMPLETED|Overall Study||301
1554016|NCT01266850|3801550|P3|COMPLETED|Overall Study||214
1554017|NCT01266850|3801551|P2|COMPLETED|Overall Study||212
1554018|NCT01266850|3801552|P1|COMPLETED|Overall Study||212
1554019|NCT01266850|3801548|P5|Received Third Vaccine|Overall Study||299
1554020|NCT01266850|3801549|P4|Received Third Vaccine|Overall Study||0
1554021|NCT01266850|3801550|P3|Received Third Vaccine|Overall Study||217
1554022|NCT01266850|3801551|P2|Received Third Vaccine|Overall Study||221
1554023|NCT01266850|3801552|P1|Received Third Vaccine|Overall Study||221
1554024|NCT01266850|3801548|P5|Received Second Vaccine|Overall Study||307
1554025|NCT01266850|3801549|P4|Received Second Vaccine|Overall Study||311
1554026|NCT01266850|3801550|P3|Received Second Vaccine|Overall Study||227
1554027|NCT01266850|3801551|P2|Received Second Vaccine|Overall Study||233
1554028|NCT01266850|3801552|P1|Received Second Vaccine|Overall Study||231
1554029|NCT01266850|3801548|P5|STARTED|Overall Study||327
1554030|NCT01266850|3801549|P4|STARTED|Overall Study||329
1554031|NCT01266850|3801550|P3|STARTED|Overall Study||238
1554032|NCT01266850|3801551|P2|STARTED|Overall Study||248
1554033|NCT01266850|3801552|P1|STARTED|Overall Study||242
1554034|NCT01266824|3801606|P2|NOT COMPLETED|Overall Study||3
1554035|NCT01266824|3801607|P1|NOT COMPLETED|Overall Study||2
1554036|NCT01266824|3801606|P2|COMPLETED|Overall Study||0
1554037|NCT01266824|3801607|P1|COMPLETED|Overall Study||0
1554038|NCT01266824|3801606|P2|STARTED|Overall Study||3
1554039|NCT01266824|3801607|P1|STARTED|Overall Study||2
1554040|NCT01266590|3801619|P1|NOT COMPLETED|Overall Study||6
1554041|NCT01266590|3801619|P1|COMPLETED|Overall Study||24
1554042|NCT01266590|3801619|P1|STARTED|Overall Study||30
1554043|NCT01266447|3801630|P1|NOT COMPLETED|Overall Study||0
1554044|NCT01266447|3801630|P1|COMPLETED|Overall Study|Eligible and treated patients|27
1554045|NCT01266447|3801630|P1|STARTED|Overall Study||27
1554046|NCT01266317|3801639|P1|NOT COMPLETED|Overall Study||2
1554047|NCT01266317|3801639|P1|COMPLETED|Overall Study||7
1554048|NCT01266317|3801639|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
1554049|NCT01266291|3801644|P1|NOT COMPLETED|Overall Study||1
1554050|NCT01266291|3801644|P1|COMPLETED|Overall Study||0
1554051|NCT01266291|3801644|P1|STARTED|Overall Study||1
1554052|NCT01266265|3801651|P2|NOT COMPLETED|Overall Study||190
1554053|NCT01266265|3801652|P1|NOT COMPLETED|Overall Study||205
1554054|NCT01266265|3801651|P2|COMPLETED|Overall Study||477
1554055|NCT01266265|3801652|P1|COMPLETED|Overall Study||461
1554056|NCT01266265|3801651|P2|STARTED|Overall Study||667
1554057|NCT01266265|3801652|P1|STARTED|Overall Study||666
1554058|NCT01266161|3801660|P2|NOT COMPLETED|Overall Study||1
1554059|NCT01266161|3801661|P1|NOT COMPLETED|Overall Study||4
1554060|NCT01266161|3801660|P2|COMPLETED|Overall Study||53
1554061|NCT01266161|3801661|P1|COMPLETED|Overall Study||48
1554062|NCT01266161|3801660|P2|STARTED|Overall Study||54
1554063|NCT01266161|3801661|P1|STARTED|Overall Study||52
1554064|NCT01266148|3801693|P2|NOT COMPLETED|Overall Study||3
1554065|NCT01266148|3801694|P1|NOT COMPLETED|Overall Study||7
1554066|NCT01266148|3801693|P2|COMPLETED|Overall Study||56
1554067|NCT01266148|3801694|P1|COMPLETED|Overall Study||49
1554068|NCT01266148|3801693|P2|STARTED|Overall Study||59
1554069|NCT01266148|3801694|P1|STARTED|Overall Study||56
1554070|NCT01266122|3801722|P2|NOT COMPLETED|Overall Study||6
1554071|NCT01266122|3801723|P1|NOT COMPLETED|Overall Study||6
1554072|NCT01266122|3801722|P2|COMPLETED|Overall Study||42
1554073|NCT01266122|3801723|P1|COMPLETED|Overall Study||42
1554074|NCT01266122|3801722|P2|STARTED|Overall Study||48
1554075|NCT01266122|3801723|P1|STARTED|Overall Study||48
1554076|NCT01266070|3801731|P1|NOT COMPLETED|Overall Study||4
1554077|NCT01266070|3801731|P1|COMPLETED|Overall Study||2
1554078|NCT01266070|3801731|P1|STARTED|Overall Study||6
1554079|NCT01266031|3801739|P3|NOT COMPLETED|Overall Study||2
1554080|NCT01266031|3801740|P2|NOT COMPLETED|Overall Study||3
1554081|NCT01266031|3801741|P1|NOT COMPLETED|Overall Study||0
1554082|NCT01266031|3801739|P3|COMPLETED|Overall Study||47
1554083|NCT01266031|3801740|P2|COMPLETED|Overall Study||38
1554084|NCT01266031|3801741|P1|COMPLETED|Overall Study||6
1554085|NCT01266031|3801739|P3|STARTED|Overall Study||49
1554086|NCT01266031|3801740|P2|STARTED|Overall Study||41
1554087|NCT01266031|3801741|P1|STARTED|Overall Study||6
1554088|NCT01266018|3801768|P2|NOT COMPLETED|Overall Study||1
1554089|NCT01266018|3801769|P1|NOT COMPLETED|Overall Study||1
1554090|NCT01266018|3801768|P2|COMPLETED|Overall Study||12
1554091|NCT01266018|3801769|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
1554092|NCT01266018|3801768|P2|STARTED|Overall Study||13
1554093|NCT01266018|3801769|P1|STARTED|Overall Study||9
1554094|NCT01265992|3801780|P1|NOT COMPLETED|Overall Study||9
1554095|NCT01265992|3801780|P1|COMPLETED|Overall Study||41
1554096|NCT01265992|3801780|P1|Received Treatment|Overall Study||49
1554097|NCT01265992|3801780|P1|STARTED|Overall Study||50
1554098|NCT01265966|3801796|P3|NOT COMPLETED|Overall Study||2
1554099|NCT01265966|3801797|P2|NOT COMPLETED|Overall Study||2
1554100|NCT01265966|3801798|P1|NOT COMPLETED|Overall Study||3
1554101|NCT01265966|3801796|P3|COMPLETED|Overall Study||27
1554102|NCT01265966|3801797|P2|COMPLETED|Overall Study||39
1554103|NCT01265966|3801798|P1|COMPLETED|Overall Study||44
1554104|NCT01265966|3801796|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
1554105|NCT01265966|3801797|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
1554106|NCT01265966|3801798|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
1554107|NCT01265966|3801796|P3|STARTED|Overall Study||29
1554108|NCT01265966|3801797|P2|STARTED|Overall Study||41
1554109|NCT01265966|3801798|P1|STARTED|Overall Study||47
1554110|NCT01265953|3801808|P2|NOT COMPLETED|Overall Study||3
1554111|NCT01265953|3801809|P1|NOT COMPLETED|Overall Study||5
1554112|NCT01265953|3801808|P2|COMPLETED|Overall Study||45
1554113|NCT01265953|3801809|P1|COMPLETED|Overall Study||45
1554114|NCT01265953|3801808|P2|STARTED|Overall Study||48
1554115|NCT01265953|3801809|P1|STARTED|Overall Study||50
1554116|NCT01265875|3801821|P1|NOT COMPLETED|Overall Study||1
1554117|NCT01265875|3801821|P1|COMPLETED|Overall Study||11
1554118|NCT01265875|3801821|P1|STARTED|Overall Study||12
1554119|NCT01265823|3801829|P1|NOT COMPLETED|Overall Study||7
1554120|NCT01265823|3801829|P1|COMPLETED|Overall Study||143
1554121|NCT01265823|3801829|P1|STARTED|Overall Study||150
1554122|NCT01265797|3801858|P2|NOT COMPLETED|Open Label Month||1
1554123|NCT01265797|3801859|P1|NOT COMPLETED|Open Label Month||0
1554124|NCT01265797|3801858|P2|COMPLETED|Open Label Month||26
1554125|NCT01265797|3801859|P1|COMPLETED|Open Label Month||24
1554126|NCT01265797|3801858|P2|STARTED|Open Label Month||27
1554127|NCT01265797|3801859|P1|STARTED|Open Label Month||24
1554128|NCT01265797|3801858|P2|NOT COMPLETED|Blinded Month||2
1554129|NCT01265797|3801859|P1|NOT COMPLETED|Blinded Month||10
1554130|NCT01265797|3801858|P2|COMPLETED|Blinded Month||27
1554131|NCT01265797|3801859|P1|COMPLETED|Blinded Month||24
1554132|NCT01265797|3801858|P2|STARTED|Blinded Month||29
1554133|NCT01265797|3801859|P1|STARTED|Blinded Month||34
1554134|NCT01265797|3801858|P2|NOT COMPLETED|Run-in Month||5
1554135|NCT01265797|3801859|P1|NOT COMPLETED|Run-in Month||0
1554136|NCT01265797|3801858|P2|COMPLETED|Run-in Month||29
1554137|NCT01265797|3801859|P1|COMPLETED|Run-in Month||34
1554138|NCT01265797|3801858|P2|STARTED|Run-in Month||34
1554139|NCT01265797|3801859|P1|STARTED|Run-in Month||34
1554140|NCT01265784|3801890|P3|NOT COMPLETED|Overall Study||4
1554141|NCT01265784|3801891|P2|NOT COMPLETED|Overall Study||8
1554142|NCT01265784|3801892|P1|NOT COMPLETED|Overall Study||12
1554143|NCT01265784|3801890|P3|COMPLETED|Overall Study||26
1554144|NCT01265784|3801891|P2|COMPLETED|Overall Study||49
1554145|NCT01265784|3801892|P1|COMPLETED|Overall Study||44
1554146|NCT01265784|3801890|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
1554147|NCT01265784|3801891|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
1554148|NCT01265784|3801892|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
1554149|NCT01265784|3801890|P3|STARTED|Overall Study||30
1554150|NCT01265784|3801891|P2|STARTED|Overall Study||57
1554151|NCT01265784|3801892|P1|STARTED|Overall Study||56
1554152|NCT01265719|3801960|P2|NOT COMPLETED|Overall Study||13
1554153|NCT01265719|3801961|P1|NOT COMPLETED|Overall Study||14
1554154|NCT01265719|3801960|P2|COMPLETED|Overall Study||60
1554155|NCT01265719|3801961|P1|COMPLETED|Overall Study||88
1554156|NCT01265719|3801960|P2|STARTED|Overall Study||73
1554157|NCT01265719|3801961|P1|STARTED|Overall Study||102
1554158|NCT01265667|3801995|P2|NOT COMPLETED|Overall Study||13
1554159|NCT01265667|3801996|P1|NOT COMPLETED|Overall Study||20
1554160|NCT01265667|3801995|P2|COMPLETED|Overall Study||135
1554161|NCT01265667|3801996|P1|COMPLETED|Overall Study||125
1554162|NCT01265667|3801995|P2|STARTED|Overall Study||148
1554163|NCT01265667|3801996|P1|STARTED|Overall Study||145
1554164|NCT01265615|3802012|P4|NOT COMPLETED|Overall Study||3
1554165|NCT01265615|3802013|P3|NOT COMPLETED|Overall Study||4
1554166|NCT01265615|3802014|P2|NOT COMPLETED|Overall Study||2
1554167|NCT01265615|3802015|P1|NOT COMPLETED|Overall Study||2
1554168|NCT01265615|3802012|P4|COMPLETED|Overall Study||27
1554169|NCT01265615|3802013|P3|COMPLETED|Overall Study||26
1554170|NCT01265615|3802014|P2|COMPLETED|Overall Study||28
1554171|NCT01265615|3802015|P1|COMPLETED|Overall Study||28
1554172|NCT01265615|3802012|P4|STARTED|Overall Study||30
1554173|NCT01265615|3802013|P3|STARTED|Overall Study||30
1554174|NCT01265615|3802014|P2|STARTED|Overall Study||30
1554175|NCT01265615|3802015|P1|STARTED|Overall Study||30
1554176|NCT01265563|3802066|P5|NOT COMPLETED|Overall Study||2
1554177|NCT01265563|3802067|P4|NOT COMPLETED|Overall Study||0
1554178|NCT01265563|3802068|P3|NOT COMPLETED|Overall Study||1
1554179|NCT01265563|3802069|P2|NOT COMPLETED|Overall Study||1
1554180|NCT01265563|3802070|P1|NOT COMPLETED|Overall Study||0
1554181|NCT01265563|3802066|P5|COMPLETED|Overall Study||14
1554182|NCT01265563|3802067|P4|COMPLETED|Overall Study||16
1554183|NCT01265563|3802068|P3|COMPLETED|Overall Study||16
1554184|NCT01265563|3802069|P2|COMPLETED|Overall Study||12
1554185|NCT01265563|3802070|P1|COMPLETED|Overall Study||16
1554186|NCT01265563|3802066|P5|STARTED|Overall Study||16
1554187|NCT01265563|3802067|P4|STARTED|Overall Study||16
1554188|NCT01265563|3802068|P3|STARTED|Overall Study||17
1554189|NCT01265563|3802069|P2|STARTED|Overall Study||13
1554190|NCT01265563|3802070|P1|STARTED|Overall Study||16
1554191|NCT01265550|3802095|P3|NOT COMPLETED|Overall Study||20
1554192|NCT01265550|3802096|P2|NOT COMPLETED|Overall Study||8
1554193|NCT01265550|3802097|P1|NOT COMPLETED|Overall Study||15
1554194|NCT01265550|3802095|P3|COMPLETED|Overall Study||6
1554195|NCT01265550|3802096|P2|COMPLETED|Overall Study||19
1554196|NCT01265550|3802097|P1|COMPLETED|Overall Study||10
1554197|NCT01265550|3802095|P3|STARTED|Overall Study||26
1554198|NCT01265550|3802096|P2|STARTED|Overall Study||27
1554199|NCT01265550|3802097|P1|STARTED|Overall Study||25
1554200|NCT01265524|3802149|P2|NOT COMPLETED|Overall Study||6
1554201|NCT01265524|3802150|P1|NOT COMPLETED|Overall Study||18
1554202|NCT01265524|3802149|P2|COMPLETED|Overall Study||46
1554203|NCT01265524|3802150|P1|COMPLETED|Overall Study||41
1554204|NCT01265524|3802149|P2|STARTED|Overall Study||52
1554205|NCT01265524|3802150|P1|STARTED|Overall Study||59
1554206|NCT01265511|3802170|P2|NOT COMPLETED|Overall Study||3
1554207|NCT01265511|3802171|P1|NOT COMPLETED|Overall Study||2
1554208|NCT01265511|3802170|P2|COMPLETED|Overall Study||5
1554209|NCT01265511|3802171|P1|COMPLETED|Overall Study||0
1554210|NCT01265511|3802170|P2|STARTED|Overall Study||8
1554211|NCT01265511|3802171|P1|STARTED|Overall Study||2
1554212|NCT01265498|3802185|P2|NOT COMPLETED|Overall Study||33
1554213|NCT01265498|3802186|P1|NOT COMPLETED|Overall Study||31
1554214|NCT01265498|3802185|P2|COMPLETED|Overall Study||109
1554215|NCT01265498|3802186|P1|COMPLETED|Overall Study||110
1554216|NCT01265498|3802185|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
1554217|NCT01265498|3802186|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
1554218|NCT01265498|3802185|P2|STARTED|Overall Study||142
1554219|NCT01265498|3802186|P1|STARTED|Overall Study||141
1554220|NCT01265459|3802289|P3|NOT COMPLETED|Overall Study||2
1554221|NCT01265459|3802290|P2|NOT COMPLETED|Overall Study||0
1554222|NCT01265459|3802291|P1|NOT COMPLETED|Overall Study||0
1554223|NCT01265459|3802289|P3|COMPLETED|Overall Study||20
1554224|NCT01265459|3802290|P2|COMPLETED|Overall Study||23
1554225|NCT01265459|3802291|P1|COMPLETED|Overall Study||23
1554226|NCT01265459|3802289|P3|STARTED|Overall Study||22
1554227|NCT01265459|3802290|P2|STARTED|Overall Study||23
1554228|NCT01265459|3802291|P1|STARTED|Overall Study||23
1554229|NCT01265446|3802313|P2|NOT COMPLETED|Overall Study||0
1554230|NCT01265446|3802314|P1|NOT COMPLETED|Overall Study||1
1554231|NCT01265446|3802313|P2|COMPLETED|Overall Study||125
1554232|NCT01265446|3802314|P1|COMPLETED|Overall Study||124
1554233|NCT01265446|3802313|P2|STARTED|Overall Study||125
1554234|NCT01265446|3802314|P1|STARTED|Overall Study||125
1554235|NCT01265420|3802322|P1|NOT COMPLETED|Overall Study||1
1554236|NCT01265420|3802322|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
1554237|NCT01265420|3802322|P1|STARTED|Overall Study||7
1554238|NCT01265394|3802326|P1|NOT COMPLETED|Overall Study||37
1554239|NCT01265394|3802326|P1|COMPLETED|Overall Study||181
1554240|NCT01265394|3802326|P1|STARTED|Overall Study||218
1554241|NCT01265056|3802333|P2|NOT COMPLETED|Follow up||3
1554242|NCT01265056|3802334|P1|NOT COMPLETED|Follow up||7
1554243|NCT01265056|3802333|P2|COMPLETED|Follow up||24
1554244|NCT01265056|3802334|P1|COMPLETED|Follow up||19
1554245|NCT01265056|3802333|P2|STARTED|Follow up||27
1554246|NCT01265056|3802334|P1|STARTED|Follow up||26
1554247|NCT01265056|3802333|P2|NOT COMPLETED|Initial Study Period||2
1554248|NCT01265056|3802334|P1|NOT COMPLETED|Initial Study Period||2
1554249|NCT01265056|3802333|P2|COMPLETED|Initial Study Period||25
1554250|NCT01265056|3802334|P1|COMPLETED|Initial Study Period||24
1554251|NCT01265056|3802333|P2|STARTED|Initial Study Period||27
1554252|NCT01265056|3802334|P1|STARTED|Initial Study Period||26
1554253|NCT01264952|3802347|P3|NOT COMPLETED|Overall Study||0
1554254|NCT01264952|3802348|P2|NOT COMPLETED|Overall Study||0
1554255|NCT01264952|3802349|P1|NOT COMPLETED|Overall Study||0
1554256|NCT01264952|3802347|P3|COMPLETED|Overall Study||8
1554257|NCT01264952|3802348|P2|COMPLETED|Overall Study||2
1554258|NCT01264952|3802349|P1|COMPLETED|Overall Study||6
1554259|NCT01264952|3802347|P3|STARTED|Overall Study||8
1554260|NCT01264952|3802348|P2|STARTED|Overall Study||2
1554261|NCT01264952|3802349|P1|STARTED|Overall Study||6
1554262|NCT01264939|3802365|P2|NOT COMPLETED|Overall Study||28
1554263|NCT01264939|3802366|P1|NOT COMPLETED|Overall Study||18
1554264|NCT01264939|3802365|P2|COMPLETED|Overall Study||224
1554265|NCT01264939|3802366|P1|COMPLETED|Overall Study||66
1554266|NCT01264939|3802365|P2|STARTED|Overall Study||252
1554267|NCT01264939|3802366|P1|STARTED|Overall Study||84
1554268|NCT01264887|3802392|P1|NOT COMPLETED|Overall Study||31
1554269|NCT01264887|3802392|P1|COMPLETED|Overall Study||0
1554270|NCT01264887|3802392|P1|STARTED|Overall Study||31
1554271|NCT01264835|3802403|P1|NOT COMPLETED|Overall Study||1
1554272|NCT01264835|3802403|P1|COMPLETED|Overall Study||1
1554273|NCT01264835|3802403|P1|STARTED|Overall Study||2
1554274|NCT01264770|3802413|P6|NOT COMPLETED|Overall Study||6
1554275|NCT01264770|3802414|P5|NOT COMPLETED|Overall Study||8
1554276|NCT01264770|3802415|P4|NOT COMPLETED|Overall Study||6
1554277|NCT01264770|3802416|P3|NOT COMPLETED|Overall Study||16
1554278|NCT01264770|3802417|P2|NOT COMPLETED|Overall Study||10
1554279|NCT01264770|3802418|P1|NOT COMPLETED|Overall Study||18
1554280|NCT01264770|3802413|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
1554281|NCT01264770|3802414|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
1554282|NCT01264770|3802415|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
1554283|NCT01264770|3802416|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
1554284|NCT01264770|3802417|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
1554285|NCT01264770|3802418|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
1554286|NCT01264770|3802413|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
1554287|NCT01264770|3802414|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
1554288|NCT01264770|3802415|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
1554289|NCT01264770|3802416|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
1554290|NCT01264770|3802417|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
1554291|NCT01264770|3802418|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
1554292|NCT01264770|3802413|P6|STARTED|Overall Study|Patients who received treatment|25
1554293|NCT01264770|3802414|P5|STARTED|Overall Study|Patients who received treatment|27
1554294|NCT01264770|3802415|P4|STARTED|Overall Study|Patients who received treatment|54
1554295|NCT01264770|3802416|P3|STARTED|Overall Study|Patients who received treatment|57
1554296|NCT01264770|3802417|P2|STARTED|Overall Study|Patients who received treatment|48
1554297|NCT01264770|3802418|P1|STARTED|Overall Study|Patients who received treatment|54
1554298|NCT01264679|3802502|P1|NOT COMPLETED|Overall Study||5
1554299|NCT01264679|3802502|P1|COMPLETED|Overall Study||3
1554300|NCT01264679|3802502|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
1554301|NCT01264679|3802502|P1|STARTED|Overall Study||8
1554302|NCT01264614|3802510|P2|NOT COMPLETED|Overall Study||2
1554303|NCT01264614|3802511|P1|NOT COMPLETED|Overall Study||1
1554304|NCT01264614|3802510|P2|COMPLETED|Overall Study||7
1554305|NCT01264614|3802511|P1|COMPLETED|Overall Study||12
1554306|NCT01264614|3802510|P2|STARTED|Overall Study||9
1554307|NCT01264614|3802511|P1|STARTED|Overall Study||13
1554308|NCT01264601|3802527|P2|NOT COMPLETED|Overall Study||0
1554309|NCT01264601|3802528|P1|NOT COMPLETED|Overall Study||0
1554310|NCT01264601|3802527|P2|COMPLETED|Overall Study||14
1554311|NCT01264601|3802528|P1|COMPLETED|Overall Study||17
1554312|NCT01264601|3802527|P2|STARTED|Overall Study||14
1554313|NCT01264601|3802528|P1|STARTED|Overall Study||17
1554314|NCT01264380|3802536|P3|NOT COMPLETED|Period C||14
1554315|NCT01264380|3802537|P2|NOT COMPLETED|Period C||0
1554316|NCT01264380|3802538|P1|NOT COMPLETED|Period C||0
1554317|NCT01264380|3802536|P3|COMPLETED|Period C||2
1554318|NCT01264380|3802537|P2|COMPLETED|Period C||0
1554319|NCT01264380|3802538|P1|COMPLETED|Period C||0
1554320|NCT01264380|3802536|P3|STARTED|Period C||16
1554321|NCT01264380|3802537|P2|STARTED|Period C||0
1554322|NCT01264380|3802538|P1|STARTED|Period C||0
1554323|NCT01264380|3802536|P3|NOT COMPLETED|Period B||0
1554324|NCT01264380|3802537|P2|NOT COMPLETED|Period B||0
1554325|NCT01264380|3802538|P1|NOT COMPLETED|Period B||0
1554326|NCT01264380|3802536|P3|COMPLETED|Period B||0
1554327|NCT01264380|3802537|P2|COMPLETED|Period B||8
1554328|NCT01264380|3802538|P1|COMPLETED|Period B||8
1554329|NCT01264380|3802536|P3|STARTED|Period B||0
1554330|NCT01264380|3802537|P2|STARTED|Period B||8
1554331|NCT01264380|3802538|P1|STARTED|Period B||8
1554332|NCT01264380|3802536|P3|NOT COMPLETED|Period A||0
1554333|NCT01264380|3802537|P2|NOT COMPLETED|Period A||0
1554334|NCT01264380|3802538|P1|NOT COMPLETED|Period A||0
1554335|NCT01264380|3802536|P3|COMPLETED|Period A||0
1554336|NCT01264380|3802537|P2|COMPLETED|Period A||8
1554337|NCT01264380|3802538|P1|COMPLETED|Period A||8
1554338|NCT01264380|3802536|P3|STARTED|Period A||0
1554339|NCT01264380|3802537|P2|STARTED|Period A||8
1554340|NCT01264380|3802538|P1|STARTED|Period A||8
1554341|NCT01264081|3802559|P1|NOT COMPLETED|Analysis||0
1554342|NCT01264081|3802559|P1|COMPLETED|Analysis||2
1554343|NCT01264081|3802559|P1|STARTED|Analysis||2
1554344|NCT01264081|3802559|P1|NOT COMPLETED|Started Treatment||2
1554345|NCT01264081|3802559|P1|COMPLETED|Started Treatment||2
1554346|NCT01264081|3802559|P1|STARTED|Started Treatment||4
1554347|NCT01264081|3802559|P1|NOT COMPLETED|Participants Screened||30
1554348|NCT01264081|3802559|P1|COMPLETED|Participants Screened||4
1554349|NCT01264081|3802559|P1|STARTED|Participants Screened||34
1554350|NCT01264016|3802564|P1|NOT COMPLETED|Overall Study||2
1554351|NCT01264016|3802564|P1|COMPLETED|Overall Study||94
1554352|NCT01264016|3802564|P1|STARTED|Overall Study||96
1554353|NCT01263925|3802572|P2|NOT COMPLETED|Overall Study||52
1554354|NCT01263925|3802573|P1|NOT COMPLETED|Overall Study||51
1554355|NCT01263925|3802572|P2|COMPLETED|Overall Study||233
1554356|NCT01263925|3802573|P1|COMPLETED|Overall Study||225
1554357|NCT01263925|3802572|P2|Full Analysis Set|Overall Study||272
1554358|NCT01263925|3802573|P1|Full Analysis Set|Overall Study||269
1554359|NCT01263925|3802572|P2|STARTED|Overall Study||285
1554360|NCT01263925|3802573|P1|STARTED|Overall Study||276
1554361|NCT01263873|3802607|P2|NOT COMPLETED|Overall Study||1
1554362|NCT01263873|3802608|P1|NOT COMPLETED|Overall Study||1
1554363|NCT01263873|3802607|P2|COMPLETED|Overall Study||29
1554364|NCT01263873|3802608|P1|COMPLETED|Overall Study||29
1554365|NCT01263873|3802607|P2|STARTED|Overall Study||30
1554366|NCT01263873|3802608|P1|STARTED|Overall Study||30
1554367|NCT01263717|3802620|P2|NOT COMPLETED|Overall Study||6
1554368|NCT01263717|3802621|P1|NOT COMPLETED|Overall Study||5
1554369|NCT01263717|3802620|P2|COMPLETED|Overall Study||20
1554370|NCT01263717|3802621|P1|COMPLETED|Overall Study||23
1554371|NCT01263717|3802620|P2|Baseline Visit|Overall Study||22
1554372|NCT01263717|3802621|P1|Baseline Visit|Overall Study||28
1554373|NCT01263717|3802620|P2|STARTED|Overall Study||26
1554374|NCT01263717|3802621|P1|STARTED|Overall Study||28
1554375|NCT01263704|3802649|P1|NOT COMPLETED|Overall Study||29
1554376|NCT01263704|3802649|P1|COMPLETED|Overall Study||13
1554377|NCT01263704|3802649|P1|STARTED|Overall Study||42
1554378|NCT01263691|3802664|P6|NOT COMPLETED|Overall Study||0
1554379|NCT01263691|3802665|P5|NOT COMPLETED|Overall Study||0
1554380|NCT01263691|3802666|P4|NOT COMPLETED|Overall Study||1
1554381|NCT01263691|3802667|P3|NOT COMPLETED|Overall Study||1
1554382|NCT01263691|3802668|P2|NOT COMPLETED|Overall Study||0
1554383|NCT01263691|3802669|P1|NOT COMPLETED|Overall Study||3
1554384|NCT01263691|3802664|P6|COMPLETED|Overall Study||15
1554385|NCT01263691|3802665|P5|COMPLETED|Overall Study||18
1554386|NCT01263691|3802666|P4|COMPLETED|Overall Study||18
1554387|NCT01263691|3802667|P3|COMPLETED|Overall Study||16
1554388|NCT01263691|3802668|P2|COMPLETED|Overall Study||18
1554389|NCT01263691|3802669|P1|COMPLETED|Overall Study||15
1554390|NCT01263691|3802664|P6|STARTED|Overall Study||15
1554391|NCT01263691|3802665|P5|STARTED|Overall Study||18
1554392|NCT01263691|3802666|P4|STARTED|Overall Study||19
1554393|NCT01263691|3802667|P3|STARTED|Overall Study||17
1554394|NCT01263691|3802668|P2|STARTED|Overall Study||18
1554395|NCT01263691|3802669|P1|STARTED|Overall Study||18
1554396|NCT01263665|3802779|P1|NOT COMPLETED|Overall Study||9
1554397|NCT01263665|3802779|P1|COMPLETED|Overall Study||62
1554398|NCT01263665|3802779|P1|STARTED|Overall Study||71
1554399|NCT01263639|3802786|P2|NOT COMPLETED|Overall Study||79
1554400|NCT01263639|3802787|P1|NOT COMPLETED|Overall Study||73
1554401|NCT01263639|3802786|P2|COMPLETED|Overall Study||42
1554402|NCT01263639|3802787|P1|COMPLETED|Overall Study||34
1554403|NCT01263639|3802786|P2|STARTED|Overall Study||121
1554404|NCT01263639|3802787|P1|STARTED|Overall Study||107
1554405|NCT01263561|3802795|P2|NOT COMPLETED|Overall Study||2
1554406|NCT01263561|3802796|P1|NOT COMPLETED|Overall Study||1
1554407|NCT01263561|3802795|P2|COMPLETED|Overall Study||31
1554408|NCT01263561|3802796|P1|COMPLETED|Overall Study||30
1554409|NCT01263561|3802795|P2|STARTED|Overall Study||33
1554410|NCT01263561|3802796|P1|STARTED|Overall Study||31
1554411|NCT01263509|3802808|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
1554412|NCT01263509|3802809|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
1554413|NCT01263509|3802810|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
1554414|NCT01263509|3802811|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
1554415|NCT01263509|3802808|P4|COMPLETED|Entered - Long-Term Extension Study||24
1554416|NCT01263509|3802809|P3|COMPLETED|Entered - Long-Term Extension Study||27
1554417|NCT01263509|3802810|P2|COMPLETED|Entered - Long-Term Extension Study||48
1554418|NCT01263509|3802811|P1|COMPLETED|Entered - Long-Term Extension Study||53
1554419|NCT01263509|3802808|P4|STARTED|Entered - Long-Term Extension Study||26
1554420|NCT01263509|3802809|P3|STARTED|Entered - Long-Term Extension Study||32
1554421|NCT01263509|3802810|P2|STARTED|Entered - Long-Term Extension Study||60
1554422|NCT01263509|3802811|P1|STARTED|Entered - Long-Term Extension Study||61
1554423|NCT01263509|3802808|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554424|NCT01263509|3802809|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554425|NCT01263509|3802810|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554426|NCT01263509|3802811|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554427|NCT01263509|3802808|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
1554428|NCT01263509|3802809|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
1554429|NCT01263509|3802810|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
1554430|NCT01263509|3802811|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
1554431|NCT01263509|3802808|P4|STARTED|Enrolled - Long-Term Extension Study||26
1554432|NCT01263509|3802809|P3|STARTED|Enrolled - Long-Term Extension Study||32
1554433|NCT01263509|3802810|P2|STARTED|Enrolled - Long-Term Extension Study||60
1554434|NCT01263509|3802811|P1|STARTED|Enrolled - Long-Term Extension Study||61
1554435|NCT01263496|3802940|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
1554436|NCT01263496|3802941|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
1554437|NCT01263496|3802942|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
1554438|NCT01263496|3802943|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
1554439|NCT01263496|3802944|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
1554440|NCT01263496|3802945|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
1554441|NCT01263496|3802946|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
1554442|NCT01263496|3802947|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
1554443|NCT01263496|3802948|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
1554444|NCT01263496|3802940|P9|COMPLETED|Entered - Long-Term Extension Study||15
1554445|NCT01263496|3802941|P8|COMPLETED|Entered - Long-Term Extension Study||16
1554446|NCT01263496|3802942|P7|COMPLETED|Entered - Long-Term Extension Study||16
1554447|NCT01263496|3802943|P6|COMPLETED|Entered - Long-Term Extension Study||16
1554448|NCT01263496|3802944|P5|COMPLETED|Entered - Long-Term Extension Study||61
1554449|NCT01263496|3802945|P4|COMPLETED|Entered - Long-Term Extension Study||68
1554450|NCT01263496|3802946|P3|COMPLETED|Entered - Long-Term Extension Study||62
1554451|NCT01263496|3802947|P2|COMPLETED|Entered - Long-Term Extension Study||59
1554452|NCT01263496|3802948|P1|COMPLETED|Entered - Long-Term Extension Study||62
1554453|NCT01263496|3802940|P9|STARTED|Entered - Long-Term Extension Study||18
1554454|NCT01263496|3802941|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
1554455|NCT01263496|3802942|P7|STARTED|Entered - Long-Term Extension Study||17
1554456|NCT01263496|3802943|P6|STARTED|Entered - Long-Term Extension Study||17
1554457|NCT01263496|3802944|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
1554458|NCT01263496|3802945|P4|STARTED|Entered - Long-Term Extension Study||74
1554459|NCT01263496|3802946|P3|STARTED|Entered - Long-Term Extension Study||72
1554460|NCT01263496|3802947|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
1554461|NCT01263496|3802948|P1|STARTED|Entered - Long-Term Extension Study||71
1554462|NCT01263496|3802940|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554463|NCT01263496|3802941|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554464|NCT01263496|3802942|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554465|NCT01263496|3802943|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554466|NCT01263496|3802944|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
1554467|NCT01263496|3802945|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1554468|NCT01263496|3802946|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554469|NCT01263496|3802947|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1554470|NCT01263496|3802948|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1554471|NCT01263496|3802940|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
1554472|NCT01263496|3802941|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
1554473|NCT01263496|3802942|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
1554474|NCT01263496|3802943|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
1554475|NCT01263496|3802944|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
1554476|NCT01263496|3802945|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
1554477|NCT01263496|3802946|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
1554478|NCT01263496|3802947|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
1554479|NCT01263496|3802948|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
1554480|NCT01263496|3802940|P9|STARTED|Enrolled - Long-Term Extension Study||18
1554481|NCT01263496|3802941|P8|STARTED|Enrolled - Long-Term Extension Study||18
1554482|NCT01263496|3802942|P7|STARTED|Enrolled - Long-Term Extension Study||17
1554483|NCT01263496|3802943|P6|STARTED|Enrolled - Long-Term Extension Study||17
1554484|NCT01263496|3802944|P5|STARTED|Enrolled - Long-Term Extension Study||74
1554485|NCT01263496|3802945|P4|STARTED|Enrolled - Long-Term Extension Study||75
1554486|NCT01263496|3802946|P3|STARTED|Enrolled - Long-Term Extension Study||72
1554487|NCT01263496|3802947|P2|STARTED|Enrolled - Long-Term Extension Study||75
1554488|NCT01263496|3802948|P1|STARTED|Enrolled - Long-Term Extension Study||72
1554489|NCT01263483|3803243|P3|NOT COMPLETED|Overall Study||5
1554490|NCT01263483|3803244|P2|NOT COMPLETED|Overall Study||2
1554491|NCT01263483|3803245|P1|NOT COMPLETED|Overall Study||7
1554492|NCT01263483|3803243|P3|COMPLETED|Overall Study||74
1554493|NCT01263483|3803244|P2|COMPLETED|Overall Study||74
1554494|NCT01263483|3803245|P1|COMPLETED|Overall Study||68
1554495|NCT01263483|3803243|P3|STARTED|Overall Study||79
1554496|NCT01263483|3803244|P2|STARTED|Overall Study||76
1554497|NCT01263483|3803245|P1|STARTED|Overall Study||75
1554498|NCT01263470|3803307|P6|NOT COMPLETED|Overall Study||5
1554499|NCT01263470|3803308|P5|NOT COMPLETED|Overall Study||3
1554500|NCT01263470|3803309|P4|NOT COMPLETED|Overall Study||3
1554501|NCT01263470|3803310|P3|NOT COMPLETED|Overall Study||4
1554502|NCT01263470|3803311|P2|NOT COMPLETED|Overall Study||5
1554503|NCT01263470|3803312|P1|NOT COMPLETED|Overall Study||2
1554504|NCT01263470|3803307|P6|COMPLETED|Overall Study||78
1554505|NCT01263470|3803308|P5|COMPLETED|Overall Study||76
1554506|NCT01263470|3803309|P4|COMPLETED|Overall Study||77
1554507|NCT01263470|3803310|P3|COMPLETED|Overall Study||80
1554508|NCT01263470|3803311|P2|COMPLETED|Overall Study||74
1554509|NCT01263470|3803312|P1|COMPLETED|Overall Study||73
1554510|NCT01263470|3803307|P6|STARTED|Overall Study||83
1554511|NCT01263470|3803308|P5|STARTED|Overall Study||79
1554512|NCT01263470|3803309|P4|STARTED|Overall Study||80
1554513|NCT01263470|3803310|P3|STARTED|Overall Study||84
1554514|NCT01263470|3803311|P2|STARTED|Overall Study||79
1554515|NCT01263470|3803312|P1|STARTED|Overall Study||75
1554516|NCT01263444|3803422|P1|NOT COMPLETED|Overall Study||10
1554517|NCT01263444|3803422|P1|COMPLETED|Overall Study||37
1554518|NCT01263444|3803422|P1|STARTED|Overall Study||47
1554519|NCT01263314|3803431|P8|NOT COMPLETED|Period 3||0
1554520|NCT01263314|3803432|P7|NOT COMPLETED|Period 3||0
1554521|NCT01263314|3803433|P6|NOT COMPLETED|Period 3||0
1554522|NCT01263314|3803434|P5|NOT COMPLETED|Period 3||0
1554523|NCT01263314|3803435|P4|NOT COMPLETED|Period 3||0
1554524|NCT01263314|3803436|P3|NOT COMPLETED|Period 3||0
1554525|NCT01263314|3803437|P2|NOT COMPLETED|Period 3||0
1554526|NCT01263314|3803438|P1|NOT COMPLETED|Period 3||0
1554527|NCT01263314|3803431|P8|COMPLETED|Period 3||2
1554528|NCT01263314|3803432|P7|COMPLETED|Period 3||2
1554529|NCT01263314|3803433|P6|COMPLETED|Period 3||2
1554530|NCT01263314|3803434|P5|COMPLETED|Period 3||2
1554531|NCT01263314|3803435|P4|COMPLETED|Period 3||2
1554532|NCT01263314|3803436|P3|COMPLETED|Period 3||2
1554533|NCT01263314|3803437|P2|COMPLETED|Period 3||2
1554534|NCT01263314|3803438|P1|COMPLETED|Period 3||2
1554535|NCT01263314|3803431|P8|STARTED|Period 3||2
1554536|NCT01263314|3803432|P7|STARTED|Period 3||2
1554537|NCT01263314|3803433|P6|STARTED|Period 3||2
1554538|NCT01263314|3803434|P5|STARTED|Period 3||2
1554539|NCT01263314|3803435|P4|STARTED|Period 3||2
1554540|NCT01263314|3803436|P3|STARTED|Period 3||2
1554541|NCT01263314|3803437|P2|STARTED|Period 3||2
1554542|NCT01263314|3803438|P1|STARTED|Period 3||2
1554543|NCT01263314|3803431|P8|NOT COMPLETED|Period 2||0
1554544|NCT01263314|3803432|P7|NOT COMPLETED|Period 2||0
1554545|NCT01263314|3803433|P6|NOT COMPLETED|Period 2||0
1554546|NCT01263314|3803434|P5|NOT COMPLETED|Period 2||0
1554547|NCT01263314|3803435|P4|NOT COMPLETED|Period 2||0
1554548|NCT01263314|3803436|P3|NOT COMPLETED|Period 2||0
1554549|NCT01263314|3803437|P2|NOT COMPLETED|Period 2||0
1554550|NCT01263314|3803438|P1|NOT COMPLETED|Period 2||0
1554551|NCT01263314|3803431|P8|COMPLETED|Period 2||2
1554552|NCT01263314|3803432|P7|COMPLETED|Period 2||2
1554553|NCT01263314|3803433|P6|COMPLETED|Period 2||2
1554554|NCT01263314|3803434|P5|COMPLETED|Period 2||2
1554555|NCT01263314|3803435|P4|COMPLETED|Period 2||2
1554556|NCT01263314|3803436|P3|COMPLETED|Period 2||2
1554557|NCT01263314|3803437|P2|COMPLETED|Period 2||2
1554558|NCT01263314|3803438|P1|COMPLETED|Period 2||2
1554559|NCT01263314|3803431|P8|STARTED|Period 2||2
1554560|NCT01263314|3803432|P7|STARTED|Period 2||2
1554561|NCT01263314|3803433|P6|STARTED|Period 2||2
1554562|NCT01263314|3803434|P5|STARTED|Period 2||2
1554563|NCT01263314|3803435|P4|STARTED|Period 2||2
1554564|NCT01263314|3803436|P3|STARTED|Period 2||2
1554565|NCT01263314|3803437|P2|STARTED|Period 2||2
1554566|NCT01263314|3803438|P1|STARTED|Period 2||2
1554567|NCT01263314|3803431|P8|NOT COMPLETED|Period 1||0
1554568|NCT01263314|3803432|P7|NOT COMPLETED|Period 1||0
1554569|NCT01263314|3803433|P6|NOT COMPLETED|Period 1||0
1554570|NCT01263314|3803434|P5|NOT COMPLETED|Period 1||0
1554571|NCT01263314|3803435|P4|NOT COMPLETED|Period 1||0
1554572|NCT01263314|3803436|P3|NOT COMPLETED|Period 1||0
1554573|NCT01263314|3803437|P2|NOT COMPLETED|Period 1||0
1554574|NCT01263314|3803438|P1|NOT COMPLETED|Period 1||0
1554575|NCT01263314|3803431|P8|COMPLETED|Period 1||2
1554576|NCT01263314|3803432|P7|COMPLETED|Period 1||2
1554577|NCT01263314|3803433|P6|COMPLETED|Period 1||2
1554578|NCT01263314|3803434|P5|COMPLETED|Period 1||2
1554579|NCT01263314|3803435|P4|COMPLETED|Period 1||2
1554580|NCT01263314|3803436|P3|COMPLETED|Period 1||2
1554581|NCT01263314|3803437|P2|COMPLETED|Period 1||2
1554582|NCT01263314|3803438|P1|COMPLETED|Period 1||2
1554583|NCT01263314|3803431|P8|STARTED|Period 1||2
1554584|NCT01263314|3803432|P7|STARTED|Period 1||2
1554585|NCT01263314|3803433|P6|STARTED|Period 1||2
1554586|NCT01263314|3803434|P5|STARTED|Period 1||2
1554587|NCT01263314|3803435|P4|STARTED|Period 1||2
1554588|NCT01263314|3803436|P3|STARTED|Period 1||2
1554589|NCT01263314|3803437|P2|STARTED|Period 1||2
1554590|NCT01263314|3803438|P1|STARTED|Period 1||2
1554591|NCT01263301|3803546|P2|NOT COMPLETED|Overall Study||0
1554592|NCT01263301|3803547|P1|NOT COMPLETED|Overall Study||0
1554593|NCT01263301|3803546|P2|COMPLETED|Overall Study||11
1554594|NCT01263301|3803547|P1|COMPLETED|Overall Study||5
1554595|NCT01263301|3803546|P2|STARTED|Overall Study||11
1554596|NCT01263301|3803547|P1|STARTED|Overall Study||5
1554597|NCT01263223|3803559|P2|NOT COMPLETED|7-day Follow-up||1
1554598|NCT01263223|3803560|P1|NOT COMPLETED|7-day Follow-up||1
1554599|NCT01263223|3803559|P2|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
1554600|NCT01263223|3803560|P1|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
1554601|NCT01263223|3803559|P2|STARTED|7-day Follow-up||11
1554602|NCT01263223|3803560|P1|STARTED|7-day Follow-up||12
1554603|NCT01263223|3803559|P2|NOT COMPLETED|Period 3||0
1554604|NCT01263223|3803560|P1|NOT COMPLETED|Period 3||0
1554605|NCT01263223|3803559|P2|COMPLETED|Period 3||11
1554606|NCT01263223|3803560|P1|COMPLETED|Period 3||12
1554607|NCT01263223|3803559|P2|STARTED|Period 3||11
1554608|NCT01263223|3803560|P1|STARTED|Period 3||12
1554609|NCT01263223|3803559|P2|NOT COMPLETED|Period 2||1
1554610|NCT01263223|3803560|P1|NOT COMPLETED|Period 2||0
1554611|NCT01263223|3803559|P2|COMPLETED|Period 2||11
1554612|NCT01263223|3803560|P1|COMPLETED|Period 2||12
1554613|NCT01263223|3803559|P2|STARTED|Period 2||12
1554614|NCT01263223|3803560|P1|STARTED|Period 2||12
1554615|NCT01263223|3803559|P2|NOT COMPLETED|3-Day Washout||0
1554616|NCT01263223|3803560|P1|NOT COMPLETED|3-Day Washout||0
1554617|NCT01263223|3803559|P2|COMPLETED|3-Day Washout||12
1554618|NCT01263223|3803560|P1|COMPLETED|3-Day Washout||12
1554619|NCT01263223|3803559|P2|STARTED|3-Day Washout||12
1554620|NCT01263223|3803560|P1|STARTED|3-Day Washout||12
1554621|NCT01263223|3803559|P2|NOT COMPLETED|Period 1||0
1554622|NCT01263223|3803560|P1|NOT COMPLETED|Period 1||0
1554623|NCT01263223|3803559|P2|COMPLETED|Period 1||12
1554624|NCT01263223|3803560|P1|COMPLETED|Period 1||12
1554625|NCT01263223|3803559|P2|STARTED|Period 1||12
1554626|NCT01263223|3803560|P1|STARTED|Period 1||12
1554627|NCT01263197|3803583|P6|NOT COMPLETED|Third Intervention (Period 3)||0
1554628|NCT01263197|3803584|P5|NOT COMPLETED|Third Intervention (Period 3)||0
1554629|NCT01263197|3803585|P4|NOT COMPLETED|Third Intervention (Period 3)||0
1554630|NCT01263197|3803586|P3|NOT COMPLETED|Third Intervention (Period 3)||0
1554631|NCT01263197|3803587|P2|NOT COMPLETED|Third Intervention (Period 3)||1
1554632|NCT01263197|3803588|P1|NOT COMPLETED|Third Intervention (Period 3)||0
1554633|NCT01263197|3803583|P6|COMPLETED|Third Intervention (Period 3)||6
1554634|NCT01263197|3803584|P5|COMPLETED|Third Intervention (Period 3)||7
1554635|NCT01263197|3803585|P4|COMPLETED|Third Intervention (Period 3)||7
1554636|NCT01263197|3803586|P3|COMPLETED|Third Intervention (Period 3)||8
1554637|NCT01263197|3803587|P2|COMPLETED|Third Intervention (Period 3)||7
1554638|NCT01263197|3803588|P1|COMPLETED|Third Intervention (Period 3)||8
1554639|NCT01263197|3803583|P6|STARTED|Third Intervention (Period 3)||6
1554640|NCT01263197|3803584|P5|STARTED|Third Intervention (Period 3)||7
1554641|NCT01263197|3803585|P4|STARTED|Third Intervention (Period 3)||7
1554642|NCT01263197|3803586|P3|STARTED|Third Intervention (Period 3)||8
1554643|NCT01263197|3803587|P2|STARTED|Third Intervention (Period 3)||8
1554644|NCT01263197|3803588|P1|STARTED|Third Intervention (Period 3)||8
1554645|NCT01263197|3803583|P6|NOT COMPLETED|Washout Period 2||1
1554646|NCT01263197|3803584|P5|NOT COMPLETED|Washout Period 2||0
1554647|NCT01263197|3803585|P4|NOT COMPLETED|Washout Period 2||1
1554648|NCT01263197|3803586|P3|NOT COMPLETED|Washout Period 2||0
1554649|NCT01263197|3803587|P2|NOT COMPLETED|Washout Period 2||0
1554650|NCT01263197|3803588|P1|NOT COMPLETED|Washout Period 2||0
1554651|NCT01263197|3803583|P6|COMPLETED|Washout Period 2||6
1554652|NCT01263197|3803584|P5|COMPLETED|Washout Period 2||7
1554653|NCT01263197|3803585|P4|COMPLETED|Washout Period 2||7
1554654|NCT01263197|3803586|P3|COMPLETED|Washout Period 2||8
1554655|NCT01263197|3803587|P2|COMPLETED|Washout Period 2||8
1554656|NCT01263197|3803588|P1|COMPLETED|Washout Period 2||8
1554657|NCT01263197|3803583|P6|STARTED|Washout Period 2||7
1554658|NCT01263197|3803584|P5|STARTED|Washout Period 2||7
1554659|NCT01263197|3803585|P4|STARTED|Washout Period 2||8
1554660|NCT01263197|3803586|P3|STARTED|Washout Period 2||8
1554661|NCT01263197|3803587|P2|STARTED|Washout Period 2||8
1554662|NCT01263197|3803588|P1|STARTED|Washout Period 2||8
1554663|NCT01263197|3803583|P6|NOT COMPLETED|Second Intervention (Period 2)||0
1554664|NCT01263197|3803584|P5|NOT COMPLETED|Second Intervention (Period 2)||0
1554665|NCT01263197|3803585|P4|NOT COMPLETED|Second Intervention (Period 2)||0
1554666|NCT01263197|3803586|P3|NOT COMPLETED|Second Intervention (Period 2)||0
1554667|NCT01263197|3803587|P2|NOT COMPLETED|Second Intervention (Period 2)||0
1554668|NCT01263197|3803588|P1|NOT COMPLETED|Second Intervention (Period 2)||0
1554669|NCT01263197|3803583|P6|COMPLETED|Second Intervention (Period 2)||7
1554670|NCT01263197|3803584|P5|COMPLETED|Second Intervention (Period 2)||7
1554671|NCT01263197|3803585|P4|COMPLETED|Second Intervention (Period 2)||8
1554672|NCT01263197|3803586|P3|COMPLETED|Second Intervention (Period 2)||8
1554673|NCT01263197|3803587|P2|COMPLETED|Second Intervention (Period 2)||8
1554674|NCT01263197|3803588|P1|COMPLETED|Second Intervention (Period 2)||8
1554675|NCT01263197|3803583|P6|STARTED|Second Intervention (Period 2)||7
1554676|NCT01263197|3803584|P5|STARTED|Second Intervention (Period 2)||7
1554677|NCT01263197|3803585|P4|STARTED|Second Intervention (Period 2)||8
1554678|NCT01263197|3803586|P3|STARTED|Second Intervention (Period 2)||8
1554679|NCT01263197|3803587|P2|STARTED|Second Intervention (Period 2)||8
1554680|NCT01263197|3803588|P1|STARTED|Second Intervention (Period 2)||8
1554681|NCT01263197|3803583|P6|NOT COMPLETED|Washout Period 1||0
1554682|NCT01263197|3803584|P5|NOT COMPLETED|Washout Period 1||1
1554683|NCT01263197|3803585|P4|NOT COMPLETED|Washout Period 1||0
1554684|NCT01263197|3803586|P3|NOT COMPLETED|Washout Period 1||0
1554685|NCT01263197|3803587|P2|NOT COMPLETED|Washout Period 1||0
1554686|NCT01263197|3803588|P1|NOT COMPLETED|Washout Period 1||0
1554687|NCT01263197|3803583|P6|COMPLETED|Washout Period 1||7
1554688|NCT01263197|3803584|P5|COMPLETED|Washout Period 1||7
1554689|NCT01263197|3803585|P4|COMPLETED|Washout Period 1||8
1554690|NCT01263197|3803586|P3|COMPLETED|Washout Period 1||8
1554691|NCT01263197|3803587|P2|COMPLETED|Washout Period 1||8
1554692|NCT01263197|3803588|P1|COMPLETED|Washout Period 1||8
1554693|NCT01263197|3803583|P6|STARTED|Washout Period 1||7
1554694|NCT01263197|3803584|P5|STARTED|Washout Period 1||8
1554695|NCT01263197|3803585|P4|STARTED|Washout Period 1||8
1554696|NCT01263197|3803586|P3|STARTED|Washout Period 1||8
1554697|NCT01263197|3803587|P2|STARTED|Washout Period 1||8
1554698|NCT01263197|3803588|P1|STARTED|Washout Period 1||8
1554699|NCT01263197|3803583|P6|NOT COMPLETED|First Intervention (Period 1)||1
1554700|NCT01263197|3803584|P5|NOT COMPLETED|First Intervention (Period 1)||0
1554701|NCT01263197|3803585|P4|NOT COMPLETED|First Intervention (Period 1)||0
1554702|NCT01263197|3803586|P3|NOT COMPLETED|First Intervention (Period 1)||0
1554703|NCT01263197|3803587|P2|NOT COMPLETED|First Intervention (Period 1)||0
1554704|NCT01263197|3803588|P1|NOT COMPLETED|First Intervention (Period 1)||0
1554705|NCT01263197|3803583|P6|COMPLETED|First Intervention (Period 1)||7
1554706|NCT01263197|3803584|P5|COMPLETED|First Intervention (Period 1)||8
1554707|NCT01263197|3803585|P4|COMPLETED|First Intervention (Period 1)||8
1554708|NCT01263197|3803586|P3|COMPLETED|First Intervention (Period 1)||8
1554709|NCT01263197|3803587|P2|COMPLETED|First Intervention (Period 1)||8
1554710|NCT01263197|3803588|P1|COMPLETED|First Intervention (Period 1)||8
1554711|NCT01263197|3803583|P6|STARTED|First Intervention (Period 1)||8
1554712|NCT01263197|3803584|P5|STARTED|First Intervention (Period 1)||8
1554713|NCT01263197|3803585|P4|STARTED|First Intervention (Period 1)||8
1554714|NCT01263197|3803586|P3|STARTED|First Intervention (Period 1)||8
1554715|NCT01263197|3803587|P2|STARTED|First Intervention (Period 1)||8
1554716|NCT01263197|3803588|P1|STARTED|First Intervention (Period 1)||8
1554717|NCT01263132|3803616|P2|NOT COMPLETED|Overall Study||0
1554718|NCT01263132|3803617|P1|NOT COMPLETED|Overall Study||0
1554719|NCT01263132|3803616|P2|COMPLETED|Overall Study||37
1554720|NCT01263132|3803617|P1|COMPLETED|Overall Study||38
1554721|NCT01263132|3803616|P2|STARTED|Overall Study||37
1554722|NCT01263132|3803617|P1|STARTED|Overall Study||38
1554723|NCT01263119|3803631|P1|NOT COMPLETED|Overall Study||4
1554724|NCT01263119|3803631|P1|COMPLETED|Overall Study||14
1554725|NCT01263119|3803631|P1|STARTED|Overall Study||18
1554726|NCT01263093|3803654|P2|NOT COMPLETED|Period 2||0
1554727|NCT01263093|3803655|P1|NOT COMPLETED|Period 2||1
1554728|NCT01263093|3803654|P2|COMPLETED|Period 2||23
1554729|NCT01263093|3803655|P1|COMPLETED|Period 2||22
1554730|NCT01263093|3803654|P2|STARTED|Period 2||23
1554731|NCT01263093|3803655|P1|STARTED|Period 2||23
1554732|NCT01263093|3803654|P2|NOT COMPLETED|Washout||0
1554733|NCT01263093|3803655|P1|NOT COMPLETED|Washout||1
1554734|NCT01263093|3803654|P2|COMPLETED|Washout||23
1554735|NCT01263093|3803655|P1|COMPLETED|Washout||23
1554736|NCT01263093|3803654|P2|STARTED|Washout||23
1554737|NCT01263093|3803655|P1|STARTED|Washout||24
1554738|NCT01263093|3803654|P2|NOT COMPLETED|Period 1||0
1554739|NCT01263093|3803655|P1|NOT COMPLETED|Period 1||0
1554740|NCT01263093|3803654|P2|COMPLETED|Period 1||23
1554741|NCT01263093|3803655|P1|COMPLETED|Period 1||24
1554742|NCT01263093|3803654|P2|STARTED|Period 1||23
1554743|NCT01263093|3803655|P1|STARTED|Period 1||24
1554744|NCT01263054|3803672|P2|NOT COMPLETED|Overall Study||6
1554745|NCT01263054|3803673|P1|NOT COMPLETED|Overall Study||5
1554746|NCT01263054|3803672|P2|COMPLETED|Overall Study||28
1554747|NCT01263054|3803673|P1|COMPLETED|Overall Study||24
1554748|NCT01263054|3803672|P2|STARTED|Overall Study||34
1554749|NCT01263054|3803673|P1|STARTED|Overall Study||29
1554750|NCT01263028|3803691|P1|NOT COMPLETED|Overall Study||6
1554751|NCT01263028|3803691|P1|COMPLETED|Overall Study||0
1554752|NCT01263028|3803691|P1|STARTED|Overall Study||6
1554753|NCT01263015|3803701|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
1554754|NCT01263015|3803702|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
1554755|NCT01263015|3803701|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
1554756|NCT01263015|3803702|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
1554757|NCT01263015|3803701|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
1554758|NCT01263015|3803702|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
1554759|NCT01263015|3803701|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
1554760|NCT01263015|3803702|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
1554761|NCT01263015|3803701|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
1554762|NCT01263015|3803702|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
1554763|NCT01263015|3803701|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
1554764|NCT01263015|3803702|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
1554765|NCT01262989|3803728|P2|NOT COMPLETED|Period 2||1
1554766|NCT01262989|3803729|P1|NOT COMPLETED|Period 2||0
1554767|NCT01262989|3803728|P2|COMPLETED|Period 2||16
1554768|NCT01262989|3803729|P1|COMPLETED|Period 2||19
1554769|NCT01262989|3803728|P2|STARTED|Period 2||17
1554770|NCT01262989|3803729|P1|STARTED|Period 2||19
1554771|NCT01262989|3803728|P2|NOT COMPLETED|7-Day Washout Period||0
1554772|NCT01262989|3803729|P1|NOT COMPLETED|7-Day Washout Period||0
1554773|NCT01262989|3803728|P2|COMPLETED|7-Day Washout Period||17
1554774|NCT01262989|3803729|P1|COMPLETED|7-Day Washout Period||19
1554775|NCT01262989|3803728|P2|STARTED|7-Day Washout Period||17
1554776|NCT01262989|3803729|P1|STARTED|7-Day Washout Period||19
1554777|NCT01262989|3803728|P2|NOT COMPLETED|Period 1||3
1554778|NCT01262989|3803729|P1|NOT COMPLETED|Period 1||1
1554779|NCT01262989|3803728|P2|COMPLETED|Period 1||17
1554780|NCT01262989|3803729|P1|COMPLETED|Period 1||19
1554781|NCT01262989|3803728|P2|STARTED|Period 1||20
1554782|NCT01262989|3803729|P1|STARTED|Period 1||20
1554783|NCT01262976|3803745|P6|NOT COMPLETED|Up to Year 3||4
1554784|NCT01262976|3803746|P5|NOT COMPLETED|Up to Year 3||2
1554785|NCT01262976|3803747|P4|NOT COMPLETED|Up to Year 3||5
1554786|NCT01262976|3803748|P3|NOT COMPLETED|Up to Year 3||7
1554787|NCT01262976|3803749|P2|NOT COMPLETED|Up to Year 3||2
1554788|NCT01262976|3803750|P1|NOT COMPLETED|Up to Year 3||6
1554789|NCT01262976|3803745|P6|COMPLETED|Up to Year 3||36
1554790|NCT01262976|3803746|P5|COMPLETED|Up to Year 3||38
1554791|NCT01262976|3803747|P4|COMPLETED|Up to Year 3||35
1554792|NCT01262976|3803748|P3|COMPLETED|Up to Year 3||33
1554793|NCT01262976|3803749|P2|COMPLETED|Up to Year 3||38
1554794|NCT01262976|3803750|P1|COMPLETED|Up to Year 3||34
1554795|NCT01262976|3803745|P6|STARTED|Up to Year 3||40
1554796|NCT01262976|3803746|P5|STARTED|Up to Year 3||40
1554797|NCT01262976|3803747|P4|STARTED|Up to Year 3||40
1554798|NCT01262976|3803748|P3|STARTED|Up to Year 3||40
1554799|NCT01262976|3803749|P2|STARTED|Up to Year 3||40
1554800|NCT01262976|3803750|P1|STARTED|Up to Year 3||40
1554801|NCT01262976|3803745|P6|NOT COMPLETED|Up to Year 2||5
1554802|NCT01262976|3803746|P5|NOT COMPLETED|Up to Year 2||4
1554803|NCT01262976|3803747|P4|NOT COMPLETED|Up to Year 2||4
1554804|NCT01262976|3803748|P3|NOT COMPLETED|Up to Year 2||5
1554805|NCT01262976|3803749|P2|NOT COMPLETED|Up to Year 2||1
1554806|NCT01262976|3803750|P1|NOT COMPLETED|Up to Year 2||5
1554807|NCT01262976|3803745|P6|COMPLETED|Up to Year 2||35
1554808|NCT01262976|3803746|P5|COMPLETED|Up to Year 2||36
1554809|NCT01262976|3803747|P4|COMPLETED|Up to Year 2||36
1554810|NCT01262976|3803748|P3|COMPLETED|Up to Year 2||35
1554811|NCT01262976|3803749|P2|COMPLETED|Up to Year 2||39
1554812|NCT01262976|3803750|P1|COMPLETED|Up to Year 2||35
1554813|NCT01262976|3803745|P6|STARTED|Up to Year 2||40
1554814|NCT01262976|3803746|P5|STARTED|Up to Year 2||40
1554815|NCT01262976|3803747|P4|STARTED|Up to Year 2||40
1554816|NCT01262976|3803748|P3|STARTED|Up to Year 2||40
1554817|NCT01262976|3803749|P2|STARTED|Up to Year 2||40
1554818|NCT01262976|3803750|P1|STARTED|Up to Year 2||40
1554819|NCT01262976|3803745|P6|NOT COMPLETED|Up to Year 1||9
1554820|NCT01262976|3803746|P5|NOT COMPLETED|Up to Year 1||11
1554821|NCT01262976|3803747|P4|NOT COMPLETED|Up to Year 1||4
1554822|NCT01262976|3803748|P3|NOT COMPLETED|Up to Year 1||3
1554823|NCT01262976|3803749|P2|NOT COMPLETED|Up to Year 1||1
1554824|NCT01262976|3803750|P1|NOT COMPLETED|Up to Year 1||9
1554825|NCT01262976|3803745|P6|COMPLETED|Up to Year 1||31
1554826|NCT01262976|3803746|P5|COMPLETED|Up to Year 1||29
1554827|NCT01262976|3803747|P4|COMPLETED|Up to Year 1||36
1554828|NCT01262976|3803748|P3|COMPLETED|Up to Year 1||37
1554829|NCT01262976|3803749|P2|COMPLETED|Up to Year 1||39
1554830|NCT01262976|3803750|P1|COMPLETED|Up to Year 1||31
1554831|NCT01262976|3803745|P6|STARTED|Up to Year 1||40
1554832|NCT01262976|3803746|P5|STARTED|Up to Year 1||40
1554833|NCT01262976|3803747|P4|STARTED|Up to Year 1||40
1554834|NCT01262976|3803748|P3|STARTED|Up to Year 1||40
1554835|NCT01262976|3803749|P2|STARTED|Up to Year 1||40
1554836|NCT01262976|3803750|P1|STARTED|Up to Year 1||40
1554837|NCT01262976|3803745|P6|NOT COMPLETED|Up to Month 7||4
1554838|NCT01262976|3803746|P5|NOT COMPLETED|Up to Month 7||2
1554839|NCT01262976|3803747|P4|NOT COMPLETED|Up to Month 7||6
1554840|NCT01262976|3803748|P3|NOT COMPLETED|Up to Month 7||6
1554841|NCT01262976|3803749|P2|NOT COMPLETED|Up to Month 7||0
1554842|NCT01262976|3803750|P1|NOT COMPLETED|Up to Month 7||5
1554843|NCT01262976|3803745|P6|COMPLETED|Up to Month 7||36
1554844|NCT01262976|3803746|P5|COMPLETED|Up to Month 7||38
1554845|NCT01262976|3803747|P4|COMPLETED|Up to Month 7||34
1554846|NCT01262976|3803748|P3|COMPLETED|Up to Month 7||34
1554847|NCT01262976|3803749|P2|COMPLETED|Up to Month 7||40
1554848|NCT01262976|3803750|P1|COMPLETED|Up to Month 7||35
1554849|NCT01262976|3803745|P6|STARTED|Up to Month 7||40
1554850|NCT01262976|3803746|P5|STARTED|Up to Month 7||40
1554851|NCT01262976|3803747|P4|STARTED|Up to Month 7||40
1554852|NCT01262976|3803748|P3|STARTED|Up to Month 7||40
1554853|NCT01262976|3803749|P2|STARTED|Up to Month 7||40
1554854|NCT01262976|3803750|P1|STARTED|Up to Month 7||40
1554855|NCT01262976|3803745|P6|NOT COMPLETED|Up to Month 2||4
1554856|NCT01262976|3803746|P5|NOT COMPLETED|Up to Month 2||2
1554857|NCT01262976|3803747|P4|NOT COMPLETED|Up to Month 2||2
1554858|NCT01262976|3803748|P3|NOT COMPLETED|Up to Month 2||1
1554859|NCT01262976|3803749|P2|NOT COMPLETED|Up to Month 2||1
1554860|NCT01262976|3803750|P1|NOT COMPLETED|Up to Month 2||3
1554861|NCT01262976|3803745|P6|COMPLETED|Up to Month 2||36
1554862|NCT01262976|3803746|P5|COMPLETED|Up to Month 2||38
1554863|NCT01262976|3803747|P4|COMPLETED|Up to Month 2||38
1554864|NCT01262976|3803748|P3|COMPLETED|Up to Month 2||39
1554865|NCT01262976|3803749|P2|COMPLETED|Up to Month 2||39
1554866|NCT01262976|3803750|P1|COMPLETED|Up to Month 2||37
1554867|NCT01262976|3803745|P6|STARTED|Up to Month 2||40
1554868|NCT01262976|3803746|P5|STARTED|Up to Month 2||40
1554869|NCT01262976|3803747|P4|STARTED|Up to Month 2||40
1554870|NCT01262976|3803748|P3|STARTED|Up to Month 2||40
1554871|NCT01262976|3803749|P2|STARTED|Up to Month 2||40
1554872|NCT01262976|3803750|P1|STARTED|Up to Month 2||40
1554873|NCT01262898|3803906|P4|NOT COMPLETED|Overall Study||0
1554874|NCT01262898|3803907|P3|NOT COMPLETED|Overall Study||0
1554875|NCT01262898|3803908|P2|NOT COMPLETED|Overall Study||2
1554876|NCT01262898|3803909|P1|NOT COMPLETED|Overall Study||3
1554877|NCT01262898|3803906|P4|COMPLETED|Overall Study||22
1554878|NCT01262898|3803907|P3|COMPLETED|Overall Study||18
1554879|NCT01262898|3803908|P2|COMPLETED|Overall Study||16
1554880|NCT01262898|3803909|P1|COMPLETED|Overall Study||18
1554881|NCT01262898|3803906|P4|STARTED|Overall Study||22
1554882|NCT01262898|3803907|P3|STARTED|Overall Study||18
1554883|NCT01262898|3803908|P2|STARTED|Overall Study||18
1554884|NCT01262898|3803909|P1|STARTED|Overall Study||21
1554885|NCT01262872|3804037|P8|NOT COMPLETED|Step 2||6
1554886|NCT01262872|3804038|P7|NOT COMPLETED|Step 2||9
1554887|NCT01262872|3804039|P6|NOT COMPLETED|Step 2||9
1554888|NCT01262872|3804040|P5|NOT COMPLETED|Step 2||5
1554889|NCT01262872|3804041|P4|NOT COMPLETED|Step 2||10
1554890|NCT01262872|3804042|P3|NOT COMPLETED|Step 2||9
1554891|NCT01262872|3804043|P2|NOT COMPLETED|Step 2||0
1554892|NCT01262872|3804044|P1|NOT COMPLETED|Step 2||0
1554893|NCT01262872|3804037|P8|COMPLETED|Step 2||194
1554894|NCT01262872|3804038|P7|COMPLETED|Step 2||191
1554895|NCT01262872|3804039|P6|COMPLETED|Step 2||191
1554896|NCT01262872|3804040|P5|COMPLETED|Step 2||195
1554897|NCT01262872|3804041|P4|COMPLETED|Step 2||190
1554898|NCT01262872|3804042|P3|COMPLETED|Step 2||191
1554899|NCT01262872|3804043|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554900|NCT01262872|3804044|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554901|NCT01262872|3804037|P8|STARTED|Step 2||200
1554902|NCT01262872|3804038|P7|STARTED|Step 2||200
1554903|NCT01262872|3804039|P6|STARTED|Step 2||200
1554904|NCT01262872|3804040|P5|STARTED|Step 2||200
1554905|NCT01262872|3804041|P4|STARTED|Step 2||200
1554906|NCT01262872|3804042|P3|STARTED|Step 2||200
1554907|NCT01262872|3804043|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554908|NCT01262872|3804044|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554909|NCT01262872|3804037|P8|NOT COMPLETED|Step 1||0
1554910|NCT01262872|3804038|P7|NOT COMPLETED|Step 1||0
1554911|NCT01262872|3804039|P6|NOT COMPLETED|Step 1||0
1554912|NCT01262872|3804040|P5|NOT COMPLETED|Step 1||0
1554913|NCT01262872|3804041|P4|NOT COMPLETED|Step 1||0
1554914|NCT01262872|3804042|P3|NOT COMPLETED|Step 1||0
1554915|NCT01262872|3804043|P2|NOT COMPLETED|Step 1||0
1554916|NCT01262872|3804044|P1|NOT COMPLETED|Step 1||0
1554917|NCT01262872|3804037|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554918|NCT01262872|3804038|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554919|NCT01262872|3804039|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554920|NCT01262872|3804040|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554921|NCT01262872|3804041|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
1554922|NCT01262872|3804042|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554923|NCT01262872|3804043|P2|COMPLETED|Step 1||60
1554924|NCT01262872|3804044|P1|COMPLETED|Step 1||60
1555006|NCT01262456|3804519|P2|COMPLETED|3-Month Double-Blind Period||100
1554925|NCT01262872|3804037|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554926|NCT01262872|3804038|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554927|NCT01262872|3804039|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554928|NCT01262872|3804040|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554929|NCT01262872|3804041|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554930|NCT01262872|3804042|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1554931|NCT01262872|3804043|P2|STARTED|Step 1||60
1554932|NCT01262872|3804044|P1|STARTED|Step 1||60
1554933|NCT01262846|3804299|P2|NOT COMPLETED|Overall Study||3
1554934|NCT01262846|3804300|P1|NOT COMPLETED|Overall Study||2
1554935|NCT01262846|3804299|P2|COMPLETED|Overall Study||97
1554936|NCT01262846|3804300|P1|COMPLETED|Overall Study||93
1554937|NCT01262846|3804299|P2|STARTED|Overall Study||100
1554938|NCT01262846|3804300|P1|STARTED|Overall Study||95
1554939|NCT01262820|3804306|P1|NOT COMPLETED|Overall Study||15
1554940|NCT01262820|3804306|P1|COMPLETED|Overall Study||0
1554941|NCT01262820|3804306|P1|STARTED|Overall Study||15
1554942|NCT01262755|3804313|P1|NOT COMPLETED|Overall Study||0
1554943|NCT01262755|3804313|P1|COMPLETED|Overall Study||450
1554944|NCT01262755|3804313|P1|STARTED|Overall Study||450
1554945|NCT01262677|3804320|P3|NOT COMPLETED|Overall Study||12
1554946|NCT01262677|3804321|P2|NOT COMPLETED|Overall Study||15
1554947|NCT01262677|3804322|P1|NOT COMPLETED|Overall Study||9
1554948|NCT01262677|3804320|P3|COMPLETED|Overall Study||98
1554949|NCT01262677|3804321|P2|COMPLETED|Overall Study||98
1554950|NCT01262677|3804322|P1|COMPLETED|Overall Study||91
1554951|NCT01262677|3804320|P3|STARTED|Overall Study||110
1554952|NCT01262677|3804321|P2|STARTED|Overall Study||113
1554953|NCT01262677|3804322|P1|STARTED|Overall Study||100
1554954|NCT01262651|3804413|P2|NOT COMPLETED|Overall Study||48
1554955|NCT01262651|3804414|P1|NOT COMPLETED|Overall Study||58
1554956|NCT01262651|3804413|P2|COMPLETED|Overall Study||150
1554957|NCT01262651|3804414|P1|COMPLETED|Overall Study||141
1554958|NCT01262651|3804413|P2|ITT Population|Overall Study||198
1554959|NCT01262651|3804414|P1|ITT Population|Overall Study||199
1554960|NCT01262651|3804413|P2|Safety Population|Overall Study||198
1554961|NCT01262651|3804414|P1|Safety Population|Overall Study||199
1554962|NCT01262651|3804413|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
1554963|NCT01262651|3804414|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
1554964|NCT01262651|3804413|P2|STARTED|Overall Study||198
1554965|NCT01262651|3804414|P1|STARTED|Overall Study||199
1554966|NCT01262599|3804442|P2|NOT COMPLETED|Overall Study||0
1554967|NCT01262599|3804443|P1|NOT COMPLETED|Overall Study||0
1554968|NCT01262599|3804442|P2|COMPLETED|Overall Study||16
1554969|NCT01262599|3804443|P1|COMPLETED|Overall Study||16
1554970|NCT01262599|3804442|P2|STARTED|Overall Study||16
1554971|NCT01262599|3804443|P1|STARTED|Overall Study||16
1554972|NCT01262573|3804455|P2|NOT COMPLETED|Overall Study||1
1554973|NCT01262573|3804456|P1|NOT COMPLETED|Overall Study||0
1554974|NCT01262573|3804455|P2|COMPLETED|Overall Study||31
1554975|NCT01262573|3804456|P1|COMPLETED|Overall Study||32
1554976|NCT01262573|3804455|P2|STARTED|Overall Study||32
1554977|NCT01262573|3804456|P1|STARTED|Overall Study||32
1554978|NCT01262560|3804467|P3|NOT COMPLETED|Overall Study||2
1554979|NCT01262560|3804468|P2|NOT COMPLETED|Overall Study||1
1554980|NCT01262560|3804469|P1|NOT COMPLETED|Overall Study||0
1554981|NCT01262560|3804467|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
1554982|NCT01262560|3804468|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
1554983|NCT01262560|3804469|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
1554984|NCT01262560|3804467|P3|STARTED|Overall Study||56
1554985|NCT01262560|3804468|P2|STARTED|Overall Study||54
1554986|NCT01262560|3804469|P1|STARTED|Overall Study||53
1554987|NCT01262547|3804504|P1|NOT COMPLETED|Overall Study||0
1554988|NCT01262547|3804504|P1|COMPLETED|Overall Study||3
1554989|NCT01262547|3804504|P1|STARTED|Overall Study||3
1554990|NCT01262456|3804518|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
1554991|NCT01262456|3804519|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
1554992|NCT01262456|3804520|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
1554993|NCT01262456|3804518|P3|COMPLETED|1-Month Open-Label Extension Period||98
1554994|NCT01262456|3804519|P2|COMPLETED|1-Month Open-Label Extension Period||97
1554995|NCT01262456|3804520|P1|COMPLETED|1-Month Open-Label Extension Period||120
1554996|NCT01262456|3804518|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
1554997|NCT01262456|3804519|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
1554998|NCT01262456|3804520|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
1554999|NCT01262456|3804518|P3|STARTED|1-Month Open-Label Extension Period||103
1555000|NCT01262456|3804519|P2|STARTED|1-Month Open-Label Extension Period||100
1555001|NCT01262456|3804520|P1|STARTED|1-Month Open-Label Extension Period||124
1555002|NCT01262456|3804518|P3|NOT COMPLETED|3-Month Double-Blind Period||26
1555003|NCT01262456|3804519|P2|NOT COMPLETED|3-Month Double-Blind Period||23
1555004|NCT01262456|3804520|P1|NOT COMPLETED|3-Month Double-Blind Period||19
1555005|NCT01262456|3804518|P3|COMPLETED|3-Month Double-Blind Period||103
1555007|NCT01262456|3804520|P1|COMPLETED|3-Month Double-Blind Period||124
1555008|NCT01262456|3804518|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
1555009|NCT01262456|3804519|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
1555010|NCT01262456|3804520|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
1555011|NCT01262456|3804518|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
1555012|NCT01262456|3804519|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
1555013|NCT01262456|3804520|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
1555014|NCT01262456|3804518|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
1555015|NCT01262456|3804519|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
1555016|NCT01262456|3804520|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
1555017|NCT01262365|3804564|P3|NOT COMPLETED|Overall Study||94
1555018|NCT01262365|3804565|P2|NOT COMPLETED|Overall Study||81
1555019|NCT01262365|3804566|P1|NOT COMPLETED|Overall Study||90
1555020|NCT01262365|3804564|P3|COMPLETED|Overall Study||171
1555021|NCT01262365|3804565|P2|COMPLETED|Overall Study||181
1555022|NCT01262365|3804566|P1|COMPLETED|Overall Study||176
1555023|NCT01262365|3804564|P3|STARTED|Overall Study||265
1555024|NCT01262365|3804565|P2|STARTED|Overall Study||262
1555025|NCT01262365|3804566|P1|STARTED|Overall Study||266
1555026|NCT01262352|3804591|P2|NOT COMPLETED|Period 2||0
1555027|NCT01262352|3804592|P1|NOT COMPLETED|Period 2||0
1555028|NCT01262352|3804591|P2|COMPLETED|Period 2||8
1555029|NCT01262352|3804592|P1|COMPLETED|Period 2||9
1555030|NCT01262352|3804591|P2|Dosed|Period 2||8
1555031|NCT01262352|3804592|P1|Dosed|Period 2||9
1555032|NCT01262352|3804591|P2|STARTED|Period 2||8
1555033|NCT01262352|3804592|P1|STARTED|Period 2||9
1555034|NCT01262352|3804591|P2|NOT COMPLETED|Washout||2
1555035|NCT01262352|3804592|P1|NOT COMPLETED|Washout||1
1555036|NCT01262352|3804591|P2|COMPLETED|Washout||8
1555037|NCT01262352|3804592|P1|COMPLETED|Washout||9
1555038|NCT01262352|3804591|P2|STARTED|Washout||10
1555039|NCT01262352|3804592|P1|STARTED|Washout||10
1555040|NCT01262352|3804591|P2|NOT COMPLETED|Period 1||0
1555041|NCT01262352|3804592|P1|NOT COMPLETED|Period 1||1
1555042|NCT01262352|3804591|P2|COMPLETED|Period 1||10
1555043|NCT01262352|3804592|P1|COMPLETED|Period 1||10
1555044|NCT01262352|3804591|P2|Dosed|Period 1||10
1555045|NCT01262352|3804592|P1|Dosed|Period 1||10
1555046|NCT01262352|3804591|P2|STARTED|Period 1||10
1555047|NCT01262352|3804592|P1|STARTED|Period 1||11
1555048|NCT01262339|3804604|P1|NOT COMPLETED|Overall Study||0
1555049|NCT01262339|3804604|P1|COMPLETED|Overall Study||2
1555050|NCT01262339|3804604|P1|STARTED|Overall Study||2
1555051|NCT01262287|3804610|P2|NOT COMPLETED|Overall Study||1
1555052|NCT01262287|3804611|P1|NOT COMPLETED|Overall Study||2
1555053|NCT01262287|3804610|P2|COMPLETED|Overall Study||18
1555054|NCT01262287|3804611|P1|COMPLETED|Overall Study||18
1555055|NCT01262287|3804610|P2|STARTED|Overall Study||19
1555056|NCT01262287|3804611|P1|STARTED|Overall Study||20
1555057|NCT01262131|3804624|P3|NOT COMPLETED|Overall Study||0
1555058|NCT01262131|3804625|P2|NOT COMPLETED|Overall Study||0
1555059|NCT01262131|3804626|P1|NOT COMPLETED|Overall Study||0
1555060|NCT01262131|3804624|P3|COMPLETED|Overall Study||4
1555061|NCT01262131|3804625|P2|COMPLETED|Overall Study||4
1555062|NCT01262131|3804626|P1|COMPLETED|Overall Study||5
1555063|NCT01262131|3804624|P3|STARTED|Overall Study||4
1555064|NCT01262131|3804625|P2|STARTED|Overall Study||4
1555065|NCT01262131|3804626|P1|STARTED|Overall Study||5
1555066|NCT01262118|3804636|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
1555067|NCT01262118|3804637|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
1555068|NCT01262118|3804636|P2|COMPLETED|Treatment Period (6 Weeks)||0
1555069|NCT01262118|3804637|P1|COMPLETED|Treatment Period (6 Weeks)||36
1555070|NCT01262118|3804636|P2|STARTED|Treatment Period (6 Weeks)||0
1555071|NCT01262118|3804637|P1|STARTED|Treatment Period (6 Weeks)||36
1555072|NCT01262118|3804636|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
1555073|NCT01262118|3804637|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
1555074|NCT01262118|3804636|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
1555075|NCT01262118|3804637|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
1555076|NCT01262118|3804636|P2|STARTED|Baseline Assessment Period (3 Days)||33
1555077|NCT01262118|3804637|P1|STARTED|Baseline Assessment Period (3 Days)||36
1555078|NCT01262105|3804663|P2|NOT COMPLETED|Overall Study||0
1555079|NCT01262105|3804664|P1|NOT COMPLETED|Overall Study||0
1555080|NCT01262105|3804663|P2|COMPLETED|Overall Study||10
1555081|NCT01262105|3804664|P1|COMPLETED|Overall Study||13
1555082|NCT01262105|3804663|P2|STARTED|Overall Study||10
1555083|NCT01262105|3804664|P1|STARTED|Overall Study||13
1555084|NCT01262092|3804672|P2|NOT COMPLETED|Gabapentin Taper||0
1555085|NCT01262092|3804673|P1|NOT COMPLETED|Gabapentin Taper||1
1555086|NCT01262092|3804672|P2|COMPLETED|Gabapentin Taper||11
1555087|NCT01262092|3804673|P1|COMPLETED|Gabapentin Taper||9
1555088|NCT01262092|3804672|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
1555089|NCT01262092|3804673|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
1555090|NCT01262092|3804672|P2|NOT COMPLETED|Buprenorphine Taper||1
1555091|NCT01262092|3804673|P1|NOT COMPLETED|Buprenorphine Taper||1
1555092|NCT01262092|3804672|P2|COMPLETED|Buprenorphine Taper||12
1555093|NCT01262092|3804673|P1|COMPLETED|Buprenorphine Taper||11
1555094|NCT01262092|3804672|P2|STARTED|Buprenorphine Taper||13
1555095|NCT01262092|3804673|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
1555096|NCT01262092|3804672|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
1555097|NCT01262092|3804673|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
1555098|NCT01262092|3804672|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
1555099|NCT01262092|3804673|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
1555100|NCT01262092|3804672|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
1555101|NCT01262092|3804673|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
1555102|NCT01262027|3804679|P1|NOT COMPLETED|Overall Study||5
1555103|NCT01262027|3804679|P1|COMPLETED|Overall Study||17
1555104|NCT01262027|3804679|P1|STARTED|Overall Study||22
1555105|NCT01261975|3804684|P1|NOT COMPLETED|Overall Study||1
1555106|NCT01261975|3804684|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
1555107|NCT01261975|3804684|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
1555108|NCT01261793|3804706|P3|NOT COMPLETED|Overall Study||82
1555109|NCT01261793|3804707|P2|NOT COMPLETED|Overall Study||91
1555110|NCT01261793|3804708|P1|NOT COMPLETED|Overall Study||85
1555111|NCT01261793|3804706|P3|COMPLETED|Overall Study||184
1555112|NCT01261793|3804707|P2|COMPLETED|Overall Study||171
1555113|NCT01261793|3804708|P1|COMPLETED|Overall Study||178
1555114|NCT01261793|3804706|P3|STARTED|Overall Study||266
1555115|NCT01261793|3804707|P2|STARTED|Overall Study||262
1555116|NCT01261793|3804708|P1|STARTED|Overall Study||263
1555117|NCT01261780|3804733|P2|NOT COMPLETED|Overall Study||2
1555118|NCT01261780|3804734|P1|NOT COMPLETED|Overall Study||2
1555119|NCT01261780|3804733|P2|COMPLETED|Overall Study||5
1555120|NCT01261780|3804734|P1|COMPLETED|Overall Study||5
1555121|NCT01261780|3804733|P2|STARTED|Overall Study||7
1555122|NCT01261780|3804734|P1|STARTED|Overall Study||7
1555123|NCT01261624|3804744|P2|NOT COMPLETED|Week 13 to Week 24||1
1555124|NCT01261624|3804745|P1|NOT COMPLETED|Week 13 to Week 24||0
1555125|NCT01261624|3804744|P2|COMPLETED|Week 13 to Week 24||10
1555126|NCT01261624|3804745|P1|COMPLETED|Week 13 to Week 24||1
1555127|NCT01261624|3804744|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
1555128|NCT01261624|3804745|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
1555129|NCT01261624|3804744|P2|NOT COMPLETED|Week 0 to Week 12||3
1555130|NCT01261624|3804745|P1|NOT COMPLETED|Week 0 to Week 12||1
1555131|NCT01261624|3804744|P2|COMPLETED|Week 0 to Week 12||3
1555132|NCT01261624|3804745|P1|COMPLETED|Week 0 to Week 12||9
1555133|NCT01261624|3804744|P2|STARTED|Week 0 to Week 12||6
1555134|NCT01261624|3804745|P1|STARTED|Week 0 to Week 12||10
1555135|NCT01261559|3804764|P2|NOT COMPLETED|Overall Study||0
1555136|NCT01261559|3804765|P1|NOT COMPLETED|Overall Study||0
1555137|NCT01261559|3804764|P2|COMPLETED|Overall Study||36
1555138|NCT01261559|3804765|P1|COMPLETED|Overall Study||36
1555139|NCT01261559|3804764|P2|STARTED|Overall Study||36
1555140|NCT01261559|3804765|P1|STARTED|Overall Study||36
1555141|NCT01261507|3804777|P1|NOT COMPLETED|Overall Study||0
1555142|NCT01261507|3804777|P1|COMPLETED|Overall Study||15
1555143|NCT01261507|3804777|P1|STARTED|Overall Study||15
1555144|NCT01261390|3804790|P4|NOT COMPLETED|Overall Study||8
1555145|NCT01261390|3804791|P3|NOT COMPLETED|Overall Study||7
1555146|NCT01261390|3804792|P2|NOT COMPLETED|Overall Study||9
1555147|NCT01261390|3804793|P1|NOT COMPLETED|Overall Study||7
1555148|NCT01261390|3804790|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
1555149|NCT01261390|3804791|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
1555150|NCT01261390|3804792|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
1555151|NCT01261390|3804793|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
1555152|NCT01261390|3804790|P4|12-Month Visit|Overall Study||19
1555153|NCT01261390|3804791|P3|12-Month Visit|Overall Study||19
1555154|NCT01261390|3804792|P2|12-Month Visit|Overall Study||21
1555155|NCT01261390|3804793|P1|12-Month Visit|Overall Study||23
1555156|NCT01261390|3804790|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
1555157|NCT01261390|3804791|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
1555158|NCT01261390|3804792|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
1555159|NCT01261390|3804793|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
1555160|NCT01261390|3804790|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
1555161|NCT01261390|3804791|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
1555162|NCT01261390|3804792|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
1555163|NCT01261390|3804793|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
1555164|NCT01261325|3804958|P3|NOT COMPLETED|Overall Study||26
1555165|NCT01261325|3804959|P2|NOT COMPLETED|Overall Study||29
1555166|NCT01261325|3804960|P1|NOT COMPLETED|Overall Study||17
1555167|NCT01261325|3804958|P3|COMPLETED|Overall Study||225
1555168|NCT01261325|3804959|P2|COMPLETED|Overall Study||225
1555169|NCT01261325|3804960|P1|COMPLETED|Overall Study||246
1555170|NCT01261325|3804958|P3|STARTED|Overall Study||251
1555171|NCT01261325|3804959|P2|STARTED|Overall Study||254
1555172|NCT01261325|3804960|P1|STARTED|Overall Study||263
1555173|NCT01261247|3804992|P1|NOT COMPLETED|Overall Study||2
1555174|NCT01261247|3804992|P1|COMPLETED|Overall Study||39
1555175|NCT01261247|3804992|P1|STARTED|Overall Study||41
1555176|NCT01261052|3804999|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
1555177|NCT01261052|3804999|P1|COMPLETED|APD Only Intervention (33 Hours)||14
1555178|NCT01261052|3804999|P1|STARTED|APD Only Intervention (33 Hours)||14
1555179|NCT01261052|3804999|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
1555180|NCT01261052|3804999|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
1555181|NCT01261052|3804999|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
1555182|NCT01261000|3805005|P1|NOT COMPLETED|Overall Study||1
1555183|NCT01261000|3805005|P1|COMPLETED|Overall Study||7
1555184|NCT01261000|3805005|P1|STARTED|Overall Study||8
1555185|NCT01260948|3805011|P2|NOT COMPLETED|Second Intervention||1
1555186|NCT01260948|3805012|P1|NOT COMPLETED|Second Intervention||0
1555187|NCT01260948|3805011|P2|COMPLETED|Second Intervention||9
1555188|NCT01260948|3805012|P1|COMPLETED|Second Intervention||12
1555189|NCT01260948|3805011|P2|STARTED|Second Intervention||10
1555190|NCT01260948|3805012|P1|STARTED|Second Intervention||12
1555191|NCT01260948|3805011|P2|NOT COMPLETED|Washout of 28 Days||3
1555192|NCT01260948|3805012|P1|NOT COMPLETED|Washout of 28 Days||1
1555193|NCT01260948|3805011|P2|COMPLETED|Washout of 28 Days||10
1555194|NCT01260948|3805012|P1|COMPLETED|Washout of 28 Days||12
1555195|NCT01260948|3805011|P2|STARTED|Washout of 28 Days||13
1555196|NCT01260948|3805012|P1|STARTED|Washout of 28 Days||13
1555197|NCT01260948|3805011|P2|NOT COMPLETED|First Intervention||0
1555198|NCT01260948|3805012|P1|NOT COMPLETED|First Intervention||0
1555199|NCT01260948|3805011|P2|COMPLETED|First Intervention||13
1555200|NCT01260948|3805012|P1|COMPLETED|First Intervention||13
1555201|NCT01260948|3805011|P2|STARTED|First Intervention||13
1555202|NCT01260948|3805012|P1|STARTED|First Intervention||13
1555203|NCT01260922|3805022|P2|NOT COMPLETED|Second Intervention||2
1555204|NCT01260922|3805023|P1|NOT COMPLETED|Second Intervention||0
1555205|NCT01260922|3805022|P2|COMPLETED|Second Intervention||8
1555206|NCT01260922|3805023|P1|COMPLETED|Second Intervention||9
1555207|NCT01260922|3805022|P2|STARTED|Second Intervention||10
1555208|NCT01260922|3805023|P1|STARTED|Second Intervention||9
1555209|NCT01260922|3805022|P2|NOT COMPLETED|Washout of 28 Days||2
1555210|NCT01260922|3805023|P1|NOT COMPLETED|Washout of 28 Days||4
1555211|NCT01260922|3805022|P2|COMPLETED|Washout of 28 Days||10
1555212|NCT01260922|3805023|P1|COMPLETED|Washout of 28 Days||9
1555213|NCT01260922|3805022|P2|STARTED|Washout of 28 Days||12
1555214|NCT01260922|3805023|P1|STARTED|Washout of 28 Days||13
1555215|NCT01260922|3805022|P2|NOT COMPLETED|First Intervention||1
1555216|NCT01260922|3805023|P1|NOT COMPLETED|First Intervention||0
1555217|NCT01260922|3805022|P2|COMPLETED|First Intervention||12
1555218|NCT01260922|3805023|P1|COMPLETED|First Intervention||13
1555219|NCT01260922|3805022|P2|STARTED|First Intervention||13
1555220|NCT01260922|3805023|P1|STARTED|First Intervention||13
1555221|NCT01260896|3805033|P2|NOT COMPLETED|Second Intervention||0
1555222|NCT01260896|3805034|P1|NOT COMPLETED|Second Intervention||0
1555223|NCT01260896|3805033|P2|COMPLETED|Second Intervention||12
1555224|NCT01260896|3805034|P1|COMPLETED|Second Intervention||10
1555225|NCT01260896|3805033|P2|STARTED|Second Intervention||12
1555226|NCT01260896|3805034|P1|STARTED|Second Intervention||10
1555227|NCT01260896|3805033|P2|NOT COMPLETED|Washout of 7 Days||0
1555228|NCT01260896|3805034|P1|NOT COMPLETED|Washout of 7 Days||0
1555229|NCT01260896|3805033|P2|COMPLETED|Washout of 7 Days||12
1555230|NCT01260896|3805034|P1|COMPLETED|Washout of 7 Days||10
1555231|NCT01260896|3805033|P2|STARTED|Washout of 7 Days||12
1555232|NCT01260896|3805034|P1|STARTED|Washout of 7 Days||10
1555233|NCT01260896|3805033|P2|NOT COMPLETED|First Intervention||0
1555234|NCT01260896|3805034|P1|NOT COMPLETED|First Intervention||2
1555235|NCT01260896|3805033|P2|COMPLETED|First Intervention||12
1555236|NCT01260896|3805034|P1|COMPLETED|First Intervention||10
1555237|NCT01260896|3805033|P2|STARTED|First Intervention||12
1555238|NCT01260896|3805034|P1|STARTED|First Intervention||12
1555239|NCT01260883|3805053|P3|NOT COMPLETED|Overall Study||0
1555240|NCT01260883|3805054|P2|NOT COMPLETED|Overall Study||0
1555241|NCT01260883|3805055|P1|NOT COMPLETED|Overall Study||0
1555242|NCT01260883|3805053|P3|COMPLETED|Overall Study||18
1555243|NCT01260883|3805054|P2|COMPLETED|Overall Study||11
1555244|NCT01260883|3805055|P1|COMPLETED|Overall Study||22
1555245|NCT01260883|3805053|P3|STARTED|Overall Study||18
1555246|NCT01260883|3805054|P2|STARTED|Overall Study||11
1555247|NCT01260883|3805055|P1|STARTED|Overall Study||22
1555248|NCT01260701|3805092|P1|NOT COMPLETED|Overall Study||75
1555249|NCT01260701|3805092|P1|COMPLETED|Overall Study||0
1555250|NCT01260701|3805092|P1|Eligible and Began Protocol Therapy|Overall Study||70
1555251|NCT01260701|3805092|P1|Eligible|Overall Study||71
1555252|NCT01260701|3805092|P1|STARTED|Overall Study||75
1555253|NCT01260688|3805101|P2|NOT COMPLETED|Overall Study||0
1555254|NCT01260688|3805102|P1|NOT COMPLETED|Overall Study||0
1555255|NCT01260688|3805101|P2|COMPLETED|Overall Study||11
1555256|NCT01260688|3805102|P1|COMPLETED|Overall Study||11
1555257|NCT01260688|3805101|P2|STARTED|Overall Study||11
1555258|NCT01260688|3805102|P1|STARTED|Overall Study||11
1555259|NCT01260662|3805139|P3|NOT COMPLETED|Overall Study||0
1555260|NCT01260662|3805140|P2|NOT COMPLETED|Overall Study||0
1555261|NCT01260662|3805141|P1|NOT COMPLETED|Overall Study||0
1555262|NCT01260662|3805139|P3|COMPLETED|Overall Study||96
1555263|NCT01260662|3805140|P2|COMPLETED|Overall Study||85
1555264|NCT01260662|3805141|P1|COMPLETED|Overall Study||90
1555265|NCT01260662|3805139|P3|STARTED|Overall Study||96
1555266|NCT01260662|3805140|P2|STARTED|Overall Study||85
1555267|NCT01260662|3805141|P1|STARTED|Overall Study||90
1555268|NCT01260649|3805160|P2|NOT COMPLETED|Overall Study||1
1555269|NCT01260649|3805161|P1|NOT COMPLETED|Overall Study||2
1555270|NCT01260649|3805160|P2|COMPLETED|Overall Study||8
1555271|NCT01260649|3805161|P1|COMPLETED|Overall Study||6
1555272|NCT01260649|3805160|P2|STARTED|Overall Study||9
1555273|NCT01260649|3805161|P1|STARTED|Overall Study||8
1555274|NCT01260584|3805173|P4|NOT COMPLETED|Period 2||1
1555275|NCT01260584|3805174|P3|NOT COMPLETED|Period 2||5
1555276|NCT01260584|3805175|P2|NOT COMPLETED|Period 2||3
1555277|NCT01260584|3805176|P1|NOT COMPLETED|Period 2||1
1555278|NCT01260584|3805173|P4|COMPLETED|Period 2||26
1555279|NCT01260584|3805174|P3|COMPLETED|Period 2||20
1555280|NCT01260584|3805175|P2|COMPLETED|Period 2||25
1555281|NCT01260584|3805176|P1|COMPLETED|Period 2||26
1555282|NCT01260584|3805173|P4|STARTED|Period 2||27
1555283|NCT01260584|3805174|P3|STARTED|Period 2||25
1555284|NCT01260584|3805175|P2|STARTED|Period 2||28
1555285|NCT01260584|3805176|P1|STARTED|Period 2||27
1555286|NCT01260584|3805173|P4|NOT COMPLETED|Period 1||1
1555287|NCT01260584|3805174|P3|NOT COMPLETED|Period 1||2
1555288|NCT01260584|3805175|P2|NOT COMPLETED|Period 1||0
1555289|NCT01260584|3805176|P1|NOT COMPLETED|Period 1||0
1555290|NCT01260584|3805173|P4|COMPLETED|Period 1||27
1555291|NCT01260584|3805174|P3|COMPLETED|Period 1||25
1555292|NCT01260584|3805175|P2|COMPLETED|Period 1||28
1555293|NCT01260584|3805176|P1|COMPLETED|Period 1||27
1555294|NCT01260584|3805173|P4|STARTED|Period 1||28
1555295|NCT01260584|3805174|P3|STARTED|Period 1||27
1555296|NCT01260584|3805175|P2|STARTED|Period 1||28
1555297|NCT01260584|3805176|P1|STARTED|Period 1||27
1555298|NCT01260493|3805212|P2|NOT COMPLETED|Overall Study||4
1555299|NCT01260493|3805213|P1|NOT COMPLETED|Overall Study||16
1555300|NCT01260493|3805212|P2|COMPLETED|Overall Study||85
1555301|NCT01260493|3805213|P1|COMPLETED|Overall Study||76
1555302|NCT01260493|3805212|P2|STARTED|Overall Study||89
1555303|NCT01260493|3805213|P1|STARTED|Overall Study||92
1555304|NCT01260467|3805219|P1|NOT COMPLETED|Overall Study||2
1555305|NCT01260467|3805219|P1|COMPLETED|Overall Study||2
1555306|NCT01260467|3805219|P1|STARTED|Overall Study||4
1555307|NCT01260454|3805225|P1|NOT COMPLETED|Overall Study||0
1555308|NCT01260454|3805225|P1|COMPLETED|Overall Study||6
1555309|NCT01260454|3805225|P1|STARTED|Overall Study||6
1555310|NCT01260350|3805251|P22|NOT COMPLETED|Overall Study||0
1555311|NCT01260350|3805252|P21|NOT COMPLETED|Overall Study||3
1555312|NCT01260350|3805253|P20|NOT COMPLETED|Overall Study||0
1555313|NCT01260350|3805254|P19|NOT COMPLETED|Overall Study||0
1555314|NCT01260350|3805255|P18|NOT COMPLETED|Overall Study||1
1555315|NCT01260350|3805256|P17|NOT COMPLETED|Overall Study||0
1555316|NCT01260350|3805257|P16|NOT COMPLETED|Overall Study||0
1555317|NCT01260350|3805258|P15|NOT COMPLETED|Overall Study||0
1555318|NCT01260350|3805259|P14|NOT COMPLETED|Overall Study||0
1555319|NCT01260350|3805260|P13|NOT COMPLETED|Overall Study||0
1555320|NCT01260350|3805261|P12|NOT COMPLETED|Overall Study||0
1555321|NCT01260350|3805262|P11|NOT COMPLETED|Overall Study||0
1555322|NCT01260350|3805263|P10|NOT COMPLETED|Overall Study||0
1555323|NCT01260350|3805264|P9|NOT COMPLETED|Overall Study||1
1555324|NCT01260350|3805265|P8|NOT COMPLETED|Overall Study||0
1555325|NCT01260350|3805266|P7|NOT COMPLETED|Overall Study||0
1555326|NCT01260350|3805267|P6|NOT COMPLETED|Overall Study||0
1555327|NCT01260350|3805268|P5|NOT COMPLETED|Overall Study||0
1555328|NCT01260350|3805269|P4|NOT COMPLETED|Overall Study||0
1555329|NCT01260350|3805270|P3|NOT COMPLETED|Overall Study||0
1555330|NCT01260350|3805271|P2|NOT COMPLETED|Overall Study||0
1555331|NCT01260350|3805272|P1|NOT COMPLETED|Overall Study||0
1555332|NCT01260350|3805251|P22|COMPLETED|Overall Study||0
1555333|NCT01260350|3805252|P21|COMPLETED|Overall Study||22
1555334|NCT01260350|3805253|P20|COMPLETED|Overall Study||14
1555335|NCT01260350|3805254|P19|COMPLETED|Overall Study||0
1555336|NCT01260350|3805255|P18|COMPLETED|Overall Study||9
1555337|NCT01260350|3805256|P17|COMPLETED|Overall Study||9
1555338|NCT01260350|3805257|P16|COMPLETED|Overall Study||10
1555339|NCT01260350|3805258|P15|COMPLETED|Overall Study||25
1555340|NCT01260350|3805259|P14|COMPLETED|Overall Study||10
1555341|NCT01260350|3805260|P13|COMPLETED|Overall Study||25
1555342|NCT01260350|3805261|P12|COMPLETED|Overall Study||9
1555343|NCT01260350|3805262|P11|COMPLETED|Overall Study||10
1555344|NCT01260350|3805263|P10|COMPLETED|Overall Study||25
1555345|NCT01260350|3805264|P9|COMPLETED|Overall Study||24
1555346|NCT01260350|3805265|P8|COMPLETED|Overall Study||25
1555347|NCT01260350|3805266|P7|COMPLETED|Overall Study||10
1555348|NCT01260350|3805267|P6|COMPLETED|Overall Study||10
1555349|NCT01260350|3805268|P5|COMPLETED|Overall Study||10
1555350|NCT01260350|3805269|P4|COMPLETED|Overall Study||11
1555351|NCT01260350|3805270|P3|COMPLETED|Overall Study||10
1555352|NCT01260350|3805271|P2|COMPLETED|Overall Study||9
1555353|NCT01260350|3805272|P1|COMPLETED|Overall Study||10
1555354|NCT01260350|3805251|P22|STARTED|Overall Study||0
1555355|NCT01260350|3805252|P21|STARTED|Overall Study||25
1555356|NCT01260350|3805253|P20|STARTED|Overall Study||14
1555357|NCT01260350|3805254|P19|STARTED|Overall Study||0
1555358|NCT01260350|3805255|P18|STARTED|Overall Study||10
1555359|NCT01260350|3805256|P17|STARTED|Overall Study||9
1555360|NCT01260350|3805257|P16|STARTED|Overall Study||10
1555361|NCT01260350|3805258|P15|STARTED|Overall Study||25
1555362|NCT01260350|3805259|P14|STARTED|Overall Study||10
1555363|NCT01260350|3805260|P13|STARTED|Overall Study||25
1555364|NCT01260350|3805261|P12|STARTED|Overall Study||9
1555365|NCT01260350|3805262|P11|STARTED|Overall Study||10
1555366|NCT01260350|3805263|P10|STARTED|Overall Study||25
1555367|NCT01260350|3805264|P9|STARTED|Overall Study||25
1555368|NCT01260350|3805265|P8|STARTED|Overall Study||25
1555369|NCT01260350|3805266|P7|STARTED|Overall Study||10
1555370|NCT01260350|3805267|P6|STARTED|Overall Study||10
1555371|NCT01260350|3805268|P5|STARTED|Overall Study||10
1555372|NCT01260350|3805269|P4|STARTED|Overall Study||11
1555373|NCT01260350|3805270|P3|STARTED|Overall Study||10
1555374|NCT01260350|3805271|P2|STARTED|Overall Study||9
1555375|NCT01260350|3805272|P1|STARTED|Overall Study||10
1555376|NCT01260324|3805464|P2|NOT COMPLETED|Overall Study||0
1555377|NCT01260324|3805465|P1|NOT COMPLETED|Overall Study||0
1555378|NCT01260324|3805464|P2|COMPLETED|Overall Study||20000
1555379|NCT01260324|3805465|P1|COMPLETED|Overall Study||1283
1555380|NCT01260324|3805464|P2|STARTED|Overall Study||20000
1555381|NCT01260324|3805465|P1|STARTED|Overall Study||1283
1555382|NCT01260311|3805479|P1|NOT COMPLETED|Overall Study||127
1555383|NCT01260311|3805479|P1|COMPLETED|Overall Study||381
1555384|NCT01260311|3805479|P1|STARTED|Overall Study||508
1555385|NCT01260272|3805489|P2|NOT COMPLETED|Overall Study||2
1555386|NCT01260272|3805490|P1|NOT COMPLETED|Overall Study||2
1555387|NCT01260272|3805489|P2|COMPLETED|Overall Study||30
1555388|NCT01260272|3805490|P1|COMPLETED|Overall Study||15
1555389|NCT01260272|3805489|P2|STARTED|Overall Study||32
1555390|NCT01260272|3805490|P1|STARTED|Overall Study||17
1555391|NCT01260194|3805510|P1|NOT COMPLETED|Overall Study||1
1555392|NCT01260194|3805510|P1|COMPLETED|Overall Study||3
1555393|NCT01260194|3805510|P1|STARTED|Overall Study||4
1555394|NCT01260181|3805522|P1|NOT COMPLETED|Overall Study||1
1555395|NCT01260181|3805522|P1|COMPLETED|Overall Study||29
1555396|NCT01260181|3805522|P1|STARTED|Overall Study||30
1555397|NCT01260142|3805537|P6|NOT COMPLETED|Treatment Period 2||0
1555398|NCT01260142|3805538|P5|NOT COMPLETED|Treatment Period 2||0
1555399|NCT01260142|3805539|P4|NOT COMPLETED|Treatment Period 2||0
1555400|NCT01260142|3805540|P3|NOT COMPLETED|Treatment Period 2||0
1555401|NCT01260142|3805541|P2|NOT COMPLETED|Treatment Period 2||0
1555402|NCT01260142|3805542|P1|NOT COMPLETED|Treatment Period 2||0
1555403|NCT01260142|3805537|P6|COMPLETED|Treatment Period 2||3
1555404|NCT01260142|3805538|P5|COMPLETED|Treatment Period 2||4
1555405|NCT01260142|3805539|P4|COMPLETED|Treatment Period 2||6
1555406|NCT01260142|3805540|P3|COMPLETED|Treatment Period 2||6
1555407|NCT01260142|3805541|P2|COMPLETED|Treatment Period 2||5
1555408|NCT01260142|3805542|P1|COMPLETED|Treatment Period 2||5
1555409|NCT01260142|3805537|P6|STARTED|Treatment Period 2||3
1555410|NCT01260142|3805538|P5|STARTED|Treatment Period 2||4
1555411|NCT01260142|3805539|P4|STARTED|Treatment Period 2||6
1555412|NCT01260142|3805540|P3|STARTED|Treatment Period 2||6
1555413|NCT01260142|3805541|P2|STARTED|Treatment Period 2||5
1555414|NCT01260142|3805542|P1|STARTED|Treatment Period 2||5
1555415|NCT01260142|3805537|P6|NOT COMPLETED|Treatment Period 1||3
1555416|NCT01260142|3805538|P5|NOT COMPLETED|Treatment Period 1||2
1555417|NCT01260142|3805539|P4|NOT COMPLETED|Treatment Period 1||0
1555418|NCT01260142|3805540|P3|NOT COMPLETED|Treatment Period 1||0
1555419|NCT01260142|3805541|P2|NOT COMPLETED|Treatment Period 1||1
1555420|NCT01260142|3805542|P1|NOT COMPLETED|Treatment Period 1||1
1555421|NCT01260142|3805537|P6|COMPLETED|Treatment Period 1||3
1555422|NCT01260142|3805538|P5|COMPLETED|Treatment Period 1||4
1555423|NCT01260142|3805539|P4|COMPLETED|Treatment Period 1||6
1555424|NCT01260142|3805540|P3|COMPLETED|Treatment Period 1||6
1555425|NCT01260142|3805541|P2|COMPLETED|Treatment Period 1||5
1555426|NCT01260142|3805542|P1|COMPLETED|Treatment Period 1||5
1555427|NCT01260142|3805537|P6|STARTED|Treatment Period 1||6
1555428|NCT01260142|3805538|P5|STARTED|Treatment Period 1||6
1555429|NCT01260142|3805539|P4|STARTED|Treatment Period 1||6
1555430|NCT01260142|3805540|P3|STARTED|Treatment Period 1||6
1555431|NCT01260142|3805541|P2|STARTED|Treatment Period 1||6
1555432|NCT01260142|3805542|P1|STARTED|Treatment Period 1||6
1555433|NCT01259856|3805594|P2|NOT COMPLETED|Overall Study||74
1555434|NCT01259856|3805595|P1|NOT COMPLETED|Overall Study||69
1555435|NCT01259856|3805594|P2|COMPLETED|Overall Study||12
1555436|NCT01259856|3805595|P1|COMPLETED|Overall Study||13
1555437|NCT01259856|3805594|P2|STARTED|Overall Study||86
1555438|NCT01259856|3805595|P1|STARTED|Overall Study||82
1555439|NCT01259726|3805619|P4|NOT COMPLETED|Overall Study||5
1555440|NCT01259726|3805620|P3|NOT COMPLETED|Overall Study||4
1555441|NCT01259726|3805621|P2|NOT COMPLETED|Overall Study||4
1555442|NCT01259726|3805622|P1|NOT COMPLETED|Overall Study||5
1555443|NCT01259726|3805619|P4|COMPLETED|Overall Study||36
1555444|NCT01259726|3805620|P3|COMPLETED|Overall Study||39
1555445|NCT01259726|3805621|P2|COMPLETED|Overall Study||37
1555446|NCT01259726|3805622|P1|COMPLETED|Overall Study||38
1555447|NCT01259726|3805619|P4|Treated|Overall Study||39
1555448|NCT01259726|3805620|P3|Treated|Overall Study||41
1555449|NCT01259726|3805621|P2|Treated|Overall Study||37
1555450|NCT01259726|3805622|P1|Treated|Overall Study||40
1555451|NCT01259726|3805619|P4|STARTED|Overall Study||41
1555452|NCT01259726|3805620|P3|STARTED|Overall Study||43
1555453|NCT01259726|3805621|P2|STARTED|Overall Study||41
1555454|NCT01259726|3805622|P1|STARTED|Overall Study||43
1555455|NCT01259713|3805654|P2|NOT COMPLETED|Overall Study||41
1555456|NCT01259713|3805655|P1|NOT COMPLETED|Overall Study||95
1555457|NCT01259713|3805654|P2|COMPLETED|Overall Study||77
1555458|NCT01259713|3805655|P1|COMPLETED|Overall Study||142
1555459|NCT01259713|3805654|P2|STARTED|Overall Study||118
1555460|NCT01259713|3805655|P1|STARTED|Overall Study||237
1555461|NCT01259596|3805679|P2|NOT COMPLETED|Overall Study||6
1555462|NCT01259596|3805680|P1|NOT COMPLETED|Overall Study||4
1555463|NCT01259596|3805679|P2|COMPLETED|Overall Study||65
1555464|NCT01259596|3805680|P1|COMPLETED|Overall Study||66
1555465|NCT01259596|3805679|P2|STARTED|Overall Study||71
1555466|NCT01259596|3805680|P1|STARTED|Overall Study||70
1555467|NCT01259492|3805702|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
1555468|NCT01259492|3805703|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
1555469|NCT01259492|3805704|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
1555470|NCT01259492|3805705|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
1555471|NCT01259492|3805702|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
1555472|NCT01259492|3805703|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
1555473|NCT01259492|3805704|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
1555474|NCT01259492|3805705|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
1555475|NCT01259492|3805702|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
1555476|NCT01259492|3805703|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
1555477|NCT01259492|3805704|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
1555478|NCT01259492|3805705|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
1555479|NCT01259492|3805702|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
1555480|NCT01259492|3805703|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
1555481|NCT01259492|3805704|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
1555482|NCT01259492|3805705|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
1555483|NCT01259492|3805702|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
1555484|NCT01259492|3805703|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
1555485|NCT01259492|3805704|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
1555486|NCT01259492|3805705|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
1555487|NCT01259492|3805702|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
1555488|NCT01259492|3805703|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
1555489|NCT01259492|3805704|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
1555490|NCT01259492|3805705|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
1555491|NCT01259492|3805702|P4|STARTED|Period 2 (Week 10 to Week 14)||153
1555492|NCT01259492|3805703|P3|STARTED|Period 2 (Week 10 to Week 14)||138
1555493|NCT01259492|3805704|P2|STARTED|Period 2 (Week 10 to Week 14)||141
1555494|NCT01259492|3805705|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
1555495|NCT01259492|3805702|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
1555496|NCT01259492|3805703|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
1555497|NCT01259492|3805704|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
1555498|NCT01259492|3805705|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
1555499|NCT01259492|3805702|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
1555500|NCT01259492|3805703|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
1555501|NCT01259492|3805704|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
1555502|NCT01259492|3805705|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
1555503|NCT01259492|3805702|P4|Full Analysis Set|Period 1 (9 Weeks)||172
1555504|NCT01259492|3805703|P3|Full Analysis Set|Period 1 (9 Weeks)||179
1555505|NCT01259492|3805704|P2|Full Analysis Set|Period 1 (9 Weeks)||175
1555506|NCT01259492|3805705|P1|Full Analysis Set|Period 1 (9 Weeks)||174
1555507|NCT01259492|3805702|P4|STARTED|Period 1 (9 Weeks)||181
1555508|NCT01259492|3805703|P3|STARTED|Period 1 (9 Weeks)||181
1555509|NCT01259492|3805704|P2|STARTED|Period 1 (9 Weeks)||182
1555510|NCT01259492|3805705|P1|STARTED|Period 1 (9 Weeks)||181
1555511|NCT01259466|3805754|P2|NOT COMPLETED|Overall Study||9
1555512|NCT01259466|3805755|P1|NOT COMPLETED|Overall Study||1
1555513|NCT01259466|3805754|P2|COMPLETED|Overall Study||18
1555514|NCT01259466|3805755|P1|COMPLETED|Overall Study||26
1555515|NCT01259466|3805754|P2|STARTED|Overall Study||27
1555516|NCT01259466|3805755|P1|STARTED|Overall Study||27
1555517|NCT01259440|3805765|P2|NOT COMPLETED|Overall Study||0
1555518|NCT01259440|3805766|P1|NOT COMPLETED|Overall Study||0
1555519|NCT01259440|3805765|P2|COMPLETED|Overall Study||10
1555520|NCT01259440|3805766|P1|COMPLETED|Overall Study||13
1555521|NCT01259440|3805765|P2|STARTED|Overall Study||10
1555522|NCT01259440|3805766|P1|STARTED|Overall Study||13
1555523|NCT01259427|3805774|P2|NOT COMPLETED|Overall Study||14
1555524|NCT01259427|3805775|P1|NOT COMPLETED|Overall Study||18
1555525|NCT01259427|3805774|P2|COMPLETED|Overall Study||110
1555526|NCT01259427|3805775|P1|COMPLETED|Overall Study||106
1555527|NCT01259427|3805774|P2|STARTED|Overall Study||124
1555528|NCT01259427|3805775|P1|STARTED|Overall Study||124
1555529|NCT01259401|3805793|P2|NOT COMPLETED|4-month Follow-up||2
1555530|NCT01259401|3805794|P1|NOT COMPLETED|4-month Follow-up||0
1555531|NCT01259401|3805793|P2|COMPLETED|4-month Follow-up||19
1555532|NCT01259401|3805794|P1|COMPLETED|4-month Follow-up||21
1555533|NCT01259401|3805793|P2|STARTED|4-month Follow-up||21
1555534|NCT01259401|3805794|P1|STARTED|4-month Follow-up||21
1555535|NCT01259401|3805793|P2|NOT COMPLETED|End of 4-week Intervention||0
1555536|NCT01259401|3805794|P1|NOT COMPLETED|End of 4-week Intervention||0
1555537|NCT01259401|3805793|P2|COMPLETED|End of 4-week Intervention||21
1555538|NCT01259401|3805794|P1|COMPLETED|End of 4-week Intervention||21
1555539|NCT01259401|3805793|P2|STARTED|End of 4-week Intervention||21
1555540|NCT01259401|3805794|P1|STARTED|End of 4-week Intervention||21
1555541|NCT01259375|3805802|P1|NOT COMPLETED|Overall Study||1
1555542|NCT01259375|3805802|P1|COMPLETED|Overall Study||23
1555543|NCT01259375|3805802|P1|STARTED|Overall Study||24
1555544|NCT01259297|3805819|P8|NOT COMPLETED|Double Blind Randomized Period||3
1555545|NCT01259297|3805820|P7|NOT COMPLETED|Double Blind Randomized Period||6
1555546|NCT01259297|3805821|P6|NOT COMPLETED|Double Blind Randomized Period||8
1555547|NCT01259297|3805822|P5|NOT COMPLETED|Double Blind Randomized Period||4
1555548|NCT01259297|3805823|P4|NOT COMPLETED|Double Blind Randomized Period||4
1555549|NCT01259297|3805824|P3|NOT COMPLETED|Double Blind Randomized Period||1
1555550|NCT01259297|3805825|P2|NOT COMPLETED|Double Blind Randomized Period||3
1555551|NCT01259297|3805826|P1|NOT COMPLETED|Double Blind Randomized Period||2
1555552|NCT01259297|3805819|P8|COMPLETED|Double Blind Randomized Period||196
1555553|NCT01259297|3805820|P7|COMPLETED|Double Blind Randomized Period||190
1555554|NCT01259297|3805821|P6|COMPLETED|Double Blind Randomized Period||245
1555555|NCT01259297|3805822|P5|COMPLETED|Double Blind Randomized Period||247
1555556|NCT01259297|3805823|P4|COMPLETED|Double Blind Randomized Period||191
1555557|NCT01259297|3805824|P3|COMPLETED|Double Blind Randomized Period||188
1555558|NCT01259297|3805825|P2|COMPLETED|Double Blind Randomized Period||229
1555559|NCT01259297|3805826|P1|COMPLETED|Double Blind Randomized Period||242
1555560|NCT01259297|3805819|P8|STARTED|Double Blind Randomized Period||199
1555561|NCT01259297|3805820|P7|STARTED|Double Blind Randomized Period||196
1555562|NCT01259297|3805821|P6|STARTED|Double Blind Randomized Period||253
1555563|NCT01259297|3805822|P5|STARTED|Double Blind Randomized Period||251
1555564|NCT01259297|3805823|P4|STARTED|Double Blind Randomized Period||195
1555565|NCT01259297|3805824|P3|STARTED|Double Blind Randomized Period||189
1555566|NCT01259297|3805825|P2|STARTED|Double Blind Randomized Period||232
1555567|NCT01259297|3805826|P1|STARTED|Double Blind Randomized Period||244
1555568|NCT01259297|3805819|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555569|NCT01259297|3805820|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555570|NCT01259297|3805821|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555571|NCT01259297|3805822|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555572|NCT01259297|3805823|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555573|NCT01259297|3805824|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
1555574|NCT01259297|3805825|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555575|NCT01259297|3805826|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
1555576|NCT01259297|3805819|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555577|NCT01259297|3805820|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555578|NCT01259297|3805821|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555579|NCT01259297|3805822|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555580|NCT01259297|3805823|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555581|NCT01259297|3805824|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
1555582|NCT01259297|3805825|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1555583|NCT01259297|3805826|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
1555584|NCT01259297|3805819|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1555585|NCT01259297|3805820|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1555586|NCT01259297|3805821|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1555587|NCT01259297|3805822|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1555588|NCT01259297|3805823|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1555589|NCT01259297|3805824|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
1555590|NCT01259297|3805825|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1555591|NCT01259297|3805826|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
1555592|NCT01259284|3805857|P3|NOT COMPLETED|Overall Study||0
1555593|NCT01259284|3805858|P2|NOT COMPLETED|Overall Study||0
1555594|NCT01259284|3805859|P1|NOT COMPLETED|Overall Study||2
1555595|NCT01259284|3805857|P3|COMPLETED|Overall Study||0
1555596|NCT01259284|3805858|P2|COMPLETED|Overall Study||0
1555597|NCT01259284|3805859|P1|COMPLETED|Overall Study||0
1555598|NCT01259284|3805857|P3|STARTED|Overall Study||0
1555599|NCT01259284|3805858|P2|STARTED|Overall Study||0
1555600|NCT01259284|3805859|P1|STARTED|Overall Study||2
1555601|NCT01259245|3805869|P2|NOT COMPLETED|Overall Study||26
1555602|NCT01259245|3805870|P1|NOT COMPLETED|Overall Study||28
1555603|NCT01259245|3805869|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
1555604|NCT01259245|3805870|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
1555605|NCT01259245|3805869|P2|STARTED|Overall Study||94
1555606|NCT01259245|3805870|P1|STARTED|Overall Study||98
1555607|NCT01259115|3805894|P2|NOT COMPLETED|Period 2||0
1555608|NCT01259115|3805895|P1|NOT COMPLETED|Period 2||1
1555609|NCT01259115|3805894|P2|COMPLETED|Period 2||9
1555610|NCT01259115|3805895|P1|COMPLETED|Period 2||6
1555611|NCT01259115|3805894|P2|STARTED|Period 2||9
1555612|NCT01259115|3805895|P1|STARTED|Period 2||7
1555613|NCT01259115|3805894|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
1555614|NCT01259115|3805895|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
1555615|NCT01259115|3805894|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
1555616|NCT01259115|3805895|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
1555617|NCT01259115|3805894|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
1555618|NCT01259115|3805895|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
1555619|NCT01259115|3805894|P2|NOT COMPLETED|Period 1||1
1555620|NCT01259115|3805895|P1|NOT COMPLETED|Period 1||3
1555621|NCT01259115|3805894|P2|COMPLETED|Period 1||9
1555622|NCT01259115|3805895|P1|COMPLETED|Period 1||7
1555623|NCT01259115|3805894|P2|STARTED|Period 1||10
1555624|NCT01259115|3805895|P1|STARTED|Period 1||10
1555625|NCT01259102|3805931|P5|NOT COMPLETED|Overall Study||1
1555626|NCT01259102|3805932|P4|NOT COMPLETED|Overall Study||2
1555627|NCT01259102|3805933|P3|NOT COMPLETED|Overall Study||2
1555628|NCT01259102|3805934|P2|NOT COMPLETED|Overall Study||0
1555629|NCT01259102|3805935|P1|NOT COMPLETED|Overall Study||1
1555630|NCT01259102|3805931|P5|COMPLETED|Overall Study||13
1555631|NCT01259102|3805932|P4|COMPLETED|Overall Study||12
1555632|NCT01259102|3805933|P3|COMPLETED|Overall Study||13
1555633|NCT01259102|3805934|P2|COMPLETED|Overall Study||14
1555634|NCT01259102|3805935|P1|COMPLETED|Overall Study||12
1555635|NCT01259102|3805931|P5|STARTED|Overall Study||14
1555636|NCT01259102|3805932|P4|STARTED|Overall Study||14
1555637|NCT01259102|3805933|P3|STARTED|Overall Study||15
1555638|NCT01259102|3805934|P2|STARTED|Overall Study||14
1555639|NCT01259102|3805935|P1|STARTED|Overall Study||13
1555640|NCT01259089|3805992|P6|NOT COMPLETED|Survival Follow up for Two Years||19
1555641|NCT01259089|3805993|P5|NOT COMPLETED|Survival Follow up for Two Years||6
1555642|NCT01259089|3805994|P4|NOT COMPLETED|Survival Follow up for Two Years||3
1555643|NCT01259089|3805995|P3|NOT COMPLETED|Survival Follow up for Two Years||2
1555644|NCT01259089|3805996|P2|NOT COMPLETED|Survival Follow up for Two Years||2
1555645|NCT01259089|3805997|P1|NOT COMPLETED|Survival Follow up for Two Years||3
1555646|NCT01259089|3805992|P6|COMPLETED|Survival Follow up for Two Years||0
1555647|NCT01259089|3805993|P5|COMPLETED|Survival Follow up for Two Years||0
1555648|NCT01259089|3805994|P4|COMPLETED|Survival Follow up for Two Years||0
1555649|NCT01259089|3805995|P3|COMPLETED|Survival Follow up for Two Years||1
1555650|NCT01259089|3805996|P2|COMPLETED|Survival Follow up for Two Years||1
1555651|NCT01259089|3805997|P1|COMPLETED|Survival Follow up for Two Years||0
1555652|NCT01259089|3805992|P6|STARTED|Survival Follow up for Two Years||19
1555653|NCT01259089|3805993|P5|STARTED|Survival Follow up for Two Years||6
1555654|NCT01259089|3805994|P4|STARTED|Survival Follow up for Two Years||3
1555655|NCT01259089|3805995|P3|STARTED|Survival Follow up for Two Years||3
1555656|NCT01259089|3805996|P2|STARTED|Survival Follow up for Two Years||3
1555657|NCT01259089|3805997|P1|STARTED|Survival Follow up for Two Years||3
1555658|NCT01259089|3805992|P6|NOT COMPLETED|Continued Treatment After 8 Weeks||1
1555659|NCT01259089|3805993|P5|NOT COMPLETED|Continued Treatment After 8 Weeks||2
1555660|NCT01259089|3805994|P4|NOT COMPLETED|Continued Treatment After 8 Weeks||1
1555661|NCT01259089|3805995|P3|NOT COMPLETED|Continued Treatment After 8 Weeks||1
1555662|NCT01259089|3805996|P2|NOT COMPLETED|Continued Treatment After 8 Weeks||1
1555663|NCT01259089|3805997|P1|NOT COMPLETED|Continued Treatment After 8 Weeks||2
1555664|NCT01259089|3805992|P6|COMPLETED|Continued Treatment After 8 Weeks||7
1555665|NCT01259089|3805993|P5|COMPLETED|Continued Treatment After 8 Weeks||0
1555666|NCT01259089|3805994|P4|COMPLETED|Continued Treatment After 8 Weeks||1
1555667|NCT01259089|3805995|P3|COMPLETED|Continued Treatment After 8 Weeks||1
1555668|NCT01259089|3805996|P2|COMPLETED|Continued Treatment After 8 Weeks||2
1555669|NCT01259089|3805997|P1|COMPLETED|Continued Treatment After 8 Weeks||1
1555670|NCT01259089|3805992|P6|STARTED|Continued Treatment After 8 Weeks||8
1555671|NCT01259089|3805993|P5|STARTED|Continued Treatment After 8 Weeks||2
1555672|NCT01259089|3805994|P4|STARTED|Continued Treatment After 8 Weeks||2
1555673|NCT01259089|3805995|P3|STARTED|Continued Treatment After 8 Weeks||2
1555674|NCT01259089|3805996|P2|STARTED|Continued Treatment After 8 Weeks||3
1555675|NCT01259089|3805997|P1|STARTED|Continued Treatment After 8 Weeks||3
1555676|NCT01259089|3805992|P6|NOT COMPLETED|Confirmed Response at 8 Weeks||10
1555677|NCT01259089|3805993|P5|NOT COMPLETED|Confirmed Response at 8 Weeks||4
1555678|NCT01259089|3805994|P4|NOT COMPLETED|Confirmed Response at 8 Weeks||1
1555679|NCT01259089|3805995|P3|NOT COMPLETED|Confirmed Response at 8 Weeks||1
1555680|NCT01259089|3805996|P2|NOT COMPLETED|Confirmed Response at 8 Weeks||0
1555681|NCT01259089|3805997|P1|NOT COMPLETED|Confirmed Response at 8 Weeks||0
1555682|NCT01259089|3805992|P6|COMPLETED|Confirmed Response at 8 Weeks||8
1555683|NCT01259089|3805993|P5|COMPLETED|Confirmed Response at 8 Weeks||2
1555684|NCT01259089|3805994|P4|COMPLETED|Confirmed Response at 8 Weeks||2
1555685|NCT01259089|3805995|P3|COMPLETED|Confirmed Response at 8 Weeks||2
1555686|NCT01259089|3805996|P2|COMPLETED|Confirmed Response at 8 Weeks||3
1555687|NCT01259089|3805997|P1|COMPLETED|Confirmed Response at 8 Weeks||3
1555688|NCT01259089|3805992|P6|STARTED|Confirmed Response at 8 Weeks||18
1555689|NCT01259089|3805993|P5|STARTED|Confirmed Response at 8 Weeks||6
1555690|NCT01259089|3805994|P4|STARTED|Confirmed Response at 8 Weeks||3
1555691|NCT01259089|3805995|P3|STARTED|Confirmed Response at 8 Weeks||3
1555692|NCT01259089|3805996|P2|STARTED|Confirmed Response at 8 Weeks||3
1555693|NCT01259089|3805997|P1|STARTED|Confirmed Response at 8 Weeks||3
1555694|NCT01259089|3805992|P6|NOT COMPLETED|Reached First Response at 4 Weeks||2
1555695|NCT01259089|3805993|P5|NOT COMPLETED|Reached First Response at 4 Weeks||0
1555696|NCT01259089|3805994|P4|NOT COMPLETED|Reached First Response at 4 Weeks||0
1555697|NCT01259089|3805995|P3|NOT COMPLETED|Reached First Response at 4 Weeks||0
1555698|NCT01259089|3805996|P2|NOT COMPLETED|Reached First Response at 4 Weeks||0
1555699|NCT01259089|3805997|P1|NOT COMPLETED|Reached First Response at 4 Weeks||0
1555700|NCT01259089|3805992|P6|COMPLETED|Reached First Response at 4 Weeks||18
1555701|NCT01259089|3805993|P5|COMPLETED|Reached First Response at 4 Weeks||6
1555702|NCT01259089|3805994|P4|COMPLETED|Reached First Response at 4 Weeks||3
1555703|NCT01259089|3805995|P3|COMPLETED|Reached First Response at 4 Weeks||3
1555704|NCT01259089|3805996|P2|COMPLETED|Reached First Response at 4 Weeks||3
1555705|NCT01259089|3805997|P1|COMPLETED|Reached First Response at 4 Weeks||3
1555706|NCT01259089|3805992|P6|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
1555707|NCT01259089|3805993|P5|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
1555708|NCT01259089|3805994|P4|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
1555709|NCT01259089|3805995|P3|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
1555710|NCT01259089|3805996|P2|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
1555711|NCT01259089|3805997|P1|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
1555712|NCT01259089|3805992|P6|Started Treatment on Study|Reached First Response at 4 Weeks||19
1555713|NCT01259089|3805993|P5|Started Treatment on Study|Reached First Response at 4 Weeks||6
1555714|NCT01259089|3805994|P4|Started Treatment on Study|Reached First Response at 4 Weeks||3
1555715|NCT01259089|3805995|P3|Started Treatment on Study|Reached First Response at 4 Weeks||3
1555716|NCT01259089|3805996|P2|Started Treatment on Study|Reached First Response at 4 Weeks||3
1555717|NCT01259089|3805997|P1|Started Treatment on Study|Reached First Response at 4 Weeks||3
1555718|NCT01259089|3805992|P6|STARTED|Reached First Response at 4 Weeks||20
1555719|NCT01259089|3805993|P5|STARTED|Reached First Response at 4 Weeks||6
1555720|NCT01259089|3805994|P4|STARTED|Reached First Response at 4 Weeks||3
1555721|NCT01259089|3805995|P3|STARTED|Reached First Response at 4 Weeks||3
1555722|NCT01259089|3805996|P2|STARTED|Reached First Response at 4 Weeks||3
1555723|NCT01259089|3805997|P1|STARTED|Reached First Response at 4 Weeks||3
1555724|NCT01259063|3806011|P1|NOT COMPLETED|Overall Study||0
1555725|NCT01259063|3806011|P1|COMPLETED|Overall Study||33
1555726|NCT01259063|3806011|P1|STARTED|Overall Study||33
1555727|NCT01259024|3806020|P1|NOT COMPLETED|Overall Study||1
1555728|NCT01259024|3806020|P1|COMPLETED|Overall Study||0
1555729|NCT01259024|3806020|P1|STARTED|Overall Study||1
1555730|NCT01259011|3806029|P2|NOT COMPLETED|After Patient Death||0
1555731|NCT01259011|3806030|P1|NOT COMPLETED|After Patient Death||0
1555732|NCT01259011|3806029|P2|COMPLETED|After Patient Death||28
1555733|NCT01259011|3806030|P1|COMPLETED|After Patient Death||17
1555734|NCT01259011|3806029|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
1555735|NCT01259011|3806030|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
1555736|NCT01259011|3806029|P2|NOT COMPLETED|Main Study Period||0
1555737|NCT01259011|3806030|P1|NOT COMPLETED|Main Study Period||0
1555738|NCT01259011|3806029|P2|COMPLETED|Main Study Period||109
1555739|NCT01259011|3806030|P1|COMPLETED|Main Study Period||101
1555740|NCT01259011|3806029|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
1555741|NCT01259011|3806030|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
1555742|NCT01258998|3806040|P1|NOT COMPLETED|Overall Study||1
1555743|NCT01258998|3806040|P1|COMPLETED|Overall Study||59
1555744|NCT01258998|3806040|P1|STARTED|Overall Study||60
1555745|NCT01258985|3806046|P2|NOT COMPLETED|Overall Study||0
1555746|NCT01258985|3806047|P1|NOT COMPLETED|Overall Study||0
1555747|NCT01258985|3806046|P2|COMPLETED|Overall Study||98
1555748|NCT01258985|3806047|P1|COMPLETED|Overall Study||106
1555749|NCT01258985|3806046|P2|STARTED|Overall Study||98
1555750|NCT01258985|3806047|P1|STARTED|Overall Study||106
1555751|NCT01258803|3806073|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1555752|NCT01258803|3806074|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1555753|NCT01258803|3806075|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1555754|NCT01258803|3806076|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1555755|NCT01258803|3806077|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1555756|NCT01258803|3806078|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1555757|NCT01258803|3806073|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
1555758|NCT01258803|3806074|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
1555759|NCT01258803|3806075|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
1555760|NCT01258803|3806076|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
1555761|NCT01258803|3806077|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
1555762|NCT01258803|3806078|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
1555763|NCT01258803|3806073|P6|STARTED|Treatment Period 4 (1 Dose)||15
1555764|NCT01258803|3806074|P5|STARTED|Treatment Period 4 (1 Dose)||15
1555765|NCT01258803|3806075|P4|STARTED|Treatment Period 4 (1 Dose)||15
1555766|NCT01258803|3806076|P3|STARTED|Treatment Period 4 (1 Dose)||14
1555767|NCT01258803|3806077|P2|STARTED|Treatment Period 4 (1 Dose)||14
1555768|NCT01258803|3806078|P1|STARTED|Treatment Period 4 (1 Dose)||14
1555769|NCT01258803|3806073|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1555770|NCT01258803|3806074|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1555771|NCT01258803|3806075|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1555772|NCT01258803|3806076|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
1555773|NCT01258803|3806077|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1555774|NCT01258803|3806078|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1555775|NCT01258803|3806073|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
1555776|NCT01258803|3806074|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
1555777|NCT01258803|3806075|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
1555778|NCT01258803|3806076|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
1555779|NCT01258803|3806077|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
1555780|NCT01258803|3806078|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
1555781|NCT01258803|3806073|P6|STARTED|Treatment Period 3 (1 Dose)||15
1555782|NCT01258803|3806074|P5|STARTED|Treatment Period 3 (1 Dose)||15
1555783|NCT01258803|3806075|P4|STARTED|Treatment Period 3 (1 Dose)||15
1555784|NCT01258803|3806076|P3|STARTED|Treatment Period 3 (1 Dose)||15
1555785|NCT01258803|3806077|P2|STARTED|Treatment Period 3 (1 Dose)||14
1555786|NCT01258803|3806078|P1|STARTED|Treatment Period 3 (1 Dose)||14
1555787|NCT01258803|3806073|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
1555788|NCT01258803|3806074|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
1555789|NCT01258803|3806075|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
1555790|NCT01258803|3806076|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
1555791|NCT01258803|3806077|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
1555792|NCT01258803|3806078|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
1555793|NCT01258803|3806073|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
1555794|NCT01258803|3806074|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
1555795|NCT01258803|3806075|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
1555796|NCT01258803|3806076|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
1555797|NCT01258803|3806077|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
1555798|NCT01258803|3806078|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
1555799|NCT01258803|3806073|P6|STARTED|Treatment Period 2 (1 Dose)||16
1555800|NCT01258803|3806074|P5|STARTED|Treatment Period 2 (1 Dose)||15
1555801|NCT01258803|3806075|P4|STARTED|Treatment Period 2 (1 Dose)||15
1555802|NCT01258803|3806076|P3|STARTED|Treatment Period 2 (1 Dose)||15
1555803|NCT01258803|3806077|P2|STARTED|Treatment Period 2 (1 Dose)||16
1555804|NCT01258803|3806078|P1|STARTED|Treatment Period 2 (1 Dose)||15
1555805|NCT01258803|3806073|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1555806|NCT01258803|3806074|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1555807|NCT01258803|3806075|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1555808|NCT01258803|3806076|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1555809|NCT01258803|3806077|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1555810|NCT01258803|3806078|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1555811|NCT01258803|3806073|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
1555812|NCT01258803|3806074|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
1555813|NCT01258803|3806075|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
1555814|NCT01258803|3806076|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
1555815|NCT01258803|3806077|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
1555816|NCT01258803|3806078|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
1555817|NCT01258803|3806073|P6|STARTED|Treatment Period 1 (1 Dose)||16
1555818|NCT01258803|3806074|P5|STARTED|Treatment Period 1 (1 Dose)||15
1555819|NCT01258803|3806075|P4|STARTED|Treatment Period 1 (1 Dose)||15
1555820|NCT01258803|3806076|P3|STARTED|Treatment Period 1 (1 Dose)||15
1555821|NCT01258803|3806077|P2|STARTED|Treatment Period 1 (1 Dose)||16
1555822|NCT01258803|3806078|P1|STARTED|Treatment Period 1 (1 Dose)||15
1555823|NCT01258790|3806106|P2|NOT COMPLETED|Overall Study||0
1555824|NCT01258790|3806107|P1|NOT COMPLETED|Overall Study||0
1555825|NCT01258790|3806106|P2|COMPLETED|Overall Study||6
1555826|NCT01258790|3806107|P1|COMPLETED|Overall Study||6
1555827|NCT01258790|3806106|P2|STARTED|Overall Study||6
1555828|NCT01258790|3806107|P1|STARTED|Overall Study||6
1555829|NCT01258738|3806115|P2|NOT COMPLETED|Open-label Period||21
1555830|NCT01258738|3806116|P1|NOT COMPLETED|Open-label Period||17
1555831|NCT01258738|3806115|P2|COMPLETED|Open-label Period||85
1555832|NCT01258738|3806116|P1|COMPLETED|Open-label Period||85
1555833|NCT01258738|3806115|P2|STARTED|Open-label Period||106
1555834|NCT01258738|3806116|P1|STARTED|Open-label Period||102
1555835|NCT01258738|3806115|P2|NOT COMPLETED|Double-blind Period||7
1555836|NCT01258738|3806116|P1|NOT COMPLETED|Double-blind Period||9
1555837|NCT01258738|3806115|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
1555838|NCT01258738|3806116|P1|COMPLETED|Double-blind Period||102
1555839|NCT01258738|3806115|P2|Treated|Double-blind Period||113
1555840|NCT01258738|3806116|P1|Treated|Double-blind Period||111
1555841|NCT01258738|3806115|P2|STARTED|Double-blind Period||114
1555842|NCT01258738|3806116|P1|STARTED|Double-blind Period||111
1555843|NCT01258660|3806254|P2|NOT COMPLETED|Overall Study||11
1555844|NCT01258660|3806255|P1|NOT COMPLETED|Overall Study||11
1555845|NCT01258660|3806254|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
1555846|NCT01258660|3806255|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
1555847|NCT01258660|3806254|P2|Completed Treatment|Overall Study||81
1555848|NCT01258660|3806255|P1|Completed Treatment|Overall Study||79
1555849|NCT01258660|3806254|P2|Received Treatment|Overall Study||82
1555850|NCT01258660|3806255|P1|Received Treatment|Overall Study||79
1555851|NCT01258660|3806254|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
1555852|NCT01258660|3806255|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
1555853|NCT01258608|3806274|P2|NOT COMPLETED|Overall Study||19
1555854|NCT01258608|3806275|P1|NOT COMPLETED|Overall Study||21
1555855|NCT01258608|3806274|P2|COMPLETED|Overall Study||31
1555856|NCT01258608|3806275|P1|COMPLETED|Overall Study||30
1555857|NCT01258608|3806274|P2|STARTED|Overall Study||50
1555858|NCT01258608|3806275|P1|STARTED|Overall Study||51
1555859|NCT01258595|3806323|P2|NOT COMPLETED|Overall Study||1
1555860|NCT01258595|3806324|P1|NOT COMPLETED|Overall Study||1
1555861|NCT01258595|3806323|P2|COMPLETED|Overall Study||151
1555862|NCT01258595|3806324|P1|COMPLETED|Overall Study||147
1555863|NCT01258595|3806323|P2|STARTED|Overall Study||152
1555864|NCT01258595|3806324|P1|STARTED|Overall Study||148
1555865|NCT01258582|3806340|P2|NOT COMPLETED|Overall Study||258
1555866|NCT01258582|3806341|P1|NOT COMPLETED|Overall Study||282
1555867|NCT01258582|3806340|P2|COMPLETED|Overall Study||563
1555868|NCT01258582|3806341|P1|COMPLETED|Overall Study||548
1555869|NCT01258582|3806340|P2|STARTED|Overall Study||821
1555870|NCT01258582|3806341|P1|STARTED|Overall Study||830
1555871|NCT01258504|3806347|P1|NOT COMPLETED|Bosentan and SJW||0
1555872|NCT01258504|3806347|P1|COMPLETED|Bosentan and SJW||13
1555873|NCT01258504|3806347|P1|STARTED|Bosentan and SJW||13
1555874|NCT01258504|3806347|P1|NOT COMPLETED|Bosentan Steady-state||0
1555875|NCT01258504|3806347|P1|COMPLETED|Bosentan Steady-state||13
1555876|NCT01258504|3806347|P1|STARTED|Bosentan Steady-state||13
1555877|NCT01258504|3806347|P1|NOT COMPLETED|Bosentan Single Dose||0
1555878|NCT01258504|3806347|P1|COMPLETED|Bosentan Single Dose||13
1555879|NCT01258504|3806347|P1|STARTED|Bosentan Single Dose||13
1555880|NCT01258387|3806366|P7|NOT COMPLETED|Overall Study||0
1555881|NCT01258387|3806367|P6|NOT COMPLETED|Overall Study||0
1555882|NCT01258387|3806368|P5|NOT COMPLETED|Overall Study||0
1555883|NCT01258387|3806369|P4|NOT COMPLETED|Overall Study||0
1555884|NCT01258387|3806370|P3|NOT COMPLETED|Overall Study||0
1555885|NCT01258387|3806371|P2|NOT COMPLETED|Overall Study||0
1555886|NCT01258387|3806372|P1|NOT COMPLETED|Overall Study||0
1555887|NCT01258387|3806366|P7|COMPLETED|Overall Study||4
1555888|NCT01258387|3806367|P6|COMPLETED|Overall Study||6
1555889|NCT01258387|3806368|P5|COMPLETED|Overall Study||6
1555890|NCT01258387|3806369|P4|COMPLETED|Overall Study||6
1555891|NCT01258387|3806370|P3|COMPLETED|Overall Study||6
1555892|NCT01258387|3806371|P2|COMPLETED|Overall Study||6
1555893|NCT01258387|3806372|P1|COMPLETED|Overall Study||6
1555894|NCT01258387|3806366|P7|Patients Randomized to Placebo|Overall Study||1
1555895|NCT01258387|3806367|P6|Patients Randomized to Placebo|Overall Study||2
1555896|NCT01258387|3806368|P5|Patients Randomized to Placebo|Overall Study||2
1555897|NCT01258387|3806369|P4|Patients Randomized to Placebo|Overall Study||2
1555898|NCT01258387|3806370|P3|Patients Randomized to Placebo|Overall Study||2
1555899|NCT01258387|3806371|P2|Patients Randomized to Placebo|Overall Study||2
1555900|NCT01258387|3806372|P1|Patients Randomized to Placebo|Overall Study||2
1555901|NCT01258387|3806366|P7|Patients Randomized to GGF2|Overall Study||3
1555902|NCT01258387|3806367|P6|Patients Randomized to GGF2|Overall Study||4
1555903|NCT01258387|3806368|P5|Patients Randomized to GGF2|Overall Study||4
1555904|NCT01258387|3806369|P4|Patients Randomized to GGF2|Overall Study||4
1555905|NCT01258387|3806370|P3|Patients Randomized to GGF2|Overall Study||4
1555906|NCT01258387|3806371|P2|Patients Randomized to GGF2|Overall Study||4
1555907|NCT01258387|3806372|P1|Patients Randomized to GGF2|Overall Study||4
1555908|NCT01258387|3806366|P7|STARTED|Overall Study||4
1555909|NCT01258387|3806367|P6|STARTED|Overall Study||6
1555910|NCT01258387|3806368|P5|STARTED|Overall Study||6
1555911|NCT01258387|3806369|P4|STARTED|Overall Study||6
1555912|NCT01258387|3806370|P3|STARTED|Overall Study||6
1555913|NCT01258387|3806371|P2|STARTED|Overall Study||6
1555914|NCT01258387|3806372|P1|STARTED|Overall Study||6
1555915|NCT01258348|3806414|P5|NOT COMPLETED|Overall Study||6
1555916|NCT01258348|3806415|P4|NOT COMPLETED|Overall Study||6
1555917|NCT01258348|3806416|P3|NOT COMPLETED|Overall Study||3
1555918|NCT01258348|3806417|P2|NOT COMPLETED|Overall Study||5
1555919|NCT01258348|3806418|P1|NOT COMPLETED|Overall Study||1
1555920|NCT01258348|3806414|P5|COMPLETED|Overall Study||0
1555921|NCT01258348|3806415|P4|COMPLETED|Overall Study||0
1555922|NCT01258348|3806416|P3|COMPLETED|Overall Study||0
1555923|NCT01258348|3806417|P2|COMPLETED|Overall Study||0
1555924|NCT01258348|3806418|P1|COMPLETED|Overall Study||0
1555925|NCT01258348|3806414|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
1555926|NCT01258348|3806415|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
1555927|NCT01258348|3806416|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
1555928|NCT01258348|3806417|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
1555929|NCT01258348|3806418|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
1555930|NCT01258348|3806414|P5|STARTED|Overall Study||6
1555931|NCT01258348|3806415|P4|STARTED|Overall Study||6
1555932|NCT01258348|3806416|P3|STARTED|Overall Study||3
1555933|NCT01258348|3806417|P2|STARTED|Overall Study||5
1555934|NCT01258348|3806418|P1|STARTED|Overall Study||1
1555935|NCT01258153|3806446|P3|NOT COMPLETED|Overall Study||1
1555936|NCT01258153|3806447|P2|NOT COMPLETED|Overall Study||1
1555937|NCT01258153|3806448|P1|NOT COMPLETED|Overall Study||1
1555938|NCT01258153|3806446|P3|COMPLETED|Overall Study||36
1555939|NCT01258153|3806447|P2|COMPLETED|Overall Study||37
1555940|NCT01258153|3806448|P1|COMPLETED|Overall Study||39
1555941|NCT01258153|3806446|P3|STARTED|Overall Study||37
1555942|NCT01258153|3806447|P2|STARTED|Overall Study||38
1555943|NCT01258153|3806448|P1|STARTED|Overall Study||40
1555944|NCT01258101|3806475|P4|NOT COMPLETED|Overall Study||25
1555945|NCT01258101|3806476|P3|NOT COMPLETED|Overall Study||11
1555946|NCT01258101|3806477|P2|NOT COMPLETED|Overall Study||34
1555947|NCT01258101|3806478|P1|NOT COMPLETED|Overall Study||33
1555948|NCT01258101|3806475|P4|COMPLETED|Overall Study||27
1555949|NCT01258101|3806476|P3|COMPLETED|Overall Study||22
1555950|NCT01258101|3806477|P2|COMPLETED|Overall Study||110
1555951|NCT01258101|3806478|P1|COMPLETED|Overall Study||118
1555952|NCT01258101|3806475|P4|Standard Analysis Population|Overall Study||26
1555953|NCT01258101|3806476|P3|Standard Analysis Population|Overall Study||21
1555954|NCT01258101|3806477|P2|Standard Analysis Population|Overall Study||110
1555955|NCT01258101|3806478|P1|Standard Analysis Population|Overall Study||115
1555956|NCT01258101|3806475|P4|Safety Analysis Population|Overall Study||48
1555957|NCT01258101|3806476|P3|Safety Analysis Population|Overall Study||30
1555958|NCT01258101|3806477|P2|Safety Analysis Population|Overall Study||141
1555959|NCT01258101|3806478|P1|Safety Analysis Population|Overall Study||144
1555960|NCT01258101|3806475|P4|STARTED|Overall Study||52
1555961|NCT01258101|3806476|P3|STARTED|Overall Study||33
1555962|NCT01258101|3806477|P2|STARTED|Overall Study||144
1555963|NCT01258101|3806478|P1|STARTED|Overall Study||151
1555964|NCT01258049|3806530|P2|NOT COMPLETED|Overall Study||2
1555965|NCT01258049|3806531|P1|NOT COMPLETED|Overall Study||2
1555966|NCT01258049|3806530|P2|COMPLETED|Overall Study||72
1555967|NCT01258049|3806531|P1|COMPLETED|Overall Study||75
1555968|NCT01258049|3806530|P2|STARTED|Overall Study||74
1555969|NCT01258049|3806531|P1|STARTED|Overall Study||77
1555970|NCT01257880|3806569|P2|NOT COMPLETED|Overall Study||0
1555971|NCT01257880|3806570|P1|NOT COMPLETED|Overall Study||0
1555972|NCT01257880|3806569|P2|COMPLETED|Overall Study||19
1555973|NCT01257880|3806570|P1|COMPLETED|Overall Study||12
1555974|NCT01257880|3806569|P2|STARTED|Overall Study||19
1555975|NCT01257880|3806570|P1|STARTED|Overall Study||12
1555976|NCT01257802|3806580|P2|NOT COMPLETED|Overall Study||6
1555977|NCT01257802|3806581|P1|NOT COMPLETED|Overall Study||1
1555978|NCT01257802|3806580|P2|COMPLETED|Overall Study||2
1555979|NCT01257802|3806581|P1|COMPLETED|Overall Study||5
1555980|NCT01257802|3806580|P2|6 Month / 24 Week Visit|Overall Study||2
1555981|NCT01257802|3806581|P1|6 Month / 24 Week Visit|Overall Study||5
1555982|NCT01257802|3806580|P2|STARTED|Overall Study||8
1555983|NCT01257802|3806581|P1|STARTED|Overall Study||6
1555984|NCT01257750|3806595|P1|NOT COMPLETED|Overall Study||0
1555985|NCT01257750|3806595|P1|COMPLETED|Overall Study||20
1555986|NCT01257750|3806595|P1|STARTED|Overall Study||20
1555987|NCT01257737|3806608|P2|NOT COMPLETED|Overall Study||4
1555988|NCT01257737|3806609|P1|NOT COMPLETED|Overall Study||2
1555989|NCT01257737|3806608|P2|COMPLETED|Overall Study||39
1555990|NCT01257737|3806609|P1|COMPLETED|Overall Study||43
1555991|NCT01257737|3806608|P2|STARTED|Overall Study||43
1555992|NCT01257737|3806609|P1|STARTED|Overall Study||45
1555993|NCT01257581|3806630|P3|NOT COMPLETED|Overall Study||6
1555994|NCT01257581|3806631|P2|NOT COMPLETED|Overall Study||3
1555995|NCT01257581|3806632|P1|NOT COMPLETED|Overall Study||5
1555996|NCT01257581|3806630|P3|COMPLETED|Overall Study||11
1555997|NCT01257581|3806631|P2|COMPLETED|Overall Study||18
1555998|NCT01257581|3806632|P1|COMPLETED|Overall Study||17
1555999|NCT01257581|3806630|P3|STARTED|Overall Study||17
1556000|NCT01257581|3806631|P2|STARTED|Overall Study||21
1556001|NCT01257581|3806632|P1|STARTED|Overall Study||22
1556002|NCT01257542|3806672|P2|NOT COMPLETED|Overall Study||7
1556003|NCT01257542|3806673|P1|NOT COMPLETED|Overall Study||3
1556004|NCT01257542|3806672|P2|COMPLETED|Overall Study||45
1556005|NCT01257542|3806673|P1|COMPLETED|Overall Study||52
1556006|NCT01257542|3806672|P2|STARTED|Overall Study||52
1556007|NCT01257542|3806673|P1|STARTED|Overall Study||55
1556008|NCT01257503|3806693|P2|NOT COMPLETED|Overall Study||11
1556009|NCT01257503|3806694|P1|NOT COMPLETED|Overall Study||8
1556010|NCT01257503|3806693|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
1556011|NCT01257503|3806694|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
1556012|NCT01257503|3806693|P2|Returned Dosage Logbooks|Overall Study||80
1556013|NCT01257503|3806694|P1|Returned Dosage Logbooks|Overall Study||75
1556014|NCT01257503|3806693|P2|Returned Symptom Diaries|Overall Study||83
1556015|NCT01257503|3806694|P1|Returned Symptom Diaries|Overall Study||80
1556016|NCT01257503|3806693|P2|STARTED|Overall Study||130
1556017|NCT01257503|3806694|P1|STARTED|Overall Study||133
1556018|NCT01257438|3806710|P2|NOT COMPLETED|Overall Study||46
1556019|NCT01257438|3806711|P1|NOT COMPLETED|Overall Study||30
1556020|NCT01257438|3806710|P2|COMPLETED|Overall Study||97
1556021|NCT01257438|3806711|P1|COMPLETED|Overall Study||102
1556022|NCT01257438|3806710|P2|STARTED|Overall Study||143
1556023|NCT01257438|3806711|P1|STARTED|Overall Study||132
1556024|NCT01257425|3806723|P2|NOT COMPLETED|Overall Study||6
1556025|NCT01257425|3806724|P1|NOT COMPLETED|Overall Study||6
1556026|NCT01257425|3806723|P2|COMPLETED|Overall Study||45
1556027|NCT01257425|3806724|P1|COMPLETED|Overall Study||46
1556028|NCT01257425|3806723|P2|STARTED|Overall Study||51
1556029|NCT01257425|3806724|P1|STARTED|Overall Study||52
1556030|NCT01257347|3806746|P4|NOT COMPLETED|Overall Study||0
1556031|NCT01257347|3806747|P3|NOT COMPLETED|Overall Study||0
1556032|NCT01257347|3806748|P2|NOT COMPLETED|Overall Study||0
1556033|NCT01257347|3806749|P1|NOT COMPLETED|Overall Study||0
1556034|NCT01257347|3806746|P4|COMPLETED|Overall Study||65
1556035|NCT01257347|3806747|P3|COMPLETED|Overall Study||35
1556036|NCT01257347|3806748|P2|COMPLETED|Overall Study||12
1556037|NCT01257347|3806749|P1|COMPLETED|Overall Study||12
1556038|NCT01257347|3806746|P4|STARTED|Overall Study||65
1556039|NCT01257347|3806747|P3|STARTED|Overall Study||35
1556040|NCT01257347|3806748|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
1556041|NCT01257347|3806749|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
1556042|NCT01257230|3806766|P3|NOT COMPLETED|Overall Study||6
1556043|NCT01257230|3806767|P2|NOT COMPLETED|Overall Study||10
1556044|NCT01257230|3806768|P1|NOT COMPLETED|Overall Study||6
1556045|NCT01257230|3806766|P3|COMPLETED|Overall Study||129
1556046|NCT01257230|3806767|P2|COMPLETED|Overall Study||115
1556047|NCT01257230|3806768|P1|COMPLETED|Overall Study||132
1556048|NCT01257230|3806766|P3|STARTED|Overall Study||135
1556049|NCT01257230|3806767|P2|STARTED|Overall Study||125
1556050|NCT01257230|3806768|P1|STARTED|Overall Study||138
1556051|NCT01257217|3806823|P2|NOT COMPLETED|Overall Study||0
1556052|NCT01257217|3806824|P1|NOT COMPLETED|Overall Study||2
1556053|NCT01257217|3806823|P2|COMPLETED|Overall Study||10
1556054|NCT01257217|3806824|P1|COMPLETED|Overall Study||13
1556055|NCT01257217|3806823|P2|STARTED|Overall Study||10
1556056|NCT01257217|3806824|P1|STARTED|Overall Study||15
1556057|NCT01257204|3806845|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
1556058|NCT01257204|3806846|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
1556059|NCT01257204|3806847|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
1556060|NCT01257204|3806845|P3|COMPLETED|Follow-up Period (up to Week 48)||39
1556061|NCT01257204|3806846|P2|COMPLETED|Follow-up Period (up to Week 48)||41
1556062|NCT01257204|3806847|P1|COMPLETED|Follow-up Period (up to Week 48)||48
1556063|NCT01257204|3806845|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
1556064|NCT01257204|3806846|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
1556065|NCT01257204|3806847|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
1556066|NCT01257204|3806845|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
1556067|NCT01257204|3806846|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
1556068|NCT01257204|3806847|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
1556069|NCT01257204|3806845|P3|COMPLETED|Treatment Period (up to Week 24)||42
1556070|NCT01257204|3806846|P2|COMPLETED|Treatment Period (up to Week 24)||44
1556071|NCT01257204|3806847|P1|COMPLETED|Treatment Period (up to Week 24)||45
1556072|NCT01257204|3806845|P3|STARTED|Treatment Period (up to Week 24)||51
1556073|NCT01257204|3806846|P2|STARTED|Treatment Period (up to Week 24)||50
1556074|NCT01257204|3806847|P1|STARTED|Treatment Period (up to Week 24)||50
1556075|NCT01256983|3806893|P2|NOT COMPLETED|Overall Study||3
1556076|NCT01256983|3806894|P1|NOT COMPLETED|Overall Study||1
1556077|NCT01256983|3806893|P2|COMPLETED|Overall Study||12
1556078|NCT01256983|3806894|P1|COMPLETED|Overall Study||14
1556079|NCT01256983|3806893|P2|STARTED|Overall Study||15
1556080|NCT01256983|3806894|P1|STARTED|Overall Study||15
1556081|NCT01256944|3806902|P2|NOT COMPLETED|Overall Study||0
1556082|NCT01256944|3806903|P1|NOT COMPLETED|Overall Study||0
1556083|NCT01256944|3806902|P2|COMPLETED|Overall Study||220
1556084|NCT01256944|3806903|P1|COMPLETED|Overall Study||70
1556085|NCT01256944|3806902|P2|STARTED|Overall Study||220
1556086|NCT01256944|3806903|P1|STARTED|Overall Study||70
1556087|NCT01256918|3806931|P1|NOT COMPLETED|Overall Study||0
1556088|NCT01256918|3806931|P1|COMPLETED|Overall Study||200
1556089|NCT01256918|3806931|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
1556090|NCT01256918|3806931|P1|STARTED|Overall Study||200
1556091|NCT01256840|3806945|P3|NOT COMPLETED|Overall Study||0
1556092|NCT01256840|3806946|P2|NOT COMPLETED|Overall Study||0
1556093|NCT01256840|3806947|P1|NOT COMPLETED|Overall Study||0
1556094|NCT01256840|3806945|P3|COMPLETED|Overall Study||25
1556095|NCT01256840|3806946|P2|COMPLETED|Overall Study||16
1556096|NCT01256840|3806947|P1|COMPLETED|Overall Study||30
1556097|NCT01256840|3806945|P3|STARTED|Overall Study||25
1556098|NCT01256840|3806946|P2|STARTED|Overall Study||16
1556099|NCT01256840|3806947|P1|STARTED|Overall Study||30
1556100|NCT01256684|3806958|P3|NOT COMPLETED|Overall Study||11
1556101|NCT01256684|3806959|P2|NOT COMPLETED|Overall Study||13
1556102|NCT01256684|3806960|P1|NOT COMPLETED|Overall Study||9
1556103|NCT01256684|3806958|P3|COMPLETED|Overall Study||76
1556104|NCT01256684|3806959|P2|COMPLETED|Overall Study||74
1556105|NCT01256684|3806960|P1|COMPLETED|Overall Study||72
1556106|NCT01256684|3806958|P3|ITT Population|Overall Study||81
1556107|NCT01256684|3806959|P2|ITT Population|Overall Study||79
1556108|NCT01256684|3806960|P1|ITT Population|Overall Study||77
1556109|NCT01256684|3806958|P3|Safety Population|Overall Study||87
1556110|NCT01256684|3806959|P2|Safety Population|Overall Study||86
1556111|NCT01256684|3806960|P1|Safety Population|Overall Study||80
1556112|NCT01256684|3806958|P3|STARTED|Overall Study||87
1556113|NCT01256684|3806959|P2|STARTED|Overall Study||87
1556114|NCT01256684|3806960|P1|STARTED|Overall Study||81
1556115|NCT01256671|3806992|P1|NOT COMPLETED|Overall Study||95
1556116|NCT01256671|3806992|P1|COMPLETED|Overall Study||435
1556117|NCT01256671|3806992|P1|Safety Population|Overall Study||521
1556118|NCT01256671|3806992|P1|STARTED|Overall Study||530
1556119|NCT01256658|3807005|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
1556120|NCT01256658|3807006|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
1556121|NCT01256658|3807005|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
1556122|NCT01256658|3807006|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
1556123|NCT01256658|3807005|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
1556124|NCT01256658|3807006|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
1556125|NCT01256658|3807005|P2|Death|Period 2 - Follow up Only - No Treatment||8
1556126|NCT01256658|3807006|P1|Death|Period 2 - Follow up Only - No Treatment||6
1556206|NCT01256411|3807149|P4|COMPLETED|Extension by Maximum Treatment||4
1556127|NCT01256658|3807005|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
1556128|NCT01256658|3807006|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
1556129|NCT01256658|3807005|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
1556130|NCT01256658|3807006|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
1556131|NCT01256658|3807005|P2|NOT COMPLETED|Period 1||748
1556132|NCT01256658|3807006|P1|NOT COMPLETED|Period 1||920
1556133|NCT01256658|3807005|P2|COMPLETED|Period 1||6510
1556134|NCT01256658|3807006|P1|COMPLETED|Period 1||5897
1556135|NCT01256658|3807005|P2|STARTED|Period 1||7258
1556136|NCT01256658|3807006|P1|STARTED|Period 1||6817
1556137|NCT01256567|3807056|P1|NOT COMPLETED|Overall Study||1
1556138|NCT01256567|3807056|P1|COMPLETED|Overall Study||6
1556139|NCT01256567|3807056|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
1556140|NCT01256567|3807056|P1|STARTED|Overall Study||7
1556141|NCT01256502|3807066|P1|NOT COMPLETED|Overall Study||10
1556142|NCT01256502|3807066|P1|COMPLETED|Overall Study||129
1556143|NCT01256502|3807066|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
1556144|NCT01256476|3807078|P2|NOT COMPLETED|Overall Study||7
1556145|NCT01256476|3807079|P1|NOT COMPLETED|Overall Study||6
1556146|NCT01256476|3807078|P2|COMPLETED|Overall Study||157
1556147|NCT01256476|3807079|P1|COMPLETED|Overall Study||158
1556148|NCT01256476|3807078|P2|STARTED|Overall Study||164
1556149|NCT01256476|3807079|P1|STARTED|Overall Study||164
1556150|NCT01256450|3807087|P3|NOT COMPLETED|Double-blind Treatment||37
1556151|NCT01256450|3807088|P2|NOT COMPLETED|Double-blind Treatment||28
1556152|NCT01256450|3807089|P1|NOT COMPLETED|Double-blind Treatment||0
1556153|NCT01256450|3807087|P3|COMPLETED|Double-blind Treatment||81
1556154|NCT01256450|3807088|P2|COMPLETED|Double-blind Treatment||89
1556155|NCT01256450|3807089|P1|COMPLETED|Double-blind Treatment||0
1556156|NCT01256450|3807087|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
1556157|NCT01256450|3807088|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
1556158|NCT01256450|3807089|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
1556159|NCT01256450|3807087|P3|NOT COMPLETED|Open-label Titration||0
1556160|NCT01256450|3807088|P2|NOT COMPLETED|Open-label Titration||0
1556161|NCT01256450|3807089|P1|NOT COMPLETED|Open-label Titration||99
1556162|NCT01256450|3807087|P3|COMPLETED|Open-label Titration||0
1556163|NCT01256450|3807088|P2|COMPLETED|Open-label Titration||0
1556164|NCT01256450|3807089|P1|COMPLETED|Open-label Titration||235
1556165|NCT01256450|3807087|P3|STARTED|Open-label Titration||0
1556166|NCT01256450|3807088|P2|STARTED|Open-label Titration||0
1556167|NCT01256450|3807089|P1|STARTED|Open-label Titration||334
1556168|NCT01256424|3807118|P4|NOT COMPLETED|Overall Study||7
1556169|NCT01256424|3807119|P3|NOT COMPLETED|Overall Study||7
1556170|NCT01256424|3807120|P2|NOT COMPLETED|Overall Study||8
1556171|NCT01256424|3807121|P1|NOT COMPLETED|Overall Study||9
1556172|NCT01256424|3807118|P4|COMPLETED|Overall Study||61
1556173|NCT01256424|3807119|P3|COMPLETED|Overall Study||55
1556174|NCT01256424|3807120|P2|COMPLETED|Overall Study||59
1556175|NCT01256424|3807121|P1|COMPLETED|Overall Study||56
1556176|NCT01256424|3807118|P4|STARTED|Overall Study||68
1556177|NCT01256424|3807119|P3|STARTED|Overall Study||62
1556178|NCT01256424|3807120|P2|STARTED|Overall Study||67
1556179|NCT01256424|3807121|P1|STARTED|Overall Study||65
1556180|NCT01256411|3807147|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
1556181|NCT01256411|3807148|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
1556182|NCT01256411|3807149|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1556183|NCT01256411|3807150|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1556184|NCT01256411|3807151|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1556185|NCT01256411|3807152|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1556186|NCT01256411|3807147|P6|COMPLETED|Extension by Mono or Combination Therapy||109
1556187|NCT01256411|3807148|P5|COMPLETED|Extension by Mono or Combination Therapy||211
1556188|NCT01256411|3807149|P4|COMPLETED|Extension by Mono or Combination Therapy||0
1556189|NCT01256411|3807150|P3|COMPLETED|Extension by Mono or Combination Therapy||0
1556190|NCT01256411|3807151|P2|COMPLETED|Extension by Mono or Combination Therapy||0
1556191|NCT01256411|3807152|P1|COMPLETED|Extension by Mono or Combination Therapy||0
1556192|NCT01256411|3807147|P6|STARTED|Extension by Mono or Combination Therapy||113
1556193|NCT01256411|3807148|P5|STARTED|Extension by Mono or Combination Therapy||228
1556194|NCT01256411|3807149|P4|STARTED|Extension by Mono or Combination Therapy||0
1556195|NCT01256411|3807150|P3|STARTED|Extension by Mono or Combination Therapy||0
1556196|NCT01256411|3807151|P2|STARTED|Extension by Mono or Combination Therapy||0
1556197|NCT01256411|3807152|P1|STARTED|Extension by Mono or Combination Therapy||0
1556198|NCT01256411|3807147|P6|NOT COMPLETED|Extension by Maximum Treatment||0
1556199|NCT01256411|3807148|P5|NOT COMPLETED|Extension by Maximum Treatment||0
1556200|NCT01256411|3807149|P4|NOT COMPLETED|Extension by Maximum Treatment||0
1556201|NCT01256411|3807150|P3|NOT COMPLETED|Extension by Maximum Treatment||4
1556202|NCT01256411|3807151|P2|NOT COMPLETED|Extension by Maximum Treatment||10
1556203|NCT01256411|3807152|P1|NOT COMPLETED|Extension by Maximum Treatment||7
1556204|NCT01256411|3807147|P6|COMPLETED|Extension by Maximum Treatment||0
1556205|NCT01256411|3807148|P5|COMPLETED|Extension by Maximum Treatment||0
1556207|NCT01256411|3807150|P3|COMPLETED|Extension by Maximum Treatment||105
1556208|NCT01256411|3807151|P2|COMPLETED|Extension by Maximum Treatment||79
1556209|NCT01256411|3807152|P1|COMPLETED|Extension by Maximum Treatment||132
1556210|NCT01256411|3807147|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1556211|NCT01256411|3807148|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1556212|NCT01256411|3807149|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1556213|NCT01256411|3807150|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1556214|NCT01256411|3807151|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1556215|NCT01256411|3807152|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
1556216|NCT01256411|3807147|P6|STARTED|Extension by Maximum Treatment||0
1556217|NCT01256411|3807148|P5|STARTED|Extension by Maximum Treatment||0
1556218|NCT01256411|3807149|P4|STARTED|Extension by Maximum Treatment||4
1556219|NCT01256411|3807150|P3|STARTED|Extension by Maximum Treatment||109
1556220|NCT01256411|3807151|P2|STARTED|Extension by Maximum Treatment||89
1556221|NCT01256411|3807152|P1|STARTED|Extension by Maximum Treatment||139
1556222|NCT01256385|3807178|P2|NOT COMPLETED|Overall Study||3
1556223|NCT01256385|3807179|P1|NOT COMPLETED|Overall Study||3
1556224|NCT01256385|3807178|P2|COMPLETED|Overall Study||40
1556225|NCT01256385|3807179|P1|COMPLETED|Overall Study||40
1556226|NCT01256385|3807178|P2|Crossover From Arm B to Arm A|Overall Study||15
1556227|NCT01256385|3807179|P1|Crossover From Arm B to Arm A|Overall Study||0
1556228|NCT01256385|3807178|P2|STARTED|Overall Study||43
1556229|NCT01256385|3807179|P1|STARTED|Overall Study||43
1556230|NCT01256294|3807199|P2|NOT COMPLETED|Overall Study||2
1556231|NCT01256294|3807200|P1|NOT COMPLETED|Overall Study||4
1556232|NCT01256294|3807199|P2|COMPLETED|Overall Study||33
1556233|NCT01256294|3807200|P1|COMPLETED|Overall Study||32
1556234|NCT01256294|3807199|P2|STARTED|Overall Study||35
1556235|NCT01256294|3807200|P1|STARTED|Overall Study||36
1556236|NCT01256281|3807216|P1|NOT COMPLETED|Overall Study||0
1556237|NCT01256281|3807216|P1|COMPLETED|Overall Study||2
1556238|NCT01256281|3807216|P1|STARTED|Overall Study||2
1556239|NCT01256190|3807222|P2|NOT COMPLETED|Overall Study||0
1556240|NCT01256190|3807223|P1|NOT COMPLETED|Overall Study||2
1556241|NCT01256190|3807222|P2|COMPLETED|Overall Study||17
1556242|NCT01256190|3807223|P1|COMPLETED|Overall Study||37
1556243|NCT01256190|3807222|P2|STARTED|Overall Study||17
1556244|NCT01256190|3807223|P1|STARTED|Overall Study||39
1556245|NCT01256177|3807239|P2|NOT COMPLETED|Overall Study||37
1556246|NCT01256177|3807240|P1|NOT COMPLETED|Overall Study||50
1556247|NCT01256177|3807239|P2|COMPLETED|Overall Study||111
1556248|NCT01256177|3807240|P1|COMPLETED|Overall Study||98
1556249|NCT01256177|3807239|P2|STARTED|Overall Study||148
1556250|NCT01256177|3807240|P1|STARTED|Overall Study||148
1556251|NCT01256164|3807264|P2|NOT COMPLETED|Overall Study||0
1556252|NCT01256164|3807265|P1|NOT COMPLETED|Overall Study||0
1556253|NCT01256164|3807264|P2|COMPLETED|Overall Study||23
1556254|NCT01256164|3807265|P1|COMPLETED|Overall Study||47
1556255|NCT01256164|3807264|P2|STARTED|Overall Study||23
1556256|NCT01256164|3807265|P1|STARTED|Overall Study||47
1556257|NCT01256086|3807283|P4|NOT COMPLETED|Treatment Day 4||0
1556258|NCT01256086|3807284|P3|NOT COMPLETED|Treatment Day 4||0
1556259|NCT01256086|3807285|P2|NOT COMPLETED|Treatment Day 4||0
1556260|NCT01256086|3807286|P1|NOT COMPLETED|Treatment Day 4||0
1556261|NCT01256086|3807283|P4|COMPLETED|Treatment Day 4||11
1556262|NCT01256086|3807284|P3|COMPLETED|Treatment Day 4||9
1556263|NCT01256086|3807285|P2|COMPLETED|Treatment Day 4||10
1556264|NCT01256086|3807286|P1|COMPLETED|Treatment Day 4||11
1556265|NCT01256086|3807283|P4|STARTED|Treatment Day 4||11
1556266|NCT01256086|3807284|P3|STARTED|Treatment Day 4||9
1556267|NCT01256086|3807285|P2|STARTED|Treatment Day 4||10
1556268|NCT01256086|3807286|P1|STARTED|Treatment Day 4||11
1556269|NCT01256086|3807283|P4|NOT COMPLETED|Treatment Day 3||0
1556270|NCT01256086|3807284|P3|NOT COMPLETED|Treatment Day 3||0
1556271|NCT01256086|3807285|P2|NOT COMPLETED|Treatment Day 3||0
1556272|NCT01256086|3807286|P1|NOT COMPLETED|Treatment Day 3||0
1556273|NCT01256086|3807283|P4|COMPLETED|Treatment Day 3||11
1556274|NCT01256086|3807284|P3|COMPLETED|Treatment Day 3||9
1556275|NCT01256086|3807285|P2|COMPLETED|Treatment Day 3||10
1556276|NCT01256086|3807286|P1|COMPLETED|Treatment Day 3||11
1556277|NCT01256086|3807283|P4|STARTED|Treatment Day 3||11
1556278|NCT01256086|3807284|P3|STARTED|Treatment Day 3||9
1556279|NCT01256086|3807285|P2|STARTED|Treatment Day 3||10
1556280|NCT01256086|3807286|P1|STARTED|Treatment Day 3||11
1556281|NCT01256086|3807283|P4|NOT COMPLETED|Treatment Day 2||0
1556282|NCT01256086|3807284|P3|NOT COMPLETED|Treatment Day 2||0
1556283|NCT01256086|3807285|P2|NOT COMPLETED|Treatment Day 2||0
1556284|NCT01256086|3807286|P1|NOT COMPLETED|Treatment Day 2||0
1556285|NCT01256086|3807283|P4|COMPLETED|Treatment Day 2||11
1556286|NCT01256086|3807284|P3|COMPLETED|Treatment Day 2||9
1556287|NCT01256086|3807285|P2|COMPLETED|Treatment Day 2||10
1556288|NCT01256086|3807286|P1|COMPLETED|Treatment Day 2||11
1556289|NCT01256086|3807283|P4|STARTED|Treatment Day 2||11
1556290|NCT01256086|3807284|P3|STARTED|Treatment Day 2||9
1556291|NCT01256086|3807285|P2|STARTED|Treatment Day 2||10
1556292|NCT01256086|3807286|P1|STARTED|Treatment Day 2||11
1556293|NCT01256086|3807283|P4|NOT COMPLETED|Treatment Day 1||0
1556294|NCT01256086|3807284|P3|NOT COMPLETED|Treatment Day 1||0
1556295|NCT01256086|3807285|P2|NOT COMPLETED|Treatment Day 1||0
1556296|NCT01256086|3807286|P1|NOT COMPLETED|Treatment Day 1||0
1556297|NCT01256086|3807283|P4|COMPLETED|Treatment Day 1||11
1556298|NCT01256086|3807284|P3|COMPLETED|Treatment Day 1||11
1556299|NCT01256086|3807285|P2|COMPLETED|Treatment Day 1||11
1556300|NCT01256086|3807286|P1|COMPLETED|Treatment Day 1||11
1556301|NCT01256086|3807283|P4|STARTED|Treatment Day 1||11
1556302|NCT01256086|3807284|P3|STARTED|Treatment Day 1||11
1556303|NCT01256086|3807285|P2|STARTED|Treatment Day 1||11
1556304|NCT01256086|3807286|P1|STARTED|Treatment Day 1||11
1556305|NCT01256060|3807296|P4|NOT COMPLETED|Overall Study||0
1556306|NCT01256060|3807297|P3|NOT COMPLETED|Overall Study||0
1556307|NCT01256060|3807298|P2|NOT COMPLETED|Overall Study||1
1556308|NCT01256060|3807299|P1|NOT COMPLETED|Overall Study||0
1556309|NCT01256060|3807296|P4|COMPLETED|Overall Study||6
1556310|NCT01256060|3807297|P3|COMPLETED|Overall Study||3
1556311|NCT01256060|3807298|P2|COMPLETED|Overall Study||2
1556312|NCT01256060|3807299|P1|COMPLETED|Overall Study||3
1556313|NCT01256060|3807296|P4|STARTED|Overall Study||6
1556314|NCT01256060|3807297|P3|STARTED|Overall Study||3
1556315|NCT01256060|3807298|P2|STARTED|Overall Study||3
1556316|NCT01256060|3807299|P1|STARTED|Overall Study||3
1556317|NCT01256034|3807308|P2|NOT COMPLETED|Overall Study||25
1556318|NCT01256034|3807309|P1|NOT COMPLETED|Overall Study||25
1556319|NCT01256034|3807308|P2|COMPLETED|Overall Study||0
1556320|NCT01256034|3807309|P1|COMPLETED|Overall Study||0
1556321|NCT01256034|3807308|P2|STARTED|Overall Study||25
1556322|NCT01256034|3807309|P1|STARTED|Overall Study||25
1556323|NCT01256008|3807318|P3|NOT COMPLETED|Overall Study||21
1556324|NCT01256008|3807319|P2|NOT COMPLETED|Overall Study||7
1556325|NCT01256008|3807320|P1|NOT COMPLETED|Overall Study||8
1556326|NCT01256008|3807318|P3|COMPLETED|Overall Study||175
1556327|NCT01256008|3807319|P2|COMPLETED|Overall Study||91
1556328|NCT01256008|3807320|P1|COMPLETED|Overall Study||90
1556329|NCT01256008|3807318|P3|STARTED|Overall Study||196
1556330|NCT01256008|3807319|P2|STARTED|Overall Study||98
1556331|NCT01256008|3807320|P1|STARTED|Overall Study||98
1556332|NCT01255904|3807342|P2|NOT COMPLETED|Overall Study||4
1556333|NCT01255904|3807343|P1|NOT COMPLETED|Overall Study||1
1556334|NCT01255904|3807342|P2|COMPLETED|Overall Study||41
1556335|NCT01255904|3807343|P1|COMPLETED|Overall Study||44
1556336|NCT01255904|3807342|P2|STARTED|Overall Study||45
1556337|NCT01255904|3807343|P1|STARTED|Overall Study||45
1556338|NCT01255787|3807353|P4|NOT COMPLETED|Overall Study||22
1556339|NCT01255787|3807354|P3|NOT COMPLETED|Overall Study||18
1556340|NCT01255787|3807355|P2|NOT COMPLETED|Overall Study||17
1556341|NCT01255787|3807356|P1|NOT COMPLETED|Overall Study||16
1556342|NCT01255787|3807353|P4|COMPLETED|Overall Study||132
1556343|NCT01255787|3807354|P3|COMPLETED|Overall Study||132
1556344|NCT01255787|3807355|P2|COMPLETED|Overall Study||127
1556345|NCT01255787|3807356|P1|COMPLETED|Overall Study||136
1556346|NCT01255787|3807353|P4|Treated|Overall Study||150
1556347|NCT01255787|3807354|P3|Treated|Overall Study||148
1556348|NCT01255787|3807355|P2|Treated|Overall Study||144
1556349|NCT01255787|3807356|P1|Treated|Overall Study||152
1556350|NCT01255787|3807353|P4|STARTED|Overall Study||154
1556351|NCT01255787|3807354|P3|STARTED|Overall Study||150
1556352|NCT01255787|3807355|P2|STARTED|Overall Study||144
1556353|NCT01255787|3807356|P1|STARTED|Overall Study||152
1556354|NCT01255761|3807384|P2|NOT COMPLETED|Overall Study||175
1556355|NCT01255761|3807385|P1|NOT COMPLETED|Overall Study||182
1556356|NCT01255761|3807384|P2|COMPLETED|Overall Study||192
1556357|NCT01255761|3807385|P1|COMPLETED|Overall Study||187
1556358|NCT01255761|3807384|P2|STARTED|Overall Study||367
1556359|NCT01255761|3807385|P1|STARTED|Overall Study||369
1556360|NCT01255722|3807470|P3|NOT COMPLETED|Overall Study||1
1556361|NCT01255722|3807471|P2|NOT COMPLETED|Overall Study||1
1556362|NCT01255722|3807472|P1|NOT COMPLETED|Overall Study||3
1556363|NCT01255722|3807470|P3|COMPLETED|Overall Study||152
1556364|NCT01255722|3807471|P2|COMPLETED|Overall Study||159
1556365|NCT01255722|3807472|P1|COMPLETED|Overall Study||152
1556366|NCT01255722|3807470|P3|STARTED|Overall Study||153
1556367|NCT01255722|3807471|P2|STARTED|Overall Study||160
1556368|NCT01255722|3807472|P1|STARTED|Overall Study||155
1556369|NCT01255631|3807497|P2|NOT COMPLETED|Overall Study||6
1556370|NCT01255631|3807498|P1|NOT COMPLETED|Overall Study||9
1556371|NCT01255631|3807497|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
1556372|NCT01255631|3807498|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
1556373|NCT01255631|3807497|P2|STARTED|Overall Study||9
1556374|NCT01255631|3807498|P1|STARTED|Overall Study||13
1556375|NCT01255592|3807516|P2|NOT COMPLETED|Overall Study||1
1556376|NCT01255592|3807517|P1|NOT COMPLETED|Overall Study||6
1556377|NCT01255592|3807516|P2|COMPLETED|Overall Study||25
1556378|NCT01255592|3807517|P1|COMPLETED|Overall Study||20
1556379|NCT01255592|3807516|P2|STARTED|Overall Study||26
1556380|NCT01255592|3807517|P1|STARTED|Overall Study||26
1556381|NCT01255449|3807573|P1|NOT COMPLETED|Overall Study||0
1556382|NCT01255449|3807573|P1|COMPLETED|Overall Study||26
1556383|NCT01255449|3807573|P1|STARTED|Overall Study||26
1556384|NCT01255436|3807580|P2|NOT COMPLETED|Overall Study||194
1556385|NCT01255436|3807581|P1|NOT COMPLETED|Overall Study||182
1556386|NCT01255436|3807580|P2|COMPLETED|Overall Study||135
1556387|NCT01255436|3807581|P1|COMPLETED|Overall Study||151
1556388|NCT01255436|3807580|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
1556389|NCT01255436|3807581|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
1556390|NCT01255423|3807595|P2|NOT COMPLETED|Overall Study||3
1556391|NCT01255423|3807596|P1|NOT COMPLETED|Overall Study||3
1556392|NCT01255423|3807595|P2|COMPLETED|Overall Study||99
1556393|NCT01255423|3807596|P1|COMPLETED|Overall Study||101
1556394|NCT01255423|3807595|P2|STARTED|Overall Study||102
1556395|NCT01255423|3807596|P1|STARTED|Overall Study||104
1556396|NCT01255306|3807612|P2|NOT COMPLETED|Overall Study||1
1556397|NCT01255306|3807613|P1|NOT COMPLETED|Overall Study||1
1556398|NCT01255306|3807612|P2|COMPLETED|Overall Study||32
1556399|NCT01255306|3807613|P1|COMPLETED|Overall Study||25
1556400|NCT01255306|3807612|P2|STARTED|Overall Study||33
1556401|NCT01255306|3807613|P1|STARTED|Overall Study||26
1556402|NCT01255163|3807624|P2|NOT COMPLETED|Overall Study||5
1556403|NCT01255163|3807625|P1|NOT COMPLETED|Overall Study||4
1556404|NCT01255163|3807624|P2|COMPLETED|Overall Study||9
1556405|NCT01255163|3807625|P1|COMPLETED|Overall Study||9
1556406|NCT01255163|3807624|P2|STARTED|Overall Study||14
1556407|NCT01255163|3807625|P1|STARTED|Overall Study||13
1556408|NCT01255137|3807647|P1|NOT COMPLETED|Overall Study||0
1556409|NCT01255137|3807647|P1|COMPLETED|Overall Study||13
1556410|NCT01255137|3807647|P1|STARTED|Overall Study||13
1556411|NCT01254890|3807654|P2|NOT COMPLETED|Overall Study||10
1556412|NCT01254890|3807655|P1|NOT COMPLETED|Overall Study||1
1556413|NCT01254890|3807654|P2|COMPLETED|Overall Study||47
1556414|NCT01254890|3807655|P1|COMPLETED|Overall Study||2
1556415|NCT01254890|3807654|P2|STARTED|Overall Study||57
1556416|NCT01254890|3807655|P1|STARTED|Overall Study||3
1556417|NCT01254877|3807664|P3|NOT COMPLETED|Overall Study||5
1556418|NCT01254877|3807665|P2|NOT COMPLETED|Overall Study||11
1556419|NCT01254877|3807666|P1|NOT COMPLETED|Overall Study||10
1556420|NCT01254877|3807664|P3|COMPLETED|Overall Study||64
1556421|NCT01254877|3807665|P2|COMPLETED|Overall Study||58
1556422|NCT01254877|3807666|P1|COMPLETED|Overall Study||57
1556423|NCT01254877|3807664|P3|STARTED|Overall Study||69
1556424|NCT01254877|3807665|P2|STARTED|Overall Study||69
1556425|NCT01254877|3807666|P1|STARTED|Overall Study||67
1556426|NCT01254851|3807691|P2|NOT COMPLETED|Overall Study||9
1556427|NCT01254851|3807692|P1|NOT COMPLETED|Overall Study||8
1556428|NCT01254851|3807691|P2|COMPLETED|Overall Study||68
1556429|NCT01254851|3807692|P1|COMPLETED|Overall Study||61
1556430|NCT01254851|3807691|P2|STARTED|Overall Study||77
1556431|NCT01254851|3807692|P1|STARTED|Overall Study||69
1556432|NCT01254760|3807698|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
1556433|NCT01254760|3807699|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
1556434|NCT01254760|3807698|P2|COMPLETED|Second Period, 5 Days of Wear||38
1556435|NCT01254760|3807699|P1|COMPLETED|Second Period, 5 Days of Wear||34
1556436|NCT01254760|3807698|P2|STARTED|Second Period, 5 Days of Wear||38
1556437|NCT01254760|3807699|P1|STARTED|Second Period, 5 Days of Wear||34
1556438|NCT01254760|3807698|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
1556439|NCT01254760|3807699|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
1556440|NCT01254760|3807698|P2|COMPLETED|First Period, 5 Days of Wear||38
1556441|NCT01254760|3807699|P1|COMPLETED|First Period, 5 Days of Wear||34
1556442|NCT01254760|3807698|P2|STARTED|First Period, 5 Days of Wear||38
1556443|NCT01254760|3807699|P1|STARTED|First Period, 5 Days of Wear||34
1556444|NCT01254747|3807717|P4|NOT COMPLETED|Overall Study||2
1556445|NCT01254747|3807718|P3|NOT COMPLETED|Overall Study||4
1556446|NCT01254747|3807719|P2|NOT COMPLETED|Overall Study||6
1556447|NCT01254747|3807720|P1|NOT COMPLETED|Overall Study||0
1556448|NCT01254747|3807717|P4|COMPLETED|Overall Study||28
1556449|NCT01254747|3807718|P3|COMPLETED|Overall Study||26
1556450|NCT01254747|3807719|P2|COMPLETED|Overall Study||23
1556451|NCT01254747|3807720|P1|COMPLETED|Overall Study||40
1556452|NCT01254747|3807717|P4|STARTED|Overall Study||30
1556453|NCT01254747|3807718|P3|STARTED|Overall Study||30
1556454|NCT01254747|3807719|P2|STARTED|Overall Study||29
1556455|NCT01254747|3807720|P1|STARTED|Overall Study||40
1556456|NCT01254721|3807760|P2|NOT COMPLETED|Overall Study||22
1556457|NCT01254721|3807761|P1|NOT COMPLETED|Overall Study||15
1556458|NCT01254721|3807760|P2|COMPLETED|Overall Study||42
1556459|NCT01254721|3807761|P1|COMPLETED|Overall Study||52
1556460|NCT01254721|3807760|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
1556461|NCT01254721|3807761|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
1556462|NCT01254669|3807771|P2|NOT COMPLETED|Overall Study||4
1556463|NCT01254669|3807772|P1|NOT COMPLETED|Overall Study||3
1556464|NCT01254669|3807771|P2|COMPLETED|Overall Study||96
1556465|NCT01254669|3807772|P1|COMPLETED|Overall Study||97
1556466|NCT01254669|3807771|P2|STARTED|Overall Study||100
1556467|NCT01254669|3807772|P1|STARTED|Overall Study||100
1556468|NCT01254656|3807783|P3|NOT COMPLETED|Overall Study||18
1556469|NCT01254656|3807784|P2|NOT COMPLETED|Overall Study||43
1556470|NCT01254656|3807785|P1|NOT COMPLETED|Overall Study||47
1556471|NCT01254656|3807783|P3|COMPLETED|Overall Study||0
1556472|NCT01254656|3807784|P2|COMPLETED|Overall Study||0
1556473|NCT01254656|3807785|P1|COMPLETED|Overall Study||0
1556474|NCT01254656|3807783|P3|Treated|Overall Study||18
1556475|NCT01254656|3807784|P2|Treated|Overall Study||43
1556476|NCT01254656|3807785|P1|Treated|Overall Study||47
1556477|NCT01254656|3807783|P3|STARTED|Overall Study||18
1556478|NCT01254656|3807784|P2|STARTED|Overall Study||43
1556479|NCT01254656|3807785|P1|STARTED|Overall Study||47
1556480|NCT01254643|3807811|P1|NOT COMPLETED|Overall Study||1
1556481|NCT01254643|3807811|P1|COMPLETED|Overall Study||99
1556482|NCT01254643|3807811|P1|Vaccination 3|Overall Study||99
1556483|NCT01254643|3807811|P1|Vaccination 2|Overall Study||99
1556484|NCT01254643|3807811|P1|Vaccination 1|Overall Study||100
1556485|NCT01254643|3807811|P1|STARTED|Overall Study||100
1556486|NCT01254630|3807823|P4|NOT COMPLETED|Overall Study||1285
1556487|NCT01254630|3807824|P3|NOT COMPLETED|Overall Study||812
1556488|NCT01254630|3807825|P2|NOT COMPLETED|Overall Study||1288
1556489|NCT01254630|3807826|P1|NOT COMPLETED|Overall Study||802
1556490|NCT01254630|3807823|P4|COMPLETED|Overall Study||0
1556491|NCT01254630|3807824|P3|COMPLETED|Overall Study||552
1556492|NCT01254630|3807825|P2|COMPLETED|Overall Study||0
1556493|NCT01254630|3807826|P1|COMPLETED|Overall Study||546
1556494|NCT01254630|3807823|P4|Received Vaccination 4|Overall Study||1160
1556495|NCT01254630|3807824|P3|Received Vaccination 4|Overall Study||1212
1556496|NCT01254630|3807825|P2|Received Vaccination 4|Overall Study||1145
1556497|NCT01254630|3807826|P1|Received Vaccination 4|Overall Study||1155
1556498|NCT01254630|3807823|P4|Received Vaccination 3|Overall Study||1194
1556499|NCT01254630|3807824|P3|Received Vaccination 3|Overall Study||1247
1556500|NCT01254630|3807825|P2|Received Vaccination 3|Overall Study||1178
1556501|NCT01254630|3807826|P1|Received Vaccination 3|Overall Study||1198
1556502|NCT01254630|3807823|P4|Received Vaccination 2|Overall Study||1226
1556503|NCT01254630|3807824|P3|Received Vaccination 2|Overall Study||1286
1556504|NCT01254630|3807825|P2|Received Vaccination 2|Overall Study||1217
1556505|NCT01254630|3807826|P1|Received Vaccination 2|Overall Study||1255
1556506|NCT01254630|3807823|P4|Received Vaccination 1|Overall Study||1275
1556507|NCT01254630|3807824|P3|Received Vaccination 1|Overall Study||1350
1556508|NCT01254630|3807825|P2|Received Vaccination 1|Overall Study||1277
1556509|NCT01254630|3807826|P1|Received Vaccination 1|Overall Study||1328
1556510|NCT01254630|3807823|P4|STARTED|Overall Study||1285
1556511|NCT01254630|3807824|P3|STARTED|Overall Study||1364
1556512|NCT01254630|3807825|P2|STARTED|Overall Study||1288
1556513|NCT01254630|3807826|P1|STARTED|Overall Study||1348
1556514|NCT01254604|3807846|P2|NOT COMPLETED|Overall Study||9
1556515|NCT01254604|3807847|P1|NOT COMPLETED|Overall Study||8
1556516|NCT01254604|3807846|P2|COMPLETED|Overall Study||86
1556517|NCT01254604|3807847|P1|COMPLETED|Overall Study||87
1556518|NCT01254604|3807846|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
1556519|NCT01254604|3807847|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
1556520|NCT01254604|3807846|P2|STARTED|Overall Study||95
1556521|NCT01254604|3807847|P1|STARTED|Overall Study||95
1556522|NCT01254565|3807865|P6|NOT COMPLETED|Overall Study||4
1556523|NCT01254565|3807866|P5|NOT COMPLETED|Overall Study||4
1556524|NCT01254565|3807867|P4|NOT COMPLETED|Overall Study||1
1556525|NCT01254565|3807868|P3|NOT COMPLETED|Overall Study||0
1556526|NCT01254565|3807869|P2|NOT COMPLETED|Overall Study||1
1556527|NCT01254565|3807870|P1|NOT COMPLETED|Overall Study||1
1556528|NCT01254565|3807865|P6|COMPLETED|Overall Study||13
1556529|NCT01254565|3807866|P5|COMPLETED|Overall Study||12
1556530|NCT01254565|3807867|P4|COMPLETED|Overall Study||20
1556531|NCT01254565|3807868|P3|COMPLETED|Overall Study||21
1556532|NCT01254565|3807869|P2|COMPLETED|Overall Study||6
1556533|NCT01254565|3807870|P1|COMPLETED|Overall Study||4
1556534|NCT01254565|3807865|P6|Received Treatment|Overall Study||13
1556535|NCT01254565|3807866|P5|Received Treatment|Overall Study||13
1556536|NCT01254565|3807867|P4|Received Treatment|Overall Study||21
1556537|NCT01254565|3807868|P3|Received Treatment|Overall Study||21
1556538|NCT01254565|3807869|P2|Received Treatment|Overall Study||6
1556539|NCT01254565|3807870|P1|Received Treatment|Overall Study||4
1556540|NCT01254565|3807865|P6|STARTED|Overall Study||17
1556541|NCT01254565|3807866|P5|STARTED|Overall Study||16
1556542|NCT01254565|3807867|P4|STARTED|Overall Study||21
1556543|NCT01254565|3807868|P3|STARTED|Overall Study||21
1556544|NCT01254565|3807869|P2|STARTED|Overall Study||7
1556545|NCT01254565|3807870|P1|STARTED|Overall Study||5
1556546|NCT01254409|3807924|P4|NOT COMPLETED|Overall Study||0
1556547|NCT01254409|3807925|P3|NOT COMPLETED|Overall Study||0
1556548|NCT01254409|3807926|P2|NOT COMPLETED|Overall Study||1
1556549|NCT01254409|3807927|P1|NOT COMPLETED|Overall Study||0
1556550|NCT01254409|3807924|P4|COMPLETED|Overall Study||4
1556551|NCT01254409|3807925|P3|COMPLETED|Overall Study||5
1556552|NCT01254409|3807926|P2|COMPLETED|Overall Study||5
1556553|NCT01254409|3807927|P1|COMPLETED|Overall Study||6
1556554|NCT01254409|3807924|P4|STARTED|Overall Study||4
1556555|NCT01254409|3807925|P3|STARTED|Overall Study||5
1556556|NCT01254409|3807926|P2|STARTED|Overall Study||6
1556557|NCT01254409|3807927|P1|STARTED|Overall Study||6
1556558|NCT01254396|3807979|P2|NOT COMPLETED|Second Intervention Period||0
1556559|NCT01254396|3807980|P1|NOT COMPLETED|Second Intervention Period||0
1556560|NCT01254396|3807979|P2|COMPLETED|Second Intervention Period||6
1556561|NCT01254396|3807980|P1|COMPLETED|Second Intervention Period||6
1556562|NCT01254396|3807979|P2|STARTED|Second Intervention Period||6
1556563|NCT01254396|3807980|P1|STARTED|Second Intervention Period||6
1556564|NCT01254396|3807979|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
1556565|NCT01254396|3807980|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
1556566|NCT01254396|3807979|P2|COMPLETED|Washout Period (at Least 1 Day)||6
1556567|NCT01254396|3807980|P1|COMPLETED|Washout Period (at Least 1 Day)||6
1556568|NCT01254396|3807979|P2|STARTED|Washout Period (at Least 1 Day)||6
1556569|NCT01254396|3807980|P1|STARTED|Washout Period (at Least 1 Day)||6
1556570|NCT01254396|3807979|P2|NOT COMPLETED|First Intervention Period||0
1556571|NCT01254396|3807980|P1|NOT COMPLETED|First Intervention Period||0
1556572|NCT01254396|3807979|P2|COMPLETED|First Intervention Period||6
1556573|NCT01254396|3807980|P1|COMPLETED|First Intervention Period||6
1556574|NCT01254396|3807979|P2|STARTED|First Intervention Period||6
1556575|NCT01254396|3807980|P1|STARTED|First Intervention Period||6
1556576|NCT01254344|3807996|P2|NOT COMPLETED|Overall Study||19
1556577|NCT01254344|3807997|P1|NOT COMPLETED|Overall Study||13
1556578|NCT01254344|3807996|P2|COMPLETED|Overall Study||281
1556579|NCT01254344|3807997|P1|COMPLETED|Overall Study||286
1556580|NCT01254344|3807996|P2|Treated|Overall Study||297
1556581|NCT01254344|3807997|P1|Treated|Overall Study||290
1556582|NCT01254344|3807996|P2|STARTED|Overall Study||300
1556583|NCT01254344|3807997|P1|STARTED|Overall Study||299
1556584|NCT01254331|3808005|P1|NOT COMPLETED|Extension Phase||4
1556585|NCT01254331|3808005|P1|COMPLETED|Extension Phase||41
1556586|NCT01254331|3808005|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
1556587|NCT01254331|3808005|P1|NOT COMPLETED|Initial Phase||5
1556588|NCT01254331|3808005|P1|COMPLETED|Initial Phase||46
1556589|NCT01254331|3808005|P1|STARTED|Initial Phase||51
1556590|NCT01254318|3808023|P1|NOT COMPLETED|Overall Study||52
1556591|NCT01254318|3808023|P1|COMPLETED|Overall Study|Alive at end of study|78
1556592|NCT01254318|3808023|P1|STARTED|Overall Study|Alive at start of study|130
1556593|NCT01254305|3808032|P3|NOT COMPLETED|Overall Study||17
1556594|NCT01254305|3808033|P2|NOT COMPLETED|Overall Study||18
1556595|NCT01254305|3808034|P1|NOT COMPLETED|Overall Study||22
1556596|NCT01254305|3808032|P3|COMPLETED|Overall Study||62
1556597|NCT01254305|3808033|P2|COMPLETED|Overall Study||72
1556598|NCT01254305|3808034|P1|COMPLETED|Overall Study||71
1556599|NCT01254305|3808032|P3|Safety Population|Overall Study||77
1556600|NCT01254305|3808033|P2|Safety Population|Overall Study||85
1556601|NCT01254305|3808034|P1|Safety Population|Overall Study||89
1556602|NCT01254305|3808032|P3|STARTED|Overall Study||79
1556603|NCT01254305|3808033|P2|STARTED|Overall Study||90
1556604|NCT01254305|3808034|P1|STARTED|Overall Study||93
1556605|NCT01254292|3808050|P2|NOT COMPLETED|LCS12 Extension Phase||0
1556606|NCT01254292|3808051|P1|NOT COMPLETED|LCS12 Extension Phase||37
1556607|NCT01254292|3808050|P2|COMPLETED|LCS12 Extension Phase||0
1556608|NCT01254292|3808051|P1|COMPLETED|LCS12 Extension Phase||163
1556609|NCT01254292|3808050|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
1556610|NCT01254292|3808051|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
1556611|NCT01254292|3808050|P2|NOT COMPLETED|Comparative Phase||81
1556612|NCT01254292|3808051|P1|NOT COMPLETED|Comparative Phase||55
1556613|NCT01254292|3808050|P2|COMPLETED|Comparative Phase||204
1556614|NCT01254292|3808051|P1|COMPLETED|Comparative Phase||227
1556615|NCT01254292|3808050|P2|Participants Received Treatment|Comparative Phase|safety population|281
1556616|NCT01254292|3808051|P1|Participants Received Treatment|Comparative Phase|safety population|279
1556617|NCT01254292|3808050|P2|STARTED|Comparative Phase||285
1556618|NCT01254292|3808051|P1|STARTED|Comparative Phase||282
1556619|NCT01254214|3808113|P2|NOT COMPLETED|Overall Study||1
1556620|NCT01254214|3808114|P1|NOT COMPLETED|Overall Study||3
1556621|NCT01254214|3808113|P2|COMPLETED|Overall Study||27
1556622|NCT01254214|3808114|P1|COMPLETED|Overall Study||24
1556623|NCT01254214|3808113|P2|STARTED|Overall Study||28
1556624|NCT01254214|3808114|P1|STARTED|Overall Study||27
1556625|NCT01254188|3808128|P1|NOT COMPLETED|Overall Study||93
1556626|NCT01254188|3808128|P1|COMPLETED|Overall Study||328
1556627|NCT01254188|3808128|P1|STARTED|Overall Study||421
1556628|NCT01254045|3808139|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1556629|NCT01254045|3808140|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1556630|NCT01254045|3808141|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1556631|NCT01254045|3808142|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1556632|NCT01254045|3808143|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1556633|NCT01254045|3808144|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1556634|NCT01254045|3808139|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1556635|NCT01254045|3808140|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1556636|NCT01254045|3808141|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1556637|NCT01254045|3808142|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
1556638|NCT01254045|3808143|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
1556639|NCT01254045|3808144|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1556640|NCT01254045|3808139|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
1556641|NCT01254045|3808140|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
1556642|NCT01254045|3808141|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
1556643|NCT01254045|3808142|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
1556644|NCT01254045|3808143|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
1556645|NCT01254045|3808144|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
1556646|NCT01254045|3808139|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1556647|NCT01254045|3808140|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1556648|NCT01254045|3808141|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1556649|NCT01254045|3808142|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1556650|NCT01254045|3808143|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1556651|NCT01254045|3808144|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1556652|NCT01254045|3808139|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1556653|NCT01254045|3808140|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1556654|NCT01254045|3808141|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1556655|NCT01254045|3808142|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
1556656|NCT01254045|3808143|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
1556657|NCT01254045|3808144|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1556658|NCT01254045|3808139|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
1556659|NCT01254045|3808140|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
1556660|NCT01254045|3808141|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
1556661|NCT01254045|3808142|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
1556662|NCT01254045|3808143|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
1556663|NCT01254045|3808144|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
1556664|NCT01254045|3808139|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1556665|NCT01254045|3808140|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1556666|NCT01254045|3808141|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1556667|NCT01254045|3808142|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1556668|NCT01254045|3808143|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1556669|NCT01254045|3808144|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
1556670|NCT01254045|3808139|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1556671|NCT01254045|3808140|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1556672|NCT01254045|3808141|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1556673|NCT01254045|3808142|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
1556674|NCT01254045|3808143|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
1556675|NCT01254045|3808144|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1556676|NCT01254045|3808139|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
1556677|NCT01254045|3808140|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
1556678|NCT01254045|3808141|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
1556679|NCT01254045|3808142|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
1556680|NCT01254045|3808143|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
1556681|NCT01254045|3808144|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
1556682|NCT01253980|3808157|P2|NOT COMPLETED|Overall Study||0
1556683|NCT01253980|3808158|P1|NOT COMPLETED|Overall Study||0
1556684|NCT01253980|3808157|P2|COMPLETED|Overall Study||39
1556685|NCT01253980|3808158|P1|COMPLETED|Overall Study||35
1556686|NCT01253980|3808157|P2|STARTED|Overall Study||39
1556687|NCT01253980|3808158|P1|STARTED|Overall Study||35
1556688|NCT01253902|3808167|P3|NOT COMPLETED|Overall Study||4
1556689|NCT01253902|3808168|P2|NOT COMPLETED|Overall Study||2
1556690|NCT01253902|3808169|P1|NOT COMPLETED|Overall Study||5
1556691|NCT01253902|3808167|P3|COMPLETED|Overall Study||51
1556692|NCT01253902|3808168|P2|COMPLETED|Overall Study||51
1556693|NCT01253902|3808169|P1|COMPLETED|Overall Study||51
1556694|NCT01253902|3808167|P3|STARTED|Overall Study||55
1556695|NCT01253902|3808168|P2|STARTED|Overall Study||53
1556696|NCT01253902|3808169|P1|STARTED|Overall Study||56
1556697|NCT01253824|3808185|P2|NOT COMPLETED|Overall Study||0
1556698|NCT01253824|3808186|P1|NOT COMPLETED|Overall Study||0
1556699|NCT01253824|3808185|P2|COMPLETED|Overall Study||7
1556700|NCT01253824|3808186|P1|COMPLETED|Overall Study||7
1556701|NCT01253824|3808185|P2|STARTED|Overall Study||7
1556702|NCT01253824|3808186|P1|STARTED|Overall Study||7
1556703|NCT01253811|3808198|P1|NOT COMPLETED|Overall Study||1
1556704|NCT01253811|3808198|P1|COMPLETED|Overall Study||5
1556705|NCT01253811|3808198|P1|Exposed|Overall Study||6
1556706|NCT01253811|3808198|P1|STARTED|Overall Study||6
1556707|NCT01253642|3808217|P1|NOT COMPLETED|Overall Study||5
1556708|NCT01253642|3808217|P1|COMPLETED|Overall Study||6
1556709|NCT01253642|3808217|P1|STARTED|Overall Study||11
1556710|NCT01253577|3808229|P1|NOT COMPLETED|Overall Study||3
1556711|NCT01253577|3808229|P1|COMPLETED|Overall Study||102
1556712|NCT01253577|3808229|P1|STARTED|Overall Study||105
1556713|NCT01253564|3808237|P1|NOT COMPLETED|Overall Study||24
1556714|NCT01253564|3808237|P1|COMPLETED|Overall Study||0
1556715|NCT01253564|3808237|P1|STARTED|Overall Study||24
1556716|NCT01253525|3808254|P1|NOT COMPLETED|Overall Study||0
1556717|NCT01253525|3808254|P1|COMPLETED|Overall Study||6
1556718|NCT01253525|3808254|P1|Received Any Quantity of Study Drug|Overall Study||6
1556719|NCT01253525|3808254|P1|STARTED|Overall Study||6
1556720|NCT01253447|3808281|P1|NOT COMPLETED|Overall Study||2
1556721|NCT01253447|3808281|P1|COMPLETED|Overall Study||17
1556722|NCT01253447|3808281|P1|STARTED|Overall Study||19
1556723|NCT01253421|3808291|P5|NOT COMPLETED|Drug+Scanning Visit||1
1556724|NCT01253421|3808292|P4|NOT COMPLETED|Drug+Scanning Visit||0
1556725|NCT01253421|3808293|P3|NOT COMPLETED|Drug+Scanning Visit||0
1556726|NCT01253421|3808294|P2|NOT COMPLETED|Drug+Scanning Visit||0
1556727|NCT01253421|3808295|P1|NOT COMPLETED|Drug+Scanning Visit||0
1556728|NCT01253421|3808291|P5|COMPLETED|Drug+Scanning Visit||14
1556729|NCT01253421|3808292|P4|COMPLETED|Drug+Scanning Visit||16
1556730|NCT01253421|3808293|P3|COMPLETED|Drug+Scanning Visit||14
1556731|NCT01253421|3808294|P2|COMPLETED|Drug+Scanning Visit||15
1556732|NCT01253421|3808295|P1|COMPLETED|Drug+Scanning Visit||0
1556733|NCT01253421|3808291|P5|Received Drug Challenge|Drug+Scanning Visit||15
1556734|NCT01253421|3808292|P4|Received Drug Challenge|Drug+Scanning Visit||16
1556735|NCT01253421|3808293|P3|Received Drug Challenge|Drug+Scanning Visit||14
1556736|NCT01253421|3808294|P2|Received Drug Challenge|Drug+Scanning Visit||15
1556737|NCT01253421|3808295|P1|Received Drug Challenge|Drug+Scanning Visit||0
1556738|NCT01253421|3808291|P5|STARTED|Drug+Scanning Visit||15
1556739|NCT01253421|3808292|P4|STARTED|Drug+Scanning Visit||16
1556740|NCT01253421|3808293|P3|STARTED|Drug+Scanning Visit||14
1556741|NCT01253421|3808294|P2|STARTED|Drug+Scanning Visit||15
1556742|NCT01253421|3808295|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
1556743|NCT01253421|3808291|P5|NOT COMPLETED|Assessment and Scheduling||0
1556744|NCT01253421|3808292|P4|NOT COMPLETED|Assessment and Scheduling||0
1556745|NCT01253421|3808293|P3|NOT COMPLETED|Assessment and Scheduling||0
1556746|NCT01253421|3808294|P2|NOT COMPLETED|Assessment and Scheduling||0
1556747|NCT01253421|3808295|P1|NOT COMPLETED|Assessment and Scheduling||99
1556748|NCT01253421|3808291|P5|COMPLETED|Assessment and Scheduling||0
1556749|NCT01253421|3808292|P4|COMPLETED|Assessment and Scheduling||0
1556750|NCT01253421|3808293|P3|COMPLETED|Assessment and Scheduling||0
1556751|NCT01253421|3808294|P2|COMPLETED|Assessment and Scheduling||0
1556752|NCT01253421|3808295|P1|COMPLETED|Assessment and Scheduling||60
1556753|NCT01253421|3808291|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
1556754|NCT01253421|3808292|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
1556755|NCT01253421|3808293|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
1556756|NCT01253421|3808294|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
1556757|NCT01253421|3808295|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
1556758|NCT01253421|3808291|P5|Eligible After Screening Visit|Assessment and Scheduling||0
1556759|NCT01253421|3808292|P4|Eligible After Screening Visit|Assessment and Scheduling||0
1556760|NCT01253421|3808293|P3|Eligible After Screening Visit|Assessment and Scheduling||0
1556761|NCT01253421|3808294|P2|Eligible After Screening Visit|Assessment and Scheduling||0
1556762|NCT01253421|3808295|P1|Eligible After Screening Visit|Assessment and Scheduling||85
1556763|NCT01253421|3808291|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
1556764|NCT01253421|3808292|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
1556765|NCT01253421|3808293|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
1556766|NCT01253421|3808294|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
1556767|NCT01253421|3808295|P1|STARTED|Assessment and Scheduling||159
1556768|NCT01253408|3808344|P3|NOT COMPLETED|Overall Study||0
1556769|NCT01253408|3808345|P2|NOT COMPLETED|Overall Study||1
1556770|NCT01253408|3808346|P1|NOT COMPLETED|Overall Study||0
1556771|NCT01253408|3808344|P3|COMPLETED|Overall Study||13
1556772|NCT01253408|3808345|P2|COMPLETED|Overall Study||12
1556773|NCT01253408|3808346|P1|COMPLETED|Overall Study||10
1556774|NCT01253408|3808344|P3|STARTED|Overall Study||13
1556775|NCT01253408|3808345|P2|STARTED|Overall Study||13
1556776|NCT01253408|3808346|P1|STARTED|Overall Study||10
1556777|NCT01253369|3808369|P1|NOT COMPLETED|Overall Study||33
1556778|NCT01253369|3808369|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1556779|NCT01253369|3808369|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
1556780|NCT01253369|3808369|P1|STARTED|Overall Study||33
1556781|NCT01253343|3808376|P2|NOT COMPLETED|Overall Study||0
1556782|NCT01253343|3808377|P1|NOT COMPLETED|Overall Study||0
1556783|NCT01253343|3808376|P2|COMPLETED|Overall Study||8
1556784|NCT01253343|3808377|P1|COMPLETED|Overall Study||9
1556785|NCT01253343|3808376|P2|STARTED|Overall Study||8
1556786|NCT01253343|3808377|P1|STARTED|Overall Study||9
1556787|NCT01253317|3808399|P1|NOT COMPLETED|Overall Study||2
1556788|NCT01253317|3808399|P1|COMPLETED|Overall Study||10
1556789|NCT01253317|3808399|P1|STARTED|Overall Study||12
1556790|NCT01253304|3808411|P4|NOT COMPLETED|Overall Study||1
1556791|NCT01253304|3808412|P3|NOT COMPLETED|Overall Study||0
1556792|NCT01253304|3808413|P2|NOT COMPLETED|Overall Study||0
1556793|NCT01253304|3808414|P1|NOT COMPLETED|Overall Study||0
1556794|NCT01253304|3808411|P4|COMPLETED|Overall Study||2
1556795|NCT01253304|3808412|P3|COMPLETED|Overall Study||6
1556796|NCT01253304|3808413|P2|COMPLETED|Overall Study||6
1556797|NCT01253304|3808414|P1|COMPLETED|Overall Study||11
1556798|NCT01253304|3808411|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
1556799|NCT01253304|3808412|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1556800|NCT01253304|3808413|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1556801|NCT01253304|3808414|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
1556802|NCT01253304|3808411|P4|STARTED|Overall Study||3
1556803|NCT01253304|3808412|P3|STARTED|Overall Study||6
1556804|NCT01253304|3808413|P2|STARTED|Overall Study||6
1556805|NCT01253304|3808414|P1|STARTED|Overall Study||11
1556806|NCT01253265|3808453|P5|NOT COMPLETED|Overall Study||1
1556807|NCT01253265|3808454|P4|NOT COMPLETED|Overall Study||0
1556808|NCT01253265|3808455|P3|NOT COMPLETED|Overall Study||0
1556809|NCT01253265|3808456|P2|NOT COMPLETED|Overall Study||0
1556810|NCT01253265|3808457|P1|NOT COMPLETED|Overall Study||1
1556811|NCT01253265|3808453|P5|COMPLETED|Overall Study||7
1556812|NCT01253265|3808454|P4|COMPLETED|Overall Study||6
1556813|NCT01253265|3808455|P3|COMPLETED|Overall Study||6
1556814|NCT01253265|3808456|P2|COMPLETED|Overall Study||6
1556815|NCT01253265|3808457|P1|COMPLETED|Overall Study||5
1556816|NCT01253265|3808453|P5|STARTED|Overall Study||8
1556817|NCT01253265|3808454|P4|STARTED|Overall Study||6
1556818|NCT01253265|3808455|P3|STARTED|Overall Study||6
1556819|NCT01253265|3808456|P2|STARTED|Overall Study||6
1556820|NCT01253265|3808457|P1|STARTED|Overall Study||6
1556821|NCT01253226|3808506|P5|NOT COMPLETED|Overall Study||2
1556822|NCT01253226|3808507|P4|NOT COMPLETED|Overall Study||1
1556823|NCT01253226|3808508|P3|NOT COMPLETED|Overall Study||1
1556824|NCT01253226|3808509|P2|NOT COMPLETED|Overall Study||1
1556825|NCT01253226|3808510|P1|NOT COMPLETED|Overall Study||0
1556826|NCT01253226|3808506|P5|COMPLETED|Overall Study||6
1556827|NCT01253226|3808507|P4|COMPLETED|Overall Study||5
1556828|NCT01253226|3808508|P3|COMPLETED|Overall Study||5
1556829|NCT01253226|3808509|P2|COMPLETED|Overall Study||5
1556830|NCT01253226|3808510|P1|COMPLETED|Overall Study||6
1556831|NCT01253226|3808506|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
1556832|NCT01253226|3808507|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
1556833|NCT01253226|3808508|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1556834|NCT01253226|3808509|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1556835|NCT01253226|3808510|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
1556836|NCT01253226|3808506|P5|STARTED|Overall Study||8
1556837|NCT01253226|3808507|P4|STARTED|Overall Study||6
1556838|NCT01253226|3808508|P3|STARTED|Overall Study||6
1556839|NCT01253226|3808509|P2|STARTED|Overall Study||6
1556840|NCT01253226|3808510|P1|STARTED|Overall Study||6
1556841|NCT01253200|3808570|P5|NOT COMPLETED|Overall Study||5
1556842|NCT01253200|3808571|P4|NOT COMPLETED|Overall Study||5
1556843|NCT01253200|3808572|P3|NOT COMPLETED|Overall Study||2
1556844|NCT01253200|3808573|P2|NOT COMPLETED|Overall Study||19
1556845|NCT01253200|3808574|P1|NOT COMPLETED|Overall Study||21
1556846|NCT01253200|3808570|P5|COMPLETED|Overall Study||0
1556847|NCT01253200|3808571|P4|COMPLETED|Overall Study||12
1556848|NCT01253200|3808572|P3|COMPLETED|Overall Study||28
1556849|NCT01253200|3808573|P2|COMPLETED|Overall Study||106
1556850|NCT01253200|3808574|P1|COMPLETED|Overall Study||104
1556851|NCT01253200|3808570|P5|3 Month Follow-up|Overall Study||0
1556852|NCT01253200|3808571|P4|3 Month Follow-up|Overall Study||12
1556853|NCT01253200|3808572|P3|3 Month Follow-up|Overall Study||28
1556854|NCT01253200|3808573|P2|3 Month Follow-up|Overall Study||106
1556855|NCT01253200|3808574|P1|3 Month Follow-up|Overall Study||104
1556856|NCT01253200|3808570|P5|10 Day Follow-up|Overall Study||0
1556857|NCT01253200|3808571|P4|10 Day Follow-up|Overall Study||12
1556858|NCT01253200|3808572|P3|10 Day Follow-up|Overall Study||28
1556859|NCT01253200|3808573|P2|10 Day Follow-up|Overall Study||111
1556860|NCT01253200|3808574|P1|10 Day Follow-up|Overall Study||106
1556861|NCT01253200|3808570|P5|Procedure|Overall Study||0
1556862|NCT01253200|3808571|P4|Procedure|Overall Study||12
1556863|NCT01253200|3808572|P3|Procedure|Overall Study||28
1556864|NCT01253200|3808573|P2|Procedure|Overall Study||111
1556865|NCT01253200|3808574|P1|Procedure|Overall Study||109
1556866|NCT01253200|3808570|P5|STARTED|Overall Study||5
1556867|NCT01253200|3808571|P4|STARTED|Overall Study||17
1556868|NCT01253200|3808572|P3|STARTED|Overall Study||30
1556869|NCT01253200|3808573|P2|STARTED|Overall Study||125
1556870|NCT01253200|3808574|P1|STARTED|Overall Study||125
1556871|NCT01253187|3808589|P6|NOT COMPLETED|Period 3||0
1556872|NCT01253187|3808590|P5|NOT COMPLETED|Period 3||1
1556873|NCT01253187|3808591|P4|NOT COMPLETED|Period 3||0
1556874|NCT01253187|3808592|P3|NOT COMPLETED|Period 3||0
1556875|NCT01253187|3808593|P2|NOT COMPLETED|Period 3||1
1556876|NCT01253187|3808594|P1|NOT COMPLETED|Period 3||1
1556877|NCT01253187|3808589|P6|COMPLETED|Period 3||6
1556878|NCT01253187|3808590|P5|COMPLETED|Period 3||7
1556879|NCT01253187|3808591|P4|COMPLETED|Period 3||7
1556880|NCT01253187|3808592|P3|COMPLETED|Period 3||7
1556881|NCT01253187|3808593|P2|COMPLETED|Period 3||7
1556882|NCT01253187|3808594|P1|COMPLETED|Period 3||6
1556883|NCT01253187|3808589|P6|STARTED|Period 3||6
1556884|NCT01253187|3808590|P5|STARTED|Period 3||8
1556885|NCT01253187|3808591|P4|STARTED|Period 3||7
1556886|NCT01253187|3808592|P3|STARTED|Period 3||7
1556887|NCT01253187|3808593|P2|STARTED|Period 3||8
1556888|NCT01253187|3808594|P1|STARTED|Period 3||7
1556889|NCT01253187|3808589|P6|NOT COMPLETED|Period 2||0
1556890|NCT01253187|3808590|P5|NOT COMPLETED|Period 2||1
1556891|NCT01253187|3808591|P4|NOT COMPLETED|Period 2||0
1556892|NCT01253187|3808592|P3|NOT COMPLETED|Period 2||0
1556893|NCT01253187|3808593|P2|NOT COMPLETED|Period 2||0
1556894|NCT01253187|3808594|P1|NOT COMPLETED|Period 2||0
1556895|NCT01253187|3808589|P6|COMPLETED|Period 2||6
1556896|NCT01253187|3808590|P5|COMPLETED|Period 2||8
1556897|NCT01253187|3808591|P4|COMPLETED|Period 2||7
1556898|NCT01253187|3808592|P3|COMPLETED|Period 2||7
1556899|NCT01253187|3808593|P2|COMPLETED|Period 2||8
1556900|NCT01253187|3808594|P1|COMPLETED|Period 2||7
1556901|NCT01253187|3808589|P6|STARTED|Period 2||6
1556902|NCT01253187|3808590|P5|STARTED|Period 2||9
1556903|NCT01253187|3808591|P4|STARTED|Period 2||7
1556904|NCT01253187|3808592|P3|STARTED|Period 2||7
1556905|NCT01253187|3808593|P2|STARTED|Period 2||8
1556906|NCT01253187|3808594|P1|STARTED|Period 2||7
1556907|NCT01253187|3808589|P6|NOT COMPLETED|Period 1||0
1556908|NCT01253187|3808590|P5|NOT COMPLETED|Period 1||0
1556909|NCT01253187|3808591|P4|NOT COMPLETED|Period 1||0
1556910|NCT01253187|3808592|P3|NOT COMPLETED|Period 1||0
1556911|NCT01253187|3808593|P2|NOT COMPLETED|Period 1||0
1556912|NCT01253187|3808594|P1|NOT COMPLETED|Period 1||0
1556913|NCT01253187|3808589|P6|COMPLETED|Period 1||6
1556914|NCT01253187|3808590|P5|COMPLETED|Period 1||9
1556915|NCT01253187|3808591|P4|COMPLETED|Period 1||7
1556916|NCT01253187|3808592|P3|COMPLETED|Period 1||7
1556917|NCT01253187|3808593|P2|COMPLETED|Period 1||8
1556918|NCT01253187|3808594|P1|COMPLETED|Period 1||7
1556919|NCT01253187|3808589|P6|STARTED|Period 1||6
1556920|NCT01253187|3808590|P5|STARTED|Period 1||9
1556921|NCT01253187|3808591|P4|STARTED|Period 1||7
1556922|NCT01253187|3808592|P3|STARTED|Period 1||7
1556923|NCT01253187|3808593|P2|STARTED|Period 1||8
1556924|NCT01253187|3808594|P1|STARTED|Period 1||7
1556925|NCT01253174|3808623|P6|NOT COMPLETED|Period 3||0
1556926|NCT01253174|3808624|P5|NOT COMPLETED|Period 3||1
1556927|NCT01253174|3808625|P4|NOT COMPLETED|Period 3||0
1556928|NCT01253174|3808626|P3|NOT COMPLETED|Period 3||1
1556929|NCT01253174|3808627|P2|NOT COMPLETED|Period 3||1
1556930|NCT01253174|3808628|P1|NOT COMPLETED|Period 3||0
1556931|NCT01253174|3808623|P6|COMPLETED|Period 3||7
1556932|NCT01253174|3808624|P5|COMPLETED|Period 3||7
1556933|NCT01253174|3808625|P4|COMPLETED|Period 3||7
1556934|NCT01253174|3808626|P3|COMPLETED|Period 3||6
1556935|NCT01253174|3808627|P2|COMPLETED|Period 3||8
1556936|NCT01253174|3808628|P1|COMPLETED|Period 3||6
1556937|NCT01253174|3808623|P6|STARTED|Period 3||7
1556938|NCT01253174|3808624|P5|STARTED|Period 3||8
1556939|NCT01253174|3808625|P4|STARTED|Period 3||7
1556940|NCT01253174|3808626|P3|STARTED|Period 3||7
1556941|NCT01253174|3808627|P2|STARTED|Period 3||9
1556942|NCT01253174|3808628|P1|STARTED|Period 3||6
1556943|NCT01253174|3808623|P6|NOT COMPLETED|Period 2||0
1556944|NCT01253174|3808624|P5|NOT COMPLETED|Period 2||0
1556945|NCT01253174|3808625|P4|NOT COMPLETED|Period 2||0
1556946|NCT01253174|3808626|P3|NOT COMPLETED|Period 2||1
1556947|NCT01253174|3808627|P2|NOT COMPLETED|Period 2||0
1556948|NCT01253174|3808628|P1|NOT COMPLETED|Period 2||0
1556949|NCT01253174|3808623|P6|COMPLETED|Period 2||7
1556950|NCT01253174|3808624|P5|COMPLETED|Period 2||8
1556951|NCT01253174|3808625|P4|COMPLETED|Period 2||7
1556952|NCT01253174|3808626|P3|COMPLETED|Period 2||7
1556953|NCT01253174|3808627|P2|COMPLETED|Period 2||9
1556954|NCT01253174|3808628|P1|COMPLETED|Period 2||6
1556955|NCT01253174|3808623|P6|STARTED|Period 2||7
1556956|NCT01253174|3808624|P5|STARTED|Period 2||8
1556957|NCT01253174|3808625|P4|STARTED|Period 2||7
1556958|NCT01253174|3808626|P3|STARTED|Period 2||8
1556959|NCT01253174|3808627|P2|STARTED|Period 2||9
1556960|NCT01253174|3808628|P1|STARTED|Period 2||6
1556961|NCT01253174|3808623|P6|NOT COMPLETED|Period 1||0
1556962|NCT01253174|3808624|P5|NOT COMPLETED|Period 1||1
1556963|NCT01253174|3808625|P4|NOT COMPLETED|Period 1||0
1556964|NCT01253174|3808626|P3|NOT COMPLETED|Period 1||1
1556965|NCT01253174|3808627|P2|NOT COMPLETED|Period 1||1
1556966|NCT01253174|3808628|P1|NOT COMPLETED|Period 1||0
1556967|NCT01253174|3808623|P6|COMPLETED|Period 1||7
1556968|NCT01253174|3808624|P5|COMPLETED|Period 1||8
1556969|NCT01253174|3808625|P4|COMPLETED|Period 1||7
1556970|NCT01253174|3808626|P3|COMPLETED|Period 1||8
1556971|NCT01253174|3808627|P2|COMPLETED|Period 1||9
1556972|NCT01253174|3808628|P1|COMPLETED|Period 1||6
1556973|NCT01253174|3808623|P6|STARTED|Period 1||7
1556974|NCT01253174|3808624|P5|STARTED|Period 1||9
1556975|NCT01253174|3808625|P4|STARTED|Period 1||7
1556976|NCT01253174|3808626|P3|STARTED|Period 1||9
1556977|NCT01253174|3808627|P2|STARTED|Period 1||10
1556978|NCT01253174|3808628|P1|STARTED|Period 1||6
1556979|NCT01253148|3808657|P1|NOT COMPLETED|Overall Study||0
1556980|NCT01253148|3808657|P1|COMPLETED|Overall Study||25
1556981|NCT01253148|3808657|P1|STARTED|Overall Study||25
1556982|NCT01253135|3808663|P1|NOT COMPLETED|Amended Protocol||1
1556983|NCT01253135|3808663|P1|COMPLETED|Amended Protocol||24
1556984|NCT01253135|3808663|P1|STARTED|Amended Protocol||25
1556985|NCT01253135|3808663|P1|NOT COMPLETED|Original Protocol||15
1556986|NCT01253135|3808663|P1|COMPLETED|Original Protocol||0
1556987|NCT01253135|3808663|P1|STARTED|Original Protocol||15
1556988|NCT01253070|3808671|P1|NOT COMPLETED|Overall Study||0
1556989|NCT01253070|3808671|P1|COMPLETED|Overall Study||54
1556990|NCT01253070|3808671|P1|STARTED|Overall Study||54
1556991|NCT01253044|3808682|P2|NOT COMPLETED|Overall Study||29
1556992|NCT01253044|3808683|P1|NOT COMPLETED|Overall Study||38
1556993|NCT01253044|3808682|P2|COMPLETED|Overall Study||51
1556994|NCT01253044|3808683|P1|COMPLETED|Overall Study||42
1556995|NCT01253044|3808682|P2|STARTED|Overall Study||80
1556996|NCT01253044|3808683|P1|STARTED|Overall Study||80
1556997|NCT01253018|3808693|P2|NOT COMPLETED|Overall Study||2
1556998|NCT01253018|3808694|P1|NOT COMPLETED|Overall Study||4
1556999|NCT01253018|3808693|P2|COMPLETED|Overall Study||21
1557000|NCT01253018|3808694|P1|COMPLETED|Overall Study||18
1557001|NCT01253018|3808693|P2|STARTED|Overall Study||23
1557002|NCT01253018|3808694|P1|STARTED|Overall Study||22
1557003|NCT01252966|3808708|P2|NOT COMPLETED|Overall Study||13
1557004|NCT01252966|3808709|P1|NOT COMPLETED|Overall Study||23
1557005|NCT01252966|3808708|P2|COMPLETED|Overall Study||92
1557006|NCT01252966|3808709|P1|COMPLETED|Overall Study||85
1557007|NCT01252966|3808708|P2|STARTED|Overall Study||105
1557008|NCT01252966|3808709|P1|STARTED|Overall Study||108
1557009|NCT01252953|3808725|P2|NOT COMPLETED|Overall Study||38
1557010|NCT01252953|3808726|P1|NOT COMPLETED|Overall Study||38
1557011|NCT01252953|3808725|P2|COMPLETED|Overall Study||15186
1557012|NCT01252953|3808726|P1|COMPLETED|Overall Study||15187
1557013|NCT01252953|3808725|P2|STARTED|Overall Study||15224
1557014|NCT01252953|3808726|P1|STARTED|Overall Study||15225
1557015|NCT01252940|3808740|P2|NOT COMPLETED|Extension Phase||3
1557016|NCT01252940|3808741|P1|NOT COMPLETED|Extension Phase||10
1557017|NCT01252940|3808740|P2|COMPLETED|Extension Phase||46
1557018|NCT01252940|3808741|P1|COMPLETED|Extension Phase||100
1557019|NCT01252940|3808740|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
1557020|NCT01252940|3808741|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
1557021|NCT01252940|3808740|P2|NOT COMPLETED|Main Study Phase||12
1557022|NCT01252940|3808741|P1|NOT COMPLETED|Main Study Phase||26
1557115|NCT01252134|3808969|P4|COMPLETED|Period 2, 8 Hours||5
1557023|NCT01252940|3808740|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
1557024|NCT01252940|3808741|P1|COMPLETED|Main Study Phase||295
1557025|NCT01252940|3808740|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
1557026|NCT01252940|3808741|P1|Completed 24 Weeks|Main Study Phase||0
1557027|NCT01252940|3808740|P2|STARTED|Main Study Phase||161
1557028|NCT01252940|3808741|P1|STARTED|Main Study Phase||321
1557029|NCT01252810|3808772|P2|NOT COMPLETED|Overall Study||3
1557030|NCT01252810|3808773|P1|NOT COMPLETED|Overall Study||14
1557031|NCT01252810|3808772|P2|COMPLETED|Overall Study||139
1557032|NCT01252810|3808773|P1|COMPLETED|Overall Study||128
1557033|NCT01252810|3808772|P2|STARTED|Overall Study||142
1557034|NCT01252810|3808773|P1|STARTED|Overall Study||142
1557035|NCT01252745|3808786|P3|NOT COMPLETED|Overall Study||0
1557036|NCT01252745|3808787|P2|NOT COMPLETED|Overall Study||0
1557037|NCT01252745|3808788|P1|NOT COMPLETED|Overall Study||0
1557038|NCT01252745|3808786|P3|COMPLETED|Overall Study||7
1557039|NCT01252745|3808787|P2|COMPLETED|Overall Study||7
1557040|NCT01252745|3808788|P1|COMPLETED|Overall Study||8
1557041|NCT01252745|3808786|P3|STARTED|Overall Study||7
1557042|NCT01252745|3808787|P2|STARTED|Overall Study||7
1557043|NCT01252745|3808788|P1|STARTED|Overall Study||8
1557044|NCT01252355|3808805|P3|NOT COMPLETED|Overall Study||179
1557045|NCT01252355|3808806|P2|NOT COMPLETED|Overall Study||178
1557046|NCT01252355|3808807|P1|NOT COMPLETED|Overall Study||177
1557047|NCT01252355|3808805|P3|COMPLETED|Overall Study||0
1557048|NCT01252355|3808806|P2|COMPLETED|Overall Study||0
1557049|NCT01252355|3808807|P1|COMPLETED|Overall Study||0
1557050|NCT01252355|3808805|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
1557051|NCT01252355|3808806|P2|Treated|Overall Study||178
1557052|NCT01252355|3808807|P1|Treated|Overall Study||175
1557053|NCT01252355|3808805|P3|STARTED|Overall Study|Randomized.|179
1557054|NCT01252355|3808806|P2|STARTED|Overall Study|Randomized.|178
1557055|NCT01252355|3808807|P1|STARTED|Overall Study|Randomized.|177
1557056|NCT01252290|3808845|P1|NOT COMPLETED|Overall Study||1
1557057|NCT01252290|3808845|P1|COMPLETED|Overall Study||34
1557058|NCT01252290|3808845|P1|STARTED|Overall Study||35
1557059|NCT01252277|3808853|P1|NOT COMPLETED|Overall Study||2
1557060|NCT01252277|3808853|P1|COMPLETED|Overall Study||34
1557061|NCT01252277|3808853|P1|STARTED|Overall Study||36
1557062|NCT01252251|3808861|P1|NOT COMPLETED|Overall Study||1
1557063|NCT01252251|3808861|P1|COMPLETED|Overall Study||13
1557064|NCT01252251|3808861|P1|STARTED|Overall Study||14
1557065|NCT01252238|3808873|P3|NOT COMPLETED|Overall Study||4
1557066|NCT01252238|3808874|P2|NOT COMPLETED|Overall Study||4
1557067|NCT01252238|3808875|P1|NOT COMPLETED|Overall Study||4
1557068|NCT01252238|3808873|P3|COMPLETED|Overall Study|sponsor terminated study|4
1557069|NCT01252238|3808874|P2|COMPLETED|Overall Study|sponsor terminated study|4
1557070|NCT01252238|3808875|P1|COMPLETED|Overall Study|sponsor terminated study|4
1557071|NCT01252238|3808873|P3|STARTED|Overall Study||8
1557072|NCT01252238|3808874|P2|STARTED|Overall Study||8
1557073|NCT01252238|3808875|P1|STARTED|Overall Study||8
1557074|NCT01252186|3808892|P3|NOT COMPLETED|Overall Study||34
1557075|NCT01252186|3808893|P2|NOT COMPLETED|Overall Study||32
1557076|NCT01252186|3808894|P1|NOT COMPLETED|Overall Study||30
1557077|NCT01252186|3808892|P3|COMPLETED|Overall Study||53
1557078|NCT01252186|3808893|P2|COMPLETED|Overall Study||59
1557079|NCT01252186|3808894|P1|COMPLETED|Overall Study||57
1557080|NCT01252186|3808892|P3|Received Study Drug|Overall Study||80
1557081|NCT01252186|3808893|P2|Received Study Drug|Overall Study||89
1557082|NCT01252186|3808894|P1|Received Study Drug|Overall Study||83
1557083|NCT01252186|3808892|P3|STARTED|Overall Study||87
1557084|NCT01252186|3808893|P2|STARTED|Overall Study||91
1557085|NCT01252186|3808894|P1|STARTED|Overall Study||87
1557086|NCT01252147|3808962|P1|NOT COMPLETED|Overall Study||0
1557087|NCT01252147|3808962|P1|COMPLETED|Overall Study||68
1557088|NCT01252147|3808962|P1|STARTED|Overall Study||68
1557089|NCT01252134|3808967|P6|NOT COMPLETED|Period 3, 8 Hours||0
1557090|NCT01252134|3808968|P5|NOT COMPLETED|Period 3, 8 Hours||0
1557091|NCT01252134|3808969|P4|NOT COMPLETED|Period 3, 8 Hours||0
1557092|NCT01252134|3808970|P3|NOT COMPLETED|Period 3, 8 Hours||0
1557093|NCT01252134|3808971|P2|NOT COMPLETED|Period 3, 8 Hours||0
1557094|NCT01252134|3808972|P1|NOT COMPLETED|Period 3, 8 Hours||0
1557095|NCT01252134|3808967|P6|COMPLETED|Period 3, 8 Hours||4
1557096|NCT01252134|3808968|P5|COMPLETED|Period 3, 8 Hours||3
1557097|NCT01252134|3808969|P4|COMPLETED|Period 3, 8 Hours||5
1557098|NCT01252134|3808970|P3|COMPLETED|Period 3, 8 Hours||2
1557099|NCT01252134|3808971|P2|COMPLETED|Period 3, 8 Hours||3
1557100|NCT01252134|3808972|P1|COMPLETED|Period 3, 8 Hours||3
1557101|NCT01252134|3808967|P6|STARTED|Period 3, 8 Hours||4
1557102|NCT01252134|3808968|P5|STARTED|Period 3, 8 Hours||3
1557103|NCT01252134|3808969|P4|STARTED|Period 3, 8 Hours||5
1557104|NCT01252134|3808970|P3|STARTED|Period 3, 8 Hours||2
1557105|NCT01252134|3808971|P2|STARTED|Period 3, 8 Hours||3
1557106|NCT01252134|3808972|P1|STARTED|Period 3, 8 Hours||3
1557107|NCT01252134|3808967|P6|NOT COMPLETED|Period 2, 8 Hours||0
1557108|NCT01252134|3808968|P5|NOT COMPLETED|Period 2, 8 Hours||0
1557109|NCT01252134|3808969|P4|NOT COMPLETED|Period 2, 8 Hours||0
1557110|NCT01252134|3808970|P3|NOT COMPLETED|Period 2, 8 Hours||0
1557111|NCT01252134|3808971|P2|NOT COMPLETED|Period 2, 8 Hours||0
1557112|NCT01252134|3808972|P1|NOT COMPLETED|Period 2, 8 Hours||0
1557113|NCT01252134|3808967|P6|COMPLETED|Period 2, 8 Hours||4
1557114|NCT01252134|3808968|P5|COMPLETED|Period 2, 8 Hours||3
1557116|NCT01252134|3808970|P3|COMPLETED|Period 2, 8 Hours||2
1557117|NCT01252134|3808971|P2|COMPLETED|Period 2, 8 Hours||3
1557118|NCT01252134|3808972|P1|COMPLETED|Period 2, 8 Hours||3
1557119|NCT01252134|3808967|P6|STARTED|Period 2, 8 Hours||4
1557120|NCT01252134|3808968|P5|STARTED|Period 2, 8 Hours||3
1557121|NCT01252134|3808969|P4|STARTED|Period 2, 8 Hours||5
1557122|NCT01252134|3808970|P3|STARTED|Period 2, 8 Hours||2
1557123|NCT01252134|3808971|P2|STARTED|Period 2, 8 Hours||3
1557124|NCT01252134|3808972|P1|STARTED|Period 2, 8 Hours||3
1557125|NCT01252134|3808967|P6|NOT COMPLETED|Period 1, 8 Hours||0
1557126|NCT01252134|3808968|P5|NOT COMPLETED|Period 1, 8 Hours||0
1557127|NCT01252134|3808969|P4|NOT COMPLETED|Period 1, 8 Hours||0
1557128|NCT01252134|3808970|P3|NOT COMPLETED|Period 1, 8 Hours||1
1557129|NCT01252134|3808971|P2|NOT COMPLETED|Period 1, 8 Hours||1
1557130|NCT01252134|3808972|P1|NOT COMPLETED|Period 1, 8 Hours||0
1557131|NCT01252134|3808967|P6|COMPLETED|Period 1, 8 Hours||4
1557132|NCT01252134|3808968|P5|COMPLETED|Period 1, 8 Hours||3
1557133|NCT01252134|3808969|P4|COMPLETED|Period 1, 8 Hours||5
1557134|NCT01252134|3808970|P3|COMPLETED|Period 1, 8 Hours||2
1557135|NCT01252134|3808971|P2|COMPLETED|Period 1, 8 Hours||3
1557136|NCT01252134|3808972|P1|COMPLETED|Period 1, 8 Hours||3
1557137|NCT01252134|3808967|P6|STARTED|Period 1, 8 Hours||4
1557138|NCT01252134|3808968|P5|STARTED|Period 1, 8 Hours||3
1557139|NCT01252134|3808969|P4|STARTED|Period 1, 8 Hours||5
1557140|NCT01252134|3808970|P3|STARTED|Period 1, 8 Hours||3
1557141|NCT01252134|3808971|P2|STARTED|Period 1, 8 Hours||4
1557142|NCT01252134|3808972|P1|STARTED|Period 1, 8 Hours||3
1557143|NCT01252095|3808991|P2|NOT COMPLETED|Overall Study||0
1557144|NCT01252095|3808992|P1|NOT COMPLETED|Overall Study||1
1557145|NCT01252095|3808991|P2|COMPLETED|Overall Study||1
1557146|NCT01252095|3808992|P1|COMPLETED|Overall Study||2
1557147|NCT01252095|3808991|P2|STARTED|Overall Study||1
1557148|NCT01252095|3808992|P1|STARTED|Overall Study||3
1557149|NCT01251978|3809000|P2|NOT COMPLETED|Overall Study||0
1557150|NCT01251978|3809001|P1|NOT COMPLETED|Overall Study||0
1557151|NCT01251978|3809000|P2|COMPLETED|Overall Study||3
1557152|NCT01251978|3809001|P1|COMPLETED|Overall Study||5
1557153|NCT01251978|3809000|P2|STARTED|Overall Study||3
1557154|NCT01251978|3809001|P1|STARTED|Overall Study||5
1557155|NCT01251952|3809010|P1|NOT COMPLETED|Overall Study||1
1557156|NCT01251952|3809010|P1|COMPLETED|Overall Study||1
1557157|NCT01251952|3809010|P1|STARTED|Overall Study||2
1557158|NCT01251770|3809016|P2|NOT COMPLETED|Overall Study||7
1557159|NCT01251770|3809017|P1|NOT COMPLETED|Overall Study||13
1557160|NCT01251770|3809016|P2|COMPLETED|Overall Study||29
1557161|NCT01251770|3809017|P1|COMPLETED|Overall Study||29
1557162|NCT01251770|3809016|P2|STARTED|Overall Study||36
1557163|NCT01251770|3809017|P1|STARTED|Overall Study||42
1557164|NCT01251757|3809028|P3|NOT COMPLETED|Overall Study||0
1557165|NCT01251757|3809029|P2|NOT COMPLETED|Overall Study||0
1557166|NCT01251757|3809030|P1|NOT COMPLETED|Overall Study||0
1557167|NCT01251757|3809028|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
1557168|NCT01251757|3809029|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
1557169|NCT01251757|3809030|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
1557170|NCT01251757|3809028|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
1557171|NCT01251757|3809029|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
1557172|NCT01251757|3809030|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
1557173|NCT01251653|3809068|P9|NOT COMPLETED|Overall Study||6
1557174|NCT01251653|3809069|P8|NOT COMPLETED|Overall Study||12
1557175|NCT01251653|3809070|P7|NOT COMPLETED|Overall Study||18
1557176|NCT01251653|3809071|P6|NOT COMPLETED|Overall Study||18
1557177|NCT01251653|3809072|P5|NOT COMPLETED|Overall Study||2
1557178|NCT01251653|3809073|P4|NOT COMPLETED|Overall Study||6
1557179|NCT01251653|3809074|P3|NOT COMPLETED|Overall Study||20
1557180|NCT01251653|3809075|P2|NOT COMPLETED|Overall Study||8
1557181|NCT01251653|3809076|P1|NOT COMPLETED|Overall Study||3
1557182|NCT01251653|3809068|P9|COMPLETED|Overall Study||0
1557183|NCT01251653|3809069|P8|COMPLETED|Overall Study||0
1557184|NCT01251653|3809070|P7|COMPLETED|Overall Study||0
1557185|NCT01251653|3809071|P6|COMPLETED|Overall Study||0
1557186|NCT01251653|3809072|P5|COMPLETED|Overall Study||0
1557187|NCT01251653|3809073|P4|COMPLETED|Overall Study||0
1557188|NCT01251653|3809074|P3|COMPLETED|Overall Study||0
1557189|NCT01251653|3809075|P2|COMPLETED|Overall Study||0
1557190|NCT01251653|3809076|P1|COMPLETED|Overall Study||0
1557191|NCT01251653|3809068|P9|STARTED|Overall Study||6
1557192|NCT01251653|3809069|P8|STARTED|Overall Study||12
1557193|NCT01251653|3809070|P7|STARTED|Overall Study||18
1557194|NCT01251653|3809071|P6|STARTED|Overall Study||18
1557195|NCT01251653|3809072|P5|STARTED|Overall Study||2
1557196|NCT01251653|3809073|P4|STARTED|Overall Study||6
1557197|NCT01251653|3809074|P3|STARTED|Overall Study||20
1557198|NCT01251653|3809075|P2|STARTED|Overall Study||8
1557199|NCT01251653|3809076|P1|STARTED|Overall Study||3
1557200|NCT01251614|3809204|P3|NOT COMPLETED|Overall Study||8
1557201|NCT01251614|3809205|P2|NOT COMPLETED|Overall Study||13
1557202|NCT01251614|3809206|P1|NOT COMPLETED|Overall Study||3
1557203|NCT01251614|3809204|P3|COMPLETED|Overall Study||30
1557204|NCT01251614|3809205|P2|COMPLETED|Overall Study||26
1557205|NCT01251614|3809206|P1|COMPLETED|Overall Study||34
1557206|NCT01251614|3809204|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
1557207|NCT01251614|3809205|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
1557208|NCT01251614|3809206|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
1557209|NCT01251614|3809204|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
1557210|NCT01251614|3809205|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
1557211|NCT01251614|3809206|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
1557212|NCT01251614|3809204|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
1557213|NCT01251614|3809205|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
1557214|NCT01251614|3809206|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
1557215|NCT01251614|3809204|P3|STARTED|Overall Study||38
1557216|NCT01251614|3809205|P2|STARTED|Overall Study||39
1557217|NCT01251614|3809206|P1|STARTED|Overall Study||37
1557218|NCT01251588|3809280|P2|NOT COMPLETED|Overall Study||4
1557219|NCT01251588|3809281|P1|NOT COMPLETED|Overall Study||0
1557220|NCT01251588|3809280|P2|COMPLETED|Overall Study||59
1557221|NCT01251588|3809281|P1|COMPLETED|Overall Study||65
1557222|NCT01251588|3809280|P2|STARTED|Overall Study||63
1557223|NCT01251588|3809281|P1|STARTED|Overall Study||65
1557224|NCT01251380|3809313|P1|NOT COMPLETED|Overall Study||22
1557225|NCT01251380|3809313|P1|COMPLETED|Overall Study||194
1557226|NCT01251380|3809313|P1|Cycle 4|Overall Study||11
1557227|NCT01251380|3809313|P1|Cycle 3|Overall Study||86
1557228|NCT01251380|3809313|P1|Cycle 2|Overall Study||175
1557229|NCT01251380|3809313|P1|Cycle 1|Overall Study||207
1557230|NCT01251380|3809313|P1|STARTED|Overall Study|Safety population.|216
1557231|NCT01251367|3809337|P1|NOT COMPLETED|Overall Study||76
1557232|NCT01251367|3809337|P1|COMPLETED|Overall Study||269
1557233|NCT01251367|3809337|P1|Cycle 4|Overall Study||139
1557234|NCT01251367|3809337|P1|Cycle 3|Overall Study||224
1557235|NCT01251367|3809337|P1|Cycle 2|Overall Study||297
1557236|NCT01251367|3809337|P1|Cycle 1|Overall Study||345
1557237|NCT01251367|3809337|P1|STARTED|Overall Study||345
1557238|NCT01251354|3809372|P1|NOT COMPLETED|Overall Study||6
1557239|NCT01251354|3809372|P1|COMPLETED|Overall Study||0
1557240|NCT01251354|3809372|P1|STARTED|Overall Study||6
1557241|NCT01251315|3809388|P6|NOT COMPLETED|Overall Study||0
1557242|NCT01251315|3809389|P5|NOT COMPLETED|Overall Study||0
1557243|NCT01251315|3809390|P4|NOT COMPLETED|Overall Study||0
1557244|NCT01251315|3809391|P3|NOT COMPLETED|Overall Study||0
1557245|NCT01251315|3809392|P2|NOT COMPLETED|Overall Study||0
1557246|NCT01251315|3809393|P1|NOT COMPLETED|Overall Study||0
1557247|NCT01251315|3809388|P6|COMPLETED|Overall Study||4
1557248|NCT01251315|3809389|P5|COMPLETED|Overall Study||4
1557249|NCT01251315|3809390|P4|COMPLETED|Overall Study||4
1557250|NCT01251315|3809391|P3|COMPLETED|Overall Study||4
1557251|NCT01251315|3809392|P2|COMPLETED|Overall Study||4
1557252|NCT01251315|3809393|P1|COMPLETED|Overall Study||4
1557253|NCT01251315|3809388|P6|STARTED|Overall Study||4
1557254|NCT01251315|3809389|P5|STARTED|Overall Study||4
1557255|NCT01251315|3809390|P4|STARTED|Overall Study||4
1557256|NCT01251315|3809391|P3|STARTED|Overall Study||4
1557257|NCT01251315|3809392|P2|STARTED|Overall Study||4
1557258|NCT01251315|3809393|P1|STARTED|Overall Study||4
1557259|NCT01251276|3809415|P2|NOT COMPLETED|Overall Study||1
1557260|NCT01251276|3809416|P1|NOT COMPLETED|Overall Study||1
1557261|NCT01251276|3809415|P2|COMPLETED|Overall Study||107
1557262|NCT01251276|3809416|P1|COMPLETED|Overall Study||95
1557263|NCT01251276|3809415|P2|Vaccinated|Overall Study||108
1557264|NCT01251276|3809416|P1|Vaccinated|Overall Study||96
1557265|NCT01251276|3809415|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
1557266|NCT01251276|3809416|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
1557267|NCT01251146|3809434|P2|NOT COMPLETED|Overall Study||10
1557268|NCT01251146|3809435|P1|NOT COMPLETED|Overall Study||3
1557269|NCT01251146|3809434|P2|COMPLETED|Overall Study||81
1557270|NCT01251146|3809435|P1|COMPLETED|Overall Study||83
1557271|NCT01251146|3809434|P2|STARTED|Overall Study||91
1557272|NCT01251146|3809435|P1|STARTED|Overall Study||86
1557273|NCT01251120|3809457|P2|NOT COMPLETED|Overall Study||1
1557274|NCT01251120|3809458|P1|NOT COMPLETED|Overall Study||0
1557275|NCT01251120|3809457|P2|COMPLETED|Overall Study||0
1557276|NCT01251120|3809458|P1|COMPLETED|Overall Study||1
1557277|NCT01251120|3809457|P2|STARTED|Overall Study||1
1557278|NCT01251120|3809458|P1|STARTED|Overall Study||1
1557279|NCT01251042|3809480|P2|NOT COMPLETED|Overall Study||0
1557280|NCT01251042|3809481|P1|NOT COMPLETED|Overall Study||0
1557281|NCT01251042|3809480|P2|COMPLETED|Overall Study||23
1557282|NCT01251042|3809481|P1|COMPLETED|Overall Study||26
1557283|NCT01251042|3809480|P2|STARTED|Overall Study||23
1557284|NCT01251042|3809481|P1|STARTED|Overall Study||26
1557285|NCT01250990|3809513|P2|NOT COMPLETED|Overall Study||2
1557286|NCT01250990|3809514|P1|NOT COMPLETED|Overall Study||4
1557287|NCT01250990|3809513|P2|COMPLETED|Overall Study||9
1557288|NCT01250990|3809514|P1|COMPLETED|Overall Study||7
1557289|NCT01250990|3809513|P2|STARTED|Overall Study||11
1557290|NCT01250990|3809514|P1|STARTED|Overall Study||11
1557291|NCT01250925|3809523|P3|NOT COMPLETED|Overall Study||2
1557292|NCT01250925|3809524|P2|NOT COMPLETED|Overall Study||3
1557293|NCT01250925|3809525|P1|NOT COMPLETED|Overall Study||5
1557294|NCT01250925|3809523|P3|COMPLETED|Overall Study||30
1557295|NCT01250925|3809524|P2|COMPLETED|Overall Study||28
1557296|NCT01250925|3809525|P1|COMPLETED|Overall Study||26
1557297|NCT01250925|3809523|P3|STARTED|Overall Study||32
1557298|NCT01250925|3809524|P2|STARTED|Overall Study||31
1557299|NCT01250925|3809525|P1|STARTED|Overall Study||31
1557300|NCT01250899|3809565|P2|NOT COMPLETED|Overall Study||0
1557301|NCT01250899|3809566|P1|NOT COMPLETED|Overall Study||0
1557302|NCT01250899|3809565|P2|COMPLETED|Overall Study||82
1557303|NCT01250899|3809566|P1|COMPLETED|Overall Study||40
1557304|NCT01250899|3809565|P2|STARTED|Overall Study||82
1557305|NCT01250899|3809566|P1|STARTED|Overall Study||40
1557306|NCT01250873|3809570|P1|NOT COMPLETED|Overall Study||3
1557307|NCT01250873|3809570|P1|COMPLETED|Overall Study||17
1557308|NCT01250873|3809570|P1|STARTED|Overall Study||20
1557309|NCT01250834|3809581|P1|NOT COMPLETED|Overall Study||0
1557310|NCT01250834|3809581|P1|COMPLETED|Overall Study||27
1557311|NCT01250834|3809581|P1|STARTED|Overall Study||27
1557312|NCT01250769|3809602|P4|NOT COMPLETED|Overall Study||0
1557313|NCT01250769|3809603|P3|NOT COMPLETED|Overall Study||2
1557314|NCT01250769|3809604|P2|NOT COMPLETED|Overall Study||1
1557315|NCT01250769|3809605|P1|NOT COMPLETED|Overall Study||0
1557316|NCT01250769|3809602|P4|COMPLETED|Overall Study||11
1557317|NCT01250769|3809603|P3|COMPLETED|Overall Study||73
1557318|NCT01250769|3809604|P2|COMPLETED|Overall Study||72
1557319|NCT01250769|3809605|P1|COMPLETED|Overall Study||11
1557320|NCT01250769|3809602|P4|Day 14|Overall Study||11
1557321|NCT01250769|3809603|P3|Day 14|Overall Study||74
1557322|NCT01250769|3809604|P2|Day 14|Overall Study||72
1557323|NCT01250769|3809605|P1|Day 14|Overall Study||11
1557324|NCT01250769|3809602|P4|STARTED|Overall Study||11
1557325|NCT01250769|3809603|P3|STARTED|Overall Study||75
1557326|NCT01250769|3809604|P2|STARTED|Overall Study||73
1557327|NCT01250769|3809605|P1|STARTED|Overall Study||11
1557328|NCT01250756|3809637|P2|NOT COMPLETED|After Toddler Dose||1
1557329|NCT01250756|3809638|P1|NOT COMPLETED|After Toddler Dose||0
1557330|NCT01250756|3809637|P2|COMPLETED|After Toddler Dose||147
1557331|NCT01250756|3809638|P1|COMPLETED|After Toddler Dose||0
1557332|NCT01250756|3809637|P2|STARTED|After Toddler Dose||148
1557333|NCT01250756|3809638|P1|STARTED|After Toddler Dose||0
1557334|NCT01250756|3809637|P2|NOT COMPLETED|Toddler Dose||1
1557335|NCT01250756|3809638|P1|NOT COMPLETED|Toddler Dose||0
1557336|NCT01250756|3809637|P2|COMPLETED|Toddler Dose||148
1557337|NCT01250756|3809638|P1|COMPLETED|Toddler Dose||122
1557338|NCT01250756|3809637|P2|STARTED|Toddler Dose||149
1557339|NCT01250756|3809638|P1|STARTED|Toddler Dose||122
1557340|NCT01250756|3809637|P2|NOT COMPLETED|After Infant Series||4
1557341|NCT01250756|3809638|P1|NOT COMPLETED|After Infant Series||11
1557342|NCT01250756|3809637|P2|COMPLETED|After Infant Series||149
1557343|NCT01250756|3809638|P1|COMPLETED|After Infant Series||122
1557344|NCT01250756|3809637|P2|STARTED|After Infant Series||153
1557345|NCT01250756|3809638|P1|STARTED|After Infant Series||133
1557346|NCT01250756|3809637|P2|NOT COMPLETED|Infant Series||7
1557347|NCT01250756|3809638|P1|NOT COMPLETED|Infant Series||28
1557348|NCT01250756|3809637|P2|COMPLETED|Infant Series||153
1557349|NCT01250756|3809638|P1|COMPLETED|Infant Series||133
1557350|NCT01250756|3809637|P2|Vaccinated Dose 3|Infant Series||155
1557351|NCT01250756|3809638|P1|Vaccinated Dose 3|Infant Series||133
1557352|NCT01250756|3809637|P2|Vaccinated Dose 2|Infant Series||157
1557353|NCT01250756|3809638|P1|Vaccinated Dose 2|Infant Series||147
1557354|NCT01250756|3809637|P2|Vaccinated Dose 1|Infant Series||158
1557355|NCT01250756|3809638|P1|Vaccinated Dose 1|Infant Series||159
1557356|NCT01250756|3809637|P2|STARTED|Infant Series||160
1557357|NCT01250756|3809638|P1|STARTED|Infant Series||161
1557358|NCT01250730|3809691|P3|NOT COMPLETED|Overall Study||0
1557359|NCT01250730|3809692|P2|NOT COMPLETED|Overall Study||0
1557360|NCT01250730|3809693|P1|NOT COMPLETED|Overall Study||0
1557361|NCT01250730|3809691|P3|COMPLETED|Overall Study||6
1557362|NCT01250730|3809692|P2|COMPLETED|Overall Study||6
1557363|NCT01250730|3809693|P1|COMPLETED|Overall Study||6
1557364|NCT01250730|3809691|P3|STARTED|Overall Study||6
1557365|NCT01250730|3809692|P2|STARTED|Overall Study||6
1557366|NCT01250730|3809693|P1|STARTED|Overall Study||6
1557367|NCT01250717|3809749|P1|NOT COMPLETED|Overall Study||0
1557368|NCT01250717|3809749|P1|COMPLETED|Overall Study||28
1557369|NCT01250717|3809749|P1|STARTED|Overall Study||28
1557370|NCT01250509|3809755|P2|NOT COMPLETED|Overall Study||2
1557371|NCT01250509|3809756|P1|NOT COMPLETED|Overall Study||5
1557372|NCT01250509|3809755|P2|COMPLETED|Overall Study||21
1557373|NCT01250509|3809756|P1|COMPLETED|Overall Study||19
1557374|NCT01250509|3809755|P2|STARTED|Overall Study||23
1557375|NCT01250509|3809756|P1|STARTED|Overall Study||24
1557376|NCT01250418|3809770|P2|NOT COMPLETED|Overall Study||1
1557377|NCT01250418|3809771|P1|NOT COMPLETED|Overall Study||1
1557378|NCT01250418|3809770|P2|COMPLETED|Overall Study||15
1557379|NCT01250418|3809771|P1|COMPLETED|Overall Study||8
1557380|NCT01250418|3809770|P2|STARTED|Overall Study||16
1557381|NCT01250418|3809771|P1|STARTED|Overall Study||9
1557382|NCT01250379|3809779|P2|NOT COMPLETED|Overall Study||193
1557383|NCT01250379|3809780|P1|NOT COMPLETED|Overall Study||202
1557384|NCT01250379|3809779|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
1557473|NCT01249833|3810030|P2|STARTED|Overall Study||63
1557385|NCT01250379|3809780|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
1557386|NCT01250379|3809779|P2|STARTED|Overall Study||247
1557387|NCT01250379|3809780|P1|STARTED|Overall Study||247
1557388|NCT01250210|3809841|P3|NOT COMPLETED|Overall Study||8
1557389|NCT01250210|3809842|P2|NOT COMPLETED|Overall Study||4
1557390|NCT01250210|3809843|P1|NOT COMPLETED|Overall Study||4
1557391|NCT01250210|3809841|P3|COMPLETED|Overall Study||25
1557392|NCT01250210|3809842|P2|COMPLETED|Overall Study||41
1557393|NCT01250210|3809843|P1|COMPLETED|Overall Study||41
1557394|NCT01250210|3809841|P3|STARTED|Overall Study||33
1557395|NCT01250210|3809842|P2|STARTED|Overall Study||45
1557396|NCT01250210|3809843|P1|STARTED|Overall Study||45
1557397|NCT01250184|3809857|P3|NOT COMPLETED|Overall Study||0
1557398|NCT01250184|3809858|P2|NOT COMPLETED|Overall Study||0
1557399|NCT01250184|3809859|P1|NOT COMPLETED|Overall Study||0
1557400|NCT01250184|3809857|P3|COMPLETED|Overall Study||43
1557401|NCT01250184|3809858|P2|COMPLETED|Overall Study||41
1557402|NCT01250184|3809859|P1|COMPLETED|Overall Study||43
1557403|NCT01250184|3809857|P3|STARTED|Overall Study||43
1557404|NCT01250184|3809858|P2|STARTED|Overall Study||41
1557405|NCT01250184|3809859|P1|STARTED|Overall Study||43
1557406|NCT01250171|3809885|P3|NOT COMPLETED|Overall Study||0
1557407|NCT01250171|3809886|P2|NOT COMPLETED|Overall Study||0
1557408|NCT01250171|3809887|P1|NOT COMPLETED|Overall Study||1
1557409|NCT01250171|3809885|P3|COMPLETED|Overall Study||24
1557410|NCT01250171|3809886|P2|COMPLETED|Overall Study||22
1557411|NCT01250171|3809887|P1|COMPLETED|Overall Study||25
1557412|NCT01250171|3809885|P3|STARTED|Overall Study||24
1557413|NCT01250171|3809886|P2|STARTED|Overall Study||22
1557414|NCT01250171|3809887|P1|STARTED|Overall Study||26
1557415|NCT01250145|3809918|P2|NOT COMPLETED|Overall Study||5
1557416|NCT01250145|3809919|P1|NOT COMPLETED|Overall Study||2
1557417|NCT01250145|3809918|P2|COMPLETED|Overall Study||205
1557418|NCT01250145|3809919|P1|COMPLETED|Overall Study||39
1557419|NCT01250145|3809918|P2|STARTED|Overall Study||210
1557420|NCT01250145|3809919|P1|STARTED|Overall Study||41
1557421|NCT01250119|3809939|P2|NOT COMPLETED|Treatment Phase||41
1557422|NCT01250119|3809940|P1|NOT COMPLETED|Treatment Phase||0
1557423|NCT01250119|3809939|P2|COMPLETED|Treatment Phase||0
1557424|NCT01250119|3809940|P1|COMPLETED|Treatment Phase||0
1557425|NCT01250119|3809939|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
1557426|NCT01250119|3809940|P1|STARTED|Treatment Phase||0
1557427|NCT01250119|3809939|P2|NOT COMPLETED|Diagnostic Phase||0
1557428|NCT01250119|3809940|P1|NOT COMPLETED|Diagnostic Phase||113
1557429|NCT01250119|3809939|P2|COMPLETED|Diagnostic Phase||0
1557430|NCT01250119|3809940|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
1557431|NCT01250119|3809939|P2|STARTED|Diagnostic Phase||0
1557432|NCT01250119|3809940|P1|STARTED|Diagnostic Phase||688
1557433|NCT01250054|3809955|P2|NOT COMPLETED|Period 2, One Week of Wear||0
1557434|NCT01250054|3809956|P1|NOT COMPLETED|Period 2, One Week of Wear||1
1557435|NCT01250054|3809955|P2|COMPLETED|Period 2, One Week of Wear||8
1557436|NCT01250054|3809956|P1|COMPLETED|Period 2, One Week of Wear||6
1557437|NCT01250054|3809955|P2|STARTED|Period 2, One Week of Wear||8
1557438|NCT01250054|3809956|P1|STARTED|Period 2, One Week of Wear||7
1557439|NCT01250054|3809955|P2|NOT COMPLETED|Period 1, One Week of Wear||0
1557440|NCT01250054|3809956|P1|NOT COMPLETED|Period 1, One Week of Wear||0
1557441|NCT01250054|3809955|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
1557442|NCT01250054|3809956|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
1557443|NCT01250054|3809955|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
1557444|NCT01250054|3809956|P1|STARTED|Period 1, One Week of Wear||8
1557445|NCT01250002|3809964|P2|NOT COMPLETED|Overall Study||3
1557446|NCT01250002|3809965|P1|NOT COMPLETED|Overall Study||4
1557447|NCT01250002|3809964|P2|COMPLETED|Overall Study||32
1557448|NCT01250002|3809965|P1|COMPLETED|Overall Study||31
1557449|NCT01250002|3809964|P2|STARTED|Overall Study||35
1557450|NCT01250002|3809965|P1|STARTED|Overall Study||35
1557451|NCT01249872|3809979|P6|NOT COMPLETED|Overall Study||0
1557452|NCT01249872|3809980|P5|NOT COMPLETED|Overall Study||0
1557453|NCT01249872|3809981|P4|NOT COMPLETED|Overall Study||0
1557454|NCT01249872|3809982|P3|NOT COMPLETED|Overall Study||0
1557455|NCT01249872|3809983|P2|NOT COMPLETED|Overall Study||0
1557456|NCT01249872|3809984|P1|NOT COMPLETED|Overall Study||0
1557457|NCT01249872|3809979|P6|COMPLETED|Overall Study||16
1557458|NCT01249872|3809980|P5|COMPLETED|Overall Study||16
1557459|NCT01249872|3809981|P4|COMPLETED|Overall Study||16
1557460|NCT01249872|3809982|P3|COMPLETED|Overall Study||16
1557461|NCT01249872|3809983|P2|COMPLETED|Overall Study||16
1557462|NCT01249872|3809984|P1|COMPLETED|Overall Study||16
1557463|NCT01249872|3809979|P6|STARTED|Overall Study||16
1557464|NCT01249872|3809980|P5|STARTED|Overall Study||16
1557465|NCT01249872|3809981|P4|STARTED|Overall Study||16
1557466|NCT01249872|3809982|P3|STARTED|Overall Study||16
1557467|NCT01249872|3809983|P2|STARTED|Overall Study||16
1557468|NCT01249872|3809984|P1|STARTED|Overall Study||16
1557469|NCT01249833|3810030|P2|NOT COMPLETED|Overall Study||1
1557470|NCT01249833|3810031|P1|NOT COMPLETED|Overall Study||0
1557471|NCT01249833|3810030|P2|COMPLETED|Overall Study||62
1557472|NCT01249833|3810031|P1|COMPLETED|Overall Study||59
1557474|NCT01249833|3810031|P1|STARTED|Overall Study||59
1557475|NCT01249664|3810045|P2|NOT COMPLETED|Overall Study||0
1557476|NCT01249664|3810046|P1|NOT COMPLETED|Overall Study||6
1557477|NCT01249664|3810045|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
1557478|NCT01249664|3810046|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
1557479|NCT01249664|3810045|P2|Completed 48 Weeks Treatment|Overall Study||24
1557480|NCT01249664|3810046|P1|Completed 48 Weeks Treatment|Overall Study||78
1557481|NCT01249664|3810045|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
1557482|NCT01249664|3810046|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
1557483|NCT01249664|3810045|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
1557484|NCT01249664|3810046|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
1557485|NCT01249664|3810045|P2|Participants Received Treatment|Overall Study|Safety population|31
1557486|NCT01249664|3810046|P1|Participants Received Treatment|Overall Study|Safety population|91
1557487|NCT01249664|3810045|P2|STARTED|Overall Study||31
1557488|NCT01249664|3810046|P1|STARTED|Overall Study||91
1557489|NCT01249651|3810096|P1|NOT COMPLETED|Overall Study||7
1557490|NCT01249651|3810096|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
1557491|NCT01249651|3810096|P1|STARTED|Overall Study|Enrolled|101
1557492|NCT01249417|3810106|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
1557493|NCT01249417|3810107|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
1557494|NCT01249417|3810108|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
1557495|NCT01249417|3810106|P3|COMPLETED|Treatment Phase - ITT Population||73
1557496|NCT01249417|3810107|P2|COMPLETED|Treatment Phase - ITT Population||75
1557497|NCT01249417|3810108|P1|COMPLETED|Treatment Phase - ITT Population||78
1557498|NCT01249417|3810106|P3|STARTED|Treatment Phase - ITT Population||77
1557499|NCT01249417|3810107|P2|STARTED|Treatment Phase - ITT Population||79
1557500|NCT01249417|3810108|P1|STARTED|Treatment Phase - ITT Population||79
1557501|NCT01249417|3810106|P3|NOT COMPLETED|Randomised Population||4
1557502|NCT01249417|3810107|P2|NOT COMPLETED|Randomised Population||1
1557503|NCT01249417|3810108|P1|NOT COMPLETED|Randomised Population||1
1557504|NCT01249417|3810106|P3|COMPLETED|Randomised Population||77
1557505|NCT01249417|3810107|P2|COMPLETED|Randomised Population||79
1557506|NCT01249417|3810108|P1|COMPLETED|Randomised Population||79
1557507|NCT01249417|3810106|P3|Treated|Randomised Population||79
1557508|NCT01249417|3810107|P2|Treated|Randomised Population||80
1557509|NCT01249417|3810108|P1|Treated|Randomised Population||80
1557510|NCT01249417|3810106|P3|STARTED|Randomised Population||81
1557511|NCT01249417|3810107|P2|STARTED|Randomised Population||80
1557512|NCT01249417|3810108|P1|STARTED|Randomised Population||80
1557513|NCT01249404|3810125|P3|NOT COMPLETED|Overall Study||7
1557514|NCT01249404|3810126|P2|NOT COMPLETED|Overall Study||8
1557515|NCT01249404|3810127|P1|NOT COMPLETED|Overall Study||7
1557516|NCT01249404|3810125|P3|COMPLETED|Overall Study||125
1557517|NCT01249404|3810126|P2|COMPLETED|Overall Study||121
1557518|NCT01249404|3810127|P1|COMPLETED|Overall Study||120
1557519|NCT01249404|3810125|P3|STARTED|Overall Study||132
1557520|NCT01249404|3810126|P2|STARTED|Overall Study||129
1557521|NCT01249404|3810127|P1|STARTED|Overall Study||127
1557522|NCT01249365|3810204|P1|NOT COMPLETED|Overall Study||1
1557523|NCT01249365|3810204|P1|COMPLETED|Overall Study||198
1557524|NCT01249365|3810204|P1|STARTED|Overall Study||199
1557525|NCT01249274|3810212|P2|NOT COMPLETED|Overall Study||6
1557526|NCT01249274|3810213|P1|NOT COMPLETED|Overall Study||4
1557527|NCT01249274|3810212|P2|COMPLETED|Overall Study||19
1557528|NCT01249274|3810213|P1|COMPLETED|Overall Study||21
1557529|NCT01249274|3810212|P2|Completed Post Trial Visit But Not tx|Overall Study||2
1557530|NCT01249274|3810213|P1|Completed Post Trial Visit But Not tx|Overall Study||1
1557531|NCT01249274|3810212|P2|Completed Treatment & Post Trial Visit|Overall Study||17
1557532|NCT01249274|3810213|P1|Completed Treatment & Post Trial Visit|Overall Study||20
1557533|NCT01249274|3810212|P2|Completed Treatment|Overall Study||19
1557534|NCT01249274|3810213|P1|Completed Treatment|Overall Study||21
1557535|NCT01249274|3810212|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
1557536|NCT01249274|3810213|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
1557537|NCT01249261|3810239|P2|NOT COMPLETED|Overall Study||0
1557538|NCT01249261|3810240|P1|NOT COMPLETED|Overall Study||1
1557539|NCT01249261|3810239|P2|COMPLETED|Overall Study||31
1557540|NCT01249261|3810240|P1|COMPLETED|Overall Study||29
1557541|NCT01249261|3810239|P2|STARTED|Overall Study||31
1557542|NCT01249261|3810240|P1|STARTED|Overall Study||30
1557543|NCT01249157|3810268|P1|NOT COMPLETED|Overall Study||1
1557544|NCT01249157|3810268|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
1557545|NCT01249157|3810268|P1|STARTED|Overall Study||1
1557546|NCT01249131|3810272|P6|NOT COMPLETED|Third Intervention||0
1557547|NCT01249131|3810273|P5|NOT COMPLETED|Third Intervention||0
1557548|NCT01249131|3810274|P4|NOT COMPLETED|Third Intervention||0
1557549|NCT01249131|3810275|P3|NOT COMPLETED|Third Intervention||0
1557550|NCT01249131|3810276|P2|NOT COMPLETED|Third Intervention||0
1557551|NCT01249131|3810277|P1|NOT COMPLETED|Third Intervention||0
1557552|NCT01249131|3810272|P6|COMPLETED|Third Intervention||4
1557553|NCT01249131|3810273|P5|COMPLETED|Third Intervention||2
1557554|NCT01249131|3810274|P4|COMPLETED|Third Intervention||3
1557555|NCT01249131|3810275|P3|COMPLETED|Third Intervention||4
1557556|NCT01249131|3810276|P2|COMPLETED|Third Intervention||3
1557557|NCT01249131|3810277|P1|COMPLETED|Third Intervention||3
1557558|NCT01249131|3810272|P6|STARTED|Third Intervention||4
1557559|NCT01249131|3810273|P5|STARTED|Third Intervention||2
1557560|NCT01249131|3810274|P4|STARTED|Third Intervention||3
1557561|NCT01249131|3810275|P3|STARTED|Third Intervention||4
1557562|NCT01249131|3810276|P2|STARTED|Third Intervention||3
1557563|NCT01249131|3810277|P1|STARTED|Third Intervention||3
1557564|NCT01249131|3810272|P6|NOT COMPLETED|Washout Period of 10 Days||0
1557565|NCT01249131|3810273|P5|NOT COMPLETED|Washout Period of 10 Days||0
1557566|NCT01249131|3810274|P4|NOT COMPLETED|Washout Period of 10 Days||0
1557567|NCT01249131|3810275|P3|NOT COMPLETED|Washout Period of 10 Days||0
1557568|NCT01249131|3810276|P2|NOT COMPLETED|Washout Period of 10 Days||0
1557569|NCT01249131|3810277|P1|NOT COMPLETED|Washout Period of 10 Days||0
1557570|NCT01249131|3810272|P6|COMPLETED|Washout Period of 10 Days||4
1557571|NCT01249131|3810273|P5|COMPLETED|Washout Period of 10 Days||2
1557572|NCT01249131|3810274|P4|COMPLETED|Washout Period of 10 Days||3
1557573|NCT01249131|3810275|P3|COMPLETED|Washout Period of 10 Days||4
1557574|NCT01249131|3810276|P2|COMPLETED|Washout Period of 10 Days||3
1557575|NCT01249131|3810277|P1|COMPLETED|Washout Period of 10 Days||3
1557576|NCT01249131|3810272|P6|STARTED|Washout Period of 10 Days||4
1557577|NCT01249131|3810273|P5|STARTED|Washout Period of 10 Days||2
1557578|NCT01249131|3810274|P4|STARTED|Washout Period of 10 Days||3
1557579|NCT01249131|3810275|P3|STARTED|Washout Period of 10 Days||4
1557580|NCT01249131|3810276|P2|STARTED|Washout Period of 10 Days||3
1557581|NCT01249131|3810277|P1|STARTED|Washout Period of 10 Days||3
1557582|NCT01249131|3810272|P6|NOT COMPLETED|Second Intervention||0
1557583|NCT01249131|3810273|P5|NOT COMPLETED|Second Intervention||0
1557584|NCT01249131|3810274|P4|NOT COMPLETED|Second Intervention||0
1557585|NCT01249131|3810275|P3|NOT COMPLETED|Second Intervention||0
1557586|NCT01249131|3810276|P2|NOT COMPLETED|Second Intervention||0
1557587|NCT01249131|3810277|P1|NOT COMPLETED|Second Intervention||0
1557588|NCT01249131|3810272|P6|COMPLETED|Second Intervention||4
1557589|NCT01249131|3810273|P5|COMPLETED|Second Intervention||2
1557590|NCT01249131|3810274|P4|COMPLETED|Second Intervention||3
1557591|NCT01249131|3810275|P3|COMPLETED|Second Intervention||4
1557592|NCT01249131|3810276|P2|COMPLETED|Second Intervention||3
1557593|NCT01249131|3810277|P1|COMPLETED|Second Intervention||3
1557594|NCT01249131|3810272|P6|STARTED|Second Intervention||4
1557595|NCT01249131|3810273|P5|STARTED|Second Intervention||2
1557596|NCT01249131|3810274|P4|STARTED|Second Intervention||3
1557597|NCT01249131|3810275|P3|STARTED|Second Intervention||4
1557598|NCT01249131|3810276|P2|STARTED|Second Intervention||3
1557599|NCT01249131|3810277|P1|STARTED|Second Intervention||3
1557600|NCT01249131|3810272|P6|NOT COMPLETED|Washout Period of 10 Days||0
1557601|NCT01249131|3810273|P5|NOT COMPLETED|Washout Period of 10 Days||1
1557602|NCT01249131|3810274|P4|NOT COMPLETED|Washout Period of 10 Days||0
1557603|NCT01249131|3810275|P3|NOT COMPLETED|Washout Period of 10 Days||0
1557604|NCT01249131|3810276|P2|NOT COMPLETED|Washout Period of 10 Days||0
1557605|NCT01249131|3810277|P1|NOT COMPLETED|Washout Period of 10 Days||0
1557606|NCT01249131|3810272|P6|COMPLETED|Washout Period of 10 Days||4
1557607|NCT01249131|3810273|P5|COMPLETED|Washout Period of 10 Days||2
1557608|NCT01249131|3810274|P4|COMPLETED|Washout Period of 10 Days||3
1557609|NCT01249131|3810275|P3|COMPLETED|Washout Period of 10 Days||4
1557610|NCT01249131|3810276|P2|COMPLETED|Washout Period of 10 Days||3
1557611|NCT01249131|3810277|P1|COMPLETED|Washout Period of 10 Days||3
1557612|NCT01249131|3810272|P6|STARTED|Washout Period of 10 Days||4
1557613|NCT01249131|3810273|P5|STARTED|Washout Period of 10 Days||3
1557614|NCT01249131|3810274|P4|STARTED|Washout Period of 10 Days||3
1557615|NCT01249131|3810275|P3|STARTED|Washout Period of 10 Days||4
1557616|NCT01249131|3810276|P2|STARTED|Washout Period of 10 Days||3
1557617|NCT01249131|3810277|P1|STARTED|Washout Period of 10 Days||3
1557618|NCT01249131|3810272|P6|NOT COMPLETED|First Intervention||0
1557619|NCT01249131|3810273|P5|NOT COMPLETED|First Intervention||0
1557620|NCT01249131|3810274|P4|NOT COMPLETED|First Intervention||0
1557621|NCT01249131|3810275|P3|NOT COMPLETED|First Intervention||0
1557622|NCT01249131|3810276|P2|NOT COMPLETED|First Intervention||0
1557623|NCT01249131|3810277|P1|NOT COMPLETED|First Intervention||0
1557624|NCT01249131|3810272|P6|COMPLETED|First Intervention||4
1557625|NCT01249131|3810273|P5|COMPLETED|First Intervention||3
1557626|NCT01249131|3810274|P4|COMPLETED|First Intervention||3
1557627|NCT01249131|3810275|P3|COMPLETED|First Intervention||4
1557628|NCT01249131|3810276|P2|COMPLETED|First Intervention||3
1557629|NCT01249131|3810277|P1|COMPLETED|First Intervention||3
1557630|NCT01249131|3810272|P6|STARTED|First Intervention||4
1557631|NCT01249131|3810273|P5|STARTED|First Intervention||3
1557632|NCT01249131|3810274|P4|STARTED|First Intervention||3
1557633|NCT01249131|3810275|P3|STARTED|First Intervention||4
1557634|NCT01249131|3810276|P2|STARTED|First Intervention||3
1557635|NCT01249131|3810277|P1|STARTED|First Intervention||3
1557636|NCT01249118|3810297|P3|NOT COMPLETED|Second Washout Period||0
1557637|NCT01249118|3810298|P2|NOT COMPLETED|Second Washout Period||0
1557638|NCT01249118|3810299|P1|NOT COMPLETED|Second Washout Period||0
1557639|NCT01249118|3810297|P3|COMPLETED|Second Washout Period||5
1557640|NCT01249118|3810298|P2|COMPLETED|Second Washout Period||5
1557641|NCT01249118|3810299|P1|COMPLETED|Second Washout Period||2
1557642|NCT01249118|3810297|P3|STARTED|Second Washout Period||5
1557643|NCT01249118|3810298|P2|STARTED|Second Washout Period||5
1557644|NCT01249118|3810299|P1|STARTED|Second Washout Period||2
1557645|NCT01249118|3810297|P3|NOT COMPLETED|Second Intervention Period||0
1557646|NCT01249118|3810298|P2|NOT COMPLETED|Second Intervention Period||0
1557647|NCT01249118|3810299|P1|NOT COMPLETED|Second Intervention Period||0
1557648|NCT01249118|3810297|P3|COMPLETED|Second Intervention Period||5
1557649|NCT01249118|3810298|P2|COMPLETED|Second Intervention Period||5
1557650|NCT01249118|3810299|P1|COMPLETED|Second Intervention Period||2
1557651|NCT01249118|3810297|P3|STARTED|Second Intervention Period||5
1557652|NCT01249118|3810298|P2|STARTED|Second Intervention Period||5
1557653|NCT01249118|3810299|P1|STARTED|Second Intervention Period||2
1557654|NCT01249118|3810297|P3|NOT COMPLETED|First Washout Period||0
1557655|NCT01249118|3810298|P2|NOT COMPLETED|First Washout Period||1
1557656|NCT01249118|3810299|P1|NOT COMPLETED|First Washout Period||0
1557657|NCT01249118|3810297|P3|COMPLETED|First Washout Period||5
1557658|NCT01249118|3810298|P2|COMPLETED|First Washout Period||5
1557659|NCT01249118|3810299|P1|COMPLETED|First Washout Period||2
1557660|NCT01249118|3810297|P3|STARTED|First Washout Period||5
1557661|NCT01249118|3810298|P2|STARTED|First Washout Period||6
1557662|NCT01249118|3810299|P1|STARTED|First Washout Period||2
1557663|NCT01249118|3810297|P3|NOT COMPLETED|First Intervention Period||0
1557664|NCT01249118|3810298|P2|NOT COMPLETED|First Intervention Period||0
1557665|NCT01249118|3810299|P1|NOT COMPLETED|First Intervention Period||0
1557666|NCT01249118|3810297|P3|COMPLETED|First Intervention Period||5
1557667|NCT01249118|3810298|P2|COMPLETED|First Intervention Period||6
1557668|NCT01249118|3810299|P1|COMPLETED|First Intervention Period||2
1557669|NCT01249118|3810297|P3|STARTED|First Intervention Period||5
1557670|NCT01249118|3810298|P2|STARTED|First Intervention Period||6
1557671|NCT01249118|3810299|P1|STARTED|First Intervention Period||2
1557672|NCT01249092|3810333|P1|NOT COMPLETED|Overall Study||2
1557673|NCT01249092|3810333|P1|COMPLETED|Overall Study||18
1557674|NCT01249092|3810333|P1|STARTED|Overall Study||20
1557675|NCT01248949|3810344|P5|NOT COMPLETED|Overall Study||4
1557676|NCT01248949|3810345|P4|NOT COMPLETED|Overall Study||10
1557677|NCT01248949|3810346|P3|NOT COMPLETED|Overall Study||37
1557678|NCT01248949|3810347|P2|NOT COMPLETED|Overall Study||13
1557679|NCT01248949|3810348|P1|NOT COMPLETED|Overall Study||33
1557680|NCT01248949|3810344|P5|COMPLETED|Overall Study||3
1557681|NCT01248949|3810345|P4|COMPLETED|Overall Study||3
1557682|NCT01248949|3810346|P3|COMPLETED|Overall Study||1
1557683|NCT01248949|3810347|P2|COMPLETED|Overall Study||3
1557684|NCT01248949|3810348|P1|COMPLETED|Overall Study||9
1557685|NCT01248949|3810344|P5|STARTED|Overall Study||7
1557686|NCT01248949|3810345|P4|STARTED|Overall Study||13
1557687|NCT01248949|3810346|P3|STARTED|Overall Study||38
1557688|NCT01248949|3810347|P2|STARTED|Overall Study||16
1557689|NCT01248949|3810348|P1|STARTED|Overall Study||42
1557690|NCT01248936|3810460|P1|NOT COMPLETED|Overall Study||374
1557691|NCT01248936|3810460|P1|COMPLETED|Overall Study||0
1557692|NCT01248936|3810460|P1|STARTED|Overall Study||374
1557693|NCT01248884|3810473|P3|NOT COMPLETED|Overall Study||1
1557694|NCT01248884|3810474|P2|NOT COMPLETED|Overall Study||3
1557695|NCT01248884|3810475|P1|NOT COMPLETED|Overall Study||2
1557696|NCT01248884|3810473|P3|COMPLETED|Overall Study||238
1557697|NCT01248884|3810474|P2|COMPLETED|Overall Study||239
1557698|NCT01248884|3810475|P1|COMPLETED|Overall Study||238
1557699|NCT01248884|3810473|P3|STARTED|Overall Study||239
1557700|NCT01248884|3810474|P2|STARTED|Overall Study||242
1557701|NCT01248884|3810475|P1|STARTED|Overall Study||240
1557702|NCT01248793|3810533|P2|NOT COMPLETED|Overall Study||6
1557703|NCT01248793|3810534|P1|NOT COMPLETED|Overall Study||4
1557704|NCT01248793|3810533|P2|COMPLETED|Overall Study||102
1557705|NCT01248793|3810534|P1|COMPLETED|Overall Study||101
1557706|NCT01248793|3810533|P2|STARTED|Overall Study||108
1557707|NCT01248793|3810534|P1|STARTED|Overall Study||105
1557708|NCT01248780|3810548|P2|NOT COMPLETED|Overall Study||15
1557709|NCT01248780|3810549|P1|NOT COMPLETED|Overall Study||9
1557710|NCT01248780|3810548|P2|COMPLETED|Overall Study||117
1557711|NCT01248780|3810549|P1|COMPLETED|Overall Study||123
1557712|NCT01248780|3810548|P2|STARTED|Overall Study||132
1557713|NCT01248780|3810549|P1|STARTED|Overall Study||132
1557714|NCT01248728|3810563|P2|NOT COMPLETED|Overall Study||2
1557715|NCT01248728|3810564|P1|NOT COMPLETED|Overall Study||4
1557716|NCT01248728|3810563|P2|COMPLETED|Overall Study||17
1557717|NCT01248728|3810564|P1|COMPLETED|Overall Study||15
1557718|NCT01248728|3810563|P2|STARTED|Overall Study||19
1557719|NCT01248728|3810564|P1|STARTED|Overall Study||19
1557720|NCT01248715|3810580|P2|NOT COMPLETED|Overall Study||510
1557721|NCT01248715|3810581|P1|NOT COMPLETED|Overall Study||501
1557722|NCT01248715|3810580|P2|COMPLETED|Overall Study||41
1557723|NCT01248715|3810581|P1|COMPLETED|Overall Study||55
1557724|NCT01248715|3810580|P2|STARTED|Overall Study||551
1557725|NCT01248715|3810581|P1|STARTED|Overall Study||556
1557726|NCT01248468|3810602|P3|NOT COMPLETED|Overall Study||4
1557727|NCT01248468|3810603|P2|NOT COMPLETED|Overall Study||14
1557728|NCT01248468|3810604|P1|NOT COMPLETED|Overall Study||15
1557729|NCT01248468|3810602|P3|COMPLETED|Overall Study||145
1557730|NCT01248468|3810603|P2|COMPLETED|Overall Study||290
1557731|NCT01248468|3810604|P1|COMPLETED|Overall Study||284
1557732|NCT01248468|3810602|P3|ITT Population|Overall Study||125
1557733|NCT01248468|3810603|P2|ITT Population|Overall Study||261
1557734|NCT01248468|3810604|P1|ITT Population|Overall Study||256
1557735|NCT01248468|3810602|P3|Safety Population|Overall Study||133
1557736|NCT01248468|3810603|P2|Safety Population|Overall Study||271
1557737|NCT01248468|3810604|P1|Safety Population|Overall Study||266
1557738|NCT01248468|3810602|P3|STARTED|Overall Study||149
1557739|NCT01248468|3810603|P2|STARTED|Overall Study||304
1557740|NCT01248468|3810604|P1|STARTED|Overall Study||299
1557741|NCT01248455|3810621|P1|NOT COMPLETED|Overall Study||1
1557742|NCT01248455|3810621|P1|COMPLETED|Overall Study||8
1557743|NCT01248455|3810621|P1|STARTED|Overall Study||9
1557744|NCT01248416|3810629|P3|NOT COMPLETED|Overall Study||1
1557745|NCT01248416|3810630|P2|NOT COMPLETED|Overall Study||0
1557746|NCT01248416|3810631|P1|NOT COMPLETED|Overall Study||4
1557747|NCT01248416|3810629|P3|COMPLETED|Overall Study||25
1557748|NCT01248416|3810630|P2|COMPLETED|Overall Study||25
1557749|NCT01248416|3810631|P1|COMPLETED|Overall Study||21
1557750|NCT01248416|3810629|P3|STARTED|Overall Study||26
1557751|NCT01248416|3810630|P2|STARTED|Overall Study||25
1557752|NCT01248416|3810631|P1|STARTED|Overall Study||25
1557753|NCT01248364|3810666|P4|NOT COMPLETED|Overall Study||0
1557754|NCT01248364|3810667|P3|NOT COMPLETED|Overall Study||0
1557755|NCT01248364|3810668|P2|NOT COMPLETED|Overall Study||1
1557756|NCT01248364|3810669|P1|NOT COMPLETED|Overall Study||0
1557757|NCT01248364|3810666|P4|COMPLETED|Overall Study||12
1557758|NCT01248364|3810667|P3|COMPLETED|Overall Study||13
1557759|NCT01248364|3810668|P2|COMPLETED|Overall Study||33
1557760|NCT01248364|3810669|P1|COMPLETED|Overall Study||32
1557761|NCT01248364|3810666|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
1557762|NCT01248364|3810667|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
1557763|NCT01248364|3810668|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
1557764|NCT01248364|3810669|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
1557765|NCT01248364|3810666|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
1557766|NCT01248364|3810667|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
1557767|NCT01248364|3810668|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
1557768|NCT01248364|3810669|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
1557769|NCT01248364|3810666|P4|STARTED|Overall Study||12
1557770|NCT01248364|3810667|P3|STARTED|Overall Study||13
1557771|NCT01248364|3810668|P2|STARTED|Overall Study||34
1557772|NCT01248364|3810669|P1|STARTED|Overall Study||32
1557773|NCT01248221|3810717|P2|NOT COMPLETED|Overall Study||0
1557774|NCT01248221|3810718|P1|NOT COMPLETED|Overall Study||0
1557775|NCT01248221|3810717|P2|COMPLETED|Overall Study||15
1557776|NCT01248221|3810718|P1|COMPLETED|Overall Study||15
1557777|NCT01248221|3810717|P2|STARTED|Overall Study||15
1557778|NCT01248221|3810718|P1|STARTED|Overall Study||15
1557779|NCT01248130|3810732|P2|NOT COMPLETED|Overall Study||0
1557780|NCT01248130|3810733|P1|NOT COMPLETED|Overall Study||2
1557781|NCT01248130|3810732|P2|COMPLETED|Overall Study||4
1557782|NCT01248130|3810733|P1|COMPLETED|Overall Study||1
1557783|NCT01248130|3810732|P2|STARTED|Overall Study||4
1557784|NCT01248130|3810733|P1|STARTED|Overall Study||3
1557785|NCT01248065|3810743|P2|NOT COMPLETED|Overall Study||22
1557786|NCT01248065|3810744|P1|NOT COMPLETED|Overall Study||26
1557787|NCT01248065|3810743|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
1557788|NCT01248065|3810744|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
1557789|NCT01248065|3810743|P2|STARTED|Overall Study||201
1557790|NCT01248065|3810744|P1|STARTED|Overall Study||207
1557791|NCT01248013|3810754|P1|NOT COMPLETED|Overall Study||14
1557792|NCT01248013|3810754|P1|COMPLETED|Overall Study||75
1557793|NCT01248013|3810754|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
1557794|NCT01248013|3810754|P1|STARTED|Overall Study||89
1557795|NCT01247974|3810760|P2|NOT COMPLETED|Overall Study||19
1557796|NCT01247974|3810761|P1|NOT COMPLETED|Overall Study||26
1557797|NCT01247974|3810760|P2|COMPLETED|Overall Study||203
1557798|NCT01247974|3810761|P1|COMPLETED|Overall Study||191
1557799|NCT01247974|3810760|P2|STARTED|Overall Study||222
1557800|NCT01247974|3810761|P1|STARTED|Overall Study||217
1557801|NCT01247922|3810769|P1|NOT COMPLETED|Overall Study||4
1557802|NCT01247922|3810769|P1|COMPLETED|Overall Study||0
1557803|NCT01247922|3810769|P1|Treated|Overall Study||4
1557804|NCT01247922|3810769|P1|STARTED|Overall Study||4
1557805|NCT01247675|3810779|P4|NOT COMPLETED|Overall Study||0
1557806|NCT01247675|3810780|P3|NOT COMPLETED|Overall Study||0
1557807|NCT01247675|3810781|P2|NOT COMPLETED|Overall Study||2
1557808|NCT01247675|3810782|P1|NOT COMPLETED|Overall Study||2
1557809|NCT01247675|3810779|P4|COMPLETED|Overall Study||8
1557810|NCT01247675|3810780|P3|COMPLETED|Overall Study||9
1557811|NCT01247675|3810781|P2|COMPLETED|Overall Study||8
1557812|NCT01247675|3810782|P1|COMPLETED|Overall Study||8
1557813|NCT01247675|3810779|P4|STARTED|Overall Study||8
1557814|NCT01247675|3810780|P3|STARTED|Overall Study||9
1557815|NCT01247675|3810781|P2|STARTED|Overall Study||10
1557816|NCT01247675|3810782|P1|STARTED|Overall Study||10
1557817|NCT01247571|3810804|P1|NOT COMPLETED|Overall Study||3
1557818|NCT01247571|3810804|P1|COMPLETED|Overall Study||19
1557819|NCT01247571|3810804|P1|STARTED|Overall Study||22
1557820|NCT01247428|3810812|P1|NOT COMPLETED|Overall Study||0
1557821|NCT01247428|3810812|P1|COMPLETED|Overall Study||30
1557822|NCT01247428|3810812|P1|STARTED|Overall Study||30
1557823|NCT01247363|3810833|P1|NOT COMPLETED|Overall Study||0
1557824|NCT01247363|3810833|P1|COMPLETED|Overall Study||20
1557825|NCT01247363|3810833|P1|STARTED|Overall Study||20
1557826|NCT01247350|3810867|P5|NOT COMPLETED|Overall Study||1
1557827|NCT01247350|3810868|P4|NOT COMPLETED|Overall Study||1
1557828|NCT01247350|3810869|P3|NOT COMPLETED|Overall Study||1
1557829|NCT01247350|3810870|P2|NOT COMPLETED|Overall Study||0
1557830|NCT01247350|3810871|P1|NOT COMPLETED|Overall Study||0
1557831|NCT01247350|3810867|P5|COMPLETED|Overall Study||8
1557832|NCT01247350|3810868|P4|COMPLETED|Overall Study||6
1557833|NCT01247350|3810869|P3|COMPLETED|Overall Study||5
1557834|NCT01247350|3810870|P2|COMPLETED|Overall Study||6
1557835|NCT01247350|3810871|P1|COMPLETED|Overall Study||6
1557836|NCT01247350|3810867|P5|Received Multiple Doses of Study Drug|Overall Study||5
1557837|NCT01247350|3810868|P4|Received Multiple Doses of Study Drug|Overall Study||6
1557838|NCT01247350|3810869|P3|Received Multiple Doses of Study Drug|Overall Study||6
1557839|NCT01247350|3810870|P2|Received Multiple Doses of Study Drug|Overall Study||0
1557840|NCT01247350|3810871|P1|Received Multiple Doses of Study Drug|Overall Study||0
1557841|NCT01247350|3810867|P5|STARTED|Overall Study||9
1557842|NCT01247350|3810868|P4|STARTED|Overall Study||7
1557843|NCT01247350|3810869|P3|STARTED|Overall Study||6
1557844|NCT01247350|3810870|P2|STARTED|Overall Study||6
1557845|NCT01247350|3810871|P1|STARTED|Overall Study||6
1557846|NCT01247324|3810929|P2|NOT COMPLETED|Overall Study||44
1557847|NCT01247324|3810930|P1|NOT COMPLETED|Overall Study||71
1557848|NCT01247324|3810929|P2|COMPLETED|Overall Study||366
1557849|NCT01247324|3810930|P1|COMPLETED|Overall Study||340
1557850|NCT01247324|3810929|P2|STARTED|Overall Study||410
1557851|NCT01247324|3810930|P1|STARTED|Overall Study||411
1557852|NCT01247298|3810961|P1|NOT COMPLETED|Overall Study||0
1557853|NCT01247298|3810961|P1|COMPLETED|Overall Study||17
1557854|NCT01247298|3810961|P1|STARTED|Overall Study||17
1557855|NCT01247285|3810971|P2|NOT COMPLETED|Second Intervention||0
1557856|NCT01247285|3810972|P1|NOT COMPLETED|Second Intervention||0
1557857|NCT01247285|3810971|P2|COMPLETED|Second Intervention||13
1557858|NCT01247285|3810972|P1|COMPLETED|Second Intervention||13
1557859|NCT01247285|3810971|P2|STARTED|Second Intervention||13
1557860|NCT01247285|3810972|P1|STARTED|Second Intervention||13
1557861|NCT01247285|3810971|P2|NOT COMPLETED|Washout of 28 Days||0
1557862|NCT01247285|3810972|P1|NOT COMPLETED|Washout of 28 Days||0
1557863|NCT01247285|3810971|P2|COMPLETED|Washout of 28 Days||13
1557864|NCT01247285|3810972|P1|COMPLETED|Washout of 28 Days||13
1557865|NCT01247285|3810971|P2|STARTED|Washout of 28 Days||13
1557866|NCT01247285|3810972|P1|STARTED|Washout of 28 Days||13
1557867|NCT01247285|3810971|P2|NOT COMPLETED|First Intervention||0
1557868|NCT01247285|3810972|P1|NOT COMPLETED|First Intervention||0
1557869|NCT01247285|3810971|P2|COMPLETED|First Intervention||13
1557870|NCT01247285|3810972|P1|COMPLETED|First Intervention||13
1557871|NCT01247285|3810971|P2|STARTED|First Intervention||13
1557872|NCT01247285|3810972|P1|STARTED|First Intervention||13
1557873|NCT01247272|3810990|P2|NOT COMPLETED|Second Intervention||0
1557874|NCT01247272|3810991|P1|NOT COMPLETED|Second Intervention||0
1557875|NCT01247272|3810990|P2|COMPLETED|Second Intervention||13
1557876|NCT01247272|3810991|P1|COMPLETED|Second Intervention||13
1557877|NCT01247272|3810990|P2|STARTED|Second Intervention||13
1557878|NCT01247272|3810991|P1|STARTED|Second Intervention||13
1557879|NCT01247272|3810990|P2|NOT COMPLETED|Washout of 28 Days||0
1557880|NCT01247272|3810991|P1|NOT COMPLETED|Washout of 28 Days||0
1557881|NCT01247272|3810990|P2|COMPLETED|Washout of 28 Days||13
1557882|NCT01247272|3810991|P1|COMPLETED|Washout of 28 Days||13
1557883|NCT01247272|3810990|P2|STARTED|Washout of 28 Days||13
1557884|NCT01247272|3810991|P1|STARTED|Washout of 28 Days||13
1557885|NCT01247272|3810990|P2|NOT COMPLETED|First Intervention||0
1557886|NCT01247272|3810991|P1|NOT COMPLETED|First Intervention||0
1557887|NCT01247272|3810990|P2|COMPLETED|First Intervention||13
1557888|NCT01247272|3810991|P1|COMPLETED|First Intervention||13
1557889|NCT01247272|3810990|P2|STARTED|First Intervention||13
1557890|NCT01247272|3810991|P1|STARTED|First Intervention||13
1557891|NCT01247220|3811009|P2|NOT COMPLETED|Overall Study||0
1557892|NCT01247220|3811010|P1|NOT COMPLETED|Overall Study||0
1557893|NCT01247220|3811009|P2|COMPLETED|Overall Study||6
1557894|NCT01247220|3811010|P1|COMPLETED|Overall Study||6
1557895|NCT01247220|3811009|P2|STARTED|Overall Study||6
1557896|NCT01247220|3811010|P1|STARTED|Overall Study||6
1557897|NCT01247090|3811023|P3|NOT COMPLETED|Overall Study||0
1557898|NCT01247090|3811024|P2|NOT COMPLETED|Overall Study||1
1557899|NCT01247090|3811025|P1|NOT COMPLETED|Overall Study||1
1557900|NCT01247090|3811023|P3|COMPLETED|Overall Study||4
1557901|NCT01247090|3811024|P2|COMPLETED|Overall Study||3
1557902|NCT01247090|3811025|P1|COMPLETED|Overall Study||3
1557903|NCT01247090|3811023|P3|STARTED|Overall Study||4
1557904|NCT01247090|3811024|P2|STARTED|Overall Study||4
1557905|NCT01247090|3811025|P1|STARTED|Overall Study||4
1557906|NCT01247064|3811035|P2|NOT COMPLETED|Overall Study||0
1557907|NCT01247064|3811036|P1|NOT COMPLETED|Overall Study||0
1557908|NCT01247064|3811035|P2|COMPLETED|Overall Study||31
1557909|NCT01247064|3811036|P1|COMPLETED|Overall Study||31
1557910|NCT01247064|3811035|P2|STARTED|Overall Study||31
1557911|NCT01247064|3811036|P1|STARTED|Overall Study||31
1557912|NCT01246999|3811054|P4|NOT COMPLETED|Overall Study||2
1557913|NCT01246999|3811055|P3|NOT COMPLETED|Overall Study||0
1557914|NCT01246999|3811056|P2|NOT COMPLETED|Overall Study||1
1557915|NCT01246999|3811057|P1|NOT COMPLETED|Overall Study||0
1557916|NCT01246999|3811054|P4|COMPLETED|Overall Study||15
1557917|NCT01246999|3811055|P3|COMPLETED|Overall Study||2
1557918|NCT01246999|3811056|P2|COMPLETED|Overall Study||3
1557919|NCT01246999|3811057|P1|COMPLETED|Overall Study||11
1557920|NCT01246999|3811054|P4|STARTED|Overall Study||17
1557921|NCT01246999|3811055|P3|STARTED|Overall Study||2
1557922|NCT01246999|3811056|P2|STARTED|Overall Study||4
1557923|NCT01246999|3811057|P1|STARTED|Overall Study||11
1557924|NCT01246973|3811092|P2|NOT COMPLETED|Overall Study||47
1557925|NCT01246973|3811093|P1|NOT COMPLETED|Overall Study||61
1557926|NCT01246973|3811092|P2|COMPLETED|Overall Study||295
1557927|NCT01246973|3811093|P1|COMPLETED|Overall Study||283
1557928|NCT01246973|3811092|P2|STARTED|Overall Study||342
1557929|NCT01246973|3811093|P1|STARTED|Overall Study||344
1557930|NCT01246960|3811103|P2|NOT COMPLETED|Overall Study||4
1557931|NCT01246960|3811104|P1|NOT COMPLETED|Overall Study||6
1557932|NCT01246960|3811103|P2|COMPLETED|Overall Study||80
1557933|NCT01246960|3811104|P1|COMPLETED|Overall Study||78
1557934|NCT01246960|3811103|P2|Received Any Quantity of Study Drug|Overall Study||80
1557935|NCT01246960|3811104|P1|Received Any Quantity of Study Drug|Overall Study||82
1557936|NCT01246960|3811103|P2|STARTED|Overall Study||84
1557937|NCT01246960|3811104|P1|STARTED|Overall Study||84
1557938|NCT01246895|3811124|P2|NOT COMPLETED|Overall Study||4
1557939|NCT01246895|3811125|P1|NOT COMPLETED|Overall Study||3
1557940|NCT01246895|3811124|P2|COMPLETED|Overall Study||26
1557941|NCT01246895|3811125|P1|COMPLETED|Overall Study||34
1557942|NCT01246895|3811124|P2|STARTED|Overall Study||30
1557943|NCT01246895|3811125|P1|STARTED|Overall Study||37
1557944|NCT01246791|3811139|P1|NOT COMPLETED|Overall Study||0
1557945|NCT01246791|3811139|P1|COMPLETED|Overall Study||12
1557946|NCT01246791|3811139|P1|STARTED|Overall Study||12
1557947|NCT01246713|3811154|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
1557948|NCT01246713|3811155|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
1557949|NCT01246713|3811154|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
1557950|NCT01246713|3811155|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
1557951|NCT01246713|3811154|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
1557952|NCT01246713|3811155|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
1557953|NCT01246713|3811154|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
1557954|NCT01246713|3811155|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
1557955|NCT01246713|3811154|P2|COMPLETED|Washout (at Least 14 Days)||9
1557956|NCT01246713|3811155|P1|COMPLETED|Washout (at Least 14 Days)||6
1557957|NCT01246713|3811154|P2|STARTED|Washout (at Least 14 Days)||9
1557958|NCT01246713|3811155|P1|STARTED|Washout (at Least 14 Days)||6
1557959|NCT01246713|3811154|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
1557960|NCT01246713|3811155|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
1557961|NCT01246713|3811154|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
1557962|NCT01246713|3811155|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
1557963|NCT01246713|3811154|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
1557964|NCT01246713|3811155|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
1557965|NCT01246479|3811161|P1|NOT COMPLETED|Overall Study||5
1557966|NCT01246479|3811161|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
1557967|NCT01246479|3811161|P1|STARTED|Overall Study||23
1557968|NCT01246401|3811167|P2|NOT COMPLETED|Overall Study||0
1557969|NCT01246401|3811168|P1|NOT COMPLETED|Overall Study||0
1557970|NCT01246401|3811167|P2|COMPLETED|Overall Study||27
1557971|NCT01246401|3811168|P1|COMPLETED|Overall Study||66
1557972|NCT01246401|3811167|P2|STARTED|Overall Study||27
1557973|NCT01246401|3811168|P1|STARTED|Overall Study||66
1557974|NCT01246349|3811194|P2|NOT COMPLETED|Overall Study||0
1557975|NCT01246349|3811195|P1|NOT COMPLETED|Overall Study||0
1557976|NCT01246349|3811194|P2|COMPLETED|Overall Study||20
1557977|NCT01246349|3811195|P1|COMPLETED|Overall Study||20
1557978|NCT01246349|3811194|P2|STARTED|Overall Study||20
1557979|NCT01246349|3811195|P1|STARTED|Overall Study||20
1557980|NCT01246258|3811207|P1|NOT COMPLETED|Overall Study||0
1557981|NCT01246258|3811207|P1|COMPLETED|Overall Study||5
1557982|NCT01246258|3811207|P1|STARTED|Overall Study||5
1557983|NCT01246206|3811212|P1|NOT COMPLETED|Overall Study||1
1557984|NCT01246206|3811212|P1|COMPLETED|Overall Study||20
1557985|NCT01246206|3811212|P1|STARTED|Overall Study||21
1557986|NCT01246076|3811223|P1|NOT COMPLETED|Overall Study||0
1557987|NCT01246076|3811223|P1|COMPLETED|Overall Study||24
1557988|NCT01246076|3811223|P1|STARTED|Overall Study||24
1557989|NCT01246011|3811235|P3|NOT COMPLETED|Overall Study||4
1557990|NCT01246011|3811236|P2|NOT COMPLETED|Overall Study||0
1557991|NCT01246011|3811237|P1|NOT COMPLETED|Overall Study||0
1557992|NCT01246011|3811235|P3|COMPLETED|Overall Study||5
1557993|NCT01246011|3811236|P2|COMPLETED|Overall Study||0
1557994|NCT01246011|3811237|P1|COMPLETED|Overall Study||0
1557995|NCT01246011|3811235|P3|STARTED|Overall Study||9
1557996|NCT01246011|3811236|P2|STARTED|Overall Study||0
1557997|NCT01246011|3811237|P1|STARTED|Overall Study||0
1557998|NCT01245764|3811252|P4|NOT COMPLETED|Study Phase B||0
1557999|NCT01245764|3811253|P3|NOT COMPLETED|Study Phase B||0
1558000|NCT01245764|3811254|P2|NOT COMPLETED|Study Phase B||0
1558001|NCT01245764|3811255|P1|NOT COMPLETED|Study Phase B||0
1558002|NCT01245764|3811252|P4|COMPLETED|Study Phase B||17
1558003|NCT01245764|3811253|P3|COMPLETED|Study Phase B||0
1558004|NCT01245764|3811254|P2|COMPLETED|Study Phase B||0
1558005|NCT01245764|3811255|P1|COMPLETED|Study Phase B||0
1558006|NCT01245764|3811252|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
1558007|NCT01245764|3811253|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
1558008|NCT01245764|3811254|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
1558009|NCT01245764|3811255|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
1558010|NCT01245764|3811252|P4|STARTED|Study Phase B||17
1558011|NCT01245764|3811253|P3|STARTED|Study Phase B||0
1558012|NCT01245764|3811254|P2|STARTED|Study Phase B||0
1558013|NCT01245764|3811255|P1|STARTED|Study Phase B||0
1558014|NCT01245764|3811252|P4|NOT COMPLETED|Study Phase A||3
1558015|NCT01245764|3811253|P3|NOT COMPLETED|Study Phase A||10
1558016|NCT01245764|3811254|P2|NOT COMPLETED|Study Phase A||5
1558017|NCT01245764|3811255|P1|NOT COMPLETED|Study Phase A||9
1558018|NCT01245764|3811252|P4|COMPLETED|Study Phase A||17
1558019|NCT01245764|3811253|P3|COMPLETED|Study Phase A||110
1558020|NCT01245764|3811254|P2|COMPLETED|Study Phase A||25
1558021|NCT01245764|3811255|P1|COMPLETED|Study Phase A||71
1558022|NCT01245764|3811252|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
1558023|NCT01245764|3811253|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
1558024|NCT01245764|3811254|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
1558025|NCT01245764|3811255|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
1558026|NCT01245764|3811252|P4|STARTED|Study Phase A||20
1558027|NCT01245764|3811253|P3|STARTED|Study Phase A||120
1558028|NCT01245764|3811254|P2|STARTED|Study Phase A||30
1558029|NCT01245764|3811255|P1|STARTED|Study Phase A||80
1558030|NCT01245751|3811293|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1558031|NCT01245751|3811294|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1558032|NCT01245751|3811295|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1558033|NCT01245751|3811296|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1558034|NCT01245751|3811293|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1558035|NCT01245751|3811294|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1558036|NCT01245751|3811295|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
1558037|NCT01245751|3811296|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
1558038|NCT01245751|3811293|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
1558039|NCT01245751|3811294|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
1558040|NCT01245751|3811295|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
1558041|NCT01245751|3811296|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
1558042|NCT01245751|3811293|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
1558043|NCT01245751|3811294|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
1558044|NCT01245751|3811295|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
1558045|NCT01245751|3811296|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
1558046|NCT01245751|3811293|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
1558047|NCT01245751|3811294|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
1558048|NCT01245751|3811295|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
1558049|NCT01245751|3811296|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
1558050|NCT01245751|3811293|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
1558051|NCT01245751|3811294|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
1558052|NCT01245751|3811295|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
1558053|NCT01245751|3811296|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
1558054|NCT01245751|3811293|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
1558055|NCT01245751|3811294|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
1558056|NCT01245751|3811295|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
1558057|NCT01245751|3811296|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
1558058|NCT01245738|3811309|P1|NOT COMPLETED|Overall Study||40
1558059|NCT01245738|3811309|P1|COMPLETED|Overall Study||474
1558060|NCT01245738|3811309|P1|STARTED|Overall Study||514
1558061|NCT01245647|3811328|P2|NOT COMPLETED|Overall Study||4
1558062|NCT01245647|3811329|P1|NOT COMPLETED|Overall Study||0
1558063|NCT01245647|3811328|P2|COMPLETED|Overall Study||8
1558064|NCT01245647|3811329|P1|COMPLETED|Overall Study||7
1558065|NCT01245647|3811328|P2|STARTED|Overall Study||12
1558066|NCT01245647|3811329|P1|STARTED|Overall Study||7
1558067|NCT01245595|3811345|P2|NOT COMPLETED|Overall Study||0
1558068|NCT01245595|3811346|P1|NOT COMPLETED|Overall Study||0
1558069|NCT01245595|3811345|P2|COMPLETED|Overall Study||72
1558070|NCT01245595|3811346|P1|COMPLETED|Overall Study||72
1558071|NCT01245595|3811345|P2|Completed Full Course of Study Drug|Overall Study||61
1558072|NCT01245595|3811346|P1|Completed Full Course of Study Drug|Overall Study||57
1558073|NCT01245595|3811345|P2|STARTED|Overall Study||72
1558074|NCT01245595|3811346|P1|STARTED|Overall Study||72
1558075|NCT01245439|3811352|P1|NOT COMPLETED|Overall Study||0
1558076|NCT01245439|3811352|P1|COMPLETED|Overall Study||65
1558077|NCT01245439|3811352|P1|STARTED|Overall Study||65
1558078|NCT01245413|3811383|P2|NOT COMPLETED|Athena First,||0
1558079|NCT01245413|3811384|P1|NOT COMPLETED|Athena First,||0
1558080|NCT01245413|3811383|P2|COMPLETED|Athena First,||16
1558081|NCT01245413|3811384|P1|COMPLETED|Athena First,||16
1558082|NCT01245413|3811383|P2|STARTED|Athena First,||16
1558083|NCT01245413|3811384|P1|STARTED|Athena First,||16
1558084|NCT01245413|3811383|P2|NOT COMPLETED|Sensura First,||0
1558085|NCT01245413|3811384|P1|NOT COMPLETED|Sensura First,||0
1558086|NCT01245413|3811383|P2|COMPLETED|Sensura First,||16
1558087|NCT01245413|3811384|P1|COMPLETED|Sensura First,||16
1558088|NCT01245413|3811383|P2|STARTED|Sensura First,||16
1558089|NCT01245413|3811384|P1|STARTED|Sensura First,||16
1558090|NCT01245387|3811390|P1|NOT COMPLETED|Overall Study||813
1558091|NCT01245387|3811390|P1|COMPLETED|Overall Study||188
1558092|NCT01245387|3811390|P1|STARTED|Overall Study||1001
1558093|NCT01245374|3811439|P1|NOT COMPLETED|Overall Study||4
1558094|NCT01245374|3811439|P1|COMPLETED|Overall Study||99
1558095|NCT01245374|3811439|P1|STARTED|Overall Study||103
1558096|NCT01245283|3811462|P3|NOT COMPLETED|Overall Study||11
1558097|NCT01245283|3811463|P2|NOT COMPLETED|Overall Study||11
1558098|NCT01245283|3811464|P1|NOT COMPLETED|Overall Study||14
1558099|NCT01245283|3811462|P3|COMPLETED|Overall Study||19
1558100|NCT01245283|3811463|P2|COMPLETED|Overall Study||17
1558101|NCT01245283|3811464|P1|COMPLETED|Overall Study||18
1558102|NCT01245283|3811462|P3|STARTED|Overall Study||30
1558103|NCT01245283|3811463|P2|STARTED|Overall Study||28
1558104|NCT01245283|3811464|P1|STARTED|Overall Study||32
1558105|NCT01245270|3811498|P2|NOT COMPLETED|Overall Study||0
1558106|NCT01245270|3811499|P1|NOT COMPLETED|Overall Study||0
1558107|NCT01245270|3811498|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1558108|NCT01245270|3811499|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1558109|NCT01245270|3811498|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1558110|NCT01245270|3811499|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1558111|NCT01245140|3811509|P2|NOT COMPLETED|Overall Study||10
1558112|NCT01245140|3811510|P1|NOT COMPLETED|Overall Study||3
1558113|NCT01245140|3811509|P2|COMPLETED|Overall Study||14
1558114|NCT01245140|3811510|P1|COMPLETED|Overall Study||6
1558115|NCT01245140|3811509|P2|STARTED|Overall Study||24
1558116|NCT01245140|3811510|P1|STARTED|Overall Study||9
1558117|NCT01245101|3811566|P2|NOT COMPLETED|Period 3 (Treatment)||0
1558118|NCT01245101|3811567|P1|NOT COMPLETED|Period 3 (Treatment)||1
1558119|NCT01245101|3811566|P2|COMPLETED|Period 3 (Treatment)||0
1558120|NCT01245101|3811567|P1|COMPLETED|Period 3 (Treatment)||11
1558121|NCT01245101|3811566|P2|STARTED|Period 3 (Treatment)||0
1558122|NCT01245101|3811567|P1|STARTED|Period 3 (Treatment)||12
1558123|NCT01245101|3811566|P2|NOT COMPLETED|Period 2 (Washout)||0
1558124|NCT01245101|3811567|P1|NOT COMPLETED|Period 2 (Washout)||1
1558125|NCT01245101|3811566|P2|COMPLETED|Period 2 (Washout)||0
1558126|NCT01245101|3811567|P1|COMPLETED|Period 2 (Washout)||12
1558127|NCT01245101|3811566|P2|STARTED|Period 2 (Washout)||0
1558128|NCT01245101|3811567|P1|STARTED|Period 2 (Washout)||13
1558129|NCT01245101|3811566|P2|NOT COMPLETED|Period 1 (Treatment)||0
1558130|NCT01245101|3811567|P1|NOT COMPLETED|Period 1 (Treatment)||2
1558131|NCT01245101|3811566|P2|COMPLETED|Period 1 (Treatment)||0
1558132|NCT01245101|3811567|P1|COMPLETED|Period 1 (Treatment)||13
1558133|NCT01245101|3811566|P2|STARTED|Period 1 (Treatment)||0
1558134|NCT01245101|3811567|P1|STARTED|Period 1 (Treatment)||15
1558135|NCT01245062|3811577|P3|NOT COMPLETED|Cross-over Phase||17
1558136|NCT01245062|3811578|P2|NOT COMPLETED|Cross-over Phase||0
1558137|NCT01245062|3811579|P1|NOT COMPLETED|Cross-over Phase||0
1558138|NCT01245062|3811577|P3|COMPLETED|Cross-over Phase||53
1558139|NCT01245062|3811578|P2|COMPLETED|Cross-over Phase||0
1558140|NCT01245062|3811579|P1|COMPLETED|Cross-over Phase||0
1558141|NCT01245062|3811577|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
1558142|NCT01245062|3811578|P2|STARTED|Cross-over Phase||0
1558143|NCT01245062|3811579|P1|STARTED|Cross-over Phase||0
1558144|NCT01245062|3811577|P3|NOT COMPLETED|Randomization and Crossover Phase||0
1558145|NCT01245062|3811578|P2|NOT COMPLETED|Randomization and Crossover Phase||31
1558146|NCT01245062|3811579|P1|NOT COMPLETED|Randomization and Crossover Phase||41
1558147|NCT01245062|3811577|P3|COMPLETED|Randomization and Crossover Phase||0
1558148|NCT01245062|3811578|P2|COMPLETED|Randomization and Crossover Phase||77
1558149|NCT01245062|3811579|P1|COMPLETED|Randomization and Crossover Phase||173
1558150|NCT01245062|3811577|P3|STARTED|Randomization and Crossover Phase||0
1558151|NCT01245062|3811578|P2|STARTED|Randomization and Crossover Phase||108
1558152|NCT01245062|3811579|P1|STARTED|Randomization and Crossover Phase||214
1558153|NCT01245049|3811617|P2|NOT COMPLETED|Overall Study||4
1558154|NCT01245049|3811618|P1|NOT COMPLETED|Overall Study||1
1558155|NCT01245049|3811617|P2|COMPLETED|Overall Study||126
1558156|NCT01245049|3811618|P1|COMPLETED|Overall Study||254
1558157|NCT01245049|3811617|P2|STARTED|Overall Study||130
1558158|NCT01245049|3811618|P1|STARTED|Overall Study||255
1558159|NCT01244984|3811671|P3|NOT COMPLETED|Overall Study||4
1558160|NCT01244984|3811672|P2|NOT COMPLETED|Overall Study||14
1558161|NCT01244984|3811673|P1|NOT COMPLETED|Overall Study||5
1558162|NCT01244984|3811671|P3|COMPLETED|Overall Study||86
1558163|NCT01244984|3811672|P2|COMPLETED|Overall Study||79
1558164|NCT01244984|3811673|P1|COMPLETED|Overall Study||55
1558165|NCT01244984|3811671|P3|STARTED|Overall Study||90
1558166|NCT01244984|3811672|P2|STARTED|Overall Study||93
1558167|NCT01244984|3811673|P1|STARTED|Overall Study||60
1558168|NCT01244906|3811747|P1|NOT COMPLETED|Overall Study||8
1558169|NCT01244906|3811747|P1|COMPLETED|Overall Study||18
1558170|NCT01244906|3811747|P1|STARTED|Overall Study||26
1558171|NCT01244893|3811756|P2|NOT COMPLETED|Final Visit||0
1558172|NCT01244893|3811757|P1|NOT COMPLETED|Final Visit||0
1558173|NCT01244893|3811756|P2|COMPLETED|Final Visit||21
1558174|NCT01244893|3811757|P1|COMPLETED|Final Visit||21
1558175|NCT01244893|3811756|P2|STARTED|Final Visit||21
1558176|NCT01244893|3811757|P1|STARTED|Final Visit||21
1558177|NCT01244893|3811756|P2|NOT COMPLETED|1-Week Follow Up||0
1558178|NCT01244893|3811757|P1|NOT COMPLETED|1-Week Follow Up||1
1558179|NCT01244893|3811756|P2|COMPLETED|1-Week Follow Up||21
1558180|NCT01244893|3811757|P1|COMPLETED|1-Week Follow Up||21
1558181|NCT01244893|3811756|P2|STARTED|1-Week Follow Up||21
1558182|NCT01244893|3811757|P1|STARTED|1-Week Follow Up||22
1558183|NCT01244893|3811756|P2|NOT COMPLETED|Baseline||1
1558184|NCT01244893|3811757|P1|NOT COMPLETED|Baseline||0
1558185|NCT01244893|3811756|P2|COMPLETED|Baseline||21
1558186|NCT01244893|3811757|P1|COMPLETED|Baseline||22
1558187|NCT01244893|3811756|P2|STARTED|Baseline||22
1558188|NCT01244893|3811757|P1|STARTED|Baseline||22
1558189|NCT01244828|3811769|P1|NOT COMPLETED|Overall Study||78
1558190|NCT01244828|3811769|P1|COMPLETED|Overall Study||79
1558191|NCT01244828|3811769|P1|STARTED|Overall Study|Received study drug|157
1558192|NCT01244815|3811785|P4|NOT COMPLETED|Overall Study||12
1558193|NCT01244815|3811786|P3|NOT COMPLETED|Overall Study||11
1558194|NCT01244815|3811787|P2|NOT COMPLETED|Overall Study||17
1558195|NCT01244815|3811788|P1|NOT COMPLETED|Overall Study||14
1558196|NCT01244815|3811785|P4|COMPLETED|Overall Study||87
1558197|NCT01244815|3811786|P3|COMPLETED|Overall Study||88
1558198|NCT01244815|3811787|P2|COMPLETED|Overall Study||88
1558199|NCT01244815|3811788|P1|COMPLETED|Overall Study||87
1558200|NCT01244815|3811785|P4|Treated|Overall Study||99
1558201|NCT01244815|3811786|P3|Treated|Overall Study||99
1558202|NCT01244815|3811787|P2|Treated|Overall Study||104
1558203|NCT01244815|3811788|P1|Treated|Overall Study||101
1558204|NCT01244815|3811785|P4|STARTED|Overall Study|Randomized|99
1558205|NCT01244815|3811786|P3|STARTED|Overall Study|Randomized|99
1558206|NCT01244815|3811787|P2|STARTED|Overall Study|Randomized|105
1558207|NCT01244815|3811788|P1|STARTED|Overall Study|Randomized|101
1558208|NCT01244724|3811862|P1|NOT COMPLETED|Overall Study||8
1558209|NCT01244724|3811862|P1|COMPLETED|Overall Study||9
1558210|NCT01244724|3811862|P1|Week 2 Visit|Overall Study||15
1558211|NCT01244724|3811862|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
1558212|NCT01244711|3811867|P1|NOT COMPLETED|Overall Study||0
1558213|NCT01244711|3811867|P1|COMPLETED|Overall Study||1
1558214|NCT01244711|3811867|P1|STARTED|Overall Study||1
1558215|NCT01244633|3811871|P1|NOT COMPLETED|Overall Study||3
1558216|NCT01244633|3811871|P1|COMPLETED|Overall Study||15
1558217|NCT01244633|3811871|P1|STARTED|Overall Study||18
1558218|NCT01244620|3811875|P4|NOT COMPLETED|Overall Study||4
1558219|NCT01244620|3811876|P3|NOT COMPLETED|Overall Study||4
1558220|NCT01244620|3811877|P2|NOT COMPLETED|Overall Study||4
1558221|NCT01244620|3811878|P1|NOT COMPLETED|Overall Study||4
1558222|NCT01244620|3811875|P4|COMPLETED|Overall Study||0
1558223|NCT01244620|3811876|P3|COMPLETED|Overall Study||0
1558224|NCT01244620|3811877|P2|COMPLETED|Overall Study||0
1558225|NCT01244620|3811878|P1|COMPLETED|Overall Study||0
1558226|NCT01244620|3811875|P4|STARTED|Overall Study||4
1558227|NCT01244620|3811876|P3|STARTED|Overall Study||4
1558228|NCT01244620|3811877|P2|STARTED|Overall Study||4
1558229|NCT01244620|3811878|P1|STARTED|Overall Study||4
1558230|NCT01244529|3811912|P1|NOT COMPLETED|Overall Study||0
1558231|NCT01244529|3811912|P1|COMPLETED|Overall Study||41
1558232|NCT01244529|3811912|P1|STARTED|Overall Study||41
1558233|NCT01244516|3811937|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
1558234|NCT01244516|3811938|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
1558235|NCT01244516|3811939|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
1558236|NCT01244516|3811937|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
1558237|NCT01244516|3811938|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
1558238|NCT01244516|3811939|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
1558239|NCT01244516|3811937|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
1558240|NCT01244516|3811938|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
1558241|NCT01244516|3811939|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
1558242|NCT01244516|3811937|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
1558243|NCT01244516|3811938|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
1558244|NCT01244516|3811939|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
1558245|NCT01244516|3811937|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
1558246|NCT01244516|3811938|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
1558247|NCT01244516|3811939|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
1558248|NCT01244516|3811937|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
1558249|NCT01244516|3811938|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
1558250|NCT01244516|3811939|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
1558251|NCT01244503|3811952|P1|NOT COMPLETED|Overall Study||0
1558252|NCT01244503|3811952|P1|COMPLETED|Overall Study||61
1558253|NCT01244503|3811952|P1|STARTED|Overall Study||61
1558254|NCT01244490|3811960|P3|NOT COMPLETED|Overall Study||23
1558255|NCT01244490|3811961|P2|NOT COMPLETED|Overall Study||24
1558256|NCT01244490|3811962|P1|NOT COMPLETED|Overall Study||19
1558257|NCT01244490|3811960|P3|COMPLETED|Overall Study||89
1558258|NCT01244490|3811961|P2|COMPLETED|Overall Study||91
1558259|NCT01244490|3811962|P1|COMPLETED|Overall Study||92
1558260|NCT01244490|3811960|P3|STARTED|Overall Study||112
1558261|NCT01244490|3811961|P2|STARTED|Overall Study||115
1558262|NCT01244490|3811962|P1|STARTED|Overall Study||111
1558263|NCT01244477|3812017|P2|NOT COMPLETED|Overall Study||3
1558264|NCT01244477|3812018|P1|NOT COMPLETED|Overall Study||20
1558265|NCT01244477|3812017|P2|COMPLETED|Overall Study||20
1558266|NCT01244477|3812018|P1|COMPLETED|Overall Study||18
1558267|NCT01244477|3812017|P2|STARTED|Overall Study||23
1558268|NCT01244477|3812018|P1|STARTED|Overall Study||38
1558269|NCT01244425|3812030|P2|NOT COMPLETED|Overall Study||3
1558270|NCT01244425|3812031|P1|NOT COMPLETED|Overall Study||3
1558271|NCT01244425|3812030|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
1558272|NCT01244425|3812031|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
1558273|NCT01244425|3812030|P2|STARTED|Overall Study||35
1558274|NCT01244425|3812031|P1|STARTED|Overall Study||35
1558275|NCT01244412|3812051|P1|NOT COMPLETED|Overall Study||0
1558276|NCT01244412|3812051|P1|COMPLETED|Overall Study||1
1558277|NCT01244412|3812051|P1|STARTED|Overall Study||1
1558278|NCT01244243|3812055|P1|NOT COMPLETED|Overall Study||0
1558279|NCT01244243|3812055|P1|COMPLETED|Overall Study||41
1558280|NCT01244243|3812055|P1|STARTED|Overall Study||41
1558281|NCT01244126|3812063|P3|NOT COMPLETED|Overall Study||9
1558282|NCT01244126|3812064|P2|NOT COMPLETED|Overall Study||3
1558283|NCT01244126|3812065|P1|NOT COMPLETED|Overall Study||3
1558284|NCT01244126|3812063|P3|COMPLETED|Overall Study||48
1558285|NCT01244126|3812064|P2|COMPLETED|Overall Study||52
1558286|NCT01244126|3812065|P1|COMPLETED|Overall Study||56
1558287|NCT01244126|3812063|P3|STARTED|Overall Study||57
1558288|NCT01244126|3812064|P2|STARTED|Overall Study||55
1558289|NCT01244126|3812065|P1|STARTED|Overall Study||59
1558290|NCT01244061|3812078|P2|NOT COMPLETED|Overall Study||103
1558291|NCT01244061|3812079|P1|NOT COMPLETED|Overall Study||82
1558292|NCT01244061|3812078|P2|COMPLETED|Overall Study||144
1558293|NCT01244061|3812079|P1|COMPLETED|Overall Study||169
1558294|NCT01244061|3812078|P2|STARTED|Overall Study||247
1558295|NCT01244061|3812079|P1|STARTED|Overall Study||251
1558296|NCT01243957|3812091|P1|NOT COMPLETED|Overall Study||0
1558297|NCT01243957|3812091|P1|COMPLETED|Overall Study||20
1558298|NCT01243957|3812091|P1|STARTED|Overall Study||20
1558299|NCT01243944|3812104|P2|NOT COMPLETED|Overall Study||108
1558300|NCT01243944|3812105|P1|NOT COMPLETED|Overall Study||17
1558301|NCT01243944|3812104|P2|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|3
1558302|NCT01243944|3812105|P1|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|93
1558303|NCT01243944|3812104|P2|STARTED|Overall Study|One subject withdrew consent 5 days after randomization to BAT arm and wasn't treated while on study|111
1558304|NCT01243944|3812105|P1|STARTED|Overall Study||110
1558305|NCT01243892|3812129|P2|NOT COMPLETED|Overall Study||0
1558306|NCT01243892|3812130|P1|NOT COMPLETED|Overall Study||2
1558307|NCT01243892|3812129|P2|COMPLETED|Overall Study||3
1558308|NCT01243892|3812130|P1|COMPLETED|Overall Study||13
1558309|NCT01243892|3812129|P2|STARTED|Overall Study||3
1558310|NCT01243892|3812130|P1|STARTED|Overall Study||15
1558311|NCT01243775|3812140|P1|NOT COMPLETED|Overall Study||2
1558312|NCT01243775|3812140|P1|COMPLETED|Overall Study||31
1558313|NCT01243775|3812140|P1|STARTED|Overall Study||33
1558314|NCT01243762|3812154|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
1558315|NCT01243762|3812155|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1558316|NCT01243762|3812156|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
1558317|NCT01243762|3812157|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
1558318|NCT01243762|3812158|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1558319|NCT01243762|3812159|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
1558320|NCT01243762|3812160|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
1558321|NCT01243762|3812154|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1558322|NCT01243762|3812155|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1558323|NCT01243762|3812156|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1558324|NCT01243762|3812157|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1558325|NCT01243762|3812158|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1558326|NCT01243762|3812159|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1558327|NCT01243762|3812160|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1558328|NCT01243762|3812154|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
1558329|NCT01243762|3812155|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
1558330|NCT01243762|3812156|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
1558331|NCT01243762|3812157|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
1558332|NCT01243762|3812158|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
1558333|NCT01243762|3812159|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
1558334|NCT01243762|3812160|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
1558335|NCT01243762|3812154|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
1558336|NCT01243762|3812155|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
1558337|NCT01243762|3812156|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
1558338|NCT01243762|3812157|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
1558339|NCT01243762|3812158|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
1558340|NCT01243762|3812159|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
1558341|NCT01243762|3812160|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
1558342|NCT01243762|3812154|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
1558343|NCT01243762|3812155|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
1558344|NCT01243762|3812156|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
1558345|NCT01243762|3812157|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
1558346|NCT01243762|3812158|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
1558347|NCT01243762|3812159|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
1558348|NCT01243762|3812160|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
1558349|NCT01243762|3812154|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
1558350|NCT01243762|3812155|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
1558351|NCT01243762|3812156|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
1558352|NCT01243762|3812157|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
1558353|NCT01243762|3812158|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
1558354|NCT01243762|3812159|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
1558355|NCT01243762|3812160|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
1558356|NCT01243671|3812179|P1|NOT COMPLETED|Overall Study||5
1558357|NCT01243671|3812179|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
1558358|NCT01243671|3812179|P1|Completed 52 Weeks of Treatment|Overall Study||17
1558359|NCT01243671|3812179|P1|Completed 24 Weeks of Treatment|Overall Study||18
1558360|NCT01243671|3812179|P1|STARTED|Overall Study||20
1558361|NCT01243619|3812192|P1|NOT COMPLETED|Overall Study||0
1558362|NCT01243619|3812192|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
1558363|NCT01243619|3812192|P1|STARTED|Overall Study||5
1558364|NCT01243580|3812198|P2|NOT COMPLETED|Overall Study||2
1558365|NCT01243580|3812199|P1|NOT COMPLETED|Overall Study||0
1558366|NCT01243580|3812198|P2|COMPLETED|Overall Study||16
1558367|NCT01243580|3812199|P1|COMPLETED|Overall Study||18
1558368|NCT01243580|3812198|P2|STARTED|Overall Study||18
1558369|NCT01243580|3812199|P1|STARTED|Overall Study||18
1558370|NCT01243567|3812228|P2|NOT COMPLETED|Overall Study||0
1558371|NCT01243567|3812229|P1|NOT COMPLETED|Overall Study||1
1558372|NCT01243567|3812228|P2|COMPLETED|Overall Study||38
1558373|NCT01243567|3812229|P1|COMPLETED|Overall Study||42
1558374|NCT01243567|3812228|P2|STARTED|Overall Study||38
1558375|NCT01243567|3812229|P1|STARTED|Overall Study||43
1558376|NCT01243450|3812246|P3|NOT COMPLETED|Overall Study||67
1558377|NCT01243450|3812247|P2|NOT COMPLETED|Overall Study||25
1558378|NCT01243450|3812248|P1|NOT COMPLETED|Overall Study||83
1558379|NCT01243450|3812246|P3|COMPLETED|Overall Study||337
1558380|NCT01243450|3812247|P2|COMPLETED|Overall Study||110
1558381|NCT01243450|3812248|P1|COMPLETED|Overall Study||318
1558382|NCT01243450|3812246|P3|STARTED|Overall Study||404
1558383|NCT01243450|3812247|P2|STARTED|Overall Study||135
1558384|NCT01243450|3812248|P1|STARTED|Overall Study||401
1558385|NCT01243411|3812256|P1|NOT COMPLETED|Overall Study||41
1558386|NCT01243411|3812256|P1|COMPLETED|Overall Study||306
1558387|NCT01243411|3812256|P1|STARTED|Overall Study||347
1558388|NCT01243320|3812268|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
1558389|NCT01243320|3812268|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
1558390|NCT01243320|3812268|P1|STARTED|32ppm Oral Silver (14 Days)||24
1558391|NCT01243320|3812268|P1|NOT COMPLETED|Washout (3 Days)||0
1558392|NCT01243320|3812268|P1|COMPLETED|Washout (3 Days)||36
1558393|NCT01243320|3812268|P1|STARTED|Washout (3 Days)||36
1558394|NCT01243320|3812268|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
1558395|NCT01243320|3812268|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
1558396|NCT01243320|3812268|P1|STARTED|10ppm Oral Silver (14 Days)||36
1558397|NCT01243320|3812268|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
1558398|NCT01243320|3812268|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
1558399|NCT01243320|3812268|P1|STARTED|10ppm Oral Silver (7 Days)||36
1558400|NCT01243320|3812268|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
1558401|NCT01243320|3812268|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
1558402|NCT01243320|3812268|P1|STARTED|10ppm Oral Silver (3 Days)||36
1558403|NCT01243294|3812344|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
1558404|NCT01243294|3812345|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
1558405|NCT01243294|3812344|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
1558406|NCT01243294|3812345|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
1558407|NCT01243294|3812344|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
1558408|NCT01243294|3812345|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
1558409|NCT01243294|3812344|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
1558410|NCT01243294|3812345|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
1558411|NCT01243294|3812344|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
1558412|NCT01243294|3812345|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
1558413|NCT01243294|3812344|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
1558414|NCT01243294|3812345|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
1558415|NCT01243268|3812361|P1|NOT COMPLETED|Overall Study||64
1558416|NCT01243268|3812361|P1|COMPLETED|Overall Study||610
1558417|NCT01243268|3812361|P1|STARTED|Overall Study||674
1558418|NCT01243242|3812371|P2|NOT COMPLETED|Overall Study||4
1558419|NCT01243242|3812372|P1|NOT COMPLETED|Overall Study||3
1558420|NCT01243242|3812371|P2|COMPLETED|Overall Study||56
1558421|NCT01243242|3812372|P1|COMPLETED|Overall Study||57
1558422|NCT01243242|3812371|P2|STARTED|Overall Study||60
1558423|NCT01243242|3812372|P1|STARTED|Overall Study||60
1558424|NCT01243177|3812386|P2|NOT COMPLETED|Overall Study||178
1558425|NCT01243177|3812387|P1|NOT COMPLETED|Overall Study||178
1558426|NCT01243177|3812386|P2|COMPLETED|Overall Study||264
1558427|NCT01243177|3812387|P1|COMPLETED|Overall Study||266
1558428|NCT01243177|3812386|P2|STARTED|Overall Study||442
1558429|NCT01243177|3812387|P1|STARTED|Overall Study||444
1558430|NCT01243112|3812403|P1|NOT COMPLETED|Overall Study||0
1558431|NCT01243112|3812403|P1|COMPLETED|Overall Study||25
1558432|NCT01243112|3812403|P1|STARTED|Overall Study||25
1558433|NCT01242813|3812408|P1|NOT COMPLETED|Overall Study||2
1558434|NCT01242813|3812408|P1|COMPLETED|Overall Study||18
1558435|NCT01242813|3812408|P1|STARTED|Overall Study||20
1558436|NCT01242748|3812430|P2|NOT COMPLETED|Overall Study||14
1558437|NCT01242748|3812431|P1|NOT COMPLETED|Overall Study||38
1558438|NCT01242748|3812430|P2|COMPLETED|Overall Study||80
1558439|NCT01242748|3812431|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
1558440|NCT01242748|3812430|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
1558441|NCT01242748|3812431|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
1558442|NCT01242748|3812430|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
1558443|NCT01242748|3812431|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
1558444|NCT01242748|3812430|P2|STARTED|Overall Study||94
1558445|NCT01242748|3812431|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
1558446|NCT01242527|3812455|P4|NOT COMPLETED|Overall Study||9
1558447|NCT01242527|3812456|P3|NOT COMPLETED|Overall Study||14
1558448|NCT01242527|3812457|P2|NOT COMPLETED|Overall Study||7
1558449|NCT01242527|3812458|P1|NOT COMPLETED|Overall Study||5
1558450|NCT01242527|3812455|P4|COMPLETED|Overall Study||90
1558451|NCT01242527|3812456|P3|COMPLETED|Overall Study||87
1558452|NCT01242527|3812457|P2|COMPLETED|Overall Study||93
1558453|NCT01242527|3812458|P1|COMPLETED|Overall Study||94
1558454|NCT01242527|3812455|P4|STARTED|Overall Study||99
1558455|NCT01242527|3812456|P3|STARTED|Overall Study||101
1558456|NCT01242527|3812457|P2|STARTED|Overall Study||100
1558457|NCT01242527|3812458|P1|STARTED|Overall Study||99
1558458|NCT01242514|3812471|P3|NOT COMPLETED|Overall Study||212
1558459|NCT01242514|3812472|P2|NOT COMPLETED|Overall Study||357
1558460|NCT01242514|3812473|P1|NOT COMPLETED|Overall Study||1343
1558461|NCT01242514|3812471|P3|COMPLETED|Overall Study|Due to project closure.|0
1558462|NCT01242514|3812472|P2|COMPLETED|Overall Study|Due to project closure.|0
1558463|NCT01242514|3812473|P1|COMPLETED|Overall Study|Due to project closure.|0
1558464|NCT01242514|3812471|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
1558465|NCT01242514|3812472|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
1558466|NCT01242514|3812473|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
1558467|NCT01242514|3812471|P3|STARTED|Overall Study|Patients who received treatment|212
1558468|NCT01242514|3812472|P2|STARTED|Overall Study|Patients who received treatment|357
1558469|NCT01242514|3812473|P1|STARTED|Overall Study|Patients who received treatment|1343
1558470|NCT01242371|3812492|P2|NOT COMPLETED|Overall Study||5
1558471|NCT01242371|3812493|P1|NOT COMPLETED|Overall Study||2
1558472|NCT01242371|3812492|P2|COMPLETED|Overall Study||27
1558473|NCT01242371|3812493|P1|COMPLETED|Overall Study||31
1558474|NCT01242371|3812492|P2|STARTED|Overall Study||32
1558475|NCT01242371|3812493|P1|STARTED|Overall Study||33
1558476|NCT01242176|3812499|P2|NOT COMPLETED|Second Intervention||0
1558477|NCT01242176|3812500|P1|NOT COMPLETED|Second Intervention||0
1558478|NCT01242176|3812499|P2|COMPLETED|Second Intervention||10
1558479|NCT01242176|3812500|P1|COMPLETED|Second Intervention||11
1558480|NCT01242176|3812499|P2|STARTED|Second Intervention||10
1558481|NCT01242176|3812500|P1|STARTED|Second Intervention||11
1558482|NCT01242176|3812499|P2|NOT COMPLETED|Washout Period of 7 Days||2
1558483|NCT01242176|3812500|P1|NOT COMPLETED|Washout Period of 7 Days||1
1558484|NCT01242176|3812499|P2|COMPLETED|Washout Period of 7 Days||10
1558485|NCT01242176|3812500|P1|COMPLETED|Washout Period of 7 Days||11
1558486|NCT01242176|3812499|P2|STARTED|Washout Period of 7 Days||12
1558487|NCT01242176|3812500|P1|STARTED|Washout Period of 7 Days||12
1558488|NCT01242176|3812499|P2|NOT COMPLETED|First Intervention||0
1558489|NCT01242176|3812500|P1|NOT COMPLETED|First Intervention||0
1558490|NCT01242176|3812499|P2|COMPLETED|First Intervention||12
1558491|NCT01242176|3812500|P1|COMPLETED|First Intervention||12
1558492|NCT01242176|3812499|P2|STARTED|First Intervention||12
1558493|NCT01242176|3812500|P1|STARTED|First Intervention||12
1558494|NCT01242111|3812510|P1|NOT COMPLETED|Overall Study||3
1558495|NCT01242111|3812510|P1|COMPLETED|Overall Study||17
1558496|NCT01242111|3812510|P1|STARTED|Overall Study||20
1558497|NCT01242085|3812522|P3|NOT COMPLETED|Overall Study||0
1558498|NCT01242085|3812523|P2|NOT COMPLETED|Overall Study||7
1558499|NCT01242085|3812524|P1|NOT COMPLETED|Overall Study||8
1558500|NCT01242085|3812522|P3|COMPLETED|Overall Study||1
1558501|NCT01242085|3812523|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
1558502|NCT01242085|3812524|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
1558503|NCT01242085|3812522|P3|STARTED|Overall Study||1
1558504|NCT01242085|3812523|P2|STARTED|Overall Study||33
1558505|NCT01242085|3812524|P1|STARTED|Overall Study||30
1558506|NCT01242020|3812534|P2|NOT COMPLETED|Overall Study||0
1558507|NCT01242020|3812535|P1|NOT COMPLETED|Overall Study||3
1558508|NCT01242020|3812534|P2|COMPLETED|Overall Study||0
1558509|NCT01242020|3812535|P1|COMPLETED|Overall Study||3
1558510|NCT01242020|3812534|P2|STARTED|Overall Study||0
1558511|NCT01242020|3812535|P1|STARTED|Overall Study||6
1558512|NCT01241916|3812545|P2|NOT COMPLETED|Overall Study||10
1558513|NCT01241916|3812546|P1|NOT COMPLETED|Overall Study||7
1558514|NCT01241916|3812545|P2|COMPLETED|Overall Study||21
1558515|NCT01241916|3812546|P1|COMPLETED|Overall Study||28
1558516|NCT01241916|3812545|P2|STARTED|Overall Study||31
1558517|NCT01241916|3812546|P1|STARTED|Overall Study||35
1558518|NCT01241903|3812556|P2|NOT COMPLETED|Overall Study||0
1558519|NCT01241903|3812557|P1|NOT COMPLETED|Overall Study||1
1558520|NCT01241903|3812556|P2|COMPLETED|Overall Study||27
1558521|NCT01241903|3812557|P1|COMPLETED|Overall Study||26
1558522|NCT01241903|3812556|P2|STARTED|Overall Study||27
1558523|NCT01241903|3812557|P1|STARTED|Overall Study||27
1558524|NCT01241760|3812565|P2|NOT COMPLETED|Overall Study||40
1558525|NCT01241760|3812566|P1|NOT COMPLETED|Overall Study||34
1558526|NCT01241760|3812565|P2|COMPLETED|Overall Study||329
1558527|NCT01241760|3812566|P1|COMPLETED|Overall Study||337
1558528|NCT01241760|3812565|P2|STARTED|Overall Study||369
1558529|NCT01241760|3812566|P1|STARTED|Overall Study||371
1558530|NCT01241591|3812589|P4|NOT COMPLETED|Overall Study||12
1558531|NCT01241591|3812590|P3|NOT COMPLETED|Overall Study||22
1558532|NCT01241591|3812591|P2|NOT COMPLETED|Overall Study||24
1558533|NCT01241591|3812592|P1|NOT COMPLETED|Overall Study||23
1558534|NCT01241591|3812589|P4|COMPLETED|Overall Study||95
1558535|NCT01241591|3812590|P3|COMPLETED|Overall Study||313
1558536|NCT01241591|3812591|P2|COMPLETED|Overall Study||306
1558537|NCT01241591|3812592|P1|COMPLETED|Overall Study||306
1558538|NCT01241591|3812589|P4|STARTED|Overall Study||107
1558539|NCT01241591|3812590|P3|STARTED|Overall Study||335
1558540|NCT01241591|3812591|P2|STARTED|Overall Study||330
1558541|NCT01241591|3812592|P1|STARTED|Overall Study||329
1558542|NCT01241565|3812782|P1|NOT COMPLETED|Overall Study||0
1558543|NCT01241565|3812782|P1|COMPLETED|Overall Study||50
1558544|NCT01241565|3812782|P1|STARTED|Overall Study||50
1558545|NCT01241552|3812795|P4|NOT COMPLETED|Overall Study||64
1558546|NCT01241552|3812796|P3|NOT COMPLETED|Overall Study||60
1558547|NCT01241552|3812797|P2|NOT COMPLETED|Overall Study||63
1558548|NCT01241552|3812798|P1|NOT COMPLETED|Overall Study||41
1558549|NCT01241552|3812795|P4|COMPLETED|Overall Study||340
1558550|NCT01241552|3812796|P3|COMPLETED|Overall Study||343
1558551|NCT01241552|3812797|P2|COMPLETED|Overall Study||340
1558552|NCT01241552|3812798|P1|COMPLETED|Overall Study||201
1558553|NCT01241552|3812795|P4|Treated|Overall Study||397
1558554|NCT01241552|3812796|P3|Treated|Overall Study||388
1558555|NCT01241552|3812797|P2|Treated|Overall Study||392
1558556|NCT01241552|3812798|P1|Treated|Overall Study||235
1558557|NCT01241552|3812795|P4|STARTED|Overall Study||404
1558558|NCT01241552|3812796|P3|STARTED|Overall Study||403
1558559|NCT01241552|3812797|P2|STARTED|Overall Study||403
1558560|NCT01241552|3812798|P1|STARTED|Overall Study||242
1558561|NCT01241539|3812864|P1|NOT COMPLETED|Period 2||0
1558562|NCT01241539|3812864|P1|COMPLETED|Period 2||7
1558563|NCT01241539|3812864|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
1558564|NCT01241539|3812864|P1|NOT COMPLETED|Period 1||0
1558565|NCT01241539|3812864|P1|COMPLETED|Period 1||7
1558566|NCT01241539|3812864|P1|STARTED|Period 1||7
1558567|NCT01241513|3812885|P2|NOT COMPLETED|Overall Study||0
1558568|NCT01241513|3812886|P1|NOT COMPLETED|Overall Study||0
1558569|NCT01241513|3812885|P2|COMPLETED|Overall Study||9
1558570|NCT01241513|3812886|P1|COMPLETED|Overall Study|Study has been completed|10
1558571|NCT01241513|3812885|P2|STARTED|Overall Study||9
1558572|NCT01241513|3812886|P1|STARTED|Overall Study||10
1558573|NCT01241461|3812893|P2|NOT COMPLETED|Overall Study||6
1558574|NCT01241461|3812894|P1|NOT COMPLETED|Overall Study||3
1558575|NCT01241461|3812893|P2|COMPLETED|Overall Study||0
1558576|NCT01241461|3812894|P1|COMPLETED|Overall Study||0
1558577|NCT01241461|3812893|P2|STARTED|Overall Study||6
1558578|NCT01241461|3812894|P1|STARTED|Overall Study||3
1558579|NCT01241448|3812914|P4|NOT COMPLETED|Overall Study||23
1558580|NCT01241448|3812915|P3|NOT COMPLETED|Overall Study||23
1558581|NCT01241448|3812916|P2|NOT COMPLETED|Overall Study||29
1558582|NCT01241448|3812917|P1|NOT COMPLETED|Overall Study||37
1558583|NCT01241448|3812914|P4|COMPLETED|Overall Study||43
1558584|NCT01241448|3812915|P3|COMPLETED|Overall Study||43
1558585|NCT01241448|3812916|P2|COMPLETED|Overall Study||36
1558586|NCT01241448|3812917|P1|COMPLETED|Overall Study||29
1558587|NCT01241448|3812914|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
1558588|NCT01241448|3812915|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
1558589|NCT01241448|3812916|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
1558590|NCT01241448|3812917|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
1558591|NCT01241448|3812914|P4|Intent-to-Treat Population (ITT)|Overall Study||64
1558592|NCT01241448|3812915|P3|Intent-to-Treat Population (ITT)|Overall Study||64
1558593|NCT01241448|3812916|P2|Intent-to-Treat Population (ITT)|Overall Study||63
1558594|NCT01241448|3812917|P1|Intent-to-Treat Population (ITT)|Overall Study||63
1558595|NCT01241448|3812914|P4|STARTED|Overall Study||66
1558596|NCT01241448|3812915|P3|STARTED|Overall Study||66
1558597|NCT01241448|3812916|P2|STARTED|Overall Study||65
1558598|NCT01241448|3812917|P1|STARTED|Overall Study||66
1558599|NCT01241435|3812985|P4|NOT COMPLETED|Overall Study||0
1558600|NCT01241435|3812986|P3|NOT COMPLETED|Overall Study||0
1558601|NCT01241435|3812987|P2|NOT COMPLETED|Overall Study||0
1558602|NCT01241435|3812988|P1|NOT COMPLETED|Overall Study||0
1558603|NCT01241435|3812985|P4|COMPLETED|Overall Study||8
1558604|NCT01241435|3812986|P3|COMPLETED|Overall Study||8
1558605|NCT01241435|3812987|P2|COMPLETED|Overall Study||8
1558606|NCT01241435|3812988|P1|COMPLETED|Overall Study||12
1558607|NCT01241435|3812985|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
1558608|NCT01241435|3812986|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
1558609|NCT01241435|3812987|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
1558610|NCT01241435|3812988|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
1558611|NCT01241435|3812985|P4|STARTED|Overall Study||8
1558612|NCT01241435|3812986|P3|STARTED|Overall Study||8
1558613|NCT01241435|3812987|P2|STARTED|Overall Study||8
1558614|NCT01241435|3812988|P1|STARTED|Overall Study||12
1558615|NCT01241292|3813008|P2|NOT COMPLETED|Overall Study||3
1558616|NCT01241292|3813009|P1|NOT COMPLETED|Overall Study||3
1558617|NCT01241292|3813008|P2|COMPLETED|Overall Study|completed=treatment on-going|0
1558618|NCT01241292|3813009|P1|COMPLETED|Overall Study|completed=treatment on-going|0
1558619|NCT01241292|3813008|P2|Entered Treatment Period|Overall Study||3
1558620|NCT01241292|3813009|P1|Entered Treatment Period|Overall Study||3
1558621|NCT01241292|3813008|P2|STARTED|Overall Study||3
1558622|NCT01241292|3813009|P1|STARTED|Overall Study||3
1558623|NCT01241279|3813033|P2|NOT COMPLETED|Overall Study||1
1558624|NCT01241279|3813034|P1|NOT COMPLETED|Overall Study||0
1558625|NCT01241279|3813033|P2|COMPLETED|Overall Study||1
1558626|NCT01241279|3813034|P1|COMPLETED|Overall Study||4
1558627|NCT01241279|3813033|P2|STARTED|Overall Study||2
1558628|NCT01241279|3813034|P1|STARTED|Overall Study||4
1558629|NCT01241240|3813044|P2|NOT COMPLETED|Overall Study||9
1558630|NCT01241240|3813045|P1|NOT COMPLETED|Overall Study||8
1558631|NCT01241240|3813044|P2|COMPLETED|Overall Study||89
1558632|NCT01241240|3813045|P1|COMPLETED|Overall Study||86
1558633|NCT01241240|3813044|P2|STARTED|Overall Study||98
1558634|NCT01241240|3813045|P1|STARTED|Overall Study||94
1558635|NCT01240915|3813063|P9|NOT COMPLETED|Overall Study||8
1558636|NCT01240915|3813064|P8|NOT COMPLETED|Overall Study||4
1558637|NCT01240915|3813065|P7|NOT COMPLETED|Overall Study||8
1558638|NCT01240915|3813066|P6|NOT COMPLETED|Overall Study||10
1558639|NCT01240915|3813067|P5|NOT COMPLETED|Overall Study||4
1558640|NCT01240915|3813068|P4|NOT COMPLETED|Overall Study||3
1558641|NCT01240915|3813069|P3|NOT COMPLETED|Overall Study||0
1558642|NCT01240915|3813070|P2|NOT COMPLETED|Overall Study||1
1558643|NCT01240915|3813071|P1|NOT COMPLETED|Overall Study||2
1558644|NCT01240915|3813063|P9|COMPLETED|Overall Study||13
1558645|NCT01240915|3813064|P8|COMPLETED|Overall Study||15
1558646|NCT01240915|3813065|P7|COMPLETED|Overall Study||17
1558647|NCT01240915|3813066|P6|COMPLETED|Overall Study||13
1558648|NCT01240915|3813067|P5|COMPLETED|Overall Study||2
1558649|NCT01240915|3813068|P4|COMPLETED|Overall Study||1
1558650|NCT01240915|3813069|P3|COMPLETED|Overall Study||2
1558651|NCT01240915|3813070|P2|COMPLETED|Overall Study||2
1558652|NCT01240915|3813071|P1|COMPLETED|Overall Study||0
1558653|NCT01240915|3813063|P9|STARTED|Overall Study||21
1558654|NCT01240915|3813064|P8|STARTED|Overall Study||19
1558655|NCT01240915|3813065|P7|STARTED|Overall Study||25
1558656|NCT01240915|3813066|P6|STARTED|Overall Study||23
1558657|NCT01240915|3813067|P5|STARTED|Overall Study||6
1558658|NCT01240915|3813068|P4|STARTED|Overall Study||4
1558659|NCT01240915|3813069|P3|STARTED|Overall Study||2
1558660|NCT01240915|3813070|P2|STARTED|Overall Study||3
1558661|NCT01240915|3813071|P1|STARTED|Overall Study||2
1558662|NCT01240902|3813254|P4|NOT COMPLETED|Overall Study||165
1558663|NCT01240902|3813255|P3|NOT COMPLETED|Overall Study||100
1558664|NCT01240902|3813256|P2|NOT COMPLETED|Overall Study||79
1558665|NCT01240902|3813257|P1|NOT COMPLETED|Overall Study||211
1558666|NCT01240902|3813254|P4|COMPLETED|Overall Study||237
1558667|NCT01240902|3813255|P3|COMPLETED|Overall Study||295
1558668|NCT01240902|3813256|P2|COMPLETED|Overall Study||77
1558669|NCT01240902|3813257|P1|COMPLETED|Overall Study||289
1558670|NCT01240902|3813254|P4|STARTED|Overall Study||402
1558671|NCT01240902|3813255|P3|STARTED|Overall Study||395
1558672|NCT01240902|3813256|P2|STARTED|Overall Study||156
1558673|NCT01240902|3813257|P1|STARTED|Overall Study||500
1558674|NCT01240863|3813345|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
1558675|NCT01240863|3813346|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
1558676|NCT01240863|3813347|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1558677|NCT01240863|3813345|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
1558678|NCT01240863|3813346|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
1558679|NCT01240863|3813347|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1558680|NCT01240863|3813345|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
1558681|NCT01240863|3813346|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
1558682|NCT01240863|3813347|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
1558683|NCT01240863|3813345|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
1558684|NCT01240863|3813346|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
1558685|NCT01240863|3813347|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
1558686|NCT01240863|3813345|P3|NOT COMPLETED|Open-label Titration Period||0
1558687|NCT01240863|3813346|P2|NOT COMPLETED|Open-label Titration Period||0
1558688|NCT01240863|3813347|P1|NOT COMPLETED|Open-label Titration Period||97
1558689|NCT01240863|3813345|P3|COMPLETED|Open-label Titration Period||0
1558690|NCT01240863|3813346|P2|COMPLETED|Open-label Titration Period||0
1558691|NCT01240863|3813347|P1|COMPLETED|Open-label Titration Period||294
1558692|NCT01240863|3813345|P3|Safety Analysis Set|Open-label Titration Period||0
1558693|NCT01240863|3813346|P2|Safety Analysis Set|Open-label Titration Period||0
1558694|NCT01240863|3813347|P1|Safety Analysis Set|Open-label Titration Period||389
1558695|NCT01240863|3813345|P3|STARTED|Open-label Titration Period||0
1558696|NCT01240863|3813346|P2|STARTED|Open-label Titration Period||0
1558697|NCT01240863|3813347|P1|STARTED|Open-label Titration Period||391
1558698|NCT01240811|3813409|P3|NOT COMPLETED|Overall Study||1
1558699|NCT01240811|3813410|P2|NOT COMPLETED|Overall Study||1
1558700|NCT01240811|3813411|P1|NOT COMPLETED|Overall Study||0
1558701|NCT01240811|3813409|P3|COMPLETED|Overall Study||16
1558702|NCT01240811|3813410|P2|COMPLETED|Overall Study||16
1558703|NCT01240811|3813411|P1|COMPLETED|Overall Study||8
1558704|NCT01240811|3813409|P3|STARTED|Overall Study||17
1558705|NCT01240811|3813410|P2|STARTED|Overall Study||17
1558706|NCT01240811|3813411|P1|STARTED|Overall Study||8
1558707|NCT01240785|3813427|P2|NOT COMPLETED|Overall Study||3
1558708|NCT01240785|3813428|P1|NOT COMPLETED|Overall Study||1
1558709|NCT01240785|3813427|P2|COMPLETED|Overall Study||107
1558710|NCT01240785|3813428|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
1558711|NCT01240785|3813427|P2|STARTED|Overall Study||110
1558712|NCT01240785|3813428|P1|STARTED|Overall Study||111
1558713|NCT01240746|3813459|P3|NOT COMPLETED|Overall Study||243
1558714|NCT01240746|3813460|P2|NOT COMPLETED|Overall Study||48
1558715|NCT01240746|3813461|P1|NOT COMPLETED|Overall Study||59
1558716|NCT01240746|3813459|P3|COMPLETED|Overall Study||2659
1558717|NCT01240746|3813460|P2|COMPLETED|Overall Study||677
1558718|NCT01240746|3813461|P1|COMPLETED|Overall Study||677
1558719|NCT01240746|3813459|P3|STARTED|Overall Study||2902
1558720|NCT01240746|3813460|P2|STARTED|Overall Study||725
1558721|NCT01240746|3813461|P1|STARTED|Overall Study||736
1558722|NCT01240590|3813516|P5|NOT COMPLETED|Phase II||1
1558723|NCT01240590|3813517|P4|NOT COMPLETED|Phase II||2
1558724|NCT01240590|3813518|P3|NOT COMPLETED|Phase II||0
1558725|NCT01240590|3813519|P2|NOT COMPLETED|Phase II||0
1558726|NCT01240590|3813520|P1|NOT COMPLETED|Phase II||0
1558727|NCT01240590|3813516|P5|COMPLETED|Phase II||0
1558728|NCT01240590|3813517|P4|COMPLETED|Phase II||15
1558729|NCT01240590|3813518|P3|COMPLETED|Phase II||0
1558730|NCT01240590|3813519|P2|COMPLETED|Phase II||0
1558731|NCT01240590|3813520|P1|COMPLETED|Phase II||0
1558732|NCT01240590|3813516|P5|STARTED|Phase II||1
1558733|NCT01240590|3813517|P4|STARTED|Phase II||17
1558734|NCT01240590|3813518|P3|STARTED|Phase II||0
1558735|NCT01240590|3813519|P2|STARTED|Phase II||0
1558736|NCT01240590|3813520|P1|STARTED|Phase II||0
1558737|NCT01240590|3813516|P5|NOT COMPLETED|Phase I||0
1558738|NCT01240590|3813517|P4|NOT COMPLETED|Phase I||0
1558739|NCT01240590|3813518|P3|NOT COMPLETED|Phase I||3
1558740|NCT01240590|3813519|P2|NOT COMPLETED|Phase I||0
1558741|NCT01240590|3813520|P1|NOT COMPLETED|Phase I||0
1558742|NCT01240590|3813516|P5|COMPLETED|Phase I||0
1558743|NCT01240590|3813517|P4|COMPLETED|Phase I||0
1558744|NCT01240590|3813518|P3|COMPLETED|Phase I||0
1558745|NCT01240590|3813519|P2|COMPLETED|Phase I||6
1558746|NCT01240590|3813520|P1|COMPLETED|Phase I||0
1558747|NCT01240590|3813516|P5|STARTED|Phase I||0
1558748|NCT01240590|3813517|P4|STARTED|Phase I||0
1558749|NCT01240590|3813518|P3|STARTED|Phase I||3
1558750|NCT01240590|3813519|P2|STARTED|Phase I||6
1558751|NCT01240590|3813520|P1|STARTED|Phase I||0
1558752|NCT01240551|3813548|P2|NOT COMPLETED|Overall Study||3
1558753|NCT01240551|3813549|P1|NOT COMPLETED|Overall Study||4
1558754|NCT01240551|3813548|P2|COMPLETED|Overall Study||27
1558755|NCT01240551|3813549|P1|COMPLETED|Overall Study||26
1558756|NCT01240551|3813548|P2|STARTED|Overall Study||30
1558757|NCT01240551|3813549|P1|STARTED|Overall Study||30
1558758|NCT01240382|3813559|P2|NOT COMPLETED|Overall Study||4
1558759|NCT01240382|3813560|P1|NOT COMPLETED|Overall Study||2
1558760|NCT01240382|3813559|P2|COMPLETED|Overall Study||139
1558761|NCT01240382|3813560|P1|COMPLETED|Overall Study||142
1558762|NCT01240382|3813559|P2|STARTED|Overall Study||143
1558763|NCT01240382|3813560|P1|STARTED|Overall Study||144
1558764|NCT01240356|3813570|P2|NOT COMPLETED|Overall Study||0
1558765|NCT01240356|3813571|P1|NOT COMPLETED|Overall Study||3
1558766|NCT01240356|3813570|P2|COMPLETED|Overall Study||20
1558767|NCT01240356|3813571|P1|COMPLETED|Overall Study||15
1558768|NCT01240356|3813570|P2|STARTED|Overall Study||20
1558769|NCT01240356|3813571|P1|STARTED|Overall Study||18
1558770|NCT01240330|3813582|P1|NOT COMPLETED|Overall Study||0
1558771|NCT01240330|3813582|P1|COMPLETED|Overall Study||33
1558772|NCT01240330|3813582|P1|STARTED|Overall Study||33
1558773|NCT01240200|3813590|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
1558774|NCT01240200|3813591|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
1558775|NCT01240200|3813590|P2|COMPLETED|12-week Crossover Phase - Period 2||23
1558776|NCT01240200|3813591|P1|COMPLETED|12-week Crossover Phase - Period 2||23
1558777|NCT01240200|3813590|P2|STARTED|12-week Crossover Phase - Period 2||23
1558778|NCT01240200|3813591|P1|STARTED|12-week Crossover Phase - Period 2||23
1558779|NCT01240200|3813590|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
1558780|NCT01240200|3813591|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
1558781|NCT01240200|3813590|P2|COMPLETED|12-week Crossover Phase - Period 1||23
1558782|NCT01240200|3813591|P1|COMPLETED|12-week Crossover Phase - Period 1||23
1558783|NCT01240200|3813590|P2|STARTED|12-week Crossover Phase - Period 1||24
1558784|NCT01240200|3813591|P1|STARTED|12-week Crossover Phase - Period 1||25
1558785|NCT01240135|3813609|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
1558786|NCT01240135|3813610|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
1558787|NCT01240135|3813609|P2|COMPLETED|Period Two, 14 Days of Wear||43
1558788|NCT01240135|3813610|P1|COMPLETED|Period Two, 14 Days of Wear||43
1558789|NCT01240135|3813609|P2|STARTED|Period Two, 14 Days of Wear||45
1558790|NCT01240135|3813610|P1|STARTED|Period Two, 14 Days of Wear||44
1558791|NCT01240135|3813609|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
1558792|NCT01240135|3813610|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
1558793|NCT01240135|3813609|P2|COMPLETED|Period One, 14 Days of Wear||45
1558794|NCT01240135|3813610|P1|COMPLETED|Period One, 14 Days of Wear||44
1558795|NCT01240135|3813609|P2|STARTED|Period One, 14 Days of Wear||45
1558796|NCT01240135|3813610|P1|STARTED|Period One, 14 Days of Wear||44
1558797|NCT01240122|3813618|P1|NOT COMPLETED|Overall Study||0
1558798|NCT01240122|3813618|P1|COMPLETED|Overall Study||29
1558799|NCT01240122|3813618|P1|STARTED|Overall Study||29
1558800|NCT01239992|3813627|P1|NOT COMPLETED|Overall Study||2
1558801|NCT01239992|3813627|P1|COMPLETED|Overall Study||10
1558802|NCT01239992|3813627|P1|STARTED|Overall Study||12
1558803|NCT01239797|3813636|P2|NOT COMPLETED|Treated Participants||274
1558804|NCT01239797|3813637|P1|NOT COMPLETED|Treated Participants||235
1558805|NCT01239797|3813636|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
1558806|NCT01239797|3813637|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
1558807|NCT01239797|3813636|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
1558808|NCT01239797|3813637|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
1558809|NCT01239797|3813636|P2|NOT COMPLETED|Randomized Participants||9
1558810|NCT01239797|3813637|P1|NOT COMPLETED|Randomized Participants||2
1558811|NCT01239797|3813636|P2|COMPLETED|Randomized Participants||316
1558812|NCT01239797|3813637|P1|COMPLETED|Randomized Participants||319
1558813|NCT01239797|3813636|P2|STARTED|Randomized Participants||325
1558814|NCT01239797|3813637|P1|STARTED|Randomized Participants||321
1558815|NCT01239745|3813645|P1|NOT COMPLETED|Overall Study||46
1558816|NCT01239745|3813645|P1|COMPLETED|Overall Study||0
1558817|NCT01239745|3813645|P1|STARTED|Overall Study||46
1558818|NCT01239732|3813656|P1|NOT COMPLETED|Overall Study||1021
1558819|NCT01239732|3813656|P1|COMPLETED|Overall Study||0
1558820|NCT01239732|3813656|P1|STARTED|Overall Study||1021
1558821|NCT01239680|3813669|P2|NOT COMPLETED|Overall Study||0
1558822|NCT01239680|3813670|P1|NOT COMPLETED|Overall Study||2
1558823|NCT01239680|3813669|P2|COMPLETED|Overall Study||2
1558824|NCT01239680|3813670|P1|COMPLETED|Overall Study||1
1558825|NCT01239680|3813669|P2|STARTED|Overall Study||2
1558826|NCT01239680|3813670|P1|STARTED|Overall Study||3
1558827|NCT01239511|3813680|P4|NOT COMPLETED|Overall Study||9
1558828|NCT01239511|3813681|P3|NOT COMPLETED|Overall Study||4
1558829|NCT01239511|3813682|P2|NOT COMPLETED|Overall Study||5
1558830|NCT01239511|3813683|P1|NOT COMPLETED|Overall Study||1
1558831|NCT01239511|3813680|P4|COMPLETED|Overall Study||38
1558832|NCT01239511|3813681|P3|COMPLETED|Overall Study||43
1558833|NCT01239511|3813682|P2|COMPLETED|Overall Study||40
1558834|NCT01239511|3813683|P1|COMPLETED|Overall Study||46
1558835|NCT01239511|3813680|P4|STARTED|Overall Study||47
1558836|NCT01239511|3813681|P3|STARTED|Overall Study||47
1558837|NCT01239511|3813682|P2|STARTED|Overall Study||45
1558838|NCT01239511|3813683|P1|STARTED|Overall Study||47
1558839|NCT01239394|3813693|P1|NOT COMPLETED|Overall Study||1
1558840|NCT01239394|3813693|P1|COMPLETED|Overall Study||41
1558841|NCT01239394|3813693|P1|STARTED|Overall Study||42
1558842|NCT01239381|3813700|P1|NOT COMPLETED|Overall Study||2
1558843|NCT01239381|3813700|P1|COMPLETED|Overall Study||90
1558844|NCT01239381|3813700|P1|STARTED|Overall Study||92
1558845|NCT01239368|3813720|P10|NOT COMPLETED|Overall Study||4
1558846|NCT01239368|3813721|P9|NOT COMPLETED|Overall Study||0
1558847|NCT01239368|3813722|P8|NOT COMPLETED|Overall Study||0
1558848|NCT01239368|3813723|P7|NOT COMPLETED|Overall Study||6
1558849|NCT01239368|3813724|P6|NOT COMPLETED|Overall Study||4
1558850|NCT01239368|3813725|P5|NOT COMPLETED|Overall Study||5
1558851|NCT01239368|3813726|P4|NOT COMPLETED|Overall Study||1
1558852|NCT01239368|3813727|P3|NOT COMPLETED|Overall Study||1
1558853|NCT01239368|3813728|P2|NOT COMPLETED|Overall Study||1
1558854|NCT01239368|3813729|P1|NOT COMPLETED|Overall Study||2
1558855|NCT01239368|3813720|P10|COMPLETED|Overall Study||1
1558856|NCT01239368|3813721|P9|COMPLETED|Overall Study||1
1558857|NCT01239368|3813722|P8|COMPLETED|Overall Study||0
1558858|NCT01239368|3813723|P7|COMPLETED|Overall Study||1
1558859|NCT01239368|3813724|P6|COMPLETED|Overall Study||1
1558860|NCT01239368|3813725|P5|COMPLETED|Overall Study||2
1558861|NCT01239368|3813726|P4|COMPLETED|Overall Study||1
1558862|NCT01239368|3813727|P3|COMPLETED|Overall Study||0
1558863|NCT01239368|3813728|P2|COMPLETED|Overall Study||0
1558864|NCT01239368|3813729|P1|COMPLETED|Overall Study||0
1558865|NCT01239368|3813720|P10|STARTED|Overall Study||5
1558866|NCT01239368|3813721|P9|STARTED|Overall Study||1
1558867|NCT01239368|3813722|P8|STARTED|Overall Study||0
1558868|NCT01239368|3813723|P7|STARTED|Overall Study||7
1558869|NCT01239368|3813724|P6|STARTED|Overall Study||5
1558870|NCT01239368|3813725|P5|STARTED|Overall Study||7
1558871|NCT01239368|3813726|P4|STARTED|Overall Study||2
1558872|NCT01239368|3813727|P3|STARTED|Overall Study||1
1558873|NCT01239368|3813728|P2|STARTED|Overall Study||1
1558874|NCT01239368|3813729|P1|STARTED|Overall Study||2
1558875|NCT01239355|3813773|P1|NOT COMPLETED|Overall Study||0
1558876|NCT01239355|3813773|P1|COMPLETED|Overall Study||15
1558877|NCT01239355|3813773|P1|STARTED|Overall Study||15
1558878|NCT01239342|3813781|P2|NOT COMPLETED|Overall Study||6
1558879|NCT01239342|3813782|P1|NOT COMPLETED|Overall Study||3
1558880|NCT01239342|3813781|P2|COMPLETED|Overall Study||8
1558881|NCT01239342|3813782|P1|COMPLETED|Overall Study||26
1558882|NCT01239342|3813781|P2|STARTED|Overall Study||14
1558883|NCT01239342|3813782|P1|STARTED|Overall Study||29
1558884|NCT01239316|3813798|P1|NOT COMPLETED|Overall Study||12
1558885|NCT01239316|3813798|P1|COMPLETED|Overall Study||0
1558886|NCT01239316|3813798|P1|STARTED|Overall Study||12
1558887|NCT01239212|3813806|P1|NOT COMPLETED|Overall Study||0
1558888|NCT01239212|3813806|P1|COMPLETED|Overall Study||7
1558889|NCT01239212|3813806|P1|STARTED|Overall Study||7
1558890|NCT01239121|3813813|P3|NOT COMPLETED|Overall Study||0
1558891|NCT01239121|3813814|P2|NOT COMPLETED|Overall Study||4
1558892|NCT01239121|3813815|P1|NOT COMPLETED|Overall Study||2
1558893|NCT01239121|3813813|P3|COMPLETED|Overall Study||15
1558894|NCT01239121|3813814|P2|COMPLETED|Overall Study||195
1558895|NCT01239121|3813815|P1|COMPLETED|Overall Study||186
1558896|NCT01239121|3813813|P3|STARTED|Overall Study||15
1558897|NCT01239121|3813814|P2|STARTED|Overall Study||199
1558898|NCT01239121|3813815|P1|STARTED|Overall Study||188
1558899|NCT01239056|3813829|P1|NOT COMPLETED|Overall Study||0
1558900|NCT01239056|3813829|P1|COMPLETED|Overall Study||20
1558901|NCT01239056|3813829|P1|STARTED|Overall Study||20
1558902|NCT01239043|3813837|P2|NOT COMPLETED|Overall Study||1
1558903|NCT01239043|3813838|P1|NOT COMPLETED|Overall Study||2
1558904|NCT01239043|3813837|P2|COMPLETED|Overall Study||102
1558905|NCT01239043|3813838|P1|COMPLETED|Overall Study||34
1558906|NCT01239043|3813837|P2|STARTED|Overall Study||103
1558907|NCT01239043|3813838|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
1558908|NCT01238991|3813866|P10|NOT COMPLETED|Overall Study||2
1558909|NCT01238991|3813867|P9|NOT COMPLETED|Overall Study||4
1558910|NCT01238991|3813868|P8|NOT COMPLETED|Overall Study||5
1558911|NCT01238991|3813869|P7|NOT COMPLETED|Overall Study||8
1558912|NCT01238991|3813870|P6|NOT COMPLETED|Overall Study||0
1558913|NCT01238991|3813871|P5|NOT COMPLETED|Overall Study||2
1558914|NCT01238991|3813872|P4|NOT COMPLETED|Overall Study||2
1558915|NCT01238991|3813873|P3|NOT COMPLETED|Overall Study||6
1558916|NCT01238991|3813874|P2|NOT COMPLETED|Overall Study||0
1558917|NCT01238991|3813875|P1|NOT COMPLETED|Overall Study||2
1558918|NCT01238991|3813866|P10|COMPLETED|Overall Study||0
1558919|NCT01238991|3813867|P9|COMPLETED|Overall Study||0
1558920|NCT01238991|3813868|P8|COMPLETED|Overall Study||0
1558921|NCT01238991|3813869|P7|COMPLETED|Overall Study||0
1558922|NCT01238991|3813870|P6|COMPLETED|Overall Study||2
1558923|NCT01238991|3813871|P5|COMPLETED|Overall Study||3
1558924|NCT01238991|3813872|P4|COMPLETED|Overall Study||4
1558925|NCT01238991|3813873|P3|COMPLETED|Overall Study||5
1558926|NCT01238991|3813874|P2|COMPLETED|Overall Study||3
1558927|NCT01238991|3813875|P1|COMPLETED|Overall Study||5
1558928|NCT01238991|3813866|P10|Received Treatment|Overall Study||2
1558929|NCT01238991|3813867|P9|Received Treatment|Overall Study||4
1558930|NCT01238991|3813868|P8|Received Treatment|Overall Study||5
1558931|NCT01238991|3813869|P7|Received Treatment|Overall Study||8
1558932|NCT01238991|3813870|P6|Received Treatment|Overall Study||2
1558933|NCT01238991|3813871|P5|Received Treatment|Overall Study||5
1558934|NCT01238991|3813872|P4|Received Treatment|Overall Study||6
1558935|NCT01238991|3813873|P3|Received Treatment|Overall Study||11
1558936|NCT01238991|3813874|P2|Received Treatment|Overall Study||3
1558937|NCT01238991|3813875|P1|Received Treatment|Overall Study||7
1558938|NCT01238991|3813866|P10|STARTED|Overall Study||2
1558939|NCT01238991|3813867|P9|STARTED|Overall Study||4
1558940|NCT01238991|3813868|P8|STARTED|Overall Study||5
1558941|NCT01238991|3813869|P7|STARTED|Overall Study||8
1558942|NCT01238991|3813870|P6|STARTED|Overall Study||2
1558943|NCT01238991|3813871|P5|STARTED|Overall Study||5
1558944|NCT01238991|3813872|P4|STARTED|Overall Study||6
1558945|NCT01238991|3813873|P3|STARTED|Overall Study||11
1558946|NCT01238991|3813874|P2|STARTED|Overall Study||3
1558947|NCT01238991|3813875|P1|STARTED|Overall Study||7
1558948|NCT01238900|3813962|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
1558949|NCT01238900|3813962|P1|COMPLETED|<12 Months Post Stent Removal||18
1558950|NCT01238900|3813962|P1|STARTED|<12 Months Post Stent Removal||23
1558951|NCT01238900|3813962|P1|NOT COMPLETED|6 Months Post Stent Placement||0
1558952|NCT01238900|3813962|P1|COMPLETED|6 Months Post Stent Placement||23
1558953|NCT01238900|3813962|P1|STARTED|6 Months Post Stent Placement||23
1558954|NCT01238861|3813976|P6|NOT COMPLETED|Overall Study||15
1558955|NCT01238861|3813977|P5|NOT COMPLETED|Overall Study||13
1558956|NCT01238861|3813978|P4|NOT COMPLETED|Overall Study||13
1558957|NCT01238861|3813979|P3|NOT COMPLETED|Overall Study||11
1558958|NCT01238861|3813980|P2|NOT COMPLETED|Overall Study||8
1558959|NCT01238861|3813981|P1|NOT COMPLETED|Overall Study||11
1558960|NCT01238861|3813976|P6|COMPLETED|Overall Study||125
1558961|NCT01238861|3813977|P5|COMPLETED|Overall Study||129
1558962|NCT01238861|3813978|P4|COMPLETED|Overall Study||69
1558963|NCT01238861|3813979|P3|COMPLETED|Overall Study||70
1558964|NCT01238861|3813980|P2|COMPLETED|Overall Study||73
1558965|NCT01238861|3813981|P1|COMPLETED|Overall Study||69
1558966|NCT01238861|3813976|P6|STARTED|Overall Study||140
1558967|NCT01238861|3813977|P5|STARTED|Overall Study||142
1558968|NCT01238861|3813978|P4|STARTED|Overall Study||82
1558969|NCT01238861|3813979|P3|STARTED|Overall Study||81
1558970|NCT01238861|3813980|P2|STARTED|Overall Study||81
1558971|NCT01238861|3813981|P1|STARTED|Overall Study||80
1558972|NCT01238848|3814061|P2|NOT COMPLETED|Overall Study||5
1558973|NCT01238848|3814062|P1|NOT COMPLETED|Overall Study||13
1558974|NCT01238848|3814061|P2|COMPLETED|Overall Study||45
1558975|NCT01238848|3814062|P1|COMPLETED|Overall Study||37
1558976|NCT01238848|3814061|P2|STARTED|Overall Study||50
1558977|NCT01238848|3814062|P1|STARTED|Overall Study||50
1558978|NCT01238822|3814070|P1|NOT COMPLETED|Overall Study||3
1558979|NCT01238822|3814070|P1|COMPLETED|Overall Study||93
1558980|NCT01238822|3814070|P1|Received High Dosage|Overall Study||93
1558981|NCT01238822|3814070|P1|Received Medium Dosage|Overall Study||93
1558982|NCT01238822|3814070|P1|Received Low Dosage|Overall Study||93
1558983|NCT01238822|3814070|P1|Received Placebo|Overall Study||93
1558984|NCT01238822|3814070|P1|STARTED|Overall Study||96
1558985|NCT01238640|3814080|P1|NOT COMPLETED|Overall Study||0
1558986|NCT01238640|3814080|P1|COMPLETED|Overall Study||84
1558987|NCT01238640|3814080|P1|STARTED|Overall Study||84
1558988|NCT01238588|3814097|P1|NOT COMPLETED|Overall Study||3
1558989|NCT01238588|3814097|P1|COMPLETED|Overall Study||9
1558990|NCT01238588|3814097|P1|STARTED|Overall Study||12
1558991|NCT01238575|3814110|P2|NOT COMPLETED|Overall Study||4
1558992|NCT01238575|3814111|P1|NOT COMPLETED|Overall Study||4
1558993|NCT01238575|3814110|P2|COMPLETED|Overall Study||28
1558994|NCT01238575|3814111|P1|COMPLETED|Overall Study||26
1558995|NCT01238575|3814110|P2|STARTED|Overall Study||32
1558996|NCT01238575|3814111|P1|STARTED|Overall Study||30
1558997|NCT01238549|3814147|P1|NOT COMPLETED|Overall Study||36
1558998|NCT01238549|3814147|P1|COMPLETED|Overall Study||248
1558999|NCT01238549|3814147|P1|STARTED|Overall Study||284
1559000|NCT01238536|3814166|P2|NOT COMPLETED|Overall Study||50
1559001|NCT01238536|3814167|P1|NOT COMPLETED|Overall Study||47
1559002|NCT01238536|3814166|P2|COMPLETED|Overall Study||150
1559003|NCT01238536|3814167|P1|COMPLETED|Overall Study||153
1559004|NCT01238536|3814166|P2|STARTED|Overall Study||200
1559005|NCT01238536|3814167|P1|STARTED|Overall Study||200
1559006|NCT01238471|3814181|P2|NOT COMPLETED|Overall Study||0
1559007|NCT01238471|3814182|P1|NOT COMPLETED|Overall Study||0
1559008|NCT01238471|3814181|P2|COMPLETED|Overall Study||10
1559009|NCT01238471|3814182|P1|COMPLETED|Overall Study||10
1559010|NCT01238471|3814181|P2|STARTED|Overall Study||10
1559011|NCT01238471|3814182|P1|STARTED|Overall Study||10
1559012|NCT01238341|3814188|P1|NOT COMPLETED|Overall Study||0
1559013|NCT01238341|3814188|P1|COMPLETED|Overall Study||7
1559014|NCT01238341|3814188|P1|STARTED|Overall Study||7
1559015|NCT01238211|3814195|P1|NOT COMPLETED|Overall Study||58
1559016|NCT01238211|3814195|P1|COMPLETED|Overall Study||3
1559017|NCT01238211|3814195|P1|STARTED|Overall Study||61
1559018|NCT01237678|3814202|P3|NOT COMPLETED|Phase II||50
1559019|NCT01237678|3814203|P2|NOT COMPLETED|Phase II||98
1559020|NCT01237678|3814204|P1|NOT COMPLETED|Phase II||0
1559021|NCT01237678|3814202|P3|COMPLETED|Phase II||0
1559022|NCT01237678|3814203|P2|COMPLETED|Phase II||0
1559023|NCT01237678|3814204|P1|COMPLETED|Phase II||0
1559024|NCT01237678|3814202|P3|Received Intervention|Phase II||47
1559025|NCT01237678|3814203|P2|Received Intervention|Phase II||94
1559026|NCT01237678|3814204|P1|Received Intervention|Phase II||0
1559027|NCT01237678|3814202|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
1559028|NCT01237678|3814203|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
1559029|NCT01237678|3814204|P1|STARTED|Phase II||0
1559030|NCT01237678|3814202|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1559031|NCT01237678|3814203|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1559032|NCT01237678|3814204|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
1559033|NCT01237678|3814202|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1559034|NCT01237678|3814203|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1559035|NCT01237678|3814204|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
1559036|NCT01237678|3814202|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
1559037|NCT01237678|3814203|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
1559038|NCT01237678|3814204|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
1559039|NCT01237678|3814202|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
1559040|NCT01237678|3814203|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
1559041|NCT01237678|3814204|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
1559042|NCT01237613|3814223|P1|NOT COMPLETED|Overall Study||0
1559043|NCT01237613|3814223|P1|COMPLETED|Overall Study||4
1559044|NCT01237613|3814223|P1|STARTED|Overall Study||4
1559045|NCT01237587|3814249|P2|NOT COMPLETED|Taper Phase||10
1559046|NCT01237587|3814250|P1|NOT COMPLETED|Taper Phase||5
1559047|NCT01237587|3814249|P2|COMPLETED|Taper Phase||34
1559048|NCT01237587|3814250|P1|COMPLETED|Taper Phase||31
1559049|NCT01237587|3814249|P2|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
1559050|NCT01237587|3814250|P1|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
1559051|NCT01237587|3814249|P2|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
1559052|NCT01237587|3814250|P1|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
1559053|NCT01237587|3814249|P2|COMPLETED|Open Label Treatment (Extension Phase)||50
1559054|NCT01237587|3814250|P1|COMPLETED|Open Label Treatment (Extension Phase)||56
1559055|NCT01237587|3814249|P2|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
1559056|NCT01237587|3814250|P1|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
1559057|NCT01237587|3814249|P2|STARTED|Open Label Treatment (Extension Phase)||75
1559058|NCT01237587|3814250|P1|STARTED|Open Label Treatment (Extension Phase)||74
1559059|NCT01237587|3814249|P2|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
1559060|NCT01237587|3814250|P1|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
1559061|NCT01237587|3814249|P2|COMPLETED|Double Blind Treatment (Acute Phase)||75
1559062|NCT01237587|3814250|P1|COMPLETED|Double Blind Treatment (Acute Phase)||74
1559063|NCT01237587|3814249|P2|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
1559064|NCT01237587|3814250|P1|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
1559065|NCT01237587|3814249|P2|STARTED|Double Blind Treatment (Acute Phase)||93
1559066|NCT01237587|3814250|P1|STARTED|Double Blind Treatment (Acute Phase)||91
1559067|NCT01237353|3814297|P1|NOT COMPLETED|Overall Study||0
1559068|NCT01237353|3814297|P1|COMPLETED|Overall Study||6
1559069|NCT01237353|3814297|P1|STARTED|Overall Study||6
1559070|NCT01237340|3814302|P1|NOT COMPLETED|Overall Study||40
1559071|NCT01237340|3814302|P1|COMPLETED|Overall Study||19
1559072|NCT01237340|3814302|P1|STARTED|Overall Study||59
1559073|NCT01237327|3814316|P2|NOT COMPLETED|Overall Study||40
1559074|NCT01237327|3814317|P1|NOT COMPLETED|Overall Study||42
1559075|NCT01237327|3814316|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
1559076|NCT01237327|3814317|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
1559077|NCT01237327|3814316|P2|Continued Treatment in Extension Study|Overall Study||17
1559078|NCT01237327|3814317|P1|Continued Treatment in Extension Study|Overall Study||21
1559079|NCT01237327|3814316|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
1559080|NCT01237327|3814317|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
1559081|NCT01237327|3814316|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
1559082|NCT01237327|3814317|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
1559083|NCT01237327|3814316|P2|STARTED|Overall Study||41
1559084|NCT01237327|3814317|P1|STARTED|Overall Study||43
1559085|NCT01237301|3814333|P2|NOT COMPLETED|Overall Study||4
1559086|NCT01237301|3814334|P1|NOT COMPLETED|Overall Study||5
1559087|NCT01237301|3814333|P2|COMPLETED|Overall Study||55
1559088|NCT01237301|3814334|P1|COMPLETED|Overall Study||60
1559089|NCT01237301|3814333|P2|STARTED|Overall Study||59
1559090|NCT01237301|3814334|P1|STARTED|Overall Study||65
1559091|NCT01237223|3814352|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
1559092|NCT01237223|3814353|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
1559093|NCT01237223|3814354|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
1559094|NCT01237223|3814355|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
1559095|NCT01237223|3814356|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
1559096|NCT01237223|3814357|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
1559097|NCT01237223|3814352|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
1559098|NCT01237223|3814353|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
1559099|NCT01237223|3814354|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
1559100|NCT01237223|3814355|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
1559101|NCT01237223|3814356|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
1559102|NCT01237223|3814357|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
1559103|NCT01237223|3814352|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
1559104|NCT01237223|3814353|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
1559105|NCT01237223|3814354|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
1559106|NCT01237223|3814355|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
1559107|NCT01237223|3814356|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
1559108|NCT01237223|3814357|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
1559109|NCT01237223|3814352|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559110|NCT01237223|3814353|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559111|NCT01237223|3814354|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559112|NCT01237223|3814355|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559113|NCT01237223|3814356|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559114|NCT01237223|3814357|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
1559115|NCT01237223|3814352|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559116|NCT01237223|3814353|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559117|NCT01237223|3814354|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559118|NCT01237223|3814355|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559119|NCT01237223|3814356|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1559120|NCT01237223|3814357|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
1559121|NCT01237223|3814352|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1559122|NCT01237223|3814353|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1559123|NCT01237223|3814354|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1559124|NCT01237223|3814355|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1559125|NCT01237223|3814356|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1559126|NCT01237223|3814357|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
1559127|NCT01237197|3814398|P2|NOT COMPLETED|Open Label Period||0
1559128|NCT01237197|3814399|P1|NOT COMPLETED|Open Label Period||0
1559129|NCT01237197|3814398|P2|COMPLETED|Open Label Period||10
1559130|NCT01237197|3814399|P1|COMPLETED|Open Label Period||12
1559131|NCT01237197|3814398|P2|STARTED|Open Label Period||10
1559132|NCT01237197|3814399|P1|STARTED|Open Label Period||12
1559133|NCT01237197|3814398|P2|NOT COMPLETED|Randomization Period||3
1559134|NCT01237197|3814399|P1|NOT COMPLETED|Randomization Period||1
1559135|NCT01237197|3814398|P2|COMPLETED|Randomization Period||10
1559136|NCT01237197|3814399|P1|COMPLETED|Randomization Period||12
1559137|NCT01237197|3814398|P2|STARTED|Randomization Period||13
1559138|NCT01237197|3814399|P1|STARTED|Randomization Period||13
1559139|NCT01237080|3814407|P2|NOT COMPLETED|Overall Study||0
1559140|NCT01237080|3814408|P1|NOT COMPLETED|Overall Study||0
1559141|NCT01237080|3814407|P2|COMPLETED|Overall Study||50
1559142|NCT01237080|3814408|P1|COMPLETED|Overall Study||50
1559143|NCT01237080|3814407|P2|STARTED|Overall Study||50
1559144|NCT01237080|3814408|P1|STARTED|Overall Study||50
1559145|NCT01237054|3814416|P1|NOT COMPLETED|Overall Study||1
1559146|NCT01237054|3814416|P1|COMPLETED|Overall Study||30
1559147|NCT01237054|3814416|P1|STARTED|Overall Study||31
1559148|NCT01237041|3814442|P5|NOT COMPLETED|Overall Study||0
1559149|NCT01237041|3814443|P4|NOT COMPLETED|Overall Study||0
1559150|NCT01237041|3814444|P3|NOT COMPLETED|Overall Study||0
1559151|NCT01237041|3814445|P2|NOT COMPLETED|Overall Study||0
1559152|NCT01237041|3814446|P1|NOT COMPLETED|Overall Study||0
1559153|NCT01237041|3814442|P5|COMPLETED|Overall Study||5
1559154|NCT01237041|3814443|P4|COMPLETED|Overall Study||5
1559155|NCT01237041|3814444|P3|COMPLETED|Overall Study||2
1559156|NCT01237041|3814445|P2|COMPLETED|Overall Study||3
1559157|NCT01237041|3814446|P1|COMPLETED|Overall Study||2
1559158|NCT01237041|3814442|P5|STARTED|Overall Study||5
1559159|NCT01237041|3814443|P4|STARTED|Overall Study||5
1559160|NCT01237041|3814444|P3|STARTED|Overall Study||2
1559161|NCT01237041|3814445|P2|STARTED|Overall Study||3
1559162|NCT01237041|3814446|P1|STARTED|Overall Study||2
1559163|NCT01236768|3814470|P2|NOT COMPLETED|Overall Study||61
1559164|NCT01236768|3814471|P1|NOT COMPLETED|Overall Study||89
1559165|NCT01236768|3814470|P2|COMPLETED|Overall Study||145
1559166|NCT01236768|3814471|P1|COMPLETED|Overall Study||112
1559167|NCT01236768|3814470|P2|STARTED|Overall Study||206
1559168|NCT01236768|3814471|P1|STARTED|Overall Study||201
1559169|NCT01236742|3814488|P3|NOT COMPLETED|Overall Study||3
1559170|NCT01236742|3814489|P2|NOT COMPLETED|Overall Study||3
1559171|NCT01236742|3814490|P1|NOT COMPLETED|Overall Study||3
1559172|NCT01236742|3814488|P3|COMPLETED|Overall Study||13
1559173|NCT01236742|3814489|P2|COMPLETED|Overall Study||16
1559174|NCT01236742|3814490|P1|COMPLETED|Overall Study||15
1559175|NCT01236742|3814488|P3|STARTED|Overall Study||16
1559176|NCT01236742|3814489|P2|STARTED|Overall Study||19
1559177|NCT01236742|3814490|P1|STARTED|Overall Study||18
1559178|NCT01236573|3814512|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
1559179|NCT01236573|3814513|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559180|NCT01236573|3814514|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559181|NCT01236573|3814515|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559182|NCT01236573|3814516|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559183|NCT01236573|3814517|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559184|NCT01236573|3814518|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559185|NCT01236573|3814519|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559186|NCT01236573|3814520|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559187|NCT01236573|3814521|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559188|NCT01236573|3814522|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559189|NCT01236573|3814512|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
1559190|NCT01236573|3814513|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559191|NCT01236573|3814514|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559192|NCT01236573|3814515|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559193|NCT01236573|3814516|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559194|NCT01236573|3814517|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559195|NCT01236573|3814518|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559196|NCT01236573|3814519|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559197|NCT01236573|3814520|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559198|NCT01236573|3814521|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559199|NCT01236573|3814522|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559200|NCT01236573|3814512|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
1559201|NCT01236573|3814513|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559202|NCT01236573|3814514|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559203|NCT01236573|3814515|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559204|NCT01236573|3814516|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559205|NCT01236573|3814517|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559206|NCT01236573|3814518|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559207|NCT01236573|3814519|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559208|NCT01236573|3814520|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559209|NCT01236573|3814521|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559210|NCT01236573|3814522|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1559211|NCT01236573|3814512|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559212|NCT01236573|3814513|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
1559213|NCT01236573|3814514|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
1559214|NCT01236573|3814515|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559215|NCT01236573|3814516|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
1559216|NCT01236573|3814517|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559217|NCT01236573|3814518|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559218|NCT01236573|3814519|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559219|NCT01236573|3814520|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559220|NCT01236573|3814521|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559221|NCT01236573|3814522|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559222|NCT01236573|3814512|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559223|NCT01236573|3814513|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
1559224|NCT01236573|3814514|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
1559225|NCT01236573|3814515|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
1559226|NCT01236573|3814516|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
1559227|NCT01236573|3814517|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
1559228|NCT01236573|3814518|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
1559229|NCT01236573|3814519|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559230|NCT01236573|3814520|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559231|NCT01236573|3814521|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559232|NCT01236573|3814522|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559233|NCT01236573|3814512|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559234|NCT01236573|3814513|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
1559235|NCT01236573|3814514|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
1559236|NCT01236573|3814515|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
1559237|NCT01236573|3814516|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
1559238|NCT01236573|3814517|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
1559239|NCT01236573|3814518|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
1559240|NCT01236573|3814519|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559241|NCT01236573|3814520|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559242|NCT01236573|3814521|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559243|NCT01236573|3814522|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1559244|NCT01236573|3814512|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559245|NCT01236573|3814513|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559246|NCT01236573|3814514|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559247|NCT01236573|3814515|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559248|NCT01236573|3814516|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559249|NCT01236573|3814517|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559250|NCT01236573|3814518|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559251|NCT01236573|3814519|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559252|NCT01236573|3814520|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559253|NCT01236573|3814521|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559254|NCT01236573|3814522|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559255|NCT01236573|3814512|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559256|NCT01236573|3814513|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559257|NCT01236573|3814514|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559258|NCT01236573|3814515|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559259|NCT01236573|3814516|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559260|NCT01236573|3814517|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559261|NCT01236573|3814518|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559262|NCT01236573|3814519|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
1559263|NCT01236573|3814520|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
1559264|NCT01236573|3814521|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
1559265|NCT01236573|3814522|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
1559266|NCT01236573|3814512|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559267|NCT01236573|3814513|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559268|NCT01236573|3814514|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559269|NCT01236573|3814515|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559270|NCT01236573|3814516|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559271|NCT01236573|3814517|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559272|NCT01236573|3814518|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1559273|NCT01236573|3814519|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
1559274|NCT01236573|3814520|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
1559275|NCT01236573|3814521|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
1559276|NCT01236573|3814522|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
1559277|NCT01236534|3814560|P2|NOT COMPLETED|Overall Study||0
1559278|NCT01236534|3814561|P1|NOT COMPLETED|Overall Study||3
1559279|NCT01236534|3814560|P2|COMPLETED|Overall Study||10
1559280|NCT01236534|3814561|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
1559281|NCT01236534|3814560|P2|STARTED|Overall Study||10
1559282|NCT01236534|3814561|P1|STARTED|Overall Study||11
1559283|NCT01236521|3814571|P2|NOT COMPLETED|Overall Study||25
1559284|NCT01236521|3814572|P1|NOT COMPLETED|Overall Study||21
1559285|NCT01236521|3814571|P2|COMPLETED|Overall Study||105
1559286|NCT01236521|3814572|P1|COMPLETED|Overall Study||110
1559287|NCT01236521|3814571|P2|12-moth Completed|Overall Study||105
1559288|NCT01236521|3814572|P1|12-moth Completed|Overall Study||110
1559289|NCT01236521|3814571|P2|9-month Completed|Overall Study||101
1559290|NCT01236521|3814572|P1|9-month Completed|Overall Study||115
1559291|NCT01236521|3814571|P2|6-month Completed|Overall Study||116
1559292|NCT01236521|3814572|P1|6-month Completed|Overall Study||122
1559293|NCT01236521|3814571|P2|3-month Completed|Overall Study||119
1559294|NCT01236521|3814572|P1|3-month Completed|Overall Study||122
1559295|NCT01236521|3814571|P2|STARTED|Overall Study||130
1559296|NCT01236521|3814572|P1|STARTED|Overall Study||131
1559297|NCT01236391|3814600|P1|NOT COMPLETED|Overall Study||16
1559298|NCT01236391|3814600|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
1559299|NCT01236391|3814600|P1|STARTED|Overall Study|Participants who received study treatment|111
1559300|NCT01236378|3814608|P1|NOT COMPLETED|Overall Study||0
1559301|NCT01236378|3814608|P1|COMPLETED|Overall Study||24
1559302|NCT01236378|3814608|P1|STARTED|Overall Study||24
1559303|NCT01236365|3814622|P2|NOT COMPLETED|Overall Study||2
1559304|NCT01236365|3814623|P1|NOT COMPLETED|Overall Study||2
1559305|NCT01236365|3814622|P2|COMPLETED|Overall Study||19
1559306|NCT01236365|3814623|P1|COMPLETED|Overall Study||19
1559307|NCT01236365|3814622|P2|STARTED|Overall Study||21
1559308|NCT01236365|3814623|P1|STARTED|Overall Study||21
1559309|NCT01236339|3814637|P2|NOT COMPLETED|Overall Study||13
1559310|NCT01236339|3814638|P1|NOT COMPLETED|Overall Study||11
1559311|NCT01236339|3814637|P2|COMPLETED|Overall Study||0
1559312|NCT01236339|3814638|P1|COMPLETED|Overall Study||2
1559313|NCT01236339|3814637|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
1559314|NCT01236339|3814638|P1|LVP Crossover to TIPS|Overall Study||0
1559315|NCT01236339|3814637|P2|STARTED|Overall Study||13
1559316|NCT01236339|3814638|P1|STARTED|Overall Study||13
1559317|NCT01236326|3814658|P2|NOT COMPLETED|Overall Study||4
1559318|NCT01236326|3814659|P1|NOT COMPLETED|Overall Study||1
1559319|NCT01236326|3814658|P2|COMPLETED|Overall Study||51
1559320|NCT01236326|3814659|P1|COMPLETED|Overall Study||49
1559321|NCT01236326|3814658|P2|STARTED|Overall Study||55
1559322|NCT01236326|3814659|P1|STARTED|Overall Study||50
1559323|NCT01236300|3814673|P1|NOT COMPLETED|Overall Study||0
1559324|NCT01236300|3814673|P1|COMPLETED|Overall Study||66
1559325|NCT01236300|3814673|P1|STARTED|Overall Study||66
1559326|NCT01236196|3814683|P2|NOT COMPLETED|Overall Study||8
1559327|NCT01236196|3814684|P1|NOT COMPLETED|Overall Study||1
1559328|NCT01236196|3814683|P2|COMPLETED|Overall Study||13
1559329|NCT01236196|3814684|P1|COMPLETED|Overall Study||17
1559330|NCT01236196|3814683|P2|STARTED|Overall Study||21
1559331|NCT01236196|3814684|P1|STARTED|Overall Study||18
1559332|NCT01236170|3814696|P1|NOT COMPLETED|Overall Study||15
1559333|NCT01236170|3814696|P1|COMPLETED|Overall Study||482
1559334|NCT01236170|3814696|P1|STARTED|Overall Study||497
1559335|NCT01236118|3814706|P3|NOT COMPLETED|Overall Study||3
1559336|NCT01236118|3814707|P2|NOT COMPLETED|Overall Study||1
1559337|NCT01236118|3814708|P1|NOT COMPLETED|Overall Study||2
1559338|NCT01236118|3814706|P3|COMPLETED|Overall Study||14
1559339|NCT01236118|3814707|P2|COMPLETED|Overall Study||4
1559340|NCT01236118|3814708|P1|COMPLETED|Overall Study||4
1559341|NCT01236118|3814706|P3|STARTED|Overall Study||17
1559342|NCT01236118|3814707|P2|STARTED|Overall Study||5
1559343|NCT01236118|3814708|P1|STARTED|Overall Study||6
1559344|NCT01236105|3814716|P1|NOT COMPLETED|Overall Study||0
1559345|NCT01236105|3814716|P1|COMPLETED|Overall Study||21
1559346|NCT01236105|3814716|P1|STARTED|Overall Study||21
1559347|NCT01236053|3814752|P22|NOT COMPLETED|Overall Study||0
1559348|NCT01236053|3814753|P21|NOT COMPLETED|Overall Study||0
1559349|NCT01236053|3814754|P20|NOT COMPLETED|Overall Study||0
1559350|NCT01236053|3814755|P19|NOT COMPLETED|Overall Study||0
1559351|NCT01236053|3814756|P18|NOT COMPLETED|Overall Study||0
1559352|NCT01236053|3814757|P17|NOT COMPLETED|Overall Study||0
1559353|NCT01236053|3814758|P16|NOT COMPLETED|Overall Study||0
1559354|NCT01236053|3814759|P15|NOT COMPLETED|Overall Study||0
1559355|NCT01236053|3814760|P14|NOT COMPLETED|Overall Study||0
1559356|NCT01236053|3814761|P13|NOT COMPLETED|Overall Study||0
1559357|NCT01236053|3814762|P12|NOT COMPLETED|Overall Study||0
1559358|NCT01236053|3814763|P11|NOT COMPLETED|Overall Study||0
1559359|NCT01236053|3814764|P10|NOT COMPLETED|Overall Study||0
1559360|NCT01236053|3814765|P9|NOT COMPLETED|Overall Study||0
1559361|NCT01236053|3814766|P8|NOT COMPLETED|Overall Study||0
1559362|NCT01236053|3814767|P7|NOT COMPLETED|Overall Study||0
1559363|NCT01236053|3814768|P6|NOT COMPLETED|Overall Study||0
1559364|NCT01236053|3814769|P5|NOT COMPLETED|Overall Study||0
1559365|NCT01236053|3814770|P4|NOT COMPLETED|Overall Study||0
1559366|NCT01236053|3814771|P3|NOT COMPLETED|Overall Study||0
1559367|NCT01236053|3814772|P2|NOT COMPLETED|Overall Study||0
1559368|NCT01236053|3814773|P1|NOT COMPLETED|Overall Study||0
1559369|NCT01236053|3814752|P22|COMPLETED|Overall Study||12167
1559370|NCT01236053|3814753|P21|COMPLETED|Overall Study||1272
1559371|NCT01236053|3814754|P20|COMPLETED|Overall Study||20382
1559372|NCT01236053|3814755|P19|COMPLETED|Overall Study||2155
1559373|NCT01236053|3814756|P18|COMPLETED|Overall Study||380
1559374|NCT01236053|3814757|P17|COMPLETED|Overall Study||38
1559375|NCT01236053|3814758|P16|COMPLETED|Overall Study||43559
1559376|NCT01236053|3814759|P15|COMPLETED|Overall Study||4600
1559377|NCT01236053|3814760|P14|COMPLETED|Overall Study||1396
1559378|NCT01236053|3814761|P13|COMPLETED|Overall Study||148
1559379|NCT01236053|3814762|P12|COMPLETED|Overall Study||188924
1559380|NCT01236053|3814763|P11|COMPLETED|Overall Study||19564
1559381|NCT01236053|3814764|P10|COMPLETED|Overall Study||2935
1559382|NCT01236053|3814765|P9|COMPLETED|Overall Study||300
1559383|NCT01236053|3814766|P8|COMPLETED|Overall Study||102836
1559384|NCT01236053|3814767|P7|COMPLETED|Overall Study||10855
1559385|NCT01236053|3814768|P6|COMPLETED|Overall Study||2067
1559386|NCT01236053|3814769|P5|COMPLETED|Overall Study||212
1559387|NCT01236053|3814770|P4|COMPLETED|Overall Study||17853
1559388|NCT01236053|3814771|P3|COMPLETED|Overall Study||1877
1559389|NCT01236053|3814772|P2|COMPLETED|Overall Study||1710950
1559390|NCT01236053|3814773|P1|COMPLETED|Overall Study||179138
1559391|NCT01236053|3814752|P22|STARTED|Overall Study||12167
1559392|NCT01236053|3814753|P21|STARTED|Overall Study||1272
1559393|NCT01236053|3814754|P20|STARTED|Overall Study||20382
1559394|NCT01236053|3814755|P19|STARTED|Overall Study||2155
1559395|NCT01236053|3814756|P18|STARTED|Overall Study||380
1559396|NCT01236053|3814757|P17|STARTED|Overall Study||38
1559397|NCT01236053|3814758|P16|STARTED|Overall Study||43559
1559398|NCT01236053|3814759|P15|STARTED|Overall Study||4600
1559399|NCT01236053|3814760|P14|STARTED|Overall Study||1396
1559400|NCT01236053|3814761|P13|STARTED|Overall Study||148
1559401|NCT01236053|3814762|P12|STARTED|Overall Study||188924
1559402|NCT01236053|3814763|P11|STARTED|Overall Study||19564
1559403|NCT01236053|3814764|P10|STARTED|Overall Study||2935
1559404|NCT01236053|3814765|P9|STARTED|Overall Study||300
1559405|NCT01236053|3814766|P8|STARTED|Overall Study||102836
1559406|NCT01236053|3814767|P7|STARTED|Overall Study||10855
1559407|NCT01236053|3814768|P6|STARTED|Overall Study||2067
1559408|NCT01236053|3814769|P5|STARTED|Overall Study||212
1559409|NCT01236053|3814770|P4|STARTED|Overall Study||17853
1559410|NCT01236053|3814771|P3|STARTED|Overall Study||1877
1559411|NCT01236053|3814772|P2|STARTED|Overall Study||1710950
1559412|NCT01236053|3814773|P1|STARTED|Overall Study||179138
1559413|NCT01236001|3814909|P2|NOT COMPLETED|Overall Study||22
1559414|NCT01236001|3814910|P1|NOT COMPLETED|Overall Study||18
1559415|NCT01236001|3814909|P2|COMPLETED|Overall Study||65
1559416|NCT01236001|3814910|P1|COMPLETED|Overall Study||87
1559417|NCT01236001|3814909|P2|STARTED|Overall Study||87
1559418|NCT01236001|3814910|P1|STARTED|Overall Study||105
1559419|NCT01235975|3814942|P2|NOT COMPLETED|Overall Study||7
1559420|NCT01235975|3814943|P1|NOT COMPLETED|Overall Study||17
1559421|NCT01235975|3814942|P2|COMPLETED|Overall Study||88
1559422|NCT01235975|3814943|P1|COMPLETED|Overall Study||257
1559423|NCT01235975|3814942|P2|STARTED|Overall Study||95
1559424|NCT01235975|3814943|P1|STARTED|Overall Study||274
1559425|NCT01235923|3814977|P2|NOT COMPLETED|Overall Study||0
1559426|NCT01235923|3814978|P1|NOT COMPLETED|Overall Study||0
1559427|NCT01235923|3814977|P2|COMPLETED|Overall Study||10
1559428|NCT01235923|3814978|P1|COMPLETED|Overall Study||10
1559429|NCT01235923|3814977|P2|STARTED|Overall Study||10
1559430|NCT01235923|3814978|P1|STARTED|Overall Study||10
1559431|NCT01235910|3814986|P1|NOT COMPLETED|Overall Study||0
1559432|NCT01235910|3814986|P1|COMPLETED|Overall Study||1
1559433|NCT01235910|3814986|P1|STARTED|Overall Study||1
1559434|NCT01235897|3814992|P1|NOT COMPLETED|Overall Study||0
1559435|NCT01235897|3814992|P1|COMPLETED|Overall Study||16
1559436|NCT01235897|3814992|P1|STARTED|Overall Study||16
1559437|NCT01235793|3814997|P1|NOT COMPLETED|Overall Study||6
1559438|NCT01235793|3814997|P1|COMPLETED|Overall Study||5
1559439|NCT01235793|3814997|P1|STARTED|Overall Study||11
1559440|NCT01235741|3815005|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
1559441|NCT01235741|3815006|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
1559442|NCT01235741|3815007|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
1559443|NCT01235741|3815005|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
1559444|NCT01235741|3815006|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
1559445|NCT01235741|3815007|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
1559446|NCT01235741|3815005|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
1559447|NCT01235741|3815006|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
1559448|NCT01235741|3815007|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
1559449|NCT01235741|3815005|P3|NOT COMPLETED|Randomized to Treatment||36
1559450|NCT01235741|3815006|P2|NOT COMPLETED|Randomized to Treatment||36
1559451|NCT01235741|3815007|P1|NOT COMPLETED|Randomized to Treatment||0
1559452|NCT01235741|3815005|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
1559453|NCT01235741|3815006|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
1559454|NCT01235741|3815007|P1|COMPLETED|Randomized to Treatment||0
1559455|NCT01235741|3815005|P3|STARTED|Randomized to Treatment||36
1559456|NCT01235741|3815006|P2|STARTED|Randomized to Treatment||36
1559457|NCT01235741|3815007|P1|STARTED|Randomized to Treatment||0
1559458|NCT01235741|3815005|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1559459|NCT01235741|3815006|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1559460|NCT01235741|3815007|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
1559461|NCT01235741|3815005|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1559462|NCT01235741|3815006|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1559463|NCT01235741|3815007|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
1559464|NCT01235741|3815005|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
1559465|NCT01235741|3815006|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
1559466|NCT01235741|3815007|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
1559467|NCT01235728|3815034|P8|NOT COMPLETED|Overall Study||0
1559468|NCT01235728|3815035|P7|NOT COMPLETED|Overall Study||0
1559469|NCT01235728|3815036|P6|NOT COMPLETED|Overall Study||0
1559470|NCT01235728|3815037|P5|NOT COMPLETED|Overall Study||0
1559471|NCT01235728|3815038|P4|NOT COMPLETED|Overall Study||1
1559472|NCT01235728|3815039|P3|NOT COMPLETED|Overall Study||0
1559473|NCT01235728|3815040|P2|NOT COMPLETED|Overall Study||0
1559474|NCT01235728|3815041|P1|NOT COMPLETED|Overall Study||0
1559475|NCT01235728|3815034|P8|COMPLETED|Overall Study||3
1559476|NCT01235728|3815035|P7|COMPLETED|Overall Study||3
1559477|NCT01235728|3815036|P6|COMPLETED|Overall Study||3
1559478|NCT01235728|3815037|P5|COMPLETED|Overall Study||3
1559479|NCT01235728|3815038|P4|COMPLETED|Overall Study||2
1559480|NCT01235728|3815039|P3|COMPLETED|Overall Study||3
1559481|NCT01235728|3815040|P2|COMPLETED|Overall Study||3
1559482|NCT01235728|3815041|P1|COMPLETED|Overall Study||3
1559483|NCT01235728|3815034|P8|STARTED|Overall Study||3
1559484|NCT01235728|3815035|P7|STARTED|Overall Study||3
1559485|NCT01235728|3815036|P6|STARTED|Overall Study||3
1559486|NCT01235728|3815037|P5|STARTED|Overall Study||3
1559487|NCT01235728|3815038|P4|STARTED|Overall Study||3
1559488|NCT01235728|3815039|P3|STARTED|Overall Study||3
1559489|NCT01235728|3815040|P2|STARTED|Overall Study||3
1559490|NCT01235728|3815041|P1|STARTED|Overall Study||3
1559491|NCT01235715|3815051|P2|NOT COMPLETED|Overall Study||2
1559492|NCT01235715|3815052|P1|NOT COMPLETED|Overall Study||0
1559493|NCT01235715|3815051|P2|COMPLETED|Overall Study||100
1559494|NCT01235715|3815052|P1|COMPLETED|Overall Study||98
1559495|NCT01235715|3815051|P2|STARTED|Overall Study||102
1559496|NCT01235715|3815052|P1|STARTED|Overall Study||98
1559497|NCT01235689|3815092|P2|NOT COMPLETED|Overall Study||32
1559498|NCT01235689|3815093|P1|NOT COMPLETED|Overall Study||29
1559499|NCT01235689|3815092|P2|COMPLETED|Overall Study||90
1559500|NCT01235689|3815093|P1|COMPLETED|Overall Study||93
1559501|NCT01235689|3815092|P2|Randomized at Week 9|Overall Study||53
1559502|NCT01235689|3815093|P1|Randomized at Week 9|Overall Study||59
1559503|NCT01235689|3815092|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
1559504|NCT01235689|3815093|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
1559505|NCT01235689|3815092|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
1559506|NCT01235689|3815093|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
1559507|NCT01235598|3815165|P2|NOT COMPLETED|Overall Study||4
1559508|NCT01235598|3815166|P1|NOT COMPLETED|Overall Study||1
1559509|NCT01235598|3815165|P2|COMPLETED|Overall Study||24
1559510|NCT01235598|3815166|P1|COMPLETED|Overall Study||12
1559511|NCT01235598|3815165|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
1559512|NCT01235598|3815166|P1|STARTED|Overall Study||13
1559513|NCT01235546|3815211|P2|NOT COMPLETED|Overall Study||1
1559514|NCT01235546|3815212|P1|NOT COMPLETED|Overall Study||2
1559515|NCT01235546|3815211|P2|COMPLETED|Overall Study||1018
1559516|NCT01235546|3815212|P1|COMPLETED|Overall Study||992
1559517|NCT01235546|3815211|P2|STARTED|Overall Study||1019
1559518|NCT01235546|3815212|P1|STARTED|Overall Study||994
1559519|NCT01235507|3815236|P1|NOT COMPLETED|Overall Study||2
1559520|NCT01235507|3815236|P1|COMPLETED|Overall Study||69
1559521|NCT01235507|3815236|P1|STARTED|Overall Study||71
1559522|NCT01235442|3815250|P2|NOT COMPLETED|Overall Study||44
1559523|NCT01235442|3815251|P1|NOT COMPLETED|Overall Study||44
1559524|NCT01235442|3815250|P2|COMPLETED|Overall Study||251
1559525|NCT01235442|3815251|P1|COMPLETED|Overall Study||253
1559526|NCT01235442|3815250|P2|STARTED|Overall Study||295
1559527|NCT01235442|3815251|P1|STARTED|Overall Study||297
1559528|NCT01235403|3815269|P1|NOT COMPLETED|Overall Study||26
1559529|NCT01235403|3815269|P1|COMPLETED|Overall Study||74
1559530|NCT01235403|3815269|P1|STARTED|Overall Study||100
1559531|NCT01235377|3815277|P2|NOT COMPLETED|Overall Study||1
1559532|NCT01235377|3815278|P1|NOT COMPLETED|Overall Study||1
1559533|NCT01235377|3815277|P2|COMPLETED|Overall Study||8
1559534|NCT01235377|3815278|P1|COMPLETED|Overall Study||10
1559535|NCT01235377|3815277|P2|STARTED|Overall Study||9
1559536|NCT01235377|3815278|P1|STARTED|Overall Study||11
1559537|NCT01235338|3815286|P2|NOT COMPLETED|Overall Study||5
1559538|NCT01235338|3815287|P1|NOT COMPLETED|Overall Study||11
1559539|NCT01235338|3815286|P2|COMPLETED|Overall Study||33
1559540|NCT01235338|3815287|P1|COMPLETED|Overall Study||31
1559541|NCT01235338|3815286|P2|STARTED|Overall Study||38
1559542|NCT01235338|3815287|P1|STARTED|Overall Study||42
1559543|NCT01235234|3815332|P3|NOT COMPLETED|Overall Study||1
1559544|NCT01235234|3815333|P2|NOT COMPLETED|Overall Study||2
1559545|NCT01235234|3815334|P1|NOT COMPLETED|Overall Study||2
1559546|NCT01235234|3815332|P3|COMPLETED|Overall Study||80
1559547|NCT01235234|3815333|P2|COMPLETED|Overall Study||76
1559548|NCT01235234|3815334|P1|COMPLETED|Overall Study||75
1559549|NCT01235234|3815332|P3|STARTED|Overall Study||81
1559550|NCT01235234|3815333|P2|STARTED|Overall Study||78
1559551|NCT01235234|3815334|P1|STARTED|Overall Study||77
1559552|NCT01235195|3815342|P2|NOT COMPLETED|Second Intervention||0
1559553|NCT01235195|3815343|P1|NOT COMPLETED|Second Intervention||0
1559554|NCT01235195|3815342|P2|COMPLETED|Second Intervention||15
1559555|NCT01235195|3815343|P1|COMPLETED|Second Intervention||15
1559556|NCT01235195|3815342|P2|STARTED|Second Intervention||15
1559557|NCT01235195|3815343|P1|STARTED|Second Intervention||15
1559558|NCT01235195|3815342|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
1559559|NCT01235195|3815343|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
1559560|NCT01235195|3815342|P2|COMPLETED|Washout Period of At Least 8 Days||15
1559561|NCT01235195|3815343|P1|COMPLETED|Washout Period of At Least 8 Days||15
1559562|NCT01235195|3815342|P2|STARTED|Washout Period of At Least 8 Days||15
1559563|NCT01235195|3815343|P1|STARTED|Washout Period of At Least 8 Days||15
1559564|NCT01235195|3815342|P2|NOT COMPLETED|First Intervention||0
1559565|NCT01235195|3815343|P1|NOT COMPLETED|First Intervention||0
1559566|NCT01235195|3815342|P2|COMPLETED|First Intervention||15
1559567|NCT01235195|3815343|P1|COMPLETED|First Intervention||15
1559568|NCT01235195|3815342|P2|STARTED|First Intervention||15
1559569|NCT01235195|3815343|P1|STARTED|First Intervention||15
1559570|NCT01234922|3815363|P4|NOT COMPLETED|Overall Study||0
1559571|NCT01234922|3815364|P3|NOT COMPLETED|Overall Study||0
1559572|NCT01234922|3815365|P2|NOT COMPLETED|Overall Study||0
1559573|NCT01234922|3815366|P1|NOT COMPLETED|Overall Study||0
1559574|NCT01234922|3815363|P4|COMPLETED|Overall Study||2
1559575|NCT01234922|3815364|P3|COMPLETED|Overall Study||2
1559576|NCT01234922|3815365|P2|COMPLETED|Overall Study||1
1559577|NCT01234922|3815366|P1|COMPLETED|Overall Study||1
1559578|NCT01234922|3815363|P4|STARTED|Overall Study||2
1559579|NCT01234922|3815364|P3|STARTED|Overall Study||2
1559580|NCT01234922|3815365|P2|STARTED|Overall Study||1
1559581|NCT01234922|3815366|P1|STARTED|Overall Study||1
1559582|NCT01234883|3815382|P2|NOT COMPLETED|Overall Study||13
1559583|NCT01234883|3815383|P1|NOT COMPLETED|Overall Study||10
1559584|NCT01234883|3815382|P2|COMPLETED|Overall Study||36
1559585|NCT01234883|3815383|P1|COMPLETED|Overall Study||41
1559586|NCT01234883|3815382|P2|STARTED|Overall Study||49
1559587|NCT01234883|3815383|P1|STARTED|Overall Study||51
1559588|NCT01234870|3815389|P1|NOT COMPLETED|Overall Study||0
1559589|NCT01234870|3815389|P1|COMPLETED|Overall Study||40
1559590|NCT01234870|3815389|P1|STARTED|Overall Study||40
1559591|NCT01234831|3815396|P2|NOT COMPLETED|Overall Study||4
1559592|NCT01234831|3815397|P1|NOT COMPLETED|Overall Study||2
1559593|NCT01234831|3815396|P2|COMPLETED|Overall Study||198
1559594|NCT01234831|3815397|P1|COMPLETED|Overall Study||259
1559595|NCT01234831|3815396|P2|STARTED|Overall Study||202
1559596|NCT01234831|3815397|P1|STARTED|Overall Study||261
1559597|NCT01234766|3815409|P1|NOT COMPLETED|Overall Study||4
1559598|NCT01234766|3815409|P1|COMPLETED|Overall Study||35
1559599|NCT01234766|3815409|P1|STARTED|Overall Study||39
1559600|NCT01234714|3815413|P1|NOT COMPLETED|Overall Study||0
1559601|NCT01234714|3815413|P1|COMPLETED|Overall Study||84
1559602|NCT01234714|3815413|P1|STARTED|Overall Study||84
1559603|NCT01234675|3815430|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1559604|NCT01234675|3815431|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
1559605|NCT01234675|3815430|P2|COMPLETED|Second Intervention (6 Weeks)||8
1559606|NCT01234675|3815431|P1|COMPLETED|Second Intervention (6 Weeks)||7
1559607|NCT01234675|3815430|P2|STARTED|Second Intervention (6 Weeks)||8
1559608|NCT01234675|3815431|P1|STARTED|Second Intervention (6 Weeks)||9
1559609|NCT01234675|3815430|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
1559610|NCT01234675|3815431|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
1559611|NCT01234675|3815430|P2|COMPLETED|First Intervention (6 Weeks)||8
1559612|NCT01234675|3815431|P1|COMPLETED|First Intervention (6 Weeks)||9
1559613|NCT01234675|3815430|P2|STARTED|First Intervention (6 Weeks)||9
1559614|NCT01234675|3815431|P1|STARTED|First Intervention (6 Weeks)||10
1559615|NCT01234467|3815445|P1|NOT COMPLETED|Overall Study||12
1559616|NCT01234467|3815445|P1|COMPLETED|Overall Study||11
1559617|NCT01234467|3815445|P1|STARTED|Overall Study||23
1559618|NCT01234337|3815456|P2|NOT COMPLETED|Overall Study||271
1559619|NCT01234337|3815457|P1|NOT COMPLETED|Overall Study||266
1559620|NCT01234337|3815456|P2|COMPLETED|Overall Study||0
1559621|NCT01234337|3815457|P1|COMPLETED|Overall Study||0
1559622|NCT01234337|3815456|P2|Participants Received Treatment|Overall Study||267
1559623|NCT01234337|3815457|P1|Participants Received Treatment|Overall Study||260
1559624|NCT01234337|3815456|P2|STARTED|Overall Study||271
1559625|NCT01234337|3815457|P1|STARTED|Overall Study||266
1559626|NCT01234207|3815485|P2|NOT COMPLETED|Second Intervention||0
1559627|NCT01234207|3815486|P1|NOT COMPLETED|Second Intervention||0
1559628|NCT01234207|3815485|P2|COMPLETED|Second Intervention||48
1559629|NCT01234207|3815486|P1|COMPLETED|Second Intervention||47
1559630|NCT01234207|3815485|P2|STARTED|Second Intervention||48
1559631|NCT01234207|3815486|P1|STARTED|Second Intervention||47
1559632|NCT01234207|3815485|P2|NOT COMPLETED|1-Week Washout Period||0
1559633|NCT01234207|3815486|P1|NOT COMPLETED|1-Week Washout Period||0
1559634|NCT01234207|3815485|P2|COMPLETED|1-Week Washout Period||48
1559635|NCT01234207|3815486|P1|COMPLETED|1-Week Washout Period||47
1559636|NCT01234207|3815485|P2|STARTED|1-Week Washout Period||48
1559637|NCT01234207|3815486|P1|STARTED|1-Week Washout Period||47
1559638|NCT01234207|3815485|P2|NOT COMPLETED|First Intervention||0
1559639|NCT01234207|3815486|P1|NOT COMPLETED|First Intervention||0
1559640|NCT01234207|3815485|P2|COMPLETED|First Intervention||48
1559641|NCT01234207|3815486|P1|COMPLETED|First Intervention||47
1559642|NCT01234207|3815485|P2|STARTED|First Intervention||48
1559643|NCT01234207|3815486|P1|STARTED|First Intervention||47
1559644|NCT01234103|3815508|P2|NOT COMPLETED|Overall Study||0
1559645|NCT01234103|3815509|P1|NOT COMPLETED|Overall Study||0
1559646|NCT01234103|3815508|P2|COMPLETED|Overall Study||391
1559647|NCT01234103|3815509|P1|COMPLETED|Overall Study||542
1559648|NCT01234103|3815508|P2|STARTED|Overall Study||391
1559649|NCT01234103|3815509|P1|STARTED|Overall Study||542
1559650|NCT01233999|3815517|P1|NOT COMPLETED|Overall Study||2
1559651|NCT01233999|3815517|P1|COMPLETED|Overall Study||8
1559652|NCT01233999|3815517|P1|STARTED|Overall Study||10
1559653|NCT01233921|3815523|P2|NOT COMPLETED|Overall Study||0
1559654|NCT01233921|3815524|P1|NOT COMPLETED|Overall Study||0
1559655|NCT01233921|3815523|P2|COMPLETED|Overall Study||3
1559656|NCT01233921|3815524|P1|COMPLETED|Overall Study||3
1559657|NCT01233921|3815523|P2|STARTED|Overall Study||3
1559658|NCT01233921|3815524|P1|STARTED|Overall Study||3
1559659|NCT01233869|3815536|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
1559660|NCT01233869|3815537|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
1559661|NCT01233869|3815538|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
1559662|NCT01233869|3815539|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
1559663|NCT01233869|3815536|P4|COMPLETED|Extended Treatment Period (46 Months)||18
1559664|NCT01233869|3815537|P3|COMPLETED|Extended Treatment Period (46 Months)||17
1559665|NCT01233869|3815538|P2|COMPLETED|Extended Treatment Period (46 Months)||0
1559666|NCT01233869|3815539|P1|COMPLETED|Extended Treatment Period (46 Months)||20
1559667|NCT01233869|3815536|P4|STARTED|Extended Treatment Period (46 Months)||34
1559668|NCT01233869|3815537|P3|STARTED|Extended Treatment Period (46 Months)||22
1559669|NCT01233869|3815538|P2|STARTED|Extended Treatment Period (46 Months)||3
1559670|NCT01233869|3815539|P1|STARTED|Extended Treatment Period (46 Months)||34
1559671|NCT01233869|3815536|P4|NOT COMPLETED|Washout Period 30 Days||0
1559672|NCT01233869|3815537|P3|NOT COMPLETED|Washout Period 30 Days||0
1559673|NCT01233869|3815538|P2|NOT COMPLETED|Washout Period 30 Days||0
1559674|NCT01233869|3815539|P1|NOT COMPLETED|Washout Period 30 Days||0
1559675|NCT01233869|3815536|P4|COMPLETED|Washout Period 30 Days||34
1559676|NCT01233869|3815537|P3|COMPLETED|Washout Period 30 Days||22
1559677|NCT01233869|3815538|P2|COMPLETED|Washout Period 30 Days||3
1559678|NCT01233869|3815539|P1|COMPLETED|Washout Period 30 Days||34
1559679|NCT01233869|3815536|P4|STARTED|Washout Period 30 Days||34
1559680|NCT01233869|3815537|P3|STARTED|Washout Period 30 Days||22
1559681|NCT01233869|3815538|P2|STARTED|Washout Period 30 Days||3
1559682|NCT01233869|3815539|P1|STARTED|Washout Period 30 Days||34
1559683|NCT01233869|3815536|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
1559684|NCT01233869|3815537|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
1559685|NCT01233869|3815538|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
1559686|NCT01233869|3815539|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
1559687|NCT01233869|3815536|P4|COMPLETED|Initial Treatment Period (24 Months)||34
1559688|NCT01233869|3815537|P3|COMPLETED|Initial Treatment Period (24 Months)||22
1559689|NCT01233869|3815538|P2|COMPLETED|Initial Treatment Period (24 Months)||3
1559690|NCT01233869|3815539|P1|COMPLETED|Initial Treatment Period (24 Months)||34
1559691|NCT01233869|3815536|P4|STARTED|Initial Treatment Period (24 Months)||56
1559692|NCT01233869|3815537|P3|STARTED|Initial Treatment Period (24 Months)||24
1559693|NCT01233869|3815538|P2|STARTED|Initial Treatment Period (24 Months)||31
1559694|NCT01233869|3815539|P1|STARTED|Initial Treatment Period (24 Months)||58
1559695|NCT01233817|3815625|P1|NOT COMPLETED|Overall Study||3
1559696|NCT01233817|3815625|P1|COMPLETED|Overall Study||9
1559697|NCT01233817|3815625|P1|STARTED|Overall Study||12
1559698|NCT01233726|3815632|P3|NOT COMPLETED|Overall Study||1
1559699|NCT01233726|3815633|P2|NOT COMPLETED|Overall Study||0
1559700|NCT01233726|3815634|P1|NOT COMPLETED|Overall Study||1
1559701|NCT01233726|3815632|P3|COMPLETED|Overall Study||52
1559702|NCT01233726|3815633|P2|COMPLETED|Overall Study||53
1559703|NCT01233726|3815634|P1|COMPLETED|Overall Study||52
1559704|NCT01233726|3815632|P3|STARTED|Overall Study||53
1559705|NCT01233726|3815633|P2|STARTED|Overall Study||53
1559706|NCT01233726|3815634|P1|STARTED|Overall Study||53
1559707|NCT01233687|3815672|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
1559708|NCT01233687|3815672|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
1559709|NCT01233687|3815672|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
1559710|NCT01233687|3815672|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
1559711|NCT01233687|3815672|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
1559712|NCT01233687|3815672|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
1559713|NCT01233687|3815672|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
1559714|NCT01233609|3815682|P2|NOT COMPLETED|Overall Study||2
1559715|NCT01233609|3815683|P1|NOT COMPLETED|Overall Study||9
1559716|NCT01233609|3815682|P2|COMPLETED|Overall Study||42
1559717|NCT01233609|3815683|P1|COMPLETED|Overall Study||37
1559718|NCT01233609|3815682|P2|STARTED|Overall Study||44
1559719|NCT01233609|3815683|P1|STARTED|Overall Study||46
1559720|NCT01233284|3815707|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
1559721|NCT01233284|3815708|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
1559722|NCT01233284|3815709|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
1559723|NCT01233284|3815710|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
1559724|NCT01233284|3815711|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
1559725|NCT01233284|3815707|P5|COMPLETED|Period 4 (4 Weeks)||1
1559726|NCT01233284|3815708|P4|COMPLETED|Period 4 (4 Weeks)||33
1559727|NCT01233284|3815709|P3|COMPLETED|Period 4 (4 Weeks)||35
1559728|NCT01233284|3815710|P2|COMPLETED|Period 4 (4 Weeks)||36
1559729|NCT01233284|3815711|P1|COMPLETED|Period 4 (4 Weeks)||36
1559730|NCT01233284|3815707|P5|STARTED|Period 4 (4 Weeks)||1
1559731|NCT01233284|3815708|P4|STARTED|Period 4 (4 Weeks)||34
1559732|NCT01233284|3815709|P3|STARTED|Period 4 (4 Weeks)||35
1559733|NCT01233284|3815710|P2|STARTED|Period 4 (4 Weeks)||37
1559734|NCT01233284|3815711|P1|STARTED|Period 4 (4 Weeks)||36
1559735|NCT01233284|3815707|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
1559736|NCT01233284|3815708|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
1559737|NCT01233284|3815709|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
1559738|NCT01233284|3815710|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
1559739|NCT01233284|3815711|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
1559740|NCT01233284|3815707|P5|COMPLETED|Period 3 (4 Weeks)||1
1559741|NCT01233284|3815708|P4|COMPLETED|Period 3 (4 Weeks)||34
1559742|NCT01233284|3815709|P3|COMPLETED|Period 3 (4 Weeks)||35
1559743|NCT01233284|3815710|P2|COMPLETED|Period 3 (4 Weeks)||37
1559744|NCT01233284|3815711|P1|COMPLETED|Period 3 (4 Weeks)||36
1559745|NCT01233284|3815707|P5|STARTED|Period 3 (4 Weeks)||1
1559746|NCT01233284|3815708|P4|STARTED|Period 3 (4 Weeks)||35
1559747|NCT01233284|3815709|P3|STARTED|Period 3 (4 Weeks)||36
1559748|NCT01233284|3815710|P2|STARTED|Period 3 (4 Weeks)||37
1559749|NCT01233284|3815711|P1|STARTED|Period 3 (4 Weeks)||36
1559750|NCT01233284|3815707|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
1559751|NCT01233284|3815708|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
1559752|NCT01233284|3815709|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
1559753|NCT01233284|3815710|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
1559754|NCT01233284|3815711|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
1559755|NCT01233284|3815707|P5|COMPLETED|Period 2 (4 Weeks)||1
1559756|NCT01233284|3815708|P4|COMPLETED|Period 2 (4 Weeks)||35
1559757|NCT01233284|3815709|P3|COMPLETED|Period 2 (4 Weeks)||36
1559758|NCT01233284|3815710|P2|COMPLETED|Period 2 (4 Weeks)||37
1559759|NCT01233284|3815711|P1|COMPLETED|Period 2 (4 Weeks)||36
1559760|NCT01233284|3815707|P5|STARTED|Period 2 (4 Weeks)||1
1559761|NCT01233284|3815708|P4|STARTED|Period 2 (4 Weeks)||35
1559762|NCT01233284|3815709|P3|STARTED|Period 2 (4 Weeks)||37
1559763|NCT01233284|3815710|P2|STARTED|Period 2 (4 Weeks)||37
1559764|NCT01233284|3815711|P1|STARTED|Period 2 (4 Weeks)||36
1559765|NCT01233284|3815707|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
1559766|NCT01233284|3815708|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
1559767|NCT01233284|3815709|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
1559768|NCT01233284|3815710|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
1559769|NCT01233284|3815711|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
1559770|NCT01233284|3815707|P5|COMPLETED|Period 1 (4 Weeks)||1
1559771|NCT01233284|3815708|P4|COMPLETED|Period 1 (4 Weeks)||35
1559772|NCT01233284|3815709|P3|COMPLETED|Period 1 (4 Weeks)||37
1559773|NCT01233284|3815710|P2|COMPLETED|Period 1 (4 Weeks)||37
1559774|NCT01233284|3815711|P1|COMPLETED|Period 1 (4 Weeks)||36
1559775|NCT01233284|3815707|P5|STARTED|Period 1 (4 Weeks)||1
1559776|NCT01233284|3815708|P4|STARTED|Period 1 (4 Weeks)||35
1559777|NCT01233284|3815709|P3|STARTED|Period 1 (4 Weeks)||38
1559778|NCT01233284|3815710|P2|STARTED|Period 1 (4 Weeks)||38
1559779|NCT01233284|3815711|P1|STARTED|Period 1 (4 Weeks)||37
1559780|NCT01233258|3815792|P6|NOT COMPLETED|Second Intervention (6 Months)||0
1559781|NCT01233258|3815793|P5|NOT COMPLETED|Second Intervention (6 Months)||0
1559782|NCT01233258|3815794|P4|NOT COMPLETED|Second Intervention (6 Months)||0
1559783|NCT01233258|3815795|P3|NOT COMPLETED|Second Intervention (6 Months)||0
1559784|NCT01233258|3815796|P2|NOT COMPLETED|Second Intervention (6 Months)||0
1559785|NCT01233258|3815797|P1|NOT COMPLETED|Second Intervention (6 Months)||0
1559786|NCT01233258|3815792|P6|COMPLETED|Second Intervention (6 Months)||15
1559787|NCT01233258|3815793|P5|COMPLETED|Second Intervention (6 Months)||16
1559788|NCT01233258|3815794|P4|COMPLETED|Second Intervention (6 Months)||15
1559789|NCT01233258|3815795|P3|COMPLETED|Second Intervention (6 Months)||13
1559790|NCT01233258|3815796|P2|COMPLETED|Second Intervention (6 Months)||10
1559791|NCT01233258|3815797|P1|COMPLETED|Second Intervention (6 Months)||10
1559792|NCT01233258|3815792|P6|STARTED|Second Intervention (6 Months)||15
1559793|NCT01233258|3815793|P5|STARTED|Second Intervention (6 Months)||16
1559794|NCT01233258|3815794|P4|STARTED|Second Intervention (6 Months)||15
1559795|NCT01233258|3815795|P3|STARTED|Second Intervention (6 Months)||13
1559796|NCT01233258|3815796|P2|STARTED|Second Intervention (6 Months)||10
1559797|NCT01233258|3815797|P1|STARTED|Second Intervention (6 Months)||10
1559798|NCT01233258|3815792|P6|NOT COMPLETED|Washout (2-3 Days)||0
1559799|NCT01233258|3815793|P5|NOT COMPLETED|Washout (2-3 Days)||0
1559800|NCT01233258|3815794|P4|NOT COMPLETED|Washout (2-3 Days)||0
1559801|NCT01233258|3815795|P3|NOT COMPLETED|Washout (2-3 Days)||0
1559802|NCT01233258|3815796|P2|NOT COMPLETED|Washout (2-3 Days)||0
1559803|NCT01233258|3815797|P1|NOT COMPLETED|Washout (2-3 Days)||0
1559804|NCT01233258|3815792|P6|COMPLETED|Washout (2-3 Days)||15
1559805|NCT01233258|3815793|P5|COMPLETED|Washout (2-3 Days)||16
1559806|NCT01233258|3815794|P4|COMPLETED|Washout (2-3 Days)||15
1559807|NCT01233258|3815795|P3|COMPLETED|Washout (2-3 Days)||13
1559808|NCT01233258|3815796|P2|COMPLETED|Washout (2-3 Days)||10
1559809|NCT01233258|3815797|P1|COMPLETED|Washout (2-3 Days)||10
1559810|NCT01233258|3815792|P6|STARTED|Washout (2-3 Days)||15
1559811|NCT01233258|3815793|P5|STARTED|Washout (2-3 Days)||16
1559812|NCT01233258|3815794|P4|STARTED|Washout (2-3 Days)||15
1559813|NCT01233258|3815795|P3|STARTED|Washout (2-3 Days)||13
1559814|NCT01233258|3815796|P2|STARTED|Washout (2-3 Days)||10
1559815|NCT01233258|3815797|P1|STARTED|Washout (2-3 Days)||10
1559816|NCT01233258|3815792|P6|NOT COMPLETED|First Intervention (6 Months)||1
1559817|NCT01233258|3815793|P5|NOT COMPLETED|First Intervention (6 Months)||0
1559818|NCT01233258|3815794|P4|NOT COMPLETED|First Intervention (6 Months)||1
1559819|NCT01233258|3815795|P3|NOT COMPLETED|First Intervention (6 Months)||1
1559820|NCT01233258|3815796|P2|NOT COMPLETED|First Intervention (6 Months)||0
1559821|NCT01233258|3815797|P1|NOT COMPLETED|First Intervention (6 Months)||1
1559822|NCT01233258|3815792|P6|COMPLETED|First Intervention (6 Months)||15
1559823|NCT01233258|3815793|P5|COMPLETED|First Intervention (6 Months)||16
1559824|NCT01233258|3815794|P4|COMPLETED|First Intervention (6 Months)||15
1559825|NCT01233258|3815795|P3|COMPLETED|First Intervention (6 Months)||13
1559826|NCT01233258|3815796|P2|COMPLETED|First Intervention (6 Months)||10
1559827|NCT01233258|3815797|P1|COMPLETED|First Intervention (6 Months)||10
1559828|NCT01233258|3815792|P6|Participants Received Treatment|First Intervention (6 Months)||15
1559829|NCT01233258|3815793|P5|Participants Received Treatment|First Intervention (6 Months)||16
1559830|NCT01233258|3815794|P4|Participants Received Treatment|First Intervention (6 Months)||15
1559831|NCT01233258|3815795|P3|Participants Received Treatment|First Intervention (6 Months)||13
1559832|NCT01233258|3815796|P2|Participants Received Treatment|First Intervention (6 Months)||10
1559833|NCT01233258|3815797|P1|Participants Received Treatment|First Intervention (6 Months)||11
1559834|NCT01233258|3815792|P6|STARTED|First Intervention (6 Months)||16
1559835|NCT01233258|3815793|P5|STARTED|First Intervention (6 Months)||16
1559836|NCT01233258|3815794|P4|STARTED|First Intervention (6 Months)||16
1559837|NCT01233258|3815795|P3|STARTED|First Intervention (6 Months)||14
1559838|NCT01233258|3815796|P2|STARTED|First Intervention (6 Months)||10
1559839|NCT01233258|3815797|P1|STARTED|First Intervention (6 Months)||11
1559840|NCT01233232|3815817|P3|NOT COMPLETED|Overall Study||0
1559841|NCT01233232|3815818|P2|NOT COMPLETED|Overall Study||0
1559842|NCT01233232|3815819|P1|NOT COMPLETED|Overall Study||1
1559843|NCT01233232|3815817|P3|COMPLETED|Overall Study||28
1559844|NCT01233232|3815818|P2|COMPLETED|Overall Study||30
1559845|NCT01233232|3815819|P1|COMPLETED|Overall Study||28
1559846|NCT01233232|3815817|P3|STARTED|Overall Study||28
1559847|NCT01233232|3815818|P2|STARTED|Overall Study||30
1559848|NCT01233232|3815819|P1|STARTED|Overall Study||29
1559849|NCT01233076|3815872|P2|NOT COMPLETED|Period 2, One Week||0
1559850|NCT01233076|3815873|P1|NOT COMPLETED|Period 2, One Week||1
1559851|NCT01233076|3815872|P2|COMPLETED|Period 2, One Week||30
1559852|NCT01233076|3815873|P1|COMPLETED|Period 2, One Week||29
1559853|NCT01233076|3815872|P2|STARTED|Period 2, One Week||30
1559854|NCT01233076|3815873|P1|STARTED|Period 2, One Week||30
1559855|NCT01233076|3815872|P2|NOT COMPLETED|Period 1, One Week||0
1559856|NCT01233076|3815873|P1|NOT COMPLETED|Period 1, One Week||0
1559857|NCT01233076|3815872|P2|COMPLETED|Period 1, One Week||30
1559858|NCT01233076|3815873|P1|COMPLETED|Period 1, One Week||30
1559859|NCT01233076|3815872|P2|STARTED|Period 1, One Week||30
1559860|NCT01233076|3815873|P1|STARTED|Period 1, One Week||30
1559861|NCT01233050|3815881|P2|NOT COMPLETED|Overall Study||6
1559862|NCT01233050|3815882|P1|NOT COMPLETED|Overall Study||8
1559863|NCT01233050|3815881|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
1559864|NCT01233050|3815882|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
1559865|NCT01233050|3815881|P2|STARTED|Overall Study||402
1559866|NCT01233050|3815882|P1|STARTED|Overall Study||400
1559867|NCT01232920|3815900|P2|NOT COMPLETED|Overall Study||7
1559868|NCT01232920|3815901|P1|NOT COMPLETED|Overall Study||6
1559869|NCT01232920|3815900|P2|COMPLETED|Overall Study||32
1559870|NCT01232920|3815901|P1|COMPLETED|Overall Study||35
1559871|NCT01232920|3815900|P2|STARTED|Overall Study||39
1559872|NCT01232920|3815901|P1|STARTED|Overall Study||41
1559873|NCT01232894|3815915|P2|NOT COMPLETED|Overall Study||8
1559874|NCT01232894|3815916|P1|NOT COMPLETED|Overall Study||12
1559875|NCT01232894|3815915|P2|COMPLETED|Overall Study||22
1559876|NCT01232894|3815916|P1|COMPLETED|Overall Study||48
1559877|NCT01232894|3815915|P2|Received Study Drug|Overall Study||28
1559878|NCT01232894|3815916|P1|Received Study Drug|Overall Study||59
1559879|NCT01232894|3815915|P2|STARTED|Overall Study||30
1559880|NCT01232894|3815916|P1|STARTED|Overall Study||60
1559881|NCT01232868|3815924|P2|NOT COMPLETED|Overall Study||4
1559882|NCT01232868|3815925|P1|NOT COMPLETED|Overall Study||2
1559883|NCT01232868|3815924|P2|COMPLETED|Overall Study||40
1559884|NCT01232868|3815925|P1|COMPLETED|Overall Study||20
1559885|NCT01232868|3815924|P2|STARTED|Overall Study||44
1559886|NCT01232868|3815925|P1|STARTED|Overall Study||22
1559887|NCT01232829|3815933|P1|NOT COMPLETED|Overall Study||0
1559888|NCT01232829|3815933|P1|COMPLETED|Overall Study||18
1559889|NCT01232829|3815933|P1|STARTED|Overall Study||18
1559890|NCT01232790|3815939|P2|NOT COMPLETED|Second Crossover||2
1559891|NCT01232790|3815940|P1|NOT COMPLETED|Second Crossover||1
1559892|NCT01232790|3815939|P2|COMPLETED|Second Crossover||9
1559893|NCT01232790|3815940|P1|COMPLETED|Second Crossover||10
1559894|NCT01232790|3815939|P2|STARTED|Second Crossover||11
1559895|NCT01232790|3815940|P1|STARTED|Second Crossover||11
1559896|NCT01232790|3815939|P2|NOT COMPLETED|First Crossover||0
1559897|NCT01232790|3815940|P1|NOT COMPLETED|First Crossover||1
1559898|NCT01232790|3815939|P2|COMPLETED|First Crossover||11
1559899|NCT01232790|3815940|P1|COMPLETED|First Crossover||11
1559900|NCT01232790|3815939|P2|STARTED|First Crossover||11
1559901|NCT01232790|3815940|P1|STARTED|First Crossover||12
1559902|NCT01232790|3815939|P2|NOT COMPLETED|Initial Assessment||1
1559903|NCT01232790|3815940|P1|NOT COMPLETED|Initial Assessment||0
1559904|NCT01232790|3815939|P2|COMPLETED|Initial Assessment||11
1559905|NCT01232790|3815940|P1|COMPLETED|Initial Assessment||12
1559906|NCT01232790|3815939|P2|STARTED|Initial Assessment||12
1559907|NCT01232790|3815940|P1|STARTED|Initial Assessment||12
1559908|NCT01232790|3815939|P2|NOT COMPLETED|Randomization||2
1559909|NCT01232790|3815940|P1|NOT COMPLETED|Randomization||2
1559910|NCT01232790|3815939|P2|COMPLETED|Randomization||12
1559911|NCT01232790|3815940|P1|COMPLETED|Randomization||12
1559912|NCT01232790|3815939|P2|STARTED|Randomization||14
1559913|NCT01232790|3815940|P1|STARTED|Randomization||14
1559914|NCT01232738|3815994|P1|NOT COMPLETED|Overall Study||13
1559915|NCT01232738|3815994|P1|COMPLETED|Overall Study||23
1559916|NCT01232738|3815994|P1|STARTED|Overall Study||36
1559917|NCT01232569|3816010|P4|NOT COMPLETED|Open-label Extension Period||27
1559918|NCT01232569|3816011|P3|NOT COMPLETED|Open-label Extension Period||27
1559919|NCT01232569|3816012|P2|NOT COMPLETED|Open-label Extension Period||0
1559920|NCT01232569|3816013|P1|NOT COMPLETED|Open-label Extension Period||0
1559921|NCT01232569|3816010|P4|COMPLETED|Open-label Extension Period||200
1559922|NCT01232569|3816011|P3|COMPLETED|Open-label Extension Period||203
1559923|NCT01232569|3816012|P2|COMPLETED|Open-label Extension Period||0
1559924|NCT01232569|3816013|P1|COMPLETED|Open-label Extension Period||0
1559925|NCT01232569|3816010|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
1559926|NCT01232569|3816011|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
1559927|NCT01232569|3816012|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
1559928|NCT01232569|3816013|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
1559929|NCT01232569|3816010|P4|NOT COMPLETED|Double-blind Treatment Period||0
1559930|NCT01232569|3816011|P3|NOT COMPLETED|Double-blind Treatment Period||0
1559931|NCT01232569|3816012|P2|NOT COMPLETED|Double-blind Treatment Period||9
1559932|NCT01232569|3816013|P1|NOT COMPLETED|Double-blind Treatment Period||28
1559933|NCT01232569|3816010|P4|COMPLETED|Double-blind Treatment Period||0
1559934|NCT01232569|3816011|P3|COMPLETED|Double-blind Treatment Period||0
1559935|NCT01232569|3816012|P2|COMPLETED|Double-blind Treatment Period||209
1559936|NCT01232569|3816013|P1|COMPLETED|Double-blind Treatment Period||410
1559937|NCT01232569|3816010|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
1559938|NCT01232569|3816011|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
1559939|NCT01232569|3816012|P2|STARTED|Double-blind Treatment Period||218
1559940|NCT01232569|3816013|P1|STARTED|Double-blind Treatment Period||438
1559941|NCT01232556|3816056|P2|NOT COMPLETED|Overall Study||171
1559942|NCT01232556|3816057|P1|NOT COMPLETED|Overall Study||159
1559943|NCT01232556|3816056|P2|COMPLETED|Overall Study||1
1559944|NCT01232556|3816057|P1|COMPLETED|Overall Study||7
1559945|NCT01232556|3816056|P2|Treated|Overall Study||167
1559946|NCT01232556|3816057|P1|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
1559947|NCT01232556|3816056|P2|STARTED|Overall Study||172
1559948|NCT01232556|3816057|P1|STARTED|Overall Study||166
1559949|NCT01232504|3816080|P3|NOT COMPLETED|Overall Study||8
1559950|NCT01232504|3816081|P2|NOT COMPLETED|Overall Study||2
1559951|NCT01232504|3816082|P1|NOT COMPLETED|Overall Study||9
1559952|NCT01232504|3816080|P3|COMPLETED|Overall Study||61
1559953|NCT01232504|3816081|P2|COMPLETED|Overall Study||67
1559954|NCT01232504|3816082|P1|COMPLETED|Overall Study||59
1559955|NCT01232504|3816080|P3|STARTED|Overall Study||69
1559956|NCT01232504|3816081|P2|STARTED|Overall Study||69
1559957|NCT01232504|3816082|P1|STARTED|Overall Study||68
1559958|NCT01232491|3816116|P2|NOT COMPLETED|Overall Study||63
1559959|NCT01232491|3816117|P1|NOT COMPLETED|Overall Study||60
1559960|NCT01232491|3816116|P2|COMPLETED|Overall Study||242
1559961|NCT01232491|3816117|P1|COMPLETED|Overall Study||246
1559962|NCT01232491|3816116|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
1559963|NCT01232491|3816117|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
1559964|NCT01232491|3816116|P2|STARTED|Overall Study||305
1559965|NCT01232491|3816117|P1|STARTED|Overall Study||306
1559966|NCT01232465|3816137|P2|NOT COMPLETED|Overall Study||0
1559967|NCT01232465|3816138|P1|NOT COMPLETED|Overall Study||0
1559968|NCT01232465|3816137|P2|COMPLETED|Overall Study||402
1559969|NCT01232465|3816138|P1|COMPLETED|Overall Study||337
1559970|NCT01232465|3816137|P2|STARTED|Overall Study||402
1559971|NCT01232465|3816138|P1|STARTED|Overall Study||337
1559972|NCT01232452|3816146|P2|NOT COMPLETED|Overall Study||39
1559973|NCT01232452|3816147|P1|NOT COMPLETED|Overall Study||39
1559974|NCT01232452|3816146|P2|COMPLETED|Overall Study||46
1559975|NCT01232452|3816147|P1|COMPLETED|Overall Study||48
1559976|NCT01232452|3816146|P2|Received at Least One Dose of Study Drug|Overall Study||81
1559977|NCT01232452|3816147|P1|Received at Least One Dose of Study Drug|Overall Study||85
1559978|NCT01232452|3816146|P2|STARTED|Overall Study||85
1559979|NCT01232452|3816147|P1|STARTED|Overall Study||87
1559980|NCT01232296|3816173|P2|NOT COMPLETED|Overall Study||83
1559981|NCT01232296|3816174|P1|NOT COMPLETED|Overall Study||82
1559982|NCT01232296|3816173|P2|COMPLETED|Overall Study||0
1559983|NCT01232296|3816174|P1|COMPLETED|Overall Study||0
1559984|NCT01232296|3816173|P2|Safety Set|Overall Study||83
1559985|NCT01232296|3816174|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
1559986|NCT01232296|3816173|P2|Full Analysis Set|Overall Study||83
1559987|NCT01232296|3816174|P1|Full Analysis Set|Overall Study||82
1559988|NCT01232296|3816173|P2|STARTED|Overall Study||83
1559989|NCT01232296|3816174|P1|STARTED|Overall Study||82
1559990|NCT01232283|3816191|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
1559991|NCT01232283|3816192|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
1559992|NCT01232283|3816193|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1559993|NCT01232283|3816194|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1559994|NCT01232283|3816195|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1559995|NCT01232283|3816196|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1559996|NCT01232283|3816197|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1559997|NCT01232283|3816198|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1559998|NCT01232283|3816199|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1559999|NCT01232283|3816200|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1560000|NCT01232283|3816191|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
1560001|NCT01232283|3816192|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
1560002|NCT01232283|3816193|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1560003|NCT01232283|3816194|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1560004|NCT01232283|3816195|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1560005|NCT01232283|3816196|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1560006|NCT01232283|3816197|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1560007|NCT01232283|3816198|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1560008|NCT01232283|3816199|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1560009|NCT01232283|3816200|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
1560010|NCT01232283|3816191|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
1560011|NCT01232283|3816192|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
1560012|NCT01232283|3816193|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1560013|NCT01232283|3816194|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1560014|NCT01232283|3816195|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1560015|NCT01232283|3816196|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1560016|NCT01232283|3816197|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1560017|NCT01232283|3816198|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1560018|NCT01232283|3816199|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1560019|NCT01232283|3816200|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
1560020|NCT01232283|3816191|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560021|NCT01232283|3816192|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560022|NCT01232283|3816193|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
1560023|NCT01232283|3816194|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
1560024|NCT01232283|3816195|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
1560025|NCT01232283|3816196|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
1560026|NCT01232283|3816197|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560027|NCT01232283|3816198|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560028|NCT01232283|3816199|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560029|NCT01232283|3816200|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560030|NCT01232283|3816191|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560031|NCT01232283|3816192|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560032|NCT01232283|3816193|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
1560033|NCT01232283|3816194|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
1560034|NCT01232283|3816195|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
1560035|NCT01232283|3816196|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
1560036|NCT01232283|3816197|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560037|NCT01232283|3816198|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560038|NCT01232283|3816199|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560039|NCT01232283|3816200|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560040|NCT01232283|3816191|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1560041|NCT01232283|3816192|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1560042|NCT01232283|3816193|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
1560043|NCT01232283|3816194|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
1560044|NCT01232283|3816195|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1560045|NCT01232283|3816196|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1560046|NCT01232283|3816197|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1560047|NCT01232283|3816198|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1560048|NCT01232283|3816199|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1560049|NCT01232283|3816200|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1560050|NCT01232283|3816191|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560051|NCT01232283|3816192|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560052|NCT01232283|3816193|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
1560053|NCT01232283|3816194|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
1560054|NCT01232283|3816195|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
1560055|NCT01232283|3816196|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
1560056|NCT01232283|3816197|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560057|NCT01232283|3816198|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560058|NCT01232283|3816199|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560059|NCT01232283|3816200|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1560060|NCT01232283|3816191|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1560061|NCT01232283|3816192|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1560062|NCT01232283|3816193|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1560063|NCT01232283|3816194|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1560064|NCT01232283|3816195|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1560065|NCT01232283|3816196|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1560066|NCT01232283|3816197|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
1560067|NCT01232283|3816198|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
1560068|NCT01232283|3816199|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1560069|NCT01232283|3816200|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1560070|NCT01232283|3816191|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
1560071|NCT01232283|3816192|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
1560072|NCT01232283|3816193|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
1560073|NCT01232283|3816194|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
1560074|NCT01232283|3816195|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
1560075|NCT01232283|3816196|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
1560076|NCT01232283|3816197|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
1560077|NCT01232283|3816198|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
1560078|NCT01232283|3816199|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
1560079|NCT01232283|3816200|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
1560080|NCT01232283|3816191|P10|STARTED|Maintenance Phase (Weeks16-32)||0
1560081|NCT01232283|3816192|P9|STARTED|Maintenance Phase (Weeks16-32)||0
1560082|NCT01232283|3816193|P8|STARTED|Maintenance Phase (Weeks16-32)||0
1560083|NCT01232283|3816194|P7|STARTED|Maintenance Phase (Weeks16-32)||0
1560084|NCT01232283|3816195|P6|STARTED|Maintenance Phase (Weeks16-32)||0
1560085|NCT01232283|3816196|P5|STARTED|Maintenance Phase (Weeks16-32)||0
1560086|NCT01232283|3816197|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
1560087|NCT01232283|3816198|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
1560088|NCT01232283|3816199|P2|STARTED|Maintenance Phase (Weeks16-32)||0
1560089|NCT01232283|3816200|P1|STARTED|Maintenance Phase (Weeks16-32)||0
1560090|NCT01232283|3816191|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560091|NCT01232283|3816192|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560092|NCT01232283|3816193|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560093|NCT01232283|3816194|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560094|NCT01232283|3816195|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560095|NCT01232283|3816196|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560096|NCT01232283|3816197|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560097|NCT01232283|3816198|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560098|NCT01232283|3816199|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
1560099|NCT01232283|3816200|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
1560100|NCT01232283|3816191|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560101|NCT01232283|3816192|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560102|NCT01232283|3816193|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560103|NCT01232283|3816194|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560104|NCT01232283|3816195|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560105|NCT01232283|3816196|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560106|NCT01232283|3816197|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560107|NCT01232283|3816198|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1560108|NCT01232283|3816199|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
1560109|NCT01232283|3816200|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
1560110|NCT01232283|3816191|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1560111|NCT01232283|3816192|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1560112|NCT01232283|3816193|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1560113|NCT01232283|3816194|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1560114|NCT01232283|3816195|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1560115|NCT01232283|3816196|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1560116|NCT01232283|3816197|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1560117|NCT01232283|3816198|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1560118|NCT01232283|3816199|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
1560119|NCT01232283|3816200|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
1560120|NCT01232283|3816191|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1560121|NCT01232283|3816192|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1560122|NCT01232283|3816193|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1560123|NCT01232283|3816194|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1560124|NCT01232283|3816195|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1560125|NCT01232283|3816196|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1560126|NCT01232283|3816197|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1560127|NCT01232283|3816198|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1560128|NCT01232283|3816199|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
1560129|NCT01232283|3816200|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
1560130|NCT01232205|3816234|P2|NOT COMPLETED|Overall Study||3
1560131|NCT01232205|3816235|P1|NOT COMPLETED|Overall Study||3
1560132|NCT01232205|3816234|P2|COMPLETED|Overall Study||55
1560133|NCT01232205|3816235|P1|COMPLETED|Overall Study||49
1560134|NCT01232205|3816234|P2|STARTED|Overall Study||58
1560135|NCT01232205|3816235|P1|STARTED|Overall Study||52
1560136|NCT01232127|3816241|P3|NOT COMPLETED|Period 3: Days 18-24||0
1560137|NCT01232127|3816242|P2|NOT COMPLETED|Period 3: Days 18-24||0
1560138|NCT01232127|3816243|P1|NOT COMPLETED|Period 3: Days 18-24||0
1560139|NCT01232127|3816241|P3|COMPLETED|Period 3: Days 18-24||24
1560140|NCT01232127|3816242|P2|COMPLETED|Period 3: Days 18-24||0
1560141|NCT01232127|3816243|P1|COMPLETED|Period 3: Days 18-24||0
1560142|NCT01232127|3816241|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
1560143|NCT01232127|3816242|P2|STARTED|Period 3: Days 18-24||0
1560144|NCT01232127|3816243|P1|STARTED|Period 3: Days 18-24||0
1560145|NCT01232127|3816241|P3|NOT COMPLETED|Period 2: Days 11-17||0
1560146|NCT01232127|3816242|P2|NOT COMPLETED|Period 2: Days 11-17||0
1560147|NCT01232127|3816243|P1|NOT COMPLETED|Period 2: Days 11-17||0
1560148|NCT01232127|3816241|P3|COMPLETED|Period 2: Days 11-17||0
1560149|NCT01232127|3816242|P2|COMPLETED|Period 2: Days 11-17||24
1560150|NCT01232127|3816243|P1|COMPLETED|Period 2: Days 11-17||0
1560151|NCT01232127|3816241|P3|STARTED|Period 2: Days 11-17||0
1560152|NCT01232127|3816242|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
1560153|NCT01232127|3816243|P1|STARTED|Period 2: Days 11-17||0
1560154|NCT01232127|3816241|P3|NOT COMPLETED|Period 1: Days 1-10||0
1560155|NCT01232127|3816242|P2|NOT COMPLETED|Period 1: Days 1-10||0
1560156|NCT01232127|3816243|P1|NOT COMPLETED|Period 1: Days 1-10||1
1560157|NCT01232127|3816241|P3|COMPLETED|Period 1: Days 1-10||0
1560158|NCT01232127|3816242|P2|COMPLETED|Period 1: Days 1-10||0
1560159|NCT01232127|3816243|P1|COMPLETED|Period 1: Days 1-10||24
1560160|NCT01232127|3816241|P3|STARTED|Period 1: Days 1-10||0
1560161|NCT01232127|3816242|P2|STARTED|Period 1: Days 1-10||0
1560162|NCT01232127|3816243|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
1560163|NCT01231984|3816267|P4|NOT COMPLETED|Study Period 2||4
1560164|NCT01231984|3816268|P3|NOT COMPLETED|Study Period 2||0
1560165|NCT01231984|3816269|P2|NOT COMPLETED|Study Period 2||2
1560166|NCT01231984|3816270|P1|NOT COMPLETED|Study Period 2||3
1560167|NCT01231984|3816267|P4|COMPLETED|Study Period 2||56
1560168|NCT01231984|3816268|P3|COMPLETED|Study Period 2||59
1560169|NCT01231984|3816269|P2|COMPLETED|Study Period 2||61
1560170|NCT01231984|3816270|P1|COMPLETED|Study Period 2||54
1560171|NCT01231984|3816267|P4|STARTED|Study Period 2||60
1560172|NCT01231984|3816268|P3|STARTED|Study Period 2||59
1560173|NCT01231984|3816269|P2|STARTED|Study Period 2||63
1560174|NCT01231984|3816270|P1|STARTED|Study Period 2||57
1560175|NCT01231984|3816267|P4|NOT COMPLETED|Study Period 1||9
1560176|NCT01231984|3816268|P3|NOT COMPLETED|Study Period 1||7
1560177|NCT01231984|3816269|P2|NOT COMPLETED|Study Period 1||7
1560178|NCT01231984|3816270|P1|NOT COMPLETED|Study Period 1||12
1560179|NCT01231984|3816267|P4|COMPLETED|Study Period 1||60
1560180|NCT01231984|3816268|P3|COMPLETED|Study Period 1||59
1560181|NCT01231984|3816269|P2|COMPLETED|Study Period 1||63
1560182|NCT01231984|3816270|P1|COMPLETED|Study Period 1||57
1560183|NCT01231984|3816267|P4|STARTED|Study Period 1||69
1560184|NCT01231984|3816268|P3|STARTED|Study Period 1||66
1560185|NCT01231984|3816269|P2|STARTED|Study Period 1||70
1560186|NCT01231984|3816270|P1|STARTED|Study Period 1||69
1560187|NCT01231841|3816291|P1|NOT COMPLETED|Overall Study||0
1560188|NCT01231841|3816291|P1|COMPLETED|Overall Study||20
1560189|NCT01231841|3816291|P1|STARTED|Overall Study||20
1560190|NCT01231750|3816297|P2|NOT COMPLETED|Overall Study||0
1560191|NCT01231750|3816298|P1|NOT COMPLETED|Overall Study||0
1560192|NCT01231750|3816297|P2|COMPLETED|Overall Study||4
1560193|NCT01231750|3816298|P1|COMPLETED|Overall Study||3
1560194|NCT01231750|3816297|P2|STARTED|Overall Study||4
1560195|NCT01231750|3816298|P1|STARTED|Overall Study||3
1560196|NCT01231646|3816316|P2|NOT COMPLETED|Overall Study||0
1560197|NCT01231646|3816317|P1|NOT COMPLETED|Overall Study||0
1560198|NCT01231646|3816316|P2|COMPLETED|Overall Study||10
1560199|NCT01231646|3816317|P1|COMPLETED|Overall Study||28
1560200|NCT01231646|3816316|P2|STARTED|Overall Study||10
1560201|NCT01231646|3816317|P1|STARTED|Overall Study||28
1560202|NCT01231633|3816325|P2|NOT COMPLETED|Overall Study||0
1560203|NCT01231633|3816326|P1|NOT COMPLETED|Overall Study||0
1560204|NCT01231633|3816325|P2|COMPLETED|Overall Study||13
1560205|NCT01231633|3816326|P1|COMPLETED|Overall Study||14
1560206|NCT01231633|3816325|P2|STARTED|Overall Study||13
1560207|NCT01231633|3816326|P1|STARTED|Overall Study||14
1560208|NCT01231620|3816339|P3|NOT COMPLETED|Overall Study||39
1560209|NCT01231620|3816340|P2|NOT COMPLETED|Overall Study||31
1560210|NCT01231620|3816341|P1|NOT COMPLETED|Overall Study||26
1560211|NCT01231620|3816339|P3|COMPLETED|Overall Study||166
1560212|NCT01231620|3816340|P2|COMPLETED|Overall Study||178
1560213|NCT01231620|3816341|P1|COMPLETED|Overall Study||175
1560214|NCT01231620|3816339|P3|STARTED|Overall Study||205
1560215|NCT01231620|3816340|P2|STARTED|Overall Study||209
1560216|NCT01231620|3816341|P1|STARTED|Overall Study||201
1560217|NCT01231607|3816447|P5|NOT COMPLETED|Overall Study||24
1560218|NCT01231607|3816448|P4|NOT COMPLETED|Overall Study||38
1560219|NCT01231607|3816449|P3|NOT COMPLETED|Overall Study||31
1560220|NCT01231607|3816450|P2|NOT COMPLETED|Overall Study||34
1560221|NCT01231607|3816451|P1|NOT COMPLETED|Overall Study||29
1560222|NCT01231607|3816447|P5|COMPLETED|Overall Study||157
1560223|NCT01231607|3816448|P4|COMPLETED|Overall Study||141
1560224|NCT01231607|3816449|P3|COMPLETED|Overall Study||153
1560225|NCT01231607|3816450|P2|COMPLETED|Overall Study||154
1560226|NCT01231607|3816451|P1|COMPLETED|Overall Study||156
1560227|NCT01231607|3816447|P5|STARTED|Overall Study||181
1560228|NCT01231607|3816448|P4|STARTED|Overall Study||179
1560229|NCT01231607|3816449|P3|STARTED|Overall Study||184
1560230|NCT01231607|3816450|P2|STARTED|Overall Study||188
1560231|NCT01231607|3816451|P1|STARTED|Overall Study||185
1560232|NCT01231581|3816543|P2|NOT COMPLETED|Overall Study||80
1560233|NCT01231581|3816544|P1|NOT COMPLETED|Overall Study||80
1560234|NCT01231581|3816543|P2|COMPLETED|Overall Study||0
1560235|NCT01231581|3816544|P1|COMPLETED|Overall Study||0
1560236|NCT01231581|3816543|P2|Ongoing|Overall Study||0
1560237|NCT01231581|3816544|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
1560238|NCT01231581|3816543|P2|STARTED|Overall Study||80
1560239|NCT01231581|3816544|P1|STARTED|Overall Study||80
1560240|NCT01231555|3816565|P3|NOT COMPLETED|Overall Study||8
1560241|NCT01231555|3816566|P2|NOT COMPLETED|Overall Study||7
1560242|NCT01231555|3816567|P1|NOT COMPLETED|Overall Study||8
1560243|NCT01231555|3816565|P3|COMPLETED|Overall Study||0
1560244|NCT01231555|3816566|P2|COMPLETED|Overall Study||0
1560245|NCT01231555|3816567|P1|COMPLETED|Overall Study||0
1560246|NCT01231555|3816565|P3|STARTED|Overall Study||8
1560247|NCT01231555|3816566|P2|STARTED|Overall Study||7
1560248|NCT01231555|3816567|P1|STARTED|Overall Study||8
1560249|NCT01231516|3816598|P2|NOT COMPLETED|Open-label Phase||26
1560250|NCT01231516|3816599|P1|NOT COMPLETED|Open-label Phase||295
1560251|NCT01231516|3816598|P2|COMPLETED|Open-label Phase||1
1560252|NCT01231516|3816599|P1|COMPLETED|Open-label Phase||0
1560253|NCT01231516|3816598|P2|Ongoing at the Time of Analysis|Open-label Phase||23
1560254|NCT01231516|3816599|P1|Ongoing at the Time of Analysis|Open-label Phase||282
1560255|NCT01231516|3816598|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
1560256|NCT01231516|3816599|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
1560257|NCT01231516|3816598|P2|NOT COMPLETED|48 Week Double-blind Phase||79
1560258|NCT01231516|3816599|P1|NOT COMPLETED|48 Week Double-blind Phase||58
1560259|NCT01231516|3816598|P2|COMPLETED|48 Week Double-blind Phase||283
1560260|NCT01231516|3816599|P1|COMPLETED|48 Week Double-blind Phase||299
1560261|NCT01231516|3816598|P2|STARTED|48 Week Double-blind Phase||362
1560262|NCT01231516|3816599|P1|STARTED|48 Week Double-blind Phase||357
1560263|NCT01231503|3816629|P8|NOT COMPLETED|Overall Study||8
1560264|NCT01231503|3816630|P7|NOT COMPLETED|Overall Study||7
1560265|NCT01231503|3816631|P6|NOT COMPLETED|Overall Study||16
1560266|NCT01231503|3816632|P5|NOT COMPLETED|Overall Study||10
1560267|NCT01231503|3816633|P4|NOT COMPLETED|Overall Study||8
1560268|NCT01231503|3816634|P3|NOT COMPLETED|Overall Study||12
1560269|NCT01231503|3816635|P2|NOT COMPLETED|Overall Study||13
1560270|NCT01231503|3816636|P1|NOT COMPLETED|Overall Study||14
1560271|NCT01231503|3816629|P8|COMPLETED|Overall Study||52
1560272|NCT01231503|3816630|P7|COMPLETED|Overall Study||53
1560273|NCT01231503|3816631|P6|COMPLETED|Overall Study||44
1560274|NCT01231503|3816632|P5|COMPLETED|Overall Study||50
1560275|NCT01231503|3816633|P4|COMPLETED|Overall Study||52
1560276|NCT01231503|3816634|P3|COMPLETED|Overall Study||48
1560277|NCT01231503|3816635|P2|COMPLETED|Overall Study||46
1560278|NCT01231503|3816636|P1|COMPLETED|Overall Study||46
1560279|NCT01231503|3816629|P8|STARTED|Overall Study||60
1560280|NCT01231503|3816630|P7|STARTED|Overall Study||60
1560281|NCT01231503|3816631|P6|STARTED|Overall Study||60
1560282|NCT01231503|3816632|P5|STARTED|Overall Study||60
1560283|NCT01231503|3816633|P4|STARTED|Overall Study||60
1560284|NCT01231503|3816634|P3|STARTED|Overall Study||60
1560285|NCT01231503|3816635|P2|STARTED|Overall Study||59
1560286|NCT01231503|3816636|P1|STARTED|Overall Study||60
1560287|NCT01231464|3816876|P2|NOT COMPLETED|Overall Study||7
1560288|NCT01231464|3816877|P1|NOT COMPLETED|Overall Study||5
1560289|NCT01231464|3816876|P2|COMPLETED|Overall Study||176
1560290|NCT01231464|3816877|P1|COMPLETED|Overall Study||177
1560291|NCT01231464|3816876|P2|STARTED|Overall Study||183
1560292|NCT01231464|3816877|P1|STARTED|Overall Study||182
1560293|NCT01231412|3816890|P3|NOT COMPLETED|Overall Study||0
1560294|NCT01231412|3816891|P2|NOT COMPLETED|Overall Study||1
1560295|NCT01231412|3816892|P1|NOT COMPLETED|Overall Study||0
1560296|NCT01231412|3816890|P3|COMPLETED|Overall Study||6
1560297|NCT01231412|3816891|P2|COMPLETED|Overall Study||90
1560298|NCT01231412|3816892|P1|COMPLETED|Overall Study||77
1560299|NCT01231412|3816890|P3|STARTED|Overall Study||6
1560300|NCT01231412|3816891|P2|STARTED|Overall Study||91
1560301|NCT01231412|3816892|P1|STARTED|Overall Study||77
1560302|NCT01231399|3816915|P1|NOT COMPLETED|Overall Study||0
1560303|NCT01231399|3816915|P1|COMPLETED|Overall Study||6
1560304|NCT01231399|3816915|P1|STARTED|Overall Study||6
1560305|NCT01231373|3816926|P4|NOT COMPLETED|Overall Study||1
1560306|NCT01231373|3816927|P3|NOT COMPLETED|Overall Study||0
1560307|NCT01231373|3816928|P2|NOT COMPLETED|Overall Study||1
1560308|NCT01231373|3816929|P1|NOT COMPLETED|Overall Study||3
1560309|NCT01231373|3816926|P4|COMPLETED|Overall Study||57
1560310|NCT01231373|3816927|P3|COMPLETED|Overall Study||60
1560311|NCT01231373|3816928|P2|COMPLETED|Overall Study||57
1560312|NCT01231373|3816929|P1|COMPLETED|Overall Study||56
1560313|NCT01231373|3816926|P4|Patients Receiving Blinded Treatment|Overall Study||58
1560314|NCT01231373|3816927|P3|Patients Receiving Blinded Treatment|Overall Study||60
1560315|NCT01231373|3816928|P2|Patients Receiving Blinded Treatment|Overall Study||57
1560316|NCT01231373|3816929|P1|Patients Receiving Blinded Treatment|Overall Study||57
1560317|NCT01231373|3816926|P4|STARTED|Overall Study||58
1560318|NCT01231373|3816927|P3|STARTED|Overall Study||60
1560319|NCT01231373|3816928|P2|STARTED|Overall Study||58
1560320|NCT01231373|3816929|P1|STARTED|Overall Study||59
1560321|NCT01231334|3816949|P2|NOT COMPLETED|Overall Study||21
1560322|NCT01231334|3816950|P1|NOT COMPLETED|Overall Study||19
1560323|NCT01231334|3816949|P2|COMPLETED|Overall Study||120
1560324|NCT01231334|3816950|P1|COMPLETED|Overall Study||126
1560325|NCT01231334|3816949|P2|STARTED|Overall Study||141
1560326|NCT01231334|3816950|P1|STARTED|Overall Study||145
1560327|NCT01231321|3816968|P1|NOT COMPLETED|Overall Study||5
1560328|NCT01231321|3816968|P1|COMPLETED|Overall Study||95
1560329|NCT01231321|3816968|P1|STARTED|Overall Study||100
1560330|NCT01231230|3816979|P1|NOT COMPLETED|Overall Study||0
1560331|NCT01231230|3816979|P1|COMPLETED|Overall Study||14
1560332|NCT01231230|3816979|P1|Placebo|Overall Study||14
1560333|NCT01231230|3816979|P1|Fluticasone/Salmeterol|Overall Study||14
1560334|NCT01231230|3816979|P1|Salmeterol|Overall Study||14
1560335|NCT01231230|3816979|P1|Fluticasone|Overall Study||14
1560336|NCT01231230|3816979|P1|STARTED|Overall Study||14
1560337|NCT01230931|3816991|P2|NOT COMPLETED|Overall Study||0
1560338|NCT01230931|3816992|P1|NOT COMPLETED|Overall Study||0
1560339|NCT01230931|3816991|P2|COMPLETED|Overall Study||10
1560340|NCT01230931|3816992|P1|COMPLETED|Overall Study||10
1560341|NCT01230931|3816991|P2|STARTED|Overall Study||10
1560342|NCT01230931|3816992|P1|STARTED|Overall Study||10
1560343|NCT01230892|3817016|P2|NOT COMPLETED|Overall Study||1
1560344|NCT01230892|3817017|P1|NOT COMPLETED|Overall Study||3
1560345|NCT01230892|3817016|P2|COMPLETED|Overall Study||13
1560346|NCT01230892|3817017|P1|COMPLETED|Overall Study||12
1560347|NCT01230892|3817016|P2|STARTED|Overall Study||14
1560348|NCT01230892|3817017|P1|STARTED|Overall Study||15
1560349|NCT01230827|3817027|P4|NOT COMPLETED|Overall Study||78
1560350|NCT01230827|3817028|P3|NOT COMPLETED|Overall Study||65
1560351|NCT01230827|3817029|P2|NOT COMPLETED|Overall Study||11
1560352|NCT01230827|3817030|P1|NOT COMPLETED|Overall Study||19
1560353|NCT01230827|3817027|P4|COMPLETED|Overall Study||0
1560354|NCT01230827|3817028|P3|COMPLETED|Overall Study||0
1560355|NCT01230827|3817029|P2|COMPLETED|Overall Study||0
1560356|NCT01230827|3817030|P1|COMPLETED|Overall Study||0
1560357|NCT01230827|3817027|P4|STARTED|Overall Study||78
1560358|NCT01230827|3817028|P3|STARTED|Overall Study||65
1560359|NCT01230827|3817029|P2|STARTED|Overall Study||11
1560360|NCT01230827|3817030|P1|STARTED|Overall Study||19
1560361|NCT01230814|3817046|P2|NOT COMPLETED|Overall Study||4
1560362|NCT01230814|3817047|P1|NOT COMPLETED|Overall Study||13
1560363|NCT01230814|3817046|P2|COMPLETED|Overall Study||112
1560364|NCT01230814|3817047|P1|COMPLETED|Overall Study||105
1560365|NCT01230814|3817046|P2|STARTED|Overall Study||116
1560366|NCT01230814|3817047|P1|STARTED|Overall Study||118
1560367|NCT01230801|3817062|P3|NOT COMPLETED|Overall Study||1
1560368|NCT01230801|3817063|P2|NOT COMPLETED|Overall Study||0
1560369|NCT01230801|3817064|P1|NOT COMPLETED|Overall Study||0
1560370|NCT01230801|3817062|P3|COMPLETED|Overall Study||15
1560371|NCT01230801|3817063|P2|COMPLETED|Overall Study||3
1560372|NCT01230801|3817064|P1|COMPLETED|Overall Study||3
1560373|NCT01230801|3817062|P3|STARTED|Overall Study||16
1560374|NCT01230801|3817063|P2|STARTED|Overall Study||3
1560375|NCT01230801|3817064|P1|STARTED|Overall Study||3
1560376|NCT01230788|3817097|P1|NOT COMPLETED|Overall Study||1
1560377|NCT01230788|3817097|P1|COMPLETED|Overall Study||0
1560378|NCT01230788|3817097|P1|STARTED|Overall Study||1
1560379|NCT01230749|3817109|P4|NOT COMPLETED|Overall Study||2
1560380|NCT01230749|3817110|P3|NOT COMPLETED|Overall Study||2
1560381|NCT01230749|3817111|P2|NOT COMPLETED|Overall Study||2
1560382|NCT01230749|3817112|P1|NOT COMPLETED|Overall Study||0
1560383|NCT01230749|3817109|P4|COMPLETED|Overall Study||20
1560384|NCT01230749|3817110|P3|COMPLETED|Overall Study||21
1560385|NCT01230749|3817111|P2|COMPLETED|Overall Study||20
1560386|NCT01230749|3817112|P1|COMPLETED|Overall Study||22
1560387|NCT01230749|3817109|P4|STARTED|Overall Study||22
1560388|NCT01230749|3817110|P3|STARTED|Overall Study||23
1560389|NCT01230749|3817111|P2|STARTED|Overall Study||22
1560390|NCT01230749|3817112|P1|STARTED|Overall Study||22
1560391|NCT01230710|3817147|P1|NOT COMPLETED|Overall Study||49
1560392|NCT01230710|3817147|P1|COMPLETED|Overall Study||2
1560393|NCT01230710|3817147|P1|STARTED|Overall Study||51
1560394|NCT01230593|3817158|P3|NOT COMPLETED|Overall Study||12
1560395|NCT01230593|3817159|P2|NOT COMPLETED|Overall Study||18
1560396|NCT01230593|3817160|P1|NOT COMPLETED|Overall Study||15
1560397|NCT01230593|3817158|P3|COMPLETED|Overall Study||38
1560398|NCT01230593|3817159|P2|COMPLETED|Overall Study||32
1560399|NCT01230593|3817160|P1|COMPLETED|Overall Study||35
1560400|NCT01230593|3817158|P3|STARTED|Overall Study||50
1560401|NCT01230593|3817159|P2|STARTED|Overall Study||50
1560402|NCT01230593|3817160|P1|STARTED|Overall Study||50
1560403|NCT01230502|3817174|P3|NOT COMPLETED|Overall Study||0
1560404|NCT01230502|3817175|P2|NOT COMPLETED|Overall Study||0
1560405|NCT01230502|3817176|P1|NOT COMPLETED|Overall Study||0
1560406|NCT01230502|3817174|P3|COMPLETED|Overall Study||0
1560407|NCT01230502|3817175|P2|COMPLETED|Overall Study||0
1560408|NCT01230502|3817176|P1|COMPLETED|Overall Study||9
1560409|NCT01230502|3817174|P3|STARTED|Overall Study||0
1560410|NCT01230502|3817175|P2|STARTED|Overall Study||0
1560411|NCT01230502|3817176|P1|STARTED|Overall Study||9
1560412|NCT01230489|3817187|P1|NOT COMPLETED|Overall Study||5
1560413|NCT01230489|3817187|P1|COMPLETED|Overall Study||8
1560414|NCT01230489|3817187|P1|STARTED|Overall Study||13
1560415|NCT01230424|3817193|P2|NOT COMPLETED|Overall Study||0
1560416|NCT01230424|3817194|P1|NOT COMPLETED|Overall Study||0
1560417|NCT01230424|3817193|P2|COMPLETED|Overall Study||70
1560418|NCT01230424|3817194|P1|COMPLETED|Overall Study||70
1560419|NCT01230424|3817193|P2|STARTED|Overall Study||70
1560420|NCT01230424|3817194|P1|STARTED|Overall Study||70
1560421|NCT01230307|3817222|P2|NOT COMPLETED|Overall Study||2
1560422|NCT01230307|3817223|P1|NOT COMPLETED|Overall Study||0
1560423|NCT01230307|3817222|P2|COMPLETED|Overall Study||4
1560424|NCT01230307|3817223|P1|COMPLETED|Overall Study||6
1560425|NCT01230307|3817222|P2|STARTED|Overall Study||6
1560426|NCT01230307|3817223|P1|STARTED|Overall Study||6
1560427|NCT01230177|3817235|P1|NOT COMPLETED|Overall Study||0
1560428|NCT01230177|3817235|P1|COMPLETED|Overall Study||3
1560429|NCT01230177|3817235|P1|STARTED|Overall Study||3
1560430|NCT01230060|3817243|P1|NOT COMPLETED|Overall Study||1
1560431|NCT01230060|3817243|P1|COMPLETED|Overall Study||121
1560432|NCT01230060|3817243|P1|STARTED|Overall Study||122
1560433|NCT01230021|3817247|P1|NOT COMPLETED|Overall Study||0
1560434|NCT01230021|3817247|P1|COMPLETED|Overall Study||6
1560435|NCT01230021|3817247|P1|STARTED|Overall Study||6
1560436|NCT01229943|3817269|P2|NOT COMPLETED|Overall Study||17
1560437|NCT01229943|3817270|P1|NOT COMPLETED|Overall Study||18
1560438|NCT01229943|3817269|P2|COMPLETED|Overall Study||58
1560439|NCT01229943|3817270|P1|COMPLETED|Overall Study||57
1560440|NCT01229943|3817269|P2|STARTED|Overall Study||75
1560441|NCT01229943|3817270|P1|STARTED|Overall Study||75
1560442|NCT01229891|3817283|P3|NOT COMPLETED|Overall Study||0
1560443|NCT01229891|3817284|P2|NOT COMPLETED|Overall Study||0
1560444|NCT01229891|3817285|P1|NOT COMPLETED|Overall Study||0
1560445|NCT01229891|3817283|P3|COMPLETED|Overall Study||30
1560446|NCT01229891|3817284|P2|COMPLETED|Overall Study||30
1560447|NCT01229891|3817285|P1|COMPLETED|Overall Study||30
1560448|NCT01229891|3817283|P3|STARTED|Overall Study||30
1560449|NCT01229891|3817284|P2|STARTED|Overall Study||30
1560450|NCT01229891|3817285|P1|STARTED|Overall Study||30
1560451|NCT01229735|3817316|P2|NOT COMPLETED|Overall Study||66
1560452|NCT01229735|3817317|P1|NOT COMPLETED|Overall Study||66
1560453|NCT01229735|3817316|P2|COMPLETED|Overall Study||100
1560454|NCT01229735|3817317|P1|COMPLETED|Overall Study||111
1560455|NCT01229735|3817316|P2|STARTED|Overall Study||166
1560456|NCT01229735|3817317|P1|STARTED|Overall Study||177
1560457|NCT01229722|3817333|P2|NOT COMPLETED|Overall Study||0
1560458|NCT01229722|3817334|P1|NOT COMPLETED|Overall Study||4
1560459|NCT01229722|3817333|P2|COMPLETED|Overall Study||36
1560460|NCT01229722|3817334|P1|COMPLETED|Overall Study||30
1560461|NCT01229722|3817333|P2|STARTED|Overall Study||36
1560462|NCT01229722|3817334|P1|STARTED|Overall Study||34
1560463|NCT01229527|3817343|P3|NOT COMPLETED|Overall Study||0
1560464|NCT01229527|3817344|P2|NOT COMPLETED|Overall Study||0
1560465|NCT01229527|3817345|P1|NOT COMPLETED|Overall Study||0
1560466|NCT01229527|3817343|P3|COMPLETED|Overall Study||30
1560467|NCT01229527|3817344|P2|COMPLETED|Overall Study||30
1560468|NCT01229527|3817345|P1|COMPLETED|Overall Study||30
1560469|NCT01229527|3817343|P3|STARTED|Overall Study||30
1560470|NCT01229527|3817344|P2|STARTED|Overall Study||30
1560471|NCT01229527|3817345|P1|STARTED|Overall Study||30
1560472|NCT01229462|3817358|P2|NOT COMPLETED|Overall Study||9
1560473|NCT01229462|3817359|P1|NOT COMPLETED|Overall Study||5
1560474|NCT01229462|3817358|P2|COMPLETED|Overall Study||109
1560475|NCT01229462|3817359|P1|COMPLETED|Overall Study||115
1560476|NCT01229462|3817358|P2|STARTED|Overall Study||118
1560477|NCT01229462|3817359|P1|STARTED|Overall Study||120
1560478|NCT01229449|3817370|P5|NOT COMPLETED|Overall Study||1
1560479|NCT01229449|3817371|P4|NOT COMPLETED|Overall Study||1
1560480|NCT01229449|3817372|P3|NOT COMPLETED|Overall Study||2
1560481|NCT01229449|3817373|P2|NOT COMPLETED|Overall Study||4
1560482|NCT01229449|3817374|P1|NOT COMPLETED|Overall Study||1
1560483|NCT01229449|3817370|P5|COMPLETED|Overall Study||54
1560484|NCT01229449|3817371|P4|COMPLETED|Overall Study||112
1560485|NCT01229449|3817372|P3|COMPLETED|Overall Study||167
1560486|NCT01229449|3817373|P2|COMPLETED|Overall Study||164
1560487|NCT01229449|3817374|P1|COMPLETED|Overall Study||172
1560488|NCT01229449|3817370|P5|STARTED|Overall Study||55
1560489|NCT01229449|3817371|P4|STARTED|Overall Study||113
1560490|NCT01229449|3817372|P3|STARTED|Overall Study||169
1560491|NCT01229449|3817373|P2|STARTED|Overall Study||168
1560492|NCT01229449|3817374|P1|STARTED|Overall Study||173
1560493|NCT01229436|3817431|P1|NOT COMPLETED|Overall Study||5
1560494|NCT01229436|3817431|P1|COMPLETED|Overall Study||249
1560495|NCT01229436|3817431|P1|STARTED|Overall Study||254
1560496|NCT01229423|3817469|P1|NOT COMPLETED|Overall Study||15
1560497|NCT01229423|3817469|P1|COMPLETED|Overall Study||47
1560498|NCT01229423|3817469|P1|STARTED|Overall Study||62
1560499|NCT01229410|3817480|P2|NOT COMPLETED|Overall Study||3
1560500|NCT01229410|3817481|P1|NOT COMPLETED|Overall Study||5
1560501|NCT01229410|3817480|P2|COMPLETED|Overall Study||9
1560502|NCT01229410|3817481|P1|COMPLETED|Overall Study||7
1560503|NCT01229410|3817480|P2|STARTED|Overall Study||12
1560504|NCT01229410|3817481|P1|STARTED|Overall Study||12
1560505|NCT01229397|3817493|P2|NOT COMPLETED|Overall Study||9
1560506|NCT01229397|3817494|P1|NOT COMPLETED|Overall Study||11
1560507|NCT01229397|3817493|P2|COMPLETED|Overall Study||93
1560508|NCT01229397|3817494|P1|COMPLETED|Overall Study||92
1560509|NCT01229397|3817493|P2|STARTED|Overall Study||102
1560510|NCT01229397|3817494|P1|STARTED|Overall Study||103
1560511|NCT01229371|3817512|P4|NOT COMPLETED|Overall Study||0
1560512|NCT01229371|3817513|P3|NOT COMPLETED|Overall Study||0
1560513|NCT01229371|3817514|P2|NOT COMPLETED|Overall Study||1
1560514|NCT01229371|3817515|P1|NOT COMPLETED|Overall Study||0
1560515|NCT01229371|3817512|P4|COMPLETED|Overall Study||110
1560516|NCT01229371|3817513|P3|COMPLETED|Overall Study||110
1560517|NCT01229371|3817514|P2|COMPLETED|Overall Study||110
1560518|NCT01229371|3817515|P1|COMPLETED|Overall Study||109
1560519|NCT01229371|3817512|P4|STARTED|Overall Study||110
1560520|NCT01229371|3817513|P3|STARTED|Overall Study||110
1560521|NCT01229371|3817514|P2|STARTED|Overall Study||111
1560522|NCT01229371|3817515|P1|STARTED|Overall Study||109
1560523|NCT01229267|3817542|P5|NOT COMPLETED|Overall Study||220
1560524|NCT01229267|3817543|P4|NOT COMPLETED|Overall Study||35
1560525|NCT01229267|3817544|P3|NOT COMPLETED|Overall Study||86
1560526|NCT01229267|3817545|P2|NOT COMPLETED|Overall Study||82
1560527|NCT01229267|3817546|P1|NOT COMPLETED|Overall Study||81
1560528|NCT01229267|3817542|P5|COMPLETED|Overall Study||344
1560529|NCT01229267|3817543|P4|COMPLETED|Overall Study||71
1560530|NCT01229267|3817544|P3|COMPLETED|Overall Study||101
1560531|NCT01229267|3817545|P2|COMPLETED|Overall Study||102
1560532|NCT01229267|3817546|P1|COMPLETED|Overall Study||108
1560533|NCT01229267|3817542|P5|Received Vaccination 4|Overall Study||477
1560534|NCT01229267|3817543|P4|Received Vaccination 4|Overall Study||87
1560535|NCT01229267|3817544|P3|Received Vaccination 4|Overall Study||149
1560536|NCT01229267|3817545|P2|Received Vaccination 4|Overall Study||149
1560537|NCT01229267|3817546|P1|Received Vaccination 4|Overall Study||155
1560538|NCT01229267|3817542|P5|Received Vaccination 3|Overall Study||491
1560539|NCT01229267|3817543|P4|Received Vaccination 3|Overall Study||89
1560540|NCT01229267|3817544|P3|Received Vaccination 3|Overall Study||160
1560541|NCT01229267|3817545|P2|Received Vaccination 3|Overall Study||155
1560542|NCT01229267|3817546|P1|Received Vaccination 3|Overall Study||163
1560543|NCT01229267|3817542|P5|Received Vaccination 2|Overall Study||511
1560544|NCT01229267|3817543|P4|Received Vaccination 2|Overall Study||94
1560545|NCT01229267|3817544|P3|Received Vaccination 2|Overall Study||168
1560546|NCT01229267|3817545|P2|Received Vaccination 2|Overall Study||163
1560547|NCT01229267|3817546|P1|Received Vaccination 2|Overall Study||171
1560548|NCT01229267|3817542|P5|Received Vaccination 1|Overall Study||556
1560549|NCT01229267|3817543|P4|Received Vaccination 1|Overall Study||104
1560550|NCT01229267|3817544|P3|Received Vaccination 1|Overall Study||186
1560551|NCT01229267|3817545|P2|Received Vaccination 1|Overall Study||180
1560552|NCT01229267|3817546|P1|Received Vaccination 1|Overall Study||188
1560553|NCT01229267|3817542|P5|STARTED|Overall Study||564
1560554|NCT01229267|3817543|P4|STARTED|Overall Study||106
1560555|NCT01229267|3817544|P3|STARTED|Overall Study||187
1560556|NCT01229267|3817545|P2|STARTED|Overall Study||184
1560557|NCT01229267|3817546|P1|STARTED|Overall Study||189
1560558|NCT01229254|3817565|P3|NOT COMPLETED|Overall Study||12
1560559|NCT01229254|3817566|P2|NOT COMPLETED|Overall Study||16
1560560|NCT01229254|3817567|P1|NOT COMPLETED|Overall Study||15
1560561|NCT01229254|3817565|P3|COMPLETED|Overall Study||61
1560562|NCT01229254|3817566|P2|COMPLETED|Overall Study||58
1560563|NCT01229254|3817567|P1|COMPLETED|Overall Study||27
1560564|NCT01229254|3817565|P3|STARTED|Overall Study||73
1560565|NCT01229254|3817566|P2|STARTED|Overall Study||74
1560566|NCT01229254|3817567|P1|STARTED|Overall Study||42
1560567|NCT01229228|3817581|P5|NOT COMPLETED|Overall Study||1
1560568|NCT01229228|3817582|P4|NOT COMPLETED|Overall Study||0
1560569|NCT01229228|3817583|P3|NOT COMPLETED|Overall Study||1
1560570|NCT01229228|3817584|P2|NOT COMPLETED|Overall Study||0
1560571|NCT01229228|3817585|P1|NOT COMPLETED|Overall Study||1
1560572|NCT01229228|3817581|P5|COMPLETED|Overall Study||50
1560573|NCT01229228|3817582|P4|COMPLETED|Overall Study||51
1560574|NCT01229228|3817583|P3|COMPLETED|Overall Study||49
1560575|NCT01229228|3817584|P2|COMPLETED|Overall Study||51
1560576|NCT01229228|3817585|P1|COMPLETED|Overall Study||50
1560577|NCT01229228|3817581|P5|STARTED|Overall Study||51
1560578|NCT01229228|3817582|P4|STARTED|Overall Study||51
1560579|NCT01229228|3817583|P3|STARTED|Overall Study||50
1560580|NCT01229228|3817584|P2|STARTED|Overall Study||51
1560581|NCT01229228|3817585|P1|STARTED|Overall Study||51
1560582|NCT01229176|3817605|P8|NOT COMPLETED|Overall Study||3
1560583|NCT01229176|3817606|P7|NOT COMPLETED|Overall Study||0
1560584|NCT01229176|3817607|P6|NOT COMPLETED|Overall Study||2
1560585|NCT01229176|3817608|P5|NOT COMPLETED|Overall Study||2
1560586|NCT01229176|3817609|P4|NOT COMPLETED|Overall Study||1
1560587|NCT01229176|3817610|P3|NOT COMPLETED|Overall Study||0
1560588|NCT01229176|3817611|P2|NOT COMPLETED|Overall Study||3
1560589|NCT01229176|3817612|P1|NOT COMPLETED|Overall Study||0
1560590|NCT01229176|3817605|P8|COMPLETED|Overall Study||17
1560591|NCT01229176|3817606|P7|COMPLETED|Overall Study||20
1560592|NCT01229176|3817607|P6|COMPLETED|Overall Study||18
1560593|NCT01229176|3817608|P5|COMPLETED|Overall Study||18
1560594|NCT01229176|3817609|P4|COMPLETED|Overall Study||19
1560595|NCT01229176|3817610|P3|COMPLETED|Overall Study||20
1560596|NCT01229176|3817611|P2|COMPLETED|Overall Study||37
1560597|NCT01229176|3817612|P1|COMPLETED|Overall Study||40
1560598|NCT01229176|3817605|P8|STARTED|Overall Study||20
1560599|NCT01229176|3817606|P7|STARTED|Overall Study||20
1560600|NCT01229176|3817607|P6|STARTED|Overall Study||20
1560601|NCT01229176|3817608|P5|STARTED|Overall Study||20
1560602|NCT01229176|3817609|P4|STARTED|Overall Study||20
1560603|NCT01229176|3817610|P3|STARTED|Overall Study||20
1560604|NCT01229176|3817611|P2|STARTED|Overall Study||40
1560605|NCT01229176|3817612|P1|STARTED|Overall Study||40
1560606|NCT01229150|3817666|P4|NOT COMPLETED|Overall Study||0
1560607|NCT01229150|3817667|P3|NOT COMPLETED|Overall Study||0
1560608|NCT01229150|3817668|P2|NOT COMPLETED|Overall Study||2
1560609|NCT01229150|3817669|P1|NOT COMPLETED|Overall Study||2
1560610|NCT01229150|3817666|P4|COMPLETED|Overall Study||19
1560611|NCT01229150|3817667|P3|COMPLETED|Overall Study||19
1560612|NCT01229150|3817668|P2|COMPLETED|Overall Study||9
1560613|NCT01229150|3817669|P1|COMPLETED|Overall Study||28
1560614|NCT01229150|3817666|P4|STARTED|Overall Study||19
1560615|NCT01229150|3817667|P3|STARTED|Overall Study||19
1560616|NCT01229150|3817668|P2|STARTED|Overall Study||11
1560617|NCT01229150|3817669|P1|STARTED|Overall Study||30
1560618|NCT01229111|3817726|P1|NOT COMPLETED|Overall Study||1
1560619|NCT01229111|3817726|P1|COMPLETED|Overall Study||13
1560620|NCT01229111|3817726|P1|STARTED|Overall Study||14
1560621|NCT01228968|3817734|P1|NOT COMPLETED|Overall Study||0
1560622|NCT01228968|3817734|P1|COMPLETED|Overall Study||9
1560623|NCT01228968|3817734|P1|STARTED|Overall Study||9
1560624|NCT01228929|3817744|P3|NOT COMPLETED|High Temperature Condition||0
1560625|NCT01228929|3817745|P2|NOT COMPLETED|High Temperature Condition||0
1560626|NCT01228929|3817746|P1|NOT COMPLETED|High Temperature Condition||0
1560627|NCT01228929|3817744|P3|COMPLETED|High Temperature Condition||6
1560628|NCT01228929|3817745|P2|COMPLETED|High Temperature Condition||6
1560629|NCT01228929|3817746|P1|COMPLETED|High Temperature Condition||6
1560630|NCT01228929|3817744|P3|STARTED|High Temperature Condition||6
1560631|NCT01228929|3817745|P2|STARTED|High Temperature Condition||6
1560632|NCT01228929|3817746|P1|STARTED|High Temperature Condition||6
1560633|NCT01228929|3817744|P3|NOT COMPLETED|Low Humidity Condition||0
1560634|NCT01228929|3817745|P2|NOT COMPLETED|Low Humidity Condition||0
1560635|NCT01228929|3817746|P1|NOT COMPLETED|Low Humidity Condition||0
1560636|NCT01228929|3817744|P3|COMPLETED|Low Humidity Condition||6
1560637|NCT01228929|3817745|P2|COMPLETED|Low Humidity Condition||6
1560638|NCT01228929|3817746|P1|COMPLETED|Low Humidity Condition||6
1560639|NCT01228929|3817744|P3|STARTED|Low Humidity Condition||6
1560640|NCT01228929|3817745|P2|STARTED|Low Humidity Condition||6
1560641|NCT01228929|3817746|P1|STARTED|Low Humidity Condition||6
1560642|NCT01228929|3817744|P3|NOT COMPLETED|Nominal Condition||0
1560643|NCT01228929|3817745|P2|NOT COMPLETED|Nominal Condition||0
1560644|NCT01228929|3817746|P1|NOT COMPLETED|Nominal Condition||0
1560645|NCT01228929|3817744|P3|COMPLETED|Nominal Condition||6
1560646|NCT01228929|3817745|P2|COMPLETED|Nominal Condition||6
1560647|NCT01228929|3817746|P1|COMPLETED|Nominal Condition||6
1560648|NCT01228929|3817744|P3|STARTED|Nominal Condition||6
1560649|NCT01228929|3817745|P2|STARTED|Nominal Condition||6
1560650|NCT01228929|3817746|P1|STARTED|Nominal Condition||6
1560651|NCT01228903|3817756|P2|NOT COMPLETED|Overall Study||5
1560652|NCT01228903|3817757|P1|NOT COMPLETED|Overall Study||5
1560653|NCT01228903|3817756|P2|COMPLETED|Overall Study||34
1560654|NCT01228903|3817757|P1|COMPLETED|Overall Study||36
1560655|NCT01228903|3817756|P2|STARTED|Overall Study||39
1560656|NCT01228903|3817757|P1|STARTED|Overall Study||41
1560657|NCT01228747|3817775|P2|NOT COMPLETED|Overall Study||45
1560658|NCT01228747|3817776|P1|NOT COMPLETED|Overall Study||65
1560659|NCT01228747|3817775|P2|COMPLETED|Overall Study||81
1560660|NCT01228747|3817776|P1|COMPLETED|Overall Study||60
1560661|NCT01228747|3817775|P2|STARTED|Overall Study||126
1560662|NCT01228747|3817776|P1|STARTED|Overall Study||125
1560663|NCT01228734|3817792|P2|NOT COMPLETED|Overall Study||8
1560664|NCT01228734|3817793|P1|NOT COMPLETED|Overall Study||16
1560665|NCT01228734|3817792|P2|COMPLETED|Overall Study||196
1560666|NCT01228734|3817793|P1|COMPLETED|Overall Study||177
1560667|NCT01228734|3817792|P2|Modified Safety Population|Overall Study||199
1560668|NCT01228734|3817793|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
1560669|NCT01228734|3817792|P2|Modified Intent-to-treat (MITT) Populati|Overall Study||200
1560670|NCT01228734|3817793|P1|Modified Intent-to-treat (MITT) Populati|Overall Study||193
1560671|NCT01228734|3817792|P2|STARTED|Overall Study||204
1560672|NCT01228734|3817793|P1|STARTED|Overall Study||193
1560673|NCT01228591|3817807|P2|NOT COMPLETED|Final Visit||0
1560674|NCT01228591|3817808|P1|NOT COMPLETED|Final Visit||0
1560675|NCT01228591|3817807|P2|COMPLETED|Final Visit||16
1560676|NCT01228591|3817808|P1|COMPLETED|Final Visit||17
1560677|NCT01228591|3817807|P2|STARTED|Final Visit||16
1560678|NCT01228591|3817808|P1|STARTED|Final Visit||17
1560679|NCT01228591|3817807|P2|NOT COMPLETED|1-Week Follow-Up||0
1560680|NCT01228591|3817808|P1|NOT COMPLETED|1-Week Follow-Up||0
1560681|NCT01228591|3817807|P2|COMPLETED|1-Week Follow-Up||16
1560682|NCT01228591|3817808|P1|COMPLETED|1-Week Follow-Up||17
1560683|NCT01228591|3817807|P2|STARTED|1-Week Follow-Up||16
1560684|NCT01228591|3817808|P1|STARTED|1-Week Follow-Up||17
1560685|NCT01228591|3817807|P2|NOT COMPLETED|Baseline||2
1560686|NCT01228591|3817808|P1|NOT COMPLETED|Baseline||1
1560687|NCT01228591|3817807|P2|COMPLETED|Baseline||16
1560688|NCT01228591|3817808|P1|COMPLETED|Baseline||17
1560689|NCT01228591|3817807|P2|STARTED|Baseline||18
1560690|NCT01228591|3817808|P1|STARTED|Baseline||18
1560691|NCT01228435|3817826|P2|NOT COMPLETED|Overall Study||0
1560692|NCT01228435|3817827|P1|NOT COMPLETED|Overall Study||0
1560693|NCT01228435|3817826|P2|COMPLETED|Overall Study||2
1560694|NCT01228435|3817827|P1|COMPLETED|Overall Study||1
1560695|NCT01228435|3817826|P2|STARTED|Overall Study||2
1560696|NCT01228435|3817827|P1|STARTED|Overall Study||1
1560697|NCT01228318|3817837|P2|NOT COMPLETED|Overall Study||7
1560698|NCT01228318|3817838|P1|NOT COMPLETED|Overall Study||4
1560699|NCT01228318|3817837|P2|COMPLETED|Overall Study||22
1560700|NCT01228318|3817838|P1|COMPLETED|Overall Study||30
1560701|NCT01228318|3817837|P2|STARTED|Overall Study||29
1560702|NCT01228318|3817838|P1|STARTED|Overall Study||34
1560703|NCT01228175|3817854|P2|NOT COMPLETED|Overall Study||53
1560704|NCT01228175|3817855|P1|NOT COMPLETED|Overall Study||66
1560705|NCT01228175|3817854|P2|COMPLETED|Overall Study||46
1560706|NCT01228175|3817855|P1|COMPLETED|Overall Study||53
1560707|NCT01228175|3817854|P2|STARTED|Overall Study||99
1560708|NCT01228175|3817855|P1|STARTED|Overall Study||119
1560709|NCT01228149|3817863|P2|NOT COMPLETED|Overall Study||4
1560710|NCT01228149|3817864|P1|NOT COMPLETED|Overall Study||5
1560711|NCT01228149|3817863|P2|COMPLETED|Overall Study||26
1560712|NCT01228149|3817864|P1|COMPLETED|Overall Study||27
1560713|NCT01228149|3817863|P2|STARTED|Overall Study||30
1560714|NCT01228149|3817864|P1|STARTED|Overall Study||32
1560715|NCT01228084|3817886|P1|NOT COMPLETED|Overall Study||4
1560716|NCT01228084|3817886|P1|COMPLETED|Overall Study||16
1560717|NCT01228084|3817886|P1|STARTED|Overall Study||20
1560718|NCT01228071|3817897|P1|NOT COMPLETED|Overall Study||2
1560719|NCT01228071|3817897|P1|COMPLETED|Overall Study||32
1560720|NCT01228071|3817897|P1|STARTED|Overall Study||34
1560721|NCT01228019|3817903|P1|NOT COMPLETED|Overall Study||304
1560722|NCT01228019|3817903|P1|COMPLETED|Overall Study||862
1560723|NCT01228019|3817903|P1|STARTED|Overall Study||1166
1560724|NCT01227993|3817918|P1|NOT COMPLETED|Overall Study||0
1560725|NCT01227993|3817918|P1|COMPLETED|Overall Study||3
1560726|NCT01227993|3817918|P1|STARTED|Overall Study||3
1560727|NCT01227980|3817930|P2|NOT COMPLETED|Overall Study||5
1560728|NCT01227980|3817931|P1|NOT COMPLETED|Overall Study||2
1560729|NCT01227980|3817930|P2|COMPLETED|Overall Study||25
1560730|NCT01227980|3817931|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
1560731|NCT01227980|3817930|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
1560732|NCT01227980|3817931|P1|Measure Drug Level Concentration|Overall Study||10
1560733|NCT01227980|3817930|P2|Scripts Challenge Sessions|Overall Study||25
1560734|NCT01227980|3817931|P1|Scripts Challenge Sessions|Overall Study||26
1560735|NCT01227980|3817930|P2|STARTED|Overall Study||30
1560736|NCT01227980|3817931|P1|STARTED|Overall Study||40
1560737|NCT01227967|3817969|P2|NOT COMPLETED|Overall Study||13
1560738|NCT01227967|3817970|P1|NOT COMPLETED|Overall Study||16
1560739|NCT01227967|3817969|P2|COMPLETED|Overall Study||303
1560740|NCT01227967|3817970|P1|COMPLETED|Overall Study||298
1560741|NCT01227967|3817969|P2|STARTED|Overall Study||316
1560742|NCT01227967|3817970|P1|STARTED|Overall Study||314
1560743|NCT01227954|3818004|P1|NOT COMPLETED|Overall Study||13
1560744|NCT01227954|3818004|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
1560745|NCT01227954|3818004|P1|STARTED|Overall Study||113
1560746|NCT01227928|3818018|P2|NOT COMPLETED|Overall Study||17
1560747|NCT01227928|3818019|P1|NOT COMPLETED|Overall Study||22
1560748|NCT01227928|3818018|P2|COMPLETED|Overall Study||56
1560749|NCT01227928|3818019|P1|COMPLETED|Overall Study||50
1560750|NCT01227928|3818018|P2|STARTED|Overall Study||73
1560751|NCT01227928|3818019|P1|STARTED|Overall Study||72
1560752|NCT01227902|3818057|P4|NOT COMPLETED|Overall Study||10
1560753|NCT01227902|3818058|P3|NOT COMPLETED|Overall Study||19
1560754|NCT01227902|3818059|P2|NOT COMPLETED|Overall Study||13
1560755|NCT01227902|3818060|P1|NOT COMPLETED|Overall Study||18
1560756|NCT01227902|3818057|P4|COMPLETED|Overall Study||42
1560757|NCT01227902|3818058|P3|COMPLETED|Overall Study||25
1560758|NCT01227902|3818059|P2|COMPLETED|Overall Study||38
1560759|NCT01227902|3818060|P1|COMPLETED|Overall Study||38
1560760|NCT01227902|3818057|P4|STARTED|Overall Study||52
1560761|NCT01227902|3818058|P3|STARTED|Overall Study||44
1560762|NCT01227902|3818059|P2|STARTED|Overall Study||51
1560763|NCT01227902|3818060|P1|STARTED|Overall Study||56
1560764|NCT01227889|3818153|P2|NOT COMPLETED|Crossover Phase||37
1560765|NCT01227889|3818154|P1|NOT COMPLETED|Crossover Phase||0
1560766|NCT01227889|3818153|P2|COMPLETED|Crossover Phase||0
1560767|NCT01227889|3818154|P1|COMPLETED|Crossover Phase||0
1560768|NCT01227889|3818153|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
1560769|NCT01227889|3818154|P1|STARTED|Crossover Phase||0
1560770|NCT01227889|3818153|P2|NOT COMPLETED|Randomized Phase (RP)||63
1560771|NCT01227889|3818154|P1|NOT COMPLETED|Randomized Phase (RP)||187
1560772|NCT01227889|3818153|P2|COMPLETED|Randomized Phase (RP)||0
1560773|NCT01227889|3818154|P1|COMPLETED|Randomized Phase (RP)||0
1560774|NCT01227889|3818153|P2|STARTED|Randomized Phase (RP)||63
1560775|NCT01227889|3818154|P1|STARTED|Randomized Phase (RP)||187
1560776|NCT01227824|3818181|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
1560777|NCT01227824|3818182|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
1560778|NCT01227824|3818183|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
1560779|NCT01227824|3818181|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
1560780|NCT01227824|3818182|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
1560781|NCT01227824|3818183|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
1560782|NCT01227824|3818181|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
1560783|NCT01227824|3818182|P2|STARTED|Open-label Phase: Median of 1267 Days||0
1560784|NCT01227824|3818183|P1|STARTED|Open-label Phase: Median of 1267 Days||0
1560785|NCT01227824|3818181|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
1560786|NCT01227824|3818182|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
1560787|NCT01227824|3818183|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
1560788|NCT01227824|3818181|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
1560789|NCT01227824|3818182|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
1560790|NCT01227824|3818183|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
1560791|NCT01227824|3818181|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
1560792|NCT01227824|3818182|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
1560793|NCT01227824|3818183|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
1560794|NCT01227785|3818212|P1|NOT COMPLETED|Overall Study||12
1560795|NCT01227785|3818212|P1|COMPLETED|Overall Study||108
1560796|NCT01227785|3818212|P1|STARTED|Overall Study||120
1560797|NCT01227707|3818278|P1|NOT COMPLETED|Overall Study||24
1560798|NCT01227707|3818278|P1|COMPLETED|Overall Study||19
1560799|NCT01227707|3818278|P1|STARTED|Overall Study||43
1560800|NCT01227681|3818297|P3|NOT COMPLETED|Overall Study||0
1560801|NCT01227681|3818298|P2|NOT COMPLETED|Overall Study||0
1560802|NCT01227681|3818299|P1|NOT COMPLETED|Overall Study||0
1560803|NCT01227681|3818297|P3|COMPLETED|Overall Study||0
1560804|NCT01227681|3818298|P2|COMPLETED|Overall Study||0
1560805|NCT01227681|3818299|P1|COMPLETED|Overall Study||4
1560806|NCT01227681|3818297|P3|STARTED|Overall Study||0
1560807|NCT01227681|3818298|P2|STARTED|Overall Study||0
1560808|NCT01227681|3818299|P1|STARTED|Overall Study||4
1560809|NCT01227668|3818305|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
1560810|NCT01227668|3818306|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
1560811|NCT01227668|3818305|P2|COMPLETED|Phase 2 (Randomization Phase)||19
1560812|NCT01227668|3818306|P1|COMPLETED|Phase 2 (Randomization Phase)||22
1560813|NCT01227668|3818305|P2|Received Treatment|Phase 2 (Randomization Phase)||43
1560814|NCT01227668|3818306|P1|Received Treatment|Phase 2 (Randomization Phase)||39
1560815|NCT01227668|3818305|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
1560816|NCT01227668|3818306|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
1560817|NCT01227668|3818305|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
1560818|NCT01227668|3818306|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
1560819|NCT01227668|3818305|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
1560820|NCT01227668|3818306|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
1560821|NCT01227668|3818305|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
1560822|NCT01227668|3818306|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
1560823|NCT01227668|3818305|P2|STARTED|Phase 1 (Stabilization Phase)||0
1560824|NCT01227668|3818306|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
1560825|NCT01227655|3818323|P3|NOT COMPLETED|Overall Study||14
1560826|NCT01227655|3818324|P2|NOT COMPLETED|Overall Study||26
1560827|NCT01227655|3818325|P1|NOT COMPLETED|Overall Study||11
1560828|NCT01227655|3818323|P3|COMPLETED|Overall Study||130
1560829|NCT01227655|3818324|P2|COMPLETED|Overall Study||128
1560830|NCT01227655|3818325|P1|COMPLETED|Overall Study||118
1560831|NCT01227655|3818323|P3|Full Analysis Set|Overall Study||135
1560832|NCT01227655|3818324|P2|Full Analysis Set|Overall Study||147
1560833|NCT01227655|3818325|P1|Full Analysis Set|Overall Study||125
1560834|NCT01227655|3818323|P3|Safety Set|Overall Study||136
1560835|NCT01227655|3818324|P2|Safety Set|Overall Study||150
1560836|NCT01227655|3818325|P1|Safety Set|Overall Study||125
1560837|NCT01227655|3818323|P3|STARTED|Overall Study||144
1560838|NCT01227655|3818324|P2|STARTED|Overall Study||154
1560839|NCT01227655|3818325|P1|STARTED|Overall Study||129
1560840|NCT01227629|3818352|P10|NOT COMPLETED|Overall Study||2
1560841|NCT01227629|3818353|P9|NOT COMPLETED|Overall Study||6
1560842|NCT01227629|3818354|P8|NOT COMPLETED|Overall Study||6
1560843|NCT01227629|3818355|P7|NOT COMPLETED|Overall Study||8
1560844|NCT01227629|3818356|P6|NOT COMPLETED|Overall Study||1
1560845|NCT01227629|3818357|P5|NOT COMPLETED|Overall Study||2
1560846|NCT01227629|3818358|P4|NOT COMPLETED|Overall Study||8
1560847|NCT01227629|3818359|P3|NOT COMPLETED|Overall Study||1
1560848|NCT01227629|3818360|P2|NOT COMPLETED|Overall Study||2
1560849|NCT01227629|3818361|P1|NOT COMPLETED|Overall Study||2
1560850|NCT01227629|3818352|P10|COMPLETED|Overall Study||68
1560851|NCT01227629|3818353|P9|COMPLETED|Overall Study||24
1560852|NCT01227629|3818354|P8|COMPLETED|Overall Study||27
1560853|NCT01227629|3818355|P7|COMPLETED|Overall Study||90
1560854|NCT01227629|3818356|P6|COMPLETED|Overall Study||32
1560855|NCT01227629|3818357|P5|COMPLETED|Overall Study||32
1560856|NCT01227629|3818358|P4|COMPLETED|Overall Study||91
1560857|NCT01227629|3818359|P3|COMPLETED|Overall Study||26
1560858|NCT01227629|3818360|P2|COMPLETED|Overall Study||18
1560859|NCT01227629|3818361|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
1560860|NCT01227629|3818352|P10|STARTED|Overall Study||70
1560861|NCT01227629|3818353|P9|STARTED|Overall Study||30
1560862|NCT01227629|3818354|P8|STARTED|Overall Study||33
1560863|NCT01227629|3818355|P7|STARTED|Overall Study||98
1560864|NCT01227629|3818356|P6|STARTED|Overall Study||33
1560865|NCT01227629|3818357|P5|STARTED|Overall Study||34
1560866|NCT01227629|3818358|P4|STARTED|Overall Study||99
1560867|NCT01227629|3818359|P3|STARTED|Overall Study||27
1560868|NCT01227629|3818360|P2|STARTED|Overall Study||20
1560869|NCT01227629|3818361|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
1560870|NCT01227577|3818597|P1|NOT COMPLETED|Overall Study||35
1560871|NCT01227577|3818597|P1|COMPLETED|Overall Study||93
1560872|NCT01227577|3818597|P1|STARTED|Overall Study||128
1560873|NCT01227564|3818612|P3|NOT COMPLETED|Overall Study||6
1560874|NCT01227564|3818613|P2|NOT COMPLETED|Overall Study||2
1560875|NCT01227564|3818614|P1|NOT COMPLETED|Overall Study||4
1560876|NCT01227564|3818612|P3|COMPLETED|Overall Study|Completed study|15
1560877|NCT01227564|3818613|P2|COMPLETED|Overall Study|Completed study|18
1560878|NCT01227564|3818614|P1|COMPLETED|Overall Study|Completed study|18
1560879|NCT01227564|3818612|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
1560880|NCT01227564|3818613|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
1560881|NCT01227564|3818614|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
1560882|NCT01227564|3818612|P3|Treated|Overall Study||21
1560883|NCT01227564|3818613|P2|Treated|Overall Study||20
1560884|NCT01227564|3818614|P1|Treated|Overall Study||22
1560885|NCT01227564|3818612|P3|STARTED|Overall Study||21
1560886|NCT01227564|3818613|P2|STARTED|Overall Study||20
1560887|NCT01227564|3818614|P1|STARTED|Overall Study||22
1560888|NCT01227551|3818745|P1|NOT COMPLETED|Overall Study||34
1560889|NCT01227551|3818745|P1|COMPLETED|Overall Study||23
1560890|NCT01227551|3818745|P1|STARTED|Overall Study||57
1560891|NCT01227512|3818752|P2|NOT COMPLETED|Overall Study||10
1560892|NCT01227512|3818753|P1|NOT COMPLETED|Overall Study||13
1560893|NCT01227512|3818752|P2|COMPLETED|Overall Study||48
1560894|NCT01227512|3818753|P1|COMPLETED|Overall Study||53
1560895|NCT01227512|3818752|P2|STARTED|Overall Study||58
1560896|NCT01227512|3818753|P1|STARTED|Overall Study||66
1560897|NCT01227434|3818775|P2|NOT COMPLETED|Overall Study||0
1560898|NCT01227434|3818776|P1|NOT COMPLETED|Overall Study||0
1560899|NCT01227434|3818775|P2|COMPLETED|Overall Study||16
1560900|NCT01227434|3818776|P1|COMPLETED|Overall Study||6
1560901|NCT01227434|3818775|P2|STARTED|Overall Study||16
1560902|NCT01227434|3818776|P1|STARTED|Overall Study||6
1560903|NCT01227421|3818787|P3|NOT COMPLETED|Overall Study||10
1560904|NCT01227421|3818788|P2|NOT COMPLETED|Overall Study||18
1560905|NCT01227421|3818789|P1|NOT COMPLETED|Overall Study||11
1560906|NCT01227421|3818787|P3|COMPLETED|Overall Study||201
1560907|NCT01227421|3818788|P2|COMPLETED|Overall Study||194
1560908|NCT01227421|3818789|P1|COMPLETED|Overall Study||190
1560909|NCT01227421|3818787|P3|STARTED|Overall Study||211
1560910|NCT01227421|3818788|P2|STARTED|Overall Study||212
1560911|NCT01227421|3818789|P1|STARTED|Overall Study||201
1560912|NCT01227395|3818841|P2|NOT COMPLETED|Overall Study||1
1560913|NCT01227395|3818842|P1|NOT COMPLETED|Overall Study||0
1560914|NCT01227395|3818841|P2|COMPLETED|Overall Study||84
1560915|NCT01227395|3818842|P1|COMPLETED|Overall Study||391
1560916|NCT01227395|3818841|P2|STARTED|Overall Study||85
1560917|NCT01227395|3818842|P1|STARTED|Overall Study||391
1560918|NCT01227382|3818870|P1|NOT COMPLETED|Overall Study||0
1560919|NCT01227382|3818870|P1|COMPLETED|Overall Study||26
1560920|NCT01227382|3818870|P1|STARTED|Overall Study||26
1560921|NCT01227278|3818882|P2|NOT COMPLETED|Overall Study||8
1560922|NCT01227278|3818883|P1|NOT COMPLETED|Overall Study||5
1560923|NCT01227278|3818882|P2|COMPLETED|Overall Study||43
1560924|NCT01227278|3818883|P1|COMPLETED|Overall Study||45
1560925|NCT01227278|3818882|P2|STARTED|Overall Study||51
1560926|NCT01227278|3818883|P1|STARTED|Overall Study||50
1560927|NCT01227265|3818910|P3|NOT COMPLETED|Overall Study||14
1560928|NCT01227265|3818911|P2|NOT COMPLETED|Overall Study||20
1560929|NCT01227265|3818912|P1|NOT COMPLETED|Overall Study||19
1560930|NCT01227265|3818910|P3|COMPLETED|Overall Study||145
1560931|NCT01227265|3818911|P2|COMPLETED|Overall Study||139
1560932|NCT01227265|3818912|P1|COMPLETED|Overall Study||139
1560933|NCT01227265|3818910|P3|Treated|Overall Study||159
1560934|NCT01227265|3818911|P2|Treated|Overall Study||157
1560935|NCT01227265|3818912|P1|Treated|Overall Study||157
1560936|NCT01227265|3818910|P3|STARTED|Overall Study||159
1560937|NCT01227265|3818911|P2|STARTED|Overall Study||159
1560938|NCT01227265|3818912|P1|STARTED|Overall Study||158
1560939|NCT01227057|3818940|P2|NOT COMPLETED|Overall Study||8
1560940|NCT01227057|3818941|P1|NOT COMPLETED|Overall Study||6
1560941|NCT01227057|3818940|P2|COMPLETED|Overall Study||19
1560942|NCT01227057|3818941|P1|COMPLETED|Overall Study||25
1560943|NCT01227057|3818940|P2|STARTED|Overall Study||27
1560944|NCT01227057|3818941|P1|STARTED|Overall Study||31
1560945|NCT01227018|3818951|P1|NOT COMPLETED|Overall Study||15
1560946|NCT01227018|3818951|P1|COMPLETED|Overall Study||0
1560947|NCT01227018|3818951|P1|STARTED|Overall Study||15
1560948|NCT01227005|3818961|P2|NOT COMPLETED|Overall Study||1
1560949|NCT01227005|3818962|P1|NOT COMPLETED|Overall Study||5
1560950|NCT01227005|3818961|P2|COMPLETED|Overall Study||51
1560951|NCT01227005|3818962|P1|COMPLETED|Overall Study||50
1560952|NCT01227005|3818961|P2|STARTED|Overall Study||52
1560953|NCT01227005|3818962|P1|STARTED|Overall Study||55
1560954|NCT01226745|3818978|P6|NOT COMPLETED|Overall Study||5
1560955|NCT01226745|3818979|P5|NOT COMPLETED|Overall Study||4
1560956|NCT01226745|3818980|P4|NOT COMPLETED|Overall Study||5
1560957|NCT01226745|3818981|P3|NOT COMPLETED|Overall Study||20
1560958|NCT01226745|3818982|P2|NOT COMPLETED|Overall Study||16
1560959|NCT01226745|3818983|P1|NOT COMPLETED|Overall Study||17
1560960|NCT01226745|3818978|P6|COMPLETED|Overall Study||24
1560961|NCT01226745|3818979|P5|COMPLETED|Overall Study||22
1560962|NCT01226745|3818980|P4|COMPLETED|Overall Study||24
1560963|NCT01226745|3818981|P3|COMPLETED|Overall Study||69
1560964|NCT01226745|3818982|P2|COMPLETED|Overall Study||71
1560965|NCT01226745|3818983|P1|COMPLETED|Overall Study||63
1560966|NCT01226745|3818978|P6|STARTED|Overall Study||29
1560967|NCT01226745|3818979|P5|STARTED|Overall Study||26
1560968|NCT01226745|3818980|P4|STARTED|Overall Study||29
1560969|NCT01226745|3818981|P3|STARTED|Overall Study||89
1560970|NCT01226745|3818982|P2|STARTED|Overall Study||87
1560971|NCT01226745|3818983|P1|STARTED|Overall Study||80
1560972|NCT01226732|3819063|P6|NOT COMPLETED|Overall Study||6
1560973|NCT01226732|3819064|P5|NOT COMPLETED|Overall Study||3
1560974|NCT01226732|3819065|P4|NOT COMPLETED|Overall Study||5
1560975|NCT01226732|3819066|P3|NOT COMPLETED|Overall Study||3
1560976|NCT01226732|3819067|P2|NOT COMPLETED|Overall Study||3
1560977|NCT01226732|3819068|P1|NOT COMPLETED|Overall Study||3
1560978|NCT01226732|3819063|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1560979|NCT01226732|3819064|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1560980|NCT01226732|3819065|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1560981|NCT01226732|3819066|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1560982|NCT01226732|3819067|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1560983|NCT01226732|3819068|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1560984|NCT01226732|3819063|P6|STARTED|Overall Study||6
1560985|NCT01226732|3819064|P5|STARTED|Overall Study||3
1560986|NCT01226732|3819065|P4|STARTED|Overall Study||5
1560987|NCT01226732|3819066|P3|STARTED|Overall Study||3
1560988|NCT01226732|3819067|P2|STARTED|Overall Study||3
1560989|NCT01226732|3819068|P1|STARTED|Overall Study||3
1560990|NCT01226719|3819084|P1|NOT COMPLETED|Overall Study||13
1560991|NCT01226719|3819084|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
1560992|NCT01226719|3819084|P1|STARTED|Overall Study||15
1560993|NCT01226706|3819094|P2|NOT COMPLETED|Overall Study||0
1560994|NCT01226706|3819095|P1|NOT COMPLETED|Overall Study||0
1560995|NCT01226706|3819094|P2|COMPLETED|Overall Study||11
1560996|NCT01226706|3819095|P1|COMPLETED|Overall Study||10
1560997|NCT01226706|3819094|P2|STARTED|Overall Study||11
1560998|NCT01226706|3819095|P1|STARTED|Overall Study||10
1560999|NCT01226511|3819179|P2|NOT COMPLETED|Taper Period||3
1561000|NCT01226511|3819180|P1|NOT COMPLETED|Taper Period||5
1561001|NCT01226511|3819179|P2|COMPLETED|Taper Period||54
1561002|NCT01226511|3819180|P1|COMPLETED|Taper Period||46
1561003|NCT01226511|3819179|P2|STARTED|Taper Period||57
1561004|NCT01226511|3819180|P1|STARTED|Taper Period||51
1561005|NCT01226511|3819179|P2|NOT COMPLETED|Extension Treatment Period||27
1561006|NCT01226511|3819180|P1|NOT COMPLETED|Extension Treatment Period||27
1561007|NCT01226511|3819179|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
1561008|NCT01226511|3819180|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
1561009|NCT01226511|3819179|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
1561010|NCT01226511|3819180|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
1561011|NCT01226511|3819179|P2|NOT COMPLETED|Acute Treatment Period||31
1561012|NCT01226511|3819180|P1|NOT COMPLETED|Acute Treatment Period||32
1561013|NCT01226511|3819179|P2|COMPLETED|Acute Treatment Period||110
1561014|NCT01226511|3819180|P1|COMPLETED|Acute Treatment Period||108
1561015|NCT01226511|3819179|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
1561016|NCT01226511|3819180|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
1561017|NCT01226459|3819218|P2|NOT COMPLETED|Overall Study||32
1561018|NCT01226459|3819219|P1|NOT COMPLETED|Overall Study||21
1561019|NCT01226459|3819218|P2|COMPLETED|Overall Study||171
1561020|NCT01226459|3819219|P1|COMPLETED|Overall Study||180
1561021|NCT01226459|3819218|P2|STARTED|Overall Study||203
1561022|NCT01226459|3819219|P1|STARTED|Overall Study||201
1561023|NCT01226420|3819229|P1|NOT COMPLETED|Overall Study||0
1561024|NCT01226420|3819229|P1|COMPLETED|Overall Study||6
1561025|NCT01226420|3819229|P1|STARTED|Overall Study||6
1561026|NCT01226121|3819237|P3|NOT COMPLETED|Overall Study||1
1561027|NCT01226121|3819238|P2|NOT COMPLETED|Overall Study||0
1561028|NCT01226121|3819239|P1|NOT COMPLETED|Overall Study||2
1561029|NCT01226121|3819237|P3|COMPLETED|Overall Study||12
1561030|NCT01226121|3819238|P2|COMPLETED|Overall Study||11
1561031|NCT01226121|3819239|P1|COMPLETED|Overall Study||11
1561032|NCT01226121|3819237|P3|30 Day Evaluation|Overall Study||13
1561033|NCT01226121|3819238|P2|30 Day Evaluation|Overall Study||11
1561034|NCT01226121|3819239|P1|30 Day Evaluation|Overall Study||12
1561035|NCT01226121|3819237|P3|STARTED|Overall Study||13
1561036|NCT01226121|3819238|P2|STARTED|Overall Study||11
1561037|NCT01226121|3819239|P1|STARTED|Overall Study||13
1561038|NCT01226095|3819250|P1|NOT COMPLETED|Overall Study||1
1561039|NCT01226095|3819250|P1|COMPLETED|Overall Study||518
1561040|NCT01226095|3819250|P1|STARTED|Overall Study||519
1561041|NCT01226043|3819275|P4|NOT COMPLETED|30-week Observational Phase||13
1561042|NCT01226043|3819276|P3|NOT COMPLETED|30-week Observational Phase||6
1561043|NCT01226043|3819277|P2|NOT COMPLETED|30-week Observational Phase||0
1561044|NCT01226043|3819278|P1|NOT COMPLETED|30-week Observational Phase||0
1561045|NCT01226043|3819275|P4|COMPLETED|30-week Observational Phase||140
1561046|NCT01226043|3819276|P3|COMPLETED|30-week Observational Phase||153
1561047|NCT01226043|3819277|P2|COMPLETED|30-week Observational Phase||0
1561048|NCT01226043|3819278|P1|COMPLETED|30-week Observational Phase||0
1561049|NCT01226043|3819275|P4|TREATED|30-week Observational Phase||153
1561050|NCT01226043|3819276|P3|TREATED|30-week Observational Phase||159
1561051|NCT01226043|3819277|P2|TREATED|30-week Observational Phase||0
1561052|NCT01226043|3819278|P1|TREATED|30-week Observational Phase||0
1561053|NCT01226043|3819275|P4|STARTED|30-week Observational Phase||153
1561054|NCT01226043|3819276|P3|STARTED|30-week Observational Phase||159
1561055|NCT01226043|3819277|P2|STARTED|30-week Observational Phase||0
1561056|NCT01226043|3819278|P1|STARTED|30-week Observational Phase||0
1561057|NCT01226043|3819275|P4|NOT COMPLETED|6-week Re-randomization Phase||11
1561058|NCT01226043|3819276|P3|NOT COMPLETED|6-week Re-randomization Phase||7
1561059|NCT01226043|3819277|P2|NOT COMPLETED|6-week Re-randomization Phase||0
1561060|NCT01226043|3819278|P1|NOT COMPLETED|6-week Re-randomization Phase||0
1561061|NCT01226043|3819275|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
1561062|NCT01226043|3819276|P3|COMPLETED|6-week Re-randomization Phase||159
1561063|NCT01226043|3819277|P2|COMPLETED|6-week Re-randomization Phase||0
1561064|NCT01226043|3819278|P1|COMPLETED|6-week Re-randomization Phase||0
1561065|NCT01226043|3819275|P4|TREATED|6-week Re-randomization Phase||165
1561066|NCT01226043|3819276|P3|TREATED|6-week Re-randomization Phase||165
1561067|NCT01226043|3819277|P2|TREATED|6-week Re-randomization Phase||0
1561068|NCT01226043|3819278|P1|TREATED|6-week Re-randomization Phase||0
1561069|NCT01226043|3819275|P4|STARTED|6-week Re-randomization Phase||167
1561070|NCT01226043|3819276|P3|STARTED|6-week Re-randomization Phase||166
1561071|NCT01226043|3819277|P2|STARTED|6-week Re-randomization Phase||0
1561072|NCT01226043|3819278|P1|STARTED|6-week Re-randomization Phase||0
1561073|NCT01226043|3819275|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
1561074|NCT01226043|3819276|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
1561075|NCT01226043|3819277|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
1561076|NCT01226043|3819278|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
1561077|NCT01226043|3819275|P4|COMPLETED|4-week Crossover Phase - Period 2||0
1561078|NCT01226043|3819276|P3|COMPLETED|4-week Crossover Phase - Period 2||0
1561079|NCT01226043|3819277|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
1561080|NCT01226043|3819278|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
1561081|NCT01226043|3819275|P4|TREATED|4-week Crossover Phase - Period 2||0
1561082|NCT01226043|3819276|P3|TREATED|4-week Crossover Phase - Period 2||0
1561083|NCT01226043|3819277|P2|TREATED|4-week Crossover Phase - Period 2||194
1561084|NCT01226043|3819278|P1|TREATED|4-week Crossover Phase - Period 2||199
1561085|NCT01226043|3819275|P4|STARTED|4-week Crossover Phase - Period 2||0
1561086|NCT01226043|3819276|P3|STARTED|4-week Crossover Phase - Period 2||0
1561087|NCT01226043|3819277|P2|STARTED|4-week Crossover Phase - Period 2||194
1561088|NCT01226043|3819278|P1|STARTED|4-week Crossover Phase - Period 2||199
1561089|NCT01226043|3819275|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
1561090|NCT01226043|3819276|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
1561091|NCT01226043|3819277|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
1561092|NCT01226043|3819278|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
1561093|NCT01226043|3819275|P4|COMPLETED|4-week Crossover Phase - Period 1||0
1561094|NCT01226043|3819276|P3|COMPLETED|4-week Crossover Phase - Period 1||0
1561095|NCT01226043|3819277|P2|COMPLETED|4-week Crossover Phase - Period 1||194
1561096|NCT01226043|3819278|P1|COMPLETED|4-week Crossover Phase - Period 1||199
1561097|NCT01226043|3819275|P4|TREATED|4-week Crossover Phase - Period 1||0
1561098|NCT01226043|3819276|P3|TREATED|4-week Crossover Phase - Period 1||0
1561099|NCT01226043|3819277|P2|TREATED|4-week Crossover Phase - Period 1||200
1561100|NCT01226043|3819278|P1|TREATED|4-week Crossover Phase - Period 1||202
1561101|NCT01226043|3819275|P4|STARTED|4-week Crossover Phase - Period 1||0
1561102|NCT01226043|3819276|P3|STARTED|4-week Crossover Phase - Period 1||0
1561103|NCT01226043|3819277|P2|STARTED|4-week Crossover Phase - Period 1||203
1561104|NCT01226043|3819278|P1|STARTED|4-week Crossover Phase - Period 1||202
1561105|NCT01225991|3819316|P1|NOT COMPLETED|Overall Study||6
1561106|NCT01225991|3819316|P1|COMPLETED|Overall Study||12
1561107|NCT01225991|3819316|P1|STARTED|Overall Study||18
1561108|NCT01225952|3819327|P3|NOT COMPLETED|Overall Study||6
1561109|NCT01225952|3819328|P2|NOT COMPLETED|Overall Study||4
1561110|NCT01225952|3819329|P1|NOT COMPLETED|Overall Study||6
1561111|NCT01225952|3819327|P3|COMPLETED|Overall Study||25
1561112|NCT01225952|3819328|P2|COMPLETED|Overall Study||27
1561113|NCT01225952|3819329|P1|COMPLETED|Overall Study||25
1561114|NCT01225952|3819327|P3|STARTED|Overall Study||31
1561115|NCT01225952|3819328|P2|STARTED|Overall Study||31
1561116|NCT01225952|3819329|P1|STARTED|Overall Study||31
1561117|NCT01225926|3819414|P2|NOT COMPLETED|Overall Study||0
1561118|NCT01225926|3819415|P1|NOT COMPLETED|Overall Study||0
1561119|NCT01225926|3819414|P2|COMPLETED|Overall Study||12
1561120|NCT01225926|3819415|P1|COMPLETED|Overall Study||12
1561121|NCT01225926|3819414|P2|STARTED|Overall Study||12
1561122|NCT01225926|3819415|P1|STARTED|Overall Study||12
1561123|NCT01225887|3819421|P1|NOT COMPLETED|Overall Study||5
1561124|NCT01225887|3819421|P1|COMPLETED|Overall Study||32
1561125|NCT01225887|3819421|P1|STARTED|Overall Study||37
1561126|NCT01225835|3819431|P2|NOT COMPLETED|Overall Study||3
1561127|NCT01225835|3819432|P1|NOT COMPLETED|Overall Study||7
1561128|NCT01225835|3819431|P2|COMPLETED|Overall Study|hCG criterion met|59
1561129|NCT01225835|3819432|P1|COMPLETED|Overall Study|hCG criterion met|55
1561130|NCT01225835|3819431|P2|Per Protocol Population|Overall Study||58
1561131|NCT01225835|3819432|P1|Per Protocol Population|Overall Study||48
1561132|NCT01225835|3819431|P2|STARTED|Overall Study||62
1561133|NCT01225835|3819432|P1|STARTED|Overall Study||62
1561134|NCT01225822|3819480|P5|NOT COMPLETED|Overall Study||31
1561135|NCT01225822|3819481|P4|NOT COMPLETED|Overall Study||52
1561136|NCT01225822|3819482|P3|NOT COMPLETED|Overall Study||38
1561137|NCT01225822|3819483|P2|NOT COMPLETED|Overall Study||56
1561138|NCT01225822|3819484|P1|NOT COMPLETED|Overall Study||38
1561139|NCT01225822|3819480|P5|COMPLETED|Overall Study||361
1561140|NCT01225822|3819481|P4|COMPLETED|Overall Study||333
1561141|NCT01225822|3819482|P3|COMPLETED|Overall Study||355
1561142|NCT01225822|3819483|P2|COMPLETED|Overall Study||334
1561143|NCT01225822|3819484|P1|COMPLETED|Overall Study||351
1561144|NCT01225822|3819480|P5|STARTED|Overall Study||392
1561145|NCT01225822|3819481|P4|STARTED|Overall Study||385
1561146|NCT01225822|3819482|P3|STARTED|Overall Study||393
1561147|NCT01225822|3819483|P2|STARTED|Overall Study||390
1561148|NCT01225822|3819484|P1|STARTED|Overall Study||389
1561149|NCT01225731|3819551|P13|NOT COMPLETED|Part 3||7
1561150|NCT01225731|3819552|P12|NOT COMPLETED|Part 3||10
1561151|NCT01225731|3819553|P11|NOT COMPLETED|Part 3||6
1561152|NCT01225731|3819554|P10|NOT COMPLETED|Part 3||0
1561153|NCT01225731|3819555|P9|NOT COMPLETED|Part 3||0
1561154|NCT01225731|3819556|P8|NOT COMPLETED|Part 3||0
1561155|NCT01225731|3819557|P7|NOT COMPLETED|Part 3||0
1561156|NCT01225731|3819558|P6|NOT COMPLETED|Part 3||0
1561157|NCT01225731|3819559|P5|NOT COMPLETED|Part 3||0
1561158|NCT01225731|3819560|P4|NOT COMPLETED|Part 3||0
1561159|NCT01225731|3819561|P3|NOT COMPLETED|Part 3||0
1561160|NCT01225731|3819562|P2|NOT COMPLETED|Part 3||0
1561161|NCT01225731|3819563|P1|NOT COMPLETED|Part 3||0
1561162|NCT01225731|3819551|P13|COMPLETED|Part 3||60
1561163|NCT01225731|3819552|P12|COMPLETED|Part 3||116
1561164|NCT01225731|3819553|P11|COMPLETED|Part 3||80
1561165|NCT01225731|3819554|P10|COMPLETED|Part 3||10
1561166|NCT01225731|3819555|P9|COMPLETED|Part 3||0
1561167|NCT01225731|3819556|P8|COMPLETED|Part 3||0
1561168|NCT01225731|3819557|P7|COMPLETED|Part 3||0
1561169|NCT01225731|3819558|P6|COMPLETED|Part 3||0
1561170|NCT01225731|3819559|P5|COMPLETED|Part 3||0
1561171|NCT01225731|3819560|P4|COMPLETED|Part 3||0
1561172|NCT01225731|3819561|P3|COMPLETED|Part 3||0
1561173|NCT01225731|3819562|P2|COMPLETED|Part 3||0
1561174|NCT01225731|3819563|P1|COMPLETED|Part 3||0
1561175|NCT01225731|3819551|P13|STARTED|Part 3|Not all participants entered follow-up|67
1561176|NCT01225731|3819552|P12|STARTED|Part 3|Not all participants entered follow-up|126
1561177|NCT01225731|3819553|P11|STARTED|Part 3|Not all participants entered follow-up|86
1561178|NCT01225731|3819554|P10|STARTED|Part 3|Not all participants entered follow-up|10
1561179|NCT01225731|3819555|P9|STARTED|Part 3|Participants could enter the follow-up period|0
1561180|NCT01225731|3819556|P8|STARTED|Part 3|Participants could enter the follow-up period|0
1561181|NCT01225731|3819557|P7|STARTED|Part 3|Participants could enter the follow-up period|0
1561182|NCT01225731|3819558|P6|STARTED|Part 3|Participants could enter the follow-up period|0
1561183|NCT01225731|3819559|P5|STARTED|Part 3||0
1561184|NCT01225731|3819560|P4|STARTED|Part 3||0
1561185|NCT01225731|3819561|P3|STARTED|Part 3||0
1561186|NCT01225731|3819562|P2|STARTED|Part 3||0
1561187|NCT01225731|3819563|P1|STARTED|Part 3||0
1561188|NCT01225731|3819551|P13|NOT COMPLETED|Part 2||0
1561189|NCT01225731|3819552|P12|NOT COMPLETED|Part 2||0
1561190|NCT01225731|3819553|P11|NOT COMPLETED|Part 2||0
1561191|NCT01225731|3819554|P10|NOT COMPLETED|Part 2||0
1561192|NCT01225731|3819555|P9|NOT COMPLETED|Part 2||11
1561193|NCT01225731|3819556|P8|NOT COMPLETED|Part 2||25
1561194|NCT01225731|3819557|P7|NOT COMPLETED|Part 2||8
1561195|NCT01225731|3819558|P6|NOT COMPLETED|Part 2||3
1561196|NCT01225731|3819559|P5|NOT COMPLETED|Part 2||0
1561197|NCT01225731|3819560|P4|NOT COMPLETED|Part 2||0
1561198|NCT01225731|3819561|P3|NOT COMPLETED|Part 2||0
1561199|NCT01225731|3819562|P2|NOT COMPLETED|Part 2||0
1561200|NCT01225731|3819563|P1|NOT COMPLETED|Part 2||0
1561201|NCT01225731|3819551|P13|COMPLETED|Part 2||0
1561202|NCT01225731|3819552|P12|COMPLETED|Part 2||0
1561203|NCT01225731|3819553|P11|COMPLETED|Part 2||0
1561204|NCT01225731|3819554|P10|COMPLETED|Part 2||0
1561205|NCT01225731|3819555|P9|COMPLETED|Part 2||68
1561206|NCT01225731|3819556|P8|COMPLETED|Part 2||128
1561207|NCT01225731|3819557|P7|COMPLETED|Part 2||86
1561208|NCT01225731|3819558|P6|COMPLETED|Part 2||10
1561209|NCT01225731|3819559|P5|COMPLETED|Part 2||0
1561210|NCT01225731|3819560|P4|COMPLETED|Part 2||0
1561211|NCT01225731|3819561|P3|COMPLETED|Part 2||0
1561212|NCT01225731|3819562|P2|COMPLETED|Part 2||0
1561213|NCT01225731|3819563|P1|COMPLETED|Part 2||0
1561214|NCT01225731|3819551|P13|STARTED|Part 2||0
1561215|NCT01225731|3819552|P12|STARTED|Part 2||0
1561216|NCT01225731|3819553|P11|STARTED|Part 2||0
1561217|NCT01225731|3819554|P10|STARTED|Part 2||0
1561218|NCT01225731|3819555|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
1561219|NCT01225731|3819556|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
1561220|NCT01225731|3819557|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
1561221|NCT01225731|3819558|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
1561222|NCT01225731|3819559|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
1561223|NCT01225731|3819560|P4|STARTED|Part 2|Participants could progress into Part 2|0
1561224|NCT01225731|3819561|P3|STARTED|Part 2|Participants could progress into Part 2|0
1561225|NCT01225731|3819562|P2|STARTED|Part 2|Participants could progress into Part 2|0
1561226|NCT01225731|3819563|P1|STARTED|Part 2|Participants could progress into Part 2|0
1561227|NCT01225731|3819551|P13|NOT COMPLETED|Part 1||0
1561228|NCT01225731|3819552|P12|NOT COMPLETED|Part 1||0
1561229|NCT01225731|3819553|P11|NOT COMPLETED|Part 1||0
1561230|NCT01225731|3819554|P10|NOT COMPLETED|Part 1||0
1561231|NCT01225731|3819555|P9|NOT COMPLETED|Part 1||0
1561232|NCT01225731|3819556|P8|NOT COMPLETED|Part 1||0
1561233|NCT01225731|3819557|P7|NOT COMPLETED|Part 1||0
1561234|NCT01225731|3819558|P6|NOT COMPLETED|Part 1||0
1561235|NCT01225731|3819559|P5|NOT COMPLETED|Part 1||6
1561236|NCT01225731|3819560|P4|NOT COMPLETED|Part 1||2
1561237|NCT01225731|3819561|P3|NOT COMPLETED|Part 1||1
1561238|NCT01225731|3819562|P2|NOT COMPLETED|Part 1||5
1561239|NCT01225731|3819563|P1|NOT COMPLETED|Part 1||2
1561240|NCT01225731|3819551|P13|COMPLETED|Part 1||0
1561241|NCT01225731|3819552|P12|COMPLETED|Part 1||0
1561242|NCT01225731|3819553|P11|COMPLETED|Part 1||0
1561243|NCT01225731|3819554|P10|COMPLETED|Part 1||0
1561244|NCT01225731|3819555|P9|COMPLETED|Part 1||0
1561245|NCT01225731|3819556|P8|COMPLETED|Part 1||0
1561246|NCT01225731|3819557|P7|COMPLETED|Part 1||0
1561247|NCT01225731|3819558|P6|COMPLETED|Part 1||0
1561248|NCT01225731|3819559|P5|COMPLETED|Part 1||40
1561249|NCT01225731|3819560|P4|COMPLETED|Part 1||84
1561250|NCT01225731|3819561|P3|COMPLETED|Part 1||88
1561251|NCT01225731|3819562|P2|COMPLETED|Part 1||87
1561252|NCT01225731|3819563|P1|COMPLETED|Part 1||40
1561253|NCT01225731|3819551|P13|STARTED|Part 1||0
1561254|NCT01225731|3819552|P12|STARTED|Part 1||0
1561255|NCT01225731|3819553|P11|STARTED|Part 1||0
1561256|NCT01225731|3819554|P10|STARTED|Part 1||0
1561257|NCT01225731|3819555|P9|STARTED|Part 1||0
1561258|NCT01225731|3819556|P8|STARTED|Part 1||0
1561259|NCT01225731|3819557|P7|STARTED|Part 1||0
1561260|NCT01225731|3819558|P6|STARTED|Part 1||0
1561261|NCT01225731|3819559|P5|STARTED|Part 1||46
1561262|NCT01225731|3819560|P4|STARTED|Part 1||86
1561263|NCT01225731|3819561|P3|STARTED|Part 1||89
1561264|NCT01225731|3819562|P2|STARTED|Part 1||92
1561265|NCT01225731|3819563|P1|STARTED|Part 1||42
1561266|NCT01225562|3819658|P3|NOT COMPLETED|Overall Study||53
1561267|NCT01225562|3819659|P2|NOT COMPLETED|Overall Study||56
1561268|NCT01225562|3819660|P1|NOT COMPLETED|Overall Study||55
1561269|NCT01225562|3819658|P3|COMPLETED|Overall Study||7014
1561270|NCT01225562|3819659|P2|COMPLETED|Overall Study||6989
1561271|NCT01225562|3819660|P1|COMPLETED|Overall Study||6995
1561272|NCT01225562|3819658|P3|STARTED|Overall Study||7067
1561273|NCT01225562|3819659|P2|STARTED|Overall Study||7045
1561274|NCT01225562|3819660|P1|STARTED|Overall Study||7050
1561275|NCT01225549|3819677|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561276|NCT01225549|3819678|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561277|NCT01225549|3819679|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561278|NCT01225549|3819680|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561279|NCT01225549|3819681|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561280|NCT01225549|3819682|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561281|NCT01225549|3819683|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561282|NCT01225549|3819684|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561283|NCT01225549|3819685|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561284|NCT01225549|3819686|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1561285|NCT01225549|3819677|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
1561286|NCT01225549|3819678|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
1561287|NCT01225549|3819679|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
1561288|NCT01225549|3819680|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
1561289|NCT01225549|3819681|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
1561290|NCT01225549|3819682|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
1561291|NCT01225549|3819683|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
1561292|NCT01225549|3819684|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
1561293|NCT01225549|3819685|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
1561294|NCT01225549|3819686|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
1561295|NCT01225549|3819677|P10|STARTED|Period 7 - Fourth Treatment Period||1
1561296|NCT01225549|3819678|P9|STARTED|Period 7 - Fourth Treatment Period||4
1561297|NCT01225549|3819679|P8|STARTED|Period 7 - Fourth Treatment Period||1
1561298|NCT01225549|3819680|P7|STARTED|Period 7 - Fourth Treatment Period||3
1561299|NCT01225549|3819681|P6|STARTED|Period 7 - Fourth Treatment Period||1
1561300|NCT01225549|3819682|P5|STARTED|Period 7 - Fourth Treatment Period||1
1561301|NCT01225549|3819683|P4|STARTED|Period 7 - Fourth Treatment Period||0
1561302|NCT01225549|3819684|P3|STARTED|Period 7 - Fourth Treatment Period||3
1561303|NCT01225549|3819685|P2|STARTED|Period 7 - Fourth Treatment Period||3
1561304|NCT01225549|3819686|P1|STARTED|Period 7 - Fourth Treatment Period||1
1561305|NCT01225549|3819677|P10|NOT COMPLETED|Period 6 - Washout||0
1561306|NCT01225549|3819678|P9|NOT COMPLETED|Period 6 - Washout||0
1561307|NCT01225549|3819679|P8|NOT COMPLETED|Period 6 - Washout||0
1561308|NCT01225549|3819680|P7|NOT COMPLETED|Period 6 - Washout||0
1561309|NCT01225549|3819681|P6|NOT COMPLETED|Period 6 - Washout||0
1561310|NCT01225549|3819682|P5|NOT COMPLETED|Period 6 - Washout||0
1561311|NCT01225549|3819683|P4|NOT COMPLETED|Period 6 - Washout||1
1561312|NCT01225549|3819684|P3|NOT COMPLETED|Period 6 - Washout||0
1561313|NCT01225549|3819685|P2|NOT COMPLETED|Period 6 - Washout||0
1561314|NCT01225549|3819686|P1|NOT COMPLETED|Period 6 - Washout||0
1561315|NCT01225549|3819677|P10|COMPLETED|Period 6 - Washout||1
1561316|NCT01225549|3819678|P9|COMPLETED|Period 6 - Washout||4
1561317|NCT01225549|3819679|P8|COMPLETED|Period 6 - Washout||1
1561318|NCT01225549|3819680|P7|COMPLETED|Period 6 - Washout||3
1561319|NCT01225549|3819681|P6|COMPLETED|Period 6 - Washout||1
1561320|NCT01225549|3819682|P5|COMPLETED|Period 6 - Washout||1
1561321|NCT01225549|3819683|P4|COMPLETED|Period 6 - Washout||0
1561322|NCT01225549|3819684|P3|COMPLETED|Period 6 - Washout||3
1561323|NCT01225549|3819685|P2|COMPLETED|Period 6 - Washout||3
1561324|NCT01225549|3819686|P1|COMPLETED|Period 6 - Washout||1
1561325|NCT01225549|3819677|P10|STARTED|Period 6 - Washout||1
1561326|NCT01225549|3819678|P9|STARTED|Period 6 - Washout||4
1561327|NCT01225549|3819679|P8|STARTED|Period 6 - Washout||1
1561328|NCT01225549|3819680|P7|STARTED|Period 6 - Washout||3
1561329|NCT01225549|3819681|P6|STARTED|Period 6 - Washout||1
1561330|NCT01225549|3819682|P5|STARTED|Period 6 - Washout||1
1561331|NCT01225549|3819683|P4|STARTED|Period 6 - Washout||1
1561332|NCT01225549|3819684|P3|STARTED|Period 6 - Washout||3
1561333|NCT01225549|3819685|P2|STARTED|Period 6 - Washout||3
1561334|NCT01225549|3819686|P1|STARTED|Period 6 - Washout||1
1561335|NCT01225549|3819677|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561336|NCT01225549|3819678|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561337|NCT01225549|3819679|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561338|NCT01225549|3819680|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561339|NCT01225549|3819681|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561340|NCT01225549|3819682|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561341|NCT01225549|3819683|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561342|NCT01225549|3819684|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561343|NCT01225549|3819685|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561344|NCT01225549|3819686|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
1561345|NCT01225549|3819677|P10|COMPLETED|Period 5 - Third Treatment Period||1
1561346|NCT01225549|3819678|P9|COMPLETED|Period 5 - Third Treatment Period||4
1561347|NCT01225549|3819679|P8|COMPLETED|Period 5 - Third Treatment Period||1
1561348|NCT01225549|3819680|P7|COMPLETED|Period 5 - Third Treatment Period||3
1561349|NCT01225549|3819681|P6|COMPLETED|Period 5 - Third Treatment Period||1
1561350|NCT01225549|3819682|P5|COMPLETED|Period 5 - Third Treatment Period||1
1561351|NCT01225549|3819683|P4|COMPLETED|Period 5 - Third Treatment Period||1
1561352|NCT01225549|3819684|P3|COMPLETED|Period 5 - Third Treatment Period||3
1561353|NCT01225549|3819685|P2|COMPLETED|Period 5 - Third Treatment Period||3
1561354|NCT01225549|3819686|P1|COMPLETED|Period 5 - Third Treatment Period||1
1561355|NCT01225549|3819677|P10|STARTED|Period 5 - Third Treatment Period||1
1561356|NCT01225549|3819678|P9|STARTED|Period 5 - Third Treatment Period||4
1561357|NCT01225549|3819679|P8|STARTED|Period 5 - Third Treatment Period||1
1561358|NCT01225549|3819680|P7|STARTED|Period 5 - Third Treatment Period||3
1561359|NCT01225549|3819681|P6|STARTED|Period 5 - Third Treatment Period||1
1561360|NCT01225549|3819682|P5|STARTED|Period 5 - Third Treatment Period||1
1561361|NCT01225549|3819683|P4|STARTED|Period 5 - Third Treatment Period||1
1561362|NCT01225549|3819684|P3|STARTED|Period 5 - Third Treatment Period||3
1561363|NCT01225549|3819685|P2|STARTED|Period 5 - Third Treatment Period||3
1561364|NCT01225549|3819686|P1|STARTED|Period 5 - Third Treatment Period||1
1561365|NCT01225549|3819677|P10|NOT COMPLETED|Period 4 - Washout||0
1561366|NCT01225549|3819678|P9|NOT COMPLETED|Period 4 - Washout||0
1561367|NCT01225549|3819679|P8|NOT COMPLETED|Period 4 - Washout||0
1561368|NCT01225549|3819680|P7|NOT COMPLETED|Period 4 - Washout||0
1561369|NCT01225549|3819681|P6|NOT COMPLETED|Period 4 - Washout||0
1561370|NCT01225549|3819682|P5|NOT COMPLETED|Period 4 - Washout||0
1561371|NCT01225549|3819683|P4|NOT COMPLETED|Period 4 - Washout||0
1561372|NCT01225549|3819684|P3|NOT COMPLETED|Period 4 - Washout||0
1561373|NCT01225549|3819685|P2|NOT COMPLETED|Period 4 - Washout||1
1561374|NCT01225549|3819686|P1|NOT COMPLETED|Period 4 - Washout||0
1561375|NCT01225549|3819677|P10|COMPLETED|Period 4 - Washout||1
1561376|NCT01225549|3819678|P9|COMPLETED|Period 4 - Washout||4
1561377|NCT01225549|3819679|P8|COMPLETED|Period 4 - Washout||1
1561378|NCT01225549|3819680|P7|COMPLETED|Period 4 - Washout||3
1561379|NCT01225549|3819681|P6|COMPLETED|Period 4 - Washout||1
1561380|NCT01225549|3819682|P5|COMPLETED|Period 4 - Washout||1
1561381|NCT01225549|3819683|P4|COMPLETED|Period 4 - Washout||1
1561382|NCT01225549|3819684|P3|COMPLETED|Period 4 - Washout||3
1561383|NCT01225549|3819685|P2|COMPLETED|Period 4 - Washout||3
1561384|NCT01225549|3819686|P1|COMPLETED|Period 4 - Washout||1
1561385|NCT01225549|3819677|P10|STARTED|Period 4 - Washout||1
1561386|NCT01225549|3819678|P9|STARTED|Period 4 - Washout||4
1561387|NCT01225549|3819679|P8|STARTED|Period 4 - Washout||1
1561388|NCT01225549|3819680|P7|STARTED|Period 4 - Washout||3
1561389|NCT01225549|3819681|P6|STARTED|Period 4 - Washout||1
1561390|NCT01225549|3819682|P5|STARTED|Period 4 - Washout||1
1561391|NCT01225549|3819683|P4|STARTED|Period 4 - Washout||1
1561392|NCT01225549|3819684|P3|STARTED|Period 4 - Washout||3
1561393|NCT01225549|3819685|P2|STARTED|Period 4 - Washout||4
1561394|NCT01225549|3819686|P1|STARTED|Period 4 - Washout||1
1561395|NCT01225549|3819677|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561396|NCT01225549|3819678|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561397|NCT01225549|3819679|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561398|NCT01225549|3819680|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561399|NCT01225549|3819681|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561400|NCT01225549|3819682|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561401|NCT01225549|3819683|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561402|NCT01225549|3819684|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561403|NCT01225549|3819685|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561404|NCT01225549|3819686|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
1561405|NCT01225549|3819677|P10|COMPLETED|Period 3 - Second Treatment Period||1
1561406|NCT01225549|3819678|P9|COMPLETED|Period 3 - Second Treatment Period||4
1561407|NCT01225549|3819679|P8|COMPLETED|Period 3 - Second Treatment Period||1
1561408|NCT01225549|3819680|P7|COMPLETED|Period 3 - Second Treatment Period||3
1561409|NCT01225549|3819681|P6|COMPLETED|Period 3 - Second Treatment Period||1
1561410|NCT01225549|3819682|P5|COMPLETED|Period 3 - Second Treatment Period||1
1561411|NCT01225549|3819683|P4|COMPLETED|Period 3 - Second Treatment Period||1
1561412|NCT01225549|3819684|P3|COMPLETED|Period 3 - Second Treatment Period||3
1561413|NCT01225549|3819685|P2|COMPLETED|Period 3 - Second Treatment Period||4
1561414|NCT01225549|3819686|P1|COMPLETED|Period 3 - Second Treatment Period||1
1561415|NCT01225549|3819677|P10|STARTED|Period 3 - Second Treatment Period||1
1561416|NCT01225549|3819678|P9|STARTED|Period 3 - Second Treatment Period||4
1561417|NCT01225549|3819679|P8|STARTED|Period 3 - Second Treatment Period||1
1561418|NCT01225549|3819680|P7|STARTED|Period 3 - Second Treatment Period||3
1561419|NCT01225549|3819681|P6|STARTED|Period 3 - Second Treatment Period||1
1561420|NCT01225549|3819682|P5|STARTED|Period 3 - Second Treatment Period||1
1561421|NCT01225549|3819683|P4|STARTED|Period 3 - Second Treatment Period||1
1561422|NCT01225549|3819684|P3|STARTED|Period 3 - Second Treatment Period||3
1561423|NCT01225549|3819685|P2|STARTED|Period 3 - Second Treatment Period||4
1561424|NCT01225549|3819686|P1|STARTED|Period 3 - Second Treatment Period||1
1561425|NCT01225549|3819677|P10|NOT COMPLETED|Period 2 - Washout||0
1561426|NCT01225549|3819678|P9|NOT COMPLETED|Period 2 - Washout||0
1561427|NCT01225549|3819679|P8|NOT COMPLETED|Period 2 - Washout||0
1561428|NCT01225549|3819680|P7|NOT COMPLETED|Period 2 - Washout||0
1561429|NCT01225549|3819681|P6|NOT COMPLETED|Period 2 - Washout||0
1561430|NCT01225549|3819682|P5|NOT COMPLETED|Period 2 - Washout||0
1561431|NCT01225549|3819683|P4|NOT COMPLETED|Period 2 - Washout||0
1561432|NCT01225549|3819684|P3|NOT COMPLETED|Period 2 - Washout||0
1561433|NCT01225549|3819685|P2|NOT COMPLETED|Period 2 - Washout||0
1561434|NCT01225549|3819686|P1|NOT COMPLETED|Period 2 - Washout||0
1561435|NCT01225549|3819677|P10|COMPLETED|Period 2 - Washout||1
1561436|NCT01225549|3819678|P9|COMPLETED|Period 2 - Washout||4
1561437|NCT01225549|3819679|P8|COMPLETED|Period 2 - Washout||1
1561438|NCT01225549|3819680|P7|COMPLETED|Period 2 - Washout||3
1561439|NCT01225549|3819681|P6|COMPLETED|Period 2 - Washout||1
1561440|NCT01225549|3819682|P5|COMPLETED|Period 2 - Washout||1
1561441|NCT01225549|3819683|P4|COMPLETED|Period 2 - Washout||1
1561442|NCT01225549|3819684|P3|COMPLETED|Period 2 - Washout||3
1561443|NCT01225549|3819685|P2|COMPLETED|Period 2 - Washout||4
1561444|NCT01225549|3819686|P1|COMPLETED|Period 2 - Washout||1
1561445|NCT01225549|3819677|P10|STARTED|Period 2 - Washout||1
1561446|NCT01225549|3819678|P9|STARTED|Period 2 - Washout||4
1561447|NCT01225549|3819679|P8|STARTED|Period 2 - Washout||1
1561448|NCT01225549|3819680|P7|STARTED|Period 2 - Washout||3
1561449|NCT01225549|3819681|P6|STARTED|Period 2 - Washout||1
1561450|NCT01225549|3819682|P5|STARTED|Period 2 - Washout||1
1561451|NCT01225549|3819683|P4|STARTED|Period 2 - Washout||1
1561452|NCT01225549|3819684|P3|STARTED|Period 2 - Washout||3
1561453|NCT01225549|3819685|P2|STARTED|Period 2 - Washout||4
1561454|NCT01225549|3819686|P1|STARTED|Period 2 - Washout||1
1561455|NCT01225549|3819677|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
1561456|NCT01225549|3819678|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
1561457|NCT01225549|3819679|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
1561458|NCT01225549|3819680|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
1561459|NCT01225549|3819681|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
1561460|NCT01225549|3819682|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
1561461|NCT01225549|3819683|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
1561462|NCT01225549|3819684|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
1561463|NCT01225549|3819685|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
1561464|NCT01225549|3819686|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
1561465|NCT01225549|3819677|P10|COMPLETED|Period 1 - First Treatment Period||1
1561466|NCT01225549|3819678|P9|COMPLETED|Period 1 - First Treatment Period||4
1561467|NCT01225549|3819679|P8|COMPLETED|Period 1 - First Treatment Period||1
1561468|NCT01225549|3819680|P7|COMPLETED|Period 1 - First Treatment Period||3
1561469|NCT01225549|3819681|P6|COMPLETED|Period 1 - First Treatment Period||1
1561470|NCT01225549|3819682|P5|COMPLETED|Period 1 - First Treatment Period||1
1561471|NCT01225549|3819683|P4|COMPLETED|Period 1 - First Treatment Period||1
1561472|NCT01225549|3819684|P3|COMPLETED|Period 1 - First Treatment Period||3
1561473|NCT01225549|3819685|P2|COMPLETED|Period 1 - First Treatment Period||4
1561474|NCT01225549|3819686|P1|COMPLETED|Period 1 - First Treatment Period||1
1561475|NCT01225549|3819677|P10|STARTED|Period 1 - First Treatment Period||1
1561476|NCT01225549|3819678|P9|STARTED|Period 1 - First Treatment Period||4
1561477|NCT01225549|3819679|P8|STARTED|Period 1 - First Treatment Period||1
1561478|NCT01225549|3819680|P7|STARTED|Period 1 - First Treatment Period||3
1561479|NCT01225549|3819681|P6|STARTED|Period 1 - First Treatment Period||1
1561480|NCT01225549|3819682|P5|STARTED|Period 1 - First Treatment Period||1
1561481|NCT01225549|3819683|P4|STARTED|Period 1 - First Treatment Period||1
1561482|NCT01225549|3819684|P3|STARTED|Period 1 - First Treatment Period||3
1561483|NCT01225549|3819685|P2|STARTED|Period 1 - First Treatment Period||4
1561484|NCT01225549|3819686|P1|STARTED|Period 1 - First Treatment Period||1
1561485|NCT01225354|3819728|P1|NOT COMPLETED|Overall Study||1
1561486|NCT01225354|3819728|P1|COMPLETED|Overall Study||19
1561487|NCT01225354|3819728|P1|STARTED|Overall Study||20
1561488|NCT01225289|3819735|P2|NOT COMPLETED|Overall Study||1
1561489|NCT01225289|3819736|P1|NOT COMPLETED|Overall Study||0
1561490|NCT01225289|3819735|P2|COMPLETED|Overall Study||17
1561491|NCT01225289|3819736|P1|COMPLETED|Overall Study||18
1561492|NCT01225289|3819735|P2|STARTED|Overall Study||18
1561493|NCT01225289|3819736|P1|STARTED|Overall Study||18
1561494|NCT01225263|3819750|P2|NOT COMPLETED|Weeks 13 to 24||1
1561495|NCT01225263|3819751|P1|NOT COMPLETED|Weeks 13 to 24||4
1561496|NCT01225263|3819750|P2|COMPLETED|Weeks 13 to 24||28
1561497|NCT01225263|3819751|P1|COMPLETED|Weeks 13 to 24||24
1561498|NCT01225263|3819750|P2|STARTED|Weeks 13 to 24||29
1561499|NCT01225263|3819751|P1|STARTED|Weeks 13 to 24||28
1561500|NCT01225263|3819750|P2|NOT COMPLETED|Weeks 1 to 12||0
1561501|NCT01225263|3819751|P1|NOT COMPLETED|Weeks 1 to 12||0
1561502|NCT01225263|3819750|P2|COMPLETED|Weeks 1 to 12||29
1561503|NCT01225263|3819751|P1|COMPLETED|Weeks 1 to 12||28
1561504|NCT01225263|3819750|P2|STARTED|Weeks 1 to 12||29
1561505|NCT01225263|3819751|P1|STARTED|Weeks 1 to 12||28
1561506|NCT01225211|3819769|P10|NOT COMPLETED|Overall Study||5
1561507|NCT01225211|3819770|P9|NOT COMPLETED|Overall Study||1
1561508|NCT01225211|3819771|P8|NOT COMPLETED|Overall Study||0
1561509|NCT01225211|3819772|P7|NOT COMPLETED|Overall Study||1
1561510|NCT01225211|3819773|P6|NOT COMPLETED|Overall Study||0
1561511|NCT01225211|3819774|P5|NOT COMPLETED|Overall Study||0
1561512|NCT01225211|3819775|P4|NOT COMPLETED|Overall Study||0
1561513|NCT01225211|3819776|P3|NOT COMPLETED|Overall Study||1
1561514|NCT01225211|3819777|P2|NOT COMPLETED|Overall Study||0
1561515|NCT01225211|3819778|P1|NOT COMPLETED|Overall Study||0
1561516|NCT01225211|3819769|P10|COMPLETED|Overall Study||57
1561517|NCT01225211|3819770|P9|COMPLETED|Overall Study||62
1561518|NCT01225211|3819771|P8|COMPLETED|Overall Study||11
1561519|NCT01225211|3819772|P7|COMPLETED|Overall Study||41
1561520|NCT01225211|3819773|P6|COMPLETED|Overall Study||21
1561521|NCT01225211|3819774|P5|COMPLETED|Overall Study||23
1561522|NCT01225211|3819775|P4|COMPLETED|Overall Study||27
1561523|NCT01225211|3819776|P3|COMPLETED|Overall Study||20
1561524|NCT01225211|3819777|P2|COMPLETED|Overall Study||20
1561525|NCT01225211|3819778|P1|COMPLETED|Overall Study||21
1561526|NCT01225211|3819769|P10|STARTED|Overall Study||62
1561527|NCT01225211|3819770|P9|STARTED|Overall Study||63
1561528|NCT01225211|3819771|P8|STARTED|Overall Study||11
1561529|NCT01225211|3819772|P7|STARTED|Overall Study||42
1561530|NCT01225211|3819773|P6|STARTED|Overall Study||21
1561531|NCT01225211|3819774|P5|STARTED|Overall Study||23
1561532|NCT01225211|3819775|P4|STARTED|Overall Study||27
1561533|NCT01225211|3819776|P3|STARTED|Overall Study||21
1561534|NCT01225211|3819777|P2|STARTED|Overall Study||20
1561535|NCT01225211|3819778|P1|STARTED|Overall Study||21
1561536|NCT01225159|3819881|P2|NOT COMPLETED|Overall Study||0
1561537|NCT01225159|3819882|P1|NOT COMPLETED|Overall Study||1
1561538|NCT01225159|3819881|P2|COMPLETED|Overall Study||100
1561539|NCT01225159|3819882|P1|COMPLETED|Overall Study||99
1561540|NCT01225159|3819881|P2|STARTED|Overall Study||100
1561541|NCT01225159|3819882|P1|STARTED|Overall Study||100
1561542|NCT01225146|3819892|P2|NOT COMPLETED|Overall Study||2
1561543|NCT01225146|3819893|P1|NOT COMPLETED|Overall Study||0
1561544|NCT01225146|3819892|P2|COMPLETED|Overall Study||0
1561545|NCT01225146|3819893|P1|COMPLETED|Overall Study||6
1561546|NCT01225146|3819892|P2|STARTED|Overall Study||2
1561547|NCT01225146|3819893|P1|STARTED|Overall Study||6
1561548|NCT01225068|3819911|P2|NOT COMPLETED|Overall Study||1
1561549|NCT01225068|3819912|P1|NOT COMPLETED|Overall Study||4
1561550|NCT01225068|3819911|P2|COMPLETED|Overall Study||19
1561551|NCT01225068|3819912|P1|COMPLETED|Overall Study||16
1561552|NCT01225068|3819911|P2|STARTED|Overall Study||20
1561553|NCT01225068|3819912|P1|STARTED|Overall Study||20
1561554|NCT01225055|3819921|P3|NOT COMPLETED|Overall Study||3
1561555|NCT01225055|3819922|P2|NOT COMPLETED|Overall Study||2
1561556|NCT01225055|3819923|P1|NOT COMPLETED|Overall Study||0
1561557|NCT01225055|3819921|P3|COMPLETED|Overall Study||18
1561558|NCT01225055|3819922|P2|COMPLETED|Overall Study||18
1561559|NCT01225055|3819923|P1|COMPLETED|Overall Study||20
1561560|NCT01225055|3819921|P3|STARTED|Overall Study||21
1561561|NCT01225055|3819922|P2|STARTED|Overall Study||20
1561562|NCT01225055|3819923|P1|STARTED|Overall Study||20
1561563|NCT01225029|3819948|P2|NOT COMPLETED|Overall Study||0
1561564|NCT01225029|3819949|P1|NOT COMPLETED|Overall Study||0
1561565|NCT01225029|3819948|P2|COMPLETED|Overall Study||32
1561566|NCT01225029|3819949|P1|COMPLETED|Overall Study||32
1561567|NCT01225029|3819948|P2|STARTED|Overall Study||32
1561568|NCT01225029|3819949|P1|STARTED|Overall Study||32
1561569|NCT01224821|3819959|P1|NOT COMPLETED|Long-Term Follow-Up||11
1561570|NCT01224821|3819959|P1|COMPLETED|Long-Term Follow-Up||0
1561571|NCT01224821|3819959|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
1561572|NCT01224821|3819959|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
1561573|NCT01224821|3819959|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
1561574|NCT01224821|3819959|P1|STARTED|Dosimetric and Therapeutic Treatment||47
1561575|NCT01224782|3819978|P1|NOT COMPLETED|Overall Study||264
1561576|NCT01224782|3819978|P1|COMPLETED|Overall Study||730
1561577|NCT01224782|3819978|P1|STARTED|Overall Study||994
1561578|NCT01224678|3819989|P2|NOT COMPLETED|Overall Study||0
1561579|NCT01224678|3819990|P1|NOT COMPLETED|Overall Study||0
1561580|NCT01224678|3819989|P2|COMPLETED|Overall Study||150
1561581|NCT01224678|3819990|P1|COMPLETED|Overall Study||150
1561582|NCT01224678|3819989|P2|STARTED|Overall Study||150
1561583|NCT01224678|3819990|P1|STARTED|Overall Study||150
1561584|NCT01224639|3820004|P8|NOT COMPLETED|Overall Study||2
1561585|NCT01224639|3820005|P7|NOT COMPLETED|Overall Study||1
1561586|NCT01224639|3820006|P6|NOT COMPLETED|Overall Study||0
1561587|NCT01224639|3820007|P5|NOT COMPLETED|Overall Study||2
1561588|NCT01224639|3820008|P4|NOT COMPLETED|Overall Study||0
1561589|NCT01224639|3820009|P3|NOT COMPLETED|Overall Study||0
1561590|NCT01224639|3820010|P2|NOT COMPLETED|Overall Study||0
1561591|NCT01224639|3820011|P1|NOT COMPLETED|Overall Study||0
1561592|NCT01224639|3820004|P8|COMPLETED|Overall Study||3
1561593|NCT01224639|3820005|P7|COMPLETED|Overall Study||17
1561594|NCT01224639|3820006|P6|COMPLETED|Overall Study||4
1561595|NCT01224639|3820007|P5|COMPLETED|Overall Study||19
1561596|NCT01224639|3820008|P4|COMPLETED|Overall Study||3
1561597|NCT01224639|3820009|P3|COMPLETED|Overall Study||21
1561598|NCT01224639|3820010|P2|COMPLETED|Overall Study||5
1561599|NCT01224639|3820011|P1|COMPLETED|Overall Study||19
1561600|NCT01224639|3820004|P8|STARTED|Overall Study||5
1561601|NCT01224639|3820005|P7|STARTED|Overall Study||18
1561602|NCT01224639|3820006|P6|STARTED|Overall Study||4
1561603|NCT01224639|3820007|P5|STARTED|Overall Study||21
1561604|NCT01224639|3820008|P4|STARTED|Overall Study||3
1561605|NCT01224639|3820009|P3|STARTED|Overall Study||21
1561606|NCT01224639|3820010|P2|STARTED|Overall Study||5
1561607|NCT01224639|3820011|P1|STARTED|Overall Study||19
1561608|NCT01224626|3820117|P1|NOT COMPLETED|Overall Study||1
1561609|NCT01224626|3820117|P1|COMPLETED|Overall Study||41
1561610|NCT01224626|3820117|P1|STARTED|Overall Study||42
1561611|NCT01224444|3820123|P1|NOT COMPLETED|Overall Study||0
1561612|NCT01224444|3820123|P1|COMPLETED|Overall Study||269
1561613|NCT01224444|3820123|P1|STARTED|Overall Study||269
1561614|NCT01224431|3820129|P2|NOT COMPLETED|Overall Study||5
1561615|NCT01224431|3820130|P1|NOT COMPLETED|Overall Study||0
1561616|NCT01224431|3820129|P2|COMPLETED|Overall Study||25
1561617|NCT01224431|3820130|P1|COMPLETED|Overall Study||30
1561618|NCT01224431|3820129|P2|STARTED|Overall Study||30
1561619|NCT01224431|3820130|P1|STARTED|Overall Study||30
1561620|NCT01224236|3820140|P2|NOT COMPLETED|Overall Study||1
1561621|NCT01224236|3820141|P1|NOT COMPLETED|Overall Study||1
1561622|NCT01224236|3820140|P2|COMPLETED|Overall Study||73
1561623|NCT01224236|3820141|P1|COMPLETED|Overall Study||75
1561624|NCT01224236|3820140|P2|STARTED|Overall Study||74
1561625|NCT01224236|3820141|P1|STARTED|Overall Study||76
1561626|NCT01224171|3820151|P2|NOT COMPLETED|Overall Study||13
1561627|NCT01224171|3820152|P1|NOT COMPLETED|Overall Study||15
1561628|NCT01224171|3820151|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
1561629|NCT01224171|3820152|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
1561630|NCT01224171|3820151|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
1561631|NCT01224171|3820152|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
1561632|NCT01224171|3820151|P2|STARTED|Overall Study||209
1561633|NCT01224171|3820152|P1|STARTED|Overall Study||207
1561634|NCT01224015|3820175|P3|NOT COMPLETED|Overall Study||13
1561635|NCT01224015|3820176|P2|NOT COMPLETED|Overall Study||16
1561636|NCT01224015|3820177|P1|NOT COMPLETED|Overall Study||14
1561637|NCT01224015|3820175|P3|COMPLETED|Overall Study||83
1561638|NCT01224015|3820176|P2|COMPLETED|Overall Study||211
1561639|NCT01224015|3820177|P1|COMPLETED|Overall Study||347
1561640|NCT01224015|3820175|P3|STARTED|Overall Study||96
1561641|NCT01224015|3820176|P2|STARTED|Overall Study||227
1561642|NCT01224015|3820177|P1|STARTED|Overall Study||361
1561643|NCT01223963|3820185|P1|NOT COMPLETED|Overall Study||0
1561644|NCT01223963|3820185|P1|COMPLETED|Overall Study||93
1561645|NCT01223963|3820185|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
1561646|NCT01223937|3820192|P2|NOT COMPLETED|Overall Study||18
1561647|NCT01223937|3820193|P1|NOT COMPLETED|Overall Study||17
1561648|NCT01223937|3820192|P2|COMPLETED|Overall Study||119
1561649|NCT01223937|3820193|P1|COMPLETED|Overall Study||114
1561650|NCT01223937|3820192|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
1561651|NCT01223937|3820193|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
1561652|NCT01223937|3820192|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
1561653|NCT01223937|3820193|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
1561654|NCT01223937|3820192|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
1561655|NCT01223937|3820193|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
1561656|NCT01223703|3820217|P2|NOT COMPLETED|Overall Study||0
1561657|NCT01223703|3820218|P1|NOT COMPLETED|Overall Study||0
1561658|NCT01223703|3820217|P2|COMPLETED|Overall Study||66
1561659|NCT01223703|3820218|P1|COMPLETED|Overall Study||67
1561660|NCT01223703|3820217|P2|STARTED|Overall Study||66
1561661|NCT01223703|3820218|P1|STARTED|Overall Study||67
1561662|NCT01223469|3820232|P2|NOT COMPLETED|Overall Study||0
1561663|NCT01223469|3820233|P1|NOT COMPLETED|Overall Study||0
1561664|NCT01223469|3820232|P2|COMPLETED|Overall Study||43
1561665|NCT01223469|3820233|P1|COMPLETED|Overall Study||34
1561666|NCT01223469|3820232|P2|STARTED|Overall Study||43
1561667|NCT01223469|3820233|P1|STARTED|Overall Study||34
1561668|NCT01223404|3820239|P6|NOT COMPLETED|Third Intervention (1 Day)||0
1561669|NCT01223404|3820240|P5|NOT COMPLETED|Third Intervention (1 Day)||0
1561670|NCT01223404|3820241|P4|NOT COMPLETED|Third Intervention (1 Day)||1
1561671|NCT01223404|3820242|P3|NOT COMPLETED|Third Intervention (1 Day)||0
1561672|NCT01223404|3820243|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1561673|NCT01223404|3820244|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1561674|NCT01223404|3820239|P6|COMPLETED|Third Intervention (1 Day)||3
1561675|NCT01223404|3820240|P5|COMPLETED|Third Intervention (1 Day)||2
1561676|NCT01223404|3820241|P4|COMPLETED|Third Intervention (1 Day)||3
1561677|NCT01223404|3820242|P3|COMPLETED|Third Intervention (1 Day)||4
1561678|NCT01223404|3820243|P2|COMPLETED|Third Intervention (1 Day)||3
1561679|NCT01223404|3820244|P1|COMPLETED|Third Intervention (1 Day)||3
1561680|NCT01223404|3820239|P6|STARTED|Third Intervention (1 Day)||3
1561681|NCT01223404|3820240|P5|STARTED|Third Intervention (1 Day)||2
1561682|NCT01223404|3820241|P4|STARTED|Third Intervention (1 Day)||4
1561683|NCT01223404|3820242|P3|STARTED|Third Intervention (1 Day)||4
1561684|NCT01223404|3820243|P2|STARTED|Third Intervention (1 Day)||3
1561685|NCT01223404|3820244|P1|STARTED|Third Intervention (1 Day)||3
1561686|NCT01223404|3820239|P6|NOT COMPLETED|Second Intervention (1 Day)||0
1561687|NCT01223404|3820240|P5|NOT COMPLETED|Second Intervention (1 Day)||0
1561688|NCT01223404|3820241|P4|NOT COMPLETED|Second Intervention (1 Day)||0
1561689|NCT01223404|3820242|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1561690|NCT01223404|3820243|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1561691|NCT01223404|3820244|P1|NOT COMPLETED|Second Intervention (1 Day)||1
1561692|NCT01223404|3820239|P6|COMPLETED|Second Intervention (1 Day)||3
1561693|NCT01223404|3820240|P5|COMPLETED|Second Intervention (1 Day)||2
1561694|NCT01223404|3820241|P4|COMPLETED|Second Intervention (1 Day)||4
1561695|NCT01223404|3820242|P3|COMPLETED|Second Intervention (1 Day)||4
1561696|NCT01223404|3820243|P2|COMPLETED|Second Intervention (1 Day)||3
1561697|NCT01223404|3820244|P1|COMPLETED|Second Intervention (1 Day)||3
1561698|NCT01223404|3820239|P6|STARTED|Second Intervention (1 Day)||3
1561699|NCT01223404|3820240|P5|STARTED|Second Intervention (1 Day)||2
1561700|NCT01223404|3820241|P4|STARTED|Second Intervention (1 Day)||4
1561701|NCT01223404|3820242|P3|STARTED|Second Intervention (1 Day)||4
1561702|NCT01223404|3820243|P2|STARTED|Second Intervention (1 Day)||3
1561703|NCT01223404|3820244|P1|STARTED|Second Intervention (1 Day)||4
1561704|NCT01223404|3820239|P6|NOT COMPLETED|First Intervention (1 Day)||0
1561705|NCT01223404|3820240|P5|NOT COMPLETED|First Intervention (1 Day)||0
1561706|NCT01223404|3820241|P4|NOT COMPLETED|First Intervention (1 Day)||1
1561707|NCT01223404|3820242|P3|NOT COMPLETED|First Intervention (1 Day)||0
1561708|NCT01223404|3820243|P2|NOT COMPLETED|First Intervention (1 Day)||0
1561709|NCT01223404|3820244|P1|NOT COMPLETED|First Intervention (1 Day)||0
1561710|NCT01223404|3820239|P6|COMPLETED|First Intervention (1 Day)||3
1561711|NCT01223404|3820240|P5|COMPLETED|First Intervention (1 Day)||2
1561712|NCT01223404|3820241|P4|COMPLETED|First Intervention (1 Day)||4
1561713|NCT01223404|3820242|P3|COMPLETED|First Intervention (1 Day)||4
1561714|NCT01223404|3820243|P2|COMPLETED|First Intervention (1 Day)||3
1561715|NCT01223404|3820244|P1|COMPLETED|First Intervention (1 Day)||4
1561716|NCT01223404|3820239|P6|STARTED|First Intervention (1 Day)||3
1561717|NCT01223404|3820240|P5|STARTED|First Intervention (1 Day)||2
1561718|NCT01223404|3820241|P4|STARTED|First Intervention (1 Day)||5
1561719|NCT01223404|3820242|P3|STARTED|First Intervention (1 Day)||4
1561720|NCT01223404|3820243|P2|STARTED|First Intervention (1 Day)||3
1561721|NCT01223404|3820244|P1|STARTED|First Intervention (1 Day)||4
1561722|NCT01223378|3820272|P5|NOT COMPLETED|Overall Study||3
1561723|NCT01223378|3820273|P4|NOT COMPLETED|Overall Study||1
1561724|NCT01223378|3820274|P3|NOT COMPLETED|Overall Study||3
1561725|NCT01223378|3820275|P2|NOT COMPLETED|Overall Study||4
1561726|NCT01223378|3820276|P1|NOT COMPLETED|Overall Study||6
1561727|NCT01223378|3820272|P5|COMPLETED|Overall Study||79
1561728|NCT01223378|3820273|P4|COMPLETED|Overall Study||80
1561729|NCT01223378|3820274|P3|COMPLETED|Overall Study||80
1561730|NCT01223378|3820275|P2|COMPLETED|Overall Study||81
1561731|NCT01223378|3820276|P1|COMPLETED|Overall Study||76
1561732|NCT01223378|3820272|P5|STARTED|Overall Study||82
1561733|NCT01223378|3820273|P4|STARTED|Overall Study||81
1561734|NCT01223378|3820274|P3|STARTED|Overall Study||83
1561735|NCT01223378|3820275|P2|STARTED|Overall Study||85
1561736|NCT01223378|3820276|P1|STARTED|Overall Study||82
1561737|NCT01223365|3820308|P1|NOT COMPLETED|Open-label Treatment Period||102
1561738|NCT01223365|3820308|P1|COMPLETED|Open-label Treatment Period||189
1561739|NCT01223365|3820308|P1|STARTED|Open-label Treatment Period||291
1561740|NCT01223365|3820308|P1|NOT COMPLETED|Open-label Titration Period||39
1561741|NCT01223365|3820308|P1|COMPLETED|Open-label Titration Period||291
1561742|NCT01223365|3820308|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
1561743|NCT01223365|3820308|P1|Safety Analysis Set|Open-label Titration Period||329
1561744|NCT01223365|3820308|P1|STARTED|Open-label Titration Period||330
1561745|NCT01223352|3820351|P2|NOT COMPLETED|Overall Study||0
1561746|NCT01223352|3820352|P1|NOT COMPLETED|Overall Study||0
1561747|NCT01223352|3820351|P2|COMPLETED|Overall Study||33
1561748|NCT01223352|3820352|P1|COMPLETED|Overall Study||31
1561749|NCT01223352|3820351|P2|STARTED|Overall Study||33
1561750|NCT01223352|3820352|P1|STARTED|Overall Study||31
1561751|NCT01223235|3820372|P1|NOT COMPLETED|Overall Study||1
1561752|NCT01223235|3820372|P1|COMPLETED|Overall Study||21
1561753|NCT01223235|3820372|P1|STARTED|Overall Study||22
1561754|NCT01223196|3820380|P2|NOT COMPLETED|Overall Study||0
1561755|NCT01223196|3820381|P1|NOT COMPLETED|Overall Study||4
1561756|NCT01223196|3820380|P2|COMPLETED|Overall Study||11
1561757|NCT01223196|3820381|P1|COMPLETED|Overall Study||9
1561758|NCT01223196|3820380|P2|STARTED|Overall Study||11
1561759|NCT01223196|3820381|P1|STARTED|Overall Study||13
1561760|NCT01223183|3820393|P2|NOT COMPLETED|Imaging Day 2||0
1561761|NCT01223183|3820394|P1|NOT COMPLETED|Imaging Day 2||0
1561762|NCT01223183|3820393|P2|COMPLETED|Imaging Day 2||9
1561763|NCT01223183|3820394|P1|COMPLETED|Imaging Day 2||8
1561764|NCT01223183|3820393|P2|STARTED|Imaging Day 2||9
1561765|NCT01223183|3820394|P1|STARTED|Imaging Day 2||8
1561766|NCT01223183|3820393|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
1561767|NCT01223183|3820394|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
1561768|NCT01223183|3820393|P2|COMPLETED|Washout Period (5-24 Days)||9
1561769|NCT01223183|3820394|P1|COMPLETED|Washout Period (5-24 Days)||8
1561770|NCT01223183|3820393|P2|STARTED|Washout Period (5-24 Days)||9
1561771|NCT01223183|3820394|P1|STARTED|Washout Period (5-24 Days)||10
1561772|NCT01223183|3820393|P2|NOT COMPLETED|Imaging Day 1||1
1561773|NCT01223183|3820394|P1|NOT COMPLETED|Imaging Day 1||0
1561774|NCT01223183|3820393|P2|COMPLETED|Imaging Day 1||9
1561775|NCT01223183|3820394|P1|COMPLETED|Imaging Day 1||10
1561776|NCT01223183|3820393|P2|STARTED|Imaging Day 1||10
1561777|NCT01223183|3820394|P1|STARTED|Imaging Day 1||10
1561778|NCT01223027|3820404|P2|NOT COMPLETED|Overall Study||277
1561779|NCT01223027|3820405|P1|NOT COMPLETED|Overall Study||274
1561780|NCT01223027|3820404|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
1561781|NCT01223027|3820405|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
1561782|NCT01223027|3820404|P2|STARTED|Overall Study||286
1561783|NCT01223027|3820405|P1|STARTED|Overall Study||284
1561784|NCT01223001|3820428|P2|NOT COMPLETED|Overall Study||4
1561785|NCT01223001|3820429|P1|NOT COMPLETED|Overall Study||4
1561786|NCT01223001|3820428|P2|COMPLETED|Overall Study||0
1561787|NCT01223001|3820429|P1|COMPLETED|Overall Study||0
1561788|NCT01223001|3820428|P2|STARTED|Overall Study||4
1561789|NCT01223001|3820429|P1|STARTED|Overall Study||4
1561790|NCT01222884|3820437|P2|NOT COMPLETED|Overall Study||4
1561791|NCT01222884|3820438|P1|NOT COMPLETED|Overall Study||24
1561792|NCT01222884|3820437|P2|COMPLETED|Overall Study||113
1561793|NCT01222884|3820438|P1|COMPLETED|Overall Study||210
1561794|NCT01222884|3820437|P2|STARTED|Overall Study||117
1561795|NCT01222884|3820438|P1|STARTED|Overall Study||234
1561796|NCT01222871|3820448|P2|NOT COMPLETED|Overall Study||0
1561797|NCT01222871|3820449|P1|NOT COMPLETED|Overall Study||0
1561798|NCT01222871|3820448|P2|COMPLETED|Overall Study||0
1561799|NCT01222871|3820449|P1|COMPLETED|Overall Study||0
1561800|NCT01222871|3820448|P2|STARTED|Overall Study||0
1561801|NCT01222871|3820449|P1|STARTED|Overall Study||0
1561802|NCT01222832|3820458|P2|NOT COMPLETED|Overall Study||1
1561803|NCT01222832|3820459|P1|NOT COMPLETED|Overall Study||0
1561804|NCT01222832|3820458|P2|COMPLETED|Overall Study||112
1561805|NCT01222832|3820459|P1|COMPLETED|Overall Study||113
1561806|NCT01222832|3820458|P2|STARTED|Overall Study||113
1561807|NCT01222832|3820459|P1|STARTED|Overall Study||113
1561808|NCT01222715|3820467|P2|NOT COMPLETED|Overall Study||27
1561809|NCT01222715|3820468|P1|NOT COMPLETED|Overall Study||36
1561810|NCT01222715|3820467|P2|COMPLETED|Overall Study||16
1561811|NCT01222715|3820468|P1|COMPLETED|Overall Study||8
1561812|NCT01222715|3820467|P2|STARTED|Overall Study||43
1561813|NCT01222715|3820468|P1|STARTED|Overall Study||44
1561814|NCT01222689|3820478|P1|NOT COMPLETED|Overall Study||0
1561815|NCT01222689|3820478|P1|COMPLETED|Overall Study||46
1561816|NCT01222689|3820478|P1|STARTED|Overall Study||46
1561817|NCT01222585|3820491|P1|NOT COMPLETED|Overall Study||0
1561818|NCT01222585|3820491|P1|COMPLETED|Overall Study||24
1561819|NCT01222585|3820491|P1|STARTED|Overall Study||24
1561820|NCT01222572|3820501|P3|NOT COMPLETED|Overall Study||0
1561821|NCT01222572|3820502|P2|NOT COMPLETED|Overall Study||0
1561822|NCT01222572|3820503|P1|NOT COMPLETED|Overall Study||0
1561823|NCT01222572|3820501|P3|COMPLETED|Overall Study||0
1561824|NCT01222572|3820502|P2|COMPLETED|Overall Study||0
1561825|NCT01222572|3820503|P1|COMPLETED|Overall Study||1
1561826|NCT01222572|3820501|P3|STARTED|Overall Study||0
1561827|NCT01222572|3820502|P2|STARTED|Overall Study||0
1561828|NCT01222572|3820503|P1|STARTED|Overall Study||1
1561829|NCT01222533|3820507|P1|NOT COMPLETED|Overall Study||14
1561830|NCT01222533|3820507|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
1561831|NCT01222533|3820507|P1|Received Tio HH18|Overall Study||146
1561832|NCT01222533|3820507|P1|Received Tio R5|Overall Study||150
1561833|NCT01222533|3820507|P1|Received Tio R2.5|Overall Study||145
1561834|NCT01222533|3820507|P1|Received Tio R1.25|Overall Study||147
1561835|NCT01222533|3820507|P1|Received Placebo|Overall Study||147
1561836|NCT01222533|3820507|P1|STARTED|Overall Study|Entered and treated.|154
1561837|NCT01222520|3820646|P2|NOT COMPLETED|Double-blind Period||2
1561838|NCT01222520|3820647|P1|NOT COMPLETED|Double-blind Period||1
1561839|NCT01222520|3820646|P2|COMPLETED|Double-blind Period||85
1561840|NCT01222520|3820647|P1|COMPLETED|Double-blind Period||86
1561841|NCT01222520|3820646|P2|STARTED|Double-blind Period||87
1561842|NCT01222520|3820647|P1|STARTED|Double-blind Period||87
1561843|NCT01222520|3820646|P2|NOT COMPLETED|Open-label run-in Period||23
1561844|NCT01222520|3820647|P1|NOT COMPLETED|Open-label run-in Period||0
1561845|NCT01222520|3820646|P2|COMPLETED|Open-label run-in Period||174
1561846|NCT01222520|3820647|P1|COMPLETED|Open-label run-in Period||0
1561847|NCT01222520|3820646|P2|STARTED|Open-label run-in Period||197
1561848|NCT01222520|3820647|P1|STARTED|Open-label run-in Period||0
1561849|NCT01222507|3820665|P1|NOT COMPLETED|Overall Study||2
1561850|NCT01222507|3820665|P1|COMPLETED|Overall Study||60
1561851|NCT01222507|3820665|P1|STARTED|Overall Study||62
1561852|NCT01222494|3820672|P3|NOT COMPLETED|Overall Study||4
1561853|NCT01222494|3820673|P2|NOT COMPLETED|Overall Study||4
1561854|NCT01222494|3820674|P1|NOT COMPLETED|Overall Study||1
1561855|NCT01222494|3820672|P3|COMPLETED|Overall Study||17
1561856|NCT01222494|3820673|P2|COMPLETED|Overall Study||15
1561857|NCT01222494|3820674|P1|COMPLETED|Overall Study||6
1561858|NCT01222494|3820672|P3|STARTED|Overall Study||21
1561859|NCT01222494|3820673|P2|STARTED|Overall Study||19
1561860|NCT01222494|3820674|P1|STARTED|Overall Study||7
1561861|NCT01222416|3820693|P2|NOT COMPLETED|Overall Study||0
1561862|NCT01222416|3820694|P1|NOT COMPLETED|Overall Study||20
1561863|NCT01222416|3820693|P2|COMPLETED|Overall Study||0
1561864|NCT01222416|3820694|P1|COMPLETED|Overall Study||30
1561865|NCT01222416|3820693|P2|STARTED|Overall Study||0
1561866|NCT01222416|3820694|P1|STARTED|Overall Study||50
1561867|NCT01222403|3820704|P2|NOT COMPLETED|Overall Study||2
1561868|NCT01222403|3820705|P1|NOT COMPLETED|Overall Study||0
1561869|NCT01222403|3820704|P2|COMPLETED|Overall Study||379
1561870|NCT01222403|3820705|P1|COMPLETED|Overall Study||386
1561871|NCT01222403|3820704|P2|STARTED|Overall Study||381
1561872|NCT01222403|3820705|P1|STARTED|Overall Study||386
1561873|NCT01222390|3820715|P1|NOT COMPLETED|Overall Study||0
1561874|NCT01222390|3820715|P1|COMPLETED|Overall Study||12
1561875|NCT01222390|3820715|P1|STARTED|Overall Study||12
1561876|NCT01222286|3820721|P2|NOT COMPLETED|Overall Study||0
1561877|NCT01222286|3820722|P1|NOT COMPLETED|Overall Study||0
1561878|NCT01222286|3820721|P2|COMPLETED|Overall Study||14
1561879|NCT01222286|3820722|P1|COMPLETED|Overall Study||16
1561880|NCT01222286|3820721|P2|STARTED|Overall Study||14
1561881|NCT01222286|3820722|P1|STARTED|Overall Study||16
1561882|NCT01222273|3820734|P1|NOT COMPLETED|Overall Study||0
1561883|NCT01222273|3820734|P1|COMPLETED|Overall Study||7
1561884|NCT01222273|3820734|P1|STARTED|Overall Study||7
1561885|NCT01222234|3820743|P3|NOT COMPLETED|Overall Study||2
1561886|NCT01222234|3820744|P2|NOT COMPLETED|Overall Study||2
1561887|NCT01222234|3820745|P1|NOT COMPLETED|Overall Study||0
1561888|NCT01222234|3820743|P3|COMPLETED|Overall Study||22
1561889|NCT01222234|3820744|P2|COMPLETED|Overall Study||15
1561890|NCT01222234|3820745|P1|COMPLETED|Overall Study||15
1561891|NCT01222234|3820743|P3|STARTED|Overall Study||24
1561892|NCT01222234|3820744|P2|STARTED|Overall Study||17
1561893|NCT01222234|3820745|P1|STARTED|Overall Study||15
1561894|NCT01222195|3820754|P1|NOT COMPLETED|Overall Study||0
1561895|NCT01222195|3820754|P1|COMPLETED|Overall Study||1
1561896|NCT01222195|3820754|P1|STARTED|Overall Study||1
1561897|NCT01222117|3820769|P11|NOT COMPLETED|Overall Study||0
1561898|NCT01222117|3820770|P10|NOT COMPLETED|Overall Study||2
1561899|NCT01222117|3820771|P9|NOT COMPLETED|Overall Study||3
1561900|NCT01222117|3820772|P8|NOT COMPLETED|Overall Study||0
1561901|NCT01222117|3820773|P7|NOT COMPLETED|Overall Study||0
1561902|NCT01222117|3820774|P6|NOT COMPLETED|Overall Study||1
1561903|NCT01222117|3820775|P5|NOT COMPLETED|Overall Study||1
1561904|NCT01222117|3820776|P4|NOT COMPLETED|Overall Study||1
1561905|NCT01222117|3820777|P3|NOT COMPLETED|Overall Study||0
1561906|NCT01222117|3820778|P2|NOT COMPLETED|Overall Study||1
1561907|NCT01222117|3820779|P1|NOT COMPLETED|Overall Study||3
1561908|NCT01222117|3820769|P11|COMPLETED|Overall Study||6
1561909|NCT01222117|3820770|P10|COMPLETED|Overall Study||17
1561910|NCT01222117|3820771|P9|COMPLETED|Overall Study||20
1561911|NCT01222117|3820772|P8|COMPLETED|Overall Study||12
1561912|NCT01222117|3820773|P7|COMPLETED|Overall Study||13
1561913|NCT01222117|3820774|P6|COMPLETED|Overall Study||9
1561914|NCT01222117|3820775|P5|COMPLETED|Overall Study||8
1561915|NCT01222117|3820776|P4|COMPLETED|Overall Study||19
1561916|NCT01222117|3820777|P3|COMPLETED|Overall Study||22
1561917|NCT01222117|3820778|P2|COMPLETED|Overall Study||19
1561918|NCT01222117|3820779|P1|COMPLETED|Overall Study||17
1561919|NCT01222117|3820769|P11|STARTED|Overall Study||6
1561920|NCT01222117|3820770|P10|STARTED|Overall Study||19
1561921|NCT01222117|3820771|P9|STARTED|Overall Study||23
1561922|NCT01222117|3820772|P8|STARTED|Overall Study||12
1561923|NCT01222117|3820773|P7|STARTED|Overall Study||13
1561924|NCT01222117|3820774|P6|STARTED|Overall Study||10
1561925|NCT01222117|3820775|P5|STARTED|Overall Study||9
1561926|NCT01222117|3820776|P4|STARTED|Overall Study||20
1561927|NCT01222117|3820777|P3|STARTED|Overall Study||22
1561928|NCT01222117|3820778|P2|STARTED|Overall Study||20
1561929|NCT01222117|3820779|P1|STARTED|Overall Study||20
1561930|NCT01222104|3820814|P1|NOT COMPLETED|Overall Study||47
1561931|NCT01222104|3820814|P1|COMPLETED|Overall Study||587
1561932|NCT01222104|3820814|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
1561933|NCT01222104|3820814|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
1561934|NCT01222104|3820814|P1|Successful Deployment and Hemostasis|Overall Study||524
1561935|NCT01222104|3820814|P1|Successful Deployment|Overall Study||529
1561936|NCT01222104|3820814|P1|Angio-Seal Deployment Attempted|Overall Study||534
1561937|NCT01222104|3820814|P1|STARTED|Overall Study||634
1561938|NCT01222091|3820828|P2|NOT COMPLETED|Overall Study||0
1561939|NCT01222091|3820829|P1|NOT COMPLETED|Overall Study||0
1561940|NCT01222091|3820828|P2|COMPLETED|Overall Study||5
1561941|NCT01222091|3820829|P1|COMPLETED|Overall Study||5
1561942|NCT01222091|3820828|P2|STARTED|Overall Study||5
1561943|NCT01222091|3820829|P1|STARTED|Overall Study||5
1561944|NCT01222078|3820837|P1|NOT COMPLETED|Overall Study||1
1561945|NCT01222078|3820837|P1|COMPLETED|Overall Study||0
1561946|NCT01222078|3820837|P1|STARTED|Overall Study||1
1561947|NCT01221948|3820871|P1|NOT COMPLETED|Overall Study||14
1561948|NCT01221948|3820871|P1|COMPLETED|Overall Study||39
1561949|NCT01221948|3820871|P1|STARTED|Overall Study||53
1561950|NCT01221753|3820882|P1|NOT COMPLETED|Overall Study||1
1561951|NCT01221753|3820882|P1|COMPLETED|Overall Study||6
1561952|NCT01221753|3820882|P1|STARTED|Overall Study||7
1561953|NCT01221727|3820889|P2|NOT COMPLETED|Overall Study||1
1561954|NCT01221727|3820890|P1|NOT COMPLETED|Overall Study||3
1561955|NCT01221727|3820889|P2|COMPLETED|Overall Study||8
1561956|NCT01221727|3820890|P1|COMPLETED|Overall Study||18
1561957|NCT01221727|3820889|P2|Treated|Overall Study|Number of subjects received investigational product|8
1561958|NCT01221727|3820890|P1|Treated|Overall Study|Number of subjects received investigational product|19
1561959|NCT01221727|3820889|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
1561960|NCT01221727|3820890|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
1561961|NCT01221623|3820911|P2|NOT COMPLETED|Overall Study||14
1561962|NCT01221623|3820912|P1|NOT COMPLETED|Overall Study||38
1561963|NCT01221623|3820911|P2|COMPLETED|Overall Study||127
1561964|NCT01221623|3820912|P1|COMPLETED|Overall Study||236
1561965|NCT01221623|3820911|P2|STARTED|Overall Study||141
1561966|NCT01221623|3820912|P1|STARTED|Overall Study||274
1561967|NCT01221597|3820936|P2|NOT COMPLETED|Overall Study||16
1561968|NCT01221597|3820937|P1|NOT COMPLETED|Overall Study||36
1561969|NCT01221597|3820936|P2|COMPLETED|Overall Study||124
1561970|NCT01221597|3820937|P1|COMPLETED|Overall Study||241
1561971|NCT01221597|3820936|P2|STARTED|Overall Study||140
1561972|NCT01221597|3820937|P1|STARTED|Overall Study||277
1561973|NCT01221441|3820961|P2|NOT COMPLETED|Overall Study||12
1561974|NCT01221441|3820962|P1|NOT COMPLETED|Overall Study||22
1561975|NCT01221441|3820961|P2|COMPLETED|Overall Study||23
1561976|NCT01221441|3820962|P1|COMPLETED|Overall Study||45
1561977|NCT01221441|3820961|P2|STARTED|Overall Study||35
1561978|NCT01221441|3820962|P1|STARTED|Overall Study||67
1561979|NCT01221363|3820994|P2|NOT COMPLETED|Overall Study||5
1561980|NCT01221363|3820995|P1|NOT COMPLETED|Overall Study||12
1561981|NCT01221363|3820994|P2|COMPLETED|Overall Study||68
1561982|NCT01221363|3820995|P1|COMPLETED|Overall Study||81
1561983|NCT01221363|3820994|P2|STARTED|Overall Study||73
1561984|NCT01221363|3820995|P1|STARTED|Overall Study||93
1561985|NCT01221350|3821005|P2|NOT COMPLETED|Overall Study||3
1561986|NCT01221350|3821006|P1|NOT COMPLETED|Overall Study||5
1561987|NCT01221350|3821005|P2|COMPLETED|Overall Study||24
1561988|NCT01221350|3821006|P1|COMPLETED|Overall Study||23
1561989|NCT01221350|3821005|P2|Analysis Population|Overall Study||24
1561990|NCT01221350|3821006|P1|Analysis Population|Overall Study||23
1561991|NCT01221350|3821005|P2|Received Intervention|Overall Study||27
1561992|NCT01221350|3821006|P1|Received Intervention|Overall Study||28
1561993|NCT01221350|3821005|P2|STARTED|Overall Study||27
1561994|NCT01221350|3821006|P1|STARTED|Overall Study||28
1561995|NCT01221311|3821048|P2|NOT COMPLETED|Overall Study||0
1561996|NCT01221311|3821049|P1|NOT COMPLETED|Overall Study||0
1561997|NCT01221311|3821048|P2|COMPLETED|Overall Study||55
1561998|NCT01221311|3821049|P1|COMPLETED|Overall Study||57
1561999|NCT01221311|3821048|P2|STARTED|Overall Study||55
1562000|NCT01221311|3821049|P1|STARTED|Overall Study||57
1562001|NCT01221298|3821055|P1|NOT COMPLETED|Overall Study||0
1562002|NCT01221298|3821055|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
1562003|NCT01221298|3821055|P1|STARTED|Overall Study||11
1562004|NCT01221285|3821065|P1|NOT COMPLETED|Overall Study||1
1562005|NCT01221285|3821065|P1|COMPLETED|Overall Study||10
1562006|NCT01221285|3821065|P1|STARTED|Overall Study||11
1562007|NCT01221272|3821074|P2|NOT COMPLETED|Period 2||2
1562008|NCT01221272|3821075|P1|NOT COMPLETED|Period 2||0
1562009|NCT01221272|3821074|P2|COMPLETED|Period 2||37
1562010|NCT01221272|3821075|P1|COMPLETED|Period 2||39
1562011|NCT01221272|3821074|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
1562012|NCT01221272|3821075|P1|STARTED|Period 2||39
1562013|NCT01221272|3821074|P2|NOT COMPLETED|Period 1||2
1562014|NCT01221272|3821075|P1|NOT COMPLETED|Period 1||2
1562015|NCT01221272|3821074|P2|COMPLETED|Period 1||38
1562016|NCT01221272|3821075|P1|COMPLETED|Period 1||39
1562017|NCT01221272|3821074|P2|STARTED|Period 1||40
1562018|NCT01221272|3821075|P1|STARTED|Period 1||41
1562019|NCT01221090|3821094|P4|NOT COMPLETED|Overall Study||22
1562020|NCT01221090|3821095|P3|NOT COMPLETED|Overall Study||42
1562021|NCT01221090|3821096|P2|NOT COMPLETED|Overall Study||34
1562022|NCT01221090|3821097|P1|NOT COMPLETED|Overall Study||15
1562023|NCT01221090|3821094|P4|COMPLETED|Overall Study||73
1562024|NCT01221090|3821095|P3|COMPLETED|Overall Study||57
1562025|NCT01221090|3821096|P2|COMPLETED|Overall Study||47
1562026|NCT01221090|3821097|P1|COMPLETED|Overall Study||86
1562027|NCT01221090|3821094|P4|STARTED|Overall Study||95
1562028|NCT01221090|3821095|P3|STARTED|Overall Study||99
1562029|NCT01221090|3821096|P2|STARTED|Overall Study||81
1562030|NCT01221090|3821097|P1|STARTED|Overall Study||101
1562031|NCT01220973|3821123|P1|NOT COMPLETED|Overall Study||4
1562032|NCT01220973|3821123|P1|COMPLETED|Overall Study||23
1562033|NCT01220973|3821123|P1|STARTED|Overall Study||27
1562034|NCT01220869|3821127|P1|NOT COMPLETED|Overall Study||6
1562035|NCT01220869|3821127|P1|COMPLETED|Overall Study||104
1562036|NCT01220869|3821127|P1|STARTED|Overall Study||110
1562037|NCT01220739|3821137|P2|NOT COMPLETED|Overall Study||0
1562038|NCT01220739|3821138|P1|NOT COMPLETED|Overall Study||0
1562039|NCT01220739|3821137|P2|COMPLETED|Overall Study||5
1562040|NCT01220739|3821138|P1|COMPLETED|Overall Study||7
1562041|NCT01220739|3821137|P2|STARTED|Overall Study||5
1562042|NCT01220739|3821138|P1|STARTED|Overall Study||7
1562043|NCT01220609|3821146|P1|NOT COMPLETED|Overall Study||3
1562044|NCT01220609|3821146|P1|COMPLETED|Overall Study|Eligible and treated patients|23
1562045|NCT01220609|3821146|P1|STARTED|Overall Study||26
1562046|NCT01220557|3821160|P2|NOT COMPLETED|Overall Study||5
1562047|NCT01220557|3821161|P1|NOT COMPLETED|Overall Study||6
1562142|NCT01219673|3821601|P7|NOT COMPLETED|Overall Study||0
1562048|NCT01220557|3821160|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
1562049|NCT01220557|3821161|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
1562050|NCT01220557|3821160|P2|STARTED|Overall Study||79
1562051|NCT01220557|3821161|P1|STARTED|Overall Study||81
1562052|NCT01220466|3821170|P3|NOT COMPLETED|Overall Study||0
1562053|NCT01220466|3821171|P2|NOT COMPLETED|Overall Study||0
1562054|NCT01220466|3821172|P1|NOT COMPLETED|Overall Study||0
1562055|NCT01220466|3821170|P3|COMPLETED|Overall Study|16 eyes|10
1562056|NCT01220466|3821171|P2|COMPLETED|Overall Study|108 eyes|56
1562057|NCT01220466|3821172|P1|COMPLETED|Overall Study|19 eyes|11
1562058|NCT01220466|3821170|P3|STARTED|Overall Study|16 eyes|10
1562059|NCT01220466|3821171|P2|STARTED|Overall Study|108 eyes|56
1562060|NCT01220466|3821172|P1|STARTED|Overall Study|19 eyes|11
1562061|NCT01220414|3821194|P4|NOT COMPLETED|Overall Study||1
1562062|NCT01220414|3821195|P3|NOT COMPLETED|Overall Study||0
1562063|NCT01220414|3821196|P2|NOT COMPLETED|Overall Study||0
1562064|NCT01220414|3821197|P1|NOT COMPLETED|Overall Study||1
1562065|NCT01220414|3821194|P4|COMPLETED|Overall Study||14
1562066|NCT01220414|3821195|P3|COMPLETED|Overall Study||14
1562067|NCT01220414|3821196|P2|COMPLETED|Overall Study||14
1562068|NCT01220414|3821197|P1|COMPLETED|Overall Study||14
1562069|NCT01220414|3821194|P4|STARTED|Overall Study||15
1562070|NCT01220414|3821195|P3|STARTED|Overall Study||14
1562071|NCT01220414|3821196|P2|STARTED|Overall Study||14
1562072|NCT01220414|3821197|P1|STARTED|Overall Study||15
1562073|NCT01220401|3821204|P1|NOT COMPLETED|Overall Study||3
1562074|NCT01220401|3821204|P1|COMPLETED|Overall Study||18
1562075|NCT01220401|3821204|P1|STARTED|Overall Study||21
1562076|NCT01220297|3821213|P1|NOT COMPLETED|Overall Study||3
1562077|NCT01220297|3821213|P1|COMPLETED|Overall Study||0
1562078|NCT01220297|3821213|P1|STARTED|Overall Study||3
1562079|NCT01220180|3821230|P1|NOT COMPLETED|Overall Study||207
1562080|NCT01220180|3821230|P1|COMPLETED|Overall Study||3968
1562081|NCT01220180|3821230|P1|Treated|Overall Study||4174
1562082|NCT01220180|3821230|P1|STARTED|Overall Study||4175
1562083|NCT01220128|3821260|P7|NOT COMPLETED|Overall Study||5
1562084|NCT01220128|3821261|P6|NOT COMPLETED|Overall Study||0
1562085|NCT01220128|3821262|P5|NOT COMPLETED|Overall Study||0
1562086|NCT01220128|3821263|P4|NOT COMPLETED|Overall Study||0
1562087|NCT01220128|3821264|P3|NOT COMPLETED|Overall Study||3
1562088|NCT01220128|3821265|P2|NOT COMPLETED|Overall Study||1
1562089|NCT01220128|3821266|P1|NOT COMPLETED|Overall Study||4
1562090|NCT01220128|3821260|P7|COMPLETED|Overall Study||3
1562091|NCT01220128|3821261|P6|COMPLETED|Overall Study||4
1562092|NCT01220128|3821262|P5|COMPLETED|Overall Study||11
1562093|NCT01220128|3821263|P4|COMPLETED|Overall Study||6
1562094|NCT01220128|3821264|P3|COMPLETED|Overall Study||6
1562095|NCT01220128|3821265|P2|COMPLETED|Overall Study||6
1562096|NCT01220128|3821266|P1|COMPLETED|Overall Study||11
1562097|NCT01220128|3821260|P7|STARTED|Overall Study||8
1562098|NCT01220128|3821261|P6|STARTED|Overall Study||4
1562099|NCT01220128|3821262|P5|STARTED|Overall Study||11
1562100|NCT01220128|3821263|P4|STARTED|Overall Study||6
1562101|NCT01220128|3821264|P3|STARTED|Overall Study||9
1562102|NCT01220128|3821265|P2|STARTED|Overall Study||7
1562103|NCT01220128|3821266|P1|STARTED|Overall Study||15
1562104|NCT01219985|3821471|P1|NOT COMPLETED|Overall Study||20
1562105|NCT01219985|3821471|P1|COMPLETED|Overall Study||30
1562106|NCT01219985|3821471|P1|STARTED|Overall Study||50
1562107|NCT01219933|3821477|P1|NOT COMPLETED|Overall Study||38
1562108|NCT01219933|3821477|P1|COMPLETED|Overall Study||30
1562109|NCT01219933|3821477|P1|STARTED|Overall Study||68
1562110|NCT01219881|3821516|P2|NOT COMPLETED|Overall Study||5
1562111|NCT01219881|3821517|P1|NOT COMPLETED|Overall Study||4
1562112|NCT01219881|3821516|P2|COMPLETED|Overall Study||32
1562113|NCT01219881|3821517|P1|COMPLETED|Overall Study||34
1562114|NCT01219881|3821516|P2|STARTED|Overall Study||37
1562115|NCT01219881|3821517|P1|STARTED|Overall Study||38
1562116|NCT01219855|3821534|P5|NOT COMPLETED|Overall Study||1
1562117|NCT01219855|3821535|P4|NOT COMPLETED|Overall Study||1
1562118|NCT01219855|3821536|P3|NOT COMPLETED|Overall Study||1
1562119|NCT01219855|3821537|P2|NOT COMPLETED|Overall Study||5
1562120|NCT01219855|3821538|P1|NOT COMPLETED|Overall Study||1
1562121|NCT01219855|3821534|P5|COMPLETED|Overall Study||13
1562122|NCT01219855|3821535|P4|COMPLETED|Overall Study||12
1562123|NCT01219855|3821536|P3|COMPLETED|Overall Study||16
1562124|NCT01219855|3821537|P2|COMPLETED|Overall Study||12
1562125|NCT01219855|3821538|P1|COMPLETED|Overall Study||16
1562126|NCT01219855|3821534|P5|STARTED|Overall Study||14
1562127|NCT01219855|3821535|P4|STARTED|Overall Study||13
1562128|NCT01219855|3821536|P3|STARTED|Overall Study||17
1562129|NCT01219855|3821537|P2|STARTED|Overall Study||17
1562130|NCT01219855|3821538|P1|STARTED|Overall Study||17
1562131|NCT01219777|3821574|P1|NOT COMPLETED|Overall Study||0
1562132|NCT01219777|3821574|P1|COMPLETED|Overall Study||9
1562133|NCT01219777|3821574|P1|STARTED|Overall Study||9
1562134|NCT01219738|3821579|P1|NOT COMPLETED|Overall Study||0
1562135|NCT01219738|3821579|P1|COMPLETED|Overall Study||20
1562136|NCT01219738|3821579|P1|Budesonide 720- 4 Times|Overall Study||20
1562137|NCT01219738|3821579|P1|Budesonide 1440|Overall Study||20
1562138|NCT01219738|3821579|P1|Budesonide 720|Overall Study||20
1562139|NCT01219738|3821579|P1|Budesonide 360|Overall Study||20
1562140|NCT01219738|3821579|P1|STARTED|Overall Study||20
1562141|NCT01219673|3821600|P8|NOT COMPLETED|Overall Study||0
1562143|NCT01219673|3821602|P6|NOT COMPLETED|Overall Study||0
1562144|NCT01219673|3821603|P5|NOT COMPLETED|Overall Study||0
1562145|NCT01219673|3821604|P4|NOT COMPLETED|Overall Study||0
1562146|NCT01219673|3821605|P3|NOT COMPLETED|Overall Study||0
1562147|NCT01219673|3821606|P2|NOT COMPLETED|Overall Study||0
1562148|NCT01219673|3821607|P1|NOT COMPLETED|Overall Study||0
1562149|NCT01219673|3821600|P8|COMPLETED|Overall Study||0
1562150|NCT01219673|3821601|P7|COMPLETED|Overall Study||0
1562151|NCT01219673|3821602|P6|COMPLETED|Overall Study||0
1562152|NCT01219673|3821603|P5|COMPLETED|Overall Study||0
1562153|NCT01219673|3821604|P4|COMPLETED|Overall Study||0
1562154|NCT01219673|3821605|P3|COMPLETED|Overall Study||1
1562155|NCT01219673|3821606|P2|COMPLETED|Overall Study||0
1562156|NCT01219673|3821607|P1|COMPLETED|Overall Study||0
1562157|NCT01219673|3821600|P8|STARTED|Overall Study||0
1562158|NCT01219673|3821601|P7|STARTED|Overall Study||0
1562159|NCT01219673|3821602|P6|STARTED|Overall Study||0
1562160|NCT01219673|3821603|P5|STARTED|Overall Study||0
1562161|NCT01219673|3821604|P4|STARTED|Overall Study||0
1562162|NCT01219673|3821605|P3|STARTED|Overall Study||1
1562163|NCT01219673|3821606|P2|STARTED|Overall Study||0
1562164|NCT01219673|3821607|P1|STARTED|Overall Study||0
1562165|NCT01218997|3821627|P2|NOT COMPLETED|Overall Study||41
1562166|NCT01218997|3821628|P1|NOT COMPLETED|Overall Study||245
1562167|NCT01218997|3821627|P2|COMPLETED|Overall Study||24
1562168|NCT01218997|3821628|P1|COMPLETED|Overall Study||126
1562169|NCT01218997|3821627|P2|STARTED|Overall Study||65
1562170|NCT01218997|3821628|P1|STARTED|Overall Study||371
1562171|NCT01218984|3821637|P3|NOT COMPLETED|Overall Study||3
1562172|NCT01218984|3821638|P2|NOT COMPLETED|Overall Study||2
1562173|NCT01218984|3821639|P1|NOT COMPLETED|Overall Study||1
1562174|NCT01218984|3821637|P3|COMPLETED|Overall Study||7
1562175|NCT01218984|3821638|P2|COMPLETED|Overall Study||6
1562176|NCT01218984|3821639|P1|COMPLETED|Overall Study||8
1562177|NCT01218984|3821637|P3|STARTED|Overall Study||10
1562178|NCT01218984|3821638|P2|STARTED|Overall Study||8
1562179|NCT01218984|3821639|P1|STARTED|Overall Study||9
1562180|NCT01218971|3821649|P2|NOT COMPLETED|Overall Study||80
1562181|NCT01218971|3821650|P1|NOT COMPLETED|Overall Study||104
1562182|NCT01218971|3821649|P2|COMPLETED|Overall Study||77
1562183|NCT01218971|3821650|P1|COMPLETED|Overall Study||71
1562184|NCT01218971|3821649|P2|STARTED|Overall Study||157
1562185|NCT01218971|3821650|P1|STARTED|Overall Study||175
1562186|NCT01218958|3821663|P3|NOT COMPLETED|Overall Study||81
1562187|NCT01218958|3821664|P2|NOT COMPLETED|Overall Study||81
1562188|NCT01218958|3821665|P1|NOT COMPLETED|Overall Study||84
1562189|NCT01218958|3821663|P3|COMPLETED|Overall Study||128
1562190|NCT01218958|3821664|P2|COMPLETED|Overall Study||124
1562191|NCT01218958|3821665|P1|COMPLETED|Overall Study||126
1562192|NCT01218958|3821663|P3|STARTED|Overall Study||209
1562193|NCT01218958|3821664|P2|STARTED|Overall Study||205
1562194|NCT01218958|3821665|P1|STARTED|Overall Study||210
1562195|NCT01218867|3821687|P11|NOT COMPLETED|Overall Study||0
1562196|NCT01218867|3821688|P10|NOT COMPLETED|Overall Study||0
1562197|NCT01218867|3821689|P9|NOT COMPLETED|Overall Study||0
1562198|NCT01218867|3821690|P8|NOT COMPLETED|Overall Study||0
1562199|NCT01218867|3821691|P7|NOT COMPLETED|Overall Study||1
1562200|NCT01218867|3821692|P6|NOT COMPLETED|Overall Study||0
1562201|NCT01218867|3821693|P5|NOT COMPLETED|Overall Study||0
1562202|NCT01218867|3821694|P4|NOT COMPLETED|Overall Study||0
1562203|NCT01218867|3821695|P3|NOT COMPLETED|Overall Study||0
1562204|NCT01218867|3821696|P2|NOT COMPLETED|Overall Study||0
1562205|NCT01218867|3821697|P1|NOT COMPLETED|Overall Study||0
1562206|NCT01218867|3821687|P11|COMPLETED|Overall Study||2
1562207|NCT01218867|3821688|P10|COMPLETED|Overall Study||4
1562208|NCT01218867|3821689|P9|COMPLETED|Overall Study||3
1562209|NCT01218867|3821690|P8|COMPLETED|Overall Study||3
1562210|NCT01218867|3821691|P7|COMPLETED|Overall Study||3
1562211|NCT01218867|3821692|P6|COMPLETED|Overall Study||1
1562212|NCT01218867|3821693|P5|COMPLETED|Overall Study||1
1562213|NCT01218867|3821694|P4|COMPLETED|Overall Study||1
1562214|NCT01218867|3821695|P3|COMPLETED|Overall Study||3
1562215|NCT01218867|3821696|P2|COMPLETED|Overall Study||1
1562216|NCT01218867|3821697|P1|COMPLETED|Overall Study||1
1562217|NCT01218867|3821687|P11|STARTED|Overall Study||2
1562218|NCT01218867|3821688|P10|STARTED|Overall Study||4
1562219|NCT01218867|3821689|P9|STARTED|Overall Study||3
1562220|NCT01218867|3821690|P8|STARTED|Overall Study||3
1562221|NCT01218867|3821691|P7|STARTED|Overall Study||4
1562222|NCT01218867|3821692|P6|STARTED|Overall Study||1
1562223|NCT01218867|3821693|P5|STARTED|Overall Study||1
1562224|NCT01218867|3821694|P4|STARTED|Overall Study||1
1562225|NCT01218867|3821695|P3|STARTED|Overall Study||3
1562226|NCT01218867|3821696|P2|STARTED|Overall Study||1
1562227|NCT01218867|3821697|P1|STARTED|Overall Study||1
1562228|NCT01218802|3821745|P2|NOT COMPLETED|Overall Study||18
1562229|NCT01218802|3821746|P1|NOT COMPLETED|Overall Study||10
1562230|NCT01218802|3821745|P2|COMPLETED|Overall Study||57
1562231|NCT01218802|3821746|P1|COMPLETED|Overall Study||62
1562232|NCT01218802|3821745|P2|STARTED|Overall Study||75
1562233|NCT01218802|3821746|P1|STARTED|Overall Study||72
1562234|NCT01218659|3821756|P3|NOT COMPLETED|12-Month OLE||10
1562235|NCT01218659|3821757|P2|NOT COMPLETED|12-Month OLE||0
1562236|NCT01218659|3821758|P1|NOT COMPLETED|12-Month OLE||0
1562237|NCT01218659|3821756|P3|COMPLETED|12-Month OLE||42
1562318|NCT01218243|3822053|P2|STARTED|Overall Study||50
1562319|NCT01218243|3822054|P1|STARTED|Overall Study||50
1562238|NCT01218659|3821757|P2|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1562239|NCT01218659|3821758|P1|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1562240|NCT01218659|3821756|P3|Modified Intent-to-Treat (mITT)|12-Month OLE||46
1562241|NCT01218659|3821757|P2|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1562242|NCT01218659|3821758|P1|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1562243|NCT01218659|3821756|P3|Safety Population|12-Month OLE||51
1562244|NCT01218659|3821757|P2|Safety Population|12-Month OLE||0
1562245|NCT01218659|3821758|P1|Safety Population|12-Month OLE||0
1562246|NCT01218659|3821756|P3|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
1562247|NCT01218659|3821757|P2|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1562248|NCT01218659|3821758|P1|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
1562249|NCT01218659|3821756|P3|NOT COMPLETED|18-Month Randomized Period||0
1562250|NCT01218659|3821757|P2|NOT COMPLETED|18-Month Randomized Period||6
1562251|NCT01218659|3821758|P1|NOT COMPLETED|18-Month Randomized Period||2
1562252|NCT01218659|3821756|P3|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
1562253|NCT01218659|3821757|P2|COMPLETED|18-Month Randomized Period||18
1562254|NCT01218659|3821758|P1|COMPLETED|18-Month Randomized Period||34
1562255|NCT01218659|3821756|P3|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
1562256|NCT01218659|3821757|P2|Safety Population|18-Month Randomized Period||21
1562257|NCT01218659|3821758|P1|Safety Population|18-Month Randomized Period||36
1562258|NCT01218659|3821756|P3|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
1562259|NCT01218659|3821757|P2|STARTED|18-Month Randomized Period||24
1562260|NCT01218659|3821758|P1|STARTED|18-Month Randomized Period||36
1562261|NCT01218646|3821773|P4|NOT COMPLETED|Overall Study||1
1562262|NCT01218646|3821774|P3|NOT COMPLETED|Overall Study||2
1562263|NCT01218646|3821775|P2|NOT COMPLETED|Overall Study||0
1562264|NCT01218646|3821776|P1|NOT COMPLETED|Overall Study||1
1562265|NCT01218646|3821773|P4|COMPLETED|Overall Study||63
1562266|NCT01218646|3821774|P3|COMPLETED|Overall Study||223
1562267|NCT01218646|3821775|P2|COMPLETED|Overall Study||225
1562268|NCT01218646|3821776|P1|COMPLETED|Overall Study||224
1562269|NCT01218646|3821773|P4|STARTED|Overall Study||64
1562270|NCT01218646|3821774|P3|STARTED|Overall Study||225
1562271|NCT01218646|3821775|P2|STARTED|Overall Study||225
1562272|NCT01218646|3821776|P1|STARTED|Overall Study||225
1562273|NCT01218594|3821814|P1|NOT COMPLETED|Overall Study||12
1562274|NCT01218594|3821814|P1|COMPLETED|Overall Study||36
1562275|NCT01218594|3821814|P1|STARTED|Overall Study||48
1562276|NCT01218477|3821822|P4|NOT COMPLETED|Overall Study||2
1562277|NCT01218477|3821823|P3|NOT COMPLETED|Overall Study||14
1562278|NCT01218477|3821824|P2|NOT COMPLETED|Overall Study||8
1562279|NCT01218477|3821825|P1|NOT COMPLETED|Overall Study||3
1562280|NCT01218477|3821822|P4|COMPLETED|Overall Study|Still receiving study drug|0
1562281|NCT01218477|3821823|P3|COMPLETED|Overall Study|Still receiving study drug|0
1562282|NCT01218477|3821824|P2|COMPLETED|Overall Study|Still receiving study drug|0
1562283|NCT01218477|3821825|P1|COMPLETED|Overall Study|Still receiving study drug|0
1562284|NCT01218477|3821822|P4|STARTED|Overall Study|Participants who received treatment|2
1562285|NCT01218477|3821823|P3|STARTED|Overall Study|Participants who received treatment|14
1562286|NCT01218477|3821824|P2|STARTED|Overall Study|Participants who received treatment|8
1562287|NCT01218477|3821825|P1|STARTED|Overall Study|Participants who received treatment|3
1562288|NCT01218438|3821842|P1|NOT COMPLETED|Epoch 4||3
1562289|NCT01218438|3821842|P1|COMPLETED|Epoch 4||67
1562290|NCT01218438|3821842|P1|STARTED|Epoch 4||70
1562291|NCT01218438|3821842|P1|NOT COMPLETED|Epoch 3||4
1562292|NCT01218438|3821842|P1|COMPLETED|Epoch 3||70
1562293|NCT01218438|3821842|P1|STARTED|Epoch 3||74
1562294|NCT01218438|3821842|P1|NOT COMPLETED|Epoch 2||0
1562295|NCT01218438|3821842|P1|COMPLETED|Epoch 2||45
1562296|NCT01218438|3821842|P1|STARTED|Epoch 2||45
1562297|NCT01218438|3821842|P1|NOT COMPLETED|Epoch 1||3
1562298|NCT01218438|3821842|P1|COMPLETED|Epoch 1||74
1562299|NCT01218438|3821842|P1|STARTED|Epoch 1||77
1562300|NCT01218399|3821997|P2|NOT COMPLETED|Overall Study||0
1562301|NCT01218399|3821998|P1|NOT COMPLETED|Overall Study||0
1562302|NCT01218399|3821997|P2|COMPLETED|Overall Study||5
1562303|NCT01218399|3821998|P1|COMPLETED|Overall Study||5
1562304|NCT01218399|3821997|P2|STARTED|Overall Study||5
1562305|NCT01218399|3821998|P1|STARTED|Overall Study||5
1562306|NCT01218308|3822008|P2|NOT COMPLETED|Overall Study||120
1562307|NCT01218308|3822009|P1|NOT COMPLETED|Overall Study||103
1562308|NCT01218308|3822008|P2|COMPLETED|Overall Study||2464
1562309|NCT01218308|3822009|P1|COMPLETED|Overall Study||2481
1562310|NCT01218308|3822008|P2|STARTED|Overall Study||2584
1562311|NCT01218308|3822009|P1|STARTED|Overall Study||2584
1562312|NCT01218243|3822053|P2|NOT COMPLETED|Overall Study||14
1562313|NCT01218243|3822054|P1|NOT COMPLETED|Overall Study||9
1562314|NCT01218243|3822053|P2|COMPLETED|Overall Study||36
1562315|NCT01218243|3822054|P1|COMPLETED|Overall Study||41
1562316|NCT01218243|3822053|P2|Treatment Completed|Overall Study||42
1562317|NCT01218243|3822054|P1|Treatment Completed|Overall Study||45
1562320|NCT01218204|3822070|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
1562321|NCT01218204|3822071|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
1562322|NCT01218204|3822072|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
1562323|NCT01218204|3822073|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
1562324|NCT01218204|3822070|P4|COMPLETED|Part B Pooled Treatment Arm||127
1562325|NCT01218204|3822071|P3|COMPLETED|Part B Pooled Treatment Arm||0
1562326|NCT01218204|3822072|P2|COMPLETED|Part B Pooled Treatment Arm||0
1562327|NCT01218204|3822073|P1|COMPLETED|Part B Pooled Treatment Arm||0
1562328|NCT01218204|3822070|P4|STARTED|Part B Pooled Treatment Arm||130
1562329|NCT01218204|3822071|P3|STARTED|Part B Pooled Treatment Arm||0
1562330|NCT01218204|3822072|P2|STARTED|Part B Pooled Treatment Arm||0
1562331|NCT01218204|3822073|P1|STARTED|Part B Pooled Treatment Arm||0
1562332|NCT01218204|3822070|P4|NOT COMPLETED|Part B Run-in||0
1562333|NCT01218204|3822071|P3|NOT COMPLETED|Part B Run-in||6
1562334|NCT01218204|3822072|P2|NOT COMPLETED|Part B Run-in||0
1562335|NCT01218204|3822073|P1|NOT COMPLETED|Part B Run-in||0
1562336|NCT01218204|3822070|P4|COMPLETED|Part B Run-in||0
1562337|NCT01218204|3822071|P3|COMPLETED|Part B Run-in||83
1562338|NCT01218204|3822072|P2|COMPLETED|Part B Run-in||0
1562339|NCT01218204|3822073|P1|COMPLETED|Part B Run-in||0
1562340|NCT01218204|3822070|P4|STARTED|Part B Run-in||0
1562341|NCT01218204|3822071|P3|STARTED|Part B Run-in||89
1562342|NCT01218204|3822072|P2|STARTED|Part B Run-in||0
1562343|NCT01218204|3822073|P1|STARTED|Part B Run-in||0
1562344|NCT01218204|3822070|P4|NOT COMPLETED|Part B Washout||0
1562345|NCT01218204|3822071|P3|NOT COMPLETED|Part B Washout||0
1562346|NCT01218204|3822072|P2|NOT COMPLETED|Part B Washout||145
1562347|NCT01218204|3822073|P1|NOT COMPLETED|Part B Washout||0
1562348|NCT01218204|3822070|P4|COMPLETED|Part B Washout||0
1562349|NCT01218204|3822071|P3|COMPLETED|Part B Washout||0
1562350|NCT01218204|3822072|P2|COMPLETED|Part B Washout||136
1562351|NCT01218204|3822073|P1|COMPLETED|Part B Washout||0
1562352|NCT01218204|3822070|P4|STARTED|Part B Washout||0
1562353|NCT01218204|3822071|P3|STARTED|Part B Washout||0
1562354|NCT01218204|3822072|P2|STARTED|Part B Washout||281
1562355|NCT01218204|3822073|P1|STARTED|Part B Washout||0
1562356|NCT01218204|3822070|P4|NOT COMPLETED|Part A||0
1562357|NCT01218204|3822071|P3|NOT COMPLETED|Part A||0
1562358|NCT01218204|3822072|P2|NOT COMPLETED|Part A||0
1562359|NCT01218204|3822073|P1|NOT COMPLETED|Part A||0
1562360|NCT01218204|3822070|P4|COMPLETED|Part A||0
1562361|NCT01218204|3822071|P3|COMPLETED|Part A||0
1562362|NCT01218204|3822072|P2|COMPLETED|Part A||0
1562363|NCT01218204|3822073|P1|COMPLETED|Part A||6
1562364|NCT01218204|3822070|P4|STARTED|Part A||0
1562365|NCT01218204|3822071|P3|STARTED|Part A||0
1562366|NCT01218204|3822072|P2|STARTED|Part A||0
1562367|NCT01218204|3822073|P1|STARTED|Part A||6
1562368|NCT01218126|3822337|P4|NOT COMPLETED|Overall Study||35
1562369|NCT01218126|3822338|P3|NOT COMPLETED|Overall Study||24
1562370|NCT01218126|3822339|P2|NOT COMPLETED|Overall Study||22
1562371|NCT01218126|3822340|P1|NOT COMPLETED|Overall Study||24
1562372|NCT01218126|3822337|P4|COMPLETED|Overall Study||114
1562373|NCT01218126|3822338|P3|COMPLETED|Overall Study||127
1562374|NCT01218126|3822339|P2|COMPLETED|Overall Study||127
1562375|NCT01218126|3822340|P1|COMPLETED|Overall Study||129
1562376|NCT01218126|3822337|P4|STARTED|Overall Study||149
1562377|NCT01218126|3822338|P3|STARTED|Overall Study||151
1562378|NCT01218126|3822339|P2|STARTED|Overall Study||149
1562379|NCT01218126|3822340|P1|STARTED|Overall Study||153
1562380|NCT01218113|3822381|P3|NOT COMPLETED|Overall Study||6
1562381|NCT01218113|3822382|P2|NOT COMPLETED|Overall Study||1
1562382|NCT01218113|3822383|P1|NOT COMPLETED|Overall Study||5
1562383|NCT01218113|3822381|P3|COMPLETED|Overall Study||58
1562384|NCT01218113|3822382|P2|COMPLETED|Overall Study||63
1562385|NCT01218113|3822383|P1|COMPLETED|Overall Study||57
1562386|NCT01218113|3822381|P3|STARTED|Overall Study||64
1562387|NCT01218113|3822382|P2|STARTED|Overall Study||64
1562388|NCT01218113|3822383|P1|STARTED|Overall Study||62
1562389|NCT01218100|3822564|P4|NOT COMPLETED|Overall Study||34
1562390|NCT01218100|3822565|P3|NOT COMPLETED|Overall Study||27
1562391|NCT01218100|3822566|P2|NOT COMPLETED|Overall Study||25
1562392|NCT01218100|3822567|P1|NOT COMPLETED|Overall Study||24
1562393|NCT01218100|3822564|P4|COMPLETED|Overall Study||156
1562394|NCT01218100|3822565|P3|COMPLETED|Overall Study||162
1562395|NCT01218100|3822566|P2|COMPLETED|Overall Study||165
1562396|NCT01218100|3822567|P1|COMPLETED|Overall Study||71
1562397|NCT01218100|3822564|P4|STARTED|Overall Study||190
1562398|NCT01218100|3822565|P3|STARTED|Overall Study||189
1562399|NCT01218100|3822566|P2|STARTED|Overall Study||190
1562400|NCT01218100|3822567|P1|STARTED|Overall Study||95
1562401|NCT01218087|3822583|P2|NOT COMPLETED|Overall Study||6
1562402|NCT01218087|3822584|P1|NOT COMPLETED|Overall Study||15
1562403|NCT01218087|3822583|P2|COMPLETED|Overall Study||35
1562404|NCT01218087|3822584|P1|COMPLETED|Overall Study||27
1562405|NCT01218087|3822583|P2|STARTED|Overall Study||41
1562406|NCT01218087|3822584|P1|STARTED|Overall Study||42
1562407|NCT01218048|3822592|P1|NOT COMPLETED|Overall Study||0
1562408|NCT01218048|3822592|P1|COMPLETED|Overall Study||40
1562409|NCT01218048|3822592|P1|STARTED|Overall Study||40
1562410|NCT01218009|3822606|P2|NOT COMPLETED|Overall Study||165
1562411|NCT01218009|3822607|P1|NOT COMPLETED|Overall Study||166
1562412|NCT01218009|3822606|P2|COMPLETED|Overall Study||0
1562413|NCT01218009|3822607|P1|COMPLETED|Overall Study||0
1562414|NCT01218009|3822606|P2|STARTED|Overall Study||165
1562415|NCT01218009|3822607|P1|STARTED|Overall Study||166
1562416|NCT01217957|3822630|P5|NOT COMPLETED|Phase 2||1
1562417|NCT01217957|3822631|P4|NOT COMPLETED|Phase 2||0
1562418|NCT01217957|3822632|P3|NOT COMPLETED|Phase 2||0
1562419|NCT01217957|3822633|P2|NOT COMPLETED|Phase 2||0
1562420|NCT01217957|3822634|P1|NOT COMPLETED|Phase 2||0
1562421|NCT01217957|3822630|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
1562422|NCT01217957|3822631|P4|COMPLETED|Phase 2||0
1562423|NCT01217957|3822632|P3|COMPLETED|Phase 2||0
1562424|NCT01217957|3822633|P2|COMPLETED|Phase 2||0
1562425|NCT01217957|3822634|P1|COMPLETED|Phase 2||0
1562426|NCT01217957|3822630|P5|STARTED|Phase 2||50
1562427|NCT01217957|3822631|P4|STARTED|Phase 2||0
1562428|NCT01217957|3822632|P3|STARTED|Phase 2||0
1562429|NCT01217957|3822633|P2|STARTED|Phase 2||0
1562430|NCT01217957|3822634|P1|STARTED|Phase 2||0
1562431|NCT01217957|3822630|P5|NOT COMPLETED|Phase 1||0
1562432|NCT01217957|3822631|P4|NOT COMPLETED|Phase 1||1
1562433|NCT01217957|3822632|P3|NOT COMPLETED|Phase 1||1
1562434|NCT01217957|3822633|P2|NOT COMPLETED|Phase 1||0
1562435|NCT01217957|3822634|P1|NOT COMPLETED|Phase 1||1
1562436|NCT01217957|3822630|P5|COMPLETED|Phase 1||0
1562437|NCT01217957|3822631|P4|COMPLETED|Phase 1||2
1562438|NCT01217957|3822632|P3|COMPLETED|Phase 1||5
1562439|NCT01217957|3822633|P2|COMPLETED|Phase 1||3
1562440|NCT01217957|3822634|P1|COMPLETED|Phase 1||2
1562441|NCT01217957|3822630|P5|STARTED|Phase 1||0
1562442|NCT01217957|3822631|P4|STARTED|Phase 1||3
1562443|NCT01217957|3822632|P3|STARTED|Phase 1||6
1562444|NCT01217957|3822633|P2|STARTED|Phase 1||3
1562445|NCT01217957|3822634|P1|STARTED|Phase 1||3
1562446|NCT01217944|3822693|P3|NOT COMPLETED|Overall Study||0
1562447|NCT01217944|3822694|P2|NOT COMPLETED|Overall Study||4
1562448|NCT01217944|3822695|P1|NOT COMPLETED|Overall Study||6
1562449|NCT01217944|3822693|P3|COMPLETED|Overall Study||55
1562450|NCT01217944|3822694|P2|COMPLETED|Overall Study||112
1562451|NCT01217944|3822695|P1|COMPLETED|Overall Study||100
1562452|NCT01217944|3822693|P3|Completed 6 Months|Overall Study||55
1562453|NCT01217944|3822694|P2|Completed 6 Months|Overall Study||116
1562454|NCT01217944|3822695|P1|Completed 6 Months|Overall Study||103
1562455|NCT01217944|3822693|P3|Completed 3 Months|Overall Study||55
1562456|NCT01217944|3822694|P2|Completed 3 Months|Overall Study||116
1562457|NCT01217944|3822695|P1|Completed 3 Months|Overall Study||105
1562458|NCT01217944|3822693|P3|STARTED|Overall Study||55
1562459|NCT01217944|3822694|P2|STARTED|Overall Study||116
1562460|NCT01217944|3822695|P1|STARTED|Overall Study||106
1562461|NCT01217892|3822738|P4|NOT COMPLETED|Overall Study||8
1562462|NCT01217892|3822739|P3|NOT COMPLETED|Overall Study||9
1562463|NCT01217892|3822740|P2|NOT COMPLETED|Overall Study||6
1562464|NCT01217892|3822741|P1|NOT COMPLETED|Overall Study||7
1562465|NCT01217892|3822738|P4|COMPLETED|Overall Study||93
1562466|NCT01217892|3822739|P3|COMPLETED|Overall Study||90
1562467|NCT01217892|3822740|P2|COMPLETED|Overall Study||94
1562468|NCT01217892|3822741|P1|COMPLETED|Overall Study||93
1562469|NCT01217892|3822738|P4|STARTED|Overall Study||101
1562470|NCT01217892|3822739|P3|STARTED|Overall Study||99
1562471|NCT01217892|3822740|P2|STARTED|Overall Study||100
1562472|NCT01217892|3822741|P1|STARTED|Overall Study||100
1562473|NCT01217840|3822769|P2|NOT COMPLETED|Overall Study||3
1562474|NCT01217840|3822770|P1|NOT COMPLETED|Overall Study||6
1562475|NCT01217840|3822769|P2|COMPLETED|Overall Study||17
1562476|NCT01217840|3822770|P1|COMPLETED|Overall Study||14
1562477|NCT01217840|3822769|P2|STARTED|Overall Study||20
1562478|NCT01217840|3822770|P1|STARTED|Overall Study||20
1562479|NCT01217827|3822794|P2|NOT COMPLETED|Overall Study||0
1562480|NCT01217827|3822795|P1|NOT COMPLETED|Overall Study||0
1562481|NCT01217827|3822794|P2|COMPLETED|Overall Study||43
1562482|NCT01217827|3822795|P1|COMPLETED|Overall Study||46
1562483|NCT01217827|3822794|P2|STARTED|Overall Study||43
1562484|NCT01217827|3822795|P1|STARTED|Overall Study||46
1562485|NCT01217814|3822804|P3|NOT COMPLETED|Overall Study||1
1562486|NCT01217814|3822805|P2|NOT COMPLETED|Overall Study||1
1562487|NCT01217814|3822806|P1|NOT COMPLETED|Overall Study||1
1562488|NCT01217814|3822804|P3|COMPLETED|Overall Study||6
1562489|NCT01217814|3822805|P2|COMPLETED|Overall Study||4
1562490|NCT01217814|3822806|P1|COMPLETED|Overall Study||3
1562491|NCT01217814|3822804|P3|STARTED|Overall Study||7
1562492|NCT01217814|3822805|P2|STARTED|Overall Study||5
1562493|NCT01217814|3822806|P1|STARTED|Overall Study||4
1562494|NCT01217801|3822832|P2|NOT COMPLETED|Period 2||0
1562495|NCT01217801|3822833|P1|NOT COMPLETED|Period 2||0
1562496|NCT01217801|3822832|P2|COMPLETED|Period 2||22
1562497|NCT01217801|3822833|P1|COMPLETED|Period 2||23
1562498|NCT01217801|3822832|P2|STARTED|Period 2||22
1562499|NCT01217801|3822833|P1|STARTED|Period 2||23
1562500|NCT01217801|3822832|P2|NOT COMPLETED|Period 1||2
1562501|NCT01217801|3822833|P1|NOT COMPLETED|Period 1||1
1562502|NCT01217801|3822832|P2|COMPLETED|Period 1||22
1562503|NCT01217801|3822833|P1|COMPLETED|Period 1||23
1562504|NCT01217801|3822832|P2|STARTED|Period 1||24
1562505|NCT01217801|3822833|P1|STARTED|Period 1||24
1562506|NCT01217749|3822842|P3|NOT COMPLETED|Overall Study||2
1562507|NCT01217749|3822843|P2|NOT COMPLETED|Overall Study||3
1562508|NCT01217749|3822844|P1|NOT COMPLETED|Overall Study||3
1562509|NCT01217749|3822842|P3|COMPLETED|Overall Study||22
1562510|NCT01217749|3822843|P2|COMPLETED|Overall Study||17
1562511|NCT01217749|3822844|P1|COMPLETED|Overall Study||24
1562512|NCT01217749|3822842|P3|STARTED|Overall Study||24
1562513|NCT01217749|3822843|P2|STARTED|Overall Study||20
1562514|NCT01217749|3822844|P1|STARTED|Overall Study||27
1562515|NCT01217606|3822862|P2|NOT COMPLETED|9-Month Masked Extension||11
1562516|NCT01217606|3822863|P1|NOT COMPLETED|9-Month Masked Extension||13
1562517|NCT01217606|3822862|P2|COMPLETED|9-Month Masked Extension||62
1562518|NCT01217606|3822863|P1|COMPLETED|9-Month Masked Extension||54
1562519|NCT01217606|3822862|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
1562520|NCT01217606|3822863|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
1562521|NCT01217606|3822862|P2|STARTED|9-Month Masked Extension||73
1562522|NCT01217606|3822863|P1|STARTED|9-Month Masked Extension||67
1562523|NCT01217606|3822862|P2|NOT COMPLETED|Initial Treatment Phase||12
1562524|NCT01217606|3822863|P1|NOT COMPLETED|Initial Treatment Phase||14
1562525|NCT01217606|3822862|P2|COMPLETED|Initial Treatment Phase||83
1562526|NCT01217606|3822863|P1|COMPLETED|Initial Treatment Phase||76
1562527|NCT01217606|3822862|P2|STARTED|Initial Treatment Phase||95
1562528|NCT01217606|3822863|P1|STARTED|Initial Treatment Phase||90
1562529|NCT01217515|3822876|P3|NOT COMPLETED|Overall Study||10
1562530|NCT01217515|3822877|P2|NOT COMPLETED|Overall Study||8
1562531|NCT01217515|3822878|P1|NOT COMPLETED|Overall Study||7
1562532|NCT01217515|3822876|P3|COMPLETED|Overall Study||145
1562533|NCT01217515|3822877|P2|COMPLETED|Overall Study||148
1562534|NCT01217515|3822878|P1|COMPLETED|Overall Study||147
1562535|NCT01217515|3822876|P3|STARTED|Overall Study||155
1562536|NCT01217515|3822877|P2|STARTED|Overall Study||156
1562537|NCT01217515|3822878|P1|STARTED|Overall Study||154
1562538|NCT01217476|3822894|P2|NOT COMPLETED|Overall Study||7
1562539|NCT01217476|3822895|P1|NOT COMPLETED|Overall Study||12
1562540|NCT01217476|3822894|P2|COMPLETED|Overall Study||95
1562541|NCT01217476|3822895|P1|COMPLETED|Overall Study||93
1562542|NCT01217476|3822894|P2|STARTED|Overall Study||102
1562543|NCT01217476|3822895|P1|STARTED|Overall Study||105
1562544|NCT01217463|3822905|P2|NOT COMPLETED|Overall Study||8
1562545|NCT01217463|3822906|P1|NOT COMPLETED|Overall Study||13
1562546|NCT01217463|3822905|P2|COMPLETED|Overall Study||94
1562547|NCT01217463|3822906|P1|COMPLETED|Overall Study||86
1562548|NCT01217463|3822905|P2|STARTED|Overall Study||102
1562549|NCT01217463|3822906|P1|STARTED|Overall Study||99
1562550|NCT01217411|3822917|P3|NOT COMPLETED|Overall Study||0
1562551|NCT01217411|3822918|P2|NOT COMPLETED|Overall Study||0
1562552|NCT01217411|3822919|P1|NOT COMPLETED|Overall Study||0
1562553|NCT01217411|3822917|P3|COMPLETED|Overall Study||0
1562554|NCT01217411|3822918|P2|COMPLETED|Overall Study||0
1562555|NCT01217411|3822919|P1|COMPLETED|Overall Study||5
1562556|NCT01217411|3822917|P3|STARTED|Overall Study||0
1562557|NCT01217411|3822918|P2|STARTED|Overall Study||0
1562558|NCT01217411|3822919|P1|STARTED|Overall Study||5
1562559|NCT01217307|3822926|P2|NOT COMPLETED|Overall Study||1
1562560|NCT01217307|3822927|P1|NOT COMPLETED|Overall Study||0
1562561|NCT01217307|3822926|P2|COMPLETED|Overall Study||188
1562562|NCT01217307|3822927|P1|COMPLETED|Overall Study||191
1562563|NCT01217307|3822926|P2|STARTED|Overall Study||189
1562564|NCT01217307|3822927|P1|STARTED|Overall Study||191
1562565|NCT01217229|3822933|P1|NOT COMPLETED|Overall Study||0
1562566|NCT01217229|3822933|P1|COMPLETED|Overall Study||20
1562567|NCT01217229|3822933|P1|STARTED|Overall Study||20
1562568|NCT01217112|3822942|P5|NOT COMPLETED|Overall Study||1
1562569|NCT01217112|3822943|P4|NOT COMPLETED|Overall Study||2
1562570|NCT01217112|3822944|P3|NOT COMPLETED|Overall Study||1
1562571|NCT01217112|3822945|P2|NOT COMPLETED|Overall Study||2
1562572|NCT01217112|3822946|P1|NOT COMPLETED|Overall Study||0
1562573|NCT01217112|3822942|P5|COMPLETED|Overall Study||13
1562574|NCT01217112|3822943|P4|COMPLETED|Overall Study||10
1562575|NCT01217112|3822944|P3|COMPLETED|Overall Study||12
1562576|NCT01217112|3822945|P2|COMPLETED|Overall Study||10
1562577|NCT01217112|3822946|P1|COMPLETED|Overall Study||11
1562578|NCT01217112|3822942|P5|STARTED|Overall Study||14
1562579|NCT01217112|3822943|P4|STARTED|Overall Study||12
1562580|NCT01217112|3822944|P3|STARTED|Overall Study||13
1562581|NCT01217112|3822945|P2|STARTED|Overall Study||12
1562582|NCT01217112|3822946|P1|STARTED|Overall Study||11
1562583|NCT01217073|3823179|P8|NOT COMPLETED|Extension Period||20
1562584|NCT01217073|3823180|P7|NOT COMPLETED|Extension Period||91
1562585|NCT01217073|3823181|P6|NOT COMPLETED|Extension Period||0
1562586|NCT01217073|3823182|P5|NOT COMPLETED|Extension Period||0
1562587|NCT01217073|3823183|P4|NOT COMPLETED|Extension Period||0
1562588|NCT01217073|3823184|P3|NOT COMPLETED|Extension Period||0
1562589|NCT01217073|3823185|P2|NOT COMPLETED|Extension Period||0
1562590|NCT01217073|3823186|P1|NOT COMPLETED|Extension Period||0
1562591|NCT01217073|3823179|P8|COMPLETED|Extension Period||60
1562592|NCT01217073|3823180|P7|COMPLETED|Extension Period||314
1562593|NCT01217073|3823181|P6|COMPLETED|Extension Period||0
1562594|NCT01217073|3823182|P5|COMPLETED|Extension Period||0
1562595|NCT01217073|3823183|P4|COMPLETED|Extension Period||0
1562596|NCT01217073|3823184|P3|COMPLETED|Extension Period||0
1562597|NCT01217073|3823185|P2|COMPLETED|Extension Period||0
1562598|NCT01217073|3823186|P1|COMPLETED|Extension Period||0
1562599|NCT01217073|3823179|P8|STARTED|Extension Period||80
1562600|NCT01217073|3823180|P7|STARTED|Extension Period||405
1562601|NCT01217073|3823181|P6|STARTED|Extension Period||0
1562602|NCT01217073|3823182|P5|STARTED|Extension Period||0
1562603|NCT01217073|3823183|P4|STARTED|Extension Period||0
1562604|NCT01217073|3823184|P3|STARTED|Extension Period||0
1562605|NCT01217073|3823185|P2|STARTED|Extension Period||0
1562606|NCT01217073|3823186|P1|STARTED|Extension Period||0
1562607|NCT01217073|3823179|P8|NOT COMPLETED|Base Period||0
1562608|NCT01217073|3823180|P7|NOT COMPLETED|Base Period||0
1562609|NCT01217073|3823181|P6|NOT COMPLETED|Base Period||9
1562610|NCT01217073|3823182|P5|NOT COMPLETED|Base Period||15
1562611|NCT01217073|3823183|P4|NOT COMPLETED|Base Period||2
1562612|NCT01217073|3823184|P3|NOT COMPLETED|Base Period||7
1562613|NCT01217073|3823185|P2|NOT COMPLETED|Base Period||5
1562614|NCT01217073|3823186|P1|NOT COMPLETED|Base Period||7
1562615|NCT01217073|3823179|P8|COMPLETED|Base Period||0
1562616|NCT01217073|3823180|P7|COMPLETED|Base Period||0
1562617|NCT01217073|3823181|P6|COMPLETED|Base Period||105
1562618|NCT01217073|3823182|P5|COMPLETED|Base Period||99
1562619|NCT01217073|3823183|P4|COMPLETED|Base Period||113
1562620|NCT01217073|3823184|P3|COMPLETED|Base Period||107
1562621|NCT01217073|3823185|P2|COMPLETED|Base Period||110
1562622|NCT01217073|3823186|P1|COMPLETED|Base Period||106
1562623|NCT01217073|3823179|P8|STARTED|Base Period||0
1562624|NCT01217073|3823180|P7|STARTED|Base Period||0
1562625|NCT01217073|3823181|P6|STARTED|Base Period||114
1562626|NCT01217073|3823182|P5|STARTED|Base Period||114
1562627|NCT01217073|3823183|P4|STARTED|Base Period||115
1562628|NCT01217073|3823184|P3|STARTED|Base Period||114
1562629|NCT01217073|3823185|P2|STARTED|Base Period||115
1562630|NCT01217073|3823186|P1|STARTED|Base Period||113
1562631|NCT01216943|3823254|P1|NOT COMPLETED|Overall Study||13
1562632|NCT01216943|3823254|P1|COMPLETED|Overall Study||113
1562633|NCT01216943|3823254|P1|STARTED|Overall Study||126
1562634|NCT01216761|3823258|P3|NOT COMPLETED|Overall Study||0
1562635|NCT01216761|3823259|P2|NOT COMPLETED|Overall Study||0
1562636|NCT01216761|3823260|P1|NOT COMPLETED|Overall Study||0
1562637|NCT01216761|3823258|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
1562638|NCT01216761|3823259|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
1562639|NCT01216761|3823260|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
1562640|NCT01216761|3823258|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
1562641|NCT01216761|3823259|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
1562642|NCT01216761|3823260|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
1562643|NCT01216748|3823268|P1|NOT COMPLETED|Overall Study||0
1562644|NCT01216748|3823268|P1|COMPLETED|Overall Study||10
1562645|NCT01216748|3823268|P1|Eucapnic Hyperventilation|Overall Study||10
1562646|NCT01216748|3823268|P1|Hypercapnic Hyperventilation|Overall Study||10
1562647|NCT01216748|3823268|P1|Hypocapnic Hyperventilation|Overall Study||10
1562648|NCT01216748|3823268|P1|Quiet Breathing|Overall Study||10
1562649|NCT01216748|3823268|P1|STARTED|Overall Study||10
1562650|NCT01216735|3823275|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
1562651|NCT01216735|3823276|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
1562652|NCT01216735|3823275|P2|COMPLETED|Second Intervention (3 Weeks)||7
1562653|NCT01216735|3823276|P1|COMPLETED|Second Intervention (3 Weeks)||8
1562654|NCT01216735|3823275|P2|STARTED|Second Intervention (3 Weeks)||7
1562655|NCT01216735|3823276|P1|STARTED|Second Intervention (3 Weeks)||8
1562656|NCT01216735|3823275|P2|NOT COMPLETED|Washout (3 Weeks)||0
1562657|NCT01216735|3823276|P1|NOT COMPLETED|Washout (3 Weeks)||0
1562658|NCT01216735|3823275|P2|COMPLETED|Washout (3 Weeks)||7
1562659|NCT01216735|3823276|P1|COMPLETED|Washout (3 Weeks)||8
1562660|NCT01216735|3823275|P2|STARTED|Washout (3 Weeks)||7
1562661|NCT01216735|3823276|P1|STARTED|Washout (3 Weeks)||8
1562662|NCT01216735|3823275|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
1562663|NCT01216735|3823276|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
1562664|NCT01216735|3823275|P2|COMPLETED|First Intervention (3 Weeks)||7
1562665|NCT01216735|3823276|P1|COMPLETED|First Intervention (3 Weeks)||8
1562666|NCT01216735|3823275|P2|STARTED|First Intervention (3 Weeks)||7
1562667|NCT01216735|3823276|P1|STARTED|First Intervention (3 Weeks)||8
1562668|NCT01216631|3823287|P3|NOT COMPLETED|Overall Study||0
1562669|NCT01216631|3823288|P2|NOT COMPLETED|Overall Study||0
1562670|NCT01216631|3823289|P1|NOT COMPLETED|Overall Study||0
1562671|NCT01216631|3823287|P3|COMPLETED|Overall Study||1
1562672|NCT01216631|3823288|P2|COMPLETED|Overall Study||0
1562673|NCT01216631|3823289|P1|COMPLETED|Overall Study||0
1562674|NCT01216631|3823287|P3|STARTED|Overall Study||1
1562675|NCT01216631|3823288|P2|STARTED|Overall Study||0
1562676|NCT01216631|3823289|P1|STARTED|Overall Study||0
1562677|NCT01216410|3823300|P3|NOT COMPLETED|Overall Study||3
1562678|NCT01216410|3823301|P2|NOT COMPLETED|Overall Study||1
1562679|NCT01216410|3823302|P1|NOT COMPLETED|Overall Study||2
1562680|NCT01216410|3823300|P3|COMPLETED|Overall Study||100
1562681|NCT01216410|3823301|P2|COMPLETED|Overall Study||99
1562682|NCT01216410|3823302|P1|COMPLETED|Overall Study||101
1562683|NCT01216410|3823300|P3|STARTED|Overall Study||103
1562684|NCT01216410|3823301|P2|STARTED|Overall Study||100
1562685|NCT01216410|3823302|P1|STARTED|Overall Study||103
1562686|NCT01216397|3823322|P2|NOT COMPLETED|Period 2||0
1562687|NCT01216397|3823323|P1|NOT COMPLETED|Period 2||0
1562688|NCT01216397|3823322|P2|COMPLETED|Period 2||20
1562689|NCT01216397|3823323|P1|COMPLETED|Period 2||20
1562690|NCT01216397|3823322|P2|STARTED|Period 2||20
1562691|NCT01216397|3823323|P1|STARTED|Period 2||20
1562692|NCT01216397|3823322|P2|NOT COMPLETED|Washout (35 Days)||0
1562693|NCT01216397|3823323|P1|NOT COMPLETED|Washout (35 Days)||0
1562694|NCT01216397|3823322|P2|COMPLETED|Washout (35 Days)||20
1562695|NCT01216397|3823323|P1|COMPLETED|Washout (35 Days)||20
1562696|NCT01216397|3823322|P2|STARTED|Washout (35 Days)||20
1562697|NCT01216397|3823323|P1|STARTED|Washout (35 Days)||20
1562698|NCT01216397|3823322|P2|NOT COMPLETED|Period 1||0
1562699|NCT01216397|3823323|P1|NOT COMPLETED|Period 1||0
1562700|NCT01216397|3823322|P2|COMPLETED|Period 1||20
1562701|NCT01216397|3823323|P1|COMPLETED|Period 1||20
1562702|NCT01216397|3823322|P2|STARTED|Period 1||20
1562703|NCT01216397|3823323|P1|STARTED|Period 1||20
1562704|NCT01216319|3823375|P1|NOT COMPLETED|Overall Study||4
1562705|NCT01216319|3823375|P1|COMPLETED|Overall Study||46
1562706|NCT01216319|3823375|P1|STARTED|Overall Study||50
1562707|NCT01216241|3823382|P2|NOT COMPLETED|Overall Study||0
1562708|NCT01216241|3823383|P1|NOT COMPLETED|Overall Study||0
1562709|NCT01216241|3823382|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
1562710|NCT01216241|3823383|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
1562711|NCT01216241|3823382|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
1562712|NCT01216241|3823383|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
1562713|NCT01216163|3823392|P3|NOT COMPLETED|Overall Study||0
1562714|NCT01216163|3823393|P2|NOT COMPLETED|Overall Study||1
1562715|NCT01216163|3823394|P1|NOT COMPLETED|Overall Study||1
1562716|NCT01216163|3823392|P3|COMPLETED|Overall Study||85
1562717|NCT01216163|3823393|P2|COMPLETED|Overall Study||87
1562718|NCT01216163|3823394|P1|COMPLETED|Overall Study||44
1562719|NCT01216163|3823392|P3|STARTED|Overall Study||85
1562720|NCT01216163|3823393|P2|STARTED|Overall Study||88
1562721|NCT01216163|3823394|P1|STARTED|Overall Study||45
1562722|NCT01216072|3823446|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
1562723|NCT01216072|3823447|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
1562724|NCT01216072|3823446|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
1562725|NCT01216072|3823447|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
1562726|NCT01216072|3823446|P2|Safety Set|Open-Label Extension Period (3 Months)||193
1562727|NCT01216072|3823447|P1|Safety Set|Open-Label Extension Period (3 Months)||0
1562728|NCT01216072|3823446|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
1562729|NCT01216072|3823447|P1|STARTED|Open-Label Extension Period (3 Months)||0
1562730|NCT01216072|3823446|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
1562731|NCT01216072|3823447|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
1562732|NCT01216072|3823446|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
1562733|NCT01216072|3823447|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
1562734|NCT01216072|3823446|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
1562735|NCT01216072|3823447|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
1562736|NCT01216072|3823446|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
1562737|NCT01216072|3823447|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
1562738|NCT01216072|3823446|P2|STARTED|Open-Label Core Period ( 6 Months)||263
1562739|NCT01216072|3823447|P1|STARTED|Open-Label Core Period ( 6 Months)||790
1562740|NCT01215981|3823475|P2|NOT COMPLETED|Overall Study||1
1562741|NCT01215981|3823476|P1|NOT COMPLETED|Overall Study||2
1562742|NCT01215981|3823475|P2|COMPLETED|Overall Study||32
1562743|NCT01215981|3823476|P1|COMPLETED|Overall Study||33
1562744|NCT01215981|3823475|P2|STARTED|Overall Study||33
1562745|NCT01215981|3823476|P1|STARTED|Overall Study||35
1562746|NCT01215968|3823486|P2|NOT COMPLETED|Overall Study||7
1562747|NCT01215968|3823487|P1|NOT COMPLETED|Overall Study||2
1562748|NCT01215968|3823486|P2|COMPLETED|Overall Study||18
1562749|NCT01215968|3823487|P1|COMPLETED|Overall Study||11
1562750|NCT01215968|3823486|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
1562751|NCT01215968|3823487|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
1562752|NCT01215968|3823486|P2|STARTED|Overall Study||25
1562753|NCT01215968|3823487|P1|STARTED|Overall Study||13
1562754|NCT01215955|3823507|P4|NOT COMPLETED|Overall Study||53
1562755|NCT01215955|3823508|P3|NOT COMPLETED|Overall Study||48
1562756|NCT01215955|3823509|P2|NOT COMPLETED|Overall Study||53
1562757|NCT01215955|3823510|P1|NOT COMPLETED|Overall Study||45
1562758|NCT01215955|3823507|P4|COMPLETED|Overall Study||241
1562759|NCT01215955|3823508|P3|COMPLETED|Overall Study||244
1562760|NCT01215955|3823509|P2|COMPLETED|Overall Study||210
1562761|NCT01215955|3823510|P1|COMPLETED|Overall Study||223
1562762|NCT01215955|3823507|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
1562763|NCT01215955|3823508|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
1562764|NCT01215955|3823509|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
1562765|NCT01215955|3823510|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
1562766|NCT01215955|3823507|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
1562767|NCT01215955|3823508|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
1562768|NCT01215955|3823509|P2|STARTED|Overall Study||263
1562769|NCT01215955|3823510|P1|STARTED|Overall Study||268
1562770|NCT01215942|3823578|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||146
1562771|NCT01215942|3823579|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||85
1562772|NCT01215942|3823578|P2|COMPLETED|Post-Treatment Follow-Up Period||445
1562773|NCT01215942|3823579|P1|COMPLETED|Post-Treatment Follow-Up Period||283
1562958|NCT01215110|3824175|P2|COMPLETED|Overall Study||15
1562774|NCT01215942|3823578|P2|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
1562775|NCT01215942|3823579|P1|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
1562776|NCT01215942|3823578|P2|NOT COMPLETED|Treatment Period||672
1562777|NCT01215942|3823579|P1|NOT COMPLETED|Treatment Period||414
1562778|NCT01215942|3823578|P2|COMPLETED|Treatment Period||0
1562779|NCT01215942|3823579|P1|COMPLETED|Treatment Period||0
1562780|NCT01215942|3823578|P2|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
1562781|NCT01215942|3823579|P1|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
1562782|NCT01215929|3823696|P2|NOT COMPLETED|Overall Study||5
1562783|NCT01215929|3823697|P1|NOT COMPLETED|Overall Study||6
1562784|NCT01215929|3823696|P2|COMPLETED|Overall Study||12
1562785|NCT01215929|3823697|P1|COMPLETED|Overall Study||12
1562786|NCT01215929|3823696|P2|STARTED|Overall Study||17
1562787|NCT01215929|3823697|P1|STARTED|Overall Study||18
1562788|NCT01215851|3823709|P6|NOT COMPLETED|Follow up Period||1
1562789|NCT01215851|3823710|P5|NOT COMPLETED|Follow up Period||0
1562790|NCT01215851|3823711|P4|NOT COMPLETED|Follow up Period||0
1562791|NCT01215851|3823712|P3|NOT COMPLETED|Follow up Period||0
1562792|NCT01215851|3823713|P2|NOT COMPLETED|Follow up Period||0
1562793|NCT01215851|3823714|P1|NOT COMPLETED|Follow up Period||0
1562794|NCT01215851|3823709|P6|COMPLETED|Follow up Period||13
1562795|NCT01215851|3823710|P5|COMPLETED|Follow up Period||10
1562796|NCT01215851|3823711|P4|COMPLETED|Follow up Period||12
1562797|NCT01215851|3823712|P3|COMPLETED|Follow up Period||14
1562798|NCT01215851|3823713|P2|COMPLETED|Follow up Period||14
1562799|NCT01215851|3823714|P1|COMPLETED|Follow up Period||14
1562800|NCT01215851|3823709|P6|STARTED|Follow up Period||14
1562801|NCT01215851|3823710|P5|STARTED|Follow up Period||10
1562802|NCT01215851|3823711|P4|STARTED|Follow up Period||12
1562803|NCT01215851|3823712|P3|STARTED|Follow up Period||14
1562804|NCT01215851|3823713|P2|STARTED|Follow up Period||14
1562805|NCT01215851|3823714|P1|STARTED|Follow up Period||14
1562806|NCT01215851|3823709|P6|NOT COMPLETED|Treatment Period||1
1562807|NCT01215851|3823710|P5|NOT COMPLETED|Treatment Period||0
1562808|NCT01215851|3823711|P4|NOT COMPLETED|Treatment Period||3
1562809|NCT01215851|3823712|P3|NOT COMPLETED|Treatment Period||1
1562810|NCT01215851|3823713|P2|NOT COMPLETED|Treatment Period||1
1562811|NCT01215851|3823714|P1|NOT COMPLETED|Treatment Period||1
1562812|NCT01215851|3823709|P6|COMPLETED|Treatment Period||14
1562813|NCT01215851|3823710|P5|COMPLETED|Treatment Period||10
1562814|NCT01215851|3823711|P4|COMPLETED|Treatment Period||12
1562815|NCT01215851|3823712|P3|COMPLETED|Treatment Period||14
1562816|NCT01215851|3823713|P2|COMPLETED|Treatment Period||14
1562817|NCT01215851|3823714|P1|COMPLETED|Treatment Period||14
1562818|NCT01215851|3823709|P6|STARTED|Treatment Period||15
1562819|NCT01215851|3823710|P5|STARTED|Treatment Period||10
1562820|NCT01215851|3823711|P4|STARTED|Treatment Period||15
1562821|NCT01215851|3823712|P3|STARTED|Treatment Period||15
1562822|NCT01215851|3823713|P2|STARTED|Treatment Period||15
1562823|NCT01215851|3823714|P1|STARTED|Treatment Period||15
1562824|NCT01215786|3823755|P3|NOT COMPLETED|Overall Study||0
1562825|NCT01215786|3823756|P2|NOT COMPLETED|Overall Study||0
1562826|NCT01215786|3823757|P1|NOT COMPLETED|Overall Study||0
1562827|NCT01215786|3823755|P3|COMPLETED|Overall Study||10
1562828|NCT01215786|3823756|P2|COMPLETED|Overall Study||19
1562829|NCT01215786|3823757|P1|COMPLETED|Overall Study||21
1562830|NCT01215786|3823755|P3|STARTED|Overall Study||10
1562831|NCT01215786|3823756|P2|STARTED|Overall Study||19
1562832|NCT01215786|3823757|P1|STARTED|Overall Study||21
1562833|NCT01215734|3823773|P2|NOT COMPLETED|Overall Study||1
1562834|NCT01215734|3823774|P1|NOT COMPLETED|Overall Study||0
1562835|NCT01215734|3823773|P2|COMPLETED|Overall Study||14
1562836|NCT01215734|3823774|P1|COMPLETED|Overall Study||29
1562837|NCT01215734|3823773|P2|STARTED|Overall Study||15
1562838|NCT01215734|3823774|P1|STARTED|Overall Study||29
1562839|NCT01215721|3823782|P1|NOT COMPLETED|Overall Study||2
1562840|NCT01215721|3823782|P1|COMPLETED|Overall Study||38
1562841|NCT01215721|3823782|P1|STARTED|Overall Study||40
1562842|NCT01215695|3823788|P2|NOT COMPLETED|Overall Study||0
1562843|NCT01215695|3823789|P1|NOT COMPLETED|Overall Study||0
1562844|NCT01215695|3823788|P2|COMPLETED|Overall Study||70
1562845|NCT01215695|3823789|P1|COMPLETED|Overall Study||70
1562846|NCT01215695|3823788|P2|STARTED|Overall Study||70
1562847|NCT01215695|3823789|P1|STARTED|Overall Study||70
1562848|NCT01215643|3823808|P5|NOT COMPLETED|Overall Study||11
1562849|NCT01215643|3823809|P4|NOT COMPLETED|Overall Study||4
1562850|NCT01215643|3823810|P3|NOT COMPLETED|Overall Study||12
1562851|NCT01215643|3823811|P2|NOT COMPLETED|Overall Study||4
1562852|NCT01215643|3823812|P1|NOT COMPLETED|Overall Study||9
1562853|NCT01215643|3823808|P5|COMPLETED|Overall Study||29
1562854|NCT01215643|3823809|P4|COMPLETED|Overall Study||35
1562855|NCT01215643|3823810|P3|COMPLETED|Overall Study||82
1562856|NCT01215643|3823811|P2|COMPLETED|Overall Study||80
1562857|NCT01215643|3823812|P1|COMPLETED|Overall Study||74
1562858|NCT01215643|3823808|P5|STARTED|Overall Study||40
1562859|NCT01215643|3823809|P4|STARTED|Overall Study||39
1562860|NCT01215643|3823810|P3|STARTED|Overall Study||94
1562861|NCT01215643|3823811|P2|STARTED|Overall Study||84
1562862|NCT01215643|3823812|P1|STARTED|Overall Study||83
1562863|NCT01215513|3823914|P1|NOT COMPLETED|Overall Study||45
1562864|NCT01215513|3823914|P1|COMPLETED|Overall Study||112
1562865|NCT01215513|3823914|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
1562866|NCT01215513|3823914|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
1562867|NCT01215513|3823914|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
1562868|NCT01215513|3823914|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
1562869|NCT01215435|3823923|P2|NOT COMPLETED|Overall Study||16
1562870|NCT01215435|3823924|P1|NOT COMPLETED|Overall Study||19
1562871|NCT01215435|3823923|P2|COMPLETED|Overall Study||107
1562872|NCT01215435|3823924|P1|COMPLETED|Overall Study||103
1562873|NCT01215435|3823923|P2|STARTED|Overall Study||123
1562874|NCT01215435|3823924|P1|STARTED|Overall Study||122
1562875|NCT01215422|3823938|P4|NOT COMPLETED|Overall Study||8
1562876|NCT01215422|3823939|P3|NOT COMPLETED|Overall Study||3
1562877|NCT01215422|3823940|P2|NOT COMPLETED|Overall Study||0
1562878|NCT01215422|3823941|P1|NOT COMPLETED|Overall Study||8
1562879|NCT01215422|3823938|P4|COMPLETED|Overall Study||193
1562880|NCT01215422|3823939|P3|COMPLETED|Overall Study||193
1562881|NCT01215422|3823940|P2|COMPLETED|Overall Study||249
1562882|NCT01215422|3823941|P1|COMPLETED|Overall Study||6
1562883|NCT01215422|3823938|P4|STARTED|Overall Study||201
1562884|NCT01215422|3823939|P3|STARTED|Overall Study||196
1562885|NCT01215422|3823940|P2|STARTED|Overall Study||249
1562886|NCT01215422|3823941|P1|STARTED|Overall Study||14
1562887|NCT01215357|3823963|P1|NOT COMPLETED|Overall Study||12
1562888|NCT01215357|3823963|P1|COMPLETED|Overall Study||22
1562889|NCT01215357|3823963|P1|STARTED|Overall Study||34
1562890|NCT01215344|3823969|P2|NOT COMPLETED|Overall Study||0
1562891|NCT01215344|3823970|P1|NOT COMPLETED|Overall Study||10
1562892|NCT01215344|3823969|P2|COMPLETED|Overall Study||3
1562893|NCT01215344|3823970|P1|COMPLETED|Overall Study||23
1562894|NCT01215344|3823969|P2|STARTED|Overall Study||3
1562895|NCT01215344|3823970|P1|STARTED|Overall Study||33
1562896|NCT01215292|3823983|P5|NOT COMPLETED|Overall Study||0
1562897|NCT01215292|3823984|P4|NOT COMPLETED|Overall Study||0
1562898|NCT01215292|3823985|P3|NOT COMPLETED|Overall Study||0
1562899|NCT01215292|3823986|P2|NOT COMPLETED|Overall Study||0
1562900|NCT01215292|3823987|P1|NOT COMPLETED|Overall Study||0
1562901|NCT01215292|3823983|P5|COMPLETED|Overall Study||8
1562902|NCT01215292|3823984|P4|COMPLETED|Overall Study||8
1562903|NCT01215292|3823985|P3|COMPLETED|Overall Study||8
1562904|NCT01215292|3823986|P2|COMPLETED|Overall Study||8
1562905|NCT01215292|3823987|P1|COMPLETED|Overall Study||8
1562906|NCT01215292|3823983|P5|STARTED|Overall Study||8
1562907|NCT01215292|3823984|P4|STARTED|Overall Study||8
1562908|NCT01215292|3823985|P3|STARTED|Overall Study||8
1562909|NCT01215292|3823986|P2|STARTED|Overall Study||8
1562910|NCT01215292|3823987|P1|STARTED|Overall Study||8
1562911|NCT01215279|3824011|P2|NOT COMPLETED|Overall Study||0
1562912|NCT01215279|3824012|P1|NOT COMPLETED|Overall Study||0
1562913|NCT01215279|3824011|P2|COMPLETED|Overall Study||32
1562914|NCT01215279|3824012|P1|COMPLETED|Overall Study||31
1562915|NCT01215279|3824011|P2|STARTED|Overall Study||32
1562916|NCT01215279|3824012|P1|STARTED|Overall Study||31
1562917|NCT01215253|3824078|P2|NOT COMPLETED|Overall Study||63
1562918|NCT01215253|3824079|P1|NOT COMPLETED|Overall Study||86
1562919|NCT01215253|3824078|P2|COMPLETED|Overall Study||439
1562920|NCT01215253|3824079|P1|COMPLETED|Overall Study||424
1562921|NCT01215253|3824078|P2|STARTED|Overall Study||502
1562922|NCT01215253|3824079|P1|STARTED|Overall Study||510
1562923|NCT01215227|3824113|P6|NOT COMPLETED|Overall Study||58
1562924|NCT01215227|3824114|P5|NOT COMPLETED|Overall Study||48
1562925|NCT01215227|3824115|P4|NOT COMPLETED|Overall Study||49
1562926|NCT01215227|3824116|P3|NOT COMPLETED|Overall Study||57
1562927|NCT01215227|3824117|P2|NOT COMPLETED|Overall Study||119
1562928|NCT01215227|3824118|P1|NOT COMPLETED|Overall Study||121
1562929|NCT01215227|3824113|P6|COMPLETED|Overall Study||51
1562930|NCT01215227|3824114|P5|COMPLETED|Overall Study||45
1562931|NCT01215227|3824115|P4|COMPLETED|Overall Study||48
1562932|NCT01215227|3824116|P3|COMPLETED|Overall Study||50
1562933|NCT01215227|3824117|P2|COMPLETED|Overall Study||96
1562934|NCT01215227|3824118|P1|COMPLETED|Overall Study||97
1562935|NCT01215227|3824113|P6|Treated|Overall Study||108
1562936|NCT01215227|3824114|P5|Treated|Overall Study||93
1562937|NCT01215227|3824115|P4|Treated|Overall Study||96
1562938|NCT01215227|3824116|P3|Treated|Overall Study||106
1562939|NCT01215227|3824117|P2|Treated|Overall Study||215
1562940|NCT01215227|3824118|P1|Treated|Overall Study||218
1562941|NCT01215227|3824113|P6|STARTED|Overall Study||109
1562942|NCT01215227|3824114|P5|STARTED|Overall Study||93
1562943|NCT01215227|3824115|P4|STARTED|Overall Study||97
1562944|NCT01215227|3824116|P3|STARTED|Overall Study||107
1562945|NCT01215227|3824117|P2|STARTED|Overall Study||215
1562946|NCT01215227|3824118|P1|STARTED|Overall Study||218
1562947|NCT01215123|3824162|P1|NOT COMPLETED|Overall Study||0
1562948|NCT01215123|3824162|P1|COMPLETED|Overall Study||28
1562949|NCT01215123|3824162|P1|STARTED|Overall Study||28
1562950|NCT01215110|3824172|P5|NOT COMPLETED|Overall Study||0
1562951|NCT01215110|3824173|P4|NOT COMPLETED|Overall Study||1
1562952|NCT01215110|3824174|P3|NOT COMPLETED|Overall Study||2
1562953|NCT01215110|3824175|P2|NOT COMPLETED|Overall Study||0
1562954|NCT01215110|3824176|P1|NOT COMPLETED|Overall Study||0
1562955|NCT01215110|3824172|P5|COMPLETED|Overall Study||8
1562956|NCT01215110|3824173|P4|COMPLETED|Overall Study||14
1562957|NCT01215110|3824174|P3|COMPLETED|Overall Study||13
1562959|NCT01215110|3824176|P1|COMPLETED|Overall Study||15
1562960|NCT01215110|3824172|P5|STARTED|Overall Study||8
1562961|NCT01215110|3824173|P4|STARTED|Overall Study||15
1562962|NCT01215110|3824174|P3|STARTED|Overall Study||15
1562963|NCT01215110|3824175|P2|STARTED|Overall Study||15
1562964|NCT01215110|3824176|P1|STARTED|Overall Study||15
1562965|NCT01215097|3824237|P2|NOT COMPLETED|Overall Study||14
1562966|NCT01215097|3824238|P1|NOT COMPLETED|Overall Study||12
1562967|NCT01215097|3824237|P2|COMPLETED|Overall Study||191
1562968|NCT01215097|3824238|P1|COMPLETED|Overall Study||88
1562969|NCT01215097|3824237|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
1562970|NCT01215097|3824238|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
1562971|NCT01215032|3824270|P1|NOT COMPLETED|Overall Study||20
1562972|NCT01215032|3824270|P1|COMPLETED|Overall Study||1
1562973|NCT01215032|3824270|P1|STARTED|Overall Study||21
1562974|NCT01214980|3824280|P2|NOT COMPLETED|Overall Study||2
1562975|NCT01214980|3824281|P1|NOT COMPLETED|Overall Study||3
1562976|NCT01214980|3824280|P2|COMPLETED|Overall Study||14
1562977|NCT01214980|3824281|P1|COMPLETED|Overall Study||13
1562978|NCT01214980|3824280|P2|STARTED|Overall Study||16
1562979|NCT01214980|3824281|P1|STARTED|Overall Study||16
1562980|NCT01214915|3824295|P1|NOT COMPLETED|Overall Study||11
1562981|NCT01214915|3824295|P1|COMPLETED|Overall Study||42
1562982|NCT01214915|3824295|P1|STARTED|Overall Study||53
1562983|NCT01214850|3824306|P3|NOT COMPLETED|Overall Study||161
1562984|NCT01214850|3824307|P2|NOT COMPLETED|Overall Study||144
1562985|NCT01214850|3824308|P1|NOT COMPLETED|Overall Study||183
1562986|NCT01214850|3824306|P3|COMPLETED|Overall Study||826
1562987|NCT01214850|3824307|P2|COMPLETED|Overall Study||844
1562988|NCT01214850|3824308|P1|COMPLETED|Overall Study||796
1562989|NCT01214850|3824306|P3|STARTED|Overall Study||987
1562990|NCT01214850|3824307|P2|STARTED|Overall Study||988
1562991|NCT01214850|3824308|P1|STARTED|Overall Study||979
1562992|NCT01214837|3824392|P3|NOT COMPLETED|Overall Study||62
1562993|NCT01214837|3824393|P2|NOT COMPLETED|Overall Study||64
1562994|NCT01214837|3824394|P1|NOT COMPLETED|Overall Study||54
1562995|NCT01214837|3824392|P3|COMPLETED|Overall Study||184
1562996|NCT01214837|3824393|P2|COMPLETED|Overall Study||192
1562997|NCT01214837|3824394|P1|COMPLETED|Overall Study||195
1562998|NCT01214837|3824392|P3|STARTED|Overall Study||246
1562999|NCT01214837|3824393|P2|STARTED|Overall Study||256
1563000|NCT01214837|3824394|P1|STARTED|Overall Study||249
1563001|NCT01214824|3824431|P1|NOT COMPLETED|Overall Study||3
1563002|NCT01214824|3824431|P1|COMPLETED|Overall Study||29
1563003|NCT01214824|3824431|P1|STARTED|Overall Study||32
1563004|NCT01214811|3824438|P1|NOT COMPLETED|Overall Study||3
1563005|NCT01214811|3824438|P1|COMPLETED|Overall Study||24
1563006|NCT01214811|3824438|P1|STARTED|Overall Study||27
1563007|NCT01214759|3824442|P1|NOT COMPLETED|Overall Study||48
1563008|NCT01214759|3824442|P1|COMPLETED|Overall Study||55
1563009|NCT01214759|3824442|P1|28 Days nPEP Completion|Overall Study||85
1563010|NCT01214759|3824442|P1|STARTED|Overall Study||103
1563011|NCT01214720|3824450|P2|NOT COMPLETED|Overall Study||68
1563012|NCT01214720|3824451|P1|NOT COMPLETED|Overall Study||85
1563013|NCT01214720|3824450|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
1563014|NCT01214720|3824451|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
1563015|NCT01214720|3824450|P2|STARTED|Overall Study||301
1563016|NCT01214720|3824451|P1|STARTED|Overall Study||306
1563017|NCT01214668|3824474|P6|NOT COMPLETED|Overall Study||6
1563018|NCT01214668|3824475|P5|NOT COMPLETED|Overall Study||6
1563019|NCT01214668|3824476|P4|NOT COMPLETED|Overall Study||6
1563020|NCT01214668|3824477|P3|NOT COMPLETED|Overall Study||6
1563021|NCT01214668|3824478|P2|NOT COMPLETED|Overall Study||3
1563022|NCT01214668|3824479|P1|NOT COMPLETED|Overall Study||4
1563023|NCT01214668|3824474|P6|COMPLETED|Overall Study||0
1563024|NCT01214668|3824475|P5|COMPLETED|Overall Study||0
1563025|NCT01214668|3824476|P4|COMPLETED|Overall Study||0
1563026|NCT01214668|3824477|P3|COMPLETED|Overall Study||0
1563027|NCT01214668|3824478|P2|COMPLETED|Overall Study||0
1563028|NCT01214668|3824479|P1|COMPLETED|Overall Study||0
1563029|NCT01214668|3824474|P6|Received at Least One Dose of Study Drug|Overall Study||6
1563030|NCT01214668|3824475|P5|Received at Least One Dose of Study Drug|Overall Study||6
1563031|NCT01214668|3824476|P4|Received at Least One Dose of Study Drug|Overall Study||6
1563032|NCT01214668|3824477|P3|Received at Least One Dose of Study Drug|Overall Study||6
1563033|NCT01214668|3824478|P2|Received at Least One Dose of Study Drug|Overall Study||3
1563034|NCT01214668|3824479|P1|Received at Least One Dose of Study Drug|Overall Study||4
1563035|NCT01214668|3824474|P6|STARTED|Overall Study||6
1563036|NCT01214668|3824475|P5|STARTED|Overall Study||6
1563037|NCT01214668|3824476|P4|STARTED|Overall Study||6
1563038|NCT01214668|3824477|P3|STARTED|Overall Study||6
1563039|NCT01214668|3824478|P2|STARTED|Overall Study||3
1563040|NCT01214668|3824479|P1|STARTED|Overall Study||4
1563041|NCT01214642|3824525|P12|NOT COMPLETED|Overall Study||6
1563042|NCT01214642|3824526|P11|NOT COMPLETED|Overall Study||4
1563043|NCT01214642|3824527|P10|NOT COMPLETED|Overall Study||4
1563044|NCT01214642|3824528|P9|NOT COMPLETED|Overall Study||13
1563045|NCT01214642|3824529|P8|NOT COMPLETED|Overall Study||3
1563046|NCT01214642|3824530|P7|NOT COMPLETED|Overall Study||6
1563047|NCT01214642|3824531|P6|NOT COMPLETED|Overall Study||3
1563048|NCT01214642|3824532|P5|NOT COMPLETED|Overall Study||6
1563049|NCT01214642|3824533|P4|NOT COMPLETED|Overall Study||6
1563050|NCT01214642|3824534|P3|NOT COMPLETED|Overall Study||6
1563051|NCT01214642|3824535|P2|NOT COMPLETED|Overall Study||3
1563052|NCT01214642|3824536|P1|NOT COMPLETED|Overall Study||3
1563053|NCT01214642|3824525|P12|COMPLETED|Overall Study||0
1563054|NCT01214642|3824526|P11|COMPLETED|Overall Study||0
1563055|NCT01214642|3824527|P10|COMPLETED|Overall Study||0
1563056|NCT01214642|3824528|P9|COMPLETED|Overall Study||0
1563057|NCT01214642|3824529|P8|COMPLETED|Overall Study||0
1563058|NCT01214642|3824530|P7|COMPLETED|Overall Study||0
1563059|NCT01214642|3824531|P6|COMPLETED|Overall Study||0
1563060|NCT01214642|3824532|P5|COMPLETED|Overall Study||0
1563061|NCT01214642|3824533|P4|COMPLETED|Overall Study||0
1563062|NCT01214642|3824534|P3|COMPLETED|Overall Study||0
1563063|NCT01214642|3824535|P2|COMPLETED|Overall Study||0
1563064|NCT01214642|3824536|P1|COMPLETED|Overall Study||0
1563065|NCT01214642|3824525|P12|Complete at Least 2 Cycles of Study Drug|Overall Study||5
1563066|NCT01214642|3824526|P11|Complete at Least 2 Cycles of Study Drug|Overall Study||2
1563067|NCT01214642|3824527|P10|Complete at Least 2 Cycles of Study Drug|Overall Study||2
1563068|NCT01214642|3824528|P9|Complete at Least 2 Cycles of Study Drug|Overall Study||12
1563069|NCT01214642|3824529|P8|Complete at Least 2 Cycles of Study Drug|Overall Study||3
1563070|NCT01214642|3824530|P7|Complete at Least 2 Cycles of Study Drug|Overall Study||6
1563071|NCT01214642|3824531|P6|Complete at Least 2 Cycles of Study Drug|Overall Study||1
1563072|NCT01214642|3824532|P5|Complete at Least 2 Cycles of Study Drug|Overall Study||6
1563073|NCT01214642|3824533|P4|Complete at Least 2 Cycles of Study Drug|Overall Study||4
1563074|NCT01214642|3824534|P3|Complete at Least 2 Cycles of Study Drug|Overall Study||5
1563075|NCT01214642|3824535|P2|Complete at Least 2 Cycles of Study Drug|Overall Study||1
1563076|NCT01214642|3824536|P1|Complete at Least 2 Cycles of Study Drug|Overall Study||3
1563077|NCT01214642|3824525|P12|Received at Least 1 Dose of Study Drug|Overall Study||6
1563078|NCT01214642|3824526|P11|Received at Least 1 Dose of Study Drug|Overall Study||4
1563079|NCT01214642|3824527|P10|Received at Least 1 Dose of Study Drug|Overall Study||4
1563080|NCT01214642|3824528|P9|Received at Least 1 Dose of Study Drug|Overall Study||13
1563081|NCT01214642|3824529|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
1563082|NCT01214642|3824530|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
1563083|NCT01214642|3824531|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
1563084|NCT01214642|3824532|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
1563085|NCT01214642|3824533|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
1563086|NCT01214642|3824534|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1563087|NCT01214642|3824535|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
1563088|NCT01214642|3824536|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1563089|NCT01214642|3824525|P12|STARTED|Overall Study||6
1563090|NCT01214642|3824526|P11|STARTED|Overall Study||4
1563091|NCT01214642|3824527|P10|STARTED|Overall Study||4
1563092|NCT01214642|3824528|P9|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
1563093|NCT01214642|3824529|P8|STARTED|Overall Study||3
1563094|NCT01214642|3824530|P7|STARTED|Overall Study||6
1563095|NCT01214642|3824531|P6|STARTED|Overall Study||3
1563096|NCT01214642|3824532|P5|STARTED|Overall Study||6
1563097|NCT01214642|3824533|P4|STARTED|Overall Study||6
1563098|NCT01214642|3824534|P3|STARTED|Overall Study||6
1563099|NCT01214642|3824535|P2|STARTED|Overall Study||3
1563100|NCT01214642|3824536|P1|STARTED|Overall Study||3
1563101|NCT01214629|3824616|P11|NOT COMPLETED|Overall Study||2
1563102|NCT01214629|3824617|P10|NOT COMPLETED|Overall Study||7
1563103|NCT01214629|3824618|P9|NOT COMPLETED|Overall Study||1
1563104|NCT01214629|3824619|P8|NOT COMPLETED|Overall Study||1
1563105|NCT01214629|3824620|P7|NOT COMPLETED|Overall Study||1
1563106|NCT01214629|3824621|P6|NOT COMPLETED|Overall Study||4
1563107|NCT01214629|3824622|P5|NOT COMPLETED|Overall Study||2
1563108|NCT01214629|3824623|P4|NOT COMPLETED|Overall Study||2
1563109|NCT01214629|3824624|P3|NOT COMPLETED|Overall Study||0
1563110|NCT01214629|3824625|P2|NOT COMPLETED|Overall Study||1
1563111|NCT01214629|3824626|P1|NOT COMPLETED|Overall Study||1
1563112|NCT01214629|3824616|P11|COMPLETED|Overall Study||1
1563113|NCT01214629|3824617|P10|COMPLETED|Overall Study||11
1563114|NCT01214629|3824618|P9|COMPLETED|Overall Study||2
1563115|NCT01214629|3824619|P8|COMPLETED|Overall Study||2
1563116|NCT01214629|3824620|P7|COMPLETED|Overall Study||4
1563117|NCT01214629|3824621|P6|COMPLETED|Overall Study||9
1563118|NCT01214629|3824622|P5|COMPLETED|Overall Study||1
1563119|NCT01214629|3824623|P4|COMPLETED|Overall Study||1
1563120|NCT01214629|3824624|P3|COMPLETED|Overall Study||1
1563121|NCT01214629|3824625|P2|COMPLETED|Overall Study||0
1563122|NCT01214629|3824626|P1|COMPLETED|Overall Study||0
1563123|NCT01214629|3824616|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
1563124|NCT01214629|3824617|P10|Received at Least 1 Dose of Study Drug|Overall Study||18
1563125|NCT01214629|3824618|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
1563126|NCT01214629|3824619|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
1563127|NCT01214629|3824620|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
1563128|NCT01214629|3824621|P6|Received at Least 1 Dose of Study Drug|Overall Study||13
1563129|NCT01214629|3824622|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
1563130|NCT01214629|3824623|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
1563131|NCT01214629|3824624|P3|Received at Least 1 Dose of Study Drug|Overall Study||1
1563132|NCT01214629|3824625|P2|Received at Least 1 Dose of Study Drug|Overall Study||1
1563133|NCT01214629|3824626|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
1563134|NCT01214629|3824616|P11|STARTED|Overall Study||3
1563135|NCT01214629|3824617|P10|STARTED|Overall Study||18
1563136|NCT01214629|3824618|P9|STARTED|Overall Study||3
1563137|NCT01214629|3824619|P8|STARTED|Overall Study||3
1563138|NCT01214629|3824620|P7|STARTED|Overall Study||5
1563139|NCT01214629|3824621|P6|STARTED|Overall Study||13
1563140|NCT01214629|3824622|P5|STARTED|Overall Study||3
1563141|NCT01214629|3824623|P4|STARTED|Overall Study||3
1563142|NCT01214629|3824624|P3|STARTED|Overall Study||1
1563143|NCT01214629|3824625|P2|STARTED|Overall Study||1
1563144|NCT01214629|3824626|P1|STARTED|Overall Study||1
1563145|NCT01214616|3824691|P4|NOT COMPLETED|Overall Study||6
1563146|NCT01214616|3824692|P3|NOT COMPLETED|Overall Study||3
1563147|NCT01214616|3824693|P2|NOT COMPLETED|Overall Study||5
1563148|NCT01214616|3824694|P1|NOT COMPLETED|Overall Study||3
1563149|NCT01214616|3824691|P4|COMPLETED|Overall Study||0
1563150|NCT01214616|3824692|P3|COMPLETED|Overall Study||0
1563151|NCT01214616|3824693|P2|COMPLETED|Overall Study||0
1563152|NCT01214616|3824694|P1|COMPLETED|Overall Study||0
1563153|NCT01214616|3824691|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
1563154|NCT01214616|3824692|P3|STARTED|Overall Study||3
1563155|NCT01214616|3824693|P2|STARTED|Overall Study||5
1563156|NCT01214616|3824694|P1|STARTED|Overall Study||3
1563157|NCT01214603|3824731|P3|NOT COMPLETED|Overall Study||4
1563158|NCT01214603|3824732|P2|NOT COMPLETED|Overall Study||1
1563159|NCT01214603|3824733|P1|NOT COMPLETED|Overall Study||5
1563160|NCT01214603|3824731|P3|COMPLETED|Overall Study||3
1563161|NCT01214603|3824732|P2|COMPLETED|Overall Study||5
1563162|NCT01214603|3824733|P1|COMPLETED|Overall Study||2
1563163|NCT01214603|3824731|P3|Received at Least 1 Dose of LY2090314|Overall Study||7
1563164|NCT01214603|3824732|P2|Received at Least 1 Dose of LY2090314|Overall Study||6
1563165|NCT01214603|3824733|P1|Received at Least 1 Dose of LY2090314|Overall Study||7
1563166|NCT01214603|3824731|P3|STARTED|Overall Study||7
1563167|NCT01214603|3824732|P2|STARTED|Overall Study||6
1563168|NCT01214603|3824733|P1|STARTED|Overall Study||7
1563169|NCT01214434|3824756|P2|NOT COMPLETED|Overall Study||2
1563170|NCT01214434|3824757|P1|NOT COMPLETED|Overall Study||4
1563171|NCT01214434|3824756|P2|COMPLETED|Overall Study||25
1563172|NCT01214434|3824757|P1|COMPLETED|Overall Study||11
1563173|NCT01214434|3824756|P2|STARTED|Overall Study||27
1563174|NCT01214434|3824757|P1|STARTED|Overall Study||15
1563175|NCT01214395|3824773|P1|NOT COMPLETED|Overall Study||5
1563176|NCT01214395|3824773|P1|COMPLETED|Overall Study||0
1563177|NCT01214395|3824773|P1|STARTED|Overall Study||5
1563178|NCT01214356|3824780|P2|NOT COMPLETED|Overall Study||14
1563179|NCT01214356|3824781|P1|NOT COMPLETED|Overall Study||17
1563180|NCT01214356|3824780|P2|COMPLETED|Overall Study||13
1563181|NCT01214356|3824781|P1|COMPLETED|Overall Study||10
1563182|NCT01214356|3824780|P2|STARTED|Overall Study||27
1563183|NCT01214356|3824781|P1|STARTED|Overall Study||27
1563184|NCT01214330|3824787|P1|NOT COMPLETED|Overall Study||48
1563185|NCT01214330|3824787|P1|COMPLETED|Overall Study||102
1563186|NCT01214330|3824787|P1|STARTED|Overall Study||150
1563187|NCT01214252|3824791|P1|NOT COMPLETED|Overall Study||82
1563188|NCT01214252|3824791|P1|COMPLETED|Overall Study||343
1563189|NCT01214252|3824791|P1|STARTED|Overall Study||425
1563190|NCT01214239|3824799|P2|NOT COMPLETED|Overall Study||18
1563191|NCT01214239|3824800|P1|NOT COMPLETED|Overall Study||12
1563192|NCT01214239|3824799|P2|COMPLETED|Overall Study||182
1563193|NCT01214239|3824800|P1|COMPLETED|Overall Study||87
1563194|NCT01214239|3824799|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
1563195|NCT01214239|3824800|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
1563196|NCT01214187|3824834|P2|NOT COMPLETED|Overall Study||6
1563197|NCT01214187|3824835|P1|NOT COMPLETED|Overall Study||7
1563198|NCT01214187|3824834|P2|COMPLETED|Overall Study||23
1563199|NCT01214187|3824835|P1|COMPLETED|Overall Study||22
1563200|NCT01214187|3824834|P2|STARTED|Overall Study||29
1563201|NCT01214187|3824835|P1|STARTED|Overall Study||29
1563202|NCT01214174|3824852|P3|NOT COMPLETED|Overall Study||1
1563203|NCT01214174|3824853|P2|NOT COMPLETED|Overall Study||0
1563204|NCT01214174|3824854|P1|NOT COMPLETED|Overall Study||0
1563205|NCT01214174|3824852|P3|COMPLETED|Overall Study||13
1563206|NCT01214174|3824853|P2|COMPLETED|Overall Study||16
1563207|NCT01214174|3824854|P1|COMPLETED|Overall Study||13
1563208|NCT01214174|3824852|P3|STARTED|Overall Study||14
1563209|NCT01214174|3824853|P2|STARTED|Overall Study||16
1563210|NCT01214174|3824854|P1|STARTED|Overall Study||13
1563211|NCT01214161|3824864|P2|NOT COMPLETED|Overall Study||0
1563212|NCT01214161|3824865|P1|NOT COMPLETED|Overall Study||0
1563213|NCT01214161|3824864|P2|COMPLETED|Overall Study||100
1563214|NCT01214161|3824865|P1|COMPLETED|Overall Study||100
1563215|NCT01214161|3824864|P2|STARTED|Overall Study||100
1563216|NCT01214161|3824865|P1|STARTED|Overall Study||100
1563217|NCT01214109|3824875|P4|NOT COMPLETED|Overall Study||0
1563218|NCT01214109|3824876|P3|NOT COMPLETED|Overall Study||0
1563219|NCT01214109|3824877|P2|NOT COMPLETED|Overall Study||0
1563220|NCT01214109|3824878|P1|NOT COMPLETED|Overall Study||0
1563221|NCT01214109|3824875|P4|COMPLETED|Overall Study||24
1563222|NCT01214109|3824876|P3|COMPLETED|Overall Study||24
1563223|NCT01214109|3824877|P2|COMPLETED|Overall Study||24
1563224|NCT01214109|3824878|P1|COMPLETED|Overall Study||24
1563225|NCT01214109|3824875|P4|STARTED|Overall Study||24
1563226|NCT01214109|3824876|P3|STARTED|Overall Study||24
1563227|NCT01214109|3824877|P2|STARTED|Overall Study||24
1563228|NCT01214109|3824878|P1|STARTED|Overall Study||24
1563229|NCT01214083|3824970|P3|NOT COMPLETED|Overall Study||10
1563230|NCT01214083|3824971|P2|NOT COMPLETED|Overall Study||10
1563231|NCT01214083|3824972|P1|NOT COMPLETED|Overall Study||12
1563232|NCT01214083|3824970|P3|COMPLETED|Overall Study||21
1563233|NCT01214083|3824971|P2|COMPLETED|Overall Study||23
1563234|NCT01214083|3824972|P1|COMPLETED|Overall Study||19
1563235|NCT01214083|3824970|P3|STARTED|Overall Study||31
1563236|NCT01214083|3824971|P2|STARTED|Overall Study||33
1563237|NCT01214083|3824972|P1|STARTED|Overall Study||31
1563238|NCT01213966|3825008|P4|NOT COMPLETED|Overall Study||1
1563239|NCT01213966|3825009|P3|NOT COMPLETED|Overall Study||3
1563240|NCT01213966|3825010|P2|NOT COMPLETED|Overall Study||0
1563241|NCT01213966|3825011|P1|NOT COMPLETED|Overall Study||1
1563242|NCT01213966|3825008|P4|COMPLETED|Overall Study||20
1563243|NCT01213966|3825009|P3|COMPLETED|Overall Study||17
1563244|NCT01213966|3825010|P2|COMPLETED|Overall Study||20
1563245|NCT01213966|3825011|P1|COMPLETED|Overall Study||19
1563246|NCT01213966|3825008|P4|STARTED|Overall Study||21
1563247|NCT01213966|3825009|P3|STARTED|Overall Study||20
1563248|NCT01213966|3825010|P2|STARTED|Overall Study||20
1563249|NCT01213966|3825011|P1|STARTED|Overall Study||20
1563250|NCT01213836|3825023|P2|NOT COMPLETED|Period 2, Second Intervention||0
1563251|NCT01213836|3825024|P1|NOT COMPLETED|Period 2, Second Intervention||0
1563252|NCT01213836|3825023|P2|COMPLETED|Period 2, Second Intervention||29
1563253|NCT01213836|3825024|P1|COMPLETED|Period 2, Second Intervention||31
1563254|NCT01213836|3825023|P2|STARTED|Period 2, Second Intervention||29
1563255|NCT01213836|3825024|P1|STARTED|Period 2, Second Intervention||31
1563256|NCT01213836|3825023|P2|NOT COMPLETED|Period 1, First Intervention||3
1563257|NCT01213836|3825024|P1|NOT COMPLETED|Period 1, First Intervention||3
1563258|NCT01213836|3825023|P2|COMPLETED|Period 1, First Intervention||29
1563259|NCT01213836|3825024|P1|COMPLETED|Period 1, First Intervention||31
1563260|NCT01213836|3825023|P2|STARTED|Period 1, First Intervention||32
1563261|NCT01213836|3825024|P1|STARTED|Period 1, First Intervention||34
1563262|NCT01213823|3825044|P2|NOT COMPLETED|Overall Study||0
1563263|NCT01213823|3825045|P1|NOT COMPLETED|Overall Study||0
1563264|NCT01213823|3825044|P2|COMPLETED|Overall Study||467
1563265|NCT01213823|3825045|P1|COMPLETED|Overall Study||69
1563266|NCT01213823|3825044|P2|STARTED|Overall Study||467
1563267|NCT01213823|3825045|P1|STARTED|Overall Study||69
1563268|NCT01213706|3825051|P1|NOT COMPLETED|WBPA||0
1563269|NCT01213706|3825051|P1|COMPLETED|WBPA||45
1563270|NCT01213706|3825051|P1|STARTED|WBPA||45
1563271|NCT01213706|3825051|P1|NOT COMPLETED|Washout (1 Hour)||0
1563272|NCT01213706|3825051|P1|COMPLETED|Washout (1 Hour)||45
1563273|NCT01213706|3825051|P1|STARTED|Washout (1 Hour)||45
1563274|NCT01213706|3825051|P1|NOT COMPLETED|Sham WBPA||0
1563275|NCT01213706|3825051|P1|COMPLETED|Sham WBPA||45
1563276|NCT01213706|3825051|P1|STARTED|Sham WBPA||45
1563277|NCT01213589|3825060|P3|NOT COMPLETED|Overall Study||8
1563278|NCT01213589|3825061|P2|NOT COMPLETED|Overall Study||5
1563279|NCT01213589|3825062|P1|NOT COMPLETED|Overall Study||13
1563280|NCT01213589|3825060|P3|COMPLETED|Overall Study||18
1563281|NCT01213589|3825061|P2|COMPLETED|Overall Study||19
1563282|NCT01213589|3825062|P1|COMPLETED|Overall Study||37
1563283|NCT01213589|3825060|P3|STARTED|Overall Study||26
1563284|NCT01213589|3825061|P2|STARTED|Overall Study||24
1563285|NCT01213589|3825062|P1|STARTED|Overall Study||50
1563286|NCT01213576|3825092|P4|NOT COMPLETED|Overall Study||4
1563287|NCT01213576|3825093|P3|NOT COMPLETED|Overall Study||5
1563288|NCT01213576|3825094|P2|NOT COMPLETED|Overall Study||4
1563289|NCT01213576|3825095|P1|NOT COMPLETED|Overall Study||3
1563290|NCT01213576|3825092|P4|COMPLETED|Overall Study||13
1563291|NCT01213576|3825093|P3|COMPLETED|Overall Study||13
1563292|NCT01213576|3825094|P2|COMPLETED|Overall Study||13
1563293|NCT01213576|3825095|P1|COMPLETED|Overall Study||15
1563294|NCT01213576|3825092|P4|STARTED|Overall Study||17
1563295|NCT01213576|3825093|P3|STARTED|Overall Study||18
1563296|NCT01213576|3825094|P2|STARTED|Overall Study||17
1563297|NCT01213576|3825095|P1|STARTED|Overall Study||18
1563298|NCT01213329|3825111|P2|NOT COMPLETED|Phase 2||0
1563299|NCT01213329|3825112|P1|NOT COMPLETED|Phase 2||0
1563300|NCT01213329|3825111|P2|COMPLETED|Phase 2||0
1563301|NCT01213329|3825112|P1|COMPLETED|Phase 2||0
1563302|NCT01213329|3825111|P2|STARTED|Phase 2||0
1563303|NCT01213329|3825112|P1|STARTED|Phase 2||0
1563304|NCT01213329|3825111|P2|NOT COMPLETED|Screening||0
1563305|NCT01213329|3825112|P1|NOT COMPLETED|Screening||0
1563306|NCT01213329|3825111|P2|COMPLETED|Screening||25
1563307|NCT01213329|3825112|P1|COMPLETED|Screening||25
1563308|NCT01213329|3825111|P2|STARTED|Screening||25
1563309|NCT01213329|3825112|P1|STARTED|Screening||25
1563310|NCT01213316|3825118|P1|NOT COMPLETED|Overall Study||0
1563311|NCT01213316|3825118|P1|COMPLETED|Overall Study||451
1563312|NCT01213316|3825118|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
1563313|NCT01213316|3825118|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
1563314|NCT01213316|3825118|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
1563315|NCT01213316|3825118|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
1563316|NCT01213316|3825118|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
1563317|NCT01213264|3825137|P3|NOT COMPLETED|Overall Study||6
1563318|NCT01213264|3825138|P2|NOT COMPLETED|Overall Study||2
1563319|NCT01213264|3825139|P1|NOT COMPLETED|Overall Study||2
1563320|NCT01213264|3825137|P3|COMPLETED|Overall Study||321
1563321|NCT01213264|3825138|P2|COMPLETED|Overall Study||175
1563322|NCT01213264|3825139|P1|COMPLETED|Overall Study||153
1563323|NCT01213264|3825137|P3|STARTED|Overall Study||327
1563324|NCT01213264|3825138|P2|STARTED|Overall Study||177
1563325|NCT01213264|3825139|P1|STARTED|Overall Study||155
1563326|NCT01213251|3825159|P3|NOT COMPLETED|Overall Study||11
1563327|NCT01213251|3825160|P2|NOT COMPLETED|Overall Study||4
1563328|NCT01213251|3825161|P1|NOT COMPLETED|Overall Study||6
1563329|NCT01213251|3825159|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
1563330|NCT01213251|3825160|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
1563331|NCT01213251|3825161|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
1563332|NCT01213251|3825159|P3|STARTED|Overall Study||45
1563333|NCT01213251|3825160|P2|STARTED|Overall Study||41
1563334|NCT01213251|3825161|P1|STARTED|Overall Study||40
1563335|NCT01213199|3825182|P1|NOT COMPLETED|Overall Study||4
1563336|NCT01213199|3825182|P1|COMPLETED|Overall Study||16
1563337|NCT01213199|3825182|P1|STARTED|Overall Study||20
1563338|NCT01213173|3825188|P2|NOT COMPLETED|Overall Study||16
1563339|NCT01213173|3825189|P1|NOT COMPLETED|Overall Study||12
1563340|NCT01213173|3825188|P2|COMPLETED|Overall Study|Patients who completed the study|110
1563341|NCT01213173|3825189|P1|COMPLETED|Overall Study|Patients who completed the study|113
1563342|NCT01213173|3825188|P2|Patients Included in PP Population|Overall Study||89
1563343|NCT01213173|3825189|P1|Patients Included in PP Population|Overall Study||102
1563344|NCT01213173|3825188|P2|Patients Included in ITT Population|Overall Study||115
1563345|NCT01213173|3825189|P1|Patients Included in ITT Population|Overall Study||116
1563346|NCT01213173|3825188|P2|Patients Included in Safety Population|Overall Study||112
1563347|NCT01213173|3825189|P1|Patients Included in Safety Population|Overall Study||139
1563348|NCT01213173|3825188|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
1563349|NCT01213173|3825189|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
1563350|NCT01213082|3825222|P3|NOT COMPLETED|Overall Study||5
1563351|NCT01213082|3825223|P2|NOT COMPLETED|Overall Study||7
1563352|NCT01213082|3825224|P1|NOT COMPLETED|Overall Study||6
1563353|NCT01213082|3825222|P3|COMPLETED|Overall Study||6
1563354|NCT01213082|3825223|P2|COMPLETED|Overall Study||4
1563355|NCT01213082|3825224|P1|COMPLETED|Overall Study||6
1563356|NCT01213082|3825222|P3|STARTED|Overall Study||11
1563357|NCT01213082|3825223|P2|STARTED|Overall Study||11
1563358|NCT01213082|3825224|P1|STARTED|Overall Study||12
1563359|NCT01213043|3825237|P2|NOT COMPLETED|Follow-up||0
1563360|NCT01213043|3825238|P1|NOT COMPLETED|Follow-up||0
1563361|NCT01213043|3825237|P2|COMPLETED|Follow-up||15
1563362|NCT01213043|3825238|P1|COMPLETED|Follow-up||15
1563363|NCT01213043|3825237|P2|STARTED|Follow-up||15
1563364|NCT01213043|3825238|P1|STARTED|Follow-up||15
1563365|NCT01213043|3825237|P2|NOT COMPLETED|Treatment Period 2||0
1563366|NCT01213043|3825238|P1|NOT COMPLETED|Treatment Period 2||0
1563367|NCT01213043|3825237|P2|COMPLETED|Treatment Period 2||15
1563368|NCT01213043|3825238|P1|COMPLETED|Treatment Period 2||15
1563369|NCT01213043|3825237|P2|STARTED|Treatment Period 2||15
1563370|NCT01213043|3825238|P1|STARTED|Treatment Period 2||15
1563371|NCT01213043|3825237|P2|NOT COMPLETED|Washout Period||0
1563372|NCT01213043|3825238|P1|NOT COMPLETED|Washout Period||0
1563373|NCT01213043|3825237|P2|COMPLETED|Washout Period||15
1563374|NCT01213043|3825238|P1|COMPLETED|Washout Period||15
1563375|NCT01213043|3825237|P2|STARTED|Washout Period||15
1563376|NCT01213043|3825238|P1|STARTED|Washout Period||15
1563377|NCT01213043|3825237|P2|NOT COMPLETED|Treatment Period 1||0
1563378|NCT01213043|3825238|P1|NOT COMPLETED|Treatment Period 1||0
1563379|NCT01213043|3825237|P2|COMPLETED|Treatment Period 1||15
1563380|NCT01213043|3825238|P1|COMPLETED|Treatment Period 1||15
1563381|NCT01213043|3825237|P2|STARTED|Treatment Period 1||15
1563382|NCT01213043|3825238|P1|STARTED|Treatment Period 1||15
1563383|NCT01212991|3825266|P2|NOT COMPLETED|Overall Study||374
1563384|NCT01212991|3825267|P1|NOT COMPLETED|Overall Study||613
1563385|NCT01212991|3825266|P2|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|471
1563386|NCT01212991|3825267|P1|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|259
1563387|NCT01212991|3825266|P2|STARTED|Overall Study||845
1563388|NCT01212991|3825267|P1|STARTED|Overall Study||872
1563389|NCT01212900|3825287|P2|NOT COMPLETED|Overall Study||7
1563390|NCT01212900|3825288|P1|NOT COMPLETED|Overall Study||12
1563391|NCT01212900|3825287|P2|COMPLETED|Overall Study||107
1563392|NCT01212900|3825288|P1|COMPLETED|Overall Study||104
1563393|NCT01212900|3825287|P2|STARTED|Overall Study||114
1563394|NCT01212900|3825288|P1|STARTED|Overall Study||116
1563395|NCT01212874|3825296|P2|NOT COMPLETED|Overall Study||23
1563396|NCT01212874|3825297|P1|NOT COMPLETED|Overall Study||22
1563397|NCT01212874|3825296|P2|COMPLETED|Overall Study||12
1563398|NCT01212874|3825297|P1|COMPLETED|Overall Study||13
1563399|NCT01212874|3825296|P2|Received Allocated Intervention|Overall Study||12
1563400|NCT01212874|3825297|P1|Received Allocated Intervention|Overall Study||13
1563401|NCT01212874|3825296|P2|STARTED|Overall Study||35
1563402|NCT01212874|3825297|P1|STARTED|Overall Study||35
1563403|NCT01212770|3825308|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
1563404|NCT01212770|3825309|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
1563405|NCT01212770|3825310|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1563406|NCT01212770|3825311|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1563407|NCT01212770|3825312|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1563408|NCT01212770|3825313|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1563409|NCT01212770|3825314|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
1563410|NCT01212770|3825315|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
1563411|NCT01212770|3825316|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
1563412|NCT01212770|3825308|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
1563413|NCT01212770|3825309|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
1563414|NCT01212770|3825310|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
1563415|NCT01212770|3825311|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
1563416|NCT01212770|3825312|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
1563417|NCT01212770|3825313|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
1563418|NCT01212770|3825314|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
1563419|NCT01212770|3825315|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
1563420|NCT01212770|3825316|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
1563421|NCT01212770|3825308|P9|STARTED|Long-term Safety Phase (Year 5)||42
1563422|NCT01212770|3825309|P8|STARTED|Long-term Safety Phase (Year 5)||32
1563423|NCT01212770|3825310|P7|STARTED|Long-term Safety Phase (Year 5)||0
1563424|NCT01212770|3825311|P6|STARTED|Long-term Safety Phase (Year 5)||0
1563425|NCT01212770|3825312|P5|STARTED|Long-term Safety Phase (Year 5)||0
1563426|NCT01212770|3825313|P4|STARTED|Long-term Safety Phase (Year 5)||0
1563427|NCT01212770|3825314|P3|STARTED|Long-term Safety Phase (Year 5)||83
1563428|NCT01212770|3825315|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
1563429|NCT01212770|3825316|P1|STARTED|Long-term Safety Phase (Year 5)||0
1563430|NCT01212770|3825308|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
1563431|NCT01212770|3825309|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
1563432|NCT01212770|3825310|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1563433|NCT01212770|3825311|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1563434|NCT01212770|3825312|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1563435|NCT01212770|3825313|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1563436|NCT01212770|3825314|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
1563437|NCT01212770|3825315|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
1563438|NCT01212770|3825316|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
1563439|NCT01212770|3825308|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
1563440|NCT01212770|3825309|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
1563441|NCT01212770|3825310|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
1563442|NCT01212770|3825311|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
1563443|NCT01212770|3825312|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
1563444|NCT01212770|3825313|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
1563445|NCT01212770|3825314|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
1563446|NCT01212770|3825315|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
1563447|NCT01212770|3825316|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
1563448|NCT01212770|3825308|P9|STARTED|Long-term Safety Phase (Year 4)||44
1563449|NCT01212770|3825309|P8|STARTED|Long-term Safety Phase (Year 4)||35
1563450|NCT01212770|3825310|P7|STARTED|Long-term Safety Phase (Year 4)||0
1563451|NCT01212770|3825311|P6|STARTED|Long-term Safety Phase (Year 4)||0
1563452|NCT01212770|3825312|P5|STARTED|Long-term Safety Phase (Year 4)||0
1563453|NCT01212770|3825313|P4|STARTED|Long-term Safety Phase (Year 4)||0
1563454|NCT01212770|3825314|P3|STARTED|Long-term Safety Phase (Year 4)||94
1563455|NCT01212770|3825315|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
1563456|NCT01212770|3825316|P1|STARTED|Long-term Safety Phase (Year 4)||0
1563457|NCT01212770|3825308|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
1563458|NCT01212770|3825309|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
1563459|NCT01212770|3825310|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1563460|NCT01212770|3825311|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1563461|NCT01212770|3825312|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1563462|NCT01212770|3825313|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1563463|NCT01212770|3825314|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
1563464|NCT01212770|3825315|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
1563465|NCT01212770|3825316|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
1563466|NCT01212770|3825308|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
1563467|NCT01212770|3825309|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
1563468|NCT01212770|3825310|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
1563469|NCT01212770|3825311|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
1563470|NCT01212770|3825312|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
1563471|NCT01212770|3825313|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
1563472|NCT01212770|3825314|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
1563473|NCT01212770|3825315|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
1563474|NCT01212770|3825316|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
1563475|NCT01212770|3825308|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
1563476|NCT01212770|3825309|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
1563477|NCT01212770|3825310|P7|STARTED|Long-term Safety Phase (Year 3)||0
1563478|NCT01212770|3825311|P6|STARTED|Long-term Safety Phase (Year 3)||0
1563479|NCT01212770|3825312|P5|STARTED|Long-term Safety Phase (Year 3)||0
1563480|NCT01212770|3825313|P4|STARTED|Long-term Safety Phase (Year 3)||0
1563481|NCT01212770|3825314|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
1563482|NCT01212770|3825315|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
1563483|NCT01212770|3825316|P1|STARTED|Long-term Safety Phase (Year 3)||0
1563484|NCT01212770|3825308|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
1563485|NCT01212770|3825309|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
1563486|NCT01212770|3825310|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1563487|NCT01212770|3825311|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1563488|NCT01212770|3825312|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1563489|NCT01212770|3825313|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1563490|NCT01212770|3825314|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
1563491|NCT01212770|3825315|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
1563492|NCT01212770|3825316|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
1563493|NCT01212770|3825308|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
1563494|NCT01212770|3825309|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
1563495|NCT01212770|3825310|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
1563496|NCT01212770|3825311|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
1563497|NCT01212770|3825312|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
1563498|NCT01212770|3825313|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
1563499|NCT01212770|3825314|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
1563500|NCT01212770|3825315|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
1563501|NCT01212770|3825316|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
1563502|NCT01212770|3825308|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
1563503|NCT01212770|3825309|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
1563504|NCT01212770|3825310|P7|STARTED|Long-term Safety Phase (Year 2)||0
1563505|NCT01212770|3825311|P6|STARTED|Long-term Safety Phase (Year 2)||0
1563506|NCT01212770|3825312|P5|STARTED|Long-term Safety Phase (Year 2)||0
1563507|NCT01212770|3825313|P4|STARTED|Long-term Safety Phase (Year 2)||0
1563508|NCT01212770|3825314|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
1563509|NCT01212770|3825315|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
1563510|NCT01212770|3825316|P1|STARTED|Long-term Safety Phase (Year 2)||0
1563511|NCT01212770|3825308|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1563512|NCT01212770|3825309|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1563513|NCT01212770|3825310|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
1563514|NCT01212770|3825311|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
1563515|NCT01212770|3825312|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
1563516|NCT01212770|3825313|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
1563517|NCT01212770|3825314|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
1563518|NCT01212770|3825315|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
1563519|NCT01212770|3825316|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1563520|NCT01212770|3825308|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1563521|NCT01212770|3825309|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1563522|NCT01212770|3825310|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
1563523|NCT01212770|3825311|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
1563524|NCT01212770|3825312|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
1563525|NCT01212770|3825313|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
1563526|NCT01212770|3825314|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
1563527|NCT01212770|3825315|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
1563528|NCT01212770|3825316|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1563529|NCT01212770|3825308|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
1563530|NCT01212770|3825309|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
1563531|NCT01212770|3825310|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
1563532|NCT01212770|3825311|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
1563533|NCT01212770|3825312|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
1563534|NCT01212770|3825313|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
1563535|NCT01212770|3825314|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
1563536|NCT01212770|3825315|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
1563537|NCT01212770|3825316|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
1563538|NCT01212770|3825308|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563539|NCT01212770|3825309|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563540|NCT01212770|3825310|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563541|NCT01212770|3825311|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563542|NCT01212770|3825312|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563543|NCT01212770|3825313|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563544|NCT01212770|3825314|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1563545|NCT01212770|3825315|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1563546|NCT01212770|3825316|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
1563547|NCT01212770|3825308|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563548|NCT01212770|3825309|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563549|NCT01212770|3825310|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563550|NCT01212770|3825311|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563551|NCT01212770|3825312|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563552|NCT01212770|3825313|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563553|NCT01212770|3825314|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
1563554|NCT01212770|3825315|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
1563555|NCT01212770|3825316|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
1563556|NCT01212770|3825308|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563557|NCT01212770|3825309|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563558|NCT01212770|3825310|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563559|NCT01212770|3825311|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563560|NCT01212770|3825312|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563561|NCT01212770|3825313|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563562|NCT01212770|3825314|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
1563563|NCT01212770|3825315|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
1563564|NCT01212770|3825316|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
1563565|NCT01212770|3825308|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563566|NCT01212770|3825309|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563567|NCT01212770|3825310|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563568|NCT01212770|3825311|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563569|NCT01212770|3825312|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563570|NCT01212770|3825313|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563571|NCT01212770|3825314|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
1563572|NCT01212770|3825315|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
1563573|NCT01212770|3825316|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
1563574|NCT01212770|3825308|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563575|NCT01212770|3825309|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563576|NCT01212770|3825310|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563577|NCT01212770|3825311|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563578|NCT01212770|3825312|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563579|NCT01212770|3825313|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563580|NCT01212770|3825314|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
1563581|NCT01212770|3825315|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
1563582|NCT01212770|3825316|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
1563583|NCT01212770|3825308|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563584|NCT01212770|3825309|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563585|NCT01212770|3825310|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563586|NCT01212770|3825311|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563587|NCT01212770|3825312|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563588|NCT01212770|3825313|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563589|NCT01212770|3825314|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
1563590|NCT01212770|3825315|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
1563591|NCT01212770|3825316|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
1563592|NCT01212757|3825513|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
1563593|NCT01212757|3825514|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
1563594|NCT01212757|3825515|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1563595|NCT01212757|3825516|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1563596|NCT01212757|3825517|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1563597|NCT01212757|3825518|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1563598|NCT01212757|3825519|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
1563599|NCT01212757|3825520|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
1563600|NCT01212757|3825521|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
1563601|NCT01212757|3825513|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
1563602|NCT01212757|3825514|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
1563603|NCT01212757|3825515|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
1563604|NCT01212757|3825516|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
1563605|NCT01212757|3825517|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
1563606|NCT01212757|3825518|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
1563607|NCT01212757|3825519|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
1563608|NCT01212757|3825520|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
1563609|NCT01212757|3825521|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
1563610|NCT01212757|3825513|P9|STARTED|Long-Term Safety Phase (Year 5)||39
1563611|NCT01212757|3825514|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
1563612|NCT01212757|3825515|P7|STARTED|Long-Term Safety Phase (Year 5)||0
1563613|NCT01212757|3825516|P6|STARTED|Long-Term Safety Phase (Year 5)||0
1563614|NCT01212757|3825517|P5|STARTED|Long-Term Safety Phase (Year 5)||0
1563615|NCT01212757|3825518|P4|STARTED|Long-Term Safety Phase (Year 5)||0
1563616|NCT01212757|3825519|P3|STARTED|Long-Term Safety Phase (Year 5)||77
1563617|NCT01212757|3825520|P2|STARTED|Long-Term Safety Phase (Year 5)||80
1563618|NCT01212757|3825521|P1|STARTED|Long-Term Safety Phase (Year 5)||0
1563619|NCT01212757|3825513|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
1563620|NCT01212757|3825514|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
1563621|NCT01212757|3825515|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1563622|NCT01212757|3825516|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1563623|NCT01212757|3825517|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1563624|NCT01212757|3825518|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1563625|NCT01212757|3825519|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
1563626|NCT01212757|3825520|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
1563627|NCT01212757|3825521|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
1563628|NCT01212757|3825513|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
1563629|NCT01212757|3825514|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
1563630|NCT01212757|3825515|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
1563631|NCT01212757|3825516|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
1563632|NCT01212757|3825517|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
1563633|NCT01212757|3825518|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
1563634|NCT01212757|3825519|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
1563635|NCT01212757|3825520|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
1563636|NCT01212757|3825521|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
1563637|NCT01212757|3825513|P9|STARTED|Long-Term Safety Phase (Year 4)||46
1563638|NCT01212757|3825514|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
1563639|NCT01212757|3825515|P7|STARTED|Long-Term Safety Phase (Year 4)||0
1563640|NCT01212757|3825516|P6|STARTED|Long-Term Safety Phase (Year 4)||0
1563641|NCT01212757|3825517|P5|STARTED|Long-Term Safety Phase (Year 4)||0
1563642|NCT01212757|3825518|P4|STARTED|Long-Term Safety Phase (Year 4)||0
1563643|NCT01212757|3825519|P3|STARTED|Long-Term Safety Phase (Year 4)||84
1563644|NCT01212757|3825520|P2|STARTED|Long-Term Safety Phase (Year 4)||89
1563645|NCT01212757|3825521|P1|STARTED|Long-Term Safety Phase (Year 4)||0
1563646|NCT01212757|3825513|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
1563647|NCT01212757|3825514|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
1563648|NCT01212757|3825515|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1563649|NCT01212757|3825516|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1563650|NCT01212757|3825517|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1563651|NCT01212757|3825518|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1563652|NCT01212757|3825519|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
1563653|NCT01212757|3825520|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
1563654|NCT01212757|3825521|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
1563655|NCT01212757|3825513|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
1563656|NCT01212757|3825514|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
1563657|NCT01212757|3825515|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
1563658|NCT01212757|3825516|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
1563659|NCT01212757|3825517|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
1563660|NCT01212757|3825518|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
1563661|NCT01212757|3825519|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
1563662|NCT01212757|3825520|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
1563663|NCT01212757|3825521|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
1563664|NCT01212757|3825513|P9|STARTED|Long-Term Safety Phase (Year 3)||51
1563665|NCT01212757|3825514|P8|STARTED|Long-Term Safety Phase (Year 3)||48
1563666|NCT01212757|3825515|P7|STARTED|Long-Term Safety Phase (Year 3)||0
1563667|NCT01212757|3825516|P6|STARTED|Long-Term Safety Phase (Year 3)||0
1563668|NCT01212757|3825517|P5|STARTED|Long-Term Safety Phase (Year 3)||0
1563669|NCT01212757|3825518|P4|STARTED|Long-Term Safety Phase (Year 3)||0
1563670|NCT01212757|3825519|P3|STARTED|Long-Term Safety Phase (Year 3)||95
1563671|NCT01212757|3825520|P2|STARTED|Long-Term Safety Phase (Year 3)||107
1563672|NCT01212757|3825521|P1|STARTED|Long-Term Safety Phase (Year 3)||0
1563673|NCT01212757|3825513|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
1563674|NCT01212757|3825514|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
1563675|NCT01212757|3825515|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1563676|NCT01212757|3825516|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1563677|NCT01212757|3825517|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1563678|NCT01212757|3825518|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1563679|NCT01212757|3825519|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
1563680|NCT01212757|3825520|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
1563681|NCT01212757|3825521|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
1563682|NCT01212757|3825513|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
1563683|NCT01212757|3825514|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
1563684|NCT01212757|3825515|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
1563685|NCT01212757|3825516|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
1563686|NCT01212757|3825517|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
1563687|NCT01212757|3825518|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
1563688|NCT01212757|3825519|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
1563689|NCT01212757|3825520|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
1563690|NCT01212757|3825521|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
1563691|NCT01212757|3825513|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
1563692|NCT01212757|3825514|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
1563693|NCT01212757|3825515|P7|STARTED|Long-Term Safety Phase (Year 2)||0
1563694|NCT01212757|3825516|P6|STARTED|Long-Term Safety Phase (Year 2)||0
1563695|NCT01212757|3825517|P5|STARTED|Long-Term Safety Phase (Year 2)||0
1563696|NCT01212757|3825518|P4|STARTED|Long-Term Safety Phase (Year 2)||0
1563846|NCT01212094|3825796|P1|COMPLETED|Year 1: Baseline Monitoring||27
1563697|NCT01212757|3825519|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
1563698|NCT01212757|3825520|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
1563699|NCT01212757|3825521|P1|STARTED|Long-Term Safety Phase (Year 2)||0
1563700|NCT01212757|3825513|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1563701|NCT01212757|3825514|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1563702|NCT01212757|3825515|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1563703|NCT01212757|3825516|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
1563704|NCT01212757|3825517|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
1563705|NCT01212757|3825518|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
1563706|NCT01212757|3825519|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
1563707|NCT01212757|3825520|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
1563708|NCT01212757|3825521|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1563709|NCT01212757|3825513|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1563710|NCT01212757|3825514|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1563711|NCT01212757|3825515|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
1563712|NCT01212757|3825516|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
1563713|NCT01212757|3825517|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
1563714|NCT01212757|3825518|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
1563715|NCT01212757|3825519|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
1563716|NCT01212757|3825520|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
1563717|NCT01212757|3825521|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
1563718|NCT01212757|3825513|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1563719|NCT01212757|3825514|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1563720|NCT01212757|3825515|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
1563721|NCT01212757|3825516|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
1563722|NCT01212757|3825517|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
1563723|NCT01212757|3825518|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
1563724|NCT01212757|3825519|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
1563725|NCT01212757|3825520|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
1563726|NCT01212757|3825521|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
1563727|NCT01212757|3825513|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563728|NCT01212757|3825514|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563729|NCT01212757|3825515|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563730|NCT01212757|3825516|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563731|NCT01212757|3825517|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563732|NCT01212757|3825518|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563733|NCT01212757|3825519|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
1563734|NCT01212757|3825520|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
1563735|NCT01212757|3825521|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
1563736|NCT01212757|3825513|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563737|NCT01212757|3825514|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563738|NCT01212757|3825515|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563739|NCT01212757|3825516|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563740|NCT01212757|3825517|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563741|NCT01212757|3825518|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1563742|NCT01212757|3825519|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
1563743|NCT01212757|3825520|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
1563744|NCT01212757|3825521|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
1563745|NCT01212757|3825513|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563746|NCT01212757|3825514|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563747|NCT01212757|3825515|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563748|NCT01212757|3825516|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563749|NCT01212757|3825517|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563750|NCT01212757|3825518|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563751|NCT01212757|3825519|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
1563752|NCT01212757|3825520|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
1563753|NCT01212757|3825521|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
1563754|NCT01212757|3825513|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563755|NCT01212757|3825514|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563756|NCT01212757|3825515|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563757|NCT01212757|3825516|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563758|NCT01212757|3825517|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563759|NCT01212757|3825518|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1563760|NCT01212757|3825519|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
1563761|NCT01212757|3825520|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
1563762|NCT01212757|3825521|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
1563763|NCT01212757|3825513|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563764|NCT01212757|3825514|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563765|NCT01212757|3825515|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563766|NCT01212757|3825516|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563767|NCT01212757|3825517|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563768|NCT01212757|3825518|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1563769|NCT01212757|3825519|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
1563770|NCT01212757|3825520|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
1563771|NCT01212757|3825521|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
1563772|NCT01212757|3825513|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563773|NCT01212757|3825514|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563774|NCT01212757|3825515|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563775|NCT01212757|3825516|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563776|NCT01212757|3825517|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563777|NCT01212757|3825518|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1563778|NCT01212757|3825519|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
1563779|NCT01212757|3825520|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
1563780|NCT01212757|3825521|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
1563781|NCT01212627|3825705|P1|NOT COMPLETED|Overall Study||0
1563782|NCT01212627|3825705|P1|COMPLETED|Overall Study||12
1563783|NCT01212627|3825705|P1|STARTED|Overall Study||12
1563784|NCT01212484|3825709|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
1563785|NCT01212484|3825710|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
1563786|NCT01212484|3825709|P2|COMPLETED|Second Intervention (4 Weeks)||3
1563787|NCT01212484|3825710|P1|COMPLETED|Second Intervention (4 Weeks)||5
1563788|NCT01212484|3825709|P2|STARTED|Second Intervention (4 Weeks)||4
1563789|NCT01212484|3825710|P1|STARTED|Second Intervention (4 Weeks)||5
1563790|NCT01212484|3825709|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
1563791|NCT01212484|3825710|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
1563792|NCT01212484|3825709|P2|COMPLETED|First Intervention (4 Weeks)||4
1563793|NCT01212484|3825710|P1|COMPLETED|First Intervention (4 Weeks)||5
1563794|NCT01212484|3825709|P2|STARTED|First Intervention (4 Weeks)||6
1563795|NCT01212484|3825710|P1|STARTED|First Intervention (4 Weeks)||5
1563796|NCT01212484|3825709|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
1563797|NCT01212484|3825710|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
1563798|NCT01212484|3825709|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
1563799|NCT01212484|3825710|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
1563800|NCT01212484|3825709|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
1563801|NCT01212484|3825710|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
1563802|NCT01212445|3825723|P3|NOT COMPLETED|Overall Study||0
1563803|NCT01212445|3825724|P2|NOT COMPLETED|Overall Study||0
1563804|NCT01212445|3825725|P1|NOT COMPLETED|Overall Study||0
1563805|NCT01212445|3825723|P3|COMPLETED|Overall Study||51
1563806|NCT01212445|3825724|P2|COMPLETED|Overall Study||51
1563807|NCT01212445|3825725|P1|COMPLETED|Overall Study||52
1563808|NCT01212445|3825723|P3|STARTED|Overall Study||51
1563809|NCT01212445|3825724|P2|STARTED|Overall Study||51
1563810|NCT01212445|3825725|P1|STARTED|Overall Study||52
1563811|NCT01212302|3825754|P1|NOT COMPLETED|Overall Study||0
1563812|NCT01212302|3825754|P1|COMPLETED|Overall Study||504
1563813|NCT01212302|3825754|P1|STARTED|Overall Study||504
1563814|NCT01212185|3825760|P2|NOT COMPLETED|Overall Study||1
1563815|NCT01212185|3825761|P1|NOT COMPLETED|Overall Study||2
1563816|NCT01212185|3825760|P2|COMPLETED|Overall Study||7
1563817|NCT01212185|3825761|P1|COMPLETED|Overall Study||4
1563818|NCT01212185|3825760|P2|STARTED|Overall Study||8
1563819|NCT01212185|3825761|P1|STARTED|Overall Study||6
1563820|NCT01212172|3825769|P2|NOT COMPLETED|Overall Study||1
1563821|NCT01212172|3825770|P1|NOT COMPLETED|Overall Study||1
1563822|NCT01212172|3825769|P2|COMPLETED|Overall Study||9
1563823|NCT01212172|3825770|P1|COMPLETED|Overall Study||9
1563824|NCT01212172|3825769|P2|STARTED|Overall Study||10
1563825|NCT01212172|3825770|P1|STARTED|Overall Study||10
1563826|NCT01212159|3825780|P2|NOT COMPLETED|Overall Study||12
1563827|NCT01212159|3825781|P1|NOT COMPLETED|Overall Study||12
1563828|NCT01212159|3825780|P2|COMPLETED|Overall Study||32
1563829|NCT01212159|3825781|P1|COMPLETED|Overall Study||14
1563830|NCT01212159|3825780|P2|STARTED|Overall Study||44
1563831|NCT01212159|3825781|P1|STARTED|Overall Study||26
1563832|NCT01212094|3825794|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
1563833|NCT01212094|3825795|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
1563834|NCT01212094|3825796|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
1563835|NCT01212094|3825794|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
1563836|NCT01212094|3825795|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
1563837|NCT01212094|3825796|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
1563838|NCT01212094|3825794|P3|STARTED|Years 2 & 3: Treatment Randomization||18
1563839|NCT01212094|3825795|P2|STARTED|Years 2 & 3: Treatment Randomization||9
1563840|NCT01212094|3825796|P1|STARTED|Years 2 & 3: Treatment Randomization||0
1563841|NCT01212094|3825794|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
1563842|NCT01212094|3825795|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
1563843|NCT01212094|3825796|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
1563844|NCT01212094|3825794|P3|COMPLETED|Year 1: Baseline Monitoring||0
1563845|NCT01212094|3825795|P2|COMPLETED|Year 1: Baseline Monitoring||0
1563847|NCT01212094|3825794|P3|STARTED|Year 1: Baseline Monitoring||0
1563848|NCT01212094|3825795|P2|STARTED|Year 1: Baseline Monitoring||0
1563849|NCT01212094|3825796|P1|STARTED|Year 1: Baseline Monitoring||43
1563850|NCT01211873|3825830|P3|NOT COMPLETED|Overall Study||2
1563851|NCT01211873|3825831|P2|NOT COMPLETED|Overall Study||2
1563852|NCT01211873|3825832|P1|NOT COMPLETED|Overall Study||5
1563853|NCT01211873|3825830|P3|COMPLETED|Overall Study||36
1563854|NCT01211873|3825831|P2|COMPLETED|Overall Study||117
1563855|NCT01211873|3825832|P1|COMPLETED|Overall Study||240
1563856|NCT01211873|3825830|P3|STARTED|Overall Study||38
1563857|NCT01211873|3825831|P2|STARTED|Overall Study||119
1563858|NCT01211873|3825832|P1|STARTED|Overall Study||245
1563859|NCT01211769|3825843|P4|NOT COMPLETED|Overall Study||11
1563860|NCT01211769|3825844|P3|NOT COMPLETED|Overall Study||8
1563861|NCT01211769|3825845|P2|NOT COMPLETED|Overall Study||10
1563862|NCT01211769|3825846|P1|NOT COMPLETED|Overall Study||9
1563863|NCT01211769|3825843|P4|COMPLETED|Overall Study||9
1563864|NCT01211769|3825844|P3|COMPLETED|Overall Study||12
1563865|NCT01211769|3825845|P2|COMPLETED|Overall Study||10
1563866|NCT01211769|3825846|P1|COMPLETED|Overall Study||11
1563867|NCT01211769|3825843|P4|Participants/Group|Overall Study||20
1563868|NCT01211769|3825844|P3|Participants/Group|Overall Study||20
1563869|NCT01211769|3825845|P2|Participants/Group|Overall Study||20
1563870|NCT01211769|3825846|P1|Participants/Group|Overall Study||20
1563871|NCT01211769|3825843|P4|STARTED|Overall Study||20
1563872|NCT01211769|3825844|P3|STARTED|Overall Study||20
1563873|NCT01211769|3825845|P2|STARTED|Overall Study||20
1563874|NCT01211769|3825846|P1|STARTED|Overall Study||20
1563875|NCT01211730|3825866|P2|NOT COMPLETED|Overall Study||0
1563876|NCT01211730|3825867|P1|NOT COMPLETED|Overall Study||0
1563877|NCT01211730|3825866|P2|COMPLETED|Overall Study||82
1563878|NCT01211730|3825867|P1|COMPLETED|Overall Study||82
1563879|NCT01211730|3825866|P2|STARTED|Overall Study||82
1563880|NCT01211730|3825867|P1|STARTED|Overall Study||82
1563881|NCT01211665|3825885|P2|NOT COMPLETED|Overall Study||0
1563882|NCT01211665|3825886|P1|NOT COMPLETED|Overall Study||2
1563883|NCT01211665|3825885|P2|COMPLETED|Overall Study|completed treatment with study drug|1
1563884|NCT01211665|3825886|P1|COMPLETED|Overall Study||0
1563885|NCT01211665|3825885|P2|STARTED|Overall Study||1
1563886|NCT01211665|3825886|P1|STARTED|Overall Study||2
1563887|NCT01211613|3825913|P3|NOT COMPLETED|Overall Study||2
1563888|NCT01211613|3825914|P2|NOT COMPLETED|Overall Study||2
1563889|NCT01211613|3825915|P1|NOT COMPLETED|Overall Study||3
1563890|NCT01211613|3825913|P3|COMPLETED|Overall Study||33
1563891|NCT01211613|3825914|P2|COMPLETED|Overall Study||33
1563892|NCT01211613|3825915|P1|COMPLETED|Overall Study||34
1563893|NCT01211613|3825913|P3|STARTED|Overall Study||35
1563894|NCT01211613|3825914|P2|STARTED|Overall Study||35
1563895|NCT01211613|3825915|P1|STARTED|Overall Study||37
1563896|NCT01211535|3825928|P2|NOT COMPLETED|Overall Study||1
1563897|NCT01211535|3825929|P1|NOT COMPLETED|Overall Study||0
1563898|NCT01211535|3825928|P2|COMPLETED|Overall Study||51
1563899|NCT01211535|3825929|P1|COMPLETED|Overall Study||52
1563900|NCT01211535|3825928|P2|STARTED|Overall Study||52
1563901|NCT01211535|3825929|P1|STARTED|Overall Study||52
1563902|NCT01211340|3825937|P2|NOT COMPLETED|Overall Study||0
1563903|NCT01211340|3825938|P1|NOT COMPLETED|Overall Study||0
1563904|NCT01211340|3825937|P2|COMPLETED|Overall Study||223
1563905|NCT01211340|3825938|P1|COMPLETED|Overall Study||223
1563906|NCT01211340|3825937|P2|STARTED|Overall Study||223
1563907|NCT01211340|3825938|P1|STARTED|Overall Study||223
1563908|NCT01211197|3825948|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1563909|NCT01211197|3825949|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1563910|NCT01211197|3825950|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1563911|NCT01211197|3825951|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1563912|NCT01211197|3825952|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1563913|NCT01211197|3825953|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1563914|NCT01211197|3825948|P6|COMPLETED|Treatment Period 3 (1 Day)||2
1563915|NCT01211197|3825949|P5|COMPLETED|Treatment Period 3 (1 Day)||2
1563916|NCT01211197|3825950|P4|COMPLETED|Treatment Period 3 (1 Day)||3
1563917|NCT01211197|3825951|P3|COMPLETED|Treatment Period 3 (1 Day)||2
1563918|NCT01211197|3825952|P2|COMPLETED|Treatment Period 3 (1 Day)||3
1563919|NCT01211197|3825953|P1|COMPLETED|Treatment Period 3 (1 Day)||2
1563920|NCT01211197|3825948|P6|STARTED|Treatment Period 3 (1 Day)||2
1563921|NCT01211197|3825949|P5|STARTED|Treatment Period 3 (1 Day)||2
1563922|NCT01211197|3825950|P4|STARTED|Treatment Period 3 (1 Day)||3
1563923|NCT01211197|3825951|P3|STARTED|Treatment Period 3 (1 Day)||2
1563924|NCT01211197|3825952|P2|STARTED|Treatment Period 3 (1 Day)||3
1563925|NCT01211197|3825953|P1|STARTED|Treatment Period 3 (1 Day)||2
1563926|NCT01211197|3825948|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1563927|NCT01211197|3825949|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1563928|NCT01211197|3825950|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1563929|NCT01211197|3825951|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1563930|NCT01211197|3825952|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1563931|NCT01211197|3825953|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
1563932|NCT01211197|3825948|P6|COMPLETED|Washout Period 2 (7 Days)||2
1563933|NCT01211197|3825949|P5|COMPLETED|Washout Period 2 (7 Days)||2
1563934|NCT01211197|3825950|P4|COMPLETED|Washout Period 2 (7 Days)||3
1563935|NCT01211197|3825951|P3|COMPLETED|Washout Period 2 (7 Days)||2
1563936|NCT01211197|3825952|P2|COMPLETED|Washout Period 2 (7 Days)||3
1563937|NCT01211197|3825953|P1|COMPLETED|Washout Period 2 (7 Days)||2
1563938|NCT01211197|3825948|P6|STARTED|Washout Period 2 (7 Days)||2
1563939|NCT01211197|3825949|P5|STARTED|Washout Period 2 (7 Days)||2
1563940|NCT01211197|3825950|P4|STARTED|Washout Period 2 (7 Days)||3
1563941|NCT01211197|3825951|P3|STARTED|Washout Period 2 (7 Days)||2
1563942|NCT01211197|3825952|P2|STARTED|Washout Period 2 (7 Days)||3
1563943|NCT01211197|3825953|P1|STARTED|Washout Period 2 (7 Days)||3
1563944|NCT01211197|3825948|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1563945|NCT01211197|3825949|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1563946|NCT01211197|3825950|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1563947|NCT01211197|3825951|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1563948|NCT01211197|3825952|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1563949|NCT01211197|3825953|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1563950|NCT01211197|3825948|P6|COMPLETED|Treatment Period 2 (1 Day)||2
1563951|NCT01211197|3825949|P5|COMPLETED|Treatment Period 2 (1 Day)||2
1563952|NCT01211197|3825950|P4|COMPLETED|Treatment Period 2 (1 Day)||3
1563953|NCT01211197|3825951|P3|COMPLETED|Treatment Period 2 (1 Day)||2
1563954|NCT01211197|3825952|P2|COMPLETED|Treatment Period 2 (1 Day)||3
1563955|NCT01211197|3825953|P1|COMPLETED|Treatment Period 2 (1 Day)||3
1563956|NCT01211197|3825948|P6|STARTED|Treatment Period 2 (1 Day)||2
1563957|NCT01211197|3825949|P5|STARTED|Treatment Period 2 (1 Day)||2
1563958|NCT01211197|3825950|P4|STARTED|Treatment Period 2 (1 Day)||3
1563959|NCT01211197|3825951|P3|STARTED|Treatment Period 2 (1 Day)||2
1563960|NCT01211197|3825952|P2|STARTED|Treatment Period 2 (1 Day)||3
1563961|NCT01211197|3825953|P1|STARTED|Treatment Period 2 (1 Day)||3
1563962|NCT01211197|3825948|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1563963|NCT01211197|3825949|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1563964|NCT01211197|3825950|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1563965|NCT01211197|3825951|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
1563966|NCT01211197|3825952|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1563967|NCT01211197|3825953|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1563968|NCT01211197|3825948|P6|COMPLETED|Washout Period 1 (7 Days)||2
1563969|NCT01211197|3825949|P5|COMPLETED|Washout Period 1 (7 Days)||2
1563970|NCT01211197|3825950|P4|COMPLETED|Washout Period 1 (7 Days)||3
1563971|NCT01211197|3825951|P3|COMPLETED|Washout Period 1 (7 Days)||2
1563972|NCT01211197|3825952|P2|COMPLETED|Washout Period 1 (7 Days)||3
1563973|NCT01211197|3825953|P1|COMPLETED|Washout Period 1 (7 Days)||3
1563974|NCT01211197|3825948|P6|STARTED|Washout Period 1 (7 Days)||2
1563975|NCT01211197|3825949|P5|STARTED|Washout Period 1 (7 Days)||2
1563976|NCT01211197|3825950|P4|STARTED|Washout Period 1 (7 Days)||3
1563977|NCT01211197|3825951|P3|STARTED|Washout Period 1 (7 Days)||3
1563978|NCT01211197|3825952|P2|STARTED|Washout Period 1 (7 Days)||3
1563979|NCT01211197|3825953|P1|STARTED|Washout Period 1 (7 Days)||3
1563980|NCT01211197|3825948|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1563981|NCT01211197|3825949|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1563982|NCT01211197|3825950|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1563983|NCT01211197|3825951|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1563984|NCT01211197|3825952|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1563985|NCT01211197|3825953|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1563986|NCT01211197|3825948|P6|COMPLETED|Treatment Period 1 (1 Day)||2
1563987|NCT01211197|3825949|P5|COMPLETED|Treatment Period 1 (1 Day)||2
1563988|NCT01211197|3825950|P4|COMPLETED|Treatment Period 1 (1 Day)||3
1563989|NCT01211197|3825951|P3|COMPLETED|Treatment Period 1 (1 Day)||3
1563990|NCT01211197|3825952|P2|COMPLETED|Treatment Period 1 (1 Day)||3
1563991|NCT01211197|3825953|P1|COMPLETED|Treatment Period 1 (1 Day)||3
1563992|NCT01211197|3825948|P6|STARTED|Treatment Period 1 (1 Day)||2
1563993|NCT01211197|3825949|P5|STARTED|Treatment Period 1 (1 Day)||2
1563994|NCT01211197|3825950|P4|STARTED|Treatment Period 1 (1 Day)||3
1563995|NCT01211197|3825951|P3|STARTED|Treatment Period 1 (1 Day)||3
1563996|NCT01211197|3825952|P2|STARTED|Treatment Period 1 (1 Day)||3
1563997|NCT01211197|3825953|P1|STARTED|Treatment Period 1 (1 Day)||3
1563998|NCT01211184|3826000|P3|NOT COMPLETED|Overall Study||1
1563999|NCT01211184|3826001|P2|NOT COMPLETED|Overall Study||2
1564000|NCT01211184|3826002|P1|NOT COMPLETED|Overall Study||0
1564001|NCT01211184|3826000|P3|COMPLETED|Overall Study||19
1564002|NCT01211184|3826001|P2|COMPLETED|Overall Study||18
1564003|NCT01211184|3826002|P1|COMPLETED|Overall Study||20
1564004|NCT01211184|3826000|P3|STARTED|Overall Study||20
1564005|NCT01211184|3826001|P2|STARTED|Overall Study||20
1564006|NCT01211184|3826002|P1|STARTED|Overall Study||20
1564007|NCT01211145|3826017|P4|NOT COMPLETED|Overall Study||20
1564008|NCT01211145|3826018|P3|NOT COMPLETED|Overall Study||13
1564009|NCT01211145|3826019|P2|NOT COMPLETED|Overall Study||17
1564010|NCT01211145|3826020|P1|NOT COMPLETED|Overall Study||26
1564011|NCT01211145|3826017|P4|COMPLETED|Overall Study||268
1564012|NCT01211145|3826018|P3|COMPLETED|Overall Study||86
1564013|NCT01211145|3826019|P2|COMPLETED|Overall Study||98
1564014|NCT01211145|3826020|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
1564015|NCT01211145|3826017|P4|STARTED|Overall Study||288
1564016|NCT01211145|3826018|P3|STARTED|Overall Study||99
1564017|NCT01211145|3826019|P2|STARTED|Overall Study||115
1564018|NCT01211145|3826020|P1|STARTED|Overall Study||296
1564019|NCT01211106|3826052|P2|NOT COMPLETED|Overall Study||11
1564020|NCT01211106|3826053|P1|NOT COMPLETED|Overall Study||13
1564021|NCT01211106|3826052|P2|COMPLETED|Overall Study||77
1564022|NCT01211106|3826053|P1|COMPLETED|Overall Study||82
1564023|NCT01211106|3826052|P2|STARTED|Overall Study||88
1564024|NCT01211106|3826053|P1|STARTED|Overall Study||95
1564025|NCT01210820|3826063|P2|NOT COMPLETED|Overall Study||0
1564026|NCT01210820|3826064|P1|NOT COMPLETED|Overall Study||0
1564027|NCT01210820|3826063|P2|COMPLETED|Overall Study||4
1564028|NCT01210820|3826064|P1|COMPLETED|Overall Study||17
1564029|NCT01210820|3826063|P2|STARTED|Overall Study||4
1564030|NCT01210820|3826064|P1|STARTED|Overall Study||17
1564031|NCT01210807|3826074|P2|NOT COMPLETED|Overall Study||3
1564032|NCT01210807|3826075|P1|NOT COMPLETED|Overall Study||3
1564033|NCT01210807|3826074|P2|COMPLETED|Overall Study||31
1564034|NCT01210807|3826075|P1|COMPLETED|Overall Study||33
1564035|NCT01210807|3826074|P2|STARTED|Overall Study||34
1564036|NCT01210807|3826075|P1|STARTED|Overall Study||36
1564037|NCT01210716|3826083|P2|NOT COMPLETED|Second TPE Procedure||0
1564038|NCT01210716|3826084|P1|NOT COMPLETED|Second TPE Procedure||3
1564039|NCT01210716|3826083|P2|COMPLETED|Second TPE Procedure||15
1564040|NCT01210716|3826084|P1|COMPLETED|Second TPE Procedure||15
1564041|NCT01210716|3826083|P2|STARTED|Second TPE Procedure||15
1564042|NCT01210716|3826084|P1|STARTED|Second TPE Procedure||18
1564043|NCT01210716|3826083|P2|NOT COMPLETED|First TPE Procedure||2
1564044|NCT01210716|3826084|P1|NOT COMPLETED|First TPE Procedure||2
1564045|NCT01210716|3826083|P2|COMPLETED|First TPE Procedure||15
1564046|NCT01210716|3826084|P1|COMPLETED|First TPE Procedure||18
1564047|NCT01210716|3826083|P2|STARTED|First TPE Procedure||17
1564048|NCT01210716|3826084|P1|STARTED|First TPE Procedure||20
1564049|NCT01210690|3826090|P1|NOT COMPLETED|Overall Study||26
1564050|NCT01210690|3826090|P1|COMPLETED|Overall Study||75
1564051|NCT01210690|3826090|P1|STARTED|Overall Study||101
1564052|NCT01210664|3826103|P4|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
1564053|NCT01210664|3826104|P3|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564054|NCT01210664|3826105|P2|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564055|NCT01210664|3826106|P1|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564056|NCT01210664|3826103|P4|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
1564057|NCT01210664|3826104|P3|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564058|NCT01210664|3826105|P2|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564059|NCT01210664|3826106|P1|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564060|NCT01210664|3826103|P4|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
1564061|NCT01210664|3826104|P3|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564062|NCT01210664|3826105|P2|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564063|NCT01210664|3826106|P1|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564064|NCT01210664|3826103|P4|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
1564065|NCT01210664|3826104|P3|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564066|NCT01210664|3826105|P2|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564067|NCT01210664|3826106|P1|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
1564068|NCT01210664|3826103|P4|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564069|NCT01210664|3826104|P3|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
1564070|NCT01210664|3826105|P2|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564071|NCT01210664|3826106|P1|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564072|NCT01210664|3826103|P4|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564073|NCT01210664|3826104|P3|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
1564074|NCT01210664|3826105|P2|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564075|NCT01210664|3826106|P1|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564076|NCT01210664|3826103|P4|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564077|NCT01210664|3826104|P3|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
1564078|NCT01210664|3826105|P2|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564079|NCT01210664|3826106|P1|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564080|NCT01210664|3826103|P4|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564081|NCT01210664|3826104|P3|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
1564082|NCT01210664|3826105|P2|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564083|NCT01210664|3826106|P1|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
1564084|NCT01210664|3826103|P4|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564085|NCT01210664|3826104|P3|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564086|NCT01210664|3826105|P2|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564087|NCT01210664|3826106|P1|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564088|NCT01210664|3826103|P4|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564089|NCT01210664|3826104|P3|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564090|NCT01210664|3826105|P2|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
1564091|NCT01210664|3826106|P1|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564092|NCT01210664|3826103|P4|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564093|NCT01210664|3826104|P3|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564094|NCT01210664|3826105|P2|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
1564095|NCT01210664|3826106|P1|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564096|NCT01210664|3826103|P4|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564097|NCT01210664|3826104|P3|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564098|NCT01210664|3826105|P2|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
1564099|NCT01210664|3826106|P1|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
1564100|NCT01210664|3826103|P4|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564101|NCT01210664|3826104|P3|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564102|NCT01210664|3826105|P2|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564103|NCT01210664|3826106|P1|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564104|NCT01210664|3826103|P4|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564105|NCT01210664|3826104|P3|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564106|NCT01210664|3826105|P2|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564107|NCT01210664|3826106|P1|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
1564108|NCT01210664|3826103|P4|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564109|NCT01210664|3826104|P3|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564110|NCT01210664|3826105|P2|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564111|NCT01210664|3826106|P1|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
1564112|NCT01210664|3826103|P4|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564113|NCT01210664|3826104|P3|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564114|NCT01210664|3826105|P2|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
1564115|NCT01210664|3826106|P1|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
1564116|NCT01210651|3826134|P2|NOT COMPLETED|Overall Study||8
1564117|NCT01210651|3826135|P1|NOT COMPLETED|Overall Study||5
1564118|NCT01210651|3826134|P2|COMPLETED|Overall Study||10
1564119|NCT01210651|3826135|P1|COMPLETED|Overall Study||15
1564120|NCT01210651|3826134|P2|Number Attending 1st Assigned Session|Overall Study||12
1564121|NCT01210651|3826135|P1|Number Attending 1st Assigned Session|Overall Study||18
1564122|NCT01210651|3826134|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
1564123|NCT01210651|3826135|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
1564124|NCT01210560|3826151|P9|NOT COMPLETED|Intervention 3 (7 Days)||0
1564125|NCT01210560|3826152|P8|NOT COMPLETED|Intervention 3 (7 Days)||0
1564126|NCT01210560|3826153|P7|NOT COMPLETED|Intervention 3 (7 Days)||0
1564127|NCT01210560|3826154|P6|NOT COMPLETED|Intervention 3 (7 Days)||0
1564128|NCT01210560|3826155|P5|NOT COMPLETED|Intervention 3 (7 Days)||0
1564129|NCT01210560|3826156|P4|NOT COMPLETED|Intervention 3 (7 Days)||0
1564130|NCT01210560|3826157|P3|NOT COMPLETED|Intervention 3 (7 Days)||0
1564131|NCT01210560|3826158|P2|NOT COMPLETED|Intervention 3 (7 Days)||0
1564132|NCT01210560|3826159|P1|NOT COMPLETED|Intervention 3 (7 Days)||0
1564133|NCT01210560|3826151|P9|COMPLETED|Intervention 3 (7 Days)||5
1564134|NCT01210560|3826152|P8|COMPLETED|Intervention 3 (7 Days)||4
1564135|NCT01210560|3826153|P7|COMPLETED|Intervention 3 (7 Days)||4
1564136|NCT01210560|3826154|P6|COMPLETED|Intervention 3 (7 Days)||2
1564137|NCT01210560|3826155|P5|COMPLETED|Intervention 3 (7 Days)||2
1564138|NCT01210560|3826156|P4|COMPLETED|Intervention 3 (7 Days)||2
1564139|NCT01210560|3826157|P3|COMPLETED|Intervention 3 (7 Days)||2
1564140|NCT01210560|3826158|P2|COMPLETED|Intervention 3 (7 Days)||2
1564141|NCT01210560|3826159|P1|COMPLETED|Intervention 3 (7 Days)||2
1564142|NCT01210560|3826151|P9|STARTED|Intervention 3 (7 Days)||5
1564143|NCT01210560|3826152|P8|STARTED|Intervention 3 (7 Days)||4
1564144|NCT01210560|3826153|P7|STARTED|Intervention 3 (7 Days)||4
1564145|NCT01210560|3826154|P6|STARTED|Intervention 3 (7 Days)||2
1564146|NCT01210560|3826155|P5|STARTED|Intervention 3 (7 Days)||2
1564147|NCT01210560|3826156|P4|STARTED|Intervention 3 (7 Days)||2
1564148|NCT01210560|3826157|P3|STARTED|Intervention 3 (7 Days)||2
1564149|NCT01210560|3826158|P2|STARTED|Intervention 3 (7 Days)||2
1564150|NCT01210560|3826159|P1|STARTED|Intervention 3 (7 Days)||2
1564151|NCT01210560|3826151|P9|NOT COMPLETED|Intervention 2 (7 Days)||0
1564152|NCT01210560|3826152|P8|NOT COMPLETED|Intervention 2 (7 Days)||0
1564153|NCT01210560|3826153|P7|NOT COMPLETED|Intervention 2 (7 Days)||0
1564154|NCT01210560|3826154|P6|NOT COMPLETED|Intervention 2 (7 Days)||0
1564155|NCT01210560|3826155|P5|NOT COMPLETED|Intervention 2 (7 Days)||0
1564156|NCT01210560|3826156|P4|NOT COMPLETED|Intervention 2 (7 Days)||0
1564157|NCT01210560|3826157|P3|NOT COMPLETED|Intervention 2 (7 Days)||0
1564158|NCT01210560|3826158|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
1564159|NCT01210560|3826159|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
1564160|NCT01210560|3826151|P9|COMPLETED|Intervention 2 (7 Days)||5
1564161|NCT01210560|3826152|P8|COMPLETED|Intervention 2 (7 Days)||4
1564162|NCT01210560|3826153|P7|COMPLETED|Intervention 2 (7 Days)||4
1564163|NCT01210560|3826154|P6|COMPLETED|Intervention 2 (7 Days)||2
1564164|NCT01210560|3826155|P5|COMPLETED|Intervention 2 (7 Days)||2
1564165|NCT01210560|3826156|P4|COMPLETED|Intervention 2 (7 Days)||2
1564166|NCT01210560|3826157|P3|COMPLETED|Intervention 2 (7 Days)||2
1564167|NCT01210560|3826158|P2|COMPLETED|Intervention 2 (7 Days)||2
1564168|NCT01210560|3826159|P1|COMPLETED|Intervention 2 (7 Days)||2
1564169|NCT01210560|3826151|P9|STARTED|Intervention 2 (7 Days)||5
1564170|NCT01210560|3826152|P8|STARTED|Intervention 2 (7 Days)||4
1564171|NCT01210560|3826153|P7|STARTED|Intervention 2 (7 Days)||4
1564172|NCT01210560|3826154|P6|STARTED|Intervention 2 (7 Days)||2
1564173|NCT01210560|3826155|P5|STARTED|Intervention 2 (7 Days)||2
1564174|NCT01210560|3826156|P4|STARTED|Intervention 2 (7 Days)||2
1564175|NCT01210560|3826157|P3|STARTED|Intervention 2 (7 Days)||2
1564176|NCT01210560|3826158|P2|STARTED|Intervention 2 (7 Days)||2
1564177|NCT01210560|3826159|P1|STARTED|Intervention 2 (7 Days)||2
1564178|NCT01210560|3826151|P9|NOT COMPLETED|Intervention 1 (7 Days)||0
1564179|NCT01210560|3826152|P8|NOT COMPLETED|Intervention 1 (7 Days)||0
1564180|NCT01210560|3826153|P7|NOT COMPLETED|Intervention 1 (7 Days)||0
1564181|NCT01210560|3826154|P6|NOT COMPLETED|Intervention 1 (7 Days)||0
1564182|NCT01210560|3826155|P5|NOT COMPLETED|Intervention 1 (7 Days)||0
1564183|NCT01210560|3826156|P4|NOT COMPLETED|Intervention 1 (7 Days)||0
1564184|NCT01210560|3826157|P3|NOT COMPLETED|Intervention 1 (7 Days)||0
1564185|NCT01210560|3826158|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
1564186|NCT01210560|3826159|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
1564187|NCT01210560|3826151|P9|COMPLETED|Intervention 1 (7 Days)||5
1564188|NCT01210560|3826152|P8|COMPLETED|Intervention 1 (7 Days)||4
1564189|NCT01210560|3826153|P7|COMPLETED|Intervention 1 (7 Days)||4
1564190|NCT01210560|3826154|P6|COMPLETED|Intervention 1 (7 Days)||2
1564191|NCT01210560|3826155|P5|COMPLETED|Intervention 1 (7 Days)||2
1564192|NCT01210560|3826156|P4|COMPLETED|Intervention 1 (7 Days)||2
1564193|NCT01210560|3826157|P3|COMPLETED|Intervention 1 (7 Days)||2
1564194|NCT01210560|3826158|P2|COMPLETED|Intervention 1 (7 Days)||2
1564195|NCT01210560|3826159|P1|COMPLETED|Intervention 1 (7 Days)||2
1564196|NCT01210560|3826151|P9|STARTED|Intervention 1 (7 Days)||5
1564197|NCT01210560|3826152|P8|STARTED|Intervention 1 (7 Days)||4
1564198|NCT01210560|3826153|P7|STARTED|Intervention 1 (7 Days)||4
1564199|NCT01210560|3826154|P6|STARTED|Intervention 1 (7 Days)||2
1564200|NCT01210560|3826155|P5|STARTED|Intervention 1 (7 Days)||2
1564201|NCT01210560|3826156|P4|STARTED|Intervention 1 (7 Days)||2
1564202|NCT01210560|3826157|P3|STARTED|Intervention 1 (7 Days)||2
1564203|NCT01210560|3826158|P2|STARTED|Intervention 1 (7 Days)||2
1564204|NCT01210560|3826159|P1|STARTED|Intervention 1 (7 Days)||2
1564205|NCT01210495|3826255|P4|NOT COMPLETED|Overall Study||68
1564206|NCT01210495|3826256|P3|NOT COMPLETED|Overall Study||134
1564207|NCT01210495|3826257|P2|NOT COMPLETED|Overall Study||7
1564208|NCT01210495|3826258|P1|NOT COMPLETED|Overall Study||15
1564209|NCT01210495|3826255|P4|COMPLETED|Overall Study||0
1564210|NCT01210495|3826256|P3|COMPLETED|Overall Study||0
1564211|NCT01210495|3826257|P2|COMPLETED|Overall Study||0
1564212|NCT01210495|3826258|P1|COMPLETED|Overall Study||0
1564213|NCT01210495|3826255|P4|STARTED|Overall Study||68
1564214|NCT01210495|3826256|P3|STARTED|Overall Study||134
1564215|NCT01210495|3826257|P2|STARTED|Overall Study||7
1564216|NCT01210495|3826258|P1|STARTED|Overall Study||15
1564217|NCT01210443|3826320|P1|NOT COMPLETED|Overall Study||2
1564218|NCT01210443|3826320|P1|COMPLETED|Overall Study||0
1564219|NCT01210443|3826320|P1|STARTED|Overall Study||2
1564220|NCT01210222|3826328|P1|NOT COMPLETED|Overall Study||3
1564221|NCT01210222|3826328|P1|COMPLETED|Overall Study||32
1564222|NCT01210222|3826328|P1|STARTED|Overall Study||35
1564223|NCT01210170|3826341|P1|NOT COMPLETED|Overall Study||7
1564224|NCT01210170|3826341|P1|COMPLETED|Overall Study||15
1564225|NCT01210170|3826341|P1|STARTED|Overall Study||22
1564226|NCT01210144|3826364|P2|NOT COMPLETED|Overall Study||0
1564227|NCT01210144|3826365|P1|NOT COMPLETED|Overall Study||3
1564228|NCT01210144|3826364|P2|COMPLETED|Overall Study||11
1564229|NCT01210144|3826365|P1|COMPLETED|Overall Study||10
1564230|NCT01210144|3826364|P2|STARTED|Overall Study||11
1564231|NCT01210144|3826365|P1|STARTED|Overall Study||13
1564232|NCT01210118|3826387|P2|NOT COMPLETED|Overall Study||5
1564233|NCT01210118|3826388|P1|NOT COMPLETED|Overall Study||3
1564234|NCT01210118|3826387|P2|COMPLETED|Overall Study||42
1564235|NCT01210118|3826388|P1|COMPLETED|Overall Study||42
1564236|NCT01210118|3826387|P2|STARTED|Overall Study||47
1564237|NCT01210118|3826388|P1|STARTED|Overall Study||45
1564238|NCT01210079|3826402|P2|NOT COMPLETED|Overall Study||0
1564239|NCT01210079|3826403|P1|NOT COMPLETED|Overall Study||0
1564240|NCT01210079|3826402|P2|COMPLETED|Overall Study||16
1564241|NCT01210079|3826403|P1|COMPLETED|Overall Study||10
1564242|NCT01210079|3826402|P2|STARTED|Overall Study||16
1564243|NCT01210079|3826403|P1|STARTED|Overall Study||10
1564244|NCT01210001|3826412|P3|NOT COMPLETED|Overall Study||12
1564245|NCT01210001|3826413|P2|NOT COMPLETED|Overall Study||11
1564246|NCT01210001|3826414|P1|NOT COMPLETED|Overall Study||19
1564247|NCT01210001|3826412|P3|COMPLETED|Overall Study||156
1564248|NCT01210001|3826413|P2|COMPLETED|Overall Study||154
1564249|NCT01210001|3826414|P1|COMPLETED|Overall Study||147
1564250|NCT01210001|3826412|P3|STARTED|Overall Study||168
1564251|NCT01210001|3826413|P2|STARTED|Overall Study||165
1564252|NCT01210001|3826414|P1|STARTED|Overall Study||166
1564253|NCT01209949|3826434|P1|NOT COMPLETED|Overall Study||3
1564254|NCT01209949|3826434|P1|COMPLETED|Overall Study||27
1564255|NCT01209949|3826434|P1|STARTED|Overall Study||30
1564256|NCT01209780|3826444|P5|NOT COMPLETED|Overall Study||5
1564257|NCT01209780|3826445|P4|NOT COMPLETED|Overall Study||10
1564258|NCT01209780|3826446|P3|NOT COMPLETED|Overall Study||4
1564259|NCT01209780|3826447|P2|NOT COMPLETED|Overall Study||18
1564260|NCT01209780|3826448|P1|NOT COMPLETED|Overall Study||26
1564261|NCT01209780|3826444|P5|COMPLETED|Overall Study||407
1564262|NCT01209780|3826445|P4|COMPLETED|Overall Study||807
1564263|NCT01209780|3826446|P3|COMPLETED|Overall Study||44
1564264|NCT01209780|3826447|P2|COMPLETED|Overall Study||467
1564265|NCT01209780|3826448|P1|COMPLETED|Overall Study||1016
1564266|NCT01209780|3826444|P5|STARTED|Overall Study||412
1564267|NCT01209780|3826445|P4|STARTED|Overall Study||817
1564268|NCT01209780|3826446|P3|STARTED|Overall Study||48
1564269|NCT01209780|3826447|P2|STARTED|Overall Study||485
1564270|NCT01209780|3826448|P1|STARTED|Overall Study||1042
1564271|NCT01209767|3826474|P1|NOT COMPLETED|Overall Study||4
1564272|NCT01209767|3826474|P1|COMPLETED|Overall Study||18
1564273|NCT01209767|3826474|P1|STARTED|Overall Study||22
1564274|NCT01209702|3826484|P4|NOT COMPLETED|Overall Study||153
1564275|NCT01209702|3826485|P3|NOT COMPLETED|Overall Study||51
1564276|NCT01209702|3826486|P2|NOT COMPLETED|Overall Study||51
1564277|NCT01209702|3826487|P1|NOT COMPLETED|Overall Study||51
1564278|NCT01209702|3826484|P4|COMPLETED|Overall Study||0
1564279|NCT01209702|3826485|P3|COMPLETED|Overall Study||0
1564280|NCT01209702|3826486|P2|COMPLETED|Overall Study||0
1564281|NCT01209702|3826487|P1|COMPLETED|Overall Study||0
1564282|NCT01209702|3826484|P4|Completed 24 Weeks Treatment|Overall Study||10
1564283|NCT01209702|3826485|P3|Completed 24 Weeks Treatment|Overall Study||3
1564284|NCT01209702|3826486|P2|Completed 24 Weeks Treatment|Overall Study||28
1564285|NCT01209702|3826487|P1|Completed 24 Weeks Treatment|Overall Study||19
1564286|NCT01209702|3826484|P4|Completed 12 Weeks Treatment|Overall Study||59
1564287|NCT01209702|3826485|P3|Completed 12 Weeks Treatment|Overall Study||12
1564288|NCT01209702|3826486|P2|Completed 12 Weeks Treatment|Overall Study||48
1564289|NCT01209702|3826487|P1|Completed 12 Weeks Treatment|Overall Study||50
1564290|NCT01209702|3826484|P4|Escape or Switched to Tocilizumab|Overall Study||0
1564291|NCT01209702|3826485|P3|Escape or Switched to Tocilizumab|Overall Study||6
1564292|NCT01209702|3826486|P2|Escape or Switched to Tocilizumab|Overall Study||0
1564293|NCT01209702|3826487|P1|Escape or Switched to Tocilizumab|Overall Study||51
1564294|NCT01209702|3826484|P4|Treated|Overall Study||152
1564295|NCT01209702|3826485|P3|Treated|Overall Study||51
1564296|NCT01209702|3826486|P2|Treated|Overall Study||51
1564297|NCT01209702|3826487|P1|Treated|Overall Study||51
1564298|NCT01209702|3826484|P4|STARTED|Overall Study||153
1564299|NCT01209702|3826485|P3|STARTED|Overall Study||51
1564300|NCT01209702|3826486|P2|STARTED|Overall Study||51
1564301|NCT01209702|3826487|P1|STARTED|Overall Study||51
1564302|NCT01209689|3826543|P2|NOT COMPLETED|Overall Study||22
1564303|NCT01209689|3826544|P1|NOT COMPLETED|Overall Study||91
1564304|NCT01209689|3826543|P2|COMPLETED|Overall Study||0
1564305|NCT01209689|3826544|P1|COMPLETED|Overall Study||0
1564306|NCT01209689|3826543|P2|STARTED|Overall Study||22
1564307|NCT01209689|3826544|P1|STARTED|Overall Study||91
1564308|NCT01209624|3826550|P1|NOT COMPLETED|Overall Study||326
1564309|NCT01209624|3826550|P1|COMPLETED|Overall Study||576
1564310|NCT01209624|3826550|P1|Per Protocol Population|Overall Study||469
1564311|NCT01209624|3826550|P1|STARTED|Overall Study||902
1564312|NCT01209598|3826583|P2|NOT COMPLETED|Overall Study||0
1564313|NCT01209598|3826584|P1|NOT COMPLETED|Overall Study||1
1564314|NCT01209598|3826583|P2|COMPLETED|Overall Study||60
1564315|NCT01209598|3826584|P1|COMPLETED|Overall Study||29
1564316|NCT01209598|3826583|P2|STARTED|Overall Study||60
1564317|NCT01209598|3826584|P1|STARTED|Overall Study||30
1564318|NCT01209520|3826592|P1|NOT COMPLETED|Overall Study||3
1564319|NCT01209520|3826592|P1|COMPLETED|Overall Study||3
1564320|NCT01209520|3826592|P1|STARTED|Overall Study||6
1564321|NCT01209286|3826600|P3|NOT COMPLETED|Overall Study||3
1564322|NCT01209286|3826601|P2|NOT COMPLETED|Overall Study||10
1564323|NCT01209286|3826602|P1|NOT COMPLETED|Overall Study||5
1564324|NCT01209286|3826600|P3|COMPLETED|Overall Study||3
1564325|NCT01209286|3826601|P2|COMPLETED|Overall Study||13
1564326|NCT01209286|3826602|P1|COMPLETED|Overall Study||2
1564327|NCT01209286|3826600|P3|STARTED|Overall Study||6
1564328|NCT01209286|3826601|P2|STARTED|Overall Study||23
1564329|NCT01209286|3826602|P1|STARTED|Overall Study||7
1564330|NCT01209260|3826655|P2|NOT COMPLETED|Overall Study||0
1564331|NCT01209260|3826656|P1|NOT COMPLETED|Overall Study||0
1564332|NCT01209260|3826655|P2|COMPLETED|Overall Study||36
1564333|NCT01209260|3826656|P1|COMPLETED|Overall Study||36
1564334|NCT01209260|3826655|P2|STARTED|Overall Study||36
1564335|NCT01209260|3826656|P1|STARTED|Overall Study||36
1564336|NCT01209195|3826670|P6|NOT COMPLETED|Overall Study||0
1564337|NCT01209195|3826671|P5|NOT COMPLETED|Overall Study||0
1564338|NCT01209195|3826672|P4|NOT COMPLETED|Overall Study||0
1564339|NCT01209195|3826673|P3|NOT COMPLETED|Overall Study||0
1564340|NCT01209195|3826674|P2|NOT COMPLETED|Overall Study||0
1564341|NCT01209195|3826675|P1|NOT COMPLETED|Overall Study||0
1564342|NCT01209195|3826670|P6|COMPLETED|Overall Study||13
1564343|NCT01209195|3826671|P5|COMPLETED|Overall Study||6
1564344|NCT01209195|3826672|P4|COMPLETED|Overall Study||6
1564345|NCT01209195|3826673|P3|COMPLETED|Overall Study||6
1564346|NCT01209195|3826674|P2|COMPLETED|Overall Study||3
1564347|NCT01209195|3826675|P1|COMPLETED|Overall Study||7
1564348|NCT01209195|3826670|P6|STARTED|Overall Study||13
1564349|NCT01209195|3826671|P5|STARTED|Overall Study||6
1564350|NCT01209195|3826672|P4|STARTED|Overall Study||6
1564351|NCT01209195|3826673|P3|STARTED|Overall Study||6
1564352|NCT01209195|3826674|P2|STARTED|Overall Study||3
1564353|NCT01209195|3826675|P1|STARTED|Overall Study||7
1564354|NCT01209143|3826711|P2|NOT COMPLETED|Overall Study||20
1564355|NCT01209143|3826712|P1|NOT COMPLETED|Overall Study||19
1564356|NCT01209143|3826711|P2|COMPLETED|Overall Study||8
1564357|NCT01209143|3826712|P1|COMPLETED|Overall Study||5
1564358|NCT01209143|3826711|P2|STARTED|Overall Study||28
1564359|NCT01209143|3826712|P1|STARTED|Overall Study||24
1564360|NCT01209078|3826722|P2|NOT COMPLETED|Overall Study||3
1564361|NCT01209078|3826723|P1|NOT COMPLETED|Overall Study||16
1564362|NCT01209078|3826722|P2|COMPLETED|Overall Study||24
1564363|NCT01209078|3826723|P1|COMPLETED|Overall Study||41
1564364|NCT01209078|3826722|P2|STARTED|Overall Study||27
1564365|NCT01209078|3826723|P1|STARTED|Overall Study||57
1564366|NCT01208961|3826798|P2|NOT COMPLETED|High-Fat Period IV||0
1564367|NCT01208961|3826799|P1|NOT COMPLETED|High-Fat Period IV||0
1564368|NCT01208961|3826798|P2|COMPLETED|High-Fat Period IV||26
1564369|NCT01208961|3826799|P1|COMPLETED|High-Fat Period IV||25
1564370|NCT01208961|3826798|P2|STARTED|High-Fat Period IV||26
1564371|NCT01208961|3826799|P1|STARTED|High-Fat Period IV||25
1564372|NCT01208961|3826798|P2|NOT COMPLETED|High-Fat Period III||0
1564373|NCT01208961|3826799|P1|NOT COMPLETED|High-Fat Period III||1
1564374|NCT01208961|3826798|P2|COMPLETED|High-Fat Period III||26
1564375|NCT01208961|3826799|P1|COMPLETED|High-Fat Period III||25
1564376|NCT01208961|3826798|P2|STARTED|High-Fat Period III||26
1564377|NCT01208961|3826799|P1|STARTED|High-Fat Period III||26
1564378|NCT01208961|3826798|P2|NOT COMPLETED|Low-Fat Period II||0
1564379|NCT01208961|3826799|P1|NOT COMPLETED|Low-Fat Period II||0
1564380|NCT01208961|3826798|P2|COMPLETED|Low-Fat Period II||27
1564381|NCT01208961|3826799|P1|COMPLETED|Low-Fat Period II||26
1564382|NCT01208961|3826798|P2|STARTED|Low-Fat Period II||27
1564383|NCT01208961|3826799|P1|STARTED|Low-Fat Period II||26
1564384|NCT01208961|3826798|P2|NOT COMPLETED|Low-Fat Period I||0
1564385|NCT01208961|3826799|P1|NOT COMPLETED|Low-Fat Period I||0
1564386|NCT01208961|3826798|P2|COMPLETED|Low-Fat Period I||27
1564387|NCT01208961|3826799|P1|COMPLETED|Low-Fat Period I||27
1564388|NCT01208961|3826798|P2|STARTED|Low-Fat Period I||27
1564389|NCT01208961|3826799|P1|STARTED|Low-Fat Period I||27
1564390|NCT01208870|3826810|P2|NOT COMPLETED|Overall Study||8
1564391|NCT01208870|3826811|P1|NOT COMPLETED|Overall Study||2
1564392|NCT01208870|3826810|P2|COMPLETED|Overall Study||36
1564393|NCT01208870|3826811|P1|COMPLETED|Overall Study||44
1564394|NCT01208870|3826810|P2|Pilot 2|Overall Study||22
1564395|NCT01208870|3826811|P1|Pilot 2|Overall Study||26
1564396|NCT01208870|3826810|P2|Pilot 1|Overall Study||22
1564397|NCT01208870|3826811|P1|Pilot 1|Overall Study||20
1564398|NCT01208870|3826810|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
1564399|NCT01208870|3826811|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
1564400|NCT01208415|3826827|P1|NOT COMPLETED|Overall Study||40
1564401|NCT01208415|3826827|P1|COMPLETED|Overall Study||0
1564402|NCT01208415|3826827|P1|6 Months|Overall Study||37
1564403|NCT01208415|3826827|P1|STARTED|Overall Study||40
1564404|NCT01208402|3826833|P2|NOT COMPLETED|Overall Study||0
1564405|NCT01208402|3826834|P1|NOT COMPLETED|Overall Study||1
1564406|NCT01208402|3826833|P2|COMPLETED|Overall Study||28
1564407|NCT01208402|3826834|P1|COMPLETED|Overall Study||30
1564408|NCT01208402|3826833|P2|STARTED|Overall Study||28
1564409|NCT01208402|3826834|P1|STARTED|Overall Study||31
1564410|NCT01208337|3826850|P1|NOT COMPLETED|Overall Study||3
1564411|NCT01208337|3826850|P1|COMPLETED|Overall Study||20
1564412|NCT01208337|3826850|P1|Five-year Follow-up|Overall Study||20
1564413|NCT01208337|3826850|P1|One-year Follow-up|Overall Study||23
1564414|NCT01208337|3826850|P1|STARTED|Overall Study||23
1564415|NCT01208233|3826864|P6|NOT COMPLETED|Overall Study||21
1564416|NCT01208233|3826865|P5|NOT COMPLETED|Overall Study||24
1564417|NCT01208233|3826866|P4|NOT COMPLETED|Overall Study||1
1564418|NCT01208233|3826867|P3|NOT COMPLETED|Overall Study||4
1564419|NCT01208233|3826868|P2|NOT COMPLETED|Overall Study||3
1564420|NCT01208233|3826869|P1|NOT COMPLETED|Overall Study||5
1564421|NCT01208233|3826864|P6|COMPLETED|Overall Study||46
1564422|NCT01208233|3826865|P5|COMPLETED|Overall Study||46
1564423|NCT01208233|3826866|P4|COMPLETED|Overall Study||9
1564424|NCT01208233|3826867|P3|COMPLETED|Overall Study||7
1564425|NCT01208233|3826868|P2|COMPLETED|Overall Study||6
1564426|NCT01208233|3826869|P1|COMPLETED|Overall Study||6
1564427|NCT01208233|3826864|P6|STARTED|Overall Study||67
1564428|NCT01208233|3826865|P5|STARTED|Overall Study||70
1564429|NCT01208233|3826866|P4|STARTED|Overall Study||10
1564430|NCT01208233|3826867|P3|STARTED|Overall Study||11
1564431|NCT01208233|3826868|P2|STARTED|Overall Study||9
1564432|NCT01208233|3826869|P1|STARTED|Overall Study||11
1564433|NCT01208220|3826982|P2|NOT COMPLETED|Overall Study||0
1564434|NCT01208220|3826983|P1|NOT COMPLETED|Overall Study||0
1564435|NCT01208220|3826982|P2|COMPLETED|Overall Study||1
1564436|NCT01208220|3826983|P1|COMPLETED|Overall Study||1
1564437|NCT01208220|3826982|P2|STARTED|Overall Study||1
1564438|NCT01208220|3826983|P1|STARTED|Overall Study||1
1564439|NCT01208207|3826994|P7|NOT COMPLETED|Part II||11
1564440|NCT01208207|3826995|P6|NOT COMPLETED|Part II||16
1564441|NCT01208207|3826996|P5|NOT COMPLETED|Part II||23
1564442|NCT01208207|3826997|P4|NOT COMPLETED|Part II||32
1564443|NCT01208207|3826998|P3|NOT COMPLETED|Part II||0
1564444|NCT01208207|3826999|P2|NOT COMPLETED|Part II||0
1564445|NCT01208207|3827000|P1|NOT COMPLETED|Part II||0
1564446|NCT01208207|3826994|P7|COMPLETED|Part II||131
1564447|NCT01208207|3826995|P6|COMPLETED|Part II||129
1564448|NCT01208207|3826996|P5|COMPLETED|Part II||295
1564449|NCT01208207|3826997|P4|COMPLETED|Part II||282
1564450|NCT01208207|3826998|P3|COMPLETED|Part II||0
1564451|NCT01208207|3826999|P2|COMPLETED|Part II||0
1564452|NCT01208207|3827000|P1|COMPLETED|Part II||0
1564453|NCT01208207|3826994|P7|STARTED|Part II||142
1564454|NCT01208207|3826995|P6|STARTED|Part II||145
1564455|NCT01208207|3826996|P5|STARTED|Part II||318
1564456|NCT01208207|3826997|P4|STARTED|Part II||314
1564457|NCT01208207|3826998|P3|STARTED|Part II||0
1564458|NCT01208207|3826999|P2|STARTED|Part II||0
1564459|NCT01208207|3827000|P1|STARTED|Part II||0
1564460|NCT01208207|3826994|P7|NOT COMPLETED|Part I||0
1564461|NCT01208207|3826995|P6|NOT COMPLETED|Part I||0
1564462|NCT01208207|3826996|P5|NOT COMPLETED|Part I||0
1564463|NCT01208207|3826997|P4|NOT COMPLETED|Part I||0
1564464|NCT01208207|3826998|P3|NOT COMPLETED|Part I||15
1564465|NCT01208207|3826999|P2|NOT COMPLETED|Part I||11
1564466|NCT01208207|3827000|P1|NOT COMPLETED|Part I||70
1564467|NCT01208207|3826994|P7|COMPLETED|Part I||0
1564468|NCT01208207|3826995|P6|COMPLETED|Part I||0
1564469|NCT01208207|3826996|P5|COMPLETED|Part I||0
1564470|NCT01208207|3826997|P4|COMPLETED|Part I||0
1564471|NCT01208207|3826998|P3|COMPLETED|Part I||142
1564472|NCT01208207|3826999|P2|COMPLETED|Part I||145
1564473|NCT01208207|3827000|P1|COMPLETED|Part I||632
1564474|NCT01208207|3826994|P7|STARTED|Part I||0
1564475|NCT01208207|3826995|P6|STARTED|Part I||0
1564476|NCT01208207|3826996|P5|STARTED|Part I||0
1564477|NCT01208207|3826997|P4|STARTED|Part I||0
1564478|NCT01208207|3826998|P3|STARTED|Part I||157
1564479|NCT01208207|3826999|P2|STARTED|Part I||156
1564480|NCT01208207|3827000|P1|STARTED|Part I||702
1564481|NCT01208181|3827027|P5|NOT COMPLETED|Part 2||0
1564482|NCT01208181|3827028|P4|NOT COMPLETED|Part 2||20
1564483|NCT01208181|3827029|P3|NOT COMPLETED|Part 2||16
1564484|NCT01208181|3827030|P2|NOT COMPLETED|Part 2||0
1564485|NCT01208181|3827031|P1|NOT COMPLETED|Part 2||0
1564486|NCT01208181|3827027|P5|COMPLETED|Part 2||0
1564487|NCT01208181|3827028|P4|COMPLETED|Part 2||343
1564488|NCT01208181|3827029|P3|COMPLETED|Part 2||334
1564489|NCT01208181|3827030|P2|COMPLETED|Part 2||0
1564490|NCT01208181|3827031|P1|COMPLETED|Part 2||0
1564491|NCT01208181|3827027|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
1564492|NCT01208181|3827028|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
1564493|NCT01208181|3827029|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
1564494|NCT01208181|3827030|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
1564495|NCT01208181|3827031|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
1564496|NCT01208181|3827027|P5|NOT COMPLETED|Part 1||22
1564497|NCT01208181|3827028|P4|NOT COMPLETED|Part 1||0
1564498|NCT01208181|3827029|P3|NOT COMPLETED|Part 1||0
1564499|NCT01208181|3827030|P2|NOT COMPLETED|Part 1||55
1564500|NCT01208181|3827031|P1|NOT COMPLETED|Part 1||99
1564501|NCT01208181|3827027|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
1564502|NCT01208181|3827028|P4|COMPLETED|Part 1||0
1564503|NCT01208181|3827029|P3|COMPLETED|Part 1||0
1564504|NCT01208181|3827030|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
1564505|NCT01208181|3827031|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
1564506|NCT01208181|3827027|P5|STARTED|Part 1||118
1564507|NCT01208181|3827028|P4|STARTED|Part 1||0
1564508|NCT01208181|3827029|P3|STARTED|Part 1||0
1564509|NCT01208181|3827030|P2|STARTED|Part 1||468
1564510|NCT01208181|3827031|P1|STARTED|Part 1||818
1564511|NCT01207934|3827063|P3|NOT COMPLETED|Overall Study||0
1564512|NCT01207934|3827064|P2|NOT COMPLETED|Overall Study||0
1564513|NCT01207934|3827065|P1|NOT COMPLETED|Overall Study||0
1564514|NCT01207934|3827063|P3|COMPLETED|Overall Study||6
1564515|NCT01207934|3827064|P2|COMPLETED|Overall Study||6
1564516|NCT01207934|3827065|P1|COMPLETED|Overall Study||6
1564517|NCT01207934|3827063|P3|STARTED|Overall Study||6
1564518|NCT01207934|3827064|P2|STARTED|Overall Study||6
1564519|NCT01207934|3827065|P1|STARTED|Overall Study||6
1564520|NCT01207765|3827082|P1|NOT COMPLETED|Overall Study||0
1564521|NCT01207765|3827082|P1|COMPLETED|Overall Study||8
1564522|NCT01207765|3827082|P1|STARTED|Overall Study||8
1564523|NCT01207687|3827088|P1|NOT COMPLETED|Overall Study||2
1564524|NCT01207687|3827088|P1|COMPLETED|Overall Study||12
1564525|NCT01207687|3827088|P1|STARTED|Overall Study||14
1564526|NCT01207648|3827118|P1|NOT COMPLETED|Overall Study||0
1564527|NCT01207648|3827118|P1|COMPLETED|Overall Study||307
1564528|NCT01207648|3827118|P1|STARTED|Overall Study||307
1564529|NCT01207596|3827126|P1|NOT COMPLETED|Overall Study||9
1564530|NCT01207596|3827126|P1|COMPLETED|Overall Study||21
1564531|NCT01207596|3827126|P1|STARTED|Overall Study||30
1564532|NCT01207583|3827139|P3|NOT COMPLETED|Overall Study||1
1564533|NCT01207583|3827140|P2|NOT COMPLETED|Overall Study||5
1564534|NCT01207583|3827141|P1|NOT COMPLETED|Overall Study||1
1564535|NCT01207583|3827139|P3|COMPLETED|Overall Study||54
1564536|NCT01207583|3827140|P2|COMPLETED|Overall Study||26
1564537|NCT01207583|3827141|P1|COMPLETED|Overall Study||13
1564538|NCT01207583|3827139|P3|Dose 4|Overall Study||0
1564539|NCT01207583|3827140|P2|Dose 4|Overall Study||0
1564540|NCT01207583|3827141|P1|Dose 4|Overall Study||7
1564541|NCT01207583|3827139|P3|Dose 3|Overall Study||0
1564542|NCT01207583|3827140|P2|Dose 3|Overall Study||27
1564543|NCT01207583|3827141|P1|Dose 3|Overall Study||13
1564544|NCT01207583|3827139|P3|Dose 2|Overall Study||54
1564545|NCT01207583|3827140|P2|Dose 2|Overall Study||29
1564546|NCT01207583|3827141|P1|Dose 2|Overall Study||13
1564547|NCT01207583|3827139|P3|Dose 1|Overall Study||55
1564548|NCT01207583|3827140|P2|Dose 1|Overall Study||31
1564549|NCT01207583|3827141|P1|Dose 1|Overall Study||14
1564550|NCT01207583|3827139|P3|STARTED|Overall Study||55
1564551|NCT01207583|3827140|P2|STARTED|Overall Study||31
1564552|NCT01207583|3827141|P1|STARTED|Overall Study||14
1564553|NCT01207570|3827181|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
1564554|NCT01207570|3827182|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
1564555|NCT01207570|3827181|P2|COMPLETED|The Second Stage (After Crossover)||23
1564556|NCT01207570|3827182|P1|COMPLETED|The Second Stage (After Crossover)||31
1564557|NCT01207570|3827181|P2|STARTED|The Second Stage (After Crossover)||23
1564558|NCT01207570|3827182|P1|STARTED|The Second Stage (After Crossover)||31
1564559|NCT01207570|3827181|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
1564560|NCT01207570|3827182|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
1564561|NCT01207570|3827181|P2|COMPLETED|The First Stage (Before Crossover)||31
1564562|NCT01207570|3827182|P1|COMPLETED|The First Stage (Before Crossover)||23
1564563|NCT01207570|3827181|P2|STARTED|The First Stage (Before Crossover)||31
1564564|NCT01207570|3827182|P1|STARTED|The First Stage (Before Crossover)||23
1564565|NCT01207492|3827194|P1|NOT COMPLETED|Overall Study||15
1564566|NCT01207492|3827194|P1|COMPLETED|Overall Study||2
1564567|NCT01207492|3827194|P1|STARTED|Overall Study||17
1564568|NCT01207466|3827200|P2|NOT COMPLETED|Period 2, One Week of Wear||0
1564569|NCT01207466|3827201|P1|NOT COMPLETED|Period 2, One Week of Wear||0
1564570|NCT01207466|3827200|P2|COMPLETED|Period 2, One Week of Wear||48
1564571|NCT01207466|3827201|P1|COMPLETED|Period 2, One Week of Wear||45
1564572|NCT01207466|3827200|P2|STARTED|Period 2, One Week of Wear||48
1564573|NCT01207466|3827201|P1|STARTED|Period 2, One Week of Wear||45
1564574|NCT01207466|3827200|P2|NOT COMPLETED|Period 1, One Week of Wear||0
1564575|NCT01207466|3827201|P1|NOT COMPLETED|Period 1, One Week of Wear||0
1564576|NCT01207466|3827200|P2|COMPLETED|Period 1, One Week of Wear||48
1564577|NCT01207466|3827201|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
1564578|NCT01207466|3827200|P2|STARTED|Period 1, One Week of Wear||48
1564579|NCT01207466|3827201|P1|STARTED|Period 1, One Week of Wear||46
1564580|NCT01207453|3827209|P2|NOT COMPLETED|2nd Intervention||2
1564581|NCT01207453|3827210|P1|NOT COMPLETED|2nd Intervention||2
1564582|NCT01207453|3827209|P2|COMPLETED|2nd Intervention||15
1564583|NCT01207453|3827210|P1|COMPLETED|2nd Intervention||17
1564584|NCT01207453|3827209|P2|STARTED|2nd Intervention||17
1564585|NCT01207453|3827210|P1|STARTED|2nd Intervention||19
1564586|NCT01207453|3827209|P2|NOT COMPLETED|Washout||0
1564587|NCT01207453|3827210|P1|NOT COMPLETED|Washout||2
1564588|NCT01207453|3827209|P2|COMPLETED|Washout||17
1564589|NCT01207453|3827210|P1|COMPLETED|Washout||19
1564590|NCT01207453|3827209|P2|STARTED|Washout||17
1564591|NCT01207453|3827210|P1|STARTED|Washout||21
1564592|NCT01207453|3827209|P2|NOT COMPLETED|First Intervention||1
1564593|NCT01207453|3827210|P1|NOT COMPLETED|First Intervention||2
1564594|NCT01207453|3827209|P2|COMPLETED|First Intervention||17
1564595|NCT01207453|3827210|P1|COMPLETED|First Intervention||21
1564596|NCT01207453|3827209|P2|STARTED|First Intervention||18
1564597|NCT01207453|3827210|P1|STARTED|First Intervention||23
1564598|NCT01207427|3827232|P3|NOT COMPLETED|Run-out Placebo Period||0
1564599|NCT01207427|3827233|P2|NOT COMPLETED|Run-out Placebo Period||0
1564600|NCT01207427|3827234|P1|NOT COMPLETED|Run-out Placebo Period||0
1564601|NCT01207427|3827232|P3|COMPLETED|Run-out Placebo Period||41
1564602|NCT01207427|3827233|P2|COMPLETED|Run-out Placebo Period||43
1564603|NCT01207427|3827234|P1|COMPLETED|Run-out Placebo Period||40
1564604|NCT01207427|3827232|P3|STARTED|Run-out Placebo Period||41
1564605|NCT01207427|3827233|P2|STARTED|Run-out Placebo Period||43
1564606|NCT01207427|3827234|P1|STARTED|Run-out Placebo Period||40
1564607|NCT01207427|3827232|P3|NOT COMPLETED|Double-blind Treatment Period||2
1564608|NCT01207427|3827233|P2|NOT COMPLETED|Double-blind Treatment Period||2
1564609|NCT01207427|3827234|P1|NOT COMPLETED|Double-blind Treatment Period||3
1564610|NCT01207427|3827232|P3|COMPLETED|Double-blind Treatment Period||41
1564611|NCT01207427|3827233|P2|COMPLETED|Double-blind Treatment Period||43
1564612|NCT01207427|3827234|P1|COMPLETED|Double-blind Treatment Period||40
1564613|NCT01207427|3827232|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
1564614|NCT01207427|3827233|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
1564615|NCT01207427|3827234|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
1564616|NCT01207427|3827232|P3|STARTED|Double-blind Treatment Period||43
1564617|NCT01207427|3827233|P2|STARTED|Double-blind Treatment Period||45
1564618|NCT01207427|3827234|P1|STARTED|Double-blind Treatment Period||43
1564619|NCT01207427|3827232|P3|NOT COMPLETED|Run-in Placebo Period||0
1564620|NCT01207427|3827233|P2|NOT COMPLETED|Run-in Placebo Period||0
1564621|NCT01207427|3827234|P1|NOT COMPLETED|Run-in Placebo Period||0
1564622|NCT01207427|3827232|P3|COMPLETED|Run-in Placebo Period||43
1564623|NCT01207427|3827233|P2|COMPLETED|Run-in Placebo Period||45
1564624|NCT01207427|3827234|P1|COMPLETED|Run-in Placebo Period||43
1564625|NCT01207427|3827232|P3|STARTED|Run-in Placebo Period||43
1564626|NCT01207427|3827233|P2|STARTED|Run-in Placebo Period||45
1564627|NCT01207427|3827234|P1|STARTED|Run-in Placebo Period||43
1564628|NCT01207414|3827244|P2|NOT COMPLETED|Overall Study||82
1564629|NCT01207414|3827245|P1|NOT COMPLETED|Overall Study||73
1564630|NCT01207414|3827244|P2|COMPLETED|Overall Study||178
1564631|NCT01207414|3827245|P1|COMPLETED|Overall Study||168
1564632|NCT01207414|3827244|P2|Safety Population: Received Study Drug|Overall Study||260
1564633|NCT01207414|3827245|P1|Safety Population: Received Study Drug|Overall Study||240
1564634|NCT01207414|3827244|P2|STARTED|Overall Study||260
1564635|NCT01207414|3827245|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
1564636|NCT01207401|3827263|P2|NOT COMPLETED|Overall Study||0
1564637|NCT01207401|3827264|P1|NOT COMPLETED|Overall Study||0
1564638|NCT01207401|3827263|P2|COMPLETED|Overall Study||24
1564639|NCT01207401|3827264|P1|COMPLETED|Overall Study||26
1564640|NCT01207401|3827263|P2|STARTED|Overall Study||24
1564641|NCT01207401|3827264|P1|STARTED|Overall Study||26
1564642|NCT01207388|3827270|P1|NOT COMPLETED|Overall Study||33
1564643|NCT01207388|3827270|P1|COMPLETED|Overall Study|Completed the core study|83
1564644|NCT01207388|3827270|P1|STARTED|Overall Study||116
1564645|NCT01207219|3827293|P3|NOT COMPLETED|Overall Study||7
1564646|NCT01207219|3827294|P2|NOT COMPLETED|Overall Study||11
1564647|NCT01207219|3827295|P1|NOT COMPLETED|Overall Study||11
1564648|NCT01207219|3827293|P3|COMPLETED|Overall Study||32
1564649|NCT01207219|3827294|P2|COMPLETED|Overall Study||29
1564650|NCT01207219|3827295|P1|COMPLETED|Overall Study||34
1564651|NCT01207219|3827293|P3|Included in ITT Analysis|Overall Study||38
1564652|NCT01207219|3827294|P2|Included in ITT Analysis|Overall Study||37
1564653|NCT01207219|3827295|P1|Included in ITT Analysis|Overall Study||40
1564654|NCT01207219|3827293|P3|STARTED|Overall Study||39
1564655|NCT01207219|3827294|P2|STARTED|Overall Study||40
1564656|NCT01207219|3827295|P1|STARTED|Overall Study||45
1564657|NCT01207102|3827315|P1|NOT COMPLETED|Overall Study||10
1564658|NCT01207102|3827315|P1|COMPLETED|Overall Study||0
1564659|NCT01207102|3827315|P1|STARTED|Overall Study||10
1564660|NCT01206777|3827320|P1|NOT COMPLETED|Overall Study||2
1564661|NCT01206777|3827320|P1|COMPLETED|Overall Study||50
1564662|NCT01206777|3827320|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
1564663|NCT01206777|3827320|P1|STARTED|Overall Study||52
1564664|NCT01206738|3827329|P3|NOT COMPLETED|Overall Study||19
1564665|NCT01206738|3827330|P2|NOT COMPLETED|Overall Study||25
1564666|NCT01206738|3827331|P1|NOT COMPLETED|Overall Study||23
1564667|NCT01206738|3827329|P3|COMPLETED|Overall Study||42
1564668|NCT01206738|3827330|P2|COMPLETED|Overall Study||49
1564669|NCT01206738|3827331|P1|COMPLETED|Overall Study||40
1564670|NCT01206738|3827329|P3|STARTED|Overall Study||61
1564671|NCT01206738|3827330|P2|STARTED|Overall Study||74
1564672|NCT01206738|3827331|P1|STARTED|Overall Study||63
1564673|NCT01206660|3827343|P2|NOT COMPLETED|Overall Study||0
1564674|NCT01206660|3827344|P1|NOT COMPLETED|Overall Study||0
1564675|NCT01206660|3827343|P2|COMPLETED|Overall Study||60
1564676|NCT01206660|3827344|P1|COMPLETED|Overall Study||60
1564677|NCT01206660|3827343|P2|STARTED|Overall Study||60
1564678|NCT01206660|3827344|P1|STARTED|Overall Study||60
1564679|NCT01206608|3827356|P2|NOT COMPLETED|Overall Study||0
1564680|NCT01206608|3827357|P1|NOT COMPLETED|Overall Study||0
1564681|NCT01206608|3827356|P2|COMPLETED|Overall Study||20
1564682|NCT01206608|3827357|P1|COMPLETED|Overall Study||20
1564683|NCT01206608|3827356|P2|STARTED|Overall Study||20
1564684|NCT01206608|3827357|P1|STARTED|Overall Study||20
1564685|NCT01206595|3827365|P2|NOT COMPLETED|Overall Study||0
1564686|NCT01206595|3827366|P1|NOT COMPLETED|Overall Study||0
1564687|NCT01206595|3827365|P2|COMPLETED|Overall Study||20
1564688|NCT01206595|3827366|P1|COMPLETED|Overall Study||38
1564689|NCT01206595|3827365|P2|STARTED|Overall Study||20
1564690|NCT01206595|3827366|P1|STARTED|Overall Study||38
1564691|NCT01206582|3827376|P2|NOT COMPLETED|Overall Study||2
1564692|NCT01206582|3827377|P1|NOT COMPLETED|Overall Study||2
1564693|NCT01206582|3827376|P2|COMPLETED|Overall Study||7
1564694|NCT01206582|3827377|P1|COMPLETED|Overall Study||9
1564695|NCT01206582|3827376|P2|STARTED|Overall Study||9
1564696|NCT01206582|3827377|P1|STARTED|Overall Study||11
1564697|NCT01206517|3827409|P6|NOT COMPLETED|Overall Study||0
1564698|NCT01206517|3827410|P5|NOT COMPLETED|Overall Study||1
1564699|NCT01206517|3827411|P4|NOT COMPLETED|Overall Study||0
1564700|NCT01206517|3827412|P3|NOT COMPLETED|Overall Study||2
1564701|NCT01206517|3827413|P2|NOT COMPLETED|Overall Study||0
1564702|NCT01206517|3827414|P1|NOT COMPLETED|Overall Study||0
1564703|NCT01206517|3827409|P6|COMPLETED|Overall Study||4
1564704|NCT01206517|3827410|P5|COMPLETED|Overall Study||3
1564705|NCT01206517|3827411|P4|COMPLETED|Overall Study||4
1564706|NCT01206517|3827412|P3|COMPLETED|Overall Study||4
1564707|NCT01206517|3827413|P2|COMPLETED|Overall Study||6
1564708|NCT01206517|3827414|P1|COMPLETED|Overall Study||6
1564709|NCT01206517|3827409|P6|STARTED|Overall Study||4
1564710|NCT01206517|3827410|P5|STARTED|Overall Study||4
1564711|NCT01206517|3827411|P4|STARTED|Overall Study||4
1564712|NCT01206517|3827412|P3|STARTED|Overall Study||6
1564713|NCT01206517|3827413|P2|STARTED|Overall Study||6
1564714|NCT01206517|3827414|P1|STARTED|Overall Study||6
1564715|NCT01206478|3827445|P2|NOT COMPLETED|Overall Study||5
1564716|NCT01206478|3827446|P1|NOT COMPLETED|Overall Study||2
1564717|NCT01206478|3827445|P2|COMPLETED|Overall Study||7
1564718|NCT01206478|3827446|P1|COMPLETED|Overall Study||7
1564719|NCT01206478|3827445|P2|STARTED|Overall Study||12
1564720|NCT01206478|3827446|P1|STARTED|Overall Study||9
1564721|NCT01206465|3827454|P5|NOT COMPLETED|Overall Study||0
1564722|NCT01206465|3827455|P4|NOT COMPLETED|Overall Study||0
1564723|NCT01206465|3827456|P3|NOT COMPLETED|Overall Study||0
1564724|NCT01206465|3827457|P2|NOT COMPLETED|Overall Study||0
1564725|NCT01206465|3827458|P1|NOT COMPLETED|Overall Study||0
1564726|NCT01206465|3827454|P5|COMPLETED|Overall Study||6
1564727|NCT01206465|3827455|P4|COMPLETED|Overall Study||6
1564728|NCT01206465|3827456|P3|COMPLETED|Overall Study||6
1564729|NCT01206465|3827457|P2|COMPLETED|Overall Study||6
1564730|NCT01206465|3827458|P1|COMPLETED|Overall Study||3
1564731|NCT01206465|3827454|P5|STARTED|Overall Study||6
1564732|NCT01206465|3827455|P4|STARTED|Overall Study||6
1564733|NCT01206465|3827456|P3|STARTED|Overall Study||6
1564734|NCT01206465|3827457|P2|STARTED|Overall Study||6
1564735|NCT01206465|3827458|P1|STARTED|Overall Study||3
1564736|NCT01206452|3827479|P2|NOT COMPLETED|Overall Study||0
1564737|NCT01206452|3827480|P1|NOT COMPLETED|Overall Study||0
1564738|NCT01206452|3827479|P2|COMPLETED|Overall Study||30
1564739|NCT01206452|3827480|P1|COMPLETED|Overall Study||30
1564740|NCT01206452|3827479|P2|STARTED|Overall Study||30
1564741|NCT01206452|3827480|P1|STARTED|Overall Study||30
1564742|NCT01206439|3827494|P1|NOT COMPLETED|Overall Study||1
1564743|NCT01206439|3827494|P1|COMPLETED|Overall Study||1
1564744|NCT01206439|3827494|P1|STARTED|Overall Study||2
1564745|NCT01206387|3827500|P2|NOT COMPLETED|Overall Study||0
1564746|NCT01206387|3827501|P1|NOT COMPLETED|Overall Study||1
1564747|NCT01206387|3827500|P2|COMPLETED|Overall Study||60
1564748|NCT01206387|3827501|P1|COMPLETED|Overall Study||59
1564749|NCT01206387|3827500|P2|STARTED|Overall Study||60
1564750|NCT01206387|3827501|P1|STARTED|Overall Study||60
1564751|NCT01206322|3827517|P4|NOT COMPLETED|Overall Study||1
1564752|NCT01206322|3827518|P3|NOT COMPLETED|Overall Study||0
1564753|NCT01206322|3827519|P2|NOT COMPLETED|Overall Study||0
1564754|NCT01206322|3827520|P1|NOT COMPLETED|Overall Study||0
1564755|NCT01206322|3827517|P4|COMPLETED|Overall Study||5
1564756|NCT01206322|3827518|P3|COMPLETED|Overall Study||9
1564757|NCT01206322|3827519|P2|COMPLETED|Overall Study||11
1564758|NCT01206322|3827520|P1|COMPLETED|Overall Study||4
1564759|NCT01206322|3827517|P4|STARTED|Overall Study||6
1564760|NCT01206322|3827518|P3|STARTED|Overall Study||9
1564761|NCT01206322|3827519|P2|STARTED|Overall Study||11
1564762|NCT01206322|3827520|P1|STARTED|Overall Study||4
1564763|NCT01206140|3827536|P2|NOT COMPLETED|Overall Study||0
1564764|NCT01206140|3827537|P1|NOT COMPLETED|Overall Study||1
1564765|NCT01206140|3827536|P2|COMPLETED|Overall Study||35
1564766|NCT01206140|3827537|P1|COMPLETED|Overall Study||34
1564767|NCT01206140|3827536|P2|STARTED|Overall Study||35
1564768|NCT01206140|3827537|P1|STARTED|Overall Study||35
1564769|NCT01206101|3827549|P2|NOT COMPLETED|Overall Study||1
1564770|NCT01206101|3827550|P1|NOT COMPLETED|Overall Study||2
1564771|NCT01206101|3827549|P2|COMPLETED|Overall Study||0
1564772|NCT01206101|3827550|P1|COMPLETED|Overall Study||0
1564773|NCT01206101|3827549|P2|STARTED|Overall Study||1
1564774|NCT01206101|3827550|P1|STARTED|Overall Study||2
1564775|NCT01206062|3827568|P2|NOT COMPLETED|Overall Study||0
1564776|NCT01206062|3827569|P1|NOT COMPLETED|Overall Study||0
1564777|NCT01206062|3827568|P2|COMPLETED|Overall Study||4683
1564778|NCT01206062|3827569|P1|COMPLETED|Overall Study||4678
1564779|NCT01206062|3827568|P2|STARTED|Overall Study||4683
1564780|NCT01206062|3827569|P1|STARTED|Overall Study||4678
1564781|NCT01205828|3827581|P1|NOT COMPLETED|Overall Study||0
1564782|NCT01205828|3827581|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
1564783|NCT01205828|3827581|P1|STARTED|Overall Study||16
1564784|NCT01205776|3827591|P2|NOT COMPLETED|3 Years Follow-up||24
1564785|NCT01205776|3827592|P1|NOT COMPLETED|3 Years Follow-up||16
1564786|NCT01205776|3827591|P2|COMPLETED|3 Years Follow-up||889
1564787|NCT01205776|3827592|P1|COMPLETED|3 Years Follow-up||911
1564788|NCT01205776|3827591|P2|STARTED|3 Years Follow-up||913
1564789|NCT01205776|3827592|P1|STARTED|3 Years Follow-up||927
1564790|NCT01205776|3827591|P2|NOT COMPLETED|2 Years Follow-up||32
1564791|NCT01205776|3827592|P1|NOT COMPLETED|2 Years Follow-up||16
1564792|NCT01205776|3827591|P2|COMPLETED|2 Years Follow-up||913
1564793|NCT01205776|3827592|P1|COMPLETED|2 Years Follow-up||927
1564794|NCT01205776|3827591|P2|STARTED|2 Years Follow-up||945
1564795|NCT01205776|3827592|P1|STARTED|2 Years Follow-up||943
1564796|NCT01205776|3827591|P2|NOT COMPLETED|1 Month Follow-up||12
1564797|NCT01205776|3827592|P1|NOT COMPLETED|1 Month Follow-up||5
1564798|NCT01205776|3827591|P2|COMPLETED|1 Month Follow-up||945
1564799|NCT01205776|3827592|P1|COMPLETED|1 Month Follow-up||943
1564800|NCT01205776|3827591|P2|STARTED|1 Month Follow-up||957
1564801|NCT01205776|3827592|P1|STARTED|1 Month Follow-up||948
1564802|NCT01205685|3827732|P1|NOT COMPLETED|Overall Study||11
1564803|NCT01205685|3827732|P1|COMPLETED|Overall Study||0
1564804|NCT01205685|3827732|P1|STARTED|Overall Study||11
1564805|NCT01205646|3827739|P1|NOT COMPLETED|Overall Study||0
1564806|NCT01205646|3827739|P1|COMPLETED|Overall Study||11
1564807|NCT01205646|3827739|P1|STARTED|Overall Study||11
1564808|NCT01205581|3827752|P6|NOT COMPLETED|Overall Study||0
1564809|NCT01205581|3827753|P5|NOT COMPLETED|Overall Study||0
1564810|NCT01205581|3827754|P4|NOT COMPLETED|Overall Study||0
1564811|NCT01205581|3827755|P3|NOT COMPLETED|Overall Study||0
1564812|NCT01205581|3827756|P2|NOT COMPLETED|Overall Study||0
1564813|NCT01205581|3827757|P1|NOT COMPLETED|Overall Study||1
1564814|NCT01205581|3827752|P6|COMPLETED|Overall Study||20
1564815|NCT01205581|3827753|P5|COMPLETED|Overall Study||20
1564816|NCT01205581|3827754|P4|COMPLETED|Overall Study||9
1564817|NCT01205581|3827755|P3|COMPLETED|Overall Study||8
1564818|NCT01205581|3827756|P2|COMPLETED|Overall Study||13
1564819|NCT01205581|3827757|P1|COMPLETED|Overall Study||13
1564820|NCT01205581|3827752|P6|STARTED|Overall Study||20
1564821|NCT01205581|3827753|P5|STARTED|Overall Study||20
1564822|NCT01205581|3827754|P4|STARTED|Overall Study||9
1564823|NCT01205581|3827755|P3|STARTED|Overall Study||8
1564824|NCT01205581|3827756|P2|STARTED|Overall Study||13
1564825|NCT01205581|3827757|P1|STARTED|Overall Study||14
1564826|NCT01205568|3827821|P2|NOT COMPLETED|Overall Study||0
1564827|NCT01205568|3827822|P1|NOT COMPLETED|Overall Study||0
1564828|NCT01205568|3827821|P2|COMPLETED|Overall Study||47
1564829|NCT01205568|3827822|P1|COMPLETED|Overall Study||65
1564830|NCT01205568|3827821|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
1564831|NCT01205568|3827822|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
1564832|NCT01205529|3827827|P1|NOT COMPLETED|Overall Study||55
1564833|NCT01205529|3827827|P1|COMPLETED|Overall Study||106
1564834|NCT01205529|3827827|P1|STARTED|Overall Study||161
1564835|NCT01205503|3827833|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
1564836|NCT01205503|3827834|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
1564837|NCT01205503|3827833|P2|COMPLETED|Second Intervention (2nd Cycle)||16
1564838|NCT01205503|3827834|P1|COMPLETED|Second Intervention (2nd Cycle)||16
1564839|NCT01205503|3827833|P2|STARTED|Second Intervention (2nd Cycle)||16
1564840|NCT01205503|3827834|P1|STARTED|Second Intervention (2nd Cycle)||16
1564841|NCT01205503|3827833|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
1564842|NCT01205503|3827834|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
1564843|NCT01205503|3827833|P2|COMPLETED|First Intervention (1st Cycle)||16
1564844|NCT01205503|3827834|P1|COMPLETED|First Intervention (1st Cycle)||16
1564845|NCT01205503|3827833|P2|STARTED|First Intervention (1st Cycle)||16
1564846|NCT01205503|3827834|P1|STARTED|First Intervention (1st Cycle)||16
1564847|NCT01205451|3827850|P2|NOT COMPLETED|Overall Study||10
1564848|NCT01205451|3827851|P1|NOT COMPLETED|Overall Study||6
1564849|NCT01205451|3827850|P2|COMPLETED|Overall Study||46
1564850|NCT01205451|3827851|P1|COMPLETED|Overall Study||47
1564851|NCT01205451|3827850|P2|STARTED|Overall Study||56
1564852|NCT01205451|3827851|P1|STARTED|Overall Study||53
1564853|NCT01205438|3827896|P3|NOT COMPLETED|Overall Study||88
1564854|NCT01205438|3827897|P2|NOT COMPLETED|Overall Study||87
1564855|NCT01205438|3827898|P1|NOT COMPLETED|Overall Study||77
1564856|NCT01205438|3827896|P3|COMPLETED|Overall Study||288
1564857|NCT01205438|3827897|P2|COMPLETED|Overall Study||289
1564858|NCT01205438|3827898|P1|COMPLETED|Overall Study||295
1564859|NCT01205438|3827896|P3|Participated in Follow Up|Overall Study||66
1564860|NCT01205438|3827897|P2|Participated in Follow Up|Overall Study||78
1564861|NCT01205438|3827898|P1|Participated in Follow Up|Overall Study||72
1564862|NCT01205438|3827896|P3|Received At Least One Dose of Study Drug|Overall Study||376
1564863|NCT01205438|3827897|P2|Received At Least One Dose of Study Drug|Overall Study||374
1564864|NCT01205438|3827898|P1|Received At Least One Dose of Study Drug|Overall Study||371
1564865|NCT01205438|3827896|P3|STARTED|Overall Study||376
1564866|NCT01205438|3827897|P2|STARTED|Overall Study||376
1564867|NCT01205438|3827898|P1|STARTED|Overall Study||372
1564868|NCT01205399|3827948|P1|NOT COMPLETED|Overall Study||0
1564869|NCT01205399|3827948|P1|COMPLETED|Overall Study||78
1564870|NCT01205399|3827948|P1|STARTED|Overall Study||78
1564871|NCT01205269|3827954|P6|NOT COMPLETED|Period 5 - Third Intervention||0
1564872|NCT01205269|3827955|P5|NOT COMPLETED|Period 5 - Third Intervention||0
1564873|NCT01205269|3827956|P4|NOT COMPLETED|Period 5 - Third Intervention||0
1564874|NCT01205269|3827957|P3|NOT COMPLETED|Period 5 - Third Intervention||0
1564875|NCT01205269|3827958|P2|NOT COMPLETED|Period 5 - Third Intervention||0
1564876|NCT01205269|3827959|P1|NOT COMPLETED|Period 5 - Third Intervention||0
1564877|NCT01205269|3827954|P6|COMPLETED|Period 5 - Third Intervention||5
1564878|NCT01205269|3827955|P5|COMPLETED|Period 5 - Third Intervention||5
1564879|NCT01205269|3827956|P4|COMPLETED|Period 5 - Third Intervention||5
1564880|NCT01205269|3827957|P3|COMPLETED|Period 5 - Third Intervention||4
1564881|NCT01205269|3827958|P2|COMPLETED|Period 5 - Third Intervention||4
1564882|NCT01205269|3827959|P1|COMPLETED|Period 5 - Third Intervention||4
1564883|NCT01205269|3827954|P6|STARTED|Period 5 - Third Intervention||5
1564884|NCT01205269|3827955|P5|STARTED|Period 5 - Third Intervention||5
1564885|NCT01205269|3827956|P4|STARTED|Period 5 - Third Intervention||5
1564886|NCT01205269|3827957|P3|STARTED|Period 5 - Third Intervention||4
1564887|NCT01205269|3827958|P2|STARTED|Period 5 - Third Intervention||4
1564888|NCT01205269|3827959|P1|STARTED|Period 5 - Third Intervention||4
1564889|NCT01205269|3827954|P6|NOT COMPLETED|Period 4 - Washout||0
1564890|NCT01205269|3827955|P5|NOT COMPLETED|Period 4 - Washout||0
1564891|NCT01205269|3827956|P4|NOT COMPLETED|Period 4 - Washout||1
1564892|NCT01205269|3827957|P3|NOT COMPLETED|Period 4 - Washout||0
1564893|NCT01205269|3827958|P2|NOT COMPLETED|Period 4 - Washout||0
1564894|NCT01205269|3827959|P1|NOT COMPLETED|Period 4 - Washout||0
1564895|NCT01205269|3827954|P6|COMPLETED|Period 4 - Washout||5
1564896|NCT01205269|3827955|P5|COMPLETED|Period 4 - Washout||5
1564897|NCT01205269|3827956|P4|COMPLETED|Period 4 - Washout||5
1564898|NCT01205269|3827957|P3|COMPLETED|Period 4 - Washout||4
1564899|NCT01205269|3827958|P2|COMPLETED|Period 4 - Washout||4
1564900|NCT01205269|3827959|P1|COMPLETED|Period 4 - Washout||4
1564901|NCT01205269|3827954|P6|STARTED|Period 4 - Washout||5
1564902|NCT01205269|3827955|P5|STARTED|Period 4 - Washout||5
1564903|NCT01205269|3827956|P4|STARTED|Period 4 - Washout||6
1564904|NCT01205269|3827957|P3|STARTED|Period 4 - Washout||4
1564905|NCT01205269|3827958|P2|STARTED|Period 4 - Washout||4
1564906|NCT01205269|3827959|P1|STARTED|Period 4 - Washout||4
1564907|NCT01205269|3827954|P6|NOT COMPLETED|Period 3 - Second Intervention||0
1564908|NCT01205269|3827955|P5|NOT COMPLETED|Period 3 - Second Intervention||0
1564909|NCT01205269|3827956|P4|NOT COMPLETED|Period 3 - Second Intervention||0
1564910|NCT01205269|3827957|P3|NOT COMPLETED|Period 3 - Second Intervention||0
1564911|NCT01205269|3827958|P2|NOT COMPLETED|Period 3 - Second Intervention||0
1564912|NCT01205269|3827959|P1|NOT COMPLETED|Period 3 - Second Intervention||0
1564913|NCT01205269|3827954|P6|COMPLETED|Period 3 - Second Intervention||5
1564914|NCT01205269|3827955|P5|COMPLETED|Period 3 - Second Intervention||5
1564915|NCT01205269|3827956|P4|COMPLETED|Period 3 - Second Intervention||6
1564916|NCT01205269|3827957|P3|COMPLETED|Period 3 - Second Intervention||4
1564917|NCT01205269|3827958|P2|COMPLETED|Period 3 - Second Intervention||4
1564918|NCT01205269|3827959|P1|COMPLETED|Period 3 - Second Intervention||4
1564919|NCT01205269|3827954|P6|STARTED|Period 3 - Second Intervention||5
1564920|NCT01205269|3827955|P5|STARTED|Period 3 - Second Intervention||5
1564921|NCT01205269|3827956|P4|STARTED|Period 3 - Second Intervention||6
1564922|NCT01205269|3827957|P3|STARTED|Period 3 - Second Intervention||4
1564923|NCT01205269|3827958|P2|STARTED|Period 3 - Second Intervention||4
1564924|NCT01205269|3827959|P1|STARTED|Period 3 - Second Intervention||4
1564925|NCT01205269|3827954|P6|NOT COMPLETED|Period 2 - Washout||0
1564926|NCT01205269|3827955|P5|NOT COMPLETED|Period 2 - Washout||0
1564927|NCT01205269|3827956|P4|NOT COMPLETED|Period 2 - Washout||0
1564928|NCT01205269|3827957|P3|NOT COMPLETED|Period 2 - Washout||0
1564929|NCT01205269|3827958|P2|NOT COMPLETED|Period 2 - Washout||0
1564930|NCT01205269|3827959|P1|NOT COMPLETED|Period 2 - Washout||0
1564931|NCT01205269|3827954|P6|COMPLETED|Period 2 - Washout||5
1564932|NCT01205269|3827955|P5|COMPLETED|Period 2 - Washout||5
1564933|NCT01205269|3827956|P4|COMPLETED|Period 2 - Washout||6
1564934|NCT01205269|3827957|P3|COMPLETED|Period 2 - Washout||4
1564935|NCT01205269|3827958|P2|COMPLETED|Period 2 - Washout||4
1564936|NCT01205269|3827959|P1|COMPLETED|Period 2 - Washout||4
1564937|NCT01205269|3827954|P6|STARTED|Period 2 - Washout||5
1564938|NCT01205269|3827955|P5|STARTED|Period 2 - Washout||5
1564939|NCT01205269|3827956|P4|STARTED|Period 2 - Washout||6
1564940|NCT01205269|3827957|P3|STARTED|Period 2 - Washout||4
1564941|NCT01205269|3827958|P2|STARTED|Period 2 - Washout||4
1564942|NCT01205269|3827959|P1|STARTED|Period 2 - Washout||4
1564943|NCT01205269|3827954|P6|NOT COMPLETED|Period 1 - First Intervention||0
1564944|NCT01205269|3827955|P5|NOT COMPLETED|Period 1 - First Intervention||0
1564945|NCT01205269|3827956|P4|NOT COMPLETED|Period 1 - First Intervention||0
1564946|NCT01205269|3827957|P3|NOT COMPLETED|Period 1 - First Intervention||0
1564947|NCT01205269|3827958|P2|NOT COMPLETED|Period 1 - First Intervention||0
1564948|NCT01205269|3827959|P1|NOT COMPLETED|Period 1 - First Intervention||0
1564949|NCT01205269|3827954|P6|COMPLETED|Period 1 - First Intervention||5
1564950|NCT01205269|3827955|P5|COMPLETED|Period 1 - First Intervention||5
1564951|NCT01205269|3827956|P4|COMPLETED|Period 1 - First Intervention||6
1564952|NCT01205269|3827957|P3|COMPLETED|Period 1 - First Intervention||4
1564953|NCT01205269|3827958|P2|COMPLETED|Period 1 - First Intervention||4
1564954|NCT01205269|3827959|P1|COMPLETED|Period 1 - First Intervention||4
1564955|NCT01205269|3827954|P6|STARTED|Period 1 - First Intervention||5
1564956|NCT01205269|3827955|P5|STARTED|Period 1 - First Intervention||5
1564957|NCT01205269|3827956|P4|STARTED|Period 1 - First Intervention||6
1564958|NCT01205269|3827957|P3|STARTED|Period 1 - First Intervention||4
1564959|NCT01205269|3827958|P2|STARTED|Period 1 - First Intervention||4
1564960|NCT01205269|3827959|P1|STARTED|Period 1 - First Intervention||4
1564961|NCT01205230|3827999|P2|NOT COMPLETED|Overall Study||0
1564962|NCT01205230|3828000|P1|NOT COMPLETED|Overall Study||5
1564963|NCT01205230|3827999|P2|COMPLETED|Overall Study||13
1564964|NCT01205230|3828000|P1|COMPLETED|Overall Study||16
1564965|NCT01205230|3827999|P2|Combination Therapy|Overall Study||13
1564966|NCT01205230|3828000|P1|Combination Therapy|Overall Study||21
1564967|NCT01205230|3827999|P2|STARTED|Overall Study||13
1564968|NCT01205230|3828000|P1|STARTED|Overall Study||21
1564969|NCT01205165|3828043|P1|NOT COMPLETED|Overall Study||2
1564970|NCT01205165|3828043|P1|COMPLETED|Overall Study||102
1564971|NCT01205165|3828043|P1|STARTED|Overall Study||104
1564972|NCT01205152|3828056|P1|NOT COMPLETED|Overall Study||1
1564973|NCT01205152|3828056|P1|COMPLETED|Overall Study||9
1564974|NCT01205152|3828056|P1|STARTED|Overall Study||10
1564975|NCT01205126|3828069|P2|NOT COMPLETED|Maintenance Phase||40
1564976|NCT01205126|3828070|P1|NOT COMPLETED|Maintenance Phase||37
1564977|NCT01205126|3828069|P2|COMPLETED|Maintenance Phase||67
1564978|NCT01205126|3828070|P1|COMPLETED|Maintenance Phase||70
1564979|NCT01205126|3828069|P2|STARTED|Maintenance Phase||107
1564980|NCT01205126|3828070|P1|STARTED|Maintenance Phase||107
1564981|NCT01205126|3828069|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
1564982|NCT01205126|3828070|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
1564983|NCT01205126|3828069|P2|COMPLETED|Between Titration & Maintenance Phase||107
1564984|NCT01205126|3828070|P1|COMPLETED|Between Titration & Maintenance Phase||107
1564985|NCT01205126|3828069|P2|STARTED|Between Titration & Maintenance Phase||111
1564986|NCT01205126|3828070|P1|STARTED|Between Titration & Maintenance Phase||107
1564987|NCT01205126|3828069|P2|NOT COMPLETED|Titration Phase||19
1564988|NCT01205126|3828070|P1|NOT COMPLETED|Titration Phase||23
1564989|NCT01205126|3828069|P2|COMPLETED|Titration Phase||111
1564990|NCT01205126|3828070|P1|COMPLETED|Titration Phase||107
1564991|NCT01205126|3828069|P2|STARTED|Titration Phase||130
1564992|NCT01205126|3828070|P1|STARTED|Titration Phase||130
1564993|NCT01205035|3828088|P2|NOT COMPLETED|Overall Study||0
1564994|NCT01205035|3828089|P1|NOT COMPLETED|Overall Study||2
1564995|NCT01205035|3828088|P2|COMPLETED|Overall Study||3
1564996|NCT01205035|3828089|P1|COMPLETED|Overall Study||1
1564997|NCT01205035|3828088|P2|STARTED|Overall Study||3
1564998|NCT01205035|3828089|P1|STARTED|Overall Study||3
1564999|NCT01204918|3828106|P3|NOT COMPLETED|Overall Study||5
1565000|NCT01204918|3828107|P2|NOT COMPLETED|Overall Study||10
1565001|NCT01204918|3828108|P1|NOT COMPLETED|Overall Study||4
1565002|NCT01204918|3828106|P3|COMPLETED|Overall Study||35
1565003|NCT01204918|3828107|P2|COMPLETED|Overall Study||29
1565004|NCT01204918|3828108|P1|COMPLETED|Overall Study||21
1565005|NCT01204918|3828106|P3|Stage 2 End|Overall Study||35
1565006|NCT01204918|3828107|P2|Stage 2 End|Overall Study||29
1565007|NCT01204918|3828108|P1|Stage 2 End|Overall Study||21
1565008|NCT01204918|3828106|P3|Stage 2 Begin|Overall Study||36
1565009|NCT01204918|3828107|P2|Stage 2 Begin|Overall Study||35
1565010|NCT01204918|3828108|P1|Stage 2 Begin|Overall Study||22
1565011|NCT01204918|3828106|P3|Stage 1 End|Overall Study||36
1565012|NCT01204918|3828107|P2|Stage 1 End|Overall Study||35
1565013|NCT01204918|3828108|P1|Stage 1 End|Overall Study||22
1565014|NCT01204918|3828106|P3|Stage 1 Begin|Overall Study||40
1565015|NCT01204918|3828107|P2|Stage 1 Begin|Overall Study||39
1565016|NCT01204918|3828108|P1|Stage 1 Begin|Overall Study||25
1565017|NCT01204918|3828106|P3|STARTED|Overall Study||40
1565018|NCT01204918|3828107|P2|STARTED|Overall Study||39
1565019|NCT01204918|3828108|P1|STARTED|Overall Study||25
1565020|NCT01204905|3828125|P1|NOT COMPLETED|Overall Study||2
1565021|NCT01204905|3828125|P1|COMPLETED|Overall Study||5
1565022|NCT01204905|3828125|P1|STARTED|Overall Study||7
1565023|NCT01204853|3828130|P1|NOT COMPLETED|Overall Study||0
1565024|NCT01204853|3828130|P1|COMPLETED|Overall Study||2
1565025|NCT01204853|3828130|P1|STARTED|Overall Study||2
1565026|NCT01204788|3828142|P2|NOT COMPLETED|Overall Study||3
1565027|NCT01204788|3828143|P1|NOT COMPLETED|Overall Study||1
1565028|NCT01204788|3828142|P2|COMPLETED|Overall Study||0
1565029|NCT01204788|3828143|P1|COMPLETED|Overall Study||0
1565030|NCT01204788|3828142|P2|STARTED|Overall Study||3
1565031|NCT01204788|3828143|P1|STARTED|Overall Study||1
1565032|NCT01204775|3828151|P2|NOT COMPLETED|Overall Study||1
1565033|NCT01204775|3828152|P1|NOT COMPLETED|Overall Study||1
1565034|NCT01204775|3828151|P2|COMPLETED|Overall Study||3
1565035|NCT01204775|3828152|P1|COMPLETED|Overall Study||3
1565036|NCT01204775|3828151|P2|Double-blind Treatment Period|Overall Study||4
1565037|NCT01204775|3828152|P1|Double-blind Treatment Period|Overall Study||4
1565038|NCT01204775|3828151|P2|STARTED|Overall Study||4
1565039|NCT01204775|3828152|P1|STARTED|Overall Study||4
1565040|NCT01204736|3828162|P4|NOT COMPLETED|Overall Study||0
1565041|NCT01204736|3828163|P3|NOT COMPLETED|Overall Study||0
1565042|NCT01204736|3828164|P2|NOT COMPLETED|Overall Study||0
1565043|NCT01204736|3828165|P1|NOT COMPLETED|Overall Study||0
1565044|NCT01204736|3828162|P4|COMPLETED|Overall Study||2
1565045|NCT01204736|3828163|P3|COMPLETED|Overall Study||3
1565046|NCT01204736|3828164|P2|COMPLETED|Overall Study||5
1565047|NCT01204736|3828165|P1|COMPLETED|Overall Study||4
1565048|NCT01204736|3828162|P4|STARTED|Overall Study||2
1565049|NCT01204736|3828163|P3|STARTED|Overall Study||3
1565050|NCT01204736|3828164|P2|STARTED|Overall Study||5
1565051|NCT01204736|3828165|P1|STARTED|Overall Study||4
1565052|NCT01204710|3828177|P2|NOT COMPLETED|Optional Olaratumab Monotherapy||3
1565053|NCT01204710|3828178|P1|NOT COMPLETED|Optional Olaratumab Monotherapy||0
1565054|NCT01204710|3828177|P2|COMPLETED|Optional Olaratumab Monotherapy||16
1565055|NCT01204710|3828178|P1|COMPLETED|Optional Olaratumab Monotherapy||0
1565056|NCT01204710|3828177|P2|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
1565057|NCT01204710|3828178|P1|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
1565058|NCT01204710|3828177|P2|NOT COMPLETED|Randomization Treatment||13
1565059|NCT01204710|3828178|P1|NOT COMPLETED|Randomization Treatment||14
1565060|NCT01204710|3828177|P2|COMPLETED|Randomization Treatment||47
1565061|NCT01204710|3828178|P1|COMPLETED|Randomization Treatment||49
1565062|NCT01204710|3828177|P2|Received ≥1 Dose of Study Drug|Randomization Treatment||59
1565063|NCT01204710|3828178|P1|Received ≥1 Dose of Study Drug|Randomization Treatment||62
1565064|NCT01204710|3828177|P2|STARTED|Randomization Treatment||60
1565065|NCT01204710|3828178|P1|STARTED|Randomization Treatment||63
1565066|NCT01204697|3828214|P2|NOT COMPLETED|Overall Study||36
1565067|NCT01204697|3828215|P1|NOT COMPLETED|Overall Study||31
1565068|NCT01204697|3828214|P2|COMPLETED|Overall Study||2
1565069|NCT01204697|3828215|P1|COMPLETED|Overall Study||5
1565070|NCT01204697|3828214|P2|Treated|Overall Study||37
1565071|NCT01204697|3828215|P1|Treated|Overall Study||36
1565072|NCT01204697|3828214|P2|STARTED|Overall Study||38
1565073|NCT01204697|3828215|P1|STARTED|Overall Study||36
1565074|NCT01204671|3828236|P5|NOT COMPLETED|Overall Study||4
1565075|NCT01204671|3828237|P4|NOT COMPLETED|Overall Study||13
1565076|NCT01204671|3828238|P3|NOT COMPLETED|Overall Study||13
1565077|NCT01204671|3828239|P2|NOT COMPLETED|Overall Study||15
1565078|NCT01204671|3828240|P1|NOT COMPLETED|Overall Study||14
1565079|NCT01204671|3828236|P5|COMPLETED|Overall Study||606
1565080|NCT01204671|3828237|P4|COMPLETED|Overall Study||997
1565081|NCT01204671|3828238|P3|COMPLETED|Overall Study||998
1565082|NCT01204671|3828239|P2|COMPLETED|Overall Study||998
1565083|NCT01204671|3828240|P1|COMPLETED|Overall Study||998
1565084|NCT01204671|3828236|P5|STARTED|Overall Study||610
1565085|NCT01204671|3828237|P4|STARTED|Overall Study||1010
1565086|NCT01204671|3828238|P3|STARTED|Overall Study||1011
1565087|NCT01204671|3828239|P2|STARTED|Overall Study||1013
1565088|NCT01204671|3828240|P1|STARTED|Overall Study||1012
1565089|NCT01204658|3828302|P4|NOT COMPLETED|Booster Phase||0
1565090|NCT01204658|3828303|P3|NOT COMPLETED|Booster Phase||0
1565091|NCT01204658|3828304|P2|NOT COMPLETED|Booster Phase||0
1565092|NCT01204658|3828305|P1|NOT COMPLETED|Booster Phase||0
1565093|NCT01204658|3828302|P4|COMPLETED|Booster Phase||140
1565094|NCT01204658|3828303|P3|COMPLETED|Booster Phase||140
1565095|NCT01204658|3828304|P2|COMPLETED|Booster Phase||140
1565096|NCT01204658|3828305|P1|COMPLETED|Booster Phase||144
1565179|NCT01203852|3828539|P1|NOT COMPLETED|Washout 2 Weeks||46
1565097|NCT01204658|3828302|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
1565098|NCT01204658|3828303|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
1565099|NCT01204658|3828304|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
1565100|NCT01204658|3828305|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
1565101|NCT01204658|3828302|P4|NOT COMPLETED|Primary Phase||0
1565102|NCT01204658|3828303|P3|NOT COMPLETED|Primary Phase||1
1565103|NCT01204658|3828304|P2|NOT COMPLETED|Primary Phase||0
1565104|NCT01204658|3828305|P1|NOT COMPLETED|Primary Phase||0
1565105|NCT01204658|3828302|P4|COMPLETED|Primary Phase||142
1565106|NCT01204658|3828303|P3|COMPLETED|Primary Phase||144
1565107|NCT01204658|3828304|P2|COMPLETED|Primary Phase||142
1565108|NCT01204658|3828305|P1|COMPLETED|Primary Phase||146
1565109|NCT01204658|3828302|P4|STARTED|Primary Phase||142
1565110|NCT01204658|3828303|P3|STARTED|Primary Phase||145
1565111|NCT01204658|3828304|P2|STARTED|Primary Phase||142
1565112|NCT01204658|3828305|P1|STARTED|Primary Phase||146
1565113|NCT01204398|3828423|P1|NOT COMPLETED|Overall Study||1
1565114|NCT01204398|3828423|P1|COMPLETED|Overall Study|Completed trial medication.|26
1565115|NCT01204398|3828423|P1|STARTED|Overall Study|Entered and treated.|27
1565116|NCT01204294|3828440|P7|NOT COMPLETED|Overall Study||2
1565117|NCT01204294|3828441|P6|NOT COMPLETED|Overall Study||5
1565118|NCT01204294|3828442|P5|NOT COMPLETED|Overall Study||2
1565119|NCT01204294|3828443|P4|NOT COMPLETED|Overall Study||11
1565120|NCT01204294|3828444|P3|NOT COMPLETED|Overall Study||5
1565121|NCT01204294|3828445|P2|NOT COMPLETED|Overall Study||8
1565122|NCT01204294|3828446|P1|NOT COMPLETED|Overall Study||3
1565123|NCT01204294|3828440|P7|COMPLETED|Overall Study||59
1565124|NCT01204294|3828441|P6|COMPLETED|Overall Study||58
1565125|NCT01204294|3828442|P5|COMPLETED|Overall Study||83
1565126|NCT01204294|3828443|P4|COMPLETED|Overall Study||132
1565127|NCT01204294|3828444|P3|COMPLETED|Overall Study||69
1565128|NCT01204294|3828445|P2|COMPLETED|Overall Study||58
1565129|NCT01204294|3828446|P1|COMPLETED|Overall Study||79
1565130|NCT01204294|3828440|P7|STARTED|Overall Study||61
1565131|NCT01204294|3828441|P6|STARTED|Overall Study||63
1565132|NCT01204294|3828442|P5|STARTED|Overall Study||85
1565133|NCT01204294|3828443|P4|STARTED|Overall Study||143
1565134|NCT01204294|3828444|P3|STARTED|Overall Study||74
1565135|NCT01204294|3828445|P2|STARTED|Overall Study||66
1565136|NCT01204294|3828446|P1|STARTED|Overall Study||82
1565137|NCT01204255|3828469|P1|NOT COMPLETED|Overall Study||1
1565138|NCT01204255|3828469|P1|COMPLETED|Overall Study||10
1565139|NCT01204255|3828469|P1|STARTED|Overall Study||11
1565140|NCT01204203|3828474|P1|NOT COMPLETED|Overall Study||0
1565141|NCT01204203|3828474|P1|COMPLETED|Overall Study||8
1565142|NCT01204203|3828474|P1|STARTED|Overall Study||8
1565143|NCT01203956|3828480|P2|NOT COMPLETED|Second Two-week Period||6
1565144|NCT01203956|3828481|P1|NOT COMPLETED|Second Two-week Period||5
1565145|NCT01203956|3828480|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
1565146|NCT01203956|3828481|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
1565147|NCT01203956|3828480|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
1565148|NCT01203956|3828481|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
1565149|NCT01203956|3828480|P2|STARTED|Second Two-week Period||13
1565150|NCT01203956|3828481|P1|STARTED|Second Two-week Period||15
1565151|NCT01203956|3828480|P2|NOT COMPLETED|First Two-week Period||0
1565152|NCT01203956|3828481|P1|NOT COMPLETED|First Two-week Period||0
1565153|NCT01203956|3828480|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
1565154|NCT01203956|3828481|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
1565155|NCT01203956|3828480|P2|STARTED|First Two-week Period||13
1565156|NCT01203956|3828481|P1|STARTED|First Two-week Period||15
1565157|NCT01203930|3828490|P2|NOT COMPLETED|Overall Study||41
1565158|NCT01203930|3828491|P1|NOT COMPLETED|Overall Study||21
1565159|NCT01203930|3828490|P2|COMPLETED|Overall Study||0
1565160|NCT01203930|3828491|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
1565161|NCT01203930|3828490|P2|STARTED|Overall Study||41
1565162|NCT01203930|3828491|P1|STARTED|Overall Study||64
1565163|NCT01203917|3828513|P1|NOT COMPLETED|Overall Study||36
1565164|NCT01203917|3828513|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
1565165|NCT01203917|3828513|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
1565166|NCT01203878|3828526|P3|NOT COMPLETED|Overall Study||3
1565167|NCT01203878|3828527|P2|NOT COMPLETED|Overall Study||0
1565168|NCT01203878|3828528|P1|NOT COMPLETED|Overall Study||0
1565169|NCT01203878|3828526|P3|COMPLETED|Overall Study||0
1565170|NCT01203878|3828527|P2|COMPLETED|Overall Study||9
1565171|NCT01203878|3828528|P1|COMPLETED|Overall Study||9
1565172|NCT01203878|3828526|P3|STARTED|Overall Study||3
1565173|NCT01203878|3828527|P2|STARTED|Overall Study||9
1565174|NCT01203878|3828528|P1|STARTED|Overall Study||9
1565175|NCT01203852|3828539|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
1565176|NCT01203852|3828539|P1|COMPLETED|Chlorthalidone 8 Weeks||328
1565177|NCT01203852|3828539|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
1565178|NCT01203852|3828539|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
1565180|NCT01203852|3828539|P1|COMPLETED|Washout 2 Weeks||282
1565181|NCT01203852|3828539|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
1565182|NCT01203852|3828539|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
1565183|NCT01203852|3828539|P1|COMPLETED|Metoprolol 8 Weeks||369
1565184|NCT01203852|3828539|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
1565185|NCT01203826|3828548|P2|NOT COMPLETED|Overall Study||0
1565186|NCT01203826|3828549|P1|NOT COMPLETED|Overall Study||0
1565187|NCT01203826|3828548|P2|COMPLETED|Overall Study||6
1565188|NCT01203826|3828549|P1|COMPLETED|Overall Study||6
1565189|NCT01203826|3828548|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
1565190|NCT01203826|3828549|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
1565191|NCT01203787|3828557|P2|NOT COMPLETED|Overall Study||27
1565192|NCT01203787|3828558|P1|NOT COMPLETED|Overall Study||31
1565193|NCT01203787|3828557|P2|COMPLETED|Overall Study||30
1565194|NCT01203787|3828558|P1|COMPLETED|Overall Study||32
1565195|NCT01203787|3828557|P2|STARTED|Overall Study||57
1565196|NCT01203787|3828558|P1|STARTED|Overall Study||63
1565197|NCT01203644|3828578|P2|NOT COMPLETED|Overall Study||0
1565198|NCT01203644|3828579|P1|NOT COMPLETED|Overall Study||0
1565199|NCT01203644|3828578|P2|COMPLETED|Overall Study||50
1565200|NCT01203644|3828579|P1|COMPLETED|Overall Study||26
1565201|NCT01203644|3828578|P2|STARTED|Overall Study||50
1565202|NCT01203644|3828579|P1|STARTED|Overall Study||26
1565203|NCT01203319|3828591|P3|NOT COMPLETED|Overall Study||5
1565204|NCT01203319|3828592|P2|NOT COMPLETED|Overall Study||9
1565205|NCT01203319|3828593|P1|NOT COMPLETED|Overall Study||6
1565206|NCT01203319|3828591|P3|COMPLETED|Overall Study||217
1565207|NCT01203319|3828592|P2|COMPLETED|Overall Study||426
1565208|NCT01203319|3828593|P1|COMPLETED|Overall Study||428
1565209|NCT01203319|3828591|P3|STARTED|Overall Study||222
1565210|NCT01203319|3828592|P2|STARTED|Overall Study||435
1565211|NCT01203319|3828593|P1|STARTED|Overall Study||434
1565212|NCT01203189|3828610|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
1565213|NCT01203189|3828611|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
1565214|NCT01203189|3828612|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
1565215|NCT01203189|3828610|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
1565216|NCT01203189|3828611|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
1565217|NCT01203189|3828612|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
1565218|NCT01203189|3828610|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
1565219|NCT01203189|3828611|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
1565220|NCT01203189|3828612|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
1565221|NCT01203189|3828610|P3|NOT COMPLETED|First 4 Weeks Treatment||0
1565222|NCT01203189|3828611|P2|NOT COMPLETED|First 4 Weeks Treatment||2
1565223|NCT01203189|3828612|P1|NOT COMPLETED|First 4 Weeks Treatment||2
1565224|NCT01203189|3828610|P3|COMPLETED|First 4 Weeks Treatment||3
1565225|NCT01203189|3828611|P2|COMPLETED|First 4 Weeks Treatment||8
1565226|NCT01203189|3828612|P1|COMPLETED|First 4 Weeks Treatment||8
1565227|NCT01203189|3828610|P3|STARTED|First 4 Weeks Treatment||3
1565228|NCT01203189|3828611|P2|STARTED|First 4 Weeks Treatment||10
1565229|NCT01203189|3828612|P1|STARTED|First 4 Weeks Treatment||10
1565230|NCT01203098|3828629|P3|NOT COMPLETED|Overall Study||11
1565231|NCT01203098|3828630|P2|NOT COMPLETED|Overall Study||4
1565232|NCT01203098|3828631|P1|NOT COMPLETED|Overall Study||6
1565233|NCT01203098|3828629|P3|COMPLETED|Overall Study||78
1565234|NCT01203098|3828630|P2|COMPLETED|Overall Study||82
1565235|NCT01203098|3828631|P1|COMPLETED|Overall Study||83
1565236|NCT01203098|3828629|P3|Safety Analysis Dataset|Overall Study||87
1565237|NCT01203098|3828630|P2|Safety Analysis Dataset|Overall Study||85
1565238|NCT01203098|3828631|P1|Safety Analysis Dataset|Overall Study||89
1565239|NCT01203098|3828629|P3|STARTED|Overall Study||89
1565240|NCT01203098|3828630|P2|STARTED|Overall Study||86
1565241|NCT01203098|3828631|P1|STARTED|Overall Study||89
1565242|NCT01203072|3828647|P5|NOT COMPLETED|Overall Study||6
1565243|NCT01203072|3828648|P4|NOT COMPLETED|Overall Study||6
1565244|NCT01203072|3828649|P3|NOT COMPLETED|Overall Study||3
1565245|NCT01203072|3828650|P2|NOT COMPLETED|Overall Study||6
1565246|NCT01203072|3828651|P1|NOT COMPLETED|Overall Study||10
1565247|NCT01203072|3828647|P5|COMPLETED|Overall Study||96
1565248|NCT01203072|3828648|P4|COMPLETED|Overall Study||100
1565249|NCT01203072|3828649|P3|COMPLETED|Overall Study||101
1565250|NCT01203072|3828650|P2|COMPLETED|Overall Study||100
1565251|NCT01203072|3828651|P1|COMPLETED|Overall Study||95
1565252|NCT01203072|3828647|P5|STARTED|Overall Study||102
1565253|NCT01203072|3828648|P4|STARTED|Overall Study||106
1565254|NCT01203072|3828649|P3|STARTED|Overall Study||104
1565255|NCT01203072|3828650|P2|STARTED|Overall Study||106
1565256|NCT01203072|3828651|P1|STARTED|Overall Study||105
1565257|NCT01203046|3828670|P2|NOT COMPLETED|Overall Study||0
1565258|NCT01203046|3828671|P1|NOT COMPLETED|Overall Study||0
1565259|NCT01203046|3828670|P2|COMPLETED|Overall Study||28
1565260|NCT01203046|3828671|P1|COMPLETED|Overall Study||28
1565261|NCT01203046|3828670|P2|STARTED|Overall Study||28
1565262|NCT01203046|3828671|P1|STARTED|Overall Study||28
1565263|NCT01202994|3828679|P1|NOT COMPLETED|Overall Study||0
1565264|NCT01202994|3828679|P1|COMPLETED|Overall Study||27
1565265|NCT01202994|3828679|P1|STARTED|Overall Study||27
1565266|NCT01202955|3828686|P2|NOT COMPLETED|Period 3: 10 Days||0
1565267|NCT01202955|3828687|P1|NOT COMPLETED|Period 3: 10 Days||0
1565268|NCT01202955|3828686|P2|COMPLETED|Period 3: 10 Days||8
1565269|NCT01202955|3828687|P1|COMPLETED|Period 3: 10 Days||9
1565270|NCT01202955|3828686|P2|STARTED|Period 3: 10 Days||8
1565271|NCT01202955|3828687|P1|STARTED|Period 3: 10 Days||9
1565272|NCT01202955|3828686|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
1565273|NCT01202955|3828687|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
1565274|NCT01202955|3828686|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
1565275|NCT01202955|3828687|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
1565276|NCT01202955|3828686|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
1565277|NCT01202955|3828687|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
1565278|NCT01202955|3828686|P2|NOT COMPLETED|Period 1: 10 Days||2
1565279|NCT01202955|3828687|P1|NOT COMPLETED|Period 1: 10 Days||0
1565280|NCT01202955|3828686|P2|COMPLETED|Period 1: 10 Days||8
1565281|NCT01202955|3828687|P1|COMPLETED|Period 1: 10 Days||9
1565282|NCT01202955|3828686|P2|STARTED|Period 1: 10 Days||10
1565283|NCT01202955|3828687|P1|STARTED|Period 1: 10 Days||9
1565284|NCT01202903|3828699|P2|NOT COMPLETED|Overall Study||16
1565285|NCT01202903|3828700|P1|NOT COMPLETED|Overall Study||11
1565286|NCT01202903|3828699|P2|COMPLETED|Overall Study||292
1565287|NCT01202903|3828700|P1|COMPLETED|Overall Study||297
1565288|NCT01202903|3828699|P2|Safety Set*|Overall Study||299
1565289|NCT01202903|3828700|P1|Safety Set*|Overall Study||310
1565290|NCT01202903|3828699|P2|Full Analysis Set|Overall Study||302
1565291|NCT01202903|3828700|P1|Full Analysis Set|Overall Study||306
1565292|NCT01202903|3828699|P2|STARTED|Overall Study||308
1565293|NCT01202903|3828700|P1|STARTED|Overall Study||308
1565294|NCT01202877|3828727|P3|NOT COMPLETED|Overall Study||6
1565295|NCT01202877|3828728|P2|NOT COMPLETED|Overall Study||1
1565296|NCT01202877|3828729|P1|NOT COMPLETED|Overall Study||0
1565297|NCT01202877|3828727|P3|COMPLETED|Overall Study||34
1565298|NCT01202877|3828728|P2|COMPLETED|Overall Study||7
1565299|NCT01202877|3828729|P1|COMPLETED|Overall Study||6
1565300|NCT01202877|3828727|P3|STARTED|Overall Study||40
1565301|NCT01202877|3828728|P2|STARTED|Overall Study||8
1565302|NCT01202877|3828729|P1|STARTED|Overall Study||6
1565303|NCT01202773|3828743|P3|NOT COMPLETED|Overall Study||55
1565304|NCT01202773|3828744|P2|NOT COMPLETED|Overall Study||43
1565305|NCT01202773|3828745|P1|NOT COMPLETED|Overall Study||57
1565306|NCT01202773|3828743|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
1565307|NCT01202773|3828744|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
1565308|NCT01202773|3828745|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
1565309|NCT01202773|3828743|P3|Post-Treatment Follow-Up Population|Overall Study||51
1565310|NCT01202773|3828744|P2|Post-Treatment Follow-Up Population|Overall Study||36
1565311|NCT01202773|3828745|P1|Post-Treatment Follow-Up Population|Overall Study||46
1565312|NCT01202773|3828743|P3|Week 16 NR|Overall Study||37
1565313|NCT01202773|3828744|P2|Week 16 NR|Overall Study||33
1565314|NCT01202773|3828745|P1|Week 16 NR|Overall Study||23
1565315|NCT01202773|3828743|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
1565316|NCT01202773|3828744|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
1565317|NCT01202773|3828745|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
1565318|NCT01202773|3828743|P3|STARTED|Overall Study||155
1565319|NCT01202773|3828744|P2|STARTED|Overall Study||148
1565320|NCT01202773|3828745|P1|STARTED|Overall Study||153
1565321|NCT01202760|3828822|P3|NOT COMPLETED|Overall Study||35
1565322|NCT01202760|3828823|P2|NOT COMPLETED|Overall Study||52
1565323|NCT01202760|3828824|P1|NOT COMPLETED|Overall Study||47
1565324|NCT01202760|3828822|P3|COMPLETED|Overall Study||216
1565325|NCT01202760|3828823|P2|COMPLETED|Overall Study||322
1565326|NCT01202760|3828824|P1|COMPLETED|Overall Study||332
1565327|NCT01202760|3828822|P3|Received at Least One Dose of Study Drug|Overall Study||250
1565328|NCT01202760|3828823|P2|Received at Least One Dose of Study Drug|Overall Study||371
1565329|NCT01202760|3828824|P1|Received at Least One Dose of Study Drug|Overall Study||379
1565330|NCT01202760|3828822|P3|STARTED|Overall Study||251
1565331|NCT01202760|3828823|P2|STARTED|Overall Study||374
1565332|NCT01202760|3828824|P1|STARTED|Overall Study||379
1565333|NCT01202747|3828892|P1|NOT COMPLETED|Overall Study||1
1565334|NCT01202747|3828892|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
1565335|NCT01202747|3828892|P1|STARTED|Overall Study||50
1565336|NCT01202656|3828898|P2|NOT COMPLETED|CrossoverCycle||0
1565337|NCT01202656|3828899|P1|NOT COMPLETED|CrossoverCycle||0
1565338|NCT01202656|3828898|P2|COMPLETED|CrossoverCycle||14
1565339|NCT01202656|3828899|P1|COMPLETED|CrossoverCycle||18
1565340|NCT01202656|3828898|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
1565341|NCT01202656|3828899|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
1565342|NCT01202656|3828898|P2|NOT COMPLETED|Cycle 1||0
1565343|NCT01202656|3828899|P1|NOT COMPLETED|Cycle 1||0
1565344|NCT01202656|3828898|P2|COMPLETED|Cycle 1||62
1565345|NCT01202656|3828899|P1|COMPLETED|Cycle 1||67
1565346|NCT01202656|3828898|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
1565347|NCT01202656|3828899|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
1565348|NCT01202643|3828909|P2|NOT COMPLETED|Crossover Cycle||0
1565349|NCT01202643|3828910|P1|NOT COMPLETED|Crossover Cycle||0
1565350|NCT01202643|3828909|P2|COMPLETED|Crossover Cycle||2
1565351|NCT01202643|3828910|P1|COMPLETED|Crossover Cycle||1
1565352|NCT01202643|3828909|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
1565353|NCT01202643|3828910|P1|STARTED|Crossover Cycle|On patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
1565354|NCT01202643|3828909|P2|NOT COMPLETED|Period 1||0
1565355|NCT01202643|3828910|P1|NOT COMPLETED|Period 1||0
1565356|NCT01202643|3828909|P2|COMPLETED|Period 1||6
1565357|NCT01202643|3828910|P1|COMPLETED|Period 1||6
1565358|NCT01202643|3828909|P2|STARTED|Period 1||6
1565359|NCT01202643|3828910|P1|STARTED|Period 1||6
1565360|NCT01202591|3828924|P6|NOT COMPLETED|Overall Study||4
1565361|NCT01202591|3828925|P5|NOT COMPLETED|Overall Study||5
1565362|NCT01202591|3828926|P4|NOT COMPLETED|Overall Study||7
1565363|NCT01202591|3828927|P3|NOT COMPLETED|Overall Study||11
1565364|NCT01202591|3828928|P2|NOT COMPLETED|Overall Study||5
1565365|NCT01202591|3828929|P1|NOT COMPLETED|Overall Study||5
1565366|NCT01202591|3828924|P6|COMPLETED|Overall Study||0
1565367|NCT01202591|3828925|P5|COMPLETED|Overall Study||0
1565368|NCT01202591|3828926|P4|COMPLETED|Overall Study||2
1565369|NCT01202591|3828927|P3|COMPLETED|Overall Study||1
1565370|NCT01202591|3828928|P2|COMPLETED|Overall Study||0
1565371|NCT01202591|3828929|P1|COMPLETED|Overall Study||0
1565372|NCT01202591|3828924|P6|STARTED|Overall Study||4
1565373|NCT01202591|3828925|P5|STARTED|Overall Study||5
1565374|NCT01202591|3828926|P4|STARTED|Overall Study||9
1565375|NCT01202591|3828927|P3|STARTED|Overall Study||12
1565376|NCT01202591|3828928|P2|STARTED|Overall Study||5
1565377|NCT01202591|3828929|P1|STARTED|Overall Study||5
1565378|NCT01202578|3828943|P1|NOT COMPLETED|Overall Study||0
1565379|NCT01202578|3828943|P1|COMPLETED|Overall Study||53
1565380|NCT01202578|3828943|P1|STARTED|Overall Study||53
1565381|NCT01202565|3828950|P1|NOT COMPLETED|Overall Study||67
1565382|NCT01202565|3828950|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
1565383|NCT01202565|3828950|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
1565384|NCT01202565|3828950|P1|STARTED|Overall Study||506
1565385|NCT01202279|3828975|P2|NOT COMPLETED|Overall Study||27
1565386|NCT01202279|3828976|P1|NOT COMPLETED|Overall Study||37
1565387|NCT01202279|3828975|P2|COMPLETED|Overall Study||561
1565388|NCT01202279|3828976|P1|COMPLETED|Overall Study||554
1565389|NCT01202279|3828975|P2|STARTED|Overall Study||588
1565390|NCT01202279|3828976|P1|STARTED|Overall Study||591
1565391|NCT01202253|3828984|P1|NOT COMPLETED|Overall Study||0
1565392|NCT01202253|3828984|P1|COMPLETED|Overall Study||50
1565393|NCT01202253|3828984|P1|STARTED|Overall Study||50
1565394|NCT01202227|3829028|P1|NOT COMPLETED|Overall Study||19
1565395|NCT01202227|3829028|P1|COMPLETED|Overall Study||84
1565396|NCT01202227|3829028|P1|STARTED|Overall Study|Treated|103
1565397|NCT01202188|3829052|P5|NOT COMPLETED|Overall Study||45
1565398|NCT01202188|3829053|P4|NOT COMPLETED|Overall Study||42
1565399|NCT01202188|3829054|P3|NOT COMPLETED|Overall Study||53
1565400|NCT01202188|3829055|P2|NOT COMPLETED|Overall Study||56
1565401|NCT01202188|3829056|P1|NOT COMPLETED|Overall Study||38
1565402|NCT01202188|3829052|P5|COMPLETED|Overall Study||189
1565403|NCT01202188|3829053|P4|COMPLETED|Overall Study||441
1565404|NCT01202188|3829054|P3|COMPLETED|Overall Study||422
1565405|NCT01202188|3829055|P2|COMPLETED|Overall Study||421
1565406|NCT01202188|3829056|P1|COMPLETED|Overall Study||437
1565407|NCT01202188|3829052|P5|Safety Set; Received Study Drug|Overall Study||232
1565408|NCT01202188|3829053|P4|Safety Set; Received Study Drug|Overall Study||480
1565409|NCT01202188|3829054|P3|Safety Set; Received Study Drug|Overall Study||473
1565410|NCT01202188|3829055|P2|Safety Set; Received Study Drug|Overall Study||476
1565411|NCT01202188|3829056|P1|Safety Set; Received Study Drug|Overall Study||474
1565412|NCT01202188|3829052|P5|STARTED|Overall Study||234
1565413|NCT01202188|3829053|P4|STARTED|Overall Study||483
1565414|NCT01202188|3829054|P3|STARTED|Overall Study||475
1565415|NCT01202188|3829055|P2|STARTED|Overall Study||477
1565416|NCT01202188|3829056|P1|STARTED|Overall Study||475
1565417|NCT01202162|3829164|P2|NOT COMPLETED|Overall Study||2
1565418|NCT01202162|3829165|P1|NOT COMPLETED|Overall Study||3
1565419|NCT01202162|3829164|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
1565420|NCT01202162|3829165|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
1565421|NCT01202162|3829164|P2|STARTED|Overall Study||42
1565422|NCT01202162|3829165|P1|STARTED|Overall Study||43
1565423|NCT01202110|3829175|P2|NOT COMPLETED|Overall Study||0
1565424|NCT01202110|3829176|P1|NOT COMPLETED|Overall Study||0
1565425|NCT01202110|3829175|P2|COMPLETED|Overall Study||0
1565426|NCT01202110|3829176|P1|COMPLETED|Overall Study||10
1565427|NCT01202110|3829175|P2|STARTED|Overall Study||0
1565428|NCT01202110|3829176|P1|STARTED|Overall Study||10
1565429|NCT01202071|3829180|P4|NOT COMPLETED|Overall Study||0
1565430|NCT01202071|3829181|P3|NOT COMPLETED|Overall Study||0
1565431|NCT01202071|3829182|P2|NOT COMPLETED|Overall Study||0
1565432|NCT01202071|3829183|P1|NOT COMPLETED|Overall Study||0
1565433|NCT01202071|3829180|P4|COMPLETED|Overall Study||6
1565434|NCT01202071|3829181|P3|COMPLETED|Overall Study||6
1565435|NCT01202071|3829182|P2|COMPLETED|Overall Study||6
1565436|NCT01202071|3829183|P1|COMPLETED|Overall Study||6
1565437|NCT01202071|3829180|P4|STARTED|Overall Study||6
1565438|NCT01202071|3829181|P3|STARTED|Overall Study||6
1565439|NCT01202071|3829182|P2|STARTED|Overall Study||6
1565440|NCT01202071|3829183|P1|STARTED|Overall Study||6
1565441|NCT01201967|3829203|P2|NOT COMPLETED|Overall Study||5
1565442|NCT01201967|3829204|P1|NOT COMPLETED|Overall Study||6
1565443|NCT01201967|3829203|P2|COMPLETED|Overall Study||86
1565444|NCT01201967|3829204|P1|COMPLETED|Overall Study||86
1565445|NCT01201967|3829203|P2|STARTED|Overall Study||91
1565446|NCT01201967|3829204|P1|STARTED|Overall Study||92
1565447|NCT01201915|3829229|P3|NOT COMPLETED|Overall Study||6
1565448|NCT01201915|3829230|P2|NOT COMPLETED|Overall Study||11
1565449|NCT01201915|3829231|P1|NOT COMPLETED|Overall Study||8
1565450|NCT01201915|3829229|P3|COMPLETED|Overall Study||19
1565451|NCT01201915|3829230|P2|COMPLETED|Overall Study||14
1565452|NCT01201915|3829231|P1|COMPLETED|Overall Study||16
1565453|NCT01201915|3829229|P3|STARTED|Overall Study||25
1565454|NCT01201915|3829230|P2|STARTED|Overall Study||25
1565455|NCT01201915|3829231|P1|STARTED|Overall Study||24
1565456|NCT01201811|3829242|P1|NOT COMPLETED|Overall Study||19
1565457|NCT01201811|3829242|P1|COMPLETED|Overall Study||25
1565458|NCT01201811|3829242|P1|STARTED|Overall Study||44
1565459|NCT01201798|3829264|P2|NOT COMPLETED|Overall Study||15
1565460|NCT01201798|3829265|P1|NOT COMPLETED|Overall Study||9
1565461|NCT01201798|3829264|P2|COMPLETED|Overall Study||39
1565462|NCT01201798|3829265|P1|COMPLETED|Overall Study||47
1565463|NCT01201798|3829264|P2|STARTED|Overall Study||54
1565464|NCT01201798|3829265|P1|STARTED|Overall Study||56
1565465|NCT01201785|3829289|P1|NOT COMPLETED|Overall Study||16
1565466|NCT01201785|3829289|P1|COMPLETED|Overall Study||20
1565467|NCT01201785|3829289|P1|STARTED|Overall Study||36
1565468|NCT01201772|3829296|P3|NOT COMPLETED|Overall Study||0
1565469|NCT01201772|3829297|P2|NOT COMPLETED|Overall Study||0
1565470|NCT01201772|3829298|P1|NOT COMPLETED|Overall Study||1
1565471|NCT01201772|3829296|P3|COMPLETED|Overall Study||21
1565472|NCT01201772|3829297|P2|COMPLETED|Overall Study||21
1565473|NCT01201772|3829298|P1|COMPLETED|Overall Study||22
1565474|NCT01201772|3829296|P3|STARTED|Overall Study||21
1565475|NCT01201772|3829297|P2|STARTED|Overall Study||21
1565476|NCT01201772|3829298|P1|STARTED|Overall Study||23
1565477|NCT01201759|3829306|P2|NOT COMPLETED|Visit 5||0
1565478|NCT01201759|3829307|P1|NOT COMPLETED|Visit 5||0
1565479|NCT01201759|3829306|P2|COMPLETED|Visit 5||3
1565480|NCT01201759|3829307|P1|COMPLETED|Visit 5||7
1565481|NCT01201759|3829306|P2|STARTED|Visit 5||3
1565482|NCT01201759|3829307|P1|STARTED|Visit 5||7
1565483|NCT01201759|3829306|P2|NOT COMPLETED|Visit 4 Crossover||1
1565484|NCT01201759|3829307|P1|NOT COMPLETED|Visit 4 Crossover||0
1565485|NCT01201759|3829306|P2|COMPLETED|Visit 4 Crossover||3
1565486|NCT01201759|3829307|P1|COMPLETED|Visit 4 Crossover||7
1565487|NCT01201759|3829306|P2|STARTED|Visit 4 Crossover||4
1565488|NCT01201759|3829307|P1|STARTED|Visit 4 Crossover||7
1565489|NCT01201759|3829306|P2|NOT COMPLETED|Visit 3 - Washout||3
1565490|NCT01201759|3829307|P1|NOT COMPLETED|Visit 3 - Washout||1
1565491|NCT01201759|3829306|P2|COMPLETED|Visit 3 - Washout||4
1565492|NCT01201759|3829307|P1|COMPLETED|Visit 3 - Washout||7
1565493|NCT01201759|3829306|P2|STARTED|Visit 3 - Washout||7
1565494|NCT01201759|3829307|P1|STARTED|Visit 3 - Washout||8
1565495|NCT01201759|3829306|P2|NOT COMPLETED|Visit 2||0
1565496|NCT01201759|3829307|P1|NOT COMPLETED|Visit 2||0
1565497|NCT01201759|3829306|P2|COMPLETED|Visit 2||7
1565498|NCT01201759|3829307|P1|COMPLETED|Visit 2||8
1565499|NCT01201759|3829306|P2|STARTED|Visit 2||7
1565500|NCT01201759|3829307|P1|STARTED|Visit 2||8
1565501|NCT01201759|3829306|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
1565502|NCT01201759|3829307|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
1565503|NCT01201759|3829306|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
1565504|NCT01201759|3829307|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
1565505|NCT01201759|3829306|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
1565506|NCT01201759|3829307|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
1565507|NCT01201629|3829321|P2|NOT COMPLETED|Overall Study||0
1565508|NCT01201629|3829322|P1|NOT COMPLETED|Overall Study||0
1565509|NCT01201629|3829321|P2|COMPLETED|Overall Study||8
1565510|NCT01201629|3829322|P1|COMPLETED|Overall Study||8
1565511|NCT01201629|3829321|P2|STARTED|Overall Study||8
1565512|NCT01201629|3829322|P1|STARTED|Overall Study||8
1565513|NCT01201486|3829332|P1|NOT COMPLETED|Overall Study||0
1565514|NCT01201486|3829332|P1|COMPLETED|Overall Study||6781
1565515|NCT01201486|3829332|P1|STARTED|Overall Study||6781
1565516|NCT01201343|3829336|P1|NOT COMPLETED|Overall Study||19
1565517|NCT01201343|3829336|P1|COMPLETED|Overall Study||60
1565518|NCT01201343|3829336|P1|Treated|Overall Study||76
1565519|NCT01201343|3829336|P1|STARTED|Overall Study||79
1565520|NCT01201317|3829350|P3|NOT COMPLETED|Overall Study||8
1565521|NCT01201317|3829351|P2|NOT COMPLETED|Overall Study||7
1565522|NCT01201317|3829352|P1|NOT COMPLETED|Overall Study||9
1565523|NCT01201317|3829350|P3|COMPLETED|Overall Study||33
1565524|NCT01201317|3829351|P2|COMPLETED|Overall Study||38
1565525|NCT01201317|3829352|P1|COMPLETED|Overall Study||39
1565526|NCT01201317|3829350|P3|STARTED|Overall Study||41
1565527|NCT01201317|3829351|P2|STARTED|Overall Study||45
1565528|NCT01201317|3829352|P1|STARTED|Overall Study||48
1565529|NCT01201265|3829372|P1|NOT COMPLETED|Overall Study||38
1565530|NCT01201265|3829372|P1|COMPLETED|Overall Study||2
1565531|NCT01201265|3829372|P1|STARTED|Overall Study||40
1565532|NCT01200992|3829386|P2|NOT COMPLETED|Overall Study||41
1565533|NCT01200992|3829387|P1|NOT COMPLETED|Overall Study||37
1565534|NCT01200992|3829386|P2|COMPLETED|Overall Study||4
1565535|NCT01200992|3829387|P1|COMPLETED|Overall Study||2
1565536|NCT01200992|3829386|P2|STARTED|Overall Study||45
1565537|NCT01200992|3829387|P1|STARTED|Overall Study||39
1565538|NCT01200875|3829395|P1|NOT COMPLETED|Overall Study||0
1565539|NCT01200875|3829395|P1|COMPLETED|Overall Study||25
1565540|NCT01200875|3829395|P1|STARTED|Overall Study||25
1565541|NCT01200810|3829401|P2|NOT COMPLETED|Overall Study||5
1565542|NCT01200810|3829402|P1|NOT COMPLETED|Overall Study||5
1565543|NCT01200810|3829401|P2|COMPLETED|Overall Study||0
1565544|NCT01200810|3829402|P1|COMPLETED|Overall Study||0
1565545|NCT01200810|3829401|P2|STARTED|Overall Study||5
1565546|NCT01200810|3829402|P1|STARTED|Overall Study||5
1565547|NCT01200797|3829422|P1|NOT COMPLETED|Overall Study||19
1565548|NCT01200797|3829422|P1|COMPLETED|Overall Study||0
1565549|NCT01200797|3829422|P1|STARTED|Overall Study||19
1565550|NCT01200758|3829432|P4|NOT COMPLETED|Stage 2||50
1565551|NCT01200758|3829433|P3|NOT COMPLETED|Stage 2||41
1565552|NCT01200758|3829434|P2|NOT COMPLETED|Stage 2||0
1565553|NCT01200758|3829435|P1|NOT COMPLETED|Stage 2||0
1565554|NCT01200758|3829432|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
1565555|NCT01200758|3829433|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
1565556|NCT01200758|3829434|P2|COMPLETED|Stage 2||0
1565557|NCT01200758|3829435|P1|COMPLETED|Stage 2||0
1565558|NCT01200758|3829432|P4|STARTED|Stage 2||142
1565559|NCT01200758|3829433|P3|STARTED|Stage 2||141
1565560|NCT01200758|3829434|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
1565561|NCT01200758|3829435|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
1565562|NCT01200758|3829432|P4|NOT COMPLETED|Stage I||0
1565563|NCT01200758|3829433|P3|NOT COMPLETED|Stage I||0
1565564|NCT01200758|3829434|P2|NOT COMPLETED|Stage I||17
1565565|NCT01200758|3829435|P1|NOT COMPLETED|Stage I||18
1565566|NCT01200758|3829432|P4|COMPLETED|Stage I||0
1565567|NCT01200758|3829433|P3|COMPLETED|Stage I||0
1565568|NCT01200758|3829434|P2|COMPLETED|Stage I|Participants completed treatment period.|46
1565569|NCT01200758|3829435|P1|COMPLETED|Stage I|Participants completed treatment period.|46
1565570|NCT01200758|3829432|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
1565571|NCT01200758|3829433|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
1565572|NCT01200758|3829434|P2|STARTED|Stage I||63
1565573|NCT01200758|3829435|P1|STARTED|Stage I||64
1565574|NCT01200602|3829491|P2|NOT COMPLETED|Overall Study||0
1565575|NCT01200602|3829492|P1|NOT COMPLETED|Overall Study||0
1565576|NCT01200602|3829491|P2|COMPLETED|Overall Study||0
1565577|NCT01200602|3829492|P1|COMPLETED|Overall Study||0
1565578|NCT01200602|3829491|P2|STARTED|Overall Study||0
1565579|NCT01200602|3829492|P1|STARTED|Overall Study||0
1565580|NCT01200589|3829508|P2|NOT COMPLETED|Overall Study||189
1565581|NCT01200589|3829509|P1|NOT COMPLETED|Overall Study||190
1565582|NCT01200589|3829508|P2|COMPLETED|Overall Study||30
1565583|NCT01200589|3829509|P1|COMPLETED|Overall Study||29
1565584|NCT01200589|3829508|P2|Safety Set|Overall Study||218
1565585|NCT01200589|3829509|P1|Safety Set|Overall Study||217
1565586|NCT01200589|3829508|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
1565587|NCT01200589|3829509|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
1565588|NCT01200589|3829508|P2|STARTED|Overall Study||219
1565589|NCT01200589|3829509|P1|STARTED|Overall Study||219
1565590|NCT01200524|3829536|P3|NOT COMPLETED|Overall Study||4
1565591|NCT01200524|3829537|P2|NOT COMPLETED|Overall Study||1
1565592|NCT01200524|3829538|P1|NOT COMPLETED|Overall Study||2
1565593|NCT01200524|3829536|P3|COMPLETED|Overall Study||40
1565594|NCT01200524|3829537|P2|COMPLETED|Overall Study||47
1565595|NCT01200524|3829538|P1|COMPLETED|Overall Study||39
1565596|NCT01200524|3829536|P3|STARTED|Overall Study||44
1565597|NCT01200524|3829537|P2|STARTED|Overall Study||48
1565598|NCT01200524|3829538|P1|STARTED|Overall Study||41
1565599|NCT01200511|3829558|P1|NOT COMPLETED|Overall Study||5
1565600|NCT01200511|3829558|P1|COMPLETED|Overall Study||44
1565601|NCT01200511|3829558|P1|STARTED|Overall Study||49
1565602|NCT01200498|3829566|P1|NOT COMPLETED|Overall Study||0
1565603|NCT01200498|3829566|P1|COMPLETED|Overall Study||22
1565604|NCT01200498|3829566|P1|STARTED|Overall Study||22
1565605|NCT01200433|3829572|P2|NOT COMPLETED|Overall Study||0
1565606|NCT01200433|3829573|P1|NOT COMPLETED|Overall Study||0
1565607|NCT01200433|3829572|P2|COMPLETED|Overall Study||23
1565608|NCT01200433|3829573|P1|COMPLETED|Overall Study||21
1565609|NCT01200433|3829572|P2|STARTED|Overall Study||23
1565610|NCT01200433|3829573|P1|STARTED|Overall Study||21
1565611|NCT01200368|3829596|P3|NOT COMPLETED|Toddler Dose||1
1565612|NCT01200368|3829597|P2|NOT COMPLETED|Toddler Dose||3
1565613|NCT01200368|3829598|P1|NOT COMPLETED|Toddler Dose||0
1565614|NCT01200368|3829596|P3|COMPLETED|Toddler Dose||168
1565615|NCT01200368|3829597|P2|COMPLETED|Toddler Dose||159
1565616|NCT01200368|3829598|P1|COMPLETED|Toddler Dose||162
1565617|NCT01200368|3829596|P3|STARTED|Toddler Dose||169
1565618|NCT01200368|3829597|P2|STARTED|Toddler Dose||162
1565619|NCT01200368|3829598|P1|STARTED|Toddler Dose||162
1565620|NCT01200368|3829596|P3|NOT COMPLETED|After Infant Series||9
1565621|NCT01200368|3829597|P2|NOT COMPLETED|After Infant Series||16
1565622|NCT01200368|3829598|P1|NOT COMPLETED|After Infant Series||18
1565623|NCT01200368|3829596|P3|COMPLETED|After Infant Series||169
1565624|NCT01200368|3829597|P2|COMPLETED|After Infant Series||162
1565625|NCT01200368|3829598|P1|COMPLETED|After Infant Series||162
1565626|NCT01200368|3829596|P3|STARTED|After Infant Series||178
1565627|NCT01200368|3829597|P2|STARTED|After Infant Series||178
1565628|NCT01200368|3829598|P1|STARTED|After Infant Series||180
1565629|NCT01200368|3829596|P3|NOT COMPLETED|Infant Series||6
1565630|NCT01200368|3829597|P2|NOT COMPLETED|Infant Series||6
1565631|NCT01200368|3829598|P1|NOT COMPLETED|Infant Series||3
1565632|NCT01200368|3829596|P3|COMPLETED|Infant Series||178
1565633|NCT01200368|3829597|P2|COMPLETED|Infant Series||178
1565634|NCT01200368|3829598|P1|COMPLETED|Infant Series||180
1565635|NCT01200368|3829596|P3|Vaccinated Dose 3|Infant Series||182
1565636|NCT01200368|3829597|P2|Vaccinated Dose 3|Infant Series||178
1565637|NCT01200368|3829598|P1|Vaccinated Dose 3|Infant Series||181
1565638|NCT01200368|3829596|P3|Vaccinated Dose 2|Infant Series||183
1565639|NCT01200368|3829597|P2|Vaccinated Dose 2|Infant Series||182
1565640|NCT01200368|3829598|P1|Vaccinated Dose 2|Infant Series||183
1565641|NCT01200368|3829596|P3|Vaccinated Dose 1|Infant Series||183
1565642|NCT01200368|3829597|P2|Vaccinated Dose 1|Infant Series||183
1565643|NCT01200368|3829598|P1|Vaccinated Dose 1|Infant Series||183
1565644|NCT01200368|3829596|P3|STARTED|Infant Series||184
1565645|NCT01200368|3829597|P2|STARTED|Infant Series||184
1565646|NCT01200368|3829598|P1|STARTED|Infant Series||183
1565647|NCT01200355|3829664|P2|NOT COMPLETED|Overall Study||2
1565648|NCT01200355|3829665|P1|NOT COMPLETED|Overall Study||7
1565649|NCT01200355|3829664|P2|COMPLETED|Overall Study||53
1565650|NCT01200355|3829665|P1|COMPLETED|Overall Study||51
1565651|NCT01200355|3829664|P2|STARTED|Overall Study||55
1565652|NCT01200355|3829665|P1|STARTED|Overall Study||58
1565653|NCT01200342|3829679|P1|NOT COMPLETED|Overall Study||1
1565654|NCT01200342|3829679|P1|COMPLETED|Overall Study||6
1565655|NCT01200342|3829679|P1|STARTED|Overall Study||7
1565656|NCT01200290|3829684|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
1565657|NCT01200290|3829684|P1|COMPLETED|Post-Treatment Follow-Up Period||16
1565658|NCT01200290|3829684|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
1565659|NCT01200290|3829684|P1|NOT COMPLETED|Treatment Period||1
1565660|NCT01200290|3829684|P1|COMPLETED|Treatment Period||17
1565661|NCT01200290|3829684|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
1565662|NCT01200290|3829684|P1|STARTED|Treatment Period||18
1565663|NCT01200238|3829697|P2|NOT COMPLETED|Overall Study||10
1565664|NCT01200238|3829698|P1|NOT COMPLETED|Overall Study||7
1565665|NCT01200238|3829697|P2|COMPLETED|Overall Study||0
1565666|NCT01200238|3829698|P1|COMPLETED|Overall Study||0
1565667|NCT01200238|3829697|P2|STARTED|Overall Study||10
1565668|NCT01200238|3829698|P1|STARTED|Overall Study||7
1565669|NCT01200160|3829716|P1|NOT COMPLETED|Overall Study||62
1565670|NCT01200160|3829716|P1|COMPLETED|Overall Study||66
1565671|NCT01200160|3829716|P1|STARTED|Overall Study||128
1565672|NCT01200069|3829722|P2|NOT COMPLETED|Overall Study||1
1565673|NCT01200069|3829723|P1|NOT COMPLETED|Overall Study||0
1565674|NCT01200069|3829722|P2|COMPLETED|Overall Study||5
1565675|NCT01200069|3829723|P1|COMPLETED|Overall Study||8
1565676|NCT01200069|3829722|P2|STARTED|Overall Study||6
1565677|NCT01200069|3829723|P1|STARTED|Overall Study||8
1565678|NCT01199965|3829777|P2|NOT COMPLETED|Overall Study||0
1565679|NCT01199965|3829778|P1|NOT COMPLETED|Overall Study||1
1565680|NCT01199965|3829777|P2|COMPLETED|Overall Study||24
1565681|NCT01199965|3829778|P1|COMPLETED|Overall Study||22
1565682|NCT01199965|3829777|P2|STARTED|Overall Study||24
1565683|NCT01199965|3829778|P1|STARTED|Overall Study||23
1565684|NCT01199939|3829792|P1|NOT COMPLETED|Overall Study||13
1565685|NCT01199939|3829792|P1|COMPLETED|Overall Study||41
1565686|NCT01199939|3829792|P1|STARTED|Overall Study|Number of enrolled participants|54
1565687|NCT01199926|3829811|P2|NOT COMPLETED|Overall Study||4
1565688|NCT01199926|3829812|P1|NOT COMPLETED|Overall Study||7
1565689|NCT01199926|3829811|P2|COMPLETED|Overall Study||13
1565690|NCT01199926|3829812|P1|COMPLETED|Overall Study||10
1565691|NCT01199926|3829811|P2|STARTED|Overall Study||17
1565692|NCT01199926|3829812|P1|STARTED|Overall Study||17
1565693|NCT01199861|3829824|P2|NOT COMPLETED|Overall Study||0
1565694|NCT01199861|3829825|P1|NOT COMPLETED|Overall Study||2
1565695|NCT01199861|3829824|P2|COMPLETED|Overall Study||43
1565696|NCT01199861|3829825|P1|COMPLETED|Overall Study||93
1565697|NCT01199861|3829824|P2|STARTED|Overall Study||43
1565698|NCT01199861|3829825|P1|STARTED|Overall Study||95
1565699|NCT01199822|3829846|P3|NOT COMPLETED|Overall Study||0
1565700|NCT01199822|3829847|P2|NOT COMPLETED|Overall Study||1
1565701|NCT01199822|3829848|P1|NOT COMPLETED|Overall Study||0
1565702|NCT01199822|3829846|P3|COMPLETED|Overall Study||6
1565703|NCT01199822|3829847|P2|COMPLETED|Overall Study||6
1565704|NCT01199822|3829848|P1|COMPLETED|Overall Study||3
1565705|NCT01199822|3829846|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1565706|NCT01199822|3829847|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
1565707|NCT01199822|3829848|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1565708|NCT01199822|3829846|P3|STARTED|Overall Study||6
1565709|NCT01199822|3829847|P2|STARTED|Overall Study||7
1565710|NCT01199822|3829848|P1|STARTED|Overall Study||3
1565711|NCT01199744|3829881|P1|NOT COMPLETED|Overall Study||0
1565712|NCT01199744|3829881|P1|COMPLETED|Overall Study||1575
1565713|NCT01199744|3829881|P1|STARTED|Overall Study||1575
1565714|NCT01199731|3829897|P3|NOT COMPLETED|Overall Study||10
1565715|NCT01199731|3829898|P2|NOT COMPLETED|Overall Study||11
1565716|NCT01199731|3829899|P1|NOT COMPLETED|Overall Study||9
1565717|NCT01199731|3829897|P3|COMPLETED|Overall Study||0
1565718|NCT01199731|3829898|P2|COMPLETED|Overall Study||0
1565719|NCT01199731|3829899|P1|COMPLETED|Overall Study||0
1565720|NCT01199731|3829897|P3|STARTED|Overall Study||10
1565721|NCT01199731|3829898|P2|STARTED|Overall Study||11
1565722|NCT01199731|3829899|P1|STARTED|Overall Study||9
1565723|NCT01199705|3829937|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
1565724|NCT01199705|3829937|P1|COMPLETED|SCIG Treatment (Efficacy)||24
1565725|NCT01199705|3829937|P1|STARTED|SCIG Treatment (Efficacy)||24
1565726|NCT01199705|3829937|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
1565727|NCT01199705|3829937|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
1565728|NCT01199705|3829937|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
1565729|NCT01199705|3829937|P1|NOT COMPLETED|IVIG Treatment||0
1565730|NCT01199705|3829937|P1|COMPLETED|IVIG Treatment||25
1565731|NCT01199705|3829937|P1|STARTED|IVIG Treatment||25
1565732|NCT01199601|3829969|P2|NOT COMPLETED|Overall Study||78
1565733|NCT01199601|3829970|P1|NOT COMPLETED|Overall Study||69
1565734|NCT01199601|3829969|P2|COMPLETED|Overall Study||344
1565735|NCT01199601|3829970|P1|COMPLETED|Overall Study||353
1565736|NCT01199601|3829969|P2|STARTED|Overall Study|Intervention Group|422
1565737|NCT01199601|3829970|P1|STARTED|Overall Study|Control Group|422
1565738|NCT01199575|3829980|P1|NOT COMPLETED|Overall Study||5
1565739|NCT01199575|3829980|P1|COMPLETED|Overall Study||25
1565740|NCT01199575|3829980|P1|STARTED|Overall Study||30
1565741|NCT01199471|3829985|P1|NOT COMPLETED|Overall Study||6
1565742|NCT01199471|3829985|P1|COMPLETED|Overall Study||3994
1565743|NCT01199471|3829985|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
1565744|NCT01199237|3829996|P2|NOT COMPLETED|Overall Study||0
1565745|NCT01199237|3829997|P1|NOT COMPLETED|Overall Study||0
1565746|NCT01199237|3829996|P2|COMPLETED|Overall Study||40
1565747|NCT01199237|3829997|P1|COMPLETED|Overall Study||41
1565748|NCT01199237|3829996|P2|STARTED|Overall Study||40
1565749|NCT01199237|3829997|P1|STARTED|Overall Study||41
1565750|NCT01199146|3830011|P1|NOT COMPLETED|Overall Study||3
1565751|NCT01199146|3830011|P1|COMPLETED|Overall Study||39
1565752|NCT01199146|3830011|P1|STARTED|Overall Study||42
1565753|NCT01199042|3830017|P1|NOT COMPLETED|At Home (3 Months)||1
1565754|NCT01199042|3830017|P1|COMPLETED|At Home (3 Months)||26
1565755|NCT01199042|3830017|P1|STARTED|At Home (3 Months)||27
1565756|NCT01199042|3830017|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
1565757|NCT01199042|3830017|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
1565758|NCT01199042|3830017|P1|STARTED|Sleep Laboratory (3 Nights)||29
1565759|NCT01199016|3830026|P1|NOT COMPLETED|Overall Study||77
1565760|NCT01199016|3830026|P1|COMPLETED|Overall Study||162
1565761|NCT01199016|3830026|P1|Treated|Overall Study||236
1565762|NCT01199016|3830026|P1|STARTED|Overall Study||239
1565763|NCT01198977|3830035|P2|NOT COMPLETED|Overall Study||0
1565764|NCT01198977|3830036|P1|NOT COMPLETED|Overall Study||1
1565765|NCT01198977|3830035|P2|COMPLETED|Overall Study||33
1565766|NCT01198977|3830036|P1|COMPLETED|Overall Study||30
1565767|NCT01198977|3830035|P2|STARTED|Overall Study||33
1565768|NCT01198977|3830036|P1|STARTED|Overall Study||31
1565769|NCT01198873|3830048|P2|NOT COMPLETED|Overall Study||32
1565770|NCT01198873|3830049|P1|NOT COMPLETED|Overall Study||37
1565771|NCT01198873|3830048|P2|COMPLETED|Overall Study||3
1565772|NCT01198873|3830049|P1|COMPLETED|Overall Study||4
1565773|NCT01198873|3830048|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
1565774|NCT01198873|3830049|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
1565775|NCT01198873|3830048|P2|Treated|Overall Study||35
1565776|NCT01198873|3830049|P1|Treated|Overall Study||41
1565777|NCT01198873|3830048|P2|STARTED|Overall Study||35
1565778|NCT01198873|3830049|P1|STARTED|Overall Study||41
1565779|NCT01198795|3830063|P1|NOT COMPLETED|Overall Study||82
1565780|NCT01198795|3830063|P1|COMPLETED|Overall Study||80
1565781|NCT01198795|3830063|P1|STARTED|Overall Study||162
1565782|NCT01198769|3830067|P1|NOT COMPLETED|Overall Study||0
1565783|NCT01198769|3830067|P1|COMPLETED|Overall Study||15
1565784|NCT01198769|3830067|P1|STARTED|Overall Study||15
1565785|NCT01198756|3830080|P4|NOT COMPLETED|Overall Study||26
1565786|NCT01198756|3830081|P3|NOT COMPLETED|Overall Study||30
1565787|NCT01198756|3830082|P2|NOT COMPLETED|Overall Study||40
1565788|NCT01198756|3830083|P1|NOT COMPLETED|Overall Study||38
1565789|NCT01198756|3830080|P4|COMPLETED|Overall Study||275
1565790|NCT01198756|3830081|P3|COMPLETED|Overall Study||902
1565791|NCT01198756|3830082|P2|COMPLETED|Overall Study||889
1565792|NCT01198756|3830083|P1|COMPLETED|Overall Study||894
1565793|NCT01198756|3830080|P4|STARTED|Overall Study||301
1565794|NCT01198756|3830081|P3|STARTED|Overall Study||932
1565795|NCT01198756|3830082|P2|STARTED|Overall Study||929
1565796|NCT01198756|3830083|P1|STARTED|Overall Study||932
1565797|NCT01198691|3830181|P2|NOT COMPLETED|6 Week Post-partum Survey||24
1565798|NCT01198691|3830182|P1|NOT COMPLETED|6 Week Post-partum Survey||29
1565799|NCT01198691|3830181|P2|COMPLETED|6 Week Post-partum Survey||26
1565800|NCT01198691|3830182|P1|COMPLETED|6 Week Post-partum Survey||21
1565801|NCT01198691|3830181|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
1565802|NCT01198691|3830182|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
1565803|NCT01198691|3830181|P2|NOT COMPLETED|Survey Prior to Discharge||33
1565804|NCT01198691|3830182|P1|NOT COMPLETED|Survey Prior to Discharge||32
1565805|NCT01198691|3830181|P2|COMPLETED|Survey Prior to Discharge||17
1565806|NCT01198691|3830182|P1|COMPLETED|Survey Prior to Discharge||18
1565807|NCT01198691|3830181|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
1565808|NCT01198691|3830182|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
1565809|NCT01198691|3830181|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
1565810|NCT01198691|3830182|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
1565811|NCT01198691|3830181|P2|COMPLETED|Completed VAS Score at Discharge||44
1565812|NCT01198691|3830182|P1|COMPLETED|Completed VAS Score at Discharge||45
1565813|NCT01198691|3830181|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
1565814|NCT01198691|3830182|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
1565815|NCT01198691|3830181|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
1565816|NCT01198691|3830182|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
1565817|NCT01198691|3830181|P2|COMPLETED|Completed VAS Score Postop Day 1||46
1565818|NCT01198691|3830182|P1|COMPLETED|Completed VAS Score Postop Day 1||47
1565819|NCT01198691|3830181|P2|STARTED|Completed VAS Score Postop Day 1||50
1565820|NCT01198691|3830182|P1|STARTED|Completed VAS Score Postop Day 1||50
1565821|NCT01198691|3830181|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
1565822|NCT01198691|3830182|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
1565823|NCT01198691|3830181|P2|COMPLETED|Completed Surgery -Received Intervention||50
1565824|NCT01198691|3830182|P1|COMPLETED|Completed Surgery -Received Intervention||50
1565825|NCT01198691|3830181|P2|STARTED|Completed Surgery -Received Intervention||50
1565826|NCT01198691|3830182|P1|STARTED|Completed Surgery -Received Intervention||50
1565827|NCT01198600|3830194|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1565828|NCT01198600|3830195|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1565829|NCT01198600|3830196|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1565830|NCT01198600|3830197|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1565831|NCT01198600|3830194|P4|COMPLETED|Phase 3: 43 Days of Wear||38
1565832|NCT01198600|3830195|P3|COMPLETED|Phase 3: 43 Days of Wear||0
1565833|NCT01198600|3830196|P2|COMPLETED|Phase 3: 43 Days of Wear||0
1565834|NCT01198600|3830197|P1|COMPLETED|Phase 3: 43 Days of Wear||0
1565835|NCT01198600|3830194|P4|STARTED|Phase 3: 43 Days of Wear||38
1565836|NCT01198600|3830195|P3|STARTED|Phase 3: 43 Days of Wear||0
1565837|NCT01198600|3830196|P2|STARTED|Phase 3: 43 Days of Wear||0
1565838|NCT01198600|3830197|P1|STARTED|Phase 3: 43 Days of Wear||0
1565839|NCT01198600|3830194|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
1565840|NCT01198600|3830195|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
1565841|NCT01198600|3830196|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
1565842|NCT01198600|3830197|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
1565843|NCT01198600|3830194|P4|COMPLETED|Phase 2: 56 Days of Wear||0
1565844|NCT01198600|3830195|P3|COMPLETED|Phase 2: 56 Days of Wear||62
1565845|NCT01198600|3830196|P2|COMPLETED|Phase 2: 56 Days of Wear||0
1565846|NCT01198600|3830197|P1|COMPLETED|Phase 2: 56 Days of Wear||0
1565847|NCT01198600|3830194|P4|STARTED|Phase 2: 56 Days of Wear||0
1565848|NCT01198600|3830195|P3|STARTED|Phase 2: 56 Days of Wear||67
1565849|NCT01198600|3830196|P2|STARTED|Phase 2: 56 Days of Wear||0
1565850|NCT01198600|3830197|P1|STARTED|Phase 2: 56 Days of Wear||0
1565851|NCT01198600|3830194|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1565852|NCT01198600|3830195|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1565853|NCT01198600|3830196|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
1565854|NCT01198600|3830197|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1565855|NCT01198600|3830194|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1565856|NCT01198600|3830195|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1565857|NCT01198600|3830196|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
1565858|NCT01198600|3830197|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
1565859|NCT01198600|3830194|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
1565860|NCT01198600|3830195|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
1565861|NCT01198600|3830196|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
1565862|NCT01198600|3830197|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
1565863|NCT01198600|3830194|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1565864|NCT01198600|3830195|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1565865|NCT01198600|3830196|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
1565866|NCT01198600|3830197|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
1565867|NCT01198600|3830194|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1565868|NCT01198600|3830195|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1565869|NCT01198600|3830196|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
1565870|NCT01198600|3830197|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
1565871|NCT01198600|3830194|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
1565872|NCT01198600|3830195|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
1565873|NCT01198600|3830196|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
1565874|NCT01198600|3830197|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
1565875|NCT01198587|3830223|P4|NOT COMPLETED|Overall Study||0
1565876|NCT01198587|3830224|P3|NOT COMPLETED|Overall Study||9
1565877|NCT01198587|3830225|P2|NOT COMPLETED|Overall Study||0
1565878|NCT01198587|3830226|P1|NOT COMPLETED|Overall Study||8
1565879|NCT01198587|3830223|P4|COMPLETED|Overall Study||5
1565880|NCT01198587|3830224|P3|COMPLETED|Overall Study||21
1565881|NCT01198587|3830225|P2|COMPLETED|Overall Study||5
1565882|NCT01198587|3830226|P1|COMPLETED|Overall Study||23
1565883|NCT01198587|3830223|P4|STARTED|Overall Study||5
1565884|NCT01198587|3830224|P3|STARTED|Overall Study||30
1565885|NCT01198587|3830225|P2|STARTED|Overall Study||5
1565886|NCT01198587|3830226|P1|STARTED|Overall Study||31
1565887|NCT01198574|3830248|P4|NOT COMPLETED|Overall Study||4
1565888|NCT01198574|3830249|P3|NOT COMPLETED|Overall Study||1
1565889|NCT01198574|3830250|P2|NOT COMPLETED|Overall Study||1
1565890|NCT01198574|3830251|P1|NOT COMPLETED|Overall Study||4
1565891|NCT01198574|3830248|P4|COMPLETED|Overall Study||98
1565892|NCT01198574|3830249|P3|COMPLETED|Overall Study||99
1565893|NCT01198574|3830250|P2|COMPLETED|Overall Study||101
1565894|NCT01198574|3830251|P1|COMPLETED|Overall Study||94
1565895|NCT01198574|3830248|P4|STARTED|Overall Study||102
1565896|NCT01198574|3830249|P3|STARTED|Overall Study||100
1565897|NCT01198574|3830250|P2|STARTED|Overall Study||102
1565898|NCT01198574|3830251|P1|STARTED|Overall Study||98
1565899|NCT01198548|3830269|P1|NOT COMPLETED|Overall Study||10
1565900|NCT01198548|3830269|P1|COMPLETED|Overall Study||0
1565901|NCT01198548|3830269|P1|STARTED|Overall Study||10
1565902|NCT01198509|3830284|P6|NOT COMPLETED|Overall Study||0
1565903|NCT01198509|3830285|P5|NOT COMPLETED|Overall Study||0
1565904|NCT01198509|3830286|P4|NOT COMPLETED|Overall Study||0
1565905|NCT01198509|3830287|P3|NOT COMPLETED|Overall Study||0
1565906|NCT01198509|3830288|P2|NOT COMPLETED|Overall Study||0
1565907|NCT01198509|3830289|P1|NOT COMPLETED|Overall Study||1
1565908|NCT01198509|3830284|P6|COMPLETED|Overall Study||58
1565909|NCT01198509|3830285|P5|COMPLETED|Overall Study||20
1565910|NCT01198509|3830286|P4|COMPLETED|Overall Study||66
1565911|NCT01198509|3830287|P3|COMPLETED|Overall Study||19
1565912|NCT01198509|3830288|P2|COMPLETED|Overall Study||10
1565913|NCT01198509|3830289|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
1565914|NCT01198509|3830284|P6|STARTED|Overall Study||58
1565915|NCT01198509|3830285|P5|STARTED|Overall Study||20
1565916|NCT01198509|3830286|P4|STARTED|Overall Study||66
1565917|NCT01198509|3830287|P3|STARTED|Overall Study||19
1565918|NCT01198509|3830288|P2|STARTED|Overall Study||10
1565919|NCT01198509|3830289|P1|STARTED|Overall Study||5
1565920|NCT01198470|3830306|P1|NOT COMPLETED|Overall Study||2
1565921|NCT01198470|3830306|P1|COMPLETED|Overall Study||18
1565922|NCT01198470|3830306|P1|STARTED|Overall Study||20
1565923|NCT01198366|3830319|P6|NOT COMPLETED|Overall Study||13
1565924|NCT01198366|3830320|P5|NOT COMPLETED|Overall Study||15
1565925|NCT01198366|3830321|P4|NOT COMPLETED|Overall Study||5
1565926|NCT01198366|3830322|P3|NOT COMPLETED|Overall Study||8
1565927|NCT01198366|3830323|P2|NOT COMPLETED|Overall Study||7
1565928|NCT01198366|3830324|P1|NOT COMPLETED|Overall Study||12
1565929|NCT01198366|3830319|P6|COMPLETED|Overall Study||128
1565930|NCT01198366|3830320|P5|COMPLETED|Overall Study||125
1565931|NCT01198366|3830321|P4|COMPLETED|Overall Study||47
1565932|NCT01198366|3830322|P3|COMPLETED|Overall Study||43
1565933|NCT01198366|3830323|P2|COMPLETED|Overall Study||44
1565934|NCT01198366|3830324|P1|COMPLETED|Overall Study||40
1565935|NCT01198366|3830319|P6|STARTED|Overall Study||141
1565936|NCT01198366|3830320|P5|STARTED|Overall Study||140
1565937|NCT01198366|3830321|P4|STARTED|Overall Study||52
1565938|NCT01198366|3830322|P3|STARTED|Overall Study||51
1565939|NCT01198366|3830323|P2|STARTED|Overall Study||51
1565940|NCT01198366|3830324|P1|STARTED|Overall Study||52
1565941|NCT01198327|3830362|P1|NOT COMPLETED|Overall Study||10
1565942|NCT01198327|3830362|P1|COMPLETED|Overall Study||56
1565943|NCT01198327|3830362|P1|STARTED|Overall Study||66
1565944|NCT01198275|3830372|P2|NOT COMPLETED|Overall Study||5
1565945|NCT01198275|3830373|P1|NOT COMPLETED|Overall Study||6
1565946|NCT01198275|3830372|P2|COMPLETED|Overall Study||94
1565947|NCT01198275|3830373|P1|COMPLETED|Overall Study||94
1565948|NCT01198275|3830372|P2|STARTED|Overall Study||99
1565949|NCT01198275|3830373|P1|STARTED|Overall Study||100
1565950|NCT01198145|3830381|P2|NOT COMPLETED|Overall Study||1
1565951|NCT01198145|3830382|P1|NOT COMPLETED|Overall Study||1
1565952|NCT01198145|3830381|P2|COMPLETED|Overall Study||42
1565953|NCT01198145|3830382|P1|COMPLETED|Overall Study||43
1565954|NCT01198145|3830381|P2|STARTED|Overall Study||43
1565955|NCT01198145|3830382|P1|STARTED|Overall Study||44
1565956|NCT01198132|3830404|P2|NOT COMPLETED|Overall Study||21
1565957|NCT01198132|3830405|P1|NOT COMPLETED|Overall Study||18
1565958|NCT01198132|3830404|P2|COMPLETED|Overall Study||45
1565959|NCT01198132|3830405|P1|COMPLETED|Overall Study||45
1565960|NCT01198132|3830404|P2|STARTED|Overall Study||66
1565961|NCT01198132|3830405|P1|STARTED|Overall Study||63
1565962|NCT01198002|3830432|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
1565963|NCT01198002|3830433|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
1565964|NCT01198002|3830434|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
1565965|NCT01198002|3830432|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
1565966|NCT01198002|3830433|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
1565967|NCT01198002|3830434|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
1565968|NCT01198002|3830432|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
1565969|NCT01198002|3830433|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
1565970|NCT01198002|3830434|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
1565971|NCT01198002|3830432|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
1565972|NCT01198002|3830433|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
1565973|NCT01198002|3830434|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
1565974|NCT01198002|3830432|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
1565975|NCT01198002|3830433|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
1565976|NCT01198002|3830434|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
1565977|NCT01198002|3830432|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
1565978|NCT01198002|3830433|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
1565979|NCT01198002|3830434|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
1565980|NCT01198002|3830432|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
1565981|NCT01198002|3830433|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
1565982|NCT01198002|3830434|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
1565983|NCT01198002|3830432|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
1565984|NCT01198002|3830433|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
1565985|NCT01198002|3830434|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
1565986|NCT01198002|3830432|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
1565987|NCT01198002|3830433|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
1565988|NCT01198002|3830434|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
1565989|NCT01197911|3830549|P3|NOT COMPLETED|Overall Study||1
1565990|NCT01197911|3830550|P2|NOT COMPLETED|Overall Study||0
1565991|NCT01197911|3830551|P1|NOT COMPLETED|Overall Study||0
1565992|NCT01197911|3830549|P3|COMPLETED|Overall Study||9
1565993|NCT01197911|3830550|P2|COMPLETED|Overall Study||10
1565994|NCT01197911|3830551|P1|COMPLETED|Overall Study||18
1565995|NCT01197911|3830549|P3|STARTED|Overall Study||10
1565996|NCT01197911|3830550|P2|STARTED|Overall Study||10
1565997|NCT01197911|3830551|P1|STARTED|Overall Study||18
1565998|NCT01197898|3830636|P2|NOT COMPLETED|Overall Study||0
1565999|NCT01197898|3830637|P1|NOT COMPLETED|Overall Study||0
1566000|NCT01197898|3830636|P2|COMPLETED|Overall Study||5
1566001|NCT01197898|3830637|P1|COMPLETED|Overall Study||5
1566002|NCT01197898|3830636|P2|STARTED|Overall Study||5
1566003|NCT01197898|3830637|P1|STARTED|Overall Study||5
1566004|NCT01197833|3830646|P3|NOT COMPLETED|Overall Study||0
1566005|NCT01197833|3830647|P2|NOT COMPLETED|Overall Study||0
1566006|NCT01197833|3830648|P1|NOT COMPLETED|Overall Study||0
1566007|NCT01197833|3830646|P3|COMPLETED|Overall Study||40
1566008|NCT01197833|3830647|P2|COMPLETED|Overall Study||39
1566009|NCT01197833|3830648|P1|COMPLETED|Overall Study||38
1566010|NCT01197833|3830646|P3|STARTED|Overall Study||40
1566011|NCT01197833|3830647|P2|STARTED|Overall Study||39
1566012|NCT01197833|3830648|P1|STARTED|Overall Study||38
1566013|NCT01197794|3830666|P7|NOT COMPLETED|Overall Study||21
1566014|NCT01197794|3830667|P6|NOT COMPLETED|Overall Study||19
1566015|NCT01197794|3830668|P5|NOT COMPLETED|Overall Study||14
1566016|NCT01197794|3830669|P4|NOT COMPLETED|Overall Study||12
1566017|NCT01197794|3830670|P3|NOT COMPLETED|Overall Study||13
1566018|NCT01197794|3830671|P2|NOT COMPLETED|Overall Study||15
1566019|NCT01197794|3830672|P1|NOT COMPLETED|Overall Study||16
1566020|NCT01197794|3830666|P7|COMPLETED|Overall Study||142
1566021|NCT01197794|3830667|P6|COMPLETED|Overall Study||144
1566022|NCT01197794|3830668|P5|COMPLETED|Overall Study||149
1566023|NCT01197794|3830669|P4|COMPLETED|Overall Study||152
1566024|NCT01197794|3830670|P3|COMPLETED|Overall Study||153
1566025|NCT01197794|3830671|P2|COMPLETED|Overall Study||146
1566026|NCT01197794|3830672|P1|COMPLETED|Overall Study||148
1566027|NCT01197794|3830666|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
1566028|NCT01197794|3830667|P6|STARTED|Overall Study||163
1566029|NCT01197794|3830668|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
1566030|NCT01197794|3830669|P4|STARTED|Overall Study||164
1566031|NCT01197794|3830670|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
1566032|NCT01197794|3830671|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
1566033|NCT01197794|3830672|P1|STARTED|Overall Study||164
1566034|NCT01197755|3830754|P3|NOT COMPLETED|Overall Study||54
1566035|NCT01197755|3830755|P2|NOT COMPLETED|Overall Study||43
1566036|NCT01197755|3830756|P1|NOT COMPLETED|Overall Study||38
1566037|NCT01197755|3830754|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
1566038|NCT01197755|3830755|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
1566039|NCT01197755|3830756|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
1566040|NCT01197755|3830754|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
1566041|NCT01197755|3830755|P2|Randomised But Did Not Receive Treatment|Overall Study||0
1566042|NCT01197755|3830756|P1|Randomised But Did Not Receive Treatment|Overall Study||0
1566043|NCT01197755|3830754|P3|STARTED|Overall Study|Patients who received treatment|109
1566044|NCT01197755|3830755|P2|STARTED|Overall Study|Patients who received treatment|108
1566045|NCT01197755|3830756|P1|STARTED|Overall Study|Patients who received treatment|105
1566046|NCT01197612|3830796|P1|NOT COMPLETED|Overall Study||12
1566047|NCT01197612|3830796|P1|COMPLETED|Overall Study||6
1566048|NCT01197612|3830796|P1|Returned for Week 24|Overall Study||6
1566049|NCT01197612|3830796|P1|Week 3|Overall Study||16
1566050|NCT01197612|3830796|P1|STARTED|Overall Study||18
1566051|NCT01197573|3830811|P4|NOT COMPLETED|Overall Study||0
1566052|NCT01197573|3830812|P3|NOT COMPLETED|Overall Study||0
1566053|NCT01197573|3830813|P2|NOT COMPLETED|Overall Study||0
1566054|NCT01197573|3830814|P1|NOT COMPLETED|Overall Study||0
1566055|NCT01197573|3830811|P4|COMPLETED|Overall Study||12
1566056|NCT01197573|3830812|P3|COMPLETED|Overall Study||12
1566057|NCT01197573|3830813|P2|COMPLETED|Overall Study||46
1566058|NCT01197573|3830814|P1|COMPLETED|Overall Study||33
1566059|NCT01197573|3830811|P4|STARTED|Overall Study||12
1566060|NCT01197573|3830812|P3|STARTED|Overall Study||12
1566061|NCT01197573|3830813|P2|STARTED|Overall Study||46
1566062|NCT01197573|3830814|P1|STARTED|Overall Study||33
1566063|NCT01197560|3830828|P2|NOT COMPLETED|Overall Study||53
1566064|NCT01197560|3830829|P1|NOT COMPLETED|Overall Study||46
1566065|NCT01197560|3830828|P2|COMPLETED|Overall Study|Completed = those completed and ongoing on treatment at the time of the data cut-off of 04 July 2013|4
1566066|NCT01197560|3830829|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 04 July 2013|8
1566067|NCT01197560|3830828|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||3
1566068|NCT01197560|3830829|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||7
1566069|NCT01197560|3830828|P2|Lenalidomide Crossover|Overall Study||29
1566070|NCT01197560|3830829|P1|Lenalidomide Crossover|Overall Study||0
1566071|NCT01197560|3830828|P2|Received ≥ One Dose Study Drug|Overall Study||55
1566072|NCT01197560|3830829|P1|Received ≥ One Dose Study Drug|Overall Study||54
1566073|NCT01197560|3830828|P2|STARTED|Overall Study|This is the intent to treat population|57
1566074|NCT01197560|3830829|P1|STARTED|Overall Study|This is the intent to treat population|54
1566075|NCT01197547|3830853|P1|NOT COMPLETED|Overall Study||22
1566076|NCT01197547|3830853|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
1566077|NCT01197547|3830853|P1|STARTED|Overall Study||1014
1566078|NCT01197534|3830862|P3|NOT COMPLETED|Overall Study||173
1566079|NCT01197534|3830863|P2|NOT COMPLETED|Overall Study||130
1566080|NCT01197534|3830864|P1|NOT COMPLETED|Overall Study||134
1566081|NCT01197534|3830862|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
1566082|NCT01197534|3830863|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
1566083|NCT01197534|3830864|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
1566084|NCT01197534|3830862|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
1566085|NCT01197534|3830863|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
1566086|NCT01197534|3830864|P1|Randomised But Did Not Receive Treatment|Overall Study||0
1566087|NCT01197534|3830862|P3|STARTED|Overall Study|Patients who received treatment|302
1566088|NCT01197534|3830863|P2|STARTED|Overall Study|Patients who received treatment|298
1566089|NCT01197534|3830864|P1|STARTED|Overall Study|Patients who received treatment|308
1566090|NCT01197521|3830908|P3|NOT COMPLETED|Overall Study||143
1566091|NCT01197521|3830909|P2|NOT COMPLETED|Overall Study||113
1566092|NCT01197521|3830910|P1|NOT COMPLETED|Overall Study||103
1566093|NCT01197521|3830908|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
1566094|NCT01197521|3830909|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
1566095|NCT01197521|3830910|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
1566096|NCT01197521|3830908|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
1566097|NCT01197521|3830909|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
1566098|NCT01197521|3830910|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
1566099|NCT01197521|3830908|P3|STARTED|Overall Study|Patients who received treatment|304
1566100|NCT01197521|3830909|P2|STARTED|Overall Study|Patients who received treatment|304
1566101|NCT01197521|3830910|P1|STARTED|Overall Study|Patients who received treatment|310
1566102|NCT01197508|3830955|P4|NOT COMPLETED|Overall Study||16
1566103|NCT01197508|3830956|P3|NOT COMPLETED|Overall Study||49
1566104|NCT01197508|3830957|P2|NOT COMPLETED|Overall Study||30
1566105|NCT01197508|3830958|P1|NOT COMPLETED|Overall Study||23
1566106|NCT01197508|3830955|P4|COMPLETED|Overall Study||158
1566107|NCT01197508|3830956|P3|COMPLETED|Overall Study||125
1566108|NCT01197508|3830957|P2|COMPLETED|Overall Study||144
1566109|NCT01197508|3830958|P1|COMPLETED|Overall Study||151
1566110|NCT01197508|3830955|P4|Received Treatment|Overall Study||174
1566111|NCT01197508|3830956|P3|Received Treatment|Overall Study||171
1566112|NCT01197508|3830957|P2|Received Treatment|Overall Study||174
1566113|NCT01197508|3830958|P1|Received Treatment|Overall Study||174
1566114|NCT01197508|3830955|P4|STARTED|Overall Study||174
1566115|NCT01197508|3830956|P3|STARTED|Overall Study||174
1566116|NCT01197508|3830957|P2|STARTED|Overall Study||174
1566117|NCT01197508|3830958|P1|STARTED|Overall Study||174
1566118|NCT01197495|3831054|P2|NOT COMPLETED|Overall Study||7
1566119|NCT01197495|3831055|P1|NOT COMPLETED|Overall Study||13
1566120|NCT01197495|3831054|P2|COMPLETED|Overall Study||49
1566121|NCT01197495|3831055|P1|COMPLETED|Overall Study||144
1566122|NCT01197495|3831054|P2|STARTED|Overall Study||56
1566123|NCT01197495|3831055|P1|STARTED|Overall Study||157
1566124|NCT01197417|3831068|P2|NOT COMPLETED|Overall Study||18
1566125|NCT01197417|3831069|P1|NOT COMPLETED|Overall Study||8
1566126|NCT01197417|3831068|P2|COMPLETED|Overall Study||86
1566127|NCT01197417|3831069|P1|COMPLETED|Overall Study||96
1566128|NCT01197417|3831068|P2|Received Study Drug|Overall Study||103
1566129|NCT01197417|3831069|P1|Received Study Drug|Overall Study||101
1566130|NCT01197417|3831068|P2|STARTED|Overall Study||104
1566131|NCT01197417|3831069|P1|STARTED|Overall Study||104
1566132|NCT01197378|3831087|P1|NOT COMPLETED|Overall Study||7
1566133|NCT01197378|3831087|P1|COMPLETED|Overall Study||53
1566134|NCT01197378|3831087|P1|Received Treatment|Overall Study||59
1566135|NCT01197378|3831087|P1|STARTED|Overall Study||60
1566136|NCT01197326|3831095|P2|NOT COMPLETED|Overall Study||0
1566137|NCT01197326|3831096|P1|NOT COMPLETED|Overall Study||0
1566138|NCT01197326|3831095|P2|COMPLETED|Overall Study||209
1566139|NCT01197326|3831096|P1|COMPLETED|Overall Study||205
1566140|NCT01197326|3831095|P2|STARTED|Overall Study||209
1566141|NCT01197326|3831096|P1|STARTED|Overall Study||205
1566142|NCT01196988|3831108|P4|NOT COMPLETED|Overall Study||1
1566143|NCT01196988|3831109|P3|NOT COMPLETED|Overall Study||25
1566144|NCT01196988|3831110|P2|NOT COMPLETED|Overall Study||32
1566145|NCT01196988|3831111|P1|NOT COMPLETED|Overall Study||24
1566146|NCT01196988|3831108|P4|COMPLETED|Overall Study||276
1566147|NCT01196988|3831109|P3|COMPLETED|Overall Study||886
1566148|NCT01196988|3831110|P2|COMPLETED|Overall Study||880
1566149|NCT01196988|3831111|P1|COMPLETED|Overall Study||891
1566150|NCT01196988|3831108|P4|STARTED|Overall Study||277
1566151|NCT01196988|3831109|P3|STARTED|Overall Study||911
1566152|NCT01196988|3831110|P2|STARTED|Overall Study||912
1566153|NCT01196988|3831111|P1|STARTED|Overall Study||915
1566154|NCT01196975|3831205|P5|NOT COMPLETED|Overall Study||13
1566155|NCT01196975|3831206|P4|NOT COMPLETED|Overall Study||6
1566156|NCT01196975|3831207|P3|NOT COMPLETED|Overall Study||5
1566157|NCT01196975|3831208|P2|NOT COMPLETED|Overall Study||9
1566158|NCT01196975|3831209|P1|NOT COMPLETED|Overall Study||15
1566159|NCT01196975|3831205|P5|COMPLETED|Overall Study||205
1566160|NCT01196975|3831206|P4|COMPLETED|Overall Study||207
1566161|NCT01196975|3831207|P3|COMPLETED|Overall Study||420
1566162|NCT01196975|3831208|P2|COMPLETED|Overall Study||415
1566163|NCT01196975|3831209|P1|COMPLETED|Overall Study||408
1566164|NCT01196975|3831205|P5|STARTED|Overall Study||218
1566165|NCT01196975|3831206|P4|STARTED|Overall Study||213
1566166|NCT01196975|3831207|P3|STARTED|Overall Study||425
1566167|NCT01196975|3831208|P2|STARTED|Overall Study||424
1566168|NCT01196975|3831209|P1|STARTED|Overall Study||423
1566169|NCT01196923|3831341|P1|NOT COMPLETED|Overall Study||0
1566170|NCT01196923|3831341|P1|COMPLETED|Overall Study||20
1566171|NCT01196923|3831341|P1|STARTED|Overall Study||20
1566172|NCT01196871|3831351|P6|NOT COMPLETED|Stage 2: Period 2||0
1566173|NCT01196871|3831352|P5|NOT COMPLETED|Stage 2: Period 2||0
1566174|NCT01196871|3831353|P4|NOT COMPLETED|Stage 2: Period 2||0
1566175|NCT01196871|3831354|P3|NOT COMPLETED|Stage 2: Period 2||0
1566176|NCT01196871|3831355|P2|NOT COMPLETED|Stage 2: Period 2||0
1566177|NCT01196871|3831356|P1|NOT COMPLETED|Stage 2: Period 2||0
1566178|NCT01196871|3831351|P6|COMPLETED|Stage 2: Period 2||4
1566179|NCT01196871|3831352|P5|COMPLETED|Stage 2: Period 2||6
1566180|NCT01196871|3831353|P4|COMPLETED|Stage 2: Period 2||1
1566181|NCT01196871|3831354|P3|COMPLETED|Stage 2: Period 2||0
1566182|NCT01196871|3831355|P2|COMPLETED|Stage 2: Period 2||0
1566183|NCT01196871|3831356|P1|COMPLETED|Stage 2: Period 2||0
1566184|NCT01196871|3831351|P6|PK Population|Stage 2: Period 2||4
1566185|NCT01196871|3831352|P5|PK Population|Stage 2: Period 2||6
1566186|NCT01196871|3831353|P4|PK Population|Stage 2: Period 2||1
1566187|NCT01196871|3831354|P3|PK Population|Stage 2: Period 2||0
1566188|NCT01196871|3831355|P2|PK Population|Stage 2: Period 2||0
1566189|NCT01196871|3831356|P1|PK Population|Stage 2: Period 2||0
1566190|NCT01196871|3831351|P6|STARTED|Stage 2: Period 2||4
1566191|NCT01196871|3831352|P5|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
1566192|NCT01196871|3831353|P4|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
1566193|NCT01196871|3831354|P3|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
1566194|NCT01196871|3831355|P2|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
1566195|NCT01196871|3831356|P1|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
1566196|NCT01196871|3831351|P6|NOT COMPLETED|Stage 2: Period 1||0
1566197|NCT01196871|3831352|P5|NOT COMPLETED|Stage 2: Period 1||0
1566198|NCT01196871|3831353|P4|NOT COMPLETED|Stage 2: Period 1||0
1566199|NCT01196871|3831354|P3|NOT COMPLETED|Stage 2: Period 1||0
1566200|NCT01196871|3831355|P2|NOT COMPLETED|Stage 2: Period 1||0
1566201|NCT01196871|3831356|P1|NOT COMPLETED|Stage 2: Period 1||0
1566202|NCT01196871|3831351|P6|COMPLETED|Stage 2: Period 1||4
1566203|NCT01196871|3831352|P5|COMPLETED|Stage 2: Period 1||5
1566204|NCT01196871|3831353|P4|COMPLETED|Stage 2: Period 1||2
1566205|NCT01196871|3831354|P3|COMPLETED|Stage 2: Period 1||0
1566206|NCT01196871|3831355|P2|COMPLETED|Stage 2: Period 1||0
1566207|NCT01196871|3831356|P1|COMPLETED|Stage 2: Period 1||0
1566208|NCT01196871|3831351|P6|PK Population|Stage 2: Period 1||4
1566209|NCT01196871|3831352|P5|PK Population|Stage 2: Period 1||5
1566210|NCT01196871|3831353|P4|PK Population|Stage 2: Period 1||1
1566211|NCT01196871|3831354|P3|PK Population|Stage 2: Period 1||0
1566212|NCT01196871|3831355|P2|PK Population|Stage 2: Period 1||0
1566213|NCT01196871|3831356|P1|PK Population|Stage 2: Period 1||0
1566214|NCT01196871|3831351|P6|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
1566215|NCT01196871|3831352|P5|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
1566216|NCT01196871|3831353|P4|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
1566217|NCT01196871|3831354|P3|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
1566218|NCT01196871|3831355|P2|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
1566219|NCT01196871|3831356|P1|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
1566220|NCT01196871|3831351|P6|STARTED|Stage 2: Period 1||4
1566221|NCT01196871|3831352|P5|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
1566222|NCT01196871|3831353|P4|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
1566223|NCT01196871|3831354|P3|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
1566224|NCT01196871|3831355|P2|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
1566225|NCT01196871|3831356|P1|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
1566226|NCT01196871|3831351|P6|NOT COMPLETED|Stage 1: Period 3||0
1566227|NCT01196871|3831352|P5|NOT COMPLETED|Stage 1: Period 3||0
1566228|NCT01196871|3831353|P4|NOT COMPLETED|Stage 1: Period 3||0
1566229|NCT01196871|3831354|P3|NOT COMPLETED|Stage 1: Period 3||0
1566230|NCT01196871|3831355|P2|NOT COMPLETED|Stage 1: Period 3||0
1566231|NCT01196871|3831356|P1|NOT COMPLETED|Stage 1: Period 3||0
1566232|NCT01196871|3831351|P6|COMPLETED|Stage 1: Period 3||0
1566233|NCT01196871|3831352|P5|COMPLETED|Stage 1: Period 3||0
1566234|NCT01196871|3831353|P4|COMPLETED|Stage 1: Period 3||0
1566235|NCT01196871|3831354|P3|COMPLETED|Stage 1: Period 3||4
1566236|NCT01196871|3831355|P2|COMPLETED|Stage 1: Period 3||3
1566237|NCT01196871|3831356|P1|COMPLETED|Stage 1: Period 3||5
1566238|NCT01196871|3831351|P6|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
1566239|NCT01196871|3831352|P5|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
1566240|NCT01196871|3831353|P4|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
1566241|NCT01196871|3831354|P3|STARTED|Stage 1: Period 3||4
1566242|NCT01196871|3831355|P2|STARTED|Stage 1: Period 3||3
1566243|NCT01196871|3831356|P1|STARTED|Stage 1: Period 3||5
1566244|NCT01196871|3831351|P6|NOT COMPLETED|Stage 1: Period 2||0
1566245|NCT01196871|3831352|P5|NOT COMPLETED|Stage 1: Period 2||0
1566246|NCT01196871|3831353|P4|NOT COMPLETED|Stage 1: Period 2||0
1566247|NCT01196871|3831354|P3|NOT COMPLETED|Stage 1: Period 2||0
1566248|NCT01196871|3831355|P2|NOT COMPLETED|Stage 1: Period 2||0
1566249|NCT01196871|3831356|P1|NOT COMPLETED|Stage 1: Period 2||0
1566250|NCT01196871|3831351|P6|COMPLETED|Stage 1: Period 2||0
1566251|NCT01196871|3831352|P5|COMPLETED|Stage 1: Period 2||0
1566252|NCT01196871|3831353|P4|COMPLETED|Stage 1: Period 2||0
1566253|NCT01196871|3831354|P3|COMPLETED|Stage 1: Period 2||4
1566254|NCT01196871|3831355|P2|COMPLETED|Stage 1: Period 2||3
1566255|NCT01196871|3831356|P1|COMPLETED|Stage 1: Period 2||5
1566256|NCT01196871|3831351|P6|PK Population|Stage 1: Period 2||0
1566257|NCT01196871|3831352|P5|PK Population|Stage 1: Period 2||0
1566258|NCT01196871|3831353|P4|PK Population|Stage 1: Period 2||0
1566259|NCT01196871|3831354|P3|PK Population|Stage 1: Period 2||4
1566260|NCT01196871|3831355|P2|PK Population|Stage 1: Period 2||3
1566261|NCT01196871|3831356|P1|PK Population|Stage 1: Period 2||5
1566262|NCT01196871|3831351|P6|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
1566263|NCT01196871|3831352|P5|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
1566264|NCT01196871|3831353|P4|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
1566265|NCT01196871|3831354|P3|STARTED|Stage 1: Period 2||4
1566266|NCT01196871|3831355|P2|STARTED|Stage 1: Period 2||3
1566267|NCT01196871|3831356|P1|STARTED|Stage 1: Period 2||5
1566268|NCT01196871|3831351|P6|NOT COMPLETED|Stage 1: Period 1||0
1566269|NCT01196871|3831352|P5|NOT COMPLETED|Stage 1: Period 1||0
1566270|NCT01196871|3831353|P4|NOT COMPLETED|Stage 1: Period 1||0
1566271|NCT01196871|3831354|P3|NOT COMPLETED|Stage 1: Period 1||0
1566272|NCT01196871|3831355|P2|NOT COMPLETED|Stage 1: Period 1||0
1566273|NCT01196871|3831356|P1|NOT COMPLETED|Stage 1: Period 1||0
1566274|NCT01196871|3831351|P6|COMPLETED|Stage 1: Period 1||0
1566275|NCT01196871|3831352|P5|COMPLETED|Stage 1: Period 1||0
1566276|NCT01196871|3831353|P4|COMPLETED|Stage 1: Period 1||0
1566277|NCT01196871|3831354|P3|COMPLETED|Stage 1: Period 1||4
1566278|NCT01196871|3831355|P2|COMPLETED|Stage 1: Period 1||3
1566279|NCT01196871|3831356|P1|COMPLETED|Stage 1: Period 1||5
1566280|NCT01196871|3831351|P6|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
1566281|NCT01196871|3831352|P5|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
1566282|NCT01196871|3831353|P4|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
1566283|NCT01196871|3831354|P3|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
1566284|NCT01196871|3831355|P2|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
1566285|NCT01196871|3831356|P1|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
1566286|NCT01196871|3831351|P6|PK Population|Stage 1: Period 1||0
1566287|NCT01196871|3831352|P5|PK Population|Stage 1: Period 1||0
1566288|NCT01196871|3831353|P4|PK Population|Stage 1: Period 1||0
1566289|NCT01196871|3831354|P3|PK Population|Stage 1: Period 1||4
1566290|NCT01196871|3831355|P2|PK Population|Stage 1: Period 1||3
1566291|NCT01196871|3831356|P1|PK Population|Stage 1: Period 1||5
1566292|NCT01196871|3831351|P6|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
1566293|NCT01196871|3831352|P5|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
1566294|NCT01196871|3831353|P4|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
1566295|NCT01196871|3831354|P3|STARTED|Stage 1: Period 1||4
1566296|NCT01196871|3831355|P2|STARTED|Stage 1: Period 1||3
1566297|NCT01196871|3831356|P1|STARTED|Stage 1: Period 1||5
1566298|NCT01196819|3831441|P2|NOT COMPLETED|Overall Study||28
1566299|NCT01196819|3831442|P1|NOT COMPLETED|Overall Study||28
1566300|NCT01196819|3831441|P2|COMPLETED|Overall Study||199
1566301|NCT01196819|3831442|P1|COMPLETED|Overall Study||203
1566302|NCT01196819|3831441|P2|STARTED|Overall Study||227
1566303|NCT01196819|3831442|P1|STARTED|Overall Study||231
1566304|NCT01196741|3831464|P2|NOT COMPLETED|Overall Study||28
1566305|NCT01196741|3831465|P1|NOT COMPLETED|Overall Study||60
1566306|NCT01196741|3831464|P2|COMPLETED|Overall Study||8
1566307|NCT01196741|3831465|P1|COMPLETED|Overall Study||11
1566308|NCT01196741|3831464|P2|STARTED|Overall Study||36
1566309|NCT01196741|3831465|P1|STARTED|Overall Study||71
1566310|NCT01196442|3831479|P1|NOT COMPLETED|Overall Study||0
1566311|NCT01196442|3831479|P1|COMPLETED|Overall Study||39
1566312|NCT01196442|3831479|P1|STARTED|Overall Study||39
1566313|NCT01196429|3831491|P2|NOT COMPLETED|Overall Study||0
1566314|NCT01196429|3831492|P1|NOT COMPLETED|Overall Study||3
1566315|NCT01196429|3831491|P2|COMPLETED|Overall Study||45
1566316|NCT01196429|3831492|P1|COMPLETED|Overall Study||42
1566317|NCT01196429|3831491|P2|STARTED|Overall Study||45
1566318|NCT01196429|3831492|P1|STARTED|Overall Study||45
1566319|NCT01196416|3831508|P1|NOT COMPLETED|Overall Study||2
1566320|NCT01196416|3831508|P1|COMPLETED|Overall Study||12
1566321|NCT01196416|3831508|P1|STARTED|Overall Study||14
1566322|NCT01196377|3831519|P4|NOT COMPLETED|Overall Study||0
1566323|NCT01196377|3831520|P3|NOT COMPLETED|Overall Study||0
1566324|NCT01196377|3831521|P2|NOT COMPLETED|Overall Study||0
1566325|NCT01196377|3831522|P1|NOT COMPLETED|Overall Study||0
1566326|NCT01196377|3831519|P4|COMPLETED|Overall Study||4
1566327|NCT01196377|3831520|P3|COMPLETED|Overall Study||4
1566328|NCT01196377|3831521|P2|COMPLETED|Overall Study||4
1566329|NCT01196377|3831522|P1|COMPLETED|Overall Study||4
1566330|NCT01196377|3831519|P4|STARTED|Overall Study||4
1566331|NCT01196377|3831520|P3|STARTED|Overall Study||4
1566332|NCT01196377|3831521|P2|STARTED|Overall Study||4
1566333|NCT01196377|3831522|P1|STARTED|Overall Study||4
1566334|NCT01196104|3831534|P2|NOT COMPLETED|Overall Study||5
1566335|NCT01196104|3831535|P1|NOT COMPLETED|Overall Study||4
1566336|NCT01196104|3831534|P2|COMPLETED|Overall Study||15
1566337|NCT01196104|3831535|P1|COMPLETED|Overall Study||15
1566338|NCT01196104|3831534|P2|STARTED|Overall Study||20
1566339|NCT01196104|3831535|P1|STARTED|Overall Study||19
1566340|NCT01196091|3831578|P3|NOT COMPLETED|Overall Study||104
1566341|NCT01196091|3831579|P2|NOT COMPLETED|Overall Study||98
1566342|NCT01196091|3831580|P1|NOT COMPLETED|Overall Study||88
1566343|NCT01196091|3831578|P3|COMPLETED|Overall Study||284
1566344|NCT01196091|3831579|P2|COMPLETED|Overall Study||291
1566345|NCT01196091|3831580|P1|COMPLETED|Overall Study||299
1566346|NCT01196091|3831578|P3|Follow-Up|Overall Study||128
1566347|NCT01196091|3831579|P2|Follow-Up|Overall Study||105
1566348|NCT01196091|3831580|P1|Follow-Up|Overall Study||103
1566349|NCT01196091|3831578|P3|ITT-Received Drug and Excluded Sites|Overall Study||379
1566350|NCT01196091|3831579|P2|ITT-Received Drug and Excluded Sites|Overall Study||378
1566351|NCT01196091|3831580|P1|ITT-Received Drug and Excluded Sites|Overall Study||381
1566352|NCT01196091|3831578|P3|Received at Least 1 Dose of Study Drug|Overall Study||387
1566353|NCT01196091|3831579|P2|Received at Least 1 Dose of Study Drug|Overall Study||389
1566354|NCT01196091|3831580|P1|Received at Least 1 Dose of Study Drug|Overall Study||386
1566355|NCT01196091|3831578|P3|STARTED|Overall Study||388
1566356|NCT01196091|3831579|P2|STARTED|Overall Study||389
1566357|NCT01196091|3831580|P1|STARTED|Overall Study||387
1566358|NCT01196078|3831632|P2|NOT COMPLETED|Overall Study||37
1566359|NCT01196078|3831633|P1|NOT COMPLETED|Overall Study||33
1566360|NCT01196078|3831632|P2|COMPLETED|Overall Study||20
1566361|NCT01196078|3831633|P1|COMPLETED|Overall Study||24
1566362|NCT01196078|3831632|P2|STARTED|Overall Study||57
1566363|NCT01196078|3831633|P1|STARTED|Overall Study||57
1566364|NCT01196052|3831661|P1|NOT COMPLETED|Overall Study||23
1566365|NCT01196052|3831661|P1|COMPLETED|Overall Study||130
1566366|NCT01196052|3831661|P1|Received Trastuzumab Emtansine|Overall Study||148
1566367|NCT01196052|3831661|P1|STARTED|Overall Study||153
1566368|NCT01196026|3831678|P6|NOT COMPLETED|Overall Study||0
1566369|NCT01196026|3831679|P5|NOT COMPLETED|Overall Study||1
1566370|NCT01196026|3831680|P4|NOT COMPLETED|Overall Study||0
1566371|NCT01196026|3831681|P3|NOT COMPLETED|Overall Study||0
1566372|NCT01196026|3831682|P2|NOT COMPLETED|Overall Study||8
1566373|NCT01196026|3831683|P1|NOT COMPLETED|Overall Study||1
1566374|NCT01196026|3831678|P6|COMPLETED|Overall Study||24
1566375|NCT01196026|3831679|P5|COMPLETED|Overall Study||42
1566376|NCT01196026|3831680|P4|COMPLETED|Overall Study||10
1566377|NCT01196026|3831681|P3|COMPLETED|Overall Study||23
1566378|NCT01196026|3831682|P2|COMPLETED|Overall Study||36
1566379|NCT01196026|3831683|P1|COMPLETED|Overall Study||9
1566380|NCT01196026|3831678|P6|Completed at Day 28|Overall Study||24
1566381|NCT01196026|3831679|P5|Completed at Day 28|Overall Study||42
1566382|NCT01196026|3831680|P4|Completed at Day 28|Overall Study||10
1566383|NCT01196026|3831681|P3|Completed at Day 28|Overall Study||23
1566384|NCT01196026|3831682|P2|Completed at Day 28|Overall Study||41
1566385|NCT01196026|3831683|P1|Completed at Day 28|Overall Study||9
1566386|NCT01196026|3831678|P6|STARTED|Overall Study||24
1566387|NCT01196026|3831679|P5|STARTED|Overall Study||43
1566388|NCT01196026|3831680|P4|STARTED|Overall Study||10
1566389|NCT01196026|3831681|P3|STARTED|Overall Study||23
1566390|NCT01196026|3831682|P2|STARTED|Overall Study||44
1566391|NCT01196026|3831683|P1|STARTED|Overall Study||10
1566392|NCT01195948|3831917|P3|NOT COMPLETED|Overall Study||2
1566393|NCT01195948|3831918|P2|NOT COMPLETED|Overall Study||1
1566394|NCT01195948|3831919|P1|NOT COMPLETED|Overall Study||0
1566395|NCT01195948|3831917|P3|COMPLETED|Overall Study||9
1566396|NCT01195948|3831918|P2|COMPLETED|Overall Study||9
1566397|NCT01195948|3831919|P1|COMPLETED|Overall Study||10
1566398|NCT01195948|3831917|P3|Week 24|Overall Study||10
1566399|NCT01195948|3831918|P2|Week 24|Overall Study||10
1566400|NCT01195948|3831919|P1|Week 24|Overall Study||10
1566401|NCT01195948|3831917|P3|STARTED|Overall Study||11
1566402|NCT01195948|3831918|P2|STARTED|Overall Study||10
1566403|NCT01195948|3831919|P1|STARTED|Overall Study||10
1566404|NCT01195922|3831951|P1|NOT COMPLETED|Overall Study||0
1566405|NCT01195922|3831951|P1|COMPLETED|Overall Study||16
1566406|NCT01195922|3831951|P1|STARTED|Overall Study||16
1566407|NCT01195883|3831959|P2|NOT COMPLETED|Overall Study||26
1566408|NCT01195883|3831960|P1|NOT COMPLETED|Overall Study||19
1566409|NCT01195883|3831959|P2|COMPLETED|Overall Study||523
1566410|NCT01195883|3831960|P1|COMPLETED|Overall Study||534
1566411|NCT01195883|3831959|P2|STARTED|Overall Study||549
1566412|NCT01195883|3831960|P1|STARTED|Overall Study||553
1566413|NCT01195844|3831972|P1|NOT COMPLETED|Overall Study||40
1566414|NCT01195844|3831972|P1|COMPLETED|Overall Study||190
1566415|NCT01195844|3831972|P1|STARTED|Overall Study||230
1566416|NCT01195831|3831989|P2|NOT COMPLETED|Overall Study||10
1566417|NCT01195831|3831990|P1|NOT COMPLETED|Overall Study||8
1566418|NCT01195831|3831989|P2|COMPLETED|Overall Study||114
1566419|NCT01195831|3831990|P1|COMPLETED|Overall Study||112
1566420|NCT01195831|3831989|P2|STARTED|Overall Study||124
1566421|NCT01195831|3831990|P1|STARTED|Overall Study||120
1566422|NCT01195779|3832018|P14|NOT COMPLETED|Overall Study||0
1566423|NCT01195779|3832019|P13|NOT COMPLETED|Overall Study||0
1566424|NCT01195779|3832020|P12|NOT COMPLETED|Overall Study||0
1566425|NCT01195779|3832021|P11|NOT COMPLETED|Overall Study||0
1566426|NCT01195779|3832022|P10|NOT COMPLETED|Overall Study||0
1566427|NCT01195779|3832023|P9|NOT COMPLETED|Overall Study||0
1566428|NCT01195779|3832024|P8|NOT COMPLETED|Overall Study||0
1566429|NCT01195779|3832025|P7|NOT COMPLETED|Overall Study||0
1566430|NCT01195779|3832026|P6|NOT COMPLETED|Overall Study||0
1566431|NCT01195779|3832027|P5|NOT COMPLETED|Overall Study||0
1566432|NCT01195779|3832028|P4|NOT COMPLETED|Overall Study||0
1566433|NCT01195779|3832029|P3|NOT COMPLETED|Overall Study||0
1566434|NCT01195779|3832030|P2|NOT COMPLETED|Overall Study||0
1566435|NCT01195779|3832031|P1|NOT COMPLETED|Overall Study||0
1566436|NCT01195779|3832018|P14|COMPLETED|Overall Study||1
1566437|NCT01195779|3832019|P13|COMPLETED|Overall Study||0
1566438|NCT01195779|3832020|P12|COMPLETED|Overall Study||1
1566439|NCT01195779|3832021|P11|COMPLETED|Overall Study||0
1566440|NCT01195779|3832022|P10|COMPLETED|Overall Study||0
1566441|NCT01195779|3832023|P9|COMPLETED|Overall Study||0
1566442|NCT01195779|3832024|P8|COMPLETED|Overall Study||1
1566443|NCT01195779|3832025|P7|COMPLETED|Overall Study||0
1566444|NCT01195779|3832026|P6|COMPLETED|Overall Study||0
1566445|NCT01195779|3832027|P5|COMPLETED|Overall Study||1
1566446|NCT01195779|3832028|P4|COMPLETED|Overall Study||0
1566447|NCT01195779|3832029|P3|COMPLETED|Overall Study||0
1566448|NCT01195779|3832030|P2|COMPLETED|Overall Study||0
1566449|NCT01195779|3832031|P1|COMPLETED|Overall Study||0
1566450|NCT01195779|3832018|P14|STARTED|Overall Study||1
1566451|NCT01195779|3832019|P13|STARTED|Overall Study||0
1566452|NCT01195779|3832020|P12|STARTED|Overall Study||1
1566453|NCT01195779|3832021|P11|STARTED|Overall Study||0
1566454|NCT01195779|3832022|P10|STARTED|Overall Study||0
1566455|NCT01195779|3832023|P9|STARTED|Overall Study||0
1566456|NCT01195779|3832024|P8|STARTED|Overall Study||1
1566457|NCT01195779|3832025|P7|STARTED|Overall Study||0
1566458|NCT01195779|3832026|P6|STARTED|Overall Study||0
1566459|NCT01195779|3832027|P5|STARTED|Overall Study||1
1566460|NCT01195779|3832028|P4|STARTED|Overall Study||0
1566461|NCT01195779|3832029|P3|STARTED|Overall Study||0
1566462|NCT01195779|3832030|P2|STARTED|Overall Study||0
1566463|NCT01195779|3832031|P1|STARTED|Overall Study||0
1566464|NCT01195701|3832203|P2|NOT COMPLETED|Overall Study||5
1566465|NCT01195701|3832204|P1|NOT COMPLETED|Overall Study||0
1566466|NCT01195701|3832203|P2|COMPLETED|Overall Study||20
1566467|NCT01195701|3832204|P1|COMPLETED|Overall Study||10
1566468|NCT01195701|3832203|P2|STARTED|Overall Study||25
1566469|NCT01195701|3832204|P1|STARTED|Overall Study||10
1566470|NCT01195675|3832230|P1|NOT COMPLETED|Overall Study||3
1566471|NCT01195675|3832230|P1|COMPLETED|Overall Study||27
1566472|NCT01195675|3832230|P1|Received Placebo 2|Overall Study||28
1566473|NCT01195675|3832230|P1|Received Placebo 1|Overall Study||29
1566474|NCT01195675|3832230|P1|Received Moxifloxacin|Overall Study||29
1566475|NCT01195675|3832230|P1|Received Empa 200mg|Overall Study||30
1566476|NCT01195675|3832230|P1|Received Empa 25mg|Overall Study||28
1566477|NCT01195675|3832230|P1|STARTED|Overall Study||30
1566478|NCT01195662|3832263|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
1566479|NCT01195662|3832264|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
1566480|NCT01195662|3832265|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
1566481|NCT01195662|3832263|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
1566482|NCT01195662|3832264|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
1566483|NCT01195662|3832265|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
1566484|NCT01195662|3832263|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
1566485|NCT01195662|3832264|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
1566486|NCT01195662|3832265|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
1566487|NCT01195662|3832263|P3|NOT COMPLETED|Double Blind Treatment Period||14
1566488|NCT01195662|3832264|P2|NOT COMPLETED|Double Blind Treatment Period||14
1566489|NCT01195662|3832265|P1|NOT COMPLETED|Double Blind Treatment Period||22
1566490|NCT01195662|3832263|P3|COMPLETED|Double Blind Treatment Period||119
1566491|NCT01195662|3832264|P2|COMPLETED|Double Blind Treatment Period||211
1566492|NCT01195662|3832265|P1|COMPLETED|Double Blind Treatment Period||202
1566493|NCT01195662|3832263|P3|STARTED|Double Blind Treatment Period||133
1566494|NCT01195662|3832264|P2|STARTED|Double Blind Treatment Period||225
1566495|NCT01195662|3832265|P1|STARTED|Double Blind Treatment Period||224
1566496|NCT01195636|3832295|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
1566497|NCT01195636|3832296|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
1566498|NCT01195636|3832295|P2|COMPLETED|Second Intervention (3 Weeks)||27
1566499|NCT01195636|3832296|P1|COMPLETED|Second Intervention (3 Weeks)||27
1566500|NCT01195636|3832295|P2|STARTED|Second Intervention (3 Weeks)||29
1566501|NCT01195636|3832296|P1|STARTED|Second Intervention (3 Weeks)||28
1566502|NCT01195636|3832295|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
1566503|NCT01195636|3832296|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
1566504|NCT01195636|3832295|P2|COMPLETED|Washout Period (2 Weeks)||29
1566505|NCT01195636|3832296|P1|COMPLETED|Washout Period (2 Weeks)||28
1566506|NCT01195636|3832295|P2|STARTED|Washout Period (2 Weeks)||32
1566507|NCT01195636|3832296|P1|STARTED|Washout Period (2 Weeks)||30
1566508|NCT01195636|3832295|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
1566509|NCT01195636|3832296|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
1566510|NCT01195636|3832295|P2|COMPLETED|First Intervention (3 Weeks)||32
1566511|NCT01195636|3832296|P1|COMPLETED|First Intervention (3 Weeks)||30
1566512|NCT01195636|3832295|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
1566513|NCT01195636|3832296|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
1566514|NCT01195636|3832295|P2|STARTED|First Intervention (3 Weeks)||35
1566515|NCT01195636|3832296|P1|STARTED|First Intervention (3 Weeks)||35
1566516|NCT01195623|3832322|P2|NOT COMPLETED|Overall Study||37
1566517|NCT01195623|3832323|P1|NOT COMPLETED|Overall Study||35
1566518|NCT01195623|3832322|P2|COMPLETED|Overall Study|129 legs|108
1566519|NCT01195623|3832323|P1|COMPLETED|Overall Study|127 legs|113
1566520|NCT01195623|3832322|P2|STARTED|Overall Study|177 legs total operated|145
1566521|NCT01195623|3832323|P1|STARTED|Overall Study|166 legs total operated|148
1566522|NCT01195597|3832331|P1|NOT COMPLETED|Overall Study||13
1566523|NCT01195597|3832331|P1|COMPLETED|Overall Study||27
1566524|NCT01195597|3832331|P1|STARTED|Overall Study||40
1566525|NCT01195584|3832339|P3|NOT COMPLETED|Overall Study||0
1566526|NCT01195584|3832340|P2|NOT COMPLETED|Overall Study||0
1566527|NCT01195584|3832341|P1|NOT COMPLETED|Overall Study||0
1566528|NCT01195584|3832339|P3|COMPLETED|Overall Study||27
1566529|NCT01195584|3832340|P2|COMPLETED|Overall Study||25
1566530|NCT01195584|3832341|P1|COMPLETED|Overall Study||20
1566531|NCT01195584|3832339|P3|STARTED|Overall Study||27
1566532|NCT01195584|3832340|P2|STARTED|Overall Study||25
1566533|NCT01195584|3832341|P1|STARTED|Overall Study||20
1566534|NCT01195545|3832352|P1|NOT COMPLETED|Overall Study||4
1566535|NCT01195545|3832352|P1|COMPLETED|Overall Study||16
1566536|NCT01195545|3832352|P1|STARTED|Overall Study||20
1566537|NCT01195467|3832359|P1|NOT COMPLETED|Overall Study||10
1566538|NCT01195467|3832359|P1|COMPLETED|Overall Study||30
1566539|NCT01195467|3832359|P1|STARTED|Overall Study||40
1566540|NCT01195415|3832364|P1|NOT COMPLETED|Overall Study||2
1566541|NCT01195415|3832364|P1|COMPLETED|Overall Study||23
1566542|NCT01195415|3832364|P1|STARTED|Overall Study||25
1566543|NCT01195363|3832373|P2|NOT COMPLETED|Overall Study||9
1566544|NCT01195363|3832374|P1|NOT COMPLETED|Overall Study||11
1566545|NCT01195363|3832373|P2|COMPLETED|Overall Study||4
1566546|NCT01195363|3832374|P1|COMPLETED|Overall Study||4
1566547|NCT01195363|3832373|P2|STARTED|Overall Study||13
1566548|NCT01195363|3832374|P1|STARTED|Overall Study||15
1566549|NCT01195272|3832380|P1|NOT COMPLETED|Overall Study||4
1566550|NCT01195272|3832380|P1|COMPLETED|Overall Study||17
1566551|NCT01195272|3832380|P1|STARTED|Overall Study||21
1566552|NCT01195116|3832399|P2|NOT COMPLETED|Overall Study||0
1566553|NCT01195116|3832400|P1|NOT COMPLETED|Overall Study||0
1566554|NCT01195116|3832399|P2|COMPLETED|Overall Study||20
1566555|NCT01195116|3832400|P1|COMPLETED|Overall Study||21
1566556|NCT01195116|3832399|P2|STARTED|Overall Study||20
1566557|NCT01195116|3832400|P1|STARTED|Overall Study||21
1566558|NCT01195103|3832409|P3|NOT COMPLETED|Overall Study||0
1566559|NCT01195103|3832410|P2|NOT COMPLETED|Overall Study||0
1566560|NCT01195103|3832411|P1|NOT COMPLETED|Overall Study||1
1566561|NCT01195103|3832409|P3|COMPLETED|Overall Study||5
1566562|NCT01195103|3832410|P2|COMPLETED|Overall Study||2
1566563|NCT01195103|3832411|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
1566564|NCT01195103|3832409|P3|STARTED|Overall Study||5
1566565|NCT01195103|3832410|P2|STARTED|Overall Study||2
1566566|NCT01195103|3832411|P1|STARTED|Overall Study||6
1566567|NCT01195090|3832421|P2|NOT COMPLETED|Overall Study||8
1566568|NCT01195090|3832422|P1|NOT COMPLETED|Overall Study||6
1566569|NCT01195090|3832421|P2|COMPLETED|Overall Study||52
1566570|NCT01195090|3832422|P1|COMPLETED|Overall Study||54
1566571|NCT01195090|3832421|P2|STARTED|Overall Study||60
1566572|NCT01195090|3832422|P1|STARTED|Overall Study||60
1566573|NCT01195025|3832480|P5|NOT COMPLETED|Third Intervention C||0
1566574|NCT01195025|3832481|P4|NOT COMPLETED|Third Intervention C||0
1566575|NCT01195025|3832482|P3|NOT COMPLETED|Third Intervention C||0
1566576|NCT01195025|3832483|P2|NOT COMPLETED|Third Intervention C||0
1566577|NCT01195025|3832484|P1|NOT COMPLETED|Third Intervention C||0
1566578|NCT01195025|3832480|P5|COMPLETED|Third Intervention C||1
1566579|NCT01195025|3832481|P4|COMPLETED|Third Intervention C||2
1566580|NCT01195025|3832482|P3|COMPLETED|Third Intervention C||2
1566581|NCT01195025|3832483|P2|COMPLETED|Third Intervention C||3
1566582|NCT01195025|3832484|P1|COMPLETED|Third Intervention C||2
1566583|NCT01195025|3832480|P5|STARTED|Third Intervention C||1
1566584|NCT01195025|3832481|P4|STARTED|Third Intervention C||2
1566585|NCT01195025|3832482|P3|STARTED|Third Intervention C||2
1566586|NCT01195025|3832483|P2|STARTED|Third Intervention C||3
1566587|NCT01195025|3832484|P1|STARTED|Third Intervention C||2
1566588|NCT01195025|3832480|P5|NOT COMPLETED|Second Intervention B||0
1566589|NCT01195025|3832481|P4|NOT COMPLETED|Second Intervention B||0
1566590|NCT01195025|3832482|P3|NOT COMPLETED|Second Intervention B||0
1566591|NCT01195025|3832483|P2|NOT COMPLETED|Second Intervention B||0
1566592|NCT01195025|3832484|P1|NOT COMPLETED|Second Intervention B||0
1566593|NCT01195025|3832480|P5|COMPLETED|Second Intervention B||1
1566594|NCT01195025|3832481|P4|COMPLETED|Second Intervention B||2
1566595|NCT01195025|3832482|P3|COMPLETED|Second Intervention B||2
1566596|NCT01195025|3832483|P2|COMPLETED|Second Intervention B||3
1566597|NCT01195025|3832484|P1|COMPLETED|Second Intervention B||2
1566598|NCT01195025|3832480|P5|STARTED|Second Intervention B||1
1566599|NCT01195025|3832481|P4|STARTED|Second Intervention B||2
1566600|NCT01195025|3832482|P3|STARTED|Second Intervention B||2
1566601|NCT01195025|3832483|P2|STARTED|Second Intervention B||3
1566602|NCT01195025|3832484|P1|STARTED|Second Intervention B||2
1566603|NCT01195025|3832480|P5|NOT COMPLETED|First Intervention A||0
1566604|NCT01195025|3832481|P4|NOT COMPLETED|First Intervention A||0
1566605|NCT01195025|3832482|P3|NOT COMPLETED|First Intervention A||0
1566606|NCT01195025|3832483|P2|NOT COMPLETED|First Intervention A||0
1566607|NCT01195025|3832484|P1|NOT COMPLETED|First Intervention A||0
1566608|NCT01195025|3832480|P5|COMPLETED|First Intervention A||1
1566609|NCT01195025|3832481|P4|COMPLETED|First Intervention A||2
1566610|NCT01195025|3832482|P3|COMPLETED|First Intervention A||2
1566611|NCT01195025|3832483|P2|COMPLETED|First Intervention A||3
1566612|NCT01195025|3832484|P1|COMPLETED|First Intervention A||2
1566613|NCT01195025|3832480|P5|STARTED|First Intervention A||1
1566614|NCT01195025|3832481|P4|STARTED|First Intervention A||2
1566615|NCT01195025|3832482|P3|STARTED|First Intervention A||2
1566616|NCT01195025|3832483|P2|STARTED|First Intervention A||3
1566617|NCT01195025|3832484|P1|STARTED|First Intervention A||2
1566618|NCT01194999|3832491|P1|NOT COMPLETED|Overall Study||17
1566619|NCT01194999|3832491|P1|COMPLETED|Overall Study||115
1566620|NCT01194999|3832491|P1|STARTED|Overall Study||132
1566621|NCT01194973|3832495|P1|NOT COMPLETED|26 Week Treatment Period||3
1566622|NCT01194973|3832495|P1|COMPLETED|26 Week Treatment Period||38
1566623|NCT01194973|3832495|P1|STARTED|26 Week Treatment Period||41
1566624|NCT01194973|3832495|P1|NOT COMPLETED|Screening Period||3
1566625|NCT01194973|3832495|P1|COMPLETED|Screening Period||41
1566626|NCT01194973|3832495|P1|STARTED|Screening Period||44
1566627|NCT01194908|3832510|P1|NOT COMPLETED|Overall Study||0
1566628|NCT01194908|3832510|P1|COMPLETED|Overall Study||5
1566629|NCT01194908|3832510|P1|STARTED|Overall Study||5
1566630|NCT01194869|3832515|P1|NOT COMPLETED|Overall Study||4
1566631|NCT01194869|3832515|P1|COMPLETED|Overall Study||21
1566632|NCT01194869|3832515|P1|STARTED|Overall Study||25
1566633|NCT01194856|3832523|P2|NOT COMPLETED|Overall Study||0
1566634|NCT01194856|3832524|P1|NOT COMPLETED|Overall Study||1
1566635|NCT01194856|3832523|P2|COMPLETED|Overall Study||0
1566636|NCT01194856|3832524|P1|COMPLETED|Overall Study||0
1566637|NCT01194856|3832523|P2|STARTED|Overall Study||0
1566638|NCT01194856|3832524|P1|STARTED|Overall Study||1
1566639|NCT01194830|3832546|P2|NOT COMPLETED|Overall Study||27
1566640|NCT01194830|3832547|P1|NOT COMPLETED|Overall Study||36
1566641|NCT01194830|3832546|P2|COMPLETED|Overall Study||83
1566642|NCT01194830|3832547|P1|COMPLETED|Overall Study||88
1566643|NCT01194830|3832546|P2|STARTED|Overall Study||110
1566644|NCT01194830|3832547|P1|STARTED|Overall Study||124
1566645|NCT01194674|3832569|P1|NOT COMPLETED|Overall Study||0
1566646|NCT01194674|3832569|P1|COMPLETED|Overall Study||2
1566647|NCT01194674|3832569|P1|STARTED|Overall Study||2
1566648|NCT01194570|3832583|P2|NOT COMPLETED|Overall Study||488
1566649|NCT01194570|3832584|P1|NOT COMPLETED|Overall Study||244
1566650|NCT01194570|3832583|P2|COMPLETED|Overall Study||0
1566651|NCT01194570|3832584|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
1566652|NCT01194570|3832583|P2|STARTED|Overall Study||488
1566653|NCT01194570|3832584|P1|STARTED|Overall Study||244
1566654|NCT01194531|3832604|P2|NOT COMPLETED|Overall Study||3
1566655|NCT01194531|3832605|P1|NOT COMPLETED|Overall Study||5
1566656|NCT01194531|3832604|P2|COMPLETED|Overall Study||27
1566657|NCT01194531|3832605|P1|COMPLETED|Overall Study||24
1566658|NCT01194531|3832604|P2|STARTED|Overall Study||30
1566659|NCT01194531|3832605|P1|STARTED|Overall Study||29
1566660|NCT01194479|3832613|P4|NOT COMPLETED|Overall Study||0
1566661|NCT01194479|3832614|P3|NOT COMPLETED|Overall Study||0
1566662|NCT01194479|3832615|P2|NOT COMPLETED|Overall Study||0
1566663|NCT01194479|3832616|P1|NOT COMPLETED|Overall Study||0
1566664|NCT01194479|3832613|P4|COMPLETED|Overall Study||5
1566665|NCT01194479|3832614|P3|COMPLETED|Overall Study||2
1566666|NCT01194479|3832615|P2|COMPLETED|Overall Study||4
1566667|NCT01194479|3832616|P1|COMPLETED|Overall Study||3
1566668|NCT01194479|3832613|P4|Cross-over at Second Visit|Overall Study||5
1566669|NCT01194479|3832614|P3|Cross-over at Second Visit|Overall Study||2
1566670|NCT01194479|3832615|P2|Cross-over at Second Visit|Overall Study||4
1566671|NCT01194479|3832616|P1|Cross-over at Second Visit|Overall Study||3
1566672|NCT01194479|3832613|P4|STARTED|Overall Study||5
1566673|NCT01194479|3832614|P3|STARTED|Overall Study||2
1566674|NCT01194479|3832615|P2|STARTED|Overall Study||4
1566675|NCT01194479|3832616|P1|STARTED|Overall Study||3
1566676|NCT01194453|3832640|P2|NOT COMPLETED|Overall Study||17
1566677|NCT01194453|3832641|P1|NOT COMPLETED|Overall Study||17
1566678|NCT01194453|3832640|P2|COMPLETED|Overall Study||127
1566679|NCT01194453|3832641|P1|COMPLETED|Overall Study||127
1566680|NCT01194453|3832640|P2|STARTED|Overall Study||144
1566681|NCT01194453|3832641|P1|STARTED|Overall Study||144
1566682|NCT01194440|3832649|P1|NOT COMPLETED|6-months (2nd Dose)||4
1566683|NCT01194440|3832649|P1|COMPLETED|6-months (2nd Dose)||48
1566684|NCT01194440|3832649|P1|STARTED|6-months (2nd Dose)||52
1566685|NCT01194440|3832649|P1|NOT COMPLETED|Baseline (First Dose)||7
1566686|NCT01194440|3832649|P1|COMPLETED|Baseline (First Dose)||52
1566687|NCT01194440|3832649|P1|STARTED|Baseline (First Dose)||59
1566688|NCT01194427|3832656|P1|NOT COMPLETED|Overall Study||0
1566689|NCT01194427|3832656|P1|COMPLETED|Overall Study||2
1566690|NCT01194427|3832656|P1|STARTED|Overall Study||2
1566691|NCT01194414|3832662|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
1566692|NCT01194414|3832663|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
1566693|NCT01194414|3832664|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
1566694|NCT01194414|3832665|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
1566695|NCT01194414|3832662|P4|COMPLETED|72 Weeks Open Label Extension||160
1566696|NCT01194414|3832663|P3|COMPLETED|72 Weeks Open Label Extension||40
1566697|NCT01194414|3832664|P2|COMPLETED|72 Weeks Open Label Extension||311
1566698|NCT01194414|3832665|P1|COMPLETED|72 Weeks Open Label Extension||445
1566699|NCT01194414|3832662|P4|STARTED|72 Weeks Open Label Extension||186
1566700|NCT01194414|3832663|P3|STARTED|72 Weeks Open Label Extension||48
1566701|NCT01194414|3832664|P2|STARTED|72 Weeks Open Label Extension||377
1566702|NCT01194414|3832665|P1|STARTED|72 Weeks Open Label Extension||524
1566703|NCT01194414|3832662|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
1566704|NCT01194414|3832663|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
1566705|NCT01194414|3832664|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
1566706|NCT01194414|3832665|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
1566707|NCT01194414|3832662|P4|COMPLETED|24 Weeks Double Blind Period||0
1566708|NCT01194414|3832663|P3|COMPLETED|24 Weeks Double Blind Period||0
1566709|NCT01194414|3832664|P2|COMPLETED|24 Weeks Double Blind Period||564
1566710|NCT01194414|3832665|P1|COMPLETED|24 Weeks Double Blind Period||572
1566711|NCT01194414|3832662|P4|Per Protocol Population|24 Weeks Double Blind Period||0
1566712|NCT01194414|3832663|P3|Per Protocol Population|24 Weeks Double Blind Period||0
1566713|NCT01194414|3832664|P2|Per Protocol Population|24 Weeks Double Blind Period||537
1566714|NCT01194414|3832665|P1|Per Protocol Population|24 Weeks Double Blind Period||558
1566715|NCT01194414|3832662|P4|STARTED|24 Weeks Double Blind Period||0
1566716|NCT01194414|3832663|P3|STARTED|24 Weeks Double Blind Period||0
1566717|NCT01194414|3832664|P2|STARTED|24 Weeks Double Blind Period||631
1566718|NCT01194414|3832665|P1|STARTED|24 Weeks Double Blind Period||631
1566719|NCT01194297|3832727|P2|NOT COMPLETED|Overall Study||0
1566720|NCT01194297|3832728|P1|NOT COMPLETED|Overall Study||0
1566721|NCT01194297|3832727|P2|COMPLETED|Overall Study||1
1566722|NCT01194297|3832728|P1|COMPLETED|Overall Study||2
1566723|NCT01194297|3832727|P2|STARTED|Overall Study||1
1566724|NCT01194297|3832728|P1|STARTED|Overall Study||2
1566725|NCT01194258|3832736|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
1566726|NCT01194258|3832737|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
1566727|NCT01194258|3832738|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
1566728|NCT01194258|3832739|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
1566729|NCT01194258|3832740|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
1566730|NCT01194258|3832736|P5|COMPLETED|Period 2 (12 Weeks)||30
1566731|NCT01194258|3832737|P4|COMPLETED|Period 2 (12 Weeks)||29
1566732|NCT01194258|3832738|P3|COMPLETED|Period 2 (12 Weeks)||29
1566733|NCT01194258|3832739|P2|COMPLETED|Period 2 (12 Weeks)||27
1566734|NCT01194258|3832740|P1|COMPLETED|Period 2 (12 Weeks)||0
1566735|NCT01194258|3832736|P5|STARTED|Period 2 (12 Weeks)||32
1566736|NCT01194258|3832737|P4|STARTED|Period 2 (12 Weeks)||29
1566737|NCT01194258|3832738|P3|STARTED|Period 2 (12 Weeks)||30
1566738|NCT01194258|3832739|P2|STARTED|Period 2 (12 Weeks)||29
1566739|NCT01194258|3832740|P1|STARTED|Period 2 (12 Weeks)||0
1566740|NCT01194258|3832736|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
1566741|NCT01194258|3832737|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
1566742|NCT01194258|3832738|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
1566743|NCT01194258|3832739|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
1566744|NCT01194258|3832740|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
1566745|NCT01194258|3832736|P5|COMPLETED|Period 1 (12 Weeks)||32
1566746|NCT01194258|3832737|P4|COMPLETED|Period 1 (12 Weeks)||29
1566747|NCT01194258|3832738|P3|COMPLETED|Period 1 (12 Weeks)||30
1566748|NCT01194258|3832739|P2|COMPLETED|Period 1 (12 Weeks)||29
1566749|NCT01194258|3832740|P1|COMPLETED|Period 1 (12 Weeks)||0
1566750|NCT01194258|3832736|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
1566751|NCT01194258|3832737|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
1566752|NCT01194258|3832738|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
1566753|NCT01194258|3832739|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
1566754|NCT01194258|3832740|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
1566755|NCT01194258|3832736|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
1566756|NCT01194258|3832737|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
1566757|NCT01194258|3832738|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
1566758|NCT01194258|3832739|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
1566759|NCT01194258|3832740|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
1566760|NCT01194258|3832736|P5|NOT COMPLETED|Titration Period||0
1566761|NCT01194258|3832737|P4|NOT COMPLETED|Titration Period||0
1566762|NCT01194258|3832738|P3|NOT COMPLETED|Titration Period||0
1566763|NCT01194258|3832739|P2|NOT COMPLETED|Titration Period||0
1566764|NCT01194258|3832740|P1|NOT COMPLETED|Titration Period||11
1566765|NCT01194258|3832736|P5|COMPLETED|Titration Period||0
1566766|NCT01194258|3832737|P4|COMPLETED|Titration Period||0
1566767|NCT01194258|3832738|P3|COMPLETED|Titration Period||0
1566768|NCT01194258|3832739|P2|COMPLETED|Titration Period||0
1566769|NCT01194258|3832740|P1|COMPLETED|Titration Period||121
1566770|NCT01194258|3832736|P5|STARTED|Titration Period||0
1566771|NCT01194258|3832737|P4|STARTED|Titration Period||0
1566772|NCT01194258|3832738|P3|STARTED|Titration Period||0
1566773|NCT01194258|3832739|P2|STARTED|Titration Period||0
1566774|NCT01194258|3832740|P1|STARTED|Titration Period||132
1566775|NCT01194245|3832764|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1566776|NCT01194245|3832765|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1566777|NCT01194245|3832766|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1566778|NCT01194245|3832767|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1566779|NCT01194245|3832768|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1566780|NCT01194245|3832764|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
1566781|NCT01194245|3832765|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
1566782|NCT01194245|3832766|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
1566783|NCT01194245|3832767|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
1566784|NCT01194245|3832768|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1566785|NCT01194245|3832764|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
1566786|NCT01194245|3832765|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
1566787|NCT01194245|3832766|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
1566788|NCT01194245|3832767|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
1566789|NCT01194245|3832768|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
1566790|NCT01194245|3832764|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
1566791|NCT01194245|3832765|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
1566792|NCT01194245|3832766|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
1566793|NCT01194245|3832767|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
1566794|NCT01194245|3832768|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
1566795|NCT01194245|3832764|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
1566796|NCT01194245|3832765|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
1566797|NCT01194245|3832766|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
1566798|NCT01194245|3832767|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
1566799|NCT01194245|3832768|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
1566800|NCT01194245|3832764|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
1566801|NCT01194245|3832765|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
1566802|NCT01194245|3832766|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
1566803|NCT01194245|3832767|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
1566804|NCT01194245|3832768|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
1566805|NCT01194245|3832764|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
1566806|NCT01194245|3832765|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
1566807|NCT01194245|3832766|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
1566808|NCT01194245|3832767|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
1566809|NCT01194245|3832768|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
1566810|NCT01194245|3832764|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1566811|NCT01194245|3832765|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1566812|NCT01194245|3832766|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1566813|NCT01194245|3832767|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1566814|NCT01194245|3832768|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
1566815|NCT01194245|3832764|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
1566816|NCT01194245|3832765|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
1566817|NCT01194245|3832766|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
1566818|NCT01194245|3832767|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
1566819|NCT01194245|3832768|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
1566820|NCT01194245|3832764|P5|STARTED|Titration Period (4 to 6 Weeks)||0
1566821|NCT01194245|3832765|P4|STARTED|Titration Period (4 to 6 Weeks)||0
1566822|NCT01194245|3832766|P3|STARTED|Titration Period (4 to 6 Weeks)||0
1566823|NCT01194245|3832767|P2|STARTED|Titration Period (4 to 6 Weeks)||0
1566824|NCT01194245|3832768|P1|STARTED|Titration Period (4 to 6 Weeks)||135
1566825|NCT01194219|3832789|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
1566826|NCT01194219|3832790|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
1566827|NCT01194219|3832791|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566828|NCT01194219|3832792|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566829|NCT01194219|3832793|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566830|NCT01194219|3832794|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566831|NCT01194219|3832795|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566832|NCT01194219|3832796|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566833|NCT01194219|3832797|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566834|NCT01194219|3832798|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566835|NCT01194219|3832789|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
1566836|NCT01194219|3832790|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
1566837|NCT01194219|3832791|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566838|NCT01194219|3832792|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566839|NCT01194219|3832793|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566840|NCT01194219|3832794|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566841|NCT01194219|3832795|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566842|NCT01194219|3832796|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566843|NCT01194219|3832797|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566844|NCT01194219|3832798|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
1566845|NCT01194219|3832789|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
1566846|NCT01194219|3832790|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
1566847|NCT01194219|3832791|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1566848|NCT01194219|3832792|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1566849|NCT01194219|3832793|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1566850|NCT01194219|3832794|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1566851|NCT01194219|3832795|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1566852|NCT01194219|3832796|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1566853|NCT01194219|3832797|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1566854|NCT01194219|3832798|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
1566855|NCT01194219|3832789|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
1566856|NCT01194219|3832790|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
1566857|NCT01194219|3832791|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
1566858|NCT01194219|3832792|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
1566859|NCT01194219|3832793|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
1566860|NCT01194219|3832794|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
1566861|NCT01194219|3832795|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
1566862|NCT01194219|3832796|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
1566863|NCT01194219|3832797|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
1566864|NCT01194219|3832798|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
1566865|NCT01194219|3832789|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566866|NCT01194219|3832790|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566867|NCT01194219|3832791|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
1566868|NCT01194219|3832792|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
1566869|NCT01194219|3832793|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
1566870|NCT01194219|3832794|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
1566871|NCT01194219|3832795|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566872|NCT01194219|3832796|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566873|NCT01194219|3832797|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566874|NCT01194219|3832798|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566875|NCT01194219|3832789|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566876|NCT01194219|3832790|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566877|NCT01194219|3832791|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
1566878|NCT01194219|3832792|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
1566879|NCT01194219|3832793|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
1566880|NCT01194219|3832794|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
1566881|NCT01194219|3832795|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566882|NCT01194219|3832796|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566883|NCT01194219|3832797|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566884|NCT01194219|3832798|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
1566885|NCT01194219|3832789|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1566886|NCT01194219|3832790|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1566887|NCT01194219|3832791|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
1566888|NCT01194219|3832792|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
1566889|NCT01194219|3832793|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1566890|NCT01194219|3832794|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1566891|NCT01194219|3832795|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1566892|NCT01194219|3832796|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1566893|NCT01194219|3832797|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1566894|NCT01194219|3832798|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
1566895|NCT01194219|3832789|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1566896|NCT01194219|3832790|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1566897|NCT01194219|3832791|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
1566898|NCT01194219|3832792|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
1566899|NCT01194219|3832793|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
1566900|NCT01194219|3832794|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
1566901|NCT01194219|3832795|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1566902|NCT01194219|3832796|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1566903|NCT01194219|3832797|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1566904|NCT01194219|3832798|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
1566905|NCT01194219|3832789|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1566906|NCT01194219|3832790|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1566907|NCT01194219|3832791|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1566908|NCT01194219|3832792|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1566909|NCT01194219|3832793|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1566910|NCT01194219|3832794|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1566911|NCT01194219|3832795|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
1566912|NCT01194219|3832796|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
1566913|NCT01194219|3832797|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1566914|NCT01194219|3832798|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
1566915|NCT01194219|3832789|P10|COMPLETED|Maintenance Phase Weeks16-32||0
1566916|NCT01194219|3832790|P9|COMPLETED|Maintenance Phase Weeks16-32||0
1566917|NCT01194219|3832791|P8|COMPLETED|Maintenance Phase Weeks16-32||0
1566918|NCT01194219|3832792|P7|COMPLETED|Maintenance Phase Weeks16-32||0
1566919|NCT01194219|3832793|P6|COMPLETED|Maintenance Phase Weeks16-32||0
1566920|NCT01194219|3832794|P5|COMPLETED|Maintenance Phase Weeks16-32||0
1566921|NCT01194219|3832795|P4|COMPLETED|Maintenance Phase Weeks16-32||215
1566922|NCT01194219|3832796|P3|COMPLETED|Maintenance Phase Weeks16-32||424
1566923|NCT01194219|3832797|P2|COMPLETED|Maintenance Phase Weeks16-32||0
1566924|NCT01194219|3832798|P1|COMPLETED|Maintenance Phase Weeks16-32||0
1566925|NCT01194219|3832789|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
1566926|NCT01194219|3832790|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
1566927|NCT01194219|3832791|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
1566928|NCT01194219|3832792|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
1566929|NCT01194219|3832793|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
1566930|NCT01194219|3832794|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
1566931|NCT01194219|3832795|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
1566932|NCT01194219|3832796|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
1566933|NCT01194219|3832797|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
1566934|NCT01194219|3832798|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
1566935|NCT01194219|3832789|P10|STARTED|Maintenance Phase Weeks16-32||0
1566936|NCT01194219|3832790|P9|STARTED|Maintenance Phase Weeks16-32||0
1566937|NCT01194219|3832791|P8|STARTED|Maintenance Phase Weeks16-32||0
1566938|NCT01194219|3832792|P7|STARTED|Maintenance Phase Weeks16-32||0
1566939|NCT01194219|3832793|P6|STARTED|Maintenance Phase Weeks16-32||0
1566940|NCT01194219|3832794|P5|STARTED|Maintenance Phase Weeks16-32||0
1566941|NCT01194219|3832795|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
1566942|NCT01194219|3832796|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
1566943|NCT01194219|3832797|P2|STARTED|Maintenance Phase Weeks16-32||0
1566944|NCT01194219|3832798|P1|STARTED|Maintenance Phase Weeks16-32||0
1566945|NCT01194219|3832789|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566946|NCT01194219|3832790|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566947|NCT01194219|3832791|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566948|NCT01194219|3832792|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566949|NCT01194219|3832793|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566950|NCT01194219|3832794|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566951|NCT01194219|3832795|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566952|NCT01194219|3832796|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566953|NCT01194219|3832797|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
1566954|NCT01194219|3832798|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
1566955|NCT01194219|3832789|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566956|NCT01194219|3832790|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566957|NCT01194219|3832791|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566958|NCT01194219|3832792|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566959|NCT01194219|3832793|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566960|NCT01194219|3832794|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566961|NCT01194219|3832795|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566962|NCT01194219|3832796|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
1566963|NCT01194219|3832797|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
1566964|NCT01194219|3832798|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
1566965|NCT01194219|3832789|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1566966|NCT01194219|3832790|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1567054|NCT01193842|3832982|P2|COMPLETED|Phase II: Randomized Groups||0
1566967|NCT01194219|3832791|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1566968|NCT01194219|3832792|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1566969|NCT01194219|3832793|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1566970|NCT01194219|3832794|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1566971|NCT01194219|3832795|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1566972|NCT01194219|3832796|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
1566973|NCT01194219|3832797|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
1566974|NCT01194219|3832798|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
1566975|NCT01194219|3832789|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1566976|NCT01194219|3832790|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1566977|NCT01194219|3832791|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1566978|NCT01194219|3832792|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1566979|NCT01194219|3832793|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1566980|NCT01194219|3832794|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1566981|NCT01194219|3832795|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1566982|NCT01194219|3832796|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
1566983|NCT01194219|3832797|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
1566984|NCT01194219|3832798|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
1566985|NCT01194154|3832832|P2|NOT COMPLETED|Overall Study||33
1566986|NCT01194154|3832833|P1|NOT COMPLETED|Overall Study||49
1566987|NCT01194154|3832832|P2|COMPLETED|Overall Study||91
1566988|NCT01194154|3832833|P1|COMPLETED|Overall Study||68
1566989|NCT01194154|3832832|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
1566990|NCT01194154|3832833|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
1566991|NCT01194154|3832832|P2|Full Analysis Set|Overall Study||120
1566992|NCT01194154|3832833|P1|Full Analysis Set|Overall Study||115
1566993|NCT01194154|3832832|P2|STARTED|Overall Study||124
1566994|NCT01194154|3832833|P1|STARTED|Overall Study||117
1566995|NCT01194089|3832853|P2|NOT COMPLETED|Overall Study||0
1566996|NCT01194089|3832854|P1|NOT COMPLETED|Overall Study||0
1566997|NCT01194089|3832853|P2|COMPLETED|Overall Study||47
1566998|NCT01194089|3832854|P1|COMPLETED|Overall Study||42
1566999|NCT01194089|3832853|P2|STARTED|Overall Study||47
1567000|NCT01194089|3832854|P1|STARTED|Overall Study||42
1567001|NCT01193920|3832874|P10|NOT COMPLETED|Overall Study||7
1567002|NCT01193920|3832875|P9|NOT COMPLETED|Overall Study||5
1567003|NCT01193920|3832876|P8|NOT COMPLETED|Overall Study||4
1567004|NCT01193920|3832877|P7|NOT COMPLETED|Overall Study||6
1567005|NCT01193920|3832878|P6|NOT COMPLETED|Overall Study||4
1567006|NCT01193920|3832879|P5|NOT COMPLETED|Overall Study||6
1567007|NCT01193920|3832880|P4|NOT COMPLETED|Overall Study||4
1567008|NCT01193920|3832881|P3|NOT COMPLETED|Overall Study||6
1567009|NCT01193920|3832882|P2|NOT COMPLETED|Overall Study||0
1567010|NCT01193920|3832883|P1|NOT COMPLETED|Overall Study||3
1567011|NCT01193920|3832874|P10|COMPLETED|Overall Study||74
1567012|NCT01193920|3832875|P9|COMPLETED|Overall Study||71
1567013|NCT01193920|3832876|P8|COMPLETED|Overall Study||76
1567014|NCT01193920|3832877|P7|COMPLETED|Overall Study||74
1567015|NCT01193920|3832878|P6|COMPLETED|Overall Study||76
1567016|NCT01193920|3832879|P5|COMPLETED|Overall Study||74
1567017|NCT01193920|3832880|P4|COMPLETED|Overall Study||76
1567018|NCT01193920|3832881|P3|COMPLETED|Overall Study||74
1567019|NCT01193920|3832882|P2|COMPLETED|Overall Study||20
1567020|NCT01193920|3832883|P1|COMPLETED|Overall Study||37
1567021|NCT01193920|3832874|P10|STARTED|Overall Study||81
1567022|NCT01193920|3832875|P9|STARTED|Overall Study||76
1567023|NCT01193920|3832876|P8|STARTED|Overall Study||80
1567024|NCT01193920|3832877|P7|STARTED|Overall Study||80
1567025|NCT01193920|3832878|P6|STARTED|Overall Study||80
1567026|NCT01193920|3832879|P5|STARTED|Overall Study||80
1567027|NCT01193920|3832880|P4|STARTED|Overall Study||80
1567028|NCT01193920|3832881|P3|STARTED|Overall Study||80
1567029|NCT01193920|3832882|P2|STARTED|Overall Study||20
1567030|NCT01193920|3832883|P1|STARTED|Overall Study||40
1567031|NCT01193907|3832937|P4|NOT COMPLETED|Overall Study||1
1567032|NCT01193907|3832938|P3|NOT COMPLETED|Overall Study||0
1567033|NCT01193907|3832939|P2|NOT COMPLETED|Overall Study||0
1567034|NCT01193907|3832940|P1|NOT COMPLETED|Overall Study||1
1567035|NCT01193907|3832937|P4|COMPLETED|Overall Study||21
1567036|NCT01193907|3832938|P3|COMPLETED|Overall Study||22
1567037|NCT01193907|3832939|P2|COMPLETED|Overall Study||22
1567038|NCT01193907|3832940|P1|COMPLETED|Overall Study||21
1567039|NCT01193907|3832937|P4|STARTED|Overall Study||22
1567040|NCT01193907|3832938|P3|STARTED|Overall Study||22
1567041|NCT01193907|3832939|P2|STARTED|Overall Study||22
1567042|NCT01193907|3832940|P1|STARTED|Overall Study||22
1567043|NCT01193868|3832962|P1|NOT COMPLETED|Overall Study||0
1567044|NCT01193868|3832962|P1|COMPLETED|Overall Study||6
1567045|NCT01193868|3832962|P1|STARTED|Overall Study||6
1567046|NCT01193842|3832979|P5|NOT COMPLETED|Phase II: Randomized Groups||10
1567047|NCT01193842|3832980|P4|NOT COMPLETED|Phase II: Randomized Groups||12
1567048|NCT01193842|3832981|P3|NOT COMPLETED|Phase II: Randomized Groups||0
1567049|NCT01193842|3832982|P2|NOT COMPLETED|Phase II: Randomized Groups||0
1567050|NCT01193842|3832983|P1|NOT COMPLETED|Phase II: Randomized Groups||0
1567051|NCT01193842|3832979|P5|COMPLETED|Phase II: Randomized Groups||36
1567052|NCT01193842|3832980|P4|COMPLETED|Phase II: Randomized Groups||33
1567053|NCT01193842|3832981|P3|COMPLETED|Phase II: Randomized Groups||0
1567055|NCT01193842|3832983|P1|COMPLETED|Phase II: Randomized Groups||0
1567056|NCT01193842|3832979|P5|STARTED|Phase II: Randomized Groups||46
1567057|NCT01193842|3832980|P4|STARTED|Phase II: Randomized Groups||45
1567058|NCT01193842|3832981|P3|STARTED|Phase II: Randomized Groups||0
1567059|NCT01193842|3832982|P2|STARTED|Phase II: Randomized Groups||0
1567060|NCT01193842|3832983|P1|STARTED|Phase II: Randomized Groups||0
1567061|NCT01193842|3832979|P5|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
1567062|NCT01193842|3832980|P4|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
1567063|NCT01193842|3832981|P3|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
1567064|NCT01193842|3832982|P2|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
1567065|NCT01193842|3832983|P1|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
1567066|NCT01193842|3832979|P5|COMPLETED|Phase I: VR-CHOP, DL 1||0
1567067|NCT01193842|3832980|P4|COMPLETED|Phase I: VR-CHOP, DL 1||0
1567068|NCT01193842|3832981|P3|COMPLETED|Phase I: VR-CHOP, DL 1||1
1567069|NCT01193842|3832982|P2|COMPLETED|Phase I: VR-CHOP, DL 1||0
1567070|NCT01193842|3832983|P1|COMPLETED|Phase I: VR-CHOP, DL 1||0
1567071|NCT01193842|3832979|P5|STARTED|Phase I: VR-CHOP, DL 1||0
1567072|NCT01193842|3832980|P4|STARTED|Phase I: VR-CHOP, DL 1||0
1567073|NCT01193842|3832981|P3|STARTED|Phase I: VR-CHOP, DL 1||2
1567074|NCT01193842|3832982|P2|STARTED|Phase I: VR-CHOP, DL 1||0
1567075|NCT01193842|3832983|P1|STARTED|Phase I: VR-CHOP, DL 1||0
1567076|NCT01193842|3832979|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567077|NCT01193842|3832980|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567078|NCT01193842|3832981|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567079|NCT01193842|3832982|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567080|NCT01193842|3832983|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
1567081|NCT01193842|3832979|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567082|NCT01193842|3832980|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567083|NCT01193842|3832981|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567084|NCT01193842|3832982|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567085|NCT01193842|3832983|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
1567086|NCT01193842|3832979|P5|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567087|NCT01193842|3832980|P4|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567088|NCT01193842|3832981|P3|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567089|NCT01193842|3832982|P2|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
1567090|NCT01193842|3832983|P1|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
1567091|NCT01193842|3832979|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1567092|NCT01193842|3832980|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1567093|NCT01193842|3832981|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1567094|NCT01193842|3832982|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
1567095|NCT01193842|3832983|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1567096|NCT01193842|3832979|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1567097|NCT01193842|3832980|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1567098|NCT01193842|3832981|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1567099|NCT01193842|3832982|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
1567100|NCT01193842|3832983|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
1567101|NCT01193842|3832979|P5|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
1567102|NCT01193842|3832980|P4|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
1567103|NCT01193842|3832981|P3|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
1567104|NCT01193842|3832982|P2|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
1567105|NCT01193842|3832983|P1|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
1567106|NCT01193842|3832979|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567107|NCT01193842|3832980|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567108|NCT01193842|3832981|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567109|NCT01193842|3832982|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567110|NCT01193842|3832983|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567111|NCT01193842|3832979|P5|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567112|NCT01193842|3832980|P4|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567113|NCT01193842|3832981|P3|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567114|NCT01193842|3832982|P2|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567115|NCT01193842|3832983|P1|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
1567116|NCT01193842|3832979|P5|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567117|NCT01193842|3832980|P4|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567118|NCT01193842|3832981|P3|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567119|NCT01193842|3832982|P2|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
1567120|NCT01193842|3832983|P1|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
1567121|NCT01193686|3833018|P2|NOT COMPLETED|Overall Study||1
1567122|NCT01193686|3833019|P1|NOT COMPLETED|Overall Study||7
1567123|NCT01193686|3833018|P2|COMPLETED|Overall Study||8
1567124|NCT01193686|3833019|P1|COMPLETED|Overall Study||8
1567125|NCT01193686|3833018|P2|Completed Visits and Final Assessment|Overall Study||8
1567126|NCT01193686|3833019|P1|Completed Visits and Final Assessment|Overall Study||8
1567127|NCT01193686|3833018|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
1567128|NCT01193686|3833019|P1|Completed Mentor Training|Overall Study||9
1567129|NCT01193686|3833018|P2|Completed Baseline Assessment|Overall Study||9
1567130|NCT01193686|3833019|P1|Completed Baseline Assessment|Overall Study||15
1567131|NCT01193686|3833018|P2|STARTED|Overall Study||9
1567132|NCT01193686|3833019|P1|STARTED|Overall Study||15
1567133|NCT01193660|3833036|P3|NOT COMPLETED|Overall Study||2
1567134|NCT01193660|3833037|P2|NOT COMPLETED|Overall Study||3
1567135|NCT01193660|3833038|P1|NOT COMPLETED|Overall Study||4
1567136|NCT01193660|3833036|P3|COMPLETED|Overall Study||32
1567137|NCT01193660|3833037|P2|COMPLETED|Overall Study||33
1567138|NCT01193660|3833038|P1|COMPLETED|Overall Study||31
1567139|NCT01193660|3833036|P3|STARTED|Overall Study||34
1567140|NCT01193660|3833037|P2|STARTED|Overall Study||36
1567141|NCT01193660|3833038|P1|STARTED|Overall Study||35
1567142|NCT01193608|3833082|P6|NOT COMPLETED|Overall Study||2
1567143|NCT01193608|3833083|P5|NOT COMPLETED|Overall Study||5
1567144|NCT01193608|3833084|P4|NOT COMPLETED|Overall Study||3
1567145|NCT01193608|3833085|P3|NOT COMPLETED|Overall Study||2
1567146|NCT01193608|3833086|P2|NOT COMPLETED|Overall Study||2
1567147|NCT01193608|3833087|P1|NOT COMPLETED|Overall Study||0
1567148|NCT01193608|3833082|P6|COMPLETED|Overall Study||17
1567149|NCT01193608|3833083|P5|COMPLETED|Overall Study||19
1567150|NCT01193608|3833084|P4|COMPLETED|Overall Study||14
1567151|NCT01193608|3833085|P3|COMPLETED|Overall Study||14
1567152|NCT01193608|3833086|P2|COMPLETED|Overall Study||4
1567153|NCT01193608|3833087|P1|COMPLETED|Overall Study||6
1567154|NCT01193608|3833082|P6|STARTED|Overall Study||19
1567155|NCT01193608|3833083|P5|STARTED|Overall Study||24
1567156|NCT01193608|3833084|P4|STARTED|Overall Study||17
1567157|NCT01193608|3833085|P3|STARTED|Overall Study||16
1567158|NCT01193608|3833086|P2|STARTED|Overall Study||6
1567159|NCT01193608|3833087|P1|STARTED|Overall Study||6
1567160|NCT01193582|3833324|P4|NOT COMPLETED|12 Month Follow-up||11
1567161|NCT01193582|3833325|P3|NOT COMPLETED|12 Month Follow-up||4
1567162|NCT01193582|3833326|P2|NOT COMPLETED|12 Month Follow-up||0
1567163|NCT01193582|3833327|P1|NOT COMPLETED|12 Month Follow-up||6
1567164|NCT01193582|3833324|P4|COMPLETED|12 Month Follow-up||166
1567165|NCT01193582|3833325|P3|COMPLETED|12 Month Follow-up||113
1567166|NCT01193582|3833326|P2|COMPLETED|12 Month Follow-up||88
1567167|NCT01193582|3833327|P1|COMPLETED|12 Month Follow-up||83
1567168|NCT01193582|3833324|P4|STARTED|12 Month Follow-up||177
1567169|NCT01193582|3833325|P3|STARTED|12 Month Follow-up||117
1567170|NCT01193582|3833326|P2|STARTED|12 Month Follow-up||88
1567171|NCT01193582|3833327|P1|STARTED|12 Month Follow-up||89
1567172|NCT01193582|3833324|P4|NOT COMPLETED|Vaccination Series||3
1567173|NCT01193582|3833325|P3|NOT COMPLETED|Vaccination Series||8
1567174|NCT01193582|3833326|P2|NOT COMPLETED|Vaccination Series||13
1567175|NCT01193582|3833327|P1|NOT COMPLETED|Vaccination Series||11
1567176|NCT01193582|3833324|P4|COMPLETED|Vaccination Series||177
1567177|NCT01193582|3833325|P3|COMPLETED|Vaccination Series||117
1567178|NCT01193582|3833326|P2|COMPLETED|Vaccination Series||88
1567179|NCT01193582|3833327|P1|COMPLETED|Vaccination Series||89
1567180|NCT01193582|3833324|P4|Vaccinated Dose 4|Vaccination Series||0
1567181|NCT01193582|3833325|P3|Vaccinated Dose 4|Vaccination Series||0
1567182|NCT01193582|3833326|P2|Vaccinated Dose 4|Vaccination Series||0
1567183|NCT01193582|3833327|P1|Vaccinated Dose 4|Vaccination Series||90
1567184|NCT01193582|3833324|P4|Vaccinated Dose 3|Vaccination Series||0
1567185|NCT01193582|3833325|P3|Vaccinated Dose 3|Vaccination Series||0
1567186|NCT01193582|3833326|P2|Vaccinated Dose 3|Vaccination Series||89
1567187|NCT01193582|3833327|P1|Vaccinated Dose 3|Vaccination Series||90
1567188|NCT01193582|3833324|P4|Vaccinated Dose 2|Vaccination Series||0
1567189|NCT01193582|3833325|P3|Vaccinated Dose 2|Vaccination Series||118
1567190|NCT01193582|3833326|P2|Vaccinated Dose 2|Vaccination Series||91
1567191|NCT01193582|3833327|P1|Vaccinated Dose 2|Vaccination Series||92
1567192|NCT01193582|3833324|P4|Vaccinated Dose 1|Vaccination Series||180
1567193|NCT01193582|3833325|P3|Vaccinated Dose 1|Vaccination Series||125
1567194|NCT01193582|3833326|P2|Vaccinated Dose 1|Vaccination Series||100
1567195|NCT01193582|3833327|P1|Vaccinated Dose 1|Vaccination Series||100
1567196|NCT01193582|3833324|P4|STARTED|Vaccination Series||180
1567197|NCT01193582|3833325|P3|STARTED|Vaccination Series||125
1567198|NCT01193582|3833326|P2|STARTED|Vaccination Series||101
1567199|NCT01193582|3833327|P1|STARTED|Vaccination Series||100
1567200|NCT01193556|3833357|P2|NOT COMPLETED|Overall Study||25
1567201|NCT01193556|3833358|P1|NOT COMPLETED|Overall Study||26
1567202|NCT01193556|3833357|P2|COMPLETED|Overall Study||0
1567203|NCT01193556|3833358|P1|COMPLETED|Overall Study||0
1567204|NCT01193556|3833357|P2|STARTED|Overall Study||25
1567205|NCT01193556|3833358|P1|STARTED|Overall Study||26
1567206|NCT01193348|3833366|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
1567207|NCT01193348|3833366|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
1567208|NCT01193348|3833366|P1|STARTED|Post Treatment Period (Patients Who Disc||10
1567209|NCT01193348|3833366|P1|NOT COMPLETED|Extension Treatment Period||1
1567210|NCT01193348|3833366|P1|COMPLETED|Extension Treatment Period||16
1567211|NCT01193348|3833366|P1|STARTED|Extension Treatment Period||17
1567212|NCT01193348|3833366|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
1567213|NCT01193348|3833366|P1|COMPLETED|Treatment Period (26 Weeks)||19
1567214|NCT01193348|3833366|P1|STARTED|Treatment Period (26 Weeks)||22
1567215|NCT01193348|3833366|P1|NOT COMPLETED|Screening Period||5
1567216|NCT01193348|3833366|P1|COMPLETED|Screening Period||22
1567217|NCT01193348|3833366|P1|STARTED|Screening Period||27
1567218|NCT01193335|3833386|P2|NOT COMPLETED|2-Year Follow-up||8
1567219|NCT01193335|3833387|P1|NOT COMPLETED|2-Year Follow-up||7
1567220|NCT01193335|3833386|P2|COMPLETED|2-Year Follow-up||80
1567221|NCT01193335|3833387|P1|COMPLETED|2-Year Follow-up||81
1567222|NCT01193335|3833386|P2|STARTED|2-Year Follow-up||88
1567223|NCT01193335|3833387|P1|STARTED|2-Year Follow-up||88
1567224|NCT01193335|3833386|P2|NOT COMPLETED|1-Year Follow-up||9
1567225|NCT01193335|3833387|P1|NOT COMPLETED|1-Year Follow-up||11
1567226|NCT01193335|3833386|P2|COMPLETED|1-Year Follow-up||88
1567227|NCT01193335|3833387|P1|COMPLETED|1-Year Follow-up||88
1567228|NCT01193335|3833386|P2|STARTED|1-Year Follow-up||97
1567229|NCT01193335|3833387|P1|STARTED|1-Year Follow-up||99
1567230|NCT01193335|3833386|P2|NOT COMPLETED|Toddler Dose||0
1567231|NCT01193335|3833387|P1|NOT COMPLETED|Toddler Dose||0
1567232|NCT01193335|3833386|P2|COMPLETED|Toddler Dose||97
1567233|NCT01193335|3833387|P1|COMPLETED|Toddler Dose||99
1567234|NCT01193335|3833386|P2|STARTED|Toddler Dose||97
1567235|NCT01193335|3833387|P1|STARTED|Toddler Dose||99
1567236|NCT01193335|3833386|P2|NOT COMPLETED|After Infant Series||3
1567237|NCT01193335|3833387|P1|NOT COMPLETED|After Infant Series||1
1567238|NCT01193335|3833386|P2|COMPLETED|After Infant Series||97
1567239|NCT01193335|3833387|P1|COMPLETED|After Infant Series||99
1567240|NCT01193335|3833386|P2|STARTED|After Infant Series||100
1567241|NCT01193335|3833387|P1|STARTED|After Infant Series||100
1567242|NCT01193335|3833386|P2|NOT COMPLETED|Infant Series||0
1567243|NCT01193335|3833387|P1|NOT COMPLETED|Infant Series||0
1567244|NCT01193335|3833386|P2|COMPLETED|Infant Series||100
1567245|NCT01193335|3833387|P1|COMPLETED|Infant Series||100
1567246|NCT01193335|3833386|P2|STARTED|Infant Series||100
1567247|NCT01193335|3833387|P1|STARTED|Infant Series||100
1567248|NCT01193283|3833482|P1|NOT COMPLETED|Overall Study||1
1567249|NCT01193283|3833482|P1|COMPLETED|Overall Study||21
1567250|NCT01193283|3833482|P1|STARTED|Overall Study||22
1567251|NCT01193257|3833488|P2|NOT COMPLETED|Overall Study||734
1567252|NCT01193257|3833489|P1|NOT COMPLETED|Overall Study||365
1567253|NCT01193257|3833488|P2|COMPLETED|Overall Study||0
1567254|NCT01193257|3833489|P1|COMPLETED|Overall Study||0
1567255|NCT01193257|3833488|P2|Treated|Overall Study||732
1567256|NCT01193257|3833489|P1|Treated|Overall Study||363
1567257|NCT01193257|3833488|P2|STARTED|Overall Study||734
1567258|NCT01193257|3833489|P1|STARTED|Overall Study||365
1567259|NCT01193244|3833539|P2|NOT COMPLETED|Overall Study||390
1567260|NCT01193244|3833540|P1|NOT COMPLETED|Overall Study||388
1567261|NCT01193244|3833539|P2|COMPLETED|Overall Study||391
1567262|NCT01193244|3833540|P1|COMPLETED|Overall Study||391
1567263|NCT01193244|3833539|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
1567264|NCT01193244|3833540|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
1567265|NCT01193244|3833539|P2|STARTED|Overall Study||781
1567266|NCT01193244|3833540|P1|STARTED|Overall Study||779
1567267|NCT01193218|3833595|P8|NOT COMPLETED|12-52 Weeks||4
1567268|NCT01193218|3833596|P7|NOT COMPLETED|12-52 Weeks||3
1567269|NCT01193218|3833597|P6|NOT COMPLETED|12-52 Weeks||5
1567270|NCT01193218|3833598|P5|NOT COMPLETED|12-52 Weeks||4
1567271|NCT01193218|3833599|P4|NOT COMPLETED|12-52 Weeks||3
1567272|NCT01193218|3833600|P3|NOT COMPLETED|12-52 Weeks||4
1567273|NCT01193218|3833601|P2|NOT COMPLETED|12-52 Weeks||0
1567274|NCT01193218|3833602|P1|NOT COMPLETED|12-52 Weeks||5
1567275|NCT01193218|3833595|P8|COMPLETED|12-52 Weeks||49
1567276|NCT01193218|3833596|P7|COMPLETED|12-52 Weeks||51
1567277|NCT01193218|3833597|P6|COMPLETED|12-52 Weeks||101
1567278|NCT01193218|3833598|P5|COMPLETED|12-52 Weeks||104
1567279|NCT01193218|3833599|P4|COMPLETED|12-52 Weeks||50
1567280|NCT01193218|3833600|P3|COMPLETED|12-52 Weeks||50
1567281|NCT01193218|3833601|P2|COMPLETED|12-52 Weeks||50
1567282|NCT01193218|3833602|P1|COMPLETED|12-52 Weeks||45
1567283|NCT01193218|3833595|P8|STARTED|12-52 Weeks||53
1567284|NCT01193218|3833596|P7|STARTED|12-52 Weeks||54
1567285|NCT01193218|3833597|P6|STARTED|12-52 Weeks||106
1567286|NCT01193218|3833598|P5|STARTED|12-52 Weeks||108
1567287|NCT01193218|3833599|P4|STARTED|12-52 Weeks||53
1567288|NCT01193218|3833600|P3|STARTED|12-52 Weeks||54
1567289|NCT01193218|3833601|P2|STARTED|12-52 Weeks||50
1567290|NCT01193218|3833602|P1|STARTED|12-52 Weeks||50
1567291|NCT01193218|3833595|P8|NOT COMPLETED|0-12 Weeks||0
1567292|NCT01193218|3833596|P7|NOT COMPLETED|0-12 Weeks||3
1567293|NCT01193218|3833597|P6|NOT COMPLETED|0-12 Weeks||3
1567294|NCT01193218|3833598|P5|NOT COMPLETED|0-12 Weeks||1
1567295|NCT01193218|3833599|P4|NOT COMPLETED|0-12 Weeks||0
1567296|NCT01193218|3833600|P3|NOT COMPLETED|0-12 Weeks||3
1567297|NCT01193218|3833601|P2|NOT COMPLETED|0-12 Weeks||0
1567298|NCT01193218|3833602|P1|NOT COMPLETED|0-12 Weeks||9
1567299|NCT01193218|3833595|P8|COMPLETED|0-12 Weeks||0
1567300|NCT01193218|3833596|P7|COMPLETED|0-12 Weeks||107
1567301|NCT01193218|3833597|P6|COMPLETED|0-12 Weeks||106
1567302|NCT01193218|3833598|P5|COMPLETED|0-12 Weeks||108
1567303|NCT01193218|3833599|P4|COMPLETED|0-12 Weeks||0
1567304|NCT01193218|3833600|P3|COMPLETED|0-12 Weeks||107
1567305|NCT01193218|3833601|P2|COMPLETED|0-12 Weeks||0
1567306|NCT01193218|3833602|P1|COMPLETED|0-12 Weeks||100
1567307|NCT01193218|3833595|P8|STARTED|0-12 Weeks|It is actually N/A|0
1567308|NCT01193218|3833596|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
1567309|NCT01193218|3833597|P6|STARTED|0-12 Weeks||109
1567310|NCT01193218|3833598|P5|STARTED|0-12 Weeks||109
1567311|NCT01193218|3833599|P4|STARTED|0-12 Weeks|It is actually N/A|0
1567312|NCT01193218|3833600|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
1567313|NCT01193218|3833601|P2|STARTED|0-12 Weeks|It is actually N/A|0
1567314|NCT01193218|3833602|P1|STARTED|0-12 Weeks|It is actually placebo group|109
1567315|NCT01193153|3833633|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
1567316|NCT01193153|3833634|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
1567317|NCT01193153|3833633|P2|COMPLETED|Double Blind Relapse Prevention Period||65
1567318|NCT01193153|3833634|P1|COMPLETED|Double Blind Relapse Prevention Period||100
1567319|NCT01193153|3833633|P2|STARTED|Double Blind Relapse Prevention Period||170
1567320|NCT01193153|3833634|P1|STARTED|Double Blind Relapse Prevention Period||164
1567321|NCT01193153|3833633|P2|NOT COMPLETED|Open-label Stabilization Period||0
1567322|NCT01193153|3833634|P1|NOT COMPLETED|Open-label Stabilization Period||98
1567323|NCT01193153|3833633|P2|COMPLETED|Open-label Stabilization Period||0
1567324|NCT01193153|3833634|P1|COMPLETED|Open-label Stabilization Period||334
1567325|NCT01193153|3833633|P2|STARTED|Open-label Stabilization Period||0
1567326|NCT01193153|3833634|P1|STARTED|Open-label Stabilization Period||432
1567327|NCT01193153|3833633|P2|NOT COMPLETED|Open-label Lead in Period||0
1567328|NCT01193153|3833634|P1|NOT COMPLETED|Open-label Lead in Period||235
1567329|NCT01193153|3833633|P2|COMPLETED|Open-label Lead in Period||0
1567330|NCT01193153|3833634|P1|COMPLETED|Open-label Lead in Period||432
1567331|NCT01193153|3833633|P2|STARTED|Open-label Lead in Period||0
1567332|NCT01193153|3833634|P1|STARTED|Open-label Lead in Period||667
1567333|NCT01193127|3833669|P4|NOT COMPLETED|Treated||1
1567334|NCT01193127|3833670|P3|NOT COMPLETED|Treated||0
1567335|NCT01193127|3833671|P2|NOT COMPLETED|Treated||0
1567336|NCT01193127|3833672|P1|NOT COMPLETED|Treated||0
1567337|NCT01193127|3833669|P4|COMPLETED|Treated||55
1567338|NCT01193127|3833670|P3|COMPLETED|Treated||55
1567339|NCT01193127|3833671|P2|COMPLETED|Treated||54
1567340|NCT01193127|3833672|P1|COMPLETED|Treated||57
1567341|NCT01193127|3833669|P4|STARTED|Treated||56
1567342|NCT01193127|3833670|P3|STARTED|Treated||55
1567343|NCT01193127|3833671|P2|STARTED|Treated||54
1567344|NCT01193127|3833672|P1|STARTED|Treated||57
1567345|NCT01193127|3833669|P4|NOT COMPLETED|Randomized||1
1567346|NCT01193127|3833670|P3|NOT COMPLETED|Randomized||0
1567347|NCT01193127|3833671|P2|NOT COMPLETED|Randomized||0
1567348|NCT01193127|3833672|P1|NOT COMPLETED|Randomized||0
1567349|NCT01193127|3833669|P4|COMPLETED|Randomized||56
1567350|NCT01193127|3833670|P3|COMPLETED|Randomized||55
1567351|NCT01193127|3833671|P2|COMPLETED|Randomized||54
1567352|NCT01193127|3833672|P1|COMPLETED|Randomized||57
1567353|NCT01193127|3833669|P4|STARTED|Randomized||57
1567354|NCT01193127|3833670|P3|STARTED|Randomized||55
1567355|NCT01193127|3833671|P2|STARTED|Randomized||54
1567356|NCT01193127|3833672|P1|STARTED|Randomized||57
1567357|NCT01193114|3833976|P2|NOT COMPLETED|Overall Study||0
1567358|NCT01193114|3833977|P1|NOT COMPLETED|Overall Study||0
1567359|NCT01193114|3833976|P2|COMPLETED|Overall Study||30
1567360|NCT01193114|3833977|P1|COMPLETED|Overall Study||30
1567361|NCT01193114|3833976|P2|STARTED|Overall Study||30
1567362|NCT01193114|3833977|P1|STARTED|Overall Study||30
1567363|NCT01193101|3833997|P4|NOT COMPLETED|Overall Study||12
1567364|NCT01193101|3833998|P3|NOT COMPLETED|Overall Study||3
1567365|NCT01193101|3833999|P2|NOT COMPLETED|Overall Study||7
1567366|NCT01193101|3834000|P1|NOT COMPLETED|Overall Study||5
1567367|NCT01193101|3833997|P4|COMPLETED|Overall Study||80
1567368|NCT01193101|3833998|P3|COMPLETED|Overall Study||93
1567369|NCT01193101|3833999|P2|COMPLETED|Overall Study||94
1567370|NCT01193101|3834000|P1|COMPLETED|Overall Study||95
1567371|NCT01193101|3833997|P4|Placebo Withdrawal Set|Overall Study||80
1567372|NCT01193101|3833998|P3|Placebo Withdrawal Set|Overall Study||93
1567373|NCT01193101|3833999|P2|Placebo Withdrawal Set|Overall Study||94
1567374|NCT01193101|3834000|P1|Placebo Withdrawal Set|Overall Study||95
1567375|NCT01193101|3833997|P4|Full Analysis Set|Overall Study||92
1567376|NCT01193101|3833998|P3|Full Analysis Set|Overall Study||96
1567377|NCT01193101|3833999|P2|Full Analysis Set|Overall Study||101
1567378|NCT01193101|3834000|P1|Full Analysis Set|Overall Study||100
1567379|NCT01193101|3833997|P4|STARTED|Overall Study||92
1567380|NCT01193101|3833998|P3|STARTED|Overall Study||96
1567381|NCT01193101|3833999|P2|STARTED|Overall Study||101
1567382|NCT01193101|3834000|P1|STARTED|Overall Study||100
1567383|NCT01193049|3834056|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
1567384|NCT01193049|3834057|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
1567385|NCT01193049|3834056|P2|COMPLETED|Period 3 : Double Blind Crossover||6
1567386|NCT01193049|3834057|P1|COMPLETED|Period 3 : Double Blind Crossover||5
1567387|NCT01193049|3834056|P2|STARTED|Period 3 : Double Blind Crossover||6
1567388|NCT01193049|3834057|P1|STARTED|Period 3 : Double Blind Crossover||5
1567389|NCT01193049|3834056|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
1567390|NCT01193049|3834057|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
1567391|NCT01193049|3834056|P2|COMPLETED|Washout 2 : 21 Day Washout||6
1567392|NCT01193049|3834057|P1|COMPLETED|Washout 2 : 21 Day Washout||5
1567393|NCT01193049|3834056|P2|STARTED|Washout 2 : 21 Day Washout||6
1567394|NCT01193049|3834057|P1|STARTED|Washout 2 : 21 Day Washout||5
1567395|NCT01193049|3834056|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
1567396|NCT01193049|3834057|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
1567397|NCT01193049|3834056|P2|COMPLETED|Period 2 : Double Blind Crossover||6
1567398|NCT01193049|3834057|P1|COMPLETED|Period 2 : Double Blind Crossover||5
1567399|NCT01193049|3834056|P2|STARTED|Period 2 : Double Blind Crossover||6
1567400|NCT01193049|3834057|P1|STARTED|Period 2 : Double Blind Crossover||5
1567401|NCT01193049|3834056|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
1567402|NCT01193049|3834057|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
1567403|NCT01193049|3834056|P2|COMPLETED|Washout 1 : 21 Day Washout||6
1567404|NCT01193049|3834057|P1|COMPLETED|Washout 1 : 21 Day Washout||5
1567405|NCT01193049|3834056|P2|STARTED|Washout 1 : 21 Day Washout||6
1567406|NCT01193049|3834057|P1|STARTED|Washout 1 : 21 Day Washout||5
1567407|NCT01193049|3834056|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
1567408|NCT01193049|3834057|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
1567409|NCT01193049|3834056|P2|COMPLETED|Period 1: Placebo Run-In||6
1567410|NCT01193049|3834057|P1|COMPLETED|Period 1: Placebo Run-In||5
1567411|NCT01193049|3834056|P2|STARTED|Period 1: Placebo Run-In||6
1567412|NCT01193049|3834057|P1|STARTED|Period 1: Placebo Run-In||5
1567413|NCT01192828|3834087|P1|NOT COMPLETED|Overall Study||0
1567414|NCT01192828|3834087|P1|COMPLETED|Overall Study||14
1567415|NCT01192828|3834087|P1|STARTED|Overall Study||14
1567416|NCT01192776|3834106|P4|NOT COMPLETED|Overall Study||20
1567417|NCT01192776|3834107|P3|NOT COMPLETED|Overall Study||21
1567418|NCT01192776|3834108|P2|NOT COMPLETED|Overall Study||21
1567419|NCT01192776|3834109|P1|NOT COMPLETED|Overall Study||11
1567420|NCT01192776|3834106|P4|COMPLETED|Overall Study||63
1567421|NCT01192776|3834107|P3|COMPLETED|Overall Study||75
1567422|NCT01192776|3834108|P2|COMPLETED|Overall Study||69
1567423|NCT01192776|3834109|P1|COMPLETED|Overall Study||84
1567424|NCT01192776|3834106|P4|Died After Discharge|Overall Study||1
1567425|NCT01192776|3834107|P3|Died After Discharge|Overall Study||3
1567426|NCT01192776|3834108|P2|Died After Discharge|Overall Study||2
1567427|NCT01192776|3834109|P1|Died After Discharge|Overall Study||1
1567428|NCT01192776|3834106|P4|Died Prior to Discharge|Overall Study||14
1567429|NCT01192776|3834107|P3|Died Prior to Discharge|Overall Study||15
1567430|NCT01192776|3834108|P2|Died Prior to Discharge|Overall Study||13
1567431|NCT01192776|3834109|P1|Died Prior to Discharge|Overall Study||7
1567432|NCT01192776|3834106|P4|STARTED|Overall Study||83
1567433|NCT01192776|3834107|P3|STARTED|Overall Study||96
1567434|NCT01192776|3834108|P2|STARTED|Overall Study||90
1567435|NCT01192776|3834109|P1|STARTED|Overall Study||95
1567436|NCT01192698|3834161|P2|NOT COMPLETED|Overall Study||0
1567437|NCT01192698|3834162|P1|NOT COMPLETED|Overall Study||0
1567438|NCT01192698|3834161|P2|COMPLETED|Overall Study||5
1567439|NCT01192698|3834162|P1|COMPLETED|Overall Study||10
1567440|NCT01192698|3834161|P2|STARTED|Overall Study||5
1567441|NCT01192698|3834162|P1|STARTED|Overall Study||10
1567442|NCT01192542|3834168|P2|NOT COMPLETED|Period 2||0
1567443|NCT01192542|3834169|P1|NOT COMPLETED|Period 2||0
1567444|NCT01192542|3834168|P2|COMPLETED|Period 2||20
1567445|NCT01192542|3834169|P1|COMPLETED|Period 2||18
1567446|NCT01192542|3834168|P2|STARTED|Period 2||20
1567447|NCT01192542|3834169|P1|STARTED|Period 2||18
1567448|NCT01192542|3834168|P2|NOT COMPLETED|Period 1||0
1567449|NCT01192542|3834169|P1|NOT COMPLETED|Period 1||0
1567450|NCT01192542|3834168|P2|COMPLETED|Period 1||20
1567451|NCT01192542|3834169|P1|COMPLETED|Period 1||18
1567452|NCT01192542|3834168|P2|STARTED|Period 1||20
1567453|NCT01192542|3834169|P1|STARTED|Period 1||18
1567454|NCT01192516|3834183|P3|NOT COMPLETED|Overall Study||8
1567455|NCT01192516|3834184|P2|NOT COMPLETED|Overall Study||17
1567456|NCT01192516|3834185|P1|NOT COMPLETED|Overall Study||20
1567457|NCT01192516|3834183|P3|COMPLETED|Overall Study||55
1567458|NCT01192516|3834184|P2|COMPLETED|Overall Study||49
1567459|NCT01192516|3834185|P1|COMPLETED|Overall Study||46
1567460|NCT01192516|3834183|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
1567461|NCT01192516|3834184|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
1567462|NCT01192516|3834185|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
1567463|NCT01192412|3834219|P2|NOT COMPLETED|Overall Study||2
1567464|NCT01192412|3834220|P1|NOT COMPLETED|Overall Study||4
1567465|NCT01192412|3834219|P2|COMPLETED|Overall Study||488
1567466|NCT01192412|3834220|P1|COMPLETED|Overall Study||493
1567467|NCT01192412|3834219|P2|STARTED|Overall Study||490
1567468|NCT01192412|3834220|P1|STARTED|Overall Study||497
1567469|NCT01192399|3834228|P1|NOT COMPLETED|Overall Study||2
1567470|NCT01192399|3834228|P1|COMPLETED|Overall Study||27
1567471|NCT01192399|3834228|P1|STARTED|Overall Study||29
1567472|NCT01192347|3834238|P1|NOT COMPLETED|Overall Study||12
1567473|NCT01192347|3834238|P1|COMPLETED|Overall Study||163
1567474|NCT01192347|3834238|P1|STARTED|Overall Study||175
1567475|NCT01192295|3834261|P2|NOT COMPLETED|Overall Study||23
1567476|NCT01192295|3834262|P1|NOT COMPLETED|Overall Study||10
1567477|NCT01192295|3834261|P2|COMPLETED|Overall Study||105
1567478|NCT01192295|3834262|P1|COMPLETED|Overall Study||17
1567479|NCT01192295|3834261|P2|STARTED|Overall Study||128
1567480|NCT01192295|3834262|P1|STARTED|Overall Study||27
1567481|NCT01192282|3834279|P1|NOT COMPLETED|Overall Study||0
1567482|NCT01192282|3834279|P1|COMPLETED|Overall Study||156
1567483|NCT01192282|3834279|P1|STARTED|Overall Study||156
1567484|NCT01192204|3834296|P2|NOT COMPLETED|Overall Study||0
1567485|NCT01192204|3834297|P1|NOT COMPLETED|Overall Study||1
1567486|NCT01192204|3834296|P2|COMPLETED|Overall Study||18
1567487|NCT01192204|3834297|P1|COMPLETED|Overall Study||22
1567488|NCT01192204|3834296|P2|STARTED|Overall Study||18
1567489|NCT01192204|3834297|P1|STARTED|Overall Study||23
1567490|NCT01192191|3834309|P2|NOT COMPLETED|Overall Study||21
1567491|NCT01192191|3834310|P1|NOT COMPLETED|Overall Study||11
1567492|NCT01192191|3834309|P2|COMPLETED|Overall Study||106
1567493|NCT01192191|3834310|P1|COMPLETED|Overall Study||49
1567494|NCT01192191|3834309|P2|STARTED|Overall Study||127
1567495|NCT01192191|3834310|P1|STARTED|Overall Study||60
1567496|NCT01192178|3834336|P2|NOT COMPLETED|Overall Study||23
1567497|NCT01192178|3834337|P1|NOT COMPLETED|Overall Study||24
1567498|NCT01192178|3834336|P2|COMPLETED|Overall Study||145
1567499|NCT01192178|3834337|P1|COMPLETED|Overall Study||147
1567500|NCT01192178|3834336|P2|STARTED|Overall Study||168
1567501|NCT01192178|3834337|P1|STARTED|Overall Study||171
1567502|NCT01192152|3834357|P2|NOT COMPLETED|Period 3||0
1567503|NCT01192152|3834358|P1|NOT COMPLETED|Period 3||1
1567504|NCT01192152|3834357|P2|COMPLETED|Period 3||0
1567505|NCT01192152|3834358|P1|COMPLETED|Period 3||14
1567506|NCT01192152|3834357|P2|STARTED|Period 3||0
1567507|NCT01192152|3834358|P1|STARTED|Period 3||15
1567508|NCT01192152|3834357|P2|NOT COMPLETED|Period 2||0
1567509|NCT01192152|3834358|P1|NOT COMPLETED|Period 2||0
1567510|NCT01192152|3834357|P2|COMPLETED|Period 2||14
1567511|NCT01192152|3834358|P1|COMPLETED|Period 2||15
1567512|NCT01192152|3834357|P2|STARTED|Period 2||14
1567513|NCT01192152|3834358|P1|STARTED|Period 2||15
1567514|NCT01192152|3834357|P2|NOT COMPLETED|Period 1||1
1567515|NCT01192152|3834358|P1|NOT COMPLETED|Period 1||0
1567516|NCT01192152|3834357|P2|COMPLETED|Period 1||14
1567517|NCT01192152|3834358|P1|COMPLETED|Period 1||15
1567518|NCT01192152|3834357|P2|STARTED|Period 1||15
1567519|NCT01192152|3834358|P1|STARTED|Period 1||15
1567520|NCT01192139|3834459|P6|NOT COMPLETED|Period 3||0
1567521|NCT01192139|3834460|P5|NOT COMPLETED|Period 3||0
1567522|NCT01192139|3834461|P4|NOT COMPLETED|Period 3||0
1567523|NCT01192139|3834462|P3|NOT COMPLETED|Period 3||0
1567524|NCT01192139|3834463|P2|NOT COMPLETED|Period 3||0
1567525|NCT01192139|3834464|P1|NOT COMPLETED|Period 3||0
1567526|NCT01192139|3834459|P6|COMPLETED|Period 3||5
1567527|NCT01192139|3834460|P5|COMPLETED|Period 3||5
1567528|NCT01192139|3834461|P4|COMPLETED|Period 3||5
1567529|NCT01192139|3834462|P3|COMPLETED|Period 3||5
1567530|NCT01192139|3834463|P2|COMPLETED|Period 3||5
1567531|NCT01192139|3834464|P1|COMPLETED|Period 3||5
1567532|NCT01192139|3834459|P6|STARTED|Period 3||5
1567533|NCT01192139|3834460|P5|STARTED|Period 3||5
1567534|NCT01192139|3834461|P4|STARTED|Period 3||5
1567535|NCT01192139|3834462|P3|STARTED|Period 3||5
1567536|NCT01192139|3834463|P2|STARTED|Period 3||5
1567537|NCT01192139|3834464|P1|STARTED|Period 3||5
1567538|NCT01192139|3834459|P6|NOT COMPLETED|Period 2||0
1567539|NCT01192139|3834460|P5|NOT COMPLETED|Period 2||0
1567540|NCT01192139|3834461|P4|NOT COMPLETED|Period 2||0
1567541|NCT01192139|3834462|P3|NOT COMPLETED|Period 2||0
1567542|NCT01192139|3834463|P2|NOT COMPLETED|Period 2||0
1567543|NCT01192139|3834464|P1|NOT COMPLETED|Period 2||0
1567544|NCT01192139|3834459|P6|COMPLETED|Period 2||5
1567545|NCT01192139|3834460|P5|COMPLETED|Period 2||5
1567546|NCT01192139|3834461|P4|COMPLETED|Period 2||5
1567547|NCT01192139|3834462|P3|COMPLETED|Period 2||5
1567548|NCT01192139|3834463|P2|COMPLETED|Period 2||5
1567549|NCT01192139|3834464|P1|COMPLETED|Period 2||5
1567550|NCT01192139|3834459|P6|STARTED|Period 2||5
1567551|NCT01192139|3834460|P5|STARTED|Period 2||5
1567552|NCT01192139|3834461|P4|STARTED|Period 2||5
1567553|NCT01192139|3834462|P3|STARTED|Period 2||5
1567554|NCT01192139|3834463|P2|STARTED|Period 2||5
1567555|NCT01192139|3834464|P1|STARTED|Period 2||5
1567556|NCT01192139|3834459|P6|NOT COMPLETED|Period 1||0
1567557|NCT01192139|3834460|P5|NOT COMPLETED|Period 1||0
1567558|NCT01192139|3834461|P4|NOT COMPLETED|Period 1||0
1567559|NCT01192139|3834462|P3|NOT COMPLETED|Period 1||0
1567560|NCT01192139|3834463|P2|NOT COMPLETED|Period 1||0
1567561|NCT01192139|3834464|P1|NOT COMPLETED|Period 1||0
1567562|NCT01192139|3834459|P6|COMPLETED|Period 1||5
1567563|NCT01192139|3834460|P5|COMPLETED|Period 1||5
1567564|NCT01192139|3834461|P4|COMPLETED|Period 1||5
1567565|NCT01192139|3834462|P3|COMPLETED|Period 1||5
1567566|NCT01192139|3834463|P2|COMPLETED|Period 1||5
1567567|NCT01192139|3834464|P1|COMPLETED|Period 1||5
1567568|NCT01192139|3834459|P6|STARTED|Period 1||5
1567569|NCT01192139|3834460|P5|STARTED|Period 1||5
1567570|NCT01192139|3834461|P4|STARTED|Period 1||5
1567571|NCT01192139|3834462|P3|STARTED|Period 1||5
1567572|NCT01192139|3834463|P2|STARTED|Period 1||5
1567573|NCT01192139|3834464|P1|STARTED|Period 1||5
1567574|NCT01192126|3834529|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1567575|NCT01192126|3834530|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1567576|NCT01192126|3834529|P2|COMPLETED|Second Intervention (1 Week)||50
1567577|NCT01192126|3834530|P1|COMPLETED|Second Intervention (1 Week)||49
1567578|NCT01192126|3834529|P2|STARTED|Second Intervention (1 Week)||50
1567579|NCT01192126|3834530|P1|STARTED|Second Intervention (1 Week)||49
1567580|NCT01192126|3834529|P2|NOT COMPLETED|First Intervention (1 Week)||1
1567581|NCT01192126|3834530|P1|NOT COMPLETED|First Intervention (1 Week)||2
1567582|NCT01192126|3834529|P2|COMPLETED|First Intervention (1 Week)||50
1567583|NCT01192126|3834530|P1|COMPLETED|First Intervention (1 Week)||49
1567584|NCT01192126|3834529|P2|STARTED|First Intervention (1 Week)||51
1567585|NCT01192126|3834530|P1|STARTED|First Intervention (1 Week)||51
1567586|NCT01192022|3834542|P5|NOT COMPLETED|Overall Study||1
1567587|NCT01192022|3834543|P4|NOT COMPLETED|Overall Study||2
1567588|NCT01192022|3834544|P3|NOT COMPLETED|Overall Study||1
1567589|NCT01192022|3834545|P2|NOT COMPLETED|Overall Study||11
1567590|NCT01192022|3834546|P1|NOT COMPLETED|Overall Study||13
1567591|NCT01192022|3834542|P5|COMPLETED|Overall Study||11
1567592|NCT01192022|3834543|P4|COMPLETED|Overall Study||7
1567593|NCT01192022|3834544|P3|COMPLETED|Overall Study||7
1567594|NCT01192022|3834545|P2|COMPLETED|Overall Study||99
1567595|NCT01192022|3834546|P1|COMPLETED|Overall Study||101
1567596|NCT01192022|3834542|P5|Safety Population-Received Treatment|Overall Study||12
1567597|NCT01192022|3834543|P4|Safety Population-Received Treatment|Overall Study||9
1567598|NCT01192022|3834544|P3|Safety Population-Received Treatment|Overall Study||8
1567599|NCT01192022|3834545|P2|Safety Population-Received Treatment|Overall Study||109
1567600|NCT01192022|3834546|P1|Safety Population-Received Treatment|Overall Study||114
1567601|NCT01192022|3834542|P5|STARTED|Overall Study||12
1567602|NCT01192022|3834543|P4|STARTED|Overall Study||9
1567603|NCT01192022|3834544|P3|STARTED|Overall Study||8
1567604|NCT01192022|3834545|P2|STARTED|Overall Study||110
1567605|NCT01192022|3834546|P1|STARTED|Overall Study||114
1567606|NCT01191944|3834569|P2|NOT COMPLETED|Overall Study||19
1567607|NCT01191944|3834570|P1|NOT COMPLETED|Overall Study||17
1567608|NCT01191944|3834569|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
1567609|NCT01191944|3834570|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
1567610|NCT01191944|3834569|P2|STARTED|Overall Study|Treated titration/maintenance|239
1567611|NCT01191944|3834570|P1|STARTED|Overall Study|Treated titration/maintenance|234
1567612|NCT01191840|3834616|P2|NOT COMPLETED|Overall Study||15
1567613|NCT01191840|3834617|P1|NOT COMPLETED|Overall Study||14
1567614|NCT01191840|3834616|P2|COMPLETED|Overall Study||240
1567615|NCT01191840|3834617|P1|COMPLETED|Overall Study||240
1567616|NCT01191840|3834616|P2|STARTED|Overall Study||255
1567617|NCT01191840|3834617|P1|STARTED|Overall Study||254
1567618|NCT01191827|3834633|P2|NOT COMPLETED|Overall Study||0
1567619|NCT01191827|3834634|P1|NOT COMPLETED|Overall Study||0
1567620|NCT01191827|3834633|P2|COMPLETED|Overall Study||20
1567621|NCT01191827|3834634|P1|COMPLETED|Overall Study||20
1567622|NCT01191827|3834633|P2|STARTED|Overall Study||20
1567623|NCT01191827|3834634|P1|STARTED|Overall Study||20
1567624|NCT01191801|3834642|P2|NOT COMPLETED|Overall Study||337
1567625|NCT01191801|3834643|P1|NOT COMPLETED|Overall Study||316
1567626|NCT01191801|3834642|P2|COMPLETED|Overall Study||18
1567627|NCT01191801|3834643|P1|COMPLETED|Overall Study||40
1567628|NCT01191801|3834642|P2|STARTED|Overall Study||355
1567629|NCT01191801|3834643|P1|STARTED|Overall Study||356
1567630|NCT01191788|3834663|P2|NOT COMPLETED|Overall Study||22
1567631|NCT01191788|3834664|P1|NOT COMPLETED|Overall Study||21
1567632|NCT01191788|3834663|P2|COMPLETED|Overall Study|Completed 3-month followup|137
1567633|NCT01191788|3834664|P1|COMPLETED|Overall Study|Completed 3-month followup|119
1567634|NCT01191788|3834663|P2|STARTED|Overall Study||159
1567635|NCT01191788|3834664|P1|STARTED|Overall Study||140
1567636|NCT01191762|3834674|P2|NOT COMPLETED|Overall Study||0
1567637|NCT01191762|3834675|P1|NOT COMPLETED|Overall Study||1
1567638|NCT01191762|3834674|P2|COMPLETED|Overall Study||15
1567639|NCT01191762|3834675|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
1567640|NCT01191762|3834674|P2|STARTED|Overall Study||15
1567641|NCT01191762|3834675|P1|STARTED|Overall Study||15
1567642|NCT01191749|3834681|P1|NOT COMPLETED|Overall Study||0
1567643|NCT01191749|3834681|P1|COMPLETED|Overall Study||7
1567644|NCT01191749|3834681|P1|STARTED|Overall Study||7
1567645|NCT01191736|3834692|P7|NOT COMPLETED|Overall Study||0
1567646|NCT01191736|3834693|P6|NOT COMPLETED|Overall Study||0
1567647|NCT01191736|3834694|P5|NOT COMPLETED|Overall Study||0
1567648|NCT01191736|3834695|P4|NOT COMPLETED|Overall Study||0
1567649|NCT01191736|3834696|P3|NOT COMPLETED|Overall Study||0
1567650|NCT01191736|3834697|P2|NOT COMPLETED|Overall Study||0
1567651|NCT01191736|3834698|P1|NOT COMPLETED|Overall Study||0
1567652|NCT01191736|3834692|P7|COMPLETED|Overall Study||45
1567653|NCT01191736|3834693|P6|COMPLETED|Overall Study||50
1567654|NCT01191736|3834694|P5|COMPLETED|Overall Study||48
1567655|NCT01191736|3834695|P4|COMPLETED|Overall Study||46
1567656|NCT01191736|3834696|P3|COMPLETED|Overall Study||49
1567657|NCT01191736|3834697|P2|COMPLETED|Overall Study||47
1567658|NCT01191736|3834698|P1|COMPLETED|Overall Study||51
1567659|NCT01191736|3834692|P7|STARTED|Overall Study||45
1567660|NCT01191736|3834693|P6|STARTED|Overall Study||50
1567661|NCT01191736|3834694|P5|STARTED|Overall Study||48
1567662|NCT01191736|3834695|P4|STARTED|Overall Study||46
1567663|NCT01191736|3834696|P3|STARTED|Overall Study||49
1567664|NCT01191736|3834697|P2|STARTED|Overall Study||47
1567665|NCT01191736|3834698|P1|STARTED|Overall Study||51
1567666|NCT01191723|3834721|P6|NOT COMPLETED|Overall Study||0
1567667|NCT01191723|3834722|P5|NOT COMPLETED|Overall Study||0
1567668|NCT01191723|3834723|P4|NOT COMPLETED|Overall Study||0
1567669|NCT01191723|3834724|P3|NOT COMPLETED|Overall Study||0
1567670|NCT01191723|3834725|P2|NOT COMPLETED|Overall Study||0
1567671|NCT01191723|3834726|P1|NOT COMPLETED|Overall Study||0
1567672|NCT01191723|3834721|P6|COMPLETED|Overall Study||9
1567673|NCT01191723|3834722|P5|COMPLETED|Overall Study||9
1567674|NCT01191723|3834723|P4|COMPLETED|Overall Study||9
1567675|NCT01191723|3834724|P3|COMPLETED|Overall Study||9
1567676|NCT01191723|3834725|P2|COMPLETED|Overall Study||9
1567677|NCT01191723|3834726|P1|COMPLETED|Overall Study||9
1567678|NCT01191723|3834721|P6|STARTED|Overall Study||9
1567679|NCT01191723|3834722|P5|STARTED|Overall Study||9
1567680|NCT01191723|3834723|P4|STARTED|Overall Study||9
1567681|NCT01191723|3834724|P3|STARTED|Overall Study||9
1567682|NCT01191723|3834725|P2|STARTED|Overall Study||9
1567683|NCT01191723|3834726|P1|STARTED|Overall Study||9
1567684|NCT01191476|3834747|P3|NOT COMPLETED|Overall Study||0
1567685|NCT01191476|3834748|P2|NOT COMPLETED|Overall Study||4
1567686|NCT01191476|3834749|P1|NOT COMPLETED|Overall Study||3
1567687|NCT01191476|3834747|P3|COMPLETED|Overall Study||111
1567688|NCT01191476|3834748|P2|COMPLETED|Overall Study||107
1567689|NCT01191476|3834749|P1|COMPLETED|Overall Study||109
1567690|NCT01191476|3834747|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
1567691|NCT01191476|3834748|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
1567692|NCT01191476|3834749|P1|STARTED|Overall Study||112
1567693|NCT01191411|3834772|P3|NOT COMPLETED|Overall Study||3427
1567694|NCT01191411|3834773|P2|NOT COMPLETED|Overall Study||361
1567695|NCT01191411|3834774|P1|NOT COMPLETED|Overall Study||945
1567696|NCT01191411|3834772|P3|COMPLETED|Overall Study||471
1567697|NCT01191411|3834773|P2|COMPLETED|Overall Study||118
1567698|NCT01191411|3834774|P1|COMPLETED|Overall Study||648
1567699|NCT01191411|3834772|P3|STARTED|Overall Study||3898
1567700|NCT01191411|3834773|P2|STARTED|Overall Study||479
1567701|NCT01191411|3834774|P1|STARTED|Overall Study||1593
1567702|NCT01191398|3834785|P3|NOT COMPLETED|Overall Study||0
1567703|NCT01191398|3834786|P2|NOT COMPLETED|Overall Study||0
1567704|NCT01191398|3834787|P1|NOT COMPLETED|Overall Study||0
1567705|NCT01191398|3834785|P3|COMPLETED|Overall Study||18
1567706|NCT01191398|3834786|P2|COMPLETED|Overall Study||17
1567707|NCT01191398|3834787|P1|COMPLETED|Overall Study||17
1567708|NCT01191398|3834785|P3|STARTED|Overall Study||18
1567709|NCT01191398|3834786|P2|STARTED|Overall Study||17
1567710|NCT01191398|3834787|P1|STARTED|Overall Study||17
1567711|NCT01191333|3834800|P2|NOT COMPLETED|Overall Study||18
1567712|NCT01191333|3834801|P1|NOT COMPLETED|Overall Study||21
1567713|NCT01191333|3834800|P2|COMPLETED|Overall Study||65
1567714|NCT01191333|3834801|P1|COMPLETED|Overall Study||60
1567715|NCT01191333|3834800|P2|STARTED|Overall Study||83
1567716|NCT01191333|3834801|P1|STARTED|Overall Study||81
1567717|NCT01191320|3834820|P3|NOT COMPLETED|Overall Study||7
1567718|NCT01191320|3834821|P2|NOT COMPLETED|Overall Study||6
1567719|NCT01191320|3834822|P1|NOT COMPLETED|Overall Study||7
1567720|NCT01191320|3834820|P3|COMPLETED|Overall Study||31
1567721|NCT01191320|3834821|P2|COMPLETED|Overall Study||32
1567722|NCT01191320|3834822|P1|COMPLETED|Overall Study||36
1567723|NCT01191320|3834820|P3|STARTED|Overall Study||38
1567724|NCT01191320|3834821|P2|STARTED|Overall Study||38
1567725|NCT01191320|3834822|P1|STARTED|Overall Study||43
1567726|NCT01191268|3834833|P3|NOT COMPLETED|Overall Study||52
1567727|NCT01191268|3834834|P2|NOT COMPLETED|Overall Study||55
1567728|NCT01191268|3834835|P1|NOT COMPLETED|Overall Study||58
1567729|NCT01191268|3834833|P3|COMPLETED|Overall Study||244
1567730|NCT01191268|3834834|P2|COMPLETED|Overall Study||238
1567731|NCT01191268|3834835|P1|COMPLETED|Overall Study||237
1567732|NCT01191268|3834833|P3|Received at Least One Dose of Study Drug|Overall Study||296
1567733|NCT01191268|3834834|P2|Received at Least One Dose of Study Drug|Overall Study||293
1567734|NCT01191268|3834835|P1|Received at Least One Dose of Study Drug|Overall Study||295
1567735|NCT01191268|3834833|P3|STARTED|Overall Study||296
1567736|NCT01191268|3834834|P2|STARTED|Overall Study||293
1567737|NCT01191268|3834835|P1|STARTED|Overall Study||295
1567738|NCT01191255|3834932|P4|NOT COMPLETED|Efficacy Assessment Period||6
1567739|NCT01191255|3834933|P3|NOT COMPLETED|Efficacy Assessment Period||26
1567740|NCT01191255|3834934|P2|NOT COMPLETED|Efficacy Assessment Period||0
1567741|NCT01191255|3834935|P1|NOT COMPLETED|Efficacy Assessment Period||0
1567742|NCT01191255|3834932|P4|COMPLETED|Efficacy Assessment Period||90
1567743|NCT01191255|3834933|P3|COMPLETED|Efficacy Assessment Period||70
1567744|NCT01191255|3834934|P2|COMPLETED|Efficacy Assessment Period||0
1567745|NCT01191255|3834935|P1|COMPLETED|Efficacy Assessment Period||0
1567746|NCT01191255|3834932|P4|STARTED|Efficacy Assessment Period||96
1567747|NCT01191255|3834933|P3|STARTED|Efficacy Assessment Period||96
1567748|NCT01191255|3834934|P2|STARTED|Efficacy Assessment Period||0
1567749|NCT01191255|3834935|P1|STARTED|Efficacy Assessment Period||0
1567750|NCT01191255|3834932|P4|NOT COMPLETED|Safety Assessment Period||0
1567751|NCT01191255|3834933|P3|NOT COMPLETED|Safety Assessment Period||0
1567752|NCT01191255|3834934|P2|NOT COMPLETED|Safety Assessment Period||99
1567753|NCT01191255|3834935|P1|NOT COMPLETED|Safety Assessment Period||38
1567754|NCT01191255|3834932|P4|COMPLETED|Safety Assessment Period||0
1567755|NCT01191255|3834933|P3|COMPLETED|Safety Assessment Period||0
1567756|NCT01191255|3834934|P2|COMPLETED|Safety Assessment Period||193
1567757|NCT01191255|3834935|P1|COMPLETED|Safety Assessment Period||111
1567758|NCT01191255|3834932|P4|Safety Population|Safety Assessment Period||0
1567759|NCT01191255|3834933|P3|Safety Population|Safety Assessment Period||0
1567760|NCT01191255|3834934|P2|Safety Population|Safety Assessment Period||289
1567761|NCT01191255|3834935|P1|Safety Population|Safety Assessment Period||149
1567762|NCT01191255|3834932|P4|STARTED|Safety Assessment Period||0
1567763|NCT01191255|3834933|P3|STARTED|Safety Assessment Period||0
1567764|NCT01191255|3834934|P2|STARTED|Safety Assessment Period||292
1567765|NCT01191255|3834935|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
1567766|NCT01191242|3834961|P1|NOT COMPLETED|Overall Study||0
1567767|NCT01191242|3834961|P1|COMPLETED|Overall Study||31
1567768|NCT01191242|3834961|P1|STARTED|Overall Study||31
1567769|NCT01191190|3834976|P1|NOT COMPLETED|Overall Study||1
1567770|NCT01191190|3834976|P1|COMPLETED|Overall Study||20
1567771|NCT01191190|3834976|P1|STARTED|Overall Study||21
1567772|NCT01191086|3834989|P1|NOT COMPLETED|Overall Study||62
1567773|NCT01191086|3834989|P1|COMPLETED|Overall Study||148
1567774|NCT01191086|3834989|P1|STARTED|Overall Study||210
1567775|NCT01191008|3834993|P1|NOT COMPLETED|Overall Study||15
1567776|NCT01191008|3834993|P1|COMPLETED|Overall Study||618
1567777|NCT01191008|3834993|P1|STARTED|Overall Study||633
1567778|NCT01190891|3835001|P2|NOT COMPLETED|Overall Study||0
1567779|NCT01190891|3835002|P1|NOT COMPLETED|Overall Study||6
1567780|NCT01190891|3835001|P2|COMPLETED|Overall Study||52
1567781|NCT01190891|3835002|P1|COMPLETED|Overall Study||46
1567782|NCT01190891|3835001|P2|STARTED|Overall Study||52
1567783|NCT01190891|3835002|P1|STARTED|Overall Study||52
1567784|NCT01190878|3835014|P4|NOT COMPLETED|Overall Study||20
1567785|NCT01190878|3835015|P3|NOT COMPLETED|Overall Study||5
1567786|NCT01190878|3835016|P2|NOT COMPLETED|Overall Study||3
1567787|NCT01190878|3835017|P1|NOT COMPLETED|Overall Study||3
1567788|NCT01190878|3835014|P4|COMPLETED|Overall Study||22
1567789|NCT01190878|3835015|P3|COMPLETED|Overall Study||37
1567790|NCT01190878|3835016|P2|COMPLETED|Overall Study||42
1567791|NCT01190878|3835017|P1|COMPLETED|Overall Study||37
1567792|NCT01190878|3835014|P4|STARTED|Overall Study||42
1567793|NCT01190878|3835015|P3|STARTED|Overall Study||42
1567794|NCT01190878|3835016|P2|STARTED|Overall Study||45
1567795|NCT01190878|3835017|P1|STARTED|Overall Study||40
1567796|NCT01190865|3835027|P1|NOT COMPLETED|Overall Study||3
1567797|NCT01190865|3835027|P1|COMPLETED|Overall Study||25
1567798|NCT01190865|3835027|P1|STARTED|Overall Study||28
1567799|NCT01190839|3835034|P2|NOT COMPLETED|Overall Study||147
1567800|NCT01190839|3835035|P1|NOT COMPLETED|Overall Study||150
1567801|NCT01190839|3835034|P2|COMPLETED|Overall Study||0
1567802|NCT01190839|3835035|P1|COMPLETED|Overall Study||0
1567803|NCT01190839|3835034|P2|Treated|Overall Study||143
1567804|NCT01190839|3835035|P1|Treated|Overall Study||148
1567805|NCT01190839|3835034|P2|STARTED|Overall Study||147
1567806|NCT01190839|3835035|P1|STARTED|Overall Study||150
1567807|NCT01190813|3835049|P2|NOT COMPLETED|Overall Study||4
1567808|NCT01190813|3835050|P1|NOT COMPLETED|Overall Study||4
1567809|NCT01190813|3835049|P2|COMPLETED|Overall Study||45
1567810|NCT01190813|3835050|P1|COMPLETED|Overall Study||86
1567811|NCT01190813|3835049|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
1567812|NCT01190813|3835050|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
1567813|NCT01190813|3835049|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
1567814|NCT01190813|3835050|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
1567815|NCT01190813|3835049|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
1567816|NCT01190813|3835050|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
1567817|NCT01190813|3835049|P2|16-week Visit|Overall Study|2 dropped|46
1567818|NCT01190813|3835050|P1|16-week Visit|Overall Study|1 dropped|87
1567819|NCT01190813|3835049|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
1567820|NCT01190813|3835050|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
1567821|NCT01190813|3835049|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
1567822|NCT01190813|3835050|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
1567823|NCT01190813|3835049|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
1567824|NCT01190813|3835050|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
1567825|NCT01190813|3835049|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
1567826|NCT01190813|3835050|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
1567827|NCT01190813|3835049|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
1567828|NCT01190813|3835050|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
1567829|NCT01190813|3835049|P2|STARTED|Overall Study||49
1567830|NCT01190813|3835050|P1|STARTED|Overall Study||90
1567831|NCT01190566|3835142|P2|NOT COMPLETED|Overall Study||0
1567832|NCT01190566|3835143|P1|NOT COMPLETED|Overall Study||0
1567833|NCT01190566|3835142|P2|COMPLETED|Overall Study||42
1567834|NCT01190566|3835143|P1|COMPLETED|Overall Study||6
1567835|NCT01190566|3835142|P2|STARTED|Overall Study||42
1567836|NCT01190566|3835143|P1|STARTED|Overall Study||6
1567837|NCT01190527|3835164|P1|NOT COMPLETED|Overall Study||0
1567838|NCT01190527|3835164|P1|COMPLETED|Overall Study||42
1567839|NCT01190527|3835164|P1|STARTED|Overall Study||42
1567840|NCT01190514|3835171|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
1567841|NCT01190514|3835172|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
1567842|NCT01190514|3835173|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
1567843|NCT01190514|3835174|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
1567844|NCT01190514|3835171|P4|COMPLETED|Fourth Intervention (Period 4)||10
1567845|NCT01190514|3835172|P3|COMPLETED|Fourth Intervention (Period 4)||10
1567846|NCT01190514|3835173|P2|COMPLETED|Fourth Intervention (Period 4)||10
1567847|NCT01190514|3835174|P1|COMPLETED|Fourth Intervention (Period 4)||9
1567848|NCT01190514|3835171|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
1567849|NCT01190514|3835172|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
1567850|NCT01190514|3835173|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
1567851|NCT01190514|3835174|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
1567852|NCT01190514|3835171|P4|NOT COMPLETED|Third Intervention (Period 3)||0
1567853|NCT01190514|3835172|P3|NOT COMPLETED|Third Intervention (Period 3)||0
1567854|NCT01190514|3835173|P2|NOT COMPLETED|Third Intervention (Period 3)||0
1567855|NCT01190514|3835174|P1|NOT COMPLETED|Third Intervention (Period 3)||1
1567856|NCT01190514|3835171|P4|COMPLETED|Third Intervention (Period 3)||10
1567857|NCT01190514|3835172|P3|COMPLETED|Third Intervention (Period 3)||10
1567858|NCT01190514|3835173|P2|COMPLETED|Third Intervention (Period 3)||10
1567859|NCT01190514|3835174|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
1567860|NCT01190514|3835171|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
1567861|NCT01190514|3835172|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
1567862|NCT01190514|3835173|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
1567863|NCT01190514|3835174|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
1567864|NCT01190514|3835171|P4|NOT COMPLETED|Second Intervention (Period 2)||0
1567865|NCT01190514|3835172|P3|NOT COMPLETED|Second Intervention (Period 2)||0
1567866|NCT01190514|3835173|P2|NOT COMPLETED|Second Intervention (Period 2)||0
1567867|NCT01190514|3835174|P1|NOT COMPLETED|Second Intervention (Period 2)||0
1567868|NCT01190514|3835171|P4|COMPLETED|Second Intervention (Period 2)||10
1567869|NCT01190514|3835172|P3|COMPLETED|Second Intervention (Period 2)||10
1567870|NCT01190514|3835173|P2|COMPLETED|Second Intervention (Period 2)||10
1567871|NCT01190514|3835174|P1|COMPLETED|Second Intervention (Period 2)||10
1567872|NCT01190514|3835171|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
1567873|NCT01190514|3835172|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
1567874|NCT01190514|3835173|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
1567875|NCT01190514|3835174|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
1567876|NCT01190514|3835171|P4|NOT COMPLETED|First Intervention (Period 1)||0
1567877|NCT01190514|3835172|P3|NOT COMPLETED|First Intervention (Period 1)||0
1567878|NCT01190514|3835173|P2|NOT COMPLETED|First Intervention (Period 1)||0
1567879|NCT01190514|3835174|P1|NOT COMPLETED|First Intervention (Period 1)||1
1567880|NCT01190514|3835171|P4|COMPLETED|First Intervention (Period 1)||10
1567881|NCT01190514|3835172|P3|COMPLETED|First Intervention (Period 1)||10
1567882|NCT01190514|3835173|P2|COMPLETED|First Intervention (Period 1)||10
1567883|NCT01190514|3835174|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
1567884|NCT01190514|3835171|P4|STARTED|First Intervention (Period 1)||10
1567885|NCT01190514|3835172|P3|STARTED|First Intervention (Period 1)||10
1567886|NCT01190514|3835173|P2|STARTED|First Intervention (Period 1)||10
1567887|NCT01190514|3835174|P1|STARTED|First Intervention (Period 1)||11
1567888|NCT01190475|3835207|P3|NOT COMPLETED|Overall Study||1
1567889|NCT01190475|3835208|P2|NOT COMPLETED|Overall Study||0
1567890|NCT01190475|3835209|P1|NOT COMPLETED|Overall Study||0
1567891|NCT01190475|3835207|P3|COMPLETED|Overall Study||1
1567892|NCT01190475|3835208|P2|COMPLETED|Overall Study||2
1567893|NCT01190475|3835209|P1|COMPLETED|Overall Study||2
1567894|NCT01190475|3835207|P3|STARTED|Overall Study||2
1567895|NCT01190475|3835208|P2|STARTED|Overall Study||2
1567896|NCT01190475|3835209|P1|STARTED|Overall Study||2
1567897|NCT01190449|3835219|P2|NOT COMPLETED|Overall Study||4
1567898|NCT01190449|3835220|P1|NOT COMPLETED|Overall Study||0
1567899|NCT01190449|3835219|P2|COMPLETED|Overall Study||32
1567900|NCT01190449|3835220|P1|COMPLETED|Overall Study||15
1567901|NCT01190449|3835219|P2|STARTED|Overall Study||36
1567902|NCT01190449|3835220|P1|STARTED|Overall Study||15
1567903|NCT01190436|3835228|P1|NOT COMPLETED|Overall Study||39
1567904|NCT01190436|3835228|P1|COMPLETED|Overall Study||86
1567905|NCT01190436|3835228|P1|STARTED|Overall Study||125
1567906|NCT01190306|3835244|P2|NOT COMPLETED|Overall Study||0
1567907|NCT01190306|3835245|P1|NOT COMPLETED|Overall Study||0
1567908|NCT01190306|3835244|P2|COMPLETED|Overall Study||66
1567909|NCT01190306|3835245|P1|COMPLETED|Overall Study||61
1567910|NCT01190306|3835244|P2|STARTED|Overall Study||66
1567911|NCT01190306|3835245|P1|STARTED|Overall Study||61
1567912|NCT01190267|3835253|P2|NOT COMPLETED|Overall Study||4
1567913|NCT01190267|3835254|P1|NOT COMPLETED|Overall Study||41
1567914|NCT01190267|3835253|P2|COMPLETED|Overall Study||4
1567915|NCT01190267|3835254|P1|COMPLETED|Overall Study||155
1567916|NCT01190267|3835253|P2|STARTED|Overall Study||8
1567917|NCT01190267|3835254|P1|STARTED|Overall Study||196
1567918|NCT01190254|3835265|P3|NOT COMPLETED|Overall Study||22
1567919|NCT01190254|3835266|P2|NOT COMPLETED|Overall Study||17
1567920|NCT01190254|3835267|P1|NOT COMPLETED|Overall Study||21
1567921|NCT01190254|3835265|P3|COMPLETED|Overall Study||84
1567922|NCT01190254|3835266|P2|COMPLETED|Overall Study||81
1567923|NCT01190254|3835267|P1|COMPLETED|Overall Study||81
1567924|NCT01190254|3835265|P3|Treated|Overall Study||106
1567925|NCT01190254|3835266|P2|Treated|Overall Study||98
1567926|NCT01190254|3835267|P1|Treated|Overall Study||102
1567927|NCT01190254|3835265|P3|STARTED|Overall Study||106
1567928|NCT01190254|3835266|P2|STARTED|Overall Study||98
1567929|NCT01190254|3835267|P1|STARTED|Overall Study||102
1567930|NCT01190228|3835332|P3|NOT COMPLETED|Overall Study||0
1567931|NCT01190228|3835333|P2|NOT COMPLETED|Overall Study||0
1567932|NCT01190228|3835334|P1|NOT COMPLETED|Overall Study||5
1567933|NCT01190228|3835332|P3|COMPLETED|Overall Study||59
1567934|NCT01190228|3835333|P2|COMPLETED|Overall Study||46
1567935|NCT01190228|3835334|P1|COMPLETED|Overall Study||344
1567936|NCT01190228|3835332|P3|STARTED|Overall Study||59
1567937|NCT01190228|3835333|P2|STARTED|Overall Study||46
1567938|NCT01190228|3835334|P1|STARTED|Overall Study||349
1567939|NCT01190215|3835357|P2|NOT COMPLETED|Up to Month 6||0
1567940|NCT01190215|3835358|P1|NOT COMPLETED|Up to Month 6||2
1567941|NCT01190215|3835357|P2|COMPLETED|Up to Month 6||39
1567942|NCT01190215|3835358|P1|COMPLETED|Up to Month 6||36
1567943|NCT01190215|3835357|P2|STARTED|Up to Month 6||39
1567944|NCT01190215|3835358|P1|STARTED|Up to Month 6||38
1567945|NCT01190215|3835357|P2|NOT COMPLETED|Up to Day 28||0
1567946|NCT01190215|3835358|P1|NOT COMPLETED|Up to Day 28||0
1567947|NCT01190215|3835357|P2|COMPLETED|Up to Day 28||39
1567948|NCT01190215|3835358|P1|COMPLETED|Up to Day 28||38
1567949|NCT01190215|3835357|P2|STARTED|Up to Day 28||39
1567950|NCT01190215|3835358|P1|STARTED|Up to Day 28||38
1567951|NCT01190189|3835426|P1|NOT COMPLETED|Overall Study||6
1567952|NCT01190189|3835426|P1|COMPLETED|Overall Study||131
1567953|NCT01190189|3835426|P1|STARTED|Overall Study||137
1567954|NCT01190176|3835433|P1|NOT COMPLETED|Overall Study||2
1567955|NCT01190176|3835433|P1|COMPLETED|Overall Study||30
1567956|NCT01190176|3835433|P1|STARTED|Overall Study||32
1567957|NCT01190150|3835454|P2|NOT COMPLETED|Second Treatment||0
1567958|NCT01190150|3835455|P1|NOT COMPLETED|Second Treatment||0
1567959|NCT01190150|3835454|P2|COMPLETED|Second Treatment||7
1567960|NCT01190150|3835455|P1|COMPLETED|Second Treatment||10
1567961|NCT01190150|3835454|P2|STARTED|Second Treatment||7
1567962|NCT01190150|3835455|P1|STARTED|Second Treatment||10
1567963|NCT01190150|3835454|P2|NOT COMPLETED|Washout||2
1567964|NCT01190150|3835455|P1|NOT COMPLETED|Washout||0
1567965|NCT01190150|3835454|P2|COMPLETED|Washout||7
1567966|NCT01190150|3835455|P1|COMPLETED|Washout||10
1567967|NCT01190150|3835454|P2|STARTED|Washout||9
1567968|NCT01190150|3835455|P1|STARTED|Washout||10
1567969|NCT01190150|3835454|P2|NOT COMPLETED|First Treatment||0
1567970|NCT01190150|3835455|P1|NOT COMPLETED|First Treatment||1
1567971|NCT01190150|3835454|P2|COMPLETED|First Treatment||9
1567972|NCT01190150|3835455|P1|COMPLETED|First Treatment||10
1567973|NCT01190150|3835454|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
1567974|NCT01190150|3835455|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
1567975|NCT01190124|3835482|P3|NOT COMPLETED|Overall Study||1
1567976|NCT01190124|3835483|P2|NOT COMPLETED|Overall Study||0
1567977|NCT01190124|3835484|P1|NOT COMPLETED|Overall Study||17
1567978|NCT01190124|3835482|P3|COMPLETED|Overall Study||19
1567979|NCT01190124|3835483|P2|COMPLETED|Overall Study||24
1567980|NCT01190124|3835484|P1|COMPLETED|Overall Study||90
1567981|NCT01190124|3835482|P3|STARTED|Overall Study||20
1567982|NCT01190124|3835483|P2|STARTED|Overall Study||24
1567983|NCT01190124|3835484|P1|STARTED|Overall Study||107
1567984|NCT01190098|3835522|P2|NOT COMPLETED|Overall Study||2
1567985|NCT01190098|3835523|P1|NOT COMPLETED|Overall Study||3
1567986|NCT01190098|3835522|P2|COMPLETED|Overall Study||8
1567987|NCT01190098|3835523|P1|COMPLETED|Overall Study||39
1567988|NCT01190098|3835522|P2|STARTED|Overall Study||10
1567989|NCT01190098|3835523|P1|STARTED|Overall Study||42
1567990|NCT01190085|3835546|P3|NOT COMPLETED|Overall Study||0
1567991|NCT01190085|3835547|P2|NOT COMPLETED|Overall Study||0
1567992|NCT01190085|3835548|P1|NOT COMPLETED|Overall Study||0
1567993|NCT01190085|3835546|P3|COMPLETED|Overall Study||18
1567994|NCT01190085|3835547|P2|COMPLETED|Overall Study||14
1567995|NCT01190085|3835548|P1|COMPLETED|Overall Study||13
1567996|NCT01190085|3835546|P3|STARTED|Overall Study||18
1567997|NCT01190085|3835547|P2|STARTED|Overall Study||14
1567998|NCT01190085|3835548|P1|STARTED|Overall Study||13
1567999|NCT01190007|3835562|P1|NOT COMPLETED|Overall Study||14
1568000|NCT01190007|3835562|P1|COMPLETED|Overall Study||145
1568001|NCT01190007|3835562|P1|STARTED|Overall Study|Treated|159
1568002|NCT01189890|3835579|P2|NOT COMPLETED|Overall Study||39
1568003|NCT01189890|3835580|P1|NOT COMPLETED|Overall Study||37
1568004|NCT01189890|3835579|P2|COMPLETED|Overall Study||200
1568005|NCT01189890|3835580|P1|COMPLETED|Overall Study||204
1568006|NCT01189890|3835579|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
1568007|NCT01189890|3835580|P1|STARTED|Overall Study||241
1568008|NCT01189812|3835602|P2|NOT COMPLETED|Overall Study||8
1568009|NCT01189812|3835603|P1|NOT COMPLETED|Overall Study||8
1568010|NCT01189812|3835602|P2|COMPLETED|Overall Study||32
1568011|NCT01189812|3835603|P1|COMPLETED|Overall Study||32
1568012|NCT01189812|3835602|P2|STARTED|Overall Study||40
1568013|NCT01189812|3835603|P1|STARTED|Overall Study||40
1568014|NCT01189760|3835612|P3|NOT COMPLETED|Overall Study||51
1568015|NCT01189760|3835613|P2|NOT COMPLETED|Overall Study||23
1568016|NCT01189760|3835614|P1|NOT COMPLETED|Overall Study||14
1568017|NCT01189760|3835612|P3|COMPLETED|Overall Study||255
1568018|NCT01189760|3835613|P2|COMPLETED|Overall Study||283
1568019|NCT01189760|3835614|P1|COMPLETED|Overall Study||291
1568020|NCT01189760|3835612|P3|STARTED|Overall Study||306
1568021|NCT01189760|3835613|P2|STARTED|Overall Study||306
1568022|NCT01189760|3835614|P1|STARTED|Overall Study||305
1568023|NCT01189747|3835648|P2|NOT COMPLETED|Overall Study||18
1568024|NCT01189747|3835649|P1|NOT COMPLETED|Overall Study||12
1568025|NCT01189747|3835648|P2|COMPLETED|Overall Study||206
1568026|NCT01189747|3835649|P1|COMPLETED|Overall Study||210
1568027|NCT01189747|3835648|P2|STARTED|Overall Study||224
1568028|NCT01189747|3835649|P1|STARTED|Overall Study||222
1568029|NCT01189617|3835673|P2|NOT COMPLETED|Overall Study||0
1568030|NCT01189617|3835674|P1|NOT COMPLETED|Overall Study||0
1568031|NCT01189617|3835673|P2|COMPLETED|Overall Study||35
1568032|NCT01189617|3835674|P1|COMPLETED|Overall Study||35
1568033|NCT01189617|3835673|P2|STARTED|Overall Study||35
1568034|NCT01189617|3835674|P1|STARTED|Overall Study||35
1568035|NCT01189604|3835687|P7|NOT COMPLETED|Overall Study||1
1568036|NCT01189604|3835688|P6|NOT COMPLETED|Overall Study||1
1568037|NCT01189604|3835689|P5|NOT COMPLETED|Overall Study||2
1568038|NCT01189604|3835690|P4|NOT COMPLETED|Overall Study||0
1568039|NCT01189604|3835691|P3|NOT COMPLETED|Overall Study||0
1568040|NCT01189604|3835692|P2|NOT COMPLETED|Overall Study||1
1568041|NCT01189604|3835693|P1|NOT COMPLETED|Overall Study||1
1568042|NCT01189604|3835687|P7|COMPLETED|Overall Study||9
1568043|NCT01189604|3835688|P6|COMPLETED|Overall Study||10
1568044|NCT01189604|3835689|P5|COMPLETED|Overall Study||18
1568045|NCT01189604|3835690|P4|COMPLETED|Overall Study||20
1568046|NCT01189604|3835691|P3|COMPLETED|Overall Study||20
1568047|NCT01189604|3835692|P2|COMPLETED|Overall Study||20
1568048|NCT01189604|3835693|P1|COMPLETED|Overall Study||20
1568049|NCT01189604|3835687|P7|Administered Study Drug|Overall Study||10
1568050|NCT01189604|3835688|P6|Administered Study Drug|Overall Study||10
1568051|NCT01189604|3835689|P5|Administered Study Drug|Overall Study||20
1568052|NCT01189604|3835690|P4|Administered Study Drug|Overall Study||20
1568053|NCT01189604|3835691|P3|Administered Study Drug|Overall Study||20
1568054|NCT01189604|3835692|P2|Administered Study Drug|Overall Study||20
1568055|NCT01189604|3835693|P1|Administered Study Drug|Overall Study||20
1568056|NCT01189604|3835687|P7|STARTED|Overall Study||10
1568057|NCT01189604|3835688|P6|STARTED|Overall Study||11
1568058|NCT01189604|3835689|P5|STARTED|Overall Study||20
1568059|NCT01189604|3835690|P4|STARTED|Overall Study||20
1568060|NCT01189604|3835691|P3|STARTED|Overall Study||20
1568061|NCT01189604|3835692|P2|STARTED|Overall Study||21
1568062|NCT01189604|3835693|P1|STARTED|Overall Study||21
1568063|NCT01189500|3835737|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
1568064|NCT01189500|3835737|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
1568065|NCT01189500|3835737|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
1568066|NCT01189500|3835737|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
1568067|NCT01189500|3835737|P1|COMPLETED|Period 1: TAMOX Alone||29
1568068|NCT01189500|3835737|P1|STARTED|Period 1: TAMOX Alone||30
1568069|NCT01189487|3835798|P1|NOT COMPLETED|Overall Study||3
1568070|NCT01189487|3835798|P1|COMPLETED|Overall Study||44
1568071|NCT01189487|3835798|P1|STARTED|Overall Study|Treated participants|47
1568072|NCT01189461|3835806|P1|NOT COMPLETED|Overall Study||34
1568073|NCT01189461|3835806|P1|COMPLETED|Overall Study||12
1568074|NCT01189461|3835806|P1|STARTED|Overall Study||46
1568075|NCT01189435|3835813|P1|NOT COMPLETED|Overall Study||2
1568076|NCT01189435|3835813|P1|COMPLETED|Overall Study||0
1568077|NCT01189435|3835813|P1|STARTED|Overall Study||2
1568078|NCT01189409|3835819|P2|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
1568079|NCT01189409|3835820|P1|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
1568080|NCT01189409|3835819|P2|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
1568081|NCT01189409|3835820|P1|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
1568082|NCT01189409|3835819|P2|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
1568083|NCT01189409|3835820|P1|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
1568084|NCT01189409|3835819|P2|NOT COMPLETED|First 3 Weeks||10
1568085|NCT01189409|3835820|P1|NOT COMPLETED|First 3 Weeks||18
1568086|NCT01189409|3835819|P2|COMPLETED|First 3 Weeks||23
1568087|NCT01189409|3835820|P1|COMPLETED|First 3 Weeks||19
1568088|NCT01189409|3835819|P2|STARTED|First 3 Weeks||33
1568089|NCT01189409|3835820|P1|STARTED|First 3 Weeks||37
1568090|NCT01189370|3835835|P3|NOT COMPLETED|Dose Level 3||6
1568091|NCT01189370|3835836|P2|NOT COMPLETED|Dose Level 3||0
1568092|NCT01189370|3835837|P1|NOT COMPLETED|Dose Level 3||0
1568093|NCT01189370|3835835|P3|COMPLETED|Dose Level 3||6
1568094|NCT01189370|3835836|P2|COMPLETED|Dose Level 3||0
1568095|NCT01189370|3835837|P1|COMPLETED|Dose Level 3||0
1568096|NCT01189370|3835835|P3|STARTED|Dose Level 3||12
1568097|NCT01189370|3835836|P2|STARTED|Dose Level 3||0
1568098|NCT01189370|3835837|P1|STARTED|Dose Level 3||0
1568099|NCT01189370|3835835|P3|NOT COMPLETED|Dose Level 2||0
1568100|NCT01189370|3835836|P2|NOT COMPLETED|Dose Level 2||4
1568101|NCT01189370|3835837|P1|NOT COMPLETED|Dose Level 2||0
1568102|NCT01189370|3835835|P3|COMPLETED|Dose Level 2||0
1568103|NCT01189370|3835836|P2|COMPLETED|Dose Level 2||12
1568104|NCT01189370|3835837|P1|COMPLETED|Dose Level 2||0
1568105|NCT01189370|3835835|P3|STARTED|Dose Level 2||0
1568106|NCT01189370|3835836|P2|STARTED|Dose Level 2||16
1568107|NCT01189370|3835837|P1|STARTED|Dose Level 2||0
1568108|NCT01189370|3835835|P3|NOT COMPLETED|Dose Level 1||0
1568109|NCT01189370|3835836|P2|NOT COMPLETED|Dose Level 1||0
1568110|NCT01189370|3835837|P1|NOT COMPLETED|Dose Level 1||9
1568111|NCT01189370|3835835|P3|COMPLETED|Dose Level 1||0
1568112|NCT01189370|3835836|P2|COMPLETED|Dose Level 1||0
1568113|NCT01189370|3835837|P1|COMPLETED|Dose Level 1||16
1568114|NCT01189370|3835835|P3|STARTED|Dose Level 1||0
1568115|NCT01189370|3835836|P2|STARTED|Dose Level 1||0
1568116|NCT01189370|3835837|P1|STARTED|Dose Level 1||25
1568117|NCT01189292|3835846|P2|NOT COMPLETED|Per Protocol Analysis||16
1568118|NCT01189292|3835847|P1|NOT COMPLETED|Per Protocol Analysis||11
1568119|NCT01189292|3835846|P2|COMPLETED|Per Protocol Analysis||60
1568120|NCT01189292|3835847|P1|COMPLETED|Per Protocol Analysis||65
1568121|NCT01189292|3835846|P2|STARTED|Per Protocol Analysis||76
1568122|NCT01189292|3835847|P1|STARTED|Per Protocol Analysis||76
1568123|NCT01189292|3835846|P2|NOT COMPLETED|Intention to Treat Analysis||0
1568124|NCT01189292|3835847|P1|NOT COMPLETED|Intention to Treat Analysis||0
1568125|NCT01189292|3835846|P2|COMPLETED|Intention to Treat Analysis||76
1568126|NCT01189292|3835847|P1|COMPLETED|Intention to Treat Analysis||76
1568127|NCT01189292|3835846|P2|STARTED|Intention to Treat Analysis||76
1568128|NCT01189292|3835847|P1|STARTED|Intention to Treat Analysis||76
1568129|NCT01189279|3835868|P3|NOT COMPLETED|Overall Study||1
1568130|NCT01189279|3835869|P2|NOT COMPLETED|Overall Study||0
1568131|NCT01189279|3835870|P1|NOT COMPLETED|Overall Study||1
1568132|NCT01189279|3835868|P3|COMPLETED|Overall Study||13
1568133|NCT01189279|3835869|P2|COMPLETED|Overall Study||14
1568134|NCT01189279|3835870|P1|COMPLETED|Overall Study||13
1568135|NCT01189279|3835868|P3|STARTED|Overall Study||14
1568136|NCT01189279|3835869|P2|STARTED|Overall Study||14
1568137|NCT01189279|3835870|P1|STARTED|Overall Study||14
1568138|NCT01189240|3835890|P3|NOT COMPLETED|Overall Study||0
1568139|NCT01189240|3835891|P2|NOT COMPLETED|Overall Study||0
1568140|NCT01189240|3835892|P1|NOT COMPLETED|Overall Study||0
1568141|NCT01189240|3835890|P3|COMPLETED|Overall Study||3
1568142|NCT01189240|3835891|P2|COMPLETED|Overall Study||6
1568143|NCT01189240|3835892|P1|COMPLETED|Overall Study||4
1568144|NCT01189240|3835890|P3|STARTED|Overall Study||3
1568145|NCT01189240|3835891|P2|STARTED|Overall Study||6
1568146|NCT01189240|3835892|P1|STARTED|Overall Study||4
1568147|NCT01189227|3835913|P2|NOT COMPLETED|Overall Study||3
1568148|NCT01189227|3835914|P1|NOT COMPLETED|Overall Study||6
1568149|NCT01189227|3835913|P2|COMPLETED|Overall Study||0
1568150|NCT01189227|3835914|P1|COMPLETED|Overall Study||0
1568151|NCT01189227|3835913|P2|STARTED|Overall Study||3
1568152|NCT01189227|3835914|P1|STARTED|Overall Study||6
1568153|NCT01189201|3835920|P1|NOT COMPLETED|Overall Study||1
1568154|NCT01189201|3835920|P1|COMPLETED|Overall Study||41
1568155|NCT01189201|3835920|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
1568156|NCT01189201|3835920|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
1568157|NCT01189201|3835920|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
1568158|NCT01189201|3835920|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
1568159|NCT01189201|3835920|P1|STARTED|Overall Study||42
1568160|NCT01189136|3835976|P2|NOT COMPLETED|Overall Study||0
1568161|NCT01189136|3835977|P1|NOT COMPLETED|Overall Study||0
1568162|NCT01189136|3835976|P2|COMPLETED|Overall Study||42
1568163|NCT01189136|3835977|P1|COMPLETED|Overall Study||42
1568164|NCT01189136|3835976|P2|STARTED|Overall Study||42
1568165|NCT01189136|3835977|P1|STARTED|Overall Study||42
1568166|NCT01189123|3835991|P2|NOT COMPLETED|Overall Study||6
1568167|NCT01189123|3835992|P1|NOT COMPLETED|Overall Study||2
1568168|NCT01189123|3835991|P2|COMPLETED|Overall Study||47
1568169|NCT01189123|3835992|P1|COMPLETED|Overall Study||50
1568170|NCT01189123|3835991|P2|STARTED|Overall Study||53
1568171|NCT01189123|3835992|P1|STARTED|Overall Study||52
1568172|NCT01189110|3836002|P2|NOT COMPLETED|Overall Study||0
1568173|NCT01189110|3836003|P1|NOT COMPLETED|Overall Study||0
1568174|NCT01189110|3836002|P2|COMPLETED|Overall Study||61
1568175|NCT01189110|3836003|P1|COMPLETED|Overall Study|February, 2011|64
1568176|NCT01189110|3836002|P2|STARTED|Overall Study||61
1568177|NCT01189110|3836003|P1|STARTED|Overall Study|September, 2010|64
1568178|NCT01189071|3836011|P2|NOT COMPLETED|Overall Study||0
1568179|NCT01189071|3836012|P1|NOT COMPLETED|Overall Study||0
1568180|NCT01189071|3836011|P2|COMPLETED|Overall Study||0
1568181|NCT01189071|3836012|P1|COMPLETED|Overall Study||0
1568182|NCT01189071|3836011|P2|STARTED|Overall Study||0
1568183|NCT01189071|3836012|P1|STARTED|Overall Study||0
1568184|NCT01189032|3836023|P3|NOT COMPLETED|Overall Study||6
1568185|NCT01189032|3836024|P2|NOT COMPLETED|Overall Study||7
1568186|NCT01189032|3836025|P1|NOT COMPLETED|Overall Study||5
1568187|NCT01189032|3836023|P3|COMPLETED|Overall Study||90
1568188|NCT01189032|3836024|P2|COMPLETED|Overall Study||89
1568189|NCT01189032|3836025|P1|COMPLETED|Overall Study||89
1568190|NCT01189032|3836023|P3|STARTED|Overall Study||96
1568191|NCT01189032|3836024|P2|STARTED|Overall Study||96
1568192|NCT01189032|3836025|P1|STARTED|Overall Study||94
1568193|NCT01188967|3836035|P2|NOT COMPLETED|Overall Study||4
1568194|NCT01188967|3836036|P1|NOT COMPLETED|Overall Study||5
1568195|NCT01188967|3836035|P2|COMPLETED|Overall Study||4
1568196|NCT01188967|3836036|P1|COMPLETED|Overall Study||5
1568197|NCT01188967|3836035|P2|STARTED|Overall Study||8
1568198|NCT01188967|3836036|P1|STARTED|Overall Study||10
1568199|NCT01188928|3836052|P4|NOT COMPLETED|Overall Study||18
1568200|NCT01188928|3836053|P3|NOT COMPLETED|Overall Study||14
1568201|NCT01188928|3836054|P2|NOT COMPLETED|Overall Study||62
1568202|NCT01188928|3836055|P1|NOT COMPLETED|Overall Study||38
1568203|NCT01188928|3836052|P4|COMPLETED|Overall Study||77
1568204|NCT01188928|3836053|P3|COMPLETED|Overall Study||82
1568205|NCT01188928|3836054|P2|COMPLETED|Overall Study||417
1568206|NCT01188928|3836055|P1|COMPLETED|Overall Study||444
1568207|NCT01188928|3836052|P4|STARTED|Overall Study||95
1568208|NCT01188928|3836053|P3|STARTED|Overall Study||96
1568209|NCT01188928|3836054|P2|STARTED|Overall Study||479
1568210|NCT01188928|3836055|P1|STARTED|Overall Study||482
1568211|NCT01188876|3836077|P1|NOT COMPLETED|Overall Study||0
1568212|NCT01188876|3836077|P1|COMPLETED|Overall Study||50
1568213|NCT01188876|3836077|P1|STARTED|Overall Study||50
1568214|NCT01188811|3836089|P2|NOT COMPLETED|Overall Study||2
1568215|NCT01188811|3836090|P1|NOT COMPLETED|Overall Study||6
1568216|NCT01188811|3836089|P2|COMPLETED|Overall Study||24
1568217|NCT01188811|3836090|P1|COMPLETED|Overall Study||22
1568218|NCT01188811|3836089|P2|STARTED|Overall Study||26
1568219|NCT01188811|3836090|P1|STARTED|Overall Study||28
1568220|NCT01188798|3836102|P2|NOT COMPLETED|Overall Study||3
1568221|NCT01188798|3836103|P1|NOT COMPLETED|Overall Study||2
1568222|NCT01188798|3836102|P2|COMPLETED|Overall Study||1
1568223|NCT01188798|3836103|P1|COMPLETED|Overall Study||0
1568224|NCT01188798|3836102|P2|STARTED|Overall Study||4
1568225|NCT01188798|3836103|P1|STARTED|Overall Study||2
1568226|NCT01188772|3836115|P4|NOT COMPLETED|Overall Study||1
1568227|NCT01188772|3836116|P3|NOT COMPLETED|Overall Study||11
1568228|NCT01188772|3836117|P2|NOT COMPLETED|Overall Study||3
1568229|NCT01188772|3836118|P1|NOT COMPLETED|Overall Study||5
1568230|NCT01188772|3836115|P4|COMPLETED|Overall Study||24
1568231|NCT01188772|3836116|P3|COMPLETED|Overall Study||15
1568232|NCT01188772|3836117|P2|COMPLETED|Overall Study||45
1568233|NCT01188772|3836118|P1|COMPLETED|Overall Study||43
1568234|NCT01188772|3836115|P4|Randomized and Treated|Overall Study||25
1568235|NCT01188772|3836116|P3|Randomized and Treated|Overall Study||26
1568236|NCT01188772|3836117|P2|Randomized and Treated|Overall Study||47
1568237|NCT01188772|3836118|P1|Randomized and Treated|Overall Study||48
1568238|NCT01188772|3836115|P4|STARTED|Overall Study||25
1568239|NCT01188772|3836116|P3|STARTED|Overall Study||26
1568240|NCT01188772|3836117|P2|STARTED|Overall Study||48
1568241|NCT01188772|3836118|P1|STARTED|Overall Study||48
1568242|NCT01188694|3836176|P3|NOT COMPLETED|Overall Study||1
1568243|NCT01188694|3836177|P2|NOT COMPLETED|Overall Study||1
1568244|NCT01188694|3836178|P1|NOT COMPLETED|Overall Study||5
1568245|NCT01188694|3836176|P3|COMPLETED|Overall Study||10
1568246|NCT01188694|3836177|P2|COMPLETED|Overall Study||15
1568247|NCT01188694|3836178|P1|COMPLETED|Overall Study||10
1568248|NCT01188694|3836176|P3|STARTED|Overall Study||11
1568249|NCT01188694|3836177|P2|STARTED|Overall Study||16
1568250|NCT01188694|3836178|P1|STARTED|Overall Study||15
1568251|NCT01188681|3836190|P4|NOT COMPLETED|Overall Study||1
1568252|NCT01188681|3836191|P3|NOT COMPLETED|Overall Study||1
1568253|NCT01188681|3836192|P2|NOT COMPLETED|Overall Study||0
1568254|NCT01188681|3836193|P1|NOT COMPLETED|Overall Study||0
1568255|NCT01188681|3836190|P4|COMPLETED|Overall Study||33
1568256|NCT01188681|3836191|P3|COMPLETED|Overall Study||32
1568257|NCT01188681|3836192|P2|COMPLETED|Overall Study||6
1568258|NCT01188681|3836193|P1|COMPLETED|Overall Study||6
1568259|NCT01188681|3836190|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
1568260|NCT01188681|3836191|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
1568261|NCT01188681|3836192|P2|STARTED|Overall Study||6
1568262|NCT01188681|3836193|P1|STARTED|Overall Study||6
1568263|NCT01188668|3836207|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
1568264|NCT01188668|3836207|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
1568265|NCT01188668|3836207|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
1568266|NCT01188668|3836207|P1|NOT COMPLETED|Period 1: ARIP Alone||2
1568267|NCT01188668|3836207|P1|COMPLETED|Period 1: ARIP Alone||36
1568268|NCT01188668|3836207|P1|STARTED|Period 1: ARIP Alone||38
1568269|NCT01188655|3836240|P1|NOT COMPLETED|Overall Study||13
1568270|NCT01188655|3836240|P1|COMPLETED|Overall Study||76
1568271|NCT01188655|3836240|P1|STARTED|Overall Study||89
1568272|NCT01188603|3836255|P1|NOT COMPLETED|Overall Study||0
1568273|NCT01188603|3836255|P1|COMPLETED|Overall Study||24
1568274|NCT01188603|3836255|P1|STARTED|Overall Study||24
1568275|NCT01188577|3836265|P2|NOT COMPLETED|Visit 2||0
1568276|NCT01188577|3836266|P1|NOT COMPLETED|Visit 2||0
1568277|NCT01188577|3836265|P2|COMPLETED|Visit 2||12
1568278|NCT01188577|3836266|P1|COMPLETED|Visit 2||11
1568279|NCT01188577|3836265|P2|STARTED|Visit 2||12
1568280|NCT01188577|3836266|P1|STARTED|Visit 2||11
1568281|NCT01188577|3836265|P2|NOT COMPLETED|3-14 Day Washout||0
1568282|NCT01188577|3836266|P1|NOT COMPLETED|3-14 Day Washout||0
1568283|NCT01188577|3836265|P2|COMPLETED|3-14 Day Washout||12
1568284|NCT01188577|3836266|P1|COMPLETED|3-14 Day Washout||11
1568285|NCT01188577|3836265|P2|STARTED|3-14 Day Washout||12
1568286|NCT01188577|3836266|P1|STARTED|3-14 Day Washout||11
1568287|NCT01188577|3836265|P2|NOT COMPLETED|Visit 1||0
1568288|NCT01188577|3836266|P1|NOT COMPLETED|Visit 1||0
1568289|NCT01188577|3836265|P2|COMPLETED|Visit 1||12
1568290|NCT01188577|3836266|P1|COMPLETED|Visit 1||11
1568291|NCT01188577|3836265|P2|STARTED|Visit 1||12
1568292|NCT01188577|3836266|P1|STARTED|Visit 1||11
1568293|NCT01188564|3836284|P2|NOT COMPLETED|Open Label Phase||0
1568294|NCT01188564|3836285|P1|NOT COMPLETED|Open Label Phase||0
1568295|NCT01188564|3836284|P2|COMPLETED|Open Label Phase||20
1568296|NCT01188564|3836285|P1|COMPLETED|Open Label Phase||24
1568297|NCT01188564|3836284|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
1568298|NCT01188564|3836285|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
1568299|NCT01188564|3836284|P2|NOT COMPLETED|Double-blind Phase||0
1568300|NCT01188564|3836285|P1|NOT COMPLETED|Double-blind Phase||1
1568301|NCT01188564|3836284|P2|COMPLETED|Double-blind Phase||31
1568302|NCT01188564|3836285|P1|COMPLETED|Double-blind Phase||43
1568303|NCT01188564|3836284|P2|STARTED|Double-blind Phase||31
1568304|NCT01188564|3836285|P1|STARTED|Double-blind Phase||44
1568305|NCT01188551|3836297|P4|NOT COMPLETED|Overall Study||0
1568306|NCT01188551|3836298|P3|NOT COMPLETED|Overall Study||0
1568307|NCT01188551|3836299|P2|NOT COMPLETED|Overall Study||0
1568308|NCT01188551|3836300|P1|NOT COMPLETED|Overall Study||1
1568309|NCT01188551|3836297|P4|COMPLETED|Overall Study||25
1568310|NCT01188551|3836298|P3|COMPLETED|Overall Study||25
1568311|NCT01188551|3836299|P2|COMPLETED|Overall Study||25
1568312|NCT01188551|3836300|P1|COMPLETED|Overall Study||24
1568313|NCT01188551|3836297|P4|STARTED|Overall Study||25
1568314|NCT01188551|3836298|P3|STARTED|Overall Study||25
1568315|NCT01188551|3836299|P2|STARTED|Overall Study||25
1568316|NCT01188551|3836300|P1|STARTED|Overall Study||25
1568317|NCT01188538|3836316|P2|NOT COMPLETED|Overall Study||1
1568318|NCT01188538|3836317|P1|NOT COMPLETED|Overall Study||0
1568319|NCT01188538|3836316|P2|COMPLETED|Overall Study||19
1568320|NCT01188538|3836317|P1|COMPLETED|Overall Study||20
1568321|NCT01188538|3836316|P2|STARTED|Overall Study||20
1568322|NCT01188538|3836317|P1|STARTED|Overall Study||20
1568323|NCT01188499|3836330|P5|NOT COMPLETED|Overall Study||0
1568324|NCT01188499|3836331|P4|NOT COMPLETED|Overall Study||0
1568325|NCT01188499|3836332|P3|NOT COMPLETED|Overall Study||0
1568326|NCT01188499|3836333|P2|NOT COMPLETED|Overall Study||0
1568327|NCT01188499|3836334|P1|NOT COMPLETED|Overall Study||0
1568328|NCT01188499|3836330|P5|COMPLETED|Overall Study||18
1568329|NCT01188499|3836331|P4|COMPLETED|Overall Study||18
1568330|NCT01188499|3836332|P3|COMPLETED|Overall Study||33
1568331|NCT01188499|3836333|P2|COMPLETED|Overall Study||83
1568332|NCT01188499|3836334|P1|COMPLETED|Overall Study||24
1568333|NCT01188499|3836330|P5|STARTED|Overall Study||18
1568334|NCT01188499|3836331|P4|STARTED|Overall Study||18
1568335|NCT01188499|3836332|P3|STARTED|Overall Study||33
1568336|NCT01188499|3836333|P2|STARTED|Overall Study||83
1568337|NCT01188499|3836334|P1|STARTED|Overall Study||24
1568338|NCT01188460|3836353|P2|NOT COMPLETED|Overall Study||0
1568339|NCT01188460|3836354|P1|NOT COMPLETED|Overall Study||0
1568340|NCT01188460|3836353|P2|COMPLETED|Overall Study||23
1568341|NCT01188460|3836354|P1|COMPLETED|Overall Study||25
1568342|NCT01188460|3836353|P2|STARTED|Overall Study||23
1568343|NCT01188460|3836354|P1|STARTED|Overall Study||25
1568344|NCT01188447|3836380|P1|NOT COMPLETED|Overall Study||0
1568345|NCT01188447|3836380|P1|COMPLETED|Overall Study||4034
1568346|NCT01188447|3836380|P1|STARTED|Overall Study||4034
1568347|NCT01188421|3836391|P3|NOT COMPLETED|Overall Study||14
1568348|NCT01188421|3836392|P2|NOT COMPLETED|Overall Study||10
1568349|NCT01188421|3836393|P1|NOT COMPLETED|Overall Study||3
1568350|NCT01188421|3836391|P3|COMPLETED|Overall Study||22
1568351|NCT01188421|3836392|P2|COMPLETED|Overall Study||26
1568352|NCT01188421|3836393|P1|COMPLETED|Overall Study||28
1568353|NCT01188421|3836391|P3|STARTED|Overall Study||36
1568354|NCT01188421|3836392|P2|STARTED|Overall Study||36
1568355|NCT01188421|3836393|P1|STARTED|Overall Study||31
1568356|NCT01188369|3836403|P2|NOT COMPLETED|Overall Study||0
1568357|NCT01188369|3836404|P1|NOT COMPLETED|Overall Study||0
1568358|NCT01188369|3836403|P2|COMPLETED|Overall Study||10
1568359|NCT01188369|3836404|P1|COMPLETED|Overall Study||10
1568360|NCT01188369|3836403|P2|STARTED|Overall Study||10
1568361|NCT01188369|3836404|P1|STARTED|Overall Study||10
1568362|NCT01188343|3836413|P3|NOT COMPLETED|Overall Study||1
1568363|NCT01188343|3836414|P2|NOT COMPLETED|Overall Study||26
1568364|NCT01188343|3836415|P1|NOT COMPLETED|Overall Study||1
1568365|NCT01188343|3836413|P3|COMPLETED|Overall Study||220
1568366|NCT01188343|3836414|P2|COMPLETED|Overall Study||193
1568367|NCT01188343|3836415|P1|COMPLETED|Overall Study||101
1568368|NCT01188343|3836413|P3|STARTED|Overall Study||221
1568369|NCT01188343|3836414|P2|STARTED|Overall Study||219
1568370|NCT01188343|3836415|P1|STARTED|Overall Study||102
1568371|NCT01188226|3836441|P1|NOT COMPLETED|Overall Study||4
1568372|NCT01188226|3836441|P1|COMPLETED|Overall Study||6
1568373|NCT01188226|3836441|P1|STARTED|Overall Study||10
1568374|NCT01188109|3836480|P1|NOT COMPLETED|Overall Study||0
1568375|NCT01188109|3836480|P1|COMPLETED|Overall Study||22
1568376|NCT01188109|3836480|P1|STARTED|Overall Study||22
1568377|NCT01187953|3836487|P2|NOT COMPLETED|Overall Study||21
1568378|NCT01187953|3836488|P1|NOT COMPLETED|Overall Study||15
1568379|NCT01187953|3836487|P2|COMPLETED|Overall Study||254
1568380|NCT01187953|3836488|P1|COMPLETED|Overall Study||253
1568381|NCT01187953|3836487|P2|Dosed|Overall Study||271
1568382|NCT01187953|3836488|P1|Dosed|Overall Study||266
1568383|NCT01187953|3836487|P2|STARTED|Overall Study||275
1568384|NCT01187953|3836488|P1|STARTED|Overall Study||268
1568385|NCT01187914|3836496|P1|NOT COMPLETED|Overall Study||0
1568386|NCT01187914|3836496|P1|COMPLETED|Overall Study||40
1568387|NCT01187914|3836496|P1|STARTED|Overall Study||40
1568388|NCT01187901|3836502|P2|NOT COMPLETED|Overall Study||10
1568389|NCT01187901|3836503|P1|NOT COMPLETED|Overall Study||9
1568390|NCT01187901|3836502|P2|COMPLETED|Overall Study||36
1568391|NCT01187901|3836503|P1|COMPLETED|Overall Study||37
1568392|NCT01187901|3836502|P2|STARTED|Overall Study||46
1568393|NCT01187901|3836503|P1|STARTED|Overall Study||46
1568394|NCT01187771|3836521|P2|NOT COMPLETED|Overall Study||3
1568395|NCT01187771|3836522|P1|NOT COMPLETED|Overall Study||3
1568396|NCT01187771|3836521|P2|COMPLETED|Overall Study||18
1568397|NCT01187771|3836522|P1|COMPLETED|Overall Study||25
1568398|NCT01187771|3836521|P2|STARTED|Overall Study||21
1568399|NCT01187771|3836522|P1|STARTED|Overall Study||28
1568400|NCT01187550|3836544|P2|NOT COMPLETED|Overall Study||1
1568401|NCT01187550|3836545|P1|NOT COMPLETED|Overall Study||14
1568402|NCT01187550|3836544|P2|COMPLETED|Overall Study||29
1568403|NCT01187550|3836545|P1|COMPLETED|Overall Study||169
1568404|NCT01187550|3836544|P2|Treated|Overall Study||30
1568405|NCT01187550|3836545|P1|Treated|Overall Study||175
1568406|NCT01187550|3836544|P2|STARTED|Overall Study||30
1568407|NCT01187550|3836545|P1|STARTED|Overall Study||183
1568408|NCT01187511|3836563|P2|NOT COMPLETED|Overall Study||1
1568409|NCT01187511|3836564|P1|NOT COMPLETED|Overall Study||8
1568410|NCT01187511|3836563|P2|COMPLETED|Overall Study||21
1568411|NCT01187511|3836564|P1|COMPLETED|Overall Study||14
1568412|NCT01187511|3836563|P2|STARTED|Overall Study||22
1568413|NCT01187511|3836564|P1|STARTED|Overall Study||22
1568414|NCT01187498|3836672|P2|NOT COMPLETED|Overall Study||10
1568415|NCT01187498|3836673|P1|NOT COMPLETED|Overall Study||9
1568416|NCT01187498|3836672|P2|COMPLETED|Overall Study||60
1568417|NCT01187498|3836673|P1|COMPLETED|Overall Study||64
1568418|NCT01187498|3836672|P2|STARTED|Overall Study||70
1568419|NCT01187498|3836673|P1|STARTED|Overall Study||73
1568420|NCT01187446|3836701|P2|NOT COMPLETED|Overall Study||1
1568421|NCT01187446|3836702|P1|NOT COMPLETED|Overall Study||0
1568422|NCT01187446|3836701|P2|COMPLETED|Overall Study||13
1568423|NCT01187446|3836702|P1|COMPLETED|Overall Study||14
1568424|NCT01187446|3836701|P2|STARTED|Overall Study||14
1568425|NCT01187446|3836702|P1|STARTED|Overall Study||14
1568426|NCT01187433|3836718|P2|NOT COMPLETED|Overall Study||4
1568427|NCT01187433|3836719|P1|NOT COMPLETED|Overall Study||11
1568428|NCT01187433|3836718|P2|COMPLETED|Overall Study||46
1568429|NCT01187433|3836719|P1|COMPLETED|Overall Study||89
1568430|NCT01187433|3836718|P2|STARTED|Overall Study||50
1568431|NCT01187433|3836719|P1|STARTED|Overall Study||100
1568432|NCT01187407|3836749|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
1568433|NCT01187407|3836750|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
1568434|NCT01187407|3836751|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
1568435|NCT01187407|3836752|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
1568436|NCT01187407|3836753|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1568437|NCT01187407|3836749|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
1568438|NCT01187407|3836750|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
1568439|NCT01187407|3836751|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
1568440|NCT01187407|3836752|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
1568441|NCT01187407|3836753|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1568442|NCT01187407|3836749|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
1568443|NCT01187407|3836750|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
1568444|NCT01187407|3836751|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
1568445|NCT01187407|3836752|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
1568446|NCT01187407|3836753|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1568447|NCT01187407|3836749|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
1568448|NCT01187407|3836750|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
1568449|NCT01187407|3836751|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
1568450|NCT01187407|3836752|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
1568451|NCT01187407|3836753|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1568452|NCT01187407|3836749|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568453|NCT01187407|3836750|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568454|NCT01187407|3836751|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568455|NCT01187407|3836752|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568456|NCT01187407|3836753|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
1568457|NCT01187407|3836749|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568458|NCT01187407|3836750|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568459|NCT01187407|3836751|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568460|NCT01187407|3836752|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568461|NCT01187407|3836753|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
1568462|NCT01187407|3836749|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1568463|NCT01187407|3836750|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1568464|NCT01187407|3836751|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1568465|NCT01187407|3836752|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1568466|NCT01187407|3836753|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
1568467|NCT01187407|3836749|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1568468|NCT01187407|3836750|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1568469|NCT01187407|3836751|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1568470|NCT01187407|3836752|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1568471|NCT01187407|3836753|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
1568472|NCT01187381|3836823|P1|NOT COMPLETED|Overall Study||0
1568473|NCT01187381|3836823|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
1568474|NCT01187381|3836823|P1|STARTED|Overall Study||250
1568475|NCT01187355|3836835|P2|NOT COMPLETED|Overall Study||20
1568476|NCT01187355|3836836|P1|NOT COMPLETED|Overall Study||18
1568477|NCT01187355|3836835|P2|COMPLETED|Overall Study||277
1568478|NCT01187355|3836836|P1|COMPLETED|Overall Study||276
1568479|NCT01187355|3836835|P2|STARTED|Overall Study||297
1568480|NCT01187355|3836836|P1|STARTED|Overall Study||294
1568481|NCT01187329|3836848|P2|NOT COMPLETED|Overall Study||2
1568482|NCT01187329|3836849|P1|NOT COMPLETED|Overall Study||1
1568483|NCT01187329|3836848|P2|COMPLETED|Overall Study||48
1568484|NCT01187329|3836849|P1|COMPLETED|Overall Study||49
1568485|NCT01187329|3836848|P2|STARTED|Overall Study||50
1568486|NCT01187329|3836849|P1|STARTED|Overall Study||50
1568487|NCT01187043|3836866|P5|NOT COMPLETED|Overall Study||2
1568488|NCT01187043|3836867|P4|NOT COMPLETED|Overall Study||0
1568489|NCT01187043|3836868|P3|NOT COMPLETED|Overall Study||4
1568490|NCT01187043|3836869|P2|NOT COMPLETED|Overall Study||0
1568491|NCT01187043|3836870|P1|NOT COMPLETED|Overall Study||1
1568492|NCT01187043|3836866|P5|COMPLETED|Overall Study||10
1568493|NCT01187043|3836867|P4|COMPLETED|Overall Study||12
1568494|NCT01187043|3836868|P3|COMPLETED|Overall Study||8
1568495|NCT01187043|3836869|P2|COMPLETED|Overall Study||10
1568496|NCT01187043|3836870|P1|COMPLETED|Overall Study||11
1568497|NCT01187043|3836866|P5|STARTED|Overall Study||12
1568498|NCT01187043|3836867|P4|STARTED|Overall Study||12
1568499|NCT01187043|3836868|P3|STARTED|Overall Study||12
1568500|NCT01187043|3836869|P2|STARTED|Overall Study||10
1568501|NCT01187043|3836870|P1|STARTED|Overall Study||12
1568502|NCT01187017|3836882|P1|NOT COMPLETED|Overall Study||0
1568503|NCT01187017|3836882|P1|COMPLETED|Overall Study||1
1568504|NCT01187017|3836882|P1|STARTED|Overall Study||1
1568505|NCT01187004|3836888|P2|NOT COMPLETED|Overall Study||0
1568506|NCT01187004|3836889|P1|NOT COMPLETED|Overall Study||0
1568507|NCT01187004|3836888|P2|COMPLETED|Overall Study||144
1568508|NCT01187004|3836889|P1|COMPLETED|Overall Study||20
1568509|NCT01187004|3836888|P2|STARTED|Overall Study||144
1568510|NCT01187004|3836889|P1|STARTED|Overall Study||20
1568511|NCT01186939|3836896|P1|NOT COMPLETED|Overall Study||40
1568512|NCT01186939|3836896|P1|COMPLETED|Overall Study||0
1568513|NCT01186939|3836896|P1|STARTED|Overall Study||40
1568514|NCT01186848|3836900|P1|NOT COMPLETED|Overall Study||8
1568515|NCT01186848|3836900|P1|COMPLETED|Overall Study||22
1568516|NCT01186848|3836900|P1|STARTED|Overall Study||30
1568517|NCT01186796|3836908|P2|NOT COMPLETED|Overall Study||2
1568518|NCT01186796|3836909|P1|NOT COMPLETED|Overall Study||4
1568519|NCT01186796|3836908|P2|COMPLETED|Overall Study||14
1568520|NCT01186796|3836909|P1|COMPLETED|Overall Study||10
1568521|NCT01186796|3836908|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
1568522|NCT01186796|3836909|P1|STARTED|Overall Study||14
1568523|NCT01186744|3836929|P6|NOT COMPLETED|Overall Study||26
1568524|NCT01186744|3836930|P5|NOT COMPLETED|Overall Study||6
1568525|NCT01186744|3836931|P4|NOT COMPLETED|Overall Study||12
1568526|NCT01186744|3836932|P3|NOT COMPLETED|Overall Study||6
1568527|NCT01186744|3836933|P2|NOT COMPLETED|Overall Study||152
1568528|NCT01186744|3836934|P1|NOT COMPLETED|Overall Study||208
1568529|NCT01186744|3836929|P6|COMPLETED|Overall Study||107
1568530|NCT01186744|3836930|P5|COMPLETED|Overall Study||39
1568531|NCT01186744|3836931|P4|COMPLETED|Overall Study||70
1568532|NCT01186744|3836932|P3|COMPLETED|Overall Study||25
1568533|NCT01186744|3836933|P2|COMPLETED|Overall Study||5
1568534|NCT01186744|3836934|P1|COMPLETED|Overall Study||10
1568535|NCT01186744|3836929|P6|STARTED|Overall Study||133
1568536|NCT01186744|3836930|P5|STARTED|Overall Study||45
1568537|NCT01186744|3836931|P4|STARTED|Overall Study||82
1568538|NCT01186744|3836932|P3|STARTED|Overall Study||31
1568539|NCT01186744|3836933|P2|STARTED|Overall Study||157
1568540|NCT01186744|3836934|P1|STARTED|Overall Study||218
1568541|NCT01186705|3837350|P1|NOT COMPLETED|Overall Study||0
1568542|NCT01186705|3837350|P1|COMPLETED|Overall Study||1
1568543|NCT01186705|3837350|P1|STARTED|Overall Study||1
1568544|NCT01186692|3837354|P1|NOT COMPLETED|Overall Study||32
1568545|NCT01186692|3837354|P1|COMPLETED|Overall Study||99
1568546|NCT01186692|3837354|P1|STARTED|Overall Study||131
1568547|NCT01186562|3837364|P2|NOT COMPLETED|Overall Study||2
1568548|NCT01186562|3837365|P1|NOT COMPLETED|Overall Study||4
1568549|NCT01186562|3837364|P2|COMPLETED|Overall Study||27
1568550|NCT01186562|3837365|P1|COMPLETED|Overall Study||50
1568551|NCT01186562|3837364|P2|STARTED|Overall Study||29
1568552|NCT01186562|3837365|P1|STARTED|Overall Study||54
1568553|NCT01186458|3837381|P1|NOT COMPLETED|Overall Study||1
1568554|NCT01186458|3837381|P1|COMPLETED|Overall Study||3
1568555|NCT01186458|3837381|P1|STARTED|Overall Study||4
1568556|NCT01186419|3837390|P2|NOT COMPLETED|Overall Study||9
1568557|NCT01186419|3837391|P1|NOT COMPLETED|Overall Study||7
1568558|NCT01186419|3837390|P2|COMPLETED|Overall Study||18
1568559|NCT01186419|3837391|P1|COMPLETED|Overall Study||17
1568560|NCT01186419|3837390|P2|STARTED|Overall Study||27
1568561|NCT01186419|3837391|P1|STARTED|Overall Study||24
1568562|NCT01186406|3837398|P1|NOT COMPLETED|Overall Study||0
1568563|NCT01186406|3837398|P1|COMPLETED|Overall Study||41
1568564|NCT01186406|3837398|P1|STARTED|Overall Study||41
1568565|NCT01186250|3837407|P2|NOT COMPLETED|Overall Study||0
1568566|NCT01186250|3837408|P1|NOT COMPLETED|Overall Study||1
1568567|NCT01186250|3837407|P2|COMPLETED|Overall Study||9
1568568|NCT01186250|3837408|P1|COMPLETED|Overall Study||8
1568569|NCT01186250|3837407|P2|STARTED|Overall Study||9
1568570|NCT01186250|3837408|P1|STARTED|Overall Study||9
1568571|NCT01185964|3837429|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
1568572|NCT01185964|3837430|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1568573|NCT01185964|3837431|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1568574|NCT01185964|3837432|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1568575|NCT01185964|3837429|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
1568576|NCT01185964|3837430|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1568577|NCT01185964|3837431|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1568578|NCT01185964|3837432|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1568579|NCT01185964|3837429|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
1568580|NCT01185964|3837430|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
1568581|NCT01185964|3837431|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
1568582|NCT01185964|3837432|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
1568583|NCT01185964|3837429|P4|NOT COMPLETED|Phase 1b and Phase 2||0
1568584|NCT01185964|3837430|P3|NOT COMPLETED|Phase 1b and Phase 2||9
1568585|NCT01185964|3837431|P2|NOT COMPLETED|Phase 1b and Phase 2||10
1568586|NCT01185964|3837432|P1|NOT COMPLETED|Phase 1b and Phase 2||2
1568587|NCT01185964|3837429|P4|COMPLETED|Phase 1b and Phase 2||0
1568588|NCT01185964|3837430|P3|COMPLETED|Phase 1b and Phase 2||58
1568589|NCT01185964|3837431|P2|COMPLETED|Phase 1b and Phase 2||56
1568590|NCT01185964|3837432|P1|COMPLETED|Phase 1b and Phase 2||13
1568591|NCT01185964|3837429|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
1568592|NCT01185964|3837430|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
1568593|NCT01185964|3837431|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
1568594|NCT01185964|3837432|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
1568595|NCT01185964|3837429|P4|STARTED|Phase 1b and Phase 2||0
1568596|NCT01185964|3837430|P3|STARTED|Phase 1b and Phase 2||67
1568597|NCT01185964|3837431|P2|STARTED|Phase 1b and Phase 2||66
1568598|NCT01185964|3837432|P1|STARTED|Phase 1b and Phase 2||15
1568599|NCT01185834|3837458|P1|NOT COMPLETED|Overall Study||14
1568600|NCT01185834|3837458|P1|COMPLETED|Overall Study||104
1568601|NCT01185834|3837458|P1|STARTED|Overall Study||118
1568602|NCT01185821|3837468|P5|NOT COMPLETED|Overall Study||24
1568603|NCT01185821|3837469|P4|NOT COMPLETED|Overall Study||6
1568604|NCT01185821|3837470|P3|NOT COMPLETED|Overall Study||10
1568605|NCT01185821|3837471|P2|NOT COMPLETED|Overall Study||9
1568606|NCT01185821|3837472|P1|NOT COMPLETED|Overall Study||7
1568607|NCT01185821|3837468|P5|COMPLETED|Overall Study||26
1568608|NCT01185821|3837469|P4|COMPLETED|Overall Study||23
1568609|NCT01185821|3837470|P3|COMPLETED|Overall Study||33
1568610|NCT01185821|3837471|P2|COMPLETED|Overall Study||20
1568611|NCT01185821|3837472|P1|COMPLETED|Overall Study||26
1568612|NCT01185821|3837468|P5|Patients on Placebo in Core|Overall Study||2
1568613|NCT01185821|3837469|P4|Patients on Placebo in Core|Overall Study||8
1568614|NCT01185821|3837470|P3|Patients on Placebo in Core|Overall Study||9
1568615|NCT01185821|3837471|P2|Patients on Placebo in Core|Overall Study||7
1568616|NCT01185821|3837472|P1|Patients on Placebo in Core|Overall Study||8
1568617|NCT01185821|3837468|P5|Patients Without Washout|Overall Study||17
1568618|NCT01185821|3837469|P4|Patients Without Washout|Overall Study||0
1568619|NCT01185821|3837470|P3|Patients Without Washout|Overall Study||4
1568620|NCT01185821|3837471|P2|Patients Without Washout|Overall Study||0
1568621|NCT01185821|3837472|P1|Patients Without Washout|Overall Study||0
1568622|NCT01185821|3837468|P5|Patients With Washout|Overall Study||33
1568623|NCT01185821|3837469|P4|Patients With Washout|Overall Study||29
1568624|NCT01185821|3837470|P3|Patients With Washout|Overall Study||39
1568625|NCT01185821|3837471|P2|Patients With Washout|Overall Study||29
1568626|NCT01185821|3837472|P1|Patients With Washout|Overall Study||33
1568627|NCT01185821|3837468|P5|STARTED|Overall Study||50
1568628|NCT01185821|3837469|P4|STARTED|Overall Study||29
1568629|NCT01185821|3837470|P3|STARTED|Overall Study||43
1568630|NCT01185821|3837471|P2|STARTED|Overall Study||29
1568631|NCT01185821|3837472|P1|STARTED|Overall Study||33
1568632|NCT01185782|3837523|P2|NOT COMPLETED|Overall Study||11
1568633|NCT01185782|3837524|P1|NOT COMPLETED|Overall Study||6
1568634|NCT01185782|3837523|P2|COMPLETED|Overall Study||125
1568635|NCT01185782|3837524|P1|COMPLETED|Overall Study||123
1568636|NCT01185782|3837523|P2|Treated|Overall Study||132
1568637|NCT01185782|3837524|P1|Treated|Overall Study||129
1568638|NCT01185782|3837523|P2|STARTED|Overall Study||136
1568639|NCT01185782|3837524|P1|STARTED|Overall Study||129
1568640|NCT01185704|3837552|P2|NOT COMPLETED|Overall Study||8
1568641|NCT01185704|3837553|P1|NOT COMPLETED|Overall Study||13
1568642|NCT01185704|3837552|P2|COMPLETED|Overall Study||60
1568643|NCT01185704|3837553|P1|COMPLETED|Overall Study||55
1568644|NCT01185704|3837552|P2|Treated|Overall Study||65
1568645|NCT01185704|3837553|P1|Treated|Overall Study||65
1568646|NCT01185704|3837552|P2|STARTED|Overall Study||68
1568647|NCT01185704|3837553|P1|STARTED|Overall Study||68
1568648|NCT01185600|3837589|P2|NOT COMPLETED|Overall Study||45
1568649|NCT01185600|3837590|P1|NOT COMPLETED|Overall Study||32
1568650|NCT01185600|3837589|P2|COMPLETED|Overall Study||59
1568651|NCT01185600|3837590|P1|COMPLETED|Overall Study||41
1568652|NCT01185600|3837589|P2|STARTED|Overall Study||104
1568653|NCT01185600|3837590|P1|STARTED|Overall Study||73
1568654|NCT01185561|3837612|P2|NOT COMPLETED|Overall Study||12
1568655|NCT01185561|3837613|P1|NOT COMPLETED|Overall Study||2
1568656|NCT01185561|3837612|P2|COMPLETED|Overall Study||26
1568657|NCT01185561|3837613|P1|COMPLETED|Overall Study||34
1568658|NCT01185561|3837612|P2|STARTED|Overall Study||38
1568659|NCT01185561|3837613|P1|STARTED|Overall Study||36
1568660|NCT01185548|3837625|P1|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
1568661|NCT01185548|3837625|P1|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
1568662|NCT01185548|3837625|P1|STARTED|Period 3: Tasisulam and Tolbutamide||2
1568663|NCT01185548|3837625|P1|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
1568664|NCT01185548|3837625|P1|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
1568665|NCT01185548|3837625|P1|STARTED|Period 2: Tasisulam and Tolbutamide||4
1568666|NCT01185548|3837625|P1|NOT COMPLETED|Period 1 : Tolbutamide||0
1568667|NCT01185548|3837625|P1|COMPLETED|Period 1 : Tolbutamide||4
1568668|NCT01185548|3837625|P1|STARTED|Period 1 : Tolbutamide||4
1568669|NCT01185522|3837638|P1|NOT COMPLETED|Overall Study||108
1568670|NCT01185522|3837638|P1|COMPLETED|Overall Study||585
1568671|NCT01185522|3837638|P1|STARTED|Overall Study||693
1568672|NCT01185509|3837664|P2|NOT COMPLETED|Overall Study||20
1568673|NCT01185509|3837665|P1|NOT COMPLETED|Overall Study||11
1568674|NCT01185509|3837664|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1568675|NCT01185509|3837665|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1568676|NCT01185509|3837664|P2|STARTED|Overall Study||20
1568677|NCT01185509|3837665|P1|STARTED|Overall Study||11
1568678|NCT01185353|3837680|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
1568679|NCT01185353|3837681|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
1568680|NCT01185353|3837682|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
1568681|NCT01185353|3837683|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1568682|NCT01185353|3837684|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1568683|NCT01185353|3837685|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1568684|NCT01185353|3837686|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1568685|NCT01185353|3837687|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1568686|NCT01185353|3837688|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1568687|NCT01185353|3837689|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1568688|NCT01185353|3837680|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
1568689|NCT01185353|3837681|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
1568690|NCT01185353|3837682|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
1568691|NCT01185353|3837683|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
1568692|NCT01185353|3837684|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
1568693|NCT01185353|3837685|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
1568694|NCT01185353|3837686|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
1568695|NCT01185353|3837687|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
1568696|NCT01185353|3837688|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
1568697|NCT01185353|3837689|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
1568698|NCT01185353|3837680|P10|STARTED|Part D (Weeks 76 Through 128)||18
1568699|NCT01185353|3837681|P9|STARTED|Part D (Weeks 76 Through 128)||47
1568700|NCT01185353|3837682|P8|STARTED|Part D (Weeks 76 Through 128)||79
1568701|NCT01185353|3837683|P7|STARTED|Part D (Weeks 76 Through 128)||0
1568702|NCT01185353|3837684|P6|STARTED|Part D (Weeks 76 Through 128)||0
1568703|NCT01185353|3837685|P5|STARTED|Part D (Weeks 76 Through 128)||0
1568704|NCT01185353|3837686|P4|STARTED|Part D (Weeks 76 Through 128)||0
1568705|NCT01185353|3837687|P3|STARTED|Part D (Weeks 76 Through 128)||0
1568706|NCT01185353|3837688|P2|STARTED|Part D (Weeks 76 Through 128)||0
1568707|NCT01185353|3837689|P1|STARTED|Part D (Weeks 76 Through 128)||0
1568708|NCT01185353|3837680|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
1568709|NCT01185353|3837681|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
1568710|NCT01185353|3837682|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
1568711|NCT01185353|3837683|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1568712|NCT01185353|3837684|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1568713|NCT01185353|3837685|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1568714|NCT01185353|3837686|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1568715|NCT01185353|3837687|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1568716|NCT01185353|3837688|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1568717|NCT01185353|3837689|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1568718|NCT01185353|3837680|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
1568719|NCT01185353|3837681|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
1568720|NCT01185353|3837682|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
1568721|NCT01185353|3837683|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
1568722|NCT01185353|3837684|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
1568723|NCT01185353|3837685|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
1568724|NCT01185353|3837686|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
1568725|NCT01185353|3837687|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
1568726|NCT01185353|3837688|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
1568727|NCT01185353|3837689|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
1568728|NCT01185353|3837680|P10|STARTED|Part C (Weeks 24 Through 76)||32
1568729|NCT01185353|3837681|P9|STARTED|Part C (Weeks 24 Through 76)||61
1568730|NCT01185353|3837682|P8|STARTED|Part C (Weeks 24 Through 76)||108
1568731|NCT01185353|3837683|P7|STARTED|Part C (Weeks 24 Through 76)||0
1568732|NCT01185353|3837684|P6|STARTED|Part C (Weeks 24 Through 76)||0
1568733|NCT01185353|3837685|P5|STARTED|Part C (Weeks 24 Through 76)||0
1568734|NCT01185353|3837686|P4|STARTED|Part C (Weeks 24 Through 76)||0
1568735|NCT01185353|3837687|P3|STARTED|Part C (Weeks 24 Through 76)||0
1568736|NCT01185353|3837688|P2|STARTED|Part C (Weeks 24 Through 76)||0
1568737|NCT01185353|3837689|P1|STARTED|Part C (Weeks 24 Through 76)||0
1568738|NCT01185353|3837680|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1568739|NCT01185353|3837681|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1568740|NCT01185353|3837682|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1568741|NCT01185353|3837683|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
1568742|NCT01185353|3837684|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
1568743|NCT01185353|3837685|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1568744|NCT01185353|3837686|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
1568745|NCT01185353|3837687|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
1568746|NCT01185353|3837688|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
1568747|NCT01185353|3837689|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1568748|NCT01185353|3837680|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
1568749|NCT01185353|3837681|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
1568750|NCT01185353|3837682|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
1568751|NCT01185353|3837683|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
1568752|NCT01185353|3837684|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
1568753|NCT01185353|3837685|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
1568754|NCT01185353|3837686|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
1568755|NCT01185353|3837687|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
1568756|NCT01185353|3837688|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
1568757|NCT01185353|3837689|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
1568758|NCT01185353|3837680|P10|STARTED|Part B (Weeks 12 Through 24)||0
1568759|NCT01185353|3837681|P9|STARTED|Part B (Weeks 12 Through 24)||0
1568760|NCT01185353|3837682|P8|STARTED|Part B (Weeks 12 Through 24)||0
1568761|NCT01185353|3837683|P7|STARTED|Part B (Weeks 12 Through 24)||63
1568762|NCT01185353|3837684|P6|STARTED|Part B (Weeks 12 Through 24)||63
1568763|NCT01185353|3837685|P5|STARTED|Part B (Weeks 12 Through 24)||0
1568764|NCT01185353|3837686|P4|STARTED|Part B (Weeks 12 Through 24)||49
1568765|NCT01185353|3837687|P3|STARTED|Part B (Weeks 12 Through 24)||50
1568766|NCT01185353|3837688|P2|STARTED|Part B (Weeks 12 Through 24)||51
1568767|NCT01185353|3837689|P1|STARTED|Part B (Weeks 12 Through 24)||0
1568768|NCT01185353|3837680|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1568769|NCT01185353|3837681|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1568770|NCT01185353|3837682|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1568771|NCT01185353|3837683|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1568772|NCT01185353|3837684|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1568773|NCT01185353|3837685|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
1568774|NCT01185353|3837686|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
1568775|NCT01185353|3837687|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
1568776|NCT01185353|3837688|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
1568777|NCT01185353|3837689|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
1568778|NCT01185353|3837680|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
1568779|NCT01185353|3837681|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
1568780|NCT01185353|3837682|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
1568781|NCT01185353|3837683|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
1568782|NCT01185353|3837684|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
1568783|NCT01185353|3837685|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
1568784|NCT01185353|3837686|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
1568785|NCT01185353|3837687|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
1568786|NCT01185353|3837688|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
1568787|NCT01185353|3837689|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
1568788|NCT01185353|3837680|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1568789|NCT01185353|3837681|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1568790|NCT01185353|3837682|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1568791|NCT01185353|3837683|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1568792|NCT01185353|3837684|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1568793|NCT01185353|3837685|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
1568794|NCT01185353|3837686|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
1568795|NCT01185353|3837687|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
1568796|NCT01185353|3837688|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
1568797|NCT01185353|3837689|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
1568798|NCT01185353|3837680|P10|STARTED|Part A (Weeks 0 Through 12)||0
1568799|NCT01185353|3837681|P9|STARTED|Part A (Weeks 0 Through 12)||0
1568800|NCT01185353|3837682|P8|STARTED|Part A (Weeks 0 Through 12)||0
1568801|NCT01185353|3837683|P7|STARTED|Part A (Weeks 0 Through 12)||0
1568802|NCT01185353|3837684|P6|STARTED|Part A (Weeks 0 Through 12)||0
1568803|NCT01185353|3837685|P5|STARTED|Part A (Weeks 0 Through 12)||98
1568804|NCT01185353|3837686|P4|STARTED|Part A (Weeks 0 Through 12)||50
1568805|NCT01185353|3837687|P3|STARTED|Part A (Weeks 0 Through 12)||52
1568806|NCT01185353|3837688|P2|STARTED|Part A (Weeks 0 Through 12)||52
1568807|NCT01185353|3837689|P1|STARTED|Part A (Weeks 0 Through 12)||49
1568808|NCT01185340|3837850|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
1568809|NCT01185340|3837851|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
1568810|NCT01185340|3837852|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
1568811|NCT01185340|3837853|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1568812|NCT01185340|3837850|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
1568813|NCT01185340|3837851|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
1568814|NCT01185340|3837852|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
1568815|NCT01185340|3837853|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1568816|NCT01185340|3837850|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
1568817|NCT01185340|3837851|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
1568818|NCT01185340|3837852|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
1568819|NCT01185340|3837853|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1568820|NCT01185340|3837850|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
1568821|NCT01185340|3837851|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
1568822|NCT01185340|3837852|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
1568823|NCT01185340|3837853|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1568824|NCT01185340|3837850|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568825|NCT01185340|3837851|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568826|NCT01185340|3837852|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568827|NCT01185340|3837853|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
1568828|NCT01185340|3837850|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568829|NCT01185340|3837851|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568830|NCT01185340|3837852|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1568915|NCT01184859|3838090|P4|COMPLETED|Washout Period||22
1568831|NCT01185340|3837853|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
1568832|NCT01185340|3837850|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1568833|NCT01185340|3837851|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1568834|NCT01185340|3837852|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
1568835|NCT01185340|3837853|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
1568836|NCT01185340|3837850|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1568837|NCT01185340|3837851|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1568838|NCT01185340|3837852|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1568839|NCT01185340|3837853|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
1568840|NCT01185301|3837905|P4|NOT COMPLETED|Overall Study||9
1568841|NCT01185301|3837906|P3|NOT COMPLETED|Overall Study||6
1568842|NCT01185301|3837907|P2|NOT COMPLETED|Overall Study||7
1568843|NCT01185301|3837908|P1|NOT COMPLETED|Overall Study||15
1568844|NCT01185301|3837905|P4|COMPLETED|Overall Study||89
1568845|NCT01185301|3837906|P3|COMPLETED|Overall Study||93
1568846|NCT01185301|3837907|P2|COMPLETED|Overall Study||93
1568847|NCT01185301|3837908|P1|COMPLETED|Overall Study||83
1568848|NCT01185301|3837905|P4|STARTED|Overall Study||98
1568849|NCT01185301|3837906|P3|STARTED|Overall Study||99
1568850|NCT01185301|3837907|P2|STARTED|Overall Study||100
1568851|NCT01185301|3837908|P1|STARTED|Overall Study||98
1568852|NCT01185288|3837968|P2|NOT COMPLETED|Overall Study||16
1568853|NCT01185288|3837969|P1|NOT COMPLETED|Overall Study||19
1568854|NCT01185288|3837968|P2|COMPLETED|Overall Study||139
1568855|NCT01185288|3837969|P1|COMPLETED|Overall Study||135
1568856|NCT01185288|3837968|P2|STARTED|Overall Study||155
1568857|NCT01185288|3837969|P1|STARTED|Overall Study||154
1568858|NCT01185249|3837987|P1|NOT COMPLETED|Overall Study||42
1568859|NCT01185249|3837987|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
1568860|NCT01185249|3837987|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
1568861|NCT01185080|3837995|P3|NOT COMPLETED|Overall Study||1
1568862|NCT01185080|3837996|P2|NOT COMPLETED|Overall Study||1
1568863|NCT01185080|3837997|P1|NOT COMPLETED|Overall Study||1
1568864|NCT01185080|3837995|P3|COMPLETED|Overall Study||16
1568865|NCT01185080|3837996|P2|COMPLETED|Overall Study||15
1568866|NCT01185080|3837997|P1|COMPLETED|Overall Study||49
1568867|NCT01185080|3837995|P3|STARTED|Overall Study||17
1568868|NCT01185080|3837996|P2|STARTED|Overall Study||16
1568869|NCT01185080|3837997|P1|STARTED|Overall Study||50
1568870|NCT01185028|3838044|P1|NOT COMPLETED|Overall Study||4
1568871|NCT01185028|3838044|P1|COMPLETED|Overall Study||4
1568872|NCT01185028|3838044|P1|STARTED|Overall Study||8
1568873|NCT01184989|3838049|P1|NOT COMPLETED|Overall Study||12
1568874|NCT01184989|3838049|P1|COMPLETED|Overall Study||100
1568875|NCT01184989|3838049|P1|STARTED|Overall Study|Treated Patients|112
1568876|NCT01184898|3838055|P1|NOT COMPLETED|Overall Study||0
1568877|NCT01184898|3838055|P1|COMPLETED|Overall Study||36
1568878|NCT01184898|3838055|P1|STARTED|Overall Study||36
1568879|NCT01184885|3838062|P1|NOT COMPLETED|Overall Study||0
1568880|NCT01184885|3838062|P1|COMPLETED|Overall Study||7
1568881|NCT01184885|3838062|P1|STARTED|Overall Study||7
1568882|NCT01184872|3838069|P2|NOT COMPLETED|Overall Study||8
1568883|NCT01184872|3838070|P1|NOT COMPLETED|Overall Study||10
1568884|NCT01184872|3838069|P2|COMPLETED|Overall Study||31
1568885|NCT01184872|3838070|P1|COMPLETED|Overall Study||71
1568886|NCT01184872|3838069|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
1568887|NCT01184872|3838070|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
1568888|NCT01184872|3838069|P2|Clinical Evaluable Set (CES)|Overall Study||30
1568889|NCT01184872|3838070|P1|Clinical Evaluable Set (CES)|Overall Study||73
1568890|NCT01184872|3838069|P2|Safety Set|Overall Study||40
1568891|NCT01184872|3838070|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
1568892|NCT01184872|3838069|P2|STARTED|Overall Study||39
1568893|NCT01184872|3838070|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
1568894|NCT01184859|3838089|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
1568895|NCT01184859|3838090|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
1568896|NCT01184859|3838091|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
1568897|NCT01184859|3838092|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
1568898|NCT01184859|3838093|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
1568899|NCT01184859|3838089|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
1568900|NCT01184859|3838090|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
1568901|NCT01184859|3838091|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
1568902|NCT01184859|3838092|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
1568903|NCT01184859|3838093|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
1568904|NCT01184859|3838089|P5|STARTED|Period 2: Daily Dose for 28 Days||23
1568905|NCT01184859|3838090|P4|STARTED|Period 2: Daily Dose for 28 Days||22
1568906|NCT01184859|3838091|P3|STARTED|Period 2: Daily Dose for 28 Days||22
1568907|NCT01184859|3838092|P2|STARTED|Period 2: Daily Dose for 28 Days||23
1568908|NCT01184859|3838093|P1|STARTED|Period 2: Daily Dose for 28 Days||23
1568909|NCT01184859|3838089|P5|NOT COMPLETED|Washout Period||0
1568910|NCT01184859|3838090|P4|NOT COMPLETED|Washout Period||0
1568911|NCT01184859|3838091|P3|NOT COMPLETED|Washout Period||0
1568912|NCT01184859|3838092|P2|NOT COMPLETED|Washout Period||0
1568913|NCT01184859|3838093|P1|NOT COMPLETED|Washout Period||0
1568914|NCT01184859|3838089|P5|COMPLETED|Washout Period||23
1568916|NCT01184859|3838091|P3|COMPLETED|Washout Period||22
1568917|NCT01184859|3838092|P2|COMPLETED|Washout Period||23
1568918|NCT01184859|3838093|P1|COMPLETED|Washout Period||23
1568919|NCT01184859|3838089|P5|STARTED|Washout Period||23
1568920|NCT01184859|3838090|P4|STARTED|Washout Period||22
1568921|NCT01184859|3838091|P3|STARTED|Washout Period||22
1568922|NCT01184859|3838092|P2|STARTED|Washout Period||23
1568923|NCT01184859|3838093|P1|STARTED|Washout Period||23
1568924|NCT01184859|3838089|P5|NOT COMPLETED|Period 1: Single Dose||1
1568925|NCT01184859|3838090|P4|NOT COMPLETED|Period 1: Single Dose||0
1568926|NCT01184859|3838091|P3|NOT COMPLETED|Period 1: Single Dose||0
1568927|NCT01184859|3838092|P2|NOT COMPLETED|Period 1: Single Dose||2
1568928|NCT01184859|3838093|P1|NOT COMPLETED|Period 1: Single Dose||0
1568929|NCT01184859|3838089|P5|COMPLETED|Period 1: Single Dose||23
1568930|NCT01184859|3838090|P4|COMPLETED|Period 1: Single Dose||22
1568931|NCT01184859|3838091|P3|COMPLETED|Period 1: Single Dose||22
1568932|NCT01184859|3838092|P2|COMPLETED|Period 1: Single Dose||23
1568933|NCT01184859|3838093|P1|COMPLETED|Period 1: Single Dose||23
1568934|NCT01184859|3838089|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
1568935|NCT01184859|3838090|P4|Per Protocol (PP)|Period 1: Single Dose||21
1568936|NCT01184859|3838091|P3|Per Protocol (PP)|Period 1: Single Dose||22
1568937|NCT01184859|3838092|P2|Per Protocol (PP)|Period 1: Single Dose||23
1568938|NCT01184859|3838093|P1|Per Protocol (PP)|Period 1: Single Dose||23
1568939|NCT01184859|3838089|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
1568940|NCT01184859|3838090|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
1568941|NCT01184859|3838091|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
1568942|NCT01184859|3838092|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
1568943|NCT01184859|3838093|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
1568944|NCT01184859|3838089|P5|STARTED|Period 1: Single Dose||24
1568945|NCT01184859|3838090|P4|STARTED|Period 1: Single Dose||22
1568946|NCT01184859|3838091|P3|STARTED|Period 1: Single Dose||22
1568947|NCT01184859|3838092|P2|STARTED|Period 1: Single Dose||25
1568948|NCT01184859|3838093|P1|STARTED|Period 1: Single Dose||23
1568949|NCT01184846|3838185|P1|NOT COMPLETED|Overall Study||3
1568950|NCT01184846|3838185|P1|COMPLETED|Overall Study||25
1568951|NCT01184846|3838185|P1|STARTED|Overall Study||28
1568952|NCT01184755|3838206|P3|NOT COMPLETED|Overall Study||6
1568953|NCT01184755|3838207|P2|NOT COMPLETED|Overall Study||11
1568954|NCT01184755|3838208|P1|NOT COMPLETED|Overall Study||25
1568955|NCT01184755|3838206|P3|COMPLETED|Overall Study||56
1568956|NCT01184755|3838207|P2|COMPLETED|Overall Study||54
1568957|NCT01184755|3838208|P1|COMPLETED|Overall Study||101
1568958|NCT01184755|3838206|P3|STARTED|Overall Study||62
1568959|NCT01184755|3838207|P2|STARTED|Overall Study||65
1568960|NCT01184755|3838208|P1|STARTED|Overall Study||126
1568961|NCT01184508|3838218|P2|NOT COMPLETED|Overall Study||15
1568962|NCT01184508|3838219|P1|NOT COMPLETED|Overall Study||16
1568963|NCT01184508|3838218|P2|COMPLETED|Overall Study||27
1568964|NCT01184508|3838219|P1|COMPLETED|Overall Study||29
1568965|NCT01184508|3838218|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
1568966|NCT01184508|3838219|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
1568967|NCT01184508|3838218|P2|STARTED|Overall Study||42
1568968|NCT01184508|3838219|P1|STARTED|Overall Study||45
1568969|NCT01184417|3838246|P2|NOT COMPLETED|Overall Study||0
1568970|NCT01184417|3838247|P1|NOT COMPLETED|Overall Study||0
1568971|NCT01184417|3838246|P2|COMPLETED|Overall Study||51
1568972|NCT01184417|3838247|P1|COMPLETED|Overall Study||51
1568973|NCT01184417|3838246|P2|STARTED|Overall Study||51
1568974|NCT01184417|3838247|P1|STARTED|Overall Study||51
1568975|NCT01184326|3838267|P1|NOT COMPLETED|Overall Study||5
1568976|NCT01184326|3838267|P1|COMPLETED|Overall Study||18
1568977|NCT01184326|3838267|P1|STARTED|Overall Study||23
1568978|NCT01184118|3838275|P1|NOT COMPLETED|Overall Study||18
1568979|NCT01184118|3838275|P1|COMPLETED|Overall Study||18
1568980|NCT01184118|3838275|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
1568981|NCT01184118|3838275|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
1568982|NCT01184118|3838275|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
1568983|NCT01184118|3838275|P1|STARTED|Overall Study||36
1568984|NCT01184079|3838283|P2|NOT COMPLETED|Overall Study||2
1568985|NCT01184079|3838284|P1|NOT COMPLETED|Overall Study||14
1568986|NCT01184079|3838283|P2|COMPLETED|Overall Study||107
1568987|NCT01184079|3838284|P1|COMPLETED|Overall Study||97
1568988|NCT01184079|3838283|P2|Final Blood Draw|Overall Study||107
1568989|NCT01184079|3838284|P1|Final Blood Draw|Overall Study||97
1568990|NCT01184079|3838283|P2|Dose 3|Overall Study||107
1568991|NCT01184079|3838284|P1|Dose 3|Overall Study||101
1568992|NCT01184079|3838283|P2|Dose 2|Overall Study||108
1568993|NCT01184079|3838284|P1|Dose 2|Overall Study||110
1568994|NCT01184079|3838283|P2|STARTED|Overall Study||109
1568995|NCT01184079|3838284|P1|STARTED|Overall Study||111
1568996|NCT01184053|3838294|P1|NOT COMPLETED|Overall Study||3
1568997|NCT01184053|3838294|P1|COMPLETED|Overall Study||0
1568998|NCT01184053|3838294|P1|STARTED|Overall Study||3
1568999|NCT01184014|3838303|P2|NOT COMPLETED|Overall Study||6
1569000|NCT01184014|3838304|P1|NOT COMPLETED|Overall Study||5
1569001|NCT01184014|3838303|P2|COMPLETED|Overall Study||31
1569002|NCT01184014|3838304|P1|COMPLETED|Overall Study||30
1569003|NCT01184014|3838303|P2|STARTED|Overall Study||37
1569004|NCT01184014|3838304|P1|STARTED|Overall Study||35
1569005|NCT01183975|3838310|P1|NOT COMPLETED|Overall Study||73
1569006|NCT01183975|3838310|P1|COMPLETED|Overall Study||444
1569007|NCT01183975|3838310|P1|STARTED|Overall Study||517
1569008|NCT01183858|3838317|P2|NOT COMPLETED|Overall Study||156
1569009|NCT01183858|3838318|P1|NOT COMPLETED|Overall Study||153
1569010|NCT01183858|3838317|P2|COMPLETED|Overall Study||3
1569011|NCT01183858|3838318|P1|COMPLETED|Overall Study||1
1569012|NCT01183858|3838317|P2|Safety Population|Overall Study||158
1569013|NCT01183858|3838318|P1|Safety Population|Overall Study||154
1569014|NCT01183858|3838317|P2|STARTED|Overall Study||159
1569015|NCT01183858|3838318|P1|STARTED|Overall Study||154
1569016|NCT01183780|3838340|P2|NOT COMPLETED|Overall Study||25
1569017|NCT01183780|3838341|P1|NOT COMPLETED|Overall Study||31
1569018|NCT01183780|3838340|P2|COMPLETED|Overall Study||511
1569019|NCT01183780|3838341|P1|COMPLETED|Overall Study||505
1569020|NCT01183780|3838340|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
1569021|NCT01183780|3838341|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
1569022|NCT01183780|3838340|P2|STARTED|Overall Study||536
1569023|NCT01183780|3838341|P1|STARTED|Overall Study||536
1569024|NCT01183728|3838358|P1|NOT COMPLETED|Overall Study||0
1569025|NCT01183728|3838358|P1|COMPLETED|Overall Study||12
1569026|NCT01183728|3838358|P1|STARTED|Overall Study||12
1569027|NCT01183689|3838366|P3|NOT COMPLETED|Overall Study||0
1569028|NCT01183689|3838367|P2|NOT COMPLETED|Overall Study||0
1569029|NCT01183689|3838368|P1|NOT COMPLETED|Overall Study||0
1569030|NCT01183689|3838366|P3|COMPLETED|Overall Study||197
1569031|NCT01183689|3838367|P2|COMPLETED|Overall Study||200
1569032|NCT01183689|3838368|P1|COMPLETED|Overall Study||202
1569033|NCT01183689|3838366|P3|Year 4 Visit|Overall Study||30
1569034|NCT01183689|3838367|P2|Year 4 Visit|Overall Study||33
1569035|NCT01183689|3838368|P1|Year 4 Visit|Overall Study||38
1569036|NCT01183689|3838366|P3|Year 3 Visit|Overall Study||126
1569037|NCT01183689|3838367|P2|Year 3 Visit|Overall Study||125
1569038|NCT01183689|3838368|P1|Year 3 Visit|Overall Study||139
1569039|NCT01183689|3838366|P3|Year 2 Visit|Overall Study||174
1569040|NCT01183689|3838367|P2|Year 2 Visit|Overall Study||172
1569041|NCT01183689|3838368|P1|Year 2 Visit|Overall Study||178
1569042|NCT01183689|3838366|P3|Year 1 Visit|Overall Study||183
1569043|NCT01183689|3838367|P2|Year 1 Visit|Overall Study||172
1569044|NCT01183689|3838368|P1|Year 1 Visit|Overall Study||187
1569045|NCT01183689|3838366|P3|Month 4 Visit|Overall Study||187
1569046|NCT01183689|3838367|P2|Month 4 Visit|Overall Study||192
1569047|NCT01183689|3838368|P1|Month 4 Visit|Overall Study||197
1569048|NCT01183689|3838366|P3|STARTED|Overall Study||197
1569049|NCT01183689|3838367|P2|STARTED|Overall Study||200
1569050|NCT01183689|3838368|P1|STARTED|Overall Study||202
1569051|NCT01183650|3838438|P2|NOT COMPLETED|Overall Study||0
1569052|NCT01183650|3838439|P1|NOT COMPLETED|Overall Study||0
1569053|NCT01183650|3838438|P2|COMPLETED|Overall Study||12
1569054|NCT01183650|3838439|P1|COMPLETED|Overall Study||12
1569055|NCT01183650|3838438|P2|STARTED|Overall Study||12
1569056|NCT01183650|3838439|P1|STARTED|Overall Study||12
1569057|NCT01183546|3838449|P1|NOT COMPLETED|Overall Study||0
1569058|NCT01183546|3838449|P1|COMPLETED|Overall Study||53
1569059|NCT01183546|3838449|P1|STARTED|Overall Study||53
1569060|NCT01183533|3838456|P1|NOT COMPLETED|Overall Study||0
1569061|NCT01183533|3838456|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
1569062|NCT01183533|3838456|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
1569063|NCT01183481|3838462|P1|NOT COMPLETED|Overall Study||0
1569064|NCT01183481|3838462|P1|COMPLETED|Overall Study||19
1569065|NCT01183481|3838462|P1|STARTED|Overall Study||19
1569066|NCT01183468|3838474|P4|NOT COMPLETED|Overall Study||0
1569067|NCT01183468|3838475|P3|NOT COMPLETED|Overall Study||0
1569068|NCT01183468|3838476|P2|NOT COMPLETED|Overall Study||2
1569069|NCT01183468|3838477|P1|NOT COMPLETED|Overall Study||3
1569070|NCT01183468|3838474|P4|COMPLETED|Overall Study||0
1569071|NCT01183468|3838475|P3|COMPLETED|Overall Study||0
1569072|NCT01183468|3838476|P2|COMPLETED|Overall Study||7
1569073|NCT01183468|3838477|P1|COMPLETED|Overall Study||5
1569074|NCT01183468|3838474|P4|STARTED|Overall Study||0
1569075|NCT01183468|3838475|P3|STARTED|Overall Study||0
1569076|NCT01183468|3838476|P2|STARTED|Overall Study||9
1569077|NCT01183468|3838477|P1|STARTED|Overall Study||8
1569078|NCT01183390|3838487|P2|NOT COMPLETED|Second Intervention||0
1569079|NCT01183390|3838488|P1|NOT COMPLETED|Second Intervention||0
1569080|NCT01183390|3838487|P2|COMPLETED|Second Intervention||10
1569081|NCT01183390|3838488|P1|COMPLETED|Second Intervention||11
1569082|NCT01183390|3838487|P2|STARTED|Second Intervention||10
1569083|NCT01183390|3838488|P1|STARTED|Second Intervention||11
1569084|NCT01183390|3838487|P2|NOT COMPLETED|Washout of 21 Days||0
1569085|NCT01183390|3838488|P1|NOT COMPLETED|Washout of 21 Days||0
1569086|NCT01183390|3838487|P2|COMPLETED|Washout of 21 Days||10
1569087|NCT01183390|3838488|P1|COMPLETED|Washout of 21 Days||11
1569088|NCT01183390|3838487|P2|STARTED|Washout of 21 Days||10
1569089|NCT01183390|3838488|P1|STARTED|Washout of 21 Days||11
1569090|NCT01183390|3838487|P2|NOT COMPLETED|First Intervention||1
1569091|NCT01183390|3838488|P1|NOT COMPLETED|First Intervention||0
1569092|NCT01183390|3838487|P2|COMPLETED|First Intervention||10
1569093|NCT01183390|3838488|P1|COMPLETED|First Intervention||11
1569094|NCT01183390|3838487|P2|STARTED|First Intervention||11
1569095|NCT01183390|3838488|P1|STARTED|First Intervention||11
1569096|NCT01183312|3838498|P2|NOT COMPLETED|Second Intervention Day||0
1569097|NCT01183312|3838499|P1|NOT COMPLETED|Second Intervention Day||0
1569098|NCT01183312|3838498|P2|COMPLETED|Second Intervention Day||5
1569099|NCT01183312|3838499|P1|COMPLETED|Second Intervention Day||5
1569100|NCT01183312|3838498|P2|STARTED|Second Intervention Day||5
1569101|NCT01183312|3838499|P1|STARTED|Second Intervention Day||5
1569102|NCT01183312|3838498|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
1569103|NCT01183312|3838499|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
1569104|NCT01183312|3838498|P2|COMPLETED|Washout Period of at Least 1 Week||5
1569105|NCT01183312|3838499|P1|COMPLETED|Washout Period of at Least 1 Week||5
1569106|NCT01183312|3838498|P2|STARTED|Washout Period of at Least 1 Week||5
1569107|NCT01183312|3838499|P1|STARTED|Washout Period of at Least 1 Week||5
1569108|NCT01183312|3838498|P2|NOT COMPLETED|First Intervention Day||0
1569109|NCT01183312|3838499|P1|NOT COMPLETED|First Intervention Day||0
1569110|NCT01183312|3838498|P2|COMPLETED|First Intervention Day||5
1569111|NCT01183312|3838499|P1|COMPLETED|First Intervention Day||5
1569112|NCT01183312|3838498|P2|STARTED|First Intervention Day||5
1569113|NCT01183312|3838499|P1|STARTED|First Intervention Day||5
1569114|NCT01183260|3838521|P2|NOT COMPLETED|Overall Study||2
1569115|NCT01183260|3838522|P1|NOT COMPLETED|Overall Study||4
1569116|NCT01183260|3838521|P2|COMPLETED|Overall Study||9
1569117|NCT01183260|3838522|P1|COMPLETED|Overall Study||10
1569118|NCT01183260|3838521|P2|STARTED|Overall Study||11
1569119|NCT01183260|3838522|P1|STARTED|Overall Study||14
1569120|NCT01183234|3838532|P2|NOT COMPLETED|Second Intervention||0
1569121|NCT01183234|3838533|P1|NOT COMPLETED|Second Intervention||0
1569122|NCT01183234|3838532|P2|COMPLETED|Second Intervention||14
1569123|NCT01183234|3838533|P1|COMPLETED|Second Intervention||13
1569124|NCT01183234|3838532|P2|STARTED|Second Intervention||14
1569125|NCT01183234|3838533|P1|STARTED|Second Intervention||13
1569126|NCT01183234|3838532|P2|NOT COMPLETED|Washout||0
1569127|NCT01183234|3838533|P1|NOT COMPLETED|Washout||0
1569128|NCT01183234|3838532|P2|COMPLETED|Washout||14
1569129|NCT01183234|3838533|P1|COMPLETED|Washout||13
1569130|NCT01183234|3838532|P2|STARTED|Washout||14
1569131|NCT01183234|3838533|P1|STARTED|Washout||13
1569132|NCT01183234|3838532|P2|NOT COMPLETED|First Intervention||0
1569133|NCT01183234|3838533|P1|NOT COMPLETED|First Intervention||1
1569134|NCT01183234|3838532|P2|COMPLETED|First Intervention||14
1569135|NCT01183234|3838533|P1|COMPLETED|First Intervention||13
1569136|NCT01183234|3838532|P2|STARTED|First Intervention||14
1569137|NCT01183234|3838533|P1|STARTED|First Intervention||14
1569138|NCT01183169|3838547|P7|NOT COMPLETED|Post-switch Phase||9
1569139|NCT01183169|3838548|P6|NOT COMPLETED|Post-switch Phase||14
1569140|NCT01183169|3838549|P5|NOT COMPLETED|Post-switch Phase||0
1569141|NCT01183169|3838550|P4|NOT COMPLETED|Post-switch Phase||0
1569142|NCT01183169|3838551|P3|NOT COMPLETED|Post-switch Phase||0
1569143|NCT01183169|3838552|P2|NOT COMPLETED|Post-switch Phase||0
1569144|NCT01183169|3838553|P1|NOT COMPLETED|Post-switch Phase||0
1569145|NCT01183169|3838547|P7|COMPLETED|Post-switch Phase||21
1569146|NCT01183169|3838548|P6|COMPLETED|Post-switch Phase||21
1569147|NCT01183169|3838549|P5|COMPLETED|Post-switch Phase||0
1569148|NCT01183169|3838550|P4|COMPLETED|Post-switch Phase||0
1569149|NCT01183169|3838551|P3|COMPLETED|Post-switch Phase||0
1569150|NCT01183169|3838552|P2|COMPLETED|Post-switch Phase||0
1569151|NCT01183169|3838553|P1|COMPLETED|Post-switch Phase||0
1569152|NCT01183169|3838547|P7|Completed Treatment|Post-switch Phase||13
1569153|NCT01183169|3838548|P6|Completed Treatment|Post-switch Phase||12
1569154|NCT01183169|3838549|P5|Completed Treatment|Post-switch Phase||0
1569155|NCT01183169|3838550|P4|Completed Treatment|Post-switch Phase||0
1569156|NCT01183169|3838551|P3|Completed Treatment|Post-switch Phase||0
1569157|NCT01183169|3838552|P2|Completed Treatment|Post-switch Phase||0
1569158|NCT01183169|3838553|P1|Completed Treatment|Post-switch Phase||0
1569159|NCT01183169|3838547|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
1569160|NCT01183169|3838548|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
1569161|NCT01183169|3838549|P5|STARTED|Post-switch Phase|Not a post-switch group|0
1569162|NCT01183169|3838550|P4|STARTED|Post-switch Phase|Not a post-switch group|0
1569163|NCT01183169|3838551|P3|STARTED|Post-switch Phase|Not a post-switch group|0
1569164|NCT01183169|3838552|P2|STARTED|Post-switch Phase|Not a post-switch group|0
1569165|NCT01183169|3838553|P1|STARTED|Post-switch Phase|Not a post-switch group|0
1569166|NCT01183169|3838547|P7|NOT COMPLETED|Main Phase||0
1569167|NCT01183169|3838548|P6|NOT COMPLETED|Main Phase||0
1569168|NCT01183169|3838549|P5|NOT COMPLETED|Main Phase||26
1569169|NCT01183169|3838550|P4|NOT COMPLETED|Main Phase||37
1569170|NCT01183169|3838551|P3|NOT COMPLETED|Main Phase||41
1569171|NCT01183169|3838552|P2|NOT COMPLETED|Main Phase||22
1569172|NCT01183169|3838553|P1|NOT COMPLETED|Main Phase||27
1569173|NCT01183169|3838547|P7|COMPLETED|Main Phase||0
1569174|NCT01183169|3838548|P6|COMPLETED|Main Phase||0
1569175|NCT01183169|3838549|P5|COMPLETED|Main Phase||83
1569176|NCT01183169|3838550|P4|COMPLETED|Main Phase||18
1569177|NCT01183169|3838551|P3|COMPLETED|Main Phase||18
1569178|NCT01183169|3838552|P2|COMPLETED|Main Phase||93
1569179|NCT01183169|3838553|P1|COMPLETED|Main Phase||94
1569180|NCT01183169|3838547|P7|Switched to ALV|Main Phase||0
1569181|NCT01183169|3838548|P6|Switched to ALV|Main Phase||0
1569182|NCT01183169|3838549|P5|Switched to ALV|Main Phase||0
1569183|NCT01183169|3838550|P4|Switched to ALV|Main Phase||30
1569184|NCT01183169|3838551|P3|Switched to ALV|Main Phase||35
1569185|NCT01183169|3838552|P2|Switched to ALV|Main Phase||0
1569186|NCT01183169|3838553|P1|Switched to ALV|Main Phase||0
1569187|NCT01183169|3838547|P7|Completed Treatment|Main Phase||0
1569188|NCT01183169|3838548|P6|Completed Treatment|Main Phase||0
1569189|NCT01183169|3838549|P5|Completed Treatment|Main Phase||77
1569190|NCT01183169|3838550|P4|Completed Treatment|Main Phase||17
1569191|NCT01183169|3838551|P3|Completed Treatment|Main Phase||17
1569192|NCT01183169|3838552|P2|Completed Treatment|Main Phase||78
1569193|NCT01183169|3838553|P1|Completed Treatment|Main Phase||72
1569194|NCT01183169|3838547|P7|STARTED|Main Phase||0
1569195|NCT01183169|3838548|P6|STARTED|Main Phase||0
1569196|NCT01183169|3838549|P5|STARTED|Main Phase||109
1569197|NCT01183169|3838550|P4|STARTED|Main Phase||55
1569198|NCT01183169|3838551|P3|STARTED|Main Phase||59
1569199|NCT01183169|3838552|P2|STARTED|Main Phase||115
1569200|NCT01183169|3838553|P1|STARTED|Main Phase||121
1569201|NCT01183143|3838625|P1|NOT COMPLETED|Overall Study||150
1569202|NCT01183143|3838625|P1|COMPLETED|Overall Study||65
1569203|NCT01183143|3838625|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
1569204|NCT01183143|3838625|P1|STARTED|Overall Study||215
1569205|NCT01183104|3838641|P2|NOT COMPLETED|Overall Study||92
1569206|NCT01183104|3838642|P1|NOT COMPLETED|Overall Study||77
1569207|NCT01183104|3838641|P2|COMPLETED|Overall Study||60
1569208|NCT01183104|3838642|P1|COMPLETED|Overall Study||76
1569209|NCT01183104|3838641|P2|Enrolled in Extension Study|Overall Study||61
1569210|NCT01183104|3838642|P1|Enrolled in Extension Study|Overall Study||80
1569211|NCT01183104|3838641|P2|Completed 52-week Treatment|Overall Study||111
1569212|NCT01183104|3838642|P1|Completed 52-week Treatment|Overall Study||119
1569213|NCT01183104|3838641|P2|Continued Treatment for 12 Weeks|Overall Study||129
1569214|NCT01183104|3838642|P1|Continued Treatment for 12 Weeks|Overall Study||143
1569215|NCT01183104|3838641|P2|Received Study Drug|Overall Study||143
1569216|NCT01183104|3838642|P1|Received Study Drug|Overall Study||148
1569217|NCT01183104|3838641|P2|STARTED|Overall Study||152
1569218|NCT01183104|3838642|P1|STARTED|Overall Study||153
1569219|NCT01183065|3838658|P1|NOT COMPLETED|Overall Study||1
1569220|NCT01183065|3838658|P1|COMPLETED|Overall Study||12
1569221|NCT01183065|3838658|P1|STARTED|Overall Study||13
1569222|NCT01183013|3838669|P7|NOT COMPLETED|Overall Study||37
1569223|NCT01183013|3838670|P6|NOT COMPLETED|Overall Study||45
1569224|NCT01183013|3838671|P5|NOT COMPLETED|Overall Study||36
1569225|NCT01183013|3838672|P4|NOT COMPLETED|Overall Study||30
1569226|NCT01183013|3838673|P3|NOT COMPLETED|Overall Study||41
1569227|NCT01183013|3838674|P2|NOT COMPLETED|Overall Study||39
1569228|NCT01183013|3838675|P1|NOT COMPLETED|Overall Study||45
1569229|NCT01183013|3838669|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
1569230|NCT01183013|3838670|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
1569231|NCT01183013|3838671|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
1569232|NCT01183013|3838672|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
1569233|NCT01183013|3838673|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
1569234|NCT01183013|3838674|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
1569235|NCT01183013|3838675|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
1569236|NCT01183013|3838669|P7|STARTED|Overall Study||133
1569237|NCT01183013|3838670|P6|STARTED|Overall Study||133
1569238|NCT01183013|3838671|P5|STARTED|Overall Study||126
1569239|NCT01183013|3838672|P4|STARTED|Overall Study||135
1569240|NCT01183013|3838673|P3|STARTED|Overall Study||138
1569241|NCT01183013|3838674|P2|STARTED|Overall Study||140
1569242|NCT01183013|3838675|P1|STARTED|Overall Study||131
1569243|NCT01182805|3838754|P1|NOT COMPLETED|Overall Study||0
1569244|NCT01182805|3838754|P1|COMPLETED|Overall Study||50
1569245|NCT01182805|3838754|P1|STARTED|Overall Study||50
1569246|NCT01182727|3838763|P1|NOT COMPLETED|Overall Study||0
1569247|NCT01182727|3838763|P1|COMPLETED|Overall Study||10
1569248|NCT01182727|3838763|P1|STARTED|Overall Study||10
1569249|NCT01182675|3838769|P2|NOT COMPLETED|Overall Study||0
1569250|NCT01182675|3838770|P1|NOT COMPLETED|Overall Study||0
1569251|NCT01182675|3838769|P2|COMPLETED|Overall Study||0
1569252|NCT01182675|3838770|P1|COMPLETED|Overall Study||7
1569253|NCT01182675|3838769|P2|STARTED|Overall Study||0
1569254|NCT01182675|3838770|P1|STARTED|Overall Study||7
1569255|NCT01182610|3838786|P1|NOT COMPLETED|Overall Study||0
1569256|NCT01182610|3838786|P1|COMPLETED|Overall Study||1
1569257|NCT01182610|3838786|P1|STARTED|Overall Study||1
1569258|NCT01182493|3838796|P2|NOT COMPLETED|Overall Study||7
1569259|NCT01182493|3838797|P1|NOT COMPLETED|Overall Study||16
1569260|NCT01182493|3838796|P2|COMPLETED|Overall Study||156
1569261|NCT01182493|3838797|P1|COMPLETED|Overall Study||152
1569262|NCT01182493|3838796|P2|STARTED|Overall Study||163
1569263|NCT01182493|3838797|P1|STARTED|Overall Study||168
1569264|NCT01182480|3838815|P1|NOT COMPLETED|Overall Study||0
1569265|NCT01182480|3838815|P1|COMPLETED|Overall Study||47
1569266|NCT01182480|3838815|P1|STARTED|Overall Study||47
1569267|NCT01182441|3838821|P2|NOT COMPLETED|Overall Study||119
1569268|NCT01182441|3838822|P1|NOT COMPLETED|Overall Study||220
1569269|NCT01182441|3838821|P2|COMPLETED|Overall Study||19
1569270|NCT01182441|3838822|P1|COMPLETED|Overall Study||49
1569271|NCT01182441|3838821|P2|STARTED|Overall Study||138
1569272|NCT01182441|3838822|P1|STARTED|Overall Study||269
1569273|NCT01182428|3838833|P2|NOT COMPLETED|Overall Study||1
1569274|NCT01182428|3838834|P1|NOT COMPLETED|Overall Study||11
1569275|NCT01182428|3838833|P2|COMPLETED|Overall Study||150
1569276|NCT01182428|3838834|P1|COMPLETED|Overall Study||293
1569277|NCT01182428|3838833|P2|STARTED|Overall Study||151
1569278|NCT01182428|3838834|P1|STARTED|Overall Study||304
1569279|NCT01182415|3838898|P1|NOT COMPLETED|Overall Study||1
1569280|NCT01182415|3838898|P1|COMPLETED|Overall Study||29
1569281|NCT01182415|3838898|P1|STARTED|Overall Study||30
1569282|NCT01182376|3838907|P2|NOT COMPLETED|Overall Study||5
1569283|NCT01182376|3838908|P1|NOT COMPLETED|Overall Study||11
1569284|NCT01182376|3838907|P2|COMPLETED|Overall Study||13
1569285|NCT01182376|3838908|P1|COMPLETED|Overall Study||4
1569286|NCT01182376|3838907|P2|STARTED|Overall Study||18
1569287|NCT01182376|3838908|P1|STARTED|Overall Study||15
1569288|NCT01182337|3838916|P2|NOT COMPLETED|Overall Study||2
1569289|NCT01182337|3838917|P1|NOT COMPLETED|Overall Study||3
1569290|NCT01182337|3838916|P2|COMPLETED|Overall Study||7
1569291|NCT01182337|3838917|P1|COMPLETED|Overall Study||19
1569292|NCT01182337|3838916|P2|STARTED|Overall Study||9
1569293|NCT01182337|3838917|P1|STARTED|Overall Study||22
1569294|NCT01182298|3838935|P1|NOT COMPLETED|Overall Study||6
1569295|NCT01182298|3838935|P1|COMPLETED|Overall Study||4
1569296|NCT01182298|3838935|P1|STARTED|Overall Study||10
1569297|NCT01182285|3838939|P3|NOT COMPLETED|Third Intervention Week 11-52||8
1569298|NCT01182285|3838940|P2|NOT COMPLETED|Third Intervention Week 11-52||0
1569299|NCT01182285|3838941|P1|NOT COMPLETED|Third Intervention Week 11-52||0
1569300|NCT01182285|3838939|P3|COMPLETED|Third Intervention Week 11-52||0
1569301|NCT01182285|3838940|P2|COMPLETED|Third Intervention Week 11-52||0
1569302|NCT01182285|3838941|P1|COMPLETED|Third Intervention Week 11-52||0
1569303|NCT01182285|3838939|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
1569304|NCT01182285|3838940|P2|STARTED|Third Intervention Week 11-52||0
1569305|NCT01182285|3838941|P1|STARTED|Third Intervention Week 11-52||0
1569306|NCT01182285|3838939|P3|NOT COMPLETED|Second Intervention Week 11-17||0
1569307|NCT01182285|3838940|P2|NOT COMPLETED|Second Intervention Week 11-17||0
1569308|NCT01182285|3838941|P1|NOT COMPLETED|Second Intervention Week 11-17||0
1569309|NCT01182285|3838939|P3|COMPLETED|Second Intervention Week 11-17||0
1569310|NCT01182285|3838940|P2|COMPLETED|Second Intervention Week 11-17||0
1569311|NCT01182285|3838941|P1|COMPLETED|Second Intervention Week 11-17||0
1569312|NCT01182285|3838939|P3|STARTED|Second Intervention Week 11-17||0
1569313|NCT01182285|3838940|P2|STARTED|Second Intervention Week 11-17||0
1569314|NCT01182285|3838941|P1|STARTED|Second Intervention Week 11-17||0
1569315|NCT01182285|3838939|P3|NOT COMPLETED|First Intervention Week 1-10||0
1569316|NCT01182285|3838940|P2|NOT COMPLETED|First Intervention Week 1-10||0
1569317|NCT01182285|3838941|P1|NOT COMPLETED|First Intervention Week 1-10||3
1569318|NCT01182285|3838939|P3|COMPLETED|First Intervention Week 1-10||0
1569319|NCT01182285|3838940|P2|COMPLETED|First Intervention Week 1-10||0
1569320|NCT01182285|3838941|P1|COMPLETED|First Intervention Week 1-10||10
1569321|NCT01182285|3838939|P3|STARTED|First Intervention Week 1-10||0
1569322|NCT01182285|3838940|P2|STARTED|First Intervention Week 1-10||0
1569323|NCT01182285|3838941|P1|STARTED|First Intervention Week 1-10||13
1569324|NCT01182207|3838951|P2|NOT COMPLETED|Second Intervention||0
1569325|NCT01182207|3838952|P1|NOT COMPLETED|Second Intervention||1
1569326|NCT01182207|3838951|P2|COMPLETED|Second Intervention||14
1569327|NCT01182207|3838952|P1|COMPLETED|Second Intervention||17
1569328|NCT01182207|3838951|P2|STARTED|Second Intervention||14
1569329|NCT01182207|3838952|P1|STARTED|Second Intervention||18
1569330|NCT01182207|3838951|P2|NOT COMPLETED|Washout of 28 Days||0
1569331|NCT01182207|3838952|P1|NOT COMPLETED|Washout of 28 Days||0
1569332|NCT01182207|3838951|P2|COMPLETED|Washout of 28 Days||14
1569333|NCT01182207|3838952|P1|COMPLETED|Washout of 28 Days||18
1569334|NCT01182207|3838951|P2|STARTED|Washout of 28 Days||14
1569335|NCT01182207|3838952|P1|STARTED|Washout of 28 Days||18
1569336|NCT01182207|3838951|P2|NOT COMPLETED|First Intervention||1
1569337|NCT01182207|3838952|P1|NOT COMPLETED|First Intervention||0
1569338|NCT01182207|3838951|P2|COMPLETED|First Intervention||14
1569339|NCT01182207|3838952|P1|COMPLETED|First Intervention||18
1569340|NCT01182207|3838951|P2|STARTED|First Intervention||15
1569341|NCT01182207|3838952|P1|STARTED|First Intervention||18
1569342|NCT01182194|3838970|P2|NOT COMPLETED|Second Intervention||0
1569343|NCT01182194|3838971|P1|NOT COMPLETED|Second Intervention||0
1569344|NCT01182194|3838970|P2|COMPLETED|Second Intervention||16
1569345|NCT01182194|3838971|P1|COMPLETED|Second Intervention||15
1569346|NCT01182194|3838970|P2|STARTED|Second Intervention||16
1569347|NCT01182194|3838971|P1|STARTED|Second Intervention||15
1569348|NCT01182194|3838970|P2|NOT COMPLETED|Washout of 28 Days||0
1569349|NCT01182194|3838971|P1|NOT COMPLETED|Washout of 28 Days||1
1569350|NCT01182194|3838970|P2|COMPLETED|Washout of 28 Days||16
1569351|NCT01182194|3838971|P1|COMPLETED|Washout of 28 Days||15
1569352|NCT01182194|3838970|P2|STARTED|Washout of 28 Days||16
1569353|NCT01182194|3838971|P1|STARTED|Washout of 28 Days||16
1569354|NCT01182194|3838970|P2|NOT COMPLETED|First Intervention||0
1569355|NCT01182194|3838971|P1|NOT COMPLETED|First Intervention||0
1569356|NCT01182194|3838970|P2|COMPLETED|First Intervention||16
1569357|NCT01182194|3838971|P1|COMPLETED|First Intervention||16
1569358|NCT01182194|3838970|P2|STARTED|First Intervention||16
1569359|NCT01182194|3838971|P1|STARTED|First Intervention||16
1569360|NCT01182181|3838989|P2|NOT COMPLETED|Second Intervention||0
1569361|NCT01182181|3838990|P1|NOT COMPLETED|Second Intervention||0
1569362|NCT01182181|3838989|P2|COMPLETED|Second Intervention||10
1569363|NCT01182181|3838990|P1|COMPLETED|Second Intervention||10
1569364|NCT01182181|3838989|P2|STARTED|Second Intervention||10
1569365|NCT01182181|3838990|P1|STARTED|Second Intervention||10
1569366|NCT01182181|3838989|P2|NOT COMPLETED|Washout of 21 Days||1
1569367|NCT01182181|3838990|P1|NOT COMPLETED|Washout of 21 Days||0
1569368|NCT01182181|3838989|P2|COMPLETED|Washout of 21 Days||10
1569369|NCT01182181|3838990|P1|COMPLETED|Washout of 21 Days||10
1569370|NCT01182181|3838989|P2|STARTED|Washout of 21 Days||11
1569371|NCT01182181|3838990|P1|STARTED|Washout of 21 Days||10
1569372|NCT01182181|3838989|P2|NOT COMPLETED|First Intervention||0
1569373|NCT01182181|3838990|P1|NOT COMPLETED|First Intervention||1
1569374|NCT01182181|3838989|P2|COMPLETED|First Intervention||11
1569375|NCT01182181|3838990|P1|COMPLETED|First Intervention||10
1569376|NCT01182181|3838989|P2|STARTED|First Intervention||11
1569377|NCT01182181|3838990|P1|STARTED|First Intervention||11
1569378|NCT01182103|3839000|P2|NOT COMPLETED|Overall Study||0
1569379|NCT01182103|3839001|P1|NOT COMPLETED|Overall Study||0
1569380|NCT01182103|3839000|P2|COMPLETED|Overall Study||62
1569381|NCT01182103|3839001|P1|COMPLETED|Overall Study||48
1569382|NCT01182103|3839000|P2|STARTED|Overall Study||62
1569383|NCT01182103|3839001|P1|STARTED|Overall Study||48
1569384|NCT01181986|3839015|P3|NOT COMPLETED|Phase 2||0
1569385|NCT01181986|3839016|P2|NOT COMPLETED|Phase 2||4
1569386|NCT01181986|3839017|P1|NOT COMPLETED|Phase 2||0
1569387|NCT01181986|3839015|P3|COMPLETED|Phase 2||0
1569388|NCT01181986|3839016|P2|COMPLETED|Phase 2||18
1569389|NCT01181986|3839017|P1|COMPLETED|Phase 2||18
1569390|NCT01181986|3839015|P3|STARTED|Phase 2|N/A for Sub-study 2|0
1569391|NCT01181986|3839016|P2|STARTED|Phase 2||22
1569392|NCT01181986|3839017|P1|STARTED|Phase 2||18
1569393|NCT01181986|3839015|P3|NOT COMPLETED|Phase 1||2
1569394|NCT01181986|3839016|P2|NOT COMPLETED|Phase 1||1
1569395|NCT01181986|3839017|P1|NOT COMPLETED|Phase 1||1
1569396|NCT01181986|3839015|P3|COMPLETED|Phase 1||32
1569397|NCT01181986|3839016|P2|COMPLETED|Phase 1||22
1569398|NCT01181986|3839017|P1|COMPLETED|Phase 1||18
1569399|NCT01181986|3839015|P3|Exendin-9+Exenatide|Phase 1||33
1569400|NCT01181986|3839016|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
1569401|NCT01181986|3839017|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
1569402|NCT01181986|3839015|P3|Saline+Placebo|Phase 1||33
1569403|NCT01181986|3839016|P2|Saline+Placebo|Phase 1|N/A for this arm|0
1569404|NCT01181986|3839017|P1|Saline+Placebo|Phase 1|N/A for this arm|0
1569405|NCT01181986|3839015|P3|Saline+Exenatide|Phase 1||32
1569406|NCT01181986|3839016|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
1569407|NCT01181986|3839017|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
1569408|NCT01181986|3839015|P3|STARTED|Phase 1||34
1569409|NCT01181986|3839016|P2|STARTED|Phase 1||23
1569410|NCT01181986|3839017|P1|STARTED|Phase 1||19
1569411|NCT01181947|3839033|P1|NOT COMPLETED|Overall Study||0
1569412|NCT01181947|3839033|P1|COMPLETED|Overall Study||100
1569413|NCT01181947|3839033|P1|STARTED|Overall Study||100
1569414|NCT01181921|3839038|P1|NOT COMPLETED|Overall Study||1
1569415|NCT01181921|3839038|P1|COMPLETED|Overall Study||0
1569416|NCT01181921|3839038|P1|STARTED|Overall Study||1
1569417|NCT01181895|3839045|P3|NOT COMPLETED|Overall Study||18
1569418|NCT01181895|3839046|P2|NOT COMPLETED|Overall Study||14
1569419|NCT01181895|3839047|P1|NOT COMPLETED|Overall Study||17
1569420|NCT01181895|3839045|P3|COMPLETED|Overall Study||98
1569421|NCT01181895|3839046|P2|COMPLETED|Overall Study||101
1569422|NCT01181895|3839047|P1|COMPLETED|Overall Study||99
1569423|NCT01181895|3839045|P3|STARTED|Overall Study||116
1569424|NCT01181895|3839046|P2|STARTED|Overall Study||115
1569425|NCT01181895|3839047|P1|STARTED|Overall Study||116
1569426|NCT01181804|3839080|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
1569427|NCT01181804|3839081|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
1569428|NCT01181804|3839082|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
1569429|NCT01181804|3839083|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
1569430|NCT01181804|3839080|P4|COMPLETED|Period 4, Fasted (Part 2)||58
1569431|NCT01181804|3839081|P3|COMPLETED|Period 4, Fasted (Part 2)||58
1569432|NCT01181804|3839082|P2|COMPLETED|Period 4, Fasted (Part 2)||0
1569433|NCT01181804|3839083|P1|COMPLETED|Period 4, Fasted (Part 2)||0
1569434|NCT01181804|3839080|P4|STARTED|Period 4, Fasted (Part 2)||58
1569435|NCT01181804|3839081|P3|STARTED|Period 4, Fasted (Part 2)||59
1569436|NCT01181804|3839082|P2|STARTED|Period 4, Fasted (Part 2)||0
1569437|NCT01181804|3839083|P1|STARTED|Period 4, Fasted (Part 2)||0
1569438|NCT01181804|3839080|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1569439|NCT01181804|3839081|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1569440|NCT01181804|3839082|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1569441|NCT01181804|3839083|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1569442|NCT01181804|3839080|P4|COMPLETED|Period 3, Fasted (Part 2)||58
1569443|NCT01181804|3839081|P3|COMPLETED|Period 3, Fasted (Part 2)||59
1569444|NCT01181804|3839082|P2|COMPLETED|Period 3, Fasted (Part 2)||0
1569445|NCT01181804|3839083|P1|COMPLETED|Period 3, Fasted (Part 2)||0
1569446|NCT01181804|3839080|P4|STARTED|Period 3, Fasted (Part 2)||58
1569447|NCT01181804|3839081|P3|STARTED|Period 3, Fasted (Part 2)||59
1569448|NCT01181804|3839082|P2|STARTED|Period 3, Fasted (Part 2)||0
1569449|NCT01181804|3839083|P1|STARTED|Period 3, Fasted (Part 2)||0
1569450|NCT01181804|3839080|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
1569451|NCT01181804|3839081|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
1569452|NCT01181804|3839082|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
1569453|NCT01181804|3839083|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
1569454|NCT01181804|3839080|P4|COMPLETED|Period 2, Fed (Part 1)||0
1569455|NCT01181804|3839081|P3|COMPLETED|Period 2, Fed (Part 1)||0
1569456|NCT01181804|3839082|P2|COMPLETED|Period 2, Fed (Part 1)||30
1569457|NCT01181804|3839083|P1|COMPLETED|Period 2, Fed (Part 1)||30
1569458|NCT01181804|3839080|P4|STARTED|Period 2, Fed (Part 1)||0
1569459|NCT01181804|3839081|P3|STARTED|Period 2, Fed (Part 1)||0
1569460|NCT01181804|3839082|P2|STARTED|Period 2, Fed (Part 1)||30
1569461|NCT01181804|3839083|P1|STARTED|Period 2, Fed (Part 1)||30
1569462|NCT01181804|3839080|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
1569463|NCT01181804|3839081|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
1569464|NCT01181804|3839082|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
1569465|NCT01181804|3839083|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
1569466|NCT01181804|3839080|P4|COMPLETED|Period 1, Fed (Part 1)||0
1569467|NCT01181804|3839081|P3|COMPLETED|Period 1, Fed (Part 1)||0
1569468|NCT01181804|3839082|P2|COMPLETED|Period 1, Fed (Part 1)||30
1569469|NCT01181804|3839083|P1|COMPLETED|Period 1, Fed (Part 1)||30
1569470|NCT01181804|3839080|P4|STARTED|Period 1, Fed (Part 1)||0
1569471|NCT01181804|3839081|P3|STARTED|Period 1, Fed (Part 1)||0
1569472|NCT01181804|3839082|P2|STARTED|Period 1, Fed (Part 1)||30
1569473|NCT01181804|3839083|P1|STARTED|Period 1, Fed (Part 1)||30
1569474|NCT01181778|3839105|P1|NOT COMPLETED|Overall Study||48
1569475|NCT01181778|3839105|P1|COMPLETED|Overall Study||1871
1569476|NCT01181778|3839105|P1|STARTED|Overall Study||1919
1569477|NCT01181726|3839113|P2|NOT COMPLETED|Second Intervention||0
1569478|NCT01181726|3839114|P1|NOT COMPLETED|Second Intervention||0
1569479|NCT01181726|3839113|P2|COMPLETED|Second Intervention||20
1569480|NCT01181726|3839114|P1|COMPLETED|Second Intervention||19
1569481|NCT01181726|3839113|P2|STARTED|Second Intervention||20
1569482|NCT01181726|3839114|P1|STARTED|Second Intervention||19
1569483|NCT01181726|3839113|P2|NOT COMPLETED|Washout of 28 Days||0
1569484|NCT01181726|3839114|P1|NOT COMPLETED|Washout of 28 Days||0
1569485|NCT01181726|3839113|P2|COMPLETED|Washout of 28 Days||20
1569486|NCT01181726|3839114|P1|COMPLETED|Washout of 28 Days||19
1569487|NCT01181726|3839113|P2|STARTED|Washout of 28 Days||20
1569488|NCT01181726|3839114|P1|STARTED|Washout of 28 Days||19
1569489|NCT01181726|3839113|P2|NOT COMPLETED|First Intervention||0
1569490|NCT01181726|3839114|P1|NOT COMPLETED|First Intervention||1
1569491|NCT01181726|3839113|P2|COMPLETED|First Intervention||20
1569492|NCT01181726|3839114|P1|COMPLETED|First Intervention||19
1569493|NCT01181726|3839113|P2|STARTED|First Intervention||20
1569494|NCT01181726|3839114|P1|STARTED|First Intervention||20
1569495|NCT01181609|3839160|P1|NOT COMPLETED|Overall Study||53
1569496|NCT01181609|3839160|P1|COMPLETED|Overall Study||1
1569497|NCT01181609|3839160|P1|STARTED|Overall Study||54
1569498|NCT01181531|3839173|P2|NOT COMPLETED|Overall Study||53
1569499|NCT01181531|3839174|P1|NOT COMPLETED|Overall Study||61
1569500|NCT01181531|3839173|P2|COMPLETED|Overall Study||102
1569501|NCT01181531|3839174|P1|COMPLETED|Overall Study||96
1569502|NCT01181531|3839173|P2|Received Investigational Product|Overall Study||153
1569503|NCT01181531|3839174|P1|Received Investigational Product|Overall Study||155
1569504|NCT01181531|3839173|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
1569505|NCT01181531|3839174|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
1569506|NCT01181492|3839187|P3|NOT COMPLETED|Overall Study||0
1569507|NCT01181492|3839188|P2|NOT COMPLETED|Overall Study||0
1569508|NCT01181492|3839189|P1|NOT COMPLETED|Overall Study||0
1569509|NCT01181492|3839187|P3|COMPLETED|Overall Study||7
1569510|NCT01181492|3839188|P2|COMPLETED|Overall Study||66
1569511|NCT01181492|3839189|P1|COMPLETED|Overall Study||103
1569512|NCT01181492|3839187|P3|STARTED|Overall Study||7
1569513|NCT01181492|3839188|P2|STARTED|Overall Study||66
1569514|NCT01181492|3839189|P1|STARTED|Overall Study||103
1569515|NCT01181479|3839205|P3|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
1569516|NCT01181479|3839206|P2|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
1569517|NCT01181479|3839207|P1|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
1569518|NCT01181479|3839205|P3|COMPLETED|Crossover Subjects Recieve AG200-15||150
1569519|NCT01181479|3839206|P2|COMPLETED|Crossover Subjects Recieve AG200-15||0
1569520|NCT01181479|3839207|P1|COMPLETED|Crossover Subjects Recieve AG200-15||0
1569521|NCT01181479|3839205|P3|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
1569522|NCT01181479|3839206|P2|STARTED|Crossover Subjects Recieve AG200-15||0
1569523|NCT01181479|3839207|P1|STARTED|Crossover Subjects Recieve AG200-15||0
1569524|NCT01181479|3839205|P3|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
1569525|NCT01181479|3839206|P2|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
1569526|NCT01181479|3839207|P1|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
1569527|NCT01181479|3839205|P3|COMPLETED|Subjects Receive AG200-15 or Lessina||0
1569528|NCT01181479|3839206|P2|COMPLETED|Subjects Receive AG200-15 or Lessina||249
1569529|NCT01181479|3839207|P1|COMPLETED|Subjects Receive AG200-15 or Lessina||485
1569530|NCT01181479|3839205|P3|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
1569531|NCT01181479|3839206|P2|STARTED|Subjects Receive AG200-15 or Lessina||375
1569532|NCT01181479|3839207|P1|STARTED|Subjects Receive AG200-15 or Lessina||1129
1569533|NCT01181349|3839222|P1|NOT COMPLETED|Overall Study||0
1569534|NCT01181349|3839222|P1|COMPLETED|Overall Study||350
1569535|NCT01181349|3839222|P1|STARTED|Overall Study||350
1569536|NCT01181323|3839238|P4|NOT COMPLETED|Overall Study||3
1569537|NCT01181323|3839239|P3|NOT COMPLETED|Overall Study||1
1569538|NCT01181323|3839240|P2|NOT COMPLETED|Overall Study||3
1569539|NCT01181323|3839241|P1|NOT COMPLETED|Overall Study||1
1569540|NCT01181323|3839238|P4|COMPLETED|Overall Study||122
1569541|NCT01181323|3839239|P3|COMPLETED|Overall Study||123
1569542|NCT01181323|3839240|P2|COMPLETED|Overall Study||121
1569543|NCT01181323|3839241|P1|COMPLETED|Overall Study||123
1569544|NCT01181323|3839238|P4|STARTED|Overall Study||125
1569545|NCT01181323|3839239|P3|STARTED|Overall Study||124
1569546|NCT01181323|3839240|P2|STARTED|Overall Study||124
1569547|NCT01181323|3839241|P1|STARTED|Overall Study||124
1569548|NCT01181271|3839316|P1|NOT COMPLETED|Allogeneic Transplant||0
1569549|NCT01181271|3839316|P1|COMPLETED|Allogeneic Transplant||29
1569550|NCT01181271|3839316|P1|STARTED|Allogeneic Transplant||29
1569551|NCT01181271|3839316|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
1569552|NCT01181271|3839316|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
1569553|NCT01181271|3839316|P1|STARTED|Evaluation for Allogeneic Transplant||42
1569554|NCT01181271|3839316|P1|NOT COMPLETED|Autologous Transplant||0
1569555|NCT01181271|3839316|P1|COMPLETED|Autologous Transplant||42
1569556|NCT01181271|3839316|P1|STARTED|Autologous Transplant||42
1569557|NCT01181258|3839331|P1|NOT COMPLETED|Overall Study||0
1569558|NCT01181258|3839331|P1|COMPLETED|Overall Study||16
1569559|NCT01181258|3839331|P1|STARTED|Overall Study||16
1569560|NCT01181167|3839340|P2|NOT COMPLETED|Overall Study||32
1569561|NCT01181167|3839341|P1|NOT COMPLETED|Overall Study||23
1569562|NCT01181167|3839340|P2|COMPLETED|Overall Study||271
1569563|NCT01181167|3839341|P1|COMPLETED|Overall Study||284
1569564|NCT01181167|3839340|P2|Efficacy Analysis Population|Overall Study||248
1569565|NCT01181167|3839341|P1|Efficacy Analysis Population|Overall Study||255
1569566|NCT01181167|3839340|P2|STARTED|Overall Study||303
1569567|NCT01181167|3839341|P1|STARTED|Overall Study||307
1569568|NCT01181141|3839351|P2|NOT COMPLETED|Overall Study||4
1569569|NCT01181141|3839352|P1|NOT COMPLETED|Overall Study||12
1569570|NCT01181141|3839351|P2|COMPLETED|Overall Study||26
1569571|NCT01181141|3839352|P1|COMPLETED|Overall Study||50
1569572|NCT01181141|3839351|P2|Safety Analysis Population|Overall Study||29
1569573|NCT01181141|3839352|P1|Safety Analysis Population|Overall Study||59
1569574|NCT01181141|3839351|P2|STARTED|Overall Study||30
1569575|NCT01181141|3839352|P1|STARTED|Overall Study||62
1569576|NCT01181128|3839361|P3|NOT COMPLETED|Overall Study||1
1569577|NCT01181128|3839362|P2|NOT COMPLETED|Overall Study||5
1569578|NCT01181128|3839363|P1|NOT COMPLETED|Overall Study||6
1569579|NCT01181128|3839361|P3|COMPLETED|Overall Study||22
1569580|NCT01181128|3839362|P2|COMPLETED|Overall Study||19
1569581|NCT01181128|3839363|P1|COMPLETED|Overall Study||112
1569582|NCT01181128|3839361|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
1569583|NCT01181128|3839362|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
1569584|NCT01181128|3839363|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
1569585|NCT01181128|3839361|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
1569586|NCT01181128|3839362|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
1569587|NCT01181128|3839363|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
1569588|NCT01181128|3839361|P3|STARTED|Overall Study||23
1569589|NCT01181128|3839362|P2|STARTED|Overall Study||24
1569590|NCT01181128|3839363|P1|STARTED|Overall Study||118
1569591|NCT01181102|3839451|P2|NOT COMPLETED|Overall Study||46
1569592|NCT01181102|3839452|P1|NOT COMPLETED|Overall Study||51
1569593|NCT01181102|3839451|P2|COMPLETED|Overall Study||310
1569594|NCT01181102|3839452|P1|COMPLETED|Overall Study||309
1569595|NCT01181102|3839451|P2|Efficacy Analysis Population|Overall Study||295
1569596|NCT01181102|3839452|P1|Efficacy Analysis Population|Overall Study||299
1569597|NCT01181102|3839451|P2|Safety Analysis Set|Overall Study||349
1569598|NCT01181102|3839452|P1|Safety Analysis Set|Overall Study||354
1569599|NCT01181102|3839451|P2|STARTED|Overall Study||356
1569600|NCT01181102|3839452|P1|STARTED|Overall Study||360
1569601|NCT01181050|3839462|P2|NOT COMPLETED|Overall Study||0
1569602|NCT01181050|3839463|P1|NOT COMPLETED|Overall Study||0
1569603|NCT01181050|3839462|P2|COMPLETED|Overall Study||22
1569604|NCT01181050|3839463|P1|COMPLETED|Overall Study||41
1569605|NCT01181050|3839462|P2|STARTED|Overall Study||22
1569606|NCT01181050|3839463|P1|STARTED|Overall Study||41
1569607|NCT01181011|3839473|P1|NOT COMPLETED|Overall Study||3
1569608|NCT01181011|3839473|P1|COMPLETED|Overall Study||25
1569609|NCT01181011|3839473|P1|Received Amlodipine 5mg|Overall Study||26
1569610|NCT01181011|3839473|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
1569611|NCT01181011|3839473|P1|Received Telmisartan 80mg|Overall Study||27
1569612|NCT01181011|3839473|P1|STARTED|Overall Study||28
1569613|NCT01180998|3839523|P3|NOT COMPLETED|Overall Study||10
1569614|NCT01180998|3839524|P2|NOT COMPLETED|Overall Study||4
1569615|NCT01180998|3839525|P1|NOT COMPLETED|Overall Study||4
1569616|NCT01180998|3839523|P3|COMPLETED|Overall Study||51
1569617|NCT01180998|3839524|P2|COMPLETED|Overall Study||68
1569618|NCT01180998|3839525|P1|COMPLETED|Overall Study||63
1569619|NCT01180998|3839523|P3|STARTED|Overall Study||61
1569620|NCT01180998|3839524|P2|STARTED|Overall Study||72
1569621|NCT01180998|3839525|P1|STARTED|Overall Study||67
1569622|NCT01180985|3839539|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
1569623|NCT01180985|3839540|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
1569624|NCT01180985|3839539|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
1569625|NCT01180985|3839540|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
1569626|NCT01180985|3839539|P2|STARTED|Period 2 (7 +/- 1 Days)||26
1569627|NCT01180985|3839540|P1|STARTED|Period 2 (7 +/- 1 Days)||27
1569628|NCT01180985|3839539|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
1569629|NCT01180985|3839540|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
1569630|NCT01180985|3839539|P2|COMPLETED|Period 1 (7 +/- Days)||26
1569631|NCT01180985|3839540|P1|COMPLETED|Period 1 (7 +/- Days)||27
1569632|NCT01180985|3839539|P2|STARTED|Period 1 (7 +/- Days)||26
1569633|NCT01180985|3839540|P1|STARTED|Period 1 (7 +/- Days)||27
1569634|NCT01180894|3839559|P2|NOT COMPLETED|Overall Study||0
1569635|NCT01180894|3839560|P1|NOT COMPLETED|Overall Study||0
1569636|NCT01180894|3839559|P2|COMPLETED|Overall Study||75
1569637|NCT01180894|3839560|P1|COMPLETED|Overall Study||75
1569638|NCT01180894|3839559|P2|STARTED|Overall Study||75
1569639|NCT01180894|3839560|P1|STARTED|Overall Study||75
1569640|NCT01180790|3839579|P7|NOT COMPLETED|Overall Study||1
1569641|NCT01180790|3839580|P6|NOT COMPLETED|Overall Study||7
1569642|NCT01180790|3839581|P5|NOT COMPLETED|Overall Study||5
1569643|NCT01180790|3839582|P4|NOT COMPLETED|Overall Study||9
1569644|NCT01180790|3839583|P3|NOT COMPLETED|Overall Study||13
1569645|NCT01180790|3839584|P2|NOT COMPLETED|Overall Study||5
1569646|NCT01180790|3839585|P1|NOT COMPLETED|Overall Study||9
1569647|NCT01180790|3839579|P7|COMPLETED|Overall Study||18
1569648|NCT01180790|3839580|P6|COMPLETED|Overall Study||13
1569649|NCT01180790|3839581|P5|COMPLETED|Overall Study||14
1569650|NCT01180790|3839582|P4|COMPLETED|Overall Study||6
1569651|NCT01180790|3839583|P3|COMPLETED|Overall Study||4
1569652|NCT01180790|3839584|P2|COMPLETED|Overall Study||11
1569653|NCT01180790|3839585|P1|COMPLETED|Overall Study||7
1569654|NCT01180790|3839579|P7|STARTED|Overall Study||19
1569655|NCT01180790|3839580|P6|STARTED|Overall Study||20
1569656|NCT01180790|3839581|P5|STARTED|Overall Study||19
1569657|NCT01180790|3839582|P4|STARTED|Overall Study||15
1569658|NCT01180790|3839583|P3|STARTED|Overall Study||17
1569659|NCT01180790|3839584|P2|STARTED|Overall Study||16
1569660|NCT01180790|3839585|P1|STARTED|Overall Study||16
1569661|NCT01180777|3839650|P1|NOT COMPLETED|Overall Study||12
1569662|NCT01180777|3839650|P1|COMPLETED|Overall Study||80
1569663|NCT01180777|3839650|P1|STARTED|Overall Study||92
1569664|NCT01180660|3839664|P2|NOT COMPLETED|Overall Study||0
1569665|NCT01180660|3839665|P1|NOT COMPLETED|Overall Study||1
1569666|NCT01180660|3839664|P2|COMPLETED|Overall Study||26
1569667|NCT01180660|3839665|P1|COMPLETED|Overall Study||24
1569668|NCT01180660|3839664|P2|STARTED|Overall Study||26
1569669|NCT01180660|3839665|P1|STARTED|Overall Study||25
1569670|NCT01180647|3839675|P2|NOT COMPLETED|Overall Study||6
1569671|NCT01180647|3839676|P1|NOT COMPLETED|Overall Study||5
1569672|NCT01180647|3839675|P2|COMPLETED|Overall Study||11
1569673|NCT01180647|3839676|P1|COMPLETED|Overall Study||12
1569674|NCT01180647|3839675|P2|STARTED|Overall Study||17
1569675|NCT01180647|3839676|P1|STARTED|Overall Study||17
1569676|NCT01180478|3839694|P2|NOT COMPLETED|Overall Study||188
1569677|NCT01180478|3839695|P1|NOT COMPLETED|Overall Study||181
1569678|NCT01180478|3839694|P2|COMPLETED|Overall Study||293
1569679|NCT01180478|3839695|P1|COMPLETED|Overall Study||303
1569680|NCT01180478|3839694|P2|STARTED|Overall Study||481
1569681|NCT01180478|3839695|P1|STARTED|Overall Study||484
1569682|NCT01180400|3839711|P2|NOT COMPLETED|Overall Study||27
1569683|NCT01180400|3839712|P1|NOT COMPLETED|Overall Study||25
1569684|NCT01180400|3839711|P2|COMPLETED|Overall Study||121
1569685|NCT01180400|3839712|P1|COMPLETED|Overall Study||122
1569686|NCT01180400|3839711|P2|Received Treatment|Overall Study||146
1569687|NCT01180400|3839712|P1|Received Treatment|Overall Study||147
1569688|NCT01180400|3839711|P2|STARTED|Overall Study||148
1569689|NCT01180400|3839712|P1|STARTED|Overall Study||147
1569690|NCT01180296|3839760|P2|NOT COMPLETED|Overall Study||2
1569691|NCT01180296|3839761|P1|NOT COMPLETED|Overall Study||1
1569692|NCT01180296|3839760|P2|COMPLETED|Overall Study||14
1569693|NCT01180296|3839761|P1|COMPLETED|Overall Study||19
1569694|NCT01180296|3839760|P2|STARTED|Overall Study||16
1569695|NCT01180296|3839761|P1|STARTED|Overall Study||20
1569696|NCT01180244|3839769|P2|NOT COMPLETED|Overall Study||8
1569697|NCT01180244|3839770|P1|NOT COMPLETED|Overall Study||6
1569698|NCT01180244|3839769|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
1569699|NCT01180244|3839770|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
1569700|NCT01180244|3839769|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
1569701|NCT01180244|3839770|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
1569702|NCT01180244|3839769|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
1569703|NCT01180244|3839770|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
1569704|NCT01180127|3839788|P4|NOT COMPLETED|Overall Study||1
1569705|NCT01180127|3839789|P3|NOT COMPLETED|Overall Study||1
1569706|NCT01180127|3839790|P2|NOT COMPLETED|Overall Study||0
1569707|NCT01180127|3839791|P1|NOT COMPLETED|Overall Study||2
1569708|NCT01180127|3839788|P4|COMPLETED|Overall Study||9
1569709|NCT01180127|3839789|P3|COMPLETED|Overall Study||9
1569710|NCT01180127|3839790|P2|COMPLETED|Overall Study||11
1569711|NCT01180127|3839791|P1|COMPLETED|Overall Study||8
1569712|NCT01180127|3839788|P4|STARTED|Overall Study||10
1569713|NCT01180127|3839789|P3|STARTED|Overall Study||10
1569714|NCT01180127|3839790|P2|STARTED|Overall Study||11
1569715|NCT01180127|3839791|P1|STARTED|Overall Study||10
1569716|NCT01180049|3839815|P2|NOT COMPLETED|Overall Study||43
1569717|NCT01180049|3839816|P1|NOT COMPLETED|Overall Study||47
1569718|NCT01180049|3839815|P2|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
1569719|NCT01180049|3839816|P1|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
1569720|NCT01180049|3839815|P2|Treated|Overall Study||42
1569721|NCT01180049|3839816|P1|Treated|Overall Study||47
1569722|NCT01180049|3839815|P2|STARTED|Overall Study||43
1569723|NCT01180049|3839816|P1|STARTED|Overall Study||47
1569724|NCT01179984|3839836|P1|NOT COMPLETED|Overall Study||18
1569725|NCT01179984|3839836|P1|COMPLETED|Overall Study||58
1569726|NCT01179984|3839836|P1|STARTED|Overall Study||76
1569727|NCT01179919|3839842|P1|NOT COMPLETED|Overall Study||2
1569728|NCT01179919|3839842|P1|COMPLETED|Overall Study||19
1569729|NCT01179919|3839842|P1|STARTED|Overall Study||21
1569730|NCT01179737|3839851|P4|NOT COMPLETED|Extension||0
1569731|NCT01179737|3839852|P3|NOT COMPLETED|Extension||0
1569732|NCT01179737|3839853|P2|NOT COMPLETED|Extension||0
1569733|NCT01179737|3839854|P1|NOT COMPLETED|Extension||3
1569734|NCT01179737|3839851|P4|COMPLETED|Extension||0
1569735|NCT01179737|3839852|P3|COMPLETED|Extension||0
1569736|NCT01179737|3839853|P2|COMPLETED|Extension||0
1569737|NCT01179737|3839854|P1|COMPLETED|Extension||0
1569738|NCT01179737|3839851|P4|STARTED|Extension||0
1569739|NCT01179737|3839852|P3|STARTED|Extension||0
1569740|NCT01179737|3839853|P2|STARTED|Extension|One patient did not enrol in the extension|0
1569741|NCT01179737|3839854|P1|STARTED|Extension|Two patients did not enrol in the extension|3
1569742|NCT01179737|3839851|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1569743|NCT01179737|3839852|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1569744|NCT01179737|3839853|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1569745|NCT01179737|3839854|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
1569746|NCT01179737|3839851|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1569747|NCT01179737|3839852|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1569748|NCT01179737|3839853|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
1569749|NCT01179737|3839854|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
1569750|NCT01179737|3839851|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
1569751|NCT01179737|3839852|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
1569752|NCT01179737|3839853|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
1569753|NCT01179737|3839854|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
1569754|NCT01179737|3839851|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
1569755|NCT01179737|3839852|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
1569756|NCT01179737|3839853|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
1569757|NCT01179737|3839854|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
1569758|NCT01179737|3839851|P4|COMPLETED|Cohort 1 & Cohort 2||0
1569759|NCT01179737|3839852|P3|COMPLETED|Cohort 1 & Cohort 2||0
1569760|NCT01179737|3839853|P2|COMPLETED|Cohort 1 & Cohort 2||1
1569761|NCT01179737|3839854|P1|COMPLETED|Cohort 1 & Cohort 2||7
1569762|NCT01179737|3839851|P4|STARTED|Cohort 1 & Cohort 2||4
1569763|NCT01179737|3839852|P3|STARTED|Cohort 1 & Cohort 2||4
1569764|NCT01179737|3839853|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
1569765|NCT01179737|3839854|P1|STARTED|Cohort 1 & Cohort 2||12
1569766|NCT01179672|3839865|P2|NOT COMPLETED|Overall Study||26
1569767|NCT01179672|3839866|P1|NOT COMPLETED|Overall Study||30
1569768|NCT01179672|3839865|P2|COMPLETED|Overall Study||176
1569769|NCT01179672|3839866|P1|COMPLETED|Overall Study||173
1569770|NCT01179672|3839865|P2|Entered Taper|Overall Study||177
1569771|NCT01179672|3839866|P1|Entered Taper|Overall Study||181
1569772|NCT01179672|3839865|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
1569773|NCT01179672|3839866|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
1569774|NCT01179672|3839865|P2|STARTED|Overall Study||202
1569775|NCT01179672|3839866|P1|STARTED|Overall Study||203
1569776|NCT01179568|3839896|P4|NOT COMPLETED|Overall Study||20
1569777|NCT01179568|3839897|P3|NOT COMPLETED|Overall Study||23
1569778|NCT01179568|3839898|P2|NOT COMPLETED|Overall Study||38
1569779|NCT01179568|3839899|P1|NOT COMPLETED|Overall Study||28
1569780|NCT01179568|3839896|P4|COMPLETED|Overall Study||76
1569781|NCT01179568|3839897|P3|COMPLETED|Overall Study||76
1569782|NCT01179568|3839898|P2|COMPLETED|Overall Study||61
1569783|NCT01179568|3839899|P1|COMPLETED|Overall Study||73
1569784|NCT01179568|3839896|P4|Completed Week 12 Assessment|Overall Study||75
1569785|NCT01179568|3839897|P3|Completed Week 12 Assessment|Overall Study||76
1569786|NCT01179568|3839898|P2|Completed Week 12 Assessment|Overall Study||69
1569787|NCT01179568|3839899|P1|Completed Week 12 Assessment|Overall Study||69
1569788|NCT01179568|3839896|P4|STARTED|Overall Study||96
1569789|NCT01179568|3839897|P3|STARTED|Overall Study||99
1569790|NCT01179568|3839898|P2|STARTED|Overall Study||99
1569791|NCT01179568|3839899|P1|STARTED|Overall Study||101
1569792|NCT01179516|3839922|P3|NOT COMPLETED|Overall Study||31
1569793|NCT01179516|3839923|P2|NOT COMPLETED|Overall Study||26
1569794|NCT01179516|3839924|P1|NOT COMPLETED|Overall Study||27
1569795|NCT01179516|3839922|P3|COMPLETED|Overall Study||121
1569796|NCT01179516|3839923|P2|COMPLETED|Overall Study||131
1569797|NCT01179516|3839924|P1|COMPLETED|Overall Study||133
1569798|NCT01179516|3839922|P3|Treated|Overall Study||151
1569799|NCT01179516|3839923|P2|Treated|Overall Study||154
1569800|NCT01179516|3839924|P1|Treated|Overall Study||160
1569801|NCT01179516|3839922|P3|STARTED|Overall Study||152
1569802|NCT01179516|3839923|P2|STARTED|Overall Study||157
1569803|NCT01179516|3839924|P1|STARTED|Overall Study||160
1569804|NCT01179490|3839947|P1|NOT COMPLETED|Overall Study||0
1569805|NCT01179490|3839947|P1|COMPLETED|Overall Study||5
1569806|NCT01179490|3839947|P1|STARTED|Overall Study||5
1569807|NCT01179399|3839968|P1|NOT COMPLETED|Overall Study||32
1569808|NCT01179399|3839968|P1|COMPLETED|Overall Study||0
1569809|NCT01179399|3839968|P1|STARTED|Overall Study||32
1569810|NCT01179347|3839974|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
1569811|NCT01179347|3839975|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
1569812|NCT01179347|3839974|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
1569813|NCT01179347|3839975|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
1569814|NCT01179347|3839974|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
1569815|NCT01179347|3839975|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
1569816|NCT01179347|3839974|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
1569817|NCT01179347|3839975|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
1569818|NCT01179347|3839974|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
1569819|NCT01179347|3839975|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
1569820|NCT01179347|3839974|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
1569821|NCT01179347|3839975|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
1569822|NCT01179334|3839997|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
1569823|NCT01179334|3839998|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
1569824|NCT01179334|3839997|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
1569825|NCT01179334|3839998|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
1569826|NCT01179334|3839997|P2|STARTED|Long-term Extension (LTE) Period||6
1569827|NCT01179334|3839998|P1|STARTED|Long-term Extension (LTE) Period||11
1569828|NCT01179334|3839997|P2|NOT COMPLETED|Treatment Period||0
1569829|NCT01179334|3839998|P1|NOT COMPLETED|Treatment Period||1
1569830|NCT01179334|3839997|P2|COMPLETED|Treatment Period||6
1569831|NCT01179334|3839998|P1|COMPLETED|Treatment Period||11
1569832|NCT01179334|3839997|P2|Participants Received Treatment|Treatment Period||6
1569833|NCT01179334|3839998|P1|Participants Received Treatment|Treatment Period||12
1569834|NCT01179334|3839997|P2|STARTED|Treatment Period||6
1569835|NCT01179334|3839998|P1|STARTED|Treatment Period||12
1569836|NCT01179217|3840028|P2|NOT COMPLETED|Overall Study||19
1569837|NCT01179217|3840029|P1|NOT COMPLETED|Overall Study||55
1569838|NCT01179217|3840028|P2|COMPLETED|Overall Study||59
1569839|NCT01179217|3840029|P1|COMPLETED|Overall Study||97
1569840|NCT01179217|3840028|P2|STARTED|Overall Study||78
1569841|NCT01179217|3840029|P1|STARTED|Overall Study||152
1569842|NCT01179191|3840053|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
1569843|NCT01179191|3840053|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
1569844|NCT01179191|3840053|P1|STARTED|Maintenance Phase (8 Weeks)||351
1569845|NCT01179191|3840053|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
1569846|NCT01179191|3840053|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
1569847|NCT01179191|3840053|P1|STARTED|Titration Phase (up to 6 Weeks)||684
1569848|NCT01179113|3840072|P2|NOT COMPLETED|Overall Study||0
1569849|NCT01179113|3840073|P1|NOT COMPLETED|Overall Study||0
1569850|NCT01179113|3840072|P2|COMPLETED|Overall Study||16
1569851|NCT01179113|3840073|P1|COMPLETED|Overall Study||17
1569852|NCT01179113|3840072|P2|STARTED|Overall Study||16
1569853|NCT01179113|3840073|P1|STARTED|Overall Study||17
1569854|NCT01179048|3840085|P2|NOT COMPLETED|Overall Study||159
1569855|NCT01179048|3840086|P1|NOT COMPLETED|Overall Study||139
1569856|NCT01179048|3840085|P2|COMPLETED|Overall Study||4513
1569857|NCT01179048|3840086|P1|COMPLETED|Overall Study||4529
1569858|NCT01179048|3840085|P2|STARTED|Overall Study||4672
1569859|NCT01179048|3840086|P1|STARTED|Overall Study||4668
1569860|NCT01178944|3840102|P1|NOT COMPLETED|Overall Study||0
1569861|NCT01178944|3840102|P1|COMPLETED|Overall Study||35
1569862|NCT01178944|3840102|P1|STARTED|Overall Study||35
1569863|NCT01178853|3840113|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
1569864|NCT01178853|3840114|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
1569865|NCT01178853|3840113|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
1569866|NCT01178853|3840114|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
1569867|NCT01178853|3840113|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
1569868|NCT01178853|3840114|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
1569869|NCT01178853|3840113|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
1569870|NCT01178853|3840114|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
1569871|NCT01178853|3840113|P2|COMPLETED|Period 3 (Warfarin Titration)||22
1569872|NCT01178853|3840114|P1|COMPLETED|Period 3 (Warfarin Titration)||21
1569873|NCT01178853|3840113|P2|STARTED|Period 3 (Warfarin Titration)||22
1569874|NCT01178853|3840114|P1|STARTED|Period 3 (Warfarin Titration)||22
1569875|NCT01178853|3840113|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
1569876|NCT01178853|3840114|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
1569877|NCT01178853|3840113|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
1569878|NCT01178853|3840114|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
1569879|NCT01178853|3840113|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
1569880|NCT01178853|3840114|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
1569881|NCT01178853|3840113|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
1569882|NCT01178853|3840114|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
1569883|NCT01178853|3840113|P2|COMPLETED|Period 1 (Warfarin Titration)||22
1569884|NCT01178853|3840114|P1|COMPLETED|Period 1 (Warfarin Titration)||23
1569885|NCT01178853|3840113|P2|STARTED|Period 1 (Warfarin Titration)||24
1569886|NCT01178853|3840114|P1|STARTED|Period 1 (Warfarin Titration)||24
1569887|NCT01178827|3840123|P3|NOT COMPLETED|Overall Study||0
1569888|NCT01178827|3840124|P2|NOT COMPLETED|Overall Study||0
1569889|NCT01178827|3840125|P1|NOT COMPLETED|Overall Study||0
1569890|NCT01178827|3840123|P3|COMPLETED|Overall Study||4
1569891|NCT01178827|3840124|P2|COMPLETED|Overall Study||10
1569892|NCT01178827|3840125|P1|COMPLETED|Overall Study||6
1569893|NCT01178827|3840123|P3|STARTED|Overall Study||4
1569894|NCT01178827|3840124|P2|STARTED|Overall Study||10
1569895|NCT01178827|3840125|P1|STARTED|Overall Study||6
1569896|NCT01178762|3840154|P1|NOT COMPLETED|Overall Study||15
1569897|NCT01178762|3840154|P1|COMPLETED|Overall Study||27
1569898|NCT01178762|3840154|P1|STARTED|Overall Study||42
1569899|NCT01178671|3840160|P2|NOT COMPLETED|Overall Study||15
1569900|NCT01178671|3840161|P1|NOT COMPLETED|Overall Study||12
1569901|NCT01178671|3840160|P2|COMPLETED|Overall Study||3
1569902|NCT01178671|3840161|P1|COMPLETED|Overall Study||6
1569903|NCT01178671|3840160|P2|STARTED|Overall Study||18
1569904|NCT01178671|3840161|P1|STARTED|Overall Study||18
1569905|NCT01178528|3840188|P3|NOT COMPLETED|Overall Study||0
1569906|NCT01178528|3840189|P2|NOT COMPLETED|Overall Study||0
1569907|NCT01178528|3840190|P1|NOT COMPLETED|Overall Study||0
1569908|NCT01178528|3840188|P3|COMPLETED|Overall Study||42
1569909|NCT01178528|3840189|P2|COMPLETED|Overall Study||38
1569910|NCT01178528|3840190|P1|COMPLETED|Overall Study||41
1569911|NCT01178528|3840188|P3|STARTED|Overall Study||42
1569912|NCT01178528|3840189|P2|STARTED|Overall Study||38
1569913|NCT01178528|3840190|P1|STARTED|Overall Study||41
1569914|NCT01178385|3840209|P2|NOT COMPLETED|Overall Study||0
1569915|NCT01178385|3840210|P1|NOT COMPLETED|Overall Study||2
1569916|NCT01178385|3840209|P2|COMPLETED|Overall Study||21
1569917|NCT01178385|3840210|P1|COMPLETED|Overall Study||22
1569918|NCT01178385|3840209|P2|STARTED|Overall Study||21
1569919|NCT01178385|3840210|P1|STARTED|Overall Study||24
1569920|NCT01178333|3840223|P3|NOT COMPLETED|Overall Study||0
1569921|NCT01178333|3840224|P2|NOT COMPLETED|Overall Study||0
1569922|NCT01178333|3840225|P1|NOT COMPLETED|Overall Study||0
1569923|NCT01178333|3840223|P3|COMPLETED|Overall Study||87
1569924|NCT01178333|3840224|P2|COMPLETED|Overall Study||284
1569925|NCT01178333|3840225|P1|COMPLETED|Overall Study||71
1569926|NCT01178333|3840223|P3|STARTED|Overall Study||87
1569927|NCT01178333|3840224|P2|STARTED|Overall Study||284
1569928|NCT01178333|3840225|P1|STARTED|Overall Study||71
1569929|NCT01178294|3840279|P1|NOT COMPLETED|Overall Study||11
1569930|NCT01178294|3840279|P1|COMPLETED|Overall Study||18
1569931|NCT01178294|3840279|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
1569932|NCT01178281|3840302|P2|NOT COMPLETED|Overall Study||77
1569933|NCT01178281|3840303|P1|NOT COMPLETED|Overall Study||149
1569934|NCT01178281|3840302|P2|COMPLETED|Overall Study|Participants remain on treatment|7
1569935|NCT01178281|3840303|P1|COMPLETED|Overall Study|Participants remain on treatment|19
1569936|NCT01178281|3840302|P2|STARTED|Overall Study|Intent to Treat Population (ITT)|84
1569937|NCT01178281|3840303|P1|STARTED|Overall Study|Intent to Treat Population (ITT)|168
1569938|NCT01178268|3840311|P2|NOT COMPLETED|Overall Study||1
1569939|NCT01178268|3840312|P1|NOT COMPLETED|Overall Study||7
1569940|NCT01178268|3840311|P2|COMPLETED|Overall Study||120
1569941|NCT01178268|3840312|P1|COMPLETED|Overall Study||360
1569942|NCT01178268|3840311|P2|STARTED|Overall Study||121
1569943|NCT01178268|3840312|P1|STARTED|Overall Study||367
1569944|NCT01178216|3840529|P1|NOT COMPLETED|Overall Study||2
1569945|NCT01178216|3840529|P1|COMPLETED|Overall Study||39
1569946|NCT01178216|3840529|P1|STARTED|Overall Study||41
1569947|NCT01178138|3840538|P1|NOT COMPLETED|Overall Study||23
1569948|NCT01178138|3840538|P1|COMPLETED|Overall Study||1
1569949|NCT01178138|3840538|P1|Completed 3 Sessions|Overall Study||1
1569950|NCT01178138|3840538|P1|Completed 5 Sessions|Overall Study||1
1569951|NCT01178138|3840538|P1|Completed 6 Sessions|Overall Study||1
1569952|NCT01178138|3840538|P1|STARTED|Overall Study||24
1569953|NCT01178125|3840559|P1|NOT COMPLETED|Overall Study||1178
1569954|NCT01178125|3840559|P1|COMPLETED|Overall Study||1680
1569955|NCT01178125|3840559|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
1569956|NCT01178125|3840559|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
1569957|NCT01178125|3840559|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
1569958|NCT01178125|3840559|P1|STARTED|Overall Study|Number enrolled.|2858
1569959|NCT01178099|3840590|P2|NOT COMPLETED|Overall Study||1
1569960|NCT01178099|3840591|P1|NOT COMPLETED|Overall Study||0
1569961|NCT01178099|3840590|P2|COMPLETED|Overall Study||12
1569962|NCT01178099|3840591|P1|COMPLETED|Overall Study||13
1569963|NCT01178099|3840590|P2|STARTED|Overall Study||13
1569964|NCT01178099|3840591|P1|STARTED|Overall Study||13
1569965|NCT01178086|3840631|P1|NOT COMPLETED|Overall Study||332
1569966|NCT01178086|3840631|P1|COMPLETED|Overall Study||349
1569967|NCT01178086|3840631|P1|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
1569968|NCT01178086|3840631|P1|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
1569969|NCT01178073|3840658|P3|NOT COMPLETED|Overall Study||46
1569970|NCT01178073|3840659|P2|NOT COMPLETED|Overall Study||44
1569971|NCT01178073|3840660|P1|NOT COMPLETED|Overall Study||62
1569972|NCT01178073|3840658|P3|COMPLETED|Overall Study||105
1569973|NCT01178073|3840659|P2|COMPLETED|Overall Study||108
1569974|NCT01178073|3840660|P1|COMPLETED|Overall Study||240
1569975|NCT01178073|3840658|P3|STARTED|Overall Study||151
1569976|NCT01178073|3840659|P2|STARTED|Overall Study||152
1569977|NCT01178073|3840660|P1|STARTED|Overall Study||302
1569978|NCT01177969|3840691|P2|NOT COMPLETED|Overall Study||3
1569979|NCT01177969|3840692|P1|NOT COMPLETED|Overall Study||3
1569980|NCT01177969|3840691|P2|COMPLETED|Overall Study||11
1569981|NCT01177969|3840692|P1|COMPLETED|Overall Study||16
1569982|NCT01177969|3840691|P2|STARTED|Overall Study||14
1569983|NCT01177969|3840692|P1|STARTED|Overall Study||19
1569984|NCT01177956|3840700|P1|NOT COMPLETED|Overall Study||0
1569985|NCT01177956|3840700|P1|COMPLETED|Overall Study||68
1569986|NCT01177956|3840700|P1|STARTED|Overall Study||68
1569987|NCT01177943|3840715|P2|NOT COMPLETED|Second Intervention||0
1569988|NCT01177943|3840716|P1|NOT COMPLETED|Second Intervention||0
1569989|NCT01177943|3840715|P2|COMPLETED|Second Intervention||21
1569990|NCT01177943|3840716|P1|COMPLETED|Second Intervention||19
1569991|NCT01177943|3840715|P2|STARTED|Second Intervention||21
1569992|NCT01177943|3840716|P1|STARTED|Second Intervention||19
1569993|NCT01177943|3840715|P2|NOT COMPLETED|First Intervention||0
1569994|NCT01177943|3840716|P1|NOT COMPLETED|First Intervention||2
1569995|NCT01177943|3840715|P2|COMPLETED|First Intervention||21
1569996|NCT01177943|3840716|P1|COMPLETED|First Intervention||19
1569997|NCT01177943|3840715|P2|STARTED|First Intervention||21
1569998|NCT01177943|3840716|P1|STARTED|First Intervention||21
1569999|NCT01177813|3840729|P5|NOT COMPLETED|Overall Study||9
1570000|NCT01177813|3840730|P4|NOT COMPLETED|Overall Study||17
1570001|NCT01177813|3840731|P3|NOT COMPLETED|Overall Study||20
1570002|NCT01177813|3840732|P2|NOT COMPLETED|Overall Study||18
1570003|NCT01177813|3840733|P1|NOT COMPLETED|Overall Study||41
1570004|NCT01177813|3840729|P5|COMPLETED|Overall Study||78
1570005|NCT01177813|3840730|P4|COMPLETED|Overall Study||206
1570006|NCT01177813|3840731|P3|COMPLETED|Overall Study||204
1570007|NCT01177813|3840732|P2|COMPLETED|Overall Study||206
1570008|NCT01177813|3840733|P1|COMPLETED|Overall Study||187
1570009|NCT01177813|3840729|P5|STARTED|Overall Study||87
1570010|NCT01177813|3840730|P4|STARTED|Overall Study||223
1570011|NCT01177813|3840731|P3|STARTED|Overall Study||224
1570012|NCT01177813|3840732|P2|STARTED|Overall Study||224
1570013|NCT01177813|3840733|P1|STARTED|Overall Study||228
1570014|NCT01177800|3840762|P2|NOT COMPLETED|Overall Study||5
1570015|NCT01177800|3840763|P1|NOT COMPLETED|Overall Study||10
1570016|NCT01177800|3840762|P2|COMPLETED|Overall Study||40
1570017|NCT01177800|3840763|P1|COMPLETED|Overall Study||74
1570018|NCT01177800|3840762|P2|STARTED|Overall Study||45
1570019|NCT01177800|3840763|P1|STARTED|Overall Study||84
1570020|NCT01177735|3840777|P1|NOT COMPLETED|Overall Study||71
1570021|NCT01177735|3840777|P1|COMPLETED|Overall Study||0
1570022|NCT01177735|3840777|P1|STARTED|Overall Study||71
1570023|NCT01177722|3840785|P4|NOT COMPLETED|Overall Study||7
1570024|NCT01177722|3840786|P3|NOT COMPLETED|Overall Study||9
1570025|NCT01177722|3840787|P2|NOT COMPLETED|Overall Study||10
1570026|NCT01177722|3840788|P1|NOT COMPLETED|Overall Study||13
1570027|NCT01177722|3840785|P4|COMPLETED|Overall Study||338
1570028|NCT01177722|3840786|P3|COMPLETED|Overall Study||333
1570029|NCT01177722|3840787|P2|COMPLETED|Overall Study||334
1570030|NCT01177722|3840788|P1|COMPLETED|Overall Study||331
1570031|NCT01177722|3840785|P4|STARTED|Overall Study||345
1570032|NCT01177722|3840786|P3|STARTED|Overall Study||342
1570033|NCT01177722|3840787|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
1570034|NCT01177722|3840788|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
1570035|NCT01177709|3840814|P1|NOT COMPLETED|Overall Study||0
1570036|NCT01177709|3840814|P1|COMPLETED|Overall Study||12
1570037|NCT01177709|3840814|P1|STARTED|Overall Study||12
1570038|NCT01177670|3840820|P1|NOT COMPLETED|Overall Study||169
1570039|NCT01177670|3840820|P1|COMPLETED|Overall Study||0
1570040|NCT01177670|3840820|P1|STARTED|Overall Study||169
1570041|NCT01177553|3840827|P2|NOT COMPLETED|Overall Study||0
1570042|NCT01177553|3840828|P1|NOT COMPLETED|Overall Study||1
1570043|NCT01177553|3840827|P2|COMPLETED|Overall Study|data as of March 2009|2
1570044|NCT01177553|3840828|P1|COMPLETED|Overall Study|data as of March 2009|2
1570045|NCT01177553|3840827|P2|STARTED|Overall Study||2
1570046|NCT01177553|3840828|P1|STARTED|Overall Study||3
1570047|NCT01177410|3840837|P3|NOT COMPLETED|Overall Study||5
1570048|NCT01177410|3840838|P2|NOT COMPLETED|Overall Study||7
1570049|NCT01177410|3840839|P1|NOT COMPLETED|Overall Study||1
1570050|NCT01177410|3840837|P3|COMPLETED|Overall Study||45
1570051|NCT01177410|3840838|P2|COMPLETED|Overall Study||40
1570052|NCT01177410|3840839|P1|COMPLETED|Overall Study||50
1570053|NCT01177410|3840837|P3|STARTED|Overall Study||50
1570054|NCT01177410|3840838|P2|STARTED|Overall Study||47
1570055|NCT01177410|3840839|P1|STARTED|Overall Study||51
1570056|NCT01177384|3840852|P2|NOT COMPLETED|Overall Study||26
1570057|NCT01177384|3840853|P1|NOT COMPLETED|Overall Study||14
1570058|NCT01177384|3840852|P2|COMPLETED|Overall Study||164
1570059|NCT01177384|3840853|P1|COMPLETED|Overall Study||177
1570060|NCT01177384|3840852|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
1570061|NCT01177384|3840853|P1|STARTED|Overall Study||191
1570062|NCT01177293|3840865|P2|NOT COMPLETED|Second Intervention Period||0
1570063|NCT01177293|3840866|P1|NOT COMPLETED|Second Intervention Period||0
1570064|NCT01177293|3840865|P2|COMPLETED|Second Intervention Period||6
1570065|NCT01177293|3840866|P1|COMPLETED|Second Intervention Period||7
1570066|NCT01177293|3840865|P2|STARTED|Second Intervention Period||6
1570067|NCT01177293|3840866|P1|STARTED|Second Intervention Period||7
1570068|NCT01177293|3840865|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
1570069|NCT01177293|3840866|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
1570070|NCT01177293|3840865|P2|COMPLETED|Washout Period (of 14 Days)||6
1570071|NCT01177293|3840866|P1|COMPLETED|Washout Period (of 14 Days)||7
1570072|NCT01177293|3840865|P2|STARTED|Washout Period (of 14 Days)||7
1570073|NCT01177293|3840866|P1|STARTED|Washout Period (of 14 Days)||7
1570074|NCT01177293|3840865|P2|NOT COMPLETED|First Intervention Period||0
1570075|NCT01177293|3840866|P1|NOT COMPLETED|First Intervention Period||0
1570076|NCT01177293|3840865|P2|COMPLETED|First Intervention Period||7
1570077|NCT01177293|3840866|P1|COMPLETED|First Intervention Period||7
1570078|NCT01177293|3840865|P2|STARTED|First Intervention Period||7
1570079|NCT01177293|3840866|P1|STARTED|First Intervention Period||7
1570080|NCT01177228|3840884|P4|NOT COMPLETED|Overall Study||0
1570081|NCT01177228|3840885|P3|NOT COMPLETED|Overall Study||0
1570082|NCT01177228|3840886|P2|NOT COMPLETED|Overall Study||2
1570083|NCT01177228|3840887|P1|NOT COMPLETED|Overall Study||1
1570084|NCT01177228|3840884|P4|COMPLETED|Overall Study||11
1570085|NCT01177228|3840885|P3|COMPLETED|Overall Study||14
1570086|NCT01177228|3840886|P2|COMPLETED|Overall Study||11
1570087|NCT01177228|3840887|P1|COMPLETED|Overall Study||8
1570088|NCT01177228|3840884|P4|Received Treatment|Overall Study||11
1570089|NCT01177228|3840885|P3|Received Treatment|Overall Study||14
1570090|NCT01177228|3840886|P2|Received Treatment|Overall Study||12
1570091|NCT01177228|3840887|P1|Received Treatment|Overall Study||9
1570092|NCT01177228|3840884|P4|STARTED|Overall Study||11
1570093|NCT01177228|3840885|P3|STARTED|Overall Study||14
1570094|NCT01177228|3840886|P2|STARTED|Overall Study||13
1570095|NCT01177228|3840887|P1|STARTED|Overall Study||9
1570096|NCT01177137|3840928|P3|NOT COMPLETED|Overall Study||2
1570097|NCT01177137|3840929|P2|NOT COMPLETED|Overall Study||10
1570098|NCT01177137|3840930|P1|NOT COMPLETED|Overall Study||10
1570099|NCT01177137|3840928|P3|COMPLETED|Overall Study||47
1570100|NCT01177137|3840929|P2|COMPLETED|Overall Study||41
1570101|NCT01177137|3840930|P1|COMPLETED|Overall Study||41
1570102|NCT01177137|3840928|P3|STARTED|Overall Study||49
1570103|NCT01177137|3840929|P2|STARTED|Overall Study||51
1570104|NCT01177137|3840930|P1|STARTED|Overall Study||51
1570105|NCT01177098|3840997|P2|NOT COMPLETED|Overall Study||12
1570106|NCT01177098|3840998|P1|NOT COMPLETED|Overall Study||9
1570107|NCT01177098|3840997|P2|COMPLETED|Overall Study||271
1570108|NCT01177098|3840998|P1|COMPLETED|Overall Study||269
1570109|NCT01177098|3840997|P2|STARTED|Overall Study||283
1570110|NCT01177098|3840998|P1|STARTED|Overall Study||278
1570111|NCT01177059|3841014|P1|NOT COMPLETED|Overall Study||50
1570112|NCT01177059|3841014|P1|COMPLETED|Overall Study||18
1570113|NCT01177059|3841014|P1|STARTED|Overall Study||68
1570114|NCT01177007|3841020|P1|NOT COMPLETED|Overall Study||38
1570115|NCT01177007|3841020|P1|COMPLETED|Overall Study||12
1570116|NCT01177007|3841020|P1|Completed First Clinical and Imaging|Overall Study||43
1570117|NCT01177007|3841020|P1|Completed First Y90 Treatment|Overall Study||50
1570118|NCT01177007|3841020|P1|STARTED|Overall Study||50
1570119|NCT01176968|3841034|P2|NOT COMPLETED|Overall Study||82
1570120|NCT01176968|3841035|P1|NOT COMPLETED|Overall Study||84
1570121|NCT01176968|3841034|P2|COMPLETED|Overall Study||424
1570122|NCT01176968|3841035|P1|COMPLETED|Overall Study||422
1570123|NCT01176968|3841034|P2|Treated|Overall Study||505
1570124|NCT01176968|3841035|P1|Treated|Overall Study||505
1570125|NCT01176968|3841034|P2|STARTED|Overall Study||506
1570126|NCT01176968|3841035|P1|STARTED|Overall Study||506
1570127|NCT01176955|3841069|P2|NOT COMPLETED|Overall Study||2
1570128|NCT01176955|3841070|P1|NOT COMPLETED|Overall Study||3
1570129|NCT01176955|3841069|P2|COMPLETED|Overall Study||8
1570130|NCT01176955|3841070|P1|COMPLETED|Overall Study||7
1570131|NCT01176955|3841069|P2|STARTED|Overall Study||10
1570132|NCT01176955|3841070|P1|STARTED|Overall Study||10
1570133|NCT01176877|3841081|P1|NOT COMPLETED|Overall Study||9
1570134|NCT01176877|3841081|P1|COMPLETED|Overall Study||31
1570135|NCT01176877|3841081|P1|STARTED|Overall Study||40
1570136|NCT01176773|3841086|P1|NOT COMPLETED|Overall Study||3
1570137|NCT01176773|3841086|P1|COMPLETED|Overall Study||59
1570138|NCT01176773|3841086|P1|STARTED|Overall Study||62
1570139|NCT01176617|3841097|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
1570140|NCT01176617|3841098|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
1570141|NCT01176617|3841099|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
1570142|NCT01176617|3841097|P3|COMPLETED|6 - 12 Months (Randomized)||0
1570143|NCT01176617|3841098|P2|COMPLETED|6 - 12 Months (Randomized)||20
1570144|NCT01176617|3841099|P1|COMPLETED|6 - 12 Months (Randomized)||13
1570145|NCT01176617|3841097|P3|STARTED|6 - 12 Months (Randomized)||0
1570146|NCT01176617|3841098|P2|STARTED|6 - 12 Months (Randomized)||20
1570147|NCT01176617|3841099|P1|STARTED|6 - 12 Months (Randomized)||18
1570148|NCT01176617|3841097|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
1570149|NCT01176617|3841098|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
1570150|NCT01176617|3841099|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
1570151|NCT01176617|3841097|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
1570152|NCT01176617|3841098|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
1570153|NCT01176617|3841099|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
1570154|NCT01176617|3841097|P3|STARTED|1 - 6 Months (Ron-randomized)||38
1570155|NCT01176617|3841098|P2|STARTED|1 - 6 Months (Ron-randomized)||0
1570156|NCT01176617|3841099|P1|STARTED|1 - 6 Months (Ron-randomized)||0
1570157|NCT01176565|3841110|P2|NOT COMPLETED|Overall Study||19
1570158|NCT01176565|3841111|P1|NOT COMPLETED|Overall Study||20
1570159|NCT01176565|3841110|P2|COMPLETED|Overall Study||481
1570160|NCT01176565|3841111|P1|COMPLETED|Overall Study||480
1570161|NCT01176565|3841110|P2|STARTED|Overall Study||500
1570162|NCT01176565|3841111|P1|STARTED|Overall Study||500
1570163|NCT01176513|3841129|P1|NOT COMPLETED|Overall Study||3
1570164|NCT01176513|3841129|P1|COMPLETED|Overall Study||22
1570165|NCT01176513|3841129|P1|STARTED|Overall Study||25
1570166|NCT01176448|3841134|P1|NOT COMPLETED|Overall Study||0
1570167|NCT01176448|3841134|P1|COMPLETED|Overall Study||6
1570168|NCT01176448|3841134|P1|STARTED|Overall Study||6
1570169|NCT01176435|3841145|P3|NOT COMPLETED|Overall Study||0
1570170|NCT01176435|3841146|P2|NOT COMPLETED|Overall Study||0
1570171|NCT01176435|3841147|P1|NOT COMPLETED|Overall Study||0
1570172|NCT01176435|3841145|P3|COMPLETED|Overall Study||15
1570173|NCT01176435|3841146|P2|COMPLETED|Overall Study||15
1570174|NCT01176435|3841147|P1|COMPLETED|Overall Study||15
1570175|NCT01176435|3841145|P3|STARTED|Overall Study||15
1570176|NCT01176435|3841146|P2|STARTED|Overall Study||15
1570177|NCT01176435|3841147|P1|STARTED|Overall Study||15
1570178|NCT01176292|3841157|P2|NOT COMPLETED|Overall Study||9
1570179|NCT01176292|3841158|P1|NOT COMPLETED|Overall Study||5
1570180|NCT01176292|3841157|P2|COMPLETED|Overall Study||62
1570181|NCT01176292|3841158|P1|COMPLETED|Overall Study||66
1570182|NCT01176292|3841157|P2|STARTED|Overall Study||71
1570183|NCT01176292|3841158|P1|STARTED|Overall Study||71
1570184|NCT01176266|3841176|P1|NOT COMPLETED|Overall Study||9
1570185|NCT01176266|3841176|P1|COMPLETED|Overall Study||60
1570186|NCT01176266|3841176|P1|STARTED|Overall Study||69
1570187|NCT01176240|3841200|P2|NOT COMPLETED|Study 306B||17
1570188|NCT01176240|3841201|P1|NOT COMPLETED|Study 306B||26
1570189|NCT01176240|3841200|P2|COMPLETED|Study 306B||68
1570190|NCT01176240|3841201|P1|COMPLETED|Study 306B||63
1570191|NCT01176240|3841200|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
1570192|NCT01176240|3841201|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
1570193|NCT01176240|3841200|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
1570194|NCT01176240|3841201|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
1570195|NCT01176240|3841200|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
1570196|NCT01176240|3841201|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
1570197|NCT01176240|3841200|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
1570198|NCT01176240|3841201|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
1570199|NCT01176240|3841200|P2|STARTED|Study 306B||85
1570200|NCT01176240|3841201|P1|STARTED|Study 306B||89
1570201|NCT01176240|3841200|P2|NOT COMPLETED|Study 306A||3
1570202|NCT01176240|3841201|P1|NOT COMPLETED|Study 306A||3
1570203|NCT01176240|3841200|P2|COMPLETED|Study 306A||24
1570204|NCT01176240|3841201|P1|COMPLETED|Study 306A||21
1570205|NCT01176240|3841200|P2|STARTED|Study 306A||27
1570206|NCT01176240|3841201|P1|STARTED|Study 306A||24
1570207|NCT01176058|3841227|P2|NOT COMPLETED|Overall Study||3
1570208|NCT01176058|3841228|P1|NOT COMPLETED|Overall Study||4
1570209|NCT01176058|3841227|P2|COMPLETED|Overall Study||5
1570210|NCT01176058|3841228|P1|COMPLETED|Overall Study||5
1570211|NCT01176058|3841227|P2|STARTED|Overall Study||8
1570212|NCT01176058|3841228|P1|STARTED|Overall Study||9
1570213|NCT01176032|3841252|P2|NOT COMPLETED|Overall Study||1
1570214|NCT01176032|3841253|P1|NOT COMPLETED|Overall Study||6
1570215|NCT01176032|3841252|P2|COMPLETED|Overall Study||36
1570216|NCT01176032|3841253|P1|COMPLETED|Overall Study||31
1570217|NCT01176032|3841252|P2|Intention-to-treat (ITT) Population|Overall Study||37
1570218|NCT01176032|3841253|P1|Intention-to-treat (ITT) Population|Overall Study||32
1570219|NCT01176032|3841252|P2|STARTED|Overall Study||37
1570220|NCT01176032|3841253|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
1570221|NCT01175902|3841313|P2|NOT COMPLETED|Overall Study||0
1570222|NCT01175902|3841314|P1|NOT COMPLETED|Overall Study||0
1570223|NCT01175902|3841313|P2|COMPLETED|Overall Study||22
1570224|NCT01175902|3841314|P1|COMPLETED|Overall Study||22
1570225|NCT01175902|3841313|P2|STARTED|Overall Study||22
1570226|NCT01175902|3841314|P1|STARTED|Overall Study||22
1570227|NCT01175850|3841332|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
1570228|NCT01175850|3841333|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
1570229|NCT01175850|3841332|P2|COMPLETED|IN.PACT SFA II Phase||55
1570230|NCT01175850|3841333|P1|COMPLETED|IN.PACT SFA II Phase||109
1570231|NCT01175850|3841332|P2|STARTED|IN.PACT SFA II Phase||60
1570232|NCT01175850|3841333|P1|STARTED|IN.PACT SFA II Phase||121
1570233|NCT01175850|3841332|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
1570234|NCT01175850|3841333|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
1570235|NCT01175850|3841332|P2|COMPLETED|IN.PACT SFA I Phase||49
1570236|NCT01175850|3841333|P1|COMPLETED|IN.PACT SFA I Phase||88
1570237|NCT01175850|3841332|P2|STARTED|IN.PACT SFA I Phase||51
1570238|NCT01175850|3841333|P1|STARTED|IN.PACT SFA I Phase||99
1570239|NCT01175824|3841377|P2|NOT COMPLETED|Overall Study||22
1570240|NCT01175824|3841378|P1|NOT COMPLETED|Overall Study||16
1570241|NCT01175824|3841377|P2|COMPLETED|Overall Study||220
1570242|NCT01175824|3841378|P1|COMPLETED|Overall Study||220
1570243|NCT01175824|3841377|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
1570244|NCT01175824|3841378|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
1570245|NCT01175824|3841377|P2|STARTED|Overall Study||242
1570246|NCT01175824|3841378|P1|STARTED|Overall Study||236
1570247|NCT01175811|3841412|P2|NOT COMPLETED|Overall Study||14
1570248|NCT01175811|3841413|P1|NOT COMPLETED|Overall Study||16
1570249|NCT01175811|3841412|P2|COMPLETED|Overall Study||189
1570250|NCT01175811|3841413|P1|COMPLETED|Overall Study||183
1570251|NCT01175811|3841412|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
1570252|NCT01175811|3841413|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
1570253|NCT01175811|3841412|P2|STARTED|Overall Study||203
1570254|NCT01175811|3841413|P1|STARTED|Overall Study||199
1570255|NCT01175798|3841439|P2|NOT COMPLETED|Overall Study||21
1570256|NCT01175798|3841440|P1|NOT COMPLETED|Overall Study||7
1570257|NCT01175798|3841439|P2|COMPLETED|Overall Study||41
1570258|NCT01175798|3841440|P1|COMPLETED|Overall Study||27
1570259|NCT01175798|3841439|P2|STARTED|Overall Study||62
1570260|NCT01175798|3841440|P1|STARTED|Overall Study||34
1570261|NCT01175707|3841448|P2|NOT COMPLETED|Overall Study||6
1570262|NCT01175707|3841449|P1|NOT COMPLETED|Overall Study||4
1570263|NCT01175707|3841448|P2|COMPLETED|Overall Study||34
1570264|NCT01175707|3841449|P1|COMPLETED|Overall Study||36
1570265|NCT01175707|3841448|P2|STARTED|Overall Study||40
1570266|NCT01175707|3841449|P1|STARTED|Overall Study||40
1570267|NCT01175668|3841485|P2|NOT COMPLETED|Overall Study||0
1570268|NCT01175668|3841486|P1|NOT COMPLETED|Overall Study||2
1570269|NCT01175668|3841485|P2|COMPLETED|Overall Study||34
1570270|NCT01175668|3841486|P1|COMPLETED|Overall Study||32
1570271|NCT01175668|3841485|P2|STARTED|Overall Study||34
1570272|NCT01175668|3841486|P1|STARTED|Overall Study||34
1570273|NCT01175590|3841496|P2|NOT COMPLETED|Overall Study||10
1570274|NCT01175590|3841497|P1|NOT COMPLETED|Overall Study||12
1570275|NCT01175590|3841496|P2|COMPLETED|Overall Study||161
1570276|NCT01175590|3841497|P1|COMPLETED|Overall Study||335
1570277|NCT01175590|3841496|P2|Safety Population|Overall Study||170
1570278|NCT01175590|3841497|P1|Safety Population|Overall Study||344
1570279|NCT01175590|3841496|P2|Modified Intent to Treat Population|Overall Study||87
1570280|NCT01175590|3841497|P1|Modified Intent to Treat Population|Overall Study||212
1570281|NCT01175590|3841496|P2|STARTED|Overall Study||171
1570282|NCT01175590|3841497|P1|STARTED|Overall Study||347
1570283|NCT01175473|3841531|P2|NOT COMPLETED|Overall Study||2
1570284|NCT01175473|3841532|P1|NOT COMPLETED|Overall Study||2
1570285|NCT01175473|3841531|P2|COMPLETED|Overall Study||69
1570286|NCT01175473|3841532|P1|COMPLETED|Overall Study||75
1570287|NCT01175473|3841531|P2|Pharmacodynamic (PD) Population|Overall Study||68
1570288|NCT01175473|3841532|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
1570289|NCT01175473|3841531|P2|Safety Population|Overall Study||71
1570290|NCT01175473|3841532|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
1570291|NCT01175473|3841531|P2|STARTED|Overall Study||71
1570292|NCT01175473|3841532|P1|STARTED|Overall Study|Randomized and treated.|77
1570293|NCT01175434|3841558|P2|NOT COMPLETED|Overall Study||0
1570294|NCT01175434|3841559|P1|NOT COMPLETED|Overall Study||0
1570295|NCT01175434|3841558|P2|COMPLETED|Overall Study||51
1570296|NCT01175434|3841559|P1|COMPLETED|Overall Study||48
1570297|NCT01175434|3841558|P2|STARTED|Overall Study||51
1570298|NCT01175434|3841559|P1|STARTED|Overall Study||48
1570299|NCT01175395|3841565|P1|NOT COMPLETED|Overall Study||0
1570300|NCT01175395|3841565|P1|COMPLETED|Overall Study||10
1570301|NCT01175395|3841565|P1|STARTED|Overall Study||10
1570302|NCT01175382|3841573|P3|NOT COMPLETED|Overall Study||6
1570303|NCT01175382|3841574|P2|NOT COMPLETED|Overall Study||7
1570304|NCT01175382|3841575|P1|NOT COMPLETED|Overall Study||8
1570305|NCT01175382|3841573|P3|COMPLETED|Overall Study||59
1570306|NCT01175382|3841574|P2|COMPLETED|Overall Study||61
1570307|NCT01175382|3841575|P1|COMPLETED|Overall Study||63
1570308|NCT01175382|3841573|P3|STARTED|Overall Study||65
1570309|NCT01175382|3841574|P2|STARTED|Overall Study||68
1570310|NCT01175382|3841575|P1|STARTED|Overall Study||71
1570311|NCT01175369|3841654|P2|NOT COMPLETED|Overall Study||5
1570312|NCT01175369|3841655|P1|NOT COMPLETED|Overall Study||2
1570313|NCT01175369|3841654|P2|COMPLETED|Overall Study||260
1570314|NCT01175369|3841655|P1|COMPLETED|Overall Study||263
1570315|NCT01175369|3841654|P2|STARTED|Overall Study||265
1570316|NCT01175369|3841655|P1|STARTED|Overall Study||265
1570317|NCT01175356|3841661|P1|NOT COMPLETED|Overall Study||81
1570318|NCT01175356|3841661|P1|COMPLETED|Overall Study||18
1570319|NCT01175356|3841661|P1|STARTED|Overall Study||99
1570320|NCT01175343|3841667|P1|NOT COMPLETED|Overall Study||0
1570321|NCT01175343|3841667|P1|COMPLETED|Overall Study||44
1570322|NCT01175343|3841667|P1|STARTED|Overall Study||44
1570323|NCT01175317|3841679|P2|NOT COMPLETED|Overall Study||0
1570324|NCT01175317|3841680|P1|NOT COMPLETED|Overall Study||0
1570325|NCT01175317|3841679|P2|COMPLETED|Overall Study||31
1570326|NCT01175317|3841680|P1|COMPLETED|Overall Study||27
1570327|NCT01175317|3841679|P2|STARTED|Overall Study||31
1570328|NCT01175317|3841680|P1|STARTED|Overall Study||27
1570329|NCT01175226|3841690|P2|NOT COMPLETED|Overall Study||5
1570330|NCT01175226|3841691|P1|NOT COMPLETED|Overall Study||11
1570331|NCT01175226|3841690|P2|COMPLETED|Overall Study||140
1570332|NCT01175226|3841691|P1|COMPLETED|Overall Study||144
1570333|NCT01175226|3841690|P2|STARTED|Overall Study||145
1570334|NCT01175226|3841691|P1|STARTED|Overall Study||155
1570335|NCT01175213|3841701|P2|NOT COMPLETED|Safety Follow-up||0
1570336|NCT01175213|3841702|P1|NOT COMPLETED|Safety Follow-up||1
1570337|NCT01175213|3841701|P2|COMPLETED|Safety Follow-up||3
1570338|NCT01175213|3841702|P1|COMPLETED|Safety Follow-up||47
1570339|NCT01175213|3841701|P2|STARTED|Safety Follow-up||3
1570340|NCT01175213|3841702|P1|STARTED|Safety Follow-up||48
1570341|NCT01175213|3841701|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
1570342|NCT01175213|3841702|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
1570343|NCT01175213|3841701|P2|COMPLETED|IGSC, 10%/rHuPH20||3
1570344|NCT01175213|3841702|P1|COMPLETED|IGSC, 10%/rHuPH20||48
1570345|NCT01175213|3841701|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
1570346|NCT01175213|3841702|P1|STARTED|IGSC, 10%/rHuPH20||63
1570347|NCT01175148|3841749|P2|NOT COMPLETED|Overall Study||0
1570348|NCT01175148|3841750|P1|NOT COMPLETED|Overall Study||0
1570349|NCT01175148|3841749|P2|COMPLETED|Overall Study||30
1570350|NCT01175148|3841750|P1|COMPLETED|Overall Study||30
1570351|NCT01175148|3841749|P2|STARTED|Overall Study||30
1570352|NCT01175148|3841750|P1|STARTED|Overall Study||30
1570353|NCT01175135|3841759|P4|NOT COMPLETED|Overall Study||14
1570354|NCT01175135|3841760|P3|NOT COMPLETED|Overall Study||12
1570355|NCT01175135|3841761|P2|NOT COMPLETED|Overall Study||22
1570356|NCT01175135|3841762|P1|NOT COMPLETED|Overall Study||16
1570357|NCT01175135|3841759|P4|COMPLETED|Overall Study||60
1570358|NCT01175135|3841760|P3|COMPLETED|Overall Study||25
1570359|NCT01175135|3841761|P2|COMPLETED|Overall Study||52
1570360|NCT01175135|3841762|P1|COMPLETED|Overall Study||58
1570361|NCT01175135|3841759|P4|Analyzed for Efficacy|Overall Study||73
1570362|NCT01175135|3841760|P3|Analyzed for Efficacy|Overall Study||34
1570363|NCT01175135|3841761|P2|Analyzed for Efficacy|Overall Study||73
1570364|NCT01175135|3841762|P1|Analyzed for Efficacy|Overall Study||74
1570365|NCT01175135|3841759|P4|Treated|Overall Study||74
1570366|NCT01175135|3841760|P3|Treated|Overall Study||36
1570367|NCT01175135|3841761|P2|Treated|Overall Study||74
1570368|NCT01175135|3841762|P1|Treated|Overall Study||74
1570369|NCT01175135|3841759|P4|STARTED|Overall Study||74
1570370|NCT01175135|3841760|P3|STARTED|Overall Study||37
1570371|NCT01175135|3841761|P2|STARTED|Overall Study||74
1570372|NCT01175135|3841762|P1|STARTED|Overall Study||74
1570373|NCT01175031|3841844|P1|NOT COMPLETED|Overall Study||0
1570374|NCT01175031|3841844|P1|COMPLETED|Overall Study||45
1570375|NCT01175031|3841844|P1|STARTED|Overall Study||45
1570376|NCT01175018|3841854|P2|NOT COMPLETED|Overall Study||1
1570377|NCT01175018|3841855|P1|NOT COMPLETED|Overall Study||3
1570378|NCT01175018|3841854|P2|COMPLETED|Overall Study||14
1570379|NCT01175018|3841855|P1|COMPLETED|Overall Study||12
1570380|NCT01175018|3841854|P2|STARTED|Overall Study||15
1570381|NCT01175018|3841855|P1|STARTED|Overall Study||15
1570382|NCT01175005|3841891|P1|NOT COMPLETED|Overall Study||0
1570383|NCT01175005|3841891|P1|COMPLETED|Overall Study||62
1570384|NCT01175005|3841891|P1|STARTED|Overall Study||62
1570385|NCT01174784|3841896|P1|NOT COMPLETED|Overall Study||0
1570386|NCT01174784|3841896|P1|COMPLETED|Overall Study||88
1570387|NCT01174784|3841896|P1|STARTED|Overall Study||88
1570388|NCT01174576|3841901|P1|NOT COMPLETED|Overall Study||0
1570389|NCT01174576|3841901|P1|COMPLETED|Overall Study||16
1570390|NCT01174576|3841901|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
1570391|NCT01174563|3841942|P1|NOT COMPLETED|Overall Study||60
1570392|NCT01174563|3841942|P1|COMPLETED|Overall Study||0
1570393|NCT01174563|3841942|P1|Safety Set|Overall Study||59
1570394|NCT01174563|3841942|P1|Efficacy Set|Overall Study||59
1570395|NCT01174563|3841942|P1|STARTED|Overall Study||60
1570396|NCT01174550|3841950|P2|NOT COMPLETED|Overall Study||873
1570397|NCT01174550|3841951|P1|NOT COMPLETED|Overall Study||1270
1570398|NCT01174550|3841950|P2|COMPLETED|Overall Study||4123
1570399|NCT01174550|3841951|P1|COMPLETED|Overall Study||3737
1570400|NCT01174550|3841950|P2|STARTED|Overall Study||4996
1570401|NCT01174550|3841951|P1|STARTED|Overall Study||5007
1570402|NCT01174459|3841979|P1|NOT COMPLETED|Overall Study||5
1570403|NCT01174459|3841979|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
1570404|NCT01174459|3841979|P1|STARTED|Overall Study|Registered patients|571
1570405|NCT01174446|3841984|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1570406|NCT01174446|3841985|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1570407|NCT01174446|3841986|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
1570408|NCT01174446|3841987|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
1570409|NCT01174446|3841984|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1570410|NCT01174446|3841985|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1570411|NCT01174446|3841986|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
1570412|NCT01174446|3841987|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
1570413|NCT01174446|3841984|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
1570414|NCT01174446|3841985|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
1570415|NCT01174446|3841986|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
1570416|NCT01174446|3841987|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
1570417|NCT01174446|3841984|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
1570418|NCT01174446|3841985|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
1570419|NCT01174446|3841986|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
1570420|NCT01174446|3841987|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
1570421|NCT01174446|3841984|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
1570422|NCT01174446|3841985|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
1570423|NCT01174446|3841986|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
1570424|NCT01174446|3841987|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
1570425|NCT01174446|3841984|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
1570426|NCT01174446|3841985|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
1570427|NCT01174446|3841986|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
1570428|NCT01174446|3841987|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
1570429|NCT01174446|3841984|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1570430|NCT01174446|3841985|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1570431|NCT01174446|3841986|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1570432|NCT01174446|3841987|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1570433|NCT01174446|3841984|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1570434|NCT01174446|3841985|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1570435|NCT01174446|3841986|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
1570436|NCT01174446|3841987|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
1570437|NCT01174446|3841984|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
1570438|NCT01174446|3841985|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
1570439|NCT01174446|3841986|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
1570440|NCT01174446|3841987|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
1570441|NCT01174368|3842174|P1|NOT COMPLETED|Overall Study||1
1570442|NCT01174368|3842174|P1|COMPLETED|Overall Study||0
1570443|NCT01174368|3842174|P1|STARTED|Overall Study||1
1570444|NCT01174342|3842180|P1|NOT COMPLETED|Overall Study||4
1570445|NCT01174342|3842180|P1|COMPLETED|Overall Study||26
1570446|NCT01174342|3842180|P1|STARTED|Overall Study||30
1570447|NCT01174264|3842187|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
1570448|NCT01174264|3842188|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
1570449|NCT01174264|3842189|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
1570450|NCT01174264|3842187|P3|COMPLETED|Steady-state Pharmacokinetics||27
1570451|NCT01174264|3842188|P2|COMPLETED|Steady-state Pharmacokinetics||0
1570452|NCT01174264|3842189|P1|COMPLETED|Steady-state Pharmacokinetics||25
1570453|NCT01174264|3842187|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
1570454|NCT01174264|3842188|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
1570455|NCT01174264|3842189|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
1570456|NCT01174264|3842187|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
1570457|NCT01174264|3842188|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
1570458|NCT01174264|3842189|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
1570459|NCT01174264|3842187|P3|COMPLETED|Single Dose Pharmacokinetics||18
1570460|NCT01174264|3842188|P2|COMPLETED|Single Dose Pharmacokinetics||20
1570461|NCT01174264|3842189|P1|COMPLETED|Single Dose Pharmacokinetics||22
1570462|NCT01174264|3842187|P3|STARTED|Single Dose Pharmacokinetics||20
1570463|NCT01174264|3842188|P2|STARTED|Single Dose Pharmacokinetics||20
1570464|NCT01174264|3842189|P1|STARTED|Single Dose Pharmacokinetics||23
1570465|NCT01174238|3842221|P1|NOT COMPLETED|Overall Study||2
1570466|NCT01174238|3842221|P1|COMPLETED|Overall Study||36
1570467|NCT01174238|3842221|P1|Participants That Underwent FLT-PET Scan|Overall Study||6
1570468|NCT01174238|3842221|P1|STARTED|Overall Study||38
1570469|NCT01174186|3842232|P2|NOT COMPLETED|Overall Study||3
1570470|NCT01174186|3842233|P1|NOT COMPLETED|Overall Study||0
1570471|NCT01174186|3842232|P2|COMPLETED|Overall Study||12
1570472|NCT01174186|3842233|P1|COMPLETED|Overall Study||15
1570473|NCT01174186|3842232|P2|STARTED|Overall Study||15
1570474|NCT01174186|3842233|P1|STARTED|Overall Study|Patients were included over three years|15
1570475|NCT01174173|3842240|P1|NOT COMPLETED|Overall Study||1
1570476|NCT01174173|3842240|P1|COMPLETED|Overall Study||10
1570477|NCT01174173|3842240|P1|STARTED|Overall Study||11
1570478|NCT01174160|3842251|P2|NOT COMPLETED|Overall Study||6
1570479|NCT01174160|3842252|P1|NOT COMPLETED|Overall Study||8
1570480|NCT01174160|3842251|P2|COMPLETED|Overall Study||56
1570481|NCT01174160|3842252|P1|COMPLETED|Overall Study||53
1570482|NCT01174160|3842251|P2|Discontinued Post Dose|Overall Study||0
1570483|NCT01174160|3842252|P1|Discontinued Post Dose|Overall Study||2
1570484|NCT01174160|3842251|P2|Dosed|Overall Study||56
1570485|NCT01174160|3842252|P1|Dosed|Overall Study||55
1570486|NCT01174160|3842251|P2|Discontinued Pre Dose|Overall Study||6
1570487|NCT01174160|3842252|P1|Discontinued Pre Dose|Overall Study||6
1570488|NCT01174160|3842251|P2|STARTED|Overall Study||62
1570489|NCT01174160|3842252|P1|STARTED|Overall Study||61
1570490|NCT01174082|3842260|P2|NOT COMPLETED|Overall Study||0
1570491|NCT01174082|3842261|P1|NOT COMPLETED|Overall Study||0
1570492|NCT01174082|3842260|P2|COMPLETED|Overall Study||1
1570493|NCT01174082|3842261|P1|COMPLETED|Overall Study||1
1570494|NCT01174082|3842260|P2|STARTED|Overall Study||1
1570495|NCT01174082|3842261|P1|STARTED|Overall Study||1
1570496|NCT01174043|3842267|P1|NOT COMPLETED|Overall Study||11
1570497|NCT01174043|3842267|P1|COMPLETED|Overall Study||0
1570498|NCT01174043|3842267|P1|STARTED|Overall Study||11
1570499|NCT01174030|3842278|P5|NOT COMPLETED|Overall Study||1
1570500|NCT01174030|3842279|P4|NOT COMPLETED|Overall Study||2
1570501|NCT01174030|3842280|P3|NOT COMPLETED|Overall Study||2
1570502|NCT01174030|3842281|P2|NOT COMPLETED|Overall Study||2
1570503|NCT01174030|3842282|P1|NOT COMPLETED|Overall Study||2
1570504|NCT01174030|3842278|P5|COMPLETED|Overall Study||52
1570505|NCT01174030|3842279|P4|COMPLETED|Overall Study||53
1570506|NCT01174030|3842280|P3|COMPLETED|Overall Study||52
1570507|NCT01174030|3842281|P2|COMPLETED|Overall Study||52
1570508|NCT01174030|3842282|P1|COMPLETED|Overall Study||51
1570509|NCT01174030|3842278|P5|STARTED|Overall Study||53
1570510|NCT01174030|3842279|P4|STARTED|Overall Study||55
1570511|NCT01174030|3842280|P3|STARTED|Overall Study||54
1570512|NCT01174030|3842281|P2|STARTED|Overall Study||54
1570513|NCT01174030|3842282|P1|STARTED|Overall Study||53
1570514|NCT01174004|3842306|P2|NOT COMPLETED|Overall Study||16
1570515|NCT01174004|3842307|P1|NOT COMPLETED|Overall Study||7
1570516|NCT01174004|3842306|P2|COMPLETED|Overall Study||89
1570517|NCT01174004|3842307|P1|COMPLETED|Overall Study||87
1570518|NCT01174004|3842306|P2|STARTED|Overall Study||105
1570519|NCT01174004|3842307|P1|STARTED|Overall Study||94
1570520|NCT01173874|3842317|P2|NOT COMPLETED|Overall Study||23
1570521|NCT01173874|3842318|P1|NOT COMPLETED|Overall Study||23
1570522|NCT01173874|3842317|P2|COMPLETED|Overall Study||41
1570523|NCT01173874|3842318|P1|COMPLETED|Overall Study||33
1570524|NCT01173874|3842317|P2|STARTED|Overall Study||64
1570525|NCT01173874|3842318|P1|STARTED|Overall Study||56
1570526|NCT01173848|3842332|P2|NOT COMPLETED|Overall Study||8
1570527|NCT01173848|3842333|P1|NOT COMPLETED|Overall Study||4
1570528|NCT01173848|3842332|P2|COMPLETED|Overall Study||3
1570529|NCT01173848|3842333|P1|COMPLETED|Overall Study||4
1570530|NCT01173848|3842332|P2|STARTED|Overall Study||11
1570531|NCT01173848|3842333|P1|STARTED|Overall Study||8
1570532|NCT01173718|3842338|P1|NOT COMPLETED|Overall Study||44
1570533|NCT01173718|3842338|P1|COMPLETED|Overall Study||94
1570534|NCT01173718|3842338|P1|STARTED|Overall Study||138
1570535|NCT01173679|3842347|P1|NOT COMPLETED|Overall Study||1
1570536|NCT01173679|3842347|P1|COMPLETED|Overall Study||9
1570537|NCT01173679|3842347|P1|STARTED|Overall Study||10
1570538|NCT01173653|3842355|P2|NOT COMPLETED|Overall Study||41
1570539|NCT01173653|3842356|P1|NOT COMPLETED|Overall Study||53
1570540|NCT01173653|3842355|P2|COMPLETED|Overall Study||49
1570541|NCT01173653|3842356|P1|COMPLETED|Overall Study||56
1570542|NCT01173653|3842355|P2|STARTED|Overall Study||90
1570543|NCT01173653|3842356|P1|STARTED|Overall Study||109
1570544|NCT01173601|3842366|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
1570545|NCT01173601|3842367|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
1570546|NCT01173601|3842368|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
1570547|NCT01173601|3842369|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
1570548|NCT01173601|3842370|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1570549|NCT01173601|3842366|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
1570550|NCT01173601|3842367|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
1570551|NCT01173601|3842368|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
1570552|NCT01173601|3842369|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
1570553|NCT01173601|3842370|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1570554|NCT01173601|3842366|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
1570555|NCT01173601|3842367|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
1570556|NCT01173601|3842368|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
1570557|NCT01173601|3842369|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
1570558|NCT01173601|3842370|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1570559|NCT01173601|3842366|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1570560|NCT01173601|3842367|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1570561|NCT01173601|3842368|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
1570562|NCT01173601|3842369|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
1570563|NCT01173601|3842370|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1570564|NCT01173601|3842366|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
1570565|NCT01173601|3842367|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
1570566|NCT01173601|3842368|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
1570567|NCT01173601|3842369|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
1570568|NCT01173601|3842370|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
1570569|NCT01173601|3842366|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1570570|NCT01173601|3842367|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1570571|NCT01173601|3842368|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1570572|NCT01173601|3842369|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1570573|NCT01173601|3842370|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
1570574|NCT01173601|3842366|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1570575|NCT01173601|3842367|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1570576|NCT01173601|3842368|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1570577|NCT01173601|3842369|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
1570578|NCT01173601|3842370|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
1570579|NCT01173601|3842366|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
1570580|NCT01173601|3842367|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
1570581|NCT01173601|3842368|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
1570582|NCT01173601|3842369|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
1570583|NCT01173601|3842370|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
1570584|NCT01173601|3842366|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1570585|NCT01173601|3842367|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1570586|NCT01173601|3842368|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1570587|NCT01173601|3842369|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
1570588|NCT01173601|3842370|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
1570589|NCT01173523|3842447|P2|NOT COMPLETED|Overall Study||12
1570590|NCT01173523|3842448|P1|NOT COMPLETED|Overall Study||13
1570591|NCT01173523|3842447|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1570592|NCT01173523|3842448|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1570593|NCT01173523|3842447|P2|STARTED|Overall Study||12
1570594|NCT01173523|3842448|P1|STARTED|Overall Study||13
1570595|NCT01173471|3842464|P4|NOT COMPLETED|Overall Study||1
1570596|NCT01173471|3842465|P3|NOT COMPLETED|Overall Study||3
1570597|NCT01173471|3842466|P2|NOT COMPLETED|Overall Study||0
1570598|NCT01173471|3842467|P1|NOT COMPLETED|Overall Study||2
1570599|NCT01173471|3842464|P4|COMPLETED|Overall Study|Completed study|18
1570600|NCT01173471|3842465|P3|COMPLETED|Overall Study|Completed study|15
1570601|NCT01173471|3842466|P2|COMPLETED|Overall Study|Completed study|7
1570602|NCT01173471|3842467|P1|COMPLETED|Overall Study|Completed study|4
1570603|NCT01173471|3842464|P4|Completed Treatment|Overall Study||18
1570604|NCT01173471|3842465|P3|Completed Treatment|Overall Study||15
1570605|NCT01173471|3842466|P2|Completed Treatment|Overall Study||7
1570606|NCT01173471|3842467|P1|Completed Treatment|Overall Study||4
1570607|NCT01173471|3842464|P4|Received Treatment|Overall Study||19
1570608|NCT01173471|3842465|P3|Received Treatment|Overall Study||18
1570609|NCT01173471|3842466|P2|Received Treatment|Overall Study||7
1570610|NCT01173471|3842467|P1|Received Treatment|Overall Study||6
1570611|NCT01173471|3842464|P4|STARTED|Overall Study|Randomized|19
1570612|NCT01173471|3842465|P3|STARTED|Overall Study|Randomized|18
1570613|NCT01173471|3842466|P2|STARTED|Overall Study|Randomized|7
1570614|NCT01173471|3842467|P1|STARTED|Overall Study|Randomized|6
1570615|NCT01173211|3842491|P6|NOT COMPLETED|Overall Study||0
1570616|NCT01173211|3842492|P5|NOT COMPLETED|Overall Study||0
1570617|NCT01173211|3842493|P4|NOT COMPLETED|Overall Study||0
1570618|NCT01173211|3842494|P3|NOT COMPLETED|Overall Study||2
1570619|NCT01173211|3842495|P2|NOT COMPLETED|Overall Study||1
1570620|NCT01173211|3842496|P1|NOT COMPLETED|Overall Study||2
1570621|NCT01173211|3842491|P6|COMPLETED|Overall Study||13
1570622|NCT01173211|3842492|P5|COMPLETED|Overall Study||16
1570623|NCT01173211|3842493|P4|COMPLETED|Overall Study||15
1570624|NCT01173211|3842494|P3|COMPLETED|Overall Study||44
1570625|NCT01173211|3842495|P2|COMPLETED|Overall Study||44
1570626|NCT01173211|3842496|P1|COMPLETED|Overall Study||46
1570627|NCT01173211|3842491|P6|STARTED|Overall Study||13
1570628|NCT01173211|3842492|P5|STARTED|Overall Study||16
1570629|NCT01173211|3842493|P4|STARTED|Overall Study||15
1570630|NCT01173211|3842494|P3|STARTED|Overall Study||46
1570631|NCT01173211|3842495|P2|STARTED|Overall Study||45
1570632|NCT01173211|3842496|P1|STARTED|Overall Study||48
1570633|NCT01173120|3842597|P1|NOT COMPLETED|Overall Study||62
1570634|NCT01173120|3842597|P1|COMPLETED|Overall Study||0
1570635|NCT01173120|3842597|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
1570636|NCT01173120|3842597|P1|Switched Back to Main Study|Overall Study||57
1570637|NCT01173120|3842597|P1|STARTED|Overall Study||62
1570638|NCT01173055|3842615|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
1570639|NCT01173055|3842616|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
1570640|NCT01173055|3842615|P2|COMPLETED|Period 2 - Day 64 to 112||9
1570641|NCT01173055|3842616|P1|COMPLETED|Period 2 - Day 64 to 112||8
1570642|NCT01173055|3842615|P2|STARTED|Period 2 - Day 64 to 112||10
1570643|NCT01173055|3842616|P1|STARTED|Period 2 - Day 64 to 112||8
1570644|NCT01173055|3842615|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
1570645|NCT01173055|3842616|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
1570646|NCT01173055|3842615|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
1570647|NCT01173055|3842616|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
1570648|NCT01173055|3842615|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
1570649|NCT01173055|3842616|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
1570650|NCT01173055|3842615|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
1570651|NCT01173055|3842616|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
1570652|NCT01173055|3842615|P2|COMPLETED|Period 1 - Day 1 to 49||10
1570653|NCT01173055|3842616|P1|COMPLETED|Period 1 - Day 1 to 49||8
1570654|NCT01173055|3842615|P2|STARTED|Period 1 - Day 1 to 49||12
1570655|NCT01173055|3842616|P1|STARTED|Period 1 - Day 1 to 49||10
1570656|NCT01173029|3842634|P2|NOT COMPLETED|Overall Study||0
1570657|NCT01173029|3842635|P1|NOT COMPLETED|Overall Study||0
1570658|NCT01173029|3842634|P2|COMPLETED|Overall Study||31
1570659|NCT01173029|3842635|P1|COMPLETED|Overall Study||61
1570660|NCT01173029|3842634|P2|STARTED|Overall Study||31
1570661|NCT01173029|3842635|P1|STARTED|Overall Study||61
1570662|NCT01172938|3842655|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
1570663|NCT01172938|3842656|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
1570664|NCT01172938|3842657|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570665|NCT01172938|3842658|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570666|NCT01172938|3842659|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570667|NCT01172938|3842660|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570668|NCT01172938|3842661|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
1570669|NCT01172938|3842662|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
1570670|NCT01172938|3842663|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570671|NCT01172938|3842655|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
1570672|NCT01172938|3842656|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
1570673|NCT01172938|3842657|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570674|NCT01172938|3842658|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570675|NCT01172938|3842659|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570676|NCT01172938|3842660|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570677|NCT01172938|3842661|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
1570678|NCT01172938|3842662|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
1570679|NCT01172938|3842663|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
1570680|NCT01172938|3842655|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1570681|NCT01172938|3842656|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
1570682|NCT01172938|3842657|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1570683|NCT01172938|3842658|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1570684|NCT01172938|3842659|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1570685|NCT01172938|3842660|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1570686|NCT01172938|3842661|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1570687|NCT01172938|3842662|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1570688|NCT01172938|3842663|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
1570689|NCT01172938|3842655|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
1570690|NCT01172938|3842656|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
1570691|NCT01172938|3842657|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1570692|NCT01172938|3842658|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1570693|NCT01172938|3842659|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1570694|NCT01172938|3842660|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1570695|NCT01172938|3842661|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
1570696|NCT01172938|3842662|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
1570697|NCT01172938|3842663|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
1570698|NCT01172938|3842655|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
1570699|NCT01172938|3842656|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
1570700|NCT01172938|3842657|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570701|NCT01172938|3842658|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570702|NCT01172938|3842659|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570703|NCT01172938|3842660|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570704|NCT01172938|3842661|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
1570705|NCT01172938|3842662|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
1570706|NCT01172938|3842663|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570707|NCT01172938|3842655|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
1570708|NCT01172938|3842656|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
1570709|NCT01172938|3842657|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570710|NCT01172938|3842658|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570711|NCT01172938|3842659|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570712|NCT01172938|3842660|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570713|NCT01172938|3842661|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
1570714|NCT01172938|3842662|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
1570715|NCT01172938|3842663|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
1570716|NCT01172938|3842655|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
1570717|NCT01172938|3842656|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
1570718|NCT01172938|3842657|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1570719|NCT01172938|3842658|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1570720|NCT01172938|3842659|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1570721|NCT01172938|3842660|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1570722|NCT01172938|3842661|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
1570723|NCT01172938|3842662|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
1570724|NCT01172938|3842663|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
1570725|NCT01172938|3842655|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
1570726|NCT01172938|3842656|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
1570727|NCT01172938|3842657|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570728|NCT01172938|3842658|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570729|NCT01172938|3842659|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570730|NCT01172938|3842660|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570731|NCT01172938|3842661|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
1570732|NCT01172938|3842662|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
1570733|NCT01172938|3842663|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570734|NCT01172938|3842655|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
1570735|NCT01172938|3842656|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
1570736|NCT01172938|3842657|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570737|NCT01172938|3842658|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570738|NCT01172938|3842659|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570739|NCT01172938|3842660|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570740|NCT01172938|3842661|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
1570741|NCT01172938|3842662|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
1570742|NCT01172938|3842663|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
1570743|NCT01172938|3842655|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
1570744|NCT01172938|3842656|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
1570745|NCT01172938|3842657|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
1570746|NCT01172938|3842658|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
1570747|NCT01172938|3842659|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
1570748|NCT01172938|3842660|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
1570749|NCT01172938|3842661|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
1570750|NCT01172938|3842662|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
1570751|NCT01172938|3842663|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
1570752|NCT01172938|3842655|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
1570753|NCT01172938|3842656|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
1570754|NCT01172938|3842657|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570755|NCT01172938|3842658|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570756|NCT01172938|3842659|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570757|NCT01172938|3842660|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570758|NCT01172938|3842661|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
1570759|NCT01172938|3842662|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
1570760|NCT01172938|3842663|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570761|NCT01172938|3842655|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
1570762|NCT01172938|3842656|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
1570763|NCT01172938|3842657|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570764|NCT01172938|3842658|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570765|NCT01172938|3842659|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570766|NCT01172938|3842660|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570767|NCT01172938|3842661|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
1570768|NCT01172938|3842662|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
1570769|NCT01172938|3842663|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
1570770|NCT01172938|3842655|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
1570771|NCT01172938|3842656|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
1570772|NCT01172938|3842657|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1570773|NCT01172938|3842658|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1570774|NCT01172938|3842659|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1570775|NCT01172938|3842660|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1570776|NCT01172938|3842661|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
1570777|NCT01172938|3842662|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
1570778|NCT01172938|3842663|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
1570779|NCT01172938|3842655|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1570780|NCT01172938|3842656|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1570781|NCT01172938|3842657|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
1570782|NCT01172938|3842658|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
1570783|NCT01172938|3842659|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
1570784|NCT01172938|3842660|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
1570785|NCT01172938|3842661|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
1570786|NCT01172938|3842662|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
1570787|NCT01172938|3842663|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1570788|NCT01172938|3842655|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1570789|NCT01172938|3842656|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1570790|NCT01172938|3842657|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
1570791|NCT01172938|3842658|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
1570792|NCT01172938|3842659|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
1570793|NCT01172938|3842660|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
1570794|NCT01172938|3842661|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
1570795|NCT01172938|3842662|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
1570796|NCT01172938|3842663|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
1570797|NCT01172938|3842655|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
1570798|NCT01172938|3842656|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
1570799|NCT01172938|3842657|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
1570800|NCT01172938|3842658|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
1570801|NCT01172938|3842659|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
1570802|NCT01172938|3842660|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
1570803|NCT01172938|3842661|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
1570804|NCT01172938|3842662|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
1570805|NCT01172938|3842663|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
1570806|NCT01172938|3842655|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570807|NCT01172938|3842656|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570808|NCT01172938|3842657|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570809|NCT01172938|3842658|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570810|NCT01172938|3842659|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570811|NCT01172938|3842660|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570812|NCT01172938|3842661|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
1570813|NCT01172938|3842662|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
1570814|NCT01172938|3842663|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
1570815|NCT01172938|3842655|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570816|NCT01172938|3842656|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570817|NCT01172938|3842657|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570818|NCT01172938|3842658|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570819|NCT01172938|3842659|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570820|NCT01172938|3842660|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
1570821|NCT01172938|3842661|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
1570822|NCT01172938|3842662|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
1570823|NCT01172938|3842663|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
1570824|NCT01172938|3842655|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1570825|NCT01172938|3842656|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1570826|NCT01172938|3842657|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1570827|NCT01172938|3842658|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1570828|NCT01172938|3842659|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1570829|NCT01172938|3842660|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
1570830|NCT01172938|3842661|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
1570831|NCT01172938|3842662|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
1570832|NCT01172938|3842663|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
1570833|NCT01172938|3842655|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1570834|NCT01172938|3842656|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1570835|NCT01172938|3842657|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1570836|NCT01172938|3842658|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1570837|NCT01172938|3842659|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1570838|NCT01172938|3842660|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
1570839|NCT01172938|3842661|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
1570840|NCT01172938|3842662|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
1570841|NCT01172938|3842663|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
1570842|NCT01172938|3842655|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1570843|NCT01172938|3842656|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1570844|NCT01172938|3842657|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1570845|NCT01172938|3842658|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1570846|NCT01172938|3842659|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1570847|NCT01172938|3842660|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
1570848|NCT01172938|3842661|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
1570849|NCT01172938|3842662|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
1570850|NCT01172938|3842663|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
1570851|NCT01172938|3842655|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
1570852|NCT01172938|3842656|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
1570853|NCT01172938|3842657|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
1570854|NCT01172938|3842658|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
1570855|NCT01172938|3842659|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
1570856|NCT01172938|3842660|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
1570857|NCT01172938|3842661|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
1570858|NCT01172938|3842662|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
1570859|NCT01172938|3842663|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
1570860|NCT01172873|3842849|P2|NOT COMPLETED|Overall Study||2
1570861|NCT01172873|3842850|P1|NOT COMPLETED|Overall Study||3
1570862|NCT01172873|3842849|P2|COMPLETED|Overall Study||3
1570863|NCT01172873|3842850|P1|COMPLETED|Overall Study||8
1570864|NCT01172873|3842849|P2|STARTED|Overall Study||5
1570865|NCT01172873|3842850|P1|STARTED|Overall Study||11
1570866|NCT01172847|3842860|P1|NOT COMPLETED|Overall Study||3
1570867|NCT01172847|3842860|P1|COMPLETED|Overall Study||21
1570868|NCT01172847|3842860|P1|Oseltamivir + Rimantadine|Overall Study||21
1570869|NCT01172847|3842860|P1|Rimantadine|Overall Study||22
1570870|NCT01172847|3842860|P1|Oseltamivir|Overall Study||24
1570871|NCT01172847|3842860|P1|STARTED|Overall Study||24
1570872|NCT01172821|3842889|P4|NOT COMPLETED|Overall Study||17
1570873|NCT01172821|3842890|P3|NOT COMPLETED|Overall Study||13
1570874|NCT01172821|3842891|P2|NOT COMPLETED|Overall Study||12
1570875|NCT01172821|3842892|P1|NOT COMPLETED|Overall Study||14
1570876|NCT01172821|3842889|P4|COMPLETED|Overall Study||249
1570877|NCT01172821|3842890|P3|COMPLETED|Overall Study||240
1570878|NCT01172821|3842891|P2|COMPLETED|Overall Study||245
1570879|NCT01172821|3842892|P1|COMPLETED|Overall Study||240
1570880|NCT01172821|3842889|P4|STARTED|Overall Study|Entered and Treated|266
1570881|NCT01172821|3842890|P3|STARTED|Overall Study|Entered and Treated|253
1570882|NCT01172821|3842891|P2|STARTED|Overall Study|Entered and Treated|257
1570883|NCT01172821|3842892|P1|STARTED|Overall Study|Entered and Treated|254
1570884|NCT01172808|3842982|P4|NOT COMPLETED|Overall Study||15
1570885|NCT01172808|3842983|P3|NOT COMPLETED|Overall Study||23
1570886|NCT01172808|3842984|P2|NOT COMPLETED|Overall Study||13
1570887|NCT01172808|3842985|P1|NOT COMPLETED|Overall Study||21
1570888|NCT01172808|3842982|P4|COMPLETED|Overall Study||260
1570889|NCT01172808|3842983|P3|COMPLETED|Overall Study||241
1570890|NCT01172808|3842984|P2|COMPLETED|Overall Study||249
1570891|NCT01172808|3842985|P1|COMPLETED|Overall Study||248
1570892|NCT01172808|3842982|P4|STARTED|Overall Study|Entered and Treated|275
1570893|NCT01172808|3842983|P3|STARTED|Overall Study|Entered and Treated|264
1570894|NCT01172808|3842984|P2|STARTED|Overall Study|Entered and Treated|262
1570895|NCT01172808|3842985|P1|STARTED|Overall Study|Entered and Treated|269
1570896|NCT01172639|3843076|P5|NOT COMPLETED|Overall Study||6
1570897|NCT01172639|3843077|P4|NOT COMPLETED|Overall Study||11
1570898|NCT01172639|3843078|P3|NOT COMPLETED|Overall Study||16
1570899|NCT01172639|3843079|P2|NOT COMPLETED|Overall Study||11
1570900|NCT01172639|3843080|P1|NOT COMPLETED|Overall Study||13
1570901|NCT01172639|3843076|P5|COMPLETED|Overall Study||41
1570902|NCT01172639|3843077|P4|COMPLETED|Overall Study||32
1570903|NCT01172639|3843078|P3|COMPLETED|Overall Study||77
1570904|NCT01172639|3843079|P2|COMPLETED|Overall Study||87
1570905|NCT01172639|3843080|P1|COMPLETED|Overall Study||85
1570906|NCT01172639|3843076|P5|Week 52|Overall Study||45
1570907|NCT01172639|3843077|P4|Week 52|Overall Study||38
1570908|NCT01172639|3843078|P3|Week 52|Overall Study||88
1570909|NCT01172639|3843079|P2|Week 52|Overall Study||89
1570910|NCT01172639|3843080|P1|Week 52|Overall Study||89
1570911|NCT01172639|3843076|P5|Week 16|Overall Study||47
1570912|NCT01172639|3843077|P4|Week 16|Overall Study||39
1570913|NCT01172639|3843078|P3|Week 16|Overall Study||91
1570914|NCT01172639|3843079|P2|Week 16|Overall Study||96
1570915|NCT01172639|3843080|P1|Week 16|Overall Study||94
1570916|NCT01172639|3843076|P5|STARTED|Overall Study||47
1570917|NCT01172639|3843077|P4|STARTED|Overall Study||43
1570918|NCT01172639|3843078|P3|STARTED|Overall Study||93
1570919|NCT01172639|3843079|P2|STARTED|Overall Study||98
1570920|NCT01172639|3843080|P1|STARTED|Overall Study||98
1570921|NCT01172600|3843124|P2|NOT COMPLETED|Overall Study||0
1570922|NCT01172600|3843125|P1|NOT COMPLETED|Overall Study||0
1570923|NCT01172600|3843124|P2|COMPLETED|Overall Study||39
1570924|NCT01172600|3843125|P1|COMPLETED|Overall Study||39
1570925|NCT01172600|3843124|P2|STARTED|Overall Study||39
1570926|NCT01172600|3843125|P1|STARTED|Overall Study||39
1570927|NCT01172535|3843155|P1|NOT COMPLETED|Overall Study||8
1570928|NCT01172535|3843155|P1|COMPLETED|Overall Study||89
1570929|NCT01172535|3843155|P1|STARTED|Overall Study||97
1570930|NCT01172522|3843172|P2|NOT COMPLETED|Overall Study||0
1570931|NCT01172522|3843173|P1|NOT COMPLETED|Overall Study||0
1570932|NCT01172522|3843172|P2|COMPLETED|Overall Study||15
1570933|NCT01172522|3843173|P1|COMPLETED|Overall Study||15
1570934|NCT01172522|3843172|P2|STARTED|Overall Study||15
1570935|NCT01172522|3843173|P1|STARTED|Overall Study||15
1570936|NCT01172418|3843180|P2|NOT COMPLETED|Overall Study||0
1570937|NCT01172418|3843181|P1|NOT COMPLETED|Overall Study||0
1570938|NCT01172418|3843180|P2|COMPLETED|Overall Study||100
1570939|NCT01172418|3843181|P1|COMPLETED|Overall Study||100
1570940|NCT01172418|3843180|P2|STARTED|Overall Study||100
1570941|NCT01172418|3843181|P1|STARTED|Overall Study||100
1570942|NCT01172353|3843197|P2|NOT COMPLETED|Overall Study||0
1570943|NCT01172353|3843198|P1|NOT COMPLETED|Overall Study||0
1570944|NCT01172353|3843197|P2|COMPLETED|Overall Study||151
1570945|NCT01172353|3843198|P1|COMPLETED|Overall Study||150
1570946|NCT01172353|3843197|P2|STARTED|Overall Study||151
1570947|NCT01172353|3843198|P1|STARTED|Overall Study||150
1570948|NCT01172288|3843208|P2|NOT COMPLETED|Overall Study||1
1570949|NCT01172288|3843209|P1|NOT COMPLETED|Overall Study||1
1570950|NCT01172288|3843208|P2|COMPLETED|Overall Study||13
1570951|NCT01172288|3843209|P1|COMPLETED|Overall Study||16
1570952|NCT01172288|3843208|P2|STARTED|Overall Study||14
1570953|NCT01172288|3843209|P1|STARTED|Overall Study||17
1570954|NCT01172197|3843225|P2|NOT COMPLETED|Overall Study||0
1570955|NCT01172197|3843226|P1|NOT COMPLETED|Overall Study||0
1570956|NCT01172197|3843225|P2|COMPLETED|Overall Study||7
1570957|NCT01172197|3843226|P1|COMPLETED|Overall Study||7
1570958|NCT01172197|3843225|P2|STARTED|Overall Study||7
1570959|NCT01172197|3843226|P1|STARTED|Overall Study||7
1570960|NCT01172184|3843232|P1|NOT COMPLETED|Overall Study||0
1570961|NCT01172184|3843232|P1|COMPLETED|Overall Study||111
1570962|NCT01172184|3843232|P1|STARTED|Overall Study||111
1570963|NCT01172145|3843240|P2|NOT COMPLETED|Overall Study||0
1570964|NCT01172145|3843241|P1|NOT COMPLETED|Overall Study||0
1570965|NCT01172145|3843240|P2|COMPLETED|Overall Study||11
1570966|NCT01172145|3843241|P1|COMPLETED|Overall Study||11
1570967|NCT01172145|3843240|P2|STARTED|Overall Study||11
1570968|NCT01172145|3843241|P1|STARTED|Overall Study||11
1570969|NCT01171989|3843264|P3|NOT COMPLETED|Overall Study||1
1570970|NCT01171989|3843265|P2|NOT COMPLETED|Overall Study||0
1570971|NCT01171989|3843266|P1|NOT COMPLETED|Overall Study||0
1570972|NCT01171989|3843264|P3|COMPLETED|Overall Study||120
1570973|NCT01171989|3843265|P2|COMPLETED|Overall Study||133
1570974|NCT01171989|3843266|P1|COMPLETED|Overall Study||137
1570975|NCT01171989|3843264|P3|STARTED|Overall Study||121
1570976|NCT01171989|3843265|P2|STARTED|Overall Study||133
1570977|NCT01171989|3843266|P1|STARTED|Overall Study||137
1570978|NCT01171976|3843340|P3|NOT COMPLETED|Overall Study||15
1570979|NCT01171976|3843341|P2|NOT COMPLETED|Overall Study||11
1570980|NCT01171976|3843342|P1|NOT COMPLETED|Overall Study||14
1570981|NCT01171976|3843340|P3|COMPLETED|Overall Study||108
1570982|NCT01171976|3843341|P2|COMPLETED|Overall Study||117
1570983|NCT01171976|3843342|P1|COMPLETED|Overall Study||107
1570984|NCT01171976|3843340|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
1570985|NCT01171976|3843341|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
1570986|NCT01171976|3843342|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
1570987|NCT01171976|3843340|P3|STARTED|Overall Study||123
1570988|NCT01171976|3843341|P2|STARTED|Overall Study||128
1570989|NCT01171976|3843342|P1|STARTED|Overall Study||121
1570990|NCT01171963|3843379|P2|NOT COMPLETED|Overall Study||168
1570991|NCT01171963|3843380|P1|NOT COMPLETED|Overall Study||148
1570992|NCT01171963|3843379|P2|COMPLETED|Overall Study||1499
1570993|NCT01171963|3843380|P1|COMPLETED|Overall Study||1518
1570994|NCT01171963|3843379|P2|STARTED|Overall Study||1667
1570995|NCT01171963|3843380|P1|STARTED|Overall Study||1666
1570996|NCT01171924|3843438|P2|NOT COMPLETED|Overall Study||23
1570997|NCT01171924|3843439|P1|NOT COMPLETED|Overall Study||23
1570998|NCT01171924|3843438|P2|COMPLETED|Overall Study||0
1570999|NCT01171924|3843439|P1|COMPLETED|Overall Study||0
1571000|NCT01171924|3843438|P2|STARTED|Overall Study||23
1571001|NCT01171924|3843439|P1|STARTED|Overall Study||23
1571002|NCT01171898|3843449|P4|NOT COMPLETED|Overall Study||6
1571003|NCT01171898|3843450|P3|NOT COMPLETED|Overall Study||12
1571004|NCT01171898|3843451|P2|NOT COMPLETED|Overall Study||19
1571005|NCT01171898|3843452|P1|NOT COMPLETED|Overall Study||4
1571006|NCT01171898|3843449|P4|COMPLETED|Overall Study||15
1571007|NCT01171898|3843450|P3|COMPLETED|Overall Study||13
1571008|NCT01171898|3843451|P2|COMPLETED|Overall Study||32
1571009|NCT01171898|3843452|P1|COMPLETED|Overall Study||26
1571010|NCT01171898|3843449|P4|STARTED|Overall Study||21
1571011|NCT01171898|3843450|P3|STARTED|Overall Study||25
1571012|NCT01171898|3843451|P2|STARTED|Overall Study||51
1571013|NCT01171898|3843452|P1|STARTED|Overall Study||30
1571014|NCT01171820|3843476|P2|NOT COMPLETED|Overall Study||6
1571015|NCT01171820|3843477|P1|NOT COMPLETED|Overall Study||6
1571016|NCT01171820|3843476|P2|COMPLETED|Overall Study||212
1571017|NCT01171820|3843477|P1|COMPLETED|Overall Study||100
1571018|NCT01171820|3843476|P2|STARTED|Overall Study||218
1571019|NCT01171820|3843477|P1|STARTED|Overall Study||106
1571020|NCT01171794|3843533|P2|NOT COMPLETED|Overall Study||0
1571021|NCT01171794|3843534|P1|NOT COMPLETED|Overall Study||3
1571022|NCT01171794|3843533|P2|COMPLETED|Overall Study||42
1571023|NCT01171794|3843534|P1|COMPLETED|Overall Study||44
1571024|NCT01171794|3843533|P2|STARTED|Overall Study||42
1571025|NCT01171794|3843534|P1|STARTED|Overall Study||47
1571026|NCT01171690|3843544|P2|NOT COMPLETED|Overall Study||0
1571027|NCT01171690|3843545|P1|NOT COMPLETED|Overall Study||0
1571028|NCT01171690|3843544|P2|COMPLETED|Overall Study||5
1571029|NCT01171690|3843545|P1|COMPLETED|Overall Study||5
1571030|NCT01171690|3843544|P2|STARTED|Overall Study||5
1571031|NCT01171690|3843545|P1|STARTED|Overall Study||5
1571032|NCT01171677|3843555|P2|NOT COMPLETED|Overall Study||3
1571033|NCT01171677|3843556|P1|NOT COMPLETED|Overall Study||6
1571034|NCT01171677|3843555|P2|COMPLETED|Overall Study||12
1571035|NCT01171677|3843556|P1|COMPLETED|Overall Study||11
1571036|NCT01171677|3843555|P2|STARTED|Overall Study||15
1571037|NCT01171677|3843556|P1|STARTED|Overall Study||17
1571038|NCT01171612|3843588|P1|NOT COMPLETED|Overall Study||51
1571039|NCT01171612|3843588|P1|COMPLETED|Overall Study||432
1571040|NCT01171612|3843588|P1|STARTED|Overall Study||483
1571041|NCT01171534|3843598|P2|NOT COMPLETED|Overall Study||3
1571042|NCT01171534|3843599|P1|NOT COMPLETED|Overall Study||0
1571043|NCT01171534|3843598|P2|COMPLETED|Overall Study||4
1571044|NCT01171534|3843599|P1|COMPLETED|Overall Study||0
1571045|NCT01171534|3843598|P2|STARTED|Overall Study||7
1571046|NCT01171534|3843599|P1|STARTED|Overall Study|retrospective arm never performed on study|0
1571047|NCT01171521|3843611|P1|NOT COMPLETED|Overall Study||6
1571048|NCT01171521|3843611|P1|COMPLETED|Overall Study||0
1571049|NCT01171521|3843611|P1|STARTED|Overall Study||6
1571050|NCT01171183|3843618|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
1571051|NCT01171183|3843619|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
1571052|NCT01171183|3843618|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
1571053|NCT01171183|3843619|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
1571054|NCT01171183|3843618|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
1571055|NCT01171183|3843619|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
1571056|NCT01171183|3843618|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
1571057|NCT01171183|3843619|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
1571058|NCT01171183|3843618|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
1571059|NCT01171183|3843619|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
1571060|NCT01171183|3843618|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
1571061|NCT01171183|3843619|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
1571062|NCT01171118|3843627|P1|NOT COMPLETED|Overall Study||0
1571063|NCT01171118|3843627|P1|COMPLETED|Overall Study||10
1571064|NCT01171118|3843627|P1|STARTED|Overall Study||10
1571065|NCT01170962|3843640|P3|NOT COMPLETED|Follow up Period||6
1571066|NCT01170962|3843641|P2|NOT COMPLETED|Follow up Period||27
1571067|NCT01170962|3843642|P1|NOT COMPLETED|Follow up Period||39
1571068|NCT01170962|3843640|P3|COMPLETED|Follow up Period||9
1571069|NCT01170962|3843641|P2|COMPLETED|Follow up Period||165
1571070|NCT01170962|3843642|P1|COMPLETED|Follow up Period||159
1571071|NCT01170962|3843640|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
1571072|NCT01170962|3843641|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
1571073|NCT01170962|3843642|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
1571074|NCT01170962|3843640|P3|NOT COMPLETED|Treatment Period||12
1571075|NCT01170962|3843641|P2|NOT COMPLETED|Treatment Period||111
1571076|NCT01170962|3843642|P1|NOT COMPLETED|Treatment Period||127
1571077|NCT01170962|3843640|P3|COMPLETED|Treatment Period||5
1571078|NCT01170962|3843641|P2|COMPLETED|Treatment Period||88
1571079|NCT01170962|3843642|P1|COMPLETED|Treatment Period||76
1571080|NCT01170962|3843640|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
1571081|NCT01170962|3843641|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
1571082|NCT01170962|3843642|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
1571083|NCT01170962|3843640|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
1571084|NCT01170962|3843641|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
1571085|NCT01170962|3843642|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
1571086|NCT01170962|3843640|P3|No PDR|Treatment Period||17
1571087|NCT01170962|3843641|P2|No PDR|Treatment Period||127
1571088|NCT01170962|3843642|P1|No PDR|Treatment Period||145
1571089|NCT01170962|3843640|P3|STARTED|Treatment Period||17
1571090|NCT01170962|3843641|P2|STARTED|Treatment Period||199
1571091|NCT01170962|3843642|P1|STARTED|Treatment Period||203
1571092|NCT01170949|3843688|P2|NOT COMPLETED|Overall Study||4
1571093|NCT01170949|3843689|P1|NOT COMPLETED|Overall Study||7
1571094|NCT01170949|3843688|P2|COMPLETED|Overall Study||22
1571095|NCT01170949|3843689|P1|COMPLETED|Overall Study||43
1571096|NCT01170949|3843688|P2|STARTED|Overall Study||26
1571097|NCT01170949|3843689|P1|STARTED|Overall Study||50
1571098|NCT01170884|3843697|P2|NOT COMPLETED|Overall Study||2
1571099|NCT01170884|3843698|P1|NOT COMPLETED|Overall Study||5
1571100|NCT01170884|3843697|P2|COMPLETED|Overall Study||60
1571101|NCT01170884|3843698|P1|COMPLETED|Overall Study||54
1571102|NCT01170884|3843697|P2|STARTED|Overall Study||62
1571103|NCT01170884|3843698|P1|STARTED|Overall Study||59
1571104|NCT01170754|3843706|P2|NOT COMPLETED|Overall Study||0
1571105|NCT01170754|3843707|P1|NOT COMPLETED|Overall Study||0
1571106|NCT01170754|3843706|P2|COMPLETED|Overall Study||70
1571107|NCT01170754|3843707|P1|COMPLETED|Overall Study||66
1571108|NCT01170754|3843706|P2|STARTED|Overall Study||70
1571109|NCT01170754|3843707|P1|STARTED|Overall Study||66
1571110|NCT01170663|3843737|P2|NOT COMPLETED|Overall Study||20
1571111|NCT01170663|3843738|P1|NOT COMPLETED|Overall Study||14
1571112|NCT01170663|3843737|P2|COMPLETED|Overall Study||315
1571113|NCT01170663|3843738|P1|COMPLETED|Overall Study||316
1571114|NCT01170663|3843737|P2|Received Any Treatment (Safety Pop)|Overall Study||329
1571115|NCT01170663|3843738|P1|Received Any Treatment (Safety Pop)|Overall Study||327
1571116|NCT01170663|3843737|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
1571117|NCT01170663|3843738|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
1571118|NCT01170598|3843766|P1|NOT COMPLETED|Overall Study||6
1571119|NCT01170598|3843766|P1|COMPLETED|Overall Study||29
1571120|NCT01170598|3843766|P1|STARTED|Overall Study||35
1571121|NCT01170546|3843785|P4|NOT COMPLETED|Overall Study||0
1571122|NCT01170546|3843786|P3|NOT COMPLETED|Overall Study||0
1571123|NCT01170546|3843787|P2|NOT COMPLETED|Overall Study||0
1571124|NCT01170546|3843788|P1|NOT COMPLETED|Overall Study||0
1571125|NCT01170546|3843785|P4|COMPLETED|Overall Study||8
1571126|NCT01170546|3843786|P3|COMPLETED|Overall Study||6
1571127|NCT01170546|3843787|P2|COMPLETED|Overall Study||7
1571128|NCT01170546|3843788|P1|COMPLETED|Overall Study||7
1571129|NCT01170546|3843785|P4|STARTED|Overall Study||8
1571130|NCT01170546|3843786|P3|STARTED|Overall Study||6
1571131|NCT01170546|3843787|P2|STARTED|Overall Study||7
1571132|NCT01170546|3843788|P1|STARTED|Overall Study||7
1571133|NCT01170533|3843798|P2|NOT COMPLETED|Pantoprazole Cross-over||0
1571134|NCT01170533|3843799|P1|NOT COMPLETED|Pantoprazole Cross-over||0
1571135|NCT01170533|3843798|P2|COMPLETED|Pantoprazole Cross-over||20
1571136|NCT01170533|3843799|P1|COMPLETED|Pantoprazole Cross-over||0
1571137|NCT01170533|3843798|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
1571138|NCT01170533|3843799|P1|STARTED|Pantoprazole Cross-over||0
1571139|NCT01170533|3843798|P2|NOT COMPLETED|Omeprazole Cross-over||0
1571140|NCT01170533|3843799|P1|NOT COMPLETED|Omeprazole Cross-over||0
1571141|NCT01170533|3843798|P2|COMPLETED|Omeprazole Cross-over||0
1571142|NCT01170533|3843799|P1|COMPLETED|Omeprazole Cross-over||20
1571143|NCT01170533|3843798|P2|STARTED|Omeprazole Cross-over||0
1571144|NCT01170533|3843799|P1|STARTED|Omeprazole Cross-over||20
1571145|NCT01170390|3843811|P3|NOT COMPLETED|Randomized Treatment||0
1571146|NCT01170390|3843812|P2|NOT COMPLETED|Randomized Treatment||1
1571147|NCT01170390|3843813|P1|NOT COMPLETED|Randomized Treatment||0
1571148|NCT01170390|3843811|P3|COMPLETED|Randomized Treatment||15
1571149|NCT01170390|3843812|P2|COMPLETED|Randomized Treatment||16
1571150|NCT01170390|3843813|P1|COMPLETED|Randomized Treatment||0
1571151|NCT01170390|3843811|P3|STARTED|Randomized Treatment||15
1571152|NCT01170390|3843812|P2|STARTED|Randomized Treatment||17
1571153|NCT01170390|3843813|P1|STARTED|Randomized Treatment||0
1571154|NCT01170390|3843811|P3|NOT COMPLETED|Oral Contraceptives||0
1571155|NCT01170390|3843812|P2|NOT COMPLETED|Oral Contraceptives||0
1571156|NCT01170390|3843813|P1|NOT COMPLETED|Oral Contraceptives||1
1571157|NCT01170390|3843811|P3|COMPLETED|Oral Contraceptives||0
1571158|NCT01170390|3843812|P2|COMPLETED|Oral Contraceptives||0
1571159|NCT01170390|3843813|P1|COMPLETED|Oral Contraceptives||31
1571160|NCT01170390|3843811|P3|STARTED|Oral Contraceptives||0
1571161|NCT01170390|3843812|P2|STARTED|Oral Contraceptives||0
1571162|NCT01170390|3843813|P1|STARTED|Oral Contraceptives||32
1571163|NCT01170364|3843829|P2|NOT COMPLETED|Overall Study||1
1571164|NCT01170364|3843830|P1|NOT COMPLETED|Overall Study||4
1571165|NCT01170364|3843829|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
1571166|NCT01170364|3843830|P1|COMPLETED|Overall Study||4
1571167|NCT01170364|3843829|P2|STARTED|Overall Study||6
1571168|NCT01170364|3843830|P1|STARTED|Overall Study||8
1571169|NCT01170273|3843838|P2|NOT COMPLETED|Overall Study||9
1571170|NCT01170273|3843839|P1|NOT COMPLETED|Overall Study||8
1571171|NCT01170273|3843838|P2|COMPLETED|Overall Study||57
1571172|NCT01170273|3843839|P1|COMPLETED|Overall Study||56
1571173|NCT01170273|3843838|P2|STARTED|Overall Study||66
1571174|NCT01170273|3843839|P1|STARTED|Overall Study||64
1571175|NCT01170247|3843847|P2|NOT COMPLETED|Overall Study||0
1571176|NCT01170247|3843848|P1|NOT COMPLETED|Overall Study||0
1571177|NCT01170247|3843847|P2|COMPLETED|Overall Study||1
1571178|NCT01170247|3843848|P1|COMPLETED|Overall Study||2
1571179|NCT01170247|3843847|P2|STARTED|Overall Study||1
1571180|NCT01170247|3843848|P1|STARTED|Overall Study||2
1571181|NCT01170221|3843856|P2|NOT COMPLETED|Overall Study||28
1571182|NCT01170221|3843857|P1|NOT COMPLETED|Overall Study||33
1571183|NCT01170221|3843856|P2|COMPLETED|Overall Study||307
1571184|NCT01170221|3843857|P1|COMPLETED|Overall Study||299
1571185|NCT01170221|3843856|P2|STARTED|Overall Study||335
1571186|NCT01170221|3843857|P1|STARTED|Overall Study||332
1571187|NCT01170208|3843880|P3|NOT COMPLETED|Overall Study||2
1571188|NCT01170208|3843881|P2|NOT COMPLETED|Overall Study||0
1571189|NCT01170208|3843882|P1|NOT COMPLETED|Overall Study||6
1571190|NCT01170208|3843880|P3|COMPLETED|Overall Study||4
1571191|NCT01170208|3843881|P2|COMPLETED|Overall Study||20
1571192|NCT01170208|3843882|P1|COMPLETED|Overall Study||14
1571193|NCT01170208|3843880|P3|STARTED|Overall Study||6
1571194|NCT01170208|3843881|P2|STARTED|Overall Study||20
1571195|NCT01170208|3843882|P1|STARTED|Overall Study||20
1571196|NCT01170117|3843892|P2|NOT COMPLETED|Overall Study||20
1571197|NCT01170117|3843893|P1|NOT COMPLETED|Overall Study||30
1571198|NCT01170117|3843892|P2|COMPLETED|Overall Study||55
1571199|NCT01170117|3843893|P1|COMPLETED|Overall Study||47
1571200|NCT01170117|3843892|P2|STARTED|Overall Study||75
1571201|NCT01170117|3843893|P1|STARTED|Overall Study||77
1571202|NCT01170091|3843901|P1|NOT COMPLETED|Overall Study||24
1571203|NCT01170091|3843901|P1|COMPLETED|Overall Study||627
1571204|NCT01170091|3843901|P1|STARTED|Overall Study||651
1571205|NCT01170039|3843910|P2|NOT COMPLETED|Overall Study||6
1571206|NCT01170039|3843911|P1|NOT COMPLETED|Overall Study||8
1571207|NCT01170039|3843910|P2|COMPLETED|Overall Study||33
1571208|NCT01170039|3843911|P1|COMPLETED|Overall Study||29
1571209|NCT01170039|3843910|P2|STARTED|Overall Study||39
1571210|NCT01170039|3843911|P1|STARTED|Overall Study||37
1571211|NCT01169987|3843923|P1|NOT COMPLETED|Overall Study||31
1571212|NCT01169987|3843923|P1|COMPLETED|Overall Study||160
1571213|NCT01169987|3843923|P1|STARTED|Overall Study||191
1571214|NCT01169779|3843989|P2|NOT COMPLETED|Overall Study||17
1571215|NCT01169779|3843990|P1|NOT COMPLETED|Overall Study||11
1571216|NCT01169779|3843989|P2|COMPLETED|Overall Study||179
1571217|NCT01169779|3843990|P1|COMPLETED|Overall Study||184
1571218|NCT01169779|3843989|P2|Subgroup for Standardized Meal Test|Overall Study||121
1571219|NCT01169779|3843990|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
1571220|NCT01169779|3843989|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
1571221|NCT01169779|3843990|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
1571222|NCT01169779|3843989|P2|Treated/Safety Population|Overall Study||196
1571223|NCT01169779|3843990|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
1571224|NCT01169779|3843989|P2|STARTED|Overall Study||196
1571225|NCT01169779|3843990|P1|STARTED|Overall Study|Randomized.|195
1571226|NCT01169753|3844016|P2|NOT COMPLETED|Overall Study||1
1571227|NCT01169753|3844017|P1|NOT COMPLETED|Overall Study||0
1571228|NCT01169753|3844016|P2|COMPLETED|Overall Study||0
1571229|NCT01169753|3844017|P1|COMPLETED|Overall Study||0
1571230|NCT01169753|3844016|P2|STARTED|Overall Study||1
1571231|NCT01169753|3844017|P1|STARTED|Overall Study||0
1571232|NCT01169701|3844025|P2|NOT COMPLETED|Overall Study||10
1571233|NCT01169701|3844026|P1|NOT COMPLETED|Overall Study||5
1571234|NCT01169701|3844025|P2|COMPLETED|Overall Study||25
1571235|NCT01169701|3844026|P1|COMPLETED|Overall Study||31
1571236|NCT01169701|3844025|P2|Intent to Treat (ITT) Set|Overall Study||28
1571237|NCT01169701|3844026|P1|Intent to Treat (ITT) Set|Overall Study||32
1571238|NCT01169701|3844025|P2|Safety Set|Overall Study||35
1571239|NCT01169701|3844026|P1|Safety Set|Overall Study||36
1571240|NCT01169701|3844025|P2|STARTED|Overall Study||35
1571241|NCT01169701|3844026|P1|STARTED|Overall Study||36
1571242|NCT01169675|3844063|P5|NOT COMPLETED|Overall Study||6
1571243|NCT01169675|3844064|P4|NOT COMPLETED|Overall Study||17
1571244|NCT01169675|3844065|P3|NOT COMPLETED|Overall Study||7
1571245|NCT01169675|3844066|P2|NOT COMPLETED|Overall Study||3
1571246|NCT01169675|3844067|P1|NOT COMPLETED|Overall Study||20
1571247|NCT01169675|3844063|P5|COMPLETED|Overall Study||0
1571248|NCT01169675|3844064|P4|COMPLETED|Overall Study||0
1571249|NCT01169675|3844065|P3|COMPLETED|Overall Study||0
1571250|NCT01169675|3844066|P2|COMPLETED|Overall Study||0
1571251|NCT01169675|3844067|P1|COMPLETED|Overall Study||0
1571252|NCT01169675|3844063|P5|STARTED|Overall Study||6
1571253|NCT01169675|3844064|P4|STARTED|Overall Study||17
1571254|NCT01169675|3844065|P3|STARTED|Overall Study||7
1571255|NCT01169675|3844066|P2|STARTED|Overall Study||3
1571256|NCT01169675|3844067|P1|STARTED|Overall Study||20
1571257|NCT01169649|3844104|P1|NOT COMPLETED|Overall Study||3
1571258|NCT01169649|3844104|P1|COMPLETED|Overall Study||8
1571259|NCT01169649|3844104|P1|STARTED|Overall Study||11
1571260|NCT01169610|3844108|P1|NOT COMPLETED|Overall Study||0
1571261|NCT01169610|3844108|P1|COMPLETED|Overall Study||1
1571262|NCT01169610|3844108|P1|STARTED|Overall Study||1
1571263|NCT01169558|3844116|P1|NOT COMPLETED|Overall Study||156
1571264|NCT01169558|3844116|P1|COMPLETED|Overall Study||6
1571265|NCT01169558|3844116|P1|STARTED|Overall Study||162
1571266|NCT01169519|3844123|P1|NOT COMPLETED|Overall Study||0
1571267|NCT01169519|3844123|P1|COMPLETED|Overall Study||21
1571268|NCT01169519|3844123|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
1571269|NCT01169493|3844141|P6|NOT COMPLETED|Period 3 (6 Months)||0
1571270|NCT01169493|3844142|P5|NOT COMPLETED|Period 3 (6 Months)||0
1571271|NCT01169493|3844143|P4|NOT COMPLETED|Period 3 (6 Months)||0
1571272|NCT01169493|3844144|P3|NOT COMPLETED|Period 3 (6 Months)||1
1571273|NCT01169493|3844145|P2|NOT COMPLETED|Period 3 (6 Months)||2
1571274|NCT01169493|3844146|P1|NOT COMPLETED|Period 3 (6 Months)||0
1571275|NCT01169493|3844141|P6|COMPLETED|Period 3 (6 Months)||2
1571276|NCT01169493|3844142|P5|COMPLETED|Period 3 (6 Months)||0
1571277|NCT01169493|3844143|P4|COMPLETED|Period 3 (6 Months)||0
1571278|NCT01169493|3844144|P3|COMPLETED|Period 3 (6 Months)||2
1571279|NCT01169493|3844145|P2|COMPLETED|Period 3 (6 Months)||1
1571280|NCT01169493|3844146|P1|COMPLETED|Period 3 (6 Months)||2
1571281|NCT01169493|3844141|P6|STARTED|Period 3 (6 Months)||2
1571282|NCT01169493|3844142|P5|STARTED|Period 3 (6 Months)||0
1571283|NCT01169493|3844143|P4|STARTED|Period 3 (6 Months)||0
1571284|NCT01169493|3844144|P3|STARTED|Period 3 (6 Months)||3
1571285|NCT01169493|3844145|P2|STARTED|Period 3 (6 Months)||3
1571286|NCT01169493|3844146|P1|STARTED|Period 3 (6 Months)||2
1571287|NCT01169493|3844141|P6|NOT COMPLETED|Period 2 (6 Months)||0
1571288|NCT01169493|3844142|P5|NOT COMPLETED|Period 2 (6 Months)||0
1571289|NCT01169493|3844143|P4|NOT COMPLETED|Period 2 (6 Months)||0
1571290|NCT01169493|3844144|P3|NOT COMPLETED|Period 2 (6 Months)||0
1571291|NCT01169493|3844145|P2|NOT COMPLETED|Period 2 (6 Months)||0
1571292|NCT01169493|3844146|P1|NOT COMPLETED|Period 2 (6 Months)||0
1571293|NCT01169493|3844141|P6|COMPLETED|Period 2 (6 Months)||2
1571294|NCT01169493|3844142|P5|COMPLETED|Period 2 (6 Months)||0
1571295|NCT01169493|3844143|P4|COMPLETED|Period 2 (6 Months)||0
1571296|NCT01169493|3844144|P3|COMPLETED|Period 2 (6 Months)||3
1571297|NCT01169493|3844145|P2|COMPLETED|Period 2 (6 Months)||3
1571298|NCT01169493|3844146|P1|COMPLETED|Period 2 (6 Months)||2
1571299|NCT01169493|3844141|P6|STARTED|Period 2 (6 Months)||2
1571300|NCT01169493|3844142|P5|STARTED|Period 2 (6 Months)||0
1571301|NCT01169493|3844143|P4|STARTED|Period 2 (6 Months)||0
1571302|NCT01169493|3844144|P3|STARTED|Period 2 (6 Months)||3
1571303|NCT01169493|3844145|P2|STARTED|Period 2 (6 Months)||3
1571304|NCT01169493|3844146|P1|STARTED|Period 2 (6 Months)||2
1571305|NCT01169493|3844141|P6|NOT COMPLETED|Period 1 (6 Months)||3
1571306|NCT01169493|3844142|P5|NOT COMPLETED|Period 1 (6 Months)||0
1571307|NCT01169493|3844143|P4|NOT COMPLETED|Period 1 (6 Months)||0
1571308|NCT01169493|3844144|P3|NOT COMPLETED|Period 1 (6 Months)||2
1571309|NCT01169493|3844145|P2|NOT COMPLETED|Period 1 (6 Months)||1
1571310|NCT01169493|3844146|P1|NOT COMPLETED|Period 1 (6 Months)||0
1571311|NCT01169493|3844141|P6|COMPLETED|Period 1 (6 Months)||2
1571312|NCT01169493|3844142|P5|COMPLETED|Period 1 (6 Months)||0
1571313|NCT01169493|3844143|P4|COMPLETED|Period 1 (6 Months)||0
1571314|NCT01169493|3844144|P3|COMPLETED|Period 1 (6 Months)||3
1571315|NCT01169493|3844145|P2|COMPLETED|Period 1 (6 Months)||3
1571316|NCT01169493|3844146|P1|COMPLETED|Period 1 (6 Months)||2
1571317|NCT01169493|3844141|P6|STARTED|Period 1 (6 Months)||5
1571318|NCT01169493|3844142|P5|STARTED|Period 1 (6 Months)||0
1571319|NCT01169493|3844143|P4|STARTED|Period 1 (6 Months)||0
1571320|NCT01169493|3844144|P3|STARTED|Period 1 (6 Months)||5
1571321|NCT01169493|3844145|P2|STARTED|Period 1 (6 Months)||4
1571322|NCT01169493|3844146|P1|STARTED|Period 1 (6 Months)||2
1571323|NCT01169467|3844177|P2|NOT COMPLETED|Overall Study||4
1571324|NCT01169467|3844178|P1|NOT COMPLETED|Overall Study||7
1571325|NCT01169467|3844177|P2|COMPLETED|Overall Study||36
1571326|NCT01169467|3844178|P1|COMPLETED|Overall Study||37
1571327|NCT01169467|3844177|P2|STARTED|Overall Study||40
1571328|NCT01169467|3844178|P1|STARTED|Overall Study||44
1571329|NCT01169350|3844192|P1|NOT COMPLETED|Overall Study||5
1571330|NCT01169350|3844192|P1|COMPLETED|Overall Study||3
1571331|NCT01169350|3844192|P1|STARTED|Overall Study||8
1571332|NCT01169311|3844199|P1|NOT COMPLETED|Overall Study||0
1571333|NCT01169311|3844199|P1|COMPLETED|Overall Study||27
1571334|NCT01169311|3844199|P1|STARTED|Overall Study||27
1571335|NCT01169103|3844213|P2|NOT COMPLETED|Overall Study||4
1571336|NCT01169103|3844214|P1|NOT COMPLETED|Overall Study||6
1571337|NCT01169103|3844213|P2|COMPLETED|Overall Study||7
1571338|NCT01169103|3844214|P1|COMPLETED|Overall Study||5
1571339|NCT01169103|3844213|P2|STARTED|Overall Study||11
1571340|NCT01169103|3844214|P1|STARTED|Overall Study||11
1571341|NCT01169064|3844230|P2|NOT COMPLETED|Overall Study||0
1571342|NCT01169064|3844231|P1|NOT COMPLETED|Overall Study||0
1571343|NCT01169064|3844230|P2|COMPLETED|Overall Study||236
1571344|NCT01169064|3844231|P1|COMPLETED|Overall Study||239
1571345|NCT01169064|3844230|P2|STARTED|Overall Study||236
1571346|NCT01169064|3844231|P1|STARTED|Overall Study||239
1571347|NCT01169038|3844241|P1|NOT COMPLETED|Overall Study||7
1571348|NCT01169038|3844241|P1|COMPLETED|Overall Study||8
1571349|NCT01169038|3844241|P1|STARTED|Overall Study||15
1571350|NCT01168999|3844249|P4|NOT COMPLETED|Overall Study||0
1571351|NCT01168999|3844250|P3|NOT COMPLETED|Overall Study||0
1571352|NCT01168999|3844251|P2|NOT COMPLETED|Overall Study||1
1571353|NCT01168999|3844252|P1|NOT COMPLETED|Overall Study||2
1571354|NCT01168999|3844249|P4|COMPLETED|Overall Study||28
1571355|NCT01168999|3844250|P3|COMPLETED|Overall Study||27
1571356|NCT01168999|3844251|P2|COMPLETED|Overall Study||26
1571357|NCT01168999|3844252|P1|COMPLETED|Overall Study||26
1571358|NCT01168999|3844249|P4|STARTED|Overall Study||28
1571359|NCT01168999|3844250|P3|STARTED|Overall Study||27
1571360|NCT01168999|3844251|P2|STARTED|Overall Study||27
1571361|NCT01168999|3844252|P1|STARTED|Overall Study||28
1571362|NCT01168986|3844297|P3|NOT COMPLETED|Overall Study||0
1571363|NCT01168986|3844298|P2|NOT COMPLETED|Overall Study||1
1571364|NCT01168986|3844299|P1|NOT COMPLETED|Overall Study||2
1571365|NCT01168986|3844297|P3|COMPLETED|Overall Study||21
1571366|NCT01168986|3844298|P2|COMPLETED|Overall Study||20
1571367|NCT01168986|3844299|P1|COMPLETED|Overall Study||18
1571368|NCT01168986|3844297|P3|STARTED|Overall Study||21
1571369|NCT01168986|3844298|P2|STARTED|Overall Study||21
1571370|NCT01168986|3844299|P1|STARTED|Overall Study||20
1571371|NCT01168973|3844318|P2|NOT COMPLETED|Overall Study||611
1571372|NCT01168973|3844319|P1|NOT COMPLETED|Overall Study||613
1571373|NCT01168973|3844318|P2|COMPLETED|Overall Study||14
1571374|NCT01168973|3844319|P1|COMPLETED|Overall Study||15
1571375|NCT01168973|3844318|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
1571376|NCT01168973|3844319|P1|Received Any Quantity of Any Study Drug|Overall Study||624
1571377|NCT01168973|3844318|P2|STARTED|Overall Study||625
1571378|NCT01168973|3844319|P1|STARTED|Overall Study||628
1571379|NCT01168934|3844340|P2|NOT COMPLETED|Second Intervention Period||0
1571380|NCT01168934|3844341|P1|NOT COMPLETED|Second Intervention Period||0
1571381|NCT01168934|3844340|P2|COMPLETED|Second Intervention Period||7
1571382|NCT01168934|3844341|P1|COMPLETED|Second Intervention Period||7
1571383|NCT01168934|3844340|P2|STARTED|Second Intervention Period||7
1571384|NCT01168934|3844341|P1|STARTED|Second Intervention Period||7
1571385|NCT01168934|3844340|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1571386|NCT01168934|3844341|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1571387|NCT01168934|3844340|P2|COMPLETED|Washout Period (at Least 14 Days)||7
1571388|NCT01168934|3844341|P1|COMPLETED|Washout Period (at Least 14 Days)||7
1571389|NCT01168934|3844340|P2|STARTED|Washout Period (at Least 14 Days)||7
1571390|NCT01168934|3844341|P1|STARTED|Washout Period (at Least 14 Days)||7
1571391|NCT01168934|3844340|P2|NOT COMPLETED|First Intervention Period||0
1571392|NCT01168934|3844341|P1|NOT COMPLETED|First Intervention Period||0
1571393|NCT01168934|3844340|P2|COMPLETED|First Intervention Period||7
1571394|NCT01168934|3844341|P1|COMPLETED|First Intervention Period||7
1571395|NCT01168934|3844340|P2|STARTED|First Intervention Period||7
1571396|NCT01168934|3844341|P1|STARTED|First Intervention Period||7
1571397|NCT01168908|3844375|P2|NOT COMPLETED|Open Label||1
1571398|NCT01168908|3844376|P1|NOT COMPLETED|Open Label||1
1571399|NCT01168908|3844375|P2|COMPLETED|Open Label||7
1571400|NCT01168908|3844376|P1|COMPLETED|Open Label||6
1571401|NCT01168908|3844375|P2|STARTED|Open Label||8
1571402|NCT01168908|3844376|P1|STARTED|Open Label||7
1571403|NCT01168908|3844375|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
1571404|NCT01168908|3844376|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
1571405|NCT01168908|3844375|P2|COMPLETED|Double Blind, Placebo Controlled||8
1571406|NCT01168908|3844376|P1|COMPLETED|Double Blind, Placebo Controlled||7
1571407|NCT01168908|3844375|P2|STARTED|Double Blind, Placebo Controlled||10
1571408|NCT01168908|3844376|P1|STARTED|Double Blind, Placebo Controlled||10
1571409|NCT01168856|3844392|P2|NOT COMPLETED|Overall Study||343
1571410|NCT01168856|3844393|P1|NOT COMPLETED|Overall Study||18
1571411|NCT01168856|3844392|P2|COMPLETED|Overall Study||215
1571412|NCT01168856|3844393|P1|COMPLETED|Overall Study||158
1571413|NCT01168856|3844392|P2|STARTED|Overall Study||558
1571414|NCT01168856|3844393|P1|STARTED|Overall Study||176
1571415|NCT01168726|3844453|P3|NOT COMPLETED|Overall Study||5
1571416|NCT01168726|3844454|P2|NOT COMPLETED|Overall Study||9
1571417|NCT01168726|3844455|P1|NOT COMPLETED|Overall Study||8
1571418|NCT01168726|3844453|P3|COMPLETED|Overall Study||128
1571419|NCT01168726|3844454|P2|COMPLETED|Overall Study||112
1571420|NCT01168726|3844455|P1|COMPLETED|Overall Study||103
1571421|NCT01168726|3844453|P3|STARTED|Overall Study||133
1571422|NCT01168726|3844454|P2|STARTED|Overall Study||121
1571423|NCT01168726|3844455|P1|STARTED|Overall Study||111
1571424|NCT01168687|3844474|P2|NOT COMPLETED|Overall Study||0
1571425|NCT01168687|3844475|P1|NOT COMPLETED|Overall Study||0
1571426|NCT01168687|3844474|P2|COMPLETED|Overall Study||23
1571427|NCT01168687|3844475|P1|COMPLETED|Overall Study||23
1571428|NCT01168687|3844474|P2|STARTED|Overall Study||23
1571429|NCT01168687|3844475|P1|STARTED|Overall Study||23
1571430|NCT01168674|3844481|P2|NOT COMPLETED|Overall Study||0
1571431|NCT01168674|3844482|P1|NOT COMPLETED|Overall Study||0
1571432|NCT01168674|3844481|P2|COMPLETED|Overall Study||24
1571433|NCT01168674|3844482|P1|COMPLETED|Overall Study||25
1571434|NCT01168674|3844481|P2|STARTED|Overall Study||24
1571435|NCT01168674|3844482|P1|STARTED|Overall Study||25
1571436|NCT01168596|3844491|P2|NOT COMPLETED|Overall Study||1
1571437|NCT01168596|3844492|P1|NOT COMPLETED|Overall Study||3
1571438|NCT01168596|3844491|P2|COMPLETED|Overall Study||13
1571439|NCT01168596|3844492|P1|COMPLETED|Overall Study||13
1571440|NCT01168596|3844491|P2|STARTED|Overall Study||14
1571441|NCT01168596|3844492|P1|STARTED|Overall Study||16
1571442|NCT01168427|3844536|P1|NOT COMPLETED|Overall Study||1
1571443|NCT01168427|3844536|P1|COMPLETED|Overall Study||65
1571444|NCT01168427|3844536|P1|STARTED|Overall Study||66
1571445|NCT01168401|3844552|P11|NOT COMPLETED|Overall Study||0
1571446|NCT01168401|3844553|P10|NOT COMPLETED|Overall Study||0
1571447|NCT01168401|3844554|P9|NOT COMPLETED|Overall Study||0
1571448|NCT01168401|3844555|P8|NOT COMPLETED|Overall Study||0
1571449|NCT01168401|3844556|P7|NOT COMPLETED|Overall Study||0
1571450|NCT01168401|3844557|P6|NOT COMPLETED|Overall Study||0
1571451|NCT01168401|3844558|P5|NOT COMPLETED|Overall Study||0
1571452|NCT01168401|3844559|P4|NOT COMPLETED|Overall Study||2
1571453|NCT01168401|3844560|P3|NOT COMPLETED|Overall Study||2
1571454|NCT01168401|3844561|P2|NOT COMPLETED|Overall Study||1
1571455|NCT01168401|3844562|P1|NOT COMPLETED|Overall Study||1
1571456|NCT01168401|3844552|P11|COMPLETED|Overall Study||8
1571457|NCT01168401|3844553|P10|COMPLETED|Overall Study||8
1571458|NCT01168401|3844554|P9|COMPLETED|Overall Study||9
1571459|NCT01168401|3844555|P8|COMPLETED|Overall Study||10
1571460|NCT01168401|3844556|P7|COMPLETED|Overall Study||10
1571461|NCT01168401|3844557|P6|COMPLETED|Overall Study||9
1571462|NCT01168401|3844558|P5|COMPLETED|Overall Study||9
1571463|NCT01168401|3844559|P4|COMPLETED|Overall Study||7
1571464|NCT01168401|3844560|P3|COMPLETED|Overall Study||8
1571465|NCT01168401|3844561|P2|COMPLETED|Overall Study||9
1571466|NCT01168401|3844562|P1|COMPLETED|Overall Study||9
1571467|NCT01168401|3844552|P11|STARTED|Overall Study||8
1571468|NCT01168401|3844553|P10|STARTED|Overall Study||8
1571469|NCT01168401|3844554|P9|STARTED|Overall Study||9
1571470|NCT01168401|3844555|P8|STARTED|Overall Study||10
1571471|NCT01168401|3844556|P7|STARTED|Overall Study||10
1571472|NCT01168401|3844557|P6|STARTED|Overall Study||9
1571473|NCT01168401|3844558|P5|STARTED|Overall Study||9
1571474|NCT01168401|3844559|P4|STARTED|Overall Study||9
1571475|NCT01168401|3844560|P3|STARTED|Overall Study||10
1571476|NCT01168401|3844561|P2|STARTED|Overall Study||10
1571477|NCT01168401|3844562|P1|STARTED|Overall Study||10
1571478|NCT01168349|3844795|P1|NOT COMPLETED|Overall Study||301
1571479|NCT01168349|3844795|P1|COMPLETED|Overall Study||754
1571480|NCT01168349|3844795|P1|STARTED|Overall Study||1055
1571481|NCT01168232|3844901|P1|NOT COMPLETED|Overall Study||8
1571482|NCT01168232|3844901|P1|COMPLETED|Overall Study|Eligible and treated patients|34
1571483|NCT01168232|3844901|P1|STARTED|Overall Study||42
1571484|NCT01168219|3844908|P1|NOT COMPLETED|Overall Study||0
1571485|NCT01168219|3844908|P1|COMPLETED|Overall Study||68
1571486|NCT01168219|3844908|P1|STARTED|Overall Study||68
1571487|NCT01168024|3844914|P2|NOT COMPLETED|Overall Study||0
1571488|NCT01168024|3844915|P1|NOT COMPLETED|Overall Study||0
1571489|NCT01168024|3844914|P2|COMPLETED|Overall Study||3
1571490|NCT01168024|3844915|P1|COMPLETED|Overall Study||13
1571491|NCT01168024|3844914|P2|STARTED|Overall Study||3
1571492|NCT01168024|3844915|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
1571493|NCT01167907|3844929|P2|NOT COMPLETED|Overall Study||1
1571494|NCT01167907|3844930|P1|NOT COMPLETED|Overall Study||2
1571495|NCT01167907|3844929|P2|COMPLETED|Overall Study||14
1571496|NCT01167907|3844930|P1|COMPLETED|Overall Study||15
1571497|NCT01167907|3844929|P2|STARTED|Overall Study||15
1571498|NCT01167907|3844930|P1|STARTED|Overall Study||17
1571499|NCT01167881|3844948|P2|NOT COMPLETED|Overall Study||191
1571500|NCT01167881|3844949|P1|NOT COMPLETED|Overall Study||159
1571501|NCT01167881|3844948|P2|COMPLETED|Overall Study||589
1571502|NCT01167881|3844949|P1|COMPLETED|Overall Study||610
1571503|NCT01167881|3844948|P2|Completed After 4 Years Treatment|Overall Study||462
1571504|NCT01167881|3844949|P1|Completed After 4 Years Treatment|Overall Study||515
1571505|NCT01167881|3844948|P2|Completed After 2 Years Treatment|Overall Study||127
1571506|NCT01167881|3844949|P1|Completed After 2 Years Treatment|Overall Study||95
1571507|NCT01167881|3844948|P2|STARTED|Overall Study||780
1571508|NCT01167881|3844949|P1|STARTED|Overall Study||769
1571509|NCT01167829|3844973|P1|NOT COMPLETED|Overall Study||0
1571510|NCT01167829|3844973|P1|COMPLETED|Overall Study||12
1571511|NCT01167829|3844973|P1|STARTED|Overall Study||12
1571512|NCT01167712|3844988|P2|NOT COMPLETED|Overall Study||0
1571513|NCT01167712|3844989|P1|NOT COMPLETED|Overall Study||0
1571514|NCT01167712|3844988|P2|COMPLETED|Overall Study||346
1571515|NCT01167712|3844989|P1|COMPLETED|Overall Study||346
1571516|NCT01167712|3844988|P2|STARTED|Overall Study||346
1571517|NCT01167712|3844989|P1|STARTED|Overall Study||346
1571518|NCT01167634|3845003|P4|NOT COMPLETED|Overall Study||4
1571519|NCT01167634|3845004|P3|NOT COMPLETED|Overall Study||3
1571520|NCT01167634|3845005|P2|NOT COMPLETED|Overall Study||4
1571521|NCT01167634|3845006|P1|NOT COMPLETED|Overall Study||2
1571522|NCT01167634|3845003|P4|COMPLETED|Overall Study||29
1571523|NCT01167634|3845004|P3|COMPLETED|Overall Study||30
1571524|NCT01167634|3845005|P2|COMPLETED|Overall Study||29
1571525|NCT01167634|3845006|P1|COMPLETED|Overall Study||31
1571526|NCT01167634|3845003|P4|STARTED|Overall Study||33
1571527|NCT01167634|3845004|P3|STARTED|Overall Study||33
1571528|NCT01167634|3845005|P2|STARTED|Overall Study||33
1571529|NCT01167634|3845006|P1|STARTED|Overall Study||33
1571530|NCT01167608|3845016|P1|NOT COMPLETED|Overall Study||114
1571531|NCT01167608|3845016|P1|COMPLETED|Overall Study||769
1571532|NCT01167608|3845016|P1|STARTED|Overall Study||883
1571533|NCT01167582|3845027|P2|NOT COMPLETED|Overall Study||1
1571534|NCT01167582|3845028|P1|NOT COMPLETED|Overall Study||0
1571535|NCT01167582|3845027|P2|COMPLETED|Overall Study||54
1571536|NCT01167582|3845028|P1|COMPLETED|Overall Study||55
1571537|NCT01167582|3845027|P2|STARTED|Overall Study||55
1571538|NCT01167582|3845028|P1|STARTED|Overall Study||55
1571539|NCT01167504|3845058|P1|NOT COMPLETED|Overall Study||3
1571540|NCT01167504|3845058|P1|COMPLETED|Overall Study||12
1571541|NCT01167504|3845058|P1|STARTED|Overall Study||15
1571542|NCT01167452|3845063|P1|NOT COMPLETED|Overall Study||0
1571543|NCT01167452|3845063|P1|COMPLETED|Overall Study||36
1571544|NCT01167452|3845063|P1|STARTED|Overall Study||36
1571545|NCT01167426|3845068|P1|NOT COMPLETED|Overall Study||10
1571546|NCT01167426|3845068|P1|COMPLETED|Overall Study||138
1571547|NCT01167426|3845068|P1|STARTED|Overall Study||148
1571548|NCT01167257|3845076|P2|NOT COMPLETED|Overall Study||3
1571549|NCT01167257|3845077|P1|NOT COMPLETED|Overall Study||3
1571550|NCT01167257|3845076|P2|COMPLETED|Overall Study||28
1571551|NCT01167257|3845077|P1|COMPLETED|Overall Study||28
1571552|NCT01167257|3845076|P2|STARTED|Overall Study||31
1571553|NCT01167257|3845077|P1|STARTED|Overall Study||31
1571554|NCT01167192|3845099|P1|NOT COMPLETED|Overall Study||4
1571555|NCT01167192|3845099|P1|COMPLETED|Overall Study||6
1571556|NCT01167192|3845099|P1|STARTED|Overall Study||10
1571557|NCT01167179|3845116|P2|NOT COMPLETED|Overall Study||21
1571558|NCT01167179|3845117|P1|NOT COMPLETED|Overall Study||15
1571559|NCT01167179|3845116|P2|COMPLETED|Overall Study||59
1571560|NCT01167179|3845117|P1|COMPLETED|Overall Study||65
1571561|NCT01167179|3845116|P2|STARTED|Overall Study||80
1571562|NCT01167179|3845117|P1|STARTED|Overall Study||80
1571563|NCT01167153|3845127|P2|NOT COMPLETED|Overall Study||33
1571564|NCT01167153|3845128|P1|NOT COMPLETED|Overall Study||18
1571565|NCT01167153|3845127|P2|COMPLETED|Overall Study||249
1571566|NCT01167153|3845128|P1|COMPLETED|Overall Study||264
1571567|NCT01167153|3845127|P2|Intention to Treat (ITT)|Overall Study||268
1571568|NCT01167153|3845128|P1|Intention to Treat (ITT)|Overall Study||272
1571569|NCT01167153|3845127|P2|STARTED|Overall Study||282
1571570|NCT01167153|3845128|P1|STARTED|Overall Study||282
1571571|NCT01167140|3845146|P1|NOT COMPLETED|Overall Study||1
1571572|NCT01167140|3845146|P1|COMPLETED|Overall Study||41
1571573|NCT01167140|3845146|P1|STARTED|Overall Study||42
1571574|NCT01167023|3845154|P3|NOT COMPLETED|Overall Study||2
1571575|NCT01167023|3845155|P2|NOT COMPLETED|Overall Study||3
1571576|NCT01167023|3845156|P1|NOT COMPLETED|Overall Study||0
1571577|NCT01167023|3845154|P3|COMPLETED|Overall Study||39
1571578|NCT01167023|3845155|P2|COMPLETED|Overall Study||18
1571579|NCT01167023|3845156|P1|COMPLETED|Overall Study||0
1571580|NCT01167023|3845154|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
1571581|NCT01167023|3845155|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
1571582|NCT01167023|3845156|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
1571583|NCT01167023|3845154|P3|STARTED|Overall Study||41
1571584|NCT01167023|3845155|P2|STARTED|Overall Study||21
1571585|NCT01167023|3845156|P1|STARTED|Overall Study||0
1571586|NCT01166997|3845176|P2|NOT COMPLETED|Overall Study||0
1571587|NCT01166997|3845177|P1|NOT COMPLETED|Overall Study||2
1571588|NCT01166997|3845176|P2|COMPLETED|Overall Study||30
1571589|NCT01166997|3845177|P1|COMPLETED|Overall Study||27
1571590|NCT01166997|3845176|P2|STARTED|Overall Study||30
1571591|NCT01166997|3845177|P1|STARTED|Overall Study||29
1571592|NCT01166971|3845187|P2|NOT COMPLETED|Overall Study||1
1571593|NCT01166971|3845188|P1|NOT COMPLETED|Overall Study||1
1571594|NCT01166971|3845187|P2|COMPLETED|Overall Study||30
1571595|NCT01166971|3845188|P1|COMPLETED|Overall Study||32
1571596|NCT01166971|3845187|P2|STARTED|Overall Study||31
1571597|NCT01166971|3845188|P1|STARTED|Overall Study||33
1571598|NCT01166958|3845196|P2|NOT COMPLETED|Overall Study||0
1571599|NCT01166958|3845197|P1|NOT COMPLETED|Overall Study||1
1571600|NCT01166958|3845196|P2|COMPLETED|Overall Study||13
1571601|NCT01166958|3845197|P1|COMPLETED|Overall Study||12
1571602|NCT01166958|3845196|P2|STARTED|Overall Study||13
1571603|NCT01166958|3845197|P1|STARTED|Overall Study||13
1571604|NCT01166763|3845211|P1|NOT COMPLETED|Overall Study||3
1571605|NCT01166763|3845211|P1|COMPLETED|Overall Study||27
1571606|NCT01166763|3845211|P1|STARTED|Overall Study||30
1571607|NCT01166750|3845219|P2|NOT COMPLETED|Overall Study||0
1571608|NCT01166750|3845220|P1|NOT COMPLETED|Overall Study||1
1571609|NCT01166750|3845219|P2|COMPLETED|Overall Study||13
1571610|NCT01166750|3845220|P1|COMPLETED|Overall Study||9
1571611|NCT01166750|3845219|P2|STARTED|Overall Study||13
1571612|NCT01166750|3845220|P1|STARTED|Overall Study||10
1571613|NCT01166724|3845228|P2|NOT COMPLETED|Overall Study||5
1571614|NCT01166724|3845229|P1|NOT COMPLETED|Overall Study||7
1571615|NCT01166724|3845228|P2|COMPLETED|Overall Study||0
1571616|NCT01166724|3845229|P1|COMPLETED|Overall Study||0
1571617|NCT01166724|3845228|P2|STARTED|Overall Study||5
1571618|NCT01166724|3845229|P1|STARTED|Overall Study||7
1571619|NCT01166659|3845237|P1|NOT COMPLETED|Overall Study||13
1571620|NCT01166659|3845237|P1|COMPLETED|Overall Study||35
1571621|NCT01166659|3845237|P1|STARTED|Overall Study||48
1571622|NCT01166646|3845246|P2|NOT COMPLETED|Overall Study||1
1571623|NCT01166646|3845247|P1|NOT COMPLETED|Overall Study||1
1571624|NCT01166646|3845246|P2|COMPLETED|Overall Study||21
1571625|NCT01166646|3845247|P1|COMPLETED|Overall Study||20
1571626|NCT01166646|3845246|P2|STARTED|Overall Study||22
1571627|NCT01166646|3845247|P1|STARTED|Overall Study||21
1571628|NCT01166568|3845266|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
1571629|NCT01166568|3845267|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
1571630|NCT01166568|3845268|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
1571631|NCT01166568|3845266|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
1571632|NCT01166568|3845267|P2|COMPLETED|Implantation- Nonrandomized & Randomized||32
1571633|NCT01166568|3845268|P1|COMPLETED|Implantation- Nonrandomized & Randomized||274
1571634|NCT01166568|3845266|P3|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
1571635|NCT01166568|3845267|P2|STARTED|Implantation- Nonrandomized & Randomized||33
1571636|NCT01166568|3845268|P1|STARTED|Implantation- Nonrandomized & Randomized||288
1571637|NCT01166568|3845266|P3|NOT COMPLETED|Deferred Implantation- Randomized||1
1571638|NCT01166568|3845267|P2|NOT COMPLETED|Deferred Implantation- Randomized||0
1571639|NCT01166568|3845268|P1|NOT COMPLETED|Deferred Implantation- Randomized||0
1571640|NCT01166568|3845266|P3|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
1571641|NCT01166568|3845267|P2|COMPLETED|Deferred Implantation- Randomized||0
1571642|NCT01166568|3845268|P1|COMPLETED|Deferred Implantation- Randomized||0
1571643|NCT01166568|3845266|P3|STARTED|Deferred Implantation- Randomized||16
1571644|NCT01166568|3845267|P2|STARTED|Deferred Implantation- Randomized||0
1571645|NCT01166568|3845268|P1|STARTED|Deferred Implantation- Randomized||0
1571646|NCT01166438|3845281|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
1571647|NCT01166438|3845282|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
1571648|NCT01166438|3845281|P2|COMPLETED|Off Treatment Follow-up Phase||33
1571649|NCT01166438|3845282|P1|COMPLETED|Off Treatment Follow-up Phase||51
1571650|NCT01166438|3845281|P2|STARTED|Off Treatment Follow-up Phase||89
1571651|NCT01166438|3845282|P1|STARTED|Off Treatment Follow-up Phase||85
1571652|NCT01166438|3845281|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
1571653|NCT01166438|3845282|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
1571654|NCT01166438|3845281|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
1571655|NCT01166438|3845282|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
1571656|NCT01166438|3845281|P2|Treated|Double-blind Phase: 1st 6 Months||126
1571657|NCT01166438|3845282|P1|Treated|Double-blind Phase: 1st 6 Months||121
1571658|NCT01166438|3845281|P2|STARTED|Double-blind Phase: 1st 6 Months||127
1571659|NCT01166438|3845282|P1|STARTED|Double-blind Phase: 1st 6 Months||122
1571660|NCT01166347|3845298|P2|NOT COMPLETED|Overall Study||1
1571661|NCT01166347|3845299|P1|NOT COMPLETED|Overall Study||2
1571662|NCT01166347|3845298|P2|COMPLETED|Overall Study||148
1571663|NCT01166347|3845299|P1|COMPLETED|Overall Study||295
1571664|NCT01166347|3845298|P2|STARTED|Overall Study||149
1571665|NCT01166347|3845299|P1|STARTED|Overall Study||297
1571666|NCT01166282|3845331|P3|NOT COMPLETED|Open-label Period||17
1571667|NCT01166282|3845332|P2|NOT COMPLETED|Open-label Period||0
1571668|NCT01166282|3845333|P1|NOT COMPLETED|Open-label Period||0
1571669|NCT01166282|3845331|P3|COMPLETED|Open-label Period||29
1571670|NCT01166282|3845332|P2|COMPLETED|Open-label Period||0
1571671|NCT01166282|3845333|P1|COMPLETED|Open-label Period||0
1571672|NCT01166282|3845331|P3|STARTED|Open-label Period||46
1571673|NCT01166282|3845332|P2|STARTED|Open-label Period||0
1571674|NCT01166282|3845333|P1|STARTED|Open-label Period||0
1571675|NCT01166282|3845331|P3|NOT COMPLETED|Double-blind Period||0
1571676|NCT01166282|3845332|P2|NOT COMPLETED|Double-blind Period||0
1571677|NCT01166282|3845333|P1|NOT COMPLETED|Double-blind Period||0
1571678|NCT01166282|3845331|P3|COMPLETED|Double-blind Period||0
1571679|NCT01166282|3845332|P2|COMPLETED|Double-blind Period||31
1571680|NCT01166282|3845333|P1|COMPLETED|Double-blind Period||15
1571681|NCT01166282|3845331|P3|STARTED|Double-blind Period||0
1571682|NCT01166282|3845332|P2|STARTED|Double-blind Period||31
1571683|NCT01166282|3845333|P1|STARTED|Double-blind Period||15
1571684|NCT01166230|3845357|P2|NOT COMPLETED|Overall Study||16
1571685|NCT01166230|3845358|P1|NOT COMPLETED|Overall Study||19
1571686|NCT01166230|3845357|P2|COMPLETED|Overall Study||255
1571687|NCT01166230|3845358|P1|COMPLETED|Overall Study||261
1571688|NCT01166230|3845357|P2|STARTED|Overall Study||271
1571689|NCT01166230|3845358|P1|STARTED|Overall Study||280
1571690|NCT01166178|3845372|P2|NOT COMPLETED|Overall Study||8
1571691|NCT01166178|3845373|P1|NOT COMPLETED|Overall Study||21
1571692|NCT01166178|3845372|P2|COMPLETED|Overall Study||0
1571693|NCT01166178|3845373|P1|COMPLETED|Overall Study||0
1571694|NCT01166178|3845372|P2|STARTED|Overall Study||8
1571695|NCT01166178|3845373|P1|STARTED|Overall Study||21
1571696|NCT01166139|3845399|P1|NOT COMPLETED|Overall Study||3
1571697|NCT01166139|3845399|P1|COMPLETED|Overall Study||7
1571698|NCT01166139|3845399|P1|STARTED|Overall Study||10
1571699|NCT01166126|3845405|P1|NOT COMPLETED|Overall Study||0
1571700|NCT01166126|3845405|P1|COMPLETED|Overall Study||4
1571701|NCT01166126|3845405|P1|STARTED|Overall Study||4
1571702|NCT01165996|3845412|P1|NOT COMPLETED|Overall Study||2
1571703|NCT01165996|3845412|P1|COMPLETED|Overall Study||23
1571704|NCT01165996|3845412|P1|Maintenance Phase|Overall Study||23
1571705|NCT01165996|3845412|P1|Induction Phase|Overall Study||25
1571706|NCT01165996|3845412|P1|STARTED|Overall Study||25
1571707|NCT01165983|3845420|P2|NOT COMPLETED|Overall Study||7
1571708|NCT01165983|3845421|P1|NOT COMPLETED|Overall Study||5
1571709|NCT01165983|3845420|P2|COMPLETED|Overall Study||42
1571710|NCT01165983|3845421|P1|COMPLETED|Overall Study||46
1571711|NCT01165983|3845420|P2|STARTED|Overall Study||49
1571712|NCT01165983|3845421|P1|STARTED|Overall Study||51
1571713|NCT01165840|3845465|P1|NOT COMPLETED|Overall Study||0
1571714|NCT01165840|3845465|P1|COMPLETED|Overall Study||36
1571715|NCT01165840|3845465|P1|STARTED|Overall Study||36
1571716|NCT01165775|3845469|P1|NOT COMPLETED|Overall Study||2
1571717|NCT01165775|3845469|P1|COMPLETED|Overall Study||15
1571718|NCT01165775|3845469|P1|STARTED|Overall Study||17
1571719|NCT01165684|3845479|P2|NOT COMPLETED|Overall Study||52
1571720|NCT01165684|3845480|P1|NOT COMPLETED|Overall Study||28
1571721|NCT01165684|3845479|P2|COMPLETED|Overall Study||148
1571722|NCT01165684|3845480|P1|COMPLETED|Overall Study||173
1571723|NCT01165684|3845479|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
1571724|NCT01165684|3845480|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
1571725|NCT01165684|3845479|P2|STARTED|Overall Study||200
1571726|NCT01165684|3845480|P1|STARTED|Overall Study||201
1571727|NCT01165554|3845514|P1|NOT COMPLETED|Overall Study||23
1571728|NCT01165554|3845514|P1|COMPLETED|Overall Study||180
1571729|NCT01165554|3845514|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
1571730|NCT01165541|3845521|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
1571731|NCT01165541|3845521|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
1571732|NCT01165541|3845521|P1|STARTED|Quetiapine XR and Mirtazepine||16
1571733|NCT01165541|3845521|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
1571734|NCT01165541|3845521|P1|COMPLETED|Quetiapine XR Monotherapy||16
1571735|NCT01165541|3845521|P1|STARTED|Quetiapine XR Monotherapy||20
1571736|NCT01165450|3845527|P1|NOT COMPLETED|Overall Study||0
1571737|NCT01165450|3845527|P1|COMPLETED|Overall Study||2
1571738|NCT01165450|3845527|P1|STARTED|Overall Study||2
1571739|NCT01165424|3845537|P1|NOT COMPLETED|Overall Study||4
1571740|NCT01165424|3845537|P1|COMPLETED|Overall Study||76
1571741|NCT01165424|3845537|P1|STARTED|Overall Study||80
1571742|NCT01165320|3845544|P3|NOT COMPLETED|Overall Study||0
1571743|NCT01165320|3845545|P2|NOT COMPLETED|Overall Study||4
1571744|NCT01165320|3845546|P1|NOT COMPLETED|Overall Study||3
1571745|NCT01165320|3845544|P3|COMPLETED|Overall Study||0
1571746|NCT01165320|3845545|P2|COMPLETED|Overall Study||4
1571747|NCT01165320|3845546|P1|COMPLETED|Overall Study||9
1571748|NCT01165320|3845544|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
1571749|NCT01165320|3845545|P2|STARTED|Overall Study||8
1571750|NCT01165320|3845546|P1|STARTED|Overall Study||12
1571751|NCT01165307|3845556|P2|NOT COMPLETED|Overall Study||3
1571752|NCT01165307|3845557|P1|NOT COMPLETED|Overall Study||14
1571753|NCT01165307|3845556|P2|COMPLETED|Overall Study||31
1571754|NCT01165307|3845557|P1|COMPLETED|Overall Study||19
1571755|NCT01165307|3845556|P2|STARTED|Overall Study||34
1571756|NCT01165307|3845557|P1|STARTED|Overall Study||33
1571757|NCT01165281|3845587|P2|NOT COMPLETED|Overall Study||51
1571758|NCT01165281|3845588|P1|NOT COMPLETED|Overall Study||58
1571759|NCT01165281|3845587|P2|COMPLETED|Overall Study||121
1571760|NCT01165281|3845588|P1|COMPLETED|Overall Study||110
1571761|NCT01165281|3845587|P2|STARTED|Overall Study||172
1571762|NCT01165281|3845588|P1|STARTED|Overall Study||168
1571763|NCT01165242|3845609|P3|NOT COMPLETED|Overall Study||14
1571764|NCT01165242|3845610|P2|NOT COMPLETED|Overall Study||10
1571765|NCT01165242|3845611|P1|NOT COMPLETED|Overall Study||10
1571766|NCT01165242|3845609|P3|COMPLETED|Overall Study||324
1571767|NCT01165242|3845610|P2|COMPLETED|Overall Study||326
1571768|NCT01165242|3845611|P1|COMPLETED|Overall Study||327
1571769|NCT01165242|3845609|P3|STARTED|Overall Study||338
1571770|NCT01165242|3845610|P2|STARTED|Overall Study||336
1571771|NCT01165242|3845611|P1|STARTED|Overall Study||337
1571772|NCT01165229|3845645|P2|NOT COMPLETED|Overall Study||1189
1571773|NCT01165229|3845646|P1|NOT COMPLETED|Overall Study||1180
1571774|NCT01165229|3845645|P2|COMPLETED|Overall Study||5761
1571775|NCT01165229|3845646|P1|COMPLETED|Overall Study||5770
1571776|NCT01165229|3845645|P2|STARTED|Overall Study||6950
1571777|NCT01165229|3845646|P1|STARTED|Overall Study||6950
1571778|NCT01165216|3845774|P2|NOT COMPLETED|Overall Study||7
1571779|NCT01165216|3845775|P1|NOT COMPLETED|Overall Study||8
1571780|NCT01165216|3845774|P2|COMPLETED|Overall Study|Completed=still on study drug|0
1571781|NCT01165216|3845775|P1|COMPLETED|Overall Study|Completed=still on study drug|0
1571782|NCT01165216|3845774|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
1571783|NCT01165216|3845775|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
1571784|NCT01165216|3845774|P2|STARTED|Overall Study|Participants who received any study drug|7
1571785|NCT01165216|3845775|P1|STARTED|Overall Study|Participants who received any study drug|8
1571786|NCT01165203|3845797|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
1571787|NCT01165203|3845798|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
1571788|NCT01165203|3845797|P2|COMPLETED|Extended Safety Follow-up Phase||45
1571789|NCT01165203|3845798|P1|COMPLETED|Extended Safety Follow-up Phase||67
1571790|NCT01165203|3845797|P2|STARTED|Extended Safety Follow-up Phase||49
1571791|NCT01165203|3845798|P1|STARTED|Extended Safety Follow-up Phase||74
1571792|NCT01165203|3845797|P2|NOT COMPLETED|Active Phase||2
1571793|NCT01165203|3845798|P1|NOT COMPLETED|Active Phase||5
1571794|NCT01165203|3845797|P2|COMPLETED|Active Phase||47
1571795|NCT01165203|3845798|P1|COMPLETED|Active Phase||69
1571796|NCT01165203|3845797|P2|STARTED|Active Phase||49
1571797|NCT01165203|3845798|P1|STARTED|Active Phase||74
1571798|NCT01165177|3845888|P2|NOT COMPLETED|Overall Study||902
1571799|NCT01165177|3845889|P1|NOT COMPLETED|Overall Study||922
1571800|NCT01165177|3845888|P2|COMPLETED|Overall Study||6808
1571801|NCT01165177|3845889|P1|COMPLETED|Overall Study||6773
1571802|NCT01165177|3845888|P2|STARTED|Overall Study||7710
1571803|NCT01165177|3845889|P1|STARTED|Overall Study||7695
1571804|NCT01165138|3846014|P4|NOT COMPLETED|Overall Study||22
1571805|NCT01165138|3846015|P3|NOT COMPLETED|Overall Study||20
1571806|NCT01165138|3846016|P2|NOT COMPLETED|Overall Study||52
1571807|NCT01165138|3846017|P1|NOT COMPLETED|Overall Study||0
1571808|NCT01165138|3846014|P4|COMPLETED|Overall Study||179
1571809|NCT01165138|3846015|P3|COMPLETED|Overall Study||185
1571810|NCT01165138|3846016|P2|COMPLETED|Overall Study||151
1571811|NCT01165138|3846017|P1|COMPLETED|Overall Study||0
1571812|NCT01165138|3846014|P4|STARTED|Overall Study||201
1571813|NCT01165138|3846015|P3|STARTED|Overall Study||205
1571814|NCT01165138|3846016|P2|STARTED|Overall Study||203
1571815|NCT01165138|3846017|P1|STARTED|Overall Study||0
1571816|NCT01165112|3846076|P1|NOT COMPLETED|Overall Study||0
1571817|NCT01165112|3846076|P1|COMPLETED|Overall Study||48
1571818|NCT01165112|3846076|P1|STARTED|Overall Study||48
1571819|NCT01165047|3846083|P1|NOT COMPLETED|Overall Study||0
1571820|NCT01165047|3846083|P1|COMPLETED|Overall Study||10
1571821|NCT01165047|3846083|P1|STARTED|Overall Study||10
1571822|NCT01165021|3846087|P1|NOT COMPLETED|Overall Study||1
1571823|NCT01165021|3846087|P1|COMPLETED|Overall Study||18
1571824|NCT01165021|3846087|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
1571825|NCT01165021|3846087|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
1571826|NCT01165021|3846087|P1|≥1 Dose Chemo|Overall Study||19
1571827|NCT01165021|3846087|P1|STARTED|Overall Study||19
1571828|NCT01164891|3846095|P1|NOT COMPLETED|Overall Study||6
1571829|NCT01164891|3846095|P1|COMPLETED|Overall Study||1
1571830|NCT01164891|3846095|P1|STARTED|Overall Study||7
1571831|NCT01164865|3846115|P2|NOT COMPLETED|Overall Study||1
1571832|NCT01164865|3846116|P1|NOT COMPLETED|Overall Study||2
1571833|NCT01164865|3846115|P2|COMPLETED|Overall Study||38
1571834|NCT01164865|3846116|P1|COMPLETED|Overall Study||37
1571835|NCT01164865|3846115|P2|STARTED|Overall Study||39
1571836|NCT01164865|3846116|P1|STARTED|Overall Study||39
1571837|NCT01164722|3846126|P2|NOT COMPLETED|Overall Study||15
1571838|NCT01164722|3846127|P1|NOT COMPLETED|Overall Study||18
1571839|NCT01164722|3846126|P2|COMPLETED|Overall Study||45
1571840|NCT01164722|3846127|P1|COMPLETED|Overall Study||42
1571841|NCT01164722|3846126|P2|STARTED|Overall Study||60
1571842|NCT01164722|3846127|P1|STARTED|Overall Study||60
1571843|NCT01164644|3846143|P2|NOT COMPLETED|Overall Study||1
1571844|NCT01164644|3846144|P1|NOT COMPLETED|Overall Study||3
1571845|NCT01164644|3846143|P2|COMPLETED|Overall Study||13
1571846|NCT01164644|3846144|P1|COMPLETED|Overall Study||9
1571847|NCT01164644|3846143|P2|STARTED|Overall Study||14
1571848|NCT01164644|3846144|P1|STARTED|Overall Study||12
1571849|NCT01164579|3846157|P3|NOT COMPLETED|Overall Study||16
1571850|NCT01164579|3846158|P2|NOT COMPLETED|Overall Study||9
1571851|NCT01164579|3846159|P1|NOT COMPLETED|Overall Study||8
1571852|NCT01164579|3846157|P3|COMPLETED|Overall Study||21
1571853|NCT01164579|3846158|P2|COMPLETED|Overall Study||27
1571854|NCT01164579|3846159|P1|COMPLETED|Overall Study||28
1571855|NCT01164579|3846157|P3|STARTED|Overall Study||37
1571856|NCT01164579|3846158|P2|STARTED|Overall Study||36
1571857|NCT01164579|3846159|P1|STARTED|Overall Study||36
1571858|NCT01164501|3846239|P3|NOT COMPLETED|Overall Study||42
1571859|NCT01164501|3846240|P2|NOT COMPLETED|Overall Study||10
1571860|NCT01164501|3846241|P1|NOT COMPLETED|Overall Study||43
1571861|NCT01164501|3846239|P3|COMPLETED|Overall Study||280
1571862|NCT01164501|3846240|P2|COMPLETED|Overall Study||88
1571863|NCT01164501|3846241|P1|COMPLETED|Overall Study||278
1571864|NCT01164501|3846239|P3|STARTED|Overall Study||322
1571865|NCT01164501|3846240|P2|STARTED|Overall Study||98
1571866|NCT01164501|3846241|P1|STARTED|Overall Study||321
1571867|NCT01164475|3846258|P2|NOT COMPLETED|Overall Study||2
1571868|NCT01164475|3846259|P1|NOT COMPLETED|Overall Study||2
1571869|NCT01164475|3846258|P2|COMPLETED|Overall Study||29
1571870|NCT01164475|3846259|P1|COMPLETED|Overall Study||28
1571871|NCT01164475|3846258|P2|STARTED|Overall Study||31
1571872|NCT01164475|3846259|P1|STARTED|Overall Study||30
1571873|NCT01164137|3846285|P2|NOT COMPLETED|Overall Study||0
1571874|NCT01164137|3846286|P1|NOT COMPLETED|Overall Study||3
1571875|NCT01164137|3846285|P2|COMPLETED|Overall Study||76
1571876|NCT01164137|3846286|P1|COMPLETED|Overall Study||77
1571877|NCT01164137|3846285|P2|STARTED|Overall Study||76
1571878|NCT01164137|3846286|P1|STARTED|Overall Study||80
1571879|NCT01164098|3846302|P2|NOT COMPLETED|Overall Study||0
1571880|NCT01164098|3846303|P1|NOT COMPLETED|Overall Study||0
1571881|NCT01164098|3846302|P2|COMPLETED|Overall Study||15
1571882|NCT01164098|3846303|P1|COMPLETED|Overall Study||15
1571883|NCT01164098|3846302|P2|STARTED|Overall Study||15
1571884|NCT01164098|3846303|P1|STARTED|Overall Study||15
1571885|NCT01164007|3846313|P1|NOT COMPLETED|Overall Study||40
1571886|NCT01164007|3846313|P1|COMPLETED|Overall Study||0
1571887|NCT01164007|3846313|P1|Treated|Overall Study||37
1571888|NCT01164007|3846313|P1|STARTED|Overall Study||40
1571889|NCT01163955|3846329|P2|NOT COMPLETED|Overall Study||4
1571890|NCT01163955|3846330|P1|NOT COMPLETED|Overall Study||0
1571891|NCT01163955|3846329|P2|COMPLETED|Overall Study||26
1571892|NCT01163955|3846330|P1|COMPLETED|Overall Study||26
1571893|NCT01163955|3846329|P2|STARTED|Overall Study||30
1571894|NCT01163955|3846330|P1|STARTED|Overall Study||26
1571895|NCT01163916|3846339|P3|NOT COMPLETED|Overall Study||20
1571896|NCT01163916|3846340|P2|NOT COMPLETED|Overall Study||4
1571897|NCT01163916|3846341|P1|NOT COMPLETED|Overall Study||30
1571898|NCT01163916|3846339|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
1571899|NCT01163916|3846340|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
1571900|NCT01163916|3846341|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
1571901|NCT01163916|3846339|P3|Safety Population|Overall Study||91
1571902|NCT01163916|3846340|P2|Safety Population|Overall Study||35
1571903|NCT01163916|3846341|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
1571904|NCT01163916|3846339|P3|STARTED|Overall Study||91
1571905|NCT01163916|3846340|P2|STARTED|Overall Study||35
1571906|NCT01163916|3846341|P1|STARTED|Overall Study||126
1571907|NCT01163851|3846379|P2|NOT COMPLETED|Overall Study||1
1571908|NCT01163851|3846380|P1|NOT COMPLETED|Overall Study||1
1571909|NCT01163851|3846379|P2|COMPLETED|Overall Study||11
1571910|NCT01163851|3846380|P1|COMPLETED|Overall Study||12
1571911|NCT01163851|3846379|P2|Treated|Overall Study||12
1571912|NCT01163851|3846380|P1|Treated|Overall Study||12
1571913|NCT01163851|3846379|P2|STARTED|Overall Study||12
1571914|NCT01163851|3846380|P1|STARTED|Overall Study||13
1571915|NCT01163760|3846458|P4|NOT COMPLETED|Period 4 (Follow-up)||0
1571916|NCT01163760|3846459|P3|NOT COMPLETED|Period 4 (Follow-up)||0
1571917|NCT01163760|3846460|P2|NOT COMPLETED|Period 4 (Follow-up)||0
1571918|NCT01163760|3846461|P1|NOT COMPLETED|Period 4 (Follow-up)||0
1571919|NCT01163760|3846458|P4|COMPLETED|Period 4 (Follow-up)||12
1571920|NCT01163760|3846459|P3|COMPLETED|Period 4 (Follow-up)||13
1571921|NCT01163760|3846460|P2|COMPLETED|Period 4 (Follow-up)||13
1571922|NCT01163760|3846461|P1|COMPLETED|Period 4 (Follow-up)||12
1571923|NCT01163760|3846458|P4|STARTED|Period 4 (Follow-up)||12
1571924|NCT01163760|3846459|P3|STARTED|Period 4 (Follow-up)||13
1571925|NCT01163760|3846460|P2|STARTED|Period 4 (Follow-up)||13
1571926|NCT01163760|3846461|P1|STARTED|Period 4 (Follow-up)||12
1571927|NCT01163760|3846458|P4|NOT COMPLETED|Period 3 (Fit)||0
1571928|NCT01163760|3846459|P3|NOT COMPLETED|Period 3 (Fit)||0
1571929|NCT01163760|3846460|P2|NOT COMPLETED|Period 3 (Fit)||0
1571930|NCT01163760|3846461|P1|NOT COMPLETED|Period 3 (Fit)||0
1571931|NCT01163760|3846458|P4|COMPLETED|Period 3 (Fit)||12
1571932|NCT01163760|3846459|P3|COMPLETED|Period 3 (Fit)||13
1571933|NCT01163760|3846460|P2|COMPLETED|Period 3 (Fit)||13
1571934|NCT01163760|3846461|P1|COMPLETED|Period 3 (Fit)||12
1571935|NCT01163760|3846458|P4|STARTED|Period 3 (Fit)||12
1571936|NCT01163760|3846459|P3|STARTED|Period 3 (Fit)||13
1571937|NCT01163760|3846460|P2|STARTED|Period 3 (Fit)||13
1571938|NCT01163760|3846461|P1|STARTED|Period 3 (Fit)||12
1571939|NCT01163760|3846458|P4|NOT COMPLETED|Period 2 (Follow-up)||0
1571940|NCT01163760|3846459|P3|NOT COMPLETED|Period 2 (Follow-up)||0
1571941|NCT01163760|3846460|P2|NOT COMPLETED|Period 2 (Follow-up)||0
1571942|NCT01163760|3846461|P1|NOT COMPLETED|Period 2 (Follow-up)||0
1571943|NCT01163760|3846458|P4|COMPLETED|Period 2 (Follow-up)||12
1571944|NCT01163760|3846459|P3|COMPLETED|Period 2 (Follow-up)||13
1571945|NCT01163760|3846460|P2|COMPLETED|Period 2 (Follow-up)||13
1571946|NCT01163760|3846461|P1|COMPLETED|Period 2 (Follow-up)||12
1571947|NCT01163760|3846458|P4|STARTED|Period 2 (Follow-up)||12
1571948|NCT01163760|3846459|P3|STARTED|Period 2 (Follow-up)||13
1571949|NCT01163760|3846460|P2|STARTED|Period 2 (Follow-up)||13
1571950|NCT01163760|3846461|P1|STARTED|Period 2 (Follow-up)||12
1571951|NCT01163760|3846458|P4|NOT COMPLETED|Period 1 (Fit)||0
1571952|NCT01163760|3846459|P3|NOT COMPLETED|Period 1 (Fit)||0
1571953|NCT01163760|3846460|P2|NOT COMPLETED|Period 1 (Fit)||0
1571954|NCT01163760|3846461|P1|NOT COMPLETED|Period 1 (Fit)||0
1571955|NCT01163760|3846458|P4|COMPLETED|Period 1 (Fit)||12
1571956|NCT01163760|3846459|P3|COMPLETED|Period 1 (Fit)||13
1571957|NCT01163760|3846460|P2|COMPLETED|Period 1 (Fit)||13
1571958|NCT01163760|3846461|P1|COMPLETED|Period 1 (Fit)||12
1571959|NCT01163760|3846458|P4|STARTED|Period 1 (Fit)||12
1571960|NCT01163760|3846459|P3|STARTED|Period 1 (Fit)||13
1571961|NCT01163760|3846460|P2|STARTED|Period 1 (Fit)||13
1571962|NCT01163760|3846461|P1|STARTED|Period 1 (Fit)||12
1571963|NCT01163747|3846475|P2|NOT COMPLETED|Overall Study||11
1571964|NCT01163747|3846476|P1|NOT COMPLETED|Overall Study||6
1571965|NCT01163747|3846475|P2|COMPLETED|Overall Study||49
1571966|NCT01163747|3846476|P1|COMPLETED|Overall Study||25
1571967|NCT01163747|3846475|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
1571968|NCT01163747|3846476|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
1571969|NCT01163747|3846475|P2|STARTED|Overall Study||60
1571970|NCT01163747|3846476|P1|STARTED|Overall Study||31
1571971|NCT01163721|3846496|P2|NOT COMPLETED|Overall Study||12
1571972|NCT01163721|3846497|P1|NOT COMPLETED|Overall Study||8
1571973|NCT01163721|3846496|P2|COMPLETED|Overall Study||29
1571974|NCT01163721|3846497|P1|COMPLETED|Overall Study||31
1571975|NCT01163721|3846496|P2|STARTED|Overall Study||41
1571976|NCT01163721|3846497|P1|STARTED|Overall Study||39
1571977|NCT01163656|3846509|P2|NOT COMPLETED|Overall Study||3
1571978|NCT01163656|3846510|P1|NOT COMPLETED|Overall Study||3
1571979|NCT01163656|3846509|P2|COMPLETED|Overall Study||30
1571980|NCT01163656|3846510|P1|COMPLETED|Overall Study||30
1571981|NCT01163656|3846509|P2|STARTED|Overall Study||33
1571982|NCT01163656|3846510|P1|STARTED|Overall Study||33
1571983|NCT01163617|3846516|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1571984|NCT01163617|3846517|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1571985|NCT01163617|3846518|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1571986|NCT01163617|3846519|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1571987|NCT01163617|3846520|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1571988|NCT01163617|3846521|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1571989|NCT01163617|3846522|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1571990|NCT01163617|3846523|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1571991|NCT01163617|3846516|P8|COMPLETED|Phase B (Injection Time), Week 4||20
1571992|NCT01163617|3846517|P7|COMPLETED|Phase B (Injection Time), Week 4||16
1571993|NCT01163617|3846518|P6|COMPLETED|Phase B (Injection Time), Week 4||27
1571994|NCT01163617|3846519|P5|COMPLETED|Phase B (Injection Time), Week 4||18
1571995|NCT01163617|3846520|P4|COMPLETED|Phase B (Injection Time), Week 4||0
1571996|NCT01163617|3846521|P3|COMPLETED|Phase B (Injection Time), Week 4||0
1571997|NCT01163617|3846522|P2|COMPLETED|Phase B (Injection Time), Week 4||0
1571998|NCT01163617|3846523|P1|COMPLETED|Phase B (Injection Time), Week 4||0
1571999|NCT01163617|3846516|P8|STARTED|Phase B (Injection Time), Week 4||20
1572000|NCT01163617|3846517|P7|STARTED|Phase B (Injection Time), Week 4||16
1572001|NCT01163617|3846518|P6|STARTED|Phase B (Injection Time), Week 4||27
1572002|NCT01163617|3846519|P5|STARTED|Phase B (Injection Time), Week 4||18
1572003|NCT01163617|3846520|P4|STARTED|Phase B (Injection Time), Week 4||0
1572004|NCT01163617|3846521|P3|STARTED|Phase B (Injection Time), Week 4||0
1572005|NCT01163617|3846522|P2|STARTED|Phase B (Injection Time), Week 4||0
1572006|NCT01163617|3846523|P1|STARTED|Phase B (Injection Time), Week 4||0
1572007|NCT01163617|3846516|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572008|NCT01163617|3846517|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572009|NCT01163617|3846518|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572010|NCT01163617|3846519|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572011|NCT01163617|3846520|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572012|NCT01163617|3846521|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
1572013|NCT01163617|3846522|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
1572014|NCT01163617|3846523|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572015|NCT01163617|3846516|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572016|NCT01163617|3846517|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572017|NCT01163617|3846518|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572018|NCT01163617|3846519|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1572019|NCT01163617|3846520|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
1572020|NCT01163617|3846521|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
1572021|NCT01163617|3846522|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
1572022|NCT01163617|3846523|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
1572023|NCT01163617|3846516|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1572024|NCT01163617|3846517|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1572025|NCT01163617|3846518|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1572026|NCT01163617|3846519|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1572027|NCT01163617|3846520|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
1572028|NCT01163617|3846521|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
1572029|NCT01163617|3846522|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
1572030|NCT01163617|3846523|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
1572031|NCT01163604|3846545|P2|NOT COMPLETED|Overall Study||0
1572032|NCT01163604|3846546|P1|NOT COMPLETED|Overall Study||0
1572033|NCT01163604|3846545|P2|COMPLETED|Overall Study|August 2011|56
1572034|NCT01163604|3846546|P1|COMPLETED|Overall Study|August 2011|58
1572035|NCT01163604|3846545|P2|STARTED|Overall Study|August 2010|56
1572036|NCT01163604|3846546|P1|STARTED|Overall Study|August 2010|58
1572037|NCT01163474|3846552|P1|NOT COMPLETED|Overall Study||16
1572038|NCT01163474|3846552|P1|COMPLETED|Overall Study||24
1572039|NCT01163474|3846552|P1|STARTED|Overall Study||40
1572040|NCT01163461|3846558|P2|NOT COMPLETED|Overall Study||0
1572041|NCT01163461|3846559|P1|NOT COMPLETED|Overall Study||0
1572042|NCT01163461|3846558|P2|COMPLETED|Overall Study||14
1572043|NCT01163461|3846559|P1|COMPLETED|Overall Study||14
1572044|NCT01163461|3846558|P2|STARTED|Overall Study||14
1572045|NCT01163461|3846559|P1|STARTED|Overall Study||14
1572046|NCT01163318|3846563|P1|NOT COMPLETED|Overall Study||268
1572047|NCT01163318|3846563|P1|COMPLETED|Overall Study||284
1572048|NCT01163318|3846563|P1|STARTED|Overall Study||552
1572049|NCT01163292|3846572|P2|NOT COMPLETED|Overall Study||22
1572050|NCT01163292|3846573|P1|NOT COMPLETED|Overall Study||41
1572051|NCT01163292|3846572|P2|COMPLETED|Overall Study||92
1572052|NCT01163292|3846573|P1|COMPLETED|Overall Study||65
1572053|NCT01163292|3846572|P2|STARTED|Overall Study||114
1572054|NCT01163292|3846573|P1|STARTED|Overall Study||106
1572055|NCT01163279|3846589|P2|NOT COMPLETED|Overall Study||0
1572056|NCT01163279|3846590|P1|NOT COMPLETED|Overall Study||2
1572057|NCT01163279|3846589|P2|COMPLETED|Overall Study||9
1572058|NCT01163279|3846590|P1|COMPLETED|Overall Study||8
1572059|NCT01163279|3846589|P2|STARTED|Overall Study||9
1572060|NCT01163279|3846590|P1|STARTED|Overall Study||10
1572061|NCT01163266|3846619|P3|NOT COMPLETED|Overall Study||28
1572062|NCT01163266|3846620|P2|NOT COMPLETED|Overall Study||31
1572063|NCT01163266|3846621|P1|NOT COMPLETED|Overall Study||18
1572064|NCT01163266|3846619|P3|COMPLETED|Overall Study||122
1572065|NCT01163266|3846620|P2|COMPLETED|Overall Study||124
1572066|NCT01163266|3846621|P1|COMPLETED|Overall Study||139
1572067|NCT01163266|3846619|P3|Treated|Overall Study||150
1572068|NCT01163266|3846620|P2|Treated|Overall Study||155
1572069|NCT01163266|3846621|P1|Treated|Overall Study||157
1572070|NCT01163266|3846619|P3|STARTED|Overall Study||150
1572071|NCT01163266|3846620|P2|STARTED|Overall Study||155
1572072|NCT01163266|3846621|P1|STARTED|Overall Study||157
1572073|NCT01163253|3846646|P2|NOT COMPLETED|Overall Study||586
1572074|NCT01163253|3846647|P1|NOT COMPLETED|Overall Study||2281
1572075|NCT01163253|3846646|P2|COMPLETED|Overall Study||0
1572076|NCT01163253|3846647|P1|COMPLETED|Overall Study||0
1572077|NCT01163253|3846646|P2|STARTED|Overall Study||586
1572078|NCT01163253|3846647|P1|STARTED|Overall Study||2281
1572079|NCT01163214|3846809|P2|NOT COMPLETED|Overall Study||0
1572080|NCT01163214|3846810|P1|NOT COMPLETED|Overall Study||0
1572081|NCT01163214|3846809|P2|COMPLETED|Overall Study||81
1572082|NCT01163214|3846810|P1|COMPLETED|Overall Study||79
1572083|NCT01163214|3846809|P2|STARTED|Overall Study||81
1572084|NCT01163214|3846810|P1|STARTED|Overall Study||79
1572085|NCT01163162|3846826|P1|NOT COMPLETED|Overall Study||0
1572086|NCT01163162|3846826|P1|COMPLETED|Overall Study||16
1572087|NCT01163162|3846826|P1|STARTED|Overall Study||16
1572088|NCT01163149|3846835|P3|NOT COMPLETED|Extension Treatment Period||2
1572089|NCT01163149|3846836|P2|NOT COMPLETED|Extension Treatment Period||1
1572090|NCT01163149|3846837|P1|NOT COMPLETED|Extension Treatment Period||2
1572091|NCT01163149|3846835|P3|COMPLETED|Extension Treatment Period||4
1572092|NCT01163149|3846836|P2|COMPLETED|Extension Treatment Period||5
1572093|NCT01163149|3846837|P1|COMPLETED|Extension Treatment Period||5
1572094|NCT01163149|3846835|P3|STARTED|Extension Treatment Period||6
1572095|NCT01163149|3846836|P2|STARTED|Extension Treatment Period||6
1572096|NCT01163149|3846837|P1|STARTED|Extension Treatment Period||7
1572097|NCT01163149|3846835|P3|NOT COMPLETED|Primary Treatment Period||0
1572098|NCT01163149|3846836|P2|NOT COMPLETED|Primary Treatment Period||0
1572099|NCT01163149|3846837|P1|NOT COMPLETED|Primary Treatment Period||0
1572100|NCT01163149|3846835|P3|COMPLETED|Primary Treatment Period||6
1572101|NCT01163149|3846836|P2|COMPLETED|Primary Treatment Period||6
1572102|NCT01163149|3846837|P1|COMPLETED|Primary Treatment Period||7
1572103|NCT01163149|3846835|P3|STARTED|Primary Treatment Period||6
1572104|NCT01163149|3846836|P2|STARTED|Primary Treatment Period||6
1572105|NCT01163149|3846837|P1|STARTED|Primary Treatment Period||7
1572106|NCT01163097|3846882|P3|NOT COMPLETED|Overall Study||0
1572107|NCT01163097|3846883|P2|NOT COMPLETED|Overall Study||0
1572108|NCT01163097|3846884|P1|NOT COMPLETED|Overall Study||6
1572109|NCT01163097|3846882|P3|COMPLETED|Overall Study||8
1572110|NCT01163097|3846883|P2|COMPLETED|Overall Study||16
1572111|NCT01163097|3846884|P1|COMPLETED|Overall Study||14
1572112|NCT01163097|3846882|P3|STARTED|Overall Study||8
1572113|NCT01163097|3846883|P2|STARTED|Overall Study||16
1572114|NCT01163097|3846884|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
1572115|NCT01163032|3846937|P3|NOT COMPLETED|Open Label Extension Phase||16
1572116|NCT01163032|3846938|P2|NOT COMPLETED|Open Label Extension Phase||0
1572117|NCT01163032|3846939|P1|NOT COMPLETED|Open Label Extension Phase||0
1572118|NCT01163032|3846937|P3|COMPLETED|Open Label Extension Phase||39
1572119|NCT01163032|3846938|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1572120|NCT01163032|3846939|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1572121|NCT01163032|3846937|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
1572122|NCT01163032|3846938|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1572123|NCT01163032|3846939|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1572124|NCT01163032|3846937|P3|NOT COMPLETED|Randomization Phase||0
1572125|NCT01163032|3846938|P2|NOT COMPLETED|Randomization Phase||12
1572126|NCT01163032|3846939|P1|NOT COMPLETED|Randomization Phase||10
1572127|NCT01163032|3846937|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
1572128|NCT01163032|3846938|P2|COMPLETED|Randomization Phase||30
1572129|NCT01163032|3846939|P1|COMPLETED|Randomization Phase||32
1572130|NCT01163032|3846937|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
1572131|NCT01163032|3846938|P2|STARTED|Randomization Phase||42
1572132|NCT01163032|3846939|P1|STARTED|Randomization Phase||42
1572133|NCT01162863|3846972|P3|NOT COMPLETED|Overall Study||0
1572134|NCT01162863|3846973|P2|NOT COMPLETED|Overall Study||1
1572135|NCT01162863|3846974|P1|NOT COMPLETED|Overall Study||1
1572136|NCT01162863|3846972|P3|COMPLETED|Overall Study||17
1572137|NCT01162863|3846973|P2|COMPLETED|Overall Study||16
1572138|NCT01162863|3846974|P1|COMPLETED|Overall Study||17
1572139|NCT01162863|3846972|P3|STARTED|Overall Study||17
1572140|NCT01162863|3846973|P2|STARTED|Overall Study||17
1572141|NCT01162863|3846974|P1|STARTED|Overall Study||18
1572142|NCT01162733|3846990|P2|NOT COMPLETED|Overall Study||25
1572143|NCT01162733|3846991|P1|NOT COMPLETED|Overall Study||27
1572144|NCT01162733|3846990|P2|COMPLETED|Overall Study||25
1572145|NCT01162733|3846991|P1|COMPLETED|Overall Study||22
1572146|NCT01162733|3846990|P2|STARTED|Overall Study||50
1572147|NCT01162733|3846991|P1|STARTED|Overall Study||49
1572148|NCT01162499|3846999|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
1572149|NCT01162499|3847000|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
1572150|NCT01162499|3846999|P2|COMPLETED|Intervention 2 (4 Hours)||3
1572151|NCT01162499|3847000|P1|COMPLETED|Intervention 2 (4 Hours)||3
1572152|NCT01162499|3846999|P2|STARTED|Intervention 2 (4 Hours)||3
1572153|NCT01162499|3847000|P1|STARTED|Intervention 2 (4 Hours)||3
1572154|NCT01162499|3846999|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
1572155|NCT01162499|3847000|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
1572156|NCT01162499|3846999|P2|COMPLETED|Intervention 1 (4 Hours)||3
1572157|NCT01162499|3847000|P1|COMPLETED|Intervention 1 (4 Hours)||3
1572158|NCT01162499|3846999|P2|Received Intervention|Intervention 1 (4 Hours)||3
1572159|NCT01162499|3847000|P1|Received Intervention|Intervention 1 (4 Hours)||3
1572160|NCT01162499|3846999|P2|STARTED|Intervention 1 (4 Hours)||4
1572161|NCT01162499|3847000|P1|STARTED|Intervention 1 (4 Hours)||3
1572162|NCT01162473|3847022|P2|NOT COMPLETED|Overall Study||5
1572163|NCT01162473|3847023|P1|NOT COMPLETED|Overall Study||2
1572164|NCT01162473|3847022|P2|COMPLETED|Overall Study||12
1572165|NCT01162473|3847023|P1|COMPLETED|Overall Study||6
1572166|NCT01162473|3847022|P2|STARTED|Overall Study||17
1572167|NCT01162473|3847023|P1|STARTED|Overall Study||8
1572168|NCT01162421|3847031|P2|NOT COMPLETED|Overall Study||13
1572169|NCT01162421|3847032|P1|NOT COMPLETED|Overall Study||8
1572170|NCT01162421|3847031|P2|COMPLETED|Overall Study||27
1572171|NCT01162421|3847032|P1|COMPLETED|Overall Study||29
1572172|NCT01162421|3847031|P2|STARTED|Overall Study||40
1572173|NCT01162421|3847032|P1|STARTED|Overall Study||37
1572174|NCT01162343|3847110|P1|NOT COMPLETED|Overall Study||92
1572175|NCT01162343|3847110|P1|COMPLETED|Overall Study||406
1572176|NCT01162343|3847110|P1|STARTED|Overall Study||498
1572177|NCT01162317|3847116|P2|NOT COMPLETED|Overall Study||2
1572178|NCT01162317|3847117|P1|NOT COMPLETED|Overall Study||3
1572179|NCT01162317|3847116|P2|COMPLETED|Overall Study||28
1572180|NCT01162317|3847117|P1|COMPLETED|Overall Study||27
1572181|NCT01162317|3847116|P2|STARTED|Overall Study||30
1572182|NCT01162317|3847117|P1|STARTED|Overall Study||30
1572183|NCT01162304|3847125|P1|NOT COMPLETED|Overall Study||11
1572184|NCT01162304|3847125|P1|COMPLETED|Overall Study||7
1572185|NCT01162304|3847125|P1|STARTED|Overall Study||18
1572186|NCT01162135|3847139|P1|NOT COMPLETED|Overall Study||3
1572187|NCT01162135|3847139|P1|COMPLETED|Overall Study||13
1572188|NCT01162135|3847139|P1|STARTED|Overall Study||16
1572189|NCT01162122|3847145|P2|NOT COMPLETED|Overall Study||196
1572190|NCT01162122|3847146|P1|NOT COMPLETED|Overall Study||191
1572191|NCT01162122|3847145|P2|COMPLETED|Overall Study||3356
1572192|NCT01162122|3847146|P1|COMPLETED|Overall Study||3361
1572193|NCT01162122|3847145|P2|Vaccinated|Overall Study||3541
1572194|NCT01162122|3847146|P1|Vaccinated|Overall Study||3541
1572195|NCT01162122|3847145|P2|STARTED|Overall Study||3552
1572196|NCT01162122|3847146|P1|STARTED|Overall Study||3552
1572197|NCT01162096|3847203|P1|NOT COMPLETED|Overall Study||0
1572198|NCT01162096|3847203|P1|COMPLETED|Overall Study||34
1572199|NCT01162096|3847203|P1|STARTED|Overall Study||34
1572200|NCT01161862|3847211|P2|NOT COMPLETED|Overall Study||0
1572201|NCT01161862|3847212|P1|NOT COMPLETED|Overall Study||0
1572202|NCT01161862|3847211|P2|COMPLETED|Overall Study||12
1572203|NCT01161862|3847212|P1|COMPLETED|Overall Study||12
1572204|NCT01161862|3847211|P2|STARTED|Overall Study||12
1572205|NCT01161862|3847212|P1|STARTED|Overall Study||12
1572206|NCT01161771|3847232|P1|NOT COMPLETED|Overall Study||0
1572207|NCT01161771|3847232|P1|COMPLETED|Overall Study||32
1572208|NCT01161771|3847232|P1|STARTED|Overall Study||32
1572209|NCT01161628|3847241|P1|NOT COMPLETED|Overall Study||8
1572210|NCT01161628|3847241|P1|COMPLETED|Overall Study||17
1572211|NCT01161628|3847241|P1|STARTED|Overall Study||25
1572212|NCT01161563|3847255|P2|NOT COMPLETED|Overall Study||6
1572213|NCT01161563|3847256|P1|NOT COMPLETED|Overall Study||5
1572214|NCT01161563|3847255|P2|COMPLETED|Overall Study||49
1572215|NCT01161563|3847256|P1|COMPLETED|Overall Study||58
1572216|NCT01161563|3847255|P2|STARTED|Overall Study||55
1572217|NCT01161563|3847256|P1|STARTED|Overall Study||63
1572218|NCT01161537|3847264|P1|NOT COMPLETED|Part B||2
1572219|NCT01161537|3847264|P1|COMPLETED|Part B||7
1572220|NCT01161537|3847264|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
1572221|NCT01161537|3847264|P1|NOT COMPLETED|Part A||0
1572222|NCT01161537|3847264|P1|COMPLETED|Part A||8
1572223|NCT01161537|3847264|P1|STARTED|Part A||8
1572224|NCT01161498|3847282|P2|NOT COMPLETED|Overall Study||1
1572225|NCT01161498|3847283|P1|NOT COMPLETED|Overall Study||0
1572226|NCT01161498|3847282|P2|COMPLETED|Overall Study||1
1572227|NCT01161498|3847283|P1|COMPLETED|Overall Study||3
1572228|NCT01161498|3847282|P2|STARTED|Overall Study||2
1572229|NCT01161498|3847283|P1|STARTED|Overall Study||3
1572230|NCT01161472|3847307|P4|NOT COMPLETED|Fourth Intervention Period||0
1572231|NCT01161472|3847308|P3|NOT COMPLETED|Fourth Intervention Period||0
1572232|NCT01161472|3847309|P2|NOT COMPLETED|Fourth Intervention Period||0
1572233|NCT01161472|3847310|P1|NOT COMPLETED|Fourth Intervention Period||0
1572234|NCT01161472|3847307|P4|COMPLETED|Fourth Intervention Period||5
1572235|NCT01161472|3847308|P3|COMPLETED|Fourth Intervention Period||5
1572236|NCT01161472|3847309|P2|COMPLETED|Fourth Intervention Period||5
1572237|NCT01161472|3847310|P1|COMPLETED|Fourth Intervention Period||4
1572238|NCT01161472|3847307|P4|STARTED|Fourth Intervention Period||5
1572239|NCT01161472|3847308|P3|STARTED|Fourth Intervention Period||5
1572240|NCT01161472|3847309|P2|STARTED|Fourth Intervention Period||5
1572241|NCT01161472|3847310|P1|STARTED|Fourth Intervention Period||4
1572242|NCT01161472|3847307|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572243|NCT01161472|3847308|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572244|NCT01161472|3847309|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572245|NCT01161472|3847310|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572246|NCT01161472|3847307|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572247|NCT01161472|3847308|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572248|NCT01161472|3847309|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572249|NCT01161472|3847310|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
1572250|NCT01161472|3847307|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572251|NCT01161472|3847308|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572252|NCT01161472|3847309|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572253|NCT01161472|3847310|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
1572254|NCT01161472|3847307|P4|NOT COMPLETED|Third Intervention Period||0
1572255|NCT01161472|3847308|P3|NOT COMPLETED|Third Intervention Period||0
1572256|NCT01161472|3847309|P2|NOT COMPLETED|Third Intervention Period||0
1572257|NCT01161472|3847310|P1|NOT COMPLETED|Third Intervention Period||0
1572258|NCT01161472|3847307|P4|COMPLETED|Third Intervention Period||5
1572259|NCT01161472|3847308|P3|COMPLETED|Third Intervention Period||5
1572260|NCT01161472|3847309|P2|COMPLETED|Third Intervention Period||5
1572261|NCT01161472|3847310|P1|COMPLETED|Third Intervention Period||4
1572262|NCT01161472|3847307|P4|STARTED|Third Intervention Period||5
1572263|NCT01161472|3847308|P3|STARTED|Third Intervention Period||5
1572264|NCT01161472|3847309|P2|STARTED|Third Intervention Period||5
1572265|NCT01161472|3847310|P1|STARTED|Third Intervention Period||4
1572266|NCT01161472|3847307|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572267|NCT01161472|3847308|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572268|NCT01161472|3847309|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572269|NCT01161472|3847310|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
1572270|NCT01161472|3847307|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572271|NCT01161472|3847308|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572272|NCT01161472|3847309|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572273|NCT01161472|3847310|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
1572274|NCT01161472|3847307|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572275|NCT01161472|3847308|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572276|NCT01161472|3847309|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572277|NCT01161472|3847310|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572278|NCT01161472|3847307|P4|NOT COMPLETED|Second Intervention Period||0
1572279|NCT01161472|3847308|P3|NOT COMPLETED|Second Intervention Period||0
1572280|NCT01161472|3847309|P2|NOT COMPLETED|Second Intervention Period||0
1572281|NCT01161472|3847310|P1|NOT COMPLETED|Second Intervention Period||0
1572282|NCT01161472|3847307|P4|COMPLETED|Second Intervention Period||5
1572283|NCT01161472|3847308|P3|COMPLETED|Second Intervention Period||5
1572284|NCT01161472|3847309|P2|COMPLETED|Second Intervention Period||5
1572285|NCT01161472|3847310|P1|COMPLETED|Second Intervention Period||5
1572286|NCT01161472|3847307|P4|STARTED|Second Intervention Period||5
1572287|NCT01161472|3847308|P3|STARTED|Second Intervention Period||5
1572288|NCT01161472|3847309|P2|STARTED|Second Intervention Period||5
1572289|NCT01161472|3847310|P1|STARTED|Second Intervention Period||5
1572290|NCT01161472|3847307|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572291|NCT01161472|3847308|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572292|NCT01161472|3847309|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572293|NCT01161472|3847310|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1572294|NCT01161472|3847307|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572295|NCT01161472|3847308|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572296|NCT01161472|3847309|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572297|NCT01161472|3847310|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1572298|NCT01161472|3847307|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572299|NCT01161472|3847308|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572300|NCT01161472|3847309|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572301|NCT01161472|3847310|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
1572302|NCT01161472|3847307|P4|NOT COMPLETED|First Intervention Period||0
1572303|NCT01161472|3847308|P3|NOT COMPLETED|First Intervention Period||0
1572304|NCT01161472|3847309|P2|NOT COMPLETED|First Intervention Period||0
1572305|NCT01161472|3847310|P1|NOT COMPLETED|First Intervention Period||0
1572306|NCT01161472|3847307|P4|COMPLETED|First Intervention Period||5
1572307|NCT01161472|3847308|P3|COMPLETED|First Intervention Period||5
1572308|NCT01161472|3847309|P2|COMPLETED|First Intervention Period||5
1572309|NCT01161472|3847310|P1|COMPLETED|First Intervention Period||5
1572310|NCT01161472|3847307|P4|Treated|First Intervention Period||5
1572311|NCT01161472|3847308|P3|Treated|First Intervention Period||5
1572312|NCT01161472|3847309|P2|Treated|First Intervention Period||5
1572313|NCT01161472|3847310|P1|Treated|First Intervention Period||5
1572314|NCT01161472|3847307|P4|STARTED|First Intervention Period||5
1572315|NCT01161472|3847308|P3|STARTED|First Intervention Period||5
1572316|NCT01161472|3847309|P2|STARTED|First Intervention Period||5
1572317|NCT01161472|3847310|P1|STARTED|First Intervention Period||5
1572318|NCT01161446|3847366|P2|NOT COMPLETED|Overall Study||15
1572319|NCT01161446|3847367|P1|NOT COMPLETED|Overall Study||18
1572320|NCT01161446|3847366|P2|COMPLETED|Overall Study||99
1572321|NCT01161446|3847367|P1|COMPLETED|Overall Study||98
1572322|NCT01161446|3847366|P2|STARTED|Overall Study||114
1572323|NCT01161446|3847367|P1|STARTED|Overall Study||116
1572324|NCT01161420|3847379|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
1572325|NCT01161420|3847379|P1|COMPLETED|Withdrawal Study - Withdrawal||23
1572326|NCT01161420|3847379|P1|STARTED|Withdrawal Study - Withdrawal||23
1572327|NCT01161420|3847379|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
1572328|NCT01161420|3847379|P1|COMPLETED|Withdrawal Study - Maintenance||23
1572329|NCT01161420|3847379|P1|STARTED|Withdrawal Study - Maintenance||23
1572330|NCT01161420|3847379|P1|NOT COMPLETED|Inspire Therapy||2
1572331|NCT01161420|3847379|P1|COMPLETED|Inspire Therapy||124
1572332|NCT01161420|3847379|P1|STARTED|Inspire Therapy||126
1572333|NCT01161407|3847393|P2|NOT COMPLETED|Overall Study||1
1572334|NCT01161407|3847394|P1|NOT COMPLETED|Overall Study||3
1572335|NCT01161407|3847393|P2|COMPLETED|Overall Study||5
1572336|NCT01161407|3847394|P1|COMPLETED|Overall Study||3
1572337|NCT01161407|3847393|P2|STARTED|Overall Study||6
1572338|NCT01161407|3847394|P1|STARTED|Overall Study||6
1572339|NCT01161329|3847406|P2|NOT COMPLETED|Overall Study||10
1572340|NCT01161329|3847407|P1|NOT COMPLETED|Overall Study||4
1572341|NCT01161329|3847406|P2|COMPLETED|Overall Study||24
1572342|NCT01161329|3847407|P1|COMPLETED|Overall Study||29
1572343|NCT01161329|3847406|P2|STARTED|Overall Study||34
1572344|NCT01161329|3847407|P1|STARTED|Overall Study||33
1572345|NCT01161225|3847418|P3|NOT COMPLETED|Overall Study||2
1572346|NCT01161225|3847419|P2|NOT COMPLETED|Overall Study||9
1572347|NCT01161225|3847420|P1|NOT COMPLETED|Overall Study||14
1572348|NCT01161225|3847418|P3|COMPLETED|Overall Study||12
1572349|NCT01161225|3847419|P2|COMPLETED|Overall Study||44
1572350|NCT01161225|3847420|P1|COMPLETED|Overall Study||45
1572351|NCT01161225|3847418|P3|STARTED|Overall Study||14
1572352|NCT01161225|3847419|P2|STARTED|Overall Study||53
1572353|NCT01161225|3847420|P1|STARTED|Overall Study||59
1572354|NCT01161173|3847449|P1|NOT COMPLETED|Overall Study||347
1572355|NCT01161173|3847449|P1|COMPLETED|Overall Study||0
1572356|NCT01161173|3847449|P1|STARTED|Overall Study||347
1572357|NCT01161160|3847461|P3|NOT COMPLETED|Overall Study||0
1572358|NCT01161160|3847462|P2|NOT COMPLETED|Overall Study||0
1572359|NCT01161160|3847463|P1|NOT COMPLETED|Overall Study||0
1572360|NCT01161160|3847461|P3|COMPLETED|Overall Study||58
1572361|NCT01161160|3847462|P2|COMPLETED|Overall Study||75
1572362|NCT01161160|3847463|P1|COMPLETED|Overall Study||76
1572363|NCT01161160|3847461|P3|STARTED|Overall Study||58
1572364|NCT01161160|3847462|P2|STARTED|Overall Study||75
1572365|NCT01161160|3847463|P1|STARTED|Overall Study||76
1572366|NCT01161121|3847534|P1|NOT COMPLETED|Overall Study||0
1572367|NCT01161121|3847534|P1|COMPLETED|Overall Study||46
1572368|NCT01161121|3847534|P1|STARTED|Overall Study||46
1572369|NCT01160848|3847546|P2|NOT COMPLETED|Overall Study||0
1572370|NCT01160848|3847547|P1|NOT COMPLETED|Overall Study||0
1572371|NCT01160848|3847546|P2|COMPLETED|Overall Study||8
1572372|NCT01160848|3847547|P1|COMPLETED|Overall Study||12
1572373|NCT01160848|3847546|P2|STARTED|Overall Study||8
1572374|NCT01160848|3847547|P1|STARTED|Overall Study||12
1572375|NCT01160822|3847576|P7|NOT COMPLETED|Overall Study||9
1572376|NCT01160822|3847577|P6|NOT COMPLETED|Overall Study||7
1572377|NCT01160822|3847578|P5|NOT COMPLETED|Overall Study||9
1572378|NCT01160822|3847579|P4|NOT COMPLETED|Overall Study||0
1572379|NCT01160822|3847580|P3|NOT COMPLETED|Overall Study||0
1572380|NCT01160822|3847581|P2|NOT COMPLETED|Overall Study||0
1572381|NCT01160822|3847582|P1|NOT COMPLETED|Overall Study||0
1572382|NCT01160822|3847576|P7|COMPLETED|Overall Study||44
1572383|NCT01160822|3847577|P6|COMPLETED|Overall Study||40
1572384|NCT01160822|3847578|P5|COMPLETED|Overall Study||36
1572385|NCT01160822|3847579|P4|COMPLETED|Overall Study||5
1572386|NCT01160822|3847580|P3|COMPLETED|Overall Study||6
1572387|NCT01160822|3847581|P2|COMPLETED|Overall Study||7
1572388|NCT01160822|3847582|P1|COMPLETED|Overall Study||6
1572389|NCT01160822|3847576|P7|STARTED|Overall Study||53
1572390|NCT01160822|3847577|P6|STARTED|Overall Study||47
1572391|NCT01160822|3847578|P5|STARTED|Overall Study||45
1572392|NCT01160822|3847579|P4|STARTED|Overall Study||5
1572393|NCT01160822|3847580|P3|STARTED|Overall Study||6
1572394|NCT01160822|3847581|P2|STARTED|Overall Study||7
1572395|NCT01160822|3847582|P1|STARTED|Overall Study||6
1572396|NCT01160770|3847671|P1|NOT COMPLETED|Overall Study||79
1572397|NCT01160770|3847671|P1|COMPLETED|Overall Study||188
1572398|NCT01160770|3847671|P1|STARTED|Overall Study||267
1572399|NCT01160744|3847684|P4|NOT COMPLETED|Overall Study||22
1572400|NCT01160744|3847685|P3|NOT COMPLETED|Overall Study||20
1572401|NCT01160744|3847686|P2|NOT COMPLETED|Overall Study||25
1572402|NCT01160744|3847687|P1|NOT COMPLETED|Overall Study||20
1572403|NCT01160744|3847684|P4|COMPLETED|Overall Study||49
1572404|NCT01160744|3847685|P3|COMPLETED|Overall Study||49
1572405|NCT01160744|3847686|P2|COMPLETED|Overall Study||44
1572406|NCT01160744|3847687|P1|COMPLETED|Overall Study||51
1572407|NCT01160744|3847684|P4|Received Study Drug|Overall Study||71
1572408|NCT01160744|3847685|P3|Received Study Drug|Overall Study||63
1572409|NCT01160744|3847686|P2|Received Study Drug|Overall Study||67
1572410|NCT01160744|3847687|P1|Received Study Drug|Overall Study||69
1572411|NCT01160744|3847684|P4|STARTED|Overall Study||71
1572412|NCT01160744|3847685|P3|STARTED|Overall Study||69
1572413|NCT01160744|3847686|P2|STARTED|Overall Study||69
1572414|NCT01160744|3847687|P1|STARTED|Overall Study||71
1572415|NCT01160640|3847723|P2|NOT COMPLETED|Overall Study||6
1572416|NCT01160640|3847724|P1|NOT COMPLETED|Overall Study||4
1572417|NCT01160640|3847723|P2|COMPLETED|Overall Study||110
1572418|NCT01160640|3847724|P1|COMPLETED|Overall Study||113
1572419|NCT01160640|3847723|P2|STARTED|Overall Study||116
1572420|NCT01160640|3847724|P1|STARTED|Overall Study||117
1572421|NCT01160614|3847740|P2|NOT COMPLETED|Overall Study||2
1572422|NCT01160614|3847741|P1|NOT COMPLETED|Overall Study||0
1572423|NCT01160614|3847740|P2|COMPLETED|Overall Study||23
1572424|NCT01160614|3847741|P1|COMPLETED|Overall Study||5
1572425|NCT01160614|3847740|P2|STARTED|Overall Study||25
1572426|NCT01160614|3847741|P1|STARTED|Overall Study||5
1572427|NCT01160484|3847789|P1|NOT COMPLETED|Overall Study||18
1572428|NCT01160484|3847789|P1|COMPLETED|Overall Study||22
1572429|NCT01160484|3847789|P1|STARTED|Overall Study||40
1572430|NCT01160458|3847799|P1|NOT COMPLETED|Overall Study||0
1572431|NCT01160458|3847799|P1|COMPLETED|Overall Study||20
1572432|NCT01160458|3847799|P1|STARTED|Overall Study||20
1572433|NCT01160445|3847809|P2|NOT COMPLETED|Overall Study||0
1572434|NCT01160445|3847810|P1|NOT COMPLETED|Overall Study||0
1572435|NCT01160445|3847809|P2|COMPLETED|Overall Study||2
1572436|NCT01160445|3847810|P1|COMPLETED|Overall Study||7
1572437|NCT01160445|3847809|P2|STARTED|Overall Study||2
1572438|NCT01160445|3847810|P1|STARTED|Overall Study||7
1572439|NCT01160380|3847820|P2|NOT COMPLETED|Overall Study||5
1572440|NCT01160380|3847821|P1|NOT COMPLETED|Overall Study||8
1572441|NCT01160380|3847820|P2|COMPLETED|Overall Study||20
1572442|NCT01160380|3847821|P1|COMPLETED|Overall Study||17
1572443|NCT01160380|3847820|P2|STARTED|Overall Study||25
1572444|NCT01160380|3847821|P1|STARTED|Overall Study||25
1572445|NCT01160237|3847842|P3|NOT COMPLETED|Overall Study||0
1572446|NCT01160237|3847843|P2|NOT COMPLETED|Overall Study||0
1572447|NCT01160237|3847844|P1|NOT COMPLETED|Overall Study||0
1572448|NCT01160237|3847842|P3|COMPLETED|Overall Study||0
1572449|NCT01160237|3847843|P2|COMPLETED|Overall Study||3
1572450|NCT01160237|3847844|P1|COMPLETED|Overall Study||4
1572451|NCT01160237|3847842|P3|STARTED|Overall Study||0
1572452|NCT01160237|3847843|P2|STARTED|Overall Study||3
1572453|NCT01160237|3847844|P1|STARTED|Overall Study||4
1572454|NCT01160198|3847870|P3|NOT COMPLETED|Overall Study||1
1572455|NCT01160198|3847871|P2|NOT COMPLETED|Overall Study||3
1572456|NCT01160198|3847872|P1|NOT COMPLETED|Overall Study||2
1572457|NCT01160198|3847870|P3|COMPLETED|Overall Study||89
1572458|NCT01160198|3847871|P2|COMPLETED|Overall Study||88
1572459|NCT01160198|3847872|P1|COMPLETED|Overall Study||87
1572460|NCT01160198|3847870|P3|STARTED|Overall Study||90
1572461|NCT01160198|3847871|P2|STARTED|Overall Study||91
1572462|NCT01160198|3847872|P1|STARTED|Overall Study||89
1572463|NCT01159938|3847894|P5|NOT COMPLETED|Second Study Period||0
1572464|NCT01159938|3847895|P4|NOT COMPLETED|Second Study Period||0
1572465|NCT01159938|3847896|P3|NOT COMPLETED|Second Study Period||0
1572466|NCT01159938|3847897|P2|NOT COMPLETED|Second Study Period||0
1572467|NCT01159938|3847898|P1|NOT COMPLETED|Second Study Period||0
1572468|NCT01159938|3847894|P5|COMPLETED|Second Study Period||12
1572469|NCT01159938|3847895|P4|COMPLETED|Second Study Period||12
1572470|NCT01159938|3847896|P3|COMPLETED|Second Study Period||10
1572471|NCT01159938|3847897|P2|COMPLETED|Second Study Period||11
1572472|NCT01159938|3847898|P1|COMPLETED|Second Study Period||0
1572473|NCT01159938|3847894|P5|STARTED|Second Study Period||12
1572474|NCT01159938|3847895|P4|STARTED|Second Study Period||12
1572475|NCT01159938|3847896|P3|STARTED|Second Study Period||10
1572476|NCT01159938|3847897|P2|STARTED|Second Study Period||11
1572477|NCT01159938|3847898|P1|STARTED|Second Study Period||0
1572478|NCT01159938|3847894|P5|NOT COMPLETED|First Study Period||0
1572479|NCT01159938|3847895|P4|NOT COMPLETED|First Study Period||0
1572480|NCT01159938|3847896|P3|NOT COMPLETED|First Study Period||1
1572481|NCT01159938|3847897|P2|NOT COMPLETED|First Study Period||0
1572482|NCT01159938|3847898|P1|NOT COMPLETED|First Study Period||0
1572483|NCT01159938|3847894|P5|COMPLETED|First Study Period||12
1572484|NCT01159938|3847895|P4|COMPLETED|First Study Period||12
1572485|NCT01159938|3847896|P3|COMPLETED|First Study Period||10
1572486|NCT01159938|3847897|P2|COMPLETED|First Study Period||11
1572487|NCT01159938|3847898|P1|COMPLETED|First Study Period||26
1572488|NCT01159938|3847894|P5|Safety and Efficacy Analysis Population|First Study Period||12
1572489|NCT01159938|3847895|P4|Safety and Efficacy Analysis Population|First Study Period||12
1572490|NCT01159938|3847896|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
1572491|NCT01159938|3847897|P2|Safety and Efficacy Analysis Population|First Study Period||11
1572492|NCT01159938|3847898|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
1572493|NCT01159938|3847894|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
1572494|NCT01159938|3847895|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
1572495|NCT01159938|3847896|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
1572496|NCT01159938|3847897|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
1572497|NCT01159938|3847898|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
1572498|NCT01159938|3847894|P5|STARTED|First Study Period||12
1572499|NCT01159938|3847895|P4|STARTED|First Study Period||12
1572500|NCT01159938|3847896|P3|STARTED|First Study Period||11
1572501|NCT01159938|3847897|P2|STARTED|First Study Period||11
1572502|NCT01159938|3847898|P1|STARTED|First Study Period||26
1572503|NCT01159912|3847961|P3|NOT COMPLETED|Overall Study||26
1572504|NCT01159912|3847962|P2|NOT COMPLETED|Overall Study||22
1572505|NCT01159912|3847963|P1|NOT COMPLETED|Overall Study||40
1572506|NCT01159912|3847961|P3|COMPLETED|Overall Study||88
1572507|NCT01159912|3847962|P2|COMPLETED|Overall Study||92
1572508|NCT01159912|3847963|P1|COMPLETED|Overall Study||75
1572509|NCT01159912|3847961|P3|STARTED|Overall Study||114
1572510|NCT01159912|3847962|P2|STARTED|Overall Study||114
1572511|NCT01159912|3847963|P1|STARTED|Overall Study||115
1572512|NCT01159769|3847986|P1|NOT COMPLETED|Overall Study||1
1572513|NCT01159769|3847986|P1|COMPLETED|Overall Study||214
1572514|NCT01159769|3847986|P1|STARTED|Overall Study||215
1572515|NCT01159743|3847993|P2|NOT COMPLETED|Overall Study||0
1572516|NCT01159743|3847994|P1|NOT COMPLETED|Overall Study||0
1572517|NCT01159743|3847993|P2|COMPLETED|Overall Study||109
1572518|NCT01159743|3847994|P1|COMPLETED|Overall Study||237
1572519|NCT01159743|3847993|P2|STARTED|Overall Study||109
1572520|NCT01159743|3847994|P1|STARTED|Overall Study||237
1572521|NCT01159691|3848006|P1|NOT COMPLETED|Overall Study||22
1572522|NCT01159691|3848006|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
1572523|NCT01159691|3848006|P1|STARTED|Overall Study||76
1572524|NCT01159665|3848019|P6|NOT COMPLETED|Overall Study||0
1572525|NCT01159665|3848020|P5|NOT COMPLETED|Overall Study||0
1572526|NCT01159665|3848021|P4|NOT COMPLETED|Overall Study||0
1572527|NCT01159665|3848022|P3|NOT COMPLETED|Overall Study||0
1572528|NCT01159665|3848023|P2|NOT COMPLETED|Overall Study||1
1572529|NCT01159665|3848024|P1|NOT COMPLETED|Overall Study||0
1572530|NCT01159665|3848019|P6|COMPLETED|Overall Study||4
1572531|NCT01159665|3848020|P5|COMPLETED|Overall Study||4
1572532|NCT01159665|3848021|P4|COMPLETED|Overall Study||4
1572533|NCT01159665|3848022|P3|COMPLETED|Overall Study||8
1572534|NCT01159665|3848023|P2|COMPLETED|Overall Study||8
1572535|NCT01159665|3848024|P1|COMPLETED|Overall Study||9
1572536|NCT01159665|3848019|P6|STARTED|Overall Study||4
1572537|NCT01159665|3848020|P5|STARTED|Overall Study||4
1572538|NCT01159665|3848021|P4|STARTED|Overall Study||4
1572539|NCT01159665|3848022|P3|STARTED|Overall Study||8
1572540|NCT01159665|3848023|P2|STARTED|Overall Study||9
1572541|NCT01159665|3848024|P1|STARTED|Overall Study||9
1572542|NCT01159600|3848052|P8|NOT COMPLETED|Overall Study||18
1572543|NCT01159600|3848053|P7|NOT COMPLETED|Overall Study||19
1572544|NCT01159600|3848054|P6|NOT COMPLETED|Overall Study||18
1572545|NCT01159600|3848055|P5|NOT COMPLETED|Overall Study||24
1572546|NCT01159600|3848056|P4|NOT COMPLETED|Overall Study||11
1572547|NCT01159600|3848057|P3|NOT COMPLETED|Overall Study||18
1572548|NCT01159600|3848058|P2|NOT COMPLETED|Overall Study||8
1572549|NCT01159600|3848059|P1|NOT COMPLETED|Overall Study||21
1572550|NCT01159600|3848052|P8|COMPLETED|Overall Study||85
1572551|NCT01159600|3848053|P7|COMPLETED|Overall Study||199
1572552|NCT01159600|3848054|P6|COMPLETED|Overall Study||208
1572553|NCT01159600|3848055|P5|COMPLETED|Overall Study||201
1572554|NCT01159600|3848056|P4|COMPLETED|Overall Study||58
1572555|NCT01159600|3848057|P3|COMPLETED|Overall Study||196
1572556|NCT01159600|3848058|P2|COMPLETED|Overall Study||209
1572557|NCT01159600|3848059|P1|COMPLETED|Overall Study||186
1572558|NCT01159600|3848052|P8|STARTED|Overall Study||103
1572559|NCT01159600|3848053|P7|STARTED|Overall Study||218
1572560|NCT01159600|3848054|P6|STARTED|Overall Study||226
1572561|NCT01159600|3848055|P5|STARTED|Overall Study||225
1572562|NCT01159600|3848056|P4|STARTED|Overall Study||69
1572563|NCT01159600|3848057|P3|STARTED|Overall Study||214
1572564|NCT01159600|3848058|P2|STARTED|Overall Study||217
1572565|NCT01159600|3848059|P1|STARTED|Overall Study||207
1572566|NCT01159574|3848101|P1|NOT COMPLETED|Follow Up Phase||20
1572567|NCT01159574|3848101|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
1572568|NCT01159574|3848101|P1|STARTED|Follow Up Phase||112
1572569|NCT01159574|3848101|P1|NOT COMPLETED|Treatment Phase||21
1572570|NCT01159574|3848101|P1|COMPLETED|Treatment Phase||100
1572571|NCT01159574|3848101|P1|STARTED|Treatment Phase||121
1572572|NCT01159535|3848110|P3|NOT COMPLETED|Overall Study||31
1572573|NCT01159535|3848111|P2|NOT COMPLETED|Overall Study||24
1572574|NCT01159535|3848112|P1|NOT COMPLETED|Overall Study||24
1572575|NCT01159535|3848110|P3|COMPLETED|Overall Study||64
1572576|NCT01159535|3848111|P2|COMPLETED|Overall Study||64
1572577|NCT01159535|3848112|P1|COMPLETED|Overall Study||79
1572578|NCT01159535|3848110|P3|STARTED|Overall Study||95
1572579|NCT01159535|3848111|P2|STARTED|Overall Study||88
1572580|NCT01159535|3848112|P1|STARTED|Overall Study||103
1572581|NCT01159431|3848122|P2|NOT COMPLETED|Overall Study||6
1572582|NCT01159431|3848123|P1|NOT COMPLETED|Overall Study||2
1572583|NCT01159431|3848122|P2|COMPLETED|Overall Study||19
1572584|NCT01159431|3848123|P1|COMPLETED|Overall Study||23
1572585|NCT01159431|3848122|P2|STARTED|Overall Study||25
1572586|NCT01159431|3848123|P1|STARTED|Overall Study||25
1572587|NCT01159262|3848142|P3|NOT COMPLETED|Overall Study||0
1572588|NCT01159262|3848143|P2|NOT COMPLETED|Overall Study||0
1572589|NCT01159262|3848144|P1|NOT COMPLETED|Overall Study||0
1572590|NCT01159262|3848142|P3|COMPLETED|Overall Study||8
1572591|NCT01159262|3848143|P2|COMPLETED|Overall Study||14
1572592|NCT01159262|3848144|P1|COMPLETED|Overall Study||14
1572593|NCT01159262|3848142|P3|STARTED|Overall Study||8
1572594|NCT01159262|3848143|P2|STARTED|Overall Study||14
1572595|NCT01159262|3848144|P1|STARTED|Overall Study||14
1572596|NCT01159171|3848176|P1|NOT COMPLETED|Overall Study||50
1572597|NCT01159171|3848176|P1|COMPLETED|Overall Study||0
1572598|NCT01159171|3848176|P1|STARTED|Overall Study||50
1572599|NCT01159054|3848191|P1|NOT COMPLETED|Overall Study||20
1572600|NCT01159054|3848191|P1|COMPLETED|Overall Study||2
1572601|NCT01159054|3848191|P1|STARTED|Overall Study||22
1572602|NCT01158976|3848205|P2|NOT COMPLETED|Overall Study||4
1572603|NCT01158976|3848206|P1|NOT COMPLETED|Overall Study||9
1572604|NCT01158976|3848205|P2|COMPLETED|Overall Study||17
1572605|NCT01158976|3848206|P1|COMPLETED|Overall Study||34
1572606|NCT01158976|3848205|P2|STARTED|Overall Study||21
1572607|NCT01158976|3848206|P1|STARTED|Overall Study||43
1572608|NCT01158924|3848250|P2|NOT COMPLETED|Overall Study||3
1572609|NCT01158924|3848251|P1|NOT COMPLETED|Overall Study||1
1572610|NCT01158924|3848250|P2|COMPLETED|Overall Study||23
1572611|NCT01158924|3848251|P1|COMPLETED|Overall Study||13
1572612|NCT01158924|3848250|P2|STARTED|Overall Study||26
1572613|NCT01158924|3848251|P1|STARTED|Overall Study||14
1572614|NCT01158820|3848267|P2|NOT COMPLETED|Overall Study||0
1572615|NCT01158820|3848268|P1|NOT COMPLETED|Overall Study||0
1572616|NCT01158820|3848267|P2|COMPLETED|Overall Study||25
1572617|NCT01158820|3848268|P1|COMPLETED|Overall Study||25
1572618|NCT01158820|3848267|P2|STARTED|Overall Study||25
1572619|NCT01158820|3848268|P1|STARTED|Overall Study||25
1572620|NCT01158716|3848290|P2|NOT COMPLETED|Overall Study||1
1572621|NCT01158716|3848291|P1|NOT COMPLETED|Overall Study||1
1572622|NCT01158716|3848290|P2|COMPLETED|Overall Study||47
1572623|NCT01158716|3848291|P1|COMPLETED|Overall Study||47
1572624|NCT01158716|3848290|P2|STARTED|Overall Study||48
1572625|NCT01158716|3848291|P1|STARTED|Overall Study||48
1572626|NCT01158703|3848299|P2|NOT COMPLETED|Overall Study||0
1572627|NCT01158703|3848300|P1|NOT COMPLETED|Overall Study||0
1572628|NCT01158703|3848299|P2|COMPLETED|Overall Study||8
1572629|NCT01158703|3848300|P1|COMPLETED|Overall Study||12
1572630|NCT01158703|3848299|P2|STARTED|Overall Study||8
1572631|NCT01158703|3848300|P1|STARTED|Overall Study||12
1572632|NCT01158573|3848320|P4|NOT COMPLETED|Overall Study||0
1572633|NCT01158573|3848321|P3|NOT COMPLETED|Overall Study||0
1572634|NCT01158573|3848322|P2|NOT COMPLETED|Overall Study||0
1572635|NCT01158573|3848323|P1|NOT COMPLETED|Overall Study||0
1572636|NCT01158573|3848320|P4|COMPLETED|Overall Study||28
1572637|NCT01158573|3848321|P3|COMPLETED|Overall Study||29
1572638|NCT01158573|3848322|P2|COMPLETED|Overall Study||30
1572639|NCT01158573|3848323|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
1572640|NCT01158573|3848320|P4|STARTED|Overall Study||28
1572641|NCT01158573|3848321|P3|STARTED|Overall Study||29
1572642|NCT01158573|3848322|P2|STARTED|Overall Study||30
1572643|NCT01158573|3848323|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
1572644|NCT01158534|3848345|P1|NOT COMPLETED|Overall Study||3
1572645|NCT01158534|3848345|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
1572646|NCT01158534|3848345|P1|STARTED|Overall Study||17
1572647|NCT01158521|3848353|P1|NOT COMPLETED|Overall Study||0
1572648|NCT01158521|3848353|P1|COMPLETED|Overall Study||25
1572649|NCT01158521|3848353|P1|STARTED|Overall Study||25
1572650|NCT01158378|3848364|P2|NOT COMPLETED|Overall Study||9
1572651|NCT01158378|3848365|P1|NOT COMPLETED|Overall Study||10
1572652|NCT01158378|3848364|P2|COMPLETED|Overall Study||117
1572653|NCT01158378|3848365|P1|COMPLETED|Overall Study||114
1572654|NCT01158378|3848364|P2|STARTED|Overall Study||126
1572655|NCT01158378|3848365|P1|STARTED|Overall Study||124
1572656|NCT01158261|3848377|P1|NOT COMPLETED|Overall Study||17
1572657|NCT01158261|3848377|P1|COMPLETED|Overall Study||283
1572658|NCT01158261|3848377|P1|STARTED|Overall Study||300
1572659|NCT01158222|3848381|P1|NOT COMPLETED|Overall Study||17
1572660|NCT01158222|3848381|P1|COMPLETED|Overall Study||20
1572661|NCT01158222|3848381|P1|STARTED|Overall Study||37
1572662|NCT01158118|3848389|P2|NOT COMPLETED|Overall Study||3
1572663|NCT01158118|3848390|P1|NOT COMPLETED|Overall Study||1
1572664|NCT01158118|3848389|P2|COMPLETED|Overall Study||21
1572665|NCT01158118|3848390|P1|COMPLETED|Overall Study||23
1572666|NCT01158118|3848389|P2|STARTED|Overall Study||24
1572667|NCT01158118|3848390|P1|STARTED|Overall Study||24
1572668|NCT01157845|3848406|P1|NOT COMPLETED|Overall Study||35
1572669|NCT01157845|3848406|P1|COMPLETED|Overall Study||130
1572670|NCT01157845|3848406|P1|STARTED|Overall Study||165
1572671|NCT01157533|3848411|P1|NOT COMPLETED|Overall Study||0
1572672|NCT01157533|3848411|P1|COMPLETED|Overall Study||1
1572673|NCT01157533|3848411|P1|STARTED|Overall Study||1
1572674|NCT01157429|3848417|P2|NOT COMPLETED|Overall Study||4
1572675|NCT01157429|3848418|P1|NOT COMPLETED|Overall Study||4
1572676|NCT01157429|3848417|P2|COMPLETED|Overall Study||8
1572677|NCT01157429|3848418|P1|COMPLETED|Overall Study||8
1572678|NCT01157429|3848417|P2|STARTED|Overall Study||12
1572679|NCT01157429|3848418|P1|STARTED|Overall Study||12
1572680|NCT01157416|3848426|P2|NOT COMPLETED|Overall Study||0
1572681|NCT01157416|3848427|P1|NOT COMPLETED|Overall Study||2
1572682|NCT01157416|3848426|P2|COMPLETED|Overall Study||16
1572683|NCT01157416|3848427|P1|COMPLETED|Overall Study||15
1572684|NCT01157416|3848426|P2|STARTED|Overall Study||16
1572685|NCT01157416|3848427|P1|STARTED|Overall Study||17
1572686|NCT01157377|3848440|P7|NOT COMPLETED|Overall Study||2
1572687|NCT01157377|3848441|P6|NOT COMPLETED|Overall Study||3
1572688|NCT01157377|3848442|P5|NOT COMPLETED|Overall Study||2
1572689|NCT01157377|3848443|P4|NOT COMPLETED|Overall Study||1
1572690|NCT01157377|3848444|P3|NOT COMPLETED|Overall Study||1
1572691|NCT01157377|3848445|P2|NOT COMPLETED|Overall Study||3
1572692|NCT01157377|3848446|P1|NOT COMPLETED|Overall Study||2
1572693|NCT01157377|3848440|P7|COMPLETED|Overall Study||27
1572694|NCT01157377|3848441|P6|COMPLETED|Overall Study||16
1572695|NCT01157377|3848442|P5|COMPLETED|Overall Study||18
1572696|NCT01157377|3848443|P4|COMPLETED|Overall Study||14
1572697|NCT01157377|3848444|P3|COMPLETED|Overall Study||26
1572698|NCT01157377|3848445|P2|COMPLETED|Overall Study||20
1572699|NCT01157377|3848446|P1|COMPLETED|Overall Study||21
1572700|NCT01157377|3848440|P7|STARTED|Overall Study||29
1572701|NCT01157377|3848441|P6|STARTED|Overall Study||19
1572702|NCT01157377|3848442|P5|STARTED|Overall Study||20
1572703|NCT01157377|3848443|P4|STARTED|Overall Study||15
1572704|NCT01157377|3848444|P3|STARTED|Overall Study||27
1572705|NCT01157377|3848445|P2|STARTED|Overall Study||23
1572706|NCT01157377|3848446|P1|STARTED|Overall Study||23
1572707|NCT01157351|3848464|P2|NOT COMPLETED|Overall Study||132
1572708|NCT01157351|3848465|P1|NOT COMPLETED|Overall Study||137
1572709|NCT01157351|3848464|P2|COMPLETED|Overall Study||88
1572710|NCT01157351|3848465|P1|COMPLETED|Overall Study||93
1572711|NCT01157351|3848464|P2|Treated|Overall Study||218
1572712|NCT01157351|3848465|P1|Treated|Overall Study||226
1572713|NCT01157351|3848464|P2|STARTED|Overall Study||220
1572714|NCT01157351|3848465|P1|STARTED|Overall Study||230
1572715|NCT01157234|3848483|P2|NOT COMPLETED|Overall Study||0
1572716|NCT01157234|3848484|P1|NOT COMPLETED|Overall Study||1
1572717|NCT01157234|3848483|P2|COMPLETED|Overall Study||15
1572718|NCT01157234|3848484|P1|COMPLETED|Overall Study||14
1572719|NCT01157234|3848483|P2|STARTED|Overall Study||15
1572720|NCT01157234|3848484|P1|STARTED|Overall Study||15
1572721|NCT01157182|3848516|P2|NOT COMPLETED|Second Intervention||0
1572722|NCT01157182|3848517|P1|NOT COMPLETED|Second Intervention||0
1572723|NCT01157182|3848516|P2|COMPLETED|Second Intervention||18
1572724|NCT01157182|3848517|P1|COMPLETED|Second Intervention||16
1572725|NCT01157182|3848516|P2|STARTED|Second Intervention||18
1572726|NCT01157182|3848517|P1|STARTED|Second Intervention||16
1572727|NCT01157182|3848516|P2|NOT COMPLETED|Washout of 28 Days||0
1572728|NCT01157182|3848517|P1|NOT COMPLETED|Washout of 28 Days||2
1572729|NCT01157182|3848516|P2|COMPLETED|Washout of 28 Days||18
1572730|NCT01157182|3848517|P1|COMPLETED|Washout of 28 Days||16
1572731|NCT01157182|3848516|P2|STARTED|Washout of 28 Days||18
1572732|NCT01157182|3848517|P1|STARTED|Washout of 28 Days||18
1572733|NCT01157182|3848516|P2|NOT COMPLETED|First Intervention||0
1572734|NCT01157182|3848517|P1|NOT COMPLETED|First Intervention||0
1572735|NCT01157182|3848516|P2|COMPLETED|First Intervention||18
1572736|NCT01157182|3848517|P1|COMPLETED|First Intervention||18
1572737|NCT01157182|3848516|P2|STARTED|First Intervention||18
1572738|NCT01157182|3848517|P1|STARTED|First Intervention||18
1572739|NCT01157169|3848565|P2|NOT COMPLETED|Second Intervention||1
1572740|NCT01157169|3848566|P1|NOT COMPLETED|Second Intervention||0
1572741|NCT01157169|3848565|P2|COMPLETED|Second Intervention||17
1572742|NCT01157169|3848566|P1|COMPLETED|Second Intervention||16
1572743|NCT01157169|3848565|P2|STARTED|Second Intervention||18
1572744|NCT01157169|3848566|P1|STARTED|Second Intervention||16
1572745|NCT01157169|3848565|P2|NOT COMPLETED|Washout of 10 Days||0
1572746|NCT01157169|3848566|P1|NOT COMPLETED|Washout of 10 Days||0
1572747|NCT01157169|3848565|P2|COMPLETED|Washout of 10 Days||18
1572748|NCT01157169|3848566|P1|COMPLETED|Washout of 10 Days||16
1572749|NCT01157169|3848565|P2|STARTED|Washout of 10 Days||18
1572750|NCT01157169|3848566|P1|STARTED|Washout of 10 Days||16
1572751|NCT01157169|3848565|P2|NOT COMPLETED|First Intervention||2
1572752|NCT01157169|3848566|P1|NOT COMPLETED|First Intervention||4
1572753|NCT01157169|3848565|P2|COMPLETED|First Intervention||18
1572754|NCT01157169|3848566|P1|COMPLETED|First Intervention||16
1572755|NCT01157169|3848565|P2|STARTED|First Intervention||20
1572756|NCT01157169|3848566|P1|STARTED|First Intervention||20
1572757|NCT01157117|3848585|P3|NOT COMPLETED|Overall Study||15
1572758|NCT01157117|3848586|P2|NOT COMPLETED|Overall Study||11
1572759|NCT01157117|3848587|P1|NOT COMPLETED|Overall Study||9
1572760|NCT01157117|3848585|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
1572761|NCT01157117|3848586|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
1572762|NCT01157117|3848587|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
1572763|NCT01157117|3848585|P3|Completed Final Month 38 Study Visit|Overall Study||3
1572764|NCT01157117|3848586|P2|Completed Final Month 38 Study Visit|Overall Study||18
1572765|NCT01157117|3848587|P1|Completed Final Month 38 Study Visit|Overall Study||19
1572766|NCT01157117|3848585|P3|Completed Month 32 Tolerance OFC|Overall Study||0
1572767|NCT01157117|3848586|P2|Completed Month 32 Tolerance OFC|Overall Study||20
1572768|NCT01157117|3848587|P1|Completed Month 32 Tolerance OFC|Overall Study||24
1572769|NCT01157117|3848585|P3|Discontinued Milk OIT at Month 30|Overall Study||0
1572770|NCT01157117|3848586|P2|Discontinued Milk OIT at Month 30|Overall Study||20
1572771|NCT01157117|3848587|P1|Discontinued Milk OIT at Month 30|Overall Study||24
1572772|NCT01157117|3848585|P3|Completed Month 28 Desensitization OFC|Overall Study||0
1572773|NCT01157117|3848586|P2|Completed Month 28 Desensitization OFC|Overall Study||24
1572774|NCT01157117|3848587|P1|Completed Month 28 Desensitization OFC|Overall Study||26
1572775|NCT01157117|3848585|P3|Unblinded at Month 16|Overall Study||0
1572776|NCT01157117|3848586|P2|Unblinded at Month 16|Overall Study||26
1572777|NCT01157117|3848587|P1|Unblinded at Month 16|Overall Study||26
1572778|NCT01157117|3848585|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
1572779|NCT01157117|3848586|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
1572780|NCT01157117|3848587|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
1572781|NCT01157117|3848585|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
1572782|NCT01157117|3848586|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
1572783|NCT01157117|3848587|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
1572784|NCT01157117|3848585|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
1572785|NCT01157117|3848586|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
1572786|NCT01157117|3848587|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
1572787|NCT01157117|3848585|P3|STARTED|Overall Study||20
1572788|NCT01157117|3848586|P2|STARTED|Overall Study||29
1572789|NCT01157117|3848587|P1|STARTED|Overall Study||28
1572790|NCT01157078|3848628|P2|NOT COMPLETED|Overall Study||36
1572791|NCT01157078|3848629|P1|NOT COMPLETED|Overall Study||35
1572792|NCT01157078|3848628|P2|COMPLETED|Overall Study||124
1572793|NCT01157078|3848629|P1|COMPLETED|Overall Study||124
1572794|NCT01157078|3848628|P2|Received Treatment|Overall Study||159
1572795|NCT01157078|3848629|P1|Received Treatment|Overall Study||157
1572796|NCT01157078|3848628|P2|STARTED|Overall Study||160
1572797|NCT01157078|3848629|P1|STARTED|Overall Study||159
1572798|NCT01157065|3848679|P2|NOT COMPLETED|Overall Study||1
1572799|NCT01157065|3848680|P1|NOT COMPLETED|Overall Study||0
1572800|NCT01157065|3848679|P2|COMPLETED|Overall Study||10
1572801|NCT01157065|3848680|P1|COMPLETED|Overall Study||38
1572802|NCT01157065|3848679|P2|STARTED|Overall Study||11
1572803|NCT01157065|3848680|P1|STARTED|Overall Study||38
1572804|NCT01156987|3848690|P2|NOT COMPLETED|Overall Study||11
1572805|NCT01156987|3848691|P1|NOT COMPLETED|Overall Study||0
1572806|NCT01156987|3848690|P2|COMPLETED|Overall Study||12
1572807|NCT01156987|3848691|P1|COMPLETED|Overall Study||8
1572808|NCT01156987|3848690|P2|STARTED|Overall Study||23
1572809|NCT01156987|3848691|P1|STARTED|Overall Study||8
1572810|NCT01156844|3848701|P4|NOT COMPLETED|Overall Study||6
1572811|NCT01156844|3848702|P3|NOT COMPLETED|Overall Study||6
1572812|NCT01156844|3848703|P2|NOT COMPLETED|Overall Study||2
1572813|NCT01156844|3848704|P1|NOT COMPLETED|Overall Study||2
1572814|NCT01156844|3848701|P4|COMPLETED|Overall Study||41
1572815|NCT01156844|3848702|P3|COMPLETED|Overall Study||42
1572816|NCT01156844|3848703|P2|COMPLETED|Overall Study||46
1572817|NCT01156844|3848704|P1|COMPLETED|Overall Study||46
1572818|NCT01156844|3848701|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
1572819|NCT01156844|3848702|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
1572820|NCT01156844|3848703|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
1572821|NCT01156844|3848704|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
1572822|NCT01156844|3848701|P4|STARTED|Overall Study||47
1572823|NCT01156844|3848702|P3|STARTED|Overall Study||48
1572824|NCT01156844|3848703|P2|STARTED|Overall Study||48
1572825|NCT01156844|3848704|P1|STARTED|Overall Study|Randomized participants.|48
1572826|NCT01156792|3848723|P1|NOT COMPLETED|Overall Study||69
1572827|NCT01156792|3848723|P1|COMPLETED|Overall Study||93
1572828|NCT01156792|3848723|P1|STARTED|Overall Study||162
1572829|NCT01156701|3848788|P4|NOT COMPLETED|Overall Study||0
1572830|NCT01156701|3848789|P3|NOT COMPLETED|Overall Study||0
1572831|NCT01156701|3848790|P2|NOT COMPLETED|Overall Study||0
1572832|NCT01156701|3848791|P1|NOT COMPLETED|Overall Study||0
1572833|NCT01156701|3848788|P4|COMPLETED|Overall Study||6725
1572834|NCT01156701|3848789|P3|COMPLETED|Overall Study||163716
1572835|NCT01156701|3848790|P2|COMPLETED|Overall Study||1007
1572836|NCT01156701|3848791|P1|COMPLETED|Overall Study||257
1572837|NCT01156701|3848788|P4|STARTED|Overall Study||6725
1572838|NCT01156701|3848789|P3|STARTED|Overall Study||163716
1572839|NCT01156701|3848790|P2|STARTED|Overall Study||1007
1572840|NCT01156701|3848791|P1|STARTED|Overall Study||257
1572841|NCT01156675|3848828|P3|NOT COMPLETED|Overall Study||2
1572842|NCT01156675|3848829|P2|NOT COMPLETED|Overall Study||25
1572843|NCT01156675|3848830|P1|NOT COMPLETED|Overall Study||34
1572844|NCT01156675|3848828|P3|COMPLETED|Overall Study||0
1572845|NCT01156675|3848829|P2|COMPLETED|Overall Study||81
1572846|NCT01156675|3848830|P1|COMPLETED|Overall Study||73
1572847|NCT01156675|3848828|P3|STARTED|Overall Study||2
1572848|NCT01156675|3848829|P2|STARTED|Overall Study||106
1572849|NCT01156675|3848830|P1|STARTED|Overall Study||107
1572850|NCT01156597|3848864|P2|NOT COMPLETED|Overall Study||1
1572851|NCT01156597|3848865|P1|NOT COMPLETED|Overall Study||3
1572852|NCT01156597|3848864|P2|COMPLETED|Overall Study||13
1572853|NCT01156597|3848865|P1|COMPLETED|Overall Study||13
1572854|NCT01156597|3848864|P2|STARTED|Overall Study||14
1572855|NCT01156597|3848865|P1|STARTED|Overall Study||16
1572856|NCT01156571|3848877|P2|NOT COMPLETED|Overall Study||19
1572857|NCT01156571|3848878|P1|NOT COMPLETED|Overall Study||17
1572858|NCT01156571|3848877|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
1572859|NCT01156571|3848878|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
1572860|NCT01156571|3848877|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
1572861|NCT01156571|3848878|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
1572862|NCT01156532|3848888|P1|NOT COMPLETED|Overall Study||2
1572863|NCT01156532|3848888|P1|COMPLETED|Overall Study||28
1572864|NCT01156532|3848888|P1|STARTED|Overall Study||30
1572865|NCT01156480|3848900|P2|NOT COMPLETED|Overall Study||1
1572866|NCT01156480|3848901|P1|NOT COMPLETED|Overall Study||0
1572867|NCT01156480|3848900|P2|COMPLETED|Overall Study||1
1572868|NCT01156480|3848901|P1|COMPLETED|Overall Study||0
1572869|NCT01156480|3848900|P2|STARTED|Overall Study||2
1572870|NCT01156480|3848901|P1|STARTED|Overall Study||0
1572871|NCT01156376|3848912|P3|NOT COMPLETED|Overall Study||4
1572872|NCT01156376|3848913|P2|NOT COMPLETED|Overall Study||0
1572873|NCT01156376|3848914|P1|NOT COMPLETED|Overall Study||1
1572874|NCT01156376|3848912|P3|COMPLETED|Overall Study||23
1572875|NCT01156376|3848913|P2|COMPLETED|Overall Study||26
1572876|NCT01156376|3848914|P1|COMPLETED|Overall Study||26
1572877|NCT01156376|3848912|P3|STARTED|Overall Study||27
1572878|NCT01156376|3848913|P2|STARTED|Overall Study||26
1572879|NCT01156376|3848914|P1|STARTED|Overall Study||27
1572880|NCT01156363|3849135|P1|NOT COMPLETED|Overall Study||22
1572881|NCT01156363|3849135|P1|COMPLETED|Overall Study||64
1572882|NCT01156363|3849135|P1|STARTED|Overall Study||86
1572883|NCT01156311|3849157|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
1572884|NCT01156311|3849158|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
1572885|NCT01156311|3849159|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
1572886|NCT01156311|3849160|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
1572887|NCT01156311|3849157|P4|COMPLETED|6-month Add-on Therapy Period||37
1572888|NCT01156311|3849158|P3|COMPLETED|6-month Add-on Therapy Period||45
1572889|NCT01156311|3849159|P2|COMPLETED|6-month Add-on Therapy Period||0
1572890|NCT01156311|3849160|P1|COMPLETED|6-month Add-on Therapy Period||0
1572891|NCT01156311|3849157|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
1572892|NCT01156311|3849158|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
1572893|NCT01156311|3849159|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
1572894|NCT01156311|3849160|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
1572895|NCT01156311|3849157|P4|STARTED|6-month Add-on Therapy Period||47
1572896|NCT01156311|3849158|P3|STARTED|6-month Add-on Therapy Period||57
1572897|NCT01156311|3849159|P2|STARTED|6-month Add-on Therapy Period||0
1572898|NCT01156311|3849160|P1|STARTED|6-month Add-on Therapy Period||0
1572899|NCT01156311|3849157|P4|NOT COMPLETED|2-Month Monotherapy Period||0
1572900|NCT01156311|3849158|P3|NOT COMPLETED|2-Month Monotherapy Period||0
1572901|NCT01156311|3849159|P2|NOT COMPLETED|2-Month Monotherapy Period||2
1572902|NCT01156311|3849160|P1|NOT COMPLETED|2-Month Monotherapy Period||2
1572903|NCT01156311|3849157|P4|COMPLETED|2-Month Monotherapy Period||0
1572904|NCT01156311|3849158|P3|COMPLETED|2-Month Monotherapy Period||0
1572905|NCT01156311|3849159|P2|COMPLETED|2-Month Monotherapy Period||47
1572906|NCT01156311|3849160|P1|COMPLETED|2-Month Monotherapy Period||57
1572907|NCT01156311|3849157|P4|STARTED|2-Month Monotherapy Period||0
1572908|NCT01156311|3849158|P3|STARTED|2-Month Monotherapy Period||0
1572909|NCT01156311|3849159|P2|STARTED|2-Month Monotherapy Period||49
1572910|NCT01156311|3849160|P1|STARTED|2-Month Monotherapy Period||59
1572911|NCT01156142|3849184|P2|NOT COMPLETED|Overall Study||7
1572912|NCT01156142|3849185|P1|NOT COMPLETED|Overall Study||8
1572913|NCT01156142|3849184|P2|COMPLETED|Overall Study||71
1572914|NCT01156142|3849185|P1|COMPLETED|Overall Study||69
1572915|NCT01156142|3849184|P2|STARTED|Overall Study||78
1572916|NCT01156142|3849185|P1|STARTED|Overall Study||77
1572917|NCT01156116|3849203|P2|NOT COMPLETED|Overall Study||1
1572918|NCT01156116|3849204|P1|NOT COMPLETED|Overall Study||5
1572919|NCT01156116|3849203|P2|COMPLETED|Overall Study||12
1572920|NCT01156116|3849204|P1|COMPLETED|Overall Study||21
1572921|NCT01156116|3849203|P2|STARTED|Overall Study||13
1572922|NCT01156116|3849204|P1|STARTED|Overall Study||26
1572923|NCT01156051|3849218|P2|NOT COMPLETED|Overall Study||1
1572924|NCT01156051|3849219|P1|NOT COMPLETED|Overall Study||1
1572925|NCT01156051|3849218|P2|COMPLETED|Overall Study||16
1572926|NCT01156051|3849219|P1|COMPLETED|Overall Study||11
1572927|NCT01156051|3849218|P2|STARTED|Overall Study||17
1572928|NCT01156051|3849219|P1|STARTED|Overall Study||12
1572929|NCT01156012|3849233|P2|NOT COMPLETED|Overall Study||3
1572930|NCT01156012|3849234|P1|NOT COMPLETED|Overall Study||7
1572931|NCT01156012|3849233|P2|COMPLETED|Overall Study||186
1572932|NCT01156012|3849234|P1|COMPLETED|Overall Study||206
1572933|NCT01156012|3849233|P2|STARTED|Overall Study||189
1572934|NCT01156012|3849234|P1|STARTED|Overall Study||213
1572935|NCT01155999|3849242|P2|NOT COMPLETED|Overall Study||4
1572936|NCT01155999|3849243|P1|NOT COMPLETED|Overall Study||7
1572937|NCT01155999|3849242|P2|COMPLETED|Overall Study||136
1572938|NCT01155999|3849243|P1|COMPLETED|Overall Study||139
1572939|NCT01155999|3849242|P2|STARTED|Overall Study||140
1572940|NCT01155999|3849243|P1|STARTED|Overall Study||146
1572941|NCT01155869|3849251|P2|NOT COMPLETED|Overall Study||1
1572942|NCT01155869|3849252|P1|NOT COMPLETED|Overall Study||3
1572943|NCT01155869|3849251|P2|COMPLETED|Overall Study||3
1572944|NCT01155869|3849252|P1|COMPLETED|Overall Study||0
1572945|NCT01155869|3849251|P2|STARTED|Overall Study||4
1572946|NCT01155869|3849252|P1|STARTED|Overall Study||3
1572947|NCT01155830|3849263|P3|NOT COMPLETED|Overall Study||0
1572948|NCT01155830|3849264|P2|NOT COMPLETED|Overall Study||0
1572949|NCT01155830|3849265|P1|NOT COMPLETED|Overall Study||0
1572950|NCT01155830|3849263|P3|COMPLETED|Overall Study||21
1572951|NCT01155830|3849264|P2|COMPLETED|Overall Study||0
1572952|NCT01155830|3849265|P1|COMPLETED|Overall Study||0
1572953|NCT01155830|3849263|P3|STARTED|Overall Study||21
1572954|NCT01155830|3849264|P2|STARTED|Overall Study||0
1572955|NCT01155830|3849265|P1|STARTED|Overall Study||0
1572956|NCT01155778|3849279|P3|NOT COMPLETED|Overall Study||0
1572957|NCT01155778|3849280|P2|NOT COMPLETED|Overall Study||0
1572958|NCT01155778|3849281|P1|NOT COMPLETED|Overall Study||0
1572959|NCT01155778|3849279|P3|COMPLETED|Overall Study||4
1572960|NCT01155778|3849280|P2|COMPLETED|Overall Study||4
1572961|NCT01155778|3849281|P1|COMPLETED|Overall Study||4
1572962|NCT01155778|3849279|P3|STARTED|Overall Study||4
1572963|NCT01155778|3849280|P2|STARTED|Overall Study||4
1572964|NCT01155778|3849281|P1|STARTED|Overall Study||4
1572965|NCT01155726|3849361|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1572966|NCT01155726|3849362|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1572967|NCT01155726|3849363|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1572968|NCT01155726|3849364|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1572969|NCT01155726|3849361|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
1572970|NCT01155726|3849362|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
1572971|NCT01155726|3849363|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
1572972|NCT01155726|3849364|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
1572973|NCT01155726|3849361|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
1572974|NCT01155726|3849362|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
1572975|NCT01155726|3849363|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
1572976|NCT01155726|3849364|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
1572977|NCT01155726|3849361|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
1572978|NCT01155726|3849362|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
1572979|NCT01155726|3849363|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
1572980|NCT01155726|3849364|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
1572981|NCT01155726|3849361|P4|COMPLETED|Period 1, 3 Days (Masked)||25
1572982|NCT01155726|3849362|P3|COMPLETED|Period 1, 3 Days (Masked)||28
1572983|NCT01155726|3849363|P2|COMPLETED|Period 1, 3 Days (Masked)||20
1572984|NCT01155726|3849364|P1|COMPLETED|Period 1, 3 Days (Masked)||23
1572985|NCT01155726|3849361|P4|STARTED|Period 1, 3 Days (Masked)||25
1572986|NCT01155726|3849362|P3|STARTED|Period 1, 3 Days (Masked)||30
1572987|NCT01155726|3849363|P2|STARTED|Period 1, 3 Days (Masked)||20
1572988|NCT01155726|3849364|P1|STARTED|Period 1, 3 Days (Masked)||24
1572989|NCT01155661|3849386|P1|NOT COMPLETED|Overall Study||280
1572990|NCT01155661|3849386|P1|COMPLETED|Overall Study||328
1572991|NCT01155661|3849386|P1|STARTED|Overall Study||608
1572992|NCT01155570|3849412|P1|NOT COMPLETED|Overall Study||142
1572993|NCT01155570|3849412|P1|COMPLETED|Overall Study||592
1572994|NCT01155570|3849412|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
1572995|NCT01155570|3849412|P1|STARTED|Overall Study|Safety Analysis Population|734
1572996|NCT01155531|3849446|P4|NOT COMPLETED|Overall Study||1
1572997|NCT01155531|3849447|P3|NOT COMPLETED|Overall Study||2
1572998|NCT01155531|3849448|P2|NOT COMPLETED|Overall Study||0
1572999|NCT01155531|3849449|P1|NOT COMPLETED|Overall Study||1
1573000|NCT01155531|3849446|P4|COMPLETED|Overall Study||9
1573001|NCT01155531|3849447|P3|COMPLETED|Overall Study||8
1573002|NCT01155531|3849448|P2|COMPLETED|Overall Study||10
1573003|NCT01155531|3849449|P1|COMPLETED|Overall Study||9
1573004|NCT01155531|3849446|P4|STARTED|Overall Study||10
1573005|NCT01155531|3849447|P3|STARTED|Overall Study||10
1573006|NCT01155531|3849448|P2|STARTED|Overall Study||10
1573007|NCT01155531|3849449|P1|STARTED|Overall Study||10
1573008|NCT01155479|3849472|P5|NOT COMPLETED|Part II||55
1573009|NCT01155479|3849473|P4|NOT COMPLETED|Part II||50
1573010|NCT01155479|3849474|P3|NOT COMPLETED|Part II||58
1573011|NCT01155479|3849475|P2|NOT COMPLETED|Part II||61
1573012|NCT01155479|3849476|P1|NOT COMPLETED|Part II||59
1573013|NCT01155479|3849472|P5|COMPLETED|Part II||126
1573014|NCT01155479|3849473|P4|COMPLETED|Part II||127
1573015|NCT01155479|3849474|P3|COMPLETED|Part II||109
1573016|NCT01155479|3849475|P2|COMPLETED|Part II||116
1573017|NCT01155479|3849476|P1|COMPLETED|Part II||107
1573018|NCT01155479|3849472|P5|STARTED|Part II||181
1573019|NCT01155479|3849473|P4|STARTED|Part II||177
1573020|NCT01155479|3849474|P3|STARTED|Part II||167
1573021|NCT01155479|3849475|P2|STARTED|Part II||177
1573022|NCT01155479|3849476|P1|STARTED|Part II||166
1573023|NCT01155479|3849472|P5|NOT COMPLETED|Part I||23
1573024|NCT01155479|3849473|P4|NOT COMPLETED|Part I||27
1573025|NCT01155479|3849474|P3|NOT COMPLETED|Part I||39
1573026|NCT01155479|3849475|P2|NOT COMPLETED|Part I||27
1573027|NCT01155479|3849476|P1|NOT COMPLETED|Part I||38
1573028|NCT01155479|3849472|P5|COMPLETED|Part I||181
1573029|NCT01155479|3849473|P4|COMPLETED|Part I||177
1573030|NCT01155479|3849474|P3|COMPLETED|Part I||167
1573031|NCT01155479|3849475|P2|COMPLETED|Part I||177
1573032|NCT01155479|3849476|P1|COMPLETED|Part I||166
1573033|NCT01155479|3849472|P5|Treated|Part I||203
1573034|NCT01155479|3849473|P4|Treated|Part I||198
1573035|NCT01155479|3849474|P3|Treated|Part I||204
1573036|NCT01155479|3849475|P2|Treated|Part I||202
1573037|NCT01155479|3849476|P1|Treated|Part I||200
1573038|NCT01155479|3849472|P5|STARTED|Part I||204
1573039|NCT01155479|3849473|P4|STARTED|Part I||204
1573040|NCT01155479|3849474|P3|STARTED|Part I||206
1573041|NCT01155479|3849475|P2|STARTED|Part I||204
1573042|NCT01155479|3849476|P1|STARTED|Part I||204
1573043|NCT01155466|3849528|P5|NOT COMPLETED|Overall Study||27
1573044|NCT01155466|3849529|P4|NOT COMPLETED|Overall Study||21
1573045|NCT01155466|3849530|P3|NOT COMPLETED|Overall Study||20
1573046|NCT01155466|3849531|P2|NOT COMPLETED|Overall Study||25
1573047|NCT01155466|3849532|P1|NOT COMPLETED|Overall Study||22
1573048|NCT01155466|3849528|P5|COMPLETED|Overall Study|Completed treatment phase|129
1573049|NCT01155466|3849529|P4|COMPLETED|Overall Study|Completed treatment phase|134
1573138|NCT01155154|3849713|P1|COMPLETED|Overall Study||25
1573050|NCT01155466|3849530|P3|COMPLETED|Overall Study|Completed treatment phase|136
1573051|NCT01155466|3849531|P2|COMPLETED|Overall Study|Completed treatment phase|130
1573052|NCT01155466|3849532|P1|COMPLETED|Overall Study|Completed treatment phase|134
1573053|NCT01155466|3849528|P5|Treated|Overall Study||154
1573054|NCT01155466|3849529|P4|Treated|Overall Study||155
1573055|NCT01155466|3849530|P3|Treated|Overall Study||153
1573056|NCT01155466|3849531|P2|Treated|Overall Study||153
1573057|NCT01155466|3849532|P1|Treated|Overall Study||154
1573058|NCT01155466|3849528|P5|STARTED|Overall Study||156
1573059|NCT01155466|3849529|P4|STARTED|Overall Study||155
1573060|NCT01155466|3849530|P3|STARTED|Overall Study||156
1573061|NCT01155466|3849531|P2|STARTED|Overall Study||155
1573062|NCT01155466|3849532|P1|STARTED|Overall Study||156
1573063|NCT01155388|3849586|P2|NOT COMPLETED|Overall Study||0
1573064|NCT01155388|3849587|P1|NOT COMPLETED|Overall Study||1
1573065|NCT01155388|3849586|P2|COMPLETED|Overall Study||6
1573066|NCT01155388|3849587|P1|COMPLETED|Overall Study||7
1573067|NCT01155388|3849586|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1573068|NCT01155388|3849587|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
1573069|NCT01155388|3849586|P2|STARTED|Overall Study||6
1573070|NCT01155388|3849587|P1|STARTED|Overall Study||8
1573071|NCT01155375|3849597|P2|NOT COMPLETED|Overall Study||0
1573072|NCT01155375|3849598|P1|NOT COMPLETED|Overall Study||1
1573073|NCT01155375|3849597|P2|COMPLETED|Overall Study||6
1573074|NCT01155375|3849598|P1|COMPLETED|Overall Study||7
1573075|NCT01155375|3849597|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1573076|NCT01155375|3849598|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
1573077|NCT01155375|3849597|P2|STARTED|Overall Study||6
1573078|NCT01155375|3849598|P1|STARTED|Overall Study||8
1573079|NCT01155336|3849608|P2|NOT COMPLETED|Overall Study||0
1573080|NCT01155336|3849609|P1|NOT COMPLETED|Overall Study||0
1573081|NCT01155336|3849608|P2|COMPLETED|Overall Study|We did not complete the study.|4
1573082|NCT01155336|3849609|P1|COMPLETED|Overall Study|We did not complete the study.|0
1573083|NCT01155336|3849608|P2|STARTED|Overall Study|We did not complete the study.|4
1573084|NCT01155336|3849609|P1|STARTED|Overall Study|We did not complete the study.|0
1573085|NCT01155323|3849617|P2|NOT COMPLETED|Second Intervention||1
1573086|NCT01155323|3849618|P1|NOT COMPLETED|Second Intervention||1
1573087|NCT01155323|3849617|P2|COMPLETED|Second Intervention||56
1573088|NCT01155323|3849618|P1|COMPLETED|Second Intervention||58
1573089|NCT01155323|3849617|P2|STARTED|Second Intervention||57
1573090|NCT01155323|3849618|P1|STARTED|Second Intervention||59
1573091|NCT01155323|3849617|P2|NOT COMPLETED|First Intervention||1
1573092|NCT01155323|3849618|P1|NOT COMPLETED|First Intervention||1
1573093|NCT01155323|3849617|P2|COMPLETED|First Intervention||57
1573094|NCT01155323|3849618|P1|COMPLETED|First Intervention||59
1573095|NCT01155323|3849617|P2|STARTED|First Intervention||58
1573096|NCT01155323|3849618|P1|STARTED|First Intervention||60
1573097|NCT01155284|3849636|P2|NOT COMPLETED|Overall Study||5
1573098|NCT01155284|3849637|P1|NOT COMPLETED|Overall Study||7
1573099|NCT01155284|3849636|P2|COMPLETED|Overall Study||18
1573100|NCT01155284|3849637|P1|COMPLETED|Overall Study||40
1573101|NCT01155284|3849636|P2|STARTED|Overall Study||23
1573102|NCT01155284|3849637|P1|STARTED|Overall Study||47
1573103|NCT01155219|3849647|P2|NOT COMPLETED|Overall Study||3
1573104|NCT01155219|3849648|P1|NOT COMPLETED|Overall Study||4
1573105|NCT01155219|3849647|P2|COMPLETED|Overall Study||70
1573106|NCT01155219|3849648|P1|COMPLETED|Overall Study||73
1573107|NCT01155219|3849647|P2|STARTED|Overall Study||73
1573108|NCT01155219|3849648|P1|STARTED|Overall Study||77
1573109|NCT01155193|3849658|P4|NOT COMPLETED|Overall Study||91
1573110|NCT01155193|3849659|P3|NOT COMPLETED|Overall Study||12
1573111|NCT01155193|3849660|P2|NOT COMPLETED|Overall Study||13
1573112|NCT01155193|3849661|P1|NOT COMPLETED|Overall Study||238
1573113|NCT01155193|3849658|P4|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
1573114|NCT01155193|3849659|P3|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
1573115|NCT01155193|3849660|P2|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
1573116|NCT01155193|3849661|P1|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
1573117|NCT01155193|3849658|P4|STARTED|Overall Study||13802
1573118|NCT01155193|3849659|P3|STARTED|Overall Study||2260
1573119|NCT01155193|3849660|P2|STARTED|Overall Study||3818
1573120|NCT01155193|3849661|P1|STARTED|Overall Study||10924
1573121|NCT01155180|3849688|P2|NOT COMPLETED|Overall Study||0
1573122|NCT01155180|3849689|P1|NOT COMPLETED|Overall Study||0
1573123|NCT01155180|3849688|P2|COMPLETED|Overall Study||6
1573124|NCT01155180|3849689|P1|COMPLETED|Overall Study||18
1573125|NCT01155180|3849688|P2|STARTED|Overall Study||6
1573126|NCT01155180|3849689|P1|STARTED|Overall Study||18
1573127|NCT01155167|3849697|P2|NOT COMPLETED|Overall Study||0
1573128|NCT01155167|3849698|P1|NOT COMPLETED|Overall Study||3
1573129|NCT01155167|3849697|P2|COMPLETED|Overall Study||43
1573130|NCT01155167|3849698|P1|COMPLETED|Overall Study||40
1573131|NCT01155167|3849697|P2|STARTED|Overall Study||43
1573132|NCT01155167|3849698|P1|STARTED|Overall Study||43
1573133|NCT01155154|3849711|P3|NOT COMPLETED|Overall Study||0
1573134|NCT01155154|3849712|P2|NOT COMPLETED|Overall Study||0
1573135|NCT01155154|3849713|P1|NOT COMPLETED|Overall Study||0
1573136|NCT01155154|3849711|P3|COMPLETED|Overall Study||24
1573137|NCT01155154|3849712|P2|COMPLETED|Overall Study||24
1573139|NCT01155154|3849711|P3|STARTED|Overall Study||24
1573140|NCT01155154|3849712|P2|STARTED|Overall Study||24
1573141|NCT01155154|3849713|P1|STARTED|Overall Study||25
1573142|NCT01155141|3849721|P1|NOT COMPLETED|Overall Study||2
1573143|NCT01155141|3849721|P1|COMPLETED|Overall Study||14
1573144|NCT01155141|3849721|P1|STARTED|Overall Study||16
1573145|NCT01155063|3849733|P1|NOT COMPLETED|Overall Study||89
1573146|NCT01155063|3849733|P1|COMPLETED|Overall Study||0
1573147|NCT01155063|3849733|P1|STARTED|Overall Study||89
1573148|NCT01155024|3849743|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
1573149|NCT01155024|3849744|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
1573150|NCT01155024|3849743|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
1573151|NCT01155024|3849744|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
1573152|NCT01155024|3849743|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
1573153|NCT01155024|3849744|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
1573154|NCT01155024|3849743|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
1573155|NCT01155024|3849744|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
1573156|NCT01155024|3849743|P2|COMPLETED|Second Socket Intervention Fitting||5
1573157|NCT01155024|3849744|P1|COMPLETED|Second Socket Intervention Fitting||5
1573158|NCT01155024|3849743|P2|STARTED|Second Socket Intervention Fitting||5
1573159|NCT01155024|3849744|P1|STARTED|Second Socket Intervention Fitting||5
1573160|NCT01155024|3849743|P2|NOT COMPLETED|First Socket Intervention Fitting||0
1573161|NCT01155024|3849744|P1|NOT COMPLETED|First Socket Intervention Fitting||0
1573162|NCT01155024|3849743|P2|COMPLETED|First Socket Intervention Fitting||5
1573163|NCT01155024|3849744|P1|COMPLETED|First Socket Intervention Fitting||5
1573164|NCT01155024|3849743|P2|STARTED|First Socket Intervention Fitting||5
1573165|NCT01155024|3849744|P1|STARTED|First Socket Intervention Fitting||5
1573166|NCT01155011|3849754|P2|NOT COMPLETED|6 to 12 Months||10
1573167|NCT01155011|3849755|P1|NOT COMPLETED|6 to 12 Months||9
1573168|NCT01155011|3849754|P2|COMPLETED|6 to 12 Months||121
1573169|NCT01155011|3849755|P1|COMPLETED|6 to 12 Months||120
1573170|NCT01155011|3849754|P2|STARTED|6 to 12 Months||131
1573171|NCT01155011|3849755|P1|STARTED|6 to 12 Months||129
1573172|NCT01155011|3849754|P2|NOT COMPLETED|Baseline to 6 Months||25
1573173|NCT01155011|3849755|P1|NOT COMPLETED|Baseline to 6 Months||22
1573174|NCT01155011|3849754|P2|COMPLETED|Baseline to 6 Months||131
1573175|NCT01155011|3849755|P1|COMPLETED|Baseline to 6 Months||129
1573176|NCT01155011|3849754|P2|STARTED|Baseline to 6 Months||156
1573177|NCT01155011|3849755|P1|STARTED|Baseline to 6 Months||151
1573178|NCT01154985|3849768|P3|NOT COMPLETED|Overall Study||18
1573179|NCT01154985|3849769|P2|NOT COMPLETED|Overall Study||27
1573180|NCT01154985|3849770|P1|NOT COMPLETED|Overall Study||17
1573181|NCT01154985|3849768|P3|COMPLETED|Overall Study||68
1573182|NCT01154985|3849769|P2|COMPLETED|Overall Study||55
1573183|NCT01154985|3849770|P1|COMPLETED|Overall Study||58
1573184|NCT01154985|3849768|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
1573185|NCT01154985|3849769|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
1573186|NCT01154985|3849770|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
1573187|NCT01154985|3849768|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
1573188|NCT01154985|3849769|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
1573189|NCT01154985|3849770|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
1573190|NCT01154985|3849768|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
1573191|NCT01154985|3849769|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
1573192|NCT01154985|3849770|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
1573193|NCT01154985|3849768|P3|STARTED|Overall Study|Randomized|86
1573194|NCT01154985|3849769|P2|STARTED|Overall Study|Randomized|82
1573195|NCT01154985|3849770|P1|STARTED|Overall Study|Randomized|75
1573196|NCT01154816|3849796|P12|NOT COMPLETED|Overall Study||4
1573197|NCT01154816|3849797|P11|NOT COMPLETED|Overall Study||11
1573198|NCT01154816|3849798|P10|NOT COMPLETED|Overall Study||10
1573199|NCT01154816|3849799|P9|NOT COMPLETED|Overall Study||9
1573200|NCT01154816|3849800|P8|NOT COMPLETED|Overall Study||7
1573201|NCT01154816|3849801|P7|NOT COMPLETED|Overall Study||6
1573202|NCT01154816|3849802|P6|NOT COMPLETED|Overall Study||8
1573203|NCT01154816|3849803|P5|NOT COMPLETED|Overall Study||10
1573204|NCT01154816|3849804|P4|NOT COMPLETED|Overall Study||10
1573205|NCT01154816|3849805|P3|NOT COMPLETED|Overall Study||10
1573206|NCT01154816|3849806|P2|NOT COMPLETED|Overall Study||10
1573207|NCT01154816|3849807|P1|NOT COMPLETED|Overall Study||20
1573208|NCT01154816|3849796|P12|COMPLETED|Overall Study||0
1573209|NCT01154816|3849797|P11|COMPLETED|Overall Study||0
1573210|NCT01154816|3849798|P10|COMPLETED|Overall Study||0
1573211|NCT01154816|3849799|P9|COMPLETED|Overall Study||1
1573212|NCT01154816|3849800|P8|COMPLETED|Overall Study||0
1573213|NCT01154816|3849801|P7|COMPLETED|Overall Study||0
1573214|NCT01154816|3849802|P6|COMPLETED|Overall Study||0
1573215|NCT01154816|3849803|P5|COMPLETED|Overall Study||0
1573216|NCT01154816|3849804|P4|COMPLETED|Overall Study||0
1573217|NCT01154816|3849805|P3|COMPLETED|Overall Study||0
1573218|NCT01154816|3849806|P2|COMPLETED|Overall Study||2
1573219|NCT01154816|3849807|P1|COMPLETED|Overall Study||0
1573220|NCT01154816|3849796|P12|STARTED|Overall Study||4
1573221|NCT01154816|3849797|P11|STARTED|Overall Study||11
1573222|NCT01154816|3849798|P10|STARTED|Overall Study||10
1573223|NCT01154816|3849799|P9|STARTED|Overall Study||10
1573224|NCT01154816|3849800|P8|STARTED|Overall Study||7
1573225|NCT01154816|3849801|P7|STARTED|Overall Study||6
1573226|NCT01154816|3849802|P6|STARTED|Overall Study||8
1573227|NCT01154816|3849803|P5|STARTED|Overall Study||10
1573228|NCT01154816|3849804|P4|STARTED|Overall Study||10
1573229|NCT01154816|3849805|P3|STARTED|Overall Study||10
1573230|NCT01154816|3849806|P2|STARTED|Overall Study||12
1573231|NCT01154816|3849807|P1|STARTED|Overall Study||20
1573232|NCT01154751|3849840|P1|NOT COMPLETED|3-year Follow-up||49
1573233|NCT01154751|3849840|P1|COMPLETED|3-year Follow-up||34
1573234|NCT01154751|3849840|P1|STARTED|3-year Follow-up||83
1573235|NCT01154751|3849840|P1|NOT COMPLETED|2-year Follow-up||10
1573236|NCT01154751|3849840|P1|COMPLETED|2-year Follow-up||83
1573237|NCT01154751|3849840|P1|STARTED|2-year Follow-up||93
1573238|NCT01154751|3849840|P1|NOT COMPLETED|1-year Follow-up||5
1573239|NCT01154751|3849840|P1|COMPLETED|1-year Follow-up||93
1573240|NCT01154751|3849840|P1|STARTED|1-year Follow-up||98
1573241|NCT01154751|3849840|P1|NOT COMPLETED|6-month Follow-up||11
1573242|NCT01154751|3849840|P1|COMPLETED|6-month Follow-up||98
1573243|NCT01154751|3849840|P1|STARTED|6-month Follow-up||109
1573244|NCT01154699|3849865|P2|NOT COMPLETED|Second Intervention||0
1573245|NCT01154699|3849866|P1|NOT COMPLETED|Second Intervention||0
1573246|NCT01154699|3849865|P2|COMPLETED|Second Intervention||8
1573247|NCT01154699|3849866|P1|COMPLETED|Second Intervention||13
1573248|NCT01154699|3849865|P2|Subjects With Asthma + OSA|Second Intervention||2
1573249|NCT01154699|3849866|P1|Subjects With Asthma + OSA|Second Intervention||6
1573250|NCT01154699|3849865|P2|Subjects With Asthma Only|Second Intervention||6
1573251|NCT01154699|3849866|P1|Subjects With Asthma Only|Second Intervention||7
1573252|NCT01154699|3849865|P2|STARTED|Second Intervention||8
1573253|NCT01154699|3849866|P1|STARTED|Second Intervention||13
1573254|NCT01154699|3849865|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
1573255|NCT01154699|3849866|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
1573256|NCT01154699|3849865|P2|COMPLETED|Washout Period (4 Weeks)||8
1573257|NCT01154699|3849866|P1|COMPLETED|Washout Period (4 Weeks)||13
1573258|NCT01154699|3849865|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
1573259|NCT01154699|3849866|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
1573260|NCT01154699|3849865|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
1573261|NCT01154699|3849866|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
1573262|NCT01154699|3849865|P2|STARTED|Washout Period (4 Weeks)||8
1573263|NCT01154699|3849866|P1|STARTED|Washout Period (4 Weeks)||13
1573264|NCT01154699|3849865|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
1573265|NCT01154699|3849866|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
1573266|NCT01154699|3849865|P2|COMPLETED|First Intervention (4 Weeks)||8
1573267|NCT01154699|3849866|P1|COMPLETED|First Intervention (4 Weeks)||13
1573268|NCT01154699|3849865|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
1573269|NCT01154699|3849866|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
1573270|NCT01154699|3849865|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
1573271|NCT01154699|3849866|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
1573272|NCT01154699|3849865|P2|STARTED|First Intervention (4 Weeks)||8
1573273|NCT01154699|3849866|P1|STARTED|First Intervention (4 Weeks)||13
1573274|NCT01154673|3849884|P2|NOT COMPLETED|Overall Study||0
1573275|NCT01154673|3849885|P1|NOT COMPLETED|Overall Study||2
1573276|NCT01154673|3849884|P2|COMPLETED|Overall Study||16
1573277|NCT01154673|3849885|P1|COMPLETED|Overall Study||14
1573278|NCT01154673|3849884|P2|STARTED|Overall Study||16
1573279|NCT01154673|3849885|P1|STARTED|Overall Study||16
1573280|NCT01154634|3849895|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
1573281|NCT01154634|3849896|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
1573282|NCT01154634|3849897|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
1573283|NCT01154634|3849898|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
1573284|NCT01154634|3849895|P4|COMPLETED|Period 7 - Fourth Intervention||5
1573285|NCT01154634|3849896|P3|COMPLETED|Period 7 - Fourth Intervention||4
1573286|NCT01154634|3849897|P2|COMPLETED|Period 7 - Fourth Intervention||7
1573287|NCT01154634|3849898|P1|COMPLETED|Period 7 - Fourth Intervention||4
1573288|NCT01154634|3849895|P4|STARTED|Period 7 - Fourth Intervention||5
1573289|NCT01154634|3849896|P3|STARTED|Period 7 - Fourth Intervention||4
1573290|NCT01154634|3849897|P2|STARTED|Period 7 - Fourth Intervention||7
1573291|NCT01154634|3849898|P1|STARTED|Period 7 - Fourth Intervention||4
1573292|NCT01154634|3849895|P4|NOT COMPLETED|Period 6 - Washout||0
1573293|NCT01154634|3849896|P3|NOT COMPLETED|Period 6 - Washout||0
1573294|NCT01154634|3849897|P2|NOT COMPLETED|Period 6 - Washout||0
1573295|NCT01154634|3849898|P1|NOT COMPLETED|Period 6 - Washout||0
1573296|NCT01154634|3849895|P4|COMPLETED|Period 6 - Washout||5
1573297|NCT01154634|3849896|P3|COMPLETED|Period 6 - Washout||4
1573298|NCT01154634|3849897|P2|COMPLETED|Period 6 - Washout||7
1573299|NCT01154634|3849898|P1|COMPLETED|Period 6 - Washout||4
1573300|NCT01154634|3849895|P4|STARTED|Period 6 - Washout||5
1573301|NCT01154634|3849896|P3|STARTED|Period 6 - Washout||4
1573302|NCT01154634|3849897|P2|STARTED|Period 6 - Washout||7
1573303|NCT01154634|3849898|P1|STARTED|Period 6 - Washout||4
1573304|NCT01154634|3849895|P4|NOT COMPLETED|Period 5 - Third Intervention||0
1573305|NCT01154634|3849896|P3|NOT COMPLETED|Period 5 - Third Intervention||0
1573306|NCT01154634|3849897|P2|NOT COMPLETED|Period 5 - Third Intervention||0
1573307|NCT01154634|3849898|P1|NOT COMPLETED|Period 5 - Third Intervention||0
1573308|NCT01154634|3849895|P4|COMPLETED|Period 5 - Third Intervention||5
1573309|NCT01154634|3849896|P3|COMPLETED|Period 5 - Third Intervention||4
1573310|NCT01154634|3849897|P2|COMPLETED|Period 5 - Third Intervention||7
1573311|NCT01154634|3849898|P1|COMPLETED|Period 5 - Third Intervention||4
1573312|NCT01154634|3849895|P4|STARTED|Period 5 - Third Intervention||5
1573313|NCT01154634|3849896|P3|STARTED|Period 5 - Third Intervention||4
1573314|NCT01154634|3849897|P2|STARTED|Period 5 - Third Intervention||7
1573315|NCT01154634|3849898|P1|STARTED|Period 5 - Third Intervention||4
1573316|NCT01154634|3849895|P4|NOT COMPLETED|Period 4 - Washout||0
1573317|NCT01154634|3849896|P3|NOT COMPLETED|Period 4 - Washout||0
1573318|NCT01154634|3849897|P2|NOT COMPLETED|Period 4 - Washout||0
1573319|NCT01154634|3849898|P1|NOT COMPLETED|Period 4 - Washout||0
1573320|NCT01154634|3849895|P4|COMPLETED|Period 4 - Washout||5
1573321|NCT01154634|3849896|P3|COMPLETED|Period 4 - Washout||4
1573322|NCT01154634|3849897|P2|COMPLETED|Period 4 - Washout||7
1573323|NCT01154634|3849898|P1|COMPLETED|Period 4 - Washout||4
1573324|NCT01154634|3849895|P4|STARTED|Period 4 - Washout||5
1573325|NCT01154634|3849896|P3|STARTED|Period 4 - Washout||4
1573326|NCT01154634|3849897|P2|STARTED|Period 4 - Washout||7
1573327|NCT01154634|3849898|P1|STARTED|Period 4 - Washout||4
1573328|NCT01154634|3849895|P4|NOT COMPLETED|Period 3- Second Intervention||0
1573329|NCT01154634|3849896|P3|NOT COMPLETED|Period 3- Second Intervention||0
1573330|NCT01154634|3849897|P2|NOT COMPLETED|Period 3- Second Intervention||0
1573331|NCT01154634|3849898|P1|NOT COMPLETED|Period 3- Second Intervention||0
1573332|NCT01154634|3849895|P4|COMPLETED|Period 3- Second Intervention||5
1573333|NCT01154634|3849896|P3|COMPLETED|Period 3- Second Intervention||4
1573334|NCT01154634|3849897|P2|COMPLETED|Period 3- Second Intervention||7
1573335|NCT01154634|3849898|P1|COMPLETED|Period 3- Second Intervention||4
1573336|NCT01154634|3849895|P4|STARTED|Period 3- Second Intervention||5
1573337|NCT01154634|3849896|P3|STARTED|Period 3- Second Intervention||4
1573338|NCT01154634|3849897|P2|STARTED|Period 3- Second Intervention||7
1573339|NCT01154634|3849898|P1|STARTED|Period 3- Second Intervention||4
1573340|NCT01154634|3849895|P4|NOT COMPLETED|Period 2 - Washout||0
1573341|NCT01154634|3849896|P3|NOT COMPLETED|Period 2 - Washout||0
1573342|NCT01154634|3849897|P2|NOT COMPLETED|Period 2 - Washout||0
1573343|NCT01154634|3849898|P1|NOT COMPLETED|Period 2 - Washout||0
1573344|NCT01154634|3849895|P4|COMPLETED|Period 2 - Washout||5
1573345|NCT01154634|3849896|P3|COMPLETED|Period 2 - Washout||4
1573346|NCT01154634|3849897|P2|COMPLETED|Period 2 - Washout||7
1573347|NCT01154634|3849898|P1|COMPLETED|Period 2 - Washout||4
1573348|NCT01154634|3849895|P4|STARTED|Period 2 - Washout||5
1573349|NCT01154634|3849896|P3|STARTED|Period 2 - Washout||4
1573350|NCT01154634|3849897|P2|STARTED|Period 2 - Washout||7
1573351|NCT01154634|3849898|P1|STARTED|Period 2 - Washout||4
1573352|NCT01154634|3849895|P4|NOT COMPLETED|Period 1 - First Intervention||0
1573353|NCT01154634|3849896|P3|NOT COMPLETED|Period 1 - First Intervention||0
1573354|NCT01154634|3849897|P2|NOT COMPLETED|Period 1 - First Intervention||0
1573355|NCT01154634|3849898|P1|NOT COMPLETED|Period 1 - First Intervention||0
1573356|NCT01154634|3849895|P4|COMPLETED|Period 1 - First Intervention||5
1573357|NCT01154634|3849896|P3|COMPLETED|Period 1 - First Intervention||4
1573358|NCT01154634|3849897|P2|COMPLETED|Period 1 - First Intervention||7
1573359|NCT01154634|3849898|P1|COMPLETED|Period 1 - First Intervention||4
1573360|NCT01154634|3849895|P4|STARTED|Period 1 - First Intervention||5
1573361|NCT01154634|3849896|P3|STARTED|Period 1 - First Intervention||4
1573362|NCT01154634|3849897|P2|STARTED|Period 1 - First Intervention||7
1573363|NCT01154634|3849898|P1|STARTED|Period 1 - First Intervention||4
1573364|NCT01154452|3849940|P4|NOT COMPLETED|Phase II||6
1573365|NCT01154452|3849941|P3|NOT COMPLETED|Phase II||5
1573366|NCT01154452|3849942|P2|NOT COMPLETED|Phase II||0
1573367|NCT01154452|3849943|P1|NOT COMPLETED|Phase II||0
1573368|NCT01154452|3849940|P4|COMPLETED|Phase II||27
1573369|NCT01154452|3849941|P3|COMPLETED|Phase II||30
1573370|NCT01154452|3849942|P2|COMPLETED|Phase II||0
1573371|NCT01154452|3849943|P1|COMPLETED|Phase II||0
1573372|NCT01154452|3849940|P4|STARTED|Phase II||33
1573373|NCT01154452|3849941|P3|STARTED|Phase II||35
1573374|NCT01154452|3849942|P2|STARTED|Phase II||0
1573375|NCT01154452|3849943|P1|STARTED|Phase II||0
1573376|NCT01154452|3849940|P4|NOT COMPLETED|Phase Ib||0
1573377|NCT01154452|3849941|P3|NOT COMPLETED|Phase Ib||0
1573378|NCT01154452|3849942|P2|NOT COMPLETED|Phase Ib||1
1573379|NCT01154452|3849943|P1|NOT COMPLETED|Phase Ib||3
1573380|NCT01154452|3849940|P4|COMPLETED|Phase Ib||0
1573381|NCT01154452|3849941|P3|COMPLETED|Phase Ib||0
1573382|NCT01154452|3849942|P2|COMPLETED|Phase Ib||3
1573383|NCT01154452|3849943|P1|COMPLETED|Phase Ib||3
1573384|NCT01154452|3849940|P4|STARTED|Phase Ib||0
1573385|NCT01154452|3849941|P3|STARTED|Phase Ib||0
1573386|NCT01154452|3849942|P2|STARTED|Phase Ib||4
1573387|NCT01154452|3849943|P1|STARTED|Phase Ib||6
1573388|NCT01154335|3849959|P3|NOT COMPLETED|Overall Study||5
1573389|NCT01154335|3849960|P2|NOT COMPLETED|Overall Study||6
1573390|NCT01154335|3849961|P1|NOT COMPLETED|Overall Study||7
1573391|NCT01154335|3849959|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
1573392|NCT01154335|3849960|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
1573393|NCT01154335|3849961|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
1573394|NCT01154335|3849959|P3|STARTED|Overall Study||5
1573395|NCT01154335|3849960|P2|STARTED|Overall Study||6
1573396|NCT01154335|3849961|P1|STARTED|Overall Study||7
1573397|NCT01154322|3849968|P1|NOT COMPLETED|Overall Study||2
1573398|NCT01154322|3849968|P1|COMPLETED|Overall Study||14
1573399|NCT01154322|3849968|P1|STARTED|Overall Study||16
1573400|NCT01154296|3849975|P2|NOT COMPLETED|6-month Follow-up||328
1573401|NCT01154296|3849976|P1|NOT COMPLETED|6-month Follow-up||328
1573402|NCT01154296|3849975|P2|COMPLETED|6-month Follow-up||2179
1573403|NCT01154296|3849976|P1|COMPLETED|6-month Follow-up||2177
1573404|NCT01154296|3849975|P2|STARTED|6-month Follow-up||2507
1573405|NCT01154296|3849976|P1|STARTED|6-month Follow-up||2505
1573406|NCT01154296|3849975|P2|NOT COMPLETED|Randomization and Intervention||2
1573407|NCT01154296|3849976|P1|NOT COMPLETED|Randomization and Intervention||5
1573408|NCT01154296|3849975|P2|COMPLETED|Randomization and Intervention||2505
1573409|NCT01154296|3849976|P1|COMPLETED|Randomization and Intervention||2500
1573410|NCT01154296|3849975|P2|STARTED|Randomization and Intervention||2507
1573411|NCT01154296|3849976|P1|STARTED|Randomization and Intervention||2505
1573412|NCT01154283|3849994|P2|NOT COMPLETED|7-12 Weeks||1
1573413|NCT01154283|3849995|P1|NOT COMPLETED|7-12 Weeks||1
1573414|NCT01154283|3849994|P2|COMPLETED|7-12 Weeks||10
1573415|NCT01154283|3849995|P1|COMPLETED|7-12 Weeks||6
1573416|NCT01154283|3849994|P2|STARTED|7-12 Weeks||11
1573417|NCT01154283|3849995|P1|STARTED|7-12 Weeks||7
1573418|NCT01154283|3849994|P2|NOT COMPLETED|0-6 Weeks||3
1573419|NCT01154283|3849995|P1|NOT COMPLETED|0-6 Weeks||7
1573420|NCT01154283|3849994|P2|COMPLETED|0-6 Weeks||11
1573421|NCT01154283|3849995|P1|COMPLETED|0-6 Weeks||7
1573422|NCT01154283|3849994|P2|STARTED|0-6 Weeks||14
1573423|NCT01154283|3849995|P1|STARTED|0-6 Weeks||14
1573424|NCT01154231|3850007|P1|NOT COMPLETED|Overall Study||2
1573425|NCT01154231|3850007|P1|COMPLETED|Overall Study||312
1573426|NCT01154231|3850007|P1|STARTED|Overall Study||314
1573427|NCT01154218|3850013|P4|NOT COMPLETED|Fourth Intervention Period||0
1573428|NCT01154218|3850014|P3|NOT COMPLETED|Fourth Intervention Period||0
1573429|NCT01154218|3850015|P2|NOT COMPLETED|Fourth Intervention Period||0
1573430|NCT01154218|3850016|P1|NOT COMPLETED|Fourth Intervention Period||1
1573431|NCT01154218|3850013|P4|COMPLETED|Fourth Intervention Period||8
1573432|NCT01154218|3850014|P3|COMPLETED|Fourth Intervention Period||9
1573433|NCT01154218|3850015|P2|COMPLETED|Fourth Intervention Period||8
1573434|NCT01154218|3850016|P1|COMPLETED|Fourth Intervention Period||8
1573435|NCT01154218|3850013|P4|STARTED|Fourth Intervention Period||8
1573436|NCT01154218|3850014|P3|STARTED|Fourth Intervention Period||9
1573437|NCT01154218|3850015|P2|STARTED|Fourth Intervention Period||8
1573438|NCT01154218|3850016|P1|STARTED|Fourth Intervention Period||9
1573439|NCT01154218|3850013|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
1573440|NCT01154218|3850014|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573441|NCT01154218|3850015|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573442|NCT01154218|3850016|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573443|NCT01154218|3850013|P4|COMPLETED|Washout Period (at Least 14 Days)||8
1573444|NCT01154218|3850014|P3|COMPLETED|Washout Period (at Least 14 Days)||9
1573445|NCT01154218|3850015|P2|COMPLETED|Washout Period (at Least 14 Days)||8
1573446|NCT01154218|3850016|P1|COMPLETED|Washout Period (at Least 14 Days)||9
1573447|NCT01154218|3850013|P4|STARTED|Washout Period (at Least 14 Days)||9
1573448|NCT01154218|3850014|P3|STARTED|Washout Period (at Least 14 Days)||9
1573449|NCT01154218|3850015|P2|STARTED|Washout Period (at Least 14 Days)||8
1573450|NCT01154218|3850016|P1|STARTED|Washout Period (at Least 14 Days)||9
1573451|NCT01154218|3850013|P4|NOT COMPLETED|Third Intervention Period||0
1573452|NCT01154218|3850014|P3|NOT COMPLETED|Third Intervention Period||0
1573453|NCT01154218|3850015|P2|NOT COMPLETED|Third Intervention Period||1
1573454|NCT01154218|3850016|P1|NOT COMPLETED|Third Intervention Period||0
1573455|NCT01154218|3850013|P4|COMPLETED|Third Intervention Period||9
1573456|NCT01154218|3850014|P3|COMPLETED|Third Intervention Period||9
1573457|NCT01154218|3850015|P2|COMPLETED|Third Intervention Period||8
1573458|NCT01154218|3850016|P1|COMPLETED|Third Intervention Period||9
1573459|NCT01154218|3850013|P4|STARTED|Third Intervention Period||9
1573460|NCT01154218|3850014|P3|STARTED|Third Intervention Period||9
1573461|NCT01154218|3850015|P2|STARTED|Third Intervention Period||9
1573462|NCT01154218|3850016|P1|STARTED|Third Intervention Period||9
1573463|NCT01154218|3850013|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573464|NCT01154218|3850014|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573465|NCT01154218|3850015|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573466|NCT01154218|3850016|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573467|NCT01154218|3850013|P4|COMPLETED|Washout Period (at Least 14 Days)||9
1573468|NCT01154218|3850014|P3|COMPLETED|Washout Period (at Least 14 Days)||9
1573469|NCT01154218|3850015|P2|COMPLETED|Washout Period (at Least 14 Days)||9
1573470|NCT01154218|3850016|P1|COMPLETED|Washout Period (at Least 14 Days)||9
1573471|NCT01154218|3850013|P4|STARTED|Washout Period (at Least 14 Days)||9
1573472|NCT01154218|3850014|P3|STARTED|Washout Period (at Least 14 Days)||9
1573473|NCT01154218|3850015|P2|STARTED|Washout Period (at Least 14 Days)||9
1573474|NCT01154218|3850016|P1|STARTED|Washout Period (at Least 14 Days)||9
1573475|NCT01154218|3850013|P4|NOT COMPLETED|Second Intervention Period||0
1573476|NCT01154218|3850014|P3|NOT COMPLETED|Second Intervention Period||0
1573477|NCT01154218|3850015|P2|NOT COMPLETED|Second Intervention Period||0
1573478|NCT01154218|3850016|P1|NOT COMPLETED|Second Intervention Period||0
1573479|NCT01154218|3850013|P4|COMPLETED|Second Intervention Period||9
1573480|NCT01154218|3850014|P3|COMPLETED|Second Intervention Period||9
1573481|NCT01154218|3850015|P2|COMPLETED|Second Intervention Period||9
1573482|NCT01154218|3850016|P1|COMPLETED|Second Intervention Period||9
1573483|NCT01154218|3850013|P4|STARTED|Second Intervention Period||9
1573484|NCT01154218|3850014|P3|STARTED|Second Intervention Period||9
1573485|NCT01154218|3850015|P2|STARTED|Second Intervention Period||9
1573486|NCT01154218|3850016|P1|STARTED|Second Intervention Period||9
1573487|NCT01154218|3850013|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573488|NCT01154218|3850014|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573489|NCT01154218|3850015|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573490|NCT01154218|3850016|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1573491|NCT01154218|3850013|P4|COMPLETED|Washout Period (at Least 14 Days)||9
1573492|NCT01154218|3850014|P3|COMPLETED|Washout Period (at Least 14 Days)||9
1573493|NCT01154218|3850015|P2|COMPLETED|Washout Period (at Least 14 Days)||9
1573494|NCT01154218|3850016|P1|COMPLETED|Washout Period (at Least 14 Days)||9
1573495|NCT01154218|3850013|P4|STARTED|Washout Period (at Least 14 Days)||9
1573496|NCT01154218|3850014|P3|STARTED|Washout Period (at Least 14 Days)||9
1573497|NCT01154218|3850015|P2|STARTED|Washout Period (at Least 14 Days)||9
1573498|NCT01154218|3850016|P1|STARTED|Washout Period (at Least 14 Days)||9
1573499|NCT01154218|3850013|P4|NOT COMPLETED|First Intervention Period||0
1573500|NCT01154218|3850014|P3|NOT COMPLETED|First Intervention Period||0
1573501|NCT01154218|3850015|P2|NOT COMPLETED|First Intervention Period||0
1573502|NCT01154218|3850016|P1|NOT COMPLETED|First Intervention Period||0
1573503|NCT01154218|3850013|P4|COMPLETED|First Intervention Period||9
1573504|NCT01154218|3850014|P3|COMPLETED|First Intervention Period||9
1573505|NCT01154218|3850015|P2|COMPLETED|First Intervention Period||9
1573506|NCT01154218|3850016|P1|COMPLETED|First Intervention Period||9
1573507|NCT01154218|3850013|P4|STARTED|First Intervention Period||9
1573508|NCT01154218|3850014|P3|STARTED|First Intervention Period||9
1573509|NCT01154218|3850015|P2|STARTED|First Intervention Period||9
1573510|NCT01154218|3850016|P1|STARTED|First Intervention Period||9
1573511|NCT01154166|3850068|P2|NOT COMPLETED|Overall Study||12
1573512|NCT01154166|3850069|P1|NOT COMPLETED|Overall Study||34
1573513|NCT01154166|3850068|P2|COMPLETED|Overall Study||163
1573514|NCT01154166|3850069|P1|COMPLETED|Overall Study||135
1573515|NCT01154166|3850068|P2|STARTED|Overall Study||175
1573516|NCT01154166|3850069|P1|STARTED|Overall Study||169
1573517|NCT01154153|3850101|P2|NOT COMPLETED|Overall Study||3
1573518|NCT01154153|3850102|P1|NOT COMPLETED|Overall Study||5
1573519|NCT01154153|3850101|P2|COMPLETED|Overall Study||66
1573520|NCT01154153|3850102|P1|COMPLETED|Overall Study||66
1573521|NCT01154153|3850101|P2|STARTED|Overall Study||69
1573522|NCT01154153|3850102|P1|STARTED|Overall Study||71
1573523|NCT01154140|3850120|P2|NOT COMPLETED|Overall Study||102
1573524|NCT01154140|3850121|P1|NOT COMPLETED|Overall Study||91
1573525|NCT01154140|3850120|P2|COMPLETED|Overall Study||69
1573526|NCT01154140|3850121|P1|COMPLETED|Overall Study||81
1573527|NCT01154140|3850120|P2|Treated|Overall Study||169
1573528|NCT01154140|3850121|P1|Treated|Overall Study||171
1573529|NCT01154140|3850120|P2|STARTED|Overall Study||171
1573530|NCT01154140|3850121|P1|STARTED|Overall Study||172
1573531|NCT01154127|3850174|P2|NOT COMPLETED|Period 2 (21 Days)||1
1573532|NCT01154127|3850175|P1|NOT COMPLETED|Period 2 (21 Days)||0
1573533|NCT01154127|3850174|P2|COMPLETED|Period 2 (21 Days)||46
1573534|NCT01154127|3850175|P1|COMPLETED|Period 2 (21 Days)||49
1573535|NCT01154127|3850174|P2|STARTED|Period 2 (21 Days)||47
1573536|NCT01154127|3850175|P1|STARTED|Period 2 (21 Days)||49
1573537|NCT01154127|3850174|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
1573538|NCT01154127|3850175|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
1573539|NCT01154127|3850174|P2|COMPLETED|Washout (14 - 28 Days)||47
1573540|NCT01154127|3850175|P1|COMPLETED|Washout (14 - 28 Days)||49
1573541|NCT01154127|3850174|P2|STARTED|Washout (14 - 28 Days)||47
1573542|NCT01154127|3850175|P1|STARTED|Washout (14 - 28 Days)||52
1573543|NCT01154127|3850174|P2|NOT COMPLETED|Period 1 (21 Days)||6
1573544|NCT01154127|3850175|P1|NOT COMPLETED|Period 1 (21 Days)||3
1573545|NCT01154127|3850174|P2|COMPLETED|Period 1 (21 Days)||47
1573546|NCT01154127|3850175|P1|COMPLETED|Period 1 (21 Days)||52
1573547|NCT01154127|3850174|P2|STARTED|Period 1 (21 Days)||53
1573548|NCT01154127|3850175|P1|STARTED|Period 1 (21 Days)||55
1573549|NCT01154101|3850202|P5|NOT COMPLETED|Overall Study||1
1573550|NCT01154101|3850203|P4|NOT COMPLETED|Overall Study||2
1573551|NCT01154101|3850204|P3|NOT COMPLETED|Overall Study||3
1573552|NCT01154101|3850205|P2|NOT COMPLETED|Overall Study||4
1573553|NCT01154101|3850206|P1|NOT COMPLETED|Overall Study||0
1573554|NCT01154101|3850202|P5|COMPLETED|Overall Study||0
1573555|NCT01154101|3850203|P4|COMPLETED|Overall Study||9
1573556|NCT01154101|3850204|P3|COMPLETED|Overall Study||9
1573557|NCT01154101|3850205|P2|COMPLETED|Overall Study||5
1573558|NCT01154101|3850206|P1|COMPLETED|Overall Study||7
1573559|NCT01154101|3850202|P5|STARTED|Overall Study||1
1573560|NCT01154101|3850203|P4|STARTED|Overall Study||11
1573561|NCT01154101|3850204|P3|STARTED|Overall Study||12
1573562|NCT01154101|3850205|P2|STARTED|Overall Study||9
1573563|NCT01154101|3850206|P1|STARTED|Overall Study||7
1573564|NCT01154088|3850261|P3|NOT COMPLETED|Overall Study||7
1573565|NCT01154088|3850262|P2|NOT COMPLETED|Overall Study||6
1573566|NCT01154088|3850263|P1|NOT COMPLETED|Overall Study||4
1573567|NCT01154088|3850261|P3|COMPLETED|Overall Study||383
1573568|NCT01154088|3850262|P2|COMPLETED|Overall Study||384
1573569|NCT01154088|3850263|P1|COMPLETED|Overall Study||386
1573570|NCT01154088|3850261|P3|STARTED|Overall Study||390
1573571|NCT01154088|3850262|P2|STARTED|Overall Study||390
1573572|NCT01154088|3850263|P1|STARTED|Overall Study||390
1573573|NCT01154036|3850303|P8|NOT COMPLETED|Phase II||6
1573574|NCT01154036|3850304|P7|NOT COMPLETED|Phase II||9
1573575|NCT01154036|3850305|P6|NOT COMPLETED|Phase II||5
1573576|NCT01154036|3850306|P5|NOT COMPLETED|Phase II||8
1573577|NCT01154036|3850307|P4|NOT COMPLETED|Phase II||1
1573578|NCT01154036|3850308|P3|NOT COMPLETED|Phase II||0
1573579|NCT01154036|3850309|P2|NOT COMPLETED|Phase II||0
1573580|NCT01154036|3850310|P1|NOT COMPLETED|Phase II||0
1573581|NCT01154036|3850303|P8|COMPLETED|Phase II||200
1573582|NCT01154036|3850304|P7|COMPLETED|Phase II||225
1573583|NCT01154036|3850305|P6|COMPLETED|Phase II||121
1573584|NCT01154036|3850306|P5|COMPLETED|Phase II||116
1573585|NCT01154036|3850307|P4|COMPLETED|Phase II||27
1573586|NCT01154036|3850308|P3|COMPLETED|Phase II||0
1573587|NCT01154036|3850309|P2|COMPLETED|Phase II||0
1573588|NCT01154036|3850310|P1|COMPLETED|Phase II||0
1573589|NCT01154036|3850303|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
1573590|NCT01154036|3850304|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
1573591|NCT01154036|3850305|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
1573592|NCT01154036|3850306|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
1573593|NCT01154036|3850307|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
1573594|NCT01154036|3850308|P3|STARTED|Phase II||0
1573595|NCT01154036|3850309|P2|STARTED|Phase II||0
1573596|NCT01154036|3850310|P1|STARTED|Phase II||0
1573597|NCT01154036|3850303|P8|NOT COMPLETED|Phase I||0
1573598|NCT01154036|3850304|P7|NOT COMPLETED|Phase I||0
1573599|NCT01154036|3850305|P6|NOT COMPLETED|Phase I||0
1573600|NCT01154036|3850306|P5|NOT COMPLETED|Phase I||0
1573601|NCT01154036|3850307|P4|NOT COMPLETED|Phase I||0
1573602|NCT01154036|3850308|P3|NOT COMPLETED|Phase I||56
1573603|NCT01154036|3850309|P2|NOT COMPLETED|Phase I||28
1573604|NCT01154036|3850310|P1|NOT COMPLETED|Phase I||3
1573605|NCT01154036|3850303|P8|COMPLETED|Phase I||0
1573606|NCT01154036|3850304|P7|COMPLETED|Phase I||0
1573607|NCT01154036|3850305|P6|COMPLETED|Phase I||0
1573608|NCT01154036|3850306|P5|COMPLETED|Phase I||0
1573609|NCT01154036|3850307|P4|COMPLETED|Phase I||0
1573610|NCT01154036|3850308|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
1573611|NCT01154036|3850309|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
1573612|NCT01154036|3850310|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
1573613|NCT01154036|3850303|P8|STARTED|Phase I||0
1573614|NCT01154036|3850304|P7|STARTED|Phase I||0
1573615|NCT01154036|3850305|P6|STARTED|Phase I||0
1573616|NCT01154036|3850306|P5|STARTED|Phase I||0
1573617|NCT01154036|3850307|P4|STARTED|Phase I||0
1573618|NCT01154036|3850308|P3|STARTED|Phase I||944
1573619|NCT01154036|3850309|P2|STARTED|Phase I||483
1573620|NCT01154036|3850310|P1|STARTED|Phase I||120
1573621|NCT01154010|3850434|P2|NOT COMPLETED|Overall Study||1
1573622|NCT01154010|3850435|P1|NOT COMPLETED|Overall Study||0
1573623|NCT01154010|3850434|P2|COMPLETED|Overall Study||8
1573624|NCT01154010|3850435|P1|COMPLETED|Overall Study||9
1573625|NCT01154010|3850434|P2|STARTED|Overall Study||9
1573626|NCT01154010|3850435|P1|STARTED|Overall Study||9
1573627|NCT01153984|3850441|P1|NOT COMPLETED|Overall Study||2
1573628|NCT01153984|3850441|P1|COMPLETED|Overall Study||21
1573629|NCT01153984|3850441|P1|STARTED|Overall Study||23
1573630|NCT01153971|3850452|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
1573631|NCT01153971|3850452|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
1573632|NCT01153971|3850452|P1|STARTED|Follow-up (Months 17-40 of Study)||41
1573633|NCT01153971|3850452|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
1573634|NCT01153971|3850452|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
1573635|NCT01153971|3850452|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
1573636|NCT01153971|3850452|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
1573637|NCT01153971|3850452|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
1573638|NCT01153971|3850452|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
1573639|NCT01153958|3850475|P2|NOT COMPLETED|Overall Study||32
1573640|NCT01153958|3850476|P1|NOT COMPLETED|Overall Study||36
1573641|NCT01153958|3850475|P2|COMPLETED|Overall Study||35
1573642|NCT01153958|3850476|P1|COMPLETED|Overall Study||30
1573643|NCT01153958|3850475|P2|STARTED|Overall Study||67
1573644|NCT01153958|3850476|P1|STARTED|Overall Study||66
1573645|NCT01153893|3850494|P2|NOT COMPLETED|Overall Study||0
1573646|NCT01153893|3850495|P1|NOT COMPLETED|Overall Study||1
1573647|NCT01153893|3850494|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
1573648|NCT01153893|3850495|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
1573649|NCT01153893|3850494|P2|STARTED|Overall Study||36
1573650|NCT01153893|3850495|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
1573651|NCT01153841|3850521|P2|NOT COMPLETED|Overall Study||0
1573652|NCT01153841|3850522|P1|NOT COMPLETED|Overall Study||6
1573653|NCT01153841|3850521|P2|COMPLETED|Overall Study||99
1573654|NCT01153841|3850522|P1|COMPLETED|Overall Study||193
1573655|NCT01153841|3850521|P2|STARTED|Overall Study||99
1573656|NCT01153841|3850522|P1|STARTED|Overall Study||199
1573657|NCT01153815|3850538|P2|NOT COMPLETED|Overall Study||5
1573658|NCT01153815|3850539|P1|NOT COMPLETED|Overall Study||9
1573659|NCT01153815|3850538|P2|COMPLETED|Overall Study||82
1573660|NCT01153815|3850539|P1|COMPLETED|Overall Study||74
1573661|NCT01153815|3850538|P2|STARTED|Overall Study||87
1573662|NCT01153815|3850539|P1|STARTED|Overall Study||83
1573663|NCT01153763|3850561|P1|NOT COMPLETED|Overall Study||21
1573664|NCT01153763|3850561|P1|COMPLETED|Overall Study||71
1573665|NCT01153763|3850561|P1|STARTED|Overall Study||92
1573666|NCT01153724|3850577|P1|NOT COMPLETED|Treatment Period 2||2
1573667|NCT01153724|3850577|P1|COMPLETED|Treatment Period 2||32
1573668|NCT01153724|3850577|P1|STARTED|Treatment Period 2||34
1573669|NCT01153724|3850577|P1|NOT COMPLETED|Treatment Period 1||1
1573670|NCT01153724|3850577|P1|COMPLETED|Treatment Period 1||34
1573671|NCT01153724|3850577|P1|STARTED|Treatment Period 1||35
1573672|NCT01153711|3850597|P1|NOT COMPLETED|Overall Study||0
1573673|NCT01153711|3850597|P1|COMPLETED|Overall Study||32
1573674|NCT01153711|3850597|P1|STARTED|Overall Study||32
1573675|NCT01153698|3850617|P1|NOT COMPLETED|Overall Study||29
1573676|NCT01153698|3850617|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
1573677|NCT01153698|3850617|P1|STARTED|Overall Study|Entered and treated.|168
1573678|NCT01153685|3850633|P2|NOT COMPLETED|Overall Study||0
1573679|NCT01153685|3850634|P1|NOT COMPLETED|Overall Study||0
1573680|NCT01153685|3850633|P2|COMPLETED|Overall Study||70
1573681|NCT01153685|3850634|P1|COMPLETED|Overall Study||50
1573682|NCT01153685|3850633|P2|STARTED|Overall Study||70
1573683|NCT01153685|3850634|P1|STARTED|Overall Study||50
1573684|NCT01153672|3850658|P1|NOT COMPLETED|Overall Study||2
1573685|NCT01153672|3850658|P1|COMPLETED|Overall Study||6
1573686|NCT01153672|3850658|P1|STARTED|Overall Study||8
1573687|NCT01153633|3850668|P2|NOT COMPLETED|Overall Study||4
1573688|NCT01153633|3850669|P1|NOT COMPLETED|Overall Study||4
1573689|NCT01153633|3850668|P2|COMPLETED|Overall Study||13
1573690|NCT01153633|3850669|P1|COMPLETED|Overall Study||13
1573691|NCT01153633|3850668|P2|STARTED|Overall Study||17
1573692|NCT01153633|3850669|P1|STARTED|Overall Study||17
1573693|NCT01153620|3850687|P2|NOT COMPLETED|Overall Study||0
1573694|NCT01153620|3850688|P1|NOT COMPLETED|Overall Study||0
1573695|NCT01153620|3850687|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
1573696|NCT01153620|3850688|P1|COMPLETED|Overall Study||30
1573697|NCT01153620|3850687|P2|STARTED|Overall Study|30 patients (31 wounds)|30
1573698|NCT01153620|3850688|P1|STARTED|Overall Study||30
1573699|NCT01153581|3850694|P1|NOT COMPLETED|Overall Study||0
1573700|NCT01153581|3850694|P1|COMPLETED|Overall Study||109
1573701|NCT01153581|3850694|P1|STARTED|Overall Study||109
1573702|NCT01153503|3850707|P3|NOT COMPLETED|Overall Study||0
1573703|NCT01153503|3850708|P2|NOT COMPLETED|Overall Study||1
1573704|NCT01153503|3850709|P1|NOT COMPLETED|Overall Study||0
1573705|NCT01153503|3850707|P3|COMPLETED|Overall Study||25
1573706|NCT01153503|3850708|P2|COMPLETED|Overall Study||24
1573707|NCT01153503|3850709|P1|COMPLETED|Overall Study||25
1573708|NCT01153503|3850707|P3|STARTED|Overall Study||25
1573709|NCT01153503|3850708|P2|STARTED|Overall Study||25
1573710|NCT01153503|3850709|P1|STARTED|Overall Study||25
1573711|NCT01153425|3850719|P2|NOT COMPLETED|Overall Study||3
1573712|NCT01153425|3850720|P1|NOT COMPLETED|Overall Study||3
1573713|NCT01153425|3850719|P2|COMPLETED|Overall Study||14
1573714|NCT01153425|3850720|P1|COMPLETED|Overall Study||13
1573715|NCT01153425|3850719|P2|STARTED|Overall Study||17
1573716|NCT01153425|3850720|P1|STARTED|Overall Study||16
1573717|NCT01153347|3850732|P4|NOT COMPLETED|Overall Study||32
1573718|NCT01153347|3850733|P3|NOT COMPLETED|Overall Study||50
1573719|NCT01153347|3850734|P2|NOT COMPLETED|Overall Study||44
1573720|NCT01153347|3850735|P1|NOT COMPLETED|Overall Study||33
1573721|NCT01153347|3850732|P4|COMPLETED|Overall Study||129
1573722|NCT01153347|3850733|P3|COMPLETED|Overall Study||110
1573723|NCT01153347|3850734|P2|COMPLETED|Overall Study||116
1573724|NCT01153347|3850735|P1|COMPLETED|Overall Study||127
1573725|NCT01153347|3850732|P4|Received Treatment|Overall Study||160
1573726|NCT01153347|3850733|P3|Received Treatment|Overall Study||158
1573727|NCT01153347|3850734|P2|Received Treatment|Overall Study||158
1573728|NCT01153347|3850735|P1|Received Treatment|Overall Study||160
1573729|NCT01153347|3850732|P4|STARTED|Overall Study||161
1573730|NCT01153347|3850733|P3|STARTED|Overall Study||160
1573731|NCT01153347|3850734|P2|STARTED|Overall Study||160
1573732|NCT01153347|3850735|P1|STARTED|Overall Study||160
1573733|NCT01153321|3850835|P2|NOT COMPLETED|Overall Study||3
1573734|NCT01153321|3850836|P1|NOT COMPLETED|Overall Study||1
1573735|NCT01153321|3850835|P2|COMPLETED|Overall Study||19
1573736|NCT01153321|3850836|P1|COMPLETED|Overall Study||21
1573737|NCT01153321|3850835|P2|STARTED|Overall Study||22
1573738|NCT01153321|3850836|P1|STARTED|Overall Study||22
1573739|NCT01153269|3850948|P1|NOT COMPLETED|Overall Study||2
1573740|NCT01153269|3850948|P1|COMPLETED|Overall Study||31
1573741|NCT01153269|3850948|P1|Participants Analyzed|Overall Study||33
1573742|NCT01153269|3850948|P1|STARTED|Overall Study||33
1573743|NCT01153009|3851011|P4|NOT COMPLETED|Overall Study||37
1573744|NCT01153009|3851012|P3|NOT COMPLETED|Overall Study||41
1573745|NCT01153009|3851013|P2|NOT COMPLETED|Overall Study||34
1573746|NCT01153009|3851014|P1|NOT COMPLETED|Overall Study||32
1573747|NCT01153009|3851011|P4|COMPLETED|Overall Study||115
1573748|NCT01153009|3851012|P3|COMPLETED|Overall Study||113
1573749|NCT01153009|3851013|P2|COMPLETED|Overall Study||113
1573750|NCT01153009|3851014|P1|COMPLETED|Overall Study||129
1573751|NCT01153009|3851011|P4|Treated|Overall Study||150
1573752|NCT01153009|3851012|P3|Treated|Overall Study||154
1573753|NCT01153009|3851013|P2|Treated|Overall Study||147
1573754|NCT01153009|3851014|P1|Treated|Overall Study||159
1573755|NCT01153009|3851011|P4|STARTED|Overall Study||152
1573756|NCT01153009|3851012|P3|STARTED|Overall Study||154
1573757|NCT01153009|3851013|P2|STARTED|Overall Study||147
1573758|NCT01153009|3851014|P1|STARTED|Overall Study||161
1573759|NCT01152996|3851044|P1|NOT COMPLETED|Overall Study||537
1573760|NCT01152996|3851044|P1|COMPLETED|Overall Study||538
1573761|NCT01152996|3851044|P1|Treated|Overall Study||1073
1573762|NCT01152996|3851044|P1|STARTED|Overall Study||1075
1573763|NCT01152814|3851057|P1|NOT COMPLETED|Overall Study||2
1573764|NCT01152814|3851057|P1|COMPLETED|Overall Study||62
1573765|NCT01152814|3851057|P1|STARTED|Overall Study||64
1573766|NCT01152788|3851066|P2|NOT COMPLETED|Overall Study||4
1573767|NCT01152788|3851067|P1|NOT COMPLETED|Overall Study||0
1573768|NCT01152788|3851066|P2|COMPLETED|Overall Study||28
1573769|NCT01152788|3851067|P1|COMPLETED|Overall Study||32
1573770|NCT01152788|3851066|P2|STARTED|Overall Study||32
1573771|NCT01152788|3851067|P1|STARTED|Overall Study||32
1573772|NCT01152697|3851079|P1|NOT COMPLETED|Overall Study||19
1573773|NCT01152697|3851079|P1|COMPLETED|Overall Study||11
1573774|NCT01152697|3851079|P1|STARTED|Overall Study||30
1573775|NCT01152580|3851104|P2|NOT COMPLETED|Overall Study||1
1573776|NCT01152580|3851105|P1|NOT COMPLETED|Overall Study||0
1573777|NCT01152580|3851104|P2|COMPLETED|Overall Study||13
1573778|NCT01152580|3851105|P1|COMPLETED|Overall Study||5
1573779|NCT01152580|3851104|P2|STARTED|Overall Study||14
1573780|NCT01152580|3851105|P1|STARTED|Overall Study||5
1573781|NCT01152554|3851127|P2|NOT COMPLETED|Overall Study||111
1573782|NCT01152554|3851128|P1|NOT COMPLETED|Overall Study||334
1573783|NCT01152554|3851127|P2|COMPLETED|Overall Study||92
1573784|NCT01152554|3851128|P1|COMPLETED|Overall Study||276
1573785|NCT01152554|3851127|P2|Received Treatment|Overall Study||201
1573786|NCT01152554|3851128|P1|Received Treatment|Overall Study||607
1573787|NCT01152554|3851127|P2|STARTED|Overall Study||203
1573788|NCT01152554|3851128|P1|STARTED|Overall Study||610
1573789|NCT01152450|3851150|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
1573790|NCT01152450|3851151|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
1573791|NCT01152450|3851152|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
1573792|NCT01152450|3851153|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
1573793|NCT01152450|3851154|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
1573794|NCT01152450|3851155|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
1573795|NCT01152450|3851150|P6|COMPLETED|Period 3 (4 Weeks)||12
1573796|NCT01152450|3851151|P5|COMPLETED|Period 3 (4 Weeks)||16
1573797|NCT01152450|3851152|P4|COMPLETED|Period 3 (4 Weeks)||15
1573798|NCT01152450|3851153|P3|COMPLETED|Period 3 (4 Weeks)||16
1573799|NCT01152450|3851154|P2|COMPLETED|Period 3 (4 Weeks)||15
1573800|NCT01152450|3851155|P1|COMPLETED|Period 3 (4 Weeks)||15
1573801|NCT01152450|3851150|P6|STARTED|Period 3 (4 Weeks)||12
1573802|NCT01152450|3851151|P5|STARTED|Period 3 (4 Weeks)||16
1573803|NCT01152450|3851152|P4|STARTED|Period 3 (4 Weeks)||15
1573804|NCT01152450|3851153|P3|STARTED|Period 3 (4 Weeks)||16
1573805|NCT01152450|3851154|P2|STARTED|Period 3 (4 Weeks)||15
1573806|NCT01152450|3851155|P1|STARTED|Period 3 (4 Weeks)||15
1573807|NCT01152450|3851150|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
1573808|NCT01152450|3851151|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
1573809|NCT01152450|3851152|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
1573810|NCT01152450|3851153|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
1573811|NCT01152450|3851154|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
1573812|NCT01152450|3851155|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
1573813|NCT01152450|3851150|P6|COMPLETED|Period 2 (4 Weeks)||12
1573814|NCT01152450|3851151|P5|COMPLETED|Period 2 (4 Weeks)||16
1573815|NCT01152450|3851152|P4|COMPLETED|Period 2 (4 Weeks)||15
1573816|NCT01152450|3851153|P3|COMPLETED|Period 2 (4 Weeks)||16
1573817|NCT01152450|3851154|P2|COMPLETED|Period 2 (4 Weeks)||15
1573818|NCT01152450|3851155|P1|COMPLETED|Period 2 (4 Weeks)||15
1573819|NCT01152450|3851150|P6|STARTED|Period 2 (4 Weeks)||12
1573820|NCT01152450|3851151|P5|STARTED|Period 2 (4 Weeks)||16
1573821|NCT01152450|3851152|P4|STARTED|Period 2 (4 Weeks)||15
1573822|NCT01152450|3851153|P3|STARTED|Period 2 (4 Weeks)||16
1573823|NCT01152450|3851154|P2|STARTED|Period 2 (4 Weeks)||15
1573824|NCT01152450|3851155|P1|STARTED|Period 2 (4 Weeks)||15
1573825|NCT01152450|3851150|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
1573826|NCT01152450|3851151|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
1573827|NCT01152450|3851152|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
1573828|NCT01152450|3851153|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
1573829|NCT01152450|3851154|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
1573830|NCT01152450|3851155|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
1573831|NCT01152450|3851150|P6|COMPLETED|Period 1 (4 Weeks)||12
1573832|NCT01152450|3851151|P5|COMPLETED|Period 1 (4 Weeks)||16
1573833|NCT01152450|3851152|P4|COMPLETED|Period 1 (4 Weeks)||15
1573834|NCT01152450|3851153|P3|COMPLETED|Period 1 (4 Weeks)||16
1573835|NCT01152450|3851154|P2|COMPLETED|Period 1 (4 Weeks)||15
1573836|NCT01152450|3851155|P1|COMPLETED|Period 1 (4 Weeks)||15
1573837|NCT01152450|3851150|P6|STARTED|Period 1 (4 Weeks)||13
1573838|NCT01152450|3851151|P5|STARTED|Period 1 (4 Weeks)||18
1573839|NCT01152450|3851152|P4|STARTED|Period 1 (4 Weeks)||15
1573840|NCT01152450|3851153|P3|STARTED|Period 1 (4 Weeks)||17
1573841|NCT01152450|3851154|P2|STARTED|Period 1 (4 Weeks)||16
1573842|NCT01152450|3851155|P1|STARTED|Period 1 (4 Weeks)||15
1573843|NCT01152437|3851226|P3|NOT COMPLETED|Overall Study||43
1573844|NCT01152437|3851227|P2|NOT COMPLETED|Overall Study||15
1573845|NCT01152437|3851228|P1|NOT COMPLETED|Overall Study||36
1573846|NCT01152437|3851226|P3|COMPLETED|Overall Study||0
1573847|NCT01152437|3851227|P2|COMPLETED|Overall Study||0
1573848|NCT01152437|3851228|P1|COMPLETED|Overall Study||0
1573849|NCT01152437|3851226|P3|STARTED|Overall Study|entered|43
1573850|NCT01152437|3851227|P2|STARTED|Overall Study|randomised|15
1573851|NCT01152437|3851228|P1|STARTED|Overall Study|randomised|36
1573852|NCT01152385|3851248|P4|NOT COMPLETED|Overall Study||5
1573853|NCT01152385|3851249|P3|NOT COMPLETED|Overall Study||5
1573854|NCT01152385|3851250|P2|NOT COMPLETED|Overall Study||6
1573855|NCT01152385|3851251|P1|NOT COMPLETED|Overall Study||9
1573856|NCT01152385|3851248|P4|COMPLETED|Overall Study||50
1573857|NCT01152385|3851249|P3|COMPLETED|Overall Study||51
1573858|NCT01152385|3851250|P2|COMPLETED|Overall Study||52
1573859|NCT01152385|3851251|P1|COMPLETED|Overall Study||46
1573860|NCT01152385|3851248|P4|STARTED|Overall Study||55
1573861|NCT01152385|3851249|P3|STARTED|Overall Study||56
1573862|NCT01152385|3851250|P2|STARTED|Overall Study||58
1573863|NCT01152385|3851251|P1|STARTED|Overall Study||55
1573864|NCT01152359|3851291|P2|NOT COMPLETED|Overall Study||22
1573865|NCT01152359|3851292|P1|NOT COMPLETED|Overall Study||24
1573866|NCT01152359|3851291|P2|COMPLETED|Overall Study||80
1573867|NCT01152359|3851292|P1|COMPLETED|Overall Study||81
1573868|NCT01152359|3851291|P2|STARTED|Overall Study||102
1573869|NCT01152359|3851292|P1|STARTED|Overall Study||105
1573870|NCT01152307|3851300|P2|NOT COMPLETED|Overall Study||0
1573871|NCT01152307|3851301|P1|NOT COMPLETED|Overall Study||0
1573872|NCT01152307|3851300|P2|COMPLETED|Overall Study||214
1573873|NCT01152307|3851301|P1|COMPLETED|Overall Study||191
1573874|NCT01152307|3851300|P2|STARTED|Overall Study||214
1573875|NCT01152307|3851301|P1|STARTED|Overall Study||191
1573876|NCT01152294|3851309|P2|NOT COMPLETED|Overall Study||0
1573877|NCT01152294|3851310|P1|NOT COMPLETED|Overall Study||0
1573878|NCT01152294|3851309|P2|COMPLETED|Overall Study||188
1573879|NCT01152294|3851310|P1|COMPLETED|Overall Study||213
1573880|NCT01152294|3851309|P2|STARTED|Overall Study||188
1573881|NCT01152294|3851310|P1|STARTED|Overall Study||213
1573882|NCT01152190|3851318|P2|NOT COMPLETED|Overall Study||8
1573883|NCT01152190|3851319|P1|NOT COMPLETED|Overall Study||5
1573884|NCT01152190|3851318|P2|COMPLETED|Overall Study||39
1573885|NCT01152190|3851319|P1|COMPLETED|Overall Study||45
1573886|NCT01152190|3851318|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
1573887|NCT01152190|3851319|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
1573888|NCT01152190|3851318|P2|STARTED|Overall Study||47
1573889|NCT01152190|3851319|P1|STARTED|Overall Study||50
1573890|NCT01152112|3851333|P2|NOT COMPLETED|Overall Study||0
1573891|NCT01152112|3851334|P1|NOT COMPLETED|Overall Study||0
1573892|NCT01152112|3851333|P2|COMPLETED|Overall Study||32
1573893|NCT01152112|3851334|P1|COMPLETED|Overall Study||42
1573894|NCT01152112|3851333|P2|STARTED|Overall Study||32
1573895|NCT01152112|3851334|P1|STARTED|Overall Study||42
1573896|NCT01151904|3851340|P1|NOT COMPLETED|Overall Study||0
1573897|NCT01151904|3851340|P1|COMPLETED|Overall Study||17
1573898|NCT01151904|3851340|P1|STARTED|Overall Study||17
1573899|NCT01151852|3851348|P2|NOT COMPLETED|Overall Study||0
1573900|NCT01151852|3851349|P1|NOT COMPLETED|Overall Study||0
1573901|NCT01151852|3851348|P2|COMPLETED|Overall Study||40
1573902|NCT01151852|3851349|P1|COMPLETED|Overall Study||41
1573903|NCT01151852|3851348|P2|STARTED|Overall Study||40
1573904|NCT01151852|3851349|P1|STARTED|Overall Study||41
1573905|NCT01151761|3851365|P1|NOT COMPLETED|Overall Study||0
1573906|NCT01151761|3851365|P1|COMPLETED|Overall Study||2
1573907|NCT01151761|3851365|P1|STARTED|Overall Study||2
1573908|NCT01151579|3851378|P2|NOT COMPLETED|Overall Study||7
1573909|NCT01151579|3851379|P1|NOT COMPLETED|Overall Study||12
1573910|NCT01151579|3851378|P2|COMPLETED|Overall Study||24
1573911|NCT01151579|3851379|P1|COMPLETED|Overall Study||46
1573912|NCT01151579|3851378|P2|STARTED|Overall Study||31
1573913|NCT01151579|3851379|P1|STARTED|Overall Study||58
1573914|NCT01151553|3851389|P1|NOT COMPLETED|Overall Study||0
1573915|NCT01151553|3851389|P1|COMPLETED|Overall Study||5
1573916|NCT01151553|3851389|P1|STARTED|Overall Study||5
1573917|NCT01151449|3851393|P1|NOT COMPLETED|Overall Study||0
1573918|NCT01151449|3851393|P1|COMPLETED|Overall Study||6
1573919|NCT01151449|3851393|P1|STARTED|Overall Study||6
1573920|NCT01151436|3851401|P1|NOT COMPLETED|Overall Study||1
1573921|NCT01151436|3851401|P1|COMPLETED|Overall Study||76
1573922|NCT01151436|3851401|P1|STARTED|Overall Study||77
1573923|NCT01151410|3851433|P2|NOT COMPLETED|Overall Study||15
1573924|NCT01151410|3851434|P1|NOT COMPLETED|Overall Study||11
1573925|NCT01151410|3851433|P2|COMPLETED|Overall Study||89
1573926|NCT01151410|3851434|P1|COMPLETED|Overall Study||93
1573927|NCT01151410|3851433|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
1573928|NCT01151410|3851434|P1|Safety Set (SAF)|Overall Study||105
1573929|NCT01151410|3851433|P2|STARTED|Overall Study||104
1573930|NCT01151410|3851434|P1|STARTED|Overall Study||104
1573931|NCT01151371|3851447|P3|NOT COMPLETED|Overall Study||7
1573932|NCT01151371|3851448|P2|NOT COMPLETED|Overall Study||1
1573933|NCT01151371|3851449|P1|NOT COMPLETED|Overall Study||5
1573934|NCT01151371|3851447|P3|COMPLETED|Overall Study||146
1573935|NCT01151371|3851448|P2|COMPLETED|Overall Study||149
1573936|NCT01151371|3851449|P1|COMPLETED|Overall Study||144
1573937|NCT01151371|3851447|P3|STARTED|Overall Study||153
1573938|NCT01151371|3851448|P2|STARTED|Overall Study||150
1573939|NCT01151371|3851449|P1|STARTED|Overall Study||149
1573940|NCT01151345|3851478|P2|NOT COMPLETED|Second Intervention Period||0
1573941|NCT01151345|3851479|P1|NOT COMPLETED|Second Intervention Period||0
1573942|NCT01151345|3851478|P2|COMPLETED|Second Intervention Period||12
1573943|NCT01151345|3851479|P1|COMPLETED|Second Intervention Period||13
1573944|NCT01151345|3851478|P2|STARTED|Second Intervention Period||12
1573945|NCT01151345|3851479|P1|STARTED|Second Intervention Period||13
1573946|NCT01151345|3851478|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
1573947|NCT01151345|3851479|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
1573948|NCT01151345|3851478|P2|COMPLETED|Wash-out Period (7 Days)||12
1573949|NCT01151345|3851479|P1|COMPLETED|Wash-out Period (7 Days)||13
1573950|NCT01151345|3851478|P2|STARTED|Wash-out Period (7 Days)||12
1573951|NCT01151345|3851479|P1|STARTED|Wash-out Period (7 Days)||13
1573952|NCT01151345|3851478|P2|NOT COMPLETED|First Intervention Period||1
1573953|NCT01151345|3851479|P1|NOT COMPLETED|First Intervention Period||0
1573954|NCT01151345|3851478|P2|COMPLETED|First Intervention Period||12
1573955|NCT01151345|3851479|P1|COMPLETED|First Intervention Period||13
1573956|NCT01151345|3851478|P2|Treated|First Intervention Period||12
1573957|NCT01151345|3851479|P1|Treated|First Intervention Period||13
1573958|NCT01151345|3851478|P2|STARTED|First Intervention Period||13
1573959|NCT01151345|3851479|P1|STARTED|First Intervention Period||13
1573960|NCT01151280|3851493|P1|NOT COMPLETED|Overall Study||4
1573961|NCT01151280|3851493|P1|COMPLETED|Overall Study||6
1573962|NCT01151280|3851493|P1|STARTED|Overall Study||10
1573963|NCT01151215|3851506|P3|NOT COMPLETED|Overall Study||19
1573964|NCT01151215|3851507|P2|NOT COMPLETED|Overall Study||23
1573965|NCT01151215|3851508|P1|NOT COMPLETED|Overall Study||20
1573966|NCT01151215|3851506|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
1573967|NCT01151215|3851507|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
1573968|NCT01151215|3851508|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
1573969|NCT01151215|3851506|P3|STARTED|Overall Study||121
1573970|NCT01151215|3851507|P2|STARTED|Overall Study||118
1573971|NCT01151215|3851508|P1|STARTED|Overall Study||120
1573972|NCT01151189|3851521|P2|NOT COMPLETED|Overall Study||10
1573973|NCT01151189|3851522|P1|NOT COMPLETED|Overall Study||15
1573974|NCT01151189|3851521|P2|COMPLETED|Overall Study||314
1573975|NCT01151189|3851522|P1|COMPLETED|Overall Study||311
1573976|NCT01151189|3851521|P2|Received Vaccine|Overall Study||324
1573977|NCT01151189|3851522|P1|Received Vaccine|Overall Study||325
1573978|NCT01151189|3851521|P2|STARTED|Overall Study||324
1573979|NCT01151189|3851522|P1|STARTED|Overall Study||326
1573980|NCT01151137|3851546|P2|NOT COMPLETED|Overall Study||28
1573981|NCT01151137|3851547|P1|NOT COMPLETED|Overall Study||16
1573982|NCT01151137|3851546|P2|COMPLETED|Overall Study||1591
1573983|NCT01151137|3851547|P1|COMPLETED|Overall Study||1601
1573984|NCT01151137|3851546|P2|Discontinued Treatment|Overall Study||342
1573985|NCT01151137|3851547|P1|Discontinued Treatment|Overall Study||171
1573986|NCT01151137|3851546|P2|Treated|Overall Study||1613
1573987|NCT01151137|3851547|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
1573988|NCT01151137|3851546|P2|STARTED|Overall Study||1619
1573989|NCT01151137|3851547|P1|STARTED|Overall Study||1617
1573990|NCT01151098|3851565|P1|NOT COMPLETED|Overall Study||117
1573991|NCT01151098|3851565|P1|COMPLETED|Overall Study||72
1573992|NCT01151098|3851565|P1|STARTED|Overall Study|Extension Safety Population|189
1573993|NCT01151085|3851569|P1|NOT COMPLETED|Overall Study||56
1573994|NCT01151085|3851569|P1|COMPLETED|Overall Study||946
1573995|NCT01151085|3851569|P1|STARTED|Overall Study||1002
1573996|NCT01151046|3851587|P2|NOT COMPLETED|Overall Study||0
1573997|NCT01151046|3851588|P1|NOT COMPLETED|Overall Study||3
1573998|NCT01151046|3851587|P2|COMPLETED|Overall Study||59
1573999|NCT01151046|3851588|P1|COMPLETED|Overall Study||56
1574000|NCT01151046|3851587|P2|STARTED|Overall Study||59
1574001|NCT01151046|3851588|P1|STARTED|Overall Study||59
1574002|NCT01151020|3851600|P1|NOT COMPLETED|Overall Study||110
1574003|NCT01151020|3851600|P1|COMPLETED|Overall Study||0
1574004|NCT01151020|3851600|P1|12-month|Overall Study||99
1574005|NCT01151020|3851600|P1|30-day|Overall Study||110
1574006|NCT01151020|3851600|P1|STARTED|Overall Study||110
1574007|NCT01150981|3851607|P2|NOT COMPLETED|Overall Study||2
1574008|NCT01150981|3851608|P1|NOT COMPLETED|Overall Study||4
1574009|NCT01150981|3851607|P2|COMPLETED|Overall Study||13
1574010|NCT01150981|3851608|P1|COMPLETED|Overall Study||16
1574011|NCT01150981|3851607|P2|STARTED|Overall Study||15
1574012|NCT01150981|3851608|P1|STARTED|Overall Study||20
1574013|NCT01150903|3851618|P2|NOT COMPLETED|Overall Study||0
1574014|NCT01150903|3851619|P1|NOT COMPLETED|Overall Study||0
1574015|NCT01150903|3851618|P2|COMPLETED|Overall Study||74124
1574016|NCT01150903|3851619|P1|COMPLETED|Overall Study||24708
1574017|NCT01150903|3851618|P2|STARTED|Overall Study||74124
1574018|NCT01150903|3851619|P1|STARTED|Overall Study||24708
1574019|NCT01150760|3851635|P2|NOT COMPLETED|Overall Study||0
1574020|NCT01150760|3851636|P1|NOT COMPLETED|Overall Study||0
1574021|NCT01150760|3851635|P2|COMPLETED|Overall Study||3525
1574022|NCT01150760|3851636|P1|COMPLETED|Overall Study||3525
1574023|NCT01150760|3851635|P2|STARTED|Overall Study||3525
1574024|NCT01150760|3851636|P1|STARTED|Overall Study||3525
1574025|NCT01150500|3851668|P1|NOT COMPLETED|Overall Study||65
1574026|NCT01150500|3851668|P1|COMPLETED|Overall Study||0
1574027|NCT01150500|3851668|P1|STARTED|Overall Study||65
1574028|NCT01150474|3851679|P2|NOT COMPLETED|Overall Study||3
1574029|NCT01150474|3851680|P1|NOT COMPLETED|Overall Study||10
1574030|NCT01150474|3851679|P2|COMPLETED|Overall Study||49
1574031|NCT01150474|3851680|P1|COMPLETED|Overall Study||41
1574032|NCT01150474|3851679|P2|STARTED|Overall Study||52
1574033|NCT01150474|3851680|P1|STARTED|Overall Study||51
1574034|NCT01150461|3851704|P2|NOT COMPLETED|Overall Study||0
1574035|NCT01150461|3851705|P1|NOT COMPLETED|Overall Study||0
1574036|NCT01150461|3851704|P2|COMPLETED|Overall Study||9
1574037|NCT01150461|3851705|P1|COMPLETED|Overall Study||11
1574038|NCT01150461|3851704|P2|STARTED|Overall Study||9
1574039|NCT01150461|3851705|P1|STARTED|Overall Study||11
1574040|NCT01150409|3851715|P2|NOT COMPLETED|Overall Study||0
1574041|NCT01150409|3851716|P1|NOT COMPLETED|Overall Study||0
1574042|NCT01150409|3851715|P2|COMPLETED|Overall Study||0
1574043|NCT01150409|3851716|P1|COMPLETED|Overall Study||11
1574044|NCT01150409|3851715|P2|STARTED|Overall Study||0
1574045|NCT01150409|3851716|P1|STARTED|Overall Study||11
1574046|NCT01150357|3851725|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
1574047|NCT01150357|3851726|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
1574048|NCT01150357|3851727|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
1574049|NCT01150357|3851725|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
1574050|NCT01150357|3851726|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
1574051|NCT01150357|3851727|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
1574052|NCT01150357|3851725|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
1574053|NCT01150357|3851726|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
1574054|NCT01150357|3851727|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
1574055|NCT01150357|3851725|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
1574056|NCT01150357|3851726|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
1574057|NCT01150357|3851727|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
1574058|NCT01150357|3851725|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
1574059|NCT01150357|3851726|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
1574060|NCT01150357|3851727|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
1574061|NCT01150357|3851725|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
1574062|NCT01150357|3851726|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
1574063|NCT01150357|3851727|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
1574064|NCT01150357|3851725|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
1574065|NCT01150357|3851726|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
1574066|NCT01150357|3851727|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
1574067|NCT01150357|3851725|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
1574068|NCT01150357|3851726|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
1574069|NCT01150357|3851727|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
1574070|NCT01150357|3851725|P3|COMPLETED|Dose Response Phase (Phase 1)||102
1574071|NCT01150357|3851726|P2|COMPLETED|Dose Response Phase (Phase 1)||51
1574072|NCT01150357|3851727|P1|COMPLETED|Dose Response Phase (Phase 1)||107
1574073|NCT01150357|3851725|P3|STARTED|Dose Response Phase (Phase 1)||105
1574074|NCT01150357|3851726|P2|STARTED|Dose Response Phase (Phase 1)||54
1574075|NCT01150357|3851727|P1|STARTED|Dose Response Phase (Phase 1)||108
1574076|NCT01150123|3851807|P18|NOT COMPLETED|Overall Study||1
1574077|NCT01150123|3851808|P17|NOT COMPLETED|Overall Study||0
1574078|NCT01150123|3851809|P16|NOT COMPLETED|Overall Study||1
1574079|NCT01150123|3851810|P15|NOT COMPLETED|Overall Study||0
1574080|NCT01150123|3851811|P14|NOT COMPLETED|Overall Study||0
1574081|NCT01150123|3851812|P13|NOT COMPLETED|Overall Study||3
1574082|NCT01150123|3851813|P12|NOT COMPLETED|Overall Study||1
1574083|NCT01150123|3851814|P11|NOT COMPLETED|Overall Study||2
1574084|NCT01150123|3851815|P10|NOT COMPLETED|Overall Study||1
1574085|NCT01150123|3851816|P9|NOT COMPLETED|Overall Study||5
1574086|NCT01150123|3851817|P8|NOT COMPLETED|Overall Study||3
1574087|NCT01150123|3851818|P7|NOT COMPLETED|Overall Study||0
1574088|NCT01150123|3851819|P6|NOT COMPLETED|Overall Study||6
1574089|NCT01150123|3851820|P5|NOT COMPLETED|Overall Study||3
1574090|NCT01150123|3851821|P4|NOT COMPLETED|Overall Study||3
1574091|NCT01150123|3851822|P3|NOT COMPLETED|Overall Study||4
1574092|NCT01150123|3851823|P2|NOT COMPLETED|Overall Study||2
1574093|NCT01150123|3851824|P1|NOT COMPLETED|Overall Study||3
1574094|NCT01150123|3851807|P18|COMPLETED|Overall Study||19
1574095|NCT01150123|3851808|P17|COMPLETED|Overall Study||40
1574096|NCT01150123|3851809|P16|COMPLETED|Overall Study||39
1574097|NCT01150123|3851810|P15|COMPLETED|Overall Study||40
1574098|NCT01150123|3851811|P14|COMPLETED|Overall Study||40
1574099|NCT01150123|3851812|P13|COMPLETED|Overall Study||37
1574100|NCT01150123|3851813|P12|COMPLETED|Overall Study||39
1574101|NCT01150123|3851814|P11|COMPLETED|Overall Study||38
1574102|NCT01150123|3851815|P10|COMPLETED|Overall Study||39
1574103|NCT01150123|3851816|P9|COMPLETED|Overall Study||15
1574104|NCT01150123|3851817|P8|COMPLETED|Overall Study||37
1574105|NCT01150123|3851818|P7|COMPLETED|Overall Study||39
1574106|NCT01150123|3851819|P6|COMPLETED|Overall Study||34
1574107|NCT01150123|3851820|P5|COMPLETED|Overall Study||37
1574108|NCT01150123|3851821|P4|COMPLETED|Overall Study||37
1574109|NCT01150123|3851822|P3|COMPLETED|Overall Study||35
1574110|NCT01150123|3851823|P2|COMPLETED|Overall Study||38
1574111|NCT01150123|3851824|P1|COMPLETED|Overall Study||37
1574112|NCT01150123|3851807|P18|STARTED|Overall Study||20
1574113|NCT01150123|3851808|P17|STARTED|Overall Study||40
1574114|NCT01150123|3851809|P16|STARTED|Overall Study||40
1574115|NCT01150123|3851810|P15|STARTED|Overall Study||40
1574116|NCT01150123|3851811|P14|STARTED|Overall Study||40
1574117|NCT01150123|3851812|P13|STARTED|Overall Study||40
1574118|NCT01150123|3851813|P12|STARTED|Overall Study||40
1574119|NCT01150123|3851814|P11|STARTED|Overall Study||40
1574120|NCT01150123|3851815|P10|STARTED|Overall Study||40
1574121|NCT01150123|3851816|P9|STARTED|Overall Study||20
1574122|NCT01150123|3851817|P8|STARTED|Overall Study||40
1574123|NCT01150123|3851818|P7|STARTED|Overall Study||39
1574124|NCT01150123|3851819|P6|STARTED|Overall Study||40
1574125|NCT01150123|3851820|P5|STARTED|Overall Study||40
1574126|NCT01150123|3851821|P4|STARTED|Overall Study||40
1574127|NCT01150123|3851822|P3|STARTED|Overall Study||39
1574128|NCT01150123|3851823|P2|STARTED|Overall Study||40
1574129|NCT01150123|3851824|P1|STARTED|Overall Study||40
1574130|NCT01150097|3852000|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
1574131|NCT01150097|3852001|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
1574132|NCT01150097|3852002|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
1574133|NCT01150097|3852000|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
1574134|NCT01150097|3852001|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
1574135|NCT01150097|3852002|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
1574136|NCT01150097|3852000|P3|STARTED|Months 24 to 48 Post-transplantation||0
1574137|NCT01150097|3852001|P2|STARTED|Months 24 to 48 Post-transplantation||51
1574138|NCT01150097|3852002|P1|STARTED|Months 24 to 48 Post-transplantation||106
1574139|NCT01150097|3852000|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
1574140|NCT01150097|3852001|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
1574141|NCT01150097|3852002|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
1574142|NCT01150097|3852000|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
1574143|NCT01150097|3852001|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
1574144|NCT01150097|3852002|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
1574145|NCT01150097|3852000|P3|STARTED|Months 24 to 36 Post-transplantation||125
1574146|NCT01150097|3852001|P2|STARTED|Months 24 to 36 Post-transplantation||51
1574147|NCT01150097|3852002|P1|STARTED|Months 24 to 36 Post-transplantation||106
1574148|NCT01149876|3852029|P4|NOT COMPLETED|Overall Study||0
1574149|NCT01149876|3852030|P3|NOT COMPLETED|Overall Study||1
1574150|NCT01149876|3852031|P2|NOT COMPLETED|Overall Study||0
1574151|NCT01149876|3852032|P1|NOT COMPLETED|Overall Study||1
1574152|NCT01149876|3852029|P4|COMPLETED|Overall Study||18
1574153|NCT01149876|3852030|P3|COMPLETED|Overall Study||20
1574154|NCT01149876|3852031|P2|COMPLETED|Overall Study||20
1574155|NCT01149876|3852032|P1|COMPLETED|Overall Study||20
1574156|NCT01149876|3852029|P4|STARTED|Overall Study||18
1574157|NCT01149876|3852030|P3|STARTED|Overall Study||21
1574158|NCT01149876|3852031|P2|STARTED|Overall Study||20
1574159|NCT01149876|3852032|P1|STARTED|Overall Study||21
1574160|NCT01149863|3852046|P1|NOT COMPLETED|Overall Study||3
1574161|NCT01149863|3852046|P1|COMPLETED|Overall Study||31
1574162|NCT01149863|3852046|P1|STARTED|Overall Study||34
1574163|NCT01149785|3852051|P2|NOT COMPLETED|Second Intervention||0
1574164|NCT01149785|3852052|P1|NOT COMPLETED|Second Intervention||0
1574165|NCT01149785|3852051|P2|COMPLETED|Second Intervention||15
1574166|NCT01149785|3852052|P1|COMPLETED|Second Intervention||0
1574167|NCT01149785|3852051|P2|STARTED|Second Intervention||15
1574168|NCT01149785|3852052|P1|STARTED|Second Intervention||0
1574169|NCT01149785|3852051|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
1574170|NCT01149785|3852052|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
1574171|NCT01149785|3852051|P2|COMPLETED|Washout Period of at Least 14 Days||0
1574172|NCT01149785|3852052|P1|COMPLETED|Washout Period of at Least 14 Days||15
1574173|NCT01149785|3852051|P2|STARTED|Washout Period of at Least 14 Days||0
1574174|NCT01149785|3852052|P1|STARTED|Washout Period of at Least 14 Days||15
1574175|NCT01149785|3852051|P2|NOT COMPLETED|First Intervention||0
1574176|NCT01149785|3852052|P1|NOT COMPLETED|First Intervention||0
1574177|NCT01149785|3852051|P2|COMPLETED|First Intervention||0
1574178|NCT01149785|3852052|P1|COMPLETED|First Intervention||15
1574179|NCT01149785|3852051|P2|STARTED|First Intervention||0
1574180|NCT01149785|3852052|P1|STARTED|First Intervention||15
1574181|NCT01149772|3852086|P2|NOT COMPLETED|Overall Study||21
1574182|NCT01149772|3852087|P1|NOT COMPLETED|Overall Study||48
1574183|NCT01149772|3852086|P2|COMPLETED|Overall Study||101
1574184|NCT01149772|3852087|P1|COMPLETED|Overall Study||132
1574185|NCT01149772|3852086|P2|STARTED|Overall Study||122
1574186|NCT01149772|3852087|P1|STARTED|Overall Study||180
1574187|NCT01149759|3852103|P1|NOT COMPLETED|Overall Study||0
1574188|NCT01149759|3852103|P1|COMPLETED|Overall Study||9
1574189|NCT01149759|3852103|P1|STARTED|Overall Study||9
1574190|NCT01149733|3852110|P2|NOT COMPLETED|Overall Study||0
1574191|NCT01149733|3852111|P1|NOT COMPLETED|Overall Study||0
1574192|NCT01149733|3852110|P2|COMPLETED|Overall Study||16
1574193|NCT01149733|3852111|P1|COMPLETED|Overall Study||16
1574194|NCT01149733|3852110|P2|STARTED|Overall Study||16
1574195|NCT01149733|3852111|P1|STARTED|Overall Study||16
1574196|NCT01149655|3852123|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
1574197|NCT01149655|3852124|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
1574198|NCT01149655|3852125|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
1574199|NCT01149655|3852126|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
1574200|NCT01149655|3852123|P4|COMPLETED|Period 3-DB Maintenance Phase||6
1574201|NCT01149655|3852124|P3|COMPLETED|Period 3-DB Maintenance Phase||15
1574202|NCT01149655|3852125|P2|COMPLETED|Period 3-DB Maintenance Phase||0
1574203|NCT01149655|3852126|P1|COMPLETED|Period 3-DB Maintenance Phase||0
1574204|NCT01149655|3852123|P4|STARTED|Period 3-DB Maintenance Phase||48
1574205|NCT01149655|3852124|P3|STARTED|Period 3-DB Maintenance Phase||98
1574206|NCT01149655|3852125|P2|STARTED|Period 3-DB Maintenance Phase||0
1574207|NCT01149655|3852126|P1|STARTED|Period 3-DB Maintenance Phase||0
1574208|NCT01149655|3852123|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
1574209|NCT01149655|3852124|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
1574210|NCT01149655|3852125|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
1574211|NCT01149655|3852126|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
1574212|NCT01149655|3852123|P4|COMPLETED|Period 2-Stabilization Phase||0
1574213|NCT01149655|3852124|P3|COMPLETED|Period 2-Stabilization Phase||0
1574214|NCT01149655|3852125|P2|COMPLETED|Period 2-Stabilization Phase||146
1574215|NCT01149655|3852126|P1|COMPLETED|Period 2-Stabilization Phase||0
1574216|NCT01149655|3852123|P4|STARTED|Period 2-Stabilization Phase||0
1574217|NCT01149655|3852124|P3|STARTED|Period 2-Stabilization Phase||0
1574218|NCT01149655|3852125|P2|STARTED|Period 2-Stabilization Phase||183
1574219|NCT01149655|3852126|P1|STARTED|Period 2-Stabilization Phase||0
1574220|NCT01149655|3852123|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
1574221|NCT01149655|3852124|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
1574222|NCT01149655|3852125|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
1574223|NCT01149655|3852126|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
1574224|NCT01149655|3852123|P4|COMPLETED|Period 1 - Conversion Phase||0
1574225|NCT01149655|3852124|P3|COMPLETED|Period 1 - Conversion Phase||0
1574226|NCT01149655|3852125|P2|COMPLETED|Period 1 - Conversion Phase||0
1574227|NCT01149655|3852126|P1|COMPLETED|Period 1 - Conversion Phase||168
1574228|NCT01149655|3852123|P4|STARTED|Period 1 - Conversion Phase||0
1574229|NCT01149655|3852124|P3|STARTED|Period 1 - Conversion Phase||0
1574230|NCT01149655|3852125|P2|STARTED|Period 1 - Conversion Phase||0
1574231|NCT01149655|3852126|P1|STARTED|Period 1 - Conversion Phase||186
1574232|NCT01149616|3852156|P2|NOT COMPLETED|Overall Study||0
1574233|NCT01149616|3852157|P1|NOT COMPLETED|Overall Study||0
1574234|NCT01149616|3852156|P2|COMPLETED|Overall Study||41
1574235|NCT01149616|3852157|P1|COMPLETED|Overall Study||41
1574236|NCT01149616|3852156|P2|STARTED|Overall Study||41
1574237|NCT01149616|3852157|P1|STARTED|Overall Study||41
1574238|NCT01149538|3852169|P2|NOT COMPLETED|Overall Study||4
1574239|NCT01149538|3852170|P1|NOT COMPLETED|Overall Study||5
1574240|NCT01149538|3852169|P2|COMPLETED|Overall Study||25
1574241|NCT01149538|3852170|P1|COMPLETED|Overall Study||26
1574242|NCT01149538|3852169|P2|STARTED|Overall Study||29
1574243|NCT01149538|3852170|P1|STARTED|Overall Study||31
1574244|NCT01149512|3852184|P1|NOT COMPLETED|Overall Study||0
1574245|NCT01149512|3852184|P1|COMPLETED|Overall Study||178
1574246|NCT01149512|3852184|P1|STARTED|Overall Study||178
1574247|NCT01149486|3852191|P2|NOT COMPLETED|Second Intervention||0
1574248|NCT01149486|3852192|P1|NOT COMPLETED|Second Intervention||0
1574249|NCT01149486|3852191|P2|COMPLETED|Second Intervention||9
1574250|NCT01149486|3852192|P1|COMPLETED|Second Intervention||10
1574251|NCT01149486|3852191|P2|STARTED|Second Intervention||9
1574252|NCT01149486|3852192|P1|STARTED|Second Intervention||10
1574253|NCT01149486|3852191|P2|NOT COMPLETED|Washout of 7 Days||0
1574254|NCT01149486|3852192|P1|NOT COMPLETED|Washout of 7 Days||0
1574255|NCT01149486|3852191|P2|COMPLETED|Washout of 7 Days||9
1574256|NCT01149486|3852192|P1|COMPLETED|Washout of 7 Days||10
1574257|NCT01149486|3852191|P2|STARTED|Washout of 7 Days||9
1574258|NCT01149486|3852192|P1|STARTED|Washout of 7 Days||10
1574259|NCT01149486|3852191|P2|NOT COMPLETED|First Intervention||1
1574260|NCT01149486|3852192|P1|NOT COMPLETED|First Intervention||0
1574261|NCT01149486|3852191|P2|COMPLETED|First Intervention||9
1574262|NCT01149486|3852192|P1|COMPLETED|First Intervention||10
1574263|NCT01149486|3852191|P2|STARTED|First Intervention||10
1574264|NCT01149486|3852192|P1|STARTED|First Intervention||10
1574265|NCT01149473|3852216|P2|NOT COMPLETED|Second Intervention||0
1574266|NCT01149473|3852217|P1|NOT COMPLETED|Second Intervention||0
1574267|NCT01149473|3852216|P2|COMPLETED|Second Intervention||38
1574268|NCT01149473|3852217|P1|COMPLETED|Second Intervention||38
1574269|NCT01149473|3852216|P2|STARTED|Second Intervention||38
1574270|NCT01149473|3852217|P1|STARTED|Second Intervention||38
1574271|NCT01149473|3852216|P2|NOT COMPLETED|Washout of 7 Days||1
1574272|NCT01149473|3852217|P1|NOT COMPLETED|Washout of 7 Days||1
1574273|NCT01149473|3852216|P2|COMPLETED|Washout of 7 Days||38
1574274|NCT01149473|3852217|P1|COMPLETED|Washout of 7 Days||38
1574275|NCT01149473|3852216|P2|STARTED|Washout of 7 Days||39
1574276|NCT01149473|3852217|P1|STARTED|Washout of 7 Days||39
1574277|NCT01149473|3852216|P2|NOT COMPLETED|First Intervention||1
1574278|NCT01149473|3852217|P1|NOT COMPLETED|First Intervention||1
1574279|NCT01149473|3852216|P2|COMPLETED|First Intervention||39
1574280|NCT01149473|3852217|P1|COMPLETED|First Intervention||39
1574281|NCT01149473|3852216|P2|STARTED|First Intervention||40
1574282|NCT01149473|3852217|P1|STARTED|First Intervention||40
1574283|NCT01149460|3852235|P2|NOT COMPLETED|Overall Study||2
1574284|NCT01149460|3852236|P1|NOT COMPLETED|Overall Study||0
1574285|NCT01149460|3852235|P2|COMPLETED|Overall Study||16
1574286|NCT01149460|3852236|P1|COMPLETED|Overall Study||18
1574287|NCT01149460|3852235|P2|STARTED|Overall Study||18
1574288|NCT01149460|3852236|P1|STARTED|Overall Study||18
1574289|NCT01149434|3852254|P2|NOT COMPLETED|Overall Study||5
1574290|NCT01149434|3852255|P1|NOT COMPLETED|Overall Study||0
1574291|NCT01149434|3852254|P2|COMPLETED|Overall Study||10
1574292|NCT01149434|3852255|P1|COMPLETED|Overall Study||4
1574293|NCT01149434|3852254|P2|STARTED|Overall Study||15
1574294|NCT01149434|3852255|P1|STARTED|Overall Study||4
1574295|NCT01149421|3852269|P3|NOT COMPLETED|Overall Study||44
1574296|NCT01149421|3852270|P2|NOT COMPLETED|Overall Study||29
1574297|NCT01149421|3852271|P1|NOT COMPLETED|Overall Study||52
1574298|NCT01149421|3852269|P3|COMPLETED|Overall Study||206
1574299|NCT01149421|3852270|P2|COMPLETED|Overall Study||225
1574300|NCT01149421|3852271|P1|COMPLETED|Overall Study||199
1574301|NCT01149421|3852269|P3|Received at Least One Dose of Study Drug|Overall Study||250
1574302|NCT01149421|3852270|P2|Received at Least One Dose of Study Drug|Overall Study||254
1574303|NCT01149421|3852271|P1|Received at Least One Dose of Study Drug|Overall Study||251
1574304|NCT01149421|3852269|P3|STARTED|Overall Study||250
1574305|NCT01149421|3852270|P2|STARTED|Overall Study||254
1574306|NCT01149421|3852271|P1|STARTED|Overall Study||251
1574307|NCT01149343|3852354|P4|NOT COMPLETED|Overall Study||40
1574308|NCT01149343|3852355|P3|NOT COMPLETED|Overall Study||22
1574309|NCT01149343|3852356|P2|NOT COMPLETED|Overall Study||24
1574310|NCT01149343|3852357|P1|NOT COMPLETED|Overall Study||20
1574311|NCT01149343|3852354|P4|COMPLETED|Overall Study||0
1574312|NCT01149343|3852355|P3|COMPLETED|Overall Study||0
1574313|NCT01149343|3852356|P2|COMPLETED|Overall Study||0
1574314|NCT01149343|3852357|P1|COMPLETED|Overall Study||0
1574315|NCT01149343|3852354|P4|STARTED|Overall Study||40
1574316|NCT01149343|3852355|P3|STARTED|Overall Study||22
1574317|NCT01149343|3852356|P2|STARTED|Overall Study||24
1574318|NCT01149343|3852357|P1|STARTED|Overall Study||20
1574319|NCT01149148|3852442|P2|NOT COMPLETED|Overall Study||2
1574320|NCT01149148|3852443|P1|NOT COMPLETED|Overall Study||2
1574321|NCT01149148|3852442|P2|COMPLETED|Overall Study||11
1574322|NCT01149148|3852443|P1|COMPLETED|Overall Study||10
1574323|NCT01149148|3852442|P2|STARTED|Overall Study||13
1574324|NCT01149148|3852443|P1|STARTED|Overall Study||12
1574325|NCT01149057|3852451|P1|NOT COMPLETED|Overall Study||57
1574326|NCT01149057|3852451|P1|COMPLETED|Overall Study||88
1574327|NCT01149057|3852451|P1|STARTED|Overall Study||145
1574328|NCT01148979|3852478|P2|NOT COMPLETED|Overall Study||1
1574329|NCT01148979|3852479|P1|NOT COMPLETED|Overall Study||0
1574330|NCT01148979|3852478|P2|COMPLETED|Overall Study||15
1574331|NCT01148979|3852479|P1|COMPLETED|Overall Study||13
1574332|NCT01148979|3852478|P2|STARTED|Overall Study||16
1574333|NCT01148979|3852479|P1|STARTED|Overall Study||13
1574334|NCT01148862|3852485|P2|NOT COMPLETED|Second Intervention||2
1574335|NCT01148862|3852486|P1|NOT COMPLETED|Second Intervention||0
1574336|NCT01148862|3852485|P2|COMPLETED|Second Intervention||23
1574337|NCT01148862|3852486|P1|COMPLETED|Second Intervention||25
1574338|NCT01148862|3852485|P2|STARTED|Second Intervention||25
1574339|NCT01148862|3852486|P1|STARTED|Second Intervention||25
1574340|NCT01148862|3852485|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1574341|NCT01148862|3852486|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1574342|NCT01148862|3852485|P2|COMPLETED|Washout Period of 2 Weeks||25
1574343|NCT01148862|3852486|P1|COMPLETED|Washout Period of 2 Weeks||25
1574344|NCT01148862|3852485|P2|STARTED|Washout Period of 2 Weeks||25
1574345|NCT01148862|3852486|P1|STARTED|Washout Period of 2 Weeks||25
1574346|NCT01148862|3852485|P2|NOT COMPLETED|First Intervention||0
1574347|NCT01148862|3852486|P1|NOT COMPLETED|First Intervention||0
1574348|NCT01148862|3852485|P2|COMPLETED|First Intervention||25
1574349|NCT01148862|3852486|P1|COMPLETED|First Intervention||25
1574350|NCT01148862|3852485|P2|STARTED|First Intervention||25
1574351|NCT01148862|3852486|P1|STARTED|First Intervention||25
1574352|NCT01148836|3852496|P2|NOT COMPLETED|Overall Study||2
1574353|NCT01148836|3852497|P1|NOT COMPLETED|Overall Study||1
1574354|NCT01148836|3852496|P2|COMPLETED|Overall Study||8
1574355|NCT01148836|3852497|P1|COMPLETED|Overall Study|Enrollment completed|7
1574356|NCT01148836|3852496|P2|STARTED|Overall Study||10
1574357|NCT01148836|3852497|P1|STARTED|Overall Study|Enrollment completed|8
1574358|NCT01148771|3852518|P2|NOT COMPLETED|Second Intervention||0
1574359|NCT01148771|3852519|P1|NOT COMPLETED|Second Intervention||0
1574360|NCT01148771|3852518|P2|COMPLETED|Second Intervention||5
1574361|NCT01148771|3852519|P1|COMPLETED|Second Intervention||6
1574362|NCT01148771|3852518|P2|STARTED|Second Intervention||5
1574363|NCT01148771|3852519|P1|STARTED|Second Intervention||6
1574364|NCT01148771|3852518|P2|NOT COMPLETED|Washout Period||1
1574365|NCT01148771|3852519|P1|NOT COMPLETED|Washout Period||0
1574366|NCT01148771|3852518|P2|COMPLETED|Washout Period||5
1574367|NCT01148771|3852519|P1|COMPLETED|Washout Period||6
1574368|NCT01148771|3852518|P2|STARTED|Washout Period||6
1574369|NCT01148771|3852519|P1|STARTED|Washout Period||6
1574370|NCT01148771|3852518|P2|NOT COMPLETED|First Intervention||0
1574371|NCT01148771|3852519|P1|NOT COMPLETED|First Intervention||0
1574372|NCT01148771|3852518|P2|COMPLETED|First Intervention||6
1574373|NCT01148771|3852519|P1|COMPLETED|First Intervention||6
1574374|NCT01148771|3852518|P2|STARTED|First Intervention||6
1574375|NCT01148771|3852519|P1|STARTED|First Intervention||6
1574376|NCT01148745|3852531|P1|NOT COMPLETED|Overall Study||0
1574377|NCT01148745|3852531|P1|COMPLETED|Overall Study||15
1574378|NCT01148745|3852531|P1|STARTED|Overall Study||15
1574379|NCT01148693|3852539|P2|NOT COMPLETED|Overall Study||10
1574380|NCT01148693|3852540|P1|NOT COMPLETED|Overall Study||13
1574381|NCT01148693|3852539|P2|COMPLETED|Overall Study||57
1574382|NCT01148693|3852540|P1|COMPLETED|Overall Study||57
1574383|NCT01148693|3852539|P2|STARTED|Overall Study||67
1574384|NCT01148693|3852540|P1|STARTED|Overall Study||70
1574385|NCT01148563|3852548|P2|NOT COMPLETED|Overall Study||30
1574386|NCT01148563|3852549|P1|NOT COMPLETED|Overall Study||29
1574387|NCT01148563|3852548|P2|COMPLETED|Overall Study||37
1574388|NCT01148563|3852549|P1|COMPLETED|Overall Study||40
1574389|NCT01148563|3852548|P2|STARTED|Overall Study||67
1574390|NCT01148563|3852549|P1|STARTED|Overall Study||69
1574391|NCT01148537|3852560|P3|NOT COMPLETED|Overall Study||3
1574392|NCT01148537|3852561|P2|NOT COMPLETED|Overall Study||0
1574393|NCT01148537|3852562|P1|NOT COMPLETED|Overall Study||3
1574394|NCT01148537|3852560|P3|COMPLETED|Overall Study||41
1574395|NCT01148537|3852561|P2|COMPLETED|Overall Study||44
1574396|NCT01148537|3852562|P1|COMPLETED|Overall Study||41
1574397|NCT01148537|3852560|P3|STARTED|Overall Study||44
1574398|NCT01148537|3852561|P2|STARTED|Overall Study||44
1574399|NCT01148537|3852562|P1|STARTED|Overall Study||44
1574400|NCT01148524|3852592|P9|NOT COMPLETED|Overall Study||0
1574401|NCT01148524|3852593|P8|NOT COMPLETED|Overall Study||0
1574402|NCT01148524|3852594|P7|NOT COMPLETED|Overall Study||0
1574403|NCT01148524|3852595|P6|NOT COMPLETED|Overall Study||0
1574404|NCT01148524|3852596|P5|NOT COMPLETED|Overall Study||0
1574405|NCT01148524|3852597|P4|NOT COMPLETED|Overall Study||0
1574406|NCT01148524|3852598|P3|NOT COMPLETED|Overall Study||0
1574407|NCT01148524|3852599|P2|NOT COMPLETED|Overall Study||0
1574408|NCT01148524|3852600|P1|NOT COMPLETED|Overall Study||0
1574409|NCT01148524|3852592|P9|COMPLETED|Overall Study||151
1574410|NCT01148524|3852593|P8|COMPLETED|Overall Study||51
1574411|NCT01148524|3852594|P7|COMPLETED|Overall Study||153
1574412|NCT01148524|3852595|P6|COMPLETED|Overall Study||106
1574413|NCT01148524|3852596|P5|COMPLETED|Overall Study||57
1574414|NCT01148524|3852597|P4|COMPLETED|Overall Study||102
1574415|NCT01148524|3852598|P3|COMPLETED|Overall Study||53
1574416|NCT01148524|3852599|P2|COMPLETED|Overall Study||95
1574417|NCT01148524|3852600|P1|COMPLETED|Overall Study||49
1574418|NCT01148524|3852592|P9|STARTED|Overall Study||151
1574419|NCT01148524|3852593|P8|STARTED|Overall Study||51
1574420|NCT01148524|3852594|P7|STARTED|Overall Study||153
1574421|NCT01148524|3852595|P6|STARTED|Overall Study||106
1574422|NCT01148524|3852596|P5|STARTED|Overall Study||57
1574423|NCT01148524|3852597|P4|STARTED|Overall Study||102
1574424|NCT01148524|3852598|P3|STARTED|Overall Study||53
1574425|NCT01148524|3852599|P2|STARTED|Overall Study||95
1574426|NCT01148524|3852600|P1|STARTED|Overall Study||49
1574427|NCT01148511|3852648|P3|NOT COMPLETED|Randomized||6
1574428|NCT01148511|3852649|P2|NOT COMPLETED|Randomized||10
1574429|NCT01148511|3852650|P1|NOT COMPLETED|Randomized||0
1574430|NCT01148511|3852648|P3|COMPLETED|Randomized||39
1574431|NCT01148511|3852649|P2|COMPLETED|Randomized||38
1574432|NCT01148511|3852650|P1|COMPLETED|Randomized||0
1574433|NCT01148511|3852648|P3|STARTED|Randomized||45
1574434|NCT01148511|3852649|P2|STARTED|Randomized||48
1574435|NCT01148511|3852650|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
1574436|NCT01148511|3852648|P3|NOT COMPLETED|Exposed to Study Drug||0
1574437|NCT01148511|3852649|P2|NOT COMPLETED|Exposed to Study Drug||0
1574438|NCT01148511|3852650|P1|NOT COMPLETED|Exposed to Study Drug||6
1574439|NCT01148511|3852648|P3|COMPLETED|Exposed to Study Drug||0
1574440|NCT01148511|3852649|P2|COMPLETED|Exposed to Study Drug||0
1574441|NCT01148511|3852650|P1|COMPLETED|Exposed to Study Drug||93
1574442|NCT01148511|3852648|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
1574443|NCT01148511|3852649|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
1574444|NCT01148511|3852650|P1|STARTED|Exposed to Study Drug||99
1574445|NCT01148420|3852669|P1|NOT COMPLETED|Overall Study||0
1574446|NCT01148420|3852669|P1|COMPLETED|Overall Study||48
1574447|NCT01148420|3852669|P1|STARTED|Overall Study||48
1574448|NCT01148056|3852675|P1|NOT COMPLETED|Overall Study||0
1574449|NCT01148056|3852675|P1|COMPLETED|Overall Study||2
1574450|NCT01148056|3852675|P1|STARTED|Overall Study||2
1574451|NCT01148017|3852688|P4|NOT COMPLETED|Overall Study||0
1574452|NCT01148017|3852689|P3|NOT COMPLETED|Overall Study||0
1574453|NCT01148017|3852690|P2|NOT COMPLETED|Overall Study||34
1574454|NCT01148017|3852691|P1|NOT COMPLETED|Overall Study||80
1574455|NCT01148017|3852688|P4|COMPLETED|Overall Study||45
1574456|NCT01148017|3852689|P3|COMPLETED|Overall Study||53
1574457|NCT01148017|3852690|P2|COMPLETED|Overall Study||87
1574458|NCT01148017|3852691|P1|COMPLETED|Overall Study||134
1574459|NCT01148017|3852688|P4|STARTED|Overall Study||45
1574460|NCT01148017|3852689|P3|STARTED|Overall Study||53
1574461|NCT01148017|3852690|P2|STARTED|Overall Study||121
1574462|NCT01148017|3852691|P1|STARTED|Overall Study||214
1574463|NCT01147926|3852730|P2|NOT COMPLETED|Overall Study||29
1574464|NCT01147926|3852731|P1|NOT COMPLETED|Overall Study||27
1574465|NCT01147926|3852730|P2|COMPLETED|Overall Study||158
1574466|NCT01147926|3852731|P1|COMPLETED|Overall Study||160
1574467|NCT01147926|3852730|P2|STARTED|Overall Study||187
1574468|NCT01147926|3852731|P1|STARTED|Overall Study||187
1574469|NCT01147900|3852766|P3|NOT COMPLETED|At Year 10||0
1574470|NCT01147900|3852767|P2|NOT COMPLETED|At Year 10||1
1574471|NCT01147900|3852768|P1|NOT COMPLETED|At Year 10||0
1574472|NCT01147900|3852766|P3|COMPLETED|At Year 10||62
1574473|NCT01147900|3852767|P2|COMPLETED|At Year 10||59
1574474|NCT01147900|3852768|P1|COMPLETED|At Year 10||55
1574475|NCT01147900|3852766|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
1574476|NCT01147900|3852767|P2|STARTED|At Year 10||60
1574477|NCT01147900|3852768|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
1574478|NCT01147900|3852766|P3|NOT COMPLETED|At Year 8.5||0
1574479|NCT01147900|3852767|P2|NOT COMPLETED|At Year 8.5||0
1574480|NCT01147900|3852768|P1|NOT COMPLETED|At Year 8.5||0
1574481|NCT01147900|3852766|P3|COMPLETED|At Year 8.5||66
1574482|NCT01147900|3852767|P2|COMPLETED|At Year 8.5||60
1574483|NCT01147900|3852768|P1|COMPLETED|At Year 8.5||54
1574484|NCT01147900|3852766|P3|STARTED|At Year 8.5||66
1574485|NCT01147900|3852767|P2|STARTED|At Year 8.5||60
1574486|NCT01147900|3852768|P1|STARTED|At Year 8.5||54
1574487|NCT01147874|3852827|P1|NOT COMPLETED|Overall Study||67
1574488|NCT01147874|3852827|P1|COMPLETED|Overall Study||946
1574489|NCT01147874|3852827|P1|STARTED|Overall Study||1013
1574490|NCT01147848|3852835|P3|NOT COMPLETED|Randomized Phase||46
1574491|NCT01147848|3852836|P2|NOT COMPLETED|Randomized Phase||45
1574492|NCT01147848|3852837|P1|NOT COMPLETED|Randomized Phase||0
1574493|NCT01147848|3852835|P3|COMPLETED|Randomized Phase||357
1574494|NCT01147848|3852836|P2|COMPLETED|Randomized Phase||358
1574495|NCT01147848|3852837|P1|COMPLETED|Randomized Phase||0
1574496|NCT01147848|3852835|P3|STARTED|Randomized Phase||403
1574497|NCT01147848|3852836|P2|STARTED|Randomized Phase||403
1574498|NCT01147848|3852837|P1|STARTED|Randomized Phase||0
1574499|NCT01147848|3852835|P3|NOT COMPLETED|Run-in Period||0
1574500|NCT01147848|3852836|P2|NOT COMPLETED|Run-in Period||0
1574501|NCT01147848|3852837|P1|NOT COMPLETED|Run-in Period||758
1574502|NCT01147848|3852835|P3|COMPLETED|Run-in Period||0
1574503|NCT01147848|3852836|P2|COMPLETED|Run-in Period||0
1574504|NCT01147848|3852837|P1|COMPLETED|Run-in Period||806
1574505|NCT01147848|3852835|P3|STARTED|Run-in Period||0
1574506|NCT01147848|3852836|P2|STARTED|Run-in Period||0
1574507|NCT01147848|3852837|P1|STARTED|Run-in Period||1564
1574508|NCT01147822|3852869|P2|NOT COMPLETED|Overall Study||179
1574509|NCT01147822|3852870|P1|NOT COMPLETED|Overall Study||188
1574510|NCT01147822|3852869|P2|COMPLETED|Overall Study||0
1574511|NCT01147822|3852870|P1|COMPLETED|Overall Study||0
1574512|NCT01147822|3852869|P2|Not Completed/Ongoing|Overall Study||102
1574513|NCT01147822|3852870|P1|Not Completed/Ongoing|Overall Study||111
1574514|NCT01147822|3852869|P2|STARTED|Overall Study||179
1574515|NCT01147822|3852870|P1|STARTED|Overall Study||188
1574516|NCT01147809|3852890|P6|NOT COMPLETED|Phase II (168 Days)||33
1574517|NCT01147809|3852891|P5|NOT COMPLETED|Phase II (168 Days)||16
1574518|NCT01147809|3852892|P4|NOT COMPLETED|Phase II (168 Days)||0
1574519|NCT01147809|3852893|P3|NOT COMPLETED|Phase II (168 Days)||0
1574520|NCT01147809|3852894|P2|NOT COMPLETED|Phase II (168 Days)||0
1574521|NCT01147809|3852895|P1|NOT COMPLETED|Phase II (168 Days)||0
1574522|NCT01147809|3852890|P6|COMPLETED|Phase II (168 Days)||19
1574523|NCT01147809|3852891|P5|COMPLETED|Phase II (168 Days)||7
1574524|NCT01147809|3852892|P4|COMPLETED|Phase II (168 Days)||0
1574525|NCT01147809|3852893|P3|COMPLETED|Phase II (168 Days)||0
1574526|NCT01147809|3852894|P2|COMPLETED|Phase II (168 Days)||0
1574527|NCT01147809|3852895|P1|COMPLETED|Phase II (168 Days)||0
1574528|NCT01147809|3852890|P6|Ongoing|Phase II (168 Days)||0
1574529|NCT01147809|3852891|P5|Ongoing|Phase II (168 Days)||1
1574530|NCT01147809|3852892|P4|Ongoing|Phase II (168 Days)||0
1574531|NCT01147809|3852893|P3|Ongoing|Phase II (168 Days)||0
1574532|NCT01147809|3852894|P2|Ongoing|Phase II (168 Days)||0
1574533|NCT01147809|3852895|P1|Ongoing|Phase II (168 Days)||0
1574534|NCT01147809|3852890|P6|STARTED|Phase II (168 Days)||52
1574535|NCT01147809|3852891|P5|STARTED|Phase II (168 Days)||23
1574536|NCT01147809|3852892|P4|STARTED|Phase II (168 Days)||0
1574537|NCT01147809|3852893|P3|STARTED|Phase II (168 Days)||0
1574538|NCT01147809|3852894|P2|STARTED|Phase II (168 Days)||0
1574539|NCT01147809|3852895|P1|STARTED|Phase II (168 Days)||0
1574540|NCT01147809|3852890|P6|NOT COMPLETED|Phase I (168 Days)||0
1574541|NCT01147809|3852891|P5|NOT COMPLETED|Phase I (168 Days)||0
1574542|NCT01147809|3852892|P4|NOT COMPLETED|Phase I (168 Days)||5
1574543|NCT01147809|3852893|P3|NOT COMPLETED|Phase I (168 Days)||2
1574544|NCT01147809|3852894|P2|NOT COMPLETED|Phase I (168 Days)||1
1574545|NCT01147809|3852895|P1|NOT COMPLETED|Phase I (168 Days)||1
1574546|NCT01147809|3852890|P6|COMPLETED|Phase I (168 Days)||0
1574547|NCT01147809|3852891|P5|COMPLETED|Phase I (168 Days)||0
1574548|NCT01147809|3852892|P4|COMPLETED|Phase I (168 Days)||5
1574549|NCT01147809|3852893|P3|COMPLETED|Phase I (168 Days)||2
1574550|NCT01147809|3852894|P2|COMPLETED|Phase I (168 Days)||8
1574551|NCT01147809|3852895|P1|COMPLETED|Phase I (168 Days)||2
1574552|NCT01147809|3852890|P6|STARTED|Phase I (168 Days)||0
1574553|NCT01147809|3852891|P5|STARTED|Phase I (168 Days)||0
1574554|NCT01147809|3852892|P4|STARTED|Phase I (168 Days)||10
1574555|NCT01147809|3852893|P3|STARTED|Phase I (168 Days)||4
1574556|NCT01147809|3852894|P2|STARTED|Phase I (168 Days)||9
1574557|NCT01147809|3852895|P1|STARTED|Phase I (168 Days)||3
1574558|NCT01147744|3853016|P7|NOT COMPLETED|Overall Study||19
1574559|NCT01147744|3853017|P6|NOT COMPLETED|Overall Study||20
1574560|NCT01147744|3853018|P5|NOT COMPLETED|Overall Study||25
1574561|NCT01147744|3853019|P4|NOT COMPLETED|Overall Study||18
1574562|NCT01147744|3853020|P3|NOT COMPLETED|Overall Study||18
1574563|NCT01147744|3853021|P2|NOT COMPLETED|Overall Study||23
1574564|NCT01147744|3853022|P1|NOT COMPLETED|Overall Study||29
1574565|NCT01147744|3853016|P7|COMPLETED|Overall Study||78
1574566|NCT01147744|3853017|P6|COMPLETED|Overall Study||83
1574567|NCT01147744|3853018|P5|COMPLETED|Overall Study||76
1574568|NCT01147744|3853019|P4|COMPLETED|Overall Study||82
1574569|NCT01147744|3853020|P3|COMPLETED|Overall Study||82
1574570|NCT01147744|3853021|P2|COMPLETED|Overall Study||76
1574571|NCT01147744|3853022|P1|COMPLETED|Overall Study||71
1574572|NCT01147744|3853016|P7|STARTED|Overall Study||97
1574573|NCT01147744|3853017|P6|STARTED|Overall Study||103
1574574|NCT01147744|3853018|P5|STARTED|Overall Study||101
1574575|NCT01147744|3853019|P4|STARTED|Overall Study||100
1574576|NCT01147744|3853020|P3|STARTED|Overall Study||100
1574577|NCT01147744|3853021|P2|STARTED|Overall Study||99
1574578|NCT01147744|3853022|P1|STARTED|Overall Study||100
1574579|NCT01147653|3853117|P2|NOT COMPLETED|Year 2||3
1574580|NCT01147653|3853118|P1|NOT COMPLETED|Year 2||2
1574581|NCT01147653|3853117|P2|COMPLETED|Year 2||28
1574582|NCT01147653|3853118|P1|COMPLETED|Year 2||30
1574583|NCT01147653|3853117|P2|STARTED|Year 2||31
1574584|NCT01147653|3853118|P1|STARTED|Year 2||32
1574585|NCT01147653|3853117|P2|NOT COMPLETED|Year 1||0
1574586|NCT01147653|3853118|P1|NOT COMPLETED|Year 1||0
1574587|NCT01147653|3853117|P2|COMPLETED|Year 1||31
1574588|NCT01147653|3853118|P1|COMPLETED|Year 1||32
1574589|NCT01147653|3853117|P2|STARTED|Year 1||31
1574590|NCT01147653|3853118|P1|STARTED|Year 1||32
1574591|NCT01147640|3853179|P2|NOT COMPLETED|Overall Study||1
1574592|NCT01147640|3853180|P1|NOT COMPLETED|Overall Study||5
1574593|NCT01147640|3853179|P2|COMPLETED|Overall Study||38
1574594|NCT01147640|3853180|P1|COMPLETED|Overall Study||78
1574595|NCT01147640|3853179|P2|STARTED|Overall Study||39
1574596|NCT01147640|3853180|P1|STARTED|Overall Study||83
1574597|NCT01147627|3853191|P3|NOT COMPLETED|Overall Study||18
1574598|NCT01147627|3853192|P2|NOT COMPLETED|Overall Study||24
1574599|NCT01147627|3853193|P1|NOT COMPLETED|Overall Study||32
1574600|NCT01147627|3853191|P3|COMPLETED|Overall Study||118
1574601|NCT01147627|3853192|P2|COMPLETED|Overall Study||114
1574602|NCT01147627|3853193|P1|COMPLETED|Overall Study||110
1574603|NCT01147627|3853191|P3|STARTED|Overall Study||136
1574604|NCT01147627|3853192|P2|STARTED|Overall Study||138
1574605|NCT01147627|3853193|P1|STARTED|Overall Study||142
1574606|NCT01147601|3853203|P2|NOT COMPLETED|Overall Study||0
1574607|NCT01147601|3853204|P1|NOT COMPLETED|Overall Study||3
1574608|NCT01147601|3853203|P2|COMPLETED|Overall Study||1
1574609|NCT01147601|3853204|P1|COMPLETED|Overall Study||2
1574610|NCT01147601|3853203|P2|STARTED|Overall Study||1
1574611|NCT01147601|3853204|P1|STARTED|Overall Study||5
1574612|NCT01147497|3853212|P2|NOT COMPLETED|Overall Study||0
1574613|NCT01147497|3853213|P1|NOT COMPLETED|Overall Study||2
1574614|NCT01147497|3853212|P2|COMPLETED|Overall Study||36
1574615|NCT01147497|3853213|P1|COMPLETED|Overall Study||35
1574616|NCT01147497|3853212|P2|STARTED|Overall Study||36
1574617|NCT01147497|3853213|P1|STARTED|Overall Study||37
1574618|NCT01147471|3853233|P2|NOT COMPLETED|6 Month Follow Up||2
1574619|NCT01147471|3853234|P1|NOT COMPLETED|6 Month Follow Up||4
1574620|NCT01147471|3853233|P2|COMPLETED|6 Month Follow Up||4
1574621|NCT01147471|3853234|P1|COMPLETED|6 Month Follow Up||8
1574622|NCT01147471|3853233|P2|STARTED|6 Month Follow Up||6
1574623|NCT01147471|3853234|P1|STARTED|6 Month Follow Up||12
1574624|NCT01147471|3853233|P2|NOT COMPLETED|3 Month Follow Up||2
1574625|NCT01147471|3853234|P1|NOT COMPLETED|3 Month Follow Up||1
1574626|NCT01147471|3853233|P2|COMPLETED|3 Month Follow Up||6
1574627|NCT01147471|3853234|P1|COMPLETED|3 Month Follow Up||12
1574628|NCT01147471|3853233|P2|STARTED|3 Month Follow Up||8
1574629|NCT01147471|3853234|P1|STARTED|3 Month Follow Up||13
1574630|NCT01147471|3853233|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
1574631|NCT01147471|3853234|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
1574632|NCT01147471|3853233|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
1574633|NCT01147471|3853234|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
1574634|NCT01147471|3853233|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
1574635|NCT01147471|3853234|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
1574636|NCT01147471|3853233|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
1574637|NCT01147471|3853234|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
1574638|NCT01147471|3853233|P2|COMPLETED|Through Initial Hospital Discharge||11
1574639|NCT01147471|3853234|P1|COMPLETED|Through Initial Hospital Discharge||13
1574640|NCT01147471|3853233|P2|STARTED|Through Initial Hospital Discharge||11
1574641|NCT01147471|3853234|P1|STARTED|Through Initial Hospital Discharge||13
1574642|NCT01147458|3853248|P4|NOT COMPLETED|Second Intervention||4
1574643|NCT01147458|3853249|P3|NOT COMPLETED|Second Intervention||8
1574644|NCT01147458|3853250|P2|NOT COMPLETED|Second Intervention||7
1574645|NCT01147458|3853251|P1|NOT COMPLETED|Second Intervention||9
1574646|NCT01147458|3853248|P4|COMPLETED|Second Intervention||30
1574647|NCT01147458|3853249|P3|COMPLETED|Second Intervention||27
1574648|NCT01147458|3853250|P2|COMPLETED|Second Intervention||24
1574649|NCT01147458|3853251|P1|COMPLETED|Second Intervention||25
1574650|NCT01147458|3853248|P4|STARTED|Second Intervention||34
1574651|NCT01147458|3853249|P3|STARTED|Second Intervention||35
1574652|NCT01147458|3853250|P2|STARTED|Second Intervention||31
1574653|NCT01147458|3853251|P1|STARTED|Second Intervention||34
1574654|NCT01147458|3853248|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1574655|NCT01147458|3853249|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1574656|NCT01147458|3853250|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1574657|NCT01147458|3853251|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1574658|NCT01147458|3853248|P4|COMPLETED|Washout Period of 2 Weeks||34
1574659|NCT01147458|3853249|P3|COMPLETED|Washout Period of 2 Weeks||35
1574660|NCT01147458|3853250|P2|COMPLETED|Washout Period of 2 Weeks||31
1574661|NCT01147458|3853251|P1|COMPLETED|Washout Period of 2 Weeks||34
1574662|NCT01147458|3853248|P4|STARTED|Washout Period of 2 Weeks||34
1574663|NCT01147458|3853249|P3|STARTED|Washout Period of 2 Weeks||35
1574664|NCT01147458|3853250|P2|STARTED|Washout Period of 2 Weeks||31
1574665|NCT01147458|3853251|P1|STARTED|Washout Period of 2 Weeks||34
1574666|NCT01147458|3853248|P4|NOT COMPLETED|First Intervention||14
1574667|NCT01147458|3853249|P3|NOT COMPLETED|First Intervention||12
1574668|NCT01147458|3853250|P2|NOT COMPLETED|First Intervention||16
1574669|NCT01147458|3853251|P1|NOT COMPLETED|First Intervention||14
1574670|NCT01147458|3853248|P4|COMPLETED|First Intervention||34
1574671|NCT01147458|3853249|P3|COMPLETED|First Intervention||35
1574672|NCT01147458|3853250|P2|COMPLETED|First Intervention||31
1574673|NCT01147458|3853251|P1|COMPLETED|First Intervention||34
1574674|NCT01147458|3853248|P4|STARTED|First Intervention||48
1574675|NCT01147458|3853249|P3|STARTED|First Intervention||47
1574676|NCT01147458|3853250|P2|STARTED|First Intervention||47
1574677|NCT01147458|3853251|P1|STARTED|First Intervention||48
1574678|NCT01147406|3853305|P6|NOT COMPLETED|Overall Study||0
1574679|NCT01147406|3853306|P5|NOT COMPLETED|Overall Study||0
1574680|NCT01147406|3853307|P4|NOT COMPLETED|Overall Study||0
1574681|NCT01147406|3853308|P3|NOT COMPLETED|Overall Study||0
1574682|NCT01147406|3853309|P2|NOT COMPLETED|Overall Study||0
1574683|NCT01147406|3853310|P1|NOT COMPLETED|Overall Study||0
1574684|NCT01147406|3853305|P6|COMPLETED|Overall Study||10
1574685|NCT01147406|3853306|P5|COMPLETED|Overall Study||6
1574686|NCT01147406|3853307|P4|COMPLETED|Overall Study||6
1574687|NCT01147406|3853308|P3|COMPLETED|Overall Study||1
1574688|NCT01147406|3853309|P2|COMPLETED|Overall Study||12
1574689|NCT01147406|3853310|P1|COMPLETED|Overall Study||6
1574690|NCT01147406|3853305|P6|STARTED|Overall Study||10
1574691|NCT01147406|3853306|P5|STARTED|Overall Study||6
1574692|NCT01147406|3853307|P4|STARTED|Overall Study||6
1574693|NCT01147406|3853308|P3|STARTED|Overall Study||1
1574694|NCT01147406|3853309|P2|STARTED|Overall Study||12
1574695|NCT01147406|3853310|P1|STARTED|Overall Study||6
1574696|NCT01147393|3853330|P1|NOT COMPLETED|Dose Level -1||1
1574697|NCT01147393|3853330|P1|COMPLETED|Dose Level -1||0
1574698|NCT01147393|3853330|P1|STARTED|Dose Level -1||1
1574699|NCT01147393|3853330|P1|NOT COMPLETED|Dose Level 1||2
1574700|NCT01147393|3853330|P1|COMPLETED|Dose Level 1||1
1574701|NCT01147393|3853330|P1|STARTED|Dose Level 1||3
1574702|NCT01147380|3853340|P2|NOT COMPLETED|Overall Study||0
1574703|NCT01147380|3853341|P1|NOT COMPLETED|Overall Study||0
1574704|NCT01147380|3853340|P2|COMPLETED|Overall Study||12
1574705|NCT01147380|3853341|P1|COMPLETED|Overall Study||6
1574706|NCT01147380|3853340|P2|STARTED|Overall Study||12
1574707|NCT01147380|3853341|P1|STARTED|Overall Study||6
1574708|NCT01147341|3853351|P2|NOT COMPLETED|Open Label Period||0
1574709|NCT01147341|3853352|P1|NOT COMPLETED|Open Label Period||4
1574710|NCT01147341|3853351|P2|COMPLETED|Open Label Period||8
1574711|NCT01147341|3853352|P1|COMPLETED|Open Label Period||22
1574712|NCT01147341|3853351|P2|STARTED|Open Label Period||8
1574713|NCT01147341|3853352|P1|STARTED|Open Label Period||26
1574714|NCT01147341|3853351|P2|NOT COMPLETED|Double Blind Period||2
1574715|NCT01147341|3853352|P1|NOT COMPLETED|Double Blind Period||1
1574716|NCT01147341|3853351|P2|COMPLETED|Double Blind Period||8
1574717|NCT01147341|3853352|P1|COMPLETED|Double Blind Period||26
1574718|NCT01147341|3853351|P2|STARTED|Double Blind Period||10
1574719|NCT01147341|3853352|P1|STARTED|Double Blind Period||27
1574720|NCT01147302|3853382|P2|NOT COMPLETED|Overall Study||0
1574721|NCT01147302|3853383|P1|NOT COMPLETED|Overall Study||0
1574722|NCT01147302|3853382|P2|COMPLETED|Overall Study||9
1574723|NCT01147302|3853383|P1|COMPLETED|Overall Study||9
1574724|NCT01147302|3853382|P2|STARTED|Overall Study||9
1574725|NCT01147302|3853383|P1|STARTED|Overall Study||9
1574726|NCT01147250|3853415|P2|NOT COMPLETED|Overall Study||105
1574727|NCT01147250|3853416|P1|NOT COMPLETED|Overall Study||110
1574728|NCT01147250|3853415|P2|COMPLETED|Overall Study||2929
1574729|NCT01147250|3853416|P1|COMPLETED|Overall Study||2924
1574730|NCT01147250|3853415|P2|Treated|Overall Study||3031
1574731|NCT01147250|3853416|P1|Treated|Overall Study||3032
1574732|NCT01147250|3853415|P2|STARTED|Overall Study||3034
1574733|NCT01147250|3853416|P1|STARTED|Overall Study||3034
1574734|NCT01147172|3853428|P1|NOT COMPLETED|Overall Study||4
1574735|NCT01147172|3853428|P1|COMPLETED|Overall Study||96
1574736|NCT01147172|3853428|P1|STARTED|Overall Study||100
1574737|NCT01147068|3853446|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1574738|NCT01147068|3853447|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1574739|NCT01147068|3853448|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
1574740|NCT01147068|3853449|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
1574741|NCT01147068|3853450|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
1574742|NCT01147068|3853451|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1574743|NCT01147068|3853452|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1574744|NCT01147068|3853446|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
1574745|NCT01147068|3853447|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
1574746|NCT01147068|3853448|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
1574747|NCT01147068|3853449|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
1574748|NCT01147068|3853450|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
1574749|NCT01147068|3853451|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
1574750|NCT01147068|3853452|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
1574751|NCT01147068|3853446|P7|STARTED|Subjects That Completed Safety Follow-up||55
1574752|NCT01147068|3853447|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
1574833|NCT01146912|3853550|P5|NOT COMPLETED|Overall Study||41
1574753|NCT01147068|3853448|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
1574754|NCT01147068|3853449|P4|STARTED|Subjects That Completed Safety Follow-up||56
1574755|NCT01147068|3853450|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
1574756|NCT01147068|3853451|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
1574757|NCT01147068|3853452|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
1574758|NCT01147068|3853446|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
1574759|NCT01147068|3853447|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
1574760|NCT01147068|3853448|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
1574761|NCT01147068|3853449|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
1574762|NCT01147068|3853450|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
1574763|NCT01147068|3853451|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
1574764|NCT01147068|3853452|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
1574765|NCT01147068|3853446|P7|COMPLETED|Subjects That Received 2nd Dose||55
1574766|NCT01147068|3853447|P6|COMPLETED|Subjects That Received 2nd Dose||51
1574767|NCT01147068|3853448|P5|COMPLETED|Subjects That Received 2nd Dose||55
1574768|NCT01147068|3853449|P4|COMPLETED|Subjects That Received 2nd Dose||56
1574769|NCT01147068|3853450|P3|COMPLETED|Subjects That Received 2nd Dose||52
1574770|NCT01147068|3853451|P2|COMPLETED|Subjects That Received 2nd Dose||52
1574771|NCT01147068|3853452|P1|COMPLETED|Subjects That Received 2nd Dose||59
1574772|NCT01147068|3853446|P7|STARTED|Subjects That Received 2nd Dose||55
1574773|NCT01147068|3853447|P6|STARTED|Subjects That Received 2nd Dose||53
1574774|NCT01147068|3853448|P5|STARTED|Subjects That Received 2nd Dose||56
1574775|NCT01147068|3853449|P4|STARTED|Subjects That Received 2nd Dose||56
1574776|NCT01147068|3853450|P3|STARTED|Subjects That Received 2nd Dose||55
1574777|NCT01147068|3853451|P2|STARTED|Subjects That Received 2nd Dose||57
1574778|NCT01147068|3853452|P1|STARTED|Subjects That Received 2nd Dose||60
1574779|NCT01147068|3853446|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
1574780|NCT01147068|3853447|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
1574781|NCT01147068|3853448|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
1574782|NCT01147068|3853449|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
1574783|NCT01147068|3853450|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
1574784|NCT01147068|3853451|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
1574785|NCT01147068|3853452|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
1574786|NCT01147068|3853446|P7|COMPLETED|Subjects That Received 1st Dose||55
1574787|NCT01147068|3853447|P6|COMPLETED|Subjects That Received 1st Dose||53
1574788|NCT01147068|3853448|P5|COMPLETED|Subjects That Received 1st Dose||56
1574789|NCT01147068|3853449|P4|COMPLETED|Subjects That Received 1st Dose||56
1574790|NCT01147068|3853450|P3|COMPLETED|Subjects That Received 1st Dose||55
1574791|NCT01147068|3853451|P2|COMPLETED|Subjects That Received 1st Dose||57
1574792|NCT01147068|3853452|P1|COMPLETED|Subjects That Received 1st Dose||60
1574793|NCT01147068|3853446|P7|STARTED|Subjects That Received 1st Dose||55
1574794|NCT01147068|3853447|P6|STARTED|Subjects That Received 1st Dose||53
1574795|NCT01147068|3853448|P5|STARTED|Subjects That Received 1st Dose||56
1574796|NCT01147068|3853449|P4|STARTED|Subjects That Received 1st Dose||56
1574797|NCT01147068|3853450|P3|STARTED|Subjects That Received 1st Dose||55
1574798|NCT01147068|3853451|P2|STARTED|Subjects That Received 1st Dose||57
1574799|NCT01147068|3853452|P1|STARTED|Subjects That Received 1st Dose||60
1574800|NCT01147055|3853482|P2|NOT COMPLETED|Second Intervention Period||0
1574801|NCT01147055|3853483|P1|NOT COMPLETED|Second Intervention Period||0
1574802|NCT01147055|3853482|P2|COMPLETED|Second Intervention Period||14
1574803|NCT01147055|3853483|P1|COMPLETED|Second Intervention Period||0
1574804|NCT01147055|3853482|P2|STARTED|Second Intervention Period||14
1574805|NCT01147055|3853483|P1|STARTED|Second Intervention Period||0
1574806|NCT01147055|3853482|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1574807|NCT01147055|3853483|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1574808|NCT01147055|3853482|P2|COMPLETED|Washout Period (at Least 14 Days)||0
1574809|NCT01147055|3853483|P1|COMPLETED|Washout Period (at Least 14 Days)||14
1574810|NCT01147055|3853482|P2|STARTED|Washout Period (at Least 14 Days)||0
1574811|NCT01147055|3853483|P1|STARTED|Washout Period (at Least 14 Days)||14
1574812|NCT01147055|3853482|P2|NOT COMPLETED|First Intervention Period||0
1574813|NCT01147055|3853483|P1|NOT COMPLETED|First Intervention Period||1
1574814|NCT01147055|3853482|P2|COMPLETED|First Intervention Period||0
1574815|NCT01147055|3853483|P1|COMPLETED|First Intervention Period||14
1574816|NCT01147055|3853482|P2|STARTED|First Intervention Period||0
1574817|NCT01147055|3853483|P1|STARTED|First Intervention Period||15
1574818|NCT01147042|3853517|P2|NOT COMPLETED|Overall Study||0
1574819|NCT01147042|3853518|P1|NOT COMPLETED|Overall Study||0
1574820|NCT01147042|3853517|P2|COMPLETED|Overall Study||0
1574821|NCT01147042|3853518|P1|COMPLETED|Overall Study||2
1574822|NCT01147042|3853517|P2|STARTED|Overall Study||0
1574823|NCT01147042|3853518|P1|STARTED|Overall Study||2
1574824|NCT01146951|3853525|P2|NOT COMPLETED|Overall Study||1
1574825|NCT01146951|3853526|P1|NOT COMPLETED|Overall Study||4
1574826|NCT01146951|3853525|P2|COMPLETED|Overall Study||29
1574827|NCT01146951|3853526|P1|COMPLETED|Overall Study||25
1574828|NCT01146951|3853525|P2|STARTED|Overall Study||30
1574829|NCT01146951|3853526|P1|STARTED|Overall Study||29
1574830|NCT01146912|3853547|P8|NOT COMPLETED|Overall Study||0
1574831|NCT01146912|3853548|P7|NOT COMPLETED|Overall Study||56
1574832|NCT01146912|3853549|P6|NOT COMPLETED|Overall Study||61
1574834|NCT01146912|3853551|P4|NOT COMPLETED|Overall Study||17
1574835|NCT01146912|3853552|P3|NOT COMPLETED|Overall Study||17
1574836|NCT01146912|3853553|P2|NOT COMPLETED|Overall Study||822
1574837|NCT01146912|3853554|P1|NOT COMPLETED|Overall Study||817
1574838|NCT01146912|3853547|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
1574839|NCT01146912|3853548|P7|COMPLETED|Overall Study||1764
1574840|NCT01146912|3853549|P6|COMPLETED|Overall Study||1760
1574841|NCT01146912|3853550|P5|COMPLETED|Overall Study||1780
1574842|NCT01146912|3853551|P4|COMPLETED|Overall Study||577
1574843|NCT01146912|3853552|P3|COMPLETED|Overall Study||576
1574844|NCT01146912|3853553|P2|COMPLETED|Overall Study||3784
1574845|NCT01146912|3853554|P1|COMPLETED|Overall Study||3790
1574846|NCT01146912|3853547|P8|STARTED|Overall Study||14675
1574847|NCT01146912|3853548|P7|STARTED|Overall Study||1820
1574848|NCT01146912|3853549|P6|STARTED|Overall Study||1821
1574849|NCT01146912|3853550|P5|STARTED|Overall Study||1821
1574850|NCT01146912|3853551|P4|STARTED|Overall Study||594
1574851|NCT01146912|3853552|P3|STARTED|Overall Study||593
1574852|NCT01146912|3853553|P2|STARTED|Overall Study||4606
1574853|NCT01146912|3853554|P1|STARTED|Overall Study||4607
1574854|NCT01146873|3853576|P2|NOT COMPLETED|Overall Study||6
1574855|NCT01146873|3853577|P1|NOT COMPLETED|Overall Study||0
1574856|NCT01146873|3853576|P2|COMPLETED|Overall Study||144
1574857|NCT01146873|3853577|P1|COMPLETED|Overall Study||148
1574858|NCT01146873|3853576|P2|STARTED|Overall Study||150
1574859|NCT01146873|3853577|P1|STARTED|Overall Study||148
1574860|NCT01146860|3853593|P2|NOT COMPLETED|Overall Study||1
1574861|NCT01146860|3853594|P1|NOT COMPLETED|Overall Study||0
1574862|NCT01146860|3853593|P2|COMPLETED|Overall Study||191
1574863|NCT01146860|3853594|P1|COMPLETED|Overall Study||194
1574864|NCT01146860|3853593|P2|STARTED|Overall Study||192
1574865|NCT01146860|3853594|P1|STARTED|Overall Study||194
1574866|NCT01146808|3853608|P1|NOT COMPLETED|Overall Study||0
1574867|NCT01146808|3853608|P1|COMPLETED|Overall Study||16
1574868|NCT01146808|3853608|P1|STARTED|Overall Study||16
1574869|NCT01146782|3853614|P1|NOT COMPLETED|Primary Endpoint Cohort||6
1574870|NCT01146782|3853614|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
1574871|NCT01146782|3853614|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
1574872|NCT01146782|3853614|P1|NOT COMPLETED|Safety Cohort||83
1574873|NCT01146782|3853614|P1|COMPLETED|Safety Cohort||63
1574874|NCT01146782|3853614|P1|STARTED|Safety Cohort||146
1574875|NCT01146782|3853614|P1|NOT COMPLETED|Screening Cohort||221
1574876|NCT01146782|3853614|P1|COMPLETED|Screening Cohort||146
1574877|NCT01146782|3853614|P1|STARTED|Screening Cohort||367
1574878|NCT01146665|3853623|P2|NOT COMPLETED|Overall Study||16
1574879|NCT01146665|3853624|P1|NOT COMPLETED|Overall Study||10
1574880|NCT01146665|3853623|P2|COMPLETED|Overall Study||10
1574881|NCT01146665|3853624|P1|COMPLETED|Overall Study||8
1574882|NCT01146665|3853623|P2|3-month Post-ED Discharge (Follow-up)|Overall Study||10
1574883|NCT01146665|3853624|P1|3-month Post-ED Discharge (Follow-up)|Overall Study||8
1574884|NCT01146665|3853623|P2|1-month Post-ED Discharge (Follow-up)|Overall Study||12
1574885|NCT01146665|3853624|P1|1-month Post-ED Discharge (Follow-up)|Overall Study||9
1574886|NCT01146665|3853623|P2|STARTED|Overall Study||26
1574887|NCT01146665|3853624|P1|STARTED|Overall Study||18
1574888|NCT01146613|3853656|P2|NOT COMPLETED|Overall Study||12
1574889|NCT01146613|3853657|P1|NOT COMPLETED|Overall Study||7
1574890|NCT01146613|3853656|P2|COMPLETED|Overall Study||89
1574891|NCT01146613|3853657|P1|COMPLETED|Overall Study||92
1574892|NCT01146613|3853656|P2|STARTED|Overall Study||101
1574893|NCT01146613|3853657|P1|STARTED|Overall Study||99
1574894|NCT01146600|3853665|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
1574895|NCT01146600|3853666|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
1574896|NCT01146600|3853665|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
1574897|NCT01146600|3853666|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
1574898|NCT01146600|3853665|P2|STARTED|Period 2 (Weeks 4 & 5)||10
1574899|NCT01146600|3853666|P1|STARTED|Period 2 (Weeks 4 & 5)||10
1574900|NCT01146600|3853665|P2|NOT COMPLETED|Washout (Week 3)||0
1574901|NCT01146600|3853666|P1|NOT COMPLETED|Washout (Week 3)||0
1574902|NCT01146600|3853665|P2|COMPLETED|Washout (Week 3)||10
1574903|NCT01146600|3853666|P1|COMPLETED|Washout (Week 3)||10
1574904|NCT01146600|3853665|P2|STARTED|Washout (Week 3)||10
1574905|NCT01146600|3853666|P1|STARTED|Washout (Week 3)||10
1574906|NCT01146600|3853665|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
1574907|NCT01146600|3853666|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
1574908|NCT01146600|3853665|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
1574909|NCT01146600|3853666|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
1574910|NCT01146600|3853665|P2|STARTED|Period 1 (Weeks 1 & 2)||10
1574911|NCT01146600|3853666|P1|STARTED|Period 1 (Weeks 1 & 2)||13
1574912|NCT01146457|3853696|P5|NOT COMPLETED|Overall Study||0
1574913|NCT01146457|3853697|P4|NOT COMPLETED|Overall Study||0
1574914|NCT01146457|3853698|P3|NOT COMPLETED|Overall Study||1
1574915|NCT01146457|3853699|P2|NOT COMPLETED|Overall Study||0
1574916|NCT01146457|3853700|P1|NOT COMPLETED|Overall Study||0
1574917|NCT01146457|3853696|P5|COMPLETED|Overall Study||13
1574918|NCT01146457|3853697|P4|COMPLETED|Overall Study||13
1574919|NCT01146457|3853698|P3|COMPLETED|Overall Study||20
1574920|NCT01146457|3853699|P2|COMPLETED|Overall Study||17
1574921|NCT01146457|3853700|P1|COMPLETED|Overall Study||19
1574922|NCT01146457|3853696|P5|STARTED|Overall Study||13
1574923|NCT01146457|3853697|P4|STARTED|Overall Study||13
1574924|NCT01146457|3853698|P3|STARTED|Overall Study||21
1574925|NCT01146457|3853699|P2|STARTED|Overall Study||17
1574926|NCT01146457|3853700|P1|STARTED|Overall Study||19
1574927|NCT01146418|3853714|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
1574928|NCT01146418|3853715|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
1574929|NCT01146418|3853716|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
1574930|NCT01146418|3853717|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
1574931|NCT01146418|3853714|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
1574932|NCT01146418|3853715|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
1574933|NCT01146418|3853716|P2|COMPLETED|Live-Born Infant Follow Up||0
1574934|NCT01146418|3853717|P1|COMPLETED|Live-Born Infant Follow Up||0
1574935|NCT01146418|3853714|P4|STARTED|Live-Born Infant Follow Up||56
1574936|NCT01146418|3853715|P3|STARTED|Live-Born Infant Follow Up||61
1574937|NCT01146418|3853716|P2|STARTED|Live-Born Infant Follow Up||0
1574938|NCT01146418|3853717|P1|STARTED|Live-Born Infant Follow Up||0
1574939|NCT01146418|3853714|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
1574940|NCT01146418|3853715|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
1574941|NCT01146418|3853716|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
1574942|NCT01146418|3853717|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
1574943|NCT01146418|3853714|P4|COMPLETED|Women/Expectant Mother Follow Up||0
1574944|NCT01146418|3853715|P3|COMPLETED|Women/Expectant Mother Follow Up||0
1574945|NCT01146418|3853716|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
1574946|NCT01146418|3853717|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
1574947|NCT01146418|3853714|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
1574948|NCT01146418|3853715|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
1574949|NCT01146418|3853716|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
1574950|NCT01146418|3853717|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
1574951|NCT01146418|3853714|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
1574952|NCT01146418|3853715|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
1574953|NCT01146418|3853716|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
1574954|NCT01146418|3853717|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
1574955|NCT01146418|3853714|P4|STARTED|Women/Expectant Mother Follow Up||0
1574956|NCT01146418|3853715|P3|STARTED|Women/Expectant Mother Follow Up||0
1574957|NCT01146418|3853716|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
1574958|NCT01146418|3853717|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
1574959|NCT01146418|3853714|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
1574960|NCT01146418|3853715|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
1574961|NCT01146418|3853716|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
1574962|NCT01146418|3853717|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
1574963|NCT01146418|3853714|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
1574964|NCT01146418|3853715|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
1574965|NCT01146418|3853716|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
1574966|NCT01146418|3853717|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
1574967|NCT01146418|3853714|P4|STARTED|Base Study P06029 (NCT01144416)||0
1574968|NCT01146418|3853715|P3|STARTED|Base Study P06029 (NCT01144416)||0
1574969|NCT01146418|3853716|P2|STARTED|Base Study P06029 (NCT01144416)||696
1574970|NCT01146418|3853717|P1|STARTED|Base Study P06029 (NCT01144416)||694
1574971|NCT01146379|3853733|P4|NOT COMPLETED|Overall Study||1
1574972|NCT01146379|3853734|P3|NOT COMPLETED|Overall Study||0
1574973|NCT01146379|3853735|P2|NOT COMPLETED|Overall Study||1
1574974|NCT01146379|3853736|P1|NOT COMPLETED|Overall Study||1
1574975|NCT01146379|3853733|P4|COMPLETED|Overall Study||20
1574976|NCT01146379|3853734|P3|COMPLETED|Overall Study||21
1574977|NCT01146379|3853735|P2|COMPLETED|Overall Study||21
1574978|NCT01146379|3853736|P1|COMPLETED|Overall Study||20
1574979|NCT01146379|3853733|P4|STARTED|Overall Study||21
1574980|NCT01146379|3853734|P3|STARTED|Overall Study||21
1574981|NCT01146379|3853735|P2|STARTED|Overall Study||22
1574982|NCT01146379|3853736|P1|STARTED|Overall Study||21
1574983|NCT01146288|3853748|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1574984|NCT01146288|3853749|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1574985|NCT01146288|3853748|P2|COMPLETED|Second Intervention (1 Day)||5
1574986|NCT01146288|3853749|P1|COMPLETED|Second Intervention (1 Day)||7
1574987|NCT01146288|3853748|P2|STARTED|Second Intervention (1 Day)||5
1574988|NCT01146288|3853749|P1|STARTED|Second Intervention (1 Day)||7
1574989|NCT01146288|3853748|P2|NOT COMPLETED|First Intervention(1 Day)||1
1574990|NCT01146288|3853749|P1|NOT COMPLETED|First Intervention(1 Day)||0
1574991|NCT01146288|3853748|P2|COMPLETED|First Intervention(1 Day)||5
1574992|NCT01146288|3853749|P1|COMPLETED|First Intervention(1 Day)||7
1574993|NCT01146288|3853748|P2|STARTED|First Intervention(1 Day)||6
1574994|NCT01146288|3853749|P1|STARTED|First Intervention(1 Day)||7
1574995|NCT01146275|3853758|P1|NOT COMPLETED|Overall Study||0
1574996|NCT01146275|3853758|P1|COMPLETED|Overall Study||6
1574997|NCT01146275|3853758|P1|STARTED|Overall Study||6
1574998|NCT01146054|3853763|P1|NOT COMPLETED|Overall Study||10
1574999|NCT01146054|3853763|P1|COMPLETED|Overall Study||49
1575000|NCT01146054|3853763|P1|STARTED|Overall Study||59
1575001|NCT01145898|3853773|P2|NOT COMPLETED|3-year Treatment||16
1575002|NCT01145898|3853774|P1|NOT COMPLETED|3-year Treatment||3
1575003|NCT01145898|3853773|P2|COMPLETED|3-year Treatment||28
1575004|NCT01145898|3853774|P1|COMPLETED|3-year Treatment||9
1575005|NCT01145898|3853773|P2|STARTED|3-year Treatment||44
1575006|NCT01145898|3853774|P1|STARTED|3-year Treatment||12
1575007|NCT01145898|3853773|P2|NOT COMPLETED|6-month Treatment||0
1575008|NCT01145898|3853774|P1|NOT COMPLETED|6-month Treatment||0
1575009|NCT01145898|3853773|P2|COMPLETED|6-month Treatment||44
1575010|NCT01145898|3853774|P1|COMPLETED|6-month Treatment||12
1575011|NCT01145898|3853773|P2|STARTED|6-month Treatment||44
1575012|NCT01145898|3853774|P1|STARTED|6-month Treatment||12
1575013|NCT01145755|3853808|P3|NOT COMPLETED|Overall Study||25
1575014|NCT01145755|3853809|P2|NOT COMPLETED|Overall Study||28
1575015|NCT01145755|3853810|P1|NOT COMPLETED|Overall Study||20
1575016|NCT01145755|3853808|P3|COMPLETED|Overall Study||19
1575017|NCT01145755|3853809|P2|COMPLETED|Overall Study||19
1575018|NCT01145755|3853810|P1|COMPLETED|Overall Study||20
1575019|NCT01145755|3853808|P3|STARTED|Overall Study||44
1575020|NCT01145755|3853809|P2|STARTED|Overall Study||47
1575021|NCT01145755|3853810|P1|STARTED|Overall Study||40
1575022|NCT01145638|3853826|P2|NOT COMPLETED|Overall Study||57
1575023|NCT01145638|3853827|P1|NOT COMPLETED|Overall Study||90
1575024|NCT01145638|3853826|P2|COMPLETED|Overall Study||62
1575025|NCT01145638|3853827|P1|COMPLETED|Overall Study||141
1575026|NCT01145638|3853826|P2|STARTED|Overall Study||119
1575027|NCT01145638|3853827|P1|STARTED|Overall Study||231
1575028|NCT01145625|3853837|P2|NOT COMPLETED|Overall Study||31
1575029|NCT01145625|3853838|P1|NOT COMPLETED|Overall Study||24
1575030|NCT01145625|3853837|P2|COMPLETED|Overall Study||130
1575031|NCT01145625|3853838|P1|COMPLETED|Overall Study||137
1575032|NCT01145625|3853837|P2|STARTED|Overall Study||161
1575033|NCT01145625|3853838|P1|STARTED|Overall Study||161
1575034|NCT01145560|3853851|P3|NOT COMPLETED|Overall Study||2
1575035|NCT01145560|3853852|P2|NOT COMPLETED|Overall Study||4
1575036|NCT01145560|3853853|P1|NOT COMPLETED|Overall Study||4
1575037|NCT01145560|3853851|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
1575038|NCT01145560|3853852|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
1575039|NCT01145560|3853853|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
1575040|NCT01145560|3853851|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
1575041|NCT01145560|3853852|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
1575042|NCT01145560|3853853|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
1575043|NCT01145560|3853851|P3|Received Treatment|Overall Study||99
1575044|NCT01145560|3853852|P2|Received Treatment|Overall Study||98
1575045|NCT01145560|3853853|P1|Received Treatment|Overall Study||99
1575046|NCT01145560|3853851|P3|STARTED|Overall Study||100
1575047|NCT01145560|3853852|P2|STARTED|Overall Study||100
1575048|NCT01145560|3853853|P1|STARTED|Overall Study||100
1575049|NCT01145547|3853870|P2|NOT COMPLETED|Overall Study||0
1575050|NCT01145547|3853871|P1|NOT COMPLETED|Overall Study||0
1575051|NCT01145547|3853870|P2|COMPLETED|Overall Study||3
1575052|NCT01145547|3853871|P1|COMPLETED|Overall Study||4
1575053|NCT01145547|3853870|P2|STARTED|Overall Study||3
1575054|NCT01145547|3853871|P1|STARTED|Overall Study||4
1575055|NCT01145508|3853879|P2|NOT COMPLETED|Overall Study||2
1575056|NCT01145508|3853880|P1|NOT COMPLETED|Overall Study||5
1575057|NCT01145508|3853879|P2|COMPLETED|Overall Study||1
1575058|NCT01145508|3853880|P1|COMPLETED|Overall Study||2
1575059|NCT01145508|3853879|P2|Treated|Overall Study||2
1575060|NCT01145508|3853880|P1|Treated|Overall Study||6
1575061|NCT01145508|3853879|P2|STARTED|Overall Study||3
1575062|NCT01145508|3853880|P1|STARTED|Overall Study||7
1575063|NCT01145495|3853886|P1|NOT COMPLETED|Overall Study||12
1575064|NCT01145495|3853886|P1|COMPLETED|Overall Study||51
1575065|NCT01145495|3853886|P1|STARTED|Overall Study||63
1575066|NCT01145482|3853892|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1575067|NCT01145482|3853893|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1575068|NCT01145482|3853892|P2|COMPLETED|Second Intervention (1 Day)||6
1575069|NCT01145482|3853893|P1|COMPLETED|Second Intervention (1 Day)||5
1575070|NCT01145482|3853892|P2|STARTED|Second Intervention (1 Day)||6
1575071|NCT01145482|3853893|P1|STARTED|Second Intervention (1 Day)||5
1575072|NCT01145482|3853892|P2|NOT COMPLETED|First Intervention (1 Day)||1
1575073|NCT01145482|3853893|P1|NOT COMPLETED|First Intervention (1 Day)||0
1575074|NCT01145482|3853892|P2|COMPLETED|First Intervention (1 Day)||5
1575075|NCT01145482|3853893|P1|COMPLETED|First Intervention (1 Day)||6
1575076|NCT01145482|3853892|P2|STARTED|First Intervention (1 Day)||6
1575077|NCT01145482|3853893|P1|STARTED|First Intervention (1 Day)||6
1575078|NCT01145417|3853903|P2|NOT COMPLETED|Overall Study||47
1575079|NCT01145417|3853904|P1|NOT COMPLETED|Overall Study||41
1575080|NCT01145417|3853903|P2|COMPLETED|Overall Study||62
1575081|NCT01145417|3853904|P1|COMPLETED|Overall Study||67
1575082|NCT01145417|3853903|P2|STARTED|Overall Study||109
1575083|NCT01145417|3853904|P1|STARTED|Overall Study||108
1575084|NCT01145391|3853928|P2|NOT COMPLETED|Overall Study||0
1575085|NCT01145391|3853929|P1|NOT COMPLETED|Overall Study||0
1575086|NCT01145391|3853928|P2|COMPLETED|Overall Study||298
1575087|NCT01145391|3853929|P1|COMPLETED|Overall Study||293
1575088|NCT01145391|3853928|P2|9 Months Post-randomization|Overall Study||298
1575089|NCT01145391|3853929|P1|9 Months Post-randomization|Overall Study||293
1575090|NCT01145391|3853928|P2|STARTED|Overall Study||298
1575091|NCT01145391|3853929|P1|STARTED|Overall Study||293
1575092|NCT01145352|3853937|P1|NOT COMPLETED|Overall Study||11
1575093|NCT01145352|3853937|P1|COMPLETED|Overall Study||102
1575094|NCT01145352|3853937|P1|STARTED|Overall Study||113
1575095|NCT01145066|3853948|P3|NOT COMPLETED|Overall Study||4
1575096|NCT01145066|3853949|P2|NOT COMPLETED|Overall Study||4
1575097|NCT01145066|3853950|P1|NOT COMPLETED|Overall Study||4
1575098|NCT01145066|3853948|P3|COMPLETED|Overall Study||21
1575099|NCT01145066|3853949|P2|COMPLETED|Overall Study||16
1575100|NCT01145066|3853950|P1|COMPLETED|Overall Study||22
1575101|NCT01145066|3853948|P3|STARTED|Overall Study||25
1575102|NCT01145066|3853949|P2|STARTED|Overall Study||20
1575103|NCT01145066|3853950|P1|STARTED|Overall Study||26
1575104|NCT01145053|3854018|P1|NOT COMPLETED|Overall Study||93
1575105|NCT01145053|3854018|P1|COMPLETED|Overall Study||248
1575106|NCT01145053|3854018|P1|STARTED|Overall Study||341
1575107|NCT01145001|3854032|P4|NOT COMPLETED|Overall Study||6
1575108|NCT01145001|3854033|P3|NOT COMPLETED|Overall Study||5
1575109|NCT01145001|3854034|P2|NOT COMPLETED|Overall Study||6
1575110|NCT01145001|3854035|P1|NOT COMPLETED|Overall Study||8
1575111|NCT01145001|3854032|P4|COMPLETED|Overall Study||31
1575112|NCT01145001|3854033|P3|COMPLETED|Overall Study||39
1575113|NCT01145001|3854034|P2|COMPLETED|Overall Study||31
1575114|NCT01145001|3854035|P1|COMPLETED|Overall Study||28
1575115|NCT01145001|3854032|P4|STARTED|Overall Study||37
1575116|NCT01145001|3854033|P3|STARTED|Overall Study||44
1575117|NCT01145001|3854034|P2|STARTED|Overall Study||37
1575118|NCT01145001|3854035|P1|STARTED|Overall Study||36
1575119|NCT01144949|3854051|P2|NOT COMPLETED|Overall Study||14
1575120|NCT01144949|3854052|P1|NOT COMPLETED|Overall Study||11
1575121|NCT01144949|3854051|P2|COMPLETED|Overall Study||106
1575122|NCT01144949|3854052|P1|COMPLETED|Overall Study||108
1575123|NCT01144949|3854051|P2|STARTED|Overall Study||120
1575124|NCT01144949|3854052|P1|STARTED|Overall Study||119
1575125|NCT01144715|3854070|P2|NOT COMPLETED|Overall Study||3
1575126|NCT01144715|3854071|P1|NOT COMPLETED|Overall Study||4
1575127|NCT01144715|3854070|P2|COMPLETED|Overall Study||45
1575128|NCT01144715|3854071|P1|COMPLETED|Overall Study||47
1575129|NCT01144715|3854070|P2|STARTED|Overall Study||48
1575130|NCT01144715|3854071|P1|STARTED|Overall Study||51
1575131|NCT01144624|3854086|P3|NOT COMPLETED|Overall Study||0
1575132|NCT01144624|3854087|P2|NOT COMPLETED|Overall Study||0
1575133|NCT01144624|3854088|P1|NOT COMPLETED|Overall Study||0
1575134|NCT01144624|3854086|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
1575135|NCT01144624|3854087|P2|COMPLETED|Overall Study||7
1575136|NCT01144624|3854088|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
1575137|NCT01144624|3854086|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
1575138|NCT01144624|3854087|P2|Completed Treatment|Overall Study||7
1575139|NCT01144624|3854088|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
1575140|NCT01144624|3854086|P3|Received Treatment|Overall Study||6
1575141|NCT01144624|3854087|P2|Received Treatment|Overall Study||7
1575142|NCT01144624|3854088|P1|Received Treatment|Overall Study||7
1575143|NCT01144624|3854086|P3|STARTED|Overall Study||6
1575144|NCT01144624|3854087|P2|STARTED|Overall Study||7
1575145|NCT01144624|3854088|P1|STARTED|Overall Study||7
1575146|NCT01144598|3854102|P1|NOT COMPLETED|Overall Study||0
1575147|NCT01144598|3854102|P1|COMPLETED|Overall Study||356
1575148|NCT01144598|3854102|P1|Analysis Population|Overall Study||356
1575149|NCT01144598|3854102|P1|STARTED|Overall Study||356
1575150|NCT01144455|3854123|P3|NOT COMPLETED|Overall Study||36
1575151|NCT01144455|3854124|P2|NOT COMPLETED|Overall Study||42
1575152|NCT01144455|3854125|P1|NOT COMPLETED|Overall Study||50
1575153|NCT01144455|3854123|P3|COMPLETED|Overall Study||38
1575154|NCT01144455|3854124|P2|COMPLETED|Overall Study||29
1575155|NCT01144455|3854125|P1|COMPLETED|Overall Study||19
1575156|NCT01144455|3854123|P3|STARTED|Overall Study||74
1575157|NCT01144455|3854124|P2|STARTED|Overall Study||71
1575158|NCT01144455|3854125|P1|STARTED|Overall Study||69
1575159|NCT01144442|3854133|P1|NOT COMPLETED|Overall Study||0
1575160|NCT01144442|3854133|P1|COMPLETED|Overall Study||10
1575161|NCT01144442|3854133|P1|STARTED|Overall Study||10
1575162|NCT01144416|3854140|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
1575163|NCT01144416|3854141|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
1575164|NCT01144416|3854140|P2|COMPLETED|Pregnancy Follow-up Period||157
1575165|NCT01144416|3854141|P1|COMPLETED|Pregnancy Follow-up Period||146
1575166|NCT01144416|3854140|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
1575167|NCT01144416|3854141|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
1575168|NCT01144416|3854140|P2|NOT COMPLETED|Intervention Period||49
1575169|NCT01144416|3854141|P1|NOT COMPLETED|Intervention Period||62
1575170|NCT01144416|3854140|P2|COMPLETED|Intervention Period||647
1575171|NCT01144416|3854141|P1|COMPLETED|Intervention Period||632
1575172|NCT01144416|3854140|P2|STARTED|Intervention Period||696
1575173|NCT01144416|3854141|P1|STARTED|Intervention Period||694
1575174|NCT01144403|3854157|P1|NOT COMPLETED|Overall Study||5
1575175|NCT01144403|3854157|P1|COMPLETED|Overall Study||3
1575176|NCT01144403|3854157|P1|STARTED|Overall Study||8
1575177|NCT01144377|3854169|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
1575178|NCT01144377|3854170|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
1575179|NCT01144377|3854171|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
1575180|NCT01144377|3854172|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
1575181|NCT01144377|3854173|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
1575182|NCT01144377|3854169|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
1575183|NCT01144377|3854170|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
1575184|NCT01144377|3854171|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
1575185|NCT01144377|3854172|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
1575186|NCT01144377|3854173|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
1575187|NCT01144377|3854169|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
1575188|NCT01144377|3854170|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
1575189|NCT01144377|3854171|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
1575190|NCT01144377|3854172|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
1575191|NCT01144377|3854173|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
1575192|NCT01144377|3854169|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
1575193|NCT01144377|3854170|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
1575194|NCT01144377|3854171|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
1575195|NCT01144377|3854172|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
1575196|NCT01144377|3854173|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
1575197|NCT01144377|3854169|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
1575198|NCT01144377|3854170|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
1575199|NCT01144377|3854171|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
1575200|NCT01144377|3854172|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
1575201|NCT01144377|3854173|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
1575202|NCT01144377|3854169|P5|STARTED|12 Week Safety Follow-up Period||34
1575203|NCT01144377|3854170|P4|STARTED|12 Week Safety Follow-up Period||22
1575204|NCT01144377|3854171|P3|STARTED|12 Week Safety Follow-up Period||25
1575205|NCT01144377|3854172|P2|STARTED|12 Week Safety Follow-up Period||29
1575206|NCT01144377|3854173|P1|STARTED|12 Week Safety Follow-up Period||26
1575207|NCT01144377|3854169|P5|NOT COMPLETED|52 Week Treatment Period||3
1575208|NCT01144377|3854170|P4|NOT COMPLETED|52 Week Treatment Period||4
1575209|NCT01144377|3854171|P3|NOT COMPLETED|52 Week Treatment Period||5
1575210|NCT01144377|3854172|P2|NOT COMPLETED|52 Week Treatment Period||1
1575211|NCT01144377|3854173|P1|NOT COMPLETED|52 Week Treatment Period||5
1575212|NCT01144377|3854169|P5|COMPLETED|52 Week Treatment Period||34
1575213|NCT01144377|3854170|P4|COMPLETED|52 Week Treatment Period||22
1575214|NCT01144377|3854171|P3|COMPLETED|52 Week Treatment Period||25
1575215|NCT01144377|3854172|P2|COMPLETED|52 Week Treatment Period||29
1575216|NCT01144377|3854173|P1|COMPLETED|52 Week Treatment Period||26
1575217|NCT01144377|3854169|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
1575218|NCT01144377|3854170|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
1575219|NCT01144377|3854171|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
1575220|NCT01144377|3854172|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
1575221|NCT01144377|3854173|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
1575222|NCT01144377|3854169|P5|STARTED|52 Week Treatment Period||37
1575223|NCT01144377|3854170|P4|STARTED|52 Week Treatment Period||26
1575224|NCT01144377|3854171|P3|STARTED|52 Week Treatment Period||30
1575225|NCT01144377|3854172|P2|STARTED|52 Week Treatment Period||30
1575226|NCT01144377|3854173|P1|STARTED|52 Week Treatment Period||31
1575227|NCT01144364|3854222|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
1575228|NCT01144364|3854223|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
1575229|NCT01144364|3854224|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
1575230|NCT01144364|3854222|P3|COMPLETED|Follow-Up/Maintenance Phase||60
1575231|NCT01144364|3854223|P2|COMPLETED|Follow-Up/Maintenance Phase||66
1575232|NCT01144364|3854224|P1|COMPLETED|Follow-Up/Maintenance Phase||0
1575233|NCT01144364|3854222|P3|STARTED|Follow-Up/Maintenance Phase||101
1575234|NCT01144364|3854223|P2|STARTED|Follow-Up/Maintenance Phase||101
1575235|NCT01144364|3854224|P1|STARTED|Follow-Up/Maintenance Phase||0
1575236|NCT01144364|3854222|P3|NOT COMPLETED|Induction Phase||0
1575237|NCT01144364|3854223|P2|NOT COMPLETED|Induction Phase||0
1575238|NCT01144364|3854224|P1|NOT COMPLETED|Induction Phase||32
1575239|NCT01144364|3854222|P3|COMPLETED|Induction Phase||0
1575240|NCT01144364|3854223|P2|COMPLETED|Induction Phase||0
1575241|NCT01144364|3854224|P1|COMPLETED|Induction Phase||202
1575242|NCT01144364|3854222|P3|STARTED|Induction Phase||0
1575243|NCT01144364|3854223|P2|STARTED|Induction Phase||0
1575244|NCT01144364|3854224|P1|STARTED|Induction Phase||234
1575245|NCT01144338|3854250|P2|NOT COMPLETED|Overall Study||262
1575246|NCT01144338|3854251|P1|NOT COMPLETED|Overall Study||303
1575247|NCT01144338|3854250|P2|COMPLETED|Overall Study||7094
1575248|NCT01144338|3854251|P1|COMPLETED|Overall Study||7093
1575249|NCT01144338|3854250|P2|STARTED|Overall Study||7356
1575250|NCT01144338|3854251|P1|STARTED|Overall Study||7396
1575251|NCT01144299|3854273|P2|NOT COMPLETED|Overall Study||0
1575252|NCT01144299|3854274|P1|NOT COMPLETED|Overall Study||2
1575253|NCT01144299|3854273|P2|COMPLETED|Overall Study||54
1575254|NCT01144299|3854274|P1|COMPLETED|Overall Study||58
1575255|NCT01144299|3854273|P2|STARTED|Overall Study||54
1575256|NCT01144299|3854274|P1|STARTED|Overall Study||60
1575257|NCT01144286|3854300|P4|NOT COMPLETED|Overall Study||0
1575258|NCT01144286|3854301|P3|NOT COMPLETED|Overall Study||0
1575259|NCT01144286|3854302|P2|NOT COMPLETED|Overall Study||0
1575260|NCT01144286|3854303|P1|NOT COMPLETED|Overall Study||0
1575261|NCT01144286|3854300|P4|COMPLETED|Overall Study||56
1575262|NCT01144286|3854301|P3|COMPLETED|Overall Study||58
1575263|NCT01144286|3854302|P2|COMPLETED|Overall Study||58
1575264|NCT01144286|3854303|P1|COMPLETED|Overall Study||57
1575265|NCT01144286|3854300|P4|STARTED|Overall Study||56
1575266|NCT01144286|3854301|P3|STARTED|Overall Study||58
1575267|NCT01144286|3854302|P2|STARTED|Overall Study||58
1575268|NCT01144286|3854303|P1|STARTED|Overall Study||57
1575269|NCT01144182|3854319|P2|NOT COMPLETED|Overall Study||21
1575270|NCT01144182|3854320|P1|NOT COMPLETED|Overall Study||17
1575271|NCT01144182|3854319|P2|COMPLETED|Overall Study||47
1575272|NCT01144182|3854320|P1|COMPLETED|Overall Study||51
1575273|NCT01144182|3854319|P2|STARTED|Overall Study||68
1575274|NCT01144182|3854320|P1|STARTED|Overall Study||68
1575275|NCT01144143|3854353|P3|NOT COMPLETED|Overall Study||0
1575276|NCT01144143|3854354|P2|NOT COMPLETED|Overall Study||0
1575277|NCT01144143|3854355|P1|NOT COMPLETED|Overall Study||0
1575278|NCT01144143|3854353|P3|COMPLETED|Overall Study||4
1575279|NCT01144143|3854354|P2|COMPLETED|Overall Study||4
1575280|NCT01144143|3854355|P1|COMPLETED|Overall Study||8
1575281|NCT01144143|3854353|P3|STARTED|Overall Study||4
1575282|NCT01144143|3854354|P2|STARTED|Overall Study||4
1575283|NCT01144143|3854355|P1|STARTED|Overall Study||8
1575284|NCT01144052|3854380|P2|NOT COMPLETED|Overall Study||1
1575285|NCT01144052|3854381|P1|NOT COMPLETED|Overall Study||1
1575286|NCT01144052|3854380|P2|COMPLETED|Overall Study||8
1575287|NCT01144052|3854381|P1|COMPLETED|Overall Study||9
1575288|NCT01144052|3854380|P2|STARTED|Overall Study||9
1575289|NCT01144052|3854381|P1|STARTED|Overall Study||10
1575290|NCT01144026|3854403|P2|NOT COMPLETED|Overall Study||0
1575291|NCT01144026|3854404|P1|NOT COMPLETED|Overall Study||0
1575292|NCT01144026|3854403|P2|COMPLETED|Overall Study||5
1575293|NCT01144026|3854404|P1|COMPLETED|Overall Study||10
1575294|NCT01144026|3854403|P2|STARTED|Overall Study||5
1575295|NCT01144026|3854404|P1|STARTED|Overall Study||10
1575296|NCT01143896|3854412|P2|NOT COMPLETED|Overall Study||25
1575297|NCT01143896|3854413|P1|NOT COMPLETED|Overall Study||42
1575298|NCT01143896|3854412|P2|COMPLETED|Overall Study||128
1575299|NCT01143896|3854413|P1|COMPLETED|Overall Study||114
1575300|NCT01143896|3854412|P2|STARTED|Overall Study||153
1575301|NCT01143896|3854413|P1|STARTED|Overall Study||156
1575302|NCT01143883|3854431|P2|NOT COMPLETED|Overall Study||0
1575303|NCT01143883|3854432|P1|NOT COMPLETED|Overall Study||0
1575304|NCT01143883|3854431|P2|COMPLETED|Overall Study||55
1575305|NCT01143883|3854432|P1|COMPLETED|Overall Study||55
1575306|NCT01143883|3854431|P2|STARTED|Overall Study||55
1575307|NCT01143883|3854432|P1|STARTED|Overall Study||55
1575308|NCT01143870|3854441|P3|NOT COMPLETED|Overall Study||0
1575309|NCT01143870|3854442|P2|NOT COMPLETED|Overall Study||0
1575310|NCT01143870|3854443|P1|NOT COMPLETED|Overall Study||0
1575311|NCT01143870|3854441|P3|COMPLETED|Overall Study||61
1575312|NCT01143870|3854442|P2|COMPLETED|Overall Study||58
1575313|NCT01143870|3854443|P1|COMPLETED|Overall Study||58
1575314|NCT01143870|3854441|P3|A1C Imputed|Overall Study||30
1575315|NCT01143870|3854442|P2|A1C Imputed|Overall Study||29
1575316|NCT01143870|3854443|P1|A1C Imputed|Overall Study||31
1575317|NCT01143870|3854441|P3|Had Available 6-month A1C|Overall Study||31
1575318|NCT01143870|3854442|P2|Had Available 6-month A1C|Overall Study||29
1575319|NCT01143870|3854443|P1|Had Available 6-month A1C|Overall Study||27
1575320|NCT01143870|3854441|P3|Post-intervention Survey|Overall Study||61
1575321|NCT01143870|3854442|P2|Post-intervention Survey|Overall Study||50
1575322|NCT01143870|3854443|P1|Post-intervention Survey|Overall Study||53
1575323|NCT01143870|3854441|P3|STARTED|Overall Study||61
1575324|NCT01143870|3854442|P2|STARTED|Overall Study||58
1575325|NCT01143870|3854443|P1|STARTED|Overall Study||58
1575326|NCT01143818|3854451|P1|NOT COMPLETED|Overall Study||250
1575327|NCT01143818|3854451|P1|COMPLETED|Overall Study||799
1575328|NCT01143818|3854451|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
1575329|NCT01143792|3854461|P3|NOT COMPLETED|Overall Study||0
1575330|NCT01143792|3854462|P2|NOT COMPLETED|Overall Study||0
1575331|NCT01143792|3854463|P1|NOT COMPLETED|Overall Study||0
1575332|NCT01143792|3854461|P3|COMPLETED|Overall Study||91
1575333|NCT01143792|3854462|P2|COMPLETED|Overall Study||86
1575334|NCT01143792|3854463|P1|COMPLETED|Overall Study||93
1575335|NCT01143792|3854461|P3|STARTED|Overall Study||91
1575336|NCT01143792|3854462|P2|STARTED|Overall Study||86
1575337|NCT01143792|3854463|P1|STARTED|Overall Study||93
1575338|NCT01143766|3854497|P2|NOT COMPLETED|Overall Study||0
1575339|NCT01143766|3854498|P1|NOT COMPLETED|Overall Study||0
1575340|NCT01143766|3854497|P2|COMPLETED|Overall Study||31
1575341|NCT01143766|3854498|P1|COMPLETED|Overall Study||25
1575342|NCT01143766|3854497|P2|STARTED|Overall Study||31
1575343|NCT01143766|3854498|P1|STARTED|Overall Study||25
1575344|NCT01143727|3854514|P2|NOT COMPLETED|Overall Study||0
1575345|NCT01143727|3854515|P1|NOT COMPLETED|Overall Study||0
1575346|NCT01143727|3854514|P2|COMPLETED|Overall Study||8
1575347|NCT01143727|3854515|P1|COMPLETED|Overall Study||9
1575348|NCT01143727|3854514|P2|STARTED|Overall Study||8
1575349|NCT01143727|3854515|P1|STARTED|Overall Study||9
1575350|NCT01143714|3854525|P2|NOT COMPLETED|Overall Study||3
1575351|NCT01143714|3854526|P1|NOT COMPLETED|Overall Study||7
1575352|NCT01143714|3854525|P2|COMPLETED|Overall Study||25
1575353|NCT01143714|3854526|P1|COMPLETED|Overall Study||22
1575354|NCT01143714|3854525|P2|STARTED|Overall Study||28
1575355|NCT01143714|3854526|P1|STARTED|Overall Study||29
1575356|NCT01143701|3854536|P2|NOT COMPLETED|Overall Study||32
1575357|NCT01143701|3854537|P1|NOT COMPLETED|Overall Study||23
1575358|NCT01143701|3854536|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
1575359|NCT01143701|3854537|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
1575360|NCT01143701|3854536|P2|STARTED|Overall Study||319
1575361|NCT01143701|3854537|P1|STARTED|Overall Study||258
1575362|NCT01143688|3854545|P1|NOT COMPLETED|Overall Study||0
1575363|NCT01143688|3854545|P1|COMPLETED|Overall Study||39
1575364|NCT01143688|3854545|P1|STARTED|Overall Study||39
1575365|NCT01143649|3854564|P6|NOT COMPLETED|Overall Study||2
1575366|NCT01143649|3854565|P5|NOT COMPLETED|Overall Study||1
1575367|NCT01143649|3854566|P4|NOT COMPLETED|Overall Study||0
1575368|NCT01143649|3854567|P3|NOT COMPLETED|Overall Study||0
1575369|NCT01143649|3854568|P2|NOT COMPLETED|Overall Study||0
1575370|NCT01143649|3854569|P1|NOT COMPLETED|Overall Study||0
1575371|NCT01143649|3854564|P6|COMPLETED|Overall Study||3
1575372|NCT01143649|3854565|P5|COMPLETED|Overall Study||4
1575373|NCT01143649|3854566|P4|COMPLETED|Overall Study||10
1575374|NCT01143649|3854567|P3|COMPLETED|Overall Study||10
1575375|NCT01143649|3854568|P2|COMPLETED|Overall Study||7
1575376|NCT01143649|3854569|P1|COMPLETED|Overall Study||7
1575377|NCT01143649|3854564|P6|STARTED|Overall Study||5
1575378|NCT01143649|3854565|P5|STARTED|Overall Study||5
1575379|NCT01143649|3854566|P4|STARTED|Overall Study||10
1575380|NCT01143649|3854567|P3|STARTED|Overall Study||10
1575381|NCT01143649|3854568|P2|STARTED|Overall Study||7
1575382|NCT01143649|3854569|P1|STARTED|Overall Study||7
1575383|NCT01143636|3854586|P4|NOT COMPLETED|Overall Study||0
1575384|NCT01143636|3854587|P3|NOT COMPLETED|Overall Study||0
1575385|NCT01143636|3854588|P2|NOT COMPLETED|Overall Study||1
1575386|NCT01143636|3854589|P1|NOT COMPLETED|Overall Study||1
1575387|NCT01143636|3854586|P4|COMPLETED|Overall Study||7
1575388|NCT01143636|3854587|P3|COMPLETED|Overall Study||8
1575389|NCT01143636|3854588|P2|COMPLETED|Overall Study||4
1575390|NCT01143636|3854589|P1|COMPLETED|Overall Study||5
1575391|NCT01143636|3854586|P4|STARTED|Overall Study||7
1575392|NCT01143636|3854587|P3|STARTED|Overall Study||8
1575393|NCT01143636|3854588|P2|STARTED|Overall Study||5
1575394|NCT01143636|3854589|P1|STARTED|Overall Study||6
1575395|NCT01143610|3854619|P2|NOT COMPLETED|Overall Study||0
1575396|NCT01143610|3854620|P1|NOT COMPLETED|Overall Study||0
1575397|NCT01143610|3854619|P2|COMPLETED|Overall Study||8
1575398|NCT01143610|3854620|P1|COMPLETED|Overall Study||7
1575399|NCT01143610|3854619|P2|STARTED|Overall Study||8
1575400|NCT01143610|3854620|P1|STARTED|Overall Study||7
1575401|NCT01143402|3854631|P3|NOT COMPLETED|Overall Study||1
1575402|NCT01143402|3854632|P2|NOT COMPLETED|Overall Study||1
1575403|NCT01143402|3854633|P1|NOT COMPLETED|Overall Study||1
1575404|NCT01143402|3854631|P3|COMPLETED|Overall Study||18
1575405|NCT01143402|3854632|P2|COMPLETED|Overall Study||49
1575406|NCT01143402|3854633|P1|COMPLETED|Overall Study||50
1575407|NCT01143402|3854631|P3|STARTED|Overall Study||19
1575408|NCT01143402|3854632|P2|STARTED|Overall Study||50
1575409|NCT01143402|3854633|P1|STARTED|Overall Study||51
1575410|NCT01143389|3854644|P2|NOT COMPLETED|Overall Study||25
1575411|NCT01143389|3854645|P1|NOT COMPLETED|Overall Study||26
1575412|NCT01143389|3854644|P2|COMPLETED|Overall Study||232
1575413|NCT01143389|3854645|P1|COMPLETED|Overall Study||227
1575414|NCT01143389|3854644|P2|STARTED|Overall Study||257
1575415|NCT01143389|3854645|P1|STARTED|Overall Study||253
1575416|NCT01143337|3854659|P3|NOT COMPLETED|Overall Study||12
1575417|NCT01143337|3854660|P2|NOT COMPLETED|Overall Study||11
1575418|NCT01143337|3854661|P1|NOT COMPLETED|Overall Study||10
1575419|NCT01143337|3854659|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
1575420|NCT01143337|3854660|P2|COMPLETED|Overall Study||39
1575421|NCT01143337|3854661|P1|COMPLETED|Overall Study||39
1575422|NCT01143337|3854659|P3|STARTED|Overall Study||13
1575423|NCT01143337|3854660|P2|STARTED|Overall Study||50
1575424|NCT01143337|3854661|P1|STARTED|Overall Study||49
1575425|NCT01143324|3854675|P1|NOT COMPLETED|Overall Study||19
1575426|NCT01143324|3854675|P1|COMPLETED|Overall Study||233
1575427|NCT01143324|3854675|P1|STARTED|Overall Study||252
1575428|NCT01143272|3854693|P2|NOT COMPLETED|Overall Study||0
1575429|NCT01143272|3854694|P1|NOT COMPLETED|Overall Study||0
1575430|NCT01143272|3854693|P2|COMPLETED|Overall Study||231
1575431|NCT01143272|3854694|P1|COMPLETED|Overall Study||246
1575432|NCT01143272|3854693|P2|STARTED|Overall Study||231
1575433|NCT01143272|3854694|P1|STARTED|Overall Study||246
1575434|NCT01143259|3854714|P2|NOT COMPLETED|Overall Study||20
1575435|NCT01143259|3854715|P1|NOT COMPLETED|Overall Study||23
1575436|NCT01143259|3854714|P2|COMPLETED|Overall Study||118
1575437|NCT01143259|3854715|P1|COMPLETED|Overall Study||113
1575438|NCT01143259|3854714|P2|STARTED|Overall Study||138
1575439|NCT01143259|3854715|P1|STARTED|Overall Study||136
1575440|NCT01143207|3854723|P1|NOT COMPLETED|Overall Study||2
1575441|NCT01143207|3854723|P1|COMPLETED|Overall Study||24
1575442|NCT01143207|3854723|P1|STARTED|Overall Study||26
1575443|NCT01143142|3854734|P2|NOT COMPLETED|Overall Study||0
1575444|NCT01143142|3854735|P1|NOT COMPLETED|Overall Study||0
1575445|NCT01143142|3854734|P2|COMPLETED|Overall Study||34
1575446|NCT01143142|3854735|P1|COMPLETED|Overall Study||36
1575447|NCT01143142|3854734|P2|STARTED|Overall Study||34
1575448|NCT01143142|3854735|P1|STARTED|Overall Study||36
1575449|NCT01143090|3854743|P1|NOT COMPLETED|Overall Study||51
1575450|NCT01143090|3854743|P1|COMPLETED|Overall Study||98
1575451|NCT01143090|3854743|P1|STARTED|Overall Study||149
1575452|NCT01143077|3854750|P3|NOT COMPLETED|Overall Study||15
1575453|NCT01143077|3854751|P2|NOT COMPLETED|Overall Study||15
1575454|NCT01143077|3854752|P1|NOT COMPLETED|Overall Study||16
1575455|NCT01143077|3854750|P3|COMPLETED|Overall Study||67
1575456|NCT01143077|3854751|P2|COMPLETED|Overall Study||73
1575457|NCT01143077|3854752|P1|COMPLETED|Overall Study||58
1575458|NCT01143077|3854750|P3|STARTED|Overall Study||82
1575459|NCT01143077|3854751|P2|STARTED|Overall Study||88
1575460|NCT01143077|3854752|P1|STARTED|Overall Study||74
1575461|NCT01143051|3854769|P6|NOT COMPLETED|Visit 3||0
1575462|NCT01143051|3854770|P5|NOT COMPLETED|Visit 3||0
1575463|NCT01143051|3854771|P4|NOT COMPLETED|Visit 3||0
1575464|NCT01143051|3854772|P3|NOT COMPLETED|Visit 3||0
1575465|NCT01143051|3854773|P2|NOT COMPLETED|Visit 3||0
1575466|NCT01143051|3854774|P1|NOT COMPLETED|Visit 3||0
1575467|NCT01143051|3854769|P6|COMPLETED|Visit 3||3
1575468|NCT01143051|3854770|P5|COMPLETED|Visit 3||4
1575469|NCT01143051|3854771|P4|COMPLETED|Visit 3||4
1575470|NCT01143051|3854772|P3|COMPLETED|Visit 3||3
1575471|NCT01143051|3854773|P2|COMPLETED|Visit 3||4
1575472|NCT01143051|3854774|P1|COMPLETED|Visit 3||4
1575473|NCT01143051|3854769|P6|STARTED|Visit 3||3
1575474|NCT01143051|3854770|P5|STARTED|Visit 3||4
1575475|NCT01143051|3854771|P4|STARTED|Visit 3||4
1575476|NCT01143051|3854772|P3|STARTED|Visit 3||3
1575477|NCT01143051|3854773|P2|STARTED|Visit 3||4
1575478|NCT01143051|3854774|P1|STARTED|Visit 3||4
1575479|NCT01143051|3854769|P6|NOT COMPLETED|3-14 Day Washout||1
1575480|NCT01143051|3854770|P5|NOT COMPLETED|3-14 Day Washout||0
1575481|NCT01143051|3854771|P4|NOT COMPLETED|3-14 Day Washout||0
1575482|NCT01143051|3854772|P3|NOT COMPLETED|3-14 Day Washout||0
1575483|NCT01143051|3854773|P2|NOT COMPLETED|3-14 Day Washout||0
1575484|NCT01143051|3854774|P1|NOT COMPLETED|3-14 Day Washout||0
1575485|NCT01143051|3854769|P6|COMPLETED|3-14 Day Washout||3
1575486|NCT01143051|3854770|P5|COMPLETED|3-14 Day Washout||4
1575487|NCT01143051|3854771|P4|COMPLETED|3-14 Day Washout||4
1575488|NCT01143051|3854772|P3|COMPLETED|3-14 Day Washout||3
1575489|NCT01143051|3854773|P2|COMPLETED|3-14 Day Washout||4
1575490|NCT01143051|3854774|P1|COMPLETED|3-14 Day Washout||4
1575491|NCT01143051|3854769|P6|STARTED|3-14 Day Washout||4
1575492|NCT01143051|3854770|P5|STARTED|3-14 Day Washout||4
1575493|NCT01143051|3854771|P4|STARTED|3-14 Day Washout||4
1575494|NCT01143051|3854772|P3|STARTED|3-14 Day Washout||3
1575495|NCT01143051|3854773|P2|STARTED|3-14 Day Washout||4
1575496|NCT01143051|3854774|P1|STARTED|3-14 Day Washout||4
1575497|NCT01143051|3854769|P6|NOT COMPLETED|Visit 2||0
1575498|NCT01143051|3854770|P5|NOT COMPLETED|Visit 2||0
1575499|NCT01143051|3854771|P4|NOT COMPLETED|Visit 2||0
1575500|NCT01143051|3854772|P3|NOT COMPLETED|Visit 2||0
1575501|NCT01143051|3854773|P2|NOT COMPLETED|Visit 2||0
1575502|NCT01143051|3854774|P1|NOT COMPLETED|Visit 2||0
1575503|NCT01143051|3854769|P6|COMPLETED|Visit 2||4
1575504|NCT01143051|3854770|P5|COMPLETED|Visit 2||4
1575505|NCT01143051|3854771|P4|COMPLETED|Visit 2||4
1575506|NCT01143051|3854772|P3|COMPLETED|Visit 2||3
1575507|NCT01143051|3854773|P2|COMPLETED|Visit 2||4
1575508|NCT01143051|3854774|P1|COMPLETED|Visit 2||4
1575509|NCT01143051|3854769|P6|STARTED|Visit 2||4
1575510|NCT01143051|3854770|P5|STARTED|Visit 2||4
1575511|NCT01143051|3854771|P4|STARTED|Visit 2||4
1575512|NCT01143051|3854772|P3|STARTED|Visit 2||3
1575513|NCT01143051|3854773|P2|STARTED|Visit 2||4
1575514|NCT01143051|3854774|P1|STARTED|Visit 2||4
1575515|NCT01143051|3854769|P6|NOT COMPLETED|3-14 Day Washout||0
1575516|NCT01143051|3854770|P5|NOT COMPLETED|3-14 Day Washout||0
1575517|NCT01143051|3854771|P4|NOT COMPLETED|3-14 Day Washout||0
1575518|NCT01143051|3854772|P3|NOT COMPLETED|3-14 Day Washout||1
1575519|NCT01143051|3854773|P2|NOT COMPLETED|3-14 Day Washout||0
1575520|NCT01143051|3854774|P1|NOT COMPLETED|3-14 Day Washout||0
1575521|NCT01143051|3854769|P6|COMPLETED|3-14 Day Washout||4
1575522|NCT01143051|3854770|P5|COMPLETED|3-14 Day Washout||4
1575523|NCT01143051|3854771|P4|COMPLETED|3-14 Day Washout||4
1575524|NCT01143051|3854772|P3|COMPLETED|3-14 Day Washout||3
1575525|NCT01143051|3854773|P2|COMPLETED|3-14 Day Washout||4
1575526|NCT01143051|3854774|P1|COMPLETED|3-14 Day Washout||4
1575527|NCT01143051|3854769|P6|STARTED|3-14 Day Washout||4
1575528|NCT01143051|3854770|P5|STARTED|3-14 Day Washout||4
1575529|NCT01143051|3854771|P4|STARTED|3-14 Day Washout||4
1575530|NCT01143051|3854772|P3|STARTED|3-14 Day Washout||4
1575531|NCT01143051|3854773|P2|STARTED|3-14 Day Washout||4
1575532|NCT01143051|3854774|P1|STARTED|3-14 Day Washout||4
1575533|NCT01143051|3854769|P6|NOT COMPLETED|Visit 1||0
1575534|NCT01143051|3854770|P5|NOT COMPLETED|Visit 1||0
1575535|NCT01143051|3854771|P4|NOT COMPLETED|Visit 1||0
1575536|NCT01143051|3854772|P3|NOT COMPLETED|Visit 1||0
1575537|NCT01143051|3854773|P2|NOT COMPLETED|Visit 1||0
1575538|NCT01143051|3854774|P1|NOT COMPLETED|Visit 1||0
1575539|NCT01143051|3854769|P6|COMPLETED|Visit 1||4
1575540|NCT01143051|3854770|P5|COMPLETED|Visit 1||4
1575541|NCT01143051|3854771|P4|COMPLETED|Visit 1||4
1575542|NCT01143051|3854772|P3|COMPLETED|Visit 1||4
1575543|NCT01143051|3854773|P2|COMPLETED|Visit 1||4
1575544|NCT01143051|3854774|P1|COMPLETED|Visit 1||4
1575545|NCT01143051|3854769|P6|STARTED|Visit 1||4
1575546|NCT01143051|3854770|P5|STARTED|Visit 1||4
1575547|NCT01143051|3854771|P4|STARTED|Visit 1||4
1575548|NCT01143051|3854772|P3|STARTED|Visit 1||4
1575549|NCT01143051|3854773|P2|STARTED|Visit 1||4
1575550|NCT01143051|3854774|P1|STARTED|Visit 1||4
1575551|NCT01143038|3854823|P1|NOT COMPLETED|Overall Study||16
1575552|NCT01143038|3854823|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
1575553|NCT01143038|3854823|P1|STARTED|Overall Study||75
1575554|NCT01142908|3854833|P2|NOT COMPLETED|Overall Study||22
1575555|NCT01142908|3854834|P1|NOT COMPLETED|Overall Study||32
1575556|NCT01142908|3854833|P2|COMPLETED|Overall Study||191
1575557|NCT01142908|3854834|P1|COMPLETED|Overall Study||183
1575558|NCT01142908|3854833|P2|6 Month f/u|Overall Study||196
1575559|NCT01142908|3854834|P1|6 Month f/u|Overall Study||188
1575560|NCT01142908|3854833|P2|STARTED|Overall Study||213
1575561|NCT01142908|3854834|P1|STARTED|Overall Study||215
1575562|NCT01142726|3854883|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
1575563|NCT01142726|3854884|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
1575564|NCT01142726|3854885|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
1575565|NCT01142726|3854883|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
1575566|NCT01142726|3854884|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
1575567|NCT01142726|3854885|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
1575568|NCT01142726|3854883|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
1575569|NCT01142726|3854884|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
1575570|NCT01142726|3854885|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
1575571|NCT01142726|3854883|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
1575572|NCT01142726|3854884|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
1575573|NCT01142726|3854885|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
1575574|NCT01142726|3854883|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
1575575|NCT01142726|3854884|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
1575576|NCT01142726|3854885|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
1575577|NCT01142726|3854883|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
1575578|NCT01142726|3854884|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
1575579|NCT01142726|3854885|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
1575580|NCT01142726|3854883|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
1575581|NCT01142726|3854884|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
1575582|NCT01142726|3854885|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
1575583|NCT01142726|3854883|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
1575584|NCT01142726|3854884|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
1575585|NCT01142726|3854885|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
1575586|NCT01142726|3854883|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
1575587|NCT01142726|3854884|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
1575588|NCT01142726|3854885|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
1575589|NCT01142661|3854948|P1|NOT COMPLETED|Overall Study||4
1575590|NCT01142661|3854948|P1|COMPLETED|Overall Study||5
1575591|NCT01142661|3854948|P1|STARTED|Overall Study||9
1575592|NCT01142596|3854955|P2|NOT COMPLETED|Overall Study||86
1575593|NCT01142596|3854956|P1|NOT COMPLETED|Overall Study||29
1575594|NCT01142596|3854955|P2|COMPLETED|Overall Study||71
1575595|NCT01142596|3854956|P1|COMPLETED|Overall Study||15
1575596|NCT01142596|3854955|P2|STARTED|Overall Study||157
1575597|NCT01142596|3854956|P1|STARTED|Overall Study||44
1575598|NCT01142466|3855008|P2|NOT COMPLETED|Overall Study||2
1575599|NCT01142466|3855009|P1|NOT COMPLETED|Overall Study||3
1575600|NCT01142466|3855008|P2|COMPLETED|Overall Study||13
1575601|NCT01142466|3855009|P1|COMPLETED|Overall Study||12
1575602|NCT01142466|3855008|P2|STARTED|Overall Study||15
1575603|NCT01142466|3855009|P1|STARTED|Overall Study||15
1575604|NCT01142388|3855029|P2|NOT COMPLETED|Overall Study||47
1575605|NCT01142388|3855030|P1|NOT COMPLETED|Overall Study||47
1575606|NCT01142388|3855029|P2|COMPLETED|Overall Study||0
1575607|NCT01142388|3855030|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
1575608|NCT01142388|3855029|P2|Treated|Overall Study||44
1575609|NCT01142388|3855030|P1|Treated|Overall Study||40
1575610|NCT01142388|3855029|P2|Eligible|Overall Study||44
1575611|NCT01142388|3855030|P1|Eligible|Overall Study||43
1575612|NCT01142388|3855029|P2|STARTED|Overall Study||47
1575613|NCT01142388|3855030|P1|STARTED|Overall Study||47
1575614|NCT01142336|3855042|P2|NOT COMPLETED|Overall Study||2
1575615|NCT01142336|3855043|P1|NOT COMPLETED|Overall Study||1
1575616|NCT01142336|3855042|P2|COMPLETED|Overall Study||21
1575617|NCT01142336|3855043|P1|COMPLETED|Overall Study||25
1575618|NCT01142336|3855042|P2|STARTED|Overall Study||23
1575619|NCT01142336|3855043|P1|STARTED|Overall Study||26
1575620|NCT01142323|3855053|P1|NOT COMPLETED|Overall Study||0
1575621|NCT01142323|3855053|P1|COMPLETED|Overall Study||8
1575622|NCT01142323|3855053|P1|STARTED|Overall Study||8
1575623|NCT01142310|3855061|P2|NOT COMPLETED|Overall Study||12
1575624|NCT01142310|3855062|P1|NOT COMPLETED|Overall Study||9
1575625|NCT01142310|3855061|P2|COMPLETED|Overall Study||16
1575626|NCT01142310|3855062|P1|COMPLETED|Overall Study||17
1575627|NCT01142310|3855061|P2|STARTED|Overall Study||28
1575628|NCT01142310|3855062|P1|STARTED|Overall Study||26
1575629|NCT01142297|3855068|P1|NOT COMPLETED|Overall Study||6
1575630|NCT01142297|3855068|P1|COMPLETED|Overall Study||18
1575631|NCT01142297|3855068|P1|STARTED|Overall Study||24
1575632|NCT01142193|3855077|P2|NOT COMPLETED|Overall Study||11
1575633|NCT01142193|3855078|P1|NOT COMPLETED|Overall Study||21
1575634|NCT01142193|3855077|P2|COMPLETED|Overall Study||114
1575635|NCT01142193|3855078|P1|COMPLETED|Overall Study||103
1575636|NCT01142193|3855077|P2|STARTED|Overall Study||125
1575637|NCT01142193|3855078|P1|STARTED|Overall Study||124
1575638|NCT01142128|3855106|P1|NOT COMPLETED|Overall Study||4
1575639|NCT01142128|3855106|P1|COMPLETED|Overall Study||4
1575640|NCT01142128|3855106|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
1575641|NCT01142128|3855106|P1|Viokase 16 Plus Nexium|Overall Study||2
1575642|NCT01142128|3855106|P1|Placebo to Nexium, Alone|Overall Study||3
1575643|NCT01142128|3855106|P1|Nexium Alone|Overall Study||3
1575644|NCT01142128|3855106|P1|STARTED|Overall Study||8
1575645|NCT01142115|3855116|P2|NOT COMPLETED|Second Intervention||0
1575646|NCT01142115|3855117|P1|NOT COMPLETED|Second Intervention||0
1575647|NCT01142115|3855116|P2|COMPLETED|Second Intervention||19
1575648|NCT01142115|3855117|P1|COMPLETED|Second Intervention||19
1575649|NCT01142115|3855116|P2|STARTED|Second Intervention||19
1575650|NCT01142115|3855117|P1|STARTED|Second Intervention||19
1575651|NCT01142115|3855116|P2|NOT COMPLETED|First Intervention||1
1575652|NCT01142115|3855117|P1|NOT COMPLETED|First Intervention||2
1575653|NCT01142115|3855116|P2|COMPLETED|First Intervention||19
1575654|NCT01142115|3855117|P1|COMPLETED|First Intervention||19
1575655|NCT01142115|3855116|P2|STARTED|First Intervention||20
1575656|NCT01142115|3855117|P1|STARTED|First Intervention||21
1575657|NCT01142089|3855134|P2|NOT COMPLETED|Overall Study||21
1575658|NCT01142089|3855135|P1|NOT COMPLETED|Overall Study||12
1575659|NCT01142089|3855134|P2|COMPLETED|Overall Study||178
1575660|NCT01142089|3855135|P1|COMPLETED|Overall Study||53
1575661|NCT01142089|3855134|P2|STARTED|Overall Study||199
1575662|NCT01142089|3855135|P1|STARTED|Overall Study||65
1575663|NCT01141725|3855143|P3|NOT COMPLETED|Overall Study||0
1575664|NCT01141725|3855144|P2|NOT COMPLETED|Overall Study||0
1575665|NCT01141725|3855145|P1|NOT COMPLETED|Overall Study||0
1575666|NCT01141725|3855143|P3|COMPLETED|Overall Study||3
1575667|NCT01141725|3855144|P2|COMPLETED|Overall Study||33
1575668|NCT01141725|3855145|P1|COMPLETED|Overall Study||3
1575669|NCT01141725|3855143|P3|STARTED|Overall Study||3
1575670|NCT01141725|3855144|P2|STARTED|Overall Study||33
1575671|NCT01141725|3855145|P1|STARTED|Overall Study||3
1575672|NCT01141712|3855157|P1|NOT COMPLETED|Overall Study||3
1575673|NCT01141712|3855157|P1|COMPLETED|Overall Study||40
1575674|NCT01141712|3855157|P1|STARTED|Overall Study||43
1575675|NCT01141660|3855178|P2|NOT COMPLETED|Overall Study||12
1575676|NCT01141660|3855179|P1|NOT COMPLETED|Overall Study||0
1575677|NCT01141660|3855178|P2|COMPLETED|Overall Study||48
1575678|NCT01141660|3855179|P1|COMPLETED|Overall Study||71
1575679|NCT01141660|3855178|P2|STARTED|Overall Study||60
1575680|NCT01141660|3855179|P1|STARTED|Overall Study||71
1575681|NCT01141647|3855187|P1|NOT COMPLETED|Overall Study||46
1575682|NCT01141647|3855187|P1|COMPLETED|Overall Study||167
1575683|NCT01141647|3855187|P1|STARTED|Overall Study||213
1575684|NCT01141608|3855202|P2|NOT COMPLETED|Overall Study||0
1575685|NCT01141608|3855203|P1|NOT COMPLETED|Overall Study||0
1575686|NCT01141608|3855202|P2|COMPLETED|Overall Study||150
1575687|NCT01141608|3855203|P1|COMPLETED|Overall Study||152
1575688|NCT01141608|3855202|P2|STARTED|Overall Study||150
1575689|NCT01141608|3855203|P1|STARTED|Overall Study||152
1575690|NCT01141595|3855209|P1|NOT COMPLETED|Overall Study||2
1575691|NCT01141595|3855209|P1|COMPLETED|Overall Study||8
1575692|NCT01141595|3855209|P1|STARTED|Overall Study||10
1575693|NCT01141569|3855213|P1|NOT COMPLETED|Overall Study||0
1575694|NCT01141569|3855213|P1|COMPLETED|Overall Study||12
1575695|NCT01141569|3855213|P1|STARTED|Overall Study||12
1575696|NCT01141491|3855224|P2|NOT COMPLETED|Overall Study||47
1575697|NCT01141491|3855225|P1|NOT COMPLETED|Overall Study||48
1575698|NCT01141491|3855224|P2|COMPLETED|Overall Study||21
1575699|NCT01141491|3855225|P1|COMPLETED|Overall Study||20
1575700|NCT01141491|3855224|P2|STARTED|Overall Study||68
1575701|NCT01141491|3855225|P1|STARTED|Overall Study||68
1575702|NCT01141374|3855234|P3|NOT COMPLETED|Overall Study||0
1575703|NCT01141374|3855235|P2|NOT COMPLETED|Overall Study||0
1575704|NCT01141374|3855236|P1|NOT COMPLETED|Overall Study||0
1575705|NCT01141374|3855234|P3|COMPLETED|Overall Study||22
1575706|NCT01141374|3855235|P2|COMPLETED|Overall Study||27
1575707|NCT01141374|3855236|P1|COMPLETED|Overall Study||26
1575708|NCT01141374|3855234|P3|STARTED|Overall Study||22
1575709|NCT01141374|3855235|P2|STARTED|Overall Study||27
1575710|NCT01141374|3855236|P1|STARTED|Overall Study||26
1575711|NCT01141283|3855247|P1|NOT COMPLETED|Overall Study||88
1575712|NCT01141283|3855247|P1|COMPLETED|Overall Study||202
1575713|NCT01141283|3855247|P1|STARTED|Overall Study||290
1575714|NCT01141205|3855253|P2|NOT COMPLETED|Overall Study||2
1575715|NCT01141205|3855254|P1|NOT COMPLETED|Overall Study||3
1575716|NCT01141205|3855253|P2|COMPLETED|Overall Study||3
1575717|NCT01141205|3855254|P1|COMPLETED|Overall Study||15
1575718|NCT01141205|3855253|P2|STARTED|Overall Study||5
1575719|NCT01141205|3855254|P1|STARTED|Overall Study||18
1575720|NCT01141049|3855268|P2|NOT COMPLETED|Overall Study||8
1575721|NCT01141049|3855269|P1|NOT COMPLETED|Overall Study||5
1575722|NCT01141049|3855268|P2|COMPLETED|Overall Study||13
1575723|NCT01141049|3855269|P1|COMPLETED|Overall Study||14
1575724|NCT01141049|3855268|P2|STARTED|Overall Study||21
1575725|NCT01141049|3855269|P1|STARTED|Overall Study||19
1575726|NCT01140906|3855281|P4|NOT COMPLETED|Overall Study||16
1575727|NCT01140906|3855282|P3|NOT COMPLETED|Overall Study||26
1575728|NCT01140906|3855283|P2|NOT COMPLETED|Overall Study||34
1575729|NCT01140906|3855284|P1|NOT COMPLETED|Overall Study||25
1575730|NCT01140906|3855281|P4|COMPLETED|Overall Study||131
1575731|NCT01140906|3855282|P3|COMPLETED|Overall Study||125
1575732|NCT01140906|3855283|P2|COMPLETED|Overall Study||117
1575733|NCT01140906|3855284|P1|COMPLETED|Overall Study||133
1575734|NCT01140906|3855281|P4|STARTED|Overall Study||147
1575735|NCT01140906|3855282|P3|STARTED|Overall Study||151
1575736|NCT01140906|3855283|P2|STARTED|Overall Study||151
1575737|NCT01140906|3855284|P1|STARTED|Overall Study||158
1575738|NCT01140880|3855324|P2|NOT COMPLETED|Overall Study||44
1575739|NCT01140880|3855325|P1|NOT COMPLETED|Overall Study||14
1575740|NCT01140880|3855324|P2|COMPLETED|Overall Study||56
1575741|NCT01140880|3855325|P1|COMPLETED|Overall Study||56
1575742|NCT01140880|3855324|P2|STARTED|Overall Study||100
1575743|NCT01140880|3855325|P1|STARTED|Overall Study||70
1575744|NCT01140867|3855337|P1|NOT COMPLETED|Overall Study||33
1575745|NCT01140867|3855337|P1|COMPLETED|Overall Study||88
1575746|NCT01140867|3855337|P1|STARTED|Overall Study||121
1575747|NCT01140815|3855346|P2|NOT COMPLETED|Overall Study||0
1575748|NCT01140815|3855347|P1|NOT COMPLETED|Overall Study||0
1575749|NCT01140815|3855346|P2|COMPLETED|Overall Study||25
1575750|NCT01140815|3855347|P1|COMPLETED|Overall Study||25
1575751|NCT01140815|3855346|P2|STARTED|Overall Study||25
1575752|NCT01140815|3855347|P1|STARTED|Overall Study||25
1575753|NCT01140646|3855377|P1|NOT COMPLETED|Overall Study||9
1575754|NCT01140646|3855377|P1|COMPLETED|Overall Study||34
1575755|NCT01140646|3855377|P1|STARTED|Overall Study||43
1575756|NCT01140503|3855381|P1|NOT COMPLETED|Overall Study||1
1575757|NCT01140503|3855381|P1|COMPLETED|Overall Study||4
1575758|NCT01140503|3855381|P1|STARTED|Overall Study||5
1575759|NCT01140477|3855389|P2|NOT COMPLETED|Overall Study||6
1575760|NCT01140477|3855390|P1|NOT COMPLETED|Overall Study||8
1575761|NCT01140477|3855389|P2|COMPLETED|Overall Study||70
1575762|NCT01140477|3855390|P1|COMPLETED|Overall Study||145
1575763|NCT01140477|3855389|P2|STARTED|Overall Study||76
1575764|NCT01140477|3855390|P1|STARTED|Overall Study||153
1575765|NCT01140360|3855399|P1|NOT COMPLETED|Overall Study||6
1575766|NCT01140360|3855399|P1|COMPLETED|Overall Study||15
1575767|NCT01140360|3855399|P1|STARTED|Overall Study||21
1575768|NCT01140347|3855405|P2|NOT COMPLETED|Overall Study||14
1575769|NCT01140347|3855406|P1|NOT COMPLETED|Overall Study||18
1575770|NCT01140347|3855405|P2|COMPLETED|Overall Study||268
1575771|NCT01140347|3855406|P1|COMPLETED|Overall Study||265
1575772|NCT01140347|3855405|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
1575773|NCT01140347|3855406|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
1575774|NCT01140347|3855405|P2|STARTED|Overall Study||282
1575775|NCT01140347|3855406|P1|STARTED|Overall Study||283
1575776|NCT01140295|3855431|P2|NOT COMPLETED|Overall Study||2
1575777|NCT01140295|3855432|P1|NOT COMPLETED|Overall Study||1
1575778|NCT01140295|3855431|P2|COMPLETED|Overall Study||14
1575779|NCT01140295|3855432|P1|COMPLETED|Overall Study||16
1575780|NCT01140295|3855431|P2|STARTED|Overall Study||16
1575781|NCT01140295|3855432|P1|STARTED|Overall Study||17
1575782|NCT01140191|3855440|P1|NOT COMPLETED|Overall Study||0
1575783|NCT01140191|3855440|P1|COMPLETED|Overall Study||1
1575784|NCT01140191|3855440|P1|STARTED|Overall Study||1
1575785|NCT01140061|3855459|P10|NOT COMPLETED|Extension||1
1575786|NCT01140061|3855460|P9|NOT COMPLETED|Extension||0
1575787|NCT01140061|3855461|P8|NOT COMPLETED|Extension||0
1575788|NCT01140061|3855462|P7|NOT COMPLETED|Extension||0
1575789|NCT01140061|3855463|P6|NOT COMPLETED|Extension||0
1575790|NCT01140061|3855464|P5|NOT COMPLETED|Extension||0
1575791|NCT01140061|3855465|P4|NOT COMPLETED|Extension||0
1575792|NCT01140061|3855466|P3|NOT COMPLETED|Extension||0
1575793|NCT01140061|3855467|P2|NOT COMPLETED|Extension||0
1575794|NCT01140061|3855468|P1|NOT COMPLETED|Extension||0
1575795|NCT01140061|3855459|P10|COMPLETED|Extension||1
1575796|NCT01140061|3855460|P9|COMPLETED|Extension||7
1575797|NCT01140061|3855461|P8|COMPLETED|Extension||0
1575798|NCT01140061|3855462|P7|COMPLETED|Extension||0
1575799|NCT01140061|3855463|P6|COMPLETED|Extension||0
1575800|NCT01140061|3855464|P5|COMPLETED|Extension||0
1575801|NCT01140061|3855465|P4|COMPLETED|Extension||0
1575802|NCT01140061|3855466|P3|COMPLETED|Extension||0
1575803|NCT01140061|3855467|P2|COMPLETED|Extension||0
1575804|NCT01140061|3855468|P1|COMPLETED|Extension||0
1575805|NCT01140061|3855459|P10|STARTED|Extension||2
1575806|NCT01140061|3855460|P9|STARTED|Extension||7
1575807|NCT01140061|3855461|P8|STARTED|Extension||0
1575808|NCT01140061|3855462|P7|STARTED|Extension||0
1575809|NCT01140061|3855463|P6|STARTED|Extension||0
1575810|NCT01140061|3855464|P5|STARTED|Extension||0
1575811|NCT01140061|3855465|P4|STARTED|Extension||0
1575812|NCT01140061|3855466|P3|STARTED|Extension||0
1575813|NCT01140061|3855467|P2|STARTED|Extension||0
1575814|NCT01140061|3855468|P1|STARTED|Extension||0
1575815|NCT01140061|3855459|P10|NOT COMPLETED|Part III||0
1575816|NCT01140061|3855460|P9|NOT COMPLETED|Part III||0
1575817|NCT01140061|3855461|P8|NOT COMPLETED|Part III||0
1575818|NCT01140061|3855462|P7|NOT COMPLETED|Part III||0
1575819|NCT01140061|3855463|P6|NOT COMPLETED|Part III||0
1575820|NCT01140061|3855464|P5|NOT COMPLETED|Part III||0
1575821|NCT01140061|3855465|P4|NOT COMPLETED|Part III||0
1575822|NCT01140061|3855466|P3|NOT COMPLETED|Part III||0
1575823|NCT01140061|3855467|P2|NOT COMPLETED|Part III||0
1575824|NCT01140061|3855468|P1|NOT COMPLETED|Part III||0
1575825|NCT01140061|3855459|P10|COMPLETED|Part III||2
1575826|NCT01140061|3855460|P9|COMPLETED|Part III||7
1575827|NCT01140061|3855461|P8|COMPLETED|Part III||0
1575828|NCT01140061|3855462|P7|COMPLETED|Part III||0
1575829|NCT01140061|3855463|P6|COMPLETED|Part III||0
1575830|NCT01140061|3855464|P5|COMPLETED|Part III||0
1575831|NCT01140061|3855465|P4|COMPLETED|Part III||0
1575832|NCT01140061|3855466|P3|COMPLETED|Part III||0
1575833|NCT01140061|3855467|P2|COMPLETED|Part III||0
1575834|NCT01140061|3855468|P1|COMPLETED|Part III||0
1575835|NCT01140061|3855459|P10|STARTED|Part III|Includes 1 replacement participant|2
1575836|NCT01140061|3855460|P9|STARTED|Part III||7
1575837|NCT01140061|3855461|P8|STARTED|Part III||0
1575838|NCT01140061|3855462|P7|STARTED|Part III||0
1575839|NCT01140061|3855463|P6|STARTED|Part III||0
1575840|NCT01140061|3855464|P5|STARTED|Part III||0
1575841|NCT01140061|3855465|P4|STARTED|Part III||0
1575842|NCT01140061|3855466|P3|STARTED|Part III||0
1575843|NCT01140061|3855467|P2|STARTED|Part III||0
1575844|NCT01140061|3855468|P1|STARTED|Part III||0
1575845|NCT01140061|3855459|P10|NOT COMPLETED|Part II||0
1575846|NCT01140061|3855460|P9|NOT COMPLETED|Part II||0
1575847|NCT01140061|3855461|P8|NOT COMPLETED|Part II||0
1575848|NCT01140061|3855462|P7|NOT COMPLETED|Part II||0
1575849|NCT01140061|3855463|P6|NOT COMPLETED|Part II||0
1575850|NCT01140061|3855464|P5|NOT COMPLETED|Part II||0
1575851|NCT01140061|3855465|P4|NOT COMPLETED|Part II||0
1575852|NCT01140061|3855466|P3|NOT COMPLETED|Part II||0
1575853|NCT01140061|3855467|P2|NOT COMPLETED|Part II||0
1575854|NCT01140061|3855468|P1|NOT COMPLETED|Part II||0
1575855|NCT01140061|3855459|P10|COMPLETED|Part II||0
1575856|NCT01140061|3855460|P9|COMPLETED|Part II||0
1575857|NCT01140061|3855461|P8|COMPLETED|Part II||2
1575858|NCT01140061|3855462|P7|COMPLETED|Part II||6
1575859|NCT01140061|3855463|P6|COMPLETED|Part II||2
1575860|NCT01140061|3855464|P5|COMPLETED|Part II||6
1575861|NCT01140061|3855465|P4|COMPLETED|Part II||2
1575862|NCT01140061|3855466|P3|COMPLETED|Part II||6
1575863|NCT01140061|3855467|P2|COMPLETED|Part II||0
1575864|NCT01140061|3855468|P1|COMPLETED|Part II||0
1575865|NCT01140061|3855459|P10|STARTED|Part II||0
1575866|NCT01140061|3855460|P9|STARTED|Part II||0
1575867|NCT01140061|3855461|P8|STARTED|Part II||2
1575868|NCT01140061|3855462|P7|STARTED|Part II||6
1575869|NCT01140061|3855463|P6|STARTED|Part II||2
1575870|NCT01140061|3855464|P5|STARTED|Part II||6
1575871|NCT01140061|3855465|P4|STARTED|Part II||2
1575872|NCT01140061|3855466|P3|STARTED|Part II||6
1575873|NCT01140061|3855467|P2|STARTED|Part II||0
1575874|NCT01140061|3855468|P1|STARTED|Part II||0
1575875|NCT01140061|3855459|P10|NOT COMPLETED|Part I||0
1575876|NCT01140061|3855460|P9|NOT COMPLETED|Part I||0
1575877|NCT01140061|3855461|P8|NOT COMPLETED|Part I||0
1575878|NCT01140061|3855462|P7|NOT COMPLETED|Part I||0
1575879|NCT01140061|3855463|P6|NOT COMPLETED|Part I||0
1575880|NCT01140061|3855464|P5|NOT COMPLETED|Part I||0
1575881|NCT01140061|3855465|P4|NOT COMPLETED|Part I||0
1575882|NCT01140061|3855466|P3|NOT COMPLETED|Part I||0
1575883|NCT01140061|3855467|P2|NOT COMPLETED|Part I||0
1575884|NCT01140061|3855468|P1|NOT COMPLETED|Part I||1
1575885|NCT01140061|3855459|P10|COMPLETED|Part I||0
1575886|NCT01140061|3855460|P9|COMPLETED|Part I||0
1575887|NCT01140061|3855461|P8|COMPLETED|Part I||0
1575888|NCT01140061|3855462|P7|COMPLETED|Part I||0
1575889|NCT01140061|3855463|P6|COMPLETED|Part I||0
1575890|NCT01140061|3855464|P5|COMPLETED|Part I||0
1575891|NCT01140061|3855465|P4|COMPLETED|Part I||0
1575892|NCT01140061|3855466|P3|COMPLETED|Part I||0
1575893|NCT01140061|3855467|P2|COMPLETED|Part I||2
1575894|NCT01140061|3855468|P1|COMPLETED|Part I||6
1575895|NCT01140061|3855459|P10|STARTED|Part I||0
1575896|NCT01140061|3855460|P9|STARTED|Part I||0
1575897|NCT01140061|3855461|P8|STARTED|Part I||0
1575898|NCT01140061|3855462|P7|STARTED|Part I||0
1575899|NCT01140061|3855463|P6|STARTED|Part I||0
1575900|NCT01140061|3855464|P5|STARTED|Part I||0
1575901|NCT01140061|3855465|P4|STARTED|Part I||0
1575902|NCT01140061|3855466|P3|STARTED|Part I||0
1575903|NCT01140061|3855467|P2|STARTED|Part I||2
1575904|NCT01140061|3855468|P1|STARTED|Part I|Includes 1 replacement participant|7
1575905|NCT01140048|3855495|P1|NOT COMPLETED|Overall Study||45
1575906|NCT01140048|3855495|P1|COMPLETED|Overall Study||298
1575907|NCT01140048|3855495|P1|STARTED|Overall Study||343
1575908|NCT01139996|3855503|P2|NOT COMPLETED|Overall Study||0
1575909|NCT01139996|3855504|P1|NOT COMPLETED|Overall Study||0
1575910|NCT01139996|3855503|P2|COMPLETED|Overall Study||11
1575911|NCT01139996|3855504|P1|COMPLETED|Overall Study||11
1575912|NCT01139996|3855503|P2|STARTED|Overall Study||11
1575913|NCT01139996|3855504|P1|STARTED|Overall Study||11
1575914|NCT01139879|3855510|P1|NOT COMPLETED|Overall Study||0
1575915|NCT01139879|3855510|P1|COMPLETED|Overall Study||10
1575916|NCT01139879|3855510|P1|STARTED|Overall Study||10
1575917|NCT01139814|3855516|P1|NOT COMPLETED|Overall Study||0
1575918|NCT01139814|3855516|P1|COMPLETED|Overall Study||181
1575919|NCT01139814|3855516|P1|STARTED|Overall Study||181
1575920|NCT01139801|3855523|P2|NOT COMPLETED|Overall Study||0
1575921|NCT01139801|3855524|P1|NOT COMPLETED|Overall Study||0
1575922|NCT01139801|3855523|P2|COMPLETED|Overall Study||25
1575923|NCT01139801|3855524|P1|COMPLETED|Overall Study||25
1575924|NCT01139801|3855523|P2|STARTED|Overall Study||25
1575925|NCT01139801|3855524|P1|STARTED|Overall Study||25
1575926|NCT01139775|3855535|P3|NOT COMPLETED|Overall Study||6
1575927|NCT01139775|3855536|P2|NOT COMPLETED|Overall Study||13
1575928|NCT01139775|3855537|P1|NOT COMPLETED|Overall Study||1
1575929|NCT01139775|3855535|P3|COMPLETED|Overall Study||17
1575930|NCT01139775|3855536|P2|COMPLETED|Overall Study||26
1575931|NCT01139775|3855537|P1|COMPLETED|Overall Study||13
1575932|NCT01139775|3855535|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
1575933|NCT01139775|3855536|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
1575934|NCT01139775|3855537|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
1575935|NCT01139775|3855535|P3|STARTED|Overall Study||23
1575936|NCT01139775|3855536|P2|STARTED|Overall Study||39
1575937|NCT01139775|3855537|P1|STARTED|Overall Study||14
1575938|NCT01139762|3855569|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
1575939|NCT01139762|3855570|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
1575940|NCT01139762|3855571|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
1575941|NCT01139762|3855569|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
1575942|NCT01139762|3855570|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
1575943|NCT01139762|3855571|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
1575944|NCT01139762|3855569|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
1575945|NCT01139762|3855570|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
1575946|NCT01139762|3855571|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
1575947|NCT01139762|3855569|P3|STARTED|Double-Blind Randomized Active Treatment||350
1575948|NCT01139762|3855570|P2|STARTED|Double-Blind Randomized Active Treatment||346
1575949|NCT01139762|3855571|P1|STARTED|Double-Blind Randomized Active Treatment||0
1575950|NCT01139762|3855569|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
1575951|NCT01139762|3855570|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
1575952|NCT01139762|3855571|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
1575953|NCT01139762|3855569|P3|COMPLETED|Washout and Placebo Lead-In Period||0
1575954|NCT01139762|3855570|P2|COMPLETED|Washout and Placebo Lead-In Period||0
1575955|NCT01139762|3855571|P1|COMPLETED|Washout and Placebo Lead-In Period||696
1575956|NCT01139762|3855569|P3|STARTED|Washout and Placebo Lead-In Period||0
1575957|NCT01139762|3855570|P2|STARTED|Washout and Placebo Lead-In Period||0
1575958|NCT01139762|3855571|P1|STARTED|Washout and Placebo Lead-In Period||1070
1575959|NCT01139658|3855606|P2|NOT COMPLETED|Overall Study||113
1575960|NCT01139658|3855607|P1|NOT COMPLETED|Overall Study||56
1575961|NCT01139658|3855606|P2|COMPLETED|Overall Study||816
1575962|NCT01139658|3855607|P1|COMPLETED|Overall Study||691
1575963|NCT01139658|3855606|P2|STARTED|Overall Study||929
1575964|NCT01139658|3855607|P1|STARTED|Overall Study||747
1575965|NCT01139580|3855645|P2|NOT COMPLETED|Overall Study||18
1575966|NCT01139580|3855646|P1|NOT COMPLETED|Overall Study||23
1575967|NCT01139580|3855645|P2|COMPLETED|Overall Study||164
1575968|NCT01139580|3855646|P1|COMPLETED|Overall Study||158
1575969|NCT01139580|3855645|P2|STARTED|Overall Study||182
1575970|NCT01139580|3855646|P1|STARTED|Overall Study||181
1575971|NCT01139515|3855662|P4|NOT COMPLETED|Fourth Intervention Period||0
1575972|NCT01139515|3855663|P3|NOT COMPLETED|Fourth Intervention Period||0
1575973|NCT01139515|3855664|P2|NOT COMPLETED|Fourth Intervention Period||0
1575974|NCT01139515|3855665|P1|NOT COMPLETED|Fourth Intervention Period||0
1575975|NCT01139515|3855662|P4|COMPLETED|Fourth Intervention Period||4
1575976|NCT01139515|3855663|P3|COMPLETED|Fourth Intervention Period||4
1575977|NCT01139515|3855664|P2|COMPLETED|Fourth Intervention Period||4
1575978|NCT01139515|3855665|P1|COMPLETED|Fourth Intervention Period||4
1575979|NCT01139515|3855662|P4|STARTED|Fourth Intervention Period||4
1575980|NCT01139515|3855663|P3|STARTED|Fourth Intervention Period||4
1575981|NCT01139515|3855664|P2|STARTED|Fourth Intervention Period||4
1575982|NCT01139515|3855665|P1|STARTED|Fourth Intervention Period||4
1575983|NCT01139515|3855662|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1575984|NCT01139515|3855663|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1575985|NCT01139515|3855664|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1575986|NCT01139515|3855665|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1575987|NCT01139515|3855662|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
1575988|NCT01139515|3855663|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
1575989|NCT01139515|3855664|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
1575990|NCT01139515|3855665|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
1575991|NCT01139515|3855662|P4|STARTED|Washout Period 3 (46 Hrs)||4
1575992|NCT01139515|3855663|P3|STARTED|Washout Period 3 (46 Hrs)||4
1575993|NCT01139515|3855664|P2|STARTED|Washout Period 3 (46 Hrs)||4
1575994|NCT01139515|3855665|P1|STARTED|Washout Period 3 (46 Hrs)||4
1575995|NCT01139515|3855662|P4|NOT COMPLETED|Third Intervention Period||0
1575996|NCT01139515|3855663|P3|NOT COMPLETED|Third Intervention Period||0
1575997|NCT01139515|3855664|P2|NOT COMPLETED|Third Intervention Period||0
1575998|NCT01139515|3855665|P1|NOT COMPLETED|Third Intervention Period||0
1575999|NCT01139515|3855662|P4|COMPLETED|Third Intervention Period||4
1576000|NCT01139515|3855663|P3|COMPLETED|Third Intervention Period||4
1576001|NCT01139515|3855664|P2|COMPLETED|Third Intervention Period||4
1576002|NCT01139515|3855665|P1|COMPLETED|Third Intervention Period||4
1576003|NCT01139515|3855662|P4|STARTED|Third Intervention Period||4
1576004|NCT01139515|3855663|P3|STARTED|Third Intervention Period||4
1576005|NCT01139515|3855664|P2|STARTED|Third Intervention Period||4
1576006|NCT01139515|3855665|P1|STARTED|Third Intervention Period||4
1576007|NCT01139515|3855662|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1576008|NCT01139515|3855663|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1576009|NCT01139515|3855664|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1576010|NCT01139515|3855665|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1576011|NCT01139515|3855662|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
1576012|NCT01139515|3855663|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
1576013|NCT01139515|3855664|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
1576014|NCT01139515|3855665|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
1576015|NCT01139515|3855662|P4|STARTED|Washout Period 2 (46 Hrs)||4
1576016|NCT01139515|3855663|P3|STARTED|Washout Period 2 (46 Hrs)||4
1576017|NCT01139515|3855664|P2|STARTED|Washout Period 2 (46 Hrs)||4
1576018|NCT01139515|3855665|P1|STARTED|Washout Period 2 (46 Hrs)||4
1576019|NCT01139515|3855662|P4|NOT COMPLETED|Second Intervention Period||0
1576020|NCT01139515|3855663|P3|NOT COMPLETED|Second Intervention Period||0
1576021|NCT01139515|3855664|P2|NOT COMPLETED|Second Intervention Period||0
1576022|NCT01139515|3855665|P1|NOT COMPLETED|Second Intervention Period||0
1576023|NCT01139515|3855662|P4|COMPLETED|Second Intervention Period||4
1576024|NCT01139515|3855663|P3|COMPLETED|Second Intervention Period||4
1576025|NCT01139515|3855664|P2|COMPLETED|Second Intervention Period||4
1576026|NCT01139515|3855665|P1|COMPLETED|Second Intervention Period||4
1576027|NCT01139515|3855662|P4|STARTED|Second Intervention Period||4
1576028|NCT01139515|3855663|P3|STARTED|Second Intervention Period||4
1576029|NCT01139515|3855664|P2|STARTED|Second Intervention Period||4
1576030|NCT01139515|3855665|P1|STARTED|Second Intervention Period||4
1576031|NCT01139515|3855662|P4|NOT COMPLETED|Washout Period I (46hrs)||0
1576032|NCT01139515|3855663|P3|NOT COMPLETED|Washout Period I (46hrs)||0
1576033|NCT01139515|3855664|P2|NOT COMPLETED|Washout Period I (46hrs)||0
1576034|NCT01139515|3855665|P1|NOT COMPLETED|Washout Period I (46hrs)||0
1576035|NCT01139515|3855662|P4|COMPLETED|Washout Period I (46hrs)||4
1576036|NCT01139515|3855663|P3|COMPLETED|Washout Period I (46hrs)||4
1576037|NCT01139515|3855664|P2|COMPLETED|Washout Period I (46hrs)||4
1576038|NCT01139515|3855665|P1|COMPLETED|Washout Period I (46hrs)||4
1576039|NCT01139515|3855662|P4|STARTED|Washout Period I (46hrs)||4
1576040|NCT01139515|3855663|P3|STARTED|Washout Period I (46hrs)||4
1576041|NCT01139515|3855664|P2|STARTED|Washout Period I (46hrs)||4
1576042|NCT01139515|3855665|P1|STARTED|Washout Period I (46hrs)||4
1576043|NCT01139515|3855662|P4|NOT COMPLETED|First Intervention Period||0
1576044|NCT01139515|3855663|P3|NOT COMPLETED|First Intervention Period||0
1576045|NCT01139515|3855664|P2|NOT COMPLETED|First Intervention Period||0
1576046|NCT01139515|3855665|P1|NOT COMPLETED|First Intervention Period||0
1576047|NCT01139515|3855662|P4|COMPLETED|First Intervention Period||4
1576048|NCT01139515|3855663|P3|COMPLETED|First Intervention Period||4
1576049|NCT01139515|3855664|P2|COMPLETED|First Intervention Period||4
1576050|NCT01139515|3855665|P1|COMPLETED|First Intervention Period||4
1576051|NCT01139515|3855662|P4|STARTED|First Intervention Period||4
1576052|NCT01139515|3855663|P3|STARTED|First Intervention Period||4
1576053|NCT01139515|3855664|P2|STARTED|First Intervention Period||4
1576054|NCT01139515|3855665|P1|STARTED|First Intervention Period||4
1576055|NCT01139450|3855694|P3|NOT COMPLETED|Overall Study||38
1576056|NCT01139450|3855695|P2|NOT COMPLETED|Overall Study||25
1576057|NCT01139450|3855696|P1|NOT COMPLETED|Overall Study||27
1576058|NCT01139450|3855694|P3|COMPLETED|Overall Study||262
1576059|NCT01139450|3855695|P2|COMPLETED|Overall Study||272
1576060|NCT01139450|3855696|P1|COMPLETED|Overall Study||275
1576061|NCT01139450|3855694|P3|STARTED|Overall Study||300
1576062|NCT01139450|3855695|P2|STARTED|Overall Study||297
1576063|NCT01139450|3855696|P1|STARTED|Overall Study||302
1576064|NCT01139411|3855706|P2|NOT COMPLETED|Overall Study||4
1576065|NCT01139411|3855707|P1|NOT COMPLETED|Overall Study||2
1576066|NCT01139411|3855706|P2|COMPLETED|Overall Study||19
1576067|NCT01139411|3855707|P1|COMPLETED|Overall Study||24
1576068|NCT01139411|3855706|P2|STARTED|Overall Study||23
1576069|NCT01139411|3855707|P1|STARTED|Overall Study||26
1576070|NCT01139294|3855727|P2|NOT COMPLETED|Overall Study||0
1576071|NCT01139294|3855728|P1|NOT COMPLETED|Overall Study||0
1576072|NCT01139294|3855727|P2|COMPLETED|Overall Study||0
1576073|NCT01139294|3855728|P1|COMPLETED|Overall Study||0
1576074|NCT01139294|3855727|P2|STARTED|Overall Study||0
1576075|NCT01139294|3855728|P1|STARTED|Overall Study||0
1576076|NCT01139190|3855738|P2|NOT COMPLETED|Overall Study||1
1576077|NCT01139190|3855739|P1|NOT COMPLETED|Overall Study||0
1576078|NCT01139190|3855738|P2|COMPLETED|Overall Study||38
1576079|NCT01139190|3855739|P1|COMPLETED|Overall Study||38
1576080|NCT01139190|3855738|P2|STARTED|Overall Study||39
1576081|NCT01139190|3855739|P1|STARTED|Overall Study||38
1576082|NCT01139164|3855748|P3|NOT COMPLETED|Overall Study||0
1576083|NCT01139164|3855749|P2|NOT COMPLETED|Overall Study||2
1576084|NCT01139164|3855750|P1|NOT COMPLETED|Overall Study||0
1576085|NCT01139164|3855748|P3|COMPLETED|Overall Study||7
1576086|NCT01139164|3855749|P2|COMPLETED|Overall Study||65
1576087|NCT01139164|3855750|P1|COMPLETED|Overall Study||4
1576088|NCT01139164|3855748|P3|STARTED|Overall Study||7
1576089|NCT01139164|3855749|P2|STARTED|Overall Study||67
1576090|NCT01139164|3855750|P1|STARTED|Overall Study||4
1576091|NCT01139125|3855764|P1|NOT COMPLETED|Overall Study||1
1576092|NCT01139125|3855764|P1|COMPLETED|Overall Study||2
1576093|NCT01139125|3855764|P1|STARTED|Overall Study||3
1576094|NCT01139047|3855768|P1|NOT COMPLETED|Overall Study||1
1576095|NCT01139047|3855768|P1|COMPLETED|Overall Study||76
1576096|NCT01139047|3855768|P1|STARTED|Overall Study||77
1576097|NCT01139021|3855783|P6|NOT COMPLETED|Overall Study||0
1576098|NCT01139021|3855784|P5|NOT COMPLETED|Overall Study||9
1576099|NCT01139021|3855785|P4|NOT COMPLETED|Overall Study||1
1576100|NCT01139021|3855786|P3|NOT COMPLETED|Overall Study||0
1576101|NCT01139021|3855787|P2|NOT COMPLETED|Overall Study||0
1576102|NCT01139021|3855788|P1|NOT COMPLETED|Overall Study||1
1576103|NCT01139021|3855783|P6|COMPLETED|Overall Study||1
1576104|NCT01139021|3855784|P5|COMPLETED|Overall Study||107
1576105|NCT01139021|3855785|P4|COMPLETED|Overall Study||18
1576106|NCT01139021|3855786|P3|COMPLETED|Overall Study||67
1576107|NCT01139021|3855787|P2|COMPLETED|Overall Study||153
1576108|NCT01139021|3855788|P1|COMPLETED|Overall Study||151
1576109|NCT01139021|3855783|P6|STARTED|Overall Study||1
1576110|NCT01139021|3855784|P5|STARTED|Overall Study||116
1576111|NCT01139021|3855785|P4|STARTED|Overall Study||19
1576112|NCT01139021|3855786|P3|STARTED|Overall Study||67
1576113|NCT01139021|3855787|P2|STARTED|Overall Study||153
1576114|NCT01139021|3855788|P1|STARTED|Overall Study||152
1576115|NCT01139008|3855824|P1|NOT COMPLETED|Overall Study||6
1576116|NCT01139008|3855824|P1|COMPLETED|Overall Study||74
1576117|NCT01139008|3855824|P1|STARTED|Overall Study||80
1576118|NCT01138995|3855835|P2|NOT COMPLETED|Overall Study||25
1576119|NCT01138995|3855836|P1|NOT COMPLETED|Overall Study||10
1576120|NCT01138995|3855835|P2|COMPLETED|Overall Study||74
1576121|NCT01138995|3855836|P1|COMPLETED|Overall Study||88
1576122|NCT01138995|3855835|P2|STARTED|Overall Study||99
1576123|NCT01138995|3855836|P1|STARTED|Overall Study||98
1576124|NCT01138969|3855848|P2|NOT COMPLETED|Overall Study||0
1576125|NCT01138969|3855849|P1|NOT COMPLETED|Overall Study||0
1576126|NCT01138969|3855848|P2|COMPLETED|Overall Study||82
1576127|NCT01138969|3855849|P1|COMPLETED|Overall Study||83
1576128|NCT01138969|3855848|P2|STARTED|Overall Study||82
1576129|NCT01138969|3855849|P1|STARTED|Overall Study||83
1576130|NCT01138826|3855857|P6|NOT COMPLETED|Third Intervention Period||0
1576131|NCT01138826|3855858|P5|NOT COMPLETED|Third Intervention Period||0
1576132|NCT01138826|3855859|P4|NOT COMPLETED|Third Intervention Period||0
1576133|NCT01138826|3855860|P3|NOT COMPLETED|Third Intervention Period||0
1576134|NCT01138826|3855861|P2|NOT COMPLETED|Third Intervention Period||0
1576135|NCT01138826|3855862|P1|NOT COMPLETED|Third Intervention Period||0
1576136|NCT01138826|3855857|P6|COMPLETED|Third Intervention Period||3
1576137|NCT01138826|3855858|P5|COMPLETED|Third Intervention Period||2
1576138|NCT01138826|3855859|P4|COMPLETED|Third Intervention Period||3
1576139|NCT01138826|3855860|P3|COMPLETED|Third Intervention Period||3
1576140|NCT01138826|3855861|P2|COMPLETED|Third Intervention Period||2
1576141|NCT01138826|3855862|P1|COMPLETED|Third Intervention Period||2
1576142|NCT01138826|3855857|P6|STARTED|Third Intervention Period||3
1576143|NCT01138826|3855858|P5|STARTED|Third Intervention Period||2
1576144|NCT01138826|3855859|P4|STARTED|Third Intervention Period||3
1576145|NCT01138826|3855860|P3|STARTED|Third Intervention Period||3
1576146|NCT01138826|3855861|P2|STARTED|Third Intervention Period||2
1576147|NCT01138826|3855862|P1|STARTED|Third Intervention Period||2
1576148|NCT01138826|3855857|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
1576149|NCT01138826|3855858|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
1576150|NCT01138826|3855859|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
1576151|NCT01138826|3855860|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
1576152|NCT01138826|3855861|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
1576153|NCT01138826|3855862|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
1576154|NCT01138826|3855857|P6|COMPLETED|Washout Period II (of 16 Days)||3
1576155|NCT01138826|3855858|P5|COMPLETED|Washout Period II (of 16 Days)||2
1576156|NCT01138826|3855859|P4|COMPLETED|Washout Period II (of 16 Days)||3
1576157|NCT01138826|3855860|P3|COMPLETED|Washout Period II (of 16 Days)||3
1576158|NCT01138826|3855861|P2|COMPLETED|Washout Period II (of 16 Days)||2
1576159|NCT01138826|3855862|P1|COMPLETED|Washout Period II (of 16 Days)||2
1576160|NCT01138826|3855857|P6|STARTED|Washout Period II (of 16 Days)||3
1576161|NCT01138826|3855858|P5|STARTED|Washout Period II (of 16 Days)||2
1576162|NCT01138826|3855859|P4|STARTED|Washout Period II (of 16 Days)||3
1576163|NCT01138826|3855860|P3|STARTED|Washout Period II (of 16 Days)||3
1576164|NCT01138826|3855861|P2|STARTED|Washout Period II (of 16 Days)||2
1576165|NCT01138826|3855862|P1|STARTED|Washout Period II (of 16 Days)||2
1576166|NCT01138826|3855857|P6|NOT COMPLETED|Second Intervention Period||0
1576167|NCT01138826|3855858|P5|NOT COMPLETED|Second Intervention Period||0
1576168|NCT01138826|3855859|P4|NOT COMPLETED|Second Intervention Period||0
1576169|NCT01138826|3855860|P3|NOT COMPLETED|Second Intervention Period||0
1576170|NCT01138826|3855861|P2|NOT COMPLETED|Second Intervention Period||0
1576171|NCT01138826|3855862|P1|NOT COMPLETED|Second Intervention Period||0
1576172|NCT01138826|3855857|P6|COMPLETED|Second Intervention Period||3
1576173|NCT01138826|3855858|P5|COMPLETED|Second Intervention Period||2
1576174|NCT01138826|3855859|P4|COMPLETED|Second Intervention Period||3
1576175|NCT01138826|3855860|P3|COMPLETED|Second Intervention Period||3
1576176|NCT01138826|3855861|P2|COMPLETED|Second Intervention Period||2
1576177|NCT01138826|3855862|P1|COMPLETED|Second Intervention Period||2
1576178|NCT01138826|3855857|P6|STARTED|Second Intervention Period||3
1576179|NCT01138826|3855858|P5|STARTED|Second Intervention Period||2
1576180|NCT01138826|3855859|P4|STARTED|Second Intervention Period||3
1576181|NCT01138826|3855860|P3|STARTED|Second Intervention Period||3
1576182|NCT01138826|3855861|P2|STARTED|Second Intervention Period||2
1576183|NCT01138826|3855862|P1|STARTED|Second Intervention Period||2
1576184|NCT01138826|3855857|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
1576185|NCT01138826|3855858|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
1576186|NCT01138826|3855859|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
1576187|NCT01138826|3855860|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
1576188|NCT01138826|3855861|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
1576189|NCT01138826|3855862|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
1576190|NCT01138826|3855857|P6|COMPLETED|Washout Period I (of 16 Days)||3
1576191|NCT01138826|3855858|P5|COMPLETED|Washout Period I (of 16 Days)||2
1576192|NCT01138826|3855859|P4|COMPLETED|Washout Period I (of 16 Days)||3
1576193|NCT01138826|3855860|P3|COMPLETED|Washout Period I (of 16 Days)||3
1576194|NCT01138826|3855861|P2|COMPLETED|Washout Period I (of 16 Days)||2
1576195|NCT01138826|3855862|P1|COMPLETED|Washout Period I (of 16 Days)||2
1576196|NCT01138826|3855857|P6|STARTED|Washout Period I (of 16 Days)||3
1576197|NCT01138826|3855858|P5|STARTED|Washout Period I (of 16 Days)||3
1576198|NCT01138826|3855859|P4|STARTED|Washout Period I (of 16 Days)||3
1576199|NCT01138826|3855860|P3|STARTED|Washout Period I (of 16 Days)||3
1576200|NCT01138826|3855861|P2|STARTED|Washout Period I (of 16 Days)||3
1576201|NCT01138826|3855862|P1|STARTED|Washout Period I (of 16 Days)||3
1576202|NCT01138826|3855857|P6|NOT COMPLETED|First Intervention Period||0
1576203|NCT01138826|3855858|P5|NOT COMPLETED|First Intervention Period||0
1576204|NCT01138826|3855859|P4|NOT COMPLETED|First Intervention Period||0
1576205|NCT01138826|3855860|P3|NOT COMPLETED|First Intervention Period||0
1576206|NCT01138826|3855861|P2|NOT COMPLETED|First Intervention Period||0
1576207|NCT01138826|3855862|P1|NOT COMPLETED|First Intervention Period||0
1576208|NCT01138826|3855857|P6|COMPLETED|First Intervention Period||3
1576209|NCT01138826|3855858|P5|COMPLETED|First Intervention Period||3
1576210|NCT01138826|3855859|P4|COMPLETED|First Intervention Period||3
1576211|NCT01138826|3855860|P3|COMPLETED|First Intervention Period||3
1576212|NCT01138826|3855861|P2|COMPLETED|First Intervention Period||3
1576213|NCT01138826|3855862|P1|COMPLETED|First Intervention Period||3
1576214|NCT01138826|3855857|P6|STARTED|First Intervention Period||3
1576215|NCT01138826|3855858|P5|STARTED|First Intervention Period||3
1576216|NCT01138826|3855859|P4|STARTED|First Intervention Period||3
1576217|NCT01138826|3855860|P3|STARTED|First Intervention Period||3
1576218|NCT01138826|3855861|P2|STARTED|First Intervention Period||3
1576219|NCT01138826|3855862|P1|STARTED|First Intervention Period||3
1576220|NCT01138735|3855884|P2|NOT COMPLETED|Overall Study||17
1576221|NCT01138735|3855885|P1|NOT COMPLETED|Overall Study||8
1576222|NCT01138735|3855884|P2|COMPLETED|Overall Study||126
1576223|NCT01138735|3855885|P1|COMPLETED|Overall Study||134
1576224|NCT01138735|3855884|P2|STARTED|Overall Study||143
1576225|NCT01138735|3855885|P1|STARTED|Overall Study||142
1576226|NCT01138657|3855899|P2|NOT COMPLETED|Overall Study||18
1576227|NCT01138657|3855900|P1|NOT COMPLETED|Overall Study||8
1576228|NCT01138657|3855899|P2|COMPLETED|Overall Study||101
1576229|NCT01138657|3855900|P1|COMPLETED|Overall Study||112
1576230|NCT01138657|3855899|P2|Enrolled in Japan Sub-study|Overall Study||8
1576231|NCT01138657|3855900|P1|Enrolled in Japan Sub-study|Overall Study||8
1576232|NCT01138657|3855899|P2|Enrolled in Main Study|Overall Study||111
1576233|NCT01138657|3855900|P1|Enrolled in Main Study|Overall Study||112
1576234|NCT01138657|3855899|P2|STARTED|Overall Study||119
1576235|NCT01138657|3855900|P1|STARTED|Overall Study||120
1576236|NCT01138514|3855947|P3|NOT COMPLETED|Overall Study||93
1576237|NCT01138514|3855948|P2|NOT COMPLETED|Overall Study||53
1576238|NCT01138514|3855949|P1|NOT COMPLETED|Overall Study||48
1576239|NCT01138514|3855947|P3|COMPLETED|Overall Study||424
1576240|NCT01138514|3855948|P2|COMPLETED|Overall Study||463
1576241|NCT01138514|3855949|P1|COMPLETED|Overall Study||474
1576242|NCT01138514|3855947|P3|STARTED|Overall Study||517
1576243|NCT01138514|3855948|P2|STARTED|Overall Study||516
1576244|NCT01138514|3855949|P1|STARTED|Overall Study||522
1576245|NCT01138501|3855963|P1|NOT COMPLETED|Overall Study||5
1576246|NCT01138501|3855963|P1|COMPLETED|Overall Study||60
1576247|NCT01138501|3855963|P1|Exposed|Overall Study||63
1576248|NCT01138501|3855963|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
1576249|NCT01138475|3855971|P3|NOT COMPLETED|Overall Study||0
1576250|NCT01138475|3855972|P2|NOT COMPLETED|Overall Study||0
1576251|NCT01138475|3855973|P1|NOT COMPLETED|Overall Study||0
1576252|NCT01138475|3855971|P3|COMPLETED|Overall Study||17
1576253|NCT01138475|3855972|P2|COMPLETED|Overall Study||16
1576254|NCT01138475|3855973|P1|COMPLETED|Overall Study||16
1576255|NCT01138475|3855971|P3|STARTED|Overall Study||17
1576256|NCT01138475|3855972|P2|STARTED|Overall Study||16
1576257|NCT01138475|3855973|P1|STARTED|Overall Study||16
1576258|NCT01138150|3856007|P2|NOT COMPLETED|Overall Study||1
1576259|NCT01138150|3856008|P1|NOT COMPLETED|Overall Study||1
1576260|NCT01138150|3856007|P2|COMPLETED|Overall Study||17
1576261|NCT01138150|3856008|P1|COMPLETED|Overall Study||17
1576262|NCT01138150|3856007|P2|STARTED|Overall Study||18
1576263|NCT01138150|3856008|P1|STARTED|Overall Study||18
1576264|NCT01138124|3856064|P4|NOT COMPLETED|Overall Study||0
1576265|NCT01138124|3856065|P3|NOT COMPLETED|Overall Study||0
1576266|NCT01138124|3856066|P2|NOT COMPLETED|Overall Study||0
1576267|NCT01138124|3856067|P1|NOT COMPLETED|Overall Study||0
1576268|NCT01138124|3856064|P4|COMPLETED|Overall Study||19046
1576269|NCT01138124|3856065|P3|COMPLETED|Overall Study||1981
1576270|NCT01138124|3856066|P2|COMPLETED|Overall Study||30026
1576271|NCT01138124|3856067|P1|COMPLETED|Overall Study||3149
1576272|NCT01138124|3856064|P4|STARTED|Overall Study||19046
1576273|NCT01138124|3856065|P3|STARTED|Overall Study||1981
1576274|NCT01138124|3856066|P2|STARTED|Overall Study||30026
1576275|NCT01138124|3856067|P1|STARTED|Overall Study||3149
1576276|NCT01138111|3856089|P1|NOT COMPLETED|Overall Study||9
1576277|NCT01138111|3856089|P1|COMPLETED|Overall Study||36
1576278|NCT01138111|3856089|P1|STARTED|Overall Study||45
1576279|NCT01138098|3856120|P2|NOT COMPLETED|Overall Study||0
1576280|NCT01138098|3856121|P1|NOT COMPLETED|Overall Study||0
1576281|NCT01138098|3856120|P2|COMPLETED|Overall Study||90
1576282|NCT01138098|3856121|P1|COMPLETED|Overall Study||95
1576283|NCT01138098|3856120|P2|STARTED|Overall Study||90
1576284|NCT01138098|3856121|P1|STARTED|Overall Study||95
1576285|NCT01138046|3856143|P1|NOT COMPLETED|Overall Study||6
1576286|NCT01138046|3856143|P1|COMPLETED|Overall Study||6
1576287|NCT01138046|3856143|P1|STARTED|Overall Study||12
1576288|NCT01138007|3856163|P3|NOT COMPLETED|Overall Study||48
1576289|NCT01138007|3856164|P2|NOT COMPLETED|Overall Study||30
1576290|NCT01138007|3856165|P1|NOT COMPLETED|Overall Study||22
1576291|NCT01138007|3856163|P3|COMPLETED|Overall Study||144
1576292|NCT01138007|3856164|P2|COMPLETED|Overall Study||160
1576293|NCT01138007|3856165|P1|COMPLETED|Overall Study||165
1576294|NCT01138007|3856163|P3|STARTED|Overall Study||192
1576295|NCT01138007|3856164|P2|STARTED|Overall Study||190
1576296|NCT01138007|3856165|P1|STARTED|Overall Study||187
1576297|NCT01137890|3856199|P2|NOT COMPLETED|Overall Study||3
1576298|NCT01137890|3856200|P1|NOT COMPLETED|Overall Study||6
1576299|NCT01137890|3856199|P2|COMPLETED|Overall Study||2
1576300|NCT01137890|3856200|P1|COMPLETED|Overall Study||8
1576301|NCT01137890|3856199|P2|STARTED|Overall Study||5
1576302|NCT01137890|3856200|P1|STARTED|Overall Study||14
1576303|NCT01137812|3856272|P2|NOT COMPLETED|Overall Study||168
1576304|NCT01137812|3856273|P1|NOT COMPLETED|Overall Study||123
1576305|NCT01137812|3856272|P2|COMPLETED|Overall Study||210
1576306|NCT01137812|3856273|P1|COMPLETED|Overall Study||254
1576307|NCT01137812|3856272|P2|STARTED|Overall Study||378
1576308|NCT01137812|3856273|P1|STARTED|Overall Study||377
1576309|NCT01137786|3856293|P2|NOT COMPLETED|Overall Study||3
1576310|NCT01137786|3856294|P1|NOT COMPLETED|Overall Study||1
1576311|NCT01137786|3856293|P2|COMPLETED|Overall Study||21
1576312|NCT01137786|3856294|P1|COMPLETED|Overall Study||24
1576313|NCT01137786|3856293|P2|STARTED|Overall Study||24
1576314|NCT01137786|3856294|P1|STARTED|Overall Study||25
1576315|NCT01137773|3856304|P2|NOT COMPLETED|Overall Study||3
1576316|NCT01137773|3856305|P1|NOT COMPLETED|Overall Study||9
1576317|NCT01137773|3856304|P2|COMPLETED|Overall Study||20
1576318|NCT01137773|3856305|P1|COMPLETED|Overall Study||24
1576319|NCT01137773|3856304|P2|STARTED|Overall Study||23
1576320|NCT01137773|3856305|P1|STARTED|Overall Study||33
1576321|NCT01137682|3856316|P3|NOT COMPLETED|Overall Study||34
1576322|NCT01137682|3856317|P2|NOT COMPLETED|Overall Study||40
1576323|NCT01137682|3856318|P1|NOT COMPLETED|Overall Study||37
1576324|NCT01137682|3856316|P3|COMPLETED|Overall Study||34
1576325|NCT01137682|3856317|P2|COMPLETED|Overall Study||25
1576326|NCT01137682|3856318|P1|COMPLETED|Overall Study||28
1576327|NCT01137682|3856316|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
1576328|NCT01137682|3856317|P2|Safety Set - Extension|Overall Study||54
1576329|NCT01137682|3856318|P1|Safety Set - Extension|Overall Study||57
1576330|NCT01137682|3856316|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
1576331|NCT01137682|3856317|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
1576332|NCT01137682|3856318|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
1576333|NCT01137682|3856316|P3|Continuing Into Extension|Overall Study||63
1576334|NCT01137682|3856317|P2|Continuing Into Extension|Overall Study||54
1576335|NCT01137682|3856318|P1|Continuing Into Extension|Overall Study||57
1576336|NCT01137682|3856316|P3|Not Continuing Into Extension|Overall Study||2
1576337|NCT01137682|3856317|P2|Not Continuing Into Extension|Overall Study||3
1576338|NCT01137682|3856318|P1|Not Continuing Into Extension|Overall Study||2
1576339|NCT01137682|3856316|P3|Completed 24-Week Core Phase|Overall Study||65
1576340|NCT01137682|3856317|P2|Completed 24-Week Core Phase|Overall Study||57
1576341|NCT01137682|3856318|P1|Completed 24-Week Core Phase|Overall Study||59
1576342|NCT01137682|3856316|P3|Treated|Overall Study||67
1576343|NCT01137682|3856317|P2|Treated|Overall Study||63
1576344|NCT01137682|3856318|P1|Treated|Overall Study||63
1576345|NCT01137682|3856316|P3|Not Treated|Overall Study||1
1576346|NCT01137682|3856317|P2|Not Treated|Overall Study||2
1576347|NCT01137682|3856318|P1|Not Treated|Overall Study||2
1576348|NCT01137682|3856316|P3|STARTED|Overall Study||68
1576349|NCT01137682|3856317|P2|STARTED|Overall Study||65
1576350|NCT01137682|3856318|P1|STARTED|Overall Study||65
1576351|NCT01137604|3856368|P4|NOT COMPLETED|Overall Study||11
1576352|NCT01137604|3856369|P3|NOT COMPLETED|Overall Study||13
1576353|NCT01137604|3856370|P2|NOT COMPLETED|Overall Study||10
1576354|NCT01137604|3856371|P1|NOT COMPLETED|Overall Study||2
1576355|NCT01137604|3856368|P4|COMPLETED|Overall Study||21
1576356|NCT01137604|3856369|P3|COMPLETED|Overall Study||26
1576357|NCT01137604|3856370|P2|COMPLETED|Overall Study||32
1576358|NCT01137604|3856371|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
1576359|NCT01137604|3856368|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
1576360|NCT01137604|3856369|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
1576361|NCT01137604|3856370|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
1576362|NCT01137604|3856371|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
1576363|NCT01137604|3856368|P4|Disease Progression|Overall Study||21
1576364|NCT01137604|3856369|P3|Disease Progression|Overall Study||25
1576365|NCT01137604|3856370|P2|Disease Progression|Overall Study||29
1576366|NCT01137604|3856371|P1|Disease Progression|Overall Study||34
1576367|NCT01137604|3856368|P4|STARTED|Overall Study||32
1576368|NCT01137604|3856369|P3|STARTED|Overall Study||39
1576369|NCT01137604|3856370|P2|STARTED|Overall Study||42
1576370|NCT01137604|3856371|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
1576371|NCT01137578|3856405|P3|NOT COMPLETED|Overall Study||6
1576372|NCT01137578|3856406|P2|NOT COMPLETED|Overall Study||2
1576373|NCT01137578|3856407|P1|NOT COMPLETED|Overall Study||16
1576374|NCT01137578|3856405|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
1576375|NCT01137578|3856406|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
1576376|NCT01137578|3856407|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
1576377|NCT01137578|3856405|P3|STARTED|Overall Study||43
1576378|NCT01137578|3856406|P2|STARTED|Overall Study||14
1576379|NCT01137578|3856407|P1|STARTED|Overall Study||77
1576380|NCT01137539|3856447|P1|NOT COMPLETED|Overall Study||0
1576381|NCT01137539|3856447|P1|COMPLETED|Overall Study||50
1576382|NCT01137539|3856447|P1|STARTED|Overall Study||50
1576383|NCT01137474|3856456|P4|NOT COMPLETED|Overall Study||21
1576384|NCT01137474|3856457|P3|NOT COMPLETED|Overall Study||7
1576385|NCT01137474|3856458|P2|NOT COMPLETED|Overall Study||12
1576386|NCT01137474|3856459|P1|NOT COMPLETED|Overall Study||24
1576387|NCT01137474|3856456|P4|COMPLETED|Overall Study||281
1576388|NCT01137474|3856457|P3|COMPLETED|Overall Study||158
1576389|NCT01137474|3856458|P2|COMPLETED|Overall Study||154
1576390|NCT01137474|3856459|P1|COMPLETED|Overall Study||287
1576391|NCT01137474|3856456|P4|Received Treatment|Overall Study||302
1576392|NCT01137474|3856457|P3|Received Treatment|Overall Study||165
1576393|NCT01137474|3856458|P2|Received Treatment|Overall Study||166
1576394|NCT01137474|3856459|P1|Received Treatment|Overall Study||311
1576395|NCT01137474|3856456|P4|STARTED|Overall Study||302
1576396|NCT01137474|3856457|P3|STARTED|Overall Study||165
1576397|NCT01137474|3856458|P2|STARTED|Overall Study||166
1576398|NCT01137474|3856459|P1|STARTED|Overall Study||311
1576399|NCT01137435|3856477|P1|NOT COMPLETED|Overall Study||28
1576400|NCT01137435|3856477|P1|COMPLETED|Overall Study||659
1576401|NCT01137435|3856477|P1|STARTED|Overall Study||687
1576402|NCT01137396|3856486|P2|NOT COMPLETED|Overall Study||2
1576403|NCT01137396|3856487|P1|NOT COMPLETED|Overall Study||8
1576404|NCT01137396|3856486|P2|COMPLETED|Overall Study||25
1576405|NCT01137396|3856487|P1|COMPLETED|Overall Study||22
1576406|NCT01137396|3856486|P2|STARTED|Overall Study||27
1576407|NCT01137396|3856487|P1|STARTED|Overall Study||30
1576408|NCT01137370|3856497|P2|NOT COMPLETED|Overall Study||0
1576409|NCT01137370|3856498|P1|NOT COMPLETED|Overall Study||0
1576410|NCT01137370|3856497|P2|COMPLETED|Overall Study||87
1576411|NCT01137370|3856498|P1|COMPLETED|Overall Study||116
1576412|NCT01137370|3856497|P2|STARTED|Overall Study||87
1576413|NCT01137370|3856498|P1|STARTED|Overall Study||116
1576414|NCT01137292|3856504|P1|NOT COMPLETED|Overall Study||54
1576415|NCT01137292|3856504|P1|COMPLETED|Overall Study||123
1576416|NCT01137292|3856504|P1|STARTED|Overall Study||177
1576417|NCT01137071|3856511|P1|NOT COMPLETED|Overall Study||14
1576418|NCT01137071|3856511|P1|COMPLETED|Overall Study|Of the eligible patients|15
1576419|NCT01137071|3856511|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
1576420|NCT01137032|3856572|P1|NOT COMPLETED|Overall Study||0
1576421|NCT01137032|3856572|P1|COMPLETED|Overall Study||19
1576422|NCT01137032|3856572|P1|STARTED|Overall Study||19
1576423|NCT01136967|3856580|P2|NOT COMPLETED|Overall Study||27
1576424|NCT01136967|3856581|P1|NOT COMPLETED|Overall Study||24
1576425|NCT01136967|3856580|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
1576426|NCT01136967|3856581|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
1576427|NCT01136967|3856580|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
1576428|NCT01136967|3856581|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
1576429|NCT01136967|3856580|P2|Disease Progression|Overall Study||56
1576430|NCT01136967|3856581|P1|Disease Progression|Overall Study||55
1576431|NCT01136967|3856580|P2|STARTED|Overall Study||89
1576432|NCT01136967|3856581|P1|STARTED|Overall Study||93
1576433|NCT01136954|3856599|P2|NOT COMPLETED|Overall Study||21
1576434|NCT01136954|3856600|P1|NOT COMPLETED|Overall Study||24
1576435|NCT01136954|3856599|P2|COMPLETED|Overall Study||51
1576436|NCT01136954|3856600|P1|COMPLETED|Overall Study||48
1576437|NCT01136954|3856599|P2|STARTED|Overall Study||72
1576438|NCT01136954|3856600|P1|STARTED|Overall Study||72
1576439|NCT01136915|3856614|P2|NOT COMPLETED|Overall Study||1
1576440|NCT01136915|3856615|P1|NOT COMPLETED|Overall Study||2
1576441|NCT01136915|3856614|P2|COMPLETED|Overall Study||6
1576442|NCT01136915|3856615|P1|COMPLETED|Overall Study||6
1576443|NCT01136915|3856614|P2|STARTED|Overall Study||7
1576444|NCT01136915|3856615|P1|STARTED|Overall Study||8
1576445|NCT01136876|3856625|P2|NOT COMPLETED|Overall Study||6
1576446|NCT01136876|3856626|P1|NOT COMPLETED|Overall Study||3
1576447|NCT01136876|3856625|P2|COMPLETED|Overall Study||23
1576448|NCT01136876|3856626|P1|COMPLETED|Overall Study||25
1576449|NCT01136876|3856625|P2|STARTED|Overall Study||29
1576450|NCT01136876|3856626|P1|STARTED|Overall Study||28
1576451|NCT01136798|3856636|P2|NOT COMPLETED|Overall Study||0
1576452|NCT01136798|3856637|P1|NOT COMPLETED|Overall Study||0
1576453|NCT01136798|3856636|P2|COMPLETED|Overall Study||8
1576454|NCT01136798|3856637|P1|COMPLETED|Overall Study||10
1576455|NCT01136798|3856636|P2|STARTED|Overall Study||8
1576456|NCT01136798|3856637|P1|STARTED|Overall Study||10
1576457|NCT01136785|3856655|P2|NOT COMPLETED|Overall Study||1
1576458|NCT01136785|3856656|P1|NOT COMPLETED|Overall Study||2
1576459|NCT01136785|3856655|P2|COMPLETED|Overall Study||6
1576460|NCT01136785|3856656|P1|COMPLETED|Overall Study||13
1576461|NCT01136785|3856655|P2|STARTED|Overall Study||7
1576462|NCT01136785|3856656|P1|STARTED|Overall Study||15
1576463|NCT01136772|3856671|P2|NOT COMPLETED|Overall Study||110
1576464|NCT01136772|3856672|P1|NOT COMPLETED|Overall Study||116
1576465|NCT01136772|3856671|P2|COMPLETED|Overall Study||44
1576466|NCT01136772|3856672|P1|COMPLETED|Overall Study||41
1576467|NCT01136772|3856671|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
1576468|NCT01136772|3856672|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
1576469|NCT01136772|3856671|P2|STARTED|Overall Study||154
1576470|NCT01136772|3856672|P1|STARTED|Overall Study||157
1576471|NCT01136746|3856682|P2|NOT COMPLETED|Overall Study||3
1576472|NCT01136746|3856683|P1|NOT COMPLETED|Overall Study||3
1576473|NCT01136746|3856682|P2|COMPLETED|Overall Study||4
1576474|NCT01136746|3856683|P1|COMPLETED|Overall Study||6
1576475|NCT01136746|3856682|P2|STARTED|Overall Study||7
1576476|NCT01136746|3856683|P1|STARTED|Overall Study||9
1576477|NCT01136655|3856743|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
1576478|NCT01136655|3856743|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
1576479|NCT01136655|3856743|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
1576480|NCT01136655|3856743|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
1576481|NCT01136655|3856743|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
1576482|NCT01136655|3856743|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
1576483|NCT01136655|3856743|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
1576484|NCT01136655|3856743|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
1576485|NCT01136655|3856743|P1|STARTED|Washout After BUD 160 (7 Days)||51
1576486|NCT01136655|3856743|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
1576487|NCT01136655|3856743|P1|COMPLETED|BUD 160 (1 Dose)||51
1576488|NCT01136655|3856743|P1|STARTED|BUD 160 (1 Dose)||51
1576489|NCT01136655|3856743|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
1576490|NCT01136655|3856743|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
1576491|NCT01136655|3856743|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
1576492|NCT01136655|3856743|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
1576493|NCT01136655|3856743|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
1576494|NCT01136655|3856743|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
1576495|NCT01136655|3856743|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
1576496|NCT01136655|3856743|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
1576497|NCT01136655|3856743|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
1576498|NCT01136655|3856743|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
1576499|NCT01136655|3856743|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
1576500|NCT01136655|3856743|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
1576501|NCT01136655|3856743|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
1576502|NCT01136655|3856743|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
1576503|NCT01136655|3856743|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
1576504|NCT01136655|3856743|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
1576505|NCT01136655|3856743|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
1576506|NCT01136655|3856743|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
1576507|NCT01136486|3856769|P1|NOT COMPLETED|Overall Study||0
1576508|NCT01136486|3856769|P1|COMPLETED|Overall Study||56
1576509|NCT01136486|3856769|P1|STARTED|Overall Study||56
1576510|NCT01136408|3856776|P3|NOT COMPLETED|Overall Study||5
1576511|NCT01136408|3856777|P2|NOT COMPLETED|Overall Study||9
1576512|NCT01136408|3856778|P1|NOT COMPLETED|Overall Study||5
1576513|NCT01136408|3856776|P3|COMPLETED|Overall Study||57
1576514|NCT01136408|3856777|P2|COMPLETED|Overall Study||49
1576515|NCT01136408|3856778|P1|COMPLETED|Overall Study||41
1576516|NCT01136408|3856776|P3|STARTED|Overall Study||62
1576517|NCT01136408|3856777|P2|STARTED|Overall Study||58
1576518|NCT01136408|3856778|P1|STARTED|Overall Study||46
1576519|NCT01136382|3856835|P2|NOT COMPLETED|Overall Study||31
1576520|NCT01136382|3856836|P1|NOT COMPLETED|Overall Study||60
1576521|NCT01136382|3856835|P2|COMPLETED|Overall Study||121
1576522|NCT01136382|3856836|P1|COMPLETED|Overall Study||92
1576523|NCT01136382|3856835|P2|STARTED|Overall Study||152
1576524|NCT01136382|3856836|P1|STARTED|Overall Study||152
1576525|NCT01136356|3856862|P2|NOT COMPLETED|Second 18-day Withdrawal||1
1576526|NCT01136356|3856863|P1|NOT COMPLETED|Second 18-day Withdrawal||0
1576527|NCT01136356|3856862|P2|COMPLETED|Second 18-day Withdrawal||5
1576528|NCT01136356|3856863|P1|COMPLETED|Second 18-day Withdrawal||2
1576529|NCT01136356|3856862|P2|STARTED|Second 18-day Withdrawal||6
1576530|NCT01136356|3856863|P1|STARTED|Second 18-day Withdrawal||2
1576531|NCT01136356|3856862|P2|NOT COMPLETED|Second Intervention||0
1576532|NCT01136356|3856863|P1|NOT COMPLETED|Second Intervention||0
1576533|NCT01136356|3856862|P2|COMPLETED|Second Intervention||6
1576534|NCT01136356|3856863|P1|COMPLETED|Second Intervention||2
1576535|NCT01136356|3856862|P2|STARTED|Second Intervention||6
1576536|NCT01136356|3856863|P1|STARTED|Second Intervention||2
1576537|NCT01136356|3856862|P2|NOT COMPLETED|First 18-day Withdrawal||0
1576538|NCT01136356|3856863|P1|NOT COMPLETED|First 18-day Withdrawal||4
1576539|NCT01136356|3856862|P2|COMPLETED|First 18-day Withdrawal||6
1576540|NCT01136356|3856863|P1|COMPLETED|First 18-day Withdrawal||2
1576541|NCT01136356|3856862|P2|STARTED|First 18-day Withdrawal||6
1576542|NCT01136356|3856863|P1|STARTED|First 18-day Withdrawal||6
1576543|NCT01136356|3856862|P2|NOT COMPLETED|First Intervention||0
1576544|NCT01136356|3856863|P1|NOT COMPLETED|First Intervention||0
1576545|NCT01136356|3856862|P2|COMPLETED|First Intervention||6
1576546|NCT01136356|3856863|P1|COMPLETED|First Intervention||6
1576547|NCT01136356|3856862|P2|STARTED|First Intervention||6
1576548|NCT01136356|3856863|P1|STARTED|First Intervention||6
1576549|NCT01136291|3856874|P2|NOT COMPLETED|Overall Study||1
1576550|NCT01136291|3856875|P1|NOT COMPLETED|Overall Study||1
1576551|NCT01136291|3856874|P2|COMPLETED|Overall Study||41
1576552|NCT01136291|3856875|P1|COMPLETED|Overall Study||39
1576553|NCT01136291|3856874|P2|Follow|Overall Study||42
1576554|NCT01136291|3856875|P1|Follow|Overall Study||40
1576555|NCT01136291|3856874|P2|STARTED|Overall Study||42
1576556|NCT01136291|3856875|P1|STARTED|Overall Study||40
1576557|NCT01136226|3856885|P1|NOT COMPLETED|Overall Study||13
1576558|NCT01136226|3856885|P1|COMPLETED|Overall Study||29
1576559|NCT01136226|3856885|P1|STARTED|Overall Study||42
1576560|NCT01136174|3856894|P4|NOT COMPLETED|Overall Study||4
1576561|NCT01136174|3856895|P3|NOT COMPLETED|Overall Study||0
1576562|NCT01136174|3856896|P2|NOT COMPLETED|Overall Study||0
1576563|NCT01136174|3856897|P1|NOT COMPLETED|Overall Study||0
1576564|NCT01136174|3856894|P4|COMPLETED|Overall Study||20
1576565|NCT01136174|3856895|P3|COMPLETED|Overall Study||8
1576566|NCT01136174|3856896|P2|COMPLETED|Overall Study||6
1576567|NCT01136174|3856897|P1|COMPLETED|Overall Study||12
1576568|NCT01136174|3856894|P4|STARTED|Overall Study||24
1576569|NCT01136174|3856895|P3|STARTED|Overall Study||8
1576570|NCT01136174|3856896|P2|STARTED|Overall Study||6
1576571|NCT01136174|3856897|P1|STARTED|Overall Study||12
1576572|NCT01135992|3856977|P1|NOT COMPLETED|Overall Study||21
1576573|NCT01135992|3856977|P1|COMPLETED|Overall Study||122
1576574|NCT01135992|3856977|P1|Full Analysis Set|Overall Study||129
1576575|NCT01135992|3856977|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
1576576|NCT01135992|3856977|P1|STARTED|Overall Study||143
1576577|NCT01135914|3856989|P3|NOT COMPLETED|Overall Study||22
1576578|NCT01135914|3856990|P2|NOT COMPLETED|Overall Study||5
1576579|NCT01135914|3856991|P1|NOT COMPLETED|Overall Study||4
1576580|NCT01135914|3856989|P3|COMPLETED|Overall Study||59
1576581|NCT01135914|3856990|P2|COMPLETED|Overall Study||75
1576582|NCT01135914|3856991|P1|COMPLETED|Overall Study||74
1576583|NCT01135914|3856989|P3|Safety Population|Overall Study||74
1576584|NCT01135914|3856990|P2|Safety Population|Overall Study||75
1576585|NCT01135914|3856991|P1|Safety Population|Overall Study||73
1576586|NCT01135914|3856989|P3|Intent to Treat (ITT) Population|Overall Study||72
1576587|NCT01135914|3856990|P2|Intent to Treat (ITT) Population|Overall Study||75
1576588|NCT01135914|3856991|P1|Intent to Treat (ITT) Population|Overall Study||73
1576589|NCT01135914|3856989|P3|STARTED|Overall Study||81
1576590|NCT01135914|3856990|P2|STARTED|Overall Study||80
1576591|NCT01135914|3856991|P1|STARTED|Overall Study||78
1576592|NCT01135524|3857020|P1|NOT COMPLETED|Overall Study||196
1576593|NCT01135524|3857020|P1|COMPLETED|Overall Study||0
1576594|NCT01135524|3857020|P1|STARTED|Overall Study||196
1576595|NCT01135511|3857033|P9|NOT COMPLETED|Overall Study||1
1576596|NCT01135511|3857034|P8|NOT COMPLETED|Overall Study||1
1576597|NCT01135511|3857035|P7|NOT COMPLETED|Overall Study||1
1576598|NCT01135511|3857036|P6|NOT COMPLETED|Overall Study||1
1576599|NCT01135511|3857037|P5|NOT COMPLETED|Overall Study||1
1576600|NCT01135511|3857038|P4|NOT COMPLETED|Overall Study||3
1576601|NCT01135511|3857039|P3|NOT COMPLETED|Overall Study||8
1576602|NCT01135511|3857040|P2|NOT COMPLETED|Overall Study||3
1576603|NCT01135511|3857041|P1|NOT COMPLETED|Overall Study||0
1576604|NCT01135511|3857033|P9|COMPLETED|Overall Study||20
1576605|NCT01135511|3857034|P8|COMPLETED|Overall Study||20
1576606|NCT01135511|3857035|P7|COMPLETED|Overall Study||18
1576607|NCT01135511|3857036|P6|COMPLETED|Overall Study||20
1576608|NCT01135511|3857037|P5|COMPLETED|Overall Study||38
1576609|NCT01135511|3857038|P4|COMPLETED|Overall Study||37
1576610|NCT01135511|3857039|P3|COMPLETED|Overall Study||33
1576611|NCT01135511|3857040|P2|COMPLETED|Overall Study||39
1576612|NCT01135511|3857041|P1|COMPLETED|Overall Study||41
1576613|NCT01135511|3857033|P9|STARTED|Overall Study||21
1576614|NCT01135511|3857034|P8|STARTED|Overall Study||21
1576615|NCT01135511|3857035|P7|STARTED|Overall Study||19
1576616|NCT01135511|3857036|P6|STARTED|Overall Study||21
1576617|NCT01135511|3857037|P5|STARTED|Overall Study||39
1576618|NCT01135511|3857038|P4|STARTED|Overall Study||40
1576619|NCT01135511|3857039|P3|STARTED|Overall Study||41
1576620|NCT01135511|3857040|P2|STARTED|Overall Study||42
1576621|NCT01135511|3857041|P1|STARTED|Overall Study||41
1576622|NCT01135498|3857323|P1|NOT COMPLETED|Overall Study||90
1576623|NCT01135498|3857323|P1|COMPLETED|Overall Study||0
1576624|NCT01135498|3857323|P1|STARTED|Overall Study||90
1576625|NCT01135420|3857334|P2|NOT COMPLETED|Overall Study||32
1576626|NCT01135420|3857335|P1|NOT COMPLETED|Overall Study||44
1576627|NCT01135420|3857334|P2|COMPLETED|Overall Study||175
1576628|NCT01135420|3857335|P1|COMPLETED|Overall Study||155
1576629|NCT01135420|3857334|P2|STARTED|Overall Study||207
1576630|NCT01135420|3857335|P1|STARTED|Overall Study||199
1576631|NCT01135381|3857345|P4|NOT COMPLETED|Overall Study||1
1576632|NCT01135381|3857346|P3|NOT COMPLETED|Overall Study||4
1576633|NCT01135381|3857347|P2|NOT COMPLETED|Overall Study||7
1576634|NCT01135381|3857348|P1|NOT COMPLETED|Overall Study||21
1576635|NCT01135381|3857345|P4|COMPLETED|Overall Study||67
1576636|NCT01135381|3857346|P3|COMPLETED|Overall Study||65
1576637|NCT01135381|3857347|P2|COMPLETED|Overall Study||178
1576638|NCT01135381|3857348|P1|COMPLETED|Overall Study||168
1576639|NCT01135381|3857345|P4|STARTED|Overall Study||68
1576640|NCT01135381|3857346|P3|STARTED|Overall Study||69
1576641|NCT01135381|3857347|P2|STARTED|Overall Study||185
1576642|NCT01135381|3857348|P1|STARTED|Overall Study||189
1576643|NCT01135368|3857366|P1|NOT COMPLETED|Overall Study||251
1576644|NCT01135368|3857366|P1|COMPLETED|Overall Study||255
1576645|NCT01135368|3857366|P1|STARTED|Overall Study||506
1576646|NCT01135329|3857482|P1|NOT COMPLETED|Overall Study||0
1576647|NCT01135329|3857482|P1|COMPLETED|Overall Study||15
1576648|NCT01135329|3857482|P1|STARTED|Overall Study||15
1576649|NCT01135186|3857493|P1|NOT COMPLETED|Overall Study||0
1576650|NCT01135186|3857493|P1|COMPLETED|Overall Study||9
1576651|NCT01135186|3857493|P1|STARTED|Overall Study||9
1576652|NCT01135134|3857502|P2|NOT COMPLETED|Overall Study||1
1576653|NCT01135134|3857503|P1|NOT COMPLETED|Overall Study||2
1576654|NCT01135134|3857502|P2|COMPLETED|Overall Study||112
1576655|NCT01135134|3857503|P1|COMPLETED|Overall Study||218
1576656|NCT01135134|3857502|P2|STARTED|Overall Study||113
1576657|NCT01135134|3857503|P1|STARTED|Overall Study||220
1576658|NCT01135069|3857514|P3|NOT COMPLETED|Overall Study||10
1576659|NCT01135069|3857515|P2|NOT COMPLETED|Overall Study||32
1576660|NCT01135069|3857516|P1|NOT COMPLETED|Overall Study||36
1576661|NCT01135069|3857514|P3|COMPLETED|Overall Study||56
1576662|NCT01135069|3857515|P2|COMPLETED|Overall Study||177
1576663|NCT01135069|3857516|P1|COMPLETED|Overall Study||169
1576664|NCT01135069|3857514|P3|STARTED|Overall Study||66
1576665|NCT01135069|3857515|P2|STARTED|Overall Study||209
1576666|NCT01135069|3857516|P1|STARTED|Overall Study||205
1576667|NCT01135017|3857526|P2|NOT COMPLETED|Overall Study||12
1576668|NCT01135017|3857527|P1|NOT COMPLETED|Overall Study||6
1576669|NCT01135017|3857526|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
1576670|NCT01135017|3857527|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
1576671|NCT01135017|3857526|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
1576672|NCT01135017|3857527|P1|Evaluable for Efficacy|Overall Study||55
1576673|NCT01135017|3857526|P2|Treated|Overall Study||57
1576674|NCT01135017|3857527|P1|Treated|Overall Study||55
1576675|NCT01135017|3857526|P2|STARTED|Overall Study||57
1576676|NCT01135017|3857527|P1|STARTED|Overall Study||55
1576677|NCT01134952|3857543|P1|NOT COMPLETED|Overall Study||0
1576678|NCT01134952|3857543|P1|COMPLETED|Overall Study||11
1576679|NCT01134952|3857543|P1|STARTED|Overall Study||11
1576680|NCT01134939|3857565|P8|NOT COMPLETED|Overall Study||0
1576681|NCT01134939|3857566|P7|NOT COMPLETED|Overall Study||9
1576682|NCT01134939|3857567|P6|NOT COMPLETED|Overall Study||9
1576683|NCT01134939|3857568|P5|NOT COMPLETED|Overall Study||10
1576684|NCT01134939|3857569|P4|NOT COMPLETED|Overall Study||14
1576685|NCT01134939|3857570|P3|NOT COMPLETED|Overall Study||10
1576686|NCT01134939|3857571|P2|NOT COMPLETED|Overall Study||18
1576687|NCT01134939|3857572|P1|NOT COMPLETED|Overall Study||17
1576688|NCT01134939|3857565|P8|COMPLETED|Overall Study||1
1576689|NCT01134939|3857566|P7|COMPLETED|Overall Study||10
1576690|NCT01134939|3857567|P6|COMPLETED|Overall Study||5
1576691|NCT01134939|3857568|P5|COMPLETED|Overall Study||23
1576692|NCT01134939|3857569|P4|COMPLETED|Overall Study||32
1576693|NCT01134939|3857570|P3|COMPLETED|Overall Study||41
1576694|NCT01134939|3857571|P2|COMPLETED|Overall Study||24
1576695|NCT01134939|3857572|P1|COMPLETED|Overall Study||42
1576696|NCT01134939|3857565|P8|STARTED|Overall Study||1
1576697|NCT01134939|3857566|P7|STARTED|Overall Study||19
1576698|NCT01134939|3857567|P6|STARTED|Overall Study||14
1576699|NCT01134939|3857568|P5|STARTED|Overall Study||33
1576700|NCT01134939|3857569|P4|STARTED|Overall Study||46
1576701|NCT01134939|3857570|P3|STARTED|Overall Study||51
1576702|NCT01134939|3857571|P2|STARTED|Overall Study||42
1576703|NCT01134939|3857572|P1|STARTED|Overall Study||59
1576704|NCT01134900|3857684|P2|NOT COMPLETED|Overall Study||0
1576705|NCT01134900|3857685|P1|NOT COMPLETED|Overall Study||0
1576706|NCT01134900|3857684|P2|COMPLETED|Overall Study||196
1576707|NCT01134900|3857685|P1|COMPLETED|Overall Study||200
1576708|NCT01134900|3857684|P2|STARTED|Overall Study||196
1576709|NCT01134900|3857685|P1|STARTED|Overall Study||200
1576710|NCT01134887|3857697|P4|NOT COMPLETED|Overall Study||0
1576711|NCT01134887|3857698|P3|NOT COMPLETED|Overall Study||0
1576712|NCT01134887|3857699|P2|NOT COMPLETED|Overall Study||4
1576713|NCT01134887|3857700|P1|NOT COMPLETED|Overall Study||0
1576714|NCT01134887|3857697|P4|COMPLETED|Overall Study||5
1576715|NCT01134887|3857698|P3|COMPLETED|Overall Study||5
1576716|NCT01134887|3857699|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
1576717|NCT01134887|3857700|P1|COMPLETED|Overall Study||9
1576718|NCT01134887|3857697|P4|STARTED|Overall Study||5
1576719|NCT01134887|3857698|P3|STARTED|Overall Study||5
1576720|NCT01134887|3857699|P2|STARTED|Overall Study||11
1576721|NCT01134887|3857700|P1|STARTED|Overall Study||9
1576722|NCT01134783|3857710|P2|NOT COMPLETED|Overall Study||37
1576723|NCT01134783|3857711|P1|NOT COMPLETED|Overall Study||36
1576724|NCT01134783|3857710|P2|COMPLETED|Overall Study||180
1576725|NCT01134783|3857711|P1|COMPLETED|Overall Study||188
1576726|NCT01134783|3857710|P2|STARTED|Overall Study||217
1576727|NCT01134783|3857711|P1|STARTED|Overall Study||224
1576728|NCT01134731|3857730|P3|NOT COMPLETED|Overall Study||8
1576729|NCT01134731|3857731|P2|NOT COMPLETED|Overall Study||11
1576730|NCT01134731|3857732|P1|NOT COMPLETED|Overall Study||13
1576731|NCT01134731|3857730|P3|COMPLETED|Overall Study||2
1576732|NCT01134731|3857731|P2|COMPLETED|Overall Study||10
1576733|NCT01134731|3857732|P1|COMPLETED|Overall Study||10
1576734|NCT01134731|3857730|P3|STARTED|Overall Study||10
1576735|NCT01134731|3857731|P2|STARTED|Overall Study||21
1576736|NCT01134731|3857732|P1|STARTED|Overall Study||23
1576737|NCT01134705|3857745|P2|NOT COMPLETED|Overall Study||22
1576738|NCT01134705|3857746|P1|NOT COMPLETED|Overall Study||15
1576739|NCT01134705|3857745|P2|COMPLETED|Overall Study||216
1576740|NCT01134705|3857746|P1|COMPLETED|Overall Study||221
1576741|NCT01134705|3857745|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
1576742|NCT01134705|3857746|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
1576743|NCT01134705|3857745|P2|STARTED|Overall Study||238
1576744|NCT01134705|3857746|P1|STARTED|Overall Study||236
1576745|NCT01134627|3857758|P2|NOT COMPLETED|Overall Study||67
1576746|NCT01134627|3857759|P1|NOT COMPLETED|Overall Study||69
1576747|NCT01134627|3857758|P2|COMPLETED|Overall Study||88
1576748|NCT01134627|3857759|P1|COMPLETED|Overall Study||80
1576749|NCT01134627|3857758|P2|STARTED|Overall Study|Number of participants treated.|155
1576750|NCT01134627|3857759|P1|STARTED|Overall Study|Number of participants treated.|149
1576751|NCT01134614|3857789|P2|NOT COMPLETED|Overall Study||122
1576752|NCT01134614|3857790|P1|NOT COMPLETED|Overall Study||123
1576753|NCT01134614|3857789|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
1576754|NCT01134614|3857790|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
1576755|NCT01134614|3857789|P2|Treated and Toxicity Assessed|Overall Study||120
1576756|NCT01134614|3857790|P1|Treated and Toxicity Assessed|Overall Study||118
1576757|NCT01134614|3857789|P2|Treated|Overall Study||121
1576758|NCT01134614|3857790|P1|Treated|Overall Study||119
1576759|NCT01134614|3857789|P2|STARTED|Overall Study||122
1576760|NCT01134614|3857790|P1|STARTED|Overall Study||123
1576761|NCT01134562|3857805|P5|NOT COMPLETED|Overall Study||0
1576762|NCT01134562|3857806|P4|NOT COMPLETED|Overall Study||0
1576763|NCT01134562|3857807|P3|NOT COMPLETED|Overall Study||0
1576764|NCT01134562|3857808|P2|NOT COMPLETED|Overall Study||1
1576765|NCT01134562|3857809|P1|NOT COMPLETED|Overall Study||0
1576766|NCT01134562|3857805|P5|COMPLETED|Overall Study||8
1576767|NCT01134562|3857806|P4|COMPLETED|Overall Study||8
1576768|NCT01134562|3857807|P3|COMPLETED|Overall Study||4
1576769|NCT01134562|3857808|P2|COMPLETED|Overall Study||3
1576770|NCT01134562|3857809|P1|COMPLETED|Overall Study||4
1576771|NCT01134562|3857805|P5|STARTED|Overall Study||8
1576772|NCT01134562|3857806|P4|STARTED|Overall Study||8
1576773|NCT01134562|3857807|P3|STARTED|Overall Study||4
1576774|NCT01134562|3857808|P2|STARTED|Overall Study||4
1576775|NCT01134562|3857809|P1|STARTED|Overall Study||4
1576776|NCT01134549|3857878|P5|NOT COMPLETED|Overall Study||0
1576777|NCT01134549|3857879|P4|NOT COMPLETED|Overall Study||0
1576778|NCT01134549|3857880|P3|NOT COMPLETED|Overall Study||0
1576779|NCT01134549|3857881|P2|NOT COMPLETED|Overall Study||0
1576780|NCT01134549|3857882|P1|NOT COMPLETED|Overall Study||0
1576781|NCT01134549|3857878|P5|COMPLETED|Overall Study||6
1576782|NCT01134549|3857879|P4|COMPLETED|Overall Study||6
1576783|NCT01134549|3857880|P3|COMPLETED|Overall Study||6
1576784|NCT01134549|3857881|P2|COMPLETED|Overall Study||6
1576785|NCT01134549|3857882|P1|COMPLETED|Overall Study||8
1576786|NCT01134549|3857878|P5|STARTED|Overall Study||6
1576787|NCT01134549|3857879|P4|STARTED|Overall Study||6
1576788|NCT01134549|3857880|P3|STARTED|Overall Study||6
1576789|NCT01134549|3857881|P2|STARTED|Overall Study||6
1576790|NCT01134549|3857882|P1|STARTED|Overall Study||8
1576791|NCT01134510|3857968|P2|NOT COMPLETED|Overall Study||1
1576792|NCT01134510|3857969|P1|NOT COMPLETED|Overall Study||0
1576793|NCT01134510|3857968|P2|COMPLETED|Overall Study||9
1576794|NCT01134510|3857969|P1|COMPLETED|Overall Study||10
1576795|NCT01134510|3857968|P2|Month 3|Overall Study||9
1576796|NCT01134510|3857969|P1|Month 3|Overall Study||10
1576797|NCT01134510|3857968|P2|Month 1|Overall Study||10
1576798|NCT01134510|3857969|P1|Month 1|Overall Study||10
1576799|NCT01134510|3857968|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
1576800|NCT01134510|3857969|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
1576801|NCT01134510|3857968|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
1576802|NCT01134510|3857969|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
1576803|NCT01134510|3857968|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
1576804|NCT01134510|3857969|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
1576805|NCT01134510|3857968|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
1576806|NCT01134510|3857969|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
1576807|NCT01134510|3857968|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
1576808|NCT01134510|3857969|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
1576809|NCT01134510|3857968|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
1576810|NCT01134510|3857969|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
1576811|NCT01134510|3857968|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
1576812|NCT01134510|3857969|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
1576813|NCT01134510|3857968|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
1576814|NCT01134510|3857969|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
1576815|NCT01134393|3857981|P1|NOT COMPLETED|Overall Study||52
1576816|NCT01134393|3857981|P1|COMPLETED|Overall Study|Completed trial medication.|449
1576817|NCT01134393|3857981|P1|STARTED|Overall Study|Entered and treated.|501
1576818|NCT01134328|3857999|P4|NOT COMPLETED|Overall Study||4
1576819|NCT01134328|3858000|P3|NOT COMPLETED|Overall Study||3
1576820|NCT01134328|3858001|P2|NOT COMPLETED|Overall Study||3
1576821|NCT01134328|3858002|P1|NOT COMPLETED|Overall Study||2
1576822|NCT01134328|3857999|P4|COMPLETED|Overall Study||17
1576823|NCT01134328|3858000|P3|COMPLETED|Overall Study||17
1576824|NCT01134328|3858001|P2|COMPLETED|Overall Study||18
1576825|NCT01134328|3858002|P1|COMPLETED|Overall Study||19
1576826|NCT01134328|3857999|P4|STARTED|Overall Study||21
1576827|NCT01134328|3858000|P3|STARTED|Overall Study||20
1576828|NCT01134328|3858001|P2|STARTED|Overall Study||21
1576829|NCT01134328|3858002|P1|STARTED|Overall Study||21
1576830|NCT01134315|3858102|P2|NOT COMPLETED|Overall Study||19
1576831|NCT01134315|3858103|P1|NOT COMPLETED|Overall Study||9
1576832|NCT01134315|3858102|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
1576833|NCT01134315|3858103|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
1576834|NCT01134315|3858102|P2|STARTED|Overall Study||40
1576835|NCT01134315|3858103|P1|STARTED|Overall Study||21
1576836|NCT01134276|3858125|P2|NOT COMPLETED|Overall Study||0
1576837|NCT01134276|3858126|P1|NOT COMPLETED|Overall Study||0
1576838|NCT01134276|3858125|P2|COMPLETED|Overall Study||107
1576839|NCT01134276|3858126|P1|COMPLETED|Overall Study||104
1576840|NCT01134276|3858125|P2|STARTED|Overall Study||107
1576841|NCT01134276|3858126|P1|STARTED|Overall Study||104
1576842|NCT01134198|3858138|P2|NOT COMPLETED|Phase 2||4
1576843|NCT01134198|3858139|P1|NOT COMPLETED|Phase 2||0
1576844|NCT01134198|3858138|P2|COMPLETED|Phase 2||7
1576845|NCT01134198|3858139|P1|COMPLETED|Phase 2||9
1576846|NCT01134198|3858138|P2|STARTED|Phase 2||11
1576847|NCT01134198|3858139|P1|STARTED|Phase 2||9
1576848|NCT01134198|3858138|P2|NOT COMPLETED|Phase 1||2
1576849|NCT01134198|3858139|P1|NOT COMPLETED|Phase 1||7
1576850|NCT01134198|3858138|P2|COMPLETED|Phase 1||11
1576851|NCT01134198|3858139|P1|COMPLETED|Phase 1||9
1576852|NCT01134198|3858138|P2|STARTED|Phase 1||13
1576853|NCT01134198|3858139|P1|STARTED|Phase 1||16
1576854|NCT01134107|3858147|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
1576855|NCT01134107|3858148|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
1576856|NCT01134107|3858147|P2|COMPLETED|Period 2-Second Treatment Intervention||61
1576857|NCT01134107|3858148|P1|COMPLETED|Period 2-Second Treatment Intervention||57
1576858|NCT01134107|3858147|P2|STARTED|Period 2-Second Treatment Intervention||61
1576859|NCT01134107|3858148|P1|STARTED|Period 2-Second Treatment Intervention||61
1576860|NCT01134107|3858147|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
1576861|NCT01134107|3858148|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
1576862|NCT01134107|3858147|P2|COMPLETED|Period 1-First Treatment Intervention||61
1576863|NCT01134107|3858148|P1|COMPLETED|Period 1-First Treatment Intervention||61
1576864|NCT01134107|3858147|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
1576865|NCT01134107|3858148|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
1576866|NCT01134107|3858147|P2|STARTED|Period 1-First Treatment Intervention||66
1576867|NCT01134107|3858148|P1|STARTED|Period 1-First Treatment Intervention||67
1576868|NCT01134081|3858180|P1|NOT COMPLETED|Overall Study||0
1576869|NCT01134081|3858180|P1|COMPLETED|Overall Study||44
1576870|NCT01134081|3858180|P1|STARTED|Overall Study||44
1576871|NCT01134055|3858195|P7|NOT COMPLETED|Overall Study||11
1576872|NCT01134055|3858196|P6|NOT COMPLETED|Overall Study||7
1576873|NCT01134055|3858197|P5|NOT COMPLETED|Overall Study||6
1576874|NCT01134055|3858198|P4|NOT COMPLETED|Overall Study||6
1576875|NCT01134055|3858199|P3|NOT COMPLETED|Overall Study||3
1576876|NCT01134055|3858200|P2|NOT COMPLETED|Overall Study||6
1576877|NCT01134055|3858201|P1|NOT COMPLETED|Overall Study||8
1576878|NCT01134055|3858195|P7|COMPLETED|Overall Study||62
1576879|NCT01134055|3858196|P6|COMPLETED|Overall Study||65
1576880|NCT01134055|3858197|P5|COMPLETED|Overall Study||67
1576881|NCT01134055|3858198|P4|COMPLETED|Overall Study||67
1576882|NCT01134055|3858199|P3|COMPLETED|Overall Study||71
1576883|NCT01134055|3858200|P2|COMPLETED|Overall Study||66
1576884|NCT01134055|3858201|P1|COMPLETED|Overall Study||65
1576885|NCT01134055|3858195|P7|STARTED|Overall Study||73
1576886|NCT01134055|3858196|P6|STARTED|Overall Study||72
1576887|NCT01134055|3858197|P5|STARTED|Overall Study||73
1576888|NCT01134055|3858198|P4|STARTED|Overall Study||73
1576889|NCT01134055|3858199|P3|STARTED|Overall Study||74
1576890|NCT01134055|3858200|P2|STARTED|Overall Study||72
1576891|NCT01134055|3858201|P1|STARTED|Overall Study||73
1576892|NCT01134042|3858335|P3|NOT COMPLETED|Overall Study||34
1576893|NCT01134042|3858336|P2|NOT COMPLETED|Overall Study||28
1576894|NCT01134042|3858337|P1|NOT COMPLETED|Overall Study||48
1576895|NCT01134042|3858335|P3|COMPLETED|Overall Study||161
1576896|NCT01134042|3858336|P2|COMPLETED|Overall Study||169
1576897|NCT01134042|3858337|P1|COMPLETED|Overall Study||146
1576898|NCT01134042|3858335|P3|STARTED|Overall Study||195
1576899|NCT01134042|3858336|P2|STARTED|Overall Study||197
1576900|NCT01134042|3858337|P1|STARTED|Overall Study||194
1576901|NCT01134016|3858375|P1|NOT COMPLETED|Overall Study||3
1576902|NCT01134016|3858375|P1|COMPLETED|Overall Study||10
1576903|NCT01134016|3858375|P1|STARTED|Overall Study||13
1576904|NCT01133977|3858413|P5|NOT COMPLETED|Overall Study||38
1576905|NCT01133977|3858414|P4|NOT COMPLETED|Overall Study||39
1576906|NCT01133977|3858415|P3|NOT COMPLETED|Overall Study||6
1576907|NCT01133977|3858416|P2|NOT COMPLETED|Overall Study||7
1576908|NCT01133977|3858417|P1|NOT COMPLETED|Overall Study||3
1576909|NCT01133977|3858413|P5|COMPLETED|Overall Study||1
1576910|NCT01133977|3858414|P4|COMPLETED|Overall Study||3
1576911|NCT01133977|3858415|P3|COMPLETED|Overall Study||0
1576912|NCT01133977|3858416|P2|COMPLETED|Overall Study||0
1576913|NCT01133977|3858417|P1|COMPLETED|Overall Study||0
1576914|NCT01133977|3858413|P5|STARTED|Overall Study|Treated|39
1576915|NCT01133977|3858414|P4|STARTED|Overall Study|Treated|42
1576916|NCT01133977|3858415|P3|STARTED|Overall Study|Treated|6
1576917|NCT01133977|3858416|P2|STARTED|Overall Study|Treated|7
1576918|NCT01133977|3858417|P1|STARTED|Overall Study|Treated|3
1576919|NCT01133860|3858434|P1|NOT COMPLETED|Overall Study||0
1576920|NCT01133860|3858434|P1|COMPLETED|Overall Study||12
1576921|NCT01133860|3858434|P1|STARTED|Overall Study||12
1576922|NCT01133847|3858444|P3|NOT COMPLETED|Follow-Up Phase||7
1576923|NCT01133847|3858445|P2|NOT COMPLETED|Follow-Up Phase||3
1576924|NCT01133847|3858446|P1|NOT COMPLETED|Follow-Up Phase||1
1576925|NCT01133847|3858444|P3|COMPLETED|Follow-Up Phase||60
1576926|NCT01133847|3858445|P2|COMPLETED|Follow-Up Phase||70
1576927|NCT01133847|3858446|P1|COMPLETED|Follow-Up Phase||72
1576928|NCT01133847|3858444|P3|STARTED|Follow-Up Phase||67
1576929|NCT01133847|3858445|P2|STARTED|Follow-Up Phase||73
1576930|NCT01133847|3858446|P1|STARTED|Follow-Up Phase||73
1576931|NCT01133847|3858444|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
1576932|NCT01133847|3858445|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
1576933|NCT01133847|3858446|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
1576934|NCT01133847|3858444|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
1576935|NCT01133847|3858445|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
1576936|NCT01133847|3858446|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
1576937|NCT01133847|3858444|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
1576938|NCT01133847|3858445|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
1576939|NCT01133847|3858446|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
1576940|NCT01133821|3858486|P2|NOT COMPLETED|Overall Study||19
1576941|NCT01133821|3858487|P1|NOT COMPLETED|Overall Study||18
1576942|NCT01133821|3858486|P2|COMPLETED|Overall Study||28
1576943|NCT01133821|3858487|P1|COMPLETED|Overall Study||27
1576944|NCT01133821|3858486|P2|STARTED|Overall Study||47
1576945|NCT01133821|3858487|P1|STARTED|Overall Study||45
1576946|NCT01133756|3858498|P3|NOT COMPLETED|Overall Study||2
1576947|NCT01133756|3858499|P2|NOT COMPLETED|Overall Study||3
1576948|NCT01133756|3858500|P1|NOT COMPLETED|Overall Study||2
1576949|NCT01133756|3858498|P3|COMPLETED|Overall Study||0
1576950|NCT01133756|3858499|P2|COMPLETED|Overall Study||0
1576951|NCT01133756|3858500|P1|COMPLETED|Overall Study||0
1576952|NCT01133756|3858498|P3|Completed 6 Cycles|Overall Study||0
1576953|NCT01133756|3858499|P2|Completed 6 Cycles|Overall Study||0
1576954|NCT01133756|3858500|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
1576955|NCT01133756|3858498|P3|STARTED|Overall Study||2
1576956|NCT01133756|3858499|P2|STARTED|Overall Study||3
1576957|NCT01133756|3858500|P1|STARTED|Overall Study||2
1576958|NCT01133704|3858516|P2|NOT COMPLETED|Overall Study||26
1576959|NCT01133704|3858517|P1|NOT COMPLETED|Overall Study||49
1576960|NCT01133704|3858516|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
1576961|NCT01133704|3858517|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
1576962|NCT01133704|3858516|P2|STARTED|Overall Study||33
1576963|NCT01133704|3858517|P1|STARTED|Overall Study||65
1576964|NCT01133665|3858525|P1|NOT COMPLETED|Overall Study||2
1576965|NCT01133665|3858525|P1|COMPLETED|Overall Study||40
1576966|NCT01133665|3858525|P1|STARTED|Overall Study||42
1576967|NCT01133639|3858568|P2|NOT COMPLETED|Overall Study||0
1576968|NCT01133639|3858569|P1|NOT COMPLETED|Overall Study||0
1576969|NCT01133639|3858568|P2|COMPLETED|Overall Study|18 total subjects were enrolled, study terminated prematurely, data not available as was destroyed|0
1576970|NCT01133639|3858569|P1|COMPLETED|Overall Study|18 total subjects were enrolled, study terminated prematurely, data not available as was destroyed|0
1576971|NCT01133639|3858568|P2|STARTED|Overall Study|18 total subjects were enrolled, study terminated prematurely, data not available as was destroyed|0
1576972|NCT01133639|3858569|P1|STARTED|Overall Study|18 total subjects were enrolled, study terminated prematurely, data not available as was destroyed|0
1576973|NCT01133626|3858586|P3|NOT COMPLETED|Overall Study||2
1576974|NCT01133626|3858587|P2|NOT COMPLETED|Overall Study||5
1576975|NCT01133626|3858588|P1|NOT COMPLETED|Overall Study||1
1576976|NCT01133626|3858586|P3|COMPLETED|Overall Study||9
1576977|NCT01133626|3858587|P2|COMPLETED|Overall Study||41
1576978|NCT01133626|3858588|P1|COMPLETED|Overall Study||49
1576979|NCT01133626|3858586|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
1576980|NCT01133626|3858587|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
1576981|NCT01133626|3858588|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
1576982|NCT01133626|3858586|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
1576983|NCT01133626|3858587|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
1576984|NCT01133626|3858588|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
1576985|NCT01133626|3858586|P3|STARTED|Overall Study||11
1576986|NCT01133626|3858587|P2|STARTED|Overall Study||46
1576987|NCT01133626|3858588|P1|STARTED|Overall Study||50
1576988|NCT01133522|3858606|P10|NOT COMPLETED|Overall Study||0
1576989|NCT01133522|3858607|P9|NOT COMPLETED|Overall Study||0
1576990|NCT01133522|3858608|P8|NOT COMPLETED|Overall Study||0
1576991|NCT01133522|3858609|P7|NOT COMPLETED|Overall Study||0
1576992|NCT01133522|3858610|P6|NOT COMPLETED|Overall Study||0
1576993|NCT01133522|3858611|P5|NOT COMPLETED|Overall Study||1
1576994|NCT01133522|3858612|P4|NOT COMPLETED|Overall Study||1
1576995|NCT01133522|3858613|P3|NOT COMPLETED|Overall Study||0
1576996|NCT01133522|3858614|P2|NOT COMPLETED|Overall Study||1
1576997|NCT01133522|3858615|P1|NOT COMPLETED|Overall Study||0
1576998|NCT01133522|3858606|P10|COMPLETED|Overall Study||4
1576999|NCT01133522|3858607|P9|COMPLETED|Overall Study||2
1577000|NCT01133522|3858608|P8|COMPLETED|Overall Study||9
1577001|NCT01133522|3858609|P7|COMPLETED|Overall Study||2
1577002|NCT01133522|3858610|P6|COMPLETED|Overall Study||6
1577003|NCT01133522|3858611|P5|COMPLETED|Overall Study||6
1577004|NCT01133522|3858612|P4|COMPLETED|Overall Study||6
1577005|NCT01133522|3858613|P3|COMPLETED|Overall Study||6
1577006|NCT01133522|3858614|P2|COMPLETED|Overall Study||6
1577007|NCT01133522|3858615|P1|COMPLETED|Overall Study||10
1577008|NCT01133522|3858606|P10|Received Treatment|Overall Study||4
1577009|NCT01133522|3858607|P9|Received Treatment|Overall Study||2
1577010|NCT01133522|3858608|P8|Received Treatment|Overall Study||9
1577011|NCT01133522|3858609|P7|Received Treatment|Overall Study||2
1577012|NCT01133522|3858610|P6|Received Treatment|Overall Study||6
1577013|NCT01133522|3858611|P5|Received Treatment|Overall Study||6
1577014|NCT01133522|3858612|P4|Received Treatment|Overall Study||6
1577015|NCT01133522|3858613|P3|Received Treatment|Overall Study||6
1577016|NCT01133522|3858614|P2|Received Treatment|Overall Study||6
1577017|NCT01133522|3858615|P1|Received Treatment|Overall Study||10
1577018|NCT01133522|3858606|P10|STARTED|Overall Study||4
1577019|NCT01133522|3858607|P9|STARTED|Overall Study||2
1577020|NCT01133522|3858608|P8|STARTED|Overall Study||9
1577021|NCT01133522|3858609|P7|STARTED|Overall Study||2
1577022|NCT01133522|3858610|P6|STARTED|Overall Study||6
1577023|NCT01133522|3858611|P5|STARTED|Overall Study||7
1577024|NCT01133522|3858612|P4|STARTED|Overall Study||7
1577025|NCT01133522|3858613|P3|STARTED|Overall Study||6
1577026|NCT01133522|3858614|P2|STARTED|Overall Study||7
1577027|NCT01133522|3858615|P1|STARTED|Overall Study||10
1577028|NCT01133418|3858683|P2|NOT COMPLETED|Overall Study||6
1577029|NCT01133418|3858684|P1|NOT COMPLETED|Overall Study||5
1577030|NCT01133418|3858683|P2|COMPLETED|Overall Study||32
1577031|NCT01133418|3858684|P1|COMPLETED|Overall Study||29
1577032|NCT01133418|3858683|P2|STARTED|Overall Study||38
1577033|NCT01133418|3858684|P1|STARTED|Overall Study||34
1577034|NCT01133392|3858698|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
1577035|NCT01133392|3858699|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
1577036|NCT01133392|3858698|P2|COMPLETED|Fourth Intervention (1 Day)||16
1577037|NCT01133392|3858699|P1|COMPLETED|Fourth Intervention (1 Day)||20
1577038|NCT01133392|3858698|P2|STARTED|Fourth Intervention (1 Day)||16
1577039|NCT01133392|3858699|P1|STARTED|Fourth Intervention (1 Day)||20
1577040|NCT01133392|3858698|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
1577041|NCT01133392|3858699|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1577042|NCT01133392|3858698|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
1577043|NCT01133392|3858699|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
1577044|NCT01133392|3858698|P2|STARTED|Interval Between Dosing (4-7 Days)||17
1577045|NCT01133392|3858699|P1|STARTED|Interval Between Dosing (4-7 Days)||20
1577046|NCT01133392|3858698|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1577047|NCT01133392|3858699|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1577048|NCT01133392|3858698|P2|COMPLETED|Third Intervention (1 Day)||17
1577049|NCT01133392|3858699|P1|COMPLETED|Third Intervention (1 Day)||20
1577050|NCT01133392|3858698|P2|STARTED|Third Intervention (1 Day)||17
1577051|NCT01133392|3858699|P1|STARTED|Third Intervention (1 Day)||20
1577052|NCT01133392|3858698|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1577053|NCT01133392|3858699|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1577054|NCT01133392|3858698|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
1577055|NCT01133392|3858699|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
1577056|NCT01133392|3858698|P2|STARTED|Interval Between Dosing (4-7 Days)||17
1577057|NCT01133392|3858699|P1|STARTED|Interval Between Dosing (4-7 Days)||20
1577058|NCT01133392|3858698|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1577059|NCT01133392|3858699|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1577060|NCT01133392|3858698|P2|COMPLETED|Second Intervention (1 Day)||17
1577061|NCT01133392|3858699|P1|COMPLETED|Second Intervention (1 Day)||20
1577062|NCT01133392|3858698|P2|STARTED|Second Intervention (1 Day)||17
1577063|NCT01133392|3858699|P1|STARTED|Second Intervention (1 Day)||20
1577064|NCT01133392|3858698|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
1577065|NCT01133392|3858699|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1577066|NCT01133392|3858698|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
1577067|NCT01133392|3858699|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
1577068|NCT01133392|3858698|P2|STARTED|Interval Between Dosing (4-7 Days)||18
1577069|NCT01133392|3858699|P1|STARTED|Interval Between Dosing (4-7 Days)||20
1577070|NCT01133392|3858698|P2|NOT COMPLETED|First Intervention (1 Day )||0
1577071|NCT01133392|3858699|P1|NOT COMPLETED|First Intervention (1 Day )||0
1577072|NCT01133392|3858698|P2|COMPLETED|First Intervention (1 Day )||18
1577073|NCT01133392|3858699|P1|COMPLETED|First Intervention (1 Day )||20
1577074|NCT01133392|3858698|P2|STARTED|First Intervention (1 Day )||18
1577075|NCT01133392|3858699|P1|STARTED|First Intervention (1 Day )||20
1577076|NCT01133379|3858716|P3|NOT COMPLETED|Overall Study||2
1577077|NCT01133379|3858717|P2|NOT COMPLETED|Overall Study||2
1577078|NCT01133379|3858718|P1|NOT COMPLETED|Overall Study||1
1577079|NCT01133379|3858716|P3|COMPLETED|Overall Study||56
1577080|NCT01133379|3858717|P2|COMPLETED|Overall Study||56
1577081|NCT01133379|3858718|P1|COMPLETED|Overall Study||57
1577082|NCT01133379|3858716|P3|STARTED|Overall Study||58
1577083|NCT01133379|3858717|P2|STARTED|Overall Study||58
1577084|NCT01133379|3858718|P1|STARTED|Overall Study||58
1577085|NCT01133288|3858771|P1|NOT COMPLETED|Intervention Allocation||2
1577086|NCT01133288|3858771|P1|COMPLETED|Intervention Allocation||0
1577087|NCT01133288|3858771|P1|STARTED|Intervention Allocation||2
1577088|NCT01133288|3858771|P1|NOT COMPLETED|Eligibility Assessment||5
1577089|NCT01133288|3858771|P1|COMPLETED|Eligibility Assessment||2
1577090|NCT01133288|3858771|P1|STARTED|Eligibility Assessment||7
1577091|NCT01133275|3858776|P1|NOT COMPLETED|Overall Study||2
1577092|NCT01133275|3858776|P1|COMPLETED|Overall Study||26
1577093|NCT01133275|3858776|P1|STARTED|Overall Study||28
1577094|NCT01133171|3858784|P3|NOT COMPLETED|Overall Study||0
1577095|NCT01133171|3858785|P2|NOT COMPLETED|Overall Study||2
1577096|NCT01133171|3858786|P1|NOT COMPLETED|Overall Study||1
1577097|NCT01133171|3858784|P3|COMPLETED|Overall Study||25
1577098|NCT01133171|3858785|P2|COMPLETED|Overall Study||25
1577099|NCT01133171|3858786|P1|COMPLETED|Overall Study||24
1577100|NCT01133171|3858784|P3|STARTED|Overall Study||25
1577101|NCT01133171|3858785|P2|STARTED|Overall Study||27
1577102|NCT01133171|3858786|P1|STARTED|Overall Study||25
1577103|NCT01133158|3858796|P1|NOT COMPLETED|Overall Study||17
1577104|NCT01133158|3858796|P1|COMPLETED|Overall Study||43
1577105|NCT01133158|3858796|P1|STARTED|Overall Study||60
1577106|NCT01133067|3858802|P1|NOT COMPLETED|Overall Study||139
1577107|NCT01133067|3858802|P1|COMPLETED|Overall Study||61
1577108|NCT01133067|3858802|P1|STARTED|Overall Study||200
1577109|NCT01132846|3858810|P3|NOT COMPLETED|Overall Study||11
1577110|NCT01132846|3858811|P2|NOT COMPLETED|Overall Study||18
1577111|NCT01132846|3858812|P1|NOT COMPLETED|Overall Study||16
1577112|NCT01132846|3858810|P3|COMPLETED|Overall Study||108
1577113|NCT01132846|3858811|P2|COMPLETED|Overall Study||101
1577114|NCT01132846|3858812|P1|COMPLETED|Overall Study||106
1577115|NCT01132846|3858810|P3|STARTED|Overall Study||119
1577116|NCT01132846|3858811|P2|STARTED|Overall Study||119
1577117|NCT01132846|3858812|P1|STARTED|Overall Study||122
1577118|NCT01132820|3858862|P1|NOT COMPLETED|Overall Study||5
1577119|NCT01132820|3858862|P1|COMPLETED|Overall Study||48
1577120|NCT01132820|3858862|P1|STARTED|Overall Study||53
1577121|NCT01132690|3858873|P2|NOT COMPLETED|Overall Study||0
1577122|NCT01132690|3858874|P1|NOT COMPLETED|Overall Study||0
1577123|NCT01132690|3858873|P2|COMPLETED|Overall Study||5
1577124|NCT01132690|3858874|P1|COMPLETED|Overall Study||6
1577125|NCT01132690|3858873|P2|STARTED|Overall Study||5
1577126|NCT01132690|3858874|P1|STARTED|Overall Study||6
1577127|NCT01132664|3858895|P5|NOT COMPLETED|BM Cohort||6
1577128|NCT01132664|3858896|P4|NOT COMPLETED|BM Cohort||3
1577129|NCT01132664|3858897|P3|NOT COMPLETED|BM Cohort||0
1577130|NCT01132664|3858898|P2|NOT COMPLETED|BM Cohort||0
1577131|NCT01132664|3858899|P1|NOT COMPLETED|BM Cohort||0
1577132|NCT01132664|3858895|P5|COMPLETED|BM Cohort||0
1577133|NCT01132664|3858896|P4|COMPLETED|BM Cohort||0
1577134|NCT01132664|3858897|P3|COMPLETED|BM Cohort||0
1577135|NCT01132664|3858898|P2|COMPLETED|BM Cohort||0
1577136|NCT01132664|3858899|P1|COMPLETED|BM Cohort||0
1577137|NCT01132664|3858895|P5|STARTED|BM Cohort||6
1577138|NCT01132664|3858896|P4|STARTED|BM Cohort||3
1577139|NCT01132664|3858897|P3|STARTED|BM Cohort||0
1577140|NCT01132664|3858898|P2|STARTED|BM Cohort||0
1577141|NCT01132664|3858899|P1|STARTED|BM Cohort||0
1577142|NCT01132664|3858895|P5|NOT COMPLETED|Phase ll||0
1577143|NCT01132664|3858896|P4|NOT COMPLETED|Phase ll||0
1577144|NCT01132664|3858897|P3|NOT COMPLETED|Phase ll||50
1577145|NCT01132664|3858898|P2|NOT COMPLETED|Phase ll||0
1577146|NCT01132664|3858899|P1|NOT COMPLETED|Phase ll||0
1577147|NCT01132664|3858895|P5|COMPLETED|Phase ll||0
1577148|NCT01132664|3858896|P4|COMPLETED|Phase ll||0
1577149|NCT01132664|3858897|P3|COMPLETED|Phase ll||0
1577150|NCT01132664|3858898|P2|COMPLETED|Phase ll||0
1577151|NCT01132664|3858899|P1|COMPLETED|Phase ll||0
1577152|NCT01132664|3858895|P5|STARTED|Phase ll||0
1577153|NCT01132664|3858896|P4|STARTED|Phase ll||0
1577154|NCT01132664|3858897|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
1577155|NCT01132664|3858898|P2|STARTED|Phase ll||0
1577156|NCT01132664|3858899|P1|STARTED|Phase ll||0
1577157|NCT01132664|3858895|P5|NOT COMPLETED|Phase lb||0
1577158|NCT01132664|3858896|P4|NOT COMPLETED|Phase lb||0
1577159|NCT01132664|3858897|P3|NOT COMPLETED|Phase lb||0
1577160|NCT01132664|3858898|P2|NOT COMPLETED|Phase lb||12
1577161|NCT01132664|3858899|P1|NOT COMPLETED|Phase lb||5
1577162|NCT01132664|3858895|P5|COMPLETED|Phase lb||0
1577163|NCT01132664|3858896|P4|COMPLETED|Phase lb||0
1577164|NCT01132664|3858897|P3|COMPLETED|Phase lb||0
1577165|NCT01132664|3858898|P2|COMPLETED|Phase lb||0
1577166|NCT01132664|3858899|P1|COMPLETED|Phase lb||0
1577167|NCT01132664|3858895|P5|STARTED|Phase lb||0
1577168|NCT01132664|3858896|P4|STARTED|Phase lb||0
1577169|NCT01132664|3858897|P3|STARTED|Phase lb||0
1577170|NCT01132664|3858898|P2|STARTED|Phase lb||12
1577171|NCT01132664|3858899|P1|STARTED|Phase lb||5
1577172|NCT01132651|3858933|P2|NOT COMPLETED|Overall Study||1
1577173|NCT01132651|3858934|P1|NOT COMPLETED|Overall Study||1
1577174|NCT01132651|3858933|P2|COMPLETED|Overall Study||4
1577175|NCT01132651|3858934|P1|COMPLETED|Overall Study||3
1577176|NCT01132651|3858933|P2|STARTED|Overall Study||5
1577177|NCT01132651|3858934|P1|STARTED|Overall Study||4
1577178|NCT01132612|3858945|P3|NOT COMPLETED|Overall Study||170
1577179|NCT01132612|3858946|P2|NOT COMPLETED|Overall Study||35
1577180|NCT01132612|3858947|P1|NOT COMPLETED|Overall Study||40
1577181|NCT01132612|3858945|P3|COMPLETED|Overall Study||17
1577182|NCT01132612|3858946|P2|COMPLETED|Overall Study||7
1577183|NCT01132612|3858947|P1|COMPLETED|Overall Study||6
1577184|NCT01132612|3858945|P3|STARTED|Overall Study||187
1577185|NCT01132612|3858946|P2|STARTED|Overall Study||42
1577186|NCT01132612|3858947|P1|STARTED|Overall Study||46
1577187|NCT01132547|3858963|P2|NOT COMPLETED|Overall Study||1
1577188|NCT01132547|3858964|P1|NOT COMPLETED|Overall Study||4
1577189|NCT01132547|3858963|P2|COMPLETED|Overall Study||12
1577190|NCT01132547|3858964|P1|COMPLETED|Overall Study||5
1577191|NCT01132547|3858963|P2|STARTED|Overall Study||13
1577192|NCT01132547|3858964|P1|STARTED|Overall Study||9
1577193|NCT01132508|3858974|P1|NOT COMPLETED|Overall Study||9
1577194|NCT01132508|3858974|P1|COMPLETED|Overall Study||24
1577195|NCT01132508|3858974|P1|104 Weeks|Overall Study||27
1577196|NCT01132508|3858974|P1|78 Weeks|Overall Study||28
1577197|NCT01132508|3858974|P1|52 Weeks|Overall Study||30
1577198|NCT01132508|3858974|P1|26 Weeks|Overall Study||33
1577199|NCT01132508|3858974|P1|12 Weeks|Overall Study||33
1577200|NCT01132508|3858974|P1|6 Weeks|Overall Study||33
1577201|NCT01132508|3858974|P1|Treated at Baseline|Overall Study||33
1577202|NCT01132508|3858974|P1|STARTED|Overall Study||33
1577203|NCT01132495|3859034|P4|NOT COMPLETED|Overall Study||12
1577204|NCT01132495|3859035|P3|NOT COMPLETED|Overall Study||20
1577205|NCT01132495|3859036|P2|NOT COMPLETED|Overall Study||38
1577206|NCT01132495|3859037|P1|NOT COMPLETED|Overall Study||40
1577207|NCT01132495|3859034|P4|COMPLETED|Overall Study||104
1577208|NCT01132495|3859035|P3|COMPLETED|Overall Study||146
1577209|NCT01132495|3859036|P2|COMPLETED|Overall Study||403
1577210|NCT01132495|3859037|P1|COMPLETED|Overall Study||407
1577211|NCT01132495|3859034|P4|STARTED|Overall Study||116
1577212|NCT01132495|3859035|P3|STARTED|Overall Study||166
1577213|NCT01132495|3859036|P2|STARTED|Overall Study||441
1577214|NCT01132495|3859037|P1|STARTED|Overall Study||447
1577215|NCT01132378|3859045|P1|NOT COMPLETED|Overall Study||0
1577216|NCT01132378|3859045|P1|COMPLETED|Overall Study||40
1577217|NCT01132378|3859045|P1|STARTED|Overall Study||40
1577218|NCT01132326|3859050|P1|NOT COMPLETED|Overall Study||218
1577219|NCT01132326|3859050|P1|COMPLETED|Overall Study||132
1577220|NCT01132326|3859050|P1|STARTED|Overall Study||350
1577221|NCT01132313|3859066|P12|NOT COMPLETED|Overall Study||0
1577222|NCT01132313|3859067|P11|NOT COMPLETED|Overall Study||1
1577223|NCT01132313|3859068|P10|NOT COMPLETED|Overall Study||20
1577224|NCT01132313|3859069|P9|NOT COMPLETED|Overall Study||21
1577225|NCT01132313|3859070|P8|NOT COMPLETED|Overall Study||8
1577226|NCT01132313|3859071|P7|NOT COMPLETED|Overall Study||30
1577227|NCT01132313|3859072|P6|NOT COMPLETED|Overall Study||25
1577228|NCT01132313|3859073|P5|NOT COMPLETED|Overall Study||45
1577229|NCT01132313|3859074|P4|NOT COMPLETED|Overall Study||32
1577230|NCT01132313|3859075|P3|NOT COMPLETED|Overall Study||20
1577231|NCT01132313|3859076|P2|NOT COMPLETED|Overall Study||0
1577232|NCT01132313|3859077|P1|NOT COMPLETED|Overall Study||3
1577233|NCT01132313|3859066|P12|COMPLETED|Overall Study||2
1577234|NCT01132313|3859067|P11|COMPLETED|Overall Study||0
1577235|NCT01132313|3859068|P10|COMPLETED|Overall Study||5
1577236|NCT01132313|3859069|P9|COMPLETED|Overall Study||5
1577237|NCT01132313|3859070|P8|COMPLETED|Overall Study||24
1577238|NCT01132313|3859071|P7|COMPLETED|Overall Study||19
1577239|NCT01132313|3859072|P6|COMPLETED|Overall Study||54
1577240|NCT01132313|3859073|P5|COMPLETED|Overall Study||34
1577241|NCT01132313|3859074|P4|COMPLETED|Overall Study||48
1577242|NCT01132313|3859075|P3|COMPLETED|Overall Study||61
1577243|NCT01132313|3859076|P2|COMPLETED|Overall Study||17
1577244|NCT01132313|3859077|P1|COMPLETED|Overall Study||14
1577245|NCT01132313|3859066|P12|STARTED|Overall Study||2
1577246|NCT01132313|3859067|P11|STARTED|Overall Study||1
1577247|NCT01132313|3859068|P10|STARTED|Overall Study||25
1577248|NCT01132313|3859069|P9|STARTED|Overall Study||26
1577249|NCT01132313|3859070|P8|STARTED|Overall Study||32
1577250|NCT01132313|3859071|P7|STARTED|Overall Study||49
1577251|NCT01132313|3859072|P6|STARTED|Overall Study||79
1577252|NCT01132313|3859073|P5|STARTED|Overall Study||79
1577253|NCT01132313|3859074|P4|STARTED|Overall Study||80
1577254|NCT01132313|3859075|P3|STARTED|Overall Study||81
1577255|NCT01132313|3859076|P2|STARTED|Overall Study||17
1577256|NCT01132313|3859077|P1|STARTED|Overall Study||17
1577257|NCT01132144|3859134|P2|NOT COMPLETED|Overall Study||0
1577258|NCT01132144|3859135|P1|NOT COMPLETED|Overall Study||0
1577259|NCT01132144|3859134|P2|COMPLETED|Overall Study||79
1577260|NCT01132144|3859135|P1|COMPLETED|Overall Study||79
1577261|NCT01132144|3859134|P2|STARTED|Overall Study||79
1577262|NCT01132144|3859135|P1|STARTED|Overall Study||79
1577263|NCT01132118|3859157|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
1577264|NCT01132118|3859158|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
1577265|NCT01132118|3859157|P2|COMPLETED|Second Intervention (8 Weeks)||11
1577266|NCT01132118|3859158|P1|COMPLETED|Second Intervention (8 Weeks)||12
1577267|NCT01132118|3859157|P2|STARTED|Second Intervention (8 Weeks)||12
1577268|NCT01132118|3859158|P1|STARTED|Second Intervention (8 Weeks)||12
1577269|NCT01132118|3859157|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
1577270|NCT01132118|3859158|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
1577271|NCT01132118|3859157|P2|COMPLETED|First Intervention (8 Weeks)||12
1577272|NCT01132118|3859158|P1|COMPLETED|First Intervention (8 Weeks)||12
1577273|NCT01132118|3859157|P2|STARTED|First Intervention (8 Weeks)||15
1577274|NCT01132118|3859158|P1|STARTED|First Intervention (8 Weeks)||15
1577275|NCT01131884|3859178|P2|NOT COMPLETED|Overall Study||0
1577276|NCT01131884|3859179|P1|NOT COMPLETED|Overall Study||0
1577277|NCT01131884|3859178|P2|COMPLETED|Overall Study||0
1577278|NCT01131884|3859179|P1|COMPLETED|Overall Study||1
1577279|NCT01131884|3859178|P2|STARTED|Overall Study||0
1577280|NCT01131884|3859179|P1|STARTED|Overall Study||1
1577281|NCT01131676|3859188|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
1577282|NCT01131676|3859189|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
1577283|NCT01131676|3859190|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
1577284|NCT01131676|3859188|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
1577285|NCT01131676|3859189|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
1577286|NCT01131676|3859190|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
1577287|NCT01131676|3859188|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
1577288|NCT01131676|3859189|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
1577289|NCT01131676|3859190|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
1577290|NCT01131676|3859188|P3|STARTED|Discontinuation From Study (Treated Set)||2342
1577291|NCT01131676|3859189|P2|STARTED|Discontinuation From Study (Treated Set)||2345
1577292|NCT01131676|3859190|P1|STARTED|Discontinuation From Study (Treated Set)||2333
1577293|NCT01131676|3859188|P3|NOT COMPLETED|Discontinuation From Treatment||544
1577294|NCT01131676|3859189|P2|NOT COMPLETED|Discontinuation From Treatment||557
1577295|NCT01131676|3859190|P1|NOT COMPLETED|Discontinuation From Treatment||687
1577296|NCT01131676|3859188|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
1577297|NCT01131676|3859189|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
1577298|NCT01131676|3859190|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
1577299|NCT01131676|3859188|P3|STARTED|Discontinuation From Treatment|Randomised|2344
1577300|NCT01131676|3859189|P2|STARTED|Discontinuation From Treatment|Randomised|2347
1577301|NCT01131676|3859190|P1|STARTED|Discontinuation From Treatment|Randomised|2337
1577302|NCT01131585|3859225|P2|NOT COMPLETED|Overall Study||43
1577303|NCT01131585|3859226|P1|NOT COMPLETED|Overall Study||85
1577304|NCT01131585|3859225|P2|COMPLETED|Overall Study||0
1577305|NCT01131585|3859226|P1|COMPLETED|Overall Study||0
1577306|NCT01131585|3859225|P2|STARTED|Overall Study||43
1577307|NCT01131585|3859226|P1|STARTED|Overall Study||85
1577308|NCT01131520|3859234|P2|NOT COMPLETED|Overall Study||4
1577309|NCT01131520|3859235|P1|NOT COMPLETED|Overall Study||1
1577310|NCT01131520|3859234|P2|COMPLETED|Overall Study||176
1577311|NCT01131520|3859235|P1|COMPLETED|Overall Study||179
1577312|NCT01131520|3859234|P2|STARTED|Overall Study||180
1577313|NCT01131520|3859235|P1|STARTED|Overall Study||180
1577314|NCT01131507|3859257|P1|NOT COMPLETED|Overall Study||3
1577315|NCT01131507|3859257|P1|COMPLETED|Overall Study||12
1577316|NCT01131507|3859257|P1|STARTED|Overall Study||15
1577317|NCT01131494|3859262|P1|NOT COMPLETED|Overall Study||2
1577318|NCT01131494|3859262|P1|COMPLETED|Overall Study||15
1577319|NCT01131494|3859262|P1|STARTED|Overall Study||17
1577320|NCT01131455|3859272|P3|NOT COMPLETED|Overall Study||0
1577321|NCT01131455|3859273|P2|NOT COMPLETED|Overall Study||4
1577322|NCT01131455|3859274|P1|NOT COMPLETED|Overall Study||6
1577323|NCT01131455|3859272|P3|COMPLETED|Overall Study||0
1577324|NCT01131455|3859273|P2|COMPLETED|Overall Study||0
1577325|NCT01131455|3859274|P1|COMPLETED|Overall Study||0
1577326|NCT01131455|3859272|P3|STARTED|Overall Study||0
1577327|NCT01131455|3859273|P2|STARTED|Overall Study||4
1577328|NCT01131455|3859274|P1|STARTED|Overall Study||6
1577329|NCT01131312|3859285|P3|NOT COMPLETED|Overall Study||351
1577330|NCT01131312|3859286|P2|NOT COMPLETED|Overall Study||229
1577331|NCT01131312|3859287|P1|NOT COMPLETED|Overall Study||425
1577332|NCT01131312|3859285|P3|COMPLETED|Overall Study||1485
1577333|NCT01131312|3859286|P2|COMPLETED|Overall Study||1156
1577334|NCT01131312|3859287|P1|COMPLETED|Overall Study||1414
1577335|NCT01131312|3859285|P3|STARTED|Overall Study||1836
1577336|NCT01131312|3859286|P2|STARTED|Overall Study||1385
1577337|NCT01131312|3859287|P1|STARTED|Overall Study||1839
1577338|NCT01131299|3859298|P2|NOT COMPLETED|Overall Study||7
1577339|NCT01131299|3859299|P1|NOT COMPLETED|Overall Study||4
1577340|NCT01131299|3859298|P2|COMPLETED|Overall Study||37
1577341|NCT01131299|3859299|P1|COMPLETED|Overall Study||38
1577342|NCT01131299|3859298|P2|STARTED|Overall Study||44
1577343|NCT01131299|3859299|P1|STARTED|Overall Study||42
1577344|NCT01131182|3859312|P2|NOT COMPLETED|Overall Study||16
1577345|NCT01131182|3859313|P1|NOT COMPLETED|Overall Study||16
1577346|NCT01131182|3859312|P2|COMPLETED|Overall Study||521
1577347|NCT01131182|3859313|P1|COMPLETED|Overall Study||513
1577348|NCT01131182|3859312|P2|STARTED|Overall Study||537
1577349|NCT01131182|3859313|P1|STARTED|Overall Study||529
1577350|NCT01131130|3859321|P1|NOT COMPLETED|Period 3- Crossover||1
1577351|NCT01131130|3859321|P1|COMPLETED|Period 3- Crossover||116
1577352|NCT01131130|3859321|P1|STARTED|Period 3- Crossover||117
1577353|NCT01131130|3859321|P1|NOT COMPLETED|Period 2 - Crossover||0
1577354|NCT01131130|3859321|P1|COMPLETED|Period 2 - Crossover||117
1577355|NCT01131130|3859321|P1|STARTED|Period 2 - Crossover||117
1577356|NCT01131130|3859321|P1|NOT COMPLETED|Period 1 - Baseline||1
1577357|NCT01131130|3859321|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
1577358|NCT01131130|3859321|P1|STARTED|Period 1 - Baseline||118
1577359|NCT01131104|3859334|P1|NOT COMPLETED|Overall Study||13
1577360|NCT01131104|3859334|P1|COMPLETED|Overall Study||332
1577361|NCT01131104|3859334|P1|12-Month Analysis Set|Overall Study||26
1577362|NCT01131104|3859334|P1|42-Day Analysis Set|Overall Study||28
1577363|NCT01131104|3859334|P1|30-Day Analysis Set|Overall Study||24
1577364|NCT01131104|3859334|P1|Adjudication-Confirmed NAION Set|Overall Study||279
1577365|NCT01131104|3859334|P1|Study Set|Overall Study||344
1577366|NCT01131104|3859334|P1|STARTED|Overall Study||345
1577367|NCT01131078|3859341|P3|NOT COMPLETED|Overall Study||102
1577368|NCT01131078|3859342|P2|NOT COMPLETED|Overall Study||101
1577369|NCT01131078|3859343|P1|NOT COMPLETED|Overall Study||101
1577370|NCT01131078|3859341|P3|COMPLETED|Overall Study||1
1577371|NCT01131078|3859342|P2|COMPLETED|Overall Study||1
1577372|NCT01131078|3859343|P1|COMPLETED|Overall Study||0
1577373|NCT01131078|3859341|P3|STARTED|Overall Study||103
1577374|NCT01131078|3859342|P2|STARTED|Overall Study||102
1577375|NCT01131078|3859343|P1|STARTED|Overall Study||101
1577376|NCT01131065|3859399|P1|NOT COMPLETED|Overall Study||0
1577377|NCT01131065|3859399|P1|COMPLETED|Overall Study||15
1577378|NCT01131065|3859399|P1|STARTED|Overall Study||15
1577379|NCT01131052|3859407|P2|NOT COMPLETED|Overall Study||0
1577380|NCT01131052|3859408|P1|NOT COMPLETED|Overall Study||0
1577381|NCT01131052|3859407|P2|COMPLETED|Overall Study||75
1577382|NCT01131052|3859408|P1|COMPLETED|Overall Study||75
1577383|NCT01131052|3859407|P2|STARTED|Overall Study||75
1577384|NCT01131052|3859408|P1|STARTED|Overall Study||75
1577385|NCT01130974|3859430|P2|NOT COMPLETED|Overall Study||13
1577386|NCT01130974|3859431|P1|NOT COMPLETED|Overall Study||15
1577387|NCT01130974|3859430|P2|COMPLETED|Overall Study||87
1577388|NCT01130974|3859431|P1|COMPLETED|Overall Study||85
1577389|NCT01130974|3859430|P2|STARTED|Overall Study||100
1577390|NCT01130974|3859431|P1|STARTED|Overall Study||100
1577391|NCT01130896|3859451|P1|NOT COMPLETED|Overall Study||0
1577392|NCT01130896|3859451|P1|COMPLETED|Overall Study||1509
1577393|NCT01130896|3859451|P1|STARTED|Overall Study||1509
1577394|NCT01130883|3859457|P1|NOT COMPLETED|Overall Study||10
1577395|NCT01130883|3859457|P1|COMPLETED|Overall Study||3120
1577396|NCT01130883|3859457|P1|Participants Analyzed|Overall Study||3128
1577397|NCT01130883|3859457|P1|STARTED|Overall Study||3130
1577398|NCT01130844|3859474|P3|NOT COMPLETED|Overall Study||0
1577399|NCT01130844|3859475|P2|NOT COMPLETED|Overall Study||0
1577400|NCT01130844|3859476|P1|NOT COMPLETED|Overall Study||0
1577401|NCT01130844|3859474|P3|COMPLETED|Overall Study||9
1577402|NCT01130844|3859475|P2|COMPLETED|Overall Study||22
1577403|NCT01130844|3859476|P1|COMPLETED|Overall Study||21
1577404|NCT01130844|3859474|P3|STARTED|Overall Study||9
1577405|NCT01130844|3859475|P2|STARTED|Overall Study||22
1577406|NCT01130844|3859476|P1|STARTED|Overall Study||21
1577407|NCT01130831|3859514|P1|NOT COMPLETED|Overall Study||14
1577408|NCT01130831|3859514|P1|COMPLETED|Overall Study||52
1577409|NCT01130831|3859514|P1|STARTED|Overall Study||66
1577410|NCT01130740|3859542|P2|NOT COMPLETED|Overall Study||15
1577411|NCT01130740|3859543|P1|NOT COMPLETED|Overall Study||12
1577412|NCT01130740|3859542|P2|COMPLETED|Overall Study||136
1577413|NCT01130740|3859543|P1|COMPLETED|Overall Study||137
1577414|NCT01130740|3859542|P2|STARTED|Overall Study||151
1577415|NCT01130740|3859543|P1|STARTED|Overall Study||149
1577416|NCT01130597|3859553|P1|NOT COMPLETED|Overall Study||7
1577417|NCT01130597|3859553|P1|COMPLETED|Overall Study||56
1577418|NCT01130597|3859553|P1|STARTED|Overall Study||63
1577419|NCT01130532|3859578|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
1577420|NCT01130532|3859579|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
1577421|NCT01130532|3859580|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
1577422|NCT01130532|3859581|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
1577423|NCT01130532|3859578|P4|COMPLETED|Period IV (Weeks 13-16)||552
1577424|NCT01130532|3859579|P3|COMPLETED|Period IV (Weeks 13-16)||0
1577425|NCT01130532|3859580|P2|COMPLETED|Period IV (Weeks 13-16)||0
1577426|NCT01130532|3859581|P1|COMPLETED|Period IV (Weeks 13-16)||0
1577427|NCT01130532|3859578|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
1577428|NCT01130532|3859579|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
1577429|NCT01130532|3859580|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
1577430|NCT01130532|3859581|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
1577431|NCT01130532|3859578|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
1577432|NCT01130532|3859579|P3|STARTED|Period IV (Weeks 13-16)||0
1577433|NCT01130532|3859580|P2|STARTED|Period IV (Weeks 13-16)||0
1577434|NCT01130532|3859581|P1|STARTED|Period IV (Weeks 13-16)||0
1577435|NCT01130532|3859578|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
1577436|NCT01130532|3859579|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
1577437|NCT01130532|3859580|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
1577438|NCT01130532|3859581|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
1577439|NCT01130532|3859578|P4|COMPLETED|Period III (Weeks 0-12)||0
1577440|NCT01130532|3859579|P3|COMPLETED|Period III (Weeks 0-12)||190
1577441|NCT01130532|3859580|P2|COMPLETED|Period III (Weeks 0-12)||189
1577442|NCT01130532|3859581|P1|COMPLETED|Period III (Weeks 0-12)||186
1577443|NCT01130532|3859578|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
1577444|NCT01130532|3859579|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
1577445|NCT01130532|3859580|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
1577446|NCT01130532|3859581|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
1577447|NCT01130532|3859578|P4|STARTED|Period III (Weeks 0-12)||0
1577448|NCT01130532|3859579|P3|STARTED|Period III (Weeks 0-12)||209
1577449|NCT01130532|3859580|P2|STARTED|Period III (Weeks 0-12)||207
1577450|NCT01130532|3859581|P1|STARTED|Period III (Weeks 0-12)||207
1577451|NCT01130493|3859626|P3|NOT COMPLETED|Part 2: OLE||5
1577452|NCT01130493|3859627|P2|NOT COMPLETED|Part 2: OLE||3
1577453|NCT01130493|3859628|P1|NOT COMPLETED|Part 2: OLE||0
1577454|NCT01130493|3859626|P3|COMPLETED|Part 2: OLE||30
1577455|NCT01130493|3859627|P2|COMPLETED|Part 2: OLE||36
1577456|NCT01130493|3859628|P1|COMPLETED|Part 2: OLE||0
1577457|NCT01130493|3859626|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
1577458|NCT01130493|3859627|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
1577459|NCT01130493|3859628|P1|STARTED|Part 2: OLE||0
1577460|NCT01130493|3859626|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
1577461|NCT01130493|3859627|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
1577462|NCT01130493|3859628|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
1577463|NCT01130493|3859626|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
1577464|NCT01130493|3859627|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
1577465|NCT01130493|3859628|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
1577466|NCT01130493|3859626|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
1577467|NCT01130493|3859627|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
1577468|NCT01130493|3859628|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
1577469|NCT01130493|3859626|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
1577470|NCT01130493|3859627|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
1577471|NCT01130493|3859628|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
1577472|NCT01130493|3859626|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
1577473|NCT01130493|3859627|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
1577474|NCT01130493|3859628|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
1577475|NCT01130493|3859626|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
1577476|NCT01130493|3859627|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
1577477|NCT01130493|3859628|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
1577478|NCT01130493|3859626|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
1577479|NCT01130493|3859627|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
1577480|NCT01130493|3859628|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
1577481|NCT01130493|3859626|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
1577482|NCT01130493|3859627|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
1577483|NCT01130493|3859628|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
1577484|NCT01130493|3859626|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
1577485|NCT01130493|3859627|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
1577486|NCT01130493|3859628|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
1577487|NCT01130493|3859626|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
1577488|NCT01130493|3859627|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
1577489|NCT01130493|3859628|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
1577490|NCT01130493|3859626|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
1577491|NCT01130493|3859627|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
1577492|NCT01130493|3859628|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
1577493|NCT01130493|3859626|P3|STARTED|Open-label Dose Conversion to IPX066||0
1577494|NCT01130493|3859627|P2|STARTED|Open-label Dose Conversion to IPX066||0
1577495|NCT01130493|3859628|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
1577496|NCT01130337|3859645|P1|NOT COMPLETED|Overall Study||14
1577497|NCT01130337|3859645|P1|COMPLETED|Overall Study||22
1577498|NCT01130337|3859645|P1|STARTED|Overall Study||36
1577499|NCT01130168|3859652|P6|NOT COMPLETED|Period 3||0
1577500|NCT01130168|3859653|P5|NOT COMPLETED|Period 3||0
1577501|NCT01130168|3859654|P4|NOT COMPLETED|Period 3||0
1577502|NCT01130168|3859655|P3|NOT COMPLETED|Period 3||0
1577503|NCT01130168|3859656|P2|NOT COMPLETED|Period 3||0
1577504|NCT01130168|3859657|P1|NOT COMPLETED|Period 3||0
1577505|NCT01130168|3859652|P6|COMPLETED|Period 3||6
1577506|NCT01130168|3859653|P5|COMPLETED|Period 3||5
1577507|NCT01130168|3859654|P4|COMPLETED|Period 3||5
1577508|NCT01130168|3859655|P3|COMPLETED|Period 3||5
1577509|NCT01130168|3859656|P2|COMPLETED|Period 3||6
1577510|NCT01130168|3859657|P1|COMPLETED|Period 3||6
1577511|NCT01130168|3859652|P6|STARTED|Period 3||6
1577512|NCT01130168|3859653|P5|STARTED|Period 3||5
1577513|NCT01130168|3859654|P4|STARTED|Period 3||5
1577514|NCT01130168|3859655|P3|STARTED|Period 3||5
1577515|NCT01130168|3859656|P2|STARTED|Period 3||6
1577516|NCT01130168|3859657|P1|STARTED|Period 3||6
1577517|NCT01130168|3859652|P6|NOT COMPLETED|Period 2||0
1577518|NCT01130168|3859653|P5|NOT COMPLETED|Period 2||0
1577519|NCT01130168|3859654|P4|NOT COMPLETED|Period 2||0
1577520|NCT01130168|3859655|P3|NOT COMPLETED|Period 2||0
1577521|NCT01130168|3859656|P2|NOT COMPLETED|Period 2||0
1577522|NCT01130168|3859657|P1|NOT COMPLETED|Period 2||0
1577523|NCT01130168|3859652|P6|COMPLETED|Period 2||6
1577524|NCT01130168|3859653|P5|COMPLETED|Period 2||5
1577525|NCT01130168|3859654|P4|COMPLETED|Period 2||5
1577526|NCT01130168|3859655|P3|COMPLETED|Period 2||5
1577527|NCT01130168|3859656|P2|COMPLETED|Period 2||6
1577528|NCT01130168|3859657|P1|COMPLETED|Period 2||6
1577529|NCT01130168|3859652|P6|STARTED|Period 2||6
1577530|NCT01130168|3859653|P5|STARTED|Period 2||5
1577531|NCT01130168|3859654|P4|STARTED|Period 2||5
1577532|NCT01130168|3859655|P3|STARTED|Period 2||5
1577533|NCT01130168|3859656|P2|STARTED|Period 2||6
1577534|NCT01130168|3859657|P1|STARTED|Period 2||6
1577535|NCT01130168|3859652|P6|NOT COMPLETED|Period 1||0
1577536|NCT01130168|3859653|P5|NOT COMPLETED|Period 1||0
1577537|NCT01130168|3859654|P4|NOT COMPLETED|Period 1||3
1577538|NCT01130168|3859655|P3|NOT COMPLETED|Period 1||1
1577539|NCT01130168|3859656|P2|NOT COMPLETED|Period 1||1
1577540|NCT01130168|3859657|P1|NOT COMPLETED|Period 1||0
1577541|NCT01130168|3859652|P6|COMPLETED|Period 1||6
1577542|NCT01130168|3859653|P5|COMPLETED|Period 1||5
1577543|NCT01130168|3859654|P4|COMPLETED|Period 1||5
1577544|NCT01130168|3859655|P3|COMPLETED|Period 1||5
1577545|NCT01130168|3859656|P2|COMPLETED|Period 1||6
1577546|NCT01130168|3859657|P1|COMPLETED|Period 1||6
1577547|NCT01130168|3859652|P6|STARTED|Period 1||6
1577548|NCT01130168|3859653|P5|STARTED|Period 1||5
1577549|NCT01130168|3859654|P4|STARTED|Period 1||8
1577550|NCT01130168|3859655|P3|STARTED|Period 1||6
1577551|NCT01130168|3859656|P2|STARTED|Period 1||7
1577552|NCT01130168|3859657|P1|STARTED|Period 1||6
1577553|NCT01130103|3859694|P2|NOT COMPLETED|Maintenance Treatment||2
1577554|NCT01130103|3859695|P1|NOT COMPLETED|Maintenance Treatment||2
1577555|NCT01130103|3859694|P2|COMPLETED|Maintenance Treatment||11
1577556|NCT01130103|3859695|P1|COMPLETED|Maintenance Treatment||11
1577557|NCT01130103|3859694|P2|STARTED|Maintenance Treatment||13
1577558|NCT01130103|3859695|P1|STARTED|Maintenance Treatment||13
1577559|NCT01130103|3859694|P2|NOT COMPLETED|Randomized Treatment||5
1577560|NCT01130103|3859695|P1|NOT COMPLETED|Randomized Treatment||6
1577561|NCT01130103|3859694|P2|COMPLETED|Randomized Treatment||13
1577562|NCT01130103|3859695|P1|COMPLETED|Randomized Treatment||13
1577563|NCT01130103|3859694|P2|STARTED|Randomized Treatment||18
1577564|NCT01130103|3859695|P1|STARTED|Randomized Treatment||19
1577565|NCT01130051|3859709|P2|NOT COMPLETED|Period 2||0
1577566|NCT01130051|3859710|P1|NOT COMPLETED|Period 2||0
1577567|NCT01130051|3859709|P2|COMPLETED|Period 2||6
1577568|NCT01130051|3859710|P1|COMPLETED|Period 2||7
1577569|NCT01130051|3859709|P2|STARTED|Period 2||6
1577570|NCT01130051|3859710|P1|STARTED|Period 2||7
1577571|NCT01130051|3859709|P2|NOT COMPLETED|Washout Period of 14 Days||2
1577572|NCT01130051|3859710|P1|NOT COMPLETED|Washout Period of 14 Days||1
1577573|NCT01130051|3859709|P2|COMPLETED|Washout Period of 14 Days||6
1577574|NCT01130051|3859710|P1|COMPLETED|Washout Period of 14 Days||7
1577575|NCT01130051|3859709|P2|STARTED|Washout Period of 14 Days||8
1577576|NCT01130051|3859710|P1|STARTED|Washout Period of 14 Days||8
1577577|NCT01130051|3859709|P2|NOT COMPLETED|Period 1||0
1577578|NCT01130051|3859710|P1|NOT COMPLETED|Period 1||0
1577579|NCT01130051|3859709|P2|COMPLETED|Period 1||8
1577580|NCT01130051|3859710|P1|COMPLETED|Period 1||8
1577581|NCT01130051|3859709|P2|STARTED|Period 1||8
1577582|NCT01130051|3859710|P1|STARTED|Period 1||8
1577583|NCT01129960|3859724|P4|NOT COMPLETED|Overall Study||13
1577584|NCT01129960|3859725|P3|NOT COMPLETED|Overall Study||26
1577585|NCT01129960|3859726|P2|NOT COMPLETED|Overall Study||22
1577586|NCT01129960|3859727|P1|NOT COMPLETED|Overall Study||30
1577587|NCT01129960|3859724|P4|COMPLETED|Overall Study||70
1577588|NCT01129960|3859725|P3|COMPLETED|Overall Study||56
1577589|NCT01129960|3859726|P2|COMPLETED|Overall Study||61
1577590|NCT01129960|3859727|P1|COMPLETED|Overall Study||54
1577591|NCT01129960|3859724|P4|Full Analysis Set (FAS|Overall Study||71
1577592|NCT01129960|3859725|P3|Full Analysis Set (FAS|Overall Study||68
1577593|NCT01129960|3859726|P2|Full Analysis Set (FAS|Overall Study||67
1577594|NCT01129960|3859727|P1|Full Analysis Set (FAS|Overall Study||71
1577595|NCT01129960|3859724|P4|Per-Protocol|Overall Study||55
1577596|NCT01129960|3859725|P3|Per-Protocol|Overall Study||49
1577597|NCT01129960|3859726|P2|Per-Protocol|Overall Study||52
1577598|NCT01129960|3859727|P1|Per-Protocol|Overall Study||34
1577599|NCT01129960|3859724|P4|Intent-to-Treat|Overall Study||83
1577600|NCT01129960|3859725|P3|Intent-to-Treat|Overall Study||82
1577601|NCT01129960|3859726|P2|Intent-to-Treat|Overall Study||83
1577602|NCT01129960|3859727|P1|Intent-to-Treat|Overall Study||84
1577603|NCT01129960|3859724|P4|Safety|Overall Study||82
1577604|NCT01129960|3859725|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
1577605|NCT01129960|3859726|P2|Safety|Overall Study||83
1577606|NCT01129960|3859727|P1|Safety|Overall Study||84
1577607|NCT01129960|3859724|P4|STARTED|Overall Study||83
1577608|NCT01129960|3859725|P3|STARTED|Overall Study||82
1577609|NCT01129960|3859726|P2|STARTED|Overall Study||83
1577610|NCT01129960|3859727|P1|STARTED|Overall Study||84
1577611|NCT01129921|3859739|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
1577612|NCT01129921|3859740|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
1577613|NCT01129921|3859739|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
1577614|NCT01129921|3859740|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
1577615|NCT01129921|3859739|P2|STARTED|After Sham Cross-over to Mild, One Year||20
1577616|NCT01129921|3859740|P1|STARTED|After Sham Cross-over to Mild, One Year||20
1577617|NCT01129921|3859739|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
1577618|NCT01129921|3859740|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
1577619|NCT01129921|3859739|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
1577620|NCT01129921|3859740|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
1577621|NCT01129921|3859739|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
1577622|NCT01129921|3859740|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
1577623|NCT01129778|3859750|P1|NOT COMPLETED|Overall Study||7
1577624|NCT01129778|3859750|P1|COMPLETED|Overall Study||15
1577625|NCT01129778|3859750|P1|STARTED|Overall Study||22
1577626|NCT01129765|3859755|P1|NOT COMPLETED|Overall Study||0
1577627|NCT01129765|3859755|P1|COMPLETED|Overall Study||30
1577628|NCT01129765|3859755|P1|STARTED|Overall Study||30
1577629|NCT01129622|3859764|P1|NOT COMPLETED|Overall Study||2
1577630|NCT01129622|3859764|P1|COMPLETED|Overall Study||14
1577631|NCT01129622|3859764|P1|STARTED|Overall Study||16
1577632|NCT01129583|3859771|P2|NOT COMPLETED|Overall Study||2
1577633|NCT01129583|3859772|P1|NOT COMPLETED|Overall Study||3
1577634|NCT01129583|3859771|P2|COMPLETED|Overall Study||7
1577635|NCT01129583|3859772|P1|COMPLETED|Overall Study||6
1577636|NCT01129583|3859771|P2|STARTED|Overall Study||9
1577637|NCT01129583|3859772|P1|STARTED|Overall Study||9
1577638|NCT01129557|3859785|P3|NOT COMPLETED|Overall Study||4
1577639|NCT01129557|3859786|P2|NOT COMPLETED|Overall Study||5
1577640|NCT01129557|3859787|P1|NOT COMPLETED|Overall Study||4
1577641|NCT01129557|3859785|P3|COMPLETED|Overall Study||10
1577642|NCT01129557|3859786|P2|COMPLETED|Overall Study||12
1577643|NCT01129557|3859787|P1|COMPLETED|Overall Study||11
1577644|NCT01129557|3859785|P3|STARTED|Overall Study||14
1577645|NCT01129557|3859786|P2|STARTED|Overall Study||17
1577646|NCT01129557|3859787|P1|STARTED|Overall Study||15
1577647|NCT01129531|3859858|P3|NOT COMPLETED|Treatment Cycle 2||5
1577648|NCT01129531|3859859|P2|NOT COMPLETED|Treatment Cycle 2||3
1577649|NCT01129531|3859860|P1|NOT COMPLETED|Treatment Cycle 2||6
1577650|NCT01129531|3859858|P3|COMPLETED|Treatment Cycle 2||74
1577651|NCT01129531|3859859|P2|COMPLETED|Treatment Cycle 2||92
1577652|NCT01129531|3859860|P1|COMPLETED|Treatment Cycle 2||88
1577653|NCT01129531|3859858|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
1577654|NCT01129531|3859859|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
1577655|NCT01129531|3859860|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
1577656|NCT01129531|3859858|P3|NOT COMPLETED|Treatment Cycle 1||16
1577657|NCT01129531|3859859|P2|NOT COMPLETED|Treatment Cycle 1||6
1577658|NCT01129531|3859860|P1|NOT COMPLETED|Treatment Cycle 1||4
1577659|NCT01129531|3859858|P3|COMPLETED|Treatment Cycle 1||110
1577660|NCT01129531|3859859|P2|COMPLETED|Treatment Cycle 1||78
1577661|NCT01129531|3859860|P1|COMPLETED|Treatment Cycle 1||80
1577662|NCT01129531|3859858|P3|STARTED|Treatment Cycle 1||126
1577663|NCT01129531|3859859|P2|STARTED|Treatment Cycle 1||84
1577664|NCT01129531|3859860|P1|STARTED|Treatment Cycle 1||84
1577665|NCT01129336|3859882|P2|NOT COMPLETED|Overall Study||16
1577666|NCT01129336|3859883|P1|NOT COMPLETED|Overall Study||12
1577667|NCT01129336|3859882|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
1577668|NCT01129336|3859883|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
1577669|NCT01129336|3859882|P2|Completed Treatment|Overall Study||3
1577670|NCT01129336|3859883|P1|Completed Treatment|Overall Study||1
1577671|NCT01129336|3859882|P2|STARTED|Overall Study||29
1577672|NCT01129336|3859883|P1|STARTED|Overall Study||15
1577673|NCT01129284|3859898|P3|NOT COMPLETED|Overall Study||1
1577674|NCT01129284|3859899|P2|NOT COMPLETED|Overall Study||0
1577675|NCT01129284|3859900|P1|NOT COMPLETED|Overall Study||2
1577676|NCT01129284|3859898|P3|COMPLETED|Overall Study||4
1577677|NCT01129284|3859899|P2|COMPLETED|Overall Study||5
1577678|NCT01129284|3859900|P1|COMPLETED|Overall Study||3
1577679|NCT01129284|3859898|P3|STARTED|Overall Study||5
1577680|NCT01129284|3859899|P2|STARTED|Overall Study||5
1577681|NCT01129284|3859900|P1|STARTED|Overall Study||5
1577682|NCT01129245|3859913|P2|NOT COMPLETED|Overall Study||0
1577683|NCT01129245|3859914|P1|NOT COMPLETED|Overall Study||0
1577684|NCT01129245|3859913|P2|COMPLETED|Overall Study||4
1577685|NCT01129245|3859914|P1|COMPLETED|Overall Study||7
1577686|NCT01129245|3859913|P2|STARTED|Overall Study||4
1577687|NCT01129245|3859914|P1|STARTED|Overall Study||7
1577688|NCT01129206|3859920|P1|NOT COMPLETED|Overall Study||0
1577689|NCT01129206|3859920|P1|COMPLETED|Overall Study||6
1577690|NCT01129206|3859920|P1|STARTED|Overall Study||6
1577691|NCT01129141|3859930|P2|NOT COMPLETED|Overall Study||13
1577692|NCT01129141|3859931|P1|NOT COMPLETED|Overall Study||15
1577693|NCT01129141|3859930|P2|COMPLETED|Overall Study||91
1577694|NCT01129141|3859931|P1|COMPLETED|Overall Study||86
1577695|NCT01129141|3859930|P2|STARTED|Overall Study||104
1577696|NCT01129141|3859931|P1|STARTED|Overall Study||101
1577697|NCT01129128|3859940|P3|NOT COMPLETED|Overall Study||4
1577698|NCT01129128|3859941|P2|NOT COMPLETED|Overall Study||4
1577699|NCT01129128|3859942|P1|NOT COMPLETED|Overall Study||3
1577700|NCT01129128|3859940|P3|COMPLETED|Overall Study||19
1577701|NCT01129128|3859941|P2|COMPLETED|Overall Study||18
1577702|NCT01129128|3859942|P1|COMPLETED|Overall Study||19
1577703|NCT01129128|3859940|P3|STARTED|Overall Study||23
1577704|NCT01129128|3859941|P2|STARTED|Overall Study||22
1577705|NCT01129128|3859942|P1|STARTED|Overall Study||22
1577706|NCT01129115|3859966|P4|NOT COMPLETED|Overall Study||9
1577707|NCT01129115|3859967|P3|NOT COMPLETED|Overall Study||6
1577708|NCT01129115|3859968|P2|NOT COMPLETED|Overall Study||7
1577709|NCT01129115|3859969|P1|NOT COMPLETED|Overall Study||2
1577710|NCT01129115|3859966|P4|COMPLETED|Overall Study||15
1577711|NCT01129115|3859967|P3|COMPLETED|Overall Study||21
1577712|NCT01129115|3859968|P2|COMPLETED|Overall Study||18
1577713|NCT01129115|3859969|P1|COMPLETED|Overall Study||23
1577714|NCT01129115|3859966|P4|STARTED|Overall Study||24
1577715|NCT01129115|3859967|P3|STARTED|Overall Study||27
1577716|NCT01129115|3859968|P2|STARTED|Overall Study||25
1577717|NCT01129115|3859969|P1|STARTED|Overall Study||25
1577718|NCT01129102|3860006|P3|NOT COMPLETED|Overall Study||7
1577719|NCT01129102|3860007|P2|NOT COMPLETED|Overall Study||6
1577720|NCT01129102|3860008|P1|NOT COMPLETED|Overall Study||8
1577721|NCT01129102|3860006|P3|COMPLETED|Overall Study||48
1577722|NCT01129102|3860007|P2|COMPLETED|Overall Study||44
1577723|NCT01129102|3860008|P1|COMPLETED|Overall Study||102
1577724|NCT01129102|3860006|P3|STARTED|Overall Study||55
1577725|NCT01129102|3860007|P2|STARTED|Overall Study||50
1577726|NCT01129102|3860008|P1|STARTED|Overall Study||110
1577727|NCT01129011|3860019|P2|NOT COMPLETED|Overall Study||57
1577728|NCT01129011|3860020|P1|NOT COMPLETED|Overall Study||59
1577729|NCT01129011|3860019|P2|COMPLETED|Overall Study||153
1577730|NCT01129011|3860020|P1|COMPLETED|Overall Study||151
1577731|NCT01129011|3860019|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
1577732|NCT01129011|3860020|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
1577733|NCT01128972|3860042|P5|NOT COMPLETED|Period V||0
1577734|NCT01128972|3860043|P4|NOT COMPLETED|Period V||0
1577735|NCT01128972|3860044|P3|NOT COMPLETED|Period V||0
1577736|NCT01128972|3860045|P2|NOT COMPLETED|Period V||0
1577737|NCT01128972|3860046|P1|NOT COMPLETED|Period V||0
1577738|NCT01128972|3860042|P5|COMPLETED|Period V||7
1577739|NCT01128972|3860043|P4|COMPLETED|Period V||7
1577740|NCT01128972|3860044|P3|COMPLETED|Period V||7
1577741|NCT01128972|3860045|P2|COMPLETED|Period V||7
1577742|NCT01128972|3860046|P1|COMPLETED|Period V||8
1577743|NCT01128972|3860042|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1577744|NCT01128972|3860043|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1577745|NCT01128972|3860044|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1577746|NCT01128972|3860045|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1577747|NCT01128972|3860046|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
1577748|NCT01128972|3860042|P5|NOT COMPLETED|Period IV||0
1577749|NCT01128972|3860043|P4|NOT COMPLETED|Period IV||0
1577750|NCT01128972|3860044|P3|NOT COMPLETED|Period IV||0
1577751|NCT01128972|3860045|P2|NOT COMPLETED|Period IV||0
1577752|NCT01128972|3860046|P1|NOT COMPLETED|Period IV||0
1577753|NCT01128972|3860042|P5|COMPLETED|Period IV||7
1577754|NCT01128972|3860043|P4|COMPLETED|Period IV||7
1577755|NCT01128972|3860044|P3|COMPLETED|Period IV||7
1577756|NCT01128972|3860045|P2|COMPLETED|Period IV||8
1577757|NCT01128972|3860046|P1|COMPLETED|Period IV||7
1577758|NCT01128972|3860042|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1577759|NCT01128972|3860043|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1577760|NCT01128972|3860044|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1577761|NCT01128972|3860045|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
1577762|NCT01128972|3860046|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1577763|NCT01128972|3860042|P5|NOT COMPLETED|Period III||0
1577764|NCT01128972|3860043|P4|NOT COMPLETED|Period III||0
1577765|NCT01128972|3860044|P3|NOT COMPLETED|Period III||0
1577766|NCT01128972|3860045|P2|NOT COMPLETED|Period III||0
1577767|NCT01128972|3860046|P1|NOT COMPLETED|Period III||0
1577768|NCT01128972|3860042|P5|COMPLETED|Period III||7
1577769|NCT01128972|3860043|P4|COMPLETED|Period III||7
1577770|NCT01128972|3860044|P3|COMPLETED|Period III||8
1577771|NCT01128972|3860045|P2|COMPLETED|Period III||7
1577772|NCT01128972|3860046|P1|COMPLETED|Period III||7
1577773|NCT01128972|3860042|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1577774|NCT01128972|3860043|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1577775|NCT01128972|3860044|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
1577853|NCT01128946|3860084|P1|NOT COMPLETED|Period I||0
1577776|NCT01128972|3860045|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1577777|NCT01128972|3860046|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1577778|NCT01128972|3860042|P5|NOT COMPLETED|Period II||0
1577779|NCT01128972|3860043|P4|NOT COMPLETED|Period II||0
1577780|NCT01128972|3860044|P3|NOT COMPLETED|Period II||0
1577781|NCT01128972|3860045|P2|NOT COMPLETED|Period II||0
1577782|NCT01128972|3860046|P1|NOT COMPLETED|Period II||0
1577783|NCT01128972|3860042|P5|COMPLETED|Period II||7
1577784|NCT01128972|3860043|P4|COMPLETED|Period II||8
1577785|NCT01128972|3860044|P3|COMPLETED|Period II||7
1577786|NCT01128972|3860045|P2|COMPLETED|Period II||7
1577787|NCT01128972|3860046|P1|COMPLETED|Period II||7
1577788|NCT01128972|3860042|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1577789|NCT01128972|3860043|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
1577790|NCT01128972|3860044|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1577791|NCT01128972|3860045|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1577792|NCT01128972|3860046|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1577793|NCT01128972|3860042|P5|NOT COMPLETED|Period I||0
1577794|NCT01128972|3860043|P4|NOT COMPLETED|Period I||0
1577795|NCT01128972|3860044|P3|NOT COMPLETED|Period I||0
1577796|NCT01128972|3860045|P2|NOT COMPLETED|Period I||0
1577797|NCT01128972|3860046|P1|NOT COMPLETED|Period I||0
1577798|NCT01128972|3860042|P5|COMPLETED|Period I||8
1577799|NCT01128972|3860043|P4|COMPLETED|Period I||7
1577800|NCT01128972|3860044|P3|COMPLETED|Period I||7
1577801|NCT01128972|3860045|P2|COMPLETED|Period I||7
1577802|NCT01128972|3860046|P1|COMPLETED|Period I||7
1577803|NCT01128972|3860042|P5|STARTED|Period I||8
1577804|NCT01128972|3860043|P4|STARTED|Period I||7
1577805|NCT01128972|3860044|P3|STARTED|Period I||7
1577806|NCT01128972|3860045|P2|STARTED|Period I||7
1577807|NCT01128972|3860046|P1|STARTED|Period I||7
1577808|NCT01128959|3860075|P1|NOT COMPLETED|Treatment Period||4
1577809|NCT01128959|3860075|P1|COMPLETED|Treatment Period||101
1577810|NCT01128959|3860075|P1|STARTED|Treatment Period||105
1577811|NCT01128959|3860075|P1|NOT COMPLETED|Lead in Period||3
1577812|NCT01128959|3860075|P1|COMPLETED|Lead in Period||105
1577813|NCT01128959|3860075|P1|STARTED|Lead in Period||108
1577814|NCT01128946|3860081|P4|NOT COMPLETED|Period IV||0
1577815|NCT01128946|3860082|P3|NOT COMPLETED|Period IV||0
1577816|NCT01128946|3860083|P2|NOT COMPLETED|Period IV||0
1577817|NCT01128946|3860084|P1|NOT COMPLETED|Period IV||0
1577818|NCT01128946|3860081|P4|COMPLETED|Period IV||19
1577819|NCT01128946|3860082|P3|COMPLETED|Period IV||19
1577820|NCT01128946|3860083|P2|COMPLETED|Period IV||20
1577821|NCT01128946|3860084|P1|COMPLETED|Period IV||19
1577822|NCT01128946|3860081|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
1577823|NCT01128946|3860082|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
1577824|NCT01128946|3860083|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
1577825|NCT01128946|3860084|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
1577826|NCT01128946|3860081|P4|NOT COMPLETED|Period III||0
1577827|NCT01128946|3860082|P3|NOT COMPLETED|Period III||0
1577828|NCT01128946|3860083|P2|NOT COMPLETED|Period III||0
1577829|NCT01128946|3860084|P1|NOT COMPLETED|Period III||1
1577830|NCT01128946|3860081|P4|COMPLETED|Period III||19
1577831|NCT01128946|3860082|P3|COMPLETED|Period III||20
1577832|NCT01128946|3860083|P2|COMPLETED|Period III||19
1577833|NCT01128946|3860084|P1|COMPLETED|Period III||19
1577834|NCT01128946|3860081|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
1577835|NCT01128946|3860082|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
1577836|NCT01128946|3860083|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
1577837|NCT01128946|3860084|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
1577838|NCT01128946|3860081|P4|NOT COMPLETED|Period II||1
1577839|NCT01128946|3860082|P3|NOT COMPLETED|Period II||0
1577840|NCT01128946|3860083|P2|NOT COMPLETED|Period II||1
1577841|NCT01128946|3860084|P1|NOT COMPLETED|Period II||0
1577842|NCT01128946|3860081|P4|COMPLETED|Period II||19
1577843|NCT01128946|3860082|P3|COMPLETED|Period II||20
1577844|NCT01128946|3860083|P2|COMPLETED|Period II||19
1577845|NCT01128946|3860084|P1|COMPLETED|Period II||20
1577846|NCT01128946|3860081|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1577847|NCT01128946|3860082|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1577848|NCT01128946|3860083|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1577849|NCT01128946|3860084|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1577850|NCT01128946|3860081|P4|NOT COMPLETED|Period I||1
1577851|NCT01128946|3860082|P3|NOT COMPLETED|Period I||1
1577852|NCT01128946|3860083|P2|NOT COMPLETED|Period I||1
1577854|NCT01128946|3860081|P4|COMPLETED|Period I||20
1577855|NCT01128946|3860082|P3|COMPLETED|Period I||20
1577856|NCT01128946|3860083|P2|COMPLETED|Period I||20
1577857|NCT01128946|3860084|P1|COMPLETED|Period I||20
1577858|NCT01128946|3860081|P4|STARTED|Period I||21
1577859|NCT01128946|3860082|P3|STARTED|Period I||21
1577860|NCT01128946|3860083|P2|STARTED|Period I||21
1577861|NCT01128946|3860084|P1|STARTED|Period I||20
1577862|NCT01128894|3860102|P2|NOT COMPLETED|Overall Study||68
1577863|NCT01128894|3860103|P1|NOT COMPLETED|Overall Study||58
1577864|NCT01128894|3860102|P2|COMPLETED|Overall Study||340
1577865|NCT01128894|3860103|P1|COMPLETED|Overall Study||346
1577866|NCT01128894|3860102|P2|STARTED|Overall Study||408
1577867|NCT01128894|3860103|P1|STARTED|Overall Study||404
1577868|NCT01128842|3860121|P1|NOT COMPLETED|Overall Study||7
1577869|NCT01128842|3860121|P1|COMPLETED|Overall Study||0
1577870|NCT01128842|3860121|P1|STARTED|Overall Study||7
1577871|NCT01128829|3860131|P2|NOT COMPLETED|Overall Study||0
1577872|NCT01128829|3860132|P1|NOT COMPLETED|Overall Study||0
1577873|NCT01128829|3860131|P2|COMPLETED|Overall Study||11
1577874|NCT01128829|3860132|P1|COMPLETED|Overall Study||6
1577875|NCT01128829|3860131|P2|STARTED|Overall Study||11
1577876|NCT01128829|3860132|P1|STARTED|Overall Study||6
1577877|NCT01128738|3860138|P2|NOT COMPLETED|Second TP||3
1577878|NCT01128738|3860139|P1|NOT COMPLETED|Second TP||0
1577879|NCT01128738|3860138|P2|COMPLETED|Second TP||63
1577880|NCT01128738|3860139|P1|COMPLETED|Second TP||34
1577881|NCT01128738|3860138|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
1577882|NCT01128738|3860139|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
1577883|NCT01128738|3860138|P2|NOT COMPLETED|First Treatment Phase (TP)||1
1577884|NCT01128738|3860139|P1|NOT COMPLETED|First Treatment Phase (TP)||4
1577885|NCT01128738|3860138|P2|COMPLETED|First Treatment Phase (TP)||73
1577886|NCT01128738|3860139|P1|COMPLETED|First Treatment Phase (TP)||74
1577887|NCT01128738|3860138|P2|STARTED|First Treatment Phase (TP)||74
1577888|NCT01128738|3860139|P1|STARTED|First Treatment Phase (TP)||78
1577889|NCT01128621|3860264|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
1577890|NCT01128621|3860265|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
1577891|NCT01128621|3860264|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
1577892|NCT01128621|3860265|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
1577893|NCT01128621|3860264|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
1577894|NCT01128621|3860265|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
1577895|NCT01128621|3860264|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
1577896|NCT01128621|3860265|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
1577897|NCT01128621|3860264|P2|COMPLETED|Part A: GSK1292263 300 mg||0
1577898|NCT01128621|3860265|P1|COMPLETED|Part A: GSK1292263 300 mg||6
1577899|NCT01128621|3860264|P2|STARTED|Part A: GSK1292263 300 mg||0
1577900|NCT01128621|3860265|P1|STARTED|Part A: GSK1292263 300 mg||6
1577901|NCT01128595|3860386|P4|NOT COMPLETED|Treatment Period 4||0
1577902|NCT01128595|3860387|P3|NOT COMPLETED|Treatment Period 4||0
1577903|NCT01128595|3860388|P2|NOT COMPLETED|Treatment Period 4||0
1577904|NCT01128595|3860389|P1|NOT COMPLETED|Treatment Period 4||0
1577905|NCT01128595|3860386|P4|COMPLETED|Treatment Period 4||7
1577906|NCT01128595|3860387|P3|COMPLETED|Treatment Period 4||7
1577907|NCT01128595|3860388|P2|COMPLETED|Treatment Period 4||5
1577908|NCT01128595|3860389|P1|COMPLETED|Treatment Period 4||7
1577909|NCT01128595|3860386|P4|STARTED|Treatment Period 4||7
1577910|NCT01128595|3860387|P3|STARTED|Treatment Period 4||7
1577911|NCT01128595|3860388|P2|STARTED|Treatment Period 4||5
1577912|NCT01128595|3860389|P1|STARTED|Treatment Period 4||7
1577913|NCT01128595|3860386|P4|NOT COMPLETED|Washout Period 3||0
1577914|NCT01128595|3860387|P3|NOT COMPLETED|Washout Period 3||0
1577915|NCT01128595|3860388|P2|NOT COMPLETED|Washout Period 3||0
1577916|NCT01128595|3860389|P1|NOT COMPLETED|Washout Period 3||0
1577917|NCT01128595|3860386|P4|COMPLETED|Washout Period 3||7
1577918|NCT01128595|3860387|P3|COMPLETED|Washout Period 3||7
1577919|NCT01128595|3860388|P2|COMPLETED|Washout Period 3||5
1577920|NCT01128595|3860389|P1|COMPLETED|Washout Period 3||7
1577921|NCT01128595|3860386|P4|STARTED|Washout Period 3||7
1577922|NCT01128595|3860387|P3|STARTED|Washout Period 3||7
1577923|NCT01128595|3860388|P2|STARTED|Washout Period 3||5
1577924|NCT01128595|3860389|P1|STARTED|Washout Period 3||7
1577925|NCT01128595|3860386|P4|NOT COMPLETED|Treatment Period 3||0
1577926|NCT01128595|3860387|P3|NOT COMPLETED|Treatment Period 3||0
1577927|NCT01128595|3860388|P2|NOT COMPLETED|Treatment Period 3||1
1577928|NCT01128595|3860389|P1|NOT COMPLETED|Treatment Period 3||0
1577929|NCT01128595|3860386|P4|COMPLETED|Treatment Period 3||7
1577930|NCT01128595|3860387|P3|COMPLETED|Treatment Period 3||7
1577931|NCT01128595|3860388|P2|COMPLETED|Treatment Period 3||5
1577932|NCT01128595|3860389|P1|COMPLETED|Treatment Period 3||7
1577933|NCT01128595|3860386|P4|STARTED|Treatment Period 3||7
1577934|NCT01128595|3860387|P3|STARTED|Treatment Period 3||7
1577935|NCT01128595|3860388|P2|STARTED|Treatment Period 3||6
1577936|NCT01128595|3860389|P1|STARTED|Treatment Period 3||7
1577937|NCT01128595|3860386|P4|NOT COMPLETED|Washout Period 2||0
1577938|NCT01128595|3860387|P3|NOT COMPLETED|Washout Period 2||0
1577939|NCT01128595|3860388|P2|NOT COMPLETED|Washout Period 2||0
1577940|NCT01128595|3860389|P1|NOT COMPLETED|Washout Period 2||0
1577941|NCT01128595|3860386|P4|COMPLETED|Washout Period 2||7
1577942|NCT01128595|3860387|P3|COMPLETED|Washout Period 2||7
1577943|NCT01128595|3860388|P2|COMPLETED|Washout Period 2||6
1577944|NCT01128595|3860389|P1|COMPLETED|Washout Period 2||7
1577945|NCT01128595|3860386|P4|STARTED|Washout Period 2||7
1577946|NCT01128595|3860387|P3|STARTED|Washout Period 2||7
1577947|NCT01128595|3860388|P2|STARTED|Washout Period 2||6
1577948|NCT01128595|3860389|P1|STARTED|Washout Period 2||7
1577949|NCT01128595|3860386|P4|NOT COMPLETED|Treatment Period 2||0
1577950|NCT01128595|3860387|P3|NOT COMPLETED|Treatment Period 2||0
1577951|NCT01128595|3860388|P2|NOT COMPLETED|Treatment Period 2||0
1577952|NCT01128595|3860389|P1|NOT COMPLETED|Treatment Period 2||0
1577953|NCT01128595|3860386|P4|COMPLETED|Treatment Period 2||7
1577954|NCT01128595|3860387|P3|COMPLETED|Treatment Period 2||7
1577955|NCT01128595|3860388|P2|COMPLETED|Treatment Period 2||6
1577956|NCT01128595|3860389|P1|COMPLETED|Treatment Period 2||7
1577957|NCT01128595|3860386|P4|STARTED|Treatment Period 2||7
1577958|NCT01128595|3860387|P3|STARTED|Treatment Period 2||7
1577959|NCT01128595|3860388|P2|STARTED|Treatment Period 2||6
1577960|NCT01128595|3860389|P1|STARTED|Treatment Period 2||7
1577961|NCT01128595|3860386|P4|NOT COMPLETED|Washout Period 1||0
1577962|NCT01128595|3860387|P3|NOT COMPLETED|Washout Period 1||0
1577963|NCT01128595|3860388|P2|NOT COMPLETED|Washout Period 1||0
1577964|NCT01128595|3860389|P1|NOT COMPLETED|Washout Period 1||0
1577965|NCT01128595|3860386|P4|COMPLETED|Washout Period 1||7
1577966|NCT01128595|3860387|P3|COMPLETED|Washout Period 1||7
1577967|NCT01128595|3860388|P2|COMPLETED|Washout Period 1||6
1577968|NCT01128595|3860389|P1|COMPLETED|Washout Period 1||7
1577969|NCT01128595|3860386|P4|STARTED|Washout Period 1||7
1577970|NCT01128595|3860387|P3|STARTED|Washout Period 1||7
1577971|NCT01128595|3860388|P2|STARTED|Washout Period 1||6
1577972|NCT01128595|3860389|P1|STARTED|Washout Period 1||7
1577973|NCT01128595|3860386|P4|NOT COMPLETED|Treatment Period 1||0
1577974|NCT01128595|3860387|P3|NOT COMPLETED|Treatment Period 1||0
1577975|NCT01128595|3860388|P2|NOT COMPLETED|Treatment Period 1||0
1577976|NCT01128595|3860389|P1|NOT COMPLETED|Treatment Period 1||0
1577977|NCT01128595|3860386|P4|COMPLETED|Treatment Period 1||7
1577978|NCT01128595|3860387|P3|COMPLETED|Treatment Period 1||7
1577979|NCT01128595|3860388|P2|COMPLETED|Treatment Period 1||6
1577980|NCT01128595|3860389|P1|COMPLETED|Treatment Period 1||7
1577981|NCT01128595|3860386|P4|STARTED|Treatment Period 1||7
1577982|NCT01128595|3860387|P3|STARTED|Treatment Period 1||7
1577983|NCT01128595|3860388|P2|STARTED|Treatment Period 1||6
1577984|NCT01128595|3860389|P1|STARTED|Treatment Period 1||7
1577985|NCT01128569|3860419|P6|NOT COMPLETED|Treatment Period 3||0
1577986|NCT01128569|3860420|P5|NOT COMPLETED|Treatment Period 3||0
1577987|NCT01128569|3860421|P4|NOT COMPLETED|Treatment Period 3||0
1577988|NCT01128569|3860422|P3|NOT COMPLETED|Treatment Period 3||0
1577989|NCT01128569|3860423|P2|NOT COMPLETED|Treatment Period 3||0
1577990|NCT01128569|3860424|P1|NOT COMPLETED|Treatment Period 3||0
1577991|NCT01128569|3860419|P6|COMPLETED|Treatment Period 3||9
1577992|NCT01128569|3860420|P5|COMPLETED|Treatment Period 3||9
1577993|NCT01128569|3860421|P4|COMPLETED|Treatment Period 3||8
1577994|NCT01128569|3860422|P3|COMPLETED|Treatment Period 3||8
1577995|NCT01128569|3860423|P2|COMPLETED|Treatment Period 3||7
1577996|NCT01128569|3860424|P1|COMPLETED|Treatment Period 3||9
1577997|NCT01128569|3860419|P6|STARTED|Treatment Period 3||9
1577998|NCT01128569|3860420|P5|STARTED|Treatment Period 3||9
1577999|NCT01128569|3860421|P4|STARTED|Treatment Period 3||8
1578000|NCT01128569|3860422|P3|STARTED|Treatment Period 3||8
1578001|NCT01128569|3860423|P2|STARTED|Treatment Period 3||7
1578002|NCT01128569|3860424|P1|STARTED|Treatment Period 3||9
1578003|NCT01128569|3860419|P6|NOT COMPLETED|Washout Period 2||0
1578004|NCT01128569|3860420|P5|NOT COMPLETED|Washout Period 2||0
1578005|NCT01128569|3860421|P4|NOT COMPLETED|Washout Period 2||0
1578006|NCT01128569|3860422|P3|NOT COMPLETED|Washout Period 2||0
1578007|NCT01128569|3860423|P2|NOT COMPLETED|Washout Period 2||0
1578008|NCT01128569|3860424|P1|NOT COMPLETED|Washout Period 2||0
1578009|NCT01128569|3860419|P6|COMPLETED|Washout Period 2||9
1578010|NCT01128569|3860420|P5|COMPLETED|Washout Period 2||9
1578011|NCT01128569|3860421|P4|COMPLETED|Washout Period 2||8
1578012|NCT01128569|3860422|P3|COMPLETED|Washout Period 2||8
1578013|NCT01128569|3860423|P2|COMPLETED|Washout Period 2||7
1578014|NCT01128569|3860424|P1|COMPLETED|Washout Period 2||9
1578015|NCT01128569|3860419|P6|STARTED|Washout Period 2||9
1578016|NCT01128569|3860420|P5|STARTED|Washout Period 2||9
1578017|NCT01128569|3860421|P4|STARTED|Washout Period 2||8
1578018|NCT01128569|3860422|P3|STARTED|Washout Period 2||8
1578019|NCT01128569|3860423|P2|STARTED|Washout Period 2||7
1578020|NCT01128569|3860424|P1|STARTED|Washout Period 2||9
1578021|NCT01128569|3860419|P6|NOT COMPLETED|Treatment Period 2||0
1578022|NCT01128569|3860420|P5|NOT COMPLETED|Treatment Period 2||0
1578023|NCT01128569|3860421|P4|NOT COMPLETED|Treatment Period 2||0
1578024|NCT01128569|3860422|P3|NOT COMPLETED|Treatment Period 2||0
1578025|NCT01128569|3860423|P2|NOT COMPLETED|Treatment Period 2||1
1578026|NCT01128569|3860424|P1|NOT COMPLETED|Treatment Period 2||0
1578027|NCT01128569|3860419|P6|COMPLETED|Treatment Period 2||9
1578028|NCT01128569|3860420|P5|COMPLETED|Treatment Period 2||9
1578029|NCT01128569|3860421|P4|COMPLETED|Treatment Period 2||8
1578030|NCT01128569|3860422|P3|COMPLETED|Treatment Period 2||8
1578031|NCT01128569|3860423|P2|COMPLETED|Treatment Period 2||7
1578032|NCT01128569|3860424|P1|COMPLETED|Treatment Period 2||9
1578033|NCT01128569|3860419|P6|STARTED|Treatment Period 2||9
1578034|NCT01128569|3860420|P5|STARTED|Treatment Period 2||9
1578035|NCT01128569|3860421|P4|STARTED|Treatment Period 2||8
1578036|NCT01128569|3860422|P3|STARTED|Treatment Period 2||8
1578037|NCT01128569|3860423|P2|STARTED|Treatment Period 2||8
1578038|NCT01128569|3860424|P1|STARTED|Treatment Period 2||9
1578039|NCT01128569|3860419|P6|NOT COMPLETED|Washout Period 1||0
1578040|NCT01128569|3860420|P5|NOT COMPLETED|Washout Period 1||0
1578041|NCT01128569|3860421|P4|NOT COMPLETED|Washout Period 1||0
1578042|NCT01128569|3860422|P3|NOT COMPLETED|Washout Period 1||1
1578043|NCT01128569|3860423|P2|NOT COMPLETED|Washout Period 1||0
1578044|NCT01128569|3860424|P1|NOT COMPLETED|Washout Period 1||0
1578045|NCT01128569|3860419|P6|COMPLETED|Washout Period 1||9
1578046|NCT01128569|3860420|P5|COMPLETED|Washout Period 1||9
1578047|NCT01128569|3860421|P4|COMPLETED|Washout Period 1||8
1578048|NCT01128569|3860422|P3|COMPLETED|Washout Period 1||8
1578049|NCT01128569|3860423|P2|COMPLETED|Washout Period 1||8
1578050|NCT01128569|3860424|P1|COMPLETED|Washout Period 1||9
1578051|NCT01128569|3860419|P6|STARTED|Washout Period 1||9
1578052|NCT01128569|3860420|P5|STARTED|Washout Period 1||9
1578053|NCT01128569|3860421|P4|STARTED|Washout Period 1||8
1578054|NCT01128569|3860422|P3|STARTED|Washout Period 1||9
1578055|NCT01128569|3860423|P2|STARTED|Washout Period 1||8
1578056|NCT01128569|3860424|P1|STARTED|Washout Period 1||9
1578057|NCT01128569|3860419|P6|NOT COMPLETED|Treatment Period 1||0
1578058|NCT01128569|3860420|P5|NOT COMPLETED|Treatment Period 1||0
1578059|NCT01128569|3860421|P4|NOT COMPLETED|Treatment Period 1||0
1578060|NCT01128569|3860422|P3|NOT COMPLETED|Treatment Period 1||0
1578061|NCT01128569|3860423|P2|NOT COMPLETED|Treatment Period 1||0
1578062|NCT01128569|3860424|P1|NOT COMPLETED|Treatment Period 1||0
1578063|NCT01128569|3860419|P6|COMPLETED|Treatment Period 1||9
1578064|NCT01128569|3860420|P5|COMPLETED|Treatment Period 1||9
1578065|NCT01128569|3860421|P4|COMPLETED|Treatment Period 1||8
1578066|NCT01128569|3860422|P3|COMPLETED|Treatment Period 1||9
1578067|NCT01128569|3860423|P2|COMPLETED|Treatment Period 1||8
1578068|NCT01128569|3860424|P1|COMPLETED|Treatment Period 1||9
1578069|NCT01128569|3860419|P6|STARTED|Treatment Period 1||9
1578070|NCT01128569|3860420|P5|STARTED|Treatment Period 1||9
1578071|NCT01128569|3860421|P4|STARTED|Treatment Period 1||8
1578072|NCT01128569|3860422|P3|STARTED|Treatment Period 1||9
1578073|NCT01128569|3860423|P2|STARTED|Treatment Period 1||8
1578074|NCT01128569|3860424|P1|STARTED|Treatment Period 1||9
1578075|NCT01128543|3860441|P1|NOT COMPLETED|Overall Study||4
1578076|NCT01128543|3860441|P1|COMPLETED|Overall Study||25
1578077|NCT01128543|3860441|P1|STARTED|Overall Study||29
1578078|NCT01128426|3860447|P1|NOT COMPLETED|Overall Study||0
1578079|NCT01128426|3860447|P1|COMPLETED|Overall Study||53902
1578080|NCT01128426|3860447|P1|STARTED|Overall Study||53902
1578081|NCT01128413|3860467|P2|NOT COMPLETED|Overall Study||1
1578082|NCT01128413|3860468|P1|NOT COMPLETED|Overall Study||4
1578083|NCT01128413|3860467|P2|COMPLETED|Overall Study||10
1578084|NCT01128413|3860468|P1|COMPLETED|Overall Study||7
1578085|NCT01128413|3860467|P2|STARTED|Overall Study||11
1578086|NCT01128413|3860468|P1|STARTED|Overall Study||11
1578087|NCT01128400|3860477|P3|NOT COMPLETED|Overall Study||16
1578088|NCT01128400|3860478|P2|NOT COMPLETED|Overall Study||1
1578089|NCT01128400|3860479|P1|NOT COMPLETED|Overall Study||2
1578090|NCT01128400|3860477|P3|COMPLETED|Overall Study||7
1578091|NCT01128400|3860478|P2|COMPLETED|Overall Study||8
1578092|NCT01128400|3860479|P1|COMPLETED|Overall Study||6
1578093|NCT01128400|3860477|P3|STARTED|Overall Study||23
1578094|NCT01128400|3860478|P2|STARTED|Overall Study||9
1578095|NCT01128400|3860479|P1|STARTED|Overall Study||8
1578096|NCT01128387|3860492|P2|NOT COMPLETED|Overall Study||1
1578097|NCT01128387|3860493|P1|NOT COMPLETED|Overall Study||0
1578098|NCT01128387|3860492|P2|COMPLETED|Overall Study||5
1578099|NCT01128387|3860493|P1|COMPLETED|Overall Study||5
1578100|NCT01128387|3860492|P2|STARTED|Overall Study||6
1578101|NCT01128387|3860493|P1|STARTED|Overall Study||5
1578102|NCT01128361|3860503|P2|NOT COMPLETED|Overall Study||3
1578103|NCT01128361|3860504|P1|NOT COMPLETED|Overall Study||5
1578104|NCT01128361|3860503|P2|COMPLETED|Overall Study||34
1578105|NCT01128361|3860504|P1|COMPLETED|Overall Study||34
1578106|NCT01128361|3860503|P2|STARTED|Overall Study||37
1578107|NCT01128361|3860504|P1|STARTED|Overall Study||39
1578108|NCT01128296|3860516|P6|NOT COMPLETED|Overall Study||5
1578109|NCT01128296|3860517|P5|NOT COMPLETED|Overall Study||0
1578110|NCT01128296|3860518|P4|NOT COMPLETED|Overall Study||0
1578111|NCT01128296|3860519|P3|NOT COMPLETED|Overall Study||0
1578112|NCT01128296|3860520|P2|NOT COMPLETED|Overall Study||0
1578113|NCT01128296|3860521|P1|NOT COMPLETED|Overall Study||0
1578114|NCT01128296|3860516|P6|COMPLETED|Overall Study||21
1578115|NCT01128296|3860517|P5|COMPLETED|Overall Study||1
1578116|NCT01128296|3860518|P4|COMPLETED|Overall Study||1
1578117|NCT01128296|3860519|P3|COMPLETED|Overall Study||1
1578118|NCT01128296|3860520|P2|COMPLETED|Overall Study||1
1578119|NCT01128296|3860521|P1|COMPLETED|Overall Study||1
1578120|NCT01128296|3860516|P6|STARTED|Overall Study||26
1578121|NCT01128296|3860517|P5|STARTED|Overall Study||1
1578122|NCT01128296|3860518|P4|STARTED|Overall Study||1
1578123|NCT01128296|3860519|P3|STARTED|Overall Study||1
1578124|NCT01128296|3860520|P2|STARTED|Overall Study||1
1578125|NCT01128296|3860521|P1|STARTED|Overall Study||1
1578126|NCT01128270|3860539|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
1578127|NCT01128270|3860539|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
1578128|NCT01128270|3860539|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
1578129|NCT01128270|3860539|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
1578130|NCT01128270|3860539|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
1578131|NCT01128270|3860539|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
1578132|NCT01128270|3860539|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
1578133|NCT01128270|3860539|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
1578134|NCT01128270|3860539|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
1578135|NCT01128270|3860539|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
1578136|NCT01128270|3860539|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
1578137|NCT01128270|3860539|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
1578138|NCT01128244|3860552|P1|NOT COMPLETED|Overall Study||3
1578139|NCT01128244|3860552|P1|COMPLETED|Overall Study||10
1578140|NCT01128244|3860552|P1|STARTED|Overall Study||13
1578141|NCT01128192|3860562|P3|NOT COMPLETED|Overall Study||0
1578142|NCT01128192|3860563|P2|NOT COMPLETED|Overall Study||0
1578143|NCT01128192|3860564|P1|NOT COMPLETED|Overall Study||0
1578144|NCT01128192|3860562|P3|COMPLETED|Overall Study||7
1578145|NCT01128192|3860563|P2|COMPLETED|Overall Study||19
1578146|NCT01128192|3860564|P1|COMPLETED|Overall Study||19
1578147|NCT01128192|3860562|P3|STARTED|Overall Study||7
1578148|NCT01128192|3860563|P2|STARTED|Overall Study||19
1578149|NCT01128192|3860564|P1|STARTED|Overall Study||19
1578150|NCT01128179|3860593|P2|NOT COMPLETED|Overall Study||0
1578151|NCT01128179|3860594|P1|NOT COMPLETED|Overall Study||2
1578152|NCT01128179|3860593|P2|COMPLETED|Overall Study||12
1578153|NCT01128179|3860594|P1|COMPLETED|Overall Study||21
1578154|NCT01128179|3860593|P2|STARTED|Overall Study||12
1578155|NCT01128179|3860594|P1|STARTED|Overall Study||23
1578156|NCT01128153|3860614|P2|NOT COMPLETED|Overall Study||15
1578157|NCT01128153|3860615|P1|NOT COMPLETED|Overall Study||16
1578158|NCT01128153|3860614|P2|COMPLETED|Overall Study|Completed 24 weeks|113
1578159|NCT01128153|3860615|P1|COMPLETED|Overall Study|Completed 24 weeks|113
1578160|NCT01128153|3860614|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
1578161|NCT01128153|3860615|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
1578162|NCT01128153|3860614|P2|STARTED|Overall Study|Randomised|128
1578163|NCT01128153|3860615|P1|STARTED|Overall Study|Randomised|129
1578164|NCT01128114|3860631|P1|NOT COMPLETED|Overall Study||8
1578165|NCT01128114|3860631|P1|COMPLETED|Overall Study||24
1578166|NCT01128114|3860631|P1|STARTED|Overall Study||32
1578167|NCT01128049|3860638|P3|NOT COMPLETED|Overall Study||0
1578168|NCT01128049|3860639|P2|NOT COMPLETED|Overall Study||0
1578169|NCT01128049|3860640|P1|NOT COMPLETED|Overall Study||0
1578170|NCT01128049|3860638|P3|COMPLETED|Overall Study||5
1578171|NCT01128049|3860639|P2|COMPLETED|Overall Study||5
1578172|NCT01128049|3860640|P1|COMPLETED|Overall Study||5
1578173|NCT01128049|3860638|P3|STARTED|Overall Study||5
1578174|NCT01128049|3860639|P2|STARTED|Overall Study||5
1578175|NCT01128049|3860640|P1|STARTED|Overall Study||5
1578176|NCT01127763|3860648|P1|NOT COMPLETED|Overall Study||5
1578177|NCT01127763|3860648|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
1578178|NCT01127763|3860648|P1|STARTED|Overall Study||25
1578179|NCT01127737|3860659|P2|NOT COMPLETED|Overall Study||0
1578180|NCT01127737|3860660|P1|NOT COMPLETED|Overall Study||0
1578181|NCT01127737|3860659|P2|COMPLETED|Overall Study||38
1578182|NCT01127737|3860660|P1|COMPLETED|Overall Study||37
1578183|NCT01127737|3860659|P2|STARTED|Overall Study||38
1578184|NCT01127737|3860660|P1|STARTED|Overall Study||37
1578185|NCT01127659|3860672|P6|NOT COMPLETED|Overall Study||0
1578186|NCT01127659|3860673|P5|NOT COMPLETED|Overall Study||0
1578187|NCT01127659|3860674|P4|NOT COMPLETED|Overall Study||4
1578188|NCT01127659|3860675|P3|NOT COMPLETED|Overall Study||2
1578189|NCT01127659|3860676|P2|NOT COMPLETED|Overall Study||8
1578190|NCT01127659|3860677|P1|NOT COMPLETED|Overall Study||2
1578191|NCT01127659|3860672|P6|COMPLETED|Overall Study||21
1578192|NCT01127659|3860673|P5|COMPLETED|Overall Study||50
1578193|NCT01127659|3860674|P4|COMPLETED|Overall Study||6
1578194|NCT01127659|3860675|P3|COMPLETED|Overall Study||10
1578195|NCT01127659|3860676|P2|COMPLETED|Overall Study||14
1578196|NCT01127659|3860677|P1|COMPLETED|Overall Study||20
1578197|NCT01127659|3860672|P6|STARTED|Overall Study||21
1578198|NCT01127659|3860673|P5|STARTED|Overall Study||50
1578199|NCT01127659|3860674|P4|STARTED|Overall Study||10
1578200|NCT01127659|3860675|P3|STARTED|Overall Study||12
1578201|NCT01127659|3860676|P2|STARTED|Overall Study||22
1578202|NCT01127659|3860677|P1|STARTED|Overall Study||22
1578203|NCT01127646|3860693|P2|NOT COMPLETED|Overall Study||1
1578204|NCT01127646|3860694|P1|NOT COMPLETED|Overall Study||1
1578205|NCT01127646|3860693|P2|COMPLETED|Overall Study||7
1578206|NCT01127646|3860694|P1|COMPLETED|Overall Study||14
1578207|NCT01127646|3860693|P2|STARTED|Overall Study||8
1578208|NCT01127646|3860694|P1|STARTED|Overall Study||15
1578209|NCT01127633|3860728|P2|NOT COMPLETED|Overall Study||673
1578210|NCT01127633|3860729|P1|NOT COMPLETED|Overall Study||653
1578211|NCT01127633|3860728|P2|COMPLETED|Overall Study||61
1578212|NCT01127633|3860729|P1|COMPLETED|Overall Study||70
1578213|NCT01127633|3860728|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
1578214|NCT01127633|3860729|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
1578215|NCT01127633|3860728|P2|STARTED|Overall Study||734
1578216|NCT01127633|3860729|P1|STARTED|Overall Study||723
1578217|NCT01127607|3860761|P2|NOT COMPLETED|Phase II (Between Subjects)||2
1578218|NCT01127607|3860762|P1|NOT COMPLETED|Phase II (Between Subjects)||1
1578219|NCT01127607|3860761|P2|COMPLETED|Phase II (Between Subjects)||11
1578220|NCT01127607|3860762|P1|COMPLETED|Phase II (Between Subjects)||13
1578221|NCT01127607|3860761|P2|STARTED|Phase II (Between Subjects)||13
1578222|NCT01127607|3860762|P1|STARTED|Phase II (Between Subjects)||14
1578223|NCT01127607|3860761|P2|NOT COMPLETED|Phase I (Within Subjects)||0
1578224|NCT01127607|3860762|P1|NOT COMPLETED|Phase I (Within Subjects)||0
1578225|NCT01127607|3860761|P2|COMPLETED|Phase I (Within Subjects)||13
1578226|NCT01127607|3860762|P1|COMPLETED|Phase I (Within Subjects)||14
1578227|NCT01127607|3860761|P2|STARTED|Phase I (Within Subjects)||13
1578228|NCT01127607|3860762|P1|STARTED|Phase I (Within Subjects)||14
1578229|NCT01127581|3860835|P2|NOT COMPLETED|Overall Study||0
1578230|NCT01127581|3860836|P1|NOT COMPLETED|Overall Study||0
1578231|NCT01127581|3860835|P2|COMPLETED|Overall Study||680
1578232|NCT01127581|3860836|P1|COMPLETED|Overall Study||678
1578233|NCT01127581|3860835|P2|STARTED|Overall Study||680
1578234|NCT01127581|3860836|P1|STARTED|Overall Study||678
1578235|NCT01127503|3860864|P2|NOT COMPLETED|Overall Study||0
1578236|NCT01127503|3860865|P1|NOT COMPLETED|Overall Study||0
1578237|NCT01127503|3860864|P2|COMPLETED|Overall Study||1
1578238|NCT01127503|3860865|P1|COMPLETED|Overall Study||1
1578239|NCT01127503|3860864|P2|STARTED|Overall Study||1
1578240|NCT01127503|3860865|P1|STARTED|Overall Study||1
1578241|NCT01127438|3860877|P6|NOT COMPLETED|Overall Study||0
1578242|NCT01127438|3860878|P5|NOT COMPLETED|Overall Study||0
1578243|NCT01127438|3860879|P4|NOT COMPLETED|Overall Study||0
1578244|NCT01127438|3860880|P3|NOT COMPLETED|Overall Study||0
1578245|NCT01127438|3860881|P2|NOT COMPLETED|Overall Study||0
1578246|NCT01127438|3860882|P1|NOT COMPLETED|Overall Study||0
1578247|NCT01127438|3860877|P6|COMPLETED|Overall Study||25
1578248|NCT01127438|3860878|P5|COMPLETED|Overall Study||28
1578249|NCT01127438|3860879|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
1578250|NCT01127438|3860880|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
1578251|NCT01127438|3860881|P2|COMPLETED|Overall Study||25
1578252|NCT01127438|3860882|P1|COMPLETED|Overall Study||25
1578253|NCT01127438|3860877|P6|STARTED|Overall Study||25
1578254|NCT01127438|3860878|P5|STARTED|Overall Study||28
1578255|NCT01127438|3860879|P4|STARTED|Overall Study||24
1578256|NCT01127438|3860880|P3|STARTED|Overall Study||26
1578257|NCT01127438|3860881|P2|STARTED|Overall Study||25
1578258|NCT01127438|3860882|P1|STARTED|Overall Study||25
1578259|NCT01127321|3860909|P5|NOT COMPLETED|Overall Study||0
1578260|NCT01127321|3860910|P4|NOT COMPLETED|Overall Study||0
1578261|NCT01127321|3860911|P3|NOT COMPLETED|Overall Study||0
1578262|NCT01127321|3860912|P2|NOT COMPLETED|Overall Study||0
1578263|NCT01127321|3860913|P1|NOT COMPLETED|Overall Study||0
1578264|NCT01127321|3860909|P5|COMPLETED|Overall Study||5
1578265|NCT01127321|3860910|P4|COMPLETED|Overall Study||7
1578266|NCT01127321|3860911|P3|COMPLETED|Overall Study||1
1578267|NCT01127321|3860912|P2|COMPLETED|Overall Study||1
1578268|NCT01127321|3860913|P1|COMPLETED|Overall Study||3
1578269|NCT01127321|3860909|P5|STARTED|Overall Study||5
1578270|NCT01127321|3860910|P4|STARTED|Overall Study||7
1578271|NCT01127321|3860911|P3|STARTED|Overall Study||1
1578272|NCT01127321|3860912|P2|STARTED|Overall Study||1
1578273|NCT01127321|3860913|P1|STARTED|Overall Study||3
1578274|NCT01127256|3860937|P2|NOT COMPLETED|Overall Study||39
1578275|NCT01127256|3860938|P1|NOT COMPLETED|Overall Study||39
1578276|NCT01127256|3860937|P2|COMPLETED|Overall Study||65
1578277|NCT01127256|3860938|P1|COMPLETED|Overall Study||57
1578278|NCT01127256|3860937|P2|STARTED|Overall Study||104
1578279|NCT01127256|3860938|P1|STARTED|Overall Study||96
1578280|NCT01127165|3860950|P2|NOT COMPLETED|Overall Study||19
1578281|NCT01127165|3860951|P1|NOT COMPLETED|Overall Study||16
1578282|NCT01127165|3860950|P2|COMPLETED|Overall Study||41
1578283|NCT01127165|3860951|P1|COMPLETED|Overall Study||49
1578284|NCT01127165|3860950|P2|STARTED|Overall Study||60
1578285|NCT01127165|3860951|P1|STARTED|Overall Study||65
1578286|NCT01127139|3860963|P1|NOT COMPLETED|Overall Study||57
1578287|NCT01127139|3860963|P1|COMPLETED|Overall Study||3771
1578288|NCT01127139|3860963|P1|Number of Participants Analyzed|Overall Study||3828
1578289|NCT01127139|3860963|P1|STARTED|Overall Study||3828
1578290|NCT01127087|3860980|P2|NOT COMPLETED|Overall Study||0
1578291|NCT01127087|3860981|P1|NOT COMPLETED|Overall Study||0
1578292|NCT01127087|3860980|P2|COMPLETED|Overall Study||2
1578293|NCT01127087|3860981|P1|COMPLETED|Overall Study||8
1578294|NCT01127087|3860980|P2|STARTED|Overall Study||2
1578295|NCT01127087|3860981|P1|STARTED|Overall Study||8
1578296|NCT01126957|3860989|P1|NOT COMPLETED|Overall Study||0
1578297|NCT01126957|3860989|P1|COMPLETED|Overall Study||103
1578298|NCT01126957|3860989|P1|STARTED|Overall Study||103
1578299|NCT01126801|3860996|P2|NOT COMPLETED|Overall Study||0
1578300|NCT01126801|3860997|P1|NOT COMPLETED|Overall Study||0
1578301|NCT01126801|3860996|P2|COMPLETED|Overall Study||1
1578302|NCT01126801|3860997|P1|COMPLETED|Overall Study||1
1578303|NCT01126801|3860996|P2|STARTED|Overall Study||1
1578304|NCT01126801|3860997|P1|STARTED|Overall Study||1
1578305|NCT01126723|3861007|P2|NOT COMPLETED|Overall Study||3
1578306|NCT01126723|3861008|P1|NOT COMPLETED|Overall Study||6
1578307|NCT01126723|3861007|P2|COMPLETED|Overall Study||28
1578308|NCT01126723|3861008|P1|COMPLETED|Overall Study||29
1578309|NCT01126723|3861007|P2|STARTED|Overall Study||31
1578310|NCT01126723|3861008|P1|STARTED|Overall Study||35
1578311|NCT01126671|3861016|P2|NOT COMPLETED|Overall Study||1
1578312|NCT01126671|3861017|P1|NOT COMPLETED|Overall Study||2
1578313|NCT01126671|3861016|P2|COMPLETED|Overall Study||29
1578314|NCT01126671|3861017|P1|COMPLETED|Overall Study||24
1578315|NCT01126671|3861016|P2|STARTED|Overall Study||30
1578316|NCT01126671|3861017|P1|STARTED|Overall Study||26
1578317|NCT01126619|3861029|P1|NOT COMPLETED|Overall Study||17
1578318|NCT01126619|3861029|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
1578319|NCT01126619|3861029|P1|STARTED|Overall Study||103
1578320|NCT01126593|3861044|P3|NOT COMPLETED|Overall Study||2
1578321|NCT01126593|3861045|P2|NOT COMPLETED|Overall Study||2
1578322|NCT01126593|3861046|P1|NOT COMPLETED|Overall Study||4
1578323|NCT01126593|3861044|P3|COMPLETED|Overall Study||32
1578324|NCT01126593|3861045|P2|COMPLETED|Overall Study||27
1578325|NCT01126593|3861046|P1|COMPLETED|Overall Study||29
1578326|NCT01126593|3861044|P3|STARTED|Overall Study||34
1578327|NCT01126593|3861045|P2|STARTED|Overall Study||29
1578328|NCT01126593|3861046|P1|STARTED|Overall Study||33
1578329|NCT01126580|3861057|P3|NOT COMPLETED|Overall Study||55
1578330|NCT01126580|3861058|P2|NOT COMPLETED|Overall Study||52
1578331|NCT01126580|3861059|P1|NOT COMPLETED|Overall Study||49
1578332|NCT01126580|3861057|P3|COMPLETED|Overall Study||213
1578333|NCT01126580|3861058|P2|COMPLETED|Overall Study||218
1578334|NCT01126580|3861059|P1|COMPLETED|Overall Study||220
1578335|NCT01126580|3861057|P3|Completed 26 Weeks|Overall Study||226
1578336|NCT01126580|3861058|P2|Completed 26 Weeks|Overall Study||242
1578337|NCT01126580|3861059|P1|Completed 26 Weeks|Overall Study||233
1578338|NCT01126580|3861057|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
1578339|NCT01126580|3861058|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
1578340|NCT01126580|3861059|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
1578341|NCT01126580|3861057|P3|STARTED|Overall Study||268
1578342|NCT01126580|3861058|P2|STARTED|Overall Study||270
1578343|NCT01126580|3861059|P1|STARTED|Overall Study||269
1578344|NCT01126541|3861154|P3|NOT COMPLETED|Overall Study||26
1578345|NCT01126541|3861155|P2|NOT COMPLETED|Overall Study||12
1578346|NCT01126541|3861156|P1|NOT COMPLETED|Overall Study||10
1578347|NCT01126541|3861154|P3|COMPLETED|Overall Study||55
1578348|NCT01126541|3861155|P2|COMPLETED|Overall Study||61
1578349|NCT01126541|3861156|P1|COMPLETED|Overall Study||60
1578350|NCT01126541|3861154|P3|STARTED|Overall Study||81
1578351|NCT01126541|3861155|P2|STARTED|Overall Study||73
1578352|NCT01126541|3861156|P1|STARTED|Overall Study||70
1578353|NCT01126437|3861240|P3|NOT COMPLETED|Overall Study||1313
1578354|NCT01126437|3861241|P2|NOT COMPLETED|Overall Study||1330
1578355|NCT01126437|3861242|P1|NOT COMPLETED|Overall Study||1341
1578356|NCT01126437|3861240|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
1578357|NCT01126437|3861241|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
1578358|NCT01126437|3861242|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
1578359|NCT01126437|3861240|P3|STARTED|Overall Study||5713
1578360|NCT01126437|3861241|P2|STARTED|Overall Study||5729
1578361|NCT01126437|3861242|P1|STARTED|Overall Study||5741
1578362|NCT01126424|3861280|P6|NOT COMPLETED|Overall Study||0
1578363|NCT01126424|3861281|P5|NOT COMPLETED|Overall Study||2
1578364|NCT01126424|3861282|P4|NOT COMPLETED|Overall Study||3
1578365|NCT01126424|3861283|P3|NOT COMPLETED|Overall Study||1
1578366|NCT01126424|3861284|P2|NOT COMPLETED|Overall Study||0
1578367|NCT01126424|3861285|P1|NOT COMPLETED|Overall Study||0
1578368|NCT01126424|3861280|P6|COMPLETED|Overall Study||4
1578369|NCT01126424|3861281|P5|COMPLETED|Overall Study||2
1578370|NCT01126424|3861282|P4|COMPLETED|Overall Study||3
1578371|NCT01126424|3861283|P3|COMPLETED|Overall Study||4
1578372|NCT01126424|3861284|P2|COMPLETED|Overall Study||4
1578373|NCT01126424|3861285|P1|COMPLETED|Overall Study||3
1578374|NCT01126424|3861280|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1578375|NCT01126424|3861281|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1578376|NCT01126424|3861282|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1578377|NCT01126424|3861283|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1578378|NCT01126424|3861284|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1578379|NCT01126424|3861285|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
1578380|NCT01126424|3861280|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
1578381|NCT01126424|3861281|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
1578382|NCT01126424|3861282|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
1578383|NCT01126424|3861283|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
1578384|NCT01126424|3861284|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
1578385|NCT01126424|3861285|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
1578386|NCT01126359|3861308|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
1578387|NCT01126359|3861309|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
1578388|NCT01126359|3861308|P2|COMPLETED|Second Intervention (20-minutes)||5
1578389|NCT01126359|3861309|P1|COMPLETED|Second Intervention (20-minutes)||5
1578390|NCT01126359|3861308|P2|STARTED|Second Intervention (20-minutes)||5
1578391|NCT01126359|3861309|P1|STARTED|Second Intervention (20-minutes)||5
1578392|NCT01126359|3861308|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
1578393|NCT01126359|3861309|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
1578394|NCT01126359|3861308|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
1578395|NCT01126359|3861309|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
1578396|NCT01126359|3861308|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
1578397|NCT01126359|3861309|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
1578398|NCT01126359|3861308|P2|NOT COMPLETED|First Intervention (20-minutes)||1
1578399|NCT01126359|3861309|P1|NOT COMPLETED|First Intervention (20-minutes)||0
1578400|NCT01126359|3861308|P2|COMPLETED|First Intervention (20-minutes)||5
1578401|NCT01126359|3861309|P1|COMPLETED|First Intervention (20-minutes)||5
1578402|NCT01126359|3861308|P2|STARTED|First Intervention (20-minutes)||6
1578403|NCT01126359|3861309|P1|STARTED|First Intervention (20-minutes)||5
1578404|NCT01126268|3861321|P1|NOT COMPLETED|Overall Study||1
1578405|NCT01126268|3861321|P1|COMPLETED|Overall Study||37
1578406|NCT01126268|3861321|P1|STARTED|Overall Study||38
1578407|NCT01126099|3861345|P2|NOT COMPLETED|Open-label Extension||1
1578408|NCT01126099|3861346|P1|NOT COMPLETED|Open-label Extension||1
1578409|NCT01126099|3861345|P2|COMPLETED|Open-label Extension||6
1578410|NCT01126099|3861346|P1|COMPLETED|Open-label Extension||4
1578411|NCT01126099|3861345|P2|STARTED|Open-label Extension||7
1578412|NCT01126099|3861346|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
1578413|NCT01126099|3861345|P2|NOT COMPLETED|Double Blind Phase||2
1578414|NCT01126099|3861346|P1|NOT COMPLETED|Double Blind Phase||4
1578415|NCT01126099|3861345|P2|COMPLETED|Double Blind Phase||7
1578416|NCT01126099|3861346|P1|COMPLETED|Double Blind Phase||7
1578417|NCT01126099|3861345|P2|STARTED|Double Blind Phase||9
1578418|NCT01126099|3861346|P1|STARTED|Double Blind Phase||11
1578419|NCT01126060|3861360|P2|NOT COMPLETED|Overall Study||2
1578420|NCT01126060|3861361|P1|NOT COMPLETED|Overall Study||0
1578421|NCT01126060|3861360|P2|COMPLETED|Overall Study||38
1578422|NCT01126060|3861361|P1|COMPLETED|Overall Study||40
1578423|NCT01126060|3861360|P2|STARTED|Overall Study||40
1578424|NCT01126060|3861361|P1|STARTED|Overall Study||40
1578425|NCT01125930|3861369|P2|NOT COMPLETED|Overall Study||10
1578426|NCT01125930|3861370|P1|NOT COMPLETED|Overall Study||1
1578427|NCT01125930|3861369|P2|COMPLETED|Overall Study||36
1578428|NCT01125930|3861370|P1|COMPLETED|Overall Study||21
1578429|NCT01125930|3861369|P2|STARTED|Overall Study||46
1578430|NCT01125930|3861370|P1|STARTED|Overall Study||22
1578431|NCT01125917|3861524|P1|NOT COMPLETED|Overall Study||339
1578432|NCT01125917|3861524|P1|COMPLETED|Overall Study||15
1578433|NCT01125917|3861524|P1|STARTED|Overall Study||354
1578434|NCT01125813|3861528|P1|NOT COMPLETED|Overall Study||6
1578435|NCT01125813|3861528|P1|COMPLETED|Overall Study||30
1578436|NCT01125813|3861528|P1|STARTED|Overall Study||36
1578437|NCT01125800|3861538|P5|NOT COMPLETED|Phase II||11
1578438|NCT01125800|3861539|P4|NOT COMPLETED|Phase II||1
1578439|NCT01125800|3861540|P3|NOT COMPLETED|Phase II||0
1578440|NCT01125800|3861541|P2|NOT COMPLETED|Phase II||0
1578441|NCT01125800|3861542|P1|NOT COMPLETED|Phase II||0
1578442|NCT01125800|3861538|P5|COMPLETED|Phase II||5
1578443|NCT01125800|3861539|P4|COMPLETED|Phase II||0
1578444|NCT01125800|3861540|P3|COMPLETED|Phase II||0
1578445|NCT01125800|3861541|P2|COMPLETED|Phase II||0
1578446|NCT01125800|3861542|P1|COMPLETED|Phase II||0
1578447|NCT01125800|3861538|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
1578448|NCT01125800|3861539|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
1578449|NCT01125800|3861540|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
1578450|NCT01125800|3861541|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
1578451|NCT01125800|3861542|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
1578452|NCT01125800|3861538|P5|NOT COMPLETED|Phase I||0
1578453|NCT01125800|3861539|P4|NOT COMPLETED|Phase I||11
1578454|NCT01125800|3861540|P3|NOT COMPLETED|Phase I||4
1578455|NCT01125800|3861541|P2|NOT COMPLETED|Phase I||9
1578456|NCT01125800|3861542|P1|NOT COMPLETED|Phase I||8
1578457|NCT01125800|3861538|P5|COMPLETED|Phase I||0
1578458|NCT01125800|3861539|P4|COMPLETED|Phase I||10
1578459|NCT01125800|3861540|P3|COMPLETED|Phase I||7
1578460|NCT01125800|3861541|P2|COMPLETED|Phase I||7
1578461|NCT01125800|3861542|P1|COMPLETED|Phase I||3
1578462|NCT01125800|3861538|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
1578463|NCT01125800|3861539|P4|STARTED|Phase I||21
1578464|NCT01125800|3861540|P3|STARTED|Phase I||11
1578465|NCT01125800|3861541|P2|STARTED|Phase I||16
1578466|NCT01125800|3861542|P1|STARTED|Phase I||11
1578467|NCT01125774|3861581|P4|NOT COMPLETED|Overall Study||3
1578468|NCT01125774|3861582|P3|NOT COMPLETED|Overall Study||9
1578469|NCT01125774|3861583|P2|NOT COMPLETED|Overall Study||554
1578470|NCT01125774|3861584|P1|NOT COMPLETED|Overall Study||1125
1578471|NCT01125774|3861581|P4|COMPLETED|Overall Study|Completed study at least once|3
1578472|NCT01125774|3861582|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
1578473|NCT01125774|3861583|P2|COMPLETED|Overall Study||948
1578474|NCT01125774|3861584|P1|COMPLETED|Overall Study||1893
1578475|NCT01125774|3861581|P4|Treated|Overall Study||5
1578476|NCT01125774|3861582|P3|Treated|Overall Study|Received telcagepant|21
1578477|NCT01125774|3861583|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
1578478|NCT01125774|3861584|P1|Treated|Overall Study||2638
1578479|NCT01125774|3861581|P4|STARTED|Overall Study|Unique participants randomized|6
1578480|NCT01125774|3861582|P3|STARTED|Overall Study|Unique participants randomized|22
1578481|NCT01125774|3861583|P2|STARTED|Overall Study|Randomized|1502
1578482|NCT01125774|3861584|P1|STARTED|Overall Study|Randomized|3018
1578483|NCT01125748|3861608|P2|NOT COMPLETED|Overall Study||14
1578484|NCT01125748|3861609|P1|NOT COMPLETED|Overall Study||10
1578485|NCT01125748|3861608|P2|COMPLETED|Overall Study||74
1578486|NCT01125748|3861609|P1|COMPLETED|Overall Study||78
1578487|NCT01125748|3861608|P2|STARTED|Overall Study||88
1578488|NCT01125748|3861609|P1|STARTED|Overall Study||88
1578489|NCT01125722|3861619|P2|NOT COMPLETED|Overall Study||1
1578490|NCT01125722|3861620|P1|NOT COMPLETED|Overall Study||3
1578491|NCT01125722|3861619|P2|COMPLETED|Overall Study||36
1578492|NCT01125722|3861620|P1|COMPLETED|Overall Study||34
1578493|NCT01125722|3861619|P2|STARTED|Overall Study||37
1578494|NCT01125722|3861620|P1|STARTED|Overall Study||37
1578495|NCT01125605|3861634|P1|NOT COMPLETED|Overall Study||0
1578496|NCT01125605|3861634|P1|COMPLETED|Overall Study||325
1578497|NCT01125605|3861634|P1|Safety|Overall Study|1 patient was only analysed for safety|326
1578498|NCT01125605|3861634|P1|STARTED|Overall Study|started = had baseline values|325
1578499|NCT01125566|3861667|P3|NOT COMPLETED|Patients Who Switched From AV to TV||24
1578500|NCT01125566|3861668|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
1578501|NCT01125566|3861669|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
1578502|NCT01125566|3861667|P3|COMPLETED|Patients Who Switched From AV to TV|On TV treatment at analysis cut-off date (03Sep2013)|49
1578503|NCT01125566|3861668|P2|COMPLETED|Patients Who Switched From AV to TV||0
1578504|NCT01125566|3861669|P1|COMPLETED|Patients Who Switched From AV to TV||0
1578505|NCT01125566|3861667|P3|STARTED|Patients Who Switched From AV to TV|All patients without disease progression who chose to switch from AV to TV by 08Jun2013|73
1578506|NCT01125566|3861668|P2|STARTED|Patients Who Switched From AV to TV||0
1578507|NCT01125566|3861669|P1|STARTED|Patients Who Switched From AV to TV||0
1578508|NCT01125566|3861667|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
1578509|NCT01125566|3861668|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||136
1578510|NCT01125566|3861669|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||260
1578511|NCT01125566|3861667|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
1578512|NCT01125566|3861668|P2|COMPLETED|Patients Before the Switch (26Apr2013)|On treatment at analysis cut-off date (03Sep2013)|33
1578513|NCT01125566|3861669|P1|COMPLETED|Patients Before the Switch (26Apr2013)|All patients without disease progression who were on treatment on 08Jun2013|79
1578514|NCT01125566|3861667|P3|STARTED|Patients Before the Switch (26Apr2013)||0
1578515|NCT01125566|3861668|P2|STARTED|Patients Before the Switch (26Apr2013)|Randomised|169
1578516|NCT01125566|3861669|P1|STARTED|Patients Before the Switch (26Apr2013)|Randomised|339
1578517|NCT01125514|3861682|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
1578518|NCT01125514|3861682|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
1578519|NCT01125514|3861682|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
1578520|NCT01125514|3861682|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
1578521|NCT01125514|3861682|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
1578522|NCT01125514|3861682|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
1578523|NCT01125514|3861682|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
1578524|NCT01125514|3861682|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
1578525|NCT01125514|3861682|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
1578526|NCT01125514|3861682|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
1578527|NCT01125514|3861682|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
1578528|NCT01125202|3861756|P2|NOT COMPLETED|Overall Study||7
1578529|NCT01125202|3861757|P1|NOT COMPLETED|Overall Study||12
1578530|NCT01125202|3861756|P2|COMPLETED|Overall Study||79
1578531|NCT01125202|3861757|P1|COMPLETED|Overall Study||81
1578532|NCT01125202|3861756|P2|STARTED|Overall Study||86
1578533|NCT01125202|3861757|P1|STARTED|Overall Study||93
1578534|NCT01125189|3861782|P3|NOT COMPLETED|Follow up Period||16
1578535|NCT01125189|3861783|P2|NOT COMPLETED|Follow up Period||15
1578536|NCT01125189|3861784|P1|NOT COMPLETED|Follow up Period||20
1578537|NCT01125189|3861782|P3|COMPLETED|Follow up Period||58
1578538|NCT01125189|3861783|P2|COMPLETED|Follow up Period||138
1578539|NCT01125189|3861784|P1|COMPLETED|Follow up Period||132
1578540|NCT01125189|3861782|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
1578541|NCT01125189|3861783|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
1578542|NCT01125189|3861784|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
1578543|NCT01125189|3861782|P3|NOT COMPLETED|Treatment Period||41
1578544|NCT01125189|3861783|P2|NOT COMPLETED|Treatment Period||35
1578545|NCT01125189|3861784|P1|NOT COMPLETED|Treatment Period||31
1578546|NCT01125189|3861782|P3|COMPLETED|Treatment Period||37
1578547|NCT01125189|3861783|P2|COMPLETED|Treatment Period||123
1578548|NCT01125189|3861784|P1|COMPLETED|Treatment Period||128
1578549|NCT01125189|3861782|P3|STARTED|Treatment Period||78
1578550|NCT01125189|3861783|P2|STARTED|Treatment Period||158
1578551|NCT01125189|3861784|P1|STARTED|Treatment Period||159
1578552|NCT01125098|3861812|P2|NOT COMPLETED|Overall Study||0
1578553|NCT01125098|3861813|P1|NOT COMPLETED|Overall Study||3
1578554|NCT01125098|3861812|P2|COMPLETED|Overall Study||90
1578555|NCT01125098|3861813|P1|COMPLETED|Overall Study||88
1578556|NCT01125098|3861812|P2|STARTED|Overall Study||90
1578557|NCT01125098|3861813|P1|STARTED|Overall Study||91
1578558|NCT01124955|3861821|P2|NOT COMPLETED|Overall Study||0
1578559|NCT01124955|3861822|P1|NOT COMPLETED|Overall Study||0
1578560|NCT01124955|3861821|P2|COMPLETED|Overall Study||40
1578561|NCT01124955|3861822|P1|COMPLETED|Overall Study||40
1578562|NCT01124955|3861821|P2|STARTED|Overall Study||40
1578563|NCT01124955|3861822|P1|STARTED|Overall Study||40
1578564|NCT01124916|3861838|P2|NOT COMPLETED|Overall Study||2
1578565|NCT01124916|3861839|P1|NOT COMPLETED|Overall Study||3
1578566|NCT01124916|3861838|P2|COMPLETED|Overall Study||38
1578567|NCT01124916|3861839|P1|COMPLETED|Overall Study||35
1578568|NCT01124916|3861838|P2|STARTED|Overall Study||40
1578569|NCT01124916|3861839|P1|STARTED|Overall Study||38
1578570|NCT01124864|3861853|P6|NOT COMPLETED|Overall Study||3
1578571|NCT01124864|3861854|P5|NOT COMPLETED|Overall Study||30
1578572|NCT01124864|3861855|P4|NOT COMPLETED|Overall Study||21
1578573|NCT01124864|3861856|P3|NOT COMPLETED|Overall Study||34
1578574|NCT01124864|3861857|P2|NOT COMPLETED|Overall Study||35
1578575|NCT01124864|3861858|P1|NOT COMPLETED|Overall Study||28
1578576|NCT01124864|3861853|P6|COMPLETED|Overall Study||0
1578577|NCT01124864|3861854|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
1578578|NCT01124864|3861855|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
1578579|NCT01124864|3861856|P3|COMPLETED|Overall Study||0
1578580|NCT01124864|3861857|P2|COMPLETED|Overall Study||0
1578581|NCT01124864|3861858|P1|COMPLETED|Overall Study||0
1578582|NCT01124864|3861853|P6|STARTED|Overall Study||3
1578583|NCT01124864|3861854|P5|STARTED|Overall Study||31
1578584|NCT01124864|3861855|P4|STARTED|Overall Study||22
1578585|NCT01124864|3861856|P3|STARTED|Overall Study||34
1578586|NCT01124864|3861857|P2|STARTED|Overall Study||35
1578587|NCT01124864|3861858|P1|STARTED|Overall Study||28
1578588|NCT01124838|3861892|P2|NOT COMPLETED|Overall Study||15
1578589|NCT01124838|3861893|P1|NOT COMPLETED|Overall Study||18
1578590|NCT01124838|3861892|P2|COMPLETED|Overall Study||116
1578591|NCT01124838|3861893|P1|COMPLETED|Overall Study||112
1578592|NCT01124838|3861892|P2|Enrolled in Japan Sub-study|Overall Study||16
1578593|NCT01124838|3861893|P1|Enrolled in Japan Sub-study|Overall Study||16
1578594|NCT01124838|3861892|P2|Enrolled in Main Study|Overall Study||115
1578595|NCT01124838|3861893|P1|Enrolled in Main Study|Overall Study||114
1578596|NCT01124838|3861892|P2|STARTED|Overall Study||131
1578597|NCT01124838|3861893|P1|STARTED|Overall Study||130
1578598|NCT01124786|3861939|P2|NOT COMPLETED|Overall Study||5
1578599|NCT01124786|3861940|P1|NOT COMPLETED|Overall Study||4
1578600|NCT01124786|3861939|P2|COMPLETED|Overall Study||180
1578601|NCT01124786|3861940|P1|COMPLETED|Overall Study||178
1578602|NCT01124786|3861939|P2|Tumor Evaluable Population|Overall Study||180
1578603|NCT01124786|3861940|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
1578604|NCT01124786|3861939|P2|Safety Population|Overall Study||181
1578605|NCT01124786|3861940|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
1578606|NCT01124786|3861939|P2|Intent-to-Treat (ITT) Population|Overall Study||185
1578607|NCT01124786|3861940|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
1578608|NCT01124786|3861939|P2|STARTED|Overall Study||185
1578609|NCT01124786|3861940|P1|STARTED|Overall Study||182
1578610|NCT01124643|3861960|P1|NOT COMPLETED|Overall Study||1
1578611|NCT01124643|3861960|P1|COMPLETED|Overall Study||34
1578612|NCT01124643|3861960|P1|STARTED|Overall Study||35
1578613|NCT01124617|3861974|P2|NOT COMPLETED|Overall Study||6
1578614|NCT01124617|3861975|P1|NOT COMPLETED|Overall Study||19
1578615|NCT01124617|3861974|P2|COMPLETED|Overall Study||25
1578616|NCT01124617|3861975|P1|COMPLETED|Overall Study||41
1578617|NCT01124617|3861974|P2|STARTED|Overall Study||31
1578618|NCT01124617|3861975|P1|STARTED|Overall Study||60
1578619|NCT01124604|3862007|P2|NOT COMPLETED|Overall Study||2
1578620|NCT01124604|3862008|P1|NOT COMPLETED|Overall Study||15
1578621|NCT01124604|3862007|P2|COMPLETED|Overall Study||29
1578622|NCT01124604|3862008|P1|COMPLETED|Overall Study||45
1578623|NCT01124604|3862007|P2|STARTED|Overall Study||31
1578624|NCT01124604|3862008|P1|STARTED|Overall Study||60
1578625|NCT01124448|3862047|P2|NOT COMPLETED|Overall Study||3
1578626|NCT01124448|3862048|P1|NOT COMPLETED|Overall Study||2
1578627|NCT01124448|3862047|P2|COMPLETED|Overall Study||12
1578628|NCT01124448|3862048|P1|COMPLETED|Overall Study||23
1578629|NCT01124448|3862047|P2|STARTED|Overall Study||15
1578630|NCT01124448|3862048|P1|STARTED|Overall Study||25
1578631|NCT01124422|3862056|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
1578632|NCT01124422|3862057|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
1578633|NCT01124422|3862058|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
1578634|NCT01124422|3862056|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
1578635|NCT01124422|3862057|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
1578636|NCT01124422|3862058|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
1578637|NCT01124422|3862056|P3|STARTED|4-Week Double-blind Treatment Phase||124
1578638|NCT01124422|3862057|P2|STARTED|4-Week Double-blind Treatment Phase||131
1578639|NCT01124422|3862058|P1|STARTED|4-Week Double-blind Treatment Phase||0
1578640|NCT01124422|3862056|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
1578641|NCT01124422|3862057|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
1578642|NCT01124422|3862058|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
1578643|NCT01124422|3862056|P3|COMPLETED|4-Week Open-label Run-in Phase||0
1578644|NCT01124422|3862057|P2|COMPLETED|4-Week Open-label Run-in Phase||0
1578645|NCT01124422|3862058|P1|COMPLETED|4-Week Open-label Run-in Phase||255
1578646|NCT01124422|3862056|P3|STARTED|4-Week Open-label Run-in Phase||0
1578647|NCT01124422|3862057|P2|STARTED|4-Week Open-label Run-in Phase||0
1578648|NCT01124422|3862058|P1|STARTED|4-Week Open-label Run-in Phase||338
1578649|NCT01124370|3862100|P1|NOT COMPLETED|Overall Study||20
1578650|NCT01124370|3862100|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
1578651|NCT01124370|3862100|P1|3 Month Visit|Overall Study|Defines evaluable population|47
1578652|NCT01124370|3862100|P1|Therapy Initiated|Overall Study||48
1578653|NCT01124370|3862100|P1|Successfully Implanted|Overall Study||50
1578654|NCT01124370|3862100|P1|STARTED|Overall Study|Underwent implant attempt|57
1578655|NCT01124305|3862112|P2|NOT COMPLETED|Overall Study||10
1578656|NCT01124305|3862113|P1|NOT COMPLETED|Overall Study||8
1578657|NCT01124305|3862112|P2|COMPLETED|Overall Study||26
1578658|NCT01124305|3862113|P1|COMPLETED|Overall Study||26
1578659|NCT01124305|3862112|P2|STARTED|Overall Study||36
1578660|NCT01124305|3862113|P1|STARTED|Overall Study||34
1578661|NCT01124292|3862128|P3|NOT COMPLETED|Overall Study||10
1578662|NCT01124292|3862129|P2|NOT COMPLETED|Overall Study||15
1578663|NCT01124292|3862130|P1|NOT COMPLETED|Overall Study||2
1578664|NCT01124292|3862128|P3|COMPLETED|Overall Study||11
1578665|NCT01124292|3862129|P2|COMPLETED|Overall Study||9
1578666|NCT01124292|3862130|P1|COMPLETED|Overall Study||14
1578667|NCT01124292|3862128|P3|STARTED|Overall Study||21
1578668|NCT01124292|3862129|P2|STARTED|Overall Study||24
1578669|NCT01124292|3862130|P1|STARTED|Overall Study||16
1578670|NCT01124188|3862188|P2|NOT COMPLETED|Overall Study||6
1578671|NCT01124188|3862189|P1|NOT COMPLETED|Overall Study||8
1578672|NCT01124188|3862188|P2|COMPLETED|Overall Study||65
1578673|NCT01124188|3862189|P1|COMPLETED|Overall Study||60
1578674|NCT01124188|3862188|P2|STARTED|Overall Study||71
1578675|NCT01124188|3862189|P1|STARTED|Overall Study||68
1578676|NCT01124175|3862201|P2|NOT COMPLETED|Second Intervention||0
1578677|NCT01124175|3862202|P1|NOT COMPLETED|Second Intervention||0
1578678|NCT01124175|3862201|P2|COMPLETED|Second Intervention||38
1578679|NCT01124175|3862202|P1|COMPLETED|Second Intervention||40
1578680|NCT01124175|3862201|P2|STARTED|Second Intervention||38
1578681|NCT01124175|3862202|P1|STARTED|Second Intervention||40
1578682|NCT01124175|3862201|P2|NOT COMPLETED|Washout of 7 Days||2
1578683|NCT01124175|3862202|P1|NOT COMPLETED|Washout of 7 Days||0
1578684|NCT01124175|3862201|P2|COMPLETED|Washout of 7 Days||38
1578685|NCT01124175|3862202|P1|COMPLETED|Washout of 7 Days||40
1578686|NCT01124175|3862201|P2|STARTED|Washout of 7 Days||40
1578687|NCT01124175|3862202|P1|STARTED|Washout of 7 Days||40
1578688|NCT01124175|3862201|P2|NOT COMPLETED|First Intervention||0
1578689|NCT01124175|3862202|P1|NOT COMPLETED|First Intervention||0
1578690|NCT01124175|3862201|P2|COMPLETED|First Intervention||40
1578691|NCT01124175|3862202|P1|COMPLETED|First Intervention||40
1578692|NCT01124175|3862201|P2|STARTED|First Intervention||40
1578693|NCT01124175|3862202|P1|STARTED|First Intervention||40
1578694|NCT01124162|3862220|P2|NOT COMPLETED|Second Intervention||0
1578695|NCT01124162|3862221|P1|NOT COMPLETED|Second Intervention||0
1578696|NCT01124162|3862220|P2|COMPLETED|Second Intervention||40
1578697|NCT01124162|3862221|P1|COMPLETED|Second Intervention||37
1578698|NCT01124162|3862220|P2|STARTED|Second Intervention||40
1578699|NCT01124162|3862221|P1|STARTED|Second Intervention||37
1578700|NCT01124162|3862220|P2|NOT COMPLETED|Washout of 7 Days||0
1578701|NCT01124162|3862221|P1|NOT COMPLETED|Washout of 7 Days||1
1578702|NCT01124162|3862220|P2|COMPLETED|Washout of 7 Days||40
1578703|NCT01124162|3862221|P1|COMPLETED|Washout of 7 Days||37
1578704|NCT01124162|3862220|P2|STARTED|Washout of 7 Days||40
1578705|NCT01124162|3862221|P1|STARTED|Washout of 7 Days||38
1578706|NCT01124162|3862220|P2|NOT COMPLETED|First Intervention||0
1578707|NCT01124162|3862221|P1|NOT COMPLETED|First Intervention||2
1578708|NCT01124162|3862220|P2|COMPLETED|First Intervention||40
1578709|NCT01124162|3862221|P1|COMPLETED|First Intervention||38
1578710|NCT01124162|3862220|P2|STARTED|First Intervention||40
1578711|NCT01124162|3862221|P1|STARTED|First Intervention||40
1578712|NCT01124149|3862237|P1|NOT COMPLETED|Maintenance Phase||96
1578713|NCT01124149|3862237|P1|COMPLETED|Maintenance Phase||373
1578714|NCT01124149|3862237|P1|STARTED|Maintenance Phase||469
1578715|NCT01124149|3862237|P1|NOT COMPLETED|Acute Phase||83
1578716|NCT01124149|3862237|P1|COMPLETED|Acute Phase||639
1578717|NCT01124149|3862237|P1|STARTED|Acute Phase||722
1578718|NCT01124097|3862257|P4|NOT COMPLETED|Overall Study||14
1578719|NCT01124097|3862258|P3|NOT COMPLETED|Overall Study||20
1578720|NCT01124097|3862259|P2|NOT COMPLETED|Overall Study||22
1578721|NCT01124097|3862260|P1|NOT COMPLETED|Overall Study||34
1578722|NCT01124097|3862257|P4|COMPLETED|Overall Study||46
1578723|NCT01124097|3862258|P3|COMPLETED|Overall Study||40
1578724|NCT01124097|3862259|P2|COMPLETED|Overall Study||38
1578725|NCT01124097|3862260|P1|COMPLETED|Overall Study||26
1578726|NCT01124097|3862257|P4|Efficacy Population|Overall Study||51
1578727|NCT01124097|3862258|P3|Efficacy Population|Overall Study||53
1578728|NCT01124097|3862259|P2|Efficacy Population|Overall Study||53
1578729|NCT01124097|3862260|P1|Efficacy Population|Overall Study||52
1578730|NCT01124097|3862257|P4|Safety Population|Overall Study||60
1578731|NCT01124097|3862258|P3|Safety Population|Overall Study||60
1578732|NCT01124097|3862259|P2|Safety Population|Overall Study||60
1578733|NCT01124097|3862260|P1|Safety Population|Overall Study||60
1578734|NCT01124097|3862257|P4|STARTED|Overall Study||60
1578735|NCT01124097|3862258|P3|STARTED|Overall Study||60
1578736|NCT01124097|3862259|P2|STARTED|Overall Study||60
1578737|NCT01124097|3862260|P1|STARTED|Overall Study||60
1578738|NCT01124045|3862272|P2|NOT COMPLETED|Overall Study||3
1578739|NCT01124045|3862273|P1|NOT COMPLETED|Overall Study||0
1578740|NCT01124045|3862272|P2|COMPLETED|Overall Study||37
1578741|NCT01124045|3862273|P1|COMPLETED|Overall Study||39
1578742|NCT01124045|3862272|P2|STARTED|Overall Study||40
1578743|NCT01124045|3862273|P1|STARTED|Overall Study||39
1578744|NCT01124006|3862306|P3|NOT COMPLETED|Overall Study||2
1578745|NCT01124006|3862307|P2|NOT COMPLETED|Overall Study||2
1578746|NCT01124006|3862308|P1|NOT COMPLETED|Overall Study||3
1578747|NCT01124006|3862306|P3|COMPLETED|Overall Study||2
1578748|NCT01124006|3862307|P2|COMPLETED|Overall Study||8
1578749|NCT01124006|3862308|P1|COMPLETED|Overall Study||7
1578750|NCT01124006|3862306|P3|STARTED|Overall Study||4
1578751|NCT01124006|3862307|P2|STARTED|Overall Study||10
1578752|NCT01124006|3862308|P1|STARTED|Overall Study||10
1578753|NCT01123980|3862336|P2|NOT COMPLETED|Overall Study||24
1578754|NCT01123980|3862337|P1|NOT COMPLETED|Overall Study||19
1578755|NCT01123980|3862336|P2|COMPLETED|Overall Study||236
1578756|NCT01123980|3862337|P1|COMPLETED|Overall Study||242
1578757|NCT01123980|3862336|P2|STARTED|Overall Study||260
1578758|NCT01123980|3862337|P1|STARTED|Overall Study||261
1578759|NCT01123941|3862357|P2|NOT COMPLETED|Overall Study||1
1578760|NCT01123941|3862358|P1|NOT COMPLETED|Overall Study||2
1578761|NCT01123941|3862357|P2|COMPLETED|Overall Study||24
1578762|NCT01123941|3862358|P1|COMPLETED|Overall Study||23
1578763|NCT01123941|3862357|P2|STARTED|Overall Study||25
1578764|NCT01123941|3862358|P1|STARTED|Overall Study||25
1578765|NCT01123928|3862372|P2|NOT COMPLETED|Overall Study||0
1578766|NCT01123928|3862373|P1|NOT COMPLETED|Overall Study||0
1578767|NCT01123928|3862372|P2|COMPLETED|Overall Study||222
1578768|NCT01123928|3862373|P1|COMPLETED|Overall Study||212
1578769|NCT01123928|3862372|P2|STARTED|Overall Study||222
1578770|NCT01123928|3862373|P1|STARTED|Overall Study||212
1578771|NCT01123889|3862393|P2|NOT COMPLETED|Overall Study||1
1578772|NCT01123889|3862394|P1|NOT COMPLETED|Overall Study||3
1578773|NCT01123889|3862393|P2|COMPLETED|Overall Study||6
1578774|NCT01123889|3862394|P1|COMPLETED|Overall Study||2
1578775|NCT01123889|3862393|P2|STARTED|Overall Study||7
1578776|NCT01123889|3862394|P1|STARTED|Overall Study||5
1578777|NCT01123850|3862404|P1|NOT COMPLETED|Overall Study||45
1578778|NCT01123850|3862404|P1|COMPLETED|Overall Study||0
1578779|NCT01123850|3862404|P1|STARTED|Overall Study||45
1578780|NCT01123642|3862409|P1|NOT COMPLETED|Overall Study||68
1578781|NCT01123642|3862409|P1|COMPLETED|Overall Study||277
1578782|NCT01123642|3862409|P1|STARTED|Overall Study||345
1578783|NCT01123512|3862418|P2|NOT COMPLETED|Overall Study||21
1578784|NCT01123512|3862419|P1|NOT COMPLETED|Overall Study||26
1578785|NCT01123512|3862418|P2|COMPLETED|Overall Study||126
1578786|NCT01123512|3862419|P1|COMPLETED|Overall Study||127
1578787|NCT01123512|3862418|P2|STARTED|Overall Study||147
1578788|NCT01123512|3862419|P1|STARTED|Overall Study||153
1578789|NCT01123395|3862425|P2|NOT COMPLETED|Period 2||0
1578790|NCT01123395|3862426|P1|NOT COMPLETED|Period 2||0
1578791|NCT01123395|3862425|P2|COMPLETED|Period 2||7
1578792|NCT01123395|3862426|P1|COMPLETED|Period 2||8
1578793|NCT01123395|3862425|P2|STARTED|Period 2||7
1578794|NCT01123395|3862426|P1|STARTED|Period 2||8
1578795|NCT01123395|3862425|P2|NOT COMPLETED|Washout Period of 14 Days||1
1578796|NCT01123395|3862426|P1|NOT COMPLETED|Washout Period of 14 Days||0
1578797|NCT01123395|3862425|P2|COMPLETED|Washout Period of 14 Days||7
1578798|NCT01123395|3862426|P1|COMPLETED|Washout Period of 14 Days||8
1578799|NCT01123395|3862425|P2|STARTED|Washout Period of 14 Days||8
1578800|NCT01123395|3862426|P1|STARTED|Washout Period of 14 Days||8
1578801|NCT01123395|3862425|P2|NOT COMPLETED|Period 1||0
1578802|NCT01123395|3862426|P1|NOT COMPLETED|Period 1||0
1578803|NCT01123395|3862425|P2|COMPLETED|Period 1||8
1578804|NCT01123395|3862426|P1|COMPLETED|Period 1||8
1578805|NCT01123395|3862425|P2|STARTED|Period 1||8
1578806|NCT01123395|3862426|P1|STARTED|Period 1||8
1578807|NCT01123382|3862438|P2|NOT COMPLETED|Overall Study||6
1578808|NCT01123382|3862439|P1|NOT COMPLETED|Overall Study||2
1578809|NCT01123382|3862438|P2|COMPLETED|Overall Study||6
1578810|NCT01123382|3862439|P1|COMPLETED|Overall Study||11
1578811|NCT01123382|3862438|P2|Received Intervention|Overall Study||10
1578812|NCT01123382|3862439|P1|Received Intervention|Overall Study||12
1578813|NCT01123382|3862438|P2|STARTED|Overall Study||12
1578814|NCT01123382|3862439|P1|STARTED|Overall Study||13
1578815|NCT01123356|3862461|P1|NOT COMPLETED|Overall Study||7
1578816|NCT01123356|3862461|P1|COMPLETED|Overall Study||14
1578817|NCT01123356|3862461|P1|STARTED|Overall Study||21
1578818|NCT01123200|3862469|P1|NOT COMPLETED|Overall Study||1
1578819|NCT01123200|3862469|P1|COMPLETED|Overall Study||0
1578820|NCT01123200|3862469|P1|STARTED|Overall Study||1
1578821|NCT01123161|3862476|P2|NOT COMPLETED|Overall Study||0
1578822|NCT01123161|3862477|P1|NOT COMPLETED|Overall Study||2
1578823|NCT01123161|3862476|P2|COMPLETED|Overall Study||63
1578824|NCT01123161|3862477|P1|COMPLETED|Overall Study||55
1578825|NCT01123161|3862476|P2|STARTED|Overall Study||63
1578826|NCT01123161|3862477|P1|STARTED|Overall Study||57
1578827|NCT01123148|3862495|P1|NOT COMPLETED|Overall Study||2
1578828|NCT01123148|3862495|P1|COMPLETED|Overall Study||12
1578829|NCT01123148|3862495|P1|BCI Calibration >50% Accuracy|Overall Study||13
1578830|NCT01123148|3862495|P1|STARTED|Overall Study||14
1578831|NCT01123083|3862501|P2|NOT COMPLETED|Overall Study||15
1578832|NCT01123083|3862502|P1|NOT COMPLETED|Overall Study||11
1578833|NCT01123083|3862501|P2|COMPLETED|Overall Study||103
1578834|NCT01123083|3862502|P1|COMPLETED|Overall Study||50
1578835|NCT01123083|3862501|P2|STARTED|Overall Study||118
1578836|NCT01123083|3862502|P1|STARTED|Overall Study||61
1578837|NCT01122927|3862526|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
1578838|NCT01122927|3862527|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
1578839|NCT01122927|3862526|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
1578840|NCT01122927|3862527|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
1578841|NCT01122927|3862526|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
1578842|NCT01122927|3862527|P1|STARTED|Period 2- Open-label Treatment Phase||0
1578843|NCT01122927|3862526|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
1578844|NCT01122927|3862527|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
1578845|NCT01122927|3862526|P2|COMPLETED|Period 1 - Conversion Phase||0
1578846|NCT01122927|3862527|P1|COMPLETED|Period 1 - Conversion Phase||283
1578847|NCT01122927|3862526|P2|STARTED|Period 1 - Conversion Phase||0
1578848|NCT01122927|3862527|P1|STARTED|Period 1 - Conversion Phase||297
1578849|NCT01122901|3862560|P2|NOT COMPLETED|Overall Study||0
1578850|NCT01122901|3862561|P1|NOT COMPLETED|Overall Study||0
1578851|NCT01122901|3862560|P2|COMPLETED|Overall Study||7
1578852|NCT01122901|3862561|P1|COMPLETED|Overall Study||40
1578853|NCT01122901|3862560|P2|STARTED|Overall Study||7
1578854|NCT01122901|3862561|P1|STARTED|Overall Study||40
1578855|NCT01122862|3862579|P3|NOT COMPLETED|Period 3||0
1578856|NCT01122862|3862580|P2|NOT COMPLETED|Period 3||0
1578857|NCT01122862|3862581|P1|NOT COMPLETED|Period 3||0
1578858|NCT01122862|3862579|P3|COMPLETED|Period 3||8
1578859|NCT01122862|3862580|P2|COMPLETED|Period 3||7
1578860|NCT01122862|3862581|P1|COMPLETED|Period 3||6
1578861|NCT01122862|3862579|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
1578862|NCT01122862|3862580|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
1578863|NCT01122862|3862581|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
1578864|NCT01122862|3862579|P3|NOT COMPLETED|Period 2||1
1578865|NCT01122862|3862580|P2|NOT COMPLETED|Period 2||0
1578866|NCT01122862|3862581|P1|NOT COMPLETED|Period 2||0
1578867|NCT01122862|3862579|P3|COMPLETED|Period 2||6
1578868|NCT01122862|3862580|P2|COMPLETED|Period 2||7
1578869|NCT01122862|3862581|P1|COMPLETED|Period 2||8
1578870|NCT01122862|3862579|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
1578871|NCT01122862|3862580|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
1578872|NCT01122862|3862581|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
1578873|NCT01122862|3862579|P3|NOT COMPLETED|Period 1||0
1578874|NCT01122862|3862580|P2|NOT COMPLETED|Period 1||1
1578875|NCT01122862|3862581|P1|NOT COMPLETED|Period 1||0
1578876|NCT01122862|3862579|P3|COMPLETED|Period 1||7
1578877|NCT01122862|3862580|P2|COMPLETED|Period 1||7
1578878|NCT01122862|3862581|P1|COMPLETED|Period 1||8
1578879|NCT01122862|3862579|P3|STARTED|Period 1||7
1578880|NCT01122862|3862580|P2|STARTED|Period 1||8
1578881|NCT01122862|3862581|P1|STARTED|Period 1||8
1578882|NCT01122849|3862602|P3|NOT COMPLETED|Overall Study||0
1578883|NCT01122849|3862603|P2|NOT COMPLETED|Overall Study||0
1578884|NCT01122849|3862604|P1|NOT COMPLETED|Overall Study||0
1578885|NCT01122849|3862602|P3|COMPLETED|Overall Study||20
1578886|NCT01122849|3862603|P2|COMPLETED|Overall Study||21
1578887|NCT01122849|3862604|P1|COMPLETED|Overall Study||20
1578888|NCT01122849|3862602|P3|STARTED|Overall Study||20
1578889|NCT01122849|3862603|P2|STARTED|Overall Study||21
1578890|NCT01122849|3862604|P1|STARTED|Overall Study||20
1578891|NCT01122680|3862687|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
1578892|NCT01122680|3862688|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
1578893|NCT01122680|3862689|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
1578894|NCT01122680|3862690|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
1578895|NCT01122680|3862687|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
1578896|NCT01122680|3862688|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
1578897|NCT01122680|3862689|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
1578898|NCT01122680|3862690|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
1578899|NCT01122680|3862687|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
1578900|NCT01122680|3862688|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
1578901|NCT01122680|3862689|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
1578902|NCT01122680|3862690|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
1578903|NCT01122680|3862687|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
1578904|NCT01122680|3862688|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
1578905|NCT01122680|3862689|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
1578906|NCT01122680|3862690|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
1578907|NCT01122680|3862687|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
1578908|NCT01122680|3862688|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
1578909|NCT01122680|3862689|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
1578910|NCT01122680|3862690|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
1578911|NCT01122680|3862687|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
1578912|NCT01122680|3862688|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
1578913|NCT01122680|3862689|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
1578914|NCT01122680|3862690|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
1578915|NCT01122680|3862687|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
1578916|NCT01122680|3862688|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
1578917|NCT01122680|3862689|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
1578918|NCT01122680|3862690|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
1578919|NCT01122680|3862687|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
1578920|NCT01122680|3862688|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
1578921|NCT01122680|3862689|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
1578922|NCT01122680|3862690|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
1578923|NCT01122680|3862687|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
1578924|NCT01122680|3862688|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
1578925|NCT01122680|3862689|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
1578926|NCT01122680|3862690|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
1578927|NCT01122576|3862755|P3|NOT COMPLETED|Post-Cataract Surgery||2
1578928|NCT01122576|3862756|P2|NOT COMPLETED|Post-Cataract Surgery||0
1578929|NCT01122576|3862757|P1|NOT COMPLETED|Post-Cataract Surgery||0
1578930|NCT01122576|3862755|P3|COMPLETED|Post-Cataract Surgery||22
1578931|NCT01122576|3862756|P2|COMPLETED|Post-Cataract Surgery||25
1578932|NCT01122576|3862757|P1|COMPLETED|Post-Cataract Surgery||26
1578933|NCT01122576|3862755|P3|STARTED|Post-Cataract Surgery||24
1578934|NCT01122576|3862756|P2|STARTED|Post-Cataract Surgery||25
1578935|NCT01122576|3862757|P1|STARTED|Post-Cataract Surgery||26
1578936|NCT01122576|3862755|P3|NOT COMPLETED|Pre-Cataract Surgery||2
1578937|NCT01122576|3862756|P2|NOT COMPLETED|Pre-Cataract Surgery||1
1578938|NCT01122576|3862757|P1|NOT COMPLETED|Pre-Cataract Surgery||0
1578939|NCT01122576|3862755|P3|COMPLETED|Pre-Cataract Surgery||24
1578940|NCT01122576|3862756|P2|COMPLETED|Pre-Cataract Surgery||25
1578941|NCT01122576|3862757|P1|COMPLETED|Pre-Cataract Surgery||26
1578942|NCT01122576|3862755|P3|STARTED|Pre-Cataract Surgery||26
1578943|NCT01122576|3862756|P2|STARTED|Pre-Cataract Surgery||26
1578944|NCT01122576|3862757|P1|STARTED|Pre-Cataract Surgery||26
1578945|NCT01122511|3862896|P2|NOT COMPLETED|Overall Study||2
1578946|NCT01122511|3862897|P1|NOT COMPLETED|Overall Study||2
1578947|NCT01122511|3862896|P2|COMPLETED|Overall Study||0
1578948|NCT01122511|3862897|P1|COMPLETED|Overall Study||0
1578949|NCT01122511|3862896|P2|STARTED|Overall Study||2
1578950|NCT01122511|3862897|P1|STARTED|Overall Study||2
1578951|NCT01122394|3862911|P2|NOT COMPLETED|Overall Study||4
1578952|NCT01122394|3862912|P1|NOT COMPLETED|Overall Study||3
1578953|NCT01122394|3862911|P2|COMPLETED|Overall Study||70
1578954|NCT01122394|3862912|P1|COMPLETED|Overall Study||63
1578955|NCT01122394|3862911|P2|STARTED|Overall Study||74
1578956|NCT01122394|3862912|P1|STARTED|Overall Study||66
1578957|NCT01122381|3862928|P2|NOT COMPLETED|Overall Study||1
1578958|NCT01122381|3862929|P1|NOT COMPLETED|Overall Study||0
1578959|NCT01122381|3862928|P2|COMPLETED|Overall Study||0
1578960|NCT01122381|3862929|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
1578961|NCT01122381|3862928|P2|STARTED|Overall Study||1
1578962|NCT01122381|3862929|P1|STARTED|Overall Study||1
1578963|NCT01122264|3862938|P3|NOT COMPLETED|Overall Study||47
1578964|NCT01122264|3862939|P2|NOT COMPLETED|Overall Study||29
1578965|NCT01122264|3862940|P1|NOT COMPLETED|Overall Study||32
1578966|NCT01122264|3862938|P3|COMPLETED|Overall Study||214
1578967|NCT01122264|3862939|P2|COMPLETED|Overall Study||228
1578968|NCT01122264|3862940|P1|COMPLETED|Overall Study||220
1578969|NCT01122264|3862938|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
1578970|NCT01122264|3862939|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
1578971|NCT01122264|3862940|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
1578972|NCT01122264|3862938|P3|STARTED|Overall Study||261
1578973|NCT01122264|3862939|P2|STARTED|Overall Study||257
1578974|NCT01122264|3862940|P1|STARTED|Overall Study||252
1578975|NCT01122238|3863013|P16|NOT COMPLETED|Overall Study||0
1578976|NCT01122238|3863014|P15|NOT COMPLETED|Overall Study||0
1578977|NCT01122238|3863015|P14|NOT COMPLETED|Overall Study||1
1578978|NCT01122238|3863016|P13|NOT COMPLETED|Overall Study||2
1578979|NCT01122238|3863017|P12|NOT COMPLETED|Overall Study||2
1578980|NCT01122238|3863018|P11|NOT COMPLETED|Overall Study||0
1578981|NCT01122238|3863019|P10|NOT COMPLETED|Overall Study||1
1578982|NCT01122238|3863020|P9|NOT COMPLETED|Overall Study||1
1578983|NCT01122238|3863021|P8|NOT COMPLETED|Overall Study||0
1578984|NCT01122238|3863022|P7|NOT COMPLETED|Overall Study||1
1578985|NCT01122238|3863023|P6|NOT COMPLETED|Overall Study||1
1578986|NCT01122238|3863024|P5|NOT COMPLETED|Overall Study||0
1578987|NCT01122238|3863025|P4|NOT COMPLETED|Overall Study||0
1578988|NCT01122238|3863026|P3|NOT COMPLETED|Overall Study||5
1578989|NCT01122238|3863027|P2|NOT COMPLETED|Overall Study||1
1578990|NCT01122238|3863028|P1|NOT COMPLETED|Overall Study||2
1578991|NCT01122238|3863013|P16|COMPLETED|Overall Study||31
1578992|NCT01122238|3863014|P15|COMPLETED|Overall Study||28
1578993|NCT01122238|3863015|P14|COMPLETED|Overall Study||31
1578994|NCT01122238|3863016|P13|COMPLETED|Overall Study||28
1578995|NCT01122238|3863017|P12|COMPLETED|Overall Study||31
1578996|NCT01122238|3863018|P11|COMPLETED|Overall Study||32
1578997|NCT01122238|3863019|P10|COMPLETED|Overall Study||33
1578998|NCT01122238|3863020|P9|COMPLETED|Overall Study||31
1578999|NCT01122238|3863021|P8|COMPLETED|Overall Study||32
1579000|NCT01122238|3863022|P7|COMPLETED|Overall Study||34
1579001|NCT01122238|3863023|P6|COMPLETED|Overall Study||31
1579002|NCT01122238|3863024|P5|COMPLETED|Overall Study||33
1579003|NCT01122238|3863025|P4|COMPLETED|Overall Study||33
1579004|NCT01122238|3863026|P3|COMPLETED|Overall Study||28
1579005|NCT01122238|3863027|P2|COMPLETED|Overall Study||36
1579006|NCT01122238|3863028|P1|COMPLETED|Overall Study||28
1579007|NCT01122238|3863013|P16|STARTED|Overall Study||31
1579008|NCT01122238|3863014|P15|STARTED|Overall Study||28
1579009|NCT01122238|3863015|P14|STARTED|Overall Study||32
1579010|NCT01122238|3863016|P13|STARTED|Overall Study||30
1579011|NCT01122238|3863017|P12|STARTED|Overall Study||33
1579012|NCT01122238|3863018|P11|STARTED|Overall Study||32
1579013|NCT01122238|3863019|P10|STARTED|Overall Study||34
1579014|NCT01122238|3863020|P9|STARTED|Overall Study||32
1579015|NCT01122238|3863021|P8|STARTED|Overall Study||32
1579016|NCT01122238|3863022|P7|STARTED|Overall Study||35
1579017|NCT01122238|3863023|P6|STARTED|Overall Study||32
1579018|NCT01122238|3863024|P5|STARTED|Overall Study||33
1579019|NCT01122238|3863025|P4|STARTED|Overall Study||33
1579020|NCT01122238|3863026|P3|STARTED|Overall Study||33
1579021|NCT01122238|3863027|P2|STARTED|Overall Study||37
1579022|NCT01122238|3863028|P1|STARTED|Overall Study||30
1579023|NCT01122173|3863050|P1|NOT COMPLETED|Overall Study||9
1579024|NCT01122173|3863050|P1|COMPLETED|Overall Study||141
1579025|NCT01122173|3863050|P1|STARTED|Overall Study||150
1579026|NCT01122160|3863057|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1579027|NCT01122160|3863058|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1579028|NCT01122160|3863057|P2|COMPLETED|Second Intervention (7 Days)||5
1579029|NCT01122160|3863058|P1|COMPLETED|Second Intervention (7 Days)||6
1579030|NCT01122160|3863057|P2|STARTED|Second Intervention (7 Days)||5
1579031|NCT01122160|3863058|P1|STARTED|Second Intervention (7 Days)||6
1579032|NCT01122160|3863057|P2|NOT COMPLETED|Washout (7-14 Days)||0
1579033|NCT01122160|3863058|P1|NOT COMPLETED|Washout (7-14 Days)||0
1579034|NCT01122160|3863057|P2|COMPLETED|Washout (7-14 Days)||5
1579035|NCT01122160|3863058|P1|COMPLETED|Washout (7-14 Days)||6
1579036|NCT01122160|3863057|P2|STARTED|Washout (7-14 Days)||5
1579037|NCT01122160|3863058|P1|STARTED|Washout (7-14 Days)||6
1579038|NCT01122160|3863057|P2|NOT COMPLETED|First Intervention (7 Days)||0
1579039|NCT01122160|3863058|P1|NOT COMPLETED|First Intervention (7 Days)||0
1579040|NCT01122160|3863057|P2|COMPLETED|First Intervention (7 Days)||5
1579041|NCT01122160|3863058|P1|COMPLETED|First Intervention (7 Days)||6
1579042|NCT01122160|3863057|P2|STARTED|First Intervention (7 Days)||5
1579043|NCT01122160|3863058|P1|STARTED|First Intervention (7 Days)||6
1579044|NCT01122108|3863064|P2|NOT COMPLETED|Overall Study||0
1579045|NCT01122108|3863065|P1|NOT COMPLETED|Overall Study||0
1579046|NCT01122108|3863064|P2|COMPLETED|Overall Study||21
1579047|NCT01122108|3863065|P1|COMPLETED|Overall Study||21
1579048|NCT01122108|3863064|P2|STARTED|Overall Study||21
1579049|NCT01122108|3863065|P1|STARTED|Overall Study||21
1579050|NCT01122030|3863081|P7|NOT COMPLETED|Overall Study||0
1579051|NCT01122030|3863082|P6|NOT COMPLETED|Overall Study||0
1579052|NCT01122030|3863083|P5|NOT COMPLETED|Overall Study||0
1579053|NCT01122030|3863084|P4|NOT COMPLETED|Overall Study||0
1579054|NCT01122030|3863085|P3|NOT COMPLETED|Overall Study||0
1579055|NCT01122030|3863086|P2|NOT COMPLETED|Overall Study||0
1579056|NCT01122030|3863087|P1|NOT COMPLETED|Overall Study||0
1579057|NCT01122030|3863081|P7|COMPLETED|Overall Study||9
1579058|NCT01122030|3863082|P6|COMPLETED|Overall Study||9
1579059|NCT01122030|3863083|P5|COMPLETED|Overall Study||9
1579060|NCT01122030|3863084|P4|COMPLETED|Overall Study||9
1579061|NCT01122030|3863085|P3|COMPLETED|Overall Study||9
1579062|NCT01122030|3863086|P2|COMPLETED|Overall Study||9
1579063|NCT01122030|3863087|P1|COMPLETED|Overall Study||18
1579064|NCT01122030|3863081|P7|Received Treatment|Overall Study||9
1579065|NCT01122030|3863082|P6|Received Treatment|Overall Study||9
1579066|NCT01122030|3863083|P5|Received Treatment|Overall Study||9
1579067|NCT01122030|3863084|P4|Received Treatment|Overall Study||9
1579068|NCT01122030|3863085|P3|Received Treatment|Overall Study||9
1579069|NCT01122030|3863086|P2|Received Treatment|Overall Study||9
1579070|NCT01122030|3863087|P1|Received Treatment|Overall Study||18
1579071|NCT01122030|3863081|P7|STARTED|Overall Study||9
1579072|NCT01122030|3863082|P6|STARTED|Overall Study||9
1579073|NCT01122030|3863083|P5|STARTED|Overall Study||9
1579074|NCT01122030|3863084|P4|STARTED|Overall Study||9
1579075|NCT01122030|3863085|P3|STARTED|Overall Study||9
1579076|NCT01122030|3863086|P2|STARTED|Overall Study||9
1579077|NCT01122030|3863087|P1|STARTED|Overall Study||18
1579078|NCT01121991|3863273|P1|NOT COMPLETED|Overall Study||6
1579079|NCT01121991|3863273|P1|COMPLETED|Overall Study||46
1579080|NCT01121991|3863273|P1|STARTED|Overall Study|Number of participants treated|52
1579081|NCT01121939|3863284|P1|NOT COMPLETED|Overall Study||43
1579082|NCT01121939|3863284|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
1579083|NCT01121939|3863284|P1|STARTED|Overall Study||43
1579084|NCT01121926|3863298|P2|NOT COMPLETED|Second Intervention Period||0
1579085|NCT01121926|3863299|P1|NOT COMPLETED|Second Intervention Period||0
1579086|NCT01121926|3863298|P2|COMPLETED|Second Intervention Period||13
1579087|NCT01121926|3863299|P1|COMPLETED|Second Intervention Period||14
1579088|NCT01121926|3863298|P2|STARTED|Second Intervention Period||13
1579089|NCT01121926|3863299|P1|STARTED|Second Intervention Period||14
1579090|NCT01121926|3863298|P2|NOT COMPLETED|Washout Period||2
1579091|NCT01121926|3863299|P1|NOT COMPLETED|Washout Period||0
1579092|NCT01121926|3863298|P2|COMPLETED|Washout Period||13
1579093|NCT01121926|3863299|P1|COMPLETED|Washout Period||14
1579094|NCT01121926|3863298|P2|STARTED|Washout Period||15
1579095|NCT01121926|3863299|P1|STARTED|Washout Period||14
1579096|NCT01121926|3863298|P2|NOT COMPLETED|First Intervention Period||0
1579097|NCT01121926|3863299|P1|NOT COMPLETED|First Intervention Period||1
1579098|NCT01121926|3863298|P2|COMPLETED|First Intervention Period||15
1579099|NCT01121926|3863299|P1|COMPLETED|First Intervention Period||14
1579100|NCT01121926|3863298|P2|STARTED|First Intervention Period||15
1579101|NCT01121926|3863299|P1|STARTED|First Intervention Period||15
1579102|NCT01121913|3863317|P4|NOT COMPLETED|Fourth Intervention Period||0
1579103|NCT01121913|3863318|P3|NOT COMPLETED|Fourth Intervention Period||0
1579104|NCT01121913|3863319|P2|NOT COMPLETED|Fourth Intervention Period||0
1579105|NCT01121913|3863320|P1|NOT COMPLETED|Fourth Intervention Period||0
1579106|NCT01121913|3863317|P4|COMPLETED|Fourth Intervention Period||6
1579107|NCT01121913|3863318|P3|COMPLETED|Fourth Intervention Period||3
1579108|NCT01121913|3863319|P2|COMPLETED|Fourth Intervention Period||6
1579109|NCT01121913|3863320|P1|COMPLETED|Fourth Intervention Period||4
1579110|NCT01121913|3863317|P4|STARTED|Fourth Intervention Period||6
1579111|NCT01121913|3863318|P3|STARTED|Fourth Intervention Period||3
1579112|NCT01121913|3863319|P2|STARTED|Fourth Intervention Period||6
1579113|NCT01121913|3863320|P1|STARTED|Fourth Intervention Period||4
1579114|NCT01121913|3863317|P4|NOT COMPLETED|Third Washout Period||0
1579115|NCT01121913|3863318|P3|NOT COMPLETED|Third Washout Period||0
1579116|NCT01121913|3863319|P2|NOT COMPLETED|Third Washout Period||0
1579117|NCT01121913|3863320|P1|NOT COMPLETED|Third Washout Period||1
1579118|NCT01121913|3863317|P4|COMPLETED|Third Washout Period||6
1579119|NCT01121913|3863318|P3|COMPLETED|Third Washout Period||3
1579120|NCT01121913|3863319|P2|COMPLETED|Third Washout Period||6
1579121|NCT01121913|3863320|P1|COMPLETED|Third Washout Period||4
1579122|NCT01121913|3863317|P4|STARTED|Third Washout Period||6
1579123|NCT01121913|3863318|P3|STARTED|Third Washout Period||3
1579124|NCT01121913|3863319|P2|STARTED|Third Washout Period||6
1579125|NCT01121913|3863320|P1|STARTED|Third Washout Period||5
1579126|NCT01121913|3863317|P4|NOT COMPLETED|Third Intervention Period||0
1579127|NCT01121913|3863318|P3|NOT COMPLETED|Third Intervention Period||0
1579128|NCT01121913|3863319|P2|NOT COMPLETED|Third Intervention Period||0
1579129|NCT01121913|3863320|P1|NOT COMPLETED|Third Intervention Period||0
1579130|NCT01121913|3863317|P4|COMPLETED|Third Intervention Period||6
1579131|NCT01121913|3863318|P3|COMPLETED|Third Intervention Period||3
1579132|NCT01121913|3863319|P2|COMPLETED|Third Intervention Period||6
1579133|NCT01121913|3863320|P1|COMPLETED|Third Intervention Period||5
1579134|NCT01121913|3863317|P4|STARTED|Third Intervention Period||6
1579135|NCT01121913|3863318|P3|STARTED|Third Intervention Period||3
1579136|NCT01121913|3863319|P2|STARTED|Third Intervention Period||6
1579137|NCT01121913|3863320|P1|STARTED|Third Intervention Period||5
1579138|NCT01121913|3863317|P4|NOT COMPLETED|Second Washout Period||0
1579139|NCT01121913|3863318|P3|NOT COMPLETED|Second Washout Period||1
1579140|NCT01121913|3863319|P2|NOT COMPLETED|Second Washout Period||0
1579141|NCT01121913|3863320|P1|NOT COMPLETED|Second Washout Period||0
1579142|NCT01121913|3863317|P4|COMPLETED|Second Washout Period||6
1579143|NCT01121913|3863318|P3|COMPLETED|Second Washout Period||3
1579144|NCT01121913|3863319|P2|COMPLETED|Second Washout Period||6
1579145|NCT01121913|3863320|P1|COMPLETED|Second Washout Period||5
1579146|NCT01121913|3863317|P4|STARTED|Second Washout Period||6
1579147|NCT01121913|3863318|P3|STARTED|Second Washout Period||4
1579148|NCT01121913|3863319|P2|STARTED|Second Washout Period||6
1579149|NCT01121913|3863320|P1|STARTED|Second Washout Period||5
1579150|NCT01121913|3863317|P4|NOT COMPLETED|Second Intervention Period||0
1579151|NCT01121913|3863318|P3|NOT COMPLETED|Second Intervention Period||1
1579152|NCT01121913|3863319|P2|NOT COMPLETED|Second Intervention Period||0
1579153|NCT01121913|3863320|P1|NOT COMPLETED|Second Intervention Period||0
1579154|NCT01121913|3863317|P4|COMPLETED|Second Intervention Period||6
1579155|NCT01121913|3863318|P3|COMPLETED|Second Intervention Period||4
1579156|NCT01121913|3863319|P2|COMPLETED|Second Intervention Period||6
1579157|NCT01121913|3863320|P1|COMPLETED|Second Intervention Period||5
1579158|NCT01121913|3863317|P4|STARTED|Second Intervention Period||6
1579159|NCT01121913|3863318|P3|STARTED|Second Intervention Period||5
1579160|NCT01121913|3863319|P2|STARTED|Second Intervention Period||6
1579161|NCT01121913|3863320|P1|STARTED|Second Intervention Period||5
1579162|NCT01121913|3863317|P4|NOT COMPLETED|First Washout Period||0
1579163|NCT01121913|3863318|P3|NOT COMPLETED|First Washout Period||0
1579164|NCT01121913|3863319|P2|NOT COMPLETED|First Washout Period||0
1579165|NCT01121913|3863320|P1|NOT COMPLETED|First Washout Period||1
1579166|NCT01121913|3863317|P4|COMPLETED|First Washout Period||6
1579167|NCT01121913|3863318|P3|COMPLETED|First Washout Period||5
1579168|NCT01121913|3863319|P2|COMPLETED|First Washout Period||6
1579169|NCT01121913|3863320|P1|COMPLETED|First Washout Period||5
1579170|NCT01121913|3863317|P4|STARTED|First Washout Period||6
1579171|NCT01121913|3863318|P3|STARTED|First Washout Period||5
1579172|NCT01121913|3863319|P2|STARTED|First Washout Period||6
1579173|NCT01121913|3863320|P1|STARTED|First Washout Period||6
1579174|NCT01121913|3863317|P4|NOT COMPLETED|First Intervention Period||0
1579175|NCT01121913|3863318|P3|NOT COMPLETED|First Intervention Period||1
1579176|NCT01121913|3863319|P2|NOT COMPLETED|First Intervention Period||0
1579177|NCT01121913|3863320|P1|NOT COMPLETED|First Intervention Period||0
1579178|NCT01121913|3863317|P4|COMPLETED|First Intervention Period||6
1579179|NCT01121913|3863318|P3|COMPLETED|First Intervention Period||5
1579180|NCT01121913|3863319|P2|COMPLETED|First Intervention Period||6
1579181|NCT01121913|3863320|P1|COMPLETED|First Intervention Period||6
1579182|NCT01121913|3863317|P4|STARTED|First Intervention Period||6
1579183|NCT01121913|3863318|P3|STARTED|First Intervention Period||6
1579184|NCT01121913|3863319|P2|STARTED|First Intervention Period||6
1579185|NCT01121913|3863320|P1|STARTED|First Intervention Period||6
1579186|NCT01121900|3863350|P2|NOT COMPLETED|Second Intervention Period||0
1579187|NCT01121900|3863351|P1|NOT COMPLETED|Second Intervention Period||0
1579188|NCT01121900|3863350|P2|COMPLETED|Second Intervention Period||11
1579189|NCT01121900|3863351|P1|COMPLETED|Second Intervention Period||12
1579190|NCT01121900|3863350|P2|STARTED|Second Intervention Period||11
1579191|NCT01121900|3863351|P1|STARTED|Second Intervention Period||12
1579192|NCT01121900|3863350|P2|NOT COMPLETED|Washout Period of 7 Days||1
1579193|NCT01121900|3863351|P1|NOT COMPLETED|Washout Period of 7 Days||0
1579194|NCT01121900|3863350|P2|COMPLETED|Washout Period of 7 Days||11
1579195|NCT01121900|3863351|P1|COMPLETED|Washout Period of 7 Days||12
1579196|NCT01121900|3863350|P2|STARTED|Washout Period of 7 Days||12
1579197|NCT01121900|3863351|P1|STARTED|Washout Period of 7 Days||12
1579198|NCT01121900|3863350|P2|NOT COMPLETED|First Intervention Period||1
1579199|NCT01121900|3863351|P1|NOT COMPLETED|First Intervention Period||1
1579200|NCT01121900|3863350|P2|COMPLETED|First Intervention Period||12
1579201|NCT01121900|3863351|P1|COMPLETED|First Intervention Period||12
1579202|NCT01121900|3863350|P2|STARTED|First Intervention Period||13
1579203|NCT01121900|3863351|P1|STARTED|First Intervention Period||13
1579204|NCT01121757|3863371|P2|NOT COMPLETED|Combination||1
1579205|NCT01121757|3863372|P1|NOT COMPLETED|Combination||2
1579206|NCT01121757|3863371|P2|COMPLETED|Combination||0
1579207|NCT01121757|3863372|P1|COMPLETED|Combination||0
1579208|NCT01121757|3863371|P2|STARTED|Combination||1
1579209|NCT01121757|3863372|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
1579210|NCT01121757|3863371|P2|NOT COMPLETED|Second Drug||0
1579211|NCT01121757|3863372|P1|NOT COMPLETED|Second Drug||0
1579212|NCT01121757|3863371|P2|COMPLETED|Second Drug||1
1579213|NCT01121757|3863372|P1|COMPLETED|Second Drug||4
1579214|NCT01121757|3863371|P2|STARTED|Second Drug||1
1579215|NCT01121757|3863372|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
1579216|NCT01121757|3863371|P2|NOT COMPLETED|First Drug||2
1579217|NCT01121757|3863372|P1|NOT COMPLETED|First Drug||1
1579218|NCT01121757|3863371|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
1579219|NCT01121757|3863372|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
1579220|NCT01121757|3863371|P2|STARTED|First Drug||3
1579221|NCT01121757|3863372|P1|STARTED|First Drug||6
1579222|NCT01121666|3863388|P2|NOT COMPLETED|Overall Study||10
1579223|NCT01121666|3863389|P1|NOT COMPLETED|Overall Study||29
1579224|NCT01121666|3863388|P2|COMPLETED|Overall Study||113
1579225|NCT01121666|3863389|P1|COMPLETED|Overall Study||220
1579226|NCT01121666|3863388|P2|STARTED|Overall Study||123
1579227|NCT01121666|3863389|P1|STARTED|Overall Study||249
1579228|NCT01121575|3863445|P6|NOT COMPLETED|Overall Study||12
1579229|NCT01121575|3863446|P5|NOT COMPLETED|Overall Study||25
1579230|NCT01121575|3863447|P4|NOT COMPLETED|Overall Study||6
1579231|NCT01121575|3863448|P3|NOT COMPLETED|Overall Study||7
1579232|NCT01121575|3863449|P2|NOT COMPLETED|Overall Study||6
1579233|NCT01121575|3863450|P1|NOT COMPLETED|Overall Study||14
1579234|NCT01121575|3863445|P6|COMPLETED|Overall Study||0
1579235|NCT01121575|3863446|P5|COMPLETED|Overall Study||0
1579236|NCT01121575|3863447|P4|COMPLETED|Overall Study||0
1579237|NCT01121575|3863448|P3|COMPLETED|Overall Study||0
1579238|NCT01121575|3863449|P2|COMPLETED|Overall Study||0
1579239|NCT01121575|3863450|P1|COMPLETED|Overall Study||0
1579240|NCT01121575|3863445|P6|Treated|Overall Study||12
1579241|NCT01121575|3863446|P5|Treated|Overall Study||25
1579242|NCT01121575|3863447|P4|Treated|Overall Study||6
1579243|NCT01121575|3863448|P3|Treated|Overall Study||7
1579244|NCT01121575|3863449|P2|Treated|Overall Study||6
1579245|NCT01121575|3863450|P1|Treated|Overall Study||14
1579246|NCT01121575|3863445|P6|STARTED|Overall Study||12
1579247|NCT01121575|3863446|P5|STARTED|Overall Study||25
1579248|NCT01121575|3863447|P4|STARTED|Overall Study||6
1579249|NCT01121575|3863448|P3|STARTED|Overall Study||7
1579250|NCT01121575|3863449|P2|STARTED|Overall Study||6
1579251|NCT01121575|3863450|P1|STARTED|Overall Study||14
1579252|NCT01121562|3863574|P1|NOT COMPLETED|Overall Study||12
1579253|NCT01121562|3863574|P1|COMPLETED|Overall Study||0
1579254|NCT01121562|3863574|P1|STARTED|Overall Study||12
1579255|NCT01121549|3863583|P1|NOT COMPLETED|Overall Study||347
1579256|NCT01121549|3863583|P1|COMPLETED|Overall Study||31
1579257|NCT01121549|3863583|P1|STARTED|Overall Study||378
1579258|NCT01121536|3863594|P1|NOT COMPLETED|Overall Study||361
1579259|NCT01121536|3863594|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
1579260|NCT01121536|3863594|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
1579261|NCT01121536|3863594|P1|Safety Population|Overall Study|Participants treated|863
1579262|NCT01121536|3863594|P1|STARTED|Overall Study||867
1579263|NCT01121484|3863615|P2|NOT COMPLETED|Overall Study||43
1579264|NCT01121484|3863616|P1|NOT COMPLETED|Overall Study||33
1579265|NCT01121484|3863615|P2|COMPLETED|Overall Study||178
1579266|NCT01121484|3863616|P1|COMPLETED|Overall Study||185
1579267|NCT01121484|3863615|P2|Treated|Overall Study||217
1579268|NCT01121484|3863616|P1|Treated|Overall Study||217
1579269|NCT01121484|3863615|P2|STARTED|Overall Study||221
1579270|NCT01121484|3863616|P1|STARTED|Overall Study||218
1579271|NCT01121406|3863634|P2|NOT COMPLETED|Overall Study||55
1579272|NCT01121406|3863635|P1|NOT COMPLETED|Overall Study||55
1579273|NCT01121406|3863634|P2|COMPLETED|Overall Study||0
1579274|NCT01121406|3863635|P1|COMPLETED|Overall Study||0
1579275|NCT01121406|3863634|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
1579276|NCT01121406|3863635|P1|STARTED|Overall Study||55
1579277|NCT01121393|3863685|P2|NOT COMPLETED|Overall Study||84
1579278|NCT01121393|3863686|P1|NOT COMPLETED|Overall Study||242
1579279|NCT01121393|3863685|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
1579280|NCT01121393|3863686|P1|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
1579281|NCT01121393|3863685|P2|Treated|Overall Study|Treated|113
1579282|NCT01121393|3863686|P1|Treated|Overall Study|Treated|239
1579283|NCT01121393|3863685|P2|STARTED|Overall Study|Randomised|122
1579284|NCT01121393|3863686|P1|STARTED|Overall Study|Randomised|242
1579285|NCT01121263|3863731|P2|NOT COMPLETED|Overall Study||15
1579286|NCT01121263|3863732|P1|NOT COMPLETED|Overall Study||25
1579287|NCT01121263|3863731|P2|COMPLETED|Overall Study||83
1579288|NCT01121263|3863732|P1|COMPLETED|Overall Study||175
1579289|NCT01121263|3863731|P2|STARTED|Overall Study||98
1579290|NCT01121263|3863732|P1|STARTED|Overall Study||200
1579291|NCT01121250|3863743|P3|NOT COMPLETED|Overall Study||1
1579292|NCT01121250|3863744|P2|NOT COMPLETED|Overall Study||0
1579293|NCT01121250|3863745|P1|NOT COMPLETED|Overall Study||0
1579294|NCT01121250|3863743|P3|COMPLETED|Overall Study||75
1579295|NCT01121250|3863744|P2|COMPLETED|Overall Study||76
1579296|NCT01121250|3863745|P1|COMPLETED|Overall Study||76
1579297|NCT01121250|3863743|P3|STARTED|Overall Study||76
1579298|NCT01121250|3863744|P2|STARTED|Overall Study||76
1579299|NCT01121250|3863745|P1|STARTED|Overall Study||76
1579300|NCT01121224|3863761|P2|NOT COMPLETED|Overall Study||17
1579301|NCT01121224|3863762|P1|NOT COMPLETED|Overall Study||25
1579302|NCT01121224|3863761|P2|COMPLETED|Overall Study||275
1579303|NCT01121224|3863762|P1|COMPLETED|Overall Study||280
1579304|NCT01121224|3863761|P2|STARTED|Overall Study||292
1579305|NCT01121224|3863762|P1|STARTED|Overall Study||305
1579306|NCT01121211|3863786|P2|NOT COMPLETED|Overall Study||12
1579307|NCT01121211|3863787|P1|NOT COMPLETED|Overall Study||11
1579308|NCT01121211|3863786|P2|COMPLETED|Overall Study||35
1579309|NCT01121211|3863787|P1|COMPLETED|Overall Study||32
1579310|NCT01121211|3863786|P2|STARTED|Overall Study||47
1579311|NCT01121211|3863787|P1|STARTED|Overall Study||43
1579312|NCT01121185|3863797|P2|NOT COMPLETED|Overall Study||1
1579313|NCT01121185|3863798|P1|NOT COMPLETED|Overall Study||1
1579314|NCT01121185|3863797|P2|COMPLETED|Overall Study||5
1579315|NCT01121185|3863798|P1|COMPLETED|Overall Study||6
1579316|NCT01121185|3863797|P2|Transplanted|Overall Study||5
1579317|NCT01121185|3863798|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
1579318|NCT01121185|3863797|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
1579319|NCT01121185|3863798|P1|Infused|Overall Study||7
1579320|NCT01121185|3863797|P2|STARTED|Overall Study||6
1579321|NCT01121185|3863798|P1|STARTED|Overall Study||7
1579322|NCT01121172|3863822|P2|NOT COMPLETED|Overall Study||0
1579323|NCT01121172|3863823|P1|NOT COMPLETED|Overall Study||0
1579324|NCT01121172|3863822|P2|COMPLETED|Overall Study||90
1579325|NCT01121172|3863823|P1|COMPLETED|Overall Study||90
1579326|NCT01121172|3863822|P2|STARTED|Overall Study||90
1579327|NCT01121172|3863823|P1|STARTED|Overall Study||90
1579328|NCT01121146|3863832|P2|NOT COMPLETED|Overall Study||42
1579329|NCT01121146|3863833|P1|NOT COMPLETED|Overall Study||26
1579330|NCT01121146|3863832|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
1579331|NCT01121146|3863833|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
1579332|NCT01121146|3863832|P2|STARTED|Overall Study||114
1579333|NCT01121146|3863833|P1|STARTED|Overall Study||116
1579334|NCT01120990|3863847|P1|NOT COMPLETED|Overall Study||0
1579335|NCT01120990|3863847|P1|COMPLETED|Overall Study||51
1579336|NCT01120990|3863847|P1|STARTED|Overall Study||51
1579337|NCT01120899|3863854|P1|NOT COMPLETED|Overall Study||3
1579338|NCT01120899|3863854|P1|COMPLETED|Overall Study||3
1579339|NCT01120899|3863854|P1|Month 18|Overall Study||3
1579340|NCT01120899|3863854|P1|Month 12|Overall Study||3
1579341|NCT01120899|3863854|P1|Month 6|Overall Study||5
1579342|NCT01120899|3863854|P1|STARTED|Overall Study||6
1579343|NCT01120834|3863874|P1|NOT COMPLETED|Overall Study||0
1579344|NCT01120834|3863874|P1|COMPLETED|Overall Study||18
1579345|NCT01120834|3863874|P1|STARTED|Overall Study||18
1579346|NCT01120808|3863878|P1|NOT COMPLETED|Overall Study||46
1579347|NCT01120808|3863878|P1|COMPLETED|Overall Study||90
1579348|NCT01120808|3863878|P1|STARTED|Overall Study||136
1579349|NCT01120782|3863882|P1|NOT COMPLETED|Overall Study||11
1579350|NCT01120782|3863882|P1|COMPLETED|Overall Study||34
1579351|NCT01120782|3863882|P1|STARTED|Overall Study||45
1579352|NCT01120717|3863888|P2|NOT COMPLETED|Overall Study||24
1579353|NCT01120717|3863889|P1|NOT COMPLETED|Overall Study||32
1579354|NCT01120717|3863888|P2|COMPLETED|Overall Study||89
1579355|NCT01120717|3863889|P1|COMPLETED|Overall Study||194
1579356|NCT01120717|3863888|P2|Safety Population: Received Study Drug|Overall Study||113
1579357|NCT01120717|3863889|P1|Safety Population: Received Study Drug|Overall Study||225
1579358|NCT01120717|3863888|P2|STARTED|Overall Study||113
1579359|NCT01120717|3863889|P1|STARTED|Overall Study||226
1579360|NCT01120704|3863937|P32|NOT COMPLETED|Overall Study||1
1579361|NCT01120704|3863938|P31|NOT COMPLETED|Overall Study||2
1579362|NCT01120704|3863939|P30|NOT COMPLETED|Overall Study||3
1579363|NCT01120704|3863940|P29|NOT COMPLETED|Overall Study||5
1579364|NCT01120704|3863941|P28|NOT COMPLETED|Overall Study||2
1579365|NCT01120704|3863942|P27|NOT COMPLETED|Overall Study||3
1579366|NCT01120704|3863943|P26|NOT COMPLETED|Overall Study||0
1579367|NCT01120704|3863944|P25|NOT COMPLETED|Overall Study||2
1579368|NCT01120704|3863945|P24|NOT COMPLETED|Overall Study||3
1579369|NCT01120704|3863946|P23|NOT COMPLETED|Overall Study||4
1579370|NCT01120704|3863947|P22|NOT COMPLETED|Overall Study||0
1579371|NCT01120704|3863948|P21|NOT COMPLETED|Overall Study||3
1579372|NCT01120704|3863949|P20|NOT COMPLETED|Overall Study||3
1579373|NCT01120704|3863950|P19|NOT COMPLETED|Overall Study||2
1579374|NCT01120704|3863951|P18|NOT COMPLETED|Overall Study||0
1579375|NCT01120704|3863952|P17|NOT COMPLETED|Overall Study||1
1579376|NCT01120704|3863953|P16|NOT COMPLETED|Overall Study||2
1579377|NCT01120704|3863954|P15|NOT COMPLETED|Overall Study||1
1579378|NCT01120704|3863955|P14|NOT COMPLETED|Overall Study||4
1579379|NCT01120704|3863956|P13|NOT COMPLETED|Overall Study||3
1579380|NCT01120704|3863957|P12|NOT COMPLETED|Overall Study||2
1579381|NCT01120704|3863958|P11|NOT COMPLETED|Overall Study||1
1579382|NCT01120704|3863959|P10|NOT COMPLETED|Overall Study||1
1579383|NCT01120704|3863960|P9|NOT COMPLETED|Overall Study||3
1579384|NCT01120704|3863961|P8|NOT COMPLETED|Overall Study||2
1579385|NCT01120704|3863962|P7|NOT COMPLETED|Overall Study||3
1579386|NCT01120704|3863963|P6|NOT COMPLETED|Overall Study||1
1579387|NCT01120704|3863964|P5|NOT COMPLETED|Overall Study||2
1579388|NCT01120704|3863965|P4|NOT COMPLETED|Overall Study||4
1579389|NCT01120704|3863966|P3|NOT COMPLETED|Overall Study||1
1579390|NCT01120704|3863967|P2|NOT COMPLETED|Overall Study||4
1579391|NCT01120704|3863968|P1|NOT COMPLETED|Overall Study||3
1579392|NCT01120704|3863937|P32|COMPLETED|Overall Study||17
1579393|NCT01120704|3863938|P31|COMPLETED|Overall Study||12
1579394|NCT01120704|3863939|P30|COMPLETED|Overall Study||12
1579395|NCT01120704|3863940|P29|COMPLETED|Overall Study||14
1579396|NCT01120704|3863941|P28|COMPLETED|Overall Study||16
1579397|NCT01120704|3863942|P27|COMPLETED|Overall Study||15
1579398|NCT01120704|3863943|P26|COMPLETED|Overall Study||14
1579399|NCT01120704|3863944|P25|COMPLETED|Overall Study||16
1579400|NCT01120704|3863945|P24|COMPLETED|Overall Study||13
1579401|NCT01120704|3863946|P23|COMPLETED|Overall Study||17
1579402|NCT01120704|3863947|P22|COMPLETED|Overall Study||16
1579403|NCT01120704|3863948|P21|COMPLETED|Overall Study||14
1579404|NCT01120704|3863949|P20|COMPLETED|Overall Study||15
1579405|NCT01120704|3863950|P19|COMPLETED|Overall Study||15
1579406|NCT01120704|3863951|P18|COMPLETED|Overall Study||16
1579407|NCT01120704|3863952|P17|COMPLETED|Overall Study||13
1579408|NCT01120704|3863953|P16|COMPLETED|Overall Study||16
1579409|NCT01120704|3863954|P15|COMPLETED|Overall Study||17
1579410|NCT01120704|3863955|P14|COMPLETED|Overall Study||15
1579411|NCT01120704|3863956|P13|COMPLETED|Overall Study||14
1579412|NCT01120704|3863957|P12|COMPLETED|Overall Study||14
1579413|NCT01120704|3863958|P11|COMPLETED|Overall Study||16
1579414|NCT01120704|3863959|P10|COMPLETED|Overall Study||19
1579415|NCT01120704|3863960|P9|COMPLETED|Overall Study||19
1579416|NCT01120704|3863961|P8|COMPLETED|Overall Study||13
1579417|NCT01120704|3863962|P7|COMPLETED|Overall Study||12
1579418|NCT01120704|3863963|P6|COMPLETED|Overall Study||18
1579419|NCT01120704|3863964|P5|COMPLETED|Overall Study||14
1579420|NCT01120704|3863965|P4|COMPLETED|Overall Study||15
1579421|NCT01120704|3863966|P3|COMPLETED|Overall Study||13
1579422|NCT01120704|3863967|P2|COMPLETED|Overall Study||13
1579423|NCT01120704|3863968|P1|COMPLETED|Overall Study||10
1579424|NCT01120704|3863937|P32|STARTED|Overall Study||18
1579425|NCT01120704|3863938|P31|STARTED|Overall Study||14
1579426|NCT01120704|3863939|P30|STARTED|Overall Study||15
1579427|NCT01120704|3863940|P29|STARTED|Overall Study||19
1579428|NCT01120704|3863941|P28|STARTED|Overall Study||18
1579429|NCT01120704|3863942|P27|STARTED|Overall Study||18
1579430|NCT01120704|3863943|P26|STARTED|Overall Study||14
1579431|NCT01120704|3863944|P25|STARTED|Overall Study||18
1579432|NCT01120704|3863945|P24|STARTED|Overall Study||16
1579433|NCT01120704|3863946|P23|STARTED|Overall Study||21
1579434|NCT01120704|3863947|P22|STARTED|Overall Study||16
1579435|NCT01120704|3863948|P21|STARTED|Overall Study||17
1579436|NCT01120704|3863949|P20|STARTED|Overall Study||18
1579437|NCT01120704|3863950|P19|STARTED|Overall Study||17
1579438|NCT01120704|3863951|P18|STARTED|Overall Study||16
1579439|NCT01120704|3863952|P17|STARTED|Overall Study||14
1579440|NCT01120704|3863953|P16|STARTED|Overall Study||18
1579441|NCT01120704|3863954|P15|STARTED|Overall Study||18
1579442|NCT01120704|3863955|P14|STARTED|Overall Study||19
1579443|NCT01120704|3863956|P13|STARTED|Overall Study||17
1579444|NCT01120704|3863957|P12|STARTED|Overall Study||16
1579445|NCT01120704|3863958|P11|STARTED|Overall Study||17
1579446|NCT01120704|3863959|P10|STARTED|Overall Study||20
1579447|NCT01120704|3863960|P9|STARTED|Overall Study||22
1579448|NCT01120704|3863961|P8|STARTED|Overall Study||15
1579449|NCT01120704|3863962|P7|STARTED|Overall Study||15
1579450|NCT01120704|3863963|P6|STARTED|Overall Study||19
1579451|NCT01120704|3863964|P5|STARTED|Overall Study||16
1579452|NCT01120704|3863965|P4|STARTED|Overall Study||19
1579453|NCT01120704|3863966|P3|STARTED|Overall Study||14
1579454|NCT01120704|3863967|P2|STARTED|Overall Study||17
1579455|NCT01120704|3863968|P1|STARTED|Overall Study||13
1579456|NCT01120691|3863995|P3|NOT COMPLETED|Overall Study||183
1579457|NCT01120691|3863996|P2|NOT COMPLETED|Overall Study||203
1579458|NCT01120691|3863997|P1|NOT COMPLETED|Overall Study||171
1579459|NCT01120691|3863995|P3|COMPLETED|Overall Study||559
1579460|NCT01120691|3863996|P2|COMPLETED|Overall Study||538
1579461|NCT01120691|3863997|P1|COMPLETED|Overall Study||570
1579462|NCT01120691|3863995|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
1579463|NCT01120691|3863996|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
1579464|NCT01120691|3863997|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
1579465|NCT01120691|3863995|P3|Modified Safety Set (mSAF)|Overall Study||737
1579466|NCT01120691|3863996|P2|Modified Safety Set (mSAF)|Overall Study||740
1579467|NCT01120691|3863997|P1|Modified Safety Set (mSAF)|Overall Study||729
1579468|NCT01120691|3863995|P3|Safety Set (SAF)|Overall Study||739
1579469|NCT01120691|3863996|P2|Safety Set (SAF)|Overall Study||740
1579470|NCT01120691|3863997|P1|Safety Set (SAF)|Overall Study||736
1579471|NCT01120691|3863995|P3|Full Analysis Set (FAS)|Overall Study||739
1579472|NCT01120691|3863996|P2|Full Analysis Set (FAS)|Overall Study||739
1579473|NCT01120691|3863997|P1|Full Analysis Set (FAS)|Overall Study||736
1579474|NCT01120691|3863995|P3|STARTED|Overall Study||742
1579475|NCT01120691|3863996|P2|STARTED|Overall Study||741
1579476|NCT01120691|3863997|P1|STARTED|Overall Study||741
1579477|NCT01120626|3864041|P2|NOT COMPLETED|Overall Study||0
1579478|NCT01120626|3864042|P1|NOT COMPLETED|Overall Study||1
1579479|NCT01120626|3864041|P2|COMPLETED|Overall Study||22
1579480|NCT01120626|3864042|P1|COMPLETED|Overall Study||19
1579481|NCT01120626|3864041|P2|STARTED|Overall Study||22
1579482|NCT01120626|3864042|P1|STARTED|Overall Study||20
1579483|NCT01120600|3864052|P2|NOT COMPLETED|Overall Study||32
1579484|NCT01120600|3864053|P1|NOT COMPLETED|Overall Study||19
1579485|NCT01120600|3864052|P2|COMPLETED|Overall Study||115
1579486|NCT01120600|3864053|P1|COMPLETED|Overall Study||128
1579487|NCT01120600|3864052|P2|Treated|Overall Study||146
1579488|NCT01120600|3864053|P1|Treated|Overall Study||146
1579489|NCT01120600|3864052|P2|STARTED|Overall Study||147
1579490|NCT01120600|3864053|P1|STARTED|Overall Study||147
1579491|NCT01120405|3864079|P2|NOT COMPLETED|Overall Study||33
1579492|NCT01120405|3864080|P1|NOT COMPLETED|Overall Study||27
1579493|NCT01120405|3864079|P2|COMPLETED|Overall Study||269
1579494|NCT01120405|3864080|P1|COMPLETED|Overall Study||271
1579495|NCT01120405|3864079|P2|STARTED|Overall Study||302
1579496|NCT01120405|3864080|P1|STARTED|Overall Study||298
1579497|NCT01120379|3864108|P1|NOT COMPLETED|Four Year Timepoint||368
1579498|NCT01120379|3864108|P1|COMPLETED|Four Year Timepoint||3923
1579499|NCT01120379|3864108|P1|STARTED|Four Year Timepoint||4291
1579500|NCT01120379|3864108|P1|NOT COMPLETED|Three Year Timepoint||214
1579501|NCT01120379|3864108|P1|COMPLETED|Three Year Timepoint||4291
1579502|NCT01120379|3864108|P1|STARTED|Three Year Timepoint||4505
1579503|NCT01120379|3864108|P1|NOT COMPLETED|Two Year Timepoint||237
1579504|NCT01120379|3864108|P1|COMPLETED|Two Year Timepoint||4505
1579505|NCT01120379|3864108|P1|STARTED|Two Year Timepoint||4742
1579506|NCT01120379|3864108|P1|NOT COMPLETED|One Year Timepoint||278
1579507|NCT01120379|3864108|P1|COMPLETED|One Year Timepoint||4742
1579508|NCT01120379|3864108|P1|STARTED|One Year Timepoint||5020
1579509|NCT01120275|3864144|P1|NOT COMPLETED|Overall Study||36
1579510|NCT01120275|3864144|P1|COMPLETED|Overall Study||0
1579511|NCT01120275|3864144|P1|Eligible and Treated|Overall Study||32
1579512|NCT01120275|3864144|P1|STARTED|Overall Study||36
1579513|NCT01120236|3864153|P2|NOT COMPLETED|Overall Study||1
1579514|NCT01120236|3864154|P1|NOT COMPLETED|Overall Study||0
1579515|NCT01120236|3864153|P2|COMPLETED|Overall Study||105
1579516|NCT01120236|3864154|P1|COMPLETED|Overall Study||105
1579517|NCT01120236|3864153|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
1579518|NCT01120236|3864154|P1|Ineligble|Overall Study||0
1579519|NCT01120236|3864153|P2|STARTED|Overall Study||106
1579520|NCT01120236|3864154|P1|STARTED|Overall Study||105
1579521|NCT01120223|3864181|P1|NOT COMPLETED|Overall Study||4
1579522|NCT01120223|3864181|P1|COMPLETED|Overall Study||74
1579523|NCT01120223|3864181|P1|STARTED|Overall Study||78
1579524|NCT01120210|3864211|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
1579525|NCT01120210|3864212|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
1579526|NCT01120210|3864211|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
1579527|NCT01120210|3864212|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
1579528|NCT01120210|3864211|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
1579529|NCT01120210|3864212|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
1579530|NCT01120210|3864211|P2|NOT COMPLETED|MAIN INFUSION||1
1579531|NCT01120210|3864212|P1|NOT COMPLETED|MAIN INFUSION||1
1579532|NCT01120210|3864211|P2|COMPLETED|MAIN INFUSION||45
1579533|NCT01120210|3864212|P1|COMPLETED|MAIN INFUSION||15
1579534|NCT01120210|3864211|P2|STARTED|MAIN INFUSION||46
1579535|NCT01120210|3864212|P1|STARTED|MAIN INFUSION||16
1579536|NCT01120197|3864244|P2|NOT COMPLETED|Overall Study||10
1579537|NCT01120197|3864245|P1|NOT COMPLETED|Overall Study||9
1579538|NCT01120197|3864244|P2|COMPLETED|Overall Study||32
1579539|NCT01120197|3864245|P1|COMPLETED|Overall Study||38
1579540|NCT01120197|3864244|P2|STARTED|Overall Study||42
1579541|NCT01120197|3864245|P1|STARTED|Overall Study||47
1579542|NCT01120184|3864262|P3|NOT COMPLETED|Overall Study||363
1579543|NCT01120184|3864263|P2|NOT COMPLETED|Overall Study||367
1579544|NCT01120184|3864264|P1|NOT COMPLETED|Overall Study||365
1579545|NCT01120184|3864262|P3|COMPLETED|Overall Study||0
1579546|NCT01120184|3864263|P2|COMPLETED|Overall Study||0
1579547|NCT01120184|3864264|P1|COMPLETED|Overall Study||0
1579548|NCT01120184|3864262|P3|Treated|Overall Study||360
1579549|NCT01120184|3864263|P2|Treated|Overall Study||365
1579550|NCT01120184|3864264|P1|Treated|Overall Study||355
1579551|NCT01120184|3864262|P3|STARTED|Overall Study||363
1579552|NCT01120184|3864263|P2|STARTED|Overall Study||367
1579553|NCT01120184|3864264|P1|STARTED|Overall Study||365
1579554|NCT01120093|3864386|P5|NOT COMPLETED|Treatment Period 5||0
1579555|NCT01120093|3864387|P4|NOT COMPLETED|Treatment Period 5||1
1579556|NCT01120093|3864388|P3|NOT COMPLETED|Treatment Period 5||0
1579557|NCT01120093|3864389|P2|NOT COMPLETED|Treatment Period 5||1
1579558|NCT01120093|3864390|P1|NOT COMPLETED|Treatment Period 5||0
1579559|NCT01120093|3864386|P5|COMPLETED|Treatment Period 5||13
1579560|NCT01120093|3864387|P4|COMPLETED|Treatment Period 5||11
1579561|NCT01120093|3864388|P3|COMPLETED|Treatment Period 5||15
1579562|NCT01120093|3864389|P2|COMPLETED|Treatment Period 5||12
1579563|NCT01120093|3864390|P1|COMPLETED|Treatment Period 5||17
1579564|NCT01120093|3864386|P5|STARTED|Treatment Period 5||13
1579565|NCT01120093|3864387|P4|STARTED|Treatment Period 5||12
1579566|NCT01120093|3864388|P3|STARTED|Treatment Period 5||15
1579567|NCT01120093|3864389|P2|STARTED|Treatment Period 5||13
1579568|NCT01120093|3864390|P1|STARTED|Treatment Period 5||17
1579569|NCT01120093|3864386|P5|NOT COMPLETED|Treatment Period 4||0
1579570|NCT01120093|3864387|P4|NOT COMPLETED|Treatment Period 4||0
1579571|NCT01120093|3864388|P3|NOT COMPLETED|Treatment Period 4||0
1579572|NCT01120093|3864389|P2|NOT COMPLETED|Treatment Period 4||0
1579573|NCT01120093|3864390|P1|NOT COMPLETED|Treatment Period 4||1
1579574|NCT01120093|3864386|P5|COMPLETED|Treatment Period 4||13
1579575|NCT01120093|3864387|P4|COMPLETED|Treatment Period 4||12
1579576|NCT01120093|3864388|P3|COMPLETED|Treatment Period 4||15
1579577|NCT01120093|3864389|P2|COMPLETED|Treatment Period 4||13
1579578|NCT01120093|3864390|P1|COMPLETED|Treatment Period 4||17
1579579|NCT01120093|3864386|P5|STARTED|Treatment Period 4||13
1579580|NCT01120093|3864387|P4|STARTED|Treatment Period 4||12
1579581|NCT01120093|3864388|P3|STARTED|Treatment Period 4||15
1579582|NCT01120093|3864389|P2|STARTED|Treatment Period 4||13
1579583|NCT01120093|3864390|P1|STARTED|Treatment Period 4||18
1579584|NCT01120093|3864386|P5|NOT COMPLETED|Treatment Period 3||1
1579585|NCT01120093|3864387|P4|NOT COMPLETED|Treatment Period 3||1
1579586|NCT01120093|3864388|P3|NOT COMPLETED|Treatment Period 3||1
1579587|NCT01120093|3864389|P2|NOT COMPLETED|Treatment Period 3||0
1579588|NCT01120093|3864390|P1|NOT COMPLETED|Treatment Period 3||0
1579589|NCT01120093|3864386|P5|COMPLETED|Treatment Period 3||13
1579590|NCT01120093|3864387|P4|COMPLETED|Treatment Period 3||12
1579591|NCT01120093|3864388|P3|COMPLETED|Treatment Period 3||15
1579592|NCT01120093|3864389|P2|COMPLETED|Treatment Period 3||13
1579593|NCT01120093|3864390|P1|COMPLETED|Treatment Period 3||18
1579594|NCT01120093|3864386|P5|STARTED|Treatment Period 3||14
1579595|NCT01120093|3864387|P4|STARTED|Treatment Period 3||13
1579596|NCT01120093|3864388|P3|STARTED|Treatment Period 3||16
1579597|NCT01120093|3864389|P2|STARTED|Treatment Period 3||13
1579598|NCT01120093|3864390|P1|STARTED|Treatment Period 3||18
1579599|NCT01120093|3864386|P5|NOT COMPLETED|Treatment Period 2||1
1579600|NCT01120093|3864387|P4|NOT COMPLETED|Treatment Period 2||1
1579601|NCT01120093|3864388|P3|NOT COMPLETED|Treatment Period 2||0
1579602|NCT01120093|3864389|P2|NOT COMPLETED|Treatment Period 2||0
1579603|NCT01120093|3864390|P1|NOT COMPLETED|Treatment Period 2||0
1579604|NCT01120093|3864386|P5|COMPLETED|Treatment Period 2||14
1579605|NCT01120093|3864387|P4|COMPLETED|Treatment Period 2||13
1579606|NCT01120093|3864388|P3|COMPLETED|Treatment Period 2||16
1579607|NCT01120093|3864389|P2|COMPLETED|Treatment Period 2||13
1579608|NCT01120093|3864390|P1|COMPLETED|Treatment Period 2||18
1579609|NCT01120093|3864386|P5|STARTED|Treatment Period 2||15
1579610|NCT01120093|3864387|P4|STARTED|Treatment Period 2||14
1579611|NCT01120093|3864388|P3|STARTED|Treatment Period 2||16
1579612|NCT01120093|3864389|P2|STARTED|Treatment Period 2||13
1579613|NCT01120093|3864390|P1|STARTED|Treatment Period 2||18
1579614|NCT01120093|3864386|P5|NOT COMPLETED|Treatment Period 1||1
1579615|NCT01120093|3864387|P4|NOT COMPLETED|Treatment Period 1||0
1579616|NCT01120093|3864388|P3|NOT COMPLETED|Treatment Period 1||1
1579617|NCT01120093|3864389|P2|NOT COMPLETED|Treatment Period 1||1
1579618|NCT01120093|3864390|P1|NOT COMPLETED|Treatment Period 1||0
1579619|NCT01120093|3864386|P5|COMPLETED|Treatment Period 1||15
1579620|NCT01120093|3864387|P4|COMPLETED|Treatment Period 1||14
1579621|NCT01120093|3864388|P3|COMPLETED|Treatment Period 1||16
1579622|NCT01120093|3864389|P2|COMPLETED|Treatment Period 1||13
1579623|NCT01120093|3864390|P1|COMPLETED|Treatment Period 1||18
1579624|NCT01120093|3864386|P5|STARTED|Treatment Period 1||16
1579625|NCT01120093|3864387|P4|STARTED|Treatment Period 1||14
1579626|NCT01120093|3864388|P3|STARTED|Treatment Period 1||17
1579627|NCT01120093|3864389|P2|STARTED|Treatment Period 1||14
1579628|NCT01120093|3864390|P1|STARTED|Treatment Period 1||18
1579629|NCT01120067|3864419|P2|NOT COMPLETED|Overall Study||1
1579630|NCT01120067|3864420|P1|NOT COMPLETED|Overall Study||5
1579631|NCT01120067|3864419|P2|COMPLETED|Overall Study||10
1579632|NCT01120067|3864420|P1|COMPLETED|Overall Study||7
1579633|NCT01120067|3864419|P2|STARTED|Overall Study||11
1579634|NCT01120067|3864420|P1|STARTED|Overall Study||12
1579635|NCT01119963|3864428|P2|NOT COMPLETED|Overall Study||1
1579636|NCT01119963|3864429|P1|NOT COMPLETED|Overall Study||1
1579637|NCT01119963|3864428|P2|COMPLETED|Overall Study||77
1579638|NCT01119963|3864429|P1|COMPLETED|Overall Study||73
1579639|NCT01119963|3864428|P2|STARTED|Overall Study||78
1579640|NCT01119963|3864429|P1|STARTED|Overall Study||74
1579641|NCT01119950|3864439|P1|NOT COMPLETED|Overall Study||47
1579642|NCT01119950|3864439|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
1579643|NCT01119950|3864439|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
1579644|NCT01119950|3864439|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
1579645|NCT01119950|3864439|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
1579646|NCT01119950|3864439|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
1579647|NCT01119950|3864439|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
1579648|NCT01119950|3864439|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
1579649|NCT01119950|3864439|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
1579650|NCT01119950|3864439|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
1579651|NCT01119950|3864439|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
1579652|NCT01119937|3864686|P2|NOT COMPLETED|Overall Study||7
1579653|NCT01119937|3864687|P1|NOT COMPLETED|Overall Study||19
1579654|NCT01119937|3864686|P2|COMPLETED|Overall Study||33
1579655|NCT01119937|3864687|P1|COMPLETED|Overall Study||104
1579656|NCT01119937|3864686|P2|STARTED|Overall Study||40
1579657|NCT01119937|3864687|P1|STARTED|Overall Study||123
1579658|NCT01119859|3864715|P2|NOT COMPLETED|Overall Study||30
1579659|NCT01119859|3864716|P1|NOT COMPLETED|Overall Study||24
1579660|NCT01119859|3864715|P2|COMPLETED|Overall Study||133
1579661|NCT01119859|3864716|P1|COMPLETED|Overall Study||139
1579662|NCT01119859|3864715|P2|STARTED|Overall Study||163
1579663|NCT01119859|3864716|P1|STARTED|Overall Study||163
1579664|NCT01119846|3864735|P3|NOT COMPLETED|Overall Study||11
1579665|NCT01119846|3864736|P2|NOT COMPLETED|Overall Study||0
1579666|NCT01119846|3864737|P1|NOT COMPLETED|Overall Study||2
1579667|NCT01119846|3864735|P3|COMPLETED|Overall Study||72
1579668|NCT01119846|3864736|P2|COMPLETED|Overall Study||4
1579669|NCT01119846|3864737|P1|COMPLETED|Overall Study||11
1579670|NCT01119846|3864735|P3|STARTED|Overall Study||83
1579671|NCT01119846|3864736|P2|STARTED|Overall Study||4
1579672|NCT01119846|3864737|P1|STARTED|Overall Study||13
1579673|NCT01119794|3864945|P1|NOT COMPLETED|Overall Study||0
1579674|NCT01119794|3864945|P1|COMPLETED|Overall Study||10
1579675|NCT01119794|3864945|P1|STARTED|Overall Study||10
1579676|NCT01119768|3864951|P2|NOT COMPLETED|Follow-up||2
1579677|NCT01119768|3864952|P1|NOT COMPLETED|Follow-up||1
1579678|NCT01119768|3864951|P2|COMPLETED|Follow-up||122
1579679|NCT01119768|3864952|P1|COMPLETED|Follow-up||135
1579680|NCT01119768|3864951|P2|STARTED|Follow-up||124
1579681|NCT01119768|3864952|P1|STARTED|Follow-up||136
1579682|NCT01119768|3864951|P2|NOT COMPLETED|Treatment Period||25
1579683|NCT01119768|3864952|P1|NOT COMPLETED|Treatment Period||18
1579684|NCT01119768|3864951|P2|COMPLETED|Treatment Period||126
1579685|NCT01119768|3864952|P1|COMPLETED|Treatment Period||136
1579686|NCT01119768|3864951|P2|STARTED|Treatment Period||151
1579687|NCT01119768|3864952|P1|STARTED|Treatment Period||154
1579688|NCT01119755|3864974|P1|NOT COMPLETED|Overall Study||0
1579689|NCT01119755|3864974|P1|COMPLETED|Overall Study||80
1579690|NCT01119755|3864974|P1|STARTED|Overall Study||80
1579691|NCT01119716|3864985|P1|NOT COMPLETED|Overall Study||0
1579692|NCT01119716|3864985|P1|COMPLETED|Overall Study||4658
1579693|NCT01119716|3864985|P1|STARTED|Overall Study||4658
1579694|NCT01119703|3865008|P2|NOT COMPLETED|Overall Study||1
1579695|NCT01119703|3865009|P1|NOT COMPLETED|Overall Study||0
1579696|NCT01119703|3865008|P2|COMPLETED|Overall Study||143
1579697|NCT01119703|3865009|P1|COMPLETED|Overall Study||30
1579698|NCT01119703|3865008|P2|STARTED|Overall Study||144
1579699|NCT01119703|3865009|P1|STARTED|Overall Study||30
1579700|NCT01119625|3865023|P2|NOT COMPLETED|Overall Study||4
1579701|NCT01119625|3865024|P1|NOT COMPLETED|Overall Study||3
1579702|NCT01119625|3865023|P2|COMPLETED|Overall Study||116
1579703|NCT01119625|3865024|P1|COMPLETED|Overall Study||115
1579704|NCT01119625|3865023|P2|STARTED|Overall Study||120
1579705|NCT01119625|3865024|P1|STARTED|Overall Study||118
1579706|NCT01119443|3865066|P2|NOT COMPLETED|End of Study (All Patients)||0
1579707|NCT01119443|3865067|P1|NOT COMPLETED|End of Study (All Patients)||0
1579708|NCT01119443|3865066|P2|COMPLETED|End of Study (All Patients)||14
1579709|NCT01119443|3865067|P1|COMPLETED|End of Study (All Patients)||14
1579710|NCT01119443|3865066|P2|STARTED|End of Study (All Patients)||14
1579711|NCT01119443|3865067|P1|STARTED|End of Study (All Patients)||14
1579712|NCT01119443|3865066|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
1579713|NCT01119443|3865067|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
1579714|NCT01119443|3865066|P2|COMPLETED|Down-titration Period (1 Day)||13
1579715|NCT01119443|3865067|P1|COMPLETED|Down-titration Period (1 Day)||14
1579716|NCT01119443|3865066|P2|STARTED|Down-titration Period (1 Day)||13
1579717|NCT01119443|3865067|P1|STARTED|Down-titration Period (1 Day)||14
1579718|NCT01119443|3865066|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
1579719|NCT01119443|3865067|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
1579720|NCT01119443|3865066|P2|COMPLETED|Crossover Period 4 (5 Days)||13
1579721|NCT01119443|3865067|P1|COMPLETED|Crossover Period 4 (5 Days)||14
1579722|NCT01119443|3865066|P2|STARTED|Crossover Period 4 (5 Days)||13
1579723|NCT01119443|3865067|P1|STARTED|Crossover Period 4 (5 Days)||14
1579724|NCT01119443|3865066|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
1579725|NCT01119443|3865067|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
1579726|NCT01119443|3865066|P2|COMPLETED|Crossover Period 3 (5 Days)||13
1579727|NCT01119443|3865067|P1|COMPLETED|Crossover Period 3 (5 Days)||14
1579728|NCT01119443|3865066|P2|STARTED|Crossover Period 3 (5 Days)||13
1579729|NCT01119443|3865067|P1|STARTED|Crossover Period 3 (5 Days)||14
1579730|NCT01119443|3865066|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
1579731|NCT01119443|3865067|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
1579732|NCT01119443|3865066|P2|COMPLETED|Crossover Period 2 (5 Days)||13
1579733|NCT01119443|3865067|P1|COMPLETED|Crossover Period 2 (5 Days)||14
1579734|NCT01119443|3865066|P2|STARTED|Crossover Period 2 (5 Days)||13
1579735|NCT01119443|3865067|P1|STARTED|Crossover Period 2 (5 Days)||14
1579736|NCT01119443|3865066|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
1579737|NCT01119443|3865067|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
1579738|NCT01119443|3865066|P2|COMPLETED|Crossover Period 1 (5 Days)||13
1579739|NCT01119443|3865067|P1|COMPLETED|Crossover Period 1 (5 Days)||14
1579740|NCT01119443|3865066|P2|STARTED|Crossover Period 1 (5 Days)||14
1579741|NCT01119443|3865067|P1|STARTED|Crossover Period 1 (5 Days)||14
1579742|NCT01119443|3865066|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
1579743|NCT01119443|3865067|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
1579744|NCT01119443|3865066|P2|COMPLETED|Up-titration Period (10 Days)||14
1579745|NCT01119443|3865067|P1|COMPLETED|Up-titration Period (10 Days)||14
1579746|NCT01119443|3865066|P2|STARTED|Up-titration Period (10 Days)||14
1579747|NCT01119443|3865067|P1|STARTED|Up-titration Period (10 Days)||14
1579748|NCT01119287|3865110|P6|NOT COMPLETED|Overall Study||0
1579749|NCT01119287|3865111|P5|NOT COMPLETED|Overall Study||1
1579750|NCT01119287|3865112|P4|NOT COMPLETED|Overall Study||2
1579751|NCT01119287|3865113|P3|NOT COMPLETED|Overall Study||2
1579752|NCT01119287|3865114|P2|NOT COMPLETED|Overall Study||0
1579753|NCT01119287|3865115|P1|NOT COMPLETED|Overall Study||0
1579754|NCT01119287|3865110|P6|COMPLETED|Overall Study||32
1579755|NCT01119287|3865111|P5|COMPLETED|Overall Study||30
1579756|NCT01119287|3865112|P4|COMPLETED|Overall Study||29
1579757|NCT01119287|3865113|P3|COMPLETED|Overall Study||24
1579758|NCT01119287|3865114|P2|COMPLETED|Overall Study||24
1579759|NCT01119287|3865115|P1|COMPLETED|Overall Study||26
1579760|NCT01119287|3865110|P6|STARTED|Overall Study||32
1579761|NCT01119287|3865111|P5|STARTED|Overall Study||31
1579762|NCT01119287|3865112|P4|STARTED|Overall Study||31
1579763|NCT01119287|3865113|P3|STARTED|Overall Study||26
1579764|NCT01119287|3865114|P2|STARTED|Overall Study||24
1579765|NCT01119287|3865115|P1|STARTED|Overall Study||26
1579766|NCT01119248|3865128|P1|NOT COMPLETED|Overall Study||5
1579767|NCT01119248|3865128|P1|COMPLETED|Overall Study||115
1579768|NCT01119248|3865128|P1|STARTED|Overall Study||120
1579769|NCT01119222|3865134|P4|NOT COMPLETED|Overall Study||0
1579770|NCT01119222|3865135|P3|NOT COMPLETED|Overall Study||0
1579771|NCT01119222|3865136|P2|NOT COMPLETED|Overall Study||0
1579772|NCT01119222|3865137|P1|NOT COMPLETED|Overall Study||0
1579773|NCT01119222|3865134|P4|COMPLETED|Overall Study||4
1579774|NCT01119222|3865135|P3|COMPLETED|Overall Study||5
1579775|NCT01119222|3865136|P2|COMPLETED|Overall Study||5
1579776|NCT01119222|3865137|P1|COMPLETED|Overall Study||5
1579777|NCT01119222|3865134|P4|STARTED|Overall Study||4
1579778|NCT01119222|3865135|P3|STARTED|Overall Study||5
1579779|NCT01119222|3865136|P2|STARTED|Overall Study||5
1579780|NCT01119222|3865137|P1|STARTED|Overall Study||5
1579781|NCT01119131|3865178|P3|NOT COMPLETED|Overall Study||6
1579782|NCT01119131|3865179|P2|NOT COMPLETED|Overall Study||1
1579783|NCT01119131|3865180|P1|NOT COMPLETED|Overall Study||2
1579784|NCT01119131|3865178|P3|COMPLETED|Overall Study||24
1579785|NCT01119131|3865179|P2|COMPLETED|Overall Study||27
1579786|NCT01119131|3865180|P1|COMPLETED|Overall Study||8
1579787|NCT01119131|3865178|P3|STARTED|Overall Study||30
1579788|NCT01119131|3865179|P2|STARTED|Overall Study||28
1579789|NCT01119131|3865180|P1|STARTED|Overall Study||10
1579790|NCT01119118|3865209|P1|NOT COMPLETED|Overall Study||1
1579791|NCT01119118|3865209|P1|COMPLETED|Overall Study||5
1579792|NCT01119118|3865209|P1|STARTED|Overall Study||6
1579793|NCT01119040|3865217|P1|NOT COMPLETED|Overall Study||1
1579794|NCT01119040|3865217|P1|COMPLETED|Overall Study||0
1579795|NCT01119040|3865217|P1|STARTED|Overall Study||1
1579796|NCT01119001|3865221|P1|NOT COMPLETED|Overall Study||2
1579797|NCT01119001|3865221|P1|COMPLETED|Overall Study||11
1579798|NCT01119001|3865221|P1|STARTED|Overall Study||13
1579799|NCT01118988|3865230|P3|NOT COMPLETED|Overall Study||4
1579800|NCT01118988|3865231|P2|NOT COMPLETED|Overall Study||1
1579801|NCT01118988|3865232|P1|NOT COMPLETED|Overall Study||5
1579802|NCT01118988|3865230|P3|COMPLETED|Overall Study||3
1579803|NCT01118988|3865231|P2|COMPLETED|Overall Study||3
1579804|NCT01118988|3865232|P1|COMPLETED|Overall Study||11
1579805|NCT01118988|3865230|P3|STARTED|Overall Study||7
1579806|NCT01118988|3865231|P2|STARTED|Overall Study||4
1579807|NCT01118988|3865232|P1|STARTED|Overall Study||16
1579808|NCT01118975|3865265|P2|NOT COMPLETED|Overall Study||1
1579809|NCT01118975|3865266|P1|NOT COMPLETED|Overall Study||0
1579810|NCT01118975|3865265|P2|COMPLETED|Overall Study||2
1579811|NCT01118975|3865266|P1|COMPLETED|Overall Study||9
1579812|NCT01118975|3865265|P2|STARTED|Overall Study||3
1579813|NCT01118975|3865266|P1|STARTED|Overall Study||9
1579814|NCT01118962|3865272|P1|NOT COMPLETED|Overall Study||10
1579815|NCT01118962|3865272|P1|COMPLETED|Overall Study||29
1579816|NCT01118962|3865272|P1|STARTED|Overall Study||39
1579817|NCT01118949|3865277|P1|NOT COMPLETED|Overall Study||9
1579818|NCT01118949|3865277|P1|COMPLETED|Overall Study||40
1579819|NCT01118949|3865277|P1|STARTED|Overall Study||49
1579820|NCT01118845|3865286|P1|NOT COMPLETED|Overall Study||42
1579821|NCT01118845|3865286|P1|COMPLETED|Overall Study||17
1579822|NCT01118845|3865286|P1|STARTED|Overall Study||59
1579823|NCT01118780|3865307|P2|NOT COMPLETED|Overall Study||35
1579824|NCT01118780|3865308|P1|NOT COMPLETED|Overall Study||36
1579825|NCT01118780|3865307|P2|COMPLETED|Overall Study||105
1579826|NCT01118780|3865308|P1|COMPLETED|Overall Study||115
1579827|NCT01118780|3865307|P2|STARTED|Overall Study||140
1579828|NCT01118780|3865308|P1|STARTED|Overall Study||151
1579829|NCT01118741|3865357|P2|NOT COMPLETED|Overall Study||0
1579830|NCT01118741|3865358|P1|NOT COMPLETED|Overall Study||0
1579831|NCT01118741|3865357|P2|COMPLETED|Overall Study||10
1579832|NCT01118741|3865358|P1|COMPLETED|Overall Study||9
1579833|NCT01118741|3865357|P2|STARTED|Overall Study||10
1579834|NCT01118741|3865358|P1|STARTED|Overall Study||9
1579835|NCT01118728|3865366|P1|NOT COMPLETED|Overall Study||223
1579836|NCT01118728|3865366|P1|COMPLETED|Overall Study||0
1579837|NCT01118728|3865366|P1|STARTED|Overall Study||223
1579838|NCT01118663|3865373|P2|NOT COMPLETED|Overall Study||2
1579839|NCT01118663|3865374|P1|NOT COMPLETED|Overall Study||2
1579840|NCT01118663|3865373|P2|COMPLETED|Overall Study||8
1579841|NCT01118663|3865374|P1|COMPLETED|Overall Study||5
1579842|NCT01118663|3865373|P2|STARTED|Overall Study||10
1579843|NCT01118663|3865374|P1|STARTED|Overall Study||7
1579844|NCT01118624|3865388|P1|NOT COMPLETED|Overall Study||22
1579845|NCT01118624|3865388|P1|COMPLETED|Overall Study||0
1579846|NCT01118624|3865388|P1|STARTED|Overall Study||22
1579847|NCT01118455|3865397|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
1579848|NCT01118455|3865398|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
1579849|NCT01118455|3865397|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
1579850|NCT01118455|3865398|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
1579851|NCT01118455|3865397|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
1579852|NCT01118455|3865398|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
1579853|NCT01118455|3865397|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
1579854|NCT01118455|3865398|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
1579855|NCT01118455|3865397|P2|COMPLETED|Baseline [Visits 1 & 2]||69
1579856|NCT01118455|3865398|P1|COMPLETED|Baseline [Visits 1 & 2]||65
1579857|NCT01118455|3865397|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
1579858|NCT01118455|3865398|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
1579859|NCT01118455|3865397|P2|STARTED|Baseline [Visits 1 & 2]||69
1579860|NCT01118455|3865398|P1|STARTED|Baseline [Visits 1 & 2]||66
1579861|NCT01118377|3865426|P1|NOT COMPLETED|Overall Study||42
1579862|NCT01118377|3865426|P1|COMPLETED|Overall Study||3
1579863|NCT01118377|3865426|P1|STARTED|Overall Study||45
1579864|NCT01118325|3865435|P3|NOT COMPLETED|Overall Study||1
1579865|NCT01118325|3865436|P2|NOT COMPLETED|Overall Study||0
1579866|NCT01118325|3865437|P1|NOT COMPLETED|Overall Study||1
1579867|NCT01118325|3865435|P3|COMPLETED|Overall Study||45
1579868|NCT01118325|3865436|P2|COMPLETED|Overall Study||43
1579869|NCT01118325|3865437|P1|COMPLETED|Overall Study||49
1579870|NCT01118325|3865435|P3|STARTED|Overall Study||46
1579871|NCT01118325|3865436|P2|STARTED|Overall Study||43
1579872|NCT01118325|3865437|P1|STARTED|Overall Study||50
1579873|NCT01118312|3865483|P2|NOT COMPLETED|Overall Study||35
1579874|NCT01118312|3865484|P1|NOT COMPLETED|Overall Study||34
1579875|NCT01118312|3865483|P2|COMPLETED|Overall Study||164
1579876|NCT01118312|3865484|P1|COMPLETED|Overall Study||155
1579877|NCT01118312|3865483|P2|STARTED|Overall Study||199
1579878|NCT01118312|3865484|P1|STARTED|Overall Study||189
1579879|NCT01118273|3865498|P6|NOT COMPLETED|Overall Study||0
1579880|NCT01118273|3865499|P5|NOT COMPLETED|Overall Study||0
1579881|NCT01118273|3865500|P4|NOT COMPLETED|Overall Study||0
1579882|NCT01118273|3865501|P3|NOT COMPLETED|Overall Study||0
1579883|NCT01118273|3865502|P2|NOT COMPLETED|Overall Study||0
1579884|NCT01118273|3865503|P1|NOT COMPLETED|Overall Study||0
1579885|NCT01118273|3865498|P6|COMPLETED|Overall Study||27
1579886|NCT01118273|3865499|P5|COMPLETED|Overall Study||27
1579887|NCT01118273|3865500|P4|COMPLETED|Overall Study||27
1579888|NCT01118273|3865501|P3|COMPLETED|Overall Study||27
1579889|NCT01118273|3865502|P2|COMPLETED|Overall Study||27
1579890|NCT01118273|3865503|P1|COMPLETED|Overall Study||27
1579891|NCT01118273|3865498|P6|STARTED|Overall Study||27
1579892|NCT01118273|3865499|P5|STARTED|Overall Study||27
1579893|NCT01118273|3865500|P4|STARTED|Overall Study||27
1579894|NCT01118273|3865501|P3|STARTED|Overall Study||27
1579895|NCT01118273|3865502|P2|STARTED|Overall Study||27
1579896|NCT01118273|3865503|P1|STARTED|Overall Study||27
1579897|NCT01118221|3865669|P2|NOT COMPLETED|Overall Study||1
1579898|NCT01118221|3865670|P1|NOT COMPLETED|Overall Study||3
1579899|NCT01118221|3865669|P2|COMPLETED|Overall Study||10
1579900|NCT01118221|3865670|P1|COMPLETED|Overall Study||11
1579901|NCT01118221|3865669|P2|STARTED|Overall Study||11
1579902|NCT01118221|3865670|P1|STARTED|Overall Study||14
1579903|NCT01118143|3865682|P2|NOT COMPLETED|Overall Study||5
1579904|NCT01118143|3865683|P1|NOT COMPLETED|Overall Study||2
1579905|NCT01118143|3865682|P2|COMPLETED|Overall Study||64
1579906|NCT01118143|3865683|P1|COMPLETED|Overall Study||62
1579907|NCT01118143|3865682|P2|STARTED|Overall Study||69
1579908|NCT01118143|3865683|P1|STARTED|Overall Study||64
1579909|NCT01118117|3865693|P2|NOT COMPLETED|Overall Study||0
1579910|NCT01118117|3865694|P1|NOT COMPLETED|Overall Study||21
1579911|NCT01118117|3865693|P2|COMPLETED|Overall Study||15
1579912|NCT01118117|3865694|P1|COMPLETED|Overall Study||240
1579913|NCT01118117|3865693|P2|STARTED|Overall Study||15
1579914|NCT01118117|3865694|P1|STARTED|Overall Study||261
1579915|NCT01118091|3865715|P2|NOT COMPLETED|Overall Study||0
1579916|NCT01118091|3865716|P1|NOT COMPLETED|Overall Study||0
1579917|NCT01118091|3865715|P2|COMPLETED|Overall Study||5
1579918|NCT01118091|3865716|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
1579919|NCT01118091|3865715|P2|STARTED|Overall Study||5
1579920|NCT01118091|3865716|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
1579921|NCT01118052|3865726|P1|NOT COMPLETED|Overall Study||2
1579922|NCT01118052|3865726|P1|COMPLETED|Overall Study||20
1579923|NCT01118052|3865726|P1|STARTED|Overall Study||22
1579924|NCT01118013|3865739|P1|NOT COMPLETED|Overall Study||0
1579925|NCT01118013|3865739|P1|COMPLETED|Overall Study||6
1579926|NCT01118013|3865739|P1|STARTED|Overall Study||6
1579927|NCT01117987|3865749|P2|NOT COMPLETED|Overall Study||74
1579928|NCT01117987|3865750|P1|NOT COMPLETED|Overall Study||61
1579929|NCT01117987|3865749|P2|COMPLETED|Overall Study||4
1579930|NCT01117987|3865750|P1|COMPLETED|Overall Study||5
1579931|NCT01117987|3865749|P2|STARTED|Overall Study||78
1579932|NCT01117987|3865750|P1|STARTED|Overall Study||66
1579933|NCT01117948|3865762|P2|NOT COMPLETED|Open Label||47
1579934|NCT01117948|3865763|P1|NOT COMPLETED|Open Label||52
1579935|NCT01117948|3865762|P2|COMPLETED|Open Label||51
1579936|NCT01117948|3865763|P1|COMPLETED|Open Label||41
1579937|NCT01117948|3865762|P2|STARTED|Open Label||98
1579938|NCT01117948|3865763|P1|STARTED|Open Label||93
1579939|NCT01117948|3865762|P2|NOT COMPLETED|Double Blind||10
1579940|NCT01117948|3865763|P1|NOT COMPLETED|Double Blind||18
1579941|NCT01117948|3865762|P2|COMPLETED|Double Blind||98
1579942|NCT01117948|3865763|P1|COMPLETED|Double Blind||93
1579943|NCT01117948|3865762|P2|STARTED|Double Blind||108
1579944|NCT01117948|3865763|P1|STARTED|Double Blind||111
1579945|NCT01117870|3865771|P2|NOT COMPLETED|Overall Study||0
1579946|NCT01117870|3865772|P1|NOT COMPLETED|Overall Study||1
1579947|NCT01117870|3865771|P2|COMPLETED|Overall Study||16
1579948|NCT01117870|3865772|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
1579949|NCT01117870|3865771|P2|STARTED|Overall Study||16
1579950|NCT01117870|3865772|P1|STARTED|Overall Study||15
1579951|NCT01117857|3865786|P1|NOT COMPLETED|Overall Study||9
1579952|NCT01117857|3865786|P1|COMPLETED|Overall Study||13
1579953|NCT01117857|3865786|P1|STARTED|Overall Study||22
1579954|NCT01117766|3865794|P2|NOT COMPLETED|Second Intervention||5
1579955|NCT01117766|3865795|P1|NOT COMPLETED|Second Intervention||2
1579956|NCT01117766|3865794|P2|COMPLETED|Second Intervention||9
1579957|NCT01117766|3865795|P1|COMPLETED|Second Intervention||11
1579958|NCT01117766|3865794|P2|STARTED|Second Intervention||14
1579959|NCT01117766|3865795|P1|STARTED|Second Intervention||13
1579960|NCT01117766|3865794|P2|NOT COMPLETED|Washout Period||2
1579961|NCT01117766|3865795|P1|NOT COMPLETED|Washout Period||0
1579962|NCT01117766|3865794|P2|COMPLETED|Washout Period||14
1579963|NCT01117766|3865795|P1|COMPLETED|Washout Period||13
1579964|NCT01117766|3865794|P2|STARTED|Washout Period||16
1579965|NCT01117766|3865795|P1|STARTED|Washout Period||13
1579966|NCT01117766|3865794|P2|NOT COMPLETED|First Intervention||1
1579967|NCT01117766|3865795|P1|NOT COMPLETED|First Intervention||1
1579968|NCT01117766|3865794|P2|COMPLETED|First Intervention||16
1579969|NCT01117766|3865795|P1|COMPLETED|First Intervention||13
1579970|NCT01117766|3865794|P2|Received Treatment|First Intervention||17
1579971|NCT01117766|3865795|P1|Received Treatment|First Intervention||14
1579972|NCT01117766|3865794|P2|STARTED|First Intervention||17
1579973|NCT01117766|3865795|P1|STARTED|First Intervention||14
1579974|NCT01117727|3865819|P1|NOT COMPLETED|Overall Study||0
1579975|NCT01117727|3865819|P1|COMPLETED|Overall Study||1
1579976|NCT01117727|3865819|P1|STARTED|Overall Study||1
1579977|NCT01117623|3865832|P8|NOT COMPLETED|Overall Study||26
1579978|NCT01117623|3865833|P7|NOT COMPLETED|Overall Study||6
1579979|NCT01117623|3865834|P6|NOT COMPLETED|Overall Study||16
1579980|NCT01117623|3865835|P5|NOT COMPLETED|Overall Study||10
1579981|NCT01117623|3865836|P4|NOT COMPLETED|Overall Study||6
1579982|NCT01117623|3865837|P3|NOT COMPLETED|Overall Study||11
1579983|NCT01117623|3865838|P2|NOT COMPLETED|Overall Study||8
1579984|NCT01117623|3865839|P1|NOT COMPLETED|Overall Study||3
1579985|NCT01117623|3865832|P8|COMPLETED|Overall Study||0
1579986|NCT01117623|3865833|P7|COMPLETED|Overall Study||0
1579987|NCT01117623|3865834|P6|COMPLETED|Overall Study||0
1579988|NCT01117623|3865835|P5|COMPLETED|Overall Study||0
1579989|NCT01117623|3865836|P4|COMPLETED|Overall Study||0
1579990|NCT01117623|3865837|P3|COMPLETED|Overall Study||0
1579991|NCT01117623|3865838|P2|COMPLETED|Overall Study||0
1579992|NCT01117623|3865839|P1|COMPLETED|Overall Study||0
1579993|NCT01117623|3865832|P8|PK Population|Overall Study||24
1579994|NCT01117623|3865833|P7|PK Population|Overall Study||6
1579995|NCT01117623|3865834|P6|PK Population|Overall Study||14
1579996|NCT01117623|3865835|P5|PK Population|Overall Study||10
1579997|NCT01117623|3865836|P4|PK Population|Overall Study||6
1579998|NCT01117623|3865837|P3|PK Population|Overall Study||10
1579999|NCT01117623|3865838|P2|PK Population|Overall Study||8
1580000|NCT01117623|3865839|P1|PK Population|Overall Study||3
1580001|NCT01117623|3865832|P8|ITT Efficacy Analysis Population|Overall Study||22
1580002|NCT01117623|3865833|P7|ITT Efficacy Analysis Population|Overall Study||6
1580003|NCT01117623|3865834|P6|ITT Efficacy Analysis Population|Overall Study||16
1580004|NCT01117623|3865835|P5|ITT Efficacy Analysis Population|Overall Study||10
1580005|NCT01117623|3865836|P4|ITT Efficacy Analysis Population|Overall Study||5
1580006|NCT01117623|3865837|P3|ITT Efficacy Analysis Population|Overall Study||11
1580007|NCT01117623|3865838|P2|ITT Efficacy Analysis Population|Overall Study||8
1580008|NCT01117623|3865839|P1|ITT Efficacy Analysis Population|Overall Study||3
1580009|NCT01117623|3865832|P8|STARTED|Overall Study||26
1580010|NCT01117623|3865833|P7|STARTED|Overall Study||6
1580011|NCT01117623|3865834|P6|STARTED|Overall Study||16
1580012|NCT01117623|3865835|P5|STARTED|Overall Study||10
1580013|NCT01117623|3865836|P4|STARTED|Overall Study||6
1580014|NCT01117623|3865837|P3|STARTED|Overall Study||11
1580015|NCT01117623|3865838|P2|STARTED|Overall Study||8
1580016|NCT01117623|3865839|P1|STARTED|Overall Study||3
1580017|NCT01117480|3865991|P1|NOT COMPLETED|Overall Study||28
1580018|NCT01117480|3865991|P1|COMPLETED|Overall Study||985
1580019|NCT01117480|3865991|P1|STARTED|Overall Study||1013
1580020|NCT01117454|3865999|P2|NOT COMPLETED|Overall Study||1
1580021|NCT01117454|3866000|P1|NOT COMPLETED|Overall Study||0
1580022|NCT01117454|3865999|P2|COMPLETED|Overall Study||7
1580023|NCT01117454|3866000|P1|COMPLETED|Overall Study||6
1580024|NCT01117454|3865999|P2|STARTED|Overall Study||8
1580025|NCT01117454|3866000|P1|STARTED|Overall Study||6
1580026|NCT01117428|3866012|P6|NOT COMPLETED|Overall Study||20
1580027|NCT01117428|3866013|P5|NOT COMPLETED|Overall Study||17
1580028|NCT01117428|3866014|P4|NOT COMPLETED|Overall Study||12
1580029|NCT01117428|3866015|P3|NOT COMPLETED|Overall Study||13
1580030|NCT01117428|3866016|P2|NOT COMPLETED|Overall Study||29
1580031|NCT01117428|3866017|P1|NOT COMPLETED|Overall Study||20
1580032|NCT01117428|3866012|P6|COMPLETED|Overall Study||0
1580033|NCT01117428|3866013|P5|COMPLETED|Overall Study||0
1580034|NCT01117428|3866014|P4|COMPLETED|Overall Study||0
1580035|NCT01117428|3866015|P3|COMPLETED|Overall Study||0
1580036|NCT01117428|3866016|P2|COMPLETED|Overall Study||0
1580037|NCT01117428|3866017|P1|COMPLETED|Overall Study||0
1580038|NCT01117428|3866012|P6|STARTED|Overall Study||20
1580039|NCT01117428|3866013|P5|STARTED|Overall Study||17
1580040|NCT01117428|3866014|P4|STARTED|Overall Study||12
1580041|NCT01117428|3866015|P3|STARTED|Overall Study||13
1580042|NCT01117428|3866016|P2|STARTED|Overall Study||29
1580043|NCT01117428|3866017|P1|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
1580044|NCT01117350|3866051|P2|NOT COMPLETED|Extension Period||63
1580045|NCT01117350|3866052|P1|NOT COMPLETED|Extension Period||0
1580046|NCT01117350|3866051|P2|COMPLETED|Extension Period||147
1580047|NCT01117350|3866052|P1|COMPLETED|Extension Period||0
1580048|NCT01117350|3866051|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
1580049|NCT01117350|3866052|P1|mITT Population (Extension)|Extension Period||0
1580050|NCT01117350|3866051|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
1580051|NCT01117350|3866052|P1|TREATED = Safety Population (Extension)|Extension Period||0
1580052|NCT01117350|3866051|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
1580053|NCT01117350|3866052|P1|STARTED|Extension Period||0
1580054|NCT01117350|3866051|P2|NOT COMPLETED|Comparative Period||75
1580055|NCT01117350|3866052|P1|NOT COMPLETED|Comparative Period||42
1580056|NCT01117350|3866051|P2|COMPLETED|Comparative Period||414
1580057|NCT01117350|3866052|P1|COMPLETED|Comparative Period||447
1580058|NCT01117350|3866051|P2|mITT Population|Comparative Period||470
1580059|NCT01117350|3866052|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
1580060|NCT01117350|3866051|P2|TREATED = Safety Population|Comparative Period||481
1580061|NCT01117350|3866052|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
1580062|NCT01117350|3866051|P2|STARTED|Comparative Period||489
1580063|NCT01117350|3866052|P1|STARTED|Comparative Period|STARTED: randomized|489
1580064|NCT01117337|3866084|P2|NOT COMPLETED|Overall Study||0
1580065|NCT01117337|3866085|P1|NOT COMPLETED|Overall Study||4
1580066|NCT01117337|3866084|P2|COMPLETED|Overall Study||52
1580067|NCT01117337|3866085|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
1580068|NCT01117337|3866084|P2|Underwent Surgery|Overall Study||52
1580069|NCT01117337|3866085|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
1580070|NCT01117337|3866084|P2|STARTED|Overall Study||52
1580071|NCT01117337|3866085|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
1580072|NCT01117311|3866095|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
1580073|NCT01117311|3866096|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
1580074|NCT01117311|3866095|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
1580075|NCT01117311|3866096|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
1580076|NCT01117311|3866095|P2|STARTED|Second Intervention - Mixed Meal 3||4
1580077|NCT01117311|3866096|P1|STARTED|Second Intervention - Mixed Meal 3||3
1580078|NCT01117311|3866095|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
1580079|NCT01117311|3866096|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
1580080|NCT01117311|3866095|P2|COMPLETED|First Intervention - Mixed Meal 2||4
1580081|NCT01117311|3866096|P1|COMPLETED|First Intervention - Mixed Meal 2||3
1580082|NCT01117311|3866095|P2|STARTED|First Intervention - Mixed Meal 2||4
1580083|NCT01117311|3866096|P1|STARTED|First Intervention - Mixed Meal 2||3
1580084|NCT01117311|3866095|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
1580085|NCT01117311|3866096|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
1580086|NCT01117311|3866095|P2|COMPLETED|Lead-in Mixed Meal 1||4
1580087|NCT01117311|3866096|P1|COMPLETED|Lead-in Mixed Meal 1||3
1580088|NCT01117311|3866095|P2|STARTED|Lead-in Mixed Meal 1||4
1580089|NCT01117311|3866096|P1|STARTED|Lead-in Mixed Meal 1||3
1580090|NCT01117181|3866106|P2|NOT COMPLETED|Overall Study||2
1580091|NCT01117181|3866107|P1|NOT COMPLETED|Overall Study||1
1580092|NCT01117181|3866106|P2|COMPLETED|Overall Study||29
1580093|NCT01117181|3866107|P1|COMPLETED|Overall Study||28
1580094|NCT01117181|3866106|P2|STARTED|Overall Study||31
1580095|NCT01117181|3866107|P1|STARTED|Overall Study||29
1580096|NCT01117090|3866127|P1|NOT COMPLETED|Overall Study||0
1580097|NCT01117090|3866127|P1|COMPLETED|Overall Study||47
1580098|NCT01117090|3866127|P1|STARTED|Overall Study||47
1580099|NCT01117051|3866140|P2|NOT COMPLETED|Overall Study||11
1580100|NCT01117051|3866141|P1|NOT COMPLETED|Overall Study||13
1580101|NCT01117051|3866140|P2|COMPLETED|Overall Study||77
1580102|NCT01117051|3866141|P1|COMPLETED|Overall Study||73
1580103|NCT01117051|3866140|P2|STARTED|Overall Study||88
1580104|NCT01117051|3866141|P1|STARTED|Overall Study||86
1580105|NCT01117012|3866151|P2|NOT COMPLETED|Overall Study||5
1580106|NCT01117012|3866152|P1|NOT COMPLETED|Overall Study||8
1580107|NCT01117012|3866151|P2|COMPLETED|Overall Study||98
1580108|NCT01117012|3866152|P1|COMPLETED|Overall Study||81
1580109|NCT01117012|3866151|P2|STARTED|Overall Study||103
1580110|NCT01117012|3866152|P1|STARTED|Overall Study||89
1580111|NCT01116986|3866200|P32|NOT COMPLETED|Overall Study||3
1580112|NCT01116986|3866201|P31|NOT COMPLETED|Overall Study||1
1580113|NCT01116986|3866202|P30|NOT COMPLETED|Overall Study||0
1580114|NCT01116986|3866203|P29|NOT COMPLETED|Overall Study||0
1580115|NCT01116986|3866204|P28|NOT COMPLETED|Overall Study||1
1580116|NCT01116986|3866205|P27|NOT COMPLETED|Overall Study||4
1580117|NCT01116986|3866206|P26|NOT COMPLETED|Overall Study||0
1580118|NCT01116986|3866207|P25|NOT COMPLETED|Overall Study||3
1580119|NCT01116986|3866208|P24|NOT COMPLETED|Overall Study||2
1580120|NCT01116986|3866209|P23|NOT COMPLETED|Overall Study||4
1580121|NCT01116986|3866210|P22|NOT COMPLETED|Overall Study||2
1580122|NCT01116986|3866211|P21|NOT COMPLETED|Overall Study||2
1580123|NCT01116986|3866212|P20|NOT COMPLETED|Overall Study||2
1580124|NCT01116986|3866213|P19|NOT COMPLETED|Overall Study||3
1580125|NCT01116986|3866214|P18|NOT COMPLETED|Overall Study||5
1580126|NCT01116986|3866215|P17|NOT COMPLETED|Overall Study||3
1580127|NCT01116986|3866216|P16|NOT COMPLETED|Overall Study||6
1580128|NCT01116986|3866217|P15|NOT COMPLETED|Overall Study||0
1580129|NCT01116986|3866218|P14|NOT COMPLETED|Overall Study||3
1580130|NCT01116986|3866219|P13|NOT COMPLETED|Overall Study||1
1580131|NCT01116986|3866220|P12|NOT COMPLETED|Overall Study||0
1580132|NCT01116986|3866221|P11|NOT COMPLETED|Overall Study||1
1580133|NCT01116986|3866222|P10|NOT COMPLETED|Overall Study||4
1580134|NCT01116986|3866223|P9|NOT COMPLETED|Overall Study||1
1580135|NCT01116986|3866224|P8|NOT COMPLETED|Overall Study||2
1580136|NCT01116986|3866225|P7|NOT COMPLETED|Overall Study||2
1580137|NCT01116986|3866226|P6|NOT COMPLETED|Overall Study||2
1580138|NCT01116986|3866227|P5|NOT COMPLETED|Overall Study||4
1580139|NCT01116986|3866228|P4|NOT COMPLETED|Overall Study||2
1580140|NCT01116986|3866229|P3|NOT COMPLETED|Overall Study||2
1580141|NCT01116986|3866230|P2|NOT COMPLETED|Overall Study||3
1580142|NCT01116986|3866231|P1|NOT COMPLETED|Overall Study||2
1580143|NCT01116986|3866200|P32|COMPLETED|Overall Study||14
1580144|NCT01116986|3866201|P31|COMPLETED|Overall Study||16
1580145|NCT01116986|3866202|P30|COMPLETED|Overall Study||17
1580146|NCT01116986|3866203|P29|COMPLETED|Overall Study||17
1580147|NCT01116986|3866204|P28|COMPLETED|Overall Study||18
1580148|NCT01116986|3866205|P27|COMPLETED|Overall Study||14
1580149|NCT01116986|3866206|P26|COMPLETED|Overall Study||19
1580150|NCT01116986|3866207|P25|COMPLETED|Overall Study||15
1580151|NCT01116986|3866208|P24|COMPLETED|Overall Study||19
1580152|NCT01116986|3866209|P23|COMPLETED|Overall Study||19
1580153|NCT01116986|3866210|P22|COMPLETED|Overall Study||18
1580154|NCT01116986|3866211|P21|COMPLETED|Overall Study||22
1580155|NCT01116986|3866212|P20|COMPLETED|Overall Study||13
1580156|NCT01116986|3866213|P19|COMPLETED|Overall Study||20
1580157|NCT01116986|3866214|P18|COMPLETED|Overall Study||19
1580158|NCT01116986|3866215|P17|COMPLETED|Overall Study||13
1580159|NCT01116986|3866216|P16|COMPLETED|Overall Study||15
1580160|NCT01116986|3866217|P15|COMPLETED|Overall Study||17
1580161|NCT01116986|3866218|P14|COMPLETED|Overall Study||16
1580162|NCT01116986|3866219|P13|COMPLETED|Overall Study||16
1580163|NCT01116986|3866220|P12|COMPLETED|Overall Study||20
1580164|NCT01116986|3866221|P11|COMPLETED|Overall Study||18
1580165|NCT01116986|3866222|P10|COMPLETED|Overall Study||19
1580166|NCT01116986|3866223|P9|COMPLETED|Overall Study||19
1580167|NCT01116986|3866224|P8|COMPLETED|Overall Study||20
1580168|NCT01116986|3866225|P7|COMPLETED|Overall Study||20
1580169|NCT01116986|3866226|P6|COMPLETED|Overall Study||20
1580170|NCT01116986|3866227|P5|COMPLETED|Overall Study||20
1580171|NCT01116986|3866228|P4|COMPLETED|Overall Study||20
1580172|NCT01116986|3866229|P3|COMPLETED|Overall Study||16
1580173|NCT01116986|3866230|P2|COMPLETED|Overall Study||16
1580174|NCT01116986|3866231|P1|COMPLETED|Overall Study||22
1580175|NCT01116986|3866200|P32|STARTED|Overall Study||17
1580176|NCT01116986|3866201|P31|STARTED|Overall Study||17
1580177|NCT01116986|3866202|P30|STARTED|Overall Study||17
1580178|NCT01116986|3866203|P29|STARTED|Overall Study||17
1580179|NCT01116986|3866204|P28|STARTED|Overall Study||19
1580180|NCT01116986|3866205|P27|STARTED|Overall Study||18
1580181|NCT01116986|3866206|P26|STARTED|Overall Study||19
1580182|NCT01116986|3866207|P25|STARTED|Overall Study||18
1580183|NCT01116986|3866208|P24|STARTED|Overall Study||21
1580184|NCT01116986|3866209|P23|STARTED|Overall Study||23
1580185|NCT01116986|3866210|P22|STARTED|Overall Study||20
1580186|NCT01116986|3866211|P21|STARTED|Overall Study||24
1580187|NCT01116986|3866212|P20|STARTED|Overall Study||15
1580188|NCT01116986|3866213|P19|STARTED|Overall Study||23
1580189|NCT01116986|3866214|P18|STARTED|Overall Study||24
1580190|NCT01116986|3866215|P17|STARTED|Overall Study||16
1580191|NCT01116986|3866216|P16|STARTED|Overall Study||21
1580192|NCT01116986|3866217|P15|STARTED|Overall Study||17
1580193|NCT01116986|3866218|P14|STARTED|Overall Study||19
1580194|NCT01116986|3866219|P13|STARTED|Overall Study||17
1580195|NCT01116986|3866220|P12|STARTED|Overall Study||20
1580196|NCT01116986|3866221|P11|STARTED|Overall Study||19
1580197|NCT01116986|3866222|P10|STARTED|Overall Study||23
1580198|NCT01116986|3866223|P9|STARTED|Overall Study||20
1580199|NCT01116986|3866224|P8|STARTED|Overall Study||22
1580200|NCT01116986|3866225|P7|STARTED|Overall Study||22
1580201|NCT01116986|3866226|P6|STARTED|Overall Study||22
1580202|NCT01116986|3866227|P5|STARTED|Overall Study||24
1580203|NCT01116986|3866228|P4|STARTED|Overall Study||22
1580204|NCT01116986|3866229|P3|STARTED|Overall Study||18
1580205|NCT01116986|3866230|P2|STARTED|Overall Study||19
1580206|NCT01116986|3866231|P1|STARTED|Overall Study||24
1580207|NCT01116934|3866265|P2|NOT COMPLETED|Overall Study||0
1580208|NCT01116934|3866266|P1|NOT COMPLETED|Overall Study||0
1580209|NCT01116934|3866265|P2|COMPLETED|Overall Study||9
1580210|NCT01116934|3866266|P1|COMPLETED|Overall Study||8
1580211|NCT01116934|3866265|P2|STARTED|Overall Study||9
1580212|NCT01116934|3866266|P1|STARTED|Overall Study||8
1580213|NCT01116921|3866274|P2|NOT COMPLETED|Overall Study||0
1580214|NCT01116921|3866275|P1|NOT COMPLETED|Overall Study||0
1580215|NCT01116921|3866274|P2|COMPLETED|Overall Study||50
1580216|NCT01116921|3866275|P1|COMPLETED|Overall Study||53
1580217|NCT01116921|3866274|P2|STARTED|Overall Study||50
1580218|NCT01116921|3866275|P1|STARTED|Overall Study||53
1580219|NCT01116895|3866295|P4|NOT COMPLETED|Overall Study||3
1580220|NCT01116895|3866296|P3|NOT COMPLETED|Overall Study||4
1580221|NCT01116895|3866297|P2|NOT COMPLETED|Overall Study||7
1580222|NCT01116895|3866298|P1|NOT COMPLETED|Overall Study||4
1580223|NCT01116895|3866295|P4|COMPLETED|Overall Study||11
1580224|NCT01116895|3866296|P3|COMPLETED|Overall Study||14
1580225|NCT01116895|3866297|P2|COMPLETED|Overall Study||8
1580226|NCT01116895|3866298|P1|COMPLETED|Overall Study||12
1580227|NCT01116895|3866295|P4|STARTED|Overall Study||14
1580228|NCT01116895|3866296|P3|STARTED|Overall Study||18
1580229|NCT01116895|3866297|P2|STARTED|Overall Study||15
1580230|NCT01116895|3866298|P1|STARTED|Overall Study||16
1580231|NCT01116882|3866326|P2|NOT COMPLETED|12-month||99
1580232|NCT01116882|3866327|P1|NOT COMPLETED|12-month||267
1580233|NCT01116882|3866326|P2|COMPLETED|12-month||787
1580234|NCT01116882|3866327|P1|COMPLETED|12-month||2439
1580235|NCT01116882|3866326|P2|STARTED|12-month||886
1580236|NCT01116882|3866327|P1|STARTED|12-month||2706
1580237|NCT01116882|3866326|P2|NOT COMPLETED|30-day||31
1580238|NCT01116882|3866327|P1|NOT COMPLETED|30-day||68
1580239|NCT01116882|3866326|P2|COMPLETED|30-day||886
1580240|NCT01116882|3866327|P1|COMPLETED|30-day||2706
1580241|NCT01116882|3866326|P2|STARTED|30-day||917
1580242|NCT01116882|3866327|P1|STARTED|30-day||2774
1580243|NCT01116687|3866365|P1|NOT COMPLETED|Overall Study||4
1580244|NCT01116687|3866365|P1|COMPLETED|Overall Study||33
1580245|NCT01116687|3866365|P1|STARTED|Overall Study||37
1580246|NCT01116466|3866372|P1|NOT COMPLETED|Overall Study||0
1580247|NCT01116466|3866372|P1|COMPLETED|Overall Study||5
1580248|NCT01116466|3866372|P1|STARTED|Overall Study||5
1580249|NCT01116427|3866382|P2|NOT COMPLETED|Extension Phase||2
1580250|NCT01116427|3866383|P1|NOT COMPLETED|Extension Phase||9
1580251|NCT01116427|3866382|P2|COMPLETED|Extension Phase||18
1580252|NCT01116427|3866383|P1|COMPLETED|Extension Phase||29
1580253|NCT01116427|3866382|P2|STARTED|Extension Phase||20
1580254|NCT01116427|3866383|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
1580255|NCT01116427|3866382|P2|NOT COMPLETED|Core Phase||1
1580256|NCT01116427|3866383|P1|NOT COMPLETED|Core Phase||5
1580257|NCT01116427|3866382|P2|COMPLETED|Core Phase||20
1580258|NCT01116427|3866383|P1|COMPLETED|Core Phase||39
1580259|NCT01116427|3866382|P2|STARTED|Core Phase||21
1580260|NCT01116427|3866383|P1|STARTED|Core Phase||44
1580261|NCT01116401|3866419|P1|NOT COMPLETED|Overall Study||0
1580262|NCT01116401|3866419|P1|COMPLETED|Overall Study||29
1580263|NCT01116401|3866419|P1|STARTED|Overall Study||29
1580264|NCT01116232|3866424|P1|NOT COMPLETED|Overall Study||4
1580265|NCT01116232|3866424|P1|COMPLETED|Overall Study||0
1580266|NCT01116232|3866424|P1|STARTED|Overall Study||4
1580267|NCT01116102|3866437|P8|NOT COMPLETED|Overall Study||0
1580268|NCT01116102|3866438|P7|NOT COMPLETED|Overall Study||0
1580269|NCT01116102|3866439|P6|NOT COMPLETED|Overall Study||0
1580270|NCT01116102|3866440|P5|NOT COMPLETED|Overall Study||0
1580271|NCT01116102|3866441|P4|NOT COMPLETED|Overall Study||0
1580272|NCT01116102|3866442|P3|NOT COMPLETED|Overall Study||0
1580273|NCT01116102|3866443|P2|NOT COMPLETED|Overall Study||0
1580274|NCT01116102|3866444|P1|NOT COMPLETED|Overall Study||0
1580275|NCT01116102|3866437|P8|COMPLETED|Overall Study||3
1580276|NCT01116102|3866438|P7|COMPLETED|Overall Study||2
1580277|NCT01116102|3866439|P6|COMPLETED|Overall Study||2
1580278|NCT01116102|3866440|P5|COMPLETED|Overall Study||2
1580279|NCT01116102|3866441|P4|COMPLETED|Overall Study||3
1580280|NCT01116102|3866442|P3|COMPLETED|Overall Study||3
1580281|NCT01116102|3866443|P2|COMPLETED|Overall Study||3
1580282|NCT01116102|3866444|P1|COMPLETED|Overall Study||2
1580283|NCT01116102|3866437|P8|STARTED|Overall Study||3
1580284|NCT01116102|3866438|P7|STARTED|Overall Study||2
1580285|NCT01116102|3866439|P6|STARTED|Overall Study||2
1580286|NCT01116102|3866440|P5|STARTED|Overall Study||2
1580287|NCT01116102|3866441|P4|STARTED|Overall Study||3
1580288|NCT01116102|3866442|P3|STARTED|Overall Study||3
1580289|NCT01116102|3866443|P2|STARTED|Overall Study||3
1580290|NCT01116102|3866444|P1|STARTED|Overall Study||2
1580291|NCT01116037|3866486|P1|NOT COMPLETED|Overall Study||25
1580292|NCT01116037|3866486|P1|COMPLETED|Overall Study||1
1580293|NCT01116037|3866486|P1|STARTED|Overall Study||26
1580294|NCT01116024|3866491|P1|NOT COMPLETED|Overall Study||52
1580295|NCT01116024|3866491|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
1580296|NCT01116024|3866491|P1|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
1580297|NCT01115998|3866532|P2|NOT COMPLETED|Overall Study||6
1580298|NCT01115998|3866533|P1|NOT COMPLETED|Overall Study||6
1580299|NCT01115998|3866532|P2|COMPLETED|Overall Study||11
1580300|NCT01115998|3866533|P1|COMPLETED|Overall Study||11
1580301|NCT01115998|3866532|P2|STARTED|Overall Study||17
1580302|NCT01115998|3866533|P1|STARTED|Overall Study||17
1580303|NCT01115933|3866543|P1|NOT COMPLETED|Overall Study||1
1580304|NCT01115933|3866543|P1|COMPLETED|Overall Study||64
1580305|NCT01115933|3866543|P1|STARTED|Overall Study||65
1580306|NCT01115855|3866640|P2|NOT COMPLETED|Overall Study||36
1580307|NCT01115855|3866641|P1|NOT COMPLETED|Overall Study||36
1580308|NCT01115855|3866640|P2|COMPLETED|Overall Study||74
1580309|NCT01115855|3866641|P1|COMPLETED|Overall Study||75
1580310|NCT01115855|3866640|P2|STARTED|Overall Study||110
1580311|NCT01115855|3866641|P1|STARTED|Overall Study||111
1580312|NCT01115738|3866692|P3|NOT COMPLETED|Overall Study||27
1580313|NCT01115738|3866693|P2|NOT COMPLETED|Overall Study||21
1580314|NCT01115738|3866694|P1|NOT COMPLETED|Overall Study||25
1580315|NCT01115738|3866692|P3|COMPLETED|Overall Study||62
1580316|NCT01115738|3866693|P2|COMPLETED|Overall Study||62
1580317|NCT01115738|3866694|P1|COMPLETED|Overall Study||85
1580318|NCT01115738|3866692|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
1580319|NCT01115738|3866693|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
1580320|NCT01115738|3866694|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
1580321|NCT01115738|3866692|P3|Received Any Treatment|Overall Study||88
1580322|NCT01115738|3866693|P2|Received Any Treatment|Overall Study||79
1580323|NCT01115738|3866694|P1|Received Any Treatment|Overall Study||109
1580324|NCT01115738|3866692|P3|STARTED|Overall Study||89
1580325|NCT01115738|3866693|P2|STARTED|Overall Study||83
1580326|NCT01115738|3866694|P1|STARTED|Overall Study||110
1580327|NCT01115699|3866728|P1|NOT COMPLETED|Overall Study||0
1580328|NCT01115699|3866728|P1|COMPLETED|Overall Study||2
1580329|NCT01115699|3866728|P1|STARTED|Overall Study||2
1580330|NCT01115673|3866736|P3|NOT COMPLETED|Overall Study||0
1580331|NCT01115673|3866737|P2|NOT COMPLETED|Overall Study||0
1580332|NCT01115673|3866738|P1|NOT COMPLETED|Overall Study||0
1580333|NCT01115673|3866736|P3|COMPLETED|Overall Study||60
1580334|NCT01115673|3866737|P2|COMPLETED|Overall Study||241
1580335|NCT01115673|3866738|P1|COMPLETED|Overall Study||239
1580336|NCT01115673|3866736|P3|STARTED|Overall Study||60
1580337|NCT01115673|3866737|P2|STARTED|Overall Study||241
1580338|NCT01115673|3866738|P1|STARTED|Overall Study||239
1580339|NCT01115660|3866874|P2|NOT COMPLETED|Overall Study||0
1580340|NCT01115660|3866875|P1|NOT COMPLETED|Overall Study||1
1580341|NCT01115660|3866874|P2|COMPLETED|Overall Study||10
1580342|NCT01115660|3866875|P1|COMPLETED|Overall Study||19
1580343|NCT01115660|3866874|P2|STARTED|Overall Study||10
1580344|NCT01115660|3866875|P1|STARTED|Overall Study||20
1580345|NCT01115582|3866883|P1|NOT COMPLETED|Overall Study||0
1580346|NCT01115582|3866883|P1|COMPLETED|Overall Study||16
1580347|NCT01115582|3866883|P1|STARTED|Overall Study||16
1580348|NCT01115569|3866892|P2|NOT COMPLETED|Maintenance Phase||139
1580349|NCT01115569|3866893|P1|NOT COMPLETED|Maintenance Phase||0
1580350|NCT01115569|3866892|P2|COMPLETED|Maintenance Phase||285
1580351|NCT01115569|3866893|P1|COMPLETED|Maintenance Phase||0
1580352|NCT01115569|3866892|P2|STARTED|Maintenance Phase||424
1580353|NCT01115569|3866893|P1|STARTED|Maintenance Phase||0
1580354|NCT01115569|3866892|P2|NOT COMPLETED|Conversion/Titration Phase||0
1580355|NCT01115569|3866893|P1|NOT COMPLETED|Conversion/Titration Phase||214
1580356|NCT01115569|3866892|P2|COMPLETED|Conversion/Titration Phase||0
1580357|NCT01115569|3866893|P1|COMPLETED|Conversion/Titration Phase||424
1580358|NCT01115569|3866892|P2|STARTED|Conversion/Titration Phase||0
1580359|NCT01115569|3866893|P1|STARTED|Conversion/Titration Phase||638
1580360|NCT01115556|3866900|P2|NOT COMPLETED|Overall Study||0
1580361|NCT01115556|3866901|P1|NOT COMPLETED|Overall Study||0
1580362|NCT01115556|3866900|P2|COMPLETED|Overall Study||2
1580363|NCT01115556|3866901|P1|COMPLETED|Overall Study||7
1580364|NCT01115556|3866900|P2|STARTED|Overall Study||2
1580365|NCT01115556|3866901|P1|STARTED|Overall Study||7
1580366|NCT01115517|3866911|P2|NOT COMPLETED|Overall Study||5
1580367|NCT01115517|3866912|P1|NOT COMPLETED|Overall Study||4
1580368|NCT01115517|3866911|P2|COMPLETED|Overall Study||16
1580369|NCT01115517|3866912|P1|COMPLETED|Overall Study||14
1580370|NCT01115517|3866911|P2|STARTED|Overall Study||21
1580371|NCT01115517|3866912|P1|STARTED|Overall Study||18
1580372|NCT01115491|3866922|P1|NOT COMPLETED|Overall Study||30
1580373|NCT01115491|3866922|P1|COMPLETED|Overall Study||2
1580374|NCT01115491|3866922|P1|STARTED|Overall Study||32
1580375|NCT01115452|3866931|P1|NOT COMPLETED|Overall Study||0
1580376|NCT01115452|3866931|P1|COMPLETED|Overall Study||32
1580377|NCT01115452|3866931|P1|STARTED|Overall Study||32
1580378|NCT01115244|3866983|P2|NOT COMPLETED|Overall Study||0
1580379|NCT01115244|3866984|P1|NOT COMPLETED|Overall Study||0
1580380|NCT01115244|3866983|P2|COMPLETED|Overall Study||0
1580381|NCT01115244|3866984|P1|COMPLETED|Overall Study||0
1580382|NCT01115244|3866983|P2|STARTED|Overall Study||0
1580383|NCT01115244|3866984|P1|STARTED|Overall Study||0
1580384|NCT01115166|3866994|P1|NOT COMPLETED|Overall Study||0
1580385|NCT01115166|3866994|P1|COMPLETED|Overall Study||10
1580386|NCT01115166|3866994|P1|STARTED|Overall Study||10
1580387|NCT01115101|3867002|P2|NOT COMPLETED|Overall Study||0
1580388|NCT01115101|3867003|P1|NOT COMPLETED|Overall Study||0
1580389|NCT01115101|3867002|P2|COMPLETED|Overall Study||126
1580390|NCT01115101|3867003|P1|COMPLETED|Overall Study||113
1580391|NCT01115101|3867002|P2|STARTED|Overall Study||126
1580392|NCT01115101|3867003|P1|STARTED|Overall Study||113
1580393|NCT01114997|3867012|P3|NOT COMPLETED|Overall Study||0
1580394|NCT01114997|3867013|P2|NOT COMPLETED|Overall Study||0
1580395|NCT01114997|3867014|P1|NOT COMPLETED|Overall Study||0
1580396|NCT01114997|3867012|P3|COMPLETED|Overall Study||11
1580397|NCT01114997|3867013|P2|COMPLETED|Overall Study||10
1580398|NCT01114997|3867014|P1|COMPLETED|Overall Study||11
1580399|NCT01114997|3867012|P3|STARTED|Overall Study||11
1580400|NCT01114997|3867013|P2|STARTED|Overall Study||10
1580401|NCT01114997|3867014|P1|STARTED|Overall Study||11
1580402|NCT01114945|3867044|P4|NOT COMPLETED|Overall Study||0
1580403|NCT01114945|3867045|P3|NOT COMPLETED|Overall Study||0
1580404|NCT01114945|3867046|P2|NOT COMPLETED|Overall Study||0
1580405|NCT01114945|3867047|P1|NOT COMPLETED|Overall Study||0
1580406|NCT01114945|3867044|P4|COMPLETED|Overall Study||31
1580407|NCT01114945|3867045|P3|COMPLETED|Overall Study||30
1580408|NCT01114945|3867046|P2|COMPLETED|Overall Study||30
1580409|NCT01114945|3867047|P1|COMPLETED|Overall Study||30
1580410|NCT01114945|3867044|P4|STARTED|Overall Study||31
1580411|NCT01114945|3867045|P3|STARTED|Overall Study||30
1580412|NCT01114945|3867046|P2|STARTED|Overall Study||30
1580413|NCT01114945|3867047|P1|STARTED|Overall Study||30
1580414|NCT01114893|3867074|P5|NOT COMPLETED|Overall Study||0
1580415|NCT01114893|3867075|P4|NOT COMPLETED|Overall Study||0
1580416|NCT01114893|3867076|P3|NOT COMPLETED|Overall Study||0
1580417|NCT01114893|3867077|P2|NOT COMPLETED|Overall Study||0
1580418|NCT01114893|3867078|P1|NOT COMPLETED|Overall Study||0
1580419|NCT01114893|3867074|P5|COMPLETED|Overall Study||12
1580420|NCT01114893|3867075|P4|COMPLETED|Overall Study||13
1580421|NCT01114893|3867076|P3|COMPLETED|Overall Study||14
1580422|NCT01114893|3867077|P2|COMPLETED|Overall Study||14
1580423|NCT01114893|3867078|P1|COMPLETED|Overall Study||14
1580424|NCT01114893|3867074|P5|STARTED|Overall Study||12
1580425|NCT01114893|3867075|P4|STARTED|Overall Study||13
1580426|NCT01114893|3867076|P3|STARTED|Overall Study||14
1580427|NCT01114893|3867077|P2|STARTED|Overall Study||14
1580428|NCT01114893|3867078|P1|STARTED|Overall Study||14
1580429|NCT01114880|3867097|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
1580430|NCT01114880|3867098|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
1580431|NCT01114880|3867097|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
1580432|NCT01114880|3867098|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
1580433|NCT01114880|3867097|P2|STARTED|Period 2 (Week 12 to Week 24)||113
1580434|NCT01114880|3867098|P1|STARTED|Period 2 (Week 12 to Week 24)||224
1580435|NCT01114880|3867097|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
1580436|NCT01114880|3867098|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
1580437|NCT01114880|3867097|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
1580438|NCT01114880|3867098|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
1580439|NCT01114880|3867097|P2|STARTED|Period 1 (Week 0 to Week 12)||115
1580440|NCT01114880|3867098|P1|STARTED|Period 1 (Week 0 to Week 12)||229
1580441|NCT01114828|3867150|P2|NOT COMPLETED|Overall Study||4
1580442|NCT01114828|3867151|P1|NOT COMPLETED|Overall Study||3
1580443|NCT01114828|3867150|P2|COMPLETED|Overall Study||17
1580444|NCT01114828|3867151|P1|COMPLETED|Overall Study||16
1580445|NCT01114828|3867150|P2|STARTED|Overall Study||21
1580446|NCT01114828|3867151|P1|STARTED|Overall Study||19
1580447|NCT01114737|3867161|P2|NOT COMPLETED|Open-Label Treatment Period||2
1580448|NCT01114737|3867162|P1|NOT COMPLETED|Open-Label Treatment Period||5
1580449|NCT01114737|3867161|P2|COMPLETED|Open-Label Treatment Period||95
1580450|NCT01114737|3867162|P1|COMPLETED|Open-Label Treatment Period||100
1580451|NCT01114737|3867161|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
1580452|NCT01114737|3867162|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
1580453|NCT01114737|3867161|P2|NOT COMPLETED|Randomized Treatment Period||1
1580454|NCT01114737|3867162|P1|NOT COMPLETED|Randomized Treatment Period||3
1580455|NCT01114737|3867161|P2|COMPLETED|Randomized Treatment Period||97
1580456|NCT01114737|3867162|P1|COMPLETED|Randomized Treatment Period||105
1580457|NCT01114737|3867161|P2|STARTED|Randomized Treatment Period||98
1580458|NCT01114737|3867162|P1|STARTED|Randomized Treatment Period||108
1580459|NCT01114724|3867210|P1|NOT COMPLETED|Overall Study||10
1580460|NCT01114724|3867210|P1|COMPLETED|Overall Study||40
1580461|NCT01114724|3867210|P1|STARTED|Overall Study||50
1580462|NCT01114672|3867230|P2|NOT COMPLETED|Overall Study||2
1580463|NCT01114672|3867231|P1|NOT COMPLETED|Overall Study||4
1580464|NCT01114672|3867230|P2|COMPLETED|Overall Study||23
1580465|NCT01114672|3867231|P1|COMPLETED|Overall Study||21
1580466|NCT01114672|3867230|P2|STARTED|Overall Study||25
1580467|NCT01114672|3867231|P1|STARTED|Overall Study||25
1580468|NCT01114646|3867239|P2|NOT COMPLETED|Overall Study||2
1580469|NCT01114646|3867240|P1|NOT COMPLETED|Overall Study||3
1580470|NCT01114646|3867239|P2|COMPLETED|Overall Study||62
1580471|NCT01114646|3867240|P1|COMPLETED|Overall Study||63
1580472|NCT01114646|3867239|P2|STARTED|Overall Study||64
1580473|NCT01114646|3867240|P1|STARTED|Overall Study||66
1580474|NCT01114620|3867246|P1|NOT COMPLETED|Overall Study||0
1580475|NCT01114620|3867246|P1|COMPLETED|Overall Study||50
1580476|NCT01114620|3867246|P1|STARTED|Overall Study||50
1580477|NCT01114581|3867279|P2|NOT COMPLETED|Overall Study||0
1580478|NCT01114581|3867280|P1|NOT COMPLETED|Overall Study||0
1580479|NCT01114581|3867279|P2|COMPLETED|Overall Study||19
1580480|NCT01114581|3867280|P1|COMPLETED|Overall Study||19
1580481|NCT01114581|3867279|P2|STARTED|Overall Study||19
1580482|NCT01114581|3867280|P1|STARTED|Overall Study||19
1580483|NCT01114529|3867293|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
1580484|NCT01114529|3867294|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
1580485|NCT01114529|3867295|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
1580486|NCT01114529|3867293|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
1580487|NCT01114529|3867294|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
1580488|NCT01114529|3867295|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
1580489|NCT01114529|3867293|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
1580490|NCT01114529|3867294|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
1580491|NCT01114529|3867295|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
1580492|NCT01114529|3867293|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
1580493|NCT01114529|3867294|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
1580494|NCT01114529|3867295|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
1580495|NCT01114529|3867293|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
1580496|NCT01114529|3867294|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
1580497|NCT01114529|3867295|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
1580498|NCT01114529|3867293|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
1580499|NCT01114529|3867294|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
1580500|NCT01114529|3867295|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
1580501|NCT01114516|3867314|P2|NOT COMPLETED|Overall Study||1
1580502|NCT01114516|3867315|P1|NOT COMPLETED|Overall Study||2
1580503|NCT01114516|3867314|P2|COMPLETED|Overall Study||26
1580504|NCT01114516|3867315|P1|COMPLETED|Overall Study||24
1580505|NCT01114516|3867314|P2|STARTED|Overall Study||27
1580506|NCT01114516|3867315|P1|STARTED|Overall Study||26
1580507|NCT01114503|3867329|P1|NOT COMPLETED|Overall Study||0
1580508|NCT01114503|3867329|P1|COMPLETED|Overall Study||2
1580509|NCT01114503|3867329|P1|STARTED|Overall Study||2
1580510|NCT01114438|3867350|P1|NOT COMPLETED|Overall Study||14
1580511|NCT01114438|3867350|P1|COMPLETED|Overall Study||31
1580512|NCT01114438|3867350|P1|STARTED|Overall Study||45
1580513|NCT01114373|3867360|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
1580514|NCT01114373|3867361|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
1580515|NCT01114373|3867360|P2|COMPLETED|Intervention 2 (4 Weeks)||18
1580516|NCT01114373|3867361|P1|COMPLETED|Intervention 2 (4 Weeks)||18
1580517|NCT01114373|3867360|P2|STARTED|Intervention 2 (4 Weeks)||19
1580518|NCT01114373|3867361|P1|STARTED|Intervention 2 (4 Weeks)||18
1580519|NCT01114373|3867360|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
1580520|NCT01114373|3867361|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
1580521|NCT01114373|3867360|P2|COMPLETED|Intervention 1 (4 Weeks)||19
1580522|NCT01114373|3867361|P1|COMPLETED|Intervention 1 (4 Weeks)||18
1580523|NCT01114373|3867360|P2|STARTED|Intervention 1 (4 Weeks)||19
1580524|NCT01114373|3867361|P1|STARTED|Intervention 1 (4 Weeks)||21
1580525|NCT01114360|3867393|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
1580526|NCT01114360|3867394|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
1580527|NCT01114360|3867393|P2|COMPLETED|Intervention 2 (4 Weeks)||18
1580528|NCT01114360|3867394|P1|COMPLETED|Intervention 2 (4 Weeks)||18
1580529|NCT01114360|3867393|P2|STARTED|Intervention 2 (4 Weeks)||18
1580530|NCT01114360|3867394|P1|STARTED|Intervention 2 (4 Weeks)||18
1580531|NCT01114360|3867393|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
1580532|NCT01114360|3867394|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
1580533|NCT01114360|3867393|P2|COMPLETED|Intervention 1 (4 Weeks)||18
1580534|NCT01114360|3867394|P1|COMPLETED|Intervention 1 (4 Weeks)||18
1580535|NCT01114360|3867393|P2|STARTED|Intervention 1 (4 Weeks)||19
1580536|NCT01114360|3867394|P1|STARTED|Intervention 1 (4 Weeks)||18
1580537|NCT01114334|3867432|P2|NOT COMPLETED|Overall Study||22
1580538|NCT01114334|3867433|P1|NOT COMPLETED|Overall Study||21
1580539|NCT01114334|3867432|P2|COMPLETED|Overall Study||58
1580540|NCT01114334|3867433|P1|COMPLETED|Overall Study||67
1580541|NCT01114334|3867432|P2|STARTED|Overall Study||80
1580542|NCT01114334|3867433|P1|STARTED|Overall Study||88
1580543|NCT01114217|3867445|P2|NOT COMPLETED|Overall Study||98
1580544|NCT01114217|3867446|P1|NOT COMPLETED|Overall Study||75
1580545|NCT01114217|3867445|P2|COMPLETED|Overall Study||199
1580546|NCT01114217|3867446|P1|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
1580547|NCT01114217|3867445|P2|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
1580548|NCT01114217|3867446|P1|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
1580549|NCT01114217|3867445|P2|STARTED|Overall Study||297
1580550|NCT01114217|3867446|P1|STARTED|Overall Study||337
1580551|NCT01114204|3867458|P2|NOT COMPLETED|Overall Study||8
1580552|NCT01114204|3867459|P1|NOT COMPLETED|Overall Study||21
1580553|NCT01114204|3867458|P2|COMPLETED|Overall Study||191
1580554|NCT01114204|3867459|P1|COMPLETED|Overall Study||385
1580555|NCT01114204|3867458|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
1580556|NCT01114204|3867459|P1|Received at Least 1 Dose of Study Drug|Overall Study||406
1580557|NCT01114204|3867458|P2|STARTED|Overall Study||199
1580558|NCT01114204|3867459|P1|STARTED|Overall Study||406
1580559|NCT01114139|3867477|P2|NOT COMPLETED|Overall Study||16
1580560|NCT01114139|3867478|P1|NOT COMPLETED|Overall Study||40
1580561|NCT01114139|3867477|P2|COMPLETED|Overall Study||187
1580562|NCT01114139|3867478|P1|COMPLETED|Overall Study||569
1580563|NCT01114139|3867477|P2|Received at Least 1 Dose of Study Drug|Overall Study||200
1580564|NCT01114139|3867478|P1|Received at Least 1 Dose of Study Drug|Overall Study||608
1580565|NCT01114139|3867477|P2|STARTED|Overall Study||203
1580566|NCT01114139|3867478|P1|STARTED|Overall Study||609
1580567|NCT01113931|3867496|P2|NOT COMPLETED|Overall Study||17
1580568|NCT01113931|3867497|P1|NOT COMPLETED|Overall Study||19
1580569|NCT01113931|3867496|P2|COMPLETED|Overall Study||231
1580570|NCT01113931|3867497|P1|COMPLETED|Overall Study||228
1580571|NCT01113931|3867496|P2|mITT Population|Overall Study||190
1580572|NCT01113931|3867497|P1|mITT Population|Overall Study||188
1580573|NCT01113931|3867496|P2|Safety Population|Overall Study||248
1580574|NCT01113931|3867497|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
1580575|NCT01113931|3867496|P2|STARTED|Overall Study||248
1580576|NCT01113931|3867497|P1|STARTED|Overall Study||247
1580577|NCT01113801|3867513|P4|NOT COMPLETED|Overall Study||41
1580578|NCT01113801|3867514|P3|NOT COMPLETED|Overall Study||37
1580579|NCT01113801|3867515|P2|NOT COMPLETED|Overall Study||40
1580580|NCT01113801|3867516|P1|NOT COMPLETED|Overall Study||41
1580581|NCT01113801|3867513|P4|COMPLETED|Overall Study||65
1580582|NCT01113801|3867514|P3|COMPLETED|Overall Study||66
1580583|NCT01113801|3867515|P2|COMPLETED|Overall Study||65
1580584|NCT01113801|3867516|P1|COMPLETED|Overall Study||62
1580585|NCT01113801|3867513|P4|Received at Least One Dose of Drug|Overall Study||105
1580586|NCT01113801|3867514|P3|Received at Least One Dose of Drug|Overall Study||103
1580587|NCT01113801|3867515|P2|Received at Least One Dose of Drug|Overall Study||105
1580588|NCT01113801|3867516|P1|Received at Least One Dose of Drug|Overall Study||103
1580589|NCT01113801|3867513|P4|STARTED|Overall Study||106
1580590|NCT01113801|3867514|P3|STARTED|Overall Study||103
1580591|NCT01113801|3867515|P2|STARTED|Overall Study||105
1580592|NCT01113801|3867516|P1|STARTED|Overall Study||103
1580593|NCT01113749|3867544|P2|NOT COMPLETED|Overall Study||2
1580594|NCT01113749|3867545|P1|NOT COMPLETED|Overall Study||1
1580595|NCT01113749|3867544|P2|COMPLETED|Overall Study||127
1580596|NCT01113749|3867545|P1|COMPLETED|Overall Study||126
1580597|NCT01113749|3867544|P2|STARTED|Overall Study||129
1580598|NCT01113749|3867545|P1|STARTED|Overall Study||127
1580599|NCT01113723|3867557|P2|NOT COMPLETED|Overall Study||0
1580600|NCT01113723|3867558|P1|NOT COMPLETED|Overall Study||0
1580601|NCT01113723|3867557|P2|COMPLETED|Overall Study||70
1580602|NCT01113723|3867558|P1|COMPLETED|Overall Study||70
1580603|NCT01113723|3867557|P2|STARTED|Overall Study||70
1580604|NCT01113723|3867558|P1|STARTED|Overall Study||70
1580605|NCT01113710|3867568|P1|NOT COMPLETED|Overall Study||269
1580606|NCT01113710|3867568|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
1580607|NCT01113710|3867568|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
1580608|NCT01113632|3867579|P2|NOT COMPLETED|Overall Study||25
1580609|NCT01113632|3867580|P1|NOT COMPLETED|Overall Study||31
1580610|NCT01113632|3867579|P2|COMPLETED|Overall Study||19
1580611|NCT01113632|3867580|P1|COMPLETED|Overall Study||2
1580612|NCT01113632|3867579|P2|STARTED|Overall Study||44
1580613|NCT01113632|3867580|P1|STARTED|Overall Study||33
1580614|NCT01113580|3867596|P2|NOT COMPLETED|Overall Study||0
1580615|NCT01113580|3867597|P1|NOT COMPLETED|Overall Study||1
1580616|NCT01113580|3867596|P2|COMPLETED|Overall Study||60
1580617|NCT01113580|3867597|P1|COMPLETED|Overall Study||59
1580618|NCT01113580|3867596|P2|STARTED|Overall Study||60
1580619|NCT01113580|3867597|P1|STARTED|Overall Study||60
1580620|NCT01113541|3867611|P1|NOT COMPLETED|Overall Study||13
1580621|NCT01113541|3867611|P1|COMPLETED|Overall Study||0
1580622|NCT01113541|3867611|P1|STARTED|Overall Study||13
1580623|NCT01113463|3867644|P1|NOT COMPLETED|Overall Study||5
1580624|NCT01113463|3867644|P1|COMPLETED|Overall Study||12
1580625|NCT01113463|3867644|P1|STARTED|Overall Study||17
1580626|NCT01113398|3867649|P1|NOT COMPLETED|Overall Study||0
1580627|NCT01113398|3867649|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
1580628|NCT01113398|3867649|P1|STARTED|Overall Study||36
1580629|NCT01113385|3867656|P1|NOT COMPLETED|Overall Study||0
1580630|NCT01113385|3867656|P1|COMPLETED|Overall Study||7
1580631|NCT01113385|3867656|P1|STARTED|Overall Study||7
1580632|NCT01113008|3867663|P2|NOT COMPLETED|Overall Study||0
1580633|NCT01113008|3867664|P1|NOT COMPLETED|Overall Study||0
1580634|NCT01113008|3867663|P2|COMPLETED|Overall Study||133
1580635|NCT01113008|3867664|P1|COMPLETED|Overall Study||133
1580636|NCT01113008|3867663|P2|STARTED|Overall Study||133
1580637|NCT01113008|3867664|P1|STARTED|Overall Study||133
1580638|NCT01112917|3867674|P2|NOT COMPLETED|Overall Study||15
1580639|NCT01112917|3867675|P1|NOT COMPLETED|Overall Study||7
1580640|NCT01112917|3867674|P2|COMPLETED|Overall Study||38
1580641|NCT01112917|3867675|P1|COMPLETED|Overall Study||89
1580642|NCT01112917|3867674|P2|STARTED|Overall Study||53
1580643|NCT01112917|3867675|P1|STARTED|Overall Study||96
1580644|NCT01112865|3867680|P2|NOT COMPLETED|Second Intervention||0
1580645|NCT01112865|3867681|P1|NOT COMPLETED|Second Intervention||0
1580646|NCT01112865|3867680|P2|COMPLETED|Second Intervention||61
1580647|NCT01112865|3867681|P1|COMPLETED|Second Intervention||59
1580648|NCT01112865|3867680|P2|STARTED|Second Intervention||61
1580649|NCT01112865|3867681|P1|STARTED|Second Intervention||59
1580650|NCT01112865|3867680|P2|NOT COMPLETED|First Intervention||0
1580651|NCT01112865|3867681|P1|NOT COMPLETED|First Intervention||0
1580652|NCT01112865|3867680|P2|COMPLETED|First Intervention||61
1580653|NCT01112865|3867681|P1|COMPLETED|First Intervention||59
1580654|NCT01112865|3867680|P2|STARTED|First Intervention||61
1580655|NCT01112865|3867681|P1|STARTED|First Intervention||59
1580656|NCT01112735|3867693|P2|NOT COMPLETED|Overall Study||0
1580657|NCT01112735|3867694|P1|NOT COMPLETED|Overall Study||0
1580658|NCT01112735|3867693|P2|COMPLETED|Overall Study||20
1580659|NCT01112735|3867694|P1|COMPLETED|Overall Study||20
1580660|NCT01112735|3867693|P2|STARTED|Overall Study||20
1580661|NCT01112735|3867694|P1|STARTED|Overall Study||20
1580662|NCT01112696|3867718|P1|NOT COMPLETED|Overall Study||2
1580663|NCT01112696|3867718|P1|COMPLETED|Overall Study||98
1580664|NCT01112696|3867718|P1|STARTED|Overall Study||100
1580665|NCT01112683|3867725|P2|NOT COMPLETED|Overall Study||1
1580666|NCT01112683|3867726|P1|NOT COMPLETED|Overall Study||1
1580667|NCT01112683|3867725|P2|COMPLETED|Overall Study||19
1580668|NCT01112683|3867726|P1|COMPLETED|Overall Study||18
1580669|NCT01112683|3867725|P2|STARTED|Overall Study||20
1580670|NCT01112683|3867726|P1|STARTED|Overall Study||19
1580671|NCT01112670|3867736|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580672|NCT01112670|3867737|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580673|NCT01112670|3867738|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580674|NCT01112670|3867739|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580675|NCT01112670|3867740|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580676|NCT01112670|3867741|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580677|NCT01112670|3867736|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
1580678|NCT01112670|3867737|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580679|NCT01112670|3867738|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
1580680|NCT01112670|3867739|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580681|NCT01112670|3867740|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
1580682|NCT01112670|3867741|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580683|NCT01112670|3867736|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
1580684|NCT01112670|3867737|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580685|NCT01112670|3867738|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
1580686|NCT01112670|3867739|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580687|NCT01112670|3867740|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
1580688|NCT01112670|3867741|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
1580689|NCT01112670|3867736|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1580690|NCT01112670|3867737|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
1580691|NCT01112670|3867738|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1580692|NCT01112670|3867739|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
1580693|NCT01112670|3867740|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1580694|NCT01112670|3867741|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
1580695|NCT01112670|3867736|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1580696|NCT01112670|3867737|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
1580697|NCT01112670|3867738|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1580698|NCT01112670|3867739|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
1580793|NCT01111305|3868108|P2|NOT COMPLETED|Overall Study||0
1580699|NCT01112670|3867740|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1580700|NCT01112670|3867741|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
1580701|NCT01112670|3867736|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
1580702|NCT01112670|3867737|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
1580703|NCT01112670|3867738|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
1580704|NCT01112670|3867739|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
1580705|NCT01112670|3867740|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
1580706|NCT01112670|3867741|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
1580707|NCT01112579|3867779|P2|NOT COMPLETED|Overall Study||3
1580708|NCT01112579|3867780|P1|NOT COMPLETED|Overall Study||1
1580709|NCT01112579|3867779|P2|COMPLETED|Overall Study||21
1580710|NCT01112579|3867780|P1|COMPLETED|Overall Study||41
1580711|NCT01112579|3867779|P2|STARTED|Overall Study||24
1580712|NCT01112579|3867780|P1|STARTED|Overall Study||42
1580713|NCT01112514|3867790|P1|NOT COMPLETED|Overall Study||1
1580714|NCT01112514|3867790|P1|COMPLETED|Overall Study||3
1580715|NCT01112514|3867790|P1|STARTED|Overall Study||4
1580716|NCT01112358|3867796|P2|NOT COMPLETED|Overall Study||0
1580717|NCT01112358|3867797|P1|NOT COMPLETED|Overall Study||0
1580718|NCT01112358|3867796|P2|COMPLETED|Overall Study||33
1580719|NCT01112358|3867797|P1|COMPLETED|Overall Study||25
1580720|NCT01112358|3867796|P2|STARTED|Overall Study||33
1580721|NCT01112358|3867797|P1|STARTED|Overall Study||25
1580722|NCT01112267|3867835|P2|NOT COMPLETED|Overall Study||18
1580723|NCT01112267|3867836|P1|NOT COMPLETED|Overall Study||34
1580724|NCT01112267|3867835|P2|COMPLETED|Overall Study||104
1580725|NCT01112267|3867836|P1|COMPLETED|Overall Study||92
1580726|NCT01112267|3867835|P2|Treated|Overall Study||120
1580727|NCT01112267|3867836|P1|Treated|Overall Study||125
1580728|NCT01112267|3867835|P2|STARTED|Overall Study||122
1580729|NCT01112267|3867836|P1|STARTED|Overall Study||126
1580730|NCT01112241|3867854|P1|NOT COMPLETED|Overall Study||0
1580731|NCT01112241|3867854|P1|COMPLETED|Overall Study||17
1580732|NCT01112241|3867854|P1|STARTED|Overall Study||17
1580733|NCT01112059|3867869|P2|NOT COMPLETED|Overall Study||0
1580734|NCT01112059|3867870|P1|NOT COMPLETED|Overall Study||1
1580735|NCT01112059|3867869|P2|COMPLETED|Overall Study||20
1580736|NCT01112059|3867870|P1|COMPLETED|Overall Study||19
1580737|NCT01112059|3867869|P2|STARTED|Overall Study||20
1580738|NCT01112059|3867870|P1|STARTED|Overall Study||20
1580739|NCT01111851|3867884|P2|NOT COMPLETED|Overall Study||0
1580740|NCT01111851|3867885|P1|NOT COMPLETED|Overall Study||2
1580741|NCT01111851|3867884|P2|COMPLETED|Overall Study||8
1580742|NCT01111851|3867885|P1|COMPLETED|Overall Study||6
1580743|NCT01111851|3867884|P2|STARTED|Overall Study||8
1580744|NCT01111851|3867885|P1|STARTED|Overall Study||8
1580745|NCT01111838|3867897|P1|NOT COMPLETED|Overall Study||7
1580746|NCT01111838|3867897|P1|COMPLETED|Overall Study||15
1580747|NCT01111838|3867897|P1|STARTED|Overall Study||22
1580748|NCT01111825|3867905|P4|NOT COMPLETED|Overall Study||21
1580749|NCT01111825|3867906|P3|NOT COMPLETED|Overall Study||8
1580750|NCT01111825|3867907|P2|NOT COMPLETED|Overall Study||1
1580751|NCT01111825|3867908|P1|NOT COMPLETED|Overall Study||3
1580752|NCT01111825|3867905|P4|COMPLETED|Overall Study||27
1580753|NCT01111825|3867906|P3|COMPLETED|Overall Study||29
1580754|NCT01111825|3867907|P2|COMPLETED|Overall Study||5
1580755|NCT01111825|3867908|P1|COMPLETED|Overall Study||5
1580756|NCT01111825|3867905|P4|STARTED|Overall Study||48
1580757|NCT01111825|3867906|P3|STARTED|Overall Study||37
1580758|NCT01111825|3867907|P2|STARTED|Overall Study||6
1580759|NCT01111825|3867908|P1|STARTED|Overall Study||8
1580760|NCT01111526|3867927|P3|NOT COMPLETED|Overall Study||2
1580761|NCT01111526|3867928|P2|NOT COMPLETED|Overall Study||1
1580762|NCT01111526|3867929|P1|NOT COMPLETED|Overall Study||0
1580763|NCT01111526|3867927|P3|COMPLETED|Overall Study||8
1580764|NCT01111526|3867928|P2|COMPLETED|Overall Study||7
1580765|NCT01111526|3867929|P1|COMPLETED|Overall Study||4
1580766|NCT01111526|3867927|P3|STARTED|Overall Study||10
1580767|NCT01111526|3867928|P2|STARTED|Overall Study||8
1580768|NCT01111526|3867929|P1|STARTED|Overall Study||4
1580769|NCT01111461|3867941|P1|NOT COMPLETED|Overall Study||51
1580770|NCT01111461|3867941|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
1580771|NCT01111461|3867941|P1|STARTED|Overall Study||133
1580772|NCT01111370|3867954|P1|NOT COMPLETED|Overall Study||2
1580773|NCT01111370|3867954|P1|COMPLETED|Overall Study||58
1580774|NCT01111370|3867954|P1|STARTED|Overall Study||60
1580775|NCT01111331|3867958|P2|NOT COMPLETED|Overall Study||0
1580776|NCT01111331|3867959|P1|NOT COMPLETED|Overall Study||0
1580777|NCT01111331|3867958|P2|COMPLETED|Overall Study||9
1580778|NCT01111331|3867959|P1|COMPLETED|Overall Study||9
1580779|NCT01111331|3867958|P2|STARTED|Overall Study||9
1580780|NCT01111331|3867959|P1|STARTED|Overall Study||9
1580781|NCT01111318|3868041|P4|NOT COMPLETED|Overall Study||0
1580782|NCT01111318|3868042|P3|NOT COMPLETED|Overall Study||0
1580783|NCT01111318|3868043|P2|NOT COMPLETED|Overall Study||0
1580784|NCT01111318|3868044|P1|NOT COMPLETED|Overall Study||0
1580785|NCT01111318|3868041|P4|COMPLETED|Overall Study||8
1580786|NCT01111318|3868042|P3|COMPLETED|Overall Study||8
1580787|NCT01111318|3868043|P2|COMPLETED|Overall Study||8
1580788|NCT01111318|3868044|P1|COMPLETED|Overall Study||12
1580789|NCT01111318|3868041|P4|STARTED|Overall Study||8
1580790|NCT01111318|3868042|P3|STARTED|Overall Study||8
1580791|NCT01111318|3868043|P2|STARTED|Overall Study||8
1580792|NCT01111318|3868044|P1|STARTED|Overall Study||12
1580794|NCT01111305|3868109|P1|NOT COMPLETED|Overall Study||0
1580795|NCT01111305|3868108|P2|COMPLETED|Overall Study||4
1580796|NCT01111305|3868109|P1|COMPLETED|Overall Study||4
1580797|NCT01111305|3868108|P2|STARTED|Overall Study||4
1580798|NCT01111305|3868109|P1|STARTED|Overall Study||4
1580799|NCT01111292|3868121|P2|NOT COMPLETED|Follow-Up||0
1580800|NCT01111292|3868122|P1|NOT COMPLETED|Follow-Up||0
1580801|NCT01111292|3868121|P2|COMPLETED|Follow-Up||1
1580802|NCT01111292|3868122|P1|COMPLETED|Follow-Up||2
1580803|NCT01111292|3868121|P2|STARTED|Follow-Up||1
1580804|NCT01111292|3868122|P1|STARTED|Follow-Up||2
1580805|NCT01111292|3868121|P2|NOT COMPLETED|Post Treatment Biopsy||0
1580806|NCT01111292|3868122|P1|NOT COMPLETED|Post Treatment Biopsy||0
1580807|NCT01111292|3868121|P2|COMPLETED|Post Treatment Biopsy||1
1580808|NCT01111292|3868122|P1|COMPLETED|Post Treatment Biopsy||2
1580809|NCT01111292|3868121|P2|STARTED|Post Treatment Biopsy||1
1580810|NCT01111292|3868122|P1|STARTED|Post Treatment Biopsy||2
1580811|NCT01111292|3868121|P2|NOT COMPLETED|Treatment||1
1580812|NCT01111292|3868122|P1|NOT COMPLETED|Treatment||1
1580813|NCT01111292|3868121|P2|COMPLETED|Treatment||1
1580814|NCT01111292|3868122|P1|COMPLETED|Treatment||2
1580815|NCT01111292|3868121|P2|STARTED|Treatment||2
1580816|NCT01111292|3868122|P1|STARTED|Treatment||3
1580817|NCT01111292|3868121|P2|NOT COMPLETED|Randomization||0
1580818|NCT01111292|3868122|P1|NOT COMPLETED|Randomization||0
1580819|NCT01111292|3868121|P2|COMPLETED|Randomization||2
1580820|NCT01111292|3868122|P1|COMPLETED|Randomization||3
1580821|NCT01111292|3868121|P2|STARTED|Randomization||2
1580822|NCT01111292|3868122|P1|STARTED|Randomization||3
1580823|NCT01111240|3868128|P1|NOT COMPLETED|Overall Study||1066
1580824|NCT01111240|3868128|P1|COMPLETED|Overall Study||3569
1580825|NCT01111240|3868128|P1|STARTED|Overall Study||4635
1580826|NCT01111162|3868150|P1|NOT COMPLETED|Overall Study||0
1580827|NCT01111162|3868150|P1|COMPLETED|Overall Study||120
1580828|NCT01111162|3868150|P1|STARTED|Overall Study||120
1580829|NCT01111149|3868158|P3|NOT COMPLETED|Overall Study||4
1580830|NCT01111149|3868159|P2|NOT COMPLETED|Overall Study||1
1580831|NCT01111149|3868160|P1|NOT COMPLETED|Overall Study||2
1580832|NCT01111149|3868158|P3|COMPLETED|Overall Study||5
1580833|NCT01111149|3868159|P2|COMPLETED|Overall Study||5
1580834|NCT01111149|3868160|P1|COMPLETED|Overall Study||7
1580835|NCT01111149|3868158|P3|STARTED|Overall Study||9
1580836|NCT01111149|3868159|P2|STARTED|Overall Study||6
1580837|NCT01111149|3868160|P1|STARTED|Overall Study||9
1580838|NCT01111123|3868236|P2|NOT COMPLETED|Maintenance Phase||2
1580839|NCT01111123|3868237|P1|NOT COMPLETED|Maintenance Phase||0
1580840|NCT01111123|3868236|P2|COMPLETED|Maintenance Phase||18
1580841|NCT01111123|3868237|P1|COMPLETED|Maintenance Phase||21
1580842|NCT01111123|3868236|P2|STARTED|Maintenance Phase||20
1580843|NCT01111123|3868237|P1|STARTED|Maintenance Phase||21
1580844|NCT01111123|3868236|P2|NOT COMPLETED|Open- Label Phase||0
1580845|NCT01111123|3868237|P1|NOT COMPLETED|Open- Label Phase||14
1580846|NCT01111123|3868236|P2|COMPLETED|Open- Label Phase||0
1580847|NCT01111123|3868237|P1|COMPLETED|Open- Label Phase||41
1580848|NCT01111123|3868236|P2|STARTED|Open- Label Phase||0
1580849|NCT01111123|3868237|P1|STARTED|Open- Label Phase||55
1580850|NCT01111110|3868247|P2|NOT COMPLETED|Overall Study||0
1580851|NCT01111110|3868248|P1|NOT COMPLETED|Overall Study||0
1580852|NCT01111110|3868247|P2|COMPLETED|Overall Study||4
1580853|NCT01111110|3868248|P1|COMPLETED|Overall Study||3
1580854|NCT01111110|3868247|P2|STARTED|Overall Study||4
1580855|NCT01111110|3868248|P1|STARTED|Overall Study||3
1580856|NCT01110967|3868258|P1|NOT COMPLETED|Overall Study||9
1580857|NCT01110967|3868258|P1|COMPLETED|Overall Study||31
1580858|NCT01110967|3868258|P1|12 Months Follow up|Overall Study||31
1580859|NCT01110967|3868258|P1|6 Months Follow up|Overall Study||24
1580860|NCT01110967|3868258|P1|3 Months Follow up|Overall Study||28
1580861|NCT01110967|3868258|P1|1 Month Follow up|Overall Study||26
1580862|NCT01110967|3868258|P1|Surgery|Overall Study||40
1580863|NCT01110967|3868258|P1|STARTED|Overall Study||40
1580864|NCT01110915|3868271|P2|NOT COMPLETED|Overall Study||2
1580865|NCT01110915|3868272|P1|NOT COMPLETED|Overall Study||10
1580866|NCT01110915|3868271|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
1580867|NCT01110915|3868272|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
1580868|NCT01110915|3868271|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
1580869|NCT01110915|3868272|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
1580870|NCT01110707|3868289|P2|NOT COMPLETED|Overall Study||3
1580871|NCT01110707|3868290|P1|NOT COMPLETED|Overall Study||0
1580872|NCT01110707|3868289|P2|COMPLETED|Overall Study||65
1580873|NCT01110707|3868290|P1|COMPLETED|Overall Study||63
1580874|NCT01110707|3868289|P2|STARTED|Overall Study||68
1580875|NCT01110707|3868290|P1|STARTED|Overall Study||63
1580876|NCT01110499|3868320|P8|NOT COMPLETED|Overall Study||0
1580877|NCT01110499|3868321|P7|NOT COMPLETED|Overall Study||0
1580878|NCT01110499|3868322|P6|NOT COMPLETED|Overall Study||0
1580879|NCT01110499|3868323|P5|NOT COMPLETED|Overall Study||0
1580880|NCT01110499|3868324|P4|NOT COMPLETED|Overall Study||0
1580881|NCT01110499|3868325|P3|NOT COMPLETED|Overall Study||0
1580882|NCT01110499|3868326|P2|NOT COMPLETED|Overall Study||0
1580883|NCT01110499|3868327|P1|NOT COMPLETED|Overall Study||0
1580884|NCT01110499|3868320|P8|COMPLETED|Overall Study||40
1580885|NCT01110499|3868321|P7|COMPLETED|Overall Study||39
1580886|NCT01110499|3868322|P6|COMPLETED|Overall Study||14
1580887|NCT01110499|3868323|P5|COMPLETED|Overall Study||14
1580888|NCT01110499|3868324|P4|COMPLETED|Overall Study||14
1580889|NCT01110499|3868325|P3|COMPLETED|Overall Study||14
1580890|NCT01110499|3868326|P2|COMPLETED|Overall Study||14
1580891|NCT01110499|3868327|P1|COMPLETED|Overall Study||14
1580892|NCT01110499|3868320|P8|STARTED|Overall Study||40
1580893|NCT01110499|3868321|P7|STARTED|Overall Study||39
1580894|NCT01110499|3868322|P6|STARTED|Overall Study||14
1580895|NCT01110499|3868323|P5|STARTED|Overall Study||14
1580896|NCT01110499|3868324|P4|STARTED|Overall Study||14
1580897|NCT01110499|3868325|P3|STARTED|Overall Study||14
1580898|NCT01110499|3868326|P2|STARTED|Overall Study||14
1580899|NCT01110499|3868327|P1|STARTED|Overall Study||14
1580900|NCT01110421|3868349|P2|NOT COMPLETED|Overall Study||0
1580901|NCT01110421|3868350|P1|NOT COMPLETED|Overall Study||0
1580902|NCT01110421|3868349|P2|COMPLETED|Overall Study||2
1580903|NCT01110421|3868350|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
1580904|NCT01110421|3868349|P2|STARTED|Overall Study||2
1580905|NCT01110421|3868350|P1|STARTED|Overall Study||5
1580906|NCT01110408|3868370|P2|NOT COMPLETED|Overall Study||0
1580907|NCT01110408|3868371|P1|NOT COMPLETED|Overall Study||1
1580908|NCT01110408|3868370|P2|COMPLETED|Overall Study||10
1580909|NCT01110408|3868371|P1|COMPLETED|Overall Study||30
1580910|NCT01110408|3868370|P2|STARTED|Overall Study||10
1580911|NCT01110408|3868371|P1|STARTED|Overall Study||31
1580912|NCT01110382|3868391|P2|NOT COMPLETED|Overall Study||2
1580913|NCT01110382|3868392|P1|NOT COMPLETED|Overall Study||0
1580914|NCT01110382|3868391|P2|COMPLETED|Overall Study||8
1580915|NCT01110382|3868392|P1|COMPLETED|Overall Study||31
1580916|NCT01110382|3868391|P2|STARTED|Overall Study||10
1580917|NCT01110382|3868392|P1|STARTED|Overall Study||31
1580918|NCT01110330|3868413|P3|NOT COMPLETED|Overall Study||26
1580919|NCT01110330|3868414|P2|NOT COMPLETED|Overall Study||23
1580920|NCT01110330|3868415|P1|NOT COMPLETED|Overall Study||15
1580921|NCT01110330|3868413|P3|COMPLETED|Overall Study||208
1580922|NCT01110330|3868414|P2|COMPLETED|Overall Study||207
1580923|NCT01110330|3868415|P1|COMPLETED|Overall Study||104
1580924|NCT01110330|3868413|P3|Positive Baseline Culture Set|Overall Study||114
1580925|NCT01110330|3868414|P2|Positive Baseline Culture Set|Overall Study||111
1580926|NCT01110330|3868415|P1|Positive Baseline Culture Set|Overall Study||56
1580927|NCT01110330|3868413|P3|STARTED|Overall Study||234
1580928|NCT01110330|3868414|P2|STARTED|Overall Study||230
1580929|NCT01110330|3868415|P1|STARTED|Overall Study||119
1580930|NCT01110252|3868426|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
1580931|NCT01110252|3868426|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
1580932|NCT01110252|3868426|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
1580933|NCT01110252|3868426|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
1580934|NCT01110252|3868426|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
1580935|NCT01110252|3868426|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
1580936|NCT01110239|3868443|P4|NOT COMPLETED|10 Min Ischemia||0
1580937|NCT01110239|3868444|P3|NOT COMPLETED|10 Min Ischemia||0
1580938|NCT01110239|3868445|P2|NOT COMPLETED|10 Min Ischemia||0
1580939|NCT01110239|3868446|P1|NOT COMPLETED|10 Min Ischemia||0
1580940|NCT01110239|3868443|P4|COMPLETED|10 Min Ischemia||6
1580941|NCT01110239|3868444|P3|COMPLETED|10 Min Ischemia||0
1580942|NCT01110239|3868445|P2|COMPLETED|10 Min Ischemia||0
1580943|NCT01110239|3868446|P1|COMPLETED|10 Min Ischemia||0
1580944|NCT01110239|3868443|P4|STARTED|10 Min Ischemia||6
1580945|NCT01110239|3868444|P3|STARTED|10 Min Ischemia||0
1580946|NCT01110239|3868445|P2|STARTED|10 Min Ischemia||0
1580947|NCT01110239|3868446|P1|STARTED|10 Min Ischemia||0
1580948|NCT01110239|3868443|P4|NOT COMPLETED|7.5 Min Ischemia||0
1580949|NCT01110239|3868444|P3|NOT COMPLETED|7.5 Min Ischemia||1
1580950|NCT01110239|3868445|P2|NOT COMPLETED|7.5 Min Ischemia||0
1580951|NCT01110239|3868446|P1|NOT COMPLETED|7.5 Min Ischemia||0
1580952|NCT01110239|3868443|P4|COMPLETED|7.5 Min Ischemia||0
1580953|NCT01110239|3868444|P3|COMPLETED|7.5 Min Ischemia||6
1580954|NCT01110239|3868445|P2|COMPLETED|7.5 Min Ischemia||0
1580955|NCT01110239|3868446|P1|COMPLETED|7.5 Min Ischemia||0
1580956|NCT01110239|3868443|P4|STARTED|7.5 Min Ischemia||0
1580957|NCT01110239|3868444|P3|STARTED|7.5 Min Ischemia||7
1580958|NCT01110239|3868445|P2|STARTED|7.5 Min Ischemia||0
1580959|NCT01110239|3868446|P1|STARTED|7.5 Min Ischemia||0
1580960|NCT01110239|3868443|P4|NOT COMPLETED|5 Min Ischemia||0
1580961|NCT01110239|3868444|P3|NOT COMPLETED|5 Min Ischemia||0
1580962|NCT01110239|3868445|P2|NOT COMPLETED|5 Min Ischemia||14
1580963|NCT01110239|3868446|P1|NOT COMPLETED|5 Min Ischemia||0
1580964|NCT01110239|3868443|P4|COMPLETED|5 Min Ischemia||0
1580965|NCT01110239|3868444|P3|COMPLETED|5 Min Ischemia||0
1580966|NCT01110239|3868445|P2|COMPLETED|5 Min Ischemia||0
1580967|NCT01110239|3868446|P1|COMPLETED|5 Min Ischemia||0
1580968|NCT01110239|3868443|P4|STARTED|5 Min Ischemia||0
1580969|NCT01110239|3868444|P3|STARTED|5 Min Ischemia||0
1580970|NCT01110239|3868445|P2|STARTED|5 Min Ischemia||14
1580971|NCT01110239|3868446|P1|STARTED|5 Min Ischemia||0
1580972|NCT01110239|3868443|P4|NOT COMPLETED|Sham Preconditioning||0
1580973|NCT01110239|3868444|P3|NOT COMPLETED|Sham Preconditioning||1
1580974|NCT01110239|3868445|P2|NOT COMPLETED|Sham Preconditioning||0
1580975|NCT01110239|3868446|P1|NOT COMPLETED|Sham Preconditioning||0
1580976|NCT01110239|3868443|P4|COMPLETED|Sham Preconditioning||6
1580977|NCT01110239|3868444|P3|COMPLETED|Sham Preconditioning||6
1580978|NCT01110239|3868445|P2|COMPLETED|Sham Preconditioning||14
1580979|NCT01110239|3868446|P1|COMPLETED|Sham Preconditioning||7
1580980|NCT01110239|3868443|P4|STARTED|Sham Preconditioning||6
1580981|NCT01110239|3868444|P3|STARTED|Sham Preconditioning||7
1580982|NCT01110239|3868445|P2|STARTED|Sham Preconditioning||14
1580983|NCT01110239|3868446|P1|STARTED|Sham Preconditioning||7
1580984|NCT01110200|3868462|P2|NOT COMPLETED|Overall Study||121
1580985|NCT01110200|3868463|P1|NOT COMPLETED|Overall Study||106
1580986|NCT01110200|3868462|P2|COMPLETED|Overall Study||204
1580987|NCT01110200|3868463|P1|COMPLETED|Overall Study||208
1580988|NCT01110200|3868462|P2|STARTED|Overall Study||325
1580989|NCT01110200|3868463|P1|STARTED|Overall Study||314
1580990|NCT01110187|3868479|P2|NOT COMPLETED|Overall Study||0
1580991|NCT01110187|3868480|P1|NOT COMPLETED|Overall Study||0
1580992|NCT01110187|3868479|P2|COMPLETED|Overall Study|completed 7 day treatment|4
1580993|NCT01110187|3868480|P1|COMPLETED|Overall Study|completed 7 day treatment|7
1580994|NCT01110187|3868479|P2|STARTED|Overall Study||4
1580995|NCT01110187|3868480|P1|STARTED|Overall Study||7
1580996|NCT01110135|3868488|P1|NOT COMPLETED|Overall Study||9
1580997|NCT01110135|3868488|P1|COMPLETED|Overall Study||34
1580998|NCT01110135|3868488|P1|STARTED|Overall Study||43
1580999|NCT01110005|3868494|P2|NOT COMPLETED|Overall Study||5
1581000|NCT01110005|3868495|P1|NOT COMPLETED|Overall Study||4
1581001|NCT01110005|3868494|P2|COMPLETED|Overall Study||156
1581002|NCT01110005|3868495|P1|COMPLETED|Overall Study||153
1581003|NCT01110005|3868494|P2|STARTED|Overall Study||161
1581004|NCT01110005|3868495|P1|STARTED|Overall Study||157
1581005|NCT01109992|3868507|P2|NOT COMPLETED|Overall Study||2
1581006|NCT01109992|3868508|P1|NOT COMPLETED|Overall Study||0
1581007|NCT01109992|3868507|P2|COMPLETED|Overall Study||30
1581008|NCT01109992|3868508|P1|COMPLETED|Overall Study||11
1581009|NCT01109992|3868507|P2|Subjects Enrolled|Overall Study||32
1581010|NCT01109992|3868508|P1|Subjects Enrolled|Overall Study||11
1581011|NCT01109992|3868507|P2|STARTED|Overall Study||32
1581012|NCT01109992|3868508|P1|STARTED|Overall Study||11
1581013|NCT01109979|3868522|P2|NOT COMPLETED|Overall Study||1
1581014|NCT01109979|3868523|P1|NOT COMPLETED|Overall Study||2
1581015|NCT01109979|3868522|P2|COMPLETED|Overall Study||11
1581016|NCT01109979|3868523|P1|COMPLETED|Overall Study||10
1581017|NCT01109979|3868522|P2|STARTED|Overall Study||12
1581018|NCT01109979|3868523|P1|STARTED|Overall Study||12
1581019|NCT01109849|3868531|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
1581020|NCT01109849|3868532|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
1581021|NCT01109849|3868533|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
1581022|NCT01109849|3868534|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
1581023|NCT01109849|3868535|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
1581024|NCT01109849|3868531|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
1581025|NCT01109849|3868532|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
1581026|NCT01109849|3868533|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
1581027|NCT01109849|3868534|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
1581028|NCT01109849|3868535|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
1581029|NCT01109849|3868531|P5|STARTED|Adaptive Randomization: Weight Recovery||25
1581030|NCT01109849|3868532|P4|STARTED|Adaptive Randomization: Weight Recovery||23
1581031|NCT01109849|3868533|P3|STARTED|Adaptive Randomization: Weight Recovery||24
1581032|NCT01109849|3868534|P2|STARTED|Adaptive Randomization: Weight Recovery||0
1581033|NCT01109849|3868535|P1|STARTED|Adaptive Randomization: Weight Recovery||0
1581034|NCT01109849|3868531|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
1581035|NCT01109849|3868532|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
1581036|NCT01109849|3868533|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
1581037|NCT01109849|3868534|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
1581038|NCT01109849|3868535|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
1581039|NCT01109849|3868531|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
1581040|NCT01109849|3868532|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
1581041|NCT01109849|3868533|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
1581042|NCT01109849|3868534|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
1581043|NCT01109849|3868535|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
1581044|NCT01109849|3868531|P5|STARTED|Initial Randomization: ADHD Treatment||0
1581045|NCT01109849|3868532|P4|STARTED|Initial Randomization: ADHD Treatment||0
1581046|NCT01109849|3868533|P3|STARTED|Initial Randomization: ADHD Treatment||0
1581047|NCT01109849|3868534|P2|STARTED|Initial Randomization: ADHD Treatment||180
1581048|NCT01109849|3868535|P1|STARTED|Initial Randomization: ADHD Treatment||50
1581049|NCT01109602|3868587|P3|NOT COMPLETED|Overall Study||1
1581050|NCT01109602|3868588|P2|NOT COMPLETED|Overall Study||2
1581051|NCT01109602|3868589|P1|NOT COMPLETED|Overall Study||1
1581052|NCT01109602|3868587|P3|COMPLETED|Overall Study||9
1581053|NCT01109602|3868588|P2|COMPLETED|Overall Study||21
1581054|NCT01109602|3868589|P1|COMPLETED|Overall Study||13
1581055|NCT01109602|3868587|P3|STARTED|Overall Study||10
1581056|NCT01109602|3868588|P2|STARTED|Overall Study||23
1581057|NCT01109602|3868589|P1|STARTED|Overall Study||14
1581058|NCT01109576|3868600|P1|NOT COMPLETED|Overall Study||1
1581059|NCT01109576|3868600|P1|COMPLETED|Overall Study||12
1581060|NCT01109576|3868600|P1|STARTED|Overall Study||13
1581061|NCT01109524|3868604|P1|NOT COMPLETED|Overall Study||57
1581062|NCT01109524|3868604|P1|COMPLETED|Overall Study||3
1581063|NCT01109524|3868604|P1|STARTED|Overall Study||60
1581064|NCT01109381|3868614|P1|NOT COMPLETED|Overall Study||2
1581065|NCT01109381|3868614|P1|COMPLETED|Overall Study||31
1581066|NCT01109381|3868614|P1|STARTED|Overall Study||33
1581067|NCT01109316|3868626|P3|NOT COMPLETED|Study Period 3||1
1581068|NCT01109316|3868627|P2|NOT COMPLETED|Study Period 3||2
1581069|NCT01109316|3868628|P1|NOT COMPLETED|Study Period 3||0
1581070|NCT01109316|3868626|P3|COMPLETED|Study Period 3||38
1581071|NCT01109316|3868627|P2|COMPLETED|Study Period 3||39
1581072|NCT01109316|3868628|P1|COMPLETED|Study Period 3||39
1581073|NCT01109316|3868626|P3|STARTED|Study Period 3||39
1581074|NCT01109316|3868627|P2|STARTED|Study Period 3||41
1581075|NCT01109316|3868628|P1|STARTED|Study Period 3||39
1581076|NCT01109316|3868626|P3|NOT COMPLETED|Study Period 2||2
1581077|NCT01109316|3868627|P2|NOT COMPLETED|Study Period 2||2
1581078|NCT01109316|3868628|P1|NOT COMPLETED|Study Period 2||1
1581079|NCT01109316|3868626|P3|COMPLETED|Study Period 2||41
1581080|NCT01109316|3868627|P2|COMPLETED|Study Period 2||40
1581081|NCT01109316|3868628|P1|COMPLETED|Study Period 2||38
1581082|NCT01109316|3868626|P3|STARTED|Study Period 2||43
1581083|NCT01109316|3868627|P2|STARTED|Study Period 2||42
1581084|NCT01109316|3868628|P1|STARTED|Study Period 2||39
1581085|NCT01109316|3868626|P3|NOT COMPLETED|Study Period 1||4
1581086|NCT01109316|3868627|P2|NOT COMPLETED|Study Period 1||4
1581087|NCT01109316|3868628|P1|NOT COMPLETED|Study Period 1||0
1581088|NCT01109316|3868626|P3|COMPLETED|Study Period 1||40
1581089|NCT01109316|3868627|P2|COMPLETED|Study Period 1||40
1581090|NCT01109316|3868628|P1|COMPLETED|Study Period 1||44
1581091|NCT01109316|3868626|P3|Received at Least One Dose of Study Drug|Study Period 1||42
1581092|NCT01109316|3868627|P2|Received at Least One Dose of Study Drug|Study Period 1||44
1581093|NCT01109316|3868628|P1|Received at Least One Dose of Study Drug|Study Period 1||44
1581094|NCT01109316|3868626|P3|STARTED|Study Period 1||44
1581095|NCT01109316|3868627|P2|STARTED|Study Period 1||44
1581096|NCT01109316|3868628|P1|STARTED|Study Period 1||44
1581097|NCT01109173|3868676|P4|NOT COMPLETED|Overall Study||93
1581098|NCT01109173|3868677|P3|NOT COMPLETED|Overall Study||101
1581099|NCT01109173|3868678|P2|NOT COMPLETED|Overall Study||86
1581100|NCT01109173|3868679|P1|NOT COMPLETED|Overall Study||88
1581101|NCT01109173|3868676|P4|COMPLETED|Overall Study||120
1581102|NCT01109173|3868677|P3|COMPLETED|Overall Study||110
1581103|NCT01109173|3868678|P2|COMPLETED|Overall Study||759
1581104|NCT01109173|3868679|P1|COMPLETED|Overall Study||763
1581105|NCT01109173|3868676|P4|STARTED|Overall Study||213
1581106|NCT01109173|3868677|P3|STARTED|Overall Study||211
1581107|NCT01109173|3868678|P2|STARTED|Overall Study||845
1581108|NCT01109173|3868679|P1|STARTED|Overall Study||851
1581109|NCT01109147|3868696|P3|NOT COMPLETED|Overall Study||10
1581110|NCT01109147|3868697|P2|NOT COMPLETED|Overall Study||3
1581111|NCT01109147|3868698|P1|NOT COMPLETED|Overall Study||2
1581112|NCT01109147|3868696|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
1581113|NCT01109147|3868697|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
1581114|NCT01109147|3868698|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
1581115|NCT01109147|3868696|P3|STARTED|Overall Study||36
1581116|NCT01109147|3868697|P2|STARTED|Overall Study||14
1581117|NCT01109147|3868698|P1|STARTED|Overall Study||17
1581118|NCT01109108|3868708|P2|NOT COMPLETED|Overall Study||0
1581119|NCT01109108|3868709|P1|NOT COMPLETED|Overall Study||0
1581120|NCT01109108|3868708|P2|COMPLETED|Overall Study||4755
1581121|NCT01109108|3868709|P1|COMPLETED|Overall Study||4035
1581122|NCT01109108|3868708|P2|STARTED|Overall Study||4755
1581123|NCT01109108|3868709|P1|STARTED|Overall Study||4035
1581124|NCT01109056|3868717|P2|NOT COMPLETED|Overall Study||5
1581125|NCT01109056|3868718|P1|NOT COMPLETED|Overall Study||7
1581126|NCT01109056|3868717|P2|COMPLETED|Overall Study||53
1581127|NCT01109056|3868718|P1|COMPLETED|Overall Study||50
1581128|NCT01109056|3868717|P2|STARTED|Overall Study||58
1581129|NCT01109056|3868718|P1|STARTED|Overall Study||57
1581130|NCT01109004|3868731|P3|NOT COMPLETED|Overall Study||0
1581131|NCT01109004|3868732|P2|NOT COMPLETED|Overall Study||0
1581132|NCT01109004|3868733|P1|NOT COMPLETED|Overall Study||0
1581133|NCT01109004|3868731|P3|COMPLETED|Overall Study||257
1581134|NCT01109004|3868732|P2|COMPLETED|Overall Study||254
1581135|NCT01109004|3868733|P1|COMPLETED|Overall Study||247
1581136|NCT01109004|3868731|P3|STARTED|Overall Study||257
1581137|NCT01109004|3868732|P2|STARTED|Overall Study||254
1581138|NCT01109004|3868733|P1|STARTED|Overall Study||247
1581139|NCT01108835|3868770|P2|NOT COMPLETED|Overall Study||21
1581140|NCT01108835|3868771|P1|NOT COMPLETED|Overall Study||17
1581141|NCT01108835|3868770|P2|COMPLETED|Overall Study||69
1581142|NCT01108835|3868771|P1|COMPLETED|Overall Study||73
1581143|NCT01108835|3868770|P2|STARTED|Overall Study||90
1581144|NCT01108835|3868771|P1|STARTED|Overall Study||90
1581145|NCT01108809|3868785|P1|NOT COMPLETED|Overall Study||4
1581146|NCT01108809|3868785|P1|COMPLETED|Overall Study||291
1581147|NCT01108809|3868785|P1|STARTED|Overall Study||295
1581148|NCT01108796|3868802|P2|NOT COMPLETED|Overall Study||7
1581149|NCT01108796|3868803|P1|NOT COMPLETED|Overall Study||7
1581150|NCT01108796|3868802|P2|COMPLETED|Overall Study||1060
1581151|NCT01108796|3868803|P1|COMPLETED|Overall Study||767
1581152|NCT01108796|3868802|P2|STARTED|Overall Study||1067
1581153|NCT01108796|3868803|P1|STARTED|Overall Study||774
1581154|NCT01108757|3868837|P2|NOT COMPLETED|Overall Study||0
1581155|NCT01108757|3868838|P1|NOT COMPLETED|Overall Study||0
1581156|NCT01108757|3868837|P2|COMPLETED|Overall Study||26
1581157|NCT01108757|3868838|P1|COMPLETED|Overall Study||26
1581158|NCT01108757|3868837|P2|STARTED|Overall Study||26
1581159|NCT01108757|3868838|P1|STARTED|Overall Study||26
1581160|NCT01108731|3868846|P2|NOT COMPLETED|Overall Study||4
1581161|NCT01108731|3868847|P1|NOT COMPLETED|Overall Study||4
1581162|NCT01108731|3868846|P2|COMPLETED|Overall Study||13
1581163|NCT01108731|3868847|P1|COMPLETED|Overall Study||13
1581164|NCT01108731|3868846|P2|STARTED|Overall Study||17
1581165|NCT01108731|3868847|P1|STARTED|Overall Study||17
1581166|NCT01108718|3868859|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
1581167|NCT01108718|3868860|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
1581168|NCT01108718|3868859|P2|COMPLETED|Received Second Intervention (2 Months)||7
1581169|NCT01108718|3868860|P1|COMPLETED|Received Second Intervention (2 Months)||4
1581170|NCT01108718|3868859|P2|STARTED|Received Second Intervention (2 Months)||7
1581171|NCT01108718|3868860|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
1581172|NCT01108718|3868859|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
1581173|NCT01108718|3868860|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
1581174|NCT01108718|3868859|P2|COMPLETED|Received First Intervention (2 Months)||7
1581175|NCT01108718|3868860|P1|COMPLETED|Received First Intervention (2 Months)||5
1581176|NCT01108718|3868859|P2|STARTED|Received First Intervention (2 Months)||7
1581177|NCT01108718|3868860|P1|STARTED|Received First Intervention (2 Months)||5
1581178|NCT01108523|3868865|P1|NOT COMPLETED|Overall Study||4
1581179|NCT01108523|3868865|P1|COMPLETED|Overall Study||3
1581180|NCT01108523|3868865|P1|STARTED|Overall Study||7
1581181|NCT01108510|3868872|P2|NOT COMPLETED|Overall Study||268
1581182|NCT01108510|3868873|P1|NOT COMPLETED|Overall Study||279
1581183|NCT01108510|3868872|P2|COMPLETED|Overall Study||81
1581184|NCT01108510|3868873|P1|COMPLETED|Overall Study||70
1581185|NCT01108510|3868872|P2|STARTED|Overall Study||349
1581186|NCT01108510|3868873|P1|STARTED|Overall Study||349
1581187|NCT01108458|3868893|P1|NOT COMPLETED|Overall Study||1
1581188|NCT01108458|3868893|P1|COMPLETED|Overall Study||0
1581189|NCT01108458|3868893|P1|STARTED|Overall Study||1
1581190|NCT01108445|3868904|P2|NOT COMPLETED|Overall Study||49
1581191|NCT01108445|3868905|P1|NOT COMPLETED|Overall Study||56
1581192|NCT01108445|3868904|P2|COMPLETED|Overall Study||2
1581193|NCT01108445|3868905|P1|COMPLETED|Overall Study||1
1581194|NCT01108445|3868904|P2|STARTED|Overall Study||51
1581195|NCT01108445|3868905|P1|STARTED|Overall Study||57
1581196|NCT01108406|3868939|P1|NOT COMPLETED|Overall Study||0
1581197|NCT01108406|3868939|P1|COMPLETED|Overall Study||22
1581198|NCT01108406|3868939|P1|STARTED|Overall Study||22
1581199|NCT01108341|3868945|P1|NOT COMPLETED|Overall Study||5
1581200|NCT01108341|3868945|P1|COMPLETED|Overall Study||45
1581201|NCT01108341|3868945|P1|Safety Set (Enrolled and Treated)|Overall Study||49
1581202|NCT01108341|3868945|P1|STARTED|Overall Study||50
1581203|NCT01108263|3868952|P2|NOT COMPLETED|Overall Study||1
1581204|NCT01108263|3868953|P1|NOT COMPLETED|Overall Study||0
1581205|NCT01108263|3868952|P2|COMPLETED|Overall Study||2
1581206|NCT01108263|3868953|P1|COMPLETED|Overall Study||2
1581207|NCT01108263|3868952|P2|STARTED|Overall Study||3
1581208|NCT01108263|3868953|P1|STARTED|Overall Study||2
1581209|NCT01108237|3868963|P2|NOT COMPLETED|Overall Study||17
1581210|NCT01108237|3868964|P1|NOT COMPLETED|Overall Study||9
1581211|NCT01108237|3868963|P2|COMPLETED|Overall Study||84
1581212|NCT01108237|3868964|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
1581213|NCT01108237|3868963|P2|STARTED|Overall Study||101
1581214|NCT01108237|3868964|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
1581215|NCT01108185|3868970|P1|NOT COMPLETED|Overall Study||27
1581216|NCT01108185|3868970|P1|COMPLETED|Overall Study||3154
1581217|NCT01108185|3868970|P1|Per Protocol Population|Overall Study||3181
1581218|NCT01108185|3868970|P1|STARTED|Overall Study||3181
1581219|NCT01108094|3868987|P4|NOT COMPLETED|Overall Study||0
1581220|NCT01108094|3868988|P3|NOT COMPLETED|Overall Study||0
1581221|NCT01108094|3868989|P2|NOT COMPLETED|Overall Study||0
1581222|NCT01108094|3868990|P1|NOT COMPLETED|Overall Study||3
1581223|NCT01108094|3868987|P4|COMPLETED|Overall Study||10
1581224|NCT01108094|3868988|P3|COMPLETED|Overall Study||4
1581225|NCT01108094|3868989|P2|COMPLETED|Overall Study||3
1581226|NCT01108094|3868990|P1|COMPLETED|Overall Study||9
1581227|NCT01108094|3868987|P4|STARTED|Overall Study||10
1581228|NCT01108094|3868988|P3|STARTED|Overall Study||4
1581229|NCT01108094|3868989|P2|STARTED|Overall Study||3
1581230|NCT01108094|3868990|P1|STARTED|Overall Study||12
1581231|NCT01108081|3869015|P4|NOT COMPLETED|Overall Study||4
1581232|NCT01108081|3869016|P3|NOT COMPLETED|Overall Study||0
1581233|NCT01108081|3869017|P2|NOT COMPLETED|Overall Study||2
1581234|NCT01108081|3869018|P1|NOT COMPLETED|Overall Study||2
1581235|NCT01108081|3869015|P4|COMPLETED|Overall Study||39
1581236|NCT01108081|3869016|P3|COMPLETED|Overall Study||38
1581237|NCT01108081|3869017|P2|COMPLETED|Overall Study||40
1581238|NCT01108081|3869018|P1|COMPLETED|Overall Study||44
1581239|NCT01108081|3869015|P4|STARTED|Overall Study||43
1581240|NCT01108081|3869016|P3|STARTED|Overall Study||38
1581241|NCT01108081|3869017|P2|STARTED|Overall Study||42
1581242|NCT01108081|3869018|P1|STARTED|Overall Study||46
1581243|NCT01108068|3869034|P2|NOT COMPLETED|Overall Study||0
1581244|NCT01108068|3869035|P1|NOT COMPLETED|Overall Study||6
1581245|NCT01108068|3869034|P2|COMPLETED|Overall Study||16
1581246|NCT01108068|3869035|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
1581247|NCT01108068|3869034|P2|STARTED|Overall Study||16
1581248|NCT01108068|3869035|P1|STARTED|Overall Study||10
1581249|NCT01108055|3869042|P1|NOT COMPLETED|Overall Study||15
1581250|NCT01108055|3869042|P1|COMPLETED|Overall Study||28
1581251|NCT01108055|3869042|P1|Eligible and Started Treatment|Overall Study||32
1581252|NCT01108055|3869042|P1|STARTED|Overall Study||43
1581253|NCT01108003|3869052|P2|NOT COMPLETED|Overall Study||0
1581254|NCT01108003|3869053|P1|NOT COMPLETED|Overall Study||0
1581255|NCT01108003|3869052|P2|COMPLETED|Overall Study||3
1581256|NCT01108003|3869053|P1|COMPLETED|Overall Study||4
1581257|NCT01108003|3869052|P2|STARTED|Overall Study||3
1581258|NCT01108003|3869053|P1|STARTED|Overall Study||4
1581259|NCT01107964|3869063|P2|NOT COMPLETED|Overall Study||1
1581260|NCT01107964|3869064|P1|NOT COMPLETED|Overall Study||1
1581261|NCT01107964|3869063|P2|COMPLETED|Overall Study||13
1581262|NCT01107964|3869064|P1|COMPLETED|Overall Study||12
1581263|NCT01107964|3869063|P2|STARTED|Overall Study||14
1581264|NCT01107964|3869064|P1|STARTED|Overall Study||13
1581265|NCT01107925|3869080|P6|NOT COMPLETED|Period 3||0
1581266|NCT01107925|3869081|P5|NOT COMPLETED|Period 3||0
1581267|NCT01107925|3869082|P4|NOT COMPLETED|Period 3||0
1581268|NCT01107925|3869083|P3|NOT COMPLETED|Period 3||0
1581269|NCT01107925|3869084|P2|NOT COMPLETED|Period 3||0
1581270|NCT01107925|3869085|P1|NOT COMPLETED|Period 3||0
1581271|NCT01107925|3869080|P6|COMPLETED|Period 3||20
1581272|NCT01107925|3869081|P5|COMPLETED|Period 3||0
1581273|NCT01107925|3869082|P4|COMPLETED|Period 3||16
1581274|NCT01107925|3869083|P3|COMPLETED|Period 3||15
1581275|NCT01107925|3869084|P2|COMPLETED|Period 3||17
1581276|NCT01107925|3869085|P1|COMPLETED|Period 3||0
1581277|NCT01107925|3869080|P6|Took at Least 1 Dose of Study Drug|Period 3||20
1581278|NCT01107925|3869081|P5|Took at Least 1 Dose of Study Drug|Period 3||0
1581279|NCT01107925|3869082|P4|Took at Least 1 Dose of Study Drug|Period 3||16
1581280|NCT01107925|3869083|P3|Took at Least 1 Dose of Study Drug|Period 3||15
1581281|NCT01107925|3869084|P2|Took at Least 1 Dose of Study Drug|Period 3||17
1581282|NCT01107925|3869085|P1|Took at Least 1 Dose of Study Drug|Period 3||0
1581283|NCT01107925|3869080|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
1581284|NCT01107925|3869081|P5|STARTED|Period 3||0
1581285|NCT01107925|3869082|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
1581286|NCT01107925|3869083|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
1581287|NCT01107925|3869084|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
1581288|NCT01107925|3869085|P1|STARTED|Period 3||0
1581289|NCT01107925|3869080|P6|NOT COMPLETED|Period 2||1
1581290|NCT01107925|3869081|P5|NOT COMPLETED|Period 2||0
1581291|NCT01107925|3869082|P4|NOT COMPLETED|Period 2||0
1581292|NCT01107925|3869083|P3|NOT COMPLETED|Period 2||0
1581293|NCT01107925|3869084|P2|NOT COMPLETED|Period 2||1
1581294|NCT01107925|3869085|P1|NOT COMPLETED|Period 2||0
1581295|NCT01107925|3869080|P6|COMPLETED|Period 2||16
1581296|NCT01107925|3869081|P5|COMPLETED|Period 2||0
1581297|NCT01107925|3869082|P4|COMPLETED|Period 2||20
1581298|NCT01107925|3869083|P3|COMPLETED|Period 2||17
1581299|NCT01107925|3869084|P2|COMPLETED|Period 2||15
1581300|NCT01107925|3869085|P1|COMPLETED|Period 2||0
1581301|NCT01107925|3869080|P6|Took at Least 1 Dose of Study Drug|Period 2||17
1581302|NCT01107925|3869081|P5|Took at Least 1 Dose of Study Drug|Period 2||0
1581303|NCT01107925|3869082|P4|Took at Least 1 Dose of Study Drug|Period 2||20
1581304|NCT01107925|3869083|P3|Took at Least 1 Dose of Study Drug|Period 2||17
1581305|NCT01107925|3869084|P2|Took at Least 1 Dose of Study Drug|Period 2||16
1581306|NCT01107925|3869085|P1|Took at Least 1 Dose of Study Drug|Period 2||0
1581307|NCT01107925|3869080|P6|STARTED|Period 2||17
1581308|NCT01107925|3869081|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
1581309|NCT01107925|3869082|P4|STARTED|Period 2||20
1581310|NCT01107925|3869083|P3|STARTED|Period 2||17
1581311|NCT01107925|3869084|P2|STARTED|Period 2||16
1581312|NCT01107925|3869085|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
1581313|NCT01107925|3869080|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1581314|NCT01107925|3869081|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
1581315|NCT01107925|3869082|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1581316|NCT01107925|3869083|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1581317|NCT01107925|3869084|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1581318|NCT01107925|3869085|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
1581319|NCT01107925|3869080|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
1581320|NCT01107925|3869081|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
1581321|NCT01107925|3869082|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
1581322|NCT01107925|3869083|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
1581323|NCT01107925|3869084|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
1581324|NCT01107925|3869085|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
1581325|NCT01107925|3869080|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1581326|NCT01107925|3869081|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
1581327|NCT01107925|3869082|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1581328|NCT01107925|3869083|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1581329|NCT01107925|3869084|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1581330|NCT01107925|3869085|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
1581331|NCT01107925|3869080|P6|STARTED|Period 1-Randomization up Through Day 12||0
1581332|NCT01107925|3869081|P5|STARTED|Period 1-Randomization up Through Day 12||38
1581333|NCT01107925|3869082|P4|STARTED|Period 1-Randomization up Through Day 12||0
1581334|NCT01107925|3869083|P3|STARTED|Period 1-Randomization up Through Day 12||0
1581335|NCT01107925|3869084|P2|STARTED|Period 1-Randomization up Through Day 12||0
1581336|NCT01107925|3869085|P1|STARTED|Period 1-Randomization up Through Day 12||34
1581337|NCT01107912|3869123|P6|NOT COMPLETED|Period 3||0
1581338|NCT01107912|3869124|P5|NOT COMPLETED|Period 3||0
1581339|NCT01107912|3869125|P4|NOT COMPLETED|Period 3||1
1581340|NCT01107912|3869126|P3|NOT COMPLETED|Period 3||1
1581341|NCT01107912|3869127|P2|NOT COMPLETED|Period 3||1
1581342|NCT01107912|3869128|P1|NOT COMPLETED|Period 3||0
1581343|NCT01107912|3869123|P6|COMPLETED|Period 3||41
1581344|NCT01107912|3869124|P5|COMPLETED|Period 3||0
1581345|NCT01107912|3869125|P4|COMPLETED|Period 3||37
1581346|NCT01107912|3869126|P3|COMPLETED|Period 3||35
1581347|NCT01107912|3869127|P2|COMPLETED|Period 3||34
1581348|NCT01107912|3869128|P1|COMPLETED|Period 3||0
1581349|NCT01107912|3869123|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
1581350|NCT01107912|3869124|P5|STARTED|Period 3||0
1581351|NCT01107912|3869125|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
1581352|NCT01107912|3869126|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
1581353|NCT01107912|3869127|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
1581354|NCT01107912|3869128|P1|STARTED|Period 3||0
1581355|NCT01107912|3869123|P6|NOT COMPLETED|Period 2||0
1581356|NCT01107912|3869124|P5|NOT COMPLETED|Period 2||0
1581357|NCT01107912|3869125|P4|NOT COMPLETED|Period 2||0
1581358|NCT01107912|3869126|P3|NOT COMPLETED|Period 2||1
1581359|NCT01107912|3869127|P2|NOT COMPLETED|Period 2||0
1581360|NCT01107912|3869128|P1|NOT COMPLETED|Period 2||0
1581361|NCT01107912|3869123|P6|COMPLETED|Period 2||38
1581362|NCT01107912|3869124|P5|COMPLETED|Period 2||0
1581363|NCT01107912|3869125|P4|COMPLETED|Period 2||41
1581364|NCT01107912|3869126|P3|COMPLETED|Period 2||35
1581365|NCT01107912|3869127|P2|COMPLETED|Period 2||36
1581366|NCT01107912|3869128|P1|COMPLETED|Period 2||0
1581367|NCT01107912|3869123|P6|STARTED|Period 2||38
1581368|NCT01107912|3869124|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
1581369|NCT01107912|3869125|P4|STARTED|Period 2||41
1581370|NCT01107912|3869126|P3|STARTED|Period 2||36
1581371|NCT01107912|3869127|P2|STARTED|Period 2||36
1581372|NCT01107912|3869128|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
1581373|NCT01107912|3869123|P6|NOT COMPLETED|Period 1||0
1581374|NCT01107912|3869124|P5|NOT COMPLETED|Period 1||3
1581375|NCT01107912|3869125|P4|NOT COMPLETED|Period 1||0
1581376|NCT01107912|3869126|P3|NOT COMPLETED|Period 1||0
1581377|NCT01107912|3869127|P2|NOT COMPLETED|Period 1||0
1581378|NCT01107912|3869128|P1|NOT COMPLETED|Period 1||1
1581379|NCT01107912|3869123|P6|COMPLETED|Period 1||0
1581380|NCT01107912|3869124|P5|COMPLETED|Period 1||79
1581381|NCT01107912|3869125|P4|COMPLETED|Period 1||0
1581382|NCT01107912|3869126|P3|COMPLETED|Period 1||0
1581383|NCT01107912|3869127|P2|COMPLETED|Period 1||0
1581384|NCT01107912|3869128|P1|COMPLETED|Period 1||72
1581385|NCT01107912|3869123|P6|Received at Least 1 Dose of Study Drug|Period 1||0
1581386|NCT01107912|3869124|P5|Received at Least 1 Dose of Study Drug|Period 1||82
1581387|NCT01107912|3869125|P4|Received at Least 1 Dose of Study Drug|Period 1||0
1581388|NCT01107912|3869126|P3|Received at Least 1 Dose of Study Drug|Period 1||0
1581389|NCT01107912|3869127|P2|Received at Least 1 Dose of Study Drug|Period 1||0
1581390|NCT01107912|3869128|P1|Received at Least 1 Dose of Study Drug|Period 1||73
1581391|NCT01107912|3869123|P6|STARTED|Period 1||0
1581392|NCT01107912|3869124|P5|STARTED|Period 1||82
1581393|NCT01107912|3869125|P4|STARTED|Period 1||0
1581394|NCT01107912|3869126|P3|STARTED|Period 1||0
1581395|NCT01107912|3869127|P2|STARTED|Period 1||0
1581396|NCT01107912|3869128|P1|STARTED|Period 1||73
1581397|NCT01107899|3869165|P3|NOT COMPLETED|Overall Study||4
1581398|NCT01107899|3869166|P2|NOT COMPLETED|Overall Study||0
1581399|NCT01107899|3869167|P1|NOT COMPLETED|Overall Study||5
1581400|NCT01107899|3869165|P3|COMPLETED|Overall Study||5
1581401|NCT01107899|3869166|P2|COMPLETED|Overall Study||10
1581402|NCT01107899|3869167|P1|COMPLETED|Overall Study||5
1581403|NCT01107899|3869165|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
1581404|NCT01107899|3869166|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
1581405|NCT01107899|3869167|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
1581406|NCT01107899|3869165|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
1581407|NCT01107899|3869166|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
1581408|NCT01107899|3869167|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
1581409|NCT01107899|3869165|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
1581410|NCT01107899|3869166|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
1581493|NCT01107457|3869360|P1|COMPLETED|Part A||22
1581657|NCT01106586|3869981|P2|STARTED|Overall Study||355
1581411|NCT01107899|3869167|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
1581412|NCT01107899|3869165|P3|Received at Least One Dose of Study Drug|Overall Study||8
1581413|NCT01107899|3869166|P2|Received at Least One Dose of Study Drug|Overall Study||10
1581414|NCT01107899|3869167|P1|Received at Least One Dose of Study Drug|Overall Study||10
1581415|NCT01107899|3869165|P3|STARTED|Overall Study||9
1581416|NCT01107899|3869166|P2|STARTED|Overall Study||10
1581417|NCT01107899|3869167|P1|STARTED|Overall Study||10
1581418|NCT01107886|3869213|P2|NOT COMPLETED|Overall Study||214
1581419|NCT01107886|3869214|P1|NOT COMPLETED|Overall Study||202
1581420|NCT01107886|3869213|P2|COMPLETED|Overall Study|Completed subjects|7998
1581421|NCT01107886|3869214|P1|COMPLETED|Overall Study|Completed subjects|8078
1581422|NCT01107886|3869213|P2|STARTED|Overall Study|Randomized subjects|8212
1581423|NCT01107886|3869214|P1|STARTED|Overall Study|Randomized subjects|8280
1581424|NCT01107834|3869226|P2|NOT COMPLETED|Overall Study||0
1581425|NCT01107834|3869227|P1|NOT COMPLETED|Overall Study||0
1581426|NCT01107834|3869226|P2|COMPLETED|Overall Study||30
1581427|NCT01107834|3869227|P1|COMPLETED|Overall Study||30
1581428|NCT01107834|3869226|P2|STARTED|Overall Study||30
1581429|NCT01107834|3869227|P1|STARTED|Overall Study||30
1581430|NCT01107743|3869243|P1|NOT COMPLETED|Overall Study||46
1581431|NCT01107743|3869243|P1|COMPLETED|Overall Study||1245
1581432|NCT01107743|3869243|P1|STARTED|Overall Study||1291
1581433|NCT01107730|3869332|P3|NOT COMPLETED|Overall Study||0
1581434|NCT01107730|3869333|P2|NOT COMPLETED|Overall Study||0
1581435|NCT01107730|3869334|P1|NOT COMPLETED|Overall Study||0
1581436|NCT01107730|3869332|P3|COMPLETED|Overall Study||11
1581437|NCT01107730|3869333|P2|COMPLETED|Overall Study||11
1581438|NCT01107730|3869334|P1|COMPLETED|Overall Study||11
1581439|NCT01107730|3869332|P3|STARTED|Overall Study||11
1581440|NCT01107730|3869333|P2|STARTED|Overall Study||11
1581441|NCT01107730|3869334|P1|STARTED|Overall Study||11
1581442|NCT01107535|3869342|P1|NOT COMPLETED|Overall Study||5
1581443|NCT01107535|3869342|P1|COMPLETED|Overall Study||77
1581444|NCT01107535|3869342|P1|Number of Participants Analyzed|Overall Study||82
1581445|NCT01107535|3869342|P1|STARTED|Overall Study||82
1581446|NCT01107457|3869355|P6|NOT COMPLETED|Part B and C||120
1581447|NCT01107457|3869356|P5|NOT COMPLETED|Part B and C||0
1581448|NCT01107457|3869357|P4|NOT COMPLETED|Part B and C||0
1581449|NCT01107457|3869358|P3|NOT COMPLETED|Part B and C||0
1581450|NCT01107457|3869359|P2|NOT COMPLETED|Part B and C||0
1581451|NCT01107457|3869360|P1|NOT COMPLETED|Part B and C||0
1581452|NCT01107457|3869355|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
1581453|NCT01107457|3869356|P5|COMPLETED|Part B and C||0
1581454|NCT01107457|3869357|P4|COMPLETED|Part B and C||0
1581455|NCT01107457|3869358|P3|COMPLETED|Part B and C||0
1581456|NCT01107457|3869359|P2|COMPLETED|Part B and C||0
1581457|NCT01107457|3869360|P1|COMPLETED|Part B and C||0
1581458|NCT01107457|3869355|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
1581459|NCT01107457|3869356|P5|Post Treatment Safety Visits|Part B and C||0
1581460|NCT01107457|3869357|P4|Post Treatment Safety Visits|Part B and C||0
1581461|NCT01107457|3869358|P3|Post Treatment Safety Visits|Part B and C||0
1581462|NCT01107457|3869359|P2|Post Treatment Safety Visits|Part B and C||0
1581463|NCT01107457|3869360|P1|Post Treatment Safety Visits|Part B and C||0
1581464|NCT01107457|3869355|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
1581465|NCT01107457|3869356|P5|Completed Part C|Part B and C||0
1581466|NCT01107457|3869357|P4|Completed Part C|Part B and C||0
1581467|NCT01107457|3869358|P3|Completed Part C|Part B and C||0
1581468|NCT01107457|3869359|P2|Completed Part C|Part B and C||0
1581469|NCT01107457|3869360|P1|Completed Part C|Part B and C||0
1581470|NCT01107457|3869355|P6|Completed Part B (Week 240)|Part B and C||74
1581471|NCT01107457|3869356|P5|Completed Part B (Week 240)|Part B and C||0
1581472|NCT01107457|3869357|P4|Completed Part B (Week 240)|Part B and C||0
1581473|NCT01107457|3869358|P3|Completed Part B (Week 240)|Part B and C||0
1581474|NCT01107457|3869359|P2|Completed Part B (Week 240)|Part B and C||0
1581475|NCT01107457|3869360|P1|Completed Part B (Week 240)|Part B and C||0
1581476|NCT01107457|3869355|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
1581477|NCT01107457|3869356|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1581478|NCT01107457|3869357|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1581479|NCT01107457|3869358|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1581480|NCT01107457|3869359|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1581481|NCT01107457|3869360|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1581482|NCT01107457|3869355|P6|NOT COMPLETED|Part A||0
1581483|NCT01107457|3869356|P5|NOT COMPLETED|Part A||1
1581484|NCT01107457|3869357|P4|NOT COMPLETED|Part A||3
1581485|NCT01107457|3869358|P3|NOT COMPLETED|Part A||1
1581486|NCT01107457|3869359|P2|NOT COMPLETED|Part A||7
1581487|NCT01107457|3869360|P1|NOT COMPLETED|Part A||5
1581488|NCT01107457|3869355|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
1581489|NCT01107457|3869356|P5|COMPLETED|Part A||27
1581490|NCT01107457|3869357|P4|COMPLETED|Part A||26
1581491|NCT01107457|3869358|P3|COMPLETED|Part A||29
1581492|NCT01107457|3869359|P2|COMPLETED|Part A||21
1581494|NCT01107457|3869355|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
1581495|NCT01107457|3869356|P5|Received at Least 1 Dose of Study Drug|Part A||28
1581496|NCT01107457|3869357|P4|Received at Least 1 Dose of Study Drug|Part A||29
1581497|NCT01107457|3869358|P3|Received at Least 1 Dose of Study Drug|Part A||30
1581498|NCT01107457|3869359|P2|Received at Least 1 Dose of Study Drug|Part A||28
1581499|NCT01107457|3869360|P1|Received at Least 1 Dose of Study Drug|Part A||27
1581500|NCT01107457|3869355|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
1581501|NCT01107457|3869356|P5|STARTED|Part A||28
1581502|NCT01107457|3869357|P4|STARTED|Part A||29
1581503|NCT01107457|3869358|P3|STARTED|Part A||30
1581504|NCT01107457|3869359|P2|STARTED|Part A||28
1581505|NCT01107457|3869360|P1|STARTED|Part A||27
1581506|NCT01107418|3869490|P1|NOT COMPLETED|Overall Study||52
1581507|NCT01107418|3869490|P1|COMPLETED|Overall Study||0
1581508|NCT01107418|3869490|P1|STARTED|Overall Study||52
1581509|NCT01107405|3869563|P5|NOT COMPLETED|Overall Study||3
1581510|NCT01107405|3869564|P4|NOT COMPLETED|Overall Study||3
1581511|NCT01107405|3869565|P3|NOT COMPLETED|Overall Study||2
1581512|NCT01107405|3869566|P2|NOT COMPLETED|Overall Study||1
1581513|NCT01107405|3869567|P1|NOT COMPLETED|Overall Study||2
1581514|NCT01107405|3869563|P5|COMPLETED|Overall Study||17
1581515|NCT01107405|3869564|P4|COMPLETED|Overall Study||17
1581516|NCT01107405|3869565|P3|COMPLETED|Overall Study||18
1581517|NCT01107405|3869566|P2|COMPLETED|Overall Study||19
1581518|NCT01107405|3869567|P1|COMPLETED|Overall Study||19
1581519|NCT01107405|3869563|P5|STARTED|Overall Study||20
1581520|NCT01107405|3869564|P4|STARTED|Overall Study||20
1581521|NCT01107405|3869565|P3|STARTED|Overall Study||20
1581522|NCT01107405|3869566|P2|STARTED|Overall Study||20
1581523|NCT01107405|3869567|P1|STARTED|Overall Study||21
1581524|NCT01107392|3869606|P2|NOT COMPLETED|Overall Study||3
1581525|NCT01107392|3869607|P1|NOT COMPLETED|Overall Study||5
1581526|NCT01107392|3869606|P2|COMPLETED|Overall Study||154
1581527|NCT01107392|3869607|P1|COMPLETED|Overall Study||153
1581528|NCT01107392|3869606|P2|STARTED|Overall Study||157
1581529|NCT01107392|3869607|P1|STARTED|Overall Study||158
1581530|NCT01107379|3869619|P1|NOT COMPLETED|Overall Study||21
1581531|NCT01107379|3869619|P1|COMPLETED|Overall Study||182
1581532|NCT01107379|3869619|P1|STARTED|Overall Study||203
1581533|NCT01107353|3869630|P2|NOT COMPLETED|Overall Study||0
1581534|NCT01107353|3869631|P1|NOT COMPLETED|Overall Study||1
1581535|NCT01107353|3869630|P2|COMPLETED|Overall Study||20
1581536|NCT01107353|3869631|P1|COMPLETED|Overall Study||19
1581537|NCT01107353|3869630|P2|STARTED|Overall Study||20
1581538|NCT01107353|3869631|P1|STARTED|Overall Study||20
1581539|NCT01107197|3869639|P2|NOT COMPLETED|Overall Study||23
1581540|NCT01107197|3869640|P1|NOT COMPLETED|Overall Study||20
1581541|NCT01107197|3869639|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
1581542|NCT01107197|3869640|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
1581543|NCT01107197|3869639|P2|STARTED|Overall Study||101
1581544|NCT01107197|3869640|P1|STARTED|Overall Study||99
1581545|NCT01107015|3869662|P4|NOT COMPLETED|Overall Study||18
1581546|NCT01107015|3869663|P3|NOT COMPLETED|Overall Study||11
1581547|NCT01107015|3869664|P2|NOT COMPLETED|Overall Study||15
1581548|NCT01107015|3869665|P1|NOT COMPLETED|Overall Study||6
1581549|NCT01107015|3869662|P4|COMPLETED|Overall Study||62
1581550|NCT01107015|3869663|P3|COMPLETED|Overall Study||22
1581551|NCT01107015|3869664|P2|COMPLETED|Overall Study||23
1581552|NCT01107015|3869665|P1|COMPLETED|Overall Study||56
1581553|NCT01107015|3869662|P4|STARTED|Overall Study||80
1581554|NCT01107015|3869663|P3|STARTED|Overall Study||33
1581555|NCT01107015|3869664|P2|STARTED|Overall Study||38
1581556|NCT01107015|3869665|P1|STARTED|Overall Study||62
1581557|NCT01106976|3869675|P1|NOT COMPLETED|Overall Study||8
1581558|NCT01106976|3869675|P1|COMPLETED|Overall Study||59
1581559|NCT01106976|3869675|P1|STARTED|Overall Study||67
1581560|NCT01106950|3869679|P1|NOT COMPLETED|Overall Study||0
1581561|NCT01106950|3869679|P1|COMPLETED|Overall Study||15
1581562|NCT01106950|3869679|P1|STARTED|Overall Study||15
1581563|NCT01106911|3869689|P1|NOT COMPLETED|Overall Study||5
1581564|NCT01106911|3869689|P1|COMPLETED|Overall Study||1080
1581565|NCT01106911|3869689|P1|STARTED|Overall Study||1085
1581566|NCT01106898|3869693|P1|NOT COMPLETED|Overall Study||6
1581567|NCT01106898|3869693|P1|COMPLETED|Overall Study||94
1581568|NCT01106898|3869693|P1|STARTED|Overall Study||100
1581569|NCT01106859|3869697|P1|NOT COMPLETED|Overall Study||0
1581570|NCT01106859|3869697|P1|COMPLETED|Overall Study||40
1581571|NCT01106859|3869697|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
1581572|NCT01106846|3869738|P2|NOT COMPLETED|Overall Study||1
1581573|NCT01106846|3869739|P1|NOT COMPLETED|Overall Study||0
1581574|NCT01106846|3869738|P2|COMPLETED|Overall Study||9
1581575|NCT01106846|3869739|P1|COMPLETED|Overall Study||12
1581576|NCT01106846|3869738|P2|STARTED|Overall Study||10
1581577|NCT01106846|3869739|P1|STARTED|Overall Study||12
1581578|NCT01106833|3869747|P2|NOT COMPLETED|Overall Study||0
1581579|NCT01106833|3869748|P1|NOT COMPLETED|Overall Study||0
1581580|NCT01106833|3869747|P2|COMPLETED|Overall Study||77
1581581|NCT01106833|3869748|P1|COMPLETED|Overall Study||74
1581582|NCT01106833|3869747|P2|STARTED|Overall Study||77
1581583|NCT01106833|3869748|P1|STARTED|Overall Study||74
1581584|NCT01106690|3869789|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
1581585|NCT01106690|3869790|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
1581586|NCT01106690|3869791|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
1581587|NCT01106690|3869789|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
1581588|NCT01106690|3869790|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
1581589|NCT01106690|3869791|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
1581590|NCT01106690|3869789|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
1581591|NCT01106690|3869790|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
1581592|NCT01106690|3869791|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
1581593|NCT01106690|3869789|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
1581594|NCT01106690|3869790|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
1581595|NCT01106690|3869791|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
1581596|NCT01106690|3869789|P3|COMPLETED|Core Period: Baseline to Week 26||101
1581597|NCT01106690|3869790|P2|COMPLETED|Core Period: Baseline to Week 26||104
1581598|NCT01106690|3869791|P1|COMPLETED|Core Period: Baseline to Week 26||91
1581599|NCT01106690|3869789|P3|STARTED|Core Period: Baseline to Week 26||114
1581600|NCT01106690|3869790|P2|STARTED|Core Period: Baseline to Week 26||113
1581601|NCT01106690|3869791|P1|STARTED|Core Period: Baseline to Week 26||115
1581602|NCT01106677|3869827|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
1581603|NCT01106677|3869828|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
1581604|NCT01106677|3869829|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
1581605|NCT01106677|3869830|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
1581606|NCT01106677|3869827|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
1581607|NCT01106677|3869828|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
1581608|NCT01106677|3869829|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
1581609|NCT01106677|3869830|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
1581610|NCT01106677|3869827|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
1581611|NCT01106677|3869828|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
1581612|NCT01106677|3869829|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
1581613|NCT01106677|3869830|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
1581614|NCT01106677|3869827|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
1581615|NCT01106677|3869828|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
1581616|NCT01106677|3869829|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
1581617|NCT01106677|3869830|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
1581618|NCT01106677|3869827|P4|COMPLETED|Core Period: Baseline to Week 26||319
1581619|NCT01106677|3869828|P3|COMPLETED|Core Period: Baseline to Week 26||323
1581620|NCT01106677|3869829|P2|COMPLETED|Core Period: Baseline to Week 26||322
1581621|NCT01106677|3869830|P1|COMPLETED|Core Period: Baseline to Week 26||155
1581622|NCT01106677|3869827|P4|STARTED|Core Period: Baseline to Week 26||366
1581623|NCT01106677|3869828|P3|STARTED|Core Period: Baseline to Week 26||367
1581624|NCT01106677|3869829|P2|STARTED|Core Period: Baseline to Week 26||368
1581625|NCT01106677|3869830|P1|STARTED|Core Period: Baseline to Week 26||183
1581626|NCT01106651|3869893|P3|NOT COMPLETED|Overall Study||58
1581627|NCT01106651|3869894|P2|NOT COMPLETED|Overall Study||57
1581628|NCT01106651|3869895|P1|NOT COMPLETED|Overall Study||79
1581629|NCT01106651|3869893|P3|COMPLETED|Overall Study||178
1581630|NCT01106651|3869894|P2|COMPLETED|Overall Study||184
1581631|NCT01106651|3869895|P1|COMPLETED|Overall Study||158
1581632|NCT01106651|3869893|P3|STARTED|Overall Study||236
1581633|NCT01106651|3869894|P2|STARTED|Overall Study||241
1581634|NCT01106651|3869895|P1|STARTED|Overall Study||237
1581635|NCT01106625|3869948|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
1581636|NCT01106625|3869949|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
1581637|NCT01106625|3869950|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
1581638|NCT01106625|3869948|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
1581639|NCT01106625|3869949|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
1581640|NCT01106625|3869950|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
1581641|NCT01106625|3869948|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
1581642|NCT01106625|3869949|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
1581643|NCT01106625|3869950|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
1581644|NCT01106625|3869948|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
1581645|NCT01106625|3869949|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
1581646|NCT01106625|3869950|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
1581647|NCT01106625|3869948|P3|COMPLETED|Core Period: Baseline to Week 26||129
1581648|NCT01106625|3869949|P2|COMPLETED|Core Period: Baseline to Week 26||129
1581649|NCT01106625|3869950|P1|COMPLETED|Core Period: Baseline to Week 26||123
1581650|NCT01106625|3869948|P3|STARTED|Core Period: Baseline to Week 26||156
1581651|NCT01106625|3869949|P2|STARTED|Core Period: Baseline to Week 26||157
1581652|NCT01106625|3869950|P1|STARTED|Core Period: Baseline to Week 26||156
1581653|NCT01106586|3869981|P2|NOT COMPLETED|Overall Study||285
1581654|NCT01106586|3869982|P1|NOT COMPLETED|Overall Study||285
1581655|NCT01106586|3869981|P2|COMPLETED|Overall Study||70
1581656|NCT01106586|3869982|P1|COMPLETED|Overall Study||68
1581658|NCT01106586|3869982|P1|STARTED|Overall Study||353
1581659|NCT01106534|3870000|P1|NOT COMPLETED|Overall Study||37
1581660|NCT01106534|3870000|P1|COMPLETED|Overall Study||2960
1581661|NCT01106534|3870000|P1|STARTED|Overall Study||2997
1581662|NCT01106456|3870023|P2|NOT COMPLETED|Overall Study||124
1581663|NCT01106456|3870024|P1|NOT COMPLETED|Overall Study||103
1581664|NCT01106456|3870023|P2|COMPLETED|Overall Study||96
1581665|NCT01106456|3870024|P1|COMPLETED|Overall Study||140
1581666|NCT01106456|3870023|P2|STARTED|Overall Study||220
1581667|NCT01106456|3870024|P1|STARTED|Overall Study||243
1581668|NCT01106430|3870032|P2|NOT COMPLETED|Overall Study||33
1581669|NCT01106430|3870033|P1|NOT COMPLETED|Overall Study||33
1581670|NCT01106430|3870032|P2|COMPLETED|Overall Study||101
1581671|NCT01106430|3870033|P1|COMPLETED|Overall Study||100
1581672|NCT01106430|3870032|P2|STARTED|Overall Study||134
1581673|NCT01106430|3870033|P1|STARTED|Overall Study||133
1581674|NCT01106404|3870055|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
1581675|NCT01106404|3870056|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
1581676|NCT01106404|3870055|P2|COMPLETED|Period II (Second 6 Weeks)||38
1581677|NCT01106404|3870056|P1|COMPLETED|Period II (Second 6 Weeks)||33
1581678|NCT01106404|3870055|P2|STARTED|Period II (Second 6 Weeks)||38
1581679|NCT01106404|3870056|P1|STARTED|Period II (Second 6 Weeks)||33
1581680|NCT01106404|3870055|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
1581681|NCT01106404|3870056|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
1581682|NCT01106404|3870055|P2|COMPLETED|Period I (First 6 Weeks)||38
1581683|NCT01106404|3870056|P1|COMPLETED|Period I (First 6 Weeks)||33
1581684|NCT01106404|3870055|P2|STARTED|Period I (First 6 Weeks)||40
1581685|NCT01106404|3870056|P1|STARTED|Period I (First 6 Weeks)||36
1581686|NCT01106391|3870069|P1|NOT COMPLETED|Overall Study||0
1581687|NCT01106391|3870069|P1|COMPLETED|Overall Study||60
1581688|NCT01106391|3870069|P1|STARTED|Overall Study||60
1581689|NCT01106352|3870079|P5|NOT COMPLETED|Overall Study||8
1581690|NCT01106352|3870080|P4|NOT COMPLETED|Overall Study||13
1581691|NCT01106352|3870081|P3|NOT COMPLETED|Overall Study||2
1581692|NCT01106352|3870082|P2|NOT COMPLETED|Overall Study||0
1581693|NCT01106352|3870083|P1|NOT COMPLETED|Overall Study||1
1581694|NCT01106352|3870079|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
1581695|NCT01106352|3870080|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
1581696|NCT01106352|3870081|P3|COMPLETED|Overall Study||5
1581697|NCT01106352|3870082|P2|COMPLETED|Overall Study||3
1581698|NCT01106352|3870083|P1|COMPLETED|Overall Study||6
1581699|NCT01106352|3870079|P5|Completed Safety Cohort|Overall Study||9
1581700|NCT01106352|3870080|P4|Completed Safety Cohort|Overall Study||23
1581701|NCT01106352|3870081|P3|Completed Safety Cohort|Overall Study||0
1581702|NCT01106352|3870082|P2|Completed Safety Cohort|Overall Study||0
1581703|NCT01106352|3870083|P1|Completed Safety Cohort|Overall Study||0
1581704|NCT01106352|3870079|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
1581705|NCT01106352|3870080|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
1581706|NCT01106352|3870081|P3|Treated Safety Cohort|Overall Study||0
1581707|NCT01106352|3870082|P2|Treated Safety Cohort|Overall Study||0
1581708|NCT01106352|3870083|P1|Treated Safety Cohort|Overall Study||0
1581709|NCT01106352|3870079|P5|Started Safety Cohort|Overall Study||17
1581710|NCT01106352|3870080|P4|Started Safety Cohort|Overall Study||36
1581711|NCT01106352|3870081|P3|Started Safety Cohort|Overall Study||0
1581712|NCT01106352|3870082|P2|Started Safety Cohort|Overall Study||0
1581713|NCT01106352|3870083|P1|Started Safety Cohort|Overall Study||0
1581714|NCT01106352|3870079|P5|Completed Dose Escalation|Overall Study||0
1581715|NCT01106352|3870080|P4|Completed Dose Escalation|Overall Study||0
1581716|NCT01106352|3870081|P3|Completed Dose Escalation|Overall Study||5
1581717|NCT01106352|3870082|P2|Completed Dose Escalation|Overall Study||3
1581718|NCT01106352|3870083|P1|Completed Dose Escalation|Overall Study||6
1581719|NCT01106352|3870079|P5|Started Dose Escalation|Overall Study||0
1581720|NCT01106352|3870080|P4|Started Dose Escalation|Overall Study||0
1581721|NCT01106352|3870081|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
1581722|NCT01106352|3870082|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
1581723|NCT01106352|3870083|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
1581724|NCT01106352|3870079|P5|STARTED|Overall Study||17
1581725|NCT01106352|3870080|P4|STARTED|Overall Study||36
1581726|NCT01106352|3870081|P3|STARTED|Overall Study||7
1581727|NCT01106352|3870082|P2|STARTED|Overall Study||3
1581728|NCT01106352|3870083|P1|STARTED|Overall Study||7
1581729|NCT01106326|3870169|P1|NOT COMPLETED|Overall Study||2
1581730|NCT01106326|3870169|P1|COMPLETED|Overall Study||28
1581731|NCT01106326|3870169|P1|STARTED|Overall Study||30
1581732|NCT01106287|3870179|P4|NOT COMPLETED|Overall Study||0
1581733|NCT01106287|3870180|P3|NOT COMPLETED|Overall Study||0
1581734|NCT01106287|3870181|P2|NOT COMPLETED|Overall Study||0
1581735|NCT01106287|3870182|P1|NOT COMPLETED|Overall Study||1
1581736|NCT01106287|3870179|P4|COMPLETED|Overall Study||3
1581737|NCT01106287|3870180|P3|COMPLETED|Overall Study||3
1581738|NCT01106287|3870181|P2|COMPLETED|Overall Study||3
1581739|NCT01106287|3870182|P1|COMPLETED|Overall Study||3
1581740|NCT01106287|3870179|P4|STARTED|Overall Study||3
1581741|NCT01106287|3870180|P3|STARTED|Overall Study||3
1581742|NCT01106287|3870181|P2|STARTED|Overall Study||3
1581743|NCT01106287|3870182|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
1581744|NCT01106248|3870202|P1|NOT COMPLETED|Overall Study||3
1581745|NCT01106248|3870202|P1|COMPLETED|Overall Study||23
1581746|NCT01106248|3870202|P1|STARTED|Overall Study||26
1581747|NCT01106157|3870210|P2|NOT COMPLETED|Overall Study||0
1581748|NCT01106157|3870211|P1|NOT COMPLETED|Overall Study||1
1581749|NCT01106157|3870210|P2|COMPLETED|Overall Study||8
1581750|NCT01106157|3870211|P1|COMPLETED|Overall Study||16
1581751|NCT01106157|3870210|P2|STARTED|Overall Study||8
1581752|NCT01106157|3870211|P1|STARTED|Overall Study||17
1581753|NCT01106092|3870239|P4|NOT COMPLETED|Overall Study||1
1581754|NCT01106092|3870240|P3|NOT COMPLETED|Overall Study||0
1581755|NCT01106092|3870241|P2|NOT COMPLETED|Overall Study||0
1581756|NCT01106092|3870242|P1|NOT COMPLETED|Overall Study||0
1581757|NCT01106092|3870239|P4|COMPLETED|Overall Study||77
1581758|NCT01106092|3870240|P3|COMPLETED|Overall Study||78
1581759|NCT01106092|3870241|P2|COMPLETED|Overall Study||78
1581760|NCT01106092|3870242|P1|COMPLETED|Overall Study||78
1581761|NCT01106092|3870239|P4|STARTED|Overall Study||78
1581762|NCT01106092|3870240|P3|STARTED|Overall Study||78
1581763|NCT01106092|3870241|P2|STARTED|Overall Study||78
1581764|NCT01106092|3870242|P1|STARTED|Overall Study||78
1581765|NCT01106040|3870320|P1|NOT COMPLETED|Overall Study||11
1581766|NCT01106040|3870320|P1|COMPLETED|Overall Study||152
1581767|NCT01106040|3870320|P1|STARTED|Overall Study||163
1581768|NCT01106027|3870325|P1|NOT COMPLETED|Overall Study||1
1581769|NCT01106027|3870325|P1|COMPLETED|Overall Study||1
1581770|NCT01106027|3870325|P1|STARTED|Overall Study||2
1581771|NCT01106014|3870331|P2|NOT COMPLETED|Overall Study||330
1581772|NCT01106014|3870332|P1|NOT COMPLETED|Overall Study||285
1581773|NCT01106014|3870331|P2|COMPLETED|Overall Study||252
1581774|NCT01106014|3870332|P1|COMPLETED|Overall Study||289
1581775|NCT01106014|3870331|P2|STARTED|Overall Study||582
1581776|NCT01106014|3870332|P1|STARTED|Overall Study||574
1581777|NCT01105975|3870352|P10|NOT COMPLETED|Overall Study||9
1581778|NCT01105975|3870353|P9|NOT COMPLETED|Overall Study||6
1581779|NCT01105975|3870354|P8|NOT COMPLETED|Overall Study||7
1581780|NCT01105975|3870355|P7|NOT COMPLETED|Overall Study||8
1581781|NCT01105975|3870356|P6|NOT COMPLETED|Overall Study||5
1581782|NCT01105975|3870357|P5|NOT COMPLETED|Overall Study||6
1581783|NCT01105975|3870358|P4|NOT COMPLETED|Overall Study||2
1581784|NCT01105975|3870359|P3|NOT COMPLETED|Overall Study||10
1581785|NCT01105975|3870360|P2|NOT COMPLETED|Overall Study||5
1581786|NCT01105975|3870361|P1|NOT COMPLETED|Overall Study||5
1581787|NCT01105975|3870352|P10|COMPLETED|Overall Study||32
1581788|NCT01105975|3870353|P9|COMPLETED|Overall Study||34
1581789|NCT01105975|3870354|P8|COMPLETED|Overall Study||33
1581790|NCT01105975|3870355|P7|COMPLETED|Overall Study||34
1581791|NCT01105975|3870356|P6|COMPLETED|Overall Study||30
1581792|NCT01105975|3870357|P5|COMPLETED|Overall Study||35
1581793|NCT01105975|3870358|P4|COMPLETED|Overall Study||36
1581794|NCT01105975|3870359|P3|COMPLETED|Overall Study||32
1581795|NCT01105975|3870360|P2|COMPLETED|Overall Study||34
1581796|NCT01105975|3870361|P1|COMPLETED|Overall Study||35
1581797|NCT01105975|3870352|P10|Took at Least One Dose of Study Drug|Overall Study||41
1581798|NCT01105975|3870353|P9|Took at Least One Dose of Study Drug|Overall Study||39
1581799|NCT01105975|3870354|P8|Took at Least One Dose of Study Drug|Overall Study||40
1581800|NCT01105975|3870355|P7|Took at Least One Dose of Study Drug|Overall Study||41
1581801|NCT01105975|3870356|P6|Took at Least One Dose of Study Drug|Overall Study||35
1581802|NCT01105975|3870357|P5|Took at Least One Dose of Study Drug|Overall Study||41
1581803|NCT01105975|3870358|P4|Took at Least One Dose of Study Drug|Overall Study||38
1581804|NCT01105975|3870359|P3|Took at Least One Dose of Study Drug|Overall Study||40
1581805|NCT01105975|3870360|P2|Took at Least One Dose of Study Drug|Overall Study||38
1581806|NCT01105975|3870361|P1|Took at Least One Dose of Study Drug|Overall Study||40
1581807|NCT01105975|3870352|P10|STARTED|Overall Study||41
1581808|NCT01105975|3870353|P9|STARTED|Overall Study||40
1581809|NCT01105975|3870354|P8|STARTED|Overall Study||40
1581810|NCT01105975|3870355|P7|STARTED|Overall Study||42
1581811|NCT01105975|3870356|P6|STARTED|Overall Study||35
1581812|NCT01105975|3870357|P5|STARTED|Overall Study||41
1581813|NCT01105975|3870358|P4|STARTED|Overall Study||38
1581814|NCT01105975|3870359|P3|STARTED|Overall Study||42
1581815|NCT01105975|3870360|P2|STARTED|Overall Study||39
1581816|NCT01105975|3870361|P1|STARTED|Overall Study||40
1581817|NCT01105936|3870509|P4|NOT COMPLETED|Period 3||0
1581818|NCT01105936|3870510|P3|NOT COMPLETED|Period 3||0
1581819|NCT01105936|3870511|P2|NOT COMPLETED|Period 3||2
1581820|NCT01105936|3870512|P1|NOT COMPLETED|Period 3||0
1581821|NCT01105936|3870509|P4|COMPLETED|Period 3||7
1581822|NCT01105936|3870510|P3|COMPLETED|Period 3||7
1581823|NCT01105936|3870511|P2|COMPLETED|Period 3||6
1581824|NCT01105936|3870512|P1|COMPLETED|Period 3||7
1581825|NCT01105936|3870509|P4|STARTED|Period 3||7
1581826|NCT01105936|3870510|P3|STARTED|Period 3||7
1581827|NCT01105936|3870511|P2|STARTED|Period 3||8
1581828|NCT01105936|3870512|P1|STARTED|Period 3||7
1581829|NCT01105936|3870509|P4|NOT COMPLETED|Wash-out Period 2||0
1581830|NCT01105936|3870510|P3|NOT COMPLETED|Wash-out Period 2||0
1581831|NCT01105936|3870511|P2|NOT COMPLETED|Wash-out Period 2||0
1581832|NCT01105936|3870512|P1|NOT COMPLETED|Wash-out Period 2||0
1581833|NCT01105936|3870509|P4|COMPLETED|Wash-out Period 2||7
1581834|NCT01105936|3870510|P3|COMPLETED|Wash-out Period 2||7
1581835|NCT01105936|3870511|P2|COMPLETED|Wash-out Period 2||8
1581836|NCT01105936|3870512|P1|COMPLETED|Wash-out Period 2||7
1581837|NCT01105936|3870509|P4|STARTED|Wash-out Period 2||7
1581838|NCT01105936|3870510|P3|STARTED|Wash-out Period 2||7
1581839|NCT01105936|3870511|P2|STARTED|Wash-out Period 2||8
1581840|NCT01105936|3870512|P1|STARTED|Wash-out Period 2||7
1581841|NCT01105936|3870509|P4|NOT COMPLETED|Period 2||0
1581842|NCT01105936|3870510|P3|NOT COMPLETED|Period 2||0
1581843|NCT01105936|3870511|P2|NOT COMPLETED|Period 2||0
1581844|NCT01105936|3870512|P1|NOT COMPLETED|Period 2||1
1581845|NCT01105936|3870509|P4|COMPLETED|Period 2||7
1581846|NCT01105936|3870510|P3|COMPLETED|Period 2||7
1581847|NCT01105936|3870511|P2|COMPLETED|Period 2||8
1581848|NCT01105936|3870512|P1|COMPLETED|Period 2||7
1581849|NCT01105936|3870509|P4|STARTED|Period 2||7
1581850|NCT01105936|3870510|P3|STARTED|Period 2||7
1581851|NCT01105936|3870511|P2|STARTED|Period 2||8
1581852|NCT01105936|3870512|P1|STARTED|Period 2||8
1581853|NCT01105936|3870509|P4|NOT COMPLETED|Wash-out Period 1||0
1581854|NCT01105936|3870510|P3|NOT COMPLETED|Wash-out Period 1||0
1581855|NCT01105936|3870511|P2|NOT COMPLETED|Wash-out Period 1||0
1581856|NCT01105936|3870512|P1|NOT COMPLETED|Wash-out Period 1||0
1581857|NCT01105936|3870509|P4|COMPLETED|Wash-out Period 1||7
1581858|NCT01105936|3870510|P3|COMPLETED|Wash-out Period 1||7
1581859|NCT01105936|3870511|P2|COMPLETED|Wash-out Period 1||8
1581860|NCT01105936|3870512|P1|COMPLETED|Wash-out Period 1||8
1581861|NCT01105936|3870509|P4|STARTED|Wash-out Period 1||7
1581862|NCT01105936|3870510|P3|STARTED|Wash-out Period 1||7
1581863|NCT01105936|3870511|P2|STARTED|Wash-out Period 1||8
1581864|NCT01105936|3870512|P1|STARTED|Wash-out Period 1||8
1581865|NCT01105936|3870509|P4|NOT COMPLETED|Period 1||1
1581866|NCT01105936|3870510|P3|NOT COMPLETED|Period 1||0
1581867|NCT01105936|3870511|P2|NOT COMPLETED|Period 1||0
1581868|NCT01105936|3870512|P1|NOT COMPLETED|Period 1||0
1581869|NCT01105936|3870509|P4|COMPLETED|Period 1||7
1581870|NCT01105936|3870510|P3|COMPLETED|Period 1||7
1581871|NCT01105936|3870511|P2|COMPLETED|Period 1||8
1581872|NCT01105936|3870512|P1|COMPLETED|Period 1||8
1581873|NCT01105936|3870509|P4|STARTED|Period 1||8
1581874|NCT01105936|3870510|P3|STARTED|Period 1||7
1581875|NCT01105936|3870511|P2|STARTED|Period 1||8
1581876|NCT01105936|3870512|P1|STARTED|Period 1||8
1581877|NCT01105767|3870541|P3|NOT COMPLETED|Overall Study||1184
1581878|NCT01105767|3870542|P2|NOT COMPLETED|Overall Study||1614
1581879|NCT01105767|3870543|P1|NOT COMPLETED|Overall Study||1160
1581880|NCT01105767|3870541|P3|COMPLETED|Overall Study||8846
1581881|NCT01105767|3870542|P2|COMPLETED|Overall Study||9250
1581882|NCT01105767|3870543|P1|COMPLETED|Overall Study||8155
1581883|NCT01105767|3870541|P3|STARTED|Overall Study||10030
1581884|NCT01105767|3870542|P2|STARTED|Overall Study||10864
1581885|NCT01105767|3870543|P1|STARTED|Overall Study||9315
1581886|NCT01105754|3870556|P2|NOT COMPLETED|Overall Study||12
1581887|NCT01105754|3870557|P1|NOT COMPLETED|Overall Study||15
1581888|NCT01105754|3870556|P2|COMPLETED|Overall Study||307
1581889|NCT01105754|3870557|P1|COMPLETED|Overall Study||304
1581890|NCT01105754|3870556|P2|STARTED|Overall Study||319
1581891|NCT01105754|3870557|P1|STARTED|Overall Study||319
1581892|NCT01105702|3870565|P1|NOT COMPLETED|Overall Study||18
1581893|NCT01105702|3870565|P1|COMPLETED|Overall Study||10
1581894|NCT01105702|3870565|P1|STARTED|Overall Study||28
1581895|NCT01105650|3870575|P4|NOT COMPLETED|Overall Study||0
1581896|NCT01105650|3870576|P3|NOT COMPLETED|Overall Study||0
1581897|NCT01105650|3870577|P2|NOT COMPLETED|Overall Study||0
1581898|NCT01105650|3870578|P1|NOT COMPLETED|Overall Study||0
1581899|NCT01105650|3870575|P4|COMPLETED|Overall Study||0
1581900|NCT01105650|3870576|P3|COMPLETED|Overall Study||7
1581901|NCT01105650|3870577|P2|COMPLETED|Overall Study||3
1581902|NCT01105650|3870578|P1|COMPLETED|Overall Study||3
1581903|NCT01105650|3870575|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
1581904|NCT01105650|3870576|P3|STARTED|Overall Study||7
1581905|NCT01105650|3870577|P2|STARTED|Overall Study||3
1581906|NCT01105650|3870578|P1|STARTED|Overall Study||3
1581907|NCT01105533|3870595|P9|NOT COMPLETED|Overall Study||12
1581908|NCT01105533|3870596|P8|NOT COMPLETED|Overall Study||4
1581909|NCT01105533|3870597|P7|NOT COMPLETED|Overall Study||8
1581910|NCT01105533|3870598|P6|NOT COMPLETED|Overall Study||7
1581911|NCT01105533|3870599|P5|NOT COMPLETED|Overall Study||7
1581912|NCT01105533|3870600|P4|NOT COMPLETED|Overall Study||3
1581913|NCT01105533|3870601|P3|NOT COMPLETED|Overall Study||3
1581914|NCT01105533|3870602|P2|NOT COMPLETED|Overall Study||1
1581915|NCT01105533|3870603|P1|NOT COMPLETED|Overall Study||1
1581916|NCT01105533|3870595|P9|COMPLETED|Overall Study||0
1581917|NCT01105533|3870596|P8|COMPLETED|Overall Study||0
1581918|NCT01105533|3870597|P7|COMPLETED|Overall Study||0
1581919|NCT01105533|3870598|P6|COMPLETED|Overall Study||0
1581920|NCT01105533|3870599|P5|COMPLETED|Overall Study||0
1581921|NCT01105533|3870600|P4|COMPLETED|Overall Study||0
1581922|NCT01105533|3870601|P3|COMPLETED|Overall Study||0
1581923|NCT01105533|3870602|P2|COMPLETED|Overall Study||0
1581924|NCT01105533|3870603|P1|COMPLETED|Overall Study||0
1581925|NCT01105533|3870595|P9|STARTED|Overall Study||12
1581926|NCT01105533|3870596|P8|STARTED|Overall Study||4
1581927|NCT01105533|3870597|P7|STARTED|Overall Study||8
1581928|NCT01105533|3870598|P6|STARTED|Overall Study||7
1581929|NCT01105533|3870599|P5|STARTED|Overall Study||7
1581930|NCT01105533|3870600|P4|STARTED|Overall Study||3
1581931|NCT01105533|3870601|P3|STARTED|Overall Study||3
1581932|NCT01105533|3870602|P2|STARTED|Overall Study||1
1581933|NCT01105533|3870603|P1|STARTED|Overall Study||1
1581934|NCT01105377|3870693|P2|NOT COMPLETED|Overall Study||1
1581935|NCT01105377|3870694|P1|NOT COMPLETED|Overall Study||0
1581936|NCT01105377|3870693|P2|COMPLETED|Overall Study||22
1581937|NCT01105377|3870694|P1|COMPLETED|Overall Study||24
1581938|NCT01105377|3870693|P2|STARTED|Overall Study||23
1581939|NCT01105377|3870694|P1|STARTED|Overall Study||24
1581940|NCT01105312|3870705|P3|NOT COMPLETED|Overall Study||0
1581941|NCT01105312|3870706|P2|NOT COMPLETED|Overall Study||0
1581942|NCT01105312|3870707|P1|NOT COMPLETED|Overall Study||3
1581943|NCT01105312|3870705|P3|COMPLETED|Overall Study||6
1581944|NCT01105312|3870706|P2|COMPLETED|Overall Study||6
1581945|NCT01105312|3870707|P1|COMPLETED|Overall Study||13
1581946|NCT01105312|3870705|P3|STARTED|Overall Study||6
1581947|NCT01105312|3870706|P2|STARTED|Overall Study||6
1581948|NCT01105312|3870707|P1|STARTED|Overall Study||16
1581949|NCT01105247|3870725|P2|NOT COMPLETED|Overall Study||0
1581950|NCT01105247|3870726|P1|NOT COMPLETED|Overall Study||37
1581951|NCT01105247|3870725|P2|COMPLETED|Overall Study||16
1581952|NCT01105247|3870726|P1|COMPLETED|Overall Study||79
1581953|NCT01105247|3870725|P2|STARTED|Overall Study||16
1581954|NCT01105247|3870726|P1|STARTED|Overall Study||116
1581955|NCT01105130|3870742|P3|NOT COMPLETED|Overall Study||10
1581956|NCT01105130|3870743|P2|NOT COMPLETED|Overall Study||11
1581957|NCT01105130|3870744|P1|NOT COMPLETED|Overall Study||10
1581958|NCT01105130|3870742|P3|COMPLETED|Overall Study||37
1581959|NCT01105130|3870743|P2|COMPLETED|Overall Study||34
1581960|NCT01105130|3870744|P1|COMPLETED|Overall Study||38
1581961|NCT01105130|3870742|P3|STARTED|Overall Study||47
1581962|NCT01105130|3870743|P2|STARTED|Overall Study||45
1581963|NCT01105130|3870744|P1|STARTED|Overall Study||48
1581964|NCT01105117|3870763|P2|NOT COMPLETED|Overall Study||0
1581965|NCT01105117|3870764|P1|NOT COMPLETED|Overall Study||0
1581966|NCT01105117|3870763|P2|COMPLETED|Overall Study||1
1581967|NCT01105117|3870764|P1|COMPLETED|Overall Study||1
1581968|NCT01105117|3870763|P2|STARTED|Overall Study||1
1581969|NCT01105117|3870764|P1|STARTED|Overall Study||1
1581970|NCT01105091|3870774|P2|NOT COMPLETED|Overall Study||0
1581971|NCT01105091|3870775|P1|NOT COMPLETED|Overall Study||2
1581972|NCT01105091|3870774|P2|COMPLETED|Overall Study||10
1581973|NCT01105091|3870775|P1|COMPLETED|Overall Study||18
1581974|NCT01105091|3870774|P2|STARTED|Overall Study||10
1581975|NCT01105091|3870775|P1|STARTED|Overall Study||20
1581976|NCT01105065|3870799|P1|NOT COMPLETED|Overall Study||6
1581977|NCT01105065|3870799|P1|COMPLETED|Overall Study||17
1581978|NCT01105065|3870799|P1|STARTED|Overall Study||23
1581979|NCT01104870|3870808|P3|NOT COMPLETED|Overall Study||2
1581980|NCT01104870|3870809|P2|NOT COMPLETED|Overall Study||1
1581981|NCT01104870|3870810|P1|NOT COMPLETED|Overall Study||1
1581982|NCT01104870|3870808|P3|COMPLETED|Overall Study||18
1581983|NCT01104870|3870809|P2|COMPLETED|Overall Study||18
1581984|NCT01104870|3870810|P1|COMPLETED|Overall Study||10
1581985|NCT01104870|3870808|P3|STARTED|Overall Study||20
1581986|NCT01104870|3870809|P2|STARTED|Overall Study||19
1581987|NCT01104870|3870810|P1|STARTED|Overall Study||11
1581988|NCT01104779|3870842|P3|NOT COMPLETED|Overall Study||62
1581989|NCT01104779|3870843|P2|NOT COMPLETED|Overall Study||55
1581990|NCT01104779|3870844|P1|NOT COMPLETED|Overall Study||59
1581991|NCT01104779|3870842|P3|COMPLETED|Overall Study||86
1581992|NCT01104779|3870843|P2|COMPLETED|Overall Study||96
1581993|NCT01104779|3870844|P1|COMPLETED|Overall Study||88
1581994|NCT01104779|3870842|P3|STARTED|Overall Study||148
1581995|NCT01104779|3870843|P2|STARTED|Overall Study||151
1581996|NCT01104779|3870844|P1|STARTED|Overall Study||147
1581997|NCT01104766|3870859|P4|NOT COMPLETED|Overall Study||38
1581998|NCT01104766|3870860|P3|NOT COMPLETED|Overall Study||60
1581999|NCT01104766|3870861|P2|NOT COMPLETED|Overall Study||51
1582000|NCT01104766|3870862|P1|NOT COMPLETED|Overall Study||58
1582001|NCT01104766|3870859|P4|COMPLETED|Overall Study||114
1582002|NCT01104766|3870860|P3|COMPLETED|Overall Study||97
1582003|NCT01104766|3870861|P2|COMPLETED|Overall Study||104
1582004|NCT01104766|3870862|P1|COMPLETED|Overall Study||95
1582005|NCT01104766|3870859|P4|STARTED|Overall Study||152
1582006|NCT01104766|3870860|P3|STARTED|Overall Study||157
1582007|NCT01104766|3870861|P2|STARTED|Overall Study||155
1582008|NCT01104766|3870862|P1|STARTED|Overall Study||153
1582009|NCT01104701|3870880|P4|NOT COMPLETED|Overall Study||2
1582010|NCT01104701|3870881|P3|NOT COMPLETED|Overall Study||2
1582011|NCT01104701|3870882|P2|NOT COMPLETED|Overall Study||3
1582012|NCT01104701|3870883|P1|NOT COMPLETED|Overall Study||0
1582013|NCT01104701|3870880|P4|COMPLETED|Overall Study||28
1582014|NCT01104701|3870881|P3|COMPLETED|Overall Study||29
1582015|NCT01104701|3870882|P2|COMPLETED|Overall Study||27
1582016|NCT01104701|3870883|P1|COMPLETED|Overall Study||30
1582017|NCT01104701|3870880|P4|STARTED|Overall Study||30
1582018|NCT01104701|3870881|P3|STARTED|Overall Study||31
1582019|NCT01104701|3870882|P2|STARTED|Overall Study||30
1582020|NCT01104701|3870883|P1|STARTED|Overall Study||30
1582021|NCT01104662|3870945|P8|NOT COMPLETED|Overall Study||0
1582022|NCT01104662|3870946|P7|NOT COMPLETED|Overall Study||0
1582023|NCT01104662|3870947|P6|NOT COMPLETED|Overall Study||4
1582024|NCT01104662|3870948|P5|NOT COMPLETED|Overall Study||1
1582025|NCT01104662|3870949|P4|NOT COMPLETED|Overall Study||1
1582026|NCT01104662|3870950|P3|NOT COMPLETED|Overall Study||1
1582027|NCT01104662|3870951|P2|NOT COMPLETED|Overall Study||10
1582028|NCT01104662|3870952|P1|NOT COMPLETED|Overall Study||10
1582029|NCT01104662|3870945|P8|COMPLETED|Overall Study||6
1582030|NCT01104662|3870946|P7|COMPLETED|Overall Study||5
1582031|NCT01104662|3870947|P6|COMPLETED|Overall Study||12
1582032|NCT01104662|3870948|P5|COMPLETED|Overall Study||14
1582033|NCT01104662|3870949|P4|COMPLETED|Overall Study||3
1582034|NCT01104662|3870950|P3|COMPLETED|Overall Study||4
1582035|NCT01104662|3870951|P2|COMPLETED|Overall Study||11
1582036|NCT01104662|3870952|P1|COMPLETED|Overall Study||10
1582037|NCT01104662|3870945|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
1582038|NCT01104662|3870946|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
1582039|NCT01104662|3870947|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
1582040|NCT01104662|3870948|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
1582041|NCT01104662|3870949|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
1582042|NCT01104662|3870950|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
1582043|NCT01104662|3870951|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
1582044|NCT01104662|3870952|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
1582045|NCT01104662|3870945|P8|STARTED|Overall Study||6
1582046|NCT01104662|3870946|P7|STARTED|Overall Study||5
1582047|NCT01104662|3870947|P6|STARTED|Overall Study||16
1582048|NCT01104662|3870948|P5|STARTED|Overall Study||15
1582049|NCT01104662|3870949|P4|STARTED|Overall Study||4
1582050|NCT01104662|3870950|P3|STARTED|Overall Study||5
1582051|NCT01104662|3870951|P2|STARTED|Overall Study||21
1582052|NCT01104662|3870952|P1|STARTED|Overall Study||20
1582053|NCT01104636|3870978|P1|NOT COMPLETED|Overall Study||178
1582054|NCT01104636|3870978|P1|COMPLETED|Overall Study||999
1582055|NCT01104636|3870978|P1|STARTED|Overall Study||1177
1582056|NCT01104584|3870983|P1|NOT COMPLETED|Overall Study||23
1582057|NCT01104584|3870983|P1|COMPLETED|Overall Study|study course completed|437
1582058|NCT01104584|3870983|P1|Fulfilled Requirements of FAS Population|Overall Study||397
1582059|NCT01104584|3870983|P1|Received Treatment|Overall Study|treatment started|439
1582060|NCT01104584|3870983|P1|STARTED|Overall Study|screened and enrolled|460
1582061|NCT01104558|3871053|P1|NOT COMPLETED|Overall Study||17
1582062|NCT01104558|3871053|P1|COMPLETED|Overall Study||83
1582063|NCT01104558|3871053|P1|STARTED|Overall Study||100
1582064|NCT01104493|3871096|P2|NOT COMPLETED|Overall Study||2
1582065|NCT01104493|3871097|P1|NOT COMPLETED|Overall Study||0
1582066|NCT01104493|3871096|P2|COMPLETED|Overall Study||58
1582067|NCT01104493|3871097|P1|COMPLETED|Overall Study||240
1582068|NCT01104493|3871096|P2|STARTED|Overall Study||60
1582069|NCT01104493|3871097|P1|STARTED|Overall Study||240
1582070|NCT01104415|3871115|P1|NOT COMPLETED|Overall Study||1
1582071|NCT01104415|3871115|P1|COMPLETED|Overall Study||14
1582072|NCT01104415|3871115|P1|STARTED|Overall Study||15
1582073|NCT01104402|3871139|P2|NOT COMPLETED|Overall Study||33
1582074|NCT01104402|3871140|P1|NOT COMPLETED|Overall Study||21
1582075|NCT01104402|3871139|P2|COMPLETED|Overall Study||102
1582076|NCT01104402|3871140|P1|COMPLETED|Overall Study||111
1582077|NCT01104402|3871139|P2|STARTED|Overall Study||135
1582078|NCT01104402|3871140|P1|STARTED|Overall Study||132
1582079|NCT01104376|3871158|P1|NOT COMPLETED|Overall Study||28
1582080|NCT01104376|3871158|P1|COMPLETED|Overall Study||61
1582081|NCT01104376|3871158|P1|STARTED|Overall Study||89
1582082|NCT01104311|3871164|P2|NOT COMPLETED|Overall Study||12
1582083|NCT01104311|3871165|P1|NOT COMPLETED|Overall Study||10
1582084|NCT01104311|3871164|P2|COMPLETED|Overall Study||54
1582085|NCT01104311|3871165|P1|COMPLETED|Overall Study||56
1582086|NCT01104311|3871164|P2|STARTED|Overall Study||66
1582087|NCT01104311|3871165|P1|STARTED|Overall Study||66
1582088|NCT01104285|3871185|P2|NOT COMPLETED|Overall Study||0
1582089|NCT01104285|3871186|P1|NOT COMPLETED|Overall Study||0
1582090|NCT01104285|3871185|P2|COMPLETED|Overall Study||86
1582091|NCT01104285|3871186|P1|COMPLETED|Overall Study||112
1582092|NCT01104285|3871185|P2|STARTED|Overall Study||86
1582093|NCT01104285|3871186|P1|STARTED|Overall Study||112
1582094|NCT01104246|3871192|P1|NOT COMPLETED|Overall Study||5
1582095|NCT01104246|3871192|P1|COMPLETED|Overall Study||35
1582096|NCT01104246|3871192|P1|Baseline Characteristics Measured|Overall Study||35
1582097|NCT01104246|3871192|P1|STARTED|Overall Study||40
1582098|NCT01104207|3871198|P2|NOT COMPLETED|Overall Study||3
1582099|NCT01104207|3871199|P1|NOT COMPLETED|Overall Study||3
1582100|NCT01104207|3871198|P2|COMPLETED|Overall Study||32
1582101|NCT01104207|3871199|P1|COMPLETED|Overall Study||32
1582102|NCT01104207|3871198|P2|STARTED|Overall Study||35
1582103|NCT01104207|3871199|P1|STARTED|Overall Study||35
1582104|NCT01104155|3871207|P2|NOT COMPLETED|Overall Study||18
1582105|NCT01104155|3871208|P1|NOT COMPLETED|Overall Study||25
1582106|NCT01104155|3871207|P2|COMPLETED|Overall Study||42
1582107|NCT01104155|3871208|P1|COMPLETED|Overall Study||38
1582108|NCT01104155|3871207|P2|STARTED|Overall Study||60
1582109|NCT01104155|3871208|P1|STARTED|Overall Study||63
1582110|NCT01104116|3871222|P1|NOT COMPLETED|Overall Study||0
1582111|NCT01104116|3871222|P1|COMPLETED|Overall Study||1
1582112|NCT01104116|3871222|P1|STARTED|Overall Study||1
1582113|NCT01104103|3871229|P2|NOT COMPLETED|Overall Study||0
1582114|NCT01104103|3871230|P1|NOT COMPLETED|Overall Study||0
1582115|NCT01104103|3871229|P2|COMPLETED|Overall Study||224
1582116|NCT01104103|3871230|P1|COMPLETED|Overall Study||243
1582117|NCT01104103|3871229|P2|STARTED|Overall Study||224
1582118|NCT01104103|3871230|P1|STARTED|Overall Study||243
1582119|NCT01103973|3871240|P2|NOT COMPLETED|Overall Study||0
1582120|NCT01103973|3871241|P1|NOT COMPLETED|Overall Study||0
1582121|NCT01103973|3871240|P2|COMPLETED|Overall Study||46
1582122|NCT01103973|3871241|P1|COMPLETED|Overall Study||51
1582123|NCT01103973|3871240|P2|STARTED|Overall Study||46
1582124|NCT01103973|3871241|P1|STARTED|Overall Study||51
1582125|NCT01103960|3871251|P2|NOT COMPLETED|Overall Study||2
1582126|NCT01103960|3871252|P1|NOT COMPLETED|Overall Study||5
1582127|NCT01103960|3871251|P2|COMPLETED|Overall Study|Completed study medication.|158
1582128|NCT01103960|3871252|P1|COMPLETED|Overall Study|Completed study medication.|159
1582129|NCT01103960|3871251|P2|STARTED|Overall Study|Randomised and treated.|160
1582130|NCT01103960|3871252|P1|STARTED|Overall Study|Randomised and treated.|164
1582131|NCT01103934|3871278|P2|NOT COMPLETED|Overall Study||0
1582132|NCT01103934|3871279|P1|NOT COMPLETED|Overall Study||0
1582133|NCT01103934|3871278|P2|COMPLETED|Overall Study||18
1582134|NCT01103934|3871279|P1|COMPLETED|Overall Study||17
1582135|NCT01103934|3871278|P2|STARTED|Overall Study||18
1582136|NCT01103934|3871279|P1|STARTED|Overall Study||17
1582137|NCT01103778|3871287|P1|NOT COMPLETED|Overall Study||3
1582138|NCT01103778|3871287|P1|COMPLETED|Overall Study||8
1582139|NCT01103778|3871287|P1|STARTED|Overall Study||11
1582140|NCT01103713|3871294|P1|NOT COMPLETED|Overall Study||13
1582141|NCT01103713|3871294|P1|COMPLETED|Overall Study||155
1582142|NCT01103713|3871294|P1|STARTED|Overall Study||168
1582143|NCT01103492|3871320|P1|NOT COMPLETED|Overall Study||0
1582144|NCT01103492|3871320|P1|COMPLETED|Overall Study||1
1582145|NCT01103492|3871320|P1|STARTED|Overall Study||1
1582146|NCT01103479|3871327|P3|NOT COMPLETED|Overall Study||14
1582147|NCT01103479|3871328|P2|NOT COMPLETED|Overall Study||9
1582148|NCT01103479|3871329|P1|NOT COMPLETED|Overall Study||5
1582149|NCT01103479|3871327|P3|COMPLETED|Overall Study||174
1582150|NCT01103479|3871328|P2|COMPLETED|Overall Study||201
1582151|NCT01103479|3871329|P1|COMPLETED|Overall Study||163
1582152|NCT01103479|3871327|P3|STARTED|Overall Study||188
1582153|NCT01103479|3871328|P2|STARTED|Overall Study||210
1582154|NCT01103479|3871329|P1|STARTED|Overall Study||168
1582155|NCT01103466|3871342|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
1582156|NCT01103466|3871343|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
1582157|NCT01103466|3871344|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
1582158|NCT01103466|3871342|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
1582159|NCT01103466|3871343|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
1582160|NCT01103466|3871344|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
1582161|NCT01103466|3871342|P3|STARTED|Third Period (14 +/- 3 Days)||14
1582162|NCT01103466|3871343|P2|STARTED|Third Period (14 +/- 3 Days)||8
1582163|NCT01103466|3871344|P1|STARTED|Third Period (14 +/- 3 Days)||8
1582164|NCT01103466|3871342|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
1582165|NCT01103466|3871343|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
1582166|NCT01103466|3871344|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
1582167|NCT01103466|3871342|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
1582168|NCT01103466|3871343|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
1582169|NCT01103466|3871344|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
1582170|NCT01103466|3871342|P3|STARTED|Second Period (14 +/- 3 Days)||7
1582171|NCT01103466|3871343|P2|STARTED|Second Period (14 +/- 3 Days)||13
1582172|NCT01103466|3871344|P1|STARTED|Second Period (14 +/- 3 Days)||15
1582173|NCT01103466|3871342|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
1582174|NCT01103466|3871343|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
1582175|NCT01103466|3871344|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
1582176|NCT01103466|3871342|P3|COMPLETED|First Period (14 +/- 3 Days)||13
1582177|NCT01103466|3871343|P2|COMPLETED|First Period (14 +/- 3 Days)||12
1582178|NCT01103466|3871344|P1|COMPLETED|First Period (14 +/- 3 Days)||10
1582179|NCT01103466|3871342|P3|STARTED|First Period (14 +/- 3 Days)||13
1582180|NCT01103466|3871343|P2|STARTED|First Period (14 +/- 3 Days)||12
1582181|NCT01103466|3871344|P1|STARTED|First Period (14 +/- 3 Days)||12
1582182|NCT01103440|3871354|P2|NOT COMPLETED|Overall Study||0
1582183|NCT01103440|3871355|P1|NOT COMPLETED|Overall Study||0
1582184|NCT01103440|3871354|P2|COMPLETED|Overall Study||18
1582185|NCT01103440|3871355|P1|COMPLETED|Overall Study||18
1582186|NCT01103440|3871354|P2|STARTED|Overall Study||18
1582187|NCT01103440|3871355|P1|STARTED|Overall Study||18
1582188|NCT01103414|3871368|P5|NOT COMPLETED|Overall Study||15
1582189|NCT01103414|3871369|P4|NOT COMPLETED|Overall Study||7
1582190|NCT01103414|3871370|P3|NOT COMPLETED|Overall Study||15
1582191|NCT01103414|3871371|P2|NOT COMPLETED|Overall Study||9
1582192|NCT01103414|3871372|P1|NOT COMPLETED|Overall Study||13
1582193|NCT01103414|3871368|P5|COMPLETED|Overall Study||56
1582194|NCT01103414|3871369|P4|COMPLETED|Overall Study||64
1582195|NCT01103414|3871370|P3|COMPLETED|Overall Study||56
1582196|NCT01103414|3871371|P2|COMPLETED|Overall Study||62
1582197|NCT01103414|3871372|P1|COMPLETED|Overall Study||59
1582198|NCT01103414|3871368|P5|STARTED|Overall Study||71
1582199|NCT01103414|3871369|P4|STARTED|Overall Study||71
1582200|NCT01103414|3871370|P3|STARTED|Overall Study||71
1582201|NCT01103414|3871371|P2|STARTED|Overall Study||71
1582202|NCT01103414|3871372|P1|STARTED|Overall Study||72
1582203|NCT01103362|3871434|P1|NOT COMPLETED|Overall Study||596
1582204|NCT01103362|3871434|P1|COMPLETED|Overall Study||0
1582205|NCT01103362|3871434|P1|STARTED|Overall Study||596
1582206|NCT01103323|3871440|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
1582207|NCT01103323|3871441|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
1582208|NCT01103323|3871440|P2|COMPLETED|Switched From Placebo to Regorafenib||3
1582209|NCT01103323|3871441|P1|COMPLETED|Switched From Placebo to Regorafenib||0
1582210|NCT01103323|3871440|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
1582211|NCT01103323|3871441|P1|STARTED|Switched From Placebo to Regorafenib||0
1582212|NCT01103323|3871440|P2|NOT COMPLETED|Without/Before Drug Switch||18
1582213|NCT01103323|3871441|P1|NOT COMPLETED|Without/Before Drug Switch||76
1582214|NCT01103323|3871440|P2|COMPLETED|Without/Before Drug Switch||237
1582215|NCT01103323|3871441|P1|COMPLETED|Without/Before Drug Switch||429
1582216|NCT01103323|3871440|P2|Participants Received Treatment|Without/Before Drug Switch||253
1582217|NCT01103323|3871441|P1|Participants Received Treatment|Without/Before Drug Switch||500
1582218|NCT01103323|3871440|P2|STARTED|Without/Before Drug Switch||255
1582219|NCT01103323|3871441|P1|STARTED|Without/Before Drug Switch||505
1582220|NCT01103284|3871458|P2|NOT COMPLETED|Overall Study||44
1582221|NCT01103284|3871459|P1|NOT COMPLETED|Overall Study||42
1582222|NCT01103284|3871458|P2|COMPLETED|Overall Study||195
1582223|NCT01103284|3871459|P1|COMPLETED|Overall Study||194
1582224|NCT01103284|3871458|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
1582225|NCT01103284|3871459|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
1582226|NCT01103284|3871458|P2|Treated|Overall Study||238
1582227|NCT01103284|3871459|P1|Treated|Overall Study||236
1582228|NCT01103284|3871458|P2|STARTED|Overall Study||239
1582229|NCT01103284|3871459|P1|STARTED|Overall Study||236
1582230|NCT01103271|3871475|P2|NOT COMPLETED|Overall Study||4
1582231|NCT01103271|3871476|P1|NOT COMPLETED|Overall Study||1
1582232|NCT01103271|3871475|P2|COMPLETED|Overall Study||5
1582233|NCT01103271|3871476|P1|COMPLETED|Overall Study||10
1582234|NCT01103271|3871475|P2|STARTED|Overall Study||9
1582235|NCT01103271|3871476|P1|STARTED|Overall Study||11
1582236|NCT01103245|3871487|P4|NOT COMPLETED|Overall Study||0
1582237|NCT01103245|3871488|P3|NOT COMPLETED|Overall Study||4
1582238|NCT01103245|3871489|P2|NOT COMPLETED|Overall Study||2
1582239|NCT01103245|3871490|P1|NOT COMPLETED|Overall Study||3
1582240|NCT01103245|3871487|P4|COMPLETED|Overall Study||6
1582241|NCT01103245|3871488|P3|COMPLETED|Overall Study||8
1582242|NCT01103245|3871489|P2|COMPLETED|Overall Study||5
1582243|NCT01103245|3871490|P1|COMPLETED|Overall Study||10
1582244|NCT01103245|3871487|P4|STARTED|Overall Study||6
1582245|NCT01103245|3871488|P3|STARTED|Overall Study||12
1582246|NCT01103245|3871489|P2|STARTED|Overall Study||7
1582247|NCT01103245|3871490|P1|STARTED|Overall Study||13
1582248|NCT01103232|3871506|P2|NOT COMPLETED|Overall Study||2
1582249|NCT01103232|3871507|P1|NOT COMPLETED|Overall Study||1
1582250|NCT01103232|3871506|P2|COMPLETED|Overall Study||11
1582251|NCT01103232|3871507|P1|COMPLETED|Overall Study||12
1582252|NCT01103232|3871506|P2|STARTED|Overall Study||13
1582253|NCT01103232|3871507|P1|STARTED|Overall Study||13
1582254|NCT01103141|3871515|P2|NOT COMPLETED|Overall Study||2
1582255|NCT01103141|3871516|P1|NOT COMPLETED|Overall Study||2
1582256|NCT01103141|3871515|P2|COMPLETED|Overall Study||74
1582257|NCT01103141|3871516|P1|COMPLETED|Overall Study||65
1582258|NCT01103141|3871515|P2|STARTED|Overall Study||76
1582259|NCT01103141|3871516|P1|STARTED|Overall Study||67
1582260|NCT01103063|3871524|P2|NOT COMPLETED|Overall Study||421
1582261|NCT01103063|3871525|P1|NOT COMPLETED|Overall Study||477
1582262|NCT01103063|3871524|P2|COMPLETED|Overall Study||1024
1582263|NCT01103063|3871525|P1|COMPLETED|Overall Study||969
1582264|NCT01103063|3871524|P2|STARTED|Overall Study||1445
1582265|NCT01103063|3871525|P1|STARTED|Overall Study||1446
1582266|NCT01102972|3871593|P2|NOT COMPLETED|Overall Study||14
1582267|NCT01102972|3871594|P1|NOT COMPLETED|Overall Study||29
1582268|NCT01102972|3871593|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
1582269|NCT01102972|3871594|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
1582270|NCT01102972|3871593|P2|Completed Week 24|Overall Study||88
1582271|NCT01102972|3871594|P1|Completed Week 24|Overall Study||180
1582272|NCT01102972|3871593|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
1582273|NCT01102972|3871594|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
1582274|NCT01102894|3871646|P1|NOT COMPLETED|Overall Study||0
1582275|NCT01102894|3871646|P1|COMPLETED|Overall Study||10
1582276|NCT01102894|3871646|P1|STARTED|Overall Study||10
1582277|NCT01102803|3871658|P2|NOT COMPLETED|Post to Follow-Up||3
1582278|NCT01102803|3871659|P1|NOT COMPLETED|Post to Follow-Up||1
1582279|NCT01102803|3871658|P2|COMPLETED|Post to Follow-Up||12
1582280|NCT01102803|3871659|P1|COMPLETED|Post to Follow-Up||10
1582281|NCT01102803|3871658|P2|STARTED|Post to Follow-Up||15
1582282|NCT01102803|3871659|P1|STARTED|Post to Follow-Up||11
1582283|NCT01102803|3871658|P2|NOT COMPLETED|Baseline to Post-Treatment||0
1582284|NCT01102803|3871659|P1|NOT COMPLETED|Baseline to Post-Treatment||3
1582285|NCT01102803|3871658|P2|COMPLETED|Baseline to Post-Treatment||15
1582286|NCT01102803|3871659|P1|COMPLETED|Baseline to Post-Treatment||11
1582287|NCT01102803|3871658|P2|STARTED|Baseline to Post-Treatment||15
1582288|NCT01102803|3871659|P1|STARTED|Baseline to Post-Treatment||14
1582289|NCT01102777|3871673|P2|NOT COMPLETED|Overall Study||16
1582290|NCT01102777|3871674|P1|NOT COMPLETED|Overall Study||9
1582291|NCT01102777|3871673|P2|COMPLETED|Overall Study||139
1582292|NCT01102777|3871674|P1|COMPLETED|Overall Study||75
1582293|NCT01102777|3871673|P2|STARTED|Overall Study||155
1582294|NCT01102777|3871674|P1|STARTED|Overall Study||84
1582295|NCT01102764|3871700|P2|NOT COMPLETED|Overall Study||13
1582296|NCT01102764|3871701|P1|NOT COMPLETED|Overall Study||21
1582297|NCT01102764|3871700|P2|COMPLETED|Overall Study||55
1582298|NCT01102764|3871701|P1|COMPLETED|Overall Study||43
1582299|NCT01102764|3871700|P2|STARTED|Overall Study||68
1582300|NCT01102764|3871701|P1|STARTED|Overall Study||64
1582301|NCT01102491|3871713|P2|NOT COMPLETED|Overall Study||12
1582302|NCT01102491|3871714|P1|NOT COMPLETED|Overall Study||11
1582303|NCT01102491|3871713|P2|COMPLETED|Overall Study|12 patients were excluded|59
1582304|NCT01102491|3871714|P1|COMPLETED|Overall Study|11 patient excluded|60
1582305|NCT01102491|3871713|P2|STARTED|Overall Study||71
1582306|NCT01102491|3871714|P1|STARTED|Overall Study||71
1582307|NCT01102413|3871722|P2|NOT COMPLETED|Overall Study||12
1582308|NCT01102413|3871723|P1|NOT COMPLETED|Overall Study||25
1582309|NCT01102413|3871722|P2|COMPLETED|Overall Study||106
1582310|NCT01102413|3871723|P1|COMPLETED|Overall Study||208
1582311|NCT01102413|3871722|P2|STARTED|Overall Study||118
1582312|NCT01102413|3871723|P1|STARTED|Overall Study||233
1582313|NCT01102374|3871733|P2|NOT COMPLETED|Overall Study||19
1582314|NCT01102374|3871734|P1|NOT COMPLETED|Overall Study||16
1582315|NCT01102374|3871733|P2|COMPLETED|Overall Study||33
1582316|NCT01102374|3871734|P1|COMPLETED|Overall Study||39
1582317|NCT01102374|3871733|P2|STARTED|Overall Study||52
1582318|NCT01102374|3871734|P1|STARTED|Overall Study||55
1582319|NCT01102270|3871768|P2|NOT COMPLETED|Overall Study||0
1582320|NCT01102270|3871769|P1|NOT COMPLETED|Overall Study||0
1582321|NCT01102270|3871768|P2|COMPLETED|Overall Study||9
1582322|NCT01102270|3871769|P1|COMPLETED|Overall Study||8
1582323|NCT01102270|3871768|P2|STARTED|Overall Study||9
1582324|NCT01102270|3871769|P1|STARTED|Overall Study||8
1582325|NCT01102257|3871783|P2|NOT COMPLETED|Overall Study||0
1582326|NCT01102257|3871784|P1|NOT COMPLETED|Overall Study||2
1582327|NCT01102257|3871783|P2|COMPLETED|Overall Study||9
1582328|NCT01102257|3871784|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
1582329|NCT01102257|3871783|P2|STARTED|Overall Study||9
1582330|NCT01102257|3871784|P1|STARTED|Overall Study||9
1582331|NCT01102218|3871792|P2|NOT COMPLETED|Overall Study||10
1582332|NCT01102218|3871793|P1|NOT COMPLETED|Overall Study||11
1582333|NCT01102218|3871792|P2|COMPLETED|Overall Study||14
1582334|NCT01102218|3871793|P1|COMPLETED|Overall Study||13
1582335|NCT01102218|3871792|P2|STARTED|Overall Study||24
1582336|NCT01102218|3871793|P1|STARTED|Overall Study||24
1582337|NCT01102140|3871801|P2|NOT COMPLETED|Overall Study||2
1582338|NCT01102140|3871802|P1|NOT COMPLETED|Overall Study||3
1582339|NCT01102140|3871801|P2|COMPLETED|Overall Study||5
1582340|NCT01102140|3871802|P1|COMPLETED|Overall Study||10
1582341|NCT01102140|3871801|P2|STARTED|Overall Study||7
1582342|NCT01102140|3871802|P1|STARTED|Overall Study||13
1582343|NCT01101971|3871814|P1|NOT COMPLETED|Overall Study||0
1582344|NCT01101971|3871814|P1|COMPLETED|Overall Study||45
1582345|NCT01101971|3871814|P1|STARTED|Overall Study||45
1582346|NCT01101958|3871820|P2|NOT COMPLETED|Overall Study||5
1582347|NCT01101958|3871821|P1|NOT COMPLETED|Overall Study||11
1582348|NCT01101958|3871820|P2|COMPLETED|Overall Study||29
1582349|NCT01101958|3871821|P1|COMPLETED|Overall Study||51
1582350|NCT01101958|3871820|P2|STARTED|Overall Study||34
1582351|NCT01101958|3871821|P1|STARTED|Overall Study||62
1582352|NCT01101880|3871827|P1|NOT COMPLETED|Overall Study||0
1582353|NCT01101880|3871827|P1|COMPLETED|Overall Study||50
1582354|NCT01101880|3871827|P1|STARTED|Overall Study||50
1582355|NCT01101867|3871838|P2|NOT COMPLETED|Overall Study||4
1582356|NCT01101867|3871839|P1|NOT COMPLETED|Overall Study||1
1582357|NCT01101867|3871838|P2|COMPLETED|Overall Study||59
1582358|NCT01101867|3871839|P1|COMPLETED|Overall Study||62
1582359|NCT01101867|3871838|P2|STARTED|Overall Study||63
1582360|NCT01101867|3871839|P1|STARTED|Overall Study||63
1582361|NCT01101841|3871857|P2|NOT COMPLETED|Overall Study||67
1582362|NCT01101841|3871858|P1|NOT COMPLETED|Overall Study||50
1582363|NCT01101841|3871857|P2|COMPLETED|Overall Study||218
1582364|NCT01101841|3871858|P1|COMPLETED|Overall Study||235
1582365|NCT01101841|3871857|P2|STARTED|Overall Study||285
1582366|NCT01101841|3871858|P1|STARTED|Overall Study||285
1582367|NCT01101542|3871896|P1|NOT COMPLETED|Year 6 Surveillance Period||991
1582368|NCT01101542|3871896|P1|COMPLETED|Year 6 Surveillance Period||2100
1582369|NCT01101542|3871896|P1|STARTED|Year 6 Surveillance Period||3091
1582370|NCT01101542|3871896|P1|NOT COMPLETED|Year 5 Surveillance Period||141
1582371|NCT01101542|3871896|P1|COMPLETED|Year 5 Surveillance Period||668
1582372|NCT01101542|3871896|P1|STARTED|Year 5 Surveillance Period||809
1582373|NCT01101542|3871896|P1|NOT COMPLETED|Year 4 Surveillance Period||287
1582374|NCT01101542|3871896|P1|COMPLETED|Year 4 Surveillance Period||282
1582375|NCT01101542|3871896|P1|STARTED|Year 4 Surveillance Period||569
1582376|NCT01101542|3871896|P1|NOT COMPLETED|Year 3 Surveillance Period||11
1582377|NCT01101542|3871896|P1|COMPLETED|Year 3 Surveillance Period||94
1582378|NCT01101542|3871896|P1|STARTED|Year 3 Surveillance Period||105
1582379|NCT01101477|3871912|P3|NOT COMPLETED|Overall Study||1
1582380|NCT01101477|3871913|P2|NOT COMPLETED|Overall Study||3
1582381|NCT01101477|3871914|P1|NOT COMPLETED|Overall Study||5
1582382|NCT01101477|3871912|P3|COMPLETED|Overall Study||45
1582383|NCT01101477|3871913|P2|COMPLETED|Overall Study||46
1582384|NCT01101477|3871914|P1|COMPLETED|Overall Study||44
1582385|NCT01101477|3871912|P3|STARTED|Overall Study||46
1582386|NCT01101477|3871913|P2|STARTED|Overall Study||49
1582387|NCT01101477|3871914|P1|STARTED|Overall Study||49
1582388|NCT01101464|3871924|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
1582389|NCT01101464|3871925|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
1582390|NCT01101464|3871924|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
1582391|NCT01101464|3871925|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
1582392|NCT01101464|3871924|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
1582393|NCT01101464|3871925|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
1582394|NCT01101464|3871924|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
1582395|NCT01101464|3871925|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
1582396|NCT01101464|3871924|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
1582397|NCT01101464|3871925|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
1582398|NCT01101464|3871924|P2|STARTED|Day 1 Through AM Dose of Day 5||4
1582399|NCT01101464|3871925|P1|STARTED|Day 1 Through AM Dose of Day 5||4
1582400|NCT01101321|3871935|P2|NOT COMPLETED|Period 2||0
1582401|NCT01101321|3871936|P1|NOT COMPLETED|Period 2||0
1582402|NCT01101321|3871935|P2|COMPLETED|Period 2||24
1582403|NCT01101321|3871936|P1|COMPLETED|Period 2||26
1582404|NCT01101321|3871935|P2|STARTED|Period 2||24
1582405|NCT01101321|3871936|P1|STARTED|Period 2||26
1582406|NCT01101321|3871935|P2|NOT COMPLETED|Period 1||4
1582407|NCT01101321|3871936|P1|NOT COMPLETED|Period 1||4
1582408|NCT01101321|3871935|P2|COMPLETED|Period 1||24
1582409|NCT01101321|3871936|P1|COMPLETED|Period 1||26
1582410|NCT01101321|3871935|P2|STARTED|Period 1||28
1582411|NCT01101321|3871936|P1|STARTED|Period 1||30
1582412|NCT01101308|3871946|P2|NOT COMPLETED|Period 2||0
1582413|NCT01101308|3871947|P1|NOT COMPLETED|Period 2||0
1582414|NCT01101308|3871946|P2|COMPLETED|Period 2||27
1582415|NCT01101308|3871947|P1|COMPLETED|Period 2||24
1582416|NCT01101308|3871946|P2|STARTED|Period 2||27
1582417|NCT01101308|3871947|P1|STARTED|Period 2||24
1582418|NCT01101308|3871946|P2|NOT COMPLETED|Period 1||1
1582419|NCT01101308|3871947|P1|NOT COMPLETED|Period 1||3
1582420|NCT01101308|3871946|P2|COMPLETED|Period 1||27
1582421|NCT01101308|3871947|P1|COMPLETED|Period 1||24
1582422|NCT01101308|3871946|P2|STARTED|Period 1||28
1582423|NCT01101308|3871947|P1|STARTED|Period 1||27
1582424|NCT01101191|3871958|P2|NOT COMPLETED|Period 2||0
1582425|NCT01101191|3871959|P1|NOT COMPLETED|Period 2||0
1582426|NCT01101191|3871958|P2|COMPLETED|Period 2||40
1582427|NCT01101191|3871959|P1|COMPLETED|Period 2||40
1582428|NCT01101191|3871958|P2|STARTED|Period 2||40
1582429|NCT01101191|3871959|P1|STARTED|Period 2||40
1582430|NCT01101191|3871958|P2|NOT COMPLETED|Period 1||2
1582431|NCT01101191|3871959|P1|NOT COMPLETED|Period 1||2
1582432|NCT01101191|3871958|P2|COMPLETED|Period 1||40
1582433|NCT01101191|3871959|P1|COMPLETED|Period 1||40
1582434|NCT01101191|3871958|P2|STARTED|Period 1||42
1582435|NCT01101191|3871959|P1|STARTED|Period 1||42
1582436|NCT01101178|3871970|P2|NOT COMPLETED|Period 2||1
1582437|NCT01101178|3871971|P1|NOT COMPLETED|Period 2||0
1582438|NCT01101178|3871970|P2|COMPLETED|Period 2||34
1582439|NCT01101178|3871971|P1|COMPLETED|Period 2||36
1582440|NCT01101178|3871970|P2|STARTED|Period 2||35
1582441|NCT01101178|3871971|P1|STARTED|Period 2||36
1582442|NCT01101178|3871970|P2|NOT COMPLETED|Period 1||4
1582443|NCT01101178|3871971|P1|NOT COMPLETED|Period 1||4
1582444|NCT01101178|3871970|P2|COMPLETED|Period 1||35
1582445|NCT01101178|3871971|P1|COMPLETED|Period 1||36
1582446|NCT01101178|3871970|P2|STARTED|Period 1||39
1582447|NCT01101178|3871971|P1|STARTED|Period 1||40
1582448|NCT01101165|3871982|P2|NOT COMPLETED|Period 2||1
1582449|NCT01101165|3871983|P1|NOT COMPLETED|Period 2||4
1582450|NCT01101165|3871982|P2|COMPLETED|Period 2||39
1582451|NCT01101165|3871983|P1|COMPLETED|Period 2||41
1582452|NCT01101165|3871982|P2|STARTED|Period 2||40
1582453|NCT01101165|3871983|P1|STARTED|Period 2||45
1582454|NCT01101165|3871982|P2|NOT COMPLETED|Period 1||5
1582455|NCT01101165|3871983|P1|NOT COMPLETED|Period 1||2
1582456|NCT01101165|3871982|P2|COMPLETED|Period 1||40
1582457|NCT01101165|3871983|P1|COMPLETED|Period 1||45
1582458|NCT01101165|3871982|P2|STARTED|Period 1||45
1582459|NCT01101165|3871983|P1|STARTED|Period 1||47
1582460|NCT01101035|3871995|P2|NOT COMPLETED|Overall Study||1391
1582461|NCT01101035|3871996|P1|NOT COMPLETED|Overall Study||1397
1582462|NCT01101035|3871995|P2|COMPLETED|Overall Study||1706
1582463|NCT01101035|3871996|P1|COMPLETED|Overall Study||1704
1582464|NCT01101035|3871995|P2|STARTED|Overall Study||3097
1582465|NCT01101035|3871996|P1|STARTED|Overall Study||3101
1582466|NCT01101022|3872016|P2|NOT COMPLETED|Overall Study||27
1582467|NCT01101022|3872017|P1|NOT COMPLETED|Overall Study||17
1582468|NCT01101022|3872016|P2|COMPLETED|Overall Study||53
1582469|NCT01101022|3872017|P1|COMPLETED|Overall Study||62
1582470|NCT01101022|3872016|P2|STARTED|Overall Study||80
1582471|NCT01101022|3872017|P1|STARTED|Overall Study||79
1582472|NCT01100944|3872051|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
1582473|NCT01100944|3872052|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
1582474|NCT01100944|3872053|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
1582475|NCT01100944|3872051|P3|COMPLETED|Expansion Phase - Phase 2||18
1582476|NCT01100944|3872052|P2|COMPLETED|Expansion Phase - Phase 2||0
1582477|NCT01100944|3872053|P1|COMPLETED|Expansion Phase - Phase 2||0
1582478|NCT01100944|3872051|P3|STARTED|Expansion Phase - Phase 2||18
1582479|NCT01100944|3872052|P2|STARTED|Expansion Phase - Phase 2||0
1582480|NCT01100944|3872053|P1|STARTED|Expansion Phase - Phase 2||0
1582481|NCT01100944|3872051|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1582482|NCT01100944|3872052|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
1582483|NCT01100944|3872053|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1582484|NCT01100944|3872051|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1582485|NCT01100944|3872052|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1582486|NCT01100944|3872053|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1582487|NCT01100944|3872051|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
1582488|NCT01100944|3872052|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
1582489|NCT01100944|3872053|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
1582490|NCT01100944|3872051|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1582491|NCT01100944|3872052|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1582492|NCT01100944|3872053|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
1582493|NCT01100944|3872051|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1582494|NCT01100944|3872052|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1582495|NCT01100944|3872053|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
1582496|NCT01100944|3872051|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
1582497|NCT01100944|3872052|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
1582498|NCT01100944|3872053|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
1582499|NCT01100931|3872100|P2|NOT COMPLETED|Phase II||0
1582500|NCT01100931|3872101|P1|NOT COMPLETED|Phase II||0
1582501|NCT01100931|3872100|P2|COMPLETED|Phase II||19
1582502|NCT01100931|3872101|P1|COMPLETED|Phase II||0
1582503|NCT01100931|3872100|P2|STARTED|Phase II||19
1582504|NCT01100931|3872101|P1|STARTED|Phase II||0
1582505|NCT01100931|3872100|P2|NOT COMPLETED|Phase I||0
1582506|NCT01100931|3872101|P1|NOT COMPLETED|Phase I||0
1582507|NCT01100931|3872100|P2|COMPLETED|Phase I||0
1582508|NCT01100931|3872101|P1|COMPLETED|Phase I||22
1582509|NCT01100931|3872100|P2|STARTED|Phase I||0
1582510|NCT01100931|3872101|P1|STARTED|Phase I||22
1582511|NCT01100853|3872111|P2|NOT COMPLETED|Overall Study||23
1582512|NCT01100853|3872112|P1|NOT COMPLETED|Overall Study||27
1582513|NCT01100853|3872111|P2|COMPLETED|Overall Study||26
1582514|NCT01100853|3872112|P1|COMPLETED|Overall Study||24
1582515|NCT01100853|3872111|P2|STARTED|Overall Study||49
1582516|NCT01100853|3872112|P1|STARTED|Overall Study||51
1582517|NCT01100762|3872128|P1|NOT COMPLETED|Overall Study||0
1582518|NCT01100762|3872128|P1|COMPLETED|Overall Study||10
1582519|NCT01100762|3872128|P1|STARTED|Overall Study||10
1582520|NCT01100723|3872149|P1|NOT COMPLETED|Overall Study||14
1582521|NCT01100723|3872149|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
1582522|NCT01100723|3872149|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
1582523|NCT01100723|3872149|P1|STARTED|Overall Study||92
1582524|NCT01100658|3872158|P1|NOT COMPLETED|Overall Study||1
1582525|NCT01100658|3872158|P1|COMPLETED|Overall Study||0
1582526|NCT01100658|3872158|P1|STARTED|Overall Study||1
1582527|NCT01100606|3872163|P2|NOT COMPLETED|Second Treatment Period||0
1582528|NCT01100606|3872164|P1|NOT COMPLETED|Second Treatment Period||0
1582529|NCT01100606|3872163|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
1582530|NCT01100606|3872164|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
1582531|NCT01100606|3872163|P2|STARTED|Second Treatment Period||7
1582532|NCT01100606|3872164|P1|STARTED|Second Treatment Period||8
1582533|NCT01100606|3872163|P2|NOT COMPLETED|First Treatment Period||0
1582534|NCT01100606|3872164|P1|NOT COMPLETED|First Treatment Period||0
1582535|NCT01100606|3872163|P2|COMPLETED|First Treatment Period||7
1582536|NCT01100606|3872164|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
1582537|NCT01100606|3872163|P2|STARTED|First Treatment Period||7
1582538|NCT01100606|3872164|P1|STARTED|First Treatment Period||8
1582539|NCT01100567|3872190|P2|NOT COMPLETED|Overall Study||16
1582540|NCT01100567|3872191|P1|NOT COMPLETED|Overall Study||12
1582541|NCT01100567|3872190|P2|COMPLETED|Overall Study||35
1582542|NCT01100567|3872191|P1|COMPLETED|Overall Study||38
1582543|NCT01100567|3872190|P2|STARTED|Overall Study||51
1582544|NCT01100567|3872191|P1|STARTED|Overall Study||50
1582545|NCT01100528|3872199|P1|NOT COMPLETED|Overall Study||3
1582546|NCT01100528|3872199|P1|COMPLETED|Overall Study||35
1582547|NCT01100528|3872199|P1|STARTED|Overall Study||38
1582548|NCT01100502|3872207|P2|NOT COMPLETED|Long-Term Follow-up||139
1582549|NCT01100502|3872208|P1|NOT COMPLETED|Long-Term Follow-up||137
1582550|NCT01100502|3872207|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
1582551|NCT01100502|3872208|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
1582552|NCT01100502|3872207|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
1582553|NCT01100502|3872208|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
1582554|NCT01100502|3872207|P2|NOT COMPLETED|Treatment Period||83
1582555|NCT01100502|3872208|P1|NOT COMPLETED|Treatment Period||87
1582556|NCT01100502|3872207|P2|COMPLETED|Treatment Period||81
1582557|NCT01100502|3872208|P1|COMPLETED|Treatment Period||78
1582558|NCT01100502|3872207|P2|STARTED|Treatment Period||164
1582559|NCT01100502|3872208|P1|STARTED|Treatment Period||165
1582560|NCT01100437|3872218|P3|NOT COMPLETED|Treatment 2||0
1582561|NCT01100437|3872219|P2|NOT COMPLETED|Treatment 2||0
1582562|NCT01100437|3872220|P1|NOT COMPLETED|Treatment 2||0
1582563|NCT01100437|3872218|P3|COMPLETED|Treatment 2||0
1582564|NCT01100437|3872219|P2|COMPLETED|Treatment 2||2
1582565|NCT01100437|3872220|P1|COMPLETED|Treatment 2||4
1582566|NCT01100437|3872218|P3|STARTED|Treatment 2||0
1582567|NCT01100437|3872219|P2|STARTED|Treatment 2||2
1582568|NCT01100437|3872220|P1|STARTED|Treatment 2||4
1582569|NCT01100437|3872218|P3|NOT COMPLETED|Washout (4 Days)||0
1582570|NCT01100437|3872219|P2|NOT COMPLETED|Washout (4 Days)||0
1582571|NCT01100437|3872220|P1|NOT COMPLETED|Washout (4 Days)||0
1582572|NCT01100437|3872218|P3|COMPLETED|Washout (4 Days)||0
1582573|NCT01100437|3872219|P2|COMPLETED|Washout (4 Days)||2
1582574|NCT01100437|3872220|P1|COMPLETED|Washout (4 Days)||4
1582575|NCT01100437|3872218|P3|STARTED|Washout (4 Days)||0
1582576|NCT01100437|3872219|P2|STARTED|Washout (4 Days)||2
1582577|NCT01100437|3872220|P1|STARTED|Washout (4 Days)||4
1582578|NCT01100437|3872218|P3|NOT COMPLETED|Treatment 1||0
1582579|NCT01100437|3872219|P2|NOT COMPLETED|Treatment 1||0
1582580|NCT01100437|3872220|P1|NOT COMPLETED|Treatment 1||0
1582581|NCT01100437|3872218|P3|COMPLETED|Treatment 1||0
1582582|NCT01100437|3872219|P2|COMPLETED|Treatment 1||2
1582583|NCT01100437|3872220|P1|COMPLETED|Treatment 1||4
1582584|NCT01100437|3872218|P3|STARTED|Treatment 1||0
1582585|NCT01100437|3872219|P2|STARTED|Treatment 1||2
1582586|NCT01100437|3872220|P1|STARTED|Treatment 1||4
1582587|NCT01100437|3872218|P3|NOT COMPLETED|Maintenance||2
1582588|NCT01100437|3872219|P2|NOT COMPLETED|Maintenance||0
1582589|NCT01100437|3872220|P1|NOT COMPLETED|Maintenance||0
1582590|NCT01100437|3872218|P3|COMPLETED|Maintenance||0
1582591|NCT01100437|3872219|P2|COMPLETED|Maintenance||2
1582592|NCT01100437|3872220|P1|COMPLETED|Maintenance||4
1582593|NCT01100437|3872218|P3|STARTED|Maintenance||2
1582594|NCT01100437|3872219|P2|STARTED|Maintenance||2
1582595|NCT01100437|3872220|P1|STARTED|Maintenance||4
1582596|NCT01100437|3872218|P3|NOT COMPLETED|Titration/Stabilization||6
1582597|NCT01100437|3872219|P2|NOT COMPLETED|Titration/Stabilization||0
1582598|NCT01100437|3872220|P1|NOT COMPLETED|Titration/Stabilization||0
1582599|NCT01100437|3872218|P3|COMPLETED|Titration/Stabilization||2
1582600|NCT01100437|3872219|P2|COMPLETED|Titration/Stabilization||2
1582601|NCT01100437|3872220|P1|COMPLETED|Titration/Stabilization||4
1582602|NCT01100437|3872218|P3|STARTED|Titration/Stabilization||8
1582603|NCT01100437|3872219|P2|STARTED|Titration/Stabilization||2
1582604|NCT01100437|3872220|P1|STARTED|Titration/Stabilization||4
1582605|NCT01100437|3872218|P3|NOT COMPLETED|Screening||0
1582606|NCT01100437|3872219|P2|NOT COMPLETED|Screening||0
1582607|NCT01100437|3872220|P1|NOT COMPLETED|Screening||0
1582608|NCT01100437|3872218|P3|COMPLETED|Screening||8
1582609|NCT01100437|3872219|P2|COMPLETED|Screening||2
1582610|NCT01100437|3872220|P1|COMPLETED|Screening||4
1582611|NCT01100437|3872218|P3|STARTED|Screening||8
1582612|NCT01100437|3872219|P2|STARTED|Screening||2
1582613|NCT01100437|3872220|P1|STARTED|Screening||4
1582614|NCT01100320|3872257|P2|NOT COMPLETED|Period 2||1
1582615|NCT01100320|3872258|P1|NOT COMPLETED|Period 2||1
1582616|NCT01100320|3872257|P2|COMPLETED|Period 2||37
1582617|NCT01100320|3872258|P1|COMPLETED|Period 2||37
1582618|NCT01100320|3872257|P2|STARTED|Period 2||38
1582619|NCT01100320|3872258|P1|STARTED|Period 2||38
1582620|NCT01100320|3872257|P2|NOT COMPLETED|Period 1||7
1582621|NCT01100320|3872258|P1|NOT COMPLETED|Period 1||5
1582622|NCT01100320|3872257|P2|COMPLETED|Period 1||38
1582623|NCT01100320|3872258|P1|COMPLETED|Period 1||38
1582624|NCT01100320|3872257|P2|STARTED|Period 1||45
1582625|NCT01100320|3872258|P1|STARTED|Period 1||43
1582626|NCT01100307|3872270|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
1582627|NCT01100307|3872271|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
1582628|NCT01100307|3872270|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
1582629|NCT01100307|3872271|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
1582630|NCT01100307|3872270|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
1582631|NCT01100307|3872271|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
1582632|NCT01100307|3872270|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
1582633|NCT01100307|3872271|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
1582634|NCT01100307|3872270|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
1582635|NCT01100307|3872271|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
1582636|NCT01100307|3872270|P2|STARTED|Double Masked Phase (Up to Week 24)||120
1582637|NCT01100307|3872271|P1|STARTED|Double Masked Phase (Up to Week 24)||123
1582638|NCT01100268|3872313|P1|NOT COMPLETED|Overall Study||0
1582639|NCT01100268|3872313|P1|COMPLETED|Overall Study||4
1582640|NCT01100268|3872313|P1|STARTED|Overall Study||4
1582641|NCT01100255|3872320|P2|NOT COMPLETED|Overall Study||0
1582642|NCT01100255|3872321|P1|NOT COMPLETED|Overall Study||0
1582643|NCT01100255|3872320|P2|COMPLETED|Overall Study||7
1582644|NCT01100255|3872321|P1|COMPLETED|Overall Study||8
1582645|NCT01100255|3872320|P2|STARTED|Overall Study||7
1582646|NCT01100255|3872321|P1|STARTED|Overall Study||8
1582647|NCT01100242|3872327|P1|NOT COMPLETED|Overall Study||0
1582648|NCT01100242|3872327|P1|COMPLETED|Overall Study||17
1582649|NCT01100242|3872327|P1|STARTED|Overall Study||17
1582650|NCT01100112|3872333|P1|NOT COMPLETED|Overall Study||8
1582651|NCT01100112|3872333|P1|COMPLETED|Overall Study||52
1582652|NCT01100112|3872333|P1|STARTED|Overall Study||60
1582653|NCT01100086|3872340|P2|NOT COMPLETED|Period 2||0
1582654|NCT01100086|3872341|P1|NOT COMPLETED|Period 2||0
1582655|NCT01100086|3872340|P2|COMPLETED|Period 2||41
1582656|NCT01100086|3872341|P1|COMPLETED|Period 2||42
1582657|NCT01100086|3872340|P2|STARTED|Period 2||41
1582658|NCT01100086|3872341|P1|STARTED|Period 2||42
1582659|NCT01100086|3872340|P2|NOT COMPLETED|Period 1||0
1582660|NCT01100086|3872341|P1|NOT COMPLETED|Period 1||1
1582661|NCT01100086|3872340|P2|COMPLETED|Period 1||41
1582662|NCT01100086|3872341|P1|COMPLETED|Period 1||42
1582663|NCT01100086|3872340|P2|STARTED|Period 1||41
1582664|NCT01100086|3872341|P1|STARTED|Period 1||43
1582665|NCT01100073|3872351|P1|NOT COMPLETED|Overall Study||100
1582666|NCT01100073|3872351|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
1582667|NCT01100073|3872351|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
1582668|NCT01099969|3872370|P4|NOT COMPLETED|Overall Study||0
1582669|NCT01099969|3872371|P3|NOT COMPLETED|Overall Study||0
1582670|NCT01099969|3872372|P2|NOT COMPLETED|Overall Study||0
1582671|NCT01099969|3872373|P1|NOT COMPLETED|Overall Study||0
1582672|NCT01099969|3872370|P4|COMPLETED|Overall Study||15
1582673|NCT01099969|3872371|P3|COMPLETED|Overall Study||15
1582674|NCT01099969|3872372|P2|COMPLETED|Overall Study||15
1582675|NCT01099969|3872373|P1|COMPLETED|Overall Study||15
1582676|NCT01099969|3872370|P4|STARTED|Overall Study||15
1582677|NCT01099969|3872371|P3|STARTED|Overall Study||15
1582678|NCT01099969|3872372|P2|STARTED|Overall Study||15
1582679|NCT01099969|3872373|P1|STARTED|Overall Study||15
1582680|NCT01099917|3872395|P1|NOT COMPLETED|Overall Study||27
1582681|NCT01099917|3872395|P1|COMPLETED|Overall Study||18
1582682|NCT01099917|3872395|P1|STARTED|Overall Study||45
1582683|NCT01099774|3872401|P2|NOT COMPLETED|Overall Study||6
1582684|NCT01099774|3872402|P1|NOT COMPLETED|Overall Study||6
1582685|NCT01099774|3872401|P2|COMPLETED|Overall Study||289
1582686|NCT01099774|3872402|P1|COMPLETED|Overall Study||296
1582687|NCT01099774|3872401|P2|STARTED|Overall Study||295
1582688|NCT01099774|3872402|P1|STARTED|Overall Study||302
1582689|NCT01099761|3872418|P4|NOT COMPLETED|Overall Study||0
1582690|NCT01099761|3872419|P3|NOT COMPLETED|Overall Study||0
1582691|NCT01099761|3872420|P2|NOT COMPLETED|Overall Study||0
1582692|NCT01099761|3872421|P1|NOT COMPLETED|Overall Study||0
1582693|NCT01099761|3872418|P4|COMPLETED|Overall Study||6
1582694|NCT01099761|3872419|P3|COMPLETED|Overall Study||0
1582695|NCT01099761|3872420|P2|COMPLETED|Overall Study||9
1582696|NCT01099761|3872421|P1|COMPLETED|Overall Study||9
1582697|NCT01099761|3872418|P4|STARTED|Overall Study||6
1582698|NCT01099761|3872419|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
1582699|NCT01099761|3872420|P2|STARTED|Overall Study||9
1582700|NCT01099761|3872421|P1|STARTED|Overall Study||9
1582701|NCT01099709|3872457|P2|NOT COMPLETED|Period 2||0
1582702|NCT01099709|3872458|P1|NOT COMPLETED|Period 2||0
1582703|NCT01099709|3872457|P2|COMPLETED|Period 2||41
1582704|NCT01099709|3872458|P1|COMPLETED|Period 2||41
1582705|NCT01099709|3872457|P2|STARTED|Period 2||41
1582706|NCT01099709|3872458|P1|STARTED|Period 2||41
1582707|NCT01099709|3872457|P2|NOT COMPLETED|Period 1||2
1582708|NCT01099709|3872458|P1|NOT COMPLETED|Period 1||1
1582709|NCT01099709|3872457|P2|COMPLETED|Period 1||41
1582710|NCT01099709|3872458|P1|COMPLETED|Period 1||41
1582711|NCT01099709|3872457|P2|STARTED|Period 1||43
1582712|NCT01099709|3872458|P1|STARTED|Period 1||42
1582713|NCT01099618|3872471|P3|NOT COMPLETED|Overall Study||0
1582714|NCT01099618|3872472|P2|NOT COMPLETED|Overall Study||0
1582715|NCT01099618|3872473|P1|NOT COMPLETED|Overall Study||0
1582716|NCT01099618|3872471|P3|COMPLETED|Overall Study||15
1582717|NCT01099618|3872472|P2|COMPLETED|Overall Study||16
1582718|NCT01099618|3872473|P1|COMPLETED|Overall Study||17
1582719|NCT01099618|3872471|P3|STARTED|Overall Study||15
1582720|NCT01099618|3872472|P2|STARTED|Overall Study||16
1582721|NCT01099618|3872473|P1|STARTED|Overall Study||17
1582722|NCT01099579|3872484|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
1582723|NCT01099579|3872485|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
1582724|NCT01099579|3872486|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
1582725|NCT01099579|3872484|P3|COMPLETED|Stage 2 (ATV Capsule)||9
1582726|NCT01099579|3872485|P2|COMPLETED|Stage 2 (ATV Capsule)||9
1582727|NCT01099579|3872486|P1|COMPLETED|Stage 2 (ATV Capsule)||10
1582728|NCT01099579|3872484|P3|STARTED|Stage 2 (ATV Capsule)||15
1582729|NCT01099579|3872485|P2|STARTED|Stage 2 (ATV Capsule)||14
1582730|NCT01099579|3872486|P1|STARTED|Stage 2 (ATV Capsule)||16
1582731|NCT01099579|3872484|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
1582732|NCT01099579|3872485|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
1582733|NCT01099579|3872486|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
1582734|NCT01099579|3872484|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
1582735|NCT01099579|3872485|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
1582736|NCT01099579|3872486|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
1582737|NCT01099579|3872484|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
1582738|NCT01099579|3872485|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
1582739|NCT01099579|3872486|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
1582740|NCT01099475|3872542|P2|NOT COMPLETED|Overall Study||0
1582741|NCT01099475|3872543|P1|NOT COMPLETED|Overall Study||0
1582742|NCT01099475|3872542|P2|COMPLETED|Overall Study||10
1582743|NCT01099475|3872543|P1|COMPLETED|Overall Study||10
1582744|NCT01099475|3872542|P2|STARTED|Overall Study||10
1582745|NCT01099475|3872543|P1|STARTED|Overall Study||10
1582746|NCT01099397|3872555|P1|NOT COMPLETED|Overall Study||13
1582747|NCT01099397|3872555|P1|COMPLETED|Overall Study||26
1582748|NCT01099397|3872555|P1|STARTED|Overall Study||39
1582749|NCT01099358|3872560|P4|NOT COMPLETED|Overall Study||4
1582750|NCT01099358|3872561|P3|NOT COMPLETED|Overall Study||8
1582751|NCT01099358|3872562|P2|NOT COMPLETED|Overall Study||1
1582752|NCT01099358|3872563|P1|NOT COMPLETED|Overall Study||3
1582753|NCT01099358|3872560|P4|COMPLETED|Overall Study||12
1582754|NCT01099358|3872561|P3|COMPLETED|Overall Study||13
1582755|NCT01099358|3872562|P2|COMPLETED|Overall Study||5
1582756|NCT01099358|3872563|P1|COMPLETED|Overall Study||1
1582757|NCT01099358|3872560|P4|Received at Least One Dose of Study Drug|Overall Study||15
1582758|NCT01099358|3872561|P3|Received at Least One Dose of Study Drug|Overall Study||20
1582759|NCT01099358|3872562|P2|Received at Least One Dose of Study Drug|Overall Study||6
1582760|NCT01099358|3872563|P1|Received at Least One Dose of Study Drug|Overall Study||3
1582761|NCT01099358|3872560|P4|STARTED|Overall Study||16
1582762|NCT01099358|3872561|P3|STARTED|Overall Study||21
1582763|NCT01099358|3872562|P2|STARTED|Overall Study||6
1582764|NCT01099358|3872563|P1|STARTED|Overall Study||4
1582765|NCT01099267|3872582|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
1582766|NCT01099267|3872582|P1|COMPLETED|MDS-009 Extension Follow-up||54
1582767|NCT01099267|3872582|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
1582768|NCT01099267|3872582|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
1582769|NCT01099267|3872582|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
1582770|NCT01099267|3872582|P1|NOT COMPLETED|MDS-003 Study||124
1582771|NCT01099267|3872582|P1|COMPLETED|MDS-003 Study||24
1582772|NCT01099267|3872582|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
1582773|NCT01099215|3872592|P2|NOT COMPLETED|Overall Study||1
1582774|NCT01099215|3872593|P1|NOT COMPLETED|Overall Study||1
1582775|NCT01099215|3872592|P2|COMPLETED|Overall Study||9
1582776|NCT01099215|3872593|P1|COMPLETED|Overall Study||10
1582777|NCT01099215|3872592|P2|STARTED|Overall Study||10
1582778|NCT01099215|3872593|P1|STARTED|Overall Study||11
1582779|NCT01099202|3872631|P2|NOT COMPLETED|Overall Study||0
1582780|NCT01099202|3872632|P1|NOT COMPLETED|Overall Study||0
1582781|NCT01099202|3872631|P2|COMPLETED|Overall Study||54
1582782|NCT01099202|3872632|P1|COMPLETED|Overall Study||55
1582783|NCT01099202|3872631|P2|STARTED|Overall Study||54
1582784|NCT01099202|3872632|P1|STARTED|Overall Study||55
1582785|NCT01099111|3872645|P5|NOT COMPLETED|Overall Study||0
1582786|NCT01099111|3872646|P4|NOT COMPLETED|Overall Study||0
1582787|NCT01099111|3872647|P3|NOT COMPLETED|Overall Study||0
1582788|NCT01099111|3872648|P2|NOT COMPLETED|Overall Study||0
1582789|NCT01099111|3872649|P1|NOT COMPLETED|Overall Study||0
1582790|NCT01099111|3872645|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
1582791|NCT01099111|3872646|P4|COMPLETED|Overall Study||29
1582792|NCT01099111|3872647|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
1582793|NCT01099111|3872648|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
1582794|NCT01099111|3872649|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
1582795|NCT01099111|3872645|P5|STARTED|Overall Study||50
1582796|NCT01099111|3872646|P4|STARTED|Overall Study||29
1582797|NCT01099111|3872647|P3|STARTED|Overall Study||46
1582798|NCT01099111|3872648|P2|STARTED|Overall Study||50
1582799|NCT01099111|3872649|P1|STARTED|Overall Study||50
1582800|NCT01098851|3872663|P2|NOT COMPLETED|Overall Study||0
1582801|NCT01098851|3872664|P1|NOT COMPLETED|Overall Study||1
1582802|NCT01098851|3872663|P2|COMPLETED|Overall Study||10
1582803|NCT01098851|3872664|P1|COMPLETED|Overall Study||10
1582804|NCT01098851|3872663|P2|STARTED|Overall Study||10
1582805|NCT01098851|3872664|P1|STARTED|Overall Study||11
1582806|NCT01098812|3872675|P3|NOT COMPLETED|Overall Study||1
1582807|NCT01098812|3872676|P2|NOT COMPLETED|Overall Study||1
1582808|NCT01098812|3872677|P1|NOT COMPLETED|Overall Study||2
1582809|NCT01098812|3872675|P3|COMPLETED|Overall Study||71
1582810|NCT01098812|3872676|P2|COMPLETED|Overall Study||101
1582811|NCT01098812|3872677|P1|COMPLETED|Overall Study||93
1582812|NCT01098812|3872675|P3|STARTED|Overall Study||72
1582813|NCT01098812|3872676|P2|STARTED|Overall Study||102
1582814|NCT01098812|3872677|P1|STARTED|Overall Study||95
1582815|NCT01098747|3872691|P4|NOT COMPLETED|Overall Study||0
1582816|NCT01098747|3872692|P3|NOT COMPLETED|Overall Study||0
1582817|NCT01098747|3872693|P2|NOT COMPLETED|Overall Study||0
1582818|NCT01098747|3872694|P1|NOT COMPLETED|Overall Study||0
1582819|NCT01098747|3872691|P4|COMPLETED|Overall Study||87
1582820|NCT01098747|3872692|P3|COMPLETED|Overall Study||86
1582821|NCT01098747|3872693|P2|COMPLETED|Overall Study||95
1582822|NCT01098747|3872694|P1|COMPLETED|Overall Study||48
1582823|NCT01098747|3872691|P4|STARTED|Overall Study||87
1582824|NCT01098747|3872692|P3|STARTED|Overall Study||86
1582825|NCT01098747|3872693|P2|STARTED|Overall Study||95
1582826|NCT01098747|3872694|P1|STARTED|Overall Study||48
1582827|NCT01098578|3872744|P1|NOT COMPLETED|Overall Study||0
1582828|NCT01098578|3872744|P1|COMPLETED|Overall Study||20
1582829|NCT01098578|3872744|P1|STARTED|Overall Study||20
1582830|NCT01098539|3872753|P2|NOT COMPLETED|Overall Study||68
1582831|NCT01098539|3872754|P1|NOT COMPLETED|Overall Study||51
1582832|NCT01098539|3872753|P2|COMPLETED|Overall Study||178
1582833|NCT01098539|3872754|P1|COMPLETED|Overall Study||198
1582834|NCT01098539|3872753|P2|STARTED|Overall Study||246
1582835|NCT01098539|3872754|P1|STARTED|Overall Study||249
1582836|NCT01098500|3872790|P1|NOT COMPLETED|Overall Study||0
1582837|NCT01098500|3872790|P1|COMPLETED|Overall Study||3800
1582838|NCT01098500|3872790|P1|STARTED|Overall Study||3800
1582839|NCT01098487|3872805|P1|NOT COMPLETED|Overall Study||44
1582840|NCT01098487|3872805|P1|COMPLETED|Overall Study||118
1582841|NCT01098487|3872805|P1|STARTED|Overall Study||162
1582842|NCT01098474|3872823|P6|NOT COMPLETED|Follow Up Phase||5
1582843|NCT01098474|3872824|P5|NOT COMPLETED|Follow Up Phase||2
1582844|NCT01098474|3872825|P4|NOT COMPLETED|Follow Up Phase||2
1582845|NCT01098474|3872826|P3|NOT COMPLETED|Follow Up Phase||0
1582846|NCT01098474|3872827|P2|NOT COMPLETED|Follow Up Phase||0
1582847|NCT01098474|3872828|P1|NOT COMPLETED|Follow Up Phase||0
1582848|NCT01098474|3872823|P6|COMPLETED|Follow Up Phase||44
1582849|NCT01098474|3872824|P5|COMPLETED|Follow Up Phase||50
1582850|NCT01098474|3872825|P4|COMPLETED|Follow Up Phase||47
1582851|NCT01098474|3872826|P3|COMPLETED|Follow Up Phase||45
1582852|NCT01098474|3872827|P2|COMPLETED|Follow Up Phase||49
1582853|NCT01098474|3872828|P1|COMPLETED|Follow Up Phase||48
1582854|NCT01098474|3872823|P6|STARTED|Follow Up Phase||49
1582855|NCT01098474|3872824|P5|STARTED|Follow Up Phase||52
1582856|NCT01098474|3872825|P4|STARTED|Follow Up Phase||49
1582857|NCT01098474|3872826|P3|STARTED|Follow Up Phase||45
1582858|NCT01098474|3872827|P2|STARTED|Follow Up Phase||49
1582859|NCT01098474|3872828|P1|STARTED|Follow Up Phase||48
1582860|NCT01098474|3872823|P6|NOT COMPLETED|Active Phase||0
1582861|NCT01098474|3872824|P5|NOT COMPLETED|Active Phase||0
1582862|NCT01098474|3872825|P4|NOT COMPLETED|Active Phase||0
1582863|NCT01098474|3872826|P3|NOT COMPLETED|Active Phase||5
1582864|NCT01098474|3872827|P2|NOT COMPLETED|Active Phase||1
1582865|NCT01098474|3872828|P1|NOT COMPLETED|Active Phase||2
1582866|NCT01098474|3872823|P6|COMPLETED|Active Phase||49
1582867|NCT01098474|3872824|P5|COMPLETED|Active Phase||52
1582868|NCT01098474|3872825|P4|COMPLETED|Active Phase||49
1582869|NCT01098474|3872826|P3|COMPLETED|Active Phase||45
1582870|NCT01098474|3872827|P2|COMPLETED|Active Phase||49
1582871|NCT01098474|3872828|P1|COMPLETED|Active Phase||48
1582872|NCT01098474|3872823|P6|STARTED|Active Phase||49
1582873|NCT01098474|3872824|P5|STARTED|Active Phase||52
1582874|NCT01098474|3872825|P4|STARTED|Active Phase||49
1582875|NCT01098474|3872826|P3|STARTED|Active Phase||50
1582876|NCT01098474|3872827|P2|STARTED|Active Phase||50
1582877|NCT01098474|3872828|P1|STARTED|Active Phase||50
1582878|NCT01098461|3873062|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
1582879|NCT01098461|3873063|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
1582880|NCT01098461|3873064|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
1582881|NCT01098461|3873065|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
1582882|NCT01098461|3873062|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
1582883|NCT01098461|3873063|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
1582884|NCT01098461|3873064|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
1582885|NCT01098461|3873065|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
1582886|NCT01098461|3873062|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
1582887|NCT01098461|3873063|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
1582888|NCT01098461|3873064|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
1582889|NCT01098461|3873065|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
1582890|NCT01098461|3873062|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
1582891|NCT01098461|3873063|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
1582892|NCT01098461|3873064|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
1582893|NCT01098461|3873065|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
1582894|NCT01098461|3873062|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
1582895|NCT01098461|3873063|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
1582896|NCT01098461|3873064|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
1582897|NCT01098461|3873065|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
1582898|NCT01098461|3873062|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
1582899|NCT01098461|3873063|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
1582900|NCT01098461|3873064|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
1582901|NCT01098461|3873065|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
1582902|NCT01098318|3873098|P3|NOT COMPLETED|Overall Study||3
1582903|NCT01098318|3873099|P2|NOT COMPLETED|Overall Study||7
1582904|NCT01098318|3873100|P1|NOT COMPLETED|Overall Study||3
1582905|NCT01098318|3873098|P3|COMPLETED|Overall Study||15
1582906|NCT01098318|3873099|P2|COMPLETED|Overall Study||12
1582907|NCT01098318|3873100|P1|COMPLETED|Overall Study||17
1582908|NCT01098318|3873098|P3|STARTED|Overall Study||18
1582909|NCT01098318|3873099|P2|STARTED|Overall Study||19
1582910|NCT01098318|3873100|P1|STARTED|Overall Study||20
1582911|NCT01098305|3873125|P2|NOT COMPLETED|Overall Study||33
1582912|NCT01098305|3873126|P1|NOT COMPLETED|Overall Study||31
1582913|NCT01098305|3873125|P2|COMPLETED|Overall Study||85
1582914|NCT01098305|3873126|P1|COMPLETED|Overall Study||88
1582915|NCT01098305|3873125|P2|STARTED|Overall Study||118
1582916|NCT01098305|3873126|P1|STARTED|Overall Study||119
1582917|NCT01098253|3873136|P2|NOT COMPLETED|Overall Study||0
1582918|NCT01098253|3873137|P1|NOT COMPLETED|Overall Study||2
1582919|NCT01098253|3873136|P2|COMPLETED|Overall Study||88
1582920|NCT01098253|3873137|P1|COMPLETED|Overall Study||92
1582921|NCT01098253|3873136|P2|STARTED|Overall Study||88
1582922|NCT01098253|3873137|P1|STARTED|Overall Study||94
1582923|NCT01098240|3873145|P3|NOT COMPLETED|Double-Blind Phase||22
1582924|NCT01098240|3873146|P2|NOT COMPLETED|Double-Blind Phase||17
1582925|NCT01098240|3873147|P1|NOT COMPLETED|Double-Blind Phase||0
1582926|NCT01098240|3873145|P3|COMPLETED|Double-Blind Phase||63
1582927|NCT01098240|3873146|P2|COMPLETED|Double-Blind Phase||60
1582928|NCT01098240|3873147|P1|COMPLETED|Double-Blind Phase||0
1582929|NCT01098240|3873145|P3|STARTED|Double-Blind Phase||85
1582930|NCT01098240|3873146|P2|STARTED|Double-Blind Phase||77
1582931|NCT01098240|3873147|P1|STARTED|Double-Blind Phase||0
1582932|NCT01098240|3873145|P3|NOT COMPLETED|Open-Label Phase||0
1582933|NCT01098240|3873146|P2|NOT COMPLETED|Open-Label Phase||0
1582934|NCT01098240|3873147|P1|NOT COMPLETED|Open-Label Phase||135
1582935|NCT01098240|3873145|P3|COMPLETED|Open-Label Phase||0
1582936|NCT01098240|3873146|P2|COMPLETED|Open-Label Phase||0
1582937|NCT01098240|3873147|P1|COMPLETED|Open-Label Phase||162
1582938|NCT01098240|3873145|P3|STARTED|Open-Label Phase||0
1582939|NCT01098240|3873146|P2|STARTED|Open-Label Phase||0
1582940|NCT01098240|3873147|P1|STARTED|Open-Label Phase||297
1582941|NCT01098162|3873177|P1|NOT COMPLETED|Overall Study||112
1582942|NCT01098162|3873177|P1|COMPLETED|Overall Study||461
1582943|NCT01098162|3873177|P1|STARTED|Overall Study||573
1582944|NCT01098110|3873189|P3|NOT COMPLETED|Overall Study||94
1582945|NCT01098110|3873190|P2|NOT COMPLETED|Overall Study||73
1582946|NCT01098110|3873191|P1|NOT COMPLETED|Overall Study||62
1582947|NCT01098110|3873189|P3|COMPLETED|Overall Study||80
1582948|NCT01098110|3873190|P2|COMPLETED|Overall Study||109
1582949|NCT01098110|3873191|P1|COMPLETED|Overall Study||114
1582950|NCT01098110|3873189|P3|Treated|Overall Study|Received at least one dose of trial medication|174
1582951|NCT01098110|3873190|P2|Treated|Overall Study|Received at least one dose of trial medication|181
1582952|NCT01098110|3873191|P1|Treated|Overall Study|Received at least one dose of trial medication|175
1582953|NCT01098110|3873189|P3|STARTED|Overall Study|Randomized participants|174
1582954|NCT01098110|3873190|P2|STARTED|Overall Study|Randomized participants|182
1582955|NCT01098110|3873191|P1|STARTED|Overall Study|Randomized participants|176
1582956|NCT01098097|3873232|P1|NOT COMPLETED|Overall Study||82
1582957|NCT01098097|3873232|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
1582958|NCT01098097|3873232|P1|STARTED|Overall Study||963
1582959|NCT01098071|3873241|P1|NOT COMPLETED|Overall Study||15
1582960|NCT01098071|3873241|P1|COMPLETED|Overall Study||19
1582961|NCT01098071|3873241|P1|STARTED|Overall Study||34
1582962|NCT01098032|3873254|P2|NOT COMPLETED|Overall Study||1
1582963|NCT01098032|3873255|P1|NOT COMPLETED|Overall Study||1
1582964|NCT01098032|3873254|P2|COMPLETED|Overall Study||146
1582965|NCT01098032|3873255|P1|COMPLETED|Overall Study||146
1582966|NCT01098032|3873254|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
1582967|NCT01098032|3873255|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
1582968|NCT01098006|3873265|P4|NOT COMPLETED|Overall Study||0
1582969|NCT01098006|3873266|P3|NOT COMPLETED|Overall Study||0
1582970|NCT01098006|3873267|P2|NOT COMPLETED|Overall Study||0
1582971|NCT01098006|3873268|P1|NOT COMPLETED|Overall Study||0
1582972|NCT01098006|3873265|P4|COMPLETED|Overall Study||21
1582973|NCT01098006|3873266|P3|COMPLETED|Overall Study||60
1582974|NCT01098006|3873267|P2|COMPLETED|Overall Study||11
1582975|NCT01098006|3873268|P1|COMPLETED|Overall Study||7
1582976|NCT01098006|3873265|P4|STARTED|Overall Study||21
1582977|NCT01098006|3873266|P3|STARTED|Overall Study||60
1582978|NCT01098006|3873267|P2|STARTED|Overall Study||11
1582979|NCT01098006|3873268|P1|STARTED|Overall Study||7
1582980|NCT01097915|3873345|P3|NOT COMPLETED|Overall Study||30
1582981|NCT01097915|3873346|P2|NOT COMPLETED|Overall Study||42
1582982|NCT01097915|3873347|P1|NOT COMPLETED|Overall Study||23
1582983|NCT01097915|3873345|P3|COMPLETED|Overall Study||20
1582984|NCT01097915|3873346|P2|COMPLETED|Overall Study||28
1582985|NCT01097915|3873347|P1|COMPLETED|Overall Study||27
1582986|NCT01097915|3873345|P3|STARTED|Overall Study||50
1582987|NCT01097915|3873346|P2|STARTED|Overall Study||70
1582988|NCT01097915|3873347|P1|STARTED|Overall Study||50
1582989|NCT01097863|3873372|P3|NOT COMPLETED|Overall Study||2
1582990|NCT01097863|3873373|P2|NOT COMPLETED|Overall Study||0
1582991|NCT01097863|3873374|P1|NOT COMPLETED|Overall Study||1
1582992|NCT01097863|3873372|P3|COMPLETED|Overall Study||89
1582993|NCT01097863|3873373|P2|COMPLETED|Overall Study||98
1582994|NCT01097863|3873374|P1|COMPLETED|Overall Study||89
1582995|NCT01097863|3873372|P3|STARTED|Overall Study||91
1582996|NCT01097863|3873373|P2|STARTED|Overall Study||98
1582997|NCT01097863|3873374|P1|STARTED|Overall Study||90
1582998|NCT01097785|3873384|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
1582999|NCT01097785|3873385|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
1583000|NCT01097785|3873384|P2|COMPLETED|Cycle 3 (30 Days)||6
1583001|NCT01097785|3873385|P1|COMPLETED|Cycle 3 (30 Days)||6
1583002|NCT01097785|3873384|P2|STARTED|Cycle 3 (30 Days)||6
1583003|NCT01097785|3873385|P1|STARTED|Cycle 3 (30 Days)||6
1583004|NCT01097785|3873384|P2|NOT COMPLETED|Washout (2 Weeks)||0
1583005|NCT01097785|3873385|P1|NOT COMPLETED|Washout (2 Weeks)||0
1583006|NCT01097785|3873384|P2|COMPLETED|Washout (2 Weeks)||6
1583007|NCT01097785|3873385|P1|COMPLETED|Washout (2 Weeks)||6
1583008|NCT01097785|3873384|P2|STARTED|Washout (2 Weeks)||6
1583009|NCT01097785|3873385|P1|STARTED|Washout (2 Weeks)||6
1583010|NCT01097785|3873384|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
1583011|NCT01097785|3873385|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
1583012|NCT01097785|3873384|P2|COMPLETED|Cycle 1 (30 Days)||6
1583013|NCT01097785|3873385|P1|COMPLETED|Cycle 1 (30 Days)||6
1583014|NCT01097785|3873384|P2|STARTED|Cycle 1 (30 Days)||6
1583015|NCT01097785|3873385|P1|STARTED|Cycle 1 (30 Days)||6
1583016|NCT01097694|3873395|P2|NOT COMPLETED|Overall Study||4
1583017|NCT01097694|3873396|P1|NOT COMPLETED|Overall Study||8
1583018|NCT01097694|3873395|P2|COMPLETED|Overall Study||26
1583019|NCT01097694|3873396|P1|COMPLETED|Overall Study||24
1583020|NCT01097694|3873395|P2|STARTED|Overall Study||30
1583021|NCT01097694|3873396|P1|STARTED|Overall Study||32
1583022|NCT01097668|3873458|P2|NOT COMPLETED|Overall Study||2
1583023|NCT01097668|3873459|P1|NOT COMPLETED|Overall Study||2
1583024|NCT01097668|3873458|P2|COMPLETED|Overall Study||20
1583025|NCT01097668|3873459|P1|COMPLETED|Overall Study||19
1583026|NCT01097668|3873458|P2|Week 48|Overall Study||20
1583027|NCT01097668|3873459|P1|Week 48|Overall Study||19
1583028|NCT01097668|3873458|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
1583029|NCT01097668|3873459|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
1583030|NCT01097668|3873458|P2|STARTED|Overall Study||22
1583031|NCT01097668|3873459|P1|STARTED|Overall Study||21
1583032|NCT01097655|3873469|P1|NOT COMPLETED|Overall Study||10
1583033|NCT01097655|3873469|P1|COMPLETED|Overall Study|participants included for analysis|3039
1583034|NCT01097655|3873469|P1|STARTED|Overall Study||3049
1583035|NCT01097629|3873479|P8|NOT COMPLETED|DB RO Phase||1
1583036|NCT01097629|3873480|P7|NOT COMPLETED|DB RO Phase||3
1583037|NCT01097629|3873481|P6|NOT COMPLETED|DB RO Phase||1
1583038|NCT01097629|3873482|P5|NOT COMPLETED|DB RO Phase||0
1583039|NCT01097629|3873483|P4|NOT COMPLETED|DB RO Phase||1
1583040|NCT01097629|3873484|P3|NOT COMPLETED|DB RO Phase||0
1583041|NCT01097629|3873485|P2|NOT COMPLETED|DB RO Phase||0
1583042|NCT01097629|3873486|P1|NOT COMPLETED|DB RO Phase||0
1583043|NCT01097629|3873479|P8|COMPLETED|DB RO Phase||326
1583044|NCT01097629|3873480|P7|COMPLETED|DB RO Phase||168
1583045|NCT01097629|3873481|P6|COMPLETED|DB RO Phase||172
1583046|NCT01097629|3873482|P5|COMPLETED|DB RO Phase||108
1583047|NCT01097629|3873483|P4|COMPLETED|DB RO Phase||96
1583048|NCT01097629|3873484|P3|COMPLETED|DB RO Phase||0
1583049|NCT01097629|3873485|P2|COMPLETED|DB RO Phase||0
1583050|NCT01097629|3873486|P1|COMPLETED|DB RO Phase||0
1583051|NCT01097629|3873479|P8|STARTED|DB RO Phase||327
1583052|NCT01097629|3873480|P7|STARTED|DB RO Phase||171
1583053|NCT01097629|3873481|P6|STARTED|DB RO Phase||173
1583054|NCT01097629|3873482|P5|STARTED|DB RO Phase||108
1583055|NCT01097629|3873483|P4|STARTED|DB RO Phase||97
1583056|NCT01097629|3873484|P3|STARTED|DB RO Phase||0
1583057|NCT01097629|3873485|P2|STARTED|DB RO Phase||0
1583058|NCT01097629|3873486|P1|STARTED|DB RO Phase||0
1583059|NCT01097629|3873479|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583060|NCT01097629|3873480|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583061|NCT01097629|3873481|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583062|NCT01097629|3873482|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583063|NCT01097629|3873483|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583064|NCT01097629|3873484|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
1583065|NCT01097629|3873485|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
1583066|NCT01097629|3873486|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
1583067|NCT01097629|3873479|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583068|NCT01097629|3873480|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583069|NCT01097629|3873481|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583070|NCT01097629|3873482|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583071|NCT01097629|3873483|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583072|NCT01097629|3873484|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
1583073|NCT01097629|3873485|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
1583074|NCT01097629|3873486|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
1583075|NCT01097629|3873479|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583076|NCT01097629|3873480|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583077|NCT01097629|3873481|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583078|NCT01097629|3873482|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583079|NCT01097629|3873483|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583080|NCT01097629|3873484|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
1583081|NCT01097629|3873485|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
1583082|NCT01097629|3873486|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
1583083|NCT01097629|3873479|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583084|NCT01097629|3873480|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583085|NCT01097629|3873481|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583086|NCT01097629|3873482|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583087|NCT01097629|3873483|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583088|NCT01097629|3873484|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
1583089|NCT01097629|3873485|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
1583090|NCT01097629|3873486|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
1583091|NCT01097616|3873537|P8|NOT COMPLETED|DB RO Phase||1
1583092|NCT01097616|3873538|P7|NOT COMPLETED|DB RO Phase||1
1583093|NCT01097616|3873539|P6|NOT COMPLETED|DB RO Phase||2
1583094|NCT01097616|3873540|P5|NOT COMPLETED|DB RO Phase||1
1583095|NCT01097616|3873541|P4|NOT COMPLETED|DB RO Phase||1
1583096|NCT01097616|3873542|P3|NOT COMPLETED|DB RO Phase||0
1583097|NCT01097616|3873543|P2|NOT COMPLETED|DB RO Phase||0
1583098|NCT01097616|3873544|P1|NOT COMPLETED|DB RO Phase||0
1583099|NCT01097616|3873537|P8|COMPLETED|DB RO Phase||326
1583100|NCT01097616|3873538|P7|COMPLETED|DB RO Phase||161
1583101|NCT01097616|3873539|P6|COMPLETED|DB RO Phase||159
1583102|NCT01097616|3873540|P5|COMPLETED|DB RO Phase||111
1583103|NCT01097616|3873541|P4|COMPLETED|DB RO Phase||100
1583104|NCT01097616|3873542|P3|COMPLETED|DB RO Phase||0
1583105|NCT01097616|3873543|P2|COMPLETED|DB RO Phase||0
1583106|NCT01097616|3873544|P1|COMPLETED|DB RO Phase||0
1583107|NCT01097616|3873537|P8|STARTED|DB RO Phase||327
1583108|NCT01097616|3873538|P7|STARTED|DB RO Phase||162
1583109|NCT01097616|3873539|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
1583110|NCT01097616|3873540|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
1583111|NCT01097616|3873541|P4|STARTED|DB RO Phase||101
1583112|NCT01097616|3873542|P3|STARTED|DB RO Phase||0
1583113|NCT01097616|3873543|P2|STARTED|DB RO Phase||0
1583114|NCT01097616|3873544|P1|STARTED|DB RO Phase||0
1583115|NCT01097616|3873537|P8|NOT COMPLETED|Optional DB EXT Phase||0
1583116|NCT01097616|3873538|P7|NOT COMPLETED|Optional DB EXT Phase||0
1583117|NCT01097616|3873539|P6|NOT COMPLETED|Optional DB EXT Phase||0
1583118|NCT01097616|3873540|P5|NOT COMPLETED|Optional DB EXT Phase||0
1583119|NCT01097616|3873541|P4|NOT COMPLETED|Optional DB EXT Phase||0
1583120|NCT01097616|3873542|P3|NOT COMPLETED|Optional DB EXT Phase||10
1583121|NCT01097616|3873543|P2|NOT COMPLETED|Optional DB EXT Phase||21
1583122|NCT01097616|3873544|P1|NOT COMPLETED|Optional DB EXT Phase||15
1583123|NCT01097616|3873537|P8|COMPLETED|Optional DB EXT Phase||0
1583124|NCT01097616|3873538|P7|COMPLETED|Optional DB EXT Phase||0
1583125|NCT01097616|3873539|P6|COMPLETED|Optional DB EXT Phase||0
1583126|NCT01097616|3873540|P5|COMPLETED|Optional DB EXT Phase||0
1583127|NCT01097616|3873541|P4|COMPLETED|Optional DB EXT Phase||0
1583128|NCT01097616|3873542|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
1583129|NCT01097616|3873543|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
1583130|NCT01097616|3873544|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
1583131|NCT01097616|3873537|P8|STARTED|Optional DB EXT Phase||0
1583132|NCT01097616|3873538|P7|STARTED|Optional DB EXT Phase||0
1583133|NCT01097616|3873539|P6|STARTED|Optional DB EXT Phase||0
1583134|NCT01097616|3873540|P5|STARTED|Optional DB EXT Phase||0
1583135|NCT01097616|3873541|P4|STARTED|Optional DB EXT Phase||0
1583136|NCT01097616|3873542|P3|STARTED|Optional DB EXT Phase||151
1583137|NCT01097616|3873543|P2|STARTED|Optional DB EXT Phase||172
1583138|NCT01097616|3873544|P1|STARTED|Optional DB EXT Phase||100
1583139|NCT01097616|3873537|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583140|NCT01097616|3873538|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583141|NCT01097616|3873539|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583142|NCT01097616|3873540|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583143|NCT01097616|3873541|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583144|NCT01097616|3873542|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
1583145|NCT01097616|3873543|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
1583146|NCT01097616|3873544|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
1583147|NCT01097616|3873537|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583148|NCT01097616|3873538|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583149|NCT01097616|3873539|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583150|NCT01097616|3873540|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583151|NCT01097616|3873541|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1583152|NCT01097616|3873542|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
1583153|NCT01097616|3873543|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
1583154|NCT01097616|3873544|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
1583155|NCT01097616|3873537|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583156|NCT01097616|3873538|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583157|NCT01097616|3873539|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583158|NCT01097616|3873540|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583159|NCT01097616|3873541|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1583160|NCT01097616|3873542|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
1583161|NCT01097616|3873543|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
1583162|NCT01097616|3873544|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
1583163|NCT01097616|3873537|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583164|NCT01097616|3873538|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583165|NCT01097616|3873539|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583166|NCT01097616|3873540|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583167|NCT01097616|3873541|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1583168|NCT01097616|3873542|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
1583169|NCT01097616|3873543|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
1583170|NCT01097616|3873544|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
1583171|NCT01097460|3873615|P1|NOT COMPLETED|Overall Study||0
1583172|NCT01097460|3873615|P1|COMPLETED|Overall Study||16
1583173|NCT01097460|3873615|P1|STARTED|Overall Study||16
1583174|NCT01097421|3873619|P1|NOT COMPLETED|Overall Study||14
1583175|NCT01097421|3873619|P1|COMPLETED|Overall Study||314
1583176|NCT01097421|3873619|P1|STARTED|Overall Study||328
1583177|NCT01097343|3873629|P2|NOT COMPLETED|Second Intervention- 30 Days||0
1583178|NCT01097343|3873630|P1|NOT COMPLETED|Second Intervention- 30 Days||0
1583179|NCT01097343|3873629|P2|COMPLETED|Second Intervention- 30 Days||25
1583180|NCT01097343|3873630|P1|COMPLETED|Second Intervention- 30 Days||25
1583181|NCT01097343|3873629|P2|STARTED|Second Intervention- 30 Days||25
1583182|NCT01097343|3873630|P1|STARTED|Second Intervention- 30 Days||25
1583183|NCT01097343|3873629|P2|NOT COMPLETED|First Intervention- 30 Days||0
1583184|NCT01097343|3873630|P1|NOT COMPLETED|First Intervention- 30 Days||0
1583185|NCT01097343|3873629|P2|COMPLETED|First Intervention- 30 Days||25
1583186|NCT01097343|3873630|P1|COMPLETED|First Intervention- 30 Days||25
1583187|NCT01097343|3873629|P2|STARTED|First Intervention- 30 Days||25
1583188|NCT01097343|3873630|P1|STARTED|First Intervention- 30 Days||25
1583189|NCT01097304|3873636|P1|NOT COMPLETED|Overall Study||7
1583190|NCT01097304|3873636|P1|COMPLETED|Overall Study||29
1583191|NCT01097304|3873636|P1|STARTED|Overall Study||36
1583192|NCT01097057|3873643|P1|NOT COMPLETED|Overall Study||3
1583193|NCT01097057|3873643|P1|COMPLETED|Overall Study||17
1583194|NCT01097057|3873643|P1|STARTED|Overall Study||20
1583195|NCT01097005|3873650|P1|NOT COMPLETED|Overall Study||365
1583196|NCT01097005|3873650|P1|COMPLETED|Overall Study||101
1583197|NCT01097005|3873650|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
1583198|NCT01097005|3873650|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
1583199|NCT01097005|3873650|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
1583200|NCT01097005|3873650|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
1583201|NCT01097005|3873650|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
1583202|NCT01096875|3873658|P2|NOT COMPLETED|Overall Study||1
1583203|NCT01096875|3873659|P1|NOT COMPLETED|Overall Study||0
1583204|NCT01096875|3873658|P2|COMPLETED|Overall Study||29
1583205|NCT01096875|3873659|P1|COMPLETED|Overall Study||30
1583206|NCT01096875|3873658|P2|STARTED|Overall Study||30
1583207|NCT01096875|3873659|P1|STARTED|Overall Study||30
1583208|NCT01096849|3873674|P3|NOT COMPLETED|Overall Study||6
1583209|NCT01096849|3873675|P2|NOT COMPLETED|Overall Study||12
1583210|NCT01096849|3873676|P1|NOT COMPLETED|Overall Study||2
1583211|NCT01096849|3873674|P3|COMPLETED|Overall Study||41
1583212|NCT01096849|3873675|P2|COMPLETED|Overall Study||64
1583213|NCT01096849|3873676|P1|COMPLETED|Overall Study||20
1583214|NCT01096849|3873674|P3|STARTED|Overall Study||47
1583215|NCT01096849|3873675|P2|STARTED|Overall Study||76
1583216|NCT01096849|3873676|P1|STARTED|Overall Study||22
1583217|NCT01096823|3873731|P2|NOT COMPLETED|Overall Study||1
1583218|NCT01096823|3873732|P1|NOT COMPLETED|Overall Study||3
1583219|NCT01096823|3873731|P2|COMPLETED|Overall Study||15
1583220|NCT01096823|3873732|P1|COMPLETED|Overall Study||11
1583221|NCT01096823|3873731|P2|STARTED|Overall Study||16
1583222|NCT01096823|3873732|P1|STARTED|Overall Study||14
1583223|NCT01096810|3873744|P1|NOT COMPLETED|Overall Study||0
1583224|NCT01096810|3873744|P1|COMPLETED|Overall Study||20
1583225|NCT01096810|3873744|P1|STARTED|Overall Study||20
1583226|NCT01096784|3873752|P2|NOT COMPLETED|Overall Study||14
1583227|NCT01096784|3873753|P1|NOT COMPLETED|Overall Study||15
1583228|NCT01096784|3873752|P2|COMPLETED|Overall Study||46
1583229|NCT01096784|3873753|P1|COMPLETED|Overall Study||46
1583230|NCT01096784|3873752|P2|STARTED|Overall Study||60
1583231|NCT01096784|3873753|P1|STARTED|Overall Study||61
1583232|NCT01096771|3873787|P2|NOT COMPLETED|Overall Study||0
1583233|NCT01096771|3873788|P1|NOT COMPLETED|Overall Study||0
1583234|NCT01096771|3873787|P2|COMPLETED|Overall Study||7
1583235|NCT01096771|3873788|P1|COMPLETED|Overall Study||7
1583236|NCT01096771|3873787|P2|STARTED|Overall Study||7
1583237|NCT01096771|3873788|P1|STARTED|Overall Study||7
1583238|NCT01096680|3873817|P5|NOT COMPLETED|Overall Study||0
1583239|NCT01096680|3873818|P4|NOT COMPLETED|Overall Study||0
1583240|NCT01096680|3873819|P3|NOT COMPLETED|Overall Study||0
1583241|NCT01096680|3873820|P2|NOT COMPLETED|Overall Study||0
1583242|NCT01096680|3873821|P1|NOT COMPLETED|Overall Study||0
1583243|NCT01096680|3873817|P5|COMPLETED|Overall Study||27
1583244|NCT01096680|3873818|P4|COMPLETED|Overall Study||27
1583245|NCT01096680|3873819|P3|COMPLETED|Overall Study||27
1583246|NCT01096680|3873820|P2|COMPLETED|Overall Study||27
1583247|NCT01096680|3873821|P1|COMPLETED|Overall Study||27
1583248|NCT01096680|3873817|P5|STARTED|Overall Study||27
1583249|NCT01096680|3873818|P4|STARTED|Overall Study||27
1583250|NCT01096680|3873819|P3|STARTED|Overall Study||27
1583251|NCT01096680|3873820|P2|STARTED|Overall Study||27
1583252|NCT01096680|3873821|P1|STARTED|Overall Study||27
1583253|NCT01096667|3873858|P5|NOT COMPLETED|Overall Study||0
1583254|NCT01096667|3873859|P4|NOT COMPLETED|Overall Study||3
1583255|NCT01096667|3873860|P3|NOT COMPLETED|Overall Study||2
1583256|NCT01096667|3873861|P2|NOT COMPLETED|Overall Study||2
1583257|NCT01096667|3873862|P1|NOT COMPLETED|Overall Study||3
1583258|NCT01096667|3873858|P5|COMPLETED|Overall Study||39
1583259|NCT01096667|3873859|P4|COMPLETED|Overall Study||36
1583260|NCT01096667|3873860|P3|COMPLETED|Overall Study||36
1583261|NCT01096667|3873861|P2|COMPLETED|Overall Study||37
1583262|NCT01096667|3873862|P1|COMPLETED|Overall Study||36
1583263|NCT01096667|3873858|P5|Treated|Overall Study||39
1583264|NCT01096667|3873859|P4|Treated|Overall Study||39
1583265|NCT01096667|3873860|P3|Treated|Overall Study||38
1583266|NCT01096667|3873861|P2|Treated|Overall Study||39
1583267|NCT01096667|3873862|P1|Treated|Overall Study||38
1583268|NCT01096667|3873858|P5|STARTED|Overall Study||39
1583269|NCT01096667|3873859|P4|STARTED|Overall Study||39
1583270|NCT01096667|3873860|P3|STARTED|Overall Study||38
1583271|NCT01096667|3873861|P2|STARTED|Overall Study||39
1583272|NCT01096667|3873862|P1|STARTED|Overall Study||39
1583273|NCT01096589|3874004|P4|NOT COMPLETED|Overall Study||3
1583274|NCT01096589|3874005|P3|NOT COMPLETED|Overall Study||4
1583275|NCT01096589|3874006|P2|NOT COMPLETED|Overall Study||2
1583276|NCT01096589|3874007|P1|NOT COMPLETED|Overall Study||4
1583277|NCT01096589|3874004|P4|COMPLETED|Overall Study||15
1583278|NCT01096589|3874005|P3|COMPLETED|Overall Study||18
1583279|NCT01096589|3874006|P2|COMPLETED|Overall Study||18
1583280|NCT01096589|3874007|P1|COMPLETED|Overall Study||18
1583281|NCT01096589|3874004|P4|STARTED|Overall Study||18
1583282|NCT01096589|3874005|P3|STARTED|Overall Study||22
1583283|NCT01096589|3874006|P2|STARTED|Overall Study||20
1583284|NCT01096589|3874007|P1|STARTED|Overall Study||22
1583285|NCT01096550|3874023|P2|NOT COMPLETED|Overall Study||29
1583286|NCT01096550|3874024|P1|NOT COMPLETED|Overall Study||37
1583287|NCT01096550|3874023|P2|COMPLETED|Overall Study||146
1583288|NCT01096550|3874024|P1|COMPLETED|Overall Study||133
1583289|NCT01096550|3874023|P2|STARTED|Overall Study||175
1583290|NCT01096550|3874024|P1|STARTED|Overall Study||170
1583291|NCT01096446|3874032|P2|NOT COMPLETED|Overall Study||0
1583292|NCT01096446|3874033|P1|NOT COMPLETED|Overall Study||3
1583293|NCT01096446|3874032|P2|COMPLETED|Overall Study||10
1583294|NCT01096446|3874033|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
1583295|NCT01096446|3874032|P2|STARTED|Overall Study||10
1583296|NCT01096446|3874033|P1|STARTED|Overall Study||12
1583297|NCT01096342|3874038|P1|NOT COMPLETED|Overall Study||1
1583298|NCT01096342|3874038|P1|COMPLETED|Overall Study||15
1583299|NCT01096342|3874038|P1|STARTED|Overall Study||16
1583300|NCT01096316|3874046|P2|NOT COMPLETED|Overall Study||9
1583301|NCT01096316|3874047|P1|NOT COMPLETED|Overall Study||15
1583302|NCT01096316|3874046|P2|COMPLETED|Overall Study||94
1583303|NCT01096316|3874047|P1|COMPLETED|Overall Study||87
1583304|NCT01096316|3874046|P2|STARTED|Overall Study||103
1583305|NCT01096316|3874047|P1|STARTED|Overall Study||102
1583306|NCT01096186|3874057|P1|NOT COMPLETED|Overall Study||50
1583307|NCT01096186|3874057|P1|COMPLETED|Overall Study||567
1583308|NCT01096186|3874057|P1|STARTED|Overall Study||617
1583309|NCT01096056|3874065|P2|NOT COMPLETED|Overall Study||1
1583310|NCT01096056|3874066|P1|NOT COMPLETED|Overall Study||0
1583311|NCT01096056|3874065|P2|COMPLETED|Overall Study||19
1583312|NCT01096056|3874066|P1|COMPLETED|Overall Study||20
1583313|NCT01096056|3874065|P2|Completed at Day 42|Overall Study||20
1583314|NCT01096056|3874066|P1|Completed at Day 42|Overall Study||20
1583315|NCT01096056|3874065|P2|STARTED|Overall Study||20
1583316|NCT01096056|3874066|P1|STARTED|Overall Study||20
1583317|NCT01096017|3874098|P2|NOT COMPLETED|Treatment Period 2||1
1583318|NCT01096017|3874099|P1|NOT COMPLETED|Treatment Period 2||1
1583319|NCT01096017|3874098|P2|COMPLETED|Treatment Period 2||11
1583320|NCT01096017|3874099|P1|COMPLETED|Treatment Period 2||11
1583321|NCT01096017|3874098|P2|STARTED|Treatment Period 2||12
1583322|NCT01096017|3874099|P1|STARTED|Treatment Period 2||12
1583323|NCT01096017|3874098|P2|NOT COMPLETED|Washout 1 - 14 Days||0
1583324|NCT01096017|3874099|P1|NOT COMPLETED|Washout 1 - 14 Days||0
1583325|NCT01096017|3874098|P2|COMPLETED|Washout 1 - 14 Days||12
1583326|NCT01096017|3874099|P1|COMPLETED|Washout 1 - 14 Days||12
1583327|NCT01096017|3874098|P2|STARTED|Washout 1 - 14 Days||12
1583328|NCT01096017|3874099|P1|STARTED|Washout 1 - 14 Days||12
1583329|NCT01096017|3874098|P2|NOT COMPLETED|Treatment Period 1||0
1583330|NCT01096017|3874099|P1|NOT COMPLETED|Treatment Period 1||0
1583331|NCT01096017|3874098|P2|COMPLETED|Treatment Period 1||12
1583332|NCT01096017|3874099|P1|COMPLETED|Treatment Period 1||12
1583333|NCT01096017|3874098|P2|STARTED|Treatment Period 1||12
1583334|NCT01096017|3874099|P1|STARTED|Treatment Period 1||12
1583335|NCT01095978|3874127|P1|NOT COMPLETED|Overall Study||3
1583336|NCT01095978|3874127|P1|COMPLETED|Overall Study||2819
1583337|NCT01095978|3874127|P1|STARTED|Overall Study||2822
1583338|NCT01095887|3874154|P1|NOT COMPLETED|Overall Study||0
1583339|NCT01095887|3874154|P1|COMPLETED|Overall Study||6
1583340|NCT01095887|3874154|P1|STARTED|Overall Study||6
1583341|NCT01095835|3874161|P3|NOT COMPLETED|Overall Study||8
1583342|NCT01095835|3874162|P2|NOT COMPLETED|Overall Study||12
1583343|NCT01095835|3874163|P1|NOT COMPLETED|Overall Study||10
1583344|NCT01095835|3874161|P3|COMPLETED|Overall Study||17
1583345|NCT01095835|3874162|P2|COMPLETED|Overall Study||40
1583346|NCT01095835|3874163|P1|COMPLETED|Overall Study||41
1583347|NCT01095835|3874161|P3|STARTED|Overall Study||25
1583348|NCT01095835|3874162|P2|STARTED|Overall Study||52
1583349|NCT01095835|3874163|P1|STARTED|Overall Study||51
1583350|NCT01095796|3874201|P2|NOT COMPLETED|Overall Study||289
1583351|NCT01095796|3874202|P1|NOT COMPLETED|Overall Study||295
1583352|NCT01095796|3874201|P2|COMPLETED|Overall Study||65
1583353|NCT01095796|3874202|P1|COMPLETED|Overall Study||58
1583354|NCT01095796|3874201|P2|STARTED|Overall Study||354
1583355|NCT01095796|3874202|P1|STARTED|Overall Study||353
1583356|NCT01095757|3874220|P1|NOT COMPLETED|Overall Study||0
1583357|NCT01095757|3874220|P1|COMPLETED|Overall Study||45
1583358|NCT01095757|3874220|P1|STARTED|Overall Study||45
1583359|NCT01095666|3874232|P3|NOT COMPLETED|Overall Study||7
1583360|NCT01095666|3874233|P2|NOT COMPLETED|Overall Study||11
1583361|NCT01095666|3874234|P1|NOT COMPLETED|Overall Study||17
1583362|NCT01095666|3874232|P3|COMPLETED|Overall Study||145
1583363|NCT01095666|3874233|P2|COMPLETED|Overall Study||136
1583364|NCT01095666|3874234|P1|COMPLETED|Overall Study||128
1583365|NCT01095666|3874232|P3|STARTED|Overall Study||152
1583366|NCT01095666|3874233|P2|STARTED|Overall Study||147
1583367|NCT01095666|3874234|P1|STARTED|Overall Study||145
1583368|NCT01095653|3874257|P3|NOT COMPLETED|Overall Study||16
1583369|NCT01095653|3874258|P2|NOT COMPLETED|Overall Study||15
1583370|NCT01095653|3874259|P1|NOT COMPLETED|Overall Study||19
1583371|NCT01095653|3874257|P3|COMPLETED|Overall Study||117
1583372|NCT01095653|3874258|P2|COMPLETED|Overall Study||113
1583373|NCT01095653|3874259|P1|COMPLETED|Overall Study||113
1583374|NCT01095653|3874257|P3|STARTED|Overall Study||133
1583375|NCT01095653|3874258|P2|STARTED|Overall Study||128
1583376|NCT01095653|3874259|P1|STARTED|Overall Study||132
1583377|NCT01095510|3874282|P4|NOT COMPLETED|Overall Study||0
1583378|NCT01095510|3874283|P3|NOT COMPLETED|Overall Study||0
1583379|NCT01095510|3874284|P2|NOT COMPLETED|Overall Study||0
1583380|NCT01095510|3874285|P1|NOT COMPLETED|Overall Study||0
1583381|NCT01095510|3874282|P4|COMPLETED|Overall Study||3
1583382|NCT01095510|3874283|P3|COMPLETED|Overall Study||3
1583383|NCT01095510|3874284|P2|COMPLETED|Overall Study||0
1583384|NCT01095510|3874285|P1|COMPLETED|Overall Study||3
1583385|NCT01095510|3874282|P4|STARTED|Overall Study||3
1583386|NCT01095510|3874283|P3|STARTED|Overall Study||3
1583387|NCT01095510|3874284|P2|STARTED|Overall Study||0
1583388|NCT01095510|3874285|P1|STARTED|Overall Study||3
1583389|NCT01095497|3874304|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
1583390|NCT01095497|3874305|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
1583391|NCT01095497|3874304|P2|COMPLETED|Subcutaneous CINRYZE||12
1583392|NCT01095497|3874305|P1|COMPLETED|Subcutaneous CINRYZE||12
1583393|NCT01095497|3874304|P2|STARTED|Subcutaneous CINRYZE||12
1583394|NCT01095497|3874305|P1|STARTED|Subcutaneous CINRYZE||13
1583395|NCT01095497|3874304|P2|NOT COMPLETED|Intravenous CINRYZE||0
1583396|NCT01095497|3874305|P1|NOT COMPLETED|Intravenous CINRYZE||1
1583397|NCT01095497|3874304|P2|COMPLETED|Intravenous CINRYZE||12
1583398|NCT01095497|3874305|P1|COMPLETED|Intravenous CINRYZE||13
1583399|NCT01095497|3874304|P2|STARTED|Intravenous CINRYZE||12
1583400|NCT01095497|3874305|P1|STARTED|Intravenous CINRYZE||14
1583401|NCT01095250|3874317|P4|NOT COMPLETED|Overall Study||5
1583402|NCT01095250|3874318|P3|NOT COMPLETED|Overall Study||8
1583403|NCT01095250|3874319|P2|NOT COMPLETED|Overall Study||10
1583404|NCT01095250|3874320|P1|NOT COMPLETED|Overall Study||8
1583405|NCT01095250|3874317|P4|COMPLETED|Overall Study||0
1583406|NCT01095250|3874318|P3|COMPLETED|Overall Study||0
1583407|NCT01095250|3874319|P2|COMPLETED|Overall Study||0
1583408|NCT01095250|3874320|P1|COMPLETED|Overall Study||0
1583409|NCT01095250|3874317|P4|STARTED|Overall Study||5
1583410|NCT01095250|3874318|P3|STARTED|Overall Study||8
1583411|NCT01095250|3874319|P2|STARTED|Overall Study||10
1583412|NCT01095250|3874320|P1|STARTED|Overall Study||8
1583413|NCT01095094|3874350|P1|NOT COMPLETED|Overall Study||3
1583414|NCT01095094|3874350|P1|COMPLETED|Overall Study||16
1583415|NCT01095094|3874350|P1|STARTED|Overall Study||19
1583416|NCT01094886|3874355|P1|NOT COMPLETED|Overall Study||7
1583417|NCT01094886|3874355|P1|COMPLETED|Overall Study||46
1583418|NCT01094886|3874355|P1|STARTED|Overall Study||53
1583419|NCT01094808|3874365|P3|NOT COMPLETED|Overall Study||0
1583420|NCT01094808|3874366|P2|NOT COMPLETED|Overall Study||1
1583421|NCT01094808|3874367|P1|NOT COMPLETED|Overall Study||1
1583422|NCT01094808|3874365|P3|COMPLETED|Overall Study||21
1583423|NCT01094808|3874366|P2|COMPLETED|Overall Study||19
1583424|NCT01094808|3874367|P1|COMPLETED|Overall Study||20
1583425|NCT01094808|3874365|P3|STARTED|Overall Study||21
1583426|NCT01094808|3874366|P2|STARTED|Overall Study||20
1583427|NCT01094808|3874367|P1|STARTED|Overall Study||21
1583428|NCT01094782|3874408|P6|NOT COMPLETED|Overall Study||8
1583429|NCT01094782|3874409|P5|NOT COMPLETED|Overall Study||11
1583430|NCT01094782|3874410|P4|NOT COMPLETED|Overall Study||11
1583431|NCT01094782|3874411|P3|NOT COMPLETED|Overall Study||3
1583432|NCT01094782|3874412|P2|NOT COMPLETED|Overall Study||10
1583433|NCT01094782|3874413|P1|NOT COMPLETED|Overall Study||8
1583434|NCT01094782|3874408|P6|COMPLETED|Overall Study||30
1583435|NCT01094782|3874409|P5|COMPLETED|Overall Study||31
1583436|NCT01094782|3874410|P4|COMPLETED|Overall Study||45
1583437|NCT01094782|3874411|P3|COMPLETED|Overall Study||31
1583438|NCT01094782|3874412|P2|COMPLETED|Overall Study||29
1583439|NCT01094782|3874413|P1|COMPLETED|Overall Study||31
1583440|NCT01094782|3874408|P6|STARTED|Overall Study||38
1583441|NCT01094782|3874409|P5|STARTED|Overall Study||42
1583442|NCT01094782|3874410|P4|STARTED|Overall Study||56
1583443|NCT01094782|3874411|P3|STARTED|Overall Study||34
1583444|NCT01094782|3874412|P2|STARTED|Overall Study||39
1583445|NCT01094782|3874413|P1|STARTED|Overall Study||39
1583446|NCT01094743|3874457|P1|NOT COMPLETED|Period 2||0
1583447|NCT01094743|3874457|P1|COMPLETED|Period 2||50
1583448|NCT01094743|3874457|P1|STARTED|Period 2||50
1583449|NCT01094743|3874457|P1|NOT COMPLETED|Period 1||2
1583450|NCT01094743|3874457|P1|COMPLETED|Period 1||50
1583451|NCT01094743|3874457|P1|STARTED|Period 1||52
1583452|NCT01094730|3874474|P2|NOT COMPLETED|Period 2 (14 Days)||2
1583453|NCT01094730|3874475|P1|NOT COMPLETED|Period 2 (14 Days)||3
1583454|NCT01094730|3874474|P2|COMPLETED|Period 2 (14 Days)||84
1583455|NCT01094730|3874475|P1|COMPLETED|Period 2 (14 Days)||87
1583456|NCT01094730|3874474|P2|STARTED|Period 2 (14 Days)||86
1583457|NCT01094730|3874475|P1|STARTED|Period 2 (14 Days)||90
1583458|NCT01094730|3874474|P2|NOT COMPLETED|Period 1 (14 Days)||2
1583459|NCT01094730|3874475|P1|NOT COMPLETED|Period 1 (14 Days)||2
1583460|NCT01094730|3874474|P2|COMPLETED|Period 1 (14 Days)||86
1583461|NCT01094730|3874475|P1|COMPLETED|Period 1 (14 Days)||90
1583462|NCT01094730|3874474|P2|STARTED|Period 1 (14 Days)||88
1583463|NCT01094730|3874475|P1|STARTED|Period 1 (14 Days)||92
1583464|NCT01094704|3874488|P2|NOT COMPLETED|Overall Study||0
1583465|NCT01094704|3874489|P1|NOT COMPLETED|Overall Study||0
1583466|NCT01094704|3874488|P2|COMPLETED|Overall Study||8
1583467|NCT01094704|3874489|P1|COMPLETED|Overall Study||8
1583468|NCT01094704|3874488|P2|STARTED|Overall Study||8
1583469|NCT01094704|3874489|P1|STARTED|Overall Study||8
1583470|NCT01094574|3874501|P6|NOT COMPLETED|Overall Study||0
1583471|NCT01094574|3874502|P5|NOT COMPLETED|Overall Study||0
1583472|NCT01094574|3874503|P4|NOT COMPLETED|Overall Study||0
1583473|NCT01094574|3874504|P3|NOT COMPLETED|Overall Study||0
1583474|NCT01094574|3874505|P2|NOT COMPLETED|Overall Study||0
1583475|NCT01094574|3874506|P1|NOT COMPLETED|Overall Study||0
1583476|NCT01094574|3874501|P6|COMPLETED|Overall Study||2
1583477|NCT01094574|3874502|P5|COMPLETED|Overall Study||2
1583478|NCT01094574|3874503|P4|COMPLETED|Overall Study||2
1583479|NCT01094574|3874504|P3|COMPLETED|Overall Study||2
1583480|NCT01094574|3874505|P2|COMPLETED|Overall Study||1
1583481|NCT01094574|3874506|P1|COMPLETED|Overall Study||1
1583482|NCT01094574|3874501|P6|STARTED|Overall Study||2
1583483|NCT01094574|3874502|P5|STARTED|Overall Study||2
1583484|NCT01094574|3874503|P4|STARTED|Overall Study||2
1583485|NCT01094574|3874504|P3|STARTED|Overall Study||2
1583486|NCT01094574|3874505|P2|STARTED|Overall Study||1
1583487|NCT01094574|3874506|P1|STARTED|Overall Study||1
1583488|NCT01094561|3874553|P1|NOT COMPLETED|Overall Study||6
1583489|NCT01094561|3874553|P1|COMPLETED|Overall Study||17
1583490|NCT01094561|3874553|P1|STARTED|Overall Study||23
1583491|NCT01094548|3874560|P2|NOT COMPLETED|Overall Study||0
1583492|NCT01094548|3874561|P1|NOT COMPLETED|Overall Study||0
1583493|NCT01094548|3874560|P2|COMPLETED|Overall Study||17
1583494|NCT01094548|3874561|P1|COMPLETED|Overall Study||17
1583495|NCT01094548|3874560|P2|STARTED|Overall Study||17
1583496|NCT01094548|3874561|P1|STARTED|Overall Study||17
1583497|NCT01094522|3874581|P2|NOT COMPLETED|Overall Study||0
1583498|NCT01094522|3874582|P1|NOT COMPLETED|Overall Study||0
1583499|NCT01094522|3874581|P2|COMPLETED|Overall Study||20
1583500|NCT01094522|3874582|P1|COMPLETED|Overall Study||20
1583501|NCT01094522|3874581|P2|STARTED|Overall Study||20
1583502|NCT01094522|3874582|P1|STARTED|Overall Study||20
1583503|NCT01094301|3874592|P1|NOT COMPLETED|Implant Stage||8
1583504|NCT01094301|3874592|P1|COMPLETED|Implant Stage||5
1583505|NCT01094301|3874592|P1|Subjects Who Received SPR IPG|Implant Stage||5
1583506|NCT01094301|3874592|P1|Met Criteria for Implant Stage|Implant Stage||7
1583507|NCT01094301|3874592|P1|STARTED|Implant Stage||13
1583508|NCT01094301|3874592|P1|NOT COMPLETED|Trial Stage||1
1583509|NCT01094301|3874592|P1|COMPLETED|Trial Stage||27
1583510|NCT01094301|3874592|P1|Subjects Who Received Smartpatch Lead|Trial Stage||28
1583511|NCT01094301|3874592|P1|STARTED|Trial Stage||28
1583512|NCT01094184|3874616|P2|NOT COMPLETED|Overall Study||11
1583513|NCT01094184|3874617|P1|NOT COMPLETED|Overall Study||35
1583514|NCT01094184|3874616|P2|COMPLETED|Overall Study||2
1583515|NCT01094184|3874617|P1|COMPLETED|Overall Study||1
1583516|NCT01094184|3874616|P2|STARTED|Overall Study||13
1583517|NCT01094184|3874617|P1|STARTED|Overall Study||36
1583518|NCT01094171|3874851|P1|NOT COMPLETED|Overall Study||10
1583519|NCT01094171|3874851|P1|COMPLETED|Overall Study||390
1583520|NCT01094171|3874851|P1|STARTED|Overall Study||400
1583521|NCT01094119|3874860|P2|NOT COMPLETED|Overall Study||4
1583522|NCT01094119|3874861|P1|NOT COMPLETED|Overall Study||2
1583523|NCT01094119|3874860|P2|COMPLETED|Overall Study||32
1583524|NCT01094119|3874861|P1|COMPLETED|Overall Study||32
1583525|NCT01094119|3874860|P2|STARTED|Overall Study||36
1583526|NCT01094119|3874861|P1|STARTED|Overall Study||34
1583527|NCT01093976|3874869|P1|NOT COMPLETED|Overall Study||0
1583528|NCT01093976|3874869|P1|COMPLETED|Overall Study||14
1583529|NCT01093976|3874869|P1|STARTED|Overall Study||14
1583530|NCT01093885|3874873|P1|NOT COMPLETED|Overall Study||5
1583531|NCT01093885|3874873|P1|COMPLETED|Overall Study||10
1583532|NCT01093885|3874873|P1|STARTED|Overall Study||15
1583533|NCT01093846|3874881|P3|NOT COMPLETED|Overall Study||21
1583534|NCT01093846|3874882|P2|NOT COMPLETED|Overall Study||18
1583535|NCT01093846|3874883|P1|NOT COMPLETED|Overall Study||19
1583536|NCT01093846|3874881|P3|COMPLETED|Overall Study||1
1583537|NCT01093846|3874882|P2|COMPLETED|Overall Study||0
1583538|NCT01093846|3874883|P1|COMPLETED|Overall Study||0
1583539|NCT01093846|3874881|P3|STARTED|Overall Study||22
1583540|NCT01093846|3874882|P2|STARTED|Overall Study||18
1583541|NCT01093846|3874883|P1|STARTED|Overall Study||19
1583542|NCT01093794|3874889|P4|NOT COMPLETED|Treatment Period 4||0
1583543|NCT01093794|3874890|P3|NOT COMPLETED|Treatment Period 4||0
1583544|NCT01093794|3874891|P2|NOT COMPLETED|Treatment Period 4||0
1583545|NCT01093794|3874892|P1|NOT COMPLETED|Treatment Period 4||0
1583546|NCT01093794|3874889|P4|COMPLETED|Treatment Period 4||7
1583547|NCT01093794|3874890|P3|COMPLETED|Treatment Period 4||6
1583548|NCT01093794|3874891|P2|COMPLETED|Treatment Period 4||7
1583549|NCT01093794|3874892|P1|COMPLETED|Treatment Period 4||7
1583550|NCT01093794|3874889|P4|STARTED|Treatment Period 4||7
1583551|NCT01093794|3874890|P3|STARTED|Treatment Period 4||6
1583552|NCT01093794|3874891|P2|STARTED|Treatment Period 4||7
1583553|NCT01093794|3874892|P1|STARTED|Treatment Period 4||7
1583554|NCT01093794|3874889|P4|NOT COMPLETED|Treatment Period 3||0
1583555|NCT01093794|3874890|P3|NOT COMPLETED|Treatment Period 3||0
1583556|NCT01093794|3874891|P2|NOT COMPLETED|Treatment Period 3||0
1583557|NCT01093794|3874892|P1|NOT COMPLETED|Treatment Period 3||0
1583558|NCT01093794|3874889|P4|COMPLETED|Treatment Period 3||7
1583559|NCT01093794|3874890|P3|COMPLETED|Treatment Period 3||6
1583560|NCT01093794|3874891|P2|COMPLETED|Treatment Period 3||7
1583561|NCT01093794|3874892|P1|COMPLETED|Treatment Period 3||7
1583562|NCT01093794|3874889|P4|STARTED|Treatment Period 3||7
1583563|NCT01093794|3874890|P3|STARTED|Treatment Period 3||6
1583564|NCT01093794|3874891|P2|STARTED|Treatment Period 3||7
1583565|NCT01093794|3874892|P1|STARTED|Treatment Period 3||7
1583566|NCT01093794|3874889|P4|NOT COMPLETED|Treatment Period 2||0
1583567|NCT01093794|3874890|P3|NOT COMPLETED|Treatment Period 2||0
1583568|NCT01093794|3874891|P2|NOT COMPLETED|Treatment Period 2||0
1583569|NCT01093794|3874892|P1|NOT COMPLETED|Treatment Period 2||0
1583570|NCT01093794|3874889|P4|COMPLETED|Treatment Period 2||7
1583571|NCT01093794|3874890|P3|COMPLETED|Treatment Period 2||6
1583572|NCT01093794|3874891|P2|COMPLETED|Treatment Period 2||7
1583573|NCT01093794|3874892|P1|COMPLETED|Treatment Period 2||7
1583574|NCT01093794|3874889|P4|STARTED|Treatment Period 2||7
1583575|NCT01093794|3874890|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
1583576|NCT01093794|3874891|P2|STARTED|Treatment Period 2||7
1583577|NCT01093794|3874892|P1|STARTED|Treatment Period 2||7
1583578|NCT01093794|3874889|P4|NOT COMPLETED|Treatment Period 1||0
1583579|NCT01093794|3874890|P3|NOT COMPLETED|Treatment Period 1||0
1583580|NCT01093794|3874891|P2|NOT COMPLETED|Treatment Period 1||0
1583581|NCT01093794|3874892|P1|NOT COMPLETED|Treatment Period 1||0
1583582|NCT01093794|3874889|P4|COMPLETED|Treatment Period 1||7
1583583|NCT01093794|3874890|P3|COMPLETED|Treatment Period 1||7
1583584|NCT01093794|3874891|P2|COMPLETED|Treatment Period 1||7
1583585|NCT01093794|3874892|P1|COMPLETED|Treatment Period 1||7
1583586|NCT01093794|3874889|P4|STARTED|Treatment Period 1||7
1583587|NCT01093794|3874890|P3|STARTED|Treatment Period 1||7
1583588|NCT01093794|3874891|P2|STARTED|Treatment Period 1||7
1583589|NCT01093794|3874892|P1|STARTED|Treatment Period 1||7
1583590|NCT01093755|3874908|P2|NOT COMPLETED|Overall Study||4
1583591|NCT01093755|3874909|P1|NOT COMPLETED|Overall Study||3
1583592|NCT01093755|3874908|P2|COMPLETED|Overall Study||10
1583593|NCT01093755|3874909|P1|COMPLETED|Overall Study||13
1583594|NCT01093755|3874908|P2|STARTED|Overall Study||14
1583595|NCT01093755|3874909|P1|STARTED|Overall Study||16
1583596|NCT01093690|3874919|P2|NOT COMPLETED|Overall Study||0
1583597|NCT01093690|3874920|P1|NOT COMPLETED|Overall Study||0
1583598|NCT01093690|3874919|P2|COMPLETED|Overall Study||79
1583599|NCT01093690|3874920|P1|COMPLETED|Overall Study||83
1583600|NCT01093690|3874919|P2|STARTED|Overall Study||79
1583601|NCT01093690|3874920|P1|STARTED|Overall Study||83
1583602|NCT01093651|3874928|P2|NOT COMPLETED|Overall Study||0
1583603|NCT01093651|3874929|P1|NOT COMPLETED|Overall Study||0
1583604|NCT01093651|3874928|P2|COMPLETED|Overall Study||10
1583605|NCT01093651|3874929|P1|COMPLETED|Overall Study||10
1583606|NCT01093651|3874928|P2|STARTED|Overall Study||10
1583607|NCT01093651|3874929|P1|STARTED|Overall Study||10
1583608|NCT01093625|3874949|P2|NOT COMPLETED|1-Year Visit||3
1583609|NCT01093625|3874950|P1|NOT COMPLETED|1-Year Visit||5
1583610|NCT01093625|3874949|P2|COMPLETED|1-Year Visit||37
1583611|NCT01093625|3874950|P1|COMPLETED|1-Year Visit||29
1583612|NCT01093625|3874949|P2|STARTED|1-Year Visit||40
1583613|NCT01093625|3874950|P1|STARTED|1-Year Visit||34
1583614|NCT01093625|3874949|P2|NOT COMPLETED|6-Month Visit||9
1583615|NCT01093625|3874950|P1|NOT COMPLETED|6-Month Visit||8
1583616|NCT01093625|3874949|P2|COMPLETED|6-Month Visit||40
1583617|NCT01093625|3874950|P1|COMPLETED|6-Month Visit||34
1583618|NCT01093625|3874949|P2|STARTED|6-Month Visit||49
1583619|NCT01093625|3874950|P1|STARTED|6-Month Visit||42
1583620|NCT01093625|3874949|P2|NOT COMPLETED|3-Month Visit||0
1583621|NCT01093625|3874950|P1|NOT COMPLETED|3-Month Visit||2
1583622|NCT01093625|3874949|P2|COMPLETED|3-Month Visit||49
1583623|NCT01093625|3874950|P1|COMPLETED|3-Month Visit||42
1583624|NCT01093625|3874949|P2|STARTED|3-Month Visit||49
1583625|NCT01093625|3874950|P1|STARTED|3-Month Visit||44
1583626|NCT01093625|3874949|P2|NOT COMPLETED|1-Month Visit||0
1583627|NCT01093625|3874950|P1|NOT COMPLETED|1-Month Visit||2
1583628|NCT01093625|3874949|P2|COMPLETED|1-Month Visit||49
1583629|NCT01093625|3874950|P1|COMPLETED|1-Month Visit||44
1583630|NCT01093625|3874949|P2|STARTED|1-Month Visit||49
1583631|NCT01093625|3874950|P1|STARTED|1-Month Visit||46
1583632|NCT01093625|3874949|P2|NOT COMPLETED|2-Week Visit||0
1583633|NCT01093625|3874950|P1|NOT COMPLETED|2-Week Visit||1
1583634|NCT01093625|3874949|P2|COMPLETED|2-Week Visit||49
1583635|NCT01093625|3874950|P1|COMPLETED|2-Week Visit||46
1583636|NCT01093625|3874949|P2|STARTED|2-Week Visit||49
1583637|NCT01093625|3874950|P1|STARTED|2-Week Visit||47
1583638|NCT01093625|3874949|P2|NOT COMPLETED|Baseline and Dispensed||0
1583639|NCT01093625|3874950|P1|NOT COMPLETED|Baseline and Dispensed||2
1583640|NCT01093625|3874949|P2|COMPLETED|Baseline and Dispensed||49
1583641|NCT01093625|3874950|P1|COMPLETED|Baseline and Dispensed||47
1583642|NCT01093625|3874949|P2|STARTED|Baseline and Dispensed||49
1583643|NCT01093625|3874950|P1|STARTED|Baseline and Dispensed||49
1583644|NCT01093599|3874970|P2|NOT COMPLETED|Overall Study||46
1583645|NCT01093599|3874971|P1|NOT COMPLETED|Overall Study||32
1583646|NCT01093599|3874970|P2|COMPLETED|Overall Study||59
1583647|NCT01093599|3874971|P1|COMPLETED|Overall Study||59
1583648|NCT01093599|3874970|P2|STARTED|Overall Study||105
1583649|NCT01093599|3874971|P1|STARTED|Overall Study||91
1583650|NCT01093534|3874980|P3|NOT COMPLETED|Overall Study||9
1583651|NCT01093534|3874981|P2|NOT COMPLETED|Overall Study||16
1583652|NCT01093534|3874982|P1|NOT COMPLETED|Overall Study||10
1583653|NCT01093534|3874980|P3|COMPLETED|Overall Study||169
1583654|NCT01093534|3874981|P2|COMPLETED|Overall Study||167
1583655|NCT01093534|3874982|P1|COMPLETED|Overall Study||176
1583656|NCT01093534|3874980|P3|Received Study Treatment|Overall Study||175
1583657|NCT01093534|3874981|P2|Received Study Treatment|Overall Study||182
1583658|NCT01093534|3874982|P1|Received Study Treatment|Overall Study||186
1583659|NCT01093534|3874980|P3|STARTED|Overall Study||178
1583660|NCT01093534|3874981|P2|STARTED|Overall Study||183
1583661|NCT01093534|3874982|P1|STARTED|Overall Study||186
1583662|NCT01093521|3875087|P1|NOT COMPLETED|Overall Study||0
1583663|NCT01093521|3875087|P1|COMPLETED|Overall Study||20
1583664|NCT01093521|3875087|P1|STARTED|Overall Study||20
1583665|NCT01093482|3875102|P1|NOT COMPLETED|Overall Study||0
1583666|NCT01093482|3875102|P1|COMPLETED|Overall Study||8151
1583667|NCT01093482|3875102|P1|STARTED|Overall Study||8151
1583668|NCT01093469|3875109|P3|NOT COMPLETED|Overall Study||1
1583669|NCT01093469|3875110|P2|NOT COMPLETED|Overall Study||0
1583670|NCT01093469|3875111|P1|NOT COMPLETED|Overall Study||0
1583671|NCT01093469|3875109|P3|COMPLETED|Overall Study||12
1583672|NCT01093469|3875110|P2|COMPLETED|Overall Study||13
1583673|NCT01093469|3875111|P1|COMPLETED|Overall Study||13
1583674|NCT01093469|3875109|P3|STARTED|Overall Study||13
1583675|NCT01093469|3875110|P2|STARTED|Overall Study||13
1583676|NCT01093469|3875111|P1|STARTED|Overall Study||13
1583677|NCT01093417|3875121|P2|NOT COMPLETED|Overall Study||1
1583678|NCT01093417|3875122|P1|NOT COMPLETED|Overall Study||0
1583679|NCT01093417|3875121|P2|COMPLETED|Overall Study||29
1583680|NCT01093417|3875122|P1|COMPLETED|Overall Study||15
1583681|NCT01093417|3875121|P2|STARTED|Overall Study||30
1583682|NCT01093417|3875122|P1|STARTED|Overall Study||15
1583683|NCT01093222|3875130|P1|NOT COMPLETED|Overall Study||40
1583684|NCT01093222|3875130|P1|COMPLETED|Overall Study||0
1583685|NCT01093222|3875130|P1|Eligible and Began Protocol Therapy|Overall Study||34
1583686|NCT01093222|3875130|P1|STARTED|Overall Study||40
1583687|NCT01093183|3875137|P2|NOT COMPLETED|Overall Study||2
1583688|NCT01093183|3875138|P1|NOT COMPLETED|Overall Study||1
1583689|NCT01093183|3875137|P2|COMPLETED|Overall Study||4
1583690|NCT01093183|3875138|P1|COMPLETED|Overall Study||18
1583691|NCT01093183|3875137|P2|STARTED|Overall Study||6
1583692|NCT01093183|3875138|P1|STARTED|Overall Study||19
1583693|NCT01093027|3875148|P2|NOT COMPLETED|Visit 2||0
1583694|NCT01093027|3875149|P1|NOT COMPLETED|Visit 2||0
1583695|NCT01093027|3875148|P2|COMPLETED|Visit 2||10
1583696|NCT01093027|3875149|P1|COMPLETED|Visit 2||10
1583697|NCT01093027|3875148|P2|STARTED|Visit 2||10
1583698|NCT01093027|3875149|P1|STARTED|Visit 2||10
1583699|NCT01093027|3875148|P2|NOT COMPLETED|Visit 1||0
1583700|NCT01093027|3875149|P1|NOT COMPLETED|Visit 1||0
1583701|NCT01093027|3875148|P2|COMPLETED|Visit 1||10
1583702|NCT01093027|3875149|P1|COMPLETED|Visit 1||10
1583703|NCT01093027|3875148|P2|STARTED|Visit 1||10
1583704|NCT01093027|3875149|P1|STARTED|Visit 1||10
1583705|NCT01093014|3875160|P3|NOT COMPLETED|Overall Study||0
1583706|NCT01093014|3875161|P2|NOT COMPLETED|Overall Study||0
1583707|NCT01093014|3875162|P1|NOT COMPLETED|Overall Study||0
1583708|NCT01093014|3875160|P3|COMPLETED|Overall Study||12
1583709|NCT01093014|3875161|P2|COMPLETED|Overall Study||9
1583710|NCT01093014|3875162|P1|COMPLETED|Overall Study||12
1583711|NCT01093014|3875160|P3|STARTED|Overall Study||12
1583712|NCT01093014|3875161|P2|STARTED|Overall Study||9
1583713|NCT01093014|3875162|P1|STARTED|Overall Study||12
1583714|NCT01092923|3875181|P2|NOT COMPLETED|Overall Study||0
1583715|NCT01092923|3875182|P1|NOT COMPLETED|Overall Study||0
1583716|NCT01092923|3875181|P2|COMPLETED|Overall Study||10
1583717|NCT01092923|3875182|P1|COMPLETED|Overall Study||10
1583718|NCT01092923|3875181|P2|STARTED|Overall Study||10
1583719|NCT01092923|3875182|P1|STARTED|Overall Study||10
1583720|NCT01092910|3875191|P1|NOT COMPLETED|Overall Study||5
1583721|NCT01092910|3875191|P1|COMPLETED|Overall Study||52
1583722|NCT01092910|3875191|P1|10 Month Follow-up|Overall Study||52
1583723|NCT01092910|3875191|P1|4 Month Follow-up|Overall Study||54
1583724|NCT01092910|3875191|P1|STARTED|Overall Study||57
1583725|NCT01092832|3875203|P2|NOT COMPLETED|Overall Study||0
1583726|NCT01092832|3875204|P1|NOT COMPLETED|Overall Study||1
1583727|NCT01092832|3875203|P2|COMPLETED|Overall Study||8
1583728|NCT01092832|3875204|P1|COMPLETED|Overall Study||13
1583729|NCT01092832|3875203|P2|STARTED|Overall Study||8
1583730|NCT01092832|3875204|P1|STARTED|Overall Study||14
1583731|NCT01092780|3875216|P4|NOT COMPLETED|Treatment Period 4||0
1583732|NCT01092780|3875217|P3|NOT COMPLETED|Treatment Period 4||0
1583733|NCT01092780|3875218|P2|NOT COMPLETED|Treatment Period 4||0
1583734|NCT01092780|3875219|P1|NOT COMPLETED|Treatment Period 4||0
1583735|NCT01092780|3875216|P4|COMPLETED|Treatment Period 4||13
1583736|NCT01092780|3875217|P3|COMPLETED|Treatment Period 4||13
1583737|NCT01092780|3875218|P2|COMPLETED|Treatment Period 4||13
1583738|NCT01092780|3875219|P1|COMPLETED|Treatment Period 4||13
1583739|NCT01092780|3875216|P4|STARTED|Treatment Period 4||13
1583740|NCT01092780|3875217|P3|STARTED|Treatment Period 4||13
1583741|NCT01092780|3875218|P2|STARTED|Treatment Period 4||13
1583742|NCT01092780|3875219|P1|STARTED|Treatment Period 4||13
1583743|NCT01092780|3875216|P4|NOT COMPLETED|Washout Period 3||0
1583744|NCT01092780|3875217|P3|NOT COMPLETED|Washout Period 3||0
1583745|NCT01092780|3875218|P2|NOT COMPLETED|Washout Period 3||0
1583746|NCT01092780|3875219|P1|NOT COMPLETED|Washout Period 3||0
1583747|NCT01092780|3875216|P4|COMPLETED|Washout Period 3||13
1583748|NCT01092780|3875217|P3|COMPLETED|Washout Period 3||13
1583749|NCT01092780|3875218|P2|COMPLETED|Washout Period 3||13
1583750|NCT01092780|3875219|P1|COMPLETED|Washout Period 3||13
1583751|NCT01092780|3875216|P4|STARTED|Washout Period 3||13
1583752|NCT01092780|3875217|P3|STARTED|Washout Period 3||13
1583753|NCT01092780|3875218|P2|STARTED|Washout Period 3||13
1583754|NCT01092780|3875219|P1|STARTED|Washout Period 3||13
1583755|NCT01092780|3875216|P4|NOT COMPLETED|Treatment Period 3||0
1583756|NCT01092780|3875217|P3|NOT COMPLETED|Treatment Period 3||0
1583757|NCT01092780|3875218|P2|NOT COMPLETED|Treatment Period 3||0
1583758|NCT01092780|3875219|P1|NOT COMPLETED|Treatment Period 3||0
1583759|NCT01092780|3875216|P4|COMPLETED|Treatment Period 3||13
1583760|NCT01092780|3875217|P3|COMPLETED|Treatment Period 3||13
1583761|NCT01092780|3875218|P2|COMPLETED|Treatment Period 3||13
1583762|NCT01092780|3875219|P1|COMPLETED|Treatment Period 3||13
1583763|NCT01092780|3875216|P4|STARTED|Treatment Period 3||13
1583764|NCT01092780|3875217|P3|STARTED|Treatment Period 3||13
1583765|NCT01092780|3875218|P2|STARTED|Treatment Period 3||13
1583766|NCT01092780|3875219|P1|STARTED|Treatment Period 3||13
1583767|NCT01092780|3875216|P4|NOT COMPLETED|Washout Period 2||0
1583768|NCT01092780|3875217|P3|NOT COMPLETED|Washout Period 2||1
1583769|NCT01092780|3875218|P2|NOT COMPLETED|Washout Period 2||1
1583770|NCT01092780|3875219|P1|NOT COMPLETED|Washout Period 2||0
1583771|NCT01092780|3875216|P4|COMPLETED|Washout Period 2||13
1583772|NCT01092780|3875217|P3|COMPLETED|Washout Period 2||13
1583773|NCT01092780|3875218|P2|COMPLETED|Washout Period 2||13
1583774|NCT01092780|3875219|P1|COMPLETED|Washout Period 2||13
1583775|NCT01092780|3875216|P4|STARTED|Washout Period 2||13
1583776|NCT01092780|3875217|P3|STARTED|Washout Period 2||14
1583777|NCT01092780|3875218|P2|STARTED|Washout Period 2||14
1583778|NCT01092780|3875219|P1|STARTED|Washout Period 2||13
1583779|NCT01092780|3875216|P4|NOT COMPLETED|Treatment Period 2||0
1583780|NCT01092780|3875217|P3|NOT COMPLETED|Treatment Period 2||0
1583781|NCT01092780|3875218|P2|NOT COMPLETED|Treatment Period 2||0
1583782|NCT01092780|3875219|P1|NOT COMPLETED|Treatment Period 2||0
1583783|NCT01092780|3875216|P4|COMPLETED|Treatment Period 2||13
1583784|NCT01092780|3875217|P3|COMPLETED|Treatment Period 2||14
1583785|NCT01092780|3875218|P2|COMPLETED|Treatment Period 2||14
1583786|NCT01092780|3875219|P1|COMPLETED|Treatment Period 2||13
1583787|NCT01092780|3875216|P4|STARTED|Treatment Period 2||13
1583788|NCT01092780|3875217|P3|STARTED|Treatment Period 2||14
1583789|NCT01092780|3875218|P2|STARTED|Treatment Period 2||14
1583790|NCT01092780|3875219|P1|STARTED|Treatment Period 2||13
1583791|NCT01092780|3875216|P4|NOT COMPLETED|Washout Period 1||0
1583792|NCT01092780|3875217|P3|NOT COMPLETED|Washout Period 1||0
1583793|NCT01092780|3875218|P2|NOT COMPLETED|Washout Period 1||1
1583794|NCT01092780|3875219|P1|NOT COMPLETED|Washout Period 1||1
1583795|NCT01092780|3875216|P4|COMPLETED|Washout Period 1||13
1583796|NCT01092780|3875217|P3|COMPLETED|Washout Period 1||14
1583797|NCT01092780|3875218|P2|COMPLETED|Washout Period 1||14
1583798|NCT01092780|3875219|P1|COMPLETED|Washout Period 1||13
1583799|NCT01092780|3875216|P4|STARTED|Washout Period 1||13
1583800|NCT01092780|3875217|P3|STARTED|Washout Period 1||14
1583801|NCT01092780|3875218|P2|STARTED|Washout Period 1||15
1583802|NCT01092780|3875219|P1|STARTED|Washout Period 1||14
1583803|NCT01092780|3875216|P4|NOT COMPLETED|Treatment Period 1||0
1583804|NCT01092780|3875217|P3|NOT COMPLETED|Treatment Period 1||0
1583805|NCT01092780|3875218|P2|NOT COMPLETED|Treatment Period 1||0
1583806|NCT01092780|3875219|P1|NOT COMPLETED|Treatment Period 1||0
1583807|NCT01092780|3875216|P4|COMPLETED|Treatment Period 1||13
1583808|NCT01092780|3875217|P3|COMPLETED|Treatment Period 1||14
1583809|NCT01092780|3875218|P2|COMPLETED|Treatment Period 1||15
1583810|NCT01092780|3875219|P1|COMPLETED|Treatment Period 1||14
1583811|NCT01092780|3875216|P4|STARTED|Treatment Period 1||13
1583812|NCT01092780|3875217|P3|STARTED|Treatment Period 1||14
1583813|NCT01092780|3875218|P2|STARTED|Treatment Period 1||15
1583814|NCT01092780|3875219|P1|STARTED|Treatment Period 1||14
1583815|NCT01092767|3875249|P1|NOT COMPLETED|Overall Study||5
1583816|NCT01092767|3875249|P1|COMPLETED|Overall Study||45
1583817|NCT01092767|3875249|P1|STARTED|Overall Study||50
1583818|NCT01092728|3875255|P2|NOT COMPLETED|Overall Study||14
1583819|NCT01092728|3875256|P1|NOT COMPLETED|Overall Study||4
1583820|NCT01092728|3875255|P2|COMPLETED|Overall Study||0
1583821|NCT01092728|3875256|P1|COMPLETED|Overall Study||0
1583822|NCT01092728|3875255|P2|STARTED|Overall Study||14
1583823|NCT01092728|3875256|P1|STARTED|Overall Study||4
1583824|NCT01092702|3875264|P1|NOT COMPLETED|Overall Study||9
1583825|NCT01092702|3875264|P1|COMPLETED|Overall Study||23
1583826|NCT01092702|3875264|P1|STARTED|Overall Study||32
1583827|NCT01092663|3875270|P2|NOT COMPLETED|Overall Study||4
1583828|NCT01092663|3875271|P1|NOT COMPLETED|Overall Study||7
1583829|NCT01092663|3875270|P2|COMPLETED|Overall Study||26
1583830|NCT01092663|3875271|P1|COMPLETED|Overall Study||24
1583831|NCT01092663|3875270|P2|STARTED|Overall Study||30
1583832|NCT01092663|3875271|P1|STARTED|Overall Study||31
1583833|NCT01092637|3875319|P2|NOT COMPLETED|Overall Study||49
1583834|NCT01092637|3875320|P1|NOT COMPLETED|Overall Study||47
1583835|NCT01092637|3875319|P2|COMPLETED|Overall Study||86
1583836|NCT01092637|3875320|P1|COMPLETED|Overall Study||98
1583837|NCT01092637|3875319|P2|STARTED|Overall Study||135
1583838|NCT01092637|3875320|P1|STARTED|Overall Study||145
1583839|NCT01092559|3875330|P1|NOT COMPLETED|Overall Study||0
1583840|NCT01092559|3875330|P1|COMPLETED|Overall Study||10
1583841|NCT01092559|3875330|P1|STARTED|Overall Study||10
1583842|NCT01092546|3875335|P1|NOT COMPLETED|Overall Study||4
1583843|NCT01092546|3875335|P1|COMPLETED|Overall Study||12
1583844|NCT01092546|3875335|P1|STARTED|Overall Study||16
1583845|NCT01092507|3875342|P2|NOT COMPLETED|Overall Study||0
1583846|NCT01092507|3875343|P1|NOT COMPLETED|Overall Study||2
1583847|NCT01092507|3875342|P2|COMPLETED|Overall Study||150
1583848|NCT01092507|3875343|P1|COMPLETED|Overall Study||147
1583849|NCT01092507|3875342|P2|STARTED|Overall Study||150
1583850|NCT01092507|3875343|P1|STARTED|Overall Study||149
1583851|NCT01092442|3875363|P2|NOT COMPLETED|Overall Study||0
1583852|NCT01092442|3875364|P1|NOT COMPLETED|Overall Study||0
1583853|NCT01092442|3875363|P2|COMPLETED|Overall Study||60
1583854|NCT01092442|3875364|P1|COMPLETED|Overall Study||80
1583855|NCT01092442|3875363|P2|STARTED|Overall Study||60
1583856|NCT01092442|3875364|P1|STARTED|Overall Study||80
1583857|NCT01092416|3875378|P1|NOT COMPLETED|12-Month Follow-up||25
1583858|NCT01092416|3875378|P1|COMPLETED|12-Month Follow-up||413
1583859|NCT01092416|3875378|P1|STARTED|12-Month Follow-up||438
1583860|NCT01092416|3875378|P1|NOT COMPLETED|30-Day Follow-up||10
1583861|NCT01092416|3875378|P1|COMPLETED|30-Day Follow-up||430
1583862|NCT01092416|3875378|P1|STARTED|30-Day Follow-up||440
1583863|NCT01092416|3875378|P1|NOT COMPLETED|Enrollment||3
1583864|NCT01092416|3875378|P1|COMPLETED|Enrollment||440
1583865|NCT01092416|3875378|P1|STARTED|Enrollment||443
1583866|NCT01092364|3875390|P3|NOT COMPLETED|Overall Study||18
1583867|NCT01092364|3875391|P2|NOT COMPLETED|Overall Study||16
1583868|NCT01092364|3875392|P1|NOT COMPLETED|Overall Study||18
1583869|NCT01092364|3875390|P3|COMPLETED|Overall Study||105
1583870|NCT01092364|3875391|P2|COMPLETED|Overall Study||104
1583871|NCT01092364|3875392|P1|COMPLETED|Overall Study||104
1583872|NCT01092364|3875390|P3|STARTED|Overall Study||123
1583873|NCT01092364|3875391|P2|STARTED|Overall Study||120
1583874|NCT01092364|3875392|P1|STARTED|Overall Study||122
1583875|NCT01092338|3875402|P2|NOT COMPLETED|Overall Study||1
1583876|NCT01092338|3875403|P1|NOT COMPLETED|Overall Study||1
1583877|NCT01092338|3875402|P2|COMPLETED|Overall Study||21
1583878|NCT01092338|3875403|P1|COMPLETED|Overall Study||21
1583879|NCT01092338|3875402|P2|STARTED|Overall Study||22
1583880|NCT01092338|3875403|P1|STARTED|Overall Study||22
1583881|NCT01091974|3875415|P4|NOT COMPLETED|Overall Study||7
1583882|NCT01091974|3875416|P3|NOT COMPLETED|Overall Study||6
1583883|NCT01091974|3875417|P2|NOT COMPLETED|Overall Study||5
1583884|NCT01091974|3875418|P1|NOT COMPLETED|Overall Study||5
1583885|NCT01091974|3875415|P4|COMPLETED|Overall Study||17
1583886|NCT01091974|3875416|P3|COMPLETED|Overall Study||19
1583887|NCT01091974|3875417|P2|COMPLETED|Overall Study||18
1583888|NCT01091974|3875418|P1|COMPLETED|Overall Study||19
1583889|NCT01091974|3875415|P4|STARTED|Overall Study||24
1583890|NCT01091974|3875416|P3|STARTED|Overall Study||25
1583891|NCT01091974|3875417|P2|STARTED|Overall Study||23
1583892|NCT01091974|3875418|P1|STARTED|Overall Study||24
1583893|NCT01091948|3875434|P2|NOT COMPLETED|Overall Study||0
1583894|NCT01091948|3875435|P1|NOT COMPLETED|Overall Study||0
1583895|NCT01091948|3875434|P2|COMPLETED|Overall Study||38
1583896|NCT01091948|3875435|P1|COMPLETED|Overall Study||37
1583897|NCT01091948|3875434|P2|STARTED|Overall Study||38
1583898|NCT01091948|3875435|P1|STARTED|Overall Study||37
1583899|NCT01091675|3875453|P1|NOT COMPLETED|Overall Study||34
1583900|NCT01091675|3875453|P1|COMPLETED|Overall Study||23
1583901|NCT01091675|3875453|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
1583902|NCT01091662|3875459|P2|NOT COMPLETED|Overall Study||34
1583903|NCT01091662|3875460|P1|NOT COMPLETED|Overall Study||17
1583904|NCT01091662|3875459|P2|COMPLETED|Overall Study||80
1583905|NCT01091662|3875460|P1|COMPLETED|Overall Study||41
1583906|NCT01091662|3875459|P2|STARTED|Overall Study||114
1583907|NCT01091662|3875460|P1|STARTED|Overall Study||58
1583908|NCT01091519|3875498|P2|NOT COMPLETED|Overall Study||73
1583909|NCT01091519|3875499|P1|NOT COMPLETED|Overall Study||55
1583910|NCT01091519|3875498|P2|COMPLETED|Overall Study||362
1583911|NCT01091519|3875499|P1|COMPLETED|Overall Study||291
1583912|NCT01091519|3875498|P2|Treated|Overall Study||431
1583913|NCT01091519|3875499|P1|Treated|Overall Study||342
1583914|NCT01091519|3875498|P2|STARTED|Overall Study||435
1583915|NCT01091519|3875499|P1|STARTED|Overall Study||346
1583916|NCT01091454|3875511|P1|NOT COMPLETED|Overall Study||1
1583917|NCT01091454|3875511|P1|COMPLETED|Overall Study||47
1583918|NCT01091454|3875511|P1|STARTED|Overall Study||48
1583919|NCT01091428|3875524|P4|NOT COMPLETED|Phase 2||69
1583920|NCT01091428|3875525|P3|NOT COMPLETED|Phase 2||73
1583921|NCT01091428|3875526|P2|NOT COMPLETED|Phase 2||0
1583922|NCT01091428|3875527|P1|NOT COMPLETED|Phase 2||0
1583923|NCT01091428|3875524|P4|COMPLETED|Phase 2||0
1583924|NCT01091428|3875525|P3|COMPLETED|Phase 2||0
1583925|NCT01091428|3875526|P2|COMPLETED|Phase 2||0
1583926|NCT01091428|3875527|P1|COMPLETED|Phase 2||0
1583927|NCT01091428|3875524|P4|STARTED|Phase 2||69
1583928|NCT01091428|3875525|P3|STARTED|Phase 2||73
1583929|NCT01091428|3875526|P2|STARTED|Phase 2||0
1583930|NCT01091428|3875527|P1|STARTED|Phase 2||0
1583931|NCT01091428|3875524|P4|NOT COMPLETED|Phase 1||0
1583932|NCT01091428|3875525|P3|NOT COMPLETED|Phase 1||0
1583933|NCT01091428|3875526|P2|NOT COMPLETED|Phase 1||11
1583934|NCT01091428|3875527|P1|NOT COMPLETED|Phase 1||38
1583935|NCT01091428|3875524|P4|COMPLETED|Phase 1||0
1583936|NCT01091428|3875525|P3|COMPLETED|Phase 1||0
1583937|NCT01091428|3875526|P2|COMPLETED|Phase 1||0
1583938|NCT01091428|3875527|P1|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
1583939|NCT01091428|3875524|P4|STARTED|Phase 1||0
1583940|NCT01091428|3875525|P3|STARTED|Phase 1||0
1583941|NCT01091428|3875526|P2|STARTED|Phase 1||11
1583942|NCT01091428|3875527|P1|STARTED|Phase 1||38
1583943|NCT01091259|3875628|P1|NOT COMPLETED|Overall Study||5
1583944|NCT01091259|3875628|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
1583945|NCT01091259|3875628|P1|STARTED|Overall Study||29
1583946|NCT01091246|3875639|P3|NOT COMPLETED|Overall Study||13
1583947|NCT01091246|3875640|P2|NOT COMPLETED|Overall Study||16
1583948|NCT01091246|3875641|P1|NOT COMPLETED|Overall Study||35
1583949|NCT01091246|3875639|P3|COMPLETED|Overall Study||450
1583950|NCT01091246|3875640|P2|COMPLETED|Overall Study||448
1583951|NCT01091246|3875641|P1|COMPLETED|Overall Study||1350
1583952|NCT01091246|3875639|P3|STARTED|Overall Study||463
1583953|NCT01091246|3875640|P2|STARTED|Overall Study||464
1583954|NCT01091246|3875641|P1|STARTED|Overall Study||1385
1583955|NCT01091155|3875715|P1|NOT COMPLETED|Overall Study||9
1583956|NCT01091155|3875715|P1|COMPLETED|Overall Study||279
1583957|NCT01091155|3875715|P1|STARTED|Overall Study||288
1583958|NCT01091116|3875724|P5|NOT COMPLETED|Overall Study||11
1583959|NCT01091116|3875725|P4|NOT COMPLETED|Overall Study||4
1583960|NCT01091116|3875726|P3|NOT COMPLETED|Overall Study||11
1583961|NCT01091116|3875727|P2|NOT COMPLETED|Overall Study||8
1583962|NCT01091116|3875728|P1|NOT COMPLETED|Overall Study||6
1583963|NCT01091116|3875724|P5|COMPLETED|Overall Study||73
1583964|NCT01091116|3875725|P4|COMPLETED|Overall Study||80
1583965|NCT01091116|3875726|P3|COMPLETED|Overall Study||73
1583966|NCT01091116|3875727|P2|COMPLETED|Overall Study||80
1583967|NCT01091116|3875728|P1|COMPLETED|Overall Study||77
1583968|NCT01091116|3875724|P5|STARTED|Overall Study||84
1583969|NCT01091116|3875725|P4|STARTED|Overall Study||84
1583970|NCT01091116|3875726|P3|STARTED|Overall Study||84
1583971|NCT01091116|3875727|P2|STARTED|Overall Study||88
1583972|NCT01091116|3875728|P1|STARTED|Overall Study||83
1583973|NCT01091103|3875780|P1|NOT COMPLETED|Overall Study||4
1583974|NCT01091103|3875780|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
1583975|NCT01091103|3875780|P1|STARTED|Overall Study||60
1583976|NCT01090973|3875800|P1|NOT COMPLETED|Overall Study||1
1583977|NCT01090973|3875800|P1|COMPLETED|Overall Study||0
1583978|NCT01090973|3875800|P1|STARTED|Overall Study||1
1583979|NCT01090765|3875816|P6|NOT COMPLETED|Overall Study||1
1583980|NCT01090765|3875817|P5|NOT COMPLETED|Overall Study||2
1583981|NCT01090765|3875818|P4|NOT COMPLETED|Overall Study||1
1583982|NCT01090765|3875819|P3|NOT COMPLETED|Overall Study||0
1583983|NCT01090765|3875820|P2|NOT COMPLETED|Overall Study||0
1583984|NCT01090765|3875821|P1|NOT COMPLETED|Overall Study||0
1583985|NCT01090765|3875816|P6|COMPLETED|Overall Study||3
1583986|NCT01090765|3875817|P5|COMPLETED|Overall Study||4
1583987|NCT01090765|3875818|P4|COMPLETED|Overall Study||1
1583988|NCT01090765|3875819|P3|COMPLETED|Overall Study||3
1583989|NCT01090765|3875820|P2|COMPLETED|Overall Study||3
1583990|NCT01090765|3875821|P1|COMPLETED|Overall Study||3
1583991|NCT01090765|3875816|P6|STARTED|Overall Study||4
1583992|NCT01090765|3875817|P5|STARTED|Overall Study||6
1583993|NCT01090765|3875818|P4|STARTED|Overall Study||2
1583994|NCT01090765|3875819|P3|STARTED|Overall Study||3
1583995|NCT01090765|3875820|P2|STARTED|Overall Study||3
1583996|NCT01090765|3875821|P1|STARTED|Overall Study||3
1583997|NCT01090752|3875856|P2|NOT COMPLETED|Overall Study||0
1583998|NCT01090752|3875857|P1|NOT COMPLETED|Overall Study||0
1583999|NCT01090752|3875856|P2|COMPLETED|Overall Study||8
1584000|NCT01090752|3875857|P1|COMPLETED|Overall Study||8
1584001|NCT01090752|3875856|P2|STARTED|Overall Study||8
1584002|NCT01090752|3875857|P1|STARTED|Overall Study||8
1584003|NCT01090739|3875867|P1|NOT COMPLETED|36 Month Follow-up||23
1584004|NCT01090739|3875867|P1|COMPLETED|36 Month Follow-up||115
1584005|NCT01090739|3875867|P1|STARTED|36 Month Follow-up||138
1584006|NCT01090739|3875867|P1|NOT COMPLETED|24 Month Follow-up||9
1584007|NCT01090739|3875867|P1|COMPLETED|24 Month Follow-up||138
1584008|NCT01090739|3875867|P1|STARTED|24 Month Follow-up||147
1584009|NCT01090739|3875867|P1|NOT COMPLETED|12 Month Follow-up||5
1584010|NCT01090739|3875867|P1|COMPLETED|12 Month Follow-up||147
1584011|NCT01090739|3875867|P1|STARTED|12 Month Follow-up||152
1584012|NCT01090739|3875867|P1|NOT COMPLETED|Enrollment||55
1584013|NCT01090739|3875867|P1|COMPLETED|Enrollment||152
1584014|NCT01090739|3875867|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
1584015|NCT01090492|3875892|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
1584016|NCT01090492|3875893|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
1584017|NCT01090492|3875894|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
1584018|NCT01090492|3875895|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
1584019|NCT01090492|3875896|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
1584020|NCT01090492|3875897|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
1584021|NCT01090492|3875898|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
1584022|NCT01090492|3875899|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
1584023|NCT01090492|3875892|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
1584024|NCT01090492|3875893|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
1584025|NCT01090492|3875894|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
1584026|NCT01090492|3875895|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
1584027|NCT01090492|3875896|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
1584028|NCT01090492|3875897|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
1584029|NCT01090492|3875898|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
1584030|NCT01090492|3875899|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
1584031|NCT01090492|3875892|P8|STARTED|Second Intervention Period (4 Weeks)||27
1584032|NCT01090492|3875893|P7|STARTED|Second Intervention Period (4 Weeks)||31
1584033|NCT01090492|3875894|P6|STARTED|Second Intervention Period (4 Weeks)||30
1584034|NCT01090492|3875895|P5|STARTED|Second Intervention Period (4 Weeks)||29
1584035|NCT01090492|3875896|P4|STARTED|Second Intervention Period (4 Weeks)||22
1584036|NCT01090492|3875897|P3|STARTED|Second Intervention Period (4 Weeks)||26
1584037|NCT01090492|3875898|P2|STARTED|Second Intervention Period (4 Weeks)||24
1584038|NCT01090492|3875899|P1|STARTED|Second Intervention Period (4 Weeks)||26
1584039|NCT01090492|3875892|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1584040|NCT01090492|3875893|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1584041|NCT01090492|3875894|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1584042|NCT01090492|3875895|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1584043|NCT01090492|3875896|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1584044|NCT01090492|3875897|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1584045|NCT01090492|3875898|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1584046|NCT01090492|3875899|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
1584047|NCT01090492|3875892|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
1584048|NCT01090492|3875893|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
1584049|NCT01090492|3875894|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
1584050|NCT01090492|3875895|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
1584051|NCT01090492|3875896|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
1584052|NCT01090492|3875897|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
1584053|NCT01090492|3875898|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
1584054|NCT01090492|3875899|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
1584055|NCT01090492|3875892|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
1584056|NCT01090492|3875893|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
1584057|NCT01090492|3875894|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
1584058|NCT01090492|3875895|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
1584059|NCT01090492|3875896|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
1584060|NCT01090492|3875897|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
1584061|NCT01090492|3875898|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
1584062|NCT01090492|3875899|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
1584063|NCT01090492|3875892|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
1584064|NCT01090492|3875893|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
1584065|NCT01090492|3875894|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
1584066|NCT01090492|3875895|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
1584067|NCT01090492|3875896|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
1584068|NCT01090492|3875897|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
1584069|NCT01090492|3875898|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
1584070|NCT01090492|3875899|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
1584071|NCT01090492|3875892|P8|COMPLETED|First Intervention Period (4 Weeks)||27
1584072|NCT01090492|3875893|P7|COMPLETED|First Intervention Period (4 Weeks)||31
1584073|NCT01090492|3875894|P6|COMPLETED|First Intervention Period (4 Weeks)||30
1584074|NCT01090492|3875895|P5|COMPLETED|First Intervention Period (4 Weeks)||29
1584075|NCT01090492|3875896|P4|COMPLETED|First Intervention Period (4 Weeks)||22
1584076|NCT01090492|3875897|P3|COMPLETED|First Intervention Period (4 Weeks)||26
1584077|NCT01090492|3875898|P2|COMPLETED|First Intervention Period (4 Weeks)||24
1584078|NCT01090492|3875899|P1|COMPLETED|First Intervention Period (4 Weeks)||26
1584079|NCT01090492|3875892|P8|STARTED|First Intervention Period (4 Weeks)||33
1584080|NCT01090492|3875893|P7|STARTED|First Intervention Period (4 Weeks)||32
1584081|NCT01090492|3875894|P6|STARTED|First Intervention Period (4 Weeks)||32
1584082|NCT01090492|3875895|P5|STARTED|First Intervention Period (4 Weeks)||33
1584083|NCT01090492|3875896|P4|STARTED|First Intervention Period (4 Weeks)||28
1584084|NCT01090492|3875897|P3|STARTED|First Intervention Period (4 Weeks)||29
1584085|NCT01090492|3875898|P2|STARTED|First Intervention Period (4 Weeks)||29
1584086|NCT01090492|3875899|P1|STARTED|First Intervention Period (4 Weeks)||27
1584087|NCT01090479|3875958|P2|NOT COMPLETED|Overall Study||0
1584088|NCT01090479|3875959|P1|NOT COMPLETED|Overall Study||0
1584089|NCT01090479|3875958|P2|COMPLETED|Overall Study||50
1584090|NCT01090479|3875959|P1|COMPLETED|Overall Study||50
1584091|NCT01090479|3875958|P2|STARTED|Overall Study||50
1584092|NCT01090479|3875959|P1|STARTED|Overall Study||50
1584093|NCT01090453|3875967|P2|NOT COMPLETED|Overall Study||14
1584094|NCT01090453|3875968|P1|NOT COMPLETED|Overall Study||13
1584095|NCT01090453|3875967|P2|COMPLETED|Overall Study||228
1584096|NCT01090453|3875968|P1|COMPLETED|Overall Study||225
1584097|NCT01090453|3875967|P2|STARTED|Overall Study||242
1584098|NCT01090453|3875968|P1|STARTED|Overall Study||238
1584099|NCT01090427|3876019|P7|NOT COMPLETED|After Controlled Period||2
1584100|NCT01090427|3876020|P6|NOT COMPLETED|After Controlled Period||5
1584101|NCT01090427|3876021|P5|NOT COMPLETED|After Controlled Period||0
1584102|NCT01090427|3876022|P4|NOT COMPLETED|After Controlled Period||2
1584103|NCT01090427|3876023|P3|NOT COMPLETED|After Controlled Period||0
1584104|NCT01090427|3876024|P2|NOT COMPLETED|After Controlled Period||0
1584105|NCT01090427|3876025|P1|NOT COMPLETED|After Controlled Period||0
1584106|NCT01090427|3876019|P7|COMPLETED|After Controlled Period||34
1584107|NCT01090427|3876020|P6|COMPLETED|After Controlled Period||32
1584108|NCT01090427|3876021|P5|COMPLETED|After Controlled Period||18
1584109|NCT01090427|3876022|P4|COMPLETED|After Controlled Period||17
1584110|NCT01090427|3876023|P3|COMPLETED|After Controlled Period||0
1584111|NCT01090427|3876024|P2|COMPLETED|After Controlled Period||0
1584112|NCT01090427|3876025|P1|COMPLETED|After Controlled Period||0
1584113|NCT01090427|3876019|P7|STARTED|After Controlled Period||36
1584114|NCT01090427|3876020|P6|STARTED|After Controlled Period||37
1584115|NCT01090427|3876021|P5|STARTED|After Controlled Period||18
1584116|NCT01090427|3876022|P4|STARTED|After Controlled Period||19
1584117|NCT01090427|3876023|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1584118|NCT01090427|3876024|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1584119|NCT01090427|3876025|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1584120|NCT01090427|3876019|P7|NOT COMPLETED|Controlled Period||0
1584121|NCT01090427|3876020|P6|NOT COMPLETED|Controlled Period||0
1584122|NCT01090427|3876021|P5|NOT COMPLETED|Controlled Period||0
1584123|NCT01090427|3876022|P4|NOT COMPLETED|Controlled Period||0
1584124|NCT01090427|3876023|P3|NOT COMPLETED|Controlled Period||0
1584125|NCT01090427|3876024|P2|NOT COMPLETED|Controlled Period||0
1584126|NCT01090427|3876025|P1|NOT COMPLETED|Controlled Period||0
1584127|NCT01090427|3876019|P7|COMPLETED|Controlled Period||0
1584128|NCT01090427|3876020|P6|COMPLETED|Controlled Period||0
1584129|NCT01090427|3876021|P5|COMPLETED|Controlled Period||0
1584130|NCT01090427|3876022|P4|COMPLETED|Controlled Period||0
1584131|NCT01090427|3876023|P3|COMPLETED|Controlled Period||36
1584132|NCT01090427|3876024|P2|COMPLETED|Controlled Period||37
1584133|NCT01090427|3876025|P1|COMPLETED|Controlled Period||37
1584134|NCT01090427|3876019|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1584135|NCT01090427|3876020|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1584136|NCT01090427|3876021|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1584137|NCT01090427|3876022|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1584138|NCT01090427|3876023|P3|STARTED|Controlled Period||36
1584139|NCT01090427|3876024|P2|STARTED|Controlled Period||37
1584140|NCT01090427|3876025|P1|STARTED|Controlled Period||37
1584141|NCT01090323|3876060|P2|NOT COMPLETED|Overall Study||34
1584142|NCT01090323|3876061|P1|NOT COMPLETED|Overall Study||89
1584143|NCT01090323|3876060|P2|COMPLETED|Overall Study||19
1584144|NCT01090323|3876061|P1|COMPLETED|Overall Study||43
1584145|NCT01090323|3876060|P2|STARTED|Overall Study||53
1584146|NCT01090323|3876061|P1|STARTED|Overall Study||132
1584147|NCT01090310|3876073|P4|NOT COMPLETED|Extension Study||20
1584148|NCT01090310|3876074|P3|NOT COMPLETED|Extension Study||15
1584149|NCT01090310|3876075|P2|NOT COMPLETED|Extension Study||16
1584150|NCT01090310|3876076|P1|NOT COMPLETED|Extension Study||14
1584151|NCT01090310|3876073|P4|COMPLETED|Extension Study||1
1584152|NCT01090310|3876074|P3|COMPLETED|Extension Study||1
1584153|NCT01090310|3876075|P2|COMPLETED|Extension Study||0
1584154|NCT01090310|3876076|P1|COMPLETED|Extension Study||3
1584155|NCT01090310|3876073|P4|STARTED|Extension Study||21
1584156|NCT01090310|3876074|P3|STARTED|Extension Study||16
1584157|NCT01090310|3876075|P2|STARTED|Extension Study||16
1584158|NCT01090310|3876076|P1|STARTED|Extension Study||17
1584159|NCT01090310|3876073|P4|NOT COMPLETED|Core Study||7
1584160|NCT01090310|3876074|P3|NOT COMPLETED|Core Study||7
1584161|NCT01090310|3876075|P2|NOT COMPLETED|Core Study||11
1584162|NCT01090310|3876076|P1|NOT COMPLETED|Core Study||8
1584163|NCT01090310|3876073|P4|COMPLETED|Core Study||27
1584164|NCT01090310|3876074|P3|COMPLETED|Core Study||24
1584165|NCT01090310|3876075|P2|COMPLETED|Core Study||20
1584166|NCT01090310|3876076|P1|COMPLETED|Core Study||21
1584167|NCT01090310|3876073|P4|STARTED|Core Study||34
1584168|NCT01090310|3876074|P3|STARTED|Core Study||31
1584169|NCT01090310|3876075|P2|STARTED|Core Study||31
1584170|NCT01090310|3876076|P1|STARTED|Core Study||29
1584171|NCT01090180|3876104|P2|NOT COMPLETED|Overall Study||8
1584172|NCT01090180|3876105|P1|NOT COMPLETED|Overall Study||11
1584173|NCT01090180|3876104|P2|COMPLETED|Overall Study||21
1584174|NCT01090180|3876105|P1|COMPLETED|Overall Study||22
1584175|NCT01090180|3876104|P2|STARTED|Overall Study||29
1584176|NCT01090180|3876105|P1|STARTED|Overall Study||33
1584177|NCT01090102|3876115|P2|NOT COMPLETED|Second 12 Weeks||1
1584178|NCT01090102|3876116|P1|NOT COMPLETED|Second 12 Weeks||0
1584179|NCT01090102|3876115|P2|COMPLETED|Second 12 Weeks||15
1584180|NCT01090102|3876116|P1|COMPLETED|Second 12 Weeks||11
1584181|NCT01090102|3876115|P2|STARTED|Second 12 Weeks||16
1584182|NCT01090102|3876116|P1|STARTED|Second 12 Weeks||11
1584183|NCT01090102|3876115|P2|NOT COMPLETED|First 12 Weeks||2
1584184|NCT01090102|3876116|P1|NOT COMPLETED|First 12 Weeks||4
1584185|NCT01090102|3876115|P2|COMPLETED|First 12 Weeks||16
1584186|NCT01090102|3876116|P1|COMPLETED|First 12 Weeks||11
1584187|NCT01090102|3876115|P2|STARTED|First 12 Weeks||18
1584188|NCT01090102|3876116|P1|STARTED|First 12 Weeks||15
1584189|NCT01090076|3876126|P2|NOT COMPLETED|Overall Study||2
1584190|NCT01090076|3876127|P1|NOT COMPLETED|Overall Study||1
1584191|NCT01090076|3876126|P2|COMPLETED|Overall Study||12
1584192|NCT01090076|3876127|P1|COMPLETED|Overall Study||11
1584193|NCT01090076|3876126|P2|STARTED|Overall Study||14
1584194|NCT01090076|3876127|P1|STARTED|Overall Study||12
1584195|NCT01090063|3876137|P1|NOT COMPLETED|Treatment||4
1584196|NCT01090063|3876137|P1|COMPLETED|Treatment||20
1584197|NCT01090063|3876137|P1|STARTED|Treatment||24
1584198|NCT01090063|3876137|P1|NOT COMPLETED|Screen||4
1584199|NCT01090063|3876137|P1|COMPLETED|Screen||24
1584200|NCT01090063|3876137|P1|STARTED|Screen||28
1584201|NCT01090050|3876153|P2|NOT COMPLETED|Overall Study||7
1584202|NCT01090050|3876154|P1|NOT COMPLETED|Overall Study||1
1584203|NCT01090050|3876153|P2|COMPLETED|Overall Study||5
1584204|NCT01090050|3876154|P1|COMPLETED|Overall Study||15
1584205|NCT01090050|3876153|P2|STARTED|Overall Study||12
1584206|NCT01090050|3876154|P1|STARTED|Overall Study||16
1584207|NCT01090011|3876174|P1|NOT COMPLETED|Overall Study||171
1584208|NCT01090011|3876174|P1|COMPLETED|Overall Study||0
1584209|NCT01090011|3876174|P1|STARTED|Overall Study||171
1584210|NCT01089751|3876244|P2|NOT COMPLETED|Overall Study||27
1584211|NCT01089751|3876245|P1|NOT COMPLETED|Overall Study||34
1584212|NCT01089751|3876244|P2|COMPLETED|Overall Study||132
1584213|NCT01089751|3876245|P1|COMPLETED|Overall Study||129
1584214|NCT01089751|3876244|P2|STARTED|Overall Study||159
1584215|NCT01089751|3876245|P1|STARTED|Overall Study||163
1584216|NCT01089647|3876267|P2|NOT COMPLETED|Overall Study||4
1584217|NCT01089647|3876268|P1|NOT COMPLETED|Overall Study||4
1584218|NCT01089647|3876267|P2|COMPLETED|Overall Study||13
1584219|NCT01089647|3876268|P1|COMPLETED|Overall Study||13
1584220|NCT01089647|3876267|P2|STARTED|Overall Study||17
1584221|NCT01089647|3876268|P1|STARTED|Overall Study||17
1584222|NCT01089608|3876276|P2|NOT COMPLETED|Overall Study||6
1584223|NCT01089608|3876277|P1|NOT COMPLETED|Overall Study||0
1584224|NCT01089608|3876276|P2|COMPLETED|Overall Study||44
1584225|NCT01089608|3876277|P1|COMPLETED|Overall Study||43
1584226|NCT01089608|3876276|P2|STARTED|Overall Study||50
1584227|NCT01089608|3876277|P1|STARTED|Overall Study||43
1584228|NCT01089595|3876285|P2|NOT COMPLETED|Overall Study||0
1584229|NCT01089595|3876286|P1|NOT COMPLETED|Overall Study||0
1584230|NCT01089595|3876285|P2|COMPLETED|Overall Study||3
1584231|NCT01089595|3876286|P1|COMPLETED|Overall Study||2
1584232|NCT01089595|3876285|P2|STARTED|Overall Study||3
1584233|NCT01089595|3876286|P1|STARTED|Overall Study||2
1584234|NCT01089582|3876294|P1|NOT COMPLETED|Overall Study||30
1584235|NCT01089582|3876294|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
1584236|NCT01089582|3876294|P1|STARTED|Overall Study||603
1584237|NCT01089569|3876307|P3|NOT COMPLETED|Overall Study||4
1584238|NCT01089569|3876308|P2|NOT COMPLETED|Overall Study||3
1584239|NCT01089569|3876309|P1|NOT COMPLETED|Overall Study||4
1584240|NCT01089569|3876307|P3|COMPLETED|Overall Study||16
1584241|NCT01089569|3876308|P2|COMPLETED|Overall Study||17
1584242|NCT01089569|3876309|P1|COMPLETED|Overall Study||16
1584243|NCT01089569|3876307|P3|STARTED|Overall Study||20
1584244|NCT01089569|3876308|P2|STARTED|Overall Study||20
1584245|NCT01089569|3876309|P1|STARTED|Overall Study||20
1584246|NCT01089556|3876337|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
1584247|NCT01089556|3876338|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
1584248|NCT01089556|3876339|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
1584249|NCT01089556|3876340|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
1584250|NCT01089556|3876341|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
1584251|NCT01089556|3876342|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
1584252|NCT01089556|3876337|P6|COMPLETED|Study Period III (Weeks 9-16)||92
1584253|NCT01089556|3876338|P5|COMPLETED|Study Period III (Weeks 9-16)||83
1584254|NCT01089556|3876339|P4|COMPLETED|Study Period III (Weeks 9-16)||66
1584255|NCT01089556|3876340|P3|COMPLETED|Study Period III (Weeks 9-16)||60
1584256|NCT01089556|3876341|P2|COMPLETED|Study Period III (Weeks 9-16)||0
1584257|NCT01089556|3876342|P1|COMPLETED|Study Period III (Weeks 9-16)||0
1584258|NCT01089556|3876337|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
1584259|NCT01089556|3876338|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
1584260|NCT01089556|3876339|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
1584261|NCT01089556|3876340|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
1584262|NCT01089556|3876341|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
1584263|NCT01089556|3876342|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
1584264|NCT01089556|3876337|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
1584265|NCT01089556|3876338|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
1584266|NCT01089556|3876339|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
1584267|NCT01089556|3876340|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
1584268|NCT01089556|3876341|P2|STARTED|Study Period III (Weeks 9-16)||0
1584269|NCT01089556|3876342|P1|STARTED|Study Period III (Weeks 9-16)||0
1584270|NCT01089556|3876337|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1584271|NCT01089556|3876338|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1584272|NCT01089556|3876339|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1584273|NCT01089556|3876340|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1584274|NCT01089556|3876341|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
1584275|NCT01089556|3876342|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
1584276|NCT01089556|3876337|P6|COMPLETED|Study Period II (Weeks 1-8)||0
1584277|NCT01089556|3876338|P5|COMPLETED|Study Period II (Weeks 1-8)||0
1584278|NCT01089556|3876339|P4|COMPLETED|Study Period II (Weeks 1-8)||0
1584279|NCT01089556|3876340|P3|COMPLETED|Study Period II (Weeks 1-8)||0
1584280|NCT01089556|3876341|P2|COMPLETED|Study Period II (Weeks 1-8)||333
1584281|NCT01089556|3876342|P1|COMPLETED|Study Period II (Weeks 1-8)||333
1584282|NCT01089556|3876337|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1584283|NCT01089556|3876338|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1584284|NCT01089556|3876339|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1584285|NCT01089556|3876340|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1584286|NCT01089556|3876341|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
1584287|NCT01089556|3876342|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
1584288|NCT01089556|3876337|P6|Safety Population|Study Period II (Weeks 1-8)||0
1584289|NCT01089556|3876338|P5|Safety Population|Study Period II (Weeks 1-8)||0
1584290|NCT01089556|3876339|P4|Safety Population|Study Period II (Weeks 1-8)||0
1584291|NCT01089556|3876340|P3|Safety Population|Study Period II (Weeks 1-8)||0
1584292|NCT01089556|3876341|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
1584293|NCT01089556|3876342|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
1584294|NCT01089556|3876337|P6|STARTED|Study Period II (Weeks 1-8)||0
1584295|NCT01089556|3876338|P5|STARTED|Study Period II (Weeks 1-8)||0
1584296|NCT01089556|3876339|P4|STARTED|Study Period II (Weeks 1-8)||0
1584297|NCT01089556|3876340|P3|STARTED|Study Period II (Weeks 1-8)||0
1584298|NCT01089556|3876341|P2|STARTED|Study Period II (Weeks 1-8)||407
1584299|NCT01089556|3876342|P1|STARTED|Study Period II (Weeks 1-8)||404
1584300|NCT01089543|3876416|P4|NOT COMPLETED|Overall Study||2
1584301|NCT01089543|3876417|P3|NOT COMPLETED|Overall Study||3
1584302|NCT01089543|3876418|P2|NOT COMPLETED|Overall Study||4
1584303|NCT01089543|3876419|P1|NOT COMPLETED|Overall Study||3
1584304|NCT01089543|3876416|P4|COMPLETED|Overall Study||83
1584305|NCT01089543|3876417|P3|COMPLETED|Overall Study||81
1584306|NCT01089543|3876418|P2|COMPLETED|Overall Study||81
1584307|NCT01089543|3876419|P1|COMPLETED|Overall Study||81
1584308|NCT01089543|3876416|P4|STARTED|Overall Study||85
1584309|NCT01089543|3876417|P3|STARTED|Overall Study||84
1584310|NCT01089543|3876418|P2|STARTED|Overall Study||85
1584311|NCT01089543|3876419|P1|STARTED|Overall Study||84
1584312|NCT01089517|3876436|P3|NOT COMPLETED|Overall Study||5
1584313|NCT01089517|3876437|P2|NOT COMPLETED|Overall Study||5
1584314|NCT01089517|3876438|P1|NOT COMPLETED|Overall Study||4
1584315|NCT01089517|3876436|P3|COMPLETED|Overall Study||147
1584316|NCT01089517|3876437|P2|COMPLETED|Overall Study||144
1584317|NCT01089517|3876438|P1|COMPLETED|Overall Study||144
1584318|NCT01089517|3876436|P3|STARTED|Overall Study||152
1584319|NCT01089517|3876437|P2|STARTED|Overall Study||149
1584320|NCT01089517|3876438|P1|STARTED|Overall Study||148
1584321|NCT01089504|3876454|P2|NOT COMPLETED|Overall Study||1
1584322|NCT01089504|3876455|P1|NOT COMPLETED|Overall Study||3
1584323|NCT01089504|3876454|P2|COMPLETED|Overall Study||4
1584324|NCT01089504|3876455|P1|COMPLETED|Overall Study||5
1584325|NCT01089504|3876454|P2|STARTED|Overall Study||5
1584326|NCT01089504|3876455|P1|STARTED|Overall Study||8
1584327|NCT01089413|3876468|P1|NOT COMPLETED|Overall Study||201
1584328|NCT01089413|3876468|P1|COMPLETED|Overall Study||0
1584329|NCT01089413|3876468|P1|Received Bevacizumab in First Line|Overall Study||199
1584330|NCT01089413|3876468|P1|STARTED|Overall Study||201
1584331|NCT01089361|3876487|P2|NOT COMPLETED|Overall Study||0
1584332|NCT01089361|3876488|P1|NOT COMPLETED|Overall Study||1
1584333|NCT01089361|3876487|P2|COMPLETED|Overall Study||10
1584334|NCT01089361|3876488|P1|COMPLETED|Overall Study||8
1584335|NCT01089361|3876487|P2|STARTED|Overall Study||10
1584336|NCT01089361|3876488|P1|STARTED|Overall Study||9
1584337|NCT01089231|3876510|P4|NOT COMPLETED|Overall Study||1
1584338|NCT01089231|3876511|P3|NOT COMPLETED|Overall Study||2
1584339|NCT01089231|3876512|P2|NOT COMPLETED|Overall Study||2
1584340|NCT01089231|3876513|P1|NOT COMPLETED|Overall Study||4
1584341|NCT01089231|3876510|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
1584342|NCT01089231|3876511|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
1584343|NCT01089231|3876512|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
1584344|NCT01089231|3876513|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
1584345|NCT01089231|3876510|P4|STARTED|Overall Study||10
1584346|NCT01089231|3876511|P3|STARTED|Overall Study||10
1584347|NCT01089231|3876512|P2|STARTED|Overall Study||10
1584348|NCT01089231|3876513|P1|STARTED|Overall Study||10
1584349|NCT01089127|3876537|P6|NOT COMPLETED|Overall Study||3
1584350|NCT01089127|3876538|P5|NOT COMPLETED|Overall Study||2
1584351|NCT01089127|3876539|P4|NOT COMPLETED|Overall Study||1
1584352|NCT01089127|3876540|P3|NOT COMPLETED|Overall Study||2
1584353|NCT01089127|3876541|P2|NOT COMPLETED|Overall Study||5
1584354|NCT01089127|3876542|P1|NOT COMPLETED|Overall Study||8
1584355|NCT01089127|3876537|P6|COMPLETED|Overall Study||88
1584356|NCT01089127|3876538|P5|COMPLETED|Overall Study||90
1584357|NCT01089127|3876539|P4|COMPLETED|Overall Study||91
1584358|NCT01089127|3876540|P3|COMPLETED|Overall Study||92
1584359|NCT01089127|3876541|P2|COMPLETED|Overall Study||86
1584360|NCT01089127|3876542|P1|COMPLETED|Overall Study||84
1584361|NCT01089127|3876537|P6|Exposed to Study Drug|Overall Study||91
1584362|NCT01089127|3876538|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
1584363|NCT01089127|3876539|P4|Exposed to Study Drug|Overall Study||92
1584364|NCT01089127|3876540|P3|Exposed to Study Drug|Overall Study||94
1584365|NCT01089127|3876541|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
1584366|NCT01089127|3876542|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
1584367|NCT01089127|3876537|P6|STARTED|Overall Study||91
1584368|NCT01089127|3876538|P5|STARTED|Overall Study||92
1584369|NCT01089127|3876539|P4|STARTED|Overall Study||92
1584370|NCT01089127|3876540|P3|STARTED|Overall Study||94
1584371|NCT01089127|3876541|P2|STARTED|Overall Study||91
1584372|NCT01089127|3876542|P1|STARTED|Overall Study||92
1584373|NCT01089062|3876568|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1584374|NCT01089062|3876569|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1584375|NCT01089062|3876570|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1584376|NCT01089062|3876571|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1584377|NCT01089062|3876572|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1584378|NCT01089062|3876573|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1584379|NCT01089062|3876568|P6|COMPLETED|Follow-up Visit (Final Visit)||3
1584380|NCT01089062|3876569|P5|COMPLETED|Follow-up Visit (Final Visit)||3
1584381|NCT01089062|3876570|P4|COMPLETED|Follow-up Visit (Final Visit)||3
1584382|NCT01089062|3876571|P3|COMPLETED|Follow-up Visit (Final Visit)||3
1584383|NCT01089062|3876572|P2|COMPLETED|Follow-up Visit (Final Visit)||3
1584384|NCT01089062|3876573|P1|COMPLETED|Follow-up Visit (Final Visit)||3
1584385|NCT01089062|3876568|P6|STARTED|Follow-up Visit (Final Visit)||3
1584386|NCT01089062|3876569|P5|STARTED|Follow-up Visit (Final Visit)||3
1584387|NCT01089062|3876570|P4|STARTED|Follow-up Visit (Final Visit)||3
1584388|NCT01089062|3876571|P3|STARTED|Follow-up Visit (Final Visit)||3
1584389|NCT01089062|3876572|P2|STARTED|Follow-up Visit (Final Visit)||3
1584390|NCT01089062|3876573|P1|STARTED|Follow-up Visit (Final Visit)||3
1584391|NCT01089062|3876568|P6|NOT COMPLETED|Visit 4||0
1584392|NCT01089062|3876569|P5|NOT COMPLETED|Visit 4||0
1584393|NCT01089062|3876570|P4|NOT COMPLETED|Visit 4||0
1584394|NCT01089062|3876571|P3|NOT COMPLETED|Visit 4||0
1584395|NCT01089062|3876572|P2|NOT COMPLETED|Visit 4||0
1584396|NCT01089062|3876573|P1|NOT COMPLETED|Visit 4||0
1584397|NCT01089062|3876568|P6|COMPLETED|Visit 4||3
1584398|NCT01089062|3876569|P5|COMPLETED|Visit 4||3
1584399|NCT01089062|3876570|P4|COMPLETED|Visit 4||3
1584400|NCT01089062|3876571|P3|COMPLETED|Visit 4||3
1584401|NCT01089062|3876572|P2|COMPLETED|Visit 4||3
1584402|NCT01089062|3876573|P1|COMPLETED|Visit 4||3
1584403|NCT01089062|3876568|P6|STARTED|Visit 4||3
1584404|NCT01089062|3876569|P5|STARTED|Visit 4||3
1584405|NCT01089062|3876570|P4|STARTED|Visit 4||3
1584406|NCT01089062|3876571|P3|STARTED|Visit 4||3
1584407|NCT01089062|3876572|P2|STARTED|Visit 4||3
1584408|NCT01089062|3876573|P1|STARTED|Visit 4||3
1584409|NCT01089062|3876568|P6|NOT COMPLETED|Visit 3||0
1584410|NCT01089062|3876569|P5|NOT COMPLETED|Visit 3||0
1584411|NCT01089062|3876570|P4|NOT COMPLETED|Visit 3||1
1584412|NCT01089062|3876571|P3|NOT COMPLETED|Visit 3||0
1584413|NCT01089062|3876572|P2|NOT COMPLETED|Visit 3||0
1584414|NCT01089062|3876573|P1|NOT COMPLETED|Visit 3||0
1584415|NCT01089062|3876568|P6|COMPLETED|Visit 3||3
1584416|NCT01089062|3876569|P5|COMPLETED|Visit 3||3
1584417|NCT01089062|3876570|P4|COMPLETED|Visit 3||3
1584418|NCT01089062|3876571|P3|COMPLETED|Visit 3||3
1584419|NCT01089062|3876572|P2|COMPLETED|Visit 3||3
1584420|NCT01089062|3876573|P1|COMPLETED|Visit 3||3
1584421|NCT01089062|3876568|P6|STARTED|Visit 3||3
1584422|NCT01089062|3876569|P5|STARTED|Visit 3||3
1584423|NCT01089062|3876570|P4|STARTED|Visit 3||4
1584424|NCT01089062|3876571|P3|STARTED|Visit 3||3
1584425|NCT01089062|3876572|P2|STARTED|Visit 3||3
1584426|NCT01089062|3876573|P1|STARTED|Visit 3||3
1584427|NCT01089062|3876568|P6|NOT COMPLETED|Visit 2 (Randomization)||1
1584428|NCT01089062|3876569|P5|NOT COMPLETED|Visit 2 (Randomization)||1
1584429|NCT01089062|3876570|P4|NOT COMPLETED|Visit 2 (Randomization)||0
1584430|NCT01089062|3876571|P3|NOT COMPLETED|Visit 2 (Randomization)||1
1584431|NCT01089062|3876572|P2|NOT COMPLETED|Visit 2 (Randomization)||1
1584432|NCT01089062|3876573|P1|NOT COMPLETED|Visit 2 (Randomization)||1
1584433|NCT01089062|3876568|P6|COMPLETED|Visit 2 (Randomization)||3
1584434|NCT01089062|3876569|P5|COMPLETED|Visit 2 (Randomization)||3
1584435|NCT01089062|3876570|P4|COMPLETED|Visit 2 (Randomization)||4
1584436|NCT01089062|3876571|P3|COMPLETED|Visit 2 (Randomization)||3
1584437|NCT01089062|3876572|P2|COMPLETED|Visit 2 (Randomization)||3
1584438|NCT01089062|3876573|P1|COMPLETED|Visit 2 (Randomization)||3
1584439|NCT01089062|3876568|P6|STARTED|Visit 2 (Randomization)||4
1584440|NCT01089062|3876569|P5|STARTED|Visit 2 (Randomization)||4
1584441|NCT01089062|3876570|P4|STARTED|Visit 2 (Randomization)||4
1584442|NCT01089062|3876571|P3|STARTED|Visit 2 (Randomization)||4
1584443|NCT01089062|3876572|P2|STARTED|Visit 2 (Randomization)||4
1584444|NCT01089062|3876573|P1|STARTED|Visit 2 (Randomization)||4
1584445|NCT01089023|3876596|P1|NOT COMPLETED|Overall Study||7
1584446|NCT01089023|3876596|P1|COMPLETED|Overall Study||88
1584447|NCT01089023|3876596|P1|STARTED|Overall Study||95
1584448|NCT01088997|3876610|P2|NOT COMPLETED|Overall Study||3
1584449|NCT01088997|3876611|P1|NOT COMPLETED|Overall Study||3
1584450|NCT01088997|3876610|P2|COMPLETED|Overall Study||2
1584451|NCT01088997|3876611|P1|COMPLETED|Overall Study||4
1584452|NCT01088997|3876610|P2|STARTED|Overall Study||5
1584453|NCT01088997|3876611|P1|STARTED|Overall Study||7
1584454|NCT01088984|3876622|P2|NOT COMPLETED|Phase 2||32
1584455|NCT01088984|3876623|P1|NOT COMPLETED|Phase 2||0
1584456|NCT01088984|3876622|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
1584457|NCT01088984|3876623|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
1584458|NCT01088984|3876622|P2|STARTED|Phase 2||32
1584459|NCT01088984|3876623|P1|STARTED|Phase 2||0
1584460|NCT01088984|3876622|P2|NOT COMPLETED|Phase 1||6
1584461|NCT01088984|3876623|P1|NOT COMPLETED|Phase 1||5
1584462|NCT01088984|3876622|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
1584463|NCT01088984|3876623|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
1584464|NCT01088984|3876622|P2|STARTED|Phase 1||6
1584465|NCT01088984|3876623|P1|STARTED|Phase 1||5
1584466|NCT01088711|3876645|P4|NOT COMPLETED|Overall Study||0
1584467|NCT01088711|3876646|P3|NOT COMPLETED|Overall Study||0
1584468|NCT01088711|3876647|P2|NOT COMPLETED|Overall Study||0
1584469|NCT01088711|3876648|P1|NOT COMPLETED|Overall Study||0
1584470|NCT01088711|3876645|P4|COMPLETED|Overall Study||2
1584471|NCT01088711|3876646|P3|COMPLETED|Overall Study||6
1584472|NCT01088711|3876647|P2|COMPLETED|Overall Study||6
1584473|NCT01088711|3876648|P1|COMPLETED|Overall Study||18
1584474|NCT01088711|3876645|P4|STARTED|Overall Study||2
1584475|NCT01088711|3876646|P3|STARTED|Overall Study||6
1584476|NCT01088711|3876647|P2|STARTED|Overall Study||6
1584477|NCT01088711|3876648|P1|STARTED|Overall Study||18
1584478|NCT01088672|3876672|P1|NOT COMPLETED|Overall Study||0
1584479|NCT01088672|3876672|P1|COMPLETED|Overall Study||60
1584480|NCT01088672|3876672|P1|STARTED|Overall Study||60
1584481|NCT01088646|3876678|P1|NOT COMPLETED|Overall Study||0
1584482|NCT01088646|3876678|P1|COMPLETED|Overall Study||25
1584483|NCT01088646|3876678|P1|STARTED|Overall Study||25
1584484|NCT01088529|3876684|P2|NOT COMPLETED|Overall Study||1
1584485|NCT01088529|3876685|P1|NOT COMPLETED|Overall Study||0
1584486|NCT01088529|3876684|P2|COMPLETED|Overall Study||21
1584487|NCT01088529|3876685|P1|COMPLETED|Overall Study||44
1584488|NCT01088529|3876684|P2|Received Treatment|Overall Study||21
1584489|NCT01088529|3876685|P1|Received Treatment|Overall Study||44
1584490|NCT01088529|3876684|P2|STARTED|Overall Study||22
1584491|NCT01088529|3876685|P1|STARTED|Overall Study||44
1584492|NCT01088503|3876698|P3|NOT COMPLETED|Overall Study||17
1584493|NCT01088503|3876699|P2|NOT COMPLETED|Overall Study||685
1584494|NCT01088503|3876700|P1|NOT COMPLETED|Overall Study||182
1584495|NCT01088503|3876698|P3|COMPLETED|Overall Study||241
1584496|NCT01088503|3876699|P2|COMPLETED|Overall Study||8161
1584497|NCT01088503|3876700|P1|COMPLETED|Overall Study||2941
1584498|NCT01088503|3876698|P3|STARTED|Overall Study||258
1584499|NCT01088503|3876699|P2|STARTED|Overall Study||8846
1584500|NCT01088503|3876700|P1|STARTED|Overall Study||3123
1584501|NCT01088464|3876724|P3|NOT COMPLETED|Overall Study||0
1584502|NCT01088464|3876725|P2|NOT COMPLETED|Overall Study||0
1584503|NCT01088464|3876726|P1|NOT COMPLETED|Overall Study||0
1584504|NCT01088464|3876724|P3|COMPLETED|Overall Study||6
1584505|NCT01088464|3876725|P2|COMPLETED|Overall Study||6
1584506|NCT01088464|3876726|P1|COMPLETED|Overall Study||3
1584507|NCT01088464|3876724|P3|Received Any Quantity of Study Drug|Overall Study||6
1584508|NCT01088464|3876725|P2|Received Any Quantity of Study Drug|Overall Study||6
1584509|NCT01088464|3876726|P1|Received Any Quantity of Study Drug|Overall Study||3
1584510|NCT01088464|3876724|P3|STARTED|Overall Study||6
1584511|NCT01088464|3876725|P2|STARTED|Overall Study||6
1584512|NCT01088464|3876726|P1|STARTED|Overall Study||3
1584513|NCT01088438|3876778|P2|NOT COMPLETED|Overall Study||36
1584514|NCT01088438|3876779|P1|NOT COMPLETED|Overall Study||29
1584515|NCT01088438|3876778|P2|COMPLETED|Overall Study||59
1584516|NCT01088438|3876779|P1|COMPLETED|Overall Study||65
1584517|NCT01088438|3876778|P2|STARTED|Overall Study||95
1584518|NCT01088438|3876779|P1|STARTED|Overall Study||94
1584519|NCT01088399|3876792|P3|NOT COMPLETED|Overall Study||281
1584520|NCT01088399|3876793|P2|NOT COMPLETED|Overall Study||1347
1584521|NCT01088399|3876794|P1|NOT COMPLETED|Overall Study||7121
1584522|NCT01088399|3876792|P3|COMPLETED|Overall Study||21
1584523|NCT01088399|3876793|P2|COMPLETED|Overall Study||308
1584524|NCT01088399|3876794|P1|COMPLETED|Overall Study||1595
1584525|NCT01088399|3876792|P3|STARTED|Overall Study||302
1584526|NCT01088399|3876793|P2|STARTED|Overall Study||1655
1584527|NCT01088399|3876794|P1|STARTED|Overall Study||8716
1584528|NCT01088295|3876817|P1|NOT COMPLETED|Overall Study||1
1584529|NCT01088295|3876817|P1|COMPLETED|Overall Study||35
1584530|NCT01088295|3876817|P1|STARTED|Overall Study||36
1584531|NCT01088243|3876823|P2|NOT COMPLETED|Overall Study||0
1584532|NCT01088243|3876824|P1|NOT COMPLETED|Overall Study||1
1584533|NCT01088243|3876823|P2|COMPLETED|Overall Study||5
1584534|NCT01088243|3876824|P1|COMPLETED|Overall Study||12
1584535|NCT01088243|3876823|P2|STARTED|Overall Study||5
1584536|NCT01088243|3876824|P1|STARTED|Overall Study||13
1584537|NCT01087996|3876842|P2|NOT COMPLETED|Overall Study||0
1584538|NCT01087996|3876843|P1|NOT COMPLETED|Overall Study||0
1584539|NCT01087996|3876842|P2|COMPLETED|Overall Study||15
1584540|NCT01087996|3876843|P1|COMPLETED|Overall Study||15
1584541|NCT01087996|3876842|P2|STARTED|Overall Study||15
1584542|NCT01087996|3876843|P1|STARTED|Overall Study||15
1584543|NCT01087970|3876865|P1|NOT COMPLETED|Overall Study||2
1584544|NCT01087970|3876865|P1|COMPLETED|Overall Study||67
1584545|NCT01087970|3876865|P1|Received Carboplatin|Overall Study||63
1584635|NCT01087788|3877033|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
1584546|NCT01087970|3876865|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
1584547|NCT01087970|3876865|P1|Completed 6 Cycles|Overall Study||69
1584548|NCT01087970|3876865|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
1584549|NCT01087970|3876865|P1|STARTED|Overall Study||69
1584550|NCT01087957|3876877|P2|NOT COMPLETED|Overall Study||55
1584551|NCT01087957|3876878|P1|NOT COMPLETED|Overall Study||41
1584552|NCT01087957|3876877|P2|COMPLETED|Overall Study||187
1584553|NCT01087957|3876878|P1|COMPLETED|Overall Study||212
1584554|NCT01087957|3876877|P2|STARTED|Overall Study||242
1584555|NCT01087957|3876878|P1|STARTED|Overall Study||253
1584556|NCT01087944|3876904|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
1584557|NCT01087944|3876905|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
1584558|NCT01087944|3876904|P2|COMPLETED|Period 2 (Week 4-6)||28
1584559|NCT01087944|3876905|P1|COMPLETED|Period 2 (Week 4-6)||29
1584560|NCT01087944|3876904|P2|STARTED|Period 2 (Week 4-6)||30
1584561|NCT01087944|3876905|P1|STARTED|Period 2 (Week 4-6)||29
1584562|NCT01087944|3876904|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
1584563|NCT01087944|3876905|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
1584564|NCT01087944|3876904|P2|COMPLETED|Period 1 (Week 1-3)||30
1584565|NCT01087944|3876905|P1|COMPLETED|Period 1 (Week 1-3)||29
1584566|NCT01087944|3876904|P2|STARTED|Period 1 (Week 1-3)||30
1584567|NCT01087944|3876905|P1|STARTED|Period 1 (Week 1-3)||30
1584568|NCT01087931|3876935|P2|NOT COMPLETED|Overall Study||0
1584569|NCT01087931|3876936|P1|NOT COMPLETED|Overall Study||0
1584570|NCT01087931|3876935|P2|COMPLETED|Overall Study||20
1584571|NCT01087931|3876936|P1|COMPLETED|Overall Study||20
1584572|NCT01087931|3876935|P2|Final Follow up|Overall Study||17
1584573|NCT01087931|3876936|P1|Final Follow up|Overall Study||19
1584574|NCT01087931|3876935|P2|1st Follow up|Overall Study||19
1584575|NCT01087931|3876936|P1|1st Follow up|Overall Study||20
1584576|NCT01087931|3876935|P2|STARTED|Overall Study||20
1584577|NCT01087931|3876936|P1|STARTED|Overall Study||20
1584578|NCT01087918|3876950|P2|NOT COMPLETED|Overall Study||0
1584579|NCT01087918|3876951|P1|NOT COMPLETED|Overall Study||0
1584580|NCT01087918|3876950|P2|COMPLETED|Overall Study||4
1584581|NCT01087918|3876951|P1|COMPLETED|Overall Study||5
1584582|NCT01087918|3876950|P2|STARTED|Overall Study||4
1584583|NCT01087918|3876951|P1|STARTED|Overall Study||5
1584584|NCT01087905|3876985|P8|NOT COMPLETED|Overall Study||29
1584585|NCT01087905|3876986|P7|NOT COMPLETED|Overall Study||23
1584586|NCT01087905|3876987|P6|NOT COMPLETED|Overall Study||28
1584587|NCT01087905|3876988|P5|NOT COMPLETED|Overall Study||31
1584588|NCT01087905|3876989|P4|NOT COMPLETED|Overall Study||36
1584589|NCT01087905|3876990|P3|NOT COMPLETED|Overall Study||22
1584590|NCT01087905|3876991|P2|NOT COMPLETED|Overall Study||32
1584591|NCT01087905|3876992|P1|NOT COMPLETED|Overall Study||29
1584592|NCT01087905|3876985|P8|COMPLETED|Overall Study||98
1584593|NCT01087905|3876986|P7|COMPLETED|Overall Study||98
1584594|NCT01087905|3876987|P6|COMPLETED|Overall Study||99
1584595|NCT01087905|3876988|P5|COMPLETED|Overall Study||91
1584596|NCT01087905|3876989|P4|COMPLETED|Overall Study||86
1584597|NCT01087905|3876990|P3|COMPLETED|Overall Study||101
1584598|NCT01087905|3876991|P2|COMPLETED|Overall Study||94
1584599|NCT01087905|3876992|P1|COMPLETED|Overall Study||90
1584600|NCT01087905|3876985|P8|STARTED|Overall Study||127
1584601|NCT01087905|3876986|P7|STARTED|Overall Study||121
1584602|NCT01087905|3876987|P6|STARTED|Overall Study||127
1584603|NCT01087905|3876988|P5|STARTED|Overall Study||122
1584604|NCT01087905|3876989|P4|STARTED|Overall Study||122
1584605|NCT01087905|3876990|P3|STARTED|Overall Study||123
1584606|NCT01087905|3876991|P2|STARTED|Overall Study||126
1584607|NCT01087905|3876992|P1|STARTED|Overall Study||119
1584608|NCT01087814|3877014|P2|NOT COMPLETED|Second Intervention (5 Days)||0
1584609|NCT01087814|3877015|P1|NOT COMPLETED|Second Intervention (5 Days)||1
1584610|NCT01087814|3877014|P2|COMPLETED|Second Intervention (5 Days)||6
1584611|NCT01087814|3877015|P1|COMPLETED|Second Intervention (5 Days)||4
1584612|NCT01087814|3877014|P2|STARTED|Second Intervention (5 Days)||6
1584613|NCT01087814|3877015|P1|STARTED|Second Intervention (5 Days)||5
1584614|NCT01087814|3877014|P2|NOT COMPLETED|First Intervention (5 Days)||1
1584615|NCT01087814|3877015|P1|NOT COMPLETED|First Intervention (5 Days)||3
1584616|NCT01087814|3877014|P2|COMPLETED|First Intervention (5 Days)||6
1584617|NCT01087814|3877015|P1|COMPLETED|First Intervention (5 Days)||5
1584618|NCT01087814|3877014|P2|STARTED|First Intervention (5 Days)||7
1584619|NCT01087814|3877015|P1|STARTED|First Intervention (5 Days)||8
1584620|NCT01087801|3877023|P2|NOT COMPLETED|Overall Study||5
1584621|NCT01087801|3877024|P1|NOT COMPLETED|Overall Study||4
1584622|NCT01087801|3877023|P2|COMPLETED|Overall Study||29
1584623|NCT01087801|3877024|P1|COMPLETED|Overall Study||26
1584624|NCT01087801|3877023|P2|STARTED|Overall Study||34
1584625|NCT01087801|3877024|P1|STARTED|Overall Study||30
1584626|NCT01087788|3877033|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
1584627|NCT01087788|3877034|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
1584628|NCT01087788|3877035|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
1584629|NCT01087788|3877033|P3|COMPLETED|Open-Label Period (OL-P)||86
1584630|NCT01087788|3877034|P2|COMPLETED|Open-Label Period (OL-P)||97
1584631|NCT01087788|3877035|P1|COMPLETED|Open-Label Period (OL-P)||81
1584632|NCT01087788|3877033|P3|STARTED|Open-Label Period (OL-P)||114
1584633|NCT01087788|3877034|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
1584634|NCT01087788|3877035|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
1584636|NCT01087788|3877034|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
1584637|NCT01087788|3877035|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
1584638|NCT01087788|3877033|P3|COMPLETED|24-weeks Dose-blind Period||114
1584639|NCT01087788|3877034|P2|COMPLETED|24-weeks Dose-blind Period||123
1584640|NCT01087788|3877035|P1|COMPLETED|24-weeks Dose-blind Period||113
1584641|NCT01087788|3877033|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1584642|NCT01087788|3877034|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1584643|NCT01087788|3877035|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
1584644|NCT01087788|3877033|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1584645|NCT01087788|3877034|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1584646|NCT01087788|3877035|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
1584647|NCT01087788|3877033|P3|STARTED|24-weeks Dose-blind Period||120
1584648|NCT01087788|3877034|P2|STARTED|24-weeks Dose-blind Period||128
1584649|NCT01087788|3877035|P1|STARTED|24-weeks Dose-blind Period||120
1584650|NCT01087788|3877033|P3|NOT COMPLETED|24-weeks Double-blind Period||15
1584651|NCT01087788|3877034|P2|NOT COMPLETED|24-weeks Double-blind Period||10
1584652|NCT01087788|3877035|P1|NOT COMPLETED|24-weeks Double-blind Period||16
1584653|NCT01087788|3877033|P3|COMPLETED|24-weeks Double-blind Period||120
1584654|NCT01087788|3877034|P2|COMPLETED|24-weeks Double-blind Period||128
1584655|NCT01087788|3877035|P1|COMPLETED|24-weeks Double-blind Period||120
1584656|NCT01087788|3877033|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1584657|NCT01087788|3877034|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1584658|NCT01087788|3877035|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
1584659|NCT01087788|3877033|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1584660|NCT01087788|3877034|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1584661|NCT01087788|3877035|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
1584662|NCT01087788|3877033|P3|STARTED|24-weeks Double-blind Period||135
1584663|NCT01087788|3877034|P2|STARTED|24-weeks Double-blind Period||138
1584664|NCT01087788|3877035|P1|STARTED|24-weeks Double-blind Period||136
1584665|NCT01087762|3877065|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
1584666|NCT01087762|3877066|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
1584667|NCT01087762|3877067|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
1584668|NCT01087762|3877068|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
1584669|NCT01087762|3877069|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
1584670|NCT01087762|3877065|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
1584671|NCT01087762|3877066|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
1584672|NCT01087762|3877067|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
1584673|NCT01087762|3877068|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
1584674|NCT01087762|3877069|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
1584675|NCT01087762|3877065|P5|STARTED|Open-Label Period (Weeks 48-204)||157
1584676|NCT01087762|3877066|P4|STARTED|Open-Label Period (Weeks 48-204)||158
1584677|NCT01087762|3877067|P3|STARTED|Open-Label Period (Weeks 48-204)||0
1584678|NCT01087762|3877068|P2|STARTED|Open-Label Period (Weeks 48-204)||0
1584679|NCT01087762|3877069|P1|STARTED|Open-Label Period (Weeks 48-204)||0
1584680|NCT01087762|3877065|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
1584681|NCT01087762|3877066|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
1584682|NCT01087762|3877067|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
1584683|NCT01087762|3877068|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
1584684|NCT01087762|3877069|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
1584685|NCT01087762|3877065|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
1584686|NCT01087762|3877066|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
1584687|NCT01087762|3877067|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
1584688|NCT01087762|3877068|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
1584689|NCT01087762|3877069|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
1584690|NCT01087762|3877065|P5|STARTED|Double Blind Period (Weeks 0-24)||0
1584691|NCT01087762|3877066|P4|STARTED|Double Blind Period (Weeks 0-24)||0
1584692|NCT01087762|3877067|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
1584693|NCT01087762|3877068|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
1584694|NCT01087762|3877069|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
1584695|NCT01087736|3877117|P2|NOT COMPLETED|Overall Study||2
1584696|NCT01087736|3877118|P1|NOT COMPLETED|Overall Study||1
1584697|NCT01087736|3877117|P2|COMPLETED|Overall Study||14
1584698|NCT01087736|3877118|P1|COMPLETED|Overall Study||13
1584699|NCT01087736|3877117|P2|STARTED|Overall Study||16
1584700|NCT01087736|3877118|P1|STARTED|Overall Study||14
1584701|NCT01087723|3877128|P2|NOT COMPLETED|Overall Study||20
1584702|NCT01087723|3877129|P1|NOT COMPLETED|Overall Study||14
1584703|NCT01087723|3877128|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
1584704|NCT01087723|3877129|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
1584705|NCT01087723|3877128|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
1584796|NCT01086410|3877370|P3|STARTED|Overall Study||56
1584706|NCT01087723|3877129|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
1584707|NCT01087723|3877128|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
1584708|NCT01087723|3877129|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
1584709|NCT01087541|3877153|P2|NOT COMPLETED|Overall Study||0
1584710|NCT01087541|3877154|P1|NOT COMPLETED|Overall Study||0
1584711|NCT01087541|3877153|P2|COMPLETED|Overall Study||3523
1584712|NCT01087541|3877154|P1|COMPLETED|Overall Study||3307
1584713|NCT01087541|3877153|P2|STARTED|Overall Study||3523
1584714|NCT01087541|3877154|P1|STARTED|Overall Study||3307
1584715|NCT01087528|3877170|P1|NOT COMPLETED|Overall Study||7
1584716|NCT01087528|3877170|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
1584717|NCT01087528|3877170|P1|STARTED|Overall Study||51
1584718|NCT01087502|3877176|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
1584719|NCT01087502|3877177|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
1584720|NCT01087502|3877176|P2|COMPLETED|Up to Final Analysis (Week 52)||95
1584721|NCT01087502|3877177|P1|COMPLETED|Up to Final Analysis (Week 52)||90
1584722|NCT01087502|3877176|P2|STARTED|Up to Final Analysis (Week 52)||118
1584723|NCT01087502|3877177|P1|STARTED|Up to Final Analysis (Week 52)||123
1584724|NCT01087502|3877176|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
1584725|NCT01087502|3877177|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
1584726|NCT01087502|3877176|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
1584727|NCT01087502|3877177|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
1584728|NCT01087502|3877176|P2|STARTED|Up to Interim Analysis (Week 12)||118
1584729|NCT01087502|3877177|P1|STARTED|Up to Interim Analysis (Week 12)||123
1584730|NCT01087489|3877196|P2|NOT COMPLETED|Overall Study||3
1584731|NCT01087489|3877197|P1|NOT COMPLETED|Overall Study||0
1584732|NCT01087489|3877196|P2|COMPLETED|Overall Study||31
1584733|NCT01087489|3877197|P1|COMPLETED|Overall Study||19
1584734|NCT01087489|3877196|P2|STARTED|Overall Study||34
1584735|NCT01087489|3877197|P1|STARTED|Overall Study||19
1584736|NCT01086969|3877210|P3|NOT COMPLETED|Overall Study||0
1584737|NCT01086969|3877211|P2|NOT COMPLETED|Overall Study||2
1584738|NCT01086969|3877212|P1|NOT COMPLETED|Overall Study||1
1584739|NCT01086969|3877210|P3|COMPLETED|Overall Study||100
1584740|NCT01086969|3877211|P2|COMPLETED|Overall Study||98
1584741|NCT01086969|3877212|P1|COMPLETED|Overall Study||99
1584742|NCT01086969|3877210|P3|STARTED|Overall Study||100
1584743|NCT01086969|3877211|P2|STARTED|Overall Study||100
1584744|NCT01086969|3877212|P1|STARTED|Overall Study||100
1584745|NCT01086852|3877229|P1|NOT COMPLETED|Overall Study||0
1584746|NCT01086852|3877229|P1|COMPLETED|Overall Study||4
1584747|NCT01086852|3877229|P1|STARTED|Overall Study||4
1584748|NCT01086761|3877245|P6|NOT COMPLETED|Overall Study||0
1584749|NCT01086761|3877246|P5|NOT COMPLETED|Overall Study||0
1584750|NCT01086761|3877247|P4|NOT COMPLETED|Overall Study||0
1584751|NCT01086761|3877248|P3|NOT COMPLETED|Overall Study||0
1584752|NCT01086761|3877249|P2|NOT COMPLETED|Overall Study||0
1584753|NCT01086761|3877250|P1|NOT COMPLETED|Overall Study||0
1584754|NCT01086761|3877245|P6|COMPLETED|Overall Study||0
1584755|NCT01086761|3877246|P5|COMPLETED|Overall Study||4
1584756|NCT01086761|3877247|P4|COMPLETED|Overall Study||6
1584757|NCT01086761|3877248|P3|COMPLETED|Overall Study||6
1584758|NCT01086761|3877249|P2|COMPLETED|Overall Study||7
1584759|NCT01086761|3877250|P1|COMPLETED|Overall Study||9
1584760|NCT01086761|3877245|P6|STARTED|Overall Study||0
1584761|NCT01086761|3877246|P5|STARTED|Overall Study||4
1584762|NCT01086761|3877247|P4|STARTED|Overall Study||6
1584763|NCT01086761|3877248|P3|STARTED|Overall Study||6
1584764|NCT01086761|3877249|P2|STARTED|Overall Study||7
1584765|NCT01086761|3877250|P1|STARTED|Overall Study||9
1584766|NCT01086605|3877290|P2|NOT COMPLETED|Overall Study||0
1584767|NCT01086605|3877291|P1|NOT COMPLETED|Overall Study||0
1584768|NCT01086605|3877290|P2|COMPLETED|Overall Study||22
1584769|NCT01086605|3877291|P1|COMPLETED|Overall Study||24
1584770|NCT01086605|3877290|P2|STARTED|Overall Study||22
1584771|NCT01086605|3877291|P1|STARTED|Overall Study||24
1584772|NCT01086475|3877308|P2|NOT COMPLETED|Overall Study||0
1584773|NCT01086475|3877309|P1|NOT COMPLETED|Overall Study||0
1584774|NCT01086475|3877308|P2|COMPLETED|Overall Study||33
1584775|NCT01086475|3877309|P1|COMPLETED|Overall Study||34
1584776|NCT01086475|3877308|P2|STARTED|Overall Study||33
1584777|NCT01086475|3877309|P1|STARTED|Overall Study||34
1584778|NCT01086423|3877322|P3|NOT COMPLETED|Overall Study||9
1584779|NCT01086423|3877323|P2|NOT COMPLETED|Overall Study||3
1584780|NCT01086423|3877324|P1|NOT COMPLETED|Overall Study||10
1584781|NCT01086423|3877322|P3|COMPLETED|Overall Study||321
1584782|NCT01086423|3877323|P2|COMPLETED|Overall Study||321
1584783|NCT01086423|3877324|P1|COMPLETED|Overall Study||320
1584784|NCT01086423|3877322|P3|STARTED|Overall Study||330
1584785|NCT01086423|3877323|P2|STARTED|Overall Study||324
1584786|NCT01086423|3877324|P1|STARTED|Overall Study||330
1584787|NCT01086410|3877369|P4|NOT COMPLETED|Overall Study||2
1584788|NCT01086410|3877370|P3|NOT COMPLETED|Overall Study||1
1584789|NCT01086410|3877371|P2|NOT COMPLETED|Overall Study||2
1584790|NCT01086410|3877372|P1|NOT COMPLETED|Overall Study||3
1584791|NCT01086410|3877369|P4|COMPLETED|Overall Study||13
1584792|NCT01086410|3877370|P3|COMPLETED|Overall Study||55
1584793|NCT01086410|3877371|P2|COMPLETED|Overall Study||54
1584794|NCT01086410|3877372|P1|COMPLETED|Overall Study||55
1584795|NCT01086410|3877369|P4|STARTED|Overall Study||15
1584797|NCT01086410|3877371|P2|STARTED|Overall Study||56
1584798|NCT01086410|3877372|P1|STARTED|Overall Study||58
1584799|NCT01086384|3877468|P3|NOT COMPLETED|Treatment Period||124
1584800|NCT01086384|3877469|P2|NOT COMPLETED|Treatment Period||148
1584801|NCT01086384|3877470|P1|NOT COMPLETED|Treatment Period||0
1584802|NCT01086384|3877468|P3|COMPLETED|Treatment Period||885
1584803|NCT01086384|3877469|P2|COMPLETED|Treatment Period||863
1584804|NCT01086384|3877470|P1|COMPLETED|Treatment Period||0
1584805|NCT01086384|3877468|P3|STARTED|Treatment Period||1009
1584806|NCT01086384|3877469|P2|STARTED|Treatment Period||1011
1584807|NCT01086384|3877470|P1|STARTED|Treatment Period||0
1584808|NCT01086384|3877468|P3|NOT COMPLETED|2-week Run-in Period||0
1584809|NCT01086384|3877469|P2|NOT COMPLETED|2-week Run-in Period||0
1584810|NCT01086384|3877470|P1|NOT COMPLETED|2-week Run-in Period||163
1584811|NCT01086384|3877468|P3|COMPLETED|2-week Run-in Period||0
1584812|NCT01086384|3877469|P2|COMPLETED|2-week Run-in Period||0
1584813|NCT01086384|3877470|P1|COMPLETED|2-week Run-in Period||2020
1584814|NCT01086384|3877468|P3|STARTED|2-week Run-in Period||0
1584815|NCT01086384|3877469|P2|STARTED|2-week Run-in Period||0
1584816|NCT01086384|3877470|P1|STARTED|2-week Run-in Period||2183
1584817|NCT01086358|3877480|P2|NOT COMPLETED|Second Intervention||4
1584818|NCT01086358|3877481|P1|NOT COMPLETED|Second Intervention||4
1584819|NCT01086358|3877480|P2|COMPLETED|Second Intervention||20
1584820|NCT01086358|3877481|P1|COMPLETED|Second Intervention||17
1584821|NCT01086358|3877480|P2|STARTED|Second Intervention||24
1584822|NCT01086358|3877481|P1|STARTED|Second Intervention||21
1584823|NCT01086358|3877480|P2|NOT COMPLETED|First Intervention||5
1584824|NCT01086358|3877481|P1|NOT COMPLETED|First Intervention||9
1584825|NCT01086358|3877480|P2|COMPLETED|First Intervention||24
1584826|NCT01086358|3877481|P1|COMPLETED|First Intervention||21
1584827|NCT01086358|3877480|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
1584828|NCT01086358|3877481|P1|STARTED|First Intervention|30 subjects enrolled.|30
1584829|NCT01086228|3877493|P1|NOT COMPLETED|5-year Follow-up||652
1584830|NCT01086228|3877493|P1|COMPLETED|5-year Follow-up||1012
1584831|NCT01086228|3877493|P1|STARTED|5-year Follow-up||1664
1584832|NCT01086228|3877493|P1|NOT COMPLETED|4-year Follow-up||103
1584833|NCT01086228|3877493|P1|COMPLETED|4-year Follow-up||1664
1584834|NCT01086228|3877493|P1|STARTED|4-year Follow-up||1767
1584835|NCT01086228|3877493|P1|NOT COMPLETED|3-year Follow-up||67
1584836|NCT01086228|3877493|P1|COMPLETED|3-year Follow-up||1767
1584837|NCT01086228|3877493|P1|STARTED|3-year Follow-up||1834
1584838|NCT01086228|3877493|P1|NOT COMPLETED|2-year Follow-up||60
1584839|NCT01086228|3877493|P1|COMPLETED|2-year Follow-up||1834
1584840|NCT01086228|3877493|P1|STARTED|2-year Follow-up||1894
1584841|NCT01086228|3877493|P1|NOT COMPLETED|1-year Follow-up||44
1584842|NCT01086228|3877493|P1|COMPLETED|1-year Follow-up||1894
1584843|NCT01086228|3877493|P1|STARTED|1-year Follow-up||1938
1584844|NCT01086228|3877493|P1|NOT COMPLETED|8 Month Follow-up||71
1584845|NCT01086228|3877493|P1|COMPLETED|8 Month Follow-up||1938
1584846|NCT01086228|3877493|P1|STARTED|8 Month Follow-up|Analysis population|2009
1584847|NCT01086215|3877551|P4|NOT COMPLETED|Overall Study||3
1584848|NCT01086215|3877552|P3|NOT COMPLETED|Overall Study||26
1584849|NCT01086215|3877553|P2|NOT COMPLETED|Overall Study||47
1584850|NCT01086215|3877554|P1|NOT COMPLETED|Overall Study||36
1584851|NCT01086215|3877551|P4|COMPLETED|Overall Study||11
1584852|NCT01086215|3877552|P3|COMPLETED|Overall Study||47
1584853|NCT01086215|3877553|P2|COMPLETED|Overall Study||154
1584854|NCT01086215|3877554|P1|COMPLETED|Overall Study||176
1584855|NCT01086215|3877551|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
1584856|NCT01086215|3877552|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
1584857|NCT01086215|3877553|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
1584858|NCT01086215|3877554|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
1584859|NCT01086215|3877551|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
1584860|NCT01086215|3877552|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
1584861|NCT01086215|3877553|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
1584862|NCT01086215|3877554|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
1584863|NCT01086215|3877551|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
1584864|NCT01086215|3877552|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
1584865|NCT01086215|3877553|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
1584866|NCT01086215|3877554|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
1584867|NCT01086215|3877551|P4|STARTED|Overall Study||14
1584868|NCT01086215|3877552|P3|STARTED|Overall Study||73
1584869|NCT01086215|3877553|P2|STARTED|Overall Study||201
1584870|NCT01086215|3877554|P1|STARTED|Overall Study||212
1584871|NCT01086033|3877572|P1|NOT COMPLETED|Overall Study||304
1584872|NCT01086033|3877572|P1|COMPLETED|Overall Study||262
1584873|NCT01086033|3877572|P1|STARTED|Overall Study||566
1584874|NCT01085968|3877586|P2|NOT COMPLETED|Overall Study||4
1584875|NCT01085968|3877587|P1|NOT COMPLETED|Overall Study||10
1584876|NCT01085968|3877586|P2|COMPLETED|Overall Study||21
1584877|NCT01085968|3877587|P1|COMPLETED|Overall Study||19
1584878|NCT01085968|3877586|P2|STARTED|Overall Study||25
1584879|NCT01085968|3877587|P1|STARTED|Overall Study||29
1584880|NCT01085903|3877603|P3|NOT COMPLETED|Overall Study||0
1584881|NCT01085903|3877604|P2|NOT COMPLETED|Overall Study||0
1584882|NCT01085903|3877605|P1|NOT COMPLETED|Overall Study||0
1584883|NCT01085903|3877603|P3|COMPLETED|Overall Study||3
1584884|NCT01085903|3877604|P2|COMPLETED|Overall Study||4
1584885|NCT01085903|3877605|P1|COMPLETED|Overall Study||21
1584886|NCT01085903|3877603|P3|STARTED|Overall Study||3
1584887|NCT01085903|3877604|P2|STARTED|Overall Study||4
1584888|NCT01085903|3877605|P1|STARTED|Overall Study||21
1584889|NCT01085825|3877631|P2|NOT COMPLETED|Overall Study||1
1584890|NCT01085825|3877632|P1|NOT COMPLETED|Overall Study||1
1584891|NCT01085825|3877631|P2|COMPLETED|Overall Study||247
1584892|NCT01085825|3877632|P1|COMPLETED|Overall Study||251
1584893|NCT01085825|3877631|P2|STARTED|Overall Study||248
1584894|NCT01085825|3877632|P1|STARTED|Overall Study|1st participant enrolled|252
1584895|NCT01085786|3877640|P2|NOT COMPLETED|Overall Study||0
1584896|NCT01085786|3877641|P1|NOT COMPLETED|Overall Study||0
1584897|NCT01085786|3877640|P2|COMPLETED|Overall Study||117
1584898|NCT01085786|3877641|P1|COMPLETED|Overall Study||123
1584899|NCT01085786|3877640|P2|STARTED|Overall Study||117
1584900|NCT01085786|3877641|P1|STARTED|Overall Study||123
1584901|NCT01085760|3877651|P4|NOT COMPLETED|Overall Study||3
1584902|NCT01085760|3877652|P3|NOT COMPLETED|Overall Study||2
1584903|NCT01085760|3877653|P2|NOT COMPLETED|Overall Study||1
1584904|NCT01085760|3877654|P1|NOT COMPLETED|Overall Study||1
1584905|NCT01085760|3877651|P4|COMPLETED|Overall Study||6
1584906|NCT01085760|3877652|P3|COMPLETED|Overall Study||7
1584907|NCT01085760|3877653|P2|COMPLETED|Overall Study||8
1584908|NCT01085760|3877654|P1|COMPLETED|Overall Study||7
1584909|NCT01085760|3877651|P4|STARTED|Overall Study||9
1584910|NCT01085760|3877652|P3|STARTED|Overall Study||9
1584911|NCT01085760|3877653|P2|STARTED|Overall Study||9
1584912|NCT01085760|3877654|P1|STARTED|Overall Study||8
1584913|NCT01085734|3877678|P2|NOT COMPLETED|Overall Study||4
1584914|NCT01085734|3877679|P1|NOT COMPLETED|Overall Study||1
1584915|NCT01085734|3877678|P2|COMPLETED|Overall Study||11
1584916|NCT01085734|3877679|P1|COMPLETED|Overall Study||14
1584917|NCT01085734|3877678|P2|STARTED|Overall Study||15
1584918|NCT01085734|3877679|P1|STARTED|Overall Study||15
1584919|NCT01085682|3877691|P2|NOT COMPLETED|Overall Study||25
1584920|NCT01085682|3877692|P1|NOT COMPLETED|Overall Study||25
1584921|NCT01085682|3877691|P2|COMPLETED|Overall Study||3
1584922|NCT01085682|3877692|P1|COMPLETED|Overall Study||6
1584923|NCT01085682|3877691|P2|STARTED|Overall Study||28
1584924|NCT01085682|3877692|P1|STARTED|Overall Study||31
1584925|NCT01085643|3877698|P1|NOT COMPLETED|Overall Study||0
1584926|NCT01085643|3877698|P1|COMPLETED|Overall Study||4
1584927|NCT01085643|3877698|P1|STARTED|Overall Study||4
1584928|NCT01085591|3877710|P3|NOT COMPLETED|Overall Study||7
1584929|NCT01085591|3877711|P2|NOT COMPLETED|Overall Study||6
1584930|NCT01085591|3877712|P1|NOT COMPLETED|Overall Study||3
1584931|NCT01085591|3877710|P3|COMPLETED|Overall Study||63
1584932|NCT01085591|3877711|P2|COMPLETED|Overall Study||65
1584933|NCT01085591|3877712|P1|COMPLETED|Overall Study||66
1584934|NCT01085591|3877710|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
1584935|NCT01085591|3877711|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
1584936|NCT01085591|3877712|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
1584937|NCT01085591|3877710|P3|STARTED|Overall Study||70
1584938|NCT01085591|3877711|P2|STARTED|Overall Study||71
1584939|NCT01085591|3877712|P1|STARTED|Overall Study||69
1584940|NCT01085539|3877735|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
1584941|NCT01085539|3877735|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
1584942|NCT01085539|3877735|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
1584943|NCT01085539|3877735|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
1584944|NCT01085539|3877735|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
1584945|NCT01085539|3877735|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
1584946|NCT01085539|3877735|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
1584947|NCT01085539|3877735|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
1584948|NCT01085539|3877735|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
1584949|NCT01085539|3877735|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
1584950|NCT01085539|3877735|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
1584951|NCT01085539|3877735|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
1584952|NCT01085539|3877735|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
1584953|NCT01085539|3877735|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
1584954|NCT01085539|3877735|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
1584955|NCT01085513|3877741|P2|NOT COMPLETED|Overall Study||0
1584956|NCT01085513|3877742|P1|NOT COMPLETED|Overall Study||0
1584957|NCT01085513|3877741|P2|COMPLETED|Overall Study||68
1584958|NCT01085513|3877742|P1|COMPLETED|Overall Study|recruitment was premature terminated|75
1584959|NCT01085513|3877741|P2|STARTED|Overall Study||68
1584960|NCT01085513|3877742|P1|STARTED|Overall Study||75
1584961|NCT01085500|3877750|P2|NOT COMPLETED|Overall Study||0
1584962|NCT01085500|3877751|P1|NOT COMPLETED|Overall Study||0
1584963|NCT01085500|3877750|P2|COMPLETED|Overall Study||24
1584964|NCT01085500|3877751|P1|COMPLETED|Overall Study||26
1584965|NCT01085500|3877750|P2|STARTED|Overall Study||24
1584966|NCT01085500|3877751|P1|STARTED|Overall Study||26
1584967|NCT01085357|3877763|P2|NOT COMPLETED|Overall Study||6
1584968|NCT01085357|3877764|P1|NOT COMPLETED|Overall Study||19
1584969|NCT01085357|3877763|P2|COMPLETED|Overall Study||125
1584970|NCT01085357|3877764|P1|COMPLETED|Overall Study||355
1584971|NCT01085357|3877763|P2|STARTED|Overall Study||131
1584972|NCT01085357|3877764|P1|STARTED|Overall Study||374
1584973|NCT01085331|3877776|P2|NOT COMPLETED|Overall Study||0
1584974|NCT01085331|3877777|P1|NOT COMPLETED|Overall Study||0
1584975|NCT01085331|3877776|P2|COMPLETED|Overall Study||6
1584976|NCT01085331|3877777|P1|COMPLETED|Overall Study||10
1584977|NCT01085331|3877776|P2|STARTED|Overall Study||6
1584978|NCT01085331|3877777|P1|STARTED|Overall Study||10
1584979|NCT01085318|3877816|P2|NOT COMPLETED|Overall Study||0
1584980|NCT01085318|3877817|P1|NOT COMPLETED|Overall Study||2
1584981|NCT01085318|3877816|P2|COMPLETED|Overall Study||15
1584982|NCT01085318|3877817|P1|COMPLETED|Overall Study||21
1584983|NCT01085318|3877816|P2|STARTED|Overall Study||15
1584984|NCT01085318|3877817|P1|STARTED|Overall Study||23
1584985|NCT01085214|3877827|P1|NOT COMPLETED|Overall Study||1
1584986|NCT01085214|3877827|P1|COMPLETED|Overall Study||36
1584987|NCT01085214|3877827|P1|STARTED|Overall Study||37
1584988|NCT01085201|3877839|P5|NOT COMPLETED|Overall Study||0
1584989|NCT01085201|3877840|P4|NOT COMPLETED|Overall Study||0
1584990|NCT01085201|3877841|P3|NOT COMPLETED|Overall Study||2
1584991|NCT01085201|3877842|P2|NOT COMPLETED|Overall Study||1
1584992|NCT01085201|3877843|P1|NOT COMPLETED|Overall Study||3
1584993|NCT01085201|3877839|P5|COMPLETED|Overall Study||3
1584994|NCT01085201|3877840|P4|COMPLETED|Overall Study||6
1584995|NCT01085201|3877841|P3|COMPLETED|Overall Study||3
1584996|NCT01085201|3877842|P2|COMPLETED|Overall Study||6
1584997|NCT01085201|3877843|P1|COMPLETED|Overall Study||15
1584998|NCT01085201|3877839|P5|STARTED|Overall Study||3
1584999|NCT01085201|3877840|P4|STARTED|Overall Study||6
1585000|NCT01085201|3877841|P3|STARTED|Overall Study||5
1585001|NCT01085201|3877842|P2|STARTED|Overall Study||7
1585002|NCT01085201|3877843|P1|STARTED|Overall Study||18
1585003|NCT01085136|3877865|P3|NOT COMPLETED|Part B||26
1585004|NCT01085136|3877866|P2|NOT COMPLETED|Part B||51
1585005|NCT01085136|3877867|P1|NOT COMPLETED|Part B||0
1585006|NCT01085136|3877865|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
1585007|NCT01085136|3877866|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
1585008|NCT01085136|3877867|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
1585009|NCT01085136|3877865|P3|STARTED|Part B||68
1585010|NCT01085136|3877866|P2|STARTED|Part B||138
1585011|NCT01085136|3877867|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
1585012|NCT01085136|3877865|P3|NOT COMPLETED|Part A||0
1585013|NCT01085136|3877866|P2|NOT COMPLETED|Part A||0
1585014|NCT01085136|3877867|P1|NOT COMPLETED|Part A||323
1585015|NCT01085136|3877865|P3|COMPLETED|Part A||0
1585016|NCT01085136|3877866|P2|COMPLETED|Part A||0
1585017|NCT01085136|3877867|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
1585018|NCT01085136|3877865|P3|Randomized to Part B|Part A||0
1585019|NCT01085136|3877866|P2|Randomized to Part B|Part A||0
1585020|NCT01085136|3877867|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
1585021|NCT01085136|3877865|P3|STARTED|Part A||0
1585022|NCT01085136|3877866|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
1585023|NCT01085136|3877867|P1|STARTED|Part A||1154
1585024|NCT01085045|3877883|P1|NOT COMPLETED|Part B||15
1585025|NCT01085045|3877883|P1|COMPLETED|Part B||89
1585026|NCT01085045|3877883|P1|GP MDI 36 µg (PT001)|Part B||0
1585027|NCT01085045|3877883|P1|Foradil 12 µg|Part B||41
1585028|NCT01085045|3877883|P1|Placebo MDI|Part B||47
1585029|NCT01085045|3877883|P1|FF MDI 7.2 µg (PT005)|Part B||43
1585030|NCT01085045|3877883|P1|FF MDI 9.6 µg (PT005)|Part B||43
1585031|NCT01085045|3877883|P1|Spiriva 18 µg|Part B||0
1585032|NCT01085045|3877883|P1|GFF MDI 36/9.6 µg|Part B||0
1585033|NCT01085045|3877883|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
1585034|NCT01085045|3877883|P1|STARTED|Part B||104
1585035|NCT01085045|3877883|P1|NOT COMPLETED|Part A||18
1585036|NCT01085045|3877883|P1|COMPLETED|Part A||104
1585037|NCT01085045|3877883|P1|Foradil 12 µg|Part A||14
1585038|NCT01085045|3877883|P1|Placebo MDI|Part A||5
1585039|NCT01085045|3877883|P1|FF MDI 7.2 µg (PT005)|Part A||21
1585040|NCT01085045|3877883|P1|FF MDI 9.6 µg (PT005)|Part A||20
1585041|NCT01085045|3877883|P1|Spiriva 18 µg|Part A||58
1585042|NCT01085045|3877883|P1|GP MDI 36 µg (PT001)|Part A||40
1585043|NCT01085045|3877883|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
1585044|NCT01085045|3877883|P1|GFF MDI 72/9.6mcg|Part A||40
1585045|NCT01085045|3877883|P1|STARTED|Part A||122
1585046|NCT01085006|3877985|P2|NOT COMPLETED|Overall Study||0
1585047|NCT01085006|3877986|P1|NOT COMPLETED|Overall Study||0
1585048|NCT01085006|3877985|P2|COMPLETED|Overall Study||50
1585049|NCT01085006|3877986|P1|COMPLETED|Overall Study||50
1585050|NCT01085006|3877985|P2|STARTED|Overall Study||50
1585051|NCT01085006|3877986|P1|STARTED|Overall Study||50
1585052|NCT01084759|3877992|P1|NOT COMPLETED|Overall Study||2
1585053|NCT01084759|3877992|P1|COMPLETED|Overall Study||14
1585054|NCT01084759|3877992|P1|STARTED|Overall Study||16
1585055|NCT01084707|3877998|P1|NOT COMPLETED|Overall Study||6
1585056|NCT01084707|3877998|P1|COMPLETED|Overall Study||34
1585057|NCT01084707|3877998|P1|STARTED|Overall Study||40
1585058|NCT01084668|3878032|P1|NOT COMPLETED|Overall Study||9
1585059|NCT01084668|3878032|P1|COMPLETED|Overall Study||33
1585060|NCT01084668|3878032|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
1585061|NCT01084603|3878041|P1|NOT COMPLETED|Oral Nicotine 4||0
1585062|NCT01084603|3878041|P1|COMPLETED|Oral Nicotine 4||39
1585063|NCT01084603|3878041|P1|STARTED|Oral Nicotine 4||39
1585064|NCT01084603|3878041|P1|NOT COMPLETED|Washout Period 4||1
1585065|NCT01084603|3878041|P1|COMPLETED|Washout Period 4||39
1585066|NCT01084603|3878041|P1|STARTED|Washout Period 4||40
1585067|NCT01084603|3878041|P1|NOT COMPLETED|Oral Nicotine 2||0
1585068|NCT01084603|3878041|P1|COMPLETED|Oral Nicotine 2||40
1585069|NCT01084603|3878041|P1|STARTED|Oral Nicotine 2||40
1585070|NCT01084603|3878041|P1|NOT COMPLETED|Washout Period 3||0
1585071|NCT01084603|3878041|P1|COMPLETED|Washout Period 3||40
1585072|NCT01084603|3878041|P1|STARTED|Washout Period 3||40
1585073|NCT01084603|3878041|P1|NOT COMPLETED|Oral Nicotine 1||1
1585074|NCT01084603|3878041|P1|COMPLETED|Oral Nicotine 1||40
1585075|NCT01084603|3878041|P1|STARTED|Oral Nicotine 1||41
1585076|NCT01084603|3878041|P1|NOT COMPLETED|Washout Period 2||0
1585077|NCT01084603|3878041|P1|COMPLETED|Washout Period 2||41
1585078|NCT01084603|3878041|P1|STARTED|Washout Period 2||41
1585079|NCT01084603|3878041|P1|NOT COMPLETED|Nicorette® Gum||1
1585080|NCT01084603|3878041|P1|COMPLETED|Nicorette® Gum||41
1585081|NCT01084603|3878041|P1|STARTED|Nicorette® Gum||42
1585082|NCT01084603|3878041|P1|NOT COMPLETED|Washout Period 1||0
1585083|NCT01084603|3878041|P1|COMPLETED|Washout Period 1||42
1585084|NCT01084603|3878041|P1|STARTED|Washout Period 1||42
1585085|NCT01084603|3878041|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
1585086|NCT01084603|3878041|P1|COMPLETED|NiQuitinTM Lozenge||42
1585087|NCT01084603|3878041|P1|STARTED|NiQuitinTM Lozenge||43
1585088|NCT01084603|3878041|P1|NOT COMPLETED|Baseline||2
1585089|NCT01084603|3878041|P1|COMPLETED|Baseline||43
1585090|NCT01084603|3878041|P1|STARTED|Baseline||45
1585091|NCT01084551|3878077|P3|NOT COMPLETED|Overall Study||8
1585092|NCT01084551|3878078|P2|NOT COMPLETED|Overall Study||14
1585093|NCT01084551|3878079|P1|NOT COMPLETED|Overall Study||9
1585094|NCT01084551|3878077|P3|COMPLETED|Overall Study||86
1585095|NCT01084551|3878078|P2|COMPLETED|Overall Study||81
1585096|NCT01084551|3878079|P1|COMPLETED|Overall Study||86
1585097|NCT01084551|3878077|P3|STARTED|Overall Study||94
1585098|NCT01084551|3878078|P2|STARTED|Overall Study||95
1585099|NCT01084551|3878079|P1|STARTED|Overall Study||95
1585100|NCT01084538|3878117|P1|NOT COMPLETED|Overall Study||68
1585101|NCT01084538|3878117|P1|COMPLETED|Overall Study||113
1585102|NCT01084538|3878117|P1|STARTED|Overall Study||181
1585103|NCT01084278|3878129|P5|NOT COMPLETED|Overall Study||0
1585104|NCT01084278|3878130|P4|NOT COMPLETED|Overall Study||0
1585105|NCT01084278|3878131|P3|NOT COMPLETED|Overall Study||0
1585106|NCT01084278|3878132|P2|NOT COMPLETED|Overall Study||0
1585107|NCT01084278|3878133|P1|NOT COMPLETED|Overall Study||0
1585108|NCT01084278|3878129|P5|COMPLETED|Overall Study||8
1585109|NCT01084278|3878130|P4|COMPLETED|Overall Study||8
1585110|NCT01084278|3878131|P3|COMPLETED|Overall Study||8
1585111|NCT01084278|3878132|P2|COMPLETED|Overall Study||8
1585112|NCT01084278|3878133|P1|COMPLETED|Overall Study||8
1585113|NCT01084278|3878129|P5|STARTED|Overall Study||8
1585114|NCT01084278|3878130|P4|STARTED|Overall Study||8
1585115|NCT01084278|3878131|P3|STARTED|Overall Study||8
1585116|NCT01084278|3878132|P2|STARTED|Overall Study||8
1585117|NCT01084278|3878133|P1|STARTED|Overall Study||8
1585118|NCT01084265|3878214|P1|NOT COMPLETED|Overall Study||0
1585119|NCT01084265|3878214|P1|COMPLETED|Overall Study||31
1585120|NCT01084265|3878214|P1|STARTED|Overall Study||31
1585121|NCT01084239|3878228|P2|NOT COMPLETED|28-Day Follow-up||9
1585122|NCT01084239|3878229|P1|NOT COMPLETED|28-Day Follow-up||4
1585123|NCT01084239|3878228|P2|COMPLETED|28-Day Follow-up||490
1585124|NCT01084239|3878229|P1|COMPLETED|28-Day Follow-up||497
1585125|NCT01084239|3878228|P2|STARTED|28-Day Follow-up||499
1585126|NCT01084239|3878229|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
1585127|NCT01084239|3878228|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
1585128|NCT01084239|3878229|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
1585129|NCT01084239|3878228|P2|COMPLETED|Randomization - Index Hospitalization||499
1585130|NCT01084239|3878229|P1|COMPLETED|Randomization - Index Hospitalization||501
1585131|NCT01084239|3878228|P2|STARTED|Randomization - Index Hospitalization||499
1585132|NCT01084239|3878229|P1|STARTED|Randomization - Index Hospitalization||501
1585133|NCT01084174|3878247|P2|NOT COMPLETED|Overall Study||4
1585134|NCT01084174|3878248|P1|NOT COMPLETED|Overall Study||1
1585135|NCT01084174|3878247|P2|COMPLETED|Overall Study||7
1585136|NCT01084174|3878248|P1|COMPLETED|Overall Study||9
1585137|NCT01084174|3878247|P2|STARTED|Overall Study||11
1585138|NCT01084174|3878248|P1|STARTED|Overall Study||10
1585139|NCT01084148|3878268|P2|NOT COMPLETED|Overall Study||16
1585140|NCT01084148|3878269|P1|NOT COMPLETED|Overall Study||30
1585141|NCT01084148|3878268|P2|COMPLETED|Overall Study||102
1585142|NCT01084148|3878269|P1|COMPLETED|Overall Study||88
1585143|NCT01084148|3878268|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
1585144|NCT01084148|3878269|P1|Treated Patients|Overall Study||118
1585145|NCT01084148|3878268|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
1585146|NCT01084148|3878269|P1|STARTED|Overall Study||118
1585147|NCT01084135|3878281|P2|NOT COMPLETED|20 Week||1
1585148|NCT01084135|3878282|P1|NOT COMPLETED|20 Week||0
1585149|NCT01084135|3878281|P2|COMPLETED|20 Week||10
1585150|NCT01084135|3878282|P1|COMPLETED|20 Week||12
1585151|NCT01084135|3878281|P2|STARTED|20 Week||11
1585152|NCT01084135|3878282|P1|STARTED|20 Week||12
1585153|NCT01084135|3878281|P2|NOT COMPLETED|12 Week||0
1585154|NCT01084135|3878282|P1|NOT COMPLETED|12 Week||0
1585155|NCT01084135|3878281|P2|COMPLETED|12 Week||4
1585156|NCT01084135|3878282|P1|COMPLETED|12 Week||4
1585157|NCT01084135|3878281|P2|STARTED|12 Week||4
1585158|NCT01084135|3878282|P1|STARTED|12 Week||4
1585159|NCT01084083|3878292|P1|NOT COMPLETED|Overall Study||12
1585160|NCT01084083|3878292|P1|COMPLETED|Overall Study||78
1585161|NCT01084083|3878292|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
1585162|NCT01084083|3878292|P1|CR to Induction Therapy|Overall Study||56
1585163|NCT01084083|3878292|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
1585164|NCT01084083|3878292|P1|Eligible|Overall Study||81
1585165|NCT01084083|3878292|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
1585166|NCT01084083|3878292|P1|STARTED|Overall Study||90
1585167|NCT01084005|3878300|P2|NOT COMPLETED|Overall Study||16
1585168|NCT01084005|3878301|P1|NOT COMPLETED|Overall Study||5
1585169|NCT01084005|3878300|P2|COMPLETED|Overall Study||146
1585170|NCT01084005|3878301|P1|COMPLETED|Overall Study||74
1585171|NCT01084005|3878300|P2|STARTED|Overall Study||162
1585172|NCT01084005|3878301|P1|STARTED|Overall Study||79
1585173|NCT01083979|3878329|P1|NOT COMPLETED|Overall Study||0
1585174|NCT01083979|3878329|P1|COMPLETED|Overall Study||1
1585175|NCT01083979|3878329|P1|STARTED|Overall Study||1
1585176|NCT01083901|3878337|P3|NOT COMPLETED|Overall Study||2
1585177|NCT01083901|3878338|P2|NOT COMPLETED|Overall Study||2
1585178|NCT01083901|3878339|P1|NOT COMPLETED|Overall Study||1
1585179|NCT01083901|3878337|P3|COMPLETED|Overall Study||11
1585180|NCT01083901|3878338|P2|COMPLETED|Overall Study||6
1585181|NCT01083901|3878339|P1|COMPLETED|Overall Study||12
1585182|NCT01083901|3878337|P3|STARTED|Overall Study||13
1585183|NCT01083901|3878338|P2|STARTED|Overall Study||8
1585184|NCT01083901|3878339|P1|STARTED|Overall Study||13
1585185|NCT01083849|3878358|P2|NOT COMPLETED|Overall Study||111
1585186|NCT01083849|3878359|P1|NOT COMPLETED|Overall Study||60
1585187|NCT01083849|3878358|P2|COMPLETED|Overall Study||527
1585188|NCT01083849|3878359|P1|COMPLETED|Overall Study||61
1585189|NCT01083849|3878358|P2|STARTED|Overall Study||638
1585190|NCT01083849|3878359|P1|STARTED|Overall Study||121
1585191|NCT01083810|3878382|P3|NOT COMPLETED|Overall Study||20
1585192|NCT01083810|3878383|P2|NOT COMPLETED|Overall Study||45
1585193|NCT01083810|3878384|P1|NOT COMPLETED|Overall Study||65
1585194|NCT01083810|3878382|P3|COMPLETED|Overall Study||35
1585195|NCT01083810|3878383|P2|COMPLETED|Overall Study||47
1585196|NCT01083810|3878384|P1|COMPLETED|Overall Study||72
1585197|NCT01083810|3878382|P3|STARTED|Overall Study||55
1585198|NCT01083810|3878383|P2|STARTED|Overall Study||92
1585199|NCT01083810|3878384|P1|STARTED|Overall Study||137
1585200|NCT01083771|3878405|P1|NOT COMPLETED|Overall Study||5
1585201|NCT01083771|3878405|P1|COMPLETED|Overall Study||16
1585202|NCT01083771|3878405|P1|STARTED|Overall Study||21
1585203|NCT01083758|3878410|P1|NOT COMPLETED|Overall Study||2
1585204|NCT01083758|3878410|P1|COMPLETED|Overall Study||29
1585205|NCT01083758|3878410|P1|STARTED|Overall Study||31
1585206|NCT01083732|3878444|P3|NOT COMPLETED|Overall Study||0
1585207|NCT01083732|3878445|P2|NOT COMPLETED|Overall Study||0
1585208|NCT01083732|3878446|P1|NOT COMPLETED|Overall Study||0
1585209|NCT01083732|3878444|P3|COMPLETED|Overall Study||3
1585210|NCT01083732|3878445|P2|COMPLETED|Overall Study||9
1585211|NCT01083732|3878446|P1|COMPLETED|Overall Study||6
1585212|NCT01083732|3878444|P3|STARTED|Overall Study||3
1585213|NCT01083732|3878445|P2|STARTED|Overall Study||9
1585214|NCT01083732|3878446|P1|STARTED|Overall Study||6
1585215|NCT01083706|3878497|P1|NOT COMPLETED|Overall Study||0
1585216|NCT01083706|3878497|P1|COMPLETED|Overall Study||39
1585217|NCT01083706|3878497|P1|STARTED|Overall Study||39
1585218|NCT01083693|3878506|P3|NOT COMPLETED|Overall Study||7
1585219|NCT01083693|3878507|P2|NOT COMPLETED|Overall Study||6
1585220|NCT01083693|3878508|P1|NOT COMPLETED|Overall Study||20
1585221|NCT01083693|3878506|P3|COMPLETED|Overall Study||33
1585222|NCT01083693|3878507|P2|COMPLETED|Overall Study||22
1585223|NCT01083693|3878508|P1|COMPLETED|Overall Study||73
1585224|NCT01083693|3878506|P3|STARTED|Overall Study||40
1585225|NCT01083693|3878507|P2|STARTED|Overall Study||28
1585226|NCT01083693|3878508|P1|STARTED|Overall Study||93
1585227|NCT01083680|3878543|P1|NOT COMPLETED|Overall Study||3844
1585228|NCT01083680|3878543|P1|COMPLETED|Overall Study||263
1585229|NCT01083680|3878543|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
1585230|NCT01083680|3878543|P1|STARTED|Overall Study||4107
1585231|NCT01083667|3878552|P1|NOT COMPLETED|Overall Study||10
1585232|NCT01083667|3878552|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
1585233|NCT01083667|3878552|P1|STARTED|Overall Study|enrolled|32
1585234|NCT01083654|3878559|P2|NOT COMPLETED|Overall Study||0
1585235|NCT01083654|3878560|P1|NOT COMPLETED|Overall Study||0
1585236|NCT01083654|3878559|P2|COMPLETED|Overall Study||50
1585237|NCT01083654|3878560|P1|COMPLETED|Overall Study||53
1585238|NCT01083654|3878559|P2|STARTED|Overall Study||50
1585239|NCT01083654|3878560|P1|STARTED|Overall Study||53
1585240|NCT01083641|3878566|P1|NOT COMPLETED|Overall Study||2
1585241|NCT01083641|3878566|P1|COMPLETED|Overall Study||15
1585242|NCT01083641|3878566|P1|STARTED|Overall Study||17
1585243|NCT01083602|3878573|P1|NOT COMPLETED|Overall Study||55
1585244|NCT01083602|3878573|P1|COMPLETED|Overall Study||0
1585245|NCT01083602|3878573|P1|STARTED|Overall Study||55
1585246|NCT01083576|3878584|P2|NOT COMPLETED|Overall Study||1
1585247|NCT01083576|3878585|P1|NOT COMPLETED|Overall Study||6
1585248|NCT01083576|3878584|P2|COMPLETED|Overall Study||14
1585249|NCT01083576|3878585|P1|COMPLETED|Overall Study||9
1585250|NCT01083576|3878584|P2|STARTED|Overall Study||15
1585251|NCT01083576|3878585|P1|STARTED|Overall Study||15
1585252|NCT01083485|3878615|P2|NOT COMPLETED|Overall Study||3
1585253|NCT01083485|3878616|P1|NOT COMPLETED|Overall Study||7
1585254|NCT01083485|3878615|P2|COMPLETED|Overall Study||64
1585255|NCT01083485|3878616|P1|COMPLETED|Overall Study||63
1585256|NCT01083485|3878615|P2|STARTED|Overall Study||67
1585257|NCT01083485|3878616|P1|STARTED|Overall Study||70
1585258|NCT01083472|3878626|P2|NOT COMPLETED|Overall Study||0
1585259|NCT01083472|3878627|P1|NOT COMPLETED|Overall Study||0
1585260|NCT01083472|3878626|P2|COMPLETED|Overall Study||19
1585261|NCT01083472|3878627|P1|COMPLETED|Overall Study||18
1585262|NCT01083472|3878626|P2|STARTED|Overall Study||19
1585263|NCT01083472|3878627|P1|STARTED|Overall Study||18
1585264|NCT01083316|3878633|P1|NOT COMPLETED|Overall Study||3
1585265|NCT01083316|3878633|P1|COMPLETED|Overall Study||32
1585266|NCT01083316|3878633|P1|STARTED|Overall Study||35
1585267|NCT01083199|3878639|P1|NOT COMPLETED|Overall Study||0
1585268|NCT01083199|3878639|P1|COMPLETED|Overall Study||10
1585269|NCT01083199|3878639|P1|STARTED|Overall Study||10
1585270|NCT01083186|3878644|P1|NOT COMPLETED|Overall Study||94
1585271|NCT01083186|3878644|P1|COMPLETED|Overall Study||406
1585272|NCT01083186|3878644|P1|STARTED|Overall Study||500
1585273|NCT01083173|3878685|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
1585274|NCT01083173|3878686|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
1585275|NCT01083173|3878685|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
1585276|NCT01083173|3878686|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
1585277|NCT01083173|3878685|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
1585278|NCT01083173|3878686|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
1585279|NCT01083173|3878685|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
1585280|NCT01083173|3878686|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
1585281|NCT01083173|3878685|P2|COMPLETED|Long-term Surveillance: Safety Group||479
1585282|NCT01083173|3878686|P1|COMPLETED|Long-term Surveillance: Safety Group||0
1585283|NCT01083173|3878685|P2|STARTED|Long-term Surveillance: Safety Group||595
1585284|NCT01083173|3878686|P1|STARTED|Long-term Surveillance: Safety Group||0
1585285|NCT01083173|3878685|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
1585286|NCT01083173|3878686|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
1585287|NCT01083173|3878685|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
1585288|NCT01083173|3878686|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
1585289|NCT01083173|3878685|P2|STARTED|Main Surveillance: Effectiveness Group||0
1585290|NCT01083173|3878686|P1|STARTED|Main Surveillance: Effectiveness Group||580
1585291|NCT01083173|3878685|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
1585292|NCT01083173|3878686|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
1585293|NCT01083173|3878685|P2|COMPLETED|Main Surveillance: Safety Group||0
1585294|NCT01083173|3878686|P1|COMPLETED|Main Surveillance: Safety Group||580
1585295|NCT01083173|3878685|P2|STARTED|Main Surveillance: Safety Group||0
1585296|NCT01083173|3878686|P1|STARTED|Main Surveillance: Safety Group||595
1585297|NCT01083160|3878704|P1|NOT COMPLETED|Overall Study||1
1585298|NCT01083160|3878704|P1|COMPLETED|Overall Study||81
1585299|NCT01083160|3878704|P1|Evaluable Population|Overall Study||71
1585300|NCT01083160|3878704|P1|STARTED|Overall Study||82
1585301|NCT01083121|3878711|P1|NOT COMPLETED|Overall Study||81
1585302|NCT01083121|3878711|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
1585303|NCT01083121|3878711|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
1585304|NCT01082965|3878721|P2|NOT COMPLETED|Overall Study||2
1585305|NCT01082965|3878722|P1|NOT COMPLETED|Overall Study||1
1585306|NCT01082965|3878721|P2|COMPLETED|Overall Study||6
1585307|NCT01082965|3878722|P1|COMPLETED|Overall Study||9
1585308|NCT01082965|3878721|P2|STARTED|Overall Study||8
1585309|NCT01082965|3878722|P1|STARTED|Overall Study||10
1585310|NCT01082952|3878742|P2|NOT COMPLETED|Overall Study||0
1585311|NCT01082952|3878743|P1|NOT COMPLETED|Overall Study||0
1585312|NCT01082952|3878742|P2|COMPLETED|Overall Study||6
1585313|NCT01082952|3878743|P1|COMPLETED|Overall Study||6
1585314|NCT01082952|3878742|P2|STARTED|Overall Study||6
1585315|NCT01082952|3878743|P1|STARTED|Overall Study||6
1585316|NCT01082939|3878751|P1|NOT COMPLETED|Overall Study||0
1585317|NCT01082939|3878751|P1|COMPLETED|Overall Study||80
1585318|NCT01082939|3878751|P1|STARTED|Overall Study||80
1585319|NCT01082874|3878759|P4|NOT COMPLETED|Overall Study||13
1585320|NCT01082874|3878760|P3|NOT COMPLETED|Overall Study||11
1585321|NCT01082874|3878761|P2|NOT COMPLETED|Overall Study||12
1585322|NCT01082874|3878762|P1|NOT COMPLETED|Overall Study||11
1585323|NCT01082874|3878759|P4|COMPLETED|Overall Study||2489
1585324|NCT01082874|3878760|P3|COMPLETED|Overall Study||2488
1585325|NCT01082874|3878761|P2|COMPLETED|Overall Study||2498
1585326|NCT01082874|3878762|P1|COMPLETED|Overall Study||2488
1585327|NCT01082874|3878759|P4|STARTED|Overall Study||2502
1585328|NCT01082874|3878760|P3|STARTED|Overall Study||2499
1585329|NCT01082874|3878761|P2|STARTED|Overall Study||2510
1585330|NCT01082874|3878762|P1|STARTED|Overall Study||2499
1585331|NCT01082640|3878775|P3|NOT COMPLETED|Overall Study||8
1585332|NCT01082640|3878776|P2|NOT COMPLETED|Overall Study||15
1585333|NCT01082640|3878777|P1|NOT COMPLETED|Overall Study||17
1585334|NCT01082640|3878775|P3|COMPLETED|Overall Study||24
1585335|NCT01082640|3878776|P2|COMPLETED|Overall Study||17
1585336|NCT01082640|3878777|P1|COMPLETED|Overall Study||15
1585337|NCT01082640|3878775|P3|STARTED|Overall Study||32
1585338|NCT01082640|3878776|P2|STARTED|Overall Study||32
1585339|NCT01082640|3878777|P1|STARTED|Overall Study||32
1585340|NCT01082614|3878799|P2|NOT COMPLETED|Overall Study||5
1585341|NCT01082614|3878800|P1|NOT COMPLETED|Overall Study||3
1585342|NCT01082614|3878799|P2|COMPLETED|Overall Study||18
1585343|NCT01082614|3878800|P1|COMPLETED|Overall Study||20
1585344|NCT01082614|3878799|P2|STARTED|Overall Study||23
1585345|NCT01082614|3878800|P1|STARTED|Overall Study||23
1585346|NCT01082588|3878812|P2|NOT COMPLETED|Overall Study||5
1585347|NCT01082588|3878813|P1|NOT COMPLETED|Overall Study||6
1585348|NCT01082588|3878812|P2|COMPLETED|Overall Study||25
1585349|NCT01082588|3878813|P1|COMPLETED|Overall Study||24
1585350|NCT01082588|3878812|P2|STARTED|Overall Study||30
1585351|NCT01082588|3878813|P1|STARTED|Overall Study||30
1585352|NCT01082575|3878831|P1|NOT COMPLETED|Overall Study||0
1585353|NCT01082575|3878831|P1|COMPLETED|Overall Study||100
1585354|NCT01082575|3878831|P1|STARTED|Overall Study||100
1585355|NCT01082380|3878836|P1|NOT COMPLETED|Overall Study||0
1585356|NCT01082380|3878836|P1|COMPLETED|Overall Study||6
1585357|NCT01082380|3878836|P1|STARTED|Overall Study||6
1585358|NCT01082367|3878871|P2|NOT COMPLETED|Follow-up (F-U) Period||1
1585359|NCT01082367|3878872|P1|NOT COMPLETED|Follow-up (F-U) Period||2
1585360|NCT01082367|3878871|P2|COMPLETED|Follow-up (F-U) Period||9
1585361|NCT01082367|3878872|P1|COMPLETED|Follow-up (F-U) Period||17
1585362|NCT01082367|3878871|P2|Treated in F-U|Follow-up (F-U) Period||5
1585363|NCT01082367|3878872|P1|Treated in F-U|Follow-up (F-U) Period||5
1585364|NCT01082367|3878871|P2|STARTED|Follow-up (F-U) Period||10
1585365|NCT01082367|3878872|P1|STARTED|Follow-up (F-U) Period||19
1585366|NCT01082367|3878871|P2|NOT COMPLETED|Double-blind Period||13
1585367|NCT01082367|3878872|P1|NOT COMPLETED|Double-blind Period||5
1585368|NCT01082367|3878871|P2|COMPLETED|Double-blind Period||12
1585369|NCT01082367|3878872|P1|COMPLETED|Double-blind Period||21
1585370|NCT01082367|3878871|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
1585371|NCT01082367|3878872|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
1585372|NCT01082367|3878871|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
1585373|NCT01082367|3878872|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
1585374|NCT01082367|3878871|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
1585375|NCT01082367|3878872|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
1585376|NCT01082367|3878871|P2|Entered OL TOBI|Double-blind Period||18
1585377|NCT01082367|3878872|P1|Entered OL TOBI|Double-blind Period||4
1585378|NCT01082367|3878871|P2|Stage 2:no tx|Double-blind Period||0
1585379|NCT01082367|3878872|P1|Stage 2:no tx|Double-blind Period||0
1585380|NCT01082367|3878871|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
1585381|NCT01082367|3878872|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
1585382|NCT01082367|3878871|P2|STARTED|Double-blind Period||25
1585383|NCT01082367|3878872|P1|STARTED|Double-blind Period||26
1585384|NCT01082328|3878886|P1|NOT COMPLETED|Overall Study||1
1585385|NCT01082328|3878886|P1|COMPLETED|Overall Study||58
1585386|NCT01082328|3878886|P1|STARTED|Overall Study||59
1585387|NCT01082211|3878895|P1|NOT COMPLETED|Overall Study||7
1585388|NCT01082211|3878895|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
1585389|NCT01082211|3878895|P1|STARTED|Overall Study||65
1585390|NCT01082159|3878907|P1|NOT COMPLETED|Overall Study||9
1585391|NCT01082159|3878907|P1|COMPLETED|Overall Study||46
1585392|NCT01082159|3878907|P1|STARTED|Overall Study||55
1585393|NCT01082081|3878916|P3|NOT COMPLETED|Overall Study||2
1585394|NCT01082081|3878917|P2|NOT COMPLETED|Overall Study||1
1585395|NCT01082081|3878918|P1|NOT COMPLETED|Overall Study||0
1585396|NCT01082081|3878916|P3|COMPLETED|Overall Study||58
1585397|NCT01082081|3878917|P2|COMPLETED|Overall Study||118
1585398|NCT01082081|3878918|P1|COMPLETED|Overall Study||121
1585399|NCT01082081|3878916|P3|STARTED|Overall Study||60
1585400|NCT01082081|3878917|P2|STARTED|Overall Study||119
1585401|NCT01082081|3878918|P1|STARTED|Overall Study||121
1585402|NCT01081951|3878970|P2|NOT COMPLETED|Overall Study||55
1585403|NCT01081951|3878971|P1|NOT COMPLETED|Overall Study||56
1585404|NCT01081951|3878970|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
1585405|NCT01081951|3878971|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
1585406|NCT01081951|3878970|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
1585407|NCT01081951|3878971|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
1585408|NCT01081951|3878970|P2|Entered Maintenance Phase|Overall Study||55
1585409|NCT01081951|3878971|P1|Entered Maintenance Phase|Overall Study||66
1585410|NCT01081951|3878970|P2|Received Study Treatment|Overall Study||75
1585411|NCT01081951|3878971|P1|Received Study Treatment|Overall Study||81
1585412|NCT01081951|3878970|P2|STARTED|Overall Study||81
1585413|NCT01081951|3878971|P1|STARTED|Overall Study||81
1585414|NCT01081912|3878981|P3|NOT COMPLETED|Maintenance Treatment||92
1585415|NCT01081912|3878982|P2|NOT COMPLETED|Maintenance Treatment||27
1585416|NCT01081912|3878983|P1|NOT COMPLETED|Maintenance Treatment||0
1585417|NCT01081912|3878981|P3|COMPLETED|Maintenance Treatment||59
1585418|NCT01081912|3878982|P2|COMPLETED|Maintenance Treatment||124
1585419|NCT01081912|3878983|P1|COMPLETED|Maintenance Treatment||0
1585420|NCT01081912|3878981|P3|STARTED|Maintenance Treatment||151
1585421|NCT01081912|3878982|P2|STARTED|Maintenance Treatment||151
1585422|NCT01081912|3878983|P1|STARTED|Maintenance Treatment||0
1585423|NCT01081912|3878981|P3|NOT COMPLETED|Conversion/Titration||0
1585424|NCT01081912|3878982|P2|NOT COMPLETED|Conversion/Titration||0
1585425|NCT01081912|3878983|P1|NOT COMPLETED|Conversion/Titration||208
1585426|NCT01081912|3878981|P3|COMPLETED|Conversion/Titration||0
1585427|NCT01081912|3878982|P2|COMPLETED|Conversion/Titration||0
1585428|NCT01081912|3878983|P1|COMPLETED|Conversion/Titration||302
1585429|NCT01081912|3878981|P3|STARTED|Conversion/Titration||0
1585430|NCT01081912|3878982|P2|STARTED|Conversion/Titration||0
1585431|NCT01081912|3878983|P1|STARTED|Conversion/Titration||510
1585432|NCT01081886|3878992|P2|NOT COMPLETED|Overall Study||13
1585433|NCT01081886|3878993|P1|NOT COMPLETED|Overall Study||11
1585434|NCT01081886|3878992|P2|COMPLETED|Overall Study||0
1585435|NCT01081886|3878993|P1|COMPLETED|Overall Study||0
1585436|NCT01081886|3878992|P2|STARTED|Overall Study||13
1585437|NCT01081886|3878993|P1|STARTED|Overall Study||11
1585438|NCT01081873|3879001|P1|NOT COMPLETED|Overall Study||298
1585439|NCT01081873|3879001|P1|COMPLETED|Overall Study||2416
1585440|NCT01081873|3879001|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
1585441|NCT01081834|3879073|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
1585442|NCT01081834|3879074|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
1585443|NCT01081834|3879075|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
1585444|NCT01081834|3879076|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
1585445|NCT01081834|3879077|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
1585446|NCT01081834|3879073|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
1585447|NCT01081834|3879074|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
1585448|NCT01081834|3879075|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
1585449|NCT01081834|3879076|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
1585450|NCT01081834|3879077|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
1585451|NCT01081834|3879073|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
1585452|NCT01081834|3879074|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
1585453|NCT01081834|3879075|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
1585454|NCT01081834|3879076|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
1585455|NCT01081834|3879077|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
1585456|NCT01081834|3879073|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
1585457|NCT01081834|3879074|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
1585458|NCT01081834|3879075|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
1585459|NCT01081834|3879076|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
1585460|NCT01081834|3879077|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
1585461|NCT01081834|3879073|P5|COMPLETED|Core Period: Baseline to Week 26||40
1585462|NCT01081834|3879074|P4|COMPLETED|Core Period: Baseline to Week 26||40
1585463|NCT01081834|3879075|P3|COMPLETED|Core Period: Baseline to Week 26||175
1585464|NCT01081834|3879076|P2|COMPLETED|Core Period: Baseline to Week 26||172
1585465|NCT01081834|3879077|P1|COMPLETED|Core Period: Baseline to Week 26||160
1585466|NCT01081834|3879073|P5|STARTED|Core Period: Baseline to Week 26||44
1585467|NCT01081834|3879074|P4|STARTED|Core Period: Baseline to Week 26||47
1585468|NCT01081834|3879075|P3|STARTED|Core Period: Baseline to Week 26||197
1585469|NCT01081834|3879076|P2|STARTED|Core Period: Baseline to Week 26||195
1585470|NCT01081834|3879077|P1|STARTED|Core Period: Baseline to Week 26||192
1585471|NCT01081795|3879138|P3|NOT COMPLETED|Overall Study||30
1585472|NCT01081795|3879139|P2|NOT COMPLETED|Overall Study||35
1585473|NCT01081795|3879140|P1|NOT COMPLETED|Overall Study||33
1585474|NCT01081795|3879138|P3|COMPLETED|Overall Study||97
1585475|NCT01081795|3879139|P2|COMPLETED|Overall Study||95
1585476|NCT01081795|3879140|P1|COMPLETED|Overall Study||97
1585477|NCT01081795|3879138|P3|STARTED|Overall Study||127
1585478|NCT01081795|3879139|P2|STARTED|Overall Study||130
1585479|NCT01081795|3879140|P1|STARTED|Overall Study||130
1585480|NCT01081769|3879177|P2|NOT COMPLETED|CORE Intent-To-Treat||97
1585481|NCT01081769|3879178|P1|NOT COMPLETED|CORE Intent-To-Treat||80
1585482|NCT01081769|3879177|P2|COMPLETED|CORE Intent-To-Treat||266
1585483|NCT01081769|3879178|P1|COMPLETED|CORE Intent-To-Treat||272
1585484|NCT01081769|3879177|P2|STARTED|CORE Intent-To-Treat||363
1585485|NCT01081769|3879178|P1|STARTED|CORE Intent-To-Treat||352
1585486|NCT01081769|3879177|P2|NOT COMPLETED|Whole Intent-to-Treat||25
1585487|NCT01081769|3879178|P1|NOT COMPLETED|Whole Intent-to-Treat||24
1585488|NCT01081769|3879177|P2|COMPLETED|Whole Intent-to-Treat||363
1585489|NCT01081769|3879178|P1|COMPLETED|Whole Intent-to-Treat||352
1585490|NCT01081769|3879177|P2|STARTED|Whole Intent-to-Treat||388
1585491|NCT01081769|3879178|P1|STARTED|Whole Intent-to-Treat||376
1585492|NCT01081665|3879212|P1|NOT COMPLETED|Overall Study||95
1585493|NCT01081665|3879212|P1|COMPLETED|Overall Study||142
1585494|NCT01081665|3879212|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
1585495|NCT01081665|3879212|P1|Full Analysis Set|Overall Study||237
1585496|NCT01081665|3879212|P1|STARTED|Overall Study||237
1585497|NCT01081626|3879224|P2|NOT COMPLETED|Overall Study||61
1585498|NCT01081626|3879225|P1|NOT COMPLETED|Overall Study||60
1585499|NCT01081626|3879224|P2|COMPLETED|Overall Study||94
1585500|NCT01081626|3879225|P1|COMPLETED|Overall Study||95
1585501|NCT01081626|3879224|P2|Assessed for Efficacy|Overall Study||125
1585502|NCT01081626|3879225|P1|Assessed for Efficacy|Overall Study||122
1585503|NCT01081626|3879224|P2|STARTED|Overall Study||155
1585504|NCT01081626|3879225|P1|STARTED|Overall Study||155
1585505|NCT01081301|3879251|P1|NOT COMPLETED|Overall Study||14
1585506|NCT01081301|3879251|P1|COMPLETED|Overall Study||22
1585507|NCT01081301|3879251|P1|STARTED|Overall Study||36
1585508|NCT01081249|3879289|P2|NOT COMPLETED|Overall Study||1
1585509|NCT01081249|3879290|P1|NOT COMPLETED|Overall Study||0
1585510|NCT01081249|3879289|P2|COMPLETED|Overall Study||6
1585511|NCT01081249|3879290|P1|COMPLETED|Overall Study||11
1585512|NCT01081249|3879289|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
1585513|NCT01081249|3879290|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
1585514|NCT01081249|3879289|P2|Washout (5-10 Days)|Overall Study||6
1585515|NCT01081249|3879290|P1|Washout (5-10 Days)|Overall Study||11
1585516|NCT01081249|3879289|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
1585517|NCT01081249|3879290|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
1585518|NCT01081249|3879289|P2|STARTED|Overall Study||7
1585519|NCT01081249|3879290|P1|STARTED|Overall Study||11
1585520|NCT01081145|3879296|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
1585521|NCT01081145|3879297|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
1585522|NCT01081145|3879296|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
1585523|NCT01081145|3879297|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
1585524|NCT01081145|3879296|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
1585525|NCT01081145|3879297|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
1585526|NCT01081145|3879296|P2|NOT COMPLETED|Open-Label Phase||0
1585527|NCT01081145|3879297|P1|NOT COMPLETED|Open-Label Phase||212
1585528|NCT01081145|3879296|P2|COMPLETED|Open-Label Phase||0
1585529|NCT01081145|3879297|P1|COMPLETED|Open-Label Phase||316
1585530|NCT01081145|3879296|P2|STARTED|Open-Label Phase||0
1585531|NCT01081145|3879297|P1|STARTED|Open-Label Phase||528
1585532|NCT01081132|3879325|P2|NOT COMPLETED|Overall Study||52
1585533|NCT01081132|3879326|P1|NOT COMPLETED|Overall Study||55
1585534|NCT01081132|3879325|P2|COMPLETED|Overall Study||105
1585535|NCT01081132|3879326|P1|COMPLETED|Overall Study||102
1585536|NCT01081132|3879325|P2|STARTED|Overall Study||157
1585537|NCT01081132|3879326|P1|STARTED|Overall Study||157
1585538|NCT01081041|3879367|P3|NOT COMPLETED|Overall Study||2
1585539|NCT01081041|3879368|P2|NOT COMPLETED|Overall Study||4
1585540|NCT01081041|3879369|P1|NOT COMPLETED|Overall Study||0
1585541|NCT01081041|3879367|P3|COMPLETED|Overall Study||71
1585542|NCT01081041|3879368|P2|COMPLETED|Overall Study||77
1585543|NCT01081041|3879369|P1|COMPLETED|Overall Study||33
1585544|NCT01081041|3879367|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
1585545|NCT01081041|3879368|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
1585546|NCT01081041|3879369|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
1585547|NCT01081041|3879367|P3|STARTED|Overall Study||73
1585548|NCT01081041|3879368|P2|STARTED|Overall Study||81
1585549|NCT01081041|3879369|P1|STARTED|Overall Study||33
1585550|NCT01080976|3879399|P2|NOT COMPLETED|Overall Study||0
1585551|NCT01080976|3879400|P1|NOT COMPLETED|Overall Study||0
1585552|NCT01080976|3879399|P2|COMPLETED|Overall Study||5
1585553|NCT01080976|3879400|P1|COMPLETED|Overall Study||5
1585554|NCT01080976|3879399|P2|STARTED|Overall Study||5
1585555|NCT01080976|3879400|P1|STARTED|Overall Study||5
1585556|NCT01080807|3879410|P2|NOT COMPLETED|Overall Study||23
1585557|NCT01080807|3879411|P1|NOT COMPLETED|Overall Study||35
1585558|NCT01080807|3879410|P2|COMPLETED|Overall Study||167
1585559|NCT01080807|3879411|P1|COMPLETED|Overall Study||158
1585560|NCT01080807|3879410|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
1585561|NCT01080807|3879411|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
1585562|NCT01080794|3879469|P4|NOT COMPLETED|Overall Study||2
1585563|NCT01080794|3879470|P3|NOT COMPLETED|Overall Study||2
1585564|NCT01080794|3879471|P2|NOT COMPLETED|Overall Study||2
1585565|NCT01080794|3879472|P1|NOT COMPLETED|Overall Study||5
1585566|NCT01080794|3879469|P4|COMPLETED|Overall Study||13
1585567|NCT01080794|3879470|P3|COMPLETED|Overall Study||10
1585568|NCT01080794|3879471|P2|COMPLETED|Overall Study||12
1585569|NCT01080794|3879472|P1|COMPLETED|Overall Study||15
1585570|NCT01080794|3879469|P4|STARTED|Overall Study||15
1585571|NCT01080794|3879470|P3|STARTED|Overall Study||12
1585572|NCT01080794|3879471|P2|STARTED|Overall Study||14
1585573|NCT01080794|3879472|P1|STARTED|Overall Study||20
1585574|NCT01080768|3879520|P2|NOT COMPLETED|Overall Study||1
1585575|NCT01080768|3879521|P1|NOT COMPLETED|Overall Study||2
1585576|NCT01080768|3879520|P2|COMPLETED|Overall Study||16
1585577|NCT01080768|3879521|P1|COMPLETED|Overall Study||12
1585578|NCT01080768|3879520|P2|STARTED|Overall Study||17
1585579|NCT01080768|3879521|P1|STARTED|Overall Study||14
1585580|NCT01080716|3879531|P4|NOT COMPLETED|Part 2||0
1585581|NCT01080716|3879532|P3|NOT COMPLETED|Part 2||0
1585582|NCT01080716|3879533|P2|NOT COMPLETED|Part 2||0
1585583|NCT01080716|3879534|P1|NOT COMPLETED|Part 2||0
1585584|NCT01080716|3879531|P4|COMPLETED|Part 2||10
1585585|NCT01080716|3879532|P3|COMPLETED|Part 2||10
1585586|NCT01080716|3879533|P2|COMPLETED|Part 2||0
1585587|NCT01080716|3879534|P1|COMPLETED|Part 2||0
1585588|NCT01080716|3879531|P4|STARTED|Part 2||10
1585589|NCT01080716|3879532|P3|STARTED|Part 2||10
1585590|NCT01080716|3879533|P2|STARTED|Part 2||0
1585591|NCT01080716|3879534|P1|STARTED|Part 2||0
1585592|NCT01080716|3879531|P4|NOT COMPLETED|Part 1||0
1585593|NCT01080716|3879532|P3|NOT COMPLETED|Part 1||0
1585594|NCT01080716|3879533|P2|NOT COMPLETED|Part 1||0
1585595|NCT01080716|3879534|P1|NOT COMPLETED|Part 1||1
1585596|NCT01080716|3879531|P4|COMPLETED|Part 1||0
1585597|NCT01080716|3879532|P3|COMPLETED|Part 1||0
1585598|NCT01080716|3879533|P2|COMPLETED|Part 1||6
1585599|NCT01080716|3879534|P1|COMPLETED|Part 1||13
1585600|NCT01080716|3879531|P4|STARTED|Part 1||0
1585601|NCT01080716|3879532|P3|STARTED|Part 1||0
1585602|NCT01080716|3879533|P2|STARTED|Part 1||6
1585603|NCT01080716|3879534|P1|STARTED|Part 1||14
1585604|NCT01080677|3879551|P3|NOT COMPLETED|Overall Study||0
1585605|NCT01080677|3879552|P2|NOT COMPLETED|Overall Study||0
1585606|NCT01080677|3879553|P1|NOT COMPLETED|Overall Study||0
1585607|NCT01080677|3879551|P3|COMPLETED|Overall Study||20
1585608|NCT01080677|3879552|P2|COMPLETED|Overall Study||20
1585609|NCT01080677|3879553|P1|COMPLETED|Overall Study||20
1585610|NCT01080677|3879551|P3|STARTED|Overall Study||20
1585611|NCT01080677|3879552|P2|STARTED|Overall Study||20
1585612|NCT01080677|3879553|P1|STARTED|Overall Study||20
1585613|NCT01080625|3879573|P3|NOT COMPLETED|Overall Study||1
1585614|NCT01080625|3879574|P2|NOT COMPLETED|Overall Study||2
1585615|NCT01080625|3879575|P1|NOT COMPLETED|Overall Study||0
1585616|NCT01080625|3879573|P3|COMPLETED|Overall Study||31
1585617|NCT01080625|3879574|P2|COMPLETED|Overall Study||31
1585618|NCT01080625|3879575|P1|COMPLETED|Overall Study||31
1585619|NCT01080625|3879573|P3|STARTED|Overall Study||32
1585620|NCT01080625|3879574|P2|STARTED|Overall Study||33
1585621|NCT01080625|3879575|P1|STARTED|Overall Study||31
1585622|NCT01080391|3879585|P2|NOT COMPLETED|Overall Study||4
1585623|NCT01080391|3879586|P1|NOT COMPLETED|Overall Study||7
1585624|NCT01080391|3879585|P2|COMPLETED|Overall Study||392
1585625|NCT01080391|3879586|P1|COMPLETED|Overall Study||389
1585626|NCT01080391|3879585|P2|Treated|Overall Study||392
1585627|NCT01080391|3879586|P1|Treated|Overall Study||389
1585628|NCT01080391|3879585|P2|STARTED|Overall Study||396
1585629|NCT01080391|3879586|P1|STARTED|Overall Study||396
1585630|NCT01080326|3879604|P1|NOT COMPLETED|Overall Study||4
1585631|NCT01080326|3879604|P1|COMPLETED|Overall Study||3
1585632|NCT01080326|3879604|P1|STARTED|Overall Study||7
1585633|NCT01080300|3879610|P2|NOT COMPLETED|Overall Study||104
1585634|NCT01080300|3879611|P1|NOT COMPLETED|Overall Study||94
1585635|NCT01080300|3879610|P2|COMPLETED|Overall Study||191
1585636|NCT01080300|3879611|P1|COMPLETED|Overall Study||206
1585637|NCT01080300|3879610|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
1585638|NCT01080300|3879611|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
1585639|NCT01080261|3879619|P1|NOT COMPLETED|Overall Study||0
1585640|NCT01080261|3879619|P1|COMPLETED|Overall Study||60
1585641|NCT01080261|3879619|P1|STARTED|Overall Study||60
1585642|NCT01080248|3879634|P1|NOT COMPLETED|Overall Study||0
1585643|NCT01080248|3879634|P1|COMPLETED|Overall Study||2
1585644|NCT01080248|3879634|P1|STARTED|Overall Study||2
1585645|NCT01080209|3879648|P7|NOT COMPLETED|Overall Study||7
1585646|NCT01080209|3879649|P6|NOT COMPLETED|Overall Study||0
1585647|NCT01080209|3879650|P5|NOT COMPLETED|Overall Study||0
1585648|NCT01080209|3879651|P4|NOT COMPLETED|Overall Study||5
1585649|NCT01080209|3879652|P3|NOT COMPLETED|Overall Study||5
1585650|NCT01080209|3879653|P2|NOT COMPLETED|Overall Study||11
1585651|NCT01080209|3879654|P1|NOT COMPLETED|Overall Study||6
1585652|NCT01080209|3879648|P7|COMPLETED|Overall Study||44
1585653|NCT01080209|3879649|P6|COMPLETED|Overall Study||2
1585654|NCT01080209|3879650|P5|COMPLETED|Overall Study||6
1585655|NCT01080209|3879651|P4|COMPLETED|Overall Study||37
1585656|NCT01080209|3879652|P3|COMPLETED|Overall Study||28
1585657|NCT01080209|3879653|P2|COMPLETED|Overall Study||42
1585658|NCT01080209|3879654|P1|COMPLETED|Overall Study||22
1585659|NCT01080209|3879648|P7|STARTED|Overall Study||51
1585660|NCT01080209|3879649|P6|STARTED|Overall Study||2
1585661|NCT01080209|3879650|P5|STARTED|Overall Study||6
1585662|NCT01080209|3879651|P4|STARTED|Overall Study||42
1585663|NCT01080209|3879652|P3|STARTED|Overall Study||33
1585664|NCT01080209|3879653|P2|STARTED|Overall Study||53
1585665|NCT01080209|3879654|P1|STARTED|Overall Study||28
1585666|NCT01080196|3879679|P2|NOT COMPLETED|Overall Study||0
1585667|NCT01080196|3879680|P1|NOT COMPLETED|Overall Study||0
1585668|NCT01080196|3879679|P2|COMPLETED|Overall Study||66
1585669|NCT01080196|3879680|P1|COMPLETED|Overall Study||68
1585670|NCT01080196|3879679|P2|STARTED|Overall Study||66
1585671|NCT01080196|3879680|P1|STARTED|Overall Study||68
1585672|NCT01080131|3879696|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
1585673|NCT01080131|3879697|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
1585674|NCT01080131|3879696|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
1585675|NCT01080131|3879697|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
1585676|NCT01080131|3879696|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
1585677|NCT01080131|3879697|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
1585678|NCT01080131|3879696|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
1585679|NCT01080131|3879697|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
1585680|NCT01080131|3879696|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
1585681|NCT01080131|3879697|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
1585682|NCT01080131|3879696|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
1585683|NCT01080131|3879697|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
1585684|NCT01080131|3879696|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
1585685|NCT01080131|3879697|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
1585686|NCT01080131|3879696|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
1585687|NCT01080131|3879697|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
1585688|NCT01080131|3879696|P2|COMPLETED|Core Study (0- 12 Weeks)||103
1585689|NCT01080131|3879697|P1|COMPLETED|Core Study (0- 12 Weeks)||99
1585690|NCT01080131|3879696|P2|STARTED|Core Study (0- 12 Weeks)||114
1585691|NCT01080131|3879697|P1|STARTED|Core Study (0- 12 Weeks)||112
1585692|NCT01080118|3879776|P4|NOT COMPLETED|Overall Study||0
1585693|NCT01080118|3879777|P3|NOT COMPLETED|Overall Study||0
1585694|NCT01080118|3879778|P2|NOT COMPLETED|Overall Study||0
1585695|NCT01080118|3879779|P1|NOT COMPLETED|Overall Study||0
1585696|NCT01080118|3879776|P4|COMPLETED|Overall Study||30
1585697|NCT01080118|3879777|P3|COMPLETED|Overall Study||30
1585698|NCT01080118|3879778|P2|COMPLETED|Overall Study||15
1585699|NCT01080118|3879779|P1|COMPLETED|Overall Study||15
1585700|NCT01080118|3879776|P4|STARTED|Overall Study||30
1585701|NCT01080118|3879777|P3|STARTED|Overall Study||30
1585702|NCT01080118|3879778|P2|STARTED|Overall Study||15
1585703|NCT01080118|3879779|P1|STARTED|Overall Study||15
1585704|NCT01079988|3879792|P5|NOT COMPLETED|Overall Study||1
1585705|NCT01079988|3879793|P4|NOT COMPLETED|Overall Study||3
1585706|NCT01079988|3879794|P3|NOT COMPLETED|Overall Study||0
1585707|NCT01079988|3879795|P2|NOT COMPLETED|Overall Study||0
1585708|NCT01079988|3879796|P1|NOT COMPLETED|Overall Study||1
1585709|NCT01079988|3879792|P5|COMPLETED|Overall Study||1
1585710|NCT01079988|3879793|P4|COMPLETED|Overall Study||17
1585711|NCT01079988|3879794|P3|COMPLETED|Overall Study||8
1585712|NCT01079988|3879795|P2|COMPLETED|Overall Study||1
1585713|NCT01079988|3879796|P1|COMPLETED|Overall Study||9
1585714|NCT01079988|3879792|P5|STARTED|Overall Study||2
1585715|NCT01079988|3879793|P4|STARTED|Overall Study||20
1585716|NCT01079988|3879794|P3|STARTED|Overall Study||8
1585717|NCT01079988|3879795|P2|STARTED|Overall Study||1
1585718|NCT01079988|3879796|P1|STARTED|Overall Study||10
1585719|NCT01079962|3879815|P2|NOT COMPLETED|Overall Study||15
1585720|NCT01079962|3879816|P1|NOT COMPLETED|Overall Study||15
1585721|NCT01079962|3879815|P2|COMPLETED|Overall Study||89
1585722|NCT01079962|3879816|P1|COMPLETED|Overall Study||90
1585723|NCT01079962|3879815|P2|STARTED|Overall Study||104
1585724|NCT01079962|3879816|P1|STARTED|Overall Study||105
1585725|NCT01079949|3879844|P2|NOT COMPLETED|Overall Study||13
1585726|NCT01079949|3879845|P1|NOT COMPLETED|Overall Study||15
1585727|NCT01079949|3879844|P2|COMPLETED|Overall Study||34
1585728|NCT01079949|3879845|P1|COMPLETED|Overall Study||31
1585729|NCT01079949|3879844|P2|STARTED|Overall Study||47
1585730|NCT01079949|3879845|P1|STARTED|Overall Study||46
1585731|NCT01079936|3879891|P5|NOT COMPLETED|Phase II||1
1585732|NCT01079936|3879892|P4|NOT COMPLETED|Phase II||0
1585733|NCT01079936|3879893|P3|NOT COMPLETED|Phase II||1
1585734|NCT01079936|3879894|P2|NOT COMPLETED|Phase II||0
1585735|NCT01079936|3879895|P1|NOT COMPLETED|Phase II||0
1585736|NCT01079936|3879891|P5|COMPLETED|Phase II||25
1585737|NCT01079936|3879892|P4|COMPLETED|Phase II||24
1585738|NCT01079936|3879893|P3|COMPLETED|Phase II||5
1585739|NCT01079936|3879894|P2|COMPLETED|Phase II||3
1585740|NCT01079936|3879895|P1|COMPLETED|Phase II||0
1585741|NCT01079936|3879891|P5|STARTED|Phase II||26
1585742|NCT01079936|3879892|P4|STARTED|Phase II||24
1585743|NCT01079936|3879893|P3|STARTED|Phase II||6
1585744|NCT01079936|3879894|P2|STARTED|Phase II||3
1585745|NCT01079936|3879895|P1|STARTED|Phase II||0
1585746|NCT01079936|3879891|P5|NOT COMPLETED|Phase I: MTD||0
1585747|NCT01079936|3879892|P4|NOT COMPLETED|Phase I: MTD||0
1585748|NCT01079936|3879893|P3|NOT COMPLETED|Phase I: MTD||0
1585749|NCT01079936|3879894|P2|NOT COMPLETED|Phase I: MTD||0
1585750|NCT01079936|3879895|P1|NOT COMPLETED|Phase I: MTD||4
1585751|NCT01079936|3879891|P5|COMPLETED|Phase I: MTD||0
1585752|NCT01079936|3879892|P4|COMPLETED|Phase I: MTD||0
1585753|NCT01079936|3879893|P3|COMPLETED|Phase I: MTD||0
1585754|NCT01079936|3879894|P2|COMPLETED|Phase I: MTD||0
1585755|NCT01079936|3879895|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
1585756|NCT01079936|3879891|P5|STARTED|Phase I: MTD||0
1585757|NCT01079936|3879892|P4|STARTED|Phase I: MTD||0
1585758|NCT01079936|3879893|P3|STARTED|Phase I: MTD||0
1585759|NCT01079936|3879894|P2|STARTED|Phase I: MTD||0
1585760|NCT01079936|3879895|P1|STARTED|Phase I: MTD||16
1585761|NCT01079832|3879914|P1|NOT COMPLETED|Overall Study||1
1585762|NCT01079832|3879914|P1|COMPLETED|Overall Study||49
1585763|NCT01079832|3879914|P1|STARTED|Overall Study||50
1585764|NCT01079806|3879924|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||2
1585765|NCT01079806|3879925|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||0
1585766|NCT01079806|3879924|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||4
1585767|NCT01079806|3879925|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||14
1585768|NCT01079806|3879924|P2|STARTED|Long-term Follow-up: Day 1-End of Study||6
1585769|NCT01079806|3879925|P1|STARTED|Long-term Follow-up: Day 1-End of Study||14
1585770|NCT01079806|3879924|P2|NOT COMPLETED|Day 1 to Week 96||4
1585771|NCT01079806|3879925|P1|NOT COMPLETED|Day 1 to Week 96||4
1585772|NCT01079806|3879924|P2|COMPLETED|Day 1 to Week 96|Includes 53 continuing treatment|56
1585773|NCT01079806|3879925|P1|COMPLETED|Day 1 to Week 96|Includes 91 continuing treatment|116
1585774|NCT01079806|3879924|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
1585775|NCT01079806|3879925|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
1585776|NCT01079806|3879924|P2|Received Treatment|Day 1 to Week 96||60
1585777|NCT01079806|3879925|P1|Received Treatment|Day 1 to Week 96||120
1585778|NCT01079806|3879924|P2|STARTED|Day 1 to Week 96|Randomized|60
1585779|NCT01079806|3879925|P1|STARTED|Day 1 to Week 96|Randomized|120
1585780|NCT01079741|3879950|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
1585781|NCT01079741|3879951|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
1585782|NCT01079741|3879952|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
1585783|NCT01079741|3879953|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
1585784|NCT01079741|3879954|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
1585785|NCT01079741|3879950|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
1585786|NCT01079741|3879951|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
1585787|NCT01079741|3879952|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
1585788|NCT01079741|3879953|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
1585789|NCT01079741|3879954|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
1585790|NCT01079741|3879950|P5|STARTED|Phase 2 (Weeks 37-48)||12
1585791|NCT01079741|3879951|P4|STARTED|Phase 2 (Weeks 37-48)||12
1585792|NCT01079741|3879952|P3|STARTED|Phase 2 (Weeks 37-48)||0
1585793|NCT01079741|3879953|P2|STARTED|Phase 2 (Weeks 37-48)||0
1585794|NCT01079741|3879954|P1|STARTED|Phase 2 (Weeks 37-48)||0
1585795|NCT01079741|3879950|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585796|NCT01079741|3879951|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585797|NCT01079741|3879952|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
1585798|NCT01079741|3879953|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585799|NCT01079741|3879954|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585800|NCT01079741|3879950|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585801|NCT01079741|3879951|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585802|NCT01079741|3879952|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585803|NCT01079741|3879953|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585804|NCT01079741|3879954|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585805|NCT01079741|3879950|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585806|NCT01079741|3879951|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585807|NCT01079741|3879952|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
1585808|NCT01079741|3879953|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585809|NCT01079741|3879954|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
1585810|NCT01079741|3879950|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585811|NCT01079741|3879951|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585812|NCT01079741|3879952|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585813|NCT01079741|3879953|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
1585814|NCT01079741|3879954|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585815|NCT01079741|3879950|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585816|NCT01079741|3879951|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585817|NCT01079741|3879952|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585818|NCT01079741|3879953|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
1585819|NCT01079741|3879954|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585820|NCT01079741|3879950|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585821|NCT01079741|3879951|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585822|NCT01079741|3879952|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585823|NCT01079741|3879953|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
1585824|NCT01079741|3879954|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
1585825|NCT01079741|3879950|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585826|NCT01079741|3879951|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585827|NCT01079741|3879952|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585828|NCT01079741|3879953|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585829|NCT01079741|3879954|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585830|NCT01079741|3879950|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585831|NCT01079741|3879951|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585832|NCT01079741|3879952|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585833|NCT01079741|3879953|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585834|NCT01079741|3879954|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
1585835|NCT01079741|3879950|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585836|NCT01079741|3879951|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585837|NCT01079741|3879952|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585838|NCT01079741|3879953|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
1585839|NCT01079741|3879954|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
1585840|NCT01079598|3879968|P1|NOT COMPLETED|Overall Study||0
1585841|NCT01079598|3879968|P1|COMPLETED|Overall Study||8
1585842|NCT01079598|3879968|P1|STARTED|Overall Study||8
1585843|NCT01079390|3879978|P3|NOT COMPLETED|Overall Study||4
1585844|NCT01079390|3879979|P2|NOT COMPLETED|Overall Study||5
1585845|NCT01079390|3879980|P1|NOT COMPLETED|Overall Study||5
1585846|NCT01079390|3879978|P3|COMPLETED|Overall Study||10
1585847|NCT01079390|3879979|P2|COMPLETED|Overall Study||10
1585848|NCT01079390|3879980|P1|COMPLETED|Overall Study||10
1585849|NCT01079390|3879978|P3|STARTED|Overall Study||14
1585850|NCT01079390|3879979|P2|STARTED|Overall Study||15
1585851|NCT01079390|3879980|P1|STARTED|Overall Study||15
1585852|NCT01079299|3879992|P2|NOT COMPLETED|Overall Study||0
1585853|NCT01079299|3879993|P1|NOT COMPLETED|Overall Study||0
1585854|NCT01079299|3879992|P2|COMPLETED|Overall Study||25
1585855|NCT01079299|3879993|P1|COMPLETED|Overall Study||27
1585856|NCT01079299|3879992|P2|STARTED|Overall Study||25
1585857|NCT01079299|3879993|P1|STARTED|Overall Study||27
1585858|NCT01079234|3880002|P4|NOT COMPLETED|Extension: Week 27 to 52||16
1585859|NCT01079234|3880003|P3|NOT COMPLETED|Extension: Week 27 to 52||11
1585860|NCT01079234|3880004|P2|NOT COMPLETED|Extension: Week 27 to 52||0
1585861|NCT01079234|3880005|P1|NOT COMPLETED|Extension: Week 27 to 52||0
1585862|NCT01079234|3880002|P4|COMPLETED|Extension: Week 27 to 52||223
1585863|NCT01079234|3880003|P3|COMPLETED|Extension: Week 27 to 52||122
1585864|NCT01079234|3880004|P2|COMPLETED|Extension: Week 27 to 52||0
1585865|NCT01079234|3880005|P1|COMPLETED|Extension: Week 27 to 52||0
1585866|NCT01079234|3880002|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
1585867|NCT01079234|3880003|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
1585868|NCT01079234|3880004|P2|STARTED|Extension: Week 27 to 52||0
1585869|NCT01079234|3880005|P1|STARTED|Extension: Week 27 to 52||0
1585870|NCT01079234|3880002|P4|NOT COMPLETED|Main: Week 0 to 26||0
1585871|NCT01079234|3880003|P3|NOT COMPLETED|Main: Week 0 to 26||12
1585872|NCT01079234|3880004|P2|NOT COMPLETED|Main: Week 0 to 26||26
1585873|NCT01079234|3880005|P1|NOT COMPLETED|Main: Week 0 to 26||26
1585874|NCT01079234|3880002|P4|COMPLETED|Main: Week 0 to 26||0
1585875|NCT01079234|3880003|P3|COMPLETED|Main: Week 0 to 26||152
1585876|NCT01079234|3880004|P2|COMPLETED|Main: Week 0 to 26||139
1585877|NCT01079234|3880005|P1|COMPLETED|Main: Week 0 to 26||138
1585878|NCT01079234|3880002|P4|Exposed|Main: Week 0 to 26||0
1585879|NCT01079234|3880003|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
1585880|NCT01079234|3880004|P2|Exposed|Main: Week 0 to 26||165
1585881|NCT01079234|3880005|P1|Exposed|Main: Week 0 to 26||164
1585882|NCT01079234|3880002|P4|STARTED|Main: Week 0 to 26||0
1585883|NCT01079234|3880003|P3|STARTED|Main: Week 0 to 26||164
1585884|NCT01079234|3880004|P2|STARTED|Main: Week 0 to 26||165
1585885|NCT01079234|3880005|P1|STARTED|Main: Week 0 to 26||164
1585886|NCT01079195|3880023|P1|NOT COMPLETED|Overall Study||1431
1585887|NCT01079195|3880023|P1|COMPLETED|Overall Study||14442
1585888|NCT01079195|3880023|P1|STARTED|Overall Study||15873
1585889|NCT01079182|3880029|P1|NOT COMPLETED|Overall Study||2719
1585890|NCT01079182|3880029|P1|COMPLETED|Overall Study||1962
1585891|NCT01079182|3880029|P1|STARTED|Overall Study||4681
1585892|NCT01079143|3880060|P4|NOT COMPLETED|Overall Study||5
1585893|NCT01079143|3880061|P3|NOT COMPLETED|Overall Study||5
1585894|NCT01079143|3880062|P2|NOT COMPLETED|Overall Study||17
1585895|NCT01079143|3880063|P1|NOT COMPLETED|Overall Study||9
1585896|NCT01079143|3880060|P4|COMPLETED|Overall Study||54
1585897|NCT01079143|3880061|P3|COMPLETED|Overall Study||34
1585898|NCT01079143|3880062|P2|COMPLETED|Overall Study||43
1585899|NCT01079143|3880063|P1|COMPLETED|Overall Study||27
1585900|NCT01079143|3880060|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
1585901|NCT01079143|3880061|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
1585902|NCT01079143|3880062|P2|M3 and M12 Biopsies|Overall Study||43
1585903|NCT01079143|3880063|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
1585904|NCT01079143|3880060|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
1585905|NCT01079143|3880061|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
1585906|NCT01079143|3880062|P2|Month 12 (M12) Biopsies|Overall Study||43
1585907|NCT01079143|3880063|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
1585908|NCT01079143|3880060|P4|Month 3 (M3) Biopsies|Overall Study||59
1585909|NCT01079143|3880061|P3|Month 3 (M3) Biopsies|Overall Study||39
1585910|NCT01079143|3880062|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
1585911|NCT01079143|3880063|P1|Month 3 (M3) Biopsies|Overall Study||36
1585912|NCT01079143|3880060|P4|Exposed|Overall Study||59
1585913|NCT01079143|3880061|P3|Exposed|Overall Study||39
1585914|NCT01079143|3880062|P2|Exposed|Overall Study||60
1585915|NCT01079143|3880063|P1|Exposed|Overall Study||36
1585916|NCT01079143|3880060|P4|STARTED|Overall Study||59
1585917|NCT01079143|3880061|P3|STARTED|Overall Study||39
1585918|NCT01079143|3880062|P2|STARTED|Overall Study||60
1585919|NCT01079143|3880063|P1|STARTED|Overall Study||36
1585920|NCT01079130|3880137|P6|NOT COMPLETED|Overall Study||5
1585921|NCT01079130|3880138|P5|NOT COMPLETED|Overall Study||8
1585922|NCT01079130|3880139|P4|NOT COMPLETED|Overall Study||5
1585923|NCT01079130|3880140|P3|NOT COMPLETED|Overall Study||1
1585924|NCT01079130|3880141|P2|NOT COMPLETED|Overall Study||7
1585925|NCT01079130|3880142|P1|NOT COMPLETED|Overall Study||2
1585926|NCT01079130|3880137|P6|COMPLETED|Overall Study||80
1585927|NCT01079130|3880138|P5|COMPLETED|Overall Study||78
1585928|NCT01079130|3880139|P4|COMPLETED|Overall Study||81
1585929|NCT01079130|3880140|P3|COMPLETED|Overall Study||83
1585930|NCT01079130|3880141|P2|COMPLETED|Overall Study||78
1585931|NCT01079130|3880142|P1|COMPLETED|Overall Study||83
1585932|NCT01079130|3880137|P6|Full Analysis Set (FAS)|Overall Study||84
1585933|NCT01079130|3880138|P5|Full Analysis Set (FAS)|Overall Study||84
1585934|NCT01079130|3880139|P4|Full Analysis Set (FAS)|Overall Study||85
1585935|NCT01079130|3880140|P3|Full Analysis Set (FAS)|Overall Study||83
1585936|NCT01079130|3880141|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
1585937|NCT01079130|3880142|P1|Full Analysis Set (FAS)|Overall Study||84
1585938|NCT01079130|3880137|P6|Safety Set: Received Study Drug|Overall Study||84
1585939|NCT01079130|3880138|P5|Safety Set: Received Study Drug|Overall Study||84
1585940|NCT01079130|3880139|P4|Safety Set: Received Study Drug|Overall Study||85
1585941|NCT01079130|3880140|P3|Safety Set: Received Study Drug|Overall Study||84
1585942|NCT01079130|3880141|P2|Safety Set: Received Study Drug|Overall Study||81
1585943|NCT01079130|3880142|P1|Safety Set: Received Study Drug|Overall Study||84
1585944|NCT01079130|3880137|P6|STARTED|Overall Study||85
1585945|NCT01079130|3880138|P5|STARTED|Overall Study||86
1585946|NCT01079130|3880139|P4|STARTED|Overall Study||86
1585947|NCT01079130|3880140|P3|STARTED|Overall Study||84
1585948|NCT01079130|3880141|P2|STARTED|Overall Study||85
1585949|NCT01079130|3880142|P1|STARTED|Overall Study||85
1585950|NCT01078974|3880162|P1|NOT COMPLETED|Overall Study||3
1585951|NCT01078974|3880162|P1|COMPLETED|Overall Study||4
1585952|NCT01078974|3880162|P1|STARTED|Overall Study||7
1585953|NCT01078922|3880167|P1|NOT COMPLETED|Overall Study||1
1585954|NCT01078922|3880167|P1|COMPLETED|Overall Study||10
1585955|NCT01078922|3880167|P1|STARTED|Overall Study||11
1585956|NCT01078909|3880177|P5|NOT COMPLETED|Overall Study||2
1585957|NCT01078909|3880178|P4|NOT COMPLETED|Overall Study||1
1585958|NCT01078909|3880179|P3|NOT COMPLETED|Overall Study||1
1585959|NCT01078909|3880180|P2|NOT COMPLETED|Overall Study||4
1585960|NCT01078909|3880181|P1|NOT COMPLETED|Overall Study||2
1585961|NCT01078909|3880177|P5|COMPLETED|Overall Study||23
1585962|NCT01078909|3880178|P4|COMPLETED|Overall Study||24
1585963|NCT01078909|3880179|P3|COMPLETED|Overall Study||24
1585964|NCT01078909|3880180|P2|COMPLETED|Overall Study||21
1585965|NCT01078909|3880181|P1|COMPLETED|Overall Study||23
1585966|NCT01078909|3880177|P5|STARTED|Overall Study||25
1585967|NCT01078909|3880178|P4|STARTED|Overall Study||25
1585968|NCT01078909|3880179|P3|STARTED|Overall Study||25
1585969|NCT01078909|3880180|P2|STARTED|Overall Study||25
1585970|NCT01078909|3880181|P1|STARTED|Overall Study||25
1585971|NCT01078844|3880203|P1|NOT COMPLETED|Overall Study||4
1585972|NCT01078844|3880203|P1|COMPLETED|Overall Study||0
1585973|NCT01078844|3880203|P1|STARTED|Overall Study||4
1585974|NCT01078805|3880208|P1|NOT COMPLETED|Overall Study||2050
1585975|NCT01078805|3880208|P1|COMPLETED|Overall Study||2117
1585976|NCT01078805|3880208|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
1585977|NCT01078805|3880208|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
1585978|NCT01078805|3880208|P1|STARTED|Overall Study||4167
1585979|NCT01078753|3880222|P2|NOT COMPLETED|Treatment Period II||0
1585980|NCT01078753|3880223|P1|NOT COMPLETED|Treatment Period II||0
1585981|NCT01078753|3880222|P2|COMPLETED|Treatment Period II||44
1585982|NCT01078753|3880223|P1|COMPLETED|Treatment Period II||45
1585983|NCT01078753|3880222|P2|Full Analysis Set|Treatment Period II||44
1585984|NCT01078753|3880223|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
1585985|NCT01078753|3880222|P2|STARTED|Treatment Period II||44
1585986|NCT01078753|3880223|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
1585987|NCT01078753|3880222|P2|NOT COMPLETED|Treatment Period I||0
1585988|NCT01078753|3880223|P1|NOT COMPLETED|Treatment Period I||0
1585989|NCT01078753|3880222|P2|COMPLETED|Treatment Period I||44
1585990|NCT01078753|3880223|P1|COMPLETED|Treatment Period I||45
1585991|NCT01078753|3880222|P2|Full Analysis Set|Treatment Period I||44
1585992|NCT01078753|3880223|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
1585993|NCT01078753|3880222|P2|STARTED|Treatment Period I||44
1585994|NCT01078753|3880223|P1|STARTED|Treatment Period I||45
1585995|NCT01078675|3880235|P2|NOT COMPLETED|Overall Study||6
1585996|NCT01078675|3880236|P1|NOT COMPLETED|Overall Study||68
1585997|NCT01078675|3880235|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
1585998|NCT01078675|3880236|P1|COMPLETED|Overall Study||182
1585999|NCT01078675|3880235|P2|Patients Treated|Overall Study||0
1586000|NCT01078675|3880236|P1|Patients Treated|Overall Study||198
1586001|NCT01078675|3880235|P2|STARTED|Overall Study||65
1586002|NCT01078675|3880236|P1|STARTED|Overall Study||250
1586003|NCT01078662|3880258|P5|NOT COMPLETED|Overall Study||11
1586004|NCT01078662|3880259|P4|NOT COMPLETED|Overall Study||7
1586005|NCT01078662|3880260|P3|NOT COMPLETED|Overall Study||21
1586006|NCT01078662|3880261|P2|NOT COMPLETED|Overall Study||168
1586007|NCT01078662|3880262|P1|NOT COMPLETED|Overall Study||58
1586008|NCT01078662|3880258|P5|COMPLETED|Overall Study||1
1586009|NCT01078662|3880259|P4|COMPLETED|Overall Study||1
1586010|NCT01078662|3880260|P3|COMPLETED|Overall Study||2
1586011|NCT01078662|3880261|P2|COMPLETED|Overall Study||25
1586012|NCT01078662|3880262|P1|COMPLETED|Overall Study||4
1586013|NCT01078662|3880258|P5|STARTED|Overall Study||12
1586014|NCT01078662|3880259|P4|STARTED|Overall Study||8
1586015|NCT01078662|3880260|P3|STARTED|Overall Study||23
1586016|NCT01078662|3880261|P2|STARTED|Overall Study||193
1586017|NCT01078662|3880262|P1|STARTED|Overall Study||62
1586018|NCT01078623|3880301|P20|NOT COMPLETED|Treatment Period 4||0
1586019|NCT01078623|3880302|P19|NOT COMPLETED|Treatment Period 4||0
1586020|NCT01078623|3880303|P18|NOT COMPLETED|Treatment Period 4||0
1586021|NCT01078623|3880304|P17|NOT COMPLETED|Treatment Period 4||0
1586022|NCT01078623|3880305|P16|NOT COMPLETED|Treatment Period 4||1
1586023|NCT01078623|3880306|P15|NOT COMPLETED|Treatment Period 4||0
1586024|NCT01078623|3880307|P14|NOT COMPLETED|Treatment Period 4||0
1586025|NCT01078623|3880308|P13|NOT COMPLETED|Treatment Period 4||0
1586026|NCT01078623|3880309|P12|NOT COMPLETED|Treatment Period 4||0
1586027|NCT01078623|3880310|P11|NOT COMPLETED|Treatment Period 4||0
1586028|NCT01078623|3880311|P10|NOT COMPLETED|Treatment Period 4||0
1586029|NCT01078623|3880312|P9|NOT COMPLETED|Treatment Period 4||0
1586030|NCT01078623|3880313|P8|NOT COMPLETED|Treatment Period 4||0
1586031|NCT01078623|3880314|P7|NOT COMPLETED|Treatment Period 4||0
1586032|NCT01078623|3880315|P6|NOT COMPLETED|Treatment Period 4||0
1586033|NCT01078623|3880316|P5|NOT COMPLETED|Treatment Period 4||0
1586034|NCT01078623|3880317|P4|NOT COMPLETED|Treatment Period 4||0
1586035|NCT01078623|3880318|P3|NOT COMPLETED|Treatment Period 4||1
1586036|NCT01078623|3880319|P2|NOT COMPLETED|Treatment Period 4||0
1586037|NCT01078623|3880320|P1|NOT COMPLETED|Treatment Period 4||0
1586038|NCT01078623|3880301|P20|COMPLETED|Treatment Period 4||7
1586039|NCT01078623|3880302|P19|COMPLETED|Treatment Period 4||6
1586040|NCT01078623|3880303|P18|COMPLETED|Treatment Period 4||7
1586041|NCT01078623|3880304|P17|COMPLETED|Treatment Period 4||7
1586042|NCT01078623|3880305|P16|COMPLETED|Treatment Period 4||6
1586043|NCT01078623|3880306|P15|COMPLETED|Treatment Period 4||7
1586044|NCT01078623|3880307|P14|COMPLETED|Treatment Period 4||6
1586045|NCT01078623|3880308|P13|COMPLETED|Treatment Period 4||7
1586046|NCT01078623|3880309|P12|COMPLETED|Treatment Period 4||7
1586047|NCT01078623|3880310|P11|COMPLETED|Treatment Period 4||6
1586048|NCT01078623|3880311|P10|COMPLETED|Treatment Period 4||6
1586049|NCT01078623|3880312|P9|COMPLETED|Treatment Period 4||5
1586050|NCT01078623|3880313|P8|COMPLETED|Treatment Period 4||6
1586051|NCT01078623|3880314|P7|COMPLETED|Treatment Period 4||5
1586052|NCT01078623|3880315|P6|COMPLETED|Treatment Period 4||4
1586053|NCT01078623|3880316|P5|COMPLETED|Treatment Period 4||6
1586054|NCT01078623|3880317|P4|COMPLETED|Treatment Period 4||6
1586055|NCT01078623|3880318|P3|COMPLETED|Treatment Period 4||5
1586056|NCT01078623|3880319|P2|COMPLETED|Treatment Period 4||5
1586057|NCT01078623|3880320|P1|COMPLETED|Treatment Period 4||5
1586058|NCT01078623|3880301|P20|STARTED|Treatment Period 4||7
1586059|NCT01078623|3880302|P19|STARTED|Treatment Period 4||6
1586060|NCT01078623|3880303|P18|STARTED|Treatment Period 4||7
1586061|NCT01078623|3880304|P17|STARTED|Treatment Period 4||7
1586062|NCT01078623|3880305|P16|STARTED|Treatment Period 4||7
1586063|NCT01078623|3880306|P15|STARTED|Treatment Period 4||7
1586064|NCT01078623|3880307|P14|STARTED|Treatment Period 4||6
1586065|NCT01078623|3880308|P13|STARTED|Treatment Period 4||7
1586066|NCT01078623|3880309|P12|STARTED|Treatment Period 4||7
1586067|NCT01078623|3880310|P11|STARTED|Treatment Period 4||6
1586068|NCT01078623|3880311|P10|STARTED|Treatment Period 4||6
1586069|NCT01078623|3880312|P9|STARTED|Treatment Period 4||5
1586070|NCT01078623|3880313|P8|STARTED|Treatment Period 4||6
1586071|NCT01078623|3880314|P7|STARTED|Treatment Period 4||5
1586072|NCT01078623|3880315|P6|STARTED|Treatment Period 4||4
1586073|NCT01078623|3880316|P5|STARTED|Treatment Period 4||6
1586074|NCT01078623|3880317|P4|STARTED|Treatment Period 4||6
1586075|NCT01078623|3880318|P3|STARTED|Treatment Period 4||6
1586076|NCT01078623|3880319|P2|STARTED|Treatment Period 4||5
1586077|NCT01078623|3880320|P1|STARTED|Treatment Period 4||5
1586078|NCT01078623|3880301|P20|NOT COMPLETED|Treatment Period 3||0
1586079|NCT01078623|3880302|P19|NOT COMPLETED|Treatment Period 3||0
1586080|NCT01078623|3880303|P18|NOT COMPLETED|Treatment Period 3||0
1586081|NCT01078623|3880304|P17|NOT COMPLETED|Treatment Period 3||0
1586082|NCT01078623|3880305|P16|NOT COMPLETED|Treatment Period 3||0
1586083|NCT01078623|3880306|P15|NOT COMPLETED|Treatment Period 3||0
1586084|NCT01078623|3880307|P14|NOT COMPLETED|Treatment Period 3||1
1586085|NCT01078623|3880308|P13|NOT COMPLETED|Treatment Period 3||0
1586086|NCT01078623|3880309|P12|NOT COMPLETED|Treatment Period 3||0
1586087|NCT01078623|3880310|P11|NOT COMPLETED|Treatment Period 3||0
1586088|NCT01078623|3880311|P10|NOT COMPLETED|Treatment Period 3||0
1586089|NCT01078623|3880312|P9|NOT COMPLETED|Treatment Period 3||0
1586090|NCT01078623|3880313|P8|NOT COMPLETED|Treatment Period 3||0
1586091|NCT01078623|3880314|P7|NOT COMPLETED|Treatment Period 3||0
1586092|NCT01078623|3880315|P6|NOT COMPLETED|Treatment Period 3||0
1586093|NCT01078623|3880316|P5|NOT COMPLETED|Treatment Period 3||1
1586094|NCT01078623|3880317|P4|NOT COMPLETED|Treatment Period 3||0
1586095|NCT01078623|3880318|P3|NOT COMPLETED|Treatment Period 3||0
1586096|NCT01078623|3880319|P2|NOT COMPLETED|Treatment Period 3||0
1586097|NCT01078623|3880320|P1|NOT COMPLETED|Treatment Period 3||0
1586098|NCT01078623|3880301|P20|COMPLETED|Treatment Period 3||7
1586099|NCT01078623|3880302|P19|COMPLETED|Treatment Period 3||6
1586100|NCT01078623|3880303|P18|COMPLETED|Treatment Period 3||7
1586101|NCT01078623|3880304|P17|COMPLETED|Treatment Period 3||7
1586102|NCT01078623|3880305|P16|COMPLETED|Treatment Period 3||7
1586103|NCT01078623|3880306|P15|COMPLETED|Treatment Period 3||7
1586104|NCT01078623|3880307|P14|COMPLETED|Treatment Period 3||6
1586105|NCT01078623|3880308|P13|COMPLETED|Treatment Period 3||7
1586106|NCT01078623|3880309|P12|COMPLETED|Treatment Period 3||7
1586107|NCT01078623|3880310|P11|COMPLETED|Treatment Period 3||6
1586108|NCT01078623|3880311|P10|COMPLETED|Treatment Period 3||6
1586109|NCT01078623|3880312|P9|COMPLETED|Treatment Period 3||5
1586110|NCT01078623|3880313|P8|COMPLETED|Treatment Period 3||6
1586111|NCT01078623|3880314|P7|COMPLETED|Treatment Period 3||5
1586112|NCT01078623|3880315|P6|COMPLETED|Treatment Period 3||4
1586113|NCT01078623|3880316|P5|COMPLETED|Treatment Period 3||6
1586114|NCT01078623|3880317|P4|COMPLETED|Treatment Period 3||6
1586115|NCT01078623|3880318|P3|COMPLETED|Treatment Period 3||6
1586116|NCT01078623|3880319|P2|COMPLETED|Treatment Period 3||5
1586117|NCT01078623|3880320|P1|COMPLETED|Treatment Period 3||5
1586118|NCT01078623|3880301|P20|STARTED|Treatment Period 3||7
1586119|NCT01078623|3880302|P19|STARTED|Treatment Period 3||6
1586120|NCT01078623|3880303|P18|STARTED|Treatment Period 3||7
1586121|NCT01078623|3880304|P17|STARTED|Treatment Period 3||7
1586122|NCT01078623|3880305|P16|STARTED|Treatment Period 3||7
1586123|NCT01078623|3880306|P15|STARTED|Treatment Period 3||7
1586124|NCT01078623|3880307|P14|STARTED|Treatment Period 3||7
1586125|NCT01078623|3880308|P13|STARTED|Treatment Period 3||7
1586126|NCT01078623|3880309|P12|STARTED|Treatment Period 3||7
1586127|NCT01078623|3880310|P11|STARTED|Treatment Period 3||6
1586128|NCT01078623|3880311|P10|STARTED|Treatment Period 3||6
1586129|NCT01078623|3880312|P9|STARTED|Treatment Period 3||5
1586130|NCT01078623|3880313|P8|STARTED|Treatment Period 3||6
1586131|NCT01078623|3880314|P7|STARTED|Treatment Period 3||5
1586132|NCT01078623|3880315|P6|STARTED|Treatment Period 3||4
1586133|NCT01078623|3880316|P5|STARTED|Treatment Period 3||7
1586134|NCT01078623|3880317|P4|STARTED|Treatment Period 3||6
1586135|NCT01078623|3880318|P3|STARTED|Treatment Period 3||6
1586136|NCT01078623|3880319|P2|STARTED|Treatment Period 3||5
1586137|NCT01078623|3880320|P1|STARTED|Treatment Period 3||5
1586138|NCT01078623|3880301|P20|NOT COMPLETED|Treatment Period 2||0
1586139|NCT01078623|3880302|P19|NOT COMPLETED|Treatment Period 2||1
1586140|NCT01078623|3880303|P18|NOT COMPLETED|Treatment Period 2||0
1586141|NCT01078623|3880304|P17|NOT COMPLETED|Treatment Period 2||0
1586142|NCT01078623|3880305|P16|NOT COMPLETED|Treatment Period 2||0
1586143|NCT01078623|3880306|P15|NOT COMPLETED|Treatment Period 2||0
1586144|NCT01078623|3880307|P14|NOT COMPLETED|Treatment Period 2||0
1586145|NCT01078623|3880308|P13|NOT COMPLETED|Treatment Period 2||0
1586146|NCT01078623|3880309|P12|NOT COMPLETED|Treatment Period 2||0
1586147|NCT01078623|3880310|P11|NOT COMPLETED|Treatment Period 2||0
1586148|NCT01078623|3880311|P10|NOT COMPLETED|Treatment Period 2||0
1586149|NCT01078623|3880312|P9|NOT COMPLETED|Treatment Period 2||0
1586150|NCT01078623|3880313|P8|NOT COMPLETED|Treatment Period 2||0
1586151|NCT01078623|3880314|P7|NOT COMPLETED|Treatment Period 2||1
1586152|NCT01078623|3880315|P6|NOT COMPLETED|Treatment Period 2||1
1586153|NCT01078623|3880316|P5|NOT COMPLETED|Treatment Period 2||0
1586154|NCT01078623|3880317|P4|NOT COMPLETED|Treatment Period 2||0
1586155|NCT01078623|3880318|P3|NOT COMPLETED|Treatment Period 2||0
1586156|NCT01078623|3880319|P2|NOT COMPLETED|Treatment Period 2||0
1586157|NCT01078623|3880320|P1|NOT COMPLETED|Treatment Period 2||0
1586158|NCT01078623|3880301|P20|COMPLETED|Treatment Period 2||7
1586159|NCT01078623|3880302|P19|COMPLETED|Treatment Period 2||6
1586160|NCT01078623|3880303|P18|COMPLETED|Treatment Period 2||7
1586161|NCT01078623|3880304|P17|COMPLETED|Treatment Period 2||7
1586162|NCT01078623|3880305|P16|COMPLETED|Treatment Period 2||7
1586163|NCT01078623|3880306|P15|COMPLETED|Treatment Period 2||7
1586164|NCT01078623|3880307|P14|COMPLETED|Treatment Period 2||7
1586165|NCT01078623|3880308|P13|COMPLETED|Treatment Period 2||7
1586166|NCT01078623|3880309|P12|COMPLETED|Treatment Period 2||7
1586167|NCT01078623|3880310|P11|COMPLETED|Treatment Period 2||6
1586168|NCT01078623|3880311|P10|COMPLETED|Treatment Period 2||6
1586169|NCT01078623|3880312|P9|COMPLETED|Treatment Period 2||5
1586170|NCT01078623|3880313|P8|COMPLETED|Treatment Period 2||6
1586171|NCT01078623|3880314|P7|COMPLETED|Treatment Period 2||5
1586172|NCT01078623|3880315|P6|COMPLETED|Treatment Period 2||4
1586173|NCT01078623|3880316|P5|COMPLETED|Treatment Period 2||7
1586174|NCT01078623|3880317|P4|COMPLETED|Treatment Period 2||6
1586175|NCT01078623|3880318|P3|COMPLETED|Treatment Period 2||6
1586176|NCT01078623|3880319|P2|COMPLETED|Treatment Period 2||5
1586177|NCT01078623|3880320|P1|COMPLETED|Treatment Period 2||5
1586178|NCT01078623|3880301|P20|STARTED|Treatment Period 2||7
1586179|NCT01078623|3880302|P19|STARTED|Treatment Period 2||7
1586180|NCT01078623|3880303|P18|STARTED|Treatment Period 2||7
1586181|NCT01078623|3880304|P17|STARTED|Treatment Period 2||7
1586182|NCT01078623|3880305|P16|STARTED|Treatment Period 2||7
1586183|NCT01078623|3880306|P15|STARTED|Treatment Period 2||7
1586184|NCT01078623|3880307|P14|STARTED|Treatment Period 2||7
1586185|NCT01078623|3880308|P13|STARTED|Treatment Period 2||7
1586186|NCT01078623|3880309|P12|STARTED|Treatment Period 2||7
1586187|NCT01078623|3880310|P11|STARTED|Treatment Period 2||6
1586188|NCT01078623|3880311|P10|STARTED|Treatment Period 2||6
1586189|NCT01078623|3880312|P9|STARTED|Treatment Period 2||5
1586190|NCT01078623|3880313|P8|STARTED|Treatment Period 2||6
1586191|NCT01078623|3880314|P7|STARTED|Treatment Period 2||6
1586192|NCT01078623|3880315|P6|STARTED|Treatment Period 2||5
1586193|NCT01078623|3880316|P5|STARTED|Treatment Period 2||7
1586194|NCT01078623|3880317|P4|STARTED|Treatment Period 2||6
1586195|NCT01078623|3880318|P3|STARTED|Treatment Period 2||6
1586196|NCT01078623|3880319|P2|STARTED|Treatment Period 2||5
1586197|NCT01078623|3880320|P1|STARTED|Treatment Period 2||5
1586198|NCT01078623|3880301|P20|NOT COMPLETED|Treatment Period 1||0
1586199|NCT01078623|3880302|P19|NOT COMPLETED|Treatment Period 1||0
1586200|NCT01078623|3880303|P18|NOT COMPLETED|Treatment Period 1||0
1586201|NCT01078623|3880304|P17|NOT COMPLETED|Treatment Period 1||0
1586202|NCT01078623|3880305|P16|NOT COMPLETED|Treatment Period 1||0
1586203|NCT01078623|3880306|P15|NOT COMPLETED|Treatment Period 1||0
1586204|NCT01078623|3880307|P14|NOT COMPLETED|Treatment Period 1||0
1586205|NCT01078623|3880308|P13|NOT COMPLETED|Treatment Period 1||0
1586206|NCT01078623|3880309|P12|NOT COMPLETED|Treatment Period 1||0
1586207|NCT01078623|3880310|P11|NOT COMPLETED|Treatment Period 1||1
1586208|NCT01078623|3880311|P10|NOT COMPLETED|Treatment Period 1||1
1586209|NCT01078623|3880312|P9|NOT COMPLETED|Treatment Period 1||1
1586210|NCT01078623|3880313|P8|NOT COMPLETED|Treatment Period 1||1
1586211|NCT01078623|3880314|P7|NOT COMPLETED|Treatment Period 1||1
1586212|NCT01078623|3880315|P6|NOT COMPLETED|Treatment Period 1||1
1586213|NCT01078623|3880316|P5|NOT COMPLETED|Treatment Period 1||0
1586214|NCT01078623|3880317|P4|NOT COMPLETED|Treatment Period 1||0
1586215|NCT01078623|3880318|P3|NOT COMPLETED|Treatment Period 1||1
1586216|NCT01078623|3880319|P2|NOT COMPLETED|Treatment Period 1||1
1586217|NCT01078623|3880320|P1|NOT COMPLETED|Treatment Period 1||1
1586218|NCT01078623|3880301|P20|COMPLETED|Treatment Period 1||7
1586219|NCT01078623|3880302|P19|COMPLETED|Treatment Period 1||7
1586220|NCT01078623|3880303|P18|COMPLETED|Treatment Period 1||7
1586221|NCT01078623|3880304|P17|COMPLETED|Treatment Period 1||7
1586222|NCT01078623|3880305|P16|COMPLETED|Treatment Period 1||7
1586223|NCT01078623|3880306|P15|COMPLETED|Treatment Period 1||7
1586224|NCT01078623|3880307|P14|COMPLETED|Treatment Period 1||7
1586225|NCT01078623|3880308|P13|COMPLETED|Treatment Period 1||7
1586226|NCT01078623|3880309|P12|COMPLETED|Treatment Period 1||7
1586227|NCT01078623|3880310|P11|COMPLETED|Treatment Period 1||6
1586228|NCT01078623|3880311|P10|COMPLETED|Treatment Period 1||6
1586229|NCT01078623|3880312|P9|COMPLETED|Treatment Period 1||5
1586230|NCT01078623|3880313|P8|COMPLETED|Treatment Period 1||6
1586231|NCT01078623|3880314|P7|COMPLETED|Treatment Period 1||6
1586232|NCT01078623|3880315|P6|COMPLETED|Treatment Period 1||5
1586233|NCT01078623|3880316|P5|COMPLETED|Treatment Period 1||7
1586234|NCT01078623|3880317|P4|COMPLETED|Treatment Period 1||6
1586235|NCT01078623|3880318|P3|COMPLETED|Treatment Period 1||6
1586236|NCT01078623|3880319|P2|COMPLETED|Treatment Period 1||5
1586237|NCT01078623|3880320|P1|COMPLETED|Treatment Period 1||5
1586238|NCT01078623|3880301|P20|STARTED|Treatment Period 1||7
1586239|NCT01078623|3880302|P19|STARTED|Treatment Period 1||7
1586240|NCT01078623|3880303|P18|STARTED|Treatment Period 1||7
1586241|NCT01078623|3880304|P17|STARTED|Treatment Period 1||7
1586242|NCT01078623|3880305|P16|STARTED|Treatment Period 1||7
1586243|NCT01078623|3880306|P15|STARTED|Treatment Period 1||7
1586244|NCT01078623|3880307|P14|STARTED|Treatment Period 1||7
1586245|NCT01078623|3880308|P13|STARTED|Treatment Period 1||7
1586246|NCT01078623|3880309|P12|STARTED|Treatment Period 1||7
1586247|NCT01078623|3880310|P11|STARTED|Treatment Period 1||7
1586248|NCT01078623|3880311|P10|STARTED|Treatment Period 1||7
1586249|NCT01078623|3880312|P9|STARTED|Treatment Period 1||6
1586250|NCT01078623|3880313|P8|STARTED|Treatment Period 1||7
1586251|NCT01078623|3880314|P7|STARTED|Treatment Period 1||7
1586252|NCT01078623|3880315|P6|STARTED|Treatment Period 1||6
1586253|NCT01078623|3880316|P5|STARTED|Treatment Period 1||7
1586254|NCT01078623|3880317|P4|STARTED|Treatment Period 1||6
1586255|NCT01078623|3880318|P3|STARTED|Treatment Period 1||7
1586256|NCT01078623|3880319|P2|STARTED|Treatment Period 1||6
1586257|NCT01078623|3880320|P1|STARTED|Treatment Period 1||6
1586258|NCT01078584|3880342|P1|NOT COMPLETED|Overall Study||3010
1586259|NCT01078584|3880342|P1|COMPLETED|Overall Study||4983
1586260|NCT01078584|3880342|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
1586261|NCT01078584|3880342|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
1586262|NCT01078584|3880342|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
1586263|NCT01078584|3880342|P1|STARTED|Overall Study||7993
1586264|NCT01078571|3880423|P1|NOT COMPLETED|Overall Study||115
1586265|NCT01078571|3880423|P1|COMPLETED|Overall Study||590
1586266|NCT01078571|3880423|P1|Intent-to-treat (ITT) Population|Overall Study||591
1586267|NCT01078571|3880423|P1|Safety Population|Overall Study||675
1586268|NCT01078571|3880423|P1|STARTED|Overall Study||705
1586269|NCT01078545|3880439|P1|NOT COMPLETED|Overall Study||26
1586270|NCT01078545|3880439|P1|COMPLETED|Overall Study||703
1586271|NCT01078545|3880439|P1|Per Protocol Population|Overall Study||661
1586272|NCT01078545|3880439|P1|Intent-to-treat Population|Overall Study||729
1586273|NCT01078545|3880439|P1|STARTED|Overall Study||729
1586274|NCT01078454|3880449|P2|NOT COMPLETED|Overall Study||2
1586275|NCT01078454|3880450|P1|NOT COMPLETED|Overall Study||1
1586276|NCT01078454|3880449|P2|COMPLETED|Overall Study||3
1586277|NCT01078454|3880450|P1|COMPLETED|Overall Study||5
1586278|NCT01078454|3880449|P2|STARTED|Overall Study||5
1586279|NCT01078454|3880450|P1|STARTED|Overall Study||6
1586280|NCT01078441|3880456|P1|NOT COMPLETED|Overall Study||1
1586281|NCT01078441|3880456|P1|COMPLETED|Overall Study||1
1586282|NCT01078441|3880456|P1|STARTED|Overall Study||2
1586283|NCT01078402|3880463|P3|NOT COMPLETED|Overall Study||68
1586284|NCT01078402|3880464|P2|NOT COMPLETED|Overall Study||29
1586285|NCT01078402|3880465|P1|NOT COMPLETED|Overall Study||107
1586286|NCT01078402|3880463|P3|COMPLETED|Overall Study||166
1586287|NCT01078402|3880464|P2|COMPLETED|Overall Study||95
1586288|NCT01078402|3880465|P1|COMPLETED|Overall Study||324
1586289|NCT01078402|3880463|P3|STARTED|Overall Study||234
1586290|NCT01078402|3880464|P2|STARTED|Overall Study||124
1586291|NCT01078402|3880465|P1|STARTED|Overall Study||431
1586292|NCT01078389|3880496|P2|NOT COMPLETED|Overall Study||67
1586293|NCT01078389|3880497|P1|NOT COMPLETED|Overall Study||64
1586294|NCT01078389|3880496|P2|COMPLETED|Overall Study||90
1586295|NCT01078389|3880497|P1|COMPLETED|Overall Study||93
1586296|NCT01078389|3880496|P2|STARTED|Overall Study||157
1586297|NCT01078389|3880497|P1|STARTED|Overall Study||157
1586298|NCT01078376|3880515|P4|NOT COMPLETED|Overall Study||0
1586299|NCT01078376|3880516|P3|NOT COMPLETED|Overall Study||0
1586300|NCT01078376|3880517|P2|NOT COMPLETED|Overall Study||0
1586301|NCT01078376|3880518|P1|NOT COMPLETED|Overall Study||0
1586302|NCT01078376|3880515|P4|COMPLETED|Overall Study||3
1586303|NCT01078376|3880516|P3|COMPLETED|Overall Study||8
1586304|NCT01078376|3880517|P2|COMPLETED|Overall Study||9
1586305|NCT01078376|3880518|P1|COMPLETED|Overall Study||9
1586306|NCT01078376|3880515|P4|STARTED|Overall Study||3
1586307|NCT01078376|3880516|P3|STARTED|Overall Study||8
1586308|NCT01078376|3880517|P2|STARTED|Overall Study||9
1586309|NCT01078376|3880518|P1|STARTED|Overall Study||9
1586310|NCT01078363|3880639|P2|NOT COMPLETED|Overall Study||0
1586311|NCT01078363|3880640|P1|NOT COMPLETED|Overall Study||0
1586312|NCT01078363|3880639|P2|COMPLETED|Overall Study||49
1586313|NCT01078363|3880640|P1|COMPLETED|Overall Study||47
1586314|NCT01078363|3880639|P2|STARTED|Overall Study||49
1586315|NCT01078363|3880640|P1|STARTED|Overall Study||47
1586316|NCT01078298|3880658|P2|NOT COMPLETED|Overall Study||90
1586317|NCT01078298|3880659|P1|NOT COMPLETED|Overall Study||81
1586318|NCT01078298|3880658|P2|COMPLETED|Overall Study||179
1586319|NCT01078298|3880659|P1|COMPLETED|Overall Study||175
1586320|NCT01078298|3880658|P2|STARTED|Overall Study||269
1586321|NCT01078298|3880659|P1|STARTED|Overall Study||256
1586322|NCT01078246|3880692|P7|NOT COMPLETED|Overall Study||0
1586323|NCT01078246|3880693|P6|NOT COMPLETED|Overall Study||0
1586324|NCT01078246|3880694|P5|NOT COMPLETED|Overall Study||0
1586325|NCT01078246|3880695|P4|NOT COMPLETED|Overall Study||0
1586326|NCT01078246|3880696|P3|NOT COMPLETED|Overall Study||0
1586327|NCT01078246|3880697|P2|NOT COMPLETED|Overall Study||0
1586328|NCT01078246|3880698|P1|NOT COMPLETED|Overall Study||0
1586329|NCT01078246|3880692|P7|COMPLETED|Overall Study||22
1586330|NCT01078246|3880693|P6|COMPLETED|Overall Study||231
1586331|NCT01078246|3880694|P5|COMPLETED|Overall Study||3310
1586332|NCT01078246|3880695|P4|COMPLETED|Overall Study||152
1586333|NCT01078246|3880696|P3|COMPLETED|Overall Study||1963
1586334|NCT01078246|3880697|P2|COMPLETED|Overall Study||405
1586335|NCT01078246|3880698|P1|COMPLETED|Overall Study||1041
1586336|NCT01078246|3880692|P7|STARTED|Overall Study||22
1586337|NCT01078246|3880693|P6|STARTED|Overall Study||231
1586338|NCT01078246|3880694|P5|STARTED|Overall Study||3310
1586339|NCT01078246|3880695|P4|STARTED|Overall Study||152
1586340|NCT01078246|3880696|P3|STARTED|Overall Study||1963
1586341|NCT01078246|3880697|P2|STARTED|Overall Study||405
1586342|NCT01078246|3880698|P1|STARTED|Overall Study||1041
1586343|NCT01078233|3880730|P6|NOT COMPLETED|Overall Study||0
1586344|NCT01078233|3880731|P5|NOT COMPLETED|Overall Study||0
1586345|NCT01078233|3880732|P4|NOT COMPLETED|Overall Study||0
1586346|NCT01078233|3880733|P3|NOT COMPLETED|Overall Study||0
1586347|NCT01078233|3880734|P2|NOT COMPLETED|Overall Study||0
1586348|NCT01078233|3880735|P1|NOT COMPLETED|Overall Study||0
1586349|NCT01078233|3880730|P6|COMPLETED|Overall Study||154
1586350|NCT01078233|3880731|P5|COMPLETED|Overall Study||3199
1586351|NCT01078233|3880732|P4|COMPLETED|Overall Study||631
1586352|NCT01078233|3880733|P3|COMPLETED|Overall Study||1681
1586353|NCT01078233|3880734|P2|COMPLETED|Overall Study||296
1586354|NCT01078233|3880735|P1|COMPLETED|Overall Study||656
1586355|NCT01078233|3880730|P6|STARTED|Overall Study||154
1586356|NCT01078233|3880731|P5|STARTED|Overall Study||3199
1586357|NCT01078233|3880732|P4|STARTED|Overall Study||631
1586358|NCT01078233|3880733|P3|STARTED|Overall Study||1681
1586359|NCT01078233|3880734|P2|STARTED|Overall Study||296
1586360|NCT01078233|3880735|P1|STARTED|Overall Study||656
1586361|NCT01078220|3880752|P1|NOT COMPLETED|Overall Study||0
1586362|NCT01078220|3880752|P1|COMPLETED|Overall Study||189629
1586363|NCT01078220|3880752|P1|STARTED|Overall Study||189629
1586364|NCT01078207|3880762|P1|NOT COMPLETED|Overall Study||0
1586365|NCT01078207|3880762|P1|COMPLETED|Overall Study||100
1586366|NCT01078207|3880762|P1|STARTED|Overall Study||100
1586367|NCT01078168|3880769|P2|NOT COMPLETED|Overall Study||1
1586368|NCT01078168|3880770|P1|NOT COMPLETED|Overall Study||0
1586369|NCT01078168|3880769|P2|COMPLETED|Overall Study||10
1586370|NCT01078168|3880770|P1|COMPLETED|Overall Study||11
1586371|NCT01078168|3880769|P2|STARTED|Overall Study||11
1586372|NCT01078168|3880770|P1|STARTED|Overall Study||11
1586373|NCT01078155|3880776|P1|NOT COMPLETED|Overall Study||44
1586374|NCT01078155|3880776|P1|COMPLETED|Overall Study||87
1586375|NCT01078155|3880776|P1|STARTED|Overall Study||131
1586376|NCT01078116|3880792|P1|NOT COMPLETED|Overall Study||48
1586377|NCT01078116|3880792|P1|COMPLETED|Overall Study||76
1586378|NCT01078116|3880792|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
1586379|NCT01078090|3880800|P1|NOT COMPLETED|Overall Study||4593
1586380|NCT01078090|3880800|P1|COMPLETED|Overall Study||1152
1586381|NCT01078090|3880800|P1|STARTED|Overall Study||5745
1586382|NCT01077973|3880844|P3|NOT COMPLETED|Overall Study||0
1586383|NCT01077973|3880845|P2|NOT COMPLETED|Overall Study||0
1586384|NCT01077973|3880846|P1|NOT COMPLETED|Overall Study||0
1586385|NCT01077973|3880844|P3|COMPLETED|Overall Study||80
1586386|NCT01077973|3880845|P2|COMPLETED|Overall Study||79
1586387|NCT01077973|3880846|P1|COMPLETED|Overall Study||41
1586388|NCT01077973|3880844|P3|STARTED|Overall Study||80
1586389|NCT01077973|3880845|P2|STARTED|Overall Study||79
1586390|NCT01077973|3880846|P1|STARTED|Overall Study||41
1586391|NCT01077960|3880894|P1|NOT COMPLETED|Overall Study||16
1586392|NCT01077960|3880894|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
1586393|NCT01077960|3880894|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
1586394|NCT01077921|3880905|P2|NOT COMPLETED|Second Intervention||1
1586395|NCT01077921|3880906|P1|NOT COMPLETED|Second Intervention||0
1586396|NCT01077921|3880905|P2|COMPLETED|Second Intervention||9
1586397|NCT01077921|3880906|P1|COMPLETED|Second Intervention||13
1586398|NCT01077921|3880905|P2|STARTED|Second Intervention||10
1586399|NCT01077921|3880906|P1|STARTED|Second Intervention||13
1586400|NCT01077921|3880905|P2|NOT COMPLETED|Washout||2
1586401|NCT01077921|3880906|P1|NOT COMPLETED|Washout||0
1586402|NCT01077921|3880905|P2|COMPLETED|Washout||10
1586403|NCT01077921|3880906|P1|COMPLETED|Washout||13
1586404|NCT01077921|3880905|P2|STARTED|Washout||12
1586405|NCT01077921|3880906|P1|STARTED|Washout||13
1586406|NCT01077921|3880905|P2|NOT COMPLETED|First Intervention||1
1586407|NCT01077921|3880906|P1|NOT COMPLETED|First Intervention||1
1586408|NCT01077921|3880905|P2|COMPLETED|First Intervention||12
1586409|NCT01077921|3880906|P1|COMPLETED|First Intervention||13
1586410|NCT01077921|3880905|P2|STARTED|First Intervention||13
1586411|NCT01077921|3880906|P1|STARTED|First Intervention||14
1586412|NCT01077856|3880939|P3|NOT COMPLETED|Overall Study||0
1586413|NCT01077856|3880940|P2|NOT COMPLETED|Overall Study||0
1586414|NCT01077856|3880941|P1|NOT COMPLETED|Overall Study||0
1586415|NCT01077856|3880939|P3|COMPLETED|Overall Study||15713
1586416|NCT01077856|3880940|P2|COMPLETED|Overall Study||16604
1586417|NCT01077856|3880941|P1|COMPLETED|Overall Study||22199
1586418|NCT01077856|3880939|P3|STARTED|Overall Study||15713
1586419|NCT01077856|3880940|P2|STARTED|Overall Study||16604
1586420|NCT01077856|3880941|P1|STARTED|Overall Study||22199
1586421|NCT01077830|3881122|P2|NOT COMPLETED|Overall Study||0
1586422|NCT01077830|3881123|P1|NOT COMPLETED|Overall Study||0
1586423|NCT01077830|3881122|P2|COMPLETED|Overall Study||682
1586424|NCT01077830|3881123|P1|COMPLETED|Overall Study||677
1586425|NCT01077830|3881122|P2|STARTED|Overall Study||682
1586426|NCT01077830|3881123|P1|STARTED|Overall Study||677
1586427|NCT01077817|3881133|P1|NOT COMPLETED|Overall Study||0
1586428|NCT01077817|3881133|P1|COMPLETED|Overall Study||684815
1586429|NCT01077817|3881133|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
1586430|NCT01077804|3881144|P1|NOT COMPLETED|Overall Study||199
1586431|NCT01077804|3881144|P1|COMPLETED|Overall Study||7386
1586432|NCT01077804|3881144|P1|STARTED|Overall Study||7585
1586433|NCT01077739|3881153|P2|NOT COMPLETED|Overall Study||10
1586434|NCT01077739|3881154|P1|NOT COMPLETED|Overall Study||5
1586435|NCT01077739|3881153|P2|COMPLETED|Overall Study||40
1586436|NCT01077739|3881154|P1|COMPLETED|Overall Study||20
1586437|NCT01077739|3881153|P2|STARTED|Overall Study||50
1586438|NCT01077739|3881154|P1|STARTED|Overall Study||25
1586439|NCT01077713|3881168|P2|NOT COMPLETED|Overall Study||36
1586440|NCT01077713|3881169|P1|NOT COMPLETED|Overall Study||36
1586441|NCT01077713|3881168|P2|COMPLETED|Overall Study||6
1586442|NCT01077713|3881169|P1|COMPLETED|Overall Study||8
1586443|NCT01077713|3881168|P2|STARTED|Overall Study||42
1586444|NCT01077713|3881169|P1|STARTED|Overall Study||44
1586445|NCT01077622|3881193|P1|NOT COMPLETED|Overall Study||3
1586446|NCT01077622|3881193|P1|COMPLETED|Overall Study||7
1586447|NCT01077622|3881193|P1|STARTED|Overall Study||10
1586448|NCT01077596|3881251|P12|NOT COMPLETED|Overall Study||0
1586449|NCT01077596|3881252|P11|NOT COMPLETED|Overall Study||0
1586450|NCT01077596|3881253|P10|NOT COMPLETED|Overall Study||0
1586451|NCT01077596|3881254|P9|NOT COMPLETED|Overall Study||0
1586452|NCT01077596|3881255|P8|NOT COMPLETED|Overall Study||0
1586453|NCT01077596|3881256|P7|NOT COMPLETED|Overall Study||0
1586454|NCT01077596|3881257|P6|NOT COMPLETED|Overall Study||0
1586455|NCT01077596|3881258|P5|NOT COMPLETED|Overall Study||0
1586456|NCT01077596|3881259|P4|NOT COMPLETED|Overall Study||0
1586457|NCT01077596|3881260|P3|NOT COMPLETED|Overall Study||0
1586458|NCT01077596|3881261|P2|NOT COMPLETED|Overall Study||0
1586459|NCT01077596|3881262|P1|NOT COMPLETED|Overall Study||0
1586460|NCT01077596|3881251|P12|COMPLETED|Overall Study||22150
1586461|NCT01077596|3881252|P11|COMPLETED|Overall Study||2215
1586462|NCT01077596|3881253|P10|COMPLETED|Overall Study||28420
1586463|NCT01077596|3881254|P9|COMPLETED|Overall Study||2842
1586464|NCT01077596|3881255|P8|COMPLETED|Overall Study||837
1586465|NCT01077596|3881256|P7|COMPLETED|Overall Study||308
1586466|NCT01077596|3881257|P6|COMPLETED|Overall Study||882
1586467|NCT01077596|3881258|P5|COMPLETED|Overall Study||294
1586468|NCT01077596|3881259|P4|COMPLETED|Overall Study||1370
1586469|NCT01077596|3881260|P3|COMPLETED|Overall Study||457
1586470|NCT01077596|3881261|P2|COMPLETED|Overall Study||1050
1586471|NCT01077596|3881262|P1|COMPLETED|Overall Study||350
1586472|NCT01077596|3881251|P12|STARTED|Overall Study||22150
1586473|NCT01077596|3881252|P11|STARTED|Overall Study||2215
1586474|NCT01077596|3881253|P10|STARTED|Overall Study||28420
1586475|NCT01077596|3881254|P9|STARTED|Overall Study||2842
1586476|NCT01077596|3881255|P8|STARTED|Overall Study||837
1586477|NCT01077596|3881256|P7|STARTED|Overall Study||308
1586478|NCT01077596|3881257|P6|STARTED|Overall Study||882
1586479|NCT01077596|3881258|P5|STARTED|Overall Study||294
1586480|NCT01077596|3881259|P4|STARTED|Overall Study||1370
1586481|NCT01077596|3881260|P3|STARTED|Overall Study||457
1586482|NCT01077596|3881261|P2|STARTED|Overall Study||1050
1586483|NCT01077596|3881262|P1|STARTED|Overall Study||350
1586484|NCT01077544|3881313|P2|NOT COMPLETED|Overall Study||5
1586485|NCT01077544|3881314|P1|NOT COMPLETED|Overall Study||3
1586486|NCT01077544|3881313|P2|COMPLETED|Overall Study||2
1586487|NCT01077544|3881314|P1|COMPLETED|Overall Study||5
1586488|NCT01077544|3881313|P2|STARTED|Overall Study||7
1586489|NCT01077544|3881314|P1|STARTED|Overall Study||8
1586490|NCT01077401|3881342|P2|NOT COMPLETED|Overall Study||21
1586491|NCT01077401|3881343|P1|NOT COMPLETED|Overall Study||18
1586492|NCT01077401|3881342|P2|COMPLETED|Overall Study||54
1586493|NCT01077401|3881343|P1|COMPLETED|Overall Study||59
1586494|NCT01077401|3881342|P2|STARTED|Overall Study||75
1586495|NCT01077401|3881343|P1|STARTED|Overall Study||77
1586496|NCT01077375|3881355|P2|NOT COMPLETED|Overall Study||35
1586497|NCT01077375|3881356|P1|NOT COMPLETED|Overall Study||10
1586498|NCT01077375|3881355|P2|COMPLETED|Overall Study||51
1586499|NCT01077375|3881356|P1|COMPLETED|Overall Study||11
1586500|NCT01077375|3881355|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
1586501|NCT01077375|3881356|P1|STARTED|Overall Study||21
1586502|NCT01077362|3881367|P3|NOT COMPLETED|Overall Study||24
1586503|NCT01077362|3881368|P2|NOT COMPLETED|Overall Study||19
1586504|NCT01077362|3881369|P1|NOT COMPLETED|Overall Study||31
1586505|NCT01077362|3881367|P3|COMPLETED|Overall Study||81
1586506|NCT01077362|3881368|P2|COMPLETED|Overall Study||84
1586507|NCT01077362|3881369|P1|COMPLETED|Overall Study||73
1586508|NCT01077362|3881367|P3|STARTED|Overall Study||105
1586509|NCT01077362|3881368|P2|STARTED|Overall Study||103
1586510|NCT01077362|3881369|P1|STARTED|Overall Study||104
1586511|NCT01077323|3881405|P3|NOT COMPLETED|Overall Study||11912089
1586512|NCT01077323|3881406|P2|NOT COMPLETED|Overall Study||386263
1586513|NCT01077323|3881407|P1|NOT COMPLETED|Overall Study||11378
1586514|NCT01077323|3881405|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
1586515|NCT01077323|3881406|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
1586516|NCT01077323|3881407|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
1586517|NCT01077323|3881405|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
1586518|NCT01077323|3881406|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
1586519|NCT01077323|3881407|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
1586520|NCT01077310|3881426|P2|NOT COMPLETED|Overall Study||0
1586521|NCT01077310|3881427|P1|NOT COMPLETED|Overall Study||0
1586522|NCT01077310|3881426|P2|COMPLETED|Overall Study||33
1586523|NCT01077310|3881427|P1|COMPLETED|Overall Study||67
1586524|NCT01077310|3881426|P2|STARTED|Overall Study||33
1586525|NCT01077310|3881427|P1|STARTED|Overall Study||67
1586526|NCT01077284|3881450|P3|NOT COMPLETED|Overall Study||3
1586527|NCT01077284|3881451|P2|NOT COMPLETED|Overall Study||5
1586528|NCT01077284|3881452|P1|NOT COMPLETED|Overall Study||5
1586529|NCT01077284|3881450|P3|COMPLETED|Overall Study||30
1586530|NCT01077284|3881451|P2|COMPLETED|Overall Study||28
1586531|NCT01077284|3881452|P1|COMPLETED|Overall Study||28
1586532|NCT01077284|3881450|P3|STARTED|Overall Study||33
1586533|NCT01077284|3881451|P2|STARTED|Overall Study||33
1586534|NCT01077284|3881452|P1|STARTED|Overall Study||33
1586535|NCT01077271|3881473|P1|NOT COMPLETED|Overall Study||22
1586536|NCT01077271|3881473|P1|COMPLETED|Overall Study||102
1586537|NCT01077271|3881473|P1|Number of Participants Analyzed|Overall Study||120
1586538|NCT01077271|3881473|P1|Participants Treated With Palivizumab|Overall Study||120
1586539|NCT01077271|3881473|P1|STARTED|Overall Study||124
1586540|NCT01077258|3881511|P1|NOT COMPLETED|Overall Study||2568
1586541|NCT01077258|3881511|P1|COMPLETED|Overall Study||1640
1586542|NCT01077258|3881511|P1|STARTED|Overall Study||4208
1586543|NCT01077193|3881547|P1|NOT COMPLETED|Overall Study||44
1586544|NCT01077193|3881547|P1|COMPLETED|Overall Study||0
1586545|NCT01077193|3881547|P1|STARTED|Overall Study||44
1586546|NCT01077154|3881553|P2|NOT COMPLETED|Overall Study||2241
1586547|NCT01077154|3881554|P1|NOT COMPLETED|Overall Study||2241
1586548|NCT01077154|3881553|P2|COMPLETED|Overall Study||15
1586549|NCT01077154|3881554|P1|COMPLETED|Overall Study||12
1586550|NCT01077154|3881553|P2|Received Study Drug|Overall Study||2230
1586551|NCT01077154|3881554|P1|Received Study Drug|Overall Study||2229
1586552|NCT01077154|3881553|P2|STARTED|Overall Study||2256
1586553|NCT01077154|3881554|P1|STARTED|Overall Study||2253
1586554|NCT01077128|3881568|P1|NOT COMPLETED|Overall Study||67
1586555|NCT01077128|3881568|P1|COMPLETED|Overall Study||433
1586556|NCT01077128|3881568|P1|STARTED|Overall Study||500
1586557|NCT01077076|3881626|P6|NOT COMPLETED|Third Intervention||1
1586558|NCT01077076|3881627|P5|NOT COMPLETED|Third Intervention||0
1586559|NCT01077076|3881628|P4|NOT COMPLETED|Third Intervention||0
1586560|NCT01077076|3881629|P3|NOT COMPLETED|Third Intervention||0
1586561|NCT01077076|3881630|P2|NOT COMPLETED|Third Intervention||0
1586562|NCT01077076|3881631|P1|NOT COMPLETED|Third Intervention||0
1586563|NCT01077076|3881626|P6|COMPLETED|Third Intervention||4
1586564|NCT01077076|3881627|P5|COMPLETED|Third Intervention||5
1586565|NCT01077076|3881628|P4|COMPLETED|Third Intervention||5
1586566|NCT01077076|3881629|P3|COMPLETED|Third Intervention||5
1586567|NCT01077076|3881630|P2|COMPLETED|Third Intervention||5
1586568|NCT01077076|3881631|P1|COMPLETED|Third Intervention||4
1586569|NCT01077076|3881626|P6|STARTED|Third Intervention||5
1586570|NCT01077076|3881627|P5|STARTED|Third Intervention||5
1586571|NCT01077076|3881628|P4|STARTED|Third Intervention||5
1586572|NCT01077076|3881629|P3|STARTED|Third Intervention||5
1586573|NCT01077076|3881630|P2|STARTED|Third Intervention||5
1586574|NCT01077076|3881631|P1|STARTED|Third Intervention||4
1586575|NCT01077076|3881626|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
1586576|NCT01077076|3881627|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
1586577|NCT01077076|3881628|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1586578|NCT01077076|3881629|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1586579|NCT01077076|3881630|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1586580|NCT01077076|3881631|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1586581|NCT01077076|3881626|P6|COMPLETED|Washout Period of 2 Weeks||5
1586582|NCT01077076|3881627|P5|COMPLETED|Washout Period of 2 Weeks||5
1586583|NCT01077076|3881628|P4|COMPLETED|Washout Period of 2 Weeks||5
1586584|NCT01077076|3881629|P3|COMPLETED|Washout Period of 2 Weeks||5
1586585|NCT01077076|3881630|P2|COMPLETED|Washout Period of 2 Weeks||5
1586586|NCT01077076|3881631|P1|COMPLETED|Washout Period of 2 Weeks||4
1586587|NCT01077076|3881626|P6|STARTED|Washout Period of 2 Weeks||5
1586588|NCT01077076|3881627|P5|STARTED|Washout Period of 2 Weeks||5
1586589|NCT01077076|3881628|P4|STARTED|Washout Period of 2 Weeks||5
1586590|NCT01077076|3881629|P3|STARTED|Washout Period of 2 Weeks||5
1586591|NCT01077076|3881630|P2|STARTED|Washout Period of 2 Weeks||5
1586592|NCT01077076|3881631|P1|STARTED|Washout Period of 2 Weeks||4
1586593|NCT01077076|3881626|P6|NOT COMPLETED|Second Intervention||0
1586594|NCT01077076|3881627|P5|NOT COMPLETED|Second Intervention||0
1586595|NCT01077076|3881628|P4|NOT COMPLETED|Second Intervention||0
1586596|NCT01077076|3881629|P3|NOT COMPLETED|Second Intervention||0
1586597|NCT01077076|3881630|P2|NOT COMPLETED|Second Intervention||0
1586598|NCT01077076|3881631|P1|NOT COMPLETED|Second Intervention||0
1586599|NCT01077076|3881626|P6|COMPLETED|Second Intervention||5
1586600|NCT01077076|3881627|P5|COMPLETED|Second Intervention||5
1586601|NCT01077076|3881628|P4|COMPLETED|Second Intervention||5
1586602|NCT01077076|3881629|P3|COMPLETED|Second Intervention||5
1586603|NCT01077076|3881630|P2|COMPLETED|Second Intervention||5
1586604|NCT01077076|3881631|P1|COMPLETED|Second Intervention||4
1586605|NCT01077076|3881626|P6|STARTED|Second Intervention||5
1586606|NCT01077076|3881627|P5|STARTED|Second Intervention||5
1586607|NCT01077076|3881628|P4|STARTED|Second Intervention||5
1586608|NCT01077076|3881629|P3|STARTED|Second Intervention||5
1586609|NCT01077076|3881630|P2|STARTED|Second Intervention||5
1586610|NCT01077076|3881631|P1|STARTED|Second Intervention||4
1586611|NCT01077076|3881626|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
1586612|NCT01077076|3881627|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
1586613|NCT01077076|3881628|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1586614|NCT01077076|3881629|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1586615|NCT01077076|3881630|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1586616|NCT01077076|3881631|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1586617|NCT01077076|3881626|P6|COMPLETED|Washout Period of 2 Weeks||5
1586618|NCT01077076|3881627|P5|COMPLETED|Washout Period of 2 Weeks||5
1586619|NCT01077076|3881628|P4|COMPLETED|Washout Period of 2 Weeks||5
1586620|NCT01077076|3881629|P3|COMPLETED|Washout Period of 2 Weeks||5
1586621|NCT01077076|3881630|P2|COMPLETED|Washout Period of 2 Weeks||5
1586622|NCT01077076|3881631|P1|COMPLETED|Washout Period of 2 Weeks||4
1586623|NCT01077076|3881626|P6|STARTED|Washout Period of 2 Weeks||5
1586624|NCT01077076|3881627|P5|STARTED|Washout Period of 2 Weeks||5
1586625|NCT01077076|3881628|P4|STARTED|Washout Period of 2 Weeks||5
1586626|NCT01077076|3881629|P3|STARTED|Washout Period of 2 Weeks||5
1586627|NCT01077076|3881630|P2|STARTED|Washout Period of 2 Weeks||5
1586628|NCT01077076|3881631|P1|STARTED|Washout Period of 2 Weeks||4
1586629|NCT01077076|3881626|P6|NOT COMPLETED|First Intervention||0
1586630|NCT01077076|3881627|P5|NOT COMPLETED|First Intervention||0
1586631|NCT01077076|3881628|P4|NOT COMPLETED|First Intervention||0
1586632|NCT01077076|3881629|P3|NOT COMPLETED|First Intervention||0
1586633|NCT01077076|3881630|P2|NOT COMPLETED|First Intervention||0
1586634|NCT01077076|3881631|P1|NOT COMPLETED|First Intervention||1
1586635|NCT01077076|3881626|P6|COMPLETED|First Intervention||5
1586636|NCT01077076|3881627|P5|COMPLETED|First Intervention||5
1586637|NCT01077076|3881628|P4|COMPLETED|First Intervention||5
1586638|NCT01077076|3881629|P3|COMPLETED|First Intervention||5
1586639|NCT01077076|3881630|P2|COMPLETED|First Intervention||5
1586640|NCT01077076|3881631|P1|COMPLETED|First Intervention||4
1586641|NCT01077076|3881626|P6|STARTED|First Intervention||5
1586642|NCT01077076|3881627|P5|STARTED|First Intervention||5
1586643|NCT01077076|3881628|P4|STARTED|First Intervention||5
1586644|NCT01077076|3881629|P3|STARTED|First Intervention||5
1586645|NCT01077076|3881630|P2|STARTED|First Intervention||5
1586646|NCT01077076|3881631|P1|STARTED|First Intervention||5
1586647|NCT01077063|3881641|P2|NOT COMPLETED|Overall Study||3
1586648|NCT01077063|3881642|P1|NOT COMPLETED|Overall Study||4
1586649|NCT01077063|3881641|P2|COMPLETED|Overall Study||0
1586650|NCT01077063|3881642|P1|COMPLETED|Overall Study||0
1586651|NCT01077063|3881641|P2|STARTED|Overall Study||3
1586652|NCT01077063|3881642|P1|STARTED|Overall Study||4
1586653|NCT01077050|3881648|P1|NOT COMPLETED|Overall Study||9
1586654|NCT01077050|3881648|P1|COMPLETED|Overall Study||1942
1586655|NCT01077050|3881648|P1|STARTED|Overall Study||1951
1586656|NCT01077024|3881654|P2|NOT COMPLETED|Overall Study||28
1586657|NCT01077024|3881655|P1|NOT COMPLETED|Overall Study||31
1586658|NCT01077024|3881654|P2|COMPLETED|Overall Study||243
1586659|NCT01077024|3881655|P1|COMPLETED|Overall Study||236
1586660|NCT01077024|3881654|P2|STARTED|Overall Study||271
1586661|NCT01077024|3881655|P1|STARTED|Overall Study||267
1586662|NCT01076985|3881673|P1|NOT COMPLETED|Overall Study||0
1586663|NCT01076985|3881673|P1|COMPLETED|Overall Study||24
1586664|NCT01076985|3881673|P1|STARTED|Overall Study||24
1586665|NCT01076972|3881679|P1|NOT COMPLETED|Overall Study||0
1586666|NCT01076972|3881679|P1|COMPLETED|Overall Study||1184
1586667|NCT01076972|3881679|P1|STARTED|Overall Study||1184
1586668|NCT01076959|3881694|P1|NOT COMPLETED|Overall Study||2250
1586669|NCT01076959|3881694|P1|COMPLETED|Overall Study||5490
1586670|NCT01076959|3881694|P1|STARTED|Overall Study||7740
1586671|NCT01076686|3881715|P4|NOT COMPLETED|Overall Study||0
1586672|NCT01076686|3881716|P3|NOT COMPLETED|Overall Study||0
1586673|NCT01076686|3881717|P2|NOT COMPLETED|Overall Study||0
1586674|NCT01076686|3881718|P1|NOT COMPLETED|Overall Study||0
1586675|NCT01076686|3881715|P4|COMPLETED|Overall Study||31
1586676|NCT01076686|3881716|P3|COMPLETED|Overall Study||32
1586677|NCT01076686|3881717|P2|COMPLETED|Overall Study||14
1586678|NCT01076686|3881718|P1|COMPLETED|Overall Study||17
1586679|NCT01076686|3881715|P4|STARTED|Overall Study||31
1586680|NCT01076686|3881716|P3|STARTED|Overall Study||32
1586681|NCT01076686|3881717|P2|STARTED|Overall Study||14
1586682|NCT01076686|3881718|P1|STARTED|Overall Study||17
1586683|NCT01076647|3881730|P2|NOT COMPLETED|Overall Study||25
1586684|NCT01076647|3881731|P1|NOT COMPLETED|Overall Study||25
1586685|NCT01076647|3881730|P2|COMPLETED|Overall Study||209
1586686|NCT01076647|3881731|P1|COMPLETED|Overall Study||208
1586687|NCT01076647|3881730|P2|STARTED|Overall Study||234
1586688|NCT01076647|3881731|P1|STARTED|Overall Study||233
1586689|NCT01076504|3881739|P1|NOT COMPLETED|Overall Study||80
1586690|NCT01076504|3881739|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
1586691|NCT01076504|3881739|P1|STARTED|Overall Study||80
1586692|NCT01076452|3881749|P2|NOT COMPLETED|Overall Study||14
1586693|NCT01076452|3881750|P1|NOT COMPLETED|Overall Study||24
1586694|NCT01076452|3881749|P2|COMPLETED|Overall Study||138
1586695|NCT01076452|3881750|P1|COMPLETED|Overall Study||123
1586696|NCT01076452|3881749|P2|STARTED|Overall Study||152
1586697|NCT01076452|3881750|P1|STARTED|Overall Study||147
1586698|NCT01076400|3881762|P3|NOT COMPLETED|Overall Study||0
1586699|NCT01076400|3881763|P2|NOT COMPLETED|Overall Study||0
1586700|NCT01076400|3881764|P1|NOT COMPLETED|Overall Study||7
1586701|NCT01076400|3881762|P3|COMPLETED|Overall Study||0
1586702|NCT01076400|3881763|P2|COMPLETED|Overall Study||0
1586703|NCT01076400|3881764|P1|COMPLETED|Overall Study||0
1586704|NCT01076400|3881762|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
1586705|NCT01076400|3881763|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
1586706|NCT01076400|3881764|P1|STARTED|Overall Study||7
1586707|NCT01076361|3881770|P1|NOT COMPLETED|Overall Study||21
1586708|NCT01076361|3881770|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
1586709|NCT01076361|3881770|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
1586710|NCT01076348|3881774|P1|NOT COMPLETED|Overall Study||22
1586711|NCT01076348|3881774|P1|COMPLETED|Overall Study||51
1586712|NCT01076348|3881774|P1|STARTED|Overall Study||73
1586713|NCT01076335|3881778|P1|NOT COMPLETED|Overall Study||4
1586714|NCT01076335|3881778|P1|COMPLETED|Overall Study||36
1586715|NCT01076335|3881778|P1|STARTED|Overall Study||40
1586716|NCT01076296|3881782|P8|NOT COMPLETED|Overall Study||0
1586717|NCT01076296|3881783|P7|NOT COMPLETED|Overall Study||0
1586718|NCT01076296|3881784|P6|NOT COMPLETED|Overall Study||0
1586719|NCT01076296|3881785|P5|NOT COMPLETED|Overall Study||0
1586720|NCT01076296|3881786|P4|NOT COMPLETED|Overall Study||0
1586721|NCT01076296|3881787|P3|NOT COMPLETED|Overall Study||0
1586722|NCT01076296|3881788|P2|NOT COMPLETED|Overall Study||0
1586723|NCT01076296|3881789|P1|NOT COMPLETED|Overall Study||0
1586724|NCT01076296|3881782|P8|COMPLETED|Overall Study||199
1586725|NCT01076296|3881783|P7|COMPLETED|Overall Study||51
1586726|NCT01076296|3881784|P6|COMPLETED|Overall Study||191
1586727|NCT01076296|3881785|P5|COMPLETED|Overall Study||59
1586728|NCT01076296|3881786|P4|COMPLETED|Overall Study||199
1586729|NCT01076296|3881787|P3|COMPLETED|Overall Study||51
1586730|NCT01076296|3881788|P2|COMPLETED|Overall Study||196
1586731|NCT01076296|3881789|P1|COMPLETED|Overall Study||54
1586732|NCT01076296|3881782|P8|STARTED|Overall Study||199
1586733|NCT01076296|3881783|P7|STARTED|Overall Study||51
1586734|NCT01076296|3881784|P6|STARTED|Overall Study||191
1586735|NCT01076296|3881785|P5|STARTED|Overall Study||59
1586736|NCT01076296|3881786|P4|STARTED|Overall Study||199
1586737|NCT01076296|3881787|P3|STARTED|Overall Study||51
1586738|NCT01076296|3881788|P2|STARTED|Overall Study||196
1586739|NCT01076296|3881789|P1|STARTED|Overall Study||54
1586740|NCT01076283|3881809|P2|NOT COMPLETED|Overall Study||0
1586741|NCT01076283|3881810|P1|NOT COMPLETED|Overall Study||1
1586742|NCT01076283|3881809|P2|COMPLETED|Overall Study||7
1586743|NCT01076283|3881810|P1|COMPLETED|Overall Study||6
1586744|NCT01076283|3881809|P2|STARTED|Overall Study||7
1586745|NCT01076283|3881810|P1|STARTED|Overall Study||7
1586746|NCT01076270|3881818|P1|NOT COMPLETED|Overall Study||0
1586747|NCT01076270|3881818|P1|COMPLETED|Overall Study||1
1586748|NCT01076270|3881818|P1|STARTED|Overall Study||1
1586749|NCT01076244|3881823|P1|NOT COMPLETED|Overall Study||4
1586750|NCT01076244|3881823|P1|COMPLETED|Overall Study||42
1586751|NCT01076244|3881823|P1|STARTED|Overall Study||46
1586752|NCT01076192|3881830|P1|NOT COMPLETED|Overall Study||197
1586753|NCT01076192|3881830|P1|COMPLETED|Overall Study||350
1586754|NCT01076192|3881830|P1|STARTED|Overall Study||547
1586755|NCT01076179|3881845|P1|NOT COMPLETED|Overall Study||1
1586756|NCT01076179|3881845|P1|COMPLETED|Overall Study||501
1586757|NCT01076179|3881845|P1|STARTED|Overall Study||502
1586758|NCT01076166|3881868|P1|NOT COMPLETED|Overall Study||9
1586759|NCT01076166|3881868|P1|COMPLETED|Overall Study||328
1586760|NCT01076166|3881868|P1|STARTED|Overall Study||337
1586761|NCT01076153|3881875|P1|NOT COMPLETED|Overall Study||11
1586762|NCT01076153|3881875|P1|COMPLETED|Overall Study||749
1586763|NCT01076153|3881875|P1|STARTED|Overall Study||760
1586764|NCT01076088|3881889|P6|NOT COMPLETED|Overall Study||23
1586765|NCT01076088|3881890|P5|NOT COMPLETED|Overall Study||16
1586766|NCT01076088|3881891|P4|NOT COMPLETED|Overall Study||15
1586767|NCT01076088|3881892|P3|NOT COMPLETED|Overall Study||17
1586768|NCT01076088|3881893|P2|NOT COMPLETED|Overall Study||18
1586769|NCT01076088|3881894|P1|NOT COMPLETED|Overall Study||11
1586770|NCT01076088|3881889|P6|COMPLETED|Overall Study||104
1586771|NCT01076088|3881890|P5|COMPLETED|Overall Study||104
1586772|NCT01076088|3881891|P4|COMPLETED|Overall Study||109
1586773|NCT01076088|3881892|P3|COMPLETED|Overall Study||109
1586774|NCT01076088|3881893|P2|COMPLETED|Overall Study||107
1586775|NCT01076088|3881894|P1|COMPLETED|Overall Study||111
1586776|NCT01076088|3881889|P6|STARTED|Overall Study||127
1586777|NCT01076088|3881890|P5|STARTED|Overall Study||120
1586778|NCT01076088|3881891|P4|STARTED|Overall Study||124
1586779|NCT01076088|3881892|P3|STARTED|Overall Study||126
1586780|NCT01076088|3881893|P2|STARTED|Overall Study||125
1586781|NCT01076088|3881894|P1|STARTED|Overall Study||122
1586782|NCT01076075|3881922|P2|NOT COMPLETED|Overall Study||47
1586783|NCT01076075|3881923|P1|NOT COMPLETED|Overall Study||41
1586784|NCT01076075|3881922|P2|COMPLETED|Overall Study||167
1586785|NCT01076075|3881923|P1|COMPLETED|Overall Study||172
1586786|NCT01076075|3881922|P2|Completed Phase A|Overall Study||189
1586787|NCT01076075|3881923|P1|Completed Phase A|Overall Study||199
1586788|NCT01076075|3881922|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
1586789|NCT01076075|3881923|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
1586790|NCT01076036|3881937|P1|NOT COMPLETED|Overall Study||2
1586791|NCT01076036|3881937|P1|COMPLETED|Overall Study||8
1586792|NCT01076036|3881937|P1|Complete CorPath Procedures|Overall Study||8
1586793|NCT01076036|3881937|P1|# of Procedures|Overall Study||8
1586794|NCT01076036|3881937|P1|STARTED|Overall Study||10
1586795|NCT01075984|3881947|P5|NOT COMPLETED|Follow-up Phase||47
1586796|NCT01075984|3881948|P4|NOT COMPLETED|Follow-up Phase||2
1586797|NCT01075984|3881949|P3|NOT COMPLETED|Follow-up Phase||1
1586798|NCT01075984|3881950|P2|NOT COMPLETED|Follow-up Phase||0
1586799|NCT01075984|3881951|P1|NOT COMPLETED|Follow-up Phase||0
1586800|NCT01075984|3881947|P5|COMPLETED|Follow-up Phase||165
1586801|NCT01075984|3881948|P4|COMPLETED|Follow-up Phase||19
1586802|NCT01075984|3881949|P3|COMPLETED|Follow-up Phase||19
1586803|NCT01075984|3881950|P2|COMPLETED|Follow-up Phase||10
1586804|NCT01075984|3881951|P1|COMPLETED|Follow-up Phase||10
1586805|NCT01075984|3881947|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
1586806|NCT01075984|3881948|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
1586807|NCT01075984|3881949|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
1586808|NCT01075984|3881950|P2|STARTED|Follow-up Phase||10
1586809|NCT01075984|3881951|P1|STARTED|Follow-up Phase||10
1586810|NCT01075984|3881947|P5|NOT COMPLETED|Treatment Phase||60
1586811|NCT01075984|3881948|P4|NOT COMPLETED|Treatment Phase||7
1586812|NCT01075984|3881949|P3|NOT COMPLETED|Treatment Phase||7
1586813|NCT01075984|3881950|P2|NOT COMPLETED|Treatment Phase||1
1586814|NCT01075984|3881951|P1|NOT COMPLETED|Treatment Phase||0
1586815|NCT01075984|3881947|P5|COMPLETED|Treatment Phase||153
1586816|NCT01075984|3881948|P4|COMPLETED|Treatment Phase||17
1586817|NCT01075984|3881949|P3|COMPLETED|Treatment Phase||14
1586818|NCT01075984|3881950|P2|COMPLETED|Treatment Phase||10
1586819|NCT01075984|3881951|P1|COMPLETED|Treatment Phase||10
1586820|NCT01075984|3881947|P5|STARTED|Treatment Phase||213
1586821|NCT01075984|3881948|P4|STARTED|Treatment Phase||24
1586822|NCT01075984|3881949|P3|STARTED|Treatment Phase||21
1586823|NCT01075984|3881950|P2|STARTED|Treatment Phase||11
1586824|NCT01075984|3881951|P1|STARTED|Treatment Phase||10
1586825|NCT01075971|3882005|P1|NOT COMPLETED|Overall Study||0
1586826|NCT01075971|3882005|P1|COMPLETED|Overall Study||52
1586827|NCT01075971|3882005|P1|STARTED|Overall Study||52
1586828|NCT01075958|3882009|P1|NOT COMPLETED|Overall Study||44
1586829|NCT01075958|3882009|P1|COMPLETED|Overall Study||239
1586830|NCT01075958|3882009|P1|STARTED|Overall Study||283
1586831|NCT01075815|3882025|P2|NOT COMPLETED|Overall Study||4
1586832|NCT01075815|3882026|P1|NOT COMPLETED|Overall Study||10
1586833|NCT01075815|3882025|P2|COMPLETED|Overall Study||31
1586834|NCT01075815|3882026|P1|COMPLETED|Overall Study||30
1586835|NCT01075815|3882025|P2|STARTED|Overall Study|Number of participants treated.|35
1586836|NCT01075815|3882026|P1|STARTED|Overall Study|Number of participants treated.|40
1586837|NCT01075763|3882064|P2|NOT COMPLETED|Overall Study||4
1586838|NCT01075763|3882065|P1|NOT COMPLETED|Overall Study||4
1586839|NCT01075763|3882064|P2|COMPLETED|Overall Study||15
1586840|NCT01075763|3882065|P1|COMPLETED|Overall Study||19
1586841|NCT01075763|3882064|P2|STARTED|Overall Study||19
1586842|NCT01075763|3882065|P1|STARTED|Overall Study||23
1586843|NCT01075685|3882089|P2|NOT COMPLETED|Overall Study||226
1586844|NCT01075685|3882090|P1|NOT COMPLETED|Overall Study||592
1586845|NCT01075685|3882089|P2|COMPLETED|Overall Study||188
1586846|NCT01075685|3882090|P1|COMPLETED|Overall Study||151
1586847|NCT01075685|3882089|P2|Completed Baseline Measures|Overall Study||263
1586848|NCT01075685|3882090|P1|Completed Baseline Measures|Overall Study||225
1586849|NCT01075685|3882089|P2|Met Inclusion Criteria|Overall Study||413
1586850|NCT01075685|3882090|P1|Met Inclusion Criteria|Overall Study||734
1586851|NCT01075685|3882089|P2|STARTED|Overall Study||414
1586852|NCT01075685|3882090|P1|STARTED|Overall Study||743
1586853|NCT01075646|3882106|P4|NOT COMPLETED|Overall Study||2
1586854|NCT01075646|3882107|P3|NOT COMPLETED|Overall Study||1
1586855|NCT01075646|3882108|P2|NOT COMPLETED|Overall Study||3
1586856|NCT01075646|3882109|P1|NOT COMPLETED|Overall Study||4
1586857|NCT01075646|3882106|P4|COMPLETED|Overall Study||44
1586858|NCT01075646|3882107|P3|COMPLETED|Overall Study||52
1586859|NCT01075646|3882108|P2|COMPLETED|Overall Study||31
1586860|NCT01075646|3882109|P1|COMPLETED|Overall Study||29
1586861|NCT01075646|3882106|P4|STARTED|Overall Study||46
1586862|NCT01075646|3882107|P3|STARTED|Overall Study||53
1586863|NCT01075646|3882108|P2|STARTED|Overall Study||34
1586864|NCT01075646|3882109|P1|STARTED|Overall Study||33
1586865|NCT01075412|3882141|P2|NOT COMPLETED|Overall Study||1
1586866|NCT01075412|3882142|P1|NOT COMPLETED|Overall Study||0
1586867|NCT01075412|3882141|P2|COMPLETED|Overall Study||1
1586868|NCT01075412|3882142|P1|COMPLETED|Overall Study||4
1586869|NCT01075412|3882141|P2|STARTED|Overall Study||2
1586870|NCT01075412|3882142|P1|STARTED|Overall Study||4
1586871|NCT01075399|3882152|P1|NOT COMPLETED|Overall Study||8
1586872|NCT01075399|3882152|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
1586873|NCT01075399|3882152|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
1586874|NCT01075347|3882158|P2|NOT COMPLETED|Overall Study||0
1586875|NCT01075347|3882159|P1|NOT COMPLETED|Overall Study||0
1586876|NCT01075347|3882158|P2|COMPLETED|Overall Study||83
1586877|NCT01075347|3882159|P1|COMPLETED|Overall Study||82
1586878|NCT01075347|3882158|P2|STARTED|Overall Study||83
1586879|NCT01075347|3882159|P1|STARTED|Overall Study||82
1586880|NCT01075282|3882170|P3|NOT COMPLETED|Overall Study||27
1586881|NCT01075282|3882171|P2|NOT COMPLETED|Overall Study||29
1586882|NCT01075282|3882172|P1|NOT COMPLETED|Overall Study||31
1586883|NCT01075282|3882170|P3|COMPLETED|Overall Study||238
1586884|NCT01075282|3882171|P2|COMPLETED|Overall Study||243
1586885|NCT01075282|3882172|P1|COMPLETED|Overall Study||242
1586886|NCT01075282|3882170|P3|Received at Least One Dose of Study Drug|Overall Study||262
1586887|NCT01075282|3882171|P2|Received at Least One Dose of Study Drug|Overall Study||272
1586888|NCT01075282|3882172|P1|Received at Least One Dose of Study Drug|Overall Study||273
1586889|NCT01075282|3882170|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
1586890|NCT01075282|3882171|P2|STARTED|Overall Study||272
1586891|NCT01075282|3882172|P1|STARTED|Overall Study||273
1586892|NCT01075256|3882255|P3|NOT COMPLETED|Overall Study||0
1586893|NCT01075256|3882256|P2|NOT COMPLETED|Overall Study||0
1586894|NCT01075256|3882257|P1|NOT COMPLETED|Overall Study||1
1586895|NCT01075256|3882255|P3|COMPLETED|Overall Study||65
1586896|NCT01075256|3882256|P2|COMPLETED|Overall Study||66
1586897|NCT01075256|3882257|P1|COMPLETED|Overall Study||63
1586898|NCT01075256|3882255|P3|STARTED|Overall Study||65
1586899|NCT01075256|3882256|P2|STARTED|Overall Study||66
1586900|NCT01075256|3882257|P1|STARTED|Overall Study||64
1586901|NCT01075243|3882289|P3|NOT COMPLETED|Overall Study||0
1586902|NCT01075243|3882290|P2|NOT COMPLETED|Overall Study||3
1586903|NCT01075243|3882291|P1|NOT COMPLETED|Overall Study||6
1586904|NCT01075243|3882289|P3|COMPLETED|Overall Study||80
1586905|NCT01075243|3882290|P2|COMPLETED|Overall Study||155
1586906|NCT01075243|3882291|P1|COMPLETED|Overall Study||157
1586907|NCT01075243|3882289|P3|STARTED|Overall Study||80
1586908|NCT01075243|3882290|P2|STARTED|Overall Study||158
1586909|NCT01075243|3882291|P1|STARTED|Overall Study||163
1586910|NCT01075217|3882343|P2|NOT COMPLETED|Overall Study||1
1586911|NCT01075217|3882344|P1|NOT COMPLETED|Overall Study||2
1586912|NCT01075217|3882343|P2|COMPLETED|Overall Study||84
1586913|NCT01075217|3882344|P1|COMPLETED|Overall Study||82
1586914|NCT01075217|3882343|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
1586915|NCT01075217|3882344|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
1586916|NCT01075204|3882360|P1|NOT COMPLETED|Overall Study||0
1586917|NCT01075204|3882360|P1|COMPLETED|Overall Study||335
1586918|NCT01075204|3882360|P1|STARTED|Overall Study||335
1586919|NCT01075191|3882377|P1|NOT COMPLETED|Overall Study||18
1586920|NCT01075191|3882377|P1|COMPLETED|Overall Study||42
1586921|NCT01075191|3882377|P1|Discontinued Year 3|Overall Study||5
1586922|NCT01075191|3882377|P1|Discontinued Year 2|Overall Study||6
1586923|NCT01075191|3882377|P1|Discontinued Year 1|Overall Study||7
1586924|NCT01075191|3882377|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
1586925|NCT01075178|3882388|P2|NOT COMPLETED|Subject Chart Review||9
1586926|NCT01075178|3882389|P1|NOT COMPLETED|Subject Chart Review||9
1586927|NCT01075178|3882388|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
1586928|NCT01075178|3882389|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
1586929|NCT01075178|3882388|P2|STARTED|Subject Chart Review|subjects matched|1018
1586930|NCT01075178|3882389|P1|STARTED|Subject Chart Review|subjects matched|1018
1586931|NCT01075178|3882388|P2|NOT COMPLETED|Subject Matching||403
1586932|NCT01075178|3882389|P1|NOT COMPLETED|Subject Matching||130
1586933|NCT01075178|3882388|P2|COMPLETED|Subject Matching|subjects matched|1018
1586934|NCT01075178|3882389|P1|COMPLETED|Subject Matching|subjects matched|1018
1586935|NCT01075178|3882388|P2|STARTED|Subject Matching|eligible for matching|1421
1586936|NCT01075178|3882389|P1|STARTED|Subject Matching|eligible for matching|1148
1586937|NCT01075152|3882403|P2|NOT COMPLETED|Overall Study||0
1586938|NCT01075152|3882404|P1|NOT COMPLETED|Overall Study||1
1586939|NCT01075152|3882403|P2|COMPLETED|Overall Study||89
1586940|NCT01075152|3882404|P1|COMPLETED|Overall Study||87
1586941|NCT01075152|3882403|P2|STARTED|Overall Study|randomized|89
1586942|NCT01075152|3882404|P1|STARTED|Overall Study|randomized|88
1586943|NCT01075100|3882430|P2|NOT COMPLETED|Overall Study||53
1586944|NCT01075100|3882431|P1|NOT COMPLETED|Overall Study||49
1586945|NCT01075100|3882430|P2|COMPLETED|Overall Study||1
1586946|NCT01075100|3882431|P1|COMPLETED|Overall Study||0
1586947|NCT01075100|3882430|P2|STARTED|Overall Study||54
1586948|NCT01075100|3882431|P1|STARTED|Overall Study||49
1586949|NCT01075087|3882449|P2|NOT COMPLETED|Overall Study||0
1586950|NCT01075087|3882450|P1|NOT COMPLETED|Overall Study||0
1586951|NCT01075087|3882449|P2|COMPLETED|Overall Study||10
1586952|NCT01075087|3882450|P1|COMPLETED|Overall Study||9
1586953|NCT01075087|3882449|P2|STARTED|Overall Study||10
1586954|NCT01075087|3882450|P1|STARTED|Overall Study||9
1586955|NCT01075074|3882461|P3|NOT COMPLETED|Overall Study||2
1586956|NCT01075074|3882462|P2|NOT COMPLETED|Overall Study||2
1586957|NCT01075074|3882463|P1|NOT COMPLETED|Overall Study||1
1586958|NCT01075074|3882461|P3|COMPLETED|Overall Study||23
1586959|NCT01075074|3882462|P2|COMPLETED|Overall Study||23
1586960|NCT01075074|3882463|P1|COMPLETED|Overall Study||24
1586961|NCT01075074|3882461|P3|STARTED|Overall Study||25
1586962|NCT01075074|3882462|P2|STARTED|Overall Study||25
1586963|NCT01075074|3882463|P1|STARTED|Overall Study||25
1586964|NCT01074944|3882480|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
1586965|NCT01074944|3882481|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1586966|NCT01074944|3882482|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1586967|NCT01074944|3882483|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1586968|NCT01074944|3882484|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1586969|NCT01074944|3882480|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
1586970|NCT01074944|3882481|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
1586971|NCT01074944|3882482|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
1586972|NCT01074944|3882483|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
1586973|NCT01074944|3882484|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
1586974|NCT01074944|3882480|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
1586975|NCT01074944|3882481|P4|STARTED|Extended Treatment (up to 42 Months)||0
1586976|NCT01074944|3882482|P3|STARTED|Extended Treatment (up to 42 Months)||0
1586977|NCT01074944|3882483|P2|STARTED|Extended Treatment (up to 42 Months)||0
1586978|NCT01074944|3882484|P1|STARTED|Extended Treatment (up to 42 Months)||0
1586979|NCT01074944|3882480|P5|NOT COMPLETED|Long Term Treatment||0
1586980|NCT01074944|3882481|P4|NOT COMPLETED|Long Term Treatment||26
1586981|NCT01074944|3882482|P3|NOT COMPLETED|Long Term Treatment||0
1586982|NCT01074944|3882483|P2|NOT COMPLETED|Long Term Treatment||0
1586983|NCT01074944|3882484|P1|NOT COMPLETED|Long Term Treatment||0
1586984|NCT01074944|3882480|P5|COMPLETED|Long Term Treatment||0
1586985|NCT01074944|3882481|P4|COMPLETED|Long Term Treatment||95
1586986|NCT01074944|3882482|P3|COMPLETED|Long Term Treatment||0
1586987|NCT01074944|3882483|P2|COMPLETED|Long Term Treatment||0
1586988|NCT01074944|3882484|P1|COMPLETED|Long Term Treatment||0
1586989|NCT01074944|3882480|P5|STARTED|Long Term Treatment||0
1586990|NCT01074944|3882481|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
1586991|NCT01074944|3882482|P3|STARTED|Long Term Treatment||0
1586992|NCT01074944|3882483|P2|STARTED|Long Term Treatment||0
1586993|NCT01074944|3882484|P1|STARTED|Long Term Treatment||0
1586994|NCT01074944|3882480|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1586995|NCT01074944|3882481|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1586996|NCT01074944|3882482|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
1586997|NCT01074944|3882483|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
1586998|NCT01074944|3882484|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1586999|NCT01074944|3882480|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1587000|NCT01074944|3882481|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1587001|NCT01074944|3882482|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
1587002|NCT01074944|3882483|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
1587003|NCT01074944|3882484|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1587004|NCT01074944|3882480|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
1587005|NCT01074944|3882481|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
1587006|NCT01074944|3882482|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
1587007|NCT01074944|3882483|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
1587008|NCT01074944|3882484|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
1587009|NCT01074944|3882480|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1587010|NCT01074944|3882481|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1587011|NCT01074944|3882482|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1587012|NCT01074944|3882483|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1587013|NCT01074944|3882484|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
1587014|NCT01074944|3882480|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1587015|NCT01074944|3882481|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1587016|NCT01074944|3882482|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1587017|NCT01074944|3882483|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1587018|NCT01074944|3882484|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
1587019|NCT01074944|3882480|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
1587020|NCT01074944|3882481|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
1587021|NCT01074944|3882482|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
1587022|NCT01074944|3882483|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
1587023|NCT01074944|3882484|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
1587024|NCT01074931|3882538|P1|NOT COMPLETED|Overall Study||6
1587025|NCT01074931|3882538|P1|COMPLETED|Overall Study||92
1587026|NCT01074931|3882538|P1|STARTED|Overall Study||98
1587027|NCT01074658|3882550|P1|NOT COMPLETED|Overall Study||19
1587028|NCT01074658|3882550|P1|COMPLETED|Overall Study||996
1587029|NCT01074658|3882550|P1|Attempted Implant|Overall Study||996
1587030|NCT01074658|3882550|P1|STARTED|Overall Study||1015
1587031|NCT01074554|3882558|P2|NOT COMPLETED|Overall Study||4
1587032|NCT01074554|3882559|P1|NOT COMPLETED|Overall Study||3
1587033|NCT01074554|3882558|P2|COMPLETED|Overall Study||11
1587034|NCT01074554|3882559|P1|COMPLETED|Overall Study||11
1587035|NCT01074554|3882558|P2|STARTED|Overall Study||15
1587036|NCT01074554|3882559|P1|STARTED|Overall Study||14
1587037|NCT01074502|3882569|P1|NOT COMPLETED|Overall Study||1
1587038|NCT01074502|3882569|P1|COMPLETED|Overall Study||2
1587039|NCT01074502|3882569|P1|STARTED|Overall Study||3
1587040|NCT01074463|3882580|P2|NOT COMPLETED|Second Intervention||0
1587041|NCT01074463|3882581|P1|NOT COMPLETED|Second Intervention||0
1587042|NCT01074463|3882580|P2|COMPLETED|Second Intervention||12
1587043|NCT01074463|3882581|P1|COMPLETED|Second Intervention||12
1587044|NCT01074463|3882580|P2|STARTED|Second Intervention||12
1587045|NCT01074463|3882581|P1|STARTED|Second Intervention||12
1587046|NCT01074463|3882580|P2|NOT COMPLETED|Washout of 7 Days||0
1587047|NCT01074463|3882581|P1|NOT COMPLETED|Washout of 7 Days||0
1587048|NCT01074463|3882580|P2|COMPLETED|Washout of 7 Days||12
1587049|NCT01074463|3882581|P1|COMPLETED|Washout of 7 Days||12
1587050|NCT01074463|3882580|P2|STARTED|Washout of 7 Days||12
1587051|NCT01074463|3882581|P1|STARTED|Washout of 7 Days||12
1587052|NCT01074463|3882580|P2|NOT COMPLETED|First Intervention||0
1587053|NCT01074463|3882581|P1|NOT COMPLETED|First Intervention||0
1587054|NCT01074463|3882580|P2|COMPLETED|First Intervention||12
1587055|NCT01074463|3882581|P1|COMPLETED|First Intervention||12
1587056|NCT01074463|3882580|P2|STARTED|First Intervention||12
1587057|NCT01074463|3882581|P1|STARTED|First Intervention||12
1587058|NCT01074450|3882593|P2|NOT COMPLETED|Second Intervention||1
1587059|NCT01074450|3882594|P1|NOT COMPLETED|Second Intervention||1
1587060|NCT01074450|3882593|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
1587061|NCT01074450|3882594|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
1587062|NCT01074450|3882593|P2|STARTED|Second Intervention||10
1587063|NCT01074450|3882594|P1|STARTED|Second Intervention||12
1587064|NCT01074450|3882593|P2|NOT COMPLETED|Washout of 7 Days||0
1587065|NCT01074450|3882594|P1|NOT COMPLETED|Washout of 7 Days||0
1587066|NCT01074450|3882593|P2|COMPLETED|Washout of 7 Days||10
1587067|NCT01074450|3882594|P1|COMPLETED|Washout of 7 Days||12
1587068|NCT01074450|3882593|P2|STARTED|Washout of 7 Days||10
1587069|NCT01074450|3882594|P1|STARTED|Washout of 7 Days||12
1587070|NCT01074450|3882593|P2|NOT COMPLETED|First Intervention||2
1587071|NCT01074450|3882594|P1|NOT COMPLETED|First Intervention||0
1587072|NCT01074450|3882593|P2|COMPLETED|First Intervention||10
1587073|NCT01074450|3882594|P1|COMPLETED|First Intervention||12
1587074|NCT01074450|3882593|P2|STARTED|First Intervention||12
1587075|NCT01074450|3882594|P1|STARTED|First Intervention||12
1587076|NCT01074437|3882606|P2|NOT COMPLETED|Overall Study||0
1587077|NCT01074437|3882607|P1|NOT COMPLETED|Overall Study||0
1587078|NCT01074437|3882606|P2|COMPLETED|Overall Study||5
1587079|NCT01074437|3882607|P1|COMPLETED|Overall Study||4
1587080|NCT01074437|3882606|P2|STARTED|Overall Study||5
1587081|NCT01074437|3882607|P1|STARTED|Overall Study||4
1587082|NCT01074307|3882623|P2|NOT COMPLETED|Overall Study||12
1587083|NCT01074307|3882624|P1|NOT COMPLETED|Overall Study||22
1587084|NCT01074307|3882623|P2|COMPLETED|Overall Study||102
1587085|NCT01074307|3882624|P1|COMPLETED|Overall Study||44
1587086|NCT01074307|3882623|P2|STARTED|Overall Study||114
1587087|NCT01074307|3882624|P1|STARTED|Overall Study||66
1587088|NCT01074268|3882646|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
1587089|NCT01074268|3882647|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
1587090|NCT01074268|3882646|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
1587091|NCT01074268|3882647|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
1587092|NCT01074268|3882646|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
1587093|NCT01074268|3882647|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
1587094|NCT01074268|3882646|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
1587095|NCT01074268|3882647|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
1587096|NCT01074268|3882646|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
1587097|NCT01074268|3882647|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
1587098|NCT01074268|3882646|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
1587099|NCT01074268|3882647|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
1587100|NCT01074268|3882646|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
1587101|NCT01074268|3882647|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
1587102|NCT01074268|3882646|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
1587103|NCT01074268|3882647|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
1587104|NCT01074255|3882673|P1|NOT COMPLETED|Overall Study||2
1587105|NCT01074255|3882673|P1|COMPLETED|Overall Study||3139
1587106|NCT01074255|3882673|P1|Treated|Overall Study||3139
1587107|NCT01074255|3882673|P1|STARTED|Overall Study||3141
1587108|NCT01074242|3882677|P1|NOT COMPLETED|Overall Study||403
1587109|NCT01074242|3882677|P1|COMPLETED|Overall Study||3395
1587110|NCT01074242|3882677|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
1587111|NCT01074242|3882677|P1|STARTED|Overall Study||3798
1587112|NCT01074229|3882685|P3|NOT COMPLETED|Overall Study||4
1587113|NCT01074229|3882686|P2|NOT COMPLETED|Overall Study||3
1587114|NCT01074229|3882687|P1|NOT COMPLETED|Overall Study||2
1587115|NCT01074229|3882685|P3|COMPLETED|Overall Study||21
1587116|NCT01074229|3882686|P2|COMPLETED|Overall Study||22
1587117|NCT01074229|3882687|P1|COMPLETED|Overall Study||23
1587118|NCT01074229|3882685|P3|STARTED|Overall Study||25
1587119|NCT01074229|3882686|P2|STARTED|Overall Study||25
1587120|NCT01074229|3882687|P1|STARTED|Overall Study||25
1587121|NCT01074216|3882698|P1|NOT COMPLETED|Overall Study||13
1587122|NCT01074216|3882698|P1|COMPLETED|Overall Study||41
1587123|NCT01074216|3882698|P1|STARTED|Overall Study||54
1587124|NCT01074177|3882702|P1|NOT COMPLETED|Overall Study||0
1587125|NCT01074177|3882702|P1|COMPLETED|Overall Study||24
1587126|NCT01074177|3882702|P1|STARTED|Overall Study||24
1587127|NCT01074164|3882711|P2|NOT COMPLETED|Overall Study||1
1587128|NCT01074164|3882712|P1|NOT COMPLETED|Overall Study||3
1587129|NCT01074164|3882711|P2|COMPLETED|Overall Study||7
1587130|NCT01074164|3882712|P1|COMPLETED|Overall Study||4
1587131|NCT01074164|3882711|P2|STARTED|Overall Study||8
1587132|NCT01074164|3882712|P1|STARTED|Overall Study||7
1587133|NCT01074125|3882733|P3|NOT COMPLETED|Overall Study||12
1587134|NCT01074125|3882734|P2|NOT COMPLETED|Overall Study||5
1587135|NCT01074125|3882735|P1|NOT COMPLETED|Overall Study||12
1587136|NCT01074125|3882733|P3|COMPLETED|Overall Study||36
1587137|NCT01074125|3882734|P2|COMPLETED|Overall Study||47
1587138|NCT01074125|3882735|P1|COMPLETED|Overall Study||39
1587139|NCT01074125|3882733|P3|STARTED|Overall Study||48
1587140|NCT01074125|3882734|P2|STARTED|Overall Study||52
1587141|NCT01074125|3882735|P1|STARTED|Overall Study||51
1587142|NCT01074099|3882751|P2|NOT COMPLETED|Overall Study||0
1587143|NCT01074099|3882752|P1|NOT COMPLETED|Overall Study||0
1587144|NCT01074099|3882751|P2|COMPLETED|Overall Study||3
1587145|NCT01074099|3882752|P1|COMPLETED|Overall Study||2
1587146|NCT01074099|3882751|P2|STARTED|Overall Study||3
1587147|NCT01074099|3882752|P1|STARTED|Overall Study||2
1587148|NCT01074047|3882762|P2|NOT COMPLETED|Extension Phase||0
1587149|NCT01074047|3882763|P1|NOT COMPLETED|Extension Phase||22
1587150|NCT01074047|3882762|P2|COMPLETED|Extension Phase||0
1587151|NCT01074047|3882763|P1|COMPLETED|Extension Phase||0
1587152|NCT01074047|3882762|P2|Safety Population|Extension Phase||0
1587153|NCT01074047|3882763|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
1587154|NCT01074047|3882762|P2|STARTED|Extension Phase||0
1587155|NCT01074047|3882763|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
1587156|NCT01074047|3882762|P2|NOT COMPLETED|Survival Follow-Up Phase||136
1587157|NCT01074047|3882763|P1|NOT COMPLETED|Survival Follow-Up Phase||124
1587158|NCT01074047|3882762|P2|COMPLETED|Survival Follow-Up Phase||27
1587159|NCT01074047|3882763|P1|COMPLETED|Survival Follow-Up Phase||16
1587160|NCT01074047|3882762|P2|STARTED|Survival Follow-Up Phase||163
1587161|NCT01074047|3882763|P1|STARTED|Survival Follow-Up Phase||140
1587162|NCT01074047|3882762|P2|NOT COMPLETED|Treatment Phase||234
1587163|NCT01074047|3882763|P1|NOT COMPLETED|Treatment Phase||217
1587164|NCT01074047|3882762|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
1587165|NCT01074047|3882763|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
1587166|NCT01074047|3882762|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
1587167|NCT01074047|3882763|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
1587168|NCT01074047|3882762|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
1587169|NCT01074047|3882763|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
1587170|NCT01074047|3882762|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
1587171|NCT01074047|3882763|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
1587172|NCT01074047|3882762|P2|STARTED|Treatment Phase||247
1587173|NCT01074047|3882763|P1|STARTED|Treatment Phase||241
1587174|NCT01074034|3882837|P1|NOT COMPLETED|Overall Study||6
1587175|NCT01074034|3882837|P1|COMPLETED|Overall Study||205
1587176|NCT01074034|3882837|P1|STARTED|Overall Study||211
1587177|NCT01074008|3882851|P9|NOT COMPLETED|Overall Study||4
1587178|NCT01074008|3882852|P8|NOT COMPLETED|Overall Study||0
1587179|NCT01074008|3882853|P7|NOT COMPLETED|Overall Study||1
1587180|NCT01074008|3882854|P6|NOT COMPLETED|Overall Study||0
1587181|NCT01074008|3882855|P5|NOT COMPLETED|Overall Study||2
1587182|NCT01074008|3882856|P4|NOT COMPLETED|Overall Study||1
1587183|NCT01074008|3882857|P3|NOT COMPLETED|Overall Study||2
1587184|NCT01074008|3882858|P2|NOT COMPLETED|Overall Study||3
1587185|NCT01074008|3882859|P1|NOT COMPLETED|Overall Study||1
1587186|NCT01074008|3882851|P9|COMPLETED|Overall Study||7
1587187|NCT01074008|3882852|P8|COMPLETED|Overall Study||8
1587188|NCT01074008|3882853|P7|COMPLETED|Overall Study||7
1587189|NCT01074008|3882854|P6|COMPLETED|Overall Study||7
1587190|NCT01074008|3882855|P5|COMPLETED|Overall Study||6
1587191|NCT01074008|3882856|P4|COMPLETED|Overall Study||7
1587192|NCT01074008|3882857|P3|COMPLETED|Overall Study||6
1587193|NCT01074008|3882858|P2|COMPLETED|Overall Study||5
1587194|NCT01074008|3882859|P1|COMPLETED|Overall Study||7
1587195|NCT01074008|3882851|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
1587196|NCT01074008|3882852|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
1587197|NCT01074008|3882853|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
1587198|NCT01074008|3882854|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
1587199|NCT01074008|3882855|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
1587200|NCT01074008|3882856|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
1587201|NCT01074008|3882857|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
1587202|NCT01074008|3882858|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
1587203|NCT01074008|3882859|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
1587204|NCT01074008|3882851|P9|STARTED|Overall Study||11
1587205|NCT01074008|3882852|P8|STARTED|Overall Study||8
1587206|NCT01074008|3882853|P7|STARTED|Overall Study||8
1587207|NCT01074008|3882854|P6|STARTED|Overall Study||7
1587208|NCT01074008|3882855|P5|STARTED|Overall Study||8
1587209|NCT01074008|3882856|P4|STARTED|Overall Study||8
1587210|NCT01074008|3882857|P3|STARTED|Overall Study||8
1587211|NCT01074008|3882858|P2|STARTED|Overall Study||8
1587212|NCT01074008|3882859|P1|STARTED|Overall Study||8
1587213|NCT01073943|3882969|P2|NOT COMPLETED|Overall Study||8
1587214|NCT01073943|3882970|P1|NOT COMPLETED|Overall Study||13
1587215|NCT01073943|3882969|P2|COMPLETED|Overall Study||295
1587216|NCT01073943|3882970|P1|COMPLETED|Overall Study||287
1587217|NCT01073943|3882969|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
1587218|NCT01073943|3882970|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
1587219|NCT01073943|3882969|P2|Safety Population (Treated)|Overall Study||302
1587220|NCT01073943|3882970|P1|Safety Population (Treated)|Overall Study||296
1587221|NCT01073943|3882969|P2|STARTED|Overall Study||303
1587222|NCT01073943|3882970|P1|STARTED|Overall Study||300
1587223|NCT01073930|3882996|P2|NOT COMPLETED|Overall Study||6
1587224|NCT01073930|3882997|P1|NOT COMPLETED|Overall Study||3
1587225|NCT01073930|3882996|P2|COMPLETED|Overall Study||295
1587226|NCT01073930|3882997|P1|COMPLETED|Overall Study||304
1587227|NCT01073930|3882996|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
1587228|NCT01073930|3882997|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
1587229|NCT01073930|3882996|P2|Safety Population (Treated)|Overall Study||298
1587230|NCT01073930|3882997|P1|Safety Population (Treated)|Overall Study||305
1587231|NCT01073930|3882996|P2|STARTED|Overall Study||301
1587232|NCT01073930|3882997|P1|STARTED|Overall Study||307
1587233|NCT01073865|3883021|P2|NOT COMPLETED|Overall Study||39
1587234|NCT01073865|3883022|P1|NOT COMPLETED|Overall Study||28
1587235|NCT01073865|3883021|P2|COMPLETED|Overall Study|Number of patients completed the study|74
1587236|NCT01073865|3883022|P1|COMPLETED|Overall Study|Number of patients completed the study|81
1587237|NCT01073865|3883021|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
1587238|NCT01073865|3883022|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
1587239|NCT01073865|3883021|P2|STARTED|Overall Study|Number of patients randomised|113
1587240|NCT01073865|3883022|P1|STARTED|Overall Study|Number of patients randomised|109
1587241|NCT01073657|3883034|P2|NOT COMPLETED|Overall Study||0
1587242|NCT01073657|3883035|P1|NOT COMPLETED|Overall Study||0
1587243|NCT01073657|3883034|P2|COMPLETED|Overall Study||16
1587244|NCT01073657|3883035|P1|COMPLETED|Overall Study||17
1587245|NCT01073657|3883034|P2|STARTED|Overall Study||16
1587246|NCT01073657|3883035|P1|STARTED|Overall Study||17
1587247|NCT01073631|3883041|P1|NOT COMPLETED|Overall Study||169
1587248|NCT01073631|3883041|P1|COMPLETED|Overall Study||374
1587249|NCT01073631|3883041|P1|STARTED|Overall Study||543
1587250|NCT01073618|3883046|P1|NOT COMPLETED|Overall Study||307
1587251|NCT01073618|3883046|P1|COMPLETED|Overall Study||385
1587252|NCT01073618|3883046|P1|STARTED|Overall Study||692
1587253|NCT01073605|3883054|P3|NOT COMPLETED|Overall Study||61
1587254|NCT01073605|3883055|P2|NOT COMPLETED|Overall Study||67
1587255|NCT01073605|3883056|P1|NOT COMPLETED|Overall Study||62
1587256|NCT01073605|3883054|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
1587257|NCT01073605|3883055|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
1587258|NCT01073605|3883056|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
1587259|NCT01073605|3883054|P3|Received Treatment|Overall Study||68
1587260|NCT01073605|3883055|P2|Received Treatment|Overall Study||70
1587261|NCT01073605|3883056|P1|Received Treatment|Overall Study||68
1587262|NCT01073605|3883054|P3|STARTED|Overall Study||69
1587263|NCT01073605|3883055|P2|STARTED|Overall Study||71
1587264|NCT01073605|3883056|P1|STARTED|Overall Study||68
1587265|NCT01073566|3883102|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
1587266|NCT01073566|3883103|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
1587267|NCT01073566|3883102|P2|COMPLETED|Period 2 (6 Weeks)||19
1587268|NCT01073566|3883103|P1|COMPLETED|Period 2 (6 Weeks)||18
1587269|NCT01073566|3883102|P2|STARTED|Period 2 (6 Weeks)||19
1587270|NCT01073566|3883103|P1|STARTED|Period 2 (6 Weeks)||19
1587271|NCT01073566|3883102|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
1587272|NCT01073566|3883103|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
1587273|NCT01073566|3883102|P2|COMPLETED|Period 1 (6 Weeks)||19
1587274|NCT01073566|3883103|P1|COMPLETED|Period 1 (6 Weeks)||19
1587275|NCT01073566|3883102|P2|STARTED|Period 1 (6 Weeks)||19
1587276|NCT01073566|3883103|P1|STARTED|Period 1 (6 Weeks)||19
1587277|NCT01073462|3883115|P1|NOT COMPLETED|Overall Study||41
1587278|NCT01073462|3883115|P1|COMPLETED|Overall Study||26
1587279|NCT01073462|3883115|P1|STARTED|Overall Study||67
1587280|NCT01073449|3883126|P1|NOT COMPLETED|Overall Study||0
1587281|NCT01073449|3883126|P1|COMPLETED|Overall Study||3362
1587282|NCT01073449|3883126|P1|STARTED|Overall Study||3362
1587283|NCT01073293|3883134|P2|NOT COMPLETED|Overall Study||11
1587284|NCT01073293|3883135|P1|NOT COMPLETED|Overall Study||5
1587285|NCT01073293|3883134|P2|COMPLETED|Overall Study||517
1587286|NCT01073293|3883135|P1|COMPLETED|Overall Study||521
1587287|NCT01073293|3883134|P2|STARTED|Overall Study||528
1587288|NCT01073293|3883135|P1|STARTED|Overall Study||526
1587289|NCT01073267|3883157|P1|NOT COMPLETED|Overall Study||3
1587290|NCT01073267|3883157|P1|COMPLETED|Overall Study||1
1587291|NCT01073267|3883157|P1|STARTED|Overall Study||4
1587292|NCT01073163|3883161|P1|NOT COMPLETED|Overall Study||3
1587293|NCT01073163|3883161|P1|COMPLETED|Overall Study|Patients completed study|51
1587294|NCT01073163|3883161|P1|Treated With >=6 Cycles|Overall Study||49
1587295|NCT01073163|3883161|P1|Treated With <6 Cycles|Overall Study||4
1587296|NCT01073163|3883161|P1|Enrolled But Not Treated|Overall Study||1
1587297|NCT01073163|3883161|P1|STARTED|Overall Study||54
1587298|NCT01072929|3883184|P3|NOT COMPLETED|Overall Study||9
1587299|NCT01072929|3883185|P2|NOT COMPLETED|Overall Study||51
1587300|NCT01072929|3883186|P1|NOT COMPLETED|Overall Study||44
1587301|NCT01072929|3883184|P3|COMPLETED|Overall Study||24
1587302|NCT01072929|3883185|P2|COMPLETED|Overall Study||150
1587303|NCT01072929|3883186|P1|COMPLETED|Overall Study||155
1587304|NCT01072929|3883184|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
1587305|NCT01072929|3883185|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
1587306|NCT01072929|3883186|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
1587307|NCT01072929|3883184|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
1587308|NCT01072929|3883185|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
1587309|NCT01072929|3883186|P1|Safety Population|Overall Study|Treated participants|199
1587310|NCT01072929|3883184|P3|STARTED|Overall Study||33
1587311|NCT01072929|3883185|P2|STARTED|Overall Study||201
1587312|NCT01072929|3883186|P1|STARTED|Overall Study||199
1587313|NCT01072877|3883265|P5|NOT COMPLETED|Overall Study||0
1587314|NCT01072877|3883266|P4|NOT COMPLETED|Overall Study||2
1587315|NCT01072877|3883267|P3|NOT COMPLETED|Overall Study||0
1587316|NCT01072877|3883268|P2|NOT COMPLETED|Overall Study||1
1587317|NCT01072877|3883269|P1|NOT COMPLETED|Overall Study||1
1587318|NCT01072877|3883265|P5|COMPLETED|Overall Study||63
1587319|NCT01072877|3883266|P4|COMPLETED|Overall Study||50
1587320|NCT01072877|3883267|P3|COMPLETED|Overall Study||51
1587321|NCT01072877|3883268|P2|COMPLETED|Overall Study||56
1587322|NCT01072877|3883269|P1|COMPLETED|Overall Study||55
1587323|NCT01072877|3883265|P5|STARTED|Overall Study||63
1587324|NCT01072877|3883266|P4|STARTED|Overall Study||52
1587325|NCT01072877|3883267|P3|STARTED|Overall Study||51
1587326|NCT01072877|3883268|P2|STARTED|Overall Study||57
1587327|NCT01072877|3883269|P1|STARTED|Overall Study||56
1587328|NCT01072773|3883291|P1|NOT COMPLETED|Overall Study||0
1587329|NCT01072773|3883291|P1|COMPLETED|Overall Study||2
1587330|NCT01072773|3883291|P1|STARTED|Overall Study||2
1587331|NCT01072669|3883302|P2|NOT COMPLETED|Overall Study||0
1587332|NCT01072669|3883303|P1|NOT COMPLETED|Overall Study||0
1587333|NCT01072669|3883302|P2|COMPLETED|Overall Study||5
1587334|NCT01072669|3883303|P1|COMPLETED|Overall Study||15
1587335|NCT01072669|3883302|P2|STARTED|Overall Study||5
1587336|NCT01072669|3883303|P1|STARTED|Overall Study||15
1587337|NCT01072656|3883311|P2|NOT COMPLETED|Second Intervention||0
1587338|NCT01072656|3883312|P1|NOT COMPLETED|Second Intervention||0
1587339|NCT01072656|3883311|P2|COMPLETED|Second Intervention||4
1587340|NCT01072656|3883312|P1|COMPLETED|Second Intervention||5
1587341|NCT01072656|3883311|P2|STARTED|Second Intervention||4
1587342|NCT01072656|3883312|P1|STARTED|Second Intervention||5
1587343|NCT01072656|3883311|P2|NOT COMPLETED|First Intervention||0
1587344|NCT01072656|3883312|P1|NOT COMPLETED|First Intervention||0
1587345|NCT01072656|3883311|P2|COMPLETED|First Intervention||4
1587346|NCT01072656|3883312|P1|COMPLETED|First Intervention||5
1587347|NCT01072656|3883311|P2|STARTED|First Intervention||4
1587348|NCT01072656|3883312|P1|STARTED|First Intervention||5
1587349|NCT01072643|3883322|P1|NOT COMPLETED|Overall Study||0
1587350|NCT01072643|3883322|P1|COMPLETED|Overall Study||4
1587351|NCT01072643|3883322|P1|STARTED|Overall Study||4
1587352|NCT01072630|3883332|P3|NOT COMPLETED|Overall Study||13
1587353|NCT01072630|3883333|P2|NOT COMPLETED|Overall Study||60
1587354|NCT01072630|3883334|P1|NOT COMPLETED|Overall Study||55
1587355|NCT01072630|3883332|P3|COMPLETED|Overall Study||17
1587356|NCT01072630|3883333|P2|COMPLETED|Overall Study||172
1587357|NCT01072630|3883334|P1|COMPLETED|Overall Study||175
1587358|NCT01072630|3883332|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
1587359|NCT01072630|3883333|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
1587360|NCT01072630|3883334|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
1587361|NCT01072630|3883332|P3|Safety Population|Overall Study|Treated participants.|30
1587362|NCT01072630|3883333|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
1587363|NCT01072630|3883334|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
1587364|NCT01072630|3883332|P3|STARTED|Overall Study||30
1587365|NCT01072630|3883333|P2|STARTED|Overall Study||232
1587366|NCT01072630|3883334|P1|STARTED|Overall Study||230
1587367|NCT01072617|3883408|P1|NOT COMPLETED|Overall Study||0
1587368|NCT01072617|3883408|P1|COMPLETED|Overall Study||8
1587369|NCT01072617|3883408|P1|STARTED|Overall Study||8
1587370|NCT01072539|3883415|P1|NOT COMPLETED|Overall Study||3
1587371|NCT01072539|3883415|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
1587372|NCT01072539|3883415|P1|STARTED|Overall Study||3172
1587373|NCT01072526|3883423|P2|NOT COMPLETED|Overall Study||0
1587374|NCT01072526|3883424|P1|NOT COMPLETED|Overall Study||0
1587375|NCT01072526|3883423|P2|COMPLETED|Overall Study||0
1587376|NCT01072526|3883424|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
1587377|NCT01072526|3883423|P2|STARTED|Overall Study||0
1587378|NCT01072526|3883424|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
1587379|NCT01072500|3883439|P2|NOT COMPLETED|Overall Study||14
1587380|NCT01072500|3883440|P1|NOT COMPLETED|Overall Study||24
1587381|NCT01072500|3883439|P2|COMPLETED|Overall Study||803
1587382|NCT01072500|3883440|P1|COMPLETED|Overall Study||794
1587383|NCT01072500|3883439|P2|STARTED|Overall Study||817
1587384|NCT01072500|3883440|P1|STARTED|Overall Study||818
1587385|NCT01072448|3883450|P2|NOT COMPLETED|Overall Study||30
1587386|NCT01072448|3883451|P1|NOT COMPLETED|Overall Study||19
1587387|NCT01072448|3883450|P2|COMPLETED|Overall Study||130
1587388|NCT01072448|3883451|P1|COMPLETED|Overall Study||144
1587389|NCT01072448|3883450|P2|STARTED|Overall Study||160
1587390|NCT01072448|3883451|P1|STARTED|Overall Study||163
1587391|NCT01072409|3883459|P1|NOT COMPLETED|Overall Study||7
1587392|NCT01072409|3883459|P1|COMPLETED|Overall Study||38
1587393|NCT01072409|3883459|P1|STARTED|Overall Study||45
1587394|NCT01072396|3883465|P2|NOT COMPLETED|Period Two||3
1587395|NCT01072396|3883466|P1|NOT COMPLETED|Period Two||1
1587396|NCT01072396|3883465|P2|COMPLETED|Period Two||57
1587397|NCT01072396|3883466|P1|COMPLETED|Period Two||57
1587398|NCT01072396|3883465|P2|STARTED|Period Two||60
1587399|NCT01072396|3883466|P1|STARTED|Period Two||58
1587400|NCT01072396|3883465|P2|NOT COMPLETED|Washout Period||1
1587401|NCT01072396|3883466|P1|NOT COMPLETED|Washout Period||0
1587402|NCT01072396|3883465|P2|COMPLETED|Washout Period||60
1587403|NCT01072396|3883466|P1|COMPLETED|Washout Period||58
1587404|NCT01072396|3883465|P2|STARTED|Washout Period||61
1587405|NCT01072396|3883466|P1|STARTED|Washout Period||58
1587406|NCT01072396|3883465|P2|NOT COMPLETED|Period One||2
1587407|NCT01072396|3883466|P1|NOT COMPLETED|Period One||5
1587408|NCT01072396|3883465|P2|COMPLETED|Period One||61
1587409|NCT01072396|3883466|P1|COMPLETED|Period One||58
1587410|NCT01072396|3883465|P2|STARTED|Period One||63
1587411|NCT01072396|3883466|P1|STARTED|Period One||63
1587412|NCT01072357|3883478|P2|NOT COMPLETED|Overall Study||1
1587413|NCT01072357|3883479|P1|NOT COMPLETED|Overall Study||0
1587414|NCT01072357|3883478|P2|COMPLETED|Overall Study||14
1587415|NCT01072357|3883479|P1|COMPLETED|Overall Study||15
1587416|NCT01072357|3883478|P2|STARTED|Overall Study||15
1587417|NCT01072357|3883479|P1|STARTED|Overall Study||15
1587418|NCT01072344|3883489|P2|NOT COMPLETED|Overall Study||18
1587419|NCT01072344|3883490|P1|NOT COMPLETED|Overall Study||11
1587420|NCT01072344|3883489|P2|COMPLETED|Overall Study||29
1587421|NCT01072344|3883490|P1|COMPLETED|Overall Study||35
1587422|NCT01072344|3883489|P2|STARTED|Overall Study||47
1587423|NCT01072344|3883490|P1|STARTED|Overall Study||46
1587424|NCT01072331|3883507|P3|NOT COMPLETED|Overall Study||0
1587425|NCT01072331|3883508|P2|NOT COMPLETED|Overall Study||0
1587426|NCT01072331|3883509|P1|NOT COMPLETED|Overall Study||0
1587427|NCT01072331|3883507|P3|COMPLETED|Overall Study||32
1587428|NCT01072331|3883508|P2|COMPLETED|Overall Study||33
1587429|NCT01072331|3883509|P1|COMPLETED|Overall Study||34
1587430|NCT01072331|3883507|P3|STARTED|Overall Study||32
1587431|NCT01072331|3883508|P2|STARTED|Overall Study||33
1587432|NCT01072331|3883509|P1|STARTED|Overall Study||34
1587433|NCT01072201|3883528|P2|NOT COMPLETED|Overall Study||1
1587434|NCT01072201|3883529|P1|NOT COMPLETED|Overall Study||0
1587435|NCT01072201|3883528|P2|COMPLETED|Overall Study||29
1587436|NCT01072201|3883529|P1|COMPLETED|Overall Study||30
1587437|NCT01072201|3883528|P2|STARTED|Overall Study||30
1587438|NCT01072201|3883529|P1|STARTED|Overall Study||30
1587439|NCT01072188|3883541|P2|NOT COMPLETED|Overall Study||0
1587440|NCT01072188|3883542|P1|NOT COMPLETED|Overall Study||0
1587441|NCT01072188|3883541|P2|COMPLETED|Overall Study||23
1587442|NCT01072188|3883542|P1|COMPLETED|Overall Study||22
1587443|NCT01072188|3883541|P2|STARTED|Overall Study||23
1587444|NCT01072188|3883542|P1|STARTED|Overall Study||22
1587445|NCT01072175|3883562|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
1587446|NCT01072175|3883563|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
1587447|NCT01072175|3883564|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
1587448|NCT01072175|3883565|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
1587449|NCT01072175|3883566|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
1587450|NCT01072175|3883567|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
1587451|NCT01072175|3883568|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
1587452|NCT01072175|3883569|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
1587453|NCT01072175|3883570|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
1587454|NCT01072175|3883571|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
1587455|NCT01072175|3883572|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
1587456|NCT01072175|3883573|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
1587457|NCT01072175|3883574|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
1587458|NCT01072175|3883562|P13|COMPLETED|Part D (HPMC Capsules)||0
1587459|NCT01072175|3883563|P12|COMPLETED|Part D (HPMC Capsules)||0
1587460|NCT01072175|3883564|P11|COMPLETED|Part D (HPMC Capsules)||0
1587461|NCT01072175|3883565|P10|COMPLETED|Part D (HPMC Capsules)||0
1587462|NCT01072175|3883566|P9|COMPLETED|Part D (HPMC Capsules)||0
1587463|NCT01072175|3883567|P8|COMPLETED|Part D (HPMC Capsules)||0
1587464|NCT01072175|3883568|P7|COMPLETED|Part D (HPMC Capsules)||0
1587465|NCT01072175|3883569|P6|COMPLETED|Part D (HPMC Capsules)||0
1587466|NCT01072175|3883570|P5|COMPLETED|Part D (HPMC Capsules)||0
1587467|NCT01072175|3883571|P4|COMPLETED|Part D (HPMC Capsules)||0
1587468|NCT01072175|3883572|P3|COMPLETED|Part D (HPMC Capsules)||0
1587469|NCT01072175|3883573|P2|COMPLETED|Part D (HPMC Capsules)||0
1587470|NCT01072175|3883574|P1|COMPLETED|Part D (HPMC Capsules)||0
1587471|NCT01072175|3883562|P13|Ongoing|Part D (HPMC Capsules)||34
1587472|NCT01072175|3883563|P12|Ongoing|Part D (HPMC Capsules)||34
1587473|NCT01072175|3883564|P11|Ongoing|Part D (HPMC Capsules)||12
1587474|NCT01072175|3883565|P10|Ongoing|Part D (HPMC Capsules)||10
1587475|NCT01072175|3883566|P9|Ongoing|Part D (HPMC Capsules)||0
1587476|NCT01072175|3883567|P8|Ongoing|Part D (HPMC Capsules)||0
1587477|NCT01072175|3883568|P7|Ongoing|Part D (HPMC Capsules)||0
1587478|NCT01072175|3883569|P6|Ongoing|Part D (HPMC Capsules)||0
1587479|NCT01072175|3883570|P5|Ongoing|Part D (HPMC Capsules)||0
1587480|NCT01072175|3883571|P4|Ongoing|Part D (HPMC Capsules)||0
1587481|NCT01072175|3883572|P3|Ongoing|Part D (HPMC Capsules)||0
1587482|NCT01072175|3883573|P2|Ongoing|Part D (HPMC Capsules)||0
1587483|NCT01072175|3883574|P1|Ongoing|Part D (HPMC Capsules)||0
1587484|NCT01072175|3883562|P13|STARTED|Part D (HPMC Capsules)||39
1587485|NCT01072175|3883563|P12|STARTED|Part D (HPMC Capsules)||43
1587486|NCT01072175|3883564|P11|STARTED|Part D (HPMC Capsules)||16
1587487|NCT01072175|3883565|P10|STARTED|Part D (HPMC Capsules)||12
1587488|NCT01072175|3883566|P9|STARTED|Part D (HPMC Capsules)||0
1587489|NCT01072175|3883567|P8|STARTED|Part D (HPMC Capsules)||0
1587490|NCT01072175|3883568|P7|STARTED|Part D (HPMC Capsules)||0
1587491|NCT01072175|3883569|P6|STARTED|Part D (HPMC Capsules)||0
1587492|NCT01072175|3883570|P5|STARTED|Part D (HPMC Capsules)||0
1587493|NCT01072175|3883571|P4|STARTED|Part D (HPMC Capsules)||0
1587494|NCT01072175|3883572|P3|STARTED|Part D (HPMC Capsules)||0
1587495|NCT01072175|3883573|P2|STARTED|Part D (HPMC Capsules)||0
1587496|NCT01072175|3883574|P1|STARTED|Part D (HPMC Capsules)||0
1587497|NCT01072175|3883562|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587498|NCT01072175|3883563|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587499|NCT01072175|3883564|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587500|NCT01072175|3883565|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587501|NCT01072175|3883566|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||43
1587502|NCT01072175|3883567|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587503|NCT01072175|3883568|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587504|NCT01072175|3883569|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587505|NCT01072175|3883570|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587506|NCT01072175|3883571|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587507|NCT01072175|3883572|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587508|NCT01072175|3883573|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587509|NCT01072175|3883574|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587510|NCT01072175|3883562|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587511|NCT01072175|3883563|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587512|NCT01072175|3883564|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587513|NCT01072175|3883565|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587514|NCT01072175|3883566|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587515|NCT01072175|3883567|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587516|NCT01072175|3883568|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587517|NCT01072175|3883569|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587518|NCT01072175|3883570|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587519|NCT01072175|3883571|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587520|NCT01072175|3883572|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587521|NCT01072175|3883573|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587522|NCT01072175|3883574|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1587523|NCT01072175|3883562|P13|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587524|NCT01072175|3883563|P12|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587525|NCT01072175|3883564|P11|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587526|NCT01072175|3883565|P10|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587527|NCT01072175|3883566|P9|Ongoing|Part C (Phase II: Crossover Phase [CP])||28
1587528|NCT01072175|3883567|P8|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587529|NCT01072175|3883568|P7|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587530|NCT01072175|3883569|P6|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587531|NCT01072175|3883570|P5|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587532|NCT01072175|3883571|P4|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587533|NCT01072175|3883572|P3|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587534|NCT01072175|3883573|P2|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587535|NCT01072175|3883574|P1|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1587536|NCT01072175|3883562|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587537|NCT01072175|3883563|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587538|NCT01072175|3883564|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587539|NCT01072175|3883565|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587540|NCT01072175|3883566|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||43
1587541|NCT01072175|3883567|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587542|NCT01072175|3883568|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587543|NCT01072175|3883569|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587544|NCT01072175|3883570|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587545|NCT01072175|3883571|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587546|NCT01072175|3883572|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587547|NCT01072175|3883573|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587548|NCT01072175|3883574|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1587549|NCT01072175|3883562|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587550|NCT01072175|3883563|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587551|NCT01072175|3883564|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587552|NCT01072175|3883565|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587553|NCT01072175|3883566|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587554|NCT01072175|3883567|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
1587555|NCT01072175|3883568|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
1587556|NCT01072175|3883569|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
1587557|NCT01072175|3883570|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587558|NCT01072175|3883571|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587559|NCT01072175|3883572|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587560|NCT01072175|3883573|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587561|NCT01072175|3883574|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1587562|NCT01072175|3883562|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587563|NCT01072175|3883563|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587564|NCT01072175|3883564|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587565|NCT01072175|3883565|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587566|NCT01072175|3883566|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587567|NCT01072175|3883567|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587568|NCT01072175|3883568|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587569|NCT01072175|3883569|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587570|NCT01072175|3883570|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587571|NCT01072175|3883571|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587572|NCT01072175|3883572|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587573|NCT01072175|3883573|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587574|NCT01072175|3883574|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
1587575|NCT01072175|3883562|P13|Ongoing|Part C (Phase II: Randomized Phase)||0
1587576|NCT01072175|3883563|P12|Ongoing|Part C (Phase II: Randomized Phase)||0
1587577|NCT01072175|3883564|P11|Ongoing|Part C (Phase II: Randomized Phase)||0
1587578|NCT01072175|3883565|P10|Ongoing|Part C (Phase II: Randomized Phase)||0
1587579|NCT01072175|3883566|P9|Ongoing|Part C (Phase II: Randomized Phase)||0
1587580|NCT01072175|3883567|P8|Ongoing|Part C (Phase II: Randomized Phase)||40
1587581|NCT01072175|3883568|P7|Ongoing|Part C (Phase II: Randomized Phase)||32
1587582|NCT01072175|3883569|P6|Ongoing|Part C (Phase II: Randomized Phase)||35
1587583|NCT01072175|3883570|P5|Ongoing|Part C (Phase II: Randomized Phase)||0
1587584|NCT01072175|3883571|P4|Ongoing|Part C (Phase II: Randomized Phase)||0
1587585|NCT01072175|3883572|P3|Ongoing|Part C (Phase II: Randomized Phase)||0
1587586|NCT01072175|3883573|P2|Ongoing|Part C (Phase II: Randomized Phase)||0
1587587|NCT01072175|3883574|P1|Ongoing|Part C (Phase II: Randomized Phase)||0
1587588|NCT01072175|3883562|P13|STARTED|Part C (Phase II: Randomized Phase)||0
1587589|NCT01072175|3883563|P12|STARTED|Part C (Phase II: Randomized Phase)||0
1587590|NCT01072175|3883564|P11|STARTED|Part C (Phase II: Randomized Phase)||0
1587591|NCT01072175|3883565|P10|STARTED|Part C (Phase II: Randomized Phase)||0
1587592|NCT01072175|3883566|P9|STARTED|Part C (Phase II: Randomized Phase)||0
1587593|NCT01072175|3883567|P8|STARTED|Part C (Phase II: Randomized Phase)||54
1587594|NCT01072175|3883568|P7|STARTED|Part C (Phase II: Randomized Phase)||54
1587595|NCT01072175|3883569|P6|STARTED|Part C (Phase II: Randomized Phase)||54
1587596|NCT01072175|3883570|P5|STARTED|Part C (Phase II: Randomized Phase)||0
1587597|NCT01072175|3883571|P4|STARTED|Part C (Phase II: Randomized Phase)||0
1587598|NCT01072175|3883572|P3|STARTED|Part C (Phase II: Randomized Phase)||0
1587599|NCT01072175|3883573|P2|STARTED|Part C (Phase II: Randomized Phase)||0
1587600|NCT01072175|3883574|P1|STARTED|Part C (Phase II: Randomized Phase)||0
1587601|NCT01072175|3883562|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1587602|NCT01072175|3883563|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1587603|NCT01072175|3883564|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1587604|NCT01072175|3883565|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1587605|NCT01072175|3883566|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1587606|NCT01072175|3883567|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1587607|NCT01072175|3883568|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1587608|NCT01072175|3883569|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1587609|NCT01072175|3883570|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||79
1587610|NCT01072175|3883571|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
1587611|NCT01072175|3883572|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
1587612|NCT01072175|3883573|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
1587613|NCT01072175|3883574|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1587614|NCT01072175|3883562|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587615|NCT01072175|3883563|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587616|NCT01072175|3883564|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587617|NCT01072175|3883565|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587618|NCT01072175|3883566|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587619|NCT01072175|3883567|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587620|NCT01072175|3883568|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587621|NCT01072175|3883569|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587622|NCT01072175|3883570|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587623|NCT01072175|3883571|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587624|NCT01072175|3883572|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587625|NCT01072175|3883573|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587626|NCT01072175|3883574|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
1587627|NCT01072175|3883562|P13|Ongoing|Part B (Dose Escalation and Expansion)||0
1587628|NCT01072175|3883563|P12|Ongoing|Part B (Dose Escalation and Expansion)||0
1587629|NCT01072175|3883564|P11|Ongoing|Part B (Dose Escalation and Expansion)||0
1587630|NCT01072175|3883565|P10|Ongoing|Part B (Dose Escalation and Expansion)||0
1587631|NCT01072175|3883566|P9|Ongoing|Part B (Dose Escalation and Expansion)||0
1587632|NCT01072175|3883567|P8|Ongoing|Part B (Dose Escalation and Expansion)||0
1587633|NCT01072175|3883568|P7|Ongoing|Part B (Dose Escalation and Expansion)||0
1587634|NCT01072175|3883569|P6|Ongoing|Part B (Dose Escalation and Expansion)||0
1587635|NCT01072175|3883570|P5|Ongoing|Part B (Dose Escalation and Expansion)||28
1587636|NCT01072175|3883571|P4|Ongoing|Part B (Dose Escalation and Expansion)||9
1587637|NCT01072175|3883572|P3|Ongoing|Part B (Dose Escalation and Expansion)||10
1587638|NCT01072175|3883573|P2|Ongoing|Part B (Dose Escalation and Expansion)||2
1587639|NCT01072175|3883574|P1|Ongoing|Part B (Dose Escalation and Expansion)||0
1587640|NCT01072175|3883562|P13|STARTED|Part B (Dose Escalation and Expansion)||0
1587641|NCT01072175|3883563|P12|STARTED|Part B (Dose Escalation and Expansion)||0
1587642|NCT01072175|3883564|P11|STARTED|Part B (Dose Escalation and Expansion)||0
1587643|NCT01072175|3883565|P10|STARTED|Part B (Dose Escalation and Expansion)||0
1587644|NCT01072175|3883566|P9|STARTED|Part B (Dose Escalation and Expansion)||0
1587645|NCT01072175|3883567|P8|STARTED|Part B (Dose Escalation and Expansion)||0
1587646|NCT01072175|3883568|P7|STARTED|Part B (Dose Escalation and Expansion)||0
1587647|NCT01072175|3883569|P6|STARTED|Part B (Dose Escalation and Expansion)||0
1587648|NCT01072175|3883570|P5|STARTED|Part B (Dose Escalation and Expansion)||79
1587649|NCT01072175|3883571|P4|STARTED|Part B (Dose Escalation and Expansion)||27
1587650|NCT01072175|3883572|P3|STARTED|Part B (Dose Escalation and Expansion)||23
1587651|NCT01072175|3883573|P2|STARTED|Part B (Dose Escalation and Expansion)||6
1587652|NCT01072175|3883574|P1|STARTED|Part B (Dose Escalation and Expansion)||0
1587653|NCT01072175|3883562|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587654|NCT01072175|3883563|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587655|NCT01072175|3883564|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587656|NCT01072175|3883565|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587657|NCT01072175|3883566|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587658|NCT01072175|3883567|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587659|NCT01072175|3883568|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587660|NCT01072175|3883569|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587661|NCT01072175|3883570|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587662|NCT01072175|3883571|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587663|NCT01072175|3883572|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587664|NCT01072175|3883573|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1587665|NCT01072175|3883574|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
1587666|NCT01072175|3883562|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
1587667|NCT01072175|3883563|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
1587668|NCT01072175|3883564|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
1587669|NCT01072175|3883565|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
1587670|NCT01072175|3883566|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
1587671|NCT01072175|3883567|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
1587672|NCT01072175|3883568|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
1587673|NCT01072175|3883569|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
1587674|NCT01072175|3883570|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
1587675|NCT01072175|3883571|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
1587676|NCT01072175|3883572|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
1587677|NCT01072175|3883573|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
1587678|NCT01072175|3883574|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
1587679|NCT01072175|3883562|P13|STARTED|Part A (Drug-Drug Interaction)||0
1587680|NCT01072175|3883563|P12|STARTED|Part A (Drug-Drug Interaction)||0
1587681|NCT01072175|3883564|P11|STARTED|Part A (Drug-Drug Interaction)||0
1587682|NCT01072175|3883565|P10|STARTED|Part A (Drug-Drug Interaction)||0
1587683|NCT01072175|3883566|P9|STARTED|Part A (Drug-Drug Interaction)||0
1587684|NCT01072175|3883567|P8|STARTED|Part A (Drug-Drug Interaction)||0
1587685|NCT01072175|3883568|P7|STARTED|Part A (Drug-Drug Interaction)||0
1587686|NCT01072175|3883569|P6|STARTED|Part A (Drug-Drug Interaction)||0
1587687|NCT01072175|3883570|P5|STARTED|Part A (Drug-Drug Interaction)||0
1587688|NCT01072175|3883571|P4|STARTED|Part A (Drug-Drug Interaction)||0
1587689|NCT01072175|3883572|P3|STARTED|Part A (Drug-Drug Interaction)||0
1587690|NCT01072175|3883573|P2|STARTED|Part A (Drug-Drug Interaction)||0
1587691|NCT01072175|3883574|P1|STARTED|Part A (Drug-Drug Interaction)||8
1587692|NCT01072149|3883757|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587693|NCT01072149|3883758|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587694|NCT01072149|3883759|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587695|NCT01072149|3883760|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587696|NCT01072149|3883761|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1587697|NCT01072149|3883762|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587698|NCT01072149|3883763|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587699|NCT01072149|3883764|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587700|NCT01072149|3883765|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587701|NCT01072149|3883766|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587702|NCT01072149|3883767|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587703|NCT01072149|3883768|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587704|NCT01072149|3883769|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587705|NCT01072149|3883770|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587706|NCT01072149|3883771|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587707|NCT01072149|3883772|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1587708|NCT01072149|3883773|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587709|NCT01072149|3883774|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1587710|NCT01072149|3883757|P18|COMPLETED|Treatment Period 3 (28 Days)||2
1587711|NCT01072149|3883758|P17|COMPLETED|Treatment Period 3 (28 Days)||3
1587712|NCT01072149|3883759|P16|COMPLETED|Treatment Period 3 (28 Days)||1
1587713|NCT01072149|3883760|P15|COMPLETED|Treatment Period 3 (28 Days)||3
1587714|NCT01072149|3883761|P14|COMPLETED|Treatment Period 3 (28 Days)||2
1587715|NCT01072149|3883762|P13|COMPLETED|Treatment Period 3 (28 Days)||2
1587716|NCT01072149|3883763|P12|COMPLETED|Treatment Period 3 (28 Days)||3
1587717|NCT01072149|3883764|P11|COMPLETED|Treatment Period 3 (28 Days)||2
1587718|NCT01072149|3883765|P10|COMPLETED|Treatment Period 3 (28 Days)||3
1587719|NCT01072149|3883766|P9|COMPLETED|Treatment Period 3 (28 Days)||3
1587720|NCT01072149|3883767|P8|COMPLETED|Treatment Period 3 (28 Days)||2
1587721|NCT01072149|3883768|P7|COMPLETED|Treatment Period 3 (28 Days)||3
1587722|NCT01072149|3883769|P6|COMPLETED|Treatment Period 3 (28 Days)||3
1587723|NCT01072149|3883770|P5|COMPLETED|Treatment Period 3 (28 Days)||3
1587724|NCT01072149|3883771|P4|COMPLETED|Treatment Period 3 (28 Days)||3
1587725|NCT01072149|3883772|P3|COMPLETED|Treatment Period 3 (28 Days)||0
1587726|NCT01072149|3883773|P2|COMPLETED|Treatment Period 3 (28 Days)||2
1587727|NCT01072149|3883774|P1|COMPLETED|Treatment Period 3 (28 Days)||2
1587728|NCT01072149|3883757|P18|STARTED|Treatment Period 3 (28 Days)||2
1587729|NCT01072149|3883758|P17|STARTED|Treatment Period 3 (28 Days)||3
1587730|NCT01072149|3883759|P16|STARTED|Treatment Period 3 (28 Days)||1
1587731|NCT01072149|3883760|P15|STARTED|Treatment Period 3 (28 Days)||3
1587732|NCT01072149|3883761|P14|STARTED|Treatment Period 3 (28 Days)||3
1587733|NCT01072149|3883762|P13|STARTED|Treatment Period 3 (28 Days)||2
1587734|NCT01072149|3883763|P12|STARTED|Treatment Period 3 (28 Days)||3
1587735|NCT01072149|3883764|P11|STARTED|Treatment Period 3 (28 Days)||2
1587736|NCT01072149|3883765|P10|STARTED|Treatment Period 3 (28 Days)||3
1587737|NCT01072149|3883766|P9|STARTED|Treatment Period 3 (28 Days)||3
1587738|NCT01072149|3883767|P8|STARTED|Treatment Period 3 (28 Days)||2
1587739|NCT01072149|3883768|P7|STARTED|Treatment Period 3 (28 Days)||3
1587740|NCT01072149|3883769|P6|STARTED|Treatment Period 3 (28 Days)||3
1587741|NCT01072149|3883770|P5|STARTED|Treatment Period 3 (28 Days)||3
1587742|NCT01072149|3883771|P4|STARTED|Treatment Period 3 (28 Days)||3
1587743|NCT01072149|3883772|P3|STARTED|Treatment Period 3 (28 Days)||1
1587744|NCT01072149|3883773|P2|STARTED|Treatment Period 3 (28 Days)||2
1587745|NCT01072149|3883774|P1|STARTED|Treatment Period 3 (28 Days)||2
1587746|NCT01072149|3883757|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587747|NCT01072149|3883758|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587748|NCT01072149|3883759|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
1587749|NCT01072149|3883760|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587750|NCT01072149|3883761|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587751|NCT01072149|3883762|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
1587752|NCT01072149|3883763|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587753|NCT01072149|3883764|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587754|NCT01072149|3883765|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587755|NCT01072149|3883766|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587756|NCT01072149|3883767|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587757|NCT01072149|3883768|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587758|NCT01072149|3883769|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587759|NCT01072149|3883770|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587760|NCT01072149|3883771|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587761|NCT01072149|3883772|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587762|NCT01072149|3883773|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
1587763|NCT01072149|3883774|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
1587764|NCT01072149|3883757|P18|COMPLETED|Washout Period 2 (14 Days)||2
1587765|NCT01072149|3883758|P17|COMPLETED|Washout Period 2 (14 Days)||3
1587766|NCT01072149|3883759|P16|COMPLETED|Washout Period 2 (14 Days)||1
1587767|NCT01072149|3883760|P15|COMPLETED|Washout Period 2 (14 Days)||3
1587768|NCT01072149|3883761|P14|COMPLETED|Washout Period 2 (14 Days)||3
1587769|NCT01072149|3883762|P13|COMPLETED|Washout Period 2 (14 Days)||2
1587770|NCT01072149|3883763|P12|COMPLETED|Washout Period 2 (14 Days)||3
1587771|NCT01072149|3883764|P11|COMPLETED|Washout Period 2 (14 Days)||2
1587772|NCT01072149|3883765|P10|COMPLETED|Washout Period 2 (14 Days)||3
1587773|NCT01072149|3883766|P9|COMPLETED|Washout Period 2 (14 Days)||3
1587774|NCT01072149|3883767|P8|COMPLETED|Washout Period 2 (14 Days)||2
1587775|NCT01072149|3883768|P7|COMPLETED|Washout Period 2 (14 Days)||3
1587776|NCT01072149|3883769|P6|COMPLETED|Washout Period 2 (14 Days)||3
1587777|NCT01072149|3883770|P5|COMPLETED|Washout Period 2 (14 Days)||3
1587778|NCT01072149|3883771|P4|COMPLETED|Washout Period 2 (14 Days)||3
1587779|NCT01072149|3883772|P3|COMPLETED|Washout Period 2 (14 Days)||1
1587780|NCT01072149|3883773|P2|COMPLETED|Washout Period 2 (14 Days)||2
1587781|NCT01072149|3883774|P1|COMPLETED|Washout Period 2 (14 Days)||2
1587782|NCT01072149|3883757|P18|STARTED|Washout Period 2 (14 Days)||2
1587783|NCT01072149|3883758|P17|STARTED|Washout Period 2 (14 Days)||3
1587784|NCT01072149|3883759|P16|STARTED|Washout Period 2 (14 Days)||3
1587785|NCT01072149|3883760|P15|STARTED|Washout Period 2 (14 Days)||3
1587786|NCT01072149|3883761|P14|STARTED|Washout Period 2 (14 Days)||3
1587787|NCT01072149|3883762|P13|STARTED|Washout Period 2 (14 Days)||3
1587788|NCT01072149|3883763|P12|STARTED|Washout Period 2 (14 Days)||3
1587789|NCT01072149|3883764|P11|STARTED|Washout Period 2 (14 Days)||2
1587790|NCT01072149|3883765|P10|STARTED|Washout Period 2 (14 Days)||3
1587791|NCT01072149|3883766|P9|STARTED|Washout Period 2 (14 Days)||3
1587792|NCT01072149|3883767|P8|STARTED|Washout Period 2 (14 Days)||2
1587793|NCT01072149|3883768|P7|STARTED|Washout Period 2 (14 Days)||3
1587794|NCT01072149|3883769|P6|STARTED|Washout Period 2 (14 Days)||3
1587795|NCT01072149|3883770|P5|STARTED|Washout Period 2 (14 Days)||3
1587796|NCT01072149|3883771|P4|STARTED|Washout Period 2 (14 Days)||3
1587797|NCT01072149|3883772|P3|STARTED|Washout Period 2 (14 Days)||1
1587798|NCT01072149|3883773|P2|STARTED|Washout Period 2 (14 Days)||2
1587799|NCT01072149|3883774|P1|STARTED|Washout Period 2 (14 Days)||3
1587800|NCT01072149|3883757|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587801|NCT01072149|3883758|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587802|NCT01072149|3883759|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587803|NCT01072149|3883760|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587804|NCT01072149|3883761|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587805|NCT01072149|3883762|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587806|NCT01072149|3883763|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587807|NCT01072149|3883764|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587808|NCT01072149|3883765|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587809|NCT01072149|3883766|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587810|NCT01072149|3883767|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1587811|NCT01072149|3883768|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587812|NCT01072149|3883769|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587813|NCT01072149|3883770|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587814|NCT01072149|3883771|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587815|NCT01072149|3883772|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1587816|NCT01072149|3883773|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1587817|NCT01072149|3883774|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1587818|NCT01072149|3883757|P18|COMPLETED|Treatment Period 2 (28 Days)||2
1587819|NCT01072149|3883758|P17|COMPLETED|Treatment Period 2 (28 Days)||3
1587820|NCT01072149|3883759|P16|COMPLETED|Treatment Period 2 (28 Days)||3
1587821|NCT01072149|3883760|P15|COMPLETED|Treatment Period 2 (28 Days)||3
1587822|NCT01072149|3883761|P14|COMPLETED|Treatment Period 2 (28 Days)||3
1587823|NCT01072149|3883762|P13|COMPLETED|Treatment Period 2 (28 Days)||3
1587824|NCT01072149|3883763|P12|COMPLETED|Treatment Period 2 (28 Days)||3
1587825|NCT01072149|3883764|P11|COMPLETED|Treatment Period 2 (28 Days)||2
1587826|NCT01072149|3883765|P10|COMPLETED|Treatment Period 2 (28 Days)||3
1587827|NCT01072149|3883766|P9|COMPLETED|Treatment Period 2 (28 Days)||3
1587828|NCT01072149|3883767|P8|COMPLETED|Treatment Period 2 (28 Days)||2
1587829|NCT01072149|3883768|P7|COMPLETED|Treatment Period 2 (28 Days)||3
1587830|NCT01072149|3883769|P6|COMPLETED|Treatment Period 2 (28 Days)||3
1587831|NCT01072149|3883770|P5|COMPLETED|Treatment Period 2 (28 Days)||3
1587832|NCT01072149|3883771|P4|COMPLETED|Treatment Period 2 (28 Days)||3
1587833|NCT01072149|3883772|P3|COMPLETED|Treatment Period 2 (28 Days)||1
1587834|NCT01072149|3883773|P2|COMPLETED|Treatment Period 2 (28 Days)||2
1587835|NCT01072149|3883774|P1|COMPLETED|Treatment Period 2 (28 Days)||3
1587836|NCT01072149|3883757|P18|STARTED|Treatment Period 2 (28 Days)||2
1587837|NCT01072149|3883758|P17|STARTED|Treatment Period 2 (28 Days)||3
1587838|NCT01072149|3883759|P16|STARTED|Treatment Period 2 (28 Days)||3
1587839|NCT01072149|3883760|P15|STARTED|Treatment Period 2 (28 Days)||3
1587840|NCT01072149|3883761|P14|STARTED|Treatment Period 2 (28 Days)||3
1587841|NCT01072149|3883762|P13|STARTED|Treatment Period 2 (28 Days)||3
1587842|NCT01072149|3883763|P12|STARTED|Treatment Period 2 (28 Days)||3
1587843|NCT01072149|3883764|P11|STARTED|Treatment Period 2 (28 Days)||2
1587844|NCT01072149|3883765|P10|STARTED|Treatment Period 2 (28 Days)||3
1587845|NCT01072149|3883766|P9|STARTED|Treatment Period 2 (28 Days)||3
1587846|NCT01072149|3883767|P8|STARTED|Treatment Period 2 (28 Days)||3
1587847|NCT01072149|3883768|P7|STARTED|Treatment Period 2 (28 Days)||3
1587848|NCT01072149|3883769|P6|STARTED|Treatment Period 2 (28 Days)||3
1587849|NCT01072149|3883770|P5|STARTED|Treatment Period 2 (28 Days)||3
1587850|NCT01072149|3883771|P4|STARTED|Treatment Period 2 (28 Days)||3
1587851|NCT01072149|3883772|P3|STARTED|Treatment Period 2 (28 Days)||2
1587852|NCT01072149|3883773|P2|STARTED|Treatment Period 2 (28 Days)||3
1587853|NCT01072149|3883774|P1|STARTED|Treatment Period 2 (28 Days)||3
1587854|NCT01072149|3883757|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587855|NCT01072149|3883758|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587856|NCT01072149|3883759|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587857|NCT01072149|3883760|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587858|NCT01072149|3883761|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587859|NCT01072149|3883762|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587860|NCT01072149|3883763|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587861|NCT01072149|3883764|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587862|NCT01072149|3883765|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587863|NCT01072149|3883766|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587864|NCT01072149|3883767|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587865|NCT01072149|3883768|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587866|NCT01072149|3883769|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587867|NCT01072149|3883770|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587868|NCT01072149|3883771|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587869|NCT01072149|3883772|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587870|NCT01072149|3883773|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587871|NCT01072149|3883774|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
1587872|NCT01072149|3883757|P18|COMPLETED|Washout Period 1 (14 Days)||2
1587873|NCT01072149|3883758|P17|COMPLETED|Washout Period 1 (14 Days)||3
1587874|NCT01072149|3883759|P16|COMPLETED|Washout Period 1 (14 Days)||3
1587875|NCT01072149|3883760|P15|COMPLETED|Washout Period 1 (14 Days)||3
1587876|NCT01072149|3883761|P14|COMPLETED|Washout Period 1 (14 Days)||3
1587877|NCT01072149|3883762|P13|COMPLETED|Washout Period 1 (14 Days)||3
1587878|NCT01072149|3883763|P12|COMPLETED|Washout Period 1 (14 Days)||3
1587879|NCT01072149|3883764|P11|COMPLETED|Washout Period 1 (14 Days)||2
1587880|NCT01072149|3883765|P10|COMPLETED|Washout Period 1 (14 Days)||3
1587881|NCT01072149|3883766|P9|COMPLETED|Washout Period 1 (14 Days)||3
1587882|NCT01072149|3883767|P8|COMPLETED|Washout Period 1 (14 Days)||3
1587883|NCT01072149|3883768|P7|COMPLETED|Washout Period 1 (14 Days)||3
1587884|NCT01072149|3883769|P6|COMPLETED|Washout Period 1 (14 Days)||3
1587885|NCT01072149|3883770|P5|COMPLETED|Washout Period 1 (14 Days)||3
1587886|NCT01072149|3883771|P4|COMPLETED|Washout Period 1 (14 Days)||3
1587887|NCT01072149|3883772|P3|COMPLETED|Washout Period 1 (14 Days)||2
1587888|NCT01072149|3883773|P2|COMPLETED|Washout Period 1 (14 Days)||3
1587889|NCT01072149|3883774|P1|COMPLETED|Washout Period 1 (14 Days)||3
1587890|NCT01072149|3883757|P18|STARTED|Washout Period 1 (14 Days)||2
1587891|NCT01072149|3883758|P17|STARTED|Washout Period 1 (14 Days)||3
1587892|NCT01072149|3883759|P16|STARTED|Washout Period 1 (14 Days)||3
1587893|NCT01072149|3883760|P15|STARTED|Washout Period 1 (14 Days)||3
1587894|NCT01072149|3883761|P14|STARTED|Washout Period 1 (14 Days)||3
1587895|NCT01072149|3883762|P13|STARTED|Washout Period 1 (14 Days)||3
1587896|NCT01072149|3883763|P12|STARTED|Washout Period 1 (14 Days)||3
1587897|NCT01072149|3883764|P11|STARTED|Washout Period 1 (14 Days)||2
1587898|NCT01072149|3883765|P10|STARTED|Washout Period 1 (14 Days)||3
1587899|NCT01072149|3883766|P9|STARTED|Washout Period 1 (14 Days)||3
1587900|NCT01072149|3883767|P8|STARTED|Washout Period 1 (14 Days)||3
1587901|NCT01072149|3883768|P7|STARTED|Washout Period 1 (14 Days)||3
1587902|NCT01072149|3883769|P6|STARTED|Washout Period 1 (14 Days)||3
1587903|NCT01072149|3883770|P5|STARTED|Washout Period 1 (14 Days)||3
1587904|NCT01072149|3883771|P4|STARTED|Washout Period 1 (14 Days)||3
1587905|NCT01072149|3883772|P3|STARTED|Washout Period 1 (14 Days)||2
1587906|NCT01072149|3883773|P2|STARTED|Washout Period 1 (14 Days)||3
1587907|NCT01072149|3883774|P1|STARTED|Washout Period 1 (14 Days)||3
1587908|NCT01072149|3883757|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1587909|NCT01072149|3883758|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587910|NCT01072149|3883759|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587911|NCT01072149|3883760|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587912|NCT01072149|3883761|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587913|NCT01072149|3883762|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587914|NCT01072149|3883763|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587915|NCT01072149|3883764|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1587916|NCT01072149|3883765|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587917|NCT01072149|3883766|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587918|NCT01072149|3883767|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587919|NCT01072149|3883768|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587920|NCT01072149|3883769|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587921|NCT01072149|3883770|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587922|NCT01072149|3883771|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587923|NCT01072149|3883772|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1587924|NCT01072149|3883773|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587925|NCT01072149|3883774|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1587926|NCT01072149|3883757|P18|COMPLETED|Treatment Period 1 (28 Days)||2
1587927|NCT01072149|3883758|P17|COMPLETED|Treatment Period 1 (28 Days)||3
1587928|NCT01072149|3883759|P16|COMPLETED|Treatment Period 1 (28 Days)||3
1587929|NCT01072149|3883760|P15|COMPLETED|Treatment Period 1 (28 Days)||3
1587930|NCT01072149|3883761|P14|COMPLETED|Treatment Period 1 (28 Days)||3
1587931|NCT01072149|3883762|P13|COMPLETED|Treatment Period 1 (28 Days)||3
1587932|NCT01072149|3883763|P12|COMPLETED|Treatment Period 1 (28 Days)||3
1587933|NCT01072149|3883764|P11|COMPLETED|Treatment Period 1 (28 Days)||2
1587934|NCT01072149|3883765|P10|COMPLETED|Treatment Period 1 (28 Days)||3
1587935|NCT01072149|3883766|P9|COMPLETED|Treatment Period 1 (28 Days)||3
1587936|NCT01072149|3883767|P8|COMPLETED|Treatment Period 1 (28 Days)||3
1587937|NCT01072149|3883768|P7|COMPLETED|Treatment Period 1 (28 Days)||3
1587938|NCT01072149|3883769|P6|COMPLETED|Treatment Period 1 (28 Days)||3
1587939|NCT01072149|3883770|P5|COMPLETED|Treatment Period 1 (28 Days)||3
1587940|NCT01072149|3883771|P4|COMPLETED|Treatment Period 1 (28 Days)||3
1587941|NCT01072149|3883772|P3|COMPLETED|Treatment Period 1 (28 Days)||2
1587942|NCT01072149|3883773|P2|COMPLETED|Treatment Period 1 (28 Days)||3
1587943|NCT01072149|3883774|P1|COMPLETED|Treatment Period 1 (28 Days)||3
1587944|NCT01072149|3883757|P18|STARTED|Treatment Period 1 (28 Days)||3
1587945|NCT01072149|3883758|P17|STARTED|Treatment Period 1 (28 Days)||3
1587946|NCT01072149|3883759|P16|STARTED|Treatment Period 1 (28 Days)||3
1587947|NCT01072149|3883760|P15|STARTED|Treatment Period 1 (28 Days)||3
1587948|NCT01072149|3883761|P14|STARTED|Treatment Period 1 (28 Days)||3
1587949|NCT01072149|3883762|P13|STARTED|Treatment Period 1 (28 Days)||3
1587950|NCT01072149|3883763|P12|STARTED|Treatment Period 1 (28 Days)||3
1587951|NCT01072149|3883764|P11|STARTED|Treatment Period 1 (28 Days)||3
1587952|NCT01072149|3883765|P10|STARTED|Treatment Period 1 (28 Days)||3
1587953|NCT01072149|3883766|P9|STARTED|Treatment Period 1 (28 Days)||3
1587954|NCT01072149|3883767|P8|STARTED|Treatment Period 1 (28 Days)||3
1587955|NCT01072149|3883768|P7|STARTED|Treatment Period 1 (28 Days)||3
1587956|NCT01072149|3883769|P6|STARTED|Treatment Period 1 (28 Days)||3
1587957|NCT01072149|3883770|P5|STARTED|Treatment Period 1 (28 Days)||3
1587958|NCT01072149|3883771|P4|STARTED|Treatment Period 1 (28 Days)||3
1587959|NCT01072149|3883772|P3|STARTED|Treatment Period 1 (28 Days)||3
1587960|NCT01072149|3883773|P2|STARTED|Treatment Period 1 (28 Days)||3
1587961|NCT01072149|3883774|P1|STARTED|Treatment Period 1 (28 Days)||3
1587962|NCT01072136|3883794|P2|NOT COMPLETED|Overall Study||31
1587963|NCT01072136|3883795|P1|NOT COMPLETED|Overall Study||23
1587964|NCT01072136|3883794|P2|COMPLETED|Overall Study||12
1587965|NCT01072136|3883795|P1|COMPLETED|Overall Study||21
1587966|NCT01072136|3883794|P2|Met All Enrollment Criteria|Overall Study||25
1587967|NCT01072136|3883795|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
1587968|NCT01072136|3883794|P2|STARTED|Overall Study||43
1587969|NCT01072136|3883795|P1|STARTED|Overall Study||44
1587970|NCT01072032|3883819|P2|NOT COMPLETED|Overall Study||9
1587971|NCT01072032|3883820|P1|NOT COMPLETED|Overall Study||8
1587972|NCT01072032|3883819|P2|COMPLETED|Overall Study||5
1587973|NCT01072032|3883820|P1|COMPLETED|Overall Study||5
1587974|NCT01072032|3883819|P2|STARTED|Overall Study||14
1587975|NCT01072032|3883820|P1|STARTED|Overall Study||13
1587976|NCT01072006|3883834|P4|NOT COMPLETED|Overall Study||0
1587977|NCT01072006|3883835|P3|NOT COMPLETED|Overall Study||0
1587978|NCT01072006|3883836|P2|NOT COMPLETED|Overall Study||0
1587979|NCT01072006|3883837|P1|NOT COMPLETED|Overall Study||0
1587980|NCT01072006|3883834|P4|COMPLETED|Overall Study||11
1587981|NCT01072006|3883835|P3|COMPLETED|Overall Study||0
1587982|NCT01072006|3883836|P2|COMPLETED|Overall Study||5
1587983|NCT01072006|3883837|P1|COMPLETED|Overall Study||14
1587984|NCT01072006|3883834|P4|STARTED|Overall Study||11
1587985|NCT01072006|3883835|P3|STARTED|Overall Study||0
1587986|NCT01072006|3883836|P2|STARTED|Overall Study||5
1587987|NCT01072006|3883837|P1|STARTED|Overall Study||14
1587988|NCT01071993|3883856|P2|NOT COMPLETED|Overall Study||0
1587989|NCT01071993|3883857|P1|NOT COMPLETED|Overall Study||0
1587990|NCT01071993|3883856|P2|COMPLETED|Overall Study||0
1587991|NCT01071993|3883857|P1|COMPLETED|Overall Study||0
1587992|NCT01071993|3883856|P2|STARTED|Overall Study||0
1587993|NCT01071993|3883857|P1|STARTED|Overall Study||0
1587994|NCT01071915|3883863|P1|NOT COMPLETED|Overall Study||9
1587995|NCT01071915|3883863|P1|COMPLETED|Overall Study||148
1587996|NCT01071915|3883863|P1|Safety Analysis Set|Overall Study||156
1587997|NCT01071915|3883863|P1|Full Analysis Set (FAS)|Overall Study||155
1587998|NCT01071915|3883863|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
1587999|NCT01071798|3883873|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
1588000|NCT01071798|3883873|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
1588001|NCT01071798|3883873|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
1588002|NCT01071798|3883873|P1|STARTED|Subpopulation Who Received Two Cycles||820
1588003|NCT01071798|3883873|P1|NOT COMPLETED|Participants Who Received One Cycle||65
1588004|NCT01071798|3883873|P1|COMPLETED|Participants Who Received One Cycle||1588
1588005|NCT01071798|3883873|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
1588006|NCT01071798|3883873|P1|STARTED|Participants Who Received One Cycle||1653
1588007|NCT01071538|3883893|P1|NOT COMPLETED|Overall Study||2
1588008|NCT01071538|3883893|P1|COMPLETED|Overall Study||13
1588009|NCT01071538|3883893|P1|STARTED|Overall Study||15
1588010|NCT01071512|3883903|P1|NOT COMPLETED|Overall Study||5
1588011|NCT01071512|3883903|P1|COMPLETED|Overall Study||15
1588012|NCT01071512|3883903|P1|STARTED|Overall Study||20
1588013|NCT01071395|3883913|P2|NOT COMPLETED|Overall Study||2
1588014|NCT01071395|3883914|P1|NOT COMPLETED|Overall Study||5
1588015|NCT01071395|3883913|P2|COMPLETED|Overall Study||30
1588016|NCT01071395|3883914|P1|COMPLETED|Overall Study||31
1588017|NCT01071395|3883913|P2|STARTED|Overall Study||32
1588018|NCT01071395|3883914|P1|STARTED|Overall Study||36
1588019|NCT01071356|3883922|P2|NOT COMPLETED|Overall Study||9
1588020|NCT01071356|3883923|P1|NOT COMPLETED|Overall Study||7
1588021|NCT01071356|3883922|P2|COMPLETED|Overall Study||97
1588022|NCT01071356|3883923|P1|COMPLETED|Overall Study||104
1588023|NCT01071356|3883922|P2|STARTED|Overall Study||106
1588024|NCT01071356|3883923|P1|STARTED|Overall Study||111
1588025|NCT01071317|3883933|P2|NOT COMPLETED|Overall Study||2
1588026|NCT01071317|3883934|P1|NOT COMPLETED|Overall Study||2
1588027|NCT01071317|3883933|P2|COMPLETED|Overall Study||23
1588028|NCT01071317|3883934|P1|COMPLETED|Overall Study||23
1588029|NCT01071317|3883933|P2|STARTED|Overall Study||25
1588030|NCT01071317|3883934|P1|STARTED|Overall Study||25
1588031|NCT01071278|3883946|P1|NOT COMPLETED|Overall Study||713
1588032|NCT01071278|3883946|P1|COMPLETED|Overall Study||1677
1588033|NCT01071278|3883946|P1|STARTED|Overall Study||2390
1588034|NCT01071252|3883957|P5|NOT COMPLETED|Overall Study||11
1588035|NCT01071252|3883958|P4|NOT COMPLETED|Overall Study||7
1588036|NCT01071252|3883959|P3|NOT COMPLETED|Overall Study||4
1588037|NCT01071252|3883960|P2|NOT COMPLETED|Overall Study||10
1588038|NCT01071252|3883961|P1|NOT COMPLETED|Overall Study||15
1588039|NCT01071252|3883957|P5|COMPLETED|Overall Study||11
1588040|NCT01071252|3883958|P4|COMPLETED|Overall Study||20
1588041|NCT01071252|3883959|P3|COMPLETED|Overall Study||17
1588042|NCT01071252|3883960|P2|COMPLETED|Overall Study||16
1588043|NCT01071252|3883961|P1|COMPLETED|Overall Study||14
1588044|NCT01071252|3883957|P5|STARTED|Overall Study||22
1588045|NCT01071252|3883958|P4|STARTED|Overall Study||27
1588046|NCT01071252|3883959|P3|STARTED|Overall Study||21
1588047|NCT01071252|3883960|P2|STARTED|Overall Study||26
1588048|NCT01071252|3883961|P1|STARTED|Overall Study||29
1588049|NCT01071200|3883989|P2|NOT COMPLETED|Overall Study||3
1588050|NCT01071200|3883990|P1|NOT COMPLETED|Overall Study||7
1588051|NCT01071200|3883989|P2|COMPLETED|Overall Study||63
1588052|NCT01071200|3883990|P1|COMPLETED|Overall Study||60
1588053|NCT01071200|3883989|P2|STARTED|Overall Study||66
1588054|NCT01071200|3883990|P1|STARTED|Overall Study||67
1588055|NCT01071096|3884022|P2|NOT COMPLETED|Second Intervention (90 Days)||0
1588056|NCT01071096|3884023|P1|NOT COMPLETED|Second Intervention (90 Days)||0
1588057|NCT01071096|3884022|P2|COMPLETED|Second Intervention (90 Days)||10
1588058|NCT01071096|3884023|P1|COMPLETED|Second Intervention (90 Days)||9
1588059|NCT01071096|3884022|P2|STARTED|Second Intervention (90 Days)||10
1588060|NCT01071096|3884023|P1|STARTED|Second Intervention (90 Days)||9
1588061|NCT01071096|3884022|P2|NOT COMPLETED|Washout Period (30 Days)||0
1588062|NCT01071096|3884023|P1|NOT COMPLETED|Washout Period (30 Days)||0
1588063|NCT01071096|3884022|P2|COMPLETED|Washout Period (30 Days)||10
1588064|NCT01071096|3884023|P1|COMPLETED|Washout Period (30 Days)||9
1588065|NCT01071096|3884022|P2|STARTED|Washout Period (30 Days)||10
1588066|NCT01071096|3884023|P1|STARTED|Washout Period (30 Days)||9
1588067|NCT01071096|3884022|P2|NOT COMPLETED|First Intervention (90 Days)||0
1588068|NCT01071096|3884023|P1|NOT COMPLETED|First Intervention (90 Days)||1
1588069|NCT01071096|3884022|P2|COMPLETED|First Intervention (90 Days)||10
1588070|NCT01071096|3884023|P1|COMPLETED|First Intervention (90 Days)||9
1588071|NCT01071096|3884022|P2|STARTED|First Intervention (90 Days)||10
1588072|NCT01071096|3884023|P1|STARTED|First Intervention (90 Days)||10
1588073|NCT01071083|3884047|P5|NOT COMPLETED|Overall Study||8
1588074|NCT01071083|3884048|P4|NOT COMPLETED|Overall Study||2
1588075|NCT01071083|3884049|P3|NOT COMPLETED|Overall Study||5
1588076|NCT01071083|3884050|P2|NOT COMPLETED|Overall Study||2
1588077|NCT01071083|3884051|P1|NOT COMPLETED|Overall Study||7
1588078|NCT01071083|3884047|P5|COMPLETED|Overall Study||46
1588079|NCT01071083|3884048|P4|COMPLETED|Overall Study||15
1588080|NCT01071083|3884049|P3|COMPLETED|Overall Study||12
1588081|NCT01071083|3884050|P2|COMPLETED|Overall Study||43
1588082|NCT01071083|3884051|P1|COMPLETED|Overall Study||35
1588083|NCT01071083|3884047|P5|STARTED|Overall Study||54
1588084|NCT01071083|3884048|P4|STARTED|Overall Study||17
1588085|NCT01071083|3884049|P3|STARTED|Overall Study||17
1588086|NCT01071083|3884050|P2|STARTED|Overall Study||45
1588087|NCT01071083|3884051|P1|STARTED|Overall Study||42
1588088|NCT01071070|3884070|P2|NOT COMPLETED|Overall Study||3
1588089|NCT01071070|3884071|P1|NOT COMPLETED|Overall Study||4
1588090|NCT01071070|3884070|P2|COMPLETED|Overall Study||105
1588091|NCT01071070|3884071|P1|COMPLETED|Overall Study||104
1588092|NCT01071070|3884070|P2|STARTED|Overall Study||108
1588093|NCT01071070|3884071|P1|STARTED|Overall Study||108
1588094|NCT01071044|3884095|P2|NOT COMPLETED|Overall Study||0
1588095|NCT01071044|3884096|P1|NOT COMPLETED|Overall Study||2
1588096|NCT01071044|3884095|P2|COMPLETED|Overall Study||11
1588097|NCT01071044|3884096|P1|COMPLETED|Overall Study||13
1588098|NCT01071044|3884095|P2|STARTED|Overall Study||11
1588099|NCT01071044|3884096|P1|STARTED|Overall Study||15
1588100|NCT01070979|3884117|P3|NOT COMPLETED|Overall Study||13
1588101|NCT01070979|3884118|P2|NOT COMPLETED|Overall Study||12
1588102|NCT01070979|3884119|P1|NOT COMPLETED|Overall Study||11
1588103|NCT01070979|3884117|P3|COMPLETED|Overall Study||72
1588104|NCT01070979|3884118|P2|COMPLETED|Overall Study||73
1588105|NCT01070979|3884119|P1|COMPLETED|Overall Study||68
1588106|NCT01070979|3884117|P3|STARTED|Overall Study||85
1588107|NCT01070979|3884118|P2|STARTED|Overall Study||85
1588108|NCT01070979|3884119|P1|STARTED|Overall Study||79
1588196|NCT01070329|3884470|P1|COMPLETED|Overall Study||209
1588109|NCT01070966|3884145|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
1588110|NCT01070966|3884145|P1|COMPLETED|Participants for Efficacy Evaluation||1929
1588111|NCT01070966|3884145|P1|STARTED|Participants for Efficacy Evaluation||2011
1588112|NCT01070966|3884145|P1|NOT COMPLETED|Participants for Safety Evaluation||78
1588113|NCT01070966|3884145|P1|COMPLETED|Participants for Safety Evaluation||2011
1588114|NCT01070966|3884145|P1|STARTED|Participants for Safety Evaluation||2089
1588115|NCT01070953|3884156|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
1588116|NCT01070953|3884156|P1|COMPLETED|Participants for Efficacy Evaluation||3309
1588117|NCT01070953|3884156|P1|STARTED|Participants for Efficacy Evaluation||3536
1588118|NCT01070953|3884156|P1|NOT COMPLETED|Participants for Safety Evaluation||931
1588119|NCT01070953|3884156|P1|COMPLETED|Participants for Safety Evaluation||3536
1588120|NCT01070953|3884156|P1|STARTED|Participants for Safety Evaluation||4467
1588121|NCT01070888|3884169|P2|NOT COMPLETED|Second Intervention (14 Days)||0
1588122|NCT01070888|3884170|P1|NOT COMPLETED|Second Intervention (14 Days)||0
1588123|NCT01070888|3884169|P2|COMPLETED|Second Intervention (14 Days)||2
1588124|NCT01070888|3884170|P1|COMPLETED|Second Intervention (14 Days)||1
1588125|NCT01070888|3884169|P2|STARTED|Second Intervention (14 Days)||2
1588126|NCT01070888|3884170|P1|STARTED|Second Intervention (14 Days)||1
1588127|NCT01070888|3884169|P2|NOT COMPLETED|Washout (14 Days)||0
1588128|NCT01070888|3884170|P1|NOT COMPLETED|Washout (14 Days)||1
1588129|NCT01070888|3884169|P2|COMPLETED|Washout (14 Days)||2
1588130|NCT01070888|3884170|P1|COMPLETED|Washout (14 Days)||1
1588131|NCT01070888|3884169|P2|STARTED|Washout (14 Days)||2
1588132|NCT01070888|3884170|P1|STARTED|Washout (14 Days)||2
1588133|NCT01070888|3884169|P2|NOT COMPLETED|First Intervention (14 Days)||2
1588134|NCT01070888|3884170|P1|NOT COMPLETED|First Intervention (14 Days)||0
1588135|NCT01070888|3884169|P2|COMPLETED|First Intervention (14 Days)||2
1588136|NCT01070888|3884170|P1|COMPLETED|First Intervention (14 Days)||2
1588137|NCT01070888|3884169|P2|STARTED|First Intervention (14 Days)||4
1588138|NCT01070888|3884170|P1|STARTED|First Intervention (14 Days)||2
1588139|NCT01070810|3884178|P2|NOT COMPLETED|Overall Study||0
1588140|NCT01070810|3884179|P1|NOT COMPLETED|Overall Study||0
1588141|NCT01070810|3884178|P2|COMPLETED|Overall Study||43
1588142|NCT01070810|3884179|P1|COMPLETED|Overall Study||45
1588143|NCT01070810|3884178|P2|STARTED|Overall Study||43
1588144|NCT01070810|3884179|P1|STARTED|Overall Study||45
1588145|NCT01070784|3884195|P2|NOT COMPLETED|Overall Study||18
1588146|NCT01070784|3884196|P1|NOT COMPLETED|Overall Study||20
1588147|NCT01070784|3884195|P2|COMPLETED|Overall Study||112
1588148|NCT01070784|3884196|P1|COMPLETED|Overall Study||110
1588149|NCT01070784|3884195|P2|STARTED|Overall Study||130
1588150|NCT01070784|3884196|P1|STARTED|Overall Study||130
1588151|NCT01070771|3884284|P1|NOT COMPLETED|Overall Study||3
1588152|NCT01070771|3884284|P1|COMPLETED|Overall Study|August 2012|200
1588153|NCT01070771|3884284|P1|STARTED|Overall Study|September 2008|203
1588154|NCT01070693|3884291|P2|NOT COMPLETED|Overall Study||39
1588155|NCT01070693|3884292|P1|NOT COMPLETED|Overall Study||28
1588156|NCT01070693|3884291|P2|COMPLETED|Overall Study||110
1588157|NCT01070693|3884292|P1|COMPLETED|Overall Study||122
1588158|NCT01070693|3884291|P2|STARTED|Overall Study||149
1588159|NCT01070693|3884292|P1|STARTED|Overall Study||150
1588160|NCT01070550|3884304|P6|NOT COMPLETED|Overall Study||7
1588161|NCT01070550|3884305|P5|NOT COMPLETED|Overall Study||1
1588162|NCT01070550|3884306|P4|NOT COMPLETED|Overall Study||77
1588163|NCT01070550|3884307|P3|NOT COMPLETED|Overall Study||216
1588164|NCT01070550|3884308|P2|NOT COMPLETED|Overall Study||62
1588165|NCT01070550|3884309|P1|NOT COMPLETED|Overall Study||1285
1588166|NCT01070550|3884304|P6|COMPLETED|Overall Study||35
1588167|NCT01070550|3884305|P5|COMPLETED|Overall Study||20
1588168|NCT01070550|3884306|P4|COMPLETED|Overall Study||124
1588169|NCT01070550|3884307|P3|COMPLETED|Overall Study||528
1588170|NCT01070550|3884308|P2|COMPLETED|Overall Study||254
1588171|NCT01070550|3884309|P1|COMPLETED|Overall Study||2071
1588172|NCT01070550|3884304|P6|STARTED|Overall Study||42
1588173|NCT01070550|3884305|P5|STARTED|Overall Study||21
1588174|NCT01070550|3884306|P4|STARTED|Overall Study||201
1588175|NCT01070550|3884307|P3|STARTED|Overall Study||744
1588176|NCT01070550|3884308|P2|STARTED|Overall Study||316
1588177|NCT01070550|3884309|P1|STARTED|Overall Study||3356
1588178|NCT01070394|3884449|P1|NOT COMPLETED|Overall Study||7
1588179|NCT01070394|3884449|P1|COMPLETED|Overall Study||33
1588180|NCT01070394|3884449|P1|STARTED|Overall Study||40
1588181|NCT01070381|3884460|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
1588182|NCT01070381|3884461|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
1588183|NCT01070381|3884460|P2|COMPLETED|Period 2, 1 Week of Wear||106
1588184|NCT01070381|3884461|P1|COMPLETED|Period 2, 1 Week of Wear||108
1588185|NCT01070381|3884460|P2|STARTED|Period 2, 1 Week of Wear||107
1588186|NCT01070381|3884461|P1|STARTED|Period 2, 1 Week of Wear||109
1588187|NCT01070381|3884460|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
1588188|NCT01070381|3884461|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
1588189|NCT01070381|3884460|P2|COMPLETED|Period 1, 1 Week of Wear||107
1588190|NCT01070381|3884461|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
1588191|NCT01070381|3884460|P2|STARTED|Period 1, 1 Week of Wear||107
1588192|NCT01070381|3884461|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
1588193|NCT01070329|3884469|P2|NOT COMPLETED|Overall Study||49
1588194|NCT01070329|3884470|P1|NOT COMPLETED|Overall Study||52
1588195|NCT01070329|3884469|P2|COMPLETED|Overall Study||217
1588197|NCT01070329|3884469|P2|STARTED|Overall Study||266
1588198|NCT01070329|3884470|P1|STARTED|Overall Study||261
1588199|NCT01070316|3884502|P1|NOT COMPLETED|Extension Phase||4
1588200|NCT01070316|3884502|P1|COMPLETED|Extension Phase||14
1588201|NCT01070316|3884502|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
1588202|NCT01070316|3884502|P1|NOT COMPLETED|Main Phase||0
1588203|NCT01070316|3884502|P1|COMPLETED|Main Phase||20
1588204|NCT01070316|3884502|P1|STARTED|Main Phase||20
1588205|NCT01070303|3884509|P1|NOT COMPLETED|Overall Study||89
1588206|NCT01070303|3884509|P1|COMPLETED|Overall Study||88
1588207|NCT01070303|3884509|P1|STARTED|Overall Study||177
1588208|NCT01070173|3884568|P3|NOT COMPLETED|Overall Study||0
1588209|NCT01070173|3884569|P2|NOT COMPLETED|Overall Study||0
1588210|NCT01070173|3884570|P1|NOT COMPLETED|Overall Study||0
1588211|NCT01070173|3884568|P3|COMPLETED|Overall Study||11
1588212|NCT01070173|3884569|P2|COMPLETED|Overall Study||8
1588213|NCT01070173|3884570|P1|COMPLETED|Overall Study||33
1588214|NCT01070173|3884568|P3|STARTED|Overall Study||11
1588215|NCT01070173|3884569|P2|STARTED|Overall Study||8
1588216|NCT01070173|3884570|P1|STARTED|Overall Study||33
1588217|NCT01070043|3884583|P3|NOT COMPLETED|Double-Blind Treatment||2
1588218|NCT01070043|3884584|P2|NOT COMPLETED|Double-Blind Treatment||0
1588219|NCT01070043|3884585|P1|NOT COMPLETED|Double-Blind Treatment||0
1588220|NCT01070043|3884583|P3|COMPLETED|Double-Blind Treatment||19
1588221|NCT01070043|3884584|P2|COMPLETED|Double-Blind Treatment||21
1588222|NCT01070043|3884585|P1|COMPLETED|Double-Blind Treatment||0
1588223|NCT01070043|3884583|P3|STARTED|Double-Blind Treatment||21
1588224|NCT01070043|3884584|P2|STARTED|Double-Blind Treatment||21
1588225|NCT01070043|3884585|P1|STARTED|Double-Blind Treatment||0
1588226|NCT01070043|3884583|P3|NOT COMPLETED|Run-In Phase||0
1588227|NCT01070043|3884584|P2|NOT COMPLETED|Run-In Phase||0
1588228|NCT01070043|3884585|P1|NOT COMPLETED|Run-In Phase||18
1588229|NCT01070043|3884583|P3|COMPLETED|Run-In Phase||0
1588230|NCT01070043|3884584|P2|COMPLETED|Run-In Phase||0
1588231|NCT01070043|3884585|P1|COMPLETED|Run-In Phase||42
1588232|NCT01070043|3884583|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
1588233|NCT01070043|3884584|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
1588234|NCT01070043|3884585|P1|STARTED|Run-In Phase||60
1588235|NCT01069939|3884601|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
1588236|NCT01069939|3884602|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
1588237|NCT01069939|3884601|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
1588238|NCT01069939|3884602|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
1588239|NCT01069939|3884601|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
1588240|NCT01069939|3884602|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
1588241|NCT01069939|3884601|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
1588242|NCT01069939|3884602|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
1588243|NCT01069939|3884601|P2|COMPLETED|Randomised and Included in the Analyses||137
1588244|NCT01069939|3884602|P1|COMPLETED|Randomised and Included in the Analyses||164
1588245|NCT01069939|3884601|P2|STARTED|Randomised and Included in the Analyses||214
1588246|NCT01069939|3884602|P1|STARTED|Randomised and Included in the Analyses||213
1588247|NCT01069900|3884628|P2|NOT COMPLETED|Overall Study||4
1588248|NCT01069900|3884629|P1|NOT COMPLETED|Overall Study||18
1588249|NCT01069900|3884628|P2|COMPLETED|Overall Study||149
1588250|NCT01069900|3884629|P1|COMPLETED|Overall Study||287
1588251|NCT01069900|3884628|P2|Treated|Overall Study||150
1588252|NCT01069900|3884629|P1|Treated|Overall Study||301
1588253|NCT01069900|3884628|P2|STARTED|Overall Study||153
1588254|NCT01069900|3884629|P1|STARTED|Overall Study||305
1588255|NCT01069861|3884673|P1|NOT COMPLETED|Overall Study||3
1588256|NCT01069861|3884673|P1|COMPLETED|Overall Study||1
1588257|NCT01069861|3884673|P1|STARTED|Overall Study||4
1588258|NCT01069627|3884686|P1|NOT COMPLETED|Overall Study||20
1588259|NCT01069627|3884686|P1|COMPLETED|Overall Study||0
1588260|NCT01069627|3884686|P1|STARTED|Overall Study||20
1588261|NCT01069562|3884709|P2|NOT COMPLETED|Overall Study||0
1588262|NCT01069562|3884710|P1|NOT COMPLETED|Overall Study||0
1588263|NCT01069562|3884709|P2|COMPLETED|Overall Study||20
1588264|NCT01069562|3884710|P1|COMPLETED|Overall Study||20
1588265|NCT01069562|3884709|P2|STARTED|Overall Study||20
1588266|NCT01069562|3884710|P1|STARTED|Overall Study||20
1588267|NCT01069523|3884736|P2|NOT COMPLETED|Overall Study||7
1588268|NCT01069523|3884737|P1|NOT COMPLETED|Overall Study||4
1588269|NCT01069523|3884736|P2|COMPLETED|Overall Study||9
1588270|NCT01069523|3884737|P1|COMPLETED|Overall Study||9
1588271|NCT01069523|3884736|P2|STARTED|Overall Study||16
1588272|NCT01069523|3884737|P1|STARTED|Overall Study||13
1588273|NCT01069484|3884747|P2|NOT COMPLETED|Overall Study||3
1588274|NCT01069484|3884748|P1|NOT COMPLETED|Overall Study||12
1588275|NCT01069484|3884747|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
1588276|NCT01069484|3884748|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
1588277|NCT01069484|3884747|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
1588278|NCT01069484|3884748|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
1588279|NCT01069419|3884756|P1|NOT COMPLETED|Overall Study||715
1588280|NCT01069419|3884756|P1|COMPLETED|Overall Study||402
1588281|NCT01069419|3884756|P1|Full Analysis Set|Overall Study||851
1588282|NCT01069419|3884756|P1|Safety Set|Overall Study||1111
1588283|NCT01069419|3884756|P1|STARTED|Overall Study||1117
1588284|NCT01069354|3884763|P1|NOT COMPLETED|Overall Study||1
1588285|NCT01069354|3884763|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
1588286|NCT01069354|3884763|P1|STARTED|Overall Study||102
1588287|NCT01069341|3884785|P1|NOT COMPLETED|Overall Study||1
1588288|NCT01069341|3884785|P1|COMPLETED|Overall Study||3
1588289|NCT01069341|3884785|P1|STARTED|Overall Study||4
1588290|NCT01069289|3884798|P2|NOT COMPLETED|Overall Study||56
1588291|NCT01069289|3884799|P1|NOT COMPLETED|Overall Study||42
1588292|NCT01069289|3884798|P2|COMPLETED|Overall Study||601
1588293|NCT01069289|3884799|P1|COMPLETED|Overall Study||594
1588294|NCT01069289|3884798|P2|STARTED|Overall Study||657
1588295|NCT01069289|3884799|P1|STARTED|Overall Study||636
1588296|NCT01069185|3884839|P2|NOT COMPLETED|Overall Study||0
1588297|NCT01069185|3884840|P1|NOT COMPLETED|Overall Study||0
1588298|NCT01069185|3884839|P2|COMPLETED|Overall Study||45
1588299|NCT01069185|3884840|P1|COMPLETED|Overall Study||47
1588300|NCT01069185|3884839|P2|STARTED|Overall Study||45
1588301|NCT01069185|3884840|P1|STARTED|Overall Study||47
1588302|NCT01069172|3884848|P2|NOT COMPLETED|Overall Study||0
1588303|NCT01069172|3884849|P1|NOT COMPLETED|Overall Study||1
1588304|NCT01069172|3884848|P2|COMPLETED|Overall Study|30 eyes|30
1588305|NCT01069172|3884849|P1|COMPLETED|Overall Study|29 eyes|29
1588306|NCT01069172|3884848|P2|STARTED|Overall Study|30 eyes|30
1588307|NCT01069172|3884849|P1|STARTED|Overall Study|30 eyes|30
1588308|NCT01069120|3884859|P1|NOT COMPLETED|Overall Study||27
1588309|NCT01069120|3884859|P1|COMPLETED|Overall Study||0
1588310|NCT01069120|3884859|P1|STARTED|Overall Study||27
1588311|NCT01069003|3884868|P3|NOT COMPLETED|Overall Study||475
1588312|NCT01069003|3884869|P2|NOT COMPLETED|Overall Study||54
1588313|NCT01069003|3884870|P1|NOT COMPLETED|Overall Study||46
1588314|NCT01069003|3884868|P3|COMPLETED|Overall Study||976
1588315|NCT01069003|3884869|P2|COMPLETED|Overall Study||358
1588316|NCT01069003|3884870|P1|COMPLETED|Overall Study||353
1588317|NCT01069003|3884868|P3|STARTED|Overall Study||1451
1588318|NCT01069003|3884869|P2|STARTED|Overall Study||412
1588319|NCT01069003|3884870|P1|STARTED|Overall Study||399
1588320|NCT01068964|3884886|P2|NOT COMPLETED|Overall Study||10
1588321|NCT01068964|3884887|P1|NOT COMPLETED|Overall Study||8
1588322|NCT01068964|3884886|P2|COMPLETED|Overall Study||104
1588323|NCT01068964|3884887|P1|COMPLETED|Overall Study||113
1588324|NCT01068964|3884886|P2|STARTED|Overall Study||114
1588325|NCT01068964|3884887|P1|STARTED|Overall Study||121
1588326|NCT01068912|3884896|P3|NOT COMPLETED|Overall Study||15
1588327|NCT01068912|3884897|P2|NOT COMPLETED|Overall Study||22
1588328|NCT01068912|3884898|P1|NOT COMPLETED|Overall Study||11
1588329|NCT01068912|3884896|P3|COMPLETED|Overall Study||186
1588330|NCT01068912|3884897|P2|COMPLETED|Overall Study||173
1588331|NCT01068912|3884898|P1|COMPLETED|Overall Study||123
1588332|NCT01068912|3884896|P3|STARTED|Overall Study||201
1588333|NCT01068912|3884897|P2|STARTED|Overall Study||195
1588334|NCT01068912|3884898|P1|STARTED|Overall Study||134
1588335|NCT01068860|3884916|P10|NOT COMPLETED|Overall Study||4
1588336|NCT01068860|3884917|P9|NOT COMPLETED|Overall Study||0
1588337|NCT01068860|3884918|P8|NOT COMPLETED|Overall Study||0
1588338|NCT01068860|3884919|P7|NOT COMPLETED|Overall Study||0
1588339|NCT01068860|3884920|P6|NOT COMPLETED|Overall Study||2
1588340|NCT01068860|3884921|P5|NOT COMPLETED|Overall Study||0
1588341|NCT01068860|3884922|P4|NOT COMPLETED|Overall Study||1
1588342|NCT01068860|3884923|P3|NOT COMPLETED|Overall Study||0
1588343|NCT01068860|3884924|P2|NOT COMPLETED|Overall Study||1
1588344|NCT01068860|3884925|P1|NOT COMPLETED|Overall Study||0
1588345|NCT01068860|3884916|P10|COMPLETED|Overall Study||23
1588346|NCT01068860|3884917|P9|COMPLETED|Overall Study||28
1588347|NCT01068860|3884918|P8|COMPLETED|Overall Study||15
1588348|NCT01068860|3884919|P7|COMPLETED|Overall Study||28
1588349|NCT01068860|3884920|P6|COMPLETED|Overall Study||14
1588350|NCT01068860|3884921|P5|COMPLETED|Overall Study||32
1588351|NCT01068860|3884922|P4|COMPLETED|Overall Study||16
1588352|NCT01068860|3884923|P3|COMPLETED|Overall Study||33
1588353|NCT01068860|3884924|P2|COMPLETED|Overall Study||16
1588354|NCT01068860|3884925|P1|COMPLETED|Overall Study||33
1588355|NCT01068860|3884916|P10|STARTED|Overall Study||27
1588356|NCT01068860|3884917|P9|STARTED|Overall Study||28
1588357|NCT01068860|3884918|P8|STARTED|Overall Study||15
1588358|NCT01068860|3884919|P7|STARTED|Overall Study||28
1588359|NCT01068860|3884920|P6|STARTED|Overall Study||16
1588360|NCT01068860|3884921|P5|STARTED|Overall Study||32
1588361|NCT01068860|3884922|P4|STARTED|Overall Study||17
1588362|NCT01068860|3884923|P3|STARTED|Overall Study||33
1588363|NCT01068860|3884924|P2|STARTED|Overall Study||17
1588364|NCT01068860|3884925|P1|STARTED|Overall Study||33
1588365|NCT01068821|3885099|P2|NOT COMPLETED|Overall Study||0
1588366|NCT01068821|3885100|P1|NOT COMPLETED|Overall Study||1
1588367|NCT01068821|3885099|P2|COMPLETED|Overall Study||29
1588368|NCT01068821|3885100|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
1588369|NCT01068821|3885099|P2|STARTED|Overall Study||29
1588370|NCT01068821|3885100|P1|STARTED|Overall Study||31
1588371|NCT01068769|3885108|P1|NOT COMPLETED|Overall Study||1
1588372|NCT01068769|3885108|P1|COMPLETED|Overall Study||33
1588373|NCT01068769|3885108|P1|STARTED|Overall Study||34
1588374|NCT01068743|3885113|P4|NOT COMPLETED|Period 4||0
1588375|NCT01068743|3885114|P3|NOT COMPLETED|Period 4||0
1588376|NCT01068743|3885115|P2|NOT COMPLETED|Period 4||0
1588377|NCT01068743|3885116|P1|NOT COMPLETED|Period 4||0
1588378|NCT01068743|3885113|P4|COMPLETED|Period 4||6
1588379|NCT01068743|3885114|P3|COMPLETED|Period 4||6
1588380|NCT01068743|3885115|P2|COMPLETED|Period 4||5
1588381|NCT01068743|3885116|P1|COMPLETED|Period 4||6
1588382|NCT01068743|3885113|P4|STARTED|Period 4||6
1588383|NCT01068743|3885114|P3|STARTED|Period 4||6
1588384|NCT01068743|3885115|P2|STARTED|Period 4||5
1588385|NCT01068743|3885116|P1|STARTED|Period 4||6
1588386|NCT01068743|3885113|P4|NOT COMPLETED|Period 3||0
1588387|NCT01068743|3885114|P3|NOT COMPLETED|Period 3||0
1588388|NCT01068743|3885115|P2|NOT COMPLETED|Period 3||1
1588389|NCT01068743|3885116|P1|NOT COMPLETED|Period 3||0
1588390|NCT01068743|3885113|P4|COMPLETED|Period 3||6
1588391|NCT01068743|3885114|P3|COMPLETED|Period 3||6
1588392|NCT01068743|3885115|P2|COMPLETED|Period 3||5
1588393|NCT01068743|3885116|P1|COMPLETED|Period 3||6
1588394|NCT01068743|3885113|P4|STARTED|Period 3||6
1588395|NCT01068743|3885114|P3|STARTED|Period 3||6
1588396|NCT01068743|3885115|P2|STARTED|Period 3||6
1588397|NCT01068743|3885116|P1|STARTED|Period 3||6
1588398|NCT01068743|3885113|P4|NOT COMPLETED|Period 2||0
1588399|NCT01068743|3885114|P3|NOT COMPLETED|Period 2||0
1588400|NCT01068743|3885115|P2|NOT COMPLETED|Period 2||0
1588401|NCT01068743|3885116|P1|NOT COMPLETED|Period 2||0
1588402|NCT01068743|3885113|P4|COMPLETED|Period 2||6
1588403|NCT01068743|3885114|P3|COMPLETED|Period 2||6
1588404|NCT01068743|3885115|P2|COMPLETED|Period 2||6
1588405|NCT01068743|3885116|P1|COMPLETED|Period 2||6
1588406|NCT01068743|3885113|P4|STARTED|Period 2||6
1588407|NCT01068743|3885114|P3|STARTED|Period 2||6
1588408|NCT01068743|3885115|P2|STARTED|Period 2||6
1588409|NCT01068743|3885116|P1|STARTED|Period 2||6
1588410|NCT01068743|3885113|P4|NOT COMPLETED|Period 1||0
1588411|NCT01068743|3885114|P3|NOT COMPLETED|Period 1||0
1588412|NCT01068743|3885115|P2|NOT COMPLETED|Period 1||0
1588413|NCT01068743|3885116|P1|NOT COMPLETED|Period 1||0
1588414|NCT01068743|3885113|P4|COMPLETED|Period 1||6
1588415|NCT01068743|3885114|P3|COMPLETED|Period 1||6
1588416|NCT01068743|3885115|P2|COMPLETED|Period 1||6
1588417|NCT01068743|3885116|P1|COMPLETED|Period 1||6
1588418|NCT01068743|3885113|P4|STARTED|Period 1||6
1588419|NCT01068743|3885114|P3|STARTED|Period 1||6
1588420|NCT01068743|3885115|P2|STARTED|Period 1||6
1588421|NCT01068743|3885116|P1|STARTED|Period 1||6
1588422|NCT01068730|3885190|P4|NOT COMPLETED|Period 4||0
1588423|NCT01068730|3885191|P3|NOT COMPLETED|Period 4||0
1588424|NCT01068730|3885192|P2|NOT COMPLETED|Period 4||1
1588425|NCT01068730|3885193|P1|NOT COMPLETED|Period 4||0
1588426|NCT01068730|3885190|P4|COMPLETED|Period 4||7
1588427|NCT01068730|3885191|P3|COMPLETED|Period 4||7
1588428|NCT01068730|3885192|P2|COMPLETED|Period 4||6
1588429|NCT01068730|3885193|P1|COMPLETED|Period 4||6
1588430|NCT01068730|3885190|P4|STARTED|Period 4||7
1588431|NCT01068730|3885191|P3|STARTED|Period 4||7
1588432|NCT01068730|3885192|P2|STARTED|Period 4||7
1588433|NCT01068730|3885193|P1|STARTED|Period 4||6
1588434|NCT01068730|3885190|P4|NOT COMPLETED|Period 3||0
1588435|NCT01068730|3885191|P3|NOT COMPLETED|Period 3||0
1588436|NCT01068730|3885192|P2|NOT COMPLETED|Period 3||0
1588437|NCT01068730|3885193|P1|NOT COMPLETED|Period 3||1
1588438|NCT01068730|3885190|P4|COMPLETED|Period 3||7
1588439|NCT01068730|3885191|P3|COMPLETED|Period 3||7
1588440|NCT01068730|3885192|P2|COMPLETED|Period 3||7
1588441|NCT01068730|3885193|P1|COMPLETED|Period 3||6
1588442|NCT01068730|3885190|P4|STARTED|Period 3||7
1588443|NCT01068730|3885191|P3|STARTED|Period 3||7
1588444|NCT01068730|3885192|P2|STARTED|Period 3||7
1588445|NCT01068730|3885193|P1|STARTED|Period 3||7
1588446|NCT01068730|3885190|P4|NOT COMPLETED|Period 2||0
1588447|NCT01068730|3885191|P3|NOT COMPLETED|Period 2||0
1588448|NCT01068730|3885192|P2|NOT COMPLETED|Period 2||0
1588449|NCT01068730|3885193|P1|NOT COMPLETED|Period 2||0
1588450|NCT01068730|3885190|P4|COMPLETED|Period 2||7
1588451|NCT01068730|3885191|P3|COMPLETED|Period 2||7
1588452|NCT01068730|3885192|P2|COMPLETED|Period 2||7
1588453|NCT01068730|3885193|P1|COMPLETED|Period 2||7
1588454|NCT01068730|3885190|P4|STARTED|Period 2||7
1588455|NCT01068730|3885191|P3|STARTED|Period 2||7
1588456|NCT01068730|3885192|P2|STARTED|Period 2||7
1588457|NCT01068730|3885193|P1|STARTED|Period 2||7
1588458|NCT01068730|3885190|P4|NOT COMPLETED|Period 1||0
1588459|NCT01068730|3885191|P3|NOT COMPLETED|Period 1||0
1588460|NCT01068730|3885192|P2|NOT COMPLETED|Period 1||0
1588461|NCT01068730|3885193|P1|NOT COMPLETED|Period 1||0
1588462|NCT01068730|3885190|P4|COMPLETED|Period 1||7
1588463|NCT01068730|3885191|P3|COMPLETED|Period 1||7
1588464|NCT01068730|3885192|P2|COMPLETED|Period 1||7
1588465|NCT01068730|3885193|P1|COMPLETED|Period 1||7
1588466|NCT01068730|3885190|P4|STARTED|Period 1||7
1588467|NCT01068730|3885191|P3|STARTED|Period 1||7
1588468|NCT01068730|3885192|P2|STARTED|Period 1||7
1588469|NCT01068730|3885193|P1|STARTED|Period 1||7
1588470|NCT01068717|3885247|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1588471|NCT01068717|3885248|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1588472|NCT01068717|3885249|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1588473|NCT01068717|3885250|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1588474|NCT01068717|3885247|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
1588475|NCT01068717|3885248|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
1588476|NCT01068717|3885249|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
1588477|NCT01068717|3885250|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
1588478|NCT01068717|3885247|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
1588479|NCT01068717|3885248|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
1588480|NCT01068717|3885249|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
1588481|NCT01068717|3885250|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
1588482|NCT01068717|3885247|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1588483|NCT01068717|3885248|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1588484|NCT01068717|3885249|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1588485|NCT01068717|3885250|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1588486|NCT01068717|3885247|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
1588487|NCT01068717|3885248|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
1588488|NCT01068717|3885249|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
1588489|NCT01068717|3885250|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
1588490|NCT01068717|3885247|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
1588491|NCT01068717|3885248|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
1588492|NCT01068717|3885249|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
1588493|NCT01068717|3885250|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
1588494|NCT01068717|3885247|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1588495|NCT01068717|3885248|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1588496|NCT01068717|3885249|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1588497|NCT01068717|3885250|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1588498|NCT01068717|3885247|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
1588499|NCT01068717|3885248|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
1588500|NCT01068717|3885249|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
1588501|NCT01068717|3885250|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
1588502|NCT01068717|3885247|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
1588503|NCT01068717|3885248|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
1588504|NCT01068717|3885249|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
1588505|NCT01068717|3885250|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
1588506|NCT01068717|3885247|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
1588507|NCT01068717|3885248|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
1588508|NCT01068717|3885249|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
1588509|NCT01068717|3885250|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
1588510|NCT01068717|3885247|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
1588511|NCT01068717|3885248|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
1588512|NCT01068717|3885249|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
1588513|NCT01068717|3885250|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
1588514|NCT01068717|3885247|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
1588515|NCT01068717|3885248|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
1588516|NCT01068717|3885249|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
1588517|NCT01068717|3885250|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
1588518|NCT01068678|3885306|P2|NOT COMPLETED|Overall Study||24
1588519|NCT01068678|3885307|P1|NOT COMPLETED|Overall Study||38
1588520|NCT01068678|3885306|P2|COMPLETED|Overall Study||206
1588521|NCT01068678|3885307|P1|COMPLETED|Overall Study||192
1588522|NCT01068678|3885306|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
1588523|NCT01068678|3885307|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
1588524|NCT01068678|3885306|P2|STARTED|Overall Study||230
1588525|NCT01068678|3885307|P1|STARTED|Overall Study||230
1588526|NCT01068665|3885317|P2|NOT COMPLETED|Overall Study||29
1588527|NCT01068665|3885318|P1|NOT COMPLETED|Overall Study||30
1588528|NCT01068665|3885317|P2|COMPLETED|Overall Study||201
1588529|NCT01068665|3885318|P1|COMPLETED|Overall Study||200
1588530|NCT01068665|3885317|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
1588531|NCT01068665|3885318|P1|Exposed|Overall Study||228
1588532|NCT01068665|3885317|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
1588533|NCT01068665|3885318|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
1588534|NCT01068665|3885317|P2|STARTED|Overall Study||230
1588535|NCT01068665|3885318|P1|STARTED|Overall Study||230
1588536|NCT01068652|3885328|P2|NOT COMPLETED|Overall Study||15
1588537|NCT01068652|3885329|P1|NOT COMPLETED|Overall Study||18
1588538|NCT01068652|3885328|P2|COMPLETED|Overall Study||188
1588539|NCT01068652|3885329|P1|COMPLETED|Overall Study||182
1588540|NCT01068652|3885328|P2|STARTED|Overall Study||203
1588541|NCT01068652|3885329|P1|STARTED|Overall Study||200
1588542|NCT01068626|3885369|P2|NOT COMPLETED|Overall Study||2
1588543|NCT01068626|3885370|P1|NOT COMPLETED|Overall Study||3
1588544|NCT01068626|3885369|P2|COMPLETED|Overall Study||27
1588545|NCT01068626|3885370|P1|COMPLETED|Overall Study||27
1588546|NCT01068626|3885369|P2|STARTED|Overall Study||29
1588547|NCT01068626|3885370|P1|STARTED|Overall Study||30
1588548|NCT01068600|3885388|P2|NOT COMPLETED|Overall Study||17
1588549|NCT01068600|3885389|P1|NOT COMPLETED|Overall Study||11
1588550|NCT01068600|3885388|P2|COMPLETED|Overall Study||142
1588551|NCT01068600|3885389|P1|COMPLETED|Overall Study||148
1588552|NCT01068600|3885388|P2|STARTED|Overall Study||159
1588553|NCT01068600|3885389|P1|STARTED|Overall Study||159
1588554|NCT01068548|3885399|P2|NOT COMPLETED|Overall Study||0
1588555|NCT01068548|3885400|P1|NOT COMPLETED|Overall Study||0
1588556|NCT01068548|3885399|P2|COMPLETED|Overall Study||63
1588557|NCT01068548|3885400|P1|COMPLETED|Overall Study||66
1588558|NCT01068548|3885399|P2|STARTED|Overall Study||63
1588559|NCT01068548|3885400|P1|STARTED|Overall Study||66
1588560|NCT01068509|3885409|P3|NOT COMPLETED|Overall Study||21
1588561|NCT01068509|3885410|P2|NOT COMPLETED|Overall Study||22
1588562|NCT01068509|3885411|P1|NOT COMPLETED|Overall Study||6
1588563|NCT01068509|3885409|P3|COMPLETED|Overall Study||6
1588564|NCT01068509|3885410|P2|COMPLETED|Overall Study||7
1588565|NCT01068509|3885411|P1|COMPLETED|Overall Study||1
1588566|NCT01068509|3885409|P3|STARTED|Overall Study||27
1588567|NCT01068509|3885410|P2|STARTED|Overall Study||29
1588568|NCT01068509|3885411|P1|STARTED|Overall Study||7
1588569|NCT01068418|3885424|P1|NOT COMPLETED|Overall Study||12
1588570|NCT01068418|3885424|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
1588571|NCT01068418|3885424|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
1588572|NCT01068418|3885424|P1|STARTED|Overall Study|26 participants found to be eligible|26
1588573|NCT01068262|3885433|P4|NOT COMPLETED|Overall Study||0
1588574|NCT01068262|3885434|P3|NOT COMPLETED|Overall Study||1
1588575|NCT01068262|3885435|P2|NOT COMPLETED|Overall Study||1
1588576|NCT01068262|3885436|P1|NOT COMPLETED|Overall Study||3
1588577|NCT01068262|3885433|P4|COMPLETED|Overall Study||2
1588578|NCT01068262|3885434|P3|COMPLETED|Overall Study||9
1588579|NCT01068262|3885435|P2|COMPLETED|Overall Study||8
1588580|NCT01068262|3885436|P1|COMPLETED|Overall Study||20
1588581|NCT01068262|3885433|P4|STARTED|Overall Study||2
1588582|NCT01068262|3885434|P3|STARTED|Overall Study||10
1588583|NCT01068262|3885435|P2|STARTED|Overall Study||9
1588584|NCT01068262|3885436|P1|STARTED|Overall Study||23
1588585|NCT01068158|3885466|P2|NOT COMPLETED|Overall Study||4
1588586|NCT01068158|3885467|P1|NOT COMPLETED|Overall Study||8
1588587|NCT01068158|3885466|P2|COMPLETED|Overall Study||198
1588588|NCT01068158|3885467|P1|COMPLETED|Overall Study||161
1588589|NCT01068158|3885466|P2|STARTED|Overall Study||202
1588590|NCT01068158|3885467|P1|STARTED|Overall Study||169
1588591|NCT01067976|3885479|P1|NOT COMPLETED|Overall Study||22
1588592|NCT01067976|3885479|P1|COMPLETED|Overall Study|study course completed|424
1588593|NCT01067976|3885479|P1|Fulfilled Requirements of FAS Population|Overall Study||390
1588594|NCT01067976|3885479|P1|Received Treatment|Overall Study|treatment started|426
1588595|NCT01067976|3885479|P1|STARTED|Overall Study|screened and enrolled|446
1588596|NCT01067846|3885540|P2|NOT COMPLETED|Overall Study||19
1588597|NCT01067846|3885541|P1|NOT COMPLETED|Overall Study||19
1588598|NCT01067846|3885540|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
1588599|NCT01067846|3885541|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
1588600|NCT01067846|3885540|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
1588601|NCT01067846|3885541|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
1588602|NCT01067846|3885540|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
1588603|NCT01067846|3885541|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
1588604|NCT01067781|3885553|P4|NOT COMPLETED|180 to Day 720||89
1588605|NCT01067781|3885554|P3|NOT COMPLETED|180 to Day 720||89
1588606|NCT01067781|3885555|P2|NOT COMPLETED|180 to Day 720||164
1588607|NCT01067781|3885556|P1|NOT COMPLETED|180 to Day 720||170
1588608|NCT01067781|3885553|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
1588609|NCT01067781|3885554|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
1588610|NCT01067781|3885555|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
1588611|NCT01067781|3885556|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
1588612|NCT01067781|3885553|P4|STARTED|180 to Day 720||89
1588613|NCT01067781|3885554|P3|STARTED|180 to Day 720||89
1588614|NCT01067781|3885555|P2|STARTED|180 to Day 720||168
1588615|NCT01067781|3885556|P1|STARTED|180 to Day 720||173
1588616|NCT01067781|3885553|P4|NOT COMPLETED|Up to Day 180||12
1588617|NCT01067781|3885554|P3|NOT COMPLETED|Up to Day 180||8
1588618|NCT01067781|3885555|P2|NOT COMPLETED|Up to Day 180||31
1588619|NCT01067781|3885556|P1|NOT COMPLETED|Up to Day 180||30
1588620|NCT01067781|3885553|P4|COMPLETED|Up to Day 180||89
1588621|NCT01067781|3885554|P3|COMPLETED|Up to Day 180||89
1588622|NCT01067781|3885555|P2|COMPLETED|Up to Day 180||168
1588623|NCT01067781|3885556|P1|COMPLETED|Up to Day 180||173
1588624|NCT01067781|3885553|P4|STARTED|Up to Day 180||101
1588625|NCT01067781|3885554|P3|STARTED|Up to Day 180||97
1588626|NCT01067781|3885555|P2|STARTED|Up to Day 180||199
1588627|NCT01067781|3885556|P1|STARTED|Up to Day 180||203
1588628|NCT01067768|3885566|P2|NOT COMPLETED|Overall Study||0
1588629|NCT01067768|3885567|P1|NOT COMPLETED|Overall Study||0
1588630|NCT01067768|3885566|P2|COMPLETED|Overall Study||605
1588631|NCT01067768|3885567|P1|COMPLETED|Overall Study||604
1588632|NCT01067768|3885566|P2|STARTED|Overall Study||605
1588633|NCT01067768|3885567|P1|STARTED|Overall Study||604
1588634|NCT01067716|3885578|P3|NOT COMPLETED|Overall Study||0
1588635|NCT01067716|3885579|P2|NOT COMPLETED|Overall Study||0
1588636|NCT01067716|3885580|P1|NOT COMPLETED|Overall Study||0
1588637|NCT01067716|3885578|P3|COMPLETED|Overall Study|15 eyes|9
1588638|NCT01067716|3885579|P2|COMPLETED|Overall Study|25 eyes|13
1588639|NCT01067716|3885580|P1|COMPLETED|Overall Study|110 eyes|57
1588640|NCT01067716|3885578|P3|STARTED|Overall Study|15 eyes|9
1588641|NCT01067716|3885579|P2|STARTED|Overall Study|25 eyes|13
1588642|NCT01067716|3885580|P1|STARTED|Overall Study|110 eyes|57
1588643|NCT01067521|3885599|P2|NOT COMPLETED|Open-Label Period||158
1588644|NCT01067521|3885600|P1|NOT COMPLETED|Open-Label Period||254
1588645|NCT01067521|3885599|P2|COMPLETED|Open-Label Period||261
1588646|NCT01067521|3885600|P1|COMPLETED|Open-Label Period||580
1588647|NCT01067521|3885599|P2|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
1588648|NCT01067521|3885600|P1|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
1588649|NCT01067521|3885599|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
1588650|NCT01067521|3885600|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
1588651|NCT01067521|3885599|P2|COMPLETED|Double-Blind Placebo-Controlled Period||430
1588652|NCT01067521|3885600|P1|COMPLETED|Double-Blind Placebo-Controlled Period||859
1588653|NCT01067521|3885599|P2|STARTED|Double-Blind Placebo-Controlled Period||461
1588654|NCT01067521|3885600|P1|STARTED|Double-Blind Placebo-Controlled Period||943
1588655|NCT01067456|3885626|P2|NOT COMPLETED|Overall Study||0
1588656|NCT01067456|3885627|P1|NOT COMPLETED|Overall Study||0
1588657|NCT01067456|3885626|P2|COMPLETED|Overall Study||29
1588658|NCT01067456|3885627|P1|COMPLETED|Overall Study||30
1588659|NCT01067456|3885626|P2|STARTED|Overall Study||29
1588660|NCT01067456|3885627|P1|STARTED|Overall Study||30
1588661|NCT01067352|3885640|P3|NOT COMPLETED|Overall Study||1
1588662|NCT01067352|3885641|P2|NOT COMPLETED|Overall Study||3
1588663|NCT01067352|3885642|P1|NOT COMPLETED|Overall Study||1
1588664|NCT01067352|3885640|P3|COMPLETED|Overall Study||9
1588665|NCT01067352|3885641|P2|COMPLETED|Overall Study||3
1588666|NCT01067352|3885642|P1|COMPLETED|Overall Study||8
1588667|NCT01067352|3885640|P3|STARTED|Overall Study||10
1588668|NCT01067352|3885641|P2|STARTED|Overall Study||6
1588669|NCT01067352|3885642|P1|STARTED|Overall Study||9
1588670|NCT01067339|3885658|P2|NOT COMPLETED|Overall Study||5
1588671|NCT01067339|3885659|P1|NOT COMPLETED|Overall Study||6
1588672|NCT01067339|3885658|P2|COMPLETED|Overall Study||29
1588673|NCT01067339|3885659|P1|COMPLETED|Overall Study||25
1588674|NCT01067339|3885658|P2|STARTED|Overall Study||34
1588675|NCT01067339|3885659|P1|STARTED|Overall Study||31
1588676|NCT01067326|3885669|P2|NOT COMPLETED|Overall Study||3
1588677|NCT01067326|3885670|P1|NOT COMPLETED|Overall Study||2
1588678|NCT01067326|3885669|P2|COMPLETED|Overall Study||5
1588679|NCT01067326|3885670|P1|COMPLETED|Overall Study||12
1588680|NCT01067326|3885669|P2|STARTED|Overall Study||8
1588681|NCT01067326|3885670|P1|STARTED|Overall Study||14
1588682|NCT01067144|3885684|P2|NOT COMPLETED|Follow-up||56
1588683|NCT01067144|3885685|P1|NOT COMPLETED|Follow-up||59
1588684|NCT01067144|3885684|P2|COMPLETED|Follow-up||152
1588685|NCT01067144|3885685|P1|COMPLETED|Follow-up||144
1588686|NCT01067144|3885684|P2|Intention-to-Treat Analysis Set|Follow-up||208
1588687|NCT01067144|3885685|P1|Intention-to-Treat Analysis Set|Follow-up||202
1588688|NCT01067144|3885684|P2|STARTED|Follow-up||208
1588689|NCT01067144|3885685|P1|STARTED|Follow-up||203
1588690|NCT01067144|3885684|P2|NOT COMPLETED|Treatment||7
1588691|NCT01067144|3885685|P1|NOT COMPLETED|Treatment||4
1588692|NCT01067144|3885684|P2|COMPLETED|Treatment||208
1588693|NCT01067144|3885685|P1|COMPLETED|Treatment||203
1588694|NCT01067144|3885684|P2|STARTED|Treatment||215
1588695|NCT01067144|3885685|P1|STARTED|Treatment||207
1588696|NCT01067105|3885701|P1|NOT COMPLETED|Overall Study||141
1588697|NCT01067105|3885701|P1|COMPLETED|Overall Study||683
1588698|NCT01067105|3885701|P1|STARTED|Overall Study||824
1588699|NCT01066923|3885722|P4|NOT COMPLETED|Overall Study||8
1588700|NCT01066923|3885723|P3|NOT COMPLETED|Overall Study||8
1588701|NCT01066923|3885724|P2|NOT COMPLETED|Overall Study||3
1588702|NCT01066923|3885725|P1|NOT COMPLETED|Overall Study||3
1588703|NCT01066923|3885722|P4|COMPLETED|Overall Study||23
1588704|NCT01066923|3885723|P3|COMPLETED|Overall Study||25
1588705|NCT01066923|3885724|P2|COMPLETED|Overall Study||29
1588706|NCT01066923|3885725|P1|COMPLETED|Overall Study||25
1588707|NCT01066923|3885722|P4|Retinal Imaging|Overall Study||0
1588708|NCT01066923|3885723|P3|Retinal Imaging|Overall Study||0
1588709|NCT01066923|3885724|P2|Retinal Imaging|Overall Study||0
1588710|NCT01066923|3885725|P1|Retinal Imaging|Overall Study||0
1588711|NCT01066923|3885722|P4|Activation of Coagulation|Overall Study||0
1588712|NCT01066923|3885723|P3|Activation of Coagulation|Overall Study||0
1588713|NCT01066923|3885724|P2|Activation of Coagulation|Overall Study||0
1588714|NCT01066923|3885725|P1|Activation of Coagulation|Overall Study||0
1588715|NCT01066923|3885722|P4|Vascular Function|Overall Study||13
1588716|NCT01066923|3885723|P3|Vascular Function|Overall Study||12
1588717|NCT01066923|3885724|P2|Vascular Function|Overall Study||14
1588718|NCT01066923|3885725|P1|Vascular Function|Overall Study||13
1588719|NCT01066923|3885722|P4|Platelet Closure Time|Overall Study||23
1588720|NCT01066923|3885723|P3|Platelet Closure Time|Overall Study||25
1588721|NCT01066923|3885724|P2|Platelet Closure Time|Overall Study||29
1588722|NCT01066923|3885725|P1|Platelet Closure Time|Overall Study||25
1588723|NCT01066923|3885722|P4|STARTED|Overall Study||31
1588724|NCT01066923|3885723|P3|STARTED|Overall Study||33
1588725|NCT01066923|3885724|P2|STARTED|Overall Study||32
1588726|NCT01066923|3885725|P1|STARTED|Overall Study||28
1588727|NCT01066897|3885749|P2|NOT COMPLETED|Overall Study||0
1588728|NCT01066897|3885750|P1|NOT COMPLETED|Overall Study||2
1588729|NCT01066897|3885749|P2|COMPLETED|Overall Study||9
1588730|NCT01066897|3885750|P1|COMPLETED|Overall Study||5
1588731|NCT01066897|3885749|P2|STARTED|Overall Study||9
1588732|NCT01066897|3885750|P1|STARTED|Overall Study||7
1588733|NCT01066871|3885764|P4|NOT COMPLETED|Overall Study||5
1588734|NCT01066871|3885765|P3|NOT COMPLETED|Overall Study||6
1588735|NCT01066871|3885766|P2|NOT COMPLETED|Overall Study||5
1588736|NCT01066871|3885767|P1|NOT COMPLETED|Overall Study||4
1588737|NCT01066871|3885764|P4|COMPLETED|Overall Study||13
1588738|NCT01066871|3885765|P3|COMPLETED|Overall Study||12
1588739|NCT01066871|3885766|P2|COMPLETED|Overall Study||13
1588740|NCT01066871|3885767|P1|COMPLETED|Overall Study||16
1588741|NCT01066871|3885764|P4|STARTED|Overall Study||18
1588742|NCT01066871|3885765|P3|STARTED|Overall Study||18
1588743|NCT01066871|3885766|P2|STARTED|Overall Study||18
1588744|NCT01066871|3885767|P1|STARTED|Overall Study||20
1588745|NCT01066819|3885831|P6|NOT COMPLETED|Overall Study||6
1588746|NCT01066819|3885832|P5|NOT COMPLETED|Overall Study||4
1588747|NCT01066819|3885833|P4|NOT COMPLETED|Overall Study||17
1588748|NCT01066819|3885834|P3|NOT COMPLETED|Overall Study||146
1588749|NCT01066819|3885835|P2|NOT COMPLETED|Overall Study||171
1588750|NCT01066819|3885836|P1|NOT COMPLETED|Overall Study||689
1588751|NCT01066819|3885831|P6|COMPLETED|Overall Study||7
1588752|NCT01066819|3885832|P5|COMPLETED|Overall Study||3
1588753|NCT01066819|3885833|P4|COMPLETED|Overall Study||8
1588754|NCT01066819|3885834|P3|COMPLETED|Overall Study||111
1588755|NCT01066819|3885835|P2|COMPLETED|Overall Study||177
1588756|NCT01066819|3885836|P1|COMPLETED|Overall Study||317
1588757|NCT01066819|3885831|P6|STARTED|Overall Study||13
1588758|NCT01066819|3885832|P5|STARTED|Overall Study||7
1588759|NCT01066819|3885833|P4|STARTED|Overall Study||25
1588760|NCT01066819|3885834|P3|STARTED|Overall Study||257
1588761|NCT01066819|3885835|P2|STARTED|Overall Study||348
1588762|NCT01066819|3885836|P1|STARTED|Overall Study||1006
1588763|NCT01066793|3885977|P6|NOT COMPLETED|Overall Study||1
1588764|NCT01066793|3885978|P5|NOT COMPLETED|Overall Study||0
1588765|NCT01066793|3885979|P4|NOT COMPLETED|Overall Study||49
1588766|NCT01066793|3885980|P3|NOT COMPLETED|Overall Study||115
1588767|NCT01066793|3885981|P2|NOT COMPLETED|Overall Study||77
1588768|NCT01066793|3885982|P1|NOT COMPLETED|Overall Study||374
1588769|NCT01066793|3885977|P6|COMPLETED|Overall Study||4
1588770|NCT01066793|3885978|P5|COMPLETED|Overall Study||11
1588771|NCT01066793|3885979|P4|COMPLETED|Overall Study||94
1588772|NCT01066793|3885980|P3|COMPLETED|Overall Study||369
1588773|NCT01066793|3885981|P2|COMPLETED|Overall Study||495
1588774|NCT01066793|3885982|P1|COMPLETED|Overall Study||754
1588775|NCT01066793|3885977|P6|STARTED|Overall Study||5
1588776|NCT01066793|3885978|P5|STARTED|Overall Study||11
1588777|NCT01066793|3885979|P4|STARTED|Overall Study||143
1588778|NCT01066793|3885980|P3|STARTED|Overall Study||484
1588779|NCT01066793|3885981|P2|STARTED|Overall Study||572
1588780|NCT01066793|3885982|P1|STARTED|Overall Study||1128
1588781|NCT01066780|3886122|P2|NOT COMPLETED|Overall Study||1
1588782|NCT01066780|3886123|P1|NOT COMPLETED|Overall Study||1
1588783|NCT01066780|3886122|P2|COMPLETED|Overall Study||23
1588784|NCT01066780|3886123|P1|COMPLETED|Overall Study||23
1588785|NCT01066780|3886122|P2|STARTED|Overall Study||24
1588786|NCT01066780|3886123|P1|STARTED|Overall Study||24
1588787|NCT01066624|3886130|P3|NOT COMPLETED|Overall Study||0
1588788|NCT01066624|3886131|P2|NOT COMPLETED|Overall Study||0
1588789|NCT01066624|3886132|P1|NOT COMPLETED|Overall Study||0
1588790|NCT01066624|3886130|P3|COMPLETED|Overall Study||39
1588791|NCT01066624|3886131|P2|COMPLETED|Overall Study||40
1588792|NCT01066624|3886132|P1|COMPLETED|Overall Study||38
1588793|NCT01066624|3886130|P3|STARTED|Overall Study||39
1588794|NCT01066624|3886131|P2|STARTED|Overall Study||40
1588795|NCT01066624|3886132|P1|STARTED|Overall Study||38
1588796|NCT01066585|3886142|P2|NOT COMPLETED|Overall Study||3
1588797|NCT01066585|3886143|P1|NOT COMPLETED|Overall Study||1
1588798|NCT01066585|3886142|P2|COMPLETED|Overall Study||196
1588799|NCT01066585|3886143|P1|COMPLETED|Overall Study||210
1588800|NCT01066585|3886142|P2|STARTED|Overall Study||199
1588801|NCT01066585|3886143|P1|STARTED|Overall Study||211
1588802|NCT01066546|3886155|P1|NOT COMPLETED|Overall Study||5
1588803|NCT01066546|3886155|P1|COMPLETED|Overall Study||0
1588804|NCT01066546|3886155|P1|STARTED|Overall Study||5
1588805|NCT01066520|3886169|P3|NOT COMPLETED|Overall Study||0
1588806|NCT01066520|3886170|P2|NOT COMPLETED|Overall Study||0
1588807|NCT01066520|3886171|P1|NOT COMPLETED|Overall Study||0
1588808|NCT01066520|3886169|P3|COMPLETED|Overall Study||137
1588809|NCT01066520|3886170|P2|COMPLETED|Overall Study||140
1588810|NCT01066520|3886171|P1|COMPLETED|Overall Study||143
1588811|NCT01066520|3886169|P3|STARTED|Overall Study||137
1588812|NCT01066520|3886170|P2|STARTED|Overall Study||140
1588813|NCT01066520|3886171|P1|STARTED|Overall Study||143
1588814|NCT01066156|3886185|P1|NOT COMPLETED|Overall Study||10
1588815|NCT01066156|3886185|P1|COMPLETED|Overall Study||24
1588816|NCT01066156|3886185|P1|STARTED|Overall Study||34
1588817|NCT01066143|3886189|P1|NOT COMPLETED|Overall Study||8
1588818|NCT01066143|3886189|P1|COMPLETED|Overall Study||0
1588819|NCT01066143|3886189|P1|STARTED|Overall Study||8
1588820|NCT01066104|3886195|P2|NOT COMPLETED|Overall Study||1
1588821|NCT01066104|3886196|P1|NOT COMPLETED|Overall Study||2
1588822|NCT01066104|3886195|P2|COMPLETED|Overall Study||12
1588823|NCT01066104|3886196|P1|COMPLETED|Overall Study||12
1588824|NCT01066104|3886195|P2|STARTED|Overall Study||13
1588825|NCT01066104|3886196|P1|STARTED|Overall Study||14
1588826|NCT01066052|3886206|P2|NOT COMPLETED|Overall Study||0
1588827|NCT01066052|3886207|P1|NOT COMPLETED|Overall Study||3
1588828|NCT01066052|3886206|P2|COMPLETED|Overall Study||51
1588829|NCT01066052|3886207|P1|COMPLETED|Overall Study||61
1588830|NCT01066052|3886206|P2|Treated|Overall Study||0
1588831|NCT01066052|3886207|P1|Treated|Overall Study||61
1588832|NCT01066052|3886206|P2|STARTED|Overall Study||51
1588833|NCT01066052|3886207|P1|STARTED|Overall Study||64
1588834|NCT01066039|3886218|P1|NOT COMPLETED|Overall Study||44
1588835|NCT01066039|3886218|P1|COMPLETED|Overall Study||158
1588836|NCT01066039|3886218|P1|Treated|Overall Study||200
1588837|NCT01066039|3886218|P1|STARTED|Overall Study||202
1588838|NCT01066000|3886231|P1|NOT COMPLETED|Overall Study||9
1588839|NCT01066000|3886231|P1|COMPLETED|Overall Study||24
1588840|NCT01066000|3886231|P1|STARTED|Overall Study||33
1588841|NCT01065844|3886242|P1|NOT COMPLETED|Overall Study||5
1588842|NCT01065844|3886242|P1|COMPLETED|Overall Study||10
1588843|NCT01065844|3886242|P1|STARTED|Overall Study||15
1588844|NCT01065818|3886246|P1|NOT COMPLETED|Overall Study||2
1588845|NCT01065818|3886246|P1|COMPLETED|Overall Study||4
1588846|NCT01065818|3886246|P1|STARTED|Overall Study||6
1588847|NCT01065779|3886250|P1|NOT COMPLETED|Overall Study||82
1588848|NCT01065779|3886250|P1|COMPLETED|Overall Study||798
1588849|NCT01065779|3886250|P1|STARTED|Overall Study||880
1588850|NCT01065766|3886261|P1|NOT COMPLETED|Overall Study||32
1588851|NCT01065766|3886261|P1|COMPLETED|Overall Study||4033
1588852|NCT01065766|3886261|P1|STARTED|Overall Study||4065
1588853|NCT01065714|3886273|P1|NOT COMPLETED|Overall Study||0
1588854|NCT01065714|3886273|P1|COMPLETED|Overall Study||20
1588855|NCT01065714|3886273|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
1588856|NCT01065597|3886280|P1|NOT COMPLETED|Overall Study||1
1588857|NCT01065597|3886280|P1|COMPLETED|Overall Study||12
1588858|NCT01065597|3886280|P1|STARTED|Overall Study||13
1588859|NCT01065558|3886287|P1|NOT COMPLETED|Overall Study||0
1588860|NCT01065558|3886287|P1|COMPLETED|Overall Study||5
1588861|NCT01065558|3886287|P1|STARTED|Overall Study||5
1588862|NCT01065506|3886294|P2|NOT COMPLETED|Overall Study||38
1588863|NCT01065506|3886295|P1|NOT COMPLETED|Overall Study||32
1588864|NCT01065506|3886294|P2|COMPLETED|Overall Study||34
1588865|NCT01065506|3886295|P1|COMPLETED|Overall Study||32
1588866|NCT01065506|3886294|P2|4-Month Follow-Up|Overall Study||34
1588867|NCT01065506|3886295|P1|4-Month Follow-Up|Overall Study||35
1588868|NCT01065506|3886294|P2|End of Treatment|Overall Study||37
1588869|NCT01065506|3886295|P1|End of Treatment|Overall Study||44
1588870|NCT01065506|3886294|P2|STARTED|Overall Study||72
1588871|NCT01065506|3886295|P1|STARTED|Overall Study||64
1588872|NCT01065480|3886303|P2|NOT COMPLETED|Overall Study||0
1588873|NCT01065480|3886304|P1|NOT COMPLETED|Overall Study||0
1588874|NCT01065480|3886303|P2|COMPLETED|Overall Study||43
1588875|NCT01065480|3886304|P1|COMPLETED|Overall Study||48
1588876|NCT01065480|3886303|P2|STARTED|Overall Study||43
1588877|NCT01065480|3886304|P1|STARTED|Overall Study||48
1588878|NCT01065454|3886314|P4|NOT COMPLETED|Follow up||44
1588879|NCT01065454|3886315|P3|NOT COMPLETED|Follow up||17
1588880|NCT01065454|3886316|P2|NOT COMPLETED|Follow up||24
1588881|NCT01065454|3886317|P1|NOT COMPLETED|Follow up||39
1588882|NCT01065454|3886314|P4|COMPLETED|Follow up||13
1588883|NCT01065454|3886315|P3|COMPLETED|Follow up||6
1588884|NCT01065454|3886316|P2|COMPLETED|Follow up||4
1588885|NCT01065454|3886317|P1|COMPLETED|Follow up||15
1588886|NCT01065454|3886314|P4|Entering Follow-up|Follow up||51
1588887|NCT01065454|3886315|P3|Entering Follow-up|Follow up||23
1588888|NCT01065454|3886316|P2|Entering Follow-up|Follow up||27
1588889|NCT01065454|3886317|P1|Entering Follow-up|Follow up||49
1588890|NCT01065454|3886314|P4|STARTED|Follow up||57
1588891|NCT01065454|3886315|P3|STARTED|Follow up||23
1588892|NCT01065454|3886316|P2|STARTED|Follow up||28
1588893|NCT01065454|3886317|P1|STARTED|Follow up||54
1588894|NCT01065454|3886314|P4|NOT COMPLETED|Treatment||12
1588895|NCT01065454|3886315|P3|NOT COMPLETED|Treatment||9
1588896|NCT01065454|3886316|P2|NOT COMPLETED|Treatment||5
1588897|NCT01065454|3886317|P1|NOT COMPLETED|Treatment||13
1588898|NCT01065454|3886314|P4|COMPLETED|Treatment||57
1588899|NCT01065454|3886315|P3|COMPLETED|Treatment||23
1588900|NCT01065454|3886316|P2|COMPLETED|Treatment||28
1588901|NCT01065454|3886317|P1|COMPLETED|Treatment||54
1588902|NCT01065454|3886314|P4|STARTED|Treatment||69
1588903|NCT01065454|3886315|P3|STARTED|Treatment||32
1588904|NCT01065454|3886316|P2|STARTED|Treatment||33
1588905|NCT01065454|3886317|P1|STARTED|Treatment||67
1588906|NCT01065428|3886429|P2|NOT COMPLETED|Overall Study||0
1588907|NCT01065428|3886430|P1|NOT COMPLETED|Overall Study||0
1588908|NCT01065428|3886429|P2|COMPLETED|Overall Study||35
1588909|NCT01065428|3886430|P1|COMPLETED|Overall Study||17
1588910|NCT01065428|3886429|P2|STARTED|Overall Study||35
1588911|NCT01065428|3886430|P1|STARTED|Overall Study||17
1588912|NCT01065350|3886440|P2|NOT COMPLETED|Overall Study||1
1588913|NCT01065350|3886441|P1|NOT COMPLETED|Overall Study||0
1588914|NCT01065350|3886440|P2|COMPLETED|Overall Study||41
1588915|NCT01065350|3886441|P1|COMPLETED|Overall Study||43
1588916|NCT01065350|3886440|P2|STARTED|Overall Study||42
1588917|NCT01065350|3886441|P1|STARTED|Overall Study||43
1588918|NCT01065051|3886475|P2|NOT COMPLETED|Overall Study||0
1588919|NCT01065051|3886476|P1|NOT COMPLETED|Overall Study||0
1588920|NCT01065051|3886475|P2|COMPLETED|Overall Study||0
1588921|NCT01065051|3886476|P1|COMPLETED|Overall Study||1
1588922|NCT01065051|3886475|P2|STARTED|Overall Study||0
1588923|NCT01065051|3886476|P1|STARTED|Overall Study||1
1588924|NCT01064947|3886502|P1|NOT COMPLETED|Overall Study||41
1588925|NCT01064947|3886502|P1|COMPLETED|Overall Study||29
1588926|NCT01064947|3886502|P1|STARTED|Overall Study||70
1588927|NCT01064882|3886513|P3|NOT COMPLETED|Overall Study||2
1588928|NCT01064882|3886514|P2|NOT COMPLETED|Overall Study||2
1588929|NCT01064882|3886515|P1|NOT COMPLETED|Overall Study||2
1588930|NCT01064882|3886513|P3|COMPLETED|Overall Study||32
1588931|NCT01064882|3886514|P2|COMPLETED|Overall Study||32
1588932|NCT01064882|3886515|P1|COMPLETED|Overall Study||34
1588933|NCT01064882|3886513|P3|STARTED|Overall Study||34
1588934|NCT01064882|3886514|P2|STARTED|Overall Study||34
1588935|NCT01064882|3886515|P1|STARTED|Overall Study||36
1588936|NCT01064856|3886543|P4|NOT COMPLETED|Open-label (OL) Period||20
1588937|NCT01064856|3886544|P3|NOT COMPLETED|Open-label (OL) Period||26
1588938|NCT01064856|3886545|P2|NOT COMPLETED|Open-label (OL) Period||0
1588939|NCT01064856|3886546|P1|NOT COMPLETED|Open-label (OL) Period||0
1588940|NCT01064856|3886543|P4|COMPLETED|Open-label (OL) Period||61
1588941|NCT01064856|3886544|P3|COMPLETED|Open-label (OL) Period||56
1588942|NCT01064856|3886545|P2|COMPLETED|Open-label (OL) Period||0
1588943|NCT01064856|3886546|P1|COMPLETED|Open-label (OL) Period||0
1588944|NCT01064856|3886543|P4|STARTED|Open-label (OL) Period||81
1588945|NCT01064856|3886544|P3|STARTED|Open-label (OL) Period||82
1588946|NCT01064856|3886545|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
1588947|NCT01064856|3886546|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
1588948|NCT01064856|3886543|P4|NOT COMPLETED|Double-blind (DB) Period||0
1588949|NCT01064856|3886544|P3|NOT COMPLETED|Double-blind (DB) Period||0
1588950|NCT01064856|3886545|P2|NOT COMPLETED|Double-blind (DB) Period||0
1588951|NCT01064856|3886546|P1|NOT COMPLETED|Double-blind (DB) Period||2
1588952|NCT01064856|3886543|P4|COMPLETED|Double-blind (DB) Period||0
1588953|NCT01064856|3886544|P3|COMPLETED|Double-blind (DB) Period||0
1588954|NCT01064856|3886545|P2|COMPLETED|Double-blind (DB) Period||81
1588955|NCT01064856|3886546|P1|COMPLETED|Double-blind (DB) Period||82
1588956|NCT01064856|3886543|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
1588957|NCT01064856|3886544|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
1588958|NCT01064856|3886545|P2|STARTED|Double-blind (DB) Period||81
1588959|NCT01064856|3886546|P1|STARTED|Double-blind (DB) Period||84
1588960|NCT01064830|3886579|P2|NOT COMPLETED|Overall Study||4
1588961|NCT01064830|3886580|P1|NOT COMPLETED|Overall Study||2
1588962|NCT01064830|3886579|P2|COMPLETED|Overall Study||7
1588963|NCT01064830|3886580|P1|COMPLETED|Overall Study||8
1588964|NCT01064830|3886579|P2|STARTED|Overall Study||11
1588965|NCT01064830|3886580|P1|STARTED|Overall Study||10
1588966|NCT01064817|3886590|P2|NOT COMPLETED|Study Completion||0
1588967|NCT01064817|3886591|P1|NOT COMPLETED|Study Completion||2
1588968|NCT01064817|3886590|P2|COMPLETED|Study Completion||62
1588969|NCT01064817|3886591|P1|COMPLETED|Study Completion||60
1588970|NCT01064817|3886590|P2|STARTED|Study Completion||62
1588971|NCT01064817|3886591|P1|STARTED|Study Completion||62
1588972|NCT01064817|3886590|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
1588973|NCT01064817|3886591|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
1588974|NCT01064817|3886590|P2|COMPLETED|All Study Treatment Days 1-9||62
1588975|NCT01064817|3886591|P1|COMPLETED|All Study Treatment Days 1-9||62
1588976|NCT01064817|3886590|P2|STARTED|All Study Treatment Days 1-9||62
1588977|NCT01064817|3886591|P1|STARTED|All Study Treatment Days 1-9||62
1588978|NCT01064739|3886603|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
1588979|NCT01064739|3886603|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
1588980|NCT01064739|3886603|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
1588981|NCT01064739|3886603|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
1588982|NCT01064739|3886603|P1|COMPLETED|Fixed Sodium Study Diet||14
1588983|NCT01064739|3886603|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
1588984|NCT01064713|3886661|P2|NOT COMPLETED|Overall Study||0
1588985|NCT01064713|3886662|P1|NOT COMPLETED|Overall Study||0
1588986|NCT01064713|3886661|P2|COMPLETED|Overall Study||4
1588987|NCT01064713|3886662|P1|COMPLETED|Overall Study||13
1588988|NCT01064713|3886661|P2|STARTED|Overall Study||4
1588989|NCT01064713|3886662|P1|STARTED|Overall Study||13
1588990|NCT01064687|3886674|P4|NOT COMPLETED|Overall Study||17
1588991|NCT01064687|3886675|P3|NOT COMPLETED|Overall Study||41
1588992|NCT01064687|3886676|P2|NOT COMPLETED|Overall Study||26
1588993|NCT01064687|3886677|P1|NOT COMPLETED|Overall Study||34
1588994|NCT01064687|3886674|P4|COMPLETED|Overall Study||124
1588995|NCT01064687|3886675|P3|COMPLETED|Overall Study||237
1588996|NCT01064687|3886676|P2|COMPLETED|Overall Study||254
1588997|NCT01064687|3886677|P1|COMPLETED|Overall Study||245
1588998|NCT01064687|3886674|P4|Completed 26 Weeks|Overall Study||124
1588999|NCT01064687|3886675|P3|Completed 26 Weeks|Overall Study||252
1589000|NCT01064687|3886676|P2|Completed 26 Weeks|Overall Study||263
1589001|NCT01064687|3886677|P1|Completed 26 Weeks|Overall Study||260
1589002|NCT01064687|3886674|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
1589003|NCT01064687|3886675|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
1589004|NCT01064687|3886676|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
1589005|NCT01064687|3886677|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
1589006|NCT01064687|3886674|P4|STARTED|Overall Study||141
1589007|NCT01064687|3886675|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
1589008|NCT01064687|3886676|P2|STARTED|Overall Study||280
1589009|NCT01064687|3886677|P1|STARTED|Overall Study||279
1589010|NCT01064622|3886857|P2|NOT COMPLETED|Crossover of Arm I||0
1589011|NCT01064622|3886858|P1|NOT COMPLETED|Crossover of Arm I||0
1589012|NCT01064622|3886857|P2|COMPLETED|Crossover of Arm I||0
1589013|NCT01064622|3886858|P1|COMPLETED|Crossover of Arm I||22
1589014|NCT01064622|3886857|P2|STARTED|Crossover of Arm I||0
1589015|NCT01064622|3886858|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
1589016|NCT01064622|3886857|P2|NOT COMPLETED|Randomized Phase II||3
1589017|NCT01064622|3886858|P1|NOT COMPLETED|Randomized Phase II||2
1589018|NCT01064622|3886857|P2|COMPLETED|Randomized Phase II||53
1589019|NCT01064622|3886858|P1|COMPLETED|Randomized Phase II||53
1589020|NCT01064622|3886857|P2|STARTED|Randomized Phase II||56
1589021|NCT01064622|3886858|P1|STARTED|Randomized Phase II||55
1589022|NCT01064622|3886857|P2|NOT COMPLETED|Lead-in Phase I||0
1589023|NCT01064622|3886858|P1|NOT COMPLETED|Lead-in Phase I||0
1589024|NCT01064622|3886857|P2|COMPLETED|Lead-in Phase I||7
1589025|NCT01064622|3886858|P1|COMPLETED|Lead-in Phase I||0
1589026|NCT01064622|3886857|P2|STARTED|Lead-in Phase I||7
1589027|NCT01064622|3886858|P1|STARTED|Lead-in Phase I||0
1589028|NCT01064414|3886882|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
1589029|NCT01064414|3886883|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
1589030|NCT01064414|3886884|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
1589031|NCT01064414|3886882|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
1589032|NCT01064414|3886883|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
1589033|NCT01064414|3886884|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
1589034|NCT01064414|3886882|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
1589035|NCT01064414|3886883|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
1589036|NCT01064414|3886884|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
1589037|NCT01064414|3886882|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
1589038|NCT01064414|3886883|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
1589039|NCT01064414|3886884|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
1589040|NCT01064414|3886882|P3|COMPLETED|Core Period: Baseline to Week 26||82
1589041|NCT01064414|3886883|P2|COMPLETED|Core Period: Baseline to Week 26||75
1589042|NCT01064414|3886884|P1|COMPLETED|Core Period: Baseline to Week 26||77
1589043|NCT01064414|3886882|P3|STARTED|Core Period: Baseline to Week 26||89
1589044|NCT01064414|3886883|P2|STARTED|Core Period: Baseline to Week 26||90
1589045|NCT01064414|3886884|P1|STARTED|Core Period: Baseline to Week 26||90
1589046|NCT01064401|3886903|P2|NOT COMPLETED|Overall Study||195
1589047|NCT01064401|3886904|P1|NOT COMPLETED|Overall Study||228
1589048|NCT01064401|3886903|P2|COMPLETED|Overall Study||724
1589049|NCT01064401|3886904|P1|COMPLETED|Overall Study||694
1589050|NCT01064401|3886903|P2|STARTED|Overall Study||919
1589051|NCT01064401|3886904|P1|STARTED|Overall Study||922
1589052|NCT01064362|3886920|P2|NOT COMPLETED|Overall Study||0
1589053|NCT01064362|3886921|P1|NOT COMPLETED|Overall Study||0
1589054|NCT01064362|3886920|P2|COMPLETED|Overall Study||11883
1589055|NCT01064362|3886921|P1|COMPLETED|Overall Study||1559
1589056|NCT01064362|3886920|P2|STARTED|Overall Study||11883
1589057|NCT01064362|3886921|P1|STARTED|Overall Study||1559
1589058|NCT01064323|3886929|P1|NOT COMPLETED|Overall Study||0
1589059|NCT01064323|3886929|P1|COMPLETED|Overall Study||10
1589060|NCT01064323|3886929|P1|STARTED|Overall Study||10
1589061|NCT01064310|3886953|P3|NOT COMPLETED|Open Label Pazopinib||84
1589062|NCT01064310|3886954|P2|NOT COMPLETED|Open Label Pazopinib||0
1589063|NCT01064310|3886955|P1|NOT COMPLETED|Open Label Pazopinib||0
1589064|NCT01064310|3886953|P3|COMPLETED|Open Label Pazopinib||0
1589065|NCT01064310|3886954|P2|COMPLETED|Open Label Pazopinib||0
1589066|NCT01064310|3886955|P1|COMPLETED|Open Label Pazopinib||0
1589067|NCT01064310|3886953|P3|STARTED|Open Label Pazopinib||84
1589068|NCT01064310|3886954|P2|STARTED|Open Label Pazopinib||0
1589069|NCT01064310|3886955|P1|STARTED|Open Label Pazopinib||0
1589070|NCT01064310|3886953|P3|NOT COMPLETED|Period 2||0
1589071|NCT01064310|3886954|P2|NOT COMPLETED|Period 2||6
1589072|NCT01064310|3886955|P1|NOT COMPLETED|Period 2||4
1589073|NCT01064310|3886953|P3|COMPLETED|Period 2||0
1589074|NCT01064310|3886954|P2|COMPLETED|Period 2||62
1589075|NCT01064310|3886955|P1|COMPLETED|Period 2||64
1589076|NCT01064310|3886953|P3|STARTED|Period 2||0
1589077|NCT01064310|3886954|P2|STARTED|Period 2||68
1589078|NCT01064310|3886955|P1|STARTED|Period 2||68
1589079|NCT01064310|3886953|P3|NOT COMPLETED|Period 1||0
1589080|NCT01064310|3886954|P2|NOT COMPLETED|Period 1||18
1589081|NCT01064310|3886955|P1|NOT COMPLETED|Period 1||14
1589082|NCT01064310|3886953|P3|COMPLETED|Period 1||0
1589083|NCT01064310|3886954|P2|COMPLETED|Period 1||68
1589084|NCT01064310|3886955|P1|COMPLETED|Period 1||68
1589085|NCT01064310|3886953|P3|STARTED|Period 1||0
1589086|NCT01064310|3886954|P2|STARTED|Period 1||86
1589087|NCT01064310|3886955|P1|STARTED|Period 1||82
1589088|NCT01064297|3886985|P3|NOT COMPLETED|Overall Study||133
1589089|NCT01064297|3886986|P2|NOT COMPLETED|Overall Study||48
1589090|NCT01064297|3886987|P1|NOT COMPLETED|Overall Study||791
1589091|NCT01064297|3886985|P3|COMPLETED|Overall Study||497
1589092|NCT01064297|3886986|P2|COMPLETED|Overall Study||171
1589093|NCT01064297|3886987|P1|COMPLETED|Overall Study||1776
1589094|NCT01064297|3886985|P3|STARTED|Overall Study||630
1589095|NCT01064297|3886986|P2|STARTED|Overall Study||219
1589096|NCT01064297|3886987|P1|STARTED|Overall Study||2567
1589097|NCT01064284|3887033|P2|NOT COMPLETED|Overall Study||17
1589098|NCT01064284|3887034|P1|NOT COMPLETED|Overall Study||18
1589099|NCT01064284|3887033|P2|COMPLETED|Overall Study||109
1589100|NCT01064284|3887034|P1|COMPLETED|Overall Study||107
1589101|NCT01064284|3887033|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
1589102|NCT01064284|3887034|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
1589103|NCT01064167|3887056|P2|NOT COMPLETED|Overall Study||15
1589104|NCT01064167|3887057|P1|NOT COMPLETED|Overall Study||14
1589105|NCT01064167|3887056|P2|COMPLETED|Overall Study||115
1589106|NCT01064167|3887057|P1|COMPLETED|Overall Study||116
1589107|NCT01064167|3887056|P2|STARTED|Overall Study||130
1589108|NCT01064167|3887057|P1|STARTED|Overall Study||130
1589109|NCT01064076|3887065|P1|NOT COMPLETED|Overall Study||18
1589110|NCT01064076|3887065|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
1589111|NCT01064076|3887065|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
1589112|NCT01063907|3887070|P2|NOT COMPLETED|Overall Study||0
1589113|NCT01063907|3887071|P1|NOT COMPLETED|Overall Study||0
1589114|NCT01063907|3887070|P2|COMPLETED|Overall Study||80
1589115|NCT01063907|3887071|P1|COMPLETED|Overall Study||15
1589116|NCT01063907|3887070|P2|STARTED|Overall Study||80
1589117|NCT01063907|3887071|P1|STARTED|Overall Study||15
1589118|NCT01063881|3887104|P3|NOT COMPLETED|Overall Study||1
1589119|NCT01063881|3887105|P2|NOT COMPLETED|Overall Study||11
1589120|NCT01063881|3887106|P1|NOT COMPLETED|Overall Study||55
1589121|NCT01063881|3887104|P3|COMPLETED|Overall Study||12
1589122|NCT01063881|3887105|P2|COMPLETED|Overall Study||114
1589123|NCT01063881|3887106|P1|COMPLETED|Overall Study||92
1589124|NCT01063881|3887104|P3|STARTED|Overall Study||13
1589125|NCT01063881|3887105|P2|STARTED|Overall Study||125
1589126|NCT01063881|3887106|P1|STARTED|Overall Study||147
1589127|NCT01063868|3887130|P2|NOT COMPLETED|Overall Study||12
1589128|NCT01063868|3887131|P1|NOT COMPLETED|Overall Study||35
1589129|NCT01063868|3887130|P2|COMPLETED|Overall Study||0
1589130|NCT01063868|3887131|P1|COMPLETED|Overall Study||0
1589131|NCT01063868|3887130|P2|STARTED|Overall Study||12
1589132|NCT01063868|3887131|P1|STARTED|Overall Study||35
1589133|NCT01063855|3887139|P2|NOT COMPLETED|Overall Study||29
1589134|NCT01063855|3887140|P1|NOT COMPLETED|Overall Study||37
1589135|NCT01063855|3887139|P2|COMPLETED|Overall Study||221
1589136|NCT01063855|3887140|P1|COMPLETED|Overall Study||208
1589137|NCT01063855|3887139|P2|STARTED|Overall Study||250
1589138|NCT01063855|3887140|P1|STARTED|Overall Study||245
1589139|NCT01063829|3887166|P4|NOT COMPLETED|Overall Study||21
1589140|NCT01063829|3887167|P3|NOT COMPLETED|Overall Study||10
1589141|NCT01063829|3887168|P2|NOT COMPLETED|Overall Study||10
1589142|NCT01063829|3887169|P1|NOT COMPLETED|Overall Study||16
1589143|NCT01063829|3887166|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
1589144|NCT01063829|3887167|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
1589145|NCT01063829|3887168|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
1589146|NCT01063829|3887169|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
1589147|NCT01063829|3887166|P4|STARTED|Overall Study||33
1589148|NCT01063829|3887167|P3|STARTED|Overall Study||34
1589149|NCT01063829|3887168|P2|STARTED|Overall Study||31
1589150|NCT01063829|3887169|P1|STARTED|Overall Study||33
1589151|NCT01063764|3887187|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
1589152|NCT01063764|3887187|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
1589153|NCT01063764|3887187|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
1589154|NCT01063764|3887187|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
1589155|NCT01063764|3887187|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
1589156|NCT01063764|3887187|P1|STARTED|1st Period (From Week 8 to Week 22)||73
1589157|NCT01063712|3887201|P1|NOT COMPLETED|Overall Study||0
1589158|NCT01063712|3887201|P1|COMPLETED|Overall Study||29
1589159|NCT01063712|3887201|P1|STARTED|Overall Study||29
1589160|NCT01063595|3887206|P2|NOT COMPLETED|Second Intervention||0
1589161|NCT01063595|3887207|P1|NOT COMPLETED|Second Intervention||0
1589162|NCT01063595|3887206|P2|COMPLETED|Second Intervention||24
1589163|NCT01063595|3887207|P1|COMPLETED|Second Intervention||29
1589164|NCT01063595|3887206|P2|STARTED|Second Intervention||24
1589165|NCT01063595|3887207|P1|STARTED|Second Intervention||29
1589166|NCT01063595|3887206|P2|NOT COMPLETED|First Intervention||5
1589167|NCT01063595|3887207|P1|NOT COMPLETED|First Intervention||2
1589168|NCT01063595|3887206|P2|COMPLETED|First Intervention||24
1589169|NCT01063595|3887207|P1|COMPLETED|First Intervention||29
1589170|NCT01063595|3887206|P2|STARTED|First Intervention||29
1589171|NCT01063595|3887207|P1|STARTED|First Intervention||31
1589172|NCT01063595|3887206|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
1589173|NCT01063595|3887207|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
1589174|NCT01063595|3887206|P2|COMPLETED|Enrolled in Study and Randomized||29
1589175|NCT01063595|3887207|P1|COMPLETED|Enrolled in Study and Randomized||31
1589176|NCT01063595|3887206|P2|Received Treatment|Enrolled in Study and Randomized||29
1589177|NCT01063595|3887207|P1|Received Treatment|Enrolled in Study and Randomized||31
1589178|NCT01063595|3887206|P2|STARTED|Enrolled in Study and Randomized||31
1589179|NCT01063595|3887207|P1|STARTED|Enrolled in Study and Randomized||32
1589180|NCT01063517|3887219|P2|NOT COMPLETED|Overall Study||60
1589181|NCT01063517|3887220|P1|NOT COMPLETED|Overall Study||58
1589182|NCT01063517|3887219|P2|COMPLETED|Overall Study||2
1589183|NCT01063517|3887220|P1|COMPLETED|Overall Study||4
1589184|NCT01063517|3887219|P2|Received Randomised Treatment|Overall Study||62
1589185|NCT01063517|3887220|P1|Received Randomised Treatment|Overall Study||61
1589186|NCT01063517|3887219|P2|STARTED|Overall Study||62
1589187|NCT01063517|3887220|P1|STARTED|Overall Study||62
1589188|NCT01063348|3887260|P2|NOT COMPLETED|Overall Study||10
1589189|NCT01063348|3887261|P1|NOT COMPLETED|Overall Study||3
1589190|NCT01063348|3887260|P2|COMPLETED|Overall Study||21
1589191|NCT01063348|3887261|P1|COMPLETED|Overall Study||32
1589192|NCT01063348|3887260|P2|STARTED|Overall Study||31
1589193|NCT01063348|3887261|P1|STARTED|Overall Study||35
1589194|NCT01063153|3887271|P2|NOT COMPLETED|Overall Study||12
1589195|NCT01063153|3887272|P1|NOT COMPLETED|Overall Study||2
1589196|NCT01063153|3887271|P2|COMPLETED|Overall Study||26
1589197|NCT01063153|3887272|P1|COMPLETED|Overall Study||31
1589198|NCT01063153|3887271|P2|STARTED|Overall Study||38
1589199|NCT01063153|3887272|P1|STARTED|Overall Study||33
1589200|NCT01063075|3887282|P4|NOT COMPLETED|Overall Study||1
1589201|NCT01063075|3887283|P3|NOT COMPLETED|Overall Study||5
1589202|NCT01063075|3887284|P2|NOT COMPLETED|Overall Study||2
1589203|NCT01063075|3887285|P1|NOT COMPLETED|Overall Study||1
1589204|NCT01063075|3887282|P4|COMPLETED|Overall Study||14
1589205|NCT01063075|3887283|P3|COMPLETED|Overall Study||9
1589206|NCT01063075|3887284|P2|COMPLETED|Overall Study||1
1589207|NCT01063075|3887285|P1|COMPLETED|Overall Study||1
1589208|NCT01063075|3887282|P4|STARTED|Overall Study||15
1589209|NCT01063075|3887283|P3|STARTED|Overall Study||14
1589210|NCT01063075|3887284|P2|STARTED|Overall Study||3
1589211|NCT01063075|3887285|P1|STARTED|Overall Study||2
1589212|NCT01063062|3887303|P2|NOT COMPLETED|Overall Study||12
1589213|NCT01063062|3887304|P1|NOT COMPLETED|Overall Study||8
1589214|NCT01063062|3887303|P2|COMPLETED|Overall Study||65
1589215|NCT01063062|3887304|P1|COMPLETED|Overall Study||22
1589216|NCT01063062|3887303|P2|Received Study Drug|Overall Study||76
1589217|NCT01063062|3887304|P1|Received Study Drug|Overall Study||29
1589218|NCT01063062|3887303|P2|STARTED|Overall Study||77
1589219|NCT01063062|3887304|P1|STARTED|Overall Study||30
1589220|NCT01063049|3887345|P3|NOT COMPLETED|Overall Study||0
1589221|NCT01063049|3887346|P2|NOT COMPLETED|Overall Study||0
1589222|NCT01063049|3887347|P1|NOT COMPLETED|Overall Study||0
1589223|NCT01063049|3887345|P3|COMPLETED|Overall Study||200
1589224|NCT01063049|3887346|P2|COMPLETED|Overall Study||200
1589225|NCT01063049|3887347|P1|COMPLETED|Overall Study||200
1589226|NCT01063049|3887345|P3|STARTED|Overall Study||200
1589227|NCT01063049|3887346|P2|STARTED|Overall Study||200
1589228|NCT01063049|3887347|P1|STARTED|Overall Study||200
1589229|NCT01063036|3887358|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
1589230|NCT01063036|3887358|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
1589231|NCT01063036|3887358|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
1589232|NCT01063036|3887358|P1|NOT COMPLETED|Participants Treated With Study Drug||6
1589233|NCT01063036|3887358|P1|COMPLETED|Participants Treated With Study Drug||86
1589234|NCT01063036|3887358|P1|STARTED|Participants Treated With Study Drug||92
1589235|NCT01062893|3887374|P2|NOT COMPLETED|Overall Study||13
1589236|NCT01062893|3887375|P1|NOT COMPLETED|Overall Study||14
1589237|NCT01062893|3887374|P2|COMPLETED|Overall Study||28
1589238|NCT01062893|3887375|P1|COMPLETED|Overall Study||27
1589239|NCT01062893|3887374|P2|STARTED|Overall Study||41
1589240|NCT01062893|3887375|P1|STARTED|Overall Study||41
1589241|NCT01062841|3887403|P2|NOT COMPLETED|Overall Study||53
1589242|NCT01062841|3887404|P1|NOT COMPLETED|Overall Study||49
1589243|NCT01062841|3887403|P2|COMPLETED|Overall Study||162
1589244|NCT01062841|3887404|P1|COMPLETED|Overall Study||154
1589245|NCT01062841|3887403|P2|STARTED|Overall Study||215
1589246|NCT01062841|3887404|P1|STARTED|Overall Study||203
1589247|NCT01062763|3887434|P2|NOT COMPLETED|Overall Study||4
1589248|NCT01062763|3887435|P1|NOT COMPLETED|Overall Study||3
1589249|NCT01062763|3887434|P2|COMPLETED|Overall Study||57
1589250|NCT01062763|3887435|P1|COMPLETED|Overall Study||55
1589251|NCT01062763|3887434|P2|STARTED|Overall Study||61
1589252|NCT01062763|3887435|P1|STARTED|Overall Study|119 randomized.|58
1589253|NCT01062425|3887447|P2|NOT COMPLETED|Overall Study||6
1589254|NCT01062425|3887448|P1|NOT COMPLETED|Overall Study||3
1589255|NCT01062425|3887447|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
1589256|NCT01062425|3887448|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
1589257|NCT01062425|3887447|P2|STARTED|Overall Study||103
1589258|NCT01062425|3887448|P1|STARTED|Overall Study||55
1589259|NCT01062399|3887465|P5|NOT COMPLETED|Overall Study||4
1589260|NCT01062399|3887466|P4|NOT COMPLETED|Overall Study||6
1589261|NCT01062399|3887467|P3|NOT COMPLETED|Overall Study||0
1589262|NCT01062399|3887468|P2|NOT COMPLETED|Overall Study||1
1589263|NCT01062399|3887469|P1|NOT COMPLETED|Overall Study||0
1589264|NCT01062399|3887465|P5|COMPLETED|Overall Study||88
1589265|NCT01062399|3887466|P4|COMPLETED|Overall Study||83
1589266|NCT01062399|3887467|P3|COMPLETED|Overall Study||8
1589267|NCT01062399|3887468|P2|COMPLETED|Overall Study||9
1589268|NCT01062399|3887469|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
1589269|NCT01062399|3887465|P5|STARTED|Overall Study||92
1589270|NCT01062399|3887466|P4|STARTED|Overall Study||89
1589271|NCT01062399|3887467|P3|STARTED|Overall Study||8
1589272|NCT01062399|3887468|P2|STARTED|Overall Study||10
1589273|NCT01062399|3887469|P1|STARTED|Overall Study||8
1589274|NCT01062308|3887490|P2|NOT COMPLETED|Overall Study||10
1589275|NCT01062308|3887491|P1|NOT COMPLETED|Overall Study||16
1589276|NCT01062308|3887490|P2|COMPLETED|Overall Study||72
1589277|NCT01062308|3887491|P1|COMPLETED|Overall Study||64
1589278|NCT01062308|3887490|P2|STARTED|Overall Study||82
1589279|NCT01062308|3887491|P1|STARTED|Overall Study||80
1589280|NCT01062269|3887499|P1|NOT COMPLETED|Overall Study||0
1589281|NCT01062269|3887499|P1|COMPLETED|Overall Study||42
1589282|NCT01062269|3887499|P1|STARTED|Overall Study||42
1589283|NCT01062256|3887513|P3|NOT COMPLETED|Overall Study||4
1589284|NCT01062256|3887514|P2|NOT COMPLETED|Overall Study||7
1589285|NCT01062256|3887515|P1|NOT COMPLETED|Overall Study||3
1589286|NCT01062256|3887513|P3|COMPLETED|Overall Study||103
1589287|NCT01062256|3887514|P2|COMPLETED|Overall Study||96
1589288|NCT01062256|3887515|P1|COMPLETED|Overall Study||52
1589289|NCT01062256|3887513|P3|STARTED|Overall Study||107
1589290|NCT01062256|3887514|P2|STARTED|Overall Study||103
1589291|NCT01062256|3887515|P1|STARTED|Overall Study||55
1589292|NCT01062230|3887538|P1|NOT COMPLETED|Overall Study||0
1589293|NCT01062230|3887538|P1|COMPLETED|Overall Study||6
1589294|NCT01062230|3887538|P1|STARTED|Overall Study||6
1589295|NCT01062165|3887542|P1|NOT COMPLETED|Overall Study||0
1589296|NCT01062165|3887542|P1|COMPLETED|Overall Study||18
1589297|NCT01062165|3887542|P1|STARTED|Overall Study||18
1589298|NCT01062113|3887549|P3|NOT COMPLETED|Overall Study||31
1589299|NCT01062113|3887550|P2|NOT COMPLETED|Overall Study||22
1589300|NCT01062113|3887551|P1|NOT COMPLETED|Overall Study||40
1589301|NCT01062113|3887549|P3|COMPLETED|Overall Study||27
1589302|NCT01062113|3887550|P2|COMPLETED|Overall Study||42
1589303|NCT01062113|3887551|P1|COMPLETED|Overall Study||93
1589304|NCT01062113|3887549|P3|STARTED|Overall Study||58
1589305|NCT01062113|3887550|P2|STARTED|Overall Study||64
1589306|NCT01062113|3887551|P1|STARTED|Overall Study||133
1589307|NCT01062074|3887564|P1|NOT COMPLETED|Overall Study||0
1589308|NCT01062074|3887564|P1|COMPLETED|Overall Study||3605
1589309|NCT01062074|3887564|P1|STARTED|Overall Study||3605
1589310|NCT01062061|3887569|P1|NOT COMPLETED|Overall Study||27
1589311|NCT01062061|3887569|P1|COMPLETED|Overall Study||727
1589312|NCT01062061|3887569|P1|STARTED|Overall Study||754
1589313|NCT01061866|3887583|P1|NOT COMPLETED|Overall Study||2
1589314|NCT01061866|3887583|P1|COMPLETED|Overall Study||5
1589315|NCT01061866|3887583|P1|STARTED|Overall Study||7
1589316|NCT01061775|3887587|P1|NOT COMPLETED|Overall Study||3
1589317|NCT01061775|3887587|P1|COMPLETED|Overall Study||16
1589318|NCT01061775|3887587|P1|STARTED|Overall Study||19
1589319|NCT01061736|3887604|P10|NOT COMPLETED|Overall Study||74
1589320|NCT01061736|3887605|P9|NOT COMPLETED|Overall Study||97
1589321|NCT01061736|3887606|P8|NOT COMPLETED|Overall Study||94
1589322|NCT01061736|3887607|P7|NOT COMPLETED|Overall Study||84
1589323|NCT01061736|3887608|P6|NOT COMPLETED|Overall Study||3
1589324|NCT01061736|3887609|P5|NOT COMPLETED|Overall Study||7
1589325|NCT01061736|3887610|P4|NOT COMPLETED|Overall Study||3
1589326|NCT01061736|3887611|P3|NOT COMPLETED|Overall Study||6
1589327|NCT01061736|3887612|P2|NOT COMPLETED|Overall Study||4
1589328|NCT01061736|3887613|P1|NOT COMPLETED|Overall Study||13
1589329|NCT01061736|3887604|P10|COMPLETED|Overall Study||354
1589330|NCT01061736|3887605|P9|COMPLETED|Overall Study||330
1589331|NCT01061736|3887606|P8|COMPLETED|Overall Study||336
1589332|NCT01061736|3887607|P7|COMPLETED|Overall Study||0
1589333|NCT01061736|3887608|P6|COMPLETED|Overall Study||49
1589334|NCT01061736|3887609|P5|COMPLETED|Overall Study||45
1589335|NCT01061736|3887610|P4|COMPLETED|Overall Study||48
1589336|NCT01061736|3887611|P3|COMPLETED|Overall Study||45
1589337|NCT01061736|3887612|P2|COMPLETED|Overall Study||46
1589338|NCT01061736|3887613|P1|COMPLETED|Overall Study||37
1589339|NCT01061736|3887604|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
1589340|NCT01061736|3887605|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
1589341|NCT01061736|3887606|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
1589342|NCT01061736|3887607|P7|Rescued|Overall Study||0
1589343|NCT01061736|3887608|P6|Rescued|Overall Study||0
1589344|NCT01061736|3887609|P5|Rescued|Overall Study||0
1589345|NCT01061736|3887610|P4|Rescued|Overall Study||0
1589346|NCT01061736|3887611|P3|Rescued|Overall Study||0
1589347|NCT01061736|3887612|P2|Rescued|Overall Study||0
1589348|NCT01061736|3887613|P1|Rescued|Overall Study||0
1589349|NCT01061736|3887604|P10|Treated|Overall Study||428
1589350|NCT01061736|3887605|P9|Treated|Overall Study||426
1589351|NCT01061736|3887606|P8|Treated|Overall Study||428
1589352|NCT01061736|3887607|P7|Treated|Overall Study||84
1589353|NCT01061736|3887608|P6|Treated|Overall Study||52
1589354|NCT01061736|3887609|P5|Treated|Overall Study||51
1589355|NCT01061736|3887610|P4|Treated|Overall Study||51
1589356|NCT01061736|3887611|P3|Treated|Overall Study||51
1589357|NCT01061736|3887612|P2|Treated|Overall Study||50
1589358|NCT01061736|3887613|P1|Treated|Overall Study||50
1589359|NCT01061736|3887604|P10|STARTED|Overall Study||428
1589360|NCT01061736|3887605|P9|STARTED|Overall Study||427
1589361|NCT01061736|3887606|P8|STARTED|Overall Study||430
1589362|NCT01061736|3887607|P7|STARTED|Overall Study||84
1589363|NCT01061736|3887608|P6|STARTED|Overall Study||52
1589364|NCT01061736|3887609|P5|STARTED|Overall Study||52
1589365|NCT01061736|3887610|P4|STARTED|Overall Study||51
1589366|NCT01061736|3887611|P3|STARTED|Overall Study||51
1589367|NCT01061736|3887612|P2|STARTED|Overall Study||50
1589368|NCT01061736|3887613|P1|STARTED|Overall Study||50
1589369|NCT01061723|3887652|P6|NOT COMPLETED|Overall Study||9
1589370|NCT01061723|3887653|P5|NOT COMPLETED|Overall Study||3
1589371|NCT01061723|3887654|P4|NOT COMPLETED|Overall Study||8
1589372|NCT01061723|3887655|P3|NOT COMPLETED|Overall Study||10
1589373|NCT01061723|3887656|P2|NOT COMPLETED|Overall Study||6
1589374|NCT01061723|3887657|P1|NOT COMPLETED|Overall Study||4
1589375|NCT01061723|3887652|P6|COMPLETED|Overall Study||41
1589376|NCT01061723|3887653|P5|COMPLETED|Overall Study||47
1589377|NCT01061723|3887654|P4|COMPLETED|Overall Study||44
1589378|NCT01061723|3887655|P3|COMPLETED|Overall Study||40
1589379|NCT01061723|3887656|P2|COMPLETED|Overall Study||43
1589380|NCT01061723|3887657|P1|COMPLETED|Overall Study||46
1589381|NCT01061723|3887652|P6|Treated|Overall Study||49
1589382|NCT01061723|3887653|P5|Treated|Overall Study||50
1589383|NCT01061723|3887654|P4|Treated|Overall Study||52
1589384|NCT01061723|3887655|P3|Treated|Overall Study||50
1589385|NCT01061723|3887656|P2|Treated|Overall Study||49
1589386|NCT01061723|3887657|P1|Treated|Overall Study||50
1589387|NCT01061723|3887652|P6|STARTED|Overall Study||50
1589388|NCT01061723|3887653|P5|STARTED|Overall Study||50
1589389|NCT01061723|3887654|P4|STARTED|Overall Study||52
1589390|NCT01061723|3887655|P3|STARTED|Overall Study||50
1589391|NCT01061723|3887656|P2|STARTED|Overall Study||49
1589392|NCT01061723|3887657|P1|STARTED|Overall Study||50
1589393|NCT01061710|3887737|P1|NOT COMPLETED|Overall Study||14
1589394|NCT01061710|3887737|P1|COMPLETED|Overall Study||6
1589395|NCT01061710|3887737|P1|STARTED|Overall Study||20
1589396|NCT01061671|3887747|P2|NOT COMPLETED|Overall Study||55
1589397|NCT01061671|3887748|P1|NOT COMPLETED|Overall Study||47
1589398|NCT01061671|3887747|P2|COMPLETED|Overall Study||397
1589399|NCT01061671|3887748|P1|COMPLETED|Overall Study||386
1589400|NCT01061671|3887747|P2|STARTED|Overall Study||452
1589401|NCT01061671|3887748|P1|STARTED|Overall Study||433
1589402|NCT01061606|3887760|P1|NOT COMPLETED|Overall Study||8
1589403|NCT01061606|3887760|P1|COMPLETED|Overall Study||0
1589404|NCT01061606|3887760|P1|STARTED|Overall Study||8
1589405|NCT01061567|3887769|P1|NOT COMPLETED|Overall Study||76
1589406|NCT01061567|3887769|P1|COMPLETED|Overall Study||1738
1589407|NCT01061567|3887769|P1|STARTED|Overall Study||1814
1589408|NCT01061528|3887780|P2|NOT COMPLETED|Overall Study||2
1589409|NCT01061528|3887781|P1|NOT COMPLETED|Overall Study||3
1589410|NCT01061528|3887780|P2|COMPLETED|Overall Study||52
1589411|NCT01061528|3887781|P1|COMPLETED|Overall Study||59
1589412|NCT01061528|3887780|P2|STARTED|Overall Study||54
1589413|NCT01061528|3887781|P1|STARTED|Overall Study||62
1589414|NCT01061476|3887787|P1|NOT COMPLETED|Overall Study||0
1589415|NCT01061476|3887787|P1|COMPLETED|Overall Study||12
1589416|NCT01061476|3887787|P1|STARTED|Overall Study||12
1589417|NCT01061385|3887793|P2|NOT COMPLETED|Overall Study||1
1589418|NCT01061385|3887794|P1|NOT COMPLETED|Overall Study||1
1589419|NCT01061385|3887793|P2|COMPLETED|Overall Study||8
1589420|NCT01061385|3887794|P1|COMPLETED|Overall Study||20
1589421|NCT01061385|3887793|P2|STARTED|Overall Study||9
1589422|NCT01061385|3887794|P1|STARTED|Overall Study||21
1589423|NCT01061359|3887802|P1|NOT COMPLETED|Overall Study||1302
1589424|NCT01061359|3887802|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
1589425|NCT01061359|3887802|P1|STARTED|Overall Study||1972
1589426|NCT01061333|3887808|P2|NOT COMPLETED|Period 7: Mometasone||0
1589427|NCT01061333|3887809|P1|NOT COMPLETED|Period 7: Mometasone||0
1589428|NCT01061333|3887808|P2|COMPLETED|Period 7: Mometasone||7
1589429|NCT01061333|3887809|P1|COMPLETED|Period 7: Mometasone||8
1589430|NCT01061333|3887808|P2|STARTED|Period 7: Mometasone||7
1589431|NCT01061333|3887809|P1|STARTED|Period 7: Mometasone||8
1589432|NCT01061333|3887808|P2|NOT COMPLETED|Period 6: 20-day Washout||0
1589433|NCT01061333|3887809|P1|NOT COMPLETED|Period 6: 20-day Washout||0
1589434|NCT01061333|3887808|P2|COMPLETED|Period 6: 20-day Washout||7
1589435|NCT01061333|3887809|P1|COMPLETED|Period 6: 20-day Washout||8
1589436|NCT01061333|3887808|P2|STARTED|Period 6: 20-day Washout||7
1589437|NCT01061333|3887809|P1|STARTED|Period 6: 20-day Washout||8
1589438|NCT01061333|3887808|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
1589439|NCT01061333|3887809|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
1589440|NCT01061333|3887808|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
1589441|NCT01061333|3887809|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
1589442|NCT01061333|3887808|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
1589443|NCT01061333|3887809|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
1589444|NCT01061333|3887808|P2|NOT COMPLETED|Period 4: 20-day Washout||1
1589445|NCT01061333|3887809|P1|NOT COMPLETED|Period 4: 20-day Washout||0
1589446|NCT01061333|3887808|P2|COMPLETED|Period 4: 20-day Washout||7
1589447|NCT01061333|3887809|P1|COMPLETED|Period 4: 20-day Washout||8
1589448|NCT01061333|3887808|P2|STARTED|Period 4: 20-day Washout||8
1589449|NCT01061333|3887809|P1|STARTED|Period 4: 20-day Washout||8
1589450|NCT01061333|3887808|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
1589451|NCT01061333|3887809|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
1589452|NCT01061333|3887808|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
1589453|NCT01061333|3887809|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
1589454|NCT01061333|3887808|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
1589455|NCT01061333|3887809|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
1589456|NCT01061333|3887808|P2|NOT COMPLETED|Period 2: 20-day Washout||0
1589457|NCT01061333|3887809|P1|NOT COMPLETED|Period 2: 20-day Washout||0
1589458|NCT01061333|3887808|P2|COMPLETED|Period 2: 20-day Washout||8
1589459|NCT01061333|3887809|P1|COMPLETED|Period 2: 20-day Washout||8
1589460|NCT01061333|3887808|P2|STARTED|Period 2: 20-day Washout||8
1589461|NCT01061333|3887809|P1|STARTED|Period 2: 20-day Washout||8
1589462|NCT01061333|3887808|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
1589463|NCT01061333|3887809|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
1589464|NCT01061333|3887808|P2|COMPLETED|Period 1: Placebo Run-in||8
1589465|NCT01061333|3887809|P1|COMPLETED|Period 1: Placebo Run-in||8
1589466|NCT01061333|3887808|P2|STARTED|Period 1: Placebo Run-in||8
1589467|NCT01061333|3887809|P1|STARTED|Period 1: Placebo Run-in||8
1589468|NCT01061177|3887847|P1|NOT COMPLETED|Overall Study||208
1589469|NCT01061177|3887847|P1|COMPLETED|Overall Study||881
1589470|NCT01061177|3887847|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
1589471|NCT01061177|3887847|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
1589472|NCT01061177|3887847|P1|STARTED|Overall Study||1089
1589473|NCT01061151|3887870|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
1589474|NCT01061151|3887871|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
1589475|NCT01061151|3887872|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
1589476|NCT01061151|3887873|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
1589477|NCT01061151|3887870|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
1589478|NCT01061151|3887871|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
1589479|NCT01061151|3887872|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
1589480|NCT01061151|3887873|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
1589481|NCT01061151|3887870|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
1589482|NCT01061151|3887871|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
1589483|NCT01061151|3887872|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
1589484|NCT01061151|3887873|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
1589485|NCT01061151|3887870|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
1589486|NCT01061151|3887871|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
1589487|NCT01061151|3887872|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
1589488|NCT01061151|3887873|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
1589489|NCT01061151|3887870|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
1589490|NCT01061151|3887871|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
1589491|NCT01061151|3887872|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
1589492|NCT01061151|3887873|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
1589493|NCT01061151|3887870|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
1589494|NCT01061151|3887871|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
1589495|NCT01061151|3887872|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
1589496|NCT01061151|3887873|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
1589497|NCT01061151|3887870|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
1589498|NCT01061151|3887871|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
1589499|NCT01061151|3887872|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
1589500|NCT01061151|3887873|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
1589501|NCT01061151|3887870|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
1589502|NCT01061151|3887871|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
1589503|NCT01061151|3887872|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
1589504|NCT01061151|3887873|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
1589505|NCT01061034|3887925|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
1589506|NCT01061034|3887925|P1|COMPLETED|Aspirin Plus Omeprazole||9
1589507|NCT01061034|3887925|P1|STARTED|Aspirin Plus Omeprazole||9
1589508|NCT01061034|3887925|P1|NOT COMPLETED|Aspirin||0
1589509|NCT01061034|3887925|P1|COMPLETED|Aspirin||9
1589510|NCT01061034|3887925|P1|STARTED|Aspirin||9
1589511|NCT01061008|3887932|P2|NOT COMPLETED|Overall Study||6
1589512|NCT01061008|3887933|P1|NOT COMPLETED|Overall Study||6
1589513|NCT01061008|3887932|P2|COMPLETED|Overall Study||9
1589514|NCT01061008|3887933|P1|COMPLETED|Overall Study||10
1589515|NCT01061008|3887932|P2|STARTED|Overall Study||15
1589516|NCT01061008|3887933|P1|STARTED|Overall Study||16
1589517|NCT01060670|3887941|P2|NOT COMPLETED|Follow up Phase||35
1589518|NCT01060670|3887942|P1|NOT COMPLETED|Follow up Phase||22
1589519|NCT01060670|3887941|P2|COMPLETED|Follow up Phase||82
1589520|NCT01060670|3887942|P1|COMPLETED|Follow up Phase||106
1589521|NCT01060670|3887941|P2|Withdrew From Follow up Phase|Follow up Phase||35
1589522|NCT01060670|3887942|P1|Withdrew From Follow up Phase|Follow up Phase||22
1589523|NCT01060670|3887941|P2|Recurrence|Follow up Phase||9
1589524|NCT01060670|3887942|P1|Recurrence|Follow up Phase||14
1589525|NCT01060670|3887941|P2|STARTED|Follow up Phase||117
1589526|NCT01060670|3887942|P1|STARTED|Follow up Phase||128
1589527|NCT01060670|3887941|P2|NOT COMPLETED|Treatment Phase||36
1589528|NCT01060670|3887942|P1|NOT COMPLETED|Treatment Phase||26
1589529|NCT01060670|3887941|P2|COMPLETED|Treatment Phase||117
1589530|NCT01060670|3887942|P1|COMPLETED|Treatment Phase||128
1589531|NCT01060670|3887941|P2|Withdrew From Treatment|Treatment Phase||36
1589532|NCT01060670|3887942|P1|Withdrew From Treatment|Treatment Phase||26
1589533|NCT01060670|3887941|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
1589534|NCT01060670|3887942|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
1589535|NCT01060670|3887941|P2|Healed at End of Treatment Phase|Treatment Phase||49
1589536|NCT01060670|3887942|P1|Healed at End of Treatment Phase|Treatment Phase||79
1589537|NCT01060670|3887941|P2|STARTED|Treatment Phase||153
1589538|NCT01060670|3887942|P1|STARTED|Treatment Phase||154
1589539|NCT01060670|3887941|P2|NOT COMPLETED|Run In||238
1589540|NCT01060670|3887942|P1|NOT COMPLETED|Run In||0
1589541|NCT01060670|3887941|P2|COMPLETED|Run In||307
1589542|NCT01060670|3887942|P1|COMPLETED|Run In||0
1589543|NCT01060670|3887941|P2|STARTED|Run In||545
1589544|NCT01060670|3887942|P1|STARTED|Run In||0
1589545|NCT01060592|3887962|P2|NOT COMPLETED|12m||18
1589546|NCT01060592|3887963|P1|NOT COMPLETED|12m||0
1589547|NCT01060592|3887962|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
1589548|NCT01060592|3887963|P1|COMPLETED|12m||35
1589549|NCT01060592|3887962|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
1589550|NCT01060592|3887963|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
1589551|NCT01060592|3887962|P2|NOT COMPLETED|4-6w||10
1589552|NCT01060592|3887963|P1|NOT COMPLETED|4-6w||12
1589553|NCT01060592|3887962|P2|COMPLETED|4-6w||39
1589554|NCT01060592|3887963|P1|COMPLETED|4-6w||23
1589555|NCT01060592|3887962|P2|STARTED|4-6w||49
1589556|NCT01060592|3887963|P1|STARTED|4-6w||35
1589557|NCT01060553|3887977|P2|NOT COMPLETED|Overall Study||10
1589558|NCT01060553|3887978|P1|NOT COMPLETED|Overall Study||9
1589559|NCT01060553|3887977|P2|COMPLETED|Overall Study||5
1589560|NCT01060553|3887978|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
1589561|NCT01060553|3887977|P2|STARTED|Overall Study||15
1589562|NCT01060553|3887978|P1|STARTED|Overall Study||15
1589563|NCT01060540|3887985|P2|NOT COMPLETED|Overall Study||65
1589564|NCT01060540|3887986|P1|NOT COMPLETED|Overall Study||64
1589565|NCT01060540|3887985|P2|COMPLETED|Overall Study||233
1589566|NCT01060540|3887986|P1|COMPLETED|Overall Study||239
1589567|NCT01060540|3887985|P2|STARTED|Overall Study||298
1589568|NCT01060540|3887986|P1|STARTED|Overall Study||303
1589569|NCT01060384|3888000|P5|NOT COMPLETED|Overall Study||2
1589570|NCT01060384|3888001|P4|NOT COMPLETED|Overall Study||0
1589571|NCT01060384|3888002|P3|NOT COMPLETED|Overall Study||0
1589572|NCT01060384|3888003|P2|NOT COMPLETED|Overall Study||1
1589573|NCT01060384|3888004|P1|NOT COMPLETED|Overall Study||0
1589574|NCT01060384|3888000|P5|COMPLETED|Overall Study||34
1589575|NCT01060384|3888001|P4|COMPLETED|Overall Study||0
1589576|NCT01060384|3888002|P3|COMPLETED|Overall Study||0
1589577|NCT01060384|3888003|P2|COMPLETED|Overall Study||3
1589578|NCT01060384|3888004|P1|COMPLETED|Overall Study||6
1589579|NCT01060384|3888000|P5|STARTED|Overall Study||36
1589580|NCT01060384|3888001|P4|STARTED|Overall Study||0
1589581|NCT01060384|3888002|P3|STARTED|Overall Study||0
1589582|NCT01060384|3888003|P2|STARTED|Overall Study||4
1589583|NCT01060384|3888004|P1|STARTED|Overall Study||6
1589584|NCT01060150|3888013|P1|NOT COMPLETED|Overall Study||23
1589585|NCT01060150|3888013|P1|COMPLETED|Overall Study||92
1589586|NCT01060150|3888013|P1|Treated|Overall Study||113
1589587|NCT01060150|3888013|P1|STARTED|Overall Study||115
1589588|NCT01060124|3888028|P1|NOT COMPLETED|Overall Study||37
1589589|NCT01060124|3888028|P1|COMPLETED|Overall Study||66
1589590|NCT01060124|3888028|P1|STARTED|Overall Study||103
1589591|NCT01060111|3888039|P3|NOT COMPLETED|Overall Study||35
1589592|NCT01060111|3888040|P2|NOT COMPLETED|Overall Study||23
1589593|NCT01060111|3888041|P1|NOT COMPLETED|Overall Study||27
1589594|NCT01060111|3888039|P3|COMPLETED|Overall Study||45
1589595|NCT01060111|3888040|P2|COMPLETED|Overall Study||61
1589596|NCT01060111|3888041|P1|COMPLETED|Overall Study||54
1589597|NCT01060111|3888039|P3|Treated|Overall Study||79
1589598|NCT01060111|3888040|P2|Treated|Overall Study||83
1589599|NCT01060111|3888041|P1|Treated|Overall Study||81
1589600|NCT01060111|3888039|P3|STARTED|Overall Study||80
1589601|NCT01060111|3888040|P2|STARTED|Overall Study||84
1589602|NCT01060111|3888041|P1|STARTED|Overall Study||81
1589603|NCT01060072|3888060|P2|NOT COMPLETED|Overall Study||5
1589604|NCT01060072|3888061|P1|NOT COMPLETED|Overall Study||2
1589605|NCT01060072|3888060|P2|COMPLETED|Overall Study||196
1589606|NCT01060072|3888061|P1|COMPLETED|Overall Study||204
1589607|NCT01060072|3888060|P2|STARTED|Overall Study||201
1589608|NCT01060072|3888061|P1|STARTED|Overall Study||206
1589609|NCT01060059|3888077|P2|NOT COMPLETED|Overall Study||67
1589610|NCT01060059|3888078|P1|NOT COMPLETED|Overall Study||67
1589611|NCT01060059|3888077|P2|COMPLETED|Overall Study||371
1589612|NCT01060059|3888078|P1|COMPLETED|Overall Study||377
1589613|NCT01060059|3888077|P2|STARTED|Overall Study||438
1589614|NCT01060059|3888078|P1|STARTED|Overall Study||444
1589615|NCT01060020|3888128|P1|NOT COMPLETED|Overall Study||0
1589616|NCT01060020|3888128|P1|COMPLETED|Overall Study||20
1589617|NCT01060020|3888128|P1|STARTED|Overall Study||20
1589618|NCT01060007|3888136|P1|NOT COMPLETED|Overall Study||4
1589619|NCT01060007|3888136|P1|COMPLETED|Overall Study||76
1589620|NCT01060007|3888136|P1|STARTED|Overall Study||80
1589621|NCT01059994|3888154|P4|NOT COMPLETED|Overall Study||1
1589622|NCT01059994|3888155|P3|NOT COMPLETED|Overall Study||0
1589623|NCT01059994|3888156|P2|NOT COMPLETED|Overall Study||0
1589624|NCT01059994|3888157|P1|NOT COMPLETED|Overall Study||0
1589625|NCT01059994|3888154|P4|COMPLETED|Overall Study||3
1589626|NCT01059994|3888155|P3|COMPLETED|Overall Study||3
1589627|NCT01059994|3888156|P2|COMPLETED|Overall Study||2
1589628|NCT01059994|3888157|P1|COMPLETED|Overall Study||3
1589629|NCT01059994|3888154|P4|STARTED|Overall Study||4
1589630|NCT01059994|3888155|P3|STARTED|Overall Study||3
1589631|NCT01059994|3888156|P2|STARTED|Overall Study||2
1589632|NCT01059994|3888157|P1|STARTED|Overall Study||3
1589633|NCT01059929|3888173|P2|NOT COMPLETED|Overall Study||0
1589634|NCT01059929|3888174|P1|NOT COMPLETED|Overall Study||0
1589635|NCT01059929|3888173|P2|COMPLETED|Overall Study||21
1589636|NCT01059929|3888174|P1|COMPLETED|Overall Study||20
1589637|NCT01059929|3888173|P2|STARTED|Overall Study||21
1589638|NCT01059929|3888174|P1|STARTED|Overall Study||20
1589639|NCT01059903|3888204|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
1589640|NCT01059903|3888205|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
1589641|NCT01059903|3888204|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
1589642|NCT01059903|3888205|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
1589643|NCT01059903|3888204|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
1589644|NCT01059903|3888205|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
1589645|NCT01059903|3888204|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
1589646|NCT01059903|3888205|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
1589647|NCT01059903|3888204|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
1589648|NCT01059903|3888205|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
1589649|NCT01059903|3888204|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
1589650|NCT01059903|3888205|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
1589651|NCT01059903|3888204|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
1589652|NCT01059903|3888205|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
1589653|NCT01059903|3888204|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
1589654|NCT01059903|3888205|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
1589655|NCT01059903|3888204|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
1589656|NCT01059903|3888205|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
1589657|NCT01059903|3888204|P2|STARTED|Period 1: First Intervention- 24 Hours||25
1589658|NCT01059903|3888205|P1|STARTED|Period 1: First Intervention- 24 Hours||25
1589659|NCT01059877|3888241|P2|NOT COMPLETED|Overall Study||2
1589660|NCT01059877|3888242|P1|NOT COMPLETED|Overall Study||0
1589661|NCT01059877|3888241|P2|COMPLETED|Overall Study||3
1589662|NCT01059877|3888242|P1|COMPLETED|Overall Study||6
1589663|NCT01059877|3888241|P2|STARTED|Overall Study||5
1589664|NCT01059877|3888242|P1|STARTED|Overall Study||6
1589665|NCT01059864|3888248|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
1589666|NCT01059864|3888249|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
1589667|NCT01059864|3888250|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
1589668|NCT01059864|3888248|P3|COMPLETED|Double-Blind Treatment Phase||45
1589669|NCT01059864|3888249|P2|COMPLETED|Double-Blind Treatment Phase||47
1589670|NCT01059864|3888250|P1|COMPLETED|Double-Blind Treatment Phase||0
1589671|NCT01059864|3888248|P3|Treated|Double-Blind Treatment Phase||47
1589672|NCT01059864|3888249|P2|Treated|Double-Blind Treatment Phase||50
1589673|NCT01059864|3888250|P1|Treated|Double-Blind Treatment Phase||0
1589674|NCT01059864|3888248|P3|STARTED|Double-Blind Treatment Phase||48
1589675|NCT01059864|3888249|P2|STARTED|Double-Blind Treatment Phase||50
1589676|NCT01059864|3888250|P1|STARTED|Double-Blind Treatment Phase||0
1589677|NCT01059864|3888248|P3|NOT COMPLETED|Open-Label Run-In Phase||0
1589678|NCT01059864|3888249|P2|NOT COMPLETED|Open-Label Run-In Phase||0
1589679|NCT01059864|3888250|P1|NOT COMPLETED|Open-Label Run-In Phase||13
1589680|NCT01059864|3888248|P3|COMPLETED|Open-Label Run-In Phase||0
1589681|NCT01059864|3888249|P2|COMPLETED|Open-Label Run-In Phase||0
1589682|NCT01059864|3888250|P1|COMPLETED|Open-Label Run-In Phase||98
1589683|NCT01059864|3888248|P3|STARTED|Open-Label Run-In Phase||0
1589684|NCT01059864|3888249|P2|STARTED|Open-Label Run-In Phase||0
1589685|NCT01059864|3888250|P1|STARTED|Open-Label Run-In Phase||111
1589686|NCT01059851|3888299|P6|NOT COMPLETED|Overall Study||0
1589687|NCT01059851|3888300|P5|NOT COMPLETED|Overall Study||0
1589688|NCT01059851|3888301|P4|NOT COMPLETED|Overall Study||0
1589689|NCT01059851|3888302|P3|NOT COMPLETED|Overall Study||0
1589690|NCT01059851|3888303|P2|NOT COMPLETED|Overall Study||0
1589691|NCT01059851|3888304|P1|NOT COMPLETED|Overall Study||0
1589692|NCT01059851|3888299|P6|COMPLETED|Overall Study||0
1589693|NCT01059851|3888300|P5|COMPLETED|Overall Study||0
1589694|NCT01059851|3888301|P4|COMPLETED|Overall Study||0
1589695|NCT01059851|3888302|P3|COMPLETED|Overall Study||0
1589696|NCT01059851|3888303|P2|COMPLETED|Overall Study||8
1589697|NCT01059851|3888304|P1|COMPLETED|Overall Study||8
1589698|NCT01059851|3888299|P6|STARTED|Overall Study||0
1589699|NCT01059851|3888300|P5|STARTED|Overall Study||0
1589700|NCT01059851|3888301|P4|STARTED|Overall Study||0
1589701|NCT01059851|3888302|P3|STARTED|Overall Study||0
1589702|NCT01059851|3888303|P2|STARTED|Overall Study||8
1589703|NCT01059851|3888304|P1|STARTED|Overall Study||8
1589704|NCT01059825|3888324|P7|NOT COMPLETED|Treatment Period||0
1589705|NCT01059825|3888325|P6|NOT COMPLETED|Treatment Period||3
1589706|NCT01059825|3888326|P5|NOT COMPLETED|Treatment Period||8
1589707|NCT01059825|3888327|P4|NOT COMPLETED|Treatment Period||11
1589708|NCT01059825|3888328|P3|NOT COMPLETED|Treatment Period||6
1589709|NCT01059825|3888329|P2|NOT COMPLETED|Treatment Period||4
1589710|NCT01059825|3888330|P1|NOT COMPLETED|Treatment Period||10
1589711|NCT01059825|3888324|P7|COMPLETED|Treatment Period||0
1589712|NCT01059825|3888325|P6|COMPLETED|Treatment Period||52
1589713|NCT01059825|3888326|P5|COMPLETED|Treatment Period||47
1589714|NCT01059825|3888327|P4|COMPLETED|Treatment Period||44
1589715|NCT01059825|3888328|P3|COMPLETED|Treatment Period||49
1589716|NCT01059825|3888329|P2|COMPLETED|Treatment Period||50
1589717|NCT01059825|3888330|P1|COMPLETED|Treatment Period||44
1589718|NCT01059825|3888324|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
1589719|NCT01059825|3888325|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1589720|NCT01059825|3888326|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1589721|NCT01059825|3888327|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1589722|NCT01059825|3888328|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1589723|NCT01059825|3888329|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
1589724|NCT01059825|3888330|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
1589725|NCT01059825|3888324|P7|NOT COMPLETED|Enrolled, Run-in Period||47
1589726|NCT01059825|3888325|P6|NOT COMPLETED|Enrolled, Run-in Period||0
1589727|NCT01059825|3888326|P5|NOT COMPLETED|Enrolled, Run-in Period||0
1589728|NCT01059825|3888327|P4|NOT COMPLETED|Enrolled, Run-in Period||0
1589729|NCT01059825|3888328|P3|NOT COMPLETED|Enrolled, Run-in Period||0
1589730|NCT01059825|3888329|P2|NOT COMPLETED|Enrolled, Run-in Period||0
1589731|NCT01059825|3888330|P1|NOT COMPLETED|Enrolled, Run-in Period||0
1589732|NCT01059825|3888324|P7|COMPLETED|Enrolled, Run-in Period||328
1589733|NCT01059825|3888325|P6|COMPLETED|Enrolled, Run-in Period||0
1589734|NCT01059825|3888326|P5|COMPLETED|Enrolled, Run-in Period||0
1589735|NCT01059825|3888327|P4|COMPLETED|Enrolled, Run-in Period||0
1589736|NCT01059825|3888328|P3|COMPLETED|Enrolled, Run-in Period||0
1589737|NCT01059825|3888329|P2|COMPLETED|Enrolled, Run-in Period||0
1589738|NCT01059825|3888330|P1|COMPLETED|Enrolled, Run-in Period||0
1589739|NCT01059825|3888324|P7|STARTED|Enrolled, Run-in Period||375
1589740|NCT01059825|3888325|P6|STARTED|Enrolled, Run-in Period||0
1589741|NCT01059825|3888326|P5|STARTED|Enrolled, Run-in Period||0
1589742|NCT01059825|3888327|P4|STARTED|Enrolled, Run-in Period||0
1589743|NCT01059825|3888328|P3|STARTED|Enrolled, Run-in Period||0
1589744|NCT01059825|3888329|P2|STARTED|Enrolled, Run-in Period||0
1589745|NCT01059825|3888330|P1|STARTED|Enrolled, Run-in Period||0
1589746|NCT01059812|3888517|P2|NOT COMPLETED|Overall Study||16
1589747|NCT01059812|3888518|P1|NOT COMPLETED|Overall Study||37
1589748|NCT01059812|3888517|P2|COMPLETED|Overall Study||126
1589749|NCT01059812|3888518|P1|COMPLETED|Overall Study||245
1589750|NCT01059812|3888517|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
1589751|NCT01059812|3888518|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
1589752|NCT01059812|3888517|P2|STARTED|Overall Study||142
1589753|NCT01059812|3888518|P1|STARTED|Overall Study||282
1589754|NCT01059799|3888534|P2|NOT COMPLETED|Overall Study||10
1589755|NCT01059799|3888535|P1|NOT COMPLETED|Overall Study||31
1589756|NCT01059799|3888534|P2|COMPLETED|Overall Study||136
1589757|NCT01059799|3888535|P1|COMPLETED|Overall Study||258
1589758|NCT01059799|3888534|P2|Exposed|Overall Study||146
1589759|NCT01059799|3888535|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
1589760|NCT01059799|3888534|P2|STARTED|Overall Study||146
1589761|NCT01059799|3888535|P1|STARTED|Overall Study||289
1589762|NCT01059773|3888549|P2|NOT COMPLETED|Overall Study||24
1589763|NCT01059773|3888550|P1|NOT COMPLETED|Overall Study||20
1589764|NCT01059773|3888549|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
1589765|NCT01059773|3888550|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
1589766|NCT01059773|3888549|P2|STARTED|Overall Study||245
1589767|NCT01059773|3888550|P1|STARTED|Overall Study||244
1589768|NCT01059760|3888582|P2|NOT COMPLETED|Overall Study||0
1589769|NCT01059760|3888583|P1|NOT COMPLETED|Overall Study||0
1589770|NCT01059760|3888582|P2|COMPLETED|Overall Study||14
1589771|NCT01059760|3888583|P1|COMPLETED|Overall Study||16
1589772|NCT01059760|3888582|P2|STARTED|Overall Study||14
1589773|NCT01059760|3888583|P1|STARTED|Overall Study||16
1589774|NCT01059643|3888689|P1|NOT COMPLETED|Overall Study||6
1589775|NCT01059643|3888689|P1|COMPLETED|Overall Study||97
1589776|NCT01059643|3888689|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
1589777|NCT01059643|3888689|P1|STARTED|Overall Study||103
1589778|NCT01059630|3888704|P2|NOT COMPLETED|Maintenance Period (up to 2 Years)||108
1589779|NCT01059630|3888705|P1|NOT COMPLETED|Maintenance Period (up to 2 Years)||0
1589780|NCT01059630|3888704|P2|COMPLETED|Maintenance Period (up to 2 Years)||35
1589781|NCT01059630|3888705|P1|COMPLETED|Maintenance Period (up to 2 Years)||0
1589782|NCT01059630|3888704|P2|STARTED|Maintenance Period (up to 2 Years)|Of all participants who completed induction, 13 participants did not start maintenance.|143
1589783|NCT01059630|3888705|P1|STARTED|Maintenance Period (up to 2 Years)|Maintenance was not planned for this arm.|0
1589784|NCT01059630|3888704|P2|NOT COMPLETED|Induction Period (6 Months)||38
1589785|NCT01059630|3888705|P1|NOT COMPLETED|Induction Period (6 Months)||73
1589786|NCT01059630|3888704|P2|COMPLETED|Induction Period (6 Months)||156
1589787|NCT01059630|3888705|P1|COMPLETED|Induction Period (6 Months)||129
1589788|NCT01059630|3888704|P2|Treated|Induction Period (6 Months)||194
1589789|NCT01059630|3888705|P1|Treated|Induction Period (6 Months)||198
1589790|NCT01059630|3888704|P2|STARTED|Induction Period (6 Months)||194
1589791|NCT01059630|3888705|P1|STARTED|Induction Period (6 Months)||202
1589792|NCT01059617|3888765|P4|NOT COMPLETED|Overall Study||6
1589793|NCT01059617|3888766|P3|NOT COMPLETED|Overall Study||8
1589794|NCT01059617|3888767|P2|NOT COMPLETED|Overall Study||1
1589795|NCT01059617|3888768|P1|NOT COMPLETED|Overall Study||7
1589796|NCT01059617|3888765|P4|COMPLETED|Overall Study||27
1589797|NCT01059617|3888766|P3|COMPLETED|Overall Study||25
1589798|NCT01059617|3888767|P2|COMPLETED|Overall Study||33
1589799|NCT01059617|3888768|P1|COMPLETED|Overall Study||26
1589800|NCT01059617|3888765|P4|STARTED|Overall Study||33
1589801|NCT01059617|3888766|P3|STARTED|Overall Study||33
1589802|NCT01059617|3888767|P2|STARTED|Overall Study||34
1589803|NCT01059617|3888768|P1|STARTED|Overall Study||33
1589804|NCT01059565|3888938|P2|NOT COMPLETED|24-Week Open-Label Phase||3
1589805|NCT01059565|3888939|P1|NOT COMPLETED|24-Week Open-Label Phase||5
1589806|NCT01059565|3888938|P2|COMPLETED|24-Week Open-Label Phase||42
1589807|NCT01059565|3888939|P1|COMPLETED|24-Week Open-Label Phase||34
1589808|NCT01059565|3888938|P2|STARTED|24-Week Open-Label Phase||45
1589809|NCT01059565|3888939|P1|STARTED|24-Week Open-Label Phase||39
1589810|NCT01059565|3888938|P2|NOT COMPLETED|24-Week Randomized Phase||7
1589811|NCT01059565|3888939|P1|NOT COMPLETED|24-Week Randomized Phase||10
1589812|NCT01059565|3888938|P2|COMPLETED|24-Week Randomized Phase||45
1589813|NCT01059565|3888939|P1|COMPLETED|24-Week Randomized Phase||39
1589814|NCT01059565|3888938|P2|Randomized and Treated|24-Week Randomized Phase||52
1589815|NCT01059565|3888939|P1|Randomized and Treated|24-Week Randomized Phase||48
1589816|NCT01059565|3888938|P2|STARTED|24-Week Randomized Phase||52
1589817|NCT01059565|3888939|P1|STARTED|24-Week Randomized Phase||49
1589818|NCT01059526|3888975|P2|NOT COMPLETED|Overall Study||22
1589819|NCT01059526|3888976|P1|NOT COMPLETED|Overall Study||30
1589820|NCT01059526|3888975|P2|COMPLETED|Overall Study||18
1589821|NCT01059526|3888976|P1|COMPLETED|Overall Study||11
1589822|NCT01059526|3888975|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
1589823|NCT01059526|3888976|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
1589824|NCT01059526|3888975|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
1589825|NCT01059526|3888976|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
1589826|NCT01059357|3888984|P1|NOT COMPLETED|Overall Study||4
1589827|NCT01059357|3888984|P1|COMPLETED|Overall Study||54
1589828|NCT01059357|3888984|P1|STARTED|Overall Study||58
1589829|NCT01059344|3888995|P2|NOT COMPLETED|Overall Study||46
1589830|NCT01059344|3888996|P1|NOT COMPLETED|Overall Study||22
1589831|NCT01059344|3888995|P2|COMPLETED|Overall Study||95
1589832|NCT01059344|3888996|P1|COMPLETED|Overall Study||118
1589833|NCT01059344|3888995|P2|STARTED|Overall Study||141
1589834|NCT01059344|3888996|P1|STARTED|Overall Study||140
1589835|NCT01059305|3889014|P1|NOT COMPLETED|Overall Study||0
1589836|NCT01059305|3889014|P1|COMPLETED|Overall Study||10
1589837|NCT01059305|3889014|P1|STARTED|Overall Study||10
1589838|NCT01059175|3889020|P2|NOT COMPLETED|Overall Study||20
1589839|NCT01059175|3889021|P1|NOT COMPLETED|Overall Study||21
1589840|NCT01059175|3889020|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
1589841|NCT01059175|3889021|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
1589842|NCT01059175|3889020|P2|STARTED|Overall Study||41
1589843|NCT01059175|3889021|P1|STARTED|Overall Study||43
1589844|NCT01059071|3889043|P4|NOT COMPLETED|Overall Study||6
1589845|NCT01059071|3889044|P3|NOT COMPLETED|Overall Study||2
1589846|NCT01059071|3889045|P2|NOT COMPLETED|Overall Study||4
1589847|NCT01059071|3889046|P1|NOT COMPLETED|Overall Study||2
1589848|NCT01059071|3889043|P4|COMPLETED|Overall Study||3
1589849|NCT01059071|3889044|P3|COMPLETED|Overall Study||1
1589850|NCT01059071|3889045|P2|COMPLETED|Overall Study||1
1589851|NCT01059071|3889046|P1|COMPLETED|Overall Study||2
1589852|NCT01059071|3889043|P4|STARTED|Overall Study||9
1589853|NCT01059071|3889044|P3|STARTED|Overall Study||3
1589854|NCT01059071|3889045|P2|STARTED|Overall Study||5
1589855|NCT01059071|3889046|P1|STARTED|Overall Study||4
1589856|NCT01058993|3889058|P1|NOT COMPLETED|Overall Study||0
1589857|NCT01058993|3889058|P1|COMPLETED|Overall Study||6
1589858|NCT01058993|3889058|P1|STARTED|Overall Study||6
1589859|NCT01058941|3889064|P2|NOT COMPLETED|Overall Study||11
1589860|NCT01058941|3889065|P1|NOT COMPLETED|Overall Study||9
1589861|NCT01058941|3889064|P2|COMPLETED|Overall Study||22
1589862|NCT01058941|3889065|P1|COMPLETED|Overall Study||25
1589863|NCT01058941|3889064|P2|STARTED|Overall Study||33
1589864|NCT01058941|3889065|P1|STARTED|Overall Study||34
1589865|NCT01058863|3889073|P1|NOT COMPLETED|Overall Study||4
1589866|NCT01058863|3889073|P1|COMPLETED|Overall Study||68
1589867|NCT01058863|3889073|P1|Treated With Placebo Inhaler|Overall Study||69
1589868|NCT01058863|3889073|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
1589869|NCT01058863|3889073|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
1589870|NCT01058863|3889073|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
1589871|NCT01058863|3889073|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
1589872|NCT01058863|3889073|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
1589873|NCT01058863|3889073|P1|STARTED|Overall Study||72
1589874|NCT01058668|3889094|P3|NOT COMPLETED|Safety Follow-up||7
1589875|NCT01058668|3889095|P2|NOT COMPLETED|Safety Follow-up||0
1589876|NCT01058668|3889096|P1|NOT COMPLETED|Safety Follow-up||5
1589877|NCT01058668|3889094|P3|COMPLETED|Safety Follow-up||141
1589878|NCT01058668|3889095|P2|COMPLETED|Safety Follow-up||146
1589879|NCT01058668|3889096|P1|COMPLETED|Safety Follow-up||139
1589880|NCT01058668|3889094|P3|STARTED|Safety Follow-up||148
1589881|NCT01058668|3889095|P2|STARTED|Safety Follow-up||146
1589882|NCT01058668|3889096|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
1589883|NCT01058668|3889094|P3|NOT COMPLETED|Double-blind Treatment Phase||50
1589884|NCT01058668|3889095|P2|NOT COMPLETED|Double-blind Treatment Phase||38
1589885|NCT01058668|3889096|P1|NOT COMPLETED|Double-blind Treatment Phase||39
1589886|NCT01058668|3889094|P3|COMPLETED|Double-blind Treatment Phase||119
1589887|NCT01058668|3889095|P2|COMPLETED|Double-blind Treatment Phase||129
1589888|NCT01058668|3889096|P1|COMPLETED|Double-blind Treatment Phase||122
1589889|NCT01058668|3889094|P3|STARTED|Double-blind Treatment Phase||169
1589890|NCT01058668|3889095|P2|STARTED|Double-blind Treatment Phase||167
1589891|NCT01058668|3889096|P1|STARTED|Double-blind Treatment Phase||161
1589892|NCT01058655|3889111|P4|NOT COMPLETED|Overall Study||42
1589893|NCT01058655|3889112|P3|NOT COMPLETED|Overall Study||8
1589894|NCT01058655|3889113|P2|NOT COMPLETED|Overall Study||3
1589895|NCT01058655|3889114|P1|NOT COMPLETED|Overall Study||3
1589896|NCT01058655|3889111|P4|COMPLETED|Overall Study||0
1589897|NCT01058655|3889112|P3|COMPLETED|Overall Study||0
1589898|NCT01058655|3889113|P2|COMPLETED|Overall Study||0
1589899|NCT01058655|3889114|P1|COMPLETED|Overall Study||0
1589900|NCT01058655|3889111|P4|Evaluable|Overall Study||40
1589901|NCT01058655|3889112|P3|Evaluable|Overall Study||6
1589902|NCT01058655|3889113|P2|Evaluable|Overall Study||3
1589903|NCT01058655|3889114|P1|Evaluable|Overall Study||3
1589904|NCT01058655|3889111|P4|STARTED|Overall Study||42
1589905|NCT01058655|3889112|P3|STARTED|Overall Study||8
1589906|NCT01058655|3889113|P2|STARTED|Overall Study||3
1589907|NCT01058655|3889114|P1|STARTED|Overall Study||3
1589908|NCT01058642|3889132|P4|NOT COMPLETED|Treatment Period 2||0
1589909|NCT01058642|3889133|P3|NOT COMPLETED|Treatment Period 2||0
1589910|NCT01058642|3889134|P2|NOT COMPLETED|Treatment Period 2||0
1589911|NCT01058642|3889135|P1|NOT COMPLETED|Treatment Period 2||0
1589912|NCT01058642|3889132|P4|COMPLETED|Treatment Period 2||7
1589913|NCT01058642|3889133|P3|COMPLETED|Treatment Period 2||9
1589914|NCT01058642|3889134|P2|COMPLETED|Treatment Period 2||11
1589915|NCT01058642|3889135|P1|COMPLETED|Treatment Period 2||7
1589916|NCT01058642|3889132|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
1589917|NCT01058642|3889133|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
1589918|NCT01058642|3889134|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
1589919|NCT01058642|3889135|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
1589920|NCT01058642|3889132|P4|STARTED|Treatment Period 2||7
1589921|NCT01058642|3889133|P3|STARTED|Treatment Period 2||9
1589922|NCT01058642|3889134|P2|STARTED|Treatment Period 2||11
1589923|NCT01058642|3889135|P1|STARTED|Treatment Period 2||7
1589924|NCT01058642|3889132|P4|NOT COMPLETED|Washout Period||0
1589925|NCT01058642|3889133|P3|NOT COMPLETED|Washout Period||0
1589926|NCT01058642|3889134|P2|NOT COMPLETED|Washout Period||0
1589927|NCT01058642|3889135|P1|NOT COMPLETED|Washout Period||0
1589928|NCT01058642|3889132|P4|COMPLETED|Washout Period||7
1589929|NCT01058642|3889133|P3|COMPLETED|Washout Period||9
1589930|NCT01058642|3889134|P2|COMPLETED|Washout Period||11
1589931|NCT01058642|3889135|P1|COMPLETED|Washout Period||7
1589932|NCT01058642|3889132|P4|STARTED|Washout Period||7
1589933|NCT01058642|3889133|P3|STARTED|Washout Period||9
1589934|NCT01058642|3889134|P2|STARTED|Washout Period||11
1589935|NCT01058642|3889135|P1|STARTED|Washout Period||7
1589936|NCT01058642|3889132|P4|NOT COMPLETED|Treatment Period 1||2
1589937|NCT01058642|3889133|P3|NOT COMPLETED|Treatment Period 1||2
1589938|NCT01058642|3889134|P2|NOT COMPLETED|Treatment Period 1||1
1589939|NCT01058642|3889135|P1|NOT COMPLETED|Treatment Period 1||2
1589940|NCT01058642|3889132|P4|COMPLETED|Treatment Period 1||7
1589941|NCT01058642|3889133|P3|COMPLETED|Treatment Period 1||9
1589942|NCT01058642|3889134|P2|COMPLETED|Treatment Period 1||11
1589943|NCT01058642|3889135|P1|COMPLETED|Treatment Period 1||7
1589944|NCT01058642|3889132|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
1589945|NCT01058642|3889133|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
1589946|NCT01058642|3889134|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
1589947|NCT01058642|3889135|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
1589948|NCT01058642|3889132|P4|STARTED|Treatment Period 1||9
1589949|NCT01058642|3889133|P3|STARTED|Treatment Period 1||11
1589950|NCT01058642|3889134|P2|STARTED|Treatment Period 1||12
1589951|NCT01058642|3889135|P1|STARTED|Treatment Period 1||9
1589952|NCT01058421|3889145|P2|NOT COMPLETED|6 Month Outcomes||26
1589953|NCT01058421|3889146|P1|NOT COMPLETED|6 Month Outcomes||19
1589954|NCT01058421|3889145|P2|COMPLETED|6 Month Outcomes||24
1589955|NCT01058421|3889146|P1|COMPLETED|6 Month Outcomes||27
1589956|NCT01058421|3889145|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
1589957|NCT01058421|3889146|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
1589958|NCT01058421|3889145|P2|NOT COMPLETED|3 Month Outcomes||26
1589959|NCT01058421|3889146|P1|NOT COMPLETED|3 Month Outcomes||20
1589960|NCT01058421|3889145|P2|COMPLETED|3 Month Outcomes||29
1589961|NCT01058421|3889146|P1|COMPLETED|3 Month Outcomes||29
1589962|NCT01058421|3889145|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
1589963|NCT01058421|3889146|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
1589964|NCT01058421|3889145|P2|NOT COMPLETED|1 Month Outcomes||42
1589965|NCT01058421|3889146|P1|NOT COMPLETED|1 Month Outcomes||39
1589966|NCT01058421|3889145|P2|COMPLETED|1 Month Outcomes||19
1589967|NCT01058421|3889146|P1|COMPLETED|1 Month Outcomes||20
1589968|NCT01058421|3889145|P2|STARTED|1 Month Outcomes||61
1589969|NCT01058421|3889146|P1|STARTED|1 Month Outcomes||59
1589970|NCT01058395|3889170|P2|NOT COMPLETED|Overall Study||1
1589971|NCT01058395|3889171|P1|NOT COMPLETED|Overall Study||3
1589972|NCT01058395|3889170|P2|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
1589973|NCT01058395|3889171|P1|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
1589974|NCT01058395|3889170|P2|STARTED|Overall Study||8
1589975|NCT01058395|3889171|P1|STARTED|Overall Study||7
1589976|NCT01058356|3889180|P1|NOT COMPLETED|Overall Study||42
1589977|NCT01058356|3889180|P1|COMPLETED|Overall Study||172
1589978|NCT01058356|3889180|P1|STARTED|Overall Study||214
1589979|NCT01058304|3889187|P2|NOT COMPLETED|Overall Study||33
1589980|NCT01058304|3889188|P1|NOT COMPLETED|Overall Study||27
1589981|NCT01058304|3889187|P2|COMPLETED|Overall Study||128
1589982|NCT01058304|3889188|P1|COMPLETED|Overall Study||132
1589983|NCT01058304|3889187|P2|STARTED|Overall Study||161
1589984|NCT01058304|3889188|P1|STARTED|Overall Study||159
1589985|NCT01058265|3889198|P2|NOT COMPLETED|Overall Study||12
1589986|NCT01058265|3889199|P1|NOT COMPLETED|Overall Study||11
1589987|NCT01058265|3889198|P2|COMPLETED|Overall Study||13
1589988|NCT01058265|3889199|P1|COMPLETED|Overall Study||11
1589989|NCT01058265|3889198|P2|STARTED|Overall Study||25
1589990|NCT01058265|3889199|P1|STARTED|Overall Study||22
1589991|NCT01058239|3889207|P1|NOT COMPLETED|Overall Study||0
1589992|NCT01058239|3889207|P1|COMPLETED|Overall Study||7
1589993|NCT01058239|3889207|P1|STARTED|Overall Study||7
1589994|NCT01058096|3889218|P2|NOT COMPLETED|Safety Follow-up||4
1589995|NCT01058096|3889219|P1|NOT COMPLETED|Safety Follow-up||4
1589996|NCT01058096|3889218|P2|COMPLETED|Safety Follow-up||130
1589997|NCT01058096|3889219|P1|COMPLETED|Safety Follow-up||129
1589998|NCT01058096|3889218|P2|STARTED|Safety Follow-up||134
1589999|NCT01058096|3889219|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
1590000|NCT01058096|3889218|P2|NOT COMPLETED|Double-blind Treatment Phase||50
1590001|NCT01058096|3889219|P1|NOT COMPLETED|Double-blind Treatment Phase||48
1590002|NCT01058096|3889218|P2|COMPLETED|Double-blind Treatment Phase||108
1590003|NCT01058096|3889219|P1|COMPLETED|Double-blind Treatment Phase||106
1590004|NCT01058096|3889218|P2|STARTED|Double-blind Treatment Phase||158
1590005|NCT01058096|3889219|P1|STARTED|Double-blind Treatment Phase||154
1590006|NCT01058070|3889227|P1|NOT COMPLETED|Overall Study||11
1590007|NCT01058070|3889227|P1|COMPLETED|Overall Study||33
1590008|NCT01058070|3889227|P1|STARTED|Overall Study||44
1590009|NCT01058005|3889235|P3|NOT COMPLETED|Overall Study||20
1590010|NCT01058005|3889236|P2|NOT COMPLETED|Overall Study||25
1590011|NCT01058005|3889237|P1|NOT COMPLETED|Overall Study||38
1590012|NCT01058005|3889235|P3|COMPLETED|Overall Study||1
1590013|NCT01058005|3889236|P2|COMPLETED|Overall Study||0
1590014|NCT01058005|3889237|P1|COMPLETED|Overall Study||0
1590015|NCT01058005|3889235|P3|Dosed With Study Treatment|Overall Study||17
1590016|NCT01058005|3889236|P2|Dosed With Study Treatment|Overall Study||22
1590017|NCT01058005|3889237|P1|Dosed With Study Treatment|Overall Study||36
1590018|NCT01058005|3889235|P3|STARTED|Overall Study||21
1590019|NCT01058005|3889236|P2|STARTED|Overall Study||25
1590020|NCT01058005|3889237|P1|STARTED|Overall Study||38
1590021|NCT01057901|3889247|P2|NOT COMPLETED|Overall Study||246
1590022|NCT01057901|3889248|P1|NOT COMPLETED|Overall Study||260
1590023|NCT01057901|3889247|P2|COMPLETED|Overall Study||126
1590024|NCT01057901|3889248|P1|COMPLETED|Overall Study||116
1590025|NCT01057901|3889247|P2|STARTED|Overall Study||372
1590026|NCT01057901|3889248|P1|STARTED|Overall Study||376
1590027|NCT01057888|3889259|P3|NOT COMPLETED|Overall Study||0
1590028|NCT01057888|3889260|P2|NOT COMPLETED|Overall Study||0
1590029|NCT01057888|3889261|P1|NOT COMPLETED|Overall Study||0
1590030|NCT01057888|3889259|P3|COMPLETED|Overall Study||2494
1590031|NCT01057888|3889260|P2|COMPLETED|Overall Study||2406
1590032|NCT01057888|3889261|P1|COMPLETED|Overall Study||2504
1590033|NCT01057888|3889259|P3|STARTED|Overall Study||2494
1590034|NCT01057888|3889260|P2|STARTED|Overall Study||2406
1590035|NCT01057888|3889261|P1|STARTED|Overall Study||2504
1590036|NCT01057862|3889272|P2|NOT COMPLETED|Overall Study||2
1590037|NCT01057862|3889273|P1|NOT COMPLETED|Overall Study||1
1590038|NCT01057862|3889272|P2|COMPLETED|Overall Study||2
1590039|NCT01057862|3889273|P1|COMPLETED|Overall Study||4
1590040|NCT01057862|3889272|P2|STARTED|Overall Study||4
1590041|NCT01057862|3889273|P1|STARTED|Overall Study||5
1590042|NCT01057810|3889283|P2|NOT COMPLETED|Overall Study||398
1590043|NCT01057810|3889284|P1|NOT COMPLETED|Overall Study||198
1590044|NCT01057810|3889283|P2|COMPLETED|Overall Study||1
1590045|NCT01057810|3889284|P1|COMPLETED|Overall Study||1
1590046|NCT01057810|3889283|P2|STARTED|Overall Study||399
1590047|NCT01057810|3889284|P1|STARTED|Overall Study||199
1590048|NCT01057693|3889300|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
1590049|NCT01057693|3889301|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
1590050|NCT01057693|3889302|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
1590051|NCT01057693|3889300|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
1590052|NCT01057693|3889301|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
1590053|NCT01057693|3889302|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
1590054|NCT01057693|3889300|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
1590055|NCT01057693|3889301|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
1590056|NCT01057693|3889302|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
1590057|NCT01057693|3889300|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
1590058|NCT01057693|3889301|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
1590059|NCT01057693|3889302|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
1590060|NCT01057693|3889300|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
1590061|NCT01057693|3889301|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
1590062|NCT01057693|3889302|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
1590063|NCT01057693|3889300|P3|COMPLETED|Between Single-Blind and Double-Blind||0
1590064|NCT01057693|3889301|P2|COMPLETED|Between Single-Blind and Double-Blind||0
1590065|NCT01057693|3889302|P1|COMPLETED|Between Single-Blind and Double-Blind||296
1590066|NCT01057693|3889300|P3|STARTED|Between Single-Blind and Double-Blind||0
1590067|NCT01057693|3889301|P2|STARTED|Between Single-Blind and Double-Blind||0
1590068|NCT01057693|3889302|P1|STARTED|Between Single-Blind and Double-Blind||566
1590069|NCT01057693|3889300|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
1590070|NCT01057693|3889301|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
1590071|NCT01057693|3889302|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
1590072|NCT01057693|3889300|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
1590073|NCT01057693|3889301|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
1590074|NCT01057693|3889302|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
1590075|NCT01057693|3889300|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
1590076|NCT01057693|3889301|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
1590077|NCT01057693|3889302|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
1590078|NCT01057589|3889348|P1|NOT COMPLETED|Overall Study||66
1590079|NCT01057589|3889348|P1|COMPLETED|Overall Study||0
1590080|NCT01057589|3889348|P1|STARTED|Overall Study||66
1590081|NCT01057433|3889357|P1|NOT COMPLETED|Overall Study||1
1590082|NCT01057433|3889357|P1|COMPLETED|Overall Study||23
1590083|NCT01057433|3889357|P1|STARTED|Overall Study||24
1590084|NCT01057394|3889361|P2|NOT COMPLETED|Overall Study||2
1590085|NCT01057394|3889362|P1|NOT COMPLETED|Overall Study||0
1590086|NCT01057394|3889361|P2|COMPLETED|Overall Study|19 treated participants|19
1590087|NCT01057394|3889362|P1|COMPLETED|Overall Study||0
1590088|NCT01057394|3889361|P2|STARTED|Overall Study|21 enrolled participants|21
1590089|NCT01057394|3889362|P1|STARTED|Overall Study||0
1590090|NCT01057277|3889366|P1|NOT COMPLETED|Overall Study||0
1590091|NCT01057277|3889366|P1|COMPLETED|Overall Study||3
1590092|NCT01057277|3889366|P1|STARTED|Overall Study||3
1590093|NCT01057251|3889372|P2|NOT COMPLETED|Overall Study||29
1590094|NCT01057251|3889373|P1|NOT COMPLETED|Overall Study||28
1590095|NCT01057251|3889372|P2|COMPLETED|Overall Study||114
1590096|NCT01057251|3889373|P1|COMPLETED|Overall Study||262
1590097|NCT01057251|3889372|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
1590098|NCT01057251|3889373|P1|STARTED|Overall Study||290
1590099|NCT01057225|3889381|P6|NOT COMPLETED|Overall Study||0
1590100|NCT01057225|3889382|P5|NOT COMPLETED|Overall Study||0
1590101|NCT01057225|3889383|P4|NOT COMPLETED|Overall Study||0
1590102|NCT01057225|3889384|P3|NOT COMPLETED|Overall Study||0
1590103|NCT01057225|3889385|P2|NOT COMPLETED|Overall Study||0
1590104|NCT01057225|3889386|P1|NOT COMPLETED|Overall Study||0
1590105|NCT01057225|3889381|P6|COMPLETED|Overall Study||23
1590106|NCT01057225|3889382|P5|COMPLETED|Overall Study||22
1590107|NCT01057225|3889383|P4|COMPLETED|Overall Study||7
1590108|NCT01057225|3889384|P3|COMPLETED|Overall Study||6
1590109|NCT01057225|3889385|P2|COMPLETED|Overall Study||3
1590110|NCT01057225|3889386|P1|COMPLETED|Overall Study||3
1590111|NCT01057225|3889381|P6|STARTED|Overall Study||23
1590112|NCT01057225|3889382|P5|STARTED|Overall Study||22
1590113|NCT01057225|3889383|P4|STARTED|Overall Study||7
1590114|NCT01057225|3889384|P3|STARTED|Overall Study||6
1590115|NCT01057225|3889385|P2|STARTED|Overall Study||3
1590116|NCT01057225|3889386|P1|STARTED|Overall Study||3
1590117|NCT01057121|3889408|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1590118|NCT01057121|3889409|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1590119|NCT01057121|3889410|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1590120|NCT01057121|3889411|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1590121|NCT01057121|3889412|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1590122|NCT01057121|3889408|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
1590123|NCT01057121|3889409|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1590124|NCT01057121|3889410|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1590125|NCT01057121|3889411|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1590126|NCT01057121|3889412|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1590127|NCT01057121|3889408|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
1590128|NCT01057121|3889409|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1590129|NCT01057121|3889410|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1590130|NCT01057121|3889411|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1590131|NCT01057121|3889412|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1590132|NCT01057121|3889408|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1590133|NCT01057121|3889409|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1590134|NCT01057121|3889410|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1590135|NCT01057121|3889411|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1590136|NCT01057121|3889412|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1590137|NCT01057121|3889408|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1590138|NCT01057121|3889409|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
1590139|NCT01057121|3889410|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1590140|NCT01057121|3889411|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1590141|NCT01057121|3889412|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1590142|NCT01057121|3889408|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1590143|NCT01057121|3889409|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
1590144|NCT01057121|3889410|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1590145|NCT01057121|3889411|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1590146|NCT01057121|3889412|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1590147|NCT01057121|3889408|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1590148|NCT01057121|3889409|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1590149|NCT01057121|3889410|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1590150|NCT01057121|3889411|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1590151|NCT01057121|3889412|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1590152|NCT01057121|3889408|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1590153|NCT01057121|3889409|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1590154|NCT01057121|3889410|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
1590155|NCT01057121|3889411|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1590156|NCT01057121|3889412|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1590157|NCT01057121|3889408|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1590158|NCT01057121|3889409|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1590159|NCT01057121|3889410|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
1590160|NCT01057121|3889411|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1590161|NCT01057121|3889412|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1590162|NCT01057121|3889408|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1590163|NCT01057121|3889409|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1590164|NCT01057121|3889410|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1590165|NCT01057121|3889411|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1590166|NCT01057121|3889412|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1590167|NCT01057121|3889408|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1590168|NCT01057121|3889409|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1590169|NCT01057121|3889410|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1590170|NCT01057121|3889411|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
1590171|NCT01057121|3889412|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1590172|NCT01057121|3889408|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1590173|NCT01057121|3889409|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1590174|NCT01057121|3889410|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1590175|NCT01057121|3889411|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
1590176|NCT01057121|3889412|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1590177|NCT01057121|3889408|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1590178|NCT01057121|3889409|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1590179|NCT01057121|3889410|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1590180|NCT01057121|3889411|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1590181|NCT01057121|3889412|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1590182|NCT01057121|3889408|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1590183|NCT01057121|3889409|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1590184|NCT01057121|3889410|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1590185|NCT01057121|3889411|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1590186|NCT01057121|3889412|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
1590187|NCT01057121|3889408|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1590188|NCT01057121|3889409|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1590189|NCT01057121|3889410|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1590190|NCT01057121|3889411|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1590191|NCT01057121|3889412|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
1590192|NCT01057017|3889441|P1|NOT COMPLETED|Overall Study||0
1590193|NCT01057017|3889441|P1|COMPLETED|Overall Study||5
1590194|NCT01057017|3889441|P1|STARTED|Overall Study||5
1590195|NCT01056913|3889445|P1|NOT COMPLETED|Overall Study||0
1590196|NCT01056913|3889445|P1|COMPLETED|Overall Study||62
1590197|NCT01056913|3889445|P1|STARTED|Overall Study||62
1590198|NCT01056822|3889451|P2|NOT COMPLETED|Overall Study||7
1590199|NCT01056822|3889452|P1|NOT COMPLETED|Overall Study||8
1590200|NCT01056822|3889451|P2|COMPLETED|Overall Study||35
1590201|NCT01056822|3889452|P1|COMPLETED|Overall Study||39
1590202|NCT01056822|3889451|P2|Safety (SAF) Population: NO|Overall Study||2
1590203|NCT01056822|3889452|P1|Safety (SAF) Population: NO|Overall Study||1
1590204|NCT01056822|3889451|P2|Safety (SAF) Population: YES|Overall Study||40
1590205|NCT01056822|3889452|P1|Safety (SAF) Population: YES|Overall Study||46
1590206|NCT01056822|3889451|P2|Per-protocol (PP) Population: NO|Overall Study||17
1590207|NCT01056822|3889452|P1|Per-protocol (PP) Population: NO|Overall Study||18
1590208|NCT01056822|3889451|P2|Per-protocol (PP) Population: YES|Overall Study||25
1590209|NCT01056822|3889452|P1|Per-protocol (PP) Population: YES|Overall Study||29
1590210|NCT01056822|3889451|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
1590211|NCT01056822|3889452|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
1590212|NCT01056822|3889451|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
1590213|NCT01056822|3889452|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
1590214|NCT01056822|3889451|P2|STARTED|Overall Study||42
1590215|NCT01056822|3889452|P1|STARTED|Overall Study||47
1590216|NCT01056718|3889501|P1|NOT COMPLETED|Overall Study||3
1590217|NCT01056718|3889501|P1|COMPLETED|Overall Study||50
1590218|NCT01056718|3889501|P1|STARTED|Overall Study||53
1590219|NCT01056653|3889534|P3|NOT COMPLETED|Overall Study||2
1590220|NCT01056653|3889535|P2|NOT COMPLETED|Overall Study||0
1590221|NCT01056653|3889536|P1|NOT COMPLETED|Overall Study||0
1590222|NCT01056653|3889534|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
1590223|NCT01056653|3889535|P2|COMPLETED|Overall Study||23
1590224|NCT01056653|3889536|P1|COMPLETED|Overall Study||46
1590225|NCT01056653|3889534|P3|STARTED|Overall Study||44
1590226|NCT01056653|3889535|P2|STARTED|Overall Study||23
1590227|NCT01056653|3889536|P1|STARTED|Overall Study||46
1590228|NCT01056640|3889552|P2|NOT COMPLETED|Overall Study||12
1590229|NCT01056640|3889553|P1|NOT COMPLETED|Overall Study||26
1590230|NCT01056640|3889552|P2|COMPLETED|Overall Study||91
1590231|NCT01056640|3889553|P1|COMPLETED|Overall Study||76
1590232|NCT01056640|3889552|P2|STARTED|Overall Study||103
1590233|NCT01056640|3889553|P1|STARTED|Overall Study||102
1590234|NCT01056601|3889559|P1|NOT COMPLETED|Overall Study||0
1590235|NCT01056601|3889559|P1|COMPLETED|Overall Study||7
1590236|NCT01056601|3889559|P1|STARTED|Overall Study||7
1590237|NCT01056523|3889565|P7|NOT COMPLETED|Overall Study||1
1590238|NCT01056523|3889566|P6|NOT COMPLETED|Overall Study||0
1590239|NCT01056523|3889567|P5|NOT COMPLETED|Overall Study||0
1590240|NCT01056523|3889568|P4|NOT COMPLETED|Overall Study||3
1590241|NCT01056523|3889569|P3|NOT COMPLETED|Overall Study||2
1590242|NCT01056523|3889570|P2|NOT COMPLETED|Overall Study||0
1590243|NCT01056523|3889571|P1|NOT COMPLETED|Overall Study||1
1590244|NCT01056523|3889565|P7|COMPLETED|Overall Study||4
1590245|NCT01056523|3889566|P6|COMPLETED|Overall Study||3
1590246|NCT01056523|3889567|P5|COMPLETED|Overall Study||3
1590247|NCT01056523|3889568|P4|COMPLETED|Overall Study||3
1590248|NCT01056523|3889569|P3|COMPLETED|Overall Study||3
1590249|NCT01056523|3889570|P2|COMPLETED|Overall Study||3
1590250|NCT01056523|3889571|P1|COMPLETED|Overall Study||3
1590251|NCT01056523|3889565|P7|STARTED|Overall Study||5
1590252|NCT01056523|3889566|P6|STARTED|Overall Study||3
1590253|NCT01056523|3889567|P5|STARTED|Overall Study||3
1590254|NCT01056523|3889568|P4|STARTED|Overall Study||6
1590255|NCT01056523|3889569|P3|STARTED|Overall Study||5
1590256|NCT01056523|3889570|P2|STARTED|Overall Study||3
1590257|NCT01056523|3889571|P1|STARTED|Overall Study||4
1590258|NCT01056510|3889581|P2|NOT COMPLETED|Overall Study||64
1590259|NCT01056510|3889582|P1|NOT COMPLETED|Overall Study||54
1590260|NCT01056510|3889581|P2|COMPLETED|Overall Study||115
1590261|NCT01056510|3889582|P1|COMPLETED|Overall Study||124
1590262|NCT01056510|3889581|P2|STARTED|Overall Study||179
1590263|NCT01056510|3889582|P1|STARTED|Overall Study||178
1590264|NCT01056484|3889628|P2|NOT COMPLETED|Follow up - Non-randomized||2
1590265|NCT01056484|3889629|P1|NOT COMPLETED|Follow up - Non-randomized||0
1590266|NCT01056484|3889628|P2|COMPLETED|Follow up - Non-randomized||56
1590267|NCT01056484|3889629|P1|COMPLETED|Follow up - Non-randomized||57
1590268|NCT01056484|3889628|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
1590269|NCT01056484|3889629|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
1590270|NCT01056484|3889628|P2|NOT COMPLETED|Randomized Controlled Trial||1
1590271|NCT01056484|3889629|P1|NOT COMPLETED|Randomized Controlled Trial||7
1590272|NCT01056484|3889628|P2|COMPLETED|Randomized Controlled Trial||58
1590273|NCT01056484|3889629|P1|COMPLETED|Randomized Controlled Trial||57
1590274|NCT01056484|3889628|P2|STARTED|Randomized Controlled Trial||59
1590275|NCT01056484|3889629|P1|STARTED|Randomized Controlled Trial||64
1590276|NCT01056380|3889645|P2|NOT COMPLETED|Overall Study||3
1590277|NCT01056380|3889646|P1|NOT COMPLETED|Overall Study||2
1590278|NCT01056380|3889645|P2|COMPLETED|Overall Study||39
1590279|NCT01056380|3889646|P1|COMPLETED|Overall Study||35
1590280|NCT01056380|3889645|P2|STARTED|Overall Study||42
1590281|NCT01056380|3889646|P1|STARTED|Overall Study||37
1590282|NCT01056341|3889673|P5|NOT COMPLETED|Overall Study||14
1590283|NCT01056341|3889674|P4|NOT COMPLETED|Overall Study||36
1590284|NCT01056341|3889675|P3|NOT COMPLETED|Overall Study||15
1590285|NCT01056341|3889676|P2|NOT COMPLETED|Overall Study||36
1590286|NCT01056341|3889677|P1|NOT COMPLETED|Overall Study||36
1590287|NCT01056341|3889673|P5|COMPLETED|Overall Study||88
1590288|NCT01056341|3889674|P4|COMPLETED|Overall Study||65
1590289|NCT01056341|3889675|P3|COMPLETED|Overall Study||88
1590290|NCT01056341|3889676|P2|COMPLETED|Overall Study||63
1590291|NCT01056341|3889677|P1|COMPLETED|Overall Study||19
1590292|NCT01056341|3889673|P5|Interim Analysis|Overall Study||43
1590293|NCT01056341|3889674|P4|Interim Analysis|Overall Study||40
1590294|NCT01056341|3889675|P3|Interim Analysis|Overall Study||41
1590295|NCT01056341|3889676|P2|Interim Analysis|Overall Study||41
1590296|NCT01056341|3889677|P1|Interim Analysis|Overall Study||25
1590297|NCT01056341|3889673|P5|STARTED|Overall Study||102
1590298|NCT01056341|3889674|P4|STARTED|Overall Study||101
1590299|NCT01056341|3889675|P3|STARTED|Overall Study||103
1590300|NCT01056341|3889676|P2|STARTED|Overall Study||99
1590301|NCT01056341|3889677|P1|STARTED|Overall Study||55
1590302|NCT01056328|3889698|P2|NOT COMPLETED|Overall Study||16
1590303|NCT01056328|3889699|P1|NOT COMPLETED|Overall Study||17
1590304|NCT01056328|3889698|P2|COMPLETED|Overall Study||144
1590305|NCT01056328|3889699|P1|COMPLETED|Overall Study||147
1590306|NCT01056328|3889698|P2|STARTED|Overall Study||160
1590307|NCT01056328|3889699|P1|STARTED|Overall Study||164
1590308|NCT01056315|3889715|P2|NOT COMPLETED|Overall Study||11
1590309|NCT01056315|3889716|P1|NOT COMPLETED|Overall Study||14
1590310|NCT01056315|3889715|P2|COMPLETED|Overall Study||12
1590311|NCT01056315|3889716|P1|COMPLETED|Overall Study||13
1590312|NCT01056315|3889715|P2|STARTED|Overall Study||23
1590313|NCT01056315|3889716|P1|STARTED|Overall Study||27
1590314|NCT01056289|3889750|P4|NOT COMPLETED|Double-blind Phase||10
1590315|NCT01056289|3889751|P3|NOT COMPLETED|Double-blind Phase||13
1590316|NCT01056289|3889752|P2|NOT COMPLETED|Double-blind Phase||4
1590317|NCT01056289|3889753|P1|NOT COMPLETED|Double-blind Phase||0
1590318|NCT01056289|3889750|P4|COMPLETED|Double-blind Phase||138
1590319|NCT01056289|3889751|P3|COMPLETED|Double-blind Phase||127
1590320|NCT01056289|3889752|P2|COMPLETED|Double-blind Phase||69
1590321|NCT01056289|3889753|P1|COMPLETED|Double-blind Phase||0
1590322|NCT01056289|3889750|P4|STARTED|Double-blind Phase||148
1590323|NCT01056289|3889751|P3|STARTED|Double-blind Phase||140
1590324|NCT01056289|3889752|P2|STARTED|Double-blind Phase||73
1590325|NCT01056289|3889753|P1|STARTED|Double-blind Phase||0
1590326|NCT01056289|3889750|P4|NOT COMPLETED|Open-label Phase||0
1590327|NCT01056289|3889751|P3|NOT COMPLETED|Open-label Phase||0
1590328|NCT01056289|3889752|P2|NOT COMPLETED|Open-label Phase||0
1590329|NCT01056289|3889753|P1|NOT COMPLETED|Open-label Phase||119
1590330|NCT01056289|3889750|P4|COMPLETED|Open-label Phase||0
1590331|NCT01056289|3889751|P3|COMPLETED|Open-label Phase||0
1590332|NCT01056289|3889752|P2|COMPLETED|Open-label Phase||0
1590333|NCT01056289|3889753|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
1590334|NCT01056289|3889750|P4|STARTED|Open-label Phase||0
1590335|NCT01056289|3889751|P3|STARTED|Open-label Phase||0
1590336|NCT01056289|3889752|P2|STARTED|Open-label Phase||0
1590337|NCT01056289|3889753|P1|STARTED|Open-label Phase||480
1590338|NCT01056276|3889770|P2|NOT COMPLETED|Maintenance Therapy||28
1590339|NCT01056276|3889771|P1|NOT COMPLETED|Maintenance Therapy||0
1590340|NCT01056276|3889770|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
1590341|NCT01056276|3889771|P1|COMPLETED|Maintenance Therapy||0
1590342|NCT01056276|3889770|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
1590343|NCT01056276|3889771|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
1590344|NCT01056276|3889770|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
1590345|NCT01056276|3889771|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
1590346|NCT01056276|3889770|P2|COMPLETED|Treatment Period-Cycles 1-8||33
1590347|NCT01056276|3889771|P1|COMPLETED|Treatment Period-Cycles 1-8||5
1590348|NCT01056276|3889770|P2|STARTED|Treatment Period-Cycles 1-8||41
1590349|NCT01056276|3889771|P1|STARTED|Treatment Period-Cycles 1-8||18
1590350|NCT01056263|3889785|P1|NOT COMPLETED|Overall Study||52
1590351|NCT01056263|3889785|P1|COMPLETED|Overall Study||0
1590352|NCT01056263|3889785|P1|STARTED|Overall Study||52
1590353|NCT01056198|3889791|P2|NOT COMPLETED|Overall Study||0
1590354|NCT01056198|3889792|P1|NOT COMPLETED|Overall Study||0
1590355|NCT01056198|3889791|P2|COMPLETED|Overall Study||24
1590356|NCT01056198|3889792|P1|COMPLETED|Overall Study||24
1590357|NCT01056198|3889791|P2|STARTED|Overall Study||24
1590358|NCT01056198|3889792|P1|STARTED|Overall Study||24
1590359|NCT01056107|3889808|P4|NOT COMPLETED|Overall Study||0
1590360|NCT01056107|3889809|P3|NOT COMPLETED|Overall Study||3
1590361|NCT01056107|3889810|P2|NOT COMPLETED|Overall Study||1
1590362|NCT01056107|3889811|P1|NOT COMPLETED|Overall Study||0
1590363|NCT01056107|3889808|P4|COMPLETED|Overall Study||12
1590364|NCT01056107|3889809|P3|COMPLETED|Overall Study||9
1590365|NCT01056107|3889810|P2|COMPLETED|Overall Study||10
1590366|NCT01056107|3889811|P1|COMPLETED|Overall Study||11
1590367|NCT01056107|3889808|P4|STARTED|Overall Study||12
1590368|NCT01056107|3889809|P3|STARTED|Overall Study||12
1590369|NCT01056107|3889810|P2|STARTED|Overall Study||11
1590370|NCT01056107|3889811|P1|STARTED|Overall Study||11
1590371|NCT01056016|3889859|P2|NOT COMPLETED|Overall Study||1
1590372|NCT01056016|3889860|P1|NOT COMPLETED|Overall Study||2
1590373|NCT01056016|3889859|P2|COMPLETED|Overall Study||26
1590374|NCT01056016|3889860|P1|COMPLETED|Overall Study||20
1590375|NCT01056016|3889859|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
1590376|NCT01056016|3889860|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
1590377|NCT01055886|3889868|P2|NOT COMPLETED|Overall Study||11
1590378|NCT01055886|3889869|P1|NOT COMPLETED|Overall Study||5
1590379|NCT01055886|3889868|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
1590380|NCT01055886|3889869|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
1590381|NCT01055886|3889868|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
1590382|NCT01055886|3889869|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
1590383|NCT01055886|3889868|P2|STARTED|Overall Study||32
1590384|NCT01055886|3889869|P1|STARTED|Overall Study||33
1590385|NCT01055834|3889881|P2|NOT COMPLETED|Treatment Period III||0
1590386|NCT01055834|3889882|P1|NOT COMPLETED|Treatment Period III||0
1590387|NCT01055834|3889881|P2|COMPLETED|Treatment Period III||14
1590388|NCT01055834|3889882|P1|COMPLETED|Treatment Period III||0
1590389|NCT01055834|3889881|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
1590390|NCT01055834|3889882|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
1590391|NCT01055834|3889881|P2|NOT COMPLETED|Treatment Period II||0
1590392|NCT01055834|3889882|P1|NOT COMPLETED|Treatment Period II||0
1590393|NCT01055834|3889881|P2|COMPLETED|Treatment Period II||21
1590394|NCT01055834|3889882|P1|COMPLETED|Treatment Period II||20
1590395|NCT01055834|3889881|P2|STARTED|Treatment Period II||21
1590396|NCT01055834|3889882|P1|STARTED|Treatment Period II||20
1590397|NCT01055834|3889881|P2|NOT COMPLETED|Treatment Period I||0
1590398|NCT01055834|3889882|P1|NOT COMPLETED|Treatment Period I||1
1590399|NCT01055834|3889881|P2|COMPLETED|Treatment Period I||21
1590400|NCT01055834|3889882|P1|COMPLETED|Treatment Period I||20
1590401|NCT01055834|3889881|P2|STARTED|Treatment Period I||21
1590402|NCT01055834|3889882|P1|STARTED|Treatment Period I||21
1590403|NCT01055782|3889896|P2|NOT COMPLETED|Overall Study||0
1590404|NCT01055782|3889897|P1|NOT COMPLETED|Overall Study||0
1590405|NCT01055782|3889896|P2|COMPLETED|Overall Study||449
1590406|NCT01055782|3889897|P1|COMPLETED|Overall Study||555
1590407|NCT01055782|3889896|P2|STARTED|Overall Study||449
1590408|NCT01055782|3889897|P1|STARTED|Overall Study||555
1590409|NCT01055769|3889905|P2|NOT COMPLETED|Second Intervention||0
1590410|NCT01055769|3889906|P1|NOT COMPLETED|Second Intervention||0
1590411|NCT01055769|3889905|P2|COMPLETED|Second Intervention||10
1590412|NCT01055769|3889906|P1|COMPLETED|Second Intervention||10
1590413|NCT01055769|3889905|P2|STARTED|Second Intervention||10
1590414|NCT01055769|3889906|P1|STARTED|Second Intervention||10
1590415|NCT01055769|3889905|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
1590416|NCT01055769|3889906|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
1590417|NCT01055769|3889905|P2|COMPLETED|Washout Period of Atleast 4 Days||10
1590418|NCT01055769|3889906|P1|COMPLETED|Washout Period of Atleast 4 Days||10
1590419|NCT01055769|3889905|P2|STARTED|Washout Period of Atleast 4 Days||10
1590420|NCT01055769|3889906|P1|STARTED|Washout Period of Atleast 4 Days||10
1590421|NCT01055769|3889905|P2|NOT COMPLETED|First Intervention||0
1590422|NCT01055769|3889906|P1|NOT COMPLETED|First Intervention||0
1590423|NCT01055769|3889905|P2|COMPLETED|First Intervention||10
1590424|NCT01055769|3889906|P1|COMPLETED|First Intervention||10
1590425|NCT01055769|3889905|P2|STARTED|First Intervention||10
1590426|NCT01055769|3889906|P1|STARTED|First Intervention||10
1590427|NCT01055704|3889924|P4|NOT COMPLETED|Overall Study||0
1590428|NCT01055704|3889925|P3|NOT COMPLETED|Overall Study||0
1590429|NCT01055704|3889926|P2|NOT COMPLETED|Overall Study||0
1590430|NCT01055704|3889927|P1|NOT COMPLETED|Overall Study||0
1590431|NCT01055704|3889924|P4|COMPLETED|Overall Study||8
1590432|NCT01055704|3889925|P3|COMPLETED|Overall Study||16
1590433|NCT01055704|3889926|P2|COMPLETED|Overall Study||8
1590434|NCT01055704|3889927|P1|COMPLETED|Overall Study||16
1590435|NCT01055704|3889924|P4|STARTED|Overall Study||8
1590436|NCT01055704|3889925|P3|STARTED|Overall Study||16
1590437|NCT01055704|3889926|P2|STARTED|Overall Study||8
1590438|NCT01055704|3889927|P1|STARTED|Overall Study||16
1590439|NCT01055639|3889967|P2|NOT COMPLETED|Overall Study||29
1590440|NCT01055639|3889968|P1|NOT COMPLETED|Overall Study||21
1590441|NCT01055639|3889967|P2|COMPLETED|Overall Study||31
1590442|NCT01055639|3889968|P1|COMPLETED|Overall Study||45
1590443|NCT01055639|3889967|P2|STARTED|Overall Study||60
1590444|NCT01055639|3889968|P1|STARTED|Overall Study||66
1590445|NCT01055613|3889992|P2|NOT COMPLETED|Overall Study||4
1590446|NCT01055613|3889993|P1|NOT COMPLETED|Overall Study||9
1590447|NCT01055613|3889992|P2|COMPLETED|Overall Study||96
1590448|NCT01055613|3889993|P1|COMPLETED|Overall Study||191
1590449|NCT01055613|3889992|P2|STARTED|Overall Study||100
1590450|NCT01055613|3889993|P1|STARTED|Overall Study||200
1590451|NCT01055457|3890011|P10|NOT COMPLETED|Overall Study||1
1590452|NCT01055457|3890012|P9|NOT COMPLETED|Overall Study||0
1590453|NCT01055457|3890013|P8|NOT COMPLETED|Overall Study||1
1590454|NCT01055457|3890014|P7|NOT COMPLETED|Overall Study||1
1590455|NCT01055457|3890015|P6|NOT COMPLETED|Overall Study||3
1590456|NCT01055457|3890016|P5|NOT COMPLETED|Overall Study||3
1590457|NCT01055457|3890017|P4|NOT COMPLETED|Overall Study||3
1590458|NCT01055457|3890018|P3|NOT COMPLETED|Overall Study||2
1590459|NCT01055457|3890019|P2|NOT COMPLETED|Overall Study||1
1590460|NCT01055457|3890020|P1|NOT COMPLETED|Overall Study||1
1590461|NCT01055457|3890011|P10|COMPLETED|Overall Study||19
1590462|NCT01055457|3890012|P9|COMPLETED|Overall Study||20
1590463|NCT01055457|3890013|P8|COMPLETED|Overall Study||18
1590464|NCT01055457|3890014|P7|COMPLETED|Overall Study||18
1590465|NCT01055457|3890015|P6|COMPLETED|Overall Study||15
1590466|NCT01055457|3890016|P5|COMPLETED|Overall Study||38
1590467|NCT01055457|3890017|P4|COMPLETED|Overall Study||37
1590468|NCT01055457|3890018|P3|COMPLETED|Overall Study||36
1590469|NCT01055457|3890019|P2|COMPLETED|Overall Study||39
1590470|NCT01055457|3890020|P1|COMPLETED|Overall Study||39
1590471|NCT01055457|3890011|P10|STARTED|Overall Study||20
1590472|NCT01055457|3890012|P9|STARTED|Overall Study||20
1590473|NCT01055457|3890013|P8|STARTED|Overall Study||19
1590474|NCT01055457|3890014|P7|STARTED|Overall Study||19
1590475|NCT01055457|3890015|P6|STARTED|Overall Study||18
1590476|NCT01055457|3890016|P5|STARTED|Overall Study||41
1590477|NCT01055457|3890017|P4|STARTED|Overall Study||40
1590478|NCT01055457|3890018|P3|STARTED|Overall Study||38
1590479|NCT01055457|3890019|P2|STARTED|Overall Study||40
1590480|NCT01055457|3890020|P1|STARTED|Overall Study||40
1590481|NCT01055314|3890054|P2|NOT COMPLETED|Overall Study||38
1590482|NCT01055314|3890055|P1|NOT COMPLETED|Overall Study||45
1590483|NCT01055314|3890054|P2|COMPLETED|Overall Study||37
1590484|NCT01055314|3890055|P1|COMPLETED|Overall Study||55
1590485|NCT01055314|3890054|P2|STARTED|Overall Study||75
1590486|NCT01055314|3890055|P1|STARTED|Overall Study||100
1590487|NCT01055262|3890067|P1|NOT COMPLETED|Overall Study||9
1590488|NCT01055262|3890067|P1|COMPLETED|Overall Study||160
1590489|NCT01055262|3890067|P1|STARTED|Overall Study||169
1590490|NCT01055223|3890078|P1|NOT COMPLETED|Overall Study||0
1590491|NCT01055223|3890078|P1|COMPLETED|Overall Study||98483
1590492|NCT01055223|3890078|P1|STARTED|Overall Study||98483
1590493|NCT01055197|3890108|P2|NOT COMPLETED|Overall Study||2
1590494|NCT01055197|3890109|P1|NOT COMPLETED|Overall Study||9
1590495|NCT01055197|3890108|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
1590496|NCT01055197|3890109|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
1590497|NCT01055197|3890108|P2|STARTED|Overall Study||46
1590498|NCT01055197|3890109|P1|STARTED|Overall Study||51
1590499|NCT01055184|3890123|P1|NOT COMPLETED|Overall Study||0
1590500|NCT01055184|3890123|P1|COMPLETED|Overall Study||34
1590501|NCT01055184|3890123|P1|STARTED|Overall Study||34
1590502|NCT01055171|3890129|P2|NOT COMPLETED|Overall Study||7
1590503|NCT01055171|3890130|P1|NOT COMPLETED|Overall Study||11
1590504|NCT01055171|3890129|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
1590505|NCT01055171|3890130|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
1590506|NCT01055171|3890129|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
1590507|NCT01055171|3890130|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
1590508|NCT01055171|3890129|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
1590509|NCT01055171|3890130|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
1590510|NCT01055171|3890129|P2|STARTED|Overall Study|Randomized to receive placebo.|28
1590511|NCT01055171|3890130|P1|STARTED|Overall Study|Randomized to receive medication.|29
1590512|NCT01055132|3890144|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
1590513|NCT01055132|3890145|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
1590514|NCT01055132|3890144|P2|COMPLETED|Period 2 (5-9 Days)||32
1590515|NCT01055132|3890145|P1|COMPLETED|Period 2 (5-9 Days)||35
1590516|NCT01055132|3890144|P2|STARTED|Period 2 (5-9 Days)||33
1590517|NCT01055132|3890145|P1|STARTED|Period 2 (5-9 Days)||35
1590518|NCT01055132|3890144|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
1590519|NCT01055132|3890145|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
1590520|NCT01055132|3890144|P2|COMPLETED|Period 1 (5-9 Days)||33
1590521|NCT01055132|3890145|P1|COMPLETED|Period 1 (5-9 Days)||35
1590522|NCT01055132|3890144|P2|STARTED|Period 1 (5-9 Days)||33
1590523|NCT01055132|3890145|P1|STARTED|Period 1 (5-9 Days)||36
1590524|NCT01055028|3890158|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
1590525|NCT01055028|3890159|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
1590526|NCT01055028|3890158|P2|COMPLETED|Treatment Cycles 4 to 6||2
1590527|NCT01055028|3890159|P1|COMPLETED|Treatment Cycles 4 to 6||6
1590528|NCT01055028|3890158|P2|STARTED|Treatment Cycles 4 to 6||2
1590529|NCT01055028|3890159|P1|STARTED|Treatment Cycles 4 to 6||6
1590530|NCT01055028|3890158|P2|NOT COMPLETED|Inter-treatment Period||3
1590531|NCT01055028|3890159|P1|NOT COMPLETED|Inter-treatment Period||0
1590532|NCT01055028|3890158|P2|COMPLETED|Inter-treatment Period||2
1590533|NCT01055028|3890159|P1|COMPLETED|Inter-treatment Period||6
1590534|NCT01055028|3890158|P2|STARTED|Inter-treatment Period||5
1590535|NCT01055028|3890159|P1|STARTED|Inter-treatment Period||6
1590536|NCT01055028|3890158|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
1590537|NCT01055028|3890159|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
1590538|NCT01055028|3890158|P2|COMPLETED|Treatment Cycles 1 to 3||5
1590539|NCT01055028|3890159|P1|COMPLETED|Treatment Cycles 1 to 3||6
1590540|NCT01055028|3890158|P2|STARTED|Treatment Cycles 1 to 3||8
1590541|NCT01055028|3890159|P1|STARTED|Treatment Cycles 1 to 3||8
1590542|NCT01055028|3890158|P2|NOT COMPLETED|Screening||1
1590543|NCT01055028|3890159|P1|NOT COMPLETED|Screening||1
1590544|NCT01055028|3890158|P2|COMPLETED|Screening||8
1590545|NCT01055028|3890159|P1|COMPLETED|Screening||8
1590546|NCT01055028|3890158|P2|STARTED|Screening||9
1590547|NCT01055028|3890159|P1|STARTED|Screening||9
1590548|NCT01054976|3890173|P1|NOT COMPLETED|Overall Study||35
1590549|NCT01054976|3890173|P1|COMPLETED|Overall Study||57
1590550|NCT01054976|3890173|P1|STARTED|Overall Study||92
1590551|NCT01054911|3890181|P1|NOT COMPLETED|Overall Study||0
1590552|NCT01054911|3890181|P1|COMPLETED|Overall Study||5
1590553|NCT01054911|3890181|P1|STARTED|Overall Study||5
1590554|NCT01054885|3890194|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
1590555|NCT01054885|3890195|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
1590556|NCT01054885|3890196|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
1590557|NCT01054885|3890197|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
1590558|NCT01054885|3890198|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
1590559|NCT01054885|3890199|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
1590560|NCT01054885|3890200|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1590561|NCT01054885|3890194|P7|COMPLETED|24-week, Double-blind Treatment Period||158
1590562|NCT01054885|3890195|P6|COMPLETED|24-week, Double-blind Treatment Period||144
1590563|NCT01054885|3890196|P5|COMPLETED|24-week, Double-blind Treatment Period||161
1590564|NCT01054885|3890197|P4|COMPLETED|24-week, Double-blind Treatment Period||160
1590565|NCT01054885|3890198|P3|COMPLETED|24-week, Double-blind Treatment Period||155
1590566|NCT01054885|3890199|P2|COMPLETED|24-week, Double-blind Treatment Period||146
1590567|NCT01054885|3890200|P1|COMPLETED|24-week, Double-blind Treatment Period||0
1590568|NCT01054885|3890194|P7|STARTED|24-week, Double-blind Treatment Period||205
1590569|NCT01054885|3890195|P6|STARTED|24-week, Double-blind Treatment Period||204
1590570|NCT01054885|3890196|P5|STARTED|24-week, Double-blind Treatment Period||203
1590571|NCT01054885|3890197|P4|STARTED|24-week, Double-blind Treatment Period||203
1590572|NCT01054885|3890198|P3|STARTED|24-week, Double-blind Treatment Period||204
1590573|NCT01054885|3890199|P2|STARTED|24-week, Double-blind Treatment Period||205
1590574|NCT01054885|3890200|P1|STARTED|24-week, Double-blind Treatment Period||0
1590575|NCT01054885|3890194|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590576|NCT01054885|3890195|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590577|NCT01054885|3890196|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590578|NCT01054885|3890197|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590579|NCT01054885|3890198|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590580|NCT01054885|3890199|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590581|NCT01054885|3890200|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
1590582|NCT01054885|3890194|P7|COMPLETED|2-week, Single-blind Run-In Period||0
1590583|NCT01054885|3890195|P6|COMPLETED|2-week, Single-blind Run-In Period||0
1590584|NCT01054885|3890196|P5|COMPLETED|2-week, Single-blind Run-In Period||0
1590585|NCT01054885|3890197|P4|COMPLETED|2-week, Single-blind Run-In Period||0
1590586|NCT01054885|3890198|P3|COMPLETED|2-week, Single-blind Run-In Period||0
1590587|NCT01054885|3890199|P2|COMPLETED|2-week, Single-blind Run-In Period||0
1590588|NCT01054885|3890200|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
1590589|NCT01054885|3890194|P7|STARTED|2-week, Single-blind Run-In Period||0
1590590|NCT01054885|3890195|P6|STARTED|2-week, Single-blind Run-In Period||0
1590591|NCT01054885|3890196|P5|STARTED|2-week, Single-blind Run-In Period||0
1590592|NCT01054885|3890197|P4|STARTED|2-week, Single-blind Run-In Period||0
1590593|NCT01054885|3890198|P3|STARTED|2-week, Single-blind Run-In Period||0
1590594|NCT01054885|3890199|P2|STARTED|2-week, Single-blind Run-In Period||0
1590595|NCT01054885|3890200|P1|STARTED|2-week, Single-blind Run-In Period||1577
1590596|NCT01054846|3890240|P2|NOT COMPLETED|Overall Study||17
1590597|NCT01054846|3890241|P1|NOT COMPLETED|Overall Study||76
1590598|NCT01054846|3890240|P2|COMPLETED|Overall Study||51
1590599|NCT01054846|3890241|P1|COMPLETED|Overall Study||246
1590600|NCT01054846|3890240|P2|STARTED|Overall Study||68
1590601|NCT01054846|3890241|P1|STARTED|Overall Study||322
1590602|NCT01054820|3890248|P1|NOT COMPLETED|Overall Study||2
1590603|NCT01054820|3890248|P1|COMPLETED|Overall Study||121
1590604|NCT01054820|3890248|P1|STARTED|Overall Study||123
1590605|NCT01054742|3890262|P1|NOT COMPLETED|Overall Study||0
1590606|NCT01054742|3890262|P1|COMPLETED|Overall Study||2
1590607|NCT01054742|3890262|P1|STARTED|Overall Study||2
1590608|NCT01054729|3890270|P4|NOT COMPLETED|Overall Study||3
1590609|NCT01054729|3890271|P3|NOT COMPLETED|Overall Study||6
1590610|NCT01054729|3890272|P2|NOT COMPLETED|Overall Study||5
1590611|NCT01054729|3890273|P1|NOT COMPLETED|Overall Study||4
1590612|NCT01054729|3890270|P4|COMPLETED|Overall Study||11
1590613|NCT01054729|3890271|P3|COMPLETED|Overall Study||9
1590614|NCT01054729|3890272|P2|COMPLETED|Overall Study||14
1590615|NCT01054729|3890273|P1|COMPLETED|Overall Study||12
1590616|NCT01054729|3890270|P4|Randomized and Treated|Overall Study||14
1590617|NCT01054729|3890271|P3|Randomized and Treated|Overall Study||15
1590618|NCT01054729|3890272|P2|Randomized and Treated|Overall Study||18
1590619|NCT01054729|3890273|P1|Randomized and Treated|Overall Study||16
1590620|NCT01054729|3890270|P4|STARTED|Overall Study||14
1590621|NCT01054729|3890271|P3|STARTED|Overall Study||15
1590622|NCT01054729|3890272|P2|STARTED|Overall Study||19
1590623|NCT01054729|3890273|P1|STARTED|Overall Study||16
1590624|NCT01054703|3890334|P1|NOT COMPLETED|Overall Study||0
1590625|NCT01054703|3890334|P1|COMPLETED|Overall Study||14
1590626|NCT01054703|3890334|P1|STARTED|Overall Study||14
1590627|NCT01054625|3890341|P3|NOT COMPLETED|Overall Study||1
1590628|NCT01054625|3890342|P2|NOT COMPLETED|Overall Study||3
1590629|NCT01054625|3890343|P1|NOT COMPLETED|Overall Study||2
1590630|NCT01054625|3890341|P3|COMPLETED|Overall Study||9
1590631|NCT01054625|3890342|P2|COMPLETED|Overall Study||9
1590632|NCT01054625|3890343|P1|COMPLETED|Overall Study||6
1590633|NCT01054625|3890341|P3|STARTED|Overall Study||10
1590634|NCT01054625|3890342|P2|STARTED|Overall Study||12
1590635|NCT01054625|3890343|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
1590636|NCT01054599|3890371|P2|NOT COMPLETED|Overall Study||7
1590637|NCT01054599|3890372|P1|NOT COMPLETED|Overall Study||4
1590638|NCT01054599|3890371|P2|COMPLETED|Overall Study||9
1590639|NCT01054599|3890372|P1|COMPLETED|Overall Study||9
1590640|NCT01054599|3890371|P2|STARTED|Overall Study||16
1590641|NCT01054599|3890372|P1|STARTED|Overall Study||13
1590642|NCT01054586|3890384|P4|NOT COMPLETED|Overall Study||0
1590643|NCT01054586|3890385|P3|NOT COMPLETED|Overall Study||0
1590644|NCT01054586|3890386|P2|NOT COMPLETED|Overall Study||0
1590645|NCT01054586|3890387|P1|NOT COMPLETED|Overall Study||0
1590646|NCT01054586|3890384|P4|COMPLETED|Overall Study||101
1590647|NCT01054586|3890385|P3|COMPLETED|Overall Study||8
1590648|NCT01054586|3890386|P2|COMPLETED|Overall Study||15
1590649|NCT01054586|3890387|P1|COMPLETED|Overall Study||43
1590650|NCT01054586|3890384|P4|STARTED|Overall Study||101
1590651|NCT01054586|3890385|P3|STARTED|Overall Study||8
1590652|NCT01054586|3890386|P2|STARTED|Overall Study||15
1590653|NCT01054586|3890387|P1|STARTED|Overall Study||43
1590654|NCT01054573|3890479|P4|NOT COMPLETED|Overall Study||2
1590655|NCT01054573|3890480|P3|NOT COMPLETED|Overall Study||3
1590656|NCT01054573|3890481|P2|NOT COMPLETED|Overall Study||4
1590657|NCT01054573|3890482|P1|NOT COMPLETED|Overall Study||1
1590658|NCT01054573|3890479|P4|COMPLETED|Overall Study||25
1590659|NCT01054573|3890480|P3|COMPLETED|Overall Study||19
1590660|NCT01054573|3890481|P2|COMPLETED|Overall Study||28
1590661|NCT01054573|3890482|P1|COMPLETED|Overall Study||8
1590662|NCT01054573|3890479|P4|STARTED|Overall Study||27
1590663|NCT01054573|3890480|P3|STARTED|Overall Study||22
1590664|NCT01054573|3890481|P2|STARTED|Overall Study||32
1590665|NCT01054573|3890482|P1|STARTED|Overall Study||9
1590666|NCT01054560|3890528|P2|NOT COMPLETED|Overall Study||28
1590667|NCT01054560|3890529|P1|NOT COMPLETED|Overall Study||13
1590668|NCT01054560|3890528|P2|COMPLETED|Overall Study||27
1590669|NCT01054560|3890529|P1|COMPLETED|Overall Study||45
1590670|NCT01054560|3890528|P2|STARTED|Overall Study||55
1590671|NCT01054560|3890529|P1|STARTED|Overall Study||58
1590672|NCT01054404|3890553|P2|NOT COMPLETED|Overall Study||0
1590673|NCT01054404|3890554|P1|NOT COMPLETED|Overall Study||0
1590674|NCT01054404|3890553|P2|COMPLETED|Overall Study||13
1590675|NCT01054404|3890554|P1|COMPLETED|Overall Study||10
1590676|NCT01054404|3890553|P2|STARTED|Overall Study||13
1590677|NCT01054404|3890554|P1|STARTED|Overall Study||10
1590678|NCT01054339|3890563|P3|NOT COMPLETED|Overall Study||0
1590679|NCT01054339|3890564|P2|NOT COMPLETED|Overall Study||0
1590680|NCT01054339|3890565|P1|NOT COMPLETED|Overall Study||0
1590681|NCT01054339|3890563|P3|COMPLETED|Overall Study||3
1590682|NCT01054339|3890564|P2|COMPLETED|Overall Study||3
1590683|NCT01054339|3890565|P1|COMPLETED|Overall Study||3
1590684|NCT01054339|3890563|P3|STARTED|Overall Study||3
1590685|NCT01054339|3890564|P2|STARTED|Overall Study||3
1590686|NCT01054339|3890565|P1|STARTED|Overall Study||3
1590687|NCT01054300|3890581|P4|NOT COMPLETED|Period 2||0
1590688|NCT01054300|3890582|P3|NOT COMPLETED|Period 2||1
1590689|NCT01054300|3890583|P2|NOT COMPLETED|Period 2||0
1590690|NCT01054300|3890584|P1|NOT COMPLETED|Period 2||0
1590691|NCT01054300|3890581|P4|COMPLETED|Period 2||13
1590692|NCT01054300|3890582|P3|COMPLETED|Period 2||12
1590693|NCT01054300|3890583|P2|COMPLETED|Period 2||13
1590694|NCT01054300|3890584|P1|COMPLETED|Period 2||12
1590695|NCT01054300|3890581|P4|STARTED|Period 2||13
1590696|NCT01054300|3890582|P3|STARTED|Period 2||13
1590697|NCT01054300|3890583|P2|STARTED|Period 2||13
1590698|NCT01054300|3890584|P1|STARTED|Period 2||12
1590699|NCT01054300|3890581|P4|NOT COMPLETED|Period 1||0
1590700|NCT01054300|3890582|P3|NOT COMPLETED|Period 1||0
1590701|NCT01054300|3890583|P2|NOT COMPLETED|Period 1||0
1590702|NCT01054300|3890584|P1|NOT COMPLETED|Period 1||1
1590703|NCT01054300|3890581|P4|COMPLETED|Period 1||13
1590704|NCT01054300|3890582|P3|COMPLETED|Period 1||13
1590705|NCT01054300|3890583|P2|COMPLETED|Period 1||13
1590706|NCT01054300|3890584|P1|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
1590707|NCT01054300|3890581|P4|STARTED|Period 1||13
1590708|NCT01054300|3890582|P3|STARTED|Period 1||13
1590709|NCT01054300|3890583|P2|STARTED|Period 1||13
1590710|NCT01054300|3890584|P1|STARTED|Period 1||13
1590711|NCT01054222|3890634|P1|NOT COMPLETED|Overall Study||11
1590712|NCT01054222|3890634|P1|COMPLETED|Overall Study||20
1590713|NCT01054222|3890634|P1|STARTED|Overall Study||31
1590714|NCT01054209|3890655|P2|NOT COMPLETED|Overall Study||0
1590715|NCT01054209|3890656|P1|NOT COMPLETED|Overall Study||0
1590716|NCT01054209|3890655|P2|COMPLETED|Overall Study||58
1590717|NCT01054209|3890656|P1|COMPLETED|Overall Study||58
1590718|NCT01054209|3890655|P2|STARTED|Overall Study||58
1590719|NCT01054209|3890656|P1|STARTED|Overall Study||58
1590720|NCT01054183|3890664|P2|NOT COMPLETED|Overall Study||0
1590721|NCT01054183|3890665|P1|NOT COMPLETED|Overall Study||0
1590722|NCT01054183|3890664|P2|COMPLETED|Overall Study||12
1590723|NCT01054183|3890665|P1|COMPLETED|Overall Study||10
1590724|NCT01054183|3890664|P2|STARTED|Overall Study||12
1590725|NCT01054183|3890665|P1|STARTED|Overall Study||10
1590726|NCT01054170|3890675|P2|NOT COMPLETED|Overall Study||6
1590727|NCT01054170|3890676|P1|NOT COMPLETED|Overall Study||4
1590728|NCT01054170|3890675|P2|COMPLETED|Overall Study||21
1590729|NCT01054170|3890676|P1|COMPLETED|Overall Study||21
1590730|NCT01054170|3890675|P2|STARTED|Overall Study||27
1590731|NCT01054170|3890676|P1|STARTED|Overall Study||25
1590732|NCT01054079|3890728|P1|NOT COMPLETED|Overall Study||0
1590733|NCT01054079|3890728|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
1590734|NCT01054079|3890728|P1|# Recieved Proper PSA Testing|Overall Study||10
1590735|NCT01054079|3890728|P1|STARTED|Overall Study||20
1590736|NCT01053988|3890741|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
1590737|NCT01053988|3890742|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
1590738|NCT01053988|3890743|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
1590739|NCT01053988|3890744|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
1590740|NCT01053988|3890745|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
1590741|NCT01053988|3890746|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1590742|NCT01053988|3890741|P6|COMPLETED|24-week, Double-blind Treatment Period||151
1590743|NCT01053988|3890742|P5|COMPLETED|24-week, Double-blind Treatment Period||147
1590744|NCT01053988|3890743|P4|COMPLETED|24-week, Double-blind Treatment Period||142
1590745|NCT01053988|3890744|P3|COMPLETED|24-week, Double-blind Treatment Period||145
1590746|NCT01053988|3890745|P2|COMPLETED|24-week, Double-blind Treatment Period||138
1590747|NCT01053988|3890746|P1|COMPLETED|24-week, Double-blind Treatment Period||0
1590748|NCT01053988|3890741|P6|STARTED|24-week, Double-blind Treatment Period||206
1590749|NCT01053988|3890742|P5|STARTED|24-week, Double-blind Treatment Period||206
1590750|NCT01053988|3890743|P4|STARTED|24-week, Double-blind Treatment Period||205
1590751|NCT01053988|3890744|P3|STARTED|24-week, Double-blind Treatment Period||206
1590752|NCT01053988|3890745|P2|STARTED|24-week, Double-blind Treatment Period||207
1590753|NCT01053988|3890746|P1|STARTED|24-week, Double-blind Treatment Period||0
1590754|NCT01053988|3890741|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590755|NCT01053988|3890742|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590756|NCT01053988|3890743|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590757|NCT01053988|3890744|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590758|NCT01053988|3890745|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1590759|NCT01053988|3890746|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
1590760|NCT01053988|3890741|P6|COMPLETED|2-week, Single-blind Run-In Period||0
1590761|NCT01053988|3890742|P5|COMPLETED|2-week, Single-blind Run-In Period||0
1590762|NCT01053988|3890743|P4|COMPLETED|2-week, Single-blind Run-In Period||0
1590763|NCT01053988|3890744|P3|COMPLETED|2-week, Single-blind Run-In Period||0
1590764|NCT01053988|3890745|P2|COMPLETED|2-week, Single-blind Run-In Period||0
1590765|NCT01053988|3890746|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
1590766|NCT01053988|3890741|P6|STARTED|2-week, Single-blind Run-In Period||0
1590767|NCT01053988|3890742|P5|STARTED|2-week, Single-blind Run-In Period||0
1590768|NCT01053988|3890743|P4|STARTED|2-week, Single-blind Run-In Period||0
1590769|NCT01053988|3890744|P3|STARTED|2-week, Single-blind Run-In Period||0
1590770|NCT01053988|3890745|P2|STARTED|2-week, Single-blind Run-In Period||0
1590771|NCT01053988|3890746|P1|STARTED|2-week, Single-blind Run-In Period||1390
1590772|NCT01053897|3890778|P1|NOT COMPLETED|Overall Study||0
1590773|NCT01053897|3890778|P1|COMPLETED|Overall Study||5
1590774|NCT01053897|3890778|P1|STARTED|Overall Study||5
1590775|NCT01053819|3890790|P1|NOT COMPLETED|Overall Study||0
1590776|NCT01053819|3890790|P1|COMPLETED|Overall Study||6
1590777|NCT01053819|3890790|P1|STARTED|Overall Study||6
1590778|NCT01053741|3890797|P2|NOT COMPLETED|2nd Study Intervention||1
1590779|NCT01053741|3890798|P1|NOT COMPLETED|2nd Study Intervention||0
1590780|NCT01053741|3890797|P2|COMPLETED|2nd Study Intervention||5
1590781|NCT01053741|3890798|P1|COMPLETED|2nd Study Intervention||5
1590782|NCT01053741|3890797|P2|STARTED|2nd Study Intervention||6
1590783|NCT01053741|3890798|P1|STARTED|2nd Study Intervention||5
1590784|NCT01053741|3890797|P2|NOT COMPLETED|14 Day Washout||0
1590785|NCT01053741|3890798|P1|NOT COMPLETED|14 Day Washout||0
1590786|NCT01053741|3890797|P2|COMPLETED|14 Day Washout||6
1590787|NCT01053741|3890798|P1|COMPLETED|14 Day Washout||5
1590788|NCT01053741|3890797|P2|STARTED|14 Day Washout||6
1590789|NCT01053741|3890798|P1|STARTED|14 Day Washout||5
1590790|NCT01053741|3890797|P2|NOT COMPLETED|1st Intervention||0
1590791|NCT01053741|3890798|P1|NOT COMPLETED|1st Intervention||0
1590792|NCT01053741|3890797|P2|COMPLETED|1st Intervention||6
1590793|NCT01053741|3890798|P1|COMPLETED|1st Intervention||5
1590794|NCT01053741|3890797|P2|STARTED|1st Intervention||6
1590795|NCT01053741|3890798|P1|STARTED|1st Intervention||5
1590796|NCT01053663|3890807|P1|NOT COMPLETED|Overall Study||6
1590797|NCT01053663|3890807|P1|COMPLETED|Overall Study||3
1590798|NCT01053663|3890807|P1|STARTED|Overall Study||9
1590799|NCT01053507|3890850|P2|NOT COMPLETED|Overall Study||1
1590800|NCT01053507|3890851|P1|NOT COMPLETED|Overall Study||3
1590801|NCT01053507|3890850|P2|COMPLETED|Overall Study||11
1590802|NCT01053507|3890851|P1|COMPLETED|Overall Study||8
1590803|NCT01053507|3890850|P2|STARTED|Overall Study||12
1590804|NCT01053507|3890851|P1|STARTED|Overall Study||11
1590805|NCT01053429|3890865|P1|NOT COMPLETED|Overall Study||373
1590806|NCT01053429|3890865|P1|COMPLETED|Overall Study||3018
1590807|NCT01053429|3890865|P1|STARTED|Overall Study||3391
1590808|NCT01053312|3890874|P1|NOT COMPLETED|Overall Study||0
1590809|NCT01053312|3890874|P1|COMPLETED|Overall Study||7
1590810|NCT01053312|3890874|P1|STARTED|Overall Study||7
1590811|NCT01053247|3890895|P3|NOT COMPLETED|Overall Study||28
1590812|NCT01053247|3890896|P2|NOT COMPLETED|Overall Study||19
1590813|NCT01053247|3890897|P1|NOT COMPLETED|Overall Study||20
1590814|NCT01053247|3890895|P3|COMPLETED|Overall Study||236
1590815|NCT01053247|3890896|P2|COMPLETED|Overall Study||241
1590816|NCT01053247|3890897|P1|COMPLETED|Overall Study||249
1590817|NCT01053247|3890895|P3|STARTED|Overall Study||264
1590818|NCT01053247|3890896|P2|STARTED|Overall Study||260
1590819|NCT01053247|3890897|P1|STARTED|Overall Study||269
1590820|NCT01053156|3890907|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
1590821|NCT01053156|3890908|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
1590822|NCT01053156|3890907|P2|COMPLETED|Second Intervention (Week 13-24)||22
1590823|NCT01053156|3890908|P1|COMPLETED|Second Intervention (Week 13-24)||26
1590824|NCT01053156|3890907|P2|STARTED|Second Intervention (Week 13-24)||27
1590825|NCT01053156|3890908|P1|STARTED|Second Intervention (Week 13-24)||28
1590826|NCT01053156|3890907|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
1590827|NCT01053156|3890908|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
1590828|NCT01053156|3890907|P2|COMPLETED|First Intervention (Week 1-12)||27
1590829|NCT01053156|3890908|P1|COMPLETED|First Intervention (Week 1-12)||28
1590830|NCT01053156|3890907|P2|STARTED|First Intervention (Week 1-12)||33
1590831|NCT01053156|3890908|P1|STARTED|First Intervention (Week 1-12)||33
1590832|NCT01053078|3890946|P2|NOT COMPLETED|Overall Study||3
1590833|NCT01053078|3890947|P1|NOT COMPLETED|Overall Study||4
1590834|NCT01053078|3890946|P2|COMPLETED|Overall Study||12
1590835|NCT01053078|3890947|P1|COMPLETED|Overall Study||10
1590836|NCT01053078|3890946|P2|STARTED|Overall Study||15
1590837|NCT01053078|3890947|P1|STARTED|Overall Study||14
1590838|NCT01053000|3890953|P2|NOT COMPLETED|Overall Study||0
1590839|NCT01053000|3890954|P1|NOT COMPLETED|Overall Study||0
1590840|NCT01053000|3890953|P2|COMPLETED|Overall Study||5
1590841|NCT01053000|3890954|P1|COMPLETED|Overall Study||5
1590842|NCT01053000|3890953|P2|STARTED|Overall Study||5
1590843|NCT01053000|3890954|P1|STARTED|Overall Study||5
1590844|NCT01052948|3890964|P4|NOT COMPLETED|Overall Study||0
1590845|NCT01052948|3890965|P3|NOT COMPLETED|Overall Study||0
1590846|NCT01052948|3890966|P2|NOT COMPLETED|Overall Study||0
1590847|NCT01052948|3890967|P1|NOT COMPLETED|Overall Study||0
1590848|NCT01052948|3890964|P4|COMPLETED|Overall Study||29311
1590849|NCT01052948|3890965|P3|COMPLETED|Overall Study||15147
1590850|NCT01052948|3890966|P2|COMPLETED|Overall Study||14669
1590851|NCT01052948|3890967|P1|COMPLETED|Overall Study||27812
1590852|NCT01052948|3890964|P4|STARTED|Overall Study||29311
1590853|NCT01052948|3890965|P3|STARTED|Overall Study||15147
1590854|NCT01052948|3890966|P2|STARTED|Overall Study||14669
1590855|NCT01052948|3890967|P1|STARTED|Overall Study||27812
1590856|NCT01052844|3890991|P2|NOT COMPLETED|Overall Study||1
1590857|NCT01052844|3890992|P1|NOT COMPLETED|Overall Study||0
1590858|NCT01052844|3890991|P2|COMPLETED|Overall Study||39
1590859|NCT01052844|3890992|P1|COMPLETED|Overall Study||40
1590860|NCT01052844|3890991|P2|STARTED|Overall Study||40
1590861|NCT01052844|3890992|P1|STARTED|Overall Study||40
1590862|NCT01052831|3891002|P2|NOT COMPLETED|Overall Study||1
1590863|NCT01052831|3891003|P1|NOT COMPLETED|Overall Study||4
1590864|NCT01052831|3891002|P2|COMPLETED|Overall Study||23
1590865|NCT01052831|3891003|P1|COMPLETED|Overall Study||22
1590866|NCT01052831|3891002|P2|STARTED|Overall Study||24
1590867|NCT01052831|3891003|P1|STARTED|Overall Study||26
1590868|NCT01052779|3891013|P2|NOT COMPLETED|Overall Study||9
1590869|NCT01052779|3891014|P1|NOT COMPLETED|Overall Study||5
1590870|NCT01052779|3891013|P2|COMPLETED|Overall Study||73
1590871|NCT01052779|3891014|P1|COMPLETED|Overall Study||75
1590872|NCT01052779|3891013|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
1590873|NCT01052779|3891014|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
1590874|NCT01052779|3891013|P2|STARTED|Overall Study||82
1590875|NCT01052779|3891014|P1|STARTED|Overall Study||80
1590876|NCT01052714|3891024|P3|NOT COMPLETED|Overall Study||2
1590877|NCT01052714|3891025|P2|NOT COMPLETED|Overall Study||29
1590878|NCT01052714|3891026|P1|NOT COMPLETED|Overall Study||25
1590879|NCT01052714|3891024|P3|COMPLETED|Overall Study||15
1590880|NCT01052714|3891025|P2|COMPLETED|Overall Study||33
1590881|NCT01052714|3891026|P1|COMPLETED|Overall Study||17
1590882|NCT01052714|3891024|P3|STARTED|Overall Study||17
1590883|NCT01052714|3891025|P2|STARTED|Overall Study||62
1590884|NCT01052714|3891026|P1|STARTED|Overall Study||42
1590885|NCT01052701|3891068|P2|NOT COMPLETED|Overall Study||0
1590886|NCT01052701|3891069|P1|NOT COMPLETED|Overall Study||0
1590887|NCT01052701|3891068|P2|COMPLETED|Overall Study||12
1590888|NCT01052701|3891069|P1|COMPLETED|Overall Study||14
1590889|NCT01052701|3891068|P2|STARTED|Overall Study||12
1590890|NCT01052701|3891069|P1|STARTED|Overall Study||14
1590891|NCT01052662|3891080|P3|NOT COMPLETED|Overall Study||22
1590892|NCT01052662|3891081|P2|NOT COMPLETED|Overall Study||22
1590893|NCT01052662|3891082|P1|NOT COMPLETED|Overall Study||22
1590894|NCT01052662|3891080|P3|COMPLETED|Overall Study||10
1590895|NCT01052662|3891081|P2|COMPLETED|Overall Study||5
1590896|NCT01052662|3891082|P1|COMPLETED|Overall Study||6
1590897|NCT01052662|3891080|P3|Discontinuation Phase|Overall Study||10
1590898|NCT01052662|3891081|P2|Discontinuation Phase|Overall Study||5
1590899|NCT01052662|3891082|P1|Discontinuation Phase|Overall Study||6
1590900|NCT01052662|3891080|P3|Stabilization Phase|Overall Study||26
1590901|NCT01052662|3891081|P2|Stabilization Phase|Overall Study||21
1590902|NCT01052662|3891082|P1|Stabilization Phase|Overall Study||21
1590903|NCT01052662|3891080|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
1590904|NCT01052662|3891081|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
1590905|NCT01052662|3891082|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
1590906|NCT01052545|3891098|P2|NOT COMPLETED|Overall Study||0
1590907|NCT01052545|3891099|P1|NOT COMPLETED|Overall Study||0
1590908|NCT01052545|3891098|P2|COMPLETED|Overall Study||731
1590909|NCT01052545|3891099|P1|COMPLETED|Overall Study||867
1590910|NCT01052545|3891098|P2|STARTED|Overall Study||731
1590911|NCT01052545|3891099|P1|STARTED|Overall Study||867
1590912|NCT01052480|3891113|P2|NOT COMPLETED|Overall Study||17
1590913|NCT01052480|3891114|P1|NOT COMPLETED|Overall Study||8
1590914|NCT01052480|3891113|P2|COMPLETED|Overall Study||32
1590915|NCT01052480|3891114|P1|COMPLETED|Overall Study||41
1590916|NCT01052480|3891113|P2|STARTED|Overall Study||49
1590917|NCT01052480|3891114|P1|STARTED|Overall Study||49
1590918|NCT01052428|3891164|P2|NOT COMPLETED|Overall Study||1
1590919|NCT01052428|3891165|P1|NOT COMPLETED|Overall Study||1
1590920|NCT01052428|3891164|P2|COMPLETED|Overall Study||18
1590921|NCT01052428|3891165|P1|COMPLETED|Overall Study||18
1590922|NCT01052428|3891164|P2|STARTED|Overall Study||19
1590923|NCT01052428|3891165|P1|STARTED|Overall Study||19
1590924|NCT01052272|3891187|P4|NOT COMPLETED|Overall Study||7
1590925|NCT01052272|3891188|P3|NOT COMPLETED|Overall Study||8
1590926|NCT01052272|3891189|P2|NOT COMPLETED|Overall Study||7
1590927|NCT01052272|3891190|P1|NOT COMPLETED|Overall Study||5
1590928|NCT01052272|3891187|P4|COMPLETED|Overall Study||11
1590929|NCT01052272|3891188|P3|COMPLETED|Overall Study||10
1590930|NCT01052272|3891189|P2|COMPLETED|Overall Study||11
1590931|NCT01052272|3891190|P1|COMPLETED|Overall Study||13
1590932|NCT01052272|3891187|P4|STARTED|Overall Study||18
1590933|NCT01052272|3891188|P3|STARTED|Overall Study||18
1590934|NCT01052272|3891189|P2|STARTED|Overall Study||18
1590935|NCT01052272|3891190|P1|STARTED|Overall Study||18
1590936|NCT01052207|3891226|P2|NOT COMPLETED|Overall Study||0
1590937|NCT01052207|3891227|P1|NOT COMPLETED|Overall Study||0
1590938|NCT01052207|3891226|P2|COMPLETED|Overall Study||42
1590939|NCT01052207|3891227|P1|COMPLETED|Overall Study||60
1590940|NCT01052207|3891226|P2|STARTED|Overall Study||42
1590941|NCT01052207|3891227|P1|STARTED|Overall Study||60
1590942|NCT01052116|3891235|P2|NOT COMPLETED|Overall Study||27
1590943|NCT01052116|3891236|P1|NOT COMPLETED|Overall Study||14
1590944|NCT01052116|3891235|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
1590945|NCT01052116|3891236|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
1590946|NCT01052116|3891235|P2|STARTED|Overall Study||193
1590947|NCT01052116|3891236|P1|STARTED|Overall Study||193
1590948|NCT01052077|3891244|P4|NOT COMPLETED|Phase A+||21
1590949|NCT01052077|3891245|P3|NOT COMPLETED|Phase A+||0
1590950|NCT01052077|3891246|P2|NOT COMPLETED|Phase A+||0
1590951|NCT01052077|3891247|P1|NOT COMPLETED|Phase A+||0
1590952|NCT01052077|3891244|P4|COMPLETED|Phase A+||230
1590953|NCT01052077|3891245|P3|COMPLETED|Phase A+||0
1590954|NCT01052077|3891246|P2|COMPLETED|Phase A+||0
1590955|NCT01052077|3891247|P1|COMPLETED|Phase A+||0
1590956|NCT01052077|3891244|P4|STARTED|Phase A+||251
1590957|NCT01052077|3891245|P3|STARTED|Phase A+||0
1590958|NCT01052077|3891246|P2|STARTED|Phase A+||0
1590959|NCT01052077|3891247|P1|STARTED|Phase A+||0
1590960|NCT01052077|3891244|P4|NOT COMPLETED|Phase B||0
1590961|NCT01052077|3891245|P3|NOT COMPLETED|Phase B||16
1590962|NCT01052077|3891246|P2|NOT COMPLETED|Phase B||18
1590963|NCT01052077|3891247|P1|NOT COMPLETED|Phase B||0
1590964|NCT01052077|3891244|P4|COMPLETED|Phase B||0
1590965|NCT01052077|3891245|P3|COMPLETED|Phase B||171
1590966|NCT01052077|3891246|P2|COMPLETED|Phase B||167
1590967|NCT01052077|3891247|P1|COMPLETED|Phase B||0
1590968|NCT01052077|3891244|P4|STARTED|Phase B||0
1590969|NCT01052077|3891245|P3|STARTED|Phase B||187
1590970|NCT01052077|3891246|P2|STARTED|Phase B||185
1590971|NCT01052077|3891247|P1|STARTED|Phase B||0
1590972|NCT01052077|3891244|P4|NOT COMPLETED|Phase A||0
1590973|NCT01052077|3891245|P3|NOT COMPLETED|Phase A||0
1590974|NCT01052077|3891246|P2|NOT COMPLETED|Phase A||0
1590975|NCT01052077|3891247|P1|NOT COMPLETED|Phase A||146
1590976|NCT01052077|3891244|P4|COMPLETED|Phase A||0
1590977|NCT01052077|3891245|P3|COMPLETED|Phase A||0
1590978|NCT01052077|3891246|P2|COMPLETED|Phase A||0
1590979|NCT01052077|3891247|P1|COMPLETED|Phase A||623
1590980|NCT01052077|3891244|P4|STARTED|Phase A||0
1590981|NCT01052077|3891245|P3|STARTED|Phase A||0
1590982|NCT01052077|3891246|P2|STARTED|Phase A||0
1590983|NCT01052077|3891247|P1|STARTED|Phase A||769
1590984|NCT01052038|3891274|P3|NOT COMPLETED|Overall Study||4
1590985|NCT01052038|3891275|P2|NOT COMPLETED|Overall Study||6
1590986|NCT01052038|3891276|P1|NOT COMPLETED|Overall Study||4
1590987|NCT01052038|3891274|P3|COMPLETED|Overall Study||36
1590988|NCT01052038|3891275|P2|COMPLETED|Overall Study||34
1590989|NCT01052038|3891276|P1|COMPLETED|Overall Study||36
1590990|NCT01052038|3891274|P3|STARTED|Overall Study||40
1590991|NCT01052038|3891275|P2|STARTED|Overall Study||40
1590992|NCT01052038|3891276|P1|STARTED|Overall Study||40
1590993|NCT01051986|3891298|P2|NOT COMPLETED|Overall Study||4
1590994|NCT01051986|3891299|P1|NOT COMPLETED|Overall Study||5
1590995|NCT01051986|3891298|P2|COMPLETED|Overall Study||108
1590996|NCT01051986|3891299|P1|COMPLETED|Overall Study||107
1590997|NCT01051986|3891298|P2|STARTED|Overall Study||112
1590998|NCT01051986|3891299|P1|STARTED|Overall Study||112
1590999|NCT01051921|3891313|P1|NOT COMPLETED|Overall Study||30
1591000|NCT01051921|3891313|P1|COMPLETED|Overall Study||37
1591001|NCT01051921|3891313|P1|STARTED|Overall Study||67
1591002|NCT01051856|3891320|P2|NOT COMPLETED|Overall Study||0
1591003|NCT01051856|3891321|P1|NOT COMPLETED|Overall Study||1
1591004|NCT01051856|3891320|P2|COMPLETED|Overall Study||35
1591005|NCT01051856|3891321|P1|COMPLETED|Overall Study||32
1591006|NCT01051856|3891320|P2|STARTED|Overall Study||35
1591007|NCT01051856|3891321|P1|STARTED|Overall Study||33
1591008|NCT01051817|3891331|P2|NOT COMPLETED|Overall Study||9
1591009|NCT01051817|3891332|P1|NOT COMPLETED|Overall Study||3
1591010|NCT01051817|3891331|P2|COMPLETED|Overall Study||26
1591011|NCT01051817|3891332|P1|COMPLETED|Overall Study||35
1591012|NCT01051817|3891331|P2|STARTED|Overall Study||35
1591013|NCT01051817|3891332|P1|STARTED|Overall Study||38
1591014|NCT01051791|3891342|P1|NOT COMPLETED|Overall Study||4
1591015|NCT01051791|3891342|P1|COMPLETED|Overall Study||9
1591016|NCT01051791|3891342|P1|STARTED|Overall Study||13
1591017|NCT01051778|3891351|P2|NOT COMPLETED|Overall Study||0
1591018|NCT01051778|3891352|P1|NOT COMPLETED|Overall Study||0
1591019|NCT01051778|3891351|P2|COMPLETED|Overall Study|November 2009|30
1591020|NCT01051778|3891352|P1|COMPLETED|Overall Study|November 2009|30
1591021|NCT01051778|3891351|P2|STARTED|Overall Study|June 2006|30
1591022|NCT01051778|3891352|P1|STARTED|Overall Study|June 2006|30
1591023|NCT01051739|3891360|P2|NOT COMPLETED|Overall Study||13
1591024|NCT01051739|3891361|P1|NOT COMPLETED|Overall Study||28
1591025|NCT01051739|3891360|P2|COMPLETED|Overall Study||47
1591026|NCT01051739|3891361|P1|COMPLETED|Overall Study||92
1591027|NCT01051739|3891360|P2|STARTED|Overall Study||60
1591028|NCT01051739|3891361|P1|STARTED|Overall Study||120
1591029|NCT01051570|3891367|P1|NOT COMPLETED|Overall Study||0
1591030|NCT01051570|3891367|P1|COMPLETED|Overall Study||26
1591031|NCT01051570|3891367|P1|STARTED|Overall Study||26
1591032|NCT01051557|3891378|P7|NOT COMPLETED|Overall Study||6
1591033|NCT01051557|3891379|P6|NOT COMPLETED|Overall Study||6
1591034|NCT01051557|3891380|P5|NOT COMPLETED|Overall Study||7
1591035|NCT01051557|3891381|P4|NOT COMPLETED|Overall Study||3
1591036|NCT01051557|3891382|P3|NOT COMPLETED|Overall Study||6
1591037|NCT01051557|3891383|P2|NOT COMPLETED|Overall Study||3
1591038|NCT01051557|3891384|P1|NOT COMPLETED|Overall Study||4
1591039|NCT01051557|3891378|P7|COMPLETED|Overall Study||0
1591040|NCT01051557|3891379|P6|COMPLETED|Overall Study||0
1591041|NCT01051557|3891380|P5|COMPLETED|Overall Study||1
1591042|NCT01051557|3891381|P4|COMPLETED|Overall Study||0
1591043|NCT01051557|3891382|P3|COMPLETED|Overall Study||0
1591044|NCT01051557|3891383|P2|COMPLETED|Overall Study||0
1591045|NCT01051557|3891384|P1|COMPLETED|Overall Study||0
1591046|NCT01051557|3891378|P7|STARTED|Overall Study||6
1591047|NCT01051557|3891379|P6|STARTED|Overall Study||6
1591048|NCT01051557|3891380|P5|STARTED|Overall Study||8
1591049|NCT01051557|3891381|P4|STARTED|Overall Study||3
1591050|NCT01051557|3891382|P3|STARTED|Overall Study||6
1591051|NCT01051557|3891383|P2|STARTED|Overall Study||3
1591052|NCT01051557|3891384|P1|STARTED|Overall Study||4
1591053|NCT01051466|3891403|P2|NOT COMPLETED|Overall Study||5
1591054|NCT01051466|3891404|P1|NOT COMPLETED|Overall Study||8
1591055|NCT01051466|3891403|P2|COMPLETED|Overall Study||23
1591056|NCT01051466|3891404|P1|COMPLETED|Overall Study||24
1591057|NCT01051466|3891403|P2|STARTED|Overall Study||28
1591058|NCT01051466|3891404|P1|STARTED|Overall Study||32
1591059|NCT01051440|3891438|P2|NOT COMPLETED|Overall Study||0
1591060|NCT01051440|3891439|P1|NOT COMPLETED|Overall Study||0
1591061|NCT01051440|3891438|P2|COMPLETED|Overall Study||1
1591062|NCT01051440|3891439|P1|COMPLETED|Overall Study||1
1591063|NCT01051440|3891438|P2|STARTED|Overall Study||1
1591064|NCT01051440|3891439|P1|STARTED|Overall Study||1
1591065|NCT01051349|3891449|P1|NOT COMPLETED|Overall Study||173
1591066|NCT01051349|3891449|P1|COMPLETED|Overall Study||237
1591067|NCT01051349|3891449|P1|STARTED|Overall Study||410
1591068|NCT01051323|3891478|P1|NOT COMPLETED|Overall Study||539
1591069|NCT01051323|3891478|P1|COMPLETED|Overall Study||1041
1591070|NCT01051323|3891478|P1|Received at Least One Dose|Overall Study||1547
1591071|NCT01051323|3891478|P1|STARTED|Overall Study||1580
1591072|NCT01051063|3891502|P2|NOT COMPLETED|Overall Study||4
1591073|NCT01051063|3891503|P1|NOT COMPLETED|Overall Study||10
1591074|NCT01051063|3891502|P2|COMPLETED|Overall Study||1
1591075|NCT01051063|3891503|P1|COMPLETED|Overall Study||2
1591076|NCT01051063|3891502|P2|STARTED|Overall Study||5
1591077|NCT01051063|3891503|P1|STARTED|Overall Study||12
1591078|NCT01050998|3891523|P5|NOT COMPLETED|Overall Study||14
1591079|NCT01050998|3891524|P4|NOT COMPLETED|Overall Study||3
1591080|NCT01050998|3891525|P3|NOT COMPLETED|Overall Study||3
1591081|NCT01050998|3891526|P2|NOT COMPLETED|Overall Study||2
1591082|NCT01050998|3891527|P1|NOT COMPLETED|Overall Study||4
1591083|NCT01050998|3891523|P5|COMPLETED|Overall Study||82
1591084|NCT01050998|3891524|P4|COMPLETED|Overall Study||45
1591085|NCT01050998|3891525|P3|COMPLETED|Overall Study||46
1591086|NCT01050998|3891526|P2|COMPLETED|Overall Study||47
1591087|NCT01050998|3891527|P1|COMPLETED|Overall Study||44
1591088|NCT01050998|3891523|P5|STARTED|Overall Study||96
1591089|NCT01050998|3891524|P4|STARTED|Overall Study||48
1591090|NCT01050998|3891525|P3|STARTED|Overall Study||49
1591091|NCT01050998|3891526|P2|STARTED|Overall Study||49
1591092|NCT01050998|3891527|P1|STARTED|Overall Study||48
1591093|NCT01050946|3891851|P1|NOT COMPLETED|Overall Study||0
1591094|NCT01050946|3891851|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
1591095|NCT01050946|3891851|P1|STARTED|Overall Study||1
1591096|NCT01050816|3891861|P1|NOT COMPLETED|Overall Study||4
1591097|NCT01050816|3891861|P1|COMPLETED|Overall Study||26
1591098|NCT01050816|3891861|P1|STARTED|Overall Study||30
1591099|NCT01050790|3891867|P1|NOT COMPLETED|Overall Study||1
1591100|NCT01050790|3891867|P1|COMPLETED|Overall Study||16
1591101|NCT01050790|3891867|P1|STARTED|Overall Study||17
1591102|NCT01050764|3891877|P1|NOT COMPLETED|Overall Study||3
1591103|NCT01050764|3891877|P1|COMPLETED|Overall Study||7
1591104|NCT01050764|3891877|P1|Received Infusion of T-con Cells|Overall Study||7
1591105|NCT01050764|3891877|P1|Received Infusion of T-reg Cells|Overall Study||7
1591106|NCT01050764|3891877|P1|Received HSCT Graft|Overall Study||8
1591107|NCT01050764|3891877|P1|STARTED|Overall Study||10
1591108|NCT01050673|3891888|P2|NOT COMPLETED|Overall Study||5
1591109|NCT01050673|3891889|P1|NOT COMPLETED|Overall Study||4
1591110|NCT01050673|3891888|P2|COMPLETED|Overall Study||14
1591111|NCT01050673|3891889|P1|COMPLETED|Overall Study||17
1591112|NCT01050673|3891888|P2|STARTED|Overall Study||19
1591113|NCT01050673|3891889|P1|STARTED|Overall Study||21
1591114|NCT01050660|3891913|P2|NOT COMPLETED|Overall Study||0
1591115|NCT01050660|3891914|P1|NOT COMPLETED|Overall Study||0
1591116|NCT01050660|3891913|P2|COMPLETED|Overall Study||69
1591117|NCT01050660|3891914|P1|COMPLETED|Overall Study||67
1591118|NCT01050660|3891913|P2|STARTED|Overall Study||69
1591119|NCT01050660|3891914|P1|STARTED|Overall Study||67
1591120|NCT01050647|3891940|P2|NOT COMPLETED|Overall Study||0
1591121|NCT01050647|3891941|P1|NOT COMPLETED|Overall Study||0
1591122|NCT01050647|3891940|P2|COMPLETED|Overall Study||11
1591123|NCT01050647|3891941|P1|COMPLETED|Overall Study||10
1591124|NCT01050647|3891940|P2|STARTED|Overall Study||11
1591125|NCT01050647|3891941|P1|STARTED|Overall Study||10
1591126|NCT01050634|3891957|P1|NOT COMPLETED|Overall Study||128
1591127|NCT01050634|3891957|P1|COMPLETED|Overall Study||852
1591128|NCT01050634|3891957|P1|Received Treatment|Overall Study||924
1591129|NCT01050634|3891957|P1|STARTED|Overall Study||980
1591130|NCT01050582|3891967|P2|NOT COMPLETED|Overall Study||0
1591131|NCT01050582|3891968|P1|NOT COMPLETED|Overall Study||0
1591132|NCT01050582|3891967|P2|COMPLETED|Overall Study||51
1591133|NCT01050582|3891968|P1|COMPLETED|Overall Study||133
1591134|NCT01050582|3891967|P2|STARTED|Overall Study||51
1591135|NCT01050582|3891968|P1|STARTED|Overall Study||133
1591136|NCT01050569|3891981|P3|NOT COMPLETED|Overall Study||33
1591137|NCT01050569|3891982|P2|NOT COMPLETED|Overall Study||24
1591138|NCT01050569|3891983|P1|NOT COMPLETED|Overall Study||38
1591139|NCT01050569|3891981|P3|COMPLETED|Overall Study||47
1591140|NCT01050569|3891982|P2|COMPLETED|Overall Study||52
1591141|NCT01050569|3891983|P1|COMPLETED|Overall Study||41
1591142|NCT01050569|3891981|P3|STARTED|Overall Study||80
1591143|NCT01050569|3891982|P2|STARTED|Overall Study||76
1591144|NCT01050569|3891983|P1|STARTED|Overall Study||79
1591145|NCT01050543|3892002|P2|NOT COMPLETED|Overall Study||4
1591146|NCT01050543|3892003|P1|NOT COMPLETED|Overall Study||4
1591147|NCT01050543|3892002|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
1591148|NCT01050543|3892003|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
1591149|NCT01050543|3892002|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
1591150|NCT01050543|3892003|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
1591151|NCT01050530|3892011|P2|NOT COMPLETED|Overall Study||10
1591152|NCT01050530|3892012|P1|NOT COMPLETED|Overall Study||8
1591153|NCT01050530|3892011|P2|COMPLETED|Overall Study||70
1591154|NCT01050530|3892012|P1|COMPLETED|Overall Study||74
1591155|NCT01050530|3892011|P2|STARTED|Overall Study||80
1591156|NCT01050530|3892012|P1|STARTED|Overall Study||82
1591157|NCT01050257|3892023|P3|NOT COMPLETED|Overall Study||7
1591158|NCT01050257|3892024|P2|NOT COMPLETED|Overall Study||13
1591159|NCT01050257|3892025|P1|NOT COMPLETED|Overall Study||11
1591160|NCT01050257|3892023|P3|COMPLETED|Overall Study||8
1591161|NCT01050257|3892024|P2|COMPLETED|Overall Study||40
1591162|NCT01050257|3892025|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
1591163|NCT01050257|3892023|P3|Switched to Oral Treatment|Overall Study||3
1591164|NCT01050257|3892024|P2|Switched to Oral Treatment|Overall Study||31
1591165|NCT01050257|3892025|P1|Switched to Oral Treatment|Overall Study||28
1591166|NCT01050257|3892023|P3|Intent-to-treat Infected Confirmed|Overall Study||10
1591167|NCT01050257|3892024|P2|Intent-to-treat Infected Confirmed|Overall Study||32
1591168|NCT01050257|3892025|P1|Intent-to-treat Infected Confirmed|Overall Study||30
1591169|NCT01050257|3892023|P3|Safety Population: Actual Dose Received|Overall Study||14
1591170|NCT01050257|3892024|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
1591171|NCT01050257|3892025|P1|Safety Population: Actual Dose Received|Overall Study||48
1591172|NCT01050257|3892023|P3|Received Treatment|Overall Study||14
1591173|NCT01050257|3892024|P2|Received Treatment|Overall Study||50
1591174|NCT01050257|3892025|P1|Received Treatment|Overall Study||49
1591175|NCT01050257|3892023|P3|STARTED|Overall Study||15
1591176|NCT01050257|3892024|P2|STARTED|Overall Study||53
1591177|NCT01050257|3892025|P1|STARTED|Overall Study||50
1591178|NCT01050218|3892060|P1|NOT COMPLETED|Overall Study||95
1591179|NCT01050218|3892060|P1|COMPLETED|Overall Study||142
1591180|NCT01050218|3892060|P1|STARTED|Overall Study||237
1591181|NCT01050205|3892066|P2|NOT COMPLETED|Overall Study||4
1591182|NCT01050205|3892067|P1|NOT COMPLETED|Overall Study||11
1591183|NCT01050205|3892066|P2|COMPLETED|Overall Study||71
1591184|NCT01050205|3892067|P1|COMPLETED|Overall Study||137
1591185|NCT01050205|3892066|P2|STARTED|Overall Study||75
1591186|NCT01050205|3892067|P1|STARTED|Overall Study||148
1591187|NCT01050153|3892097|P2|NOT COMPLETED|Overall Study||0
1591188|NCT01050153|3892098|P1|NOT COMPLETED|Overall Study||0
1591189|NCT01050153|3892097|P2|COMPLETED|Overall Study||25
1591190|NCT01050153|3892098|P1|COMPLETED|Overall Study||25
1591191|NCT01050153|3892097|P2|STARTED|Overall Study||25
1591192|NCT01050153|3892098|P1|STARTED|Overall Study||25
1591193|NCT01050062|3892124|P2|NOT COMPLETED|Overall Study||112
1591194|NCT01050062|3892125|P1|NOT COMPLETED|Overall Study||271
1591195|NCT01050062|3892124|P2|COMPLETED|Overall Study||243
1591196|NCT01050062|3892125|P1|COMPLETED|Overall Study||799
1591197|NCT01050062|3892124|P2|STARTED|Overall Study||355
1591198|NCT01050062|3892125|P1|STARTED|Overall Study||1070
1591199|NCT01049984|3892147|P2|NOT COMPLETED|Overall Study||19
1591200|NCT01049984|3892148|P1|NOT COMPLETED|Overall Study||19
1591201|NCT01049984|3892147|P2|COMPLETED|Overall Study||146
1591202|NCT01049984|3892148|P1|COMPLETED|Overall Study||144
1591203|NCT01049984|3892147|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
1591204|NCT01049984|3892148|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
1591300|NCT01049360|3892305|P20|COMPLETED|Period 4||5
1591301|NCT01049360|3892306|P19|COMPLETED|Period 4||5
1591205|NCT01049984|3892147|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
1591206|NCT01049984|3892148|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
1591207|NCT01049984|3892147|P2|STARTED|Overall Study||165
1591208|NCT01049984|3892148|P1|STARTED|Overall Study||163
1591209|NCT01049945|3892166|P6|NOT COMPLETED|Overall Study||0
1591210|NCT01049945|3892167|P5|NOT COMPLETED|Overall Study||0
1591211|NCT01049945|3892168|P4|NOT COMPLETED|Overall Study||0
1591212|NCT01049945|3892169|P3|NOT COMPLETED|Overall Study||0
1591213|NCT01049945|3892170|P2|NOT COMPLETED|Overall Study||0
1591214|NCT01049945|3892171|P1|NOT COMPLETED|Overall Study||0
1591215|NCT01049945|3892166|P6|COMPLETED|Overall Study||49
1591216|NCT01049945|3892167|P5|COMPLETED|Overall Study||3
1591217|NCT01049945|3892168|P4|COMPLETED|Overall Study||6
1591218|NCT01049945|3892169|P3|COMPLETED|Overall Study||3
1591219|NCT01049945|3892170|P2|COMPLETED|Overall Study||6
1591220|NCT01049945|3892171|P1|COMPLETED|Overall Study||3
1591221|NCT01049945|3892166|P6|STARTED|Overall Study||49
1591222|NCT01049945|3892167|P5|STARTED|Overall Study||3
1591223|NCT01049945|3892168|P4|STARTED|Overall Study||6
1591224|NCT01049945|3892169|P3|STARTED|Overall Study||3
1591225|NCT01049945|3892170|P2|STARTED|Overall Study||6
1591226|NCT01049945|3892171|P1|STARTED|Overall Study||3
1591227|NCT01049802|3892187|P2|NOT COMPLETED|Overall Study||0
1591228|NCT01049802|3892188|P1|NOT COMPLETED|Overall Study||0
1591229|NCT01049802|3892187|P2|COMPLETED|Overall Study||10
1591230|NCT01049802|3892188|P1|COMPLETED|Overall Study||20
1591231|NCT01049802|3892187|P2|STARTED|Overall Study||10
1591232|NCT01049802|3892188|P1|STARTED|Overall Study||20
1591233|NCT01049776|3892202|P1|NOT COMPLETED|Overall Study||20
1591234|NCT01049776|3892202|P1|COMPLETED|Overall Study||12
1591235|NCT01049776|3892202|P1|STARTED|Overall Study||32
1591236|NCT01049581|3892208|P2|NOT COMPLETED|Overall Study||1
1591237|NCT01049581|3892209|P1|NOT COMPLETED|Overall Study||2
1591238|NCT01049581|3892208|P2|COMPLETED|Overall Study||13
1591239|NCT01049581|3892209|P1|COMPLETED|Overall Study||11
1591240|NCT01049581|3892208|P2|STARTED|Overall Study||14
1591241|NCT01049581|3892209|P1|STARTED|Overall Study||13
1591242|NCT01049503|3892224|P6|NOT COMPLETED|Overall Study||8
1591243|NCT01049503|3892225|P5|NOT COMPLETED|Overall Study||27
1591244|NCT01049503|3892226|P4|NOT COMPLETED|Overall Study||26
1591245|NCT01049503|3892227|P3|NOT COMPLETED|Overall Study||24
1591246|NCT01049503|3892228|P2|NOT COMPLETED|Overall Study||12
1591247|NCT01049503|3892229|P1|NOT COMPLETED|Overall Study||11
1591248|NCT01049503|3892224|P6|COMPLETED|Overall Study||40
1591249|NCT01049503|3892225|P5|COMPLETED|Overall Study||29
1591250|NCT01049503|3892226|P4|COMPLETED|Overall Study||29
1591251|NCT01049503|3892227|P3|COMPLETED|Overall Study||32
1591252|NCT01049503|3892228|P2|COMPLETED|Overall Study||36
1591253|NCT01049503|3892229|P1|COMPLETED|Overall Study||41
1591254|NCT01049503|3892224|P6|STARTED|Overall Study||48
1591255|NCT01049503|3892225|P5|STARTED|Overall Study||56
1591256|NCT01049503|3892226|P4|STARTED|Overall Study||55
1591257|NCT01049503|3892227|P3|STARTED|Overall Study||56
1591258|NCT01049503|3892228|P2|STARTED|Overall Study||48
1591259|NCT01049503|3892229|P1|STARTED|Overall Study||52
1591260|NCT01049412|3892260|P2|NOT COMPLETED|Period II||3
1591261|NCT01049412|3892261|P1|NOT COMPLETED|Period II||4
1591262|NCT01049412|3892260|P2|COMPLETED|Period II||52
1591263|NCT01049412|3892261|P1|COMPLETED|Period II||58
1591264|NCT01049412|3892260|P2|STARTED|Period II||55
1591265|NCT01049412|3892261|P1|STARTED|Period II||62
1591266|NCT01049412|3892260|P2|NOT COMPLETED|Period I||13
1591267|NCT01049412|3892261|P1|NOT COMPLETED|Period I||8
1591268|NCT01049412|3892260|P2|COMPLETED|Period I||55
1591269|NCT01049412|3892261|P1|COMPLETED|Period I||62
1591270|NCT01049412|3892260|P2|Took at Least One Dose of Study Drug|Period I||68
1591271|NCT01049412|3892261|P1|Took at Least One Dose of Study Drug|Period I||69
1591272|NCT01049412|3892260|P2|STARTED|Period I||68
1591273|NCT01049412|3892261|P1|STARTED|Period I||70
1591274|NCT01049373|3892290|P2|NOT COMPLETED|Overall Study||44
1591275|NCT01049373|3892291|P1|NOT COMPLETED|Overall Study||39
1591276|NCT01049373|3892290|P2|COMPLETED|Overall Study||65
1591277|NCT01049373|3892291|P1|COMPLETED|Overall Study||73
1591278|NCT01049373|3892290|P2|STARTED|Overall Study||109
1591279|NCT01049373|3892291|P1|STARTED|Overall Study||112
1591280|NCT01049360|3892305|P20|NOT COMPLETED|Period 4||0
1591281|NCT01049360|3892306|P19|NOT COMPLETED|Period 4||0
1591282|NCT01049360|3892307|P18|NOT COMPLETED|Period 4||1
1591283|NCT01049360|3892308|P17|NOT COMPLETED|Period 4||0
1591284|NCT01049360|3892309|P16|NOT COMPLETED|Period 4||0
1591285|NCT01049360|3892310|P15|NOT COMPLETED|Period 4||0
1591286|NCT01049360|3892311|P14|NOT COMPLETED|Period 4||0
1591287|NCT01049360|3892312|P13|NOT COMPLETED|Period 4||0
1591288|NCT01049360|3892313|P12|NOT COMPLETED|Period 4||0
1591289|NCT01049360|3892314|P11|NOT COMPLETED|Period 4||0
1591290|NCT01049360|3892315|P10|NOT COMPLETED|Period 4||0
1591291|NCT01049360|3892316|P9|NOT COMPLETED|Period 4||0
1591292|NCT01049360|3892317|P8|NOT COMPLETED|Period 4||0
1591293|NCT01049360|3892318|P7|NOT COMPLETED|Period 4||0
1591294|NCT01049360|3892319|P6|NOT COMPLETED|Period 4||0
1591295|NCT01049360|3892320|P5|NOT COMPLETED|Period 4||0
1591296|NCT01049360|3892321|P4|NOT COMPLETED|Period 4||1
1591297|NCT01049360|3892322|P3|NOT COMPLETED|Period 4||0
1591298|NCT01049360|3892323|P2|NOT COMPLETED|Period 4||0
1591299|NCT01049360|3892324|P1|NOT COMPLETED|Period 4||0
1591302|NCT01049360|3892307|P18|COMPLETED|Period 4||5
1591303|NCT01049360|3892308|P17|COMPLETED|Period 4||5
1591304|NCT01049360|3892309|P16|COMPLETED|Period 4||6
1591305|NCT01049360|3892310|P15|COMPLETED|Period 4||5
1591306|NCT01049360|3892311|P14|COMPLETED|Period 4||6
1591307|NCT01049360|3892312|P13|COMPLETED|Period 4||4
1591308|NCT01049360|3892313|P12|COMPLETED|Period 4||6
1591309|NCT01049360|3892314|P11|COMPLETED|Period 4||5
1591310|NCT01049360|3892315|P10|COMPLETED|Period 4||6
1591311|NCT01049360|3892316|P9|COMPLETED|Period 4||4
1591312|NCT01049360|3892317|P8|COMPLETED|Period 4||4
1591313|NCT01049360|3892318|P7|COMPLETED|Period 4||6
1591314|NCT01049360|3892319|P6|COMPLETED|Period 4||5
1591315|NCT01049360|3892320|P5|COMPLETED|Period 4||7
1591316|NCT01049360|3892321|P4|COMPLETED|Period 4||3
1591317|NCT01049360|3892322|P3|COMPLETED|Period 4||7
1591318|NCT01049360|3892323|P2|COMPLETED|Period 4||4
1591319|NCT01049360|3892324|P1|COMPLETED|Period 4||6
1591320|NCT01049360|3892305|P20|STARTED|Period 4||5
1591321|NCT01049360|3892306|P19|STARTED|Period 4||5
1591322|NCT01049360|3892307|P18|STARTED|Period 4||6
1591323|NCT01049360|3892308|P17|STARTED|Period 4||5
1591324|NCT01049360|3892309|P16|STARTED|Period 4||6
1591325|NCT01049360|3892310|P15|STARTED|Period 4||5
1591326|NCT01049360|3892311|P14|STARTED|Period 4||6
1591327|NCT01049360|3892312|P13|STARTED|Period 4||4
1591328|NCT01049360|3892313|P12|STARTED|Period 4||6
1591329|NCT01049360|3892314|P11|STARTED|Period 4||5
1591330|NCT01049360|3892315|P10|STARTED|Period 4||6
1591331|NCT01049360|3892316|P9|STARTED|Period 4||4
1591332|NCT01049360|3892317|P8|STARTED|Period 4||4
1591333|NCT01049360|3892318|P7|STARTED|Period 4||6
1591334|NCT01049360|3892319|P6|STARTED|Period 4||5
1591335|NCT01049360|3892320|P5|STARTED|Period 4||7
1591336|NCT01049360|3892321|P4|STARTED|Period 4||4
1591337|NCT01049360|3892322|P3|STARTED|Period 4||7
1591338|NCT01049360|3892323|P2|STARTED|Period 4||4
1591339|NCT01049360|3892324|P1|STARTED|Period 4||6
1591340|NCT01049360|3892305|P20|NOT COMPLETED|Period 3||0
1591341|NCT01049360|3892306|P19|NOT COMPLETED|Period 3||0
1591342|NCT01049360|3892307|P18|NOT COMPLETED|Period 3||0
1591343|NCT01049360|3892308|P17|NOT COMPLETED|Period 3||0
1591344|NCT01049360|3892309|P16|NOT COMPLETED|Period 3||0
1591345|NCT01049360|3892310|P15|NOT COMPLETED|Period 3||0
1591346|NCT01049360|3892311|P14|NOT COMPLETED|Period 3||0
1591347|NCT01049360|3892312|P13|NOT COMPLETED|Period 3||0
1591348|NCT01049360|3892313|P12|NOT COMPLETED|Period 3||0
1591349|NCT01049360|3892314|P11|NOT COMPLETED|Period 3||0
1591350|NCT01049360|3892315|P10|NOT COMPLETED|Period 3||0
1591351|NCT01049360|3892316|P9|NOT COMPLETED|Period 3||0
1591352|NCT01049360|3892317|P8|NOT COMPLETED|Period 3||0
1591353|NCT01049360|3892318|P7|NOT COMPLETED|Period 3||0
1591354|NCT01049360|3892319|P6|NOT COMPLETED|Period 3||0
1591355|NCT01049360|3892320|P5|NOT COMPLETED|Period 3||0
1591356|NCT01049360|3892321|P4|NOT COMPLETED|Period 3||0
1591357|NCT01049360|3892322|P3|NOT COMPLETED|Period 3||0
1591358|NCT01049360|3892323|P2|NOT COMPLETED|Period 3||0
1591359|NCT01049360|3892324|P1|NOT COMPLETED|Period 3||0
1591360|NCT01049360|3892305|P20|COMPLETED|Period 3||5
1591361|NCT01049360|3892306|P19|COMPLETED|Period 3||5
1591362|NCT01049360|3892307|P18|COMPLETED|Period 3||6
1591363|NCT01049360|3892308|P17|COMPLETED|Period 3||5
1591364|NCT01049360|3892309|P16|COMPLETED|Period 3||6
1591365|NCT01049360|3892310|P15|COMPLETED|Period 3||5
1591366|NCT01049360|3892311|P14|COMPLETED|Period 3||6
1591367|NCT01049360|3892312|P13|COMPLETED|Period 3||4
1591368|NCT01049360|3892313|P12|COMPLETED|Period 3||6
1591369|NCT01049360|3892314|P11|COMPLETED|Period 3||5
1591370|NCT01049360|3892315|P10|COMPLETED|Period 3||6
1591371|NCT01049360|3892316|P9|COMPLETED|Period 3||4
1591372|NCT01049360|3892317|P8|COMPLETED|Period 3||4
1591373|NCT01049360|3892318|P7|COMPLETED|Period 3||6
1591374|NCT01049360|3892319|P6|COMPLETED|Period 3||5
1591375|NCT01049360|3892320|P5|COMPLETED|Period 3||7
1591376|NCT01049360|3892321|P4|COMPLETED|Period 3||4
1591377|NCT01049360|3892322|P3|COMPLETED|Period 3||7
1591378|NCT01049360|3892323|P2|COMPLETED|Period 3||4
1591379|NCT01049360|3892324|P1|COMPLETED|Period 3||6
1591380|NCT01049360|3892305|P20|STARTED|Period 3||5
1591381|NCT01049360|3892306|P19|STARTED|Period 3||5
1591382|NCT01049360|3892307|P18|STARTED|Period 3||6
1591383|NCT01049360|3892308|P17|STARTED|Period 3||5
1591384|NCT01049360|3892309|P16|STARTED|Period 3||6
1591385|NCT01049360|3892310|P15|STARTED|Period 3||5
1591386|NCT01049360|3892311|P14|STARTED|Period 3||6
1591387|NCT01049360|3892312|P13|STARTED|Period 3||4
1591388|NCT01049360|3892313|P12|STARTED|Period 3||6
1591389|NCT01049360|3892314|P11|STARTED|Period 3||5
1591390|NCT01049360|3892315|P10|STARTED|Period 3||6
1591391|NCT01049360|3892316|P9|STARTED|Period 3||4
1591392|NCT01049360|3892317|P8|STARTED|Period 3||4
1591393|NCT01049360|3892318|P7|STARTED|Period 3||6
1591394|NCT01049360|3892319|P6|STARTED|Period 3||5
1591395|NCT01049360|3892320|P5|STARTED|Period 3||7
1591396|NCT01049360|3892321|P4|STARTED|Period 3||4
1591397|NCT01049360|3892322|P3|STARTED|Period 3||7
1591398|NCT01049360|3892323|P2|STARTED|Period 3||4
1591399|NCT01049360|3892324|P1|STARTED|Period 3||6
1591400|NCT01049360|3892305|P20|NOT COMPLETED|Period 2||2
1591401|NCT01049360|3892306|P19|NOT COMPLETED|Period 2||0
1591402|NCT01049360|3892307|P18|NOT COMPLETED|Period 2||0
1591403|NCT01049360|3892308|P17|NOT COMPLETED|Period 2||0
1591404|NCT01049360|3892309|P16|NOT COMPLETED|Period 2||1
1591405|NCT01049360|3892310|P15|NOT COMPLETED|Period 2||2
1591406|NCT01049360|3892311|P14|NOT COMPLETED|Period 2||0
1591407|NCT01049360|3892312|P13|NOT COMPLETED|Period 2||0
1591408|NCT01049360|3892313|P12|NOT COMPLETED|Period 2||0
1591409|NCT01049360|3892314|P11|NOT COMPLETED|Period 2||0
1591410|NCT01049360|3892315|P10|NOT COMPLETED|Period 2||0
1591411|NCT01049360|3892316|P9|NOT COMPLETED|Period 2||1
1591412|NCT01049360|3892317|P8|NOT COMPLETED|Period 2||0
1591413|NCT01049360|3892318|P7|NOT COMPLETED|Period 2||0
1591414|NCT01049360|3892319|P6|NOT COMPLETED|Period 2||1
1591415|NCT01049360|3892320|P5|NOT COMPLETED|Period 2||0
1591416|NCT01049360|3892321|P4|NOT COMPLETED|Period 2||2
1591417|NCT01049360|3892322|P3|NOT COMPLETED|Period 2||0
1591418|NCT01049360|3892323|P2|NOT COMPLETED|Period 2||1
1591419|NCT01049360|3892324|P1|NOT COMPLETED|Period 2||0
1591420|NCT01049360|3892305|P20|COMPLETED|Period 2||5
1591421|NCT01049360|3892306|P19|COMPLETED|Period 2||5
1591422|NCT01049360|3892307|P18|COMPLETED|Period 2||6
1591423|NCT01049360|3892308|P17|COMPLETED|Period 2||5
1591424|NCT01049360|3892309|P16|COMPLETED|Period 2||6
1591425|NCT01049360|3892310|P15|COMPLETED|Period 2||5
1591426|NCT01049360|3892311|P14|COMPLETED|Period 2||6
1591427|NCT01049360|3892312|P13|COMPLETED|Period 2||4
1591428|NCT01049360|3892313|P12|COMPLETED|Period 2||6
1591429|NCT01049360|3892314|P11|COMPLETED|Period 2||5
1591430|NCT01049360|3892315|P10|COMPLETED|Period 2||6
1591431|NCT01049360|3892316|P9|COMPLETED|Period 2||4
1591432|NCT01049360|3892317|P8|COMPLETED|Period 2||4
1591433|NCT01049360|3892318|P7|COMPLETED|Period 2||6
1591434|NCT01049360|3892319|P6|COMPLETED|Period 2||5
1591435|NCT01049360|3892320|P5|COMPLETED|Period 2||7
1591436|NCT01049360|3892321|P4|COMPLETED|Period 2||4
1591437|NCT01049360|3892322|P3|COMPLETED|Period 2||7
1591438|NCT01049360|3892323|P2|COMPLETED|Period 2||4
1591439|NCT01049360|3892324|P1|COMPLETED|Period 2||6
1591440|NCT01049360|3892305|P20|STARTED|Period 2||7
1591441|NCT01049360|3892306|P19|STARTED|Period 2||5
1591442|NCT01049360|3892307|P18|STARTED|Period 2||6
1591443|NCT01049360|3892308|P17|STARTED|Period 2||5
1591444|NCT01049360|3892309|P16|STARTED|Period 2||7
1591445|NCT01049360|3892310|P15|STARTED|Period 2||7
1591446|NCT01049360|3892311|P14|STARTED|Period 2||6
1591447|NCT01049360|3892312|P13|STARTED|Period 2||4
1591448|NCT01049360|3892313|P12|STARTED|Period 2||6
1591449|NCT01049360|3892314|P11|STARTED|Period 2||5
1591450|NCT01049360|3892315|P10|STARTED|Period 2||6
1591451|NCT01049360|3892316|P9|STARTED|Period 2||5
1591452|NCT01049360|3892317|P8|STARTED|Period 2||4
1591453|NCT01049360|3892318|P7|STARTED|Period 2||6
1591454|NCT01049360|3892319|P6|STARTED|Period 2||6
1591455|NCT01049360|3892320|P5|STARTED|Period 2||7
1591456|NCT01049360|3892321|P4|STARTED|Period 2||6
1591457|NCT01049360|3892322|P3|STARTED|Period 2||7
1591458|NCT01049360|3892323|P2|STARTED|Period 2||5
1591459|NCT01049360|3892324|P1|STARTED|Period 2||6
1591460|NCT01049360|3892305|P20|NOT COMPLETED|Period 1||0
1591461|NCT01049360|3892306|P19|NOT COMPLETED|Period 1||1
1591462|NCT01049360|3892307|P18|NOT COMPLETED|Period 1||0
1591463|NCT01049360|3892308|P17|NOT COMPLETED|Period 1||1
1591464|NCT01049360|3892309|P16|NOT COMPLETED|Period 1||0
1591465|NCT01049360|3892310|P15|NOT COMPLETED|Period 1||0
1591466|NCT01049360|3892311|P14|NOT COMPLETED|Period 1||1
1591467|NCT01049360|3892312|P13|NOT COMPLETED|Period 1||2
1591468|NCT01049360|3892313|P12|NOT COMPLETED|Period 1||0
1591469|NCT01049360|3892314|P11|NOT COMPLETED|Period 1||1
1591470|NCT01049360|3892315|P10|NOT COMPLETED|Period 1||0
1591471|NCT01049360|3892316|P9|NOT COMPLETED|Period 1||2
1591472|NCT01049360|3892317|P8|NOT COMPLETED|Period 1||2
1591473|NCT01049360|3892318|P7|NOT COMPLETED|Period 1||0
1591474|NCT01049360|3892319|P6|NOT COMPLETED|Period 1||0
1591475|NCT01049360|3892320|P5|NOT COMPLETED|Period 1||0
1591476|NCT01049360|3892321|P4|NOT COMPLETED|Period 1||1
1591477|NCT01049360|3892322|P3|NOT COMPLETED|Period 1||0
1591478|NCT01049360|3892323|P2|NOT COMPLETED|Period 1||1
1591479|NCT01049360|3892324|P1|NOT COMPLETED|Period 1||0
1591480|NCT01049360|3892305|P20|COMPLETED|Period 1||7
1591481|NCT01049360|3892306|P19|COMPLETED|Period 1||5
1591482|NCT01049360|3892307|P18|COMPLETED|Period 1||6
1591483|NCT01049360|3892308|P17|COMPLETED|Period 1||5
1591484|NCT01049360|3892309|P16|COMPLETED|Period 1||7
1591485|NCT01049360|3892310|P15|COMPLETED|Period 1||7
1591486|NCT01049360|3892311|P14|COMPLETED|Period 1||6
1591487|NCT01049360|3892312|P13|COMPLETED|Period 1||4
1591488|NCT01049360|3892313|P12|COMPLETED|Period 1||6
1591489|NCT01049360|3892314|P11|COMPLETED|Period 1||5
1591490|NCT01049360|3892315|P10|COMPLETED|Period 1||6
1591491|NCT01049360|3892316|P9|COMPLETED|Period 1||5
1591492|NCT01049360|3892317|P8|COMPLETED|Period 1||4
1591493|NCT01049360|3892318|P7|COMPLETED|Period 1||6
1591494|NCT01049360|3892319|P6|COMPLETED|Period 1||6
1591495|NCT01049360|3892320|P5|COMPLETED|Period 1||7
1591496|NCT01049360|3892321|P4|COMPLETED|Period 1||6
1591497|NCT01049360|3892322|P3|COMPLETED|Period 1||7
1591498|NCT01049360|3892323|P2|COMPLETED|Period 1||5
1591499|NCT01049360|3892324|P1|COMPLETED|Period 1||6
1591500|NCT01049360|3892305|P20|STARTED|Period 1||7
1591501|NCT01049360|3892306|P19|STARTED|Period 1||6
1591502|NCT01049360|3892307|P18|STARTED|Period 1||6
1591503|NCT01049360|3892308|P17|STARTED|Period 1||6
1591504|NCT01049360|3892309|P16|STARTED|Period 1||7
1591505|NCT01049360|3892310|P15|STARTED|Period 1||7
1591506|NCT01049360|3892311|P14|STARTED|Period 1||7
1591507|NCT01049360|3892312|P13|STARTED|Period 1||6
1591508|NCT01049360|3892313|P12|STARTED|Period 1||6
1591509|NCT01049360|3892314|P11|STARTED|Period 1||6
1591510|NCT01049360|3892315|P10|STARTED|Period 1||6
1591511|NCT01049360|3892316|P9|STARTED|Period 1||7
1591512|NCT01049360|3892317|P8|STARTED|Period 1||6
1591513|NCT01049360|3892318|P7|STARTED|Period 1||6
1591514|NCT01049360|3892319|P6|STARTED|Period 1||6
1591515|NCT01049360|3892320|P5|STARTED|Period 1||7
1591516|NCT01049360|3892321|P4|STARTED|Period 1||7
1591517|NCT01049360|3892322|P3|STARTED|Period 1||7
1591518|NCT01049360|3892323|P2|STARTED|Period 1||6
1591519|NCT01049360|3892324|P1|STARTED|Period 1||6
1591520|NCT01049334|3892348|P2|NOT COMPLETED|Overall Study||7
1591521|NCT01049334|3892349|P1|NOT COMPLETED|Overall Study||9
1591522|NCT01049334|3892348|P2|COMPLETED|Overall Study||95
1591523|NCT01049334|3892349|P1|COMPLETED|Overall Study||93
1591524|NCT01049334|3892348|P2|STARTED|Overall Study||102
1591525|NCT01049334|3892349|P1|STARTED|Overall Study||102
1591526|NCT01049308|3892385|P1|NOT COMPLETED|Pill Counts||83
1591527|NCT01049308|3892385|P1|COMPLETED|Pill Counts||168
1591528|NCT01049308|3892385|P1|STARTED|Pill Counts||251
1591529|NCT01049308|3892385|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
1591530|NCT01049308|3892385|P1|COMPLETED|Evaluation of Cognitive Impairment||251
1591531|NCT01049308|3892385|P1|STARTED|Evaluation of Cognitive Impairment||251
1591532|NCT01049243|3892392|P1|NOT COMPLETED|Overall Study||2
1591533|NCT01049243|3892392|P1|COMPLETED|Overall Study||18
1591534|NCT01049243|3892392|P1|STARTED|Overall Study||20
1591535|NCT01049217|3892399|P2|NOT COMPLETED|Overall Study||63
1591536|NCT01049217|3892400|P1|NOT COMPLETED|Overall Study||56
1591537|NCT01049217|3892399|P2|COMPLETED|Overall Study||131
1591538|NCT01049217|3892400|P1|COMPLETED|Overall Study||127
1591539|NCT01049217|3892399|P2|Treated|Overall Study||192
1591540|NCT01049217|3892400|P1|Treated|Overall Study||183
1591541|NCT01049217|3892399|P2|STARTED|Overall Study||194
1591542|NCT01049217|3892400|P1|STARTED|Overall Study||183
1591543|NCT01049009|3892472|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
1591544|NCT01049009|3892473|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
1591545|NCT01049009|3892472|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
1591546|NCT01049009|3892473|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
1591547|NCT01049009|3892472|P2|STARTED|Treatment Period 2 (12 Weeks)||18
1591548|NCT01049009|3892473|P1|STARTED|Treatment Period 2 (12 Weeks)||21
1591549|NCT01049009|3892472|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
1591550|NCT01049009|3892473|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
1591551|NCT01049009|3892472|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
1591552|NCT01049009|3892473|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
1591553|NCT01049009|3892472|P2|STARTED|Treatment Period 1 (12 Weeks)||21
1591554|NCT01049009|3892473|P1|STARTED|Treatment Period 1 (12 Weeks)||23
1591555|NCT01048944|3892485|P4|NOT COMPLETED|Overall Study||2
1591556|NCT01048944|3892486|P3|NOT COMPLETED|Overall Study||10
1591557|NCT01048944|3892487|P2|NOT COMPLETED|Overall Study||10
1591558|NCT01048944|3892488|P1|NOT COMPLETED|Overall Study||8
1591559|NCT01048944|3892485|P4|COMPLETED|Overall Study||19
1591560|NCT01048944|3892486|P3|COMPLETED|Overall Study||25
1591561|NCT01048944|3892487|P2|COMPLETED|Overall Study||28
1591562|NCT01048944|3892488|P1|COMPLETED|Overall Study||24
1591563|NCT01048944|3892485|P4|STARTED|Overall Study||21
1591564|NCT01048944|3892486|P3|STARTED|Overall Study||35
1591565|NCT01048944|3892487|P2|STARTED|Overall Study||38
1591566|NCT01048944|3892488|P1|STARTED|Overall Study||32
1591567|NCT01048879|3892505|P3|NOT COMPLETED|Overall Study||0
1591568|NCT01048879|3892506|P2|NOT COMPLETED|Overall Study||0
1591569|NCT01048879|3892507|P1|NOT COMPLETED|Overall Study||0
1591570|NCT01048879|3892505|P3|COMPLETED|Overall Study||5
1591571|NCT01048879|3892506|P2|COMPLETED|Overall Study||9
1591572|NCT01048879|3892507|P1|COMPLETED|Overall Study||1
1591573|NCT01048879|3892505|P3|STARTED|Overall Study||5
1591574|NCT01048879|3892506|P2|STARTED|Overall Study||9
1591575|NCT01048879|3892507|P1|STARTED|Overall Study||1
1591576|NCT01048866|3892520|P2|NOT COMPLETED|Overall Study||5
1591577|NCT01048866|3892521|P1|NOT COMPLETED|Overall Study||4
1591578|NCT01048866|3892520|P2|COMPLETED|Overall Study||92
1591579|NCT01048866|3892521|P1|COMPLETED|Overall Study||97
1591580|NCT01048866|3892520|P2|STARTED|Overall Study||97
1591581|NCT01048866|3892521|P1|STARTED|Overall Study||101
1591582|NCT01048788|3892566|P3|NOT COMPLETED|Overall Study||2
1591583|NCT01048788|3892567|P2|NOT COMPLETED|Overall Study||2
1591584|NCT01048788|3892568|P1|NOT COMPLETED|Overall Study||5
1591585|NCT01048788|3892566|P3|COMPLETED|Overall Study||11
1591586|NCT01048788|3892567|P2|COMPLETED|Overall Study||28
1591587|NCT01048788|3892568|P1|COMPLETED|Overall Study||3
1591588|NCT01048788|3892566|P3|STARTED|Overall Study||13
1591589|NCT01048788|3892567|P2|STARTED|Overall Study||30
1591590|NCT01048788|3892568|P1|STARTED|Overall Study||8
1591591|NCT01048723|3892576|P1|NOT COMPLETED|Overall Study||0
1591592|NCT01048723|3892576|P1|COMPLETED|Overall Study||2
1591593|NCT01048723|3892576|P1|STARTED|Overall Study||2
1591594|NCT01048697|3892583|P1|NOT COMPLETED|Overall Study||0
1591595|NCT01048697|3892583|P1|COMPLETED|Overall Study||18
1591596|NCT01048697|3892583|P1|STARTED|Overall Study||18
1591597|NCT01048671|3892590|P3|NOT COMPLETED|Overall Study||1
1591598|NCT01048671|3892591|P2|NOT COMPLETED|Overall Study||1
1591599|NCT01048671|3892592|P1|NOT COMPLETED|Overall Study||0
1591600|NCT01048671|3892590|P3|COMPLETED|Overall Study||151
1591601|NCT01048671|3892591|P2|COMPLETED|Overall Study||263
1591602|NCT01048671|3892592|P1|COMPLETED|Overall Study||66
1591603|NCT01048671|3892590|P3|STARTED|Overall Study||152
1591604|NCT01048671|3892591|P2|STARTED|Overall Study||264
1591605|NCT01048671|3892592|P1|STARTED|Overall Study||66
1591606|NCT01048658|3892615|P2|NOT COMPLETED|Overall Study||0
1591607|NCT01048658|3892616|P1|NOT COMPLETED|Overall Study||0
1591608|NCT01048658|3892615|P2|COMPLETED|Overall Study||80
1591609|NCT01048658|3892616|P1|COMPLETED|Overall Study||80
1591610|NCT01048658|3892615|P2|STARTED|Overall Study||80
1591611|NCT01048658|3892616|P1|STARTED|Overall Study||80
1591612|NCT01048606|3892634|P4|NOT COMPLETED|Overall Study||5
1591613|NCT01048606|3892635|P3|NOT COMPLETED|Overall Study||10
1591614|NCT01048606|3892636|P2|NOT COMPLETED|Overall Study||7
1591615|NCT01048606|3892637|P1|NOT COMPLETED|Overall Study||12
1591616|NCT01048606|3892634|P4|COMPLETED|Overall Study||5
1591617|NCT01048606|3892635|P3|COMPLETED|Overall Study||16
1591618|NCT01048606|3892636|P2|COMPLETED|Overall Study||8
1591619|NCT01048606|3892637|P1|COMPLETED|Overall Study||16
1591620|NCT01048606|3892634|P4|STARTED|Overall Study||10
1591621|NCT01048606|3892635|P3|STARTED|Overall Study||26
1591622|NCT01048606|3892636|P2|STARTED|Overall Study||15
1591623|NCT01048606|3892637|P1|STARTED|Overall Study||28
1591624|NCT01048593|3892650|P3|NOT COMPLETED|Overall Study||0
1591625|NCT01048593|3892651|P2|NOT COMPLETED|Overall Study||0
1591626|NCT01048593|3892652|P1|NOT COMPLETED|Overall Study||0
1591627|NCT01048593|3892650|P3|COMPLETED|Overall Study||1
1591628|NCT01048593|3892651|P2|COMPLETED|Overall Study||2
1591629|NCT01048593|3892652|P1|COMPLETED|Overall Study||3
1591630|NCT01048593|3892650|P3|STARTED|Overall Study||1
1591631|NCT01048593|3892651|P2|STARTED|Overall Study||2
1591632|NCT01048593|3892652|P1|STARTED|Overall Study||3
1591633|NCT01048541|3892672|P2|NOT COMPLETED|Overall Study||0
1591634|NCT01048541|3892673|P1|NOT COMPLETED|Overall Study||1
1591635|NCT01048541|3892672|P2|COMPLETED|Overall Study||19
1591636|NCT01048541|3892673|P1|COMPLETED|Overall Study||17
1591637|NCT01048541|3892672|P2|STARTED|Overall Study||19
1591638|NCT01048541|3892673|P1|STARTED|Overall Study||18
1591639|NCT01048502|3892683|P4|NOT COMPLETED|Overall Study||4
1591640|NCT01048502|3892684|P3|NOT COMPLETED|Overall Study||5
1591641|NCT01048502|3892685|P2|NOT COMPLETED|Overall Study||7
1591642|NCT01048502|3892686|P1|NOT COMPLETED|Overall Study||4
1591643|NCT01048502|3892683|P4|COMPLETED|Overall Study||21
1591644|NCT01048502|3892684|P3|COMPLETED|Overall Study||23
1591645|NCT01048502|3892685|P2|COMPLETED|Overall Study||16
1591646|NCT01048502|3892686|P1|COMPLETED|Overall Study||20
1591647|NCT01048502|3892683|P4|STARTED|Overall Study||25
1591648|NCT01048502|3892684|P3|STARTED|Overall Study||28
1591649|NCT01048502|3892685|P2|STARTED|Overall Study||23
1591650|NCT01048502|3892686|P1|STARTED|Overall Study||24
1591651|NCT01048424|3892699|P2|NOT COMPLETED|Overall Study||0
1591652|NCT01048424|3892700|P1|NOT COMPLETED|Overall Study||2
1591653|NCT01048424|3892699|P2|COMPLETED|Overall Study||10
1591654|NCT01048424|3892700|P1|COMPLETED|Overall Study||8
1591655|NCT01048424|3892699|P2|STARTED|Overall Study||10
1591656|NCT01048424|3892700|P1|STARTED|Overall Study||10
1591657|NCT01048333|3892722|P6|NOT COMPLETED|Treatment Period 3||0
1591658|NCT01048333|3892723|P5|NOT COMPLETED|Treatment Period 3||0
1591659|NCT01048333|3892724|P4|NOT COMPLETED|Treatment Period 3||0
1591660|NCT01048333|3892725|P3|NOT COMPLETED|Treatment Period 3||0
1591661|NCT01048333|3892726|P2|NOT COMPLETED|Treatment Period 3||0
1591662|NCT01048333|3892727|P1|NOT COMPLETED|Treatment Period 3||0
1591663|NCT01048333|3892722|P6|COMPLETED|Treatment Period 3||18
1591664|NCT01048333|3892723|P5|COMPLETED|Treatment Period 3||17
1591665|NCT01048333|3892724|P4|COMPLETED|Treatment Period 3||18
1591666|NCT01048333|3892725|P3|COMPLETED|Treatment Period 3||16
1591667|NCT01048333|3892726|P2|COMPLETED|Treatment Period 3||18
1591668|NCT01048333|3892727|P1|COMPLETED|Treatment Period 3||21
1591669|NCT01048333|3892722|P6|STARTED|Treatment Period 3||18
1591670|NCT01048333|3892723|P5|STARTED|Treatment Period 3||17
1591671|NCT01048333|3892724|P4|STARTED|Treatment Period 3||18
1591672|NCT01048333|3892725|P3|STARTED|Treatment Period 3||16
1591673|NCT01048333|3892726|P2|STARTED|Treatment Period 3||18
1591674|NCT01048333|3892727|P1|STARTED|Treatment Period 3||21
1591675|NCT01048333|3892722|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1591676|NCT01048333|3892723|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1591677|NCT01048333|3892724|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1591678|NCT01048333|3892725|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1591679|NCT01048333|3892726|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
1591680|NCT01048333|3892727|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1591681|NCT01048333|3892722|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
1591682|NCT01048333|3892723|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
1591683|NCT01048333|3892724|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
1591684|NCT01048333|3892725|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
1591685|NCT01048333|3892726|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
1591686|NCT01048333|3892727|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
1591687|NCT01048333|3892722|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
1591688|NCT01048333|3892723|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
1591689|NCT01048333|3892724|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
1591690|NCT01048333|3892725|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
1591691|NCT01048333|3892726|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
1591692|NCT01048333|3892727|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
1591693|NCT01048333|3892722|P6|NOT COMPLETED|Treatment Period 2||0
1591694|NCT01048333|3892723|P5|NOT COMPLETED|Treatment Period 2||0
1591695|NCT01048333|3892724|P4|NOT COMPLETED|Treatment Period 2||0
1591696|NCT01048333|3892725|P3|NOT COMPLETED|Treatment Period 2||0
1591697|NCT01048333|3892726|P2|NOT COMPLETED|Treatment Period 2||0
1591698|NCT01048333|3892727|P1|NOT COMPLETED|Treatment Period 2||0
1591699|NCT01048333|3892722|P6|COMPLETED|Treatment Period 2||18
1591700|NCT01048333|3892723|P5|COMPLETED|Treatment Period 2||17
1591701|NCT01048333|3892724|P4|COMPLETED|Treatment Period 2||18
1591702|NCT01048333|3892725|P3|COMPLETED|Treatment Period 2||16
1591703|NCT01048333|3892726|P2|COMPLETED|Treatment Period 2||19
1591704|NCT01048333|3892727|P1|COMPLETED|Treatment Period 2||21
1591705|NCT01048333|3892722|P6|STARTED|Treatment Period 2||18
1591706|NCT01048333|3892723|P5|STARTED|Treatment Period 2||17
1591707|NCT01048333|3892724|P4|STARTED|Treatment Period 2||18
1591708|NCT01048333|3892725|P3|STARTED|Treatment Period 2||16
1591709|NCT01048333|3892726|P2|STARTED|Treatment Period 2||19
1591710|NCT01048333|3892727|P1|STARTED|Treatment Period 2||21
1591711|NCT01048333|3892722|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1591712|NCT01048333|3892723|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1591713|NCT01048333|3892724|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1591714|NCT01048333|3892725|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1591715|NCT01048333|3892726|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1591716|NCT01048333|3892727|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1591717|NCT01048333|3892722|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
1591718|NCT01048333|3892723|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
1591719|NCT01048333|3892724|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
1591720|NCT01048333|3892725|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
1591721|NCT01048333|3892726|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
1591722|NCT01048333|3892727|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
1591723|NCT01048333|3892722|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
1591724|NCT01048333|3892723|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
1591725|NCT01048333|3892724|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
1591726|NCT01048333|3892725|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
1591727|NCT01048333|3892726|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
1591728|NCT01048333|3892727|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
1591729|NCT01048333|3892722|P6|NOT COMPLETED|Treatment Period 1||0
1591730|NCT01048333|3892723|P5|NOT COMPLETED|Treatment Period 1||0
1591731|NCT01048333|3892724|P4|NOT COMPLETED|Treatment Period 1||0
1591732|NCT01048333|3892725|P3|NOT COMPLETED|Treatment Period 1||0
1591733|NCT01048333|3892726|P2|NOT COMPLETED|Treatment Period 1||0
1591734|NCT01048333|3892727|P1|NOT COMPLETED|Treatment Period 1||0
1591735|NCT01048333|3892722|P6|COMPLETED|Treatment Period 1||18
1591736|NCT01048333|3892723|P5|COMPLETED|Treatment Period 1||17
1591737|NCT01048333|3892724|P4|COMPLETED|Treatment Period 1||18
1591738|NCT01048333|3892725|P3|COMPLETED|Treatment Period 1||16
1591739|NCT01048333|3892726|P2|COMPLETED|Treatment Period 1||19
1591740|NCT01048333|3892727|P1|COMPLETED|Treatment Period 1||21
1591741|NCT01048333|3892722|P6|STARTED|Treatment Period 1||18
1591742|NCT01048333|3892723|P5|STARTED|Treatment Period 1||17
1591743|NCT01048333|3892724|P4|STARTED|Treatment Period 1||18
1591744|NCT01048333|3892725|P3|STARTED|Treatment Period 1||16
1591745|NCT01048333|3892726|P2|STARTED|Treatment Period 1||19
1591746|NCT01048333|3892727|P1|STARTED|Treatment Period 1||21
1591747|NCT01048242|3892749|P2|NOT COMPLETED|Overall Study||2
1591748|NCT01048242|3892750|P1|NOT COMPLETED|Overall Study||4
1591749|NCT01048242|3892749|P2|COMPLETED|Overall Study||13
1591750|NCT01048242|3892750|P1|COMPLETED|Overall Study||8
1591751|NCT01048242|3892749|P2|STARTED|Overall Study||15
1591752|NCT01048242|3892750|P1|STARTED|Overall Study||12
1591753|NCT01048125|3892758|P2|NOT COMPLETED|Overall Study||0
1591754|NCT01048125|3892759|P1|NOT COMPLETED|Overall Study||0
1591755|NCT01048125|3892758|P2|COMPLETED|Overall Study||0
1591756|NCT01048125|3892759|P1|COMPLETED|Overall Study||0
1591757|NCT01048125|3892758|P2|STARTED|Overall Study||0
1591758|NCT01048125|3892759|P1|STARTED|Overall Study||0
1591759|NCT01048099|3892765|P1|NOT COMPLETED|Treatment Per Protocol||14
1591760|NCT01048099|3892765|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
1591761|NCT01048099|3892765|P1|STARTED|Treatment Per Protocol||14
1591762|NCT01048099|3892765|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
1591763|NCT01048099|3892765|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
1591764|NCT01048099|3892765|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
1591765|NCT01048099|3892765|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
1591766|NCT01048099|3892765|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
1591767|NCT01048099|3892765|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
1591768|NCT01048099|3892765|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
1591769|NCT01048099|3892765|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
1591770|NCT01048099|3892765|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
1591771|NCT01047839|3892776|P3|NOT COMPLETED|Overall Study||6
1591772|NCT01047839|3892777|P2|NOT COMPLETED|Overall Study||0
1591773|NCT01047839|3892778|P1|NOT COMPLETED|Overall Study||2
1591774|NCT01047839|3892776|P3|COMPLETED|Overall Study||53
1591775|NCT01047839|3892777|P2|COMPLETED|Overall Study||29
1591776|NCT01047839|3892778|P1|COMPLETED|Overall Study||10
1591777|NCT01047839|3892776|P3|STARTED|Overall Study||59
1591778|NCT01047839|3892777|P2|STARTED|Overall Study||29
1591779|NCT01047839|3892778|P1|STARTED|Overall Study||12
1591780|NCT01047709|3892786|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
1591781|NCT01047709|3892787|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
1591782|NCT01047709|3892786|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
1591783|NCT01047709|3892787|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
1591784|NCT01047709|3892786|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
1591785|NCT01047709|3892787|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
1591786|NCT01047709|3892786|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
1591787|NCT01047709|3892787|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
1591788|NCT01047709|3892786|P2|COMPLETED|Positional Therapy (1 Night)||9
1591789|NCT01047709|3892787|P1|COMPLETED|Positional Therapy (1 Night)||9
1591790|NCT01047709|3892786|P2|STARTED|Positional Therapy (1 Night)||9
1591791|NCT01047709|3892787|P1|STARTED|Positional Therapy (1 Night)||9
1591792|NCT01047553|3892795|P2|NOT COMPLETED|Overall Study||9
1591793|NCT01047553|3892796|P1|NOT COMPLETED|Overall Study||17
1591794|NCT01047553|3892795|P2|COMPLETED|Overall Study||117
1591795|NCT01047553|3892796|P1|COMPLETED|Overall Study||108
1591796|NCT01047553|3892795|P2|STARTED|Overall Study||126
1591797|NCT01047553|3892796|P1|STARTED|Overall Study||125
1591798|NCT01047527|3892881|P3|NOT COMPLETED|Overall Study||65
1591799|NCT01047527|3892882|P2|NOT COMPLETED|Overall Study||61
1591800|NCT01047527|3892883|P1|NOT COMPLETED|Overall Study||85
1591801|NCT01047527|3892881|P3|COMPLETED|Overall Study||107
1591802|NCT01047527|3892882|P2|COMPLETED|Overall Study||112
1591803|NCT01047527|3892883|P1|COMPLETED|Overall Study||95
1591804|NCT01047527|3892881|P3|24 Weeks|Overall Study||119
1591805|NCT01047527|3892882|P2|24 Weeks|Overall Study||123
1591806|NCT01047527|3892883|P1|24 Weeks|Overall Study||111
1591807|NCT01047527|3892881|P3|8 Weeks|Overall Study||138
1591808|NCT01047527|3892882|P2|8 Weeks|Overall Study||142
1591809|NCT01047527|3892883|P1|8 Weeks|Overall Study||148
1591810|NCT01047527|3892881|P3|STARTED|Overall Study||172
1591811|NCT01047527|3892882|P2|STARTED|Overall Study||173
1591812|NCT01047527|3892883|P1|STARTED|Overall Study||180
1591813|NCT01047475|3892894|P2|NOT COMPLETED|Overall Study||7
1591814|NCT01047475|3892895|P1|NOT COMPLETED|Overall Study||5
1591815|NCT01047475|3892894|P2|COMPLETED|Overall Study||31
1591816|NCT01047475|3892895|P1|COMPLETED|Overall Study||29
1591817|NCT01047475|3892894|P2|STARTED|Overall Study||38
1591818|NCT01047475|3892895|P1|STARTED|Overall Study||34
1591819|NCT01047436|3892903|P2|NOT COMPLETED|Overall Study||0
1591820|NCT01047436|3892904|P1|NOT COMPLETED|Overall Study||1
1591821|NCT01047436|3892903|P2|COMPLETED|Overall Study||15
1591822|NCT01047436|3892904|P1|COMPLETED|Overall Study||15
1591823|NCT01047436|3892903|P2|STARTED|Overall Study||15
1591824|NCT01047436|3892904|P1|STARTED|Overall Study||16
1591825|NCT01047358|3892920|P1|NOT COMPLETED|Overall Study||0
1591826|NCT01047358|3892920|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
1591827|NCT01047358|3892920|P1|STARTED|Overall Study||206
1591828|NCT01047345|3892929|P3|NOT COMPLETED|Extension||6
1591829|NCT01047345|3892930|P2|NOT COMPLETED|Extension||0
1591830|NCT01047345|3892931|P1|NOT COMPLETED|Extension||0
1591831|NCT01047345|3892929|P3|COMPLETED|Extension||96
1591832|NCT01047345|3892930|P2|COMPLETED|Extension||0
1591833|NCT01047345|3892931|P1|COMPLETED|Extension||0
1591834|NCT01047345|3892929|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
1591835|NCT01047345|3892930|P2|Vaccination 6|Extension||0
1591836|NCT01047345|3892931|P1|Vaccination 6|Extension||0
1591837|NCT01047345|3892929|P3|Vaccination 5|Extension||99
1591838|NCT01047345|3892930|P2|Vaccination 5|Extension||0
1591839|NCT01047345|3892931|P1|Vaccination 5|Extension||0
1591840|NCT01047345|3892929|P3|Vaccination 4|Extension||102
1591841|NCT01047345|3892930|P2|Vaccination 4|Extension||0
1591842|NCT01047345|3892931|P1|Vaccination 4|Extension||0
1591843|NCT01047345|3892929|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
1591844|NCT01047345|3892930|P2|STARTED|Extension||0
1591845|NCT01047345|3892931|P1|STARTED|Extension||0
1591846|NCT01047345|3892929|P3|NOT COMPLETED|Base Study||0
1591847|NCT01047345|3892930|P2|NOT COMPLETED|Base Study||6
1591848|NCT01047345|3892931|P1|NOT COMPLETED|Base Study||22
1591849|NCT01047345|3892929|P3|COMPLETED|Base Study||0
1591850|NCT01047345|3892930|P2|COMPLETED|Base Study||300
1591851|NCT01047345|3892931|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
1591852|NCT01047345|3892929|P3|Vaccination 3|Base Study||0
1591853|NCT01047345|3892930|P2|Vaccination 3|Base Study||300
1591854|NCT01047345|3892931|P1|Vaccination 3|Base Study||597
1591855|NCT01047345|3892929|P3|Vaccination 2|Base Study||0
1591856|NCT01047345|3892930|P2|Vaccination 2|Base Study||304
1591857|NCT01047345|3892931|P1|Vaccination 2|Base Study||604
1591858|NCT01047345|3892929|P3|Vaccination 1|Base Study||0
1591859|NCT01047345|3892930|P2|Vaccination 1|Base Study||306
1591860|NCT01047345|3892931|P1|Vaccination 1|Base Study||615
1591861|NCT01047345|3892929|P3|STARTED|Base Study||0
1591862|NCT01047345|3892930|P2|STARTED|Base Study||306
1591863|NCT01047345|3892931|P1|STARTED|Base Study||618
1591864|NCT01047332|3892953|P2|NOT COMPLETED|Overall Study||64
1591865|NCT01047332|3892954|P1|NOT COMPLETED|Overall Study||57
1591866|NCT01047332|3892953|P2|COMPLETED|Overall Study|Alive at final follow-up|4
1591867|NCT01047332|3892954|P1|COMPLETED|Overall Study|Alive at final follow-up|4
1591868|NCT01047332|3892953|P2|STARTED|Overall Study||68
1591869|NCT01047332|3892954|P1|STARTED|Overall Study||61
1591870|NCT01047306|3892968|P2|NOT COMPLETED|Overall Study||0
1591871|NCT01047306|3892969|P1|NOT COMPLETED|Overall Study||3
1591872|NCT01047306|3892968|P2|COMPLETED|Overall Study||6
1591873|NCT01047306|3892969|P1|COMPLETED|Overall Study||16
1591874|NCT01047306|3892968|P2|Discontinued From the Study|Overall Study||0
1591875|NCT01047306|3892969|P1|Discontinued From the Study|Overall Study||3
1591876|NCT01047306|3892968|P2|STARTED|Overall Study||6
1591877|NCT01047306|3892969|P1|STARTED|Overall Study||19
1591878|NCT01047293|3893043|P4|NOT COMPLETED|Overall Study||0
1591879|NCT01047293|3893044|P3|NOT COMPLETED|Overall Study||0
1591880|NCT01047293|3893045|P2|NOT COMPLETED|Overall Study||1
1591881|NCT01047293|3893046|P1|NOT COMPLETED|Overall Study||1
1591882|NCT01047293|3893043|P4|COMPLETED|Overall Study||26
1591883|NCT01047293|3893044|P3|COMPLETED|Overall Study||9
1591884|NCT01047293|3893045|P2|COMPLETED|Overall Study||7
1591885|NCT01047293|3893046|P1|COMPLETED|Overall Study||3
1591886|NCT01047293|3893043|P4|STARTED|Overall Study||26
1591887|NCT01047293|3893044|P3|STARTED|Overall Study||9
1591888|NCT01047293|3893045|P2|STARTED|Overall Study||8
1591889|NCT01047293|3893046|P1|STARTED|Overall Study||4
1591890|NCT01047241|3893053|P1|NOT COMPLETED|Overall Study||0
1591891|NCT01047241|3893053|P1|COMPLETED|Overall Study||50
1591892|NCT01047241|3893053|P1|STARTED|Overall Study||50
1591893|NCT01047189|3893064|P2|NOT COMPLETED|Overall Study||0
1591894|NCT01047189|3893065|P1|NOT COMPLETED|Overall Study||4
1591895|NCT01047189|3893064|P2|COMPLETED|Overall Study||13
1591896|NCT01047189|3893065|P1|COMPLETED|Overall Study||9
1591897|NCT01047189|3893064|P2|STARTED|Overall Study||13
1591898|NCT01047189|3893065|P1|STARTED|Overall Study||13
1591899|NCT01047007|3893077|P4|NOT COMPLETED|Overall Study||0
1591900|NCT01047007|3893078|P3|NOT COMPLETED|Overall Study||2
1591901|NCT01047007|3893079|P2|NOT COMPLETED|Overall Study||6
1591902|NCT01047007|3893080|P1|NOT COMPLETED|Overall Study||2
1591903|NCT01047007|3893077|P4|COMPLETED|Overall Study||0
1591904|NCT01047007|3893078|P3|COMPLETED|Overall Study||0
1591905|NCT01047007|3893079|P2|COMPLETED|Overall Study||0
1591906|NCT01047007|3893080|P1|COMPLETED|Overall Study||1
1591907|NCT01047007|3893077|P4|Treated|Overall Study||0
1591908|NCT01047007|3893078|P3|Treated|Overall Study||2
1591909|NCT01047007|3893079|P2|Treated|Overall Study||6
1591910|NCT01047007|3893080|P1|Treated|Overall Study||3
1591911|NCT01047007|3893077|P4|STARTED|Overall Study||0
1591912|NCT01047007|3893078|P3|STARTED|Overall Study||2
1591913|NCT01047007|3893079|P2|STARTED|Overall Study||6
1591914|NCT01047007|3893080|P1|STARTED|Overall Study||3
1591915|NCT01046903|3893091|P1|NOT COMPLETED|Overall Study||28
1591916|NCT01046903|3893091|P1|COMPLETED|Overall Study||475
1591917|NCT01046903|3893091|P1|STARTED|Overall Study||503
1591918|NCT01046877|3893104|P1|NOT COMPLETED|Overall Study||18
1591919|NCT01046877|3893104|P1|COMPLETED|Overall Study||7
1591920|NCT01046877|3893104|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
1591921|NCT01046877|3893104|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
1591922|NCT01046877|3893104|P1|STARTED|Overall Study||25
1591923|NCT01046695|3893120|P2|NOT COMPLETED|Overall Study||2
1591924|NCT01046695|3893121|P1|NOT COMPLETED|Overall Study||0
1591925|NCT01046695|3893120|P2|COMPLETED|Overall Study||20
1591926|NCT01046695|3893121|P1|COMPLETED|Overall Study||20
1591927|NCT01046695|3893120|P2|STARTED|Overall Study||22
1591928|NCT01046695|3893121|P1|STARTED|Overall Study||20
1591929|NCT01046682|3893133|P2|NOT COMPLETED|Overall Study||0
1591930|NCT01046682|3893134|P1|NOT COMPLETED|Overall Study||2
1591931|NCT01046682|3893133|P2|COMPLETED|Overall Study||20
1591932|NCT01046682|3893134|P1|COMPLETED|Overall Study||18
1591933|NCT01046682|3893133|P2|STARTED|Overall Study||20
1591934|NCT01046682|3893134|P1|STARTED|Overall Study||20
1591935|NCT01046643|3893142|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
1591936|NCT01046643|3893143|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
1591937|NCT01046643|3893144|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
1591938|NCT01046643|3893145|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
1591939|NCT01046643|3893142|P4|COMPLETED|Second Period Treatment or Placebo||7
1591940|NCT01046643|3893143|P3|COMPLETED|Second Period Treatment or Placebo||7
1591941|NCT01046643|3893144|P2|COMPLETED|Second Period Treatment or Placebo||6
1591942|NCT01046643|3893145|P1|COMPLETED|Second Period Treatment or Placebo||9
1591943|NCT01046643|3893142|P4|STARTED|Second Period Treatment or Placebo||7
1591944|NCT01046643|3893143|P3|STARTED|Second Period Treatment or Placebo||7
1591945|NCT01046643|3893144|P2|STARTED|Second Period Treatment or Placebo||6
1591946|NCT01046643|3893145|P1|STARTED|Second Period Treatment or Placebo||9
1591947|NCT01046643|3893142|P4|NOT COMPLETED|Washout Period||0
1591948|NCT01046643|3893143|P3|NOT COMPLETED|Washout Period||0
1591949|NCT01046643|3893144|P2|NOT COMPLETED|Washout Period||0
1591950|NCT01046643|3893145|P1|NOT COMPLETED|Washout Period||0
1591951|NCT01046643|3893142|P4|COMPLETED|Washout Period||7
1591952|NCT01046643|3893143|P3|COMPLETED|Washout Period||7
1591953|NCT01046643|3893144|P2|COMPLETED|Washout Period||6
1591954|NCT01046643|3893145|P1|COMPLETED|Washout Period||9
1591955|NCT01046643|3893142|P4|STARTED|Washout Period||7
1591956|NCT01046643|3893143|P3|STARTED|Washout Period||7
1591957|NCT01046643|3893144|P2|STARTED|Washout Period||6
1591958|NCT01046643|3893145|P1|STARTED|Washout Period||9
1591959|NCT01046643|3893142|P4|NOT COMPLETED|First Period Treatment or Placebo||0
1591960|NCT01046643|3893143|P3|NOT COMPLETED|First Period Treatment or Placebo||0
1591961|NCT01046643|3893144|P2|NOT COMPLETED|First Period Treatment or Placebo||1
1591962|NCT01046643|3893145|P1|NOT COMPLETED|First Period Treatment or Placebo||0
1591963|NCT01046643|3893142|P4|COMPLETED|First Period Treatment or Placebo||7
1591964|NCT01046643|3893143|P3|COMPLETED|First Period Treatment or Placebo||7
1591965|NCT01046643|3893144|P2|COMPLETED|First Period Treatment or Placebo||6
1591966|NCT01046643|3893145|P1|COMPLETED|First Period Treatment or Placebo||9
1591967|NCT01046643|3893142|P4|STARTED|First Period Treatment or Placebo||7
1591968|NCT01046643|3893143|P3|STARTED|First Period Treatment or Placebo||7
1591969|NCT01046643|3893144|P2|STARTED|First Period Treatment or Placebo||7
1591970|NCT01046643|3893145|P1|STARTED|First Period Treatment or Placebo||9
1591971|NCT01046565|3893167|P1|NOT COMPLETED|Overall Study||9
1591972|NCT01046565|3893167|P1|COMPLETED|Overall Study||66
1591973|NCT01046565|3893167|P1|STARTED|Overall Study||75
1591974|NCT01046396|3893176|P1|NOT COMPLETED|Overall Study||5
1591975|NCT01046396|3893176|P1|COMPLETED|Overall Study||64
1591976|NCT01046396|3893176|P1|STARTED|Overall Study||69
1591977|NCT01046253|3893187|P2|NOT COMPLETED|Fourth Intervention||0
1591978|NCT01046253|3893188|P1|NOT COMPLETED|Fourth Intervention||0
1591979|NCT01046253|3893187|P2|COMPLETED|Fourth Intervention||23
1591980|NCT01046253|3893188|P1|COMPLETED|Fourth Intervention||25
1591981|NCT01046253|3893187|P2|STARTED|Fourth Intervention||23
1591982|NCT01046253|3893188|P1|STARTED|Fourth Intervention||25
1591983|NCT01046253|3893187|P2|NOT COMPLETED|Third Washout of 7 Days||0
1591984|NCT01046253|3893188|P1|NOT COMPLETED|Third Washout of 7 Days||0
1591985|NCT01046253|3893187|P2|COMPLETED|Third Washout of 7 Days||23
1591986|NCT01046253|3893188|P1|COMPLETED|Third Washout of 7 Days||25
1591987|NCT01046253|3893187|P2|STARTED|Third Washout of 7 Days||23
1591988|NCT01046253|3893188|P1|STARTED|Third Washout of 7 Days||25
1591989|NCT01046253|3893187|P2|NOT COMPLETED|Third Intervention||0
1591990|NCT01046253|3893188|P1|NOT COMPLETED|Third Intervention||0
1591991|NCT01046253|3893187|P2|COMPLETED|Third Intervention||23
1591992|NCT01046253|3893188|P1|COMPLETED|Third Intervention||25
1591993|NCT01046253|3893187|P2|STARTED|Third Intervention||23
1591994|NCT01046253|3893188|P1|STARTED|Third Intervention||25
1591995|NCT01046253|3893187|P2|NOT COMPLETED|Second Washout of 7 Days||0
1591996|NCT01046253|3893188|P1|NOT COMPLETED|Second Washout of 7 Days||0
1591997|NCT01046253|3893187|P2|COMPLETED|Second Washout of 7 Days||23
1591998|NCT01046253|3893188|P1|COMPLETED|Second Washout of 7 Days||25
1591999|NCT01046253|3893187|P2|STARTED|Second Washout of 7 Days||23
1592000|NCT01046253|3893188|P1|STARTED|Second Washout of 7 Days||25
1592001|NCT01046253|3893187|P2|NOT COMPLETED|Second Intervention||2
1592002|NCT01046253|3893188|P1|NOT COMPLETED|Second Intervention||0
1592003|NCT01046253|3893187|P2|COMPLETED|Second Intervention||23
1592004|NCT01046253|3893188|P1|COMPLETED|Second Intervention||25
1592005|NCT01046253|3893187|P2|STARTED|Second Intervention||25
1592006|NCT01046253|3893188|P1|STARTED|Second Intervention||25
1592007|NCT01046253|3893187|P2|NOT COMPLETED|First Washout of 7 Days||0
1592008|NCT01046253|3893188|P1|NOT COMPLETED|First Washout of 7 Days||0
1592009|NCT01046253|3893187|P2|COMPLETED|First Washout of 7 Days||25
1592010|NCT01046253|3893188|P1|COMPLETED|First Washout of 7 Days||25
1592011|NCT01046253|3893187|P2|STARTED|First Washout of 7 Days||25
1592012|NCT01046253|3893188|P1|STARTED|First Washout of 7 Days||25
1592013|NCT01046253|3893187|P2|NOT COMPLETED|First Intervention||0
1592014|NCT01046253|3893188|P1|NOT COMPLETED|First Intervention||0
1592015|NCT01046253|3893187|P2|COMPLETED|First Intervention||25
1592016|NCT01046253|3893188|P1|COMPLETED|First Intervention||25
1592017|NCT01046253|3893187|P2|STARTED|First Intervention||25
1592018|NCT01046253|3893188|P1|STARTED|First Intervention||25
1592019|NCT01046136|3893200|P2|NOT COMPLETED|Overall Study||8
1592020|NCT01046136|3893201|P1|NOT COMPLETED|Overall Study||4
1592021|NCT01046136|3893200|P2|COMPLETED|Overall Study||182
1592022|NCT01046136|3893201|P1|COMPLETED|Overall Study||184
1592023|NCT01046136|3893200|P2|STARTED|Overall Study||190
1592024|NCT01046136|3893201|P1|STARTED|Overall Study||188
1592025|NCT01046110|3893213|P2|NOT COMPLETED|Overall Study||55
1592026|NCT01046110|3893214|P1|NOT COMPLETED|Overall Study||55
1592027|NCT01046110|3893213|P2|COMPLETED|Overall Study||174
1592028|NCT01046110|3893214|P1|COMPLETED|Overall Study||174
1592029|NCT01046110|3893213|P2|Exposed|Overall Study|1 subject was randomised in error|228
1592030|NCT01046110|3893214|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
1592031|NCT01046110|3893213|P2|STARTED|Overall Study||229
1592032|NCT01046110|3893214|P1|STARTED|Overall Study||229
1592033|NCT01046084|3893224|P2|NOT COMPLETED|Fourth Intervention||0
1592034|NCT01046084|3893225|P1|NOT COMPLETED|Fourth Intervention||0
1592035|NCT01046084|3893224|P2|COMPLETED|Fourth Intervention||25
1592036|NCT01046084|3893225|P1|COMPLETED|Fourth Intervention||23
1592037|NCT01046084|3893224|P2|STARTED|Fourth Intervention||25
1592038|NCT01046084|3893225|P1|STARTED|Fourth Intervention||23
1592039|NCT01046084|3893224|P2|NOT COMPLETED|Third Washout of 7 Days||0
1592040|NCT01046084|3893225|P1|NOT COMPLETED|Third Washout of 7 Days||2
1592041|NCT01046084|3893224|P2|COMPLETED|Third Washout of 7 Days||25
1592042|NCT01046084|3893225|P1|COMPLETED|Third Washout of 7 Days||23
1592043|NCT01046084|3893224|P2|STARTED|Third Washout of 7 Days||25
1592044|NCT01046084|3893225|P1|STARTED|Third Washout of 7 Days||25
1592045|NCT01046084|3893224|P2|NOT COMPLETED|Third Intervention||0
1592046|NCT01046084|3893225|P1|NOT COMPLETED|Third Intervention||0
1592047|NCT01046084|3893224|P2|COMPLETED|Third Intervention||25
1592048|NCT01046084|3893225|P1|COMPLETED|Third Intervention||25
1592049|NCT01046084|3893224|P2|STARTED|Third Intervention||25
1592050|NCT01046084|3893225|P1|STARTED|Third Intervention||25
1592051|NCT01046084|3893224|P2|NOT COMPLETED|Second Washout of 7 Days||0
1592052|NCT01046084|3893225|P1|NOT COMPLETED|Second Washout of 7 Days||0
1592053|NCT01046084|3893224|P2|COMPLETED|Second Washout of 7 Days||25
1592054|NCT01046084|3893225|P1|COMPLETED|Second Washout of 7 Days||25
1592055|NCT01046084|3893224|P2|STARTED|Second Washout of 7 Days||25
1592056|NCT01046084|3893225|P1|STARTED|Second Washout of 7 Days||25
1592057|NCT01046084|3893224|P2|NOT COMPLETED|Second Intervention||0
1592058|NCT01046084|3893225|P1|NOT COMPLETED|Second Intervention||0
1592059|NCT01046084|3893224|P2|COMPLETED|Second Intervention||25
1592060|NCT01046084|3893225|P1|COMPLETED|Second Intervention||25
1592061|NCT01046084|3893224|P2|STARTED|Second Intervention||25
1592062|NCT01046084|3893225|P1|STARTED|Second Intervention||25
1592063|NCT01046084|3893224|P2|NOT COMPLETED|First Washout of 7 Days||0
1592064|NCT01046084|3893225|P1|NOT COMPLETED|First Washout of 7 Days||0
1592065|NCT01046084|3893224|P2|COMPLETED|First Washout of 7 Days||25
1592066|NCT01046084|3893225|P1|COMPLETED|First Washout of 7 Days||25
1592067|NCT01046084|3893224|P2|STARTED|First Washout of 7 Days||25
1592068|NCT01046084|3893225|P1|STARTED|First Washout of 7 Days||25
1592069|NCT01046084|3893224|P2|NOT COMPLETED|First Intervention||0
1592070|NCT01046084|3893225|P1|NOT COMPLETED|First Intervention||0
1592071|NCT01046084|3893224|P2|COMPLETED|First Intervention||25
1592072|NCT01046084|3893225|P1|COMPLETED|First Intervention||25
1592073|NCT01046084|3893224|P2|STARTED|First Intervention||25
1592074|NCT01046084|3893225|P1|STARTED|First Intervention||25
1592075|NCT01045993|3893239|P4|NOT COMPLETED|Overall Study||0
1592076|NCT01045993|3893240|P3|NOT COMPLETED|Overall Study||0
1592077|NCT01045993|3893241|P2|NOT COMPLETED|Overall Study||1
1592078|NCT01045993|3893242|P1|NOT COMPLETED|Overall Study||0
1592079|NCT01045993|3893239|P4|COMPLETED|Overall Study||25
1592080|NCT01045993|3893240|P3|COMPLETED|Overall Study||5
1592081|NCT01045993|3893241|P2|COMPLETED|Overall Study||4
1592082|NCT01045993|3893242|P1|COMPLETED|Overall Study||26
1592083|NCT01045993|3893239|P4|STARTED|Overall Study||25
1592084|NCT01045993|3893240|P3|STARTED|Overall Study||5
1592085|NCT01045993|3893241|P2|STARTED|Overall Study||5
1592086|NCT01045993|3893242|P1|STARTED|Overall Study||26
1592087|NCT01045967|3893318|P2|NOT COMPLETED|Second Intervention||1
1592088|NCT01045967|3893319|P1|NOT COMPLETED|Second Intervention||0
1592089|NCT01045967|3893318|P2|COMPLETED|Second Intervention||27
1592090|NCT01045967|3893319|P1|COMPLETED|Second Intervention||28
1592091|NCT01045967|3893318|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
1592092|NCT01045967|3893319|P1|STARTED|Second Intervention||28
1592093|NCT01045967|3893318|P2|NOT COMPLETED|Washout of 7 Days||0
1592094|NCT01045967|3893319|P1|NOT COMPLETED|Washout of 7 Days||0
1592095|NCT01045967|3893318|P2|COMPLETED|Washout of 7 Days||28
1592096|NCT01045967|3893319|P1|COMPLETED|Washout of 7 Days||28
1592097|NCT01045967|3893318|P2|STARTED|Washout of 7 Days||28
1592098|NCT01045967|3893319|P1|STARTED|Washout of 7 Days||28
1592099|NCT01045967|3893318|P2|NOT COMPLETED|First Intervention||0
1592100|NCT01045967|3893319|P1|NOT COMPLETED|First Intervention||0
1592101|NCT01045967|3893318|P2|COMPLETED|First Intervention||28
1592102|NCT01045967|3893319|P1|COMPLETED|First Intervention||28
1592103|NCT01045967|3893318|P2|STARTED|First Intervention||28
1592104|NCT01045967|3893319|P1|STARTED|First Intervention||28
1592105|NCT01045798|3893331|P2|NOT COMPLETED|Overall Study||4
1592106|NCT01045798|3893332|P1|NOT COMPLETED|Overall Study||2
1592107|NCT01045798|3893331|P2|COMPLETED|Overall Study||5
1592108|NCT01045798|3893332|P1|COMPLETED|Overall Study||4
1592109|NCT01045798|3893331|P2|STARTED|Overall Study||9
1592110|NCT01045798|3893332|P1|STARTED|Overall Study||6
1592111|NCT01045707|3893340|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
1592112|NCT01045707|3893341|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
1592113|NCT01045707|3893340|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
1592114|NCT01045707|3893341|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
1592115|NCT01045707|3893340|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
1592116|NCT01045707|3893341|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
1592117|NCT01045707|3893340|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
1592118|NCT01045707|3893341|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
1592119|NCT01045707|3893340|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
1592120|NCT01045707|3893341|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
1592121|NCT01045707|3893340|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
1592122|NCT01045707|3893341|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
1592123|NCT01045707|3893340|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
1592124|NCT01045707|3893341|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
1592125|NCT01045694|3893357|P1|NOT COMPLETED|Overall Study||2
1592126|NCT01045694|3893357|P1|COMPLETED|Overall Study||6
1592127|NCT01045694|3893357|P1|STARTED|Overall Study||8
1592128|NCT01045551|3893363|P1|NOT COMPLETED|Overall Study||0
1592129|NCT01045551|3893363|P1|COMPLETED|Overall Study||10
1592130|NCT01045551|3893363|P1|STARTED|Overall Study||10
1592131|NCT01045447|3893373|P2|NOT COMPLETED|Overall Study||28
1592132|NCT01045447|3893374|P1|NOT COMPLETED|Overall Study||36
1592133|NCT01045447|3893373|P2|COMPLETED|Overall Study||205
1592134|NCT01045447|3893374|P1|COMPLETED|Overall Study||196
1592135|NCT01045447|3893373|P2|Exposed|Overall Study||233
1592136|NCT01045447|3893374|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
1592137|NCT01045447|3893373|P2|STARTED|Overall Study||233
1592138|NCT01045447|3893374|P1|STARTED|Overall Study||232
1592139|NCT01045421|3893388|P11|NOT COMPLETED|Phase 2||2
1592140|NCT01045421|3893389|P10|NOT COMPLETED|Phase 2||3
1592141|NCT01045421|3893390|P9|NOT COMPLETED|Phase 2||2
1592142|NCT01045421|3893391|P8|NOT COMPLETED|Phase 2||5
1592143|NCT01045421|3893392|P7|NOT COMPLETED|Phase 2||0
1592144|NCT01045421|3893393|P6|NOT COMPLETED|Phase 2||0
1592145|NCT01045421|3893394|P5|NOT COMPLETED|Phase 2||0
1592146|NCT01045421|3893395|P4|NOT COMPLETED|Phase 2||0
1592147|NCT01045421|3893396|P3|NOT COMPLETED|Phase 2||0
1592148|NCT01045421|3893397|P2|NOT COMPLETED|Phase 2||0
1592149|NCT01045421|3893398|P1|NOT COMPLETED|Phase 2||0
1592150|NCT01045421|3893388|P11|COMPLETED|Phase 2||58
1592151|NCT01045421|3893389|P10|COMPLETED|Phase 2||23
1592152|NCT01045421|3893390|P9|COMPLETED|Phase 2||53
1592153|NCT01045421|3893391|P8|COMPLETED|Phase 2||50
1592154|NCT01045421|3893392|P7|COMPLETED|Phase 2||53
1592155|NCT01045421|3893393|P6|COMPLETED|Phase 2||0
1592156|NCT01045421|3893394|P5|COMPLETED|Phase 2||0
1592157|NCT01045421|3893395|P4|COMPLETED|Phase 2||0
1592158|NCT01045421|3893396|P3|COMPLETED|Phase 2||0
1592159|NCT01045421|3893397|P2|COMPLETED|Phase 2||0
1592160|NCT01045421|3893398|P1|COMPLETED|Phase 2||0
1592161|NCT01045421|3893388|P11|STARTED|Phase 2||60
1592162|NCT01045421|3893389|P10|STARTED|Phase 2||26
1592163|NCT01045421|3893390|P9|STARTED|Phase 2||55
1592164|NCT01045421|3893391|P8|STARTED|Phase 2||55
1592165|NCT01045421|3893392|P7|STARTED|Phase 2||53
1592166|NCT01045421|3893393|P6|STARTED|Phase 2||0
1592167|NCT01045421|3893394|P5|STARTED|Phase 2||0
1592168|NCT01045421|3893395|P4|STARTED|Phase 2||0
1592169|NCT01045421|3893396|P3|STARTED|Phase 2||0
1592170|NCT01045421|3893397|P2|STARTED|Phase 2||0
1592171|NCT01045421|3893398|P1|STARTED|Phase 2||0
1592172|NCT01045421|3893388|P11|NOT COMPLETED|Phase 1||0
1592173|NCT01045421|3893389|P10|NOT COMPLETED|Phase 1||0
1592174|NCT01045421|3893390|P9|NOT COMPLETED|Phase 1||0
1592175|NCT01045421|3893391|P8|NOT COMPLETED|Phase 1||0
1592176|NCT01045421|3893392|P7|NOT COMPLETED|Phase 1||0
1592177|NCT01045421|3893393|P6|NOT COMPLETED|Phase 1||0
1592178|NCT01045421|3893394|P5|NOT COMPLETED|Phase 1||1
1592179|NCT01045421|3893395|P4|NOT COMPLETED|Phase 1||1
1592180|NCT01045421|3893396|P3|NOT COMPLETED|Phase 1||0
1592181|NCT01045421|3893397|P2|NOT COMPLETED|Phase 1||0
1592182|NCT01045421|3893398|P1|NOT COMPLETED|Phase 1||0
1592183|NCT01045421|3893388|P11|COMPLETED|Phase 1||0
1592184|NCT01045421|3893389|P10|COMPLETED|Phase 1||0
1592185|NCT01045421|3893390|P9|COMPLETED|Phase 1||0
1592186|NCT01045421|3893391|P8|COMPLETED|Phase 1||0
1592187|NCT01045421|3893392|P7|COMPLETED|Phase 1||0
1592188|NCT01045421|3893393|P6|COMPLETED|Phase 1||1
1592189|NCT01045421|3893394|P5|COMPLETED|Phase 1||2
1592190|NCT01045421|3893395|P4|COMPLETED|Phase 1||11
1592191|NCT01045421|3893396|P3|COMPLETED|Phase 1||4
1592192|NCT01045421|3893397|P2|COMPLETED|Phase 1||3
1592193|NCT01045421|3893398|P1|COMPLETED|Phase 1||1
1592194|NCT01045421|3893388|P11|STARTED|Phase 1||0
1592195|NCT01045421|3893389|P10|STARTED|Phase 1||0
1592196|NCT01045421|3893390|P9|STARTED|Phase 1||0
1592197|NCT01045421|3893391|P8|STARTED|Phase 1||0
1592198|NCT01045421|3893392|P7|STARTED|Phase 1||0
1592199|NCT01045421|3893393|P6|STARTED|Phase 1||1
1592200|NCT01045421|3893394|P5|STARTED|Phase 1||3
1592201|NCT01045421|3893395|P4|STARTED|Phase 1||12
1592202|NCT01045421|3893396|P3|STARTED|Phase 1||4
1592203|NCT01045421|3893397|P2|STARTED|Phase 1||3
1592204|NCT01045421|3893398|P1|STARTED|Phase 1||1
1592205|NCT01045265|3893478|P1|NOT COMPLETED|Overall Study||0
1592206|NCT01045265|3893478|P1|COMPLETED|Overall Study||16
1592207|NCT01045265|3893478|P1|STARTED|Overall Study||16
1592208|NCT01045187|3893485|P1|NOT COMPLETED|Overall Study||0
1592209|NCT01045187|3893485|P1|COMPLETED|Overall Study||15
1592210|NCT01045187|3893485|P1|STARTED|Overall Study||15
1592211|NCT01045161|3893492|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
1592212|NCT01045161|3893493|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
1592213|NCT01045161|3893494|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
1592214|NCT01045161|3893492|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
1592215|NCT01045161|3893493|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
1592216|NCT01045161|3893494|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
1592217|NCT01045161|3893492|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
1592218|NCT01045161|3893493|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
1592219|NCT01045161|3893494|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
1592220|NCT01045161|3893492|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
1592221|NCT01045161|3893493|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
1592222|NCT01045161|3893494|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
1592223|NCT01045161|3893492|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
1592224|NCT01045161|3893493|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
1592225|NCT01045161|3893494|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
1592226|NCT01045161|3893492|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
1592227|NCT01045161|3893493|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
1592228|NCT01045161|3893494|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
1592229|NCT01045122|3893514|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
1592230|NCT01045122|3893515|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
1592231|NCT01045122|3893514|P2|COMPLETED|Propofol Then Dexmedetomidine||6
1592232|NCT01045122|3893515|P1|COMPLETED|Propofol Then Dexmedetomidine||5
1592233|NCT01045122|3893514|P2|STARTED|Propofol Then Dexmedetomidine||6
1592234|NCT01045122|3893515|P1|STARTED|Propofol Then Dexmedetomidine||5
1592235|NCT01045122|3893514|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
1592236|NCT01045122|3893515|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
1592237|NCT01045122|3893514|P2|COMPLETED|Dexmedetomidine Then Propofol||6
1592238|NCT01045122|3893515|P1|COMPLETED|Dexmedetomidine Then Propofol||5
1592239|NCT01045122|3893514|P2|STARTED|Dexmedetomidine Then Propofol||6
1592240|NCT01045122|3893515|P1|STARTED|Dexmedetomidine Then Propofol||5
1592241|NCT01045096|3893524|P3|NOT COMPLETED|Overall Study||0
1592242|NCT01045096|3893525|P2|NOT COMPLETED|Overall Study||0
1592243|NCT01045096|3893526|P1|NOT COMPLETED|Overall Study||3
1592244|NCT01045096|3893524|P3|COMPLETED|Overall Study||12
1592245|NCT01045096|3893525|P2|COMPLETED|Overall Study||12
1592246|NCT01045096|3893526|P1|COMPLETED|Overall Study||9
1592247|NCT01045096|3893524|P3|Pharmacokinetic Set|Overall Study||11
1592248|NCT01045096|3893525|P2|Pharmacokinetic Set|Overall Study||11
1592249|NCT01045096|3893526|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
1592250|NCT01045096|3893524|P3|STARTED|Overall Study||12
1592251|NCT01045096|3893525|P2|STARTED|Overall Study||12
1592252|NCT01045096|3893526|P1|STARTED|Overall Study||12
1592253|NCT01045057|3893552|P1|NOT COMPLETED|Overall Study||0
1592254|NCT01045057|3893552|P1|COMPLETED|Overall Study||27
1592255|NCT01045057|3893552|P1|STARTED|Overall Study||27
1592256|NCT01045031|3893561|P2|NOT COMPLETED|Overall Study||6
1592257|NCT01045031|3893562|P1|NOT COMPLETED|Overall Study||9
1592258|NCT01045031|3893561|P2|COMPLETED|Overall Study||50
1592259|NCT01045031|3893562|P1|COMPLETED|Overall Study||49
1592260|NCT01045031|3893561|P2|STARTED|Overall Study||56
1592261|NCT01045031|3893562|P1|STARTED|Overall Study||58
1592262|NCT01044862|3893575|P3|NOT COMPLETED|Overall Study||52
1592263|NCT01044862|3893576|P2|NOT COMPLETED|Overall Study||49
1592264|NCT01044862|3893577|P1|NOT COMPLETED|Overall Study||53
1592265|NCT01044862|3893575|P3|COMPLETED|Overall Study||249
1592266|NCT01044862|3893576|P2|COMPLETED|Overall Study||251
1592267|NCT01044862|3893577|P1|COMPLETED|Overall Study||246
1592268|NCT01044862|3893575|P3|STARTED|Overall Study||301
1592269|NCT01044862|3893576|P2|STARTED|Overall Study||300
1592270|NCT01044862|3893577|P1|STARTED|Overall Study||299
1592271|NCT01044771|3893594|P1|NOT COMPLETED|Overall Study||0
1592272|NCT01044771|3893594|P1|COMPLETED|Overall Study||20
1592273|NCT01044771|3893594|P1|STARTED|Overall Study||20
1592274|NCT01044758|3893606|P7|NOT COMPLETED|Overall Study||10
1592275|NCT01044758|3893607|P6|NOT COMPLETED|Overall Study||3
1592276|NCT01044758|3893608|P5|NOT COMPLETED|Overall Study||2
1592277|NCT01044758|3893609|P4|NOT COMPLETED|Overall Study||2
1592278|NCT01044758|3893610|P3|NOT COMPLETED|Overall Study||4
1592279|NCT01044758|3893611|P2|NOT COMPLETED|Overall Study||0
1592280|NCT01044758|3893612|P1|NOT COMPLETED|Overall Study||4
1592281|NCT01044758|3893606|P7|COMPLETED|Overall Study||17
1592282|NCT01044758|3893607|P6|COMPLETED|Overall Study||8
1592283|NCT01044758|3893608|P5|COMPLETED|Overall Study||9
1592284|NCT01044758|3893609|P4|COMPLETED|Overall Study||10
1592285|NCT01044758|3893610|P3|COMPLETED|Overall Study||7
1592286|NCT01044758|3893611|P2|COMPLETED|Overall Study||12
1592287|NCT01044758|3893612|P1|COMPLETED|Overall Study||8
1592288|NCT01044758|3893606|P7|STARTED|Overall Study||27
1592289|NCT01044758|3893607|P6|STARTED|Overall Study||11
1592290|NCT01044758|3893608|P5|STARTED|Overall Study||11
1592291|NCT01044758|3893609|P4|STARTED|Overall Study||12
1592292|NCT01044758|3893610|P3|STARTED|Overall Study||11
1592293|NCT01044758|3893611|P2|STARTED|Overall Study||12
1592294|NCT01044758|3893612|P1|STARTED|Overall Study||12
1592295|NCT01044732|3893637|P2|NOT COMPLETED|Overall Study||50
1592296|NCT01044732|3893638|P1|NOT COMPLETED|Overall Study||49
1592297|NCT01044732|3893637|P2|COMPLETED|Overall Study||176
1592298|NCT01044732|3893638|P1|COMPLETED|Overall Study||173
1592299|NCT01044732|3893637|P2|STARTED|Overall Study||226
1592300|NCT01044732|3893638|P1|STARTED|Overall Study||222
1592301|NCT01044706|3893648|P2|NOT COMPLETED|Overall Study||0
1592302|NCT01044706|3893649|P1|NOT COMPLETED|Overall Study||0
1592303|NCT01044706|3893648|P2|COMPLETED|Overall Study||30
1592304|NCT01044706|3893649|P1|COMPLETED|Overall Study||30
1592305|NCT01044706|3893648|P2|STARTED|Overall Study||30
1592306|NCT01044706|3893649|P1|STARTED|Overall Study||30
1592307|NCT01044693|3893657|P16|NOT COMPLETED|Overall Study||0
1592308|NCT01044693|3893658|P15|NOT COMPLETED|Overall Study||0
1592309|NCT01044693|3893659|P14|NOT COMPLETED|Overall Study||0
1592310|NCT01044693|3893660|P13|NOT COMPLETED|Overall Study||0
1592311|NCT01044693|3893661|P12|NOT COMPLETED|Overall Study||0
1592312|NCT01044693|3893662|P11|NOT COMPLETED|Overall Study||0
1592313|NCT01044693|3893663|P10|NOT COMPLETED|Overall Study||0
1592314|NCT01044693|3893664|P9|NOT COMPLETED|Overall Study||0
1592315|NCT01044693|3893665|P8|NOT COMPLETED|Overall Study||0
1592316|NCT01044693|3893666|P7|NOT COMPLETED|Overall Study||0
1592317|NCT01044693|3893667|P6|NOT COMPLETED|Overall Study||0
1592318|NCT01044693|3893668|P5|NOT COMPLETED|Overall Study||0
1592319|NCT01044693|3893669|P4|NOT COMPLETED|Overall Study||0
1592320|NCT01044693|3893670|P3|NOT COMPLETED|Overall Study||0
1592321|NCT01044693|3893671|P2|NOT COMPLETED|Overall Study||0
1592322|NCT01044693|3893672|P1|NOT COMPLETED|Overall Study||0
1592323|NCT01044693|3893657|P16|COMPLETED|Overall Study||1
1592324|NCT01044693|3893658|P15|COMPLETED|Overall Study||1
1592325|NCT01044693|3893659|P14|COMPLETED|Overall Study||1
1592326|NCT01044693|3893660|P13|COMPLETED|Overall Study||2
1592327|NCT01044693|3893661|P12|COMPLETED|Overall Study||1
1592328|NCT01044693|3893662|P11|COMPLETED|Overall Study||1
1592329|NCT01044693|3893663|P10|COMPLETED|Overall Study||1
1592330|NCT01044693|3893664|P9|COMPLETED|Overall Study||1
1592331|NCT01044693|3893665|P8|COMPLETED|Overall Study||1
1592332|NCT01044693|3893666|P7|COMPLETED|Overall Study||1
1592333|NCT01044693|3893667|P6|COMPLETED|Overall Study||2
1592334|NCT01044693|3893668|P5|COMPLETED|Overall Study||1
1592335|NCT01044693|3893669|P4|COMPLETED|Overall Study||1
1592336|NCT01044693|3893670|P3|COMPLETED|Overall Study||1
1592337|NCT01044693|3893671|P2|COMPLETED|Overall Study||1
1592338|NCT01044693|3893672|P1|COMPLETED|Overall Study||3
1592339|NCT01044693|3893657|P16|STARTED|Overall Study||1
1592340|NCT01044693|3893658|P15|STARTED|Overall Study||1
1592341|NCT01044693|3893659|P14|STARTED|Overall Study||1
1592342|NCT01044693|3893660|P13|STARTED|Overall Study||2
1592343|NCT01044693|3893661|P12|STARTED|Overall Study||1
1592344|NCT01044693|3893662|P11|STARTED|Overall Study||1
1592345|NCT01044693|3893663|P10|STARTED|Overall Study||1
1592346|NCT01044693|3893664|P9|STARTED|Overall Study||1
1592347|NCT01044693|3893665|P8|STARTED|Overall Study||1
1592348|NCT01044693|3893666|P7|STARTED|Overall Study||1
1592349|NCT01044693|3893667|P6|STARTED|Overall Study||2
1592350|NCT01044693|3893668|P5|STARTED|Overall Study||1
1592351|NCT01044693|3893669|P4|STARTED|Overall Study||1
1592352|NCT01044693|3893670|P3|STARTED|Overall Study||1
1592353|NCT01044693|3893671|P2|STARTED|Overall Study||1
1592354|NCT01044693|3893672|P1|STARTED|Overall Study||3
1592355|NCT01044589|3893696|P2|NOT COMPLETED|Overall Study||5
1592356|NCT01044589|3893697|P1|NOT COMPLETED|Overall Study||3
1592357|NCT01044589|3893696|P2|COMPLETED|Overall Study||2
1592358|NCT01044589|3893697|P1|COMPLETED|Overall Study||3
1592359|NCT01044589|3893696|P2|STARTED|Overall Study||7
1592360|NCT01044589|3893697|P1|STARTED|Overall Study||6
1592361|NCT01044537|3893712|P7|NOT COMPLETED|Overall Study||0
1592362|NCT01044537|3893713|P6|NOT COMPLETED|Overall Study||0
1592363|NCT01044537|3893714|P5|NOT COMPLETED|Overall Study||0
1592364|NCT01044537|3893715|P4|NOT COMPLETED|Overall Study||0
1592365|NCT01044537|3893716|P3|NOT COMPLETED|Overall Study||0
1592366|NCT01044537|3893717|P2|NOT COMPLETED|Overall Study||0
1592367|NCT01044537|3893718|P1|NOT COMPLETED|Overall Study||0
1592368|NCT01044537|3893712|P7|COMPLETED|Overall Study||16
1592369|NCT01044537|3893713|P6|COMPLETED|Overall Study||5
1592370|NCT01044537|3893714|P5|COMPLETED|Overall Study||5
1592371|NCT01044537|3893715|P4|COMPLETED|Overall Study||6
1592372|NCT01044537|3893716|P3|COMPLETED|Overall Study||6
1592373|NCT01044537|3893717|P2|COMPLETED|Overall Study||6
1592374|NCT01044537|3893718|P1|COMPLETED|Overall Study||6
1592375|NCT01044537|3893712|P7|STARTED|Overall Study||16
1592376|NCT01044537|3893713|P6|STARTED|Overall Study||5
1592377|NCT01044537|3893714|P5|STARTED|Overall Study||5
1592378|NCT01044537|3893715|P4|STARTED|Overall Study||6
1592379|NCT01044537|3893716|P3|STARTED|Overall Study||6
1592380|NCT01044537|3893717|P2|STARTED|Overall Study||6
1592381|NCT01044537|3893718|P1|STARTED|Overall Study||6
1592382|NCT01044498|3893827|P2|NOT COMPLETED|Overall Study||2
1592383|NCT01044498|3893828|P1|NOT COMPLETED|Overall Study||3
1592384|NCT01044498|3893827|P2|COMPLETED|Overall Study||21
1592385|NCT01044498|3893828|P1|COMPLETED|Overall Study||20
1592386|NCT01044498|3893827|P2|STARTED|Overall Study||23
1592387|NCT01044498|3893828|P1|STARTED|Overall Study||23
1592388|NCT01044459|3893854|P2|NOT COMPLETED|Overall Study||131
1592389|NCT01044459|3893855|P1|NOT COMPLETED|Overall Study||133
1592390|NCT01044459|3893854|P2|COMPLETED|Overall Study||162
1592391|NCT01044459|3893855|P1|COMPLETED|Overall Study||179
1592392|NCT01044459|3893854|P2|STARTED|Overall Study||293
1592393|NCT01044459|3893855|P1|STARTED|Overall Study||312
1592394|NCT01044303|3893863|P1|NOT COMPLETED|Overall Study||2
1592395|NCT01044303|3893863|P1|COMPLETED|Overall Study||30
1592396|NCT01044303|3893863|P1|STARTED|Overall Study||32
1592397|NCT01044290|3893873|P3|NOT COMPLETED|Follow-Up 2||2
1592398|NCT01044290|3893874|P2|NOT COMPLETED|Follow-Up 2||2
1592399|NCT01044290|3893875|P1|NOT COMPLETED|Follow-Up 2||0
1592400|NCT01044290|3893873|P3|COMPLETED|Follow-Up 2||69
1592401|NCT01044290|3893874|P2|COMPLETED|Follow-Up 2||67
1592402|NCT01044290|3893875|P1|COMPLETED|Follow-Up 2||70
1592403|NCT01044290|3893873|P3|Completed F2 Interview|Follow-Up 2||64
1592404|NCT01044290|3893874|P2|Completed F2 Interview|Follow-Up 2||57
1592405|NCT01044290|3893875|P1|Completed F2 Interview|Follow-Up 2||64
1592406|NCT01044290|3893873|P3|STARTED|Follow-Up 2||71
1592407|NCT01044290|3893874|P2|STARTED|Follow-Up 2||69
1592408|NCT01044290|3893875|P1|STARTED|Follow-Up 2||70
1592409|NCT01044290|3893873|P3|NOT COMPLETED|Follow-up 1||1
1592410|NCT01044290|3893874|P2|NOT COMPLETED|Follow-up 1||5
1592411|NCT01044290|3893875|P1|NOT COMPLETED|Follow-up 1||5
1592412|NCT01044290|3893873|P3|COMPLETED|Follow-up 1||71
1592413|NCT01044290|3893874|P2|COMPLETED|Follow-up 1||69
1592414|NCT01044290|3893875|P1|COMPLETED|Follow-up 1||70
1592415|NCT01044290|3893873|P3|Completed F1 Interview|Follow-up 1||61
1592416|NCT01044290|3893874|P2|Completed F1 Interview|Follow-up 1||60
1592417|NCT01044290|3893875|P1|Completed F1 Interview|Follow-up 1||61
1592418|NCT01044290|3893873|P3|STARTED|Follow-up 1||72
1592419|NCT01044290|3893874|P2|STARTED|Follow-up 1||74
1592420|NCT01044290|3893875|P1|STARTED|Follow-up 1||75
1592421|NCT01044290|3893873|P3|NOT COMPLETED|Randomization||0
1592422|NCT01044290|3893874|P2|NOT COMPLETED|Randomization||0
1592423|NCT01044290|3893875|P1|NOT COMPLETED|Randomization||0
1592424|NCT01044290|3893873|P3|COMPLETED|Randomization||72
1592425|NCT01044290|3893874|P2|COMPLETED|Randomization||74
1592426|NCT01044290|3893875|P1|COMPLETED|Randomization||75
1592427|NCT01044290|3893873|P3|Randomized|Randomization||72
1592428|NCT01044290|3893874|P2|Randomized|Randomization||74
1592429|NCT01044290|3893875|P1|Randomized|Randomization||75
1592430|NCT01044290|3893873|P3|STARTED|Randomization||72
1592431|NCT01044290|3893874|P2|STARTED|Randomization||74
1592432|NCT01044290|3893875|P1|STARTED|Randomization||75
1592433|NCT01044264|3893901|P3|NOT COMPLETED|Overall Study||92
1592434|NCT01044264|3893902|P2|NOT COMPLETED|Overall Study||94
1592435|NCT01044264|3893903|P1|NOT COMPLETED|Overall Study||90
1592436|NCT01044264|3893901|P3|COMPLETED|Overall Study||108
1592437|NCT01044264|3893902|P2|COMPLETED|Overall Study||108
1592438|NCT01044264|3893903|P1|COMPLETED|Overall Study||110
1592439|NCT01044264|3893901|P3|STARTED|Overall Study||200
1592440|NCT01044264|3893902|P2|STARTED|Overall Study||202
1592441|NCT01044264|3893903|P1|STARTED|Overall Study||200
1592442|NCT01044212|3893913|P2|NOT COMPLETED|Overall Study||7
1592443|NCT01044212|3893914|P1|NOT COMPLETED|Overall Study||5
1592444|NCT01044212|3893913|P2|COMPLETED|Overall Study||30
1592445|NCT01044212|3893914|P1|COMPLETED|Overall Study||30
1592446|NCT01044212|3893913|P2|STARTED|Overall Study||37
1592447|NCT01044212|3893914|P1|STARTED|Overall Study||35
1592448|NCT01044056|3893927|P3|NOT COMPLETED|Overall Study||0
1592449|NCT01044056|3893928|P2|NOT COMPLETED|Overall Study||0
1592450|NCT01044056|3893929|P1|NOT COMPLETED|Overall Study||0
1592451|NCT01044056|3893927|P3|COMPLETED|Overall Study||8
1592452|NCT01044056|3893928|P2|COMPLETED|Overall Study||8
1592453|NCT01044056|3893929|P1|COMPLETED|Overall Study||8
1592454|NCT01044056|3893927|P3|STARTED|Overall Study||8
1592455|NCT01044056|3893928|P2|STARTED|Overall Study||8
1592456|NCT01044056|3893929|P1|STARTED|Overall Study||8
1592457|NCT01044030|3893948|P2|NOT COMPLETED|Overall Study||20
1592458|NCT01044030|3893949|P1|NOT COMPLETED|Overall Study||19
1592459|NCT01044030|3893948|P2|COMPLETED|Overall Study||146
1592460|NCT01044030|3893949|P1|COMPLETED|Overall Study||141
1592461|NCT01044030|3893948|P2|STARTED|Overall Study||166
1592462|NCT01044030|3893949|P1|STARTED|Overall Study||160
1592463|NCT01043939|3893963|P2|NOT COMPLETED|Second Intervention||0
1592464|NCT01043939|3893964|P1|NOT COMPLETED|Second Intervention||0
1592465|NCT01043939|3893963|P2|COMPLETED|Second Intervention||12
1592466|NCT01043939|3893964|P1|COMPLETED|Second Intervention||12
1592467|NCT01043939|3893963|P2|STARTED|Second Intervention||12
1592468|NCT01043939|3893964|P1|STARTED|Second Intervention||12
1592469|NCT01043939|3893963|P2|NOT COMPLETED|Washout Period||0
1592470|NCT01043939|3893964|P1|NOT COMPLETED|Washout Period||0
1592471|NCT01043939|3893963|P2|COMPLETED|Washout Period||12
1592472|NCT01043939|3893964|P1|COMPLETED|Washout Period||12
1592473|NCT01043939|3893963|P2|STARTED|Washout Period||12
1592474|NCT01043939|3893964|P1|STARTED|Washout Period||12
1592475|NCT01043939|3893963|P2|NOT COMPLETED|First Intervention||0
1592476|NCT01043939|3893964|P1|NOT COMPLETED|First Intervention||0
1592477|NCT01043939|3893963|P2|COMPLETED|First Intervention||12
1592478|NCT01043939|3893964|P1|COMPLETED|First Intervention||12
1592479|NCT01043939|3893963|P2|STARTED|First Intervention||12
1592480|NCT01043939|3893964|P1|STARTED|First Intervention||12
1592481|NCT01043926|3893978|P4|NOT COMPLETED|Overall Study||0
1592482|NCT01043926|3893979|P3|NOT COMPLETED|Overall Study||0
1592483|NCT01043926|3893980|P2|NOT COMPLETED|Overall Study||0
1592484|NCT01043926|3893981|P1|NOT COMPLETED|Overall Study||0
1592485|NCT01043926|3893978|P4|COMPLETED|Overall Study||0
1592486|NCT01043926|3893979|P3|COMPLETED|Overall Study||0
1592487|NCT01043926|3893980|P2|COMPLETED|Overall Study||8
1592488|NCT01043926|3893981|P1|COMPLETED|Overall Study||8
1592489|NCT01043926|3893978|P4|STARTED|Overall Study||0
1592490|NCT01043926|3893979|P3|STARTED|Overall Study||0
1592491|NCT01043926|3893980|P2|STARTED|Overall Study||8
1592492|NCT01043926|3893981|P1|STARTED|Overall Study||8
1592493|NCT01043874|3893995|P1|NOT COMPLETED|Overall Study||6
1592494|NCT01043874|3893995|P1|COMPLETED|Overall Study||39
1592495|NCT01043874|3893995|P1|STARTED|Overall Study||45
1592496|NCT01043705|3894005|P3|NOT COMPLETED|Overall Study||80
1592497|NCT01043705|3894006|P2|NOT COMPLETED|Overall Study||131
1592498|NCT01043705|3894007|P1|NOT COMPLETED|Overall Study||107
1592499|NCT01043705|3894005|P3|COMPLETED|Overall Study||498
1592500|NCT01043705|3894006|P2|COMPLETED|Overall Study||447
1592501|NCT01043705|3894007|P1|COMPLETED|Overall Study||352
1592502|NCT01043705|3894005|P3|STARTED|Overall Study||578
1592503|NCT01043705|3894006|P2|STARTED|Overall Study||578
1592504|NCT01043705|3894007|P1|STARTED|Overall Study||459
1592505|NCT01043653|3894017|P1|NOT COMPLETED|Overall Study||64
1592506|NCT01043653|3894017|P1|COMPLETED|Overall Study||186
1592507|NCT01043653|3894017|P1|STARTED|Overall Study||250
1592508|NCT01043640|3894022|P1|NOT COMPLETED|Overall Study||0
1592509|NCT01043640|3894022|P1|COMPLETED|Overall Study||46
1592510|NCT01043640|3894022|P1|STARTED|Overall Study||46
1592511|NCT01043562|3894037|P1|NOT COMPLETED|Overall Study||0
1592512|NCT01043562|3894037|P1|COMPLETED|Overall Study||20
1592513|NCT01043562|3894037|P1|STARTED|Overall Study||20
1592514|NCT01043523|3894044|P1|NOT COMPLETED|Overall Study||0
1592515|NCT01043523|3894044|P1|COMPLETED|Overall Study||52
1592516|NCT01043523|3894044|P1|Participants With Unenhanced Images|Overall Study||51
1592517|NCT01043523|3894044|P1|STARTED|Overall Study||52
1592518|NCT01043432|3894073|P4|NOT COMPLETED|Overall Study||0
1592519|NCT01043432|3894074|P3|NOT COMPLETED|Overall Study||0
1592520|NCT01043432|3894075|P2|NOT COMPLETED|Overall Study||0
1592521|NCT01043432|3894076|P1|NOT COMPLETED|Overall Study||0
1592522|NCT01043432|3894073|P4|COMPLETED|Overall Study||48
1592523|NCT01043432|3894074|P3|COMPLETED|Overall Study||12
1592524|NCT01043432|3894075|P2|COMPLETED|Overall Study||51
1592525|NCT01043432|3894076|P1|COMPLETED|Overall Study||22
1592526|NCT01043432|3894073|P4|STARTED|Overall Study||48
1592527|NCT01043432|3894074|P3|STARTED|Overall Study||12
1592528|NCT01043432|3894075|P2|STARTED|Overall Study||51
1592529|NCT01043432|3894076|P1|STARTED|Overall Study||22
1592530|NCT01043393|3894085|P2|NOT COMPLETED|Overall Study||0
1592531|NCT01043393|3894086|P1|NOT COMPLETED|Overall Study||0
1592532|NCT01043393|3894085|P2|COMPLETED|Overall Study||12
1592533|NCT01043393|3894086|P1|COMPLETED|Overall Study||12
1592534|NCT01043393|3894085|P2|STARTED|Overall Study||12
1592535|NCT01043393|3894086|P1|STARTED|Overall Study||12
1592536|NCT01043185|3894096|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592537|NCT01043185|3894097|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592538|NCT01043185|3894098|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592539|NCT01043185|3894099|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592540|NCT01043185|3894100|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592541|NCT01043185|3894101|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592542|NCT01043185|3894102|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592543|NCT01043185|3894103|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592544|NCT01043185|3894104|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592545|NCT01043185|3894105|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
1592546|NCT01043185|3894096|P10|COMPLETED|Period 7 - Fourth Intervention||3
1592547|NCT01043185|3894097|P9|COMPLETED|Period 7 - Fourth Intervention||2
1592548|NCT01043185|3894098|P8|COMPLETED|Period 7 - Fourth Intervention||3
1592549|NCT01043185|3894099|P7|COMPLETED|Period 7 - Fourth Intervention||3
1592550|NCT01043185|3894100|P6|COMPLETED|Period 7 - Fourth Intervention||3
1592551|NCT01043185|3894101|P5|COMPLETED|Period 7 - Fourth Intervention||2
1592552|NCT01043185|3894102|P4|COMPLETED|Period 7 - Fourth Intervention||2
1592553|NCT01043185|3894103|P3|COMPLETED|Period 7 - Fourth Intervention||3
1592554|NCT01043185|3894104|P2|COMPLETED|Period 7 - Fourth Intervention||2
1592555|NCT01043185|3894105|P1|COMPLETED|Period 7 - Fourth Intervention||3
1592556|NCT01043185|3894096|P10|STARTED|Period 7 - Fourth Intervention||3
1592557|NCT01043185|3894097|P9|STARTED|Period 7 - Fourth Intervention||2
1592558|NCT01043185|3894098|P8|STARTED|Period 7 - Fourth Intervention||3
1592559|NCT01043185|3894099|P7|STARTED|Period 7 - Fourth Intervention||3
1592560|NCT01043185|3894100|P6|STARTED|Period 7 - Fourth Intervention||3
1592561|NCT01043185|3894101|P5|STARTED|Period 7 - Fourth Intervention||2
1592562|NCT01043185|3894102|P4|STARTED|Period 7 - Fourth Intervention||2
1592563|NCT01043185|3894103|P3|STARTED|Period 7 - Fourth Intervention||3
1592564|NCT01043185|3894104|P2|STARTED|Period 7 - Fourth Intervention||2
1592565|NCT01043185|3894105|P1|STARTED|Period 7 - Fourth Intervention||3
1592566|NCT01043185|3894096|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
1592567|NCT01043185|3894097|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
1592568|NCT01043185|3894098|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
1592569|NCT01043185|3894099|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
1592570|NCT01043185|3894100|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
1592571|NCT01043185|3894101|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
1592572|NCT01043185|3894102|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
1592573|NCT01043185|3894103|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
1592574|NCT01043185|3894104|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
1592575|NCT01043185|3894105|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
1592576|NCT01043185|3894096|P10|COMPLETED|Period 6 - Third Washout Period||3
1592577|NCT01043185|3894097|P9|COMPLETED|Period 6 - Third Washout Period||2
1592578|NCT01043185|3894098|P8|COMPLETED|Period 6 - Third Washout Period||3
1592579|NCT01043185|3894099|P7|COMPLETED|Period 6 - Third Washout Period||3
1592580|NCT01043185|3894100|P6|COMPLETED|Period 6 - Third Washout Period||3
1592581|NCT01043185|3894101|P5|COMPLETED|Period 6 - Third Washout Period||2
1592582|NCT01043185|3894102|P4|COMPLETED|Period 6 - Third Washout Period||2
1592583|NCT01043185|3894103|P3|COMPLETED|Period 6 - Third Washout Period||3
1592584|NCT01043185|3894104|P2|COMPLETED|Period 6 - Third Washout Period||2
1592585|NCT01043185|3894105|P1|COMPLETED|Period 6 - Third Washout Period||3
1592586|NCT01043185|3894096|P10|STARTED|Period 6 - Third Washout Period||3
1592587|NCT01043185|3894097|P9|STARTED|Period 6 - Third Washout Period||3
1592588|NCT01043185|3894098|P8|STARTED|Period 6 - Third Washout Period||3
1592589|NCT01043185|3894099|P7|STARTED|Period 6 - Third Washout Period||3
1592590|NCT01043185|3894100|P6|STARTED|Period 6 - Third Washout Period||3
1592591|NCT01043185|3894101|P5|STARTED|Period 6 - Third Washout Period||2
1592592|NCT01043185|3894102|P4|STARTED|Period 6 - Third Washout Period||2
1592593|NCT01043185|3894103|P3|STARTED|Period 6 - Third Washout Period||3
1592594|NCT01043185|3894104|P2|STARTED|Period 6 - Third Washout Period||2
1592595|NCT01043185|3894105|P1|STARTED|Period 6 - Third Washout Period||3
1592596|NCT01043185|3894096|P10|NOT COMPLETED|Period 5 - Third Intervention||0
1592597|NCT01043185|3894097|P9|NOT COMPLETED|Period 5 - Third Intervention||0
1592598|NCT01043185|3894098|P8|NOT COMPLETED|Period 5 - Third Intervention||0
1592599|NCT01043185|3894099|P7|NOT COMPLETED|Period 5 - Third Intervention||0
1592600|NCT01043185|3894100|P6|NOT COMPLETED|Period 5 - Third Intervention||0
1592601|NCT01043185|3894101|P5|NOT COMPLETED|Period 5 - Third Intervention||0
1592602|NCT01043185|3894102|P4|NOT COMPLETED|Period 5 - Third Intervention||0
1592603|NCT01043185|3894103|P3|NOT COMPLETED|Period 5 - Third Intervention||0
1592604|NCT01043185|3894104|P2|NOT COMPLETED|Period 5 - Third Intervention||0
1592605|NCT01043185|3894105|P1|NOT COMPLETED|Period 5 - Third Intervention||0
1592606|NCT01043185|3894096|P10|COMPLETED|Period 5 - Third Intervention||3
1592607|NCT01043185|3894097|P9|COMPLETED|Period 5 - Third Intervention||3
1592608|NCT01043185|3894098|P8|COMPLETED|Period 5 - Third Intervention||3
1592609|NCT01043185|3894099|P7|COMPLETED|Period 5 - Third Intervention||3
1592610|NCT01043185|3894100|P6|COMPLETED|Period 5 - Third Intervention||3
1592611|NCT01043185|3894101|P5|COMPLETED|Period 5 - Third Intervention||2
1592612|NCT01043185|3894102|P4|COMPLETED|Period 5 - Third Intervention||2
1592613|NCT01043185|3894103|P3|COMPLETED|Period 5 - Third Intervention||3
1592614|NCT01043185|3894104|P2|COMPLETED|Period 5 - Third Intervention||2
1592615|NCT01043185|3894105|P1|COMPLETED|Period 5 - Third Intervention||3
1592616|NCT01043185|3894096|P10|STARTED|Period 5 - Third Intervention||3
1592617|NCT01043185|3894097|P9|STARTED|Period 5 - Third Intervention||3
1592618|NCT01043185|3894098|P8|STARTED|Period 5 - Third Intervention||3
1592619|NCT01043185|3894099|P7|STARTED|Period 5 - Third Intervention||3
1592620|NCT01043185|3894100|P6|STARTED|Period 5 - Third Intervention||3
1592621|NCT01043185|3894101|P5|STARTED|Period 5 - Third Intervention||2
1592622|NCT01043185|3894102|P4|STARTED|Period 5 - Third Intervention||2
1592623|NCT01043185|3894103|P3|STARTED|Period 5 - Third Intervention||3
1592624|NCT01043185|3894104|P2|STARTED|Period 5 - Third Intervention||2
1592625|NCT01043185|3894105|P1|STARTED|Period 5 - Third Intervention||3
1592626|NCT01043185|3894096|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
1592627|NCT01043185|3894097|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
1592628|NCT01043185|3894098|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
1592629|NCT01043185|3894099|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
1592630|NCT01043185|3894100|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
1592631|NCT01043185|3894101|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
1592632|NCT01043185|3894102|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
1592633|NCT01043185|3894103|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
1592634|NCT01043185|3894104|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
1592635|NCT01043185|3894105|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
1592636|NCT01043185|3894096|P10|COMPLETED|Period 4 - Second Washout Period||3
1592637|NCT01043185|3894097|P9|COMPLETED|Period 4 - Second Washout Period||3
1592638|NCT01043185|3894098|P8|COMPLETED|Period 4 - Second Washout Period||3
1592639|NCT01043185|3894099|P7|COMPLETED|Period 4 - Second Washout Period||3
1592640|NCT01043185|3894100|P6|COMPLETED|Period 4 - Second Washout Period||3
1592641|NCT01043185|3894101|P5|COMPLETED|Period 4 - Second Washout Period||2
1592642|NCT01043185|3894102|P4|COMPLETED|Period 4 - Second Washout Period||2
1592643|NCT01043185|3894103|P3|COMPLETED|Period 4 - Second Washout Period||3
1592644|NCT01043185|3894104|P2|COMPLETED|Period 4 - Second Washout Period||2
1592645|NCT01043185|3894105|P1|COMPLETED|Period 4 - Second Washout Period||3
1592646|NCT01043185|3894096|P10|STARTED|Period 4 - Second Washout Period||3
1592647|NCT01043185|3894097|P9|STARTED|Period 4 - Second Washout Period||3
1592648|NCT01043185|3894098|P8|STARTED|Period 4 - Second Washout Period||3
1592649|NCT01043185|3894099|P7|STARTED|Period 4 - Second Washout Period||3
1592650|NCT01043185|3894100|P6|STARTED|Period 4 - Second Washout Period||3
1592651|NCT01043185|3894101|P5|STARTED|Period 4 - Second Washout Period||2
1592652|NCT01043185|3894102|P4|STARTED|Period 4 - Second Washout Period||2
1592653|NCT01043185|3894103|P3|STARTED|Period 4 - Second Washout Period||3
1592654|NCT01043185|3894104|P2|STARTED|Period 4 - Second Washout Period||2
1592655|NCT01043185|3894105|P1|STARTED|Period 4 - Second Washout Period||3
1592656|NCT01043185|3894096|P10|NOT COMPLETED|Period 3 - Second Intervention||0
1592657|NCT01043185|3894097|P9|NOT COMPLETED|Period 3 - Second Intervention||0
1592658|NCT01043185|3894098|P8|NOT COMPLETED|Period 3 - Second Intervention||0
1592659|NCT01043185|3894099|P7|NOT COMPLETED|Period 3 - Second Intervention||0
1592660|NCT01043185|3894100|P6|NOT COMPLETED|Period 3 - Second Intervention||0
1592661|NCT01043185|3894101|P5|NOT COMPLETED|Period 3 - Second Intervention||0
1592662|NCT01043185|3894102|P4|NOT COMPLETED|Period 3 - Second Intervention||0
1592663|NCT01043185|3894103|P3|NOT COMPLETED|Period 3 - Second Intervention||0
1592664|NCT01043185|3894104|P2|NOT COMPLETED|Period 3 - Second Intervention||0
1592665|NCT01043185|3894105|P1|NOT COMPLETED|Period 3 - Second Intervention||0
1592666|NCT01043185|3894096|P10|COMPLETED|Period 3 - Second Intervention||3
1592667|NCT01043185|3894097|P9|COMPLETED|Period 3 - Second Intervention||3
1592668|NCT01043185|3894098|P8|COMPLETED|Period 3 - Second Intervention||3
1592669|NCT01043185|3894099|P7|COMPLETED|Period 3 - Second Intervention||3
1592670|NCT01043185|3894100|P6|COMPLETED|Period 3 - Second Intervention||3
1592671|NCT01043185|3894101|P5|COMPLETED|Period 3 - Second Intervention||2
1592672|NCT01043185|3894102|P4|COMPLETED|Period 3 - Second Intervention||2
1592673|NCT01043185|3894103|P3|COMPLETED|Period 3 - Second Intervention||3
1592674|NCT01043185|3894104|P2|COMPLETED|Period 3 - Second Intervention||2
1592675|NCT01043185|3894105|P1|COMPLETED|Period 3 - Second Intervention||3
1592676|NCT01043185|3894096|P10|STARTED|Period 3 - Second Intervention||3
1592677|NCT01043185|3894097|P9|STARTED|Period 3 - Second Intervention||3
1592678|NCT01043185|3894098|P8|STARTED|Period 3 - Second Intervention||3
1592679|NCT01043185|3894099|P7|STARTED|Period 3 - Second Intervention||3
1592680|NCT01043185|3894100|P6|STARTED|Period 3 - Second Intervention||3
1592681|NCT01043185|3894101|P5|STARTED|Period 3 - Second Intervention||2
1592682|NCT01043185|3894102|P4|STARTED|Period 3 - Second Intervention||2
1592683|NCT01043185|3894103|P3|STARTED|Period 3 - Second Intervention||3
1592684|NCT01043185|3894104|P2|STARTED|Period 3 - Second Intervention||2
1592685|NCT01043185|3894105|P1|STARTED|Period 3 - Second Intervention||3
1592686|NCT01043185|3894096|P10|NOT COMPLETED|Period 2 - First Washout Period||0
1592687|NCT01043185|3894097|P9|NOT COMPLETED|Period 2 - First Washout Period||0
1592688|NCT01043185|3894098|P8|NOT COMPLETED|Period 2 - First Washout Period||0
1592689|NCT01043185|3894099|P7|NOT COMPLETED|Period 2 - First Washout Period||0
1592690|NCT01043185|3894100|P6|NOT COMPLETED|Period 2 - First Washout Period||0
1592691|NCT01043185|3894101|P5|NOT COMPLETED|Period 2 - First Washout Period||0
1592692|NCT01043185|3894102|P4|NOT COMPLETED|Period 2 - First Washout Period||0
1592693|NCT01043185|3894103|P3|NOT COMPLETED|Period 2 - First Washout Period||0
1592694|NCT01043185|3894104|P2|NOT COMPLETED|Period 2 - First Washout Period||0
1592695|NCT01043185|3894105|P1|NOT COMPLETED|Period 2 - First Washout Period||0
1592696|NCT01043185|3894096|P10|COMPLETED|Period 2 - First Washout Period||3
1592697|NCT01043185|3894097|P9|COMPLETED|Period 2 - First Washout Period||3
1592698|NCT01043185|3894098|P8|COMPLETED|Period 2 - First Washout Period||3
1592699|NCT01043185|3894099|P7|COMPLETED|Period 2 - First Washout Period||3
1592700|NCT01043185|3894100|P6|COMPLETED|Period 2 - First Washout Period||3
1592701|NCT01043185|3894101|P5|COMPLETED|Period 2 - First Washout Period||2
1592702|NCT01043185|3894102|P4|COMPLETED|Period 2 - First Washout Period||2
1592703|NCT01043185|3894103|P3|COMPLETED|Period 2 - First Washout Period||3
1592704|NCT01043185|3894104|P2|COMPLETED|Period 2 - First Washout Period||2
1592705|NCT01043185|3894105|P1|COMPLETED|Period 2 - First Washout Period||3
1592706|NCT01043185|3894096|P10|STARTED|Period 2 - First Washout Period||3
1592707|NCT01043185|3894097|P9|STARTED|Period 2 - First Washout Period||3
1592708|NCT01043185|3894098|P8|STARTED|Period 2 - First Washout Period||3
1592709|NCT01043185|3894099|P7|STARTED|Period 2 - First Washout Period||3
1592710|NCT01043185|3894100|P6|STARTED|Period 2 - First Washout Period||3
1592711|NCT01043185|3894101|P5|STARTED|Period 2 - First Washout Period||2
1592712|NCT01043185|3894102|P4|STARTED|Period 2 - First Washout Period||2
1592713|NCT01043185|3894103|P3|STARTED|Period 2 - First Washout Period||3
1592714|NCT01043185|3894104|P2|STARTED|Period 2 - First Washout Period||2
1592715|NCT01043185|3894105|P1|STARTED|Period 2 - First Washout Period||3
1592716|NCT01043185|3894096|P10|NOT COMPLETED|Period 1 - First Intervention||0
1592717|NCT01043185|3894097|P9|NOT COMPLETED|Period 1 - First Intervention||0
1592718|NCT01043185|3894098|P8|NOT COMPLETED|Period 1 - First Intervention||0
1592719|NCT01043185|3894099|P7|NOT COMPLETED|Period 1 - First Intervention||0
1592720|NCT01043185|3894100|P6|NOT COMPLETED|Period 1 - First Intervention||0
1592721|NCT01043185|3894101|P5|NOT COMPLETED|Period 1 - First Intervention||0
1592722|NCT01043185|3894102|P4|NOT COMPLETED|Period 1 - First Intervention||0
1592723|NCT01043185|3894103|P3|NOT COMPLETED|Period 1 - First Intervention||0
1592724|NCT01043185|3894104|P2|NOT COMPLETED|Period 1 - First Intervention||0
1592725|NCT01043185|3894105|P1|NOT COMPLETED|Period 1 - First Intervention||0
1592726|NCT01043185|3894096|P10|COMPLETED|Period 1 - First Intervention||3
1592727|NCT01043185|3894097|P9|COMPLETED|Period 1 - First Intervention||3
1592728|NCT01043185|3894098|P8|COMPLETED|Period 1 - First Intervention||3
1592729|NCT01043185|3894099|P7|COMPLETED|Period 1 - First Intervention||3
1592730|NCT01043185|3894100|P6|COMPLETED|Period 1 - First Intervention||3
1592731|NCT01043185|3894101|P5|COMPLETED|Period 1 - First Intervention||2
1592732|NCT01043185|3894102|P4|COMPLETED|Period 1 - First Intervention||2
1592733|NCT01043185|3894103|P3|COMPLETED|Period 1 - First Intervention||3
1592734|NCT01043185|3894104|P2|COMPLETED|Period 1 - First Intervention||2
1592735|NCT01043185|3894105|P1|COMPLETED|Period 1 - First Intervention||3
1592736|NCT01043185|3894096|P10|STARTED|Period 1 - First Intervention||3
1592737|NCT01043185|3894097|P9|STARTED|Period 1 - First Intervention||3
1592738|NCT01043185|3894098|P8|STARTED|Period 1 - First Intervention||3
1592739|NCT01043185|3894099|P7|STARTED|Period 1 - First Intervention||3
1592740|NCT01043185|3894100|P6|STARTED|Period 1 - First Intervention||3
1592741|NCT01043185|3894101|P5|STARTED|Period 1 - First Intervention||2
1592742|NCT01043185|3894102|P4|STARTED|Period 1 - First Intervention||2
1592743|NCT01043185|3894103|P3|STARTED|Period 1 - First Intervention||3
1592744|NCT01043185|3894104|P2|STARTED|Period 1 - First Intervention||2
1592745|NCT01043185|3894105|P1|STARTED|Period 1 - First Intervention||3
1592746|NCT01043146|3894138|P6|NOT COMPLETED|Overall Study||0
1592747|NCT01043146|3894139|P5|NOT COMPLETED|Overall Study||0
1592748|NCT01043146|3894140|P4|NOT COMPLETED|Overall Study||0
1592749|NCT01043146|3894141|P3|NOT COMPLETED|Overall Study||0
1592750|NCT01043146|3894142|P2|NOT COMPLETED|Overall Study||0
1592751|NCT01043146|3894143|P1|NOT COMPLETED|Overall Study||0
1592752|NCT01043146|3894138|P6|COMPLETED|Overall Study||8
1592753|NCT01043146|3894139|P5|COMPLETED|Overall Study||8
1592754|NCT01043146|3894140|P4|COMPLETED|Overall Study||8
1592755|NCT01043146|3894141|P3|COMPLETED|Overall Study||8
1592756|NCT01043146|3894142|P2|COMPLETED|Overall Study||8
1592757|NCT01043146|3894143|P1|COMPLETED|Overall Study||10
1592758|NCT01043146|3894138|P6|STARTED|Overall Study||8
1592759|NCT01043146|3894139|P5|STARTED|Overall Study||8
1592760|NCT01043146|3894140|P4|STARTED|Overall Study||8
1592761|NCT01043146|3894141|P3|STARTED|Overall Study||8
1592762|NCT01043146|3894142|P2|STARTED|Overall Study||8
1592763|NCT01043146|3894143|P1|STARTED|Overall Study||10
1592764|NCT01043133|3894159|P2|NOT COMPLETED|Overall Study||2
1592765|NCT01043133|3894160|P1|NOT COMPLETED|Overall Study||1
1592766|NCT01043133|3894159|P2|COMPLETED|Overall Study||78
1592767|NCT01043133|3894160|P1|COMPLETED|Overall Study||74
1592768|NCT01043133|3894159|P2|STARTED|Overall Study||80
1592769|NCT01043133|3894160|P1|STARTED|Overall Study||75
1592770|NCT01043094|3894170|P2|NOT COMPLETED|Overall Study||0
1592771|NCT01043094|3894171|P1|NOT COMPLETED|Overall Study||0
1592772|NCT01043094|3894170|P2|COMPLETED|Overall Study||8
1592773|NCT01043094|3894171|P1|COMPLETED|Overall Study||8
1592774|NCT01043094|3894170|P2|STARTED|Overall Study||8
1592775|NCT01043094|3894171|P1|STARTED|Overall Study||8
1592776|NCT01042977|3894181|P2|NOT COMPLETED|Overall Study||55
1592777|NCT01042977|3894182|P1|NOT COMPLETED|Overall Study||41
1592778|NCT01042977|3894181|P2|COMPLETED|Overall Study||428
1592779|NCT01042977|3894182|P1|COMPLETED|Overall Study||441
1592780|NCT01042977|3894181|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
1592781|NCT01042977|3894182|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
1592782|NCT01042938|3894202|P2|NOT COMPLETED|Overall Study||2
1592783|NCT01042938|3894203|P1|NOT COMPLETED|Overall Study||3
1592784|NCT01042938|3894202|P2|COMPLETED|Overall Study||16
1592785|NCT01042938|3894203|P1|COMPLETED|Overall Study||14
1592786|NCT01042938|3894202|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
1592787|NCT01042938|3894203|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
1592788|NCT01042795|3894215|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
1592789|NCT01042795|3894215|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
1592790|NCT01042795|3894215|P1|STARTED|Follow up - 22 Months After Drug Start||2
1592791|NCT01042795|3894215|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
1592792|NCT01042795|3894215|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
1592793|NCT01042795|3894215|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
1592794|NCT01042678|3894222|P6|NOT COMPLETED|Overall Study||0
1592795|NCT01042678|3894223|P5|NOT COMPLETED|Overall Study||0
1592796|NCT01042678|3894224|P4|NOT COMPLETED|Overall Study||0
1592797|NCT01042678|3894225|P3|NOT COMPLETED|Overall Study||0
1592798|NCT01042678|3894226|P2|NOT COMPLETED|Overall Study||0
1592799|NCT01042678|3894227|P1|NOT COMPLETED|Overall Study||1
1592800|NCT01042678|3894222|P6|COMPLETED|Overall Study||0
1592801|NCT01042678|3894223|P5|COMPLETED|Overall Study||0
1592802|NCT01042678|3894224|P4|COMPLETED|Overall Study||0
1592803|NCT01042678|3894225|P3|COMPLETED|Overall Study||6
1592804|NCT01042678|3894226|P2|COMPLETED|Overall Study||6
1592805|NCT01042678|3894227|P1|COMPLETED|Overall Study||5
1592806|NCT01042678|3894222|P6|STARTED|Overall Study||0
1592807|NCT01042678|3894223|P5|STARTED|Overall Study||0
1592808|NCT01042678|3894224|P4|STARTED|Overall Study||0
1592809|NCT01042678|3894225|P3|STARTED|Overall Study||6
1592810|NCT01042678|3894226|P2|STARTED|Overall Study||6
1592811|NCT01042678|3894227|P1|STARTED|Overall Study||6
1592812|NCT01042613|3894252|P2|NOT COMPLETED|Overall Study||0
1592813|NCT01042613|3894253|P1|NOT COMPLETED|Overall Study||0
1592814|NCT01042613|3894252|P2|COMPLETED|Overall Study||74
1592815|NCT01042613|3894253|P1|COMPLETED|Overall Study||72
1592816|NCT01042613|3894252|P2|STARTED|Overall Study||74
1592817|NCT01042613|3894253|P1|STARTED|Overall Study||72
1592818|NCT01042600|3894265|P2|NOT COMPLETED|Overall Study||0
1592819|NCT01042600|3894266|P1|NOT COMPLETED|Overall Study||1
1592820|NCT01042600|3894265|P2|COMPLETED|Overall Study||30
1592821|NCT01042600|3894266|P1|COMPLETED|Overall Study||30
1592822|NCT01042600|3894265|P2|STARTED|Overall Study||30
1592823|NCT01042600|3894266|P1|STARTED|Overall Study||31
1592824|NCT01042535|3894274|P1|NOT COMPLETED|Overall Study||8
1592825|NCT01042535|3894274|P1|COMPLETED|Overall Study||36
1592826|NCT01042535|3894274|P1|STARTED|Overall Study||44
1592827|NCT01042509|3894282|P1|NOT COMPLETED|Overall Study||0
1592828|NCT01042509|3894282|P1|COMPLETED|Overall Study||15
1592829|NCT01042509|3894282|P1|STARTED|Overall Study||15
1592830|NCT01042496|3894289|P2|NOT COMPLETED|Overall Study||0
1592831|NCT01042496|3894290|P1|NOT COMPLETED|Overall Study||0
1592832|NCT01042496|3894289|P2|COMPLETED|Overall Study||33
1592833|NCT01042496|3894290|P1|COMPLETED|Overall Study||29
1592834|NCT01042496|3894289|P2|STARTED|Overall Study||33
1592835|NCT01042496|3894290|P1|STARTED|Overall Study||29
1592836|NCT01042392|3894308|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
1592837|NCT01042392|3894309|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
1592838|NCT01042392|3894310|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
1592839|NCT01042392|3894311|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
1592840|NCT01042392|3894308|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
1592841|NCT01042392|3894309|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
1592842|NCT01042392|3894310|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
1592843|NCT01042392|3894311|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
1592844|NCT01042392|3894308|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
1592845|NCT01042392|3894309|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
1592846|NCT01042392|3894310|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
1592847|NCT01042392|3894311|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
1592848|NCT01042392|3894308|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
1592849|NCT01042392|3894309|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
1592850|NCT01042392|3894310|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
1592851|NCT01042392|3894311|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
1592852|NCT01042392|3894308|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1592853|NCT01042392|3894309|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
1592854|NCT01042392|3894310|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1592855|NCT01042392|3894311|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
1592856|NCT01042392|3894308|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1592857|NCT01042392|3894309|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
1592858|NCT01042392|3894310|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1592859|NCT01042392|3894311|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
1592860|NCT01042392|3894308|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
1592861|NCT01042392|3894309|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
1592862|NCT01042392|3894310|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
1592863|NCT01042392|3894311|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
1592864|NCT01042392|3894308|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
1592865|NCT01042392|3894309|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
1592866|NCT01042392|3894310|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
1592867|NCT01042392|3894311|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
1592868|NCT01042366|3894340|P3|NOT COMPLETED|Overall Study||0
1592869|NCT01042366|3894341|P2|NOT COMPLETED|Overall Study||0
1592870|NCT01042366|3894342|P1|NOT COMPLETED|Overall Study||0
1592871|NCT01042366|3894340|P3|COMPLETED|Overall Study||4
1592872|NCT01042366|3894341|P2|COMPLETED|Overall Study||6
1592873|NCT01042366|3894342|P1|COMPLETED|Overall Study||5
1592874|NCT01042366|3894340|P3|STARTED|Overall Study||4
1592875|NCT01042366|3894341|P2|STARTED|Overall Study||6
1592876|NCT01042366|3894342|P1|STARTED|Overall Study||5
1592877|NCT01042288|3894351|P1|NOT COMPLETED|Overall Study||69
1592878|NCT01042288|3894351|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
1592879|NCT01042288|3894351|P1|Maintenance|Overall Study||27
1592880|NCT01042288|3894351|P1|STARTED|Overall Study||69
1592881|NCT01042236|3894359|P6|NOT COMPLETED|Treatment Period 3||0
1592882|NCT01042236|3894360|P5|NOT COMPLETED|Treatment Period 3||0
1592883|NCT01042236|3894361|P4|NOT COMPLETED|Treatment Period 3||2
1592884|NCT01042236|3894362|P3|NOT COMPLETED|Treatment Period 3||0
1592885|NCT01042236|3894363|P2|NOT COMPLETED|Treatment Period 3||0
1592886|NCT01042236|3894364|P1|NOT COMPLETED|Treatment Period 3||0
1592887|NCT01042236|3894359|P6|COMPLETED|Treatment Period 3||3
1592888|NCT01042236|3894360|P5|COMPLETED|Treatment Period 3||3
1592889|NCT01042236|3894361|P4|COMPLETED|Treatment Period 3||3
1592890|NCT01042236|3894362|P3|COMPLETED|Treatment Period 3||3
1592891|NCT01042236|3894363|P2|COMPLETED|Treatment Period 3||3
1592892|NCT01042236|3894364|P1|COMPLETED|Treatment Period 3||3
1592893|NCT01042236|3894359|P6|STARTED|Treatment Period 3||3
1592894|NCT01042236|3894360|P5|STARTED|Treatment Period 3||3
1592895|NCT01042236|3894361|P4|STARTED|Treatment Period 3||5
1592896|NCT01042236|3894362|P3|STARTED|Treatment Period 3||3
1592897|NCT01042236|3894363|P2|STARTED|Treatment Period 3||3
1592898|NCT01042236|3894364|P1|STARTED|Treatment Period 3||3
1592899|NCT01042236|3894359|P6|NOT COMPLETED|Treatment Period 2||0
1592900|NCT01042236|3894360|P5|NOT COMPLETED|Treatment Period 2||0
1592901|NCT01042236|3894361|P4|NOT COMPLETED|Treatment Period 2||0
1592902|NCT01042236|3894362|P3|NOT COMPLETED|Treatment Period 2||0
1592903|NCT01042236|3894363|P2|NOT COMPLETED|Treatment Period 2||0
1592904|NCT01042236|3894364|P1|NOT COMPLETED|Treatment Period 2||0
1592905|NCT01042236|3894359|P6|COMPLETED|Treatment Period 2||3
1592906|NCT01042236|3894360|P5|COMPLETED|Treatment Period 2||3
1592907|NCT01042236|3894361|P4|COMPLETED|Treatment Period 2||5
1592908|NCT01042236|3894362|P3|COMPLETED|Treatment Period 2||3
1592909|NCT01042236|3894363|P2|COMPLETED|Treatment Period 2||3
1592910|NCT01042236|3894364|P1|COMPLETED|Treatment Period 2||3
1592911|NCT01042236|3894359|P6|STARTED|Treatment Period 2||3
1592912|NCT01042236|3894360|P5|STARTED|Treatment Period 2||3
1592913|NCT01042236|3894361|P4|STARTED|Treatment Period 2||5
1592914|NCT01042236|3894362|P3|STARTED|Treatment Period 2||3
1592915|NCT01042236|3894363|P2|STARTED|Treatment Period 2||3
1592916|NCT01042236|3894364|P1|STARTED|Treatment Period 2||3
1592917|NCT01042236|3894359|P6|NOT COMPLETED|Treatment Period 1||0
1592918|NCT01042236|3894360|P5|NOT COMPLETED|Treatment Period 1||1
1592919|NCT01042236|3894361|P4|NOT COMPLETED|Treatment Period 1||0
1592920|NCT01042236|3894362|P3|NOT COMPLETED|Treatment Period 1||0
1592921|NCT01042236|3894363|P2|NOT COMPLETED|Treatment Period 1||1
1592922|NCT01042236|3894364|P1|NOT COMPLETED|Treatment Period 1||0
1592923|NCT01042236|3894359|P6|COMPLETED|Treatment Period 1||3
1592924|NCT01042236|3894360|P5|COMPLETED|Treatment Period 1||3
1592925|NCT01042236|3894361|P4|COMPLETED|Treatment Period 1||5
1592926|NCT01042236|3894362|P3|COMPLETED|Treatment Period 1||3
1592927|NCT01042236|3894363|P2|COMPLETED|Treatment Period 1||3
1592928|NCT01042236|3894364|P1|COMPLETED|Treatment Period 1||3
1592929|NCT01042236|3894359|P6|STARTED|Treatment Period 1||3
1592930|NCT01042236|3894360|P5|STARTED|Treatment Period 1||4
1592931|NCT01042236|3894361|P4|STARTED|Treatment Period 1||5
1592932|NCT01042236|3894362|P3|STARTED|Treatment Period 1||3
1592933|NCT01042236|3894363|P2|STARTED|Treatment Period 1||4
1592934|NCT01042236|3894364|P1|STARTED|Treatment Period 1||3
1592935|NCT01042158|3894401|P1|NOT COMPLETED|Overall Study||1
1592936|NCT01042158|3894401|P1|COMPLETED|Overall Study||24
1592937|NCT01042158|3894401|P1|STARTED|Overall Study||25
1592938|NCT01042145|3894410|P2|NOT COMPLETED|Overall Study||1
1592939|NCT01042145|3894411|P1|NOT COMPLETED|Overall Study||1
1592940|NCT01042145|3894410|P2|COMPLETED|Overall Study||45
1592941|NCT01042145|3894411|P1|COMPLETED|Overall Study||40
1592942|NCT01042145|3894410|P2|STARTED|Overall Study||46
1592943|NCT01042145|3894411|P1|STARTED|Overall Study||41
1592944|NCT01042093|3894431|P4|NOT COMPLETED|Overall Study||4
1592945|NCT01042093|3894432|P3|NOT COMPLETED|Overall Study||2
1592946|NCT01042093|3894433|P2|NOT COMPLETED|Overall Study||2
1592947|NCT01042093|3894434|P1|NOT COMPLETED|Overall Study||2
1592948|NCT01042093|3894431|P4|COMPLETED|Overall Study||36
1592949|NCT01042093|3894432|P3|COMPLETED|Overall Study||38
1592950|NCT01042093|3894433|P2|COMPLETED|Overall Study||38
1592951|NCT01042093|3894434|P1|COMPLETED|Overall Study||38
1592952|NCT01042093|3894431|P4|STARTED|Overall Study||40
1592953|NCT01042093|3894432|P3|STARTED|Overall Study||40
1592954|NCT01042093|3894433|P2|STARTED|Overall Study||40
1592955|NCT01042093|3894434|P1|STARTED|Overall Study||40
1592956|NCT01041976|3894454|P2|NOT COMPLETED|Overall Study||4
1592957|NCT01041976|3894455|P1|NOT COMPLETED|Overall Study||5
1592958|NCT01041976|3894454|P2|COMPLETED|Overall Study||38
1592959|NCT01041976|3894455|P1|COMPLETED|Overall Study||37
1592960|NCT01041976|3894454|P2|18 Month Follow-up|Overall Study||38
1592961|NCT01041976|3894455|P1|18 Month Follow-up|Overall Study||37
1592962|NCT01041976|3894454|P2|12 Month Follow-up|Overall Study||38
1592963|NCT01041976|3894455|P1|12 Month Follow-up|Overall Study||37
1592964|NCT01041976|3894454|P2|6 Month Follow-up|Overall Study||41
1592965|NCT01041976|3894455|P1|6 Month Follow-up|Overall Study||39
1592966|NCT01041976|3894454|P2|STARTED|Overall Study||42
1592967|NCT01041976|3894455|P1|STARTED|Overall Study||42
1592968|NCT01041859|3894465|P3|NOT COMPLETED|Double-Blind Maintenance||45
1592969|NCT01041859|3894466|P2|NOT COMPLETED|Double-Blind Maintenance||46
1592970|NCT01041859|3894467|P1|NOT COMPLETED|Double-Blind Maintenance||0
1592971|NCT01041859|3894465|P3|COMPLETED|Double-Blind Maintenance||107
1592972|NCT01041859|3894466|P2|COMPLETED|Double-Blind Maintenance||120
1592973|NCT01041859|3894467|P1|COMPLETED|Double-Blind Maintenance||0
1592974|NCT01041859|3894465|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
1592975|NCT01041859|3894466|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
1592976|NCT01041859|3894467|P1|STARTED|Double-Blind Maintenance||0
1592977|NCT01041859|3894465|P3|NOT COMPLETED|Open-Label Titration||0
1592978|NCT01041859|3894466|P2|NOT COMPLETED|Open-Label Titration||0
1592979|NCT01041859|3894467|P1|NOT COMPLETED|Open-Label Titration||101
1592980|NCT01041859|3894465|P3|COMPLETED|Open-Label Titration||0
1592981|NCT01041859|3894466|P2|COMPLETED|Open-Label Titration||0
1592982|NCT01041859|3894467|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
1592983|NCT01041859|3894465|P3|STARTED|Open-Label Titration||0
1592984|NCT01041859|3894466|P2|STARTED|Open-Label Titration||0
1592985|NCT01041859|3894467|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
1592986|NCT01041781|3894484|P2|NOT COMPLETED|Overall Study||0
1592987|NCT01041781|3894485|P1|NOT COMPLETED|Overall Study||0
1592988|NCT01041781|3894484|P2|COMPLETED|Overall Study||158
1592989|NCT01041781|3894485|P1|COMPLETED|Overall Study||154
1592990|NCT01041781|3894484|P2|STARTED|Overall Study||158
1592991|NCT01041781|3894485|P1|STARTED|Overall Study||154
1592992|NCT01041638|3894503|P1|NOT COMPLETED|Overall Study||27
1592993|NCT01041638|3894503|P1|COMPLETED|Overall Study||78
1592994|NCT01041638|3894503|P1|STARTED|Overall Study||105
1592995|NCT01041573|3894511|P4|NOT COMPLETED|Overall Study||2
1592996|NCT01041573|3894512|P3|NOT COMPLETED|Overall Study||7
1592997|NCT01041573|3894513|P2|NOT COMPLETED|Overall Study||13
1592998|NCT01041573|3894514|P1|NOT COMPLETED|Overall Study||5
1592999|NCT01041573|3894511|P4|COMPLETED|Overall Study||62
1593000|NCT01041573|3894512|P3|COMPLETED|Overall Study||387
1593001|NCT01041573|3894513|P2|COMPLETED|Overall Study||858
1593002|NCT01041573|3894514|P1|COMPLETED|Overall Study||535
1593003|NCT01041573|3894511|P4|STARTED|Overall Study||64
1593004|NCT01041573|3894512|P3|STARTED|Overall Study||394
1593005|NCT01041573|3894513|P2|STARTED|Overall Study||871
1593006|NCT01041573|3894514|P1|STARTED|Overall Study||540
1593007|NCT01041417|3894526|P2|NOT COMPLETED|Overall Study||3
1593008|NCT01041417|3894527|P1|NOT COMPLETED|Overall Study||7
1593009|NCT01041417|3894526|P2|COMPLETED|Overall Study||76
1593010|NCT01041417|3894527|P1|COMPLETED|Overall Study||73
1593011|NCT01041417|3894526|P2|STARTED|Overall Study||79
1593012|NCT01041417|3894527|P1|STARTED|Overall Study||80
1593013|NCT01041404|3894565|P2|NOT COMPLETED|Overall Study||294
1593014|NCT01041404|3894566|P1|NOT COMPLETED|Overall Study||290
1593015|NCT01041404|3894565|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
1593016|NCT01041404|3894566|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
1593017|NCT01041404|3894565|P2|Alive in Follow-up|Overall Study||41
1593018|NCT01041404|3894566|P1|Alive in Follow-up|Overall Study||40
1593019|NCT01041404|3894565|P2|Lost to Follow-up|Overall Study||10
1593020|NCT01041404|3894566|P1|Lost to Follow-up|Overall Study||12
1593021|NCT01041404|3894565|P2|Died in Follow-up|Overall Study||200
1593022|NCT01041404|3894566|P1|Died in Follow-up|Overall Study||199
1593023|NCT01041404|3894565|P2|Entered Follow-Up|Overall Study||251
1593024|NCT01041404|3894566|P1|Entered Follow-Up|Overall Study||251
1593025|NCT01041404|3894565|P2|STARTED|Overall Study||294
1593026|NCT01041404|3894566|P1|STARTED|Overall Study||290
1593027|NCT01041287|3894607|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
1593028|NCT01041287|3894608|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
1593029|NCT01041287|3894607|P2|COMPLETED|Treatment Period 2 (3 Months)||14
1593030|NCT01041287|3894608|P1|COMPLETED|Treatment Period 2 (3 Months)||16
1593031|NCT01041287|3894607|P2|STARTED|Treatment Period 2 (3 Months)||19
1593032|NCT01041287|3894608|P1|STARTED|Treatment Period 2 (3 Months)||19
1593033|NCT01041287|3894607|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
1593034|NCT01041287|3894608|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
1593035|NCT01041287|3894607|P2|COMPLETED|Treatment Period 1 (3 Months)||19
1593036|NCT01041287|3894608|P1|COMPLETED|Treatment Period 1 (3 Months)||19
1593037|NCT01041287|3894607|P2|STARTED|Treatment Period 1 (3 Months)||19
1593038|NCT01041287|3894608|P1|STARTED|Treatment Period 1 (3 Months)||19
1593039|NCT01041274|3894620|P2|NOT COMPLETED|Overall Study||21
1593040|NCT01041274|3894621|P1|NOT COMPLETED|Overall Study||23
1593041|NCT01041274|3894620|P2|COMPLETED|Overall Study||25
1593042|NCT01041274|3894621|P1|COMPLETED|Overall Study||26
1593043|NCT01041274|3894620|P2|STARTED|Overall Study||46
1593044|NCT01041274|3894621|P1|STARTED|Overall Study||49
1593045|NCT01041209|3894635|P2|NOT COMPLETED|Overall Study||0
1593046|NCT01041209|3894636|P1|NOT COMPLETED|Overall Study||0
1593047|NCT01041209|3894635|P2|COMPLETED|Overall Study||60
1593048|NCT01041209|3894636|P1|COMPLETED|Overall Study||60
1593049|NCT01041209|3894635|P2|STARTED|Overall Study||60
1593050|NCT01041209|3894636|P1|STARTED|Overall Study||60
1593051|NCT01040871|3894646|P2|NOT COMPLETED|Overall Study||7
1593052|NCT01040871|3894647|P1|NOT COMPLETED|Overall Study||13
1593053|NCT01040871|3894646|P2|COMPLETED|Overall Study||73
1593054|NCT01040871|3894647|P1|COMPLETED|Overall Study||71
1593055|NCT01040871|3894646|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
1593056|NCT01040871|3894647|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
1593057|NCT01040858|3894667|P2|NOT COMPLETED|Overall Study||0
1593058|NCT01040858|3894668|P1|NOT COMPLETED|Overall Study||9
1593059|NCT01040858|3894667|P2|COMPLETED|Overall Study||69
1593060|NCT01040858|3894668|P1|COMPLETED|Overall Study||50
1593061|NCT01040858|3894667|P2|STARTED|Overall Study||69
1593062|NCT01040858|3894668|P1|STARTED|Overall Study||59
1593063|NCT01040845|3894698|P2|NOT COMPLETED|Overall Study||1
1593064|NCT01040845|3894699|P1|NOT COMPLETED|Overall Study||2
1593065|NCT01040845|3894698|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
1593066|NCT01040845|3894699|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
1593067|NCT01040845|3894698|P2|STARTED|Overall Study||15
1593068|NCT01040845|3894699|P1|STARTED|Overall Study||15
1593069|NCT01040832|3894714|P2|NOT COMPLETED|Overall Study||37
1593070|NCT01040832|3894715|P1|NOT COMPLETED|Overall Study||46
1593071|NCT01040832|3894714|P2|COMPLETED|Overall Study||16
1593072|NCT01040832|3894715|P1|COMPLETED|Overall Study||8
1593073|NCT01040832|3894714|P2|STARTED|Overall Study||53
1593074|NCT01040832|3894715|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
1593075|NCT01040819|3894731|P2|NOT COMPLETED|Overall Study||0
1593076|NCT01040819|3894732|P1|NOT COMPLETED|Overall Study||0
1593077|NCT01040819|3894731|P2|COMPLETED|Overall Study||12
1593078|NCT01040819|3894732|P1|COMPLETED|Overall Study||13
1593079|NCT01040819|3894731|P2|STARTED|Overall Study||12
1593080|NCT01040819|3894732|P1|STARTED|Overall Study||13
1593081|NCT01040793|3894738|P6|NOT COMPLETED|Overall Study||1
1593082|NCT01040793|3894739|P5|NOT COMPLETED|Overall Study||4
1593083|NCT01040793|3894740|P4|NOT COMPLETED|Overall Study||4
1593084|NCT01040793|3894741|P3|NOT COMPLETED|Overall Study||3
1593085|NCT01040793|3894742|P2|NOT COMPLETED|Overall Study||5
1593086|NCT01040793|3894743|P1|NOT COMPLETED|Overall Study||6
1593087|NCT01040793|3894738|P6|COMPLETED|Overall Study||26
1593088|NCT01040793|3894739|P5|COMPLETED|Overall Study||22
1593089|NCT01040793|3894740|P4|COMPLETED|Overall Study||22
1593090|NCT01040793|3894741|P3|COMPLETED|Overall Study||23
1593091|NCT01040793|3894742|P2|COMPLETED|Overall Study||21
1593092|NCT01040793|3894743|P1|COMPLETED|Overall Study||20
1593093|NCT01040793|3894738|P6|STARTED|Overall Study||27
1593094|NCT01040793|3894739|P5|STARTED|Overall Study||26
1593095|NCT01040793|3894740|P4|STARTED|Overall Study||26
1593096|NCT01040793|3894741|P3|STARTED|Overall Study||26
1593097|NCT01040793|3894742|P2|STARTED|Overall Study||26
1593098|NCT01040793|3894743|P1|STARTED|Overall Study|Entered and treated|26
1593099|NCT01040780|3894822|P2|NOT COMPLETED|Overall Study||3
1593100|NCT01040780|3894823|P1|NOT COMPLETED|Overall Study||1
1593101|NCT01040780|3894822|P2|COMPLETED|Overall Study||196
1593102|NCT01040780|3894823|P1|COMPLETED|Overall Study||199
1593103|NCT01040780|3894822|P2|STARTED|Overall Study||199
1593104|NCT01040780|3894823|P1|STARTED|Overall Study||200
1593105|NCT01040728|3894837|P4|NOT COMPLETED|Overall Study||6
1593106|NCT01040728|3894838|P3|NOT COMPLETED|Overall Study||1
1593107|NCT01040728|3894839|P2|NOT COMPLETED|Overall Study||11
1593108|NCT01040728|3894840|P1|NOT COMPLETED|Overall Study||4
1593109|NCT01040728|3894837|P4|COMPLETED|Overall Study||24
1593110|NCT01040728|3894838|P3|COMPLETED|Overall Study||30
1593111|NCT01040728|3894839|P2|COMPLETED|Overall Study||19
1593112|NCT01040728|3894840|P1|COMPLETED|Overall Study||27
1593113|NCT01040728|3894837|P4|STARTED|Overall Study||30
1593114|NCT01040728|3894838|P3|STARTED|Overall Study||31
1593115|NCT01040728|3894839|P2|STARTED|Overall Study||30
1593116|NCT01040728|3894840|P1|STARTED|Overall Study||31
1593117|NCT01040689|3894910|P4|NOT COMPLETED|Overall Study||4
1593118|NCT01040689|3894911|P3|NOT COMPLETED|Overall Study||4
1593119|NCT01040689|3894912|P2|NOT COMPLETED|Overall Study||2
1593120|NCT01040689|3894913|P1|NOT COMPLETED|Overall Study||3
1593121|NCT01040689|3894910|P4|COMPLETED|Overall Study||23
1593122|NCT01040689|3894911|P3|COMPLETED|Overall Study||23
1593123|NCT01040689|3894912|P2|COMPLETED|Overall Study||25
1593124|NCT01040689|3894913|P1|COMPLETED|Overall Study||24
1593125|NCT01040689|3894910|P4|STARTED|Overall Study||27
1593126|NCT01040689|3894911|P3|STARTED|Overall Study||27
1593127|NCT01040689|3894912|P2|STARTED|Overall Study||27
1593128|NCT01040689|3894913|P1|STARTED|Overall Study||27
1593129|NCT01040624|3894985|P2|NOT COMPLETED|Overall Study||0
1593130|NCT01040624|3894986|P1|NOT COMPLETED|Overall Study||0
1593131|NCT01040624|3894985|P2|COMPLETED|Overall Study||19
1593132|NCT01040624|3894986|P1|COMPLETED|Overall Study||58
1593133|NCT01040624|3894985|P2|STARTED|Overall Study||19
1593134|NCT01040624|3894986|P1|STARTED|Overall Study||58
1593135|NCT01040403|3894992|P1|NOT COMPLETED|Overall Study||20
1593136|NCT01040403|3894992|P1|COMPLETED|Overall Study|All treatment periods|213
1593137|NCT01040403|3894992|P1|Completed T+O 5/10|Overall Study||107
1593138|NCT01040403|3894992|P1|Completed T+O 2.5/10|Overall Study||110
1593139|NCT01040403|3894992|P1|Completed T+O 1.25/10|Overall Study||106
1593140|NCT01040403|3894992|P1|Completed Olo 10|Overall Study||109
1593141|NCT01040403|3894992|P1|Completed T+O 5/5|Overall Study||106
1593142|NCT01040403|3894992|P1|Completed T+O 2.5/5|Overall Study||111
1593143|NCT01040403|3894992|P1|Completed T+O 1.25/5|Overall Study||105
1593144|NCT01040403|3894992|P1|Completed Olo 5|Overall Study||106
1593145|NCT01040403|3894992|P1|STARTED|Overall Study||233
1593146|NCT01040351|3895180|P2|NOT COMPLETED|Overall Study||2
1593147|NCT01040351|3895181|P1|NOT COMPLETED|Overall Study||1
1593148|NCT01040351|3895180|P2|COMPLETED|Overall Study|May 2010|53
1593149|NCT01040351|3895181|P1|COMPLETED|Overall Study|May 2010|54
1593150|NCT01040351|3895180|P2|STARTED|Overall Study|October 2006|55
1593151|NCT01040351|3895181|P1|STARTED|Overall Study|October 2006|55
1593152|NCT01040260|3895191|P2|NOT COMPLETED|Overall Study||11
1593153|NCT01040260|3895192|P1|NOT COMPLETED|Overall Study||15
1593154|NCT01040260|3895191|P2|COMPLETED|Overall Study||39
1593155|NCT01040260|3895192|P1|COMPLETED|Overall Study||38
1593156|NCT01040260|3895191|P2|STARTED|Overall Study||50
1593157|NCT01040260|3895192|P1|STARTED|Overall Study||53
1593158|NCT01040208|3895201|P3|NOT COMPLETED|Overall Study||3
1593159|NCT01040208|3895202|P2|NOT COMPLETED|Overall Study||13
1593160|NCT01040208|3895203|P1|NOT COMPLETED|Overall Study||6
1593161|NCT01040208|3895201|P3|COMPLETED|Overall Study||35
1593162|NCT01040208|3895202|P2|COMPLETED|Overall Study||15
1593163|NCT01040208|3895203|P1|COMPLETED|Overall Study||39
1593164|NCT01040208|3895201|P3|STARTED|Overall Study||38
1593165|NCT01040208|3895202|P2|STARTED|Overall Study||28
1593166|NCT01040208|3895203|P1|STARTED|Overall Study||45
1593167|NCT01040169|3895219|P2|NOT COMPLETED|Overall Study||8
1593168|NCT01040169|3895220|P1|NOT COMPLETED|Overall Study||3
1593169|NCT01040169|3895219|P2|COMPLETED|Overall Study||36
1593170|NCT01040169|3895220|P1|COMPLETED|Overall Study||32
1593171|NCT01040169|3895219|P2|STARTED|Overall Study||44
1593172|NCT01040169|3895220|P1|STARTED|Overall Study||35
1593173|NCT01040130|3895228|P6|NOT COMPLETED|Overall Study||4
1593174|NCT01040130|3895229|P5|NOT COMPLETED|Overall Study||0
1593175|NCT01040130|3895230|P4|NOT COMPLETED|Overall Study||5
1593176|NCT01040130|3895231|P3|NOT COMPLETED|Overall Study||2
1593177|NCT01040130|3895232|P2|NOT COMPLETED|Overall Study||3
1593178|NCT01040130|3895233|P1|NOT COMPLETED|Overall Study||3
1593179|NCT01040130|3895228|P6|COMPLETED|Overall Study||22
1593180|NCT01040130|3895229|P5|COMPLETED|Overall Study||25
1593181|NCT01040130|3895230|P4|COMPLETED|Overall Study||20
1593182|NCT01040130|3895231|P3|COMPLETED|Overall Study||23
1593183|NCT01040130|3895232|P2|COMPLETED|Overall Study||22
1593184|NCT01040130|3895233|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
1593185|NCT01040130|3895228|P6|STARTED|Overall Study||26
1593186|NCT01040130|3895229|P5|STARTED|Overall Study||25
1593187|NCT01040130|3895230|P4|STARTED|Overall Study||25
1593188|NCT01040130|3895231|P3|STARTED|Overall Study||25
1593189|NCT01040130|3895232|P2|STARTED|Overall Study||25
1593190|NCT01040130|3895233|P1|STARTED|Overall Study|Number of patients entered and treated|25
1593191|NCT01040052|3895310|P1|NOT COMPLETED|Overall Study||0
1593192|NCT01040052|3895310|P1|COMPLETED|Overall Study||30
1593193|NCT01040052|3895310|P1|STARTED|Overall Study||30
1593194|NCT01039792|3895316|P2|NOT COMPLETED|Overall Study||1
1593195|NCT01039792|3895317|P1|NOT COMPLETED|Overall Study||6
1593196|NCT01039792|3895316|P2|COMPLETED|Overall Study||27
1593197|NCT01039792|3895317|P1|COMPLETED|Overall Study||23
1593198|NCT01039792|3895316|P2|STARTED|Overall Study||28
1593199|NCT01039792|3895317|P1|STARTED|Overall Study||29
1593200|NCT01039688|3895326|P3|NOT COMPLETED|Overall Study||80
1593201|NCT01039688|3895327|P2|NOT COMPLETED|Overall Study||111
1593202|NCT01039688|3895328|P1|NOT COMPLETED|Overall Study||107
1593203|NCT01039688|3895326|P3|COMPLETED|Overall Study||106
1593204|NCT01039688|3895327|P2|COMPLETED|Overall Study||286
1593205|NCT01039688|3895328|P1|COMPLETED|Overall Study||266
1593206|NCT01039688|3895326|P3|STARTED|Overall Study||186
1593207|NCT01039688|3895327|P2|STARTED|Overall Study||397
1593208|NCT01039688|3895328|P1|STARTED|Overall Study||373
1593209|NCT01039675|3895599|P2|NOT COMPLETED|Overall Study||7
1593210|NCT01039675|3895600|P1|NOT COMPLETED|Overall Study||0
1593211|NCT01039675|3895599|P2|COMPLETED|Overall Study||35
1593212|NCT01039675|3895600|P1|COMPLETED|Overall Study||9
1593213|NCT01039675|3895599|P2|STARTED|Overall Study||42
1593214|NCT01039675|3895600|P1|STARTED|Overall Study||9
1593215|NCT01039584|3895613|P3|NOT COMPLETED|Overall Study||57
1593216|NCT01039584|3895614|P2|NOT COMPLETED|Overall Study||97
1593217|NCT01039584|3895615|P1|NOT COMPLETED|Overall Study||103
1593218|NCT01039584|3895613|P3|COMPLETED|Overall Study||65
1593219|NCT01039584|3895614|P2|COMPLETED|Overall Study||146
1593220|NCT01039584|3895615|P1|COMPLETED|Overall Study||143
1593221|NCT01039584|3895613|P3|STARTED|Overall Study||122
1593222|NCT01039584|3895614|P2|STARTED|Overall Study||243
1593223|NCT01039584|3895615|P1|STARTED|Overall Study||246
1593224|NCT01039519|3895629|P1|NOT COMPLETED|Survival Follow-up||27
1593225|NCT01039519|3895629|P1|COMPLETED|Survival Follow-up||0
1593226|NCT01039519|3895629|P1|STARTED|Survival Follow-up||27
1593227|NCT01039519|3895629|P1|NOT COMPLETED|Treatment||27
1593228|NCT01039519|3895629|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
1593229|NCT01039519|3895629|P1|STARTED|Treatment||27
1593230|NCT01039428|3895640|P2|NOT COMPLETED|Overall Study||0
1593231|NCT01039428|3895641|P1|NOT COMPLETED|Overall Study||2
1593232|NCT01039428|3895640|P2|COMPLETED|Overall Study||28
1593233|NCT01039428|3895641|P1|COMPLETED|Overall Study||33
1593234|NCT01039428|3895640|P2|STARTED|Overall Study||28
1593235|NCT01039428|3895641|P1|STARTED|Overall Study||35
1593236|NCT01039376|3895665|P2|NOT COMPLETED|Overall Study||202
1593237|NCT01039376|3895666|P1|NOT COMPLETED|Overall Study||206
1593238|NCT01039376|3895665|P2|COMPLETED|Overall Study||34
1593239|NCT01039376|3895666|P1|COMPLETED|Overall Study||32
1593240|NCT01039376|3895665|P2|Ongoing|Overall Study||182
1593241|NCT01039376|3895666|P1|Ongoing|Overall Study||189
1593242|NCT01039376|3895665|P2|STARTED|Overall Study||236
1593243|NCT01039376|3895666|P1|STARTED|Overall Study||238
1593244|NCT01039207|3895724|P1|NOT COMPLETED|Overall Study||0
1593245|NCT01039207|3895724|P1|COMPLETED|Overall Study||31
1593246|NCT01039207|3895724|P1|STARTED|Overall Study||31
1593247|NCT01038921|3895734|P2|NOT COMPLETED|Overall Study||0
1593248|NCT01038921|3895735|P1|NOT COMPLETED|Overall Study||2
1593249|NCT01038921|3895734|P2|COMPLETED|Overall Study||20
1593250|NCT01038921|3895735|P1|COMPLETED|Overall Study|2 subjects withdrew|17
1593251|NCT01038921|3895734|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
1593252|NCT01038921|3895735|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
1593253|NCT01038869|3895741|P1|NOT COMPLETED|Overall Study||7
1593254|NCT01038869|3895741|P1|COMPLETED|Overall Study||13
1593255|NCT01038869|3895741|P1|STARTED|Overall Study||20
1593256|NCT01038856|3895749|P1|NOT COMPLETED|Overall Study||2
1593257|NCT01038856|3895749|P1|COMPLETED|Overall Study||3
1593258|NCT01038856|3895749|P1|STARTED|Overall Study||5
1593259|NCT01038752|3895758|P2|NOT COMPLETED|Overall Study||5
1593260|NCT01038752|3895759|P1|NOT COMPLETED|Overall Study||5
1593261|NCT01038752|3895758|P2|COMPLETED|Overall Study||1
1593262|NCT01038752|3895759|P1|COMPLETED|Overall Study||3
1593263|NCT01038752|3895758|P2|STARTED|Overall Study||6
1593264|NCT01038752|3895759|P1|STARTED|Overall Study||8
1593265|NCT01038713|3895782|P3|NOT COMPLETED|Overall Study||1
1593266|NCT01038713|3895783|P2|NOT COMPLETED|Overall Study||3
1593267|NCT01038713|3895784|P1|NOT COMPLETED|Overall Study||5
1593268|NCT01038713|3895782|P3|COMPLETED|Overall Study||16
1593269|NCT01038713|3895783|P2|COMPLETED|Overall Study||17
1593270|NCT01038713|3895784|P1|COMPLETED|Overall Study||21
1593271|NCT01038713|3895782|P3|STARTED|Overall Study||17
1593272|NCT01038713|3895783|P2|STARTED|Overall Study||20
1593273|NCT01038713|3895784|P1|STARTED|Overall Study||26
1593274|NCT01038635|3895813|P9|NOT COMPLETED|Overall Study||2
1593275|NCT01038635|3895814|P8|NOT COMPLETED|Overall Study||5
1593276|NCT01038635|3895815|P7|NOT COMPLETED|Overall Study||2
1593277|NCT01038635|3895816|P6|NOT COMPLETED|Overall Study||0
1593278|NCT01038635|3895817|P5|NOT COMPLETED|Overall Study||1
1593279|NCT01038635|3895818|P4|NOT COMPLETED|Overall Study||0
1593280|NCT01038635|3895819|P3|NOT COMPLETED|Overall Study||0
1593281|NCT01038635|3895820|P2|NOT COMPLETED|Overall Study||0
1593282|NCT01038635|3895821|P1|NOT COMPLETED|Overall Study||2
1593283|NCT01038635|3895813|P9|COMPLETED|Overall Study||38
1593284|NCT01038635|3895814|P8|COMPLETED|Overall Study||15
1593285|NCT01038635|3895815|P7|COMPLETED|Overall Study||5
1593286|NCT01038635|3895816|P6|COMPLETED|Overall Study||3
1593287|NCT01038635|3895817|P5|COMPLETED|Overall Study||3
1593288|NCT01038635|3895818|P4|COMPLETED|Overall Study||3
1593289|NCT01038635|3895819|P3|COMPLETED|Overall Study||3
1593290|NCT01038635|3895820|P2|COMPLETED|Overall Study||3
1593291|NCT01038635|3895821|P1|COMPLETED|Overall Study||3
1593292|NCT01038635|3895813|P9|STARTED|Overall Study||40
1593293|NCT01038635|3895814|P8|STARTED|Overall Study||20
1593294|NCT01038635|3895815|P7|STARTED|Overall Study||7
1593295|NCT01038635|3895816|P6|STARTED|Overall Study||3
1593296|NCT01038635|3895817|P5|STARTED|Overall Study||4
1593297|NCT01038635|3895818|P4|STARTED|Overall Study||3
1593298|NCT01038635|3895819|P3|STARTED|Overall Study||3
1593299|NCT01038635|3895820|P2|STARTED|Overall Study||3
1593300|NCT01038635|3895821|P1|STARTED|Overall Study||5
1593301|NCT01038609|3895847|P5|NOT COMPLETED|Overall Study||1
1593302|NCT01038609|3895848|P4|NOT COMPLETED|Overall Study||1
1593303|NCT01038609|3895849|P3|NOT COMPLETED|Overall Study||1
1593304|NCT01038609|3895850|P2|NOT COMPLETED|Overall Study||1
1593305|NCT01038609|3895851|P1|NOT COMPLETED|Overall Study||1
1593306|NCT01038609|3895847|P5|COMPLETED|Overall Study||50
1593307|NCT01038609|3895848|P4|COMPLETED|Overall Study||47
1593308|NCT01038609|3895849|P3|COMPLETED|Overall Study||48
1593309|NCT01038609|3895850|P2|COMPLETED|Overall Study||51
1593310|NCT01038609|3895851|P1|COMPLETED|Overall Study||49
1593311|NCT01038609|3895847|P5|STARTED|Overall Study||51
1593312|NCT01038609|3895848|P4|STARTED|Overall Study||48
1593313|NCT01038609|3895849|P3|STARTED|Overall Study||49
1593314|NCT01038609|3895850|P2|STARTED|Overall Study||52
1593315|NCT01038609|3895851|P1|STARTED|Overall Study||50
1593316|NCT01038336|3895896|P3|NOT COMPLETED|Overall Study||0
1593317|NCT01038336|3895897|P2|NOT COMPLETED|Overall Study||0
1593318|NCT01038336|3895898|P1|NOT COMPLETED|Overall Study||0
1593319|NCT01038336|3895896|P3|COMPLETED|Overall Study||44
1593320|NCT01038336|3895897|P2|COMPLETED|Overall Study||42
1593321|NCT01038336|3895898|P1|COMPLETED|Overall Study||43
1593322|NCT01038336|3895896|P3|STARTED|Overall Study||44
1593323|NCT01038336|3895897|P2|STARTED|Overall Study||42
1593324|NCT01038336|3895898|P1|STARTED|Overall Study||43
1593325|NCT01038323|3895930|P3|NOT COMPLETED|Overall Study||4
1593326|NCT01038323|3895931|P2|NOT COMPLETED|Overall Study||2
1593327|NCT01038323|3895932|P1|NOT COMPLETED|Overall Study||3
1593328|NCT01038323|3895930|P3|COMPLETED|Overall Study||15
1593329|NCT01038323|3895931|P2|COMPLETED|Overall Study||17
1593330|NCT01038323|3895932|P1|COMPLETED|Overall Study||17
1593331|NCT01038323|3895930|P3|STARTED|Overall Study||19
1593332|NCT01038323|3895931|P2|STARTED|Overall Study||19
1593333|NCT01038323|3895932|P1|STARTED|Overall Study||20
1593334|NCT01038128|3895946|P1|NOT COMPLETED|Overall Study||4
1593335|NCT01038128|3895946|P1|COMPLETED|Overall Study||1
1593336|NCT01038128|3895946|P1|Baseline Visit|Overall Study||3
1593337|NCT01038128|3895946|P1|STARTED|Overall Study||5
1593338|NCT01037452|3895958|P4|NOT COMPLETED|Overall Study||0
1593339|NCT01037452|3895959|P3|NOT COMPLETED|Overall Study||0
1593340|NCT01037452|3895960|P2|NOT COMPLETED|Overall Study||0
1593341|NCT01037452|3895961|P1|NOT COMPLETED|Overall Study||0
1593342|NCT01037452|3895958|P4|COMPLETED|Overall Study||30
1593343|NCT01037452|3895959|P3|COMPLETED|Overall Study||30
1593344|NCT01037452|3895960|P2|COMPLETED|Overall Study||30
1593345|NCT01037452|3895961|P1|COMPLETED|Overall Study||30
1593346|NCT01037452|3895958|P4|STARTED|Overall Study||30
1593347|NCT01037452|3895959|P3|STARTED|Overall Study||30
1593348|NCT01037452|3895960|P2|STARTED|Overall Study||30
1593349|NCT01037452|3895961|P1|STARTED|Overall Study||30
1593350|NCT01037309|3895989|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
1593351|NCT01037309|3895990|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
1593352|NCT01037309|3895991|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
1593353|NCT01037309|3895992|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
1593354|NCT01037309|3895993|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
1593355|NCT01037309|3895994|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
1593356|NCT01037309|3895995|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
1593357|NCT01037309|3895996|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
1593358|NCT01037309|3895997|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
1593359|NCT01037309|3895989|P9|COMPLETED|Intravenous Period 7 - 9||3
1593360|NCT01037309|3895990|P8|COMPLETED|Intravenous Period 7 - 9||3
1593361|NCT01037309|3895991|P7|COMPLETED|Intravenous Period 7 - 9||3
1593362|NCT01037309|3895992|P6|COMPLETED|Intravenous Period 7 - 9||0
1593363|NCT01037309|3895993|P5|COMPLETED|Intravenous Period 7 - 9||0
1593364|NCT01037309|3895994|P4|COMPLETED|Intravenous Period 7 - 9||0
1593365|NCT01037309|3895995|P3|COMPLETED|Intravenous Period 7 - 9||0
1593366|NCT01037309|3895996|P2|COMPLETED|Intravenous Period 7 - 9||0
1593367|NCT01037309|3895997|P1|COMPLETED|Intravenous Period 7 - 9||0
1593368|NCT01037309|3895989|P9|STARTED|Intravenous Period 7 - 9||3
1593369|NCT01037309|3895990|P8|STARTED|Intravenous Period 7 - 9||3
1593370|NCT01037309|3895991|P7|STARTED|Intravenous Period 7 - 9||3
1593371|NCT01037309|3895992|P6|STARTED|Intravenous Period 7 - 9||0
1593372|NCT01037309|3895993|P5|STARTED|Intravenous Period 7 - 9||0
1593373|NCT01037309|3895994|P4|STARTED|Intravenous Period 7 - 9||0
1593374|NCT01037309|3895995|P3|STARTED|Intravenous Period 7 - 9||0
1593375|NCT01037309|3895996|P2|STARTED|Intravenous Period 7 - 9||0
1593376|NCT01037309|3895997|P1|STARTED|Intravenous Period 7 - 9||0
1593377|NCT01037309|3895989|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1593378|NCT01037309|3895990|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1593379|NCT01037309|3895991|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1593380|NCT01037309|3895992|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1593381|NCT01037309|3895993|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1593382|NCT01037309|3895994|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1593383|NCT01037309|3895995|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1593384|NCT01037309|3895996|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1593385|NCT01037309|3895997|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1593386|NCT01037309|3895989|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
1593387|NCT01037309|3895990|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
1593388|NCT01037309|3895991|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
1593389|NCT01037309|3895992|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
1593390|NCT01037309|3895993|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
1593391|NCT01037309|3895994|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
1593392|NCT01037309|3895995|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
1593393|NCT01037309|3895996|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
1593394|NCT01037309|3895997|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
1593395|NCT01037309|3895989|P9|STARTED|Subcutaneous Cohort 1 - 6||0
1593396|NCT01037309|3895990|P8|STARTED|Subcutaneous Cohort 1 - 6||0
1593397|NCT01037309|3895991|P7|STARTED|Subcutaneous Cohort 1 - 6||0
1593398|NCT01037309|3895992|P6|STARTED|Subcutaneous Cohort 1 - 6||3
1593399|NCT01037309|3895993|P5|STARTED|Subcutaneous Cohort 1 - 6||3
1593400|NCT01037309|3895994|P4|STARTED|Subcutaneous Cohort 1 - 6||3
1593401|NCT01037309|3895995|P3|STARTED|Subcutaneous Cohort 1 - 6||3
1593402|NCT01037309|3895996|P2|STARTED|Subcutaneous Cohort 1 - 6||3
1593403|NCT01037309|3895997|P1|STARTED|Subcutaneous Cohort 1 - 6||3
1593404|NCT01037244|3896039|P4|NOT COMPLETED|Overall Study||14
1593405|NCT01037244|3896040|P3|NOT COMPLETED|Overall Study||14
1593406|NCT01037244|3896041|P2|NOT COMPLETED|Overall Study||14
1593407|NCT01037244|3896042|P1|NOT COMPLETED|Overall Study||13
1593408|NCT01037244|3896039|P4|COMPLETED|Overall Study||140
1593409|NCT01037244|3896040|P3|COMPLETED|Overall Study||144
1593410|NCT01037244|3896041|P2|COMPLETED|Overall Study||138
1593411|NCT01037244|3896042|P1|COMPLETED|Overall Study||141
1593412|NCT01037244|3896039|P4|Safety Population|Overall Study||152
1593413|NCT01037244|3896040|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
1593414|NCT01037244|3896041|P2|Safety Population|Overall Study||150
1593415|NCT01037244|3896042|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
1593416|NCT01037244|3896039|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
1593417|NCT01037244|3896040|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
1593418|NCT01037244|3896041|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
1593419|NCT01037244|3896042|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
1593420|NCT01037244|3896039|P4|STARTED|Overall Study||154
1593421|NCT01037244|3896040|P3|STARTED|Overall Study||158
1593422|NCT01037244|3896041|P2|STARTED|Overall Study||152
1593423|NCT01037244|3896042|P1|STARTED|Overall Study||154
1593424|NCT01037218|3896104|P4|NOT COMPLETED|Overall Study||16
1593425|NCT01037218|3896105|P3|NOT COMPLETED|Overall Study||21
1593426|NCT01037218|3896106|P2|NOT COMPLETED|Overall Study||21
1593427|NCT01037218|3896107|P1|NOT COMPLETED|Overall Study||16
1593428|NCT01037218|3896104|P4|COMPLETED|Overall Study||134
1593429|NCT01037218|3896105|P3|COMPLETED|Overall Study||134
1593430|NCT01037218|3896106|P2|COMPLETED|Overall Study||128
1593431|NCT01037218|3896107|P1|COMPLETED|Overall Study||131
1593432|NCT01037218|3896104|P4|mITT Population|Overall Study||141
1593433|NCT01037218|3896105|P3|mITT Population|Overall Study||147
1593434|NCT01037218|3896106|P2|mITT Population|Overall Study||140
1593435|NCT01037218|3896107|P1|mITT Population|Overall Study||141
1593436|NCT01037218|3896104|P4|Safety Population|Overall Study||150
1593437|NCT01037218|3896105|P3|Safety Population|Overall Study||154
1593438|NCT01037218|3896106|P2|Safety Population|Overall Study||148
1593439|NCT01037218|3896107|P1|Safety Population|Overall Study||147
1593440|NCT01037218|3896104|P4|STARTED|Overall Study||150
1593441|NCT01037218|3896105|P3|STARTED|Overall Study||155
1593442|NCT01037218|3896106|P2|STARTED|Overall Study||149
1593443|NCT01037218|3896107|P1|STARTED|Overall Study||147
1593444|NCT01037192|3896167|P2|NOT COMPLETED|Overall Study||0
1593445|NCT01037192|3896168|P1|NOT COMPLETED|Overall Study||0
1593446|NCT01037192|3896167|P2|COMPLETED|Overall Study||1
1593447|NCT01037192|3896168|P1|COMPLETED|Overall Study||3
1593448|NCT01037192|3896167|P2|STARTED|Overall Study||1
1593449|NCT01037192|3896168|P1|STARTED|Overall Study||3
1593450|NCT01037127|3896178|P2|NOT COMPLETED|Overall Study||21
1593451|NCT01037127|3896179|P1|NOT COMPLETED|Overall Study||5
1593452|NCT01037127|3896178|P2|COMPLETED|Overall Study||36
1593453|NCT01037127|3896179|P1|COMPLETED|Overall Study||35
1593454|NCT01037127|3896178|P2|STARTED|Overall Study||57
1593455|NCT01037127|3896179|P1|STARTED|Overall Study||40
1593456|NCT01037114|3896211|P1|NOT COMPLETED|Year 20||1
1593457|NCT01037114|3896211|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
1593458|NCT01037114|3896211|P1|STARTED|Year 20||45
1593459|NCT01037114|3896211|P1|NOT COMPLETED|Year 19||0
1593460|NCT01037114|3896211|P1|COMPLETED|Year 19||45
1593461|NCT01037114|3896211|P1|STARTED|Year 19||45
1593462|NCT01037114|3896211|P1|NOT COMPLETED|Year 18||0
1593463|NCT01037114|3896211|P1|COMPLETED|Year 18||44
1593464|NCT01037114|3896211|P1|STARTED|Year 18||44
1593465|NCT01037114|3896211|P1|NOT COMPLETED|Year 17||0
1593466|NCT01037114|3896211|P1|COMPLETED|Year 17||48
1593467|NCT01037114|3896211|P1|STARTED|Year 17||48
1593468|NCT01037114|3896211|P1|NOT COMPLETED|Year 16||0
1593469|NCT01037114|3896211|P1|COMPLETED|Year 16||49
1593470|NCT01037114|3896211|P1|STARTED|Year 16||49
1593471|NCT01037088|3896224|P1|NOT COMPLETED|Overall Study||3
1593472|NCT01037088|3896224|P1|COMPLETED|Overall Study||36
1593473|NCT01037088|3896224|P1|Received Placebo|Overall Study||38
1593474|NCT01037088|3896224|P1|Received 1.29% THC|Overall Study||37
1593475|NCT01037088|3896224|P1|Received 3.53% THC|Overall Study||36
1593476|NCT01037088|3896224|P1|STARTED|Overall Study||39
1593477|NCT01036802|3896237|P2|NOT COMPLETED|Overall Study||0
1593478|NCT01036802|3896238|P1|NOT COMPLETED|Overall Study||0
1593479|NCT01036802|3896237|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
1593480|NCT01036802|3896238|P1|COMPLETED|Overall Study||2
1593481|NCT01036802|3896237|P2|STARTED|Overall Study||1
1593482|NCT01036802|3896238|P1|STARTED|Overall Study||2
1593483|NCT01036763|3896256|P1|NOT COMPLETED|Overall Study||93
1593484|NCT01036763|3896256|P1|COMPLETED|Overall Study||1171
1593485|NCT01036763|3896256|P1|STARTED|Overall Study||1264
1593486|NCT01036724|3896268|P2|NOT COMPLETED|Overall Study||8
1593487|NCT01036724|3896269|P1|NOT COMPLETED|Overall Study||6
1593488|NCT01036724|3896268|P2|COMPLETED|Overall Study||47
1593489|NCT01036724|3896269|P1|COMPLETED|Overall Study||46
1593490|NCT01036724|3896268|P2|STARTED|Overall Study||55
1593491|NCT01036724|3896269|P1|STARTED|Overall Study||52
1593492|NCT01036529|3896279|P2|NOT COMPLETED|Overall Study||15
1593493|NCT01036529|3896280|P1|NOT COMPLETED|Overall Study||13
1593494|NCT01036529|3896279|P2|COMPLETED|Overall Study||0
1593495|NCT01036529|3896280|P1|COMPLETED|Overall Study||0
1593496|NCT01036529|3896279|P2|Crossover to Other Group|Overall Study||1
1593497|NCT01036529|3896280|P1|Crossover to Other Group|Overall Study||1
1593498|NCT01036529|3896279|P2|Requested Crossover|Overall Study||2
1593499|NCT01036529|3896280|P1|Requested Crossover|Overall Study||1
1593500|NCT01036529|3896279|P2|12 Month Follow-up|Overall Study||3
1593501|NCT01036529|3896280|P1|12 Month Follow-up|Overall Study||4
1593502|NCT01036529|3896279|P2|6 Month Follow-up|Overall Study||7
1593503|NCT01036529|3896280|P1|6 Month Follow-up|Overall Study||6
1593504|NCT01036529|3896279|P2|3 Month Follow-up|Overall Study||9
1593505|NCT01036529|3896280|P1|3 Month Follow-up|Overall Study||7
1593506|NCT01036529|3896279|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
1593507|NCT01036529|3896280|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
1593508|NCT01036529|3896279|P2|Baseline Visit|Overall Study||13
1593509|NCT01036529|3896280|P1|Baseline Visit|Overall Study||10
1593510|NCT01036529|3896279|P2|STARTED|Overall Study||15
1593511|NCT01036529|3896280|P1|STARTED|Overall Study||13
1593512|NCT01036490|3896288|P2|NOT COMPLETED|Overall Study||0
1593513|NCT01036490|3896289|P1|NOT COMPLETED|Overall Study||4
1593514|NCT01036490|3896288|P2|COMPLETED|Overall Study||18
1593515|NCT01036490|3896289|P1|COMPLETED|Overall Study||14
1593516|NCT01036490|3896288|P2|STARTED|Overall Study||18
1593517|NCT01036490|3896289|P1|STARTED|Overall Study||18
1593518|NCT01036438|3896307|P2|NOT COMPLETED|Overall Study||10
1593519|NCT01036438|3896308|P1|NOT COMPLETED|Overall Study||10
1593520|NCT01036438|3896307|P2|COMPLETED|Overall Study||90
1593521|NCT01036438|3896308|P1|COMPLETED|Overall Study||91
1593522|NCT01036438|3896307|P2|STARTED|Overall Study||100
1593523|NCT01036438|3896308|P1|STARTED|Overall Study||101
1593524|NCT01036321|3896316|P2|NOT COMPLETED|Overall Study||4
1593525|NCT01036321|3896317|P1|NOT COMPLETED|Overall Study||5
1593526|NCT01036321|3896316|P2|COMPLETED|Overall Study||31
1593527|NCT01036321|3896317|P1|COMPLETED|Overall Study||31
1593528|NCT01036321|3896316|P2|STARTED|Overall Study||35
1593529|NCT01036321|3896317|P1|STARTED|Overall Study||36
1593530|NCT01036165|3896341|P1|NOT COMPLETED|Overall Study||15
1593531|NCT01036165|3896341|P1|COMPLETED|Overall Study||88
1593532|NCT01036165|3896341|P1|STARTED|Overall Study||103
1593533|NCT01036022|3896352|P6|NOT COMPLETED|Overall Study||3
1593534|NCT01036022|3896353|P5|NOT COMPLETED|Overall Study||3
1593535|NCT01036022|3896354|P4|NOT COMPLETED|Overall Study||2
1593536|NCT01036022|3896355|P3|NOT COMPLETED|Overall Study||4
1593537|NCT01036022|3896356|P2|NOT COMPLETED|Overall Study||4
1593538|NCT01036022|3896357|P1|NOT COMPLETED|Overall Study||2
1593539|NCT01036022|3896352|P6|COMPLETED|Overall Study||13
1593540|NCT01036022|3896353|P5|COMPLETED|Overall Study||9
1593541|NCT01036022|3896354|P4|COMPLETED|Overall Study||10
1593542|NCT01036022|3896355|P3|COMPLETED|Overall Study||8
1593543|NCT01036022|3896356|P2|COMPLETED|Overall Study||7
1593544|NCT01036022|3896357|P1|COMPLETED|Overall Study||13
1593545|NCT01036022|3896352|P6|STARTED|Overall Study||16
1593546|NCT01036022|3896353|P5|STARTED|Overall Study||12
1593547|NCT01036022|3896354|P4|STARTED|Overall Study||12
1593548|NCT01036022|3896355|P3|STARTED|Overall Study||12
1593549|NCT01036022|3896356|P2|STARTED|Overall Study||11
1593550|NCT01036022|3896357|P1|STARTED|Overall Study||15
1593551|NCT01036009|3896459|P2|NOT COMPLETED|Overall Study||0
1593552|NCT01036009|3896460|P1|NOT COMPLETED|Overall Study||0
1593553|NCT01036009|3896459|P2|COMPLETED|Overall Study||26
1593554|NCT01036009|3896460|P1|COMPLETED|Overall Study||17
1593555|NCT01036009|3896459|P2|STARTED|Overall Study||26
1593556|NCT01036009|3896460|P1|STARTED|Overall Study||17
1593557|NCT01035944|3896478|P4|NOT COMPLETED|Overall Study||0
1593558|NCT01035944|3896479|P3|NOT COMPLETED|Overall Study||1
1593559|NCT01035944|3896480|P2|NOT COMPLETED|Overall Study||1
1593560|NCT01035944|3896481|P1|NOT COMPLETED|Overall Study||3
1593561|NCT01035944|3896478|P4|COMPLETED|Overall Study||4
1593562|NCT01035944|3896479|P3|COMPLETED|Overall Study||4
1593563|NCT01035944|3896480|P2|COMPLETED|Overall Study||13
1593564|NCT01035944|3896481|P1|COMPLETED|Overall Study||11
1593565|NCT01035944|3896478|P4|STARTED|Overall Study||4
1593566|NCT01035944|3896479|P3|STARTED|Overall Study||5
1593567|NCT01035944|3896480|P2|STARTED|Overall Study||14
1593568|NCT01035944|3896481|P1|STARTED|Overall Study||14
1593569|NCT01035905|3896493|P2|NOT COMPLETED|Overall Study||1
1593570|NCT01035905|3896494|P1|NOT COMPLETED|Overall Study||1
1593571|NCT01035905|3896493|P2|COMPLETED|Overall Study||30
1593572|NCT01035905|3896494|P1|COMPLETED|Overall Study||31
1593573|NCT01035905|3896493|P2|STARTED|Overall Study||31
1593574|NCT01035905|3896494|P1|STARTED|Overall Study||32
1593575|NCT01035788|3896502|P2|NOT COMPLETED|Overall Study||14
1593576|NCT01035788|3896503|P1|NOT COMPLETED|Overall Study||6
1593577|NCT01035788|3896502|P2|COMPLETED|Overall Study||9
1593578|NCT01035788|3896503|P1|COMPLETED|Overall Study||17
1593579|NCT01035788|3896502|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
1593580|NCT01035788|3896503|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
1593581|NCT01035749|3896513|P4|NOT COMPLETED|Overall Study||0
1593582|NCT01035749|3896514|P3|NOT COMPLETED|Overall Study||0
1593583|NCT01035749|3896515|P2|NOT COMPLETED|Overall Study||0
1593584|NCT01035749|3896516|P1|NOT COMPLETED|Overall Study||0
1593585|NCT01035749|3896513|P4|COMPLETED|Overall Study||110
1593586|NCT01035749|3896514|P3|COMPLETED|Overall Study||68
1593587|NCT01035749|3896515|P2|COMPLETED|Overall Study||66
1593588|NCT01035749|3896516|P1|COMPLETED|Overall Study||66
1593589|NCT01035749|3896513|P4|STARTED|Overall Study||110
1593590|NCT01035749|3896514|P3|STARTED|Overall Study||68
1593591|NCT01035749|3896515|P2|STARTED|Overall Study||66
1593592|NCT01035749|3896516|P1|STARTED|Overall Study||66
1593593|NCT01035658|3896638|P4|NOT COMPLETED|Overall Study||0
1593594|NCT01035658|3896639|P3|NOT COMPLETED|Overall Study||0
1593595|NCT01035658|3896640|P2|NOT COMPLETED|Overall Study||0
1593596|NCT01035658|3896641|P1|NOT COMPLETED|Overall Study||0
1593597|NCT01035658|3896638|P4|COMPLETED|Overall Study||6
1593598|NCT01035658|3896639|P3|COMPLETED|Overall Study||3
1593599|NCT01035658|3896640|P2|COMPLETED|Overall Study||8
1593600|NCT01035658|3896641|P1|COMPLETED|Overall Study||5
1593601|NCT01035658|3896638|P4|STARTED|Overall Study||6
1593602|NCT01035658|3896639|P3|STARTED|Overall Study||3
1593603|NCT01035658|3896640|P2|STARTED|Overall Study||8
1593604|NCT01035658|3896641|P1|STARTED|Overall Study||5
1593605|NCT01035606|3896667|P3|NOT COMPLETED|Overall Study||4
1593606|NCT01035606|3896668|P2|NOT COMPLETED|Overall Study||3
1593607|NCT01035606|3896669|P1|NOT COMPLETED|Overall Study||3
1593608|NCT01035606|3896667|P3|COMPLETED|Overall Study||7
1593609|NCT01035606|3896668|P2|COMPLETED|Overall Study||16
1593610|NCT01035606|3896669|P1|COMPLETED|Overall Study||16
1593611|NCT01035606|3896667|P3|STARTED|Overall Study||11
1593612|NCT01035606|3896668|P2|STARTED|Overall Study||19
1593613|NCT01035606|3896669|P1|STARTED|Overall Study||19
1593614|NCT01035346|3896685|P2|NOT COMPLETED|Overall Study||0
1593615|NCT01035346|3896686|P1|NOT COMPLETED|Overall Study||0
1593616|NCT01035346|3896685|P2|COMPLETED|Overall Study||9
1593617|NCT01035346|3896686|P1|COMPLETED|Overall Study||7
1593618|NCT01035346|3896685|P2|STARTED|Overall Study||9
1593619|NCT01035346|3896686|P1|STARTED|Overall Study||7
1593620|NCT01035333|3896704|P1|NOT COMPLETED|Overall Study||10
1593621|NCT01035333|3896704|P1|COMPLETED|Overall Study||9
1593622|NCT01035333|3896704|P1|STARTED|Overall Study||19
1593623|NCT01035255|3896711|P2|NOT COMPLETED|Overall Study||862
1593624|NCT01035255|3896712|P1|NOT COMPLETED|Overall Study||741
1593625|NCT01035255|3896711|P2|COMPLETED|Overall Study||3371
1593626|NCT01035255|3896712|P1|COMPLETED|Overall Study||3468
1593627|NCT01035255|3896711|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
1593628|NCT01035255|3896712|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
1593629|NCT01035255|3896711|P2|Mis-randomized|Overall Study||2
1593630|NCT01035255|3896712|P1|Mis-randomized|Overall Study||4
1593631|NCT01035255|3896711|P2|GCP Violations|Overall Study||19
1593632|NCT01035255|3896712|P1|GCP Violations|Overall Study||18
1593633|NCT01035255|3896711|P2|STARTED|Overall Study||4233
1593634|NCT01035255|3896712|P1|STARTED|Overall Study||4209
1593635|NCT01035229|3896730|P2|NOT COMPLETED|Overall Study||184
1593636|NCT01035229|3896731|P1|NOT COMPLETED|Overall Study||362
1593637|NCT01035229|3896730|P2|COMPLETED|Overall Study||0
1593638|NCT01035229|3896731|P1|COMPLETED|Overall Study||0
1593639|NCT01035229|3896730|P2|STARTED|Overall Study||184
1593640|NCT01035229|3896731|P1|STARTED|Overall Study||362
1593641|NCT01035151|3896751|P2|NOT COMPLETED|Overall Study||15
1593642|NCT01035151|3896752|P1|NOT COMPLETED|Overall Study||21
1593643|NCT01035151|3896751|P2|COMPLETED|Overall Study||185
1593644|NCT01035151|3896752|P1|COMPLETED|Overall Study||188
1593645|NCT01035151|3896751|P2|STARTED|Overall Study||200
1593646|NCT01035151|3896752|P1|STARTED|Overall Study||209
1593647|NCT01035138|3896761|P3|NOT COMPLETED|Overall Study||47
1593648|NCT01035138|3896762|P2|NOT COMPLETED|Overall Study||60
1593649|NCT01035138|3896763|P1|NOT COMPLETED|Overall Study||73
1593650|NCT01035138|3896761|P3|COMPLETED|Overall Study||0
1593651|NCT01035138|3896762|P2|COMPLETED|Overall Study||0
1593652|NCT01035138|3896763|P1|COMPLETED|Overall Study||0
1593653|NCT01035138|3896761|P3|STARTED|Overall Study||47
1593654|NCT01035138|3896762|P2|STARTED|Overall Study||60
1593655|NCT01035138|3896763|P1|STARTED|Overall Study||73
1593656|NCT01035060|3896819|P2|NOT COMPLETED|Overall Study||14
1593657|NCT01035060|3896820|P1|NOT COMPLETED|Overall Study||24
1593658|NCT01035060|3896819|P2|COMPLETED|Overall Study||15
1593659|NCT01035060|3896820|P1|COMPLETED|Overall Study||15
1593660|NCT01035060|3896819|P2|STARTED|Overall Study||29
1593661|NCT01035060|3896820|P1|STARTED|Overall Study||39
1593662|NCT01035047|3896828|P2|NOT COMPLETED|Overall Study||0
1593663|NCT01035047|3896829|P1|NOT COMPLETED|Overall Study||0
1593664|NCT01035047|3896828|P2|COMPLETED|Overall Study||53
1593665|NCT01035047|3896829|P1|COMPLETED|Overall Study||52
1593666|NCT01035047|3896828|P2|STARTED|Overall Study||53
1593667|NCT01035047|3896829|P1|STARTED|Overall Study||52
1593668|NCT01034709|3896845|P2|NOT COMPLETED|Overall Study||16
1593669|NCT01034709|3896846|P1|NOT COMPLETED|Overall Study||9
1593670|NCT01034709|3896845|P2|COMPLETED|Overall Study||42
1593671|NCT01034709|3896846|P1|COMPLETED|Overall Study||44
1593672|NCT01034709|3896845|P2|STARTED|Overall Study||58
1593673|NCT01034709|3896846|P1|STARTED|Overall Study||53
1593674|NCT01034657|3896852|P3|NOT COMPLETED|Randomized Phase||1
1593675|NCT01034657|3896853|P2|NOT COMPLETED|Randomized Phase||6
1593676|NCT01034657|3896854|P1|NOT COMPLETED|Randomized Phase||5
1593677|NCT01034657|3896852|P3|COMPLETED|Randomized Phase||0
1593678|NCT01034657|3896853|P2|COMPLETED|Randomized Phase||0
1593679|NCT01034657|3896854|P1|COMPLETED|Randomized Phase||1
1593680|NCT01034657|3896852|P3|STARTED|Randomized Phase||1
1593681|NCT01034657|3896853|P2|STARTED|Randomized Phase||6
1593682|NCT01034657|3896854|P1|STARTED|Randomized Phase||6
1593683|NCT01034657|3896852|P3|NOT COMPLETED|Core Phase||0
1593684|NCT01034657|3896853|P2|NOT COMPLETED|Core Phase||0
1593685|NCT01034657|3896854|P1|NOT COMPLETED|Core Phase||14
1593686|NCT01034657|3896852|P3|COMPLETED|Core Phase||0
1593687|NCT01034657|3896853|P2|COMPLETED|Core Phase||0
1593688|NCT01034657|3896854|P1|COMPLETED|Core Phase||20
1593689|NCT01034657|3896852|P3|STARTED|Core Phase||0
1593690|NCT01034657|3896853|P2|STARTED|Core Phase||0
1593691|NCT01034657|3896854|P1|STARTED|Core Phase||34
1593692|NCT01034631|3896895|P3|NOT COMPLETED|Phase II||2
1593693|NCT01034631|3896896|P2|NOT COMPLETED|Phase II||1
1593694|NCT01034631|3896897|P1|NOT COMPLETED|Phase II||0
1593695|NCT01034631|3896895|P3|COMPLETED|Phase II||67
1593696|NCT01034631|3896896|P2|COMPLETED|Phase II||69
1593697|NCT01034631|3896897|P1|COMPLETED|Phase II||0
1593698|NCT01034631|3896895|P3|STARTED|Phase II||69
1593699|NCT01034631|3896896|P2|STARTED|Phase II||70
1593700|NCT01034631|3896897|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
1593701|NCT01034631|3896895|P3|NOT COMPLETED|Phase I||0
1593702|NCT01034631|3896896|P2|NOT COMPLETED|Phase I||0
1593703|NCT01034631|3896897|P1|NOT COMPLETED|Phase I||3
1593704|NCT01034631|3896895|P3|COMPLETED|Phase I||0
1593705|NCT01034631|3896896|P2|COMPLETED|Phase I||0
1593706|NCT01034631|3896897|P1|COMPLETED|Phase I||12
1593707|NCT01034631|3896895|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
1593708|NCT01034631|3896896|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
1593709|NCT01034631|3896897|P1|STARTED|Phase I||15
1593710|NCT01034592|3896916|P1|NOT COMPLETED|Overall Study||0
1593711|NCT01034592|3896916|P1|COMPLETED|Overall Study||2
1593712|NCT01034592|3896916|P1|STARTED|Overall Study||2
1593713|NCT01034579|3896928|P2|NOT COMPLETED|Overall Study||0
1593714|NCT01034579|3896929|P1|NOT COMPLETED|Overall Study||0
1593715|NCT01034579|3896928|P2|COMPLETED|Overall Study||166
1593716|NCT01034579|3896929|P1|COMPLETED|Overall Study||158
1593717|NCT01034579|3896928|P2|STARTED|Overall Study||166
1593718|NCT01034579|3896929|P1|STARTED|Overall Study||158
1593719|NCT01034553|3896943|P6|NOT COMPLETED|Overall Study||0
1593720|NCT01034553|3896944|P5|NOT COMPLETED|Overall Study||0
1593721|NCT01034553|3896945|P4|NOT COMPLETED|Overall Study||0
1593722|NCT01034553|3896946|P3|NOT COMPLETED|Overall Study||0
1593723|NCT01034553|3896947|P2|NOT COMPLETED|Overall Study||0
1593724|NCT01034553|3896948|P1|NOT COMPLETED|Overall Study||0
1593725|NCT01034553|3896943|P6|COMPLETED|Overall Study||7
1593726|NCT01034553|3896944|P5|COMPLETED|Overall Study||6
1593727|NCT01034553|3896945|P4|COMPLETED|Overall Study||3
1593728|NCT01034553|3896946|P3|COMPLETED|Overall Study||3
1593729|NCT01034553|3896947|P2|COMPLETED|Overall Study||4
1593730|NCT01034553|3896948|P1|COMPLETED|Overall Study||3
1593731|NCT01034553|3896943|P6|STARTED|Overall Study||7
1593732|NCT01034553|3896944|P5|STARTED|Overall Study||6
1593733|NCT01034553|3896945|P4|STARTED|Overall Study||3
1593734|NCT01034553|3896946|P3|STARTED|Overall Study||3
1593735|NCT01034553|3896947|P2|STARTED|Overall Study||4
1593736|NCT01034553|3896948|P1|STARTED|Overall Study||3
1593737|NCT01034540|3896964|P2|NOT COMPLETED|Overall Study||1
1593738|NCT01034540|3896965|P1|NOT COMPLETED|Overall Study||0
1593739|NCT01034540|3896964|P2|COMPLETED|Overall Study||11
1593740|NCT01034540|3896965|P1|COMPLETED|Overall Study||11
1593741|NCT01034540|3896964|P2|Completed 1st Treatment Intervention|Overall Study||11
1593742|NCT01034540|3896965|P1|Completed 1st Treatment Intervention|Overall Study||11
1593743|NCT01034540|3896964|P2|STARTED|Overall Study||12
1593744|NCT01034540|3896965|P1|STARTED|Overall Study||11
1593745|NCT01034462|3896975|P2|NOT COMPLETED|Overall Study||54
1593746|NCT01034462|3896976|P1|NOT COMPLETED|Overall Study||45
1593747|NCT01034462|3896975|P2|COMPLETED|Overall Study||163
1593748|NCT01034462|3896976|P1|COMPLETED|Overall Study||172
1593749|NCT01034462|3896975|P2|STARTED|Overall Study||217
1593750|NCT01034462|3896976|P1|STARTED|Overall Study||217
1593751|NCT01034397|3896986|P2|NOT COMPLETED|Overall Study||2
1593752|NCT01034397|3896987|P1|NOT COMPLETED|Overall Study||7
1593753|NCT01034397|3896986|P2|COMPLETED|Overall Study||17
1593754|NCT01034397|3896987|P1|COMPLETED|Overall Study||28
1593755|NCT01034397|3896986|P2|STARTED|Overall Study||19
1593756|NCT01034397|3896987|P1|STARTED|Overall Study||35
1593757|NCT01034358|3897136|P1|NOT COMPLETED|Overall Study||2
1593758|NCT01034358|3897136|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
1593759|NCT01034358|3897136|P1|STARTED|Overall Study||15
1593760|NCT01034306|3897142|P2|NOT COMPLETED|Overall Study||3
1593761|NCT01034306|3897143|P1|NOT COMPLETED|Overall Study||5
1593762|NCT01034306|3897142|P2|COMPLETED|Overall Study||34
1593763|NCT01034306|3897143|P1|COMPLETED|Overall Study||37
1593764|NCT01034306|3897142|P2|STARTED|Overall Study||37
1593765|NCT01034306|3897143|P1|STARTED|Overall Study||42
1593766|NCT01034176|3897151|P2|NOT COMPLETED|Overall Study||2
1593767|NCT01034176|3897152|P1|NOT COMPLETED|Overall Study||2
1593768|NCT01034176|3897151|P2|COMPLETED|Overall Study||19
1593769|NCT01034176|3897152|P1|COMPLETED|Overall Study||20
1593770|NCT01034176|3897151|P2|STARTED|Overall Study||21
1593771|NCT01034176|3897152|P1|STARTED|Overall Study||22
1593772|NCT01034163|3897162|P2|NOT COMPLETED|Overall Study||14
1593773|NCT01034163|3897163|P1|NOT COMPLETED|Overall Study||27
1593774|NCT01034163|3897162|P2|COMPLETED|Overall Study||0
1593775|NCT01034163|3897163|P1|COMPLETED|Overall Study||0
1593776|NCT01034163|3897162|P2|In Open Label Phase After Unblinding|Overall Study||0
1593777|NCT01034163|3897163|P1|In Open Label Phase After Unblinding|Overall Study||5
1593778|NCT01034163|3897162|P2|Safety Set|Overall Study||12
1593779|NCT01034163|3897163|P1|Safety Set|Overall Study||26
1593780|NCT01034163|3897162|P2|Untreated (Not in Safety Set)|Overall Study||2
1593781|NCT01034163|3897163|P1|Untreated (Not in Safety Set)|Overall Study||1
1593782|NCT01034163|3897162|P2|STARTED|Overall Study||14
1593783|NCT01034163|3897163|P1|STARTED|Overall Study||27
1593784|NCT01034137|3897172|P3|NOT COMPLETED|Overall Study||30
1593785|NCT01034137|3897173|P2|NOT COMPLETED|Overall Study||22
1593786|NCT01034137|3897174|P1|NOT COMPLETED|Overall Study||28
1593787|NCT01034137|3897172|P3|COMPLETED|Overall Study||78
1593788|NCT01034137|3897173|P2|COMPLETED|Overall Study||81
1593789|NCT01034137|3897174|P1|COMPLETED|Overall Study||78
1593790|NCT01034137|3897172|P3|STARTED|Overall Study||108
1593791|NCT01034137|3897173|P2|STARTED|Overall Study||103
1593792|NCT01034137|3897174|P1|STARTED|Overall Study||106
1593793|NCT01034111|3897305|P1|NOT COMPLETED|Overall Study||0
1593794|NCT01034111|3897305|P1|COMPLETED|Overall Study||30
1593795|NCT01034111|3897305|P1|STARTED|Overall Study||30
1593796|NCT01033942|3897313|P3|NOT COMPLETED|Overall Study||1
1593797|NCT01033942|3897314|P2|NOT COMPLETED|Overall Study||4
1593798|NCT01033942|3897315|P1|NOT COMPLETED|Overall Study||2
1593799|NCT01033942|3897313|P3|COMPLETED|Overall Study||18
1593800|NCT01033942|3897314|P2|COMPLETED|Overall Study||15
1593801|NCT01033942|3897315|P1|COMPLETED|Overall Study||18
1593802|NCT01033942|3897313|P3|STARTED|Overall Study||19
1593803|NCT01033942|3897314|P2|STARTED|Overall Study||19
1593804|NCT01033942|3897315|P1|STARTED|Overall Study||20
1593805|NCT01033864|3897587|P2|NOT COMPLETED|Overall Study||0
1593806|NCT01033864|3897588|P1|NOT COMPLETED|Overall Study||0
1593807|NCT01033864|3897587|P2|COMPLETED|Overall Study||11
1593808|NCT01033864|3897588|P1|COMPLETED|Overall Study||12
1593809|NCT01033864|3897587|P2|STARTED|Overall Study||11
1593810|NCT01033864|3897588|P1|STARTED|Overall Study||12
1593811|NCT01033851|3897613|P2|NOT COMPLETED|Overall Study||7
1593812|NCT01033851|3897614|P1|NOT COMPLETED|Overall Study||3
1593813|NCT01033851|3897613|P2|COMPLETED|Overall Study||34
1593814|NCT01033851|3897614|P1|COMPLETED|Overall Study||45
1593815|NCT01033851|3897613|P2|STARTED|Overall Study||41
1593816|NCT01033851|3897614|P1|STARTED|Overall Study||48
1593817|NCT01033825|3897629|P7|NOT COMPLETED|Overall Study||0
1593818|NCT01033825|3897630|P6|NOT COMPLETED|Overall Study||0
1593819|NCT01033825|3897631|P5|NOT COMPLETED|Overall Study||2
1593820|NCT01033825|3897632|P4|NOT COMPLETED|Overall Study||2
1593821|NCT01033825|3897633|P3|NOT COMPLETED|Overall Study||2
1593822|NCT01033825|3897634|P2|NOT COMPLETED|Overall Study||3
1593823|NCT01033825|3897635|P1|NOT COMPLETED|Overall Study||3
1593824|NCT01033825|3897629|P7|COMPLETED|Overall Study||18
1593825|NCT01033825|3897630|P6|COMPLETED|Overall Study||18
1593826|NCT01033825|3897631|P5|COMPLETED|Overall Study||56
1593827|NCT01033825|3897632|P4|COMPLETED|Overall Study||46
1593828|NCT01033825|3897633|P3|COMPLETED|Overall Study||55
1593829|NCT01033825|3897634|P2|COMPLETED|Overall Study||57
1593830|NCT01033825|3897635|P1|COMPLETED|Overall Study||48
1593831|NCT01033825|3897629|P7|STARTED|Overall Study||18
1593832|NCT01033825|3897630|P6|STARTED|Overall Study||18
1593833|NCT01033825|3897631|P5|STARTED|Overall Study||58
1593834|NCT01033825|3897632|P4|STARTED|Overall Study||48
1593835|NCT01033825|3897633|P3|STARTED|Overall Study||57
1593836|NCT01033825|3897634|P2|STARTED|Overall Study||60
1593837|NCT01033825|3897635|P1|STARTED|Overall Study||51
1593838|NCT01033747|3897856|P2|NOT COMPLETED|Overall Study||15
1593839|NCT01033747|3897857|P1|NOT COMPLETED|Overall Study||37
1593840|NCT01033747|3897856|P2|COMPLETED|Overall Study||4
1593841|NCT01033747|3897857|P1|COMPLETED|Overall Study||14
1593842|NCT01033747|3897856|P2|STARTED|Overall Study||19
1593843|NCT01033747|3897857|P1|STARTED|Overall Study||51
1593844|NCT01033734|3897865|P1|NOT COMPLETED|Overall Study||1
1593845|NCT01033734|3897865|P1|COMPLETED|Overall Study||7
1593846|NCT01033734|3897865|P1|STARTED|Overall Study||8
1593847|NCT01033565|3897917|P1|NOT COMPLETED|Overall Study||0
1593848|NCT01033565|3897917|P1|COMPLETED|Overall Study||1
1593849|NCT01033565|3897917|P1|STARTED|Overall Study||1
1593850|NCT01033487|3897921|P10|NOT COMPLETED|Fifth Intervention Period||0
1593851|NCT01033487|3897922|P9|NOT COMPLETED|Fifth Intervention Period||0
1593852|NCT01033487|3897923|P8|NOT COMPLETED|Fifth Intervention Period||0
1593853|NCT01033487|3897924|P7|NOT COMPLETED|Fifth Intervention Period||0
1593854|NCT01033487|3897925|P6|NOT COMPLETED|Fifth Intervention Period||0
1593855|NCT01033487|3897926|P5|NOT COMPLETED|Fifth Intervention Period||0
1593856|NCT01033487|3897927|P4|NOT COMPLETED|Fifth Intervention Period||0
1593857|NCT01033487|3897928|P3|NOT COMPLETED|Fifth Intervention Period||0
1593858|NCT01033487|3897929|P2|NOT COMPLETED|Fifth Intervention Period||0
1593859|NCT01033487|3897930|P1|NOT COMPLETED|Fifth Intervention Period||0
1593860|NCT01033487|3897921|P10|COMPLETED|Fifth Intervention Period||2
1593861|NCT01033487|3897922|P9|COMPLETED|Fifth Intervention Period||1
1593862|NCT01033487|3897923|P8|COMPLETED|Fifth Intervention Period||3
1593863|NCT01033487|3897924|P7|COMPLETED|Fifth Intervention Period||2
1593864|NCT01033487|3897925|P6|COMPLETED|Fifth Intervention Period||2
1593865|NCT01033487|3897926|P5|COMPLETED|Fifth Intervention Period||2
1593866|NCT01033487|3897927|P4|COMPLETED|Fifth Intervention Period||2
1593867|NCT01033487|3897928|P3|COMPLETED|Fifth Intervention Period||2
1593868|NCT01033487|3897929|P2|COMPLETED|Fifth Intervention Period||3
1593869|NCT01033487|3897930|P1|COMPLETED|Fifth Intervention Period||2
1593870|NCT01033487|3897921|P10|STARTED|Fifth Intervention Period||2
1593871|NCT01033487|3897922|P9|STARTED|Fifth Intervention Period||1
1593872|NCT01033487|3897923|P8|STARTED|Fifth Intervention Period||3
1593873|NCT01033487|3897924|P7|STARTED|Fifth Intervention Period||2
1593874|NCT01033487|3897925|P6|STARTED|Fifth Intervention Period||2
1593875|NCT01033487|3897926|P5|STARTED|Fifth Intervention Period||2
1593876|NCT01033487|3897927|P4|STARTED|Fifth Intervention Period||2
1593877|NCT01033487|3897928|P3|STARTED|Fifth Intervention Period||2
1593878|NCT01033487|3897929|P2|STARTED|Fifth Intervention Period||3
1593879|NCT01033487|3897930|P1|STARTED|Fifth Intervention Period||2
1593880|NCT01033487|3897921|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593881|NCT01033487|3897922|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593882|NCT01033487|3897923|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593883|NCT01033487|3897924|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593884|NCT01033487|3897925|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593885|NCT01033487|3897926|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593886|NCT01033487|3897927|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593887|NCT01033487|3897928|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593888|NCT01033487|3897929|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593889|NCT01033487|3897930|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1593890|NCT01033487|3897921|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1593891|NCT01033487|3897922|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
1593892|NCT01033487|3897923|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
1593893|NCT01033487|3897924|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1593894|NCT01033487|3897925|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1593895|NCT01033487|3897926|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1593896|NCT01033487|3897927|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1593897|NCT01033487|3897928|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1593898|NCT01033487|3897929|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
1593899|NCT01033487|3897930|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1593900|NCT01033487|3897921|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1593901|NCT01033487|3897922|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
1593902|NCT01033487|3897923|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
1593903|NCT01033487|3897924|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1593904|NCT01033487|3897925|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1593905|NCT01033487|3897926|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1593906|NCT01033487|3897927|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1593907|NCT01033487|3897928|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1593908|NCT01033487|3897929|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
1593909|NCT01033487|3897930|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1593910|NCT01033487|3897921|P10|NOT COMPLETED|Fourth Intervention Period||0
1593911|NCT01033487|3897922|P9|NOT COMPLETED|Fourth Intervention Period||1
1593912|NCT01033487|3897923|P8|NOT COMPLETED|Fourth Intervention Period||0
1593913|NCT01033487|3897924|P7|NOT COMPLETED|Fourth Intervention Period||0
1593914|NCT01033487|3897925|P6|NOT COMPLETED|Fourth Intervention Period||0
1593915|NCT01033487|3897926|P5|NOT COMPLETED|Fourth Intervention Period||0
1593916|NCT01033487|3897927|P4|NOT COMPLETED|Fourth Intervention Period||0
1593917|NCT01033487|3897928|P3|NOT COMPLETED|Fourth Intervention Period||0
1593918|NCT01033487|3897929|P2|NOT COMPLETED|Fourth Intervention Period||0
1593919|NCT01033487|3897930|P1|NOT COMPLETED|Fourth Intervention Period||0
1593920|NCT01033487|3897921|P10|COMPLETED|Fourth Intervention Period||2
1593921|NCT01033487|3897922|P9|COMPLETED|Fourth Intervention Period||1
1593922|NCT01033487|3897923|P8|COMPLETED|Fourth Intervention Period||3
1593923|NCT01033487|3897924|P7|COMPLETED|Fourth Intervention Period||2
1593924|NCT01033487|3897925|P6|COMPLETED|Fourth Intervention Period||2
1593925|NCT01033487|3897926|P5|COMPLETED|Fourth Intervention Period||2
1593926|NCT01033487|3897927|P4|COMPLETED|Fourth Intervention Period||2
1593927|NCT01033487|3897928|P3|COMPLETED|Fourth Intervention Period||2
1593928|NCT01033487|3897929|P2|COMPLETED|Fourth Intervention Period||3
1593929|NCT01033487|3897930|P1|COMPLETED|Fourth Intervention Period||2
1593930|NCT01033487|3897921|P10|STARTED|Fourth Intervention Period||2
1593931|NCT01033487|3897922|P9|STARTED|Fourth Intervention Period||2
1593932|NCT01033487|3897923|P8|STARTED|Fourth Intervention Period||3
1593933|NCT01033487|3897924|P7|STARTED|Fourth Intervention Period||2
1593934|NCT01033487|3897925|P6|STARTED|Fourth Intervention Period||2
1593935|NCT01033487|3897926|P5|STARTED|Fourth Intervention Period||2
1593936|NCT01033487|3897927|P4|STARTED|Fourth Intervention Period||2
1593937|NCT01033487|3897928|P3|STARTED|Fourth Intervention Period||2
1593938|NCT01033487|3897929|P2|STARTED|Fourth Intervention Period||3
1593939|NCT01033487|3897930|P1|STARTED|Fourth Intervention Period||2
1593940|NCT01033487|3897921|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593941|NCT01033487|3897922|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593942|NCT01033487|3897923|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593943|NCT01033487|3897924|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593944|NCT01033487|3897925|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593945|NCT01033487|3897926|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593946|NCT01033487|3897927|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593947|NCT01033487|3897928|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593948|NCT01033487|3897929|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593949|NCT01033487|3897930|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1593950|NCT01033487|3897921|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1593951|NCT01033487|3897922|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1593952|NCT01033487|3897923|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
1593953|NCT01033487|3897924|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1593954|NCT01033487|3897925|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1593955|NCT01033487|3897926|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1593956|NCT01033487|3897927|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1593957|NCT01033487|3897928|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1593958|NCT01033487|3897929|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
1593959|NCT01033487|3897930|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1593960|NCT01033487|3897921|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1593961|NCT01033487|3897922|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1593962|NCT01033487|3897923|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
1593963|NCT01033487|3897924|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1593964|NCT01033487|3897925|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1593965|NCT01033487|3897926|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1593966|NCT01033487|3897927|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1593967|NCT01033487|3897928|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1593968|NCT01033487|3897929|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
1593969|NCT01033487|3897930|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1593970|NCT01033487|3897921|P10|NOT COMPLETED|Third Intervention Period||0
1593971|NCT01033487|3897922|P9|NOT COMPLETED|Third Intervention Period||0
1593972|NCT01033487|3897923|P8|NOT COMPLETED|Third Intervention Period||0
1593973|NCT01033487|3897924|P7|NOT COMPLETED|Third Intervention Period||0
1593974|NCT01033487|3897925|P6|NOT COMPLETED|Third Intervention Period||0
1593975|NCT01033487|3897926|P5|NOT COMPLETED|Third Intervention Period||0
1593976|NCT01033487|3897927|P4|NOT COMPLETED|Third Intervention Period||0
1593977|NCT01033487|3897928|P3|NOT COMPLETED|Third Intervention Period||0
1593978|NCT01033487|3897929|P2|NOT COMPLETED|Third Intervention Period||0
1593979|NCT01033487|3897930|P1|NOT COMPLETED|Third Intervention Period||0
1593980|NCT01033487|3897921|P10|COMPLETED|Third Intervention Period||2
1593981|NCT01033487|3897922|P9|COMPLETED|Third Intervention Period||2
1593982|NCT01033487|3897923|P8|COMPLETED|Third Intervention Period||3
1593983|NCT01033487|3897924|P7|COMPLETED|Third Intervention Period||2
1593984|NCT01033487|3897925|P6|COMPLETED|Third Intervention Period||2
1593985|NCT01033487|3897926|P5|COMPLETED|Third Intervention Period||2
1593986|NCT01033487|3897927|P4|COMPLETED|Third Intervention Period||2
1593987|NCT01033487|3897928|P3|COMPLETED|Third Intervention Period||2
1593988|NCT01033487|3897929|P2|COMPLETED|Third Intervention Period||3
1593989|NCT01033487|3897930|P1|COMPLETED|Third Intervention Period||2
1593990|NCT01033487|3897921|P10|STARTED|Third Intervention Period||2
1593991|NCT01033487|3897922|P9|STARTED|Third Intervention Period||2
1593992|NCT01033487|3897923|P8|STARTED|Third Intervention Period||3
1593993|NCT01033487|3897924|P7|STARTED|Third Intervention Period||2
1593994|NCT01033487|3897925|P6|STARTED|Third Intervention Period||2
1593995|NCT01033487|3897926|P5|STARTED|Third Intervention Period||2
1593996|NCT01033487|3897927|P4|STARTED|Third Intervention Period||2
1593997|NCT01033487|3897928|P3|STARTED|Third Intervention Period||2
1593998|NCT01033487|3897929|P2|STARTED|Third Intervention Period||3
1593999|NCT01033487|3897930|P1|STARTED|Third Intervention Period||2
1594000|NCT01033487|3897921|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594001|NCT01033487|3897922|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594002|NCT01033487|3897923|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594003|NCT01033487|3897924|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594004|NCT01033487|3897925|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594005|NCT01033487|3897926|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594006|NCT01033487|3897927|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594007|NCT01033487|3897928|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594008|NCT01033487|3897929|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594009|NCT01033487|3897930|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1594010|NCT01033487|3897921|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1594011|NCT01033487|3897922|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1594012|NCT01033487|3897923|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
1594013|NCT01033487|3897924|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1594014|NCT01033487|3897925|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1594015|NCT01033487|3897926|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1594016|NCT01033487|3897927|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1594017|NCT01033487|3897928|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1594018|NCT01033487|3897929|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
1594019|NCT01033487|3897930|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1594020|NCT01033487|3897921|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1594021|NCT01033487|3897922|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1594022|NCT01033487|3897923|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
1594023|NCT01033487|3897924|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1594024|NCT01033487|3897925|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1594025|NCT01033487|3897926|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1594026|NCT01033487|3897927|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1594027|NCT01033487|3897928|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1594028|NCT01033487|3897929|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
1594029|NCT01033487|3897930|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1594030|NCT01033487|3897921|P10|NOT COMPLETED|Second Intervention Period||0
1594031|NCT01033487|3897922|P9|NOT COMPLETED|Second Intervention Period||0
1594032|NCT01033487|3897923|P8|NOT COMPLETED|Second Intervention Period||0
1594033|NCT01033487|3897924|P7|NOT COMPLETED|Second Intervention Period||0
1594034|NCT01033487|3897925|P6|NOT COMPLETED|Second Intervention Period||0
1594035|NCT01033487|3897926|P5|NOT COMPLETED|Second Intervention Period||0
1594036|NCT01033487|3897927|P4|NOT COMPLETED|Second Intervention Period||0
1594037|NCT01033487|3897928|P3|NOT COMPLETED|Second Intervention Period||0
1594038|NCT01033487|3897929|P2|NOT COMPLETED|Second Intervention Period||0
1594039|NCT01033487|3897930|P1|NOT COMPLETED|Second Intervention Period||0
1594040|NCT01033487|3897921|P10|COMPLETED|Second Intervention Period||2
1594041|NCT01033487|3897922|P9|COMPLETED|Second Intervention Period||2
1594042|NCT01033487|3897923|P8|COMPLETED|Second Intervention Period||3
1594043|NCT01033487|3897924|P7|COMPLETED|Second Intervention Period||2
1594044|NCT01033487|3897925|P6|COMPLETED|Second Intervention Period||2
1594045|NCT01033487|3897926|P5|COMPLETED|Second Intervention Period||2
1594046|NCT01033487|3897927|P4|COMPLETED|Second Intervention Period||2
1594047|NCT01033487|3897928|P3|COMPLETED|Second Intervention Period||2
1594048|NCT01033487|3897929|P2|COMPLETED|Second Intervention Period||3
1594049|NCT01033487|3897930|P1|COMPLETED|Second Intervention Period||2
1594050|NCT01033487|3897921|P10|STARTED|Second Intervention Period||2
1594051|NCT01033487|3897922|P9|STARTED|Second Intervention Period||2
1594052|NCT01033487|3897923|P8|STARTED|Second Intervention Period||3
1594053|NCT01033487|3897924|P7|STARTED|Second Intervention Period||2
1594054|NCT01033487|3897925|P6|STARTED|Second Intervention Period||2
1594055|NCT01033487|3897926|P5|STARTED|Second Intervention Period||2
1594056|NCT01033487|3897927|P4|STARTED|Second Intervention Period||2
1594057|NCT01033487|3897928|P3|STARTED|Second Intervention Period||2
1594058|NCT01033487|3897929|P2|STARTED|Second Intervention Period||3
1594059|NCT01033487|3897930|P1|STARTED|Second Intervention Period||2
1594060|NCT01033487|3897921|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594061|NCT01033487|3897922|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594062|NCT01033487|3897923|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594063|NCT01033487|3897924|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594064|NCT01033487|3897925|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594065|NCT01033487|3897926|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594066|NCT01033487|3897927|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594067|NCT01033487|3897928|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594068|NCT01033487|3897929|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594069|NCT01033487|3897930|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1594070|NCT01033487|3897921|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1594071|NCT01033487|3897922|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1594072|NCT01033487|3897923|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
1594073|NCT01033487|3897924|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1594074|NCT01033487|3897925|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1594075|NCT01033487|3897926|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1594076|NCT01033487|3897927|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1594077|NCT01033487|3897928|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1594078|NCT01033487|3897929|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
1594079|NCT01033487|3897930|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1594080|NCT01033487|3897921|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1594081|NCT01033487|3897922|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1594082|NCT01033487|3897923|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
1594083|NCT01033487|3897924|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1594084|NCT01033487|3897925|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1594085|NCT01033487|3897926|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1594086|NCT01033487|3897927|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1594087|NCT01033487|3897928|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1594088|NCT01033487|3897929|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
1594089|NCT01033487|3897930|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1594090|NCT01033487|3897921|P10|NOT COMPLETED|First Intervention Period||0
1594091|NCT01033487|3897922|P9|NOT COMPLETED|First Intervention Period||0
1594092|NCT01033487|3897923|P8|NOT COMPLETED|First Intervention Period||0
1594093|NCT01033487|3897924|P7|NOT COMPLETED|First Intervention Period||0
1594094|NCT01033487|3897925|P6|NOT COMPLETED|First Intervention Period||0
1594095|NCT01033487|3897926|P5|NOT COMPLETED|First Intervention Period||0
1594096|NCT01033487|3897927|P4|NOT COMPLETED|First Intervention Period||0
1594097|NCT01033487|3897928|P3|NOT COMPLETED|First Intervention Period||0
1594098|NCT01033487|3897929|P2|NOT COMPLETED|First Intervention Period||0
1594099|NCT01033487|3897930|P1|NOT COMPLETED|First Intervention Period||0
1594100|NCT01033487|3897921|P10|COMPLETED|First Intervention Period||2
1594101|NCT01033487|3897922|P9|COMPLETED|First Intervention Period||2
1594102|NCT01033487|3897923|P8|COMPLETED|First Intervention Period||3
1594103|NCT01033487|3897924|P7|COMPLETED|First Intervention Period||2
1594104|NCT01033487|3897925|P6|COMPLETED|First Intervention Period||2
1594105|NCT01033487|3897926|P5|COMPLETED|First Intervention Period||2
1594106|NCT01033487|3897927|P4|COMPLETED|First Intervention Period||2
1594107|NCT01033487|3897928|P3|COMPLETED|First Intervention Period||2
1594108|NCT01033487|3897929|P2|COMPLETED|First Intervention Period||3
1594109|NCT01033487|3897930|P1|COMPLETED|First Intervention Period||2
1594110|NCT01033487|3897921|P10|STARTED|First Intervention Period||2
1594111|NCT01033487|3897922|P9|STARTED|First Intervention Period||2
1594112|NCT01033487|3897923|P8|STARTED|First Intervention Period||3
1594113|NCT01033487|3897924|P7|STARTED|First Intervention Period||2
1594114|NCT01033487|3897925|P6|STARTED|First Intervention Period||2
1594115|NCT01033487|3897926|P5|STARTED|First Intervention Period||2
1594116|NCT01033487|3897927|P4|STARTED|First Intervention Period||2
1594117|NCT01033487|3897928|P3|STARTED|First Intervention Period||2
1594118|NCT01033487|3897929|P2|STARTED|First Intervention Period||3
1594119|NCT01033487|3897930|P1|STARTED|First Intervention Period||2
1594120|NCT01033448|3897984|P1|NOT COMPLETED|Overall Study||12
1594121|NCT01033448|3897984|P1|COMPLETED|Overall Study||47
1594122|NCT01033448|3897984|P1|STARTED|Overall Study||59
1594123|NCT01033383|3897996|P4|NOT COMPLETED|Overall Study||0
1594124|NCT01033383|3897997|P3|NOT COMPLETED|Overall Study||0
1594125|NCT01033383|3897998|P2|NOT COMPLETED|Overall Study||0
1594126|NCT01033383|3897999|P1|NOT COMPLETED|Overall Study||0
1594127|NCT01033383|3897996|P4|COMPLETED|Overall Study||20
1594128|NCT01033383|3897997|P3|COMPLETED|Overall Study||20
1594129|NCT01033383|3897998|P2|COMPLETED|Overall Study||20
1594130|NCT01033383|3897999|P1|COMPLETED|Overall Study||20
1594131|NCT01033383|3897996|P4|STARTED|Overall Study||20
1594132|NCT01033383|3897997|P3|STARTED|Overall Study||20
1594133|NCT01033383|3897998|P2|STARTED|Overall Study||20
1594134|NCT01033383|3897999|P1|STARTED|Overall Study||20
1594135|NCT01033227|3898019|P2|NOT COMPLETED|Overall Study||0
1594136|NCT01033227|3898020|P1|NOT COMPLETED|Overall Study||0
1594137|NCT01033227|3898019|P2|COMPLETED|Overall Study||2
1594138|NCT01033227|3898020|P1|COMPLETED|Overall Study||3
1594139|NCT01033227|3898019|P2|STARTED|Overall Study||2
1594140|NCT01033227|3898020|P1|STARTED|Overall Study||3
1594141|NCT01033136|3898030|P2|NOT COMPLETED|Follow-Up (3 Month)||2
1594142|NCT01033136|3898031|P1|NOT COMPLETED|Follow-Up (3 Month)||2
1594143|NCT01033136|3898030|P2|COMPLETED|Follow-Up (3 Month)||13
1594144|NCT01033136|3898031|P1|COMPLETED|Follow-Up (3 Month)||14
1594145|NCT01033136|3898030|P2|STARTED|Follow-Up (3 Month)||15
1594146|NCT01033136|3898031|P1|STARTED|Follow-Up (3 Month)||16
1594147|NCT01033136|3898030|P2|NOT COMPLETED|Post-Treatment (1 Week)||11
1594148|NCT01033136|3898031|P1|NOT COMPLETED|Post-Treatment (1 Week)||14
1594149|NCT01033136|3898030|P2|COMPLETED|Post-Treatment (1 Week)||15
1594150|NCT01033136|3898031|P1|COMPLETED|Post-Treatment (1 Week)||16
1594151|NCT01033136|3898030|P2|STARTED|Post-Treatment (1 Week)||26
1594152|NCT01033136|3898031|P1|STARTED|Post-Treatment (1 Week)||30
1594153|NCT01033136|3898030|P2|NOT COMPLETED|Baseline Assessment||6
1594154|NCT01033136|3898031|P1|NOT COMPLETED|Baseline Assessment||6
1594155|NCT01033136|3898030|P2|COMPLETED|Baseline Assessment||26
1594156|NCT01033136|3898031|P1|COMPLETED|Baseline Assessment||30
1594157|NCT01033136|3898030|P2|STARTED|Baseline Assessment||32
1594158|NCT01033136|3898031|P1|STARTED|Baseline Assessment||36
1594159|NCT01033071|3898042|P3|NOT COMPLETED|Overall Study||47
1594160|NCT01033071|3898043|P2|NOT COMPLETED|Overall Study||77
1594161|NCT01033071|3898044|P1|NOT COMPLETED|Overall Study||55
1594162|NCT01033071|3898042|P3|COMPLETED|Overall Study||317
1594163|NCT01033071|3898043|P2|COMPLETED|Overall Study||275
1594164|NCT01033071|3898044|P1|COMPLETED|Overall Study||300
1594165|NCT01033071|3898042|P3|STARTED|Overall Study||364
1594166|NCT01033071|3898043|P2|STARTED|Overall Study||352
1594167|NCT01033071|3898044|P1|STARTED|Overall Study||355
1594168|NCT01033032|3898103|P4|NOT COMPLETED|Phase II||0
1594169|NCT01033032|3898104|P3|NOT COMPLETED|Phase II||66
1594170|NCT01033032|3898105|P2|NOT COMPLETED|Phase II||0
1594171|NCT01033032|3898106|P1|NOT COMPLETED|Phase II||0
1594172|NCT01033032|3898103|P4|COMPLETED|Phase II||0
1594173|NCT01033032|3898104|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
1594174|NCT01033032|3898105|P2|COMPLETED|Phase II||0
1594175|NCT01033032|3898106|P1|COMPLETED|Phase II||0
1594176|NCT01033032|3898103|P4|STARTED|Phase II||0
1594177|NCT01033032|3898104|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
1594178|NCT01033032|3898105|P2|STARTED|Phase II||0
1594179|NCT01033032|3898106|P1|STARTED|Phase II||0
1594180|NCT01033032|3898103|P4|NOT COMPLETED|Phase I||6
1594181|NCT01033032|3898104|P3|NOT COMPLETED|Phase I||0
1594182|NCT01033032|3898105|P2|NOT COMPLETED|Phase I||3
1594183|NCT01033032|3898106|P1|NOT COMPLETED|Phase I||3
1594184|NCT01033032|3898103|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1594185|NCT01033032|3898104|P3|COMPLETED|Phase I||3
1594186|NCT01033032|3898105|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1594187|NCT01033032|3898106|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1594188|NCT01033032|3898103|P4|STARTED|Phase I||6
1594189|NCT01033032|3898104|P3|STARTED|Phase I||3
1594190|NCT01033032|3898105|P2|STARTED|Phase I||3
1594191|NCT01033032|3898106|P1|STARTED|Phase I||3
1594192|NCT01033019|3898115|P2|NOT COMPLETED|Overall Study||0
1594193|NCT01033019|3898116|P1|NOT COMPLETED|Overall Study||1
1594194|NCT01033019|3898115|P2|COMPLETED|Overall Study||8
1594195|NCT01033019|3898116|P1|COMPLETED|Overall Study||15
1594196|NCT01033019|3898115|P2|STARTED|Overall Study||8
1594197|NCT01033019|3898116|P1|STARTED|Overall Study||16
1594198|NCT01032993|3898125|P2|NOT COMPLETED|Overall Study||0
1594199|NCT01032993|3898126|P1|NOT COMPLETED|Overall Study||0
1594200|NCT01032993|3898125|P2|COMPLETED|Overall Study||20
1594201|NCT01032993|3898126|P1|COMPLETED|Overall Study||19
1594202|NCT01032993|3898125|P2|STARTED|Overall Study||20
1594203|NCT01032993|3898126|P1|STARTED|Overall Study||19
1594204|NCT01032928|3898138|P1|NOT COMPLETED|Overall Study||0
1594205|NCT01032928|3898138|P1|COMPLETED|Overall Study||30
1594206|NCT01032928|3898138|P1|STARTED|Overall Study||30
1594207|NCT01032915|3898154|P4|NOT COMPLETED|Overall Study||7
1594208|NCT01032915|3898155|P3|NOT COMPLETED|Overall Study||7
1594209|NCT01032915|3898156|P2|NOT COMPLETED|Overall Study||11
1594210|NCT01032915|3898157|P1|NOT COMPLETED|Overall Study||8
1594211|NCT01032915|3898154|P4|COMPLETED|Overall Study||27
1594212|NCT01032915|3898155|P3|COMPLETED|Overall Study||24
1594213|NCT01032915|3898156|P2|COMPLETED|Overall Study||20
1594214|NCT01032915|3898157|P1|COMPLETED|Overall Study||21
1594215|NCT01032915|3898154|P4|STARTED|Overall Study||34
1594216|NCT01032915|3898155|P3|STARTED|Overall Study||31
1594217|NCT01032915|3898156|P2|STARTED|Overall Study||31
1594218|NCT01032915|3898157|P1|STARTED|Overall Study||29
1594219|NCT01032889|3898182|P3|NOT COMPLETED|Overall Study||3
1594220|NCT01032889|3898183|P2|NOT COMPLETED|Overall Study||15
1594221|NCT01032889|3898184|P1|NOT COMPLETED|Overall Study||8
1594222|NCT01032889|3898182|P3|COMPLETED|Overall Study||42
1594223|NCT01032889|3898183|P2|COMPLETED|Overall Study||28
1594224|NCT01032889|3898184|P1|COMPLETED|Overall Study||33
1594225|NCT01032889|3898182|P3|Received Treatment|Overall Study||45
1594226|NCT01032889|3898183|P2|Received Treatment|Overall Study||43
1594227|NCT01032889|3898184|P1|Received Treatment|Overall Study||41
1594228|NCT01032889|3898182|P3|STARTED|Overall Study||45
1594229|NCT01032889|3898183|P2|STARTED|Overall Study||43
1594230|NCT01032889|3898184|P1|STARTED|Overall Study||41
1594231|NCT01032850|3898204|P1|NOT COMPLETED|Overall Study||2
1594232|NCT01032850|3898204|P1|COMPLETED|Overall Study||13
1594233|NCT01032850|3898204|P1|STARTED|Overall Study||15
1594234|NCT01032837|3898215|P4|NOT COMPLETED|Overall Study||3
1594235|NCT01032837|3898216|P3|NOT COMPLETED|Overall Study||1
1594236|NCT01032837|3898217|P2|NOT COMPLETED|Overall Study||3
1594237|NCT01032837|3898218|P1|NOT COMPLETED|Overall Study||0
1594238|NCT01032837|3898215|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
1594239|NCT01032837|3898216|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
1594240|NCT01032837|3898217|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
1594241|NCT01032837|3898218|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
1594242|NCT01032837|3898215|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
1594243|NCT01032837|3898216|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
1594244|NCT01032837|3898217|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
1594245|NCT01032837|3898218|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
1594246|NCT01032837|3898215|P4|STARTED|Overall Study||25
1594247|NCT01032837|3898216|P3|STARTED|Overall Study||25
1594248|NCT01032837|3898217|P2|STARTED|Overall Study||26
1594249|NCT01032837|3898218|P1|STARTED|Overall Study||26
1594250|NCT01032759|3898266|P2|NOT COMPLETED|Overall Study||3
1594251|NCT01032759|3898267|P1|NOT COMPLETED|Overall Study||1
1594252|NCT01032759|3898266|P2|COMPLETED|Overall Study||28
1594253|NCT01032759|3898267|P1|COMPLETED|Overall Study||31
1594254|NCT01032759|3898266|P2|Completed 48 Hour Assessment|Overall Study||28
1594255|NCT01032759|3898267|P1|Completed 48 Hour Assessment|Overall Study||31
1594256|NCT01032759|3898266|P2|Completed 24 Hour Assessment|Overall Study||30
1594257|NCT01032759|3898267|P1|Completed 24 Hour Assessment|Overall Study||32
1594258|NCT01032759|3898266|P2|STARTED|Overall Study||31
1594259|NCT01032759|3898267|P1|STARTED|Overall Study||32
1594260|NCT01032733|3898287|P2|NOT COMPLETED|Overall Study||1
1594261|NCT01032733|3898288|P1|NOT COMPLETED|Overall Study||1
1594262|NCT01032733|3898287|P2|COMPLETED|Overall Study||16
1594263|NCT01032733|3898288|P1|COMPLETED|Overall Study||16
1594264|NCT01032733|3898287|P2|STARTED|Overall Study||17
1594265|NCT01032733|3898288|P1|STARTED|Overall Study||17
1594266|NCT01032694|3898304|P2|NOT COMPLETED|Overall Study||0
1594267|NCT01032694|3898305|P1|NOT COMPLETED|Overall Study||0
1594268|NCT01032694|3898304|P2|COMPLETED|Overall Study||10
1594269|NCT01032694|3898305|P1|COMPLETED|Overall Study||20
1594270|NCT01032694|3898304|P2|STARTED|Overall Study||10
1594271|NCT01032694|3898305|P1|STARTED|Overall Study||20
1594272|NCT01032629|3898318|P3|NOT COMPLETED|Overall Study||88
1594273|NCT01032629|3898319|P2|NOT COMPLETED|Overall Study||101
1594274|NCT01032629|3898320|P1|NOT COMPLETED|Overall Study||145
1594275|NCT01032629|3898318|P3|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
1594276|NCT01032629|3898319|P2|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
1594277|NCT01032629|3898320|P1|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
1594278|NCT01032629|3898318|P3|Treated|Overall Study||1441
1594279|NCT01032629|3898319|P2|Treated|Overall Study||1445
1594280|NCT01032629|3898320|P1|Treated|Overall Study||1441
1594281|NCT01032629|3898318|P3|STARTED|Overall Study||1443
1594282|NCT01032629|3898319|P2|STARTED|Overall Study||1445
1594283|NCT01032629|3898320|P1|STARTED|Overall Study||1442
1594284|NCT01032538|3898365|P1|NOT COMPLETED|Overall Study||0
1594285|NCT01032538|3898365|P1|COMPLETED|Overall Study|Knees|99
1594286|NCT01032538|3898365|P1|STARTED|Overall Study|Knees|99
1594287|NCT01032382|3898373|P2|NOT COMPLETED|Overall Study||5
1594288|NCT01032382|3898374|P1|NOT COMPLETED|Overall Study||5
1594289|NCT01032382|3898373|P2|COMPLETED|Overall Study||9
1594290|NCT01032382|3898374|P1|COMPLETED|Overall Study||11
1594291|NCT01032382|3898373|P2|STARTED|Overall Study||14
1594292|NCT01032382|3898374|P1|STARTED|Overall Study||16
1594293|NCT01032291|3898403|P3|NOT COMPLETED|Proof of Concept||3
1594294|NCT01032291|3898404|P2|NOT COMPLETED|Proof of Concept||8
1594295|NCT01032291|3898405|P1|NOT COMPLETED|Proof of Concept||0
1594296|NCT01032291|3898403|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
1594297|NCT01032291|3898404|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
1594298|NCT01032291|3898405|P1|COMPLETED|Proof of Concept||0
1594299|NCT01032291|3898403|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
1594300|NCT01032291|3898404|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
1594301|NCT01032291|3898405|P1|Intent to Treat and Safety Populations|Proof of Concept||0
1594302|NCT01032291|3898403|P3|STARTED|Proof of Concept||21
1594303|NCT01032291|3898404|P2|STARTED|Proof of Concept||22
1594304|NCT01032291|3898405|P1|STARTED|Proof of Concept||0
1594305|NCT01032291|3898403|P3|NOT COMPLETED|Safety Lead-in||0
1594306|NCT01032291|3898404|P2|NOT COMPLETED|Safety Lead-in||0
1594307|NCT01032291|3898405|P1|NOT COMPLETED|Safety Lead-in||2
1594308|NCT01032291|3898403|P3|COMPLETED|Safety Lead-in||0
1594309|NCT01032291|3898404|P2|COMPLETED|Safety Lead-in||0
1594310|NCT01032291|3898405|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
1594311|NCT01032291|3898403|P3|STARTED|Safety Lead-in||0
1594312|NCT01032291|3898404|P2|STARTED|Safety Lead-in||0
1594313|NCT01032291|3898405|P1|STARTED|Safety Lead-in||8
1594314|NCT01032265|3898431|P2|NOT COMPLETED|Overall Study||17
1594315|NCT01032265|3898432|P1|NOT COMPLETED|Overall Study||13
1594316|NCT01032265|3898431|P2|COMPLETED|Overall Study||107
1594317|NCT01032265|3898432|P1|COMPLETED|Overall Study||113
1594318|NCT01032265|3898431|P2|STARTED|Overall Study||124
1594319|NCT01032265|3898432|P1|STARTED|Overall Study||126
1594320|NCT01032239|3898452|P2|NOT COMPLETED|Overall Study||5
1594321|NCT01032239|3898453|P1|NOT COMPLETED|Overall Study||7
1594322|NCT01032239|3898452|P2|COMPLETED|Overall Study||24
1594323|NCT01032239|3898453|P1|COMPLETED|Overall Study||24
1594324|NCT01032239|3898452|P2|Implant|Overall Study||0
1594325|NCT01032239|3898453|P1|Implant|Overall Study|implanted|25
1594326|NCT01032239|3898452|P2|STARTED|Overall Study|randomized to BMT arm|29
1594327|NCT01032239|3898453|P1|STARTED|Overall Study|randomized to ITB arm|31
1594328|NCT01032200|3898483|P2|NOT COMPLETED|Overall Study||7
1594329|NCT01032200|3898484|P1|NOT COMPLETED|Overall Study||4
1594330|NCT01032200|3898483|P2|COMPLETED|Overall Study||21
1594331|NCT01032200|3898484|P1|COMPLETED|Overall Study||22
1594332|NCT01032200|3898483|P2|STARTED|Overall Study||28
1594333|NCT01032200|3898484|P1|STARTED|Overall Study||26
1594334|NCT01032174|3898500|P2|NOT COMPLETED|Overall Study||1
1594335|NCT01032174|3898501|P1|NOT COMPLETED|Overall Study||0
1594336|NCT01032174|3898500|P2|COMPLETED|Overall Study||59
1594337|NCT01032174|3898501|P1|COMPLETED|Overall Study||63
1594338|NCT01032174|3898500|P2|STARTED|Overall Study||60
1594339|NCT01032174|3898501|P1|STARTED|Overall Study||63
1594340|NCT01032135|3898516|P7|NOT COMPLETED|8 Week Randomization||18
1594341|NCT01032135|3898517|P6|NOT COMPLETED|8 Week Randomization||17
1594342|NCT01032135|3898518|P5|NOT COMPLETED|8 Week Randomization||9
1594343|NCT01032135|3898519|P4|NOT COMPLETED|8 Week Randomization||11
1594344|NCT01032135|3898520|P3|NOT COMPLETED|8 Week Randomization||0
1594345|NCT01032135|3898521|P2|NOT COMPLETED|8 Week Randomization||0
1594346|NCT01032135|3898522|P1|NOT COMPLETED|8 Week Randomization||26
1594347|NCT01032135|3898516|P7|COMPLETED|8 Week Randomization||36
1594348|NCT01032135|3898517|P6|COMPLETED|8 Week Randomization||31
1594349|NCT01032135|3898518|P5|COMPLETED|8 Week Randomization||34
1594350|NCT01032135|3898519|P4|COMPLETED|8 Week Randomization||30
1594351|NCT01032135|3898520|P3|COMPLETED|8 Week Randomization||0
1594352|NCT01032135|3898521|P2|COMPLETED|8 Week Randomization||0
1594353|NCT01032135|3898522|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
1594354|NCT01032135|3898516|P7|12 Week Follow up|8 Week Randomization||41
1594355|NCT01032135|3898517|P6|12 Week Follow up|8 Week Randomization||36
1594356|NCT01032135|3898518|P5|12 Week Follow up|8 Week Randomization||38
1594357|NCT01032135|3898519|P4|12 Week Follow up|8 Week Randomization||34
1594358|NCT01032135|3898520|P3|12 Week Follow up|8 Week Randomization||0
1594359|NCT01032135|3898521|P2|12 Week Follow up|8 Week Randomization||0
1594360|NCT01032135|3898522|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
1594361|NCT01032135|3898516|P7|STARTED|8 Week Randomization||54
1594362|NCT01032135|3898517|P6|STARTED|8 Week Randomization||48
1594363|NCT01032135|3898518|P5|STARTED|8 Week Randomization||43
1594364|NCT01032135|3898519|P4|STARTED|8 Week Randomization||41
1594365|NCT01032135|3898520|P3|STARTED|8 Week Randomization||0
1594366|NCT01032135|3898521|P2|STARTED|8 Week Randomization||0
1594367|NCT01032135|3898522|P1|STARTED|8 Week Randomization||227
1594368|NCT01032135|3898516|P7|NOT COMPLETED|2 Week Randomization||0
1594369|NCT01032135|3898517|P6|NOT COMPLETED|2 Week Randomization||0
1594370|NCT01032135|3898518|P5|NOT COMPLETED|2 Week Randomization||0
1594371|NCT01032135|3898519|P4|NOT COMPLETED|2 Week Randomization||0
1594372|NCT01032135|3898520|P3|NOT COMPLETED|2 Week Randomization||0
1594373|NCT01032135|3898521|P2|NOT COMPLETED|2 Week Randomization||0
1594374|NCT01032135|3898522|P1|NOT COMPLETED|2 Week Randomization||0
1594375|NCT01032135|3898516|P7|COMPLETED|2 Week Randomization||0
1594376|NCT01032135|3898517|P6|COMPLETED|2 Week Randomization||0
1594377|NCT01032135|3898518|P5|COMPLETED|2 Week Randomization||0
1594378|NCT01032135|3898519|P4|COMPLETED|2 Week Randomization||0
1594379|NCT01032135|3898520|P3|COMPLETED|2 Week Randomization||96
1594380|NCT01032135|3898521|P2|COMPLETED|2 Week Randomization||93
1594381|NCT01032135|3898522|P1|COMPLETED|2 Week Randomization||311
1594382|NCT01032135|3898516|P7|STARTED|2 Week Randomization||0
1594383|NCT01032135|3898517|P6|STARTED|2 Week Randomization||0
1594384|NCT01032135|3898518|P5|STARTED|2 Week Randomization||0
1594385|NCT01032135|3898519|P4|STARTED|2 Week Randomization||0
1594386|NCT01032135|3898520|P3|STARTED|2 Week Randomization||96
1594387|NCT01032135|3898521|P2|STARTED|2 Week Randomization||93
1594388|NCT01032135|3898522|P1|STARTED|2 Week Randomization||311
1594389|NCT01032070|3898741|P2|NOT COMPLETED|Overall Study||12
1594390|NCT01032070|3898742|P1|NOT COMPLETED|Overall Study||13
1594391|NCT01032070|3898741|P2|COMPLETED|Overall Study||0
1594392|NCT01032070|3898742|P1|COMPLETED|Overall Study||0
1594393|NCT01032070|3898741|P2|STARTED|Overall Study||12
1594394|NCT01032070|3898742|P1|STARTED|Overall Study||13
1594395|NCT01032044|3898771|P2|NOT COMPLETED|Overall Study||20
1594396|NCT01032044|3898772|P1|NOT COMPLETED|Overall Study||25
1594397|NCT01032044|3898771|P2|COMPLETED|Overall Study||62
1594398|NCT01032044|3898772|P1|COMPLETED|Overall Study||57
1594399|NCT01032044|3898771|P2|Procedure|Overall Study||75
1594400|NCT01032044|3898772|P1|Procedure|Overall Study||74
1594401|NCT01032044|3898771|P2|STARTED|Overall Study||82
1594402|NCT01032044|3898772|P1|STARTED|Overall Study||82
1594403|NCT01032018|3898780|P2|NOT COMPLETED|Overall Study||6
1594404|NCT01032018|3898781|P1|NOT COMPLETED|Overall Study||6
1594405|NCT01032018|3898780|P2|COMPLETED|Overall Study||67
1594406|NCT01032018|3898781|P1|COMPLETED|Overall Study||71
1594407|NCT01032018|3898780|P2|STARTED|Overall Study||73
1594408|NCT01032018|3898781|P1|STARTED|Overall Study||77
1594409|NCT01031979|3898791|P2|NOT COMPLETED|Overall Study||4
1594410|NCT01031979|3898792|P1|NOT COMPLETED|Overall Study||5
1594411|NCT01031979|3898791|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
1594412|NCT01031979|3898792|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
1594413|NCT01031979|3898791|P2|Completed Primary Outcome Measure|Overall Study||12
1594414|NCT01031979|3898792|P1|Completed Primary Outcome Measure|Overall Study||12
1594415|NCT01031979|3898791|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
1594416|NCT01031979|3898792|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
1594417|NCT01031953|3898804|P1|NOT COMPLETED|Overall Study||0
1594418|NCT01031953|3898804|P1|COMPLETED|Overall Study||11
1594419|NCT01031953|3898804|P1|STARTED|Overall Study||11
1594420|NCT01031914|3898815|P1|NOT COMPLETED|Overall Study||0
1594421|NCT01031914|3898815|P1|COMPLETED|Overall Study||36
1594422|NCT01031914|3898815|P1|STARTED|Overall Study||36
1594423|NCT01031836|3898825|P6|NOT COMPLETED|Stage II||1
1594424|NCT01031836|3898826|P5|NOT COMPLETED|Stage II||2
1594425|NCT01031836|3898827|P4|NOT COMPLETED|Stage II||3
1594426|NCT01031836|3898828|P3|NOT COMPLETED|Stage II||2
1594427|NCT01031836|3898829|P2|NOT COMPLETED|Stage II||0
1594428|NCT01031836|3898830|P1|NOT COMPLETED|Stage II||2
1594429|NCT01031836|3898825|P6|COMPLETED|Stage II||3
1594430|NCT01031836|3898826|P5|COMPLETED|Stage II||3
1594431|NCT01031836|3898827|P4|COMPLETED|Stage II||1
1594432|NCT01031836|3898828|P3|COMPLETED|Stage II||2
1594433|NCT01031836|3898829|P2|COMPLETED|Stage II||1
1594434|NCT01031836|3898830|P1|COMPLETED|Stage II||1
1594435|NCT01031836|3898825|P6|STARTED|Stage II||4
1594436|NCT01031836|3898826|P5|STARTED|Stage II||5
1594437|NCT01031836|3898827|P4|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
1594438|NCT01031836|3898828|P3|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
1594439|NCT01031836|3898829|P2|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
1594440|NCT01031836|3898830|P1|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
1594441|NCT01031836|3898825|P6|NOT COMPLETED|Stage I||1
1594442|NCT01031836|3898826|P5|NOT COMPLETED|Stage I||0
1594443|NCT01031836|3898827|P4|NOT COMPLETED|Stage I||0
1594444|NCT01031836|3898828|P3|NOT COMPLETED|Stage I||0
1594445|NCT01031836|3898829|P2|NOT COMPLETED|Stage I||2
1594446|NCT01031836|3898830|P1|NOT COMPLETED|Stage I||1
1594447|NCT01031836|3898825|P6|COMPLETED|Stage I||4
1594448|NCT01031836|3898826|P5|COMPLETED|Stage I||5
1594449|NCT01031836|3898827|P4|COMPLETED|Stage I||5
1594450|NCT01031836|3898828|P3|COMPLETED|Stage I||5
1594451|NCT01031836|3898829|P2|COMPLETED|Stage I||3
1594452|NCT01031836|3898830|P1|COMPLETED|Stage I||4
1594453|NCT01031836|3898825|P6|STARTED|Stage I||5
1594454|NCT01031836|3898826|P5|STARTED|Stage I||5
1594455|NCT01031836|3898827|P4|STARTED|Stage I||5
1594456|NCT01031836|3898828|P3|STARTED|Stage I||5
1594457|NCT01031836|3898829|P2|STARTED|Stage I||5
1594458|NCT01031836|3898830|P1|STARTED|Stage I||5
1594459|NCT01031810|3898880|P1|NOT COMPLETED|Overall Study||4
1594460|NCT01031810|3898880|P1|COMPLETED|Overall Study||9
1594461|NCT01031810|3898880|P1|STARTED|Overall Study||13
1594462|NCT01031706|3898891|P2|NOT COMPLETED|Overall Study||1
1594463|NCT01031706|3898892|P1|NOT COMPLETED|Overall Study||2
1594464|NCT01031706|3898891|P2|COMPLETED|Overall Study||8
1594465|NCT01031706|3898892|P1|COMPLETED|Overall Study||12
1594466|NCT01031706|3898891|P2|STARTED|Overall Study||9
1594467|NCT01031706|3898892|P1|STARTED|Overall Study||14
1594468|NCT01031680|3898902|P2|NOT COMPLETED|Overall Study||58
1594469|NCT01031680|3898903|P1|NOT COMPLETED|Overall Study||57
1594470|NCT01031680|3898902|P2|COMPLETED|Overall Study||404
1594471|NCT01031680|3898903|P1|COMPLETED|Overall Study||403
1594472|NCT01031680|3898902|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
1594473|NCT01031680|3898903|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
1594474|NCT01031628|3898923|P4|NOT COMPLETED|Overall Study||0
1594475|NCT01031628|3898924|P3|NOT COMPLETED|Overall Study||3
1594476|NCT01031628|3898925|P2|NOT COMPLETED|Overall Study||1
1594477|NCT01031628|3898926|P1|NOT COMPLETED|Overall Study||0
1594478|NCT01031628|3898923|P4|COMPLETED|Overall Study||0
1594479|NCT01031628|3898924|P3|COMPLETED|Overall Study||0
1594480|NCT01031628|3898925|P2|COMPLETED|Overall Study||0
1594481|NCT01031628|3898926|P1|COMPLETED|Overall Study||0
1594482|NCT01031628|3898923|P4|STARTED|Overall Study||0
1594483|NCT01031628|3898924|P3|STARTED|Overall Study||3
1594484|NCT01031628|3898925|P2|STARTED|Overall Study||1
1594485|NCT01031628|3898926|P1|STARTED|Overall Study||0
1594486|NCT01031550|3898938|P2|NOT COMPLETED|Overall Study||0
1594487|NCT01031550|3898939|P1|NOT COMPLETED|Overall Study||0
1594488|NCT01031550|3898938|P2|COMPLETED|Overall Study||3
1594489|NCT01031550|3898939|P1|COMPLETED|Overall Study||5
1594490|NCT01031550|3898938|P2|STARTED|Overall Study||3
1594491|NCT01031550|3898939|P1|STARTED|Overall Study||5
1594492|NCT01031537|3898951|P1|NOT COMPLETED|Overall Study||32
1594493|NCT01031537|3898951|P1|COMPLETED|Overall Study||34
1594494|NCT01031537|3898951|P1|STARTED|Overall Study||66
1594495|NCT01031498|3898959|P3|NOT COMPLETED|Overall Study||2
1594496|NCT01031498|3898960|P2|NOT COMPLETED|Overall Study||3
1594497|NCT01031498|3898961|P1|NOT COMPLETED|Overall Study||2
1594498|NCT01031498|3898959|P3|COMPLETED|Overall Study||48
1594499|NCT01031498|3898960|P2|COMPLETED|Overall Study||48
1594500|NCT01031498|3898961|P1|COMPLETED|Overall Study||47
1594501|NCT01031498|3898959|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
1594502|NCT01031498|3898960|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
1594503|NCT01031498|3898961|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
1594504|NCT01031446|3898969|P1|NOT COMPLETED|Overall Study||55
1594505|NCT01031446|3898969|P1|COMPLETED|Overall Study||0
1594506|NCT01031446|3898969|P1|STARTED|Overall Study||55
1594507|NCT01031381|3898978|P1|NOT COMPLETED|Overall Study||9
1594508|NCT01031381|3898978|P1|COMPLETED|Overall Study||50
1594509|NCT01031381|3898978|P1|STARTED|Overall Study||59
1594510|NCT01031134|3898985|P2|NOT COMPLETED|Overall Study||10
1594511|NCT01031134|3898986|P1|NOT COMPLETED|Overall Study||11
1594512|NCT01031134|3898985|P2|COMPLETED|Overall Study||78
1594513|NCT01031134|3898986|P1|COMPLETED|Overall Study||103
1594514|NCT01031134|3898985|P2|STARTED|Overall Study||88
1594515|NCT01031134|3898986|P1|STARTED|Overall Study||114
1594516|NCT01031095|3898996|P2|NOT COMPLETED|Overall Study||0
1594517|NCT01031095|3898997|P1|NOT COMPLETED|Overall Study||0
1594518|NCT01031095|3898996|P2|COMPLETED|Overall Study||100
1594519|NCT01031095|3898997|P1|COMPLETED|Overall Study||100
1594520|NCT01031095|3898996|P2|STARTED|Overall Study||100
1594521|NCT01031095|3898997|P1|STARTED|Overall Study||100
1594522|NCT01031043|3899003|P1|NOT COMPLETED|Overall Study||1
1594523|NCT01031043|3899003|P1|COMPLETED|Overall Study||4
1594524|NCT01031043|3899003|P1|STARTED|Overall Study||5
1594525|NCT01031004|3899009|P2|NOT COMPLETED|Overall Study||1
1594526|NCT01031004|3899010|P1|NOT COMPLETED|Overall Study||1
1594527|NCT01031004|3899009|P2|COMPLETED|Overall Study||24
1594528|NCT01031004|3899010|P1|COMPLETED|Overall Study||24
1594529|NCT01031004|3899009|P2|STARTED|Overall Study||25
1594530|NCT01031004|3899010|P1|STARTED|Overall Study||25
1594531|NCT01030965|3899054|P4|NOT COMPLETED|Overall Study||7
1594532|NCT01030965|3899055|P3|NOT COMPLETED|Overall Study||4
1594533|NCT01030965|3899056|P2|NOT COMPLETED|Overall Study||6
1594534|NCT01030965|3899057|P1|NOT COMPLETED|Overall Study||4
1594535|NCT01030965|3899054|P4|COMPLETED|Overall Study||64
1594536|NCT01030965|3899055|P3|COMPLETED|Overall Study||68
1594537|NCT01030965|3899056|P2|COMPLETED|Overall Study||65
1594538|NCT01030965|3899057|P1|COMPLETED|Overall Study||67
1594539|NCT01030965|3899054|P4|STARTED|Overall Study||71
1594540|NCT01030965|3899055|P3|STARTED|Overall Study||72
1594541|NCT01030965|3899056|P2|STARTED|Overall Study||71
1594542|NCT01030965|3899057|P1|STARTED|Overall Study||71
1594543|NCT01030952|3899077|P2|NOT COMPLETED|Overall Study||3
1594544|NCT01030952|3899078|P1|NOT COMPLETED|Overall Study||2
1594545|NCT01030952|3899077|P2|COMPLETED|Overall Study||49
1594546|NCT01030952|3899078|P1|COMPLETED|Overall Study||49
1594547|NCT01030952|3899077|P2|STARTED|Overall Study||52
1594548|NCT01030952|3899078|P1|STARTED|Overall Study||51
1594549|NCT01030822|3899115|P3|NOT COMPLETED|Overall Study||26
1594550|NCT01030822|3899116|P2|NOT COMPLETED|Overall Study||24
1594551|NCT01030822|3899117|P1|NOT COMPLETED|Overall Study||31
1594552|NCT01030822|3899115|P3|COMPLETED|Overall Study||61
1594553|NCT01030822|3899116|P2|COMPLETED|Overall Study||71
1594554|NCT01030822|3899117|P1|COMPLETED|Overall Study||69
1594555|NCT01030822|3899115|P3|STARTED|Overall Study||87
1594556|NCT01030822|3899116|P2|STARTED|Overall Study||95
1594557|NCT01030822|3899117|P1|STARTED|Overall Study||100
1594558|NCT01030757|3899164|P1|NOT COMPLETED|Overall Study||0
1594559|NCT01030757|3899164|P1|COMPLETED|Overall Study||2
1594560|NCT01030757|3899164|P1|STARTED|Overall Study||2
1594561|NCT01030718|3899172|P3|NOT COMPLETED|Study CA180-036 Only||5
1594562|NCT01030718|3899173|P2|NOT COMPLETED|Study CA180-036 Only||7
1594563|NCT01030718|3899174|P1|NOT COMPLETED|Study CA180-036 Only||3
1594564|NCT01030718|3899172|P3|COMPLETED|Study CA180-036 Only||1
1594565|NCT01030718|3899173|P2|COMPLETED|Study CA180-036 Only||2
1594566|NCT01030718|3899174|P1|COMPLETED|Study CA180-036 Only||26
1594567|NCT01030718|3899172|P3|STARTED|Study CA180-036 Only||6
1594568|NCT01030718|3899173|P2|STARTED|Study CA180-036 Only||9
1594569|NCT01030718|3899174|P1|STARTED|Study CA180-036 Only||29
1594570|NCT01030718|3899172|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
1594571|NCT01030718|3899173|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
1594572|NCT01030718|3899174|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
1594573|NCT01030718|3899172|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
1594574|NCT01030718|3899173|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
1594575|NCT01030718|3899174|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
1594576|NCT01030718|3899172|P3|STARTED|Studies CA180-031 and -036 Combined||13
1594577|NCT01030718|3899173|P2|STARTED|Studies CA180-031 and -036 Combined||11
1594578|NCT01030718|3899174|P1|STARTED|Studies CA180-031 and -036 Combined||30
1594579|NCT01030666|3899235|P2|NOT COMPLETED|Overall Study||2
1594580|NCT01030666|3899236|P1|NOT COMPLETED|Overall Study||3
1594581|NCT01030666|3899235|P2|COMPLETED|Overall Study||31
1594582|NCT01030666|3899236|P1|COMPLETED|Overall Study||25
1594583|NCT01030666|3899235|P2|STARTED|Overall Study||33
1594584|NCT01030666|3899236|P1|STARTED|Overall Study||28
1594585|NCT01030653|3899246|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
1594586|NCT01030653|3899247|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
1594587|NCT01030653|3899246|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
1594588|NCT01030653|3899247|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
1594589|NCT01030653|3899246|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
1594590|NCT01030653|3899247|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
1594591|NCT01030653|3899246|P2|NOT COMPLETED|7-Day Washout Period||0
1594592|NCT01030653|3899247|P1|NOT COMPLETED|7-Day Washout Period||0
1594593|NCT01030653|3899246|P2|COMPLETED|7-Day Washout Period||4
1594594|NCT01030653|3899247|P1|COMPLETED|7-Day Washout Period||4
1594595|NCT01030653|3899246|P2|STARTED|7-Day Washout Period||4
1594596|NCT01030653|3899247|P1|STARTED|7-Day Washout Period||4
1594597|NCT01030653|3899246|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
1594598|NCT01030653|3899247|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
1594599|NCT01030653|3899246|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
1594600|NCT01030653|3899247|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
1594601|NCT01030653|3899246|P2|STARTED|Loading Dose & First Maintenance Regimen||4
1594602|NCT01030653|3899247|P1|STARTED|Loading Dose & First Maintenance Regimen||4
1594603|NCT01030536|3899261|P5|NOT COMPLETED|Overall Study||1
1594604|NCT01030536|3899262|P4|NOT COMPLETED|Overall Study||3
1594605|NCT01030536|3899263|P3|NOT COMPLETED|Overall Study||6
1594606|NCT01030536|3899264|P2|NOT COMPLETED|Overall Study||6
1594607|NCT01030536|3899265|P1|NOT COMPLETED|Overall Study||7
1594608|NCT01030536|3899261|P5|COMPLETED|Overall Study||0
1594609|NCT01030536|3899262|P4|COMPLETED|Overall Study||0
1594610|NCT01030536|3899263|P3|COMPLETED|Overall Study||0
1594611|NCT01030536|3899264|P2|COMPLETED|Overall Study||0
1594612|NCT01030536|3899265|P1|COMPLETED|Overall Study||0
1594613|NCT01030536|3899261|P5|STARTED|Overall Study||1
1594614|NCT01030536|3899262|P4|STARTED|Overall Study||3
1594615|NCT01030536|3899263|P3|STARTED|Overall Study||6
1594616|NCT01030536|3899264|P2|STARTED|Overall Study||6
1594617|NCT01030536|3899265|P1|STARTED|Overall Study||7
1594618|NCT01030458|3899370|P2|NOT COMPLETED|Overall Study||32
1594619|NCT01030458|3899371|P1|NOT COMPLETED|Overall Study||27
1594620|NCT01030458|3899370|P2|COMPLETED|Overall Study||57
1594621|NCT01030458|3899371|P1|COMPLETED|Overall Study||67
1594622|NCT01030458|3899370|P2|STARTED|Overall Study||89
1594623|NCT01030458|3899371|P1|STARTED|Overall Study||94
1594624|NCT01030406|3899388|P5|NOT COMPLETED|Overall Study||0
1594625|NCT01030406|3899389|P4|NOT COMPLETED|Overall Study||1
1594626|NCT01030406|3899390|P3|NOT COMPLETED|Overall Study||1
1594627|NCT01030406|3899391|P2|NOT COMPLETED|Overall Study||0
1594628|NCT01030406|3899392|P1|NOT COMPLETED|Overall Study||0
1594629|NCT01030406|3899388|P5|COMPLETED|Overall Study||9
1594630|NCT01030406|3899389|P4|COMPLETED|Overall Study||9
1594631|NCT01030406|3899390|P3|COMPLETED|Overall Study||9
1594632|NCT01030406|3899391|P2|COMPLETED|Overall Study||10
1594633|NCT01030406|3899392|P1|COMPLETED|Overall Study||10
1594634|NCT01030406|3899388|P5|STARTED|Overall Study||9
1594635|NCT01030406|3899389|P4|STARTED|Overall Study||10
1594636|NCT01030406|3899390|P3|STARTED|Overall Study||10
1594637|NCT01030406|3899391|P2|STARTED|Overall Study||10
1594638|NCT01030406|3899392|P1|STARTED|Overall Study||10
1594639|NCT01030341|3899404|P1|NOT COMPLETED|Overall Study||3
1594640|NCT01030341|3899404|P1|COMPLETED|Overall Study|42 participants completed the study|42
1594641|NCT01030341|3899404|P1|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
1594642|NCT01030289|3899409|P2|NOT COMPLETED|Overall Study||0
1594643|NCT01030289|3899410|P1|NOT COMPLETED|Overall Study||0
1594644|NCT01030289|3899409|P2|COMPLETED|Overall Study||10
1594645|NCT01030289|3899410|P1|COMPLETED|Overall Study||9
1594646|NCT01030289|3899409|P2|STARTED|Overall Study||10
1594647|NCT01030289|3899410|P1|STARTED|Overall Study||9
1594648|NCT01030133|3899427|P2|NOT COMPLETED|Overall Study||2
1594649|NCT01030133|3899428|P1|NOT COMPLETED|Overall Study||2
1594650|NCT01030133|3899427|P2|COMPLETED|Overall Study||12
1594651|NCT01030133|3899428|P1|COMPLETED|Overall Study||12
1594652|NCT01030133|3899427|P2|STARTED|Overall Study||14
1594653|NCT01030133|3899428|P1|STARTED|Overall Study||14
1594654|NCT01029925|3899440|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
1594655|NCT01029925|3899440|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
1594656|NCT01029925|3899440|P1|STARTED|Completion of Cycle 2 (56 Days)||3
1594657|NCT01029925|3899440|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
1594658|NCT01029925|3899440|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
1594659|NCT01029925|3899440|P1|STARTED|Completion of Cycle 1 (28 Days)||7
1594660|NCT01029912|3899446|P2|NOT COMPLETED|Overall Study||0
1594661|NCT01029912|3899447|P1|NOT COMPLETED|Overall Study||2
1594662|NCT01029912|3899446|P2|COMPLETED|Overall Study||12
1594663|NCT01029912|3899447|P1|COMPLETED|Overall Study||12
1594664|NCT01029912|3899446|P2|STARTED|Overall Study||12
1594665|NCT01029912|3899447|P1|STARTED|Overall Study||14
1594666|NCT01029886|3899459|P2|NOT COMPLETED|Overall Study||60
1594667|NCT01029886|3899460|P1|NOT COMPLETED|Overall Study||61
1594668|NCT01029886|3899459|P2|COMPLETED|Overall Study||391
1594669|NCT01029886|3899460|P1|COMPLETED|Overall Study||400
1594670|NCT01029886|3899459|P2|Intent to Treat (ITT)|Overall Study||450
1594671|NCT01029886|3899460|P1|Intent to Treat (ITT)|Overall Study||461
1594672|NCT01029886|3899459|P2|STARTED|Overall Study||451
1594673|NCT01029886|3899460|P1|STARTED|Overall Study||461
1594674|NCT01029795|3899488|P2|NOT COMPLETED|Overall Study||22
1594675|NCT01029795|3899489|P1|NOT COMPLETED|Overall Study||16
1594676|NCT01029795|3899488|P2|COMPLETED|Overall Study||0
1594677|NCT01029795|3899489|P1|COMPLETED|Overall Study||0
1594678|NCT01029795|3899488|P2|STARTED|Overall Study||22
1594679|NCT01029795|3899489|P1|STARTED|Overall Study||16
1594680|NCT01029782|3899543|P2|NOT COMPLETED|Overall Study||8
1594681|NCT01029782|3899544|P1|NOT COMPLETED|Overall Study||3
1594682|NCT01029782|3899543|P2|COMPLETED|Overall Study||96
1594683|NCT01029782|3899544|P1|COMPLETED|Overall Study||99
1594684|NCT01029782|3899543|P2|STARTED|Overall Study||104
1594685|NCT01029782|3899544|P1|STARTED|Overall Study||102
1594686|NCT01029730|3899550|P1|NOT COMPLETED|Maintenance Therapy||23
1594687|NCT01029730|3899550|P1|COMPLETED|Maintenance Therapy||14
1594688|NCT01029730|3899550|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
1594689|NCT01029730|3899550|P1|NOT COMPLETED|Combination Therapy||16
1594690|NCT01029730|3899550|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
1594691|NCT01029730|3899550|P1|STARTED|Combination Therapy||55
1594692|NCT01029704|3899562|P5|NOT COMPLETED|Overall Study||0
1594693|NCT01029704|3899563|P4|NOT COMPLETED|Overall Study||0
1594694|NCT01029704|3899564|P3|NOT COMPLETED|Overall Study||0
1594695|NCT01029704|3899565|P2|NOT COMPLETED|Overall Study||0
1594696|NCT01029704|3899566|P1|NOT COMPLETED|Overall Study||0
1594697|NCT01029704|3899562|P5|COMPLETED|Overall Study||26
1594698|NCT01029704|3899563|P4|COMPLETED|Overall Study||28
1594699|NCT01029704|3899564|P3|COMPLETED|Overall Study||23
1594700|NCT01029704|3899565|P2|COMPLETED|Overall Study||24
1594701|NCT01029704|3899566|P1|COMPLETED|Overall Study||28
1594702|NCT01029704|3899562|P5|STARTED|Overall Study||26
1594703|NCT01029704|3899563|P4|STARTED|Overall Study||28
1594704|NCT01029704|3899564|P3|STARTED|Overall Study||23
1594705|NCT01029704|3899565|P2|STARTED|Overall Study||24
1594706|NCT01029704|3899566|P1|STARTED|Overall Study||28
1594707|NCT01029691|3899596|P3|NOT COMPLETED|Continued APAP to Delivery||1
1594708|NCT01029691|3899597|P2|NOT COMPLETED|Continued APAP to Delivery||0
1594709|NCT01029691|3899598|P1|NOT COMPLETED|Continued APAP to Delivery||0
1594710|NCT01029691|3899596|P3|COMPLETED|Continued APAP to Delivery||76
1594711|NCT01029691|3899597|P2|COMPLETED|Continued APAP to Delivery||16
1594712|NCT01029691|3899598|P1|COMPLETED|Continued APAP to Delivery||20
1594713|NCT01029691|3899596|P3|STARTED|Continued APAP to Delivery||77
1594714|NCT01029691|3899597|P2|STARTED|Continued APAP to Delivery||16
1594715|NCT01029691|3899598|P1|STARTED|Continued APAP to Delivery||20
1594716|NCT01029691|3899596|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
1594717|NCT01029691|3899597|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
1594718|NCT01029691|3899598|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
1594719|NCT01029691|3899596|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
1594720|NCT01029691|3899597|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
1594721|NCT01029691|3899598|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
1594722|NCT01029691|3899596|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
1594723|NCT01029691|3899597|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
1594724|NCT01029691|3899598|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
1594725|NCT01029691|3899596|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
1594726|NCT01029691|3899597|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
1594727|NCT01029691|3899598|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
1594728|NCT01029691|3899596|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
1594729|NCT01029691|3899597|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
1594730|NCT01029691|3899598|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
1594731|NCT01029652|3899623|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
1594732|NCT01029652|3899624|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
1594733|NCT01029652|3899623|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
1594734|NCT01029652|3899624|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
1594735|NCT01029652|3899623|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
1594736|NCT01029652|3899624|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
1594737|NCT01029652|3899623|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
1594738|NCT01029652|3899624|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
1594739|NCT01029652|3899623|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
1594740|NCT01029652|3899624|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
1594741|NCT01029652|3899623|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
1594742|NCT01029652|3899624|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
1594743|NCT01029652|3899623|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
1594744|NCT01029652|3899624|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
1594745|NCT01029652|3899623|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
1594746|NCT01029652|3899624|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
1594747|NCT01029652|3899623|P2|COMPLETED|Core Study (0-12 Weeks)||105
1594748|NCT01029652|3899624|P1|COMPLETED|Core Study (0-12 Weeks)||109
1594749|NCT01029652|3899623|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
1594750|NCT01029652|3899624|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
1594751|NCT01029652|3899623|P2|STARTED|Core Study (0-12 Weeks)||115
1594752|NCT01029652|3899624|P1|STARTED|Core Study (0-12 Weeks)||115
1594753|NCT01029535|3899702|P1|NOT COMPLETED|Overall Study||31
1594754|NCT01029535|3899702|P1|COMPLETED|Overall Study||72
1594755|NCT01029535|3899702|P1|STARTED|Overall Study||103
1594756|NCT01029405|3899731|P4|NOT COMPLETED|Overall Study||5
1594757|NCT01029405|3899732|P3|NOT COMPLETED|Overall Study||4
1594758|NCT01029405|3899733|P2|NOT COMPLETED|Overall Study||3
1594759|NCT01029405|3899734|P1|NOT COMPLETED|Overall Study||2
1594760|NCT01029405|3899731|P4|COMPLETED|Overall Study||32
1594761|NCT01029405|3899732|P3|COMPLETED|Overall Study||31
1594762|NCT01029405|3899733|P2|COMPLETED|Overall Study||34
1594763|NCT01029405|3899734|P1|COMPLETED|Overall Study||34
1594764|NCT01029405|3899731|P4|STARTED|Overall Study||37
1594765|NCT01029405|3899732|P3|STARTED|Overall Study||35
1594766|NCT01029405|3899733|P2|STARTED|Overall Study||37
1594767|NCT01029405|3899734|P1|STARTED|Overall Study||36
1594768|NCT01029392|3899746|P2|NOT COMPLETED|Overall Study||11
1594769|NCT01029392|3899747|P1|NOT COMPLETED|Overall Study||20
1594770|NCT01029392|3899746|P2|COMPLETED|Overall Study||27
1594771|NCT01029392|3899747|P1|COMPLETED|Overall Study||17
1594772|NCT01029392|3899746|P2|STARTED|Overall Study||38
1594773|NCT01029392|3899747|P1|STARTED|Overall Study||37
1594774|NCT01029366|3899757|P2|NOT COMPLETED|Overall Study||2
1594775|NCT01029366|3899758|P1|NOT COMPLETED|Overall Study||4
1594776|NCT01029366|3899757|P2|COMPLETED|Overall Study||6
1594777|NCT01029366|3899758|P1|COMPLETED|Overall Study||14
1594778|NCT01029366|3899757|P2|STARTED|Overall Study||8
1594779|NCT01029366|3899758|P1|STARTED|Overall Study||18
1594780|NCT01029340|3899770|P6|NOT COMPLETED|Part C Follow up Period||0
1594781|NCT01029340|3899771|P5|NOT COMPLETED|Part C Follow up Period||0
1594782|NCT01029340|3899772|P4|NOT COMPLETED|Part C Follow up Period||0
1594783|NCT01029340|3899773|P3|NOT COMPLETED|Part C Follow up Period||0
1594784|NCT01029340|3899774|P2|NOT COMPLETED|Part C Follow up Period||0
1594785|NCT01029340|3899775|P1|NOT COMPLETED|Part C Follow up Period||0
1594786|NCT01029340|3899770|P6|COMPLETED|Part C Follow up Period||0
1594787|NCT01029340|3899771|P5|COMPLETED|Part C Follow up Period||5
1594788|NCT01029340|3899772|P4|COMPLETED|Part C Follow up Period||0
1594789|NCT01029340|3899773|P3|COMPLETED|Part C Follow up Period||0
1594790|NCT01029340|3899774|P2|COMPLETED|Part C Follow up Period||0
1594791|NCT01029340|3899775|P1|COMPLETED|Part C Follow up Period||0
1594792|NCT01029340|3899770|P6|STARTED|Part C Follow up Period||0
1594793|NCT01029340|3899771|P5|STARTED|Part C Follow up Period||5
1594794|NCT01029340|3899772|P4|STARTED|Part C Follow up Period||0
1594795|NCT01029340|3899773|P3|STARTED|Part C Follow up Period||0
1594796|NCT01029340|3899774|P2|STARTED|Part C Follow up Period||0
1594797|NCT01029340|3899775|P1|STARTED|Part C Follow up Period||0
1594798|NCT01029340|3899770|P6|NOT COMPLETED|Part C Treatment Period||0
1594799|NCT01029340|3899771|P5|NOT COMPLETED|Part C Treatment Period||0
1594800|NCT01029340|3899772|P4|NOT COMPLETED|Part C Treatment Period||0
1594801|NCT01029340|3899773|P3|NOT COMPLETED|Part C Treatment Period||0
1594802|NCT01029340|3899774|P2|NOT COMPLETED|Part C Treatment Period||0
1594803|NCT01029340|3899775|P1|NOT COMPLETED|Part C Treatment Period||0
1594804|NCT01029340|3899770|P6|COMPLETED|Part C Treatment Period||0
1594805|NCT01029340|3899771|P5|COMPLETED|Part C Treatment Period||5
1594806|NCT01029340|3899772|P4|COMPLETED|Part C Treatment Period||0
1594807|NCT01029340|3899773|P3|COMPLETED|Part C Treatment Period||0
1594808|NCT01029340|3899774|P2|COMPLETED|Part C Treatment Period||0
1594809|NCT01029340|3899775|P1|COMPLETED|Part C Treatment Period||0
1594810|NCT01029340|3899770|P6|Participants Received Treatment|Part C Treatment Period||0
1594811|NCT01029340|3899771|P5|Participants Received Treatment|Part C Treatment Period||5
1594812|NCT01029340|3899772|P4|Participants Received Treatment|Part C Treatment Period||0
1594813|NCT01029340|3899773|P3|Participants Received Treatment|Part C Treatment Period||0
1594814|NCT01029340|3899774|P2|Participants Received Treatment|Part C Treatment Period||0
1594815|NCT01029340|3899775|P1|Participants Received Treatment|Part C Treatment Period||0
1594816|NCT01029340|3899770|P6|STARTED|Part C Treatment Period||0
1594817|NCT01029340|3899771|P5|STARTED|Part C Treatment Period||5
1594818|NCT01029340|3899772|P4|STARTED|Part C Treatment Period||0
1594819|NCT01029340|3899773|P3|STARTED|Part C Treatment Period||0
1594820|NCT01029340|3899774|P2|STARTED|Part C Treatment Period||0
1594821|NCT01029340|3899775|P1|STARTED|Part C Treatment Period||0
1594822|NCT01029340|3899770|P6|NOT COMPLETED|Extension Period||12
1594823|NCT01029340|3899771|P5|NOT COMPLETED|Extension Period||0
1594824|NCT01029340|3899772|P4|NOT COMPLETED|Extension Period||0
1594825|NCT01029340|3899773|P3|NOT COMPLETED|Extension Period||0
1594826|NCT01029340|3899774|P2|NOT COMPLETED|Extension Period||0
1594827|NCT01029340|3899775|P1|NOT COMPLETED|Extension Period||0
1594828|NCT01029340|3899770|P6|COMPLETED|Extension Period||43
1594829|NCT01029340|3899771|P5|COMPLETED|Extension Period||0
1594830|NCT01029340|3899772|P4|COMPLETED|Extension Period||0
1594831|NCT01029340|3899773|P3|COMPLETED|Extension Period||0
1594832|NCT01029340|3899774|P2|COMPLETED|Extension Period||0
1594833|NCT01029340|3899775|P1|COMPLETED|Extension Period||0
1594834|NCT01029340|3899770|P6|STARTED|Extension Period||55
1594835|NCT01029340|3899771|P5|STARTED|Extension Period||0
1594836|NCT01029340|3899772|P4|STARTED|Extension Period||0
1594837|NCT01029340|3899773|P3|STARTED|Extension Period||0
1594838|NCT01029340|3899774|P2|STARTED|Extension Period||0
1594839|NCT01029340|3899775|P1|STARTED|Extension Period||0
1594840|NCT01029340|3899770|P6|NOT COMPLETED|Part B Follow up Period||0
1594841|NCT01029340|3899771|P5|NOT COMPLETED|Part B Follow up Period||0
1594842|NCT01029340|3899772|P4|NOT COMPLETED|Part B Follow up Period||0
1594843|NCT01029340|3899773|P3|NOT COMPLETED|Part B Follow up Period||0
1594844|NCT01029340|3899774|P2|NOT COMPLETED|Part B Follow up Period||0
1594845|NCT01029340|3899775|P1|NOT COMPLETED|Part B Follow up Period||0
1594846|NCT01029340|3899770|P6|COMPLETED|Part B Follow up Period||0
1594847|NCT01029340|3899771|P5|COMPLETED|Part B Follow up Period||0
1594848|NCT01029340|3899772|P4|COMPLETED|Part B Follow up Period||32
1594849|NCT01029340|3899773|P3|COMPLETED|Part B Follow up Period||29
1594850|NCT01029340|3899774|P2|COMPLETED|Part B Follow up Period||0
1594851|NCT01029340|3899775|P1|COMPLETED|Part B Follow up Period||0
1594852|NCT01029340|3899770|P6|STARTED|Part B Follow up Period||0
1594853|NCT01029340|3899771|P5|STARTED|Part B Follow up Period||0
1594854|NCT01029340|3899772|P4|STARTED|Part B Follow up Period||32
1594855|NCT01029340|3899773|P3|STARTED|Part B Follow up Period||29
1594856|NCT01029340|3899774|P2|STARTED|Part B Follow up Period||0
1594857|NCT01029340|3899775|P1|STARTED|Part B Follow up Period||0
1594858|NCT01029340|3899770|P6|NOT COMPLETED|Part B Treatment Period||0
1594859|NCT01029340|3899771|P5|NOT COMPLETED|Part B Treatment Period||0
1594860|NCT01029340|3899772|P4|NOT COMPLETED|Part B Treatment Period||0
1594861|NCT01029340|3899773|P3|NOT COMPLETED|Part B Treatment Period||2
1594862|NCT01029340|3899774|P2|NOT COMPLETED|Part B Treatment Period||0
1594863|NCT01029340|3899775|P1|NOT COMPLETED|Part B Treatment Period||0
1594864|NCT01029340|3899770|P6|COMPLETED|Part B Treatment Period||0
1594865|NCT01029340|3899771|P5|COMPLETED|Part B Treatment Period||0
1594866|NCT01029340|3899772|P4|COMPLETED|Part B Treatment Period||32
1594867|NCT01029340|3899773|P3|COMPLETED|Part B Treatment Period||29
1594868|NCT01029340|3899774|P2|COMPLETED|Part B Treatment Period||0
1594869|NCT01029340|3899775|P1|COMPLETED|Part B Treatment Period||0
1594870|NCT01029340|3899770|P6|Participants Received Treatment|Part B Treatment Period||0
1594871|NCT01029340|3899771|P5|Participants Received Treatment|Part B Treatment Period||0
1594872|NCT01029340|3899772|P4|Participants Received Treatment|Part B Treatment Period||32
1594873|NCT01029340|3899773|P3|Participants Received Treatment|Part B Treatment Period||30
1594874|NCT01029340|3899774|P2|Participants Received Treatment|Part B Treatment Period||0
1594875|NCT01029340|3899775|P1|Participants Received Treatment|Part B Treatment Period||0
1594876|NCT01029340|3899770|P6|STARTED|Part B Treatment Period||0
1594877|NCT01029340|3899771|P5|STARTED|Part B Treatment Period||0
1594878|NCT01029340|3899772|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
1594879|NCT01029340|3899773|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
1594880|NCT01029340|3899774|P2|STARTED|Part B Treatment Period||0
1594881|NCT01029340|3899775|P1|STARTED|Part B Treatment Period||0
1594882|NCT01029340|3899770|P6|NOT COMPLETED|Part A Follow up Period||0
1594883|NCT01029340|3899771|P5|NOT COMPLETED|Part A Follow up Period||0
1594884|NCT01029340|3899772|P4|NOT COMPLETED|Part A Follow up Period||0
1594885|NCT01029340|3899773|P3|NOT COMPLETED|Part A Follow up Period||0
1594886|NCT01029340|3899774|P2|NOT COMPLETED|Part A Follow up Period||0
1594887|NCT01029340|3899775|P1|NOT COMPLETED|Part A Follow up Period||0
1594888|NCT01029340|3899770|P6|COMPLETED|Part A Follow up Period||0
1594889|NCT01029340|3899771|P5|COMPLETED|Part A Follow up Period||0
1594890|NCT01029340|3899772|P4|COMPLETED|Part A Follow up Period||0
1594891|NCT01029340|3899773|P3|COMPLETED|Part A Follow up Period||0
1594892|NCT01029340|3899774|P2|COMPLETED|Part A Follow up Period||14
1594893|NCT01029340|3899775|P1|COMPLETED|Part A Follow up Period||14
1594894|NCT01029340|3899770|P6|STARTED|Part A Follow up Period||0
1594895|NCT01029340|3899771|P5|STARTED|Part A Follow up Period||0
1594896|NCT01029340|3899772|P4|STARTED|Part A Follow up Period||0
1594897|NCT01029340|3899773|P3|STARTED|Part A Follow up Period||0
1594898|NCT01029340|3899774|P2|STARTED|Part A Follow up Period||14
1594899|NCT01029340|3899775|P1|STARTED|Part A Follow up Period||14
1594900|NCT01029340|3899770|P6|NOT COMPLETED|Part A Treatment Period||0
1594901|NCT01029340|3899771|P5|NOT COMPLETED|Part A Treatment Period||0
1594902|NCT01029340|3899772|P4|NOT COMPLETED|Part A Treatment Period||0
1594903|NCT01029340|3899773|P3|NOT COMPLETED|Part A Treatment Period||0
1594904|NCT01029340|3899774|P2|NOT COMPLETED|Part A Treatment Period||0
1594905|NCT01029340|3899775|P1|NOT COMPLETED|Part A Treatment Period||0
1594906|NCT01029340|3899770|P6|COMPLETED|Part A Treatment Period||0
1594907|NCT01029340|3899771|P5|COMPLETED|Part A Treatment Period||0
1594908|NCT01029340|3899772|P4|COMPLETED|Part A Treatment Period||0
1594909|NCT01029340|3899773|P3|COMPLETED|Part A Treatment Period||0
1594910|NCT01029340|3899774|P2|COMPLETED|Part A Treatment Period||14
1594911|NCT01029340|3899775|P1|COMPLETED|Part A Treatment Period||14
1594912|NCT01029340|3899770|P6|Safety Population|Part A Treatment Period||0
1594913|NCT01029340|3899771|P5|Safety Population|Part A Treatment Period||0
1594914|NCT01029340|3899772|P4|Safety Population|Part A Treatment Period||0
1594915|NCT01029340|3899773|P3|Safety Population|Part A Treatment Period||0
1594916|NCT01029340|3899774|P2|Safety Population|Part A Treatment Period||14
1594917|NCT01029340|3899775|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
1594918|NCT01029340|3899770|P6|Participants Received Treatment|Part A Treatment Period||0
1594919|NCT01029340|3899771|P5|Participants Received Treatment|Part A Treatment Period||0
1594920|NCT01029340|3899772|P4|Participants Received Treatment|Part A Treatment Period||0
1594921|NCT01029340|3899773|P3|Participants Received Treatment|Part A Treatment Period||0
1594922|NCT01029340|3899774|P2|Participants Received Treatment|Part A Treatment Period||14
1594923|NCT01029340|3899775|P1|Participants Received Treatment|Part A Treatment Period||14
1594924|NCT01029340|3899770|P6|STARTED|Part A Treatment Period||0
1594925|NCT01029340|3899771|P5|STARTED|Part A Treatment Period||0
1594926|NCT01029340|3899772|P4|STARTED|Part A Treatment Period||0
1594927|NCT01029340|3899773|P3|STARTED|Part A Treatment Period||0
1594928|NCT01029340|3899774|P2|STARTED|Part A Treatment Period||14
1594929|NCT01029340|3899775|P1|STARTED|Part A Treatment Period||14
1594930|NCT01029262|3899806|P2|NOT COMPLETED|Overall Study||145
1594931|NCT01029262|3899807|P1|NOT COMPLETED|Overall Study||78
1594932|NCT01029262|3899806|P2|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|15
1594933|NCT01029262|3899807|P1|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|1
1594934|NCT01029262|3899806|P2|STARTED|Overall Study||160
1594935|NCT01029262|3899807|P1|STARTED|Overall Study||79
1594936|NCT01029054|3899863|P3|NOT COMPLETED|Phase II||0
1594937|NCT01029054|3899864|P2|NOT COMPLETED|Phase II||0
1594938|NCT01029054|3899865|P1|NOT COMPLETED|Phase II||0
1594939|NCT01029054|3899863|P3|COMPLETED|Phase II||18
1594940|NCT01029054|3899864|P2|COMPLETED|Phase II||0
1594941|NCT01029054|3899865|P1|COMPLETED|Phase II||0
1594942|NCT01029054|3899863|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
1594943|NCT01029054|3899864|P2|STARTED|Phase II||0
1594944|NCT01029054|3899865|P1|STARTED|Phase II||0
1594945|NCT01029054|3899863|P3|NOT COMPLETED|Phase I||0
1594946|NCT01029054|3899864|P2|NOT COMPLETED|Phase I||0
1594947|NCT01029054|3899865|P1|NOT COMPLETED|Phase I||0
1594948|NCT01029054|3899863|P3|COMPLETED|Phase I||18
1594949|NCT01029054|3899864|P2|COMPLETED|Phase I||13
1594950|NCT01029054|3899865|P1|COMPLETED|Phase I||4
1594951|NCT01029054|3899863|P3|STARTED|Phase I||18
1594952|NCT01029054|3899864|P2|STARTED|Phase I||13
1594953|NCT01029054|3899865|P1|STARTED|Phase I||4
1594954|NCT01028911|3899873|P2|NOT COMPLETED|Overall Study||0
1594955|NCT01028911|3899874|P1|NOT COMPLETED|Overall Study||0
1594956|NCT01028911|3899873|P2|COMPLETED|Overall Study||2
1594957|NCT01028911|3899874|P1|COMPLETED|Overall Study||7
1594958|NCT01028911|3899873|P2|STARTED|Overall Study||2
1594959|NCT01028911|3899874|P1|STARTED|Overall Study||7
1594960|NCT01028820|3899939|P1|NOT COMPLETED|Overall Study||1
1594961|NCT01028820|3899939|P1|COMPLETED|Overall Study||12
1594962|NCT01028820|3899939|P1|STARTED|Overall Study||13
1594963|NCT01028677|3899948|P2|NOT COMPLETED|Overall Study||1
1594964|NCT01028677|3899949|P1|NOT COMPLETED|Overall Study||2
1594965|NCT01028677|3899948|P2|COMPLETED|Overall Study||6
1594966|NCT01028677|3899949|P1|COMPLETED|Overall Study||8
1594967|NCT01028677|3899948|P2|STARTED|Overall Study||7
1594968|NCT01028677|3899949|P1|STARTED|Overall Study||10
1594969|NCT01028651|3899965|P1|NOT COMPLETED|Overall Study||3
1594970|NCT01028651|3899965|P1|COMPLETED|Overall Study||10
1594971|NCT01028651|3899965|P1|STARTED|Overall Study||13
1594972|NCT01028391|3899988|P2|NOT COMPLETED|Overall Study||11
1594973|NCT01028391|3899989|P1|NOT COMPLETED|Overall Study||14
1594974|NCT01028391|3899988|P2|COMPLETED|Overall Study||142
1594975|NCT01028391|3899989|P1|COMPLETED|Overall Study||150
1594976|NCT01028391|3899988|P2|STARTED|Overall Study||153
1594977|NCT01028391|3899989|P1|STARTED|Overall Study||164
1594978|NCT01028378|3899997|P1|NOT COMPLETED|Overall Study||17
1594979|NCT01028378|3899997|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
1594980|NCT01028378|3899997|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
1594981|NCT01028352|3900009|P1|NOT COMPLETED|Overall Study||6
1594982|NCT01028352|3900009|P1|COMPLETED|Overall Study||29
1594983|NCT01028352|3900009|P1|STARTED|Overall Study||35
1594984|NCT01028300|3900014|P1|NOT COMPLETED|Overall Study||4
1594985|NCT01028300|3900014|P1|COMPLETED|Overall Study||0
1594986|NCT01028300|3900014|P1|STARTED|Overall Study||4
1594987|NCT01028222|3900023|P2|NOT COMPLETED|Overall Study||13
1594988|NCT01028222|3900024|P1|NOT COMPLETED|Overall Study||38
1594989|NCT01028222|3900023|P2|COMPLETED|Overall Study||0
1594990|NCT01028222|3900024|P1|COMPLETED|Overall Study||4
1594991|NCT01028222|3900023|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
1594992|NCT01028222|3900024|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
1594993|NCT01028222|3900023|P2|STARTED|Overall Study||13
1594994|NCT01028222|3900024|P1|STARTED|Overall Study||42
1594995|NCT01028131|3900049|P4|NOT COMPLETED|Overall Study||4
1594996|NCT01028131|3900050|P3|NOT COMPLETED|Overall Study||6
1594997|NCT01028131|3900051|P2|NOT COMPLETED|Overall Study||3
1594998|NCT01028131|3900052|P1|NOT COMPLETED|Overall Study||3
1594999|NCT01028131|3900049|P4|COMPLETED|Overall Study||26
1595000|NCT01028131|3900050|P3|COMPLETED|Overall Study||22
1595001|NCT01028131|3900051|P2|COMPLETED|Overall Study||23
1595002|NCT01028131|3900052|P1|COMPLETED|Overall Study||23
1595003|NCT01028131|3900049|P4|Completed Intervention/Control Session|Overall Study||30
1595004|NCT01028131|3900050|P3|Completed Intervention/Control Session|Overall Study||28
1595005|NCT01028131|3900051|P2|Completed Intervention/Control Session|Overall Study||26
1595006|NCT01028131|3900052|P1|Completed Intervention/Control Session|Overall Study||26
1595007|NCT01028131|3900049|P4|STARTED|Overall Study||30
1595008|NCT01028131|3900050|P3|STARTED|Overall Study||28
1595009|NCT01028131|3900051|P2|STARTED|Overall Study||26
1595010|NCT01028131|3900052|P1|STARTED|Overall Study||26
1595011|NCT01028053|3900066|P1|NOT COMPLETED|Overall Study||133
1595012|NCT01028053|3900066|P1|COMPLETED|Overall Study||232
1595013|NCT01028053|3900066|P1|STARTED|Overall Study||365
1595014|NCT01028027|3900074|P2|NOT COMPLETED|Overall Study||13
1595015|NCT01028027|3900075|P1|NOT COMPLETED|Overall Study||16
1595016|NCT01028027|3900074|P2|COMPLETED|Overall Study||164
1595017|NCT01028027|3900075|P1|COMPLETED|Overall Study||164
1595018|NCT01028027|3900074|P2|STARTED|Overall Study||177
1595019|NCT01028027|3900075|P1|STARTED|Overall Study||180
1595020|NCT01028014|3900097|P6|NOT COMPLETED|Overall Study||2
1595021|NCT01028014|3900098|P5|NOT COMPLETED|Overall Study||1
1595022|NCT01028014|3900099|P4|NOT COMPLETED|Overall Study||1
1595023|NCT01028014|3900100|P3|NOT COMPLETED|Overall Study||0
1595024|NCT01028014|3900101|P2|NOT COMPLETED|Overall Study||2
1595025|NCT01028014|3900102|P1|NOT COMPLETED|Overall Study||1
1595026|NCT01028014|3900097|P6|COMPLETED|Overall Study||4
1595027|NCT01028014|3900098|P5|COMPLETED|Overall Study||9
1595028|NCT01028014|3900099|P4|COMPLETED|Overall Study||9
1595029|NCT01028014|3900100|P3|COMPLETED|Overall Study||10
1595030|NCT01028014|3900101|P2|COMPLETED|Overall Study||8
1595031|NCT01028014|3900102|P1|COMPLETED|Overall Study||9
1595032|NCT01028014|3900097|P6|STARTED|Overall Study||6
1595033|NCT01028014|3900098|P5|STARTED|Overall Study||10
1595034|NCT01028014|3900099|P4|STARTED|Overall Study||10
1595035|NCT01028014|3900100|P3|STARTED|Overall Study||10
1595036|NCT01028014|3900101|P2|STARTED|Overall Study||10
1595037|NCT01028014|3900102|P1|STARTED|Overall Study||10
1595038|NCT01027910|3900130|P2|NOT COMPLETED|Overall Study||0
1595039|NCT01027910|3900131|P1|NOT COMPLETED|Overall Study||0
1595040|NCT01027910|3900130|P2|COMPLETED|Overall Study||14
1595041|NCT01027910|3900131|P1|COMPLETED|Overall Study||6
1595042|NCT01027910|3900130|P2|STARTED|Overall Study||14
1595043|NCT01027910|3900131|P1|STARTED|Overall Study||6
1595044|NCT01027897|3900143|P1|NOT COMPLETED|Overall Study||2
1595045|NCT01027897|3900143|P1|COMPLETED|Overall Study||28
1595046|NCT01027897|3900143|P1|STARTED|Overall Study||30
1595047|NCT01027884|3900151|P2|NOT COMPLETED|Overall Study||7
1595048|NCT01027884|3900152|P1|NOT COMPLETED|Overall Study||4
1595049|NCT01027884|3900151|P2|COMPLETED|Overall Study||25
1595050|NCT01027884|3900152|P1|COMPLETED|Overall Study||30
1595051|NCT01027884|3900151|P2|STARTED|Overall Study||32
1595052|NCT01027884|3900152|P1|STARTED|Overall Study||34
1595053|NCT01027871|3900169|P3|NOT COMPLETED|Overall Study||7
1595054|NCT01027871|3900170|P2|NOT COMPLETED|Overall Study||13
1595055|NCT01027871|3900171|P1|NOT COMPLETED|Overall Study||2
1595056|NCT01027871|3900169|P3|COMPLETED|Overall Study||91
1595057|NCT01027871|3900170|P2|COMPLETED|Overall Study||85
1595058|NCT01027871|3900171|P1|COMPLETED|Overall Study||91
1595059|NCT01027871|3900169|P3|Received at Least One Dose of Study Drug|Overall Study||97
1595060|NCT01027871|3900170|P2|Received at Least One Dose of Study Drug|Overall Study||98
1595061|NCT01027871|3900171|P1|Received at Least One Dose of Study Drug|Overall Study||93
1595062|NCT01027871|3900169|P3|STARTED|Overall Study||98
1595063|NCT01027871|3900170|P2|STARTED|Overall Study||98
1595064|NCT01027871|3900171|P1|STARTED|Overall Study||93
1595065|NCT01027819|3900230|P2|NOT COMPLETED|Overall Study||0
1595066|NCT01027819|3900231|P1|NOT COMPLETED|Overall Study||0
1595067|NCT01027819|3900230|P2|COMPLETED|Overall Study||40
1595068|NCT01027819|3900231|P1|COMPLETED|Overall Study||40
1595069|NCT01027819|3900230|P2|STARTED|Overall Study||40
1595070|NCT01027819|3900231|P1|STARTED|Overall Study||40
1595071|NCT01027780|3900239|P2|NOT COMPLETED|Overall Study||1
1595072|NCT01027780|3900240|P1|NOT COMPLETED|Overall Study||0
1595073|NCT01027780|3900239|P2|COMPLETED|Overall Study||102
1595074|NCT01027780|3900240|P1|COMPLETED|Overall Study||105
1595075|NCT01027780|3900239|P2|STARTED|Overall Study||103
1595076|NCT01027780|3900240|P1|STARTED|Overall Study||105
1595077|NCT01027702|3900250|P7|NOT COMPLETED|Overall Study||1
1595078|NCT01027702|3900251|P6|NOT COMPLETED|Overall Study||0
1595079|NCT01027702|3900252|P5|NOT COMPLETED|Overall Study||1
1595080|NCT01027702|3900253|P4|NOT COMPLETED|Overall Study||4
1595081|NCT01027702|3900254|P3|NOT COMPLETED|Overall Study||1
1595082|NCT01027702|3900255|P2|NOT COMPLETED|Overall Study||2
1595083|NCT01027702|3900256|P1|NOT COMPLETED|Overall Study||1
1595084|NCT01027702|3900250|P7|COMPLETED|Overall Study||1
1595085|NCT01027702|3900251|P6|COMPLETED|Overall Study||1
1595086|NCT01027702|3900252|P5|COMPLETED|Overall Study||9
1595087|NCT01027702|3900253|P4|COMPLETED|Overall Study||10
1595088|NCT01027702|3900254|P3|COMPLETED|Overall Study||2
1595089|NCT01027702|3900255|P2|COMPLETED|Overall Study||2
1595090|NCT01027702|3900256|P1|COMPLETED|Overall Study||3
1595091|NCT01027702|3900250|P7|STARTED|Overall Study||2
1595092|NCT01027702|3900251|P6|STARTED|Overall Study||1
1595093|NCT01027702|3900252|P5|STARTED|Overall Study||10
1595094|NCT01027702|3900253|P4|STARTED|Overall Study||14
1595095|NCT01027702|3900254|P3|STARTED|Overall Study||3
1595096|NCT01027702|3900255|P2|STARTED|Overall Study||4
1595097|NCT01027702|3900256|P1|STARTED|Overall Study||4
1595098|NCT01027650|3900282|P8|NOT COMPLETED|Overall Study||0
1595099|NCT01027650|3900283|P7|NOT COMPLETED|Overall Study||1
1595100|NCT01027650|3900284|P6|NOT COMPLETED|Overall Study||2
1595101|NCT01027650|3900285|P5|NOT COMPLETED|Overall Study||2
1595102|NCT01027650|3900286|P4|NOT COMPLETED|Overall Study||0
1595103|NCT01027650|3900287|P3|NOT COMPLETED|Overall Study||0
1595104|NCT01027650|3900288|P2|NOT COMPLETED|Overall Study||0
1595105|NCT01027650|3900289|P1|NOT COMPLETED|Overall Study||0
1595106|NCT01027650|3900282|P8|COMPLETED|Overall Study||24
1595107|NCT01027650|3900283|P7|COMPLETED|Overall Study||24
1595108|NCT01027650|3900284|P6|COMPLETED|Overall Study||24
1595109|NCT01027650|3900285|P5|COMPLETED|Overall Study||23
1595110|NCT01027650|3900286|P4|COMPLETED|Overall Study||3
1595111|NCT01027650|3900287|P3|COMPLETED|Overall Study||6
1595112|NCT01027650|3900288|P2|COMPLETED|Overall Study||6
1595113|NCT01027650|3900289|P1|COMPLETED|Overall Study||6
1595114|NCT01027650|3900282|P8|STARTED|Overall Study||24
1595115|NCT01027650|3900283|P7|STARTED|Overall Study||25
1595116|NCT01027650|3900284|P6|STARTED|Overall Study||26
1595117|NCT01027650|3900285|P5|STARTED|Overall Study||25
1595118|NCT01027650|3900286|P4|STARTED|Overall Study||3
1595119|NCT01027650|3900287|P3|STARTED|Overall Study||6
1595120|NCT01027650|3900288|P2|STARTED|Overall Study||6
1595121|NCT01027650|3900289|P1|STARTED|Overall Study||6
1595122|NCT01027598|3900333|P2|NOT COMPLETED|Overall Study||67
1595123|NCT01027598|3900334|P1|NOT COMPLETED|Overall Study||134
1595124|NCT01027598|3900333|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
1595125|NCT01027598|3900334|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
1595126|NCT01027598|3900333|P2|STARTED|Overall Study||67
1595127|NCT01027598|3900334|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
1595128|NCT01027559|3900347|P3|NOT COMPLETED|Overall Study||9
1595129|NCT01027559|3900348|P2|NOT COMPLETED|Overall Study||8
1595130|NCT01027559|3900349|P1|NOT COMPLETED|Overall Study||6
1595131|NCT01027559|3900347|P3|COMPLETED|Overall Study||22
1595132|NCT01027559|3900348|P2|COMPLETED|Overall Study||26
1595133|NCT01027559|3900349|P1|COMPLETED|Overall Study||20
1595134|NCT01027559|3900347|P3|STARTED|Overall Study||31
1595135|NCT01027559|3900348|P2|STARTED|Overall Study||34
1595136|NCT01027559|3900349|P1|STARTED|Overall Study||26
1595137|NCT01027468|3900359|P1|NOT COMPLETED|Overall Study||0
1595138|NCT01027468|3900359|P1|COMPLETED|Overall Study||160
1595139|NCT01027468|3900359|P1|STARTED|Overall Study||160
1595140|NCT01027416|3900365|P2|NOT COMPLETED|Overall Study||5
1595141|NCT01027416|3900366|P1|NOT COMPLETED|Overall Study||1
1595142|NCT01027416|3900365|P2|COMPLETED|Overall Study||23
1595143|NCT01027416|3900366|P1|COMPLETED|Overall Study||30
1595144|NCT01027416|3900365|P2|STARTED|Overall Study||28
1595145|NCT01027416|3900366|P1|STARTED|Overall Study||31
1595146|NCT01027364|3900378|P4|NOT COMPLETED|Overall Study||1
1595147|NCT01027364|3900379|P3|NOT COMPLETED|Overall Study||1
1595148|NCT01027364|3900380|P2|NOT COMPLETED|Overall Study||2
1595149|NCT01027364|3900381|P1|NOT COMPLETED|Overall Study||4
1595150|NCT01027364|3900378|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
1595151|NCT01027364|3900379|P3|COMPLETED|Overall Study||26
1595152|NCT01027364|3900380|P2|COMPLETED|Overall Study||27
1595153|NCT01027364|3900381|P1|COMPLETED|Overall Study||59
1595154|NCT01027364|3900378|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
1595155|NCT01027364|3900379|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
1595156|NCT01027364|3900380|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
1595157|NCT01027364|3900381|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
1595158|NCT01027364|3900378|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
1595159|NCT01027364|3900379|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
1595160|NCT01027364|3900380|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
1595161|NCT01027364|3900381|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
1595162|NCT01027364|3900378|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
1595163|NCT01027364|3900379|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
1595164|NCT01027364|3900380|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
1595165|NCT01027364|3900381|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
1595166|NCT01027364|3900378|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
1595167|NCT01027364|3900379|P3|STARTED|Overall Study||27
1595168|NCT01027364|3900380|P2|STARTED|Overall Study||29
1595169|NCT01027364|3900381|P1|STARTED|Overall Study||63
1595170|NCT01027351|3900476|P6|NOT COMPLETED|Overall Study||5
1595171|NCT01027351|3900477|P5|NOT COMPLETED|Overall Study||11
1595172|NCT01027351|3900478|P4|NOT COMPLETED|Overall Study||2
1595173|NCT01027351|3900479|P3|NOT COMPLETED|Overall Study||1
1595174|NCT01027351|3900480|P2|NOT COMPLETED|Overall Study||1
1595175|NCT01027351|3900481|P1|NOT COMPLETED|Overall Study||3
1595176|NCT01027351|3900476|P6|COMPLETED|Overall Study||45
1595177|NCT01027351|3900477|P5|COMPLETED|Overall Study||32
1595178|NCT01027351|3900478|P4|COMPLETED|Overall Study||6
1595179|NCT01027351|3900479|P3|COMPLETED|Overall Study||13
1595180|NCT01027351|3900480|P2|COMPLETED|Overall Study||18
1595181|NCT01027351|3900481|P1|COMPLETED|Overall Study||26
1595182|NCT01027351|3900476|P6|STARTED|Overall Study||50
1595183|NCT01027351|3900477|P5|STARTED|Overall Study||43
1595184|NCT01027351|3900478|P4|STARTED|Overall Study||8
1595185|NCT01027351|3900479|P3|STARTED|Overall Study||14
1595186|NCT01027351|3900480|P2|STARTED|Overall Study||19
1595187|NCT01027351|3900481|P1|STARTED|Overall Study||29
1595188|NCT01027286|3900565|P2|NOT COMPLETED|Overall Study||1
1595189|NCT01027286|3900566|P1|NOT COMPLETED|Overall Study||1
1595190|NCT01027286|3900565|P2|COMPLETED|Overall Study||49
1595191|NCT01027286|3900566|P1|COMPLETED|Overall Study||49
1595192|NCT01027286|3900565|P2|12 Week Postoperative|Overall Study||49
1595193|NCT01027286|3900566|P1|12 Week Postoperative|Overall Study||49
1595194|NCT01027286|3900565|P2|4 Week Postoperative|Overall Study||50
1595195|NCT01027286|3900566|P1|4 Week Postoperative|Overall Study||49
1595196|NCT01027286|3900565|P2|Day of Surgery|Overall Study||50
1595197|NCT01027286|3900566|P1|Day of Surgery|Overall Study||50
1595198|NCT01027286|3900565|P2|Preoperative|Overall Study||50
1595199|NCT01027286|3900566|P1|Preoperative|Overall Study||50
1595200|NCT01027286|3900565|P2|STARTED|Overall Study||50
1595201|NCT01027286|3900566|P1|STARTED|Overall Study||50
1595202|NCT01027273|3900586|P2|NOT COMPLETED|Overall Study||33
1595203|NCT01027273|3900587|P1|NOT COMPLETED|Overall Study||59
1595204|NCT01027273|3900586|P2|COMPLETED|Overall Study||266
1595205|NCT01027273|3900587|P1|COMPLETED|Overall Study||242
1595206|NCT01027273|3900586|P2|STARTED|Overall Study||299
1595207|NCT01027273|3900587|P1|STARTED|Overall Study||301
1595208|NCT01027195|3900605|P2|NOT COMPLETED|Overall Study||0
1595209|NCT01027195|3900606|P1|NOT COMPLETED|Overall Study||0
1595210|NCT01027195|3900605|P2|COMPLETED|Overall Study||69
1595211|NCT01027195|3900606|P1|COMPLETED|Overall Study||71
1595212|NCT01027195|3900605|P2|STARTED|Overall Study||69
1595213|NCT01027195|3900606|P1|STARTED|Overall Study||71
1595214|NCT01027000|3900626|P1|NOT COMPLETED|Overall Study||0
1595215|NCT01027000|3900626|P1|COMPLETED|Overall Study||68
1595216|NCT01027000|3900626|P1|STARTED|Overall Study||68
1595217|NCT01026974|3900634|P4|NOT COMPLETED|Overall Study||3
1595218|NCT01026974|3900635|P3|NOT COMPLETED|Overall Study||12
1595219|NCT01026974|3900636|P2|NOT COMPLETED|Overall Study||2
1595220|NCT01026974|3900637|P1|NOT COMPLETED|Overall Study||1
1595221|NCT01026974|3900634|P4|COMPLETED|Overall Study||46
1595222|NCT01026974|3900635|P3|COMPLETED|Overall Study||29
1595223|NCT01026974|3900636|P2|COMPLETED|Overall Study||12
1595224|NCT01026974|3900637|P1|COMPLETED|Overall Study||15
1595225|NCT01026974|3900634|P4|STARTED|Overall Study||49
1595226|NCT01026974|3900635|P3|STARTED|Overall Study||41
1595227|NCT01026974|3900636|P2|STARTED|Overall Study||14
1595228|NCT01026974|3900637|P1|STARTED|Overall Study||16
1595229|NCT01026948|3900694|P1|NOT COMPLETED|Overall Study||8
1595230|NCT01026948|3900694|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
1595231|NCT01026948|3900694|P1|STARTED|Overall Study||70
1595232|NCT01026909|3900701|P2|NOT COMPLETED|Overall Study||0
1595233|NCT01026909|3900702|P1|NOT COMPLETED|Overall Study||0
1595234|NCT01026909|3900701|P2|COMPLETED|Overall Study||2
1595235|NCT01026909|3900702|P1|COMPLETED|Overall Study||1
1595236|NCT01026909|3900701|P2|STARTED|Overall Study||2
1595237|NCT01026909|3900702|P1|STARTED|Overall Study||1
1595238|NCT01026844|3900712|P2|NOT COMPLETED|Overall Study||0
1595239|NCT01026844|3900713|P1|NOT COMPLETED|Overall Study||0
1595240|NCT01026844|3900712|P2|COMPLETED|Overall Study||8
1595241|NCT01026844|3900713|P1|COMPLETED|Overall Study||19
1595242|NCT01026844|3900712|P2|STARTED|Overall Study||8
1595243|NCT01026844|3900713|P1|STARTED|Overall Study||19
1595244|NCT01026831|3900727|P2|NOT COMPLETED|Overall Study||11
1595245|NCT01026831|3900728|P1|NOT COMPLETED|Overall Study||14
1595246|NCT01026831|3900727|P2|COMPLETED|Overall Study||312
1595247|NCT01026831|3900728|P1|COMPLETED|Overall Study||306
1595248|NCT01026831|3900727|P2|STARTED|Overall Study|randomized|323
1595249|NCT01026831|3900728|P1|STARTED|Overall Study|randomized|320
1595250|NCT01026818|3900739|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
1595251|NCT01026818|3900740|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
1595252|NCT01026818|3900741|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
1595253|NCT01026818|3900742|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
1595254|NCT01026818|3900739|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
1595255|NCT01026818|3900740|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
1595256|NCT01026818|3900741|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
1595257|NCT01026818|3900742|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
1595258|NCT01026818|3900739|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
1595259|NCT01026818|3900740|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
1595260|NCT01026818|3900741|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
1595261|NCT01026818|3900742|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
1595262|NCT01026818|3900739|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
1595263|NCT01026818|3900740|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
1595264|NCT01026818|3900741|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
1595265|NCT01026818|3900742|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
1595266|NCT01026818|3900739|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
1595267|NCT01026818|3900740|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
1595268|NCT01026818|3900741|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
1595269|NCT01026818|3900742|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
1595270|NCT01026818|3900739|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
1595271|NCT01026818|3900740|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
1595272|NCT01026818|3900741|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
1595273|NCT01026818|3900742|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
1595274|NCT01026818|3900739|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
1595275|NCT01026818|3900740|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
1595276|NCT01026818|3900741|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
1595277|NCT01026818|3900742|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
1595278|NCT01026818|3900739|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
1595279|NCT01026818|3900740|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
1595280|NCT01026818|3900741|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
1595281|NCT01026818|3900742|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
1595282|NCT01026818|3900739|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
1595283|NCT01026818|3900740|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
1595284|NCT01026818|3900741|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
1595285|NCT01026818|3900742|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
1595286|NCT01026818|3900739|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
1595287|NCT01026818|3900740|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
1595288|NCT01026818|3900741|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
1595289|NCT01026818|3900742|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
1595290|NCT01026818|3900739|P4|NOT COMPLETED|Screening Period||0
1595291|NCT01026818|3900740|P3|NOT COMPLETED|Screening Period||0
1595292|NCT01026818|3900741|P2|NOT COMPLETED|Screening Period||0
1595293|NCT01026818|3900742|P1|NOT COMPLETED|Screening Period||160
1595294|NCT01026818|3900739|P4|COMPLETED|Screening Period||0
1595295|NCT01026818|3900740|P3|COMPLETED|Screening Period||0
1595296|NCT01026818|3900741|P2|COMPLETED|Screening Period||0
1595297|NCT01026818|3900742|P1|COMPLETED|Screening Period||423
1595298|NCT01026818|3900739|P4|STARTED|Screening Period||0
1595299|NCT01026818|3900740|P3|STARTED|Screening Period||0
1595300|NCT01026818|3900741|P2|STARTED|Screening Period||0
1595301|NCT01026818|3900742|P1|STARTED|Screening Period||583
1595302|NCT01026805|3900820|P1|NOT COMPLETED|Overall Study||0
1595303|NCT01026805|3900820|P1|COMPLETED|Overall Study||11
1595304|NCT01026805|3900820|P1|STARTED|Overall Study||11
1595305|NCT01026792|3900830|P1|NOT COMPLETED|Overall Study||1
1595306|NCT01026792|3900830|P1|COMPLETED|Overall Study||37
1595307|NCT01026792|3900830|P1|STARTED|Overall Study||38
1595308|NCT01026493|3900842|P8|NOT COMPLETED|Overall Study||1
1595309|NCT01026493|3900843|P7|NOT COMPLETED|Overall Study||4
1595310|NCT01026493|3900844|P6|NOT COMPLETED|Overall Study||3
1595311|NCT01026493|3900845|P5|NOT COMPLETED|Overall Study||2
1595312|NCT01026493|3900846|P4|NOT COMPLETED|Overall Study||0
1595313|NCT01026493|3900847|P3|NOT COMPLETED|Overall Study||0
1595314|NCT01026493|3900848|P2|NOT COMPLETED|Overall Study||1
1595315|NCT01026493|3900849|P1|NOT COMPLETED|Overall Study||0
1595316|NCT01026493|3900842|P8|COMPLETED|Overall Study||37
1595317|NCT01026493|3900843|P7|COMPLETED|Overall Study||32
1595318|NCT01026493|3900844|P6|COMPLETED|Overall Study||73
1595319|NCT01026493|3900845|P5|COMPLETED|Overall Study||73
1595320|NCT01026493|3900846|P4|COMPLETED|Overall Study||8
1595321|NCT01026493|3900847|P3|COMPLETED|Overall Study||9
1595322|NCT01026493|3900848|P2|COMPLETED|Overall Study||6
1595323|NCT01026493|3900849|P1|COMPLETED|Overall Study||8
1595324|NCT01026493|3900842|P8|STARTED|Overall Study||38
1595325|NCT01026493|3900843|P7|STARTED|Overall Study||36
1595326|NCT01026493|3900844|P6|STARTED|Overall Study||76
1595327|NCT01026493|3900845|P5|STARTED|Overall Study||75
1595328|NCT01026493|3900846|P4|STARTED|Overall Study||8
1595329|NCT01026493|3900847|P3|STARTED|Overall Study||9
1595330|NCT01026493|3900848|P2|STARTED|Overall Study||7
1595331|NCT01026493|3900849|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
1595332|NCT01026454|3900877|P2|NOT COMPLETED|Second Intervention||1
1595333|NCT01026454|3900878|P1|NOT COMPLETED|Second Intervention||1
1595334|NCT01026454|3900877|P2|COMPLETED|Second Intervention||13
1595335|NCT01026454|3900878|P1|COMPLETED|Second Intervention||16
1595336|NCT01026454|3900877|P2|STARTED|Second Intervention||14
1595337|NCT01026454|3900878|P1|STARTED|Second Intervention||17
1595338|NCT01026454|3900877|P2|NOT COMPLETED|Washout||0
1595339|NCT01026454|3900878|P1|NOT COMPLETED|Washout||0
1595340|NCT01026454|3900877|P2|COMPLETED|Washout||14
1595341|NCT01026454|3900878|P1|COMPLETED|Washout||18
1595342|NCT01026454|3900877|P2|STARTED|Washout||14
1595343|NCT01026454|3900878|P1|STARTED|Washout||18
1595344|NCT01026454|3900877|P2|NOT COMPLETED|First Intervention||0
1595345|NCT01026454|3900878|P1|NOT COMPLETED|First Intervention||0
1595346|NCT01026454|3900877|P2|COMPLETED|First Intervention||14
1595347|NCT01026454|3900878|P1|COMPLETED|First Intervention||18
1595348|NCT01026454|3900877|P2|STARTED|First Intervention||14
1595349|NCT01026454|3900878|P1|STARTED|First Intervention||18
1595350|NCT01026402|3900901|P17|NOT COMPLETED|Overall Study||0
1595351|NCT01026402|3900902|P16|NOT COMPLETED|Overall Study||0
1595352|NCT01026402|3900903|P15|NOT COMPLETED|Overall Study||0
1595353|NCT01026402|3900904|P14|NOT COMPLETED|Overall Study||0
1595354|NCT01026402|3900905|P13|NOT COMPLETED|Overall Study||0
1595355|NCT01026402|3900906|P12|NOT COMPLETED|Overall Study||0
1595356|NCT01026402|3900907|P11|NOT COMPLETED|Overall Study||0
1595357|NCT01026402|3900908|P10|NOT COMPLETED|Overall Study||0
1595358|NCT01026402|3900909|P9|NOT COMPLETED|Overall Study||0
1595359|NCT01026402|3900910|P8|NOT COMPLETED|Overall Study||0
1595360|NCT01026402|3900911|P7|NOT COMPLETED|Overall Study||0
1595361|NCT01026402|3900912|P6|NOT COMPLETED|Overall Study||0
1595362|NCT01026402|3900913|P5|NOT COMPLETED|Overall Study||0
1595363|NCT01026402|3900914|P4|NOT COMPLETED|Overall Study||0
1595364|NCT01026402|3900915|P3|NOT COMPLETED|Overall Study||0
1595365|NCT01026402|3900916|P2|NOT COMPLETED|Overall Study||0
1595366|NCT01026402|3900917|P1|NOT COMPLETED|Overall Study||0
1595367|NCT01026402|3900901|P17|COMPLETED|Overall Study||4
1595368|NCT01026402|3900902|P16|COMPLETED|Overall Study||5
1595369|NCT01026402|3900903|P15|COMPLETED|Overall Study||3
1595370|NCT01026402|3900904|P14|COMPLETED|Overall Study||6
1595371|NCT01026402|3900905|P13|COMPLETED|Overall Study||8
1595372|NCT01026402|3900906|P12|COMPLETED|Overall Study||8
1595373|NCT01026402|3900907|P11|COMPLETED|Overall Study||7
1595374|NCT01026402|3900908|P10|COMPLETED|Overall Study||3
1595375|NCT01026402|3900909|P9|COMPLETED|Overall Study||7
1595376|NCT01026402|3900910|P8|COMPLETED|Overall Study||3
1595377|NCT01026402|3900911|P7|COMPLETED|Overall Study||8
1595378|NCT01026402|3900912|P6|COMPLETED|Overall Study||5
1595379|NCT01026402|3900913|P5|COMPLETED|Overall Study||3
1595380|NCT01026402|3900914|P4|COMPLETED|Overall Study||18
1595381|NCT01026402|3900915|P3|COMPLETED|Overall Study||33
1595382|NCT01026402|3900916|P2|COMPLETED|Overall Study||8
1595383|NCT01026402|3900917|P1|COMPLETED|Overall Study||6
1595384|NCT01026402|3900901|P17|STARTED|Overall Study||4
1595385|NCT01026402|3900902|P16|STARTED|Overall Study||5
1595386|NCT01026402|3900903|P15|STARTED|Overall Study||3
1595387|NCT01026402|3900904|P14|STARTED|Overall Study||6
1595388|NCT01026402|3900905|P13|STARTED|Overall Study||8
1595389|NCT01026402|3900906|P12|STARTED|Overall Study||8
1595390|NCT01026402|3900907|P11|STARTED|Overall Study||7
1595391|NCT01026402|3900908|P10|STARTED|Overall Study||3
1595392|NCT01026402|3900909|P9|STARTED|Overall Study||7
1595393|NCT01026402|3900910|P8|STARTED|Overall Study||3
1595394|NCT01026402|3900911|P7|STARTED|Overall Study||8
1595395|NCT01026402|3900912|P6|STARTED|Overall Study||5
1595396|NCT01026402|3900913|P5|STARTED|Overall Study||3
1595397|NCT01026402|3900914|P4|STARTED|Overall Study||18
1595398|NCT01026402|3900915|P3|STARTED|Overall Study||33
1595399|NCT01026402|3900916|P2|STARTED|Overall Study||8
1595400|NCT01026402|3900917|P1|STARTED|Overall Study||6
1595401|NCT01026389|3901227|P2|NOT COMPLETED|Overall Study||5
1595402|NCT01026389|3901228|P1|NOT COMPLETED|Overall Study||5
1595403|NCT01026389|3901227|P2|COMPLETED|Overall Study||88
1595404|NCT01026389|3901228|P1|COMPLETED|Overall Study||88
1595405|NCT01026389|3901227|P2|STARTED|Overall Study||93
1595406|NCT01026389|3901228|P1|STARTED|Overall Study||93
1595407|NCT01026324|3901243|P3|NOT COMPLETED|Follow up/Survival||0
1595408|NCT01026324|3901244|P2|NOT COMPLETED|Follow up/Survival||0
1595409|NCT01026324|3901245|P1|NOT COMPLETED|Follow up/Survival||1
1595410|NCT01026324|3901243|P3|COMPLETED|Follow up/Survival||4
1595411|NCT01026324|3901244|P2|COMPLETED|Follow up/Survival||3
1595412|NCT01026324|3901245|P1|COMPLETED|Follow up/Survival||4
1595413|NCT01026324|3901243|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
1595414|NCT01026324|3901244|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
1595415|NCT01026324|3901245|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
1595416|NCT01026324|3901243|P3|STARTED|Follow up/Survival||4
1595417|NCT01026324|3901244|P2|STARTED|Follow up/Survival||3
1595418|NCT01026324|3901245|P1|STARTED|Follow up/Survival||5
1595419|NCT01026324|3901243|P3|NOT COMPLETED|Treatment Allocation||0
1595420|NCT01026324|3901244|P2|NOT COMPLETED|Treatment Allocation||0
1595421|NCT01026324|3901245|P1|NOT COMPLETED|Treatment Allocation||0
1595422|NCT01026324|3901243|P3|COMPLETED|Treatment Allocation||4
1595423|NCT01026324|3901244|P2|COMPLETED|Treatment Allocation||3
1595424|NCT01026324|3901245|P1|COMPLETED|Treatment Allocation||5
1595425|NCT01026324|3901243|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
1595426|NCT01026324|3901244|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
1595427|NCT01026324|3901245|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
1595428|NCT01026324|3901243|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
1595429|NCT01026324|3901244|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
1595430|NCT01026324|3901245|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
1595431|NCT01026324|3901243|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
1595432|NCT01026324|3901244|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
1595433|NCT01026324|3901245|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
1595434|NCT01026324|3901243|P3|STARTED|Treatment Allocation||4
1595435|NCT01026324|3901244|P2|STARTED|Treatment Allocation||3
1595436|NCT01026324|3901245|P1|STARTED|Treatment Allocation||5
1595437|NCT01026220|3901255|P3|NOT COMPLETED|Consolidation Maintenance||14
1595438|NCT01026220|3901256|P2|NOT COMPLETED|Consolidation Maintenance||6
1595439|NCT01026220|3901257|P1|NOT COMPLETED|Consolidation Maintenance||0
1595440|NCT01026220|3901255|P3|COMPLETED|Consolidation Maintenance||66
1595441|NCT01026220|3901256|P2|COMPLETED|Consolidation Maintenance||75
1595442|NCT01026220|3901257|P1|COMPLETED|Consolidation Maintenance||0
1595443|NCT01026220|3901255|P3|STARTED|Consolidation Maintenance||80
1595444|NCT01026220|3901256|P2|STARTED|Consolidation Maintenance||81
1595445|NCT01026220|3901257|P1|STARTED|Consolidation Maintenance||0
1595446|NCT01026220|3901255|P3|NOT COMPLETED|Induction||0
1595447|NCT01026220|3901256|P2|NOT COMPLETED|Induction||0
1595448|NCT01026220|3901257|P1|NOT COMPLETED|Induction||25
1595449|NCT01026220|3901255|P3|COMPLETED|Induction||0
1595450|NCT01026220|3901256|P2|COMPLETED|Induction||0
1595451|NCT01026220|3901257|P1|COMPLETED|Induction||141
1595452|NCT01026220|3901255|P3|STARTED|Induction||0
1595453|NCT01026220|3901256|P2|STARTED|Induction||0
1595454|NCT01026220|3901257|P1|STARTED|Induction||166
1595455|NCT01026194|3901281|P2|NOT COMPLETED|Period 2：Open-label Period||10
1595456|NCT01026194|3901282|P1|NOT COMPLETED|Period 2：Open-label Period||7
1595457|NCT01026194|3901281|P2|COMPLETED|Period 2：Open-label Period||88
1595458|NCT01026194|3901282|P1|COMPLETED|Period 2：Open-label Period||91
1595459|NCT01026194|3901281|P2|STARTED|Period 2：Open-label Period||98
1595460|NCT01026194|3901282|P1|STARTED|Period 2：Open-label Period||98
1595461|NCT01026194|3901281|P2|NOT COMPLETED|Period 1：Double Blind Period||5
1595462|NCT01026194|3901282|P1|NOT COMPLETED|Period 1：Double Blind Period||3
1595463|NCT01026194|3901281|P2|COMPLETED|Period 1：Double Blind Period||98
1595464|NCT01026194|3901282|P1|COMPLETED|Period 1：Double Blind Period||98
1595465|NCT01026194|3901281|P2|STARTED|Period 1：Double Blind Period||103
1595466|NCT01026194|3901282|P1|STARTED|Period 1：Double Blind Period||101
1595467|NCT01026181|3901299|P3|NOT COMPLETED|Overall Study||0
1595468|NCT01026181|3901300|P2|NOT COMPLETED|Overall Study||0
1595469|NCT01026181|3901301|P1|NOT COMPLETED|Overall Study||0
1595470|NCT01026181|3901299|P3|COMPLETED|Overall Study||48
1595471|NCT01026181|3901300|P2|COMPLETED|Overall Study||51
1595472|NCT01026181|3901301|P1|COMPLETED|Overall Study||51
1595473|NCT01026181|3901299|P3|STARTED|Overall Study||48
1595474|NCT01026181|3901300|P2|STARTED|Overall Study||51
1595475|NCT01026181|3901301|P1|STARTED|Overall Study||51
1595476|NCT01026142|3901314|P2|NOT COMPLETED|Overall Study||163
1595477|NCT01026142|3901315|P1|NOT COMPLETED|Overall Study||172
1595478|NCT01026142|3901314|P2|COMPLETED|Overall Study||65
1595479|NCT01026142|3901315|P1|COMPLETED|Overall Study||52
1595480|NCT01026142|3901314|P2|STARTED|Overall Study||228
1595481|NCT01026142|3901315|P1|STARTED|Overall Study||224
1595482|NCT01026103|3901337|P1|NOT COMPLETED|Overall Study||2
1595483|NCT01026103|3901337|P1|COMPLETED|Overall Study||28
1595484|NCT01026103|3901337|P1|Consented|Overall Study||30
1595485|NCT01026103|3901337|P1|STARTED|Overall Study||30
1595486|NCT01026038|3901347|P3|NOT COMPLETED|Overall Study||0
1595487|NCT01026038|3901348|P2|NOT COMPLETED|Overall Study||1
1595488|NCT01026038|3901349|P1|NOT COMPLETED|Overall Study||1
1595489|NCT01026038|3901347|P3|COMPLETED|Overall Study||67
1595490|NCT01026038|3901348|P2|COMPLETED|Overall Study||64
1595491|NCT01026038|3901349|P1|COMPLETED|Overall Study||129
1595492|NCT01026038|3901347|P3|STARTED|Overall Study||67
1595493|NCT01026038|3901348|P2|STARTED|Overall Study||65
1595494|NCT01026038|3901349|P1|STARTED|Overall Study||130
1595495|NCT01026012|3901384|P1|NOT COMPLETED|Overall Study||0
1595496|NCT01026012|3901384|P1|COMPLETED|Overall Study||40
1595497|NCT01026012|3901384|P1|STARTED|Overall Study||40
1595498|NCT01025843|3901398|P10|NOT COMPLETED|Period 5||0
1595499|NCT01025843|3901399|P9|NOT COMPLETED|Period 5||0
1595500|NCT01025843|3901400|P8|NOT COMPLETED|Period 5||0
1595501|NCT01025843|3901401|P7|NOT COMPLETED|Period 5||0
1595502|NCT01025843|3901402|P6|NOT COMPLETED|Period 5||0
1595503|NCT01025843|3901403|P5|NOT COMPLETED|Period 5||0
1595504|NCT01025843|3901404|P4|NOT COMPLETED|Period 5||0
1595505|NCT01025843|3901405|P3|NOT COMPLETED|Period 5||0
1595506|NCT01025843|3901406|P2|NOT COMPLETED|Period 5||0
1595507|NCT01025843|3901407|P1|NOT COMPLETED|Period 5||0
1595508|NCT01025843|3901398|P10|COMPLETED|Period 5||2
1595509|NCT01025843|3901399|P9|COMPLETED|Period 5||2
1595510|NCT01025843|3901400|P8|COMPLETED|Period 5||2
1595511|NCT01025843|3901401|P7|COMPLETED|Period 5||2
1595512|NCT01025843|3901402|P6|COMPLETED|Period 5||2
1595513|NCT01025843|3901403|P5|COMPLETED|Period 5||2
1595514|NCT01025843|3901404|P4|COMPLETED|Period 5||1
1595515|NCT01025843|3901405|P3|COMPLETED|Period 5||1
1595516|NCT01025843|3901406|P2|COMPLETED|Period 5||2
1595517|NCT01025843|3901407|P1|COMPLETED|Period 5||2
1595518|NCT01025843|3901398|P10|STARTED|Period 5||2
1595519|NCT01025843|3901399|P9|STARTED|Period 5||2
1595520|NCT01025843|3901400|P8|STARTED|Period 5||2
1595521|NCT01025843|3901401|P7|STARTED|Period 5||2
1595522|NCT01025843|3901402|P6|STARTED|Period 5||2
1595523|NCT01025843|3901403|P5|STARTED|Period 5||2
1595524|NCT01025843|3901404|P4|STARTED|Period 5||1
1595525|NCT01025843|3901405|P3|STARTED|Period 5||1
1595526|NCT01025843|3901406|P2|STARTED|Period 5||2
1595527|NCT01025843|3901407|P1|STARTED|Period 5||2
1595528|NCT01025843|3901398|P10|NOT COMPLETED|Washout 4||0
1595529|NCT01025843|3901399|P9|NOT COMPLETED|Washout 4||0
1595530|NCT01025843|3901400|P8|NOT COMPLETED|Washout 4||0
1595531|NCT01025843|3901401|P7|NOT COMPLETED|Washout 4||0
1595532|NCT01025843|3901402|P6|NOT COMPLETED|Washout 4||0
1595533|NCT01025843|3901403|P5|NOT COMPLETED|Washout 4||0
1595534|NCT01025843|3901404|P4|NOT COMPLETED|Washout 4||1
1595535|NCT01025843|3901405|P3|NOT COMPLETED|Washout 4||1
1595536|NCT01025843|3901406|P2|NOT COMPLETED|Washout 4||0
1595537|NCT01025843|3901407|P1|NOT COMPLETED|Washout 4||0
1595538|NCT01025843|3901398|P10|COMPLETED|Washout 4||2
1595539|NCT01025843|3901399|P9|COMPLETED|Washout 4||2
1595540|NCT01025843|3901400|P8|COMPLETED|Washout 4||2
1595541|NCT01025843|3901401|P7|COMPLETED|Washout 4||2
1595542|NCT01025843|3901402|P6|COMPLETED|Washout 4||2
1595543|NCT01025843|3901403|P5|COMPLETED|Washout 4||2
1595544|NCT01025843|3901404|P4|COMPLETED|Washout 4||1
1595545|NCT01025843|3901405|P3|COMPLETED|Washout 4||1
1595546|NCT01025843|3901406|P2|COMPLETED|Washout 4||2
1595547|NCT01025843|3901407|P1|COMPLETED|Washout 4||2
1595548|NCT01025843|3901398|P10|STARTED|Washout 4||2
1595549|NCT01025843|3901399|P9|STARTED|Washout 4||2
1595550|NCT01025843|3901400|P8|STARTED|Washout 4||2
1595551|NCT01025843|3901401|P7|STARTED|Washout 4||2
1595552|NCT01025843|3901402|P6|STARTED|Washout 4||2
1595553|NCT01025843|3901403|P5|STARTED|Washout 4||2
1595554|NCT01025843|3901404|P4|STARTED|Washout 4||2
1595555|NCT01025843|3901405|P3|STARTED|Washout 4||2
1595556|NCT01025843|3901406|P2|STARTED|Washout 4||2
1595557|NCT01025843|3901407|P1|STARTED|Washout 4||2
1595558|NCT01025843|3901398|P10|NOT COMPLETED|Period 4||0
1595559|NCT01025843|3901399|P9|NOT COMPLETED|Period 4||0
1595560|NCT01025843|3901400|P8|NOT COMPLETED|Period 4||0
1595561|NCT01025843|3901401|P7|NOT COMPLETED|Period 4||0
1595562|NCT01025843|3901402|P6|NOT COMPLETED|Period 4||0
1595563|NCT01025843|3901403|P5|NOT COMPLETED|Period 4||0
1595564|NCT01025843|3901404|P4|NOT COMPLETED|Period 4||0
1595565|NCT01025843|3901405|P3|NOT COMPLETED|Period 4||0
1595566|NCT01025843|3901406|P2|NOT COMPLETED|Period 4||0
1595567|NCT01025843|3901407|P1|NOT COMPLETED|Period 4||0
1595568|NCT01025843|3901398|P10|COMPLETED|Period 4||2
1595569|NCT01025843|3901399|P9|COMPLETED|Period 4||2
1595570|NCT01025843|3901400|P8|COMPLETED|Period 4||2
1595571|NCT01025843|3901401|P7|COMPLETED|Period 4||2
1595572|NCT01025843|3901402|P6|COMPLETED|Period 4||2
1595573|NCT01025843|3901403|P5|COMPLETED|Period 4||2
1595574|NCT01025843|3901404|P4|COMPLETED|Period 4||2
1595575|NCT01025843|3901405|P3|COMPLETED|Period 4||2
1595576|NCT01025843|3901406|P2|COMPLETED|Period 4||2
1595577|NCT01025843|3901407|P1|COMPLETED|Period 4||2
1595578|NCT01025843|3901398|P10|STARTED|Period 4||2
1595579|NCT01025843|3901399|P9|STARTED|Period 4||2
1595580|NCT01025843|3901400|P8|STARTED|Period 4||2
1595581|NCT01025843|3901401|P7|STARTED|Period 4||2
1595582|NCT01025843|3901402|P6|STARTED|Period 4||2
1595583|NCT01025843|3901403|P5|STARTED|Period 4||2
1595584|NCT01025843|3901404|P4|STARTED|Period 4||2
1595585|NCT01025843|3901405|P3|STARTED|Period 4||2
1595586|NCT01025843|3901406|P2|STARTED|Period 4||2
1595587|NCT01025843|3901407|P1|STARTED|Period 4||2
1595588|NCT01025843|3901398|P10|NOT COMPLETED|Washout 3||0
1595589|NCT01025843|3901399|P9|NOT COMPLETED|Washout 3||0
1595590|NCT01025843|3901400|P8|NOT COMPLETED|Washout 3||0
1595591|NCT01025843|3901401|P7|NOT COMPLETED|Washout 3||0
1595592|NCT01025843|3901402|P6|NOT COMPLETED|Washout 3||0
1595593|NCT01025843|3901403|P5|NOT COMPLETED|Washout 3||0
1595594|NCT01025843|3901404|P4|NOT COMPLETED|Washout 3||0
1595595|NCT01025843|3901405|P3|NOT COMPLETED|Washout 3||0
1595596|NCT01025843|3901406|P2|NOT COMPLETED|Washout 3||0
1595597|NCT01025843|3901407|P1|NOT COMPLETED|Washout 3||0
1595598|NCT01025843|3901398|P10|COMPLETED|Washout 3||2
1595599|NCT01025843|3901399|P9|COMPLETED|Washout 3||2
1595600|NCT01025843|3901400|P8|COMPLETED|Washout 3||2
1595601|NCT01025843|3901401|P7|COMPLETED|Washout 3||2
1595602|NCT01025843|3901402|P6|COMPLETED|Washout 3||2
1595603|NCT01025843|3901403|P5|COMPLETED|Washout 3||2
1595604|NCT01025843|3901404|P4|COMPLETED|Washout 3||2
1595605|NCT01025843|3901405|P3|COMPLETED|Washout 3||2
1595606|NCT01025843|3901406|P2|COMPLETED|Washout 3||2
1595607|NCT01025843|3901407|P1|COMPLETED|Washout 3||2
1595608|NCT01025843|3901398|P10|STARTED|Washout 3||2
1595609|NCT01025843|3901399|P9|STARTED|Washout 3||2
1595610|NCT01025843|3901400|P8|STARTED|Washout 3||2
1595611|NCT01025843|3901401|P7|STARTED|Washout 3||2
1595612|NCT01025843|3901402|P6|STARTED|Washout 3||2
1595613|NCT01025843|3901403|P5|STARTED|Washout 3||2
1595614|NCT01025843|3901404|P4|STARTED|Washout 3||2
1595615|NCT01025843|3901405|P3|STARTED|Washout 3||2
1595616|NCT01025843|3901406|P2|STARTED|Washout 3||2
1595617|NCT01025843|3901407|P1|STARTED|Washout 3||2
1595618|NCT01025843|3901398|P10|NOT COMPLETED|Period 3||0
1595619|NCT01025843|3901399|P9|NOT COMPLETED|Period 3||0
1595620|NCT01025843|3901400|P8|NOT COMPLETED|Period 3||0
1595621|NCT01025843|3901401|P7|NOT COMPLETED|Period 3||0
1595622|NCT01025843|3901402|P6|NOT COMPLETED|Period 3||0
1595623|NCT01025843|3901403|P5|NOT COMPLETED|Period 3||0
1595624|NCT01025843|3901404|P4|NOT COMPLETED|Period 3||0
1595625|NCT01025843|3901405|P3|NOT COMPLETED|Period 3||0
1595626|NCT01025843|3901406|P2|NOT COMPLETED|Period 3||0
1595627|NCT01025843|3901407|P1|NOT COMPLETED|Period 3||0
1595628|NCT01025843|3901398|P10|COMPLETED|Period 3||2
1595629|NCT01025843|3901399|P9|COMPLETED|Period 3||2
1595630|NCT01025843|3901400|P8|COMPLETED|Period 3||2
1595631|NCT01025843|3901401|P7|COMPLETED|Period 3||2
1595632|NCT01025843|3901402|P6|COMPLETED|Period 3||2
1595633|NCT01025843|3901403|P5|COMPLETED|Period 3||2
1595634|NCT01025843|3901404|P4|COMPLETED|Period 3||2
1595635|NCT01025843|3901405|P3|COMPLETED|Period 3||2
1595636|NCT01025843|3901406|P2|COMPLETED|Period 3||2
1595637|NCT01025843|3901407|P1|COMPLETED|Period 3||2
1595638|NCT01025843|3901398|P10|STARTED|Period 3||2
1595639|NCT01025843|3901399|P9|STARTED|Period 3||2
1595640|NCT01025843|3901400|P8|STARTED|Period 3||2
1595641|NCT01025843|3901401|P7|STARTED|Period 3||2
1595642|NCT01025843|3901402|P6|STARTED|Period 3||2
1595643|NCT01025843|3901403|P5|STARTED|Period 3||2
1595644|NCT01025843|3901404|P4|STARTED|Period 3||2
1595645|NCT01025843|3901405|P3|STARTED|Period 3||2
1595646|NCT01025843|3901406|P2|STARTED|Period 3||2
1595647|NCT01025843|3901407|P1|STARTED|Period 3||2
1595648|NCT01025843|3901398|P10|NOT COMPLETED|Washout 2||0
1595649|NCT01025843|3901399|P9|NOT COMPLETED|Washout 2||0
1595650|NCT01025843|3901400|P8|NOT COMPLETED|Washout 2||0
1595651|NCT01025843|3901401|P7|NOT COMPLETED|Washout 2||0
1595652|NCT01025843|3901402|P6|NOT COMPLETED|Washout 2||0
1595653|NCT01025843|3901403|P5|NOT COMPLETED|Washout 2||0
1595654|NCT01025843|3901404|P4|NOT COMPLETED|Washout 2||0
1595655|NCT01025843|3901405|P3|NOT COMPLETED|Washout 2||0
1595656|NCT01025843|3901406|P2|NOT COMPLETED|Washout 2||0
1595657|NCT01025843|3901407|P1|NOT COMPLETED|Washout 2||0
1595658|NCT01025843|3901398|P10|COMPLETED|Washout 2||2
1595659|NCT01025843|3901399|P9|COMPLETED|Washout 2||2
1595660|NCT01025843|3901400|P8|COMPLETED|Washout 2||2
1595661|NCT01025843|3901401|P7|COMPLETED|Washout 2||2
1595662|NCT01025843|3901402|P6|COMPLETED|Washout 2||2
1595663|NCT01025843|3901403|P5|COMPLETED|Washout 2||2
1595664|NCT01025843|3901404|P4|COMPLETED|Washout 2||2
1595665|NCT01025843|3901405|P3|COMPLETED|Washout 2||2
1595666|NCT01025843|3901406|P2|COMPLETED|Washout 2||2
1595667|NCT01025843|3901407|P1|COMPLETED|Washout 2||2
1595668|NCT01025843|3901398|P10|STARTED|Washout 2||2
1595669|NCT01025843|3901399|P9|STARTED|Washout 2||2
1595670|NCT01025843|3901400|P8|STARTED|Washout 2||2
1595671|NCT01025843|3901401|P7|STARTED|Washout 2||2
1595672|NCT01025843|3901402|P6|STARTED|Washout 2||2
1595673|NCT01025843|3901403|P5|STARTED|Washout 2||2
1595674|NCT01025843|3901404|P4|STARTED|Washout 2||2
1595675|NCT01025843|3901405|P3|STARTED|Washout 2||2
1595676|NCT01025843|3901406|P2|STARTED|Washout 2||2
1595677|NCT01025843|3901407|P1|STARTED|Washout 2||2
1595678|NCT01025843|3901398|P10|NOT COMPLETED|Period 2||0
1595679|NCT01025843|3901399|P9|NOT COMPLETED|Period 2||0
1595680|NCT01025843|3901400|P8|NOT COMPLETED|Period 2||0
1595681|NCT01025843|3901401|P7|NOT COMPLETED|Period 2||0
1595682|NCT01025843|3901402|P6|NOT COMPLETED|Period 2||0
1595683|NCT01025843|3901403|P5|NOT COMPLETED|Period 2||0
1595684|NCT01025843|3901404|P4|NOT COMPLETED|Period 2||0
1595685|NCT01025843|3901405|P3|NOT COMPLETED|Period 2||0
1595686|NCT01025843|3901406|P2|NOT COMPLETED|Period 2||0
1595687|NCT01025843|3901407|P1|NOT COMPLETED|Period 2||0
1595688|NCT01025843|3901398|P10|COMPLETED|Period 2||2
1595689|NCT01025843|3901399|P9|COMPLETED|Period 2||2
1595690|NCT01025843|3901400|P8|COMPLETED|Period 2||2
1595691|NCT01025843|3901401|P7|COMPLETED|Period 2||2
1595692|NCT01025843|3901402|P6|COMPLETED|Period 2||2
1595693|NCT01025843|3901403|P5|COMPLETED|Period 2||2
1595694|NCT01025843|3901404|P4|COMPLETED|Period 2||2
1595695|NCT01025843|3901405|P3|COMPLETED|Period 2||2
1595696|NCT01025843|3901406|P2|COMPLETED|Period 2||2
1595697|NCT01025843|3901407|P1|COMPLETED|Period 2||2
1595698|NCT01025843|3901398|P10|STARTED|Period 2||2
1595699|NCT01025843|3901399|P9|STARTED|Period 2||2
1595700|NCT01025843|3901400|P8|STARTED|Period 2||2
1595701|NCT01025843|3901401|P7|STARTED|Period 2||2
1595702|NCT01025843|3901402|P6|STARTED|Period 2||2
1595703|NCT01025843|3901403|P5|STARTED|Period 2||2
1595704|NCT01025843|3901404|P4|STARTED|Period 2||2
1595705|NCT01025843|3901405|P3|STARTED|Period 2||2
1595706|NCT01025843|3901406|P2|STARTED|Period 2||2
1595707|NCT01025843|3901407|P1|STARTED|Period 2||2
1595708|NCT01025843|3901398|P10|NOT COMPLETED|Washout 1||0
1595709|NCT01025843|3901399|P9|NOT COMPLETED|Washout 1||0
1595710|NCT01025843|3901400|P8|NOT COMPLETED|Washout 1||0
1595711|NCT01025843|3901401|P7|NOT COMPLETED|Washout 1||0
1595712|NCT01025843|3901402|P6|NOT COMPLETED|Washout 1||0
1595713|NCT01025843|3901403|P5|NOT COMPLETED|Washout 1||0
1595714|NCT01025843|3901404|P4|NOT COMPLETED|Washout 1||0
1595715|NCT01025843|3901405|P3|NOT COMPLETED|Washout 1||0
1595716|NCT01025843|3901406|P2|NOT COMPLETED|Washout 1||0
1595717|NCT01025843|3901407|P1|NOT COMPLETED|Washout 1||0
1595718|NCT01025843|3901398|P10|COMPLETED|Washout 1||2
1595719|NCT01025843|3901399|P9|COMPLETED|Washout 1||2
1595720|NCT01025843|3901400|P8|COMPLETED|Washout 1||2
1595721|NCT01025843|3901401|P7|COMPLETED|Washout 1||2
1595722|NCT01025843|3901402|P6|COMPLETED|Washout 1||2
1595723|NCT01025843|3901403|P5|COMPLETED|Washout 1||2
1595724|NCT01025843|3901404|P4|COMPLETED|Washout 1||2
1595725|NCT01025843|3901405|P3|COMPLETED|Washout 1||2
1595726|NCT01025843|3901406|P2|COMPLETED|Washout 1||2
1595727|NCT01025843|3901407|P1|COMPLETED|Washout 1||2
1595728|NCT01025843|3901398|P10|STARTED|Washout 1||2
1595729|NCT01025843|3901399|P9|STARTED|Washout 1||2
1595730|NCT01025843|3901400|P8|STARTED|Washout 1||2
1595731|NCT01025843|3901401|P7|STARTED|Washout 1||2
1595732|NCT01025843|3901402|P6|STARTED|Washout 1||2
1595733|NCT01025843|3901403|P5|STARTED|Washout 1||2
1595734|NCT01025843|3901404|P4|STARTED|Washout 1||2
1595735|NCT01025843|3901405|P3|STARTED|Washout 1||2
1595736|NCT01025843|3901406|P2|STARTED|Washout 1||2
1595737|NCT01025843|3901407|P1|STARTED|Washout 1||2
1595738|NCT01025843|3901398|P10|NOT COMPLETED|Period 1||0
1595739|NCT01025843|3901399|P9|NOT COMPLETED|Period 1||0
1595740|NCT01025843|3901400|P8|NOT COMPLETED|Period 1||0
1595741|NCT01025843|3901401|P7|NOT COMPLETED|Period 1||0
1595742|NCT01025843|3901402|P6|NOT COMPLETED|Period 1||0
1595743|NCT01025843|3901403|P5|NOT COMPLETED|Period 1||0
1595744|NCT01025843|3901404|P4|NOT COMPLETED|Period 1||0
1595745|NCT01025843|3901405|P3|NOT COMPLETED|Period 1||0
1595746|NCT01025843|3901406|P2|NOT COMPLETED|Period 1||0
1595747|NCT01025843|3901407|P1|NOT COMPLETED|Period 1||0
1595748|NCT01025843|3901398|P10|COMPLETED|Period 1||2
1595749|NCT01025843|3901399|P9|COMPLETED|Period 1||2
1595750|NCT01025843|3901400|P8|COMPLETED|Period 1||2
1595751|NCT01025843|3901401|P7|COMPLETED|Period 1||2
1595752|NCT01025843|3901402|P6|COMPLETED|Period 1||2
1595753|NCT01025843|3901403|P5|COMPLETED|Period 1||2
1595754|NCT01025843|3901404|P4|COMPLETED|Period 1||2
1595755|NCT01025843|3901405|P3|COMPLETED|Period 1||2
1595756|NCT01025843|3901406|P2|COMPLETED|Period 1||2
1595757|NCT01025843|3901407|P1|COMPLETED|Period 1||2
1595758|NCT01025843|3901398|P10|STARTED|Period 1||2
1595759|NCT01025843|3901399|P9|STARTED|Period 1||2
1595760|NCT01025843|3901400|P8|STARTED|Period 1||2
1595761|NCT01025843|3901401|P7|STARTED|Period 1||2
1595762|NCT01025843|3901402|P6|STARTED|Period 1||2
1595763|NCT01025843|3901403|P5|STARTED|Period 1||2
1595764|NCT01025843|3901404|P4|STARTED|Period 1||2
1595765|NCT01025843|3901405|P3|STARTED|Period 1||2
1595766|NCT01025843|3901406|P2|STARTED|Period 1||2
1595767|NCT01025843|3901407|P1|STARTED|Period 1||2
1595768|NCT01025830|3901481|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
1595769|NCT01025830|3901482|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
1595770|NCT01025830|3901481|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
1595771|NCT01025830|3901482|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
1595772|NCT01025830|3901481|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
1595773|NCT01025830|3901482|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
1595774|NCT01025830|3901481|P2|NOT COMPLETED|Washout Period of 30 Days||0
1595775|NCT01025830|3901482|P1|NOT COMPLETED|Washout Period of 30 Days||0
1595776|NCT01025830|3901481|P2|COMPLETED|Washout Period of 30 Days||12
1595777|NCT01025830|3901482|P1|COMPLETED|Washout Period of 30 Days||8
1595778|NCT01025830|3901481|P2|STARTED|Washout Period of 30 Days||12
1595779|NCT01025830|3901482|P1|STARTED|Washout Period of 30 Days||8
1595780|NCT01025830|3901481|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
1595781|NCT01025830|3901482|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
1595782|NCT01025830|3901481|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
1595783|NCT01025830|3901482|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
1595784|NCT01025830|3901481|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
1595785|NCT01025830|3901482|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
1595786|NCT01025817|3901501|P2|NOT COMPLETED|Completed Study||22
1595787|NCT01025817|3901502|P1|NOT COMPLETED|Completed Study||16
1595788|NCT01025817|3901501|P2|COMPLETED|Completed Study|Completed study phase|282
1595789|NCT01025817|3901502|P1|COMPLETED|Completed Study|Completed study phase|293
1595790|NCT01025817|3901501|P2|STARTED|Completed Study||304
1595791|NCT01025817|3901502|P1|STARTED|Completed Study||309
1595792|NCT01025817|3901501|P2|NOT COMPLETED|Completed Study Medication||72
1595793|NCT01025817|3901502|P1|NOT COMPLETED|Completed Study Medication||105
1595794|NCT01025817|3901501|P2|COMPLETED|Completed Study Medication||232
1595795|NCT01025817|3901502|P1|COMPLETED|Completed Study Medication||204
1595796|NCT01025817|3901501|P2|STARTED|Completed Study Medication||304
1595797|NCT01025817|3901502|P1|STARTED|Completed Study Medication||309
1595798|NCT01025752|3901522|P2|NOT COMPLETED|Overall Study||13
1595799|NCT01025752|3901523|P1|NOT COMPLETED|Overall Study||8
1595800|NCT01025752|3901522|P2|COMPLETED|Overall Study||50
1595801|NCT01025752|3901523|P1|COMPLETED|Overall Study||54
1595802|NCT01025752|3901522|P2|STARTED|Overall Study||63
1595803|NCT01025752|3901523|P1|STARTED|Overall Study||62
1595804|NCT01025635|3901543|P2|NOT COMPLETED|Overall Study||25
1595805|NCT01025635|3901544|P1|NOT COMPLETED|Overall Study||23
1595806|NCT01025635|3901543|P2|COMPLETED|Overall Study||178
1595807|NCT01025635|3901544|P1|COMPLETED|Overall Study||175
1595808|NCT01025635|3901543|P2|STARTED|Overall Study||203
1595809|NCT01025635|3901544|P1|STARTED|Overall Study||198
1595810|NCT01025492|3901556|P1|NOT COMPLETED|Overall Study||0
1595811|NCT01025492|3901556|P1|COMPLETED|Overall Study||24
1595812|NCT01025492|3901556|P1|STARTED|Overall Study||24
1595813|NCT01025453|3901560|P1|NOT COMPLETED|Overall Study||0
1595814|NCT01025453|3901560|P1|COMPLETED|Overall Study||37
1595815|NCT01025453|3901560|P1|STARTED|Overall Study||37
1595816|NCT01025336|3901572|P5|NOT COMPLETED|Overall Study||0
1595817|NCT01025336|3901573|P4|NOT COMPLETED|Overall Study||2
1595818|NCT01025336|3901574|P3|NOT COMPLETED|Overall Study||0
1595819|NCT01025336|3901575|P2|NOT COMPLETED|Overall Study||0
1595820|NCT01025336|3901576|P1|NOT COMPLETED|Overall Study||0
1595821|NCT01025336|3901572|P5|COMPLETED|Overall Study||222
1595822|NCT01025336|3901573|P4|COMPLETED|Overall Study||219
1595823|NCT01025336|3901574|P3|COMPLETED|Overall Study||179
1595824|NCT01025336|3901575|P2|COMPLETED|Overall Study||210
1595825|NCT01025336|3901576|P1|COMPLETED|Overall Study||130
1595826|NCT01025336|3901572|P5|STARTED|Overall Study||222
1595827|NCT01025336|3901573|P4|STARTED|Overall Study||221
1595828|NCT01025336|3901574|P3|STARTED|Overall Study||179
1595829|NCT01025336|3901575|P2|STARTED|Overall Study||210
1595830|NCT01025336|3901576|P1|STARTED|Overall Study||130
1595831|NCT01025284|3901631|P3|NOT COMPLETED|Overall Study||0
1595832|NCT01025284|3901632|P2|NOT COMPLETED|Overall Study||2
1595833|NCT01025284|3901633|P1|NOT COMPLETED|Overall Study||0
1595834|NCT01025284|3901631|P3|COMPLETED|Overall Study||8
1595835|NCT01025284|3901632|P2|COMPLETED|Overall Study||16
1595836|NCT01025284|3901633|P1|COMPLETED|Overall Study||38
1595837|NCT01025284|3901631|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
1595838|NCT01025284|3901632|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
1595839|NCT01025284|3901633|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
1595840|NCT01025284|3901631|P3|STARTED|Overall Study||8
1595841|NCT01025284|3901632|P2|STARTED|Overall Study||18
1595842|NCT01025284|3901633|P1|STARTED|Overall Study||38
1595843|NCT01025271|3901651|P1|NOT COMPLETED|Overall Study||0
1595844|NCT01025271|3901651|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
1595845|NCT01025271|3901651|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
1595846|NCT01025232|3901658|P2|NOT COMPLETED|Overall Study||6
1595847|NCT01025232|3901659|P1|NOT COMPLETED|Overall Study||3
1595848|NCT01025232|3901658|P2|COMPLETED|Overall Study||36
1595849|NCT01025232|3901659|P1|COMPLETED|Overall Study||43
1595850|NCT01025232|3901658|P2|STARTED|Overall Study||42
1595851|NCT01025232|3901659|P1|STARTED|Overall Study||46
1595852|NCT01025193|3901677|P1|NOT COMPLETED|Overall Study||4
1595853|NCT01025193|3901677|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
1595854|NCT01025193|3901677|P1|STARTED|Overall Study||8
1595855|NCT01025154|3901687|P1|NOT COMPLETED|Overall Study||2
1595856|NCT01025154|3901687|P1|COMPLETED|Overall Study||57
1595857|NCT01025154|3901687|P1|STARTED|Overall Study||59
1595858|NCT01025076|3901692|P1|NOT COMPLETED|Overall Study||0
1595859|NCT01025076|3901692|P1|COMPLETED|Overall Study||14
1595860|NCT01025076|3901692|P1|STARTED|Overall Study||14
1595861|NCT01025037|3901696|P1|NOT COMPLETED|Overall Study||11
1595862|NCT01025037|3901696|P1|COMPLETED|Overall Study||50
1595863|NCT01025037|3901696|P1|STARTED|Overall Study||61
1595864|NCT01024972|3901707|P2|NOT COMPLETED|Overall Study||0
1595865|NCT01024972|3901708|P1|NOT COMPLETED|Overall Study||0
1595866|NCT01024972|3901707|P2|COMPLETED|Overall Study||15
1595867|NCT01024972|3901708|P1|COMPLETED|Overall Study||16
1595868|NCT01024972|3901707|P2|STARTED|Overall Study||15
1595869|NCT01024972|3901708|P1|STARTED|Overall Study||16
1595870|NCT01024959|3901718|P1|NOT COMPLETED|Overall Study||41
1595871|NCT01024959|3901718|P1|COMPLETED|Overall Study||466
1595872|NCT01024959|3901718|P1|STARTED|Overall Study||507
1595873|NCT01024946|3901727|P1|NOT COMPLETED|Overall Study||5
1595874|NCT01024946|3901727|P1|COMPLETED|Overall Study||6
1595875|NCT01024946|3901727|P1|STARTED|Overall Study||11
1595876|NCT01024855|3901731|P1|NOT COMPLETED|Overall Study||1
1595877|NCT01024855|3901731|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
1595878|NCT01024855|3901731|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
1595879|NCT01024751|3901738|P2|NOT COMPLETED|Eligible Participants||3
1595880|NCT01024751|3901739|P1|NOT COMPLETED|Eligible Participants||0
1595881|NCT01024751|3901738|P2|COMPLETED|Eligible Participants||149
1595882|NCT01024751|3901739|P1|COMPLETED|Eligible Participants||153
1595883|NCT01024751|3901738|P2|STARTED|Eligible Participants||152
1595884|NCT01024751|3901739|P1|STARTED|Eligible Participants||153
1595885|NCT01024751|3901738|P2|NOT COMPLETED|Enrolled Participants||4
1595886|NCT01024751|3901739|P1|NOT COMPLETED|Enrolled Participants||3
1595887|NCT01024751|3901738|P2|COMPLETED|Enrolled Participants||152
1595888|NCT01024751|3901739|P1|COMPLETED|Enrolled Participants||153
1595889|NCT01024751|3901738|P2|STARTED|Enrolled Participants||156
1595890|NCT01024751|3901739|P1|STARTED|Enrolled Participants||156
1595891|NCT01024738|3901750|P3|NOT COMPLETED|Third Intervention:||0
1595892|NCT01024738|3901751|P2|NOT COMPLETED|Third Intervention:||0
1595893|NCT01024738|3901752|P1|NOT COMPLETED|Third Intervention:||0
1595894|NCT01024738|3901750|P3|COMPLETED|Third Intervention:||8
1595895|NCT01024738|3901751|P2|COMPLETED|Third Intervention:||7
1595896|NCT01024738|3901752|P1|COMPLETED|Third Intervention:||7
1595897|NCT01024738|3901750|P3|STARTED|Third Intervention:||8
1595898|NCT01024738|3901751|P2|STARTED|Third Intervention:||7
1595899|NCT01024738|3901752|P1|STARTED|Third Intervention:||7
1595900|NCT01024738|3901750|P3|NOT COMPLETED|Washout After 2nd Intervention||0
1595901|NCT01024738|3901751|P2|NOT COMPLETED|Washout After 2nd Intervention||0
1595902|NCT01024738|3901752|P1|NOT COMPLETED|Washout After 2nd Intervention||0
1595903|NCT01024738|3901750|P3|COMPLETED|Washout After 2nd Intervention||8
1595904|NCT01024738|3901751|P2|COMPLETED|Washout After 2nd Intervention||7
1595905|NCT01024738|3901752|P1|COMPLETED|Washout After 2nd Intervention||7
1595906|NCT01024738|3901750|P3|STARTED|Washout After 2nd Intervention||8
1595907|NCT01024738|3901751|P2|STARTED|Washout After 2nd Intervention||7
1595908|NCT01024738|3901752|P1|STARTED|Washout After 2nd Intervention||7
1595909|NCT01024738|3901750|P3|NOT COMPLETED|Second Intervention:||0
1595910|NCT01024738|3901751|P2|NOT COMPLETED|Second Intervention:||0
1595911|NCT01024738|3901752|P1|NOT COMPLETED|Second Intervention:||0
1595912|NCT01024738|3901750|P3|COMPLETED|Second Intervention:||8
1595913|NCT01024738|3901751|P2|COMPLETED|Second Intervention:||7
1595914|NCT01024738|3901752|P1|COMPLETED|Second Intervention:||7
1595915|NCT01024738|3901750|P3|STARTED|Second Intervention:||8
1595916|NCT01024738|3901751|P2|STARTED|Second Intervention:||7
1595917|NCT01024738|3901752|P1|STARTED|Second Intervention:||7
1595918|NCT01024738|3901750|P3|NOT COMPLETED|Washout After 1st Intervention||0
1595919|NCT01024738|3901751|P2|NOT COMPLETED|Washout After 1st Intervention||0
1595920|NCT01024738|3901752|P1|NOT COMPLETED|Washout After 1st Intervention||0
1595921|NCT01024738|3901750|P3|COMPLETED|Washout After 1st Intervention||8
1595922|NCT01024738|3901751|P2|COMPLETED|Washout After 1st Intervention||7
1595923|NCT01024738|3901752|P1|COMPLETED|Washout After 1st Intervention||7
1595924|NCT01024738|3901750|P3|STARTED|Washout After 1st Intervention||8
1595925|NCT01024738|3901751|P2|STARTED|Washout After 1st Intervention||7
1595926|NCT01024738|3901752|P1|STARTED|Washout After 1st Intervention||7
1595927|NCT01024738|3901750|P3|NOT COMPLETED|First Intervention:||0
1595928|NCT01024738|3901751|P2|NOT COMPLETED|First Intervention:||0
1595929|NCT01024738|3901752|P1|NOT COMPLETED|First Intervention:||0
1595930|NCT01024738|3901750|P3|COMPLETED|First Intervention:||8
1595931|NCT01024738|3901751|P2|COMPLETED|First Intervention:||7
1595932|NCT01024738|3901752|P1|COMPLETED|First Intervention:||7
1595933|NCT01024738|3901750|P3|STARTED|First Intervention:||8
1595934|NCT01024738|3901751|P2|STARTED|First Intervention:||7
1595935|NCT01024738|3901752|P1|STARTED|First Intervention:||7
1595936|NCT01024608|3901762|P2|NOT COMPLETED|Overall Study||4
1595937|NCT01024608|3901763|P1|NOT COMPLETED|Overall Study||4
1595938|NCT01024608|3901762|P2|COMPLETED|Overall Study||167
1595939|NCT01024608|3901763|P1|COMPLETED|Overall Study||165
1595940|NCT01024608|3901762|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
1595941|NCT01024608|3901763|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
1595942|NCT01024608|3901762|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
1595943|NCT01024608|3901763|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
1595944|NCT01024608|3901762|P2|STARTED|Overall Study||171
1595945|NCT01024608|3901763|P1|STARTED|Overall Study||169
1595946|NCT01024465|3901775|P1|NOT COMPLETED|Overall Study||3
1595947|NCT01024465|3901775|P1|COMPLETED|Overall Study||23
1595948|NCT01024465|3901775|P1|STARTED|Overall Study||26
1595949|NCT01024387|3901779|P1|NOT COMPLETED|Overall Study||60
1595950|NCT01024387|3901779|P1|COMPLETED|Overall Study||0
1595951|NCT01024387|3901779|P1|Evaluable for Response|Overall Study||53
1595952|NCT01024387|3901779|P1|Evaluable for PFS|Overall Study||54
1595953|NCT01024387|3901779|P1|STARTED|Overall Study||60
1595954|NCT01024335|3901789|P2|NOT COMPLETED|Overall Study||26
1595955|NCT01024335|3901790|P1|NOT COMPLETED|Overall Study||13
1595956|NCT01024335|3901789|P2|COMPLETED|Overall Study||14
1595957|NCT01024335|3901790|P1|COMPLETED|Overall Study||7
1595958|NCT01024335|3901789|P2|STARTED|Overall Study||40
1595959|NCT01024335|3901790|P1|STARTED|Overall Study||20
1595960|NCT01024309|3901800|P2|NOT COMPLETED|Overall Study||4
1595961|NCT01024309|3901801|P1|NOT COMPLETED|Overall Study||8
1595962|NCT01024309|3901800|P2|COMPLETED|Overall Study||27
1595963|NCT01024309|3901801|P1|COMPLETED|Overall Study||27
1595964|NCT01024309|3901800|P2|STARTED|Overall Study||31
1595965|NCT01024309|3901801|P1|STARTED|Overall Study||35
1595966|NCT01024296|3901823|P1|NOT COMPLETED|Overall Study||0
1595967|NCT01024296|3901823|P1|COMPLETED|Overall Study||4
1595968|NCT01024296|3901823|P1|STARTED|Overall Study||4
1595969|NCT01024244|3901833|P5|NOT COMPLETED|Overall Study||14
1595970|NCT01024244|3901834|P4|NOT COMPLETED|Overall Study||13
1595971|NCT01024244|3901835|P3|NOT COMPLETED|Overall Study||14
1595972|NCT01024244|3901836|P2|NOT COMPLETED|Overall Study||11
1595973|NCT01024244|3901837|P1|NOT COMPLETED|Overall Study||17
1595974|NCT01024244|3901833|P5|COMPLETED|Overall Study||1
1595975|NCT01024244|3901834|P4|COMPLETED|Overall Study||1
1595976|NCT01024244|3901835|P3|COMPLETED|Overall Study||1
1595977|NCT01024244|3901836|P2|COMPLETED|Overall Study||1
1595978|NCT01024244|3901837|P1|COMPLETED|Overall Study||5
1595979|NCT01024244|3901833|P5|STARTED|Overall Study||15
1595980|NCT01024244|3901834|P4|STARTED|Overall Study||14
1595981|NCT01024244|3901835|P3|STARTED|Overall Study||15
1595982|NCT01024244|3901836|P2|STARTED|Overall Study||12
1595983|NCT01024244|3901837|P1|STARTED|Overall Study||22
1595984|NCT01024036|3901951|P2|NOT COMPLETED|Follow-Up Period||3
1595985|NCT01024036|3901952|P1|NOT COMPLETED|Follow-Up Period||5
1595986|NCT01024036|3901951|P2|COMPLETED|Follow-Up Period||3
1595987|NCT01024036|3901952|P1|COMPLETED|Follow-Up Period||9
1595988|NCT01024036|3901951|P2|STARTED|Follow-Up Period||6
1595989|NCT01024036|3901952|P1|STARTED|Follow-Up Period||14
1595990|NCT01024036|3901951|P2|NOT COMPLETED|Unblinded Treatment||3
1595991|NCT01024036|3901952|P1|NOT COMPLETED|Unblinded Treatment||0
1595992|NCT01024036|3901951|P2|COMPLETED|Unblinded Treatment||10
1595993|NCT01024036|3901952|P1|COMPLETED|Unblinded Treatment||0
1595994|NCT01024036|3901951|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
1595995|NCT01024036|3901952|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
1595996|NCT01024036|3901951|P2|NOT COMPLETED|Blinded Treatment||20
1595997|NCT01024036|3901952|P1|NOT COMPLETED|Blinded Treatment||22
1595998|NCT01024036|3901951|P2|COMPLETED|Blinded Treatment||6
1595999|NCT01024036|3901952|P1|COMPLETED|Blinded Treatment||31
1596000|NCT01024036|3901951|P2|STARTED|Blinded Treatment||26
1596001|NCT01024036|3901952|P1|STARTED|Blinded Treatment||53
1596002|NCT01024010|3901985|P2|NOT COMPLETED|Overall Study||0
1596003|NCT01024010|3901986|P1|NOT COMPLETED|Overall Study||0
1596004|NCT01024010|3901985|P2|COMPLETED|Overall Study||34
1596005|NCT01024010|3901986|P1|COMPLETED|Overall Study||48
1596006|NCT01024010|3901985|P2|STARTED|Overall Study||34
1596007|NCT01024010|3901986|P1|STARTED|Overall Study||48
1596008|NCT01023958|3901999|P1|NOT COMPLETED|Overall Study||50
1596009|NCT01023958|3901999|P1|COMPLETED|Overall Study||0
1596010|NCT01023958|3901999|P1|STARTED|Overall Study||50
1596011|NCT01023841|3902028|P2|NOT COMPLETED|Overall Study||0
1596012|NCT01023841|3902029|P1|NOT COMPLETED|Overall Study||1
1596013|NCT01023841|3902028|P2|COMPLETED|Overall Study||23
1596014|NCT01023841|3902029|P1|COMPLETED|Overall Study||47
1596015|NCT01023841|3902028|P2|STARTED|Overall Study||23
1596016|NCT01023841|3902029|P1|STARTED|Overall Study||48
1596017|NCT01023815|3902047|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
1596018|NCT01023815|3902048|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
1596019|NCT01023815|3902049|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
1596020|NCT01023815|3902050|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
1596021|NCT01023815|3902047|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
1596022|NCT01023815|3902048|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
1596023|NCT01023815|3902049|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
1596024|NCT01023815|3902050|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
1596025|NCT01023815|3902047|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
1596026|NCT01023815|3902048|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
1596027|NCT01023815|3902049|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
1596028|NCT01023815|3902050|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
1596029|NCT01023815|3902047|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1596030|NCT01023815|3902048|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1596031|NCT01023815|3902049|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1596032|NCT01023815|3902050|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
1596033|NCT01023815|3902047|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1596034|NCT01023815|3902048|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1596035|NCT01023815|3902049|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1596036|NCT01023815|3902050|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
1596037|NCT01023815|3902047|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
1596038|NCT01023815|3902048|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
1596039|NCT01023815|3902049|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
1596040|NCT01023815|3902050|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
1596041|NCT01023789|3902069|P1|NOT COMPLETED|3 - Year Visit||43
1596042|NCT01023789|3902069|P1|COMPLETED|3 - Year Visit||769
1596043|NCT01023789|3902069|P1|STARTED|3 - Year Visit||812
1596044|NCT01023789|3902069|P1|NOT COMPLETED|2 - Year Visit||0
1596045|NCT01023789|3902069|P1|COMPLETED|2 - Year Visit||812
1596046|NCT01023789|3902069|P1|STARTED|2 - Year Visit||812
1596047|NCT01023789|3902069|P1|NOT COMPLETED|1 - Year Visit||0
1596048|NCT01023789|3902069|P1|COMPLETED|1 - Year Visit||812
1596049|NCT01023789|3902069|P1|STARTED|1 - Year Visit||812
1596050|NCT01023789|3902069|P1|NOT COMPLETED|180-day Clinical Follow-up||0
1596051|NCT01023789|3902069|P1|COMPLETED|180-day Clinical Follow-up||812
1596052|NCT01023789|3902069|P1|STARTED|180-day Clinical Follow-up||812
1596053|NCT01023789|3902069|P1|NOT COMPLETED|30-day Follow-up Visit||0
1596054|NCT01023789|3902069|P1|COMPLETED|30-day Follow-up Visit||812
1596055|NCT01023789|3902069|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
1596056|NCT01023776|3902136|P1|NOT COMPLETED|Overall Study||0
1596057|NCT01023776|3902136|P1|COMPLETED|Overall Study||20
1596058|NCT01023776|3902136|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
1596059|NCT01023724|3902143|P2|NOT COMPLETED|Overall Study||3
1596060|NCT01023724|3902144|P1|NOT COMPLETED|Overall Study||4
1596061|NCT01023724|3902143|P2|COMPLETED|Overall Study||22
1596062|NCT01023724|3902144|P1|COMPLETED|Overall Study||21
1596063|NCT01023724|3902143|P2|STARTED|Overall Study||25
1596064|NCT01023724|3902144|P1|STARTED|Overall Study||25
1596065|NCT01023711|3902150|P1|NOT COMPLETED|Overall Study||0
1596066|NCT01023711|3902150|P1|COMPLETED|Overall Study||107
1596067|NCT01023711|3902150|P1|STARTED|Overall Study||107
1596068|NCT01023672|3902155|P1|NOT COMPLETED|Overall Study||3
1596069|NCT01023672|3902155|P1|COMPLETED|Overall Study||17
1596070|NCT01023672|3902155|P1|STARTED|Overall Study||20
1596071|NCT01023659|3902162|P3|NOT COMPLETED|Overall Study||99
1596072|NCT01023659|3902163|P2|NOT COMPLETED|Overall Study||228
1596073|NCT01023659|3902164|P1|NOT COMPLETED|Overall Study||73
1596074|NCT01023659|3902162|P3|COMPLETED|Overall Study||165
1596075|NCT01023659|3902163|P2|COMPLETED|Overall Study||137
1596076|NCT01023659|3902164|P1|COMPLETED|Overall Study||185
1596077|NCT01023659|3902162|P3|STARTED|Overall Study||264
1596078|NCT01023659|3902163|P2|STARTED|Overall Study||365
1596079|NCT01023659|3902164|P1|STARTED|Overall Study||258
1596080|NCT01023581|3902180|P7|NOT COMPLETED|Overall Study||20
1596081|NCT01023581|3902181|P6|NOT COMPLETED|Overall Study||19
1596082|NCT01023581|3902182|P5|NOT COMPLETED|Overall Study||16
1596083|NCT01023581|3902183|P4|NOT COMPLETED|Overall Study||20
1596084|NCT01023581|3902184|P3|NOT COMPLETED|Overall Study||42
1596085|NCT01023581|3902185|P2|NOT COMPLETED|Overall Study||23
1596086|NCT01023581|3902186|P1|NOT COMPLETED|Overall Study||35
1596087|NCT01023581|3902180|P7|COMPLETED|Overall Study||94
1596088|NCT01023581|3902181|P6|COMPLETED|Overall Study||92
1596089|NCT01023581|3902182|P5|COMPLETED|Overall Study||95
1596090|NCT01023581|3902183|P4|COMPLETED|Overall Study||94
1596091|NCT01023581|3902184|P3|COMPLETED|Overall Study||71
1596092|NCT01023581|3902185|P2|COMPLETED|Overall Study||89
1596093|NCT01023581|3902186|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
1596094|NCT01023581|3902180|P7|Received Study Treatment|Overall Study||114
1596095|NCT01023581|3902181|P6|Received Study Treatment|Overall Study||106
1596096|NCT01023581|3902182|P5|Received Study Treatment|Overall Study||111
1596097|NCT01023581|3902183|P4|Received Study Treatment|Overall Study||109
1596098|NCT01023581|3902184|P3|Received Study Treatment|Overall Study||110
1596099|NCT01023581|3902185|P2|Received Study Treatment|Overall Study||112
1596100|NCT01023581|3902186|P1|Received Study Treatment|Overall Study||106
1596101|NCT01023581|3902180|P7|STARTED|Overall Study||114
1596102|NCT01023581|3902181|P6|STARTED|Overall Study||111
1596103|NCT01023581|3902182|P5|STARTED|Overall Study||111
1596104|NCT01023581|3902183|P4|STARTED|Overall Study||114
1596105|NCT01023581|3902184|P3|STARTED|Overall Study||113
1596106|NCT01023581|3902185|P2|STARTED|Overall Study||112
1596107|NCT01023581|3902186|P1|STARTED|Overall Study||109
1596108|NCT01023568|3902219|P3|NOT COMPLETED|Overall Study||0
1596109|NCT01023568|3902220|P2|NOT COMPLETED|Overall Study||0
1596110|NCT01023568|3902221|P1|NOT COMPLETED|Overall Study||0
1596111|NCT01023568|3902219|P3|COMPLETED|Overall Study||45
1596112|NCT01023568|3902220|P2|COMPLETED|Overall Study||44
1596113|NCT01023568|3902221|P1|COMPLETED|Overall Study||45
1596114|NCT01023568|3902219|P3|STARTED|Overall Study||45
1596115|NCT01023568|3902220|P2|STARTED|Overall Study||44
1596116|NCT01023568|3902221|P1|STARTED|Overall Study||45
1596117|NCT01023516|3902243|P2|NOT COMPLETED|Overall Study||18
1596118|NCT01023516|3902244|P1|NOT COMPLETED|Overall Study||24
1596119|NCT01023516|3902243|P2|COMPLETED|Overall Study||284
1596120|NCT01023516|3902244|P1|COMPLETED|Overall Study||289
1596121|NCT01023516|3902243|P2|STARTED|Overall Study||302
1596122|NCT01023516|3902244|P1|STARTED|Overall Study||313
1596123|NCT01023308|3902326|P2|NOT COMPLETED|Overall Study||279
1596124|NCT01023308|3902327|P1|NOT COMPLETED|Overall Study||285
1596125|NCT01023308|3902326|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
1596126|NCT01023308|3902327|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
1596127|NCT01023308|3902326|P2|STARTED|Overall Study||381
1596128|NCT01023308|3902327|P1|STARTED|Overall Study||387
1596129|NCT01023256|3902357|P4|NOT COMPLETED|Overall Study||5
1596130|NCT01023256|3902358|P3|NOT COMPLETED|Overall Study||1
1596131|NCT01023256|3902359|P2|NOT COMPLETED|Overall Study||3
1596132|NCT01023256|3902360|P1|NOT COMPLETED|Overall Study||4
1596133|NCT01023256|3902357|P4|COMPLETED|Overall Study||22
1596134|NCT01023256|3902358|P3|COMPLETED|Overall Study||23
1596135|NCT01023256|3902359|P2|COMPLETED|Overall Study||19
1596136|NCT01023256|3902360|P1|COMPLETED|Overall Study||21
1596137|NCT01023256|3902357|P4|STARTED|Overall Study||27
1596138|NCT01023256|3902358|P3|STARTED|Overall Study||24
1596139|NCT01023256|3902359|P2|STARTED|Overall Study||22
1596140|NCT01023256|3902360|P1|STARTED|Overall Study||25
1596141|NCT01023217|3902402|P2|NOT COMPLETED|Overall Study||0
1596142|NCT01023217|3902403|P1|NOT COMPLETED|Overall Study||1
1596143|NCT01023217|3902402|P2|COMPLETED|Overall Study||45
1596144|NCT01023217|3902403|P1|COMPLETED|Overall Study||44
1596145|NCT01023217|3902402|P2|STARTED|Overall Study||45
1596146|NCT01023217|3902403|P1|STARTED|Overall Study||45
1596147|NCT01023178|3902412|P3|NOT COMPLETED|Overall Study||3
1596148|NCT01023178|3902413|P2|NOT COMPLETED|Overall Study||2
1596149|NCT01023178|3902414|P1|NOT COMPLETED|Overall Study||2
1596150|NCT01023178|3902412|P3|COMPLETED|Overall Study||4
1596151|NCT01023178|3902413|P2|COMPLETED|Overall Study||6
1596152|NCT01023178|3902414|P1|COMPLETED|Overall Study||3
1596153|NCT01023178|3902412|P3|STARTED|Overall Study||7
1596154|NCT01023178|3902413|P2|STARTED|Overall Study||8
1596155|NCT01023178|3902414|P1|STARTED|Overall Study||5
1596156|NCT01023074|3902425|P3|NOT COMPLETED|Overall Study||0
1596157|NCT01023074|3902426|P2|NOT COMPLETED|Overall Study||0
1596158|NCT01023074|3902427|P1|NOT COMPLETED|Overall Study||0
1596159|NCT01023074|3902425|P3|COMPLETED|Overall Study||13
1596160|NCT01023074|3902426|P2|COMPLETED|Overall Study||13
1596161|NCT01023074|3902427|P1|COMPLETED|Overall Study||26
1596162|NCT01023074|3902425|P3|STARTED|Overall Study||13
1596163|NCT01023074|3902426|P2|STARTED|Overall Study||13
1596164|NCT01023074|3902427|P1|STARTED|Overall Study||26
1596165|NCT01023061|3902441|P1|NOT COMPLETED|Overall Study||2
1596166|NCT01023061|3902441|P1|COMPLETED|Overall Study||22
1596167|NCT01023061|3902441|P1|STARTED|Overall Study||24
1596168|NCT01023035|3902450|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
1596169|NCT01023035|3902451|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
1596170|NCT01023035|3902452|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
1596171|NCT01023035|3902450|P3|COMPLETED|Follow-up Period (up to Week 72)||108
1596172|NCT01023035|3902451|P2|COMPLETED|Follow-up Period (up to Week 72)||207
1596173|NCT01023035|3902452|P1|COMPLETED|Follow-up Period (up to Week 72)||210
1596174|NCT01023035|3902450|P3|STARTED|Follow-up Period (up to Week 72)||147
1596175|NCT01023035|3902451|P2|STARTED|Follow-up Period (up to Week 72)||235
1596176|NCT01023035|3902452|P1|STARTED|Follow-up Period (up to Week 72)||238
1596177|NCT01023035|3902450|P3|NOT COMPLETED|Treatment Period||118
1596178|NCT01023035|3902451|P2|NOT COMPLETED|Treatment Period||85
1596179|NCT01023035|3902452|P1|NOT COMPLETED|Treatment Period||72
1596180|NCT01023035|3902450|P3|COMPLETED|Treatment Period||69
1596181|NCT01023035|3902451|P2|COMPLETED|Treatment Period||166
1596182|NCT01023035|3902452|P1|COMPLETED|Treatment Period||177
1596183|NCT01023035|3902450|P3|STARTED|Treatment Period||187
1596184|NCT01023035|3902451|P2|STARTED|Treatment Period||251
1596185|NCT01023035|3902452|P1|STARTED|Treatment Period||249
1596186|NCT01023022|3902462|P1|NOT COMPLETED|Overall Study||14
1596187|NCT01023022|3902462|P1|COMPLETED|Overall Study||162
1596188|NCT01023022|3902462|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
1596189|NCT01022996|3902468|P1|NOT COMPLETED|Overall Study||57
1596190|NCT01022996|3902468|P1|COMPLETED|Overall Study||0
1596191|NCT01022996|3902468|P1|STARTED|Overall Study||57
1596192|NCT01022853|3902482|P5|NOT COMPLETED|Overall Study||2
1596193|NCT01022853|3902483|P4|NOT COMPLETED|Overall Study||8
1596194|NCT01022853|3902484|P3|NOT COMPLETED|Overall Study||13
1596195|NCT01022853|3902485|P2|NOT COMPLETED|Overall Study||4
1596196|NCT01022853|3902486|P1|NOT COMPLETED|Overall Study||3
1596197|NCT01022853|3902482|P5|COMPLETED|Overall Study||0
1596198|NCT01022853|3902483|P4|COMPLETED|Overall Study||0
1596199|NCT01022853|3902484|P3|COMPLETED|Overall Study||0
1596200|NCT01022853|3902485|P2|COMPLETED|Overall Study||0
1596201|NCT01022853|3902486|P1|COMPLETED|Overall Study||0
1596202|NCT01022853|3902482|P5|STARTED|Overall Study|entered and treated|2
1596203|NCT01022853|3902483|P4|STARTED|Overall Study|entered and treated|8
1596204|NCT01022853|3902484|P3|STARTED|Overall Study|entered and treated|13
1596205|NCT01022853|3902485|P2|STARTED|Overall Study|entered and treated|4
1596206|NCT01022853|3902486|P1|STARTED|Overall Study|entered and treated|3
1596207|NCT01022762|3902565|P2|NOT COMPLETED|Overall Study||28
1596208|NCT01022762|3902566|P1|NOT COMPLETED|Overall Study||22
1596209|NCT01022762|3902565|P2|COMPLETED|Overall Study||194
1596210|NCT01022762|3902566|P1|COMPLETED|Overall Study||196
1596211|NCT01022762|3902565|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
1596212|NCT01022762|3902566|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
1596213|NCT01022762|3902565|P2|STARTED|Overall Study||222
1596214|NCT01022762|3902566|P1|STARTED|Overall Study||218
1596215|NCT01022567|3902594|P2|NOT COMPLETED|Overall Study||15
1596216|NCT01022567|3902595|P1|NOT COMPLETED|Overall Study||1
1596217|NCT01022567|3902594|P2|COMPLETED|Overall Study||242
1596218|NCT01022567|3902595|P1|COMPLETED|Overall Study||272
1596219|NCT01022567|3902594|P2|STARTED|Overall Study||257
1596220|NCT01022567|3902595|P1|STARTED|Overall Study||273
1596221|NCT01022502|3902601|P1|NOT COMPLETED|Overall Study||3
1596222|NCT01022502|3902601|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
1596223|NCT01022502|3902601|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
1596224|NCT01022424|3902615|P1|NOT COMPLETED|Overall Study||4
1596225|NCT01022424|3902615|P1|COMPLETED|Overall Study||9
1596226|NCT01022424|3902615|P1|STARTED|Overall Study||13
1596227|NCT01022398|3902630|P2|NOT COMPLETED|Overall Study||2
1596228|NCT01022398|3902631|P1|NOT COMPLETED|Overall Study||2
1596229|NCT01022398|3902630|P2|COMPLETED|Overall Study||0
1596230|NCT01022398|3902631|P1|COMPLETED|Overall Study||0
1596231|NCT01022398|3902630|P2|STARTED|Overall Study||2
1596232|NCT01022398|3902631|P1|STARTED|Overall Study||2
1596233|NCT01022307|3902638|P2|NOT COMPLETED|Overall Study||4
1596234|NCT01022307|3902639|P1|NOT COMPLETED|Overall Study||0
1596235|NCT01022307|3902638|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
1596236|NCT01022307|3902639|P1|COMPLETED|Overall Study||184
1596237|NCT01022307|3902638|P2|STARTED|Overall Study||28
1596238|NCT01022307|3902639|P1|STARTED|Overall Study||184
1596239|NCT01022242|3902647|P2|NOT COMPLETED|Overall Study||19
1596240|NCT01022242|3902648|P1|NOT COMPLETED|Overall Study||21
1596241|NCT01022242|3902647|P2|COMPLETED|Overall Study||46
1596242|NCT01022242|3902648|P1|COMPLETED|Overall Study||49
1596243|NCT01022242|3902647|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
1596244|NCT01022242|3902648|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
1596245|NCT01022203|3902656|P2|NOT COMPLETED|Follow-Up Assessment||2
1596246|NCT01022203|3902657|P1|NOT COMPLETED|Follow-Up Assessment||2
1596247|NCT01022203|3902656|P2|COMPLETED|Follow-Up Assessment||40
1596248|NCT01022203|3902657|P1|COMPLETED|Follow-Up Assessment||42
1596249|NCT01022203|3902656|P2|STARTED|Follow-Up Assessment||42
1596250|NCT01022203|3902657|P1|STARTED|Follow-Up Assessment||44
1596251|NCT01022203|3902656|P2|NOT COMPLETED|Post Treatment Assessment||14
1596252|NCT01022203|3902657|P1|NOT COMPLETED|Post Treatment Assessment||14
1596253|NCT01022203|3902656|P2|COMPLETED|Post Treatment Assessment||42
1596254|NCT01022203|3902657|P1|COMPLETED|Post Treatment Assessment||44
1596255|NCT01022203|3902656|P2|STARTED|Post Treatment Assessment||56
1596256|NCT01022203|3902657|P1|STARTED|Post Treatment Assessment||58
1596257|NCT01022203|3902656|P2|NOT COMPLETED|PreTreatment Assessment||0
1596258|NCT01022203|3902657|P1|NOT COMPLETED|PreTreatment Assessment||0
1596259|NCT01022203|3902656|P2|COMPLETED|PreTreatment Assessment||56
1596260|NCT01022203|3902657|P1|COMPLETED|PreTreatment Assessment||58
1596261|NCT01022203|3902656|P2|STARTED|PreTreatment Assessment||56
1596262|NCT01022203|3902657|P1|STARTED|PreTreatment Assessment||58
1596263|NCT01022190|3902667|P1|NOT COMPLETED|Overall Study||0
1596264|NCT01022190|3902667|P1|COMPLETED|Overall Study||42
1596265|NCT01022190|3902667|P1|STARTED|Overall Study||42
1596266|NCT01022112|3902676|P5|NOT COMPLETED|Overall Study||10
1596267|NCT01022112|3902677|P4|NOT COMPLETED|Overall Study||3
1596268|NCT01022112|3902678|P3|NOT COMPLETED|Overall Study||3
1596269|NCT01022112|3902679|P2|NOT COMPLETED|Overall Study||3
1596270|NCT01022112|3902680|P1|NOT COMPLETED|Overall Study||3
1596271|NCT01022112|3902676|P5|COMPLETED|Overall Study||65
1596272|NCT01022112|3902677|P4|COMPLETED|Overall Study||72
1596273|NCT01022112|3902678|P3|COMPLETED|Overall Study||74
1596274|NCT01022112|3902679|P2|COMPLETED|Overall Study||71
1596275|NCT01022112|3902680|P1|COMPLETED|Overall Study||79
1596276|NCT01022112|3902676|P5|STARTED|Overall Study||75
1596277|NCT01022112|3902677|P4|STARTED|Overall Study||75
1596278|NCT01022112|3902678|P3|STARTED|Overall Study||77
1596279|NCT01022112|3902679|P2|STARTED|Overall Study||74
1596280|NCT01022112|3902680|P1|STARTED|Overall Study||82
1596281|NCT01022073|3902694|P2|NOT COMPLETED|Overall Study||18
1596282|NCT01022073|3902695|P1|NOT COMPLETED|Overall Study||19
1596283|NCT01022073|3902694|P2|COMPLETED|Overall Study||52
1596284|NCT01022073|3902695|P1|COMPLETED|Overall Study||67
1596285|NCT01022073|3902694|P2|STARTED|Overall Study||70
1596286|NCT01022073|3902695|P1|STARTED|Overall Study||86
1596287|NCT01021956|3902705|P4|NOT COMPLETED|Overall Study||0
1596288|NCT01021956|3902706|P3|NOT COMPLETED|Overall Study||0
1596289|NCT01021956|3902707|P2|NOT COMPLETED|Overall Study||0
1596290|NCT01021956|3902708|P1|NOT COMPLETED|Overall Study||0
1596291|NCT01021956|3902705|P4|COMPLETED|Overall Study||1
1596292|NCT01021956|3902706|P3|COMPLETED|Overall Study||3
1596293|NCT01021956|3902707|P2|COMPLETED|Overall Study||3
1596294|NCT01021956|3902708|P1|COMPLETED|Overall Study||3
1596295|NCT01021956|3902705|P4|STARTED|Overall Study||1
1596296|NCT01021956|3902706|P3|STARTED|Overall Study||3
1596297|NCT01021956|3902707|P2|STARTED|Overall Study||3
1596298|NCT01021956|3902708|P1|STARTED|Overall Study||3
1596299|NCT01021878|3902729|P2|NOT COMPLETED|Overall Study||10
1596300|NCT01021878|3902730|P1|NOT COMPLETED|Overall Study||16
1596301|NCT01021878|3902729|P2|COMPLETED|Overall Study||17
1596302|NCT01021878|3902730|P1|COMPLETED|Overall Study||17
1596303|NCT01021878|3902729|P2|Completed Follow-up|Overall Study||17
1596304|NCT01021878|3902730|P1|Completed Follow-up|Overall Study||17
1596305|NCT01021878|3902729|P2|STARTED|Overall Study||27
1596306|NCT01021878|3902730|P1|STARTED|Overall Study||33
1596307|NCT01021852|3902752|P8|NOT COMPLETED|Treatment Period 2||2
1596308|NCT01021852|3902753|P7|NOT COMPLETED|Treatment Period 2||3
1596309|NCT01021852|3902754|P6|NOT COMPLETED|Treatment Period 2||1
1596310|NCT01021852|3902755|P5|NOT COMPLETED|Treatment Period 2||2
1596311|NCT01021852|3902756|P4|NOT COMPLETED|Treatment Period 2||0
1596312|NCT01021852|3902757|P3|NOT COMPLETED|Treatment Period 2||1
1596313|NCT01021852|3902758|P2|NOT COMPLETED|Treatment Period 2||1
1596314|NCT01021852|3902759|P1|NOT COMPLETED|Treatment Period 2||0
1596315|NCT01021852|3902752|P8|COMPLETED|Treatment Period 2||38
1596316|NCT01021852|3902753|P7|COMPLETED|Treatment Period 2||37
1596317|NCT01021852|3902754|P6|COMPLETED|Treatment Period 2||37
1596318|NCT01021852|3902755|P5|COMPLETED|Treatment Period 2||37
1596319|NCT01021852|3902756|P4|COMPLETED|Treatment Period 2||37
1596320|NCT01021852|3902757|P3|COMPLETED|Treatment Period 2||38
1596321|NCT01021852|3902758|P2|COMPLETED|Treatment Period 2||38
1596322|NCT01021852|3902759|P1|COMPLETED|Treatment Period 2||37
1596323|NCT01021852|3902752|P8|STARTED|Treatment Period 2||40
1596324|NCT01021852|3902753|P7|STARTED|Treatment Period 2||40
1596325|NCT01021852|3902754|P6|STARTED|Treatment Period 2||38
1596326|NCT01021852|3902755|P5|STARTED|Treatment Period 2||39
1596327|NCT01021852|3902756|P4|STARTED|Treatment Period 2||37
1596328|NCT01021852|3902757|P3|STARTED|Treatment Period 2||39
1596329|NCT01021852|3902758|P2|STARTED|Treatment Period 2||39
1596330|NCT01021852|3902759|P1|STARTED|Treatment Period 2||37
1596331|NCT01021852|3902752|P8|NOT COMPLETED|Washout Period-No Drug||0
1596332|NCT01021852|3902753|P7|NOT COMPLETED|Washout Period-No Drug||0
1596333|NCT01021852|3902754|P6|NOT COMPLETED|Washout Period-No Drug||1
1596334|NCT01021852|3902755|P5|NOT COMPLETED|Washout Period-No Drug||0
1596335|NCT01021852|3902756|P4|NOT COMPLETED|Washout Period-No Drug||0
1596336|NCT01021852|3902757|P3|NOT COMPLETED|Washout Period-No Drug||0
1596337|NCT01021852|3902758|P2|NOT COMPLETED|Washout Period-No Drug||0
1596338|NCT01021852|3902759|P1|NOT COMPLETED|Washout Period-No Drug||1
1596339|NCT01021852|3902752|P8|COMPLETED|Washout Period-No Drug||40
1596340|NCT01021852|3902753|P7|COMPLETED|Washout Period-No Drug||40
1596341|NCT01021852|3902754|P6|COMPLETED|Washout Period-No Drug||38
1596342|NCT01021852|3902755|P5|COMPLETED|Washout Period-No Drug||39
1596343|NCT01021852|3902756|P4|COMPLETED|Washout Period-No Drug||37
1596344|NCT01021852|3902757|P3|COMPLETED|Washout Period-No Drug||39
1596345|NCT01021852|3902758|P2|COMPLETED|Washout Period-No Drug||39
1596346|NCT01021852|3902759|P1|COMPLETED|Washout Period-No Drug||37
1596347|NCT01021852|3902752|P8|STARTED|Washout Period-No Drug||40
1596348|NCT01021852|3902753|P7|STARTED|Washout Period-No Drug||40
1596349|NCT01021852|3902754|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
1596350|NCT01021852|3902755|P5|STARTED|Washout Period-No Drug||39
1596351|NCT01021852|3902756|P4|STARTED|Washout Period-No Drug||37
1596352|NCT01021852|3902757|P3|STARTED|Washout Period-No Drug||39
1596353|NCT01021852|3902758|P2|STARTED|Washout Period-No Drug||39
1596354|NCT01021852|3902759|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
1596355|NCT01021852|3902752|P8|NOT COMPLETED|Washout Period-Placebo||0
1596356|NCT01021852|3902753|P7|NOT COMPLETED|Washout Period-Placebo||1
1596357|NCT01021852|3902754|P6|NOT COMPLETED|Washout Period-Placebo||1
1596358|NCT01021852|3902755|P5|NOT COMPLETED|Washout Period-Placebo||1
1596359|NCT01021852|3902756|P4|NOT COMPLETED|Washout Period-Placebo||1
1596360|NCT01021852|3902757|P3|NOT COMPLETED|Washout Period-Placebo||0
1596361|NCT01021852|3902758|P2|NOT COMPLETED|Washout Period-Placebo||0
1596362|NCT01021852|3902759|P1|NOT COMPLETED|Washout Period-Placebo||0
1596363|NCT01021852|3902752|P8|COMPLETED|Washout Period-Placebo||40
1596364|NCT01021852|3902753|P7|COMPLETED|Washout Period-Placebo||40
1596365|NCT01021852|3902754|P6|COMPLETED|Washout Period-Placebo||38
1596366|NCT01021852|3902755|P5|COMPLETED|Washout Period-Placebo||39
1596367|NCT01021852|3902756|P4|COMPLETED|Washout Period-Placebo||37
1596368|NCT01021852|3902757|P3|COMPLETED|Washout Period-Placebo||39
1596369|NCT01021852|3902758|P2|COMPLETED|Washout Period-Placebo||39
1596370|NCT01021852|3902759|P1|COMPLETED|Washout Period-Placebo||37
1596371|NCT01021852|3902752|P8|STARTED|Washout Period-Placebo||40
1596372|NCT01021852|3902753|P7|STARTED|Washout Period-Placebo||41
1596373|NCT01021852|3902754|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
1596374|NCT01021852|3902755|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
1596375|NCT01021852|3902756|P4|STARTED|Washout Period-Placebo||38
1596376|NCT01021852|3902757|P3|STARTED|Washout Period-Placebo||39
1596377|NCT01021852|3902758|P2|STARTED|Washout Period-Placebo||39
1596378|NCT01021852|3902759|P1|STARTED|Washout Period-Placebo||37
1596379|NCT01021852|3902752|P8|NOT COMPLETED|Treatment Period 1||1
1596380|NCT01021852|3902753|P7|NOT COMPLETED|Treatment Period 1||0
1596381|NCT01021852|3902754|P6|NOT COMPLETED|Treatment Period 1||2
1596382|NCT01021852|3902755|P5|NOT COMPLETED|Treatment Period 1||3
1596383|NCT01021852|3902756|P4|NOT COMPLETED|Treatment Period 1||2
1596384|NCT01021852|3902757|P3|NOT COMPLETED|Treatment Period 1||2
1596385|NCT01021852|3902758|P2|NOT COMPLETED|Treatment Period 1||1
1596386|NCT01021852|3902759|P1|NOT COMPLETED|Treatment Period 1||3
1596387|NCT01021852|3902752|P8|COMPLETED|Treatment Period 1||40
1596388|NCT01021852|3902753|P7|COMPLETED|Treatment Period 1||41
1596389|NCT01021852|3902754|P6|COMPLETED|Treatment Period 1||39
1596390|NCT01021852|3902755|P5|COMPLETED|Treatment Period 1||39
1596391|NCT01021852|3902756|P4|COMPLETED|Treatment Period 1||38
1596392|NCT01021852|3902757|P3|COMPLETED|Treatment Period 1||39
1596393|NCT01021852|3902758|P2|COMPLETED|Treatment Period 1||39
1596394|NCT01021852|3902759|P1|COMPLETED|Treatment Period 1||37
1596395|NCT01021852|3902752|P8|Treated|Treatment Period 1||41
1596396|NCT01021852|3902753|P7|Treated|Treatment Period 1||41
1596397|NCT01021852|3902754|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
1596398|NCT01021852|3902755|P5|Treated|Treatment Period 1||42
1596399|NCT01021852|3902756|P4|Treated|Treatment Period 1||38
1596400|NCT01021852|3902757|P3|Treated|Treatment Period 1||41
1596401|NCT01021852|3902758|P2|Treated|Treatment Period 1||40
1596402|NCT01021852|3902759|P1|Treated|Treatment Period 1||40
1596403|NCT01021852|3902752|P8|STARTED|Treatment Period 1||41
1596404|NCT01021852|3902753|P7|STARTED|Treatment Period 1||41
1596405|NCT01021852|3902754|P6|STARTED|Treatment Period 1||41
1596406|NCT01021852|3902755|P5|STARTED|Treatment Period 1||42
1596407|NCT01021852|3902756|P4|STARTED|Treatment Period 1||40
1596408|NCT01021852|3902757|P3|STARTED|Treatment Period 1||41
1596409|NCT01021852|3902758|P2|STARTED|Treatment Period 1||40
1596410|NCT01021852|3902759|P1|STARTED|Treatment Period 1||40
1596411|NCT01021813|3902795|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
1596412|NCT01021813|3902796|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
1596413|NCT01021813|3902797|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
1596414|NCT01021813|3902798|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
1596415|NCT01021813|3902799|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
1596416|NCT01021813|3902795|P5|COMPLETED|DB Randomized Discontinuation Phase||157
1596417|NCT01021813|3902796|P4|COMPLETED|DB Randomized Discontinuation Phase||161
1596418|NCT01021813|3902797|P3|COMPLETED|DB Randomized Discontinuation Phase||152
1596419|NCT01021813|3902798|P2|COMPLETED|DB Randomized Discontinuation Phase||0
1596420|NCT01021813|3902799|P1|COMPLETED|DB Randomized Discontinuation Phase||0
1596421|NCT01021813|3902795|P5|STARTED|DB Randomized Discontinuation Phase||162
1596422|NCT01021813|3902796|P4|STARTED|DB Randomized Discontinuation Phase||166
1596423|NCT01021813|3902797|P3|STARTED|DB Randomized Discontinuation Phase||156
1596424|NCT01021813|3902798|P2|STARTED|DB Randomized Discontinuation Phase||0
1596425|NCT01021813|3902799|P1|STARTED|DB Randomized Discontinuation Phase||0
1596426|NCT01021813|3902795|P5|NOT COMPLETED|DB Treatment Phase||0
1596427|NCT01021813|3902796|P4|NOT COMPLETED|DB Treatment Phase||0
1596428|NCT01021813|3902797|P3|NOT COMPLETED|DB Treatment Phase||0
1596429|NCT01021813|3902798|P2|NOT COMPLETED|DB Treatment Phase||97
1596430|NCT01021813|3902799|P1|NOT COMPLETED|DB Treatment Phase||200
1596431|NCT01021813|3902795|P5|COMPLETED|DB Treatment Phase||0
1596432|NCT01021813|3902796|P4|COMPLETED|DB Treatment Phase||0
1596433|NCT01021813|3902797|P3|COMPLETED|DB Treatment Phase||0
1596434|NCT01021813|3902798|P2|COMPLETED|DB Treatment Phase||162
1596435|NCT01021813|3902799|P1|COMPLETED|DB Treatment Phase||322
1596436|NCT01021813|3902795|P5|Treated|DB Treatment Phase||0
1596437|NCT01021813|3902796|P4|Treated|DB Treatment Phase||0
1596438|NCT01021813|3902797|P3|Treated|DB Treatment Phase||0
1596439|NCT01021813|3902798|P2|Treated|DB Treatment Phase||258
1596440|NCT01021813|3902799|P1|Treated|DB Treatment Phase||521
1596441|NCT01021813|3902795|P5|STARTED|DB Treatment Phase||0
1596442|NCT01021813|3902796|P4|STARTED|DB Treatment Phase||0
1596443|NCT01021813|3902797|P3|STARTED|DB Treatment Phase||0
1596444|NCT01021813|3902798|P2|STARTED|DB Treatment Phase||259
1596445|NCT01021813|3902799|P1|STARTED|DB Treatment Phase||522
1596446|NCT01021761|3902841|P3|NOT COMPLETED|Overall Study||0
1596447|NCT01021761|3902842|P2|NOT COMPLETED|Overall Study||4
1596448|NCT01021761|3902843|P1|NOT COMPLETED|Overall Study||1
1596449|NCT01021761|3902841|P3|COMPLETED|Overall Study||42
1596450|NCT01021761|3902842|P2|COMPLETED|Overall Study||38
1596451|NCT01021761|3902843|P1|COMPLETED|Overall Study||41
1596452|NCT01021761|3902841|P3|STARTED|Overall Study||42
1596453|NCT01021761|3902842|P2|STARTED|Overall Study||42
1596454|NCT01021761|3902843|P1|STARTED|Overall Study||42
1596455|NCT01021748|3902860|P9|NOT COMPLETED|Overall Study||16
1596456|NCT01021748|3902861|P8|NOT COMPLETED|Overall Study||6
1596457|NCT01021748|3902862|P7|NOT COMPLETED|Overall Study||3
1596458|NCT01021748|3902863|P6|NOT COMPLETED|Overall Study||3
1596459|NCT01021748|3902864|P5|NOT COMPLETED|Overall Study||9
1596460|NCT01021748|3902865|P4|NOT COMPLETED|Overall Study||7
1596461|NCT01021748|3902866|P3|NOT COMPLETED|Overall Study||7
1596462|NCT01021748|3902867|P2|NOT COMPLETED|Overall Study||5
1596463|NCT01021748|3902868|P1|NOT COMPLETED|Overall Study||6
1596464|NCT01021748|3902860|P9|COMPLETED|Overall Study||1
1596465|NCT01021748|3902861|P8|COMPLETED|Overall Study||0
1596466|NCT01021748|3902862|P7|COMPLETED|Overall Study||0
1596467|NCT01021748|3902863|P6|COMPLETED|Overall Study||0
1596468|NCT01021748|3902864|P5|COMPLETED|Overall Study||0
1596469|NCT01021748|3902865|P4|COMPLETED|Overall Study||0
1596470|NCT01021748|3902866|P3|COMPLETED|Overall Study||0
1596471|NCT01021748|3902867|P2|COMPLETED|Overall Study||0
1596472|NCT01021748|3902868|P1|COMPLETED|Overall Study||0
1596473|NCT01021748|3902860|P9|Treated|Overall Study||17
1596474|NCT01021748|3902861|P8|Treated|Overall Study||6
1596475|NCT01021748|3902862|P7|Treated|Overall Study||3
1596476|NCT01021748|3902863|P6|Treated|Overall Study||3
1596477|NCT01021748|3902864|P5|Treated|Overall Study||9
1596478|NCT01021748|3902865|P4|Treated|Overall Study||7
1596479|NCT01021748|3902866|P3|Treated|Overall Study||7
1596480|NCT01021748|3902867|P2|Treated|Overall Study|One participant was allocated, but not treated.|4
1596481|NCT01021748|3902868|P1|Treated|Overall Study||6
1596482|NCT01021748|3902860|P9|STARTED|Overall Study||17
1596483|NCT01021748|3902861|P8|STARTED|Overall Study||6
1596484|NCT01021748|3902862|P7|STARTED|Overall Study||3
1596485|NCT01021748|3902863|P6|STARTED|Overall Study||3
1596486|NCT01021748|3902864|P5|STARTED|Overall Study||9
1596487|NCT01021748|3902865|P4|STARTED|Overall Study||7
1596488|NCT01021748|3902866|P3|STARTED|Overall Study||7
1596489|NCT01021748|3902867|P2|STARTED|Overall Study||5
1596490|NCT01021748|3902868|P1|STARTED|Overall Study||6
1596491|NCT01021683|3902915|P1|NOT COMPLETED|Overall Study||71
1596492|NCT01021683|3902915|P1|COMPLETED|Overall Study||132
1596493|NCT01021683|3902915|P1|STARTED|Overall Study||203
1596494|NCT01021618|3902929|P2|NOT COMPLETED|Overall Study||0
1596495|NCT01021618|3902930|P1|NOT COMPLETED|Overall Study||0
1596496|NCT01021618|3902929|P2|COMPLETED|Overall Study||96
1596497|NCT01021618|3902930|P1|COMPLETED|Overall Study||44
1596498|NCT01021618|3902929|P2|STARTED|Overall Study||96
1596499|NCT01021618|3902930|P1|STARTED|Overall Study||44
1596500|NCT01021553|3902941|P3|NOT COMPLETED|Overall Study||3
1596501|NCT01021553|3902942|P2|NOT COMPLETED|Overall Study||5
1596502|NCT01021553|3902943|P1|NOT COMPLETED|Overall Study||4
1596503|NCT01021553|3902941|P3|COMPLETED|Overall Study||25
1596504|NCT01021553|3902942|P2|COMPLETED|Overall Study||17
1596505|NCT01021553|3902943|P1|COMPLETED|Overall Study||23
1596506|NCT01021553|3902941|P3|STARTED|Overall Study||28
1596507|NCT01021553|3902942|P2|STARTED|Overall Study||22
1596508|NCT01021553|3902943|P1|STARTED|Overall Study||27
1596509|NCT01021423|3902997|P2|NOT COMPLETED|Overall Study||5
1596510|NCT01021423|3902998|P1|NOT COMPLETED|Overall Study||4
1596511|NCT01021423|3902997|P2|COMPLETED|Overall Study||0
1596512|NCT01021423|3902998|P1|COMPLETED|Overall Study||0
1596513|NCT01021423|3902997|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
1596514|NCT01021423|3902998|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
1596515|NCT01021332|3903014|P1|NOT COMPLETED|Overall Study||106
1596516|NCT01021332|3903014|P1|COMPLETED|Overall Study||960
1596517|NCT01021332|3903014|P1|Full Analysis Set (FAS)|Overall Study||1009
1596518|NCT01021332|3903014|P1|Safety Analysis Set (SAF)|Overall Study||1066
1596519|NCT01021332|3903014|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
1596520|NCT01021306|3903052|P4|NOT COMPLETED|6 Month (Follow-up)||3
1596521|NCT01021306|3903053|P3|NOT COMPLETED|6 Month (Follow-up)||0
1596522|NCT01021306|3903054|P2|NOT COMPLETED|6 Month (Follow-up)||1
1596523|NCT01021306|3903055|P1|NOT COMPLETED|6 Month (Follow-up)||3
1596524|NCT01021306|3903052|P4|COMPLETED|6 Month (Follow-up)||14
1596525|NCT01021306|3903053|P3|COMPLETED|6 Month (Follow-up)||14
1596526|NCT01021306|3903054|P2|COMPLETED|6 Month (Follow-up)||13
1596527|NCT01021306|3903055|P1|COMPLETED|6 Month (Follow-up)||11
1596528|NCT01021306|3903052|P4|STARTED|6 Month (Follow-up)||17
1596529|NCT01021306|3903053|P3|STARTED|6 Month (Follow-up)||14
1596530|NCT01021306|3903054|P2|STARTED|6 Month (Follow-up)||14
1596531|NCT01021306|3903055|P1|STARTED|6 Month (Follow-up)||14
1596532|NCT01021306|3903052|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
1596533|NCT01021306|3903053|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
1596534|NCT01021306|3903054|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
1596535|NCT01021306|3903055|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
1596536|NCT01021306|3903052|P4|COMPLETED|2 Month (Primary Outcome)||17
1596537|NCT01021306|3903053|P3|COMPLETED|2 Month (Primary Outcome)||14
1596538|NCT01021306|3903054|P2|COMPLETED|2 Month (Primary Outcome)||14
1596539|NCT01021306|3903055|P1|COMPLETED|2 Month (Primary Outcome)||14
1596540|NCT01021306|3903052|P4|STARTED|2 Month (Primary Outcome)||21
1596541|NCT01021306|3903053|P3|STARTED|2 Month (Primary Outcome)||19
1596542|NCT01021306|3903054|P2|STARTED|2 Month (Primary Outcome)||20
1596543|NCT01021306|3903055|P1|STARTED|2 Month (Primary Outcome)||20
1596544|NCT01021293|3903075|P2|NOT COMPLETED|Overall Study||24
1596545|NCT01021293|3903076|P1|NOT COMPLETED|Overall Study||12
1596546|NCT01021293|3903075|P2|COMPLETED|Overall Study||526
1596547|NCT01021293|3903076|P1|COMPLETED|Overall Study||538
1596548|NCT01021293|3903075|P2|STARTED|Overall Study||550
1596549|NCT01021293|3903076|P1|STARTED|Overall Study||550
1596550|NCT01021215|3903095|P2|NOT COMPLETED|Overall Study||0
1596551|NCT01021215|3903096|P1|NOT COMPLETED|Overall Study||3
1596552|NCT01021215|3903095|P2|COMPLETED|Overall Study||20
1596553|NCT01021215|3903096|P1|COMPLETED|Overall Study||57
1596554|NCT01021215|3903095|P2|Received Allocated Intervention|Overall Study||20
1596555|NCT01021215|3903096|P1|Received Allocated Intervention|Overall Study||60
1596556|NCT01021215|3903095|P2|STARTED|Overall Study||20
1596557|NCT01021215|3903096|P1|STARTED|Overall Study||60
1596558|NCT01021111|3903106|P1|NOT COMPLETED|Overall Study||0
1596559|NCT01021111|3903106|P1|COMPLETED|Overall Study||17
1596560|NCT01021111|3903106|P1|STARTED|Overall Study||17
1596561|NCT01021020|3903111|P1|NOT COMPLETED|Period III||0
1596562|NCT01021020|3903111|P1|COMPLETED|Period III||25
1596563|NCT01021020|3903111|P1|STARTED|Period III||25
1596564|NCT01021020|3903111|P1|NOT COMPLETED|14 Day Washout Period B||0
1596565|NCT01021020|3903111|P1|COMPLETED|14 Day Washout Period B||25
1596566|NCT01021020|3903111|P1|STARTED|14 Day Washout Period B||25
1596567|NCT01021020|3903111|P1|NOT COMPLETED|Period II||0
1596568|NCT01021020|3903111|P1|COMPLETED|Period II||25
1596569|NCT01021020|3903111|P1|STARTED|Period II||25
1596570|NCT01021020|3903111|P1|NOT COMPLETED|14 Day Washout Period A||1
1596571|NCT01021020|3903111|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
1596572|NCT01021020|3903111|P1|STARTED|14 Day Washout Period A||26
1596573|NCT01021020|3903111|P1|NOT COMPLETED|Period I||2
1596574|NCT01021020|3903111|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
1596575|NCT01021020|3903111|P1|STARTED|Period I||28
1596576|NCT01021007|3903127|P2|NOT COMPLETED|Overall Study||4
1596577|NCT01021007|3903128|P1|NOT COMPLETED|Overall Study||2
1596578|NCT01021007|3903127|P2|COMPLETED|Overall Study||33
1596579|NCT01021007|3903128|P1|COMPLETED|Overall Study||34
1596580|NCT01021007|3903127|P2|STARTED|Overall Study||37
1596581|NCT01021007|3903128|P1|STARTED|Overall Study||36
1596582|NCT01020981|3903140|P2|NOT COMPLETED|Overall Study||90
1596583|NCT01020981|3903141|P1|NOT COMPLETED|Overall Study||84
1596584|NCT01020981|3903140|P2|COMPLETED|Overall Study||60
1596585|NCT01020981|3903141|P1|COMPLETED|Overall Study||66
1596586|NCT01020981|3903140|P2|STARTED|Overall Study||150
1596587|NCT01020981|3903141|P1|STARTED|Overall Study||150
1596588|NCT01020903|3903153|P2|NOT COMPLETED|Overall Study||0
1596589|NCT01020903|3903154|P1|NOT COMPLETED|Overall Study||0
1596590|NCT01020903|3903153|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
1596591|NCT01020903|3903154|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
1596592|NCT01020903|3903153|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
1596593|NCT01020903|3903154|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
1596594|NCT01020877|3903162|P2|NOT COMPLETED|Second Intervention||0
1596595|NCT01020877|3903163|P1|NOT COMPLETED|Second Intervention||1
1596596|NCT01020877|3903162|P2|COMPLETED|Second Intervention||19
1596597|NCT01020877|3903163|P1|COMPLETED|Second Intervention||18
1596598|NCT01020877|3903162|P2|STARTED|Second Intervention||19
1596599|NCT01020877|3903163|P1|STARTED|Second Intervention||19
1596600|NCT01020877|3903162|P2|NOT COMPLETED|Washout of 7 Days||0
1596601|NCT01020877|3903163|P1|NOT COMPLETED|Washout of 7 Days||0
1596602|NCT01020877|3903162|P2|COMPLETED|Washout of 7 Days||19
1596603|NCT01020877|3903163|P1|COMPLETED|Washout of 7 Days||19
1596604|NCT01020877|3903162|P2|STARTED|Washout of 7 Days||19
1596605|NCT01020877|3903163|P1|STARTED|Washout of 7 Days||19
1596606|NCT01020877|3903162|P2|NOT COMPLETED|First Intervention||0
1596607|NCT01020877|3903163|P1|NOT COMPLETED|First Intervention||0
1596608|NCT01020877|3903162|P2|COMPLETED|First Intervention||19
1596609|NCT01020877|3903163|P1|COMPLETED|First Intervention||19
1596610|NCT01020877|3903162|P2|STARTED|First Intervention||19
1596611|NCT01020877|3903163|P1|STARTED|First Intervention||19
1596612|NCT01020838|3903173|P1|NOT COMPLETED|Overall Study||183
1596613|NCT01020838|3903173|P1|COMPLETED|Overall Study||35
1596614|NCT01020838|3903173|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
1596615|NCT01020838|3903173|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
1596616|NCT01020838|3903173|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
1596617|NCT01020838|3903173|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
1596618|NCT01020838|3903173|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
1596619|NCT01020838|3903173|P1|STARTED|Overall Study||218
1596620|NCT01020812|3903188|P1|NOT COMPLETED|Overall Study||3
1596621|NCT01020812|3903188|P1|COMPLETED|Overall Study||8
1596622|NCT01020812|3903188|P1|STARTED|Overall Study||11
1596623|NCT01020799|3903198|P3|NOT COMPLETED|Overall Study||7
1596624|NCT01020799|3903199|P2|NOT COMPLETED|Overall Study||14
1596625|NCT01020799|3903200|P1|NOT COMPLETED|Overall Study||19
1596626|NCT01020799|3903198|P3|COMPLETED|Overall Study||43
1596627|NCT01020799|3903199|P2|COMPLETED|Overall Study||85
1596628|NCT01020799|3903200|P1|COMPLETED|Overall Study||79
1596629|NCT01020799|3903198|P3|Full Analysis Set|Overall Study||49
1596630|NCT01020799|3903199|P2|Full Analysis Set|Overall Study||94
1596631|NCT01020799|3903200|P1|Full Analysis Set|Overall Study||91
1596632|NCT01020799|3903198|P3|Patients Received Treatment|Overall Study||50
1596633|NCT01020799|3903199|P2|Patients Received Treatment|Overall Study||99
1596634|NCT01020799|3903200|P1|Patients Received Treatment|Overall Study||96
1596635|NCT01020799|3903198|P3|STARTED|Overall Study||50
1596636|NCT01020799|3903199|P2|STARTED|Overall Study||99
1596637|NCT01020799|3903200|P1|STARTED|Overall Study||98
1596638|NCT01020786|3903223|P1|NOT COMPLETED|Maintenance Period||60
1596639|NCT01020786|3903223|P1|COMPLETED|Maintenance Period||0
1596640|NCT01020786|3903223|P1|STARTED|Maintenance Period||60
1596641|NCT01020786|3903223|P1|NOT COMPLETED|Induction Period||49
1596642|NCT01020786|3903223|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
1596643|NCT01020786|3903223|P1|STARTED|Induction Period||109
1596644|NCT01020773|3903237|P2|NOT COMPLETED|Overall Study||3
1596645|NCT01020773|3903238|P1|NOT COMPLETED|Overall Study||4
1596646|NCT01020773|3903237|P2|COMPLETED|Overall Study||29
1596647|NCT01020773|3903238|P1|COMPLETED|Overall Study||31
1596648|NCT01020773|3903237|P2|STARTED|Overall Study||32
1596649|NCT01020773|3903238|P1|STARTED|Overall Study||35
1596650|NCT01020747|3903244|P1|NOT COMPLETED|Overall Study||1
1596651|NCT01020747|3903244|P1|COMPLETED|Overall Study||19
1596652|NCT01020747|3903244|P1|STARTED|Overall Study||20
1596653|NCT01020591|3903251|P2|NOT COMPLETED|Overall Study||0
1596654|NCT01020591|3903252|P1|NOT COMPLETED|Overall Study||0
1596655|NCT01020591|3903251|P2|COMPLETED|Overall Study||15
1596656|NCT01020591|3903252|P1|COMPLETED|Overall Study||15
1596657|NCT01020591|3903251|P2|STARTED|Overall Study||15
1596658|NCT01020591|3903252|P1|STARTED|Overall Study||15
1596659|NCT01020526|3903260|P1|NOT COMPLETED|Overall Study||14
1596660|NCT01020526|3903260|P1|COMPLETED|Overall Study||49
1596661|NCT01020526|3903260|P1|STARTED|Overall Study||63
1596662|NCT01020474|3903266|P2|NOT COMPLETED|Overall Study||17
1596663|NCT01020474|3903267|P1|NOT COMPLETED|Overall Study||10
1596664|NCT01020474|3903266|P2|COMPLETED|Overall Study||36
1596665|NCT01020474|3903267|P1|COMPLETED|Overall Study||44
1596666|NCT01020474|3903266|P2|STARTED|Overall Study||53
1596667|NCT01020474|3903267|P1|STARTED|Overall Study||54
1596668|NCT01020448|3903287|P1|NOT COMPLETED|Treatment||26
1596669|NCT01020448|3903287|P1|COMPLETED|Treatment||299
1596670|NCT01020448|3903287|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
1596671|NCT01020448|3903287|P1|NOT COMPLETED|Pre-assignment||13
1596672|NCT01020448|3903287|P1|COMPLETED|Pre-assignment||326
1596673|NCT01020448|3903287|P1|STARTED|Pre-assignment||339
1596674|NCT01020435|3903298|P2|NOT COMPLETED|Overall Study||1
1596675|NCT01020435|3903299|P1|NOT COMPLETED|Overall Study||0
1596676|NCT01020435|3903298|P2|COMPLETED|Overall Study||26
1596677|NCT01020435|3903299|P1|COMPLETED|Overall Study||24
1596678|NCT01020435|3903298|P2|STARTED|Overall Study||27
1596679|NCT01020435|3903299|P1|STARTED|Overall Study||24
1596680|NCT01020305|3903307|P1|NOT COMPLETED|Overall Study||2
1596681|NCT01020305|3903307|P1|COMPLETED|Overall Study||3
1596682|NCT01020305|3903307|P1|STARTED|Overall Study||5
1596683|NCT01020123|3903318|P7|NOT COMPLETED|Extention Period||1
1596684|NCT01020123|3903319|P6|NOT COMPLETED|Extention Period||2
1596685|NCT01020123|3903320|P5|NOT COMPLETED|Extention Period||0
1596686|NCT01020123|3903321|P4|NOT COMPLETED|Extention Period||1
1596687|NCT01020123|3903322|P3|NOT COMPLETED|Extention Period||2
1596688|NCT01020123|3903323|P2|NOT COMPLETED|Extention Period||2
1596689|NCT01020123|3903324|P1|NOT COMPLETED|Extention Period||3
1596690|NCT01020123|3903318|P7|COMPLETED|Extention Period||18
1596691|NCT01020123|3903319|P6|COMPLETED|Extention Period||36
1596692|NCT01020123|3903320|P5|COMPLETED|Extention Period||31
1596693|NCT01020123|3903321|P4|COMPLETED|Extention Period||12
1596694|NCT01020123|3903322|P3|COMPLETED|Extention Period||17
1596695|NCT01020123|3903323|P2|COMPLETED|Extention Period||33
1596696|NCT01020123|3903324|P1|COMPLETED|Extention Period||37
1596697|NCT01020123|3903318|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
1596698|NCT01020123|3903319|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
1596699|NCT01020123|3903320|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
1596700|NCT01020123|3903321|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
1596701|NCT01020123|3903322|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
1596702|NCT01020123|3903323|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
1596703|NCT01020123|3903324|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
1596704|NCT01020123|3903318|P7|NOT COMPLETED|Main Period||11
1596705|NCT01020123|3903319|P6|NOT COMPLETED|Main Period||11
1596706|NCT01020123|3903320|P5|NOT COMPLETED|Main Period||11
1596707|NCT01020123|3903321|P4|NOT COMPLETED|Main Period||7
1596708|NCT01020123|3903322|P3|NOT COMPLETED|Main Period||8
1596709|NCT01020123|3903323|P2|NOT COMPLETED|Main Period||14
1596710|NCT01020123|3903324|P1|NOT COMPLETED|Main Period||17
1596711|NCT01020123|3903318|P7|COMPLETED|Main Period||61
1596712|NCT01020123|3903319|P6|COMPLETED|Main Period||83
1596713|NCT01020123|3903320|P5|COMPLETED|Main Period||77
1596714|NCT01020123|3903321|P4|COMPLETED|Main Period||33
1596715|NCT01020123|3903322|P3|COMPLETED|Main Period||44
1596716|NCT01020123|3903323|P2|COMPLETED|Main Period||77
1596717|NCT01020123|3903324|P1|COMPLETED|Main Period||76
1596718|NCT01020123|3903318|P7|STARTED|Main Period||72
1596719|NCT01020123|3903319|P6|STARTED|Main Period||94
1596720|NCT01020123|3903320|P5|STARTED|Main Period||88
1596721|NCT01020123|3903321|P4|STARTED|Main Period||40
1596722|NCT01020123|3903322|P3|STARTED|Main Period||52
1596723|NCT01020123|3903323|P2|STARTED|Main Period||91
1596724|NCT01020123|3903324|P1|STARTED|Main Period||93
1596725|NCT01020019|3903519|P2|NOT COMPLETED|Overall Study||29
1596726|NCT01020019|3903520|P1|NOT COMPLETED|Overall Study||26
1596727|NCT01020019|3903519|P2|COMPLETED|Overall Study||32
1596728|NCT01020019|3903520|P1|COMPLETED|Overall Study||35
1596729|NCT01020019|3903519|P2|STARTED|Overall Study||61
1596730|NCT01020019|3903520|P1|STARTED|Overall Study||61
1596731|NCT01020006|3903529|P3|NOT COMPLETED|Overall Study||16
1596732|NCT01020006|3903530|P2|NOT COMPLETED|Overall Study||18
1596733|NCT01020006|3903531|P1|NOT COMPLETED|Overall Study||8
1596734|NCT01020006|3903529|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
1596735|NCT01020006|3903530|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
1596736|NCT01020006|3903531|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
1596737|NCT01020006|3903529|P3|STARTED|Overall Study||16
1596738|NCT01020006|3903530|P2|STARTED|Overall Study||18
1596739|NCT01020006|3903531|P1|STARTED|Overall Study||8
1596740|NCT01019980|3903541|P2|NOT COMPLETED|Overall Study||0
1596741|NCT01019980|3903542|P1|NOT COMPLETED|Overall Study||2
1596742|NCT01019980|3903541|P2|COMPLETED|Overall Study||0
1596743|NCT01019980|3903542|P1|COMPLETED|Overall Study||0
1596744|NCT01019980|3903541|P2|Discontinued|Overall Study||0
1596745|NCT01019980|3903542|P1|Discontinued|Overall Study||2
1596746|NCT01019980|3903541|P2|STARTED|Overall Study||0
1596747|NCT01019980|3903542|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
1596748|NCT01019928|3903550|P2|NOT COMPLETED|Period 3||0
1596749|NCT01019928|3903551|P1|NOT COMPLETED|Period 3||0
1596750|NCT01019928|3903550|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
1596751|NCT01019928|3903551|P1|COMPLETED|Period 3||7
1596752|NCT01019928|3903550|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
1596753|NCT01019928|3903551|P1|STARTED|Period 3||7
1596754|NCT01019928|3903550|P2|NOT COMPLETED|Period 2||1
1596755|NCT01019928|3903551|P1|NOT COMPLETED|Period 2||0
1596756|NCT01019928|3903550|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
1596757|NCT01019928|3903551|P1|COMPLETED|Period 2||7
1596758|NCT01019928|3903550|P2|STARTED|Period 2||7
1596759|NCT01019928|3903551|P1|STARTED|Period 2||7
1596760|NCT01019928|3903550|P2|NOT COMPLETED|Period 1||0
1596761|NCT01019928|3903551|P1|NOT COMPLETED|Period 1||0
1596762|NCT01019928|3903550|P2|COMPLETED|Period 1||7
1596763|NCT01019928|3903551|P1|COMPLETED|Period 1||7
1596764|NCT01019928|3903550|P2|STARTED|Period 1||7
1596765|NCT01019928|3903551|P1|STARTED|Period 1||7
1596766|NCT01019707|3903591|P2|NOT COMPLETED|Second Phase||0
1596767|NCT01019707|3903592|P1|NOT COMPLETED|Second Phase||0
1596768|NCT01019707|3903591|P2|COMPLETED|Second Phase||1
1596769|NCT01019707|3903592|P1|COMPLETED|Second Phase||3
1596770|NCT01019707|3903591|P2|STARTED|Second Phase||1
1596771|NCT01019707|3903592|P1|STARTED|Second Phase||3
1596772|NCT01019707|3903591|P2|NOT COMPLETED|Washout||2
1596773|NCT01019707|3903592|P1|NOT COMPLETED|Washout||0
1596774|NCT01019707|3903591|P2|COMPLETED|Washout||1
1596775|NCT01019707|3903592|P1|COMPLETED|Washout||3
1596776|NCT01019707|3903591|P2|STARTED|Washout||3
1596777|NCT01019707|3903592|P1|STARTED|Washout||3
1596778|NCT01019707|3903591|P2|NOT COMPLETED|First Phase||0
1596779|NCT01019707|3903592|P1|NOT COMPLETED|First Phase||0
1596780|NCT01019707|3903591|P2|COMPLETED|First Phase||3
1596781|NCT01019707|3903592|P1|COMPLETED|First Phase||3
1596782|NCT01019707|3903591|P2|STARTED|First Phase||3
1596783|NCT01019707|3903592|P1|STARTED|First Phase||3
1596784|NCT01019694|3903605|P3|NOT COMPLETED|Overall Study||47
1596785|NCT01019694|3903606|P2|NOT COMPLETED|Overall Study||38
1596786|NCT01019694|3903607|P1|NOT COMPLETED|Overall Study||24
1596787|NCT01019694|3903605|P3|COMPLETED|Overall Study||110
1596788|NCT01019694|3903606|P2|COMPLETED|Overall Study||118
1596789|NCT01019694|3903607|P1|COMPLETED|Overall Study||133
1596790|NCT01019694|3903605|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
1596791|NCT01019694|3903606|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
1596792|NCT01019694|3903607|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
1596793|NCT01019486|3903732|P3|NOT COMPLETED|Overall Study||1
1596794|NCT01019486|3903733|P2|NOT COMPLETED|Overall Study||1
1596795|NCT01019486|3903734|P1|NOT COMPLETED|Overall Study||1
1596796|NCT01019486|3903732|P3|COMPLETED|Overall Study||15
1596797|NCT01019486|3903733|P2|COMPLETED|Overall Study||4
1596798|NCT01019486|3903734|P1|COMPLETED|Overall Study||4
1596799|NCT01019486|3903732|P3|STARTED|Overall Study||16
1596800|NCT01019486|3903733|P2|STARTED|Overall Study||5
1596801|NCT01019486|3903734|P1|STARTED|Overall Study||5
1596802|NCT01019369|3903748|P2|NOT COMPLETED|Overall Study||7
1596803|NCT01019369|3903749|P1|NOT COMPLETED|Overall Study||10
1596804|NCT01019369|3903748|P2|COMPLETED|Overall Study||39
1596805|NCT01019369|3903749|P1|COMPLETED|Overall Study||76
1596806|NCT01019369|3903748|P2|STARTED|Overall Study||46
1596807|NCT01019369|3903749|P1|STARTED|Overall Study||86
1596808|NCT01019317|3903757|P1|NOT COMPLETED|Overall Study||4
1596809|NCT01019317|3903757|P1|COMPLETED|Overall Study||147
1596810|NCT01019317|3903757|P1|STARTED|Overall Study||151
1596811|NCT01019252|3903763|P2|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
1596812|NCT01019252|3903764|P1|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
1596813|NCT01019252|3903763|P2|COMPLETED|Wait List Cross-over to CBT for ADHD||15
1596814|NCT01019252|3903764|P1|COMPLETED|Wait List Cross-over to CBT for ADHD||21
1596815|NCT01019252|3903763|P2|STARTED|Wait List Cross-over to CBT for ADHD||22
1596816|NCT01019252|3903764|P1|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
1596817|NCT01019252|3903763|P2|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
1596818|NCT01019252|3903764|P1|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
1596819|NCT01019252|3903763|P2|COMPLETED|Initial CBT for ADHD vs. Wait List||22
1596820|NCT01019252|3903764|P1|COMPLETED|Initial CBT for ADHD vs. Wait List||21
1596821|NCT01019252|3903763|P2|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
1596822|NCT01019252|3903764|P1|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
1596823|NCT01019135|3903777|P3|NOT COMPLETED|Overall Study||31
1596824|NCT01019135|3903778|P2|NOT COMPLETED|Overall Study||19
1596825|NCT01019135|3903779|P1|NOT COMPLETED|Overall Study||20
1596826|NCT01019135|3903777|P3|COMPLETED|Overall Study||24
1596827|NCT01019135|3903778|P2|COMPLETED|Overall Study||40
1596828|NCT01019135|3903779|P1|COMPLETED|Overall Study||35
1596829|NCT01019135|3903777|P3|STARTED|Overall Study||55
1596830|NCT01019135|3903778|P2|STARTED|Overall Study||59
1596831|NCT01019135|3903779|P1|STARTED|Overall Study||55
1596832|NCT01018992|3903807|P2|NOT COMPLETED|Overall Study||16
1596833|NCT01018992|3903808|P1|NOT COMPLETED|Overall Study||16
1596834|NCT01018992|3903807|P2|COMPLETED|Overall Study||49
1596835|NCT01018992|3903808|P1|COMPLETED|Overall Study||47
1596836|NCT01018992|3903807|P2|STARTED|Overall Study||65
1596837|NCT01018992|3903808|P1|STARTED|Overall Study||63
1596838|NCT01018979|3903822|P2|NOT COMPLETED|Overall Study||10
1596839|NCT01018979|3903823|P1|NOT COMPLETED|Overall Study||3
1596840|NCT01018979|3903822|P2|COMPLETED|Overall Study||3
1596841|NCT01018979|3903823|P1|COMPLETED|Overall Study||4
1596842|NCT01018979|3903822|P2|Received at Least One Dose|Overall Study||12
1596843|NCT01018979|3903823|P1|Received at Least One Dose|Overall Study||7
1596844|NCT01018979|3903822|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
1596845|NCT01018979|3903823|P1|STARTED|Overall Study||7
1596846|NCT01018953|3903853|P1|NOT COMPLETED|Overall Study||8
1596847|NCT01018953|3903853|P1|COMPLETED|Overall Study||0
1596848|NCT01018953|3903853|P1|BIM 23A760 4 mg|Overall Study||3
1596849|NCT01018953|3903853|P1|BIM 23A760 2 mg|Overall Study||2
1596850|NCT01018953|3903853|P1|BIM 23A760 1 mg|Overall Study||3
1596851|NCT01018953|3903853|P1|STARTED|Overall Study||8
1596852|NCT01018862|3903866|P3|NOT COMPLETED|Overall Study||16
1596853|NCT01018862|3903867|P2|NOT COMPLETED|Overall Study||10
1596854|NCT01018862|3903868|P1|NOT COMPLETED|Overall Study||13
1596855|NCT01018862|3903866|P3|COMPLETED|Overall Study||146
1596856|NCT01018862|3903867|P2|COMPLETED|Overall Study||156
1596857|NCT01018862|3903868|P1|COMPLETED|Overall Study||148
1596858|NCT01018862|3903866|P3|STARTED|Overall Study||162
1596859|NCT01018862|3903867|P2|STARTED|Overall Study||166
1596860|NCT01018862|3903868|P1|STARTED|Overall Study||161
1596861|NCT01018810|3903890|P5|NOT COMPLETED|Overall Study||1
1596862|NCT01018810|3903891|P4|NOT COMPLETED|Overall Study||1
1596863|NCT01018810|3903892|P3|NOT COMPLETED|Overall Study||1
1596864|NCT01018810|3903893|P2|NOT COMPLETED|Overall Study||1
1596865|NCT01018810|3903894|P1|NOT COMPLETED|Overall Study||2
1596866|NCT01018810|3903890|P5|COMPLETED|Overall Study||0
1596867|NCT01018810|3903891|P4|COMPLETED|Overall Study||0
1596868|NCT01018810|3903892|P3|COMPLETED|Overall Study||0
1596869|NCT01018810|3903893|P2|COMPLETED|Overall Study||0
1596870|NCT01018810|3903894|P1|COMPLETED|Overall Study||2
1596871|NCT01018810|3903890|P5|STARTED|Overall Study||1
1596872|NCT01018810|3903891|P4|STARTED|Overall Study||1
1596873|NCT01018810|3903892|P3|STARTED|Overall Study||1
1596874|NCT01018810|3903893|P2|STARTED|Overall Study||1
1596875|NCT01018810|3903894|P1|STARTED|Overall Study||4
1596876|NCT01018732|3903954|P3|NOT COMPLETED|Overall Study||4
1596877|NCT01018732|3903955|P2|NOT COMPLETED|Overall Study||2
1596878|NCT01018732|3903956|P1|NOT COMPLETED|Overall Study||1
1596879|NCT01018732|3903954|P3|COMPLETED|Overall Study||50
1596880|NCT01018732|3903955|P2|COMPLETED|Overall Study||49
1596881|NCT01018732|3903956|P1|COMPLETED|Overall Study||49
1596882|NCT01018732|3903954|P3|STARTED|Overall Study||54
1596883|NCT01018732|3903955|P2|STARTED|Overall Study||51
1596884|NCT01018732|3903956|P1|STARTED|Overall Study||50
1596885|NCT01018680|3903990|P2|NOT COMPLETED|Overall Study||75
1596886|NCT01018680|3903991|P1|NOT COMPLETED|Overall Study||61
1596887|NCT01018680|3903990|P2|COMPLETED|Overall Study||189
1596888|NCT01018680|3903991|P1|COMPLETED|Overall Study||199
1596889|NCT01018680|3903990|P2|STARTED|Overall Study||264
1596890|NCT01018680|3903991|P1|STARTED|Overall Study||260
1596891|NCT01020487|3904034|P3|NOT COMPLETED|Part 2 Open-label Period||1
1596892|NCT01020487|3904035|P2|NOT COMPLETED|Part 2 Open-label Period||4
1596893|NCT01020487|3904036|P1|NOT COMPLETED|Part 2 Open-label Period||0
1596894|NCT01020487|3904034|P3|COMPLETED|Part 2 Open-label Period||12
1596895|NCT01020487|3904035|P2|COMPLETED|Part 2 Open-label Period||12
1596896|NCT01020487|3904036|P1|COMPLETED|Part 2 Open-label Period||0
1596897|NCT01020487|3904034|P3|STARTED|Part 2 Open-label Period||13
1596898|NCT01020487|3904035|P2|STARTED|Part 2 Open-label Period||16
1596899|NCT01020487|3904036|P1|STARTED|Part 2 Open-label Period||0
1596900|NCT01020487|3904034|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
1596901|NCT01020487|3904035|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
1596902|NCT01020487|3904036|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
1596903|NCT01020487|3904034|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
1596904|NCT01020487|3904035|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
1596905|NCT01020487|3904036|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
1596906|NCT01020487|3904034|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
1596907|NCT01020487|3904035|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
1596908|NCT01020487|3904036|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
1596909|NCT01020487|3904034|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
1596910|NCT01020487|3904035|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
1596911|NCT01020487|3904036|P1|STARTED|Part 2 Double-blind Treatment Period||0
1596912|NCT01020487|3904034|P3|NOT COMPLETED|Part 1||0
1596913|NCT01020487|3904035|P2|NOT COMPLETED|Part 1||0
1596914|NCT01020487|3904036|P1|NOT COMPLETED|Part 1||0
1596915|NCT01020487|3904034|P3|COMPLETED|Part 1||0
1596916|NCT01020487|3904035|P2|COMPLETED|Part 1||0
1596917|NCT01020487|3904036|P1|COMPLETED|Part 1||12
1596918|NCT01020487|3904034|P3|STARTED|Part 1||0
1596919|NCT01020487|3904035|P2|STARTED|Part 1||0
1596920|NCT01020487|3904036|P1|STARTED|Part 1||12
1596921|NCT01018511|3904061|P4|NOT COMPLETED|Overall Study||33
1596922|NCT01018511|3904062|P3|NOT COMPLETED|Overall Study||40
1596923|NCT01018511|3904063|P2|NOT COMPLETED|Overall Study||32
1596924|NCT01018511|3904064|P1|NOT COMPLETED|Overall Study||26
1596925|NCT01018511|3904061|P4|COMPLETED|Overall Study||294
1596926|NCT01018511|3904062|P3|COMPLETED|Overall Study||299
1596927|NCT01018511|3904063|P2|COMPLETED|Overall Study||295
1596928|NCT01018511|3904064|P1|COMPLETED|Overall Study||315
1596929|NCT01018511|3904061|P4|Randomized and Treated|Overall Study||324
1596930|NCT01018511|3904062|P3|Randomized and Treated|Overall Study||338
1596931|NCT01018511|3904063|P2|Randomized and Treated|Overall Study||326
1596932|NCT01018511|3904064|P1|Randomized and Treated|Overall Study||341
1596933|NCT01018511|3904061|P4|STARTED|Overall Study||327
1596934|NCT01018511|3904062|P3|STARTED|Overall Study||339
1596935|NCT01018511|3904063|P2|STARTED|Overall Study||327
1596936|NCT01018511|3904064|P1|STARTED|Overall Study||341
1596937|NCT01018420|3904233|P2|NOT COMPLETED|Overall Study||0
1596938|NCT01018420|3904234|P1|NOT COMPLETED|Overall Study||0
1596939|NCT01018420|3904233|P2|COMPLETED|Overall Study||3
1596940|NCT01018420|3904234|P1|COMPLETED|Overall Study||15
1596941|NCT01018420|3904233|P2|STARTED|Overall Study||3
1596942|NCT01018420|3904234|P1|STARTED|Overall Study||15
1596943|NCT01018394|3904261|P2|NOT COMPLETED|Overall Study||8
1596944|NCT01018394|3904262|P1|NOT COMPLETED|Overall Study||9
1596945|NCT01018394|3904261|P2|COMPLETED|Overall Study||33
1596946|NCT01018394|3904262|P1|COMPLETED|Overall Study||31
1596947|NCT01018394|3904261|P2|STARTED|Overall Study||41
1596948|NCT01018394|3904262|P1|STARTED|Overall Study||40
1596949|NCT01018264|3904272|P2|NOT COMPLETED|Overall Study||1
1596950|NCT01018264|3904273|P1|NOT COMPLETED|Overall Study||1
1596951|NCT01018264|3904272|P2|COMPLETED|Overall Study||12
1596952|NCT01018264|3904273|P1|COMPLETED|Overall Study||9
1596953|NCT01018264|3904272|P2|STARTED|Overall Study||13
1596954|NCT01018264|3904273|P1|STARTED|Overall Study||10
1596955|NCT01018186|3904290|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
1596956|NCT01018186|3904291|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
1596957|NCT01018186|3904292|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
1596958|NCT01018186|3904293|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
1596959|NCT01018186|3904290|P4|COMPLETED|52-week Double-blind Treatment Period||71
1596960|NCT01018186|3904291|P3|COMPLETED|52-week Double-blind Treatment Period||161
1596961|NCT01018186|3904292|P2|COMPLETED|52-week Double-blind Treatment Period||161
1596962|NCT01018186|3904293|P1|COMPLETED|52-week Double-blind Treatment Period||0
1596963|NCT01018186|3904290|P4|STARTED|52-week Double-blind Treatment Period||100
1596964|NCT01018186|3904291|P3|STARTED|52-week Double-blind Treatment Period||202
1596965|NCT01018186|3904292|P2|STARTED|52-week Double-blind Treatment Period||201
1596966|NCT01018186|3904293|P1|STARTED|52-week Double-blind Treatment Period||0
1596967|NCT01018186|3904290|P4|NOT COMPLETED|2-week Run-in Period||0
1596968|NCT01018186|3904291|P3|NOT COMPLETED|2-week Run-in Period||0
1596969|NCT01018186|3904292|P2|NOT COMPLETED|2-week Run-in Period||0
1596970|NCT01018186|3904293|P1|NOT COMPLETED|2-week Run-in Period||114
1596971|NCT01018186|3904290|P4|COMPLETED|2-week Run-in Period||0
1596972|NCT01018186|3904291|P3|COMPLETED|2-week Run-in Period||0
1596973|NCT01018186|3904292|P2|COMPLETED|2-week Run-in Period||0
1596974|NCT01018186|3904293|P1|COMPLETED|2-week Run-in Period||503
1596975|NCT01018186|3904290|P4|STARTED|2-week Run-in Period||0
1596976|NCT01018186|3904291|P3|STARTED|2-week Run-in Period||0
1596977|NCT01018186|3904292|P2|STARTED|2-week Run-in Period||0
1596978|NCT01018186|3904293|P1|STARTED|2-week Run-in Period||617
1596979|NCT01018134|3904385|P6|NOT COMPLETED|Overall Study||0
1596980|NCT01018134|3904386|P5|NOT COMPLETED|Overall Study||0
1596981|NCT01018134|3904387|P4|NOT COMPLETED|Overall Study||0
1596982|NCT01018134|3904388|P3|NOT COMPLETED|Overall Study||1
1596983|NCT01018134|3904389|P2|NOT COMPLETED|Overall Study||1
1596984|NCT01018134|3904390|P1|NOT COMPLETED|Overall Study||0
1596985|NCT01018134|3904385|P6|COMPLETED|Overall Study||15
1596986|NCT01018134|3904386|P5|COMPLETED|Overall Study||15
1596987|NCT01018134|3904387|P4|COMPLETED|Overall Study||29
1596988|NCT01018134|3904388|P3|COMPLETED|Overall Study||29
1596989|NCT01018134|3904389|P2|COMPLETED|Overall Study||30
1596990|NCT01018134|3904390|P1|COMPLETED|Overall Study||30
1596991|NCT01018134|3904385|P6|STARTED|Overall Study||15
1596992|NCT01018134|3904386|P5|STARTED|Overall Study||15
1596993|NCT01018134|3904387|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
1596994|NCT01018134|3904388|P3|STARTED|Overall Study||30
1596995|NCT01018134|3904389|P2|STARTED|Overall Study||31
1596996|NCT01018134|3904390|P1|STARTED|Overall Study||30
1596997|NCT01018095|3904430|P2|NOT COMPLETED|Overall Study||62
1596998|NCT01018095|3904431|P1|NOT COMPLETED|Overall Study||56
1596999|NCT01018095|3904430|P2|COMPLETED|Overall Study||73
1597000|NCT01018095|3904431|P1|COMPLETED|Overall Study||79
1597001|NCT01018095|3904430|P2|STARTED|Overall Study||135
1597002|NCT01018095|3904431|P1|STARTED|Overall Study||135
1597003|NCT01018056|3904442|P3|NOT COMPLETED|Overall Study||1
1597004|NCT01018056|3904443|P2|NOT COMPLETED|Overall Study||2
1597005|NCT01018056|3904444|P1|NOT COMPLETED|Overall Study||3
1597006|NCT01018056|3904442|P3|COMPLETED|Overall Study||5
1597007|NCT01018056|3904443|P2|COMPLETED|Overall Study||10
1597008|NCT01018056|3904444|P1|COMPLETED|Overall Study||9
1597009|NCT01018056|3904442|P3|STARTED|Overall Study||6
1597010|NCT01018056|3904443|P2|STARTED|Overall Study||12
1597011|NCT01018056|3904444|P1|STARTED|Overall Study||12
1597012|NCT01018030|3904494|P3|NOT COMPLETED|Overall Study||13
1597013|NCT01018030|3904495|P2|NOT COMPLETED|Overall Study||11
1597014|NCT01018030|3904496|P1|NOT COMPLETED|Overall Study||19
1597015|NCT01018030|3904494|P3|COMPLETED|Overall Study||239
1597016|NCT01018030|3904495|P2|COMPLETED|Overall Study||232
1597017|NCT01018030|3904496|P1|COMPLETED|Overall Study||227
1597018|NCT01018030|3904494|P3|STARTED|Overall Study||252
1597019|NCT01018030|3904495|P2|STARTED|Overall Study||243
1597020|NCT01018030|3904496|P1|STARTED|Overall Study||246
1597021|NCT01017952|3904547|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
1597022|NCT01017952|3904548|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
1597023|NCT01017952|3904549|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
1597024|NCT01017952|3904550|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
1597025|NCT01017952|3904551|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
1597102|NCT01017536|3904699|P2|STARTED|Overall Study||13
1597026|NCT01017952|3904547|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
1597027|NCT01017952|3904548|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
1597028|NCT01017952|3904549|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
1597029|NCT01017952|3904550|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
1597030|NCT01017952|3904551|P1|COMPLETED|52-week, Double-blind Treatment Period||0
1597031|NCT01017952|3904547|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
1597032|NCT01017952|3904548|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
1597033|NCT01017952|3904549|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
1597034|NCT01017952|3904550|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
1597035|NCT01017952|3904551|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
1597036|NCT01017952|3904547|P5|STARTED|52-week, Double-blind Treatment Period||409
1597037|NCT01017952|3904548|P4|STARTED|52-week, Double-blind Treatment Period||403
1597038|NCT01017952|3904549|P3|STARTED|52-week, Double-blind Treatment Period||412
1597039|NCT01017952|3904550|P2|STARTED|52-week, Double-blind Treatment Period||409
1597040|NCT01017952|3904551|P1|STARTED|52-week, Double-blind Treatment Period||0
1597041|NCT01017952|3904547|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
1597042|NCT01017952|3904548|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
1597043|NCT01017952|3904549|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
1597044|NCT01017952|3904550|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
1597045|NCT01017952|3904551|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
1597046|NCT01017952|3904547|P5|COMPLETED|4-week, Open-label Run-In Period||0
1597047|NCT01017952|3904548|P4|COMPLETED|4-week, Open-label Run-In Period||0
1597048|NCT01017952|3904549|P3|COMPLETED|4-week, Open-label Run-In Period||0
1597049|NCT01017952|3904550|P2|COMPLETED|4-week, Open-label Run-In Period||0
1597050|NCT01017952|3904551|P1|COMPLETED|4-week, Open-label Run-In Period||1633
1597051|NCT01017952|3904547|P5|STARTED|4-week, Open-label Run-In Period||0
1597052|NCT01017952|3904548|P4|STARTED|4-week, Open-label Run-In Period||0
1597053|NCT01017952|3904549|P3|STARTED|4-week, Open-label Run-In Period||0
1597054|NCT01017952|3904550|P2|STARTED|4-week, Open-label Run-In Period||0
1597055|NCT01017952|3904551|P1|STARTED|4-week, Open-label Run-In Period||2092
1597056|NCT01017874|3904575|P2|NOT COMPLETED|Overall Study||26
1597057|NCT01017874|3904576|P1|NOT COMPLETED|Overall Study||30
1597058|NCT01017874|3904575|P2|COMPLETED|Overall Study||92
1597059|NCT01017874|3904576|P1|COMPLETED|Overall Study||88
1597060|NCT01017874|3904575|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
1597061|NCT01017874|3904576|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
1597062|NCT01017874|3904575|P2|STARTED|Overall Study||118
1597063|NCT01017874|3904576|P1|STARTED|Overall Study||118
1597064|NCT01017731|3904594|P1|NOT COMPLETED|Overall Study||8
1597065|NCT01017731|3904594|P1|COMPLETED|Overall Study||60
1597066|NCT01017731|3904594|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
1597067|NCT01017731|3904594|P1|STARTED|Overall Study||68
1597068|NCT01017653|3904611|P1|NOT COMPLETED|Overall Study||0
1597069|NCT01017653|3904611|P1|COMPLETED|Overall Study||16
1597070|NCT01017653|3904611|P1|STARTED|Overall Study||16
1597071|NCT01017601|3904623|P2|NOT COMPLETED|Overall Study||13
1597072|NCT01017601|3904624|P1|NOT COMPLETED|Overall Study||12
1597073|NCT01017601|3904623|P2|COMPLETED|Overall Study||11
1597074|NCT01017601|3904624|P1|COMPLETED|Overall Study||14
1597075|NCT01017601|3904623|P2|STARTED|Overall Study||24
1597076|NCT01017601|3904624|P1|STARTED|Overall Study||26
1597077|NCT01017575|3904651|P5|NOT COMPLETED|Overall Study||3
1597078|NCT01017575|3904652|P4|NOT COMPLETED|Overall Study||1
1597079|NCT01017575|3904653|P3|NOT COMPLETED|Overall Study||0
1597080|NCT01017575|3904654|P2|NOT COMPLETED|Overall Study||2
1597081|NCT01017575|3904655|P1|NOT COMPLETED|Overall Study||1
1597082|NCT01017575|3904651|P5|COMPLETED|Overall Study||6
1597083|NCT01017575|3904652|P4|COMPLETED|Overall Study||7
1597084|NCT01017575|3904653|P3|COMPLETED|Overall Study||8
1597085|NCT01017575|3904654|P2|COMPLETED|Overall Study||7
1597086|NCT01017575|3904655|P1|COMPLETED|Overall Study||7
1597087|NCT01017575|3904651|P5|STARTED|Overall Study||9
1597088|NCT01017575|3904652|P4|STARTED|Overall Study||8
1597089|NCT01017575|3904653|P3|STARTED|Overall Study||8
1597090|NCT01017575|3904654|P2|STARTED|Overall Study||9
1597091|NCT01017575|3904655|P1|STARTED|Overall Study||8
1597092|NCT01017549|3904692|P1|NOT COMPLETED|One-year Follow-up||7
1597093|NCT01017549|3904692|P1|COMPLETED|One-year Follow-up||36
1597094|NCT01017549|3904692|P1|STARTED|One-year Follow-up||43
1597095|NCT01017549|3904692|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
1597096|NCT01017549|3904692|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
1597097|NCT01017549|3904692|P1|STARTED|Eligibility Through 6 Month Follow-up||44
1597098|NCT01017536|3904699|P2|NOT COMPLETED|Overall Study||0
1597099|NCT01017536|3904700|P1|NOT COMPLETED|Overall Study||0
1597100|NCT01017536|3904699|P2|COMPLETED|Overall Study||13
1597101|NCT01017536|3904700|P1|COMPLETED|Overall Study||13
1597103|NCT01017536|3904700|P1|STARTED|Overall Study||13
1597104|NCT01017497|3904710|P1|NOT COMPLETED|Overall Study||0
1597105|NCT01017497|3904710|P1|COMPLETED|Overall Study||49
1597106|NCT01017497|3904710|P1|STARTED|Overall Study||49
1597107|NCT01017263|3904723|P1|NOT COMPLETED|Overall Study||12
1597108|NCT01017263|3904723|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
1597109|NCT01017263|3904723|P1|STARTED|Overall Study||14
1597110|NCT01017250|3904727|P1|NOT COMPLETED|Overall Study||0
1597111|NCT01017250|3904727|P1|COMPLETED|Overall Study||15
1597112|NCT01017250|3904727|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
1597113|NCT01017250|3904727|P1|STARTED|Overall Study||15
1597114|NCT01017237|3904749|P2|NOT COMPLETED|Overall Study||2
1597115|NCT01017237|3904750|P1|NOT COMPLETED|Overall Study||5
1597116|NCT01017237|3904749|P2|COMPLETED|Overall Study||6
1597117|NCT01017237|3904750|P1|COMPLETED|Overall Study||5
1597118|NCT01017237|3904749|P2|STARTED|Overall Study||8
1597119|NCT01017237|3904750|P1|STARTED|Overall Study||10
1597120|NCT01017146|3904804|P2|NOT COMPLETED|Overall Study||39
1597121|NCT01017146|3904805|P1|NOT COMPLETED|Overall Study||66
1597122|NCT01017146|3904804|P2|COMPLETED|Overall Study||333
1597123|NCT01017146|3904805|P1|COMPLETED|Overall Study||306
1597124|NCT01017146|3904804|P2|STARTED|Overall Study||372
1597125|NCT01017146|3904805|P1|STARTED|Overall Study||372
1597126|NCT01017120|3904843|P2|NOT COMPLETED|Overall Study||35
1597127|NCT01017120|3904844|P1|NOT COMPLETED|Overall Study||66
1597128|NCT01017120|3904843|P2|COMPLETED|Overall Study||334
1597129|NCT01017120|3904844|P1|COMPLETED|Overall Study||307
1597130|NCT01017120|3904843|P2|STARTED|Overall Study||369
1597131|NCT01017120|3904844|P1|STARTED|Overall Study||373
1597132|NCT01017042|3904892|P1|NOT COMPLETED|Overall Study||0
1597133|NCT01017042|3904892|P1|COMPLETED|Overall Study||13
1597134|NCT01017042|3904892|P1|STARTED|Overall Study||13
1597135|NCT01017029|3904905|P2|NOT COMPLETED|Overall Study||2
1597136|NCT01017029|3904906|P1|NOT COMPLETED|Overall Study||4
1597137|NCT01017029|3904905|P2|COMPLETED|Overall Study||90
1597138|NCT01017029|3904906|P1|COMPLETED|Overall Study||85
1597139|NCT01017029|3904905|P2|STARTED|Overall Study||92
1597140|NCT01017029|3904906|P1|STARTED|Overall Study||89
1597141|NCT01017003|3904922|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
1597142|NCT01017003|3904922|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
1597143|NCT01017003|3904922|P1|STARTED|Colchicine 0.6 mg Final Dose||13
1597144|NCT01017003|3904922|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
1597145|NCT01017003|3904922|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
1597146|NCT01017003|3904922|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
1597147|NCT01017003|3904922|P1|NOT COMPLETED|14 Day Washout Period||0
1597148|NCT01017003|3904922|P1|COMPLETED|14 Day Washout Period||13
1597149|NCT01017003|3904922|P1|STARTED|14 Day Washout Period||13
1597150|NCT01017003|3904922|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
1597151|NCT01017003|3904922|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
1597152|NCT01017003|3904922|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
1597153|NCT01016977|3904934|P2|NOT COMPLETED|Overall Study||2
1597154|NCT01016977|3904935|P1|NOT COMPLETED|Overall Study||3
1597155|NCT01016977|3904934|P2|COMPLETED|Overall Study||18
1597156|NCT01016977|3904935|P1|COMPLETED|Overall Study||17
1597157|NCT01016977|3904934|P2|STARTED|Overall Study||20
1597158|NCT01016977|3904935|P1|STARTED|Overall Study||20
1597159|NCT01016964|3904971|P2|NOT COMPLETED|Overall Study||3
1597160|NCT01016964|3904972|P1|NOT COMPLETED|Overall Study||3
1597161|NCT01016964|3904971|P2|COMPLETED|Overall Study||39
1597162|NCT01016964|3904972|P1|COMPLETED|Overall Study||18
1597163|NCT01016964|3904971|P2|STARTED|Overall Study||42
1597164|NCT01016964|3904972|P1|STARTED|Overall Study||21
1597165|NCT01016938|3904978|P1|NOT COMPLETED|Overall Study||9
1597166|NCT01016938|3904978|P1|COMPLETED|Overall Study||7
1597167|NCT01016938|3904978|P1|STARTED|Overall Study||16
1597168|NCT01016912|3904988|P5|NOT COMPLETED|Follow-up Period||0
1597169|NCT01016912|3904989|P4|NOT COMPLETED|Follow-up Period||1
1597170|NCT01016912|3904990|P3|NOT COMPLETED|Follow-up Period||1
1597171|NCT01016912|3904991|P2|NOT COMPLETED|Follow-up Period||0
1597172|NCT01016912|3904992|P1|NOT COMPLETED|Follow-up Period||0
1597173|NCT01016912|3904988|P5|COMPLETED|Follow-up Period||9
1597174|NCT01016912|3904989|P4|COMPLETED|Follow-up Period||8
1597175|NCT01016912|3904990|P3|COMPLETED|Follow-up Period||9
1597176|NCT01016912|3904991|P2|COMPLETED|Follow-up Period||9
1597177|NCT01016912|3904992|P1|COMPLETED|Follow-up Period||8
1597178|NCT01016912|3904988|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
1597179|NCT01016912|3904989|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
1597180|NCT01016912|3904990|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
1597181|NCT01016912|3904991|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
1597182|NCT01016912|3904992|P1|STARTED|Follow-up Period||8
1597183|NCT01016912|3904988|P5|NOT COMPLETED|End of Treatment Period||4
1597184|NCT01016912|3904989|P4|NOT COMPLETED|End of Treatment Period||4
1597185|NCT01016912|3904990|P3|NOT COMPLETED|End of Treatment Period||1
1597186|NCT01016912|3904991|P2|NOT COMPLETED|End of Treatment Period||3
1597187|NCT01016912|3904992|P1|NOT COMPLETED|End of Treatment Period||0
1597188|NCT01016912|3904988|P5|COMPLETED|End of Treatment Period||5
1597189|NCT01016912|3904989|P4|COMPLETED|End of Treatment Period||5
1597190|NCT01016912|3904990|P3|COMPLETED|End of Treatment Period||9
1597191|NCT01016912|3904991|P2|COMPLETED|End of Treatment Period||6
1597192|NCT01016912|3904992|P1|COMPLETED|End of Treatment Period||8
1597193|NCT01016912|3904988|P5|Received Treatment|End of Treatment Period||9
1597194|NCT01016912|3904989|P4|Received Treatment|End of Treatment Period||9
1597195|NCT01016912|3904990|P3|Received Treatment|End of Treatment Period||10
1597196|NCT01016912|3904991|P2|Received Treatment|End of Treatment Period||9
1597197|NCT01016912|3904992|P1|Received Treatment|End of Treatment Period||8
1597198|NCT01016912|3904988|P5|STARTED|End of Treatment Period||9
1597199|NCT01016912|3904989|P4|STARTED|End of Treatment Period||9
1597200|NCT01016912|3904990|P3|STARTED|End of Treatment Period||10
1597201|NCT01016912|3904991|P2|STARTED|End of Treatment Period||9
1597202|NCT01016912|3904992|P1|STARTED|End of Treatment Period||8
1597203|NCT01016873|3905037|P3|NOT COMPLETED|36 Months||6
1597204|NCT01016873|3905038|P2|NOT COMPLETED|36 Months||4
1597205|NCT01016873|3905039|P1|NOT COMPLETED|36 Months||11
1597206|NCT01016873|3905037|P3|COMPLETED|36 Months||67
1597207|NCT01016873|3905038|P2|COMPLETED|36 Months||64
1597208|NCT01016873|3905039|P1|COMPLETED|36 Months||58
1597209|NCT01016873|3905037|P3|STARTED|36 Months||73
1597210|NCT01016873|3905038|P2|STARTED|36 Months||68
1597211|NCT01016873|3905039|P1|STARTED|36 Months||69
1597212|NCT01016873|3905037|P3|NOT COMPLETED|24 Months||6
1597213|NCT01016873|3905038|P2|NOT COMPLETED|24 Months||4
1597214|NCT01016873|3905039|P1|NOT COMPLETED|24 Months||5
1597215|NCT01016873|3905037|P3|COMPLETED|24 Months||73
1597216|NCT01016873|3905038|P2|COMPLETED|24 Months||68
1597217|NCT01016873|3905039|P1|COMPLETED|24 Months||69
1597218|NCT01016873|3905037|P3|STARTED|24 Months||79
1597219|NCT01016873|3905038|P2|STARTED|24 Months||72
1597220|NCT01016873|3905039|P1|STARTED|24 Months||74
1597221|NCT01016873|3905037|P3|NOT COMPLETED|12 Months||1
1597222|NCT01016873|3905038|P2|NOT COMPLETED|12 Months||3
1597223|NCT01016873|3905039|P1|NOT COMPLETED|12 Months||1
1597224|NCT01016873|3905037|P3|COMPLETED|12 Months||79
1597225|NCT01016873|3905038|P2|COMPLETED|12 Months||72
1597226|NCT01016873|3905039|P1|COMPLETED|12 Months||74
1597227|NCT01016873|3905037|P3|STARTED|12 Months||80
1597228|NCT01016873|3905038|P2|STARTED|12 Months||75
1597229|NCT01016873|3905039|P1|STARTED|12 Months||75
1597230|NCT01016847|3905070|P2|NOT COMPLETED|Overall Study||0
1597231|NCT01016847|3905071|P1|NOT COMPLETED|Overall Study||0
1597232|NCT01016847|3905070|P2|COMPLETED|Overall Study||2
1597233|NCT01016847|3905071|P1|COMPLETED|Overall Study||1
1597234|NCT01016847|3905070|P2|STARTED|Overall Study||2
1597235|NCT01016847|3905071|P1|STARTED|Overall Study||1
1597236|NCT01016834|3905087|P1|NOT COMPLETED|Overall Study||22
1597237|NCT01016834|3905087|P1|COMPLETED|Overall Study||220
1597238|NCT01016834|3905087|P1|STARTED|Overall Study||242
1597239|NCT01016691|3905096|P3|NOT COMPLETED|Overall Study||0
1597240|NCT01016691|3905097|P2|NOT COMPLETED|Overall Study||0
1597241|NCT01016691|3905098|P1|NOT COMPLETED|Overall Study||0
1597242|NCT01016691|3905096|P3|COMPLETED|Overall Study||18
1597243|NCT01016691|3905097|P2|COMPLETED|Overall Study||12
1597244|NCT01016691|3905098|P1|COMPLETED|Overall Study||17
1597245|NCT01016691|3905096|P3|STARTED|Overall Study||18
1597246|NCT01016691|3905097|P2|STARTED|Overall Study||12
1597247|NCT01016691|3905098|P1|STARTED|Overall Study||17
1597248|NCT01016678|3905106|P5|NOT COMPLETED|Overall Study||6
1597249|NCT01016678|3905107|P4|NOT COMPLETED|Overall Study||0
1597250|NCT01016678|3905108|P3|NOT COMPLETED|Overall Study||4
1597251|NCT01016678|3905109|P2|NOT COMPLETED|Overall Study||3
1597252|NCT01016678|3905110|P1|NOT COMPLETED|Overall Study||2
1597253|NCT01016678|3905106|P5|COMPLETED|Overall Study||13
1597254|NCT01016678|3905107|P4|COMPLETED|Overall Study||19
1597255|NCT01016678|3905108|P3|COMPLETED|Overall Study||15
1597256|NCT01016678|3905109|P2|COMPLETED|Overall Study||14
1597257|NCT01016678|3905110|P1|COMPLETED|Overall Study||18
1597258|NCT01016678|3905106|P5|STARTED|Overall Study||19
1597259|NCT01016678|3905107|P4|STARTED|Overall Study||19
1597260|NCT01016678|3905108|P3|STARTED|Overall Study||19
1597261|NCT01016678|3905109|P2|STARTED|Overall Study||17
1597262|NCT01016678|3905110|P1|STARTED|Overall Study||20
1597263|NCT01016652|3905132|P2|NOT COMPLETED|Period 2||0
1597264|NCT01016652|3905133|P1|NOT COMPLETED|Period 2||0
1597265|NCT01016652|3905132|P2|COMPLETED|Period 2||24
1597266|NCT01016652|3905133|P1|COMPLETED|Period 2||25
1597267|NCT01016652|3905132|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
1597268|NCT01016652|3905133|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
1597269|NCT01016652|3905132|P2|NOT COMPLETED|Period 1||0
1597270|NCT01016652|3905133|P1|NOT COMPLETED|Period 1||0
1597271|NCT01016652|3905132|P2|COMPLETED|Period 1||24
1597272|NCT01016652|3905133|P1|COMPLETED|Period 1||25
1597273|NCT01016652|3905132|P2|STARTED|Period 1||24
1597274|NCT01016652|3905133|P1|STARTED|Period 1||25
1597275|NCT01016600|3905153|P4|NOT COMPLETED|Overall Study||0
1597276|NCT01016600|3905154|P3|NOT COMPLETED|Overall Study||0
1597277|NCT01016600|3905155|P2|NOT COMPLETED|Overall Study||0
1597278|NCT01016600|3905156|P1|NOT COMPLETED|Overall Study||1
1597279|NCT01016600|3905153|P4|COMPLETED|Overall Study||12
1597280|NCT01016600|3905154|P3|COMPLETED|Overall Study||6
1597281|NCT01016600|3905155|P2|COMPLETED|Overall Study||4
1597282|NCT01016600|3905156|P1|COMPLETED|Overall Study||8
1597283|NCT01016600|3905153|P4|STARTED|Overall Study||12
1597284|NCT01016600|3905154|P3|STARTED|Overall Study||6
1597285|NCT01016600|3905155|P2|STARTED|Overall Study||4
1597286|NCT01016600|3905156|P1|STARTED|Overall Study||9
1597287|NCT01016483|3905223|P4|NOT COMPLETED|Phase II||0
1597288|NCT01016483|3905224|P3|NOT COMPLETED|Phase II||0
1597289|NCT01016483|3905225|P2|NOT COMPLETED|Phase II||0
1597290|NCT01016483|3905226|P1|NOT COMPLETED|Phase II||0
1597291|NCT01016483|3905223|P4|COMPLETED|Phase II||44
1597292|NCT01016483|3905224|P3|COMPLETED|Phase II||44
1597293|NCT01016483|3905225|P2|COMPLETED|Phase II||0
1597294|NCT01016483|3905226|P1|COMPLETED|Phase II||0
1597295|NCT01016483|3905223|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
1597296|NCT01016483|3905224|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
1597297|NCT01016483|3905225|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
1597298|NCT01016483|3905226|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
1597299|NCT01016483|3905223|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
1597300|NCT01016483|3905224|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
1597301|NCT01016483|3905225|P2|STARTED|Phase II||0
1597302|NCT01016483|3905226|P1|STARTED|Phase II||0
1597303|NCT01016483|3905223|P4|NOT COMPLETED|Safety Run-in Part||0
1597304|NCT01016483|3905224|P3|NOT COMPLETED|Safety Run-in Part||0
1597305|NCT01016483|3905225|P2|NOT COMPLETED|Safety Run-in Part||0
1597306|NCT01016483|3905226|P1|NOT COMPLETED|Safety Run-in Part||0
1597307|NCT01016483|3905223|P4|COMPLETED|Safety Run-in Part||0
1597308|NCT01016483|3905224|P3|COMPLETED|Safety Run-in Part||0
1597309|NCT01016483|3905225|P2|COMPLETED|Safety Run-in Part||26
1597310|NCT01016483|3905226|P1|COMPLETED|Safety Run-in Part||27
1597311|NCT01016483|3905223|P4|STARTED|Safety Run-in Part||0
1597312|NCT01016483|3905224|P3|STARTED|Safety Run-in Part||0
1597313|NCT01016483|3905225|P2|STARTED|Safety Run-in Part||26
1597314|NCT01016483|3905226|P1|STARTED|Safety Run-in Part||27
1597315|NCT01016353|3905334|P2|NOT COMPLETED|Overall Study||1
1597316|NCT01016353|3905335|P1|NOT COMPLETED|Overall Study||2
1597317|NCT01016353|3905334|P2|COMPLETED|Overall Study||102
1597318|NCT01016353|3905335|P1|COMPLETED|Overall Study||178
1597319|NCT01016353|3905334|P2|STARTED|Overall Study||103
1597320|NCT01016353|3905335|P1|STARTED|Overall Study||180
1597321|NCT01016132|3905341|P1|NOT COMPLETED|Overall Study||1
1597322|NCT01016132|3905341|P1|COMPLETED|Overall Study||151
1597323|NCT01016132|3905341|P1|STARTED|Overall Study||152
1597324|NCT01016106|3905347|P2|NOT COMPLETED|Overall Study||0
1597325|NCT01016106|3905348|P1|NOT COMPLETED|Overall Study||0
1597326|NCT01016106|3905347|P2|COMPLETED|Overall Study||18
1597327|NCT01016106|3905348|P1|COMPLETED|Overall Study||17
1597328|NCT01016106|3905347|P2|STARTED|Overall Study||18
1597329|NCT01016106|3905348|P1|STARTED|Overall Study||17
1597330|NCT01016067|3905356|P2|NOT COMPLETED|Overall Study||4
1597331|NCT01016067|3905357|P1|NOT COMPLETED|Overall Study||2
1597332|NCT01016067|3905356|P2|COMPLETED|Overall Study||8
1597333|NCT01016067|3905357|P1|COMPLETED|Overall Study||9
1597334|NCT01016067|3905356|P2|STARTED|Overall Study||12
1597335|NCT01016067|3905357|P1|STARTED|Overall Study||11
1597336|NCT01016015|3905375|P1|NOT COMPLETED|Overall Study||19
1597337|NCT01016015|3905375|P1|COMPLETED|Overall Study||159
1597338|NCT01016015|3905375|P1|STARTED|Overall Study||178
1597339|NCT01015976|3905379|P2|NOT COMPLETED|Overall Study||0
1597340|NCT01015976|3905380|P1|NOT COMPLETED|Overall Study||0
1597341|NCT01015976|3905379|P2|COMPLETED|Overall Study||5
1597342|NCT01015976|3905380|P1|COMPLETED|Overall Study||5
1597343|NCT01015976|3905379|P2|STARTED|Overall Study||5
1597344|NCT01015976|3905380|P1|STARTED|Overall Study||5
1597345|NCT01015833|3905386|P2|NOT COMPLETED|Overall Study||5
1597346|NCT01015833|3905387|P1|NOT COMPLETED|Overall Study||13
1597347|NCT01015833|3905386|P2|COMPLETED|Overall Study||171
1597348|NCT01015833|3905387|P1|COMPLETED|Overall Study||167
1597349|NCT01015833|3905386|P2|STARTED|Overall Study||176
1597350|NCT01015833|3905387|P1|STARTED|Overall Study||180
1597351|NCT01015820|3905403|P2|NOT COMPLETED|Overall Study||0
1597352|NCT01015820|3905404|P1|NOT COMPLETED|Overall Study||1
1597353|NCT01015820|3905403|P2|COMPLETED|Overall Study||15
1597354|NCT01015820|3905404|P1|COMPLETED|Overall Study||14
1597355|NCT01015820|3905403|P2|STARTED|Overall Study||15
1597356|NCT01015820|3905404|P1|STARTED|Overall Study||15
1597357|NCT01015807|3905415|P3|NOT COMPLETED|Overall Study||0
1597358|NCT01015807|3905416|P2|NOT COMPLETED|Overall Study||0
1597359|NCT01015807|3905417|P1|NOT COMPLETED|Overall Study||0
1597360|NCT01015807|3905415|P3|COMPLETED|Overall Study||30
1597361|NCT01015807|3905416|P2|COMPLETED|Overall Study||30
1597362|NCT01015807|3905417|P1|COMPLETED|Overall Study||30
1597363|NCT01015807|3905415|P3|STARTED|Overall Study||30
1597364|NCT01015807|3905416|P2|STARTED|Overall Study||30
1597365|NCT01015807|3905417|P1|STARTED|Overall Study||30
1597366|NCT01015781|3905427|P2|NOT COMPLETED|Overall Study||29
1597367|NCT01015781|3905428|P1|NOT COMPLETED|Overall Study||37
1597368|NCT01015781|3905427|P2|COMPLETED|Overall Study||121
1597369|NCT01015781|3905428|P1|COMPLETED|Overall Study||113
1597370|NCT01015781|3905427|P2|STARTED|Overall Study||150
1597371|NCT01015781|3905428|P1|STARTED|Overall Study||150
1597372|NCT01015703|3905439|P5|NOT COMPLETED|Overall Study||0
1597373|NCT01015703|3905440|P4|NOT COMPLETED|Overall Study||0
1597374|NCT01015703|3905441|P3|NOT COMPLETED|Overall Study||0
1597375|NCT01015703|3905442|P2|NOT COMPLETED|Overall Study||1
1597376|NCT01015703|3905443|P1|NOT COMPLETED|Overall Study||2
1597377|NCT01015703|3905439|P5|COMPLETED|Overall Study||10
1597378|NCT01015703|3905440|P4|COMPLETED|Overall Study||10
1597379|NCT01015703|3905441|P3|COMPLETED|Overall Study||10
1597380|NCT01015703|3905442|P2|COMPLETED|Overall Study||9
1597381|NCT01015703|3905443|P1|COMPLETED|Overall Study||8
1597382|NCT01015703|3905439|P5|STARTED|Overall Study||10
1597383|NCT01015703|3905440|P4|STARTED|Overall Study||10
1597384|NCT01015703|3905441|P3|STARTED|Overall Study||10
1597385|NCT01015703|3905442|P2|STARTED|Overall Study||10
1597386|NCT01015703|3905443|P1|STARTED|Overall Study||10
1597387|NCT01015677|3905458|P3|NOT COMPLETED|Overall Study||0
1597388|NCT01015677|3905459|P2|NOT COMPLETED|Overall Study||4
1597389|NCT01015677|3905460|P1|NOT COMPLETED|Overall Study||1
1597390|NCT01015677|3905458|P3|COMPLETED|Overall Study||33
1597391|NCT01015677|3905459|P2|COMPLETED|Overall Study||28
1597392|NCT01015677|3905460|P1|COMPLETED|Overall Study||33
1597393|NCT01015677|3905458|P3|STARTED|Overall Study||33
1597394|NCT01015677|3905459|P2|STARTED|Overall Study||32
1597395|NCT01015677|3905460|P1|STARTED|Overall Study||34
1597396|NCT01015638|3905482|P2|NOT COMPLETED|Overall Study||0
1597397|NCT01015638|3905483|P1|NOT COMPLETED|Overall Study||1
1597398|NCT01015638|3905482|P2|COMPLETED|Overall Study||19
1597399|NCT01015638|3905483|P1|COMPLETED|Overall Study||16
1597400|NCT01015638|3905482|P2|STARTED|Overall Study||19
1597401|NCT01015638|3905483|P1|STARTED|Overall Study||17
1597402|NCT01015612|3905511|P1|NOT COMPLETED|Overall Study||153
1597403|NCT01015612|3905511|P1|COMPLETED|Overall Study||481
1597404|NCT01015612|3905511|P1|STARTED|Overall Study||634
1597405|NCT01015560|3905521|P1|NOT COMPLETED|Overall Study||3
1597406|NCT01015560|3905521|P1|COMPLETED|Overall Study||41
1597407|NCT01015560|3905521|P1|Eligible and Analyzable|Overall Study||43
1597408|NCT01015560|3905521|P1|STARTED|Overall Study||44
1597409|NCT01015534|3905527|P2|NOT COMPLETED|Overall Study||0
1597410|NCT01015534|3905528|P1|NOT COMPLETED|Overall Study||1
1597411|NCT01015534|3905527|P2|COMPLETED|Overall Study||27
1597412|NCT01015534|3905528|P1|COMPLETED|Overall Study||27
1597413|NCT01015534|3905527|P2|STARTED|Overall Study||27
1597414|NCT01015534|3905528|P1|STARTED|Overall Study||28
1597415|NCT01015443|3905542|P2|NOT COMPLETED|Overall Study||0
1597416|NCT01015443|3905543|P1|NOT COMPLETED|Overall Study||0
1597417|NCT01015443|3905542|P2|COMPLETED|Overall Study||94
1597418|NCT01015443|3905543|P1|COMPLETED|Overall Study||191
1597419|NCT01015443|3905542|P2|Treated|Overall Study||93
1597420|NCT01015443|3905543|P1|Treated|Overall Study||191
1597421|NCT01015443|3905542|P2|STARTED|Overall Study||94
1597422|NCT01015443|3905543|P1|STARTED|Overall Study||191
1597423|NCT01015326|3905561|P2|NOT COMPLETED|Overall Study||2
1597424|NCT01015326|3905562|P1|NOT COMPLETED|Overall Study||1
1597425|NCT01015326|3905561|P2|COMPLETED|Overall Study||18
1597426|NCT01015326|3905562|P1|COMPLETED|Overall Study||11
1597427|NCT01015326|3905561|P2|STARTED|Overall Study||20
1597428|NCT01015326|3905562|P1|STARTED|Overall Study||12
1597429|NCT01015287|3905570|P2|NOT COMPLETED|Overall Study||79
1597430|NCT01015287|3905571|P1|NOT COMPLETED|Overall Study||72
1597431|NCT01015287|3905570|P2|COMPLETED|Overall Study||1958
1597432|NCT01015287|3905571|P1|COMPLETED|Overall Study||1924
1597433|NCT01015287|3905570|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
1597434|NCT01015287|3905571|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
1597435|NCT01015287|3905570|P2|STARTED|Overall Study||2037
1597436|NCT01015287|3905571|P1|STARTED|Overall Study||1996
1597437|NCT01015170|3905597|P1|NOT COMPLETED|Overall Study||239
1597438|NCT01015170|3905597|P1|COMPLETED|Overall Study||215
1597439|NCT01015170|3905597|P1|STARTED|Overall Study||454
1597440|NCT01015131|3905603|P1|NOT COMPLETED|Overall Study||8
1597441|NCT01015131|3905603|P1|COMPLETED|Overall Study||36
1597442|NCT01015131|3905603|P1|STARTED|Overall Study||44
1597443|NCT01015118|3905619|P2|NOT COMPLETED|Overall Study||327
1597444|NCT01015118|3905620|P1|NOT COMPLETED|Overall Study||669
1597445|NCT01015118|3905619|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
1597446|NCT01015118|3905620|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
1597447|NCT01015118|3905619|P2|STARTED|Overall Study||455
1597448|NCT01015118|3905620|P1|STARTED|Overall Study||911
1597449|NCT01014988|3905648|P6|NOT COMPLETED|Overall Study||3
1597450|NCT01014988|3905649|P5|NOT COMPLETED|Overall Study||1
1597451|NCT01014988|3905650|P4|NOT COMPLETED|Overall Study||0
1597452|NCT01014988|3905651|P3|NOT COMPLETED|Overall Study||2
1597453|NCT01014988|3905652|P2|NOT COMPLETED|Overall Study||0
1597454|NCT01014988|3905653|P1|NOT COMPLETED|Overall Study||23
1597455|NCT01014988|3905648|P6|COMPLETED|Overall Study||11
1597456|NCT01014988|3905649|P5|COMPLETED|Overall Study||26
1597457|NCT01014988|3905650|P4|COMPLETED|Overall Study||12
1597458|NCT01014988|3905651|P3|COMPLETED|Overall Study||9
1597459|NCT01014988|3905652|P2|COMPLETED|Overall Study||7
1597460|NCT01014988|3905653|P1|COMPLETED|Overall Study||107
1597461|NCT01014988|3905648|P6|STARTED|Overall Study||14
1597462|NCT01014988|3905649|P5|STARTED|Overall Study||27
1597463|NCT01014988|3905650|P4|STARTED|Overall Study||12
1597464|NCT01014988|3905651|P3|STARTED|Overall Study||11
1597465|NCT01014988|3905652|P2|STARTED|Overall Study||7
1597466|NCT01014988|3905653|P1|STARTED|Overall Study||130
1597467|NCT01014975|3905825|P3|NOT COMPLETED|Overall Study||6
1597468|NCT01014975|3905826|P2|NOT COMPLETED|Overall Study||3
1597469|NCT01014975|3905827|P1|NOT COMPLETED|Overall Study||4
1597470|NCT01014975|3905825|P3|COMPLETED|Overall Study||10
1597471|NCT01014975|3905826|P2|COMPLETED|Overall Study||13
1597472|NCT01014975|3905827|P1|COMPLETED|Overall Study||4
1597473|NCT01014975|3905825|P3|STARTED|Overall Study||16
1597474|NCT01014975|3905826|P2|STARTED|Overall Study||16
1597475|NCT01014975|3905827|P1|STARTED|Overall Study||8
1597476|NCT01014936|3905838|P3|NOT COMPLETED|Overall Study||0
1597477|NCT01014936|3905839|P2|NOT COMPLETED|Overall Study||0
1597478|NCT01014936|3905840|P1|NOT COMPLETED|Overall Study||0
1597479|NCT01014936|3905838|P3|COMPLETED|Overall Study||62
1597480|NCT01014936|3905839|P2|COMPLETED|Overall Study||45
1597481|NCT01014936|3905840|P1|COMPLETED|Overall Study||42
1597482|NCT01014936|3905838|P3|STARTED|Overall Study||62
1597483|NCT01014936|3905839|P2|STARTED|Overall Study||45
1597484|NCT01014936|3905840|P1|STARTED|Overall Study||42
1597485|NCT01014910|3906332|P2|NOT COMPLETED|Overall Study||2
1597486|NCT01014910|3906333|P1|NOT COMPLETED|Overall Study||0
1597487|NCT01014910|3906332|P2|COMPLETED|Overall Study||79
1597488|NCT01014910|3906333|P1|COMPLETED|Overall Study||80
1597489|NCT01014910|3906332|P2|STARTED|Overall Study||81
1597490|NCT01014910|3906333|P1|STARTED|Overall Study||80
1597491|NCT01014871|3906341|P1|NOT COMPLETED|Overall Study||0
1597492|NCT01014871|3906341|P1|COMPLETED|Overall Study||30
1597493|NCT01014871|3906341|P1|STARTED|Overall Study||30
1597494|NCT01014741|3906349|P2|NOT COMPLETED|Overall Study||5
1597495|NCT01014741|3906350|P1|NOT COMPLETED|Overall Study||11
1597496|NCT01014741|3906349|P2|COMPLETED|Overall Study||90
1597497|NCT01014741|3906350|P1|COMPLETED|Overall Study||94
1597498|NCT01014741|3906349|P2|STARTED|Overall Study||95
1597499|NCT01014741|3906350|P1|STARTED|Overall Study||105
1597500|NCT01014728|3906364|P2|NOT COMPLETED|Overall Study||0
1597501|NCT01014728|3906365|P1|NOT COMPLETED|Overall Study||0
1597502|NCT01014728|3906364|P2|COMPLETED|Overall Study||15
1597503|NCT01014728|3906365|P1|COMPLETED|Overall Study||18
1597504|NCT01014728|3906364|P2|STARTED|Overall Study||15
1597505|NCT01014728|3906365|P1|STARTED|Overall Study||18
1597506|NCT01014689|3906377|P2|NOT COMPLETED|Overall Study||13
1597507|NCT01014689|3906378|P1|NOT COMPLETED|Overall Study||13
1597508|NCT01014689|3906377|P2|COMPLETED|Overall Study||174
1597509|NCT01014689|3906378|P1|COMPLETED|Overall Study||178
1597510|NCT01014689|3906377|P2|STARTED|Overall Study||187
1597511|NCT01014689|3906378|P1|STARTED|Overall Study||191
1597512|NCT01014624|3906388|P2|NOT COMPLETED|Overall Study||1
1597513|NCT01014624|3906389|P1|NOT COMPLETED|Overall Study||2
1597514|NCT01014624|3906388|P2|COMPLETED|Overall Study||26
1597515|NCT01014624|3906389|P1|COMPLETED|Overall Study||27
1597516|NCT01014624|3906388|P2|STARTED|Overall Study||27
1597517|NCT01014624|3906389|P1|STARTED|Overall Study||29
1597518|NCT01014585|3906413|P4|NOT COMPLETED|Overall Study||30
1597519|NCT01014585|3906414|P3|NOT COMPLETED|Overall Study||23
1597520|NCT01014585|3906415|P2|NOT COMPLETED|Overall Study||25
1597521|NCT01014585|3906416|P1|NOT COMPLETED|Overall Study||20
1597522|NCT01014585|3906413|P4|COMPLETED|Overall Study||99
1597523|NCT01014585|3906414|P3|COMPLETED|Overall Study||37
1597524|NCT01014585|3906415|P2|COMPLETED|Overall Study||75
1597525|NCT01014585|3906416|P1|COMPLETED|Overall Study||31
1597526|NCT01014585|3906413|P4|STARTED|Overall Study||129
1597527|NCT01014585|3906414|P3|STARTED|Overall Study||60
1597528|NCT01014585|3906415|P2|STARTED|Overall Study||100
1597529|NCT01014585|3906416|P1|STARTED|Overall Study||51
1597530|NCT01014533|3906436|P2|NOT COMPLETED|Overall Study||5
1597531|NCT01014533|3906437|P1|NOT COMPLETED|Overall Study||5
1597532|NCT01014533|3906436|P2|COMPLETED|Overall Study||25
1597533|NCT01014533|3906437|P1|COMPLETED|Overall Study||24
1597534|NCT01014533|3906436|P2|STARTED|Overall Study||30
1597535|NCT01014533|3906437|P1|STARTED|Overall Study||29
1597536|NCT01014455|3906449|P2|NOT COMPLETED|Overall Study||0
1597537|NCT01014455|3906450|P1|NOT COMPLETED|Overall Study||0
1597538|NCT01014455|3906449|P2|COMPLETED|Overall Study||87
1597539|NCT01014455|3906450|P1|COMPLETED|Overall Study||82
1597540|NCT01014455|3906449|P2|STARTED|Overall Study||87
1597541|NCT01014455|3906450|P1|STARTED|Overall Study||82
1597542|NCT01014442|3906458|P2|NOT COMPLETED|Overall Study||19
1597543|NCT01014442|3906459|P1|NOT COMPLETED|Overall Study||7
1597544|NCT01014442|3906458|P2|COMPLETED|Overall Study||16
1597545|NCT01014442|3906459|P1|COMPLETED|Overall Study||26
1597546|NCT01014442|3906458|P2|STARTED|Overall Study||35
1597547|NCT01014442|3906459|P1|STARTED|Overall Study||33
1597548|NCT01014351|3906571|P1|NOT COMPLETED|Overall Study||37
1597549|NCT01014351|3906571|P1|COMPLETED|Overall Study||33
1597550|NCT01014351|3906571|P1|STARTED|Overall Study||70
1597551|NCT01014208|3906579|P2|NOT COMPLETED|Overall Study||100
1597552|NCT01014208|3906580|P1|NOT COMPLETED|Overall Study||94
1597553|NCT01014208|3906579|P2|COMPLETED|Overall Study||122
1597554|NCT01014208|3906580|P1|COMPLETED|Overall Study||131
1597555|NCT01014208|3906579|P2|Intent-to-Treat Population|Overall Study||222
1597556|NCT01014208|3906580|P1|Intent-to-Treat Population|Overall Study||223
1597557|NCT01014208|3906579|P2|STARTED|Overall Study||222
1597558|NCT01014208|3906580|P1|STARTED|Overall Study||225
1597559|NCT01014169|3906608|P2|NOT COMPLETED|Overall Study||13
1597560|NCT01014169|3906609|P1|NOT COMPLETED|Overall Study||7
1597561|NCT01014169|3906608|P2|COMPLETED|Overall Study||48
1597562|NCT01014169|3906609|P1|COMPLETED|Overall Study||58
1597563|NCT01014169|3906608|P2|STARTED|Overall Study||61
1597564|NCT01014169|3906609|P1|STARTED|Overall Study||65
1597565|NCT01014143|3906622|P3|NOT COMPLETED|Third Intervention||0
1597566|NCT01014143|3906623|P2|NOT COMPLETED|Third Intervention||0
1597567|NCT01014143|3906624|P1|NOT COMPLETED|Third Intervention||0
1597568|NCT01014143|3906622|P3|COMPLETED|Third Intervention||9
1597569|NCT01014143|3906623|P2|COMPLETED|Third Intervention||9
1597570|NCT01014143|3906624|P1|COMPLETED|Third Intervention||8
1597571|NCT01014143|3906622|P3|STARTED|Third Intervention||9
1597572|NCT01014143|3906623|P2|STARTED|Third Intervention||9
1597573|NCT01014143|3906624|P1|STARTED|Third Intervention||8
1597574|NCT01014143|3906622|P3|NOT COMPLETED|Washout After 2nd Intervention||0
1597575|NCT01014143|3906623|P2|NOT COMPLETED|Washout After 2nd Intervention||0
1597576|NCT01014143|3906624|P1|NOT COMPLETED|Washout After 2nd Intervention||0
1597577|NCT01014143|3906622|P3|COMPLETED|Washout After 2nd Intervention||9
1597578|NCT01014143|3906623|P2|COMPLETED|Washout After 2nd Intervention||9
1597579|NCT01014143|3906624|P1|COMPLETED|Washout After 2nd Intervention||8
1597580|NCT01014143|3906622|P3|STARTED|Washout After 2nd Intervention||9
1597581|NCT01014143|3906623|P2|STARTED|Washout After 2nd Intervention||9
1597582|NCT01014143|3906624|P1|STARTED|Washout After 2nd Intervention||8
1597583|NCT01014143|3906622|P3|NOT COMPLETED|Second Intervention||0
1597584|NCT01014143|3906623|P2|NOT COMPLETED|Second Intervention||0
1597585|NCT01014143|3906624|P1|NOT COMPLETED|Second Intervention||2
1597586|NCT01014143|3906622|P3|COMPLETED|Second Intervention||9
1597587|NCT01014143|3906623|P2|COMPLETED|Second Intervention||9
1597588|NCT01014143|3906624|P1|COMPLETED|Second Intervention||8
1597589|NCT01014143|3906622|P3|STARTED|Second Intervention||9
1597590|NCT01014143|3906623|P2|STARTED|Second Intervention||9
1597591|NCT01014143|3906624|P1|STARTED|Second Intervention||10
1597592|NCT01014143|3906622|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
1597593|NCT01014143|3906623|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
1597594|NCT01014143|3906624|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
1597595|NCT01014143|3906622|P3|COMPLETED|Washout Period After 1st Intervention||9
1597596|NCT01014143|3906623|P2|COMPLETED|Washout Period After 1st Intervention||9
1597597|NCT01014143|3906624|P1|COMPLETED|Washout Period After 1st Intervention||10
1597598|NCT01014143|3906622|P3|STARTED|Washout Period After 1st Intervention||9
1597599|NCT01014143|3906623|P2|STARTED|Washout Period After 1st Intervention||9
1597600|NCT01014143|3906624|P1|STARTED|Washout Period After 1st Intervention||10
1597601|NCT01014143|3906622|P3|NOT COMPLETED|First Intervention||0
1597602|NCT01014143|3906623|P2|NOT COMPLETED|First Intervention||0
1597603|NCT01014143|3906624|P1|NOT COMPLETED|First Intervention||0
1597604|NCT01014143|3906622|P3|COMPLETED|First Intervention||9
1597605|NCT01014143|3906623|P2|COMPLETED|First Intervention||9
1597606|NCT01014143|3906624|P1|COMPLETED|First Intervention||10
1597607|NCT01014143|3906622|P3|STARTED|First Intervention||9
1597608|NCT01014143|3906623|P2|STARTED|First Intervention||9
1597609|NCT01014143|3906624|P1|STARTED|First Intervention||10
1597610|NCT01014091|3906638|P6|NOT COMPLETED|Overall Study||0
1597611|NCT01014091|3906639|P5|NOT COMPLETED|Overall Study||0
1597612|NCT01014091|3906640|P4|NOT COMPLETED|Overall Study||0
1597613|NCT01014091|3906641|P3|NOT COMPLETED|Overall Study||0
1597614|NCT01014091|3906642|P2|NOT COMPLETED|Overall Study||0
1597615|NCT01014091|3906643|P1|NOT COMPLETED|Overall Study||0
1597616|NCT01014091|3906638|P6|COMPLETED|Overall Study||12
1597617|NCT01014091|3906639|P5|COMPLETED|Overall Study||6
1597618|NCT01014091|3906640|P4|COMPLETED|Overall Study||15
1597619|NCT01014091|3906641|P3|COMPLETED|Overall Study||5
1597620|NCT01014091|3906642|P2|COMPLETED|Overall Study||13
1597621|NCT01014091|3906643|P1|COMPLETED|Overall Study||7
1597622|NCT01014091|3906638|P6|STARTED|Overall Study||12
1597623|NCT01014091|3906639|P5|STARTED|Overall Study||6
1597624|NCT01014091|3906640|P4|STARTED|Overall Study||15
1597625|NCT01014091|3906641|P3|STARTED|Overall Study||5
1597626|NCT01014091|3906642|P2|STARTED|Overall Study||13
1597627|NCT01014091|3906643|P1|STARTED|Overall Study||7
1597628|NCT01014013|3906719|P2|NOT COMPLETED|Overall Study||56
1597629|NCT01014013|3906720|P1|NOT COMPLETED|Overall Study||51
1597630|NCT01014013|3906719|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
1597631|NCT01014013|3906720|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
1597632|NCT01014013|3906719|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
1597633|NCT01014013|3906720|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
1597634|NCT01014013|3906719|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
1597635|NCT01014013|3906720|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
1597636|NCT01014013|3906719|P2|STARTED|Overall Study||136
1597637|NCT01014013|3906720|P1|STARTED|Overall Study||135
1597638|NCT01013961|3906732|P2|NOT COMPLETED|Overall Study||3
1597639|NCT01013961|3906733|P1|NOT COMPLETED|Overall Study||3
1597640|NCT01013961|3906732|P2|COMPLETED|Overall Study||12
1597641|NCT01013961|3906733|P1|COMPLETED|Overall Study||13
1597642|NCT01013961|3906732|P2|STARTED|Overall Study||15
1597643|NCT01013961|3906733|P1|STARTED|Overall Study||16
1597644|NCT01013883|3906751|P2|NOT COMPLETED|Overall Study||2
1597645|NCT01013883|3906752|P1|NOT COMPLETED|Overall Study||2
1597646|NCT01013883|3906751|P2|COMPLETED|Overall Study||241
1597647|NCT01013883|3906752|P1|COMPLETED|Overall Study||268
1597648|NCT01013883|3906751|P2|STARTED|Overall Study||243
1597649|NCT01013883|3906752|P1|STARTED|Overall Study||270
1597650|NCT01013870|3906764|P2|NOT COMPLETED|Overall Study||3
1597651|NCT01013870|3906765|P1|NOT COMPLETED|Overall Study||1
1597652|NCT01013870|3906764|P2|COMPLETED|Overall Study||21
1597653|NCT01013870|3906765|P1|COMPLETED|Overall Study||27
1597654|NCT01013870|3906764|P2|STARTED|Overall Study||24
1597655|NCT01013870|3906765|P1|STARTED|Overall Study||28
1597656|NCT01013844|3906789|P2|NOT COMPLETED|Overall Study||0
1597657|NCT01013844|3906790|P1|NOT COMPLETED|Overall Study||0
1597658|NCT01013844|3906789|P2|COMPLETED|Overall Study||65
1597659|NCT01013844|3906790|P1|COMPLETED|Overall Study||65
1597660|NCT01013844|3906789|P2|STARTED|Overall Study||65
1597661|NCT01013844|3906790|P1|STARTED|Overall Study||65
1597662|NCT01013792|3906814|P2|NOT COMPLETED|Overall Study||5
1597663|NCT01013792|3906815|P1|NOT COMPLETED|Overall Study||2
1597664|NCT01013792|3906814|P2|COMPLETED|Overall Study||11
1597665|NCT01013792|3906815|P1|COMPLETED|Overall Study||12
1597666|NCT01013792|3906814|P2|STARTED|Overall Study||16
1597667|NCT01013792|3906815|P1|STARTED|Overall Study||14
1597668|NCT01013753|3906821|P1|NOT COMPLETED|Overall Study||16
1597669|NCT01013753|3906821|P1|COMPLETED|Overall Study||182
1597670|NCT01013753|3906821|P1|Received Form 12 mcg Bid|Overall Study||125
1597671|NCT01013753|3906821|P1|Received Olo 20 mcg qd|Overall Study||124
1597672|NCT01013753|3906821|P1|Received Olo 10 mcg qd|Overall Study||127
1597673|NCT01013753|3906821|P1|Received Olo 5 mcg qd|Overall Study||130
1597674|NCT01013753|3906821|P1|Received Olo 2 mcg qd|Overall Study||121
1597675|NCT01013753|3906821|P1|Received Placebo|Overall Study||125
1597676|NCT01013753|3906821|P1|STARTED|Overall Study|Entered and treated|198
1597677|NCT01013740|3907017|P2|NOT COMPLETED|Overall Study||19
1597678|NCT01013740|3907018|P1|NOT COMPLETED|Overall Study||11
1597679|NCT01013740|3907017|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
1597680|NCT01013740|3907018|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
1597681|NCT01013740|3907017|P2|Ongoing|Overall Study||0
1597682|NCT01013740|3907018|P1|Ongoing|Overall Study||0
1597683|NCT01013740|3907017|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
1597684|NCT01013740|3907018|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
1597685|NCT01013701|3907042|P1|NOT COMPLETED|Overall Study||7
1597686|NCT01013701|3907042|P1|COMPLETED|Overall Study||0
1597687|NCT01013701|3907042|P1|STARTED|Overall Study||7
1597688|NCT01013597|3907049|P1|NOT COMPLETED|Overall Study||1
1597689|NCT01013597|3907049|P1|COMPLETED|Overall Study||12
1597690|NCT01013597|3907049|P1|STARTED|Overall Study||13
1597691|NCT01013207|3907059|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
1597692|NCT01013207|3907059|P1|COMPLETED|CPAP Post Nexus (S9)||44
1597693|NCT01013207|3907059|P1|STARTED|CPAP Post Nexus (S9)||50
1597694|NCT01013207|3907059|P1|NOT COMPLETED|Nexus (S9)||0
1597695|NCT01013207|3907059|P1|COMPLETED|Nexus (S9)||50
1597696|NCT01013207|3907059|P1|STARTED|Nexus (S9)||50
1597697|NCT01013207|3907059|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
1597698|NCT01013207|3907059|P1|COMPLETED|CPAP Pre Nexus (S9)||50
1597699|NCT01013207|3907059|P1|STARTED|CPAP Pre Nexus (S9)||50
1597700|NCT01013194|3907066|P2|NOT COMPLETED|Overall Study||0
1597701|NCT01013194|3907067|P1|NOT COMPLETED|Overall Study||0
1597702|NCT01013194|3907066|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
1597703|NCT01013194|3907067|P1|COMPLETED|Overall Study|Consecutive patients|9
1597704|NCT01013194|3907066|P2|STARTED|Overall Study||16
1597705|NCT01013194|3907067|P1|STARTED|Overall Study||9
1597706|NCT01012999|3907077|P1|NOT COMPLETED|Overall Study||1
1597707|NCT01012999|3907077|P1|COMPLETED|Overall Study||15
1597708|NCT01012999|3907077|P1|STARTED|Overall Study||16
1597709|NCT01012973|3907083|P2|NOT COMPLETED|Overall Study||19
1597710|NCT01012973|3907084|P1|NOT COMPLETED|Overall Study||16
1597711|NCT01012973|3907083|P2|COMPLETED|Overall Study||52
1597712|NCT01012973|3907084|P1|COMPLETED|Overall Study||90
1597713|NCT01012973|3907083|P2|Completed Week 52, From FAS|Overall Study||52
1597714|NCT01012973|3907084|P1|Completed Week 52, From FAS|Overall Study||91
1597715|NCT01012973|3907083|P2|Completed Week 24, From FAS|Overall Study||57
1597716|NCT01012973|3907084|P1|Completed Week 24, From FAS|Overall Study||97
1597717|NCT01012973|3907083|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
1597718|NCT01012973|3907084|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
1597719|NCT01012973|3907083|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
1597720|NCT01012973|3907084|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
1597721|NCT01012973|3907083|P2|STARTED|Overall Study||71
1597722|NCT01012973|3907084|P1|STARTED|Overall Study||106
1597723|NCT01012947|3907109|P5|NOT COMPLETED|Overall Study||142
1597724|NCT01012947|3907110|P4|NOT COMPLETED|Overall Study||118
1597725|NCT01012947|3907111|P3|NOT COMPLETED|Overall Study||130
1597726|NCT01012947|3907112|P2|NOT COMPLETED|Overall Study||135
1597727|NCT01012947|3907113|P1|NOT COMPLETED|Overall Study||131
1597728|NCT01012947|3907109|P5|COMPLETED|Overall Study||94
1597729|NCT01012947|3907110|P4|COMPLETED|Overall Study||93
1597730|NCT01012947|3907111|P3|COMPLETED|Overall Study||111
1597731|NCT01012947|3907112|P2|COMPLETED|Overall Study||80
1597732|NCT01012947|3907113|P1|COMPLETED|Overall Study||81
1597733|NCT01012947|3907109|P5|STARTED|Overall Study||236
1597734|NCT01012947|3907110|P4|STARTED|Overall Study||211
1597735|NCT01012947|3907111|P3|STARTED|Overall Study||241
1597736|NCT01012947|3907112|P2|STARTED|Overall Study||215
1597737|NCT01012947|3907113|P1|STARTED|Overall Study||212
1597738|NCT01012921|3907127|P2|NOT COMPLETED|Overall Study||13
1597739|NCT01012921|3907128|P1|NOT COMPLETED|Overall Study||10
1597740|NCT01012921|3907127|P2|COMPLETED|Overall Study||47
1597741|NCT01012921|3907128|P1|COMPLETED|Overall Study||47
1597742|NCT01012921|3907127|P2|STARTED|Overall Study||60
1597743|NCT01012921|3907128|P1|STARTED|Overall Study||57
1597744|NCT01012765|3907134|P6|NOT COMPLETED|Treatment Period 3||0
1597745|NCT01012765|3907135|P5|NOT COMPLETED|Treatment Period 3||0
1597746|NCT01012765|3907136|P4|NOT COMPLETED|Treatment Period 3||0
1597747|NCT01012765|3907137|P3|NOT COMPLETED|Treatment Period 3||0
1597748|NCT01012765|3907138|P2|NOT COMPLETED|Treatment Period 3||0
1597749|NCT01012765|3907139|P1|NOT COMPLETED|Treatment Period 3||0
1597750|NCT01012765|3907134|P6|COMPLETED|Treatment Period 3||24
1597751|NCT01012765|3907135|P5|COMPLETED|Treatment Period 3||18
1597752|NCT01012765|3907136|P4|COMPLETED|Treatment Period 3||15
1597753|NCT01012765|3907137|P3|COMPLETED|Treatment Period 3||18
1597754|NCT01012765|3907138|P2|COMPLETED|Treatment Period 3||19
1597755|NCT01012765|3907139|P1|COMPLETED|Treatment Period 3||16
1597756|NCT01012765|3907134|P6|STARTED|Treatment Period 3||24
1597757|NCT01012765|3907135|P5|STARTED|Treatment Period 3||18
1597758|NCT01012765|3907136|P4|STARTED|Treatment Period 3||15
1597759|NCT01012765|3907137|P3|STARTED|Treatment Period 3||18
1597760|NCT01012765|3907138|P2|STARTED|Treatment Period 3||19
1597761|NCT01012765|3907139|P1|STARTED|Treatment Period 3||16
1597762|NCT01012765|3907134|P6|NOT COMPLETED|Treatment Period 2||1
1597763|NCT01012765|3907135|P5|NOT COMPLETED|Treatment Period 2||1
1597764|NCT01012765|3907136|P4|NOT COMPLETED|Treatment Period 2||0
1597765|NCT01012765|3907137|P3|NOT COMPLETED|Treatment Period 2||3
1597766|NCT01012765|3907138|P2|NOT COMPLETED|Treatment Period 2||2
1597767|NCT01012765|3907139|P1|NOT COMPLETED|Treatment Period 2||1
1597768|NCT01012765|3907134|P6|COMPLETED|Treatment Period 2||24
1597769|NCT01012765|3907135|P5|COMPLETED|Treatment Period 2||18
1597770|NCT01012765|3907136|P4|COMPLETED|Treatment Period 2||15
1597771|NCT01012765|3907137|P3|COMPLETED|Treatment Period 2||18
1597772|NCT01012765|3907138|P2|COMPLETED|Treatment Period 2||19
1597773|NCT01012765|3907139|P1|COMPLETED|Treatment Period 2||16
1597774|NCT01012765|3907134|P6|STARTED|Treatment Period 2||25
1597775|NCT01012765|3907135|P5|STARTED|Treatment Period 2||19
1597776|NCT01012765|3907136|P4|STARTED|Treatment Period 2||15
1597777|NCT01012765|3907137|P3|STARTED|Treatment Period 2||21
1597778|NCT01012765|3907138|P2|STARTED|Treatment Period 2||21
1597779|NCT01012765|3907139|P1|STARTED|Treatment Period 2||17
1597780|NCT01012765|3907134|P6|NOT COMPLETED|Treatment Period 1||0
1597781|NCT01012765|3907135|P5|NOT COMPLETED|Treatment Period 1||3
1597782|NCT01012765|3907136|P4|NOT COMPLETED|Treatment Period 1||3
1597783|NCT01012765|3907137|P3|NOT COMPLETED|Treatment Period 1||2
1597784|NCT01012765|3907138|P2|NOT COMPLETED|Treatment Period 1||0
1597785|NCT01012765|3907139|P1|NOT COMPLETED|Treatment Period 1||3
1597786|NCT01012765|3907134|P6|COMPLETED|Treatment Period 1||25
1597787|NCT01012765|3907135|P5|COMPLETED|Treatment Period 1||19
1597788|NCT01012765|3907136|P4|COMPLETED|Treatment Period 1||15
1597789|NCT01012765|3907137|P3|COMPLETED|Treatment Period 1||21
1597790|NCT01012765|3907138|P2|COMPLETED|Treatment Period 1||21
1597791|NCT01012765|3907139|P1|COMPLETED|Treatment Period 1||17
1597792|NCT01012765|3907134|P6|STARTED|Treatment Period 1||25
1597793|NCT01012765|3907135|P5|STARTED|Treatment Period 1||22
1597794|NCT01012765|3907136|P4|STARTED|Treatment Period 1||18
1597795|NCT01012765|3907137|P3|STARTED|Treatment Period 1||23
1597796|NCT01012765|3907138|P2|STARTED|Treatment Period 1||21
1597797|NCT01012765|3907139|P1|STARTED|Treatment Period 1||20
1597798|NCT01012739|3907168|P4|NOT COMPLETED|Treatment Period 4||0
1597799|NCT01012739|3907169|P3|NOT COMPLETED|Treatment Period 4||0
1597800|NCT01012739|3907170|P2|NOT COMPLETED|Treatment Period 4||0
1597801|NCT01012739|3907171|P1|NOT COMPLETED|Treatment Period 4||0
1597802|NCT01012739|3907168|P4|COMPLETED|Treatment Period 4||7
1597803|NCT01012739|3907169|P3|COMPLETED|Treatment Period 4||9
1597804|NCT01012739|3907170|P2|COMPLETED|Treatment Period 4||8
1597805|NCT01012739|3907171|P1|COMPLETED|Treatment Period 4||9
1597806|NCT01012739|3907168|P4|STARTED|Treatment Period 4||7
1597807|NCT01012739|3907169|P3|STARTED|Treatment Period 4||9
1597808|NCT01012739|3907170|P2|STARTED|Treatment Period 4||8
1597809|NCT01012739|3907171|P1|STARTED|Treatment Period 4||9
1597810|NCT01012739|3907168|P4|NOT COMPLETED|Treatment Period 3||0
1597811|NCT01012739|3907169|P3|NOT COMPLETED|Treatment Period 3||0
1597812|NCT01012739|3907170|P2|NOT COMPLETED|Treatment Period 3||0
1597813|NCT01012739|3907171|P1|NOT COMPLETED|Treatment Period 3||0
1597814|NCT01012739|3907168|P4|COMPLETED|Treatment Period 3||7
1597815|NCT01012739|3907169|P3|COMPLETED|Treatment Period 3||9
1597816|NCT01012739|3907170|P2|COMPLETED|Treatment Period 3||8
1597817|NCT01012739|3907171|P1|COMPLETED|Treatment Period 3||9
1597818|NCT01012739|3907168|P4|STARTED|Treatment Period 3||7
1597819|NCT01012739|3907169|P3|STARTED|Treatment Period 3||9
1597820|NCT01012739|3907170|P2|STARTED|Treatment Period 3||8
1597821|NCT01012739|3907171|P1|STARTED|Treatment Period 3||9
1597822|NCT01012739|3907168|P4|NOT COMPLETED|Treatment Period 2||1
1597823|NCT01012739|3907169|P3|NOT COMPLETED|Treatment Period 2||0
1597824|NCT01012739|3907170|P2|NOT COMPLETED|Treatment Period 2||0
1597825|NCT01012739|3907171|P1|NOT COMPLETED|Treatment Period 2||0
1597826|NCT01012739|3907168|P4|COMPLETED|Treatment Period 2||7
1597827|NCT01012739|3907169|P3|COMPLETED|Treatment Period 2||9
1597828|NCT01012739|3907170|P2|COMPLETED|Treatment Period 2||8
1597829|NCT01012739|3907171|P1|COMPLETED|Treatment Period 2||9
1597830|NCT01012739|3907168|P4|STARTED|Treatment Period 2||8
1597831|NCT01012739|3907169|P3|STARTED|Treatment Period 2||9
1597832|NCT01012739|3907170|P2|STARTED|Treatment Period 2||8
1597833|NCT01012739|3907171|P1|STARTED|Treatment Period 2||9
1597834|NCT01012739|3907168|P4|NOT COMPLETED|Treatment Period 1||1
1597835|NCT01012739|3907169|P3|NOT COMPLETED|Treatment Period 1||0
1597836|NCT01012739|3907170|P2|NOT COMPLETED|Treatment Period 1||0
1597837|NCT01012739|3907171|P1|NOT COMPLETED|Treatment Period 1||0
1597838|NCT01012739|3907168|P4|COMPLETED|Treatment Period 1||8
1597839|NCT01012739|3907169|P3|COMPLETED|Treatment Period 1||9
1597840|NCT01012739|3907170|P2|COMPLETED|Treatment Period 1||8
1597841|NCT01012739|3907171|P1|COMPLETED|Treatment Period 1||9
1597842|NCT01012739|3907168|P4|STARTED|Treatment Period 1||9
1597843|NCT01012739|3907169|P3|STARTED|Treatment Period 1||9
1597844|NCT01012739|3907170|P2|STARTED|Treatment Period 1||8
1597845|NCT01012739|3907171|P1|STARTED|Treatment Period 1||9
1597846|NCT01012713|3907199|P1|NOT COMPLETED|Overall Study||3
1597847|NCT01012713|3907199|P1|COMPLETED|Overall Study||27
1597848|NCT01012713|3907199|P1|STARTED|Overall Study||30
1597849|NCT01012674|3907205|P1|NOT COMPLETED|Overall Study||24
1597850|NCT01012674|3907205|P1|COMPLETED|Overall Study||187
1597851|NCT01012674|3907205|P1|STARTED|Overall Study||211
1597852|NCT01012661|3907217|P1|NOT COMPLETED|Overall Study||0
1597853|NCT01012661|3907217|P1|COMPLETED|Overall Study||50
1597854|NCT01012661|3907217|P1|STARTED|Overall Study||50
1597855|NCT01012622|3907225|P1|NOT COMPLETED|Overall Study||31
1597856|NCT01012622|3907225|P1|COMPLETED|Overall Study||111
1597857|NCT01012622|3907225|P1|STARTED|Overall Study||142
1597858|NCT01012492|3907244|P1|NOT COMPLETED|Overall Study||0
1597859|NCT01012492|3907244|P1|COMPLETED|Overall Study||10
1597860|NCT01012492|3907244|P1|STARTED|Overall Study||10
1597861|NCT01012440|3907249|P1|NOT COMPLETED|Overall Study||2
1597862|NCT01012440|3907249|P1|COMPLETED|Overall Study||3
1597863|NCT01012440|3907249|P1|STARTED|Overall Study||5
1597864|NCT01012414|3907253|P1|NOT COMPLETED|Overall Study||10
1597865|NCT01012414|3907253|P1|COMPLETED|Overall Study|No subjects completed the study.|0
1597866|NCT01012414|3907253|P1|STARTED|Overall Study||10
1597867|NCT01012388|3907260|P1|NOT COMPLETED|Overall Study||0
1597868|NCT01012388|3907260|P1|COMPLETED|Overall Study||100
1597869|NCT01012388|3907260|P1|STARTED|Overall Study||100
1597870|NCT01012362|3907270|P5|NOT COMPLETED|Overall Study||0
1597871|NCT01012362|3907271|P4|NOT COMPLETED|Overall Study||0
1597872|NCT01012362|3907272|P3|NOT COMPLETED|Overall Study||0
1597873|NCT01012362|3907273|P2|NOT COMPLETED|Overall Study||0
1597874|NCT01012362|3907274|P1|NOT COMPLETED|Overall Study||0
1597875|NCT01012362|3907270|P5|COMPLETED|Overall Study||9
1597876|NCT01012362|3907271|P4|COMPLETED|Overall Study||4
1597877|NCT01012362|3907272|P3|COMPLETED|Overall Study||3
1597878|NCT01012362|3907273|P2|COMPLETED|Overall Study||6
1597879|NCT01012362|3907274|P1|COMPLETED|Overall Study||9
1597880|NCT01012362|3907270|P5|STARTED|Overall Study||9
1597881|NCT01012362|3907271|P4|STARTED|Overall Study||4
1597882|NCT01012362|3907272|P3|STARTED|Overall Study||3
1597883|NCT01012362|3907273|P2|STARTED|Overall Study||6
1597884|NCT01012362|3907274|P1|STARTED|Overall Study||9
1597885|NCT01012336|3907290|P1|NOT COMPLETED|Overall Study||0
1597886|NCT01012336|3907290|P1|COMPLETED|Overall Study||85
1597887|NCT01012336|3907290|P1|STARTED|Overall Study||85
1597888|NCT01012323|3907294|P1|NOT COMPLETED|Overall Study||1
1597889|NCT01012323|3907294|P1|COMPLETED|Overall Study||50
1597890|NCT01012323|3907294|P1|STARTED|Overall Study||51
1597891|NCT01012297|3907318|P2|NOT COMPLETED|Overall Study||0
1597892|NCT01012297|3907319|P1|NOT COMPLETED|Overall Study||0
1597893|NCT01012297|3907318|P2|COMPLETED|Overall Study||53
1597894|NCT01012297|3907319|P1|COMPLETED|Overall Study||54
1597895|NCT01012297|3907318|P2|STARTED|Overall Study||53
1597896|NCT01012297|3907319|P1|STARTED|Overall Study||54
1597897|NCT01012258|3907331|P1|NOT COMPLETED|Overall Study||66
1597898|NCT01012258|3907331|P1|COMPLETED|Overall Study||0
1597899|NCT01012258|3907331|P1|STARTED|Overall Study||66
1597900|NCT01012245|3907341|P1|NOT COMPLETED|Overall Study||2427
1597901|NCT01012245|3907341|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
1597902|NCT01012245|3907341|P1|STARTED|Overall Study||28812
1597903|NCT01012219|3907378|P1|NOT COMPLETED|Period 3||0
1597904|NCT01012219|3907378|P1|COMPLETED|Period 3||20
1597905|NCT01012219|3907378|P1|STARTED|Period 3|of the 36 who started Period 1|20
1597906|NCT01012219|3907378|P1|NOT COMPLETED|Period 2||1
1597907|NCT01012219|3907378|P1|COMPLETED|Period 2||34
1597908|NCT01012219|3907378|P1|STARTED|Period 2|Number who completed Period 1|35
1597909|NCT01012219|3907378|P1|NOT COMPLETED|Period 1||1
1597910|NCT01012219|3907378|P1|COMPLETED|Period 1||35
1597911|NCT01012219|3907378|P1|STARTED|Period 1|Number randomized|36
1597912|NCT01012167|3907388|P3|NOT COMPLETED|Overall Study||4
1597913|NCT01012167|3907389|P2|NOT COMPLETED|Overall Study||2
1597914|NCT01012167|3907390|P1|NOT COMPLETED|Overall Study||2
1597915|NCT01012167|3907388|P3|COMPLETED|Overall Study||17
1597916|NCT01012167|3907389|P2|COMPLETED|Overall Study||18
1597917|NCT01012167|3907390|P1|COMPLETED|Overall Study||15
1597918|NCT01012167|3907388|P3|Exposed to Study Drug|Overall Study||20
1597919|NCT01012167|3907389|P2|Exposed to Study Drug|Overall Study||20
1597920|NCT01012167|3907390|P1|Exposed to Study Drug|Overall Study||16
1597921|NCT01012167|3907388|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
1597922|NCT01012167|3907389|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
1597923|NCT01012167|3907390|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
1597924|NCT01012167|3907388|P3|STARTED|Overall Study||21
1597925|NCT01012167|3907389|P2|STARTED|Overall Study||20
1597926|NCT01012167|3907390|P1|STARTED|Overall Study||17
1597927|NCT01012089|3907646|P1|NOT COMPLETED|Overall Study||0
1597928|NCT01012089|3907646|P1|COMPLETED|Overall Study||6
1597929|NCT01012089|3907646|P1|STARTED|Overall Study||6
1597930|NCT01012037|3907669|P3|NOT COMPLETED|Overall Study||10
1597931|NCT01012037|3907670|P2|NOT COMPLETED|Overall Study||16
1597932|NCT01012037|3907671|P1|NOT COMPLETED|Overall Study||1
1597933|NCT01012037|3907669|P3|COMPLETED|Overall Study||214
1597934|NCT01012037|3907670|P2|COMPLETED|Overall Study||207
1597935|NCT01012037|3907671|P1|COMPLETED|Overall Study||43
1597936|NCT01012037|3907669|P3|STARTED|Overall Study||224
1597937|NCT01012037|3907670|P2|STARTED|Overall Study||223
1597938|NCT01012037|3907671|P1|STARTED|Overall Study||44
1597939|NCT01011946|3907706|P1|NOT COMPLETED|Overall Study||3
1597940|NCT01011946|3907706|P1|COMPLETED|Overall Study||33
1597941|NCT01011946|3907706|P1|STARTED|Overall Study||36
1597942|NCT01011933|3907710|P1|NOT COMPLETED|Overall Study||4
1597943|NCT01011933|3907710|P1|COMPLETED|Overall Study|total eligible and evaluable|50
1597944|NCT01011933|3907710|P1|STARTED|Overall Study|total enrolled|54
1597945|NCT01011907|3907727|P2|NOT COMPLETED|Overall Study||15
1597946|NCT01011907|3907728|P1|NOT COMPLETED|Overall Study||14
1597947|NCT01011907|3907727|P2|COMPLETED|Overall Study||18
1597948|NCT01011907|3907728|P1|COMPLETED|Overall Study||17
1597949|NCT01011907|3907727|P2|STARTED|Overall Study||33
1597950|NCT01011907|3907728|P1|STARTED|Overall Study||31
1597951|NCT01011894|3907738|P1|NOT COMPLETED|Overall Study||0
1597952|NCT01011894|3907738|P1|COMPLETED|Overall Study||26
1597953|NCT01011894|3907738|P1|STARTED|Overall Study||26
1597954|NCT01011868|3907745|P3|NOT COMPLETED|After Week 78 Follow-up||44
1597955|NCT01011868|3907746|P2|NOT COMPLETED|After Week 78 Follow-up||38
1597956|NCT01011868|3907747|P1|NOT COMPLETED|After Week 78 Follow-up||52
1597957|NCT01011868|3907745|P3|COMPLETED|After Week 78 Follow-up||111
1597958|NCT01011868|3907746|P2|COMPLETED|After Week 78 Follow-up||131
1597959|NCT01011868|3907747|P1|COMPLETED|After Week 78 Follow-up||118
1597960|NCT01011868|3907745|P3|STARTED|After Week 78 Follow-up||155
1597961|NCT01011868|3907746|P2|STARTED|After Week 78 Follow-up||169
1597962|NCT01011868|3907747|P1|STARTED|After Week 78 Follow-up||170
1597963|NCT01011868|3907745|P3|NOT COMPLETED|After Week 18 Follow-up||26
1597964|NCT01011868|3907746|P2|NOT COMPLETED|After Week 18 Follow-up||16
1597965|NCT01011868|3907747|P1|NOT COMPLETED|After Week 18 Follow-up||23
1597966|NCT01011868|3907745|P3|COMPLETED|After Week 18 Follow-up||129
1597967|NCT01011868|3907746|P2|COMPLETED|After Week 18 Follow-up||153
1597968|NCT01011868|3907747|P1|COMPLETED|After Week 18 Follow-up||147
1597969|NCT01011868|3907745|P3|STARTED|After Week 18 Follow-up||155
1597970|NCT01011868|3907746|P2|STARTED|After Week 18 Follow-up||169
1597971|NCT01011868|3907747|P1|STARTED|After Week 18 Follow-up||170
1597972|NCT01011829|3907784|P2|NOT COMPLETED|Overall Study||9
1597973|NCT01011829|3907785|P1|NOT COMPLETED|Overall Study||4
1597974|NCT01011829|3907784|P2|COMPLETED|Overall Study||1
1597975|NCT01011829|3907785|P1|COMPLETED|Overall Study||6
1597976|NCT01011829|3907784|P2|STARTED|Overall Study||10
1597977|NCT01011829|3907785|P1|STARTED|Overall Study||10
1597978|NCT01011816|3907795|P2|NOT COMPLETED|78-Week Extended Follow-up||28
1597979|NCT01011816|3907796|P1|NOT COMPLETED|78-Week Extended Follow-up||72
1597980|NCT01011816|3907795|P2|COMPLETED|78-Week Extended Follow-up||26
1597981|NCT01011816|3907796|P1|COMPLETED|78-Week Extended Follow-up||85
1597982|NCT01011816|3907795|P2|STARTED|78-Week Extended Follow-up||54
1597983|NCT01011816|3907796|P1|STARTED|78-Week Extended Follow-up||157
1597984|NCT01011816|3907795|P2|NOT COMPLETED|26-Week Primary Endpoint||2
1597985|NCT01011816|3907796|P1|NOT COMPLETED|26-Week Primary Endpoint||7
1597986|NCT01011816|3907795|P2|COMPLETED|26-Week Primary Endpoint||54
1597987|NCT01011816|3907796|P1|COMPLETED|26-Week Primary Endpoint||157
1597988|NCT01011816|3907795|P2|STARTED|26-Week Primary Endpoint||56
1597989|NCT01011816|3907796|P1|STARTED|26-Week Primary Endpoint||164
1597990|NCT01011738|3907809|P3|NOT COMPLETED|Overall Study||17
1597991|NCT01011738|3907810|P2|NOT COMPLETED|Overall Study||294
1597992|NCT01011738|3907811|P1|NOT COMPLETED|Overall Study||324
1597993|NCT01011738|3907809|P3|COMPLETED|Overall Study||36
1597994|NCT01011738|3907810|P2|COMPLETED|Overall Study||618
1597995|NCT01011738|3907811|P1|COMPLETED|Overall Study||553
1597996|NCT01011738|3907809|P3|STARTED|Overall Study||53
1597997|NCT01011738|3907810|P2|STARTED|Overall Study||912
1597998|NCT01011738|3907811|P1|STARTED|Overall Study||877
1597999|NCT01011673|3907851|P2|NOT COMPLETED|24 Hour Follow-up||3
1598000|NCT01011673|3907852|P1|NOT COMPLETED|24 Hour Follow-up||3
1598001|NCT01011673|3907851|P2|COMPLETED|24 Hour Follow-up||57
1598002|NCT01011673|3907852|P1|COMPLETED|24 Hour Follow-up||57
1598003|NCT01011673|3907851|P2|STARTED|24 Hour Follow-up||60
1598004|NCT01011673|3907852|P1|STARTED|24 Hour Follow-up||60
1598005|NCT01011673|3907851|P2|NOT COMPLETED|Emergency Department Portion||0
1598006|NCT01011673|3907852|P1|NOT COMPLETED|Emergency Department Portion||0
1598007|NCT01011673|3907851|P2|COMPLETED|Emergency Department Portion||60
1598008|NCT01011673|3907852|P1|COMPLETED|Emergency Department Portion||60
1598009|NCT01011673|3907851|P2|STARTED|Emergency Department Portion||60
1598010|NCT01011673|3907852|P1|STARTED|Emergency Department Portion||60
1598011|NCT01011673|3907851|P2|NOT COMPLETED|Randomized||1
1598012|NCT01011673|3907852|P1|NOT COMPLETED|Randomized||2
1598013|NCT01011673|3907851|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
1598014|NCT01011673|3907852|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
1598015|NCT01011673|3907851|P2|STARTED|Randomized||61
1598016|NCT01011673|3907852|P1|STARTED|Randomized||62
1598017|NCT01011634|3907862|P2|NOT COMPLETED|Overall Study||1
1598018|NCT01011634|3907863|P1|NOT COMPLETED|Overall Study||0
1598019|NCT01011634|3907862|P2|COMPLETED|Overall Study||8
1598020|NCT01011634|3907863|P1|COMPLETED|Overall Study||9
1598021|NCT01011634|3907862|P2|STARTED|Overall Study||9
1598022|NCT01011634|3907863|P1|STARTED|Overall Study||9
1598023|NCT01011556|3907875|P4|NOT COMPLETED|Overall Study||13
1598024|NCT01011556|3907876|P3|NOT COMPLETED|Overall Study||10
1598025|NCT01011556|3907877|P2|NOT COMPLETED|Overall Study||8
1598026|NCT01011556|3907878|P1|NOT COMPLETED|Overall Study||6
1598027|NCT01011556|3907875|P4|COMPLETED|Overall Study||51
1598028|NCT01011556|3907876|P3|COMPLETED|Overall Study||45
1598029|NCT01011556|3907877|P2|COMPLETED|Overall Study||48
1598030|NCT01011556|3907878|P1|COMPLETED|Overall Study||52
1598031|NCT01011556|3907875|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
1598032|NCT01011556|3907876|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
1598033|NCT01011556|3907877|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
1598034|NCT01011556|3907878|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
1598035|NCT01011556|3907875|P4|STARTED|Overall Study||64
1598036|NCT01011556|3907876|P3|STARTED|Overall Study||55
1598037|NCT01011556|3907877|P2|STARTED|Overall Study||56
1598038|NCT01011556|3907878|P1|STARTED|Overall Study||58
1598039|NCT01011465|3907956|P8|NOT COMPLETED|Overall Study||0
1598040|NCT01011465|3907957|P7|NOT COMPLETED|Overall Study||1
1598041|NCT01011465|3907958|P6|NOT COMPLETED|Overall Study||0
1598042|NCT01011465|3907959|P5|NOT COMPLETED|Overall Study||1
1598043|NCT01011465|3907960|P4|NOT COMPLETED|Overall Study||0
1598044|NCT01011465|3907961|P3|NOT COMPLETED|Overall Study||0
1598045|NCT01011465|3907962|P2|NOT COMPLETED|Overall Study||1
1598046|NCT01011465|3907963|P1|NOT COMPLETED|Overall Study||2
1598047|NCT01011465|3907956|P8|COMPLETED|Overall Study||32
1598048|NCT01011465|3907957|P7|COMPLETED|Overall Study||51
1598049|NCT01011465|3907958|P6|COMPLETED|Overall Study||29
1598050|NCT01011465|3907959|P5|COMPLETED|Overall Study||46
1598051|NCT01011465|3907960|P4|COMPLETED|Overall Study||18
1598052|NCT01011465|3907961|P3|COMPLETED|Overall Study||36
1598053|NCT01011465|3907962|P2|COMPLETED|Overall Study||19
1598054|NCT01011465|3907963|P1|COMPLETED|Overall Study||34
1598055|NCT01011465|3907956|P8|STARTED|Overall Study||32
1598056|NCT01011465|3907957|P7|STARTED|Overall Study||52
1598057|NCT01011465|3907958|P6|STARTED|Overall Study||29
1598058|NCT01011465|3907959|P5|STARTED|Overall Study||47
1598059|NCT01011465|3907960|P4|STARTED|Overall Study||18
1598060|NCT01011465|3907961|P3|STARTED|Overall Study||36
1598061|NCT01011465|3907962|P2|STARTED|Overall Study||20
1598062|NCT01011465|3907963|P1|STARTED|Overall Study||36
1598063|NCT01011439|3907991|P1|NOT COMPLETED|Overall Study||57
1598064|NCT01011439|3907991|P1|COMPLETED|Overall Study||15
1598065|NCT01011439|3907991|P1|STARTED|Overall Study||72
1598066|NCT01011387|3908001|P1|NOT COMPLETED|Overall Study||6
1598067|NCT01011387|3908001|P1|COMPLETED|Overall Study||10
1598068|NCT01011387|3908001|P1|STARTED|Overall Study||16
1598069|NCT01011335|3908009|P13|NOT COMPLETED|Overall Study||3
1598070|NCT01011335|3908010|P12|NOT COMPLETED|Overall Study||1
1598071|NCT01011335|3908011|P11|NOT COMPLETED|Overall Study||6
1598072|NCT01011335|3908012|P10|NOT COMPLETED|Overall Study||0
1598073|NCT01011335|3908013|P9|NOT COMPLETED|Overall Study||2
1598074|NCT01011335|3908014|P8|NOT COMPLETED|Overall Study||2
1598075|NCT01011335|3908015|P7|NOT COMPLETED|Overall Study||3
1598076|NCT01011335|3908016|P6|NOT COMPLETED|Overall Study||1
1598077|NCT01011335|3908017|P5|NOT COMPLETED|Overall Study||1
1598078|NCT01011335|3908018|P4|NOT COMPLETED|Overall Study||2
1598079|NCT01011335|3908019|P3|NOT COMPLETED|Overall Study||1
1598080|NCT01011335|3908020|P2|NOT COMPLETED|Overall Study||1
1598081|NCT01011335|3908021|P1|NOT COMPLETED|Overall Study||1
1598082|NCT01011335|3908009|P13|COMPLETED|Overall Study||19
1598083|NCT01011335|3908010|P12|COMPLETED|Overall Study||21
1598084|NCT01011335|3908011|P11|COMPLETED|Overall Study||6
1598085|NCT01011335|3908012|P10|COMPLETED|Overall Study||12
1598086|NCT01011335|3908013|P9|COMPLETED|Overall Study||10
1598087|NCT01011335|3908014|P8|COMPLETED|Overall Study||10
1598088|NCT01011335|3908015|P7|COMPLETED|Overall Study||9
1598089|NCT01011335|3908016|P6|COMPLETED|Overall Study||11
1598090|NCT01011335|3908017|P5|COMPLETED|Overall Study||12
1598091|NCT01011335|3908018|P4|COMPLETED|Overall Study||10
1598092|NCT01011335|3908019|P3|COMPLETED|Overall Study||11
1598093|NCT01011335|3908020|P2|COMPLETED|Overall Study||11
1598094|NCT01011335|3908021|P1|COMPLETED|Overall Study||10
1598095|NCT01011335|3908009|P13|STARTED|Overall Study||22
1598096|NCT01011335|3908010|P12|STARTED|Overall Study||22
1598097|NCT01011335|3908011|P11|STARTED|Overall Study||12
1598098|NCT01011335|3908012|P10|STARTED|Overall Study||12
1598099|NCT01011335|3908013|P9|STARTED|Overall Study||12
1598100|NCT01011335|3908014|P8|STARTED|Overall Study||12
1598101|NCT01011335|3908015|P7|STARTED|Overall Study||12
1598102|NCT01011335|3908016|P6|STARTED|Overall Study||12
1598103|NCT01011335|3908017|P5|STARTED|Overall Study||13
1598104|NCT01011335|3908018|P4|STARTED|Overall Study||12
1598105|NCT01011335|3908019|P3|STARTED|Overall Study||12
1598106|NCT01011335|3908020|P2|STARTED|Overall Study||12
1598107|NCT01011335|3908021|P1|STARTED|Overall Study||11
1598108|NCT01011309|3908061|P3|NOT COMPLETED|Overall Study||5
1598109|NCT01011309|3908062|P2|NOT COMPLETED|Overall Study||3
1598110|NCT01011309|3908063|P1|NOT COMPLETED|Overall Study||2
1598111|NCT01011309|3908061|P3|COMPLETED|Overall Study||16
1598112|NCT01011309|3908062|P2|COMPLETED|Overall Study||7
1598113|NCT01011309|3908063|P1|COMPLETED|Overall Study||12
1598114|NCT01011309|3908061|P3|STARTED|Overall Study||21
1598115|NCT01011309|3908062|P2|STARTED|Overall Study||10
1598116|NCT01011309|3908063|P1|STARTED|Overall Study||14
1598117|NCT01011283|3908079|P2|NOT COMPLETED|Overall Study||11
1598118|NCT01011283|3908080|P1|NOT COMPLETED|Overall Study||11
1598119|NCT01011283|3908079|P2|COMPLETED|Overall Study||2
1598120|NCT01011283|3908080|P1|COMPLETED|Overall Study||2
1598121|NCT01011283|3908079|P2|STARTED|Overall Study||13
1598122|NCT01011283|3908080|P1|STARTED|Overall Study||13
1598123|NCT01011218|3908092|P4|NOT COMPLETED|Overall Study||0
1598124|NCT01011218|3908093|P3|NOT COMPLETED|Overall Study||0
1598125|NCT01011218|3908094|P2|NOT COMPLETED|Overall Study||0
1598126|NCT01011218|3908095|P1|NOT COMPLETED|Overall Study||0
1598127|NCT01011218|3908092|P4|COMPLETED|Overall Study||26
1598128|NCT01011218|3908093|P3|COMPLETED|Overall Study||26
1598129|NCT01011218|3908094|P2|COMPLETED|Overall Study||9
1598130|NCT01011218|3908095|P1|COMPLETED|Overall Study||9
1598131|NCT01011218|3908092|P4|STARTED|Overall Study||26
1598132|NCT01011218|3908093|P3|STARTED|Overall Study||26
1598133|NCT01011218|3908094|P2|STARTED|Overall Study||9
1598134|NCT01011218|3908095|P1|STARTED|Overall Study||9
1598135|NCT01011179|3908119|P2|NOT COMPLETED|Overall Study||2
1598136|NCT01011179|3908120|P1|NOT COMPLETED|Overall Study||4
1598137|NCT01011179|3908119|P2|COMPLETED|Overall Study||20
1598138|NCT01011179|3908120|P1|COMPLETED|Overall Study||20
1598139|NCT01011179|3908119|P2|STARTED|Overall Study||22
1598140|NCT01011179|3908120|P1|STARTED|Overall Study||24
1598141|NCT01011153|3908129|P3|NOT COMPLETED|Overall Study||9
1598142|NCT01011153|3908130|P2|NOT COMPLETED|Overall Study||11
1598143|NCT01011153|3908131|P1|NOT COMPLETED|Overall Study||8
1598144|NCT01011153|3908129|P3|COMPLETED|Overall Study||45
1598145|NCT01011153|3908130|P2|COMPLETED|Overall Study||64
1598146|NCT01011153|3908131|P1|COMPLETED|Overall Study||46
1598147|NCT01011153|3908129|P3|STARTED|Overall Study||54
1598148|NCT01011153|3908130|P2|STARTED|Overall Study||75
1598149|NCT01011153|3908131|P1|STARTED|Overall Study||54
1598150|NCT01011075|3908149|P1|NOT COMPLETED|Overall Study||0
1598151|NCT01011075|3908149|P1|COMPLETED|Overall Study||34
1598152|NCT01011075|3908149|P1|STARTED|Overall Study||34
1598153|NCT01011049|3908160|P4|NOT COMPLETED|Overall Study||0
1598154|NCT01011049|3908161|P3|NOT COMPLETED|Overall Study||4
1598155|NCT01011049|3908162|P2|NOT COMPLETED|Overall Study||2
1598156|NCT01011049|3908163|P1|NOT COMPLETED|Overall Study||1
1598157|NCT01011049|3908160|P4|COMPLETED|Overall Study||246
1598158|NCT01011049|3908161|P3|COMPLETED|Overall Study||239
1598159|NCT01011049|3908162|P2|COMPLETED|Overall Study||250
1598160|NCT01011049|3908163|P1|COMPLETED|Overall Study||506
1598161|NCT01011049|3908160|P4|STARTED|Overall Study||246
1598162|NCT01011049|3908161|P3|STARTED|Overall Study||243
1598163|NCT01011049|3908162|P2|STARTED|Overall Study||252
1598164|NCT01011049|3908163|P1|STARTED|Overall Study||507
1598165|NCT01010984|3908185|P1|NOT COMPLETED|Overall Study||0
1598166|NCT01010984|3908185|P1|COMPLETED|Overall Study||20
1598167|NCT01010984|3908185|P1|STARTED|Overall Study||20
1598168|NCT01010971|3908193|P3|NOT COMPLETED|Overall Study||13
1598169|NCT01010971|3908194|P2|NOT COMPLETED|Overall Study||8
1598170|NCT01010971|3908195|P1|NOT COMPLETED|Overall Study||3
1598171|NCT01010971|3908193|P3|COMPLETED|Overall Study||207
1598172|NCT01010971|3908194|P2|COMPLETED|Overall Study||218
1598173|NCT01010971|3908195|P1|COMPLETED|Overall Study||222
1598174|NCT01010971|3908193|P3|STARTED|Overall Study||220
1598175|NCT01010971|3908194|P2|STARTED|Overall Study||226
1598176|NCT01010971|3908195|P1|STARTED|Overall Study||225
1598177|NCT01010932|3908280|P1|NOT COMPLETED|Overall Study||22
1598178|NCT01010932|3908280|P1|COMPLETED|Overall Study||200
1598179|NCT01010932|3908280|P1|STARTED|Overall Study||222
1598180|NCT01010906|3908298|P6|NOT COMPLETED|Overall Study||0
1598181|NCT01010906|3908299|P5|NOT COMPLETED|Overall Study||0
1598182|NCT01010906|3908300|P4|NOT COMPLETED|Overall Study||0
1598183|NCT01010906|3908301|P3|NOT COMPLETED|Overall Study||0
1598184|NCT01010906|3908302|P2|NOT COMPLETED|Overall Study||0
1598185|NCT01010906|3908303|P1|NOT COMPLETED|Overall Study||0
1598186|NCT01010906|3908298|P6|COMPLETED|Overall Study||10
1598187|NCT01010906|3908299|P5|COMPLETED|Overall Study||10
1598188|NCT01010906|3908300|P4|COMPLETED|Overall Study||10
1598189|NCT01010906|3908301|P3|COMPLETED|Overall Study||10
1598190|NCT01010906|3908302|P2|COMPLETED|Overall Study||10
1598191|NCT01010906|3908303|P1|COMPLETED|Overall Study||10
1598192|NCT01010906|3908298|P6|STARTED|Overall Study||10
1598193|NCT01010906|3908299|P5|STARTED|Overall Study||10
1598194|NCT01010906|3908300|P4|STARTED|Overall Study||10
1598195|NCT01010906|3908301|P3|STARTED|Overall Study||10
1598196|NCT01010906|3908302|P2|STARTED|Overall Study||10
1598197|NCT01010906|3908303|P1|STARTED|Overall Study||10
1598198|NCT01010867|3908323|P1|NOT COMPLETED|Overall Study||1
1598199|NCT01010867|3908323|P1|COMPLETED|Overall Study||30
1598200|NCT01010867|3908323|P1|STARTED|Overall Study||31
1598201|NCT01010854|3908330|P1|NOT COMPLETED|Overall Study||0
1598202|NCT01010854|3908330|P1|COMPLETED|Overall Study||6
1598203|NCT01010854|3908330|P1|STARTED|Overall Study||6
1598204|NCT01010776|3908335|P1|NOT COMPLETED|Extension Phase||3
1598205|NCT01010776|3908335|P1|COMPLETED|Extension Phase||156
1598206|NCT01010776|3908335|P1|STARTED|Extension Phase||159
1598207|NCT01010776|3908335|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
1598208|NCT01010776|3908335|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
1598209|NCT01010776|3908335|P1|STARTED|In-Between Main Phase & Extension Phase||174
1598210|NCT01010776|3908335|P1|NOT COMPLETED|Main Phase||49
1598211|NCT01010776|3908335|P1|COMPLETED|Main Phase||174
1598212|NCT01010776|3908335|P1|Treated|Main Phase||218
1598213|NCT01010776|3908335|P1|STARTED|Main Phase||223
1598214|NCT01010750|3908363|P6|NOT COMPLETED|Third Intervention||0
1598215|NCT01010750|3908364|P5|NOT COMPLETED|Third Intervention||0
1598216|NCT01010750|3908365|P4|NOT COMPLETED|Third Intervention||0
1598217|NCT01010750|3908366|P3|NOT COMPLETED|Third Intervention||0
1598218|NCT01010750|3908367|P2|NOT COMPLETED|Third Intervention||0
1598219|NCT01010750|3908368|P1|NOT COMPLETED|Third Intervention||0
1598220|NCT01010750|3908363|P6|COMPLETED|Third Intervention||3
1598221|NCT01010750|3908364|P5|COMPLETED|Third Intervention||2
1598222|NCT01010750|3908365|P4|COMPLETED|Third Intervention||3
1598223|NCT01010750|3908366|P3|COMPLETED|Third Intervention||3
1598224|NCT01010750|3908367|P2|COMPLETED|Third Intervention||3
1598225|NCT01010750|3908368|P1|COMPLETED|Third Intervention||3
1598226|NCT01010750|3908363|P6|STARTED|Third Intervention||3
1598227|NCT01010750|3908364|P5|STARTED|Third Intervention||2
1598228|NCT01010750|3908365|P4|STARTED|Third Intervention||3
1598229|NCT01010750|3908366|P3|STARTED|Third Intervention||3
1598230|NCT01010750|3908367|P2|STARTED|Third Intervention||3
1598231|NCT01010750|3908368|P1|STARTED|Third Intervention||3
1598232|NCT01010750|3908363|P6|NOT COMPLETED|Second Intervention||0
1598233|NCT01010750|3908364|P5|NOT COMPLETED|Second Intervention||0
1598234|NCT01010750|3908365|P4|NOT COMPLETED|Second Intervention||0
1598235|NCT01010750|3908366|P3|NOT COMPLETED|Second Intervention||0
1598236|NCT01010750|3908367|P2|NOT COMPLETED|Second Intervention||1
1598237|NCT01010750|3908368|P1|NOT COMPLETED|Second Intervention||0
1598238|NCT01010750|3908363|P6|COMPLETED|Second Intervention||3
1598239|NCT01010750|3908364|P5|COMPLETED|Second Intervention||2
1598240|NCT01010750|3908365|P4|COMPLETED|Second Intervention||3
1598241|NCT01010750|3908366|P3|COMPLETED|Second Intervention||3
1598242|NCT01010750|3908367|P2|COMPLETED|Second Intervention||3
1598243|NCT01010750|3908368|P1|COMPLETED|Second Intervention||3
1598244|NCT01010750|3908363|P6|STARTED|Second Intervention||3
1598245|NCT01010750|3908364|P5|STARTED|Second Intervention||2
1598246|NCT01010750|3908365|P4|STARTED|Second Intervention||3
1598247|NCT01010750|3908366|P3|STARTED|Second Intervention||3
1598248|NCT01010750|3908367|P2|STARTED|Second Intervention||4
1598249|NCT01010750|3908368|P1|STARTED|Second Intervention||3
1598250|NCT01010750|3908363|P6|NOT COMPLETED|First Intervention||0
1598251|NCT01010750|3908364|P5|NOT COMPLETED|First Intervention||0
1598252|NCT01010750|3908365|P4|NOT COMPLETED|First Intervention||0
1598253|NCT01010750|3908366|P3|NOT COMPLETED|First Intervention||0
1598254|NCT01010750|3908367|P2|NOT COMPLETED|First Intervention||0
1598255|NCT01010750|3908368|P1|NOT COMPLETED|First Intervention||0
1598256|NCT01010750|3908363|P6|COMPLETED|First Intervention||3
1598257|NCT01010750|3908364|P5|COMPLETED|First Intervention||2
1598258|NCT01010750|3908365|P4|COMPLETED|First Intervention||3
1598259|NCT01010750|3908366|P3|COMPLETED|First Intervention||3
1598260|NCT01010750|3908367|P2|COMPLETED|First Intervention||4
1598261|NCT01010750|3908368|P1|COMPLETED|First Intervention||3
1598262|NCT01010750|3908363|P6|STARTED|First Intervention||3
1598263|NCT01010750|3908364|P5|STARTED|First Intervention||2
1598264|NCT01010750|3908365|P4|STARTED|First Intervention||3
1598265|NCT01010750|3908366|P3|STARTED|First Intervention||3
1598266|NCT01010750|3908367|P2|STARTED|First Intervention||4
1598267|NCT01010750|3908368|P1|STARTED|First Intervention||3
1598268|NCT01010633|3908393|P2|NOT COMPLETED|Overall Study||5
1598269|NCT01010633|3908394|P1|NOT COMPLETED|Overall Study||4
1598270|NCT01010633|3908393|P2|COMPLETED|Overall Study||198
1598271|NCT01010633|3908394|P1|COMPLETED|Overall Study||199
1598272|NCT01010633|3908393|P2|STARTED|Overall Study||203
1598273|NCT01010633|3908394|P1|STARTED|Overall Study||203
1598274|NCT01010568|3908404|P1|NOT COMPLETED|Overall Study||5
1598275|NCT01010568|3908404|P1|COMPLETED|Overall Study||5
1598276|NCT01010568|3908404|P1|STARTED|Overall Study||10
1598277|NCT01010555|3908410|P2|NOT COMPLETED|Second Four Weeks of Wear||0
1598278|NCT01010555|3908411|P1|NOT COMPLETED|Second Four Weeks of Wear||0
1598279|NCT01010555|3908410|P2|COMPLETED|Second Four Weeks of Wear||9
1598280|NCT01010555|3908411|P1|COMPLETED|Second Four Weeks of Wear||10
1598281|NCT01010555|3908410|P2|STARTED|Second Four Weeks of Wear||9
1598282|NCT01010555|3908411|P1|STARTED|Second Four Weeks of Wear||10
1598283|NCT01010555|3908410|P2|NOT COMPLETED|First Four Weeks of Wear||0
1598284|NCT01010555|3908411|P1|NOT COMPLETED|First Four Weeks of Wear||0
1598285|NCT01010555|3908410|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
1598286|NCT01010555|3908411|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
1598287|NCT01010555|3908410|P2|STARTED|First Four Weeks of Wear||10
1598288|NCT01010555|3908411|P1|STARTED|First Four Weeks of Wear||11
1598289|NCT01010503|3908421|P1|NOT COMPLETED|Overall Study||2
1598290|NCT01010503|3908421|P1|COMPLETED|Overall Study||30
1598291|NCT01010503|3908421|P1|STARTED|Overall Study||32
1598292|NCT01010477|3908441|P2|NOT COMPLETED|Overall Study||3
1598293|NCT01010477|3908442|P1|NOT COMPLETED|Overall Study||6
1598294|NCT01010477|3908441|P2|COMPLETED|Overall Study||22
1598295|NCT01010477|3908442|P1|COMPLETED|Overall Study||21
1598296|NCT01010477|3908441|P2|STARTED|Overall Study||25
1598297|NCT01010477|3908442|P1|STARTED|Overall Study||27
1598298|NCT01010399|3908448|P1|NOT COMPLETED|Overall Study||5
1598299|NCT01010399|3908448|P1|COMPLETED|Overall Study||31
1598300|NCT01010399|3908448|P1|STARTED|Overall Study||36
1598301|NCT01010282|3908456|P3|NOT COMPLETED|Overall Study||19
1598302|NCT01010282|3908457|P2|NOT COMPLETED|Overall Study||7
1598303|NCT01010282|3908458|P1|NOT COMPLETED|Overall Study||6
1598304|NCT01010282|3908456|P3|COMPLETED|Overall Study||77
1598305|NCT01010282|3908457|P2|COMPLETED|Overall Study||88
1598306|NCT01010282|3908458|P1|COMPLETED|Overall Study||91
1598307|NCT01010282|3908456|P3|STARTED|Overall Study||96
1598308|NCT01010282|3908457|P2|STARTED|Overall Study||95
1598309|NCT01010282|3908458|P1|STARTED|Overall Study||97
1598310|NCT01010230|3908480|P2|NOT COMPLETED|Overall Study||7
1598311|NCT01010230|3908481|P1|NOT COMPLETED|Overall Study||10
1598312|NCT01010230|3908480|P2|COMPLETED|Overall Study||26
1598313|NCT01010230|3908481|P1|COMPLETED|Overall Study||22
1598314|NCT01010230|3908480|P2|STARTED|Overall Study||33
1598315|NCT01010230|3908481|P1|STARTED|Overall Study||32
1598316|NCT01010204|3908513|P2|NOT COMPLETED|Overall Study||9
1598317|NCT01010204|3908514|P1|NOT COMPLETED|Overall Study||7
1598318|NCT01010204|3908513|P2|COMPLETED|Overall Study||20
1598319|NCT01010204|3908514|P1|COMPLETED|Overall Study||24
1598320|NCT01010204|3908513|P2|STARTED|Overall Study||29
1598321|NCT01010204|3908514|P1|STARTED|Overall Study||31
1598322|NCT01010061|3908526|P2|NOT COMPLETED|Overall Study||40
1598323|NCT01010061|3908527|P1|NOT COMPLETED|Overall Study||48
1598324|NCT01010061|3908526|P2|COMPLETED|Overall Study||78
1598325|NCT01010061|3908527|P1|COMPLETED|Overall Study|Completed=Completed treatment.|190
1598326|NCT01010061|3908526|P2|Received Study Drug|Overall Study||116
1598327|NCT01010061|3908527|P1|Received Study Drug|Overall Study||236
1598328|NCT01010061|3908526|P2|STARTED|Overall Study||118
1598329|NCT01010061|3908527|P1|STARTED|Overall Study||238
1598330|NCT01010009|3908562|P3|NOT COMPLETED|Overall Study||0
1598331|NCT01010009|3908563|P2|NOT COMPLETED|Overall Study||0
1598332|NCT01010009|3908564|P1|NOT COMPLETED|Overall Study||0
1598333|NCT01010009|3908562|P3|COMPLETED|Overall Study||8
1598334|NCT01010009|3908563|P2|COMPLETED|Overall Study||8
1598335|NCT01010009|3908564|P1|COMPLETED|Overall Study||8
1598336|NCT01010009|3908562|P3|STARTED|Overall Study||8
1598337|NCT01010009|3908563|P2|STARTED|Overall Study||8
1598338|NCT01010009|3908564|P1|STARTED|Overall Study||8
1598339|NCT01009983|3908578|P1|NOT COMPLETED|Overall Study||1
1598340|NCT01009983|3908578|P1|COMPLETED|Overall Study||13
1598341|NCT01009983|3908578|P1|STARTED|Overall Study||14
1598342|NCT01009931|3908585|P1|NOT COMPLETED|Overall Study||1
1598343|NCT01009931|3908585|P1|COMPLETED|Overall Study||0
1598344|NCT01009931|3908585|P1|STARTED|Overall Study||1
1598345|NCT01009840|3908591|P1|NOT COMPLETED|Overall Study||14
1598346|NCT01009840|3908591|P1|COMPLETED|Overall Study||16
1598347|NCT01009840|3908591|P1|STARTED|Overall Study||30
1598348|NCT01009762|3908606|P2|NOT COMPLETED|Overall Study||0
1598349|NCT01009762|3908607|P1|NOT COMPLETED|Overall Study||0
1598350|NCT01009762|3908606|P2|COMPLETED|Overall Study|10 participants received vaccine|10
1598351|NCT01009762|3908607|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
1598352|NCT01009762|3908606|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
1598353|NCT01009762|3908607|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
1598354|NCT01009762|3908606|P2|STARTED|Overall Study||10
1598355|NCT01009762|3908607|P1|STARTED|Overall Study||1
1598356|NCT01009645|3908621|P4|NOT COMPLETED|Overall Study||5
1598357|NCT01009645|3908622|P3|NOT COMPLETED|Overall Study||4
1598358|NCT01009645|3908623|P2|NOT COMPLETED|Overall Study||8
1598359|NCT01009645|3908624|P1|NOT COMPLETED|Overall Study||2
1598360|NCT01009645|3908621|P4|COMPLETED|Overall Study||26
1598361|NCT01009645|3908622|P3|COMPLETED|Overall Study||28
1598362|NCT01009645|3908623|P2|COMPLETED|Overall Study||23
1598363|NCT01009645|3908624|P1|COMPLETED|Overall Study||29
1598364|NCT01009645|3908621|P4|STARTED|Overall Study||31
1598365|NCT01009645|3908622|P3|STARTED|Overall Study||32
1598366|NCT01009645|3908623|P2|STARTED|Overall Study||31
1598367|NCT01009645|3908624|P1|STARTED|Overall Study||31
1598368|NCT01009619|3908640|P2|NOT COMPLETED|Overall Study||0
1598369|NCT01009619|3908641|P1|NOT COMPLETED|Overall Study||0
1598370|NCT01009619|3908640|P2|COMPLETED|Overall Study||43
1598371|NCT01009619|3908641|P1|COMPLETED|Overall Study||40
1598372|NCT01009619|3908640|P2|STARTED|Overall Study||43
1598373|NCT01009619|3908641|P1|STARTED|Overall Study||40
1598374|NCT01009580|3908661|P2|NOT COMPLETED|Overall Study||35
1598375|NCT01009580|3908662|P1|NOT COMPLETED|Overall Study||27
1598376|NCT01009580|3908661|P2|COMPLETED|Overall Study||188
1598377|NCT01009580|3908662|P1|COMPLETED|Overall Study||197
1598378|NCT01009580|3908661|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
1598379|NCT01009580|3908662|P1|Exposed|Overall Study||224
1598380|NCT01009580|3908661|P2|STARTED|Overall Study||223
1598381|NCT01009580|3908662|P1|STARTED|Overall Study||224
1598382|NCT01009554|3908676|P2|NOT COMPLETED|Overall Study||7
1598383|NCT01009554|3908677|P1|NOT COMPLETED|Overall Study||2
1598384|NCT01009554|3908676|P2|COMPLETED|Overall Study||41
1598385|NCT01009554|3908677|P1|COMPLETED|Overall Study||46
1598386|NCT01009554|3908676|P2|STARTED|Overall Study||48
1598387|NCT01009554|3908677|P1|STARTED|Overall Study||48
1598388|NCT01009515|3908809|P1|NOT COMPLETED|Overall Study||3
1598389|NCT01009515|3908809|P1|COMPLETED|Overall Study||16
1598390|NCT01009515|3908809|P1|STARTED|Overall Study||19
1598391|NCT01009463|3908820|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
1598392|NCT01009463|3908821|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
1598393|NCT01009463|3908822|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
1598394|NCT01009463|3908823|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
1598395|NCT01009463|3908824|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
1598396|NCT01009463|3908820|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
1598397|NCT01009463|3908821|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
1598398|NCT01009463|3908822|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
1598399|NCT01009463|3908823|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
1598400|NCT01009463|3908824|P1|COMPLETED|52-week, Double-blind Treatment Period||0
1598401|NCT01009463|3908820|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
1598402|NCT01009463|3908821|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
1598403|NCT01009463|3908822|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
1598404|NCT01009463|3908823|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
1598405|NCT01009463|3908824|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
1598406|NCT01009463|3908820|P5|STARTED|52-week, Double-blind Treatment Period||402
1598407|NCT01009463|3908821|P4|STARTED|52-week, Double-blind Treatment Period||403
1598408|NCT01009463|3908822|P3|STARTED|52-week, Double-blind Treatment Period||408
1598409|NCT01009463|3908823|P2|STARTED|52-week, Double-blind Treatment Period||409
1598410|NCT01009463|3908824|P1|STARTED|52-week, Double-blind Treatment Period||0
1598411|NCT01009463|3908820|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
1598412|NCT01009463|3908821|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
1598413|NCT01009463|3908822|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
1598414|NCT01009463|3908823|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
1598415|NCT01009463|3908824|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
1598416|NCT01009463|3908820|P5|COMPLETED|4-week, Open-label Run-In Period||0
1598417|NCT01009463|3908821|P4|COMPLETED|4-week, Open-label Run-In Period||0
1598418|NCT01009463|3908822|P3|COMPLETED|4-week, Open-label Run-In Period||0
1598419|NCT01009463|3908823|P2|COMPLETED|4-week, Open-label Run-In Period||0
1598420|NCT01009463|3908824|P1|COMPLETED|4-week, Open-label Run-In Period||1622
1598421|NCT01009463|3908820|P5|STARTED|4-week, Open-label Run-In Period||0
1598422|NCT01009463|3908821|P4|STARTED|4-week, Open-label Run-In Period||0
1598423|NCT01009463|3908822|P3|STARTED|4-week, Open-label Run-In Period||0
1598424|NCT01009463|3908823|P2|STARTED|4-week, Open-label Run-In Period||0
1598425|NCT01009463|3908824|P1|STARTED|4-week, Open-label Run-In Period||2071
1598426|NCT01009346|3908846|P1|NOT COMPLETED|Overall Study||4
1598427|NCT01009346|3908846|P1|COMPLETED|Overall Study||5
1598428|NCT01009346|3908846|P1|STARTED|Overall Study||9
1598429|NCT01009333|3908851|P6|NOT COMPLETED|Week 3||0
1598430|NCT01009333|3908852|P5|NOT COMPLETED|Week 3||0
1598431|NCT01009333|3908853|P4|NOT COMPLETED|Week 3||0
1598432|NCT01009333|3908854|P3|NOT COMPLETED|Week 3||0
1598433|NCT01009333|3908855|P2|NOT COMPLETED|Week 3||0
1598434|NCT01009333|3908856|P1|NOT COMPLETED|Week 3||0
1598435|NCT01009333|3908851|P6|COMPLETED|Week 3||2
1598436|NCT01009333|3908852|P5|COMPLETED|Week 3||2
1598437|NCT01009333|3908853|P4|COMPLETED|Week 3||2
1598438|NCT01009333|3908854|P3|COMPLETED|Week 3||2
1598439|NCT01009333|3908855|P2|COMPLETED|Week 3||2
1598440|NCT01009333|3908856|P1|COMPLETED|Week 3||2
1598441|NCT01009333|3908851|P6|STARTED|Week 3||2
1598442|NCT01009333|3908852|P5|STARTED|Week 3||2
1598443|NCT01009333|3908853|P4|STARTED|Week 3||2
1598444|NCT01009333|3908854|P3|STARTED|Week 3||2
1598445|NCT01009333|3908855|P2|STARTED|Week 3||2
1598446|NCT01009333|3908856|P1|STARTED|Week 3||2
1598447|NCT01009333|3908851|P6|NOT COMPLETED|Week 2||0
1598448|NCT01009333|3908852|P5|NOT COMPLETED|Week 2||0
1598449|NCT01009333|3908853|P4|NOT COMPLETED|Week 2||0
1598450|NCT01009333|3908854|P3|NOT COMPLETED|Week 2||0
1598451|NCT01009333|3908855|P2|NOT COMPLETED|Week 2||0
1598452|NCT01009333|3908856|P1|NOT COMPLETED|Week 2||0
1598453|NCT01009333|3908851|P6|COMPLETED|Week 2||2
1598454|NCT01009333|3908852|P5|COMPLETED|Week 2||2
1598455|NCT01009333|3908853|P4|COMPLETED|Week 2||2
1598456|NCT01009333|3908854|P3|COMPLETED|Week 2||2
1598457|NCT01009333|3908855|P2|COMPLETED|Week 2||2
1598458|NCT01009333|3908856|P1|COMPLETED|Week 2||2
1598459|NCT01009333|3908851|P6|STARTED|Week 2||2
1598460|NCT01009333|3908852|P5|STARTED|Week 2||2
1598461|NCT01009333|3908853|P4|STARTED|Week 2||2
1598462|NCT01009333|3908854|P3|STARTED|Week 2||2
1598463|NCT01009333|3908855|P2|STARTED|Week 2||2
1598464|NCT01009333|3908856|P1|STARTED|Week 2||2
1598465|NCT01009333|3908851|P6|NOT COMPLETED|Week 1||0
1598466|NCT01009333|3908852|P5|NOT COMPLETED|Week 1||0
1598467|NCT01009333|3908853|P4|NOT COMPLETED|Week 1||0
1598468|NCT01009333|3908854|P3|NOT COMPLETED|Week 1||0
1598469|NCT01009333|3908855|P2|NOT COMPLETED|Week 1||0
1598470|NCT01009333|3908856|P1|NOT COMPLETED|Week 1||0
1598471|NCT01009333|3908851|P6|COMPLETED|Week 1||2
1598472|NCT01009333|3908852|P5|COMPLETED|Week 1||2
1598473|NCT01009333|3908853|P4|COMPLETED|Week 1||2
1598474|NCT01009333|3908854|P3|COMPLETED|Week 1||2
1598475|NCT01009333|3908855|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
1598476|NCT01009333|3908856|P1|COMPLETED|Week 1||2
1598477|NCT01009333|3908851|P6|STARTED|Week 1||2
1598478|NCT01009333|3908852|P5|STARTED|Week 1||2
1598479|NCT01009333|3908853|P4|STARTED|Week 1||2
1598480|NCT01009333|3908854|P3|STARTED|Week 1||2
1598481|NCT01009333|3908855|P2|STARTED|Week 1||3
1598482|NCT01009333|3908856|P1|STARTED|Week 1||2
1598483|NCT01009203|3908870|P1|NOT COMPLETED|Overall Study||7
1598484|NCT01009203|3908870|P1|COMPLETED|Overall Study||6
1598485|NCT01009203|3908870|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
1598486|NCT01009203|3908870|P1|STARTED|Overall Study||13
1598487|NCT01009138|3908879|P2|NOT COMPLETED|Overall Study||20
1598488|NCT01009138|3908880|P1|NOT COMPLETED|Overall Study||13
1598489|NCT01009138|3908879|P2|COMPLETED|Overall Study||88
1598490|NCT01009138|3908880|P1|COMPLETED|Overall Study||93
1598491|NCT01009138|3908879|P2|STARTED|Overall Study||108
1598492|NCT01009138|3908880|P1|STARTED|Overall Study||106
1598493|NCT01009099|3908910|P2|NOT COMPLETED|Overall Study||4
1598494|NCT01009099|3908911|P1|NOT COMPLETED|Overall Study||5
1598495|NCT01009099|3908910|P2|COMPLETED|Overall Study||57
1598496|NCT01009099|3908911|P1|COMPLETED|Overall Study||53
1598497|NCT01009099|3908910|P2|STARTED|Overall Study||61
1598498|NCT01009099|3908911|P1|STARTED|Overall Study||58
1598499|NCT01009086|3908920|P3|NOT COMPLETED|Overall Study||34
1598500|NCT01009086|3908921|P2|NOT COMPLETED|Overall Study||47
1598501|NCT01009086|3908922|P1|NOT COMPLETED|Overall Study||44
1598502|NCT01009086|3908920|P3|COMPLETED|Overall Study||170
1598503|NCT01009086|3908921|P2|COMPLETED|Overall Study||158
1598504|NCT01009086|3908922|P1|COMPLETED|Overall Study||162
1598505|NCT01009086|3908920|P3|STARTED|Overall Study||204
1598506|NCT01009086|3908921|P2|STARTED|Overall Study||205
1598507|NCT01009086|3908922|P1|STARTED|Overall Study||206
1598508|NCT01009060|3908957|P2|NOT COMPLETED|Overall Study||5
1598509|NCT01009060|3908958|P1|NOT COMPLETED|Overall Study||4
1598510|NCT01009060|3908957|P2|COMPLETED|Overall Study||20
1598511|NCT01009060|3908958|P1|COMPLETED|Overall Study||21
1598512|NCT01009060|3908957|P2|STARTED|Overall Study||25
1598513|NCT01009060|3908958|P1|STARTED|Overall Study||25
1598514|NCT01009047|3908996|P2|NOT COMPLETED|Overall Study||26
1598515|NCT01009047|3908997|P1|NOT COMPLETED|Overall Study||28
1598516|NCT01009047|3908996|P2|COMPLETED|Overall Study||89
1598517|NCT01009047|3908997|P1|COMPLETED|Overall Study||85
1598518|NCT01009047|3908996|P2|STARTED|Overall Study||115
1598519|NCT01009047|3908997|P1|STARTED|Overall Study||113
1598520|NCT01009034|3909019|P1|NOT COMPLETED|Overall Study||4
1598521|NCT01009034|3909019|P1|COMPLETED|Overall Study||10
1598522|NCT01009034|3909019|P1|STARTED|Overall Study||14
1598523|NCT01008995|3909027|P4|NOT COMPLETED|After Controlled Period||1
1598524|NCT01008995|3909028|P3|NOT COMPLETED|After Controlled Period||2
1598525|NCT01008995|3909029|P2|NOT COMPLETED|After Controlled Period||0
1598526|NCT01008995|3909030|P1|NOT COMPLETED|After Controlled Period||0
1598527|NCT01008995|3909027|P4|COMPLETED|After Controlled Period||156
1598528|NCT01008995|3909028|P3|COMPLETED|After Controlled Period||156
1598529|NCT01008995|3909029|P2|COMPLETED|After Controlled Period||0
1598530|NCT01008995|3909030|P1|COMPLETED|After Controlled Period||0
1598531|NCT01008995|3909027|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
1598532|NCT01008995|3909028|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
1598533|NCT01008995|3909029|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1598534|NCT01008995|3909030|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1598535|NCT01008995|3909027|P4|NOT COMPLETED|Controlled Period||0
1598536|NCT01008995|3909028|P3|NOT COMPLETED|Controlled Period||0
1598537|NCT01008995|3909029|P2|NOT COMPLETED|Controlled Period||3
1598538|NCT01008995|3909030|P1|NOT COMPLETED|Controlled Period||3
1598539|NCT01008995|3909027|P4|COMPLETED|Controlled Period||0
1598540|NCT01008995|3909028|P3|COMPLETED|Controlled Period||0
1598541|NCT01008995|3909029|P2|COMPLETED|Controlled Period||157
1598542|NCT01008995|3909030|P1|COMPLETED|Controlled Period||159
1598543|NCT01008995|3909027|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1598544|NCT01008995|3909028|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1598545|NCT01008995|3909029|P2|STARTED|Controlled Period||160
1598546|NCT01008995|3909030|P1|STARTED|Controlled Period||162
1598547|NCT01008969|3909042|P1|NOT COMPLETED|Overall Study||0
1598548|NCT01008969|3909042|P1|COMPLETED|Overall Study||10
1598549|NCT01008969|3909042|P1|STARTED|Overall Study||10
1598550|NCT01008943|3909047|P1|NOT COMPLETED|Overall Study||1
1598551|NCT01008943|3909047|P1|COMPLETED|Overall Study||15
1598552|NCT01008943|3909047|P1|STARTED|Overall Study||16
1598553|NCT01008904|3909054|P1|NOT COMPLETED|Overall Study||4
1598554|NCT01008904|3909054|P1|COMPLETED|Overall Study||25
1598555|NCT01008904|3909054|P1|STARTED|Overall Study||29
1598556|NCT01008722|3909061|P2|NOT COMPLETED|Overall Study||0
1598557|NCT01008722|3909062|P1|NOT COMPLETED|Overall Study||0
1598558|NCT01008722|3909061|P2|COMPLETED|Overall Study||71
1598559|NCT01008722|3909062|P1|COMPLETED|Overall Study||36
1598560|NCT01008722|3909061|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
1598561|NCT01008722|3909062|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
1598562|NCT01008696|3909072|P2|NOT COMPLETED|Overall Study||17
1598563|NCT01008696|3909073|P1|NOT COMPLETED|Overall Study||17
1598564|NCT01008696|3909072|P2|COMPLETED|Overall Study||92
1598565|NCT01008696|3909073|P1|COMPLETED|Overall Study||91
1598566|NCT01008696|3909072|P2|STARTED|Overall Study||109
1598567|NCT01008696|3909073|P1|STARTED|Overall Study||108
1598568|NCT01008618|3909083|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
1598569|NCT01008618|3909084|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
1598570|NCT01008618|3909085|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
1598571|NCT01008618|3909083|P3|COMPLETED|Period 2 (Double-Blind Period)||39
1598572|NCT01008618|3909084|P2|COMPLETED|Period 2 (Double-Blind Period)||37
1598573|NCT01008618|3909085|P1|COMPLETED|Period 2 (Double-Blind Period)||0
1598574|NCT01008618|3909083|P3|STARTED|Period 2 (Double-Blind Period)||77
1598575|NCT01008618|3909084|P2|STARTED|Period 2 (Double-Blind Period)||73
1598576|NCT01008618|3909085|P1|STARTED|Period 2 (Double-Blind Period)||0
1598577|NCT01008618|3909083|P3|NOT COMPLETED|Period 1 (Titration Period)||0
1598578|NCT01008618|3909084|P2|NOT COMPLETED|Period 1 (Titration Period)||0
1598579|NCT01008618|3909085|P1|NOT COMPLETED|Period 1 (Titration Period)||68
1598580|NCT01008618|3909083|P3|COMPLETED|Period 1 (Titration Period)||0
1598581|NCT01008618|3909084|P2|COMPLETED|Period 1 (Titration Period)||0
1598582|NCT01008618|3909085|P1|COMPLETED|Period 1 (Titration Period)||150
1598583|NCT01008618|3909083|P3|STARTED|Period 1 (Titration Period)||0
1598584|NCT01008618|3909084|P2|STARTED|Period 1 (Titration Period)||0
1598585|NCT01008618|3909085|P1|STARTED|Period 1 (Titration Period)||218
1598586|NCT01008605|3909110|P1|NOT COMPLETED|Overall Study||0
1598587|NCT01008605|3909110|P1|COMPLETED|Overall Study||48
1598588|NCT01008605|3909110|P1|STARTED|Overall Study||48
1598589|NCT01008553|3909134|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
1598590|NCT01008553|3909135|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
1598591|NCT01008553|3909136|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
1598592|NCT01008553|3909134|P3|COMPLETED|Period 2 (Double-Blind Period)||28
1598593|NCT01008553|3909135|P2|COMPLETED|Period 2 (Double-Blind Period)||47
1598594|NCT01008553|3909136|P1|COMPLETED|Period 2 (Double-Blind Period)||0
1598595|NCT01008553|3909134|P3|STARTED|Period 2 (Double-Blind Period)||79
1598596|NCT01008553|3909135|P2|STARTED|Period 2 (Double-Blind Period)||84
1598597|NCT01008553|3909136|P1|STARTED|Period 2 (Double-Blind Period)||0
1598598|NCT01008553|3909134|P3|NOT COMPLETED|Period 1 (Titration Period)||0
1598599|NCT01008553|3909135|P2|NOT COMPLETED|Period 1 (Titration Period)||0
1598600|NCT01008553|3909136|P1|NOT COMPLETED|Period 1 (Titration Period)||95
1598601|NCT01008553|3909134|P3|COMPLETED|Period 1 (Titration Period)||0
1598602|NCT01008553|3909135|P2|COMPLETED|Period 1 (Titration Period)||0
1598603|NCT01008553|3909136|P1|COMPLETED|Period 1 (Titration Period)||163
1598604|NCT01008553|3909134|P3|STARTED|Period 1 (Titration Period)||0
1598605|NCT01008553|3909135|P2|STARTED|Period 1 (Titration Period)||0
1598606|NCT01008553|3909136|P1|STARTED|Period 1 (Titration Period)||258
1598607|NCT01008475|3909168|P7|NOT COMPLETED|Overall Study||4
1598608|NCT01008475|3909169|P6|NOT COMPLETED|Overall Study||6
1598609|NCT01008475|3909170|P5|NOT COMPLETED|Overall Study||5
1598610|NCT01008475|3909171|P4|NOT COMPLETED|Overall Study||0
1598611|NCT01008475|3909172|P3|NOT COMPLETED|Overall Study||0
1598612|NCT01008475|3909173|P2|NOT COMPLETED|Overall Study||0
1598613|NCT01008475|3909174|P1|NOT COMPLETED|Overall Study||0
1598614|NCT01008475|3909168|P7|COMPLETED|Overall Study||67
1598615|NCT01008475|3909169|P6|COMPLETED|Overall Study||67
1598616|NCT01008475|3909170|P5|COMPLETED|Overall Study||67
1598617|NCT01008475|3909171|P4|COMPLETED|Overall Study||3
1598618|NCT01008475|3909172|P3|COMPLETED|Overall Study||7
1598619|NCT01008475|3909173|P2|COMPLETED|Overall Study||3
1598620|NCT01008475|3909174|P1|COMPLETED|Overall Study||3
1598621|NCT01008475|3909168|P7|Safety Analysis Set|Overall Study||69
1598622|NCT01008475|3909169|P6|Safety Analysis Set|Overall Study||72
1598623|NCT01008475|3909170|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
1598624|NCT01008475|3909171|P4|Safety Analysis Set|Overall Study||3
1598625|NCT01008475|3909172|P3|Safety Analysis Set|Overall Study||7
1598626|NCT01008475|3909173|P2|Safety Analysis Set|Overall Study||3
1598627|NCT01008475|3909174|P1|Safety Analysis Set|Overall Study||3
1598628|NCT01008475|3909168|P7|STARTED|Overall Study||71
1598629|NCT01008475|3909169|P6|STARTED|Overall Study||73
1598630|NCT01008475|3909170|P5|STARTED|Overall Study||72
1598631|NCT01008475|3909171|P4|STARTED|Overall Study||3
1598632|NCT01008475|3909172|P3|STARTED|Overall Study||7
1598633|NCT01008475|3909173|P2|STARTED|Overall Study||3
1598634|NCT01008475|3909174|P1|STARTED|Overall Study||3
1598635|NCT01008449|3909204|P2|NOT COMPLETED|Overall Study||19
1598636|NCT01008449|3909205|P1|NOT COMPLETED|Overall Study||29
1598637|NCT01008449|3909204|P2|COMPLETED|Overall Study||179
1598638|NCT01008449|3909205|P1|COMPLETED|Overall Study||171
1598639|NCT01008449|3909204|P2|STARTED|Overall Study||198
1598640|NCT01008449|3909205|P1|STARTED|Overall Study||200
1598641|NCT01008319|3909227|P2|NOT COMPLETED|Overall Study||0
1598642|NCT01008319|3909228|P1|NOT COMPLETED|Overall Study||0
1598643|NCT01008319|3909227|P2|COMPLETED|Overall Study||60
1598644|NCT01008319|3909228|P1|COMPLETED|Overall Study||60
1598645|NCT01008319|3909227|P2|STARTED|Overall Study||60
1598646|NCT01008319|3909228|P1|STARTED|Overall Study||60
1598647|NCT01008280|3909240|P2|NOT COMPLETED|Overall Study||19
1598648|NCT01008280|3909241|P1|NOT COMPLETED|Overall Study||21
1598649|NCT01008280|3909240|P2|COMPLETED|Overall Study||73
1598650|NCT01008280|3909241|P1|COMPLETED|Overall Study||67
1598651|NCT01008280|3909240|P2|STARTED|Overall Study||92
1598652|NCT01008280|3909241|P1|STARTED|Overall Study||88
1598653|NCT01008150|3909255|P4|NOT COMPLETED|Overall Study||0
1598654|NCT01008150|3909256|P3|NOT COMPLETED|Overall Study||1
1598655|NCT01008150|3909257|P2|NOT COMPLETED|Overall Study||1
1598656|NCT01008150|3909258|P1|NOT COMPLETED|Overall Study||1
1598657|NCT01008150|3909255|P4|COMPLETED|Overall Study||12
1598658|NCT01008150|3909256|P3|COMPLETED|Overall Study||42
1598659|NCT01008150|3909257|P2|COMPLETED|Overall Study||42
1598660|NCT01008150|3909258|P1|COMPLETED|Overall Study||42
1598661|NCT01008150|3909255|P4|STARTED|Overall Study||12
1598662|NCT01008150|3909256|P3|STARTED|Overall Study||43
1598663|NCT01008150|3909257|P2|STARTED|Overall Study||43
1598664|NCT01008150|3909258|P1|STARTED|Overall Study||43
1598665|NCT01007916|3909288|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
1598666|NCT01007916|3909289|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
1598667|NCT01007916|3909288|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
1598668|NCT01007916|3909289|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
1598669|NCT01007916|3909288|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
1598670|NCT01007916|3909289|P1|STARTED|Period 2, 4 Weeks of Wear||22
1598671|NCT01007916|3909288|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
1598672|NCT01007916|3909289|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
1598673|NCT01007916|3909288|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
1598674|NCT01007916|3909289|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
1598675|NCT01007916|3909288|P2|STARTED|Period 1, 4 Weeks of Wear||26
1598676|NCT01007916|3909289|P1|STARTED|Period 1, 4 Weeks of Wear||23
1598677|NCT01007942|3909297|P2|NOT COMPLETED|Overall Study||278
1598678|NCT01007942|3909298|P1|NOT COMPLETED|Overall Study||281
1598679|NCT01007942|3909297|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
1598680|NCT01007942|3909298|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
1598681|NCT01007942|3909297|P2|STARTED|Overall Study||285
1598682|NCT01007942|3909298|P1|STARTED|Overall Study||284
1598683|NCT01007838|3909324|P4|NOT COMPLETED|Overall Study||0
1598684|NCT01007838|3909325|P3|NOT COMPLETED|Overall Study||0
1598685|NCT01007838|3909326|P2|NOT COMPLETED|Overall Study||0
1598686|NCT01007838|3909327|P1|NOT COMPLETED|Overall Study||3
1598687|NCT01007838|3909324|P4|COMPLETED|Overall Study||4
1598688|NCT01007838|3909325|P3|COMPLETED|Overall Study||5
1598689|NCT01007838|3909326|P2|COMPLETED|Overall Study||11
1598690|NCT01007838|3909327|P1|COMPLETED|Overall Study||9
1598691|NCT01007838|3909324|P4|STARTED|Overall Study||4
1598692|NCT01007838|3909325|P3|STARTED|Overall Study||5
1598693|NCT01007838|3909326|P2|STARTED|Overall Study||11
1598694|NCT01007838|3909327|P1|STARTED|Overall Study||12
1598695|NCT01007812|3909337|P2|NOT COMPLETED|Period 2, One Week||0
1598696|NCT01007812|3909338|P1|NOT COMPLETED|Period 2, One Week||0
1598697|NCT01007812|3909337|P2|COMPLETED|Period 2, One Week||24
1598698|NCT01007812|3909338|P1|COMPLETED|Period 2, One Week||24
1598699|NCT01007812|3909337|P2|STARTED|Period 2, One Week||24
1598700|NCT01007812|3909338|P1|STARTED|Period 2, One Week||24
1598701|NCT01007812|3909337|P2|NOT COMPLETED|Period 1, One Week||1
1598702|NCT01007812|3909338|P1|NOT COMPLETED|Period 1, One Week||1
1598703|NCT01007812|3909337|P2|COMPLETED|Period 1, One Week||24
1598704|NCT01007812|3909338|P1|COMPLETED|Period 1, One Week||24
1598705|NCT01007812|3909337|P2|STARTED|Period 1, One Week||25
1598706|NCT01007812|3909338|P1|STARTED|Period 1, One Week||25
1598707|NCT01007656|3909344|P1|NOT COMPLETED|Overall Study||0
1598708|NCT01007656|3909344|P1|COMPLETED|Overall Study||31
1598709|NCT01007656|3909344|P1|STARTED|Overall Study||31
1598710|NCT01007643|3909364|P2|NOT COMPLETED|Overall Study||0
1598711|NCT01007643|3909365|P1|NOT COMPLETED|Overall Study||0
1598712|NCT01007643|3909364|P2|COMPLETED|Overall Study||14
1598713|NCT01007643|3909365|P1|COMPLETED|Overall Study||8
1598714|NCT01007643|3909364|P2|STARTED|Overall Study||14
1598715|NCT01007643|3909365|P1|STARTED|Overall Study||8
1598716|NCT01007552|3909371|P1|NOT COMPLETED|Overall Study||1
1598717|NCT01007552|3909371|P1|COMPLETED|Overall Study||49
1598718|NCT01007552|3909371|P1|STARTED|Overall Study||50
1598719|NCT01007435|3909385|P4|NOT COMPLETED|Overall Study||56
1598720|NCT01007435|3909386|P3|NOT COMPLETED|Overall Study||64
1598721|NCT01007435|3909387|P2|NOT COMPLETED|Overall Study||59
1598722|NCT01007435|3909388|P1|NOT COMPLETED|Overall Study||63
1598723|NCT01007435|3909385|P4|COMPLETED|Overall Study||236
1598724|NCT01007435|3909386|P3|COMPLETED|Overall Study||227
1598725|NCT01007435|3909387|P2|COMPLETED|Overall Study||231
1598726|NCT01007435|3909388|P1|COMPLETED|Overall Study||226
1598727|NCT01007435|3909385|P4|STARTED|Overall Study||292
1598728|NCT01007435|3909386|P3|STARTED|Overall Study||291
1598729|NCT01007435|3909387|P2|STARTED|Overall Study||290
1598730|NCT01007435|3909388|P1|STARTED|Overall Study||289
1598731|NCT01007396|3909430|P1|NOT COMPLETED|Overall Study||47
1598732|NCT01007396|3909430|P1|COMPLETED|Overall Study||275
1598733|NCT01007396|3909430|P1|STARTED|Overall Study||322
1598734|NCT01007253|3909435|P4|NOT COMPLETED|Fourth Intervention||0
1598735|NCT01007253|3909436|P3|NOT COMPLETED|Fourth Intervention||0
1598736|NCT01007253|3909437|P2|NOT COMPLETED|Fourth Intervention||0
1598737|NCT01007253|3909438|P1|NOT COMPLETED|Fourth Intervention||0
1598738|NCT01007253|3909435|P4|COMPLETED|Fourth Intervention||5
1598739|NCT01007253|3909436|P3|COMPLETED|Fourth Intervention||5
1598740|NCT01007253|3909437|P2|COMPLETED|Fourth Intervention||5
1598741|NCT01007253|3909438|P1|COMPLETED|Fourth Intervention||5
1598742|NCT01007253|3909435|P4|STARTED|Fourth Intervention||5
1598743|NCT01007253|3909436|P3|STARTED|Fourth Intervention||5
1598744|NCT01007253|3909437|P2|STARTED|Fourth Intervention||5
1598745|NCT01007253|3909438|P1|STARTED|Fourth Intervention||5
1598746|NCT01007253|3909435|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
1598747|NCT01007253|3909436|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
1598748|NCT01007253|3909437|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
1598749|NCT01007253|3909438|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
1598750|NCT01007253|3909435|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
1598751|NCT01007253|3909436|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
1598752|NCT01007253|3909437|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
1598753|NCT01007253|3909438|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
1598754|NCT01007253|3909435|P4|STARTED|Washout Period (2 Weeks) # 3||5
1598755|NCT01007253|3909436|P3|STARTED|Washout Period (2 Weeks) # 3||5
1598756|NCT01007253|3909437|P2|STARTED|Washout Period (2 Weeks) # 3||5
1598757|NCT01007253|3909438|P1|STARTED|Washout Period (2 Weeks) # 3||6
1598758|NCT01007253|3909435|P4|NOT COMPLETED|Third Intervention||0
1598759|NCT01007253|3909436|P3|NOT COMPLETED|Third Intervention||0
1598760|NCT01007253|3909437|P2|NOT COMPLETED|Third Intervention||0
1598761|NCT01007253|3909438|P1|NOT COMPLETED|Third Intervention||0
1598762|NCT01007253|3909435|P4|COMPLETED|Third Intervention||5
1598763|NCT01007253|3909436|P3|COMPLETED|Third Intervention||5
1598764|NCT01007253|3909437|P2|COMPLETED|Third Intervention||5
1598765|NCT01007253|3909438|P1|COMPLETED|Third Intervention||6
1598766|NCT01007253|3909435|P4|STARTED|Third Intervention||5
1598767|NCT01007253|3909436|P3|STARTED|Third Intervention||5
1598768|NCT01007253|3909437|P2|STARTED|Third Intervention||5
1598769|NCT01007253|3909438|P1|STARTED|Third Intervention||6
1598770|NCT01007253|3909435|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1598771|NCT01007253|3909436|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1598772|NCT01007253|3909437|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1598773|NCT01007253|3909438|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1598774|NCT01007253|3909435|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
1598775|NCT01007253|3909436|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
1598776|NCT01007253|3909437|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
1598777|NCT01007253|3909438|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
1598778|NCT01007253|3909435|P4|STARTED|Washout Period (2 Weeks) # 2||5
1598779|NCT01007253|3909436|P3|STARTED|Washout Period (2 Weeks) # 2||5
1598780|NCT01007253|3909437|P2|STARTED|Washout Period (2 Weeks) # 2||5
1598781|NCT01007253|3909438|P1|STARTED|Washout Period (2 Weeks) # 2||6
1598782|NCT01007253|3909435|P4|NOT COMPLETED|Second Intervention||0
1598783|NCT01007253|3909436|P3|NOT COMPLETED|Second Intervention||0
1598784|NCT01007253|3909437|P2|NOT COMPLETED|Second Intervention||0
1598785|NCT01007253|3909438|P1|NOT COMPLETED|Second Intervention||0
1598786|NCT01007253|3909435|P4|COMPLETED|Second Intervention||5
1598787|NCT01007253|3909436|P3|COMPLETED|Second Intervention||5
1598788|NCT01007253|3909437|P2|COMPLETED|Second Intervention||5
1598789|NCT01007253|3909438|P1|COMPLETED|Second Intervention||6
1598790|NCT01007253|3909435|P4|STARTED|Second Intervention||5
1598791|NCT01007253|3909436|P3|STARTED|Second Intervention||5
1598792|NCT01007253|3909437|P2|STARTED|Second Intervention||5
1598793|NCT01007253|3909438|P1|STARTED|Second Intervention||6
1598794|NCT01007253|3909435|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1598795|NCT01007253|3909436|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1598796|NCT01007253|3909437|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1598797|NCT01007253|3909438|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1598798|NCT01007253|3909435|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
1598799|NCT01007253|3909436|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
1598800|NCT01007253|3909437|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
1598801|NCT01007253|3909438|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
1598802|NCT01007253|3909435|P4|STARTED|Washout Period (2 Weeks) # 1||5
1598803|NCT01007253|3909436|P3|STARTED|Washout Period (2 Weeks) # 1||5
1598804|NCT01007253|3909437|P2|STARTED|Washout Period (2 Weeks) # 1||5
1598805|NCT01007253|3909438|P1|STARTED|Washout Period (2 Weeks) # 1||6
1598806|NCT01007253|3909435|P4|NOT COMPLETED|First Intervention||0
1598807|NCT01007253|3909436|P3|NOT COMPLETED|First Intervention||0
1598808|NCT01007253|3909437|P2|NOT COMPLETED|First Intervention||0
1598809|NCT01007253|3909438|P1|NOT COMPLETED|First Intervention||0
1598810|NCT01007253|3909435|P4|COMPLETED|First Intervention||5
1598811|NCT01007253|3909436|P3|COMPLETED|First Intervention||5
1598812|NCT01007253|3909437|P2|COMPLETED|First Intervention||5
1598813|NCT01007253|3909438|P1|COMPLETED|First Intervention||6
1598814|NCT01007253|3909435|P4|STARTED|First Intervention||5
1598815|NCT01007253|3909436|P3|STARTED|First Intervention||5
1598816|NCT01007253|3909437|P2|STARTED|First Intervention||5
1598817|NCT01007253|3909438|P1|STARTED|First Intervention||6
1598818|NCT01007149|3909470|P2|NOT COMPLETED|Overall Study||1
1598819|NCT01007149|3909471|P1|NOT COMPLETED|Overall Study||0
1598820|NCT01007149|3909470|P2|COMPLETED|Overall Study||20
1598821|NCT01007149|3909471|P1|COMPLETED|Overall Study||20
1598822|NCT01007149|3909470|P2|STARTED|Overall Study||21
1598823|NCT01007149|3909471|P1|STARTED|Overall Study||20
1598824|NCT01007123|3909497|P4|NOT COMPLETED|Overall Study||6
1598825|NCT01007123|3909498|P3|NOT COMPLETED|Overall Study||11
1598826|NCT01007123|3909499|P2|NOT COMPLETED|Overall Study||6
1598827|NCT01007123|3909500|P1|NOT COMPLETED|Overall Study||6
1598828|NCT01007123|3909497|P4|COMPLETED|Overall Study||41
1598829|NCT01007123|3909498|P3|COMPLETED|Overall Study||37
1598830|NCT01007123|3909499|P2|COMPLETED|Overall Study||41
1598831|NCT01007123|3909500|P1|COMPLETED|Overall Study||42
1598832|NCT01007123|3909497|P4|STARTED|Overall Study||47
1598833|NCT01007123|3909498|P3|STARTED|Overall Study||48
1598834|NCT01007123|3909499|P2|STARTED|Overall Study||47
1598835|NCT01007123|3909500|P1|STARTED|Overall Study||48
1598836|NCT01007110|3909531|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
1598837|NCT01007110|3909532|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
1598838|NCT01007110|3909531|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
1598839|NCT01007110|3909532|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
1598840|NCT01007110|3909531|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
1598841|NCT01007110|3909532|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
1598842|NCT01007110|3909531|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
1598843|NCT01007110|3909532|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
1598844|NCT01007110|3909531|P2|COMPLETED|Follow-Up at 36 Weeks||20
1598845|NCT01007110|3909532|P1|COMPLETED|Follow-Up at 36 Weeks||24
1598846|NCT01007110|3909531|P2|STARTED|Follow-Up at 36 Weeks||22
1598847|NCT01007110|3909532|P1|STARTED|Follow-Up at 36 Weeks||24
1598848|NCT01007110|3909531|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
1598849|NCT01007110|3909532|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
1598850|NCT01007110|3909531|P2|COMPLETED|Follow-Up at 32 Weeks||22
1598851|NCT01007110|3909532|P1|COMPLETED|Follow-Up at 32 Weeks||24
1598852|NCT01007110|3909531|P2|STARTED|Follow-Up at 32 Weeks||23
1598853|NCT01007110|3909532|P1|STARTED|Follow-Up at 32 Weeks||25
1598854|NCT01007110|3909531|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
1598855|NCT01007110|3909532|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
1598856|NCT01007110|3909531|P2|COMPLETED|Follow-Up at 24 Weeks||23
1598857|NCT01007110|3909532|P1|COMPLETED|Follow-Up at 24 Weeks||25
1598858|NCT01007110|3909531|P2|STARTED|Follow-Up at 24 Weeks||27
1598859|NCT01007110|3909532|P1|STARTED|Follow-Up at 24 Weeks||25
1598860|NCT01007110|3909531|P2|NOT COMPLETED|Allocation||8
1598861|NCT01007110|3909532|P1|NOT COMPLETED|Allocation||7
1598862|NCT01007110|3909531|P2|COMPLETED|Allocation||27
1598863|NCT01007110|3909532|P1|COMPLETED|Allocation||25
1598864|NCT01007110|3909531|P2|STARTED|Allocation||35
1598865|NCT01007110|3909532|P1|STARTED|Allocation||32
1598866|NCT01007071|3909548|P2|NOT COMPLETED|Overall Study||0
1598867|NCT01007071|3909549|P1|NOT COMPLETED|Overall Study||0
1598868|NCT01007071|3909548|P2|COMPLETED|Overall Study||5
1598869|NCT01007071|3909549|P1|COMPLETED|Overall Study||6
1598870|NCT01007071|3909548|P2|STARTED|Overall Study||5
1598871|NCT01007071|3909549|P1|STARTED|Overall Study||6
1598872|NCT01006980|3909559|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
1598873|NCT01006980|3909560|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
1598874|NCT01006980|3909559|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
1598875|NCT01006980|3909560|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
1598876|NCT01006980|3909559|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
1598877|NCT01006980|3909560|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
1598878|NCT01006980|3909559|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
1598879|NCT01006980|3909560|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
1598880|NCT01006980|3909559|P2|COMPLETED|Vemurafenib and Dacarbazine||0
1598881|NCT01006980|3909560|P1|COMPLETED|Vemurafenib and Dacarbazine||0
1598882|NCT01006980|3909559|P2|Treated|Vemurafenib and Dacarbazine||293
1598883|NCT01006980|3909560|P1|Treated|Vemurafenib and Dacarbazine||336
1598884|NCT01006980|3909559|P2|STARTED|Vemurafenib and Dacarbazine||338
1598885|NCT01006980|3909560|P1|STARTED|Vemurafenib and Dacarbazine||337
1598886|NCT01006967|3909582|P2|NOT COMPLETED|Overall Study||63
1598887|NCT01006967|3909583|P1|NOT COMPLETED|Overall Study||66
1598888|NCT01006967|3909582|P2|COMPLETED|Overall Study||190
1598889|NCT01006967|3909583|P1|COMPLETED|Overall Study||187
1598890|NCT01006967|3909582|P2|3 Month Follow-up|Overall Study||210
1598891|NCT01006967|3909583|P1|3 Month Follow-up|Overall Study||212
1598892|NCT01006967|3909582|P2|Received Treatment|Overall Study||245
1598893|NCT01006967|3909583|P1|Received Treatment|Overall Study||245
1598894|NCT01006967|3909582|P2|STARTED|Overall Study||253
1598895|NCT01006967|3909583|P1|STARTED|Overall Study||253
1598896|NCT01006889|3909599|P1|NOT COMPLETED|Overall Study||3
1598897|NCT01006889|3909599|P1|COMPLETED|Overall Study||17
1598898|NCT01006889|3909599|P1|STARTED|Overall Study||20
1598899|NCT01006707|3909610|P3|NOT COMPLETED|Study Session 3||0
1598900|NCT01006707|3909611|P2|NOT COMPLETED|Study Session 3||0
1598901|NCT01006707|3909612|P1|NOT COMPLETED|Study Session 3||0
1598902|NCT01006707|3909610|P3|COMPLETED|Study Session 3||6
1598903|NCT01006707|3909611|P2|COMPLETED|Study Session 3||4
1598904|NCT01006707|3909612|P1|COMPLETED|Study Session 3||0
1598905|NCT01006707|3909610|P3|STARTED|Study Session 3||6
1598906|NCT01006707|3909611|P2|STARTED|Study Session 3||4
1598907|NCT01006707|3909612|P1|STARTED|Study Session 3||0
1598908|NCT01006707|3909610|P3|NOT COMPLETED|Study Session 2||0
1598909|NCT01006707|3909611|P2|NOT COMPLETED|Study Session 2||0
1598910|NCT01006707|3909612|P1|NOT COMPLETED|Study Session 2||0
1598911|NCT01006707|3909610|P3|COMPLETED|Study Session 2||6
1598912|NCT01006707|3909611|P2|COMPLETED|Study Session 2||4
1598913|NCT01006707|3909612|P1|COMPLETED|Study Session 2||0
1598914|NCT01006707|3909610|P3|STARTED|Study Session 2||6
1598915|NCT01006707|3909611|P2|STARTED|Study Session 2||4
1598916|NCT01006707|3909612|P1|STARTED|Study Session 2||0
1598917|NCT01006707|3909610|P3|NOT COMPLETED|Study Session 1||0
1598918|NCT01006707|3909611|P2|NOT COMPLETED|Study Session 1||0
1598919|NCT01006707|3909612|P1|NOT COMPLETED|Study Session 1||5
1598920|NCT01006707|3909610|P3|COMPLETED|Study Session 1||0
1598921|NCT01006707|3909611|P2|COMPLETED|Study Session 1||0
1598922|NCT01006707|3909612|P1|COMPLETED|Study Session 1||10
1598923|NCT01006707|3909610|P3|STARTED|Study Session 1||0
1598924|NCT01006707|3909611|P2|STARTED|Study Session 1||0
1598925|NCT01006707|3909612|P1|STARTED|Study Session 1||15
1598926|NCT01006655|3909625|P2|NOT COMPLETED|Second Intervention||0
1598927|NCT01006655|3909626|P1|NOT COMPLETED|Second Intervention||0
1598928|NCT01006655|3909625|P2|COMPLETED|Second Intervention||10
1598929|NCT01006655|3909626|P1|COMPLETED|Second Intervention||11
1598930|NCT01006655|3909625|P2|STARTED|Second Intervention||10
1598931|NCT01006655|3909626|P1|STARTED|Second Intervention||11
1598932|NCT01006655|3909625|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1598933|NCT01006655|3909626|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1598934|NCT01006655|3909625|P2|COMPLETED|Washout Period of 2 Weeks||10
1598935|NCT01006655|3909626|P1|COMPLETED|Washout Period of 2 Weeks||11
1598936|NCT01006655|3909625|P2|STARTED|Washout Period of 2 Weeks||10
1598937|NCT01006655|3909626|P1|STARTED|Washout Period of 2 Weeks||11
1598938|NCT01006655|3909625|P2|NOT COMPLETED|First Intervention||0
1598939|NCT01006655|3909626|P1|NOT COMPLETED|First Intervention||0
1598940|NCT01006655|3909625|P2|COMPLETED|First Intervention||10
1598941|NCT01006655|3909626|P1|COMPLETED|First Intervention||11
1598942|NCT01006655|3909625|P2|STARTED|First Intervention||10
1598943|NCT01006655|3909626|P1|STARTED|First Intervention||11
1598944|NCT01006629|3909632|P1|NOT COMPLETED|Overall Study||6
1598945|NCT01006629|3909632|P1|COMPLETED|Overall Study||94
1598946|NCT01006629|3909632|P1|STARTED|Overall Study||100
1598947|NCT01006616|3909647|P4|NOT COMPLETED|Period 2 (18 Months)||82
1598948|NCT01006616|3909648|P3|NOT COMPLETED|Period 2 (18 Months)||55
1598949|NCT01006616|3909649|P2|NOT COMPLETED|Period 2 (18 Months)||63
1598950|NCT01006616|3909650|P1|NOT COMPLETED|Period 2 (18 Months)||75
1598951|NCT01006616|3909647|P4|COMPLETED|Period 2 (18 Months)||0
1598952|NCT01006616|3909648|P3|COMPLETED|Period 2 (18 Months)||0
1598953|NCT01006616|3909649|P2|COMPLETED|Period 2 (18 Months)||0
1598954|NCT01006616|3909650|P1|COMPLETED|Period 2 (18 Months)||0
1598955|NCT01006616|3909647|P4|Treated|Period 2 (18 Months)||82
1598956|NCT01006616|3909648|P3|Treated|Period 2 (18 Months)||55
1598957|NCT01006616|3909649|P2|Treated|Period 2 (18 Months)||63
1598958|NCT01006616|3909650|P1|Treated|Period 2 (18 Months)||75
1598959|NCT01006616|3909647|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
1598960|NCT01006616|3909648|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
1598961|NCT01006616|3909649|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
1598962|NCT01006616|3909650|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
1598963|NCT01006616|3909647|P4|NOT COMPLETED|Period 1 (6 Months)||27
1598964|NCT01006616|3909648|P3|NOT COMPLETED|Period 1 (6 Months)||51
1598965|NCT01006616|3909649|P2|NOT COMPLETED|Period 1 (6 Months)||54
1598966|NCT01006616|3909650|P1|NOT COMPLETED|Period 1 (6 Months)||26
1598967|NCT01006616|3909647|P4|COMPLETED|Period 1 (6 Months)||128
1598968|NCT01006616|3909648|P3|COMPLETED|Period 1 (6 Months)||102
1598969|NCT01006616|3909649|P2|COMPLETED|Period 1 (6 Months)||102
1598970|NCT01006616|3909650|P1|COMPLETED|Period 1 (6 Months)||126
1598971|NCT01006616|3909647|P4|Treated|Period 1 (6 Months)||154
1598972|NCT01006616|3909648|P3|Treated|Period 1 (6 Months)||152
1598973|NCT01006616|3909649|P2|Treated|Period 1 (6 Months)||156
1598974|NCT01006616|3909650|P1|Treated|Period 1 (6 Months)||152
1598975|NCT01006616|3909647|P4|STARTED|Period 1 (6 Months)||155
1598976|NCT01006616|3909648|P3|STARTED|Period 1 (6 Months)||153
1598977|NCT01006616|3909649|P2|STARTED|Period 1 (6 Months)||156
1598978|NCT01006616|3909650|P1|STARTED|Period 1 (6 Months)||152
1598979|NCT01006603|3909786|P2|NOT COMPLETED|Overall Study||75
1598980|NCT01006603|3909787|P1|NOT COMPLETED|Overall Study||71
1598981|NCT01006603|3909786|P2|COMPLETED|Overall Study||285
1598982|NCT01006603|3909787|P1|COMPLETED|Overall Study||289
1598983|NCT01006603|3909786|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
1598984|NCT01006603|3909787|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
1598985|NCT01006590|3909807|P2|NOT COMPLETED|Overall Study||32
1598986|NCT01006590|3909808|P1|NOT COMPLETED|Overall Study||28
1598987|NCT01006590|3909807|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
1599067|NCT01005966|3909953|P2|COMPLETED|Washout Period 4 (4 Days)||10
1598988|NCT01006590|3909808|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
1598989|NCT01006590|3909807|P2|STARTED|Overall Study|Randomised and treated|139
1598990|NCT01006590|3909808|P1|STARTED|Overall Study|Randomised and treated|147
1598991|NCT01006356|3909824|P1|NOT COMPLETED|Overall Study||42
1598992|NCT01006356|3909824|P1|COMPLETED|Overall Study||99
1598993|NCT01006356|3909824|P1|STARTED|Overall Study||141
1598994|NCT01006291|3909839|P3|NOT COMPLETED|Overall Study||27
1598995|NCT01006291|3909840|P2|NOT COMPLETED|Overall Study||24
1598996|NCT01006291|3909841|P1|NOT COMPLETED|Overall Study||26
1598997|NCT01006291|3909839|P3|COMPLETED|Overall Study||203
1598998|NCT01006291|3909840|P2|COMPLETED|Overall Study||204
1598999|NCT01006291|3909841|P1|COMPLETED|Overall Study||203
1599000|NCT01006291|3909839|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
1599001|NCT01006291|3909840|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
1599002|NCT01006291|3909841|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
1599003|NCT01006291|3909839|P3|STARTED|Overall Study||230
1599004|NCT01006291|3909840|P2|STARTED|Overall Study||228
1599005|NCT01006291|3909841|P1|STARTED|Overall Study||229
1599006|NCT01006252|3909860|P2|NOT COMPLETED|Overall Study||0
1599007|NCT01006252|3909861|P1|NOT COMPLETED|Overall Study||0
1599008|NCT01006252|3909860|P2|COMPLETED|Overall Study||168
1599009|NCT01006252|3909861|P1|COMPLETED|Overall Study||168
1599010|NCT01006252|3909860|P2|Received Treatment|Overall Study||161
1599011|NCT01006252|3909861|P1|Received Treatment|Overall Study||164
1599012|NCT01006252|3909860|P2|STARTED|Overall Study||168
1599013|NCT01006252|3909861|P1|STARTED|Overall Study||168
1599014|NCT01006135|3909891|P1|NOT COMPLETED|Overall Study||140
1599015|NCT01006135|3909891|P1|COMPLETED|Overall Study||4712
1599016|NCT01006135|3909891|P1|STARTED|Overall Study||4852
1599017|NCT01006122|3909898|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
1599018|NCT01006122|3909899|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
1599019|NCT01006122|3909898|P2|COMPLETED|Second Double-blind Intervention Period||24
1599020|NCT01006122|3909899|P1|COMPLETED|Second Double-blind Intervention Period||29
1599021|NCT01006122|3909898|P2|STARTED|Second Double-blind Intervention Period||31
1599022|NCT01006122|3909899|P1|STARTED|Second Double-blind Intervention Period||31
1599023|NCT01006122|3909898|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1599024|NCT01006122|3909899|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1599025|NCT01006122|3909898|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
1599026|NCT01006122|3909899|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
1599027|NCT01006122|3909898|P2|STARTED|Wash-out Period (at Least 7 Days)||31
1599028|NCT01006122|3909899|P1|STARTED|Wash-out Period (at Least 7 Days)||31
1599029|NCT01006122|3909898|P2|NOT COMPLETED|First Double-blind Intervention Period||17
1599030|NCT01006122|3909899|P1|NOT COMPLETED|First Double-blind Intervention Period||16
1599031|NCT01006122|3909898|P2|COMPLETED|First Double-blind Intervention Period||31
1599032|NCT01006122|3909899|P1|COMPLETED|First Double-blind Intervention Period||31
1599033|NCT01006122|3909898|P2|STARTED|First Double-blind Intervention Period||48
1599034|NCT01006122|3909899|P1|STARTED|First Double-blind Intervention Period||47
1599035|NCT01006018|3909940|P3|NOT COMPLETED|Overall Study||0
1599036|NCT01006018|3909941|P2|NOT COMPLETED|Overall Study||0
1599037|NCT01006018|3909942|P1|NOT COMPLETED|Overall Study||0
1599038|NCT01006018|3909940|P3|COMPLETED|Overall Study||0
1599039|NCT01006018|3909941|P2|COMPLETED|Overall Study||0
1599040|NCT01006018|3909942|P1|COMPLETED|Overall Study||0
1599041|NCT01006018|3909940|P3|STARTED|Overall Study||0
1599042|NCT01006018|3909941|P2|STARTED|Overall Study||0
1599043|NCT01006018|3909942|P1|STARTED|Overall Study||0
1599044|NCT01005966|3909950|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1599045|NCT01005966|3909951|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1599046|NCT01005966|3909952|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1599047|NCT01005966|3909953|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1599048|NCT01005966|3909954|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1599049|NCT01005966|3909950|P5|COMPLETED|Treatment Period 5 (14 Days)||10
1599050|NCT01005966|3909951|P4|COMPLETED|Treatment Period 5 (14 Days)||11
1599051|NCT01005966|3909952|P3|COMPLETED|Treatment Period 5 (14 Days)||11
1599052|NCT01005966|3909953|P2|COMPLETED|Treatment Period 5 (14 Days)||12
1599053|NCT01005966|3909954|P1|COMPLETED|Treatment Period 5 (14 Days)||9
1599054|NCT01005966|3909950|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
1599055|NCT01005966|3909951|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
1599056|NCT01005966|3909952|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
1599057|NCT01005966|3909953|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
1599058|NCT01005966|3909954|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
1599059|NCT01005966|3909950|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
1599060|NCT01005966|3909951|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
1599061|NCT01005966|3909952|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
1599062|NCT01005966|3909953|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
1599063|NCT01005966|3909954|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
1599064|NCT01005966|3909950|P5|COMPLETED|Washout Period 4 (4 Days)||12
1599065|NCT01005966|3909951|P4|COMPLETED|Washout Period 4 (4 Days)||10
1599066|NCT01005966|3909952|P3|COMPLETED|Washout Period 4 (4 Days)||11
1599068|NCT01005966|3909954|P1|COMPLETED|Washout Period 4 (4 Days)||10
1599069|NCT01005966|3909950|P5|STARTED|Washout Period 4 (4 Days)||12
1599070|NCT01005966|3909951|P4|STARTED|Washout Period 4 (4 Days)||10
1599071|NCT01005966|3909952|P3|STARTED|Washout Period 4 (4 Days)||11
1599072|NCT01005966|3909953|P2|STARTED|Washout Period 4 (4 Days)||10
1599073|NCT01005966|3909954|P1|STARTED|Washout Period 4 (4 Days)||10
1599074|NCT01005966|3909950|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
1599075|NCT01005966|3909951|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
1599076|NCT01005966|3909952|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
1599077|NCT01005966|3909953|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
1599078|NCT01005966|3909954|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
1599079|NCT01005966|3909950|P5|COMPLETED|Treatment Period 4 (14 Days)||12
1599080|NCT01005966|3909951|P4|COMPLETED|Treatment Period 4 (14 Days)||10
1599081|NCT01005966|3909952|P3|COMPLETED|Treatment Period 4 (14 Days)||11
1599082|NCT01005966|3909953|P2|COMPLETED|Treatment Period 4 (14 Days)||10
1599083|NCT01005966|3909954|P1|COMPLETED|Treatment Period 4 (14 Days)||10
1599084|NCT01005966|3909950|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
1599085|NCT01005966|3909951|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1599086|NCT01005966|3909952|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
1599087|NCT01005966|3909953|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
1599088|NCT01005966|3909954|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1599089|NCT01005966|3909950|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1599090|NCT01005966|3909951|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1599091|NCT01005966|3909952|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1599092|NCT01005966|3909953|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1599093|NCT01005966|3909954|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1599094|NCT01005966|3909950|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
1599095|NCT01005966|3909951|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
1599096|NCT01005966|3909952|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
1599097|NCT01005966|3909953|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
1599098|NCT01005966|3909954|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
1599099|NCT01005966|3909950|P5|STARTED|Washout Period 3 ( 4 Days)||11
1599100|NCT01005966|3909951|P4|STARTED|Washout Period 3 ( 4 Days)||13
1599101|NCT01005966|3909952|P3|STARTED|Washout Period 3 ( 4 Days)||12
1599102|NCT01005966|3909953|P2|STARTED|Washout Period 3 ( 4 Days)||7
1599103|NCT01005966|3909954|P1|STARTED|Washout Period 3 ( 4 Days)||12
1599104|NCT01005966|3909950|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1599105|NCT01005966|3909951|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1599106|NCT01005966|3909952|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1599107|NCT01005966|3909953|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1599108|NCT01005966|3909954|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1599109|NCT01005966|3909950|P5|COMPLETED|Treatment Period 3 (14 Days)||11
1599110|NCT01005966|3909951|P4|COMPLETED|Treatment Period 3 (14 Days)||13
1599111|NCT01005966|3909952|P3|COMPLETED|Treatment Period 3 (14 Days)||12
1599112|NCT01005966|3909953|P2|COMPLETED|Treatment Period 3 (14 Days)||7
1599113|NCT01005966|3909954|P1|COMPLETED|Treatment Period 3 (14 Days)||12
1599114|NCT01005966|3909950|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1599115|NCT01005966|3909951|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
1599116|NCT01005966|3909952|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1599117|NCT01005966|3909953|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
1599118|NCT01005966|3909954|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1599119|NCT01005966|3909950|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
1599120|NCT01005966|3909951|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
1599121|NCT01005966|3909952|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
1599122|NCT01005966|3909953|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
1599123|NCT01005966|3909954|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
1599124|NCT01005966|3909950|P5|COMPLETED|Washout Period 2 (4 Days)||11
1599125|NCT01005966|3909951|P4|COMPLETED|Washout Period 2 (4 Days)||11
1599126|NCT01005966|3909952|P3|COMPLETED|Washout Period 2 (4 Days)||10
1599127|NCT01005966|3909953|P2|COMPLETED|Washout Period 2 (4 Days)||12
1599128|NCT01005966|3909954|P1|COMPLETED|Washout Period 2 (4 Days)||13
1599129|NCT01005966|3909950|P5|STARTED|Washout Period 2 (4 Days)||11
1599130|NCT01005966|3909951|P4|STARTED|Washout Period 2 (4 Days)||11
1599131|NCT01005966|3909952|P3|STARTED|Washout Period 2 (4 Days)||10
1599132|NCT01005966|3909953|P2|STARTED|Washout Period 2 (4 Days)||12
1599133|NCT01005966|3909954|P1|STARTED|Washout Period 2 (4 Days)||13
1599134|NCT01005966|3909950|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1599135|NCT01005966|3909951|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1599136|NCT01005966|3909952|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
1599137|NCT01005966|3909953|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1599138|NCT01005966|3909954|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1599139|NCT01005966|3909950|P5|COMPLETED|Treatment Period 2 (14 Days)||11
1599140|NCT01005966|3909951|P4|COMPLETED|Treatment Period 2 (14 Days)||11
1599141|NCT01005966|3909952|P3|COMPLETED|Treatment Period 2 (14 Days)||10
1599142|NCT01005966|3909953|P2|COMPLETED|Treatment Period 2 (14 Days)||12
1599143|NCT01005966|3909954|P1|COMPLETED|Treatment Period 2 (14 Days)||13
1599144|NCT01005966|3909950|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
1599145|NCT01005966|3909951|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
1599146|NCT01005966|3909952|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
1599147|NCT01005966|3909953|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1599148|NCT01005966|3909954|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1599149|NCT01005966|3909950|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
1599150|NCT01005966|3909951|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
1599151|NCT01005966|3909952|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
1599152|NCT01005966|3909953|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
1599153|NCT01005966|3909954|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
1599154|NCT01005966|3909950|P5|COMPLETED|Washout Period 1 (4 Days)||13
1599155|NCT01005966|3909951|P4|COMPLETED|Washout Period 1 (4 Days)||12
1599156|NCT01005966|3909952|P3|COMPLETED|Washout Period 1 (4 Days)||12
1599157|NCT01005966|3909953|P2|COMPLETED|Washout Period 1 (4 Days)||13
1599158|NCT01005966|3909954|P1|COMPLETED|Washout Period 1 (4 Days)||11
1599159|NCT01005966|3909950|P5|STARTED|Washout Period 1 (4 Days)||13
1599160|NCT01005966|3909951|P4|STARTED|Washout Period 1 (4 Days)||13
1599161|NCT01005966|3909952|P3|STARTED|Washout Period 1 (4 Days)||12
1599162|NCT01005966|3909953|P2|STARTED|Washout Period 1 (4 Days)||13
1599163|NCT01005966|3909954|P1|STARTED|Washout Period 1 (4 Days)||11
1599164|NCT01005966|3909950|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1599165|NCT01005966|3909951|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1599166|NCT01005966|3909952|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1599167|NCT01005966|3909953|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1599168|NCT01005966|3909954|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1599169|NCT01005966|3909950|P5|COMPLETED|Treatment Period 1 (14 Days)||13
1599170|NCT01005966|3909951|P4|COMPLETED|Treatment Period 1 (14 Days)||13
1599171|NCT01005966|3909952|P3|COMPLETED|Treatment Period 1 (14 Days)||12
1599172|NCT01005966|3909953|P2|COMPLETED|Treatment Period 1 (14 Days)||13
1599173|NCT01005966|3909954|P1|COMPLETED|Treatment Period 1 (14 Days)||11
1599174|NCT01005966|3909950|P5|STARTED|Treatment Period 1 (14 Days)||13
1599175|NCT01005966|3909951|P4|STARTED|Treatment Period 1 (14 Days)||13
1599176|NCT01005966|3909952|P3|STARTED|Treatment Period 1 (14 Days)||13
1599177|NCT01005966|3909953|P2|STARTED|Treatment Period 1 (14 Days)||13
1599178|NCT01005966|3909954|P1|STARTED|Treatment Period 1 (14 Days)||13
1599179|NCT01005914|3909974|P1|NOT COMPLETED|Overall Study||10
1599180|NCT01005914|3909974|P1|COMPLETED|Overall Study||1
1599181|NCT01005914|3909974|P1|STARTED|Overall Study||11
1599182|NCT01005901|3909980|P2|NOT COMPLETED|Overall Study||58
1599183|NCT01005901|3909981|P1|NOT COMPLETED|Overall Study||102
1599184|NCT01005901|3909980|P2|COMPLETED|Overall Study||212
1599185|NCT01005901|3909981|P1|COMPLETED|Overall Study||450
1599186|NCT01005901|3909980|P2|Full Analysis Set|Overall Study||260
1599187|NCT01005901|3909981|P1|Full Analysis Set|Overall Study||534
1599188|NCT01005901|3909980|P2|Safety Population|Overall Study||267
1599189|NCT01005901|3909981|P1|Safety Population|Overall Study||550
1599190|NCT01005901|3909980|P2|STARTED|Overall Study||270
1599191|NCT01005901|3909981|P1|STARTED|Overall Study||552
1599192|NCT01005888|3910023|P2|NOT COMPLETED|Second Intervention||1
1599193|NCT01005888|3910024|P1|NOT COMPLETED|Second Intervention||1
1599194|NCT01005888|3910023|P2|COMPLETED|Second Intervention||10
1599195|NCT01005888|3910024|P1|COMPLETED|Second Intervention||10
1599196|NCT01005888|3910023|P2|STARTED|Second Intervention||11
1599197|NCT01005888|3910024|P1|STARTED|Second Intervention||11
1599198|NCT01005888|3910023|P2|NOT COMPLETED|First Intervention||1
1599199|NCT01005888|3910024|P1|NOT COMPLETED|First Intervention||1
1599200|NCT01005888|3910023|P2|COMPLETED|First Intervention||11
1599201|NCT01005888|3910024|P1|COMPLETED|First Intervention||11
1599202|NCT01005888|3910023|P2|STARTED|First Intervention||12
1599203|NCT01005888|3910024|P1|STARTED|First Intervention||12
1599204|NCT01005875|3910044|P1|NOT COMPLETED|Overall Study||3
1599205|NCT01005875|3910044|P1|COMPLETED|Overall Study||2
1599206|NCT01005875|3910044|P1|STARTED|Overall Study||5
1599207|NCT01005810|3910054|P2|NOT COMPLETED|Overall Study||25
1599208|NCT01005810|3910055|P1|NOT COMPLETED|Overall Study||21
1599209|NCT01005810|3910054|P2|COMPLETED|Overall Study||33
1599210|NCT01005810|3910055|P1|COMPLETED|Overall Study||37
1599211|NCT01005810|3910054|P2|STARTED|Overall Study||58
1599212|NCT01005810|3910055|P1|STARTED|Overall Study||58
1599213|NCT01005745|3910061|P1|NOT COMPLETED|Overall Study||6
1599214|NCT01005745|3910061|P1|COMPLETED|Overall Study||13
1599215|NCT01005745|3910061|P1|STARTED|Overall Study||19
1599216|NCT01005732|3910066|P1|NOT COMPLETED|Overall Study||11
1599217|NCT01005732|3910066|P1|COMPLETED|Overall Study||43
1599218|NCT01005732|3910066|P1|STARTED|Overall Study||54
1599219|NCT01005719|3910082|P6|NOT COMPLETED|Period 3||0
1599220|NCT01005719|3910083|P5|NOT COMPLETED|Period 3||0
1599221|NCT01005719|3910084|P4|NOT COMPLETED|Period 3||0
1599222|NCT01005719|3910085|P3|NOT COMPLETED|Period 3||0
1599223|NCT01005719|3910086|P2|NOT COMPLETED|Period 3||0
1599224|NCT01005719|3910087|P1|NOT COMPLETED|Period 3||0
1599225|NCT01005719|3910082|P6|COMPLETED|Period 3||9
1599226|NCT01005719|3910083|P5|COMPLETED|Period 3||10
1599227|NCT01005719|3910084|P4|COMPLETED|Period 3||10
1599228|NCT01005719|3910085|P3|COMPLETED|Period 3||10
1599229|NCT01005719|3910086|P2|COMPLETED|Period 3||10
1599230|NCT01005719|3910087|P1|COMPLETED|Period 3||10
1599231|NCT01005719|3910082|P6|STARTED|Period 3||9
1599232|NCT01005719|3910083|P5|STARTED|Period 3||10
1599233|NCT01005719|3910084|P4|STARTED|Period 3||10
1599234|NCT01005719|3910085|P3|STARTED|Period 3||10
1599235|NCT01005719|3910086|P2|STARTED|Period 3||10
1599236|NCT01005719|3910087|P1|STARTED|Period 3||10
1599237|NCT01005719|3910082|P6|NOT COMPLETED|Period 2||1
1599238|NCT01005719|3910083|P5|NOT COMPLETED|Period 2||1
1599239|NCT01005719|3910084|P4|NOT COMPLETED|Period 2||0
1599240|NCT01005719|3910085|P3|NOT COMPLETED|Period 2||0
1599241|NCT01005719|3910086|P2|NOT COMPLETED|Period 2||0
1599242|NCT01005719|3910087|P1|NOT COMPLETED|Period 2||0
1599243|NCT01005719|3910082|P6|COMPLETED|Period 2||9
1599244|NCT01005719|3910083|P5|COMPLETED|Period 2||10
1599245|NCT01005719|3910084|P4|COMPLETED|Period 2||10
1599246|NCT01005719|3910085|P3|COMPLETED|Period 2||10
1599247|NCT01005719|3910086|P2|COMPLETED|Period 2||10
1599248|NCT01005719|3910087|P1|COMPLETED|Period 2||10
1599249|NCT01005719|3910082|P6|STARTED|Period 2||10
1599250|NCT01005719|3910083|P5|STARTED|Period 2||11
1599251|NCT01005719|3910084|P4|STARTED|Period 2||10
1599252|NCT01005719|3910085|P3|STARTED|Period 2||10
1599253|NCT01005719|3910086|P2|STARTED|Period 2||10
1599254|NCT01005719|3910087|P1|STARTED|Period 2||10
1599255|NCT01005719|3910082|P6|NOT COMPLETED|Period 1||1
1599256|NCT01005719|3910083|P5|NOT COMPLETED|Period 1||0
1599257|NCT01005719|3910084|P4|NOT COMPLETED|Period 1||1
1599258|NCT01005719|3910085|P3|NOT COMPLETED|Period 1||0
1599259|NCT01005719|3910086|P2|NOT COMPLETED|Period 1||0
1599260|NCT01005719|3910087|P1|NOT COMPLETED|Period 1||0
1599261|NCT01005719|3910082|P6|COMPLETED|Period 1||10
1599262|NCT01005719|3910083|P5|COMPLETED|Period 1||11
1599263|NCT01005719|3910084|P4|COMPLETED|Period 1||10
1599264|NCT01005719|3910085|P3|COMPLETED|Period 1||10
1599265|NCT01005719|3910086|P2|COMPLETED|Period 1||10
1599266|NCT01005719|3910087|P1|COMPLETED|Period 1||10
1599267|NCT01005719|3910082|P6|STARTED|Period 1||11
1599268|NCT01005719|3910083|P5|STARTED|Period 1||11
1599269|NCT01005719|3910084|P4|STARTED|Period 1||11
1599270|NCT01005719|3910085|P3|STARTED|Period 1||10
1599271|NCT01005719|3910086|P2|STARTED|Period 1||10
1599272|NCT01005719|3910087|P1|STARTED|Period 1||10
1599273|NCT01005706|3910145|P2|NOT COMPLETED|Overall Study||0
1599274|NCT01005706|3910146|P1|NOT COMPLETED|Overall Study||0
1599275|NCT01005706|3910145|P2|COMPLETED|Overall Study||17
1599276|NCT01005706|3910146|P1|COMPLETED|Overall Study||23
1599277|NCT01005706|3910145|P2|STARTED|Overall Study||17
1599278|NCT01005706|3910146|P1|STARTED|Overall Study||23
1599279|NCT01005680|3910154|P2|NOT COMPLETED|Overall Study||11
1599280|NCT01005680|3910155|P1|NOT COMPLETED|Overall Study||6
1599281|NCT01005680|3910154|P2|COMPLETED|Overall Study||119
1599282|NCT01005680|3910155|P1|COMPLETED|Overall Study||120
1599283|NCT01005680|3910154|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
1599284|NCT01005680|3910155|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
1599285|NCT01005680|3910154|P2|STARTED|Overall Study||130
1599286|NCT01005680|3910155|P1|STARTED|Overall Study||126
1599287|NCT01005602|3910179|P2|NOT COMPLETED|Overall Study||0
1599288|NCT01005602|3910180|P1|NOT COMPLETED|Overall Study||1
1599289|NCT01005602|3910179|P2|COMPLETED|Overall Study||66
1599290|NCT01005602|3910180|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
1599291|NCT01005602|3910179|P2|STARTED|Overall Study||66
1599292|NCT01005602|3910180|P1|STARTED|Overall Study||66
1599293|NCT01005576|3910200|P1|NOT COMPLETED|Overall Study||0
1599294|NCT01005576|3910200|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
1599295|NCT01005576|3910200|P1|STARTED|Overall Study||21
1599296|NCT01005459|3910210|P2|NOT COMPLETED|Overall Study||0
1599297|NCT01005459|3910211|P1|NOT COMPLETED|Overall Study||0
1599298|NCT01005459|3910210|P2|COMPLETED|Overall Study||23
1599299|NCT01005459|3910211|P1|COMPLETED|Overall Study||23
1599300|NCT01005459|3910210|P2|STARTED|Overall Study||23
1599301|NCT01005459|3910211|P1|STARTED|Overall Study||23
1599302|NCT01005407|3910219|P2|NOT COMPLETED|Overall Study||32
1599303|NCT01005407|3910220|P1|NOT COMPLETED|Overall Study||151
1599304|NCT01005407|3910219|P2|COMPLETED|Overall Study||451
1599305|NCT01005407|3910220|P1|COMPLETED|Overall Study||1818
1599306|NCT01005407|3910219|P2|STARTED|Overall Study||483
1599307|NCT01005407|3910220|P1|STARTED|Overall Study||1969
1599308|NCT01005355|3910231|P3|NOT COMPLETED|Overall Study||0
1599309|NCT01005355|3910232|P2|NOT COMPLETED|Overall Study||0
1599310|NCT01005355|3910233|P1|NOT COMPLETED|Overall Study||0
1599311|NCT01005355|3910231|P3|COMPLETED|Overall Study||6
1599312|NCT01005355|3910232|P2|COMPLETED|Overall Study||6
1599313|NCT01005355|3910233|P1|COMPLETED|Overall Study||3
1599314|NCT01005355|3910231|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1599315|NCT01005355|3910232|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1599316|NCT01005355|3910233|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1599317|NCT01005355|3910231|P3|STARTED|Overall Study||6
1599318|NCT01005355|3910232|P2|STARTED|Overall Study||6
1599319|NCT01005355|3910233|P1|STARTED|Overall Study||3
1599320|NCT01005329|3910268|P1|NOT COMPLETED|Overall Study||4
1599321|NCT01005329|3910268|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
1599322|NCT01005329|3910268|P1|STARTED|Overall Study||34
1599323|NCT01005316|3910281|P4|NOT COMPLETED|Overall Study||108
1599324|NCT01005316|3910282|P3|NOT COMPLETED|Overall Study||11
1599325|NCT01005316|3910283|P2|NOT COMPLETED|Overall Study||76
1599326|NCT01005316|3910284|P1|NOT COMPLETED|Overall Study||50
1599327|NCT01005316|3910281|P4|COMPLETED|Overall Study||19
1599328|NCT01005316|3910282|P3|COMPLETED|Overall Study||5
1599329|NCT01005316|3910283|P2|COMPLETED|Overall Study||21
1599330|NCT01005316|3910284|P1|COMPLETED|Overall Study||0
1599331|NCT01005316|3910281|P4|STARTED|Overall Study||127
1599332|NCT01005316|3910282|P3|STARTED|Overall Study||16
1599333|NCT01005316|3910283|P2|STARTED|Overall Study||97
1599334|NCT01005316|3910284|P1|STARTED|Overall Study||50
1599335|NCT01005290|3910336|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
1599336|NCT01005290|3910337|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
1599337|NCT01005290|3910338|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
1599338|NCT01005290|3910336|P3|COMPLETED|Period 2 (5 Weeks)||7
1599339|NCT01005290|3910337|P2|COMPLETED|Period 2 (5 Weeks)||13
1599340|NCT01005290|3910338|P1|COMPLETED|Period 2 (5 Weeks)||0
1599341|NCT01005290|3910336|P3|STARTED|Period 2 (5 Weeks)||9
1599342|NCT01005290|3910337|P2|STARTED|Period 2 (5 Weeks)||13
1599343|NCT01005290|3910338|P1|STARTED|Period 2 (5 Weeks)||0
1599344|NCT01005290|3910336|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
1599345|NCT01005290|3910337|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
1599346|NCT01005290|3910338|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
1599347|NCT01005290|3910336|P3|COMPLETED|Washout Period (2 Weeks)||9
1599348|NCT01005290|3910337|P2|COMPLETED|Washout Period (2 Weeks)||13
1599349|NCT01005290|3910338|P1|COMPLETED|Washout Period (2 Weeks)||0
1599350|NCT01005290|3910336|P3|STARTED|Washout Period (2 Weeks)||9
1599351|NCT01005290|3910337|P2|STARTED|Washout Period (2 Weeks)||13
1599352|NCT01005290|3910338|P1|STARTED|Washout Period (2 Weeks)||0
1599353|NCT01005290|3910336|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
1599354|NCT01005290|3910337|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
1599355|NCT01005290|3910338|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
1599356|NCT01005290|3910336|P3|COMPLETED|Period 1 (5 Weeks)||9
1599357|NCT01005290|3910337|P2|COMPLETED|Period 1 (5 Weeks)||13
1599358|NCT01005290|3910338|P1|COMPLETED|Period 1 (5 Weeks)||0
1599359|NCT01005290|3910336|P3|STARTED|Period 1 (5 Weeks)||18
1599360|NCT01005290|3910337|P2|STARTED|Period 1 (5 Weeks)||20
1599361|NCT01005290|3910338|P1|STARTED|Period 1 (5 Weeks)||0
1599362|NCT01005290|3910336|P3|NOT COMPLETED|Run-In||0
1599363|NCT01005290|3910337|P2|NOT COMPLETED|Run-In||0
1599364|NCT01005290|3910338|P1|NOT COMPLETED|Run-In||14
1599365|NCT01005290|3910336|P3|COMPLETED|Run-In||0
1599366|NCT01005290|3910337|P2|COMPLETED|Run-In||0
1599367|NCT01005290|3910338|P1|COMPLETED|Run-In||38
1599368|NCT01005290|3910336|P3|STARTED|Run-In||0
1599369|NCT01005290|3910337|P2|STARTED|Run-In||0
1599370|NCT01005290|3910338|P1|STARTED|Run-In||52
1599371|NCT01005251|3910351|P5|NOT COMPLETED|Overall Study||18
1599372|NCT01005251|3910352|P4|NOT COMPLETED|Overall Study||12
1599373|NCT01005251|3910353|P3|NOT COMPLETED|Overall Study||22
1599374|NCT01005251|3910354|P2|NOT COMPLETED|Overall Study||16
1599375|NCT01005251|3910355|P1|NOT COMPLETED|Overall Study||13
1599376|NCT01005251|3910351|P5|COMPLETED|Overall Study||122
1599377|NCT01005251|3910352|P4|COMPLETED|Overall Study||114
1599378|NCT01005251|3910353|P3|COMPLETED|Overall Study||114
1599379|NCT01005251|3910354|P2|COMPLETED|Overall Study||109
1599380|NCT01005251|3910355|P1|COMPLETED|Overall Study||121
1599381|NCT01005251|3910351|P5|STARTED|Overall Study||140
1599382|NCT01005251|3910352|P4|STARTED|Overall Study||126
1599383|NCT01005251|3910353|P3|STARTED|Overall Study||136
1599384|NCT01005251|3910354|P2|STARTED|Overall Study||125
1599385|NCT01005251|3910355|P1|STARTED|Overall Study||134
1599386|NCT01004991|3910372|P1|NOT COMPLETED|Overall Study||0
1599387|NCT01004991|3910372|P1|COMPLETED|Overall Study||12
1599388|NCT01004991|3910372|P1|STARTED|Overall Study||12
1599389|NCT01004939|3910376|P1|NOT COMPLETED|Overall Study||0
1599390|NCT01004939|3910376|P1|COMPLETED|Overall Study||120
1599391|NCT01004939|3910376|P1|STARTED|Overall Study||120
1599392|NCT01004874|3910417|P1|NOT COMPLETED|Overall Study||0
1599393|NCT01004874|3910417|P1|COMPLETED|Overall Study||80
1599394|NCT01004874|3910417|P1|STARTED|Overall Study||80
1599395|NCT01004848|3910428|P2|NOT COMPLETED|Overall Study||45
1599396|NCT01004848|3910429|P1|NOT COMPLETED|Overall Study||55
1599397|NCT01004848|3910428|P2|COMPLETED|Overall Study||147
1599398|NCT01004848|3910429|P1|COMPLETED|Overall Study||155
1599399|NCT01004848|3910428|P2|STARTED|Overall Study||192
1599400|NCT01004848|3910429|P1|STARTED|Overall Study||210
1599401|NCT01004822|3910467|P8|NOT COMPLETED|Overall Study||5
1599402|NCT01004822|3910468|P7|NOT COMPLETED|Overall Study||4
1599403|NCT01004822|3910469|P6|NOT COMPLETED|Overall Study||4
1599404|NCT01004822|3910470|P5|NOT COMPLETED|Overall Study||4
1599405|NCT01004822|3910471|P4|NOT COMPLETED|Overall Study||4
1599406|NCT01004822|3910472|P3|NOT COMPLETED|Overall Study||4
1599407|NCT01004822|3910473|P2|NOT COMPLETED|Overall Study||3
1599408|NCT01004822|3910474|P1|NOT COMPLETED|Overall Study||3
1599409|NCT01004822|3910467|P8|COMPLETED|Overall Study||0
1599410|NCT01004822|3910468|P7|COMPLETED|Overall Study||0
1599411|NCT01004822|3910469|P6|COMPLETED|Overall Study||0
1599412|NCT01004822|3910470|P5|COMPLETED|Overall Study||0
1599413|NCT01004822|3910471|P4|COMPLETED|Overall Study||0
1599414|NCT01004822|3910472|P3|COMPLETED|Overall Study||0
1599415|NCT01004822|3910473|P2|COMPLETED|Overall Study||0
1599416|NCT01004822|3910474|P1|COMPLETED|Overall Study||0
1599417|NCT01004822|3910467|P8|Treated|Overall Study||5
1599418|NCT01004822|3910468|P7|Treated|Overall Study||4
1599419|NCT01004822|3910469|P6|Treated|Overall Study||4
1599420|NCT01004822|3910470|P5|Treated|Overall Study||4
1599421|NCT01004822|3910471|P4|Treated|Overall Study||4
1599422|NCT01004822|3910472|P3|Treated|Overall Study||3
1599423|NCT01004822|3910473|P2|Treated|Overall Study||3
1599424|NCT01004822|3910474|P1|Treated|Overall Study||3
1599425|NCT01004822|3910467|P8|STARTED|Overall Study||5
1599426|NCT01004822|3910468|P7|STARTED|Overall Study||4
1599427|NCT01004822|3910469|P6|STARTED|Overall Study||4
1599428|NCT01004822|3910470|P5|STARTED|Overall Study||4
1599429|NCT01004822|3910471|P4|STARTED|Overall Study||4
1599430|NCT01004822|3910472|P3|STARTED|Overall Study||4
1599431|NCT01004822|3910473|P2|STARTED|Overall Study||3
1599432|NCT01004822|3910474|P1|STARTED|Overall Study||3
1599433|NCT01004770|3910588|P5|NOT COMPLETED|Overall Study||0
1599434|NCT01004770|3910589|P4|NOT COMPLETED|Overall Study||0
1599435|NCT01004770|3910590|P3|NOT COMPLETED|Overall Study||0
1599436|NCT01004770|3910591|P2|NOT COMPLETED|Overall Study||0
1599437|NCT01004770|3910592|P1|NOT COMPLETED|Overall Study||0
1599438|NCT01004770|3910588|P5|COMPLETED|Overall Study||10
1599439|NCT01004770|3910589|P4|COMPLETED|Overall Study||10
1599440|NCT01004770|3910590|P3|COMPLETED|Overall Study||10
1599441|NCT01004770|3910591|P2|COMPLETED|Overall Study||10
1599442|NCT01004770|3910592|P1|COMPLETED|Overall Study||10
1599443|NCT01004770|3910588|P5|STARTED|Overall Study||10
1599444|NCT01004770|3910589|P4|STARTED|Overall Study||10
1599445|NCT01004770|3910590|P3|STARTED|Overall Study||10
1599446|NCT01004770|3910591|P2|STARTED|Overall Study||10
1599447|NCT01004770|3910592|P1|STARTED|Overall Study||10
1599448|NCT01004705|3910624|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
1599449|NCT01004705|3910625|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
1599450|NCT01004705|3910626|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
1599451|NCT01004705|3910624|P3|COMPLETED|Period 2 (12 Weeks)||9
1599452|NCT01004705|3910625|P2|COMPLETED|Period 2 (12 Weeks)||13
1599453|NCT01004705|3910626|P1|COMPLETED|Period 2 (12 Weeks)||0
1599454|NCT01004705|3910624|P3|STARTED|Period 2 (12 Weeks)||13
1599455|NCT01004705|3910625|P2|STARTED|Period 2 (12 Weeks)||13
1599456|NCT01004705|3910626|P1|STARTED|Period 2 (12 Weeks)||0
1599457|NCT01004705|3910624|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
1599458|NCT01004705|3910625|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
1599459|NCT01004705|3910626|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
1599460|NCT01004705|3910624|P3|COMPLETED|Washout Period (6 Weeks)||13
1599461|NCT01004705|3910625|P2|COMPLETED|Washout Period (6 Weeks)||13
1599462|NCT01004705|3910626|P1|COMPLETED|Washout Period (6 Weeks)||0
1599463|NCT01004705|3910624|P3|STARTED|Washout Period (6 Weeks)||13
1599464|NCT01004705|3910625|P2|STARTED|Washout Period (6 Weeks)||13
1599465|NCT01004705|3910626|P1|STARTED|Washout Period (6 Weeks)||0
1599466|NCT01004705|3910624|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
1599467|NCT01004705|3910625|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
1599468|NCT01004705|3910626|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
1599469|NCT01004705|3910624|P3|COMPLETED|Period 1 (12 Weeks)||13
1599470|NCT01004705|3910625|P2|COMPLETED|Period 1 (12 Weeks)||13
1599471|NCT01004705|3910626|P1|COMPLETED|Period 1 (12 Weeks)||0
1599472|NCT01004705|3910624|P3|STARTED|Period 1 (12 Weeks)||18
1599473|NCT01004705|3910625|P2|STARTED|Period 1 (12 Weeks)||18
1599474|NCT01004705|3910626|P1|STARTED|Period 1 (12 Weeks)||0
1599475|NCT01004705|3910624|P3|NOT COMPLETED|Run-In||0
1599476|NCT01004705|3910625|P2|NOT COMPLETED|Run-In||0
1599477|NCT01004705|3910626|P1|NOT COMPLETED|Run-In||8
1599478|NCT01004705|3910624|P3|COMPLETED|Run-In||0
1599479|NCT01004705|3910625|P2|COMPLETED|Run-In||0
1599480|NCT01004705|3910626|P1|COMPLETED|Run-In||36
1599481|NCT01004705|3910624|P3|STARTED|Run-In||0
1599482|NCT01004705|3910625|P2|STARTED|Run-In||0
1599483|NCT01004705|3910626|P1|STARTED|Run-In||44
1599484|NCT01004614|3910639|P4|NOT COMPLETED|Second Intervention||0
1599485|NCT01004614|3910640|P3|NOT COMPLETED|Second Intervention||0
1599486|NCT01004614|3910641|P2|NOT COMPLETED|Second Intervention||0
1599487|NCT01004614|3910642|P1|NOT COMPLETED|Second Intervention||0
1599488|NCT01004614|3910639|P4|COMPLETED|Second Intervention||12
1599489|NCT01004614|3910640|P3|COMPLETED|Second Intervention||12
1599490|NCT01004614|3910641|P2|COMPLETED|Second Intervention||11
1599491|NCT01004614|3910642|P1|COMPLETED|Second Intervention||12
1599492|NCT01004614|3910639|P4|STARTED|Second Intervention||12
1599493|NCT01004614|3910640|P3|STARTED|Second Intervention||12
1599494|NCT01004614|3910641|P2|STARTED|Second Intervention||11
1599495|NCT01004614|3910642|P1|STARTED|Second Intervention||12
1599496|NCT01004614|3910639|P4|NOT COMPLETED|Washout||0
1599497|NCT01004614|3910640|P3|NOT COMPLETED|Washout||0
1599498|NCT01004614|3910641|P2|NOT COMPLETED|Washout||1
1599499|NCT01004614|3910642|P1|NOT COMPLETED|Washout||0
1599500|NCT01004614|3910639|P4|COMPLETED|Washout||12
1599501|NCT01004614|3910640|P3|COMPLETED|Washout||12
1599502|NCT01004614|3910641|P2|COMPLETED|Washout||11
1599503|NCT01004614|3910642|P1|COMPLETED|Washout||12
1599504|NCT01004614|3910639|P4|STARTED|Washout||12
1599505|NCT01004614|3910640|P3|STARTED|Washout||12
1599506|NCT01004614|3910641|P2|STARTED|Washout||12
1599507|NCT01004614|3910642|P1|STARTED|Washout||12
1599508|NCT01004614|3910639|P4|NOT COMPLETED|First Intervention||0
1599509|NCT01004614|3910640|P3|NOT COMPLETED|First Intervention||0
1599510|NCT01004614|3910641|P2|NOT COMPLETED|First Intervention||0
1599511|NCT01004614|3910642|P1|NOT COMPLETED|First Intervention||0
1599512|NCT01004614|3910639|P4|COMPLETED|First Intervention||12
1599513|NCT01004614|3910640|P3|COMPLETED|First Intervention||12
1599514|NCT01004614|3910641|P2|COMPLETED|First Intervention||12
1599515|NCT01004614|3910642|P1|COMPLETED|First Intervention||12
1599516|NCT01004614|3910639|P4|STARTED|First Intervention||12
1599517|NCT01004614|3910640|P3|STARTED|First Intervention||12
1599518|NCT01004614|3910641|P2|STARTED|First Intervention||12
1599519|NCT01004614|3910642|P1|STARTED|First Intervention||12
1599520|NCT01004510|3910676|P1|NOT COMPLETED|Overall Study||1
1599521|NCT01004510|3910676|P1|COMPLETED|Overall Study||2
1599522|NCT01004510|3910676|P1|STARTED|Overall Study||3
1599523|NCT01004432|3910680|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
1599524|NCT01004432|3910681|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1599525|NCT01004432|3910682|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1599526|NCT01004432|3910683|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1599527|NCT01004432|3910684|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1599528|NCT01004432|3910680|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
1599529|NCT01004432|3910681|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
1599530|NCT01004432|3910682|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
1599531|NCT01004432|3910683|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
1599532|NCT01004432|3910684|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
1599533|NCT01004432|3910680|P5|STARTED|OL Study Extension (Week 52 - 76)||212
1599534|NCT01004432|3910681|P4|STARTED|OL Study Extension (Week 52 - 76)||0
1599535|NCT01004432|3910682|P3|STARTED|OL Study Extension (Week 52 - 76)||0
1599536|NCT01004432|3910683|P2|STARTED|OL Study Extension (Week 52 - 76)||0
1599537|NCT01004432|3910684|P1|STARTED|OL Study Extension (Week 52 - 76)||0
1599538|NCT01004432|3910680|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1599539|NCT01004432|3910681|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
1599540|NCT01004432|3910682|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
1599541|NCT01004432|3910683|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
1599542|NCT01004432|3910684|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1599543|NCT01004432|3910680|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1599544|NCT01004432|3910681|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
1599545|NCT01004432|3910682|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
1599546|NCT01004432|3910683|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
1599547|NCT01004432|3910684|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1599548|NCT01004432|3910680|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
1599549|NCT01004432|3910681|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
1599550|NCT01004432|3910682|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
1599551|NCT01004432|3910683|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
1599552|NCT01004432|3910684|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
1599553|NCT01004432|3910680|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1599554|NCT01004432|3910681|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1599555|NCT01004432|3910682|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1599556|NCT01004432|3910683|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1599557|NCT01004432|3910684|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
1599558|NCT01004432|3910680|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1599559|NCT01004432|3910681|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1599560|NCT01004432|3910682|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1599561|NCT01004432|3910683|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1599562|NCT01004432|3910684|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
1599563|NCT01004432|3910680|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
1599564|NCT01004432|3910681|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
1599565|NCT01004432|3910682|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
1599566|NCT01004432|3910683|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
1599567|NCT01004432|3910684|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
1599568|NCT01004393|3910704|P1|NOT COMPLETED|Overall Study||0
1599569|NCT01004393|3910704|P1|COMPLETED|Overall Study||12
1599570|NCT01004393|3910704|P1|STARTED|Overall Study||12
1599571|NCT01004354|3910715|P1|NOT COMPLETED|Overall Study||0
1599572|NCT01004354|3910715|P1|COMPLETED|Overall Study||12
1599573|NCT01004354|3910715|P1|STARTED|Overall Study||12
1599574|NCT01004263|3910727|P1|NOT COMPLETED|Overall Study||179
1599575|NCT01004263|3910727|P1|COMPLETED|Overall Study||427
1599576|NCT01004263|3910727|P1|STARTED|Overall Study|Participants who took study drug|606
1599577|NCT01004250|3910735|P1|NOT COMPLETED|Follow-Up (FU) Period||1
1599578|NCT01004250|3910735|P1|COMPLETED|Follow-Up (FU) Period||100
1599579|NCT01004250|3910735|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
1599580|NCT01004250|3910735|P1|NOT COMPLETED|Maintenance Therapy Period||26
1599581|NCT01004250|3910735|P1|COMPLETED|Maintenance Therapy Period||46
1599582|NCT01004250|3910735|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
1599583|NCT01004250|3910735|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
1599584|NCT01004250|3910735|P1|NOT COMPLETED|Induction Therapy Period||15
1599585|NCT01004250|3910735|P1|COMPLETED|Induction Therapy Period||94
1599679|NCT01003275|3910975|P2|STARTED|Overall Study||11
1599586|NCT01004250|3910735|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
1599587|NCT01004250|3910735|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
1599588|NCT01004250|3910735|P1|STARTED|Induction Therapy Period||109
1599589|NCT01004185|3910747|P2|NOT COMPLETED|Overall Study||9
1599590|NCT01004185|3910748|P1|NOT COMPLETED|Overall Study||9
1599591|NCT01004185|3910747|P2|COMPLETED|Overall Study||11
1599592|NCT01004185|3910748|P1|COMPLETED|Overall Study||10
1599593|NCT01004185|3910747|P2|STARTED|Overall Study||20
1599594|NCT01004185|3910748|P1|STARTED|Overall Study||19
1599595|NCT01004172|3910756|P1|NOT COMPLETED|Overall Study||38
1599596|NCT01004172|3910756|P1|COMPLETED|Overall Study||0
1599597|NCT01004172|3910756|P1|STARTED|Overall Study||38
1599598|NCT01004159|3910764|P1|NOT COMPLETED|Overall Study||20
1599599|NCT01004159|3910764|P1|COMPLETED|Overall Study||0
1599600|NCT01004159|3910764|P1|STARTED|Overall Study||20
1599601|NCT01004146|3910771|P2|NOT COMPLETED|Overall Study||5
1599602|NCT01004146|3910772|P1|NOT COMPLETED|Overall Study||4
1599603|NCT01004146|3910771|P2|COMPLETED|Overall Study||20
1599604|NCT01004146|3910772|P1|COMPLETED|Overall Study||21
1599605|NCT01004146|3910771|P2|Have Incentive Spirometry Data|Overall Study||20
1599606|NCT01004146|3910772|P1|Have Incentive Spirometry Data|Overall Study||21
1599607|NCT01004146|3910771|P2|STARTED|Overall Study||25
1599608|NCT01004146|3910772|P1|STARTED|Overall Study||25
1599609|NCT01004107|3910780|P2|NOT COMPLETED|Overall Study||2
1599610|NCT01004107|3910781|P1|NOT COMPLETED|Overall Study||1
1599611|NCT01004107|3910780|P2|COMPLETED|Overall Study||23
1599612|NCT01004107|3910781|P1|COMPLETED|Overall Study||75
1599613|NCT01004107|3910780|P2|STARTED|Overall Study||25
1599614|NCT01004107|3910781|P1|STARTED|Overall Study||76
1599615|NCT01004003|3910866|P9|NOT COMPLETED|Overall Study||30
1599616|NCT01004003|3910867|P8|NOT COMPLETED|Overall Study||60
1599617|NCT01004003|3910868|P7|NOT COMPLETED|Overall Study||8
1599618|NCT01004003|3910869|P6|NOT COMPLETED|Overall Study||4
1599619|NCT01004003|3910870|P5|NOT COMPLETED|Overall Study||4
1599620|NCT01004003|3910871|P4|NOT COMPLETED|Overall Study||3
1599621|NCT01004003|3910872|P3|NOT COMPLETED|Overall Study||4
1599622|NCT01004003|3910873|P2|NOT COMPLETED|Overall Study||3
1599623|NCT01004003|3910874|P1|NOT COMPLETED|Overall Study||6
1599624|NCT01004003|3910866|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
1599625|NCT01004003|3910867|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
1599626|NCT01004003|3910868|P7|COMPLETED|Overall Study||0
1599627|NCT01004003|3910869|P6|COMPLETED|Overall Study||0
1599628|NCT01004003|3910870|P5|COMPLETED|Overall Study||0
1599629|NCT01004003|3910871|P4|COMPLETED|Overall Study||0
1599630|NCT01004003|3910872|P3|COMPLETED|Overall Study||0
1599631|NCT01004003|3910873|P2|COMPLETED|Overall Study||0
1599632|NCT01004003|3910874|P1|COMPLETED|Overall Study||0
1599633|NCT01004003|3910866|P9|STARTED|Overall Study||31
1599634|NCT01004003|3910867|P8|STARTED|Overall Study||62
1599635|NCT01004003|3910868|P7|STARTED|Overall Study||8
1599636|NCT01004003|3910869|P6|STARTED|Overall Study||4
1599637|NCT01004003|3910870|P5|STARTED|Overall Study||4
1599638|NCT01004003|3910871|P4|STARTED|Overall Study||3
1599639|NCT01004003|3910872|P3|STARTED|Overall Study||4
1599640|NCT01004003|3910873|P2|STARTED|Overall Study||3
1599641|NCT01004003|3910874|P1|STARTED|Overall Study||6
1599642|NCT01003990|3910905|P3|NOT COMPLETED|Overall Study||43
1599643|NCT01003990|3910906|P2|NOT COMPLETED|Overall Study||51
1599644|NCT01003990|3910907|P1|NOT COMPLETED|Overall Study||92
1599645|NCT01003990|3910905|P3|COMPLETED|Overall Study||53
1599646|NCT01003990|3910906|P2|COMPLETED|Overall Study||103
1599647|NCT01003990|3910907|P1|COMPLETED|Overall Study||367
1599648|NCT01003990|3910905|P3|STARTED|Overall Study||96
1599649|NCT01003990|3910906|P2|STARTED|Overall Study||154
1599650|NCT01003990|3910907|P1|STARTED|Overall Study||459
1599651|NCT01003938|3910915|P1|NOT COMPLETED|Overall Study||0
1599652|NCT01003938|3910915|P1|COMPLETED|Overall Study||6
1599653|NCT01003938|3910915|P1|STARTED|Overall Study||6
1599654|NCT01003899|3910924|P1|NOT COMPLETED|Overall Study||47
1599655|NCT01003899|3910924|P1|COMPLETED|Overall Study||0
1599656|NCT01003899|3910924|P1|STARTED|Overall Study|enrolled|47
1599657|NCT01003886|3910933|P1|NOT COMPLETED|Overall Study||230
1599658|NCT01003886|3910933|P1|COMPLETED|Overall Study||759
1599659|NCT01003886|3910933|P1|STARTED|Overall Study||989
1599660|NCT01003639|3910944|P2|NOT COMPLETED|Overall Study||22
1599661|NCT01003639|3910945|P1|NOT COMPLETED|Overall Study||17
1599662|NCT01003639|3910944|P2|COMPLETED|Overall Study||57
1599663|NCT01003639|3910945|P1|COMPLETED|Overall Study||69
1599664|NCT01003639|3910944|P2|STARTED|Overall Study||79
1599665|NCT01003639|3910945|P1|STARTED|Overall Study||86
1599666|NCT01003301|3910959|P2|NOT COMPLETED|Overall Study||0
1599667|NCT01003301|3910960|P1|NOT COMPLETED|Overall Study||0
1599668|NCT01003301|3910959|P2|COMPLETED|Overall Study||9
1599669|NCT01003301|3910960|P1|COMPLETED|Overall Study||10
1599670|NCT01003301|3910959|P2|STARTED|Overall Study||9
1599671|NCT01003301|3910960|P1|STARTED|Overall Study||10
1599672|NCT01003288|3910968|P1|NOT COMPLETED|Overall Study||0
1599673|NCT01003288|3910968|P1|COMPLETED|Overall Study||255
1599674|NCT01003288|3910968|P1|STARTED|Overall Study||255
1599675|NCT01003275|3910975|P2|NOT COMPLETED|Overall Study||0
1599676|NCT01003275|3910976|P1|NOT COMPLETED|Overall Study||1
1599677|NCT01003275|3910975|P2|COMPLETED|Overall Study||11
1599678|NCT01003275|3910976|P1|COMPLETED|Overall Study||10
1599680|NCT01003275|3910976|P1|STARTED|Overall Study||11
1599681|NCT01003249|3910982|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
1599682|NCT01003249|3910983|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
1599683|NCT01003249|3910982|P2|COMPLETED|Second Intervention (4 Weeks)||2
1599684|NCT01003249|3910983|P1|COMPLETED|Second Intervention (4 Weeks)||3
1599685|NCT01003249|3910982|P2|STARTED|Second Intervention (4 Weeks)||3
1599686|NCT01003249|3910983|P1|STARTED|Second Intervention (4 Weeks)||4
1599687|NCT01003249|3910982|P2|NOT COMPLETED|Washout (3 Weeks)||0
1599688|NCT01003249|3910983|P1|NOT COMPLETED|Washout (3 Weeks)||0
1599689|NCT01003249|3910982|P2|COMPLETED|Washout (3 Weeks)||3
1599690|NCT01003249|3910983|P1|COMPLETED|Washout (3 Weeks)||4
1599691|NCT01003249|3910982|P2|STARTED|Washout (3 Weeks)||3
1599692|NCT01003249|3910983|P1|STARTED|Washout (3 Weeks)||4
1599693|NCT01003249|3910982|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
1599694|NCT01003249|3910983|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
1599695|NCT01003249|3910982|P2|COMPLETED|First Intervention (4 Weeks)||3
1599696|NCT01003249|3910983|P1|COMPLETED|First Intervention (4 Weeks)||5
1599697|NCT01003249|3910982|P2|Received Intervention|First Intervention (4 Weeks)||5
1599698|NCT01003249|3910983|P1|Received Intervention|First Intervention (4 Weeks)||7
1599699|NCT01003249|3910982|P2|STARTED|First Intervention (4 Weeks)||5
1599700|NCT01003249|3910983|P1|STARTED|First Intervention (4 Weeks)||7
1599701|NCT01003210|3911001|P2|NOT COMPLETED|Overall Study||3
1599702|NCT01003210|3911002|P1|NOT COMPLETED|Overall Study||1
1599703|NCT01003210|3911001|P2|COMPLETED|Overall Study||102
1599704|NCT01003210|3911002|P1|COMPLETED|Overall Study||104
1599705|NCT01003210|3911001|P2|STARTED|Overall Study||105
1599706|NCT01003210|3911002|P1|STARTED|Overall Study||105
1599707|NCT01003184|3911014|P2|NOT COMPLETED|Overall Study||12
1599708|NCT01003184|3911015|P1|NOT COMPLETED|Overall Study||19
1599709|NCT01003184|3911014|P2|COMPLETED|Overall Study||99
1599710|NCT01003184|3911015|P1|COMPLETED|Overall Study||92
1599711|NCT01003184|3911014|P2|Full Analysis Set (FAS)|Overall Study||105
1599712|NCT01003184|3911015|P1|Full Analysis Set (FAS)|Overall Study||111
1599713|NCT01003184|3911014|P2|STARTED|Overall Study||111
1599714|NCT01003184|3911015|P1|STARTED|Overall Study||111
1599715|NCT01003106|3911051|P8|NOT COMPLETED|Month 6-Month 36||0
1599716|NCT01003106|3911052|P7|NOT COMPLETED|Month 6-Month 36||1
1599717|NCT01003106|3911053|P6|NOT COMPLETED|Month 6-Month 36||0
1599718|NCT01003106|3911054|P5|NOT COMPLETED|Month 6-Month 36||0
1599719|NCT01003106|3911055|P4|NOT COMPLETED|Month 6-Month 36||0
1599720|NCT01003106|3911056|P3|NOT COMPLETED|Month 6-Month 36||1
1599721|NCT01003106|3911057|P2|NOT COMPLETED|Month 6-Month 36||0
1599722|NCT01003106|3911058|P1|NOT COMPLETED|Month 6-Month 36||0
1599723|NCT01003106|3911051|P8|COMPLETED|Month 6-Month 36||18
1599724|NCT01003106|3911052|P7|COMPLETED|Month 6-Month 36||19
1599725|NCT01003106|3911053|P6|COMPLETED|Month 6-Month 36||0
1599726|NCT01003106|3911054|P5|COMPLETED|Month 6-Month 36||0
1599727|NCT01003106|3911055|P4|COMPLETED|Month 6-Month 36||20
1599728|NCT01003106|3911056|P3|COMPLETED|Month 6-Month 36||18
1599729|NCT01003106|3911057|P2|COMPLETED|Month 6-Month 36||0
1599730|NCT01003106|3911058|P1|COMPLETED|Month 6-Month 36||0
1599731|NCT01003106|3911051|P8|STARTED|Month 6-Month 36||18
1599732|NCT01003106|3911052|P7|STARTED|Month 6-Month 36||20
1599733|NCT01003106|3911053|P6|STARTED|Month 6-Month 36||0
1599734|NCT01003106|3911054|P5|STARTED|Month 6-Month 36||0
1599735|NCT01003106|3911055|P4|STARTED|Month 6-Month 36||20
1599736|NCT01003106|3911056|P3|STARTED|Month 6-Month 36||19
1599737|NCT01003106|3911057|P2|STARTED|Month 6-Month 36||0
1599738|NCT01003106|3911058|P1|STARTED|Month 6-Month 36||0
1599739|NCT01003106|3911051|P8|NOT COMPLETED|Baseline to Month 6||0
1599740|NCT01003106|3911052|P7|NOT COMPLETED|Baseline to Month 6||0
1599741|NCT01003106|3911053|P6|NOT COMPLETED|Baseline to Month 6||0
1599742|NCT01003106|3911054|P5|NOT COMPLETED|Baseline to Month 6||0
1599743|NCT01003106|3911055|P4|NOT COMPLETED|Baseline to Month 6||0
1599744|NCT01003106|3911056|P3|NOT COMPLETED|Baseline to Month 6||0
1599745|NCT01003106|3911057|P2|NOT COMPLETED|Baseline to Month 6||0
1599746|NCT01003106|3911058|P1|NOT COMPLETED|Baseline to Month 6||0
1599747|NCT01003106|3911051|P8|COMPLETED|Baseline to Month 6||0
1599748|NCT01003106|3911052|P7|COMPLETED|Baseline to Month 6||0
1599749|NCT01003106|3911053|P6|COMPLETED|Baseline to Month 6||20
1599750|NCT01003106|3911054|P5|COMPLETED|Baseline to Month 6||19
1599751|NCT01003106|3911055|P4|COMPLETED|Baseline to Month 6||0
1599752|NCT01003106|3911056|P3|COMPLETED|Baseline to Month 6||0
1599753|NCT01003106|3911057|P2|COMPLETED|Baseline to Month 6||20
1599754|NCT01003106|3911058|P1|COMPLETED|Baseline to Month 6||22
1599755|NCT01003106|3911051|P8|STARTED|Baseline to Month 6||0
1599756|NCT01003106|3911052|P7|STARTED|Baseline to Month 6||0
1599757|NCT01003106|3911053|P6|STARTED|Baseline to Month 6||20
1599758|NCT01003106|3911054|P5|STARTED|Baseline to Month 6||19
1599759|NCT01003106|3911055|P4|STARTED|Baseline to Month 6||0
1599760|NCT01003106|3911056|P3|STARTED|Baseline to Month 6||0
1599761|NCT01003106|3911057|P2|STARTED|Baseline to Month 6||20
1599762|NCT01003106|3911058|P1|STARTED|Baseline to Month 6||22
1599763|NCT01003080|3911082|P2|NOT COMPLETED|Overall Study||0
1599764|NCT01003080|3911083|P1|NOT COMPLETED|Overall Study||0
1599765|NCT01003080|3911082|P2|COMPLETED|Overall Study||61
1599766|NCT01003080|3911083|P1|COMPLETED|Overall Study||50
1599767|NCT01003080|3911082|P2|STARTED|Overall Study||61
1599768|NCT01003080|3911083|P1|STARTED|Overall Study||50
1599769|NCT01003067|3911091|P2|NOT COMPLETED|Overall Study||24
1599770|NCT01003067|3911092|P1|NOT COMPLETED|Overall Study||33
1599771|NCT01003067|3911091|P2|COMPLETED|Overall Study||107
1599772|NCT01003067|3911092|P1|COMPLETED|Overall Study||103
1599773|NCT01003067|3911091|P2|STARTED|Overall Study||131
1599774|NCT01003067|3911092|P1|STARTED|Overall Study||136
1599775|NCT01002989|3911098|P1|NOT COMPLETED|Overall Study||5
1599776|NCT01002989|3911098|P1|COMPLETED|Overall Study||93
1599777|NCT01002989|3911098|P1|STARTED|Overall Study||98
1599778|NCT01002742|3911107|P2|NOT COMPLETED|Overall Study||1
1599779|NCT01002742|3911108|P1|NOT COMPLETED|Overall Study||0
1599780|NCT01002742|3911107|P2|COMPLETED|Overall Study||116
1599781|NCT01002742|3911108|P1|COMPLETED|Overall Study||119
1599782|NCT01002742|3911107|P2|STARTED|Overall Study||117
1599783|NCT01002742|3911108|P1|STARTED|Overall Study||119
1599784|NCT01002573|3911144|P2|NOT COMPLETED|Overall Study||7
1599785|NCT01002573|3911145|P1|NOT COMPLETED|Overall Study||11
1599786|NCT01002573|3911144|P2|COMPLETED|Overall Study||53
1599787|NCT01002573|3911145|P1|COMPLETED|Overall Study||47
1599788|NCT01002573|3911144|P2|STARTED|Overall Study||60
1599789|NCT01002573|3911145|P1|STARTED|Overall Study||58
1599790|NCT01002547|3911166|P3|NOT COMPLETED|Overall Study||8
1599791|NCT01002547|3911167|P2|NOT COMPLETED|Overall Study||3
1599792|NCT01002547|3911168|P1|NOT COMPLETED|Overall Study||8
1599793|NCT01002547|3911166|P3|COMPLETED|Overall Study||29
1599794|NCT01002547|3911167|P2|COMPLETED|Overall Study||33
1599795|NCT01002547|3911168|P1|COMPLETED|Overall Study||24
1599796|NCT01002547|3911166|P3|STARTED|Overall Study||37
1599797|NCT01002547|3911167|P2|STARTED|Overall Study||36
1599798|NCT01002547|3911168|P1|STARTED|Overall Study||32
1599799|NCT01002482|3911226|P2|NOT COMPLETED|Overall Study||21
1599800|NCT01002482|3911227|P1|NOT COMPLETED|Overall Study||15
1599801|NCT01002482|3911226|P2|COMPLETED|Overall Study||1312
1599802|NCT01002482|3911227|P1|COMPLETED|Overall Study||1336
1599803|NCT01002482|3911226|P2|STARTED|Overall Study||1333
1599804|NCT01002482|3911227|P1|STARTED|Overall Study||1351
1599805|NCT01002456|3911249|P2|NOT COMPLETED|Overall Study||0
1599806|NCT01002456|3911250|P1|NOT COMPLETED|Overall Study||0
1599807|NCT01002456|3911249|P2|COMPLETED|Overall Study||122
1599808|NCT01002456|3911250|P1|COMPLETED|Overall Study||98
1599809|NCT01002456|3911249|P2|STARTED|Overall Study||122
1599810|NCT01002456|3911250|P1|STARTED|Overall Study||98
1599811|NCT01002339|3911261|P3|NOT COMPLETED|Overall Study||5
1599812|NCT01002339|3911262|P2|NOT COMPLETED|Overall Study||1
1599813|NCT01002339|3911263|P1|NOT COMPLETED|Overall Study||0
1599814|NCT01002339|3911261|P3|COMPLETED|Overall Study||42
1599815|NCT01002339|3911262|P2|COMPLETED|Overall Study||42
1599816|NCT01002339|3911263|P1|COMPLETED|Overall Study||44
1599817|NCT01002339|3911261|P3|STARTED|Overall Study||47
1599818|NCT01002339|3911262|P2|STARTED|Overall Study||43
1599819|NCT01002339|3911263|P1|STARTED|Overall Study||44
1599820|NCT01002287|3911318|P2|NOT COMPLETED|Overall Study||0
1599821|NCT01002287|3911319|P1|NOT COMPLETED|Overall Study||0
1599822|NCT01002287|3911318|P2|COMPLETED|Overall Study||3
1599823|NCT01002287|3911319|P1|COMPLETED|Overall Study||8
1599824|NCT01002287|3911318|P2|STARTED|Overall Study||3
1599825|NCT01002287|3911319|P1|STARTED|Overall Study||8
1599826|NCT01002118|3911331|P1|NOT COMPLETED|Overall Study||0
1599827|NCT01002118|3911331|P1|COMPLETED|Overall Study||1
1599828|NCT01002118|3911331|P1|Randomized Only Patient|Overall Study||1
1599829|NCT01002118|3911331|P1|STARTED|Overall Study||1
1599830|NCT01002105|3911339|P2|NOT COMPLETED|Overall Study||21
1599831|NCT01002105|3911340|P1|NOT COMPLETED|Overall Study||19
1599832|NCT01002105|3911339|P2|COMPLETED|Overall Study||11
1599833|NCT01002105|3911340|P1|COMPLETED|Overall Study||13
1599834|NCT01002105|3911339|P2|STARTED|Overall Study||32
1599835|NCT01002105|3911340|P1|STARTED|Overall Study||32
1599836|NCT01001988|3911356|P1|NOT COMPLETED|Overall Study||117
1599837|NCT01001988|3911356|P1|COMPLETED|Overall Study||479
1599838|NCT01001988|3911356|P1|STARTED|Overall Study||596
1599839|NCT01001975|3911363|P2|NOT COMPLETED|Overall Study||0
1599840|NCT01001975|3911364|P1|NOT COMPLETED|Overall Study||0
1599841|NCT01001975|3911363|P2|COMPLETED|Overall Study||5
1599842|NCT01001975|3911364|P1|COMPLETED|Overall Study||5
1599843|NCT01001975|3911363|P2|STARTED|Overall Study||5
1599844|NCT01001975|3911364|P1|STARTED|Overall Study||5
1599845|NCT01001832|3911374|P2|NOT COMPLETED|Follow-up Period||21
1599846|NCT01001832|3911375|P1|NOT COMPLETED|Follow-up Period||18
1599847|NCT01001832|3911374|P2|COMPLETED|Follow-up Period||30
1599848|NCT01001832|3911375|P1|COMPLETED|Follow-up Period||34
1599849|NCT01001832|3911374|P2|STARTED|Follow-up Period||51
1599850|NCT01001832|3911375|P1|STARTED|Follow-up Period||52
1599851|NCT01001832|3911374|P2|NOT COMPLETED|Long-term Period||5
1599852|NCT01001832|3911375|P1|NOT COMPLETED|Long-term Period||4
1599853|NCT01001832|3911374|P2|COMPLETED|Long-term Period||51
1599854|NCT01001832|3911375|P1|COMPLETED|Long-term Period||52
1599855|NCT01001832|3911374|P2|STARTED|Long-term Period||56
1599856|NCT01001832|3911375|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
1599857|NCT01001832|3911374|P2|NOT COMPLETED|Short-term Period||3
1599858|NCT01001832|3911375|P1|NOT COMPLETED|Short-term Period||2
1599859|NCT01001832|3911374|P2|COMPLETED|Short-term Period||56
1599860|NCT01001832|3911375|P1|COMPLETED|Short-term Period||57
1599861|NCT01001832|3911374|P2|STARTED|Short-term Period||59
1599862|NCT01001832|3911375|P1|STARTED|Short-term Period||59
1599863|NCT01001806|3911421|P3|NOT COMPLETED|Overall Study||4
1599864|NCT01001806|3911422|P2|NOT COMPLETED|Overall Study||1
1599865|NCT01001806|3911423|P1|NOT COMPLETED|Overall Study||0
1599866|NCT01001806|3911421|P3|COMPLETED|Overall Study||38
1599867|NCT01001806|3911422|P2|COMPLETED|Overall Study||41
1599868|NCT01001806|3911423|P1|COMPLETED|Overall Study||42
1599869|NCT01001806|3911421|P3|STARTED|Overall Study||42
1599870|NCT01001806|3911422|P2|STARTED|Overall Study||42
1599871|NCT01001806|3911423|P1|STARTED|Overall Study||42
1599872|NCT01001767|3911433|P2|NOT COMPLETED|Overall Study||0
1599873|NCT01001767|3911434|P1|NOT COMPLETED|Overall Study||4
1599874|NCT01001767|3911433|P2|COMPLETED|Overall Study||17
1599875|NCT01001767|3911434|P1|COMPLETED|Overall Study||14
1599876|NCT01001767|3911433|P2|STARTED|Overall Study||17
1599877|NCT01001767|3911434|P1|STARTED|Overall Study||18
1599878|NCT01001702|3911440|P1|NOT COMPLETED|Overall Study||72
1599879|NCT01001702|3911440|P1|COMPLETED|Overall Study||13
1599880|NCT01001702|3911440|P1|STARTED|Overall Study||85
1599881|NCT01001572|3911453|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
1599882|NCT01001572|3911454|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
1599883|NCT01001572|3911455|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
1599884|NCT01001572|3911453|P3|COMPLETED|Double-Blind Treatment Phase||306
1599885|NCT01001572|3911454|P2|COMPLETED|Double-Blind Treatment Phase||319
1599886|NCT01001572|3911455|P1|COMPLETED|Double-Blind Treatment Phase||0
1599887|NCT01001572|3911453|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
1599888|NCT01001572|3911454|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
1599889|NCT01001572|3911455|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
1599890|NCT01001572|3911453|P3|STARTED|Double-Blind Treatment Phase||325
1599891|NCT01001572|3911454|P2|STARTED|Double-Blind Treatment Phase||329
1599892|NCT01001572|3911455|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
1599893|NCT01001572|3911453|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
1599894|NCT01001572|3911454|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
1599895|NCT01001572|3911455|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
1599896|NCT01001572|3911453|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
1599897|NCT01001572|3911454|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
1599898|NCT01001572|3911455|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
1599899|NCT01001572|3911453|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
1599900|NCT01001572|3911454|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
1599901|NCT01001572|3911455|P1|STARTED|Single-Blind Valsartan 160 mg||932
1599902|NCT01001559|3911471|P2|NOT COMPLETED|Overall Study||0
1599903|NCT01001559|3911472|P1|NOT COMPLETED|Overall Study||0
1599904|NCT01001559|3911471|P2|COMPLETED|Overall Study||147
1599905|NCT01001559|3911472|P1|COMPLETED|Overall Study||95
1599906|NCT01001559|3911471|P2|STARTED|Overall Study||147
1599907|NCT01001559|3911472|P1|STARTED|Overall Study||95
1599908|NCT01001546|3911486|P2|NOT COMPLETED|Overall Study||0
1599909|NCT01001546|3911487|P1|NOT COMPLETED|Overall Study||0
1599910|NCT01001546|3911486|P2|COMPLETED|Overall Study||207
1599911|NCT01001546|3911487|P1|COMPLETED|Overall Study||206
1599912|NCT01001546|3911486|P2|STARTED|Overall Study||207
1599913|NCT01001546|3911487|P1|STARTED|Overall Study||206
1599914|NCT01001520|3911493|P2|NOT COMPLETED|Medication Period 2||3
1599915|NCT01001520|3911494|P1|NOT COMPLETED|Medication Period 2||0
1599916|NCT01001520|3911493|P2|COMPLETED|Medication Period 2||13
1599917|NCT01001520|3911494|P1|COMPLETED|Medication Period 2||16
1599918|NCT01001520|3911493|P2|STARTED|Medication Period 2||16
1599919|NCT01001520|3911494|P1|STARTED|Medication Period 2||16
1599920|NCT01001520|3911493|P2|NOT COMPLETED|Washout Period||1
1599921|NCT01001520|3911494|P1|NOT COMPLETED|Washout Period||2
1599922|NCT01001520|3911493|P2|COMPLETED|Washout Period||16
1599923|NCT01001520|3911494|P1|COMPLETED|Washout Period||16
1599924|NCT01001520|3911493|P2|STARTED|Washout Period||17
1599925|NCT01001520|3911494|P1|STARTED|Washout Period||18
1599926|NCT01001520|3911493|P2|NOT COMPLETED|Medication Period 1||7
1599927|NCT01001520|3911494|P1|NOT COMPLETED|Medication Period 1||4
1599928|NCT01001520|3911493|P2|COMPLETED|Medication Period 1||17
1599929|NCT01001520|3911494|P1|COMPLETED|Medication Period 1||18
1599930|NCT01001520|3911493|P2|STARTED|Medication Period 1||24
1599931|NCT01001520|3911494|P1|STARTED|Medication Period 1||22
1599932|NCT01001494|3911521|P3|NOT COMPLETED|Overall Study||41
1599933|NCT01001494|3911522|P2|NOT COMPLETED|Overall Study||17
1599934|NCT01001494|3911523|P1|NOT COMPLETED|Overall Study||24
1599935|NCT01001494|3911521|P3|COMPLETED|Overall Study||232
1599936|NCT01001494|3911522|P2|COMPLETED|Overall Study||252
1599937|NCT01001494|3911523|P1|COMPLETED|Overall Study||253
1599938|NCT01001494|3911521|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
1599939|NCT01001494|3911522|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
1599940|NCT01001494|3911523|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
1599941|NCT01001442|3911551|P8|NOT COMPLETED|Overall Study||2
1599942|NCT01001442|3911552|P7|NOT COMPLETED|Overall Study||4
1599943|NCT01001442|3911553|P6|NOT COMPLETED|Overall Study||0
1599944|NCT01001442|3911554|P5|NOT COMPLETED|Overall Study||2
1599945|NCT01001442|3911555|P4|NOT COMPLETED|Overall Study||0
1599946|NCT01001442|3911556|P3|NOT COMPLETED|Overall Study||0
1599947|NCT01001442|3911557|P2|NOT COMPLETED|Overall Study||0
1599948|NCT01001442|3911558|P1|NOT COMPLETED|Overall Study||0
1599949|NCT01001442|3911551|P8|COMPLETED|Overall Study||2
1599950|NCT01001442|3911552|P7|COMPLETED|Overall Study||6
1599951|NCT01001442|3911553|P6|COMPLETED|Overall Study||3
1599952|NCT01001442|3911554|P5|COMPLETED|Overall Study||2
1599953|NCT01001442|3911555|P4|COMPLETED|Overall Study||3
1599954|NCT01001442|3911556|P3|COMPLETED|Overall Study||4
1599955|NCT01001442|3911557|P2|COMPLETED|Overall Study||3
1599956|NCT01001442|3911558|P1|COMPLETED|Overall Study||4
1599957|NCT01001442|3911551|P8|STARTED|Overall Study||4
1599958|NCT01001442|3911552|P7|STARTED|Overall Study||10
1599959|NCT01001442|3911553|P6|STARTED|Overall Study||3
1599960|NCT01001442|3911554|P5|STARTED|Overall Study||4
1599961|NCT01001442|3911555|P4|STARTED|Overall Study||3
1599962|NCT01001442|3911556|P3|STARTED|Overall Study||4
1599963|NCT01001442|3911557|P2|STARTED|Overall Study||3
1599964|NCT01001442|3911558|P1|STARTED|Overall Study||4
1599965|NCT01001429|3911608|P2|NOT COMPLETED|Overall Study||1
1599966|NCT01001429|3911609|P1|NOT COMPLETED|Overall Study||0
1599967|NCT01001429|3911608|P2|COMPLETED|Overall Study||37
1599968|NCT01001429|3911609|P1|COMPLETED|Overall Study||39
1599969|NCT01001429|3911608|P2|STARTED|Overall Study||38
1599970|NCT01001429|3911609|P1|STARTED|Overall Study||39
1599971|NCT01001403|3911641|P2|NOT COMPLETED|Overall Study||0
1599972|NCT01001403|3911642|P1|NOT COMPLETED|Overall Study||0
1599973|NCT01001403|3911641|P2|COMPLETED|Overall Study||31
1599974|NCT01001403|3911642|P1|COMPLETED|Overall Study||31
1599975|NCT01001403|3911641|P2|STARTED|Overall Study||31
1599976|NCT01001403|3911642|P1|STARTED|Overall Study||31
1599977|NCT01001390|3911648|P2|NOT COMPLETED|Overall Study||0
1599978|NCT01001390|3911649|P1|NOT COMPLETED|Overall Study||2
1599979|NCT01001390|3911648|P2|COMPLETED|Overall Study||0
1599980|NCT01001390|3911649|P1|COMPLETED|Overall Study||0
1599981|NCT01001390|3911648|P2|STARTED|Overall Study||0
1599982|NCT01001390|3911649|P1|STARTED|Overall Study||2
1599983|NCT01001377|3911657|P2|NOT COMPLETED|Overall Study||421
1599984|NCT01001377|3911658|P1|NOT COMPLETED|Overall Study||426
1599985|NCT01001377|3911657|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
1599986|NCT01001377|3911658|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
1599987|NCT01001377|3911657|P2|Received Treatment|Overall Study||499
1599988|NCT01001377|3911658|P1|Received Treatment|Overall Study||500
1599989|NCT01001377|3911657|P2|STARTED|Overall Study||506
1599990|NCT01001377|3911658|P1|STARTED|Overall Study||504
1599991|NCT01001325|3911688|P2|NOT COMPLETED|Overall Study||10
1599992|NCT01001325|3911689|P1|NOT COMPLETED|Overall Study||18
1599993|NCT01001325|3911688|P2|COMPLETED|Overall Study||224
1599994|NCT01001325|3911689|P1|COMPLETED|Overall Study||216
1599995|NCT01001325|3911688|P2|STARTED|Overall Study||234
1599996|NCT01001325|3911689|P1|STARTED|Overall Study||234
1599997|NCT01001299|3911695|P1|NOT COMPLETED|Overall Study||25
1599998|NCT01001299|3911695|P1|COMPLETED|Overall Study||0
1599999|NCT01001299|3911695|P1|STARTED|Overall Study||25
1600000|NCT01001234|3911724|P5|NOT COMPLETED|Overall Study||0
1600001|NCT01001234|3911725|P4|NOT COMPLETED|Overall Study||25
1600002|NCT01001234|3911726|P3|NOT COMPLETED|Overall Study||32
1600003|NCT01001234|3911727|P2|NOT COMPLETED|Overall Study||26
1600004|NCT01001234|3911728|P1|NOT COMPLETED|Overall Study||405
1600005|NCT01001234|3911724|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
1600006|NCT01001234|3911725|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
1600007|NCT01001234|3911726|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
1600008|NCT01001234|3911727|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
1600009|NCT01001234|3911728|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
1600010|NCT01001234|3911724|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
1600011|NCT01001234|3911725|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
1600012|NCT01001234|3911726|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
1600013|NCT01001234|3911727|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
1600014|NCT01001234|3911728|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
1600015|NCT01001234|3911724|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
1600016|NCT01001234|3911725|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
1600017|NCT01001234|3911726|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
1600018|NCT01001234|3911727|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
1600019|NCT01001234|3911728|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
1600020|NCT01001234|3911724|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
1600021|NCT01001234|3911725|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
1600022|NCT01001234|3911726|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
1600023|NCT01001234|3911727|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
1600024|NCT01001234|3911728|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
1600025|NCT01001221|3911744|P5|NOT COMPLETED|Overall Study||0
1600026|NCT01001221|3911745|P4|NOT COMPLETED|Overall Study||6
1600027|NCT01001221|3911746|P3|NOT COMPLETED|Overall Study||3
1600028|NCT01001221|3911747|P2|NOT COMPLETED|Overall Study||5
1600029|NCT01001221|3911748|P1|NOT COMPLETED|Overall Study||5
1600030|NCT01001221|3911744|P5|COMPLETED|Overall Study||0
1600031|NCT01001221|3911745|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1600032|NCT01001221|3911746|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1600033|NCT01001221|3911747|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1600034|NCT01001221|3911748|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1600035|NCT01001221|3911744|P5|Completed 1st Treatment Cycle|Overall Study||0
1600036|NCT01001221|3911745|P4|Completed 1st Treatment Cycle|Overall Study||6
1600037|NCT01001221|3911746|P3|Completed 1st Treatment Cycle|Overall Study||2
1600038|NCT01001221|3911747|P2|Completed 1st Treatment Cycle|Overall Study||5
1600039|NCT01001221|3911748|P1|Completed 1st Treatment Cycle|Overall Study||5
1600040|NCT01001221|3911744|P5|Treated|Overall Study||0
1600041|NCT01001221|3911745|P4|Treated|Overall Study||6
1600042|NCT01001221|3911746|P3|Treated|Overall Study||2
1600043|NCT01001221|3911747|P2|Treated|Overall Study||5
1600044|NCT01001221|3911748|P1|Treated|Overall Study||5
1600045|NCT01001221|3911744|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
1600046|NCT01001221|3911745|P4|STARTED|Overall Study||6
1600047|NCT01001221|3911746|P3|STARTED|Overall Study||3
1600048|NCT01001221|3911747|P2|STARTED|Overall Study||5
1600049|NCT01001221|3911748|P1|STARTED|Overall Study||5
1600050|NCT01001208|3911923|P2|NOT COMPLETED|Overall Study||33
1600051|NCT01001208|3911924|P1|NOT COMPLETED|Overall Study||28
1600052|NCT01001208|3911923|P2|COMPLETED|Overall Study||206
1600053|NCT01001208|3911924|P1|COMPLETED|Overall Study||211
1600054|NCT01001208|3911923|P2|STARTED|Overall Study||239
1600055|NCT01001208|3911924|P1|STARTED|Overall Study||239
1600056|NCT01001195|3911952|P4|NOT COMPLETED|Overall Study||0
1600057|NCT01001195|3911953|P3|NOT COMPLETED|Overall Study||0
1600058|NCT01001195|3911954|P2|NOT COMPLETED|Overall Study||2
1600059|NCT01001195|3911955|P1|NOT COMPLETED|Overall Study||2
1600060|NCT01001195|3911952|P4|COMPLETED|Overall Study||41
1600061|NCT01001195|3911953|P3|COMPLETED|Overall Study||44
1600062|NCT01001195|3911954|P2|COMPLETED|Overall Study||39
1600063|NCT01001195|3911955|P1|COMPLETED|Overall Study||37
1600064|NCT01001195|3911952|P4|STARTED|Overall Study||41
1600065|NCT01001195|3911953|P3|STARTED|Overall Study||44
1600066|NCT01001195|3911954|P2|STARTED|Overall Study||41
1600067|NCT01001195|3911955|P1|STARTED|Overall Study||39
1600068|NCT01001169|3911967|P2|NOT COMPLETED|Overall Study||1
1600069|NCT01001169|3911968|P1|NOT COMPLETED|Overall Study||2
1600070|NCT01001169|3911967|P2|COMPLETED|Overall Study||29
1600071|NCT01001169|3911968|P1|COMPLETED|Overall Study||28
1600072|NCT01001169|3911967|P2|STARTED|Overall Study||30
1600073|NCT01001169|3911968|P1|STARTED|Overall Study||30
1600074|NCT01001104|3912076|P4|NOT COMPLETED|Overall Study||3
1600075|NCT01001104|3912077|P3|NOT COMPLETED|Overall Study||1
1600076|NCT01001104|3912078|P2|NOT COMPLETED|Overall Study||1
1600077|NCT01001104|3912079|P1|NOT COMPLETED|Overall Study||2
1600078|NCT01001104|3912076|P4|COMPLETED|Overall Study||34
1600079|NCT01001104|3912077|P3|COMPLETED|Overall Study||35
1600080|NCT01001104|3912078|P2|COMPLETED|Overall Study||36
1600081|NCT01001104|3912079|P1|COMPLETED|Overall Study||33
1600082|NCT01001104|3912076|P4|STARTED|Overall Study||37
1600083|NCT01001104|3912077|P3|STARTED|Overall Study||36
1600084|NCT01001104|3912078|P2|STARTED|Overall Study||37
1600085|NCT01001104|3912079|P1|STARTED|Overall Study||35
1600086|NCT01001078|3912126|P2|NOT COMPLETED|Overall Study||0
1600087|NCT01001078|3912127|P1|NOT COMPLETED|Overall Study||0
1600088|NCT01001078|3912126|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
1600089|NCT01001078|3912127|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
1600090|NCT01001078|3912126|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
1600091|NCT01001078|3912127|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
1600092|NCT01001078|3912126|P2|Intubated|Overall Study||1
1600093|NCT01001078|3912127|P1|Intubated|Overall Study||2
1600094|NCT01001078|3912126|P2|Received Crossover|Overall Study||3
1600095|NCT01001078|3912127|P1|Received Crossover|Overall Study||2
1600096|NCT01001078|3912126|P2|Received Allocated Intervention|Overall Study||46
1600097|NCT01001078|3912127|P1|Received Allocated Intervention|Overall Study||46
1600098|NCT01001078|3912126|P2|STARTED|Overall Study||50
1600099|NCT01001078|3912127|P1|STARTED|Overall Study||50
1600100|NCT01001052|3912143|P2|NOT COMPLETED|Overall Study||0
1600101|NCT01001052|3912144|P1|NOT COMPLETED|Overall Study||0
1600102|NCT01001052|3912143|P2|COMPLETED|Overall Study||18
1600103|NCT01001052|3912144|P1|COMPLETED|Overall Study||20
1600104|NCT01001052|3912143|P2|STARTED|Overall Study||18
1600105|NCT01001052|3912144|P1|STARTED|Overall Study||20
1600106|NCT01000987|3912157|P3|NOT COMPLETED|Overall Study||0
1600107|NCT01000987|3912158|P2|NOT COMPLETED|Overall Study||0
1600108|NCT01000987|3912159|P1|NOT COMPLETED|Overall Study||0
1600109|NCT01000987|3912157|P3|COMPLETED|Overall Study||17
1600110|NCT01000987|3912158|P2|COMPLETED|Overall Study||15
1600111|NCT01000987|3912159|P1|COMPLETED|Overall Study||12
1600112|NCT01000987|3912157|P3|STARTED|Overall Study||17
1600113|NCT01000987|3912158|P2|STARTED|Overall Study||15
1600114|NCT01000987|3912159|P1|STARTED|Overall Study||12
1600115|NCT01000974|3912170|P3|NOT COMPLETED|Booster Vaccination Phase||14
1600116|NCT01000974|3912171|P2|NOT COMPLETED|Booster Vaccination Phase||12
1600117|NCT01000974|3912172|P1|NOT COMPLETED|Booster Vaccination Phase||67
1600118|NCT01000974|3912170|P3|COMPLETED|Booster Vaccination Phase||386
1600119|NCT01000974|3912171|P2|COMPLETED|Booster Vaccination Phase||423
1600120|NCT01000974|3912172|P1|COMPLETED|Booster Vaccination Phase||2270
1600121|NCT01000974|3912170|P3|STARTED|Booster Vaccination Phase||400
1600122|NCT01000974|3912171|P2|STARTED|Booster Vaccination Phase||435
1600123|NCT01000974|3912172|P1|STARTED|Booster Vaccination Phase||2337
1600124|NCT01000974|3912170|P3|NOT COMPLETED|Primary Vaccination Phase||63
1600125|NCT01000974|3912171|P2|NOT COMPLETED|Primary Vaccination Phase||50
1600126|NCT01000974|3912172|P1|NOT COMPLETED|Primary Vaccination Phase||338
1600127|NCT01000974|3912170|P3|COMPLETED|Primary Vaccination Phase||457
1600128|NCT01000974|3912171|P2|COMPLETED|Primary Vaccination Phase||470
1600129|NCT01000974|3912172|P1|COMPLETED|Primary Vaccination Phase||2625
1600130|NCT01000974|3912170|P3|STARTED|Primary Vaccination Phase||520
1600131|NCT01000974|3912171|P2|STARTED|Primary Vaccination Phase||520
1600132|NCT01000974|3912172|P1|STARTED|Primary Vaccination Phase||2963
1600133|NCT01000961|3912279|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
1600134|NCT01000961|3912280|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
1600135|NCT01000961|3912279|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
1600136|NCT01000961|3912280|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
1600137|NCT01000961|3912279|P2|STARTED|Second Intervention (3 Weeks)||20
1600138|NCT01000961|3912280|P1|STARTED|Second Intervention (3 Weeks)||21
1600139|NCT01000961|3912279|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
1600140|NCT01000961|3912280|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
1600141|NCT01000961|3912279|P2|COMPLETED|First Intervention (3 Weeks)||20
1600142|NCT01000961|3912280|P1|COMPLETED|First Intervention (3 Weeks)||21
1600143|NCT01000961|3912279|P2|STARTED|First Intervention (3 Weeks)||22
1600144|NCT01000961|3912280|P1|STARTED|First Intervention (3 Weeks)||21
1600145|NCT01000961|3912279|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
1600146|NCT01000961|3912280|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
1600147|NCT01000961|3912279|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
1600148|NCT01000961|3912280|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
1600149|NCT01000961|3912279|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
1600150|NCT01000961|3912280|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
1600151|NCT01000818|3912292|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
1600152|NCT01000818|3912292|P1|COMPLETED|Omeprazole + Raltegravir||18
1600153|NCT01000818|3912292|P1|STARTED|Omeprazole + Raltegravir||18
1600154|NCT01000818|3912292|P1|NOT COMPLETED|Famotidine + Raltegravir||0
1600155|NCT01000818|3912292|P1|COMPLETED|Famotidine + Raltegravir||18
1600156|NCT01000818|3912292|P1|STARTED|Famotidine + Raltegravir||18
1600157|NCT01000818|3912292|P1|NOT COMPLETED|Raltegravir||0
1600158|NCT01000818|3912292|P1|COMPLETED|Raltegravir||18
1600159|NCT01000818|3912292|P1|STARTED|Raltegravir||18
1600160|NCT01000805|3912303|P2|NOT COMPLETED|Overall Study||62
1600161|NCT01000805|3912304|P1|NOT COMPLETED|Overall Study||70
1600162|NCT01000805|3912303|P2|COMPLETED|Overall Study||204
1600163|NCT01000805|3912304|P1|COMPLETED|Overall Study||192
1600164|NCT01000805|3912303|P2|STARTED|Overall Study||266
1600165|NCT01000805|3912304|P1|STARTED|Overall Study||262
1600166|NCT01000727|3912338|P2|NOT COMPLETED|Overall Study||176
1600167|NCT01000727|3912339|P1|NOT COMPLETED|Overall Study||175
1600168|NCT01000727|3912338|P2|COMPLETED|Overall Study||6328
1600169|NCT01000727|3912339|P1|COMPLETED|Overall Study||6347
1600170|NCT01000727|3912338|P2|STARTED|Overall Study||6504
1600171|NCT01000727|3912339|P1|STARTED|Overall Study||6522
1600172|NCT01000662|3912369|P2|NOT COMPLETED|Overall Study||8
1600173|NCT01000662|3912370|P1|NOT COMPLETED|Overall Study||4
1600174|NCT01000662|3912369|P2|COMPLETED|Overall Study||198
1600175|NCT01000662|3912370|P1|COMPLETED|Overall Study||202
1600176|NCT01000662|3912369|P2|STARTED|Overall Study||206
1600177|NCT01000662|3912370|P1|STARTED|Overall Study||206
1600178|NCT01000649|3912380|P4|NOT COMPLETED|Overall Study||6
1600179|NCT01000649|3912381|P3|NOT COMPLETED|Overall Study||2
1600180|NCT01000649|3912382|P2|NOT COMPLETED|Overall Study||3
1600181|NCT01000649|3912383|P1|NOT COMPLETED|Overall Study||5
1600182|NCT01000649|3912380|P4|COMPLETED|Overall Study||15
1600183|NCT01000649|3912381|P3|COMPLETED|Overall Study||0
1600184|NCT01000649|3912382|P2|COMPLETED|Overall Study||16
1600185|NCT01000649|3912383|P1|COMPLETED|Overall Study||5
1600186|NCT01000649|3912380|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
1600187|NCT01000649|3912381|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
1600188|NCT01000649|3912382|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
1600189|NCT01000649|3912383|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
1600190|NCT01000649|3912380|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
1600191|NCT01000649|3912381|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
1600192|NCT01000649|3912382|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
1600193|NCT01000649|3912383|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
1600194|NCT01000610|3912464|P1|NOT COMPLETED|Overall Study||6
1600195|NCT01000610|3912464|P1|COMPLETED|Overall Study||12
1600196|NCT01000610|3912464|P1|STARTED|Overall Study||18
1600197|NCT01000506|3912475|P4|NOT COMPLETED|Overall Study||23
1600198|NCT01000506|3912476|P3|NOT COMPLETED|Overall Study||21
1600199|NCT01000506|3912477|P2|NOT COMPLETED|Overall Study||24
1600200|NCT01000506|3912478|P1|NOT COMPLETED|Overall Study||28
1600201|NCT01000506|3912475|P4|COMPLETED|Overall Study||133
1600202|NCT01000506|3912476|P3|COMPLETED|Overall Study||131
1600203|NCT01000506|3912477|P2|COMPLETED|Overall Study||129
1600204|NCT01000506|3912478|P1|COMPLETED|Overall Study||127
1600205|NCT01000506|3912475|P4|STARTED|Overall Study||156
1600206|NCT01000506|3912476|P3|STARTED|Overall Study||152
1600207|NCT01000506|3912477|P2|STARTED|Overall Study||153
1600208|NCT01000506|3912478|P1|STARTED|Overall Study||155
1600209|NCT01000493|3912522|P2|NOT COMPLETED|Overall Study||55
1600210|NCT01000493|3912523|P1|NOT COMPLETED|Overall Study||39
1600211|NCT01000493|3912522|P2|COMPLETED|Overall Study||14
1600212|NCT01000493|3912523|P1|COMPLETED|Overall Study||21
1600213|NCT01000493|3912522|P2|STARTED|Overall Study||69
1600214|NCT01000493|3912523|P1|STARTED|Overall Study||60
1600215|NCT01000480|3912573|P1|NOT COMPLETED|Follow-Up Period||0
1600216|NCT01000480|3912573|P1|COMPLETED|Follow-Up Period||88
1600217|NCT01000480|3912573|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
1600218|NCT01000480|3912573|P1|NOT COMPLETED|Concurrent Therapy Phase||10
1600219|NCT01000480|3912573|P1|COMPLETED|Concurrent Therapy Phase||65
1600220|NCT01000480|3912573|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
1600221|NCT01000480|3912573|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
1600222|NCT01000480|3912573|P1|NOT COMPLETED|Induction Phase||7
1600223|NCT01000480|3912573|P1|COMPLETED|Induction Phase||83
1600224|NCT01000480|3912573|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
1600225|NCT01000480|3912573|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
1600226|NCT01000480|3912573|P1|STARTED|Induction Phase||90
1600227|NCT01000376|3912581|P2|NOT COMPLETED|Cycle 1 Day 15||0
1600228|NCT01000376|3912582|P1|NOT COMPLETED|Cycle 1 Day 15||0
1600229|NCT01000376|3912581|P2|COMPLETED|Cycle 1 Day 15||6
1600230|NCT01000376|3912582|P1|COMPLETED|Cycle 1 Day 15||4
1600231|NCT01000376|3912581|P2|STARTED|Cycle 1 Day 15||6
1600232|NCT01000376|3912582|P1|STARTED|Cycle 1 Day 15||4
1600233|NCT01000376|3912581|P2|NOT COMPLETED|Cycle 1 Day 1||0
1600234|NCT01000376|3912582|P1|NOT COMPLETED|Cycle 1 Day 1||2
1600235|NCT01000376|3912581|P2|COMPLETED|Cycle 1 Day 1||6
1600236|NCT01000376|3912582|P1|COMPLETED|Cycle 1 Day 1||4
1600237|NCT01000376|3912581|P2|STARTED|Cycle 1 Day 1||6
1600238|NCT01000376|3912582|P1|STARTED|Cycle 1 Day 1||6
1600239|NCT01000337|3912592|P2|NOT COMPLETED|Overall Study||3
1600240|NCT01000337|3912593|P1|NOT COMPLETED|Overall Study||4
1600241|NCT01000337|3912592|P2|COMPLETED|Overall Study||30
1600242|NCT01000337|3912593|P1|COMPLETED|Overall Study||30
1600243|NCT01000337|3912592|P2|STARTED|Overall Study||33
1600244|NCT01000337|3912593|P1|STARTED|Overall Study||34
1600245|NCT01000324|3912599|P1|NOT COMPLETED|Year 20||0
1600246|NCT01000324|3912599|P1|COMPLETED|Year 20||28
1600247|NCT01000324|3912599|P1|STARTED|Year 20||28
1600248|NCT01000324|3912599|P1|NOT COMPLETED|Year 19||0
1600249|NCT01000324|3912599|P1|COMPLETED|Year 19||28
1600250|NCT01000324|3912599|P1|STARTED|Year 19||28
1600251|NCT01000324|3912599|P1|NOT COMPLETED|Year 18||0
1600252|NCT01000324|3912599|P1|COMPLETED|Year 18||29
1600253|NCT01000324|3912599|P1|STARTED|Year 18||29
1600254|NCT01000324|3912599|P1|NOT COMPLETED|Year 17||0
1600255|NCT01000324|3912599|P1|COMPLETED|Year 17||32
1600256|NCT01000324|3912599|P1|STARTED|Year 17||32
1600257|NCT01000324|3912599|P1|NOT COMPLETED|Year 16||0
1600258|NCT01000324|3912599|P1|COMPLETED|Year 16||40
1600259|NCT01000324|3912599|P1|STARTED|Year 16||40
1600260|NCT01000311|3912611|P2|NOT COMPLETED|Overall Study||70
1600261|NCT01000311|3912612|P1|NOT COMPLETED|Overall Study||45
1600262|NCT01000311|3912611|P2|COMPLETED|Overall Study||201
1600263|NCT01000311|3912612|P1|COMPLETED|Overall Study||213
1600264|NCT01000311|3912611|P2|STARTED|Overall Study||271
1600265|NCT01000311|3912612|P1|STARTED|Overall Study||258
1600266|NCT01000285|3912642|P1|NOT COMPLETED|Overall Study||0
1600267|NCT01000285|3912642|P1|COMPLETED|Overall Study||18
1600268|NCT01000285|3912642|P1|STARTED|Overall Study||18
1600269|NCT01000155|3912662|P1|NOT COMPLETED|Overall Study||2
1600270|NCT01000155|3912662|P1|COMPLETED|Overall Study||3
1600271|NCT01000155|3912662|P1|STARTED|Overall Study||5
1600272|NCT01000064|3912668|P2|NOT COMPLETED|Overall Study||1
1600273|NCT01000064|3912669|P1|NOT COMPLETED|Overall Study||1
1600274|NCT01000064|3912668|P2|COMPLETED|Overall Study||5
1600275|NCT01000064|3912669|P1|COMPLETED|Overall Study||6
1600276|NCT01000064|3912668|P2|STARTED|Overall Study||6
1600277|NCT01000064|3912669|P1|STARTED|Overall Study||7
1600278|NCT01000025|3912692|P2|NOT COMPLETED|Overall Study||238
1600279|NCT01000025|3912693|P1|NOT COMPLETED|Overall Study||468
1600280|NCT01000025|3912692|P2|COMPLETED|Overall Study||2
1600281|NCT01000025|3912693|P1|COMPLETED|Overall Study||12
1600282|NCT01000025|3912692|P2|STARTED|Overall Study||240
1600283|NCT01000025|3912693|P1|STARTED|Overall Study||480
1600284|NCT00999921|3912711|P2|NOT COMPLETED|Overall Study||19
1600285|NCT00999921|3912712|P1|NOT COMPLETED|Overall Study||10
1600286|NCT00999921|3912711|P2|COMPLETED|Overall Study||110
1600287|NCT00999921|3912712|P1|COMPLETED|Overall Study||117
1600288|NCT00999921|3912711|P2|STARTED|Overall Study||129
1600289|NCT00999921|3912712|P1|STARTED|Overall Study||127
1600290|NCT00999908|3912722|P3|NOT COMPLETED|Treatment Period 3||0
1600291|NCT00999908|3912723|P2|NOT COMPLETED|Treatment Period 3||0
1600292|NCT00999908|3912724|P1|NOT COMPLETED|Treatment Period 3||0
1600293|NCT00999908|3912722|P3|COMPLETED|Treatment Period 3||19
1600294|NCT00999908|3912723|P2|COMPLETED|Treatment Period 3||16
1600295|NCT00999908|3912724|P1|COMPLETED|Treatment Period 3||16
1600296|NCT00999908|3912722|P3|STARTED|Treatment Period 3||19
1600297|NCT00999908|3912723|P2|STARTED|Treatment Period 3||16
1600298|NCT00999908|3912724|P1|STARTED|Treatment Period 3||16
1600299|NCT00999908|3912722|P3|NOT COMPLETED|Treatment Period 2||0
1600300|NCT00999908|3912723|P2|NOT COMPLETED|Treatment Period 2||0
1600301|NCT00999908|3912724|P1|NOT COMPLETED|Treatment Period 2||1
1600302|NCT00999908|3912722|P3|COMPLETED|Treatment Period 2||19
1600303|NCT00999908|3912723|P2|COMPLETED|Treatment Period 2||16
1600304|NCT00999908|3912724|P1|COMPLETED|Treatment Period 2||16
1600305|NCT00999908|3912722|P3|STARTED|Treatment Period 2||19
1600306|NCT00999908|3912723|P2|STARTED|Treatment Period 2||16
1600307|NCT00999908|3912724|P1|STARTED|Treatment Period 2||17
1600308|NCT00999908|3912722|P3|NOT COMPLETED|Treatment Period 1||0
1600309|NCT00999908|3912723|P2|NOT COMPLETED|Treatment Period 1||0
1600310|NCT00999908|3912724|P1|NOT COMPLETED|Treatment Period 1||2
1600311|NCT00999908|3912722|P3|COMPLETED|Treatment Period 1||19
1600312|NCT00999908|3912723|P2|COMPLETED|Treatment Period 1||16
1600313|NCT00999908|3912724|P1|COMPLETED|Treatment Period 1||17
1600314|NCT00999908|3912722|P3|STARTED|Treatment Period 1||19
1600315|NCT00999908|3912723|P2|STARTED|Treatment Period 1||16
1600316|NCT00999908|3912724|P1|STARTED|Treatment Period 1||19
1600317|NCT00999830|3912740|P2|NOT COMPLETED|Overall Study||0
1600318|NCT00999830|3912741|P1|NOT COMPLETED|Overall Study||0
1600319|NCT00999830|3912740|P2|COMPLETED|Overall Study||13
1600320|NCT00999830|3912741|P1|COMPLETED|Overall Study||14
1600321|NCT00999830|3912740|P2|STARTED|Overall Study||13
1600322|NCT00999830|3912741|P1|STARTED|Overall Study||14
1600323|NCT00999804|3912753|P2|NOT COMPLETED|Overall Study||5
1600324|NCT00999804|3912754|P1|NOT COMPLETED|Overall Study||21
1600325|NCT00999804|3912753|P2|COMPLETED|Overall Study||38
1600326|NCT00999804|3912754|P1|COMPLETED|Overall Study||64
1600327|NCT00999804|3912753|P2|STARTED|Overall Study||43
1600328|NCT00999804|3912754|P1|STARTED|Overall Study||85
1600329|NCT00999713|3912768|P2|NOT COMPLETED|Overall Study||0
1600330|NCT00999713|3912769|P1|NOT COMPLETED|Overall Study||2
1600331|NCT00999713|3912768|P2|COMPLETED|Overall Study||17
1600332|NCT00999713|3912769|P1|COMPLETED|Overall Study||24
1600333|NCT00999713|3912768|P2|STARTED|Overall Study||17
1600334|NCT00999713|3912769|P1|STARTED|Overall Study||26
1600335|NCT00999687|3912783|P1|NOT COMPLETED|Second Intervention||3
1600336|NCT00999687|3912783|P1|COMPLETED|Second Intervention||27
1600337|NCT00999687|3912783|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
1600338|NCT00999687|3912783|P1|NOT COMPLETED|First Intervention||1
1600339|NCT00999687|3912783|P1|COMPLETED|First Intervention||30
1600340|NCT00999687|3912783|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
1600341|NCT00999661|3912790|P1|NOT COMPLETED|Overall Study||70
1600342|NCT00999661|3912790|P1|COMPLETED|Overall Study||161
1600343|NCT00999661|3912790|P1|STARTED|Overall Study||231
1600344|NCT00999609|3912798|P2|NOT COMPLETED|Overall Study||1
1600345|NCT00999609|3912799|P1|NOT COMPLETED|Overall Study||1
1600346|NCT00999609|3912798|P2|COMPLETED|Overall Study|1 year post intervention|9
1600347|NCT00999609|3912799|P1|COMPLETED|Overall Study|1 year post intervention|20
1600348|NCT00999609|3912798|P2|STARTED|Overall Study||10
1600349|NCT00999609|3912799|P1|STARTED|Overall Study|Before intervention|21
1600350|NCT00999596|3912811|P1|NOT COMPLETED|Overall Study||101
1600351|NCT00999596|3912811|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
1600352|NCT00999596|3912811|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
1600353|NCT00999596|3912811|P1|STARTED|Overall Study||107
1600354|NCT00999544|3912816|P1|NOT COMPLETED|Overall Study||1
1600355|NCT00999544|3912816|P1|COMPLETED|Overall Study||8
1600356|NCT00999544|3912816|P1|STARTED|Overall Study||9
1600357|NCT00999466|3912852|P3|NOT COMPLETED|Main Part||4
1600358|NCT00999466|3912853|P2|NOT COMPLETED|Main Part||4
1600359|NCT00999466|3912854|P1|NOT COMPLETED|Main Part||0
1600360|NCT00999466|3912852|P3|COMPLETED|Main Part||21
1600361|NCT00999466|3912853|P2|COMPLETED|Main Part||22
1600362|NCT00999466|3912854|P1|COMPLETED|Main Part||0
1600363|NCT00999466|3912852|P3|STARTED|Main Part||25
1600364|NCT00999466|3912853|P2|STARTED|Main Part||26
1600365|NCT00999466|3912854|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
1600366|NCT00999466|3912852|P3|NOT COMPLETED|Pilot Part||0
1600367|NCT00999466|3912853|P2|NOT COMPLETED|Pilot Part||0
1600368|NCT00999466|3912854|P1|NOT COMPLETED|Pilot Part||0
1600369|NCT00999466|3912852|P3|COMPLETED|Pilot Part||3
1600370|NCT00999466|3912853|P2|COMPLETED|Pilot Part||0
1600371|NCT00999466|3912854|P1|COMPLETED|Pilot Part||6
1600372|NCT00999466|3912852|P3|STARTED|Pilot Part||3
1600373|NCT00999466|3912853|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
1600374|NCT00999466|3912854|P1|STARTED|Pilot Part||6
1600375|NCT00999167|3913131|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
1600376|NCT00999167|3913132|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
1600377|NCT00999167|3913133|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
1600378|NCT00999167|3913131|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
1600379|NCT00999167|3913132|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
1600380|NCT00999167|3913133|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
1600381|NCT00999167|3913131|P3|STARTED|Part B: Randomized, Placebo Controlled||88
1600382|NCT00999167|3913132|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
1600383|NCT00999167|3913133|P1|STARTED|Part B: Randomized, Placebo Controlled||0
1600384|NCT00999167|3913131|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
1600385|NCT00999167|3913132|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
1600386|NCT00999167|3913133|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
1600387|NCT00999167|3913131|P3|COMPLETED|Part A: Open Label Safety run-in||0
1600388|NCT00999167|3913132|P2|COMPLETED|Part A: Open Label Safety run-in||0
1600389|NCT00999167|3913133|P1|COMPLETED|Part A: Open Label Safety run-in||8
1600390|NCT00999167|3913131|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
1600391|NCT00999167|3913132|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
1600392|NCT00999167|3913133|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
1600393|NCT00999167|3913131|P3|STARTED|Part A: Open Label Safety run-in||0
1600394|NCT00999167|3913132|P2|STARTED|Part A: Open Label Safety run-in||0
1600395|NCT00999167|3913133|P1|STARTED|Part A: Open Label Safety run-in||15
1600396|NCT00999141|3913147|P1|NOT COMPLETED|Overall Study||0
1600397|NCT00999141|3913147|P1|COMPLETED|Overall Study||75
1600398|NCT00999141|3913147|P1|STARTED|Overall Study|Randomized and treated|75
1600399|NCT00999102|3913229|P2|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
1600400|NCT00999102|3913230|P1|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
1600401|NCT00999102|3913229|P2|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
1600402|NCT00999102|3913230|P1|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
1600403|NCT00999102|3913229|P2|STARTED|4 Weeks at Higher Dose of Second Drug||16
1600404|NCT00999102|3913230|P1|STARTED|4 Weeks at Higher Dose of Second Drug||15
1600405|NCT00999102|3913229|P2|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
1600406|NCT00999102|3913230|P1|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
1600407|NCT00999102|3913229|P2|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
1600408|NCT00999102|3913230|P1|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
1600409|NCT00999102|3913229|P2|STARTED|4 Weeks at Lower Dose of Second Drug||16
1600410|NCT00999102|3913230|P1|STARTED|4 Weeks at Lower Dose of Second Drug||15
1600411|NCT00999102|3913229|P2|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
1600412|NCT00999102|3913230|P1|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
1600413|NCT00999102|3913229|P2|COMPLETED|4 Weeks at Higher Dose of First Drug||16
1600414|NCT00999102|3913230|P1|COMPLETED|4 Weeks at Higher Dose of First Drug||15
1600415|NCT00999102|3913229|P2|STARTED|4 Weeks at Higher Dose of First Drug||16
1600416|NCT00999102|3913230|P1|STARTED|4 Weeks at Higher Dose of First Drug||15
1600417|NCT00999102|3913229|P2|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
1600418|NCT00999102|3913230|P1|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
1600419|NCT00999102|3913229|P2|COMPLETED|4 Weeks at Lower Dose of First Drug||16
1600420|NCT00999102|3913230|P1|COMPLETED|4 Weeks at Lower Dose of First Drug||15
1600421|NCT00999102|3913229|P2|STARTED|4 Weeks at Lower Dose of First Drug||17
1600422|NCT00999102|3913230|P1|STARTED|4 Weeks at Lower Dose of First Drug||16
1600423|NCT00999037|3913246|P2|NOT COMPLETED|Overall Study||0
1600424|NCT00999037|3913247|P1|NOT COMPLETED|Overall Study||0
1600425|NCT00999037|3913246|P2|COMPLETED|Overall Study||9
1600426|NCT00999037|3913247|P1|COMPLETED|Overall Study||9
1600427|NCT00999037|3913246|P2|STARTED|Overall Study|20|9
1600428|NCT00999037|3913247|P1|STARTED|Overall Study||9
1600429|NCT00998985|3913271|P14|NOT COMPLETED|Overall Study||0
1600430|NCT00998985|3913272|P13|NOT COMPLETED|Overall Study||0
1600431|NCT00998985|3913273|P12|NOT COMPLETED|Overall Study||0
1600432|NCT00998985|3913274|P11|NOT COMPLETED|Overall Study||0
1600433|NCT00998985|3913275|P10|NOT COMPLETED|Overall Study||0
1600434|NCT00998985|3913276|P9|NOT COMPLETED|Overall Study||1
1600435|NCT00998985|3913277|P8|NOT COMPLETED|Overall Study||0
1600436|NCT00998985|3913278|P7|NOT COMPLETED|Overall Study||0
1600437|NCT00998985|3913279|P6|NOT COMPLETED|Overall Study||1
1600438|NCT00998985|3913280|P5|NOT COMPLETED|Overall Study||0
1600439|NCT00998985|3913281|P4|NOT COMPLETED|Overall Study||0
1600440|NCT00998985|3913282|P3|NOT COMPLETED|Overall Study||0
1600441|NCT00998985|3913283|P2|NOT COMPLETED|Overall Study||0
1600442|NCT00998985|3913284|P1|NOT COMPLETED|Overall Study||0
1600443|NCT00998985|3913271|P14|COMPLETED|Overall Study||15
1600444|NCT00998985|3913272|P13|COMPLETED|Overall Study||5
1600445|NCT00998985|3913273|P12|COMPLETED|Overall Study||5
1600446|NCT00998985|3913274|P11|COMPLETED|Overall Study||5
1600447|NCT00998985|3913275|P10|COMPLETED|Overall Study||5
1600448|NCT00998985|3913276|P9|COMPLETED|Overall Study||5
1600449|NCT00998985|3913277|P8|COMPLETED|Overall Study||5
1600450|NCT00998985|3913278|P7|COMPLETED|Overall Study||5
1600451|NCT00998985|3913279|P6|COMPLETED|Overall Study||4
1600452|NCT00998985|3913280|P5|COMPLETED|Overall Study||5
1600453|NCT00998985|3913281|P4|COMPLETED|Overall Study||5
1600454|NCT00998985|3913282|P3|COMPLETED|Overall Study||15
1600455|NCT00998985|3913283|P2|COMPLETED|Overall Study||5
1600456|NCT00998985|3913284|P1|COMPLETED|Overall Study||5
1600457|NCT00998985|3913271|P14|STARTED|Overall Study||15
1600458|NCT00998985|3913272|P13|STARTED|Overall Study||5
1600459|NCT00998985|3913273|P12|STARTED|Overall Study||5
1600460|NCT00998985|3913274|P11|STARTED|Overall Study||5
1600461|NCT00998985|3913275|P10|STARTED|Overall Study||5
1600462|NCT00998985|3913276|P9|STARTED|Overall Study||6
1600463|NCT00998985|3913277|P8|STARTED|Overall Study||5
1600464|NCT00998985|3913278|P7|STARTED|Overall Study||5
1600465|NCT00998985|3913279|P6|STARTED|Overall Study||5
1600466|NCT00998985|3913280|P5|STARTED|Overall Study||5
1600467|NCT00998985|3913281|P4|STARTED|Overall Study||5
1600468|NCT00998985|3913282|P3|STARTED|Overall Study||15
1600469|NCT00998985|3913283|P2|STARTED|Overall Study||5
1600470|NCT00998985|3913284|P1|STARTED|Overall Study||5
1600471|NCT00998881|3913352|P2|NOT COMPLETED|Overall Study||2
1600472|NCT00998881|3913353|P1|NOT COMPLETED|Overall Study||8
1600473|NCT00998881|3913352|P2|COMPLETED|Overall Study||97
1600474|NCT00998881|3913353|P1|COMPLETED|Overall Study||96
1600475|NCT00998881|3913352|P2|STARTED|Overall Study||99
1600476|NCT00998881|3913353|P1|STARTED|Overall Study||104
1600477|NCT00998868|3913365|P1|NOT COMPLETED|Overall Study||0
1600478|NCT00998868|3913365|P1|COMPLETED|Overall Study||51
1600479|NCT00998868|3913365|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
1600480|NCT00998790|3913372|P1|NOT COMPLETED|Overall Study||21
1600481|NCT00998790|3913372|P1|COMPLETED|Overall Study||93
1600482|NCT00998790|3913372|P1|Participants Who Were Treated|Overall Study||113
1600483|NCT00998790|3913372|P1|STARTED|Overall Study||114
1600484|NCT00998764|3913382|P2|NOT COMPLETED|Overall Study||274
1600485|NCT00998764|3913383|P1|NOT COMPLETED|Overall Study||216
1600486|NCT00998764|3913382|P2|COMPLETED|Overall Study||2
1600487|NCT00998764|3913383|P1|COMPLETED|Overall Study||0
1600488|NCT00998764|3913382|P2|Treated|Overall Study||275
1600489|NCT00998764|3913383|P1|Treated|Overall Study||215
1600490|NCT00998764|3913382|P2|STARTED|Overall Study||276
1600491|NCT00998764|3913383|P1|STARTED|Overall Study||216
1600492|NCT00998738|3913405|P1|NOT COMPLETED|Overall Study||1
1600493|NCT00998738|3913405|P1|COMPLETED|Overall Study||0
1600494|NCT00998738|3913405|P1|STARTED|Overall Study||1
1600495|NCT00998660|3913420|P1|NOT COMPLETED|Overall Study||13
1600496|NCT00998660|3913420|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
1600497|NCT00998660|3913420|P1|Month 3 Visit|Overall Study||87
1600498|NCT00998660|3913420|P1|Implanted|Overall Study||93
1600499|NCT00998660|3913420|P1|STARTED|Overall Study||100
1600500|NCT00998582|3913426|P2|NOT COMPLETED|Overall Study||0
1600501|NCT00998582|3913427|P1|NOT COMPLETED|Overall Study||0
1600502|NCT00998582|3913426|P2|COMPLETED|Overall Study||14
1600503|NCT00998582|3913427|P1|COMPLETED|Overall Study||13
1600504|NCT00998582|3913426|P2|STARTED|Overall Study||14
1600505|NCT00998582|3913427|P1|STARTED|Overall Study||13
1600506|NCT00998517|3913438|P3|NOT COMPLETED|Overall Study||0
1600507|NCT00998517|3913439|P2|NOT COMPLETED|Overall Study||0
1600508|NCT00998517|3913440|P1|NOT COMPLETED|Overall Study||0
1600509|NCT00998517|3913438|P3|COMPLETED|Overall Study||918
1600510|NCT00998517|3913439|P2|COMPLETED|Overall Study||906
1600511|NCT00998517|3913440|P1|COMPLETED|Overall Study||888
1600512|NCT00998517|3913438|P3|STARTED|Overall Study||918
1600513|NCT00998517|3913439|P2|STARTED|Overall Study||906
1600514|NCT00998517|3913440|P1|STARTED|Overall Study||888
1600515|NCT00998426|3913466|P1|NOT COMPLETED|Overall Study||0
1600516|NCT00998426|3913466|P1|COMPLETED|Overall Study||5
1600517|NCT00998426|3913466|P1|Blood Glucose Monitoring|Overall Study||5
1600518|NCT00998426|3913466|P1|STARTED|Overall Study||5
1600519|NCT00998374|3913473|P2|NOT COMPLETED|Overall Study||11
1600520|NCT00998374|3913474|P1|NOT COMPLETED|Overall Study||12
1600521|NCT00998374|3913473|P2|COMPLETED|Overall Study||12
1600522|NCT00998374|3913474|P1|COMPLETED|Overall Study||27
1600523|NCT00998374|3913473|P2|STARTED|Overall Study||23
1600524|NCT00998374|3913474|P1|STARTED|Overall Study||39
1600525|NCT00998335|3913488|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
1600526|NCT00998335|3913489|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
1600527|NCT00998335|3913488|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
1600528|NCT00998335|3913489|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
1600529|NCT00998335|3913488|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
1600530|NCT00998335|3913489|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
1600531|NCT00998335|3913488|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
1600532|NCT00998335|3913489|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
1600533|NCT00998335|3913488|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
1600534|NCT00998335|3913489|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
1600535|NCT00998335|3913488|P2|STARTED|Initial Treatment (Months 0 - 3)||0
1600536|NCT00998335|3913489|P1|STARTED|Initial Treatment (Months 0 - 3)||30
1600537|NCT00998309|3913517|P1|NOT COMPLETED|Overall Study||4
1600538|NCT00998309|3913517|P1|COMPLETED|Overall Study||498
1600539|NCT00998309|3913517|P1|STARTED|Overall Study||502
1600540|NCT00998296|3913584|P11|NOT COMPLETED|Overall Study||7
1600541|NCT00998296|3913585|P10|NOT COMPLETED|Overall Study||18
1600542|NCT00998296|3913586|P9|NOT COMPLETED|Overall Study||2
1600543|NCT00998296|3913587|P8|NOT COMPLETED|Overall Study||2
1600544|NCT00998296|3913588|P7|NOT COMPLETED|Overall Study||1
1600545|NCT00998296|3913589|P6|NOT COMPLETED|Overall Study||0
1600546|NCT00998296|3913590|P5|NOT COMPLETED|Overall Study||2
1600547|NCT00998296|3913591|P4|NOT COMPLETED|Overall Study||0
1600548|NCT00998296|3913592|P3|NOT COMPLETED|Overall Study||0
1600549|NCT00998296|3913593|P2|NOT COMPLETED|Overall Study||1
1600550|NCT00998296|3913594|P1|NOT COMPLETED|Overall Study||0
1600551|NCT00998296|3913584|P11|COMPLETED|Overall Study||0
1600552|NCT00998296|3913585|P10|COMPLETED|Overall Study||0
1600553|NCT00998296|3913586|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
1600554|NCT00998296|3913587|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
1600555|NCT00998296|3913588|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
1600556|NCT00998296|3913589|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
1600557|NCT00998296|3913590|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
1600558|NCT00998296|3913591|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
1600559|NCT00998296|3913592|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
1600560|NCT00998296|3913593|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
1600561|NCT00998296|3913594|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
1600562|NCT00998296|3913584|P11|STARTED|Overall Study||7
1600563|NCT00998296|3913585|P10|STARTED|Overall Study||18
1600564|NCT00998296|3913586|P9|STARTED|Overall Study||6
1600565|NCT00998296|3913587|P8|STARTED|Overall Study||6
1600566|NCT00998296|3913588|P7|STARTED|Overall Study||7
1600567|NCT00998296|3913589|P6|STARTED|Overall Study||3
1600568|NCT00998296|3913590|P5|STARTED|Overall Study||8
1600569|NCT00998296|3913591|P4|STARTED|Overall Study||3
1600570|NCT00998296|3913592|P3|STARTED|Overall Study||3
1600571|NCT00998296|3913593|P2|STARTED|Overall Study||3
1600572|NCT00998296|3913594|P1|STARTED|Overall Study||6
1600573|NCT00998205|3913661|P1|NOT COMPLETED|Overall Study||0
1600574|NCT00998205|3913661|P1|COMPLETED|Overall Study||16
1600575|NCT00998205|3913661|P1|STARTED|Overall Study||16
1600576|NCT00998049|3913666|P1|NOT COMPLETED|Overall Study||0
1600577|NCT00998049|3913666|P1|COMPLETED|Overall Study||39
1600578|NCT00998049|3913666|P1|STARTED|Overall Study||39
1600579|NCT00998023|3913677|P2|NOT COMPLETED|Overall Study||0
1600580|NCT00998023|3913678|P1|NOT COMPLETED|Overall Study||0
1600581|NCT00998023|3913677|P2|COMPLETED|Overall Study||32
1600582|NCT00998023|3913678|P1|COMPLETED|Overall Study||32
1600583|NCT00998023|3913677|P2|STARTED|Overall Study||32
1600584|NCT00998023|3913678|P1|STARTED|Overall Study||32
1600585|NCT00997984|3913689|P3|NOT COMPLETED|Overall Study||26
1600586|NCT00997984|3913690|P2|NOT COMPLETED|Overall Study||34
1600587|NCT00997984|3913691|P1|NOT COMPLETED|Overall Study||37
1600588|NCT00997984|3913689|P3|COMPLETED|Overall Study||88
1600589|NCT00997984|3913690|P2|COMPLETED|Overall Study||79
1600590|NCT00997984|3913691|P1|COMPLETED|Overall Study||76
1600591|NCT00997984|3913689|P3|STARTED|Overall Study||114
1600592|NCT00997984|3913690|P2|STARTED|Overall Study||113
1600593|NCT00997984|3913691|P1|STARTED|Overall Study||113
1600594|NCT00997932|3913757|P1|NOT COMPLETED|Overall Study||2
1600595|NCT00997932|3913757|P1|COMPLETED|Overall Study||27
1600596|NCT00997932|3913757|P1|STARTED|Overall Study||29
1600597|NCT00997672|3913764|P2|NOT COMPLETED|Overall Study||4
1600598|NCT00997672|3913765|P1|NOT COMPLETED|Overall Study||4
1600599|NCT00997672|3913764|P2|COMPLETED|Overall Study||1
1600600|NCT00997672|3913765|P1|COMPLETED|Overall Study||0
1600601|NCT00997672|3913764|P2|STARTED|Overall Study||5
1600602|NCT00997672|3913765|P1|STARTED|Overall Study||4
1600603|NCT00997620|3913773|P2|NOT COMPLETED|Overall Study||0
1600604|NCT00997620|3913774|P1|NOT COMPLETED|Overall Study||0
1600605|NCT00997620|3913773|P2|COMPLETED|Overall Study||21
1600606|NCT00997620|3913774|P1|COMPLETED|Overall Study||19
1600607|NCT00997620|3913773|P2|STARTED|Overall Study||21
1600608|NCT00997620|3913774|P1|STARTED|Overall Study||19
1600609|NCT00997594|3913792|P2|NOT COMPLETED|Overall Study||0
1600610|NCT00997594|3913793|P1|NOT COMPLETED|Overall Study||0
1600611|NCT00997594|3913792|P2|COMPLETED|Overall Study||9
1600612|NCT00997594|3913793|P1|COMPLETED|Overall Study||9
1600613|NCT00997594|3913792|P2|Completion of Ablation Procedure|Overall Study||9
1600614|NCT00997594|3913793|P1|Completion of Ablation Procedure|Overall Study||9
1600615|NCT00997594|3913792|P2|STARTED|Overall Study||9
1600616|NCT00997594|3913793|P1|STARTED|Overall Study||9
1600617|NCT00997555|3913801|P2|NOT COMPLETED|Overall Study||0
1600618|NCT00997555|3913802|P1|NOT COMPLETED|Overall Study||0
1600619|NCT00997555|3913801|P2|COMPLETED|Overall Study||15
1600620|NCT00997555|3913802|P1|COMPLETED|Overall Study||13
1600621|NCT00997555|3913801|P2|STARTED|Overall Study||15
1600622|NCT00997555|3913802|P1|STARTED|Overall Study||13
1600623|NCT00997516|3913820|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
1600624|NCT00997516|3913821|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
1600625|NCT00997516|3913820|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
1600626|NCT00997516|3913821|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
1600627|NCT00997516|3913820|P2|STARTED|Long-term Follow-up (After 6 Months)||38
1600628|NCT00997516|3913821|P1|STARTED|Long-term Follow-up (After 6 Months)||37
1600629|NCT00997516|3913820|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
1600630|NCT00997516|3913821|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
1600631|NCT00997516|3913820|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
1600632|NCT00997516|3913821|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
1600633|NCT00997516|3913820|P2|STARTED|Short-term Follow-up (Post Operative)||38
1600634|NCT00997516|3913821|P1|STARTED|Short-term Follow-up (Post Operative)||37
1600635|NCT00997503|3913849|P1|NOT COMPLETED|Overall Study||273
1600636|NCT00997503|3913849|P1|COMPLETED|Overall Study||3926
1600724|NCT00996944|3914090|P1|COMPLETED|Long-term Treatment Period||0
1600637|NCT00997503|3913849|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
1600638|NCT00997503|3913849|P1|STARTED|Overall Study||4199
1600639|NCT00997438|3913892|P3|NOT COMPLETED|Overall Study||4
1600640|NCT00997438|3913893|P2|NOT COMPLETED|Overall Study||3
1600641|NCT00997438|3913894|P1|NOT COMPLETED|Overall Study||5
1600642|NCT00997438|3913892|P3|COMPLETED|Overall Study||20
1600643|NCT00997438|3913893|P2|COMPLETED|Overall Study||21
1600644|NCT00997438|3913894|P1|COMPLETED|Overall Study||16
1600645|NCT00997438|3913892|P3|STARTED|Overall Study||24
1600646|NCT00997438|3913893|P2|STARTED|Overall Study||24
1600647|NCT00997438|3913894|P1|STARTED|Overall Study||21
1600648|NCT00997425|3913929|P1|NOT COMPLETED|Overall Study||0
1600649|NCT00997425|3913929|P1|COMPLETED|Overall Study||19
1600650|NCT00997425|3913929|P1|STARTED|Overall Study||19
1600651|NCT00997386|3913934|P1|NOT COMPLETED|Overall Study||7
1600652|NCT00997386|3913934|P1|COMPLETED|Overall Study||9
1600653|NCT00997386|3913934|P1|STARTED|Overall Study||16
1600654|NCT00997373|3913943|P2|NOT COMPLETED|Overall Study||0
1600655|NCT00997373|3913944|P1|NOT COMPLETED|Overall Study||15
1600656|NCT00997373|3913943|P2|COMPLETED|Overall Study||15
1600657|NCT00997373|3913944|P1|COMPLETED|Overall Study||13
1600658|NCT00997373|3913943|P2|Completed Hysterectomy|Overall Study||15
1600659|NCT00997373|3913944|P1|Completed Hysterectomy|Overall Study||17
1600660|NCT00997373|3913943|P2|Received Letrozole|Overall Study||0
1600661|NCT00997373|3913944|P1|Received Letrozole|Overall Study||23
1600662|NCT00997373|3913943|P2|STARTED|Overall Study||15
1600663|NCT00997373|3913944|P1|STARTED|Overall Study||28
1600664|NCT00997334|3913950|P1|NOT COMPLETED|Overall Study||25
1600665|NCT00997334|3913950|P1|COMPLETED|Overall Study||35
1600666|NCT00997334|3913950|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
1600667|NCT00997334|3913950|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
1600668|NCT00997334|3913950|P1|STARTED|Overall Study||60
1600669|NCT00997321|3913959|P2|NOT COMPLETED|Overall Study||3
1600670|NCT00997321|3913960|P1|NOT COMPLETED|Overall Study||0
1600671|NCT00997321|3913959|P2|COMPLETED|Overall Study||47
1600672|NCT00997321|3913960|P1|COMPLETED|Overall Study||50
1600673|NCT00997321|3913959|P2|STARTED|Overall Study||50
1600674|NCT00997321|3913960|P1|STARTED|Overall Study||50
1600675|NCT00997243|3913972|P1|NOT COMPLETED|Overall Study||7
1600676|NCT00997243|3913972|P1|COMPLETED|Overall Study||0
1600677|NCT00997243|3913972|P1|STARTED|Overall Study||7
1600678|NCT00997204|3913984|P2|NOT COMPLETED|Self-administration Phase||1
1600679|NCT00997204|3913985|P1|NOT COMPLETED|Self-administration Phase||0
1600680|NCT00997204|3913984|P2|COMPLETED|Self-administration Phase||77
1600681|NCT00997204|3913985|P1|COMPLETED|Self-administration Phase||19
1600682|NCT00997204|3913984|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
1600683|NCT00997204|3913985|P1|STARTED|Self-administration Phase||19
1600684|NCT00997204|3913984|P2|NOT COMPLETED|Naive Treatment Phase||79
1600685|NCT00997204|3913985|P1|NOT COMPLETED|Naive Treatment Phase||6
1600686|NCT00997204|3913984|P2|COMPLETED|Naive Treatment Phase||0
1600687|NCT00997204|3913985|P1|COMPLETED|Naive Treatment Phase||19
1600688|NCT00997204|3913984|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
1600689|NCT00997204|3913985|P1|STARTED|Naive Treatment Phase||25
1600690|NCT00997139|3913996|P1|NOT COMPLETED|Overall Study||186
1600691|NCT00997139|3913996|P1|COMPLETED|Overall Study||30
1600692|NCT00997139|3913996|P1|Treated for Positive Baseline Culture|Overall Study||30
1600693|NCT00997139|3913996|P1|STARTED|Overall Study||216
1600694|NCT00997126|3914004|P2|NOT COMPLETED|Overall Study||11
1600695|NCT00997126|3914005|P1|NOT COMPLETED|Overall Study||7
1600696|NCT00997126|3914004|P2|COMPLETED|Overall Study||52
1600697|NCT00997126|3914005|P1|COMPLETED|Overall Study||56
1600698|NCT00997126|3914004|P2|STARTED|Overall Study||63
1600699|NCT00997126|3914005|P1|STARTED|Overall Study||63
1600700|NCT00997113|3914021|P2|NOT COMPLETED|Overall Study||0
1600701|NCT00997113|3914022|P1|NOT COMPLETED|Overall Study||0
1600702|NCT00997113|3914021|P2|COMPLETED|Overall Study||10
1600703|NCT00997113|3914022|P1|COMPLETED|Overall Study||10
1600704|NCT00997113|3914021|P2|STARTED|Overall Study||10
1600705|NCT00997113|3914022|P1|STARTED|Overall Study||10
1600706|NCT00997035|3914034|P2|NOT COMPLETED|3-month Follow-up Visit||6
1600707|NCT00997035|3914035|P1|NOT COMPLETED|3-month Follow-up Visit||12
1600708|NCT00997035|3914034|P2|COMPLETED|3-month Follow-up Visit||107
1600709|NCT00997035|3914035|P1|COMPLETED|3-month Follow-up Visit||100
1600710|NCT00997035|3914034|P2|STARTED|3-month Follow-up Visit||113
1600711|NCT00997035|3914035|P1|STARTED|3-month Follow-up Visit||112
1600712|NCT00997035|3914034|P2|NOT COMPLETED|3-week Followup Visit||6
1600713|NCT00997035|3914035|P1|NOT COMPLETED|3-week Followup Visit||9
1600714|NCT00997035|3914034|P2|COMPLETED|3-week Followup Visit||113
1600715|NCT00997035|3914035|P1|COMPLETED|3-week Followup Visit||112
1600716|NCT00997035|3914034|P2|STARTED|3-week Followup Visit||119
1600717|NCT00997035|3914035|P1|STARTED|3-week Followup Visit||121
1600718|NCT00996996|3914055|P1|NOT COMPLETED|Overall Study||33
1600719|NCT00996996|3914055|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
1600720|NCT00996996|3914055|P1|STARTED|Overall Study||77
1600721|NCT00996944|3914089|P2|NOT COMPLETED|Long-term Treatment Period||5
1600722|NCT00996944|3914090|P1|NOT COMPLETED|Long-term Treatment Period||12
1600723|NCT00996944|3914089|P2|COMPLETED|Long-term Treatment Period||0
1600725|NCT00996944|3914089|P2|STARTED|Long-term Treatment Period||5
1600726|NCT00996944|3914090|P1|STARTED|Long-term Treatment Period||12
1600727|NCT00996944|3914089|P2|NOT COMPLETED|Double-blind Treatment Period||7
1600728|NCT00996944|3914090|P1|NOT COMPLETED|Double-blind Treatment Period||10
1600729|NCT00996944|3914089|P2|COMPLETED|Double-blind Treatment Period||5
1600730|NCT00996944|3914090|P1|COMPLETED|Double-blind Treatment Period||12
1600731|NCT00996944|3914089|P2|STARTED|Double-blind Treatment Period||12
1600732|NCT00996944|3914090|P1|STARTED|Double-blind Treatment Period||22
1600733|NCT00996931|3914132|P1|NOT COMPLETED|Overall Study||0
1600734|NCT00996931|3914132|P1|COMPLETED|Overall Study||6
1600735|NCT00996931|3914132|P1|STARTED|Overall Study||6
1600736|NCT00996918|3914142|P5|NOT COMPLETED|Overall Study||4
1600737|NCT00996918|3914143|P4|NOT COMPLETED|Overall Study||56
1600738|NCT00996918|3914144|P3|NOT COMPLETED|Overall Study||37
1600739|NCT00996918|3914145|P2|NOT COMPLETED|Overall Study||66
1600740|NCT00996918|3914146|P1|NOT COMPLETED|Overall Study||39
1600741|NCT00996918|3914142|P5|COMPLETED|Overall Study||0
1600742|NCT00996918|3914143|P4|COMPLETED|Overall Study||0
1600743|NCT00996918|3914144|P3|COMPLETED|Overall Study||0
1600744|NCT00996918|3914145|P2|COMPLETED|Overall Study||0
1600745|NCT00996918|3914146|P1|COMPLETED|Overall Study||0
1600746|NCT00996918|3914142|P5|Treated|Overall Study||4
1600747|NCT00996918|3914143|P4|Treated|Overall Study||56
1600748|NCT00996918|3914144|P3|Treated|Overall Study||37
1600749|NCT00996918|3914145|P2|Treated|Overall Study||66
1600750|NCT00996918|3914146|P1|Treated|Overall Study||39
1600751|NCT00996918|3914142|P5|STARTED|Overall Study||4
1600752|NCT00996918|3914143|P4|STARTED|Overall Study||56
1600753|NCT00996918|3914144|P3|STARTED|Overall Study||37
1600754|NCT00996918|3914145|P2|STARTED|Overall Study||66
1600755|NCT00996918|3914146|P1|STARTED|Overall Study||39
1600756|NCT00996892|3914190|P20|NOT COMPLETED|Expansion Stage 2A||45
1600757|NCT00996892|3914191|P19|NOT COMPLETED|Expansion Stage 2A||0
1600758|NCT00996892|3914192|P18|NOT COMPLETED|Expansion Stage 2A||0
1600759|NCT00996892|3914193|P17|NOT COMPLETED|Expansion Stage 2A||0
1600760|NCT00996892|3914194|P16|NOT COMPLETED|Expansion Stage 2A||0
1600761|NCT00996892|3914195|P15|NOT COMPLETED|Expansion Stage 2A||0
1600762|NCT00996892|3914196|P14|NOT COMPLETED|Expansion Stage 2A||0
1600763|NCT00996892|3914197|P13|NOT COMPLETED|Expansion Stage 2A||0
1600764|NCT00996892|3914198|P12|NOT COMPLETED|Expansion Stage 2A||0
1600765|NCT00996892|3914199|P11|NOT COMPLETED|Expansion Stage 2A||0
1600766|NCT00996892|3914200|P10|NOT COMPLETED|Expansion Stage 2A||0
1600767|NCT00996892|3914201|P9|NOT COMPLETED|Expansion Stage 2A||0
1600768|NCT00996892|3914202|P8|NOT COMPLETED|Expansion Stage 2A||0
1600769|NCT00996892|3914203|P7|NOT COMPLETED|Expansion Stage 2A||0
1600770|NCT00996892|3914204|P6|NOT COMPLETED|Expansion Stage 2A||0
1600771|NCT00996892|3914205|P5|NOT COMPLETED|Expansion Stage 2A||0
1600772|NCT00996892|3914206|P4|NOT COMPLETED|Expansion Stage 2A||0
1600773|NCT00996892|3914207|P3|NOT COMPLETED|Expansion Stage 2A||0
1600774|NCT00996892|3914208|P2|NOT COMPLETED|Expansion Stage 2A||0
1600775|NCT00996892|3914209|P1|NOT COMPLETED|Expansion Stage 2A||0
1600776|NCT00996892|3914190|P20|COMPLETED|Expansion Stage 2A||0
1600777|NCT00996892|3914191|P19|COMPLETED|Expansion Stage 2A||0
1600778|NCT00996892|3914192|P18|COMPLETED|Expansion Stage 2A||0
1600779|NCT00996892|3914193|P17|COMPLETED|Expansion Stage 2A||0
1600780|NCT00996892|3914194|P16|COMPLETED|Expansion Stage 2A||0
1600781|NCT00996892|3914195|P15|COMPLETED|Expansion Stage 2A||0
1600782|NCT00996892|3914196|P14|COMPLETED|Expansion Stage 2A||0
1600783|NCT00996892|3914197|P13|COMPLETED|Expansion Stage 2A||0
1600784|NCT00996892|3914198|P12|COMPLETED|Expansion Stage 2A||0
1600785|NCT00996892|3914199|P11|COMPLETED|Expansion Stage 2A||0
1600786|NCT00996892|3914200|P10|COMPLETED|Expansion Stage 2A||0
1600787|NCT00996892|3914201|P9|COMPLETED|Expansion Stage 2A||0
1600788|NCT00996892|3914202|P8|COMPLETED|Expansion Stage 2A||0
1600789|NCT00996892|3914203|P7|COMPLETED|Expansion Stage 2A||0
1600790|NCT00996892|3914204|P6|COMPLETED|Expansion Stage 2A||0
1600791|NCT00996892|3914205|P5|COMPLETED|Expansion Stage 2A||0
1600792|NCT00996892|3914206|P4|COMPLETED|Expansion Stage 2A||0
1600793|NCT00996892|3914207|P3|COMPLETED|Expansion Stage 2A||0
1600794|NCT00996892|3914208|P2|COMPLETED|Expansion Stage 2A||0
1600795|NCT00996892|3914209|P1|COMPLETED|Expansion Stage 2A||0
1600796|NCT00996892|3914190|P20|STARTED|Expansion Stage 2A||45
1600797|NCT00996892|3914191|P19|STARTED|Expansion Stage 2A||0
1600798|NCT00996892|3914192|P18|STARTED|Expansion Stage 2A||0
1600799|NCT00996892|3914193|P17|STARTED|Expansion Stage 2A||0
1600800|NCT00996892|3914194|P16|STARTED|Expansion Stage 2A||0
1600801|NCT00996892|3914195|P15|STARTED|Expansion Stage 2A||0
1600802|NCT00996892|3914196|P14|STARTED|Expansion Stage 2A||0
1600803|NCT00996892|3914197|P13|STARTED|Expansion Stage 2A||0
1600804|NCT00996892|3914198|P12|STARTED|Expansion Stage 2A||0
1600805|NCT00996892|3914199|P11|STARTED|Expansion Stage 2A||0
1600806|NCT00996892|3914200|P10|STARTED|Expansion Stage 2A||0
1600807|NCT00996892|3914201|P9|STARTED|Expansion Stage 2A||0
1600808|NCT00996892|3914202|P8|STARTED|Expansion Stage 2A||0
1600809|NCT00996892|3914203|P7|STARTED|Expansion Stage 2A||0
1600810|NCT00996892|3914204|P6|STARTED|Expansion Stage 2A||0
1600811|NCT00996892|3914205|P5|STARTED|Expansion Stage 2A||0
1600812|NCT00996892|3914206|P4|STARTED|Expansion Stage 2A||0
1600813|NCT00996892|3914207|P3|STARTED|Expansion Stage 2A||0
1600814|NCT00996892|3914208|P2|STARTED|Expansion Stage 2A||0
1600815|NCT00996892|3914209|P1|STARTED|Expansion Stage 2A||0
1600816|NCT00996892|3914190|P20|NOT COMPLETED|Expansion Stage 2||0
1600817|NCT00996892|3914191|P19|NOT COMPLETED|Expansion Stage 2||35
1600818|NCT00996892|3914192|P18|NOT COMPLETED|Expansion Stage 2||0
1600819|NCT00996892|3914193|P17|NOT COMPLETED|Expansion Stage 2||0
1600820|NCT00996892|3914194|P16|NOT COMPLETED|Expansion Stage 2||0
1600821|NCT00996892|3914195|P15|NOT COMPLETED|Expansion Stage 2||0
1600822|NCT00996892|3914196|P14|NOT COMPLETED|Expansion Stage 2||0
1600823|NCT00996892|3914197|P13|NOT COMPLETED|Expansion Stage 2||0
1600824|NCT00996892|3914198|P12|NOT COMPLETED|Expansion Stage 2||0
1600825|NCT00996892|3914199|P11|NOT COMPLETED|Expansion Stage 2||0
1600826|NCT00996892|3914200|P10|NOT COMPLETED|Expansion Stage 2||0
1600827|NCT00996892|3914201|P9|NOT COMPLETED|Expansion Stage 2||0
1600828|NCT00996892|3914202|P8|NOT COMPLETED|Expansion Stage 2||0
1600829|NCT00996892|3914203|P7|NOT COMPLETED|Expansion Stage 2||0
1600830|NCT00996892|3914204|P6|NOT COMPLETED|Expansion Stage 2||0
1600831|NCT00996892|3914205|P5|NOT COMPLETED|Expansion Stage 2||0
1600832|NCT00996892|3914206|P4|NOT COMPLETED|Expansion Stage 2||0
1600833|NCT00996892|3914207|P3|NOT COMPLETED|Expansion Stage 2||0
1600834|NCT00996892|3914208|P2|NOT COMPLETED|Expansion Stage 2||0
1600835|NCT00996892|3914209|P1|NOT COMPLETED|Expansion Stage 2||0
1600836|NCT00996892|3914190|P20|COMPLETED|Expansion Stage 2||0
1600837|NCT00996892|3914191|P19|COMPLETED|Expansion Stage 2||0
1600838|NCT00996892|3914192|P18|COMPLETED|Expansion Stage 2||0
1600839|NCT00996892|3914193|P17|COMPLETED|Expansion Stage 2||0
1600840|NCT00996892|3914194|P16|COMPLETED|Expansion Stage 2||0
1600841|NCT00996892|3914195|P15|COMPLETED|Expansion Stage 2||0
1600842|NCT00996892|3914196|P14|COMPLETED|Expansion Stage 2||0
1600843|NCT00996892|3914197|P13|COMPLETED|Expansion Stage 2||0
1600844|NCT00996892|3914198|P12|COMPLETED|Expansion Stage 2||0
1600845|NCT00996892|3914199|P11|COMPLETED|Expansion Stage 2||0
1600846|NCT00996892|3914200|P10|COMPLETED|Expansion Stage 2||0
1600847|NCT00996892|3914201|P9|COMPLETED|Expansion Stage 2||0
1600848|NCT00996892|3914202|P8|COMPLETED|Expansion Stage 2||0
1600849|NCT00996892|3914203|P7|COMPLETED|Expansion Stage 2||0
1600850|NCT00996892|3914204|P6|COMPLETED|Expansion Stage 2||0
1600851|NCT00996892|3914205|P5|COMPLETED|Expansion Stage 2||0
1600852|NCT00996892|3914206|P4|COMPLETED|Expansion Stage 2||0
1600853|NCT00996892|3914207|P3|COMPLETED|Expansion Stage 2||0
1600854|NCT00996892|3914208|P2|COMPLETED|Expansion Stage 2||0
1600855|NCT00996892|3914209|P1|COMPLETED|Expansion Stage 2||0
1600856|NCT00996892|3914190|P20|STARTED|Expansion Stage 2||0
1600857|NCT00996892|3914191|P19|STARTED|Expansion Stage 2||35
1600858|NCT00996892|3914192|P18|STARTED|Expansion Stage 2||0
1600859|NCT00996892|3914193|P17|STARTED|Expansion Stage 2||0
1600860|NCT00996892|3914194|P16|STARTED|Expansion Stage 2||0
1600861|NCT00996892|3914195|P15|STARTED|Expansion Stage 2||0
1600862|NCT00996892|3914196|P14|STARTED|Expansion Stage 2||0
1600863|NCT00996892|3914197|P13|STARTED|Expansion Stage 2||0
1600864|NCT00996892|3914198|P12|STARTED|Expansion Stage 2||0
1600865|NCT00996892|3914199|P11|STARTED|Expansion Stage 2||0
1600866|NCT00996892|3914200|P10|STARTED|Expansion Stage 2||0
1600867|NCT00996892|3914201|P9|STARTED|Expansion Stage 2||0
1600868|NCT00996892|3914202|P8|STARTED|Expansion Stage 2||0
1600869|NCT00996892|3914203|P7|STARTED|Expansion Stage 2||0
1600870|NCT00996892|3914204|P6|STARTED|Expansion Stage 2||0
1600871|NCT00996892|3914205|P5|STARTED|Expansion Stage 2||0
1600872|NCT00996892|3914206|P4|STARTED|Expansion Stage 2||0
1600873|NCT00996892|3914207|P3|STARTED|Expansion Stage 2||0
1600874|NCT00996892|3914208|P2|STARTED|Expansion Stage 2||0
1600875|NCT00996892|3914209|P1|STARTED|Expansion Stage 2||0
1600876|NCT00996892|3914190|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600877|NCT00996892|3914191|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600878|NCT00996892|3914192|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
1600879|NCT00996892|3914193|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
1600880|NCT00996892|3914194|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
1600881|NCT00996892|3914195|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
1600882|NCT00996892|3914196|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600883|NCT00996892|3914197|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600884|NCT00996892|3914198|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600885|NCT00996892|3914199|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600886|NCT00996892|3914200|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600887|NCT00996892|3914201|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600888|NCT00996892|3914202|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600889|NCT00996892|3914203|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600890|NCT00996892|3914204|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600891|NCT00996892|3914205|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600892|NCT00996892|3914206|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600893|NCT00996892|3914207|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600894|NCT00996892|3914208|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600895|NCT00996892|3914209|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
1600896|NCT00996892|3914190|P20|COMPLETED|Dose-Escalation Stage 1B||0
1600897|NCT00996892|3914191|P19|COMPLETED|Dose-Escalation Stage 1B||0
1600898|NCT00996892|3914192|P18|COMPLETED|Dose-Escalation Stage 1B||0
1600899|NCT00996892|3914193|P17|COMPLETED|Dose-Escalation Stage 1B||0
1600900|NCT00996892|3914194|P16|COMPLETED|Dose-Escalation Stage 1B||0
1600901|NCT00996892|3914195|P15|COMPLETED|Dose-Escalation Stage 1B||0
1600902|NCT00996892|3914196|P14|COMPLETED|Dose-Escalation Stage 1B||0
1600903|NCT00996892|3914197|P13|COMPLETED|Dose-Escalation Stage 1B||0
1600904|NCT00996892|3914198|P12|COMPLETED|Dose-Escalation Stage 1B||0
1600905|NCT00996892|3914199|P11|COMPLETED|Dose-Escalation Stage 1B||0
1600906|NCT00996892|3914200|P10|COMPLETED|Dose-Escalation Stage 1B||0
1600907|NCT00996892|3914201|P9|COMPLETED|Dose-Escalation Stage 1B||0
1600908|NCT00996892|3914202|P8|COMPLETED|Dose-Escalation Stage 1B||0
1600909|NCT00996892|3914203|P7|COMPLETED|Dose-Escalation Stage 1B||0
1600910|NCT00996892|3914204|P6|COMPLETED|Dose-Escalation Stage 1B||0
1600911|NCT00996892|3914205|P5|COMPLETED|Dose-Escalation Stage 1B||0
1600912|NCT00996892|3914206|P4|COMPLETED|Dose-Escalation Stage 1B||0
1600913|NCT00996892|3914207|P3|COMPLETED|Dose-Escalation Stage 1B||0
1600914|NCT00996892|3914208|P2|COMPLETED|Dose-Escalation Stage 1B||0
1600915|NCT00996892|3914209|P1|COMPLETED|Dose-Escalation Stage 1B||0
1600916|NCT00996892|3914190|P20|STARTED|Dose-Escalation Stage 1B||0
1600917|NCT00996892|3914191|P19|STARTED|Dose-Escalation Stage 1B||0
1600918|NCT00996892|3914192|P18|STARTED|Dose-Escalation Stage 1B||5
1600919|NCT00996892|3914193|P17|STARTED|Dose-Escalation Stage 1B||3
1600920|NCT00996892|3914194|P16|STARTED|Dose-Escalation Stage 1B||3
1600921|NCT00996892|3914195|P15|STARTED|Dose-Escalation Stage 1B||4
1600922|NCT00996892|3914196|P14|STARTED|Dose-Escalation Stage 1B||0
1600923|NCT00996892|3914197|P13|STARTED|Dose-Escalation Stage 1B||0
1600924|NCT00996892|3914198|P12|STARTED|Dose-Escalation Stage 1B||0
1600925|NCT00996892|3914199|P11|STARTED|Dose-Escalation Stage 1B||0
1600926|NCT00996892|3914200|P10|STARTED|Dose-Escalation Stage 1B||0
1600927|NCT00996892|3914201|P9|STARTED|Dose-Escalation Stage 1B||0
1600928|NCT00996892|3914202|P8|STARTED|Dose-Escalation Stage 1B||0
1600929|NCT00996892|3914203|P7|STARTED|Dose-Escalation Stage 1B||0
1600930|NCT00996892|3914204|P6|STARTED|Dose-Escalation Stage 1B||0
1600931|NCT00996892|3914205|P5|STARTED|Dose-Escalation Stage 1B||0
1600932|NCT00996892|3914206|P4|STARTED|Dose-Escalation Stage 1B||0
1600933|NCT00996892|3914207|P3|STARTED|Dose-Escalation Stage 1B||0
1600934|NCT00996892|3914208|P2|STARTED|Dose-Escalation Stage 1B||0
1600935|NCT00996892|3914209|P1|STARTED|Dose-Escalation Stage 1B||0
1600936|NCT00996892|3914190|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600937|NCT00996892|3914191|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600938|NCT00996892|3914192|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600939|NCT00996892|3914193|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600940|NCT00996892|3914194|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600941|NCT00996892|3914195|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600942|NCT00996892|3914196|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
1600943|NCT00996892|3914197|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
1600944|NCT00996892|3914198|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
1600945|NCT00996892|3914199|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
1600946|NCT00996892|3914200|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
1600947|NCT00996892|3914201|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
1600948|NCT00996892|3914202|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
1600949|NCT00996892|3914203|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600950|NCT00996892|3914204|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600951|NCT00996892|3914205|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600952|NCT00996892|3914206|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600953|NCT00996892|3914207|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600954|NCT00996892|3914208|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600955|NCT00996892|3914209|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
1600956|NCT00996892|3914190|P20|COMPLETED|Dose-Escalation Stage 1A||0
1600957|NCT00996892|3914191|P19|COMPLETED|Dose-Escalation Stage 1A||0
1600958|NCT00996892|3914192|P18|COMPLETED|Dose-Escalation Stage 1A||0
1600959|NCT00996892|3914193|P17|COMPLETED|Dose-Escalation Stage 1A||0
1600960|NCT00996892|3914194|P16|COMPLETED|Dose-Escalation Stage 1A||0
1600961|NCT00996892|3914195|P15|COMPLETED|Dose-Escalation Stage 1A||0
1600962|NCT00996892|3914196|P14|COMPLETED|Dose-Escalation Stage 1A||0
1600963|NCT00996892|3914197|P13|COMPLETED|Dose-Escalation Stage 1A||0
1600964|NCT00996892|3914198|P12|COMPLETED|Dose-Escalation Stage 1A||0
1600965|NCT00996892|3914199|P11|COMPLETED|Dose-Escalation Stage 1A||0
1600966|NCT00996892|3914200|P10|COMPLETED|Dose-Escalation Stage 1A||0
1600967|NCT00996892|3914201|P9|COMPLETED|Dose-Escalation Stage 1A||0
1600968|NCT00996892|3914202|P8|COMPLETED|Dose-Escalation Stage 1A||0
1600969|NCT00996892|3914203|P7|COMPLETED|Dose-Escalation Stage 1A||0
1600970|NCT00996892|3914204|P6|COMPLETED|Dose-Escalation Stage 1A||0
1600971|NCT00996892|3914205|P5|COMPLETED|Dose-Escalation Stage 1A||0
1600972|NCT00996892|3914206|P4|COMPLETED|Dose-Escalation Stage 1A||0
1600973|NCT00996892|3914207|P3|COMPLETED|Dose-Escalation Stage 1A||0
1600974|NCT00996892|3914208|P2|COMPLETED|Dose-Escalation Stage 1A||0
1600975|NCT00996892|3914209|P1|COMPLETED|Dose-Escalation Stage 1A||0
1600976|NCT00996892|3914190|P20|STARTED|Dose-Escalation Stage 1A||0
1600977|NCT00996892|3914191|P19|STARTED|Dose-Escalation Stage 1A||0
1600978|NCT00996892|3914192|P18|STARTED|Dose-Escalation Stage 1A||0
1600979|NCT00996892|3914193|P17|STARTED|Dose-Escalation Stage 1A||0
1600980|NCT00996892|3914194|P16|STARTED|Dose-Escalation Stage 1A||0
1600981|NCT00996892|3914195|P15|STARTED|Dose-Escalation Stage 1A||0
1600982|NCT00996892|3914196|P14|STARTED|Dose-Escalation Stage 1A||5
1600983|NCT00996892|3914197|P13|STARTED|Dose-Escalation Stage 1A||8
1600984|NCT00996892|3914198|P12|STARTED|Dose-Escalation Stage 1A||9
1600985|NCT00996892|3914199|P11|STARTED|Dose-Escalation Stage 1A||7
1600986|NCT00996892|3914200|P10|STARTED|Dose-Escalation Stage 1A||4
1600987|NCT00996892|3914201|P9|STARTED|Dose-Escalation Stage 1A||3
1600988|NCT00996892|3914202|P8|STARTED|Dose-Escalation Stage 1A||3
1600989|NCT00996892|3914203|P7|STARTED|Dose-Escalation Stage 1A||0
1600990|NCT00996892|3914204|P6|STARTED|Dose-Escalation Stage 1A||0
1600991|NCT00996892|3914205|P5|STARTED|Dose-Escalation Stage 1A||0
1600992|NCT00996892|3914206|P4|STARTED|Dose-Escalation Stage 1A||0
1600993|NCT00996892|3914207|P3|STARTED|Dose-Escalation Stage 1A||0
1600994|NCT00996892|3914208|P2|STARTED|Dose-Escalation Stage 1A||0
1600995|NCT00996892|3914209|P1|STARTED|Dose-Escalation Stage 1A||0
1600996|NCT00996892|3914190|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
1600997|NCT00996892|3914191|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
1600998|NCT00996892|3914192|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
1600999|NCT00996892|3914193|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
1601000|NCT00996892|3914194|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
1601001|NCT00996892|3914195|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
1601002|NCT00996892|3914196|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
1601003|NCT00996892|3914197|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
1601004|NCT00996892|3914198|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
1601005|NCT00996892|3914199|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
1601006|NCT00996892|3914200|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
1601007|NCT00996892|3914201|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
1601008|NCT00996892|3914202|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
1601009|NCT00996892|3914203|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
1601010|NCT00996892|3914204|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
1601011|NCT00996892|3914205|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
1601012|NCT00996892|3914206|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
1601013|NCT00996892|3914207|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
1601014|NCT00996892|3914208|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
1601015|NCT00996892|3914209|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
1601016|NCT00996892|3914190|P20|COMPLETED|Dose-Escalation Stage 1||0
1601017|NCT00996892|3914191|P19|COMPLETED|Dose-Escalation Stage 1||0
1601018|NCT00996892|3914192|P18|COMPLETED|Dose-Escalation Stage 1||0
1601019|NCT00996892|3914193|P17|COMPLETED|Dose-Escalation Stage 1||0
1601020|NCT00996892|3914194|P16|COMPLETED|Dose-Escalation Stage 1||0
1601021|NCT00996892|3914195|P15|COMPLETED|Dose-Escalation Stage 1||0
1601022|NCT00996892|3914196|P14|COMPLETED|Dose-Escalation Stage 1||0
1601023|NCT00996892|3914197|P13|COMPLETED|Dose-Escalation Stage 1||0
1601024|NCT00996892|3914198|P12|COMPLETED|Dose-Escalation Stage 1||0
1601025|NCT00996892|3914199|P11|COMPLETED|Dose-Escalation Stage 1||0
1601026|NCT00996892|3914200|P10|COMPLETED|Dose-Escalation Stage 1||0
1601027|NCT00996892|3914201|P9|COMPLETED|Dose-Escalation Stage 1||0
1601028|NCT00996892|3914202|P8|COMPLETED|Dose-Escalation Stage 1||0
1601029|NCT00996892|3914203|P7|COMPLETED|Dose-Escalation Stage 1||0
1601030|NCT00996892|3914204|P6|COMPLETED|Dose-Escalation Stage 1||0
1601031|NCT00996892|3914205|P5|COMPLETED|Dose-Escalation Stage 1||0
1601032|NCT00996892|3914206|P4|COMPLETED|Dose-Escalation Stage 1||0
1601033|NCT00996892|3914207|P3|COMPLETED|Dose-Escalation Stage 1||0
1601034|NCT00996892|3914208|P2|COMPLETED|Dose-Escalation Stage 1||0
1601035|NCT00996892|3914209|P1|COMPLETED|Dose-Escalation Stage 1||0
1601036|NCT00996892|3914190|P20|STARTED|Dose-Escalation Stage 1||0
1601037|NCT00996892|3914191|P19|STARTED|Dose-Escalation Stage 1||0
1601038|NCT00996892|3914192|P18|STARTED|Dose-Escalation Stage 1||0
1601039|NCT00996892|3914193|P17|STARTED|Dose-Escalation Stage 1||0
1601040|NCT00996892|3914194|P16|STARTED|Dose-Escalation Stage 1||0
1601041|NCT00996892|3914195|P15|STARTED|Dose-Escalation Stage 1||0
1601042|NCT00996892|3914196|P14|STARTED|Dose-Escalation Stage 1||0
1601043|NCT00996892|3914197|P13|STARTED|Dose-Escalation Stage 1||0
1601044|NCT00996892|3914198|P12|STARTED|Dose-Escalation Stage 1||0
1601045|NCT00996892|3914199|P11|STARTED|Dose-Escalation Stage 1||0
1601046|NCT00996892|3914200|P10|STARTED|Dose-Escalation Stage 1||0
1601047|NCT00996892|3914201|P9|STARTED|Dose-Escalation Stage 1||0
1601048|NCT00996892|3914202|P8|STARTED|Dose-Escalation Stage 1||0
1601049|NCT00996892|3914203|P7|STARTED|Dose-Escalation Stage 1||4
1601050|NCT00996892|3914204|P6|STARTED|Dose-Escalation Stage 1||10
1601051|NCT00996892|3914205|P5|STARTED|Dose-Escalation Stage 1||11
1601052|NCT00996892|3914206|P4|STARTED|Dose-Escalation Stage 1||9
1601053|NCT00996892|3914207|P3|STARTED|Dose-Escalation Stage 1||3
1601054|NCT00996892|3914208|P2|STARTED|Dose-Escalation Stage 1||3
1601055|NCT00996892|3914209|P1|STARTED|Dose-Escalation Stage 1||4
1601056|NCT00996840|3914803|P5|NOT COMPLETED|Overall Study||2
1601057|NCT00996840|3914804|P4|NOT COMPLETED|Overall Study||1
1601058|NCT00996840|3914805|P3|NOT COMPLETED|Overall Study||1
1601059|NCT00996840|3914806|P2|NOT COMPLETED|Overall Study||2
1601060|NCT00996840|3914807|P1|NOT COMPLETED|Overall Study||1
1601061|NCT00996840|3914803|P5|COMPLETED|Overall Study||16
1601062|NCT00996840|3914804|P4|COMPLETED|Overall Study||17
1601063|NCT00996840|3914805|P3|COMPLETED|Overall Study||11
1601064|NCT00996840|3914806|P2|COMPLETED|Overall Study||7
1601065|NCT00996840|3914807|P1|COMPLETED|Overall Study||19
1601066|NCT00996840|3914803|P5|STARTED|Overall Study||18
1601067|NCT00996840|3914804|P4|STARTED|Overall Study||18
1601068|NCT00996840|3914805|P3|STARTED|Overall Study||12
1601069|NCT00996840|3914806|P2|STARTED|Overall Study||9
1601070|NCT00996840|3914807|P1|STARTED|Overall Study||20
1601071|NCT00996801|3914957|P6|NOT COMPLETED|Overall Study||19
1601072|NCT00996801|3914958|P5|NOT COMPLETED|Overall Study||88
1601073|NCT00996801|3914959|P4|NOT COMPLETED|Overall Study||31
1601074|NCT00996801|3914960|P3|NOT COMPLETED|Overall Study||23
1601075|NCT00996801|3914961|P2|NOT COMPLETED|Overall Study||16
1601076|NCT00996801|3914962|P1|NOT COMPLETED|Overall Study||20
1601077|NCT00996801|3914957|P6|COMPLETED|Overall Study||68
1601078|NCT00996801|3914958|P5|COMPLETED|Overall Study||0
1601079|NCT00996801|3914959|P4|COMPLETED|Overall Study||56
1601080|NCT00996801|3914960|P3|COMPLETED|Overall Study||65
1601081|NCT00996801|3914961|P2|COMPLETED|Overall Study||72
1601082|NCT00996801|3914962|P1|COMPLETED|Overall Study||68
1601083|NCT00996801|3914957|P6|STARTED|Overall Study||87
1601084|NCT00996801|3914958|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
1601085|NCT00996801|3914959|P4|STARTED|Overall Study||87
1601086|NCT00996801|3914960|P3|STARTED|Overall Study||88
1601087|NCT00996801|3914961|P2|STARTED|Overall Study||88
1601088|NCT00996801|3914962|P1|STARTED|Overall Study||88
1601089|NCT00996775|3915065|P2|NOT COMPLETED|Overall Study||14
1601090|NCT00996775|3915066|P1|NOT COMPLETED|Overall Study||11
1601091|NCT00996775|3915065|P2|COMPLETED|Overall Study||75
1601092|NCT00996775|3915066|P1|COMPLETED|Overall Study||67
1601093|NCT00996775|3915065|P2|STARTED|Overall Study||89
1601094|NCT00996775|3915066|P1|STARTED|Overall Study||78
1601095|NCT00996736|3915074|P2|NOT COMPLETED|Overall Study||18
1601096|NCT00996736|3915075|P1|NOT COMPLETED|Overall Study||21
1601097|NCT00996736|3915074|P2|COMPLETED|Overall Study||143
1601098|NCT00996736|3915075|P1|COMPLETED|Overall Study||141
1601099|NCT00996736|3915074|P2|3-month Visit|Overall Study||146
1601100|NCT00996736|3915075|P1|3-month Visit|Overall Study||146
1601101|NCT00996736|3915074|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
1601102|NCT00996736|3915075|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
1601103|NCT00996736|3915074|P2|STARTED|Overall Study||161
1601104|NCT00996736|3915075|P1|STARTED|Overall Study||162
1601105|NCT00996658|3915095|P2|NOT COMPLETED|Overall Study||21
1601106|NCT00996658|3915096|P1|NOT COMPLETED|Overall Study||16
1601107|NCT00996658|3915095|P2|COMPLETED|Overall Study||165
1601108|NCT00996658|3915096|P1|COMPLETED|Overall Study||76
1601109|NCT00996658|3915095|P2|STARTED|Overall Study||186
1601110|NCT00996658|3915096|P1|STARTED|Overall Study||92
1601111|NCT00996632|3915124|P2|NOT COMPLETED|Overall Study||0
1601112|NCT00996632|3915125|P1|NOT COMPLETED|Overall Study||0
1601113|NCT00996632|3915124|P2|COMPLETED|Overall Study||56
1601114|NCT00996632|3915125|P1|COMPLETED|Overall Study||38
1601115|NCT00996632|3915124|P2|STARTED|Overall Study||56
1601116|NCT00996632|3915125|P1|STARTED|Overall Study||38
1601117|NCT00996606|3915133|P1|NOT COMPLETED|Overall Study||8
1601118|NCT00996606|3915133|P1|COMPLETED|Overall Study||50
1601119|NCT00996606|3915133|P1|STARTED|Overall Study||58
1601120|NCT00996593|3915227|P1|NOT COMPLETED|Long-Term Follow-Up||3
1601121|NCT00996593|3915227|P1|COMPLETED|Long-Term Follow-Up||6
1601122|NCT00996593|3915227|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
1601123|NCT00996593|3915227|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
1601124|NCT00996593|3915227|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
1601125|NCT00996593|3915227|P1|STARTED|Dosimetric and Therapeutic Treatment||43
1601126|NCT00996580|3915255|P1|NOT COMPLETED|Overall Study||1453
1601127|NCT00996580|3915255|P1|COMPLETED|Overall Study||2144
1601128|NCT00996580|3915255|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
1601129|NCT00996580|3915255|P1|STARTED|Overall Study||3597
1601130|NCT00996502|3915283|P1|NOT COMPLETED|Overall Study||0
1601131|NCT00996502|3915283|P1|COMPLETED|Overall Study||4
1601132|NCT00996502|3915283|P1|STARTED|Overall Study||4
1601133|NCT00996476|3915292|P5|NOT COMPLETED|Overall Study||2
1601134|NCT00996476|3915293|P4|NOT COMPLETED|Overall Study||0
1601135|NCT00996476|3915294|P3|NOT COMPLETED|Overall Study||1
1601136|NCT00996476|3915295|P2|NOT COMPLETED|Overall Study||3
1601137|NCT00996476|3915296|P1|NOT COMPLETED|Overall Study||1
1601138|NCT00996476|3915292|P5|COMPLETED|Overall Study||11
1601139|NCT00996476|3915293|P4|COMPLETED|Overall Study||13
1601140|NCT00996476|3915294|P3|COMPLETED|Overall Study||12
1601141|NCT00996476|3915295|P2|COMPLETED|Overall Study||23
1601142|NCT00996476|3915296|P1|COMPLETED|Overall Study||26
1601143|NCT00996476|3915292|P5|STARTED|Overall Study||13
1601144|NCT00996476|3915293|P4|STARTED|Overall Study||13
1601145|NCT00996476|3915294|P3|STARTED|Overall Study||13
1601146|NCT00996476|3915295|P2|STARTED|Overall Study||26
1601147|NCT00996476|3915296|P1|STARTED|Overall Study||27
1601148|NCT00996437|3915364|P2|NOT COMPLETED|Overall Study||7
1601149|NCT00996437|3915365|P1|NOT COMPLETED|Overall Study||5
1601150|NCT00996437|3915364|P2|COMPLETED|Overall Study||129
1601151|NCT00996437|3915365|P1|COMPLETED|Overall Study||120
1601152|NCT00996437|3915364|P2|STARTED|Overall Study||136
1601153|NCT00996437|3915365|P1|STARTED|Overall Study||125
1601154|NCT00996372|3915387|P2|NOT COMPLETED|Overall Study||84
1601155|NCT00996372|3915388|P1|NOT COMPLETED|Overall Study||103
1601156|NCT00996372|3915387|P2|COMPLETED|Overall Study||397
1601157|NCT00996372|3915388|P1|COMPLETED|Overall Study||365
1601158|NCT00996372|3915387|P2|STARTED|Overall Study||481
1601159|NCT00996372|3915388|P1|STARTED|Overall Study||468
1601160|NCT00996346|3915401|P3|NOT COMPLETED|Overall Study||0
1601161|NCT00996346|3915402|P2|NOT COMPLETED|Overall Study||0
1601162|NCT00996346|3915403|P1|NOT COMPLETED|Overall Study||0
1601163|NCT00996346|3915401|P3|COMPLETED|Overall Study||3
1601164|NCT00996346|3915402|P2|COMPLETED|Overall Study||8
1601165|NCT00996346|3915403|P1|COMPLETED|Overall Study||6
1601166|NCT00996346|3915401|P3|STARTED|Overall Study||3
1601167|NCT00996346|3915402|P2|STARTED|Overall Study||8
1601168|NCT00996346|3915403|P1|STARTED|Overall Study||6
1601169|NCT00996333|3915410|P1|NOT COMPLETED|Overall Study||13
1601170|NCT00996333|3915410|P1|COMPLETED|Overall Study||33
1601171|NCT00996333|3915410|P1|STARTED|Overall Study||46
1601172|NCT00996307|3915420|P4|NOT COMPLETED|Overall Study||21
1601173|NCT00996307|3915421|P3|NOT COMPLETED|Overall Study||14
1601174|NCT00996307|3915422|P2|NOT COMPLETED|Overall Study||17
1601175|NCT00996307|3915423|P1|NOT COMPLETED|Overall Study||20
1601176|NCT00996307|3915420|P4|COMPLETED|Overall Study||144
1601177|NCT00996307|3915421|P3|COMPLETED|Overall Study||146
1601178|NCT00996307|3915422|P2|COMPLETED|Overall Study||148
1601179|NCT00996307|3915423|P1|COMPLETED|Overall Study||144
1601180|NCT00996307|3915420|P4|STARTED|Overall Study||165
1601181|NCT00996307|3915421|P3|STARTED|Overall Study||160
1601182|NCT00996307|3915422|P2|STARTED|Overall Study||165
1601183|NCT00996307|3915423|P1|STARTED|Overall Study||164
1601184|NCT00996281|3915483|P2|NOT COMPLETED|Overall Study||89
1601185|NCT00996281|3915484|P1|NOT COMPLETED|Overall Study||131
1601186|NCT00996281|3915483|P2|COMPLETED|Overall Study||330
1601187|NCT00996281|3915484|P1|COMPLETED|Overall Study||287
1601188|NCT00996281|3915483|P2|STARTED|Overall Study||419
1601189|NCT00996281|3915484|P1|STARTED|Overall Study||418
1601190|NCT00996216|3915492|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
1601191|NCT00996216|3915492|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
1601192|NCT00996216|3915492|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
1601193|NCT00996216|3915492|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
1601194|NCT00996216|3915492|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
1601195|NCT00996216|3915492|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
1601196|NCT00996203|3915508|P1|NOT COMPLETED|Overall Study||7
1601197|NCT00996203|3915508|P1|COMPLETED|Overall Study||194
1601198|NCT00996203|3915508|P1|STARTED|Overall Study||201
1601199|NCT00996164|3915529|P2|NOT COMPLETED|Overall Study||101
1601200|NCT00996164|3915530|P1|NOT COMPLETED|Overall Study||135
1601201|NCT00996164|3915529|P2|COMPLETED|Overall Study||446
1601202|NCT00996164|3915530|P1|COMPLETED|Overall Study||408
1601203|NCT00996164|3915529|P2|STARTED|Overall Study||547
1601204|NCT00996164|3915530|P1|STARTED|Overall Study||543
1601205|NCT00996125|3915540|P2|NOT COMPLETED|Overall Study||11
1601206|NCT00996125|3915541|P1|NOT COMPLETED|Overall Study||5
1601207|NCT00996125|3915540|P2|COMPLETED|Overall Study||365
1601208|NCT00996125|3915541|P1|COMPLETED|Overall Study||369
1601209|NCT00996125|3915540|P2|STARTED|Overall Study||376
1601210|NCT00996125|3915541|P1|STARTED|Overall Study||374
1601211|NCT00996034|3915561|P1|NOT COMPLETED|Overall Study||3
1601212|NCT00996034|3915561|P1|COMPLETED|Overall Study||11
1601213|NCT00996034|3915561|P1|STARTED|Overall Study||14
1601214|NCT00995930|3915567|P2|NOT COMPLETED|Overall Study||28
1601215|NCT00995930|3915568|P1|NOT COMPLETED|Overall Study||21
1601216|NCT00995930|3915567|P2|COMPLETED|Overall Study||67
1601217|NCT00995930|3915568|P1|COMPLETED|Overall Study||73
1601218|NCT00995930|3915567|P2|Imaging Analysis Set|Overall Study||92
1601219|NCT00995930|3915568|P1|Imaging Analysis Set|Overall Study||92
1601220|NCT00995930|3915567|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
1601221|NCT00995930|3915568|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
1601222|NCT00995930|3915567|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
1601223|NCT00995930|3915568|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1601224|NCT00995930|3915567|P2|Safety Analysis Set|Overall Study||95
1601225|NCT00995930|3915568|P1|Safety Analysis Set|Overall Study||94
1601226|NCT00995930|3915567|P2|STARTED|Overall Study||95
1601227|NCT00995930|3915568|P1|STARTED|Overall Study||94
1601228|NCT00995904|3915597|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1601229|NCT00995904|3915598|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1601230|NCT00995904|3915599|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1601231|NCT00995904|3915600|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1601232|NCT00995904|3915601|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1601233|NCT00995904|3915602|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1601234|NCT00995904|3915597|P6|COMPLETED|Follow-up Visit (Final Visit)||3
1601235|NCT00995904|3915598|P5|COMPLETED|Follow-up Visit (Final Visit)||5
1601236|NCT00995904|3915599|P4|COMPLETED|Follow-up Visit (Final Visit)||5
1601237|NCT00995904|3915600|P3|COMPLETED|Follow-up Visit (Final Visit)||4
1601238|NCT00995904|3915601|P2|COMPLETED|Follow-up Visit (Final Visit)||3
1601239|NCT00995904|3915602|P1|COMPLETED|Follow-up Visit (Final Visit)||4
1601240|NCT00995904|3915597|P6|STARTED|Follow-up Visit (Final Visit)||3
1601241|NCT00995904|3915598|P5|STARTED|Follow-up Visit (Final Visit)||5
1601242|NCT00995904|3915599|P4|STARTED|Follow-up Visit (Final Visit)||5
1601243|NCT00995904|3915600|P3|STARTED|Follow-up Visit (Final Visit)||4
1601244|NCT00995904|3915601|P2|STARTED|Follow-up Visit (Final Visit)||3
1601245|NCT00995904|3915602|P1|STARTED|Follow-up Visit (Final Visit)||4
1601246|NCT00995904|3915597|P6|NOT COMPLETED|Visit 4||0
1601247|NCT00995904|3915598|P5|NOT COMPLETED|Visit 4||0
1601248|NCT00995904|3915599|P4|NOT COMPLETED|Visit 4||0
1601249|NCT00995904|3915600|P3|NOT COMPLETED|Visit 4||0
1601250|NCT00995904|3915601|P2|NOT COMPLETED|Visit 4||0
1601251|NCT00995904|3915602|P1|NOT COMPLETED|Visit 4||0
1601252|NCT00995904|3915597|P6|COMPLETED|Visit 4||3
1601253|NCT00995904|3915598|P5|COMPLETED|Visit 4||5
1601254|NCT00995904|3915599|P4|COMPLETED|Visit 4||5
1601255|NCT00995904|3915600|P3|COMPLETED|Visit 4||4
1601256|NCT00995904|3915601|P2|COMPLETED|Visit 4||3
1601257|NCT00995904|3915602|P1|COMPLETED|Visit 4||4
1601258|NCT00995904|3915597|P6|STARTED|Visit 4||3
1601259|NCT00995904|3915598|P5|STARTED|Visit 4||5
1601260|NCT00995904|3915599|P4|STARTED|Visit 4||5
1601261|NCT00995904|3915600|P3|STARTED|Visit 4||4
1601262|NCT00995904|3915601|P2|STARTED|Visit 4||3
1601263|NCT00995904|3915602|P1|STARTED|Visit 4||4
1601264|NCT00995904|3915597|P6|NOT COMPLETED|Visit 3||0
1601265|NCT00995904|3915598|P5|NOT COMPLETED|Visit 3||0
1601266|NCT00995904|3915599|P4|NOT COMPLETED|Visit 3||0
1601267|NCT00995904|3915600|P3|NOT COMPLETED|Visit 3||0
1601268|NCT00995904|3915601|P2|NOT COMPLETED|Visit 3||0
1601269|NCT00995904|3915602|P1|NOT COMPLETED|Visit 3||0
1601270|NCT00995904|3915597|P6|COMPLETED|Visit 3||3
1601271|NCT00995904|3915598|P5|COMPLETED|Visit 3||5
1601272|NCT00995904|3915599|P4|COMPLETED|Visit 3||5
1601273|NCT00995904|3915600|P3|COMPLETED|Visit 3||4
1601274|NCT00995904|3915601|P2|COMPLETED|Visit 3||3
1601275|NCT00995904|3915602|P1|COMPLETED|Visit 3||4
1601276|NCT00995904|3915597|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
1601277|NCT00995904|3915598|P5|STARTED|Visit 3||5
1601278|NCT00995904|3915599|P4|STARTED|Visit 3||5
1601279|NCT00995904|3915600|P3|STARTED|Visit 3||4
1601280|NCT00995904|3915601|P2|STARTED|Visit 3||3
1601281|NCT00995904|3915602|P1|STARTED|Visit 3||4
1601282|NCT00995904|3915597|P6|NOT COMPLETED|Visit 2 (Randomization)||0
1601283|NCT00995904|3915598|P5|NOT COMPLETED|Visit 2 (Randomization)||0
1601284|NCT00995904|3915599|P4|NOT COMPLETED|Visit 2 (Randomization)||0
1601285|NCT00995904|3915600|P3|NOT COMPLETED|Visit 2 (Randomization)||0
1601286|NCT00995904|3915601|P2|NOT COMPLETED|Visit 2 (Randomization)||0
1601287|NCT00995904|3915602|P1|NOT COMPLETED|Visit 2 (Randomization)||0
1601288|NCT00995904|3915597|P6|COMPLETED|Visit 2 (Randomization)||4
1601289|NCT00995904|3915598|P5|COMPLETED|Visit 2 (Randomization)||5
1601290|NCT00995904|3915599|P4|COMPLETED|Visit 2 (Randomization)||5
1601291|NCT00995904|3915600|P3|COMPLETED|Visit 2 (Randomization)||4
1601292|NCT00995904|3915601|P2|COMPLETED|Visit 2 (Randomization)||3
1601293|NCT00995904|3915602|P1|COMPLETED|Visit 2 (Randomization)||4
1601294|NCT00995904|3915597|P6|STARTED|Visit 2 (Randomization)||4
1601295|NCT00995904|3915598|P5|STARTED|Visit 2 (Randomization)||5
1601296|NCT00995904|3915599|P4|STARTED|Visit 2 (Randomization)||5
1601297|NCT00995904|3915600|P3|STARTED|Visit 2 (Randomization)||4
1601298|NCT00995904|3915601|P2|STARTED|Visit 2 (Randomization)||3
1601299|NCT00995904|3915602|P1|STARTED|Visit 2 (Randomization)||4
1601300|NCT00995865|3915619|P3|NOT COMPLETED|Overall Study||1
1601301|NCT00995865|3915620|P2|NOT COMPLETED|Overall Study||0
1601302|NCT00995865|3915621|P1|NOT COMPLETED|Overall Study||2
1601303|NCT00995865|3915619|P3|COMPLETED|Overall Study||11
1601304|NCT00995865|3915620|P2|COMPLETED|Overall Study||24
1601305|NCT00995865|3915621|P1|COMPLETED|Overall Study||22
1601306|NCT00995865|3915619|P3|STARTED|Overall Study||12
1601307|NCT00995865|3915620|P2|STARTED|Overall Study||24
1601308|NCT00995865|3915621|P1|STARTED|Overall Study||24
1601309|NCT00995774|3915643|P2|NOT COMPLETED|Training Period 2||0
1601310|NCT00995774|3915644|P1|NOT COMPLETED|Training Period 2||2
1601311|NCT00995774|3915643|P2|COMPLETED|Training Period 2||5
1601312|NCT00995774|3915644|P1|COMPLETED|Training Period 2||5
1601313|NCT00995774|3915643|P2|STARTED|Training Period 2||5
1601314|NCT00995774|3915644|P1|STARTED|Training Period 2||7
1601315|NCT00995774|3915643|P2|NOT COMPLETED|Washout Period||0
1601316|NCT00995774|3915644|P1|NOT COMPLETED|Washout Period||0
1601317|NCT00995774|3915643|P2|COMPLETED|Washout Period||5
1601318|NCT00995774|3915644|P1|COMPLETED|Washout Period||7
1601319|NCT00995774|3915643|P2|STARTED|Washout Period||5
1601320|NCT00995774|3915644|P1|STARTED|Washout Period||7
1601321|NCT00995774|3915643|P2|NOT COMPLETED|Training Period 1||0
1601322|NCT00995774|3915644|P1|NOT COMPLETED|Training Period 1||0
1601323|NCT00995774|3915643|P2|COMPLETED|Training Period 1||5
1601324|NCT00995774|3915644|P1|COMPLETED|Training Period 1||7
1601325|NCT00995774|3915643|P2|STARTED|Training Period 1||5
1601326|NCT00995774|3915644|P1|STARTED|Training Period 1||7
1601327|NCT00995761|3915654|P1|NOT COMPLETED|Overall Study||0
1601328|NCT00995761|3915654|P1|COMPLETED|Overall Study||48
1601329|NCT00995761|3915654|P1|STARTED|Overall Study||48
1601330|NCT00995722|3915660|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
1601331|NCT00995722|3915661|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
1601332|NCT00995722|3915660|P2|COMPLETED|Overall Study: 36 Weeks||2
1601333|NCT00995722|3915661|P1|COMPLETED|Overall Study: 36 Weeks||3
1601334|NCT00995722|3915660|P2|STARTED|Overall Study: 36 Weeks||4
1601335|NCT00995722|3915661|P1|STARTED|Overall Study: 36 Weeks||5
1601336|NCT00995722|3915660|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
1601337|NCT00995722|3915661|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
1601338|NCT00995722|3915660|P2|COMPLETED|Double Blinded: 16 Weeks||4
1601339|NCT00995722|3915661|P1|COMPLETED|Double Blinded: 16 Weeks||5
1601340|NCT00995722|3915660|P2|STARTED|Double Blinded: 16 Weeks||5
1601341|NCT00995722|3915661|P1|STARTED|Double Blinded: 16 Weeks||6
1601342|NCT00995709|3915678|P3|NOT COMPLETED|Overall Study||5
1601343|NCT00995709|3915679|P2|NOT COMPLETED|Overall Study||9
1601344|NCT00995709|3915680|P1|NOT COMPLETED|Overall Study||7
1601345|NCT00995709|3915678|P3|COMPLETED|Overall Study||34
1601346|NCT00995709|3915679|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
1601347|NCT00995709|3915680|P1|COMPLETED|Overall Study||32
1601348|NCT00995709|3915678|P3|STARTED|Overall Study||39
1601349|NCT00995709|3915679|P2|STARTED|Overall Study||40
1601350|NCT00995709|3915680|P1|STARTED|Overall Study||39
1601351|NCT00995670|3915706|P3|NOT COMPLETED|Overall Study||3
1601352|NCT00995670|3915707|P2|NOT COMPLETED|Overall Study||0
1601353|NCT00995670|3915708|P1|NOT COMPLETED|Overall Study||1
1601354|NCT00995670|3915706|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
1601355|NCT00995670|3915707|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
1601356|NCT00995670|3915708|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
1601357|NCT00995670|3915706|P3|STARTED|Overall Study||17
1601358|NCT00995670|3915707|P2|STARTED|Overall Study||16
1601359|NCT00995670|3915708|P1|STARTED|Overall Study||26
1601360|NCT00995566|3915716|P1|NOT COMPLETED|Overall Study||54
1601361|NCT00995566|3915716|P1|COMPLETED|Overall Study||0
1601362|NCT00995566|3915716|P1|STARTED|Overall Study||54
1601363|NCT00995553|3915730|P2|NOT COMPLETED|Overall Study||6
1601364|NCT00995553|3915731|P1|NOT COMPLETED|Overall Study||2
1601365|NCT00995553|3915730|P2|COMPLETED|Overall Study||35
1601366|NCT00995553|3915731|P1|COMPLETED|Overall Study||38
1601367|NCT00995553|3915730|P2|STARTED|Overall Study||41
1601368|NCT00995553|3915731|P1|STARTED|Overall Study||40
1601369|NCT00995501|3915747|P8|NOT COMPLETED|Overall Study||0
1601370|NCT00995501|3915748|P7|NOT COMPLETED|Overall Study||0
1601371|NCT00995501|3915749|P6|NOT COMPLETED|Overall Study||0
1601372|NCT00995501|3915750|P5|NOT COMPLETED|Overall Study||0
1601373|NCT00995501|3915751|P4|NOT COMPLETED|Overall Study||0
1601374|NCT00995501|3915752|P3|NOT COMPLETED|Overall Study||0
1601375|NCT00995501|3915753|P2|NOT COMPLETED|Overall Study||0
1601376|NCT00995501|3915754|P1|NOT COMPLETED|Overall Study||0
1601377|NCT00995501|3915747|P8|COMPLETED|Overall Study||46
1601378|NCT00995501|3915748|P7|COMPLETED|Overall Study||49
1601379|NCT00995501|3915749|P6|COMPLETED|Overall Study||44
1601380|NCT00995501|3915750|P5|COMPLETED|Overall Study||46
1601381|NCT00995501|3915751|P4|COMPLETED|Overall Study||46
1601382|NCT00995501|3915752|P3|COMPLETED|Overall Study||47
1601383|NCT00995501|3915753|P2|COMPLETED|Overall Study||51
1601384|NCT00995501|3915754|P1|COMPLETED|Overall Study||52
1601385|NCT00995501|3915747|P8|STARTED|Overall Study||46
1601386|NCT00995501|3915748|P7|STARTED|Overall Study||49
1601387|NCT00995501|3915749|P6|STARTED|Overall Study||44
1601388|NCT00995501|3915750|P5|STARTED|Overall Study||46
1601389|NCT00995501|3915751|P4|STARTED|Overall Study||46
1601390|NCT00995501|3915752|P3|STARTED|Overall Study||47
1601391|NCT00995501|3915753|P2|STARTED|Overall Study||51
1601392|NCT00995501|3915754|P1|STARTED|Overall Study||52
1601393|NCT00995488|3915780|P1|NOT COMPLETED|Overall Study||1
1601394|NCT00995488|3915780|P1|COMPLETED|Overall Study||15
1601395|NCT00995488|3915780|P1|STARTED|Overall Study||16
1601396|NCT00995449|3915789|P4|NOT COMPLETED|Overall Study||0
1601397|NCT00995449|3915790|P3|NOT COMPLETED|Overall Study||2
1601398|NCT00995449|3915791|P2|NOT COMPLETED|Overall Study||0
1601399|NCT00995449|3915792|P1|NOT COMPLETED|Overall Study||0
1601400|NCT00995449|3915789|P4|COMPLETED|Overall Study||2
1601401|NCT00995449|3915790|P3|COMPLETED|Overall Study||5
1601402|NCT00995449|3915791|P2|COMPLETED|Overall Study||0
1601403|NCT00995449|3915792|P1|COMPLETED|Overall Study||0
1601404|NCT00995449|3915789|P4|STARTED|Overall Study||2
1601405|NCT00995449|3915790|P3|STARTED|Overall Study||7
1601406|NCT00995449|3915791|P2|STARTED|Overall Study||0
1601407|NCT00995449|3915792|P1|STARTED|Overall Study||0
1601408|NCT00995436|3915803|P3|NOT COMPLETED|Overall Study||0
1601409|NCT00995436|3915804|P2|NOT COMPLETED|Overall Study||5
1601410|NCT00995436|3915805|P1|NOT COMPLETED|Overall Study||2
1601411|NCT00995436|3915803|P3|COMPLETED|Overall Study||26
1601412|NCT00995436|3915804|P2|COMPLETED|Overall Study||22
1601413|NCT00995436|3915805|P1|COMPLETED|Overall Study||23
1601414|NCT00995436|3915803|P3|STARTED|Overall Study||26
1601415|NCT00995436|3915804|P2|STARTED|Overall Study||27
1601416|NCT00995436|3915805|P1|STARTED|Overall Study|25|25
1601417|NCT00995410|3915813|P1|NOT COMPLETED|Overall Study||88
1601418|NCT00995410|3915813|P1|COMPLETED|Overall Study||292
1601419|NCT00995410|3915813|P1|Treated|Overall Study||379
1601420|NCT00995410|3915813|P1|STARTED|Overall Study||380
1601421|NCT00995371|3915820|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
1601422|NCT00995371|3915821|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
1601423|NCT00995371|3915820|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
1601424|NCT00995371|3915821|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
1601425|NCT00995371|3915820|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
1601426|NCT00995371|3915821|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
1601427|NCT00995371|3915820|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
1601428|NCT00995371|3915821|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
1601429|NCT00995371|3915820|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
1601430|NCT00995371|3915821|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
1601431|NCT00995371|3915820|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
1601432|NCT00995371|3915821|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
1601433|NCT00995345|3915839|P5|NOT COMPLETED|Overall Study||5
1601434|NCT00995345|3915840|P4|NOT COMPLETED|Overall Study||5
1601435|NCT00995345|3915841|P3|NOT COMPLETED|Overall Study||7
1601436|NCT00995345|3915842|P2|NOT COMPLETED|Overall Study||7
1601437|NCT00995345|3915843|P1|NOT COMPLETED|Overall Study||11
1601438|NCT00995345|3915839|P5|COMPLETED|Overall Study||75
1601439|NCT00995345|3915840|P4|COMPLETED|Overall Study||76
1601440|NCT00995345|3915841|P3|COMPLETED|Overall Study||73
1601441|NCT00995345|3915842|P2|COMPLETED|Overall Study||74
1601442|NCT00995345|3915843|P1|COMPLETED|Overall Study||70
1601443|NCT00995345|3915839|P5|STARTED|Overall Study||80
1601444|NCT00995345|3915840|P4|STARTED|Overall Study||81
1601445|NCT00995345|3915841|P3|STARTED|Overall Study||80
1601446|NCT00995345|3915842|P2|STARTED|Overall Study||81
1601447|NCT00995345|3915843|P1|STARTED|Overall Study||81
1601448|NCT00995085|3915870|P1|NOT COMPLETED|Overall Study||5
1601449|NCT00995085|3915870|P1|COMPLETED|Overall Study||38
1601450|NCT00995085|3915870|P1|STARTED|Overall Study||43
1601451|NCT00995020|3915876|P2|NOT COMPLETED|Overall Study||7
1601452|NCT00995020|3915877|P1|NOT COMPLETED|Overall Study||3
1601453|NCT00995020|3915876|P2|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
1601454|NCT00995020|3915877|P1|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
1601455|NCT00995020|3915876|P2|STARTED|Overall Study||52
1601456|NCT00995020|3915877|P1|STARTED|Overall Study||51
1601457|NCT00995007|3915887|P2|NOT COMPLETED|Overall Study||2
1601458|NCT00995007|3915888|P1|NOT COMPLETED|Overall Study||17
1601459|NCT00995007|3915887|P2|COMPLETED|Overall Study||54
1601460|NCT00995007|3915888|P1|COMPLETED|Overall Study||39
1601461|NCT00995007|3915887|P2|Crossover to Vandetanib|Overall Study||0
1601462|NCT00995007|3915888|P1|Crossover to Vandetanib|Overall Study||42
1601463|NCT00995007|3915887|P2|STARTED|Overall Study||56
1601464|NCT00995007|3915888|P1|STARTED|Overall Study||56
1601465|NCT00994929|3915904|P1|NOT COMPLETED|Overall Study||0
1601466|NCT00994929|3915904|P1|COMPLETED|Overall Study||9
1601467|NCT00994929|3915904|P1|STARTED|Overall Study||9
1601468|NCT00994760|3915910|P1|NOT COMPLETED|Overall Study||24
1601469|NCT00994760|3915910|P1|COMPLETED|Overall Study||107
1601470|NCT00994760|3915910|P1|STARTED|Overall Study||131
1601471|NCT00994682|3915951|P2|NOT COMPLETED|Pioglitazone Open Label||7
1601472|NCT00994682|3915952|P1|NOT COMPLETED|Pioglitazone Open Label||13
1601473|NCT00994682|3915951|P2|COMPLETED|Pioglitazone Open Label||34
1601474|NCT00994682|3915952|P1|COMPLETED|Pioglitazone Open Label||29
1601475|NCT00994682|3915951|P2|STARTED|Pioglitazone Open Label||41
1601476|NCT00994682|3915952|P1|STARTED|Pioglitazone Open Label||42
1601477|NCT00994682|3915951|P2|NOT COMPLETED|Double Bilnd||9
1601478|NCT00994682|3915952|P1|NOT COMPLETED|Double Bilnd||9
1601479|NCT00994682|3915951|P2|COMPLETED|Double Bilnd||41
1601480|NCT00994682|3915952|P1|COMPLETED|Double Bilnd||42
1601481|NCT00994682|3915951|P2|STARTED|Double Bilnd||50
1601482|NCT00994682|3915952|P1|STARTED|Double Bilnd||51
1601483|NCT00994643|3915996|P1|NOT COMPLETED|Overall Study||1
1601484|NCT00994643|3915996|P1|COMPLETED|Overall Study||10
1601485|NCT00994643|3915996|P1|STARTED|Overall Study||11
1601486|NCT00994604|3916000|P1|NOT COMPLETED|Overall Study||6
1601487|NCT00994604|3916000|P1|COMPLETED|Overall Study||45
1601488|NCT00994604|3916000|P1|STARTED|Overall Study||51
1601489|NCT00994461|3916010|P3|NOT COMPLETED|Overall Study||0
1601490|NCT00994461|3916011|P2|NOT COMPLETED|Overall Study||1
1601491|NCT00994461|3916012|P1|NOT COMPLETED|Overall Study||2
1601492|NCT00994461|3916010|P3|COMPLETED|Overall Study||37
1601493|NCT00994461|3916011|P2|COMPLETED|Overall Study||75
1601494|NCT00994461|3916012|P1|COMPLETED|Overall Study||74
1601495|NCT00994461|3916010|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
1601496|NCT00994461|3916011|P2|STARTED|Overall Study||76
1601497|NCT00994461|3916012|P1|STARTED|Overall Study||76
1601498|NCT00994448|3916040|P2|NOT COMPLETED|Overall Study||2
1601499|NCT00994448|3916041|P1|NOT COMPLETED|Overall Study||8
1601500|NCT00994448|3916040|P2|COMPLETED|Overall Study||5
1601501|NCT00994448|3916041|P1|COMPLETED|Overall Study||4
1601502|NCT00994448|3916040|P2|STARTED|Overall Study||7
1601503|NCT00994448|3916041|P1|STARTED|Overall Study||12
1601504|NCT00994422|3916049|P2|NOT COMPLETED|Overall Study||1
1601505|NCT00994422|3916050|P1|NOT COMPLETED|Overall Study||7
1601506|NCT00994422|3916049|P2|COMPLETED|Overall Study||54
1601507|NCT00994422|3916050|P1|COMPLETED|Overall Study||185
1601508|NCT00994422|3916049|P2|STARTED|Overall Study||55
1601509|NCT00994422|3916050|P1|STARTED|Overall Study||192
1601510|NCT00994318|3916063|P3|NOT COMPLETED|Overall Study||67
1601511|NCT00994318|3916064|P2|NOT COMPLETED|Overall Study||18
1601512|NCT00994318|3916065|P1|NOT COMPLETED|Overall Study||22
1601513|NCT00994318|3916063|P3|COMPLETED|Overall Study||250
1601514|NCT00994318|3916064|P2|COMPLETED|Overall Study||136
1601515|NCT00994318|3916065|P1|COMPLETED|Overall Study||133
1601516|NCT00994318|3916063|P3|STARTED|Overall Study||317
1601517|NCT00994318|3916064|P2|STARTED|Overall Study||154
1601518|NCT00994318|3916065|P1|STARTED|Overall Study||155
1601519|NCT00994279|3916075|P2|NOT COMPLETED|Overall Study||5
1601520|NCT00994279|3916076|P1|NOT COMPLETED|Overall Study||4
1601521|NCT00994279|3916075|P2|COMPLETED|Overall Study||13
1601522|NCT00994279|3916076|P1|COMPLETED|Overall Study||18
1601523|NCT00994279|3916075|P2|STARTED|Overall Study||18
1601524|NCT00994279|3916076|P1|STARTED|Overall Study||22
1601525|NCT00994240|3916086|P2|NOT COMPLETED|Overall Study||5
1601526|NCT00994240|3916087|P1|NOT COMPLETED|Overall Study||6
1601527|NCT00994240|3916086|P2|COMPLETED|Overall Study||39
1601528|NCT00994240|3916087|P1|COMPLETED|Overall Study||35
1601529|NCT00994240|3916086|P2|STARTED|Overall Study||44
1601530|NCT00994240|3916087|P1|STARTED|Overall Study||41
1601531|NCT00994214|3916097|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
1601532|NCT00994214|3916098|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
1601533|NCT00994214|3916099|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
1601534|NCT00994214|3916100|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
1601535|NCT00994214|3916097|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1601536|NCT00994214|3916098|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1601537|NCT00994214|3916099|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1601538|NCT00994214|3916100|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1601539|NCT00994214|3916097|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
1601540|NCT00994214|3916098|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
1601541|NCT00994214|3916099|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
1601542|NCT00994214|3916100|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
1601543|NCT00994214|3916097|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
1601544|NCT00994214|3916098|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
1601545|NCT00994214|3916099|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
1601546|NCT00994214|3916100|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
1601547|NCT00994214|3916097|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
1601548|NCT00994214|3916098|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
1601549|NCT00994214|3916099|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
1601550|NCT00994214|3916100|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
1601551|NCT00994214|3916097|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1601552|NCT00994214|3916098|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1601553|NCT00994214|3916099|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1601554|NCT00994214|3916100|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1601555|NCT00994214|3916097|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
1601556|NCT00994214|3916098|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
1601557|NCT00994214|3916099|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
1601558|NCT00994214|3916100|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
1601559|NCT00994214|3916097|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
1601560|NCT00994214|3916098|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
1601561|NCT00994214|3916099|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
1601562|NCT00994214|3916100|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
1601563|NCT00994214|3916097|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
1601564|NCT00994214|3916098|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
1601565|NCT00994214|3916099|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
1601566|NCT00994214|3916100|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
1601567|NCT00994214|3916097|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
1601568|NCT00994214|3916098|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
1601569|NCT00994214|3916099|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
1601570|NCT00994214|3916100|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
1601571|NCT00994175|3916144|P2|NOT COMPLETED|Second Intervention||0
1601572|NCT00994175|3916145|P1|NOT COMPLETED|Second Intervention||0
1601573|NCT00994175|3916144|P2|COMPLETED|Second Intervention||8
1601574|NCT00994175|3916145|P1|COMPLETED|Second Intervention||4
1601575|NCT00994175|3916144|P2|STARTED|Second Intervention||8
1601576|NCT00994175|3916145|P1|STARTED|Second Intervention||4
1601577|NCT00994175|3916144|P2|NOT COMPLETED|First Intervention||1
1601578|NCT00994175|3916145|P1|NOT COMPLETED|First Intervention||2
1601579|NCT00994175|3916144|P2|COMPLETED|First Intervention||8
1601580|NCT00994175|3916145|P1|COMPLETED|First Intervention||4
1601581|NCT00994175|3916144|P2|STARTED|First Intervention||9
1601582|NCT00994175|3916145|P1|STARTED|First Intervention||6
1601583|NCT00994123|3916156|P3|NOT COMPLETED|Overall Study||0
1601584|NCT00994123|3916157|P2|NOT COMPLETED|Overall Study||0
1601585|NCT00994123|3916158|P1|NOT COMPLETED|Overall Study||0
1601586|NCT00994123|3916156|P3|COMPLETED|Overall Study||44
1601587|NCT00994123|3916157|P2|COMPLETED|Overall Study||85
1601588|NCT00994123|3916158|P1|COMPLETED|Overall Study||33
1601589|NCT00994123|3916156|P3|STARTED|Overall Study||44
1601590|NCT00994123|3916157|P2|STARTED|Overall Study||85
1601591|NCT00994123|3916158|P1|STARTED|Overall Study||33
1601592|NCT00994110|3916179|P2|NOT COMPLETED|Overall Study||74
1601593|NCT00994110|3916180|P1|NOT COMPLETED|Overall Study||65
1601594|NCT00994110|3916179|P2|COMPLETED|Overall Study||148
1601595|NCT00994110|3916180|P1|COMPLETED|Overall Study||152
1601596|NCT00994110|3916179|P2|STARTED|Overall Study||222
1601597|NCT00994110|3916180|P1|STARTED|Overall Study||217
1601598|NCT00993967|3916186|P1|NOT COMPLETED|Overall Study||61
1601599|NCT00993967|3916186|P1|COMPLETED|Overall Study||139
1601600|NCT00993967|3916186|P1|STARTED|Overall Study||200
1601601|NCT00993954|3916193|P2|NOT COMPLETED|Overall Study||2
1601602|NCT00993954|3916194|P1|NOT COMPLETED|Overall Study||21
1601603|NCT00993954|3916193|P2|COMPLETED|Overall Study||121
1601604|NCT00993954|3916194|P1|COMPLETED|Overall Study||124
1601605|NCT00993954|3916193|P2|STARTED|Overall Study||123
1601606|NCT00993954|3916194|P1|STARTED|Overall Study||145
1601607|NCT00993928|3916207|P2|NOT COMPLETED|Overall Study||7
1601608|NCT00993928|3916208|P1|NOT COMPLETED|Overall Study||5
1601609|NCT00993928|3916207|P2|COMPLETED|Overall Study||38
1601610|NCT00993928|3916208|P1|COMPLETED|Overall Study||43
1601611|NCT00993928|3916207|P2|STARTED|Overall Study||45
1601612|NCT00993928|3916208|P1|STARTED|Overall Study||48
1601613|NCT00993915|3916222|P1|NOT COMPLETED|Overall Study||9
1601614|NCT00993915|3916222|P1|COMPLETED|Overall Study||678
1601615|NCT00993915|3916222|P1|STARTED|Overall Study||687
1601616|NCT00993824|3916233|P2|NOT COMPLETED|Overall Study||0
1601617|NCT00993824|3916234|P1|NOT COMPLETED|Overall Study||0
1601618|NCT00993824|3916233|P2|COMPLETED|Overall Study||10
1601619|NCT00993824|3916234|P1|COMPLETED|Overall Study||11
1601620|NCT00993824|3916233|P2|STARTED|Overall Study||10
1601621|NCT00993824|3916234|P1|STARTED|Overall Study||11
1601622|NCT00993668|3916248|P2|NOT COMPLETED|Open-Label Period||15
1601623|NCT00993668|3916249|P1|NOT COMPLETED|Open-Label Period||23
1601624|NCT00993668|3916248|P2|COMPLETED|Open-Label Period||91
1601625|NCT00993668|3916249|P1|COMPLETED|Open-Label Period||86
1601626|NCT00993668|3916248|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
1601627|NCT00993668|3916249|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
1601628|NCT00993668|3916248|P2|NOT COMPLETED|Single-Blind Period||3
1601629|NCT00993668|3916249|P1|NOT COMPLETED|Single-Blind Period||4
1601630|NCT00993668|3916248|P2|COMPLETED|Single-Blind Period||107
1601631|NCT00993668|3916249|P1|COMPLETED|Single-Blind Period||110
1601632|NCT00993668|3916248|P2|STARTED|Single-Blind Period||110
1601633|NCT00993668|3916249|P1|STARTED|Single-Blind Period||114
1601634|NCT00993655|3916277|P3|NOT COMPLETED|Overall Study||0
1601635|NCT00993655|3916278|P2|NOT COMPLETED|Overall Study||0
1601636|NCT00993655|3916279|P1|NOT COMPLETED|Overall Study||0
1601637|NCT00993655|3916277|P3|COMPLETED|Overall Study||102
1601638|NCT00993655|3916278|P2|COMPLETED|Overall Study||72
1601639|NCT00993655|3916279|P1|COMPLETED|Overall Study||101
1601640|NCT00993655|3916277|P3|STARTED|Overall Study||102
1601641|NCT00993655|3916278|P2|STARTED|Overall Study||72
1601642|NCT00993655|3916279|P1|STARTED|Overall Study||101
1601643|NCT00993616|3916293|P1|NOT COMPLETED|Overall Study||2
1601644|NCT00993616|3916293|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
1601645|NCT00993616|3916293|P1|STARTED|Overall Study||29
1601646|NCT00993499|3916311|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
1601647|NCT00993499|3916312|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
1601648|NCT00993499|3916313|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
1601649|NCT00993499|3916314|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
1601650|NCT00993499|3916315|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
1601651|NCT00993499|3916316|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
1601652|NCT00993499|3916311|P6|COMPLETED|Discontinued After Starting Course 3||0
1601653|NCT00993499|3916312|P5|COMPLETED|Discontinued After Starting Course 3||0
1601654|NCT00993499|3916313|P4|COMPLETED|Discontinued After Starting Course 3||1
1601655|NCT00993499|3916314|P3|COMPLETED|Discontinued After Starting Course 3||3
1601656|NCT00993499|3916315|P2|COMPLETED|Discontinued After Starting Course 3||4
1601657|NCT00993499|3916316|P1|COMPLETED|Discontinued After Starting Course 3||4
1601658|NCT00993499|3916311|P6|STARTED|Discontinued After Starting Course 3||3
1601659|NCT00993499|3916312|P5|STARTED|Discontinued After Starting Course 3||3
1601660|NCT00993499|3916313|P4|STARTED|Discontinued After Starting Course 3||3
1601661|NCT00993499|3916314|P3|STARTED|Discontinued After Starting Course 3||9
1601662|NCT00993499|3916315|P2|STARTED|Discontinued After Starting Course 3||9
1601663|NCT00993499|3916316|P1|STARTED|Discontinued After Starting Course 3||12
1601664|NCT00993499|3916311|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
1601665|NCT00993499|3916312|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
1601666|NCT00993499|3916313|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
1601667|NCT00993499|3916314|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
1601668|NCT00993499|3916315|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
1601669|NCT00993499|3916316|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
1601670|NCT00993499|3916311|P6|COMPLETED|Discontinued Before Starting Course 3||3
1601671|NCT00993499|3916312|P5|COMPLETED|Discontinued Before Starting Course 3||3
1601672|NCT00993499|3916313|P4|COMPLETED|Discontinued Before Starting Course 3||2
1601673|NCT00993499|3916314|P3|COMPLETED|Discontinued Before Starting Course 3||6
1601674|NCT00993499|3916315|P2|COMPLETED|Discontinued Before Starting Course 3||5
1601675|NCT00993499|3916316|P1|COMPLETED|Discontinued Before Starting Course 3||8
1601676|NCT00993499|3916311|P6|STARTED|Discontinued Before Starting Course 3||3
1601677|NCT00993499|3916312|P5|STARTED|Discontinued Before Starting Course 3||3
1601678|NCT00993499|3916313|P4|STARTED|Discontinued Before Starting Course 3||3
1601679|NCT00993499|3916314|P3|STARTED|Discontinued Before Starting Course 3||9
1601680|NCT00993499|3916315|P2|STARTED|Discontinued Before Starting Course 3||9
1601681|NCT00993499|3916316|P1|STARTED|Discontinued Before Starting Course 3||12
1601682|NCT00993499|3916311|P6|NOT COMPLETED|Run-in Period (8 Days)||0
1601683|NCT00993499|3916312|P5|NOT COMPLETED|Run-in Period (8 Days)||0
1601684|NCT00993499|3916313|P4|NOT COMPLETED|Run-in Period (8 Days)||0
1601685|NCT00993499|3916314|P3|NOT COMPLETED|Run-in Period (8 Days)||1
1601686|NCT00993499|3916315|P2|NOT COMPLETED|Run-in Period (8 Days)||3
1601687|NCT00993499|3916316|P1|NOT COMPLETED|Run-in Period (8 Days)||1
1601688|NCT00993499|3916311|P6|COMPLETED|Run-in Period (8 Days)||3
1601689|NCT00993499|3916312|P5|COMPLETED|Run-in Period (8 Days)||3
1601690|NCT00993499|3916313|P4|COMPLETED|Run-in Period (8 Days)||3
1601691|NCT00993499|3916314|P3|COMPLETED|Run-in Period (8 Days)||9
1601692|NCT00993499|3916315|P2|COMPLETED|Run-in Period (8 Days)||9
1601693|NCT00993499|3916316|P1|COMPLETED|Run-in Period (8 Days)||12
1601694|NCT00993499|3916311|P6|STARTED|Run-in Period (8 Days)||3
1601695|NCT00993499|3916312|P5|STARTED|Run-in Period (8 Days)||3
1601696|NCT00993499|3916313|P4|STARTED|Run-in Period (8 Days)||3
1601697|NCT00993499|3916314|P3|STARTED|Run-in Period (8 Days)||10
1601698|NCT00993499|3916315|P2|STARTED|Run-in Period (8 Days)||12
1601699|NCT00993499|3916316|P1|STARTED|Run-in Period (8 Days)||13
1601700|NCT00993473|3916398|P2|NOT COMPLETED|Overall Study||10
1601701|NCT00993473|3916399|P1|NOT COMPLETED|Overall Study||4
1601702|NCT00993473|3916398|P2|COMPLETED|Overall Study||54
1601703|NCT00993473|3916399|P1|COMPLETED|Overall Study||57
1601704|NCT00993473|3916398|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
1601705|NCT00993473|3916399|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
1601706|NCT00993447|3916437|P2|NOT COMPLETED|Overall Study||19
1601707|NCT00993447|3916438|P1|NOT COMPLETED|Overall Study||37
1601708|NCT00993447|3916437|P2|COMPLETED|Overall Study||180
1601709|NCT00993447|3916438|P1|COMPLETED|Overall Study||364
1601710|NCT00993447|3916437|P2|STARTED|Overall Study||199
1601711|NCT00993447|3916438|P1|STARTED|Overall Study||401
1601712|NCT00993421|3916475|P7|NOT COMPLETED|Overall Study||42
1601713|NCT00993421|3916476|P6|NOT COMPLETED|Overall Study||46
1601714|NCT00993421|3916477|P5|NOT COMPLETED|Overall Study||46
1601715|NCT00993421|3916478|P4|NOT COMPLETED|Overall Study||45
1601716|NCT00993421|3916479|P3|NOT COMPLETED|Overall Study||43
1601717|NCT00993421|3916480|P2|NOT COMPLETED|Overall Study||45
1601718|NCT00993421|3916481|P1|NOT COMPLETED|Overall Study||44
1601719|NCT00993421|3916475|P7|COMPLETED|Overall Study||4
1601720|NCT00993421|3916476|P6|COMPLETED|Overall Study||4
1601721|NCT00993421|3916477|P5|COMPLETED|Overall Study||6
1601722|NCT00993421|3916478|P4|COMPLETED|Overall Study||4
1601723|NCT00993421|3916479|P3|COMPLETED|Overall Study||5
1601724|NCT00993421|3916480|P2|COMPLETED|Overall Study||4
1601725|NCT00993421|3916481|P1|COMPLETED|Overall Study||5
1601726|NCT00993421|3916475|P7|STARTED|Overall Study||46
1601727|NCT00993421|3916476|P6|STARTED|Overall Study||50
1601728|NCT00993421|3916477|P5|STARTED|Overall Study||52
1601729|NCT00993421|3916478|P4|STARTED|Overall Study||49
1601730|NCT00993421|3916479|P3|STARTED|Overall Study||48
1601731|NCT00993421|3916480|P2|STARTED|Overall Study||49
1601732|NCT00993421|3916481|P1|STARTED|Overall Study||49
1601733|NCT00993317|3916632|P2|NOT COMPLETED|Overall Study||25
1601734|NCT00993317|3916633|P1|NOT COMPLETED|Overall Study||21
1601735|NCT00993317|3916632|P2|COMPLETED|Overall Study||60
1601736|NCT00993317|3916633|P1|COMPLETED|Overall Study||21
1601737|NCT00993317|3916632|P2|STARTED|Overall Study||85
1601738|NCT00993317|3916633|P1|STARTED|Overall Study||42
1601739|NCT00993291|3916651|P1|NOT COMPLETED|Overall Study||1
1601740|NCT00993291|3916651|P1|COMPLETED|Overall Study||19
1601741|NCT00993291|3916651|P1|STARTED|Overall Study||20
1601742|NCT00993265|3916657|P2|NOT COMPLETED|Overall Study||0
1601743|NCT00993265|3916658|P1|NOT COMPLETED|Overall Study||4
1601744|NCT00993265|3916657|P2|COMPLETED|Overall Study||19
1601745|NCT00993265|3916658|P1|COMPLETED|Overall Study||16
1601746|NCT00993265|3916657|P2|STARTED|Overall Study||19
1601747|NCT00993265|3916658|P1|STARTED|Overall Study||20
1601748|NCT00993200|3916678|P2|NOT COMPLETED|Overall Study||0
1601749|NCT00993200|3916679|P1|NOT COMPLETED|Overall Study||0
1601750|NCT00993200|3916678|P2|COMPLETED|Overall Study||13
1601751|NCT00993200|3916679|P1|COMPLETED|Overall Study||13
1601752|NCT00993200|3916678|P2|STARTED|Overall Study||13
1601753|NCT00993200|3916679|P1|STARTED|Overall Study||13
1601754|NCT00993187|3916691|P2|NOT COMPLETED|Overall Study||37
1601755|NCT00993187|3916692|P1|NOT COMPLETED|Overall Study||26
1601756|NCT00993187|3916691|P2|COMPLETED|Overall Study||108
1601757|NCT00993187|3916692|P1|COMPLETED|Overall Study||121
1601758|NCT00993187|3916691|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
1601759|NCT00993187|3916692|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
1601760|NCT00993187|3916691|P2|STARTED|Overall Study||145
1601761|NCT00993187|3916692|P1|STARTED|Overall Study||147
1601762|NCT00993148|3916710|P1|NOT COMPLETED|Overall Study||3
1601763|NCT00993148|3916710|P1|COMPLETED|Overall Study||22
1601764|NCT00993148|3916710|P1|STARTED|Overall Study||25
1601765|NCT00993044|3916722|P1|NOT COMPLETED|Irinotecan 50 mg||1
1601766|NCT00993044|3916722|P1|COMPLETED|Irinotecan 50 mg||6
1601767|NCT00993044|3916722|P1|STARTED|Irinotecan 50 mg||7
1601768|NCT00993044|3916722|P1|NOT COMPLETED|Irinotecan 30 mg||0
1601769|NCT00993044|3916722|P1|COMPLETED|Irinotecan 30 mg||6
1601770|NCT00993044|3916722|P1|STARTED|Irinotecan 30 mg||6
1601771|NCT00993031|3916729|P2|NOT COMPLETED|Overall Study||19
1601772|NCT00993031|3916730|P1|NOT COMPLETED|Overall Study||22
1601773|NCT00993031|3916729|P2|COMPLETED|Overall Study||175
1601774|NCT00993031|3916730|P1|COMPLETED|Overall Study||173
1601775|NCT00993031|3916729|P2|Delivered|Overall Study||190
1601776|NCT00993031|3916730|P1|Delivered|Overall Study||187
1601777|NCT00993031|3916729|P2|STARTED|Overall Study||194
1601778|NCT00993031|3916730|P1|STARTED|Overall Study||195
1601779|NCT00992992|3916748|P1|NOT COMPLETED|Overall Study||25
1601780|NCT00992992|3916748|P1|COMPLETED|Overall Study||0
1601781|NCT00992992|3916748|P1|STARTED|Overall Study||25
1601782|NCT00992927|3916770|P2|NOT COMPLETED|Overall Study||0
1601783|NCT00992927|3916771|P1|NOT COMPLETED|Overall Study||0
1601784|NCT00992927|3916770|P2|COMPLETED|Overall Study||22
1601785|NCT00992927|3916771|P1|COMPLETED|Overall Study||32
1601786|NCT00992927|3916770|P2|STARTED|Overall Study||22
1601787|NCT00992927|3916771|P1|STARTED|Overall Study||32
1601788|NCT00992836|3916779|P1|NOT COMPLETED|Overall Study||5
1601789|NCT00992836|3916779|P1|COMPLETED|Overall Study||150
1601790|NCT00992836|3916779|P1|Received Both Study Vaccinations|Overall Study||150
1601791|NCT00992836|3916779|P1|STARTED|Overall Study||155
1601792|NCT00992784|3916794|P3|NOT COMPLETED|Overall Study||1
1601793|NCT00992784|3916795|P2|NOT COMPLETED|Overall Study||2
1601794|NCT00992784|3916796|P1|NOT COMPLETED|Overall Study||3
1601795|NCT00992784|3916794|P3|COMPLETED|Overall Study||85
1601796|NCT00992784|3916795|P2|COMPLETED|Overall Study||102
1601797|NCT00992784|3916796|P1|COMPLETED|Overall Study||177
1601798|NCT00992784|3916794|P3|STARTED|Overall Study||86
1601799|NCT00992784|3916795|P2|STARTED|Overall Study||104
1601800|NCT00992784|3916796|P1|STARTED|Overall Study||180
1601801|NCT00992719|3916867|P3|NOT COMPLETED|Overall Study||0
1601802|NCT00992719|3916868|P2|NOT COMPLETED|Overall Study||1
1601803|NCT00992719|3916869|P1|NOT COMPLETED|Overall Study||1
1601804|NCT00992719|3916867|P3|COMPLETED|Overall Study||28
1601805|NCT00992719|3916868|P2|COMPLETED|Overall Study||27
1601806|NCT00992719|3916869|P1|COMPLETED|Overall Study||27
1601807|NCT00992719|3916867|P3|STARTED|Overall Study||28
1601808|NCT00992719|3916868|P2|STARTED|Overall Study||28
1601809|NCT00992719|3916869|P1|STARTED|Overall Study||28
1601810|NCT00992602|3916903|P1|NOT COMPLETED|Overall Study||3
1601811|NCT00992602|3916903|P1|COMPLETED|Overall Study||0
1601812|NCT00992602|3916903|P1|STARTED|Overall Study||3
1601813|NCT00992589|3916908|P4|NOT COMPLETED|Double-Blind Phase||10
1601814|NCT00992589|3916909|P3|NOT COMPLETED|Double-Blind Phase||13
1601815|NCT00992589|3916910|P2|NOT COMPLETED|Double-Blind Phase||13
1601816|NCT00992589|3916911|P1|NOT COMPLETED|Double-Blind Phase||0
1601817|NCT00992589|3916908|P4|COMPLETED|Double-Blind Phase||78
1601818|NCT00992589|3916909|P3|COMPLETED|Double-Blind Phase||77
1601819|NCT00992589|3916910|P2|COMPLETED|Double-Blind Phase||76
1601820|NCT00992589|3916911|P1|COMPLETED|Double-Blind Phase||0
1601821|NCT00992589|3916908|P4|STARTED|Double-Blind Phase||88
1601822|NCT00992589|3916909|P3|STARTED|Double-Blind Phase||90
1601823|NCT00992589|3916910|P2|STARTED|Double-Blind Phase||89
1601824|NCT00992589|3916911|P1|STARTED|Double-Blind Phase||0
1601825|NCT00992589|3916908|P4|NOT COMPLETED|Open-Label Phase||0
1601826|NCT00992589|3916909|P3|NOT COMPLETED|Open-Label Phase||0
1601827|NCT00992589|3916910|P2|NOT COMPLETED|Open-Label Phase||0
1601828|NCT00992589|3916911|P1|NOT COMPLETED|Open-Label Phase||77
1601829|NCT00992589|3916908|P4|COMPLETED|Open-Label Phase||0
1601830|NCT00992589|3916909|P3|COMPLETED|Open-Label Phase||0
1601831|NCT00992589|3916910|P2|COMPLETED|Open-Label Phase||0
1601832|NCT00992589|3916911|P1|COMPLETED|Open-Label Phase||267
1601833|NCT00992589|3916908|P4|STARTED|Open-Label Phase||0
1601834|NCT00992589|3916909|P3|STARTED|Open-Label Phase||0
1601835|NCT00992589|3916910|P2|STARTED|Open-Label Phase||0
1601836|NCT00992589|3916911|P1|STARTED|Open-Label Phase||344
1601837|NCT00992459|3916955|P2|NOT COMPLETED|Overall Study||1
1601838|NCT00992459|3916956|P1|NOT COMPLETED|Overall Study||1
1601839|NCT00992459|3916955|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
1601840|NCT00992459|3916956|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
1601841|NCT00992459|3916955|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
1601842|NCT00992459|3916956|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
1601843|NCT00992446|3916980|P1|NOT COMPLETED|Overall Study||8
1601844|NCT00992446|3916980|P1|COMPLETED|Overall Study||19
1601845|NCT00992446|3916980|P1|STARTED|Overall Study||27
1601846|NCT00992433|3916987|P2|NOT COMPLETED|Overall Study||7
1601847|NCT00992433|3916988|P1|NOT COMPLETED|Overall Study||4
1601848|NCT00992433|3916987|P2|COMPLETED|Overall Study||90
1601849|NCT00992433|3916988|P1|COMPLETED|Overall Study||91
1601850|NCT00992433|3916987|P2|STARTED|Overall Study||97
1601851|NCT00992433|3916988|P1|STARTED|Overall Study||95
1601852|NCT00992407|3917052|P2|NOT COMPLETED|Overall Study||24
1601853|NCT00992407|3917053|P1|NOT COMPLETED|Overall Study||31
1601854|NCT00992407|3917052|P2|COMPLETED|Overall Study||14
1601855|NCT00992407|3917053|P1|COMPLETED|Overall Study||6
1601856|NCT00992407|3917052|P2|Treated|Overall Study||25
1601857|NCT00992407|3917053|P1|Treated|Overall Study||20
1601858|NCT00992407|3917052|P2|STARTED|Overall Study||38
1601859|NCT00992407|3917053|P1|STARTED|Overall Study||37
1601860|NCT00992394|3917103|P2|NOT COMPLETED|Overall Study||14
1601861|NCT00992394|3917104|P1|NOT COMPLETED|Overall Study||24
1601862|NCT00992394|3917103|P2|COMPLETED|Overall Study||72
1601863|NCT00992394|3917104|P1|COMPLETED|Overall Study||64
1601864|NCT00992394|3917103|P2|mITT Population|Overall Study||84
1601865|NCT00992394|3917104|P1|mITT Population|Overall Study||86
1601866|NCT00992394|3917103|P2|Safety Population|Overall Study||84
1601867|NCT00992394|3917104|P1|Safety Population|Overall Study||87
1601868|NCT00992394|3917103|P2|STARTED|Overall Study||86
1601869|NCT00992394|3917104|P1|STARTED|Overall Study||88
1601870|NCT00992264|3917162|P16|NOT COMPLETED|Overall Study||0
1601871|NCT00992264|3917163|P15|NOT COMPLETED|Overall Study||0
1601872|NCT00992264|3917164|P14|NOT COMPLETED|Overall Study||0
1601873|NCT00992264|3917165|P13|NOT COMPLETED|Overall Study||0
1601874|NCT00992264|3917166|P12|NOT COMPLETED|Overall Study||0
1601875|NCT00992264|3917167|P11|NOT COMPLETED|Overall Study||0
1601876|NCT00992264|3917168|P10|NOT COMPLETED|Overall Study||0
1601877|NCT00992264|3917169|P9|NOT COMPLETED|Overall Study||0
1601878|NCT00992264|3917170|P8|NOT COMPLETED|Overall Study||0
1601879|NCT00992264|3917171|P7|NOT COMPLETED|Overall Study||0
1601880|NCT00992264|3917172|P6|NOT COMPLETED|Overall Study||0
1601881|NCT00992264|3917173|P5|NOT COMPLETED|Overall Study||0
1601882|NCT00992264|3917174|P4|NOT COMPLETED|Overall Study||0
1601883|NCT00992264|3917175|P3|NOT COMPLETED|Overall Study||0
1601884|NCT00992264|3917176|P2|NOT COMPLETED|Overall Study||0
1601885|NCT00992264|3917177|P1|NOT COMPLETED|Overall Study||0
1601886|NCT00992264|3917162|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1601887|NCT00992264|3917163|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1601888|NCT00992264|3917164|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1601889|NCT00992264|3917165|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1601890|NCT00992264|3917166|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1601891|NCT00992264|3917167|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1601892|NCT00992264|3917168|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1601893|NCT00992264|3917169|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1601894|NCT00992264|3917170|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1601895|NCT00992264|3917171|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1601896|NCT00992264|3917172|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1601897|NCT00992264|3917173|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1601898|NCT00992264|3917174|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1601899|NCT00992264|3917175|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1601900|NCT00992264|3917176|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1601901|NCT00992264|3917177|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1601902|NCT00992264|3917162|P16|STARTED|Overall Study||116
1601903|NCT00992264|3917163|P15|STARTED|Overall Study||117
1601904|NCT00992264|3917164|P14|STARTED|Overall Study||117
1601905|NCT00992264|3917165|P13|STARTED|Overall Study||116
1601906|NCT00992264|3917166|P12|STARTED|Overall Study||117
1601907|NCT00992264|3917167|P11|STARTED|Overall Study||117
1601908|NCT00992264|3917168|P10|STARTED|Overall Study||116
1601909|NCT00992264|3917169|P9|STARTED|Overall Study||116
1601910|NCT00992264|3917170|P8|STARTED|Overall Study||117
1601911|NCT00992264|3917171|P7|STARTED|Overall Study||116
1601912|NCT00992264|3917172|P6|STARTED|Overall Study||117
1601913|NCT00992264|3917173|P5|STARTED|Overall Study||117
1601914|NCT00992264|3917174|P4|STARTED|Overall Study||117
1601915|NCT00992264|3917175|P3|STARTED|Overall Study||117
1601916|NCT00992264|3917176|P2|STARTED|Overall Study||116
1601917|NCT00992264|3917177|P1|STARTED|Overall Study||116
1601918|NCT00992225|3917191|P1|NOT COMPLETED|Overall Study||10
1601919|NCT00992225|3917191|P1|COMPLETED|Overall Study||33
1601920|NCT00992225|3917191|P1|Received at Least One Dose of Study Drug|Overall Study||33
1601921|NCT00992225|3917191|P1|STARTED|Overall Study||43
1601922|NCT00992186|3917201|P1|NOT COMPLETED|Overall Study||46
1601923|NCT00992186|3917201|P1|COMPLETED|Overall Study||0
1601924|NCT00992186|3917201|P1|STARTED|Overall Study||46
1601925|NCT00992108|3917220|P2|NOT COMPLETED|Overall Study||1
1601926|NCT00992108|3917221|P1|NOT COMPLETED|Overall Study||0
1601927|NCT00992108|3917220|P2|COMPLETED|Overall Study||9
1601928|NCT00992108|3917221|P1|COMPLETED|Overall Study||7
1601929|NCT00992108|3917220|P2|STARTED|Overall Study||10
1601930|NCT00992108|3917221|P1|STARTED|Overall Study||7
1601931|NCT00992056|3917235|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
1601932|NCT00992056|3917236|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
1601933|NCT00992056|3917235|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
1601934|NCT00992056|3917236|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
1601935|NCT00992056|3917235|P2|STARTED|Treatment Period 2 (6 Weeks)||10
1601936|NCT00992056|3917236|P1|STARTED|Treatment Period 2 (6 Weeks)||10
1601937|NCT00992056|3917235|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
1601938|NCT00992056|3917236|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
1601939|NCT00992056|3917235|P2|COMPLETED|Washout Period (2 Weeks)||10
1601940|NCT00992056|3917236|P1|COMPLETED|Washout Period (2 Weeks)||10
1601941|NCT00992056|3917235|P2|STARTED|Washout Period (2 Weeks)||10
1601942|NCT00992056|3917236|P1|STARTED|Washout Period (2 Weeks)||11
1601943|NCT00992056|3917235|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
1601944|NCT00992056|3917236|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
1601945|NCT00992056|3917235|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
1601946|NCT00992056|3917236|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
1601947|NCT00992056|3917235|P2|STARTED|Treatment Period 1 (6 Weeks)||12
1601948|NCT00992056|3917236|P1|STARTED|Treatment Period 1 (6 Weeks)||12
1601949|NCT00992017|3917242|P1|NOT COMPLETED|Overall Study||10
1601950|NCT00992017|3917242|P1|COMPLETED|Overall Study||118
1601951|NCT00992017|3917242|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
1601952|NCT00992017|3917242|P1|Received Both Study Vaccinations|Overall Study||124
1601953|NCT00992017|3917242|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
1601954|NCT00991952|3917257|P2|NOT COMPLETED|Overall Study||1
1601955|NCT00991952|3917258|P1|NOT COMPLETED|Overall Study||0
1601956|NCT00991952|3917257|P2|COMPLETED|Overall Study||5
1601957|NCT00991952|3917258|P1|COMPLETED|Overall Study||13
1601958|NCT00991952|3917257|P2|STARTED|Overall Study||6
1601959|NCT00991952|3917258|P1|STARTED|Overall Study||13
1601960|NCT00991939|3917266|P2|NOT COMPLETED|Overall Study||2
1601961|NCT00991939|3917267|P1|NOT COMPLETED|Overall Study||5
1601962|NCT00991939|3917266|P2|COMPLETED|Overall Study||1
1601963|NCT00991939|3917267|P1|COMPLETED|Overall Study||0
1601964|NCT00991939|3917266|P2|STARTED|Overall Study||3
1601965|NCT00991939|3917267|P1|STARTED|Overall Study||5
1601966|NCT00991887|3917301|P2|NOT COMPLETED|Overall Study||1
1601967|NCT00991887|3917302|P1|NOT COMPLETED|Overall Study||2
1601968|NCT00991887|3917301|P2|COMPLETED|Overall Study||21
1601969|NCT00991887|3917302|P1|COMPLETED|Overall Study||24
1601970|NCT00991887|3917301|P2|STARTED|Overall Study||22
1601971|NCT00991887|3917302|P1|STARTED|Overall Study||26
1601972|NCT00991809|3917310|P2|NOT COMPLETED|Overall Study||6
1601973|NCT00991809|3917311|P1|NOT COMPLETED|Overall Study||4
1601974|NCT00991809|3917310|P2|COMPLETED|Overall Study||4
1601975|NCT00991809|3917311|P1|COMPLETED|Overall Study||8
1601976|NCT00991809|3917310|P2|STARTED|Overall Study||10
1601977|NCT00991809|3917311|P1|STARTED|Overall Study||12
1601978|NCT00991510|3917321|P2|NOT COMPLETED|Period III (Days 29-112)||1
1601979|NCT00991510|3917322|P1|NOT COMPLETED|Period III (Days 29-112)||1
1601980|NCT00991510|3917321|P2|COMPLETED|Period III (Days 29-112)||20
1601981|NCT00991510|3917322|P1|COMPLETED|Period III (Days 29-112)||20
1601982|NCT00991510|3917321|P2|STARTED|Period III (Days 29-112)||21
1601983|NCT00991510|3917322|P1|STARTED|Period III (Days 29-112)||21
1601984|NCT00991510|3917321|P2|NOT COMPLETED|Period II (Days 15-28)||0
1601985|NCT00991510|3917322|P1|NOT COMPLETED|Period II (Days 15-28)||0
1601986|NCT00991510|3917321|P2|COMPLETED|Period II (Days 15-28)||21
1601987|NCT00991510|3917322|P1|COMPLETED|Period II (Days 15-28)||21
1601988|NCT00991510|3917321|P2|STARTED|Period II (Days 15-28)||21
1601989|NCT00991510|3917322|P1|STARTED|Period II (Days 15-28)||21
1601990|NCT00991510|3917321|P2|NOT COMPLETED|Period I (Days 1-14)||0
1601991|NCT00991510|3917322|P1|NOT COMPLETED|Period I (Days 1-14)||1
1601992|NCT00991510|3917321|P2|COMPLETED|Period I (Days 1-14)||21
1601993|NCT00991510|3917322|P1|COMPLETED|Period I (Days 1-14)||21
1601994|NCT00991510|3917321|P2|STARTED|Period I (Days 1-14)||21
1601995|NCT00991510|3917322|P1|STARTED|Period I (Days 1-14)||22
1601996|NCT00991458|3917347|P3|NOT COMPLETED|Overall Study||25
1601997|NCT00991458|3917348|P2|NOT COMPLETED|Overall Study||28
1601998|NCT00991458|3917349|P1|NOT COMPLETED|Overall Study||20
1601999|NCT00991458|3917347|P3|COMPLETED|Overall Study||180
1602000|NCT00991458|3917348|P2|COMPLETED|Overall Study||181
1602001|NCT00991458|3917349|P1|COMPLETED|Overall Study||187
1602002|NCT00991458|3917347|P3|STARTED|Overall Study||205
1602003|NCT00991458|3917348|P2|STARTED|Overall Study||209
1602004|NCT00991458|3917349|P1|STARTED|Overall Study||207
1602005|NCT00991341|3917368|P2|NOT COMPLETED|Overall Study||179
1602006|NCT00991341|3917369|P1|NOT COMPLETED|Overall Study||204
1602007|NCT00991341|3917368|P2|COMPLETED|Overall Study||560
1602008|NCT00991341|3917369|P1|COMPLETED|Overall Study||538
1602009|NCT00991341|3917368|P2|STARTED|Overall Study||739
1602010|NCT00991341|3917369|P1|STARTED|Overall Study||742
1602011|NCT00991302|3917407|P2|NOT COMPLETED|Overall Study||13
1602012|NCT00991302|3917408|P1|NOT COMPLETED|Overall Study||14
1602013|NCT00991302|3917407|P2|COMPLETED|Overall Study||73
1602014|NCT00991302|3917408|P1|COMPLETED|Overall Study||72
1602015|NCT00991302|3917407|P2|STARTED|Overall Study||86
1602016|NCT00991302|3917408|P1|STARTED|Overall Study||86
1602017|NCT00991289|3917424|P1|NOT COMPLETED|Overall Study||12
1602018|NCT00991289|3917424|P1|COMPLETED|Overall Study|Completed study.|55
1602019|NCT00991289|3917424|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
1602020|NCT00991289|3917424|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
1602021|NCT00991276|3917444|P6|NOT COMPLETED|Third Intervention Period||1
1602022|NCT00991276|3917445|P5|NOT COMPLETED|Third Intervention Period||0
1602023|NCT00991276|3917446|P4|NOT COMPLETED|Third Intervention Period||1
1602024|NCT00991276|3917447|P3|NOT COMPLETED|Third Intervention Period||1
1602025|NCT00991276|3917448|P2|NOT COMPLETED|Third Intervention Period||0
1602026|NCT00991276|3917449|P1|NOT COMPLETED|Third Intervention Period||1
1602027|NCT00991276|3917444|P6|COMPLETED|Third Intervention Period||10
1602028|NCT00991276|3917445|P5|COMPLETED|Third Intervention Period||10
1602029|NCT00991276|3917446|P4|COMPLETED|Third Intervention Period||8
1602030|NCT00991276|3917447|P3|COMPLETED|Third Intervention Period||13
1602031|NCT00991276|3917448|P2|COMPLETED|Third Intervention Period||8
1602032|NCT00991276|3917449|P1|COMPLETED|Third Intervention Period||13
1602033|NCT00991276|3917444|P6|STARTED|Third Intervention Period||11
1602034|NCT00991276|3917445|P5|STARTED|Third Intervention Period||10
1602035|NCT00991276|3917446|P4|STARTED|Third Intervention Period||9
1602036|NCT00991276|3917447|P3|STARTED|Third Intervention Period||14
1602037|NCT00991276|3917448|P2|STARTED|Third Intervention Period||8
1602038|NCT00991276|3917449|P1|STARTED|Third Intervention Period||14
1602039|NCT00991276|3917444|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602040|NCT00991276|3917445|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602041|NCT00991276|3917446|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602042|NCT00991276|3917447|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602043|NCT00991276|3917448|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602044|NCT00991276|3917449|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602045|NCT00991276|3917444|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
1602046|NCT00991276|3917445|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
1602047|NCT00991276|3917446|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
1602048|NCT00991276|3917447|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
1602049|NCT00991276|3917448|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
1602050|NCT00991276|3917449|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
1602051|NCT00991276|3917444|P6|STARTED|Placebo Wash-out Period (7 Days)||11
1602052|NCT00991276|3917445|P5|STARTED|Placebo Wash-out Period (7 Days)||10
1602053|NCT00991276|3917446|P4|STARTED|Placebo Wash-out Period (7 Days)||9
1602054|NCT00991276|3917447|P3|STARTED|Placebo Wash-out Period (7 Days)||14
1602055|NCT00991276|3917448|P2|STARTED|Placebo Wash-out Period (7 Days)||8
1602056|NCT00991276|3917449|P1|STARTED|Placebo Wash-out Period (7 Days)||14
1602057|NCT00991276|3917444|P6|NOT COMPLETED|Second Intervention Period||1
1602058|NCT00991276|3917445|P5|NOT COMPLETED|Second Intervention Period||1
1602059|NCT00991276|3917446|P4|NOT COMPLETED|Second Intervention Period||2
1602060|NCT00991276|3917447|P3|NOT COMPLETED|Second Intervention Period||0
1602061|NCT00991276|3917448|P2|NOT COMPLETED|Second Intervention Period||2
1602062|NCT00991276|3917449|P1|NOT COMPLETED|Second Intervention Period||1
1602063|NCT00991276|3917444|P6|COMPLETED|Second Intervention Period||11
1602064|NCT00991276|3917445|P5|COMPLETED|Second Intervention Period||10
1602065|NCT00991276|3917446|P4|COMPLETED|Second Intervention Period||9
1602066|NCT00991276|3917447|P3|COMPLETED|Second Intervention Period||14
1602067|NCT00991276|3917448|P2|COMPLETED|Second Intervention Period||8
1602068|NCT00991276|3917449|P1|COMPLETED|Second Intervention Period||14
1602069|NCT00991276|3917444|P6|STARTED|Second Intervention Period||12
1602070|NCT00991276|3917445|P5|STARTED|Second Intervention Period||11
1602071|NCT00991276|3917446|P4|STARTED|Second Intervention Period||11
1602072|NCT00991276|3917447|P3|STARTED|Second Intervention Period||14
1602073|NCT00991276|3917448|P2|STARTED|Second Intervention Period||10
1602074|NCT00991276|3917449|P1|STARTED|Second Intervention Period||15
1602075|NCT00991276|3917444|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602076|NCT00991276|3917445|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602077|NCT00991276|3917446|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602078|NCT00991276|3917447|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602079|NCT00991276|3917448|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602080|NCT00991276|3917449|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1602081|NCT00991276|3917444|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
1602082|NCT00991276|3917445|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
1602083|NCT00991276|3917446|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
1602084|NCT00991276|3917447|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
1602085|NCT00991276|3917448|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
1602086|NCT00991276|3917449|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
1602087|NCT00991276|3917444|P6|STARTED|Placebo Wash-out Period (7 Days)||12
1602088|NCT00991276|3917445|P5|STARTED|Placebo Wash-out Period (7 Days)||11
1602089|NCT00991276|3917446|P4|STARTED|Placebo Wash-out Period (7 Days)||11
1602090|NCT00991276|3917447|P3|STARTED|Placebo Wash-out Period (7 Days)||14
1602091|NCT00991276|3917448|P2|STARTED|Placebo Wash-out Period (7 Days)||10
1602092|NCT00991276|3917449|P1|STARTED|Placebo Wash-out Period (7 Days)||15
1602093|NCT00991276|3917444|P6|NOT COMPLETED|First Intervention Period||1
1602094|NCT00991276|3917445|P5|NOT COMPLETED|First Intervention Period||4
1602095|NCT00991276|3917446|P4|NOT COMPLETED|First Intervention Period||4
1602096|NCT00991276|3917447|P3|NOT COMPLETED|First Intervention Period||0
1602097|NCT00991276|3917448|P2|NOT COMPLETED|First Intervention Period||3
1602098|NCT00991276|3917449|P1|NOT COMPLETED|First Intervention Period||0
1602099|NCT00991276|3917444|P6|COMPLETED|First Intervention Period||12
1602100|NCT00991276|3917445|P5|COMPLETED|First Intervention Period||11
1602101|NCT00991276|3917446|P4|COMPLETED|First Intervention Period||11
1602102|NCT00991276|3917447|P3|COMPLETED|First Intervention Period||14
1602103|NCT00991276|3917448|P2|COMPLETED|First Intervention Period||10
1602104|NCT00991276|3917449|P1|COMPLETED|First Intervention Period||15
1602105|NCT00991276|3917444|P6|STARTED|First Intervention Period||13
1602106|NCT00991276|3917445|P5|STARTED|First Intervention Period||15
1602107|NCT00991276|3917446|P4|STARTED|First Intervention Period||15
1602108|NCT00991276|3917447|P3|STARTED|First Intervention Period||14
1602109|NCT00991276|3917448|P2|STARTED|First Intervention Period||13
1602110|NCT00991276|3917449|P1|STARTED|First Intervention Period||15
1602111|NCT00991185|3917547|P1|NOT COMPLETED|Overall Study||0
1602112|NCT00991185|3917547|P1|COMPLETED|Overall Study||8
1602113|NCT00991185|3917547|P1|STARTED|Overall Study||8
1602114|NCT00991081|3917553|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
1602115|NCT00991081|3917554|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
1602116|NCT00991081|3917555|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
1602117|NCT00991081|3917553|P3|COMPLETED|Phase II, Randomized Control Trial||15
1602118|NCT00991081|3917554|P2|COMPLETED|Phase II, Randomized Control Trial||15
1602119|NCT00991081|3917555|P1|COMPLETED|Phase II, Randomized Control Trial||0
1602120|NCT00991081|3917553|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
1602121|NCT00991081|3917554|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
1602122|NCT00991081|3917555|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
1602123|NCT00991081|3917553|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
1602212|NCT00990561|3917721|P3|NOT COMPLETED|Period 2||0
1602124|NCT00991081|3917554|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
1602125|NCT00991081|3917555|P1|STARTED|Phase II, Randomized Control Trial||0
1602126|NCT00991081|3917553|P3|NOT COMPLETED|Phase I, Formative Research||0
1602127|NCT00991081|3917554|P2|NOT COMPLETED|Phase I, Formative Research||0
1602128|NCT00991081|3917555|P1|NOT COMPLETED|Phase I, Formative Research||0
1602129|NCT00991081|3917553|P3|COMPLETED|Phase I, Formative Research||0
1602130|NCT00991081|3917554|P2|COMPLETED|Phase I, Formative Research||0
1602131|NCT00991081|3917555|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
1602132|NCT00991081|3917553|P3|STARTED|Phase I, Formative Research||0
1602133|NCT00991081|3917554|P2|STARTED|Phase I, Formative Research||0
1602134|NCT00991081|3917555|P1|STARTED|Phase I, Formative Research||20
1602135|NCT00991029|3917589|P2|NOT COMPLETED|Overall Study||168
1602136|NCT00991029|3917590|P1|NOT COMPLETED|Overall Study||156
1602137|NCT00991029|3917589|P2|COMPLETED|Overall Study||2281
1602138|NCT00991029|3917590|P1|COMPLETED|Overall Study||2276
1602139|NCT00991029|3917589|P2|STARTED|Overall Study||2449
1602140|NCT00991029|3917590|P1|STARTED|Overall Study||2432
1602141|NCT00990964|3917620|P1|NOT COMPLETED|Overall Study||212
1602142|NCT00990964|3917620|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
1602143|NCT00990964|3917620|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
1602144|NCT00990964|3917620|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
1602145|NCT00990821|3917639|P14|NOT COMPLETED|Overall Study||1
1602146|NCT00990821|3917640|P13|NOT COMPLETED|Overall Study||2
1602147|NCT00990821|3917641|P12|NOT COMPLETED|Overall Study||5
1602148|NCT00990821|3917642|P11|NOT COMPLETED|Overall Study||3
1602149|NCT00990821|3917643|P10|NOT COMPLETED|Overall Study||1
1602150|NCT00990821|3917644|P9|NOT COMPLETED|Overall Study||0
1602151|NCT00990821|3917645|P8|NOT COMPLETED|Overall Study||0
1602152|NCT00990821|3917646|P7|NOT COMPLETED|Overall Study||1
1602153|NCT00990821|3917647|P6|NOT COMPLETED|Overall Study||3
1602154|NCT00990821|3917648|P5|NOT COMPLETED|Overall Study||3
1602155|NCT00990821|3917649|P4|NOT COMPLETED|Overall Study||0
1602156|NCT00990821|3917650|P3|NOT COMPLETED|Overall Study||0
1602157|NCT00990821|3917651|P2|NOT COMPLETED|Overall Study||2
1602158|NCT00990821|3917652|P1|NOT COMPLETED|Overall Study||0
1602159|NCT00990821|3917639|P14|COMPLETED|Overall Study||11
1602160|NCT00990821|3917640|P13|COMPLETED|Overall Study||10
1602161|NCT00990821|3917641|P12|COMPLETED|Overall Study||9
1602162|NCT00990821|3917642|P11|COMPLETED|Overall Study||9
1602163|NCT00990821|3917643|P10|COMPLETED|Overall Study||13
1602164|NCT00990821|3917644|P9|COMPLETED|Overall Study||12
1602165|NCT00990821|3917645|P8|COMPLETED|Overall Study||14
1602166|NCT00990821|3917646|P7|COMPLETED|Overall Study||11
1602167|NCT00990821|3917647|P6|COMPLETED|Overall Study||14
1602168|NCT00990821|3917648|P5|COMPLETED|Overall Study||14
1602169|NCT00990821|3917649|P4|COMPLETED|Overall Study||8
1602170|NCT00990821|3917650|P3|COMPLETED|Overall Study||14
1602171|NCT00990821|3917651|P2|COMPLETED|Overall Study||14
1602172|NCT00990821|3917652|P1|COMPLETED|Overall Study||14
1602173|NCT00990821|3917639|P14|STARTED|Overall Study||12
1602174|NCT00990821|3917640|P13|STARTED|Overall Study||12
1602175|NCT00990821|3917641|P12|STARTED|Overall Study||14
1602176|NCT00990821|3917642|P11|STARTED|Overall Study||12
1602177|NCT00990821|3917643|P10|STARTED|Overall Study||14
1602178|NCT00990821|3917644|P9|STARTED|Overall Study||12
1602179|NCT00990821|3917645|P8|STARTED|Overall Study||14
1602180|NCT00990821|3917646|P7|STARTED|Overall Study||12
1602181|NCT00990821|3917647|P6|STARTED|Overall Study||17
1602182|NCT00990821|3917648|P5|STARTED|Overall Study||17
1602183|NCT00990821|3917649|P4|STARTED|Overall Study||8
1602184|NCT00990821|3917650|P3|STARTED|Overall Study||14
1602185|NCT00990821|3917651|P2|STARTED|Overall Study||16
1602186|NCT00990821|3917652|P1|STARTED|Overall Study||14
1602187|NCT00990782|3917669|P1|NOT COMPLETED|Overall Study||5
1602188|NCT00990782|3917669|P1|COMPLETED|Overall Study||88
1602189|NCT00990782|3917669|P1|STARTED|Overall Study||93
1602190|NCT00990769|3917676|P2|NOT COMPLETED|Overall Study||0
1602191|NCT00990769|3917677|P1|NOT COMPLETED|Overall Study||0
1602192|NCT00990769|3917676|P2|COMPLETED|Overall Study||18
1602193|NCT00990769|3917677|P1|COMPLETED|Overall Study||22
1602194|NCT00990769|3917676|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
1602195|NCT00990769|3917677|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
1602196|NCT00990704|3917689|P2|NOT COMPLETED|Overall Study||2
1602197|NCT00990704|3917690|P1|NOT COMPLETED|Overall Study||1
1602198|NCT00990704|3917689|P2|COMPLETED|Overall Study||31
1602199|NCT00990704|3917690|P1|COMPLETED|Overall Study||13
1602200|NCT00990704|3917689|P2|STARTED|Overall Study||33
1602201|NCT00990704|3917690|P1|STARTED|Overall Study||14
1602202|NCT00990652|3917710|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
1602203|NCT00990652|3917710|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
1602204|NCT00990652|3917710|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
1602205|NCT00990652|3917710|P1|NOT COMPLETED|Surgical Resection||0
1602206|NCT00990652|3917710|P1|COMPLETED|Surgical Resection||9
1602207|NCT00990652|3917710|P1|STARTED|Surgical Resection||9
1602208|NCT00990652|3917710|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
1602209|NCT00990652|3917710|P1|COMPLETED|Pre-surgical Bortezomib||9
1602210|NCT00990652|3917710|P1|STARTED|Pre-surgical Bortezomib||10
1602211|NCT00990561|3917720|P4|NOT COMPLETED|Period 2||2
1602213|NCT00990561|3917722|P2|NOT COMPLETED|Period 2||0
1602214|NCT00990561|3917723|P1|NOT COMPLETED|Period 2||0
1602215|NCT00990561|3917720|P4|COMPLETED|Period 2||17
1602216|NCT00990561|3917721|P3|COMPLETED|Period 2||20
1602217|NCT00990561|3917722|P2|COMPLETED|Period 2||0
1602218|NCT00990561|3917723|P1|COMPLETED|Period 2||0
1602219|NCT00990561|3917720|P4|STARTED|Period 2||19
1602220|NCT00990561|3917721|P3|STARTED|Period 2||20
1602221|NCT00990561|3917722|P2|STARTED|Period 2||0
1602222|NCT00990561|3917723|P1|STARTED|Period 2||0
1602223|NCT00990561|3917720|P4|NOT COMPLETED|Period 1||0
1602224|NCT00990561|3917721|P3|NOT COMPLETED|Period 1||0
1602225|NCT00990561|3917722|P2|NOT COMPLETED|Period 1||1
1602226|NCT00990561|3917723|P1|NOT COMPLETED|Period 1||0
1602227|NCT00990561|3917720|P4|COMPLETED|Period 1||0
1602228|NCT00990561|3917721|P3|COMPLETED|Period 1||0
1602229|NCT00990561|3917722|P2|COMPLETED|Period 1||19
1602230|NCT00990561|3917723|P1|COMPLETED|Period 1||20
1602231|NCT00990561|3917720|P4|STARTED|Period 1||0
1602232|NCT00990561|3917721|P3|STARTED|Period 1||0
1602233|NCT00990561|3917722|P2|STARTED|Period 1||20
1602234|NCT00990561|3917723|P1|STARTED|Period 1||20
1602235|NCT00990509|3917731|P2|NOT COMPLETED|Overall Study||1
1602236|NCT00990509|3917732|P1|NOT COMPLETED|Overall Study||0
1602237|NCT00990509|3917731|P2|COMPLETED|Overall Study||8
1602238|NCT00990509|3917732|P1|COMPLETED|Overall Study||5
1602239|NCT00990509|3917731|P2|STARTED|Overall Study||9
1602240|NCT00990509|3917732|P1|STARTED|Overall Study||5
1602241|NCT00990340|3917744|P2|NOT COMPLETED|Second 14-day Treatment||0
1602242|NCT00990340|3917745|P1|NOT COMPLETED|Second 14-day Treatment||0
1602243|NCT00990340|3917744|P2|COMPLETED|Second 14-day Treatment||21
1602244|NCT00990340|3917745|P1|COMPLETED|Second 14-day Treatment||21
1602245|NCT00990340|3917744|P2|STARTED|Second 14-day Treatment||21
1602246|NCT00990340|3917745|P1|STARTED|Second 14-day Treatment||21
1602247|NCT00990340|3917744|P2|NOT COMPLETED|First 14-day Treatment||4
1602248|NCT00990340|3917745|P1|NOT COMPLETED|First 14-day Treatment||6
1602249|NCT00990340|3917744|P2|COMPLETED|First 14-day Treatment||21
1602250|NCT00990340|3917745|P1|COMPLETED|First 14-day Treatment||21
1602251|NCT00990340|3917744|P2|STARTED|First 14-day Treatment||25
1602252|NCT00990340|3917745|P1|STARTED|First 14-day Treatment||27
1602253|NCT00990288|3917761|P2|NOT COMPLETED|Overall Study||0
1602254|NCT00990288|3917762|P1|NOT COMPLETED|Overall Study||0
1602255|NCT00990288|3917761|P2|COMPLETED|Overall Study||99
1602256|NCT00990288|3917762|P1|COMPLETED|Overall Study||97
1602257|NCT00990288|3917761|P2|STARTED|Overall Study||99
1602258|NCT00990288|3917762|P1|STARTED|Overall Study||97
1602259|NCT00990249|3917792|P1|NOT COMPLETED|Overall Study||13
1602260|NCT00990249|3917792|P1|COMPLETED|Overall Study||107
1602261|NCT00990249|3917792|P1|STARTED|Overall Study||120
1602262|NCT00990184|3917796|P1|NOT COMPLETED|Overall Study||1
1602263|NCT00990184|3917796|P1|COMPLETED|Overall Study||20
1602264|NCT00990184|3917796|P1|STARTED|Overall Study||21
1602265|NCT00990106|3917804|P2|NOT COMPLETED|Overall Study||12
1602266|NCT00990106|3917805|P1|NOT COMPLETED|Overall Study||9
1602267|NCT00990106|3917804|P2|COMPLETED|Overall Study||23
1602268|NCT00990106|3917805|P1|COMPLETED|Overall Study||23
1602269|NCT00990106|3917804|P2|STARTED|Overall Study||35
1602270|NCT00990106|3917805|P1|STARTED|Overall Study||32
1602271|NCT00990093|3917815|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
1602272|NCT00990093|3917816|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
1602273|NCT00990093|3917815|P2|COMPLETED|Test Period 2 (15-28 Days)||14
1602274|NCT00990093|3917816|P1|COMPLETED|Test Period 2 (15-28 Days)||13
1602275|NCT00990093|3917815|P2|STARTED|Test Period 2 (15-28 Days)||15
1602276|NCT00990093|3917816|P1|STARTED|Test Period 2 (15-28 Days)||15
1602277|NCT00990093|3917815|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
1602278|NCT00990093|3917816|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
1602279|NCT00990093|3917815|P2|COMPLETED|Test Period 1 (1-14 Days)||15
1602280|NCT00990093|3917816|P1|COMPLETED|Test Period 1 (1-14 Days)||15
1602281|NCT00990093|3917815|P2|STARTED|Test Period 1 (1-14 Days)||17
1602282|NCT00990093|3917816|P1|STARTED|Test Period 1 (1-14 Days)||19
1602283|NCT00989989|3917825|P3|NOT COMPLETED|Overall Study||23
1602284|NCT00989989|3917826|P2|NOT COMPLETED|Overall Study||10
1602285|NCT00989989|3917827|P1|NOT COMPLETED|Overall Study||18
1602286|NCT00989989|3917825|P3|COMPLETED|Overall Study||108
1602287|NCT00989989|3917826|P2|COMPLETED|Overall Study||123
1602288|NCT00989989|3917827|P1|COMPLETED|Overall Study||114
1602289|NCT00989989|3917825|P3|STARTED|Overall Study||131
1602290|NCT00989989|3917826|P2|STARTED|Overall Study||133
1602291|NCT00989989|3917827|P1|STARTED|Overall Study||132
1602292|NCT00989950|3917869|P4|NOT COMPLETED|Randomized Phase||0
1602293|NCT00989950|3917870|P3|NOT COMPLETED|Randomized Phase||0
1602294|NCT00989950|3917871|P2|NOT COMPLETED|Randomized Phase||1
1602295|NCT00989950|3917872|P1|NOT COMPLETED|Randomized Phase||1
1602296|NCT00989950|3917869|P4|COMPLETED|Randomized Phase||7
1602297|NCT00989950|3917870|P3|COMPLETED|Randomized Phase||4
1602298|NCT00989950|3917871|P2|COMPLETED|Randomized Phase||8
1602299|NCT00989950|3917872|P1|COMPLETED|Randomized Phase||5
1602300|NCT00989950|3917869|P4|STARTED|Randomized Phase||7
1602301|NCT00989950|3917870|P3|STARTED|Randomized Phase||4
1602302|NCT00989950|3917871|P2|STARTED|Randomized Phase||9
1602303|NCT00989950|3917872|P1|STARTED|Randomized Phase||6
1602304|NCT00989950|3917869|P4|NOT COMPLETED|Open Label Dose Optimization||0
1602305|NCT00989950|3917870|P3|NOT COMPLETED|Open Label Dose Optimization||0
1602306|NCT00989950|3917871|P2|NOT COMPLETED|Open Label Dose Optimization||0
1602307|NCT00989950|3917872|P1|NOT COMPLETED|Open Label Dose Optimization||0
1602308|NCT00989950|3917869|P4|COMPLETED|Open Label Dose Optimization||7
1602309|NCT00989950|3917870|P3|COMPLETED|Open Label Dose Optimization||4
1602310|NCT00989950|3917871|P2|COMPLETED|Open Label Dose Optimization||9
1602311|NCT00989950|3917872|P1|COMPLETED|Open Label Dose Optimization||6
1602312|NCT00989950|3917869|P4|STARTED|Open Label Dose Optimization||7
1602313|NCT00989950|3917870|P3|STARTED|Open Label Dose Optimization||4
1602314|NCT00989950|3917871|P2|STARTED|Open Label Dose Optimization||9
1602315|NCT00989950|3917872|P1|STARTED|Open Label Dose Optimization||6
1602316|NCT00989911|3917882|P1|NOT COMPLETED|Overall Study||3
1602317|NCT00989911|3917882|P1|COMPLETED|Overall Study||7
1602318|NCT00989911|3917882|P1|STARTED|Overall Study||10
1602319|NCT00989833|3917889|P3|NOT COMPLETED|Overall Study||2
1602320|NCT00989833|3917890|P2|NOT COMPLETED|Overall Study||3
1602321|NCT00989833|3917891|P1|NOT COMPLETED|Overall Study||2
1602322|NCT00989833|3917889|P3|COMPLETED|Overall Study||21
1602323|NCT00989833|3917890|P2|COMPLETED|Overall Study||19
1602324|NCT00989833|3917891|P1|COMPLETED|Overall Study||19
1602325|NCT00989833|3917889|P3|STARTED|Overall Study||23
1602326|NCT00989833|3917890|P2|STARTED|Overall Study||22
1602327|NCT00989833|3917891|P1|STARTED|Overall Study||21
1602328|NCT00989781|3917922|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
1602329|NCT00989781|3917923|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
1602330|NCT00989781|3917922|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
1602331|NCT00989781|3917923|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
1602332|NCT00989781|3917922|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
1602333|NCT00989781|3917923|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
1602334|NCT00989781|3917922|P2|NOT COMPLETED|Ovarian Response to hCG||2
1602335|NCT00989781|3917923|P1|NOT COMPLETED|Ovarian Response to hCG||3
1602336|NCT00989781|3917922|P2|COMPLETED|Ovarian Response to hCG||18
1602337|NCT00989781|3917923|P1|COMPLETED|Ovarian Response to hCG||18
1602338|NCT00989781|3917922|P2|STARTED|Ovarian Response to hCG||20
1602339|NCT00989781|3917923|P1|STARTED|Ovarian Response to hCG||21
1602340|NCT00989768|3917942|P1|NOT COMPLETED|Overall Study||1
1602341|NCT00989768|3917942|P1|COMPLETED|Overall Study||28
1602342|NCT00989768|3917942|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
1602343|NCT00989664|3917953|P1|NOT COMPLETED|Long-Term Follow-Up||3
1602344|NCT00989664|3917953|P1|COMPLETED|Long-Term Follow-Up||11
1602345|NCT00989664|3917953|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
1602346|NCT00989664|3917953|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
1602347|NCT00989664|3917953|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
1602348|NCT00989664|3917953|P1|STARTED|Dosimetric and Therapeutic Treatment||61
1602349|NCT00989586|3917983|P2|NOT COMPLETED|Overall Study||0
1602350|NCT00989586|3917984|P1|NOT COMPLETED|Overall Study||0
1602351|NCT00989586|3917983|P2|COMPLETED|Overall Study||17
1602352|NCT00989586|3917984|P1|COMPLETED|Overall Study||18
1602353|NCT00989586|3917983|P2|STARTED|Overall Study||17
1602354|NCT00989586|3917984|P1|STARTED|Overall Study||18
1602355|NCT00989287|3917999|P2|NOT COMPLETED|Overall Study||1
1602356|NCT00989287|3918000|P1|NOT COMPLETED|Overall Study||1
1602357|NCT00989287|3917999|P2|COMPLETED|Overall Study||65
1602358|NCT00989287|3918000|P1|COMPLETED|Overall Study||64
1602359|NCT00989287|3917999|P2|STARTED|Overall Study||66
1602360|NCT00989287|3918000|P1|STARTED|Overall Study||65
1602361|NCT00989235|3918102|P2|NOT COMPLETED|Overall Study||6
1602362|NCT00989235|3918103|P1|NOT COMPLETED|Overall Study||3
1602363|NCT00989235|3918102|P2|COMPLETED|Overall Study||44
1602364|NCT00989235|3918103|P1|COMPLETED|Overall Study||55
1602365|NCT00989235|3918102|P2|Number Completing Double-Blind Treatment|Overall Study||41
1602366|NCT00989235|3918103|P1|Number Completing Double-Blind Treatment|Overall Study||51
1602367|NCT00989235|3918102|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
1602368|NCT00989235|3918103|P1|Number Rescued to Open-Label Treatment|Overall Study||4
1602369|NCT00989235|3918102|P2|STARTED|Overall Study||50
1602370|NCT00989235|3918103|P1|STARTED|Overall Study||58
1602371|NCT00989196|3918148|P2|NOT COMPLETED|Treatment Period||0
1602372|NCT00989196|3918149|P1|NOT COMPLETED|Treatment Period||1
1602373|NCT00989196|3918148|P2|COMPLETED|Treatment Period||12
1602374|NCT00989196|3918149|P1|COMPLETED|Treatment Period||9
1602375|NCT00989196|3918148|P2|STARTED|Treatment Period||12
1602376|NCT00989196|3918149|P1|STARTED|Treatment Period||10
1602377|NCT00989196|3918148|P2|NOT COMPLETED|PK Crossover Period||0
1602378|NCT00989196|3918149|P1|NOT COMPLETED|PK Crossover Period||0
1602379|NCT00989196|3918148|P2|COMPLETED|PK Crossover Period||12
1602380|NCT00989196|3918149|P1|COMPLETED|PK Crossover Period||10
1602381|NCT00989196|3918148|P2|STARTED|PK Crossover Period||12
1602382|NCT00989196|3918149|P1|STARTED|PK Crossover Period||10
1602383|NCT00989157|3918170|P2|NOT COMPLETED|Overall Study||0
1602384|NCT00989157|3918171|P1|NOT COMPLETED|Overall Study||0
1602385|NCT00989157|3918170|P2|COMPLETED|Overall Study||10
1602386|NCT00989157|3918171|P1|COMPLETED|Overall Study||10
1602387|NCT00989157|3918170|P2|STARTED|Overall Study||10
1602388|NCT00989157|3918171|P1|STARTED|Overall Study||10
1602389|NCT00989092|3918187|P2|NOT COMPLETED|Overall Study||28
1602390|NCT00989092|3918188|P1|NOT COMPLETED|Overall Study||90
1602391|NCT00989092|3918187|P2|COMPLETED|Overall Study||31
1602392|NCT00989092|3918188|P1|COMPLETED|Overall Study||138
1602393|NCT00989092|3918187|P2|Treated With Darbepoetin Alfa|Overall Study||33
1602394|NCT00989092|3918188|P1|Treated With Darbepoetin Alfa|Overall Study||226
1602395|NCT00989092|3918187|P2|STARTED|Overall Study||59
1602396|NCT00989092|3918188|P1|STARTED|Overall Study||228
1602397|NCT00989014|3918225|P4|NOT COMPLETED|Overall Study||0
1602398|NCT00989014|3918226|P3|NOT COMPLETED|Overall Study||0
1602399|NCT00989014|3918227|P2|NOT COMPLETED|Overall Study||0
1602400|NCT00989014|3918228|P1|NOT COMPLETED|Overall Study||0
1602401|NCT00989014|3918225|P4|COMPLETED|Overall Study||32
1602402|NCT00989014|3918226|P3|COMPLETED|Overall Study||28
1602403|NCT00989014|3918227|P2|COMPLETED|Overall Study||31
1602404|NCT00989014|3918228|P1|COMPLETED|Overall Study||31
1602405|NCT00989014|3918225|P4|STARTED|Overall Study||32
1602406|NCT00989014|3918226|P3|STARTED|Overall Study||28
1602407|NCT00989014|3918227|P2|STARTED|Overall Study||31
1602408|NCT00989014|3918228|P1|STARTED|Overall Study||31
1602409|NCT00988884|3918240|P2|NOT COMPLETED|Overall Study||36
1602410|NCT00988884|3918241|P1|NOT COMPLETED|Overall Study||35
1602411|NCT00988884|3918240|P2|COMPLETED|Overall Study||584
1602412|NCT00988884|3918241|P1|COMPLETED|Overall Study||586
1602413|NCT00988884|3918240|P2|STARTED|Overall Study||620
1602414|NCT00988884|3918241|P1|STARTED|Overall Study||621
1602415|NCT00988858|3918263|P1|NOT COMPLETED|Overall Study||10
1602416|NCT00988858|3918263|P1|COMPLETED|Overall Study||45
1602417|NCT00988858|3918263|P1|STARTED|Overall Study||55
1602418|NCT00988832|3918275|P1|NOT COMPLETED|Overall Study||0
1602419|NCT00988832|3918275|P1|COMPLETED|Overall Study||380
1602420|NCT00988832|3918275|P1|STARTED|Overall Study||380
1602421|NCT00988637|3918312|P2|NOT COMPLETED|Overall Study||3
1602422|NCT00988637|3918313|P1|NOT COMPLETED|Overall Study||3
1602423|NCT00988637|3918312|P2|COMPLETED|Overall Study||65
1602424|NCT00988637|3918313|P1|COMPLETED|Overall Study||67
1602425|NCT00988637|3918312|P2|STARTED|Overall Study||68
1602426|NCT00988637|3918313|P1|STARTED|Overall Study||70
1602427|NCT00988559|3918347|P4|NOT COMPLETED|Overall Study||1
1602428|NCT00988559|3918348|P3|NOT COMPLETED|Overall Study||2
1602429|NCT00988559|3918349|P2|NOT COMPLETED|Overall Study||2
1602430|NCT00988559|3918350|P1|NOT COMPLETED|Overall Study||1
1602431|NCT00988559|3918347|P4|COMPLETED|Overall Study||6
1602432|NCT00988559|3918348|P3|COMPLETED|Overall Study||9
1602433|NCT00988559|3918349|P2|COMPLETED|Overall Study||9
1602434|NCT00988559|3918350|P1|COMPLETED|Overall Study||9
1602435|NCT00988559|3918347|P4|STARTED|Overall Study||7
1602436|NCT00988559|3918348|P3|STARTED|Overall Study||11
1602437|NCT00988559|3918349|P2|STARTED|Overall Study||11
1602438|NCT00988559|3918350|P1|STARTED|Overall Study||10
1602439|NCT00988533|3918364|P1|NOT COMPLETED|Overall Study||3
1602440|NCT00988533|3918364|P1|COMPLETED|Overall Study||27
1602441|NCT00988533|3918364|P1|STARTED|Overall Study||30
1602442|NCT00988442|3918378|P2|NOT COMPLETED|Overall Study||28
1602443|NCT00988442|3918379|P1|NOT COMPLETED|Overall Study||30
1602444|NCT00988442|3918378|P2|COMPLETED|Overall Study||1
1602445|NCT00988442|3918379|P1|COMPLETED|Overall Study||0
1602446|NCT00988442|3918378|P2|STARTED|Overall Study||29
1602447|NCT00988442|3918379|P1|STARTED|Overall Study||30
1602448|NCT00988429|3918442|P3|NOT COMPLETED|Overall Study||69
1602449|NCT00988429|3918443|P2|NOT COMPLETED|Overall Study||43
1602450|NCT00988429|3918444|P1|NOT COMPLETED|Overall Study||37
1602451|NCT00988429|3918442|P3|COMPLETED|Overall Study||142
1602452|NCT00988429|3918443|P2|COMPLETED|Overall Study||173
1602453|NCT00988429|3918444|P1|COMPLETED|Overall Study||189
1602454|NCT00988429|3918442|P3|Intention-to-treat (ITT) Population|Overall Study||205
1602455|NCT00988429|3918443|P2|Intention-to-treat (ITT) Population|Overall Study||215
1602456|NCT00988429|3918444|P1|Intention-to-treat (ITT) Population|Overall Study||220
1602457|NCT00988429|3918442|P3|Safety Population|Overall Study||210
1602458|NCT00988429|3918443|P2|Safety Population|Overall Study||216
1602459|NCT00988429|3918444|P1|Safety Population|Overall Study||224
1602460|NCT00988429|3918442|P3|STARTED|Overall Study||211
1602461|NCT00988429|3918443|P2|STARTED|Overall Study||216
1602462|NCT00988429|3918444|P1|STARTED|Overall Study||226
1602463|NCT00988351|3918457|P2|NOT COMPLETED|Overall Study||12
1602464|NCT00988351|3918458|P1|NOT COMPLETED|Overall Study||19
1602465|NCT00988351|3918457|P2|COMPLETED|Overall Study||66
1602466|NCT00988351|3918458|P1|COMPLETED|Overall Study||59
1602467|NCT00988351|3918457|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
1602468|NCT00988351|3918458|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
1602469|NCT00988351|3918457|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
1602470|NCT00988351|3918458|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
1602471|NCT00988351|3918457|P2|PAP Setup|Overall Study|APAP treatment started|78
1602472|NCT00988351|3918458|P1|PAP Setup|Overall Study|CPAP treatment started|70
1602473|NCT00988351|3918457|P2|CPAP Titration|Overall Study|no titration needed|78
1602474|NCT00988351|3918458|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
1602475|NCT00988351|3918457|P2|STARTED|Overall Study||78
1602476|NCT00988351|3918458|P1|STARTED|Overall Study||78
1602477|NCT00988325|3918475|P3|NOT COMPLETED|Overall Study||0
1602478|NCT00988325|3918476|P2|NOT COMPLETED|Overall Study||0
1602479|NCT00988325|3918477|P1|NOT COMPLETED|Overall Study||0
1602480|NCT00988325|3918475|P3|COMPLETED|Overall Study||5
1602481|NCT00988325|3918476|P2|COMPLETED|Overall Study||20
1602482|NCT00988325|3918477|P1|COMPLETED|Overall Study||40
1602483|NCT00988325|3918475|P3|STARTED|Overall Study||5
1602484|NCT00988325|3918476|P2|STARTED|Overall Study||20
1602485|NCT00988325|3918477|P1|STARTED|Overall Study||40
1602486|NCT00988247|3918535|P2|NOT COMPLETED|Overall Study||26
1602487|NCT00988247|3918536|P1|NOT COMPLETED|Overall Study||83
1602488|NCT00988247|3918535|P2|COMPLETED|Overall Study||85
1602489|NCT00988247|3918536|P1|COMPLETED|Overall Study||335
1602490|NCT00988247|3918535|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
1602491|NCT00988247|3918536|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
1602492|NCT00988247|3918535|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
1602493|NCT00988247|3918536|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
1602494|NCT00988247|3918535|P2|STARTED|Overall Study||111
1602495|NCT00988247|3918536|P1|STARTED|Overall Study||418
1602496|NCT00988221|3918555|P4|NOT COMPLETED|Part III||0
1602497|NCT00988221|3918556|P3|NOT COMPLETED|Part III||3
1602498|NCT00988221|3918557|P2|NOT COMPLETED|Part III||1
1602499|NCT00988221|3918558|P1|NOT COMPLETED|Part III||1
1602500|NCT00988221|3918555|P4|COMPLETED|Part III||0
1602501|NCT00988221|3918556|P3|COMPLETED|Part III||103
1602502|NCT00988221|3918557|P2|COMPLETED|Part III||23
1602503|NCT00988221|3918558|P1|COMPLETED|Part III||29
1602504|NCT00988221|3918555|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
1602505|NCT00988221|3918556|P3|STARTED|Part III||106
1602506|NCT00988221|3918557|P2|STARTED|Part III||24
1602507|NCT00988221|3918558|P1|STARTED|Part III||30
1602508|NCT00988221|3918555|P4|NOT COMPLETED|Part II||3
1602509|NCT00988221|3918556|P3|NOT COMPLETED|Part II||3
1602510|NCT00988221|3918557|P2|NOT COMPLETED|Part II||0
1602511|NCT00988221|3918558|P1|NOT COMPLETED|Part II||1
1602512|NCT00988221|3918555|P4|COMPLETED|Part II||81
1602513|NCT00988221|3918556|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
1602514|NCT00988221|3918557|P2|COMPLETED|Part II||11
1602515|NCT00988221|3918558|P1|COMPLETED|Part II||15
1602516|NCT00988221|3918555|P4|STARTED|Part II||84
1602517|NCT00988221|3918556|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
1602518|NCT00988221|3918557|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
1602519|NCT00988221|3918558|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
1602520|NCT00988221|3918555|P4|NOT COMPLETED|Part I||0
1602521|NCT00988221|3918556|P3|NOT COMPLETED|Part I||8
1602522|NCT00988221|3918557|P2|NOT COMPLETED|Part I||10
1602523|NCT00988221|3918558|P1|NOT COMPLETED|Part I||4
1602524|NCT00988221|3918555|P4|COMPLETED|Part I||0
1602525|NCT00988221|3918556|P3|COMPLETED|Part I||111
1602526|NCT00988221|3918557|P2|COMPLETED|Part I||24
1602527|NCT00988221|3918558|P1|COMPLETED|Part I||31
1602528|NCT00988221|3918555|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
1602529|NCT00988221|3918556|P3|STARTED|Part I||119
1602530|NCT00988221|3918557|P2|STARTED|Part I||34
1602531|NCT00988221|3918558|P1|STARTED|Part I||35
1602532|NCT00988208|3918731|P2|NOT COMPLETED|Overall Study||438
1602533|NCT00988208|3918732|P1|NOT COMPLETED|Overall Study||431
1602534|NCT00988208|3918731|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
1602535|NCT00988208|3918732|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
1602536|NCT00988208|3918731|P2|Treated|Overall Study||525
1602537|NCT00988208|3918732|P1|Treated|Overall Study||521
1602538|NCT00988208|3918731|P2|STARTED|Overall Study||533
1602539|NCT00988208|3918732|P1|STARTED|Overall Study||526
1602540|NCT00988169|3918750|P1|NOT COMPLETED|Overall Study||1
1602541|NCT00988169|3918750|P1|COMPLETED|Overall Study||5
1602542|NCT00988169|3918750|P1|STARTED|Overall Study||6
1602543|NCT00988156|3918756|P2|NOT COMPLETED|Overall Study||20
1602544|NCT00988156|3918757|P1|NOT COMPLETED|Overall Study||17
1602545|NCT00988156|3918756|P2|COMPLETED|Overall Study||135
1602546|NCT00988156|3918757|P1|COMPLETED|Overall Study||132
1602547|NCT00988156|3918756|P2|Safety Set|Overall Study||134
1602548|NCT00988156|3918757|P1|Safety Set|Overall Study||129
1602549|NCT00988156|3918756|P2|Per Protocol Set (PP)|Overall Study||97
1602550|NCT00988156|3918757|P1|Per Protocol Set (PP)|Overall Study||101
1602551|NCT00988156|3918756|P2|Intention-to-Treat Set (ITT)|Overall Study||134
1602552|NCT00988156|3918757|P1|Intention-to-Treat Set (ITT)|Overall Study||129
1602553|NCT00988156|3918756|P2|STARTED|Overall Study||155
1602554|NCT00988156|3918757|P1|STARTED|Overall Study||149
1602555|NCT00988143|3918768|P3|NOT COMPLETED|Overall Study||0
1602556|NCT00988143|3918769|P2|NOT COMPLETED|Overall Study||0
1602557|NCT00988143|3918770|P1|NOT COMPLETED|Overall Study||0
1602558|NCT00988143|3918768|P3|COMPLETED|Overall Study||190
1602559|NCT00988143|3918769|P2|COMPLETED|Overall Study||190
1602560|NCT00988143|3918770|P1|COMPLETED|Overall Study||220
1602561|NCT00988143|3918768|P3|STARTED|Overall Study||190
1602562|NCT00988143|3918769|P2|STARTED|Overall Study||190
1602563|NCT00988143|3918770|P1|STARTED|Overall Study||220
1602564|NCT00988117|3918802|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
1602565|NCT00988117|3918802|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
1602566|NCT00988117|3918802|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
1602567|NCT00988117|3918802|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
1602568|NCT00988117|3918802|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
1602569|NCT00988117|3918802|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
1602570|NCT00988091|3918811|P2|NOT COMPLETED|Open-label Period||33
1602571|NCT00988091|3918812|P1|NOT COMPLETED|Open-label Period||21
1602572|NCT00988091|3918811|P2|COMPLETED|Open-label Period||192
1602573|NCT00988091|3918812|P1|COMPLETED|Open-label Period||208
1602574|NCT00988091|3918811|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
1602575|NCT00988091|3918812|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
1602576|NCT00988091|3918811|P2|NOT COMPLETED|Double-blind Period||47
1602577|NCT00988091|3918812|P1|NOT COMPLETED|Double-blind Period||43
1602578|NCT00988091|3918811|P2|COMPLETED|Double-blind Period||251
1602579|NCT00988091|3918812|P1|COMPLETED|Double-blind Period||255
1602580|NCT00988091|3918811|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
1602581|NCT00988091|3918812|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
1602582|NCT00988091|3918811|P2|STARTED|Double-blind Period||298
1602583|NCT00988091|3918812|P1|STARTED|Double-blind Period||298
1602584|NCT00988065|3918834|P3|NOT COMPLETED|Overall Study||15
1602585|NCT00988065|3918835|P2|NOT COMPLETED|Overall Study||23
1602586|NCT00988065|3918836|P1|NOT COMPLETED|Overall Study||13
1602587|NCT00988065|3918834|P3|COMPLETED|Overall Study||135
1602588|NCT00988065|3918835|P2|COMPLETED|Overall Study||127
1602589|NCT00988065|3918836|P1|COMPLETED|Overall Study||135
1602590|NCT00988065|3918834|P3|Received Third Randomized Dose|Overall Study||135
1602591|NCT00988065|3918835|P2|Received Third Randomized Dose|Overall Study||127
1602592|NCT00988065|3918836|P1|Received Third Randomized Dose|Overall Study||135
1602593|NCT00988065|3918834|P3|Received Second Randomized Dose|Overall Study||145
1602594|NCT00988065|3918835|P2|Received Second Randomized Dose|Overall Study||135
1602595|NCT00988065|3918836|P1|Received Second Randomized Dose|Overall Study||139
1602596|NCT00988065|3918834|P3|Received First Randomized Dose|Overall Study||150
1602597|NCT00988065|3918835|P2|Received First Randomized Dose|Overall Study||150
1602598|NCT00988065|3918836|P1|Received First Randomized Dose|Overall Study||148
1602599|NCT00988065|3918834|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
1602600|NCT00988065|3918835|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
1602601|NCT00988065|3918836|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
1602602|NCT00987948|3918856|P1|NOT COMPLETED|Overall Study||3
1602603|NCT00987948|3918856|P1|COMPLETED|Overall Study||12
1602604|NCT00987948|3918856|P1|STARTED|Overall Study||15
1602605|NCT00987935|3918870|P9|NOT COMPLETED|Overall Study||32
1602606|NCT00987935|3918871|P8|NOT COMPLETED|Overall Study||62
1602607|NCT00987935|3918872|P7|NOT COMPLETED|Overall Study||15
1602608|NCT00987935|3918873|P6|NOT COMPLETED|Overall Study||3
1602609|NCT00987935|3918874|P5|NOT COMPLETED|Overall Study||7
1602610|NCT00987935|3918875|P4|NOT COMPLETED|Overall Study||3
1602611|NCT00987935|3918876|P3|NOT COMPLETED|Overall Study||3
1602612|NCT00987935|3918877|P2|NOT COMPLETED|Overall Study||3
1602613|NCT00987935|3918878|P1|NOT COMPLETED|Overall Study||4
1602614|NCT00987935|3918870|P9|COMPLETED|Overall Study||0
1602615|NCT00987935|3918871|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
1602616|NCT00987935|3918872|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
1602617|NCT00987935|3918873|P6|COMPLETED|Overall Study||0
1602618|NCT00987935|3918874|P5|COMPLETED|Overall Study||0
1602619|NCT00987935|3918875|P4|COMPLETED|Overall Study||0
1602620|NCT00987935|3918876|P3|COMPLETED|Overall Study||0
1602621|NCT00987935|3918877|P2|COMPLETED|Overall Study||0
1602622|NCT00987935|3918878|P1|COMPLETED|Overall Study||0
1602623|NCT00987935|3918870|P9|STARTED|Overall Study||32
1602624|NCT00987935|3918871|P8|STARTED|Overall Study||63
1602625|NCT00987935|3918872|P7|STARTED|Overall Study||16
1602626|NCT00987935|3918873|P6|STARTED|Overall Study||3
1602627|NCT00987935|3918874|P5|STARTED|Overall Study||7
1602628|NCT00987935|3918875|P4|STARTED|Overall Study||3
1602629|NCT00987935|3918876|P3|STARTED|Overall Study||3
1602630|NCT00987935|3918877|P2|STARTED|Overall Study||3
1602631|NCT00987935|3918878|P1|STARTED|Overall Study||4
1602632|NCT00987831|3918934|P3|NOT COMPLETED|Overall Study||0
1602633|NCT00987831|3918935|P2|NOT COMPLETED|Overall Study||3
1602634|NCT00987831|3918936|P1|NOT COMPLETED|Overall Study||1
1602635|NCT00987831|3918934|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
1602636|NCT00987831|3918935|P2|COMPLETED|Overall Study|all controls returned for two visits|52
1602637|NCT00987831|3918936|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
1602638|NCT00987831|3918934|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
1602639|NCT00987831|3918935|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
1602640|NCT00987831|3918936|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
1602641|NCT00987727|3918947|P2|NOT COMPLETED|Overall Study||7
1602642|NCT00987727|3918948|P1|NOT COMPLETED|Overall Study||5
1602643|NCT00987727|3918947|P2|COMPLETED|Overall Study||34
1602644|NCT00987727|3918948|P1|COMPLETED|Overall Study||36
1602645|NCT00987727|3918947|P2|STARTED|Overall Study||41
1602646|NCT00987727|3918948|P1|STARTED|Overall Study||41
1602647|NCT00987623|3918958|P2|NOT COMPLETED|Overall Study||3
1602648|NCT00987623|3918959|P1|NOT COMPLETED|Overall Study||5
1602649|NCT00987623|3918958|P2|COMPLETED|Overall Study||151
1602650|NCT00987623|3918959|P1|COMPLETED|Overall Study||140
1602651|NCT00987623|3918958|P2|STARTED|Overall Study||154
1602652|NCT00987623|3918959|P1|STARTED|Overall Study||145
1602653|NCT00987558|3918965|P2|NOT COMPLETED|Overall Study||5
1602654|NCT00987558|3918966|P1|NOT COMPLETED|Overall Study||1
1602655|NCT00987558|3918965|P2|COMPLETED|Overall Study||12
1602656|NCT00987558|3918966|P1|COMPLETED|Overall Study||12
1602657|NCT00987558|3918965|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
1602658|NCT00987558|3918966|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
1602659|NCT00987558|3918965|P2|Washout|Overall Study||12
1602660|NCT00987558|3918966|P1|Washout|Overall Study||13
1602661|NCT00987558|3918965|P2|Simvastatin|Overall Study||12
1602662|NCT00987558|3918966|P1|Simvastatin|Overall Study||13
1602663|NCT00987558|3918965|P2|STARTED|Overall Study||17
1602664|NCT00987558|3918966|P1|STARTED|Overall Study||13
1602665|NCT00987480|3918979|P1|NOT COMPLETED|Overall Study||0
1602666|NCT00987480|3918979|P1|COMPLETED|Overall Study||45
1602667|NCT00987480|3918979|P1|STARTED|Overall Study||45
1602668|NCT00987467|3918988|P1|NOT COMPLETED|Overall Study||2
1602669|NCT00987467|3918988|P1|COMPLETED|Overall Study||10
1602670|NCT00987467|3918988|P1|STARTED|Overall Study||12
1602671|NCT00987415|3918995|P2|NOT COMPLETED|Overall Study||9
1602672|NCT00987415|3918996|P1|NOT COMPLETED|Overall Study||9
1602673|NCT00987415|3918995|P2|COMPLETED|Overall Study||116
1602674|NCT00987415|3918996|P1|COMPLETED|Overall Study||119
1602675|NCT00987415|3918995|P2|STARTED|Overall Study||125
1602676|NCT00987415|3918996|P1|STARTED|Overall Study||128
1602677|NCT00987402|3919012|P2|NOT COMPLETED|Overall Study||98
1602678|NCT00987402|3919013|P1|NOT COMPLETED|Overall Study||86
1602679|NCT00987402|3919012|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
1602680|NCT00987402|3919013|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
1602681|NCT00987402|3919012|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
1602682|NCT00987402|3919013|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
1602683|NCT00987337|3919022|P3|NOT COMPLETED|Overall Study||51
1602684|NCT00987337|3919023|P2|NOT COMPLETED|Overall Study||55
1602685|NCT00987337|3919024|P1|NOT COMPLETED|Overall Study||57
1602686|NCT00987337|3919022|P3|COMPLETED|Overall Study||45
1602687|NCT00987337|3919023|P2|COMPLETED|Overall Study||41
1602688|NCT00987337|3919024|P1|COMPLETED|Overall Study||39
1602689|NCT00987337|3919022|P3|STARTED|Overall Study||96
1602690|NCT00987337|3919023|P2|STARTED|Overall Study||96
1602691|NCT00987337|3919024|P1|STARTED|Overall Study||96
1602692|NCT00986999|3919068|P1|NOT COMPLETED|Overall Study||1
1602693|NCT00986999|3919068|P1|COMPLETED|Overall Study||6
1602694|NCT00986999|3919068|P1|STARTED|Overall Study||7
1602695|NCT00986986|3919079|P2|NOT COMPLETED|Overall Study||1
1602696|NCT00986986|3919080|P1|NOT COMPLETED|Overall Study||0
1602697|NCT00986986|3919079|P2|COMPLETED|Overall Study||9
1602698|NCT00986986|3919080|P1|COMPLETED|Overall Study||10
1602699|NCT00986986|3919079|P2|STARTED|Overall Study||10
1602700|NCT00986986|3919080|P1|STARTED|Overall Study||10
1602701|NCT00986973|3919090|P1|NOT COMPLETED|Overall Study||1
1602702|NCT00986973|3919090|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
1602703|NCT00986973|3919090|P1|STARTED|Overall Study||6
1602704|NCT00986960|3919102|P2|NOT COMPLETED|Overall Study||0
1602705|NCT00986960|3919103|P1|NOT COMPLETED|Overall Study||0
1602706|NCT00986960|3919102|P2|COMPLETED|Overall Study||0
1602707|NCT00986960|3919103|P1|COMPLETED|Overall Study||0
1602708|NCT00986960|3919102|P2|STARTED|Overall Study||0
1602709|NCT00986960|3919103|P1|STARTED|Overall Study||0
1602710|NCT00986947|3919109|P1|NOT COMPLETED|Overall Study||20
1602711|NCT00986947|3919109|P1|COMPLETED|Overall Study||0
1602712|NCT00986947|3919109|P1|STARTED|Overall Study||20
1602713|NCT00986921|3919116|P2|NOT COMPLETED|Overall Study||0
1602714|NCT00986921|3919117|P1|NOT COMPLETED|Overall Study||1
1602715|NCT00986921|3919116|P2|COMPLETED|Overall Study||25
1602716|NCT00986921|3919117|P1|COMPLETED|Overall Study||24
1602717|NCT00986921|3919116|P2|STARTED|Overall Study||25
1602718|NCT00986921|3919117|P1|STARTED|Overall Study||25
1602719|NCT00986856|3919129|P2|NOT COMPLETED|Overall Study||0
1602720|NCT00986856|3919130|P1|NOT COMPLETED|Overall Study||0
1602721|NCT00986856|3919129|P2|COMPLETED|Overall Study||16
1602722|NCT00986856|3919130|P1|COMPLETED|Overall Study||42
1602723|NCT00986856|3919129|P2|STARTED|Overall Study||16
1602724|NCT00986856|3919130|P1|STARTED|Overall Study||42
1602725|NCT00986674|3919153|P3|NOT COMPLETED|Overall Study||48
1602726|NCT00986674|3919154|P2|NOT COMPLETED|Overall Study||45
1602727|NCT00986674|3919155|P1|NOT COMPLETED|Overall Study||47
1602728|NCT00986674|3919153|P3|COMPLETED|Overall Study||0
1602729|NCT00986674|3919154|P2|COMPLETED|Overall Study||0
1602730|NCT00986674|3919155|P1|COMPLETED|Overall Study||0
1602731|NCT00986674|3919153|P3|Eligible and Treated|Overall Study||47
1602732|NCT00986674|3919154|P2|Eligible and Treated|Overall Study||41
1602733|NCT00986674|3919155|P1|Eligible and Treated|Overall Study||39
1602734|NCT00986674|3919153|P3|Treated|Overall Study||47
1602735|NCT00986674|3919154|P2|Treated|Overall Study||42
1602736|NCT00986674|3919155|P1|Treated|Overall Study||43
1602737|NCT00986674|3919153|P3|STARTED|Overall Study||48
1602738|NCT00986674|3919154|P2|STARTED|Overall Study||45
1602739|NCT00986674|3919155|P1|STARTED|Overall Study||47
1602740|NCT00986583|3919171|P2|NOT COMPLETED|Overall Study||0
1602741|NCT00986583|3919172|P1|NOT COMPLETED|Overall Study||0
1602742|NCT00986583|3919171|P2|COMPLETED|Overall Study||32
1602743|NCT00986583|3919172|P1|COMPLETED|Overall Study||38
1602744|NCT00986583|3919171|P2|STARTED|Overall Study||32
1602745|NCT00986583|3919172|P1|STARTED|Overall Study||38
1602746|NCT00986570|3919188|P1|NOT COMPLETED|Overall Study||7
1602747|NCT00986570|3919188|P1|COMPLETED|Overall Study||114
1602748|NCT00986570|3919188|P1|STARTED|Overall Study||121
1602749|NCT00986544|3919194|P2|NOT COMPLETED|Overall Study||0
1602750|NCT00986544|3919195|P1|NOT COMPLETED|Overall Study||0
1602751|NCT00986544|3919194|P2|COMPLETED|Overall Study||53
1602752|NCT00986544|3919195|P1|COMPLETED|Overall Study||53
1602753|NCT00986544|3919194|P2|STARTED|Overall Study||53
1602754|NCT00986544|3919195|P1|STARTED|Overall Study||53
1602755|NCT00986479|3919205|P2|NOT COMPLETED|Period 2||0
1602756|NCT00986479|3919206|P1|NOT COMPLETED|Period 2||0
1602757|NCT00986479|3919205|P2|COMPLETED|Period 2||10
1602758|NCT00986479|3919206|P1|COMPLETED|Period 2||10
1602759|NCT00986479|3919205|P2|STARTED|Period 2||10
1602760|NCT00986479|3919206|P1|STARTED|Period 2||10
1602761|NCT00986479|3919205|P2|NOT COMPLETED|Period 1||0
1602762|NCT00986479|3919206|P1|NOT COMPLETED|Period 1||2
1602763|NCT00986479|3919205|P2|COMPLETED|Period 1||10
1602764|NCT00986479|3919206|P1|COMPLETED|Period 1||10
1602765|NCT00986479|3919205|P2|STARTED|Period 1||10
1602766|NCT00986479|3919206|P1|STARTED|Period 1||12
1602767|NCT00986453|3919236|P1|NOT COMPLETED|Overall Study||2
1602768|NCT00986453|3919236|P1|COMPLETED|Overall Study||43
1602769|NCT00986453|3919236|P1|STARTED|Overall Study||45
1602770|NCT00986427|3919252|P2|NOT COMPLETED|Overall Study||0
1602771|NCT00986427|3919253|P1|NOT COMPLETED|Overall Study||4
1602772|NCT00986427|3919252|P2|COMPLETED|Overall Study||12
1602773|NCT00986427|3919253|P1|COMPLETED|Overall Study||8
1602774|NCT00986427|3919252|P2|STARTED|Overall Study||12
1602775|NCT00986427|3919253|P1|STARTED|Overall Study||12
1602776|NCT00986401|3919269|P2|NOT COMPLETED|Period 2||0
1602777|NCT00986401|3919270|P1|NOT COMPLETED|Period 2||0
1602778|NCT00986401|3919269|P2|COMPLETED|Period 2||21
1602779|NCT00986401|3919270|P1|COMPLETED|Period 2||22
1602780|NCT00986401|3919269|P2|STARTED|Period 2||21
1602781|NCT00986401|3919270|P1|STARTED|Period 2||22
1602782|NCT00986401|3919269|P2|NOT COMPLETED|Period 1||1
1602783|NCT00986401|3919270|P1|NOT COMPLETED|Period 1||0
1602784|NCT00986401|3919269|P2|COMPLETED|Period 1||21
1602785|NCT00986401|3919270|P1|COMPLETED|Period 1||22
1602786|NCT00986401|3919269|P2|STARTED|Period 1||22
1602787|NCT00986401|3919270|P1|STARTED|Period 1||22
1602788|NCT00986362|3919281|P2|NOT COMPLETED|Overall Study||1
1602789|NCT00986362|3919282|P1|NOT COMPLETED|Overall Study||2
1602790|NCT00986362|3919281|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
1602791|NCT00986362|3919282|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
1602792|NCT00986362|3919281|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
1602793|NCT00986362|3919282|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
1602794|NCT00986349|3919288|P1|NOT COMPLETED|Overall Study||7
1602795|NCT00986349|3919288|P1|COMPLETED|Overall Study||16
1602796|NCT00986349|3919288|P1|Early Explant|Overall Study||4
1602797|NCT00986349|3919288|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
1602798|NCT00986349|3919288|P1|STARTED|Overall Study|attempted implant procedures|23
1602799|NCT00986258|3919301|P1|NOT COMPLETED|Maintenance Period||9
1602800|NCT00986258|3919301|P1|COMPLETED|Maintenance Period||93
1602801|NCT00986258|3919301|P1|STARTED|Maintenance Period||102
1602802|NCT00986258|3919301|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
1602803|NCT00986258|3919301|P1|COMPLETED|Titration and Optimal Dose Period||102
1602804|NCT00986258|3919301|P1|STARTED|Titration and Optimal Dose Period||125
1602805|NCT00986258|3919301|P1|NOT COMPLETED|Observation Period||11
1602806|NCT00986258|3919301|P1|COMPLETED|Observation Period||125
1602807|NCT00986258|3919301|P1|STARTED|Observation Period||136
1602808|NCT00986245|3919329|P2|NOT COMPLETED|Second Intervention||1
1602809|NCT00986245|3919330|P1|NOT COMPLETED|Second Intervention||2
1602810|NCT00986245|3919329|P2|COMPLETED|Second Intervention||32
1602811|NCT00986245|3919330|P1|COMPLETED|Second Intervention||29
1602812|NCT00986245|3919329|P2|STARTED|Second Intervention||33
1602813|NCT00986245|3919330|P1|STARTED|Second Intervention||31
1602814|NCT00986245|3919329|P2|NOT COMPLETED|First Intervention||8
1602815|NCT00986245|3919330|P1|NOT COMPLETED|First Intervention||10
1602816|NCT00986245|3919329|P2|COMPLETED|First Intervention||33
1602817|NCT00986245|3919330|P1|COMPLETED|First Intervention||31
1602818|NCT00986245|3919329|P2|STARTED|First Intervention||41
1602819|NCT00986245|3919330|P1|STARTED|First Intervention||41
1602820|NCT00986232|3919367|P4|NOT COMPLETED|Overall Study||20
1602821|NCT00986232|3919368|P3|NOT COMPLETED|Overall Study||35
1602822|NCT00986232|3919369|P2|NOT COMPLETED|Overall Study||50
1602823|NCT00986232|3919370|P1|NOT COMPLETED|Overall Study||51
1602824|NCT00986232|3919367|P4|COMPLETED|Overall Study||370
1602825|NCT00986232|3919368|P3|COMPLETED|Overall Study||346
1602826|NCT00986232|3919369|P2|COMPLETED|Overall Study||343
1602827|NCT00986232|3919370|P1|COMPLETED|Overall Study||336
1602828|NCT00986232|3919367|P4|Vaccination Visit 2|Overall Study||0
1602829|NCT00986232|3919368|P3|Vaccination Visit 2|Overall Study||360
1602830|NCT00986232|3919369|P2|Vaccination Visit 2|Overall Study||365
1602831|NCT00986232|3919370|P1|Vaccination Visit 2|Overall Study||360
1602832|NCT00986232|3919367|P4|Vaccination Visit 1|Overall Study||390
1602833|NCT00986232|3919368|P3|Vaccination Visit 1|Overall Study||381
1602834|NCT00986232|3919369|P2|Vaccination Visit 1|Overall Study||393
1602835|NCT00986232|3919370|P1|Vaccination Visit 1|Overall Study||387
1602836|NCT00986232|3919367|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
1602837|NCT00986232|3919368|P3|STARTED|Overall Study||381
1602838|NCT00986232|3919369|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
1602839|NCT00986232|3919370|P1|STARTED|Overall Study||387
1602840|NCT00986180|3919444|P2|NOT COMPLETED|Overall Study||56
1602841|NCT00986180|3919445|P1|NOT COMPLETED|Overall Study||44
1602842|NCT00986180|3919444|P2|COMPLETED|Overall Study||268
1602843|NCT00986180|3919445|P1|COMPLETED|Overall Study||277
1602844|NCT00986180|3919444|P2|STARTED|Overall Study||324
1602845|NCT00986180|3919445|P1|STARTED|Overall Study||321
1602846|NCT00986154|3919523|P2|NOT COMPLETED|Overall Study||194
1602847|NCT00986154|3919524|P1|NOT COMPLETED|Overall Study||206
1602848|NCT00986154|3919523|P2|COMPLETED|Overall Study||3955
1602849|NCT00986154|3919524|P1|COMPLETED|Overall Study||3937
1602850|NCT00986154|3919523|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
1602851|NCT00986154|3919524|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
1602852|NCT00986154|3919523|P2|STARTED|Overall Study||4149
1602853|NCT00986154|3919524|P1|STARTED|Overall Study||4143
1602854|NCT00986102|3919538|P4|NOT COMPLETED|Overall Study||1
1602855|NCT00986102|3919539|P3|NOT COMPLETED|Overall Study||0
1602856|NCT00986102|3919540|P2|NOT COMPLETED|Overall Study||2
1602857|NCT00986102|3919541|P1|NOT COMPLETED|Overall Study||1
1602858|NCT00986102|3919538|P4|COMPLETED|Overall Study||66
1602859|NCT00986102|3919539|P3|COMPLETED|Overall Study||19
1602860|NCT00986102|3919540|P2|COMPLETED|Overall Study||75
1602861|NCT00986102|3919541|P1|COMPLETED|Overall Study||52
1602862|NCT00986102|3919538|P4|STARTED|Overall Study|Number of participants who received study medication|67
1602863|NCT00986102|3919539|P3|STARTED|Overall Study|Number of participants who received study medication|19
1602864|NCT00986102|3919540|P2|STARTED|Overall Study|Number of participants who received study medication|77
1602865|NCT00986102|3919541|P1|STARTED|Overall Study|Number of participants who received study medication|53
1602866|NCT00985985|3919591|P4|NOT COMPLETED|Overall Study||13
1602867|NCT00985985|3919592|P3|NOT COMPLETED|Overall Study||11
1602868|NCT00985985|3919593|P2|NOT COMPLETED|Overall Study||24
1602869|NCT00985985|3919594|P1|NOT COMPLETED|Overall Study||24
1602870|NCT00985985|3919591|P4|COMPLETED|Overall Study||107
1602871|NCT00985985|3919592|P3|COMPLETED|Overall Study||109
1602872|NCT00985985|3919593|P2|COMPLETED|Overall Study||218
1602873|NCT00985985|3919594|P1|COMPLETED|Overall Study||217
1602874|NCT00985985|3919591|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
1602875|NCT00985985|3919592|P3|Full Analysis Set (FAS) Population|Overall Study||120
1602876|NCT00985985|3919593|P2|Full Analysis Set (FAS) Population|Overall Study||242
1602877|NCT00985985|3919594|P1|Full Analysis Set (FAS) Population|Overall Study||241
1602878|NCT00985985|3919591|P4|Safety Population|Overall Study||118
1602879|NCT00985985|3919592|P3|Safety Population|Overall Study||119
1602880|NCT00985985|3919593|P2|Safety Population|Overall Study||242
1602881|NCT00985985|3919594|P1|Safety Population|Overall Study||241
1602882|NCT00985985|3919591|P4|STARTED|Overall Study||120
1602883|NCT00985985|3919592|P3|STARTED|Overall Study||120
1602884|NCT00985985|3919593|P2|STARTED|Overall Study||242
1602885|NCT00985985|3919594|P1|STARTED|Overall Study||241
1602886|NCT00985959|3919635|P3|NOT COMPLETED|Overall Study||59
1602887|NCT00985959|3919636|P2|NOT COMPLETED|Overall Study||3
1602888|NCT00985959|3919637|P1|NOT COMPLETED|Overall Study||3
1602889|NCT00985959|3919635|P3|COMPLETED|Overall Study||28
1602890|NCT00985959|3919636|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
1602891|NCT00985959|3919637|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
1602892|NCT00985959|3919635|P3|STARTED|Overall Study|Number of participants treated|87
1602893|NCT00985959|3919636|P2|STARTED|Overall Study|Number of participants treated|6
1602894|NCT00985959|3919637|P1|STARTED|Overall Study|Number of participants treated|6
1602895|NCT00985946|3919660|P1|NOT COMPLETED|Overall Study||7
1602896|NCT00985946|3919660|P1|COMPLETED|Overall Study||8
1602897|NCT00985946|3919660|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
1602898|NCT00985829|3919668|P1|NOT COMPLETED|Overall Study||0
1602899|NCT00985829|3919668|P1|COMPLETED|Overall Study||28
1602900|NCT00985829|3919668|P1|STARTED|Overall Study||28
1602901|NCT00985790|3919679|P2|NOT COMPLETED|Overall Study||8
1602902|NCT00985790|3919680|P1|NOT COMPLETED|Overall Study||7
1602903|NCT00985790|3919679|P2|COMPLETED|Overall Study||293
1602904|NCT00985790|3919680|P1|COMPLETED|Overall Study||291
1602905|NCT00985790|3919679|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
1602906|NCT00985790|3919680|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
1602907|NCT00985751|3919721|P5|NOT COMPLETED|Overall Study||1
1602908|NCT00985751|3919722|P4|NOT COMPLETED|Overall Study||0
1602909|NCT00985751|3919723|P3|NOT COMPLETED|Overall Study||0
1602910|NCT00985751|3919724|P2|NOT COMPLETED|Overall Study||0
1602911|NCT00985751|3919725|P1|NOT COMPLETED|Overall Study||0
1602912|NCT00985751|3919721|P5|COMPLETED|Overall Study||50
1602913|NCT00985751|3919722|P4|COMPLETED|Overall Study||51
1602914|NCT00985751|3919723|P3|COMPLETED|Overall Study||52
1602915|NCT00985751|3919724|P2|COMPLETED|Overall Study||52
1602916|NCT00985751|3919725|P1|COMPLETED|Overall Study||51
1602917|NCT00985751|3919721|P5|STARTED|Overall Study||51
1602918|NCT00985751|3919722|P4|STARTED|Overall Study||51
1602919|NCT00985751|3919723|P3|STARTED|Overall Study||52
1602920|NCT00985751|3919724|P2|STARTED|Overall Study||52
1602921|NCT00985751|3919725|P1|STARTED|Overall Study||51
1602922|NCT00985738|3919788|P2|NOT COMPLETED|Overall Study||8
1602923|NCT00985738|3919789|P1|NOT COMPLETED|Overall Study||8
1602924|NCT00985738|3919788|P2|COMPLETED|Overall Study||0
1602925|NCT00985738|3919789|P1|COMPLETED|Overall Study||0
1602926|NCT00985738|3919788|P2|STARTED|Overall Study||8
1602927|NCT00985738|3919789|P1|STARTED|Overall Study||8
1602928|NCT00985725|3919797|P2|NOT COMPLETED|Overall Study||13
1602929|NCT00985725|3919798|P1|NOT COMPLETED|Overall Study||11
1602930|NCT00985725|3919797|P2|COMPLETED|Overall Study||59
1602931|NCT00985725|3919798|P1|COMPLETED|Overall Study||60
1602932|NCT00985725|3919797|P2|STARTED|Overall Study||72
1602933|NCT00985725|3919798|P1|STARTED|Overall Study||71
1602934|NCT00985712|3919834|P2|NOT COMPLETED|Overall Study||7
1602935|NCT00985712|3919835|P1|NOT COMPLETED|Overall Study||6
1602936|NCT00985712|3919834|P2|COMPLETED|Overall Study||123
1602937|NCT00985712|3919835|P1|COMPLETED|Overall Study||127
1602938|NCT00985712|3919834|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
1602939|NCT00985712|3919835|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
1602940|NCT00985712|3919834|P2|Received at Least One Dose of Study Drug|Overall Study||130
1602941|NCT00985712|3919835|P1|Received at Least One Dose of Study Drug|Overall Study||131
1602942|NCT00985712|3919834|P2|STARTED|Overall Study||130
1602943|NCT00985712|3919835|P1|STARTED|Overall Study||133
1602944|NCT00985686|3919853|P4|NOT COMPLETED|Overall Study||2
1602945|NCT00985686|3919854|P3|NOT COMPLETED|Overall Study||0
1602946|NCT00985686|3919855|P2|NOT COMPLETED|Overall Study||1
1602947|NCT00985686|3919856|P1|NOT COMPLETED|Overall Study||1
1602948|NCT00985686|3919853|P4|COMPLETED|Overall Study||14
1602949|NCT00985686|3919854|P3|COMPLETED|Overall Study||13
1602950|NCT00985686|3919855|P2|COMPLETED|Overall Study||15
1602951|NCT00985686|3919856|P1|COMPLETED|Overall Study||17
1602952|NCT00985686|3919853|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
1602953|NCT00985686|3919854|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
1602954|NCT00985686|3919855|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
1602955|NCT00985686|3919856|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
1602956|NCT00985686|3919853|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
1602957|NCT00985686|3919854|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
1602958|NCT00985686|3919855|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
1602959|NCT00985686|3919856|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
1602960|NCT00985686|3919853|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
1602961|NCT00985686|3919854|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
1602962|NCT00985686|3919855|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
1602963|NCT00985686|3919856|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
1602964|NCT00985686|3919853|P4|Visit 1: Baseline Data Collection|Overall Study||16
1602965|NCT00985686|3919854|P3|Visit 1: Baseline Data Collection|Overall Study||13
1602966|NCT00985686|3919855|P2|Visit 1: Baseline Data Collection|Overall Study||15
1602967|NCT00985686|3919856|P1|Visit 1: Baseline Data Collection|Overall Study||18
1602968|NCT00985686|3919853|P4|STARTED|Overall Study||16
1602969|NCT00985686|3919854|P3|STARTED|Overall Study||13
1602970|NCT00985686|3919855|P2|STARTED|Overall Study||16
1602971|NCT00985686|3919856|P1|STARTED|Overall Study||18
1602972|NCT00985673|3919870|P6|NOT COMPLETED|Overall Study||6
1602973|NCT00985673|3919871|P5|NOT COMPLETED|Overall Study||8
1602974|NCT00985673|3919872|P4|NOT COMPLETED|Overall Study||12
1602975|NCT00985673|3919873|P3|NOT COMPLETED|Overall Study||12
1602976|NCT00985673|3919874|P2|NOT COMPLETED|Overall Study||11
1602977|NCT00985673|3919875|P1|NOT COMPLETED|Overall Study||7
1602978|NCT00985673|3919870|P6|COMPLETED|Overall Study||96
1602979|NCT00985673|3919871|P5|COMPLETED|Overall Study||93
1602980|NCT00985673|3919872|P4|COMPLETED|Overall Study||88
1602981|NCT00985673|3919873|P3|COMPLETED|Overall Study||90
1602982|NCT00985673|3919874|P2|COMPLETED|Overall Study||93
1602983|NCT00985673|3919875|P1|COMPLETED|Overall Study||95
1602984|NCT00985673|3919870|P6|STARTED|Overall Study||102
1602985|NCT00985673|3919871|P5|STARTED|Overall Study||101
1602986|NCT00985673|3919872|P4|STARTED|Overall Study||100
1602987|NCT00985673|3919873|P3|STARTED|Overall Study||102
1602988|NCT00985673|3919874|P2|STARTED|Overall Study||104
1602989|NCT00985673|3919875|P1|STARTED|Overall Study||102
1602990|NCT00985543|3920126|P1|NOT COMPLETED|Overall Study||0
1602991|NCT00985543|3920126|P1|COMPLETED|Overall Study||22
1602992|NCT00985543|3920126|P1|STARTED|Overall Study||22
1602993|NCT00985504|3920137|P2|NOT COMPLETED|Optimization Period||23
1602994|NCT00985504|3920138|P1|NOT COMPLETED|Optimization Period||26
1602995|NCT00985504|3920137|P2|COMPLETED|Optimization Period||204
1602996|NCT00985504|3920138|P1|COMPLETED|Optimization Period||203
1602997|NCT00985504|3920137|P2|STARTED|Optimization Period||227
1602998|NCT00985504|3920138|P1|STARTED|Optimization Period||229
1602999|NCT00985504|3920137|P2|NOT COMPLETED|Acute Treatment Period||12
1603000|NCT00985504|3920138|P1|NOT COMPLETED|Acute Treatment Period||15
1603001|NCT00985504|3920137|P2|COMPLETED|Acute Treatment Period||227
1603002|NCT00985504|3920138|P1|COMPLETED|Acute Treatment Period||229
1603003|NCT00985504|3920137|P2|STARTED|Acute Treatment Period||239
1603004|NCT00985504|3920138|P1|STARTED|Acute Treatment Period||244
1603005|NCT00985491|3920164|P1|NOT COMPLETED|Overall Study||19
1603006|NCT00985491|3920164|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
1603007|NCT00985491|3920164|P1|Received Device|Overall Study||43
1603008|NCT00985491|3920164|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
1603009|NCT00985465|3920171|P2|NOT COMPLETED|Overall Study||3
1603010|NCT00985465|3920172|P1|NOT COMPLETED|Overall Study||1
1603011|NCT00985465|3920171|P2|COMPLETED|Overall Study||66
1603012|NCT00985465|3920172|P1|COMPLETED|Overall Study||140
1603013|NCT00985465|3920171|P2|STARTED|Overall Study||69
1603014|NCT00985465|3920172|P1|STARTED|Overall Study||141
1603015|NCT00985439|3920199|P4|NOT COMPLETED|Overall Study||0
1603016|NCT00985439|3920200|P3|NOT COMPLETED|Overall Study||1
1603017|NCT00985439|3920201|P2|NOT COMPLETED|Overall Study||0
1603018|NCT00985439|3920202|P1|NOT COMPLETED|Overall Study||0
1603019|NCT00985439|3920199|P4|COMPLETED|Overall Study||51
1603020|NCT00985439|3920200|P3|COMPLETED|Overall Study||50
1603021|NCT00985439|3920201|P2|COMPLETED|Overall Study||51
1603022|NCT00985439|3920202|P1|COMPLETED|Overall Study||49
1603023|NCT00985439|3920199|P4|STARTED|Overall Study||51
1603024|NCT00985439|3920200|P3|STARTED|Overall Study||51
1603025|NCT00985439|3920201|P2|STARTED|Overall Study||51
1603026|NCT00985439|3920202|P1|STARTED|Overall Study||49
1603027|NCT00985257|3920212|P1|NOT COMPLETED|Overall Study||0
1603028|NCT00985257|3920212|P1|COMPLETED|Overall Study||123
1603029|NCT00985257|3920212|P1|STARTED|Overall Study||123
1603030|NCT00985231|3920218|P2|NOT COMPLETED|Overall Study||3
1603031|NCT00985231|3920219|P1|NOT COMPLETED|Overall Study||3
1603032|NCT00985231|3920218|P2|COMPLETED|Overall Study||129
1603033|NCT00985231|3920219|P1|COMPLETED|Overall Study||130
1603034|NCT00985231|3920218|P2|STARTED|Overall Study||132
1603035|NCT00985231|3920219|P1|STARTED|Overall Study||133
1603036|NCT00985192|3920227|P1|NOT COMPLETED|Overall Study||4
1603037|NCT00985192|3920227|P1|COMPLETED|Overall Study||45
1603038|NCT00985192|3920227|P1|STARTED|Overall Study||49
1603039|NCT00985166|3920239|P3|NOT COMPLETED|Overall Study||7
1603040|NCT00985166|3920240|P2|NOT COMPLETED|Overall Study||4
1603041|NCT00985166|3920241|P1|NOT COMPLETED|Overall Study||9
1603042|NCT00985166|3920239|P3|COMPLETED|Overall Study||188
1603043|NCT00985166|3920240|P2|COMPLETED|Overall Study||201
1603044|NCT00985166|3920241|P1|COMPLETED|Overall Study||392
1603045|NCT00985166|3920239|P3|Vaccinated at Visit 1|Overall Study||195
1603046|NCT00985166|3920240|P2|Vaccinated at Visit 1|Overall Study||205
1603047|NCT00985166|3920241|P1|Vaccinated at Visit 1|Overall Study||399
1603048|NCT00985166|3920239|P3|STARTED|Overall Study||195
1603049|NCT00985166|3920240|P2|STARTED|Overall Study||205
1603050|NCT00985166|3920241|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
1603051|NCT00985153|3920261|P4|NOT COMPLETED|Overall Study||47
1603052|NCT00985153|3920262|P3|NOT COMPLETED|Overall Study||44
1603053|NCT00985153|3920263|P2|NOT COMPLETED|Overall Study||44
1603054|NCT00985153|3920264|P1|NOT COMPLETED|Overall Study||35
1603055|NCT00985153|3920261|P4|COMPLETED|Overall Study||965
1603056|NCT00985153|3920262|P3|COMPLETED|Overall Study||918
1603057|NCT00985153|3920263|P2|COMPLETED|Overall Study||924
1603058|NCT00985153|3920264|P1|COMPLETED|Overall Study||950
1603059|NCT00985153|3920261|P4|Vaccinated at Visit 1|Overall Study||1012
1603060|NCT00985153|3920262|P3|Vaccinated at Visit 1|Overall Study||962
1603061|NCT00985153|3920263|P2|Vaccinated at Visit 1|Overall Study||968
1603062|NCT00985153|3920264|P1|Vaccinated at Visit 1|Overall Study||985
1603063|NCT00985153|3920261|P4|STARTED|Overall Study||1012
1603064|NCT00985153|3920262|P3|STARTED|Overall Study||962
1603065|NCT00985153|3920263|P2|STARTED|Overall Study||968
1603066|NCT00985153|3920264|P1|STARTED|Overall Study||985
1603067|NCT00985140|3920306|P1|NOT COMPLETED|Overall Study||0
1603068|NCT00985140|3920306|P1|COMPLETED|Overall Study||15
1603069|NCT00985140|3920306|P1|STARTED|Overall Study||15
1603070|NCT00985114|3920312|P2|NOT COMPLETED|Overall Study||2
1603071|NCT00985114|3920313|P1|NOT COMPLETED|Overall Study||1
1603072|NCT00985114|3920312|P2|COMPLETED|Overall Study||37
1603073|NCT00985114|3920313|P1|COMPLETED|Overall Study||33
1603074|NCT00985114|3920312|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
1603075|NCT00985114|3920313|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
1603076|NCT00985114|3920312|P2|STARTED|Overall Study||39
1603077|NCT00985114|3920313|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
1603078|NCT00985088|3920327|P8|NOT COMPLETED|Overall Study||6
1603079|NCT00985088|3920328|P7|NOT COMPLETED|Overall Study||4
1603080|NCT00985088|3920329|P6|NOT COMPLETED|Overall Study||7
1603081|NCT00985088|3920330|P5|NOT COMPLETED|Overall Study||9
1603082|NCT00985088|3920331|P4|NOT COMPLETED|Overall Study||7
1603083|NCT00985088|3920332|P3|NOT COMPLETED|Overall Study||4
1603084|NCT00985088|3920333|P2|NOT COMPLETED|Overall Study||2
1603085|NCT00985088|3920334|P1|NOT COMPLETED|Overall Study||11
1603086|NCT00985088|3920327|P8|COMPLETED|Overall Study||216
1603087|NCT00985088|3920328|P7|COMPLETED|Overall Study||107
1603088|NCT00985088|3920329|P6|COMPLETED|Overall Study||108
1603089|NCT00985088|3920330|P5|COMPLETED|Overall Study||214
1603090|NCT00985088|3920331|P4|COMPLETED|Overall Study||214
1603091|NCT00985088|3920332|P3|COMPLETED|Overall Study||108
1603092|NCT00985088|3920333|P2|COMPLETED|Overall Study||112
1603093|NCT00985088|3920334|P1|COMPLETED|Overall Study||211
1603094|NCT00985088|3920327|P8|STARTED|Overall Study||222
1603095|NCT00985088|3920328|P7|STARTED|Overall Study||111
1603096|NCT00985088|3920329|P6|STARTED|Overall Study||115
1603097|NCT00985088|3920330|P5|STARTED|Overall Study||223
1603098|NCT00985088|3920331|P4|STARTED|Overall Study||221
1603099|NCT00985088|3920332|P3|STARTED|Overall Study||112
1603100|NCT00985088|3920333|P2|STARTED|Overall Study||114
1603101|NCT00985088|3920334|P1|STARTED|Overall Study||222
1603102|NCT00985010|3920592|P2|NOT COMPLETED|Overall Study||0
1603103|NCT00985010|3920593|P1|NOT COMPLETED|Overall Study||0
1603104|NCT00985010|3920592|P2|COMPLETED|Overall Study||5
1603105|NCT00985010|3920593|P1|COMPLETED|Overall Study||4
1603106|NCT00985010|3920592|P2|STARTED|Overall Study||5
1603107|NCT00985010|3920593|P1|STARTED|Overall Study||4
1603108|NCT00984867|3920603|P2|NOT COMPLETED|Overall Study||17
1603109|NCT00984867|3920604|P1|NOT COMPLETED|Overall Study||23
1603110|NCT00984867|3920603|P2|COMPLETED|Overall Study||208
1603111|NCT00984867|3920604|P1|COMPLETED|Overall Study||203
1603112|NCT00984867|3920603|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
1603113|NCT00984867|3920604|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
1603114|NCT00984815|3920622|P1|NOT COMPLETED|Overall Study||30
1603115|NCT00984815|3920622|P1|COMPLETED|Overall Study||56
1603116|NCT00984815|3920622|P1|STARTED|Overall Study||86
1603117|NCT00984698|3920631|P2|NOT COMPLETED|Overall Study||8
1603118|NCT00984698|3920632|P1|NOT COMPLETED|Overall Study||3
1603119|NCT00984698|3920631|P2|COMPLETED|Overall Study||14
1603120|NCT00984698|3920632|P1|COMPLETED|Overall Study||18
1603121|NCT00984698|3920631|P2|STARTED|Overall Study||22
1603122|NCT00984698|3920632|P1|STARTED|Overall Study||21
1603123|NCT00984659|3920644|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
1603124|NCT00984659|3920645|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
1603125|NCT00984659|3920646|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
1603126|NCT00984659|3920647|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
1603127|NCT00984659|3920644|P4|COMPLETED|6-week Double-blind Treatment Period||126
1603128|NCT00984659|3920645|P3|COMPLETED|6-week Double-blind Treatment Period||141
1603129|NCT00984659|3920646|P2|COMPLETED|6-week Double-blind Treatment Period||69
1603130|NCT00984659|3920647|P1|COMPLETED|6-week Double-blind Treatment Period||0
1603131|NCT00984659|3920644|P4|STARTED|6-week Double-blind Treatment Period||139
1603132|NCT00984659|3920645|P3|STARTED|6-week Double-blind Treatment Period||152
1603133|NCT00984659|3920646|P2|STARTED|6-week Double-blind Treatment Period||75
1603134|NCT00984659|3920647|P1|STARTED|6-week Double-blind Treatment Period||0
1603135|NCT00984659|3920644|P4|NOT COMPLETED|2-week Run-in Period||0
1603136|NCT00984659|3920645|P3|NOT COMPLETED|2-week Run-in Period||0
1603137|NCT00984659|3920646|P2|NOT COMPLETED|2-week Run-in Period||0
1603138|NCT00984659|3920647|P1|NOT COMPLETED|2-week Run-in Period||52
1603139|NCT00984659|3920644|P4|COMPLETED|2-week Run-in Period||0
1603140|NCT00984659|3920645|P3|COMPLETED|2-week Run-in Period||0
1603141|NCT00984659|3920646|P2|COMPLETED|2-week Run-in Period||0
1603142|NCT00984659|3920647|P1|COMPLETED|2-week Run-in Period||366
1603143|NCT00984659|3920644|P4|STARTED|2-week Run-in Period||0
1603144|NCT00984659|3920645|P3|STARTED|2-week Run-in Period||0
1603145|NCT00984659|3920646|P2|STARTED|2-week Run-in Period||0
1603146|NCT00984659|3920647|P1|STARTED|2-week Run-in Period||418
1603147|NCT00984620|3920674|P2|NOT COMPLETED|Overall Study||12
1603148|NCT00984620|3920675|P1|NOT COMPLETED|Overall Study||6
1603149|NCT00984620|3920674|P2|COMPLETED|Overall Study||67
1603150|NCT00984620|3920675|P1|COMPLETED|Overall Study||75
1603151|NCT00984620|3920674|P2|STARTED|Overall Study||79
1603152|NCT00984620|3920675|P1|STARTED|Overall Study||81
1603153|NCT00984594|3920713|P2|NOT COMPLETED|Overall Study||1
1603154|NCT00984594|3920714|P1|NOT COMPLETED|Overall Study||1
1603155|NCT00984594|3920713|P2|COMPLETED|Overall Study||1
1603156|NCT00984594|3920714|P1|COMPLETED|Overall Study||1
1603157|NCT00984594|3920713|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
1603158|NCT00984594|3920714|P1|STARTED|Overall Study||2
1603159|NCT00984568|3920730|P2|NOT COMPLETED|Overall Study||6
1603160|NCT00984568|3920731|P1|NOT COMPLETED|Overall Study||8
1603161|NCT00984568|3920730|P2|COMPLETED|Overall Study||7
1603162|NCT00984568|3920731|P1|COMPLETED|Overall Study||7
1603163|NCT00984568|3920730|P2|STARTED|Overall Study||13
1603164|NCT00984568|3920731|P1|STARTED|Overall Study||15
1603165|NCT00984542|3920739|P1|NOT COMPLETED|Overall Study||41
1603166|NCT00984542|3920739|P1|COMPLETED|Overall Study||9
1603167|NCT00984542|3920739|P1|STARTED|Overall Study||50
1603168|NCT00984490|3920747|P1|NOT COMPLETED|Overall Study||0
1603169|NCT00984490|3920747|P1|COMPLETED|Overall Study||5
1603170|NCT00984490|3920747|P1|STARTED|Overall Study||5
1603171|NCT00984334|3920757|P5|NOT COMPLETED|Overall Study||1
1603172|NCT00984334|3920758|P4|NOT COMPLETED|Overall Study||1
1603173|NCT00984334|3920759|P3|NOT COMPLETED|Overall Study||0
1603174|NCT00984334|3920760|P2|NOT COMPLETED|Overall Study||1
1603175|NCT00984334|3920761|P1|NOT COMPLETED|Overall Study||1
1603176|NCT00984334|3920757|P5|COMPLETED|Overall Study||7
1603177|NCT00984334|3920758|P4|COMPLETED|Overall Study||7
1603178|NCT00984334|3920759|P3|COMPLETED|Overall Study||8
1603179|NCT00984334|3920760|P2|COMPLETED|Overall Study||7
1603180|NCT00984334|3920761|P1|COMPLETED|Overall Study||7
1603181|NCT00984334|3920757|P5|STARTED|Overall Study||8
1603182|NCT00984334|3920758|P4|STARTED|Overall Study||8
1603183|NCT00984334|3920759|P3|STARTED|Overall Study||8
1603184|NCT00984334|3920760|P2|STARTED|Overall Study||8
1603185|NCT00984334|3920761|P1|STARTED|Overall Study||8
1603186|NCT00984308|3920775|P2|NOT COMPLETED|Overall Study||6
1603187|NCT00984308|3920776|P1|NOT COMPLETED|Overall Study||18
1603188|NCT00984308|3920775|P2|COMPLETED|Overall Study||109
1603189|NCT00984308|3920776|P1|COMPLETED|Overall Study||92
1603190|NCT00984308|3920775|P2|STARTED|Overall Study||115
1603191|NCT00984308|3920776|P1|STARTED|Overall Study||110
1603192|NCT00984295|3920789|P3|NOT COMPLETED|Overall Study||37
1603193|NCT00984295|3920790|P2|NOT COMPLETED|Overall Study||32
1603194|NCT00984295|3920791|P1|NOT COMPLETED|Overall Study||65
1603195|NCT00984295|3920789|P3|COMPLETED|Overall Study||442
1603196|NCT00984295|3920790|P2|COMPLETED|Overall Study||453
1603197|NCT00984295|3920791|P1|COMPLETED|Overall Study||884
1603198|NCT00984295|3920789|P3|Visit 2|Overall Study||453
1603199|NCT00984295|3920790|P2|Visit 2|Overall Study||468
1603200|NCT00984295|3920791|P1|Visit 2|Overall Study||909
1603201|NCT00984295|3920789|P3|Visit 1|Overall Study||479
1603202|NCT00984295|3920790|P2|Visit 1|Overall Study||485
1603203|NCT00984295|3920791|P1|Visit 1|Overall Study||949
1603204|NCT00984295|3920789|P3|STARTED|Overall Study||479
1603205|NCT00984295|3920790|P2|STARTED|Overall Study||485
1603206|NCT00984295|3920791|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
1603207|NCT00984282|3920858|P2|NOT COMPLETED|Long Term Follow-up||120
1603208|NCT00984282|3920859|P1|NOT COMPLETED|Long Term Follow-up||69
1603209|NCT00984282|3920858|P2|COMPLETED|Long Term Follow-up||4
1603210|NCT00984282|3920859|P1|COMPLETED|Long Term Follow-up||3
1603211|NCT00984282|3920858|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
1603212|NCT00984282|3920859|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
1603213|NCT00984282|3920858|P2|NOT COMPLETED|Open-label Treatment||161
1603214|NCT00984282|3920859|P1|NOT COMPLETED|Open-label Treatment||86
1603215|NCT00984282|3920858|P2|COMPLETED|Open-label Treatment||0
1603216|NCT00984282|3920859|P1|COMPLETED|Open-label Treatment||0
1603217|NCT00984282|3920858|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
1603218|NCT00984282|3920859|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
1603219|NCT00984282|3920858|P2|STARTED|Open-label Treatment||161
1603220|NCT00984282|3920859|P1|STARTED|Open-label Treatment||86
1603221|NCT00984282|3920858|P2|NOT COMPLETED|Double Blind Treatment||38
1603222|NCT00984282|3920859|P1|NOT COMPLETED|Double Blind Treatment||104
1603223|NCT00984282|3920858|P2|COMPLETED|Double Blind Treatment||172
1603224|NCT00984282|3920859|P1|COMPLETED|Double Blind Treatment||103
1603225|NCT00984282|3920858|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
1603226|NCT00984282|3920859|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
1603227|NCT00984282|3920858|P2|STARTED|Double Blind Treatment||210
1603228|NCT00984282|3920859|P1|STARTED|Double Blind Treatment||207
1603229|NCT00984256|3920882|P2|NOT COMPLETED|Overall Study||1
1603230|NCT00984256|3920883|P1|NOT COMPLETED|Overall Study||0
1603231|NCT00984256|3920882|P2|COMPLETED|Overall Study||29
1603232|NCT00984256|3920883|P1|COMPLETED|Overall Study||6
1603233|NCT00984256|3920882|P2|STARTED|Overall Study||30
1603234|NCT00984256|3920883|P1|STARTED|Overall Study||6
1603235|NCT00984204|3920903|P1|NOT COMPLETED|Overall Study||15
1603236|NCT00984204|3920903|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
1603237|NCT00984204|3920903|P1|STARTED|Overall Study||188
1603238|NCT00984165|3920913|P4|NOT COMPLETED|Overall Study||4
1603239|NCT00984165|3920914|P3|NOT COMPLETED|Overall Study||0
1603240|NCT00984165|3920915|P2|NOT COMPLETED|Overall Study||1
1603241|NCT00984165|3920916|P1|NOT COMPLETED|Overall Study||7
1603242|NCT00984165|3920913|P4|COMPLETED|Overall Study||0
1603243|NCT00984165|3920914|P3|COMPLETED|Overall Study||4
1603244|NCT00984165|3920915|P2|COMPLETED|Overall Study||0
1603245|NCT00984165|3920916|P1|COMPLETED|Overall Study||2
1603246|NCT00984165|3920913|P4|STARTED|Overall Study||4
1603247|NCT00984165|3920914|P3|STARTED|Overall Study||4
1603248|NCT00984165|3920915|P2|STARTED|Overall Study||1
1603249|NCT00984165|3920916|P1|STARTED|Overall Study||9
1603250|NCT00984139|3920929|P1|NOT COMPLETED|Overall Study||0
1603251|NCT00984139|3920929|P1|COMPLETED|Overall Study||306
1603252|NCT00984139|3920929|P1|STARTED|Overall Study||306
1603253|NCT00984126|3920945|P4|NOT COMPLETED|Overall Study||59
1603254|NCT00984126|3920946|P3|NOT COMPLETED|Overall Study||7
1603255|NCT00984126|3920947|P2|NOT COMPLETED|Overall Study||8
1603256|NCT00984126|3920948|P1|NOT COMPLETED|Overall Study||7
1603257|NCT00984126|3920945|P4|COMPLETED|Overall Study||76
1603258|NCT00984126|3920946|P3|COMPLETED|Overall Study||16
1603259|NCT00984126|3920947|P2|COMPLETED|Overall Study||20
1603260|NCT00984126|3920948|P1|COMPLETED|Overall Study||20
1603261|NCT00984126|3920945|P4|STARTED|Overall Study||135
1603262|NCT00984126|3920946|P3|STARTED|Overall Study||23
1603263|NCT00984126|3920947|P2|STARTED|Overall Study||28
1603264|NCT00984126|3920948|P1|STARTED|Overall Study||27
1603265|NCT00984061|3920973|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
1603266|NCT00984061|3920973|P1|COMPLETED|Colchicine With Clarithromycin||23
1603267|NCT00984061|3920973|P1|STARTED|Colchicine With Clarithromycin||23
1603268|NCT00984061|3920973|P1|NOT COMPLETED|Clarithromycin Alone||1
1603269|NCT00984061|3920973|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
1603270|NCT00984061|3920973|P1|STARTED|Clarithromycin Alone||24
1603271|NCT00984061|3920973|P1|NOT COMPLETED|21 Day Washout Period||0
1603272|NCT00984061|3920973|P1|COMPLETED|21 Day Washout Period||24
1603273|NCT00984061|3920973|P1|STARTED|21 Day Washout Period||24
1603274|NCT00984061|3920973|P1|NOT COMPLETED|Colchicine Alone||0
1603275|NCT00984061|3920973|P1|COMPLETED|Colchicine Alone||24
1603276|NCT00984061|3920973|P1|STARTED|Colchicine Alone||24
1603277|NCT00984022|3920986|P2|NOT COMPLETED|Overall Study||14
1603278|NCT00984022|3920987|P1|NOT COMPLETED|Overall Study||10
1603279|NCT00984022|3920986|P2|COMPLETED|Overall Study||35
1603280|NCT00984022|3920987|P1|COMPLETED|Overall Study||33
1603281|NCT00984022|3920986|P2|STARTED|Overall Study||49
1603282|NCT00984022|3920987|P1|STARTED|Overall Study||43
1603283|NCT00984009|3920997|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
1603284|NCT00984009|3920997|P1|COMPLETED|Colchicine With Grapefruit Juice||21
1603285|NCT00984009|3920997|P1|STARTED|Colchicine With Grapefruit Juice||21
1603286|NCT00984009|3920997|P1|NOT COMPLETED|Grapefruit Juice Alone||1
1603287|NCT00984009|3920997|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
1603288|NCT00984009|3920997|P1|STARTED|Grapefruit Juice Alone||22
1603289|NCT00984009|3920997|P1|NOT COMPLETED|14 Day Washout Period||0
1603290|NCT00984009|3920997|P1|COMPLETED|14 Day Washout Period||22
1603291|NCT00984009|3920997|P1|STARTED|14 Day Washout Period||22
1603292|NCT00984009|3920997|P1|NOT COMPLETED|Colchicine Alone||0
1603293|NCT00984009|3920997|P1|COMPLETED|Colchicine Alone||22
1603294|NCT00984009|3920997|P1|STARTED|Colchicine Alone||22
1603295|NCT00983983|3921011|P3|NOT COMPLETED|Overall Study||1
1603296|NCT00983983|3921012|P2|NOT COMPLETED|Overall Study||1
1603297|NCT00983983|3921013|P1|NOT COMPLETED|Overall Study||2
1603298|NCT00983983|3921011|P3|COMPLETED|Overall Study||6
1603299|NCT00983983|3921012|P2|COMPLETED|Overall Study||8
1603300|NCT00983983|3921013|P1|COMPLETED|Overall Study||6
1603301|NCT00983983|3921011|P3|STARTED|Overall Study||7
1603302|NCT00983983|3921012|P2|STARTED|Overall Study||9
1603303|NCT00983983|3921013|P1|STARTED|Overall Study||8
1603304|NCT00983957|3921030|P1|NOT COMPLETED|Overall Study||2
1603305|NCT00983957|3921030|P1|COMPLETED|Overall Study||18
1603306|NCT00983957|3921030|P1|Treatment C|Overall Study||18
1603307|NCT00983957|3921030|P1|Treatment B|Overall Study||20
1603308|NCT00983957|3921030|P1|Treatment A|Overall Study||20
1603309|NCT00983957|3921030|P1|STARTED|Overall Study||20
1603310|NCT00983931|3921064|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
1603311|NCT00983931|3921064|P1|COMPLETED|Colchicine With Cyclosporine||23
1603312|NCT00983931|3921064|P1|STARTED|Colchicine With Cyclosporine||23
1603313|NCT00983931|3921064|P1|NOT COMPLETED|14 Day Washout Period||1
1603314|NCT00983931|3921064|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
1603315|NCT00983931|3921064|P1|STARTED|14 Day Washout Period||24
1603316|NCT00983931|3921064|P1|NOT COMPLETED|Colchicine Alone||0
1603317|NCT00983931|3921064|P1|COMPLETED|Colchicine Alone||24
1603318|NCT00983931|3921064|P1|STARTED|Colchicine Alone||24
1603319|NCT00983918|3921078|P4|NOT COMPLETED|Overall Study||2
1603320|NCT00983918|3921079|P3|NOT COMPLETED|Overall Study||2
1603321|NCT00983918|3921080|P2|NOT COMPLETED|Overall Study||2
1603322|NCT00983918|3921081|P1|NOT COMPLETED|Overall Study||0
1603323|NCT00983918|3921078|P4|COMPLETED|Overall Study||18
1603324|NCT00983918|3921079|P3|COMPLETED|Overall Study||18
1603325|NCT00983918|3921080|P2|COMPLETED|Overall Study||18
1603326|NCT00983918|3921081|P1|COMPLETED|Overall Study||20
1603327|NCT00983918|3921078|P4|STARTED|Overall Study||20
1603328|NCT00983918|3921079|P3|STARTED|Overall Study||20
1603329|NCT00983918|3921080|P2|STARTED|Overall Study||20
1603330|NCT00983918|3921081|P1|STARTED|Overall Study||20
1603331|NCT00983905|3921091|P1|NOT COMPLETED|Theophylline With Colchicine||0
1603332|NCT00983905|3921091|P1|COMPLETED|Theophylline With Colchicine||27
1603333|NCT00983905|3921091|P1|STARTED|Theophylline With Colchicine||27
1603334|NCT00983905|3921091|P1|NOT COMPLETED|Colchicine Alone||2
1603335|NCT00983905|3921091|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
1603336|NCT00983905|3921091|P1|STARTED|Colchicine Alone||29
1603337|NCT00983905|3921091|P1|NOT COMPLETED|4 Day Washout Period||0
1603338|NCT00983905|3921091|P1|COMPLETED|4 Day Washout Period||29
1603339|NCT00983905|3921091|P1|STARTED|4 Day Washout Period||29
1603340|NCT00983905|3921091|P1|NOT COMPLETED|Theophylline Alone||1
1603341|NCT00983905|3921091|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
1603342|NCT00983905|3921091|P1|STARTED|Theophylline Alone||30
1603343|NCT00983892|3921104|P2|NOT COMPLETED|Overall Study||12
1603344|NCT00983892|3921105|P1|NOT COMPLETED|Overall Study||10
1603345|NCT00983892|3921104|P2|COMPLETED|Overall Study||56
1603346|NCT00983892|3921105|P1|COMPLETED|Overall Study||56
1603347|NCT00983892|3921104|P2|STARTED|Overall Study||68
1603348|NCT00983892|3921105|P1|STARTED|Overall Study||66
1603349|NCT00983853|3921117|P6|NOT COMPLETED|Overall Study||1
1603350|NCT00983853|3921118|P5|NOT COMPLETED|Overall Study||3
1603351|NCT00983853|3921119|P4|NOT COMPLETED|Overall Study||2
1603352|NCT00983853|3921120|P3|NOT COMPLETED|Overall Study||3
1603353|NCT00983853|3921121|P2|NOT COMPLETED|Overall Study||2
1603354|NCT00983853|3921122|P1|NOT COMPLETED|Overall Study||1
1603355|NCT00983853|3921117|P6|COMPLETED|Overall Study||7
1603356|NCT00983853|3921118|P5|COMPLETED|Overall Study||12
1603357|NCT00983853|3921119|P4|COMPLETED|Overall Study||6
1603358|NCT00983853|3921120|P3|COMPLETED|Overall Study||14
1603359|NCT00983853|3921121|P2|COMPLETED|Overall Study||5
1603360|NCT00983853|3921122|P1|COMPLETED|Overall Study||6
1603361|NCT00983853|3921117|P6|STARTED|Overall Study||8
1603362|NCT00983853|3921118|P5|STARTED|Overall Study||15
1603363|NCT00983853|3921119|P4|STARTED|Overall Study||8
1603364|NCT00983853|3921120|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
1603365|NCT00983853|3921121|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
1603366|NCT00983853|3921122|P1|STARTED|Overall Study||7
1603367|NCT00983827|3921150|P1|NOT COMPLETED|Overall Study||1
1603368|NCT00983827|3921150|P1|COMPLETED|Overall Study||7
1603369|NCT00983827|3921150|P1|STARTED|Overall Study||8
1603370|NCT00983801|3921154|P1|NOT COMPLETED|Overall Study||0
1603371|NCT00983801|3921154|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
1603372|NCT00983801|3921154|P1|STARTED|Overall Study|Participants who received treatment.|52
1603373|NCT00983749|3921168|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
1603374|NCT00983749|3921169|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
1603375|NCT00983749|3921168|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
1603376|NCT00983749|3921169|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
1603377|NCT00983749|3921168|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
1603378|NCT00983749|3921169|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
1603379|NCT00983749|3921168|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
1603380|NCT00983749|3921169|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
1603381|NCT00983749|3921168|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
1603382|NCT00983749|3921169|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
1603383|NCT00983749|3921168|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
1603384|NCT00983749|3921169|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
1603385|NCT00983645|3921179|P2|NOT COMPLETED|Overall Study||0
1603386|NCT00983645|3921180|P1|NOT COMPLETED|Overall Study||0
1603387|NCT00983645|3921179|P2|COMPLETED|Overall Study||7
1603388|NCT00983645|3921180|P1|COMPLETED|Overall Study||8
1603389|NCT00983645|3921179|P2|STARTED|Overall Study||7
1603390|NCT00983645|3921180|P1|STARTED|Overall Study||8
1603391|NCT00983580|3921194|P2|NOT COMPLETED|Overall Study||4
1603392|NCT00983580|3921195|P1|NOT COMPLETED|Overall Study||5
1603393|NCT00983580|3921194|P2|COMPLETED|Overall Study||49
1603394|NCT00983580|3921195|P1|COMPLETED|Overall Study||49
1603395|NCT00983580|3921194|P2|STARTED|Overall Study||53
1603396|NCT00983580|3921195|P1|STARTED|Overall Study||54
1603397|NCT00983541|3921211|P1|NOT COMPLETED|Overall Study||0
1603398|NCT00983541|3921211|P1|COMPLETED|Overall Study||1
1603399|NCT00983541|3921211|P1|STARTED|Overall Study||1
1603400|NCT00983515|3921221|P1|NOT COMPLETED|Colchicine With Ritonavir||1
1603401|NCT00983515|3921221|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
1603402|NCT00983515|3921221|P1|STARTED|Colchicine With Ritonavir||18
1603403|NCT00983515|3921221|P1|NOT COMPLETED|Ritonavir Alone||6
1603404|NCT00983515|3921221|P1|COMPLETED|Ritonavir Alone||18
1603405|NCT00983515|3921221|P1|STARTED|Ritonavir Alone||24
1603406|NCT00983515|3921221|P1|NOT COMPLETED|14 Day Washout Period||0
1603407|NCT00983515|3921221|P1|COMPLETED|14 Day Washout Period||24
1603408|NCT00983515|3921221|P1|STARTED|14 Day Washout Period||24
1603409|NCT00983515|3921221|P1|NOT COMPLETED|Colchicine Alone||0
1603410|NCT00983515|3921221|P1|COMPLETED|Colchicine Alone||24
1603411|NCT00983515|3921221|P1|STARTED|Colchicine Alone||24
1603412|NCT00983489|3921235|P3|NOT COMPLETED|Overall Study||312
1603413|NCT00983489|3921236|P2|NOT COMPLETED|Overall Study||285
1603414|NCT00983489|3921237|P1|NOT COMPLETED|Overall Study||185
1603415|NCT00983489|3921235|P3|COMPLETED|Overall Study||135
1603416|NCT00983489|3921236|P2|COMPLETED|Overall Study||168
1603417|NCT00983489|3921237|P1|COMPLETED|Overall Study||326
1603418|NCT00983489|3921235|P3|STARTED|Overall Study||447
1603419|NCT00983489|3921236|P2|STARTED|Overall Study||453
1603420|NCT00983489|3921237|P1|STARTED|Overall Study||511
1603421|NCT00983476|3921248|P3|NOT COMPLETED|Overall Study||0
1603422|NCT00983476|3921249|P2|NOT COMPLETED|Overall Study||22
1603423|NCT00983476|3921250|P1|NOT COMPLETED|Overall Study||17
1603424|NCT00983476|3921248|P3|COMPLETED|Overall Study||88
1603425|NCT00983476|3921249|P2|COMPLETED|Overall Study||71
1603426|NCT00983476|3921250|P1|COMPLETED|Overall Study||78
1603427|NCT00983476|3921248|P3|6 Month Follow up Assessment|Overall Study||74
1603428|NCT00983476|3921249|P2|6 Month Follow up Assessment|Overall Study||62
1603429|NCT00983476|3921250|P1|6 Month Follow up Assessment|Overall Study||71
1603430|NCT00983476|3921248|P3|STARTED|Overall Study||88
1603431|NCT00983476|3921249|P2|STARTED|Overall Study||93
1603432|NCT00983476|3921250|P1|STARTED|Overall Study||95
1603433|NCT00983437|3921282|P1|NOT COMPLETED|Overall Study||47
1603434|NCT00983437|3921282|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
1603435|NCT00983437|3921282|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
1603436|NCT00983437|3921282|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
1603437|NCT00983437|3921282|P1|STARTED|Overall Study||47
1603438|NCT00983385|3921301|P1|NOT COMPLETED|Maintenance Period||23
1603439|NCT00983385|3921301|P1|COMPLETED|Maintenance Period||117
1603440|NCT00983385|3921301|P1|STARTED|Maintenance Period||140
1603441|NCT00983385|3921301|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
1603442|NCT00983385|3921301|P1|COMPLETED|Titration and Optimal Dose Period||140
1603443|NCT00983385|3921301|P1|STARTED|Titration and Optimal Dose Period||176
1603444|NCT00983385|3921301|P1|NOT COMPLETED|Observation Period||32
1603445|NCT00983385|3921301|P1|COMPLETED|Observation Period||176
1603446|NCT00983385|3921301|P1|STARTED|Observation Period||208
1603447|NCT00983372|3921346|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
1603448|NCT00983372|3921346|P1|COMPLETED|Colchicine With Diltiazem ER||20
1603449|NCT00983372|3921346|P1|STARTED|Colchicine With Diltiazem ER||20
1603450|NCT00983372|3921346|P1|NOT COMPLETED|Diltiazem ER Alone||3
1603451|NCT00983372|3921346|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
1603452|NCT00983372|3921346|P1|STARTED|Diltiazem ER Alone||23
1603453|NCT00983372|3921346|P1|NOT COMPLETED|14 Day Washout Period||1
1603454|NCT00983372|3921346|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
1603455|NCT00983372|3921346|P1|STARTED|14 Day Washout Period||24
1603456|NCT00983372|3921346|P1|NOT COMPLETED|Colchicine Alone||0
1603457|NCT00983372|3921346|P1|COMPLETED|Colchicine Alone||24
1603458|NCT00983372|3921346|P1|STARTED|Colchicine Alone||24
1603459|NCT00983359|3921357|P1|NOT COMPLETED|Overall Study||1
1603460|NCT00983359|3921357|P1|COMPLETED|Overall Study||39
1603461|NCT00983359|3921357|P1|Not Eligible for Analysis|Overall Study||1
1603462|NCT00983359|3921357|P1|STARTED|Overall Study||40
1603463|NCT00983346|3921365|P1|NOT COMPLETED|Overall Study||0
1603464|NCT00983346|3921365|P1|COMPLETED|Overall Study||17
1603465|NCT00983346|3921365|P1|STARTED|Overall Study||17
1603466|NCT00983307|3921369|P1|NOT COMPLETED|Overall Study||0
1603467|NCT00983307|3921369|P1|COMPLETED|Overall Study||17
1603468|NCT00983307|3921369|P1|STARTED|Overall Study||17
1603469|NCT00983294|3921373|P1|NOT COMPLETED|Colchicine With Azithromycin||1
1603470|NCT00983294|3921373|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
1603471|NCT00983294|3921373|P1|STARTED|Colchicine With Azithromycin||22
1603472|NCT00983294|3921373|P1|NOT COMPLETED|Azithromycin Alone||0
1603473|NCT00983294|3921373|P1|COMPLETED|Azithromycin Alone||22
1603474|NCT00983294|3921373|P1|STARTED|Azithromycin Alone||22
1603475|NCT00983294|3921373|P1|NOT COMPLETED|14 Day Washout Period||2
1603476|NCT00983294|3921373|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
1603477|NCT00983294|3921373|P1|STARTED|14 Day Washout Period||24
1603478|NCT00983294|3921373|P1|NOT COMPLETED|Colchicine Alone||0
1603479|NCT00983294|3921373|P1|COMPLETED|Colchicine Alone||24
1603480|NCT00983294|3921373|P1|STARTED|Colchicine Alone||24
1603481|NCT00983281|3921386|P2|NOT COMPLETED|Overall Study||0
1603482|NCT00983281|3921387|P1|NOT COMPLETED|Overall Study||0
1603483|NCT00983281|3921386|P2|COMPLETED|Overall Study||909
1603484|NCT00983281|3921387|P1|COMPLETED|Overall Study||805
1603485|NCT00983281|3921386|P2|STARTED|Overall Study||909
1603486|NCT00983281|3921387|P1|STARTED|Overall Study||805
1603487|NCT00983242|3921393|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
1603488|NCT00983242|3921393|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
1603489|NCT00983242|3921393|P1|STARTED|Colchicine With Verapamil HCl ER||24
1603490|NCT00983242|3921393|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
1603491|NCT00983242|3921393|P1|COMPLETED|Verapamil HCl ER Alone||24
1603492|NCT00983242|3921393|P1|STARTED|Verapamil HCl ER Alone||24
1603493|NCT00983242|3921393|P1|NOT COMPLETED|14 Day Washout Period||0
1603494|NCT00983242|3921393|P1|COMPLETED|14 Day Washout Period||24
1603495|NCT00983242|3921393|P1|STARTED|14 Day Washout Period||24
1603496|NCT00983242|3921393|P1|NOT COMPLETED|Colchicine Alone||0
1603497|NCT00983242|3921393|P1|COMPLETED|Colchicine Alone||24
1603498|NCT00983242|3921393|P1|STARTED|Colchicine Alone||24
1603499|NCT00983216|3921404|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
1603500|NCT00983216|3921404|P1|COMPLETED|Colchicine With Ketoconazole||24
1603501|NCT00983216|3921404|P1|STARTED|Colchicine With Ketoconazole||24
1603502|NCT00983216|3921404|P1|NOT COMPLETED|Ketoconazole Alone||0
1603503|NCT00983216|3921404|P1|COMPLETED|Ketoconazole Alone||24
1603504|NCT00983216|3921404|P1|STARTED|Ketoconazole Alone||24
1603505|NCT00983216|3921404|P1|NOT COMPLETED|14 Day Washout Period||0
1603506|NCT00983216|3921404|P1|COMPLETED|14 Day Washout Period||24
1603507|NCT00983216|3921404|P1|STARTED|14 Day Washout Period||24
1603508|NCT00983216|3921404|P1|NOT COMPLETED|Colchicine Alone||0
1603509|NCT00983216|3921404|P1|COMPLETED|Colchicine Alone||24
1603510|NCT00983216|3921404|P1|STARTED|Colchicine Alone||24
1603511|NCT00983073|3921415|P1|NOT COMPLETED|Maintenance Period||16
1603512|NCT00983073|3921415|P1|COMPLETED|Maintenance Period||144
1603513|NCT00983073|3921415|P1|STARTED|Maintenance Period||160
1603514|NCT00983073|3921415|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
1603515|NCT00983073|3921415|P1|COMPLETED|Titration and Optimal Dose Period||160
1603516|NCT00983073|3921415|P1|STARTED|Titration and Optimal Dose Period||200
1603517|NCT00983073|3921415|P1|NOT COMPLETED|Observation Period||24
1603518|NCT00983073|3921415|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
1603519|NCT00983073|3921415|P1|STARTED|Observation Period||224
1603520|NCT00982995|3921436|P1|NOT COMPLETED|Overall Study||0
1603521|NCT00982995|3921436|P1|COMPLETED|Overall Study||3
1603522|NCT00982995|3921436|P1|STARTED|Overall Study||3
1603523|NCT00982865|3921445|P4|NOT COMPLETED|Overall Study||0
1603524|NCT00982865|3921446|P3|NOT COMPLETED|Overall Study||0
1603525|NCT00982865|3921447|P2|NOT COMPLETED|Overall Study||0
1603526|NCT00982865|3921448|P1|NOT COMPLETED|Overall Study||0
1603527|NCT00982865|3921445|P4|COMPLETED|Overall Study||34
1603528|NCT00982865|3921446|P3|COMPLETED|Overall Study||15
1603529|NCT00982865|3921447|P2|COMPLETED|Overall Study||82
1603530|NCT00982865|3921448|P1|COMPLETED|Overall Study||49
1603531|NCT00982865|3921445|P4|STARTED|Overall Study||34
1603532|NCT00982865|3921446|P3|STARTED|Overall Study||15
1603533|NCT00982865|3921447|P2|STARTED|Overall Study||82
1603534|NCT00982865|3921448|P1|STARTED|Overall Study||49
1603535|NCT00982735|3921734|P1|NOT COMPLETED|Overall Study||230
1603536|NCT00982735|3921734|P1|COMPLETED|Overall Study||757
1603537|NCT00982735|3921734|P1|STARTED|Overall Study||987
1603538|NCT00982657|3921744|P4|NOT COMPLETED|Overall Study||9
1603539|NCT00982657|3921745|P3|NOT COMPLETED|Overall Study||2
1603540|NCT00982657|3921746|P2|NOT COMPLETED|Overall Study||0
1603541|NCT00982657|3921747|P1|NOT COMPLETED|Overall Study||1
1603542|NCT00982657|3921744|P4|COMPLETED|Overall Study||7
1603543|NCT00982657|3921745|P3|COMPLETED|Overall Study||1
1603544|NCT00982657|3921746|P2|COMPLETED|Overall Study||3
1603545|NCT00982657|3921747|P1|COMPLETED|Overall Study||11
1603546|NCT00982657|3921744|P4|STARTED|Overall Study||16
1603547|NCT00982657|3921745|P3|STARTED|Overall Study||3
1603548|NCT00982657|3921746|P2|STARTED|Overall Study||3
1603549|NCT00982657|3921747|P1|STARTED|Overall Study||12
1603550|NCT00982644|3921788|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
1603551|NCT00982644|3921789|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
1603552|NCT00982644|3921788|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
1603553|NCT00982644|3921789|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
1603554|NCT00982644|3921788|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
1603555|NCT00982644|3921789|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
1603556|NCT00982644|3921788|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
1603557|NCT00982644|3921789|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
1603558|NCT00982644|3921788|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
1603559|NCT00982644|3921789|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
1603560|NCT00982644|3921788|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
1603561|NCT00982644|3921789|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
1603562|NCT00982644|3921788|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
1603563|NCT00982644|3921789|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
1603564|NCT00982644|3921788|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
1603565|NCT00982644|3921789|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
1603566|NCT00982592|3921813|P2|NOT COMPLETED|Overall Study||33
1603567|NCT00982592|3921814|P1|NOT COMPLETED|Overall Study||31
1603568|NCT00982592|3921813|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
1603569|NCT00982592|3921814|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
1603570|NCT00982592|3921813|P2|Treatment Received|Overall Study||52
1603571|NCT00982592|3921814|P1|Treatment Received|Overall Study||63
1603572|NCT00982592|3921813|P2|STARTED|Overall Study||60
1603573|NCT00982592|3921814|P1|STARTED|Overall Study||64
1603574|NCT00982553|3921828|P1|NOT COMPLETED|Overall Study||0
1603575|NCT00982553|3921828|P1|COMPLETED|Overall Study||14
1603576|NCT00982553|3921828|P1|STARTED|Overall Study||14
1603577|NCT00982488|3921840|P5|NOT COMPLETED|Overall Study||1
1603578|NCT00982488|3921841|P4|NOT COMPLETED|Overall Study||3
1603579|NCT00982488|3921842|P3|NOT COMPLETED|Overall Study||34
1603580|NCT00982488|3921843|P2|NOT COMPLETED|Overall Study||14
1603581|NCT00982488|3921844|P1|NOT COMPLETED|Overall Study||185
1603582|NCT00982488|3921840|P5|COMPLETED|Overall Study|Still receiving treatment|0
1603583|NCT00982488|3921841|P4|COMPLETED|Overall Study|Still receiving treatment|0
1603584|NCT00982488|3921842|P3|COMPLETED|Overall Study|Still receiving treatment|0
1603585|NCT00982488|3921843|P2|COMPLETED|Overall Study|Still receiving treatment|0
1603586|NCT00982488|3921844|P1|COMPLETED|Overall Study|Still receiving treatment|0
1603587|NCT00982488|3921840|P5|STARTED|Overall Study|Received treatment|1
1603588|NCT00982488|3921841|P4|STARTED|Overall Study|Received treatment|3
1603589|NCT00982488|3921842|P3|STARTED|Overall Study|Received treatment|34
1603590|NCT00982488|3921843|P2|STARTED|Overall Study|Received treatment|14
1603591|NCT00982488|3921844|P1|STARTED|Overall Study|Received treatment|185
1603592|NCT00982423|3921858|P2|NOT COMPLETED|Overall Study||0
1603593|NCT00982423|3921859|P1|NOT COMPLETED|Overall Study||0
1603594|NCT00982423|3921858|P2|COMPLETED|Overall Study||19
1603595|NCT00982423|3921859|P1|COMPLETED|Overall Study||13
1603596|NCT00982423|3921858|P2|STARTED|Overall Study||19
1603597|NCT00982423|3921859|P1|STARTED|Overall Study||13
1603598|NCT00982410|3921877|P2|NOT COMPLETED|12-month Follow-up Assessment||9
1603599|NCT00982410|3921878|P1|NOT COMPLETED|12-month Follow-up Assessment||9
1603600|NCT00982410|3921877|P2|COMPLETED|12-month Follow-up Assessment||55
1603601|NCT00982410|3921878|P1|COMPLETED|12-month Follow-up Assessment||56
1603602|NCT00982410|3921877|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
1603603|NCT00982410|3921878|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
1603604|NCT00982410|3921877|P2|NOT COMPLETED|6-month Follow-up Assessment||11
1603605|NCT00982410|3921878|P1|NOT COMPLETED|6-month Follow-up Assessment||6
1603606|NCT00982410|3921877|P2|COMPLETED|6-month Follow-up Assessment||53
1603607|NCT00982410|3921878|P1|COMPLETED|6-month Follow-up Assessment||59
1603608|NCT00982410|3921877|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
1603609|NCT00982410|3921878|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
1603610|NCT00982410|3921877|P2|NOT COMPLETED|3-month Follow-up Assessment||13
1603611|NCT00982410|3921878|P1|NOT COMPLETED|3-month Follow-up Assessment||9
1603612|NCT00982410|3921877|P2|COMPLETED|3-month Follow-up Assessment||53
1603613|NCT00982410|3921878|P1|COMPLETED|3-month Follow-up Assessment||56
1603614|NCT00982410|3921877|P2|STARTED|3-month Follow-up Assessment||66
1603615|NCT00982410|3921878|P1|STARTED|3-month Follow-up Assessment||65
1603616|NCT00982397|3921902|P2|NOT COMPLETED|Phase II/Overall Study||0
1603617|NCT00982397|3921903|P1|NOT COMPLETED|Phase II/Overall Study||0
1603618|NCT00982397|3921902|P2|COMPLETED|Phase II/Overall Study||751
1603619|NCT00982397|3921903|P1|COMPLETED|Phase II/Overall Study||2019
1603620|NCT00982397|3921902|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
1603621|NCT00982397|3921903|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
1603622|NCT00982397|3921902|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
1603623|NCT00982397|3921903|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
1603624|NCT00982397|3921902|P2|STARTED|Phase II/Overall Study||751
1603625|NCT00982397|3921903|P1|STARTED|Phase II/Overall Study||2019
1603626|NCT00982397|3921902|P2|NOT COMPLETED|Phase I||0
1603627|NCT00982397|3921903|P1|NOT COMPLETED|Phase I||0
1603628|NCT00982397|3921902|P2|COMPLETED|Phase I||0
1603629|NCT00982397|3921903|P1|COMPLETED|Phase I||236
1603630|NCT00982397|3921902|P2|STARTED|Phase I||0
1603631|NCT00982397|3921903|P1|STARTED|Phase I||236
1603632|NCT00982345|3921913|P1|NOT COMPLETED|Overall Study||2
1603633|NCT00982345|3921913|P1|COMPLETED|Overall Study||18
1603634|NCT00982345|3921913|P1|STARTED|Overall Study||20
1603635|NCT00982319|3921919|P2|NOT COMPLETED|Overall Study||2
1603636|NCT00982319|3921920|P1|NOT COMPLETED|Overall Study||2
1603637|NCT00982319|3921919|P2|COMPLETED|Overall Study||15
1603638|NCT00982319|3921920|P1|COMPLETED|Overall Study||15
1603639|NCT00982319|3921919|P2|STARTED|Overall Study||17
1603640|NCT00982319|3921920|P1|STARTED|Overall Study||17
1603641|NCT00982280|3921928|P1|NOT COMPLETED|Maintenance Period||1
1603642|NCT00982280|3921928|P1|COMPLETED|Maintenance Period||54
1603643|NCT00982280|3921928|P1|STARTED|Maintenance Period||55
1603644|NCT00982280|3921928|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
1603645|NCT00982280|3921928|P1|COMPLETED|Titration and Optimal Dose Period||55
1603646|NCT00982280|3921928|P1|STARTED|Titration and Optimal Dose Period||63
1603647|NCT00982280|3921928|P1|NOT COMPLETED|Observation Period||19
1603648|NCT00982280|3921928|P1|COMPLETED|Observation Period||63
1603649|NCT00982280|3921928|P1|STARTED|Observation Period||82
1603650|NCT00982228|3921953|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
1603651|NCT00982228|3921954|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
1603652|NCT00982228|3921953|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
1603653|NCT00982228|3921954|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
1603654|NCT00982228|3921953|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
1603655|NCT00982228|3921954|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
1603656|NCT00982228|3921953|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
1603657|NCT00982228|3921954|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
1603658|NCT00982228|3921953|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
1603659|NCT00982228|3921954|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
1603660|NCT00982228|3921953|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
1603661|NCT00982228|3921954|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
1603662|NCT00982228|3921953|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
1603663|NCT00982228|3921954|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
1603664|NCT00982228|3921953|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
1603665|NCT00982228|3921954|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
1603666|NCT00982189|3921982|P4|NOT COMPLETED|Overall Study||0
1603667|NCT00982189|3921983|P3|NOT COMPLETED|Overall Study||0
1603668|NCT00982189|3921984|P2|NOT COMPLETED|Overall Study||0
1603669|NCT00982189|3921985|P1|NOT COMPLETED|Overall Study||0
1603670|NCT00982189|3921982|P4|COMPLETED|Overall Study||9
1603671|NCT00982189|3921983|P3|COMPLETED|Overall Study||9
1603672|NCT00982189|3921984|P2|COMPLETED|Overall Study||9
1603673|NCT00982189|3921985|P1|COMPLETED|Overall Study||10
1603674|NCT00982189|3921982|P4|STARTED|Overall Study||9
1603675|NCT00982189|3921983|P3|STARTED|Overall Study||9
1603676|NCT00982189|3921984|P2|STARTED|Overall Study||9
1603677|NCT00982189|3921985|P1|STARTED|Overall Study||10
1603678|NCT00982137|3922013|P4|NOT COMPLETED|Overall Study||1
1603679|NCT00982137|3922014|P3|NOT COMPLETED|Overall Study||0
1603680|NCT00982137|3922015|P2|NOT COMPLETED|Overall Study||1
1603681|NCT00982137|3922016|P1|NOT COMPLETED|Overall Study||0
1603682|NCT00982137|3922013|P4|COMPLETED|Overall Study||17
1603683|NCT00982137|3922014|P3|COMPLETED|Overall Study||18
1603684|NCT00982137|3922015|P2|COMPLETED|Overall Study||35
1603685|NCT00982137|3922016|P1|COMPLETED|Overall Study||36
1603686|NCT00982137|3922013|P4|STARTED|Overall Study||18
1603687|NCT00982137|3922014|P3|STARTED|Overall Study||18
1603688|NCT00982137|3922015|P2|STARTED|Overall Study||36
1603689|NCT00982137|3922016|P1|STARTED|Overall Study||36
1603690|NCT00982111|3922048|P2|NOT COMPLETED|Overall Study||66
1603691|NCT00982111|3922049|P1|NOT COMPLETED|Overall Study||75
1603692|NCT00982111|3922048|P2|COMPLETED|Overall Study||252
1603693|NCT00982111|3922049|P1|COMPLETED|Overall Study||240
1603694|NCT00982111|3922048|P2|On Study at Conclusion, Off Treatment|Overall Study||6
1603695|NCT00982111|3922049|P1|On Study at Conclusion, Off Treatment|Overall Study||4
1603696|NCT00982111|3922048|P2|Death Due to Any Cause|Overall Study||246
1603697|NCT00982111|3922049|P1|Death Due to Any Cause|Overall Study||236
1603698|NCT00982111|3922048|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
1603699|NCT00982111|3922049|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
1603700|NCT00982111|3922048|P2|STARTED|Overall Study||318
1603701|NCT00982111|3922049|P1|STARTED|Overall Study||315
1603702|NCT00982033|3922073|P2|NOT COMPLETED|Overall Study||0
1603703|NCT00982033|3922074|P1|NOT COMPLETED|Overall Study||0
1603704|NCT00982033|3922073|P2|COMPLETED|Overall Study||27
1603705|NCT00982033|3922074|P1|COMPLETED|Overall Study||25
1603706|NCT00982033|3922073|P2|STARTED|Overall Study||27
1603707|NCT00982033|3922074|P1|STARTED|Overall Study||25
1603708|NCT00982020|3922082|P2|NOT COMPLETED|Overall Study||64
1603709|NCT00982020|3922083|P1|NOT COMPLETED|Overall Study||57
1603710|NCT00982020|3922082|P2|COMPLETED|Overall Study||37
1603711|NCT00982020|3922083|P1|COMPLETED|Overall Study||45
1603712|NCT00982020|3922082|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
1603713|NCT00982020|3922083|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
1603714|NCT00982020|3922082|P2|STARTED|Overall Study||101
1603715|NCT00982020|3922083|P1|STARTED|Overall Study||102
1603716|NCT00982007|3922107|P4|NOT COMPLETED|Overall Study||6
1603717|NCT00982007|3922108|P3|NOT COMPLETED|Overall Study||0
1603718|NCT00982007|3922109|P2|NOT COMPLETED|Overall Study||4
1603719|NCT00982007|3922110|P1|NOT COMPLETED|Overall Study||4
1603720|NCT00982007|3922107|P4|COMPLETED|Overall Study||245
1603721|NCT00982007|3922108|P3|COMPLETED|Overall Study||253
1603722|NCT00982007|3922109|P2|COMPLETED|Overall Study||253
1603723|NCT00982007|3922110|P1|COMPLETED|Overall Study||246
1603724|NCT00982007|3922107|P4|STARTED|Overall Study||251
1603725|NCT00982007|3922108|P3|STARTED|Overall Study||253
1603726|NCT00982007|3922109|P2|STARTED|Overall Study||257
1603727|NCT00982007|3922110|P1|STARTED|Overall Study||250
1603728|NCT00981825|3922122|P2|NOT COMPLETED|Second Intervention||0
1603729|NCT00981825|3922123|P1|NOT COMPLETED|Second Intervention||0
1603730|NCT00981825|3922122|P2|COMPLETED|Second Intervention||11
1603731|NCT00981825|3922123|P1|COMPLETED|Second Intervention||11
1603732|NCT00981825|3922122|P2|STARTED|Second Intervention||11
1603733|NCT00981825|3922123|P1|STARTED|Second Intervention||11
1603734|NCT00981825|3922122|P2|NOT COMPLETED|Washout After 1st Intervention||0
1603735|NCT00981825|3922123|P1|NOT COMPLETED|Washout After 1st Intervention||0
1603736|NCT00981825|3922122|P2|COMPLETED|Washout After 1st Intervention||11
1603737|NCT00981825|3922123|P1|COMPLETED|Washout After 1st Intervention||11
1603738|NCT00981825|3922122|P2|STARTED|Washout After 1st Intervention||11
1603739|NCT00981825|3922123|P1|STARTED|Washout After 1st Intervention||11
1603740|NCT00981825|3922122|P2|NOT COMPLETED|First Intervention||0
1603741|NCT00981825|3922123|P1|NOT COMPLETED|First Intervention||0
1603742|NCT00981825|3922122|P2|COMPLETED|First Intervention||11
1603743|NCT00981825|3922123|P1|COMPLETED|First Intervention||11
1603744|NCT00981825|3922122|P2|STARTED|First Intervention||11
1603745|NCT00981825|3922123|P1|STARTED|First Intervention||11
1603746|NCT00981812|3922129|P1|NOT COMPLETED|Overall Study||0
1603747|NCT00981812|3922129|P1|COMPLETED|Overall Study||20
1603748|NCT00981812|3922129|P1|STARTED|Overall Study||20
1603749|NCT00981747|3922133|P1|NOT COMPLETED|Sildenafil and Losartan||0
1603750|NCT00981747|3922133|P1|COMPLETED|Sildenafil and Losartan||9
1603751|NCT00981747|3922133|P1|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
1603752|NCT00981747|3922133|P1|Started Sildenafil and Losartan|Sildenafil and Losartan||9
1603753|NCT00981747|3922133|P1|STARTED|Sildenafil and Losartan||9
1603754|NCT00981747|3922133|P1|NOT COMPLETED|Sildenafil||0
1603755|NCT00981747|3922133|P1|COMPLETED|Sildenafil||9
1603756|NCT00981747|3922133|P1|Completed Sildenafil|Sildenafil||9
1603757|NCT00981747|3922133|P1|Started Sildenafil|Sildenafil||9
1603758|NCT00981747|3922133|P1|STARTED|Sildenafil||9
1603759|NCT00981747|3922133|P1|NOT COMPLETED|Placebo Oral Tablet||1
1603760|NCT00981747|3922133|P1|COMPLETED|Placebo Oral Tablet||9
1603761|NCT00981747|3922133|P1|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
1603762|NCT00981747|3922133|P1|Started Placebo Oral Tablet|Placebo Oral Tablet||10
1603763|NCT00981747|3922133|P1|STARTED|Placebo Oral Tablet||10
1603764|NCT00981747|3922133|P1|NOT COMPLETED|Losartan||2
1603765|NCT00981747|3922133|P1|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
1603766|NCT00981747|3922133|P1|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
1603767|NCT00981747|3922133|P1|Started Losartan|Losartan||12
1603768|NCT00981747|3922133|P1|STARTED|Losartan||12
1603769|NCT00981669|3922153|P2|NOT COMPLETED|Overall Study||0
1603770|NCT00981669|3922154|P1|NOT COMPLETED|Overall Study||1
1603771|NCT00981669|3922153|P2|COMPLETED|Overall Study||40
1603772|NCT00981669|3922154|P1|COMPLETED|Overall Study||39
1603773|NCT00981669|3922153|P2|STARTED|Overall Study||40
1603774|NCT00981669|3922154|P1|STARTED|Overall Study||40
1603775|NCT00981630|3922166|P4|NOT COMPLETED|Overall Study||0
1603776|NCT00981630|3922167|P3|NOT COMPLETED|Overall Study||0
1603777|NCT00981630|3922168|P2|NOT COMPLETED|Overall Study||0
1603778|NCT00981630|3922169|P1|NOT COMPLETED|Overall Study||0
1603779|NCT00981630|3922166|P4|COMPLETED|Overall Study||32
1603780|NCT00981630|3922167|P3|COMPLETED|Overall Study||32
1603781|NCT00981630|3922168|P2|COMPLETED|Overall Study||32
1603782|NCT00981630|3922169|P1|COMPLETED|Overall Study||32
1603783|NCT00981630|3922166|P4|STARTED|Overall Study||32
1603784|NCT00981630|3922167|P3|STARTED|Overall Study||32
1603785|NCT00981630|3922168|P2|STARTED|Overall Study||32
1603786|NCT00981630|3922169|P1|STARTED|Overall Study||32
1603787|NCT00981526|3922201|P2|NOT COMPLETED|Overall Study||6
1603788|NCT00981526|3922202|P1|NOT COMPLETED|Overall Study||4
1603789|NCT00981526|3922201|P2|COMPLETED|Overall Study||22
1603790|NCT00981526|3922202|P1|COMPLETED|Overall Study||22
1603791|NCT00981526|3922201|P2|STARTED|Overall Study||28
1603792|NCT00981526|3922202|P1|STARTED|Overall Study||26
1603793|NCT00981461|3922220|P2|NOT COMPLETED|Overall Study||2
1603794|NCT00981461|3922221|P1|NOT COMPLETED|Overall Study||5
1603795|NCT00981461|3922220|P2|COMPLETED|Overall Study||22
1603796|NCT00981461|3922221|P1|COMPLETED|Overall Study||43
1603797|NCT00981461|3922220|P2|STARTED|Overall Study||24
1603798|NCT00981461|3922221|P1|STARTED|Overall Study||48
1603799|NCT00981435|3922230|P3|NOT COMPLETED|Overall Study||0
1603800|NCT00981435|3922231|P2|NOT COMPLETED|Overall Study||0
1603801|NCT00981435|3922232|P1|NOT COMPLETED|Overall Study||0
1603802|NCT00981435|3922230|P3|COMPLETED|Overall Study||37
1603803|NCT00981435|3922231|P2|COMPLETED|Overall Study||29
1603804|NCT00981435|3922232|P1|COMPLETED|Overall Study||31
1603805|NCT00981435|3922230|P3|STARTED|Overall Study||37
1603806|NCT00981435|3922231|P2|STARTED|Overall Study||29
1603807|NCT00981435|3922232|P1|STARTED|Overall Study||31
1603808|NCT00981409|3922245|P2|NOT COMPLETED|Overall Study||1
1603809|NCT00981409|3922246|P1|NOT COMPLETED|Overall Study||6
1603810|NCT00981409|3922245|P2|COMPLETED|Overall Study||10
1603811|NCT00981409|3922246|P1|COMPLETED|Overall Study||24
1603812|NCT00981409|3922245|P2|STARTED|Overall Study||11
1603813|NCT00981409|3922246|P1|STARTED|Overall Study||30
1603814|NCT00981370|3922260|P1|NOT COMPLETED|Overall Study||0
1603815|NCT00981370|3922260|P1|COMPLETED|Overall Study||0
1603816|NCT00981370|3922260|P1|STARTED|Overall Study||0
1603817|NCT00981305|3922266|P2|NOT COMPLETED|Overall Study||10
1603818|NCT00981305|3922267|P1|NOT COMPLETED|Overall Study||19
1603819|NCT00981305|3922266|P2|COMPLETED|Overall Study||57
1603820|NCT00981305|3922267|P1|COMPLETED|Overall Study||50
1603821|NCT00981305|3922266|P2|STARTED|Overall Study||67
1603822|NCT00981305|3922267|P1|STARTED|Overall Study||69
1603823|NCT00981292|3922285|P6|NOT COMPLETED|Day 3||1
1603824|NCT00981292|3922286|P5|NOT COMPLETED|Day 3||0
1603825|NCT00981292|3922287|P4|NOT COMPLETED|Day 3||0
1603826|NCT00981292|3922288|P3|NOT COMPLETED|Day 3||0
1603827|NCT00981292|3922289|P2|NOT COMPLETED|Day 3||0
1603828|NCT00981292|3922290|P1|NOT COMPLETED|Day 3||0
1603829|NCT00981292|3922285|P6|COMPLETED|Day 3||4
1603830|NCT00981292|3922286|P5|COMPLETED|Day 3||4
1603831|NCT00981292|3922287|P4|COMPLETED|Day 3||4
1603832|NCT00981292|3922288|P3|COMPLETED|Day 3||6
1603833|NCT00981292|3922289|P2|COMPLETED|Day 3||4
1603834|NCT00981292|3922290|P1|COMPLETED|Day 3||4
1603835|NCT00981292|3922285|P6|STARTED|Day 3||5
1603836|NCT00981292|3922286|P5|STARTED|Day 3||4
1603837|NCT00981292|3922287|P4|STARTED|Day 3||4
1603838|NCT00981292|3922288|P3|STARTED|Day 3||6
1603839|NCT00981292|3922289|P2|STARTED|Day 3||4
1603840|NCT00981292|3922290|P1|STARTED|Day 3||4
1603841|NCT00981292|3922285|P6|NOT COMPLETED|Day 2||0
1603842|NCT00981292|3922286|P5|NOT COMPLETED|Day 2||0
1603843|NCT00981292|3922287|P4|NOT COMPLETED|Day 2||0
1603844|NCT00981292|3922288|P3|NOT COMPLETED|Day 2||0
1603845|NCT00981292|3922289|P2|NOT COMPLETED|Day 2||0
1603846|NCT00981292|3922290|P1|NOT COMPLETED|Day 2||2
1603847|NCT00981292|3922285|P6|COMPLETED|Day 2||5
1603848|NCT00981292|3922286|P5|COMPLETED|Day 2||4
1603849|NCT00981292|3922287|P4|COMPLETED|Day 2||4
1603850|NCT00981292|3922288|P3|COMPLETED|Day 2||6
1603851|NCT00981292|3922289|P2|COMPLETED|Day 2||4
1603852|NCT00981292|3922290|P1|COMPLETED|Day 2||4
1603853|NCT00981292|3922285|P6|STARTED|Day 2||5
1603854|NCT00981292|3922286|P5|STARTED|Day 2||4
1603855|NCT00981292|3922287|P4|STARTED|Day 2||4
1603856|NCT00981292|3922288|P3|STARTED|Day 2||6
1603857|NCT00981292|3922289|P2|STARTED|Day 2||4
1603858|NCT00981292|3922290|P1|STARTED|Day 2||6
1603859|NCT00981292|3922285|P6|NOT COMPLETED|Day 1||2
1603860|NCT00981292|3922286|P5|NOT COMPLETED|Day 1||0
1603861|NCT00981292|3922287|P4|NOT COMPLETED|Day 1||0
1603862|NCT00981292|3922288|P3|NOT COMPLETED|Day 1||0
1603863|NCT00981292|3922289|P2|NOT COMPLETED|Day 1||0
1603864|NCT00981292|3922290|P1|NOT COMPLETED|Day 1||1
1603865|NCT00981292|3922285|P6|COMPLETED|Day 1||5
1603866|NCT00981292|3922286|P5|COMPLETED|Day 1||4
1603867|NCT00981292|3922287|P4|COMPLETED|Day 1||4
1603868|NCT00981292|3922288|P3|COMPLETED|Day 1||6
1603869|NCT00981292|3922289|P2|COMPLETED|Day 1||4
1603870|NCT00981292|3922290|P1|COMPLETED|Day 1||6
1603871|NCT00981292|3922285|P6|STARTED|Day 1||7
1603872|NCT00981292|3922286|P5|STARTED|Day 1||4
1603873|NCT00981292|3922287|P4|STARTED|Day 1||4
1603874|NCT00981292|3922288|P3|STARTED|Day 1||6
1603875|NCT00981292|3922289|P2|STARTED|Day 1||4
1603876|NCT00981292|3922290|P1|STARTED|Day 1||7
1603877|NCT00981253|3922309|P2|NOT COMPLETED|Overall Study||3
1603878|NCT00981253|3922310|P1|NOT COMPLETED|Overall Study||3
1603879|NCT00981253|3922309|P2|COMPLETED|Overall Study||72
1603880|NCT00981253|3922310|P1|COMPLETED|Overall Study||73
1603881|NCT00981253|3922309|P2|STARTED|Overall Study||75
1603882|NCT00981253|3922310|P1|STARTED|Overall Study||76
1603883|NCT00981227|3922334|P6|NOT COMPLETED|Overall Study||18
1603884|NCT00981227|3922335|P5|NOT COMPLETED|Overall Study||30
1603885|NCT00981227|3922336|P4|NOT COMPLETED|Overall Study||21
1603886|NCT00981227|3922337|P3|NOT COMPLETED|Overall Study||21
1603887|NCT00981227|3922338|P2|NOT COMPLETED|Overall Study||19
1603888|NCT00981227|3922339|P1|NOT COMPLETED|Overall Study||22
1603889|NCT00981227|3922334|P6|COMPLETED|Overall Study||75
1603890|NCT00981227|3922335|P5|COMPLETED|Overall Study||60
1603891|NCT00981227|3922336|P4|COMPLETED|Overall Study||73
1603892|NCT00981227|3922337|P3|COMPLETED|Overall Study||73
1603893|NCT00981227|3922338|P2|COMPLETED|Overall Study||75
1603894|NCT00981227|3922339|P1|COMPLETED|Overall Study||80
1603895|NCT00981227|3922334|P6|Per–Protocol|Overall Study||70
1603896|NCT00981227|3922335|P5|Per–Protocol|Overall Study||50
1603897|NCT00981227|3922336|P4|Per–Protocol|Overall Study||68
1603898|NCT00981227|3922337|P3|Per–Protocol|Overall Study||67
1603899|NCT00981227|3922338|P2|Per–Protocol|Overall Study||72
1603900|NCT00981227|3922339|P1|Per–Protocol|Overall Study||69
1603901|NCT00981227|3922334|P6|Safety Population|Overall Study||93
1603902|NCT00981227|3922335|P5|Safety Population|Overall Study||90
1603903|NCT00981227|3922336|P4|Safety Population|Overall Study||94
1603904|NCT00981227|3922337|P3|Safety Population|Overall Study||94
1603905|NCT00981227|3922338|P2|Safety Population|Overall Study||94
1603906|NCT00981227|3922339|P1|Safety Population|Overall Study||102
1603907|NCT00981227|3922334|P6|Randomized|Overall Study||93
1603908|NCT00981227|3922335|P5|Randomized|Overall Study||90
1603909|NCT00981227|3922336|P4|Randomized|Overall Study||94
1603910|NCT00981227|3922337|P3|Randomized|Overall Study||94
1603911|NCT00981227|3922338|P2|Randomized|Overall Study||94
1603912|NCT00981227|3922339|P1|Randomized|Overall Study||102
1603913|NCT00981227|3922334|P6|STARTED|Overall Study||93
1603914|NCT00981227|3922335|P5|STARTED|Overall Study||90
1603915|NCT00981227|3922336|P4|STARTED|Overall Study||94
1603916|NCT00981227|3922337|P3|STARTED|Overall Study||94
1603917|NCT00981227|3922338|P2|STARTED|Overall Study||94
1603918|NCT00981227|3922339|P1|STARTED|Overall Study||102
1603919|NCT00981214|3922357|P1|NOT COMPLETED|Overall Study||0
1603920|NCT00981214|3922357|P1|COMPLETED|Overall Study||19
1603921|NCT00981214|3922357|P1|STARTED|Overall Study||19
1603922|NCT00981175|3922374|P2|NOT COMPLETED|Booster Dose Vaccination||3
1603923|NCT00981175|3922375|P1|NOT COMPLETED|Booster Dose Vaccination||2
1603924|NCT00981175|3922374|P2|COMPLETED|Booster Dose Vaccination||40
1603925|NCT00981175|3922375|P1|COMPLETED|Booster Dose Vaccination||53
1603926|NCT00981175|3922374|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
1603927|NCT00981175|3922375|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
1603928|NCT00981175|3922374|P2|NOT COMPLETED|Primary Dose Vaccination||2
1603929|NCT00981175|3922375|P1|NOT COMPLETED|Primary Dose Vaccination||3
1603930|NCT00981175|3922374|P2|COMPLETED|Primary Dose Vaccination||99
1603931|NCT00981175|3922375|P1|COMPLETED|Primary Dose Vaccination||98
1603932|NCT00981175|3922374|P2|STARTED|Primary Dose Vaccination||101
1603933|NCT00981175|3922375|P1|STARTED|Primary Dose Vaccination||101
1603934|NCT00981149|3922400|P2|NOT COMPLETED|Overall Study||3
1603935|NCT00981149|3922401|P1|NOT COMPLETED|Overall Study||2
1603936|NCT00981149|3922400|P2|COMPLETED|Overall Study||9
1603937|NCT00981149|3922401|P1|COMPLETED|Overall Study||10
1603938|NCT00981149|3922400|P2|STARTED|Overall Study||12
1603939|NCT00981149|3922401|P1|STARTED|Overall Study||12
1603940|NCT00981084|3922411|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
1603941|NCT00981084|3922412|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
1603942|NCT00981084|3922411|P2|COMPLETED|Post Intervention (Data Analysis)||16
1603943|NCT00981084|3922412|P1|COMPLETED|Post Intervention (Data Analysis)||14
1603944|NCT00981084|3922411|P2|STARTED|Post Intervention (Data Analysis)||17
1603945|NCT00981084|3922412|P1|STARTED|Post Intervention (Data Analysis)||16
1603946|NCT00981084|3922411|P2|NOT COMPLETED|Second Intervention (One Day)||0
1603947|NCT00981084|3922412|P1|NOT COMPLETED|Second Intervention (One Day)||0
1603948|NCT00981084|3922411|P2|COMPLETED|Second Intervention (One Day)||17
1603949|NCT00981084|3922412|P1|COMPLETED|Second Intervention (One Day)||16
1603950|NCT00981084|3922411|P2|STARTED|Second Intervention (One Day)||17
1603951|NCT00981084|3922412|P1|STARTED|Second Intervention (One Day)||16
1603952|NCT00981084|3922411|P2|NOT COMPLETED|Washout Period (7 Days)||0
1603953|NCT00981084|3922412|P1|NOT COMPLETED|Washout Period (7 Days)||0
1603954|NCT00981084|3922411|P2|COMPLETED|Washout Period (7 Days)||17
1603955|NCT00981084|3922412|P1|COMPLETED|Washout Period (7 Days)||16
1603956|NCT00981084|3922411|P2|STARTED|Washout Period (7 Days)||17
1603957|NCT00981084|3922412|P1|STARTED|Washout Period (7 Days)||16
1603958|NCT00981084|3922411|P2|NOT COMPLETED|First Intervention (One Day)||0
1603959|NCT00981084|3922412|P1|NOT COMPLETED|First Intervention (One Day)||0
1603960|NCT00981084|3922411|P2|COMPLETED|First Intervention (One Day)||17
1603961|NCT00981084|3922412|P1|COMPLETED|First Intervention (One Day)||16
1603962|NCT00981084|3922411|P2|STARTED|First Intervention (One Day)||17
1603963|NCT00981084|3922412|P1|STARTED|First Intervention (One Day)||16
1603964|NCT00981058|3922428|P2|NOT COMPLETED|Overall Study||97
1603965|NCT00981058|3922429|P1|NOT COMPLETED|Overall Study||120
1603966|NCT00981058|3922428|P2|COMPLETED|Overall Study||451
1603967|NCT00981058|3922429|P1|COMPLETED|Overall Study||425
1603968|NCT00981058|3922428|P2|Death Due to Any Cause|Overall Study||442
1603969|NCT00981058|3922429|P1|Death Due to Any Cause|Overall Study||418
1603970|NCT00981058|3922428|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
1603971|NCT00981058|3922429|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
1603972|NCT00981058|3922428|P2|STARTED|Overall Study||548
1603973|NCT00981058|3922429|P1|STARTED|Overall Study||545
1603974|NCT00981045|3922451|P2|NOT COMPLETED|Overall Study||9
1603975|NCT00981045|3922452|P1|NOT COMPLETED|Overall Study||14
1603976|NCT00981045|3922451|P2|COMPLETED|Overall Study||1285
1603977|NCT00981045|3922452|P1|COMPLETED|Overall Study||1276
1603978|NCT00981045|3922451|P2|STARTED|Overall Study||1294
1603979|NCT00981045|3922452|P1|STARTED|Overall Study||1290
1603980|NCT00981019|3922460|P1|NOT COMPLETED|Overall Study||477
1603981|NCT00981019|3922460|P1|COMPLETED|Overall Study||301
1603982|NCT00981019|3922460|P1|STARTED|Overall Study||778
1603983|NCT00980980|3922467|P3|NOT COMPLETED|Overall Study||0
1603984|NCT00980980|3922468|P2|NOT COMPLETED|Overall Study||1
1603985|NCT00980980|3922469|P1|NOT COMPLETED|Overall Study||0
1603986|NCT00980980|3922467|P3|COMPLETED|Overall Study||13
1603987|NCT00980980|3922468|P2|COMPLETED|Overall Study||13
1603988|NCT00980980|3922469|P1|COMPLETED|Overall Study||16
1603989|NCT00980980|3922467|P3|STARTED|Overall Study||13
1603990|NCT00980980|3922468|P2|STARTED|Overall Study||14
1603991|NCT00980980|3922469|P1|STARTED|Overall Study||16
1603992|NCT00980798|3922500|P2|NOT COMPLETED|Overall Study||55
1603993|NCT00980798|3922501|P1|NOT COMPLETED|Overall Study||33
1603994|NCT00980798|3922500|P2|COMPLETED|Overall Study||84
1603995|NCT00980798|3922501|P1|COMPLETED|Overall Study||116
1603996|NCT00980798|3922500|P2|STARTED|Overall Study||139
1603997|NCT00980798|3922501|P1|STARTED|Overall Study||149
1603998|NCT00980746|3922515|P6|NOT COMPLETED|Overall Study||18
1603999|NCT00980746|3922516|P5|NOT COMPLETED|Overall Study||17
1604000|NCT00980746|3922517|P4|NOT COMPLETED|Overall Study||36
1604001|NCT00980746|3922518|P3|NOT COMPLETED|Overall Study||20
1604002|NCT00980746|3922519|P2|NOT COMPLETED|Overall Study||22
1604003|NCT00980746|3922520|P1|NOT COMPLETED|Overall Study||27
1604004|NCT00980746|3922515|P6|COMPLETED|Overall Study||78
1604005|NCT00980746|3922516|P5|COMPLETED|Overall Study||75
1604006|NCT00980746|3922517|P4|COMPLETED|Overall Study||64
1604007|NCT00980746|3922518|P3|COMPLETED|Overall Study||75
1604008|NCT00980746|3922519|P2|COMPLETED|Overall Study||67
1604009|NCT00980746|3922520|P1|COMPLETED|Overall Study||58
1604010|NCT00980746|3922515|P6|Per-protocol|Overall Study||74
1604011|NCT00980746|3922516|P5|Per-protocol|Overall Study||73
1604012|NCT00980746|3922517|P4|Per-protocol|Overall Study||62
1604013|NCT00980746|3922518|P3|Per-protocol|Overall Study||73
1604014|NCT00980746|3922519|P2|Per-protocol|Overall Study||66
1604015|NCT00980746|3922520|P1|Per-protocol|Overall Study||55
1604016|NCT00980746|3922515|P6|Safety Population|Overall Study||96
1604017|NCT00980746|3922516|P5|Safety Population|Overall Study||92
1604018|NCT00980746|3922517|P4|Safety Population|Overall Study||100
1604019|NCT00980746|3922518|P3|Safety Population|Overall Study||95
1604020|NCT00980746|3922519|P2|Safety Population|Overall Study||89
1604021|NCT00980746|3922520|P1|Safety Population|Overall Study||85
1604022|NCT00980746|3922515|P6|Randomized|Overall Study||96
1604023|NCT00980746|3922516|P5|Randomized|Overall Study||92
1604024|NCT00980746|3922517|P4|Randomized|Overall Study||100
1604025|NCT00980746|3922518|P3|Randomized|Overall Study||95
1604026|NCT00980746|3922519|P2|Randomized|Overall Study||89
1604027|NCT00980746|3922520|P1|Randomized|Overall Study||85
1604028|NCT00980746|3922515|P6|STARTED|Overall Study||96
1604029|NCT00980746|3922516|P5|STARTED|Overall Study||92
1604030|NCT00980746|3922517|P4|STARTED|Overall Study||100
1604031|NCT00980746|3922518|P3|STARTED|Overall Study||95
1604032|NCT00980746|3922519|P2|STARTED|Overall Study||89
1604033|NCT00980746|3922520|P1|STARTED|Overall Study||85
1604034|NCT00980681|3922534|P1|NOT COMPLETED|Dotarem MRA||0
1604035|NCT00980681|3922534|P1|COMPLETED|Dotarem MRA||10
1604036|NCT00980681|3922534|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
1604037|NCT00980681|3922534|P1|NOT COMPLETED|TOF MRA||0
1604038|NCT00980681|3922534|P1|COMPLETED|TOF MRA||10
1604039|NCT00980681|3922534|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
1604040|NCT00980655|3922542|P2|NOT COMPLETED|Overall Study||51
1604041|NCT00980655|3922543|P1|NOT COMPLETED|Overall Study||16
1604042|NCT00980655|3922542|P2|COMPLETED|Overall Study||139
1604043|NCT00980655|3922543|P1|COMPLETED|Overall Study||45
1604044|NCT00980655|3922542|P2|Vaccinated 23vPS Dose|Overall Study||140
1604045|NCT00980655|3922543|P1|Vaccinated 23vPS Dose|Overall Study||45
1604046|NCT00980655|3922542|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
1604047|NCT00980655|3922543|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
1604048|NCT00980655|3922542|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
1604049|NCT00980655|3922543|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
1604050|NCT00980655|3922542|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
1604051|NCT00980655|3922543|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
1604052|NCT00980655|3922542|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
1604053|NCT00980655|3922543|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
1604054|NCT00980655|3922542|P2|STARTED|Overall Study||190
1604055|NCT00980655|3922543|P1|STARTED|Overall Study||61
1604056|NCT00980642|3922591|P2|NOT COMPLETED|Overall Study||0
1604057|NCT00980642|3922592|P1|NOT COMPLETED|Overall Study||0
1604058|NCT00980642|3922591|P2|COMPLETED|Overall Study||20
1604059|NCT00980642|3922592|P1|COMPLETED|Overall Study||36
1604060|NCT00980642|3922591|P2|STARTED|Overall Study||20
1604061|NCT00980642|3922592|P1|STARTED|Overall Study||36
1604062|NCT00980590|3922604|P2|NOT COMPLETED|Overall Study||0
1604063|NCT00980590|3922605|P1|NOT COMPLETED|Overall Study||0
1604064|NCT00980590|3922604|P2|COMPLETED|Overall Study||50
1604065|NCT00980590|3922605|P1|COMPLETED|Overall Study||50
1604066|NCT00980590|3922604|P2|STARTED|Overall Study||50
1604067|NCT00980590|3922605|P1|STARTED|Overall Study||50
1604068|NCT00980343|3922619|P2|NOT COMPLETED|Overall Study||3
1604069|NCT00980343|3922620|P1|NOT COMPLETED|Overall Study||1
1604070|NCT00980343|3922619|P2|COMPLETED|Overall Study||20
1604071|NCT00980343|3922620|P1|COMPLETED|Overall Study||20
1604072|NCT00980343|3922619|P2|STARTED|Overall Study||23
1604073|NCT00980343|3922620|P1|STARTED|Overall Study||21
1604074|NCT00980330|3922644|P7|NOT COMPLETED|Overall Study||7
1604075|NCT00980330|3922645|P6|NOT COMPLETED|Overall Study||4
1604076|NCT00980330|3922646|P5|NOT COMPLETED|Overall Study||5
1604077|NCT00980330|3922647|P4|NOT COMPLETED|Overall Study||5
1604078|NCT00980330|3922648|P3|NOT COMPLETED|Overall Study||8
1604079|NCT00980330|3922649|P2|NOT COMPLETED|Overall Study||5
1604080|NCT00980330|3922650|P1|NOT COMPLETED|Overall Study||5
1604081|NCT00980330|3922644|P7|COMPLETED|Overall Study||59
1604082|NCT00980330|3922645|P6|COMPLETED|Overall Study||61
1604083|NCT00980330|3922646|P5|COMPLETED|Overall Study||63
1604084|NCT00980330|3922647|P4|COMPLETED|Overall Study||61
1604085|NCT00980330|3922648|P3|COMPLETED|Overall Study||58
1604086|NCT00980330|3922649|P2|COMPLETED|Overall Study||60
1604087|NCT00980330|3922650|P1|COMPLETED|Overall Study||61
1604088|NCT00980330|3922644|P7|STARTED|Overall Study||66
1604089|NCT00980330|3922645|P6|STARTED|Overall Study||65
1604090|NCT00980330|3922646|P5|STARTED|Overall Study||68
1604091|NCT00980330|3922647|P4|STARTED|Overall Study||66
1604092|NCT00980330|3922648|P3|STARTED|Overall Study||66
1604093|NCT00980330|3922649|P2|STARTED|Overall Study||65
1604094|NCT00980330|3922650|P1|STARTED|Overall Study||66
1604095|NCT00980278|3922750|P2|NOT COMPLETED|Overall Study||0
1604096|NCT00980278|3922751|P1|NOT COMPLETED|Overall Study||2
1604097|NCT00980278|3922750|P2|COMPLETED|Overall Study||13
1604098|NCT00980278|3922751|P1|COMPLETED|Overall Study||11
1604099|NCT00980278|3922750|P2|STARTED|Overall Study||13
1604100|NCT00980278|3922751|P1|STARTED|Overall Study||13
1604101|NCT00980200|3922765|P5|NOT COMPLETED|7-day Treatment Period 5||0
1604102|NCT00980200|3922766|P4|NOT COMPLETED|7-day Treatment Period 5||0
1604103|NCT00980200|3922767|P3|NOT COMPLETED|7-day Treatment Period 5||0
1604104|NCT00980200|3922768|P2|NOT COMPLETED|7-day Treatment Period 5||0
1604105|NCT00980200|3922769|P1|NOT COMPLETED|7-day Treatment Period 5||0
1604106|NCT00980200|3922765|P5|COMPLETED|7-day Treatment Period 5||14
1604107|NCT00980200|3922766|P4|COMPLETED|7-day Treatment Period 5||16
1604108|NCT00980200|3922767|P3|COMPLETED|7-day Treatment Period 5||15
1604109|NCT00980200|3922768|P2|COMPLETED|7-day Treatment Period 5||12
1604110|NCT00980200|3922769|P1|COMPLETED|7-day Treatment Period 5||15
1604111|NCT00980200|3922765|P5|STARTED|7-day Treatment Period 5||14
1604112|NCT00980200|3922766|P4|STARTED|7-day Treatment Period 5||16
1604113|NCT00980200|3922767|P3|STARTED|7-day Treatment Period 5||15
1604114|NCT00980200|3922768|P2|STARTED|7-day Treatment Period 5||12
1604115|NCT00980200|3922769|P1|STARTED|7-day Treatment Period 5||15
1604116|NCT00980200|3922765|P5|NOT COMPLETED|7-day Washout Period 4||0
1604117|NCT00980200|3922766|P4|NOT COMPLETED|7-day Washout Period 4||0
1604118|NCT00980200|3922767|P3|NOT COMPLETED|7-day Washout Period 4||0
1604119|NCT00980200|3922768|P2|NOT COMPLETED|7-day Washout Period 4||0
1604120|NCT00980200|3922769|P1|NOT COMPLETED|7-day Washout Period 4||0
1604121|NCT00980200|3922765|P5|COMPLETED|7-day Washout Period 4||14
1604122|NCT00980200|3922766|P4|COMPLETED|7-day Washout Period 4||16
1604123|NCT00980200|3922767|P3|COMPLETED|7-day Washout Period 4||15
1604124|NCT00980200|3922768|P2|COMPLETED|7-day Washout Period 4||12
1604125|NCT00980200|3922769|P1|COMPLETED|7-day Washout Period 4||15
1604126|NCT00980200|3922765|P5|STARTED|7-day Washout Period 4||14
1604127|NCT00980200|3922766|P4|STARTED|7-day Washout Period 4||16
1604128|NCT00980200|3922767|P3|STARTED|7-day Washout Period 4||15
1604129|NCT00980200|3922768|P2|STARTED|7-day Washout Period 4||12
1604130|NCT00980200|3922769|P1|STARTED|7-day Washout Period 4||15
1604131|NCT00980200|3922765|P5|NOT COMPLETED|7-day Treatment Period 4||0
1604132|NCT00980200|3922766|P4|NOT COMPLETED|7-day Treatment Period 4||0
1604133|NCT00980200|3922767|P3|NOT COMPLETED|7-day Treatment Period 4||0
1604134|NCT00980200|3922768|P2|NOT COMPLETED|7-day Treatment Period 4||0
1604135|NCT00980200|3922769|P1|NOT COMPLETED|7-day Treatment Period 4||0
1604136|NCT00980200|3922765|P5|COMPLETED|7-day Treatment Period 4||14
1604137|NCT00980200|3922766|P4|COMPLETED|7-day Treatment Period 4||16
1604138|NCT00980200|3922767|P3|COMPLETED|7-day Treatment Period 4||15
1604139|NCT00980200|3922768|P2|COMPLETED|7-day Treatment Period 4||12
1604140|NCT00980200|3922769|P1|COMPLETED|7-day Treatment Period 4||15
1604141|NCT00980200|3922765|P5|STARTED|7-day Treatment Period 4||14
1604142|NCT00980200|3922766|P4|STARTED|7-day Treatment Period 4||16
1604143|NCT00980200|3922767|P3|STARTED|7-day Treatment Period 4||15
1604144|NCT00980200|3922768|P2|STARTED|7-day Treatment Period 4||12
1604145|NCT00980200|3922769|P1|STARTED|7-day Treatment Period 4||15
1604146|NCT00980200|3922765|P5|NOT COMPLETED|7-day Washout Period 3||0
1604147|NCT00980200|3922766|P4|NOT COMPLETED|7-day Washout Period 3||0
1604148|NCT00980200|3922767|P3|NOT COMPLETED|7-day Washout Period 3||0
1604149|NCT00980200|3922768|P2|NOT COMPLETED|7-day Washout Period 3||0
1604150|NCT00980200|3922769|P1|NOT COMPLETED|7-day Washout Period 3||0
1604151|NCT00980200|3922765|P5|COMPLETED|7-day Washout Period 3||14
1604152|NCT00980200|3922766|P4|COMPLETED|7-day Washout Period 3||16
1604153|NCT00980200|3922767|P3|COMPLETED|7-day Washout Period 3||15
1604154|NCT00980200|3922768|P2|COMPLETED|7-day Washout Period 3||12
1604155|NCT00980200|3922769|P1|COMPLETED|7-day Washout Period 3||15
1604156|NCT00980200|3922765|P5|STARTED|7-day Washout Period 3||14
1604157|NCT00980200|3922766|P4|STARTED|7-day Washout Period 3||16
1604158|NCT00980200|3922767|P3|STARTED|7-day Washout Period 3||15
1604159|NCT00980200|3922768|P2|STARTED|7-day Washout Period 3||12
1604160|NCT00980200|3922769|P1|STARTED|7-day Washout Period 3||15
1604161|NCT00980200|3922765|P5|NOT COMPLETED|7-day Treatment Period 3||1
1604162|NCT00980200|3922766|P4|NOT COMPLETED|7-day Treatment Period 3||0
1604163|NCT00980200|3922767|P3|NOT COMPLETED|7-day Treatment Period 3||0
1604164|NCT00980200|3922768|P2|NOT COMPLETED|7-day Treatment Period 3||1
1604165|NCT00980200|3922769|P1|NOT COMPLETED|7-day Treatment Period 3||0
1604166|NCT00980200|3922765|P5|COMPLETED|7-day Treatment Period 3||14
1604167|NCT00980200|3922766|P4|COMPLETED|7-day Treatment Period 3||16
1604168|NCT00980200|3922767|P3|COMPLETED|7-day Treatment Period 3||15
1604169|NCT00980200|3922768|P2|COMPLETED|7-day Treatment Period 3||12
1604170|NCT00980200|3922769|P1|COMPLETED|7-day Treatment Period 3||15
1604171|NCT00980200|3922765|P5|STARTED|7-day Treatment Period 3||15
1604172|NCT00980200|3922766|P4|STARTED|7-day Treatment Period 3||16
1604173|NCT00980200|3922767|P3|STARTED|7-day Treatment Period 3||15
1604174|NCT00980200|3922768|P2|STARTED|7-day Treatment Period 3||13
1604175|NCT00980200|3922769|P1|STARTED|7-day Treatment Period 3||15
1604176|NCT00980200|3922765|P5|NOT COMPLETED|7-day Washout Period 2||0
1604177|NCT00980200|3922766|P4|NOT COMPLETED|7-day Washout Period 2||0
1604178|NCT00980200|3922767|P3|NOT COMPLETED|7-day Washout Period 2||0
1604179|NCT00980200|3922768|P2|NOT COMPLETED|7-day Washout Period 2||0
1604180|NCT00980200|3922769|P1|NOT COMPLETED|7-day Washout Period 2||0
1604181|NCT00980200|3922765|P5|COMPLETED|7-day Washout Period 2||15
1604182|NCT00980200|3922766|P4|COMPLETED|7-day Washout Period 2||16
1604183|NCT00980200|3922767|P3|COMPLETED|7-day Washout Period 2||15
1604184|NCT00980200|3922768|P2|COMPLETED|7-day Washout Period 2||13
1604185|NCT00980200|3922769|P1|COMPLETED|7-day Washout Period 2||15
1604186|NCT00980200|3922765|P5|STARTED|7-day Washout Period 2||15
1604187|NCT00980200|3922766|P4|STARTED|7-day Washout Period 2||16
1604188|NCT00980200|3922767|P3|STARTED|7-day Washout Period 2||15
1604189|NCT00980200|3922768|P2|STARTED|7-day Washout Period 2||13
1604190|NCT00980200|3922769|P1|STARTED|7-day Washout Period 2||15
1604191|NCT00980200|3922765|P5|NOT COMPLETED|7-day Treatment Period 2||0
1604192|NCT00980200|3922766|P4|NOT COMPLETED|7-day Treatment Period 2||0
1604193|NCT00980200|3922767|P3|NOT COMPLETED|7-day Treatment Period 2||0
1604194|NCT00980200|3922768|P2|NOT COMPLETED|7-day Treatment Period 2||0
1604195|NCT00980200|3922769|P1|NOT COMPLETED|7-day Treatment Period 2||0
1604196|NCT00980200|3922765|P5|COMPLETED|7-day Treatment Period 2||15
1604197|NCT00980200|3922766|P4|COMPLETED|7-day Treatment Period 2||16
1604198|NCT00980200|3922767|P3|COMPLETED|7-day Treatment Period 2||15
1604199|NCT00980200|3922768|P2|COMPLETED|7-day Treatment Period 2||13
1604200|NCT00980200|3922769|P1|COMPLETED|7-day Treatment Period 2||15
1604201|NCT00980200|3922765|P5|STARTED|7-day Treatment Period 2||15
1604202|NCT00980200|3922766|P4|STARTED|7-day Treatment Period 2||16
1604203|NCT00980200|3922767|P3|STARTED|7-day Treatment Period 2||15
1604204|NCT00980200|3922768|P2|STARTED|7-day Treatment Period 2||13
1604205|NCT00980200|3922769|P1|STARTED|7-day Treatment Period 2||15
1604206|NCT00980200|3922765|P5|NOT COMPLETED|7-day Washout Period 1||0
1604207|NCT00980200|3922766|P4|NOT COMPLETED|7-day Washout Period 1||0
1604208|NCT00980200|3922767|P3|NOT COMPLETED|7-day Washout Period 1||0
1604209|NCT00980200|3922768|P2|NOT COMPLETED|7-day Washout Period 1||0
1604210|NCT00980200|3922769|P1|NOT COMPLETED|7-day Washout Period 1||0
1604211|NCT00980200|3922765|P5|COMPLETED|7-day Washout Period 1||15
1604212|NCT00980200|3922766|P4|COMPLETED|7-day Washout Period 1||16
1604213|NCT00980200|3922767|P3|COMPLETED|7-day Washout Period 1||15
1604214|NCT00980200|3922768|P2|COMPLETED|7-day Washout Period 1||13
1604215|NCT00980200|3922769|P1|COMPLETED|7-day Washout Period 1||15
1604216|NCT00980200|3922765|P5|STARTED|7-day Washout Period 1||15
1604217|NCT00980200|3922766|P4|STARTED|7-day Washout Period 1||16
1604218|NCT00980200|3922767|P3|STARTED|7-day Washout Period 1||15
1604219|NCT00980200|3922768|P2|STARTED|7-day Washout Period 1||13
1604220|NCT00980200|3922769|P1|STARTED|7-day Washout Period 1||15
1604221|NCT00980200|3922765|P5|NOT COMPLETED|7-day Treatment Period 1||0
1604222|NCT00980200|3922766|P4|NOT COMPLETED|7-day Treatment Period 1||0
1604223|NCT00980200|3922767|P3|NOT COMPLETED|7-day Treatment Period 1||0
1604224|NCT00980200|3922768|P2|NOT COMPLETED|7-day Treatment Period 1||1
1604225|NCT00980200|3922769|P1|NOT COMPLETED|7-day Treatment Period 1||0
1604226|NCT00980200|3922765|P5|COMPLETED|7-day Treatment Period 1||15
1604227|NCT00980200|3922766|P4|COMPLETED|7-day Treatment Period 1||16
1604228|NCT00980200|3922767|P3|COMPLETED|7-day Treatment Period 1||15
1604229|NCT00980200|3922768|P2|COMPLETED|7-day Treatment Period 1||13
1604230|NCT00980200|3922769|P1|COMPLETED|7-day Treatment Period 1||15
1604231|NCT00980200|3922765|P5|STARTED|7-day Treatment Period 1||15
1604232|NCT00980200|3922766|P4|STARTED|7-day Treatment Period 1||16
1604233|NCT00980200|3922767|P3|STARTED|7-day Treatment Period 1||15
1604234|NCT00980200|3922768|P2|STARTED|7-day Treatment Period 1||14
1604235|NCT00980200|3922769|P1|STARTED|7-day Treatment Period 1||15
1604236|NCT00980174|3922788|P2|NOT COMPLETED|Overall Study||10
1604237|NCT00980174|3922789|P1|NOT COMPLETED|Overall Study||4
1604238|NCT00980174|3922788|P2|COMPLETED|Overall Study||111
1604239|NCT00980174|3922789|P1|COMPLETED|Overall Study||117
1604240|NCT00980174|3922788|P2|STARTED|Overall Study||121
1604241|NCT00980174|3922789|P1|STARTED|Overall Study||121
1604242|NCT00980148|3922807|P2|NOT COMPLETED|Overall Study||128
1604243|NCT00980148|3922808|P1|NOT COMPLETED|Overall Study||129
1604244|NCT00980148|3922807|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
1604245|NCT00980148|3922808|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
1604246|NCT00980148|3922807|P2|STARTED|Overall Study||283
1604247|NCT00980148|3922808|P1|STARTED|Overall Study||284
1604248|NCT00980057|3922816|P2|NOT COMPLETED|Overall Study||5
1604249|NCT00980057|3922817|P1|NOT COMPLETED|Overall Study||19
1604250|NCT00980057|3922816|P2|COMPLETED|Overall Study||155
1604251|NCT00980057|3922817|P1|COMPLETED|Overall Study||299
1604252|NCT00980057|3922816|P2|STARTED|Overall Study||160
1604253|NCT00980057|3922817|P1|STARTED|Overall Study||318
1604254|NCT00980044|3922840|P3|NOT COMPLETED|Overall Study||5
1604255|NCT00980044|3922841|P2|NOT COMPLETED|Overall Study||7
1604256|NCT00980044|3922842|P1|NOT COMPLETED|Overall Study||5
1604257|NCT00980044|3922840|P3|COMPLETED|Overall Study||12
1604258|NCT00980044|3922841|P2|COMPLETED|Overall Study||12
1604259|NCT00980044|3922842|P1|COMPLETED|Overall Study||12
1604260|NCT00980044|3922840|P3|STARTED|Overall Study||17
1604261|NCT00980044|3922841|P2|STARTED|Overall Study||19
1604262|NCT00980044|3922842|P1|STARTED|Overall Study||17
1604263|NCT00980005|3922861|P2|NOT COMPLETED|Overall Study||63
1604264|NCT00980005|3922862|P1|NOT COMPLETED|Overall Study||47
1604265|NCT00980005|3922861|P2|COMPLETED|Overall Study||998
1604266|NCT00980005|3922862|P1|COMPLETED|Overall Study||1008
1604267|NCT00980005|3922861|P2|STARTED|Overall Study||1061
1604268|NCT00980005|3922862|P1|STARTED|Overall Study||1055
1604269|NCT00979992|3922902|P1|NOT COMPLETED|Overall Study||5
1604270|NCT00979992|3922902|P1|COMPLETED|Overall Study||30
1604271|NCT00979992|3922902|P1|STARTED|Overall Study||35
1604272|NCT00979953|3922914|P4|NOT COMPLETED|Overall Study||7
1604273|NCT00979953|3922915|P3|NOT COMPLETED|Overall Study||22
1604274|NCT00979953|3922916|P2|NOT COMPLETED|Overall Study||5
1604275|NCT00979953|3922917|P1|NOT COMPLETED|Overall Study||8
1604276|NCT00979953|3922914|P4|COMPLETED|Overall Study||97
1604277|NCT00979953|3922915|P3|COMPLETED|Overall Study||82
1604278|NCT00979953|3922916|P2|COMPLETED|Overall Study||94
1604279|NCT00979953|3922917|P1|COMPLETED|Overall Study||93
1604280|NCT00979953|3922914|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
1604281|NCT00979953|3922915|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
1604282|NCT00979953|3922916|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
1604283|NCT00979953|3922917|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
1604284|NCT00979953|3922914|P4|STARTED|Overall Study||104
1604285|NCT00979953|3922915|P3|STARTED|Overall Study||104
1604286|NCT00979953|3922916|P2|STARTED|Overall Study||99
1604287|NCT00979953|3922917|P1|STARTED|Overall Study||101
1604288|NCT00979940|3922929|P2|NOT COMPLETED|Overall Study||0
1604289|NCT00979940|3922930|P1|NOT COMPLETED|Overall Study||0
1604290|NCT00979940|3922929|P2|COMPLETED|Overall Study||28
1604291|NCT00979940|3922930|P1|COMPLETED|Overall Study||32
1604292|NCT00979940|3922929|P2|STARTED|Overall Study||28
1604293|NCT00979940|3922930|P1|STARTED|Overall Study||32
1604294|NCT00979901|3922940|P4|NOT COMPLETED|Overall Study||116
1604295|NCT00979901|3922941|P3|NOT COMPLETED|Overall Study||29
1604296|NCT00979901|3922942|P2|NOT COMPLETED|Overall Study||12
1604297|NCT00979901|3922943|P1|NOT COMPLETED|Overall Study||18
1604298|NCT00979901|3922940|P4|COMPLETED|Overall Study||159
1604299|NCT00979901|3922941|P3|COMPLETED|Overall Study||573
1604300|NCT00979901|3922942|P2|COMPLETED|Overall Study||336
1604301|NCT00979901|3922943|P1|COMPLETED|Overall Study||334
1604302|NCT00979901|3922940|P4|STARTED|Overall Study||275
1604303|NCT00979901|3922941|P3|STARTED|Overall Study||602
1604304|NCT00979901|3922942|P2|STARTED|Overall Study||348
1604305|NCT00979901|3922943|P1|STARTED|Overall Study||352
1604306|NCT00979875|3922967|P6|NOT COMPLETED|Intervention 3||0
1604307|NCT00979875|3922968|P5|NOT COMPLETED|Intervention 3||0
1604308|NCT00979875|3922969|P4|NOT COMPLETED|Intervention 3||0
1604309|NCT00979875|3922970|P3|NOT COMPLETED|Intervention 3||0
1604310|NCT00979875|3922971|P2|NOT COMPLETED|Intervention 3||0
1604311|NCT00979875|3922972|P1|NOT COMPLETED|Intervention 3||0
1604312|NCT00979875|3922967|P6|COMPLETED|Intervention 3||2
1604313|NCT00979875|3922968|P5|COMPLETED|Intervention 3||3
1604314|NCT00979875|3922969|P4|COMPLETED|Intervention 3||2
1604315|NCT00979875|3922970|P3|COMPLETED|Intervention 3||3
1604316|NCT00979875|3922971|P2|COMPLETED|Intervention 3||2
1604317|NCT00979875|3922972|P1|COMPLETED|Intervention 3||2
1604318|NCT00979875|3922967|P6|STARTED|Intervention 3||2
1604319|NCT00979875|3922968|P5|STARTED|Intervention 3||3
1604320|NCT00979875|3922969|P4|STARTED|Intervention 3||2
1604321|NCT00979875|3922970|P3|STARTED|Intervention 3||3
1604322|NCT00979875|3922971|P2|STARTED|Intervention 3||2
1604323|NCT00979875|3922972|P1|STARTED|Intervention 3||2
1604324|NCT00979875|3922967|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1604325|NCT00979875|3922968|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1604326|NCT00979875|3922969|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1604327|NCT00979875|3922970|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1604328|NCT00979875|3922971|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1604329|NCT00979875|3922972|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1604330|NCT00979875|3922967|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
1604331|NCT00979875|3922968|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
1604332|NCT00979875|3922969|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
1604333|NCT00979875|3922970|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
1604334|NCT00979875|3922971|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
1604335|NCT00979875|3922972|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
1604336|NCT00979875|3922967|P6|STARTED|Washout 2 (3 to 14 Days)||2
1604337|NCT00979875|3922968|P5|STARTED|Washout 2 (3 to 14 Days)||3
1604338|NCT00979875|3922969|P4|STARTED|Washout 2 (3 to 14 Days)||2
1604339|NCT00979875|3922970|P3|STARTED|Washout 2 (3 to 14 Days)||3
1604340|NCT00979875|3922971|P2|STARTED|Washout 2 (3 to 14 Days)||2
1604341|NCT00979875|3922972|P1|STARTED|Washout 2 (3 to 14 Days)||2
1604342|NCT00979875|3922967|P6|NOT COMPLETED|Intervention 2||0
1604343|NCT00979875|3922968|P5|NOT COMPLETED|Intervention 2||0
1604344|NCT00979875|3922969|P4|NOT COMPLETED|Intervention 2||0
1604345|NCT00979875|3922970|P3|NOT COMPLETED|Intervention 2||0
1604346|NCT00979875|3922971|P2|NOT COMPLETED|Intervention 2||0
1604347|NCT00979875|3922972|P1|NOT COMPLETED|Intervention 2||0
1604348|NCT00979875|3922967|P6|COMPLETED|Intervention 2||2
1604349|NCT00979875|3922968|P5|COMPLETED|Intervention 2||3
1604350|NCT00979875|3922969|P4|COMPLETED|Intervention 2||2
1604351|NCT00979875|3922970|P3|COMPLETED|Intervention 2||3
1604352|NCT00979875|3922971|P2|COMPLETED|Intervention 2||2
1604353|NCT00979875|3922972|P1|COMPLETED|Intervention 2||2
1604354|NCT00979875|3922967|P6|STARTED|Intervention 2||2
1604355|NCT00979875|3922968|P5|STARTED|Intervention 2||3
1604356|NCT00979875|3922969|P4|STARTED|Intervention 2||2
1604357|NCT00979875|3922970|P3|STARTED|Intervention 2||3
1604358|NCT00979875|3922971|P2|STARTED|Intervention 2||2
1604359|NCT00979875|3922972|P1|STARTED|Intervention 2||2
1604360|NCT00979875|3922967|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1604361|NCT00979875|3922968|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1604362|NCT00979875|3922969|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1604363|NCT00979875|3922970|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1604364|NCT00979875|3922971|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1604365|NCT00979875|3922972|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1604366|NCT00979875|3922967|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
1604367|NCT00979875|3922968|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
1604368|NCT00979875|3922969|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
1604369|NCT00979875|3922970|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
1604370|NCT00979875|3922971|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
1604371|NCT00979875|3922972|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
1604372|NCT00979875|3922967|P6|STARTED|Washout 1 (3 to 14 Days)||2
1604373|NCT00979875|3922968|P5|STARTED|Washout 1 (3 to 14 Days)||3
1604374|NCT00979875|3922969|P4|STARTED|Washout 1 (3 to 14 Days)||2
1604375|NCT00979875|3922970|P3|STARTED|Washout 1 (3 to 14 Days)||3
1604376|NCT00979875|3922971|P2|STARTED|Washout 1 (3 to 14 Days)||2
1604377|NCT00979875|3922972|P1|STARTED|Washout 1 (3 to 14 Days)||2
1604378|NCT00979875|3922967|P6|NOT COMPLETED|Intervention 1||0
1604379|NCT00979875|3922968|P5|NOT COMPLETED|Intervention 1||0
1604380|NCT00979875|3922969|P4|NOT COMPLETED|Intervention 1||0
1604381|NCT00979875|3922970|P3|NOT COMPLETED|Intervention 1||0
1604382|NCT00979875|3922971|P2|NOT COMPLETED|Intervention 1||0
1604383|NCT00979875|3922972|P1|NOT COMPLETED|Intervention 1||0
1604384|NCT00979875|3922967|P6|COMPLETED|Intervention 1||2
1604385|NCT00979875|3922968|P5|COMPLETED|Intervention 1||3
1604386|NCT00979875|3922969|P4|COMPLETED|Intervention 1||2
1604387|NCT00979875|3922970|P3|COMPLETED|Intervention 1||3
1604388|NCT00979875|3922971|P2|COMPLETED|Intervention 1||2
1604389|NCT00979875|3922972|P1|COMPLETED|Intervention 1||2
1604390|NCT00979875|3922967|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
1604391|NCT00979875|3922968|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
1604392|NCT00979875|3922969|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
1604393|NCT00979875|3922970|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
1604394|NCT00979875|3922971|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
1604395|NCT00979875|3922972|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
1604396|NCT00979875|3922967|P6|STARTED|Intervention 1||2
1604397|NCT00979875|3922968|P5|STARTED|Intervention 1||3
1604398|NCT00979875|3922969|P4|STARTED|Intervention 1||2
1604399|NCT00979875|3922970|P3|STARTED|Intervention 1||3
1604400|NCT00979875|3922971|P2|STARTED|Intervention 1||2
1604401|NCT00979875|3922972|P1|STARTED|Intervention 1||2
1604402|NCT00979654|3923016|P1|NOT COMPLETED|Overall Study||36
1604403|NCT00979654|3923016|P1|COMPLETED|Overall Study||67
1604404|NCT00979654|3923016|P1|STARTED|Overall Study||103
1604405|NCT00979628|3923031|P3|NOT COMPLETED|Overall Study||6
1604406|NCT00979628|3923032|P2|NOT COMPLETED|Overall Study||9
1604407|NCT00979628|3923033|P1|NOT COMPLETED|Overall Study||9
1604408|NCT00979628|3923031|P3|COMPLETED|Overall Study||74
1604409|NCT00979628|3923032|P2|COMPLETED|Overall Study||133
1604410|NCT00979628|3923033|P1|COMPLETED|Overall Study||144
1604411|NCT00979628|3923031|P3|STARTED|Overall Study||80
1604412|NCT00979628|3923032|P2|STARTED|Overall Study||142
1604413|NCT00979628|3923033|P1|STARTED|Overall Study||153
1604414|NCT00979615|3923046|P2|NOT COMPLETED|Overall Study||8
1604415|NCT00979615|3923047|P1|NOT COMPLETED|Overall Study||6
1604416|NCT00979615|3923046|P2|COMPLETED|Overall Study||58
1604417|NCT00979615|3923047|P1|COMPLETED|Overall Study||57
1604418|NCT00979615|3923046|P2|STARTED|Overall Study||66
1604419|NCT00979615|3923047|P1|STARTED|Overall Study||63
1604420|NCT00979602|3923063|P2|NOT COMPLETED|Overall Study||133
1604421|NCT00979602|3923064|P1|NOT COMPLETED|Overall Study||145
1604422|NCT00979602|3923063|P2|COMPLETED|Overall Study||1890
1604423|NCT00979602|3923064|P1|COMPLETED|Overall Study||1880
1604424|NCT00979602|3923063|P2|STARTED|Overall Study||2023
1604425|NCT00979602|3923064|P1|STARTED|Overall Study||2025
1604426|NCT00979576|3923235|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
1604427|NCT00979576|3923236|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
1604428|NCT00979576|3923237|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
1604429|NCT00979576|3923235|P3|COMPLETED|Combination Followed by Monotherapy||0
1604430|NCT00979576|3923236|P2|COMPLETED|Combination Followed by Monotherapy||0
1604431|NCT00979576|3923237|P1|COMPLETED|Combination Followed by Monotherapy||0
1604432|NCT00979576|3923235|P3|STARTED|Combination Followed by Monotherapy||1
1604433|NCT00979576|3923236|P2|STARTED|Combination Followed by Monotherapy||2
1604434|NCT00979576|3923237|P1|STARTED|Combination Followed by Monotherapy||0
1604435|NCT00979576|3923235|P3|NOT COMPLETED|Combination Treatment Phase||9
1604436|NCT00979576|3923236|P2|NOT COMPLETED|Combination Treatment Phase||6
1604437|NCT00979576|3923237|P1|NOT COMPLETED|Combination Treatment Phase||3
1604438|NCT00979576|3923235|P3|COMPLETED|Combination Treatment Phase||0
1604439|NCT00979576|3923236|P2|COMPLETED|Combination Treatment Phase||0
1604440|NCT00979576|3923237|P1|COMPLETED|Combination Treatment Phase||0
1604441|NCT00979576|3923235|P3|STARTED|Combination Treatment Phase||9
1604442|NCT00979576|3923236|P2|STARTED|Combination Treatment Phase||6
1604443|NCT00979576|3923237|P1|STARTED|Combination Treatment Phase||3
1604444|NCT00979550|3923270|P2|NOT COMPLETED|Overall Study||0
1604445|NCT00979550|3923271|P1|NOT COMPLETED|Overall Study||0
1604446|NCT00979550|3923270|P2|COMPLETED|Overall Study||3
1604447|NCT00979550|3923271|P1|COMPLETED|Overall Study||4
1604448|NCT00979550|3923270|P2|STARTED|Overall Study||3
1604449|NCT00979550|3923271|P1|STARTED|Overall Study||4
1604450|NCT00979459|3923277|P2|NOT COMPLETED|Second Intervention||0
1604451|NCT00979459|3923278|P1|NOT COMPLETED|Second Intervention||0
1604452|NCT00979459|3923277|P2|COMPLETED|Second Intervention||6
1604453|NCT00979459|3923278|P1|COMPLETED|Second Intervention||6
1604454|NCT00979459|3923277|P2|STARTED|Second Intervention||6
1604455|NCT00979459|3923278|P1|STARTED|Second Intervention||6
1604456|NCT00979459|3923277|P2|NOT COMPLETED|7-day Washout Period||0
1604457|NCT00979459|3923278|P1|NOT COMPLETED|7-day Washout Period||0
1604458|NCT00979459|3923277|P2|COMPLETED|7-day Washout Period||6
1604459|NCT00979459|3923278|P1|COMPLETED|7-day Washout Period||6
1604460|NCT00979459|3923277|P2|STARTED|7-day Washout Period||6
1604461|NCT00979459|3923278|P1|STARTED|7-day Washout Period||6
1604462|NCT00979459|3923277|P2|NOT COMPLETED|First Intervention||0
1604463|NCT00979459|3923278|P1|NOT COMPLETED|First Intervention||0
1604464|NCT00979459|3923277|P2|COMPLETED|First Intervention||6
1604465|NCT00979459|3923278|P1|COMPLETED|First Intervention||6
1604466|NCT00979459|3923277|P2|STARTED|First Intervention||6
1604467|NCT00979459|3923278|P1|STARTED|First Intervention||6
1604468|NCT00979420|3923294|P4|NOT COMPLETED|Overall Study||2
1604469|NCT00979420|3923295|P3|NOT COMPLETED|Overall Study||1
1604470|NCT00979420|3923296|P2|NOT COMPLETED|Overall Study||0
1604471|NCT00979420|3923297|P1|NOT COMPLETED|Overall Study||7
1604472|NCT00979420|3923294|P4|COMPLETED|Overall Study||59
1604473|NCT00979420|3923295|P3|COMPLETED|Overall Study||59
1604474|NCT00979420|3923296|P2|COMPLETED|Overall Study||57
1604475|NCT00979420|3923297|P1|COMPLETED|Overall Study||171
1604476|NCT00979420|3923294|P4|STARTED|Overall Study||61
1604477|NCT00979420|3923295|P3|STARTED|Overall Study||60
1604478|NCT00979420|3923296|P2|STARTED|Overall Study||57
1604479|NCT00979420|3923297|P1|STARTED|Overall Study||178
1604480|NCT00979407|3923367|P2|NOT COMPLETED|Overall Study||7
1604481|NCT00979407|3923368|P1|NOT COMPLETED|Overall Study||6
1604482|NCT00979407|3923367|P2|COMPLETED|Overall Study||160
1604483|NCT00979407|3923368|P1|COMPLETED|Overall Study||161
1604484|NCT00979407|3923367|P2|STARTED|Overall Study||167
1604485|NCT00979407|3923368|P1|STARTED|Overall Study||167
1604486|NCT00979303|3923410|P2|NOT COMPLETED|Overall Study||0
1604487|NCT00979303|3923411|P1|NOT COMPLETED|Overall Study||0
1604488|NCT00979303|3923410|P2|COMPLETED|Overall Study||37
1604489|NCT00979303|3923411|P1|COMPLETED|Overall Study||37
1604490|NCT00979303|3923410|P2|STARTED|Overall Study||37
1604491|NCT00979303|3923411|P1|STARTED|Overall Study||37
1604492|NCT00979212|3923421|P2|NOT COMPLETED|Overall Study||8
1604493|NCT00979212|3923422|P1|NOT COMPLETED|Overall Study||2
1604494|NCT00979212|3923421|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
1604495|NCT00979212|3923422|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
1604496|NCT00979212|3923421|P2|STARTED|Overall Study||47
1604497|NCT00979212|3923422|P1|STARTED|Overall Study||24
1604498|NCT00979199|3923440|P1|NOT COMPLETED|Overall Study||222
1604499|NCT00979199|3923440|P1|COMPLETED|Overall Study||475
1604500|NCT00979199|3923440|P1|STARTED|Overall Study||697
1604501|NCT00979121|3923446|P2|NOT COMPLETED|Overall Study||0
1604502|NCT00979121|3923447|P1|NOT COMPLETED|Overall Study||0
1604503|NCT00979121|3923446|P2|COMPLETED|Overall Study||366
1604504|NCT00979121|3923447|P1|COMPLETED|Overall Study||379
1604505|NCT00979121|3923446|P2|STARTED|Overall Study||366
1604506|NCT00979121|3923447|P1|STARTED|Overall Study||379
1604507|NCT00979069|3923465|P2|NOT COMPLETED|Overall Study||2
1604508|NCT00979069|3923466|P1|NOT COMPLETED|Overall Study||0
1604509|NCT00979069|3923465|P2|COMPLETED|Overall Study||8
1604510|NCT00979069|3923466|P1|COMPLETED|Overall Study||10
1604511|NCT00979069|3923465|P2|STARTED|Overall Study||10
1604512|NCT00979069|3923466|P1|STARTED|Overall Study||10
1604513|NCT00979017|3923472|P1|NOT COMPLETED|Overall Study||0
1604514|NCT00979017|3923472|P1|COMPLETED|Overall Study||41
1604515|NCT00979017|3923472|P1|STARTED|Overall Study||41
1604516|NCT00978757|3923482|P2|NOT COMPLETED|Overall Study||3
1604517|NCT00978757|3923483|P1|NOT COMPLETED|Overall Study||1
1604518|NCT00978757|3923482|P2|COMPLETED|Overall Study|June 2008|17
1604519|NCT00978757|3923483|P1|COMPLETED|Overall Study|June 2008|21
1604520|NCT00978757|3923482|P2|STARTED|Overall Study|June 2001|20
1604521|NCT00978757|3923483|P1|STARTED|Overall Study|June 2001|22
1604522|NCT00978731|3923493|P4|NOT COMPLETED|Overall Study||4
1604523|NCT00978731|3923494|P3|NOT COMPLETED|Overall Study||5
1604524|NCT00978731|3923495|P2|NOT COMPLETED|Overall Study||15
1604525|NCT00978731|3923496|P1|NOT COMPLETED|Overall Study||22
1604526|NCT00978731|3923493|P4|COMPLETED|Overall Study||0
1604527|NCT00978731|3923494|P3|COMPLETED|Overall Study||0
1604528|NCT00978731|3923495|P2|COMPLETED|Overall Study||0
1604529|NCT00978731|3923496|P1|COMPLETED|Overall Study||0
1604530|NCT00978731|3923493|P4|STARTED|Overall Study||4
1604531|NCT00978731|3923494|P3|STARTED|Overall Study||5
1604532|NCT00978731|3923495|P2|STARTED|Overall Study||15
1604533|NCT00978731|3923496|P1|STARTED|Overall Study||22
1604534|NCT00978627|3923536|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
1604535|NCT00978627|3923537|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
1604536|NCT00978627|3923536|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
1604537|NCT00978627|3923537|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
1604538|NCT00978627|3923536|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
1604539|NCT00978627|3923537|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
1604540|NCT00978627|3923536|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
1604541|NCT00978627|3923537|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
1604542|NCT00978627|3923536|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
1604543|NCT00978627|3923537|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
1604544|NCT00978627|3923536|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
1604545|NCT00978627|3923537|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
1604546|NCT00978627|3923536|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
1604547|NCT00978627|3923537|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
1604548|NCT00978562|3923559|P1|NOT COMPLETED|Overall Study||0
1604549|NCT00978562|3923559|P1|COMPLETED|Overall Study||7
1604550|NCT00978562|3923559|P1|STARTED|Overall Study||7
1604551|NCT00978445|3923564|P2|NOT COMPLETED|Overall Study||1
1604552|NCT00978445|3923565|P1|NOT COMPLETED|Overall Study||2
1604553|NCT00978445|3923564|P2|COMPLETED|Overall Study||12
1604554|NCT00978445|3923565|P1|COMPLETED|Overall Study||10
1604555|NCT00978445|3923564|P2|STARTED|Overall Study||13
1604556|NCT00978445|3923565|P1|STARTED|Overall Study||12
1604557|NCT00978432|3923575|P3|NOT COMPLETED|Overall Study||5
1604558|NCT00978432|3923576|P2|NOT COMPLETED|Overall Study||1
1604559|NCT00978432|3923577|P1|NOT COMPLETED|Overall Study||3
1604560|NCT00978432|3923575|P3|COMPLETED|Overall Study||13
1604561|NCT00978432|3923576|P2|COMPLETED|Overall Study||4
1604562|NCT00978432|3923577|P1|COMPLETED|Overall Study||7
1604563|NCT00978432|3923575|P3|STARTED|Overall Study||18
1604564|NCT00978432|3923576|P2|STARTED|Overall Study||5
1604565|NCT00978432|3923577|P1|STARTED|Overall Study||10
1604566|NCT00978419|3923599|P2|NOT COMPLETED|Overall Study||0
1604567|NCT00978419|3923600|P1|NOT COMPLETED|Overall Study||0
1604568|NCT00978419|3923599|P2|COMPLETED|Overall Study||0
1604569|NCT00978419|3923600|P1|COMPLETED|Overall Study||0
1604570|NCT00978419|3923599|P2|STARTED|Overall Study||0
1604571|NCT00978419|3923600|P1|STARTED|Overall Study||0
1604572|NCT00978380|3923628|P1|NOT COMPLETED|Overall Study||19
1604573|NCT00978380|3923628|P1|COMPLETED|Overall Study||44
1604574|NCT00978380|3923628|P1|STARTED|Overall Study||63
1604575|NCT00978341|3923634|P2|NOT COMPLETED|Second Intervention||0
1604576|NCT00978341|3923635|P1|NOT COMPLETED|Second Intervention||0
1604577|NCT00978341|3923634|P2|COMPLETED|Second Intervention||7
1604578|NCT00978341|3923635|P1|COMPLETED|Second Intervention||7
1604579|NCT00978341|3923634|P2|STARTED|Second Intervention||7
1604580|NCT00978341|3923635|P1|STARTED|Second Intervention||7
1604581|NCT00978341|3923634|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1604582|NCT00978341|3923635|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
1604583|NCT00978341|3923634|P2|COMPLETED|Washout Period of 2 Weeks||7
1604584|NCT00978341|3923635|P1|COMPLETED|Washout Period of 2 Weeks||7
1604585|NCT00978341|3923634|P2|STARTED|Washout Period of 2 Weeks||7
1604586|NCT00978341|3923635|P1|STARTED|Washout Period of 2 Weeks||8
1604587|NCT00978341|3923634|P2|NOT COMPLETED|First Intervention||0
1604588|NCT00978341|3923635|P1|NOT COMPLETED|First Intervention||0
1604589|NCT00978341|3923634|P2|COMPLETED|First Intervention||7
1604590|NCT00978341|3923635|P1|COMPLETED|First Intervention||8
1604591|NCT00978341|3923634|P2|STARTED|First Intervention||7
1604592|NCT00978341|3923635|P1|STARTED|First Intervention||8
1604593|NCT00978120|3923657|P4|NOT COMPLETED|Overall Study||2
1604594|NCT00978120|3923658|P3|NOT COMPLETED|Overall Study||3
1604595|NCT00978120|3923659|P2|NOT COMPLETED|Overall Study||0
1604596|NCT00978120|3923660|P1|NOT COMPLETED|Overall Study||2
1604597|NCT00978120|3923657|P4|COMPLETED|Overall Study||84
1604598|NCT00978120|3923658|P3|COMPLETED|Overall Study||84
1604599|NCT00978120|3923659|P2|COMPLETED|Overall Study||107
1604600|NCT00978120|3923660|P1|COMPLETED|Overall Study||108
1604601|NCT00978120|3923657|P4|STARTED|Overall Study||86
1604602|NCT00978120|3923658|P3|STARTED|Overall Study||87
1604603|NCT00978120|3923659|P2|STARTED|Overall Study||107
1604604|NCT00978120|3923660|P1|STARTED|Overall Study||110
1604605|NCT00978068|3923712|P2|NOT COMPLETED|Overall Study||9
1604606|NCT00978068|3923713|P1|NOT COMPLETED|Overall Study||4
1604607|NCT00978068|3923712|P2|COMPLETED|Overall Study||80
1604608|NCT00978068|3923713|P1|COMPLETED|Overall Study||83
1604609|NCT00978068|3923712|P2|Initiated Study Drugs|Overall Study||86
1604610|NCT00978068|3923713|P1|Initiated Study Drugs|Overall Study||84
1604611|NCT00978068|3923712|P2|STARTED|Overall Study||89
1604612|NCT00978068|3923713|P1|STARTED|Overall Study||87
1604613|NCT00978042|3923731|P2|NOT COMPLETED|Received Repeat Treatment||3
1604614|NCT00978042|3923732|P1|NOT COMPLETED|Received Repeat Treatment||43
1604615|NCT00978042|3923731|P2|COMPLETED|Received Repeat Treatment||23
1604616|NCT00978042|3923732|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
1604617|NCT00978042|3923731|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
1604618|NCT00978042|3923732|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
1604619|NCT00978042|3923731|P2|NOT COMPLETED|Initial Treatment Period||15
1604620|NCT00978042|3923732|P1|NOT COMPLETED|Initial Treatment Period||61
1604621|NCT00978042|3923731|P2|COMPLETED|Initial Treatment Period||32
1604622|NCT00978042|3923732|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
1604623|NCT00978042|3923731|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
1604624|NCT00978042|3923732|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
1604625|NCT00978042|3923731|P2|STARTED|Initial Treatment Period||47
1604626|NCT00978042|3923732|P1|STARTED|Initial Treatment Period||235
1604627|NCT00978029|3923745|P3|NOT COMPLETED|Overall Study||6
1604628|NCT00978029|3923746|P2|NOT COMPLETED|Overall Study||3
1604629|NCT00978029|3923747|P1|NOT COMPLETED|Overall Study||1
1604630|NCT00978029|3923745|P3|COMPLETED|Overall Study||59
1604631|NCT00978029|3923746|P2|COMPLETED|Overall Study||63
1604632|NCT00978029|3923747|P1|COMPLETED|Overall Study||64
1604633|NCT00978029|3923745|P3|STARTED|Overall Study||65
1604634|NCT00978029|3923746|P2|STARTED|Overall Study||66
1604635|NCT00978029|3923747|P1|STARTED|Overall Study||65
1604636|NCT00977938|3923774|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
1604637|NCT00977938|3923775|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
1604638|NCT00977938|3923776|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
1604639|NCT00977938|3923777|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
1604640|NCT00977938|3923774|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
1604641|NCT00977938|3923775|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
1604642|NCT00977938|3923776|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
1604643|NCT00977938|3923777|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
1604644|NCT00977938|3923774|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
1604645|NCT00977938|3923775|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
1604646|NCT00977938|3923776|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
1604647|NCT00977938|3923777|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
1604648|NCT00977938|3923774|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
1604649|NCT00977938|3923775|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
1604650|NCT00977938|3923776|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
1604651|NCT00977938|3923777|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
1604652|NCT00977938|3923774|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
1604653|NCT00977938|3923775|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
1604654|NCT00977938|3923776|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
1604655|NCT00977938|3923777|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
1604656|NCT00977938|3923774|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
1604657|NCT00977938|3923775|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
1604658|NCT00977938|3923776|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
1604659|NCT00977938|3923777|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
1604660|NCT00977808|3923811|P1|NOT COMPLETED|Overall Study||1
1604661|NCT00977808|3923811|P1|COMPLETED|Overall Study||11
1604662|NCT00977808|3923811|P1|Completion of Closed-Loop Admission|Overall Study||11
1604663|NCT00977808|3923811|P1|Completion of Open-Loop Admission|Overall Study||12
1604664|NCT00977808|3923811|P1|STARTED|Overall Study||12
1604665|NCT00977769|3923819|P3|NOT COMPLETED|Overall Study||0
1604666|NCT00977769|3923820|P2|NOT COMPLETED|Overall Study||0
1604667|NCT00977769|3923821|P1|NOT COMPLETED|Overall Study||0
1604668|NCT00977769|3923819|P3|COMPLETED|Overall Study||25
1604669|NCT00977769|3923820|P2|COMPLETED|Overall Study||26
1604670|NCT00977769|3923821|P1|COMPLETED|Overall Study||25
1604671|NCT00977769|3923819|P3|STARTED|Overall Study||25
1604672|NCT00977769|3923820|P2|STARTED|Overall Study||26
1604673|NCT00977769|3923821|P1|STARTED|Overall Study||25
1604674|NCT00977704|3923835|P1|NOT COMPLETED|Overall Study||0
1604675|NCT00977704|3923835|P1|COMPLETED|Overall Study||20
1604676|NCT00977704|3923835|P1|STARTED|Overall Study||20
1604677|NCT00977665|3923841|P2|NOT COMPLETED|Overall Study||15
1604678|NCT00977665|3923842|P1|NOT COMPLETED|Overall Study||21
1604679|NCT00977665|3923841|P2|COMPLETED|Overall Study||75
1604680|NCT00977665|3923842|P1|COMPLETED|Overall Study||63
1604681|NCT00977665|3923841|P2|STARTED|Overall Study||90
1604682|NCT00977665|3923842|P1|STARTED|Overall Study||84
1604683|NCT00977613|3923874|P1|NOT COMPLETED|Overall Study||16
1604684|NCT00977613|3923874|P1|COMPLETED|Overall Study||34
1604685|NCT00977613|3923874|P1|STARTED|Overall Study||50
1604686|NCT00977574|3923881|P3|NOT COMPLETED|Overall Study||4
1604687|NCT00977574|3923882|P2|NOT COMPLETED|Overall Study||2
1604688|NCT00977574|3923883|P1|NOT COMPLETED|Overall Study||4
1604689|NCT00977574|3923881|P3|COMPLETED|Overall Study||114
1604690|NCT00977574|3923882|P2|COMPLETED|Overall Study||113
1604691|NCT00977574|3923883|P1|COMPLETED|Overall Study||112
1604692|NCT00977574|3923881|P3|STARTED|Overall Study||118
1604693|NCT00977574|3923882|P2|STARTED|Overall Study||115
1604694|NCT00977574|3923883|P1|STARTED|Overall Study||116
1604695|NCT00977561|3923902|P2|NOT COMPLETED|Overall Study||4
1604696|NCT00977561|3923903|P1|NOT COMPLETED|Overall Study||5
1604697|NCT00977561|3923902|P2|COMPLETED|Overall Study||0
1604698|NCT00977561|3923903|P1|COMPLETED|Overall Study||0
1604699|NCT00977561|3923902|P2|STARTED|Overall Study||4
1604700|NCT00977561|3923903|P1|STARTED|Overall Study||5
1604701|NCT00977548|3923930|P1|NOT COMPLETED|Overall Study||13
1604702|NCT00977548|3923930|P1|COMPLETED|Overall Study||26
1604703|NCT00977548|3923930|P1|STARTED|Overall Study||39
1604704|NCT00977470|3923939|P2|NOT COMPLETED|Overall Study||38
1604705|NCT00977470|3923940|P1|NOT COMPLETED|Overall Study||38
1604706|NCT00977470|3923939|P2|COMPLETED|Overall Study||0
1604707|NCT00977470|3923940|P1|COMPLETED|Overall Study||0
1604708|NCT00977470|3923939|P2|STARTED|Overall Study||38
1604709|NCT00977470|3923940|P1|STARTED|Overall Study||38
1604710|NCT00977379|3923960|P2|NOT COMPLETED|Overall Study||12
1604711|NCT00977379|3923961|P1|NOT COMPLETED|Overall Study||12
1604712|NCT00977379|3923960|P2|COMPLETED|Overall Study||0
1604713|NCT00977379|3923961|P1|COMPLETED|Overall Study||0
1604714|NCT00977379|3923960|P2|Treated|Overall Study||11
1604715|NCT00977379|3923961|P1|Treated|Overall Study||12
1604716|NCT00977379|3923960|P2|STARTED|Overall Study|Randomized|12
1604717|NCT00977379|3923961|P1|STARTED|Overall Study|Randomized|12
1604718|NCT00977314|3923997|P2|NOT COMPLETED|Overall Study||0
1604719|NCT00977314|3923998|P1|NOT COMPLETED|Overall Study||2
1604720|NCT00977314|3923997|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
1604721|NCT00977314|3923998|P1|COMPLETED|Overall Study||28
1604722|NCT00977314|3923997|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
1604723|NCT00977314|3923998|P1|STARTED|Overall Study||30
1604724|NCT00977197|3924006|P2|NOT COMPLETED|Overall Study||9
1604725|NCT00977197|3924007|P1|NOT COMPLETED|Overall Study||9
1604726|NCT00977197|3924006|P2|COMPLETED|Overall Study||35
1604727|NCT00977197|3924007|P1|COMPLETED|Overall Study||32
1604728|NCT00977197|3924006|P2|STARTED|Overall Study||44
1604729|NCT00977197|3924007|P1|STARTED|Overall Study||41
1604730|NCT00977184|3924037|P2|NOT COMPLETED|Overall Study||0
1604731|NCT00977184|3924038|P1|NOT COMPLETED|Overall Study||0
1604732|NCT00977184|3924037|P2|COMPLETED|Overall Study||13
1604733|NCT00977184|3924038|P1|COMPLETED|Overall Study||13
1604734|NCT00977184|3924037|P2|STARTED|Overall Study||13
1604735|NCT00977184|3924038|P1|STARTED|Overall Study||13
1604736|NCT00977171|3924064|P1|NOT COMPLETED|Overall Study||0
1604737|NCT00977171|3924064|P1|COMPLETED|Overall Study||3
1604738|NCT00977171|3924064|P1|STARTED|Overall Study||3
1604739|NCT00977106|3924070|P2|NOT COMPLETED|Overall Study||11
1604740|NCT00977106|3924071|P1|NOT COMPLETED|Overall Study||10
1604741|NCT00977106|3924070|P2|COMPLETED|Overall Study||45
1604742|NCT00977106|3924071|P1|COMPLETED|Overall Study||37
1604743|NCT00977106|3924070|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
1604744|NCT00977106|3924071|P1|STARTED|Overall Study||47
1604745|NCT00977080|3924163|P4|NOT COMPLETED|Overall Study||17
1604746|NCT00977080|3924164|P3|NOT COMPLETED|Overall Study||16
1604747|NCT00977080|3924165|P2|NOT COMPLETED|Overall Study||20
1604748|NCT00977080|3924166|P1|NOT COMPLETED|Overall Study||12
1604749|NCT00977080|3924163|P4|COMPLETED|Overall Study||53
1604750|NCT00977080|3924164|P3|COMPLETED|Overall Study||56
1604751|NCT00977080|3924165|P2|COMPLETED|Overall Study||44
1604752|NCT00977080|3924166|P1|COMPLETED|Overall Study||50
1604753|NCT00977080|3924163|P4|STARTED|Overall Study||70
1604754|NCT00977080|3924164|P3|STARTED|Overall Study||72
1604755|NCT00977080|3924165|P2|STARTED|Overall Study||64
1604756|NCT00977080|3924166|P1|STARTED|Overall Study||62
1604757|NCT00976989|3924199|P3|NOT COMPLETED|Overall Study||17
1604758|NCT00976989|3924200|P2|NOT COMPLETED|Overall Study||12
1604759|NCT00976989|3924201|P1|NOT COMPLETED|Overall Study||13
1604760|NCT00976989|3924199|P3|COMPLETED|Overall Study||60
1604761|NCT00976989|3924200|P2|COMPLETED|Overall Study||63
1604762|NCT00976989|3924201|P1|COMPLETED|Overall Study||60
1604763|NCT00976989|3924199|P3|STARTED|Overall Study||77
1604764|NCT00976989|3924200|P2|STARTED|Overall Study||75
1604765|NCT00976989|3924201|P1|STARTED|Overall Study||73
1604766|NCT00976950|3924242|P1|NOT COMPLETED|Overall Study||6
1604767|NCT00976950|3924242|P1|COMPLETED|Overall Study||36
1604768|NCT00976950|3924242|P1|STARTED|Overall Study||42
1604769|NCT00976937|3924250|P2|NOT COMPLETED|Overall Study||11
1604770|NCT00976937|3924251|P1|NOT COMPLETED|Overall Study||16
1604771|NCT00976937|3924250|P2|COMPLETED|Overall Study||150
1604772|NCT00976937|3924251|P1|COMPLETED|Overall Study||142
1604773|NCT00976937|3924250|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
1604774|NCT00976937|3924251|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
1604775|NCT00976937|3924250|P2|Treated/Safety Population|Overall Study||161
1604776|NCT00976937|3924251|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
1604777|NCT00976937|3924250|P2|STARTED|Overall Study||161
1604778|NCT00976937|3924251|P1|STARTED|Overall Study|Randomized|158
1604779|NCT00976911|3924293|P2|NOT COMPLETED|Overall Study||179
1604780|NCT00976911|3924294|P1|NOT COMPLETED|Overall Study||182
1604781|NCT00976911|3924293|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
1604782|NCT00976911|3924294|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
1604783|NCT00976911|3924293|P2|STARTED|Overall Study||179
1604784|NCT00976911|3924294|P1|STARTED|Overall Study||182
1604785|NCT00976898|3924312|P1|NOT COMPLETED|Overall Study||5
1604786|NCT00976898|3924312|P1|COMPLETED|Overall Study||78
1604787|NCT00976898|3924312|P1|STARTED|Overall Study||83
1604788|NCT00976820|3924323|P4|NOT COMPLETED|Overall Study||7
1604789|NCT00976820|3924324|P3|NOT COMPLETED|Overall Study||4
1604790|NCT00976820|3924325|P2|NOT COMPLETED|Overall Study||20
1604791|NCT00976820|3924326|P1|NOT COMPLETED|Overall Study||8
1604792|NCT00976820|3924323|P4|COMPLETED|Overall Study||56
1604793|NCT00976820|3924324|P3|COMPLETED|Overall Study||60
1604794|NCT00976820|3924325|P2|COMPLETED|Overall Study||108
1604795|NCT00976820|3924326|P1|COMPLETED|Overall Study||59
1604796|NCT00976820|3924323|P4|STARTED|Overall Study||63
1604797|NCT00976820|3924324|P3|STARTED|Overall Study||64
1604798|NCT00976820|3924325|P2|STARTED|Overall Study||128
1604799|NCT00976820|3924326|P1|STARTED|Overall Study||67
1604800|NCT00976716|3924662|P1|NOT COMPLETED|Overall Study||1
1604801|NCT00976716|3924662|P1|COMPLETED|Overall Study||79
1604802|NCT00976716|3924662|P1|STARTED|Overall Study||80
1604803|NCT00976703|3924680|P2|NOT COMPLETED|Overall Study||3
1604804|NCT00976703|3924681|P1|NOT COMPLETED|Overall Study||3
1604805|NCT00976703|3924680|P2|COMPLETED|Overall Study||95
1604806|NCT00976703|3924681|P1|COMPLETED|Overall Study||96
1604807|NCT00976703|3924680|P2|STARTED|Overall Study||98
1604808|NCT00976703|3924681|P1|STARTED|Overall Study||99
1604809|NCT00976677|3924695|P2|NOT COMPLETED|Overall Study||5
1604810|NCT00976677|3924696|P1|NOT COMPLETED|Overall Study||5
1604811|NCT00976677|3924695|P2|COMPLETED|Overall Study||0
1604812|NCT00976677|3924696|P1|COMPLETED|Overall Study||0
1604813|NCT00976677|3924695|P2|STARTED|Overall Study||5
1604814|NCT00976677|3924696|P1|STARTED|Overall Study||5
1604815|NCT00976664|3924704|P2|NOT COMPLETED|Overall Study||1
1604816|NCT00976664|3924705|P1|NOT COMPLETED|Overall Study||3
1604817|NCT00976664|3924704|P2|COMPLETED|Overall Study||24
1604818|NCT00976664|3924705|P1|COMPLETED|Overall Study||22
1604819|NCT00976664|3924704|P2|STARTED|Overall Study||25
1604820|NCT00976664|3924705|P1|STARTED|Overall Study||25
1604821|NCT00976599|3924715|P2|NOT COMPLETED|Overall Study||0
1604822|NCT00976599|3924716|P1|NOT COMPLETED|Overall Study||0
1604823|NCT00976599|3924715|P2|COMPLETED|Overall Study||14
1604824|NCT00976599|3924716|P1|COMPLETED|Overall Study||15
1604825|NCT00976599|3924715|P2|STARTED|Overall Study||14
1604826|NCT00976599|3924716|P1|STARTED|Overall Study||15
1604827|NCT00976573|3924904|P2|NOT COMPLETED|Overall Study||3
1604828|NCT00976573|3924905|P1|NOT COMPLETED|Overall Study||4
1604829|NCT00976573|3924904|P2|COMPLETED|Overall Study||71
1604830|NCT00976573|3924905|P1|COMPLETED|Overall Study||71
1604831|NCT00976573|3924904|P2|STARTED|Overall Study||74
1604832|NCT00976573|3924905|P1|STARTED|Overall Study||75
1604833|NCT00976560|3924919|P2|NOT COMPLETED|Overall Study||13
1604834|NCT00976560|3924920|P1|NOT COMPLETED|Overall Study||14
1604835|NCT00976560|3924919|P2|COMPLETED|Overall Study||51
1604836|NCT00976560|3924920|P1|COMPLETED|Overall Study||50
1604837|NCT00976560|3924919|P2|STARTED|Overall Study||64
1604838|NCT00976560|3924920|P1|STARTED|Overall Study||64
1604839|NCT00976521|3924972|P4|NOT COMPLETED|Overall Study||19
1604840|NCT00976521|3924973|P3|NOT COMPLETED|Overall Study||9
1604841|NCT00976521|3924974|P2|NOT COMPLETED|Overall Study||12
1604842|NCT00976521|3924975|P1|NOT COMPLETED|Overall Study||9
1604843|NCT00976521|3924972|P4|COMPLETED|Overall Study||93
1604844|NCT00976521|3924973|P3|COMPLETED|Overall Study||102
1604845|NCT00976521|3924974|P2|COMPLETED|Overall Study||99
1604846|NCT00976521|3924975|P1|COMPLETED|Overall Study||109
1604847|NCT00976521|3924972|P4|STARTED|Overall Study||112
1604848|NCT00976521|3924973|P3|STARTED|Overall Study||111
1604849|NCT00976521|3924974|P2|STARTED|Overall Study||111
1604850|NCT00976521|3924975|P1|STARTED|Overall Study||118
1604851|NCT00976508|3924989|P2|NOT COMPLETED|Overall Study||6
1604852|NCT00976508|3924990|P1|NOT COMPLETED|Overall Study||14
1604853|NCT00976508|3924989|P2|COMPLETED|Overall Study||0
1604854|NCT00976508|3924990|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
1604855|NCT00976508|3924989|P2|STARTED|Overall Study||6
1604856|NCT00976508|3924990|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
1604857|NCT00976495|3925023|P3|NOT COMPLETED|Overall Study||0
1604858|NCT00976495|3925024|P2|NOT COMPLETED|Overall Study||1
1604859|NCT00976495|3925025|P1|NOT COMPLETED|Overall Study||0
1604860|NCT00976495|3925023|P3|COMPLETED|Overall Study||26
1604861|NCT00976495|3925024|P2|COMPLETED|Overall Study||23
1604862|NCT00976495|3925025|P1|COMPLETED|Overall Study||25
1604863|NCT00976495|3925023|P3|STARTED|Overall Study||26
1604864|NCT00976495|3925024|P2|STARTED|Overall Study||24
1604865|NCT00976495|3925025|P1|STARTED|Overall Study||25
1604866|NCT00976482|3925042|P1|NOT COMPLETED|Overall Study||259
1604867|NCT00976482|3925042|P1|COMPLETED|Overall Study||1486
1604868|NCT00976482|3925042|P1|Eligible for Last Follow up|Overall Study||1487
1604869|NCT00976482|3925042|P1|STARTED|Overall Study||1745
1604870|NCT00976456|3925048|P2|NOT COMPLETED|Overall Study||38
1604871|NCT00976456|3925049|P1|NOT COMPLETED|Overall Study||43
1604872|NCT00976456|3925048|P2|COMPLETED|Overall Study||98
1604873|NCT00976456|3925049|P1|COMPLETED|Overall Study||92
1604874|NCT00976456|3925048|P2|STARTED|Overall Study||136
1604875|NCT00976456|3925049|P1|STARTED|Overall Study||135
1604876|NCT00976404|3925059|P2|NOT COMPLETED|Overall Study||0
1604877|NCT00976404|3925060|P1|NOT COMPLETED|Overall Study||0
1604878|NCT00976404|3925059|P2|COMPLETED|Overall Study||14
1604879|NCT00976404|3925060|P1|COMPLETED|Overall Study||14
1604880|NCT00976404|3925059|P2|STARTED|Overall Study||14
1604881|NCT00976404|3925060|P1|STARTED|Overall Study||14
1604882|NCT00976391|3925076|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
1604883|NCT00976391|3925077|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
1604884|NCT00976391|3925076|P2|COMPLETED|Follow-up Period (8 Weeks)||247
1604885|NCT00976391|3925077|P1|COMPLETED|Follow-up Period (8 Weeks)||256
1604886|NCT00976391|3925076|P2|STARTED|Follow-up Period (8 Weeks)||281
1604887|NCT00976391|3925077|P1|STARTED|Follow-up Period (8 Weeks)||285
1604888|NCT00976391|3925076|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
1604889|NCT00976391|3925077|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
1604890|NCT00976391|3925076|P2|COMPLETED|Treatment Period (52 Weeks)||242
1604891|NCT00976391|3925077|P1|COMPLETED|Treatment Period (52 Weeks)||243
1604892|NCT00976391|3925076|P2|STARTED|Treatment Period (52 Weeks)||281
1604893|NCT00976391|3925077|P1|STARTED|Treatment Period (52 Weeks)||285
1604894|NCT00976352|3925099|P2|NOT COMPLETED|Overall Study||4
1604895|NCT00976352|3925100|P1|NOT COMPLETED|Overall Study||0
1604896|NCT00976352|3925099|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
1604897|NCT00976352|3925100|P1|COMPLETED|Overall Study||3
1604898|NCT00976352|3925099|P2|STARTED|Overall Study||10
1604899|NCT00976352|3925100|P1|STARTED|Overall Study||3
1604900|NCT00976339|3925114|P2|NOT COMPLETED|Overall Study||0
1604901|NCT00976339|3925115|P1|NOT COMPLETED|Overall Study||0
1604902|NCT00976339|3925114|P2|COMPLETED|Overall Study||10
1604903|NCT00976339|3925115|P1|COMPLETED|Overall Study||10
1604904|NCT00976339|3925114|P2|STARTED|Overall Study||10
1604905|NCT00976339|3925115|P1|STARTED|Overall Study||10
1604906|NCT00976274|3925125|P2|NOT COMPLETED|Overall Study||8
1604907|NCT00976274|3925126|P1|NOT COMPLETED|Overall Study||7
1604908|NCT00976274|3925125|P2|COMPLETED|Overall Study||21
1604909|NCT00976274|3925126|P1|COMPLETED|Overall Study||24
1604910|NCT00976274|3925125|P2|STARTED|Overall Study||29
1604911|NCT00976274|3925126|P1|STARTED|Overall Study||31
1604912|NCT00976248|3925134|P1|NOT COMPLETED|Overall Study||0
1604913|NCT00976248|3925134|P1|COMPLETED|Overall Study||33
1604914|NCT00976248|3925134|P1|STARTED|Overall Study||33
1604915|NCT00976209|3925142|P2|NOT COMPLETED|Treatment Period 2||2
1604916|NCT00976209|3925143|P1|NOT COMPLETED|Treatment Period 2||0
1604917|NCT00976209|3925142|P2|COMPLETED|Treatment Period 2||161
1604918|NCT00976209|3925143|P1|COMPLETED|Treatment Period 2||158
1604919|NCT00976209|3925142|P2|STARTED|Treatment Period 2||163
1604920|NCT00976209|3925143|P1|STARTED|Treatment Period 2||158
1604921|NCT00976209|3925142|P2|NOT COMPLETED|Wash-out Period||2
1604922|NCT00976209|3925143|P1|NOT COMPLETED|Wash-out Period||4
1604923|NCT00976209|3925142|P2|COMPLETED|Wash-out Period||163
1604924|NCT00976209|3925143|P1|COMPLETED|Wash-out Period||158
1604925|NCT00976209|3925142|P2|STARTED|Wash-out Period||165
1604926|NCT00976209|3925143|P1|STARTED|Wash-out Period||162
1604927|NCT00976209|3925142|P2|NOT COMPLETED|Treatment Period 1||1
1604928|NCT00976209|3925143|P1|NOT COMPLETED|Treatment Period 1||3
1604929|NCT00976209|3925142|P2|COMPLETED|Treatment Period 1||165
1604930|NCT00976209|3925143|P1|COMPLETED|Treatment Period 1||162
1604931|NCT00976209|3925142|P2|STARTED|Treatment Period 1||166
1604932|NCT00976209|3925143|P1|STARTED|Treatment Period 1||165
1604933|NCT00976183|3925149|P1|NOT COMPLETED|Overall Study||0
1604934|NCT00976183|3925149|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
1604935|NCT00976183|3925149|P1|STARTED|Overall Study||18
1604936|NCT00976027|3925156|P2|NOT COMPLETED|Overall Study||215
1604937|NCT00976027|3925157|P1|NOT COMPLETED|Overall Study||411
1604938|NCT00976027|3925156|P2|COMPLETED|Overall Study||2835
1604939|NCT00976027|3925157|P1|COMPLETED|Overall Study||5697
1604940|NCT00976027|3925156|P2|STARTED|Overall Study||3050
1604941|NCT00976027|3925157|P1|STARTED|Overall Study||6108
1604942|NCT00975975|3925169|P1|NOT COMPLETED|Overall Study||6
1604943|NCT00975975|3925169|P1|COMPLETED|Overall Study||11
1604944|NCT00975975|3925169|P1|STARTED|Overall Study||17
1604945|NCT00975923|3925177|P2|NOT COMPLETED|Overall Study||1
1604946|NCT00975923|3925178|P1|NOT COMPLETED|Overall Study||0
1604947|NCT00975923|3925177|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
1604948|NCT00975923|3925178|P1|COMPLETED|Overall Study||30
1604949|NCT00975923|3925177|P2|STARTED|Overall Study||30
1604950|NCT00975923|3925178|P1|STARTED|Overall Study||30
1604951|NCT00975806|3925189|P3|NOT COMPLETED|Overall Study||4
1604952|NCT00975806|3925190|P2|NOT COMPLETED|Overall Study||7
1604953|NCT00975806|3925191|P1|NOT COMPLETED|Overall Study||5
1604954|NCT00975806|3925189|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
1604955|NCT00975806|3925190|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
1604956|NCT00975806|3925191|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
1604957|NCT00975806|3925189|P3|STARTED|Overall Study||4
1604958|NCT00975806|3925190|P2|STARTED|Overall Study||7
1604959|NCT00975806|3925191|P1|STARTED|Overall Study||5
1604960|NCT00975780|3925215|P2|NOT COMPLETED|Follow Up||157
1604961|NCT00975780|3925216|P1|NOT COMPLETED|Follow Up||102
1604962|NCT00975780|3925215|P2|COMPLETED|Follow Up||277
1604963|NCT00975780|3925216|P1|COMPLETED|Follow Up||298
1604964|NCT00975780|3925215|P2|STARTED|Follow Up||434
1604965|NCT00975780|3925216|P1|STARTED|Follow Up||400
1604966|NCT00975780|3925215|P2|NOT COMPLETED|Allocation||0
1604967|NCT00975780|3925216|P1|NOT COMPLETED|Allocation||0
1604968|NCT00975780|3925215|P2|COMPLETED|Allocation||434
1604969|NCT00975780|3925216|P1|COMPLETED|Allocation||400
1604970|NCT00975780|3925215|P2|STARTED|Allocation||434
1604971|NCT00975780|3925216|P1|STARTED|Allocation||400
1604972|NCT00975715|3925226|P2|NOT COMPLETED|Maintenance Period||1
1604973|NCT00975715|3925227|P1|NOT COMPLETED|Maintenance Period||2
1604974|NCT00975715|3925226|P2|COMPLETED|Maintenance Period||50
1604975|NCT00975715|3925227|P1|COMPLETED|Maintenance Period||39
1604976|NCT00975715|3925226|P2|STARTED|Maintenance Period||51
1604977|NCT00975715|3925227|P1|STARTED|Maintenance Period||41
1604978|NCT00975715|3925226|P2|NOT COMPLETED|Titration Period||0
1604979|NCT00975715|3925227|P1|NOT COMPLETED|Titration Period||7
1604980|NCT00975715|3925226|P2|COMPLETED|Titration Period||51
1604981|NCT00975715|3925227|P1|COMPLETED|Titration Period||41
1604982|NCT00975715|3925226|P2|STARTED|Titration Period||51
1604983|NCT00975715|3925227|P1|STARTED|Titration Period||48
1604984|NCT00975689|3925243|P2|NOT COMPLETED|Overall Study||3
1604985|NCT00975689|3925244|P1|NOT COMPLETED|Overall Study||2
1604986|NCT00975689|3925243|P2|COMPLETED|Overall Study||15
1604987|NCT00975689|3925244|P1|COMPLETED|Overall Study||15
1604988|NCT00975689|3925243|P2|STARTED|Overall Study||18
1604989|NCT00975689|3925244|P1|STARTED|Overall Study||17
1604990|NCT00975650|3925250|P4|NOT COMPLETED|Period 4||0
1604991|NCT00975650|3925251|P3|NOT COMPLETED|Period 4||0
1604992|NCT00975650|3925252|P2|NOT COMPLETED|Period 4||0
1604993|NCT00975650|3925253|P1|NOT COMPLETED|Period 4||0
1604994|NCT00975650|3925250|P4|COMPLETED|Period 4||14
1604995|NCT00975650|3925251|P3|COMPLETED|Period 4||14
1604996|NCT00975650|3925252|P2|COMPLETED|Period 4||14
1604997|NCT00975650|3925253|P1|COMPLETED|Period 4||12
1604998|NCT00975650|3925250|P4|STARTED|Period 4||14
1604999|NCT00975650|3925251|P3|STARTED|Period 4||14
1605000|NCT00975650|3925252|P2|STARTED|Period 4||14
1605001|NCT00975650|3925253|P1|STARTED|Period 4||12
1605002|NCT00975650|3925250|P4|NOT COMPLETED|Period 3||0
1605003|NCT00975650|3925251|P3|NOT COMPLETED|Period 3||0
1605004|NCT00975650|3925252|P2|NOT COMPLETED|Period 3||0
1605005|NCT00975650|3925253|P1|NOT COMPLETED|Period 3||0
1605006|NCT00975650|3925250|P4|COMPLETED|Period 3||14
1605007|NCT00975650|3925251|P3|COMPLETED|Period 3||14
1605008|NCT00975650|3925252|P2|COMPLETED|Period 3||14
1605009|NCT00975650|3925253|P1|COMPLETED|Period 3||12
1605010|NCT00975650|3925250|P4|STARTED|Period 3||14
1605011|NCT00975650|3925251|P3|STARTED|Period 3||14
1605012|NCT00975650|3925252|P2|STARTED|Period 3||14
1605013|NCT00975650|3925253|P1|STARTED|Period 3||12
1605014|NCT00975650|3925250|P4|NOT COMPLETED|Period 2||0
1605015|NCT00975650|3925251|P3|NOT COMPLETED|Period 2||0
1605016|NCT00975650|3925252|P2|NOT COMPLETED|Period 2||2
1605017|NCT00975650|3925253|P1|NOT COMPLETED|Period 2||1
1605018|NCT00975650|3925250|P4|COMPLETED|Period 2||14
1605019|NCT00975650|3925251|P3|COMPLETED|Period 2||14
1605020|NCT00975650|3925252|P2|COMPLETED|Period 2||14
1605021|NCT00975650|3925253|P1|COMPLETED|Period 2||12
1605022|NCT00975650|3925250|P4|STARTED|Period 2||14
1605023|NCT00975650|3925251|P3|STARTED|Period 2||14
1605024|NCT00975650|3925252|P2|STARTED|Period 2||16
1605025|NCT00975650|3925253|P1|STARTED|Period 2||13
1605026|NCT00975650|3925250|P4|NOT COMPLETED|Period 1||0
1605027|NCT00975650|3925251|P3|NOT COMPLETED|Period 1||0
1605028|NCT00975650|3925252|P2|NOT COMPLETED|Period 1||0
1605029|NCT00975650|3925253|P1|NOT COMPLETED|Period 1||0
1605030|NCT00975650|3925250|P4|COMPLETED|Period 1||14
1605031|NCT00975650|3925251|P3|COMPLETED|Period 1||14
1605032|NCT00975650|3925252|P2|COMPLETED|Period 1||16
1605033|NCT00975650|3925253|P1|COMPLETED|Period 1||13
1605034|NCT00975650|3925250|P4|STARTED|Period 1||14
1605035|NCT00975650|3925251|P3|STARTED|Period 1||14
1605036|NCT00975650|3925252|P2|STARTED|Period 1||16
1605037|NCT00975650|3925253|P1|STARTED|Period 1||13
1605038|NCT00975637|3925292|P5|NOT COMPLETED|Overall Study||2
1605039|NCT00975637|3925293|P4|NOT COMPLETED|Overall Study||6
1605040|NCT00975637|3925294|P3|NOT COMPLETED|Overall Study||2
1605041|NCT00975637|3925295|P2|NOT COMPLETED|Overall Study||1
1605042|NCT00975637|3925296|P1|NOT COMPLETED|Overall Study||3
1605043|NCT00975637|3925292|P5|COMPLETED|Overall Study||37
1605044|NCT00975637|3925293|P4|COMPLETED|Overall Study||32
1605045|NCT00975637|3925294|P3|COMPLETED|Overall Study||40
1605046|NCT00975637|3925295|P2|COMPLETED|Overall Study||38
1605047|NCT00975637|3925296|P1|COMPLETED|Overall Study||37
1605048|NCT00975637|3925292|P5|STARTED|Overall Study||39
1605049|NCT00975637|3925293|P4|STARTED|Overall Study||38
1605050|NCT00975637|3925294|P3|STARTED|Overall Study||42
1605051|NCT00975637|3925295|P2|STARTED|Overall Study||39
1605052|NCT00975637|3925296|P1|STARTED|Overall Study||40
1605053|NCT00975611|3925313|P1|NOT COMPLETED|Overall Study||17
1605054|NCT00975611|3925313|P1|COMPLETED|Overall Study||5
1605055|NCT00975611|3925313|P1|STARTED|Overall Study||22
1605056|NCT00975585|3925319|P2|NOT COMPLETED|Overall Study||12
1605057|NCT00975585|3925320|P1|NOT COMPLETED|Overall Study||7
1605058|NCT00975585|3925319|P2|COMPLETED|Overall Study||183
1605059|NCT00975585|3925320|P1|COMPLETED|Overall Study||177
1605060|NCT00975585|3925319|P2|STARTED|Overall Study||195
1605061|NCT00975585|3925320|P1|STARTED|Overall Study||184
1605062|NCT00975507|3925340|P2|NOT COMPLETED|Overall Study||4
1605063|NCT00975507|3925341|P1|NOT COMPLETED|Overall Study||20
1605064|NCT00975507|3925340|P2|COMPLETED|Overall Study||153
1605065|NCT00975507|3925341|P1|COMPLETED|Overall Study||303
1605066|NCT00975507|3925340|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
1605067|NCT00975507|3925341|P1|Vaccinated at Visit 2|Overall Study||310
1605068|NCT00975507|3925340|P2|Vaccinated at Visit 1|Overall Study||157
1605069|NCT00975507|3925341|P1|Vaccinated at Visit 1|Overall Study||323
1605070|NCT00975507|3925340|P2|STARTED|Overall Study||157
1605071|NCT00975507|3925341|P1|STARTED|Overall Study||323
1605072|NCT00975481|3925361|P6|NOT COMPLETED|Sixth Intervention Period||0
1605073|NCT00975481|3925362|P5|NOT COMPLETED|Sixth Intervention Period||0
1605074|NCT00975481|3925363|P4|NOT COMPLETED|Sixth Intervention Period||0
1605075|NCT00975481|3925364|P3|NOT COMPLETED|Sixth Intervention Period||0
1605076|NCT00975481|3925365|P2|NOT COMPLETED|Sixth Intervention Period||0
1605077|NCT00975481|3925366|P1|NOT COMPLETED|Sixth Intervention Period||0
1605078|NCT00975481|3925361|P6|COMPLETED|Sixth Intervention Period||6
1605079|NCT00975481|3925362|P5|COMPLETED|Sixth Intervention Period||5
1605080|NCT00975481|3925363|P4|COMPLETED|Sixth Intervention Period||5
1605081|NCT00975481|3925364|P3|COMPLETED|Sixth Intervention Period||4
1605082|NCT00975481|3925365|P2|COMPLETED|Sixth Intervention Period||5
1605083|NCT00975481|3925366|P1|COMPLETED|Sixth Intervention Period||4
1605084|NCT00975481|3925361|P6|STARTED|Sixth Intervention Period||6
1605085|NCT00975481|3925362|P5|STARTED|Sixth Intervention Period||5
1605086|NCT00975481|3925363|P4|STARTED|Sixth Intervention Period||5
1605087|NCT00975481|3925364|P3|STARTED|Sixth Intervention Period||4
1605088|NCT00975481|3925365|P2|STARTED|Sixth Intervention Period||5
1605089|NCT00975481|3925366|P1|STARTED|Sixth Intervention Period||4
1605090|NCT00975481|3925361|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605091|NCT00975481|3925362|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605092|NCT00975481|3925363|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605093|NCT00975481|3925364|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605094|NCT00975481|3925365|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605095|NCT00975481|3925366|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605096|NCT00975481|3925361|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1605097|NCT00975481|3925362|P5|COMPLETED|Washout Period (at Least 7 Days)||5
1605098|NCT00975481|3925363|P4|COMPLETED|Washout Period (at Least 7 Days)||5
1605099|NCT00975481|3925364|P3|COMPLETED|Washout Period (at Least 7 Days)||4
1605100|NCT00975481|3925365|P2|COMPLETED|Washout Period (at Least 7 Days)||5
1605101|NCT00975481|3925366|P1|COMPLETED|Washout Period (at Least 7 Days)||4
1605102|NCT00975481|3925361|P6|STARTED|Washout Period (at Least 7 Days)||6
1605103|NCT00975481|3925362|P5|STARTED|Washout Period (at Least 7 Days)||5
1605104|NCT00975481|3925363|P4|STARTED|Washout Period (at Least 7 Days)||5
1605105|NCT00975481|3925364|P3|STARTED|Washout Period (at Least 7 Days)||4
1605106|NCT00975481|3925365|P2|STARTED|Washout Period (at Least 7 Days)||5
1605107|NCT00975481|3925366|P1|STARTED|Washout Period (at Least 7 Days)||4
1605108|NCT00975481|3925361|P6|NOT COMPLETED|Fifth Intervention Period||0
1605109|NCT00975481|3925362|P5|NOT COMPLETED|Fifth Intervention Period||1
1605110|NCT00975481|3925363|P4|NOT COMPLETED|Fifth Intervention Period||0
1605111|NCT00975481|3925364|P3|NOT COMPLETED|Fifth Intervention Period||0
1605112|NCT00975481|3925365|P2|NOT COMPLETED|Fifth Intervention Period||0
1605113|NCT00975481|3925366|P1|NOT COMPLETED|Fifth Intervention Period||0
1605114|NCT00975481|3925361|P6|COMPLETED|Fifth Intervention Period||6
1605115|NCT00975481|3925362|P5|COMPLETED|Fifth Intervention Period||5
1605116|NCT00975481|3925363|P4|COMPLETED|Fifth Intervention Period||5
1605117|NCT00975481|3925364|P3|COMPLETED|Fifth Intervention Period||4
1605118|NCT00975481|3925365|P2|COMPLETED|Fifth Intervention Period||5
1605119|NCT00975481|3925366|P1|COMPLETED|Fifth Intervention Period||4
1605120|NCT00975481|3925361|P6|STARTED|Fifth Intervention Period||6
1605121|NCT00975481|3925362|P5|STARTED|Fifth Intervention Period||6
1605122|NCT00975481|3925363|P4|STARTED|Fifth Intervention Period||5
1605123|NCT00975481|3925364|P3|STARTED|Fifth Intervention Period||4
1605124|NCT00975481|3925365|P2|STARTED|Fifth Intervention Period||5
1605125|NCT00975481|3925366|P1|STARTED|Fifth Intervention Period||4
1605126|NCT00975481|3925361|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605127|NCT00975481|3925362|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605128|NCT00975481|3925363|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605129|NCT00975481|3925364|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605130|NCT00975481|3925365|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605131|NCT00975481|3925366|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605132|NCT00975481|3925361|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1605133|NCT00975481|3925362|P5|COMPLETED|Washout Period (at Least 7 Days)||6
1605134|NCT00975481|3925363|P4|COMPLETED|Washout Period (at Least 7 Days)||5
1605135|NCT00975481|3925364|P3|COMPLETED|Washout Period (at Least 7 Days)||4
1605136|NCT00975481|3925365|P2|COMPLETED|Washout Period (at Least 7 Days)||5
1605137|NCT00975481|3925366|P1|COMPLETED|Washout Period (at Least 7 Days)||4
1605138|NCT00975481|3925361|P6|STARTED|Washout Period (at Least 7 Days)||6
1605139|NCT00975481|3925362|P5|STARTED|Washout Period (at Least 7 Days)||6
1605140|NCT00975481|3925363|P4|STARTED|Washout Period (at Least 7 Days)||5
1605141|NCT00975481|3925364|P3|STARTED|Washout Period (at Least 7 Days)||4
1605142|NCT00975481|3925365|P2|STARTED|Washout Period (at Least 7 Days)||5
1605143|NCT00975481|3925366|P1|STARTED|Washout Period (at Least 7 Days)||4
1605144|NCT00975481|3925361|P6|NOT COMPLETED|Fourth Intervention Period||0
1605145|NCT00975481|3925362|P5|NOT COMPLETED|Fourth Intervention Period||0
1605146|NCT00975481|3925363|P4|NOT COMPLETED|Fourth Intervention Period||1
1605147|NCT00975481|3925364|P3|NOT COMPLETED|Fourth Intervention Period||1
1605148|NCT00975481|3925365|P2|NOT COMPLETED|Fourth Intervention Period||0
1605149|NCT00975481|3925366|P1|NOT COMPLETED|Fourth Intervention Period||0
1605150|NCT00975481|3925361|P6|COMPLETED|Fourth Intervention Period||6
1605151|NCT00975481|3925362|P5|COMPLETED|Fourth Intervention Period||6
1605152|NCT00975481|3925363|P4|COMPLETED|Fourth Intervention Period||5
1605153|NCT00975481|3925364|P3|COMPLETED|Fourth Intervention Period||4
1605154|NCT00975481|3925365|P2|COMPLETED|Fourth Intervention Period||5
1605155|NCT00975481|3925366|P1|COMPLETED|Fourth Intervention Period||4
1605156|NCT00975481|3925361|P6|STARTED|Fourth Intervention Period||6
1605157|NCT00975481|3925362|P5|STARTED|Fourth Intervention Period||6
1605158|NCT00975481|3925363|P4|STARTED|Fourth Intervention Period||6
1605159|NCT00975481|3925364|P3|STARTED|Fourth Intervention Period||5
1605160|NCT00975481|3925365|P2|STARTED|Fourth Intervention Period||5
1605161|NCT00975481|3925366|P1|STARTED|Fourth Intervention Period||4
1605162|NCT00975481|3925361|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605163|NCT00975481|3925362|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605164|NCT00975481|3925363|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605165|NCT00975481|3925364|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605166|NCT00975481|3925365|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605167|NCT00975481|3925366|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605168|NCT00975481|3925361|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1605169|NCT00975481|3925362|P5|COMPLETED|Washout Period (at Least 7 Days)||6
1605170|NCT00975481|3925363|P4|COMPLETED|Washout Period (at Least 7 Days)||6
1605171|NCT00975481|3925364|P3|COMPLETED|Washout Period (at Least 7 Days)||5
1605172|NCT00975481|3925365|P2|COMPLETED|Washout Period (at Least 7 Days)||5
1605173|NCT00975481|3925366|P1|COMPLETED|Washout Period (at Least 7 Days)||4
1605174|NCT00975481|3925361|P6|STARTED|Washout Period (at Least 7 Days)||6
1605175|NCT00975481|3925362|P5|STARTED|Washout Period (at Least 7 Days)||6
1605176|NCT00975481|3925363|P4|STARTED|Washout Period (at Least 7 Days)||6
1605177|NCT00975481|3925364|P3|STARTED|Washout Period (at Least 7 Days)||5
1605178|NCT00975481|3925365|P2|STARTED|Washout Period (at Least 7 Days)||5
1605179|NCT00975481|3925366|P1|STARTED|Washout Period (at Least 7 Days)||4
1605180|NCT00975481|3925361|P6|NOT COMPLETED|Third Intervention Period||0
1605181|NCT00975481|3925362|P5|NOT COMPLETED|Third Intervention Period||0
1605182|NCT00975481|3925363|P4|NOT COMPLETED|Third Intervention Period||0
1605183|NCT00975481|3925364|P3|NOT COMPLETED|Third Intervention Period||0
1605184|NCT00975481|3925365|P2|NOT COMPLETED|Third Intervention Period||0
1605185|NCT00975481|3925366|P1|NOT COMPLETED|Third Intervention Period||0
1605186|NCT00975481|3925361|P6|COMPLETED|Third Intervention Period||6
1605187|NCT00975481|3925362|P5|COMPLETED|Third Intervention Period||6
1605188|NCT00975481|3925363|P4|COMPLETED|Third Intervention Period||6
1605189|NCT00975481|3925364|P3|COMPLETED|Third Intervention Period||5
1605190|NCT00975481|3925365|P2|COMPLETED|Third Intervention Period||5
1605191|NCT00975481|3925366|P1|COMPLETED|Third Intervention Period||4
1605192|NCT00975481|3925361|P6|STARTED|Third Intervention Period||6
1605193|NCT00975481|3925362|P5|STARTED|Third Intervention Period||6
1605194|NCT00975481|3925363|P4|STARTED|Third Intervention Period||6
1605195|NCT00975481|3925364|P3|STARTED|Third Intervention Period||5
1605196|NCT00975481|3925365|P2|STARTED|Third Intervention Period||5
1605197|NCT00975481|3925366|P1|STARTED|Third Intervention Period||4
1605198|NCT00975481|3925361|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605199|NCT00975481|3925362|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605200|NCT00975481|3925363|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605201|NCT00975481|3925364|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605202|NCT00975481|3925365|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605203|NCT00975481|3925366|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605204|NCT00975481|3925361|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1605205|NCT00975481|3925362|P5|COMPLETED|Washout Period (at Least 7 Days)||6
1605206|NCT00975481|3925363|P4|COMPLETED|Washout Period (at Least 7 Days)||6
1605207|NCT00975481|3925364|P3|COMPLETED|Washout Period (at Least 7 Days)||5
1605208|NCT00975481|3925365|P2|COMPLETED|Washout Period (at Least 7 Days)||5
1605209|NCT00975481|3925366|P1|COMPLETED|Washout Period (at Least 7 Days)||4
1605210|NCT00975481|3925361|P6|STARTED|Washout Period (at Least 7 Days)||6
1605211|NCT00975481|3925362|P5|STARTED|Washout Period (at Least 7 Days)||6
1605212|NCT00975481|3925363|P4|STARTED|Washout Period (at Least 7 Days)||6
1605213|NCT00975481|3925364|P3|STARTED|Washout Period (at Least 7 Days)||5
1605214|NCT00975481|3925365|P2|STARTED|Washout Period (at Least 7 Days)||5
1605215|NCT00975481|3925366|P1|STARTED|Washout Period (at Least 7 Days)||4
1605216|NCT00975481|3925361|P6|NOT COMPLETED|Second Intervention Period||0
1605217|NCT00975481|3925362|P5|NOT COMPLETED|Second Intervention Period||0
1605218|NCT00975481|3925363|P4|NOT COMPLETED|Second Intervention Period||0
1605219|NCT00975481|3925364|P3|NOT COMPLETED|Second Intervention Period||1
1605220|NCT00975481|3925365|P2|NOT COMPLETED|Second Intervention Period||1
1605221|NCT00975481|3925366|P1|NOT COMPLETED|Second Intervention Period||2
1605222|NCT00975481|3925361|P6|COMPLETED|Second Intervention Period||6
1605223|NCT00975481|3925362|P5|COMPLETED|Second Intervention Period||6
1605224|NCT00975481|3925363|P4|COMPLETED|Second Intervention Period||6
1605225|NCT00975481|3925364|P3|COMPLETED|Second Intervention Period||5
1605226|NCT00975481|3925365|P2|COMPLETED|Second Intervention Period||5
1605227|NCT00975481|3925366|P1|COMPLETED|Second Intervention Period||4
1605228|NCT00975481|3925361|P6|STARTED|Second Intervention Period||6
1605229|NCT00975481|3925362|P5|STARTED|Second Intervention Period||6
1605230|NCT00975481|3925363|P4|STARTED|Second Intervention Period||6
1605231|NCT00975481|3925364|P3|STARTED|Second Intervention Period||6
1605232|NCT00975481|3925365|P2|STARTED|Second Intervention Period||6
1605233|NCT00975481|3925366|P1|STARTED|Second Intervention Period||6
1605234|NCT00975481|3925361|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605235|NCT00975481|3925362|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605236|NCT00975481|3925363|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605237|NCT00975481|3925364|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605238|NCT00975481|3925365|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605239|NCT00975481|3925366|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1605240|NCT00975481|3925361|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1605241|NCT00975481|3925362|P5|COMPLETED|Washout Period (at Least 7 Days)||6
1605242|NCT00975481|3925363|P4|COMPLETED|Washout Period (at Least 7 Days)||6
1605243|NCT00975481|3925364|P3|COMPLETED|Washout Period (at Least 7 Days)||6
1605244|NCT00975481|3925365|P2|COMPLETED|Washout Period (at Least 7 Days)||6
1605245|NCT00975481|3925366|P1|COMPLETED|Washout Period (at Least 7 Days)||6
1605246|NCT00975481|3925361|P6|STARTED|Washout Period (at Least 7 Days)||6
1605247|NCT00975481|3925362|P5|STARTED|Washout Period (at Least 7 Days)||6
1605248|NCT00975481|3925363|P4|STARTED|Washout Period (at Least 7 Days)||6
1605249|NCT00975481|3925364|P3|STARTED|Washout Period (at Least 7 Days)||6
1605250|NCT00975481|3925365|P2|STARTED|Washout Period (at Least 7 Days)||6
1605251|NCT00975481|3925366|P1|STARTED|Washout Period (at Least 7 Days)||6
1605252|NCT00975481|3925361|P6|NOT COMPLETED|First Intervention Period||0
1605253|NCT00975481|3925362|P5|NOT COMPLETED|First Intervention Period||0
1605254|NCT00975481|3925363|P4|NOT COMPLETED|First Intervention Period||0
1605255|NCT00975481|3925364|P3|NOT COMPLETED|First Intervention Period||0
1605256|NCT00975481|3925365|P2|NOT COMPLETED|First Intervention Period||0
1605257|NCT00975481|3925366|P1|NOT COMPLETED|First Intervention Period||0
1605258|NCT00975481|3925361|P6|COMPLETED|First Intervention Period||6
1605259|NCT00975481|3925362|P5|COMPLETED|First Intervention Period||6
1605260|NCT00975481|3925363|P4|COMPLETED|First Intervention Period||6
1605261|NCT00975481|3925364|P3|COMPLETED|First Intervention Period||6
1605262|NCT00975481|3925365|P2|COMPLETED|First Intervention Period||6
1605263|NCT00975481|3925366|P1|COMPLETED|First Intervention Period||6
1605264|NCT00975481|3925361|P6|STARTED|First Intervention Period||6
1605265|NCT00975481|3925362|P5|STARTED|First Intervention Period||6
1605266|NCT00975481|3925363|P4|STARTED|First Intervention Period||6
1605267|NCT00975481|3925364|P3|STARTED|First Intervention Period||6
1605268|NCT00975481|3925365|P2|STARTED|First Intervention Period||6
1605269|NCT00975481|3925366|P1|STARTED|First Intervention Period||6
1605270|NCT00975416|3925466|P2|NOT COMPLETED|Overall Study||5
1605271|NCT00975416|3925467|P1|NOT COMPLETED|Overall Study||3
1605272|NCT00975416|3925466|P2|COMPLETED|Overall Study||11
1605273|NCT00975416|3925467|P1|COMPLETED|Overall Study||11
1605274|NCT00975416|3925466|P2|STARTED|Overall Study||16
1605275|NCT00975416|3925467|P1|STARTED|Overall Study||14
1605276|NCT00975286|3925476|P2|NOT COMPLETED|Overall Study||29
1605277|NCT00975286|3925477|P1|NOT COMPLETED|Overall Study||12
1605278|NCT00975286|3925476|P2|COMPLETED|Overall Study||194
1605279|NCT00975286|3925477|P1|COMPLETED|Overall Study||211
1605280|NCT00975286|3925476|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
1605281|NCT00975286|3925477|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
1605282|NCT00975286|3925476|P2|Safety Population|Overall Study||223
1605283|NCT00975286|3925477|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
1605284|NCT00975286|3925476|P2|STARTED|Overall Study||223
1605285|NCT00975286|3925477|P1|STARTED|Overall Study|Randomized.|223
1605286|NCT00975221|3925509|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
1605287|NCT00975221|3925510|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
1605288|NCT00975221|3925509|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
1605289|NCT00975221|3925510|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
1605290|NCT00975221|3925509|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
1605291|NCT00975221|3925510|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
1605292|NCT00975221|3925509|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
1605293|NCT00975221|3925510|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
1605294|NCT00975221|3925509|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
1605295|NCT00975221|3925510|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
1605296|NCT00975221|3925509|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
1605297|NCT00975221|3925510|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
1605298|NCT00975221|3925509|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
1605299|NCT00975221|3925510|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
1605300|NCT00975221|3925509|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
1605301|NCT00975221|3925510|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
1605302|NCT00975221|3925509|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
1605303|NCT00975221|3925510|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
1605304|NCT00975221|3925509|P2|STARTED|Titration Phase (Weeks 1-12)||33
1605305|NCT00975221|3925510|P1|STARTED|Titration Phase (Weeks 1-12)||34
1605306|NCT00975195|3925526|P2|NOT COMPLETED|Overall Study||233
1605307|NCT00975195|3925527|P1|NOT COMPLETED|Overall Study||228
1605308|NCT00975195|3925526|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
1605309|NCT00975195|3925527|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
1605310|NCT00975195|3925526|P2|STARTED|Overall Study||1244
1605311|NCT00975195|3925527|P1|STARTED|Overall Study||1244
1605312|NCT00975156|3925587|P2|NOT COMPLETED|Overall Study||1
1605313|NCT00975156|3925588|P1|NOT COMPLETED|Overall Study||0
1605314|NCT00975156|3925587|P2|COMPLETED|Overall Study||9
1605315|NCT00975156|3925588|P1|COMPLETED|Overall Study||11
1605316|NCT00975156|3925587|P2|STARTED|Overall Study||10
1605317|NCT00975156|3925588|P1|STARTED|Overall Study||11
1605318|NCT00975143|3925600|P2|NOT COMPLETED|Overall Study||60
1605319|NCT00975143|3925601|P1|NOT COMPLETED|Overall Study||70
1605320|NCT00975143|3925600|P2|COMPLETED|Overall Study||401
1605321|NCT00975143|3925601|P1|COMPLETED|Overall Study||394
1605322|NCT00975143|3925600|P2|Completed Treatment (Week 20)|Overall Study||410
1605323|NCT00975143|3925601|P1|Completed Treatment (Week 20)|Overall Study||403
1605324|NCT00975143|3925600|P2|STARTED|Overall Study||461
1605325|NCT00975143|3925601|P1|STARTED|Overall Study||464
1605326|NCT00975130|3925611|P3|NOT COMPLETED|Study Part 2||17
1605327|NCT00975130|3925612|P2|NOT COMPLETED|Study Part 2||38
1605328|NCT00975130|3925613|P1|NOT COMPLETED|Study Part 2||0
1605329|NCT00975130|3925611|P3|COMPLETED|Study Part 2||238
1605330|NCT00975130|3925612|P2|COMPLETED|Study Part 2||212
1605331|NCT00975130|3925613|P1|COMPLETED|Study Part 2||0
1605332|NCT00975130|3925611|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
1605333|NCT00975130|3925612|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
1605334|NCT00975130|3925613|P1|STARTED|Study Part 2||0
1605335|NCT00975130|3925611|P3|NOT COMPLETED|Study Part 1||0
1605336|NCT00975130|3925612|P2|NOT COMPLETED|Study Part 1||0
1605337|NCT00975130|3925613|P1|NOT COMPLETED|Study Part 1||280
1605338|NCT00975130|3925611|P3|COMPLETED|Study Part 1||0
1605339|NCT00975130|3925612|P2|COMPLETED|Study Part 1||0
1605340|NCT00975130|3925613|P1|COMPLETED|Study Part 1||3086
1605341|NCT00975130|3925611|P3|STARTED|Study Part 1||0
1605342|NCT00975130|3925612|P2|STARTED|Study Part 1||0
1605343|NCT00975130|3925613|P1|STARTED|Study Part 1||3366
1605344|NCT00975000|3925797|P2|NOT COMPLETED|Overall Study||5
1605345|NCT00975000|3925798|P1|NOT COMPLETED|Overall Study||5
1605346|NCT00975000|3925797|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
1605347|NCT00975000|3925798|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
1605348|NCT00975000|3925797|P2|Completed Maintenance Phase|Overall Study||52
1605349|NCT00975000|3925798|P1|Completed Maintenance Phase|Overall Study||52
1605350|NCT00975000|3925797|P2|Completed Efficacy Assessment Phase|Overall Study||54
1605351|NCT00975000|3925798|P1|Completed Efficacy Assessment Phase|Overall Study||54
1605352|NCT00975000|3925797|P2|Completed Titration Phase|Overall Study||55
1605353|NCT00975000|3925798|P1|Completed Titration Phase|Overall Study||54
1605354|NCT00975000|3925797|P2|STARTED|Overall Study||57
1605355|NCT00975000|3925798|P1|STARTED|Overall Study||57
1605356|NCT00974974|3925822|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
1605357|NCT00974974|3925823|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
1605358|NCT00974974|3925822|P2|COMPLETED|Maintenance - Double Blind Treatment||182
1605359|NCT00974974|3925823|P1|COMPLETED|Maintenance - Double Blind Treatment||186
1605360|NCT00974974|3925822|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
1605361|NCT00974974|3925823|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
1605362|NCT00974974|3925822|P2|NOT COMPLETED|IPX066 Dose Conversion||0
1605363|NCT00974974|3925823|P1|NOT COMPLETED|IPX066 Dose Conversion||57
1605364|NCT00974974|3925822|P2|COMPLETED|IPX066 Dose Conversion||0
1605365|NCT00974974|3925823|P1|COMPLETED|IPX066 Dose Conversion||393
1605366|NCT00974974|3925822|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
1605367|NCT00974974|3925823|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
1605368|NCT00974974|3925822|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
1605369|NCT00974974|3925823|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
1605370|NCT00974974|3925822|P2|COMPLETED|IR CD-LD Dose Adjustment||450
1605371|NCT00974974|3925823|P1|COMPLETED|IR CD-LD Dose Adjustment||0
1605372|NCT00974974|3925822|P2|STARTED|IR CD-LD Dose Adjustment||471
1605373|NCT00974974|3925823|P1|STARTED|IR CD-LD Dose Adjustment||0
1605374|NCT00974922|3925833|P1|NOT COMPLETED|Overall Study||24
1605375|NCT00974922|3925833|P1|COMPLETED|Overall Study||16
1605376|NCT00974922|3925833|P1|STARTED|Overall Study||40
1605377|NCT00974818|3925840|P2|NOT COMPLETED|Overall Study||0
1605378|NCT00974818|3925841|P1|NOT COMPLETED|Overall Study||0
1605379|NCT00974818|3925840|P2|COMPLETED|Overall Study||25
1605380|NCT00974818|3925841|P1|COMPLETED|Overall Study||25
1605381|NCT00974818|3925840|P2|STARTED|Overall Study||25
1605382|NCT00974818|3925841|P1|STARTED|Overall Study||25
1605383|NCT00974675|3925851|P4|NOT COMPLETED|Overall Study||2
1605384|NCT00974675|3925852|P3|NOT COMPLETED|Overall Study||2
1605385|NCT00974675|3925853|P2|NOT COMPLETED|Overall Study||1
1605386|NCT00974675|3925854|P1|NOT COMPLETED|Overall Study||2
1605387|NCT00974675|3925851|P4|COMPLETED|Overall Study||2
1605388|NCT00974675|3925852|P3|COMPLETED|Overall Study||1
1605389|NCT00974675|3925853|P2|COMPLETED|Overall Study||7
1605390|NCT00974675|3925854|P1|COMPLETED|Overall Study||6
1605391|NCT00974675|3925851|P4|STARTED|Overall Study||4
1605392|NCT00974675|3925852|P3|STARTED|Overall Study||3
1605393|NCT00974675|3925853|P2|STARTED|Overall Study||8
1605394|NCT00974675|3925854|P1|STARTED|Overall Study||8
1605395|NCT00974571|3925903|P3|NOT COMPLETED|Overall Study||83
1605396|NCT00974571|3925904|P2|NOT COMPLETED|Overall Study||16
1605397|NCT00974571|3925905|P1|NOT COMPLETED|Overall Study||68
1605398|NCT00974571|3925903|P3|COMPLETED|Overall Study||530
1605399|NCT00974571|3925904|P2|COMPLETED|Overall Study||106
1605400|NCT00974571|3925905|P1|COMPLETED|Overall Study||562
1605401|NCT00974571|3925903|P3|STARTED|Overall Study||613
1605402|NCT00974571|3925904|P2|STARTED|Overall Study||122
1605403|NCT00974571|3925905|P1|STARTED|Overall Study||630
1605404|NCT00974480|3925928|P3|NOT COMPLETED|Overall Study||10
1605405|NCT00974480|3925929|P2|NOT COMPLETED|Overall Study||7
1605406|NCT00974480|3925930|P1|NOT COMPLETED|Overall Study||11
1605407|NCT00974480|3925928|P3|COMPLETED|Overall Study||30
1605408|NCT00974480|3925929|P2|COMPLETED|Overall Study||33
1605409|NCT00974480|3925930|P1|COMPLETED|Overall Study||29
1605410|NCT00974480|3925928|P3|STARTED|Overall Study||40
1605411|NCT00974480|3925929|P2|STARTED|Overall Study||40
1605412|NCT00974480|3925930|P1|STARTED|Overall Study||40
1605413|NCT00974376|3925970|P2|NOT COMPLETED|Overall Study||33
1605414|NCT00974376|3925971|P1|NOT COMPLETED|Overall Study||34
1605415|NCT00974376|3925970|P2|COMPLETED|Overall Study||42
1605416|NCT00974376|3925971|P1|COMPLETED|Overall Study||41
1605417|NCT00974376|3925970|P2|STARTED|Overall Study||75
1605418|NCT00974376|3925971|P1|STARTED|Overall Study||75
1605419|NCT00974363|3925979|P2|NOT COMPLETED|Overall Study||0
1605420|NCT00974363|3925980|P1|NOT COMPLETED|Overall Study||0
1605421|NCT00974363|3925979|P2|COMPLETED|Overall Study||168
1605422|NCT00974363|3925980|P1|COMPLETED|Overall Study||521
1605423|NCT00974363|3925979|P2|STARTED|Overall Study||168
1605424|NCT00974363|3925980|P1|STARTED|Overall Study||521
1605425|NCT00974311|3926002|P2|NOT COMPLETED|OLE Phase (up to 77 Months)||50
1605426|NCT00974311|3926003|P1|NOT COMPLETED|OLE Phase (up to 77 Months)||109
1605427|NCT00974311|3926002|P2|COMPLETED|OLE Phase (up to 77 Months)||0
1605428|NCT00974311|3926003|P1|COMPLETED|OLE Phase (up to 77 Months)||0
1605429|NCT00974311|3926002|P2|STARTED|OLE Phase (up to 77 Months)||50
1605430|NCT00974311|3926003|P1|STARTED|OLE Phase (up to 77 Months)||109
1605431|NCT00974311|3926002|P2|NOT COMPLETED|DB Phase (up to 24 Months)||349
1605432|NCT00974311|3926003|P1|NOT COMPLETED|DB Phase (up to 24 Months)||691
1605433|NCT00974311|3926002|P2|COMPLETED|DB Phase (up to 24 Months)||50
1605434|NCT00974311|3926003|P1|COMPLETED|DB Phase (up to 24 Months)||109
1605435|NCT00974311|3926002|P2|STARTED|DB Phase (up to 24 Months)||399
1605436|NCT00974311|3926003|P1|STARTED|DB Phase (up to 24 Months)||800
1605437|NCT00974246|3926039|P1|NOT COMPLETED|Overall Study||0
1605438|NCT00974246|3926039|P1|COMPLETED|Overall Study||27
1605439|NCT00974246|3926039|P1|STARTED|Overall Study||27
1605440|NCT00974233|3926045|P1|NOT COMPLETED|Maintenance Lenalidomide||13
1605441|NCT00974233|3926045|P1|COMPLETED|Maintenance Lenalidomide||6
1605442|NCT00974233|3926045|P1|STARTED|Maintenance Lenalidomide||19
1605443|NCT00974233|3926045|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
1605444|NCT00974233|3926045|P1|COMPLETED|Induction Chemoimmunotherapy||19
1605445|NCT00974233|3926045|P1|STARTED|Induction Chemoimmunotherapy||34
1605446|NCT00974220|3926060|P2|NOT COMPLETED|Treatment Period 2||0
1605447|NCT00974220|3926061|P1|NOT COMPLETED|Treatment Period 2||0
1605448|NCT00974220|3926060|P2|COMPLETED|Treatment Period 2||5
1605449|NCT00974220|3926061|P1|COMPLETED|Treatment Period 2||7
1605450|NCT00974220|3926060|P2|STARTED|Treatment Period 2||5
1605451|NCT00974220|3926061|P1|STARTED|Treatment Period 2||7
1605452|NCT00974220|3926060|P2|NOT COMPLETED|Treatment Period 1||2
1605453|NCT00974220|3926061|P1|NOT COMPLETED|Treatment Period 1||2
1605454|NCT00974220|3926060|P2|COMPLETED|Treatment Period 1||5
1605455|NCT00974220|3926061|P1|COMPLETED|Treatment Period 1||7
1605456|NCT00974220|3926060|P2|STARTED|Treatment Period 1||7
1605457|NCT00974220|3926061|P1|STARTED|Treatment Period 1||9
1605458|NCT00974142|3926071|P2|NOT COMPLETED|Overall Study||0
1605459|NCT00974142|3926072|P1|NOT COMPLETED|Overall Study||0
1605460|NCT00974142|3926071|P2|COMPLETED|Overall Study||9
1605461|NCT00974142|3926072|P1|COMPLETED|Overall Study||8
1605462|NCT00974142|3926071|P2|STARTED|Overall Study||9
1605463|NCT00974142|3926072|P1|STARTED|Overall Study||8
1605464|NCT00974090|3926106|P2|NOT COMPLETED|Period 2: Open-label Period||10
1605465|NCT00974090|3926107|P1|NOT COMPLETED|Period 2: Open-label Period||8
1605466|NCT00974090|3926106|P2|COMPLETED|Period 2: Open-label Period||85
1605467|NCT00974090|3926107|P1|COMPLETED|Period 2: Open-label Period||87
1605468|NCT00974090|3926106|P2|STARTED|Period 2: Open-label Period||95
1605469|NCT00974090|3926107|P1|STARTED|Period 2: Open-label Period||95
1605470|NCT00974090|3926106|P2|NOT COMPLETED|Period 1: Double Blind Period||1
1605471|NCT00974090|3926107|P1|NOT COMPLETED|Period 1: Double Blind Period||3
1605472|NCT00974090|3926106|P2|COMPLETED|Period 1: Double Blind Period||95
1605473|NCT00974090|3926107|P1|COMPLETED|Period 1: Double Blind Period||95
1605474|NCT00974090|3926106|P2|STARTED|Period 1: Double Blind Period||96
1605475|NCT00974090|3926107|P1|STARTED|Period 1: Double Blind Period||98
1605476|NCT00974051|3926121|P3|NOT COMPLETED|Overall Study||0
1605477|NCT00974051|3926122|P2|NOT COMPLETED|Overall Study||0
1605478|NCT00974051|3926123|P1|NOT COMPLETED|Overall Study||0
1605479|NCT00974051|3926121|P3|COMPLETED|Overall Study||6
1605480|NCT00974051|3926122|P2|COMPLETED|Overall Study||4
1605481|NCT00974051|3926123|P1|COMPLETED|Overall Study||6
1605482|NCT00974051|3926121|P3|STARTED|Overall Study||6
1605483|NCT00974051|3926122|P2|STARTED|Overall Study||4
1605484|NCT00974051|3926123|P1|STARTED|Overall Study||6
1605485|NCT00973973|3926143|P2|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
1605486|NCT00973973|3926144|P1|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
1605487|NCT00973973|3926143|P2|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
1605488|NCT00973973|3926144|P1|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
1605489|NCT00973973|3926143|P2|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
1605490|NCT00973973|3926144|P1|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
1605491|NCT00973973|3926143|P2|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
1605492|NCT00973973|3926144|P1|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
1605493|NCT00973973|3926143|P2|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
1605494|NCT00973973|3926144|P1|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
1605495|NCT00973973|3926143|P2|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
1605496|NCT00973973|3926144|P1|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
1605497|NCT00973973|3926143|P2|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
1605498|NCT00973973|3926144|P1|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
1605499|NCT00973921|3926204|P1|NOT COMPLETED|Overall Study||9
1605500|NCT00973921|3926204|P1|COMPLETED|Overall Study||31
1605501|NCT00973921|3926204|P1|STARTED|Overall Study||40
1605502|NCT00973765|3926213|P2|NOT COMPLETED|Overall Study||14
1605503|NCT00973765|3926214|P1|NOT COMPLETED|Overall Study||8
1605504|NCT00973765|3926213|P2|COMPLETED|Overall Study|102|102
1605505|NCT00973765|3926214|P1|COMPLETED|Overall Study|88|88
1605506|NCT00973765|3926213|P2|STARTED|Overall Study|116|116
1605507|NCT00973765|3926214|P1|STARTED|Overall Study|96|96
1605508|NCT00973752|3926220|P1|NOT COMPLETED|Overall Study||0
1605509|NCT00973752|3926220|P1|COMPLETED|Overall Study||30
1605510|NCT00973752|3926220|P1|STARTED|Overall Study||30
1605511|NCT00973739|3926224|P1|NOT COMPLETED|Overall Study||4
1605512|NCT00973739|3926224|P1|COMPLETED|Overall Study||17
1605513|NCT00973739|3926224|P1|STARTED|Overall Study||21
1605514|NCT00973700|3926236|P5|NOT COMPLETED|Overall Study||10
1605515|NCT00973700|3926237|P4|NOT COMPLETED|Overall Study||18
1605516|NCT00973700|3926238|P3|NOT COMPLETED|Overall Study||10
1605517|NCT00973700|3926239|P2|NOT COMPLETED|Overall Study||2
1605518|NCT00973700|3926240|P1|NOT COMPLETED|Overall Study||7
1605519|NCT00973700|3926236|P5|COMPLETED|Overall Study||158
1605520|NCT00973700|3926237|P4|COMPLETED|Overall Study||318
1605521|NCT00973700|3926238|P3|COMPLETED|Overall Study||158
1605522|NCT00973700|3926239|P2|COMPLETED|Overall Study||54
1605523|NCT00973700|3926240|P1|COMPLETED|Overall Study||49
1605524|NCT00973700|3926236|P5|STARTED|Overall Study||168
1605525|NCT00973700|3926237|P4|STARTED|Overall Study||336
1605526|NCT00973700|3926238|P3|STARTED|Overall Study||168
1605527|NCT00973700|3926239|P2|STARTED|Overall Study||56
1605528|NCT00973700|3926240|P1|STARTED|Overall Study||56
1605529|NCT00973622|3926289|P2|NOT COMPLETED|Overall Study||5
1605530|NCT00973622|3926290|P1|NOT COMPLETED|Overall Study||31
1605531|NCT00973622|3926289|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
1605532|NCT00973622|3926290|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
1605533|NCT00973622|3926289|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
1605534|NCT00973622|3926290|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
1605535|NCT00973479|3926298|P2|NOT COMPLETED|Overall Study||69
1605536|NCT00973479|3926299|P1|NOT COMPLETED|Overall Study||37
1605537|NCT00973479|3926298|P2|COMPLETED|Overall Study||326
1605538|NCT00973479|3926299|P1|COMPLETED|Overall Study||160
1605539|NCT00973479|3926298|P2|STARTED|Overall Study||395
1605540|NCT00973479|3926299|P1|STARTED|Overall Study||197
1605541|NCT00973362|3926317|P2|NOT COMPLETED|3-Year Follow-up||0
1605542|NCT00973362|3926318|P1|NOT COMPLETED|3-Year Follow-up||17
1605543|NCT00973362|3926317|P2|COMPLETED|3-Year Follow-up||0
1605544|NCT00973362|3926318|P1|COMPLETED|3-Year Follow-up||10854
1605545|NCT00973362|3926317|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
1605546|NCT00973362|3926318|P1|STARTED|3-Year Follow-up||10871
1605547|NCT00973362|3926317|P2|NOT COMPLETED|Baseline Evaluation||223
1605548|NCT00973362|3926318|P1|NOT COMPLETED|Baseline Evaluation||773
1605549|NCT00973362|3926317|P2|COMPLETED|Baseline Evaluation||1029
1605550|NCT00973362|3926318|P1|COMPLETED|Baseline Evaluation||10871
1605551|NCT00973362|3926317|P2|Conclusive Disease Status|Baseline Evaluation||939
1605552|NCT00973362|3926318|P1|Conclusive Disease Status|Baseline Evaluation||819
1605553|NCT00973362|3926317|P2|Evaluable for Analysis|Baseline Evaluation||958
1605554|NCT00973362|3926318|P1|Evaluable for Analysis|Baseline Evaluation||10871
1605555|NCT00973362|3926317|P2|STARTED|Baseline Evaluation||1252
1605556|NCT00973362|3926318|P1|STARTED|Baseline Evaluation||11644
1605557|NCT00973349|3926343|P16|NOT COMPLETED|Overall Study||2
1605558|NCT00973349|3926344|P15|NOT COMPLETED|Overall Study||2
1605559|NCT00973349|3926345|P14|NOT COMPLETED|Overall Study||0
1605560|NCT00973349|3926346|P13|NOT COMPLETED|Overall Study||1
1605561|NCT00973349|3926347|P12|NOT COMPLETED|Overall Study||2
1605562|NCT00973349|3926348|P11|NOT COMPLETED|Overall Study||0
1605563|NCT00973349|3926349|P10|NOT COMPLETED|Overall Study||6
1605564|NCT00973349|3926350|P9|NOT COMPLETED|Overall Study||4
1605565|NCT00973349|3926351|P8|NOT COMPLETED|Overall Study||3
1605566|NCT00973349|3926352|P7|NOT COMPLETED|Overall Study||2
1605567|NCT00973349|3926353|P6|NOT COMPLETED|Overall Study||4
1605568|NCT00973349|3926354|P5|NOT COMPLETED|Overall Study||5
1605569|NCT00973349|3926355|P4|NOT COMPLETED|Overall Study||5
1605570|NCT00973349|3926356|P3|NOT COMPLETED|Overall Study||5
1605571|NCT00973349|3926357|P2|NOT COMPLETED|Overall Study||3
1605572|NCT00973349|3926358|P1|NOT COMPLETED|Overall Study||4
1605573|NCT00973349|3926343|P16|COMPLETED|Overall Study||165
1605574|NCT00973349|3926344|P15|COMPLETED|Overall Study||168
1605575|NCT00973349|3926345|P14|COMPLETED|Overall Study||171
1605576|NCT00973349|3926346|P13|COMPLETED|Overall Study||168
1605577|NCT00973349|3926347|P12|COMPLETED|Overall Study||167
1605578|NCT00973349|3926348|P11|COMPLETED|Overall Study||174
1605579|NCT00973349|3926349|P10|COMPLETED|Overall Study||163
1605580|NCT00973349|3926350|P9|COMPLETED|Overall Study||167
1605581|NCT00973349|3926351|P8|COMPLETED|Overall Study||166
1605582|NCT00973349|3926352|P7|COMPLETED|Overall Study||172
1605583|NCT00973349|3926353|P6|COMPLETED|Overall Study||165
1605584|NCT00973349|3926354|P5|COMPLETED|Overall Study||165
1605585|NCT00973349|3926355|P4|COMPLETED|Overall Study||163
1605586|NCT00973349|3926356|P3|COMPLETED|Overall Study||166
1605587|NCT00973349|3926357|P2|COMPLETED|Overall Study||165
1605588|NCT00973349|3926358|P1|COMPLETED|Overall Study||166
1605589|NCT00973349|3926343|P16|STARTED|Overall Study||167
1605590|NCT00973349|3926344|P15|STARTED|Overall Study||170
1605591|NCT00973349|3926345|P14|STARTED|Overall Study||171
1605592|NCT00973349|3926346|P13|STARTED|Overall Study||169
1605593|NCT00973349|3926347|P12|STARTED|Overall Study||169
1605594|NCT00973349|3926348|P11|STARTED|Overall Study||174
1605595|NCT00973349|3926349|P10|STARTED|Overall Study||169
1605596|NCT00973349|3926350|P9|STARTED|Overall Study||171
1605597|NCT00973349|3926351|P8|STARTED|Overall Study||169
1605598|NCT00973349|3926352|P7|STARTED|Overall Study||174
1605599|NCT00973349|3926353|P6|STARTED|Overall Study||169
1605600|NCT00973349|3926354|P5|STARTED|Overall Study||170
1605601|NCT00973349|3926355|P4|STARTED|Overall Study||168
1605602|NCT00973349|3926356|P3|STARTED|Overall Study||171
1605603|NCT00973349|3926357|P2|STARTED|Overall Study||168
1605604|NCT00973349|3926358|P1|STARTED|Overall Study||170
1605605|NCT00972959|3926456|P1|NOT COMPLETED|Overall Study||0
1605606|NCT00972959|3926456|P1|COMPLETED|Overall Study||17
1605607|NCT00972959|3926456|P1|STARTED|Overall Study||17
1605608|NCT00972816|3926479|P8|NOT COMPLETED|Overall Study||9
1605609|NCT00972816|3926480|P7|NOT COMPLETED|Overall Study||10
1605610|NCT00972816|3926481|P6|NOT COMPLETED|Overall Study||11
1605611|NCT00972816|3926482|P5|NOT COMPLETED|Overall Study||12
1605612|NCT00972816|3926483|P4|NOT COMPLETED|Overall Study||8
1605613|NCT00972816|3926484|P3|NOT COMPLETED|Overall Study||9
1605614|NCT00972816|3926485|P2|NOT COMPLETED|Overall Study||11
1605615|NCT00972816|3926486|P1|NOT COMPLETED|Overall Study||17
1605616|NCT00972816|3926479|P8|COMPLETED|Overall Study||161
1605617|NCT00972816|3926480|P7|COMPLETED|Overall Study||159
1605618|NCT00972816|3926481|P6|COMPLETED|Overall Study||158
1605619|NCT00972816|3926482|P5|COMPLETED|Overall Study||157
1605620|NCT00972816|3926483|P4|COMPLETED|Overall Study||161
1605621|NCT00972816|3926484|P3|COMPLETED|Overall Study||160
1605622|NCT00972816|3926485|P2|COMPLETED|Overall Study||158
1605623|NCT00972816|3926486|P1|COMPLETED|Overall Study||156
1605624|NCT00972816|3926479|P8|STARTED|Overall Study||170
1605625|NCT00972816|3926480|P7|STARTED|Overall Study||169
1605626|NCT00972816|3926481|P6|STARTED|Overall Study||169
1605627|NCT00972816|3926482|P5|STARTED|Overall Study||169
1605628|NCT00972816|3926483|P4|STARTED|Overall Study||169
1605629|NCT00972816|3926484|P3|STARTED|Overall Study||169
1605630|NCT00972816|3926485|P2|STARTED|Overall Study||169
1605631|NCT00972816|3926486|P1|STARTED|Overall Study||173
1605632|NCT00972777|3926570|P2|NOT COMPLETED|Overall Study||14
1605633|NCT00972777|3926571|P1|NOT COMPLETED|Overall Study||14
1605634|NCT00972777|3926570|P2|COMPLETED|Overall Study||229
1605635|NCT00972777|3926571|P1|COMPLETED|Overall Study||217
1605636|NCT00972777|3926570|P2|STARTED|Overall Study||243
1605637|NCT00972777|3926571|P1|STARTED|Overall Study||231
1605638|NCT00972738|3926586|P3|NOT COMPLETED|Overall Study||29
1605639|NCT00972738|3926587|P2|NOT COMPLETED|Overall Study||6
1605640|NCT00972738|3926588|P1|NOT COMPLETED|Overall Study||21
1605641|NCT00972738|3926586|P3|COMPLETED|Overall Study||492
1605642|NCT00972738|3926587|P2|COMPLETED|Overall Study||165
1605643|NCT00972738|3926588|P1|COMPLETED|Overall Study||501
1605644|NCT00972738|3926586|P3|STARTED|Overall Study||521
1605645|NCT00972738|3926587|P2|STARTED|Overall Study||171
1605646|NCT00972738|3926588|P1|STARTED|Overall Study||522
1605647|NCT00972725|3926613|P2|NOT COMPLETED|Overall Study||0
1605648|NCT00972725|3926614|P1|NOT COMPLETED|Overall Study||0
1605649|NCT00972725|3926613|P2|COMPLETED|Overall Study||15
1605650|NCT00972725|3926614|P1|COMPLETED|Overall Study||13
1605651|NCT00972725|3926613|P2|STARTED|Overall Study||15
1605652|NCT00972725|3926614|P1|STARTED|Overall Study||13
1605653|NCT00972621|3926696|P2|NOT COMPLETED|Overall Study||1
1605654|NCT00972621|3926697|P1|NOT COMPLETED|Overall Study||0
1605655|NCT00972621|3926696|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
1605656|NCT00972621|3926697|P1|COMPLETED|Overall Study||200
1605657|NCT00972621|3926696|P2|STARTED|Overall Study||200
1605658|NCT00972621|3926697|P1|STARTED|Overall Study||200
1605659|NCT00972595|3926705|P2|NOT COMPLETED|Period 2||0
1605660|NCT00972595|3926706|P1|NOT COMPLETED|Period 2||0
1605661|NCT00972595|3926705|P2|COMPLETED|Period 2||22
1605662|NCT00972595|3926706|P1|COMPLETED|Period 2||22
1605663|NCT00972595|3926705|P2|STARTED|Period 2||22
1605664|NCT00972595|3926706|P1|STARTED|Period 2||22
1605665|NCT00972595|3926705|P2|NOT COMPLETED|Period 1||0
1605666|NCT00972595|3926706|P1|NOT COMPLETED|Period 1||1
1605667|NCT00972595|3926705|P2|COMPLETED|Period 1||22
1605668|NCT00972595|3926706|P1|COMPLETED|Period 1||22
1605669|NCT00972595|3926705|P2|STARTED|Period 1||22
1605670|NCT00972595|3926706|P1|STARTED|Period 1||23
1605671|NCT00972543|3926716|P2|NOT COMPLETED|Overall Study||1
1605672|NCT00972543|3926717|P1|NOT COMPLETED|Overall Study||5
1605673|NCT00972543|3926716|P2|COMPLETED|Overall Study||0
1605674|NCT00972543|3926717|P1|COMPLETED|Overall Study||0
1605675|NCT00972543|3926716|P2|STARTED|Overall Study||1
1605676|NCT00972543|3926717|P1|STARTED|Overall Study||5
1605677|NCT00972530|3926793|P2|NOT COMPLETED|Overall Study||0
1605678|NCT00972530|3926794|P1|NOT COMPLETED|Overall Study||0
1605679|NCT00972530|3926793|P2|COMPLETED|Overall Study||46
1605680|NCT00972530|3926794|P1|COMPLETED|Overall Study||44
1605681|NCT00972530|3926793|P2|STARTED|Overall Study||46
1605682|NCT00972530|3926794|P1|STARTED|Overall Study||44
1605683|NCT00972517|3926800|P6|NOT COMPLETED|Overall Study||0
1605684|NCT00972517|3926801|P5|NOT COMPLETED|Overall Study||1
1605685|NCT00972517|3926802|P4|NOT COMPLETED|Overall Study||3
1605686|NCT00972517|3926803|P3|NOT COMPLETED|Overall Study||0
1605687|NCT00972517|3926804|P2|NOT COMPLETED|Overall Study||1
1605688|NCT00972517|3926805|P1|NOT COMPLETED|Overall Study||0
1605689|NCT00972517|3926800|P6|COMPLETED|Overall Study||58
1605690|NCT00972517|3926801|P5|COMPLETED|Overall Study||33
1605691|NCT00972517|3926802|P4|COMPLETED|Overall Study||27
1605692|NCT00972517|3926803|P3|COMPLETED|Overall Study||60
1605693|NCT00972517|3926804|P2|COMPLETED|Overall Study||30
1605694|NCT00972517|3926805|P1|COMPLETED|Overall Study||31
1605695|NCT00972517|3926800|P6|STARTED|Overall Study||58
1605696|NCT00972517|3926801|P5|STARTED|Overall Study||34
1605697|NCT00972517|3926802|P4|STARTED|Overall Study||30
1605698|NCT00972517|3926803|P3|STARTED|Overall Study||60
1605699|NCT00972517|3926804|P2|STARTED|Overall Study||31
1605700|NCT00972517|3926805|P1|STARTED|Overall Study||31
1605701|NCT00972504|3926900|P1|NOT COMPLETED|Overall Study||3
1605702|NCT00972504|3926900|P1|COMPLETED|Overall Study||51
1605703|NCT00972504|3926900|P1|STARTED|Overall Study||54
1605704|NCT00972478|3926932|P2|NOT COMPLETED|Overall Study||38
1605705|NCT00972478|3926933|P1|NOT COMPLETED|Overall Study||7
1605706|NCT00972478|3926932|P2|COMPLETED|Overall Study||34
1605707|NCT00972478|3926933|P1|COMPLETED|Overall Study||4
1605708|NCT00972478|3926932|P2|Eligible and Began Protocol Therapy|Overall Study||63
1605709|NCT00972478|3926933|P1|Eligible and Began Protocol Therapy|Overall Study||9
1605710|NCT00972478|3926932|P2|STARTED|Overall Study||72
1605711|NCT00972478|3926933|P1|STARTED|Overall Study||11
1605712|NCT00972439|3926945|P2|NOT COMPLETED|Overall Study||0
1605713|NCT00972439|3926946|P1|NOT COMPLETED|Overall Study||0
1605714|NCT00972439|3926945|P2|COMPLETED|Overall Study||16
1605715|NCT00972439|3926946|P1|COMPLETED|Overall Study||17
1605716|NCT00972439|3926945|P2|STARTED|Overall Study||16
1605717|NCT00972439|3926946|P1|STARTED|Overall Study||17
1605718|NCT00972374|3926955|P3|NOT COMPLETED|Overall Study||1
1605719|NCT00972374|3926956|P2|NOT COMPLETED|Overall Study||0
1605720|NCT00972374|3926957|P1|NOT COMPLETED|Overall Study||2
1605721|NCT00972374|3926955|P3|COMPLETED|Overall Study||13
1605722|NCT00972374|3926956|P2|COMPLETED|Overall Study||15
1605723|NCT00972374|3926957|P1|COMPLETED|Overall Study||13
1605724|NCT00972374|3926955|P3|STARTED|Overall Study||14
1605725|NCT00972374|3926956|P2|STARTED|Overall Study||15
1605726|NCT00972374|3926957|P1|STARTED|Overall Study||15
1605727|NCT00972335|3926971|P1|NOT COMPLETED|Overall Study||17
1605728|NCT00972335|3926971|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
1605729|NCT00972335|3926971|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
1605730|NCT00972322|3926978|P2|NOT COMPLETED|Overall Study||3
1605731|NCT00972322|3926979|P1|NOT COMPLETED|Overall Study||3
1605732|NCT00972322|3926978|P2|COMPLETED|Overall Study||25
1605733|NCT00972322|3926979|P1|COMPLETED|Overall Study||25
1605734|NCT00972322|3926978|P2|STARTED|Overall Study||28
1605735|NCT00972322|3926979|P1|STARTED|Overall Study||28
1605736|NCT00972283|3926991|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
1605737|NCT00972283|3926992|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
1605738|NCT00972283|3926991|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
1605739|NCT00972283|3926992|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
1605740|NCT00972283|3926991|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
1605741|NCT00972283|3926992|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
1605742|NCT00972283|3926991|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
1605743|NCT00972283|3926992|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
1605744|NCT00972283|3926991|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
1605745|NCT00972283|3926992|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
1605746|NCT00972283|3926991|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
1605747|NCT00972283|3926992|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
1605748|NCT00972283|3926991|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
1605749|NCT00972283|3926992|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
1605750|NCT00972283|3926991|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
1605751|NCT00972283|3926992|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
1605752|NCT00972244|3927019|P5|NOT COMPLETED|Overall Study||9
1605753|NCT00972244|3927020|P4|NOT COMPLETED|Overall Study||0
1605754|NCT00972244|3927021|P3|NOT COMPLETED|Overall Study||2
1605755|NCT00972244|3927022|P2|NOT COMPLETED|Overall Study||5
1605756|NCT00972244|3927023|P1|NOT COMPLETED|Overall Study||5
1605757|NCT00972244|3927019|P5|COMPLETED|Overall Study||45
1605758|NCT00972244|3927020|P4|COMPLETED|Overall Study||52
1605759|NCT00972244|3927021|P3|COMPLETED|Overall Study||56
1605760|NCT00972244|3927022|P2|COMPLETED|Overall Study||51
1605761|NCT00972244|3927023|P1|COMPLETED|Overall Study||54
1605762|NCT00972244|3927019|P5|STARTED|Overall Study||54
1605763|NCT00972244|3927020|P4|STARTED|Overall Study||52
1605764|NCT00972244|3927021|P3|STARTED|Overall Study||58
1605765|NCT00972244|3927022|P2|STARTED|Overall Study||56
1605766|NCT00972244|3927023|P1|STARTED|Overall Study||59
1605767|NCT00972205|3927045|P1|NOT COMPLETED|Overall Study||0
1605768|NCT00972205|3927045|P1|COMPLETED|Overall Study||12
1605769|NCT00972205|3927045|P1|STARTED|Overall Study||12
1605770|NCT00972153|3927055|P3|NOT COMPLETED|Overall Study||0
1605771|NCT00972153|3927056|P2|NOT COMPLETED|Overall Study||1
1605772|NCT00972153|3927057|P1|NOT COMPLETED|Overall Study||0
1605773|NCT00972153|3927055|P3|COMPLETED|Overall Study||12
1605774|NCT00972153|3927056|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
1605775|NCT00972153|3927057|P1|COMPLETED|Overall Study||12
1605776|NCT00972153|3927055|P3|STARTED|Overall Study||12
1605777|NCT00972153|3927056|P2|STARTED|Overall Study||12
1605778|NCT00972153|3927057|P1|STARTED|Overall Study||12
1605779|NCT00972088|3927068|P1|NOT COMPLETED|Overall Study||0
1605780|NCT00972088|3927068|P1|COMPLETED|Overall Study||26
1605781|NCT00972088|3927068|P1|STARTED|Overall Study||26
1605782|NCT00972023|3927072|P1|NOT COMPLETED|Overall Study||1
1605783|NCT00972023|3927072|P1|COMPLETED|Overall Study||0
1605784|NCT00972023|3927072|P1|STARTED|Overall Study||1
1605785|NCT00971997|3927079|P1|NOT COMPLETED|Overall Study||19
1605786|NCT00971997|3927079|P1|COMPLETED|Overall Study||116
1605787|NCT00971997|3927079|P1|STARTED|Overall Study||135
1605788|NCT00971932|3927097|P1|NOT COMPLETED|Overall Study||7
1605789|NCT00971932|3927097|P1|COMPLETED|Overall Study||26
1605790|NCT00971932|3927097|P1|STARTED|Overall Study|Number of participants treated.|33
1605791|NCT00971841|3927107|P1|NOT COMPLETED|Overall Study||0
1605792|NCT00971841|3927107|P1|COMPLETED|Overall Study||1
1605793|NCT00971841|3927107|P1|STARTED|Overall Study||1
1605794|NCT00971789|3927112|P1|NOT COMPLETED|Overall Study||0
1605795|NCT00971789|3927112|P1|COMPLETED|Overall Study||18
1605796|NCT00971789|3927112|P1|STARTED|Overall Study||18
1605797|NCT00971750|3927117|P1|NOT COMPLETED|Overall Study||0
1605798|NCT00971750|3927117|P1|COMPLETED|Overall Study||253
1605799|NCT00971750|3927117|P1|STARTED|Overall Study||253
1605800|NCT00971633|3927126|P6|NOT COMPLETED|Period 3||0
1605801|NCT00971633|3927127|P5|NOT COMPLETED|Period 3||0
1605802|NCT00971633|3927128|P4|NOT COMPLETED|Period 3||0
1605803|NCT00971633|3927129|P3|NOT COMPLETED|Period 3||0
1605804|NCT00971633|3927130|P2|NOT COMPLETED|Period 3||0
1605805|NCT00971633|3927131|P1|NOT COMPLETED|Period 3||0
1605806|NCT00971633|3927126|P6|COMPLETED|Period 3||2
1605807|NCT00971633|3927127|P5|COMPLETED|Period 3||2
1605808|NCT00971633|3927128|P4|COMPLETED|Period 3||2
1605809|NCT00971633|3927129|P3|COMPLETED|Period 3||2
1605810|NCT00971633|3927130|P2|COMPLETED|Period 3||2
1605811|NCT00971633|3927131|P1|COMPLETED|Period 3||2
1605812|NCT00971633|3927126|P6|STARTED|Period 3||2
1605813|NCT00971633|3927127|P5|STARTED|Period 3||2
1605814|NCT00971633|3927128|P4|STARTED|Period 3||2
1605815|NCT00971633|3927129|P3|STARTED|Period 3||2
1605816|NCT00971633|3927130|P2|STARTED|Period 3||2
1605817|NCT00971633|3927131|P1|STARTED|Period 3||2
1605818|NCT00971633|3927126|P6|NOT COMPLETED|Period 2||0
1605819|NCT00971633|3927127|P5|NOT COMPLETED|Period 2||0
1605820|NCT00971633|3927128|P4|NOT COMPLETED|Period 2||0
1605821|NCT00971633|3927129|P3|NOT COMPLETED|Period 2||0
1605822|NCT00971633|3927130|P2|NOT COMPLETED|Period 2||0
1605823|NCT00971633|3927131|P1|NOT COMPLETED|Period 2||0
1605824|NCT00971633|3927126|P6|COMPLETED|Period 2||2
1605825|NCT00971633|3927127|P5|COMPLETED|Period 2||2
1605826|NCT00971633|3927128|P4|COMPLETED|Period 2||2
1605827|NCT00971633|3927129|P3|COMPLETED|Period 2||2
1605828|NCT00971633|3927130|P2|COMPLETED|Period 2||2
1605829|NCT00971633|3927131|P1|COMPLETED|Period 2||2
1605830|NCT00971633|3927126|P6|STARTED|Period 2||2
1605831|NCT00971633|3927127|P5|STARTED|Period 2||2
1605832|NCT00971633|3927128|P4|STARTED|Period 2||2
1605833|NCT00971633|3927129|P3|STARTED|Period 2||2
1605834|NCT00971633|3927130|P2|STARTED|Period 2||2
1605835|NCT00971633|3927131|P1|STARTED|Period 2||2
1605836|NCT00971633|3927126|P6|NOT COMPLETED|Period 1||0
1605837|NCT00971633|3927127|P5|NOT COMPLETED|Period 1||0
1605838|NCT00971633|3927128|P4|NOT COMPLETED|Period 1||0
1605839|NCT00971633|3927129|P3|NOT COMPLETED|Period 1||0
1605840|NCT00971633|3927130|P2|NOT COMPLETED|Period 1||0
1605841|NCT00971633|3927131|P1|NOT COMPLETED|Period 1||0
1605842|NCT00971633|3927126|P6|COMPLETED|Period 1||2
1605843|NCT00971633|3927127|P5|COMPLETED|Period 1||2
1605844|NCT00971633|3927128|P4|COMPLETED|Period 1||2
1605845|NCT00971633|3927129|P3|COMPLETED|Period 1||2
1605846|NCT00971633|3927130|P2|COMPLETED|Period 1||2
1605847|NCT00971633|3927131|P1|COMPLETED|Period 1||2
1605848|NCT00971633|3927126|P6|STARTED|Period 1||2
1605849|NCT00971633|3927127|P5|STARTED|Period 1||2
1605850|NCT00971633|3927128|P4|STARTED|Period 1||2
1605851|NCT00971633|3927129|P3|STARTED|Period 1||2
1605852|NCT00971633|3927130|P2|STARTED|Period 1||2
1605853|NCT00971633|3927131|P1|STARTED|Period 1||2
1605854|NCT00971620|3927144|P2|NOT COMPLETED|Overall Study||0
1605855|NCT00971620|3927145|P1|NOT COMPLETED|Overall Study||0
1605856|NCT00971620|3927144|P2|COMPLETED|Overall Study||9
1605857|NCT00971620|3927145|P1|COMPLETED|Overall Study||9
1605858|NCT00971620|3927144|P2|STARTED|Overall Study||9
1605859|NCT00971620|3927145|P1|STARTED|Overall Study||9
1605860|NCT00971425|3927177|P2|NOT COMPLETED|Overall Study||2
1605861|NCT00971425|3927178|P1|NOT COMPLETED|Overall Study||1
1605862|NCT00971425|3927177|P2|COMPLETED|Overall Study||71
1605863|NCT00971425|3927178|P1|COMPLETED|Overall Study||71
1605864|NCT00971425|3927177|P2|STARTED|Overall Study||73
1605865|NCT00971425|3927178|P1|STARTED|Overall Study||72
1605866|NCT00971295|3927212|P2|NOT COMPLETED|Overall Study||1
1605867|NCT00971295|3927213|P1|NOT COMPLETED|Overall Study||0
1605868|NCT00971295|3927212|P2|COMPLETED|Overall Study||9
1605869|NCT00971295|3927213|P1|COMPLETED|Overall Study||10
1605870|NCT00971295|3927212|P2|STARTED|Overall Study||10
1605871|NCT00971295|3927213|P1|STARTED|Overall Study||10
1605872|NCT00971282|3927223|P1|NOT COMPLETED|Overall Study||0
1605873|NCT00971282|3927223|P1|COMPLETED|Overall Study||30
1605874|NCT00971282|3927223|P1|STARTED|Overall Study||30
1605875|NCT00971243|3927242|P5|NOT COMPLETED|Open-label Period||6
1605876|NCT00971243|3927243|P4|NOT COMPLETED|Open-label Period||10
1605877|NCT00971243|3927244|P3|NOT COMPLETED|Open-label Period||5
1605878|NCT00971243|3927245|P2|NOT COMPLETED|Open-label Period||10
1605879|NCT00971243|3927246|P1|NOT COMPLETED|Open-label Period||8
1605880|NCT00971243|3927242|P5|COMPLETED|Open-label Period||64
1605881|NCT00971243|3927243|P4|COMPLETED|Open-label Period||64
1605882|NCT00971243|3927244|P3|COMPLETED|Open-label Period||66
1605883|NCT00971243|3927245|P2|COMPLETED|Open-label Period||71
1605884|NCT00971243|3927246|P1|COMPLETED|Open-label Period||60
1605885|NCT00971243|3927242|P5|STARTED|Open-label Period||70
1605886|NCT00971243|3927243|P4|STARTED|Open-label Period||74
1605887|NCT00971243|3927244|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
1605888|NCT00971243|3927245|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
1605889|NCT00971243|3927246|P1|STARTED|Open-label Period||68
1605890|NCT00971243|3927242|P5|NOT COMPLETED|Double Blind Period||18
1605891|NCT00971243|3927243|P4|NOT COMPLETED|Double Blind Period||14
1605892|NCT00971243|3927244|P3|NOT COMPLETED|Double Blind Period||19
1605893|NCT00971243|3927245|P2|NOT COMPLETED|Double Blind Period||11
1605894|NCT00971243|3927246|P1|NOT COMPLETED|Double Blind Period||19
1605895|NCT00971243|3927242|P5|COMPLETED|Double Blind Period||70
1605896|NCT00971243|3927243|P4|COMPLETED|Double Blind Period||74
1605897|NCT00971243|3927244|P3|COMPLETED|Double Blind Period||72
1605898|NCT00971243|3927245|P2|COMPLETED|Double Blind Period||82
1605899|NCT00971243|3927246|P1|COMPLETED|Double Blind Period||68
1605900|NCT00971243|3927242|P5|STARTED|Double Blind Period||88
1605901|NCT00971243|3927243|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
1605902|NCT00971243|3927244|P3|STARTED|Double Blind Period||91
1605903|NCT00971243|3927245|P2|STARTED|Double Blind Period||93
1605904|NCT00971243|3927246|P1|STARTED|Double Blind Period||87
1605905|NCT00971204|3927263|P1|NOT COMPLETED|Overall Study||24
1605906|NCT00971204|3927263|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
1605907|NCT00971204|3927263|P1|Treated|Overall Study||86
1605908|NCT00971204|3927263|P1|STARTED|Overall Study|100 enrolled participants|100
1605909|NCT00971048|3927271|P4|NOT COMPLETED|Overall Study||2
1605910|NCT00971048|3927272|P3|NOT COMPLETED|Overall Study||1
1605911|NCT00971048|3927273|P2|NOT COMPLETED|Overall Study||2
1605912|NCT00971048|3927274|P1|NOT COMPLETED|Overall Study||1
1605913|NCT00971048|3927271|P4|COMPLETED|Overall Study||11
1605914|NCT00971048|3927272|P3|COMPLETED|Overall Study||11
1605915|NCT00971048|3927273|P2|COMPLETED|Overall Study||31
1605916|NCT00971048|3927274|P1|COMPLETED|Overall Study||29
1605917|NCT00971048|3927271|P4|STARTED|Overall Study||13
1605918|NCT00971048|3927272|P3|STARTED|Overall Study||12
1605919|NCT00971048|3927273|P2|STARTED|Overall Study||33
1605920|NCT00971048|3927274|P1|STARTED|Overall Study||30
1605921|NCT00970944|3927298|P2|NOT COMPLETED|Overall Study||2
1605922|NCT00970944|3927299|P1|NOT COMPLETED|Overall Study||1
1605923|NCT00970944|3927298|P2|COMPLETED|Overall Study||95
1605924|NCT00970944|3927299|P1|COMPLETED|Overall Study||86
1605925|NCT00970944|3927298|P2|STARTED|Overall Study||97
1605926|NCT00970944|3927299|P1|STARTED|Overall Study||87
1605927|NCT00970853|3927309|P2|NOT COMPLETED|Overall Study||0
1605928|NCT00970853|3927310|P1|NOT COMPLETED|Overall Study||0
1605929|NCT00970853|3927309|P2|COMPLETED|Overall Study||98
1605930|NCT00970853|3927310|P1|COMPLETED|Overall Study||89
1605931|NCT00970853|3927309|P2|STARTED|Overall Study||98
1605932|NCT00970853|3927310|P1|STARTED|Overall Study||89
1605933|NCT00970814|3927334|P2|NOT COMPLETED|Overall Study||14
1605934|NCT00970814|3927335|P1|NOT COMPLETED|Overall Study||8
1605935|NCT00970814|3927334|P2|COMPLETED|Overall Study||50
1605936|NCT00970814|3927335|P1|COMPLETED|Overall Study||58
1605937|NCT00970814|3927334|P2|STARTED|Overall Study||64
1605938|NCT00970814|3927335|P1|STARTED|Overall Study||66
1605939|NCT00970736|3927345|P1|NOT COMPLETED|Overall Study||2
1605940|NCT00970736|3927345|P1|COMPLETED|Overall Study||18
1605941|NCT00970736|3927345|P1|STARTED|Overall Study||20
1605942|NCT00970684|3927351|P1|NOT COMPLETED|Overall Study||10
1605943|NCT00970684|3927351|P1|COMPLETED|Overall Study||3
1605944|NCT00970684|3927351|P1|STARTED|Overall Study||13
1605945|NCT00970632|3927360|P3|NOT COMPLETED|Overall Study||18
1605946|NCT00970632|3927361|P2|NOT COMPLETED|Overall Study||15
1605947|NCT00970632|3927362|P1|NOT COMPLETED|Overall Study||24
1605948|NCT00970632|3927360|P3|COMPLETED|Overall Study||150
1605949|NCT00970632|3927361|P2|COMPLETED|Overall Study||156
1605950|NCT00970632|3927362|P1|COMPLETED|Overall Study||148
1605951|NCT00970632|3927360|P3|STARTED|Overall Study||168
1605952|NCT00970632|3927361|P2|STARTED|Overall Study||171
1605953|NCT00970632|3927362|P1|STARTED|Overall Study||172
1605954|NCT00970606|3927420|P2|NOT COMPLETED|Overall Study||0
1605955|NCT00970606|3927421|P1|NOT COMPLETED|Overall Study||0
1605956|NCT00970606|3927420|P2|COMPLETED|Overall Study||3
1605957|NCT00970606|3927421|P1|COMPLETED|Overall Study||4
1605958|NCT00970606|3927420|P2|STARTED|Overall Study||3
1605959|NCT00970606|3927421|P1|STARTED|Overall Study||4
1605960|NCT00970502|3927427|P1|NOT COMPLETED|Overall Study||1
1605961|NCT00970502|3927427|P1|COMPLETED|Overall Study||14
1605962|NCT00970502|3927427|P1|STARTED|Overall Study||15
1605963|NCT00970489|3927438|P2|NOT COMPLETED|Overall Study||41
1605964|NCT00970489|3927439|P1|NOT COMPLETED|Overall Study||54
1605965|NCT00970489|3927438|P2|COMPLETED|Overall Study||717
1605966|NCT00970489|3927439|P1|COMPLETED|Overall Study||704
1605967|NCT00970489|3927438|P2|STARTED|Overall Study||758
1605968|NCT00970489|3927439|P1|STARTED|Overall Study||758
1605969|NCT00970359|3927451|P1|NOT COMPLETED|Overall Study||4
1605970|NCT00970359|3927451|P1|COMPLETED|Overall Study||20
1605971|NCT00970359|3927451|P1|STARTED|Overall Study||24
1605972|NCT00970320|3927462|P5|NOT COMPLETED|Overall Study||540
1605973|NCT00970320|3927463|P4|NOT COMPLETED|Overall Study||14
1605974|NCT00970320|3927464|P3|NOT COMPLETED|Overall Study||13
1605975|NCT00970320|3927465|P2|NOT COMPLETED|Overall Study||11
1605976|NCT00970320|3927466|P1|NOT COMPLETED|Overall Study||0
1605977|NCT00970320|3927462|P5|COMPLETED|Overall Study||1031
1605978|NCT00970320|3927463|P4|COMPLETED|Overall Study||36
1605979|NCT00970320|3927464|P3|COMPLETED|Overall Study||35
1605980|NCT00970320|3927465|P2|COMPLETED|Overall Study||13
1605981|NCT00970320|3927466|P1|COMPLETED|Overall Study||25
1605982|NCT00970320|3927462|P5|STARTED|Overall Study||1571
1605983|NCT00970320|3927463|P4|STARTED|Overall Study||50
1605984|NCT00970320|3927464|P3|STARTED|Overall Study||48
1605985|NCT00970320|3927465|P2|STARTED|Overall Study||24
1605986|NCT00970320|3927466|P1|STARTED|Overall Study||25
1605987|NCT00970307|3927481|P3|NOT COMPLETED|Overall Study||2
1605988|NCT00970307|3927482|P2|NOT COMPLETED|Overall Study||3
1605989|NCT00970307|3927483|P1|NOT COMPLETED|Overall Study||3
1605990|NCT00970307|3927481|P3|COMPLETED|Overall Study||139
1605991|NCT00970307|3927482|P2|COMPLETED|Overall Study||136
1605992|NCT00970307|3927483|P1|COMPLETED|Overall Study||138
1605993|NCT00970307|3927481|P3|STARTED|Overall Study||141
1605994|NCT00970307|3927482|P2|STARTED|Overall Study||139
1605995|NCT00970307|3927483|P1|STARTED|Overall Study||141
1605996|NCT00970294|3927557|P1|NOT COMPLETED|Overall Study||5
1605997|NCT00970294|3927557|P1|COMPLETED|Overall Study||6
1605998|NCT00970294|3927557|P1|STARTED|Overall Study||11
1605999|NCT00970281|3927565|P2|NOT COMPLETED|Overall Study||16
1606000|NCT00970281|3927566|P1|NOT COMPLETED|Overall Study||2
1606001|NCT00970281|3927565|P2|COMPLETED|Overall Study||29
1606002|NCT00970281|3927566|P1|COMPLETED|Overall Study||44
1606003|NCT00970281|3927565|P2|Full Analysis Set|Overall Study||45
1606004|NCT00970281|3927566|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
1606005|NCT00970281|3927565|P2|STARTED|Overall Study||45
1606006|NCT00970281|3927566|P1|STARTED|Overall Study||46
1606007|NCT00970268|3927584|P2|NOT COMPLETED|Overall Study||49
1606008|NCT00970268|3927585|P1|NOT COMPLETED|Overall Study||43
1606009|NCT00970268|3927584|P2|COMPLETED|Overall Study||103
1606010|NCT00970268|3927585|P1|COMPLETED|Overall Study||96
1606011|NCT00970268|3927584|P2|STARTED|Overall Study||152
1606012|NCT00970268|3927585|P1|STARTED|Overall Study||139
1606013|NCT00970216|3927599|P1|NOT COMPLETED|Overall Study||80
1606014|NCT00970216|3927599|P1|COMPLETED|Overall Study||80
1606015|NCT00970216|3927599|P1|STARTED|Overall Study||160
1606016|NCT00970073|3927606|P3|NOT COMPLETED|Overall Study||0
1606017|NCT00970073|3927607|P2|NOT COMPLETED|Overall Study||0
1606018|NCT00970073|3927608|P1|NOT COMPLETED|Overall Study||0
1606019|NCT00970073|3927606|P3|COMPLETED|Overall Study||10
1606020|NCT00970073|3927607|P2|COMPLETED|Overall Study||10
1606021|NCT00970073|3927608|P1|COMPLETED|Overall Study||10
1606022|NCT00970073|3927606|P3|STARTED|Overall Study||10
1606023|NCT00970073|3927607|P2|STARTED|Overall Study||10
1606024|NCT00970073|3927608|P1|STARTED|Overall Study||10
1606025|NCT00969878|3927627|P2|NOT COMPLETED|Overall Study||26
1606026|NCT00969878|3927628|P1|NOT COMPLETED|Overall Study||30
1606027|NCT00969878|3927627|P2|COMPLETED|Overall Study||126
1606028|NCT00969878|3927628|P1|COMPLETED|Overall Study||118
1606029|NCT00969878|3927627|P2|STARTED|Overall Study||152
1606030|NCT00969878|3927628|P1|STARTED|Overall Study||148
1606031|NCT00969709|3927640|P4|NOT COMPLETED|Overall Study||63
1606032|NCT00969709|3927641|P3|NOT COMPLETED|Overall Study||58
1606033|NCT00969709|3927642|P2|NOT COMPLETED|Overall Study||48
1606034|NCT00969709|3927643|P1|NOT COMPLETED|Overall Study||38
1606035|NCT00969709|3927640|P4|COMPLETED|Overall Study||117
1606036|NCT00969709|3927641|P3|COMPLETED|Overall Study||121
1606037|NCT00969709|3927642|P2|COMPLETED|Overall Study||130
1606038|NCT00969709|3927643|P1|COMPLETED|Overall Study||138
1606039|NCT00969709|3927640|P4|STARTED|Overall Study||180
1606040|NCT00969709|3927641|P3|STARTED|Overall Study||179
1606041|NCT00969709|3927642|P2|STARTED|Overall Study||178
1606042|NCT00969709|3927643|P1|STARTED|Overall Study||176
1606043|NCT00969618|3927657|P1|NOT COMPLETED|Overall Study||78
1606044|NCT00969618|3927657|P1|COMPLETED|Overall Study||133
1606045|NCT00969618|3927657|P1|STARTED|Overall Study||211
1606046|NCT00969540|3927670|P2|NOT COMPLETED|Overall Study||1
1606047|NCT00969540|3927671|P1|NOT COMPLETED|Overall Study||1
1606048|NCT00969540|3927670|P2|COMPLETED|Overall Study||3
1606049|NCT00969540|3927671|P1|COMPLETED|Overall Study||3
1606050|NCT00969540|3927670|P2|STARTED|Overall Study||4
1606051|NCT00969540|3927671|P1|STARTED|Overall Study||4
1606052|NCT00969501|3927689|P1|NOT COMPLETED|Overall Study||5
1606053|NCT00969501|3927689|P1|COMPLETED|Overall Study||27
1606054|NCT00969501|3927689|P1|STARTED|Overall Study||32
1606055|NCT00969436|3927696|P3|NOT COMPLETED|Overall Study||11
1606056|NCT00969436|3927697|P2|NOT COMPLETED|Overall Study||21
1606057|NCT00969436|3927698|P1|NOT COMPLETED|Overall Study||25
1606058|NCT00969436|3927696|P3|COMPLETED|Overall Study||79
1606059|NCT00969436|3927697|P2|COMPLETED|Overall Study||159
1606060|NCT00969436|3927698|P1|COMPLETED|Overall Study||155
1606061|NCT00969436|3927696|P3|STARTED|Overall Study||90
1606062|NCT00969436|3927697|P2|STARTED|Overall Study||180
1606063|NCT00969436|3927698|P1|STARTED|Overall Study||180
1606064|NCT00969280|3927732|P2|NOT COMPLETED|Overall Study||3
1606065|NCT00969280|3927733|P1|NOT COMPLETED|Overall Study||2
1606066|NCT00969280|3927732|P2|COMPLETED|Overall Study||18
1606067|NCT00969280|3927733|P1|COMPLETED|Overall Study||19
1606068|NCT00969280|3927732|P2|STARTED|Overall Study||21
1606069|NCT00969280|3927733|P1|STARTED|Overall Study||21
1606070|NCT00969228|3927741|P2|NOT COMPLETED|Overall Study||14
1606071|NCT00969228|3927742|P1|NOT COMPLETED|Overall Study||43
1606072|NCT00969228|3927741|P2|COMPLETED|Overall Study||162
1606073|NCT00969228|3927742|P1|COMPLETED|Overall Study||465
1606074|NCT00969228|3927741|P2|STARTED|Overall Study||176
1606075|NCT00969228|3927742|P1|STARTED|Overall Study||508
1606076|NCT00969150|3927760|P2|NOT COMPLETED|Overall Study||40
1606077|NCT00969150|3927761|P1|NOT COMPLETED|Overall Study||33
1606078|NCT00969150|3927760|P2|COMPLETED|Overall Study||135
1606079|NCT00969150|3927761|P1|COMPLETED|Overall Study||149
1606080|NCT00969150|3927760|P2|STARTED|Overall Study||175
1606081|NCT00969150|3927761|P1|STARTED|Overall Study||182
1606082|NCT00969124|3927769|P1|NOT COMPLETED|Overall Study||30
1606083|NCT00969124|3927769|P1|COMPLETED|Overall Study||298
1606084|NCT00969124|3927769|P1|STARTED|Overall Study||328
1606085|NCT00968981|3927778|P3|NOT COMPLETED|Overall Study||22
1606086|NCT00968981|3927779|P2|NOT COMPLETED|Overall Study||22
1606087|NCT00968981|3927780|P1|NOT COMPLETED|Overall Study||22
1606088|NCT00968981|3927778|P3|COMPLETED|Overall Study||0
1606089|NCT00968981|3927779|P2|COMPLETED|Overall Study||0
1606090|NCT00968981|3927780|P1|COMPLETED|Overall Study||1
1606091|NCT00968981|3927778|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
1606092|NCT00968981|3927779|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
1606093|NCT00968981|3927780|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
1606094|NCT00968981|3927778|P3|STARTED|Overall Study||22
1606095|NCT00968981|3927779|P2|STARTED|Overall Study||22
1606096|NCT00968981|3927780|P1|STARTED|Overall Study||23
1606097|NCT00968890|3927818|P2|NOT COMPLETED|Overall Study||0
1606098|NCT00968890|3927819|P1|NOT COMPLETED|Overall Study||0
1606099|NCT00968890|3927818|P2|COMPLETED|Overall Study||84
1606100|NCT00968890|3927819|P1|COMPLETED|Overall Study||84
1606101|NCT00968890|3927818|P2|STARTED|Overall Study||84
1606102|NCT00968890|3927819|P1|STARTED|Overall Study||84
1606103|NCT00968864|3927847|P1|NOT COMPLETED|Overall Study||1
1606104|NCT00968864|3927847|P1|COMPLETED|Overall Study||52
1606105|NCT00968864|3927847|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
1606106|NCT00968838|3927865|P2|NOT COMPLETED|Overall Study||0
1606107|NCT00968838|3927866|P1|NOT COMPLETED|Overall Study||0
1606108|NCT00968838|3927865|P2|COMPLETED|Overall Study||58
1606109|NCT00968838|3927866|P1|COMPLETED|Overall Study||50
1606110|NCT00968838|3927865|P2|STARTED|Overall Study||58
1606111|NCT00968838|3927866|P1|STARTED|Overall Study||50
1606112|NCT00968812|3927875|P3|NOT COMPLETED|Overall Study||168
1606113|NCT00968812|3927876|P2|NOT COMPLETED|Overall Study||162
1606114|NCT00968812|3927877|P1|NOT COMPLETED|Overall Study||140
1606115|NCT00968812|3927875|P3|COMPLETED|Overall Study||314
1606116|NCT00968812|3927876|P2|COMPLETED|Overall Study||323
1606117|NCT00968812|3927877|P1|COMPLETED|Overall Study||343
1606118|NCT00968812|3927875|P3|STARTED|Overall Study||482
1606119|NCT00968812|3927876|P2|STARTED|Overall Study||485
1606120|NCT00968812|3927877|P1|STARTED|Overall Study||483
1606121|NCT00968799|3927897|P1|NOT COMPLETED|Overall Study||2
1606122|NCT00968799|3927897|P1|COMPLETED|Overall Study||4
1606123|NCT00968799|3927897|P1|STARTED|Overall Study||6
1606124|NCT00968708|3927907|P2|NOT COMPLETED|Overall Study||298
1606125|NCT00968708|3927908|P1|NOT COMPLETED|Overall Study||318
1606126|NCT00968708|3927907|P2|COMPLETED|Overall Study||2403
1606127|NCT00968708|3927908|P1|COMPLETED|Overall Study||2361
1606128|NCT00968708|3927907|P2|Treated|Overall Study||2698
1606129|NCT00968708|3927908|P1|Treated|Overall Study||2676
1606130|NCT00968708|3927907|P2|STARTED|Overall Study||2701
1606131|NCT00968708|3927908|P1|STARTED|Overall Study||2679
1606132|NCT00968669|3927920|P4|NOT COMPLETED|Overall Study||9
1606133|NCT00968669|3927921|P3|NOT COMPLETED|Overall Study||11
1606134|NCT00968669|3927922|P2|NOT COMPLETED|Overall Study||18
1606135|NCT00968669|3927923|P1|NOT COMPLETED|Overall Study||18
1606136|NCT00968669|3927920|P4|COMPLETED|Overall Study||72
1606137|NCT00968669|3927921|P3|COMPLETED|Overall Study||72
1606138|NCT00968669|3927922|P2|COMPLETED|Overall Study||63
1606139|NCT00968669|3927923|P1|COMPLETED|Overall Study||64
1606140|NCT00968669|3927920|P4|STARTED|Overall Study||81
1606141|NCT00968669|3927921|P3|STARTED|Overall Study||83
1606142|NCT00968669|3927922|P2|STARTED|Overall Study||81
1606143|NCT00968669|3927923|P1|STARTED|Overall Study||82
1606144|NCT00968617|3928013|P1|NOT COMPLETED|Overall Study||6
1606145|NCT00968617|3928013|P1|COMPLETED|Overall Study||1
1606146|NCT00968617|3928013|P1|STARTED|Overall Study||7
1606147|NCT00968539|3928027|P2|NOT COMPLETED|Overall Study||0
1606148|NCT00968539|3928028|P1|NOT COMPLETED|Overall Study||1
1606149|NCT00968539|3928027|P2|COMPLETED|Overall Study||66
1606150|NCT00968539|3928028|P1|COMPLETED|Overall Study||63
1606151|NCT00968539|3928027|P2|STARTED|Overall Study||66
1606152|NCT00968539|3928028|P1|STARTED|Overall Study||64
1606153|NCT00968526|3928088|P2|NOT COMPLETED|Overall Study||0
1606154|NCT00968526|3928089|P1|NOT COMPLETED|Overall Study||3
1606155|NCT00968526|3928088|P2|COMPLETED|Overall Study||102
1606156|NCT00968526|3928089|P1|COMPLETED|Overall Study||135
1606157|NCT00968526|3928088|P2|STARTED|Overall Study||102
1606158|NCT00968526|3928089|P1|STARTED|Overall Study||138
1606159|NCT00968253|3928182|P3|NOT COMPLETED|Overall Study||7
1606160|NCT00968253|3928183|P2|NOT COMPLETED|Overall Study||3
1606161|NCT00968253|3928184|P1|NOT COMPLETED|Overall Study||0
1606162|NCT00968253|3928182|P3|COMPLETED|Overall Study||5
1606163|NCT00968253|3928183|P2|COMPLETED|Overall Study||6
1606164|NCT00968253|3928184|P1|COMPLETED|Overall Study||3
1606165|NCT00968253|3928182|P3|STARTED|Overall Study||12
1606166|NCT00968253|3928183|P2|STARTED|Overall Study||9
1606167|NCT00968253|3928184|P1|STARTED|Overall Study||3
1606168|NCT00968227|3928198|P1|NOT COMPLETED|Overall Study||0
1606169|NCT00968227|3928198|P1|COMPLETED|Overall Study||56
1606170|NCT00968227|3928198|P1|STARTED|Overall Study||56
1606171|NCT00968201|3928205|P3|NOT COMPLETED|Extension Study - (Period III)||280
1606172|NCT00968201|3928206|P2|NOT COMPLETED|Extension Study - (Period III)||124
1606173|NCT00968201|3928207|P1|NOT COMPLETED|Extension Study - (Period III)||0
1606174|NCT00968201|3928205|P3|COMPLETED|Extension Study - (Period III)||84
1606175|NCT00968201|3928206|P2|COMPLETED|Extension Study - (Period III)||33
1606176|NCT00968201|3928207|P1|COMPLETED|Extension Study - (Period III)||0
1606177|NCT00968201|3928205|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
1606178|NCT00968201|3928206|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
1606179|NCT00968201|3928207|P1|STARTED|Extension Study - (Period III)||0
1606180|NCT00968201|3928205|P3|NOT COMPLETED|Base Study - (Period II)||45
1606181|NCT00968201|3928206|P2|NOT COMPLETED|Base Study - (Period II)||0
1606182|NCT00968201|3928207|P1|NOT COMPLETED|Base Study - (Period II)||26
1606183|NCT00968201|3928205|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
1606184|NCT00968201|3928206|P2|COMPLETED|Base Study - (Period II)||0
1606185|NCT00968201|3928207|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
1606186|NCT00968201|3928205|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
1606187|NCT00968201|3928206|P2|STARTED|Base Study - (Period II)||0
1606188|NCT00968201|3928207|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
1606189|NCT00968149|3928268|P2|NOT COMPLETED|Overall Study||6
1606190|NCT00968149|3928269|P1|NOT COMPLETED|Overall Study||11
1606191|NCT00968149|3928268|P2|COMPLETED|Overall Study||127
1606192|NCT00968149|3928269|P1|COMPLETED|Overall Study||269
1606193|NCT00968149|3928268|P2|STARTED|Overall Study||133
1606194|NCT00968149|3928269|P1|STARTED|Overall Study||280
1606195|NCT00968071|3928289|P1|NOT COMPLETED|Overall Study||0
1606196|NCT00968071|3928289|P1|COMPLETED|Overall Study||71
1606197|NCT00968071|3928289|P1|STARTED|Overall Study||71
1606198|NCT00968032|3928293|P1|NOT COMPLETED|Overall Study||2
1606199|NCT00968032|3928293|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
1606200|NCT00968032|3928293|P1|STARTED|Overall Study||63
1606201|NCT00968019|3928297|P1|NOT COMPLETED|Overall Study||15
1606202|NCT00968019|3928297|P1|COMPLETED|Overall Study||303
1606203|NCT00968019|3928297|P1|STARTED|Overall Study||318
1606204|NCT00967993|3928318|P1|NOT COMPLETED|Overall Study||4
1606205|NCT00967993|3928318|P1|COMPLETED|Overall Study||18
1606206|NCT00967993|3928318|P1|STARTED|Overall Study||22
1606207|NCT00967798|3928324|P2|NOT COMPLETED|Overall Study||3
1606208|NCT00967798|3928325|P1|NOT COMPLETED|Overall Study||9
1606209|NCT00967798|3928324|P2|COMPLETED|Overall Study||13
1606210|NCT00967798|3928325|P1|COMPLETED|Overall Study||8
1606211|NCT00967798|3928324|P2|STARTED|Overall Study||16
1606212|NCT00967798|3928325|P1|STARTED|Overall Study||17
1606213|NCT00967694|3928339|P1|NOT COMPLETED|Overall Study||6
1606214|NCT00967694|3928339|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
1606215|NCT00967694|3928339|P1|STARTED|Overall Study||26
1606216|NCT00967668|3928346|P3|NOT COMPLETED|Overall Study||69
1606217|NCT00967668|3928347|P2|NOT COMPLETED|Overall Study||56
1606218|NCT00967668|3928348|P1|NOT COMPLETED|Overall Study||71
1606219|NCT00967668|3928346|P3|COMPLETED|Overall Study||90
1606220|NCT00967668|3928347|P2|COMPLETED|Overall Study||104
1606221|NCT00967668|3928348|P1|COMPLETED|Overall Study||91
1606222|NCT00967668|3928346|P3|18-mo Assessment|Overall Study||92
1606223|NCT00967668|3928347|P2|18-mo Assessment|Overall Study||102
1606224|NCT00967668|3928348|P1|18-mo Assessment|Overall Study||95
1606225|NCT00967668|3928346|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
1606226|NCT00967668|3928347|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
1606227|NCT00967668|3928348|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
1606228|NCT00967668|3928346|P3|3-mo Assessment|Overall Study||115
1606229|NCT00967668|3928347|P2|3-mo Assessment|Overall Study||127
1606230|NCT00967668|3928348|P1|3-mo Assessment|Overall Study||131
1606231|NCT00967668|3928346|P3|STARTED|Overall Study||159
1606232|NCT00967668|3928347|P2|STARTED|Overall Study||160
1606233|NCT00967668|3928348|P1|STARTED|Overall Study||162
1606234|NCT00967551|3928361|P2|NOT COMPLETED|Overall Study||0
1606235|NCT00967551|3928362|P1|NOT COMPLETED|Overall Study||0
1606236|NCT00967551|3928361|P2|COMPLETED|Overall Study||75
1606237|NCT00967551|3928362|P1|COMPLETED|Overall Study||68
1606238|NCT00967551|3928361|P2|STARTED|Overall Study||75
1606239|NCT00967551|3928362|P1|STARTED|Overall Study||68
1606240|NCT00967486|3928372|P2|NOT COMPLETED|Overall Study||0
1606241|NCT00967486|3928373|P1|NOT COMPLETED|Overall Study||0
1606242|NCT00967486|3928372|P2|COMPLETED|Overall Study||102
1606243|NCT00967486|3928373|P1|COMPLETED|Overall Study||98
1606244|NCT00967486|3928372|P2|STARTED|Overall Study||102
1606245|NCT00967486|3928373|P1|STARTED|Overall Study||98
1606246|NCT00967473|3928379|P1|NOT COMPLETED|Overall Study||0
1606247|NCT00967473|3928379|P1|COMPLETED|Overall Study||15
1606248|NCT00967473|3928379|P1|STARTED|Overall Study||15
1606249|NCT00967447|3928385|P1|NOT COMPLETED|Overall Study||0
1606250|NCT00967447|3928385|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
1606251|NCT00967447|3928385|P1|STARTED|Overall Study|there are no collected data in CRF|2
1606252|NCT00967330|3928394|P2|NOT COMPLETED|Overall Study||60
1606253|NCT00967330|3928395|P1|NOT COMPLETED|Overall Study||122
1606254|NCT00967330|3928394|P2|COMPLETED|Overall Study||0
1606255|NCT00967330|3928395|P1|COMPLETED|Overall Study||0
1606256|NCT00967330|3928394|P2|STARTED|Overall Study||60
1606257|NCT00967330|3928395|P1|STARTED|Overall Study||122
1606258|NCT00967226|3928425|P2|NOT COMPLETED|Overall Study||6
1606259|NCT00967226|3928426|P1|NOT COMPLETED|Overall Study||2
1606260|NCT00967226|3928425|P2|COMPLETED|Overall Study||2
1606261|NCT00967226|3928426|P1|COMPLETED|Overall Study||9
1606262|NCT00967226|3928425|P2|STARTED|Overall Study||8
1606263|NCT00967226|3928426|P1|STARTED|Overall Study||11
1606264|NCT00967044|3928456|P1|NOT COMPLETED|Overall Study||0
1606265|NCT00967044|3928456|P1|COMPLETED|Overall Study||30
1606266|NCT00967044|3928456|P1|STARTED|Overall Study||30
1606267|NCT00967018|3928460|P1|NOT COMPLETED|Overall Study||21
1606268|NCT00967018|3928460|P1|COMPLETED|Overall Study||56
1606269|NCT00967018|3928460|P1|STARTED|Overall Study||77
1606270|NCT00967005|3928469|P2|NOT COMPLETED|Overall Study||10
1606271|NCT00967005|3928470|P1|NOT COMPLETED|Overall Study||7
1606272|NCT00967005|3928469|P2|COMPLETED|Overall Study||5
1606273|NCT00967005|3928470|P1|COMPLETED|Overall Study||6
1606274|NCT00967005|3928469|P2|Treatment Completion|Overall Study||10
1606275|NCT00967005|3928470|P1|Treatment Completion|Overall Study||10
1606276|NCT00967005|3928469|P2|STARTED|Overall Study||15
1606277|NCT00967005|3928470|P1|STARTED|Overall Study||13
1606278|NCT00966992|3928524|P2|NOT COMPLETED|Overall Study||0
1606279|NCT00966992|3928525|P1|NOT COMPLETED|Overall Study||0
1606280|NCT00966992|3928524|P2|COMPLETED|Overall Study||0
1606281|NCT00966992|3928525|P1|COMPLETED|Overall Study||3
1606282|NCT00966992|3928524|P2|STARTED|Overall Study||0
1606283|NCT00966992|3928525|P1|STARTED|Overall Study||3
1606284|NCT00966953|3928545|P4|NOT COMPLETED|4th Intervention Order||0
1606285|NCT00966953|3928546|P3|NOT COMPLETED|4th Intervention Order||0
1606286|NCT00966953|3928547|P2|NOT COMPLETED|4th Intervention Order||0
1606287|NCT00966953|3928548|P1|NOT COMPLETED|4th Intervention Order||0
1606288|NCT00966953|3928545|P4|COMPLETED|4th Intervention Order||7
1606289|NCT00966953|3928546|P3|COMPLETED|4th Intervention Order||6
1606290|NCT00966953|3928547|P2|COMPLETED|4th Intervention Order||6
1606291|NCT00966953|3928548|P1|COMPLETED|4th Intervention Order||6
1606292|NCT00966953|3928545|P4|STARTED|4th Intervention Order||7
1606293|NCT00966953|3928546|P3|STARTED|4th Intervention Order||6
1606294|NCT00966953|3928547|P2|STARTED|4th Intervention Order||6
1606295|NCT00966953|3928548|P1|STARTED|4th Intervention Order||6
1606296|NCT00966953|3928545|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1606297|NCT00966953|3928546|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1606298|NCT00966953|3928547|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1606299|NCT00966953|3928548|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1606300|NCT00966953|3928545|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
1606301|NCT00966953|3928546|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
1606302|NCT00966953|3928547|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
1606303|NCT00966953|3928548|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
1606304|NCT00966953|3928545|P4|STARTED|1 Week Washout After 3rd Intervention||7
1606305|NCT00966953|3928546|P3|STARTED|1 Week Washout After 3rd Intervention||6
1606306|NCT00966953|3928547|P2|STARTED|1 Week Washout After 3rd Intervention||6
1606307|NCT00966953|3928548|P1|STARTED|1 Week Washout After 3rd Intervention||6
1606308|NCT00966953|3928545|P4|NOT COMPLETED|3rd Intervention Order||0
1606309|NCT00966953|3928546|P3|NOT COMPLETED|3rd Intervention Order||0
1606310|NCT00966953|3928547|P2|NOT COMPLETED|3rd Intervention Order||0
1606311|NCT00966953|3928548|P1|NOT COMPLETED|3rd Intervention Order||0
1606312|NCT00966953|3928545|P4|COMPLETED|3rd Intervention Order||7
1606313|NCT00966953|3928546|P3|COMPLETED|3rd Intervention Order||6
1606314|NCT00966953|3928547|P2|COMPLETED|3rd Intervention Order||6
1606315|NCT00966953|3928548|P1|COMPLETED|3rd Intervention Order||6
1606316|NCT00966953|3928545|P4|STARTED|3rd Intervention Order||7
1606317|NCT00966953|3928546|P3|STARTED|3rd Intervention Order||6
1606318|NCT00966953|3928547|P2|STARTED|3rd Intervention Order||6
1606319|NCT00966953|3928548|P1|STARTED|3rd Intervention Order||6
1606320|NCT00966953|3928545|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1606321|NCT00966953|3928546|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1606322|NCT00966953|3928547|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1606323|NCT00966953|3928548|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1606324|NCT00966953|3928545|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
1606325|NCT00966953|3928546|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
1606326|NCT00966953|3928547|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
1606327|NCT00966953|3928548|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
1606328|NCT00966953|3928545|P4|STARTED|1 Week Washout After 2nd Intervention||7
1606329|NCT00966953|3928546|P3|STARTED|1 Week Washout After 2nd Intervention||6
1606330|NCT00966953|3928547|P2|STARTED|1 Week Washout After 2nd Intervention||6
1606331|NCT00966953|3928548|P1|STARTED|1 Week Washout After 2nd Intervention||6
1606332|NCT00966953|3928545|P4|NOT COMPLETED|2nd Intervention||0
1606333|NCT00966953|3928546|P3|NOT COMPLETED|2nd Intervention||0
1606334|NCT00966953|3928547|P2|NOT COMPLETED|2nd Intervention||0
1606335|NCT00966953|3928548|P1|NOT COMPLETED|2nd Intervention||0
1606336|NCT00966953|3928545|P4|COMPLETED|2nd Intervention||7
1606337|NCT00966953|3928546|P3|COMPLETED|2nd Intervention||6
1606338|NCT00966953|3928547|P2|COMPLETED|2nd Intervention||6
1606339|NCT00966953|3928548|P1|COMPLETED|2nd Intervention||6
1606340|NCT00966953|3928545|P4|STARTED|2nd Intervention||7
1606341|NCT00966953|3928546|P3|STARTED|2nd Intervention||6
1606342|NCT00966953|3928547|P2|STARTED|2nd Intervention||6
1606343|NCT00966953|3928548|P1|STARTED|2nd Intervention||6
1606344|NCT00966953|3928545|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1606345|NCT00966953|3928546|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1606346|NCT00966953|3928547|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1606347|NCT00966953|3928548|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1606348|NCT00966953|3928545|P4|COMPLETED|1 Week Washout After 1st Intervention||7
1606349|NCT00966953|3928546|P3|COMPLETED|1 Week Washout After 1st Intervention||6
1606350|NCT00966953|3928547|P2|COMPLETED|1 Week Washout After 1st Intervention||6
1606351|NCT00966953|3928548|P1|COMPLETED|1 Week Washout After 1st Intervention||6
1606352|NCT00966953|3928545|P4|STARTED|1 Week Washout After 1st Intervention||7
1606353|NCT00966953|3928546|P3|STARTED|1 Week Washout After 1st Intervention||6
1606354|NCT00966953|3928547|P2|STARTED|1 Week Washout After 1st Intervention||6
1606355|NCT00966953|3928548|P1|STARTED|1 Week Washout After 1st Intervention||6
1606356|NCT00966953|3928545|P4|NOT COMPLETED|1st Intervention||0
1606357|NCT00966953|3928546|P3|NOT COMPLETED|1st Intervention||0
1606358|NCT00966953|3928547|P2|NOT COMPLETED|1st Intervention||0
1606359|NCT00966953|3928548|P1|NOT COMPLETED|1st Intervention||0
1606360|NCT00966953|3928545|P4|COMPLETED|1st Intervention||7
1606361|NCT00966953|3928546|P3|COMPLETED|1st Intervention||6
1606362|NCT00966953|3928547|P2|COMPLETED|1st Intervention||6
1606363|NCT00966953|3928548|P1|COMPLETED|1st Intervention||6
1606364|NCT00966953|3928545|P4|STARTED|1st Intervention||7
1606365|NCT00966953|3928546|P3|STARTED|1st Intervention||6
1606366|NCT00966953|3928547|P2|STARTED|1st Intervention||6
1606367|NCT00966953|3928548|P1|STARTED|1st Intervention||6
1606368|NCT00966940|3928556|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
1606369|NCT00966940|3928557|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
1606370|NCT00966940|3928556|P2|COMPLETED|Period 2, Second 6 Weeks||23
1606371|NCT00966940|3928557|P1|COMPLETED|Period 2, Second 6 Weeks||25
1606372|NCT00966940|3928556|P2|STARTED|Period 2, Second 6 Weeks||23
1606373|NCT00966940|3928557|P1|STARTED|Period 2, Second 6 Weeks||25
1606374|NCT00966940|3928556|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
1606375|NCT00966940|3928557|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
1606376|NCT00966940|3928556|P2|COMPLETED|Period 1, First 6 Weeks||23
1606377|NCT00966940|3928557|P1|COMPLETED|Period 1, First 6 Weeks||25
1606378|NCT00966940|3928556|P2|STARTED|Period 1, First 6 Weeks||23
1606379|NCT00966940|3928557|P1|STARTED|Period 1, First 6 Weeks||28
1606380|NCT00966875|3928584|P9|NOT COMPLETED|Part B||18
1606381|NCT00966875|3928585|P8|NOT COMPLETED|Part B||19
1606382|NCT00966875|3928586|P7|NOT COMPLETED|Part B||22
1606383|NCT00966875|3928587|P6|NOT COMPLETED|Part B||6
1606384|NCT00966875|3928588|P5|NOT COMPLETED|Part B||7
1606385|NCT00966875|3928589|P4|NOT COMPLETED|Part B||3
1606386|NCT00966875|3928590|P3|NOT COMPLETED|Part B||6
1606387|NCT00966875|3928591|P2|NOT COMPLETED|Part B||3
1606388|NCT00966875|3928592|P1|NOT COMPLETED|Part B||5
1606389|NCT00966875|3928584|P9|COMPLETED|Part B||32
1606390|NCT00966875|3928585|P8|COMPLETED|Part B||38
1606391|NCT00966875|3928586|P7|COMPLETED|Part B||29
1606392|NCT00966875|3928587|P6|COMPLETED|Part B||26
1606393|NCT00966875|3928588|P5|COMPLETED|Part B||44
1606394|NCT00966875|3928589|P4|COMPLETED|Part B||31
1606395|NCT00966875|3928590|P3|COMPLETED|Part B||27
1606396|NCT00966875|3928591|P2|COMPLETED|Part B||33
1606397|NCT00966875|3928592|P1|COMPLETED|Part B||41
1606398|NCT00966875|3928584|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
1606399|NCT00966875|3928585|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
1606400|NCT00966875|3928586|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
1606401|NCT00966875|3928587|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
1606402|NCT00966875|3928588|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
1606403|NCT00966875|3928589|P4|STARTED|Part B||34
1606404|NCT00966875|3928590|P3|STARTED|Part B||33
1606405|NCT00966875|3928591|P2|STARTED|Part B||36
1606406|NCT00966875|3928592|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
1606407|NCT00966875|3928584|P9|NOT COMPLETED|Part A||8
1606408|NCT00966875|3928585|P8|NOT COMPLETED|Part A||7
1606409|NCT00966875|3928586|P7|NOT COMPLETED|Part A||12
1606410|NCT00966875|3928587|P6|NOT COMPLETED|Part A||4
1606411|NCT00966875|3928588|P5|NOT COMPLETED|Part A||5
1606412|NCT00966875|3928589|P4|NOT COMPLETED|Part A||3
1606413|NCT00966875|3928590|P3|NOT COMPLETED|Part A||2
1606414|NCT00966875|3928591|P2|NOT COMPLETED|Part A||4
1606415|NCT00966875|3928592|P1|NOT COMPLETED|Part A||6
1606416|NCT00966875|3928584|P9|COMPLETED|Part A||51
1606417|NCT00966875|3928585|P8|COMPLETED|Part A||58
1606418|NCT00966875|3928586|P7|COMPLETED|Part A||52
1606419|NCT00966875|3928587|P6|COMPLETED|Part A||33
1606420|NCT00966875|3928588|P5|COMPLETED|Part A||52
1606421|NCT00966875|3928589|P4|COMPLETED|Part A||34
1606422|NCT00966875|3928590|P3|COMPLETED|Part A||33
1606423|NCT00966875|3928591|P2|COMPLETED|Part A||36
1606424|NCT00966875|3928592|P1|COMPLETED|Part A||48
1606425|NCT00966875|3928584|P9|Received ≥1 Doses of Study Drug|Part A||59
1606426|NCT00966875|3928585|P8|Received ≥1 Doses of Study Drug|Part A||65
1606427|NCT00966875|3928586|P7|Received ≥1 Doses of Study Drug|Part A||64
1606428|NCT00966875|3928587|P6|Received ≥1 Doses of Study Drug|Part A||37
1606429|NCT00966875|3928588|P5|Received ≥1 Doses of Study Drug|Part A||57
1606430|NCT00966875|3928589|P4|Received ≥1 Doses of Study Drug|Part A||37
1606431|NCT00966875|3928590|P3|Received ≥1 Doses of Study Drug|Part A||35
1606432|NCT00966875|3928591|P2|Received ≥1 Doses of Study Drug|Part A||40
1606433|NCT00966875|3928592|P1|Received ≥1 Doses of Study Drug|Part A||54
1606434|NCT00966875|3928584|P9|STARTED|Part A||59
1606435|NCT00966875|3928585|P8|STARTED|Part A||65
1606436|NCT00966875|3928586|P7|STARTED|Part A||64
1606437|NCT00966875|3928587|P6|STARTED|Part A||37
1606438|NCT00966875|3928588|P5|STARTED|Part A||57
1606439|NCT00966875|3928589|P4|STARTED|Part A||37
1606440|NCT00966875|3928590|P3|STARTED|Part A||35
1606441|NCT00966875|3928591|P2|STARTED|Part A||40
1606442|NCT00966875|3928592|P1|STARTED|Part A||54
1606443|NCT00966823|3928911|P1|NOT COMPLETED|Overall Study||1
1606444|NCT00966823|3928911|P1|COMPLETED|Overall Study||2
1606445|NCT00966823|3928911|P1|STARTED|Overall Study||3
1606446|NCT00966654|3928919|P1|NOT COMPLETED|Overall Study||12
1606447|NCT00966654|3928919|P1|COMPLETED|Overall Study||0
1606448|NCT00966654|3928919|P1|STARTED|Overall Study||12
1606449|NCT00966641|3928927|P2|NOT COMPLETED|Second Intervention||0
1606450|NCT00966641|3928928|P1|NOT COMPLETED|Second Intervention||0
1606451|NCT00966641|3928927|P2|COMPLETED|Second Intervention||17
1606452|NCT00966641|3928928|P1|COMPLETED|Second Intervention||17
1606453|NCT00966641|3928927|P2|STARTED|Second Intervention||17
1606454|NCT00966641|3928928|P1|STARTED|Second Intervention||17
1606455|NCT00966641|3928927|P2|NOT COMPLETED|First Intervention||0
1606456|NCT00966641|3928928|P1|NOT COMPLETED|First Intervention||0
1606457|NCT00966641|3928927|P2|COMPLETED|First Intervention||17
1606458|NCT00966641|3928928|P1|COMPLETED|First Intervention||17
1606459|NCT00966641|3928927|P2|STARTED|First Intervention||17
1606460|NCT00966641|3928928|P1|STARTED|First Intervention||17
1606461|NCT00966550|3928936|P2|NOT COMPLETED|Overall Study||0
1606462|NCT00966550|3928937|P1|NOT COMPLETED|Overall Study||0
1606463|NCT00966550|3928936|P2|COMPLETED|Overall Study||12
1606464|NCT00966550|3928937|P1|COMPLETED|Overall Study||13
1606465|NCT00966550|3928936|P2|STARTED|Overall Study||12
1606466|NCT00966550|3928937|P1|STARTED|Overall Study||13
1606467|NCT00966446|3928946|P3|NOT COMPLETED|Overall Study||21
1606468|NCT00966446|3928947|P2|NOT COMPLETED|Overall Study||25
1606469|NCT00966446|3928948|P1|NOT COMPLETED|Overall Study||28
1606470|NCT00966446|3928946|P3|COMPLETED|Overall Study||52
1606471|NCT00966446|3928947|P2|COMPLETED|Overall Study||49
1606472|NCT00966446|3928948|P1|COMPLETED|Overall Study||48
1606473|NCT00966446|3928946|P3|STARTED|Overall Study||73
1606474|NCT00966446|3928947|P2|STARTED|Overall Study||74
1606475|NCT00966446|3928948|P1|STARTED|Overall Study||76
1606476|NCT00966433|3928965|P3|NOT COMPLETED|Overall Study||0
1606477|NCT00966433|3928966|P2|NOT COMPLETED|Overall Study||1
1606478|NCT00966433|3928967|P1|NOT COMPLETED|Overall Study||1
1606479|NCT00966433|3928965|P3|COMPLETED|Overall Study||11
1606480|NCT00966433|3928966|P2|COMPLETED|Overall Study||10
1606481|NCT00966433|3928967|P1|COMPLETED|Overall Study||10
1606482|NCT00966433|3928965|P3|STARTED|Overall Study||11
1606483|NCT00966433|3928966|P2|STARTED|Overall Study||11
1606484|NCT00966433|3928967|P1|STARTED|Overall Study||11
1606485|NCT00966355|3928993|P3|NOT COMPLETED|Overall Study||84
1606486|NCT00966355|3928994|P2|NOT COMPLETED|Overall Study||86
1606487|NCT00966355|3928995|P1|NOT COMPLETED|Overall Study||84
1606488|NCT00966355|3928993|P3|COMPLETED|Overall Study||261
1606489|NCT00966355|3928994|P2|COMPLETED|Overall Study||259
1606490|NCT00966355|3928995|P1|COMPLETED|Overall Study||260
1606491|NCT00966355|3928993|P3|STARTED|Overall Study||345
1606492|NCT00966355|3928994|P2|STARTED|Overall Study||345
1606493|NCT00966355|3928995|P1|STARTED|Overall Study||344
1606494|NCT00966277|3929008|P2|NOT COMPLETED|Overall Study||4
1606495|NCT00966277|3929009|P1|NOT COMPLETED|Overall Study||4
1606496|NCT00966277|3929008|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
1606497|NCT00966277|3929009|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
1606498|NCT00966277|3929008|P2|STARTED|Overall Study||37
1606499|NCT00966277|3929009|P1|STARTED|Overall Study||38
1606500|NCT00966264|3929017|P2|NOT COMPLETED|Overall Study||3
1606501|NCT00966264|3929018|P1|NOT COMPLETED|Overall Study||4
1606502|NCT00966264|3929017|P2|COMPLETED|Overall Study|5 years results|114
1606503|NCT00966264|3929018|P1|COMPLETED|Overall Study|5 years results|115
1606504|NCT00966264|3929017|P2|STARTED|Overall Study||117
1606505|NCT00966264|3929018|P1|STARTED|Overall Study||119
1606506|NCT00966238|3929030|P6|NOT COMPLETED|Overall Study||0
1606507|NCT00966238|3929031|P5|NOT COMPLETED|Overall Study||0
1606508|NCT00966238|3929032|P4|NOT COMPLETED|Overall Study||0
1606509|NCT00966238|3929033|P3|NOT COMPLETED|Overall Study||0
1606510|NCT00966238|3929034|P2|NOT COMPLETED|Overall Study||0
1606511|NCT00966238|3929035|P1|NOT COMPLETED|Overall Study||0
1606512|NCT00966238|3929030|P6|COMPLETED|Overall Study||20
1606513|NCT00966238|3929031|P5|COMPLETED|Overall Study||20
1606514|NCT00966238|3929032|P4|COMPLETED|Overall Study||20
1606515|NCT00966238|3929033|P3|COMPLETED|Overall Study||20
1606516|NCT00966238|3929034|P2|COMPLETED|Overall Study||20
1606517|NCT00966238|3929035|P1|COMPLETED|Overall Study||20
1606518|NCT00966238|3929030|P6|STARTED|Overall Study||20
1606519|NCT00966238|3929031|P5|STARTED|Overall Study||20
1606520|NCT00966238|3929032|P4|STARTED|Overall Study||20
1606521|NCT00966238|3929033|P3|STARTED|Overall Study||20
1606522|NCT00966238|3929034|P2|STARTED|Overall Study||20
1606523|NCT00966238|3929035|P1|STARTED|Overall Study||20
1606524|NCT00966186|3929057|P2|NOT COMPLETED|Overall Study||0
1606525|NCT00966186|3929058|P1|NOT COMPLETED|Overall Study||0
1606526|NCT00966186|3929057|P2|COMPLETED|Overall Study||60
1606527|NCT00966186|3929058|P1|COMPLETED|Overall Study||60
1606528|NCT00966186|3929057|P2|STARTED|Overall Study||60
1606529|NCT00966186|3929058|P1|STARTED|Overall Study||60
1606530|NCT00965848|3929064|P3|NOT COMPLETED|Overall Study||10
1606531|NCT00965848|3929065|P2|NOT COMPLETED|Overall Study||2
1606532|NCT00965848|3929066|P1|NOT COMPLETED|Overall Study||29
1606533|NCT00965848|3929064|P3|COMPLETED|Overall Study||117
1606534|NCT00965848|3929065|P2|COMPLETED|Overall Study||32
1606535|NCT00965848|3929066|P1|COMPLETED|Overall Study||78
1606536|NCT00965848|3929064|P3|STARTED|Overall Study||127
1606537|NCT00965848|3929065|P2|STARTED|Overall Study||34
1606538|NCT00965848|3929066|P1|STARTED|Overall Study||107
1606539|NCT00965757|3929085|P4|NOT COMPLETED|Extension Phase||24
1606540|NCT00965757|3929086|P3|NOT COMPLETED|Extension Phase||33
1606541|NCT00965757|3929087|P2|NOT COMPLETED|Extension Phase||0
1606542|NCT00965757|3929088|P1|NOT COMPLETED|Extension Phase||0
1606543|NCT00965757|3929085|P4|COMPLETED|Extension Phase||64
1606544|NCT00965757|3929086|P3|COMPLETED|Extension Phase||132
1606545|NCT00965757|3929087|P2|COMPLETED|Extension Phase||0
1606546|NCT00965757|3929088|P1|COMPLETED|Extension Phase||0
1606547|NCT00965757|3929085|P4|STARTED|Extension Phase||88
1606548|NCT00965757|3929086|P3|STARTED|Extension Phase||165
1606549|NCT00965757|3929087|P2|STARTED|Extension Phase||0
1606550|NCT00965757|3929088|P1|STARTED|Extension Phase||0
1606551|NCT00965757|3929085|P4|NOT COMPLETED|Double-blind Phase||0
1606552|NCT00965757|3929086|P3|NOT COMPLETED|Double-blind Phase||0
1606553|NCT00965757|3929087|P2|NOT COMPLETED|Double-blind Phase||18
1606554|NCT00965757|3929088|P1|NOT COMPLETED|Double-blind Phase||17
1606555|NCT00965757|3929085|P4|COMPLETED|Double-blind Phase||0
1606556|NCT00965757|3929086|P3|COMPLETED|Double-blind Phase||0
1606557|NCT00965757|3929087|P2|COMPLETED|Double-blind Phase||70
1606558|NCT00965757|3929088|P1|COMPLETED|Double-blind Phase||148
1606559|NCT00965757|3929085|P4|STARTED|Double-blind Phase||0
1606560|NCT00965757|3929086|P3|STARTED|Double-blind Phase||0
1606561|NCT00965757|3929087|P2|STARTED|Double-blind Phase||88
1606562|NCT00965757|3929088|P1|STARTED|Double-blind Phase||165
1606563|NCT00965731|3929122|P2|NOT COMPLETED|Overall Study||20
1606564|NCT00965731|3929123|P1|NOT COMPLETED|Overall Study||7
1606565|NCT00965731|3929122|P2|COMPLETED|Overall Study||0
1606566|NCT00965731|3929123|P1|COMPLETED|Overall Study||0
1606567|NCT00965731|3929122|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
1606568|NCT00965731|3929123|P1|STARTED|Overall Study||7
1606569|NCT00965718|3929187|P1|NOT COMPLETED|Overall Study||4
1606570|NCT00965718|3929187|P1|COMPLETED|Overall Study||16
1606571|NCT00965718|3929187|P1|STARTED|Overall Study||20
1606572|NCT00965562|3929200|P3|NOT COMPLETED|Overall Study||3
1606573|NCT00965562|3929201|P2|NOT COMPLETED|Overall Study||4
1606574|NCT00965562|3929202|P1|NOT COMPLETED|Overall Study||3
1606575|NCT00965562|3929200|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
1606576|NCT00965562|3929201|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
1606577|NCT00965562|3929202|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
1606578|NCT00965562|3929200|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
1606579|NCT00965562|3929201|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
1606580|NCT00965562|3929202|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
1606581|NCT00965562|3929200|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
1606582|NCT00965562|3929201|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
1606583|NCT00965562|3929202|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
1606584|NCT00965562|3929200|P3|STARTED|Overall Study||16
1606585|NCT00965562|3929201|P2|STARTED|Overall Study||17
1606586|NCT00965562|3929202|P1|STARTED|Overall Study||16
1606587|NCT00965523|3929240|P1|NOT COMPLETED|Study 224||6
1606588|NCT00965523|3929240|P1|COMPLETED|Study 224||0
1606589|NCT00965523|3929240|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
1606590|NCT00965523|3929240|P1|NOT COMPLETED|Study 221||7
1606591|NCT00965523|3929240|P1|COMPLETED|Study 221||74
1606592|NCT00965523|3929240|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
1606593|NCT00965497|3929245|P1|NOT COMPLETED|Overall Study||1
1606594|NCT00965497|3929245|P1|COMPLETED|Overall Study||13
1606595|NCT00965497|3929245|P1|STARTED|Overall Study||14
1606596|NCT00965484|3929250|P1|NOT COMPLETED|Overall Study||2
1606597|NCT00965484|3929250|P1|COMPLETED|Overall Study||134
1606598|NCT00965484|3929250|P1|STARTED|Overall Study||136
1606599|NCT00965458|3929259|P2|NOT COMPLETED|Overall Study||4
1606600|NCT00965458|3929260|P1|NOT COMPLETED|Overall Study||2
1606601|NCT00965458|3929259|P2|COMPLETED|Overall Study||12
1606602|NCT00965458|3929260|P1|COMPLETED|Overall Study||31
1606603|NCT00965458|3929259|P2|STARTED|Overall Study||16
1606604|NCT00965458|3929260|P1|STARTED|Overall Study||33
1606605|NCT00965419|3929276|P1|NOT COMPLETED|Follow-up Phase||62
1606606|NCT00965419|3929276|P1|COMPLETED|Follow-up Phase||18
1606607|NCT00965419|3929276|P1|STARTED|Follow-up Phase||80
1606608|NCT00965419|3929276|P1|NOT COMPLETED|Open Label Treatment for Responders||247
1606609|NCT00965419|3929276|P1|COMPLETED|Open Label Treatment for Responders||20
1606610|NCT00965419|3929276|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
1606611|NCT00965419|3929276|P1|STARTED|Open Label Treatment for Responders||267
1606612|NCT00965341|3929322|P2|NOT COMPLETED|Overall Study||8
1606613|NCT00965341|3929323|P1|NOT COMPLETED|Overall Study||6
1606614|NCT00965341|3929322|P2|COMPLETED|Overall Study||16
1606615|NCT00965341|3929323|P1|COMPLETED|Overall Study||13
1606616|NCT00965341|3929322|P2|STARTED|Overall Study||24
1606617|NCT00965341|3929323|P1|STARTED|Overall Study||19
1606618|NCT00965263|3929333|P2|NOT COMPLETED|Overall Study||3
1606619|NCT00965263|3929334|P1|NOT COMPLETED|Overall Study||2
1606620|NCT00965263|3929333|P2|COMPLETED|Overall Study||6
1606621|NCT00965263|3929334|P1|COMPLETED|Overall Study||4
1606622|NCT00965263|3929333|P2|STARTED|Overall Study||9
1606623|NCT00965263|3929334|P1|STARTED|Overall Study||6
1606624|NCT00965250|3929366|P2|NOT COMPLETED|Overall Study||0
1606625|NCT00965250|3929367|P1|NOT COMPLETED|Overall Study||0
1606626|NCT00965250|3929366|P2|COMPLETED|Overall Study||12
1606627|NCT00965250|3929367|P1|COMPLETED|Overall Study||37
1606628|NCT00965250|3929366|P2|STARTED|Overall Study||12
1606629|NCT00965250|3929367|P1|STARTED|Overall Study||37
1606630|NCT00965237|3929385|P2|NOT COMPLETED|Period 2, One Week of Wear||0
1606631|NCT00965237|3929386|P1|NOT COMPLETED|Period 2, One Week of Wear||0
1606632|NCT00965237|3929385|P2|COMPLETED|Period 2, One Week of Wear||8
1606633|NCT00965237|3929386|P1|COMPLETED|Period 2, One Week of Wear||8
1606634|NCT00965237|3929385|P2|STARTED|Period 2, One Week of Wear||8
1606635|NCT00965237|3929386|P1|STARTED|Period 2, One Week of Wear||8
1606636|NCT00965237|3929385|P2|NOT COMPLETED|Period 1, One Week of Wear||0
1606637|NCT00965237|3929386|P1|NOT COMPLETED|Period 1, One Week of Wear||0
1606638|NCT00965237|3929385|P2|COMPLETED|Period 1, One Week of Wear||8
1606639|NCT00965237|3929386|P1|COMPLETED|Period 1, One Week of Wear||8
1606640|NCT00965237|3929385|P2|STARTED|Period 1, One Week of Wear||8
1606641|NCT00965237|3929386|P1|STARTED|Period 1, One Week of Wear||8
1606642|NCT00965185|3929394|P2|NOT COMPLETED|Overall Study||1
1606643|NCT00965185|3929395|P1|NOT COMPLETED|Overall Study||2
1606644|NCT00965185|3929394|P2|COMPLETED|Overall Study||20
1606645|NCT00965185|3929395|P1|COMPLETED|Overall Study||17
1606646|NCT00965185|3929394|P2|9 Month Visit|Overall Study||21
1606647|NCT00965185|3929395|P1|9 Month Visit|Overall Study||18
1606648|NCT00965185|3929394|P2|6 Month Visit|Overall Study||21
1606649|NCT00965185|3929395|P1|6 Month Visit|Overall Study||18
1606650|NCT00965185|3929394|P2|3 Month Visit|Overall Study||21
1606651|NCT00965185|3929395|P1|3 Month Visit|Overall Study||18
1606652|NCT00965185|3929394|P2|1 Month Visit|Overall Study||21
1606653|NCT00965185|3929395|P1|1 Month Visit|Overall Study||18
1606654|NCT00965185|3929394|P2|STARTED|Overall Study||21
1606655|NCT00965185|3929395|P1|STARTED|Overall Study||19
1606656|NCT00965146|3929415|P1|NOT COMPLETED|Overall Study||210
1606657|NCT00965146|3929415|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
1606658|NCT00965146|3929415|P1|STARTED|Overall Study||210
1606659|NCT00965094|3929422|P2|NOT COMPLETED|Overall Study||1
1606660|NCT00965094|3929423|P1|NOT COMPLETED|Overall Study||5
1606661|NCT00965094|3929422|P2|COMPLETED|Overall Study||16
1606662|NCT00965094|3929423|P1|COMPLETED|Overall Study||14
1606663|NCT00965094|3929422|P2|STARTED|Overall Study||17
1606664|NCT00965094|3929423|P1|STARTED|Overall Study||19
1606665|NCT00965081|3929439|P2|NOT COMPLETED|Overall Study||43
1606666|NCT00965081|3929440|P1|NOT COMPLETED|Overall Study||34
1606667|NCT00965081|3929439|P2|COMPLETED|Overall Study||110
1606668|NCT00965081|3929440|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
1606669|NCT00965081|3929439|P2|STARTED|Overall Study||153
1606670|NCT00965081|3929440|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
1606671|NCT00964886|3929467|P4|NOT COMPLETED|Overall Study||9
1606672|NCT00964886|3929468|P3|NOT COMPLETED|Overall Study||16
1606673|NCT00964886|3929469|P2|NOT COMPLETED|Overall Study||7
1606674|NCT00964886|3929470|P1|NOT COMPLETED|Overall Study||11
1606675|NCT00964886|3929467|P4|COMPLETED|Overall Study||24
1606676|NCT00964886|3929468|P3|COMPLETED|Overall Study||21
1606677|NCT00964886|3929469|P2|COMPLETED|Overall Study||27
1606678|NCT00964886|3929470|P1|COMPLETED|Overall Study||27
1606679|NCT00964886|3929467|P4|STARTED|Overall Study||33
1606680|NCT00964886|3929468|P3|STARTED|Overall Study||37
1606681|NCT00964886|3929469|P2|STARTED|Overall Study||34
1606682|NCT00964886|3929470|P1|STARTED|Overall Study||38
1606683|NCT00964860|3929486|P2|NOT COMPLETED|Overall Study||1
1606684|NCT00964860|3929487|P1|NOT COMPLETED|Overall Study||0
1606685|NCT00964860|3929486|P2|COMPLETED|Overall Study||29
1606686|NCT00964860|3929487|P1|COMPLETED|Overall Study||30
1606687|NCT00964860|3929486|P2|STARTED|Overall Study||30
1606688|NCT00964860|3929487|P1|STARTED|Overall Study||30
1606689|NCT00964795|3929495|P1|NOT COMPLETED|Overall Study||307
1606690|NCT00964795|3929495|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
1606691|NCT00964795|3929495|P1|Number of Participants Treated|Overall Study||320
1606692|NCT00964795|3929495|P1|STARTED|Overall Study|randomized|323
1606693|NCT00964743|3929502|P1|NOT COMPLETED|Overall Study||2
1606694|NCT00964743|3929502|P1|COMPLETED|Overall Study||0
1606695|NCT00964743|3929502|P1|STARTED|Overall Study||2
1606696|NCT00964678|3929510|P1|NOT COMPLETED|Overall Study||4
1606697|NCT00964678|3929510|P1|COMPLETED|Overall Study||6
1606698|NCT00964678|3929510|P1|STARTED|Overall Study||10
1606699|NCT00964548|3929519|P2|NOT COMPLETED|Overall Study||0
1606700|NCT00964548|3929520|P1|NOT COMPLETED|Overall Study||0
1606701|NCT00964548|3929519|P2|COMPLETED|Overall Study||5
1606702|NCT00964548|3929520|P1|COMPLETED|Overall Study||5
1606703|NCT00964548|3929519|P2|STARTED|Overall Study||5
1606704|NCT00964548|3929520|P1|STARTED|Overall Study||5
1606705|NCT00964496|3929532|P2|NOT COMPLETED|Overall Study||1
1606706|NCT00964496|3929533|P1|NOT COMPLETED|Overall Study||2
1606707|NCT00964496|3929532|P2|COMPLETED|Overall Study||26
1606708|NCT00964496|3929533|P1|COMPLETED|Overall Study||26
1606709|NCT00964496|3929532|P2|STARTED|Overall Study||27
1606710|NCT00964496|3929533|P1|STARTED|Overall Study||28
1606711|NCT00964444|3929551|P1|NOT COMPLETED|Overall Study||0
1606712|NCT00964444|3929551|P1|COMPLETED|Overall Study||10
1606713|NCT00964444|3929551|P1|STARTED|Overall Study||10
1606714|NCT00964431|3929559|P4|NOT COMPLETED|Overall Study||0
1606715|NCT00964431|3929560|P3|NOT COMPLETED|Overall Study||0
1606716|NCT00964431|3929561|P2|NOT COMPLETED|Overall Study||0
1606717|NCT00964431|3929562|P1|NOT COMPLETED|Overall Study||0
1606718|NCT00964431|3929559|P4|COMPLETED|Overall Study||51
1606719|NCT00964431|3929560|P3|COMPLETED|Overall Study||51
1606720|NCT00964431|3929561|P2|COMPLETED|Overall Study||51
1606721|NCT00964431|3929562|P1|COMPLETED|Overall Study||50
1606722|NCT00964431|3929559|P4|STARTED|Overall Study||51
1606723|NCT00964431|3929560|P3|STARTED|Overall Study||51
1606724|NCT00964431|3929561|P2|STARTED|Overall Study||51
1606725|NCT00964431|3929562|P1|STARTED|Overall Study||50
1606726|NCT00964392|3929574|P2|NOT COMPLETED|Overall Study||190
1606727|NCT00964392|3929575|P1|NOT COMPLETED|Overall Study||53
1606728|NCT00964392|3929574|P2|COMPLETED|Overall Study||92
1606729|NCT00964392|3929575|P1|COMPLETED|Overall Study||72
1606730|NCT00964392|3929574|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
1606731|NCT00964392|3929575|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
1606732|NCT00964366|3929585|P2|NOT COMPLETED|Overall Study||1
1606733|NCT00964366|3929586|P1|NOT COMPLETED|Overall Study||1
1606734|NCT00964366|3929585|P2|COMPLETED|Overall Study||24
1606735|NCT00964366|3929586|P1|COMPLETED|Overall Study||27
1606736|NCT00964366|3929585|P2|STARTED|Overall Study||25
1606737|NCT00964366|3929586|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
1606738|NCT00964223|3929600|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
1606739|NCT00964223|3929600|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
1606740|NCT00964223|3929600|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
1606741|NCT00964223|3929600|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
1606742|NCT00964223|3929600|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
1606743|NCT00964223|3929600|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
1606744|NCT00964158|3929668|P3|NOT COMPLETED|Overall Study||8
1606745|NCT00964158|3929669|P2|NOT COMPLETED|Overall Study||1
1606746|NCT00964158|3929670|P1|NOT COMPLETED|Overall Study||0
1606747|NCT00964158|3929668|P3|COMPLETED|Overall Study||92
1606748|NCT00964158|3929669|P2|COMPLETED|Overall Study||56
1606749|NCT00964158|3929670|P1|COMPLETED|Overall Study||53
1606750|NCT00964158|3929668|P3|STARTED|Overall Study||100
1606751|NCT00964158|3929669|P2|STARTED|Overall Study||57
1606752|NCT00964158|3929670|P1|STARTED|Overall Study||53
1606753|NCT00964119|3929739|P1|NOT COMPLETED|Overall Study||0
1606754|NCT00964119|3929739|P1|COMPLETED|Overall Study||15
1606755|NCT00964119|3929739|P1|STARTED|Overall Study||15
1606756|NCT00964028|3929745|P2|NOT COMPLETED|Overall Study||1
1606757|NCT00964028|3929746|P1|NOT COMPLETED|Overall Study||0
1606758|NCT00964028|3929745|P2|COMPLETED|Overall Study||24
1606759|NCT00964028|3929746|P1|COMPLETED|Overall Study||25
1606760|NCT00964028|3929745|P2|STARTED|Overall Study||25
1606761|NCT00964028|3929746|P1|STARTED|Overall Study||25
1606762|NCT00963937|3929761|P3|NOT COMPLETED|Overall Study||4
1606763|NCT00963937|3929762|P2|NOT COMPLETED|Overall Study||11
1606764|NCT00963937|3929763|P1|NOT COMPLETED|Overall Study||19
1606765|NCT00963937|3929761|P3|COMPLETED|Overall Study||41
1606766|NCT00963937|3929762|P2|COMPLETED|Overall Study||33
1606767|NCT00963937|3929763|P1|COMPLETED|Overall Study||70
1606768|NCT00963937|3929761|P3|STARTED|Overall Study||45
1606769|NCT00963937|3929762|P2|STARTED|Overall Study||44
1606770|NCT00963937|3929763|P1|STARTED|Overall Study||89
1606771|NCT00963924|3929801|P2|NOT COMPLETED|Overall Study||3
1606772|NCT00963924|3929802|P1|NOT COMPLETED|Overall Study||1
1606773|NCT00963924|3929801|P2|COMPLETED|Overall Study||15
1606774|NCT00963924|3929802|P1|COMPLETED|Overall Study||17
1606775|NCT00963924|3929801|P2|STARTED|Overall Study||18
1606776|NCT00963924|3929802|P1|STARTED|Overall Study||18
1606777|NCT00963872|3929826|P2|NOT COMPLETED|Overall Study||1
1606778|NCT00963872|3929827|P1|NOT COMPLETED|Overall Study||1
1606779|NCT00963872|3929826|P2|COMPLETED|Overall Study||5
1606780|NCT00963872|3929827|P1|COMPLETED|Overall Study||24
1606781|NCT00963872|3929826|P2|STARTED|Overall Study||6
1606782|NCT00963872|3929827|P1|STARTED|Overall Study||25
1606783|NCT00963859|3929871|P1|NOT COMPLETED|Overall Study||0
1606784|NCT00963859|3929871|P1|COMPLETED|Overall Study||11
1606785|NCT00963859|3929871|P1|STARTED|Overall Study||11
1606786|NCT00963820|3929876|P12|NOT COMPLETED|Expansion Phase||4
1606787|NCT00963820|3929877|P11|NOT COMPLETED|Expansion Phase||5
1606788|NCT00963820|3929878|P10|NOT COMPLETED|Expansion Phase||9
1606789|NCT00963820|3929879|P9|NOT COMPLETED|Expansion Phase||10
1606790|NCT00963820|3929880|P8|NOT COMPLETED|Expansion Phase||0
1606791|NCT00963820|3929881|P7|NOT COMPLETED|Expansion Phase||0
1606792|NCT00963820|3929882|P6|NOT COMPLETED|Expansion Phase||0
1606793|NCT00963820|3929883|P5|NOT COMPLETED|Expansion Phase||0
1606794|NCT00963820|3929884|P4|NOT COMPLETED|Expansion Phase||0
1606795|NCT00963820|3929885|P3|NOT COMPLETED|Expansion Phase||0
1606796|NCT00963820|3929886|P2|NOT COMPLETED|Expansion Phase||0
1606797|NCT00963820|3929887|P1|NOT COMPLETED|Expansion Phase||0
1606798|NCT00963820|3929876|P12|COMPLETED|Expansion Phase||0
1606799|NCT00963820|3929877|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
1606800|NCT00963820|3929878|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
1606801|NCT00963820|3929879|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
1606802|NCT00963820|3929880|P8|COMPLETED|Expansion Phase||0
1606803|NCT00963820|3929881|P7|COMPLETED|Expansion Phase||0
1606804|NCT00963820|3929882|P6|COMPLETED|Expansion Phase||0
1606805|NCT00963820|3929883|P5|COMPLETED|Expansion Phase||0
1606806|NCT00963820|3929884|P4|COMPLETED|Expansion Phase||0
1606807|NCT00963820|3929885|P3|COMPLETED|Expansion Phase||0
1606808|NCT00963820|3929886|P2|COMPLETED|Expansion Phase||0
1606809|NCT00963820|3929887|P1|COMPLETED|Expansion Phase||0
1606810|NCT00963820|3929876|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
1606811|NCT00963820|3929877|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
1606812|NCT00963820|3929878|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
1606813|NCT00963820|3929879|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
1606814|NCT00963820|3929880|P8|STARTED|Expansion Phase||0
1606815|NCT00963820|3929881|P7|STARTED|Expansion Phase||0
1606816|NCT00963820|3929882|P6|STARTED|Expansion Phase||0
1606817|NCT00963820|3929883|P5|STARTED|Expansion Phase||0
1606818|NCT00963820|3929884|P4|STARTED|Expansion Phase||0
1606819|NCT00963820|3929885|P3|STARTED|Expansion Phase||0
1606820|NCT00963820|3929886|P2|STARTED|Expansion Phase||0
1606821|NCT00963820|3929887|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
1606822|NCT00963820|3929876|P12|NOT COMPLETED|Dose Escalation Phase||0
1606823|NCT00963820|3929877|P11|NOT COMPLETED|Dose Escalation Phase||0
1606824|NCT00963820|3929878|P10|NOT COMPLETED|Dose Escalation Phase||0
1606825|NCT00963820|3929879|P9|NOT COMPLETED|Dose Escalation Phase||0
1606826|NCT00963820|3929880|P8|NOT COMPLETED|Dose Escalation Phase||5
1606827|NCT00963820|3929881|P7|NOT COMPLETED|Dose Escalation Phase||8
1606828|NCT00963820|3929882|P6|NOT COMPLETED|Dose Escalation Phase||3
1606829|NCT00963820|3929883|P5|NOT COMPLETED|Dose Escalation Phase||4
1606830|NCT00963820|3929884|P4|NOT COMPLETED|Dose Escalation Phase||3
1606831|NCT00963820|3929885|P3|NOT COMPLETED|Dose Escalation Phase||3
1606832|NCT00963820|3929886|P2|NOT COMPLETED|Dose Escalation Phase||3
1606833|NCT00963820|3929887|P1|NOT COMPLETED|Dose Escalation Phase||3
1606834|NCT00963820|3929876|P12|COMPLETED|Dose Escalation Phase||0
1606835|NCT00963820|3929877|P11|COMPLETED|Dose Escalation Phase||0
1606836|NCT00963820|3929878|P10|COMPLETED|Dose Escalation Phase||0
1606837|NCT00963820|3929879|P9|COMPLETED|Dose Escalation Phase||0
1606838|NCT00963820|3929880|P8|COMPLETED|Dose Escalation Phase||0
1606839|NCT00963820|3929881|P7|COMPLETED|Dose Escalation Phase||0
1606840|NCT00963820|3929882|P6|COMPLETED|Dose Escalation Phase||0
1606841|NCT00963820|3929883|P5|COMPLETED|Dose Escalation Phase||0
1606842|NCT00963820|3929884|P4|COMPLETED|Dose Escalation Phase||0
1606843|NCT00963820|3929885|P3|COMPLETED|Dose Escalation Phase||0
1606844|NCT00963820|3929886|P2|COMPLETED|Dose Escalation Phase||0
1606845|NCT00963820|3929887|P1|COMPLETED|Dose Escalation Phase||0
1606846|NCT00963820|3929876|P12|STARTED|Dose Escalation Phase||0
1606847|NCT00963820|3929877|P11|STARTED|Dose Escalation Phase||0
1606848|NCT00963820|3929878|P10|STARTED|Dose Escalation Phase||0
1606849|NCT00963820|3929879|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
1606850|NCT00963820|3929880|P8|STARTED|Dose Escalation Phase||5
1606851|NCT00963820|3929881|P7|STARTED|Dose Escalation Phase||8
1606852|NCT00963820|3929882|P6|STARTED|Dose Escalation Phase||3
1606853|NCT00963820|3929883|P5|STARTED|Dose Escalation Phase||4
1606854|NCT00963820|3929884|P4|STARTED|Dose Escalation Phase||3
1606855|NCT00963820|3929885|P3|STARTED|Dose Escalation Phase||3
1606856|NCT00963820|3929886|P2|STARTED|Dose Escalation Phase||3
1606857|NCT00963820|3929887|P1|STARTED|Dose Escalation Phase||3
1606858|NCT00963807|3930023|P1|NOT COMPLETED|Overall Study||18
1606859|NCT00963807|3930023|P1|COMPLETED|Overall Study||8
1606860|NCT00963807|3930023|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
1606861|NCT00963807|3930023|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
1606862|NCT00963807|3930023|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
1606863|NCT00963807|3930023|P1|Completed Baseline Imaging|Overall Study||11
1606864|NCT00963807|3930023|P1|STARTED|Overall Study||26
1606865|NCT00963677|3930034|P2|NOT COMPLETED|Overall Study||2
1606866|NCT00963677|3930035|P1|NOT COMPLETED|Overall Study||0
1606867|NCT00963677|3930034|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
1606868|NCT00963677|3930035|P1|COMPLETED|Overall Study||35
1606869|NCT00963677|3930034|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
1606870|NCT00963677|3930035|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
1606871|NCT00963638|3930045|P2|NOT COMPLETED|Overall Study||0
1606872|NCT00963638|3930046|P1|NOT COMPLETED|Overall Study||0
1606873|NCT00963638|3930045|P2|COMPLETED|Overall Study||20
1606874|NCT00963638|3930046|P1|COMPLETED|Overall Study||20
1606875|NCT00963638|3930045|P2|STARTED|Overall Study||20
1606876|NCT00963638|3930046|P1|STARTED|Overall Study||20
1606877|NCT00963599|3930056|P4|NOT COMPLETED|Overall Study||14
1606878|NCT00963599|3930057|P3|NOT COMPLETED|Overall Study||9
1606879|NCT00963599|3930058|P2|NOT COMPLETED|Overall Study||6
1606880|NCT00963599|3930059|P1|NOT COMPLETED|Overall Study||6
1606881|NCT00963599|3930056|P4|COMPLETED|Overall Study||288
1606882|NCT00963599|3930057|P3|COMPLETED|Overall Study||292
1606883|NCT00963599|3930058|P2|COMPLETED|Overall Study||149
1606884|NCT00963599|3930059|P1|COMPLETED|Overall Study||143
1606885|NCT00963599|3930056|P4|STARTED|Overall Study||302
1606886|NCT00963599|3930057|P3|STARTED|Overall Study||301
1606887|NCT00963599|3930058|P2|STARTED|Overall Study||155
1606888|NCT00963599|3930059|P1|STARTED|Overall Study||149
1606889|NCT00963560|3930116|P3|NOT COMPLETED|Overall Study||0
1606890|NCT00963560|3930117|P2|NOT COMPLETED|Overall Study||3
1606891|NCT00963560|3930118|P1|NOT COMPLETED|Overall Study||3
1606892|NCT00963560|3930116|P3|COMPLETED|Overall Study||41
1606893|NCT00963560|3930117|P2|COMPLETED|Overall Study||41
1606894|NCT00963560|3930118|P1|COMPLETED|Overall Study||44
1606895|NCT00963560|3930116|P3|STARTED|Overall Study||41
1606896|NCT00963560|3930117|P2|STARTED|Overall Study||44
1606897|NCT00963560|3930118|P1|STARTED|Overall Study||47
1606898|NCT00963547|3930130|P7|NOT COMPLETED|Overall Study||0
1606899|NCT00963547|3930131|P6|NOT COMPLETED|Overall Study||0
1606900|NCT00963547|3930132|P5|NOT COMPLETED|Overall Study||0
1606901|NCT00963547|3930133|P4|NOT COMPLETED|Overall Study||6
1606902|NCT00963547|3930134|P3|NOT COMPLETED|Overall Study||12
1606903|NCT00963547|3930135|P2|NOT COMPLETED|Overall Study||11
1606904|NCT00963547|3930136|P1|NOT COMPLETED|Overall Study||4
1606905|NCT00963547|3930130|P7|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
1606906|NCT00963547|3930131|P6|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
1606907|NCT00963547|3930132|P5|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
1606908|NCT00963547|3930133|P4|COMPLETED|Overall Study||0
1606909|NCT00963547|3930134|P3|COMPLETED|Overall Study||0
1606910|NCT00963547|3930135|P2|COMPLETED|Overall Study||0
1606911|NCT00963547|3930136|P1|COMPLETED|Overall Study||0
1606912|NCT00963547|3930130|P7|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
1606913|NCT00963547|3930131|P6|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
1606914|NCT00963547|3930132|P5|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
1606915|NCT00963547|3930133|P4|Treated|Overall Study||6
1606916|NCT00963547|3930134|P3|Treated|Overall Study||11
1606917|NCT00963547|3930135|P2|Treated|Overall Study||11
1606918|NCT00963547|3930136|P1|Treated|Overall Study||3
1606919|NCT00963547|3930130|P7|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
1606920|NCT00963547|3930131|P6|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
1606921|NCT00963547|3930132|P5|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
1606922|NCT00963547|3930133|P4|STARTED|Overall Study||6
1606923|NCT00963547|3930134|P3|STARTED|Overall Study||12
1606924|NCT00963547|3930135|P2|STARTED|Overall Study||11
1606925|NCT00963547|3930136|P1|STARTED|Overall Study||4
1606926|NCT00963508|3930162|P2|NOT COMPLETED|Overall Study||28
1606927|NCT00963508|3930163|P1|NOT COMPLETED|Overall Study||10
1606928|NCT00963508|3930162|P2|COMPLETED|Overall Study||169
1606929|NCT00963508|3930163|P1|COMPLETED|Overall Study||196
1606930|NCT00963508|3930162|P2|STARTED|Overall Study||197
1606931|NCT00963508|3930163|P1|STARTED|Overall Study||206
1606932|NCT00963482|3930173|P2|NOT COMPLETED|Overall Study||17
1606933|NCT00963482|3930174|P1|NOT COMPLETED|Overall Study||28
1606934|NCT00963482|3930173|P2|COMPLETED|Overall Study||33
1606935|NCT00963482|3930174|P1|COMPLETED|Overall Study||25
1606936|NCT00963482|3930173|P2|STARTED|Overall Study||50
1606937|NCT00963482|3930174|P1|STARTED|Overall Study||53
1606938|NCT00963469|3930183|P3|NOT COMPLETED|Overall Study||10
1606939|NCT00963469|3930184|P2|NOT COMPLETED|Overall Study||28
1606940|NCT00963469|3930185|P1|NOT COMPLETED|Overall Study||41
1606941|NCT00963469|3930183|P3|COMPLETED|Overall Study||170
1606942|NCT00963469|3930184|P2|COMPLETED|Overall Study||420
1606943|NCT00963469|3930185|P1|COMPLETED|Overall Study||410
1606944|NCT00963469|3930183|P3|STARTED|Overall Study||180
1606945|NCT00963469|3930184|P2|STARTED|Overall Study||448
1606946|NCT00963469|3930185|P1|STARTED|Overall Study||451
1606947|NCT00963430|3930213|P2|NOT COMPLETED|Overall Study||3
1606948|NCT00963430|3930214|P1|NOT COMPLETED|Overall Study||1
1606949|NCT00963430|3930213|P2|COMPLETED|Overall Study||57
1606950|NCT00963430|3930214|P1|COMPLETED|Overall Study||59
1606951|NCT00963430|3930213|P2|STARTED|Overall Study||60
1606952|NCT00963430|3930214|P1|STARTED|Overall Study||60
1606953|NCT00963235|3930252|P1|NOT COMPLETED|Overall Study||60
1606954|NCT00963235|3930252|P1|COMPLETED|Overall Study||271
1606955|NCT00963235|3930252|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
1606956|NCT00963235|3930252|P1|Vaccinated Dose 3|Overall Study||279
1606957|NCT00963235|3930252|P1|Vaccinated Dose 2|Overall Study||300
1606958|NCT00963235|3930252|P1|Vaccinated Dose 1|Overall Study||329
1606959|NCT00963235|3930252|P1|STARTED|Overall Study||331
1606960|NCT00963157|3930276|P5|NOT COMPLETED|Overall Study||2
1606961|NCT00963157|3930277|P4|NOT COMPLETED|Overall Study||7
1606962|NCT00963157|3930278|P3|NOT COMPLETED|Overall Study||5
1606963|NCT00963157|3930279|P2|NOT COMPLETED|Overall Study||4
1606964|NCT00963157|3930280|P1|NOT COMPLETED|Overall Study||5
1606965|NCT00963157|3930276|P5|COMPLETED|Overall Study||151
1606966|NCT00963157|3930277|P4|COMPLETED|Overall Study||150
1606967|NCT00963157|3930278|P3|COMPLETED|Overall Study||155
1606968|NCT00963157|3930279|P2|COMPLETED|Overall Study||159
1606969|NCT00963157|3930280|P1|COMPLETED|Overall Study||151
1606970|NCT00963157|3930276|P5|STARTED|Overall Study||153
1606971|NCT00963157|3930277|P4|STARTED|Overall Study||157
1606972|NCT00963157|3930278|P3|STARTED|Overall Study||160
1606973|NCT00963157|3930279|P2|STARTED|Overall Study||163
1606974|NCT00963157|3930280|P1|STARTED|Overall Study||156
1606975|NCT00963105|3930475|P3|NOT COMPLETED|Overall Study||0
1606976|NCT00963105|3930476|P2|NOT COMPLETED|Overall Study||0
1606977|NCT00963105|3930477|P1|NOT COMPLETED|Overall Study||0
1606978|NCT00963105|3930475|P3|COMPLETED|Overall Study||35
1606979|NCT00963105|3930476|P2|COMPLETED|Overall Study||35
1606980|NCT00963105|3930477|P1|COMPLETED|Overall Study||34
1606981|NCT00963105|3930475|P3|Received Treatment|Overall Study||35
1606982|NCT00963105|3930476|P2|Received Treatment|Overall Study||34
1606983|NCT00963105|3930477|P1|Received Treatment|Overall Study||34
1606984|NCT00963105|3930475|P3|STARTED|Overall Study||35
1606985|NCT00963105|3930476|P2|STARTED|Overall Study||35
1606986|NCT00963105|3930477|P1|STARTED|Overall Study||34
1606987|NCT00962949|3930508|P2|NOT COMPLETED|Overall Study||0
1606988|NCT00962949|3930509|P1|NOT COMPLETED|Overall Study||0
1606989|NCT00962949|3930508|P2|COMPLETED|Overall Study||15
1606990|NCT00962949|3930509|P1|COMPLETED|Overall Study||13
1606991|NCT00962949|3930508|P2|STARTED|Overall Study||15
1606992|NCT00962949|3930509|P1|STARTED|Overall Study||13
1606993|NCT00962871|3930525|P4|NOT COMPLETED|Overall Study||0
1606994|NCT00962871|3930526|P3|NOT COMPLETED|Overall Study||0
1606995|NCT00962871|3930527|P2|NOT COMPLETED|Overall Study||0
1606996|NCT00962871|3930528|P1|NOT COMPLETED|Overall Study||0
1606997|NCT00962871|3930525|P4|COMPLETED|Overall Study||6
1606998|NCT00962871|3930526|P3|COMPLETED|Overall Study||12
1606999|NCT00962871|3930527|P2|COMPLETED|Overall Study||6
1607000|NCT00962871|3930528|P1|COMPLETED|Overall Study||6
1607001|NCT00962871|3930525|P4|STARTED|Overall Study||6
1607002|NCT00962871|3930526|P3|STARTED|Overall Study||12
1607003|NCT00962871|3930527|P2|STARTED|Overall Study||6
1607004|NCT00962871|3930528|P1|STARTED|Overall Study||6
1607005|NCT00962780|3930544|P2|NOT COMPLETED|Overall Study||14
1607006|NCT00962780|3930545|P1|NOT COMPLETED|Overall Study||10
1607007|NCT00962780|3930544|P2|COMPLETED|Overall Study||138
1607008|NCT00962780|3930545|P1|COMPLETED|Overall Study||141
1607009|NCT00962780|3930544|P2|Vaccinated 23vPS Dose|Overall Study||139
1607010|NCT00962780|3930545|P1|Vaccinated 23vPS Dose|Overall Study||143
1607011|NCT00962780|3930544|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
1607012|NCT00962780|3930545|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
1607013|NCT00962780|3930544|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
1607014|NCT00962780|3930545|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
1607015|NCT00962780|3930544|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
1607016|NCT00962780|3930545|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
1607017|NCT00962780|3930544|P2|STARTED|Overall Study||152
1607018|NCT00962780|3930545|P1|STARTED|Overall Study||151
1607019|NCT00962754|3930609|P2|NOT COMPLETED|Overall Study||0
1607020|NCT00962754|3930610|P1|NOT COMPLETED|Overall Study||0
1607021|NCT00962754|3930609|P2|COMPLETED|Overall Study||84
1607022|NCT00962754|3930610|P1|COMPLETED|Overall Study||86
1607023|NCT00962754|3930609|P2|STARTED|Overall Study||84
1607024|NCT00962754|3930610|P1|STARTED|Overall Study||86
1607025|NCT00962741|3930620|P1|NOT COMPLETED|Overall Study||8
1607026|NCT00962741|3930620|P1|COMPLETED|Overall Study||119
1607027|NCT00962741|3930620|P1|STARTED|Overall Study||127
1607028|NCT00962650|3930711|P1|NOT COMPLETED|Overall Study||2
1607029|NCT00962650|3930711|P1|COMPLETED|Overall Study||8
1607030|NCT00962650|3930711|P1|STARTED|Overall Study||10
1607031|NCT00962598|3930717|P2|NOT COMPLETED|Overall Study||0
1607032|NCT00962598|3930718|P1|NOT COMPLETED|Overall Study||0
1607033|NCT00962598|3930717|P2|COMPLETED|Overall Study||9
1607034|NCT00962598|3930718|P1|COMPLETED|Overall Study||7
1607035|NCT00962598|3930717|P2|STARTED|Overall Study||9
1607036|NCT00962598|3930718|P1|STARTED|Overall Study||7
1607037|NCT00962585|3930730|P4|NOT COMPLETED|Overall Study||0
1607038|NCT00962585|3930731|P3|NOT COMPLETED|Overall Study||3
1607039|NCT00962585|3930732|P2|NOT COMPLETED|Overall Study||2
1607040|NCT00962585|3930733|P1|NOT COMPLETED|Overall Study||6
1607041|NCT00962585|3930730|P4|COMPLETED|Overall Study||42
1607042|NCT00962585|3930731|P3|COMPLETED|Overall Study||39
1607043|NCT00962585|3930732|P2|COMPLETED|Overall Study||40
1607044|NCT00962585|3930733|P1|COMPLETED|Overall Study||37
1607045|NCT00962585|3930730|P4|STARTED|Overall Study||42
1607046|NCT00962585|3930731|P3|STARTED|Overall Study||42
1607047|NCT00962585|3930732|P2|STARTED|Overall Study||42
1607048|NCT00962585|3930733|P1|STARTED|Overall Study||43
1607049|NCT00962390|3930795|P4|NOT COMPLETED|Overall Study||1
1607050|NCT00962390|3930796|P3|NOT COMPLETED|Overall Study||4
1607051|NCT00962390|3930797|P2|NOT COMPLETED|Overall Study||3
1607052|NCT00962390|3930798|P1|NOT COMPLETED|Overall Study||4
1607053|NCT00962390|3930795|P4|COMPLETED|Overall Study||28
1607054|NCT00962390|3930796|P3|COMPLETED|Overall Study||25
1607055|NCT00962390|3930797|P2|COMPLETED|Overall Study||26
1607056|NCT00962390|3930798|P1|COMPLETED|Overall Study||25
1607057|NCT00962390|3930795|P4|STARTED|Overall Study||29
1607058|NCT00962390|3930796|P3|STARTED|Overall Study||29
1607059|NCT00962390|3930797|P2|STARTED|Overall Study||29
1607060|NCT00962390|3930798|P1|STARTED|Overall Study||29
1607061|NCT00962247|3930860|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
1607062|NCT00962247|3930860|P1|COMPLETED|50% Reduction of Sedentary Activity||56
1607063|NCT00962247|3930860|P1|STARTED|50% Reduction of Sedentary Activity||56
1607064|NCT00962247|3930860|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
1607065|NCT00962247|3930860|P1|COMPLETED|25% Reduction of Sedentary Activity||56
1607066|NCT00962247|3930860|P1|STARTED|25% Reduction of Sedentary Activity||61
1607067|NCT00962247|3930860|P1|NOT COMPLETED|Usual Sedentary||18
1607068|NCT00962247|3930860|P1|COMPLETED|Usual Sedentary||61
1607069|NCT00962247|3930860|P1|STARTED|Usual Sedentary||79
1607070|NCT00962208|3930871|P2|NOT COMPLETED|Overall Study||10
1607071|NCT00962208|3930872|P1|NOT COMPLETED|Overall Study||14
1607072|NCT00962208|3930871|P2|COMPLETED|Overall Study||41
1607073|NCT00962208|3930872|P1|COMPLETED|Overall Study||37
1607074|NCT00962208|3930871|P2|STARTED|Overall Study||51
1607075|NCT00962208|3930872|P1|STARTED|Overall Study||51
1607076|NCT00962104|3930880|P2|NOT COMPLETED|Overall Study||25
1607077|NCT00962104|3930881|P1|NOT COMPLETED|Overall Study||40
1607078|NCT00962104|3930880|P2|COMPLETED|Overall Study||171
1607079|NCT00962104|3930881|P1|COMPLETED|Overall Study||155
1607080|NCT00962104|3930880|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
1607081|NCT00962104|3930881|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
1607082|NCT00962104|3930880|P2|STARTED|Overall Study||196
1607083|NCT00962104|3930881|P1|STARTED|Overall Study||195
1607084|NCT00962065|3930910|P3|NOT COMPLETED|Overall Study||0
1607085|NCT00962065|3930911|P2|NOT COMPLETED|Overall Study||0
1607086|NCT00962065|3930912|P1|NOT COMPLETED|Overall Study||0
1607087|NCT00962065|3930910|P3|COMPLETED|Overall Study||12
1607088|NCT00962065|3930911|P2|COMPLETED|Overall Study||12
1607089|NCT00962065|3930912|P1|COMPLETED|Overall Study||12
1607090|NCT00962065|3930910|P3|STARTED|Overall Study||12
1607091|NCT00962065|3930911|P2|STARTED|Overall Study||12
1607092|NCT00962065|3930912|P1|STARTED|Overall Study||12
1607093|NCT00962013|3930935|P1|NOT COMPLETED|Overall Study||68
1607094|NCT00962013|3930935|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
1607095|NCT00962013|3930935|P1|STARTED|Overall Study||120
1607096|NCT00962000|3930944|P2|NOT COMPLETED|Period 4 - 1 Week||0
1607097|NCT00962000|3930945|P1|NOT COMPLETED|Period 4 - 1 Week||0
1607098|NCT00962000|3930944|P2|COMPLETED|Period 4 - 1 Week||21
1607099|NCT00962000|3930945|P1|COMPLETED|Period 4 - 1 Week||21
1607100|NCT00962000|3930944|P2|STARTED|Period 4 - 1 Week||21
1607101|NCT00962000|3930945|P1|STARTED|Period 4 - 1 Week||21
1607102|NCT00962000|3930944|P2|NOT COMPLETED|Period 3 - 1 Week||0
1607103|NCT00962000|3930945|P1|NOT COMPLETED|Period 3 - 1 Week||0
1607104|NCT00962000|3930944|P2|COMPLETED|Period 3 - 1 Week||21
1607105|NCT00962000|3930945|P1|COMPLETED|Period 3 - 1 Week||21
1607106|NCT00962000|3930944|P2|STARTED|Period 3 - 1 Week||21
1607107|NCT00962000|3930945|P1|STARTED|Period 3 - 1 Week||21
1607108|NCT00962000|3930944|P2|NOT COMPLETED|Period 2 - 1 Week||0
1607109|NCT00962000|3930945|P1|NOT COMPLETED|Period 2 - 1 Week||0
1607110|NCT00962000|3930944|P2|COMPLETED|Period 2 - 1 Week||21
1607111|NCT00962000|3930945|P1|COMPLETED|Period 2 - 1 Week||21
1607112|NCT00962000|3930944|P2|STARTED|Period 2 - 1 Week||21
1607113|NCT00962000|3930945|P1|STARTED|Period 2 - 1 Week||21
1607114|NCT00962000|3930944|P2|NOT COMPLETED|Period 1 - 1 Week||0
1607115|NCT00962000|3930945|P1|NOT COMPLETED|Period 1 - 1 Week||0
1607116|NCT00962000|3930944|P2|COMPLETED|Period 1 - 1 Week||21
1607117|NCT00962000|3930945|P1|COMPLETED|Period 1 - 1 Week||21
1607118|NCT00962000|3930944|P2|STARTED|Period 1 - 1 Week||21
1607119|NCT00962000|3930945|P1|STARTED|Period 1 - 1 Week||21
1607120|NCT00961896|3930958|P3|NOT COMPLETED|Overall Study||1
1607121|NCT00961896|3930959|P2|NOT COMPLETED|Overall Study||0
1607122|NCT00961896|3930960|P1|NOT COMPLETED|Overall Study||0
1607123|NCT00961896|3930958|P3|COMPLETED|Overall Study||6
1607124|NCT00961896|3930959|P2|COMPLETED|Overall Study||3
1607125|NCT00961896|3930960|P1|COMPLETED|Overall Study||8
1607126|NCT00961896|3930958|P3|STARTED|Overall Study||7
1607127|NCT00961896|3930959|P2|STARTED|Overall Study||3
1607128|NCT00961896|3930960|P1|STARTED|Overall Study||8
1607129|NCT00961805|3930981|P2|NOT COMPLETED|Overall Study||0
1607130|NCT00961805|3930982|P1|NOT COMPLETED|Overall Study||0
1607131|NCT00961805|3930981|P2|COMPLETED|Overall Study||40
1607132|NCT00961805|3930982|P1|COMPLETED|Overall Study||40
1607133|NCT00961805|3930981|P2|STARTED|Overall Study||40
1607134|NCT00961805|3930982|P1|STARTED|Overall Study||40
1607135|NCT00961662|3931013|P3|NOT COMPLETED|Overall Study||19
1607136|NCT00961662|3931014|P2|NOT COMPLETED|Overall Study||19
1607137|NCT00961662|3931015|P1|NOT COMPLETED|Overall Study||22
1607138|NCT00961662|3931013|P3|COMPLETED|Overall Study||34
1607139|NCT00961662|3931014|P2|COMPLETED|Overall Study||32
1607140|NCT00961662|3931015|P1|COMPLETED|Overall Study||35
1607141|NCT00961662|3931013|P3|STARTED|Overall Study||53
1607142|NCT00961662|3931014|P2|STARTED|Overall Study||51
1607143|NCT00961662|3931015|P1|STARTED|Overall Study||57
1607144|NCT00961649|3931027|P4|NOT COMPLETED|Overall Study||4
1607145|NCT00961649|3931028|P3|NOT COMPLETED|Overall Study||5
1607146|NCT00961649|3931029|P2|NOT COMPLETED|Overall Study||4
1607147|NCT00961649|3931030|P1|NOT COMPLETED|Overall Study||9
1607148|NCT00961649|3931027|P4|COMPLETED|Overall Study||37
1607149|NCT00961649|3931028|P3|COMPLETED|Overall Study||39
1607150|NCT00961649|3931029|P2|COMPLETED|Overall Study||40
1607151|NCT00961649|3931030|P1|COMPLETED|Overall Study||32
1607152|NCT00961649|3931027|P4|STARTED|Overall Study||41
1607153|NCT00961649|3931028|P3|STARTED|Overall Study||44
1607154|NCT00961649|3931029|P2|STARTED|Overall Study||44
1607155|NCT00961649|3931030|P1|STARTED|Overall Study||41
1607156|NCT00961636|3931044|P3|NOT COMPLETED|Overall Study||32
1607157|NCT00961636|3931045|P2|NOT COMPLETED|Overall Study||131
1607158|NCT00961636|3931046|P1|NOT COMPLETED|Overall Study||107
1607159|NCT00961636|3931044|P3|COMPLETED|Overall Study||201
1607160|NCT00961636|3931045|P2|COMPLETED|Overall Study||325
1607161|NCT00961636|3931046|P1|COMPLETED|Overall Study||356
1607162|NCT00961636|3931044|P3|STARTED|Overall Study||233
1607163|NCT00961636|3931045|P2|STARTED|Overall Study||456
1607164|NCT00961636|3931046|P1|STARTED|Overall Study||463
1607165|NCT00961571|3931057|P1|NOT COMPLETED|Overall Study||39
1607166|NCT00961571|3931057|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
1607167|NCT00961571|3931057|P1|STARTED|Overall Study||50
1607168|NCT00961532|3931061|P1|NOT COMPLETED|Overall Study||0
1607169|NCT00961532|3931061|P1|COMPLETED|Overall Study||14
1607170|NCT00961532|3931061|P1|STARTED|Overall Study||14
1607171|NCT00961441|3931068|P2|NOT COMPLETED|Overall Study||0
1607172|NCT00961441|3931069|P1|NOT COMPLETED|Overall Study||0
1607173|NCT00961441|3931068|P2|COMPLETED|Overall Study||13
1607174|NCT00961441|3931069|P1|COMPLETED|Overall Study||12
1607175|NCT00961441|3931068|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
1607176|NCT00961441|3931069|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
1607177|NCT00961441|3931068|P2|STARTED|Overall Study||13
1607178|NCT00961441|3931069|P1|STARTED|Overall Study||12
1607179|NCT00961415|3931085|P3|NOT COMPLETED|Maintenance Treatment Phase||45
1607180|NCT00961415|3931086|P2|NOT COMPLETED|Maintenance Treatment Phase||48
1607181|NCT00961415|3931087|P1|NOT COMPLETED|Maintenance Treatment Phase||0
1607182|NCT00961415|3931085|P3|COMPLETED|Maintenance Treatment Phase||83
1607183|NCT00961415|3931086|P2|COMPLETED|Maintenance Treatment Phase||77
1607184|NCT00961415|3931087|P1|COMPLETED|Maintenance Treatment Phase||0
1607185|NCT00961415|3931085|P3|STARTED|Maintenance Treatment Phase||128
1607186|NCT00961415|3931086|P2|STARTED|Maintenance Treatment Phase||125
1607187|NCT00961415|3931087|P1|STARTED|Maintenance Treatment Phase||0
1607188|NCT00961415|3931085|P3|NOT COMPLETED|Induction Treatment Phase||0
1607189|NCT00961415|3931086|P2|NOT COMPLETED|Induction Treatment Phase||0
1607190|NCT00961415|3931087|P1|NOT COMPLETED|Induction Treatment Phase||123
1607191|NCT00961415|3931085|P3|COMPLETED|Induction Treatment Phase||0
1607192|NCT00961415|3931086|P2|COMPLETED|Induction Treatment Phase||0
1607193|NCT00961415|3931087|P1|COMPLETED|Induction Treatment Phase||253
1607194|NCT00961415|3931085|P3|STARTED|Induction Treatment Phase||0
1607195|NCT00961415|3931086|P2|STARTED|Induction Treatment Phase||0
1607196|NCT00961415|3931087|P1|STARTED|Induction Treatment Phase||376
1607197|NCT00961402|3931112|P2|NOT COMPLETED|Overall Study||5
1607198|NCT00961402|3931113|P1|NOT COMPLETED|Overall Study||1
1607199|NCT00961402|3931112|P2|COMPLETED|Overall Study||61
1607200|NCT00961402|3931113|P1|COMPLETED|Overall Study||63
1607201|NCT00961402|3931112|P2|Randomized|Overall Study||66
1607202|NCT00961402|3931113|P1|Randomized|Overall Study||64
1607203|NCT00961402|3931112|P2|STARTED|Overall Study||66
1607204|NCT00961402|3931113|P1|STARTED|Overall Study||64
1607205|NCT00961350|3931127|P2|NOT COMPLETED|Overall Study||67
1607206|NCT00961350|3931128|P1|NOT COMPLETED|Overall Study||47
1607207|NCT00961350|3931127|P2|COMPLETED|Overall Study||198
1607208|NCT00961350|3931128|P1|COMPLETED|Overall Study||218
1607209|NCT00961350|3931127|P2|Safety Population|Overall Study||265
1607210|NCT00961350|3931128|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
1607211|NCT00961350|3931127|P2|Intent-to-Treat Population (ITT)|Overall Study||265
1607212|NCT00961350|3931128|P1|Intent-to-Treat Population (ITT)|Overall Study||265
1607213|NCT00961350|3931127|P2|STARTED|Overall Study||265
1607214|NCT00961350|3931128|P1|STARTED|Overall Study||265
1607215|NCT00961311|3931142|P1|NOT COMPLETED|Overall Study||0
1607216|NCT00961311|3931142|P1|COMPLETED|Overall Study||51
1607217|NCT00961311|3931142|P1|STARTED|Overall Study||51
1607218|NCT00961298|3931149|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
1607219|NCT00961298|3931149|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
1607220|NCT00961298|3931149|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
1607221|NCT00961298|3931149|P1|NOT COMPLETED|Two Week Placebo Run in||1
1607222|NCT00961298|3931149|P1|COMPLETED|Two Week Placebo Run in||14
1607223|NCT00961298|3931149|P1|STARTED|Two Week Placebo Run in||15
1607224|NCT00961259|3931156|P3|NOT COMPLETED|Third Intervention||0
1607225|NCT00961259|3931157|P2|NOT COMPLETED|Third Intervention||0
1607226|NCT00961259|3931158|P1|NOT COMPLETED|Third Intervention||0
1607227|NCT00961259|3931156|P3|COMPLETED|Third Intervention||18
1607228|NCT00961259|3931157|P2|COMPLETED|Third Intervention||17
1607229|NCT00961259|3931158|P1|COMPLETED|Third Intervention||18
1607230|NCT00961259|3931156|P3|STARTED|Third Intervention||18
1607231|NCT00961259|3931157|P2|STARTED|Third Intervention||17
1607232|NCT00961259|3931158|P1|STARTED|Third Intervention||18
1607233|NCT00961259|3931156|P3|NOT COMPLETED|Washout Period of 7 Days||0
1607234|NCT00961259|3931157|P2|NOT COMPLETED|Washout Period of 7 Days||0
1607235|NCT00961259|3931158|P1|NOT COMPLETED|Washout Period of 7 Days||0
1607236|NCT00961259|3931156|P3|COMPLETED|Washout Period of 7 Days||18
1607237|NCT00961259|3931157|P2|COMPLETED|Washout Period of 7 Days||17
1607238|NCT00961259|3931158|P1|COMPLETED|Washout Period of 7 Days||18
1607239|NCT00961259|3931156|P3|STARTED|Washout Period of 7 Days||18
1607240|NCT00961259|3931157|P2|STARTED|Washout Period of 7 Days||17
1607241|NCT00961259|3931158|P1|STARTED|Washout Period of 7 Days||18
1607242|NCT00961259|3931156|P3|NOT COMPLETED|Second Intervention||0
1607243|NCT00961259|3931157|P2|NOT COMPLETED|Second Intervention||0
1607244|NCT00961259|3931158|P1|NOT COMPLETED|Second Intervention||0
1607245|NCT00961259|3931156|P3|COMPLETED|Second Intervention||18
1607246|NCT00961259|3931157|P2|COMPLETED|Second Intervention||17
1607247|NCT00961259|3931158|P1|COMPLETED|Second Intervention||18
1607248|NCT00961259|3931156|P3|STARTED|Second Intervention||18
1607249|NCT00961259|3931157|P2|STARTED|Second Intervention||17
1607250|NCT00961259|3931158|P1|STARTED|Second Intervention||18
1607251|NCT00961259|3931156|P3|NOT COMPLETED|Washout Period of 7 Days||0
1607252|NCT00961259|3931157|P2|NOT COMPLETED|Washout Period of 7 Days||1
1607253|NCT00961259|3931158|P1|NOT COMPLETED|Washout Period of 7 Days||0
1607254|NCT00961259|3931156|P3|COMPLETED|Washout Period of 7 Days||18
1607255|NCT00961259|3931157|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
1607256|NCT00961259|3931158|P1|COMPLETED|Washout Period of 7 Days||18
1607257|NCT00961259|3931156|P3|STARTED|Washout Period of 7 Days||18
1607258|NCT00961259|3931157|P2|STARTED|Washout Period of 7 Days||18
1607259|NCT00961259|3931158|P1|STARTED|Washout Period of 7 Days||18
1607260|NCT00961259|3931156|P3|NOT COMPLETED|First Intervention||0
1607261|NCT00961259|3931157|P2|NOT COMPLETED|First Intervention||0
1607262|NCT00961259|3931158|P1|NOT COMPLETED|First Intervention||0
1607263|NCT00961259|3931156|P3|COMPLETED|First Intervention||18
1607264|NCT00961259|3931157|P2|COMPLETED|First Intervention||18
1607265|NCT00961259|3931158|P1|COMPLETED|First Intervention||18
1607266|NCT00961259|3931156|P3|STARTED|First Intervention||18
1607267|NCT00961259|3931157|P2|STARTED|First Intervention||18
1607268|NCT00961259|3931158|P1|STARTED|First Intervention||18
1607269|NCT00961233|3931177|P2|NOT COMPLETED|Overall Study||1
1607270|NCT00961233|3931178|P1|NOT COMPLETED|Overall Study||2
1607271|NCT00961233|3931177|P2|COMPLETED|Overall Study||11
1607272|NCT00961233|3931178|P1|COMPLETED|Overall Study||11
1607273|NCT00961233|3931177|P2|STARTED|Overall Study||12
1607274|NCT00961233|3931178|P1|STARTED|Overall Study||13
1607275|NCT00961220|3931186|P1|NOT COMPLETED|Overall Study||7
1607276|NCT00961220|3931186|P1|COMPLETED|Overall Study||10
1607277|NCT00961220|3931186|P1|STARTED|Overall Study||17
1607278|NCT00961181|3931202|P1|NOT COMPLETED|Overall Study||5
1607279|NCT00961181|3931202|P1|COMPLETED|Overall Study||76
1607280|NCT00961181|3931202|P1|STARTED|Overall Study||81
1607281|NCT00961116|3931215|P2|NOT COMPLETED|Second Intervention||0
1607282|NCT00961116|3931216|P1|NOT COMPLETED|Second Intervention||0
1607283|NCT00961116|3931215|P2|COMPLETED|Second Intervention||24
1607284|NCT00961116|3931216|P1|COMPLETED|Second Intervention||25
1607285|NCT00961116|3931215|P2|STARTED|Second Intervention||24
1607286|NCT00961116|3931216|P1|STARTED|Second Intervention||25
1607287|NCT00961116|3931215|P2|NOT COMPLETED|Washout Period of 7 Days||3
1607288|NCT00961116|3931216|P1|NOT COMPLETED|Washout Period of 7 Days||2
1607289|NCT00961116|3931215|P2|COMPLETED|Washout Period of 7 Days||24
1607290|NCT00961116|3931216|P1|COMPLETED|Washout Period of 7 Days||25
1607291|NCT00961116|3931215|P2|STARTED|Washout Period of 7 Days||27
1607292|NCT00961116|3931216|P1|STARTED|Washout Period of 7 Days||27
1607293|NCT00961116|3931215|P2|NOT COMPLETED|First Intervention||0
1607294|NCT00961116|3931216|P1|NOT COMPLETED|First Intervention||0
1607295|NCT00961116|3931215|P2|COMPLETED|First Intervention||27
1607296|NCT00961116|3931216|P1|COMPLETED|First Intervention||27
1607297|NCT00961116|3931215|P2|STARTED|First Intervention||27
1607298|NCT00961116|3931216|P1|STARTED|First Intervention||27
1607299|NCT00961051|3931228|P2|NOT COMPLETED|Overall Study||14
1607300|NCT00961051|3931229|P1|NOT COMPLETED|Overall Study||12
1607301|NCT00961051|3931228|P2|COMPLETED|Overall Study||79
1607302|NCT00961051|3931229|P1|COMPLETED|Overall Study||165
1607303|NCT00961051|3931228|P2|STARTED|Overall Study||93
1607304|NCT00961051|3931229|P1|STARTED|Overall Study||177
1607305|NCT00960999|3931239|P2|NOT COMPLETED|Overall Study||2
1607306|NCT00960999|3931240|P1|NOT COMPLETED|Overall Study||8
1607307|NCT00960999|3931239|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|45
1607308|NCT00960999|3931240|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|39
1607309|NCT00960999|3931239|P2|STARTED|Overall Study||47
1607310|NCT00960999|3931240|P1|STARTED|Overall Study||47
1607311|NCT00960986|3931250|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
1607312|NCT00960986|3931251|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
1607313|NCT00960986|3931252|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
1607314|NCT00960986|3931253|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
1607315|NCT00960986|3931250|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
1607316|NCT00960986|3931251|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
1607317|NCT00960986|3931252|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
1607318|NCT00960986|3931253|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
1607319|NCT00960986|3931250|P4|STARTED|Period 3 (7-week Therapy Period)||61
1607320|NCT00960986|3931251|P3|STARTED|Period 3 (7-week Therapy Period)||59
1607321|NCT00960986|3931252|P2|STARTED|Period 3 (7-week Therapy Period)||59
1607322|NCT00960986|3931253|P1|STARTED|Period 3 (7-week Therapy Period)||56
1607323|NCT00960986|3931250|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1607324|NCT00960986|3931251|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1607325|NCT00960986|3931252|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1607326|NCT00960986|3931253|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1607327|NCT00960986|3931250|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
1607328|NCT00960986|3931251|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
1607329|NCT00960986|3931252|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
1607330|NCT00960986|3931253|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
1607331|NCT00960986|3931250|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
1607332|NCT00960986|3931251|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
1607333|NCT00960986|3931252|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
1607334|NCT00960986|3931253|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
1607335|NCT00960986|3931250|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
1607336|NCT00960986|3931251|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
1607337|NCT00960986|3931252|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
1607338|NCT00960986|3931253|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
1607339|NCT00960986|3931250|P4|COMPLETED|Period 1 (Screening and Washout)||61
1607340|NCT00960986|3931251|P3|COMPLETED|Period 1 (Screening and Washout)||59
1607341|NCT00960986|3931252|P2|COMPLETED|Period 1 (Screening and Washout)||59
1607342|NCT00960986|3931253|P1|COMPLETED|Period 1 (Screening and Washout)||56
1607343|NCT00960986|3931250|P4|STARTED|Period 1 (Screening and Washout)||64
1607344|NCT00960986|3931251|P3|STARTED|Period 1 (Screening and Washout)||63
1607345|NCT00960986|3931252|P2|STARTED|Period 1 (Screening and Washout)||63
1607346|NCT00960986|3931253|P1|STARTED|Period 1 (Screening and Washout)||59
1607347|NCT00960934|3931329|P6|NOT COMPLETED|Overall Study||64
1607348|NCT00960934|3931330|P5|NOT COMPLETED|Overall Study||64
1607349|NCT00960934|3931331|P4|NOT COMPLETED|Overall Study||64
1607350|NCT00960934|3931332|P3|NOT COMPLETED|Overall Study||64
1607351|NCT00960934|3931333|P2|NOT COMPLETED|Overall Study||63
1607352|NCT00960934|3931334|P1|NOT COMPLETED|Overall Study||64
1607353|NCT00960934|3931329|P6|COMPLETED|Overall Study||0
1607354|NCT00960934|3931330|P5|COMPLETED|Overall Study||0
1607355|NCT00960934|3931331|P4|COMPLETED|Overall Study||0
1607356|NCT00960934|3931332|P3|COMPLETED|Overall Study||0
1607357|NCT00960934|3931333|P2|COMPLETED|Overall Study||0
1607358|NCT00960934|3931334|P1|COMPLETED|Overall Study||0
1607359|NCT00960934|3931329|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
1607360|NCT00960934|3931330|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
1607361|NCT00960934|3931331|P4|Number Treated|Overall Study||64
1607362|NCT00960934|3931332|P3|Number Treated|Overall Study||64
1607363|NCT00960934|3931333|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
1607364|NCT00960934|3931334|P1|Number Treated|Overall Study||64
1607365|NCT00960934|3931329|P6|STARTED|Overall Study||64
1607366|NCT00960934|3931330|P5|STARTED|Overall Study||64
1607367|NCT00960934|3931331|P4|STARTED|Overall Study||64
1607368|NCT00960934|3931332|P3|STARTED|Overall Study||64
1607369|NCT00960934|3931333|P2|STARTED|Overall Study||63
1607370|NCT00960934|3931334|P1|STARTED|Overall Study||64
1607371|NCT00960869|3931446|P2|NOT COMPLETED|Overall Study||62
1607372|NCT00960869|3931447|P1|NOT COMPLETED|Overall Study||53
1607373|NCT00960869|3931446|P2|COMPLETED|Overall Study||198
1607374|NCT00960869|3931447|P1|COMPLETED|Overall Study||206
1607375|NCT00960869|3931446|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
1607376|NCT00960869|3931447|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
1607377|NCT00960869|3931446|P2|Intent-to-Treat Population (ITT)|Overall Study||260
1607378|NCT00960869|3931447|P1|Intent-to-Treat Population (ITT)|Overall Study||259
1607379|NCT00960869|3931446|P2|STARTED|Overall Study||260
1607380|NCT00960869|3931447|P1|STARTED|Overall Study||259
1607381|NCT00960856|3931461|P4|NOT COMPLETED|Period IV||0
1607382|NCT00960856|3931462|P3|NOT COMPLETED|Period IV||0
1607383|NCT00960856|3931463|P2|NOT COMPLETED|Period IV||0
1607384|NCT00960856|3931464|P1|NOT COMPLETED|Period IV||0
1607385|NCT00960856|3931461|P4|COMPLETED|Period IV||9
1607386|NCT00960856|3931462|P3|COMPLETED|Period IV||8
1607387|NCT00960856|3931463|P2|COMPLETED|Period IV||7
1607388|NCT00960856|3931464|P1|COMPLETED|Period IV||10
1607389|NCT00960856|3931461|P4|STARTED|Period IV||9
1607390|NCT00960856|3931462|P3|STARTED|Period IV||8
1607391|NCT00960856|3931463|P2|STARTED|Period IV||7
1607392|NCT00960856|3931464|P1|STARTED|Period IV||10
1607393|NCT00960856|3931461|P4|NOT COMPLETED|Washout Period of 7 Days||0
1607394|NCT00960856|3931462|P3|NOT COMPLETED|Washout Period of 7 Days||1
1607395|NCT00960856|3931463|P2|NOT COMPLETED|Washout Period of 7 Days||0
1607396|NCT00960856|3931464|P1|NOT COMPLETED|Washout Period of 7 Days||0
1607397|NCT00960856|3931461|P4|COMPLETED|Washout Period of 7 Days||9
1607398|NCT00960856|3931462|P3|COMPLETED|Washout Period of 7 Days||8
1607399|NCT00960856|3931463|P2|COMPLETED|Washout Period of 7 Days||7
1607400|NCT00960856|3931464|P1|COMPLETED|Washout Period of 7 Days||10
1607401|NCT00960856|3931461|P4|STARTED|Washout Period of 7 Days||9
1607402|NCT00960856|3931462|P3|STARTED|Washout Period of 7 Days||9
1607403|NCT00960856|3931463|P2|STARTED|Washout Period of 7 Days||7
1607404|NCT00960856|3931464|P1|STARTED|Washout Period of 7 Days||10
1607405|NCT00960856|3931461|P4|NOT COMPLETED|Period III||0
1607406|NCT00960856|3931462|P3|NOT COMPLETED|Period III||0
1607407|NCT00960856|3931463|P2|NOT COMPLETED|Period III||0
1607408|NCT00960856|3931464|P1|NOT COMPLETED|Period III||0
1607409|NCT00960856|3931461|P4|COMPLETED|Period III||9
1607410|NCT00960856|3931462|P3|COMPLETED|Period III||9
1607411|NCT00960856|3931463|P2|COMPLETED|Period III||7
1607412|NCT00960856|3931464|P1|COMPLETED|Period III||10
1607413|NCT00960856|3931461|P4|STARTED|Period III||9
1607414|NCT00960856|3931462|P3|STARTED|Period III||9
1607415|NCT00960856|3931463|P2|STARTED|Period III||7
1607416|NCT00960856|3931464|P1|STARTED|Period III||10
1607417|NCT00960856|3931461|P4|NOT COMPLETED|Washout Period of 7 Days||0
1607418|NCT00960856|3931462|P3|NOT COMPLETED|Washout Period of 7 Days||0
1607419|NCT00960856|3931463|P2|NOT COMPLETED|Washout Period of 7 Days||0
1607420|NCT00960856|3931464|P1|NOT COMPLETED|Washout Period of 7 Days||0
1607421|NCT00960856|3931461|P4|COMPLETED|Washout Period of 7 Days||9
1607422|NCT00960856|3931462|P3|COMPLETED|Washout Period of 7 Days||9
1607423|NCT00960856|3931463|P2|COMPLETED|Washout Period of 7 Days||7
1607424|NCT00960856|3931464|P1|COMPLETED|Washout Period of 7 Days||10
1607425|NCT00960856|3931461|P4|STARTED|Washout Period of 7 Days||9
1607426|NCT00960856|3931462|P3|STARTED|Washout Period of 7 Days||9
1607427|NCT00960856|3931463|P2|STARTED|Washout Period of 7 Days||7
1607428|NCT00960856|3931464|P1|STARTED|Washout Period of 7 Days||10
1607429|NCT00960856|3931461|P4|NOT COMPLETED|Period II||0
1607430|NCT00960856|3931462|P3|NOT COMPLETED|Period II||0
1607431|NCT00960856|3931463|P2|NOT COMPLETED|Period II||0
1607432|NCT00960856|3931464|P1|NOT COMPLETED|Period II||0
1607433|NCT00960856|3931461|P4|COMPLETED|Period II||9
1607434|NCT00960856|3931462|P3|COMPLETED|Period II||9
1607435|NCT00960856|3931463|P2|COMPLETED|Period II||7
1607436|NCT00960856|3931464|P1|COMPLETED|Period II||10
1607437|NCT00960856|3931461|P4|STARTED|Period II||9
1607438|NCT00960856|3931462|P3|STARTED|Period II||9
1607439|NCT00960856|3931463|P2|STARTED|Period II||7
1607440|NCT00960856|3931464|P1|STARTED|Period II||10
1607441|NCT00960856|3931461|P4|NOT COMPLETED|Washout Period of 7 Days||0
1607442|NCT00960856|3931462|P3|NOT COMPLETED|Washout Period of 7 Days||0
1607443|NCT00960856|3931463|P2|NOT COMPLETED|Washout Period of 7 Days||2
1607444|NCT00960856|3931464|P1|NOT COMPLETED|Washout Period of 7 Days||0
1607445|NCT00960856|3931461|P4|COMPLETED|Washout Period of 7 Days||9
1607446|NCT00960856|3931462|P3|COMPLETED|Washout Period of 7 Days||9
1607447|NCT00960856|3931463|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
1607448|NCT00960856|3931464|P1|COMPLETED|Washout Period of 7 Days||10
1607449|NCT00960856|3931461|P4|STARTED|Washout Period of 7 Days||9
1607450|NCT00960856|3931462|P3|STARTED|Washout Period of 7 Days||9
1607451|NCT00960856|3931463|P2|STARTED|Washout Period of 7 Days||9
1607452|NCT00960856|3931464|P1|STARTED|Washout Period of 7 Days||10
1607453|NCT00960856|3931461|P4|NOT COMPLETED|Period I||0
1607454|NCT00960856|3931462|P3|NOT COMPLETED|Period I||0
1607455|NCT00960856|3931463|P2|NOT COMPLETED|Period I||0
1607456|NCT00960856|3931464|P1|NOT COMPLETED|Period I||0
1607457|NCT00960856|3931461|P4|COMPLETED|Period I||9
1607458|NCT00960856|3931462|P3|COMPLETED|Period I||9
1607459|NCT00960856|3931463|P2|COMPLETED|Period I||9
1607460|NCT00960856|3931464|P1|COMPLETED|Period I||10
1607461|NCT00960856|3931461|P4|STARTED|Period I||9
1607462|NCT00960856|3931462|P3|STARTED|Period I||9
1607463|NCT00960856|3931463|P2|STARTED|Period I||9
1607464|NCT00960856|3931464|P1|STARTED|Period I||10
1607465|NCT00960843|3931484|P2|NOT COMPLETED|Overall Study||5
1607466|NCT00960843|3931485|P1|NOT COMPLETED|Overall Study||2
1607467|NCT00960843|3931484|P2|COMPLETED|Overall Study||21
1607468|NCT00960843|3931485|P1|COMPLETED|Overall Study||23
1607469|NCT00960843|3931484|P2|STARTED|Overall Study||26
1607470|NCT00960843|3931485|P1|STARTED|Overall Study||25
1607471|NCT00960778|3931497|P2|NOT COMPLETED|Overall Study||3
1607472|NCT00960778|3931498|P1|NOT COMPLETED|Overall Study||9
1607473|NCT00960778|3931497|P2|COMPLETED|Overall Study||13
1607474|NCT00960778|3931498|P1|COMPLETED|Overall Study||8
1607475|NCT00960778|3931497|P2|STARTED|Overall Study||16
1607476|NCT00960778|3931498|P1|STARTED|Overall Study||17
1607477|NCT00960687|3931506|P2|NOT COMPLETED|Second Intervention||0
1607478|NCT00960687|3931507|P1|NOT COMPLETED|Second Intervention||0
1607479|NCT00960687|3931506|P2|COMPLETED|Second Intervention||24
1607480|NCT00960687|3931507|P1|COMPLETED|Second Intervention||23
1607481|NCT00960687|3931506|P2|STARTED|Second Intervention||24
1607482|NCT00960687|3931507|P1|STARTED|Second Intervention||23
1607483|NCT00960687|3931506|P2|NOT COMPLETED|Washout Period of 7 Days||3
1607484|NCT00960687|3931507|P1|NOT COMPLETED|Washout Period of 7 Days||4
1607485|NCT00960687|3931506|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
1607486|NCT00960687|3931507|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
1607487|NCT00960687|3931506|P2|STARTED|Washout Period of 7 Days||27
1607488|NCT00960687|3931507|P1|STARTED|Washout Period of 7 Days||27
1607489|NCT00960687|3931506|P2|NOT COMPLETED|First Intervention||0
1607490|NCT00960687|3931507|P1|NOT COMPLETED|First Intervention||0
1607491|NCT00960687|3931506|P2|COMPLETED|First Intervention||27
1607492|NCT00960687|3931507|P1|COMPLETED|First Intervention||27
1607493|NCT00960687|3931506|P2|STARTED|First Intervention||27
1607494|NCT00960687|3931507|P1|STARTED|First Intervention||27
1607495|NCT00960661|3931519|P3|NOT COMPLETED|Interventional Phase||46
1607496|NCT00960661|3931520|P2|NOT COMPLETED|Interventional Phase||52
1607497|NCT00960661|3931521|P1|NOT COMPLETED|Interventional Phase||0
1607498|NCT00960661|3931519|P3|COMPLETED|Interventional Phase||275
1607499|NCT00960661|3931520|P2|COMPLETED|Interventional Phase||264
1607500|NCT00960661|3931521|P1|COMPLETED|Interventional Phase||0
1607501|NCT00960661|3931519|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
1607502|NCT00960661|3931520|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
1607503|NCT00960661|3931521|P1|Per Protocol Population|Interventional Phase||0
1607504|NCT00960661|3931519|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
1607505|NCT00960661|3931520|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
1607506|NCT00960661|3931521|P1|Intent to Treat Population|Interventional Phase||0
1607507|NCT00960661|3931519|P3|STARTED|Interventional Phase||321
1607508|NCT00960661|3931520|P2|STARTED|Interventional Phase||316
1607509|NCT00960661|3931521|P1|STARTED|Interventional Phase||0
1607510|NCT00960661|3931519|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1607511|NCT00960661|3931520|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1607512|NCT00960661|3931521|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
1607513|NCT00960661|3931519|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1607514|NCT00960661|3931520|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1607515|NCT00960661|3931521|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
1607516|NCT00960661|3931519|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
1607517|NCT00960661|3931520|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
1607518|NCT00960661|3931521|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
1607519|NCT00960622|3931553|P2|NOT COMPLETED|Overall Study||3
1607520|NCT00960622|3931554|P1|NOT COMPLETED|Overall Study||0
1607521|NCT00960622|3931553|P2|COMPLETED|Overall Study||7
1607522|NCT00960622|3931554|P1|COMPLETED|Overall Study||10
1607523|NCT00960622|3931553|P2|STARTED|Overall Study||10
1607524|NCT00960622|3931554|P1|STARTED|Overall Study||10
1607525|NCT00960570|3931560|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
1607526|NCT00960570|3931560|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
1607527|NCT00960570|3931560|P1|STARTED|Efavirenz and Fenofibric Acid||25
1607528|NCT00960570|3931560|P1|NOT COMPLETED|1 Day Period Between Dosing||3
1607529|NCT00960570|3931560|P1|COMPLETED|1 Day Period Between Dosing||25
1607530|NCT00960570|3931560|P1|STARTED|1 Day Period Between Dosing||28
1607531|NCT00960570|3931560|P1|NOT COMPLETED|Fenofibric Acid Alone||0
1607532|NCT00960570|3931560|P1|COMPLETED|Fenofibric Acid Alone||28
1607533|NCT00960570|3931560|P1|STARTED|Fenofibric Acid Alone||28
1607534|NCT00960570|3931560|P1|NOT COMPLETED|21 Day Washout Period||2
1607535|NCT00960570|3931560|P1|COMPLETED|21 Day Washout Period||28
1607536|NCT00960570|3931560|P1|STARTED|21 Day Washout Period||30
1607537|NCT00960570|3931560|P1|NOT COMPLETED|Efavirenz Alone||0
1607538|NCT00960570|3931560|P1|COMPLETED|Efavirenz Alone||30
1607539|NCT00960570|3931560|P1|STARTED|Efavirenz Alone||30
1607540|NCT00960531|3931581|P10|NOT COMPLETED|Overall Study||1
1607541|NCT00960531|3931582|P9|NOT COMPLETED|Overall Study||14
1607542|NCT00960531|3931583|P8|NOT COMPLETED|Overall Study||4
1607543|NCT00960531|3931584|P7|NOT COMPLETED|Overall Study||24
1607544|NCT00960531|3931585|P6|NOT COMPLETED|Overall Study||3
1607545|NCT00960531|3931586|P5|NOT COMPLETED|Overall Study||2
1607546|NCT00960531|3931587|P4|NOT COMPLETED|Overall Study||8
1607547|NCT00960531|3931588|P3|NOT COMPLETED|Overall Study||26
1607548|NCT00960531|3931589|P2|NOT COMPLETED|Overall Study||1
1607549|NCT00960531|3931590|P1|NOT COMPLETED|Overall Study||10
1607550|NCT00960531|3931581|P10|COMPLETED|Overall Study|Completed study|3
1607551|NCT00960531|3931582|P9|COMPLETED|Overall Study|Completed study|2
1607552|NCT00960531|3931583|P8|COMPLETED|Overall Study|Completed study|2
1607553|NCT00960531|3931584|P7|COMPLETED|Overall Study|Completed study|3
1607554|NCT00960531|3931585|P6|COMPLETED|Overall Study|Completed study|6
1607555|NCT00960531|3931586|P5|COMPLETED|Overall Study|Completed study|3
1607556|NCT00960531|3931587|P4|COMPLETED|Overall Study|Completed study|17
1607557|NCT00960531|3931588|P3|COMPLETED|Overall Study|Completed study|15
1607558|NCT00960531|3931589|P2|COMPLETED|Overall Study|Completed study|5
1607559|NCT00960531|3931590|P1|COMPLETED|Overall Study|Completed study|11
1607560|NCT00960531|3931581|P10|Completed Treatment|Overall Study||4
1607561|NCT00960531|3931582|P9|Completed Treatment|Overall Study||2
1607562|NCT00960531|3931583|P8|Completed Treatment|Overall Study||3
1607563|NCT00960531|3931584|P7|Completed Treatment|Overall Study||4
1607564|NCT00960531|3931585|P6|Completed Treatment|Overall Study||7
1607565|NCT00960531|3931586|P5|Completed Treatment|Overall Study||3
1607566|NCT00960531|3931587|P4|Completed Treatment|Overall Study||17
1607567|NCT00960531|3931588|P3|Completed Treatment|Overall Study||15
1607568|NCT00960531|3931589|P2|Completed Treatment|Overall Study||5
1607569|NCT00960531|3931590|P1|Completed Treatment|Overall Study||12
1607570|NCT00960531|3931581|P10|Treated|Overall Study||4
1607571|NCT00960531|3931582|P9|Treated|Overall Study||16
1607572|NCT00960531|3931583|P8|Treated|Overall Study||6
1607573|NCT00960531|3931584|P7|Treated|Overall Study||27
1607574|NCT00960531|3931585|P6|Treated|Overall Study||9
1607575|NCT00960531|3931586|P5|Treated|Overall Study||5
1607576|NCT00960531|3931587|P4|Treated|Overall Study||24
1607577|NCT00960531|3931588|P3|Treated|Overall Study||41
1607578|NCT00960531|3931589|P2|Treated|Overall Study||6
1607579|NCT00960531|3931590|P1|Treated|Overall Study||21
1607580|NCT00960531|3931581|P10|STARTED|Overall Study|Started=Randomized|4
1607581|NCT00960531|3931582|P9|STARTED|Overall Study|Started=Randomized|16
1607582|NCT00960531|3931583|P8|STARTED|Overall Study|Started=Randomized|6
1607583|NCT00960531|3931584|P7|STARTED|Overall Study|Started=Randomized|27
1607584|NCT00960531|3931585|P6|STARTED|Overall Study|Started=Randomized|9
1607585|NCT00960531|3931586|P5|STARTED|Overall Study|Started=Randomized|5
1607586|NCT00960531|3931587|P4|STARTED|Overall Study|Started=Randomized.|25
1607587|NCT00960531|3931588|P3|STARTED|Overall Study|Started=Randomized|41
1607588|NCT00960531|3931589|P2|STARTED|Overall Study|Started=Randomized|6
1607589|NCT00960531|3931590|P1|STARTED|Overall Study|Started=Randomized|21
1607590|NCT00960440|3931638|P4|NOT COMPLETED|Overall Study||18
1607591|NCT00960440|3931639|P3|NOT COMPLETED|Overall Study||13
1607592|NCT00960440|3931640|P2|NOT COMPLETED|Overall Study||31
1607593|NCT00960440|3931641|P1|NOT COMPLETED|Overall Study||26
1607594|NCT00960440|3931638|P4|COMPLETED|Overall Study||48
1607595|NCT00960440|3931639|P3|COMPLETED|Overall Study||53
1607596|NCT00960440|3931640|P2|COMPLETED|Overall Study||103
1607597|NCT00960440|3931641|P1|COMPLETED|Overall Study||107
1607598|NCT00960440|3931638|P4|STARTED|Overall Study||66
1607599|NCT00960440|3931639|P3|STARTED|Overall Study||66
1607600|NCT00960440|3931640|P2|STARTED|Overall Study||134
1607601|NCT00960440|3931641|P1|STARTED|Overall Study||133
1607602|NCT00960375|3931813|P2|NOT COMPLETED|Overall Study||22
1607603|NCT00960375|3931814|P1|NOT COMPLETED|Overall Study||20
1607604|NCT00960375|3931813|P2|COMPLETED|Overall Study||65
1607605|NCT00960375|3931814|P1|COMPLETED|Overall Study||72
1607606|NCT00960375|3931813|P2|STARTED|Overall Study||87
1607607|NCT00960375|3931814|P1|STARTED|Overall Study||92
1607608|NCT00960323|3931822|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
1607609|NCT00960323|3931822|P1|COMPLETED|Colchicine and Atorvastatin||23
1607610|NCT00960323|3931822|P1|STARTED|Colchicine and Atorvastatin||23
1607611|NCT00960323|3931822|P1|NOT COMPLETED|Atorvastatin Alone||1
1607612|NCT00960323|3931822|P1|COMPLETED|Atorvastatin Alone||23
1607613|NCT00960323|3931822|P1|STARTED|Atorvastatin Alone||24
1607614|NCT00960323|3931822|P1|NOT COMPLETED|14 Day Washout Period||0
1607615|NCT00960323|3931822|P1|COMPLETED|14 Day Washout Period||24
1607616|NCT00960323|3931822|P1|STARTED|14 Day Washout Period||24
1607617|NCT00960323|3931822|P1|NOT COMPLETED|Colchicine Alone||0
1607618|NCT00960323|3931822|P1|COMPLETED|Colchicine Alone||24
1607619|NCT00960323|3931822|P1|STARTED|Colchicine Alone||24
1607620|NCT00960297|3931833|P1|NOT COMPLETED|Overall Study||3
1607621|NCT00960297|3931833|P1|COMPLETED|Overall Study||1
1607622|NCT00960297|3931833|P1|STARTED|Overall Study||4
1607623|NCT00960206|3931840|P3|NOT COMPLETED|Overall Study||12
1607624|NCT00960206|3931841|P2|NOT COMPLETED|Overall Study||27
1607625|NCT00960206|3931842|P1|NOT COMPLETED|Overall Study||40
1607626|NCT00960206|3931840|P3|COMPLETED|Overall Study||77
1607627|NCT00960206|3931841|P2|COMPLETED|Overall Study||158
1607628|NCT00960206|3931842|P1|COMPLETED|Overall Study||150
1607629|NCT00960206|3931840|P3|STARTED|Overall Study||89
1607630|NCT00960206|3931841|P2|STARTED|Overall Study||185
1607631|NCT00960206|3931842|P1|STARTED|Overall Study||190
1607632|NCT00960193|3931860|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
1607633|NCT00960193|3931860|P1|COMPLETED|Colchicine With Seville Orange Juice||23
1607634|NCT00960193|3931860|P1|STARTED|Colchicine With Seville Orange Juice||23
1607635|NCT00960193|3931860|P1|NOT COMPLETED|Seville Orange Juice Alone||0
1607636|NCT00960193|3931860|P1|COMPLETED|Seville Orange Juice Alone||23
1607637|NCT00960193|3931860|P1|STARTED|Seville Orange Juice Alone||23
1607638|NCT00960193|3931860|P1|NOT COMPLETED|14 Day Washout Period||1
1607639|NCT00960193|3931860|P1|COMPLETED|14 Day Washout Period||23
1607640|NCT00960193|3931860|P1|STARTED|14 Day Washout Period||24
1607641|NCT00960193|3931860|P1|NOT COMPLETED|Colchicine Alone||0
1607642|NCT00960193|3931860|P1|COMPLETED|Colchicine Alone||24
1607643|NCT00960193|3931860|P1|STARTED|Colchicine Alone||24
1607644|NCT00960154|3931873|P2|NOT COMPLETED|Overall Study||25
1607645|NCT00960154|3931874|P1|NOT COMPLETED|Overall Study||25
1607646|NCT00960154|3931873|P2|COMPLETED|Overall Study||0
1607647|NCT00960154|3931874|P1|COMPLETED|Overall Study||0
1607648|NCT00960154|3931873|P2|STARTED|Overall Study||25
1607649|NCT00960154|3931874|P1|STARTED|Overall Study||25
1607650|NCT00960141|3931885|P3|NOT COMPLETED|Overall Study||7
1607651|NCT00960141|3931886|P2|NOT COMPLETED|Overall Study||17
1607652|NCT00960141|3931887|P1|NOT COMPLETED|Overall Study||10
1607653|NCT00960141|3931885|P3|COMPLETED|Overall Study||163
1607654|NCT00960141|3931886|P2|COMPLETED|Overall Study||309
1607655|NCT00960141|3931887|P1|COMPLETED|Overall Study||323
1607656|NCT00960141|3931885|P3|STARTED|Overall Study||170
1607657|NCT00960141|3931886|P2|STARTED|Overall Study||326
1607658|NCT00960141|3931887|P1|STARTED|Overall Study||333
1607659|NCT00960115|3931912|P2|NOT COMPLETED|Overall Study||15
1607660|NCT00960115|3931913|P1|NOT COMPLETED|Overall Study||19
1607661|NCT00960115|3931912|P2|COMPLETED|Overall Study||43
1607662|NCT00960115|3931913|P1|COMPLETED|Overall Study||95
1607663|NCT00960115|3931912|P2|STARTED|Overall Study||58
1607664|NCT00960115|3931913|P1|STARTED|Overall Study||114
1607665|NCT00960076|3931927|P2|NOT COMPLETED|Overall Study||25
1607666|NCT00960076|3931928|P1|NOT COMPLETED|Overall Study||8
1607667|NCT00960076|3931927|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
1607668|NCT00960076|3931928|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
1607669|NCT00960076|3931927|P2|STARTED|Overall Study|Randomized and treated|144
1607670|NCT00960076|3931928|P1|STARTED|Overall Study|Randomized and treated|138
1607671|NCT00960063|3931943|P3|NOT COMPLETED|Overall Study||3
1607672|NCT00960063|3931944|P2|NOT COMPLETED|Overall Study||0
1607673|NCT00960063|3931945|P1|NOT COMPLETED|Overall Study||1
1607674|NCT00960063|3931943|P3|COMPLETED|Overall Study||0
1607675|NCT00960063|3931944|P2|COMPLETED|Overall Study||0
1607676|NCT00960063|3931945|P1|COMPLETED|Overall Study||0
1607677|NCT00960063|3931943|P3|STARTED|Overall Study||3
1607678|NCT00960063|3931944|P2|STARTED|Overall Study||0
1607679|NCT00960063|3931945|P1|STARTED|Overall Study||1
1607680|NCT00959985|3931987|P4|NOT COMPLETED|Overall Study||0
1607681|NCT00959985|3931988|P3|NOT COMPLETED|Overall Study||0
1607682|NCT00959985|3931989|P2|NOT COMPLETED|Overall Study||0
1607683|NCT00959985|3931990|P1|NOT COMPLETED|Overall Study||0
1607684|NCT00959985|3931987|P4|COMPLETED|Overall Study||4
1607685|NCT00959985|3931988|P3|COMPLETED|Overall Study||4
1607686|NCT00959985|3931989|P2|COMPLETED|Overall Study||7
1607687|NCT00959985|3931990|P1|COMPLETED|Overall Study||8
1607688|NCT00959985|3931987|P4|STARTED|Overall Study||4
1607689|NCT00959985|3931988|P3|STARTED|Overall Study||4
1607690|NCT00959985|3931989|P2|STARTED|Overall Study||7
1607691|NCT00959985|3931990|P1|STARTED|Overall Study||8
1607692|NCT00959946|3932036|P8|NOT COMPLETED|Overall Study||2
1607693|NCT00959946|3932037|P7|NOT COMPLETED|Overall Study||2
1607694|NCT00959946|3932038|P6|NOT COMPLETED|Overall Study||9
1607695|NCT00959946|3932039|P5|NOT COMPLETED|Overall Study||4
1607696|NCT00959946|3932040|P4|NOT COMPLETED|Overall Study||5
1607697|NCT00959946|3932041|P3|NOT COMPLETED|Overall Study||4
1607698|NCT00959946|3932042|P2|NOT COMPLETED|Overall Study||4
1607699|NCT00959946|3932043|P1|NOT COMPLETED|Overall Study||2
1607700|NCT00959946|3932036|P8|COMPLETED|Overall Study||0
1607701|NCT00959946|3932037|P7|COMPLETED|Overall Study||0
1607702|NCT00959946|3932038|P6|COMPLETED|Overall Study||0
1607703|NCT00959946|3932039|P5|COMPLETED|Overall Study||0
1607704|NCT00959946|3932040|P4|COMPLETED|Overall Study||0
1607705|NCT00959946|3932041|P3|COMPLETED|Overall Study||0
1607706|NCT00959946|3932042|P2|COMPLETED|Overall Study||0
1607707|NCT00959946|3932043|P1|COMPLETED|Overall Study||0
1607708|NCT00959946|3932036|P8|STARTED|Overall Study||2
1607709|NCT00959946|3932037|P7|STARTED|Overall Study||2
1607710|NCT00959946|3932038|P6|STARTED|Overall Study||9
1607711|NCT00959946|3932039|P5|STARTED|Overall Study||4
1607712|NCT00959946|3932040|P4|STARTED|Overall Study||5
1607713|NCT00959946|3932041|P3|STARTED|Overall Study||4
1607714|NCT00959946|3932042|P2|STARTED|Overall Study||4
1607715|NCT00959946|3932043|P1|STARTED|Overall Study||2
1607716|NCT00959920|3932096|P2|NOT COMPLETED|Overall Study||1
1607717|NCT00959920|3932097|P1|NOT COMPLETED|Overall Study||0
1607718|NCT00959920|3932096|P2|COMPLETED|Overall Study||66
1607719|NCT00959920|3932097|P1|COMPLETED|Overall Study||72
1607720|NCT00959920|3932096|P2|STARTED|Overall Study||67
1607721|NCT00959920|3932097|P1|STARTED|Overall Study||72
1607722|NCT00959907|3932107|P2|NOT COMPLETED|Overall Study||1
1607723|NCT00959907|3932108|P1|NOT COMPLETED|Overall Study||3
1607724|NCT00959907|3932107|P2|COMPLETED|Overall Study||28
1607725|NCT00959907|3932108|P1|COMPLETED|Overall Study||27
1607726|NCT00959907|3932107|P2|STARTED|Overall Study||29
1607727|NCT00959907|3932108|P1|STARTED|Overall Study||30
1607728|NCT00959894|3932118|P1|NOT COMPLETED|Overall Study||16
1607729|NCT00959894|3932118|P1|COMPLETED|Overall Study||63
1607730|NCT00959894|3932118|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
1607731|NCT00959764|3932149|P3|NOT COMPLETED|Overall Study||36
1607732|NCT00959764|3932150|P2|NOT COMPLETED|Overall Study||57
1607733|NCT00959764|3932151|P1|NOT COMPLETED|Overall Study||95
1607734|NCT00959764|3932149|P3|COMPLETED|Overall Study||73
1607735|NCT00959764|3932150|P2|COMPLETED|Overall Study||128
1607736|NCT00959764|3932151|P1|COMPLETED|Overall Study||176
1607737|NCT00959764|3932149|P3|STARTED|Overall Study||109
1607738|NCT00959764|3932150|P2|STARTED|Overall Study||185
1607739|NCT00959764|3932151|P1|STARTED|Overall Study||271
1607740|NCT00959751|3932167|P2|NOT COMPLETED|Overall Study||12
1607741|NCT00959751|3932168|P1|NOT COMPLETED|Overall Study||9
1607742|NCT00959751|3932167|P2|COMPLETED|Overall Study||86
1607743|NCT00959751|3932168|P1|COMPLETED|Overall Study||88
1607744|NCT00959751|3932167|P2|STARTED|Overall Study||98
1607745|NCT00959751|3932168|P1|STARTED|Overall Study||97
1607746|NCT00959699|3932190|P2|NOT COMPLETED|Follow-up Period||6
1607747|NCT00959699|3932191|P1|NOT COMPLETED|Follow-up Period||6
1607748|NCT00959699|3932190|P2|COMPLETED|Follow-up Period||56
1607749|NCT00959699|3932191|P1|COMPLETED|Follow-up Period||27
1607750|NCT00959699|3932190|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
1607751|NCT00959699|3932191|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
1607752|NCT00959699|3932190|P2|NOT COMPLETED|Treatment Period||25
1607753|NCT00959699|3932191|P1|NOT COMPLETED|Treatment Period||23
1607754|NCT00959699|3932190|P2|COMPLETED|Treatment Period||40
1607755|NCT00959699|3932191|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
1607756|NCT00959699|3932190|P2|Treated|Treatment Period||64
1607757|NCT00959699|3932191|P1|Treated|Treatment Period||34
1607758|NCT00959699|3932190|P2|STARTED|Treatment Period||65
1607759|NCT00959699|3932191|P1|STARTED|Treatment Period||34
1607760|NCT00959660|3932212|P4|NOT COMPLETED|Overall Study||3
1607761|NCT00959660|3932213|P3|NOT COMPLETED|Overall Study||3
1607762|NCT00959660|3932214|P2|NOT COMPLETED|Overall Study||0
1607763|NCT00959660|3932215|P1|NOT COMPLETED|Overall Study||2
1607764|NCT00959660|3932212|P4|COMPLETED|Overall Study||22
1607765|NCT00959660|3932213|P3|COMPLETED|Overall Study||22
1607766|NCT00959660|3932214|P2|COMPLETED|Overall Study||24
1607767|NCT00959660|3932215|P1|COMPLETED|Overall Study||24
1607768|NCT00959660|3932212|P4|STARTED|Overall Study||25
1607769|NCT00959660|3932213|P3|STARTED|Overall Study||25
1607770|NCT00959660|3932214|P2|STARTED|Overall Study||24
1607771|NCT00959660|3932215|P1|STARTED|Overall Study||26
1607772|NCT00959647|3932237|P1|NOT COMPLETED|Overall Study||19
1607773|NCT00959647|3932237|P1|COMPLETED|Overall Study||0
1607774|NCT00959647|3932237|P1|STARTED|Overall Study||19
1607775|NCT00959374|3932242|P1|NOT COMPLETED|Overall Study||23
1607776|NCT00959374|3932242|P1|COMPLETED|Overall Study||218
1607777|NCT00959374|3932242|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
1607778|NCT00959192|3932256|P4|NOT COMPLETED|Overall Study||1
1607779|NCT00959192|3932257|P3|NOT COMPLETED|Overall Study||3
1607780|NCT00959192|3932258|P2|NOT COMPLETED|Overall Study||1
1607781|NCT00959192|3932259|P1|NOT COMPLETED|Overall Study||2
1607782|NCT00959192|3932256|P4|COMPLETED|Overall Study||7
1607783|NCT00959192|3932257|P3|COMPLETED|Overall Study||6
1607784|NCT00959192|3932258|P2|COMPLETED|Overall Study||8
1607785|NCT00959192|3932259|P1|COMPLETED|Overall Study||4
1607786|NCT00959192|3932256|P4|STARTED|Overall Study||8
1607787|NCT00959192|3932257|P3|STARTED|Overall Study||9
1607788|NCT00959192|3932258|P2|STARTED|Overall Study||9
1607789|NCT00959192|3932259|P1|STARTED|Overall Study||6
1607790|NCT00959049|3932307|P6|NOT COMPLETED|Overall Study||1
1607791|NCT00959049|3932308|P5|NOT COMPLETED|Overall Study||9
1607792|NCT00959049|3932309|P4|NOT COMPLETED|Overall Study||11
1607793|NCT00959049|3932310|P3|NOT COMPLETED|Overall Study||1
1607794|NCT00959049|3932311|P2|NOT COMPLETED|Overall Study||7
1607795|NCT00959049|3932312|P1|NOT COMPLETED|Overall Study||18
1607796|NCT00959049|3932307|P6|COMPLETED|Overall Study||249
1607797|NCT00959049|3932308|P5|COMPLETED|Overall Study||248
1607798|NCT00959049|3932309|P4|COMPLETED|Overall Study||217
1607799|NCT00959049|3932310|P3|COMPLETED|Overall Study||253
1607800|NCT00959049|3932311|P2|COMPLETED|Overall Study||247
1607801|NCT00959049|3932312|P1|COMPLETED|Overall Study||213
1607802|NCT00959049|3932307|P6|STARTED|Overall Study||250
1607803|NCT00959049|3932308|P5|STARTED|Overall Study||257
1607804|NCT00959049|3932309|P4|STARTED|Overall Study||228
1607805|NCT00959049|3932310|P3|STARTED|Overall Study||254
1607806|NCT00959049|3932311|P2|STARTED|Overall Study||254
1607807|NCT00959049|3932312|P1|STARTED|Overall Study||231
1607808|NCT00958919|3932362|P2|NOT COMPLETED|Second Intervention||0
1607809|NCT00958919|3932363|P1|NOT COMPLETED|Second Intervention||0
1607810|NCT00958919|3932362|P2|COMPLETED|Second Intervention||7
1607811|NCT00958919|3932363|P1|COMPLETED|Second Intervention||7
1607812|NCT00958919|3932362|P2|STARTED|Second Intervention||7
1607813|NCT00958919|3932363|P1|STARTED|Second Intervention||7
1607814|NCT00958919|3932362|P2|NOT COMPLETED|First Intervention||0
1607815|NCT00958919|3932363|P1|NOT COMPLETED|First Intervention||0
1607816|NCT00958919|3932362|P2|COMPLETED|First Intervention||7
1607817|NCT00958919|3932363|P1|COMPLETED|First Intervention||7
1607818|NCT00958919|3932362|P2|STARTED|First Intervention||7
1607819|NCT00958919|3932363|P1|STARTED|First Intervention||7
1607820|NCT00958893|3932377|P1|NOT COMPLETED|Overall Study||4
1607821|NCT00958893|3932377|P1|COMPLETED|Overall Study||0
1607822|NCT00958893|3932377|P1|STARTED|Overall Study||4
1607823|NCT00958880|3932383|P2|NOT COMPLETED|Overall Study||2
1607824|NCT00958880|3932384|P1|NOT COMPLETED|Overall Study||2
1607825|NCT00958880|3932383|P2|COMPLETED|Overall Study||18
1607826|NCT00958880|3932384|P1|COMPLETED|Overall Study||18
1607827|NCT00958880|3932383|P2|STARTED|Overall Study||20
1607828|NCT00958880|3932384|P1|STARTED|Overall Study||20
1607829|NCT00958841|3932392|P1|NOT COMPLETED|Overall Study||96
1607830|NCT00958841|3932392|P1|COMPLETED|Overall Study|Completed = Completed extension|22
1607831|NCT00958841|3932392|P1|Entered in Extension|Overall Study||63
1607832|NCT00958841|3932392|P1|Completed Month 6 (M6)|Overall Study||90
1607833|NCT00958841|3932392|P1|STARTED|Overall Study||118
1607834|NCT00958828|3932410|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
1607835|NCT00958828|3932411|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
1607836|NCT00958828|3932410|P2|COMPLETED|Period 2, 1 Week of Wear||87
1607837|NCT00958828|3932411|P1|COMPLETED|Period 2, 1 Week of Wear||89
1607838|NCT00958828|3932410|P2|STARTED|Period 2, 1 Week of Wear||88
1607839|NCT00958828|3932411|P1|STARTED|Period 2, 1 Week of Wear||89
1607840|NCT00958828|3932410|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
1607841|NCT00958828|3932411|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
1607842|NCT00958828|3932410|P2|COMPLETED|Period 1, 1 Week of Wear||88
1607843|NCT00958828|3932411|P1|COMPLETED|Period 1, 1 Week of Wear||89
1607844|NCT00958828|3932410|P2|STARTED|Period 1, 1 Week of Wear||89
1607845|NCT00958828|3932411|P1|STARTED|Period 1, 1 Week of Wear||89
1607846|NCT00958789|3932417|P1|NOT COMPLETED|Overall Study||50
1607847|NCT00958789|3932417|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|131
1607848|NCT00958789|3932417|P1|STARTED|Overall Study||181
1607849|NCT00958776|3932424|P2|NOT COMPLETED|Overall Study||29
1607850|NCT00958776|3932425|P1|NOT COMPLETED|Overall Study||16
1607851|NCT00958776|3932424|P2|COMPLETED|Overall Study||239
1607852|NCT00958776|3932425|P1|COMPLETED|Overall Study||121
1607853|NCT00958776|3932424|P2|STARTED|Overall Study||268
1607854|NCT00958776|3932425|P1|STARTED|Overall Study||137
1607855|NCT00958724|3932455|P1|NOT COMPLETED|Overall Study||6
1607856|NCT00958724|3932455|P1|COMPLETED|Overall Study||0
1607857|NCT00958724|3932455|P1|STARTED|Overall Study||6
1607858|NCT00958581|3932468|P3|NOT COMPLETED|Overall Study||0
1607859|NCT00958581|3932469|P2|NOT COMPLETED|Overall Study||0
1607860|NCT00958581|3932470|P1|NOT COMPLETED|Overall Study||0
1607861|NCT00958581|3932468|P3|COMPLETED|Overall Study||55
1607862|NCT00958581|3932469|P2|COMPLETED|Overall Study||61
1607863|NCT00958581|3932470|P1|COMPLETED|Overall Study||61
1607864|NCT00958581|3932468|P3|STARTED|Overall Study||55
1607865|NCT00958581|3932469|P2|STARTED|Overall Study||61
1607866|NCT00958581|3932470|P1|STARTED|Overall Study||61
1607867|NCT00958568|3932484|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
1607868|NCT00958568|3932485|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
1607869|NCT00958568|3932486|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1607870|NCT00958568|3932487|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1607871|NCT00958568|3932484|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
1607872|NCT00958568|3932485|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
1607873|NCT00958568|3932486|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1607874|NCT00958568|3932487|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1607875|NCT00958568|3932484|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
1607876|NCT00958568|3932485|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
1607877|NCT00958568|3932486|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1607878|NCT00958568|3932487|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1607879|NCT00958568|3932484|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1607880|NCT00958568|3932485|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1607881|NCT00958568|3932486|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
1607882|NCT00958568|3932487|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1607883|NCT00958568|3932484|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1607884|NCT00958568|3932485|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1607885|NCT00958568|3932486|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
1607886|NCT00958568|3932487|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1607887|NCT00958568|3932484|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
1607888|NCT00958568|3932485|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
1607889|NCT00958568|3932486|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
1607890|NCT00958568|3932487|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
1607891|NCT00958568|3932484|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1607892|NCT00958568|3932485|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1607893|NCT00958568|3932486|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1607894|NCT00958568|3932487|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
1607895|NCT00958568|3932484|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1607896|NCT00958568|3932485|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1607897|NCT00958568|3932486|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1607898|NCT00958568|3932487|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
1607899|NCT00958568|3932484|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
1607900|NCT00958568|3932485|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
1607901|NCT00958568|3932486|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
1607902|NCT00958568|3932487|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
1607903|NCT00958477|3932572|P4|NOT COMPLETED|Overall Study||0
1607904|NCT00958477|3932573|P3|NOT COMPLETED|Overall Study||0
1607905|NCT00958477|3932574|P2|NOT COMPLETED|Overall Study||0
1607906|NCT00958477|3932575|P1|NOT COMPLETED|Overall Study||0
1607907|NCT00958477|3932572|P4|COMPLETED|Overall Study||6
1607908|NCT00958477|3932573|P3|COMPLETED|Overall Study||6
1607909|NCT00958477|3932574|P2|COMPLETED|Overall Study||6
1607910|NCT00958477|3932575|P1|COMPLETED|Overall Study||8
1607911|NCT00958477|3932572|P4|STARTED|Overall Study||6
1607912|NCT00958477|3932573|P3|STARTED|Overall Study||6
1607913|NCT00958477|3932574|P2|STARTED|Overall Study||6
1607914|NCT00958477|3932575|P1|STARTED|Overall Study||8
1607915|NCT00958438|3932724|P3|NOT COMPLETED|Overall Study||6
1607916|NCT00958438|3932725|P2|NOT COMPLETED|Overall Study||10
1607917|NCT00958438|3932726|P1|NOT COMPLETED|Overall Study||10
1607918|NCT00958438|3932724|P3|COMPLETED|Overall Study||78
1607919|NCT00958438|3932725|P2|COMPLETED|Overall Study||72
1607920|NCT00958438|3932726|P1|COMPLETED|Overall Study||72
1607921|NCT00958438|3932724|P3|STARTED|Overall Study||84
1607922|NCT00958438|3932725|P2|STARTED|Overall Study||82
1607923|NCT00958438|3932726|P1|STARTED|Overall Study||82
1607924|NCT00958360|3932751|P2|NOT COMPLETED|Overall Study||10
1607925|NCT00958360|3932752|P1|NOT COMPLETED|Overall Study||11
1607926|NCT00958360|3932751|P2|COMPLETED|Overall Study||150
1607927|NCT00958360|3932752|P1|COMPLETED|Overall Study||152
1607928|NCT00958360|3932751|P2|STARTED|Overall Study||160
1607929|NCT00958360|3932752|P1|STARTED|Overall Study||163
1607930|NCT00958347|3932766|P1|NOT COMPLETED|Overall Study||226
1607931|NCT00958347|3932766|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
1607932|NCT00958347|3932766|P1|STARTED|Overall Study||226
1607933|NCT00958334|3932773|P3|NOT COMPLETED|Overall Study||13
1607934|NCT00958334|3932774|P2|NOT COMPLETED|Overall Study||17
1607935|NCT00958334|3932775|P1|NOT COMPLETED|Overall Study||14
1607936|NCT00958334|3932773|P3|COMPLETED|Overall Study||8
1607937|NCT00958334|3932774|P2|COMPLETED|Overall Study||5
1607938|NCT00958334|3932775|P1|COMPLETED|Overall Study||8
1607939|NCT00958334|3932773|P3|STARTED|Overall Study||21
1607940|NCT00958334|3932774|P2|STARTED|Overall Study||22
1607941|NCT00958334|3932775|P1|STARTED|Overall Study||22
1607942|NCT00958308|3932786|P3|NOT COMPLETED|Overall Study||0
1607943|NCT00958308|3932787|P2|NOT COMPLETED|Overall Study||0
1607944|NCT00958308|3932788|P1|NOT COMPLETED|Overall Study||0
1607945|NCT00958308|3932786|P3|COMPLETED|Overall Study||86
1607946|NCT00958308|3932787|P2|COMPLETED|Overall Study||85
1607947|NCT00958308|3932788|P1|COMPLETED|Overall Study||84
1607948|NCT00958308|3932786|P3|STARTED|Overall Study||86
1607949|NCT00958308|3932787|P2|STARTED|Overall Study||85
1607950|NCT00958308|3932788|P1|STARTED|Overall Study||84
1607951|NCT00958282|3932798|P2|NOT COMPLETED|Overall Study||6
1607952|NCT00958282|3932799|P1|NOT COMPLETED|Overall Study||10
1607953|NCT00958282|3932798|P2|COMPLETED|Overall Study||15
1607954|NCT00958282|3932799|P1|COMPLETED|Overall Study||12
1607955|NCT00958282|3932798|P2|STARTED|Overall Study||21
1607956|NCT00958282|3932799|P1|STARTED|Overall Study||22
1607957|NCT00958256|3932807|P1|NOT COMPLETED|Overall Study||3
1607958|NCT00958256|3932807|P1|COMPLETED|Overall Study||18
1607959|NCT00958256|3932807|P1|STARTED|Overall Study||21
1607960|NCT00958243|3932817|P6|NOT COMPLETED|Overall Study||10
1607961|NCT00958243|3932818|P5|NOT COMPLETED|Overall Study||9
1607962|NCT00958243|3932819|P4|NOT COMPLETED|Overall Study||3
1607963|NCT00958243|3932820|P3|NOT COMPLETED|Overall Study||14
1607964|NCT00958243|3932821|P2|NOT COMPLETED|Overall Study||6
1607965|NCT00958243|3932822|P1|NOT COMPLETED|Overall Study||2
1607966|NCT00958243|3932817|P6|COMPLETED|Overall Study||99
1607967|NCT00958243|3932818|P5|COMPLETED|Overall Study||100
1607968|NCT00958243|3932819|P4|COMPLETED|Overall Study||25
1607969|NCT00958243|3932820|P3|COMPLETED|Overall Study||82
1607970|NCT00958243|3932821|P2|COMPLETED|Overall Study||99
1607971|NCT00958243|3932822|P1|COMPLETED|Overall Study||24
1607972|NCT00958243|3932817|P6|STARTED|Overall Study||109
1607973|NCT00958243|3932818|P5|STARTED|Overall Study||109
1607974|NCT00958243|3932819|P4|STARTED|Overall Study||28
1607975|NCT00958243|3932820|P3|STARTED|Overall Study||96
1607976|NCT00958243|3932821|P2|STARTED|Overall Study||105
1607977|NCT00958243|3932822|P1|STARTED|Overall Study||26
1607978|NCT00958217|3932880|P2|NOT COMPLETED|Overall Study||25
1607979|NCT00958217|3932881|P1|NOT COMPLETED|Overall Study||24
1607980|NCT00958217|3932880|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
1607981|NCT00958217|3932881|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
1607982|NCT00958217|3932880|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
1607983|NCT00958217|3932881|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
1607984|NCT00958217|3932880|P2|STARTED|Overall Study||62
1607985|NCT00958217|3932881|P1|STARTED|Overall Study||61
1607986|NCT00958191|3932892|P1|NOT COMPLETED|Overall Study||111
1607987|NCT00958191|3932892|P1|COMPLETED|Overall Study||110
1607988|NCT00958191|3932892|P1|STARTED|Overall Study||221
1607989|NCT00958165|3932907|P1|NOT COMPLETED|Overall Study||14
1607990|NCT00958165|3932907|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
1607991|NCT00958165|3932907|P1|Treated|Overall Study||72
1607992|NCT00958165|3932907|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
1607993|NCT00958126|3932919|P8|NOT COMPLETED|Overall Study||0
1607994|NCT00958126|3932920|P7|NOT COMPLETED|Overall Study||1
1607995|NCT00958126|3932921|P6|NOT COMPLETED|Overall Study||1
1607996|NCT00958126|3932922|P5|NOT COMPLETED|Overall Study||0
1607997|NCT00958126|3932923|P4|NOT COMPLETED|Overall Study||11
1607998|NCT00958126|3932924|P3|NOT COMPLETED|Overall Study||10
1607999|NCT00958126|3932925|P2|NOT COMPLETED|Overall Study||9
1608000|NCT00958126|3932926|P1|NOT COMPLETED|Overall Study||1
1608001|NCT00958126|3932919|P8|COMPLETED|Overall Study||202
1608002|NCT00958126|3932920|P7|COMPLETED|Overall Study||199
1608003|NCT00958126|3932921|P6|COMPLETED|Overall Study||202
1608004|NCT00958126|3932922|P5|COMPLETED|Overall Study||50
1608005|NCT00958126|3932923|P4|COMPLETED|Overall Study||192
1608006|NCT00958126|3932924|P3|COMPLETED|Overall Study||191
1608007|NCT00958126|3932925|P2|COMPLETED|Overall Study||196
1608008|NCT00958126|3932926|P1|COMPLETED|Overall Study||48
1608009|NCT00958126|3932919|P8|STARTED|Overall Study||202
1608010|NCT00958126|3932920|P7|STARTED|Overall Study||200
1608011|NCT00958126|3932921|P6|STARTED|Overall Study||203
1608012|NCT00958126|3932922|P5|STARTED|Overall Study||50
1608013|NCT00958126|3932923|P4|STARTED|Overall Study||203
1608014|NCT00958126|3932924|P3|STARTED|Overall Study||201
1608015|NCT00958126|3932925|P2|STARTED|Overall Study||205
1608016|NCT00958126|3932926|P1|STARTED|Overall Study||49
1608017|NCT00958074|3932998|P2|NOT COMPLETED|Overall Study||1
1608018|NCT00958074|3932999|P1|NOT COMPLETED|Overall Study||0
1608019|NCT00958074|3932998|P2|COMPLETED|Overall Study||6
1608020|NCT00958074|3932999|P1|COMPLETED|Overall Study||4
1608021|NCT00958074|3932998|P2|STARTED|Overall Study||7
1608022|NCT00958074|3932999|P1|STARTED|Overall Study||4
1608023|NCT00958035|3933015|P2|NOT COMPLETED|Overall Study||4
1608024|NCT00958035|3933016|P1|NOT COMPLETED|Overall Study||3
1608025|NCT00958035|3933015|P2|COMPLETED|Overall Study||39
1608026|NCT00958035|3933016|P1|COMPLETED|Overall Study||43
1608027|NCT00958035|3933015|P2|STARTED|Overall Study||43
1608028|NCT00958035|3933016|P1|STARTED|Overall Study||46
1608029|NCT00958009|3933022|P1|NOT COMPLETED|Overall Study||2
1608030|NCT00958009|3933022|P1|COMPLETED|Overall Study||107
1608031|NCT00958009|3933022|P1|STARTED|Overall Study||109
1608032|NCT00957996|3933029|P2|NOT COMPLETED|Overall Study||28
1608033|NCT00957996|3933030|P1|NOT COMPLETED|Overall Study||26
1608034|NCT00957996|3933029|P2|COMPLETED|Overall Study||89
1608035|NCT00957996|3933030|P1|COMPLETED|Overall Study||91
1608036|NCT00957996|3933029|P2|STARTED|Overall Study||117
1608037|NCT00957996|3933030|P1|STARTED|Overall Study||117
1608038|NCT00957944|3933062|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
1608039|NCT00957944|3933063|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
1608040|NCT00957944|3933062|P2|COMPLETED|Second Intervention- 24 Hours||19
1608041|NCT00957944|3933063|P1|COMPLETED|Second Intervention- 24 Hours||20
1608042|NCT00957944|3933062|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
1608043|NCT00957944|3933063|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
1608044|NCT00957944|3933062|P2|STARTED|Second Intervention- 24 Hours||19
1608045|NCT00957944|3933063|P1|STARTED|Second Intervention- 24 Hours||20
1608046|NCT00957944|3933062|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
1608047|NCT00957944|3933063|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
1608048|NCT00957944|3933062|P2|COMPLETED|Washout Period of at Least 5 Days||19
1608049|NCT00957944|3933063|P1|COMPLETED|Washout Period of at Least 5 Days||20
1608050|NCT00957944|3933062|P2|STARTED|Washout Period of at Least 5 Days||19
1608051|NCT00957944|3933063|P1|STARTED|Washout Period of at Least 5 Days||20
1608052|NCT00957944|3933062|P2|NOT COMPLETED|First Intervention- 24 Hours||1
1608053|NCT00957944|3933063|P1|NOT COMPLETED|First Intervention- 24 Hours||0
1608054|NCT00957944|3933062|P2|COMPLETED|First Intervention- 24 Hours||19
1608055|NCT00957944|3933063|P1|COMPLETED|First Intervention- 24 Hours||20
1608056|NCT00957944|3933062|P2|STARTED|First Intervention- 24 Hours||20
1608057|NCT00957944|3933063|P1|STARTED|First Intervention- 24 Hours||20
1608058|NCT00957931|3933097|P1|NOT COMPLETED|Overall Study||4
1608059|NCT00957931|3933097|P1|COMPLETED|Overall Study||2
1608060|NCT00957931|3933097|P1|STARTED|Overall Study||6
1608061|NCT00957905|3933107|P2|NOT COMPLETED|Part B||4
1608062|NCT00957905|3933108|P1|NOT COMPLETED|Part B||0
1608063|NCT00957905|3933107|P2|COMPLETED|Part B||25
1608064|NCT00957905|3933108|P1|COMPLETED|Part B||0
1608065|NCT00957905|3933107|P2|STARTED|Part B||29
1608066|NCT00957905|3933108|P1|STARTED|Part B||0
1608067|NCT00957905|3933107|P2|NOT COMPLETED|Part A||0
1608068|NCT00957905|3933108|P1|NOT COMPLETED|Part A||0
1608069|NCT00957905|3933107|P2|COMPLETED|Part A||0
1608070|NCT00957905|3933108|P1|COMPLETED|Part A||7
1608071|NCT00957905|3933107|P2|STARTED|Part A||0
1608072|NCT00957905|3933108|P1|STARTED|Part A||7
1608073|NCT00957801|3933118|P4|NOT COMPLETED|Overall Study||1
1608074|NCT00957801|3933119|P3|NOT COMPLETED|Overall Study||0
1608075|NCT00957801|3933120|P2|NOT COMPLETED|Overall Study||0
1608076|NCT00957801|3933121|P1|NOT COMPLETED|Overall Study||0
1608077|NCT00957801|3933118|P4|COMPLETED|Overall Study||7
1608078|NCT00957801|3933119|P3|COMPLETED|Overall Study||7
1608079|NCT00957801|3933120|P2|COMPLETED|Overall Study||7
1608080|NCT00957801|3933121|P1|COMPLETED|Overall Study||7
1608081|NCT00957801|3933118|P4|STARTED|Overall Study||8
1608082|NCT00957801|3933119|P3|STARTED|Overall Study||7
1608083|NCT00957801|3933120|P2|STARTED|Overall Study||7
1608084|NCT00957801|3933121|P1|STARTED|Overall Study||7
1608085|NCT00957723|3933287|P1|NOT COMPLETED|Overall Study||113
1608086|NCT00957723|3933287|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
1608087|NCT00957723|3933287|P1|STARTED|Overall Study||411
1608088|NCT00957684|3933305|P5|NOT COMPLETED|PART II||75
1608089|NCT00957684|3933306|P4|NOT COMPLETED|PART II||0
1608090|NCT00957684|3933307|P3|NOT COMPLETED|PART II||0
1608091|NCT00957684|3933308|P2|NOT COMPLETED|PART II||0
1608092|NCT00957684|3933309|P1|NOT COMPLETED|PART II||0
1608093|NCT00957684|3933305|P5|COMPLETED|PART II||239
1608094|NCT00957684|3933306|P4|COMPLETED|PART II||0
1608095|NCT00957684|3933307|P3|COMPLETED|PART II||0
1608096|NCT00957684|3933308|P2|COMPLETED|PART II||0
1608097|NCT00957684|3933309|P1|COMPLETED|PART II||0
1608098|NCT00957684|3933305|P5|Patients Entered Part II|PART II||314
1608099|NCT00957684|3933306|P4|Patients Entered Part II|PART II||0
1608100|NCT00957684|3933307|P3|Patients Entered Part II|PART II||0
1608101|NCT00957684|3933308|P2|Patients Entered Part II|PART II||0
1608102|NCT00957684|3933309|P1|Patients Entered Part II|PART II||0
1608103|NCT00957684|3933305|P5|STARTED|PART II||314
1608104|NCT00957684|3933306|P4|STARTED|PART II||0
1608105|NCT00957684|3933307|P3|STARTED|PART II||0
1608106|NCT00957684|3933308|P2|STARTED|PART II||0
1608107|NCT00957684|3933309|P1|STARTED|PART II||0
1608108|NCT00957684|3933305|P5|NOT COMPLETED|PART I||0
1608109|NCT00957684|3933306|P4|NOT COMPLETED|PART I||18
1608110|NCT00957684|3933307|P3|NOT COMPLETED|PART I||10
1608111|NCT00957684|3933308|P2|NOT COMPLETED|PART I||13
1608112|NCT00957684|3933309|P1|NOT COMPLETED|PART I||31
1608113|NCT00957684|3933305|P5|COMPLETED|PART I||0
1608114|NCT00957684|3933306|P4|COMPLETED|PART I||84
1608115|NCT00957684|3933307|P3|COMPLETED|PART I||90
1608116|NCT00957684|3933308|P2|COMPLETED|PART I||85
1608117|NCT00957684|3933309|P1|COMPLETED|PART I||71
1608118|NCT00957684|3933305|P5|Per-protocol (PP)Population|PART I||0
1608119|NCT00957684|3933306|P4|Per-protocol (PP)Population|PART I||91
1608120|NCT00957684|3933307|P3|Per-protocol (PP)Population|PART I||94
1608121|NCT00957684|3933308|P2|Per-protocol (PP)Population|PART I||86
1608122|NCT00957684|3933309|P1|Per-protocol (PP)Population|PART I||72
1608123|NCT00957684|3933305|P5|Intention-to-treat (ITT) Population|PART I||0
1608124|NCT00957684|3933306|P4|Intention-to-treat (ITT) Population|PART I||102
1608125|NCT00957684|3933307|P3|Intention-to-treat (ITT) Population|PART I||99
1608126|NCT00957684|3933308|P2|Intention-to-treat (ITT) Population|PART I||98
1608127|NCT00957684|3933309|P1|Intention-to-treat (ITT) Population|PART I||98
1608128|NCT00957684|3933305|P5|Randomised (Safety Population)|PART I||0
1608129|NCT00957684|3933306|P4|Randomised (Safety Population)|PART I||102
1608130|NCT00957684|3933307|P3|Randomised (Safety Population)|PART I||100
1608131|NCT00957684|3933308|P2|Randomised (Safety Population)|PART I||98
1608132|NCT00957684|3933309|P1|Randomised (Safety Population)|PART I||102
1608133|NCT00957684|3933305|P5|STARTED|PART I||0
1608134|NCT00957684|3933306|P4|STARTED|PART I||102
1608135|NCT00957684|3933307|P3|STARTED|PART I||100
1608136|NCT00957684|3933308|P2|STARTED|PART I||98
1608137|NCT00957684|3933309|P1|STARTED|PART I||102
1608138|NCT00957671|3933319|P1|NOT COMPLETED|Overall Study||0
1608139|NCT00957671|3933319|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
1608140|NCT00957671|3933319|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
1608141|NCT00957658|3933376|P1|NOT COMPLETED|Overall Study||65
1608142|NCT00957658|3933376|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
1608143|NCT00957658|3933376|P1|STARTED|Overall Study||234
1608144|NCT00957593|3933391|P2|NOT COMPLETED|Overall Study||0
1608145|NCT00957593|3933392|P1|NOT COMPLETED|Overall Study||0
1608146|NCT00957593|3933391|P2|COMPLETED|Overall Study||125
1608147|NCT00957593|3933392|P1|COMPLETED|Overall Study||127
1608148|NCT00957593|3933391|P2|STARTED|Overall Study||125
1608149|NCT00957593|3933392|P1|STARTED|Overall Study||127
1608150|NCT00957580|3933401|P3|NOT COMPLETED|Overall Study||0
1608151|NCT00957580|3933402|P2|NOT COMPLETED|Overall Study||2
1608152|NCT00957580|3933403|P1|NOT COMPLETED|Overall Study||0
1608153|NCT00957580|3933401|P3|COMPLETED|Overall Study||15
1608154|NCT00957580|3933402|P2|COMPLETED|Overall Study||31
1608155|NCT00957580|3933403|P1|COMPLETED|Overall Study||33
1608156|NCT00957580|3933401|P3|Treated|Overall Study||15
1608157|NCT00957580|3933402|P2|Treated|Overall Study||32
1608158|NCT00957580|3933403|P1|Treated|Overall Study||33
1608159|NCT00957580|3933401|P3|STARTED|Overall Study||15
1608160|NCT00957580|3933402|P2|STARTED|Overall Study||33
1608161|NCT00957580|3933403|P1|STARTED|Overall Study||33
1608162|NCT00957528|3933550|P3|NOT COMPLETED|Overall Study||1
1608163|NCT00957528|3933551|P2|NOT COMPLETED|Overall Study||1
1608164|NCT00957528|3933552|P1|NOT COMPLETED|Overall Study||0
1608165|NCT00957528|3933550|P3|COMPLETED|Overall Study||8
1608166|NCT00957528|3933551|P2|COMPLETED|Overall Study||8
1608167|NCT00957528|3933552|P1|COMPLETED|Overall Study||8
1608168|NCT00957528|3933550|P3|STARTED|Overall Study||9
1608169|NCT00957528|3933551|P2|STARTED|Overall Study||9
1608170|NCT00957528|3933552|P1|STARTED|Overall Study||8
1608171|NCT00957424|3933575|P1|NOT COMPLETED|Overall Study||23
1608172|NCT00957424|3933575|P1|COMPLETED|Overall Study||44
1608173|NCT00957424|3933575|P1|Follow-up #2|Overall Study||50
1608174|NCT00957424|3933575|P1|Follow-up #1|Overall Study||59
1608175|NCT00957424|3933575|P1|STARTED|Overall Study||67
1608176|NCT00957372|3933585|P4|NOT COMPLETED|PART II||44
1608177|NCT00957372|3933586|P3|NOT COMPLETED|PART II||0
1608178|NCT00957372|3933587|P2|NOT COMPLETED|PART II||0
1608179|NCT00957372|3933588|P1|NOT COMPLETED|PART II||0
1608180|NCT00957372|3933585|P4|COMPLETED|PART II||150
1608181|NCT00957372|3933586|P3|COMPLETED|PART II||0
1608182|NCT00957372|3933587|P2|COMPLETED|PART II||0
1608183|NCT00957372|3933588|P1|COMPLETED|PART II||0
1608184|NCT00957372|3933585|P4|Per-Protocol Population|PART II||108
1608185|NCT00957372|3933586|P3|Per-Protocol Population|PART II||0
1608186|NCT00957372|3933587|P2|Per-Protocol Population|PART II||0
1608187|NCT00957372|3933588|P1|Per-Protocol Population|PART II||0
1608188|NCT00957372|3933585|P4|Intention-to-treat (ITT) Population|PART II||191
1608189|NCT00957372|3933586|P3|Intention-to-treat (ITT) Population|PART II||0
1608190|NCT00957372|3933587|P2|Intention-to-treat (ITT) Population|PART II||0
1608191|NCT00957372|3933588|P1|Intention-to-treat (ITT) Population|PART II||0
1608192|NCT00957372|3933585|P4|Safety Population|PART II||194
1608193|NCT00957372|3933586|P3|Safety Population|PART II||0
1608194|NCT00957372|3933587|P2|Safety Population|PART II||0
1608195|NCT00957372|3933588|P1|Safety Population|PART II||0
1608196|NCT00957372|3933585|P4|STARTED|PART II||194
1608197|NCT00957372|3933586|P3|STARTED|PART II||0
1608198|NCT00957372|3933587|P2|STARTED|PART II||0
1608199|NCT00957372|3933588|P1|STARTED|PART II||0
1608200|NCT00957372|3933585|P4|NOT COMPLETED|PART I||0
1608201|NCT00957372|3933586|P3|NOT COMPLETED|PART I||1
1608202|NCT00957372|3933587|P2|NOT COMPLETED|PART I||0
1608203|NCT00957372|3933588|P1|NOT COMPLETED|PART I||0
1608204|NCT00957372|3933585|P4|COMPLETED|PART I||0
1608205|NCT00957372|3933586|P3|COMPLETED|PART I||87
1608206|NCT00957372|3933587|P2|COMPLETED|PART I||85
1608207|NCT00957372|3933588|P1|COMPLETED|PART I||80
1608208|NCT00957372|3933585|P4|Randomized But Not Treated|PART I||0
1608209|NCT00957372|3933586|P3|Randomized But Not Treated|PART I||1
1608210|NCT00957372|3933587|P2|Randomized But Not Treated|PART I||0
1608211|NCT00957372|3933588|P1|Randomized But Not Treated|PART I||0
1608212|NCT00957372|3933585|P4|Per-Protocol Population|PART I||0
1608213|NCT00957372|3933586|P3|Per-Protocol Population|PART I||51
1608214|NCT00957372|3933587|P2|Per-Protocol Population|PART I||47
1608215|NCT00957372|3933588|P1|Per-Protocol Population|PART I||35
1608216|NCT00957372|3933585|P4|Intention-to-Treat Population|PART I||0
1608217|NCT00957372|3933586|P3|Intention-to-Treat Population|PART I||84
1608218|NCT00957372|3933587|P2|Intention-to-Treat Population|PART I||84
1608219|NCT00957372|3933588|P1|Intention-to-Treat Population|PART I||77
1608220|NCT00957372|3933585|P4|Safety Population|PART I||0
1608221|NCT00957372|3933586|P3|Safety Population|PART I||87
1608222|NCT00957372|3933587|P2|Safety Population|PART I||85
1608223|NCT00957372|3933588|P1|Safety Population|PART I||80
1608224|NCT00957372|3933585|P4|STARTED|PART I||0
1608225|NCT00957372|3933586|P3|STARTED|PART I||88
1608226|NCT00957372|3933587|P2|STARTED|PART I||85
1608227|NCT00957372|3933588|P1|STARTED|PART I||80
1608228|NCT00957333|3933604|P1|NOT COMPLETED|Overall Study||0
1608229|NCT00957333|3933604|P1|COMPLETED|Overall Study||44
1608230|NCT00957333|3933604|P1|STARTED|Overall Study||44
1608231|NCT00957268|3933613|P5|NOT COMPLETED|Overall Study||0
1608232|NCT00957268|3933614|P4|NOT COMPLETED|Overall Study||0
1608233|NCT00957268|3933615|P3|NOT COMPLETED|Overall Study||1
1608234|NCT00957268|3933616|P2|NOT COMPLETED|Overall Study||0
1608235|NCT00957268|3933617|P1|NOT COMPLETED|Overall Study||0
1608236|NCT00957268|3933613|P5|COMPLETED|Overall Study||22
1608237|NCT00957268|3933614|P4|COMPLETED|Overall Study||7
1608238|NCT00957268|3933615|P3|COMPLETED|Overall Study||7
1608239|NCT00957268|3933616|P2|COMPLETED|Overall Study||4
1608240|NCT00957268|3933617|P1|COMPLETED|Overall Study||5
1608241|NCT00957268|3933613|P5|STARTED|Overall Study||22
1608242|NCT00957268|3933614|P4|STARTED|Overall Study||7
1608243|NCT00957268|3933615|P3|STARTED|Overall Study||8
1608244|NCT00957268|3933616|P2|STARTED|Overall Study||4
1608245|NCT00957268|3933617|P1|STARTED|Overall Study||5
1608246|NCT00957242|3933681|P2|NOT COMPLETED|Overall Study||0
1608247|NCT00957242|3933682|P1|NOT COMPLETED|Overall Study||0
1608248|NCT00957242|3933681|P2|COMPLETED|Overall Study||72
1608249|NCT00957242|3933682|P1|COMPLETED|Overall Study||73
1608250|NCT00957242|3933681|P2|STARTED|Overall Study||72
1608251|NCT00957242|3933682|P1|STARTED|Overall Study||73
1608252|NCT00957047|3933714|P5|NOT COMPLETED|PART II||102
1608253|NCT00957047|3933715|P4|NOT COMPLETED|PART II||0
1608254|NCT00957047|3933716|P3|NOT COMPLETED|PART II||0
1608255|NCT00957047|3933717|P2|NOT COMPLETED|PART II||0
1608256|NCT00957047|3933718|P1|NOT COMPLETED|PART II||0
1608257|NCT00957047|3933714|P5|COMPLETED|PART II||223
1608258|NCT00957047|3933715|P4|COMPLETED|PART II||0
1608259|NCT00957047|3933716|P3|COMPLETED|PART II||0
1608260|NCT00957047|3933717|P2|COMPLETED|PART II||0
1608261|NCT00957047|3933718|P1|COMPLETED|PART II||0
1608262|NCT00957047|3933714|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
1608263|NCT00957047|3933715|P4|Terminated Prematurely|PART II||0
1608264|NCT00957047|3933716|P3|Terminated Prematurely|PART II||0
1608265|NCT00957047|3933717|P2|Terminated Prematurely|PART II||0
1608266|NCT00957047|3933718|P1|Terminated Prematurely|PART II||0
1608267|NCT00957047|3933714|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
1608268|NCT00957047|3933715|P4|STARTED|PART II||0
1608269|NCT00957047|3933716|P3|STARTED|PART II||0
1608270|NCT00957047|3933717|P2|STARTED|PART II||0
1608271|NCT00957047|3933718|P1|STARTED|PART II||0
1608272|NCT00957047|3933714|P5|NOT COMPLETED|PART I||0
1608273|NCT00957047|3933715|P4|NOT COMPLETED|PART I||30
1608274|NCT00957047|3933716|P3|NOT COMPLETED|PART I||21
1608275|NCT00957047|3933717|P2|NOT COMPLETED|PART I||13
1608276|NCT00957047|3933718|P1|NOT COMPLETED|PART I||6
1608277|NCT00957047|3933714|P5|COMPLETED|PART I||0
1608278|NCT00957047|3933715|P4|COMPLETED|PART I||68
1608279|NCT00957047|3933716|P3|COMPLETED|PART I||80
1608280|NCT00957047|3933717|P2|COMPLETED|PART I||83
1608281|NCT00957047|3933718|P1|COMPLETED|PART I||94
1608282|NCT00957047|3933714|P5|Per-Protocol Population|PART I||0
1608283|NCT00957047|3933715|P4|Per-Protocol Population|PART I||54
1608284|NCT00957047|3933716|P3|Per-Protocol Population|PART I||75
1608285|NCT00957047|3933717|P2|Per-Protocol Population|PART I||70
1608286|NCT00957047|3933718|P1|Per-Protocol Population|PART I||81
1608287|NCT00957047|3933714|P5|Intention-to-treat (ITT) Population|PART I||0
1608288|NCT00957047|3933715|P4|Intention-to-treat (ITT) Population|PART I||97
1608289|NCT00957047|3933716|P3|Intention-to-treat (ITT) Population|PART I||100
1608290|NCT00957047|3933717|P2|Intention-to-treat (ITT) Population|PART I||96
1608291|NCT00957047|3933718|P1|Intention-to-treat (ITT) Population|PART I||100
1608292|NCT00957047|3933714|P5|Randomized/Safety Population|PART I||0
1608293|NCT00957047|3933715|P4|Randomized/Safety Population|PART I||98
1608294|NCT00957047|3933716|P3|Randomized/Safety Population|PART I||101
1608295|NCT00957047|3933717|P2|Randomized/Safety Population|PART I||96
1608296|NCT00957047|3933718|P1|Randomized/Safety Population|PART I||100
1608297|NCT00957047|3933714|P5|STARTED|PART I||0
1608298|NCT00957047|3933715|P4|STARTED|PART I||98
1608299|NCT00957047|3933716|P3|STARTED|PART I||101
1608300|NCT00957047|3933717|P2|STARTED|PART I||96
1608301|NCT00957047|3933718|P1|STARTED|PART I||100
1608302|NCT00957034|3933739|P3|NOT COMPLETED|Overall Study||6
1608303|NCT00957034|3933740|P2|NOT COMPLETED|Overall Study||4
1608304|NCT00957034|3933741|P1|NOT COMPLETED|Overall Study||6
1608305|NCT00957034|3933739|P3|COMPLETED|Overall Study||1
1608306|NCT00957034|3933740|P2|COMPLETED|Overall Study||0
1608307|NCT00957034|3933741|P1|COMPLETED|Overall Study||0
1608308|NCT00957034|3933739|P3|STARTED|Overall Study||7
1608309|NCT00957034|3933740|P2|STARTED|Overall Study||4
1608310|NCT00957034|3933741|P1|STARTED|Overall Study||6
1608311|NCT00957021|3933764|P1|NOT COMPLETED|Overall Study||117
1608312|NCT00957021|3933764|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
1608313|NCT00957021|3933764|P1|STARTED|Overall Study||354
1608314|NCT00957008|3933777|P4|NOT COMPLETED|Overall Study||24
1608315|NCT00957008|3933778|P3|NOT COMPLETED|Overall Study||17
1608316|NCT00957008|3933779|P2|NOT COMPLETED|Overall Study||12
1608317|NCT00957008|3933780|P1|NOT COMPLETED|Overall Study||21
1608318|NCT00957008|3933777|P4|COMPLETED|Overall Study||26
1608319|NCT00957008|3933778|P3|COMPLETED|Overall Study||32
1608320|NCT00957008|3933779|P2|COMPLETED|Overall Study||37
1608321|NCT00957008|3933780|P1|COMPLETED|Overall Study||28
1608322|NCT00957008|3933777|P4|STARTED|Overall Study||50
1608323|NCT00957008|3933778|P3|STARTED|Overall Study||49
1608324|NCT00957008|3933779|P2|STARTED|Overall Study||49
1608325|NCT00957008|3933780|P1|STARTED|Overall Study||49
1608326|NCT00956943|3933808|P2|NOT COMPLETED|Overall Study||10
1608327|NCT00956943|3933809|P1|NOT COMPLETED|Overall Study||9
1608328|NCT00956943|3933808|P2|COMPLETED|Overall Study||34
1608329|NCT00956943|3933809|P1|COMPLETED|Overall Study||34
1608330|NCT00956943|3933808|P2|Baseline|Overall Study||44
1608331|NCT00956943|3933809|P1|Baseline|Overall Study||43
1608332|NCT00956943|3933808|P2|STARTED|Overall Study||44
1608333|NCT00956943|3933809|P1|STARTED|Overall Study||43
1608334|NCT00956839|3933820|P3|NOT COMPLETED|Overall Study||3
1608335|NCT00956839|3933821|P2|NOT COMPLETED|Overall Study||0
1608336|NCT00956839|3933822|P1|NOT COMPLETED|Overall Study||3
1608337|NCT00956839|3933820|P3|COMPLETED|Overall Study||10
1608338|NCT00956839|3933821|P2|COMPLETED|Overall Study||13
1608339|NCT00956839|3933822|P1|COMPLETED|Overall Study||11
1608340|NCT00956839|3933820|P3|STARTED|Overall Study||13
1608341|NCT00956839|3933821|P2|STARTED|Overall Study||13
1608342|NCT00956839|3933822|P1|STARTED|Overall Study||14
1608343|NCT00956813|3933835|P2|NOT COMPLETED|Continuation Phase||0
1608344|NCT00956813|3933836|P1|NOT COMPLETED|Continuation Phase||0
1608345|NCT00956813|3933835|P2|COMPLETED|Continuation Phase||0
1608346|NCT00956813|3933836|P1|COMPLETED|Continuation Phase||80
1608347|NCT00956813|3933835|P2|STARTED|Continuation Phase||0
1608348|NCT00956813|3933836|P1|STARTED|Continuation Phase||80
1608349|NCT00956813|3933835|P2|NOT COMPLETED|Flaxseed and Placebo||5
1608350|NCT00956813|3933836|P1|NOT COMPLETED|Flaxseed and Placebo||8
1608351|NCT00956813|3933835|P2|COMPLETED|Flaxseed and Placebo||100
1608352|NCT00956813|3933836|P1|COMPLETED|Flaxseed and Placebo||97
1608353|NCT00956813|3933835|P2|STARTED|Flaxseed and Placebo||105
1608354|NCT00956813|3933836|P1|STARTED|Flaxseed and Placebo||105
1608355|NCT00956761|3933851|P1|NOT COMPLETED|Overall Study||0
1608356|NCT00956761|3933851|P1|COMPLETED|Overall Study||63
1608357|NCT00956761|3933851|P1|STARTED|Overall Study||63
1608358|NCT00956709|3933860|P2|NOT COMPLETED|Overall Study||0
1608359|NCT00956709|3933861|P1|NOT COMPLETED|Overall Study||0
1608360|NCT00956709|3933860|P2|COMPLETED|Overall Study||19
1608361|NCT00956709|3933861|P1|COMPLETED|Overall Study||16
1608362|NCT00956709|3933860|P2|STARTED|Overall Study||19
1608363|NCT00956709|3933861|P1|STARTED|Overall Study||16
1608364|NCT00956657|3933873|P2|NOT COMPLETED|Overall Study||0
1608365|NCT00956657|3933874|P1|NOT COMPLETED|Overall Study||0
1608366|NCT00956657|3933873|P2|COMPLETED|Overall Study||13
1608367|NCT00956657|3933874|P1|COMPLETED|Overall Study||18
1608368|NCT00956657|3933873|P2|STARTED|Overall Study||13
1608369|NCT00956657|3933874|P1|STARTED|Overall Study||18
1608370|NCT00956631|3933880|P1|NOT COMPLETED|Overall Study||16
1608371|NCT00956631|3933880|P1|COMPLETED|Overall Study||62
1608372|NCT00956631|3933880|P1|STARTED|Overall Study||78
1608373|NCT00956592|3933888|P2|NOT COMPLETED|Overall Study||3
1608374|NCT00956592|3933889|P1|NOT COMPLETED|Overall Study||1
1608375|NCT00956592|3933888|P2|COMPLETED|Overall Study||147
1608376|NCT00956592|3933889|P1|COMPLETED|Overall Study||149
1608377|NCT00956592|3933888|P2|STARTED|Overall Study||150
1608378|NCT00956592|3933889|P1|STARTED|Overall Study||150
1608379|NCT00956540|3933909|P4|NOT COMPLETED|Overall Study||4
1608380|NCT00956540|3933910|P3|NOT COMPLETED|Overall Study||3
1608381|NCT00956540|3933911|P2|NOT COMPLETED|Overall Study||4
1608382|NCT00956540|3933912|P1|NOT COMPLETED|Overall Study||3
1608383|NCT00956540|3933909|P4|COMPLETED|Overall Study||41
1608384|NCT00956540|3933910|P3|COMPLETED|Overall Study||43
1608385|NCT00956540|3933911|P2|COMPLETED|Overall Study||46
1608386|NCT00956540|3933912|P1|COMPLETED|Overall Study||51
1608387|NCT00956540|3933909|P4|STARTED|Overall Study||45
1608388|NCT00956540|3933910|P3|STARTED|Overall Study||46
1608389|NCT00956540|3933911|P2|STARTED|Overall Study||50
1608390|NCT00956540|3933912|P1|STARTED|Overall Study||54
1608391|NCT00956293|3933924|P3|NOT COMPLETED|Follow-up Period||0
1608392|NCT00956293|3933925|P2|NOT COMPLETED|Follow-up Period||32
1608393|NCT00956293|3933926|P1|NOT COMPLETED|Follow-up Period||20
1608394|NCT00956293|3933924|P3|COMPLETED|Follow-up Period||0
1608395|NCT00956293|3933925|P2|COMPLETED|Follow-up Period||0
1608396|NCT00956293|3933926|P1|COMPLETED|Follow-up Period||0
1608397|NCT00956293|3933924|P3|STARTED|Follow-up Period||0
1608398|NCT00956293|3933925|P2|STARTED|Follow-up Period||32
1608399|NCT00956293|3933926|P1|STARTED|Follow-up Period||20
1608400|NCT00956293|3933924|P3|NOT COMPLETED|Main Period (Randomization)||0
1608401|NCT00956293|3933925|P2|NOT COMPLETED|Main Period (Randomization)||27
1608402|NCT00956293|3933926|P1|NOT COMPLETED|Main Period (Randomization)||1
1608403|NCT00956293|3933924|P3|COMPLETED|Main Period (Randomization)||0
1608404|NCT00956293|3933925|P2|COMPLETED|Main Period (Randomization)||26
1608405|NCT00956293|3933926|P1|COMPLETED|Main Period (Randomization)||23
1608406|NCT00956293|3933924|P3|Randomized Safety Set|Main Period (Randomization)||0
1608407|NCT00956293|3933925|P2|Randomized Safety Set|Main Period (Randomization)||51
1608408|NCT00956293|3933926|P1|Randomized Safety Set|Main Period (Randomization)||24
1608409|NCT00956293|3933924|P3|Full Analysis Set|Main Period (Randomization)||0
1608410|NCT00956293|3933925|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
1608411|NCT00956293|3933926|P1|Full Analysis Set|Main Period (Randomization)||24
1608412|NCT00956293|3933924|P3|STARTED|Main Period (Randomization)||0
1608413|NCT00956293|3933925|P2|STARTED|Main Period (Randomization)||53
1608414|NCT00956293|3933926|P1|STARTED|Main Period (Randomization)||24
1608415|NCT00956293|3933924|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
1608416|NCT00956293|3933925|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
1608417|NCT00956293|3933926|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
1608418|NCT00956293|3933924|P3|COMPLETED|Main Period (Pre-randomization)||77
1608419|NCT00956293|3933925|P2|COMPLETED|Main Period (Pre-randomization)||0
1608420|NCT00956293|3933926|P1|COMPLETED|Main Period (Pre-randomization)||0
1608421|NCT00956293|3933924|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
1608422|NCT00956293|3933925|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
1608423|NCT00956293|3933926|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
1608424|NCT00956293|3933924|P3|STARTED|Main Period (Pre-randomization)||207
1608425|NCT00956293|3933925|P2|STARTED|Main Period (Pre-randomization)||0
1608426|NCT00956293|3933926|P1|STARTED|Main Period (Pre-randomization)||0
1608427|NCT00956254|3933950|P1|NOT COMPLETED|Overall Study||0
1608428|NCT00956254|3933950|P1|COMPLETED|Overall Study||18
1608429|NCT00956254|3933950|P1|STARTED|Overall Study||18
1608430|NCT00956085|3933960|P1|NOT COMPLETED|Overall Study||0
1608431|NCT00956085|3933960|P1|COMPLETED|Overall Study||12
1608432|NCT00956085|3933960|P1|STARTED|Overall Study||12
1608433|NCT00956020|3933964|P1|NOT COMPLETED|Overall Study||0
1608434|NCT00956020|3933964|P1|COMPLETED|Overall Study||4
1608435|NCT00956020|3933964|P1|STARTED|Overall Study||4
1608436|NCT00955968|3933981|P2|NOT COMPLETED|Overall Study||126
1608437|NCT00955968|3933982|P1|NOT COMPLETED|Overall Study||137
1608438|NCT00955968|3933981|P2|COMPLETED|Overall Study||699
1608439|NCT00955968|3933982|P1|COMPLETED|Overall Study||691
1608440|NCT00955968|3933981|P2|STARTED|Overall Study||825
1608441|NCT00955968|3933982|P1|STARTED|Overall Study||828
1608442|NCT00955955|3934020|P3|NOT COMPLETED|Overall Study||0
1608443|NCT00955955|3934021|P2|NOT COMPLETED|Overall Study||0
1608444|NCT00955955|3934022|P1|NOT COMPLETED|Overall Study||2
1608445|NCT00955955|3934020|P3|COMPLETED|Overall Study||28
1608446|NCT00955955|3934021|P2|COMPLETED|Overall Study||28
1608447|NCT00955955|3934022|P1|COMPLETED|Overall Study||17
1608448|NCT00955955|3934020|P3|STARTED|Overall Study||28
1608449|NCT00955955|3934021|P2|STARTED|Overall Study||28
1608450|NCT00955955|3934022|P1|STARTED|Overall Study||19
1608451|NCT00955916|3934036|P1|NOT COMPLETED|Overall Study||0
1608452|NCT00955916|3934036|P1|COMPLETED|Overall Study||38
1608453|NCT00955916|3934036|P1|STARTED|Overall Study||38
1608454|NCT00955903|3934045|P3|NOT COMPLETED|Overall Study||7
1608455|NCT00955903|3934046|P2|NOT COMPLETED|Overall Study||3
1608456|NCT00955903|3934047|P1|NOT COMPLETED|Overall Study||6
1608457|NCT00955903|3934045|P3|COMPLETED|Overall Study||48
1608458|NCT00955903|3934046|P2|COMPLETED|Overall Study||51
1608459|NCT00955903|3934047|P1|COMPLETED|Overall Study||49
1608460|NCT00955903|3934045|P3|STARTED|Overall Study||55
1608461|NCT00955903|3934046|P2|STARTED|Overall Study||54
1608462|NCT00955903|3934047|P1|STARTED|Overall Study||55
1608463|NCT00955877|3934064|P3|NOT COMPLETED|Overall Study||0
1608464|NCT00955877|3934065|P2|NOT COMPLETED|Overall Study||0
1608465|NCT00955877|3934066|P1|NOT COMPLETED|Overall Study||0
1608466|NCT00955877|3934064|P3|COMPLETED|Overall Study||7
1608467|NCT00955877|3934065|P2|COMPLETED|Overall Study||0
1608468|NCT00955877|3934066|P1|COMPLETED|Overall Study||6
1608469|NCT00955877|3934064|P3|STARTED|Overall Study||7
1608470|NCT00955877|3934065|P2|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
1608471|NCT00955877|3934066|P1|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
1608472|NCT00955825|3934106|P2|NOT COMPLETED|Overall Study||17
1608473|NCT00955825|3934107|P1|NOT COMPLETED|Overall Study||26
1608474|NCT00955825|3934106|P2|COMPLETED|Overall Study||223
1608475|NCT00955825|3934107|P1|COMPLETED|Overall Study||207
1608476|NCT00955825|3934106|P2|STARTED|Overall Study||240
1608477|NCT00955825|3934107|P1|STARTED|Overall Study||233
1608478|NCT00955747|3934115|P2|NOT COMPLETED|Overall Study||69
1608479|NCT00955747|3934116|P1|NOT COMPLETED|Overall Study||69
1608480|NCT00955747|3934115|P2|COMPLETED|Overall Study||172
1608481|NCT00955747|3934116|P1|COMPLETED|Overall Study||184
1608482|NCT00955747|3934115|P2|STARTED|Overall Study||241
1608483|NCT00955747|3934116|P1|STARTED|Overall Study||253
1608484|NCT00955721|3934124|P2|NOT COMPLETED|Overall Study||0
1608485|NCT00955721|3934125|P1|NOT COMPLETED|Overall Study||3
1608486|NCT00955721|3934124|P2|COMPLETED|Overall Study||0
1608487|NCT00955721|3934125|P1|COMPLETED|Overall Study||6
1608488|NCT00955721|3934124|P2|STARTED|Overall Study||0
1608489|NCT00955721|3934125|P1|STARTED|Overall Study||9
1608490|NCT00955617|3934135|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
1608491|NCT00955617|3934136|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
1608492|NCT00955617|3934135|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
1608493|NCT00955617|3934136|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
1608494|NCT00955617|3934135|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
1608495|NCT00955617|3934136|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
1608496|NCT00955617|3934135|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
1608497|NCT00955617|3934136|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
1608498|NCT00955617|3934135|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
1608499|NCT00955617|3934136|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
1608500|NCT00955617|3934135|P2|STARTED|First MRA (Between Day0 and Day21)||10
1608501|NCT00955617|3934136|P1|STARTED|First MRA (Between Day0 and Day21)||10
1608502|NCT00955513|3934149|P3|NOT COMPLETED|Overall Study||3
1608503|NCT00955513|3934150|P2|NOT COMPLETED|Overall Study||2
1608504|NCT00955513|3934151|P1|NOT COMPLETED|Overall Study||1
1608505|NCT00955513|3934149|P3|COMPLETED|Overall Study||79
1608506|NCT00955513|3934150|P2|COMPLETED|Overall Study||78
1608507|NCT00955513|3934151|P1|COMPLETED|Overall Study||79
1608508|NCT00955513|3934149|P3|STARTED|Overall Study||82
1608509|NCT00955513|3934150|P2|STARTED|Overall Study||80
1608510|NCT00955513|3934151|P1|STARTED|Overall Study||80
1608511|NCT00955487|3934161|P6|NOT COMPLETED|Overall Study||0
1608512|NCT00955487|3934162|P5|NOT COMPLETED|Overall Study||0
1608513|NCT00955487|3934163|P4|NOT COMPLETED|Overall Study||0
1608514|NCT00955487|3934164|P3|NOT COMPLETED|Overall Study||0
1608515|NCT00955487|3934165|P2|NOT COMPLETED|Overall Study||0
1608516|NCT00955487|3934166|P1|NOT COMPLETED|Overall Study||0
1608517|NCT00955487|3934161|P6|COMPLETED|Overall Study||35
1608518|NCT00955487|3934162|P5|COMPLETED|Overall Study||32
1608519|NCT00955487|3934163|P4|COMPLETED|Overall Study||21
1608520|NCT00955487|3934164|P3|COMPLETED|Overall Study||17
1608521|NCT00955487|3934165|P2|COMPLETED|Overall Study||9
1608522|NCT00955487|3934166|P1|COMPLETED|Overall Study||10
1608523|NCT00955487|3934161|P6|STARTED|Overall Study||35
1608524|NCT00955487|3934162|P5|STARTED|Overall Study||32
1608525|NCT00955487|3934163|P4|STARTED|Overall Study||21
1608526|NCT00955487|3934164|P3|STARTED|Overall Study||17
1608527|NCT00955487|3934165|P2|STARTED|Overall Study||9
1608528|NCT00955487|3934166|P1|STARTED|Overall Study||10
1608529|NCT00955474|3934200|P2|NOT COMPLETED|Overall Study||5
1608530|NCT00955474|3934201|P1|NOT COMPLETED|Overall Study||7
1608531|NCT00955474|3934200|P2|COMPLETED|Overall Study||8
1608532|NCT00955474|3934201|P1|COMPLETED|Overall Study||5
1608533|NCT00955474|3934200|P2|STARTED|Overall Study||13
1608534|NCT00955474|3934201|P1|STARTED|Overall Study||12
1608535|NCT00955357|3934237|P2|NOT COMPLETED|Maintenance Phase||45
1608536|NCT00955357|3934238|P1|NOT COMPLETED|Maintenance Phase||12
1608537|NCT00955357|3934237|P2|COMPLETED|Maintenance Phase||249
1608538|NCT00955357|3934238|P1|COMPLETED|Maintenance Phase||68
1608539|NCT00955357|3934237|P2|STARTED|Maintenance Phase||294
1608540|NCT00955357|3934238|P1|STARTED|Maintenance Phase||80
1608541|NCT00955357|3934237|P2|NOT COMPLETED|Titration Phase||66
1608542|NCT00955357|3934238|P1|NOT COMPLETED|Titration Phase||16
1608543|NCT00955357|3934237|P2|COMPLETED|Titration Phase||294
1608544|NCT00955357|3934238|P1|COMPLETED|Titration Phase||80
1608545|NCT00955357|3934237|P2|STARTED|Titration Phase||360
1608546|NCT00955357|3934238|P1|STARTED|Titration Phase||96
1608547|NCT00955305|3934246|P2|NOT COMPLETED|Overall Study||87
1608548|NCT00955305|3934247|P1|NOT COMPLETED|Overall Study||88
1608549|NCT00955305|3934246|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
1608550|NCT00955305|3934247|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
1608551|NCT00955305|3934246|P2|Eligible and Treated|Overall Study||75
1608552|NCT00955305|3934247|P1|Eligible and Treated|Overall Study||78
1608553|NCT00955305|3934246|P2|Treated|Overall Study||82
1608554|NCT00955305|3934247|P1|Treated|Overall Study||83
1608555|NCT00955305|3934246|P2|STARTED|Overall Study||87
1608556|NCT00955305|3934247|P1|STARTED|Overall Study||88
1608557|NCT00955279|3934260|P3|NOT COMPLETED|Overall Study||8
1608558|NCT00955279|3934261|P2|NOT COMPLETED|Overall Study||4
1608559|NCT00955279|3934262|P1|NOT COMPLETED|Overall Study||3
1608560|NCT00955279|3934260|P3|COMPLETED|Overall Study||52
1608561|NCT00955279|3934261|P2|COMPLETED|Overall Study||51
1608562|NCT00955279|3934262|P1|COMPLETED|Overall Study||55
1608563|NCT00955279|3934260|P3|STARTED|Overall Study||60
1608564|NCT00955279|3934261|P2|STARTED|Overall Study||55
1608565|NCT00955279|3934262|P1|STARTED|Overall Study||58
1608566|NCT00955266|3934284|P2|NOT COMPLETED|Overall Study||0
1608567|NCT00955266|3934285|P1|NOT COMPLETED|Overall Study||0
1608568|NCT00955266|3934284|P2|COMPLETED|Overall Study||4
1608569|NCT00955266|3934285|P1|COMPLETED|Overall Study||4
1608570|NCT00955266|3934284|P2|STARTED|Overall Study||4
1608571|NCT00955266|3934285|P1|STARTED|Overall Study||4
1608572|NCT00955110|3934299|P1|NOT COMPLETED|Treatment Phase||6
1608573|NCT00955110|3934299|P1|COMPLETED|Treatment Phase||35
1608574|NCT00955110|3934299|P1|Oxycodone CR 60 mg|Treatment Phase||40
1608575|NCT00955110|3934299|P1|Oxycodone CR 30 mg|Treatment Phase||40
1608576|NCT00955110|3934299|P1|Oxymorphone ER 30 mg|Treatment Phase||38
1608577|NCT00955110|3934299|P1|Oxymorphone ER 15 mg|Treatment Phase||37
1608578|NCT00955110|3934299|P1|Placebo|Treatment Phase||38
1608579|NCT00955110|3934299|P1|STARTED|Treatment Phase||41
1608580|NCT00955110|3934299|P1|NOT COMPLETED|Qualification Phase||24
1608581|NCT00955110|3934299|P1|COMPLETED|Qualification Phase||54
1608582|NCT00955110|3934299|P1|STARTED|Qualification Phase||78
1608583|NCT00955032|3934313|P2|NOT COMPLETED|Overall Study||0
1608584|NCT00955032|3934314|P1|NOT COMPLETED|Overall Study||0
1608585|NCT00955032|3934313|P2|COMPLETED|Overall Study||8
1608586|NCT00955032|3934314|P1|COMPLETED|Overall Study||16
1608587|NCT00955032|3934313|P2|STARTED|Overall Study||8
1608588|NCT00955032|3934314|P1|STARTED|Overall Study||16
1608589|NCT00954993|3934334|P1|NOT COMPLETED|Period 2||0
1608590|NCT00954993|3934334|P1|COMPLETED|Period 2||3
1608591|NCT00954993|3934334|P1|STARTED|Period 2||3
1608592|NCT00954993|3934334|P1|NOT COMPLETED|Washout||0
1608593|NCT00954993|3934334|P1|COMPLETED|Washout||3
1608594|NCT00954993|3934334|P1|STARTED|Washout||3
1608595|NCT00954993|3934334|P1|NOT COMPLETED|Period 1||0
1608596|NCT00954993|3934334|P1|COMPLETED|Period 1||3
1608597|NCT00954993|3934334|P1|STARTED|Period 1||3
1608598|NCT00954941|3934346|P2|NOT COMPLETED|Overall Study||7
1608599|NCT00954941|3934347|P1|NOT COMPLETED|Overall Study||8
1608600|NCT00954941|3934346|P2|COMPLETED|Overall Study||41
1608601|NCT00954941|3934347|P1|COMPLETED|Overall Study||42
1608602|NCT00954941|3934346|P2|STARTED|Overall Study||48
1608603|NCT00954941|3934347|P1|STARTED|Overall Study||50
1608604|NCT00954915|3934355|P1|NOT COMPLETED|Overall Study||0
1608605|NCT00954915|3934355|P1|COMPLETED|Overall Study||1
1608606|NCT00954915|3934355|P1|STARTED|Overall Study||1
1608607|NCT00954824|3934359|P1|NOT COMPLETED|Overall Study||50
1608608|NCT00954824|3934359|P1|COMPLETED|Overall Study||50
1608609|NCT00954824|3934359|P1|STARTED|Overall Study||100
1608610|NCT00954733|3934363|P1|NOT COMPLETED|Overall Study||1
1608611|NCT00954733|3934363|P1|COMPLETED|Overall Study||39
1608612|NCT00954733|3934363|P1|STARTED|Overall Study||40
1608613|NCT00954707|3934367|P1|NOT COMPLETED|Overall Study||167
1608614|NCT00954707|3934367|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
1608615|NCT00954707|3934367|P1|STARTED|Overall Study||2509
1608616|NCT00954681|3934383|P1|NOT COMPLETED|Overall Study||5
1608617|NCT00954681|3934383|P1|COMPLETED|Overall Study||10
1608618|NCT00954681|3934383|P1|STARTED|Overall Study||15
1608619|NCT00954538|3934389|P6|NOT COMPLETED|Part III||0
1608620|NCT00954538|3934390|P5|NOT COMPLETED|Part III||1
1608621|NCT00954538|3934391|P4|NOT COMPLETED|Part III||0
1608622|NCT00954538|3934392|P3|NOT COMPLETED|Part III||0
1608623|NCT00954538|3934393|P2|NOT COMPLETED|Part III||0
1608624|NCT00954538|3934394|P1|NOT COMPLETED|Part III||0
1608625|NCT00954538|3934389|P6|COMPLETED|Part III||2
1608626|NCT00954538|3934390|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
1608627|NCT00954538|3934391|P4|COMPLETED|Part III||4
1608628|NCT00954538|3934392|P3|COMPLETED|Part III||0
1608629|NCT00954538|3934393|P2|COMPLETED|Part III||0
1608630|NCT00954538|3934394|P1|COMPLETED|Part III||0
1608631|NCT00954538|3934389|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
1608632|NCT00954538|3934390|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
1608727|NCT00954187|3934514|P1|COMPLETED|Overall Study||0
1608633|NCT00954538|3934391|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
1608634|NCT00954538|3934392|P3|STARTED|Part III||0
1608635|NCT00954538|3934393|P2|STARTED|Part III||0
1608636|NCT00954538|3934394|P1|STARTED|Part III||0
1608637|NCT00954538|3934389|P6|NOT COMPLETED|Part II||0
1608638|NCT00954538|3934390|P5|NOT COMPLETED|Part II||0
1608639|NCT00954538|3934391|P4|NOT COMPLETED|Part II||0
1608640|NCT00954538|3934392|P3|NOT COMPLETED|Part II||0
1608641|NCT00954538|3934393|P2|NOT COMPLETED|Part II||0
1608642|NCT00954538|3934394|P1|NOT COMPLETED|Part II||0
1608643|NCT00954538|3934389|P6|COMPLETED|Part II||2
1608644|NCT00954538|3934390|P5|COMPLETED|Part II||0
1608645|NCT00954538|3934391|P4|COMPLETED|Part II||0
1608646|NCT00954538|3934392|P3|COMPLETED|Part II||3
1608647|NCT00954538|3934393|P2|COMPLETED|Part II||1
1608648|NCT00954538|3934394|P1|COMPLETED|Part II||0
1608649|NCT00954538|3934389|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
1608650|NCT00954538|3934390|P5|STARTED|Part II||0
1608651|NCT00954538|3934391|P4|STARTED|Part II||0
1608652|NCT00954538|3934392|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
1608653|NCT00954538|3934393|P2|STARTED|Part II|This subject did not participate in Part I or III|1
1608654|NCT00954538|3934394|P1|STARTED|Part II||0
1608655|NCT00954538|3934389|P6|NOT COMPLETED|Part I||0
1608656|NCT00954538|3934390|P5|NOT COMPLETED|Part I||0
1608657|NCT00954538|3934391|P4|NOT COMPLETED|Part I||0
1608658|NCT00954538|3934392|P3|NOT COMPLETED|Part I||0
1608659|NCT00954538|3934393|P2|NOT COMPLETED|Part I||0
1608660|NCT00954538|3934394|P1|NOT COMPLETED|Part I||0
1608661|NCT00954538|3934389|P6|COMPLETED|Part I||0
1608662|NCT00954538|3934390|P5|COMPLETED|Part I||0
1608663|NCT00954538|3934391|P4|COMPLETED|Part I||0
1608664|NCT00954538|3934392|P3|COMPLETED|Part I||0
1608665|NCT00954538|3934393|P2|COMPLETED|Part I||0
1608666|NCT00954538|3934394|P1|COMPLETED|Part I||3
1608667|NCT00954538|3934389|P6|STARTED|Part I||0
1608668|NCT00954538|3934390|P5|STARTED|Part I||0
1608669|NCT00954538|3934391|P4|STARTED|Part I||0
1608670|NCT00954538|3934392|P3|STARTED|Part I||0
1608671|NCT00954538|3934393|P2|STARTED|Part I||0
1608672|NCT00954538|3934394|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
1608673|NCT00954512|3934411|P6|NOT COMPLETED|Overall Study||4
1608674|NCT00954512|3934412|P5|NOT COMPLETED|Overall Study||4
1608675|NCT00954512|3934413|P4|NOT COMPLETED|Overall Study||2
1608676|NCT00954512|3934414|P3|NOT COMPLETED|Overall Study||0
1608677|NCT00954512|3934415|P2|NOT COMPLETED|Overall Study||3
1608678|NCT00954512|3934416|P1|NOT COMPLETED|Overall Study||2
1608679|NCT00954512|3934411|P6|COMPLETED|Overall Study||0
1608680|NCT00954512|3934412|P5|COMPLETED|Overall Study||0
1608681|NCT00954512|3934413|P4|COMPLETED|Overall Study||0
1608682|NCT00954512|3934414|P3|COMPLETED|Overall Study||0
1608683|NCT00954512|3934415|P2|COMPLETED|Overall Study||0
1608684|NCT00954512|3934416|P1|COMPLETED|Overall Study||0
1608685|NCT00954512|3934411|P6|STARTED|Overall Study||4
1608686|NCT00954512|3934412|P5|STARTED|Overall Study||4
1608687|NCT00954512|3934413|P4|STARTED|Overall Study||2
1608688|NCT00954512|3934414|P3|STARTED|Overall Study||0
1608689|NCT00954512|3934415|P2|STARTED|Overall Study||3
1608690|NCT00954512|3934416|P1|STARTED|Overall Study||2
1608691|NCT00954447|3934437|P2|NOT COMPLETED|Overall Study||88
1608692|NCT00954447|3934438|P1|NOT COMPLETED|Overall Study||110
1608693|NCT00954447|3934437|P2|COMPLETED|Overall Study||543
1608694|NCT00954447|3934438|P1|COMPLETED|Overall Study||520
1608695|NCT00954447|3934437|P2|STARTED|Overall Study||631
1608696|NCT00954447|3934438|P1|STARTED|Overall Study||630
1608697|NCT00954421|3934474|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
1608698|NCT00954421|3934474|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
1608699|NCT00954421|3934474|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
1608700|NCT00954421|3934474|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
1608701|NCT00954421|3934474|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
1608702|NCT00954421|3934474|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
1608703|NCT00954421|3934474|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
1608704|NCT00954421|3934474|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
1608705|NCT00954421|3934474|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
1608706|NCT00954421|3934474|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
1608707|NCT00954421|3934474|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
1608708|NCT00954421|3934474|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
1608709|NCT00954421|3934474|P1|NOT COMPLETED|6 Months of DBS||1
1608710|NCT00954421|3934474|P1|COMPLETED|6 Months of DBS||12
1608711|NCT00954421|3934474|P1|STARTED|6 Months of DBS||13
1608712|NCT00954421|3934474|P1|NOT COMPLETED|Baseline||0
1608713|NCT00954421|3934474|P1|COMPLETED|Baseline||13
1608714|NCT00954421|3934474|P1|STARTED|Baseline||13
1608715|NCT00954421|3934474|P1|NOT COMPLETED|Screening||3
1608716|NCT00954421|3934474|P1|COMPLETED|Screening||13
1608717|NCT00954421|3934474|P1|STARTED|Screening||16
1608718|NCT00954356|3934482|P2|NOT COMPLETED|Overall Study||0
1608719|NCT00954356|3934483|P1|NOT COMPLETED|Overall Study||0
1608720|NCT00954356|3934482|P2|COMPLETED|Overall Study||20
1608721|NCT00954356|3934483|P1|COMPLETED|Overall Study||41
1608722|NCT00954356|3934482|P2|STARTED|Overall Study||20
1608723|NCT00954356|3934483|P1|STARTED|Overall Study||41
1608724|NCT00954187|3934513|P2|NOT COMPLETED|Overall Study||0
1608725|NCT00954187|3934514|P1|NOT COMPLETED|Overall Study||0
1608726|NCT00954187|3934513|P2|COMPLETED|Overall Study||0
1608728|NCT00954187|3934513|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
1608729|NCT00954187|3934514|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
1608730|NCT00954122|3934520|P1|NOT COMPLETED|Overall Study||7
1608731|NCT00954122|3934520|P1|COMPLETED|Overall Study||28
1608732|NCT00954122|3934520|P1|STARTED|Overall Study||35
1608733|NCT00954109|3934530|P1|NOT COMPLETED|Overall Study||0
1608734|NCT00954109|3934530|P1|COMPLETED|Overall Study||11
1608735|NCT00954109|3934530|P1|STARTED|Overall Study||11
1608736|NCT00953927|3934537|P2|NOT COMPLETED|Overall Study||95
1608737|NCT00953927|3934538|P1|NOT COMPLETED|Overall Study||105
1608738|NCT00953927|3934537|P2|COMPLETED|Overall Study||1303
1608739|NCT00953927|3934538|P1|COMPLETED|Overall Study||1294
1608740|NCT00953927|3934537|P2|STARTED|Overall Study||1398
1608741|NCT00953927|3934538|P1|STARTED|Overall Study||1399
1608742|NCT00953862|3934556|P1|NOT COMPLETED|Overall Study||6
1608743|NCT00953862|3934556|P1|COMPLETED|Overall Study||12
1608744|NCT00953862|3934556|P1|STARTED|Overall Study||18
1608745|NCT00953849|3934566|P4|NOT COMPLETED|Overall Study||0
1608746|NCT00953849|3934567|P3|NOT COMPLETED|Overall Study||0
1608747|NCT00953849|3934568|P2|NOT COMPLETED|Overall Study||0
1608748|NCT00953849|3934569|P1|NOT COMPLETED|Overall Study||0
1608749|NCT00953849|3934566|P4|COMPLETED|Overall Study||5
1608750|NCT00953849|3934567|P3|COMPLETED|Overall Study||4
1608751|NCT00953849|3934568|P2|COMPLETED|Overall Study||6
1608752|NCT00953849|3934569|P1|COMPLETED|Overall Study||6
1608753|NCT00953849|3934566|P4|STARTED|Overall Study||5
1608754|NCT00953849|3934567|P3|STARTED|Overall Study||4
1608755|NCT00953849|3934568|P2|STARTED|Overall Study||6
1608756|NCT00953849|3934569|P1|STARTED|Overall Study||6
1608757|NCT00953745|3934593|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
1608758|NCT00953745|3934594|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
1608759|NCT00953745|3934593|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
1608760|NCT00953745|3934594|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
1608761|NCT00953745|3934593|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
1608762|NCT00953745|3934594|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
1608763|NCT00953745|3934593|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
1608764|NCT00953745|3934594|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
1608765|NCT00953745|3934593|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
1608766|NCT00953745|3934594|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
1608767|NCT00953745|3934593|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
1608768|NCT00953745|3934594|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
1608769|NCT00953745|3934593|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
1608770|NCT00953745|3934594|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
1608771|NCT00953745|3934593|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
1608772|NCT00953745|3934594|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
1608773|NCT00953745|3934593|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
1608774|NCT00953745|3934594|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
1608775|NCT00953719|3934604|P2|NOT COMPLETED|Overall Study||5
1608776|NCT00953719|3934605|P1|NOT COMPLETED|Overall Study||19
1608777|NCT00953719|3934604|P2|COMPLETED|Overall Study||69
1608778|NCT00953719|3934605|P1|COMPLETED|Overall Study||150
1608779|NCT00953719|3934604|P2|STARTED|Overall Study||74
1608780|NCT00953719|3934605|P1|STARTED|Overall Study||169
1608781|NCT00953706|3934627|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
1608782|NCT00953706|3934628|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
1608783|NCT00953706|3934629|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
1608784|NCT00953706|3934630|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
1608785|NCT00953706|3934627|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
1608786|NCT00953706|3934628|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
1608787|NCT00953706|3934629|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
1608788|NCT00953706|3934630|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
1608789|NCT00953706|3934627|P4|STARTED|Part B (96-Week Open-Label Extension)||33
1608790|NCT00953706|3934628|P3|STARTED|Part B (96-Week Open-Label Extension)||5
1608791|NCT00953706|3934629|P2|STARTED|Part B (96-Week Open-Label Extension)||0
1608792|NCT00953706|3934630|P1|STARTED|Part B (96-Week Open-Label Extension)||0
1608793|NCT00953706|3934627|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1608794|NCT00953706|3934628|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1608795|NCT00953706|3934629|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
1608796|NCT00953706|3934630|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
1608797|NCT00953706|3934627|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1608798|NCT00953706|3934628|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1608799|NCT00953706|3934629|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
1608800|NCT00953706|3934630|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
1608801|NCT00953706|3934627|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
1608802|NCT00953706|3934628|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
1608803|NCT00953706|3934629|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
1608804|NCT00953706|3934630|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
1608805|NCT00953680|3934662|P2|NOT COMPLETED|Period 2||0
1608806|NCT00953680|3934663|P1|NOT COMPLETED|Period 2||0
1608807|NCT00953680|3934662|P2|COMPLETED|Period 2||38
1608808|NCT00953680|3934663|P1|COMPLETED|Period 2||38
1608809|NCT00953680|3934662|P2|STARTED|Period 2||38
1608810|NCT00953680|3934663|P1|STARTED|Period 2||38
1608811|NCT00953680|3934662|P2|NOT COMPLETED|Period 1||1
1608812|NCT00953680|3934663|P1|NOT COMPLETED|Period 1||0
1608813|NCT00953680|3934662|P2|COMPLETED|Period 1||38
1608814|NCT00953680|3934663|P1|COMPLETED|Period 1||38
1608815|NCT00953680|3934662|P2|STARTED|Period 1||39
1608816|NCT00953680|3934663|P1|STARTED|Period 1||38
1608817|NCT00953667|3934675|P1|NOT COMPLETED|Overall Study||123
1608818|NCT00953667|3934675|P1|COMPLETED|Overall Study||277
1608819|NCT00953667|3934675|P1|STARTED|Overall Study||400
1608820|NCT00953654|3934683|P3|NOT COMPLETED|Overall Study||0
1608821|NCT00953654|3934684|P2|NOT COMPLETED|Overall Study||0
1608822|NCT00953654|3934685|P1|NOT COMPLETED|Overall Study||0
1608823|NCT00953654|3934683|P3|COMPLETED|Overall Study||10
1608824|NCT00953654|3934684|P2|COMPLETED|Overall Study||10
1608825|NCT00953654|3934685|P1|COMPLETED|Overall Study||10
1608826|NCT00953654|3934683|P3|STARTED|Overall Study||10
1608827|NCT00953654|3934684|P2|STARTED|Overall Study||10
1608828|NCT00953654|3934685|P1|STARTED|Overall Study||10
1608829|NCT00953615|3934696|P1|NOT COMPLETED|Overall Study||1
1608830|NCT00953615|3934696|P1|COMPLETED|Overall Study||0
1608831|NCT00953615|3934696|P1|STARTED|Overall Study||1
1608832|NCT00953576|3934705|P2|NOT COMPLETED|Overall Study||1
1608833|NCT00953576|3934706|P1|NOT COMPLETED|Overall Study||2
1608834|NCT00953576|3934705|P2|COMPLETED|Overall Study||4
1608835|NCT00953576|3934706|P1|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
1608836|NCT00953576|3934705|P2|Pharmacokinetic (PK) Evaluable|Overall Study||3
1608837|NCT00953576|3934706|P1|Pharmacokinetic (PK) Evaluable|Overall Study||4
1608838|NCT00953576|3934705|P2|Treated|Overall Study||5
1608839|NCT00953576|3934706|P1|Treated|Overall Study||4
1608840|NCT00953576|3934705|P2|DLT Evaluable|Overall Study||5
1608841|NCT00953576|3934706|P1|DLT Evaluable|Overall Study||3
1608842|NCT00953576|3934705|P2|STARTED|Overall Study||5
1608843|NCT00953576|3934706|P1|STARTED|Overall Study||6
1608844|NCT00953524|3934721|P4|NOT COMPLETED|Overall Study||8
1608845|NCT00953524|3934722|P3|NOT COMPLETED|Overall Study||14
1608846|NCT00953524|3934723|P2|NOT COMPLETED|Overall Study||15
1608847|NCT00953524|3934724|P1|NOT COMPLETED|Overall Study||22
1608848|NCT00953524|3934721|P4|COMPLETED|Overall Study||91
1608849|NCT00953524|3934722|P3|COMPLETED|Overall Study||233
1608850|NCT00953524|3934723|P2|COMPLETED|Overall Study||239
1608851|NCT00953524|3934724|P1|COMPLETED|Overall Study||227
1608852|NCT00953524|3934721|P4|STARTED|Overall Study||99
1608853|NCT00953524|3934722|P3|STARTED|Overall Study||247
1608854|NCT00953524|3934723|P2|STARTED|Overall Study||254
1608855|NCT00953524|3934724|P1|STARTED|Overall Study||249
1608856|NCT00953407|3934767|P5|NOT COMPLETED|Overall Study||1
1608857|NCT00953407|3934768|P4|NOT COMPLETED|Overall Study||2
1608858|NCT00953407|3934769|P3|NOT COMPLETED|Overall Study||1
1608859|NCT00953407|3934770|P2|NOT COMPLETED|Overall Study||1
1608860|NCT00953407|3934771|P1|NOT COMPLETED|Overall Study||1
1608861|NCT00953407|3934767|P5|COMPLETED|Overall Study||23
1608862|NCT00953407|3934768|P4|COMPLETED|Overall Study||23
1608863|NCT00953407|3934769|P3|COMPLETED|Overall Study||25
1608864|NCT00953407|3934770|P2|COMPLETED|Overall Study||24
1608865|NCT00953407|3934771|P1|COMPLETED|Overall Study||25
1608866|NCT00953407|3934767|P5|STARTED|Overall Study||24
1608867|NCT00953407|3934768|P4|STARTED|Overall Study||25
1608868|NCT00953407|3934769|P3|STARTED|Overall Study||26
1608869|NCT00953407|3934770|P2|STARTED|Overall Study||25
1608870|NCT00953407|3934771|P1|STARTED|Overall Study||26
1608871|NCT00953329|3934783|P1|NOT COMPLETED|Overall Study||1
1608872|NCT00953329|3934783|P1|COMPLETED|Overall Study||0
1608873|NCT00953329|3934783|P1|STARTED|Overall Study||1
1608874|NCT00953290|3934787|P1|NOT COMPLETED|Overall Study||0
1608875|NCT00953290|3934787|P1|COMPLETED|Overall Study||4
1608876|NCT00953290|3934787|P1|STARTED|Overall Study||4
1608877|NCT00953225|3934796|P2|NOT COMPLETED|Overall Study||0
1608878|NCT00953225|3934797|P1|NOT COMPLETED|Overall Study||2
1608879|NCT00953225|3934796|P2|COMPLETED|Overall Study||37
1608880|NCT00953225|3934797|P1|COMPLETED|Overall Study||44
1608881|NCT00953225|3934796|P2|STARTED|Overall Study||37
1608882|NCT00953225|3934797|P1|STARTED|Overall Study||46
1608883|NCT00953212|3934809|P4|NOT COMPLETED|Overall Study||0
1608884|NCT00953212|3934810|P3|NOT COMPLETED|Overall Study||0
1608885|NCT00953212|3934811|P2|NOT COMPLETED|Overall Study||0
1608886|NCT00953212|3934812|P1|NOT COMPLETED|Overall Study||0
1608887|NCT00953212|3934809|P4|COMPLETED|Overall Study||76
1608888|NCT00953212|3934810|P3|COMPLETED|Overall Study||78
1608889|NCT00953212|3934811|P2|COMPLETED|Overall Study||74
1608890|NCT00953212|3934812|P1|COMPLETED|Overall Study||76
1608891|NCT00953212|3934809|P4|STARTED|Overall Study||76
1608892|NCT00953212|3934810|P3|STARTED|Overall Study||78
1608893|NCT00953212|3934811|P2|STARTED|Overall Study||74
1608894|NCT00953212|3934812|P1|STARTED|Overall Study||76
1608895|NCT00953199|3934868|P2|NOT COMPLETED|Overall Study||0
1608896|NCT00953199|3934869|P1|NOT COMPLETED|Overall Study||0
1608897|NCT00953199|3934868|P2|COMPLETED|Overall Study||252
1608898|NCT00953199|3934869|P1|COMPLETED|Overall Study||254
1608899|NCT00953199|3934868|P2|STARTED|Overall Study||252
1608900|NCT00953199|3934869|P1|STARTED|Overall Study||254
1608901|NCT00953173|3934877|P1|NOT COMPLETED|Overall Study||282
1608902|NCT00953173|3934877|P1|COMPLETED|Overall Study||389
1608903|NCT00953173|3934877|P1|STARTED|Overall Study||671
1608904|NCT00953160|3934881|P1|NOT COMPLETED|Overall Study||27
1608905|NCT00953160|3934881|P1|COMPLETED|Overall Study||49
1608906|NCT00953160|3934881|P1|STARTED|Overall Study||76
1608907|NCT00953147|3934890|P3|NOT COMPLETED|Overall Study||42
1608908|NCT00953147|3934891|P2|NOT COMPLETED|Overall Study||66
1608909|NCT00953147|3934892|P1|NOT COMPLETED|Overall Study||37
1608910|NCT00953147|3934890|P3|COMPLETED|Overall Study||265
1608911|NCT00953147|3934891|P2|COMPLETED|Overall Study||439
1608912|NCT00953147|3934892|P1|COMPLETED|Overall Study||261
1608913|NCT00953147|3934890|P3|STARTED|Overall Study||307
1608914|NCT00953147|3934891|P2|STARTED|Overall Study||505
1608915|NCT00953147|3934892|P1|STARTED|Overall Study||298
1608916|NCT00953121|3934942|P3|NOT COMPLETED|Overall Study||0
1608917|NCT00953121|3934943|P2|NOT COMPLETED|Overall Study||0
1608918|NCT00953121|3934944|P1|NOT COMPLETED|Overall Study||0
1608919|NCT00953121|3934942|P3|COMPLETED|Overall Study||25
1608920|NCT00953121|3934943|P2|COMPLETED|Overall Study||39
1608921|NCT00953121|3934944|P1|COMPLETED|Overall Study||40
1608922|NCT00953121|3934942|P3|STARTED|Overall Study||25
1608923|NCT00953121|3934943|P2|STARTED|Overall Study||39
1608924|NCT00953121|3934944|P1|STARTED|Overall Study||40
1608925|NCT00953056|3934970|P6|NOT COMPLETED|Overall Study||4
1608926|NCT00953056|3934971|P5|NOT COMPLETED|Overall Study||2
1608927|NCT00953056|3934972|P4|NOT COMPLETED|Overall Study||0
1608928|NCT00953056|3934973|P3|NOT COMPLETED|Overall Study||0
1608929|NCT00953056|3934974|P2|NOT COMPLETED|Overall Study||0
1608930|NCT00953056|3934975|P1|NOT COMPLETED|Overall Study||0
1608931|NCT00953056|3934970|P6|COMPLETED|Overall Study||20
1608932|NCT00953056|3934971|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
1608933|NCT00953056|3934972|P4|COMPLETED|Overall Study||24
1608934|NCT00953056|3934973|P3|COMPLETED|Overall Study||24
1608935|NCT00953056|3934974|P2|COMPLETED|Overall Study||24
1608936|NCT00953056|3934975|P1|COMPLETED|Overall Study||24
1608937|NCT00953056|3934970|P6|STARTED|Overall Study||24
1608938|NCT00953056|3934971|P5|STARTED|Overall Study||24
1608939|NCT00953056|3934972|P4|STARTED|Overall Study||24
1608940|NCT00953056|3934973|P3|STARTED|Overall Study||24
1608941|NCT00953056|3934974|P2|STARTED|Overall Study||24
1608942|NCT00953056|3934975|P1|STARTED|Overall Study||24
1608943|NCT00953043|3934999|P2|NOT COMPLETED|Overall Study||2
1608944|NCT00953043|3935000|P1|NOT COMPLETED|Overall Study||4
1608945|NCT00953043|3934999|P2|COMPLETED|Overall Study||28
1608946|NCT00953043|3935000|P1|COMPLETED|Overall Study||26
1608947|NCT00953043|3934999|P2|STARTED|Overall Study||30
1608948|NCT00953043|3935000|P1|STARTED|Overall Study||30
1608949|NCT00953017|3935024|P4|NOT COMPLETED|Overall Study||5
1608950|NCT00953017|3935025|P3|NOT COMPLETED|Overall Study||6
1608951|NCT00953017|3935026|P2|NOT COMPLETED|Overall Study||6
1608952|NCT00953017|3935027|P1|NOT COMPLETED|Overall Study||5
1608953|NCT00953017|3935024|P4|COMPLETED|Overall Study||101
1608954|NCT00953017|3935025|P3|COMPLETED|Overall Study||100
1608955|NCT00953017|3935026|P2|COMPLETED|Overall Study||101
1608956|NCT00953017|3935027|P1|COMPLETED|Overall Study||101
1608957|NCT00953017|3935024|P4|STARTED|Overall Study||106
1608958|NCT00953017|3935025|P3|STARTED|Overall Study||106
1608959|NCT00953017|3935026|P2|STARTED|Overall Study||107
1608960|NCT00953017|3935027|P1|STARTED|Overall Study||106
1608961|NCT00952848|3935049|P1|NOT COMPLETED|Overall Study||4
1608962|NCT00952848|3935049|P1|COMPLETED|Overall Study||14
1608963|NCT00952848|3935049|P1|STARTED|Overall Study||18
1608964|NCT00952822|3935056|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
1608965|NCT00952822|3935057|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
1608966|NCT00952822|3935058|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
1608967|NCT00952822|3935059|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
1608968|NCT00952822|3935056|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
1608969|NCT00952822|3935057|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
1608970|NCT00952822|3935058|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
1608971|NCT00952822|3935059|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
1608972|NCT00952822|3935056|P4|STARTED|2nd Pharmacokinetic Evaluation||4
1608973|NCT00952822|3935057|P3|STARTED|2nd Pharmacokinetic Evaluation||11
1608974|NCT00952822|3935058|P2|STARTED|2nd Pharmacokinetic Evaluation||17
1608975|NCT00952822|3935059|P1|STARTED|2nd Pharmacokinetic Evaluation||9
1608976|NCT00952822|3935056|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
1608977|NCT00952822|3935057|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
1608978|NCT00952822|3935058|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
1608979|NCT00952822|3935059|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
1608980|NCT00952822|3935056|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
1608981|NCT00952822|3935057|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
1608982|NCT00952822|3935058|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
1608983|NCT00952822|3935059|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
1608984|NCT00952822|3935056|P4|STARTED|1st Pharmacokinetic Evaluation||4
1608985|NCT00952822|3935057|P3|STARTED|1st Pharmacokinetic Evaluation||11
1608986|NCT00952822|3935058|P2|STARTED|1st Pharmacokinetic Evaluation||18
1608987|NCT00952822|3935059|P1|STARTED|1st Pharmacokinetic Evaluation||9
1608988|NCT00952731|3935091|P2|NOT COMPLETED|Overall Study||0
1608989|NCT00952731|3935092|P1|NOT COMPLETED|Overall Study||1
1608990|NCT00952731|3935091|P2|COMPLETED|Overall Study||14
1608991|NCT00952731|3935092|P1|COMPLETED|Overall Study||12
1608992|NCT00952731|3935091|P2|Follow-up|Overall Study||14
1608993|NCT00952731|3935092|P1|Follow-up|Overall Study||12
1608994|NCT00952731|3935091|P2|Surgery|Overall Study||14
1608995|NCT00952731|3935092|P1|Surgery|Overall Study||12
1608996|NCT00952731|3935091|P2|Treatment & Pre-Surgery|Overall Study||14
1608997|NCT00952731|3935092|P1|Treatment & Pre-Surgery|Overall Study||12
1608998|NCT00952731|3935091|P2|Randomization|Overall Study||14
1608999|NCT00952731|3935092|P1|Randomization|Overall Study||13
1609000|NCT00952731|3935091|P2|STARTED|Overall Study||14
1609001|NCT00952731|3935092|P1|STARTED|Overall Study||13
1609002|NCT00952705|3935111|P3|NOT COMPLETED|Overall Study||10
1609003|NCT00952705|3935112|P2|NOT COMPLETED|Overall Study||10
1609004|NCT00952705|3935113|P1|NOT COMPLETED|Overall Study||33
1609005|NCT00952705|3935111|P3|COMPLETED|Overall Study||288
1609006|NCT00952705|3935112|P2|COMPLETED|Overall Study||290
1609007|NCT00952705|3935113|P1|COMPLETED|Overall Study||1169
1609008|NCT00952705|3935111|P3|STARTED|Overall Study||298
1609009|NCT00952705|3935112|P2|STARTED|Overall Study||300
1609010|NCT00952705|3935113|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
1609011|NCT00952653|3935175|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
1609012|NCT00952653|3935175|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
1609013|NCT00952653|3935175|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
1609014|NCT00952653|3935175|P1|NOT COMPLETED|Period 1: MDZ Alone||0
1609015|NCT00952653|3935175|P1|COMPLETED|Period 1: MDZ Alone||28
1609016|NCT00952653|3935175|P1|STARTED|Period 1: MDZ Alone||28
1609017|NCT00952614|3935200|P1|NOT COMPLETED|Overall Study||7
1609018|NCT00952614|3935200|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
1609019|NCT00952614|3935200|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
1609020|NCT00952614|3935200|P1|STARTED|Overall Study||30
1609021|NCT00952588|3935207|P2|NOT COMPLETED|Overall Study||24
1609022|NCT00952588|3935208|P1|NOT COMPLETED|Overall Study||36
1609023|NCT00952588|3935207|P2|COMPLETED|Overall Study||2
1609024|NCT00952588|3935208|P1|COMPLETED|Overall Study||12
1609025|NCT00952588|3935207|P2|STARTED|Overall Study||26
1609026|NCT00952588|3935208|P1|STARTED|Overall Study||48
1609027|NCT00952523|3935226|P1|NOT COMPLETED|Overall Study||7
1609028|NCT00952523|3935226|P1|COMPLETED|Overall Study||155
1609029|NCT00952523|3935226|P1|STARTED|Overall Study||162
1609030|NCT00952484|3935235|P3|NOT COMPLETED|Overall Study||0
1609031|NCT00952484|3935236|P2|NOT COMPLETED|Overall Study||1
1609032|NCT00952484|3935237|P1|NOT COMPLETED|Overall Study||0
1609033|NCT00952484|3935235|P3|COMPLETED|Overall Study||16
1609034|NCT00952484|3935236|P2|COMPLETED|Overall Study||6
1609035|NCT00952484|3935237|P1|COMPLETED|Overall Study||6
1609036|NCT00952484|3935235|P3|STARTED|Overall Study||16
1609037|NCT00952484|3935236|P2|STARTED|Overall Study||7
1609038|NCT00952484|3935237|P1|STARTED|Overall Study||6
1609039|NCT00952419|3935264|P3|NOT COMPLETED|Overall Study||0
1609040|NCT00952419|3935265|P2|NOT COMPLETED|Overall Study||10
1609041|NCT00952419|3935266|P1|NOT COMPLETED|Overall Study||6
1609042|NCT00952419|3935264|P3|COMPLETED|Overall Study||51
1609043|NCT00952419|3935265|P2|COMPLETED|Overall Study||198
1609044|NCT00952419|3935266|P1|COMPLETED|Overall Study||209
1609045|NCT00952419|3935264|P3|STARTED|Overall Study||51
1609046|NCT00952419|3935265|P2|STARTED|Overall Study||208
1609047|NCT00952419|3935266|P1|STARTED|Overall Study||215
1609048|NCT00952393|3935298|P1|NOT COMPLETED|Overall Study||0
1609049|NCT00952393|3935298|P1|COMPLETED|Overall Study||10
1609050|NCT00952393|3935298|P1|STARTED|Overall Study|10|10
1609051|NCT00952367|3935302|P1|NOT COMPLETED|Overall Study||6
1609052|NCT00952367|3935302|P1|COMPLETED|Overall Study||3635
1609053|NCT00952367|3935302|P1|STARTED|Overall Study||3641
1609054|NCT00952341|3935317|P2|NOT COMPLETED|Cycle 2||12
1609055|NCT00952341|3935318|P1|NOT COMPLETED|Cycle 2||9
1609056|NCT00952341|3935317|P2|COMPLETED|Cycle 2||118
1609057|NCT00952341|3935318|P1|COMPLETED|Cycle 2||101
1609058|NCT00952341|3935317|P2|STARTED|Cycle 2||130
1609059|NCT00952341|3935318|P1|STARTED|Cycle 2||110
1609060|NCT00952341|3935317|P2|NOT COMPLETED|Cycle 1||13
1609061|NCT00952341|3935318|P1|NOT COMPLETED|Cycle 1||20
1609062|NCT00952341|3935317|P2|COMPLETED|Cycle 1||199
1609063|NCT00952341|3935318|P1|COMPLETED|Cycle 1||189
1609064|NCT00952341|3935317|P2|STARTED|Cycle 1||212
1609065|NCT00952341|3935318|P1|STARTED|Cycle 1||209
1609066|NCT00952289|3935340|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
1609067|NCT00952289|3935341|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
1609068|NCT00952289|3935340|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
1609069|NCT00952289|3935341|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
1609070|NCT00952289|3935340|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
1609071|NCT00952289|3935341|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
1609072|NCT00952289|3935340|P2|NOT COMPLETED|All Participants||40
1609073|NCT00952289|3935341|P1|NOT COMPLETED|All Participants||21
1609074|NCT00952289|3935340|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
1609075|NCT00952289|3935341|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
1609076|NCT00952289|3935340|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
1609077|NCT00952289|3935341|P1|Safety Population|All Participants||155
1609078|NCT00952289|3935340|P2|STARTED|All Participants||154
1609079|NCT00952289|3935341|P1|STARTED|All Participants||155
1609080|NCT00952276|3935370|P5|NOT COMPLETED|Overall Study||0
1609081|NCT00952276|3935371|P4|NOT COMPLETED|Overall Study||1
1609082|NCT00952276|3935372|P3|NOT COMPLETED|Overall Study||0
1609083|NCT00952276|3935373|P2|NOT COMPLETED|Overall Study||0
1609084|NCT00952276|3935374|P1|NOT COMPLETED|Overall Study||1
1609085|NCT00952276|3935370|P5|COMPLETED|Overall Study||63
1609086|NCT00952276|3935371|P4|COMPLETED|Overall Study||120
1609087|NCT00952276|3935372|P3|COMPLETED|Overall Study||122
1609088|NCT00952276|3935373|P2|COMPLETED|Overall Study||115
1609089|NCT00952276|3935374|P1|COMPLETED|Overall Study||126
1609090|NCT00952276|3935370|P5|STARTED|Overall Study||63
1609091|NCT00952276|3935371|P4|STARTED|Overall Study||121
1609092|NCT00952276|3935372|P3|STARTED|Overall Study||122
1609093|NCT00952276|3935373|P2|STARTED|Overall Study||115
1609094|NCT00952276|3935374|P1|STARTED|Overall Study||127
1609095|NCT00952211|3935423|P2|NOT COMPLETED|Overall Study||0
1609096|NCT00952211|3935424|P1|NOT COMPLETED|Overall Study||0
1609097|NCT00952211|3935423|P2|COMPLETED|Overall Study||0
1609098|NCT00952211|3935424|P1|COMPLETED|Overall Study||3
1609099|NCT00952211|3935423|P2|STARTED|Overall Study||0
1609100|NCT00952211|3935424|P1|STARTED|Overall Study||3
1609101|NCT00952133|3935434|P2|NOT COMPLETED|Overall Study||0
1609102|NCT00952133|3935435|P1|NOT COMPLETED|Overall Study||0
1609103|NCT00952133|3935434|P2|COMPLETED|Overall Study||59
1609104|NCT00952133|3935435|P1|COMPLETED|Overall Study||59
1609105|NCT00952133|3935434|P2|STARTED|Overall Study||59
1609106|NCT00952133|3935435|P1|STARTED|Overall Study||59
1609107|NCT00952120|3935446|P3|NOT COMPLETED|Overall Study||0
1609108|NCT00952120|3935447|P2|NOT COMPLETED|Overall Study||0
1609109|NCT00952120|3935448|P1|NOT COMPLETED|Overall Study||0
1609110|NCT00952120|3935446|P3|COMPLETED|Overall Study||5
1609111|NCT00952120|3935447|P2|COMPLETED|Overall Study||47
1609112|NCT00952120|3935448|P1|COMPLETED|Overall Study||52
1609113|NCT00952120|3935446|P3|STARTED|Overall Study||5
1609114|NCT00952120|3935447|P2|STARTED|Overall Study||47
1609115|NCT00952120|3935448|P1|STARTED|Overall Study||52
1609116|NCT00952081|3935456|P1|NOT COMPLETED|Overall Study||0
1609117|NCT00952081|3935456|P1|COMPLETED|Overall Study||22
1609118|NCT00952081|3935456|P1|STARTED|Overall Study||22
1609119|NCT00952068|3935460|P1|NOT COMPLETED|Overall Study||7
1609120|NCT00952068|3935460|P1|COMPLETED|Overall Study||40
1609121|NCT00952068|3935460|P1|STARTED|Overall Study||47
1609122|NCT00951912|3935471|P3|NOT COMPLETED|Overall Study||2
1609123|NCT00951912|3935472|P2|NOT COMPLETED|Overall Study||5
1609124|NCT00951912|3935473|P1|NOT COMPLETED|Overall Study||7
1609125|NCT00951912|3935471|P3|COMPLETED|Overall Study||54
1609126|NCT00951912|3935472|P2|COMPLETED|Overall Study||50
1609127|NCT00951912|3935473|P1|COMPLETED|Overall Study||47
1609128|NCT00951912|3935471|P3|STARTED|Overall Study||56
1609129|NCT00951912|3935472|P2|STARTED|Overall Study||55
1609130|NCT00951912|3935473|P1|STARTED|Overall Study||54
1609131|NCT00951899|3935525|P2|NOT COMPLETED|Overall Study||0
1609132|NCT00951899|3935526|P1|NOT COMPLETED|Overall Study||0
1609133|NCT00951899|3935525|P2|COMPLETED|Overall Study||19
1609134|NCT00951899|3935526|P1|COMPLETED|Overall Study||19
1609135|NCT00951899|3935525|P2|STARTED|Overall Study||19
1609136|NCT00951899|3935526|P1|STARTED|Overall Study||19
1609137|NCT00951821|3935550|P2|NOT COMPLETED|Overall Study||0
1609138|NCT00951821|3935551|P1|NOT COMPLETED|Overall Study||0
1609139|NCT00951821|3935550|P2|COMPLETED|Overall Study||8
1609140|NCT00951821|3935551|P1|COMPLETED|Overall Study||16
1609141|NCT00951821|3935550|P2|STARTED|Overall Study||8
1609142|NCT00951821|3935551|P1|STARTED|Overall Study||16
1609143|NCT00951808|3935559|P3|NOT COMPLETED|Overall Study||4
1609144|NCT00951808|3935560|P2|NOT COMPLETED|Overall Study||0
1609145|NCT00951808|3935561|P1|NOT COMPLETED|Overall Study||0
1609146|NCT00951808|3935559|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
1609147|NCT00951808|3935560|P2|COMPLETED|Overall Study||6
1609148|NCT00951808|3935561|P1|COMPLETED|Overall Study||4
1609149|NCT00951808|3935559|P3|STARTED|Overall Study||227
1609150|NCT00951808|3935560|P2|STARTED|Overall Study||6
1609151|NCT00951808|3935561|P1|STARTED|Overall Study||4
1609152|NCT00951665|3935573|P6|NOT COMPLETED|Phase 2a||7
1609153|NCT00951665|3935574|P5|NOT COMPLETED|Phase 2a||12
1609154|NCT00951665|3935575|P4|NOT COMPLETED|Phase 2a||0
1609155|NCT00951665|3935576|P3|NOT COMPLETED|Phase 2a||0
1609156|NCT00951665|3935577|P2|NOT COMPLETED|Phase 2a||0
1609157|NCT00951665|3935578|P1|NOT COMPLETED|Phase 2a||0
1609158|NCT00951665|3935573|P6|COMPLETED|Phase 2a||15
1609159|NCT00951665|3935574|P5|COMPLETED|Phase 2a||10
1609160|NCT00951665|3935575|P4|COMPLETED|Phase 2a||0
1609161|NCT00951665|3935576|P3|COMPLETED|Phase 2a||0
1609162|NCT00951665|3935577|P2|COMPLETED|Phase 2a||0
1609163|NCT00951665|3935578|P1|COMPLETED|Phase 2a||0
1609164|NCT00951665|3935573|P6|STARTED|Phase 2a||22
1609165|NCT00951665|3935574|P5|STARTED|Phase 2a||22
1609166|NCT00951665|3935575|P4|STARTED|Phase 2a||0
1609167|NCT00951665|3935576|P3|STARTED|Phase 2a||0
1609168|NCT00951665|3935577|P2|STARTED|Phase 2a||0
1609169|NCT00951665|3935578|P1|STARTED|Phase 2a||0
1609170|NCT00951665|3935573|P6|NOT COMPLETED|Phase 1b||0
1609171|NCT00951665|3935574|P5|NOT COMPLETED|Phase 1b||0
1609172|NCT00951665|3935575|P4|NOT COMPLETED|Phase 1b||1
1609173|NCT00951665|3935576|P3|NOT COMPLETED|Phase 1b||17
1609174|NCT00951665|3935577|P2|NOT COMPLETED|Phase 1b||4
1609175|NCT00951665|3935578|P1|NOT COMPLETED|Phase 1b||22
1609176|NCT00951665|3935573|P6|COMPLETED|Phase 1b||0
1609177|NCT00951665|3935574|P5|COMPLETED|Phase 1b||0
1609178|NCT00951665|3935575|P4|COMPLETED|Phase 1b||2
1609179|NCT00951665|3935576|P3|COMPLETED|Phase 1b||4
1609180|NCT00951665|3935577|P2|COMPLETED|Phase 1b||6
1609181|NCT00951665|3935578|P1|COMPLETED|Phase 1b||7
1609182|NCT00951665|3935573|P6|Started Treatment|Phase 1b||0
1609183|NCT00951665|3935574|P5|Started Treatment|Phase 1b||0
1609184|NCT00951665|3935575|P4|Started Treatment|Phase 1b||3
1609185|NCT00951665|3935576|P3|Started Treatment|Phase 1b||21
1609186|NCT00951665|3935577|P2|Started Treatment|Phase 1b||10
1609187|NCT00951665|3935578|P1|Started Treatment|Phase 1b||26
1609188|NCT00951665|3935573|P6|STARTED|Phase 1b||0
1609189|NCT00951665|3935574|P5|STARTED|Phase 1b||0
1609190|NCT00951665|3935575|P4|STARTED|Phase 1b||3
1609191|NCT00951665|3935576|P3|STARTED|Phase 1b||21
1609192|NCT00951665|3935577|P2|STARTED|Phase 1b||10
1609193|NCT00951665|3935578|P1|STARTED|Phase 1b||29
1609194|NCT00951561|3935679|P4|NOT COMPLETED|Overall Study||1
1609195|NCT00951561|3935680|P3|NOT COMPLETED|Overall Study||3
1609196|NCT00951561|3935681|P2|NOT COMPLETED|Overall Study||0
1609197|NCT00951561|3935682|P1|NOT COMPLETED|Overall Study||0
1609198|NCT00951561|3935679|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
1609199|NCT00951561|3935680|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
1609200|NCT00951561|3935681|P2|COMPLETED|Overall Study||29
1609201|NCT00951561|3935682|P1|COMPLETED|Overall Study||25
1609202|NCT00951561|3935679|P4|STARTED|Overall Study||27
1609203|NCT00951561|3935680|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
1609204|NCT00951561|3935681|P2|STARTED|Overall Study||29
1609205|NCT00951561|3935682|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
1609206|NCT00951509|3935687|P1|NOT COMPLETED|Overall Study||2
1609207|NCT00951509|3935687|P1|COMPLETED|Overall Study||29
1609208|NCT00951509|3935687|P1|Driving Condition 5|Overall Study||30
1609209|NCT00951509|3935687|P1|Driving Condition 4|Overall Study||28
1609210|NCT00951509|3935687|P1|Driving Condition 3|Overall Study||25
1609211|NCT00951509|3935687|P1|Driving Condition 2|Overall Study||29
1609212|NCT00951509|3935687|P1|Driving Condition 1|Overall Study||29
1609213|NCT00951509|3935687|P1|STARTED|Overall Study||31
1609214|NCT00951496|3935698|P3|NOT COMPLETED|Overall Study||13
1609215|NCT00951496|3935699|P2|NOT COMPLETED|Overall Study||8
1609216|NCT00951496|3935700|P1|NOT COMPLETED|Overall Study||10
1609217|NCT00951496|3935698|P3|COMPLETED|Overall Study||508
1609218|NCT00951496|3935699|P2|COMPLETED|Overall Study||510
1609219|NCT00951496|3935700|P1|COMPLETED|Overall Study||511
1609220|NCT00951496|3935698|P3|STARTED|Overall Study||521
1609221|NCT00951496|3935699|P2|STARTED|Overall Study||518
1609222|NCT00951496|3935700|P1|STARTED|Overall Study||521
1609223|NCT00951483|3935728|P2|NOT COMPLETED|Overall Study||0
1609224|NCT00951483|3935729|P1|NOT COMPLETED|Overall Study||19
1609225|NCT00951483|3935728|P2|COMPLETED|Overall Study||44
1609226|NCT00951483|3935729|P1|COMPLETED|Overall Study||28
1609227|NCT00951483|3935728|P2|STARTED|Overall Study||44
1609228|NCT00951483|3935729|P1|STARTED|Overall Study||47
1609229|NCT00951379|3935749|P2|NOT COMPLETED|Overall Study||2
1609230|NCT00951379|3935750|P1|NOT COMPLETED|Overall Study||6
1609231|NCT00951379|3935749|P2|COMPLETED|Overall Study||23
1609232|NCT00951379|3935750|P1|COMPLETED|Overall Study||21
1609233|NCT00951379|3935749|P2|STARTED|Overall Study||25
1609234|NCT00951379|3935750|P1|STARTED|Overall Study||27
1609235|NCT00951275|3935792|P1|NOT COMPLETED|Overall Study||13
1609236|NCT00951275|3935792|P1|COMPLETED|Overall Study||92
1609237|NCT00951275|3935792|P1|STARTED|Overall Study||105
1609238|NCT00951171|3935824|P2|NOT COMPLETED|Overall Study||0
1609239|NCT00951171|3935825|P1|NOT COMPLETED|Overall Study||2
1609240|NCT00951171|3935824|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
1609241|NCT00951171|3935825|P1|COMPLETED|Overall Study||38
1609242|NCT00951171|3935824|P2|Pregnancy|Overall Study||7
1609243|NCT00951171|3935825|P1|Pregnancy|Overall Study||1
1609244|NCT00951171|3935824|P2|STARTED|Overall Study||55
1609245|NCT00951171|3935825|P1|STARTED|Overall Study||40
1609246|NCT00951093|3935831|P1|NOT COMPLETED|6 Months After GBP||0
1609247|NCT00951093|3935831|P1|COMPLETED|6 Months After GBP||53
1609248|NCT00951093|3935831|P1|STARTED|6 Months After GBP||53
1609249|NCT00951093|3935831|P1|NOT COMPLETED|Before GBP||0
1609250|NCT00951093|3935831|P1|COMPLETED|Before GBP||53
1609251|NCT00951093|3935831|P1|STARTED|Before GBP||53
1609252|NCT00951041|3935857|P2|NOT COMPLETED|Overall Study||1
1609253|NCT00951041|3935858|P1|NOT COMPLETED|Overall Study||5
1609254|NCT00951041|3935857|P2|COMPLETED|Overall Study||65
1609255|NCT00951041|3935858|P1|COMPLETED|Overall Study||59
1609256|NCT00951041|3935857|P2|STARTED|Overall Study||66
1609257|NCT00951041|3935858|P1|STARTED|Overall Study||64
1609258|NCT00951015|3935913|P5|NOT COMPLETED|Open-label Phase||50
1609259|NCT00951015|3935914|P4|NOT COMPLETED|Open-label Phase||0
1609260|NCT00951015|3935915|P3|NOT COMPLETED|Open-label Phase||0
1609261|NCT00951015|3935916|P2|NOT COMPLETED|Open-label Phase||0
1609262|NCT00951015|3935917|P1|NOT COMPLETED|Open-label Phase||0
1609263|NCT00951015|3935913|P5|COMPLETED|Open-label Phase||88
1609264|NCT00951015|3935914|P4|COMPLETED|Open-label Phase||0
1609265|NCT00951015|3935915|P3|COMPLETED|Open-label Phase||0
1609266|NCT00951015|3935916|P2|COMPLETED|Open-label Phase||0
1609267|NCT00951015|3935917|P1|COMPLETED|Open-label Phase||0
1609268|NCT00951015|3935913|P5|STARTED|Open-label Phase||138
1609269|NCT00951015|3935914|P4|STARTED|Open-label Phase||0
1609270|NCT00951015|3935915|P3|STARTED|Open-label Phase||0
1609271|NCT00951015|3935916|P2|STARTED|Open-label Phase||0
1609272|NCT00951015|3935917|P1|STARTED|Open-label Phase||0
1609273|NCT00951015|3935913|P5|NOT COMPLETED|Randomization Phase 96 Week||0
1609274|NCT00951015|3935914|P4|NOT COMPLETED|Randomization Phase 96 Week||10
1609275|NCT00951015|3935915|P3|NOT COMPLETED|Randomization Phase 96 Week||5
1609276|NCT00951015|3935916|P2|NOT COMPLETED|Randomization Phase 96 Week||7
1609277|NCT00951015|3935917|P1|NOT COMPLETED|Randomization Phase 96 Week||5
1609278|NCT00951015|3935913|P5|COMPLETED|Randomization Phase 96 Week||0
1609279|NCT00951015|3935914|P4|COMPLETED|Randomization Phase 96 Week||40
1609280|NCT00951015|3935915|P3|COMPLETED|Randomization Phase 96 Week||46
1609281|NCT00951015|3935916|P2|COMPLETED|Randomization Phase 96 Week||44
1609282|NCT00951015|3935917|P1|COMPLETED|Randomization Phase 96 Week||48
1609283|NCT00951015|3935913|P5|STARTED|Randomization Phase 96 Week||0
1609284|NCT00951015|3935914|P4|STARTED|Randomization Phase 96 Week||50
1609285|NCT00951015|3935915|P3|STARTED|Randomization Phase 96 Week||51
1609286|NCT00951015|3935916|P2|STARTED|Randomization Phase 96 Week||51
1609287|NCT00951015|3935917|P1|STARTED|Randomization Phase 96 Week||53
1609288|NCT00950963|3936014|P2|NOT COMPLETED|Overall Study||24
1609289|NCT00950963|3936015|P1|NOT COMPLETED|Overall Study||29
1609290|NCT00950963|3936014|P2|COMPLETED|Overall Study||357
1609291|NCT00950963|3936015|P1|COMPLETED|Overall Study||352
1609292|NCT00950963|3936014|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
1609293|NCT00950963|3936015|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
1609294|NCT00950937|3936031|P2|NOT COMPLETED|Overall Study||0
1609295|NCT00950937|3936032|P1|NOT COMPLETED|Overall Study||0
1609296|NCT00950937|3936031|P2|COMPLETED|Overall Study||14
1609297|NCT00950937|3936032|P1|COMPLETED|Overall Study||14
1609298|NCT00950937|3936031|P2|STARTED|Overall Study||14
1609299|NCT00950937|3936032|P1|STARTED|Overall Study||14
1609300|NCT00950911|3936050|P2|NOT COMPLETED|Overall Study||15
1609301|NCT00950911|3936051|P1|NOT COMPLETED|Overall Study||12
1609302|NCT00950911|3936050|P2|COMPLETED|Overall Study||3
1609303|NCT00950911|3936051|P1|COMPLETED|Overall Study||5
1609304|NCT00950911|3936050|P2|STARTED|Overall Study||18
1609305|NCT00950911|3936051|P1|STARTED|Overall Study||17
1609306|NCT00950872|3936057|P1|NOT COMPLETED|Overall Study||3
1609307|NCT00950872|3936057|P1|COMPLETED|Overall Study||26
1609308|NCT00950872|3936057|P1|STARTED|Overall Study||29
1609309|NCT00950859|3936066|P2|NOT COMPLETED|Overall Study||10
1609310|NCT00950859|3936067|P1|NOT COMPLETED|Overall Study||16
1609311|NCT00950859|3936066|P2|COMPLETED|Overall Study||14
1609312|NCT00950859|3936067|P1|COMPLETED|Overall Study||11
1609313|NCT00950859|3936066|P2|STARTED|Overall Study||24
1609314|NCT00950859|3936067|P1|STARTED|Overall Study||27
1609315|NCT00950833|3936110|P3|NOT COMPLETED|Overall Study||0
1609316|NCT00950833|3936111|P2|NOT COMPLETED|Overall Study||0
1609317|NCT00950833|3936112|P1|NOT COMPLETED|Overall Study||0
1609318|NCT00950833|3936110|P3|COMPLETED|Overall Study||223
1609319|NCT00950833|3936111|P2|COMPLETED|Overall Study||108
1609320|NCT00950833|3936112|P1|COMPLETED|Overall Study||112
1609321|NCT00950833|3936110|P3|STARTED|Overall Study||223
1609322|NCT00950833|3936111|P2|STARTED|Overall Study||108
1609323|NCT00950833|3936112|P1|STARTED|Overall Study||112
1609324|NCT00950807|3936166|P10|NOT COMPLETED|Treatment Period 3||1
1609325|NCT00950807|3936167|P9|NOT COMPLETED|Treatment Period 3||0
1609326|NCT00950807|3936168|P8|NOT COMPLETED|Treatment Period 3||1
1609327|NCT00950807|3936169|P7|NOT COMPLETED|Treatment Period 3||1
1609328|NCT00950807|3936170|P6|NOT COMPLETED|Treatment Period 3||0
1609329|NCT00950807|3936171|P5|NOT COMPLETED|Treatment Period 3||0
1609330|NCT00950807|3936172|P4|NOT COMPLETED|Treatment Period 3||0
1609331|NCT00950807|3936173|P3|NOT COMPLETED|Treatment Period 3||0
1609332|NCT00950807|3936174|P2|NOT COMPLETED|Treatment Period 3||0
1609333|NCT00950807|3936175|P1|NOT COMPLETED|Treatment Period 3||1
1609334|NCT00950807|3936166|P10|COMPLETED|Treatment Period 3||10
1609335|NCT00950807|3936167|P9|COMPLETED|Treatment Period 3||9
1609336|NCT00950807|3936168|P8|COMPLETED|Treatment Period 3||9
1609337|NCT00950807|3936169|P7|COMPLETED|Treatment Period 3||11
1609338|NCT00950807|3936170|P6|COMPLETED|Treatment Period 3||9
1609339|NCT00950807|3936171|P5|COMPLETED|Treatment Period 3||12
1609340|NCT00950807|3936172|P4|COMPLETED|Treatment Period 3||11
1609341|NCT00950807|3936173|P3|COMPLETED|Treatment Period 3||10
1609342|NCT00950807|3936174|P2|COMPLETED|Treatment Period 3||9
1609343|NCT00950807|3936175|P1|COMPLETED|Treatment Period 3||45
1609344|NCT00950807|3936166|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
1609345|NCT00950807|3936167|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
1609346|NCT00950807|3936168|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
1609347|NCT00950807|3936169|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
1609348|NCT00950807|3936170|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
1609349|NCT00950807|3936171|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
1609350|NCT00950807|3936172|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
1609351|NCT00950807|3936173|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
1609352|NCT00950807|3936174|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
1609353|NCT00950807|3936175|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
1609354|NCT00950807|3936166|P10|NOT COMPLETED|Washout Period 2||0
1609355|NCT00950807|3936167|P9|NOT COMPLETED|Washout Period 2||0
1609356|NCT00950807|3936168|P8|NOT COMPLETED|Washout Period 2||1
1609357|NCT00950807|3936169|P7|NOT COMPLETED|Washout Period 2||1
1609358|NCT00950807|3936170|P6|NOT COMPLETED|Washout Period 2||0
1609359|NCT00950807|3936171|P5|NOT COMPLETED|Washout Period 2||1
1609360|NCT00950807|3936172|P4|NOT COMPLETED|Washout Period 2||1
1609361|NCT00950807|3936173|P3|NOT COMPLETED|Washout Period 2||0
1609362|NCT00950807|3936174|P2|NOT COMPLETED|Washout Period 2||1
1609363|NCT00950807|3936175|P1|NOT COMPLETED|Washout Period 2||4
1609364|NCT00950807|3936166|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1609365|NCT00950807|3936167|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1609366|NCT00950807|3936168|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
1609367|NCT00950807|3936169|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
1609368|NCT00950807|3936170|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
1609369|NCT00950807|3936171|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
1609370|NCT00950807|3936172|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1609371|NCT00950807|3936173|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
1609372|NCT00950807|3936174|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1609373|NCT00950807|3936175|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
1609374|NCT00950807|3936166|P10|STARTED|Washout Period 2||11
1609375|NCT00950807|3936167|P9|STARTED|Washout Period 2||11
1609376|NCT00950807|3936168|P8|STARTED|Washout Period 2||10
1609377|NCT00950807|3936169|P7|STARTED|Washout Period 2||9
1609378|NCT00950807|3936170|P6|STARTED|Washout Period 2||9
1609379|NCT00950807|3936171|P5|STARTED|Washout Period 2||13
1609380|NCT00950807|3936172|P4|STARTED|Washout Period 2||12
1609381|NCT00950807|3936173|P3|STARTED|Washout Period 2||10
1609382|NCT00950807|3936174|P2|STARTED|Washout Period 2||12
1609383|NCT00950807|3936175|P1|STARTED|Washout Period 2||51
1609384|NCT00950807|3936166|P10|NOT COMPLETED|Treatment Period 2||0
1609385|NCT00950807|3936167|P9|NOT COMPLETED|Treatment Period 2||0
1609386|NCT00950807|3936168|P8|NOT COMPLETED|Treatment Period 2||3
1609387|NCT00950807|3936169|P7|NOT COMPLETED|Treatment Period 2||1
1609388|NCT00950807|3936170|P6|NOT COMPLETED|Treatment Period 2||1
1609389|NCT00950807|3936171|P5|NOT COMPLETED|Treatment Period 2||0
1609390|NCT00950807|3936172|P4|NOT COMPLETED|Treatment Period 2||1
1609391|NCT00950807|3936173|P3|NOT COMPLETED|Treatment Period 2||0
1609392|NCT00950807|3936174|P2|NOT COMPLETED|Treatment Period 2||1
1609393|NCT00950807|3936175|P1|NOT COMPLETED|Treatment Period 2||2
1609394|NCT00950807|3936166|P10|COMPLETED|Treatment Period 2||11
1609395|NCT00950807|3936167|P9|COMPLETED|Treatment Period 2||11
1609396|NCT00950807|3936168|P8|COMPLETED|Treatment Period 2||10
1609397|NCT00950807|3936169|P7|COMPLETED|Treatment Period 2||9
1609398|NCT00950807|3936170|P6|COMPLETED|Treatment Period 2||9
1609399|NCT00950807|3936171|P5|COMPLETED|Treatment Period 2||13
1609400|NCT00950807|3936172|P4|COMPLETED|Treatment Period 2||12
1609401|NCT00950807|3936173|P3|COMPLETED|Treatment Period 2||10
1609402|NCT00950807|3936174|P2|COMPLETED|Treatment Period 2||12
1609403|NCT00950807|3936175|P1|COMPLETED|Treatment Period 2||51
1609404|NCT00950807|3936166|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
1609405|NCT00950807|3936167|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
1609406|NCT00950807|3936168|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1609407|NCT00950807|3936169|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
1609408|NCT00950807|3936170|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
1609409|NCT00950807|3936171|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1609410|NCT00950807|3936172|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1609411|NCT00950807|3936173|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
1609412|NCT00950807|3936174|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1609413|NCT00950807|3936175|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
1609414|NCT00950807|3936166|P10|NOT COMPLETED|Washout Period 1||0
1609415|NCT00950807|3936167|P9|NOT COMPLETED|Washout Period 1||1
1609416|NCT00950807|3936168|P8|NOT COMPLETED|Washout Period 1||1
1609417|NCT00950807|3936169|P7|NOT COMPLETED|Washout Period 1||2
1609418|NCT00950807|3936170|P6|NOT COMPLETED|Washout Period 1||0
1609419|NCT00950807|3936171|P5|NOT COMPLETED|Washout Period 1||1
1609420|NCT00950807|3936172|P4|NOT COMPLETED|Washout Period 1||1
1609421|NCT00950807|3936173|P3|NOT COMPLETED|Washout Period 1||0
1609422|NCT00950807|3936174|P2|NOT COMPLETED|Washout Period 1||0
1609423|NCT00950807|3936175|P1|NOT COMPLETED|Washout Period 1||5
1609424|NCT00950807|3936166|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1609425|NCT00950807|3936167|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1609426|NCT00950807|3936168|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1609427|NCT00950807|3936169|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
1609428|NCT00950807|3936170|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1609429|NCT00950807|3936171|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1609430|NCT00950807|3936172|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1609431|NCT00950807|3936173|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1609432|NCT00950807|3936174|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1609433|NCT00950807|3936175|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
1609434|NCT00950807|3936166|P10|STARTED|Washout Period 1||13
1609435|NCT00950807|3936167|P9|STARTED|Washout Period 1||12
1609436|NCT00950807|3936168|P8|STARTED|Washout Period 1||14
1609437|NCT00950807|3936169|P7|STARTED|Washout Period 1||12
1609438|NCT00950807|3936170|P6|STARTED|Washout Period 1||11
1609439|NCT00950807|3936171|P5|STARTED|Washout Period 1||12
1609440|NCT00950807|3936172|P4|STARTED|Washout Period 1||12
1609441|NCT00950807|3936173|P3|STARTED|Washout Period 1||13
1609442|NCT00950807|3936174|P2|STARTED|Washout Period 1||13
1609443|NCT00950807|3936175|P1|STARTED|Washout Period 1||56
1609444|NCT00950807|3936166|P10|NOT COMPLETED|Treatment Period 1||0
1609445|NCT00950807|3936167|P9|NOT COMPLETED|Treatment Period 1||1
1609446|NCT00950807|3936168|P8|NOT COMPLETED|Treatment Period 1||0
1609447|NCT00950807|3936169|P7|NOT COMPLETED|Treatment Period 1||0
1609448|NCT00950807|3936170|P6|NOT COMPLETED|Treatment Period 1||2
1609449|NCT00950807|3936171|P5|NOT COMPLETED|Treatment Period 1||1
1609450|NCT00950807|3936172|P4|NOT COMPLETED|Treatment Period 1||0
1609451|NCT00950807|3936173|P3|NOT COMPLETED|Treatment Period 1||1
1609452|NCT00950807|3936174|P2|NOT COMPLETED|Treatment Period 1||0
1609453|NCT00950807|3936175|P1|NOT COMPLETED|Treatment Period 1||3
1609454|NCT00950807|3936166|P10|COMPLETED|Treatment Period 1||13
1609455|NCT00950807|3936167|P9|COMPLETED|Treatment Period 1||12
1609456|NCT00950807|3936168|P8|COMPLETED|Treatment Period 1||14
1609457|NCT00950807|3936169|P7|COMPLETED|Treatment Period 1||12
1609458|NCT00950807|3936170|P6|COMPLETED|Treatment Period 1||11
1609459|NCT00950807|3936171|P5|COMPLETED|Treatment Period 1||12
1609460|NCT00950807|3936172|P4|COMPLETED|Treatment Period 1||12
1609461|NCT00950807|3936173|P3|COMPLETED|Treatment Period 1||13
1609462|NCT00950807|3936174|P2|COMPLETED|Treatment Period 1||13
1609463|NCT00950807|3936175|P1|COMPLETED|Treatment Period 1||56
1609464|NCT00950807|3936166|P10|STARTED|Treatment Period 1||13
1609465|NCT00950807|3936167|P9|STARTED|Treatment Period 1||13
1609466|NCT00950807|3936168|P8|STARTED|Treatment Period 1||14
1609467|NCT00950807|3936169|P7|STARTED|Treatment Period 1||12
1609468|NCT00950807|3936170|P6|STARTED|Treatment Period 1||13
1609469|NCT00950807|3936171|P5|STARTED|Treatment Period 1||13
1609470|NCT00950807|3936172|P4|STARTED|Treatment Period 1||12
1609471|NCT00950807|3936173|P3|STARTED|Treatment Period 1||14
1609472|NCT00950807|3936174|P2|STARTED|Treatment Period 1||13
1609473|NCT00950807|3936175|P1|STARTED|Treatment Period 1||59
1609474|NCT00950755|3936217|P1|NOT COMPLETED|Long-Term Follow-Up||9
1609475|NCT00950755|3936217|P1|COMPLETED|Long-Term Follow-Up||9
1609476|NCT00950755|3936217|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
1609477|NCT00950755|3936217|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
1609478|NCT00950755|3936217|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
1609479|NCT00950755|3936217|P1|STARTED|Dosimetric and Therapeutic Treatment||41
1609480|NCT00950742|3936243|P2|NOT COMPLETED|Overall Study||2
1609481|NCT00950742|3936244|P1|NOT COMPLETED|Overall Study||16
1609482|NCT00950742|3936243|P2|COMPLETED|Overall Study||0
1609483|NCT00950742|3936244|P1|COMPLETED|Overall Study||0
1609484|NCT00950742|3936243|P2|STARTED|Overall Study|entered and treated|2
1609485|NCT00950742|3936244|P1|STARTED|Overall Study|entered and treated|16
1609486|NCT00950729|3936260|P1|NOT COMPLETED|Driving With Aircast||0
1609487|NCT00950729|3936260|P1|COMPLETED|Driving With Aircast||48
1609488|NCT00950729|3936260|P1|STARTED|Driving With Aircast||48
1609489|NCT00950729|3936260|P1|NOT COMPLETED|Driving With Plaster Cast||0
1609490|NCT00950729|3936260|P1|COMPLETED|Driving With Plaster Cast||48
1609491|NCT00950729|3936260|P1|STARTED|Driving With Plaster Cast||48
1609492|NCT00950729|3936260|P1|NOT COMPLETED|Driving With Running Shoes||0
1609493|NCT00950729|3936260|P1|COMPLETED|Driving With Running Shoes|June 2007|48
1609494|NCT00950729|3936260|P1|STARTED|Driving With Running Shoes|March 2007|48
1609495|NCT00950690|3936265|P1|NOT COMPLETED|Overall Study||244
1609496|NCT00950690|3936265|P1|COMPLETED|Overall Study||1105
1609497|NCT00950690|3936265|P1|STARTED|Overall Study||1349
1609498|NCT00950664|3936272|P2|NOT COMPLETED|Second Intervention||48
1609499|NCT00950664|3936273|P1|NOT COMPLETED|Second Intervention||46
1609500|NCT00950664|3936272|P2|COMPLETED|Second Intervention||0
1609501|NCT00950664|3936273|P1|COMPLETED|Second Intervention||0
1609502|NCT00950664|3936272|P2|STARTED|Second Intervention||48
1609503|NCT00950664|3936273|P1|STARTED|Second Intervention||46
1609504|NCT00950664|3936272|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
1609505|NCT00950664|3936273|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
1609506|NCT00950664|3936272|P2|COMPLETED|Washout Period of 4 Weeks||48
1609507|NCT00950664|3936273|P1|COMPLETED|Washout Period of 4 Weeks||46
1609508|NCT00950664|3936272|P2|STARTED|Washout Period of 4 Weeks||48
1609509|NCT00950664|3936273|P1|STARTED|Washout Period of 4 Weeks||46
1609510|NCT00950664|3936272|P2|NOT COMPLETED|First Intervention||5
1609511|NCT00950664|3936273|P1|NOT COMPLETED|First Intervention||3
1609512|NCT00950664|3936272|P2|COMPLETED|First Intervention||48
1609513|NCT00950664|3936273|P1|COMPLETED|First Intervention||46
1609514|NCT00950664|3936272|P2|STARTED|First Intervention||53
1609515|NCT00950664|3936273|P1|STARTED|First Intervention||49
1609516|NCT00950651|3936293|P2|NOT COMPLETED|Overall Study||35
1609517|NCT00950651|3936294|P1|NOT COMPLETED|Overall Study||31
1609518|NCT00950651|3936293|P2|COMPLETED|Overall Study||181
1609519|NCT00950651|3936294|P1|COMPLETED|Overall Study||184
1609520|NCT00950651|3936293|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
1609521|NCT00950651|3936294|P1|STARTED|Overall Study||215
1609522|NCT00950612|3936342|P2|NOT COMPLETED|Overall Study||0
1609523|NCT00950612|3936343|P1|NOT COMPLETED|Overall Study||0
1609524|NCT00950612|3936342|P2|COMPLETED|Overall Study||20
1609525|NCT00950612|3936343|P1|COMPLETED|Overall Study||40
1609526|NCT00950612|3936342|P2|STARTED|Overall Study||20
1609527|NCT00950612|3936343|P1|STARTED|Overall Study||40
1609528|NCT00950599|3936387|P10|NOT COMPLETED|Follow-Up Period||2
1609529|NCT00950599|3936388|P9|NOT COMPLETED|Follow-Up Period||13
1609530|NCT00950599|3936389|P8|NOT COMPLETED|Follow-Up Period||0
1609531|NCT00950599|3936390|P7|NOT COMPLETED|Follow-Up Period||0
1609532|NCT00950599|3936391|P6|NOT COMPLETED|Follow-Up Period||0
1609533|NCT00950599|3936392|P5|NOT COMPLETED|Follow-Up Period||0
1609534|NCT00950599|3936393|P4|NOT COMPLETED|Follow-Up Period||0
1609535|NCT00950599|3936394|P3|NOT COMPLETED|Follow-Up Period||0
1609536|NCT00950599|3936395|P2|NOT COMPLETED|Follow-Up Period||0
1609537|NCT00950599|3936396|P1|NOT COMPLETED|Follow-Up Period||0
1609538|NCT00950599|3936387|P10|COMPLETED|Follow-Up Period||78
1609539|NCT00950599|3936388|P9|COMPLETED|Follow-Up Period||296
1609540|NCT00950599|3936389|P8|COMPLETED|Follow-Up Period||0
1609541|NCT00950599|3936390|P7|COMPLETED|Follow-Up Period||0
1609542|NCT00950599|3936391|P6|COMPLETED|Follow-Up Period||0
1609543|NCT00950599|3936392|P5|COMPLETED|Follow-Up Period||0
1609544|NCT00950599|3936393|P4|COMPLETED|Follow-Up Period||0
1609545|NCT00950599|3936394|P3|COMPLETED|Follow-Up Period||0
1609546|NCT00950599|3936395|P2|COMPLETED|Follow-Up Period||0
1609547|NCT00950599|3936396|P1|COMPLETED|Follow-Up Period||0
1609548|NCT00950599|3936387|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
1609549|NCT00950599|3936388|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
1609550|NCT00950599|3936389|P8|STARTED|Follow-Up Period||0
1609551|NCT00950599|3936390|P7|STARTED|Follow-Up Period||0
1609552|NCT00950599|3936391|P6|STARTED|Follow-Up Period||0
1609553|NCT00950599|3936392|P5|STARTED|Follow-Up Period||0
1609554|NCT00950599|3936393|P4|STARTED|Follow-Up Period||0
1609555|NCT00950599|3936394|P3|STARTED|Follow-Up Period||0
1609556|NCT00950599|3936395|P2|STARTED|Follow-Up Period||0
1609557|NCT00950599|3936396|P1|STARTED|Follow-Up Period||0
1609558|NCT00950599|3936387|P10|NOT COMPLETED|Double-Blind Treatment Period||0
1609559|NCT00950599|3936388|P9|NOT COMPLETED|Double-Blind Treatment Period||0
1609560|NCT00950599|3936389|P8|NOT COMPLETED|Double-Blind Treatment Period||6
1609561|NCT00950599|3936390|P7|NOT COMPLETED|Double-Blind Treatment Period||0
1609562|NCT00950599|3936391|P6|NOT COMPLETED|Double-Blind Treatment Period||12
1609563|NCT00950599|3936392|P5|NOT COMPLETED|Double-Blind Treatment Period||7
1609564|NCT00950599|3936393|P4|NOT COMPLETED|Double-Blind Treatment Period||11
1609565|NCT00950599|3936394|P3|NOT COMPLETED|Double-Blind Treatment Period||9
1609566|NCT00950599|3936395|P2|NOT COMPLETED|Double-Blind Treatment Period||10
1609567|NCT00950599|3936396|P1|NOT COMPLETED|Double-Blind Treatment Period||7
1609568|NCT00950599|3936387|P10|COMPLETED|Double-Blind Treatment Period||0
1609569|NCT00950599|3936388|P9|COMPLETED|Double-Blind Treatment Period||0
1609570|NCT00950599|3936389|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
1609571|NCT00950599|3936390|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
1609572|NCT00950599|3936391|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
1609573|NCT00950599|3936392|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
1609574|NCT00950599|3936393|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
1609575|NCT00950599|3936394|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
1609576|NCT00950599|3936395|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
1609577|NCT00950599|3936396|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
1609578|NCT00950599|3936387|P10|STARTED|Double-Blind Treatment Period||0
1609579|NCT00950599|3936388|P9|STARTED|Double-Blind Treatment Period||0
1609580|NCT00950599|3936389|P8|STARTED|Double-Blind Treatment Period||41
1609581|NCT00950599|3936390|P7|STARTED|Double-Blind Treatment Period||44
1609582|NCT00950599|3936391|P6|STARTED|Double-Blind Treatment Period||67
1609583|NCT00950599|3936392|P5|STARTED|Double-Blind Treatment Period||52
1609584|NCT00950599|3936393|P4|STARTED|Double-Blind Treatment Period||54
1609585|NCT00950599|3936394|P3|STARTED|Double-Blind Treatment Period||63
1609586|NCT00950599|3936395|P2|STARTED|Double-Blind Treatment Period||47
1609587|NCT00950599|3936396|P1|STARTED|Double-Blind Treatment Period||55
1609588|NCT00950352|3936960|P2|NOT COMPLETED|Overall Study||11
1609589|NCT00950352|3936961|P1|NOT COMPLETED|Overall Study||42
1609590|NCT00950352|3936960|P2|COMPLETED|Overall Study||21
1609591|NCT00950352|3936961|P1|COMPLETED|Overall Study||30
1609592|NCT00950352|3936960|P2|STARTED|Overall Study||32
1609593|NCT00950352|3936961|P1|STARTED|Overall Study||72
1609594|NCT00950300|3936969|P2|NOT COMPLETED|SFU Period||78
1609595|NCT00950300|3936970|P1|NOT COMPLETED|SFU Period||78
1609596|NCT00950300|3936969|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
1609597|NCT00950300|3936970|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
1609598|NCT00950300|3936969|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
1609599|NCT00950300|3936970|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
1609600|NCT00950300|3936969|P2|NOT COMPLETED|TFFU Period||107
1609601|NCT00950300|3936970|P1|NOT COMPLETED|TFFU Period||100
1609602|NCT00950300|3936969|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
1609603|NCT00950300|3936970|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
1609604|NCT00950300|3936969|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
1609605|NCT00950300|3936970|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
1609606|NCT00950300|3936969|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
1609607|NCT00950300|3936970|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
1609608|NCT00950300|3936969|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
1609609|NCT00950300|3936970|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
1609610|NCT00950300|3936969|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
1609611|NCT00950300|3936970|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
1609612|NCT00950300|3936969|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
1609613|NCT00950300|3936970|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
1609614|NCT00950300|3936969|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
1609615|NCT00950300|3936970|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
1609616|NCT00950300|3936969|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
1609617|NCT00950300|3936970|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
1609618|NCT00950235|3937019|P2|NOT COMPLETED|Overall Study||4
1609619|NCT00950235|3937020|P1|NOT COMPLETED|Overall Study||2
1609620|NCT00950235|3937019|P2|COMPLETED|Overall Study||54
1609621|NCT00950235|3937020|P1|COMPLETED|Overall Study||58
1609622|NCT00950235|3937019|P2|STARTED|Overall Study||58
1609623|NCT00950235|3937020|P1|STARTED|Overall Study||60
1609624|NCT00950183|3937030|P1|NOT COMPLETED|Overall Study||36
1609625|NCT00950183|3937030|P1|COMPLETED|Overall Study||0
1609626|NCT00950183|3937030|P1|STARTED|Overall Study||36
1609627|NCT00949975|3937042|P4|NOT COMPLETED|Overall Study||28
1609628|NCT00949975|3937043|P3|NOT COMPLETED|Overall Study||19
1609629|NCT00949975|3937044|P2|NOT COMPLETED|Overall Study||29
1609630|NCT00949975|3937045|P1|NOT COMPLETED|Overall Study||27
1609631|NCT00949975|3937042|P4|COMPLETED|Overall Study||190
1609632|NCT00949975|3937043|P3|COMPLETED|Overall Study||183
1609633|NCT00949975|3937044|P2|COMPLETED|Overall Study||177
1609634|NCT00949975|3937045|P1|COMPLETED|Overall Study||185
1609635|NCT00949975|3937042|P4|STARTED|Overall Study||218
1609636|NCT00949975|3937043|P3|STARTED|Overall Study||202
1609637|NCT00949975|3937044|P2|STARTED|Overall Study||206
1609638|NCT00949975|3937045|P1|STARTED|Overall Study||212
1609639|NCT00949910|3937163|P1|NOT COMPLETED|Overall Study||6576
1609640|NCT00949910|3937163|P1|COMPLETED|Overall Study||10
1609641|NCT00949910|3937163|P1|STARTED|Overall Study||6586
1609642|NCT00949884|3937176|P3|NOT COMPLETED|Overall Study||58
1609643|NCT00949884|3937177|P2|NOT COMPLETED|Overall Study||15
1609644|NCT00949884|3937178|P1|NOT COMPLETED|Overall Study||50
1609645|NCT00949884|3937176|P3|COMPLETED|Overall Study||411
1609646|NCT00949884|3937177|P2|COMPLETED|Overall Study||37
1609647|NCT00949884|3937178|P1|COMPLETED|Overall Study||370
1609648|NCT00949884|3937176|P3|STARTED|Overall Study||469
1609649|NCT00949884|3937177|P2|STARTED|Overall Study||52
1609650|NCT00949884|3937178|P1|STARTED|Overall Study||420
1609651|NCT00949715|3937233|P2|NOT COMPLETED|Overall Study||0
1609652|NCT00949715|3937234|P1|NOT COMPLETED|Overall Study||4
1609653|NCT00949715|3937233|P2|COMPLETED|Overall Study||33
1609654|NCT00949715|3937234|P1|COMPLETED|Overall Study||28
1609655|NCT00949715|3937233|P2|STARTED|Overall Study||33
1609656|NCT00949715|3937234|P1|STARTED|Overall Study||32
1609657|NCT00949702|3937245|P1|NOT COMPLETED|Overall Study||48
1609658|NCT00949702|3937245|P1|COMPLETED|Overall Study||84
1609659|NCT00949702|3937245|P1|STARTED|Overall Study||132
1609660|NCT00949650|3937262|P2|NOT COMPLETED|Overall Study||115
1609661|NCT00949650|3937263|P1|NOT COMPLETED|Overall Study||230
1609662|NCT00949650|3937262|P2|COMPLETED|Overall Study||0
1609663|NCT00949650|3937263|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
1609664|NCT00949650|3937262|P2|STARTED|Overall Study|Treated patients.|115
1609665|NCT00949650|3937263|P1|STARTED|Overall Study|Treated patients.|230
1609666|NCT00949533|3937301|P2|NOT COMPLETED|Overall Study||1
1609667|NCT00949533|3937302|P1|NOT COMPLETED|Overall Study||0
1609668|NCT00949533|3937301|P2|COMPLETED|Overall Study||17
1609669|NCT00949533|3937302|P1|COMPLETED|Overall Study||19
1609670|NCT00949533|3937301|P2|STARTED|Overall Study||18
1609671|NCT00949533|3937302|P1|STARTED|Overall Study||19
1609672|NCT00949234|3937314|P1|NOT COMPLETED|Overall Study||42
1609673|NCT00949234|3937314|P1|COMPLETED|Overall Study||225
1609674|NCT00949234|3937314|P1|STARTED|Overall Study||267
1609675|NCT00949117|3937320|P2|NOT COMPLETED|Overall Study||5
1609676|NCT00949117|3937321|P1|NOT COMPLETED|Overall Study||3
1609677|NCT00949117|3937320|P2|COMPLETED|Overall Study||0
1609678|NCT00949117|3937321|P1|COMPLETED|Overall Study||1
1609679|NCT00949117|3937320|P2|STARTED|Overall Study||5
1609680|NCT00949117|3937321|P1|STARTED|Overall Study||4
1609681|NCT00949078|3937337|P2|NOT COMPLETED|Overall Study||0
1609682|NCT00949078|3937338|P1|NOT COMPLETED|Overall Study||0
1609683|NCT00949078|3937337|P2|COMPLETED|Overall Study||9
1609684|NCT00949078|3937338|P1|COMPLETED|Overall Study||5
1609685|NCT00949078|3937337|P2|STARTED|Overall Study||9
1609686|NCT00949078|3937338|P1|STARTED|Overall Study||5
1609687|NCT00948974|3937362|P2|NOT COMPLETED|Overall Study||20
1609688|NCT00948974|3937363|P1|NOT COMPLETED|Overall Study||23
1609689|NCT00948974|3937362|P2|COMPLETED|Overall Study||28
1609690|NCT00948974|3937363|P1|COMPLETED|Overall Study||17
1609691|NCT00948974|3937362|P2|STARTED|Overall Study||48
1609692|NCT00948974|3937363|P1|STARTED|Overall Study||40
1609693|NCT00948922|3937376|P3|NOT COMPLETED|Overall Study||4
1609694|NCT00948922|3937377|P2|NOT COMPLETED|Overall Study||12
1609695|NCT00948922|3937378|P1|NOT COMPLETED|Overall Study||8
1609696|NCT00948922|3937376|P3|COMPLETED|Overall Study||35
1609697|NCT00948922|3937377|P2|COMPLETED|Overall Study||39
1609698|NCT00948922|3937378|P1|COMPLETED|Overall Study||26
1609699|NCT00948922|3937376|P3|STARTED|Overall Study||39
1609700|NCT00948922|3937377|P2|STARTED|Overall Study||51
1609701|NCT00948922|3937378|P1|STARTED|Overall Study||34
1609702|NCT00948896|3937394|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
1609703|NCT00948896|3937395|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
1609704|NCT00948896|3937396|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
1609705|NCT00948896|3937397|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
1609706|NCT00948896|3937398|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
1609707|NCT00948896|3937399|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
1609708|NCT00948896|3937400|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
1609709|NCT00948896|3937401|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
1609710|NCT00948896|3937394|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
1609711|NCT00948896|3937395|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
1609712|NCT00948896|3937396|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
1609713|NCT00948896|3937397|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
1609714|NCT00948896|3937398|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
1609715|NCT00948896|3937399|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
1609716|NCT00948896|3937400|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
1609717|NCT00948896|3937401|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
1609718|NCT00948896|3937394|P8|STARTED|24 Months of Age to 36 Months of Age||45
1609719|NCT00948896|3937395|P7|STARTED|24 Months of Age to 36 Months of Age||43
1609720|NCT00948896|3937396|P6|STARTED|24 Months of Age to 36 Months of Age||42
1609721|NCT00948896|3937397|P5|STARTED|24 Months of Age to 36 Months of Age||44
1609722|NCT00948896|3937398|P4|STARTED|24 Months of Age to 36 Months of Age||87
1609723|NCT00948896|3937399|P3|STARTED|24 Months of Age to 36 Months of Age||90
1609724|NCT00948896|3937400|P2|STARTED|24 Months of Age to 36 Months of Age||85
1609725|NCT00948896|3937401|P1|STARTED|24 Months of Age to 36 Months of Age||90
1609726|NCT00948896|3937394|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
1609727|NCT00948896|3937395|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
1609728|NCT00948896|3937396|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
1609729|NCT00948896|3937397|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
1609730|NCT00948896|3937398|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
1609731|NCT00948896|3937399|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
1609732|NCT00948896|3937400|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
1609733|NCT00948896|3937401|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
1609734|NCT00948896|3937394|P8|COMPLETED|Randomization to 24 Months of Age||45
1609735|NCT00948896|3937395|P7|COMPLETED|Randomization to 24 Months of Age||43
1609736|NCT00948896|3937396|P6|COMPLETED|Randomization to 24 Months of Age||42
1609737|NCT00948896|3937397|P5|COMPLETED|Randomization to 24 Months of Age||44
1609738|NCT00948896|3937398|P4|COMPLETED|Randomization to 24 Months of Age||87
1609739|NCT00948896|3937399|P3|COMPLETED|Randomization to 24 Months of Age||90
1609740|NCT00948896|3937400|P2|COMPLETED|Randomization to 24 Months of Age||85
1609741|NCT00948896|3937401|P1|COMPLETED|Randomization to 24 Months of Age||90
1609742|NCT00948896|3937394|P8|STARTED|Randomization to 24 Months of Age||47
1609743|NCT00948896|3937395|P7|STARTED|Randomization to 24 Months of Age||47
1609744|NCT00948896|3937396|P6|STARTED|Randomization to 24 Months of Age||46
1609745|NCT00948896|3937397|P5|STARTED|Randomization to 24 Months of Age||46
1609746|NCT00948896|3937398|P4|STARTED|Randomization to 24 Months of Age||98
1609747|NCT00948896|3937399|P3|STARTED|Randomization to 24 Months of Age||99
1609748|NCT00948896|3937400|P2|STARTED|Randomization to 24 Months of Age||98
1609749|NCT00948896|3937401|P1|STARTED|Randomization to 24 Months of Age||98
1609750|NCT00948857|3937437|P2|NOT COMPLETED|Overall Study||0
1609751|NCT00948857|3937438|P1|NOT COMPLETED|Overall Study||1
1609752|NCT00948857|3937437|P2|COMPLETED|Overall Study||2
1609753|NCT00948857|3937438|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
1609754|NCT00948857|3937437|P2|STARTED|Overall Study||2
1609755|NCT00948857|3937438|P1|STARTED|Overall Study||3
1609756|NCT00948818|3937446|P2|NOT COMPLETED|Overall Study||94
1609757|NCT00948818|3937447|P1|NOT COMPLETED|Overall Study||62
1609758|NCT00948818|3937446|P2|COMPLETED|Overall Study||312
1609759|NCT00948818|3937447|P1|COMPLETED|Overall Study||335
1609760|NCT00948818|3937446|P2|STARTED|Overall Study||406
1609761|NCT00948818|3937447|P1|STARTED|Overall Study||397
1609762|NCT00948792|3937482|P1|NOT COMPLETED|Overall Study||0
1609763|NCT00948792|3937482|P1|COMPLETED|Overall Study||21
1609764|NCT00948792|3937482|P1|STARTED|Overall Study||21
1609765|NCT00948766|3937494|P2|NOT COMPLETED|Extension Study||0
1609766|NCT00948766|3937495|P1|NOT COMPLETED|Extension Study||91
1609767|NCT00948766|3937494|P2|COMPLETED|Extension Study||0
1609768|NCT00948766|3937495|P1|COMPLETED|Extension Study||306
1609769|NCT00948766|3937494|P2|Exposed to Study Medication|Extension Study||0
1609770|NCT00948766|3937495|P1|Exposed to Study Medication|Extension Study||396
1609771|NCT00948766|3937494|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
1609772|NCT00948766|3937495|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
1609773|NCT00948766|3937494|P2|NOT COMPLETED|Core Study||126
1609774|NCT00948766|3937495|P1|NOT COMPLETED|Core Study||127
1609775|NCT00948766|3937494|P2|COMPLETED|Core Study||234
1609776|NCT00948766|3937495|P1|COMPLETED|Core Study||229
1609777|NCT00948766|3937494|P2|Exposed to Study Medication|Core Study||359
1609778|NCT00948766|3937495|P1|Exposed to Study Medication|Core Study||355
1609779|NCT00948766|3937494|P2|STARTED|Core Study||360
1609780|NCT00948766|3937495|P1|STARTED|Core Study||356
1609781|NCT00948688|3937511|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
1609782|NCT00948688|3937512|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
1609783|NCT00948688|3937511|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
1609784|NCT00948688|3937512|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
1609785|NCT00948688|3937511|P2|STARTED|Period 2: 100 mg Vorinostat||6
1609786|NCT00948688|3937512|P1|STARTED|Period 2: 100 mg Vorinostat||0
1609787|NCT00948688|3937511|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
1609788|NCT00948688|3937512|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
1609789|NCT00948688|3937511|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
1609790|NCT00948688|3937512|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
1609791|NCT00948688|3937511|P2|STARTED|Period 1: 200 mg Vorinostat||0
1609792|NCT00948688|3937512|P1|STARTED|Period 1: 200 mg Vorinostat||4
1609793|NCT00948675|3937526|P2|NOT COMPLETED|Overall Study||4
1609794|NCT00948675|3937527|P1|NOT COMPLETED|Overall Study||7
1609795|NCT00948675|3937526|P2|COMPLETED|Overall Study||175
1609796|NCT00948675|3937527|P1|COMPLETED|Overall Study||175
1609797|NCT00948675|3937526|P2|STARTED|Overall Study||179
1609798|NCT00948675|3937527|P1|STARTED|Overall Study||182
1609799|NCT00948610|3937543|P2|NOT COMPLETED|Overall Study||1
1609800|NCT00948610|3937544|P1|NOT COMPLETED|Overall Study||1
1609801|NCT00948610|3937543|P2|COMPLETED|Overall Study||9
1609802|NCT00948610|3937544|P1|COMPLETED|Overall Study||9
1609803|NCT00948610|3937543|P2|STARTED|Overall Study||10
1609804|NCT00948610|3937544|P1|STARTED|Overall Study||10
1609805|NCT00948506|3937554|P2|NOT COMPLETED|Overall Study||1
1609806|NCT00948506|3937555|P1|NOT COMPLETED|Overall Study||3
1609807|NCT00948506|3937554|P2|COMPLETED|Overall Study||8
1609808|NCT00948506|3937555|P1|COMPLETED|Overall Study||8
1609809|NCT00948506|3937554|P2|STARTED|Overall Study||9
1609810|NCT00948506|3937555|P1|STARTED|Overall Study||11
1609811|NCT00948441|3937566|P2|NOT COMPLETED|Overall Study||4
1609812|NCT00948441|3937567|P1|NOT COMPLETED|Overall Study||1
1609813|NCT00948441|3937566|P2|COMPLETED|Overall Study||4
1609814|NCT00948441|3937567|P1|COMPLETED|Overall Study||7
1609815|NCT00948441|3937566|P2|STARTED|Overall Study||8
1609816|NCT00948441|3937567|P1|STARTED|Overall Study||8
1609817|NCT00948389|3937580|P5|NOT COMPLETED|Overall Study||1
1609818|NCT00948389|3937581|P4|NOT COMPLETED|Overall Study||9
1609819|NCT00948389|3937582|P3|NOT COMPLETED|Overall Study||7
1609820|NCT00948389|3937583|P2|NOT COMPLETED|Overall Study||3
1609821|NCT00948389|3937584|P1|NOT COMPLETED|Overall Study||6
1609822|NCT00948389|3937580|P5|COMPLETED|Overall Study||0
1609823|NCT00948389|3937581|P4|COMPLETED|Overall Study||0
1609824|NCT00948389|3937582|P3|COMPLETED|Overall Study||0
1609825|NCT00948389|3937583|P2|COMPLETED|Overall Study||0
1609826|NCT00948389|3937584|P1|COMPLETED|Overall Study||0
1609827|NCT00948389|3937580|P5|STARTED|Overall Study||1
1609828|NCT00948389|3937581|P4|STARTED|Overall Study||9
1609829|NCT00948389|3937582|P3|STARTED|Overall Study||7
1609830|NCT00948389|3937583|P2|STARTED|Overall Study||3
1609831|NCT00948389|3937584|P1|STARTED|Overall Study||6
1609832|NCT00948298|3937623|P2|NOT COMPLETED|Overall Study||5
1609833|NCT00948298|3937624|P1|NOT COMPLETED|Overall Study||10
1609834|NCT00948298|3937623|P2|COMPLETED|Overall Study||60
1609835|NCT00948298|3937624|P1|COMPLETED|Overall Study||55
1609836|NCT00948298|3937623|P2|STARTED|Overall Study||65
1609837|NCT00948298|3937624|P1|STARTED|Overall Study||65
1609838|NCT00948246|3937632|P1|NOT COMPLETED|Overall Study||24
1609839|NCT00948246|3937632|P1|COMPLETED|Overall Study||86
1609840|NCT00948246|3937632|P1|STARTED|Overall Study||110
1609841|NCT00948155|3937641|P2|NOT COMPLETED|Second Intervention 21 Days||3
1609842|NCT00948155|3937642|P1|NOT COMPLETED|Second Intervention 21 Days||2
1609843|NCT00948155|3937641|P2|COMPLETED|Second Intervention 21 Days||8
1609844|NCT00948155|3937642|P1|COMPLETED|Second Intervention 21 Days||9
1609845|NCT00948155|3937641|P2|STARTED|Second Intervention 21 Days||11
1609846|NCT00948155|3937642|P1|STARTED|Second Intervention 21 Days||11
1609847|NCT00948155|3937641|P2|NOT COMPLETED|Washout 14 Days||2
1609848|NCT00948155|3937642|P1|NOT COMPLETED|Washout 14 Days||1
1609849|NCT00948155|3937641|P2|COMPLETED|Washout 14 Days||11
1609850|NCT00948155|3937642|P1|COMPLETED|Washout 14 Days||11
1609851|NCT00948155|3937641|P2|STARTED|Washout 14 Days||13
1609852|NCT00948155|3937642|P1|STARTED|Washout 14 Days||12
1609853|NCT00948155|3937641|P2|NOT COMPLETED|First Intervention 21 Days||2
1609854|NCT00948155|3937642|P1|NOT COMPLETED|First Intervention 21 Days||2
1609855|NCT00948155|3937641|P2|COMPLETED|First Intervention 21 Days||13
1609856|NCT00948155|3937642|P1|COMPLETED|First Intervention 21 Days||12
1609857|NCT00948155|3937641|P2|STARTED|First Intervention 21 Days||15
1609858|NCT00948155|3937642|P1|STARTED|First Intervention 21 Days||14
1609859|NCT00948090|3937664|P4|NOT COMPLETED|Overall Study||11
1609860|NCT00948090|3937665|P3|NOT COMPLETED|Overall Study||56
1609861|NCT00948090|3937666|P2|NOT COMPLETED|Overall Study||1
1609862|NCT00948090|3937667|P1|NOT COMPLETED|Overall Study||43
1609863|NCT00948090|3937664|P4|COMPLETED|Overall Study||7
1609864|NCT00948090|3937665|P3|COMPLETED|Overall Study||67
1609865|NCT00948090|3937666|P2|COMPLETED|Overall Study||0
1609866|NCT00948090|3937667|P1|COMPLETED|Overall Study||22
1609867|NCT00948090|3937664|P4|STARTED|Overall Study||18
1609868|NCT00948090|3937665|P3|STARTED|Overall Study||123
1609869|NCT00948090|3937666|P2|STARTED|Overall Study||1
1609870|NCT00948090|3937667|P1|STARTED|Overall Study||65
1609871|NCT00948064|3937689|P3|NOT COMPLETED|Phase II||1
1609872|NCT00948064|3937690|P2|NOT COMPLETED|Phase II||1
1609873|NCT00948064|3937691|P1|NOT COMPLETED|Phase II||0
1609874|NCT00948064|3937689|P3|COMPLETED|Phase II||26
1609875|NCT00948064|3937690|P2|COMPLETED|Phase II||51
1609876|NCT00948064|3937691|P1|COMPLETED|Phase II||0
1609877|NCT00948064|3937689|P3|STARTED|Phase II||27
1609878|NCT00948064|3937690|P2|STARTED|Phase II||52
1609879|NCT00948064|3937691|P1|STARTED|Phase II||0
1609880|NCT00948064|3937689|P3|NOT COMPLETED|Phase I||0
1609881|NCT00948064|3937690|P2|NOT COMPLETED|Phase I||0
1609882|NCT00948064|3937691|P1|NOT COMPLETED|Phase I||1
1609883|NCT00948064|3937689|P3|COMPLETED|Phase I||0
1609884|NCT00948064|3937690|P2|COMPLETED|Phase I||0
1609885|NCT00948064|3937691|P1|COMPLETED|Phase I||30
1609886|NCT00948064|3937689|P3|STARTED|Phase I||0
1609887|NCT00948064|3937690|P2|STARTED|Phase I||0
1609888|NCT00948064|3937691|P1|STARTED|Phase I||31
1609889|NCT00947882|3937706|P4|NOT COMPLETED|Overall Study||82
1609890|NCT00947882|3937707|P3|NOT COMPLETED|Overall Study||79
1609891|NCT00947882|3937708|P2|NOT COMPLETED|Overall Study||77
1609892|NCT00947882|3937709|P1|NOT COMPLETED|Overall Study||74
1609893|NCT00947882|3937706|P4|COMPLETED|Overall Study||20
1609894|NCT00947882|3937707|P3|COMPLETED|Overall Study||22
1609895|NCT00947882|3937708|P2|COMPLETED|Overall Study||24
1609896|NCT00947882|3937709|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
1609897|NCT00947882|3937706|P4|Visit 12, Month 6|Overall Study||95
1609898|NCT00947882|3937707|P3|Visit 12, Month 6|Overall Study||90
1609899|NCT00947882|3937708|P2|Visit 12, Month 6|Overall Study||91
1609900|NCT00947882|3937709|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
1609901|NCT00947882|3937706|P4|Safety Analysis Set|Overall Study||105
1609902|NCT00947882|3937707|P3|Safety Analysis Set|Overall Study||100
1609903|NCT00947882|3937708|P2|Safety Analysis Set|Overall Study||101
1609904|NCT00947882|3937709|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
1609905|NCT00947882|3937706|P4|Actual Treatment|Overall Study||105
1609906|NCT00947882|3937707|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
1609907|NCT00947882|3937708|P2|Actual Treatment|Overall Study||101
1609908|NCT00947882|3937709|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
1609909|NCT00947882|3937706|P4|Full Analysis Set (FAS)|Overall Study||102
1609910|NCT00947882|3937707|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
1609911|NCT00947882|3937708|P2|Full Analysis Set (FAS)|Overall Study||101
1609912|NCT00947882|3937709|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
1609913|NCT00947882|3937706|P4|STARTED|Overall Study||102
1609914|NCT00947882|3937707|P3|STARTED|Overall Study||101
1609915|NCT00947882|3937708|P2|STARTED|Overall Study||101
1609916|NCT00947882|3937709|P1|STARTED|Overall Study|Started: Randomised.|100
1609917|NCT00947856|3937737|P2|NOT COMPLETED|Follow-up Period||23
1609918|NCT00947856|3937738|P1|NOT COMPLETED|Follow-up Period||51
1609919|NCT00947856|3937737|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
1609920|NCT00947856|3937738|P1|COMPLETED|Follow-up Period||27
1609921|NCT00947856|3937737|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
1609922|NCT00947856|3937738|P1|STARTED|Follow-up Period||78
1609923|NCT00947856|3937737|P2|NOT COMPLETED|Treatment Period||32
1609924|NCT00947856|3937738|P1|NOT COMPLETED|Treatment Period||78
1609925|NCT00947856|3937737|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
1609926|NCT00947856|3937738|P1|COMPLETED|Treatment Period||0
1609927|NCT00947856|3937737|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
1609928|NCT00947856|3937738|P1|STARTED|Treatment Period||78
1609929|NCT00947791|3937767|P2|NOT COMPLETED|Overall Study||0
1609930|NCT00947791|3937768|P1|NOT COMPLETED|Overall Study||0
1609931|NCT00947791|3937767|P2|COMPLETED|Overall Study||1
1609932|NCT00947791|3937768|P1|COMPLETED|Overall Study||0
1609933|NCT00947791|3937767|P2|STARTED|Overall Study||1
1609934|NCT00947791|3937768|P1|STARTED|Overall Study||0
1609935|NCT00947765|3937786|P2|NOT COMPLETED|Overall Study||0
1609936|NCT00947765|3937787|P1|NOT COMPLETED|Overall Study||0
1609937|NCT00947765|3937786|P2|COMPLETED|Overall Study||30
1609938|NCT00947765|3937787|P1|COMPLETED|Overall Study||30
1609939|NCT00947765|3937786|P2|STARTED|Overall Study||30
1609940|NCT00947765|3937787|P1|STARTED|Overall Study||30
1609941|NCT00947752|3937809|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
1609942|NCT00947752|3937810|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
1609943|NCT00947752|3937809|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
1609944|NCT00947752|3937810|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
1609945|NCT00947752|3937809|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
1609946|NCT00947752|3937810|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
1609947|NCT00947752|3937809|P2|NOT COMPLETED|1st 14-day Treatment Period||0
1609948|NCT00947752|3937810|P1|NOT COMPLETED|1st 14-day Treatment Period||0
1609949|NCT00947752|3937809|P2|COMPLETED|1st 14-day Treatment Period||71
1609950|NCT00947752|3937810|P1|COMPLETED|1st 14-day Treatment Period||76
1609951|NCT00947752|3937809|P2|STARTED|1st 14-day Treatment Period||71
1609952|NCT00947752|3937810|P1|STARTED|1st 14-day Treatment Period||76
1609953|NCT00947752|3937809|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
1609954|NCT00947752|3937810|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
1609955|NCT00947752|3937809|P2|COMPLETED|7-Day Run-in Treatment Period||0
1609956|NCT00947752|3937810|P1|COMPLETED|7-Day Run-in Treatment Period||147
1609957|NCT00947752|3937809|P2|STARTED|7-Day Run-in Treatment Period||0
1609958|NCT00947752|3937810|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
1609959|NCT00947661|3937820|P2|NOT COMPLETED|Overall Study||15
1609960|NCT00947661|3937821|P1|NOT COMPLETED|Overall Study||13
1609961|NCT00947661|3937820|P2|COMPLETED|Overall Study||274
1609962|NCT00947661|3937821|P1|COMPLETED|Overall Study||276
1609963|NCT00947661|3937820|P2|STARTED|Overall Study||289
1609964|NCT00947661|3937821|P1|STARTED|Overall Study||289
1609965|NCT00947544|3937827|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
1609966|NCT00947544|3937828|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
1609967|NCT00947544|3937827|P2|COMPLETED|Safety-Extension Period (12 Months)||6
1609968|NCT00947544|3937828|P1|COMPLETED|Safety-Extension Period (12 Months)||10
1609969|NCT00947544|3937827|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
1609970|NCT00947544|3937828|P1|STARTED|Safety-Extension Period (12 Months)||11
1609971|NCT00947544|3937827|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
1609972|NCT00947544|3937828|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
1609973|NCT00947544|3937827|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
1609974|NCT00947544|3937828|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
1609975|NCT00947544|3937827|P2|STARTED|Switch-Over Period (2 Weeks)||0
1609976|NCT00947544|3937828|P1|STARTED|Switch-Over Period (2 Weeks)||11
1609977|NCT00947531|3937854|P2|NOT COMPLETED|Overall Study||11
1609978|NCT00947531|3937855|P1|NOT COMPLETED|Overall Study||14
1609979|NCT00947531|3937854|P2|COMPLETED|Overall Study||110
1609980|NCT00947531|3937855|P1|COMPLETED|Overall Study||107
1609981|NCT00947531|3937854|P2|STARTED|Overall Study||121
1609982|NCT00947531|3937855|P1|STARTED|Overall Study||121
1609983|NCT00947518|3937864|P3|NOT COMPLETED|Overall Study||0
1609984|NCT00947518|3937865|P2|NOT COMPLETED|Overall Study||0
1609985|NCT00947518|3937866|P1|NOT COMPLETED|Overall Study||0
1609986|NCT00947518|3937864|P3|COMPLETED|Overall Study||20
1609987|NCT00947518|3937865|P2|COMPLETED|Overall Study||20
1609988|NCT00947518|3937866|P1|COMPLETED|Overall Study||20
1609989|NCT00947518|3937864|P3|STARTED|Overall Study||20
1609990|NCT00947518|3937865|P2|STARTED|Overall Study||20
1609991|NCT00947518|3937866|P1|STARTED|Overall Study||20
1609992|NCT00947505|3937882|P2|NOT COMPLETED|Overall Study||2
1609993|NCT00947505|3937883|P1|NOT COMPLETED|Overall Study||9
1609994|NCT00947505|3937882|P2|COMPLETED|Overall Study||14
1609995|NCT00947505|3937883|P1|COMPLETED|Overall Study||24
1609996|NCT00947505|3937882|P2|STARTED|Overall Study||16
1609997|NCT00947505|3937883|P1|STARTED|Overall Study||33
1609998|NCT00947427|3937891|P2|NOT COMPLETED|Overall Study||4
1609999|NCT00947427|3937892|P1|NOT COMPLETED|Overall Study||1
1610000|NCT00947427|3937891|P2|COMPLETED|Overall Study||45
1610001|NCT00947427|3937892|P1|COMPLETED|Overall Study||21
1610002|NCT00947427|3937891|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
1610003|NCT00947427|3937892|P1|STARTED|Overall Study||22
1610004|NCT00947349|3937902|P4|NOT COMPLETED|Overall Study Standard of Care||2
1610005|NCT00947349|3937903|P3|NOT COMPLETED|Overall Study Standard of Care||2
1610006|NCT00947349|3937904|P2|NOT COMPLETED|Overall Study Standard of Care||0
1610007|NCT00947349|3937905|P1|NOT COMPLETED|Overall Study Standard of Care||0
1610008|NCT00947349|3937902|P4|COMPLETED|Overall Study Standard of Care||4
1610009|NCT00947349|3937903|P3|COMPLETED|Overall Study Standard of Care||4
1610010|NCT00947349|3937904|P2|COMPLETED|Overall Study Standard of Care||5
1610011|NCT00947349|3937905|P1|COMPLETED|Overall Study Standard of Care||4
1610012|NCT00947349|3937902|P4|STARTED|Overall Study Standard of Care||6
1610013|NCT00947349|3937903|P3|STARTED|Overall Study Standard of Care||6
1610014|NCT00947349|3937904|P2|STARTED|Overall Study Standard of Care||5
1610015|NCT00947349|3937905|P1|STARTED|Overall Study Standard of Care||4
1610016|NCT00947349|3937902|P4|NOT COMPLETED|Triple Treatment Combination Period||0
1610017|NCT00947349|3937903|P3|NOT COMPLETED|Triple Treatment Combination Period||0
1610018|NCT00947349|3937904|P2|NOT COMPLETED|Triple Treatment Combination Period||1
1610019|NCT00947349|3937905|P1|NOT COMPLETED|Triple Treatment Combination Period||0
1610020|NCT00947349|3937902|P4|COMPLETED|Triple Treatment Combination Period||6
1610021|NCT00947349|3937903|P3|COMPLETED|Triple Treatment Combination Period||6
1610022|NCT00947349|3937904|P2|COMPLETED|Triple Treatment Combination Period||5
1610023|NCT00947349|3937905|P1|COMPLETED|Triple Treatment Combination Period||4
1610024|NCT00947349|3937902|P4|STARTED|Triple Treatment Combination Period||6
1610025|NCT00947349|3937903|P3|STARTED|Triple Treatment Combination Period||6
1610026|NCT00947349|3937904|P2|STARTED|Triple Treatment Combination Period||6
1610027|NCT00947349|3937905|P1|STARTED|Triple Treatment Combination Period||4
1610028|NCT00947310|3938040|P3|NOT COMPLETED|Overall Study||0
1610029|NCT00947310|3938041|P2|NOT COMPLETED|Overall Study||0
1610030|NCT00947310|3938042|P1|NOT COMPLETED|Overall Study||0
1610031|NCT00947310|3938040|P3|COMPLETED|Overall Study||486
1610032|NCT00947310|3938041|P2|COMPLETED|Overall Study||500
1610033|NCT00947310|3938042|P1|COMPLETED|Overall Study||514
1610034|NCT00947310|3938040|P3|STARTED|Overall Study||486
1610035|NCT00947310|3938041|P2|STARTED|Overall Study||500
1610036|NCT00947310|3938042|P1|STARTED|Overall Study||514
1610037|NCT00947297|3938056|P1|NOT COMPLETED|Overall Study||7
1610038|NCT00947297|3938056|P1|COMPLETED|Overall Study||53
1610039|NCT00947297|3938056|P1|STARTED|Overall Study||60
1610040|NCT00947284|3938063|P2|NOT COMPLETED|Overall Study||3
1610041|NCT00947284|3938064|P1|NOT COMPLETED|Overall Study||0
1610042|NCT00947284|3938063|P2|COMPLETED|Overall Study||0
1610043|NCT00947284|3938064|P1|COMPLETED|Overall Study||0
1610044|NCT00947284|3938063|P2|STARTED|Overall Study||3
1610045|NCT00947284|3938064|P1|STARTED|Overall Study||0
1610046|NCT00947271|3938072|P4|NOT COMPLETED|12 Months Post Intervention||62
1610047|NCT00947271|3938073|P3|NOT COMPLETED|12 Months Post Intervention||59
1610048|NCT00947271|3938074|P2|NOT COMPLETED|12 Months Post Intervention||60
1610049|NCT00947271|3938075|P1|NOT COMPLETED|12 Months Post Intervention||71
1610050|NCT00947271|3938072|P4|COMPLETED|12 Months Post Intervention||188
1610051|NCT00947271|3938073|P3|COMPLETED|12 Months Post Intervention||195
1610052|NCT00947271|3938074|P2|COMPLETED|12 Months Post Intervention||192
1610053|NCT00947271|3938075|P1|COMPLETED|12 Months Post Intervention||183
1610054|NCT00947271|3938072|P4|STARTED|12 Months Post Intervention||250
1610055|NCT00947271|3938073|P3|STARTED|12 Months Post Intervention||254
1610056|NCT00947271|3938074|P2|STARTED|12 Months Post Intervention||252
1610057|NCT00947271|3938075|P1|STARTED|12 Months Post Intervention||254
1610058|NCT00947271|3938072|P4|NOT COMPLETED|9 Months Post Intervention||59
1610059|NCT00947271|3938073|P3|NOT COMPLETED|9 Months Post Intervention||61
1610060|NCT00947271|3938074|P2|NOT COMPLETED|9 Months Post Intervention||60
1610061|NCT00947271|3938075|P1|NOT COMPLETED|9 Months Post Intervention||70
1610062|NCT00947271|3938072|P4|COMPLETED|9 Months Post Intervention||191
1610063|NCT00947271|3938073|P3|COMPLETED|9 Months Post Intervention||193
1610064|NCT00947271|3938074|P2|COMPLETED|9 Months Post Intervention||192
1610065|NCT00947271|3938075|P1|COMPLETED|9 Months Post Intervention||184
1610066|NCT00947271|3938072|P4|STARTED|9 Months Post Intervention||250
1610067|NCT00947271|3938073|P3|STARTED|9 Months Post Intervention||254
1610068|NCT00947271|3938074|P2|STARTED|9 Months Post Intervention||252
1610069|NCT00947271|3938075|P1|STARTED|9 Months Post Intervention||254
1610070|NCT00947271|3938072|P4|NOT COMPLETED|6 Months Post Intervention||54
1610071|NCT00947271|3938073|P3|NOT COMPLETED|6 Months Post Intervention||58
1610072|NCT00947271|3938074|P2|NOT COMPLETED|6 Months Post Intervention||53
1610073|NCT00947271|3938075|P1|NOT COMPLETED|6 Months Post Intervention||55
1610074|NCT00947271|3938072|P4|COMPLETED|6 Months Post Intervention||196
1610075|NCT00947271|3938073|P3|COMPLETED|6 Months Post Intervention||196
1610076|NCT00947271|3938074|P2|COMPLETED|6 Months Post Intervention||199
1610077|NCT00947271|3938075|P1|COMPLETED|6 Months Post Intervention||199
1610078|NCT00947271|3938072|P4|STARTED|6 Months Post Intervention||250
1610079|NCT00947271|3938073|P3|STARTED|6 Months Post Intervention||254
1610080|NCT00947271|3938074|P2|STARTED|6 Months Post Intervention||252
1610081|NCT00947271|3938075|P1|STARTED|6 Months Post Intervention||254
1610082|NCT00947271|3938072|P4|NOT COMPLETED|3 Months Post Intervention||44
1610083|NCT00947271|3938073|P3|NOT COMPLETED|3 Months Post Intervention||36
1610084|NCT00947271|3938074|P2|NOT COMPLETED|3 Months Post Intervention||48
1610085|NCT00947271|3938075|P1|NOT COMPLETED|3 Months Post Intervention||52
1610086|NCT00947271|3938072|P4|COMPLETED|3 Months Post Intervention||206
1610087|NCT00947271|3938073|P3|COMPLETED|3 Months Post Intervention||218
1610088|NCT00947271|3938074|P2|COMPLETED|3 Months Post Intervention||204
1610089|NCT00947271|3938075|P1|COMPLETED|3 Months Post Intervention||202
1610090|NCT00947271|3938072|P4|STARTED|3 Months Post Intervention||250
1610091|NCT00947271|3938073|P3|STARTED|3 Months Post Intervention||254
1610092|NCT00947271|3938074|P2|STARTED|3 Months Post Intervention||252
1610093|NCT00947271|3938075|P1|STARTED|3 Months Post Intervention||254
1610094|NCT00947219|3938104|P3|NOT COMPLETED|Overall Study||4
1610095|NCT00947219|3938105|P2|NOT COMPLETED|Overall Study||4
1610096|NCT00947219|3938106|P1|NOT COMPLETED|Overall Study||6
1610097|NCT00947219|3938104|P3|COMPLETED|Overall Study||22
1610098|NCT00947219|3938105|P2|COMPLETED|Overall Study||21
1610099|NCT00947219|3938106|P1|COMPLETED|Overall Study||22
1610100|NCT00947219|3938104|P3|STARTED|Overall Study||26
1610101|NCT00947219|3938105|P2|STARTED|Overall Study||25
1610102|NCT00947219|3938106|P1|STARTED|Overall Study||28
1610103|NCT00947167|3938114|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
1610104|NCT00947167|3938114|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
1610105|NCT00947167|3938114|P1|STARTED|Erlotinib Added to Pertuzumab||3
1610106|NCT00947167|3938114|P1|NOT COMPLETED|Pertuzumab Alone||0
1610107|NCT00947167|3938114|P1|COMPLETED|Pertuzumab Alone||4
1610108|NCT00947167|3938114|P1|STARTED|Pertuzumab Alone||4
1610109|NCT00947154|3938119|P1|NOT COMPLETED|Overall Study||1
1610110|NCT00947154|3938119|P1|COMPLETED|Overall Study||11
1610111|NCT00947154|3938119|P1|STARTED|Overall Study||12
1610112|NCT00947115|3938129|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
1610113|NCT00947115|3938130|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
1610114|NCT00947115|3938131|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
1610115|NCT00947115|3938129|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
1610116|NCT00947115|3938130|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
1610117|NCT00947115|3938131|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
1610118|NCT00947115|3938129|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
1610119|NCT00947115|3938130|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
1610120|NCT00947115|3938131|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
1610121|NCT00947115|3938129|P3|NOT COMPLETED|Year 10 (Month 120)||0
1610122|NCT00947115|3938130|P2|NOT COMPLETED|Year 10 (Month 120)||0
1610123|NCT00947115|3938131|P1|NOT COMPLETED|Year 10 (Month 120)||0
1610124|NCT00947115|3938129|P3|COMPLETED|Year 10 (Month 120)||156
1610125|NCT00947115|3938130|P2|COMPLETED|Year 10 (Month 120)||172
1610126|NCT00947115|3938131|P1|COMPLETED|Year 10 (Month 120)||142
1610127|NCT00947115|3938129|P3|STARTED|Year 10 (Month 120)||156
1610128|NCT00947115|3938130|P2|STARTED|Year 10 (Month 120)||172
1610129|NCT00947115|3938131|P1|STARTED|Year 10 (Month 120)||142
1610130|NCT00947115|3938129|P3|NOT COMPLETED|Year 9 (Month 108)||0
1610131|NCT00947115|3938130|P2|NOT COMPLETED|Year 9 (Month 108)||0
1610132|NCT00947115|3938131|P1|NOT COMPLETED|Year 9 (Month 108)||0
1610133|NCT00947115|3938129|P3|COMPLETED|Year 9 (Month 108)||157
1610134|NCT00947115|3938130|P2|COMPLETED|Year 9 (Month 108)||180
1610135|NCT00947115|3938131|P1|COMPLETED|Year 9 (Month 108)||146
1610136|NCT00947115|3938129|P3|STARTED|Year 9 (Month 108)||157
1610137|NCT00947115|3938130|P2|STARTED|Year 9 (Month 108)||180
1610138|NCT00947115|3938131|P1|STARTED|Year 9 (Month 108)||146
1610139|NCT00947115|3938129|P3|NOT COMPLETED|Year 8 (Month 96)||0
1610140|NCT00947115|3938130|P2|NOT COMPLETED|Year 8 (Month 96)||0
1610141|NCT00947115|3938131|P1|NOT COMPLETED|Year 8 (Month 96)||0
1610142|NCT00947115|3938129|P3|COMPLETED|Year 8 (Month 96)||141
1610143|NCT00947115|3938130|P2|COMPLETED|Year 8 (Month 96)||152
1610144|NCT00947115|3938131|P1|COMPLETED|Year 8 (Month 96)||137
1610145|NCT00947115|3938129|P3|STARTED|Year 8 (Month 96)||141
1610146|NCT00947115|3938130|P2|STARTED|Year 8 (Month 96)||152
1610147|NCT00947115|3938131|P1|STARTED|Year 8 (Month 96)||137
1610148|NCT00947115|3938129|P3|NOT COMPLETED|Year 7 (Month 84)||0
1610149|NCT00947115|3938130|P2|NOT COMPLETED|Year 7 (Month 84)||0
1610150|NCT00947115|3938131|P1|NOT COMPLETED|Year 7 (Month 84)||0
1610151|NCT00947115|3938129|P3|COMPLETED|Year 7 (Month 84)||160
1610152|NCT00947115|3938130|P2|COMPLETED|Year 7 (Month 84)||165
1610153|NCT00947115|3938131|P1|COMPLETED|Year 7 (Month 84)||149
1610154|NCT00947115|3938129|P3|STARTED|Year 7 (Month 84)||160
1610155|NCT00947115|3938130|P2|STARTED|Year 7 (Month 84)||165
1610156|NCT00947115|3938131|P1|STARTED|Year 7 (Month 84)||149
1610157|NCT00947115|3938129|P3|NOT COMPLETED|Year 6 (Month 72)||0
1610158|NCT00947115|3938130|P2|NOT COMPLETED|Year 6 (Month 72)||0
1610159|NCT00947115|3938131|P1|NOT COMPLETED|Year 6 (Month 72)||0
1610160|NCT00947115|3938129|P3|COMPLETED|Year 6 (Month 72)||164
1610161|NCT00947115|3938130|P2|COMPLETED|Year 6 (Month 72)||177
1610162|NCT00947115|3938131|P1|COMPLETED|Year 6 (Month 72)||147
1610163|NCT00947115|3938129|P3|STARTED|Year 6 (Month 72)||164
1610164|NCT00947115|3938130|P2|STARTED|Year 6 (Month 72)||177
1610165|NCT00947115|3938131|P1|STARTED|Year 6 (Month 72)||147
1610166|NCT00947115|3938129|P3|NOT COMPLETED|Year 5 (Month 60)||0
1610167|NCT00947115|3938130|P2|NOT COMPLETED|Year 5 (Month 60)||0
1610168|NCT00947115|3938131|P1|NOT COMPLETED|Year 5 (Month 60)||0
1610169|NCT00947115|3938129|P3|COMPLETED|Year 5 (Month 60)||170
1610170|NCT00947115|3938130|P2|COMPLETED|Year 5 (Month 60)||184
1610171|NCT00947115|3938131|P1|COMPLETED|Year 5 (Month 60)||153
1610172|NCT00947115|3938129|P3|STARTED|Year 5 (Month 60)||170
1610173|NCT00947115|3938130|P2|STARTED|Year 5 (Month 60)||184
1610174|NCT00947115|3938131|P1|STARTED|Year 5 (Month 60)||153
1610175|NCT00947011|3938193|P1|NOT COMPLETED|Overall Study||12
1610176|NCT00947011|3938193|P1|COMPLETED|Overall Study||0
1610177|NCT00947011|3938193|P1|STARTED|Overall Study||12
1610178|NCT00946998|3938203|P2|NOT COMPLETED|Overall Study||3
1610179|NCT00946998|3938204|P1|NOT COMPLETED|Overall Study||5
1610180|NCT00946998|3938203|P2|COMPLETED|Overall Study||96
1610181|NCT00946998|3938204|P1|COMPLETED|Overall Study||97
1610182|NCT00946998|3938203|P2|Received Treatment as Randomized|Overall Study||99
1610183|NCT00946998|3938204|P1|Received Treatment as Randomized|Overall Study||102
1610184|NCT00946998|3938203|P2|STARTED|Overall Study||99
1610185|NCT00946998|3938204|P1|STARTED|Overall Study||102
1610186|NCT00946985|3938218|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
1610187|NCT00946985|3938218|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
1610188|NCT00946985|3938218|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
1610189|NCT00946985|3938218|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
1610190|NCT00946985|3938218|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
1610191|NCT00946985|3938218|P1|STARTED|Stabilization Phase (25 Weeks)||162
1610192|NCT00946920|3938224|P2|NOT COMPLETED|Overall Study||44
1610193|NCT00946920|3938225|P1|NOT COMPLETED|Overall Study||110
1610194|NCT00946920|3938224|P2|COMPLETED|Overall Study||239
1610195|NCT00946920|3938225|P1|COMPLETED|Overall Study||455
1610196|NCT00946920|3938224|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
1610197|NCT00946920|3938225|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
1610198|NCT00946920|3938224|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
1610199|NCT00946920|3938225|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
1610200|NCT00946881|3938240|P1|NOT COMPLETED|Retreatment||1
1610201|NCT00946881|3938240|P1|COMPLETED|Retreatment||7
1610202|NCT00946881|3938240|P1|STARTED|Retreatment|Only 8 of the 28 patients who completed the study underwent a retreatment.|8
1610203|NCT00946881|3938240|P1|NOT COMPLETED|First Treatment||2
1610204|NCT00946881|3938240|P1|COMPLETED|First Treatment||28
1610205|NCT00946881|3938240|P1|STARTED|First Treatment||30
1610206|NCT00946530|3938273|P4|NOT COMPLETED|Overall Study||4
1610207|NCT00946530|3938274|P3|NOT COMPLETED|Overall Study||1
1610208|NCT00946530|3938275|P2|NOT COMPLETED|Overall Study||4
1610209|NCT00946530|3938276|P1|NOT COMPLETED|Overall Study||1
1610210|NCT00946530|3938273|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
1610211|NCT00946530|3938274|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
1610212|NCT00946530|3938275|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
1610213|NCT00946530|3938276|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
1610214|NCT00946530|3938273|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
1610215|NCT00946530|3938274|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
1610216|NCT00946530|3938275|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
1610217|NCT00946530|3938276|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
1610218|NCT00946478|3938292|P2|NOT COMPLETED|Overall Study||0
1610219|NCT00946478|3938293|P1|NOT COMPLETED|Overall Study||0
1610220|NCT00946478|3938292|P2|COMPLETED|Overall Study||20
1610221|NCT00946478|3938293|P1|COMPLETED|Overall Study||20
1610222|NCT00946478|3938292|P2|STARTED|Overall Study||20
1610223|NCT00946478|3938293|P1|STARTED|Overall Study||20
1610224|NCT00946348|3938301|P2|NOT COMPLETED|Overall Study||0
1610225|NCT00946348|3938302|P1|NOT COMPLETED|Overall Study||0
1610226|NCT00946348|3938301|P2|COMPLETED|Overall Study||6
1610227|NCT00946348|3938302|P1|COMPLETED|Overall Study||6
1610228|NCT00946348|3938301|P2|STARTED|Overall Study||6
1610229|NCT00946348|3938302|P1|STARTED|Overall Study||6
1610230|NCT00946322|3938308|P1|NOT COMPLETED|Post-treatment||2
1610231|NCT00946322|3938308|P1|COMPLETED|Post-treatment||9
1610232|NCT00946322|3938308|P1|STARTED|Post-treatment||11
1610233|NCT00946322|3938308|P1|NOT COMPLETED|Pre-treatment||1
1610234|NCT00946322|3938308|P1|COMPLETED|Pre-treatment||11
1610235|NCT00946322|3938308|P1|STARTED|Pre-treatment||12
1610236|NCT00946309|3938321|P2|NOT COMPLETED|Overall Study||4
1610237|NCT00946309|3938322|P1|NOT COMPLETED|Overall Study||1
1610238|NCT00946309|3938321|P2|COMPLETED|Overall Study||19
1610239|NCT00946309|3938322|P1|COMPLETED|Overall Study||21
1610240|NCT00946309|3938321|P2|STARTED|Overall Study||23
1610241|NCT00946309|3938322|P1|STARTED|Overall Study||22
1610242|NCT00946296|3938340|P2|NOT COMPLETED|Overall Study||0
1610243|NCT00946296|3938341|P1|NOT COMPLETED|Overall Study||3
1610244|NCT00946296|3938340|P2|COMPLETED|Overall Study||15
1610245|NCT00946296|3938341|P1|COMPLETED|Overall Study||18
1610246|NCT00946296|3938340|P2|STARTED|Overall Study||15
1610247|NCT00946296|3938341|P1|STARTED|Overall Study||21
1610248|NCT00946114|3938349|P2|NOT COMPLETED|Overall Study||2
1610249|NCT00946114|3938350|P1|NOT COMPLETED|Overall Study||8
1610250|NCT00946114|3938349|P2|COMPLETED|Overall Study||10
1610251|NCT00946114|3938350|P1|COMPLETED|Overall Study||12
1610252|NCT00946114|3938349|P2|STARTED|Overall Study||12
1610253|NCT00946114|3938350|P1|STARTED|Overall Study||20
1610254|NCT00946101|3938358|P2|NOT COMPLETED|Overall Study||2
1610255|NCT00946101|3938359|P1|NOT COMPLETED|Overall Study||4
1610256|NCT00946101|3938358|P2|COMPLETED|Overall Study||63
1610257|NCT00946101|3938359|P1|COMPLETED|Overall Study||257
1610258|NCT00946101|3938358|P2|Day 15 Post Dose 2|Overall Study||63
1610259|NCT00946101|3938359|P1|Day 15 Post Dose 2|Overall Study||254
1610260|NCT00946101|3938358|P2|Day 15 Post Dose 1|Overall Study||64
1610261|NCT00946101|3938359|P1|Day 15 Post Dose 1|Overall Study||260
1610262|NCT00946101|3938358|P2|STARTED|Overall Study||65
1610263|NCT00946101|3938359|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
1610264|NCT00946088|3938425|P2|NOT COMPLETED|Overall Study||1
1610265|NCT00946088|3938426|P1|NOT COMPLETED|Overall Study||0
1610266|NCT00946088|3938425|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
1610267|NCT00946088|3938426|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
1610268|NCT00946088|3938425|P2|STARTED|Overall Study||3
1610269|NCT00946088|3938426|P1|STARTED|Overall Study||4
1610270|NCT00946023|3938448|P1|NOT COMPLETED|Overall Study||0
1610271|NCT00946023|3938448|P1|COMPLETED|Overall Study||83
1610272|NCT00946023|3938448|P1|STARTED|Overall Study||83
1610273|NCT00945958|3938463|P1|NOT COMPLETED|Overall Study||12
1610274|NCT00945958|3938463|P1|COMPLETED|Overall Study||149
1610275|NCT00945958|3938463|P1|STARTED|Overall Study||161
1610276|NCT00945945|3938470|P2|NOT COMPLETED|Overall Study||55
1610277|NCT00945945|3938471|P1|NOT COMPLETED|Overall Study||36
1610278|NCT00945945|3938470|P2|COMPLETED|Overall Study||162
1610279|NCT00945945|3938471|P1|COMPLETED|Overall Study||171
1610280|NCT00945945|3938470|P2|STARTED|Overall Study||217
1610281|NCT00945945|3938471|P1|STARTED|Overall Study||207
1610282|NCT00945906|3938497|P1|NOT COMPLETED|Overall Study||7
1610283|NCT00945906|3938497|P1|COMPLETED|Overall Study||54
1610284|NCT00945906|3938497|P1|STARTED|Overall Study||61
1610285|NCT00945893|3938508|P2|NOT COMPLETED|Overall Study||10
1610286|NCT00945893|3938509|P1|NOT COMPLETED|Overall Study||3
1610287|NCT00945893|3938508|P2|COMPLETED|Overall Study||230
1610288|NCT00945893|3938509|P1|COMPLETED|Overall Study||57
1610289|NCT00945893|3938508|P2|Day 15 Post Dose 2|Overall Study||226
1610290|NCT00945893|3938509|P1|Day 15 Post Dose 2|Overall Study||54
1610291|NCT00945893|3938508|P2|Day 15 Post Dose 1|Overall Study||238
1610292|NCT00945893|3938509|P1|Day 15 Post Dose 1|Overall Study||60
1610293|NCT00945893|3938508|P2|STARTED|Overall Study||240
1610294|NCT00945893|3938509|P1|STARTED|Overall Study||60
1610295|NCT00945854|3938575|P2|NOT COMPLETED|Overall Study||4
1610296|NCT00945854|3938576|P1|NOT COMPLETED|Overall Study||2
1610297|NCT00945854|3938575|P2|COMPLETED|Overall Study||26
1610298|NCT00945854|3938576|P1|COMPLETED|Overall Study||28
1610299|NCT00945854|3938575|P2|STARTED|Overall Study||30
1610300|NCT00945854|3938576|P1|STARTED|Overall Study||30
1610301|NCT00945815|3938586|P1|NOT COMPLETED|Overall Study||8
1610302|NCT00945815|3938586|P1|COMPLETED|Overall Study||27
1610303|NCT00945815|3938586|P1|Eligible and Began Protocol Therapy|Overall Study||31
1610304|NCT00945815|3938586|P1|Eligible|Overall Study||32
1610305|NCT00945815|3938586|P1|STARTED|Overall Study||35
1610306|NCT00945750|3938597|P6|NOT COMPLETED|Period III||0
1610307|NCT00945750|3938598|P5|NOT COMPLETED|Period III||0
1610308|NCT00945750|3938599|P4|NOT COMPLETED|Period III||0
1610309|NCT00945750|3938600|P3|NOT COMPLETED|Period III||0
1610310|NCT00945750|3938601|P2|NOT COMPLETED|Period III||0
1610311|NCT00945750|3938602|P1|NOT COMPLETED|Period III||0
1610312|NCT00945750|3938597|P6|COMPLETED|Period III||5
1610313|NCT00945750|3938598|P5|COMPLETED|Period III||5
1610314|NCT00945750|3938599|P4|COMPLETED|Period III||5
1610315|NCT00945750|3938600|P3|COMPLETED|Period III||5
1610316|NCT00945750|3938601|P2|COMPLETED|Period III||5
1610317|NCT00945750|3938602|P1|COMPLETED|Period III||5
1610318|NCT00945750|3938597|P6|STARTED|Period III||5
1610319|NCT00945750|3938598|P5|STARTED|Period III||5
1610320|NCT00945750|3938599|P4|STARTED|Period III||5
1610321|NCT00945750|3938600|P3|STARTED|Period III||5
1610322|NCT00945750|3938601|P2|STARTED|Period III||5
1610323|NCT00945750|3938602|P1|STARTED|Period III||5
1610324|NCT00945750|3938597|P6|NOT COMPLETED|Period II||0
1610325|NCT00945750|3938598|P5|NOT COMPLETED|Period II||0
1610326|NCT00945750|3938599|P4|NOT COMPLETED|Period II||0
1610327|NCT00945750|3938600|P3|NOT COMPLETED|Period II||0
1610328|NCT00945750|3938601|P2|NOT COMPLETED|Period II||0
1610329|NCT00945750|3938602|P1|NOT COMPLETED|Period II||0
1610330|NCT00945750|3938597|P6|COMPLETED|Period II||5
1610331|NCT00945750|3938598|P5|COMPLETED|Period II||5
1610332|NCT00945750|3938599|P4|COMPLETED|Period II||5
1610333|NCT00945750|3938600|P3|COMPLETED|Period II||5
1610334|NCT00945750|3938601|P2|COMPLETED|Period II||5
1610335|NCT00945750|3938602|P1|COMPLETED|Period II||5
1610336|NCT00945750|3938597|P6|STARTED|Period II||5
1610337|NCT00945750|3938598|P5|STARTED|Period II||5
1610338|NCT00945750|3938599|P4|STARTED|Period II||5
1610339|NCT00945750|3938600|P3|STARTED|Period II||5
1610340|NCT00945750|3938601|P2|STARTED|Period II||5
1610341|NCT00945750|3938602|P1|STARTED|Period II||5
1610342|NCT00945750|3938597|P6|NOT COMPLETED|Period I||0
1610343|NCT00945750|3938598|P5|NOT COMPLETED|Period I||0
1610344|NCT00945750|3938599|P4|NOT COMPLETED|Period I||0
1610345|NCT00945750|3938600|P3|NOT COMPLETED|Period I||0
1610346|NCT00945750|3938601|P2|NOT COMPLETED|Period I||0
1610347|NCT00945750|3938602|P1|NOT COMPLETED|Period I||0
1610348|NCT00945750|3938597|P6|COMPLETED|Period I||5
1610349|NCT00945750|3938598|P5|COMPLETED|Period I||5
1610350|NCT00945750|3938599|P4|COMPLETED|Period I||5
1610351|NCT00945750|3938600|P3|COMPLETED|Period I||5
1610352|NCT00945750|3938601|P2|COMPLETED|Period I||5
1610353|NCT00945750|3938602|P1|COMPLETED|Period I||5
1610354|NCT00945750|3938597|P6|STARTED|Period I||5
1610355|NCT00945750|3938598|P5|STARTED|Period I||5
1610356|NCT00945750|3938599|P4|STARTED|Period I||5
1610357|NCT00945750|3938600|P3|STARTED|Period I||5
1610358|NCT00945750|3938601|P2|STARTED|Period I||5
1610359|NCT00945750|3938602|P1|STARTED|Period I||5
1610360|NCT00945659|3938618|P3|NOT COMPLETED|Overall Study||17
1610361|NCT00945659|3938619|P2|NOT COMPLETED|Overall Study||20
1610362|NCT00945659|3938620|P1|NOT COMPLETED|Overall Study||7
1610363|NCT00945659|3938618|P3|COMPLETED|Overall Study||20
1610364|NCT00945659|3938619|P2|COMPLETED|Overall Study||20
1610365|NCT00945659|3938620|P1|COMPLETED|Overall Study||32
1610366|NCT00945659|3938618|P3|12-Months|Overall Study||20
1610367|NCT00945659|3938619|P2|12-Months|Overall Study||20
1610368|NCT00945659|3938620|P1|12-Months|Overall Study||32
1610369|NCT00945659|3938618|P3|9-Months|Overall Study||20
1610370|NCT00945659|3938619|P2|9-Months|Overall Study||20
1610371|NCT00945659|3938620|P1|9-Months|Overall Study||32
1610372|NCT00945659|3938618|P3|6-Months|Overall Study||25
1610373|NCT00945659|3938619|P2|6-Months|Overall Study||29
1610374|NCT00945659|3938620|P1|6-Months|Overall Study||31
1610375|NCT00945659|3938618|P3|3-Months|Overall Study||35
1610376|NCT00945659|3938619|P2|3-Months|Overall Study||39
1610377|NCT00945659|3938620|P1|3-Months|Overall Study||38
1610378|NCT00945659|3938618|P3|Baseline|Overall Study||37
1610379|NCT00945659|3938619|P2|Baseline|Overall Study||40
1610380|NCT00945659|3938620|P1|Baseline|Overall Study||39
1610381|NCT00945659|3938618|P3|STARTED|Overall Study||37
1610382|NCT00945659|3938619|P2|STARTED|Overall Study||40
1610383|NCT00945659|3938620|P1|STARTED|Overall Study||39
1610384|NCT00945555|3938664|P1|NOT COMPLETED|Overall Study||28
1610385|NCT00945555|3938664|P1|COMPLETED|Overall Study||236
1610386|NCT00945555|3938664|P1|STARTED|Overall Study||264
1610387|NCT00945477|3938675|P1|NOT COMPLETED|Overall Study||6
1610388|NCT00945477|3938675|P1|COMPLETED|Overall Study||5
1610389|NCT00945477|3938675|P1|STARTED|Overall Study||11
1610390|NCT00945334|3938682|P2|NOT COMPLETED|Overall Study||3
1610391|NCT00945334|3938683|P1|NOT COMPLETED|Overall Study||3
1610392|NCT00945334|3938682|P2|COMPLETED|Overall Study||15
1610393|NCT00945334|3938683|P1|COMPLETED|Overall Study||16
1610394|NCT00945334|3938682|P2|STARTED|Overall Study||18
1610395|NCT00945334|3938683|P1|STARTED|Overall Study||19
1610396|NCT00945321|3938691|P6|NOT COMPLETED|Period 4||1
1610397|NCT00945321|3938692|P5|NOT COMPLETED|Period 4||0
1610398|NCT00945321|3938693|P4|NOT COMPLETED|Period 4||0
1610399|NCT00945321|3938694|P3|NOT COMPLETED|Period 4||0
1610400|NCT00945321|3938695|P2|NOT COMPLETED|Period 4||0
1610401|NCT00945321|3938696|P1|NOT COMPLETED|Period 4||0
1610402|NCT00945321|3938691|P6|COMPLETED|Period 4||6
1610403|NCT00945321|3938692|P5|COMPLETED|Period 4||6
1610404|NCT00945321|3938693|P4|COMPLETED|Period 4||7
1610405|NCT00945321|3938694|P3|COMPLETED|Period 4||7
1610406|NCT00945321|3938695|P2|COMPLETED|Period 4||7
1610407|NCT00945321|3938696|P1|COMPLETED|Period 4||7
1610408|NCT00945321|3938691|P6|STARTED|Period 4||7
1610409|NCT00945321|3938692|P5|STARTED|Period 4||6
1610410|NCT00945321|3938693|P4|STARTED|Period 4||7
1610411|NCT00945321|3938694|P3|STARTED|Period 4||7
1610412|NCT00945321|3938695|P2|STARTED|Period 4||7
1610413|NCT00945321|3938696|P1|STARTED|Period 4||7
1610414|NCT00945321|3938691|P6|NOT COMPLETED|Period 3||0
1610415|NCT00945321|3938692|P5|NOT COMPLETED|Period 3||0
1610416|NCT00945321|3938693|P4|NOT COMPLETED|Period 3||0
1610417|NCT00945321|3938694|P3|NOT COMPLETED|Period 3||0
1610418|NCT00945321|3938695|P2|NOT COMPLETED|Period 3||0
1610419|NCT00945321|3938696|P1|NOT COMPLETED|Period 3||0
1610420|NCT00945321|3938691|P6|COMPLETED|Period 3||7
1610421|NCT00945321|3938692|P5|COMPLETED|Period 3||6
1610422|NCT00945321|3938693|P4|COMPLETED|Period 3||7
1610423|NCT00945321|3938694|P3|COMPLETED|Period 3||7
1610424|NCT00945321|3938695|P2|COMPLETED|Period 3||7
1610425|NCT00945321|3938696|P1|COMPLETED|Period 3||7
1610426|NCT00945321|3938691|P6|STARTED|Period 3||7
1610427|NCT00945321|3938692|P5|STARTED|Period 3||6
1610428|NCT00945321|3938693|P4|STARTED|Period 3||7
1610429|NCT00945321|3938694|P3|STARTED|Period 3||7
1610430|NCT00945321|3938695|P2|STARTED|Period 3||7
1610431|NCT00945321|3938696|P1|STARTED|Period 3||7
1610432|NCT00945321|3938691|P6|NOT COMPLETED|Period 2||0
1610433|NCT00945321|3938692|P5|NOT COMPLETED|Period 2||0
1610434|NCT00945321|3938693|P4|NOT COMPLETED|Period 2||0
1610435|NCT00945321|3938694|P3|NOT COMPLETED|Period 2||0
1610436|NCT00945321|3938695|P2|NOT COMPLETED|Period 2||0
1610437|NCT00945321|3938696|P1|NOT COMPLETED|Period 2||0
1610438|NCT00945321|3938691|P6|COMPLETED|Period 2||7
1610439|NCT00945321|3938692|P5|COMPLETED|Period 2||6
1610440|NCT00945321|3938693|P4|COMPLETED|Period 2||7
1610441|NCT00945321|3938694|P3|COMPLETED|Period 2||7
1610442|NCT00945321|3938695|P2|COMPLETED|Period 2||7
1610443|NCT00945321|3938696|P1|COMPLETED|Period 2||7
1610444|NCT00945321|3938691|P6|STARTED|Period 2||7
1610445|NCT00945321|3938692|P5|STARTED|Period 2||6
1610446|NCT00945321|3938693|P4|STARTED|Period 2||7
1610447|NCT00945321|3938694|P3|STARTED|Period 2||7
1610448|NCT00945321|3938695|P2|STARTED|Period 2||7
1610449|NCT00945321|3938696|P1|STARTED|Period 2||7
1610450|NCT00945321|3938691|P6|NOT COMPLETED|Period 1||0
1610451|NCT00945321|3938692|P5|NOT COMPLETED|Period 1||1
1610452|NCT00945321|3938693|P4|NOT COMPLETED|Period 1||0
1610453|NCT00945321|3938694|P3|NOT COMPLETED|Period 1||0
1610454|NCT00945321|3938695|P2|NOT COMPLETED|Period 1||0
1610455|NCT00945321|3938696|P1|NOT COMPLETED|Period 1||0
1610456|NCT00945321|3938691|P6|COMPLETED|Period 1||7
1610457|NCT00945321|3938692|P5|COMPLETED|Period 1||6
1610458|NCT00945321|3938693|P4|COMPLETED|Period 1||7
1610459|NCT00945321|3938694|P3|COMPLETED|Period 1||7
1610460|NCT00945321|3938695|P2|COMPLETED|Period 1||7
1610461|NCT00945321|3938696|P1|COMPLETED|Period 1||7
1610462|NCT00945321|3938691|P6|STARTED|Period 1||7
1610463|NCT00945321|3938692|P5|STARTED|Period 1||7
1610464|NCT00945321|3938693|P4|STARTED|Period 1||7
1610465|NCT00945321|3938694|P3|STARTED|Period 1||7
1610466|NCT00945321|3938695|P2|STARTED|Period 1||7
1610467|NCT00945321|3938696|P1|STARTED|Period 1||7
1610468|NCT00945295|3938718|P2|NOT COMPLETED|Overall Study||2
1610469|NCT00945295|3938719|P1|NOT COMPLETED|Overall Study||0
1610470|NCT00945295|3938718|P2|COMPLETED|Overall Study||14
1610471|NCT00945295|3938719|P1|COMPLETED|Overall Study||15
1610472|NCT00945295|3938718|P2|STARTED|Overall Study||16
1610473|NCT00945295|3938719|P1|STARTED|Overall Study||15
1610474|NCT00945282|3938729|P2|NOT COMPLETED|Overall Study||0
1610475|NCT00945282|3938730|P1|NOT COMPLETED|Overall Study||0
1610476|NCT00945282|3938729|P2|COMPLETED|Overall Study||2
1610477|NCT00945282|3938730|P1|COMPLETED|Overall Study||6
1610478|NCT00945282|3938729|P2|STARTED|Overall Study||2
1610479|NCT00945282|3938730|P1|STARTED|Overall Study||6
1610480|NCT00945256|3938813|P5|NOT COMPLETED|Overall Study||1
1610481|NCT00945256|3938814|P4|NOT COMPLETED|Overall Study||9
1610482|NCT00945256|3938815|P3|NOT COMPLETED|Overall Study||8
1610483|NCT00945256|3938816|P2|NOT COMPLETED|Overall Study||2
1610484|NCT00945256|3938817|P1|NOT COMPLETED|Overall Study||4
1610485|NCT00945256|3938813|P5|COMPLETED|Overall Study||7
1610486|NCT00945256|3938814|P4|COMPLETED|Overall Study||7
1610487|NCT00945256|3938815|P3|COMPLETED|Overall Study||7
1610488|NCT00945256|3938816|P2|COMPLETED|Overall Study||8
1610489|NCT00945256|3938817|P1|COMPLETED|Overall Study||9
1610490|NCT00945256|3938813|P5|STARTED|Overall Study||8
1610491|NCT00945256|3938814|P4|STARTED|Overall Study||16
1610492|NCT00945256|3938815|P3|STARTED|Overall Study||15
1610493|NCT00945256|3938816|P2|STARTED|Overall Study||10
1610494|NCT00945256|3938817|P1|STARTED|Overall Study||13
1610495|NCT00945243|3938829|P1|NOT COMPLETED|Overall Study||3
1610496|NCT00945243|3938829|P1|COMPLETED|Overall Study||8
1610497|NCT00945243|3938829|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
1610498|NCT00945139|3938835|P1|NOT COMPLETED|Overall Study||0
1610499|NCT00945139|3938835|P1|COMPLETED|Overall Study||46
1610500|NCT00945139|3938835|P1|STARTED|Overall Study||46
1610501|NCT00945100|3938846|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
1610502|NCT00945100|3938847|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
1610503|NCT00945100|3938846|P2|COMPLETED|Post-10 Week Primary Outcome||56
1610504|NCT00945100|3938847|P1|COMPLETED|Post-10 Week Primary Outcome||51
1610505|NCT00945100|3938846|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
1610506|NCT00945100|3938847|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
1610507|NCT00945100|3938846|P2|NOT COMPLETED|10-week Primary Outcome||3
1610508|NCT00945100|3938847|P1|NOT COMPLETED|10-week Primary Outcome||1
1610509|NCT00945100|3938846|P2|COMPLETED|10-week Primary Outcome||83
1610510|NCT00945100|3938847|P1|COMPLETED|10-week Primary Outcome||82
1610511|NCT00945100|3938846|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
1610512|NCT00945100|3938847|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
1610513|NCT00945100|3938846|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
1610514|NCT00945100|3938847|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
1610515|NCT00945100|3938846|P2|STARTED|10-week Primary Outcome||86
1610516|NCT00945100|3938847|P1|STARTED|10-week Primary Outcome||83
1610517|NCT00945035|3938911|P2|NOT COMPLETED|Period 2||0
1610518|NCT00945035|3938912|P1|NOT COMPLETED|Period 2||0
1610519|NCT00945035|3938911|P2|COMPLETED|Period 2||18
1610520|NCT00945035|3938912|P1|COMPLETED|Period 2||18
1610521|NCT00945035|3938911|P2|STARTED|Period 2||18
1610522|NCT00945035|3938912|P1|STARTED|Period 2||18
1610523|NCT00945035|3938911|P2|NOT COMPLETED|Period 1||0
1610524|NCT00945035|3938912|P1|NOT COMPLETED|Period 1||0
1610525|NCT00945035|3938911|P2|COMPLETED|Period 1||18
1610526|NCT00945035|3938912|P1|COMPLETED|Period 1||18
1610527|NCT00945035|3938911|P2|STARTED|Period 1||18
1610528|NCT00945035|3938912|P1|STARTED|Period 1||18
1610529|NCT00944749|3938920|P1|NOT COMPLETED|Overall Study||1
1610530|NCT00944749|3938920|P1|COMPLETED|Overall Study||22
1610531|NCT00944749|3938920|P1|STARTED|Overall Study||23
1610532|NCT00944710|3938927|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
1610533|NCT00944710|3938928|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
1610534|NCT00944710|3938927|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
1610535|NCT00944710|3938928|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
1610536|NCT00944710|3938927|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
1610537|NCT00944710|3938928|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
1610538|NCT00944710|3938927|P2|STARTED|Additional Post 10-week Primary Outcome||33
1610539|NCT00944710|3938928|P1|STARTED|Additional Post 10-week Primary Outcome||40
1610540|NCT00944710|3938927|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
1610541|NCT00944710|3938928|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
1610542|NCT00944710|3938927|P2|COMPLETED|12-week Visit (Off-treatment)||33
1610543|NCT00944710|3938928|P1|COMPLETED|12-week Visit (Off-treatment)||40
1610544|NCT00944710|3938927|P2|STARTED|12-week Visit (Off-treatment)||33
1610545|NCT00944710|3938928|P1|STARTED|12-week Visit (Off-treatment)||40
1610546|NCT00944710|3938927|P2|NOT COMPLETED|10-week Primary Outcome||0
1610547|NCT00944710|3938928|P1|NOT COMPLETED|10-week Primary Outcome||0
1610548|NCT00944710|3938927|P2|COMPLETED|10-week Primary Outcome||33
1610549|NCT00944710|3938928|P1|COMPLETED|10-week Primary Outcome||40
1610550|NCT00944710|3938927|P2|STARTED|10-week Primary Outcome||33
1610551|NCT00944710|3938928|P1|STARTED|10-week Primary Outcome||40
1610552|NCT00944697|3938986|P2|NOT COMPLETED|Overall Study||5
1610553|NCT00944697|3938987|P1|NOT COMPLETED|Overall Study||2
1610554|NCT00944697|3938986|P2|COMPLETED|Overall Study||43
1610555|NCT00944697|3938987|P1|COMPLETED|Overall Study||48
1610556|NCT00944697|3938986|P2|STARTED|Overall Study||48
1610557|NCT00944697|3938987|P1|STARTED|Overall Study||50
1610558|NCT00944671|3938999|P6|NOT COMPLETED|Period III||0
1610559|NCT00944671|3939000|P5|NOT COMPLETED|Period III||0
1610560|NCT00944671|3939001|P4|NOT COMPLETED|Period III||0
1610561|NCT00944671|3939002|P3|NOT COMPLETED|Period III||0
1610562|NCT00944671|3939003|P2|NOT COMPLETED|Period III||0
1610563|NCT00944671|3939004|P1|NOT COMPLETED|Period III||0
1610564|NCT00944671|3938999|P6|COMPLETED|Period III||4
1610565|NCT00944671|3939000|P5|COMPLETED|Period III||4
1610566|NCT00944671|3939001|P4|COMPLETED|Period III||4
1610567|NCT00944671|3939002|P3|COMPLETED|Period III||4
1610568|NCT00944671|3939003|P2|COMPLETED|Period III||4
1610569|NCT00944671|3939004|P1|COMPLETED|Period III||4
1610570|NCT00944671|3938999|P6|STARTED|Period III||4
1610571|NCT00944671|3939000|P5|STARTED|Period III||4
1610572|NCT00944671|3939001|P4|STARTED|Period III||4
1610573|NCT00944671|3939002|P3|STARTED|Period III||4
1610574|NCT00944671|3939003|P2|STARTED|Period III||4
1610575|NCT00944671|3939004|P1|STARTED|Period III||4
1610576|NCT00944671|3938999|P6|NOT COMPLETED|Period II||0
1610577|NCT00944671|3939000|P5|NOT COMPLETED|Period II||0
1610578|NCT00944671|3939001|P4|NOT COMPLETED|Period II||0
1610579|NCT00944671|3939002|P3|NOT COMPLETED|Period II||0
1610580|NCT00944671|3939003|P2|NOT COMPLETED|Period II||0
1610581|NCT00944671|3939004|P1|NOT COMPLETED|Period II||0
1610582|NCT00944671|3938999|P6|COMPLETED|Period II||4
1610583|NCT00944671|3939000|P5|COMPLETED|Period II||4
1610584|NCT00944671|3939001|P4|COMPLETED|Period II||4
1610585|NCT00944671|3939002|P3|COMPLETED|Period II||4
1610586|NCT00944671|3939003|P2|COMPLETED|Period II||4
1610587|NCT00944671|3939004|P1|COMPLETED|Period II||4
1610588|NCT00944671|3938999|P6|STARTED|Period II||4
1610589|NCT00944671|3939000|P5|STARTED|Period II||4
1610590|NCT00944671|3939001|P4|STARTED|Period II||4
1610591|NCT00944671|3939002|P3|STARTED|Period II||4
1610592|NCT00944671|3939003|P2|STARTED|Period II||4
1610593|NCT00944671|3939004|P1|STARTED|Period II||4
1610594|NCT00944671|3938999|P6|NOT COMPLETED|Period I||0
1610595|NCT00944671|3939000|P5|NOT COMPLETED|Period I||0
1610596|NCT00944671|3939001|P4|NOT COMPLETED|Period I||0
1610597|NCT00944671|3939002|P3|NOT COMPLETED|Period I||0
1610598|NCT00944671|3939003|P2|NOT COMPLETED|Period I||0
1610599|NCT00944671|3939004|P1|NOT COMPLETED|Period I||0
1610600|NCT00944671|3938999|P6|COMPLETED|Period I||4
1610601|NCT00944671|3939000|P5|COMPLETED|Period I||4
1610602|NCT00944671|3939001|P4|COMPLETED|Period I||4
1610603|NCT00944671|3939002|P3|COMPLETED|Period I||4
1610604|NCT00944671|3939003|P2|COMPLETED|Period I||4
1610605|NCT00944671|3939004|P1|COMPLETED|Period I||4
1610606|NCT00944671|3938999|P6|STARTED|Period I||4
1610607|NCT00944671|3939000|P5|STARTED|Period I||4
1610608|NCT00944671|3939001|P4|STARTED|Period I||4
1610609|NCT00944671|3939002|P3|STARTED|Period I||4
1610610|NCT00944671|3939003|P2|STARTED|Period I||4
1610611|NCT00944671|3939004|P1|STARTED|Period I||4
1610612|NCT00944645|3939017|P2|NOT COMPLETED|Period 2||9
1610613|NCT00944645|3939018|P1|NOT COMPLETED|Period 2||8
1610614|NCT00944645|3939017|P2|COMPLETED|Period 2||85
1610615|NCT00944645|3939018|P1|COMPLETED|Period 2||86
1610616|NCT00944645|3939017|P2|STARTED|Period 2||94
1610617|NCT00944645|3939018|P1|STARTED|Period 2||94
1610618|NCT00944645|3939017|P2|NOT COMPLETED|Period 1||0
1610619|NCT00944645|3939018|P1|NOT COMPLETED|Period 1||0
1610620|NCT00944645|3939017|P2|COMPLETED|Period 1||94
1610621|NCT00944645|3939018|P1|COMPLETED|Period 1||94
1610622|NCT00944645|3939017|P2|STARTED|Period 1||94
1610623|NCT00944645|3939018|P1|STARTED|Period 1||94
1610624|NCT00944554|3939032|P2|NOT COMPLETED|Overall Study||29
1610625|NCT00944554|3939033|P1|NOT COMPLETED|Overall Study||28
1610626|NCT00944554|3939032|P2|COMPLETED|Overall Study||25
1610627|NCT00944554|3939033|P1|COMPLETED|Overall Study||22
1610628|NCT00944554|3939032|P2|STARTED|Overall Study||54
1610629|NCT00944554|3939033|P1|STARTED|Overall Study||50
1610630|NCT00944450|3939039|P2|NOT COMPLETED|Period 2||0
1610631|NCT00944450|3939040|P1|NOT COMPLETED|Period 2||0
1610632|NCT00944450|3939039|P2|COMPLETED|Period 2||6
1610633|NCT00944450|3939040|P1|COMPLETED|Period 2||6
1610634|NCT00944450|3939039|P2|STARTED|Period 2||6
1610635|NCT00944450|3939040|P1|STARTED|Period 2||6
1610636|NCT00944450|3939039|P2|NOT COMPLETED|Period 1||0
1610637|NCT00944450|3939040|P1|NOT COMPLETED|Period 1||0
1610638|NCT00944450|3939039|P2|COMPLETED|Period 1||6
1610639|NCT00944450|3939040|P1|COMPLETED|Period 1||6
1610640|NCT00944450|3939039|P2|STARTED|Period 1||6
1610641|NCT00944450|3939040|P1|STARTED|Period 1||6
1610642|NCT00944229|3939048|P1|NOT COMPLETED|Overall Study||25
1610643|NCT00944229|3939048|P1|COMPLETED|Overall Study||33
1610644|NCT00944229|3939048|P1|STARTED|Overall Study||58
1610645|NCT00944125|3939054|P2|NOT COMPLETED|6 Months to Study Completion||2
1610646|NCT00944125|3939055|P1|NOT COMPLETED|6 Months to Study Completion||0
1610647|NCT00944125|3939054|P2|COMPLETED|6 Months to Study Completion||18
1610648|NCT00944125|3939055|P1|COMPLETED|6 Months to Study Completion||19
1610649|NCT00944125|3939054|P2|STARTED|6 Months to Study Completion||20
1610650|NCT00944125|3939055|P1|STARTED|6 Months to Study Completion||19
1610651|NCT00944125|3939054|P2|NOT COMPLETED|3 to 6 Months||2
1610652|NCT00944125|3939055|P1|NOT COMPLETED|3 to 6 Months||0
1610653|NCT00944125|3939054|P2|COMPLETED|3 to 6 Months||20
1610654|NCT00944125|3939055|P1|COMPLETED|3 to 6 Months||19
1610655|NCT00944125|3939054|P2|STARTED|3 to 6 Months||22
1610656|NCT00944125|3939055|P1|STARTED|3 to 6 Months||19
1610657|NCT00944125|3939054|P2|NOT COMPLETED|Baseline to 3 Months||0
1610658|NCT00944125|3939055|P1|NOT COMPLETED|Baseline to 3 Months||0
1610659|NCT00944125|3939054|P2|COMPLETED|Baseline to 3 Months||22
1610660|NCT00944125|3939055|P1|COMPLETED|Baseline to 3 Months||19
1610661|NCT00944125|3939054|P2|STARTED|Baseline to 3 Months||22
1610662|NCT00944125|3939055|P1|STARTED|Baseline to 3 Months||19
1610663|NCT00944073|3939063|P2|NOT COMPLETED|Overall Study||4
1610664|NCT00944073|3939064|P1|NOT COMPLETED|Overall Study||5
1610665|NCT00944073|3939063|P2|COMPLETED|Overall Study||287
1610666|NCT00944073|3939064|P1|COMPLETED|Overall Study||287
1610667|NCT00944073|3939063|P2|STARTED|Overall Study||291
1610668|NCT00944073|3939064|P1|STARTED|Overall Study||292
1610669|NCT00944047|3939142|P1|NOT COMPLETED|Overall Study||5
1610670|NCT00944047|3939142|P1|COMPLETED|Overall Study||27
1610671|NCT00944047|3939142|P1|STARTED|Overall Study||32
1610672|NCT00944034|3939158|P12|NOT COMPLETED|Overall Study||4
1610673|NCT00944034|3939159|P11|NOT COMPLETED|Overall Study||1
1610674|NCT00944034|3939160|P10|NOT COMPLETED|Overall Study||10
1610675|NCT00944034|3939161|P9|NOT COMPLETED|Overall Study||10
1610676|NCT00944034|3939162|P8|NOT COMPLETED|Overall Study||5
1610677|NCT00944034|3939163|P7|NOT COMPLETED|Overall Study||4
1610678|NCT00944034|3939164|P6|NOT COMPLETED|Overall Study||20
1610679|NCT00944034|3939165|P5|NOT COMPLETED|Overall Study||14
1610680|NCT00944034|3939166|P4|NOT COMPLETED|Overall Study||4
1610681|NCT00944034|3939167|P3|NOT COMPLETED|Overall Study||9
1610682|NCT00944034|3939168|P2|NOT COMPLETED|Overall Study||7
1610683|NCT00944034|3939169|P1|NOT COMPLETED|Overall Study||5
1610684|NCT00944034|3939158|P12|COMPLETED|Overall Study||52
1610685|NCT00944034|3939159|P11|COMPLETED|Overall Study||50
1610686|NCT00944034|3939160|P10|COMPLETED|Overall Study||236
1610687|NCT00944034|3939161|P9|COMPLETED|Overall Study||63
1610688|NCT00944034|3939162|P8|COMPLETED|Overall Study||73
1610689|NCT00944034|3939163|P7|COMPLETED|Overall Study||102
1610690|NCT00944034|3939164|P6|COMPLETED|Overall Study||123
1610691|NCT00944034|3939165|P5|COMPLETED|Overall Study||150
1610692|NCT00944034|3939166|P4|COMPLETED|Overall Study||170
1610693|NCT00944034|3939167|P3|COMPLETED|Overall Study||143
1610694|NCT00944034|3939168|P2|COMPLETED|Overall Study||150
1610695|NCT00944034|3939169|P1|COMPLETED|Overall Study||183
1610696|NCT00944034|3939158|P12|STARTED|Overall Study||56
1610697|NCT00944034|3939159|P11|STARTED|Overall Study||51
1610698|NCT00944034|3939160|P10|STARTED|Overall Study||246
1610699|NCT00944034|3939161|P9|STARTED|Overall Study||73
1610700|NCT00944034|3939162|P8|STARTED|Overall Study||78
1610701|NCT00944034|3939163|P7|STARTED|Overall Study||106
1610702|NCT00944034|3939164|P6|STARTED|Overall Study||143
1610703|NCT00944034|3939165|P5|STARTED|Overall Study||164
1610704|NCT00944034|3939166|P4|STARTED|Overall Study||174
1610705|NCT00944034|3939167|P3|STARTED|Overall Study||152
1610706|NCT00944034|3939168|P2|STARTED|Overall Study||157
1610707|NCT00944034|3939169|P1|STARTED|Overall Study||188
1610708|NCT00944021|3939239|P5|NOT COMPLETED|Overall Study||0
1610709|NCT00944021|3939240|P4|NOT COMPLETED|Overall Study||0
1610710|NCT00944021|3939241|P3|NOT COMPLETED|Overall Study||0
1610711|NCT00944021|3939242|P2|NOT COMPLETED|Overall Study||0
1610712|NCT00944021|3939243|P1|NOT COMPLETED|Overall Study||1
1610713|NCT00944021|3939239|P5|COMPLETED|Overall Study||8
1610714|NCT00944021|3939240|P4|COMPLETED|Overall Study||16
1610715|NCT00944021|3939241|P3|COMPLETED|Overall Study||15
1610716|NCT00944021|3939242|P2|COMPLETED|Overall Study||15
1610717|NCT00944021|3939243|P1|COMPLETED|Overall Study||14
1610718|NCT00944021|3939239|P5|STARTED|Overall Study||8
1610719|NCT00944021|3939240|P4|STARTED|Overall Study||16
1610720|NCT00944021|3939241|P3|STARTED|Overall Study||15
1610721|NCT00944021|3939242|P2|STARTED|Overall Study||15
1610722|NCT00944021|3939243|P1|STARTED|Overall Study||15
1610723|NCT00943917|3939315|P15|NOT COMPLETED|Stage II Continuation||4
1610724|NCT00943917|3939316|P14|NOT COMPLETED|Stage II Continuation||3
1610725|NCT00943917|3939317|P13|NOT COMPLETED|Stage II Continuation||3
1610726|NCT00943917|3939318|P12|NOT COMPLETED|Stage II Continuation||2
1610727|NCT00943917|3939319|P11|NOT COMPLETED|Stage II Continuation||0
1610728|NCT00943917|3939320|P10|NOT COMPLETED|Stage II Continuation||1
1610729|NCT00943917|3939321|P9|NOT COMPLETED|Stage II Continuation||0
1610730|NCT00943917|3939322|P8|NOT COMPLETED|Stage II Continuation||0
1610731|NCT00943917|3939323|P7|NOT COMPLETED|Stage II Continuation||0
1610732|NCT00943917|3939324|P6|NOT COMPLETED|Stage II Continuation||0
1610733|NCT00943917|3939325|P5|NOT COMPLETED|Stage II Continuation||0
1610734|NCT00943917|3939326|P4|NOT COMPLETED|Stage II Continuation||0
1610735|NCT00943917|3939327|P3|NOT COMPLETED|Stage II Continuation||0
1610736|NCT00943917|3939328|P2|NOT COMPLETED|Stage II Continuation||0
1610737|NCT00943917|3939329|P1|NOT COMPLETED|Stage II Continuation||0
1610738|NCT00943917|3939315|P15|COMPLETED|Stage II Continuation||8
1610739|NCT00943917|3939316|P14|COMPLETED|Stage II Continuation||12
1610740|NCT00943917|3939317|P13|COMPLETED|Stage II Continuation||13
1610741|NCT00943917|3939318|P12|COMPLETED|Stage II Continuation||11
1610742|NCT00943917|3939319|P11|COMPLETED|Stage II Continuation||15
1610743|NCT00943917|3939320|P10|COMPLETED|Stage II Continuation||14
1610744|NCT00943917|3939321|P9|COMPLETED|Stage II Continuation||0
1610745|NCT00943917|3939322|P8|COMPLETED|Stage II Continuation||0
1610746|NCT00943917|3939323|P7|COMPLETED|Stage II Continuation||0
1610747|NCT00943917|3939324|P6|COMPLETED|Stage II Continuation||0
1610748|NCT00943917|3939325|P5|COMPLETED|Stage II Continuation||0
1610749|NCT00943917|3939326|P4|COMPLETED|Stage II Continuation||0
1610750|NCT00943917|3939327|P3|COMPLETED|Stage II Continuation||0
1610751|NCT00943917|3939328|P2|COMPLETED|Stage II Continuation||0
1610752|NCT00943917|3939329|P1|COMPLETED|Stage II Continuation||0
1610753|NCT00943917|3939315|P15|STARTED|Stage II Continuation||12
1610754|NCT00943917|3939316|P14|STARTED|Stage II Continuation||15
1610755|NCT00943917|3939317|P13|STARTED|Stage II Continuation||16
1610756|NCT00943917|3939318|P12|STARTED|Stage II Continuation||13
1610757|NCT00943917|3939319|P11|STARTED|Stage II Continuation||15
1610758|NCT00943917|3939320|P10|STARTED|Stage II Continuation||15
1610759|NCT00943917|3939321|P9|STARTED|Stage II Continuation||0
1610760|NCT00943917|3939322|P8|STARTED|Stage II Continuation||0
1610761|NCT00943917|3939323|P7|STARTED|Stage II Continuation||0
1610762|NCT00943917|3939324|P6|STARTED|Stage II Continuation||0
1610763|NCT00943917|3939325|P5|STARTED|Stage II Continuation||0
1610764|NCT00943917|3939326|P4|STARTED|Stage II Continuation||0
1610765|NCT00943917|3939327|P3|STARTED|Stage II Continuation||0
1610766|NCT00943917|3939328|P2|STARTED|Stage II Continuation||0
1610767|NCT00943917|3939329|P1|STARTED|Stage II Continuation||0
1610768|NCT00943917|3939315|P15|NOT COMPLETED|Stage II||0
1610769|NCT00943917|3939316|P14|NOT COMPLETED|Stage II||0
1610770|NCT00943917|3939317|P13|NOT COMPLETED|Stage II||0
1610771|NCT00943917|3939318|P12|NOT COMPLETED|Stage II||0
1610772|NCT00943917|3939319|P11|NOT COMPLETED|Stage II||0
1610773|NCT00943917|3939320|P10|NOT COMPLETED|Stage II||0
1610774|NCT00943917|3939321|P9|NOT COMPLETED|Stage II||1
1610775|NCT00943917|3939322|P8|NOT COMPLETED|Stage II||0
1610776|NCT00943917|3939323|P7|NOT COMPLETED|Stage II||3
1610777|NCT00943917|3939324|P6|NOT COMPLETED|Stage II||3
1610778|NCT00943917|3939325|P5|NOT COMPLETED|Stage II||0
1610779|NCT00943917|3939326|P4|NOT COMPLETED|Stage II||0
1610780|NCT00943917|3939327|P3|NOT COMPLETED|Stage II||0
1610781|NCT00943917|3939328|P2|NOT COMPLETED|Stage II||0
1610782|NCT00943917|3939329|P1|NOT COMPLETED|Stage II||0
1610783|NCT00943917|3939315|P15|COMPLETED|Stage II||0
1610784|NCT00943917|3939316|P14|COMPLETED|Stage II||0
1610785|NCT00943917|3939317|P13|COMPLETED|Stage II||0
1610786|NCT00943917|3939318|P12|COMPLETED|Stage II||0
1610787|NCT00943917|3939319|P11|COMPLETED|Stage II||0
1610788|NCT00943917|3939320|P10|COMPLETED|Stage II||0
1610789|NCT00943917|3939321|P9|COMPLETED|Stage II||20
1610790|NCT00943917|3939322|P8|COMPLETED|Stage II||23
1610791|NCT00943917|3939323|P7|COMPLETED|Stage II||20
1610792|NCT00943917|3939324|P6|COMPLETED|Stage II||20
1610793|NCT00943917|3939325|P5|COMPLETED|Stage II||21
1610794|NCT00943917|3939326|P4|COMPLETED|Stage II||20
1610795|NCT00943917|3939327|P3|COMPLETED|Stage II||0
1610796|NCT00943917|3939328|P2|COMPLETED|Stage II||0
1610797|NCT00943917|3939329|P1|COMPLETED|Stage II||0
1610798|NCT00943917|3939315|P15|STARTED|Stage II||0
1610799|NCT00943917|3939316|P14|STARTED|Stage II||0
1610800|NCT00943917|3939317|P13|STARTED|Stage II||0
1610801|NCT00943917|3939318|P12|STARTED|Stage II||0
1610802|NCT00943917|3939319|P11|STARTED|Stage II||0
1610803|NCT00943917|3939320|P10|STARTED|Stage II||0
1610804|NCT00943917|3939321|P9|STARTED|Stage II||21
1610805|NCT00943917|3939322|P8|STARTED|Stage II||23
1610806|NCT00943917|3939323|P7|STARTED|Stage II||23
1610807|NCT00943917|3939324|P6|STARTED|Stage II||23
1610808|NCT00943917|3939325|P5|STARTED|Stage II||21
1610809|NCT00943917|3939326|P4|STARTED|Stage II||20
1610810|NCT00943917|3939327|P3|STARTED|Stage II||0
1610811|NCT00943917|3939328|P2|STARTED|Stage II||0
1610812|NCT00943917|3939329|P1|STARTED|Stage II||0
1610813|NCT00943917|3939315|P15|NOT COMPLETED|Stage I||0
1610814|NCT00943917|3939316|P14|NOT COMPLETED|Stage I||0
1610815|NCT00943917|3939317|P13|NOT COMPLETED|Stage I||0
1610816|NCT00943917|3939318|P12|NOT COMPLETED|Stage I||0
1610817|NCT00943917|3939319|P11|NOT COMPLETED|Stage I||0
1610818|NCT00943917|3939320|P10|NOT COMPLETED|Stage I||0
1610819|NCT00943917|3939321|P9|NOT COMPLETED|Stage I||0
1610820|NCT00943917|3939322|P8|NOT COMPLETED|Stage I||0
1610821|NCT00943917|3939323|P7|NOT COMPLETED|Stage I||0
1610822|NCT00943917|3939324|P6|NOT COMPLETED|Stage I||0
1610823|NCT00943917|3939325|P5|NOT COMPLETED|Stage I||0
1610824|NCT00943917|3939326|P4|NOT COMPLETED|Stage I||0
1610825|NCT00943917|3939327|P3|NOT COMPLETED|Stage I||6
1610826|NCT00943917|3939328|P2|NOT COMPLETED|Stage I||3
1610827|NCT00943917|3939329|P1|NOT COMPLETED|Stage I||4
1610828|NCT00943917|3939315|P15|COMPLETED|Stage I||0
1610829|NCT00943917|3939316|P14|COMPLETED|Stage I||0
1610830|NCT00943917|3939317|P13|COMPLETED|Stage I||0
1610831|NCT00943917|3939318|P12|COMPLETED|Stage I||0
1610832|NCT00943917|3939319|P11|COMPLETED|Stage I||0
1610833|NCT00943917|3939320|P10|COMPLETED|Stage I||0
1610834|NCT00943917|3939321|P9|COMPLETED|Stage I||0
1610835|NCT00943917|3939322|P8|COMPLETED|Stage I||0
1610836|NCT00943917|3939323|P7|COMPLETED|Stage I||0
1610837|NCT00943917|3939324|P6|COMPLETED|Stage I||0
1610838|NCT00943917|3939325|P5|COMPLETED|Stage I||0
1610839|NCT00943917|3939326|P4|COMPLETED|Stage I||0
1610840|NCT00943917|3939327|P3|COMPLETED|Stage I||47
1610841|NCT00943917|3939328|P2|COMPLETED|Stage I||48
1610842|NCT00943917|3939329|P1|COMPLETED|Stage I||47
1610843|NCT00943917|3939315|P15|STARTED|Stage I||0
1610844|NCT00943917|3939316|P14|STARTED|Stage I||0
1610845|NCT00943917|3939317|P13|STARTED|Stage I||0
1610846|NCT00943917|3939318|P12|STARTED|Stage I||0
1610847|NCT00943917|3939319|P11|STARTED|Stage I||0
1610848|NCT00943917|3939320|P10|STARTED|Stage I||0
1610849|NCT00943917|3939321|P9|STARTED|Stage I||0
1610850|NCT00943917|3939322|P8|STARTED|Stage I||0
1610851|NCT00943917|3939323|P7|STARTED|Stage I||0
1610852|NCT00943917|3939324|P6|STARTED|Stage I||0
1610853|NCT00943917|3939325|P5|STARTED|Stage I||0
1610854|NCT00943917|3939326|P4|STARTED|Stage I||0
1610855|NCT00943917|3939327|P3|STARTED|Stage I||53
1610856|NCT00943917|3939328|P2|STARTED|Stage I||51
1610857|NCT00943917|3939329|P1|STARTED|Stage I||51
1610858|NCT00943878|3939380|P4|NOT COMPLETED|Overall Study||2
1610859|NCT00943878|3939381|P3|NOT COMPLETED|Overall Study||6
1610860|NCT00943878|3939382|P2|NOT COMPLETED|Overall Study||2
1610861|NCT00943878|3939383|P1|NOT COMPLETED|Overall Study||2
1610862|NCT00943878|3939380|P4|COMPLETED|Overall Study||198
1610863|NCT00943878|3939381|P3|COMPLETED|Overall Study||197
1610864|NCT00943878|3939382|P2|COMPLETED|Overall Study||198
1610865|NCT00943878|3939383|P1|COMPLETED|Overall Study||200
1610866|NCT00943878|3939380|P4|STARTED|Overall Study||200
1610867|NCT00943878|3939381|P3|STARTED|Overall Study||203
1610868|NCT00943878|3939382|P2|STARTED|Overall Study||200
1610869|NCT00943878|3939383|P1|STARTED|Overall Study||202
1610870|NCT00943852|3939505|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610871|NCT00943852|3939506|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610872|NCT00943852|3939507|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610873|NCT00943852|3939508|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610874|NCT00943852|3939509|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610875|NCT00943852|3939510|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610876|NCT00943852|3939511|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610877|NCT00943852|3939512|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610878|NCT00943852|3939513|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610879|NCT00943852|3939514|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1610880|NCT00943852|3939505|P10|COMPLETED|Fifth Period of Treatment Intervention||1
1610881|NCT00943852|3939506|P9|COMPLETED|Fifth Period of Treatment Intervention||1
1610882|NCT00943852|3939507|P8|COMPLETED|Fifth Period of Treatment Intervention||0
1610883|NCT00943852|3939508|P7|COMPLETED|Fifth Period of Treatment Intervention||0
1610884|NCT00943852|3939509|P6|COMPLETED|Fifth Period of Treatment Intervention||0
1610885|NCT00943852|3939510|P5|COMPLETED|Fifth Period of Treatment Intervention||1
1610886|NCT00943852|3939511|P4|COMPLETED|Fifth Period of Treatment Intervention||0
1610887|NCT00943852|3939512|P3|COMPLETED|Fifth Period of Treatment Intervention||0
1610888|NCT00943852|3939513|P2|COMPLETED|Fifth Period of Treatment Intervention||1
1610889|NCT00943852|3939514|P1|COMPLETED|Fifth Period of Treatment Intervention||1
1610890|NCT00943852|3939505|P10|STARTED|Fifth Period of Treatment Intervention||1
1610891|NCT00943852|3939506|P9|STARTED|Fifth Period of Treatment Intervention||1
1610892|NCT00943852|3939507|P8|STARTED|Fifth Period of Treatment Intervention||0
1610893|NCT00943852|3939508|P7|STARTED|Fifth Period of Treatment Intervention||0
1610894|NCT00943852|3939509|P6|STARTED|Fifth Period of Treatment Intervention||0
1610895|NCT00943852|3939510|P5|STARTED|Fifth Period of Treatment Intervention||1
1610896|NCT00943852|3939511|P4|STARTED|Fifth Period of Treatment Intervention||0
1610897|NCT00943852|3939512|P3|STARTED|Fifth Period of Treatment Intervention||0
1610898|NCT00943852|3939513|P2|STARTED|Fifth Period of Treatment Intervention||1
1610899|NCT00943852|3939514|P1|STARTED|Fifth Period of Treatment Intervention||1
1610900|NCT00943852|3939505|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1610901|NCT00943852|3939506|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1610902|NCT00943852|3939507|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1610903|NCT00943852|3939508|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1610904|NCT00943852|3939509|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1610905|NCT00943852|3939510|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1610906|NCT00943852|3939511|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1610907|NCT00943852|3939512|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1610908|NCT00943852|3939513|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1610909|NCT00943852|3939514|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1610910|NCT00943852|3939505|P10|COMPLETED|Washout Period After Period 4 Treatment||1
1610911|NCT00943852|3939506|P9|COMPLETED|Washout Period After Period 4 Treatment||1
1610912|NCT00943852|3939507|P8|COMPLETED|Washout Period After Period 4 Treatment||0
1610913|NCT00943852|3939508|P7|COMPLETED|Washout Period After Period 4 Treatment||0
1610914|NCT00943852|3939509|P6|COMPLETED|Washout Period After Period 4 Treatment||0
1610915|NCT00943852|3939510|P5|COMPLETED|Washout Period After Period 4 Treatment||1
1610916|NCT00943852|3939511|P4|COMPLETED|Washout Period After Period 4 Treatment||0
1610917|NCT00943852|3939512|P3|COMPLETED|Washout Period After Period 4 Treatment||0
1610918|NCT00943852|3939513|P2|COMPLETED|Washout Period After Period 4 Treatment||1
1610919|NCT00943852|3939514|P1|COMPLETED|Washout Period After Period 4 Treatment||1
1610920|NCT00943852|3939505|P10|STARTED|Washout Period After Period 4 Treatment||1
1610921|NCT00943852|3939506|P9|STARTED|Washout Period After Period 4 Treatment||1
1610922|NCT00943852|3939507|P8|STARTED|Washout Period After Period 4 Treatment||1
1610923|NCT00943852|3939508|P7|STARTED|Washout Period After Period 4 Treatment||1
1611227|NCT00943631|3939682|P1|STARTED|Overall Study||202
1610924|NCT00943852|3939509|P6|STARTED|Washout Period After Period 4 Treatment||0
1610925|NCT00943852|3939510|P5|STARTED|Washout Period After Period 4 Treatment||1
1610926|NCT00943852|3939511|P4|STARTED|Washout Period After Period 4 Treatment||1
1610927|NCT00943852|3939512|P3|STARTED|Washout Period After Period 4 Treatment||1
1610928|NCT00943852|3939513|P2|STARTED|Washout Period After Period 4 Treatment||1
1610929|NCT00943852|3939514|P1|STARTED|Washout Period After Period 4 Treatment||2
1610930|NCT00943852|3939505|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610931|NCT00943852|3939506|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610932|NCT00943852|3939507|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610933|NCT00943852|3939508|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610934|NCT00943852|3939509|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610935|NCT00943852|3939510|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610936|NCT00943852|3939511|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610937|NCT00943852|3939512|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610938|NCT00943852|3939513|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610939|NCT00943852|3939514|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1610940|NCT00943852|3939505|P10|COMPLETED|Fourth Period of Treatment Intervention||1
1610941|NCT00943852|3939506|P9|COMPLETED|Fourth Period of Treatment Intervention||1
1610942|NCT00943852|3939507|P8|COMPLETED|Fourth Period of Treatment Intervention||1
1610943|NCT00943852|3939508|P7|COMPLETED|Fourth Period of Treatment Intervention||1
1610944|NCT00943852|3939509|P6|COMPLETED|Fourth Period of Treatment Intervention||0
1610945|NCT00943852|3939510|P5|COMPLETED|Fourth Period of Treatment Intervention||1
1610946|NCT00943852|3939511|P4|COMPLETED|Fourth Period of Treatment Intervention||1
1610947|NCT00943852|3939512|P3|COMPLETED|Fourth Period of Treatment Intervention||1
1610948|NCT00943852|3939513|P2|COMPLETED|Fourth Period of Treatment Intervention||1
1610949|NCT00943852|3939514|P1|COMPLETED|Fourth Period of Treatment Intervention||2
1610950|NCT00943852|3939505|P10|STARTED|Fourth Period of Treatment Intervention||1
1610951|NCT00943852|3939506|P9|STARTED|Fourth Period of Treatment Intervention||1
1610952|NCT00943852|3939507|P8|STARTED|Fourth Period of Treatment Intervention||1
1610953|NCT00943852|3939508|P7|STARTED|Fourth Period of Treatment Intervention||1
1610954|NCT00943852|3939509|P6|STARTED|Fourth Period of Treatment Intervention||0
1610955|NCT00943852|3939510|P5|STARTED|Fourth Period of Treatment Intervention||1
1610956|NCT00943852|3939511|P4|STARTED|Fourth Period of Treatment Intervention||1
1610957|NCT00943852|3939512|P3|STARTED|Fourth Period of Treatment Intervention||1
1610958|NCT00943852|3939513|P2|STARTED|Fourth Period of Treatment Intervention||1
1610959|NCT00943852|3939514|P1|STARTED|Fourth Period of Treatment Intervention||2
1610960|NCT00943852|3939505|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1610961|NCT00943852|3939506|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1610962|NCT00943852|3939507|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1610963|NCT00943852|3939508|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
1610964|NCT00943852|3939509|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1610965|NCT00943852|3939510|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1610966|NCT00943852|3939511|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1610967|NCT00943852|3939512|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1610968|NCT00943852|3939513|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1610969|NCT00943852|3939514|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1610970|NCT00943852|3939505|P10|COMPLETED|Washout Period After Period 3 Treatment||1
1610971|NCT00943852|3939506|P9|COMPLETED|Washout Period After Period 3 Treatment||1
1610972|NCT00943852|3939507|P8|COMPLETED|Washout Period After Period 3 Treatment||1
1610973|NCT00943852|3939508|P7|COMPLETED|Washout Period After Period 3 Treatment||1
1610974|NCT00943852|3939509|P6|COMPLETED|Washout Period After Period 3 Treatment||0
1610975|NCT00943852|3939510|P5|COMPLETED|Washout Period After Period 3 Treatment||1
1610976|NCT00943852|3939511|P4|COMPLETED|Washout Period After Period 3 Treatment||1
1610977|NCT00943852|3939512|P3|COMPLETED|Washout Period After Period 3 Treatment||1
1610978|NCT00943852|3939513|P2|COMPLETED|Washout Period After Period 3 Treatment||1
1610979|NCT00943852|3939514|P1|COMPLETED|Washout Period After Period 3 Treatment||2
1610980|NCT00943852|3939505|P10|STARTED|Washout Period After Period 3 Treatment||1
1610981|NCT00943852|3939506|P9|STARTED|Washout Period After Period 3 Treatment||1
1610982|NCT00943852|3939507|P8|STARTED|Washout Period After Period 3 Treatment||1
1610983|NCT00943852|3939508|P7|STARTED|Washout Period After Period 3 Treatment||2
1610984|NCT00943852|3939509|P6|STARTED|Washout Period After Period 3 Treatment||0
1610985|NCT00943852|3939510|P5|STARTED|Washout Period After Period 3 Treatment||1
1610986|NCT00943852|3939511|P4|STARTED|Washout Period After Period 3 Treatment||1
1610987|NCT00943852|3939512|P3|STARTED|Washout Period After Period 3 Treatment||1
1610988|NCT00943852|3939513|P2|STARTED|Washout Period After Period 3 Treatment||1
1610989|NCT00943852|3939514|P1|STARTED|Washout Period After Period 3 Treatment||2
1610990|NCT00943852|3939505|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
1610991|NCT00943852|3939506|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
1610992|NCT00943852|3939507|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
1610993|NCT00943852|3939508|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
1610994|NCT00943852|3939509|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
1610995|NCT00943852|3939510|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
1610996|NCT00943852|3939511|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
1610997|NCT00943852|3939512|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
1610998|NCT00943852|3939513|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
1610999|NCT00943852|3939514|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
1611000|NCT00943852|3939505|P10|COMPLETED|Third Period of Treatment Intervention||1
1611001|NCT00943852|3939506|P9|COMPLETED|Third Period of Treatment Intervention||1
1611002|NCT00943852|3939507|P8|COMPLETED|Third Period of Treatment Intervention||1
1611003|NCT00943852|3939508|P7|COMPLETED|Third Period of Treatment Intervention||2
1611004|NCT00943852|3939509|P6|COMPLETED|Third Period of Treatment Intervention||0
1611005|NCT00943852|3939510|P5|COMPLETED|Third Period of Treatment Intervention||1
1611006|NCT00943852|3939511|P4|COMPLETED|Third Period of Treatment Intervention||1
1611007|NCT00943852|3939512|P3|COMPLETED|Third Period of Treatment Intervention||1
1611008|NCT00943852|3939513|P2|COMPLETED|Third Period of Treatment Intervention||1
1611009|NCT00943852|3939514|P1|COMPLETED|Third Period of Treatment Intervention||2
1611010|NCT00943852|3939505|P10|STARTED|Third Period of Treatment Intervention||1
1611011|NCT00943852|3939506|P9|STARTED|Third Period of Treatment Intervention||1
1611012|NCT00943852|3939507|P8|STARTED|Third Period of Treatment Intervention||1
1611013|NCT00943852|3939508|P7|STARTED|Third Period of Treatment Intervention||2
1611014|NCT00943852|3939509|P6|STARTED|Third Period of Treatment Intervention||0
1611015|NCT00943852|3939510|P5|STARTED|Third Period of Treatment Intervention||1
1611016|NCT00943852|3939511|P4|STARTED|Third Period of Treatment Intervention||1
1611017|NCT00943852|3939512|P3|STARTED|Third Period of Treatment Intervention||1
1611018|NCT00943852|3939513|P2|STARTED|Third Period of Treatment Intervention||1
1611019|NCT00943852|3939514|P1|STARTED|Third Period of Treatment Intervention||2
1611020|NCT00943852|3939505|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1611021|NCT00943852|3939506|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1611022|NCT00943852|3939507|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1611023|NCT00943852|3939508|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1611024|NCT00943852|3939509|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
1611025|NCT00943852|3939510|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1611026|NCT00943852|3939511|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1611027|NCT00943852|3939512|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1611028|NCT00943852|3939513|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1611029|NCT00943852|3939514|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1611030|NCT00943852|3939505|P10|COMPLETED|Washout Period After Period 2 Treatment||1
1611031|NCT00943852|3939506|P9|COMPLETED|Washout Period After Period 2 Treatment||1
1611032|NCT00943852|3939507|P8|COMPLETED|Washout Period After Period 2 Treatment||1
1611033|NCT00943852|3939508|P7|COMPLETED|Washout Period After Period 2 Treatment||2
1611034|NCT00943852|3939509|P6|COMPLETED|Washout Period After Period 2 Treatment||0
1611035|NCT00943852|3939510|P5|COMPLETED|Washout Period After Period 2 Treatment||1
1611036|NCT00943852|3939511|P4|COMPLETED|Washout Period After Period 2 Treatment||1
1611037|NCT00943852|3939512|P3|COMPLETED|Washout Period After Period 2 Treatment||1
1611038|NCT00943852|3939513|P2|COMPLETED|Washout Period After Period 2 Treatment||1
1611039|NCT00943852|3939514|P1|COMPLETED|Washout Period After Period 2 Treatment||2
1611040|NCT00943852|3939505|P10|STARTED|Washout Period After Period 2 Treatment||1
1611041|NCT00943852|3939506|P9|STARTED|Washout Period After Period 2 Treatment||1
1611042|NCT00943852|3939507|P8|STARTED|Washout Period After Period 2 Treatment||1
1611043|NCT00943852|3939508|P7|STARTED|Washout Period After Period 2 Treatment||2
1611044|NCT00943852|3939509|P6|STARTED|Washout Period After Period 2 Treatment||1
1611045|NCT00943852|3939510|P5|STARTED|Washout Period After Period 2 Treatment||1
1611046|NCT00943852|3939511|P4|STARTED|Washout Period After Period 2 Treatment||1
1611047|NCT00943852|3939512|P3|STARTED|Washout Period After Period 2 Treatment||1
1611048|NCT00943852|3939513|P2|STARTED|Washout Period After Period 2 Treatment||1
1611049|NCT00943852|3939514|P1|STARTED|Washout Period After Period 2 Treatment||2
1611050|NCT00943852|3939505|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
1611051|NCT00943852|3939506|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
1611052|NCT00943852|3939507|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
1611053|NCT00943852|3939508|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
1611054|NCT00943852|3939509|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
1611055|NCT00943852|3939510|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
1611056|NCT00943852|3939511|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
1611057|NCT00943852|3939512|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
1611058|NCT00943852|3939513|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
1611059|NCT00943852|3939514|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
1611060|NCT00943852|3939505|P10|COMPLETED|Second Period of Treatment Intervention||1
1611061|NCT00943852|3939506|P9|COMPLETED|Second Period of Treatment Intervention||1
1611062|NCT00943852|3939507|P8|COMPLETED|Second Period of Treatment Intervention||1
1611063|NCT00943852|3939508|P7|COMPLETED|Second Period of Treatment Intervention||2
1611064|NCT00943852|3939509|P6|COMPLETED|Second Period of Treatment Intervention||1
1611065|NCT00943852|3939510|P5|COMPLETED|Second Period of Treatment Intervention||1
1611066|NCT00943852|3939511|P4|COMPLETED|Second Period of Treatment Intervention||1
1611067|NCT00943852|3939512|P3|COMPLETED|Second Period of Treatment Intervention||1
1611068|NCT00943852|3939513|P2|COMPLETED|Second Period of Treatment Intervention||1
1611069|NCT00943852|3939514|P1|COMPLETED|Second Period of Treatment Intervention||2
1611228|NCT00943605|3939734|P2|NOT COMPLETED|Overall Study||30
1611070|NCT00943852|3939505|P10|STARTED|Second Period of Treatment Intervention||1
1611071|NCT00943852|3939506|P9|STARTED|Second Period of Treatment Intervention||1
1611072|NCT00943852|3939507|P8|STARTED|Second Period of Treatment Intervention||1
1611073|NCT00943852|3939508|P7|STARTED|Second Period of Treatment Intervention||2
1611074|NCT00943852|3939509|P6|STARTED|Second Period of Treatment Intervention||1
1611075|NCT00943852|3939510|P5|STARTED|Second Period of Treatment Intervention||1
1611076|NCT00943852|3939511|P4|STARTED|Second Period of Treatment Intervention||1
1611077|NCT00943852|3939512|P3|STARTED|Second Period of Treatment Intervention||1
1611078|NCT00943852|3939513|P2|STARTED|Second Period of Treatment Intervention||1
1611079|NCT00943852|3939514|P1|STARTED|Second Period of Treatment Intervention||2
1611080|NCT00943852|3939505|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1611081|NCT00943852|3939506|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1611082|NCT00943852|3939507|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1611083|NCT00943852|3939508|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1611084|NCT00943852|3939509|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1611085|NCT00943852|3939510|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1611086|NCT00943852|3939511|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
1611087|NCT00943852|3939512|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1611088|NCT00943852|3939513|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1611089|NCT00943852|3939514|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1611090|NCT00943852|3939505|P10|COMPLETED|Washout Period After Period 1 Treatment||1
1611091|NCT00943852|3939506|P9|COMPLETED|Washout Period After Period 1 Treatment||1
1611092|NCT00943852|3939507|P8|COMPLETED|Washout Period After Period 1 Treatment||1
1611093|NCT00943852|3939508|P7|COMPLETED|Washout Period After Period 1 Treatment||2
1611094|NCT00943852|3939509|P6|COMPLETED|Washout Period After Period 1 Treatment||1
1611095|NCT00943852|3939510|P5|COMPLETED|Washout Period After Period 1 Treatment||1
1611096|NCT00943852|3939511|P4|COMPLETED|Washout Period After Period 1 Treatment||1
1611097|NCT00943852|3939512|P3|COMPLETED|Washout Period After Period 1 Treatment||1
1611098|NCT00943852|3939513|P2|COMPLETED|Washout Period After Period 1 Treatment||1
1611099|NCT00943852|3939514|P1|COMPLETED|Washout Period After Period 1 Treatment||2
1611100|NCT00943852|3939505|P10|STARTED|Washout Period After Period 1 Treatment||1
1611101|NCT00943852|3939506|P9|STARTED|Washout Period After Period 1 Treatment||1
1611102|NCT00943852|3939507|P8|STARTED|Washout Period After Period 1 Treatment||1
1611103|NCT00943852|3939508|P7|STARTED|Washout Period After Period 1 Treatment||2
1611104|NCT00943852|3939509|P6|STARTED|Washout Period After Period 1 Treatment||1
1611105|NCT00943852|3939510|P5|STARTED|Washout Period After Period 1 Treatment||1
1611106|NCT00943852|3939511|P4|STARTED|Washout Period After Period 1 Treatment||2
1611107|NCT00943852|3939512|P3|STARTED|Washout Period After Period 1 Treatment||1
1611108|NCT00943852|3939513|P2|STARTED|Washout Period After Period 1 Treatment||1
1611109|NCT00943852|3939514|P1|STARTED|Washout Period After Period 1 Treatment||2
1611110|NCT00943852|3939505|P10|NOT COMPLETED|First Period of Treatment Intervention||0
1611111|NCT00943852|3939506|P9|NOT COMPLETED|First Period of Treatment Intervention||0
1611112|NCT00943852|3939507|P8|NOT COMPLETED|First Period of Treatment Intervention||0
1611113|NCT00943852|3939508|P7|NOT COMPLETED|First Period of Treatment Intervention||0
1611114|NCT00943852|3939509|P6|NOT COMPLETED|First Period of Treatment Intervention||0
1611115|NCT00943852|3939510|P5|NOT COMPLETED|First Period of Treatment Intervention||0
1611116|NCT00943852|3939511|P4|NOT COMPLETED|First Period of Treatment Intervention||0
1611117|NCT00943852|3939512|P3|NOT COMPLETED|First Period of Treatment Intervention||0
1611118|NCT00943852|3939513|P2|NOT COMPLETED|First Period of Treatment Intervention||0
1611119|NCT00943852|3939514|P1|NOT COMPLETED|First Period of Treatment Intervention||0
1611120|NCT00943852|3939505|P10|COMPLETED|First Period of Treatment Intervention||1
1611121|NCT00943852|3939506|P9|COMPLETED|First Period of Treatment Intervention||1
1611122|NCT00943852|3939507|P8|COMPLETED|First Period of Treatment Intervention||1
1611123|NCT00943852|3939508|P7|COMPLETED|First Period of Treatment Intervention||2
1611124|NCT00943852|3939509|P6|COMPLETED|First Period of Treatment Intervention||1
1611125|NCT00943852|3939510|P5|COMPLETED|First Period of Treatment Intervention||1
1611126|NCT00943852|3939511|P4|COMPLETED|First Period of Treatment Intervention||2
1611127|NCT00943852|3939512|P3|COMPLETED|First Period of Treatment Intervention||1
1611128|NCT00943852|3939513|P2|COMPLETED|First Period of Treatment Intervention||1
1611129|NCT00943852|3939514|P1|COMPLETED|First Period of Treatment Intervention||2
1611130|NCT00943852|3939505|P10|STARTED|First Period of Treatment Intervention||1
1611131|NCT00943852|3939506|P9|STARTED|First Period of Treatment Intervention||1
1611132|NCT00943852|3939507|P8|STARTED|First Period of Treatment Intervention||1
1611133|NCT00943852|3939508|P7|STARTED|First Period of Treatment Intervention||2
1611134|NCT00943852|3939509|P6|STARTED|First Period of Treatment Intervention||1
1611135|NCT00943852|3939510|P5|STARTED|First Period of Treatment Intervention||1
1611136|NCT00943852|3939511|P4|STARTED|First Period of Treatment Intervention||2
1611137|NCT00943852|3939512|P3|STARTED|First Period of Treatment Intervention||1
1611138|NCT00943852|3939513|P2|STARTED|First Period of Treatment Intervention||1
1611139|NCT00943852|3939514|P1|STARTED|First Period of Treatment Intervention||2
1611140|NCT00943826|3939527|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
1611141|NCT00943826|3939528|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
1611142|NCT00943826|3939527|P2|COMPLETED|After Primary Overall Survival Analysis||0
1611143|NCT00943826|3939528|P1|COMPLETED|After Primary Overall Survival Analysis||0
1611144|NCT00943826|3939527|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
1611145|NCT00943826|3939528|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
1611146|NCT00943826|3939527|P2|NOT COMPLETED|Monotherapy Phase||16
1611147|NCT00943826|3939528|P1|NOT COMPLETED|Monotherapy Phase||65
1611148|NCT00943826|3939527|P2|COMPLETED|Monotherapy Phase||143
1611149|NCT00943826|3939528|P1|COMPLETED|Monotherapy Phase||204
1611150|NCT00943826|3939527|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
1611151|NCT00943826|3939528|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
1611152|NCT00943826|3939527|P2|NOT COMPLETED|Maintenance Phase||39
1611153|NCT00943826|3939528|P1|NOT COMPLETED|Maintenance Phase||43
1611154|NCT00943826|3939527|P2|COMPLETED|Maintenance Phase||331
1611155|NCT00943826|3939528|P1|COMPLETED|Maintenance Phase||353
1611156|NCT00943826|3939527|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
1611157|NCT00943826|3939528|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
1611158|NCT00943826|3939527|P2|NOT COMPLETED|Concurrent Phase||42
1611159|NCT00943826|3939528|P1|NOT COMPLETED|Concurrent Phase||61
1611160|NCT00943826|3939527|P2|COMPLETED|Concurrent Phase||421
1611161|NCT00943826|3939528|P1|COMPLETED|Concurrent Phase||397
1611162|NCT00943826|3939527|P2|Treated|Concurrent Phase||459
1611163|NCT00943826|3939528|P1|Treated|Concurrent Phase||452
1611164|NCT00943826|3939527|P2|STARTED|Concurrent Phase||463
1611165|NCT00943826|3939528|P1|STARTED|Concurrent Phase||458
1611166|NCT00943787|3939546|P1|NOT COMPLETED|Overall Study||7
1611167|NCT00943787|3939546|P1|COMPLETED|Overall Study||34
1611168|NCT00943787|3939546|P1|STARTED|Overall Study||41
1611169|NCT00943761|3939553|P2|NOT COMPLETED|Overall Study||1
1611170|NCT00943761|3939554|P1|NOT COMPLETED|Overall Study||4
1611171|NCT00943761|3939553|P2|COMPLETED|Overall Study||23
1611172|NCT00943761|3939554|P1|COMPLETED|Overall Study||17
1611173|NCT00943761|3939553|P2|STARTED|Overall Study||24
1611174|NCT00943761|3939554|P1|STARTED|Overall Study||21
1611175|NCT00943735|3939566|P1|NOT COMPLETED|Overall Study||32
1611176|NCT00943735|3939566|P1|COMPLETED|Overall Study||742
1611177|NCT00943735|3939566|P1|Per Protocol Population|Overall Study||500
1611178|NCT00943735|3939566|P1|STARTED|Overall Study||774
1611179|NCT00943722|3939604|P5|NOT COMPLETED|Overall Study||22
1611180|NCT00943722|3939605|P4|NOT COMPLETED|Overall Study||22
1611181|NCT00943722|3939606|P3|NOT COMPLETED|Overall Study||13
1611182|NCT00943722|3939607|P2|NOT COMPLETED|Overall Study||22
1611183|NCT00943722|3939608|P1|NOT COMPLETED|Overall Study||25
1611184|NCT00943722|3939604|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
1611185|NCT00943722|3939605|P4|COMPLETED|Overall Study||647
1611186|NCT00943722|3939606|P3|COMPLETED|Overall Study||631
1611187|NCT00943722|3939607|P2|COMPLETED|Overall Study||621
1611188|NCT00943722|3939608|P1|COMPLETED|Overall Study||623
1611189|NCT00943722|3939604|P5|Vaccination 3|Overall Study||455
1611190|NCT00943722|3939605|P4|Vaccination 3|Overall Study||653
1611191|NCT00943722|3939606|P3|Vaccination 3|Overall Study||637
1611192|NCT00943722|3939607|P2|Vaccination 3|Overall Study||627
1611193|NCT00943722|3939608|P1|Vaccination 3|Overall Study||635
1611194|NCT00943722|3939604|P5|Vaccination 2|Overall Study||462
1611195|NCT00943722|3939605|P4|Vaccination 2|Overall Study||658
1611196|NCT00943722|3939606|P3|Vaccination 2|Overall Study||638
1611197|NCT00943722|3939607|P2|Vaccination 2|Overall Study||633
1611198|NCT00943722|3939608|P1|Vaccination 2|Overall Study||637
1611199|NCT00943722|3939604|P5|Vaccination 1|Overall Study||468
1611200|NCT00943722|3939605|P4|Vaccination 1|Overall Study||666
1611201|NCT00943722|3939606|P3|Vaccination 1|Overall Study||644
1611202|NCT00943722|3939607|P2|Vaccination 1|Overall Study||642
1611203|NCT00943722|3939608|P1|Vaccination 1|Overall Study||646
1611204|NCT00943722|3939604|P5|STARTED|Overall Study||470
1611205|NCT00943722|3939605|P4|STARTED|Overall Study||669
1611206|NCT00943722|3939606|P3|STARTED|Overall Study||644
1611207|NCT00943722|3939607|P2|STARTED|Overall Study||643
1611208|NCT00943722|3939608|P1|STARTED|Overall Study||648
1611209|NCT00943683|3939638|P2|NOT COMPLETED|Overall Study||6
1611210|NCT00943683|3939639|P1|NOT COMPLETED|Overall Study||7
1611211|NCT00943683|3939638|P2|COMPLETED|Overall Study||169
1611212|NCT00943683|3939639|P1|COMPLETED|Overall Study||74
1611213|NCT00943683|3939638|P2|STARTED|Overall Study||175
1611214|NCT00943683|3939639|P1|STARTED|Overall Study||81
1611215|NCT00943670|3939645|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
1611216|NCT00943670|3939645|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
1611217|NCT00943670|3939645|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
1611218|NCT00943670|3939645|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
1611219|NCT00943670|3939645|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
1611220|NCT00943670|3939645|P1|Treated|Single-agent Trastuzumab Emtansine||51
1611221|NCT00943670|3939645|P1|STARTED|Single-agent Trastuzumab Emtansine||51
1611222|NCT00943631|3939681|P2|NOT COMPLETED|Overall Study||2
1611223|NCT00943631|3939682|P1|NOT COMPLETED|Overall Study||4
1611224|NCT00943631|3939681|P2|COMPLETED|Overall Study||202
1611225|NCT00943631|3939682|P1|COMPLETED|Overall Study||198
1611226|NCT00943631|3939681|P2|STARTED|Overall Study||204
1611229|NCT00943605|3939735|P1|NOT COMPLETED|Overall Study||30
1611230|NCT00943605|3939734|P2|COMPLETED|Overall Study||0
1611231|NCT00943605|3939735|P1|COMPLETED|Overall Study||0
1611232|NCT00943605|3939734|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
1611233|NCT00943605|3939735|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
1611234|NCT00943592|3939745|P1|NOT COMPLETED|Overall Study||3
1611235|NCT00943592|3939745|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
1611236|NCT00943592|3939745|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
1611237|NCT00943592|3939745|P1|STARTED|Overall Study||82
1611238|NCT00943579|3939758|P2|NOT COMPLETED|Overall Study||5
1611239|NCT00943579|3939759|P1|NOT COMPLETED|Overall Study||6
1611240|NCT00943579|3939758|P2|COMPLETED|Overall Study||15
1611241|NCT00943579|3939759|P1|COMPLETED|Overall Study||15
1611242|NCT00943579|3939758|P2|STARTED|Overall Study||20
1611243|NCT00943579|3939759|P1|STARTED|Overall Study||21
1611244|NCT00943488|3939780|P2|NOT COMPLETED|Overall Study||2
1611245|NCT00943488|3939781|P1|NOT COMPLETED|Overall Study||1
1611246|NCT00943488|3939780|P2|COMPLETED|Overall Study||202
1611247|NCT00943488|3939781|P1|COMPLETED|Overall Study||203
1611248|NCT00943488|3939780|P2|STARTED|Overall Study||204
1611249|NCT00943488|3939781|P1|STARTED|Overall Study||204
1611250|NCT00943436|3939837|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
1611251|NCT00943436|3939838|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
1611252|NCT00943436|3939837|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
1611253|NCT00943436|3939838|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
1611254|NCT00943436|3939837|P2|STARTED|Rest Session: 45 Minutes of Reading||10
1611255|NCT00943436|3939838|P1|STARTED|Rest Session: 45 Minutes of Reading||10
1611256|NCT00943436|3939837|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
1611257|NCT00943436|3939838|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
1611258|NCT00943436|3939837|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
1611259|NCT00943436|3939838|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
1611260|NCT00943436|3939837|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
1611261|NCT00943436|3939838|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
1611262|NCT00943397|3939860|P2|NOT COMPLETED|Overall Study||72
1611263|NCT00943397|3939861|P1|NOT COMPLETED|Overall Study||15
1611264|NCT00943397|3939860|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
1611265|NCT00943397|3939861|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
1611266|NCT00943397|3939860|P2|STARTED|Overall Study||158
1611267|NCT00943397|3939861|P1|STARTED|Overall Study||32
1611268|NCT00943384|3939867|P1|NOT COMPLETED|Overall Study||49
1611269|NCT00943384|3939867|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
1611270|NCT00943384|3939867|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
1611271|NCT00943384|3939867|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
1611272|NCT00943384|3939867|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
1611273|NCT00943306|3939881|P1|NOT COMPLETED|Overall Study||3
1611274|NCT00943306|3939881|P1|COMPLETED|Overall Study||16
1611275|NCT00943306|3939881|P1|STARTED|Overall Study||19
1611276|NCT00943202|3939942|P4|NOT COMPLETED|Overall Study||1
1611277|NCT00943202|3939943|P3|NOT COMPLETED|Overall Study||0
1611278|NCT00943202|3939944|P2|NOT COMPLETED|Overall Study||2
1611279|NCT00943202|3939945|P1|NOT COMPLETED|Overall Study||1
1611280|NCT00943202|3939942|P4|COMPLETED|Overall Study||131
1611281|NCT00943202|3939943|P3|COMPLETED|Overall Study||133
1611282|NCT00943202|3939944|P2|COMPLETED|Overall Study||131
1611283|NCT00943202|3939945|P1|COMPLETED|Overall Study||132
1611284|NCT00943202|3939942|P4|STARTED|Overall Study||132
1611285|NCT00943202|3939943|P3|STARTED|Overall Study||133
1611286|NCT00943202|3939944|P2|STARTED|Overall Study||133
1611287|NCT00943202|3939945|P1|STARTED|Overall Study||133
1611288|NCT00943150|3940161|P2|NOT COMPLETED|Overall Study||0
1611289|NCT00943150|3940162|P1|NOT COMPLETED|Overall Study||0
1611290|NCT00943150|3940161|P2|COMPLETED|Overall Study||10
1611291|NCT00943150|3940162|P1|COMPLETED|Overall Study||10
1611292|NCT00943150|3940161|P2|STARTED|Overall Study||10
1611293|NCT00943150|3940162|P1|STARTED|Overall Study||10
1611294|NCT00943124|3940183|P2|NOT COMPLETED|Period 2||0
1611295|NCT00943124|3940184|P1|NOT COMPLETED|Period 2||0
1611296|NCT00943124|3940183|P2|COMPLETED|Period 2||108
1611297|NCT00943124|3940184|P1|COMPLETED|Period 2||108
1611298|NCT00943124|3940183|P2|STARTED|Period 2||108
1611299|NCT00943124|3940184|P1|STARTED|Period 2||108
1611300|NCT00943124|3940183|P2|NOT COMPLETED|Period 1||2
1611301|NCT00943124|3940184|P1|NOT COMPLETED|Period 1||2
1611302|NCT00943124|3940183|P2|COMPLETED|Period 1||108
1611303|NCT00943124|3940184|P1|COMPLETED|Period 1||108
1611304|NCT00943124|3940183|P2|STARTED|Period 1||110
1611305|NCT00943124|3940184|P1|STARTED|Period 1||110
1611306|NCT00943111|3940206|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
1611307|NCT00943111|3940207|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
1611308|NCT00943111|3940208|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
1611309|NCT00943111|3940206|P3|COMPLETED|5 Years Long-term Treatment Period||77
1611310|NCT00943111|3940207|P2|COMPLETED|5 Years Long-term Treatment Period||0
1611311|NCT00943111|3940208|P1|COMPLETED|5 Years Long-term Treatment Period||0
1611312|NCT00943111|3940206|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
1611313|NCT00943111|3940207|P2|STARTED|5 Years Long-term Treatment Period||0
1611314|NCT00943111|3940208|P1|STARTED|5 Years Long-term Treatment Period||0
1611315|NCT00943111|3940206|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
1611316|NCT00943111|3940207|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
1611317|NCT00943111|3940208|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
1611318|NCT00943111|3940206|P3|COMPLETED|52-Weeks Primary Analysis Period||0
1611319|NCT00943111|3940207|P2|COMPLETED|52-Weeks Primary Analysis Period||52
1611320|NCT00943111|3940208|P1|COMPLETED|52-Weeks Primary Analysis Period||104
1611321|NCT00943111|3940206|P3|Treated|52-Weeks Primary Analysis Period||0
1611322|NCT00943111|3940207|P2|Treated|52-Weeks Primary Analysis Period||53
1611323|NCT00943111|3940208|P1|Treated|52-Weeks Primary Analysis Period||106
1611324|NCT00943111|3940206|P3|STARTED|52-Weeks Primary Analysis Period||0
1611325|NCT00943111|3940207|P2|STARTED|52-Weeks Primary Analysis Period||54
1611326|NCT00943111|3940208|P1|STARTED|52-Weeks Primary Analysis Period||106
1611327|NCT00943098|3940241|P2|NOT COMPLETED|Overall Study||0
1611328|NCT00943098|3940242|P1|NOT COMPLETED|Overall Study||0
1611329|NCT00943098|3940241|P2|COMPLETED|Overall Study||72
1611330|NCT00943098|3940242|P1|COMPLETED|Overall Study||70
1611331|NCT00943098|3940241|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
1611332|NCT00943098|3940242|P1|STARTED|Overall Study||70
1611333|NCT00943072|3940276|P2|NOT COMPLETED|Overall Study||14
1611334|NCT00943072|3940277|P1|NOT COMPLETED|Overall Study||5
1611335|NCT00943072|3940276|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
1611336|NCT00943072|3940277|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
1611337|NCT00943072|3940276|P2|Full Analysis Set (FAS) Population|Overall Study||73
1611338|NCT00943072|3940277|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
1611339|NCT00943072|3940276|P2|Participants Received Treatment|Overall Study||74
1611340|NCT00943072|3940277|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
1611341|NCT00943072|3940276|P2|STARTED|Overall Study||74
1611342|NCT00943072|3940277|P1|STARTED|Overall Study||115
1611343|NCT00942994|3940295|P2|NOT COMPLETED|Overall Study||19
1611344|NCT00942994|3940296|P1|NOT COMPLETED|Overall Study||16
1611345|NCT00942994|3940295|P2|COMPLETED|Overall Study||190
1611346|NCT00942994|3940296|P1|COMPLETED|Overall Study||187
1611347|NCT00942994|3940295|P2|STARTED|Overall Study||209
1611348|NCT00942994|3940296|P1|STARTED|Overall Study||203
1611349|NCT00942968|3940312|P1|NOT COMPLETED|Overall Study||229
1611350|NCT00942968|3940312|P1|COMPLETED|Overall Study||109
1611351|NCT00942968|3940312|P1|Treated|Overall Study||334
1611352|NCT00942968|3940312|P1|STARTED|Overall Study||338
1611353|NCT00942903|3940333|P1|NOT COMPLETED|Overall Study||0
1611354|NCT00942903|3940333|P1|COMPLETED|Overall Study||20
1611355|NCT00942903|3940333|P1|STARTED|Overall Study||20
1611356|NCT00942890|3940340|P2|NOT COMPLETED|Overall Study||0
1611357|NCT00942890|3940341|P1|NOT COMPLETED|Overall Study||0
1611358|NCT00942890|3940340|P2|COMPLETED|Overall Study||23
1611359|NCT00942890|3940341|P1|COMPLETED|Overall Study||21
1611360|NCT00942890|3940340|P2|STARTED|Overall Study||23
1611361|NCT00942890|3940341|P1|STARTED|Overall Study||21
1611362|NCT00942851|3940363|P2|NOT COMPLETED|Overall Study||1
1611363|NCT00942851|3940364|P1|NOT COMPLETED|Overall Study||0
1611364|NCT00942851|3940363|P2|COMPLETED|Overall Study||11
1611365|NCT00942851|3940364|P1|COMPLETED|Overall Study||12
1611366|NCT00942851|3940363|P2|STARTED|Overall Study||12
1611367|NCT00942851|3940364|P1|STARTED|Overall Study||12
1611368|NCT00942825|3940376|P2|NOT COMPLETED|Overall Study||0
1611369|NCT00942825|3940377|P1|NOT COMPLETED|Overall Study||0
1611370|NCT00942825|3940376|P2|COMPLETED|Overall Study||98
1611371|NCT00942825|3940377|P1|COMPLETED|Overall Study||97
1611372|NCT00942825|3940376|P2|STARTED|Overall Study||98
1611373|NCT00942825|3940377|P1|STARTED|Overall Study||97
1611374|NCT00942786|3940383|P1|NOT COMPLETED|Overall Study||0
1611375|NCT00942786|3940383|P1|COMPLETED|Overall Study|date of last follow-up|297
1611376|NCT00942786|3940383|P1|STARTED|Overall Study||297
1611377|NCT00942734|3940390|P1|NOT COMPLETED|Overall Study||8
1611378|NCT00942734|3940390|P1|COMPLETED|Overall Study||35
1611379|NCT00942734|3940390|P1|STARTED|Overall Study||43
1611380|NCT00942604|3940396|P2|NOT COMPLETED|Overall Study||4
1611381|NCT00942604|3940397|P1|NOT COMPLETED|Overall Study||2
1611382|NCT00942604|3940396|P2|COMPLETED|Overall Study||99
1611383|NCT00942604|3940397|P1|COMPLETED|Overall Study||98
1611384|NCT00942604|3940396|P2|STARTED|Overall Study||103
1611385|NCT00942604|3940397|P1|STARTED|Overall Study||100
1611386|NCT00942578|3940408|P3|NOT COMPLETED|Expansion Phase||0
1611387|NCT00942578|3940409|P2|NOT COMPLETED|Expansion Phase||0
1611388|NCT00942578|3940410|P1|NOT COMPLETED|Expansion Phase||0
1611389|NCT00942578|3940408|P3|COMPLETED|Expansion Phase||43
1611390|NCT00942578|3940409|P2|COMPLETED|Expansion Phase||0
1611391|NCT00942578|3940410|P1|COMPLETED|Expansion Phase||11
1611392|NCT00942578|3940408|P3|STARTED|Expansion Phase||43
1611393|NCT00942578|3940409|P2|STARTED|Expansion Phase||0
1611394|NCT00942578|3940410|P1|STARTED|Expansion Phase||11
1611395|NCT00942578|3940408|P3|NOT COMPLETED|Dose Escalation Phase||0
1611396|NCT00942578|3940409|P2|NOT COMPLETED|Dose Escalation Phase||0
1611397|NCT00942578|3940410|P1|NOT COMPLETED|Dose Escalation Phase||0
1611398|NCT00942578|3940408|P3|COMPLETED|Dose Escalation Phase||3
1611399|NCT00942578|3940409|P2|COMPLETED|Dose Escalation Phase||3
1611400|NCT00942578|3940410|P1|COMPLETED|Dose Escalation Phase||3
1611401|NCT00942578|3940408|P3|STARTED|Dose Escalation Phase||3
1611402|NCT00942578|3940409|P2|STARTED|Dose Escalation Phase||3
1611403|NCT00942578|3940410|P1|STARTED|Dose Escalation Phase||3
1611404|NCT00942448|3940440|P4|NOT COMPLETED|Overall Study||0
1611405|NCT00942448|3940441|P3|NOT COMPLETED|Overall Study||0
1611406|NCT00942448|3940442|P2|NOT COMPLETED|Overall Study||0
1611407|NCT00942448|3940443|P1|NOT COMPLETED|Overall Study||0
1611408|NCT00942448|3940440|P4|COMPLETED|Overall Study||75
1611409|NCT00942448|3940441|P3|COMPLETED|Overall Study||78
1611410|NCT00942448|3940442|P2|COMPLETED|Overall Study||76
1611411|NCT00942448|3940443|P1|COMPLETED|Overall Study||77
1611412|NCT00942448|3940440|P4|STARTED|Overall Study||75
1611413|NCT00942448|3940441|P3|STARTED|Overall Study||78
1611414|NCT00942448|3940442|P2|STARTED|Overall Study||76
1611415|NCT00942448|3940443|P1|STARTED|Overall Study||77
1611416|NCT00942422|3940505|P1|NOT COMPLETED|Overall Study||3
1611417|NCT00942422|3940505|P1|COMPLETED|Overall Study||5
1611418|NCT00942422|3940505|P1|STARTED|Overall Study||8
1611419|NCT00942409|3940509|P1|NOT COMPLETED|Overall Study||3
1611420|NCT00942409|3940509|P1|COMPLETED|Overall Study||2
1611421|NCT00942409|3940509|P1|STARTED|Overall Study||5
1611422|NCT00942357|3940515|P2|NOT COMPLETED|Overall Study||40
1611423|NCT00942357|3940516|P1|NOT COMPLETED|Overall Study||37
1611424|NCT00942357|3940515|P2|COMPLETED|Overall Study||366
1611425|NCT00942357|3940516|P1|COMPLETED|Overall Study||370
1611426|NCT00942357|3940515|P2|STARTED|Overall Study||406
1611427|NCT00942357|3940516|P1|STARTED|Overall Study||407
1611428|NCT00942266|3940532|P2|NOT COMPLETED|Overall Study||15
1611429|NCT00942266|3940533|P1|NOT COMPLETED|Overall Study||43
1611430|NCT00942266|3940532|P2|COMPLETED|Overall Study||0
1611431|NCT00942266|3940533|P1|COMPLETED|Overall Study||0
1611432|NCT00942266|3940532|P2|STARTED|Overall Study||15
1611433|NCT00942266|3940533|P1|STARTED|Overall Study||43
1611434|NCT00942188|3940555|P4|NOT COMPLETED|Overall Study||4
1611435|NCT00942188|3940556|P3|NOT COMPLETED|Overall Study||9
1611436|NCT00942188|3940557|P2|NOT COMPLETED|Overall Study||10
1611437|NCT00942188|3940558|P1|NOT COMPLETED|Overall Study||4
1611438|NCT00942188|3940555|P4|COMPLETED|Overall Study||23
1611439|NCT00942188|3940556|P3|COMPLETED|Overall Study||18
1611440|NCT00942188|3940557|P2|COMPLETED|Overall Study||16
1611441|NCT00942188|3940558|P1|COMPLETED|Overall Study||22
1611442|NCT00942188|3940555|P4|STARTED|Overall Study||27
1611443|NCT00942188|3940556|P3|STARTED|Overall Study||27
1611444|NCT00942188|3940557|P2|STARTED|Overall Study||26
1611445|NCT00942188|3940558|P1|STARTED|Overall Study||26
1611446|NCT00942175|3940597|P4|NOT COMPLETED|Overall Study||2
1611447|NCT00942175|3940598|P3|NOT COMPLETED|Overall Study||2
1611448|NCT00942175|3940599|P2|NOT COMPLETED|Overall Study||4
1611449|NCT00942175|3940600|P1|NOT COMPLETED|Overall Study||2
1611450|NCT00942175|3940597|P4|COMPLETED|Overall Study||38
1611451|NCT00942175|3940598|P3|COMPLETED|Overall Study||38
1611452|NCT00942175|3940599|P2|COMPLETED|Overall Study||36
1611453|NCT00942175|3940600|P1|COMPLETED|Overall Study||38
1611454|NCT00942175|3940597|P4|STARTED|Overall Study||40
1611455|NCT00942175|3940598|P3|STARTED|Overall Study||40
1611456|NCT00942175|3940599|P2|STARTED|Overall Study||40
1611457|NCT00942175|3940600|P1|STARTED|Overall Study||40
1611458|NCT00942162|3940653|P3|NOT COMPLETED|Overall Study||1
1611459|NCT00942162|3940654|P2|NOT COMPLETED|Overall Study||47
1611460|NCT00942162|3940655|P1|NOT COMPLETED|Overall Study||68
1611461|NCT00942162|3940653|P3|COMPLETED|Overall Study||1
1611462|NCT00942162|3940654|P2|COMPLETED|Overall Study||3
1611463|NCT00942162|3940655|P1|COMPLETED|Overall Study||3
1611464|NCT00942162|3940653|P3|STARTED|Overall Study||2
1611465|NCT00942162|3940654|P2|STARTED|Overall Study||50
1611466|NCT00942162|3940655|P1|STARTED|Overall Study||71
1611467|NCT00942149|3940720|P1|NOT COMPLETED|Overall Study||0
1611468|NCT00942149|3940720|P1|COMPLETED|Overall Study||20
1611469|NCT00942149|3940720|P1|STARTED|Overall Study||20
1611470|NCT00942084|3940724|P1|NOT COMPLETED|Overall Study||2
1611471|NCT00942084|3940724|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
1611472|NCT00942084|3940724|P1|STARTED|Overall Study||32
1611473|NCT00941993|3940733|P1|NOT COMPLETED|Overall Study||0
1611474|NCT00941993|3940733|P1|COMPLETED|Overall Study||109
1611475|NCT00941993|3940733|P1|STARTED|Overall Study||109
1611476|NCT00941928|3940741|P1|NOT COMPLETED|Overall Study||2
1611477|NCT00941928|3940741|P1|COMPLETED|Overall Study||0
1611478|NCT00941928|3940741|P1|STARTED|Overall Study||2
1611479|NCT00941889|3940747|P2|NOT COMPLETED|Overall Study||12
1611480|NCT00941889|3940748|P1|NOT COMPLETED|Overall Study||12
1611481|NCT00941889|3940747|P2|COMPLETED|Overall Study||3
1611482|NCT00941889|3940748|P1|COMPLETED|Overall Study||5
1611483|NCT00941889|3940747|P2|STARTED|Overall Study||15
1611484|NCT00941889|3940748|P1|STARTED|Overall Study||17
1611485|NCT00941863|3940759|P5|NOT COMPLETED|Continued After PCD||19
1611486|NCT00941863|3940760|P4|NOT COMPLETED|Continued After PCD||0
1611487|NCT00941863|3940761|P3|NOT COMPLETED|Continued After PCD||0
1611488|NCT00941863|3940762|P2|NOT COMPLETED|Continued After PCD||0
1611489|NCT00941863|3940763|P1|NOT COMPLETED|Continued After PCD||0
1611490|NCT00941863|3940759|P5|COMPLETED|Continued After PCD||6
1611491|NCT00941863|3940760|P4|COMPLETED|Continued After PCD||0
1611492|NCT00941863|3940761|P3|COMPLETED|Continued After PCD||0
1611493|NCT00941863|3940762|P2|COMPLETED|Continued After PCD||0
1611494|NCT00941863|3940763|P1|COMPLETED|Continued After PCD||0
1611495|NCT00941863|3940759|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
1611496|NCT00941863|3940760|P4|STARTED|Continued After PCD||0
1611497|NCT00941863|3940761|P3|STARTED|Continued After PCD||0
1611498|NCT00941863|3940762|P2|STARTED|Continued After PCD||0
1611499|NCT00941863|3940763|P1|STARTED|Continued After PCD||0
1611500|NCT00941863|3940759|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
1611501|NCT00941863|3940760|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
1611502|NCT00941863|3940761|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
1611503|NCT00941863|3940762|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
1611504|NCT00941863|3940763|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
1611505|NCT00941863|3940759|P5|COMPLETED|Until Primary Completion Date (PCD)||25
1611506|NCT00941863|3940760|P4|COMPLETED|Until Primary Completion Date (PCD)||0
1611507|NCT00941863|3940761|P3|COMPLETED|Until Primary Completion Date (PCD)||0
1611508|NCT00941863|3940762|P2|COMPLETED|Until Primary Completion Date (PCD)||0
1611509|NCT00941863|3940763|P1|COMPLETED|Until Primary Completion Date (PCD)||0
1611510|NCT00941863|3940759|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
1611511|NCT00941863|3940760|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
1611512|NCT00941863|3940761|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
1611513|NCT00941863|3940762|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
1611514|NCT00941863|3940763|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
1611515|NCT00941863|3940759|P5|STARTED|Until Primary Completion Date (PCD)||119
1611516|NCT00941863|3940760|P4|STARTED|Until Primary Completion Date (PCD)||17
1611517|NCT00941863|3940761|P3|STARTED|Until Primary Completion Date (PCD)||12
1611518|NCT00941863|3940762|P2|STARTED|Until Primary Completion Date (PCD)||3
1611519|NCT00941863|3940763|P1|STARTED|Until Primary Completion Date (PCD)||7
1611520|NCT00941798|3940790|P2|NOT COMPLETED|Overall Study||185
1611521|NCT00941798|3940791|P1|NOT COMPLETED|Overall Study||194
1611522|NCT00941798|3940790|P2|COMPLETED|Overall Study||578
1611523|NCT00941798|3940791|P1|COMPLETED|Overall Study||561
1611524|NCT00941798|3940790|P2|Full Analysis Set|Overall Study||759
1611525|NCT00941798|3940791|P1|Full Analysis Set|Overall Study||749
1611526|NCT00941798|3940790|P2|STARTED|Overall Study||763
1611527|NCT00941798|3940791|P1|STARTED|Overall Study||755
1611528|NCT00941733|3940821|P2|NOT COMPLETED|Overall Study||28
1611529|NCT00941733|3940822|P1|NOT COMPLETED|Overall Study||74
1611530|NCT00941733|3940821|P2|COMPLETED|Overall Study|1 year follow-up|91
1611531|NCT00941733|3940822|P1|COMPLETED|Overall Study|1 year follow-up|165
1611532|NCT00941733|3940821|P2|STARTED|Overall Study||119
1611533|NCT00941733|3940822|P1|STARTED|Overall Study||239
1611534|NCT00941720|3940862|P1|NOT COMPLETED|Overall Study||14
1611535|NCT00941720|3940862|P1|COMPLETED|Overall Study||57
1611536|NCT00941720|3940862|P1|STARTED|Overall Study||71
1611537|NCT00941681|3940871|P3|NOT COMPLETED|Overall Study||0
1611538|NCT00941681|3940872|P2|NOT COMPLETED|Overall Study||1
1611539|NCT00941681|3940873|P1|NOT COMPLETED|Overall Study||0
1611540|NCT00941681|3940871|P3|COMPLETED|Overall Study||12
1611541|NCT00941681|3940872|P2|COMPLETED|Overall Study||10
1611542|NCT00941681|3940873|P1|COMPLETED|Overall Study||12
1611543|NCT00941681|3940871|P3|STARTED|Overall Study||12
1611544|NCT00941681|3940872|P2|STARTED|Overall Study||11
1611545|NCT00941681|3940873|P1|STARTED|Overall Study||12
1611546|NCT00941668|3940898|P2|NOT COMPLETED|Overall Study||25
1611547|NCT00941668|3940899|P1|NOT COMPLETED|Overall Study||24
1611548|NCT00941668|3940898|P2|COMPLETED|Overall Study||0
1611549|NCT00941668|3940899|P1|COMPLETED|Overall Study||0
1611550|NCT00941668|3940898|P2|STARTED|Overall Study||25
1611551|NCT00941668|3940899|P1|STARTED|Overall Study||24
1611552|NCT00941655|3940909|P2|NOT COMPLETED|Overall Study||5
1611553|NCT00941655|3940910|P1|NOT COMPLETED|Overall Study||5
1611554|NCT00941655|3940909|P2|COMPLETED|Overall Study||2
1611555|NCT00941655|3940910|P1|COMPLETED|Overall Study||3
1611556|NCT00941655|3940909|P2|STARTED|Overall Study||7
1611557|NCT00941655|3940910|P1|STARTED|Overall Study||8
1611558|NCT00941603|3940935|P6|NOT COMPLETED|Overall Study||3
1611559|NCT00941603|3940936|P5|NOT COMPLETED|Overall Study||4
1611560|NCT00941603|3940937|P4|NOT COMPLETED|Overall Study||4
1611561|NCT00941603|3940938|P3|NOT COMPLETED|Overall Study||5
1611562|NCT00941603|3940939|P2|NOT COMPLETED|Overall Study||16
1611563|NCT00941603|3940940|P1|NOT COMPLETED|Overall Study||11
1611564|NCT00941603|3940935|P6|COMPLETED|Overall Study||94
1611565|NCT00941603|3940936|P5|COMPLETED|Overall Study||101
1611566|NCT00941603|3940937|P4|COMPLETED|Overall Study||100
1611567|NCT00941603|3940938|P3|COMPLETED|Overall Study||99
1611568|NCT00941603|3940939|P2|COMPLETED|Overall Study||89
1611569|NCT00941603|3940940|P1|COMPLETED|Overall Study||93
1611570|NCT00941603|3940935|P6|STARTED|Overall Study||97
1611571|NCT00941603|3940936|P5|STARTED|Overall Study||105
1611572|NCT00941603|3940937|P4|STARTED|Overall Study||104
1611573|NCT00941603|3940938|P3|STARTED|Overall Study||104
1611574|NCT00941603|3940939|P2|STARTED|Overall Study||105
1611575|NCT00941603|3940940|P1|STARTED|Overall Study||104
1611576|NCT00941330|3940962|P2|NOT COMPLETED|Overall Study||2
1611577|NCT00941330|3940963|P1|NOT COMPLETED|Overall Study||1
1611578|NCT00941330|3940962|P2|COMPLETED|Overall Study||9
1611579|NCT00941330|3940963|P1|COMPLETED|Overall Study||14
1611580|NCT00941330|3940962|P2|STARTED|Overall Study||11
1611581|NCT00941330|3940963|P1|STARTED|Overall Study||15
1611582|NCT00941304|3940976|P5|NOT COMPLETED|Overall Study||0
1611583|NCT00941304|3940977|P4|NOT COMPLETED|Overall Study||0
1611584|NCT00941304|3940978|P3|NOT COMPLETED|Overall Study||0
1611585|NCT00941304|3940979|P2|NOT COMPLETED|Overall Study||0
1611586|NCT00941304|3940980|P1|NOT COMPLETED|Overall Study||1
1611587|NCT00941304|3940976|P5|COMPLETED|Overall Study||31
1611588|NCT00941304|3940977|P4|COMPLETED|Overall Study||30
1611589|NCT00941304|3940978|P3|COMPLETED|Overall Study||31
1611590|NCT00941304|3940979|P2|COMPLETED|Overall Study||30
1611591|NCT00941304|3940980|P1|COMPLETED|Overall Study||30
1611592|NCT00941304|3940976|P5|STARTED|Overall Study||31
1611593|NCT00941304|3940977|P4|STARTED|Overall Study||30
1611594|NCT00941304|3940978|P3|STARTED|Overall Study||31
1611595|NCT00941304|3940979|P2|STARTED|Overall Study||30
1611596|NCT00941304|3940980|P1|STARTED|Overall Study||31
1611597|NCT00941070|3941042|P1|NOT COMPLETED|Overall Study||1
1611598|NCT00941070|3941042|P1|COMPLETED|Overall Study||25
1611599|NCT00941070|3941042|P1|STARTED|Overall Study||26
1611600|NCT00941031|3941062|P7|NOT COMPLETED|Maintenance Period||43
1611601|NCT00941031|3941063|P6|NOT COMPLETED|Maintenance Period||6
1611602|NCT00941031|3941064|P5|NOT COMPLETED|Maintenance Period||9
1611603|NCT00941031|3941065|P4|NOT COMPLETED|Maintenance Period||0
1611604|NCT00941031|3941066|P3|NOT COMPLETED|Maintenance Period||0
1611605|NCT00941031|3941067|P2|NOT COMPLETED|Maintenance Period||0
1611606|NCT00941031|3941068|P1|NOT COMPLETED|Maintenance Period||0
1611607|NCT00941031|3941062|P7|COMPLETED|Maintenance Period||204
1611608|NCT00941031|3941063|P6|COMPLETED|Maintenance Period||61
1611609|NCT00941031|3941064|P5|COMPLETED|Maintenance Period||56
1611610|NCT00941031|3941065|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
1611611|NCT00941031|3941066|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1611612|NCT00941031|3941067|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1611613|NCT00941031|3941068|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1611614|NCT00941031|3941062|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
1611615|NCT00941031|3941063|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
1611616|NCT00941031|3941064|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
1611617|NCT00941031|3941065|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
1611618|NCT00941031|3941066|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1611619|NCT00941031|3941067|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1611620|NCT00941031|3941068|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1611621|NCT00941031|3941062|P7|NOT COMPLETED|Induction Period||0
1611622|NCT00941031|3941063|P6|NOT COMPLETED|Induction Period||0
1611623|NCT00941031|3941064|P5|NOT COMPLETED|Induction Period||0
1611624|NCT00941031|3941065|P4|NOT COMPLETED|Induction Period||9
1611625|NCT00941031|3941066|P3|NOT COMPLETED|Induction Period||6
1611626|NCT00941031|3941067|P2|NOT COMPLETED|Induction Period||4
1611627|NCT00941031|3941068|P1|NOT COMPLETED|Induction Period||5
1611628|NCT00941031|3941062|P7|COMPLETED|Induction Period||0
1611629|NCT00941031|3941063|P6|COMPLETED|Induction Period||0
1611630|NCT00941031|3941064|P5|COMPLETED|Induction Period||0
1611631|NCT00941031|3941065|P4|COMPLETED|Induction Period||58
1611632|NCT00941031|3941066|P3|COMPLETED|Induction Period||127
1611633|NCT00941031|3941067|P2|COMPLETED|Induction Period||134
1611634|NCT00941031|3941068|P1|COMPLETED|Induction Period||61
1611635|NCT00941031|3941062|P7|STARTED|Induction Period||0
1611636|NCT00941031|3941063|P6|STARTED|Induction Period||0
1611637|NCT00941031|3941064|P5|STARTED|Induction Period||0
1611638|NCT00941031|3941065|P4|STARTED|Induction Period||67
1611639|NCT00941031|3941066|P3|STARTED|Induction Period||133
1611640|NCT00941031|3941067|P2|STARTED|Induction Period||138
1611641|NCT00941031|3941068|P1|STARTED|Induction Period||66
1611642|NCT00940992|3941094|P3|NOT COMPLETED|Overall Study||2
1611643|NCT00940992|3941095|P2|NOT COMPLETED|Overall Study||2
1611644|NCT00940992|3941096|P1|NOT COMPLETED|Overall Study||4
1611645|NCT00940992|3941094|P3|COMPLETED|Overall Study||28
1611646|NCT00940992|3941095|P2|COMPLETED|Overall Study||28
1611647|NCT00940992|3941096|P1|COMPLETED|Overall Study||28
1611648|NCT00940992|3941094|P3|STARTED|Overall Study||30
1611649|NCT00940992|3941095|P2|STARTED|Overall Study||30
1611650|NCT00940992|3941096|P1|STARTED|Overall Study||32
1611651|NCT00940927|3941107|P1|NOT COMPLETED|Overall Study||0
1611652|NCT00940927|3941107|P1|COMPLETED|Overall Study||81
1611653|NCT00940927|3941107|P1|STARTED|Overall Study||81
1611654|NCT00940901|3941114|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
1611655|NCT00940901|3941115|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
1611656|NCT00940901|3941114|P2|COMPLETED|Week 9-16 (Phase 2)||4
1611657|NCT00940901|3941115|P1|COMPLETED|Week 9-16 (Phase 2)||4
1611658|NCT00940901|3941114|P2|STARTED|Week 9-16 (Phase 2)||7
1611659|NCT00940901|3941115|P1|STARTED|Week 9-16 (Phase 2)||6
1611660|NCT00940901|3941114|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
1611661|NCT00940901|3941115|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
1611662|NCT00940901|3941114|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
1611663|NCT00940901|3941115|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
1611664|NCT00940901|3941114|P2|STARTED|Weeks 1-8 (Phase 1)||7
1611665|NCT00940901|3941115|P1|STARTED|Weeks 1-8 (Phase 1)||6
1611666|NCT00940888|3941125|P1|NOT COMPLETED|Overall Study||835
1611667|NCT00940888|3941125|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
1611668|NCT00940888|3941125|P1|STARTED|Overall Study|Total number of subjects consented|1701
1611669|NCT00940875|3941132|P2|NOT COMPLETED|Post-Study Treatment||3
1611670|NCT00940875|3941133|P1|NOT COMPLETED|Post-Study Treatment||0
1611671|NCT00940875|3941132|P2|COMPLETED|Post-Study Treatment||1
1611672|NCT00940875|3941133|P1|COMPLETED|Post-Study Treatment||0
1611673|NCT00940875|3941132|P2|STARTED|Post-Study Treatment||4
1611674|NCT00940875|3941133|P1|STARTED|Post-Study Treatment||0
1611675|NCT00940875|3941132|P2|NOT COMPLETED|Treatment Phase||19
1611676|NCT00940875|3941133|P1|NOT COMPLETED|Treatment Phase||26
1611677|NCT00940875|3941132|P2|COMPLETED|Treatment Phase||4
1611678|NCT00940875|3941133|P1|COMPLETED|Treatment Phase||5
1611679|NCT00940875|3941132|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
1611680|NCT00940875|3941133|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
1611681|NCT00940823|3941153|P2|NOT COMPLETED|Overall Study||32
1611682|NCT00940823|3941154|P1|NOT COMPLETED|Overall Study||35
1611683|NCT00940823|3941153|P2|COMPLETED|Overall Study||82
1611684|NCT00940823|3941154|P1|COMPLETED|Overall Study||89
1611685|NCT00940823|3941153|P2|STARTED|Overall Study||114
1611686|NCT00940823|3941154|P1|STARTED|Overall Study||124
1611687|NCT00940589|3941172|P2|NOT COMPLETED|Overall Study||5
1611688|NCT00940589|3941173|P1|NOT COMPLETED|Overall Study||8
1611689|NCT00940589|3941172|P2|COMPLETED|Overall Study||29
1611690|NCT00940589|3941173|P1|COMPLETED|Overall Study||31
1611691|NCT00940589|3941172|P2|STARTED|Overall Study||34
1611692|NCT00940589|3941173|P1|STARTED|Overall Study||39
1611693|NCT00940576|3941183|P2|NOT COMPLETED|Overall Study||0
1611694|NCT00940576|3941184|P1|NOT COMPLETED|Overall Study||0
1611695|NCT00940576|3941183|P2|COMPLETED|Overall Study||9
1611696|NCT00940576|3941184|P1|COMPLETED|Overall Study||8
1611697|NCT00940576|3941183|P2|STARTED|Overall Study||9
1611698|NCT00940576|3941184|P1|STARTED|Overall Study||8
1611699|NCT00940537|3941193|P2|NOT COMPLETED|Overall Study||0
1611700|NCT00940537|3941194|P1|NOT COMPLETED|Overall Study||0
1611701|NCT00940537|3941193|P2|COMPLETED|Overall Study||9
1611702|NCT00940537|3941194|P1|COMPLETED|Overall Study||5
1611703|NCT00940537|3941193|P2|STARTED|Overall Study||9
1611704|NCT00940537|3941194|P1|STARTED|Overall Study||5
1611705|NCT00940498|3941211|P8|NOT COMPLETED|Overall Study||1
1611706|NCT00940498|3941212|P7|NOT COMPLETED|Overall Study||1
1611707|NCT00940498|3941213|P6|NOT COMPLETED|Overall Study||1
1611708|NCT00940498|3941214|P5|NOT COMPLETED|Overall Study||9
1611709|NCT00940498|3941215|P4|NOT COMPLETED|Overall Study||2
1611710|NCT00940498|3941216|P3|NOT COMPLETED|Overall Study||3
1611711|NCT00940498|3941217|P2|NOT COMPLETED|Overall Study||1
1611712|NCT00940498|3941218|P1|NOT COMPLETED|Overall Study||3
1611713|NCT00940498|3941211|P8|COMPLETED|Overall Study||3
1611714|NCT00940498|3941212|P7|COMPLETED|Overall Study||7
1611715|NCT00940498|3941213|P6|COMPLETED|Overall Study||6
1611716|NCT00940498|3941214|P5|COMPLETED|Overall Study||34
1611717|NCT00940498|3941215|P4|COMPLETED|Overall Study||2
1611718|NCT00940498|3941216|P3|COMPLETED|Overall Study||1
1611719|NCT00940498|3941217|P2|COMPLETED|Overall Study||3
1611720|NCT00940498|3941218|P1|COMPLETED|Overall Study||1
1611721|NCT00940498|3941211|P8|STARTED|Overall Study||4
1611722|NCT00940498|3941212|P7|STARTED|Overall Study||8
1611723|NCT00940498|3941213|P6|STARTED|Overall Study||7
1611724|NCT00940498|3941214|P5|STARTED|Overall Study||43
1611725|NCT00940498|3941215|P4|STARTED|Overall Study||4
1611726|NCT00940498|3941216|P3|STARTED|Overall Study||4
1611727|NCT00940498|3941217|P2|STARTED|Overall Study||4
1611728|NCT00940498|3941218|P1|STARTED|Overall Study||4
1611729|NCT00940485|3941336|P2|NOT COMPLETED|Overall Study||7
1611730|NCT00940485|3941337|P1|NOT COMPLETED|Overall Study||15
1611731|NCT00940485|3941336|P2|COMPLETED|Overall Study||93
1611732|NCT00940485|3941337|P1|COMPLETED|Overall Study||82
1611733|NCT00940485|3941336|P2|STARTED|Overall Study||100
1611734|NCT00940485|3941337|P1|STARTED|Overall Study||97
1611735|NCT00940446|3941363|P2|NOT COMPLETED|Overall Study||0
1611736|NCT00940446|3941364|P1|NOT COMPLETED|Overall Study||0
1611737|NCT00940446|3941363|P2|COMPLETED|Overall Study||30
1611738|NCT00940446|3941364|P1|COMPLETED|Overall Study||30
1611739|NCT00940446|3941363|P2|STARTED|Overall Study||30
1611740|NCT00940446|3941364|P1|STARTED|Overall Study||30
1611741|NCT00940342|3941375|P3|NOT COMPLETED|Overall Study||1
1611742|NCT00940342|3941376|P2|NOT COMPLETED|Overall Study||2
1611743|NCT00940342|3941377|P1|NOT COMPLETED|Overall Study||0
1611744|NCT00940342|3941375|P3|COMPLETED|Overall Study||39
1611745|NCT00940342|3941376|P2|COMPLETED|Overall Study||38
1611746|NCT00940342|3941377|P1|COMPLETED|Overall Study||50
1611747|NCT00940342|3941375|P3|STARTED|Overall Study||40
1611748|NCT00940342|3941376|P2|STARTED|Overall Study||40
1611749|NCT00940342|3941377|P1|STARTED|Overall Study||50
1611750|NCT00940290|3941389|P4|NOT COMPLETED|Overall Study||0
1611751|NCT00940290|3941390|P3|NOT COMPLETED|Overall Study||0
1611752|NCT00940290|3941391|P2|NOT COMPLETED|Overall Study||0
1611753|NCT00940290|3941392|P1|NOT COMPLETED|Overall Study||0
1611754|NCT00940290|3941389|P4|COMPLETED|Overall Study||54
1611755|NCT00940290|3941390|P3|COMPLETED|Overall Study||55
1611756|NCT00940290|3941391|P2|COMPLETED|Overall Study||53
1611757|NCT00940290|3941392|P1|COMPLETED|Overall Study||54
1611758|NCT00940290|3941389|P4|STARTED|Overall Study||54
1611759|NCT00940290|3941390|P3|STARTED|Overall Study||55
1611760|NCT00940290|3941391|P2|STARTED|Overall Study||53
1611761|NCT00940290|3941392|P1|STARTED|Overall Study||54
1611762|NCT00940108|3941406|P4|NOT COMPLETED|Overall Study||5
1611763|NCT00940108|3941407|P3|NOT COMPLETED|Overall Study||3
1611764|NCT00940108|3941408|P2|NOT COMPLETED|Overall Study||9
1611765|NCT00940108|3941409|P1|NOT COMPLETED|Overall Study||5
1611766|NCT00940108|3941406|P4|COMPLETED|Overall Study||99
1611767|NCT00940108|3941407|P3|COMPLETED|Overall Study||100
1611768|NCT00940108|3941408|P2|COMPLETED|Overall Study||71
1611769|NCT00940108|3941409|P1|COMPLETED|Overall Study||77
1611770|NCT00940108|3941406|P4|STARTED|Overall Study||104
1611771|NCT00940108|3941407|P3|STARTED|Overall Study||103
1611772|NCT00940108|3941408|P2|STARTED|Overall Study||80
1611773|NCT00940108|3941409|P1|STARTED|Overall Study||82
1611774|NCT00940017|3941459|P1|NOT COMPLETED|Overall Study||4
1611775|NCT00940017|3941459|P1|COMPLETED|Overall Study||20
1611776|NCT00940017|3941459|P1|Subjects Treated|Overall Study||21
1611777|NCT00940017|3941459|P1|STARTED|Overall Study||24
1611778|NCT00939991|3941480|P2|NOT COMPLETED|Overall Study||0
1611779|NCT00939991|3941481|P1|NOT COMPLETED|Overall Study||0
1611780|NCT00939991|3941480|P2|COMPLETED|Overall Study||39
1611781|NCT00939991|3941481|P1|COMPLETED|Overall Study||9
1611782|NCT00939991|3941480|P2|STARTED|Overall Study||39
1611783|NCT00939991|3941481|P1|STARTED|Overall Study||9
1611784|NCT00939952|3941491|P1|NOT COMPLETED|Overall Study||0
1611785|NCT00939952|3941491|P1|COMPLETED|Overall Study||7
1611786|NCT00939952|3941491|P1|STARTED|Overall Study||7
1611787|NCT00939900|3941503|P2|NOT COMPLETED|Overall Study||7
1611788|NCT00939900|3941504|P1|NOT COMPLETED|Overall Study||2
1611789|NCT00939900|3941503|P2|COMPLETED|Overall Study||48
1611790|NCT00939900|3941504|P1|COMPLETED|Overall Study||53
1611791|NCT00939900|3941503|P2|STARTED|Overall Study||55
1611792|NCT00939900|3941504|P1|STARTED|Overall Study||55
1611793|NCT00939874|3941510|P1|NOT COMPLETED|Overall Study||20
1611794|NCT00939874|3941510|P1|COMPLETED|Overall Study||32
1611795|NCT00939874|3941510|P1|Completed Week 48|Overall Study||37
1611796|NCT00939874|3941510|P1|STARTED|Overall Study||52
1611797|NCT00939809|3941515|P1|NOT COMPLETED|Overall Study||3
1611798|NCT00939809|3941515|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
1611799|NCT00939809|3941515|P1|STARTED|Overall Study||31
1611800|NCT00939796|3941524|P1|NOT COMPLETED|Overall Study||0
1611801|NCT00939796|3941524|P1|COMPLETED|Overall Study||16
1611802|NCT00939796|3941524|P1|STARTED|Overall Study||16
1611803|NCT00939783|3941530|P1|NOT COMPLETED|Overall Study||649
1611804|NCT00939783|3941530|P1|COMPLETED|Overall Study||0
1611805|NCT00939783|3941530|P1|Treated|Overall Study||648
1611806|NCT00939783|3941530|P1|STARTED|Overall Study||649
1611807|NCT00939731|3941537|P2|NOT COMPLETED|Second Intervention Period||0
1611808|NCT00939731|3941538|P1|NOT COMPLETED|Second Intervention Period||0
1611809|NCT00939731|3941537|P2|COMPLETED|Second Intervention Period||12
1611810|NCT00939731|3941538|P1|COMPLETED|Second Intervention Period||12
1611811|NCT00939731|3941537|P2|STARTED|Second Intervention Period||12
1611812|NCT00939731|3941538|P1|STARTED|Second Intervention Period||12
1611813|NCT00939731|3941537|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1611814|NCT00939731|3941538|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1611815|NCT00939731|3941537|P2|COMPLETED|Washout Period (at Least 14 Days)||12
1611816|NCT00939731|3941538|P1|COMPLETED|Washout Period (at Least 14 Days)||12
1611817|NCT00939731|3941537|P2|STARTED|Washout Period (at Least 14 Days)||12
1611818|NCT00939731|3941538|P1|STARTED|Washout Period (at Least 14 Days)||12
1611819|NCT00939731|3941537|P2|NOT COMPLETED|First Intervention Period||0
1611820|NCT00939731|3941538|P1|NOT COMPLETED|First Intervention Period||0
1611821|NCT00939731|3941537|P2|COMPLETED|First Intervention Period||12
1611822|NCT00939731|3941538|P1|COMPLETED|First Intervention Period||12
1611823|NCT00939731|3941537|P2|STARTED|First Intervention Period||12
1611824|NCT00939731|3941538|P1|STARTED|First Intervention Period||12
1611825|NCT00939705|3941558|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
1611826|NCT00939705|3941559|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
1611827|NCT00939705|3941558|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
1611828|NCT00939705|3941559|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
1611829|NCT00939705|3941558|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
1611830|NCT00939705|3941559|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
1611831|NCT00939705|3941558|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
1611832|NCT00939705|3941559|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
1611833|NCT00939705|3941558|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
1611834|NCT00939705|3941559|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
1611835|NCT00939705|3941558|P2|STARTED|Period 2 - Washout Period - 21 Days||9
1611836|NCT00939705|3941559|P1|STARTED|Period 2 - Washout Period - 21 Days||9
1611837|NCT00939705|3941558|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
1611838|NCT00939705|3941559|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
1611839|NCT00939705|3941558|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
1611840|NCT00939705|3941559|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
1611841|NCT00939705|3941558|P2|STARTED|Period 1 - First Intervention - 5 Days||9
1611842|NCT00939705|3941559|P1|STARTED|Period 1 - First Intervention - 5 Days||9
1611843|NCT00939692|3941571|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
1611844|NCT00939692|3941572|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
1611845|NCT00939692|3941571|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
1611846|NCT00939692|3941572|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
1611847|NCT00939692|3941571|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
1611848|NCT00939692|3941572|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
1611849|NCT00939692|3941571|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
1611850|NCT00939692|3941572|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
1611851|NCT00939692|3941571|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
1611852|NCT00939692|3941572|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
1611853|NCT00939692|3941571|P2|STARTED|Period 1 - First Intervention - 5 Days||13
1611854|NCT00939692|3941572|P1|STARTED|Period 1 - First Intervention - 5 Days||13
1611855|NCT00939640|3941582|P1|NOT COMPLETED|Overall Study||1
1611856|NCT00939640|3941582|P1|COMPLETED|Overall Study||13
1611857|NCT00939640|3941582|P1|STARTED|Overall Study||14
1611858|NCT00939627|3941605|P3|NOT COMPLETED|Overall Study||0
1611859|NCT00939627|3941606|P2|NOT COMPLETED|Overall Study||28
1611860|NCT00939627|3941607|P1|NOT COMPLETED|Overall Study||27
1611861|NCT00939627|3941605|P3|COMPLETED|Overall Study||0
1611862|NCT00939627|3941606|P2|COMPLETED|Overall Study||0
1611863|NCT00939627|3941607|P1|COMPLETED|Overall Study||0
1611864|NCT00939627|3941605|P3|STARTED|Overall Study||0
1611865|NCT00939627|3941606|P2|STARTED|Overall Study||28
1611866|NCT00939627|3941607|P1|STARTED|Overall Study||27
1611867|NCT00939562|3941625|P2|NOT COMPLETED|Period 2||0
1611868|NCT00939562|3941626|P1|NOT COMPLETED|Period 2||0
1611869|NCT00939562|3941625|P2|COMPLETED|Period 2||12
1611870|NCT00939562|3941626|P1|COMPLETED|Period 2||12
1611871|NCT00939562|3941625|P2|STARTED|Period 2||12
1611872|NCT00939562|3941626|P1|STARTED|Period 2||12
1611873|NCT00939562|3941625|P2|NOT COMPLETED|Period 1||0
1611874|NCT00939562|3941626|P1|NOT COMPLETED|Period 1||0
1611875|NCT00939562|3941625|P2|COMPLETED|Period 1||12
1611876|NCT00939562|3941626|P1|COMPLETED|Period 1||12
1611877|NCT00939562|3941625|P2|STARTED|Period 1||12
1611878|NCT00939562|3941626|P1|STARTED|Period 1||12
1611879|NCT00939536|3941636|P2|NOT COMPLETED|Second Intervention||0
1611880|NCT00939536|3941637|P1|NOT COMPLETED|Second Intervention||0
1611881|NCT00939536|3941636|P2|COMPLETED|Second Intervention||12
1611882|NCT00939536|3941637|P1|COMPLETED|Second Intervention||12
1611883|NCT00939536|3941636|P2|STARTED|Second Intervention||12
1611884|NCT00939536|3941637|P1|STARTED|Second Intervention||12
1611885|NCT00939536|3941636|P2|NOT COMPLETED|First Intervention||0
1611886|NCT00939536|3941637|P1|NOT COMPLETED|First Intervention||0
1611887|NCT00939536|3941636|P2|COMPLETED|First Intervention||12
1611888|NCT00939536|3941637|P1|COMPLETED|First Intervention||12
1611889|NCT00939536|3941636|P2|STARTED|First Intervention||12
1611890|NCT00939536|3941637|P1|STARTED|First Intervention||12
1611891|NCT00939510|3941647|P1|NOT COMPLETED|Overall Study||1
1611892|NCT00939510|3941647|P1|COMPLETED|Overall Study||31
1611893|NCT00939510|3941647|P1|STARTED|Overall Study||32
1611894|NCT00939484|3941656|P3|NOT COMPLETED|Overall Study||3
1611895|NCT00939484|3941657|P2|NOT COMPLETED|Overall Study||20
1611896|NCT00939484|3941658|P1|NOT COMPLETED|Overall Study||8
1611897|NCT00939484|3941656|P3|COMPLETED|Overall Study||0
1611898|NCT00939484|3941657|P2|COMPLETED|Overall Study||0
1611899|NCT00939484|3941658|P1|COMPLETED|Overall Study||0
1611900|NCT00939484|3941656|P3|STARTED|Overall Study||3
1611901|NCT00939484|3941657|P2|STARTED|Overall Study||20
1611902|NCT00939484|3941658|P1|STARTED|Overall Study||8
1611903|NCT00939471|3941671|P1|NOT COMPLETED|Overall Study||11
1611904|NCT00939471|3941671|P1|COMPLETED|Overall Study||33
1611905|NCT00939471|3941671|P1|STARTED|Overall Study||44
1611906|NCT00939393|3941684|P2|NOT COMPLETED|Overall Study||0
1611907|NCT00939393|3941685|P1|NOT COMPLETED|Overall Study||4
1611908|NCT00939393|3941684|P2|COMPLETED|Overall Study||35
1611909|NCT00939393|3941685|P1|COMPLETED|Overall Study||33
1611910|NCT00939393|3941684|P2|STARTED|Overall Study||35
1611911|NCT00939393|3941685|P1|STARTED|Overall Study||37
1611912|NCT00939367|3941705|P2|NOT COMPLETED|Second Intervention||0
1611913|NCT00939367|3941706|P1|NOT COMPLETED|Second Intervention||0
1611914|NCT00939367|3941705|P2|COMPLETED|Second Intervention||15
1611915|NCT00939367|3941706|P1|COMPLETED|Second Intervention||15
1611916|NCT00939367|3941705|P2|STARTED|Second Intervention||15
1611917|NCT00939367|3941706|P1|STARTED|Second Intervention||15
1611918|NCT00939367|3941705|P2|NOT COMPLETED|First Intervention||0
1611919|NCT00939367|3941706|P1|NOT COMPLETED|First Intervention||0
1611920|NCT00939367|3941705|P2|COMPLETED|First Intervention||15
1611921|NCT00939367|3941706|P1|COMPLETED|First Intervention||15
1611922|NCT00939367|3941705|P2|STARTED|First Intervention||15
1611923|NCT00939367|3941706|P1|STARTED|First Intervention||15
1611924|NCT00939341|3941716|P1|NOT COMPLETED|Overall Study||66
1611925|NCT00939341|3941716|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
1611926|NCT00939341|3941716|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
1611927|NCT00939211|3941736|P1|NOT COMPLETED|Placebo||0
1611928|NCT00939211|3941736|P1|COMPLETED|Placebo||28
1611929|NCT00939211|3941736|P1|STARTED|Placebo||28
1611930|NCT00939211|3941736|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
1611931|NCT00939211|3941736|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
1611932|NCT00939211|3941736|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
1611933|NCT00939211|3941736|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
1611934|NCT00939211|3941736|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
1611935|NCT00939211|3941736|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
1611936|NCT00939211|3941736|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
1611937|NCT00939211|3941736|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
1611938|NCT00939211|3941736|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
1611939|NCT00939211|3941736|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
1611940|NCT00939211|3941736|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
1611941|NCT00939211|3941736|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
1611942|NCT00939198|3941798|P1|NOT COMPLETED|Overall Study||0
1611943|NCT00939198|3941798|P1|COMPLETED|Overall Study||87
1611944|NCT00939198|3941798|P1|STARTED|Overall Study||87
1611945|NCT00939185|3941803|P1|NOT COMPLETED|Overall Study||25
1611946|NCT00939185|3941803|P1|COMPLETED|Overall Study||375
1611947|NCT00939185|3941803|P1|Received Treatment|Overall Study||390
1611948|NCT00939185|3941803|P1|STARTED|Overall Study||400
1611949|NCT00939159|3941810|P1|NOT COMPLETED|Overall Study||0
1611950|NCT00939159|3941810|P1|COMPLETED|Overall Study||13
1611951|NCT00939159|3941810|P1|STARTED|Overall Study||13
1611952|NCT00939120|3941816|P2|NOT COMPLETED|Overall Study||5
1611953|NCT00939120|3941817|P1|NOT COMPLETED|Overall Study||8
1611954|NCT00939120|3941816|P2|COMPLETED|Overall Study||18
1611955|NCT00939120|3941817|P1|COMPLETED|Overall Study||15
1611956|NCT00939120|3941816|P2|STARTED|Overall Study||23
1611957|NCT00939120|3941817|P1|STARTED|Overall Study||23
1611958|NCT00939107|3941841|P2|NOT COMPLETED|Overall Study||12
1611959|NCT00939107|3941842|P1|NOT COMPLETED|Overall Study||14
1611960|NCT00939107|3941841|P2|COMPLETED|Overall Study||163
1611961|NCT00939107|3941842|P1|COMPLETED|Overall Study||161
1611962|NCT00939107|3941841|P2|12 Months Follow-up|Overall Study||163
1611963|NCT00939107|3941842|P1|12 Months Follow-up|Overall Study||161
1611964|NCT00939107|3941841|P2|STARTED|Overall Study||175
1611965|NCT00939107|3941842|P1|STARTED|Overall Study||175
1611966|NCT00939094|3941856|P2|NOT COMPLETED|Overall Study||10
1611967|NCT00939094|3941857|P1|NOT COMPLETED|Overall Study||14
1611968|NCT00939094|3941856|P2|COMPLETED|Overall Study||35
1611969|NCT00939094|3941857|P1|COMPLETED|Overall Study||28
1611970|NCT00939094|3941856|P2|STARTED|Overall Study||45
1611971|NCT00939094|3941857|P1|STARTED|Overall Study||42
1611972|NCT00939055|3941879|P2|NOT COMPLETED|Overall Study||0
1611973|NCT00939055|3941880|P1|NOT COMPLETED|Overall Study||4
1611974|NCT00939055|3941879|P2|COMPLETED|Overall Study||39
1611975|NCT00939055|3941880|P1|COMPLETED|Overall Study||69
1611976|NCT00939055|3941879|P2|STARTED|Overall Study||39
1611977|NCT00939055|3941880|P1|STARTED|Overall Study||73
1611978|NCT00939029|3941890|P2|NOT COMPLETED|Overall Study||12
1611979|NCT00939029|3941891|P1|NOT COMPLETED|Overall Study||6
1611980|NCT00939029|3941890|P2|COMPLETED|Overall Study||15
1611981|NCT00939029|3941891|P1|COMPLETED|Overall Study||19
1611982|NCT00939029|3941890|P2|STARTED|Overall Study||27
1611983|NCT00939029|3941891|P1|STARTED|Overall Study||25
1611984|NCT00939003|3941903|P2|NOT COMPLETED|Open-label Treatment Period||29
1611985|NCT00939003|3941904|P1|NOT COMPLETED|Open-label Treatment Period||29
1611986|NCT00939003|3941903|P2|COMPLETED|Open-label Treatment Period||62
1611987|NCT00939003|3941904|P1|COMPLETED|Open-label Treatment Period||66
1611988|NCT00939003|3941903|P2|STARTED|Open-label Treatment Period||91
1611989|NCT00939003|3941904|P1|STARTED|Open-label Treatment Period||95
1611990|NCT00939003|3941903|P2|NOT COMPLETED|Double-blind Treatment Period||4
1611991|NCT00939003|3941904|P1|NOT COMPLETED|Double-blind Treatment Period||2
1611992|NCT00939003|3941903|P2|COMPLETED|Double-blind Treatment Period||91
1611993|NCT00939003|3941904|P1|COMPLETED|Double-blind Treatment Period||95
1611994|NCT00939003|3941903|P2|STARTED|Double-blind Treatment Period||95
1611995|NCT00939003|3941904|P1|STARTED|Double-blind Treatment Period||97
1611996|NCT00938964|3941941|P2|NOT COMPLETED|Overall Study||28
1611997|NCT00938964|3941942|P1|NOT COMPLETED|Overall Study||30
1611998|NCT00938964|3941941|P2|COMPLETED|Overall Study||209
1611999|NCT00938964|3941942|P1|COMPLETED|Overall Study||211
1612000|NCT00938964|3941941|P2|STARTED|Overall Study||237
1612001|NCT00938964|3941942|P1|STARTED|Overall Study||241
1612002|NCT00938886|3942006|P2|NOT COMPLETED|Overall Study||10
1612003|NCT00938886|3942007|P1|NOT COMPLETED|Overall Study||7
1612004|NCT00938886|3942006|P2|COMPLETED|Overall Study||65
1612005|NCT00938886|3942007|P1|COMPLETED|Overall Study||68
1612006|NCT00938886|3942006|P2|Attended 1 Counseling Session|Overall Study||70
1612007|NCT00938886|3942007|P1|Attended 1 Counseling Session|Overall Study||70
1612008|NCT00938886|3942006|P2|STARTED|Overall Study||75
1612009|NCT00938886|3942007|P1|STARTED|Overall Study||75
1612010|NCT00938860|3942017|P2|NOT COMPLETED|Overall Study||17
1612011|NCT00938860|3942018|P1|NOT COMPLETED|Overall Study||25
1612012|NCT00938860|3942017|P2|COMPLETED|Overall Study||25
1612013|NCT00938860|3942018|P1|COMPLETED|Overall Study||25
1612014|NCT00938860|3942017|P2|Efficacy Population|Overall Study||41
1612015|NCT00938860|3942018|P1|Efficacy Population|Overall Study||40
1612016|NCT00938860|3942017|P2|STARTED|Overall Study||42
1612017|NCT00938860|3942018|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
1612018|NCT00938782|3942042|P2|NOT COMPLETED|Overall Study||0
1612019|NCT00938782|3942043|P1|NOT COMPLETED|Overall Study||0
1612020|NCT00938782|3942042|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
1612021|NCT00938782|3942043|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
1612022|NCT00938782|3942042|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
1612023|NCT00938782|3942043|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
1612024|NCT00938717|3942051|P2|NOT COMPLETED|Overall Study||108
1612025|NCT00938717|3942052|P1|NOT COMPLETED|Overall Study||98
1612026|NCT00938717|3942051|P2|COMPLETED|Overall Study||294
1612027|NCT00938717|3942052|P1|COMPLETED|Overall Study||305
1612028|NCT00938717|3942051|P2|STARTED|Overall Study||402
1612029|NCT00938717|3942052|P1|STARTED|Overall Study||403
1612030|NCT00938704|3942086|P2|NOT COMPLETED|Overall Study||0
1612031|NCT00938704|3942087|P1|NOT COMPLETED|Overall Study||0
1612032|NCT00938704|3942086|P2|COMPLETED|Overall Study||37
1612033|NCT00938704|3942087|P1|COMPLETED|Overall Study||33
1612034|NCT00938704|3942086|P2|STARTED|Overall Study||37
1612035|NCT00938704|3942087|P1|STARTED|Overall Study||33
1612036|NCT00938639|3942103|P2|NOT COMPLETED|Overall Study||4
1612037|NCT00938639|3942104|P1|NOT COMPLETED|Overall Study||3
1612038|NCT00938639|3942103|P2|COMPLETED|Overall Study||116
1612039|NCT00938639|3942104|P1|COMPLETED|Overall Study||117
1612040|NCT00938639|3942103|P2|STARTED|Overall Study||120
1612041|NCT00938639|3942104|P1|STARTED|Overall Study||120
1612042|NCT00938548|3942174|P2|NOT COMPLETED|Overall Study||0
1612043|NCT00938548|3942175|P1|NOT COMPLETED|Overall Study||0
1612044|NCT00938548|3942174|P2|COMPLETED|Overall Study||35
1612045|NCT00938548|3942175|P1|COMPLETED|Overall Study||35
1612046|NCT00938548|3942174|P2|STARTED|Overall Study||35
1612047|NCT00938548|3942175|P1|STARTED|Overall Study||35
1612048|NCT00938470|3942187|P2|NOT COMPLETED|Overall Study||3
1612049|NCT00938470|3942188|P1|NOT COMPLETED|Overall Study||7
1612050|NCT00938470|3942187|P2|COMPLETED|Overall Study||25
1612051|NCT00938470|3942188|P1|COMPLETED|Overall Study||27
1612052|NCT00938470|3942187|P2|STARTED|Overall Study||28
1612053|NCT00938470|3942188|P1|STARTED|Overall Study||34
1612054|NCT00938457|3942202|P1|NOT COMPLETED|Overall Study||0
1612055|NCT00938457|3942202|P1|COMPLETED|Overall Study||3
1612056|NCT00938457|3942202|P1|STARTED|Overall Study||3
1612057|NCT00938431|3942218|P3|NOT COMPLETED|Overall Study||8
1612058|NCT00938431|3942219|P2|NOT COMPLETED|Overall Study||9
1612059|NCT00938431|3942220|P1|NOT COMPLETED|Overall Study||6
1612060|NCT00938431|3942218|P3|COMPLETED|Overall Study||1
1612061|NCT00938431|3942219|P2|COMPLETED|Overall Study||14
1612062|NCT00938431|3942220|P1|COMPLETED|Overall Study||9
1612063|NCT00938431|3942218|P3|STARTED|Overall Study||9
1612064|NCT00938431|3942219|P2|STARTED|Overall Study||23
1612065|NCT00938431|3942220|P1|STARTED|Overall Study||15
1612066|NCT00938392|3942247|P2|NOT COMPLETED|Overall Study||4
1612067|NCT00938392|3942248|P1|NOT COMPLETED|Overall Study||2
1612068|NCT00938392|3942247|P2|COMPLETED|Overall Study||358
1612069|NCT00938392|3942248|P1|COMPLETED|Overall Study||360
1612070|NCT00938392|3942247|P2|STARTED|Overall Study||362
1612071|NCT00938392|3942248|P1|STARTED|Overall Study||362
1612072|NCT00938366|3942274|P2|NOT COMPLETED|Overall Study||0
1612073|NCT00938366|3942275|P1|NOT COMPLETED|Overall Study||1
1612074|NCT00938366|3942274|P2|COMPLETED|Overall Study||9
1612075|NCT00938366|3942275|P1|COMPLETED|Overall Study||8
1612076|NCT00938366|3942274|P2|STARTED|Overall Study||9
1612077|NCT00938366|3942275|P1|STARTED|Overall Study||9
1612078|NCT00938340|3942295|P1|NOT COMPLETED|Overall Study||5
1612079|NCT00938340|3942295|P1|COMPLETED|Overall Study||15
1612080|NCT00938340|3942295|P1|Received Walnut Oil Intervention|Overall Study||15
1612081|NCT00938340|3942295|P1|Received Walnut Skins Intervention|Overall Study||15
1612082|NCT00938340|3942295|P1|Received Walnut Nutmeat Intervention|Overall Study||19
1612083|NCT00938340|3942295|P1|Received Whole Walnut Intervention|Overall Study||16
1612084|NCT00938340|3942295|P1|STARTED|Overall Study||20
1612085|NCT00938327|3942425|P1|NOT COMPLETED|Overall Study||60
1612086|NCT00938327|3942425|P1|COMPLETED|Overall Study||272
1612087|NCT00938327|3942425|P1|STARTED|Overall Study||332
1612088|NCT00938314|3942436|P4|NOT COMPLETED|Cohort 3||1
1612089|NCT00938314|3942437|P3|NOT COMPLETED|Cohort 3||4
1612090|NCT00938314|3942438|P2|NOT COMPLETED|Cohort 3||0
1612091|NCT00938314|3942439|P1|NOT COMPLETED|Cohort 3||0
1612092|NCT00938314|3942436|P4|COMPLETED|Cohort 3||7
1612093|NCT00938314|3942437|P3|COMPLETED|Cohort 3||20
1612094|NCT00938314|3942438|P2|COMPLETED|Cohort 3||0
1612095|NCT00938314|3942439|P1|COMPLETED|Cohort 3||0
1612096|NCT00938314|3942436|P4|STARTED|Cohort 3||8
1612097|NCT00938314|3942437|P3|STARTED|Cohort 3||24
1612098|NCT00938314|3942438|P2|STARTED|Cohort 3||0
1612099|NCT00938314|3942439|P1|STARTED|Cohort 3||0
1612100|NCT00938314|3942436|P4|NOT COMPLETED|Cohort 2||2
1612101|NCT00938314|3942437|P3|NOT COMPLETED|Cohort 2||0
1612102|NCT00938314|3942438|P2|NOT COMPLETED|Cohort 2||6
1612103|NCT00938314|3942439|P1|NOT COMPLETED|Cohort 2||0
1612104|NCT00938314|3942436|P4|COMPLETED|Cohort 2||6
1612105|NCT00938314|3942437|P3|COMPLETED|Cohort 2||0
1612106|NCT00938314|3942438|P2|COMPLETED|Cohort 2||18
1612107|NCT00938314|3942439|P1|COMPLETED|Cohort 2||0
1612108|NCT00938314|3942436|P4|STARTED|Cohort 2||8
1612109|NCT00938314|3942437|P3|STARTED|Cohort 2||0
1612110|NCT00938314|3942438|P2|STARTED|Cohort 2||24
1612111|NCT00938314|3942439|P1|STARTED|Cohort 2||0
1612112|NCT00938314|3942436|P4|NOT COMPLETED|Cohort 1||2
1612113|NCT00938314|3942437|P3|NOT COMPLETED|Cohort 1||0
1612114|NCT00938314|3942438|P2|NOT COMPLETED|Cohort 1||0
1612115|NCT00938314|3942439|P1|NOT COMPLETED|Cohort 1||2
1612116|NCT00938314|3942436|P4|COMPLETED|Cohort 1||6
1612117|NCT00938314|3942437|P3|COMPLETED|Cohort 1||0
1612118|NCT00938314|3942438|P2|COMPLETED|Cohort 1||0
1612119|NCT00938314|3942439|P1|COMPLETED|Cohort 1||22
1612120|NCT00938314|3942436|P4|STARTED|Cohort 1||8
1612121|NCT00938314|3942437|P3|STARTED|Cohort 1||0
1612122|NCT00938314|3942438|P2|STARTED|Cohort 1||0
1612123|NCT00938314|3942439|P1|STARTED|Cohort 1||24
1612124|NCT00938041|3942493|P1|NOT COMPLETED|Overall Study||27
1612125|NCT00938041|3942493|P1|COMPLETED|Overall Study||5
1612126|NCT00938041|3942493|P1|STARTED|Overall Study||32
1612127|NCT00938015|3942502|P1|NOT COMPLETED|Overall Study||147
1612128|NCT00938015|3942502|P1|COMPLETED|Overall Study||156
1612129|NCT00938015|3942502|P1|STARTED|Overall Study||303
1612130|NCT00937950|3942518|P1|NOT COMPLETED|Overall Study||216
1612131|NCT00937950|3942518|P1|COMPLETED|Overall Study||1787
1612132|NCT00937950|3942518|P1|STARTED|Overall Study||2003
1612133|NCT00937937|3942534|P1|NOT COMPLETED|Overall Study||72
1612134|NCT00937937|3942534|P1|COMPLETED|Overall Study||0
1612135|NCT00937937|3942534|P1|STARTED|Overall Study||72
1612136|NCT00937833|3942543|P2|NOT COMPLETED|Overall Study||17
1612137|NCT00937833|3942544|P1|NOT COMPLETED|Overall Study||15
1612138|NCT00937833|3942543|P2|COMPLETED|Overall Study||60
1612139|NCT00937833|3942544|P1|COMPLETED|Overall Study||58
1612140|NCT00937833|3942543|P2|STARTED|Overall Study||77
1612141|NCT00937833|3942544|P1|STARTED|Overall Study||73
1612142|NCT00937794|3942550|P1|NOT COMPLETED|Overall Study||0
1612143|NCT00937794|3942550|P1|COMPLETED|Overall Study||33
1612144|NCT00937794|3942550|P1|STARTED|Overall Study||33
1612145|NCT00937768|3942557|P2|NOT COMPLETED|Overall Study||8
1612146|NCT00937768|3942558|P1|NOT COMPLETED|Overall Study||8
1612147|NCT00937768|3942557|P2|COMPLETED|Overall Study||0
1612148|NCT00937768|3942558|P1|COMPLETED|Overall Study||0
1612149|NCT00937768|3942557|P2|STARTED|Overall Study||8
1612150|NCT00937768|3942558|P1|STARTED|Overall Study||8
1612151|NCT00937560|3942564|P1|NOT COMPLETED|Maintenance Treatment||18
1612152|NCT00937560|3942564|P1|COMPLETED|Maintenance Treatment||150
1612153|NCT00937560|3942564|P1|STARTED|Maintenance Treatment||168
1612154|NCT00937560|3942564|P1|NOT COMPLETED|Initial Treatment||21
1612155|NCT00937560|3942564|P1|COMPLETED|Initial Treatment||168
1612156|NCT00937560|3942564|P1|Received Treatment|Initial Treatment||189
1612157|NCT00937560|3942564|P1|STARTED|Initial Treatment||189
1612158|NCT00937547|3942575|P3|NOT COMPLETED|Overall Study||7
1612159|NCT00937547|3942576|P2|NOT COMPLETED|Overall Study||6
1612160|NCT00937547|3942577|P1|NOT COMPLETED|Overall Study||1
1612161|NCT00937547|3942575|P3|COMPLETED|Overall Study||142
1612162|NCT00937547|3942576|P2|COMPLETED|Overall Study||78
1612163|NCT00937547|3942577|P1|COMPLETED|Overall Study||95
1612164|NCT00937547|3942575|P3|Histological Samples|Overall Study||142
1612165|NCT00937547|3942576|P2|Histological Samples|Overall Study||78
1612166|NCT00937547|3942577|P1|Histological Samples|Overall Study||95
1612167|NCT00937547|3942575|P3|STARTED|Overall Study||149
1612168|NCT00937547|3942576|P2|STARTED|Overall Study||84
1612169|NCT00937547|3942577|P1|STARTED|Overall Study||96
1612170|NCT00937521|3942614|P8|NOT COMPLETED|Booster Phase||2
1612171|NCT00937521|3942615|P7|NOT COMPLETED|Booster Phase||5
1612172|NCT00937521|3942616|P6|NOT COMPLETED|Booster Phase||5
1612173|NCT00937521|3942617|P5|NOT COMPLETED|Booster Phase||5
1612174|NCT00937521|3942618|P4|NOT COMPLETED|Booster Phase||3
1612175|NCT00937521|3942619|P3|NOT COMPLETED|Booster Phase||5
1612176|NCT00937521|3942620|P2|NOT COMPLETED|Booster Phase||2
1612177|NCT00937521|3942621|P1|NOT COMPLETED|Booster Phase||3
1612178|NCT00937521|3942614|P8|COMPLETED|Booster Phase||159
1612179|NCT00937521|3942615|P7|COMPLETED|Booster Phase||160
1612180|NCT00937521|3942616|P6|COMPLETED|Booster Phase||160
1612181|NCT00937521|3942617|P5|COMPLETED|Booster Phase||163
1612182|NCT00937521|3942618|P4|COMPLETED|Booster Phase||167
1612183|NCT00937521|3942619|P3|COMPLETED|Booster Phase||164
1612184|NCT00937521|3942620|P2|COMPLETED|Booster Phase||161
1612185|NCT00937521|3942621|P1|COMPLETED|Booster Phase||152
1612186|NCT00937521|3942614|P8|Premature Withdrawal|Booster Phase||2
1612187|NCT00937521|3942615|P7|Premature Withdrawal|Booster Phase||5
1612188|NCT00937521|3942616|P6|Premature Withdrawal|Booster Phase||5
1612189|NCT00937521|3942617|P5|Premature Withdrawal|Booster Phase||5
1612190|NCT00937521|3942618|P4|Premature Withdrawal|Booster Phase||3
1612191|NCT00937521|3942619|P3|Premature Withdrawal|Booster Phase||5
1612192|NCT00937521|3942620|P2|Premature Withdrawal|Booster Phase||2
1612193|NCT00937521|3942621|P1|Premature Withdrawal|Booster Phase||3
1612194|NCT00937521|3942614|P8|STARTED|Booster Phase||161
1612195|NCT00937521|3942615|P7|STARTED|Booster Phase||165
1612196|NCT00937521|3942616|P6|STARTED|Booster Phase||165
1612197|NCT00937521|3942617|P5|STARTED|Booster Phase||168
1612198|NCT00937521|3942618|P4|STARTED|Booster Phase||170
1612199|NCT00937521|3942619|P3|STARTED|Booster Phase||169
1612200|NCT00937521|3942620|P2|STARTED|Booster Phase||163
1612201|NCT00937521|3942621|P1|STARTED|Booster Phase||155
1612202|NCT00937521|3942614|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
1612203|NCT00937521|3942615|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
1612204|NCT00937521|3942616|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
1612205|NCT00937521|3942617|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
1612206|NCT00937521|3942618|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
1612207|NCT00937521|3942619|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
1612208|NCT00937521|3942620|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
1612209|NCT00937521|3942621|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
1612210|NCT00937521|3942614|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
1612211|NCT00937521|3942615|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
1612212|NCT00937521|3942616|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
1612213|NCT00937521|3942617|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
1612214|NCT00937521|3942618|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
1612215|NCT00937521|3942619|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
1612216|NCT00937521|3942620|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
1612217|NCT00937521|3942621|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
1612218|NCT00937521|3942614|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
1612219|NCT00937521|3942615|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
1612220|NCT00937521|3942616|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
1612221|NCT00937521|3942617|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
1612222|NCT00937521|3942618|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
1612223|NCT00937521|3942619|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
1612224|NCT00937521|3942620|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
1612225|NCT00937521|3942621|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
1612226|NCT00937521|3942614|P8|STARTED|Overall Study - Prior to Booster Dose||184
1612227|NCT00937521|3942615|P7|STARTED|Overall Study - Prior to Booster Dose||186
1612228|NCT00937521|3942616|P6|STARTED|Overall Study - Prior to Booster Dose||188
1612229|NCT00937521|3942617|P5|STARTED|Overall Study - Prior to Booster Dose||191
1612230|NCT00937521|3942618|P4|STARTED|Overall Study - Prior to Booster Dose||188
1612231|NCT00937521|3942619|P3|STARTED|Overall Study - Prior to Booster Dose||192
1612232|NCT00937521|3942620|P2|STARTED|Overall Study - Prior to Booster Dose||190
1612233|NCT00937521|3942621|P1|STARTED|Overall Study - Prior to Booster Dose||188
1612234|NCT00937495|3942727|P1|NOT COMPLETED|Overall Study||2
1612235|NCT00937495|3942727|P1|COMPLETED|Overall Study||14
1612236|NCT00937495|3942727|P1|STARTED|Overall Study||16
1612237|NCT00937404|3942733|P1|NOT COMPLETED|Overall Study||2
1612238|NCT00937404|3942733|P1|COMPLETED|Overall Study||23
1612239|NCT00937404|3942733|P1|STARTED|Overall Study||25
1612240|NCT00937391|3942742|P1|NOT COMPLETED|Stage 2||1
1612241|NCT00937391|3942742|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
1612242|NCT00937391|3942742|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
1612243|NCT00937391|3942742|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
1612244|NCT00937391|3942742|P1|NOT COMPLETED|Stage 1||0
1612245|NCT00937391|3942742|P1|COMPLETED|Stage 1||20
1612246|NCT00937391|3942742|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
1612247|NCT00937391|3942742|P1|STARTED|Stage 1||20
1612248|NCT00937326|3942798|P5|NOT COMPLETED|Overall Study||5
1612249|NCT00937326|3942799|P4|NOT COMPLETED|Overall Study||5
1612250|NCT00937326|3942800|P3|NOT COMPLETED|Overall Study||4
1612251|NCT00937326|3942801|P2|NOT COMPLETED|Overall Study||7
1612252|NCT00937326|3942802|P1|NOT COMPLETED|Overall Study||3
1612253|NCT00937326|3942798|P5|COMPLETED|Overall Study||40
1612254|NCT00937326|3942799|P4|COMPLETED|Overall Study||40
1612255|NCT00937326|3942800|P3|COMPLETED|Overall Study||42
1612256|NCT00937326|3942801|P2|COMPLETED|Overall Study||38
1612257|NCT00937326|3942802|P1|COMPLETED|Overall Study||43
1612258|NCT00937326|3942798|P5|STARTED|Overall Study||45
1612259|NCT00937326|3942799|P4|STARTED|Overall Study||45
1612260|NCT00937326|3942800|P3|STARTED|Overall Study||46
1612261|NCT00937326|3942801|P2|STARTED|Overall Study||45
1612262|NCT00937326|3942802|P1|STARTED|Overall Study||46
1612263|NCT00937235|3943030|P2|NOT COMPLETED|Overall Study||0
1612264|NCT00937235|3943031|P1|NOT COMPLETED|Overall Study||0
1612265|NCT00937235|3943030|P2|COMPLETED|Overall Study||70
1612266|NCT00937235|3943031|P1|COMPLETED|Overall Study||72
1612267|NCT00937235|3943030|P2|STARTED|Overall Study||70
1612268|NCT00937235|3943031|P1|STARTED|Overall Study||72
1612269|NCT00937157|3943051|P1|NOT COMPLETED|Overall Study||4
1612270|NCT00937157|3943051|P1|COMPLETED|Overall Study||8
1612271|NCT00937157|3943051|P1|STARTED|Overall Study||12
1612272|NCT00937118|3943055|P1|NOT COMPLETED|Overall Study||0
1612273|NCT00937118|3943055|P1|COMPLETED|Overall Study||41
1612274|NCT00937118|3943055|P1|STARTED|Overall Study||41
1612275|NCT00937105|3943064|P2|NOT COMPLETED|Overall Study||39
1612276|NCT00937105|3943065|P1|NOT COMPLETED|Overall Study||40
1612277|NCT00937105|3943064|P2|COMPLETED|Overall Study||70
1612278|NCT00937105|3943065|P1|COMPLETED|Overall Study||69
1612279|NCT00937105|3943064|P2|STARTED|Overall Study||109
1612280|NCT00937105|3943065|P1|STARTED|Overall Study||109
1612281|NCT00937040|3943082|P2|NOT COMPLETED|Overall Study||37
1612282|NCT00937040|3943083|P1|NOT COMPLETED|Overall Study||41
1612283|NCT00937040|3943082|P2|COMPLETED|Overall Study||141
1612284|NCT00937040|3943083|P1|COMPLETED|Overall Study||138
1612285|NCT00937040|3943082|P2|STARTED|Overall Study||178
1612286|NCT00937040|3943083|P1|STARTED|Overall Study||179
1612287|NCT00936975|3943125|P1|NOT COMPLETED|Overall Study||6
1612288|NCT00936975|3943125|P1|COMPLETED|Overall Study||12
1612289|NCT00936975|3943125|P1|STARTED|Overall Study||18
1612290|NCT00936910|3943134|P1|NOT COMPLETED|Overall Study||3
1612291|NCT00936910|3943134|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
1612292|NCT00936910|3943134|P1|STARTED|Overall Study||13
1612293|NCT00936897|3943143|P2|NOT COMPLETED|Overall Study||60
1612294|NCT00936897|3943144|P1|NOT COMPLETED|Overall Study||19
1612295|NCT00936897|3943143|P2|COMPLETED|Overall Study||356
1612296|NCT00936897|3943144|P1|COMPLETED|Overall Study||398
1612297|NCT00936897|3943143|P2|STARTED|Overall Study|Randomized|416
1612298|NCT00936897|3943144|P1|STARTED|Overall Study|Randomized|417
1612299|NCT00936741|3943156|P1|NOT COMPLETED|Overall Study||9
1612300|NCT00936741|3943156|P1|COMPLETED|Overall Study||21
1612301|NCT00936741|3943156|P1|STARTED|Overall Study||30
1612302|NCT00936715|3943161|P1|NOT COMPLETED|Overall Study||6
1612303|NCT00936715|3943161|P1|COMPLETED|Overall Study||18
1612304|NCT00936715|3943161|P1|STARTED|Overall Study||24
1612305|NCT00936702|3943165|P1|NOT COMPLETED|Overall Study||46
1612306|NCT00936702|3943165|P1|COMPLETED|Overall Study||0
1612307|NCT00936702|3943165|P1|STARTED|Overall Study||46
1612308|NCT00936663|3943175|P2|NOT COMPLETED|Overall Study||0
1612309|NCT00936663|3943176|P1|NOT COMPLETED|Overall Study||0
1612310|NCT00936663|3943175|P2|COMPLETED|Overall Study||2
1612311|NCT00936663|3943176|P1|COMPLETED|Overall Study||1
1612312|NCT00936663|3943175|P2|STARTED|Overall Study||2
1612313|NCT00936663|3943176|P1|STARTED|Overall Study||1
1612314|NCT00936598|3943198|P2|NOT COMPLETED|Overall Study||0
1612315|NCT00936598|3943199|P1|NOT COMPLETED|Overall Study||2
1612316|NCT00936598|3943198|P2|COMPLETED|Overall Study||1
1612317|NCT00936598|3943199|P1|COMPLETED|Overall Study||2
1612318|NCT00936598|3943198|P2|STARTED|Overall Study||1
1612319|NCT00936598|3943199|P1|STARTED|Overall Study||4
1612320|NCT00936585|3943209|P1|NOT COMPLETED|Overall Study||0
1612321|NCT00936585|3943209|P1|COMPLETED|Overall Study||2
1612322|NCT00936585|3943209|P1|STARTED|Overall Study||2
1612323|NCT00936481|3943215|P2|NOT COMPLETED|Overall Study||0
1612324|NCT00936481|3943216|P1|NOT COMPLETED|Overall Study||0
1612325|NCT00936481|3943215|P2|COMPLETED|Overall Study||17
1612326|NCT00936481|3943216|P1|COMPLETED|Overall Study||17
1612327|NCT00936481|3943215|P2|STARTED|Overall Study||17
1612328|NCT00936481|3943216|P1|STARTED|Overall Study||17
1612329|NCT00936455|3943226|P2|NOT COMPLETED|Overall Study||0
1612330|NCT00936455|3943227|P1|NOT COMPLETED|Overall Study||0
1612331|NCT00936455|3943226|P2|COMPLETED|Overall Study||38
1612332|NCT00936455|3943227|P1|COMPLETED|Overall Study||37
1612333|NCT00936455|3943226|P2|STARTED|Overall Study||38
1612334|NCT00936455|3943227|P1|STARTED|Overall Study||37
1612335|NCT00936377|3943242|P3|NOT COMPLETED|Overall Study||0
1612336|NCT00936377|3943243|P2|NOT COMPLETED|Overall Study||0
1612337|NCT00936377|3943244|P1|NOT COMPLETED|Overall Study||0
1612338|NCT00936377|3943242|P3|COMPLETED|Overall Study||8
1612339|NCT00936377|3943243|P2|COMPLETED|Overall Study||8
1612340|NCT00936377|3943244|P1|COMPLETED|Overall Study||8
1612341|NCT00936377|3943242|P3|STARTED|Overall Study||8
1612342|NCT00936377|3943243|P2|STARTED|Overall Study||8
1612343|NCT00936377|3943244|P1|STARTED|Overall Study||8
1612344|NCT00936351|3943275|P2|NOT COMPLETED|Overall Study||2
1612345|NCT00936351|3943276|P1|NOT COMPLETED|Overall Study||3
1612346|NCT00936351|3943275|P2|COMPLETED|Overall Study||14
1612347|NCT00936351|3943276|P1|COMPLETED|Overall Study||15
1612348|NCT00936351|3943275|P2|STARTED|Overall Study||16
1612349|NCT00936351|3943276|P1|STARTED|Overall Study||18
1612350|NCT00936221|3943288|P2|NOT COMPLETED|Overall Study||1
1612351|NCT00936221|3943289|P1|NOT COMPLETED|Overall Study||1
1612352|NCT00936221|3943288|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
1612353|NCT00936221|3943289|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
1612354|NCT00936221|3943288|P2|Received Treatment|Overall Study||45
1612355|NCT00936221|3943289|P1|Received Treatment|Overall Study||44
1612356|NCT00936221|3943288|P2|STARTED|Overall Study||46
1612357|NCT00936221|3943289|P1|STARTED|Overall Study||45
1612358|NCT00936208|3943303|P2|NOT COMPLETED|Overall Study||22
1612359|NCT00936208|3943304|P1|NOT COMPLETED|Overall Study||37
1612360|NCT00936208|3943303|P2|COMPLETED|Overall Study||1574
1612361|NCT00936208|3943304|P1|COMPLETED|Overall Study||1462
1612362|NCT00936208|3943303|P2|STARTED|Overall Study||1596
1612363|NCT00936208|3943304|P1|STARTED|Overall Study||1499
1612364|NCT00936117|3943322|P1|NOT COMPLETED|Overall Study||10
1612365|NCT00936117|3943322|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
1612366|NCT00936117|3943322|P1|STARTED|Overall Study||20
1612367|NCT00936065|3943330|P3|NOT COMPLETED|Overall Study||7
1612368|NCT00936065|3943331|P2|NOT COMPLETED|Overall Study||4
1612369|NCT00936065|3943332|P1|NOT COMPLETED|Overall Study||4
1612370|NCT00936065|3943330|P3|COMPLETED|Overall Study||12
1612371|NCT00936065|3943331|P2|COMPLETED|Overall Study||16
1612372|NCT00936065|3943332|P1|COMPLETED|Overall Study||17
1612373|NCT00936065|3943330|P3|Study Assessments Performed|Overall Study||18
1612374|NCT00936065|3943331|P2|Study Assessments Performed|Overall Study||19
1612375|NCT00936065|3943332|P1|Study Assessments Performed|Overall Study||21
1612376|NCT00936065|3943330|P3|Received Treatment|Overall Study||18
1612377|NCT00936065|3943331|P2|Received Treatment|Overall Study||20
1612378|NCT00936065|3943332|P1|Received Treatment|Overall Study||21
1612379|NCT00936065|3943330|P3|STARTED|Overall Study||19
1612380|NCT00936065|3943331|P2|STARTED|Overall Study||20
1612381|NCT00936065|3943332|P1|STARTED|Overall Study||21
1612382|NCT00935883|3943438|P2|NOT COMPLETED|Follow-Up Period||0
1612383|NCT00935883|3943439|P1|NOT COMPLETED|Follow-Up Period||0
1612384|NCT00935883|3943438|P2|COMPLETED|Follow-Up Period||38
1612385|NCT00935883|3943439|P1|COMPLETED|Follow-Up Period||19
1612386|NCT00935883|3943438|P2|STARTED|Follow-Up Period||38
1612387|NCT00935883|3943439|P1|STARTED|Follow-Up Period||19
1612388|NCT00935883|3943438|P2|NOT COMPLETED|Treatment Period||2
1612389|NCT00935883|3943439|P1|NOT COMPLETED|Treatment Period||1
1612390|NCT00935883|3943438|P2|COMPLETED|Treatment Period||38
1612391|NCT00935883|3943439|P1|COMPLETED|Treatment Period||19
1612392|NCT00935883|3943438|P2|STARTED|Treatment Period||40
1612393|NCT00935883|3943439|P1|STARTED|Treatment Period||20
1612394|NCT00935857|3943453|P2|NOT COMPLETED|Overall Study||0
1612395|NCT00935857|3943454|P1|NOT COMPLETED|Overall Study||0
1612396|NCT00935857|3943453|P2|COMPLETED|Overall Study||16
1612397|NCT00935857|3943454|P1|COMPLETED|Overall Study||14
1612398|NCT00935857|3943453|P2|STARTED|Overall Study||16
1612399|NCT00935857|3943454|P1|STARTED|Overall Study||14
1612400|NCT00935818|3943466|P2|NOT COMPLETED|Overall Study||100
1612401|NCT00935818|3943467|P1|NOT COMPLETED|Overall Study||91
1612402|NCT00935818|3943466|P2|COMPLETED|Overall Study||157
1612403|NCT00935818|3943467|P1|COMPLETED|Overall Study||158
1612404|NCT00935818|3943466|P2|End of Medication Phase|Overall Study||184
1612405|NCT00935818|3943467|P1|End of Medication Phase|Overall Study||182
1612406|NCT00935818|3943466|P2|STARTED|Overall Study||257
1612407|NCT00935818|3943467|P1|STARTED|Overall Study||249
1612408|NCT00935792|3943488|P3|NOT COMPLETED|Overall Study||0
1612409|NCT00935792|3943489|P2|NOT COMPLETED|Overall Study||3
1612410|NCT00935792|3943490|P1|NOT COMPLETED|Overall Study||1
1612411|NCT00935792|3943488|P3|COMPLETED|Overall Study||12
1612412|NCT00935792|3943489|P2|COMPLETED|Overall Study||6
1612413|NCT00935792|3943490|P1|COMPLETED|Overall Study||6
1612414|NCT00935792|3943488|P3|STARTED|Overall Study||12
1612415|NCT00935792|3943489|P2|STARTED|Overall Study||9
1612416|NCT00935792|3943490|P1|STARTED|Overall Study||7
1612417|NCT00935766|3943507|P2|NOT COMPLETED|Overall Study||7
1612418|NCT00935766|3943508|P1|NOT COMPLETED|Overall Study||7
1612419|NCT00935766|3943507|P2|COMPLETED|Overall Study||27
1612420|NCT00935766|3943508|P1|COMPLETED|Overall Study||35
1612421|NCT00935766|3943507|P2|STARTED|Overall Study||34
1612422|NCT00935766|3943508|P1|STARTED|Overall Study||42
1612423|NCT00935701|3943518|P1|NOT COMPLETED|Overall Study||1
1612424|NCT00935701|3943518|P1|COMPLETED|Overall Study||9
1612425|NCT00935701|3943518|P1|Transition Acupressure to Acupuncture|Overall Study||9
1612426|NCT00935701|3943518|P1|STARTED|Overall Study||10
1612427|NCT00935649|3943525|P1|NOT COMPLETED|Overall Study||5
1612428|NCT00935649|3943525|P1|COMPLETED|Overall Study||134
1612429|NCT00935649|3943525|P1|STARTED|Overall Study||139
1612430|NCT00935584|3943535|P2|NOT COMPLETED|Overall Study||4
1612431|NCT00935584|3943536|P1|NOT COMPLETED|Overall Study||49
1612432|NCT00935584|3943535|P2|COMPLETED|Overall Study||19
1612433|NCT00935584|3943536|P1|COMPLETED|Overall Study||77
1612434|NCT00935584|3943535|P2|STARTED|Overall Study||23
1612435|NCT00935584|3943536|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
1612436|NCT00935532|3943548|P2|NOT COMPLETED|Overall Study||11
1612437|NCT00935532|3943549|P1|NOT COMPLETED|Overall Study||22
1612438|NCT00935532|3943548|P2|COMPLETED|Overall Study||201
1612439|NCT00935532|3943549|P1|COMPLETED|Overall Study||193
1612440|NCT00935532|3943548|P2|STARTED|Overall Study||212
1612441|NCT00935532|3943549|P1|STARTED|Overall Study||215
1612442|NCT00935493|3943578|P3|NOT COMPLETED|Overall Study||1
1612443|NCT00935493|3943579|P2|NOT COMPLETED|Overall Study||2
1612444|NCT00935493|3943580|P1|NOT COMPLETED|Overall Study||1
1612445|NCT00935493|3943578|P3|COMPLETED|Overall Study||40
1612446|NCT00935493|3943579|P2|COMPLETED|Overall Study||39
1612447|NCT00935493|3943580|P1|COMPLETED|Overall Study||40
1612448|NCT00935493|3943578|P3|STARTED|Overall Study||41
1612449|NCT00935493|3943579|P2|STARTED|Overall Study||41
1612450|NCT00935493|3943580|P1|STARTED|Overall Study||41
1612451|NCT00935311|3943597|P3|NOT COMPLETED|Overall Study||0
1612452|NCT00935311|3943598|P2|NOT COMPLETED|Overall Study||0
1612453|NCT00935311|3943599|P1|NOT COMPLETED|Overall Study||0
1612454|NCT00935311|3943597|P3|COMPLETED|Overall Study||40
1612455|NCT00935311|3943598|P2|COMPLETED|Overall Study||39
1612456|NCT00935311|3943599|P1|COMPLETED|Overall Study||43
1612457|NCT00935311|3943597|P3|STARTED|Overall Study||40
1612458|NCT00935311|3943598|P2|STARTED|Overall Study||39
1612459|NCT00935311|3943599|P1|STARTED|Overall Study||43
1612460|NCT00935272|3943618|P2|NOT COMPLETED|Overall Study||6
1612461|NCT00935272|3943619|P1|NOT COMPLETED|Overall Study||19
1612462|NCT00935272|3943618|P2|COMPLETED|Overall Study||39
1612463|NCT00935272|3943619|P1|COMPLETED|Overall Study||116
1612464|NCT00935272|3943618|P2|STARTED|Overall Study||45
1612465|NCT00935272|3943619|P1|STARTED|Overall Study||135
1612466|NCT00935259|3943628|P2|NOT COMPLETED|Period 2||0
1612467|NCT00935259|3943629|P1|NOT COMPLETED|Period 2||0
1612468|NCT00935259|3943628|P2|COMPLETED|Period 2||14
1612469|NCT00935259|3943629|P1|COMPLETED|Period 2||15
1612470|NCT00935259|3943628|P2|STARTED|Period 2||14
1612471|NCT00935259|3943629|P1|STARTED|Period 2||15
1612472|NCT00935259|3943628|P2|NOT COMPLETED|Period 1||1
1612473|NCT00935259|3943629|P1|NOT COMPLETED|Period 1||1
1612474|NCT00935259|3943628|P2|COMPLETED|Period 1||14
1612475|NCT00935259|3943629|P1|COMPLETED|Period 1||15
1612476|NCT00935259|3943628|P2|STARTED|Period 1||15
1612477|NCT00935259|3943629|P1|STARTED|Period 1||16
1612478|NCT00935220|3943643|P1|NOT COMPLETED|Overall Study||2
1612479|NCT00935220|3943643|P1|COMPLETED|Overall Study||39
1612480|NCT00935220|3943643|P1|STARTED|Overall Study||41
1612481|NCT00935064|3943657|P2|NOT COMPLETED|Overall Study||0
1612482|NCT00935064|3943658|P1|NOT COMPLETED|Overall Study||0
1612483|NCT00935064|3943657|P2|COMPLETED|Overall Study||30
1612484|NCT00935064|3943658|P1|COMPLETED|Overall Study||30
1612485|NCT00935064|3943657|P2|STARTED|Overall Study||30
1612486|NCT00935064|3943658|P1|STARTED|Overall Study||30
1612487|NCT00934947|3943674|P2|NOT COMPLETED|Overall Study||2
1612488|NCT00934947|3943675|P1|NOT COMPLETED|Overall Study||0
1612489|NCT00934947|3943674|P2|COMPLETED|Overall Study||20
1612490|NCT00934947|3943675|P1|COMPLETED|Overall Study||23
1612491|NCT00934947|3943674|P2|STARTED|Overall Study||22
1612492|NCT00934947|3943675|P1|STARTED|Overall Study||23
1612493|NCT00934921|3943689|P2|NOT COMPLETED|Second Intervention||0
1612494|NCT00934921|3943690|P1|NOT COMPLETED|Second Intervention||0
1612495|NCT00934921|3943689|P2|COMPLETED|Second Intervention||12
1612496|NCT00934921|3943690|P1|COMPLETED|Second Intervention||12
1612497|NCT00934921|3943689|P2|STARTED|Second Intervention||12
1612498|NCT00934921|3943690|P1|STARTED|Second Intervention||12
1612499|NCT00934921|3943689|P2|NOT COMPLETED|First Intervention||0
1612500|NCT00934921|3943690|P1|NOT COMPLETED|First Intervention||0
1612501|NCT00934921|3943689|P2|COMPLETED|First Intervention||12
1612502|NCT00934921|3943690|P1|COMPLETED|First Intervention||12
1612503|NCT00934921|3943689|P2|STARTED|First Intervention||12
1612504|NCT00934921|3943690|P1|STARTED|First Intervention||12
1612505|NCT00934856|3943704|P6|NOT COMPLETED|Extension Part||5
1612506|NCT00934856|3943705|P5|NOT COMPLETED|Extension Part||4
1612507|NCT00934856|3943706|P4|NOT COMPLETED|Extension Part||2
1612508|NCT00934856|3943707|P3|NOT COMPLETED|Extension Part||0
1612509|NCT00934856|3943708|P2|NOT COMPLETED|Extension Part||0
1612510|NCT00934856|3943709|P1|NOT COMPLETED|Extension Part||0
1612511|NCT00934856|3943704|P6|COMPLETED|Extension Part||19
1612512|NCT00934856|3943705|P5|COMPLETED|Extension Part||24
1612513|NCT00934856|3943706|P4|COMPLETED|Extension Part||2
1612514|NCT00934856|3943707|P3|COMPLETED|Extension Part||0
1612515|NCT00934856|3943708|P2|COMPLETED|Extension Part||0
1612516|NCT00934856|3943709|P1|COMPLETED|Extension Part||0
1612517|NCT00934856|3943704|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
1612518|NCT00934856|3943705|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
1612519|NCT00934856|3943706|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
1612520|NCT00934856|3943707|P3|STARTED|Extension Part||0
1612521|NCT00934856|3943708|P2|STARTED|Extension Part||0
1612522|NCT00934856|3943709|P1|STARTED|Extension Part||0
1612523|NCT00934856|3943704|P6|NOT COMPLETED|Feasibility Part||3
1612524|NCT00934856|3943705|P5|NOT COMPLETED|Feasibility Part||0
1612525|NCT00934856|3943706|P4|NOT COMPLETED|Feasibility Part||5
1612526|NCT00934856|3943707|P3|NOT COMPLETED|Feasibility Part||3
1612527|NCT00934856|3943708|P2|NOT COMPLETED|Feasibility Part||5
1612528|NCT00934856|3943709|P1|NOT COMPLETED|Feasibility Part||5
1612529|NCT00934856|3943704|P6|COMPLETED|Feasibility Part||6
1612530|NCT00934856|3943705|P5|COMPLETED|Feasibility Part||12
1612531|NCT00934856|3943706|P4|COMPLETED|Feasibility Part||1
1612532|NCT00934856|3943707|P3|COMPLETED|Feasibility Part||0
1612533|NCT00934856|3943708|P2|COMPLETED|Feasibility Part||1
1612534|NCT00934856|3943709|P1|COMPLETED|Feasibility Part||1
1612535|NCT00934856|3943704|P6|STARTED|Feasibility Part||9
1612536|NCT00934856|3943705|P5|STARTED|Feasibility Part||12
1612537|NCT00934856|3943706|P4|STARTED|Feasibility Part||6
1612538|NCT00934856|3943707|P3|STARTED|Feasibility Part||3
1612539|NCT00934856|3943708|P2|STARTED|Feasibility Part||6
1612540|NCT00934856|3943709|P1|STARTED|Feasibility Part||6
1612541|NCT00934843|3943807|P2|NOT COMPLETED|Overall Study||1
1612542|NCT00934843|3943808|P1|NOT COMPLETED|Overall Study||0
1612543|NCT00934843|3943807|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
1612544|NCT00934843|3943808|P1|COMPLETED|Overall Study||37
1612545|NCT00934843|3943807|P2|STARTED|Overall Study||40
1612546|NCT00934843|3943808|P1|STARTED|Overall Study||37
1612547|NCT00934791|3943824|P2|NOT COMPLETED|Overall Study||0
1612548|NCT00934791|3943825|P1|NOT COMPLETED|Overall Study||1
1612549|NCT00934791|3943824|P2|COMPLETED|Overall Study||0
1612550|NCT00934791|3943825|P1|COMPLETED|Overall Study||0
1612551|NCT00934791|3943824|P2|STARTED|Overall Study||0
1612552|NCT00934791|3943825|P1|STARTED|Overall Study||1
1612553|NCT00934661|3943833|P2|NOT COMPLETED|Overall Study||0
1612554|NCT00934661|3943834|P1|NOT COMPLETED|Overall Study||1
1612555|NCT00934661|3943833|P2|COMPLETED|Overall Study||20
1612556|NCT00934661|3943834|P1|COMPLETED|Overall Study||19
1612557|NCT00934661|3943833|P2|STARTED|Overall Study||20
1612558|NCT00934661|3943834|P1|STARTED|Overall Study||20
1612559|NCT00934648|3943854|P1|NOT COMPLETED|Overall Study||9
1612560|NCT00934648|3943854|P1|COMPLETED|Overall Study||6
1612561|NCT00934648|3943854|P1|STARTED|Overall Study||15
1612562|NCT00934635|3943870|P9|NOT COMPLETED|Overall Study||0
1612563|NCT00934635|3943871|P8|NOT COMPLETED|Overall Study||0
1612564|NCT00934635|3943872|P7|NOT COMPLETED|Overall Study||0
1612565|NCT00934635|3943873|P6|NOT COMPLETED|Overall Study||0
1612566|NCT00934635|3943874|P5|NOT COMPLETED|Overall Study||0
1612567|NCT00934635|3943875|P4|NOT COMPLETED|Overall Study||0
1612568|NCT00934635|3943876|P3|NOT COMPLETED|Overall Study||0
1612569|NCT00934635|3943877|P2|NOT COMPLETED|Overall Study||0
1612570|NCT00934635|3943878|P1|NOT COMPLETED|Overall Study||0
1612571|NCT00934635|3943870|P9|COMPLETED|Overall Study||1
1612572|NCT00934635|3943871|P8|COMPLETED|Overall Study||0
1612573|NCT00934635|3943872|P7|COMPLETED|Overall Study||0
1612574|NCT00934635|3943873|P6|COMPLETED|Overall Study||0
1612575|NCT00934635|3943874|P5|COMPLETED|Overall Study||0
1612576|NCT00934635|3943875|P4|COMPLETED|Overall Study||0
1612577|NCT00934635|3943876|P3|COMPLETED|Overall Study||0
1612578|NCT00934635|3943877|P2|COMPLETED|Overall Study||1
1612579|NCT00934635|3943878|P1|COMPLETED|Overall Study||0
1612580|NCT00934635|3943870|P9|STARTED|Overall Study||1
1612581|NCT00934635|3943871|P8|STARTED|Overall Study||0
1612582|NCT00934635|3943872|P7|STARTED|Overall Study||0
1612583|NCT00934635|3943873|P6|STARTED|Overall Study||0
1612584|NCT00934635|3943874|P5|STARTED|Overall Study||0
1612585|NCT00934635|3943875|P4|STARTED|Overall Study||0
1612586|NCT00934635|3943876|P3|STARTED|Overall Study||0
1612587|NCT00934635|3943877|P2|STARTED|Overall Study||1
1612588|NCT00934635|3943878|P1|STARTED|Overall Study||0
1612589|NCT00934622|3943898|P1|NOT COMPLETED|Overall Study||8
1612590|NCT00934622|3943898|P1|COMPLETED|Overall Study||68
1612591|NCT00934622|3943898|P1|STARTED|Overall Study||76
1612592|NCT00934596|3943905|P2|NOT COMPLETED|Overall Study||0
1612593|NCT00934596|3943906|P1|NOT COMPLETED|Overall Study||0
1612594|NCT00934596|3943905|P2|COMPLETED|Overall Study||10
1612595|NCT00934596|3943906|P1|COMPLETED|Overall Study||10
1612596|NCT00934596|3943905|P2|STARTED|Overall Study||10
1612597|NCT00934596|3943906|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
1612598|NCT00934544|3943936|P2|NOT COMPLETED|Overall Study||42
1612599|NCT00934544|3943937|P1|NOT COMPLETED|Overall Study||55
1612600|NCT00934544|3943936|P2|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for the BAT group|31
1612601|NCT00934544|3943937|P1|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for INC424/INCB018424 group|91
1612602|NCT00934544|3943936|P2|STARTED|Overall Study||73
1612603|NCT00934544|3943937|P1|STARTED|Overall Study||146
1612604|NCT00934440|3943951|P1|NOT COMPLETED|Overall Study||1
1612605|NCT00934440|3943951|P1|COMPLETED|Overall Study||10
1612606|NCT00934440|3943951|P1|STARTED|Overall Study||11
1612607|NCT00934375|3943958|P2|NOT COMPLETED|Overall Study||22
1612608|NCT00934375|3943959|P1|NOT COMPLETED|Overall Study||13
1612609|NCT00934375|3943958|P2|COMPLETED|Overall Study||55
1612610|NCT00934375|3943959|P1|COMPLETED|Overall Study||55
1612611|NCT00934375|3943958|P2|STARTED|Overall Study||77
1612612|NCT00934375|3943959|P1|STARTED|Overall Study||68
1612613|NCT00934362|3943967|P2|NOT COMPLETED|Overall Study||0
1612614|NCT00934362|3943968|P1|NOT COMPLETED|Overall Study||1
1612615|NCT00934362|3943967|P2|COMPLETED|Overall Study||8
1612616|NCT00934362|3943968|P1|COMPLETED|Overall Study||7
1612617|NCT00934362|3943967|P2|STARTED|Overall Study||8
1612618|NCT00934362|3943968|P1|STARTED|Overall Study||8
1612619|NCT00934180|3943978|P2|NOT COMPLETED|Second Intervention||0
1612620|NCT00934180|3943979|P1|NOT COMPLETED|Second Intervention||0
1612621|NCT00934180|3943978|P2|COMPLETED|Second Intervention||12
1612622|NCT00934180|3943979|P1|COMPLETED|Second Intervention||12
1612623|NCT00934180|3943978|P2|STARTED|Second Intervention||12
1612624|NCT00934180|3943979|P1|STARTED|Second Intervention||12
1612625|NCT00934180|3943978|P2|NOT COMPLETED|First Intervention||0
1612626|NCT00934180|3943979|P1|NOT COMPLETED|First Intervention||0
1612627|NCT00934180|3943978|P2|COMPLETED|First Intervention||12
1612628|NCT00934180|3943979|P1|COMPLETED|First Intervention||12
1612629|NCT00934180|3943978|P2|STARTED|First Intervention||12
1612630|NCT00934180|3943979|P1|STARTED|First Intervention||12
1612631|NCT00934141|3943991|P4|NOT COMPLETED|Overall Study||3
1612632|NCT00934141|3943992|P3|NOT COMPLETED|Overall Study||0
1612633|NCT00934141|3943993|P2|NOT COMPLETED|Overall Study||3
1612634|NCT00934141|3943994|P1|NOT COMPLETED|Overall Study||4
1612635|NCT00934141|3943991|P4|COMPLETED|Overall Study||51
1612636|NCT00934141|3943992|P3|COMPLETED|Overall Study||48
1612637|NCT00934141|3943993|P2|COMPLETED|Overall Study||47
1612638|NCT00934141|3943994|P1|COMPLETED|Overall Study||45
1612639|NCT00934141|3943991|P4|STARTED|Overall Study||54
1612640|NCT00934141|3943992|P3|STARTED|Overall Study||48
1612641|NCT00934141|3943993|P2|STARTED|Overall Study||50
1612642|NCT00934141|3943994|P1|STARTED|Overall Study||49
1612643|NCT00934128|3944018|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
1612644|NCT00934128|3944019|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
1612645|NCT00934128|3944018|P2|COMPLETED|Second Intervention (2 Hours)||5
1612646|NCT00934128|3944019|P1|COMPLETED|Second Intervention (2 Hours)||3
1612647|NCT00934128|3944018|P2|STARTED|Second Intervention (2 Hours)||8
1612648|NCT00934128|3944019|P1|STARTED|Second Intervention (2 Hours)||3
1612649|NCT00934128|3944018|P2|NOT COMPLETED|Washout Period (1 Hour)||5
1612650|NCT00934128|3944019|P1|NOT COMPLETED|Washout Period (1 Hour)||7
1612651|NCT00934128|3944018|P2|COMPLETED|Washout Period (1 Hour)||8
1612652|NCT00934128|3944019|P1|COMPLETED|Washout Period (1 Hour)||3
1612653|NCT00934128|3944018|P2|STARTED|Washout Period (1 Hour)||13
1612654|NCT00934128|3944019|P1|STARTED|Washout Period (1 Hour)||10
1612655|NCT00934128|3944018|P2|NOT COMPLETED|First Intervention (2 Hours)||2
1612656|NCT00934128|3944019|P1|NOT COMPLETED|First Intervention (2 Hours)||5
1612657|NCT00934128|3944018|P2|COMPLETED|First Intervention (2 Hours)||13
1612658|NCT00934128|3944019|P1|COMPLETED|First Intervention (2 Hours)||10
1612659|NCT00934128|3944018|P2|STARTED|First Intervention (2 Hours)||15
1612660|NCT00934128|3944019|P1|STARTED|First Intervention (2 Hours)||15
1612661|NCT00934102|3944027|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
1612662|NCT00934102|3944028|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
1612663|NCT00934102|3944029|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
1612664|NCT00934102|3944027|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
1612665|NCT00934102|3944028|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
1612666|NCT00934102|3944029|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
1612667|NCT00934102|3944027|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
1612668|NCT00934102|3944028|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
1612669|NCT00934102|3944029|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
1612670|NCT00934102|3944027|P3|NOT COMPLETED|Period 1, One Night of Wear||0
1612671|NCT00934102|3944028|P2|NOT COMPLETED|Period 1, One Night of Wear||0
1612672|NCT00934102|3944029|P1|NOT COMPLETED|Period 1, One Night of Wear||1
1612673|NCT00934102|3944027|P3|COMPLETED|Period 1, One Night of Wear||15
1612674|NCT00934102|3944028|P2|COMPLETED|Period 1, One Night of Wear||15
1612675|NCT00934102|3944029|P1|COMPLETED|Period 1, One Night of Wear||15
1612676|NCT00934102|3944027|P3|STARTED|Period 1, One Night of Wear||15
1612677|NCT00934102|3944028|P2|STARTED|Period 1, One Night of Wear||15
1612678|NCT00934102|3944029|P1|STARTED|Period 1, One Night of Wear||16
1612679|NCT00934050|3944043|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
1612680|NCT00934050|3944044|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
1612681|NCT00934050|3944045|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1612682|NCT00934050|3944046|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1612683|NCT00934050|3944047|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1612684|NCT00934050|3944048|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1612685|NCT00934050|3944043|P6|COMPLETED|Enrolled After 15 Dec 2009||23
1612686|NCT00934050|3944044|P5|COMPLETED|Enrolled After 15 Dec 2009||19
1612687|NCT00934050|3944045|P4|COMPLETED|Enrolled After 15 Dec 2009||0
1612688|NCT00934050|3944046|P3|COMPLETED|Enrolled After 15 Dec 2009||0
1612689|NCT00934050|3944047|P2|COMPLETED|Enrolled After 15 Dec 2009||0
1612690|NCT00934050|3944048|P1|COMPLETED|Enrolled After 15 Dec 2009||0
1612691|NCT00934050|3944043|P6|STARTED|Enrolled After 15 Dec 2009||27
1612692|NCT00934050|3944044|P5|STARTED|Enrolled After 15 Dec 2009||26
1612693|NCT00934050|3944045|P4|STARTED|Enrolled After 15 Dec 2009||0
1612694|NCT00934050|3944046|P3|STARTED|Enrolled After 15 Dec 2009||0
1612695|NCT00934050|3944047|P2|STARTED|Enrolled After 15 Dec 2009||0
1612696|NCT00934050|3944048|P1|STARTED|Enrolled After 15 Dec 2009||0
1612697|NCT00934050|3944043|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
1612698|NCT00934050|3944044|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
1612699|NCT00934050|3944045|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
1612700|NCT00934050|3944046|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
1612701|NCT00934050|3944047|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
1612702|NCT00934050|3944048|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
1612703|NCT00934050|3944043|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1612704|NCT00934050|3944044|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1612705|NCT00934050|3944045|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1612706|NCT00934050|3944046|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1612707|NCT00934050|3944047|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1612708|NCT00934050|3944048|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1612709|NCT00934050|3944043|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
1612710|NCT00934050|3944044|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
1612711|NCT00934050|3944045|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
1612712|NCT00934050|3944046|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
1612713|NCT00934050|3944047|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
1612714|NCT00934050|3944048|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
1612715|NCT00934024|3944060|P2|NOT COMPLETED|Overall Study||5
1612716|NCT00934024|3944061|P1|NOT COMPLETED|Overall Study||0
1612717|NCT00934024|3944060|P2|COMPLETED|Overall Study||6
1612718|NCT00934024|3944061|P1|COMPLETED|Overall Study||10
1612719|NCT00934024|3944060|P2|STARTED|Overall Study||11
1612720|NCT00934024|3944061|P1|STARTED|Overall Study||10
1612721|NCT00933933|3944071|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
1612722|NCT00933933|3944072|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
1612723|NCT00933933|3944073|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
1612724|NCT00933933|3944071|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
1612725|NCT00933933|3944072|P2|COMPLETED|Pediatric From 2 to 21 Years||64
1612726|NCT00933933|3944073|P1|COMPLETED|Pediatric From 2 to 21 Years||588
1612727|NCT00933933|3944071|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
1612728|NCT00933933|3944072|P2|STARTED|Pediatric From 2 to 21 Years||64
1612729|NCT00933933|3944073|P1|STARTED|Pediatric From 2 to 21 Years||588
1612730|NCT00933933|3944071|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
1612731|NCT00933933|3944072|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
1612732|NCT00933933|3944073|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
1612733|NCT00933933|3944071|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
1612734|NCT00933933|3944072|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
1612735|NCT00933933|3944073|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
1612736|NCT00933933|3944071|P3|STARTED|Pregnant Females Between 16-44 Years||203
1612737|NCT00933933|3944072|P2|STARTED|Pregnant Females Between 16-44 Years||67
1612738|NCT00933933|3944073|P1|STARTED|Pregnant Females Between 16-44 Years||448
1612739|NCT00933933|3944071|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
1612740|NCT00933933|3944072|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
1612741|NCT00933933|3944073|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
1612742|NCT00933933|3944071|P3|COMPLETED|General Population From 16 to 89 Years||1206
1612743|NCT00933933|3944072|P2|COMPLETED|General Population From 16 to 89 Years||1267
1612744|NCT00933933|3944073|P1|COMPLETED|General Population From 16 to 89 Years||6164
1612745|NCT00933933|3944071|P3|STARTED|General Population From 16 to 89 Years||1206
1612746|NCT00933933|3944072|P2|STARTED|General Population From 16 to 89 Years||1287
1612747|NCT00933933|3944073|P1|STARTED|General Population From 16 to 89 Years||6164
1612748|NCT00933686|3944091|P2|NOT COMPLETED|Overall Study||11
1612749|NCT00933686|3944092|P1|NOT COMPLETED|Overall Study||10
1612750|NCT00933686|3944091|P2|COMPLETED|Overall Study||47
1612751|NCT00933686|3944092|P1|COMPLETED|Overall Study||45
1612752|NCT00933686|3944091|P2|STARTED|Overall Study||58
1612753|NCT00933686|3944092|P1|STARTED|Overall Study||55
1612754|NCT00933608|3944112|P2|NOT COMPLETED|Overall Study||2
1612755|NCT00933608|3944113|P1|NOT COMPLETED|Overall Study||5
1612756|NCT00933608|3944112|P2|COMPLETED|Overall Study||8
1612757|NCT00933608|3944113|P1|COMPLETED|Overall Study||2
1612758|NCT00933608|3944112|P2|STARTED|Overall Study||10
1612759|NCT00933608|3944113|P1|STARTED|Overall Study||7
1612760|NCT00933543|3944121|P2|NOT COMPLETED|Overall Study||7
1612761|NCT00933543|3944122|P1|NOT COMPLETED|Overall Study||3
1612762|NCT00933543|3944121|P2|COMPLETED|Overall Study||46
1612763|NCT00933543|3944122|P1|COMPLETED|Overall Study||51
1612764|NCT00933543|3944121|P2|STARTED|Overall Study||53
1612765|NCT00933543|3944122|P1|STARTED|Overall Study||54
1612766|NCT00933491|3944180|P2|NOT COMPLETED|Overall Study||0
1612767|NCT00933491|3944181|P1|NOT COMPLETED|Overall Study||0
1612768|NCT00933491|3944180|P2|COMPLETED|Overall Study||18
1612769|NCT00933491|3944181|P1|COMPLETED|Overall Study||14
1612770|NCT00933491|3944180|P2|STARTED|Overall Study||18
1612771|NCT00933491|3944181|P1|STARTED|Overall Study||14
1612772|NCT00933335|3944191|P2|NOT COMPLETED|Overall Study||16
1612773|NCT00933335|3944192|P1|NOT COMPLETED|Overall Study||2
1612774|NCT00933335|3944191|P2|COMPLETED|Overall Study||20
1612775|NCT00933335|3944192|P1|COMPLETED|Overall Study||0
1612776|NCT00933335|3944191|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
1612777|NCT00933335|3944192|P1|STARTED|Overall Study||2
1612778|NCT00933270|3944262|P1|NOT COMPLETED|Overall Study||87
1612779|NCT00933270|3944262|P1|COMPLETED|Overall Study||177
1612780|NCT00933270|3944262|P1|STARTED|Overall Study|ITT population|264
1612781|NCT00933244|3944356|P3|NOT COMPLETED|Overall Study||3
1612782|NCT00933244|3944357|P2|NOT COMPLETED|Overall Study||1
1612783|NCT00933244|3944358|P1|NOT COMPLETED|Overall Study||5
1612784|NCT00933244|3944356|P3|COMPLETED|Overall Study||73
1612785|NCT00933244|3944357|P2|COMPLETED|Overall Study||74
1612786|NCT00933244|3944358|P1|COMPLETED|Overall Study||74
1612787|NCT00933244|3944356|P3|STARTED|Overall Study||76
1612788|NCT00933244|3944357|P2|STARTED|Overall Study||75
1612789|NCT00933244|3944358|P1|STARTED|Overall Study||79
1612790|NCT00933166|3944375|P1|NOT COMPLETED|Overall Study||18
1612791|NCT00933166|3944375|P1|COMPLETED|Overall Study||151
1612792|NCT00933166|3944375|P1|STARTED|Overall Study||169
1612793|NCT00932893|3944381|P2|NOT COMPLETED|Overall Study||170
1612794|NCT00932893|3944382|P1|NOT COMPLETED|Overall Study||133
1612795|NCT00932893|3944381|P2|COMPLETED|Overall Study||4
1612796|NCT00932893|3944382|P1|COMPLETED|Overall Study||40
1612797|NCT00932893|3944381|P2|Treated|Overall Study||171
1612798|NCT00932893|3944382|P1|Treated|Overall Study||172
1612799|NCT00932893|3944381|P2|STARTED|Overall Study||174
1612800|NCT00932893|3944382|P1|STARTED|Overall Study||173
1612801|NCT00932828|3944413|P1|NOT COMPLETED|Overall Study||5
1612802|NCT00932828|3944413|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
1612803|NCT00932828|3944413|P1|STARTED|Overall Study||37
1612804|NCT00932659|3944419|P1|NOT COMPLETED|Overall Study||0
1612805|NCT00932659|3944419|P1|COMPLETED|Overall Study||8
1612806|NCT00932659|3944419|P1|STARTED|Overall Study||8
1612807|NCT00932646|3944424|P4|NOT COMPLETED|Overall Study||1
1612808|NCT00932646|3944425|P3|NOT COMPLETED|Overall Study||4
1612809|NCT00932646|3944426|P2|NOT COMPLETED|Overall Study||3
1612810|NCT00932646|3944427|P1|NOT COMPLETED|Overall Study||5
1612811|NCT00932646|3944424|P4|COMPLETED|Overall Study||24
1612812|NCT00932646|3944425|P3|COMPLETED|Overall Study||21
1612813|NCT00932646|3944426|P2|COMPLETED|Overall Study||22
1612814|NCT00932646|3944427|P1|COMPLETED|Overall Study||20
1612815|NCT00932646|3944424|P4|STARTED|Overall Study||25
1612816|NCT00932646|3944425|P3|STARTED|Overall Study||25
1612817|NCT00932646|3944426|P2|STARTED|Overall Study||25
1612818|NCT00932646|3944427|P1|STARTED|Overall Study||25
1612819|NCT00932620|3944483|P2|NOT COMPLETED|Overall Study||0
1612820|NCT00932620|3944484|P1|NOT COMPLETED|Overall Study||0
1612821|NCT00932620|3944483|P2|COMPLETED|Overall Study||50
1612822|NCT00932620|3944484|P1|COMPLETED|Overall Study||50
1612823|NCT00932620|3944483|P2|STARTED|Overall Study||50
1612824|NCT00932620|3944484|P1|STARTED|Overall Study||50
1612825|NCT00932477|3944492|P6|NOT COMPLETED|Treatment 3||0
1612826|NCT00932477|3944493|P5|NOT COMPLETED|Treatment 3||0
1612827|NCT00932477|3944494|P4|NOT COMPLETED|Treatment 3||0
1612828|NCT00932477|3944495|P3|NOT COMPLETED|Treatment 3||0
1612829|NCT00932477|3944496|P2|NOT COMPLETED|Treatment 3||0
1612830|NCT00932477|3944497|P1|NOT COMPLETED|Treatment 3||0
1612831|NCT00932477|3944492|P6|COMPLETED|Treatment 3||8
1612832|NCT00932477|3944493|P5|COMPLETED|Treatment 3||8
1612833|NCT00932477|3944494|P4|COMPLETED|Treatment 3||7
1612834|NCT00932477|3944495|P3|COMPLETED|Treatment 3||9
1612835|NCT00932477|3944496|P2|COMPLETED|Treatment 3||8
1612836|NCT00932477|3944497|P1|COMPLETED|Treatment 3||7
1612837|NCT00932477|3944492|P6|STARTED|Treatment 3||8
1612838|NCT00932477|3944493|P5|STARTED|Treatment 3||8
1612839|NCT00932477|3944494|P4|STARTED|Treatment 3||7
1612840|NCT00932477|3944495|P3|STARTED|Treatment 3||9
1612841|NCT00932477|3944496|P2|STARTED|Treatment 3||8
1612842|NCT00932477|3944497|P1|STARTED|Treatment 3||7
1612843|NCT00932477|3944492|P6|NOT COMPLETED|Treatment 2||0
1612844|NCT00932477|3944493|P5|NOT COMPLETED|Treatment 2||0
1612845|NCT00932477|3944494|P4|NOT COMPLETED|Treatment 2||0
1612846|NCT00932477|3944495|P3|NOT COMPLETED|Treatment 2||0
1612847|NCT00932477|3944496|P2|NOT COMPLETED|Treatment 2||0
1612848|NCT00932477|3944497|P1|NOT COMPLETED|Treatment 2||0
1612849|NCT00932477|3944492|P6|COMPLETED|Treatment 2||8
1612850|NCT00932477|3944493|P5|COMPLETED|Treatment 2||8
1612851|NCT00932477|3944494|P4|COMPLETED|Treatment 2||7
1612852|NCT00932477|3944495|P3|COMPLETED|Treatment 2||9
1612853|NCT00932477|3944496|P2|COMPLETED|Treatment 2||8
1612854|NCT00932477|3944497|P1|COMPLETED|Treatment 2||7
1612855|NCT00932477|3944492|P6|STARTED|Treatment 2||8
1612856|NCT00932477|3944493|P5|STARTED|Treatment 2||8
1612857|NCT00932477|3944494|P4|STARTED|Treatment 2||7
1612858|NCT00932477|3944495|P3|STARTED|Treatment 2||9
1612859|NCT00932477|3944496|P2|STARTED|Treatment 2||8
1612860|NCT00932477|3944497|P1|STARTED|Treatment 2||7
1612861|NCT00932477|3944492|P6|NOT COMPLETED|Treatment 1||0
1612862|NCT00932477|3944493|P5|NOT COMPLETED|Treatment 1||0
1612863|NCT00932477|3944494|P4|NOT COMPLETED|Treatment 1||0
1612864|NCT00932477|3944495|P3|NOT COMPLETED|Treatment 1||0
1612865|NCT00932477|3944496|P2|NOT COMPLETED|Treatment 1||0
1612866|NCT00932477|3944497|P1|NOT COMPLETED|Treatment 1||0
1612867|NCT00932477|3944492|P6|COMPLETED|Treatment 1||8
1612868|NCT00932477|3944493|P5|COMPLETED|Treatment 1||8
1612869|NCT00932477|3944494|P4|COMPLETED|Treatment 1||7
1612870|NCT00932477|3944495|P3|COMPLETED|Treatment 1||9
1612871|NCT00932477|3944496|P2|COMPLETED|Treatment 1||8
1612872|NCT00932477|3944497|P1|COMPLETED|Treatment 1||7
1612873|NCT00932477|3944492|P6|STARTED|Treatment 1||8
1612874|NCT00932477|3944493|P5|STARTED|Treatment 1||8
1612875|NCT00932477|3944494|P4|STARTED|Treatment 1||7
1612876|NCT00932477|3944495|P3|STARTED|Treatment 1||9
1612877|NCT00932477|3944496|P2|STARTED|Treatment 1||8
1612878|NCT00932477|3944497|P1|STARTED|Treatment 1||7
1612879|NCT00932451|3944514|P1|NOT COMPLETED|Overall Study||822
1612880|NCT00932451|3944514|P1|COMPLETED|Overall Study||244
1612881|NCT00932451|3944514|P1|STARTED|Overall Study||1066
1612882|NCT00932425|3944538|P2|NOT COMPLETED|Overall Study||2
1612883|NCT00932425|3944539|P1|NOT COMPLETED|Overall Study||0
1612884|NCT00932425|3944538|P2|COMPLETED|Overall Study||18
1612885|NCT00932425|3944539|P1|COMPLETED|Overall Study||20
1612886|NCT00932425|3944538|P2|STARTED|Overall Study||20
1612887|NCT00932425|3944539|P1|STARTED|Overall Study||20
1612888|NCT00932399|3944554|P2|NOT COMPLETED|Overall Study||0
1612889|NCT00932399|3944555|P1|NOT COMPLETED|Overall Study||0
1612890|NCT00932399|3944554|P2|COMPLETED|Overall Study||3790
1612891|NCT00932399|3944555|P1|COMPLETED|Overall Study||759
1612892|NCT00932399|3944554|P2|STARTED|Overall Study||3790
1612893|NCT00932399|3944555|P1|STARTED|Overall Study||759
1612894|NCT00932373|3944572|P11|NOT COMPLETED|Overall Study||3
1612895|NCT00932373|3944573|P10|NOT COMPLETED|Overall Study||13
1612896|NCT00932373|3944574|P9|NOT COMPLETED|Overall Study||2
1612897|NCT00932373|3944575|P8|NOT COMPLETED|Overall Study||3
1612898|NCT00932373|3944576|P7|NOT COMPLETED|Overall Study||1
1612899|NCT00932373|3944577|P6|NOT COMPLETED|Overall Study||3
1612900|NCT00932373|3944578|P5|NOT COMPLETED|Overall Study||14
1612901|NCT00932373|3944579|P4|NOT COMPLETED|Overall Study||0
1612902|NCT00932373|3944580|P3|NOT COMPLETED|Overall Study||1
1612903|NCT00932373|3944581|P2|NOT COMPLETED|Overall Study||1
1612904|NCT00932373|3944582|P1|NOT COMPLETED|Overall Study||3
1612905|NCT00932373|3944572|P11|COMPLETED|Overall Study||0
1612906|NCT00932373|3944573|P10|COMPLETED|Overall Study||3
1612907|NCT00932373|3944574|P9|COMPLETED|Overall Study||1
1612908|NCT00932373|3944575|P8|COMPLETED|Overall Study||0
1612909|NCT00932373|3944576|P7|COMPLETED|Overall Study||2
1612910|NCT00932373|3944577|P6|COMPLETED|Overall Study||0
1612911|NCT00932373|3944578|P5|COMPLETED|Overall Study||1
1612912|NCT00932373|3944579|P4|COMPLETED|Overall Study||1
1612913|NCT00932373|3944580|P3|COMPLETED|Overall Study||0
1612914|NCT00932373|3944581|P2|COMPLETED|Overall Study||0
1612915|NCT00932373|3944582|P1|COMPLETED|Overall Study||0
1612916|NCT00932373|3944572|P11|STARTED|Overall Study||3
1612917|NCT00932373|3944573|P10|STARTED|Overall Study||16
1612918|NCT00932373|3944574|P9|STARTED|Overall Study||3
1612919|NCT00932373|3944575|P8|STARTED|Overall Study||3
1612920|NCT00932373|3944576|P7|STARTED|Overall Study||3
1612921|NCT00932373|3944577|P6|STARTED|Overall Study||3
1612922|NCT00932373|3944578|P5|STARTED|Overall Study||15
1612923|NCT00932373|3944579|P4|STARTED|Overall Study||1
1612924|NCT00932373|3944580|P3|STARTED|Overall Study||1
1612925|NCT00932373|3944581|P2|STARTED|Overall Study||1
1612926|NCT00932373|3944582|P1|STARTED|Overall Study||3
1612927|NCT00932321|3944684|P2|NOT COMPLETED|Overall Study||46
1612928|NCT00932321|3944685|P1|NOT COMPLETED|Overall Study||171
1612929|NCT00932321|3944684|P2|COMPLETED|Overall Study||141
1612930|NCT00932321|3944685|P1|COMPLETED|Overall Study||580
1612931|NCT00932321|3944684|P2|MITT Population|Overall Study||181
1612932|NCT00932321|3944685|P1|MITT Population|Overall Study||705
1612933|NCT00932321|3944684|P2|STARTED|Overall Study||187
1612934|NCT00932321|3944685|P1|STARTED|Overall Study||751
1612935|NCT00932282|3944695|P2|NOT COMPLETED|OIT Maintenance Phase||2
1612936|NCT00932282|3944696|P1|NOT COMPLETED|OIT Maintenance Phase||1
1612937|NCT00932282|3944695|P2|COMPLETED|OIT Maintenance Phase||2
1612938|NCT00932282|3944696|P1|COMPLETED|OIT Maintenance Phase||4
1612939|NCT00932282|3944695|P2|STARTED|OIT Maintenance Phase||4
1612940|NCT00932282|3944696|P1|STARTED|OIT Maintenance Phase||5
1612941|NCT00932282|3944695|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
1612942|NCT00932282|3944696|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
1612943|NCT00932282|3944695|P2|COMPLETED|Biweekly OIT Buildup Phase||4
1612944|NCT00932282|3944696|P1|COMPLETED|Biweekly OIT Buildup Phase||5
1612945|NCT00932282|3944695|P2|STARTED|Biweekly OIT Buildup Phase||5
1612946|NCT00932282|3944696|P1|STARTED|Biweekly OIT Buildup Phase||6
1612947|NCT00932282|3944695|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
1612948|NCT00932282|3944696|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
1612949|NCT00932282|3944695|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
1612950|NCT00932282|3944696|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
1612951|NCT00932282|3944695|P2|STARTED|Modified OIT Rush Desensitization Phase||5
1612952|NCT00932282|3944696|P1|STARTED|Modified OIT Rush Desensitization Phase||6
1612953|NCT00932282|3944695|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
1612954|NCT00932282|3944696|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
1612955|NCT00932282|3944695|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
1612956|NCT00932282|3944696|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
1612957|NCT00932282|3944695|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
1612958|NCT00932282|3944696|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
1612959|NCT00932165|3944710|P1|NOT COMPLETED|Overall Study||1
1612960|NCT00932165|3944710|P1|COMPLETED|Overall Study||450
1612961|NCT00932165|3944710|P1|STARTED|Overall Study||451
1612962|NCT00932152|3944723|P2|NOT COMPLETED|Overall Study||2
1612963|NCT00932152|3944724|P1|NOT COMPLETED|Overall Study||1
1612964|NCT00932152|3944723|P2|COMPLETED|Overall Study||0
1612965|NCT00932152|3944724|P1|COMPLETED|Overall Study||0
1612966|NCT00932152|3944723|P2|STARTED|Overall Study||2
1612967|NCT00932152|3944724|P1|STARTED|Overall Study||1
1612968|NCT00932126|3944734|P8|NOT COMPLETED|Overall Study||10
1612969|NCT00932126|3944735|P7|NOT COMPLETED|Overall Study||5
1612970|NCT00932126|3944736|P6|NOT COMPLETED|Overall Study||3
1612971|NCT00932126|3944737|P5|NOT COMPLETED|Overall Study||5
1612972|NCT00932126|3944738|P4|NOT COMPLETED|Overall Study||3
1612973|NCT00932126|3944739|P3|NOT COMPLETED|Overall Study||3
1612974|NCT00932126|3944740|P2|NOT COMPLETED|Overall Study||3
1612975|NCT00932126|3944741|P1|NOT COMPLETED|Overall Study||3
1612976|NCT00932126|3944734|P8|COMPLETED|Overall Study||0
1612977|NCT00932126|3944735|P7|COMPLETED|Overall Study||0
1612978|NCT00932126|3944736|P6|COMPLETED|Overall Study||0
1612979|NCT00932126|3944737|P5|COMPLETED|Overall Study||0
1612980|NCT00932126|3944738|P4|COMPLETED|Overall Study||0
1612981|NCT00932126|3944739|P3|COMPLETED|Overall Study||0
1612982|NCT00932126|3944740|P2|COMPLETED|Overall Study||0
1612983|NCT00932126|3944741|P1|COMPLETED|Overall Study||0
1612984|NCT00932126|3944734|P8|STARTED|Overall Study||10
1612985|NCT00932126|3944735|P7|STARTED|Overall Study||5
1612986|NCT00932126|3944736|P6|STARTED|Overall Study||3
1612987|NCT00932126|3944737|P5|STARTED|Overall Study||5
1612988|NCT00932126|3944738|P4|STARTED|Overall Study||3
1612989|NCT00932126|3944739|P3|STARTED|Overall Study||3
1612990|NCT00932126|3944740|P2|STARTED|Overall Study||3
1612991|NCT00932126|3944741|P1|STARTED|Overall Study||3
1612992|NCT00932113|3944779|P2|NOT COMPLETED|Overall Study||0
1612993|NCT00932113|3944780|P1|NOT COMPLETED|Overall Study||1
1612994|NCT00932113|3944779|P2|COMPLETED|Overall Study||15
1612995|NCT00932113|3944780|P1|COMPLETED|Overall Study||14
1612996|NCT00932113|3944779|P2|STARTED|Overall Study||15
1612997|NCT00932113|3944780|P1|STARTED|Overall Study||15
1612998|NCT00932035|3944798|P2|NOT COMPLETED|Overall Study||0
1612999|NCT00932035|3944799|P1|NOT COMPLETED|Overall Study||0
1613000|NCT00932035|3944798|P2|COMPLETED|Overall Study||21
1613001|NCT00932035|3944799|P1|COMPLETED|Overall Study||18
1613002|NCT00932035|3944798|P2|STARTED|Overall Study||21
1613003|NCT00932035|3944799|P1|STARTED|Overall Study||18
1613004|NCT00932022|3944811|P2|NOT COMPLETED|Overall Study||4
1613005|NCT00932022|3944812|P1|NOT COMPLETED|Overall Study||5
1613006|NCT00932022|3944811|P2|COMPLETED|Overall Study||59
1613007|NCT00932022|3944812|P1|COMPLETED|Overall Study||59
1613008|NCT00932022|3944811|P2|STARTED|Overall Study||63
1613009|NCT00932022|3944812|P1|STARTED|Overall Study||64
1613010|NCT00931996|3944826|P1|NOT COMPLETED|Overall Study||7
1613011|NCT00931996|3944826|P1|COMPLETED|Overall Study||5
1613012|NCT00931996|3944826|P1|STARTED|Overall Study||12
1613013|NCT00931918|3944832|P2|NOT COMPLETED|Overall Study||17
1613014|NCT00931918|3944833|P1|NOT COMPLETED|Overall Study||17
1613015|NCT00931918|3944832|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
1613016|NCT00931918|3944833|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
1613017|NCT00931918|3944832|P2|Safety Population: Received Study Drug|Overall Study||101
1613018|NCT00931918|3944833|P1|Safety Population: Received Study Drug|Overall Study||100
1613019|NCT00931918|3944832|P2|STARTED|Overall Study||103
1613020|NCT00931918|3944833|P1|STARTED|Overall Study||103
1613021|NCT00931879|3944859|P2|NOT COMPLETED|Overall Study||3
1613022|NCT00931879|3944860|P1|NOT COMPLETED|Overall Study||3
1613023|NCT00931879|3944859|P2|COMPLETED|Overall Study||19
1613024|NCT00931879|3944860|P1|COMPLETED|Overall Study||19
1613025|NCT00931879|3944859|P2|STARTED|Overall Study||22
1613026|NCT00931879|3944860|P1|STARTED|Overall Study||22
1613027|NCT00931801|3944885|P3|NOT COMPLETED|Overall Study||4
1613028|NCT00931801|3944886|P2|NOT COMPLETED|Overall Study||1
1613029|NCT00931801|3944887|P1|NOT COMPLETED|Overall Study||1
1613030|NCT00931801|3944885|P3|COMPLETED|Overall Study||10
1613031|NCT00931801|3944886|P2|COMPLETED|Overall Study||14
1613032|NCT00931801|3944887|P1|COMPLETED|Overall Study||13
1613033|NCT00931801|3944885|P3|STARTED|Overall Study||14
1613034|NCT00931801|3944886|P2|STARTED|Overall Study||15
1613035|NCT00931801|3944887|P1|STARTED|Overall Study||14
1613036|NCT00931723|3944910|P2|NOT COMPLETED|Overall Study||39
1613037|NCT00931723|3944911|P1|NOT COMPLETED|Overall Study||26
1613038|NCT00931723|3944910|P2|COMPLETED|Overall Study||144
1613039|NCT00931723|3944911|P1|COMPLETED|Overall Study||147
1613040|NCT00931723|3944910|P2|STARTED|Overall Study||183
1613041|NCT00931723|3944911|P1|STARTED|Overall Study||173
1613042|NCT00931710|3944959|P2|NOT COMPLETED|Overall Study||38
1613043|NCT00931710|3944960|P1|NOT COMPLETED|Overall Study||34
1613044|NCT00931710|3944959|P2|COMPLETED|Overall Study||209
1613045|NCT00931710|3944960|P1|COMPLETED|Overall Study||207
1613046|NCT00931710|3944959|P2|STARTED|Overall Study||247
1613047|NCT00931710|3944960|P1|STARTED|Overall Study||241
1613048|NCT00931632|3944978|P2|NOT COMPLETED|Overall Study||18
1613049|NCT00931632|3944979|P1|NOT COMPLETED|Overall Study||21
1613050|NCT00931632|3944978|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
1613051|NCT00931632|3944979|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
1613052|NCT00931632|3944978|P2|STARTED|Overall Study|Randomized|222
1613053|NCT00931632|3944979|P1|STARTED|Overall Study|Randomized|229
1613054|NCT00931528|3945001|P2|NOT COMPLETED|Overall Study||60
1613055|NCT00931528|3945002|P1|NOT COMPLETED|Overall Study||41
1613056|NCT00931528|3945001|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
1613057|NCT00931528|3945002|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
1613058|NCT00931528|3945001|P2|STARTED|Overall Study||121
1613059|NCT00931528|3945002|P1|STARTED|Overall Study||121
1613060|NCT00931515|3945022|P2|NOT COMPLETED|Overall Study||5
1613061|NCT00931515|3945023|P1|NOT COMPLETED|Overall Study||2
1613062|NCT00931515|3945022|P2|COMPLETED|Overall Study||10
1613063|NCT00931515|3945023|P1|COMPLETED|Overall Study||13
1613064|NCT00931515|3945022|P2|STARTED|Overall Study||15
1613065|NCT00931515|3945023|P1|STARTED|Overall Study||15
1613066|NCT00931489|3945034|P5|NOT COMPLETED|Overall Study||0
1613067|NCT00931489|3945035|P4|NOT COMPLETED|Overall Study||0
1613068|NCT00931489|3945036|P3|NOT COMPLETED|Overall Study||0
1613069|NCT00931489|3945037|P2|NOT COMPLETED|Overall Study||0
1613070|NCT00931489|3945038|P1|NOT COMPLETED|Overall Study||0
1613071|NCT00931489|3945034|P5|COMPLETED|Overall Study||7
1613072|NCT00931489|3945035|P4|COMPLETED|Overall Study||39
1613073|NCT00931489|3945036|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
1613074|NCT00931489|3945037|P2|COMPLETED|Overall Study||40
1613075|NCT00931489|3945038|P1|COMPLETED|Overall Study||40
1613076|NCT00931489|3945034|P5|STARTED|Overall Study||7
1613077|NCT00931489|3945035|P4|STARTED|Overall Study||39
1613078|NCT00931489|3945036|P3|STARTED|Overall Study||5
1613079|NCT00931489|3945037|P2|STARTED|Overall Study||40
1613080|NCT00931489|3945038|P1|STARTED|Overall Study||40
1613081|NCT00931463|3945053|P2|NOT COMPLETED|Overall Study||5
1613082|NCT00931463|3945054|P1|NOT COMPLETED|Overall Study||17
1613083|NCT00931463|3945053|P2|COMPLETED|Overall Study||265
1613084|NCT00931463|3945054|P1|COMPLETED|Overall Study||254
1613085|NCT00931463|3945053|P2|STARTED|Overall Study||270
1613086|NCT00931463|3945054|P1|STARTED|Overall Study||271
1613087|NCT00931411|3945070|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
1613088|NCT00931411|3945071|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
1613089|NCT00931411|3945070|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
1613090|NCT00931411|3945071|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
1613091|NCT00931411|3945070|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
1613092|NCT00931411|3945071|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
1613093|NCT00931411|3945070|P2|NOT COMPLETED|First Intervention - 42 Days||3
1613094|NCT00931411|3945071|P1|NOT COMPLETED|First Intervention - 42 Days||4
1613095|NCT00931411|3945070|P2|COMPLETED|First Intervention - 42 Days||35
1613096|NCT00931411|3945071|P1|COMPLETED|First Intervention - 42 Days||31
1613097|NCT00931411|3945070|P2|STARTED|First Intervention - 42 Days||38
1613098|NCT00931411|3945071|P1|STARTED|First Intervention - 42 Days||35
1613099|NCT00931385|3945092|P4|NOT COMPLETED|Overall Study||5
1613100|NCT00931385|3945093|P3|NOT COMPLETED|Overall Study||1
1613101|NCT00931385|3945094|P2|NOT COMPLETED|Overall Study||2
1613102|NCT00931385|3945095|P1|NOT COMPLETED|Overall Study||2
1613103|NCT00931385|3945092|P4|COMPLETED|Overall Study||21
1613104|NCT00931385|3945093|P3|COMPLETED|Overall Study||24
1613105|NCT00931385|3945094|P2|COMPLETED|Overall Study||21
1613106|NCT00931385|3945095|P1|COMPLETED|Overall Study||23
1613107|NCT00931385|3945092|P4|STARTED|Overall Study||26
1613108|NCT00931385|3945093|P3|STARTED|Overall Study||25
1613109|NCT00931385|3945094|P2|STARTED|Overall Study||23
1613110|NCT00931385|3945095|P1|STARTED|Overall Study||25
1613111|NCT00931359|3945151|P2|NOT COMPLETED|Overall Study||13
1613112|NCT00931359|3945152|P1|NOT COMPLETED|Overall Study||6
1613113|NCT00931359|3945151|P2|COMPLETED|Overall Study||68
1613114|NCT00931359|3945152|P1|COMPLETED|Overall Study||33
1613115|NCT00931359|3945151|P2|STARTED|Overall Study||81
1613116|NCT00931359|3945152|P1|STARTED|Overall Study||39
1613117|NCT00931307|3945164|P1|NOT COMPLETED|Overall Study||13
1613118|NCT00931307|3945164|P1|COMPLETED|Overall Study||9
1613119|NCT00931307|3945164|P1|STARTED|Overall Study||22
1613120|NCT00931268|3945168|P1|NOT COMPLETED|Overall Study||6
1613121|NCT00931268|3945168|P1|COMPLETED|Overall Study||4
1613122|NCT00931268|3945168|P1|STARTED|Overall Study||10
1613123|NCT00931255|3945180|P2|NOT COMPLETED|Overall Study||3
1613124|NCT00931255|3945181|P1|NOT COMPLETED|Overall Study||2
1613125|NCT00931255|3945180|P2|COMPLETED|Overall Study||12
1613126|NCT00931255|3945181|P1|COMPLETED|Overall Study||15
1613127|NCT00931255|3945180|P2|STARTED|Overall Study||15
1613128|NCT00931255|3945181|P1|STARTED|Overall Study||17
1613129|NCT00931242|3945205|P2|NOT COMPLETED|Overall Study||2
1613130|NCT00931242|3945206|P1|NOT COMPLETED|Overall Study||5
1613131|NCT00931242|3945205|P2|COMPLETED|Overall Study||0
1613132|NCT00931242|3945206|P1|COMPLETED|Overall Study||5
1613133|NCT00931242|3945205|P2|STARTED|Overall Study||2
1613134|NCT00931242|3945206|P1|STARTED|Overall Study||10
1613135|NCT00931164|3945212|P1|NOT COMPLETED|Overall Study||0
1613136|NCT00931164|3945212|P1|COMPLETED|Overall Study||6
1613137|NCT00931164|3945212|P1|STARTED|Overall Study||6
1613138|NCT00930982|3945218|P2|NOT COMPLETED|Overall Study||29
1613139|NCT00930982|3945219|P1|NOT COMPLETED|Overall Study||21
1613140|NCT00930982|3945218|P2|COMPLETED|Overall Study||35
1613141|NCT00930982|3945219|P1|COMPLETED|Overall Study||39
1613142|NCT00930982|3945218|P2|STARTED|Overall Study||64
1613143|NCT00930982|3945219|P1|STARTED|Overall Study||60
1613144|NCT00930969|3945253|P1|NOT COMPLETED|Overall Study||38
1613145|NCT00930969|3945253|P1|COMPLETED|Overall Study||137
1613146|NCT00930969|3945253|P1|STARTED|Overall Study||175
1613147|NCT00930930|3945263|P2|NOT COMPLETED|Overall Study||9
1613148|NCT00930930|3945264|P1|NOT COMPLETED|Overall Study||21
1613149|NCT00930930|3945263|P2|COMPLETED|Overall Study||40
1613150|NCT00930930|3945264|P1|COMPLETED|Overall Study||75
1613151|NCT00930930|3945263|P2|STARTED|Overall Study||49
1613152|NCT00930930|3945264|P1|STARTED|Overall Study||96
1613153|NCT00930813|3945278|P2|NOT COMPLETED|Overall Study||14
1613154|NCT00930813|3945279|P1|NOT COMPLETED|Overall Study||8
1613155|NCT00930813|3945278|P2|COMPLETED|Overall Study||38
1613156|NCT00930813|3945279|P1|COMPLETED|Overall Study||41
1613157|NCT00930813|3945278|P2|STARTED|Overall Study||52
1613158|NCT00930813|3945279|P1|STARTED|Overall Study||49
1613159|NCT00930787|3945289|P2|NOT COMPLETED|Overall Study||0
1613160|NCT00930787|3945290|P1|NOT COMPLETED|Overall Study||0
1613161|NCT00930787|3945289|P2|COMPLETED|Overall Study||9
1613162|NCT00930787|3945290|P1|COMPLETED|Overall Study||14
1613163|NCT00930787|3945289|P2|STARTED|Overall Study||9
1613164|NCT00930787|3945290|P1|STARTED|Overall Study||14
1613165|NCT00930774|3945300|P4|NOT COMPLETED|Overall Study||0
1613166|NCT00930774|3945301|P3|NOT COMPLETED|Overall Study||2
1613167|NCT00930774|3945302|P2|NOT COMPLETED|Overall Study||9
1613168|NCT00930774|3945303|P1|NOT COMPLETED|Overall Study||1
1613169|NCT00930774|3945300|P4|COMPLETED|Overall Study||25
1613170|NCT00930774|3945301|P3|COMPLETED|Overall Study||22
1613171|NCT00930774|3945302|P2|COMPLETED|Overall Study||16
1613172|NCT00930774|3945303|P1|COMPLETED|Overall Study||24
1613173|NCT00930774|3945300|P4|STARTED|Overall Study||25
1613174|NCT00930774|3945301|P3|STARTED|Overall Study||24
1613175|NCT00930774|3945302|P2|STARTED|Overall Study||25
1613176|NCT00930774|3945303|P1|STARTED|Overall Study||25
1613177|NCT00930761|3945343|P2|NOT COMPLETED|Overall Study||3
1613178|NCT00930761|3945344|P1|NOT COMPLETED|Overall Study||4
1613179|NCT00930761|3945343|P2|COMPLETED|Overall Study||48
1613180|NCT00930761|3945344|P1|COMPLETED|Overall Study||46
1613181|NCT00930761|3945343|P2|STARTED|Overall Study||51
1613182|NCT00930761|3945344|P1|STARTED|Overall Study||50
1613183|NCT00930722|3945356|P1|NOT COMPLETED|Overall Study||27
1613184|NCT00930722|3945356|P1|COMPLETED|Overall Study||302
1613185|NCT00930722|3945356|P1|STARTED|Overall Study||329
1613186|NCT00930644|3945371|P1|NOT COMPLETED|Overall Study||23
1613187|NCT00930644|3945371|P1|COMPLETED|Overall Study||65
1613188|NCT00930644|3945371|P1|STARTED|Overall Study||88
1613189|NCT00930553|3945384|P1|NOT COMPLETED|Overall Study||223
1613190|NCT00930553|3945384|P1|COMPLETED|Overall Study||1091
1613191|NCT00930553|3945384|P1|Participants Entered From CAMMS324|Overall Study||685
1613192|NCT00930553|3945384|P1|Participants Entered From CAMMS323|Overall Study||488
1613193|NCT00930553|3945384|P1|Participants Entered From CAMMS223|Overall Study||141
1613194|NCT00930553|3945384|P1|STARTED|Overall Study||1314
1613195|NCT00930293|3945452|P2|NOT COMPLETED|Overall Study||7
1613196|NCT00930293|3945453|P1|NOT COMPLETED|Overall Study||7
1613197|NCT00930293|3945452|P2|COMPLETED|Overall Study||19
1613198|NCT00930293|3945453|P1|COMPLETED|Overall Study||17
1613199|NCT00930293|3945452|P2|STARTED|Overall Study||26
1613200|NCT00930293|3945453|P1|STARTED|Overall Study||24
1613201|NCT00930176|3945461|P1|NOT COMPLETED|Overall Study||1
1613202|NCT00930176|3945461|P1|COMPLETED|Overall Study||15
1613203|NCT00930176|3945461|P1|STARTED|Overall Study||16
1613204|NCT00929981|3945466|P1|NOT COMPLETED|Overall Study||0
1613205|NCT00929981|3945466|P1|COMPLETED|Overall Study||80
1613206|NCT00929981|3945466|P1|STARTED|Overall Study||80
1613207|NCT00929864|3945478|P2|NOT COMPLETED|Overall Study||83
1613208|NCT00929864|3945479|P1|NOT COMPLETED|Overall Study||66
1613209|NCT00929864|3945478|P2|COMPLETED|Overall Study||245
1613210|NCT00929864|3945479|P1|COMPLETED|Overall Study||252
1613211|NCT00929864|3945478|P2|STARTED|Overall Study||328
1613212|NCT00929864|3945479|P1|STARTED|Overall Study||318
1613213|NCT00929773|3945499|P2|NOT COMPLETED|Overall Study||0
1613214|NCT00929773|3945500|P1|NOT COMPLETED|Overall Study||0
1613215|NCT00929773|3945499|P2|COMPLETED|Overall Study||50
1613216|NCT00929773|3945500|P1|COMPLETED|Overall Study||50
1613217|NCT00929773|3945499|P2|STARTED|Overall Study||50
1613218|NCT00929773|3945500|P1|STARTED|Overall Study||50
1613219|NCT00929734|3945518|P2|NOT COMPLETED|Overall Study||3
1613220|NCT00929734|3945519|P1|NOT COMPLETED|Overall Study||2
1613221|NCT00929734|3945518|P2|COMPLETED|Overall Study||47
1613222|NCT00929734|3945519|P1|COMPLETED|Overall Study||47
1613223|NCT00929734|3945518|P2|STARTED|Overall Study||50
1613224|NCT00929734|3945519|P1|STARTED|Overall Study||49
1613225|NCT00929708|3945536|P5|NOT COMPLETED|Overall Study||6
1613226|NCT00929708|3945537|P4|NOT COMPLETED|Overall Study||6
1613227|NCT00929708|3945538|P3|NOT COMPLETED|Overall Study||3
1613228|NCT00929708|3945539|P2|NOT COMPLETED|Overall Study||3
1613229|NCT00929708|3945540|P1|NOT COMPLETED|Overall Study||4
1613230|NCT00929708|3945536|P5|COMPLETED|Overall Study||57
1613231|NCT00929708|3945537|P4|COMPLETED|Overall Study||61
1613232|NCT00929708|3945538|P3|COMPLETED|Overall Study||62
1613233|NCT00929708|3945539|P2|COMPLETED|Overall Study||66
1613234|NCT00929708|3945540|P1|COMPLETED|Overall Study||61
1613235|NCT00929708|3945536|P5|STARTED|Overall Study||63
1613236|NCT00929708|3945537|P4|STARTED|Overall Study||67
1613237|NCT00929708|3945538|P3|STARTED|Overall Study||65
1613238|NCT00929708|3945539|P2|STARTED|Overall Study||69
1613239|NCT00929708|3945540|P1|STARTED|Overall Study||65
1613240|NCT00929695|3945594|P2|NOT COMPLETED|Overall Study||6
1613241|NCT00929695|3945595|P1|NOT COMPLETED|Overall Study||8
1613242|NCT00929695|3945594|P2|COMPLETED|Overall Study||77
1613243|NCT00929695|3945595|P1|COMPLETED|Overall Study||73
1613244|NCT00929695|3945594|P2|STARTED|Overall Study||83
1613245|NCT00929695|3945595|P1|STARTED|Overall Study||81
1613246|NCT00929669|3945625|P1|NOT COMPLETED|Overall Study||1
1613247|NCT00929669|3945625|P1|COMPLETED|Overall Study||1
1613248|NCT00929669|3945625|P1|STARTED|Overall Study||2
1613249|NCT00929656|3945632|P2|NOT COMPLETED|Overall Study||1
1613250|NCT00929656|3945633|P1|NOT COMPLETED|Overall Study||0
1613251|NCT00929656|3945632|P2|COMPLETED|Overall Study||8
1613252|NCT00929656|3945633|P1|COMPLETED|Overall Study||13
1613253|NCT00929656|3945632|P2|STARTED|Overall Study||9
1613254|NCT00929656|3945633|P1|STARTED|Overall Study||13
1613255|NCT00929643|3945647|P1|NOT COMPLETED|Overall Study||2
1613256|NCT00929643|3945647|P1|COMPLETED|Overall Study||201
1613257|NCT00929643|3945647|P1|STARTED|Overall Study||203
1613258|NCT00929578|3945656|P1|NOT COMPLETED|Overall Study||0
1613259|NCT00929578|3945656|P1|COMPLETED|Overall Study||15
1613260|NCT00929578|3945656|P1|STARTED|Overall Study||15
1613261|NCT00929526|3945669|P2|NOT COMPLETED|Overall Study||29
1613262|NCT00929526|3945670|P1|NOT COMPLETED|Overall Study||17
1613263|NCT00929526|3945669|P2|COMPLETED|Overall Study||348
1613264|NCT00929526|3945670|P1|COMPLETED|Overall Study||358
1613265|NCT00929526|3945669|P2|STARTED|Overall Study||377
1613266|NCT00929526|3945670|P1|STARTED|Overall Study||375
1613267|NCT00929500|3945706|P2|NOT COMPLETED|Overall Study||0
1613268|NCT00929500|3945707|P1|NOT COMPLETED|Overall Study||4
1613269|NCT00929500|3945706|P2|COMPLETED|Overall Study||4
1613270|NCT00929500|3945707|P1|COMPLETED|Overall Study||4
1613271|NCT00929500|3945706|P2|STARTED|Overall Study||4
1613272|NCT00929500|3945707|P1|STARTED|Overall Study||8
1613273|NCT00929474|3945721|P2|NOT COMPLETED|Overall Study||9
1613274|NCT00929474|3945722|P1|NOT COMPLETED|Overall Study||8
1613275|NCT00929474|3945721|P2|COMPLETED|Overall Study||0
1613276|NCT00929474|3945722|P1|COMPLETED|Overall Study||0
1613277|NCT00929474|3945721|P2|STARTED|Overall Study||9
1613278|NCT00929474|3945722|P1|STARTED|Overall Study||8
1613279|NCT00929383|3945728|P1|NOT COMPLETED|Overall Study||15
1613280|NCT00929383|3945728|P1|COMPLETED|Overall Study||67
1613281|NCT00929383|3945728|P1|STARTED|Overall Study||82
1613282|NCT00929357|3945738|P2|NOT COMPLETED|Overall Study||0
1613283|NCT00929357|3945739|P1|NOT COMPLETED|Overall Study||0
1613284|NCT00929357|3945738|P2|COMPLETED|Overall Study||64
1613285|NCT00929357|3945739|P1|COMPLETED|Overall Study||92
1613286|NCT00929357|3945738|P2|STARTED|Overall Study||64
1613287|NCT00929357|3945739|P1|STARTED|Overall Study||92
1613288|NCT00929344|3945762|P3|NOT COMPLETED|Overall Study||21
1613289|NCT00929344|3945763|P2|NOT COMPLETED|Overall Study||13
1613290|NCT00929344|3945764|P1|NOT COMPLETED|Overall Study||22
1613291|NCT00929344|3945762|P3|COMPLETED|Overall Study||29
1613292|NCT00929344|3945763|P2|COMPLETED|Overall Study||37
1613293|NCT00929344|3945764|P1|COMPLETED|Overall Study||28
1613294|NCT00929344|3945762|P3|STARTED|Overall Study||50
1613295|NCT00929344|3945763|P2|STARTED|Overall Study||50
1613296|NCT00929344|3945764|P1|STARTED|Overall Study||50
1613297|NCT00929331|3945780|P2|NOT COMPLETED|Overall Study||0
1613298|NCT00929331|3945781|P1|NOT COMPLETED|Overall Study||0
1613299|NCT00929331|3945780|P2|COMPLETED|Overall Study||55
1613300|NCT00929331|3945781|P1|COMPLETED|Overall Study||55
1613301|NCT00929331|3945780|P2|STARTED|Overall Study||55
1613302|NCT00929331|3945781|P1|STARTED|Overall Study||55
1613303|NCT00929305|3945815|P2|NOT COMPLETED|Overall Study||0
1613304|NCT00929305|3945816|P1|NOT COMPLETED|Overall Study||0
1613305|NCT00929305|3945815|P2|COMPLETED|Overall Study||43
1613306|NCT00929305|3945816|P1|COMPLETED|Overall Study||43
1613307|NCT00929305|3945815|P2|STARTED|Overall Study||43
1613308|NCT00929305|3945816|P1|STARTED|Overall Study||43
1613309|NCT00929240|3945824|P3|NOT COMPLETED|Maintenance Phase||91
1613310|NCT00929240|3945825|P2|NOT COMPLETED|Maintenance Phase||94
1613311|NCT00929240|3945826|P1|NOT COMPLETED|Maintenance Phase||0
1613312|NCT00929240|3945824|P3|COMPLETED|Maintenance Phase||0
1613313|NCT00929240|3945825|P2|COMPLETED|Maintenance Phase||0
1613314|NCT00929240|3945826|P1|COMPLETED|Maintenance Phase||0
1613315|NCT00929240|3945824|P3|STARTED|Maintenance Phase||91
1613316|NCT00929240|3945825|P2|STARTED|Maintenance Phase||94
1613317|NCT00929240|3945826|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
1613318|NCT00929240|3945824|P3|NOT COMPLETED|Initial Treatment Phase||0
1613319|NCT00929240|3945825|P2|NOT COMPLETED|Initial Treatment Phase||0
1613320|NCT00929240|3945826|P1|NOT COMPLETED|Initial Treatment Phase||99
1613321|NCT00929240|3945824|P3|COMPLETED|Initial Treatment Phase||0
1613322|NCT00929240|3945825|P2|COMPLETED|Initial Treatment Phase||0
1613323|NCT00929240|3945826|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
1613324|NCT00929240|3945824|P3|STARTED|Initial Treatment Phase||0
1613325|NCT00929240|3945825|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
1613326|NCT00929240|3945826|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
1613327|NCT00929201|3945853|P2|NOT COMPLETED|Period 2||0
1613328|NCT00929201|3945854|P1|NOT COMPLETED|Period 2||0
1613329|NCT00929201|3945853|P2|COMPLETED|Period 2||30
1613330|NCT00929201|3945854|P1|COMPLETED|Period 2||30
1613331|NCT00929201|3945853|P2|STARTED|Period 2||30
1613332|NCT00929201|3945854|P1|STARTED|Period 2||30
1613333|NCT00929201|3945853|P2|NOT COMPLETED|7-day Washout||0
1613334|NCT00929201|3945854|P1|NOT COMPLETED|7-day Washout||0
1613335|NCT00929201|3945853|P2|COMPLETED|7-day Washout||30
1613336|NCT00929201|3945854|P1|COMPLETED|7-day Washout||30
1613337|NCT00929201|3945853|P2|STARTED|7-day Washout||30
1613338|NCT00929201|3945854|P1|STARTED|7-day Washout||30
1613339|NCT00929201|3945853|P2|NOT COMPLETED|Period 1||1
1613340|NCT00929201|3945854|P1|NOT COMPLETED|Period 1||0
1613341|NCT00929201|3945853|P2|COMPLETED|Period 1||30
1613342|NCT00929201|3945854|P1|COMPLETED|Period 1||30
1613343|NCT00929201|3945853|P2|STARTED|Period 1||31
1613344|NCT00929201|3945854|P1|STARTED|Period 1||30
1613345|NCT00929162|3945864|P2|NOT COMPLETED|Overall Study||42
1613346|NCT00929162|3945865|P1|NOT COMPLETED|Overall Study||48
1613347|NCT00929162|3945864|P2|COMPLETED|Overall Study||19
1613348|NCT00929162|3945865|P1|COMPLETED|Overall Study||11
1613349|NCT00929162|3945864|P2|Patients Who Received Treatment|Overall Study||58
1613350|NCT00929162|3945865|P1|Patients Who Received Treatment|Overall Study||58
1613351|NCT00929162|3945864|P2|STARTED|Overall Study||61
1613352|NCT00929162|3945865|P1|STARTED|Overall Study||59
1613353|NCT00929110|3945878|P3|NOT COMPLETED|Overall Study||62
1613354|NCT00929110|3945879|P2|NOT COMPLETED|Overall Study||76
1613355|NCT00929110|3945880|P1|NOT COMPLETED|Overall Study||118
1613356|NCT00929110|3945878|P3|COMPLETED|Overall Study||206
1613357|NCT00929110|3945879|P2|COMPLETED|Overall Study||193
1613358|NCT00929110|3945880|P1|COMPLETED|Overall Study||411
1613359|NCT00929110|3945878|P3|STARTED|Overall Study||268
1613360|NCT00929110|3945879|P2|STARTED|Overall Study||269
1613361|NCT00929110|3945880|P1|STARTED|Overall Study||529
1613362|NCT00929071|3945945|P1|NOT COMPLETED|Overall Study||0
1613363|NCT00929071|3945945|P1|COMPLETED|Overall Study||10
1613364|NCT00929071|3945945|P1|STARTED|Overall Study||10
1613365|NCT00928954|3945952|P2|NOT COMPLETED|Overall Study||0
1613366|NCT00928954|3945953|P1|NOT COMPLETED|Overall Study||0
1613367|NCT00928954|3945952|P2|COMPLETED|Overall Study||6
1613368|NCT00928954|3945953|P1|COMPLETED|Overall Study||4
1613369|NCT00928954|3945952|P2|STARTED|Overall Study||6
1613370|NCT00928954|3945953|P1|STARTED|Overall Study||4
1613371|NCT00928889|3945963|P2|NOT COMPLETED|Overall Study||2
1613372|NCT00928889|3945964|P1|NOT COMPLETED|Overall Study||5
1613373|NCT00928889|3945963|P2|COMPLETED|Overall Study||78
1613374|NCT00928889|3945964|P1|COMPLETED|Overall Study||75
1613375|NCT00928889|3945963|P2|STARTED|Overall Study||80
1613376|NCT00928889|3945964|P1|STARTED|Overall Study||80
1613377|NCT00928772|3945991|P3|NOT COMPLETED|Overall Study||0
1613378|NCT00928772|3945992|P2|NOT COMPLETED|Overall Study||0
1613379|NCT00928772|3945993|P1|NOT COMPLETED|Overall Study||0
1613380|NCT00928772|3945991|P3|COMPLETED|Overall Study||38
1613381|NCT00928772|3945992|P2|COMPLETED|Overall Study||38
1613382|NCT00928772|3945993|P1|COMPLETED|Overall Study||39
1613383|NCT00928772|3945991|P3|STARTED|Overall Study||38
1613384|NCT00928772|3945992|P2|STARTED|Overall Study||38
1613385|NCT00928772|3945993|P1|STARTED|Overall Study||39
1613386|NCT00928746|3946010|P1|NOT COMPLETED|Overall Study||6
1613387|NCT00928746|3946010|P1|COMPLETED|Overall Study||136
1613388|NCT00928746|3946010|P1|STARTED|Overall Study||142
1613389|NCT00928720|3946033|P3|NOT COMPLETED|Overall Study||3
1613390|NCT00928720|3946034|P2|NOT COMPLETED|Overall Study||6
1613391|NCT00928720|3946035|P1|NOT COMPLETED|Overall Study||2
1613392|NCT00928720|3946033|P3|COMPLETED|Overall Study||15
1613393|NCT00928720|3946034|P2|COMPLETED|Overall Study||14
1613394|NCT00928720|3946035|P1|COMPLETED|Overall Study||17
1613395|NCT00928720|3946033|P3|STARTED|Overall Study||18
1613396|NCT00928720|3946034|P2|STARTED|Overall Study||20
1613397|NCT00928720|3946035|P1|STARTED|Overall Study||19
1613398|NCT00928694|3946058|P2|NOT COMPLETED|Second Intervention||0
1613399|NCT00928694|3946059|P1|NOT COMPLETED|Second Intervention||0
1613400|NCT00928694|3946058|P2|COMPLETED|Second Intervention||7
1613401|NCT00928694|3946059|P1|COMPLETED|Second Intervention||7
1613402|NCT00928694|3946058|P2|STARTED|Second Intervention||7
1613403|NCT00928694|3946059|P1|STARTED|Second Intervention||7
1613404|NCT00928694|3946058|P2|NOT COMPLETED|First Intervention||0
1613405|NCT00928694|3946059|P1|NOT COMPLETED|First Intervention||0
1613406|NCT00928694|3946058|P2|COMPLETED|First Intervention||7
1613407|NCT00928694|3946059|P1|COMPLETED|First Intervention||7
1613408|NCT00928694|3946058|P2|STARTED|First Intervention||7
1613409|NCT00928694|3946059|P1|STARTED|First Intervention||7
1613410|NCT00928668|3946067|P5|NOT COMPLETED|Overall Study||1
1613411|NCT00928668|3946068|P4|NOT COMPLETED|Overall Study||1
1613412|NCT00928668|3946069|P3|NOT COMPLETED|Overall Study||1
1613413|NCT00928668|3946070|P2|NOT COMPLETED|Overall Study||1
1613414|NCT00928668|3946071|P1|NOT COMPLETED|Overall Study||1
1613415|NCT00928668|3946067|P5|COMPLETED|Overall Study||5
1613416|NCT00928668|3946068|P4|COMPLETED|Overall Study||3
1613417|NCT00928668|3946069|P3|COMPLETED|Overall Study||6
1613418|NCT00928668|3946070|P2|COMPLETED|Overall Study||6
1613419|NCT00928668|3946071|P1|COMPLETED|Overall Study||6
1613420|NCT00928668|3946067|P5|STARTED|Overall Study||6
1613421|NCT00928668|3946068|P4|STARTED|Overall Study||4
1613422|NCT00928668|3946069|P3|STARTED|Overall Study||7
1613423|NCT00928668|3946070|P2|STARTED|Overall Study||7
1613424|NCT00928668|3946071|P1|STARTED|Overall Study||7
1613425|NCT00928642|3946113|P1|NOT COMPLETED|Overall Study||0
1613426|NCT00928642|3946113|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
1613427|NCT00928642|3946113|P1|STARTED|Overall Study||8
1613428|NCT00928512|3946127|P5|NOT COMPLETED|Overall Study||15
1613429|NCT00928512|3946128|P4|NOT COMPLETED|Overall Study||21
1613430|NCT00928512|3946129|P3|NOT COMPLETED|Overall Study||11
1613431|NCT00928512|3946130|P2|NOT COMPLETED|Overall Study||6
1613432|NCT00928512|3946131|P1|NOT COMPLETED|Overall Study||10
1613433|NCT00928512|3946127|P5|COMPLETED|Overall Study||35
1613434|NCT00928512|3946128|P4|COMPLETED|Overall Study||33
1613435|NCT00928512|3946129|P3|COMPLETED|Overall Study||38
1613436|NCT00928512|3946130|P2|COMPLETED|Overall Study||37
1613437|NCT00928512|3946131|P1|COMPLETED|Overall Study||31
1613438|NCT00928512|3946127|P5|Entered/Continued to Week 20 (All)|Overall Study||45
1613439|NCT00928512|3946128|P4|Entered/Continued to Week 20 (All)|Overall Study||45
1613440|NCT00928512|3946129|P3|Entered/Continued to Week 20 (All)|Overall Study||46
1613441|NCT00928512|3946130|P2|Entered/Continued to Week 20 (All)|Overall Study||43
1613442|NCT00928512|3946131|P1|Entered/Continued to Week 20 (All)|Overall Study||37
1613443|NCT00928512|3946127|P5|Completed Week 16|Overall Study||45
1613444|NCT00928512|3946128|P4|Completed Week 16|Overall Study||48
1613445|NCT00928512|3946129|P3|Completed Week 16|Overall Study||47
1613446|NCT00928512|3946130|P2|Completed Week 16|Overall Study||43
1613447|NCT00928512|3946131|P1|Completed Week 16|Overall Study||38
1613448|NCT00928512|3946127|P5|New Groups After Reassignment|Overall Study||0
1613449|NCT00928512|3946128|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
1613450|NCT00928512|3946129|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
1613451|NCT00928512|3946130|P2|New Groups After Reassignment|Overall Study||115
1613452|NCT00928512|3946131|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
1613453|NCT00928512|3946127|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
1613454|NCT00928512|3946128|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
1613455|NCT00928512|3946129|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
1613456|NCT00928512|3946130|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
1613457|NCT00928512|3946131|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
1613458|NCT00928512|3946127|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
1613459|NCT00928512|3946128|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
1613460|NCT00928512|3946129|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
1613461|NCT00928512|3946130|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
1613462|NCT00928512|3946131|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
1613463|NCT00928512|3946127|P5|Discontinued Prior to Week 16|Overall Study||5
1613464|NCT00928512|3946128|P4|Discontinued Prior to Week 16|Overall Study||6
1613465|NCT00928512|3946129|P3|Discontinued Prior to Week 16|Overall Study||2
1613466|NCT00928512|3946130|P2|Discontinued Prior to Week 16|Overall Study||0
1613467|NCT00928512|3946131|P1|Discontinued Prior to Week 16|Overall Study||3
1613468|NCT00928512|3946127|P5|STARTED|Overall Study||50
1613469|NCT00928512|3946128|P4|STARTED|Overall Study||54
1613470|NCT00928512|3946129|P3|STARTED|Overall Study||49
1613471|NCT00928512|3946130|P2|STARTED|Overall Study||43
1613472|NCT00928512|3946131|P1|STARTED|Overall Study||41
1613473|NCT00928486|3946232|P1|NOT COMPLETED|Overall Study||10
1613474|NCT00928486|3946232|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
1613475|NCT00928486|3946232|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
1613476|NCT00928486|3946232|P1|STARTED|Overall Study||25
1613477|NCT00928434|3946241|P3|NOT COMPLETED|Overall Study||44
1613478|NCT00928434|3946242|P2|NOT COMPLETED|Overall Study||14
1613479|NCT00928434|3946243|P1|NOT COMPLETED|Overall Study||44
1613480|NCT00928434|3946241|P3|COMPLETED|Overall Study||134
1613481|NCT00928434|3946242|P2|COMPLETED|Overall Study||36
1613482|NCT00928434|3946243|P1|COMPLETED|Overall Study||131
1613483|NCT00928434|3946241|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
1613484|NCT00928434|3946242|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
1613485|NCT00928434|3946243|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
1613486|NCT00928434|3946241|P3|STARTED|Overall Study|Full Analysis Set Patients|178
1613487|NCT00928434|3946242|P2|STARTED|Overall Study|Full Analysis Set Patients|50
1613488|NCT00928434|3946243|P1|STARTED|Overall Study|Full Analysis Set Patients|175
1613489|NCT00928421|3946315|P1|NOT COMPLETED|Overall Study||0
1613490|NCT00928421|3946315|P1|COMPLETED|Overall Study||16
1613491|NCT00928421|3946315|P1|Treated With Study Drug|Overall Study||16
1613492|NCT00928421|3946315|P1|STARTED|Overall Study||16
1613493|NCT00928408|3946319|P1|NOT COMPLETED|Overall Study||23
1613494|NCT00928408|3946319|P1|COMPLETED|Overall Study||282
1613495|NCT00928408|3946319|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
1613496|NCT00928408|3946319|P1|STARTED|Overall Study|Number Enrolled|305
1613497|NCT00928395|3946348|P1|NOT COMPLETED|Overall Study||21
1613498|NCT00928395|3946348|P1|COMPLETED|Overall Study||29
1613499|NCT00928395|3946348|P1|STARTED|Overall Study||50
1613500|NCT00928304|3946352|P2|NOT COMPLETED|Overall Study||0
1613501|NCT00928304|3946353|P1|NOT COMPLETED|Overall Study||0
1613502|NCT00928304|3946352|P2|COMPLETED|Overall Study||70
1613503|NCT00928304|3946353|P1|COMPLETED|Overall Study||39
1613504|NCT00928304|3946352|P2|STARTED|Overall Study||70
1613505|NCT00928304|3946353|P1|STARTED|Overall Study||39
1613506|NCT00928252|3946365|P1|NOT COMPLETED|Overall Study||3
1613507|NCT00928252|3946365|P1|COMPLETED|Overall Study||42
1613508|NCT00928252|3946365|P1|STARTED|Overall Study||45
1613509|NCT00928187|3946374|P3|NOT COMPLETED|Overall Study||5
1613510|NCT00928187|3946375|P2|NOT COMPLETED|Overall Study||6
1613511|NCT00928187|3946376|P1|NOT COMPLETED|Overall Study||2
1613512|NCT00928187|3946374|P3|COMPLETED|Overall Study||150
1613513|NCT00928187|3946375|P2|COMPLETED|Overall Study||141
1613514|NCT00928187|3946376|P1|COMPLETED|Overall Study||150
1613515|NCT00928187|3946374|P3|Analysed|Overall Study||154
1613516|NCT00928187|3946375|P2|Analysed|Overall Study||145
1613517|NCT00928187|3946376|P1|Analysed|Overall Study||152
1613518|NCT00928187|3946374|P3|STARTED|Overall Study||155
1613519|NCT00928187|3946375|P2|STARTED|Overall Study||147
1613520|NCT00928187|3946376|P1|STARTED|Overall Study||152
1613521|NCT00928174|3946420|P1|NOT COMPLETED|Overall Study||5
1613522|NCT00928174|3946420|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
1613523|NCT00928174|3946420|P1|STARTED|Overall Study||27
1613524|NCT00928083|3946427|P9|NOT COMPLETED|Overall Study||0
1613525|NCT00928083|3946428|P8|NOT COMPLETED|Overall Study||0
1613526|NCT00928083|3946429|P7|NOT COMPLETED|Overall Study||0
1613527|NCT00928083|3946430|P6|NOT COMPLETED|Overall Study||0
1613528|NCT00928083|3946431|P5|NOT COMPLETED|Overall Study||1
1613529|NCT00928083|3946432|P4|NOT COMPLETED|Overall Study||1
1613530|NCT00928083|3946433|P3|NOT COMPLETED|Overall Study||0
1613531|NCT00928083|3946434|P2|NOT COMPLETED|Overall Study||0
1613532|NCT00928083|3946435|P1|NOT COMPLETED|Overall Study||4
1613533|NCT00928083|3946427|P9|COMPLETED|Overall Study||6
1613534|NCT00928083|3946428|P8|COMPLETED|Overall Study||6
1613535|NCT00928083|3946429|P7|COMPLETED|Overall Study||6
1613536|NCT00928083|3946430|P6|COMPLETED|Overall Study||6
1613537|NCT00928083|3946431|P5|COMPLETED|Overall Study||6
1613538|NCT00928083|3946432|P4|COMPLETED|Overall Study||5
1613539|NCT00928083|3946433|P3|COMPLETED|Overall Study||8
1613540|NCT00928083|3946434|P2|COMPLETED|Overall Study||8
1613541|NCT00928083|3946435|P1|COMPLETED|Overall Study||6
1613542|NCT00928083|3946427|P9|STARTED|Overall Study||6
1613543|NCT00928083|3946428|P8|STARTED|Overall Study||6
1613544|NCT00928083|3946429|P7|STARTED|Overall Study||6
1613545|NCT00928083|3946430|P6|STARTED|Overall Study||6
1613546|NCT00928083|3946431|P5|STARTED|Overall Study||7
1613547|NCT00928083|3946432|P4|STARTED|Overall Study||6
1613548|NCT00928083|3946433|P3|STARTED|Overall Study||8
1613549|NCT00928083|3946434|P2|STARTED|Overall Study||8
1613550|NCT00928083|3946435|P1|STARTED|Overall Study||10
1613551|NCT00928070|3946546|P2|NOT COMPLETED|Overall Study||57
1613552|NCT00928070|3946547|P1|NOT COMPLETED|Overall Study||63
1613553|NCT00928070|3946546|P2|COMPLETED|Overall Study||226
1613554|NCT00928070|3946547|P1|COMPLETED|Overall Study||220
1613555|NCT00928070|3946546|P2|Treated|Overall Study||281
1613556|NCT00928070|3946547|P1|Treated|Overall Study||281
1613557|NCT00928070|3946546|P2|STARTED|Overall Study||283
1613558|NCT00928070|3946547|P1|STARTED|Overall Study||283
1613559|NCT00928057|3946605|P2|NOT COMPLETED|Overall Study||4
1613560|NCT00928057|3946606|P1|NOT COMPLETED|Overall Study||2
1613561|NCT00928057|3946605|P2|COMPLETED|Overall Study||85
1613562|NCT00928057|3946606|P1|COMPLETED|Overall Study||82
1613563|NCT00928057|3946605|P2|STARTED|Overall Study||89
1613564|NCT00928057|3946606|P1|STARTED|Overall Study||84
1613565|NCT00928018|3946631|P2|NOT COMPLETED|Overall Study||0
1613566|NCT00928018|3946632|P1|NOT COMPLETED|Overall Study||1
1613567|NCT00928018|3946631|P2|COMPLETED|Overall Study||73
1613568|NCT00928018|3946632|P1|COMPLETED|Overall Study||65
1613569|NCT00928018|3946631|P2|STARTED|Overall Study||73
1613570|NCT00928018|3946632|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
1613571|NCT00927992|3946650|P1|NOT COMPLETED|Overall Study||0
1613572|NCT00927992|3946650|P1|COMPLETED|Overall Study||11
1613573|NCT00927992|3946650|P1|STARTED|Overall Study||11
1613574|NCT00927953|3946662|P2|NOT COMPLETED|Overall Study||1
1613575|NCT00927953|3946663|P1|NOT COMPLETED|Overall Study||2
1613576|NCT00927953|3946662|P2|COMPLETED|Overall Study||6
1613577|NCT00927953|3946663|P1|COMPLETED|Overall Study||4
1613578|NCT00927953|3946662|P2|STARTED|Overall Study||7
1613579|NCT00927953|3946663|P1|STARTED|Overall Study||6
1613580|NCT00927940|3946677|P1|NOT COMPLETED|Overall Study||1
1613581|NCT00927940|3946677|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
1613582|NCT00927940|3946677|P1|STARTED|Overall Study||100
1613583|NCT00927927|3946697|P15|NOT COMPLETED|Overall Study||0
1613584|NCT00927927|3946698|P14|NOT COMPLETED|Overall Study||0
1613585|NCT00927927|3946699|P13|NOT COMPLETED|Overall Study||0
1613586|NCT00927927|3946700|P12|NOT COMPLETED|Overall Study||2
1613587|NCT00927927|3946701|P11|NOT COMPLETED|Overall Study||0
1613588|NCT00927927|3946702|P10|NOT COMPLETED|Overall Study||0
1613589|NCT00927927|3946703|P9|NOT COMPLETED|Overall Study||0
1613590|NCT00927927|3946704|P8|NOT COMPLETED|Overall Study||2
1613591|NCT00927927|3946705|P7|NOT COMPLETED|Overall Study||0
1613592|NCT00927927|3946706|P6|NOT COMPLETED|Overall Study||0
1613593|NCT00927927|3946707|P5|NOT COMPLETED|Overall Study||0
1613594|NCT00927927|3946708|P4|NOT COMPLETED|Overall Study||0
1613595|NCT00927927|3946709|P3|NOT COMPLETED|Overall Study||0
1613596|NCT00927927|3946710|P2|NOT COMPLETED|Overall Study||0
1613597|NCT00927927|3946711|P1|NOT COMPLETED|Overall Study||0
1613598|NCT00927927|3946697|P15|COMPLETED|Overall Study||9
1613599|NCT00927927|3946698|P14|COMPLETED|Overall Study||5
1613600|NCT00927927|3946699|P13|COMPLETED|Overall Study||5
1613601|NCT00927927|3946700|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
1613602|NCT00927927|3946701|P11|COMPLETED|Overall Study||5
1613603|NCT00927927|3946702|P10|COMPLETED|Overall Study||3
1613604|NCT00927927|3946703|P9|COMPLETED|Overall Study||8
1613605|NCT00927927|3946704|P8|COMPLETED|Overall Study||1
1613606|NCT00927927|3946705|P7|COMPLETED|Overall Study||3
1613607|NCT00927927|3946706|P6|COMPLETED|Overall Study||3
1613608|NCT00927927|3946707|P5|COMPLETED|Overall Study||3
1613609|NCT00927927|3946708|P4|COMPLETED|Overall Study||3
1613610|NCT00927927|3946709|P3|COMPLETED|Overall Study||3
1613611|NCT00927927|3946710|P2|COMPLETED|Overall Study||3
1613612|NCT00927927|3946711|P1|COMPLETED|Overall Study||3
1613613|NCT00927927|3946697|P15|Exposed|Overall Study||9
1613614|NCT00927927|3946698|P14|Exposed|Overall Study||5
1613615|NCT00927927|3946699|P13|Exposed|Overall Study||5
1613616|NCT00927927|3946700|P12|Exposed|Overall Study||5
1613617|NCT00927927|3946701|P11|Exposed|Overall Study||5
1613618|NCT00927927|3946702|P10|Exposed|Overall Study||3
1613619|NCT00927927|3946703|P9|Exposed|Overall Study||8
1613620|NCT00927927|3946704|P8|Exposed|Overall Study||3
1613621|NCT00927927|3946705|P7|Exposed|Overall Study||3
1613622|NCT00927927|3946706|P6|Exposed|Overall Study||3
1613623|NCT00927927|3946707|P5|Exposed|Overall Study||3
1613624|NCT00927927|3946708|P4|Exposed|Overall Study||3
1613625|NCT00927927|3946709|P3|Exposed|Overall Study||3
1613626|NCT00927927|3946710|P2|Exposed|Overall Study||3
1613627|NCT00927927|3946711|P1|Exposed|Overall Study||3
1613628|NCT00927927|3946697|P15|STARTED|Overall Study||9
1613629|NCT00927927|3946698|P14|STARTED|Overall Study||5
1613630|NCT00927927|3946699|P13|STARTED|Overall Study||5
1613631|NCT00927927|3946700|P12|STARTED|Overall Study||6
1613632|NCT00927927|3946701|P11|STARTED|Overall Study||5
1613633|NCT00927927|3946702|P10|STARTED|Overall Study||3
1613634|NCT00927927|3946703|P9|STARTED|Overall Study||8
1613635|NCT00927927|3946704|P8|STARTED|Overall Study||3
1613636|NCT00927927|3946705|P7|STARTED|Overall Study||3
1613637|NCT00927927|3946706|P6|STARTED|Overall Study||3
1613638|NCT00927927|3946707|P5|STARTED|Overall Study||3
1613639|NCT00927927|3946708|P4|STARTED|Overall Study||3
1613640|NCT00927927|3946709|P3|STARTED|Overall Study||3
1613641|NCT00927927|3946710|P2|STARTED|Overall Study||3
1613642|NCT00927927|3946711|P1|STARTED|Overall Study||3
1613643|NCT00927901|3946758|P4|NOT COMPLETED|Treatment Period 4||1
1613644|NCT00927901|3946759|P3|NOT COMPLETED|Treatment Period 4||1
1613645|NCT00927901|3946760|P2|NOT COMPLETED|Treatment Period 4||0
1613646|NCT00927901|3946761|P1|NOT COMPLETED|Treatment Period 4||0
1613647|NCT00927901|3946758|P4|COMPLETED|Treatment Period 4||8
1613648|NCT00927901|3946759|P3|COMPLETED|Treatment Period 4||5
1613649|NCT00927901|3946760|P2|COMPLETED|Treatment Period 4||7
1613650|NCT00927901|3946761|P1|COMPLETED|Treatment Period 4||7
1613651|NCT00927901|3946758|P4|STARTED|Treatment Period 4||9
1613652|NCT00927901|3946759|P3|STARTED|Treatment Period 4||6
1613653|NCT00927901|3946760|P2|STARTED|Treatment Period 4||7
1613654|NCT00927901|3946761|P1|STARTED|Treatment Period 4||7
1613655|NCT00927901|3946758|P4|NOT COMPLETED|Treatment Period 3||0
1613656|NCT00927901|3946759|P3|NOT COMPLETED|Treatment Period 3||0
1613657|NCT00927901|3946760|P2|NOT COMPLETED|Treatment Period 3||0
1613658|NCT00927901|3946761|P1|NOT COMPLETED|Treatment Period 3||0
1613659|NCT00927901|3946758|P4|COMPLETED|Treatment Period 3||9
1613660|NCT00927901|3946759|P3|COMPLETED|Treatment Period 3||6
1613661|NCT00927901|3946760|P2|COMPLETED|Treatment Period 3||7
1613662|NCT00927901|3946761|P1|COMPLETED|Treatment Period 3||7
1613663|NCT00927901|3946758|P4|STARTED|Treatment Period 3||9
1613664|NCT00927901|3946759|P3|STARTED|Treatment Period 3||6
1613665|NCT00927901|3946760|P2|STARTED|Treatment Period 3||7
1613666|NCT00927901|3946761|P1|STARTED|Treatment Period 3||7
1613667|NCT00927901|3946758|P4|NOT COMPLETED|Treatment Period 2||0
1613668|NCT00927901|3946759|P3|NOT COMPLETED|Treatment Period 2||0
1613669|NCT00927901|3946760|P2|NOT COMPLETED|Treatment Period 2||0
1613670|NCT00927901|3946761|P1|NOT COMPLETED|Treatment Period 2||0
1613671|NCT00927901|3946758|P4|COMPLETED|Treatment Period 2||9
1613672|NCT00927901|3946759|P3|COMPLETED|Treatment Period 2||6
1613673|NCT00927901|3946760|P2|COMPLETED|Treatment Period 2||7
1613674|NCT00927901|3946761|P1|COMPLETED|Treatment Period 2||7
1613675|NCT00927901|3946758|P4|STARTED|Treatment Period 2||9
1613676|NCT00927901|3946759|P3|STARTED|Treatment Period 2||6
1613677|NCT00927901|3946760|P2|STARTED|Treatment Period 2||7
1613678|NCT00927901|3946761|P1|STARTED|Treatment Period 2||7
1613679|NCT00927901|3946758|P4|NOT COMPLETED|Treatment Period 1||0
1613680|NCT00927901|3946759|P3|NOT COMPLETED|Treatment Period 1||1
1613681|NCT00927901|3946760|P2|NOT COMPLETED|Treatment Period 1||0
1613682|NCT00927901|3946761|P1|NOT COMPLETED|Treatment Period 1||0
1613683|NCT00927901|3946758|P4|COMPLETED|Treatment Period 1||9
1613684|NCT00927901|3946759|P3|COMPLETED|Treatment Period 1||6
1613685|NCT00927901|3946760|P2|COMPLETED|Treatment Period 1||7
1613686|NCT00927901|3946761|P1|COMPLETED|Treatment Period 1||7
1613687|NCT00927901|3946758|P4|STARTED|Treatment Period 1||9
1613688|NCT00927901|3946759|P3|STARTED|Treatment Period 1||7
1613689|NCT00927901|3946760|P2|STARTED|Treatment Period 1||7
1613690|NCT00927901|3946761|P1|STARTED|Treatment Period 1||7
1613691|NCT00927888|3946791|P2|NOT COMPLETED|Overall Study||0
1613692|NCT00927888|3946792|P1|NOT COMPLETED|Overall Study||0
1613693|NCT00927888|3946791|P2|COMPLETED|Overall Study||27
1613694|NCT00927888|3946792|P1|COMPLETED|Overall Study||29
1613695|NCT00927888|3946791|P2|STARTED|Overall Study||27
1613696|NCT00927888|3946792|P1|STARTED|Overall Study||29
1613697|NCT00927862|3946802|P2|NOT COMPLETED|Overall Study||45
1613698|NCT00927862|3946803|P1|NOT COMPLETED|Overall Study||27
1613699|NCT00927862|3946802|P2|COMPLETED|Overall Study||1866
1613700|NCT00927862|3946803|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
1613701|NCT00927862|3946802|P2|STARTED|Overall Study||1911
1613702|NCT00927862|3946803|P1|STARTED|Overall Study||504
1613703|NCT00927849|3946828|P3|NOT COMPLETED|Overall Study||0
1613704|NCT00927849|3946829|P2|NOT COMPLETED|Overall Study||0
1613705|NCT00927849|3946830|P1|NOT COMPLETED|Overall Study||0
1613706|NCT00927849|3946828|P3|COMPLETED|Overall Study||21
1613707|NCT00927849|3946829|P2|COMPLETED|Overall Study||21
1613708|NCT00927849|3946830|P1|COMPLETED|Overall Study||21
1613709|NCT00927849|3946828|P3|STARTED|Overall Study||21
1613710|NCT00927849|3946829|P2|STARTED|Overall Study||21
1613711|NCT00927849|3946830|P1|STARTED|Overall Study||21
1613712|NCT00927823|3946838|P4|NOT COMPLETED|Continuous Dosing Period||5
1613713|NCT00927823|3946839|P3|NOT COMPLETED|Continuous Dosing Period||26
1613714|NCT00927823|3946840|P2|NOT COMPLETED|Continuous Dosing Period||3
1613715|NCT00927823|3946841|P1|NOT COMPLETED|Continuous Dosing Period||3
1613716|NCT00927823|3946838|P4|COMPLETED|Continuous Dosing Period||0
1613717|NCT00927823|3946839|P3|COMPLETED|Continuous Dosing Period||0
1613718|NCT00927823|3946840|P2|COMPLETED|Continuous Dosing Period||0
1613719|NCT00927823|3946841|P1|COMPLETED|Continuous Dosing Period||0
1613720|NCT00927823|3946838|P4|Treated|Continuous Dosing Period||5
1613721|NCT00927823|3946839|P3|Treated|Continuous Dosing Period||23
1613722|NCT00927823|3946840|P2|Treated|Continuous Dosing Period||3
1613723|NCT00927823|3946841|P1|Treated|Continuous Dosing Period||3
1613724|NCT00927823|3946838|P4|STARTED|Continuous Dosing Period||5
1613725|NCT00927823|3946839|P3|STARTED|Continuous Dosing Period||26
1613726|NCT00927823|3946840|P2|STARTED|Continuous Dosing Period||3
1613727|NCT00927823|3946841|P1|STARTED|Continuous Dosing Period||3
1613728|NCT00927823|3946838|P4|NOT COMPLETED|Lead-In Period||0
1613729|NCT00927823|3946839|P3|NOT COMPLETED|Lead-In Period||0
1613730|NCT00927823|3946840|P2|NOT COMPLETED|Lead-In Period||0
1613731|NCT00927823|3946841|P1|NOT COMPLETED|Lead-In Period||0
1613732|NCT00927823|3946838|P4|COMPLETED|Lead-In Period||5
1613733|NCT00927823|3946839|P3|COMPLETED|Lead-In Period||26
1613734|NCT00927823|3946840|P2|COMPLETED|Lead-In Period||3
1613735|NCT00927823|3946841|P1|COMPLETED|Lead-In Period||3
1613736|NCT00927823|3946838|P4|STARTED|Lead-In Period||5
1613737|NCT00927823|3946839|P3|STARTED|Lead-In Period||26
1613738|NCT00927823|3946840|P2|STARTED|Lead-In Period||3
1613739|NCT00927823|3946841|P1|STARTED|Lead-In Period||3
1613740|NCT00927758|3946905|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1613741|NCT00927758|3946906|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1613742|NCT00927758|3946907|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1613743|NCT00927758|3946908|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1613744|NCT00927758|3946909|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1613745|NCT00927758|3946910|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1613746|NCT00927758|3946905|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
1613747|NCT00927758|3946906|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
1613748|NCT00927758|3946907|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
1613749|NCT00927758|3946908|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
1613750|NCT00927758|3946909|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
1613751|NCT00927758|3946910|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
1613752|NCT00927758|3946905|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
1613753|NCT00927758|3946906|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
1613754|NCT00927758|3946907|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
1613755|NCT00927758|3946908|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
1613756|NCT00927758|3946909|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
1613757|NCT00927758|3946910|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
1613758|NCT00927758|3946905|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1613759|NCT00927758|3946906|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
1613760|NCT00927758|3946907|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1613761|NCT00927758|3946908|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1613762|NCT00927758|3946909|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
1613763|NCT00927758|3946910|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
1613764|NCT00927758|3946905|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
1613765|NCT00927758|3946906|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
1613766|NCT00927758|3946907|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1613767|NCT00927758|3946908|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
1613768|NCT00927758|3946909|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
1613769|NCT00927758|3946910|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
1613770|NCT00927758|3946905|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
1613771|NCT00927758|3946906|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
1613772|NCT00927758|3946907|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
1613773|NCT00927758|3946908|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
1613774|NCT00927758|3946909|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
1613775|NCT00927758|3946910|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
1613776|NCT00927758|3946905|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
1613777|NCT00927758|3946906|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
1613778|NCT00927758|3946907|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
1613779|NCT00927758|3946908|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
1613780|NCT00927758|3946909|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
1613781|NCT00927758|3946910|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
1613782|NCT00927758|3946905|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
1613783|NCT00927758|3946906|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1613784|NCT00927758|3946907|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
1613785|NCT00927758|3946908|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1613786|NCT00927758|3946909|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1613787|NCT00927758|3946910|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1613788|NCT00927758|3946905|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
1613789|NCT00927758|3946906|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
1613790|NCT00927758|3946907|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
1613791|NCT00927758|3946908|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
1613792|NCT00927758|3946909|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
1613793|NCT00927758|3946910|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
1613794|NCT00927758|3946905|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
1613795|NCT00927758|3946906|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
1613796|NCT00927758|3946907|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
1613797|NCT00927758|3946908|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
1613798|NCT00927758|3946909|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
1613799|NCT00927758|3946910|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
1613800|NCT00927758|3946905|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
1613801|NCT00927758|3946906|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
1613802|NCT00927758|3946907|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
1613803|NCT00927758|3946908|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
1613804|NCT00927758|3946909|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
1613805|NCT00927758|3946910|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
1613806|NCT00927589|3946918|P1|NOT COMPLETED|Overall Study||16
1613807|NCT00927589|3946918|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
1613808|NCT00927589|3946918|P1|STARTED|Overall Study||59
1613809|NCT00927576|3946942|P2|NOT COMPLETED|Overall Study||0
1613810|NCT00927576|3946943|P1|NOT COMPLETED|Overall Study||0
1613811|NCT00927576|3946942|P2|COMPLETED|Overall Study||28
1613812|NCT00927576|3946943|P1|COMPLETED|Overall Study||237
1613813|NCT00927576|3946942|P2|Cognitive Testing|Overall Study||28
1613814|NCT00927576|3946943|P1|Cognitive Testing|Overall Study||237
1613815|NCT00927576|3946942|P2|STARTED|Overall Study||28
1613816|NCT00927576|3946943|P1|STARTED|Overall Study||237
1613817|NCT00927563|3946948|P1|NOT COMPLETED|Overall Study||2
1613818|NCT00927563|3946948|P1|COMPLETED|Overall Study||22
1613819|NCT00927563|3946948|P1|STARTED|Overall Study||24
1613820|NCT00927472|3946956|P2|NOT COMPLETED|Overall Study||22
1613821|NCT00927472|3946957|P1|NOT COMPLETED|Overall Study||11
1613822|NCT00927472|3946956|P2|COMPLETED|Overall Study||106
1613823|NCT00927472|3946957|P1|COMPLETED|Overall Study||115
1613824|NCT00927472|3946956|P2|STARTED|Overall Study||128
1613825|NCT00927472|3946957|P1|STARTED|Overall Study||126
1613826|NCT00927394|3946983|P2|NOT COMPLETED|Overall Study||85
1613827|NCT00927394|3946984|P1|NOT COMPLETED|Overall Study||77
1613828|NCT00927394|3946983|P2|COMPLETED|Overall Study||483
1613829|NCT00927394|3946984|P1|COMPLETED|Overall Study||498
1613830|NCT00927394|3946983|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
1613831|NCT00927394|3946984|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
1613832|NCT00927394|3946983|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
1613833|NCT00927394|3946984|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
1613834|NCT00927394|3946983|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
1613835|NCT00927394|3946984|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
1613836|NCT00927394|3946983|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
1613837|NCT00927394|3946984|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
1613838|NCT00927394|3946983|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
1613839|NCT00927394|3946984|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
1613840|NCT00927394|3946983|P2|Cohort 2 (Randomized)|Overall Study||403
1613841|NCT00927394|3946984|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
1613842|NCT00927394|3946983|P2|Cohort 1 (Randomized)|Overall Study||165
1613843|NCT00927394|3946984|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
1613844|NCT00927394|3946983|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
1613845|NCT00927394|3946984|P1|STARTED|Overall Study||575
1613846|NCT00927368|3947015|P3|NOT COMPLETED|Overall Study||5
1613847|NCT00927368|3947016|P2|NOT COMPLETED|Overall Study||5
1613848|NCT00927368|3947017|P1|NOT COMPLETED|Overall Study||6
1613849|NCT00927368|3947015|P3|COMPLETED|Overall Study||138
1613850|NCT00927368|3947016|P2|COMPLETED|Overall Study||152
1613851|NCT00927368|3947017|P1|COMPLETED|Overall Study||147
1613852|NCT00927368|3947015|P3|STARTED|Overall Study||143
1613853|NCT00927368|3947016|P2|STARTED|Overall Study||157
1613854|NCT00927368|3947017|P1|STARTED|Overall Study||153
1613855|NCT00927355|3947036|P2|NOT COMPLETED|Overall Study||1
1613856|NCT00927355|3947037|P1|NOT COMPLETED|Overall Study||1
1613857|NCT00927355|3947036|P2|COMPLETED|Overall Study||4
1613858|NCT00927355|3947037|P1|COMPLETED|Overall Study||4
1613859|NCT00927355|3947036|P2|STARTED|Overall Study||5
1613860|NCT00927355|3947037|P1|STARTED|Overall Study||5
1613861|NCT00927264|3947057|P2|NOT COMPLETED|Overall Study||25
1613862|NCT00927264|3947058|P1|NOT COMPLETED|Overall Study||56
1613863|NCT00927264|3947057|P2|COMPLETED|Overall Study||140
1613864|NCT00927264|3947058|P1|COMPLETED|Overall Study||109
1613865|NCT00927264|3947057|P2|STARTED|Overall Study||165
1613866|NCT00927264|3947058|P1|STARTED|Overall Study||165
1613867|NCT00927251|3947072|P1|NOT COMPLETED|Overall Study||8
1613868|NCT00927251|3947072|P1|COMPLETED|Overall Study||82
1613869|NCT00927251|3947072|P1|STARTED|Overall Study||90
1613870|NCT00927186|3947078|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
1613871|NCT00927186|3947079|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
1613872|NCT00927186|3947078|P2|COMPLETED|12 - 24 Months Extension Treatment||11
1613873|NCT00927186|3947079|P1|COMPLETED|12 - 24 Months Extension Treatment||10
1613874|NCT00927186|3947078|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
1613875|NCT00927186|3947079|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
1613876|NCT00927186|3947078|P2|NOT COMPLETED|12 Months Primary Study||4
1613877|NCT00927186|3947079|P1|NOT COMPLETED|12 Months Primary Study||7
1613878|NCT00927186|3947078|P2|COMPLETED|12 Months Primary Study||31
1613879|NCT00927186|3947079|P1|COMPLETED|12 Months Primary Study||27
1613880|NCT00927186|3947078|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
1613881|NCT00927186|3947079|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
1613882|NCT00927186|3947078|P2|STARTED|12 Months Primary Study||35
1613883|NCT00927186|3947079|P1|STARTED|12 Months Primary Study||34
1613884|NCT00927160|3947197|P2|NOT COMPLETED|Overall Study||0
1613885|NCT00927160|3947198|P1|NOT COMPLETED|Overall Study||0
1613886|NCT00927160|3947197|P2|COMPLETED|Overall Study||173
1613887|NCT00927160|3947198|P1|COMPLETED|Overall Study||173
1613888|NCT00927160|3947197|P2|STARTED|Overall Study||173
1613889|NCT00927160|3947198|P1|STARTED|Overall Study||173
1613890|NCT00927095|3947209|P3|NOT COMPLETED|Overall Study||2
1613891|NCT00927095|3947210|P2|NOT COMPLETED|Overall Study||4
1613892|NCT00927095|3947211|P1|NOT COMPLETED|Overall Study||6
1613893|NCT00927095|3947209|P3|COMPLETED|Overall Study||22
1613894|NCT00927095|3947210|P2|COMPLETED|Overall Study||17
1613895|NCT00927095|3947211|P1|COMPLETED|Overall Study||16
1613896|NCT00927095|3947209|P3|STARTED|Overall Study||24
1613897|NCT00927095|3947210|P2|STARTED|Overall Study||21
1613898|NCT00927095|3947211|P1|STARTED|Overall Study||22
1613899|NCT00927082|3947223|P4|NOT COMPLETED|Overall Study||19
1613900|NCT00927082|3947224|P3|NOT COMPLETED|Overall Study||22
1613901|NCT00927082|3947225|P2|NOT COMPLETED|Overall Study||10
1613902|NCT00927082|3947226|P1|NOT COMPLETED|Overall Study||12
1613903|NCT00927082|3947223|P4|COMPLETED|Overall Study||78
1613904|NCT00927082|3947224|P3|COMPLETED|Overall Study||86
1613905|NCT00927082|3947225|P2|COMPLETED|Overall Study||77
1613906|NCT00927082|3947226|P1|COMPLETED|Overall Study||79
1613907|NCT00927082|3947223|P4|STARTED|Overall Study||97
1613908|NCT00927082|3947224|P3|STARTED|Overall Study||108
1613909|NCT00927082|3947225|P2|STARTED|Overall Study||87
1613910|NCT00927082|3947226|P1|STARTED|Overall Study||91
1613911|NCT00927069|3947290|P4|NOT COMPLETED|Week 12 to Week 24||3
1613912|NCT00927069|3947291|P3|NOT COMPLETED|Week 12 to Week 24||3
1613913|NCT00927069|3947292|P2|NOT COMPLETED|Week 12 to Week 24||0
1613914|NCT00927069|3947293|P1|NOT COMPLETED|Week 12 to Week 24||2
1613915|NCT00927069|3947290|P4|COMPLETED|Week 12 to Week 24||20
1613916|NCT00927069|3947291|P3|COMPLETED|Week 12 to Week 24||28
1613917|NCT00927069|3947292|P2|COMPLETED|Week 12 to Week 24||11
1613918|NCT00927069|3947293|P1|COMPLETED|Week 12 to Week 24||16
1613919|NCT00927069|3947290|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
1613920|NCT00927069|3947291|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
1613921|NCT00927069|3947292|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
1613922|NCT00927069|3947293|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
1613923|NCT00927069|3947290|P4|NOT COMPLETED|Week 0 to Week 12||0
1613924|NCT00927069|3947291|P3|NOT COMPLETED|Week 0 to Week 12||0
1613925|NCT00927069|3947292|P2|NOT COMPLETED|Week 0 to Week 12||1
1613926|NCT00927069|3947293|P1|NOT COMPLETED|Week 0 to Week 12||1
1613927|NCT00927069|3947290|P4|COMPLETED|Week 0 to Week 12||0
1613928|NCT00927069|3947291|P3|COMPLETED|Week 0 to Week 12||0
1613929|NCT00927069|3947292|P2|COMPLETED|Week 0 to Week 12||34
1613930|NCT00927069|3947293|P1|COMPLETED|Week 0 to Week 12||49
1613931|NCT00927069|3947290|P4|STARTED|Week 0 to Week 12||0
1613932|NCT00927069|3947291|P3|STARTED|Week 0 to Week 12||0
1613933|NCT00927069|3947292|P2|STARTED|Week 0 to Week 12||35
1613934|NCT00927069|3947293|P1|STARTED|Week 0 to Week 12||50
1613935|NCT00926952|3947303|P1|NOT COMPLETED|Overall Study||0
1613936|NCT00926952|3947303|P1|COMPLETED|Overall Study||20
1613937|NCT00926952|3947303|P1|STARTED|Overall Study||20
1613938|NCT00926887|3947317|P2|NOT COMPLETED|Overall Study||0
1613939|NCT00926887|3947318|P1|NOT COMPLETED|Overall Study||0
1613940|NCT00926887|3947317|P2|COMPLETED|Overall Study||50
1613941|NCT00926887|3947318|P1|COMPLETED|Overall Study||54
1613942|NCT00926887|3947317|P2|STARTED|Overall Study||50
1613943|NCT00926887|3947318|P1|STARTED|Overall Study||54
1613944|NCT00926848|3947330|P2|NOT COMPLETED|Overall Study||0
1613945|NCT00926848|3947331|P1|NOT COMPLETED|Overall Study||0
1613946|NCT00926848|3947330|P2|COMPLETED|Overall Study||34
1613947|NCT00926848|3947331|P1|COMPLETED|Overall Study||34
1613948|NCT00926848|3947330|P2|STARTED|Overall Study||34
1613949|NCT00926848|3947331|P1|STARTED|Overall Study||34
1613950|NCT00926796|3947349|P2|NOT COMPLETED|Overall Study||106
1613951|NCT00926796|3947350|P1|NOT COMPLETED|Overall Study||107
1613952|NCT00926796|3947349|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
1613953|NCT00926796|3947350|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
1613954|NCT00926796|3947349|P2|STARTED|Overall Study|Number randomized|305
1613955|NCT00926796|3947350|P1|STARTED|Overall Study|Number randomized|309
1613956|NCT00926783|3947371|P2|NOT COMPLETED|Overall Study||3
1613957|NCT00926783|3947372|P1|NOT COMPLETED|Overall Study||3
1613958|NCT00926783|3947371|P2|COMPLETED|Overall Study||38
1613959|NCT00926783|3947372|P1|COMPLETED|Overall Study||39
1613960|NCT00926783|3947371|P2|STARTED|Overall Study||41
1613961|NCT00926783|3947372|P1|STARTED|Overall Study||42
1613962|NCT00926588|3947390|P2|NOT COMPLETED|Overall Study||4
1613963|NCT00926588|3947391|P1|NOT COMPLETED|Overall Study||8
1613964|NCT00926588|3947390|P2|COMPLETED|Overall Study||122
1613965|NCT00926588|3947391|P1|COMPLETED|Overall Study||116
1613966|NCT00926588|3947390|P2|STARTED|Overall Study||126
1613967|NCT00926588|3947391|P1|STARTED|Overall Study||124
1613968|NCT00926575|3947399|P2|NOT COMPLETED|Overall Study||17
1613969|NCT00926575|3947400|P1|NOT COMPLETED|Overall Study||16
1613970|NCT00926575|3947399|P2|COMPLETED|Overall Study||53
1613971|NCT00926575|3947400|P1|COMPLETED|Overall Study||54
1613972|NCT00926575|3947399|P2|STARTED|Overall Study||70
1613973|NCT00926575|3947400|P1|STARTED|Overall Study||70
1613974|NCT00926536|3947412|P2|NOT COMPLETED|Overall Study||2
1613975|NCT00926536|3947413|P1|NOT COMPLETED|Overall Study||1
1613976|NCT00926536|3947412|P2|COMPLETED|Overall Study||41
1613977|NCT00926536|3947413|P1|COMPLETED|Overall Study||43
1613978|NCT00926536|3947412|P2|STARTED|Overall Study||43
1613979|NCT00926536|3947413|P1|STARTED|Overall Study||44
1613980|NCT00926497|3947423|P2|NOT COMPLETED|Overall Study||0
1613981|NCT00926497|3947424|P1|NOT COMPLETED|Overall Study||0
1613982|NCT00926497|3947423|P2|COMPLETED|Overall Study||61
1613983|NCT00926497|3947424|P1|COMPLETED|Overall Study||60
1613984|NCT00926497|3947423|P2|STARTED|Overall Study||61
1613985|NCT00926497|3947424|P1|STARTED|Overall Study||60
1613986|NCT00926393|3947434|P2|NOT COMPLETED|Overall Study||3
1613987|NCT00926393|3947435|P1|NOT COMPLETED|Overall Study||2
1613988|NCT00926393|3947434|P2|COMPLETED|Overall Study||67
1613989|NCT00926393|3947435|P1|COMPLETED|Overall Study||67
1613990|NCT00926393|3947434|P2|STARTED|Overall Study||70
1613991|NCT00926393|3947435|P1|STARTED|Overall Study||69
1613992|NCT00926380|3947468|P3|NOT COMPLETED|Year 2||5
1613993|NCT00926380|3947469|P2|NOT COMPLETED|Year 2||2
1613994|NCT00926380|3947470|P1|NOT COMPLETED|Year 2||2
1613995|NCT00926380|3947468|P3|COMPLETED|Year 2||24
1613996|NCT00926380|3947469|P2|COMPLETED|Year 2||28
1613997|NCT00926380|3947470|P1|COMPLETED|Year 2||31
1613998|NCT00926380|3947468|P3|STARTED|Year 2||29
1613999|NCT00926380|3947469|P2|STARTED|Year 2||30
1614000|NCT00926380|3947470|P1|STARTED|Year 2||33
1614001|NCT00926380|3947468|P3|NOT COMPLETED|Year 1||1
1614002|NCT00926380|3947469|P2|NOT COMPLETED|Year 1||1
1614003|NCT00926380|3947470|P1|NOT COMPLETED|Year 1||0
1614004|NCT00926380|3947468|P3|COMPLETED|Year 1||29
1614005|NCT00926380|3947469|P2|COMPLETED|Year 1||30
1614006|NCT00926380|3947470|P1|COMPLETED|Year 1||33
1614007|NCT00926380|3947468|P3|STARTED|Year 1||30
1614008|NCT00926380|3947469|P2|STARTED|Year 1||31
1614009|NCT00926380|3947470|P1|STARTED|Year 1||33
1614010|NCT00926367|3947480|P2|NOT COMPLETED|Overall Study||3
1614011|NCT00926367|3947481|P1|NOT COMPLETED|Overall Study||2
1614012|NCT00926367|3947480|P2|COMPLETED|Overall Study||24
1614013|NCT00926367|3947481|P1|COMPLETED|Overall Study||23
1614014|NCT00926367|3947480|P2|STARTED|Overall Study||27
1614015|NCT00926367|3947481|P1|STARTED|Overall Study||25
1614016|NCT00926328|3947523|P2|NOT COMPLETED|Overall Study||14
1614017|NCT00926328|3947524|P1|NOT COMPLETED|Overall Study||12
1614018|NCT00926328|3947523|P2|COMPLETED|Overall Study||46
1614019|NCT00926328|3947524|P1|COMPLETED|Overall Study||48
1614020|NCT00926328|3947523|P2|STARTED|Overall Study||60
1614021|NCT00926328|3947524|P1|STARTED|Overall Study||60
1614022|NCT00926289|3947534|P2|NOT COMPLETED|Overall Study||36
1614023|NCT00926289|3947535|P1|NOT COMPLETED|Overall Study||25
1614024|NCT00926289|3947534|P2|COMPLETED|Overall Study||558
1614025|NCT00926289|3947535|P1|COMPLETED|Overall Study||269
1614026|NCT00926289|3947534|P2|STARTED|Overall Study|Number of treated patients|594
1614027|NCT00926289|3947535|P1|STARTED|Overall Study|Number of treated patients|294
1614028|NCT00926263|3947571|P2|NOT COMPLETED|Overall Study||0
1614029|NCT00926263|3947572|P1|NOT COMPLETED|Overall Study||0
1614030|NCT00926263|3947571|P2|COMPLETED|Overall Study||12
1614031|NCT00926263|3947572|P1|COMPLETED|Overall Study||16
1614032|NCT00926263|3947571|P2|STARTED|Overall Study||12
1614033|NCT00926263|3947572|P1|STARTED|Overall Study||16
1614034|NCT00926211|3947603|P1|NOT COMPLETED|Overall Study||1
1614035|NCT00926211|3947603|P1|COMPLETED|Overall Study||35
1614036|NCT00926211|3947603|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
1614037|NCT00926185|3947614|P4|NOT COMPLETED|Overall Study||10
1614038|NCT00926185|3947615|P3|NOT COMPLETED|Overall Study||10
1614039|NCT00926185|3947616|P2|NOT COMPLETED|Overall Study||6
1614040|NCT00926185|3947617|P1|NOT COMPLETED|Overall Study||3
1614041|NCT00926185|3947614|P4|COMPLETED|Overall Study||48
1614042|NCT00926185|3947615|P3|COMPLETED|Overall Study||48
1614043|NCT00926185|3947616|P2|COMPLETED|Overall Study||51
1614044|NCT00926185|3947617|P1|COMPLETED|Overall Study||54
1614045|NCT00926185|3947614|P4|STARTED|Overall Study||58
1614046|NCT00926185|3947615|P3|STARTED|Overall Study||58
1614047|NCT00926185|3947616|P2|STARTED|Overall Study||57
1614048|NCT00926185|3947617|P1|STARTED|Overall Study||57
1614049|NCT00926029|3947634|P3|NOT COMPLETED|Overall Study||1
1614050|NCT00926029|3947635|P2|NOT COMPLETED|Overall Study||1
1614051|NCT00926029|3947636|P1|NOT COMPLETED|Overall Study||2
1614052|NCT00926029|3947634|P3|COMPLETED|Overall Study||33
1614053|NCT00926029|3947635|P2|COMPLETED|Overall Study||33
1614054|NCT00926029|3947636|P1|COMPLETED|Overall Study||32
1614055|NCT00926029|3947634|P3|STARTED|Overall Study||34
1614056|NCT00926029|3947635|P2|STARTED|Overall Study||34
1614057|NCT00926029|3947636|P1|STARTED|Overall Study||34
1614058|NCT00925990|3947649|P2|NOT COMPLETED|Overall Study||11
1614059|NCT00925990|3947650|P1|NOT COMPLETED|Overall Study||5
1614060|NCT00925990|3947649|P2|COMPLETED|Overall Study||24
1614061|NCT00925990|3947650|P1|COMPLETED|Overall Study||30
1614062|NCT00925990|3947649|P2|STARTED|Overall Study||35
1614063|NCT00925990|3947650|P1|STARTED|Overall Study||35
1614064|NCT00925938|3947661|P3|NOT COMPLETED|Overall Study||0
1614065|NCT00925938|3947662|P2|NOT COMPLETED|Overall Study||0
1614066|NCT00925938|3947663|P1|NOT COMPLETED|Overall Study||0
1614067|NCT00925938|3947661|P3|COMPLETED|Overall Study||17
1614068|NCT00925938|3947662|P2|COMPLETED|Overall Study||25
1614069|NCT00925938|3947663|P1|COMPLETED|Overall Study||9
1614070|NCT00925938|3947661|P3|STARTED|Overall Study||17
1614071|NCT00925938|3947662|P2|STARTED|Overall Study||25
1614072|NCT00925938|3947663|P1|STARTED|Overall Study||9
1614073|NCT00925899|3947685|P2|NOT COMPLETED|Part 2||12
1614074|NCT00925899|3947686|P1|NOT COMPLETED|Part 2||6
1614075|NCT00925899|3947685|P2|COMPLETED|Part 2||9
1614076|NCT00925899|3947686|P1|COMPLETED|Part 2||9
1614077|NCT00925899|3947685|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
1614078|NCT00925899|3947686|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
1614079|NCT00925899|3947685|P2|NOT COMPLETED|Part 1||11
1614080|NCT00925899|3947686|P1|NOT COMPLETED|Part 1||11
1614081|NCT00925899|3947685|P2|COMPLETED|Part 1||27
1614082|NCT00925899|3947686|P1|COMPLETED|Part 1||23
1614083|NCT00925899|3947685|P2|STARTED|Part 1||38
1614084|NCT00925899|3947686|P1|STARTED|Part 1||34
1614085|NCT00925782|3947704|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
1614086|NCT00925782|3947705|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
1614087|NCT00925782|3947704|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
1614088|NCT00925782|3947705|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
1614089|NCT00925782|3947704|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
1614090|NCT00925782|3947705|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
1614091|NCT00925782|3947704|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
1614092|NCT00925782|3947705|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
1614093|NCT00925782|3947704|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
1614094|NCT00925782|3947705|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
1614095|NCT00925782|3947704|P2|STARTED|Study Period (Day -3 to Day 0)||12
1614096|NCT00925782|3947705|P1|STARTED|Study Period (Day -3 to Day 0)||12
1614097|NCT00925782|3947704|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
1614098|NCT00925782|3947705|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
1614099|NCT00925782|3947704|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
1614100|NCT00925782|3947705|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
1614101|NCT00925782|3947704|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
1614102|NCT00925782|3947705|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
1614103|NCT00925769|3947714|P6|NOT COMPLETED|Overall Study||3
1614104|NCT00925769|3947715|P5|NOT COMPLETED|Overall Study||3
1614105|NCT00925769|3947716|P4|NOT COMPLETED|Overall Study||6
1614106|NCT00925769|3947717|P3|NOT COMPLETED|Overall Study||6
1614107|NCT00925769|3947718|P2|NOT COMPLETED|Overall Study||6
1614108|NCT00925769|3947719|P1|NOT COMPLETED|Overall Study||6
1614109|NCT00925769|3947714|P6|COMPLETED|Overall Study||0
1614110|NCT00925769|3947715|P5|COMPLETED|Overall Study||0
1614111|NCT00925769|3947716|P4|COMPLETED|Overall Study||0
1614112|NCT00925769|3947717|P3|COMPLETED|Overall Study||0
1614113|NCT00925769|3947718|P2|COMPLETED|Overall Study||0
1614114|NCT00925769|3947719|P1|COMPLETED|Overall Study||0
1614115|NCT00925769|3947714|P6|STARTED|Overall Study||3
1614116|NCT00925769|3947715|P5|STARTED|Overall Study||3
1614117|NCT00925769|3947716|P4|STARTED|Overall Study||6
1614118|NCT00925769|3947717|P3|STARTED|Overall Study||6
1614119|NCT00925769|3947718|P2|STARTED|Overall Study||6
1614120|NCT00925769|3947719|P1|STARTED|Overall Study||6
1614121|NCT00925704|3947787|P6|NOT COMPLETED|Third Intervention||1
1614122|NCT00925704|3947788|P5|NOT COMPLETED|Third Intervention||0
1614123|NCT00925704|3947789|P4|NOT COMPLETED|Third Intervention||0
1614124|NCT00925704|3947790|P3|NOT COMPLETED|Third Intervention||0
1614125|NCT00925704|3947791|P2|NOT COMPLETED|Third Intervention||0
1614126|NCT00925704|3947792|P1|NOT COMPLETED|Third Intervention||0
1614127|NCT00925704|3947787|P6|COMPLETED|Third Intervention||6
1614128|NCT00925704|3947788|P5|COMPLETED|Third Intervention||5
1614129|NCT00925704|3947789|P4|COMPLETED|Third Intervention||6
1614130|NCT00925704|3947790|P3|COMPLETED|Third Intervention||7
1614131|NCT00925704|3947791|P2|COMPLETED|Third Intervention||7
1614132|NCT00925704|3947792|P1|COMPLETED|Third Intervention||5
1614133|NCT00925704|3947787|P6|STARTED|Third Intervention||7
1614134|NCT00925704|3947788|P5|STARTED|Third Intervention||5
1614135|NCT00925704|3947789|P4|STARTED|Third Intervention||6
1614136|NCT00925704|3947790|P3|STARTED|Third Intervention||7
1614137|NCT00925704|3947791|P2|STARTED|Third Intervention||7
1614138|NCT00925704|3947792|P1|STARTED|Third Intervention||5
1614139|NCT00925704|3947787|P6|NOT COMPLETED|Washout||0
1614140|NCT00925704|3947788|P5|NOT COMPLETED|Washout||0
1614141|NCT00925704|3947789|P4|NOT COMPLETED|Washout||0
1614142|NCT00925704|3947790|P3|NOT COMPLETED|Washout||0
1614143|NCT00925704|3947791|P2|NOT COMPLETED|Washout||0
1614144|NCT00925704|3947792|P1|NOT COMPLETED|Washout||0
1614145|NCT00925704|3947787|P6|COMPLETED|Washout||7
1614146|NCT00925704|3947788|P5|COMPLETED|Washout||5
1614147|NCT00925704|3947789|P4|COMPLETED|Washout||6
1614148|NCT00925704|3947790|P3|COMPLETED|Washout||7
1614149|NCT00925704|3947791|P2|COMPLETED|Washout||7
1614150|NCT00925704|3947792|P1|COMPLETED|Washout||5
1614151|NCT00925704|3947787|P6|STARTED|Washout||7
1614152|NCT00925704|3947788|P5|STARTED|Washout||5
1614153|NCT00925704|3947789|P4|STARTED|Washout||6
1614154|NCT00925704|3947790|P3|STARTED|Washout||7
1614155|NCT00925704|3947791|P2|STARTED|Washout||7
1614156|NCT00925704|3947792|P1|STARTED|Washout||5
1614157|NCT00925704|3947787|P6|NOT COMPLETED|Second Intervention||0
1614158|NCT00925704|3947788|P5|NOT COMPLETED|Second Intervention||1
1614159|NCT00925704|3947789|P4|NOT COMPLETED|Second Intervention||0
1614160|NCT00925704|3947790|P3|NOT COMPLETED|Second Intervention||0
1614161|NCT00925704|3947791|P2|NOT COMPLETED|Second Intervention||0
1614162|NCT00925704|3947792|P1|NOT COMPLETED|Second Intervention||1
1614163|NCT00925704|3947787|P6|COMPLETED|Second Intervention||7
1614164|NCT00925704|3947788|P5|COMPLETED|Second Intervention||5
1614165|NCT00925704|3947789|P4|COMPLETED|Second Intervention||6
1614166|NCT00925704|3947790|P3|COMPLETED|Second Intervention||7
1614167|NCT00925704|3947791|P2|COMPLETED|Second Intervention||7
1614168|NCT00925704|3947792|P1|COMPLETED|Second Intervention||5
1614169|NCT00925704|3947787|P6|STARTED|Second Intervention||7
1614170|NCT00925704|3947788|P5|STARTED|Second Intervention||6
1614171|NCT00925704|3947789|P4|STARTED|Second Intervention||6
1614172|NCT00925704|3947790|P3|STARTED|Second Intervention||7
1614173|NCT00925704|3947791|P2|STARTED|Second Intervention||7
1614174|NCT00925704|3947792|P1|STARTED|Second Intervention||6
1614175|NCT00925704|3947787|P6|NOT COMPLETED|Washout||0
1614176|NCT00925704|3947788|P5|NOT COMPLETED|Washout||0
1614177|NCT00925704|3947789|P4|NOT COMPLETED|Washout||0
1614178|NCT00925704|3947790|P3|NOT COMPLETED|Washout||0
1614179|NCT00925704|3947791|P2|NOT COMPLETED|Washout||0
1614180|NCT00925704|3947792|P1|NOT COMPLETED|Washout||0
1614181|NCT00925704|3947787|P6|COMPLETED|Washout||7
1614182|NCT00925704|3947788|P5|COMPLETED|Washout||6
1614183|NCT00925704|3947789|P4|COMPLETED|Washout||6
1614184|NCT00925704|3947790|P3|COMPLETED|Washout||7
1614185|NCT00925704|3947791|P2|COMPLETED|Washout||7
1614186|NCT00925704|3947792|P1|COMPLETED|Washout||6
1614187|NCT00925704|3947787|P6|STARTED|Washout||7
1614188|NCT00925704|3947788|P5|STARTED|Washout||6
1614189|NCT00925704|3947789|P4|STARTED|Washout||6
1614190|NCT00925704|3947790|P3|STARTED|Washout||7
1614191|NCT00925704|3947791|P2|STARTED|Washout||7
1614192|NCT00925704|3947792|P1|STARTED|Washout||6
1614193|NCT00925704|3947787|P6|NOT COMPLETED|First Intervention||0
1614194|NCT00925704|3947788|P5|NOT COMPLETED|First Intervention||1
1614195|NCT00925704|3947789|P4|NOT COMPLETED|First Intervention||1
1614196|NCT00925704|3947790|P3|NOT COMPLETED|First Intervention||0
1614197|NCT00925704|3947791|P2|NOT COMPLETED|First Intervention||0
1614198|NCT00925704|3947792|P1|NOT COMPLETED|First Intervention||0
1614199|NCT00925704|3947787|P6|COMPLETED|First Intervention||7
1614200|NCT00925704|3947788|P5|COMPLETED|First Intervention||6
1614201|NCT00925704|3947789|P4|COMPLETED|First Intervention||6
1614202|NCT00925704|3947790|P3|COMPLETED|First Intervention||7
1614203|NCT00925704|3947791|P2|COMPLETED|First Intervention||7
1614204|NCT00925704|3947792|P1|COMPLETED|First Intervention||6
1614205|NCT00925704|3947787|P6|STARTED|First Intervention||7
1614206|NCT00925704|3947788|P5|STARTED|First Intervention||7
1614207|NCT00925704|3947789|P4|STARTED|First Intervention||7
1614208|NCT00925704|3947790|P3|STARTED|First Intervention||7
1614209|NCT00925704|3947791|P2|STARTED|First Intervention||7
1614210|NCT00925704|3947792|P1|STARTED|First Intervention||6
1614211|NCT00925600|3947805|P2|NOT COMPLETED|Overall Study||28
1614212|NCT00925600|3947806|P1|NOT COMPLETED|Overall Study||32
1614213|NCT00925600|3947805|P2|COMPLETED|Overall Study||355
1614214|NCT00925600|3947806|P1|COMPLETED|Overall Study||354
1614215|NCT00925600|3947805|P2|Received Treatment|Overall Study||382
1614216|NCT00925600|3947806|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
1614217|NCT00925600|3947805|P2|STARTED|Overall Study||383
1614218|NCT00925600|3947806|P1|STARTED|Overall Study||386
1614219|NCT00925587|3947828|P2|NOT COMPLETED|Overall Study||25
1614220|NCT00925587|3947829|P1|NOT COMPLETED|Overall Study||36
1614221|NCT00925587|3947828|P2|COMPLETED|Overall Study||155
1614222|NCT00925587|3947829|P1|COMPLETED|Overall Study||142
1614223|NCT00925587|3947828|P2|STARTED|Overall Study||180
1614224|NCT00925587|3947829|P1|STARTED|Overall Study||178
1614225|NCT00925548|3947943|P2|NOT COMPLETED|Overall Study||5
1614226|NCT00925548|3947944|P1|NOT COMPLETED|Overall Study||10
1614227|NCT00925548|3947943|P2|COMPLETED|Overall Study||0
1614228|NCT00925548|3947944|P1|COMPLETED|Overall Study||1
1614229|NCT00925548|3947943|P2|STARTED|Overall Study||5
1614230|NCT00925548|3947944|P1|STARTED|Overall Study||11
1614231|NCT00925522|3947970|P1|NOT COMPLETED|Overall Study||0
1614232|NCT00925522|3947970|P1|COMPLETED|Overall Study||20
1614233|NCT00925522|3947970|P1|STARTED|Overall Study||20
1614234|NCT00925353|3947974|P1|NOT COMPLETED|Overall Study||3
1614235|NCT00925353|3947974|P1|COMPLETED|Overall Study||10
1614236|NCT00925353|3947974|P1|STARTED|Overall Study||13
1614237|NCT00925301|3947980|P4|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
1614238|NCT00925301|3947981|P3|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
1614239|NCT00925301|3947982|P2|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
1614240|NCT00925301|3947983|P1|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
1614241|NCT00925301|3947980|P4|COMPLETED|12-Month Open-label Extension (Optional)||54
1614242|NCT00925301|3947981|P3|COMPLETED|12-Month Open-label Extension (Optional)||0
1614243|NCT00925301|3947982|P2|COMPLETED|12-Month Open-label Extension (Optional)||0
1614244|NCT00925301|3947983|P1|COMPLETED|12-Month Open-label Extension (Optional)||0
1614245|NCT00925301|3947980|P4|ITT-amenable|12-Month Open-label Extension (Optional)||42
1614246|NCT00925301|3947981|P3|ITT-amenable|12-Month Open-label Extension (Optional)||0
1614247|NCT00925301|3947982|P2|ITT-amenable|12-Month Open-label Extension (Optional)||0
1614248|NCT00925301|3947983|P1|ITT-amenable|12-Month Open-label Extension (Optional)||0
1614249|NCT00925301|3947980|P4|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
1614250|NCT00925301|3947981|P3|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
1614251|NCT00925301|3947982|P2|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
1614252|NCT00925301|3947983|P1|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
1614253|NCT00925301|3947980|P4|NOT COMPLETED|6-Month Open-label (Stage 2)||0
1614254|NCT00925301|3947981|P3|NOT COMPLETED|6-Month Open-label (Stage 2)||3
1614255|NCT00925301|3947982|P2|NOT COMPLETED|6-Month Open-label (Stage 2)||0
1614256|NCT00925301|3947983|P1|NOT COMPLETED|6-Month Open-label (Stage 2)||0
1614257|NCT00925301|3947980|P4|COMPLETED|6-Month Open-label (Stage 2)||0
1614258|NCT00925301|3947981|P3|COMPLETED|6-Month Open-label (Stage 2)||60
1614259|NCT00925301|3947982|P2|COMPLETED|6-Month Open-label (Stage 2)||0
1614260|NCT00925301|3947983|P1|COMPLETED|6-Month Open-label (Stage 2)||0
1614261|NCT00925301|3947980|P4|ITT-amenable|6-Month Open-label (Stage 2)||0
1614262|NCT00925301|3947981|P3|ITT-amenable|6-Month Open-label (Stage 2)||47
1614263|NCT00925301|3947982|P2|ITT-amenable|6-Month Open-label (Stage 2)||0
1614264|NCT00925301|3947983|P1|ITT-amenable|6-Month Open-label (Stage 2)||0
1614265|NCT00925301|3947980|P4|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
1614266|NCT00925301|3947981|P3|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
1614267|NCT00925301|3947982|P2|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
1614268|NCT00925301|3947983|P1|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
1614269|NCT00925301|3947980|P4|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
1614270|NCT00925301|3947981|P3|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
1614271|NCT00925301|3947982|P2|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
1614272|NCT00925301|3947983|P1|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
1614273|NCT00925301|3947980|P4|COMPLETED|6-Month Double-blind (Stage 1)||0
1614274|NCT00925301|3947981|P3|COMPLETED|6-Month Double-blind (Stage 1)||0
1614275|NCT00925301|3947982|P2|COMPLETED|6-Month Double-blind (Stage 1)||30
1614276|NCT00925301|3947983|P1|COMPLETED|6-Month Double-blind (Stage 1)||34
1614277|NCT00925301|3947980|P4|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
1614278|NCT00925301|3947981|P3|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
1614279|NCT00925301|3947982|P2|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
1614280|NCT00925301|3947983|P1|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
1614281|NCT00925301|3947980|P4|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
1614282|NCT00925301|3947981|P3|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
1614283|NCT00925301|3947982|P2|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
1614284|NCT00925301|3947983|P1|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
1614285|NCT00925301|3947980|P4|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
1614286|NCT00925301|3947981|P3|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
1614287|NCT00925301|3947982|P2|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
1614288|NCT00925301|3947983|P1|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
1614289|NCT00925301|3947980|P4|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
1614290|NCT00925301|3947981|P3|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
1614291|NCT00925301|3947982|P2|STARTED|6-Month Double-blind (Stage 1)||33
1614292|NCT00925301|3947983|P1|STARTED|6-Month Double-blind (Stage 1)||34
1614293|NCT00925288|3947999|P2|NOT COMPLETED|Overall Study||7
1614294|NCT00925288|3948000|P1|NOT COMPLETED|Overall Study||9
1614295|NCT00925288|3947999|P2|COMPLETED|Overall Study||93
1614296|NCT00925288|3948000|P1|COMPLETED|Overall Study||91
1614297|NCT00925288|3947999|P2|STARTED|Overall Study||100
1614298|NCT00925288|3948000|P1|STARTED|Overall Study||100
1614299|NCT00925132|3948012|P5|NOT COMPLETED|Overall Study||5
1614300|NCT00925132|3948013|P4|NOT COMPLETED|Overall Study||0
1614301|NCT00925132|3948014|P3|NOT COMPLETED|Overall Study||0
1614302|NCT00925132|3948015|P2|NOT COMPLETED|Overall Study||0
1614303|NCT00925132|3948016|P1|NOT COMPLETED|Overall Study||2
1614304|NCT00925132|3948012|P5|COMPLETED|Overall Study||17
1614305|NCT00925132|3948013|P4|COMPLETED|Overall Study||4
1614306|NCT00925132|3948014|P3|COMPLETED|Overall Study||4
1614307|NCT00925132|3948015|P2|COMPLETED|Overall Study||4
1614308|NCT00925132|3948016|P1|COMPLETED|Overall Study||3
1614309|NCT00925132|3948012|P5|STARTED|Overall Study||22
1614310|NCT00925132|3948013|P4|STARTED|Overall Study||4
1614311|NCT00925132|3948014|P3|STARTED|Overall Study||4
1614312|NCT00925132|3948015|P2|STARTED|Overall Study||4
1614313|NCT00925132|3948016|P1|STARTED|Overall Study||5
1614314|NCT00925119|3948022|P1|NOT COMPLETED|Overall Study||12
1614315|NCT00925119|3948022|P1|COMPLETED|Overall Study||19
1614316|NCT00925119|3948022|P1|STARTED|Overall Study||31
1614317|NCT00925015|3948035|P3|NOT COMPLETED|Overall Study||6
1614318|NCT00925015|3948036|P2|NOT COMPLETED|Overall Study||6
1614319|NCT00925015|3948037|P1|NOT COMPLETED|Overall Study||8
1614320|NCT00925015|3948035|P3|COMPLETED|Overall Study||0
1614321|NCT00925015|3948036|P2|COMPLETED|Overall Study||0
1614322|NCT00925015|3948037|P1|COMPLETED|Overall Study||0
1614323|NCT00925015|3948035|P3|STARTED|Overall Study||6
1614324|NCT00925015|3948036|P2|STARTED|Overall Study||6
1614325|NCT00925015|3948037|P1|STARTED|Overall Study||8
1614326|NCT00924950|3948093|P1|NOT COMPLETED|Overall Study||2
1614327|NCT00924950|3948093|P1|COMPLETED|Overall Study||28
1614328|NCT00924950|3948093|P1|STARTED|Overall Study||30
1614329|NCT00924898|3948098|P1|NOT COMPLETED|Overall Study||2
1614330|NCT00924898|3948098|P1|COMPLETED|Overall Study||90
1614331|NCT00924898|3948098|P1|STARTED|Overall Study||92
1614332|NCT00924833|3948110|P3|NOT COMPLETED|Overall Study||0
1614333|NCT00924833|3948111|P2|NOT COMPLETED|Overall Study||0
1614334|NCT00924833|3948112|P1|NOT COMPLETED|Overall Study||0
1614335|NCT00924833|3948110|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
1614336|NCT00924833|3948111|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
1614337|NCT00924833|3948112|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
1614338|NCT00924833|3948110|P3|STARTED|Overall Study||9
1614339|NCT00924833|3948111|P2|STARTED|Overall Study||9
1614340|NCT00924833|3948112|P1|STARTED|Overall Study||9
1614341|NCT00924807|3948126|P1|NOT COMPLETED|Overall Study||0
1614342|NCT00924807|3948126|P1|COMPLETED|Overall Study||4
1614343|NCT00924807|3948126|P1|STARTED|Overall Study||4
1614344|NCT00924781|3948135|P2|NOT COMPLETED|Overall Study||10
1614345|NCT00924781|3948136|P1|NOT COMPLETED|Overall Study||12
1614346|NCT00924781|3948135|P2|COMPLETED|Overall Study||9
1614347|NCT00924781|3948136|P1|COMPLETED|Overall Study||8
1614348|NCT00924781|3948135|P2|STARTED|Overall Study||19
1614349|NCT00924781|3948136|P1|STARTED|Overall Study||20
1614350|NCT00924729|3948170|P2|NOT COMPLETED|Overall Study||0
1614351|NCT00924729|3948171|P1|NOT COMPLETED|Overall Study||2
1614352|NCT00924729|3948170|P2|COMPLETED|Overall Study||25
1614353|NCT00924729|3948171|P1|COMPLETED|Overall Study||23
1614354|NCT00924729|3948170|P2|STARTED|Overall Study||25
1614355|NCT00924729|3948171|P1|STARTED|Overall Study||25
1614356|NCT00924651|3948181|P2|NOT COMPLETED|Overall Study||25
1614357|NCT00924651|3948182|P1|NOT COMPLETED|Overall Study||25
1614358|NCT00924651|3948181|P2|COMPLETED|Overall Study||312
1614359|NCT00924651|3948182|P1|COMPLETED|Overall Study||331
1614360|NCT00924651|3948181|P2|STARTED|Overall Study||337
1614361|NCT00924651|3948182|P1|STARTED|Overall Study||356
1614362|NCT00924638|3948190|P2|NOT COMPLETED|Overall Study||13
1614363|NCT00924638|3948191|P1|NOT COMPLETED|Overall Study||12
1614364|NCT00924638|3948190|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
1614365|NCT00924638|3948191|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
1614366|NCT00924638|3948190|P2|STARTED|Overall Study|Randomized to Control Arm|220
1614367|NCT00924638|3948191|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
1614368|NCT00924560|3948213|P3|NOT COMPLETED|Overall Study||83
1614369|NCT00924560|3948214|P2|NOT COMPLETED|Overall Study||208
1614370|NCT00924560|3948215|P1|NOT COMPLETED|Overall Study||211
1614371|NCT00924560|3948213|P3|COMPLETED|Overall Study||372
1614372|NCT00924560|3948214|P2|COMPLETED|Overall Study||240
1614373|NCT00924560|3948215|P1|COMPLETED|Overall Study||247
1614374|NCT00924560|3948213|P3|Received Treatment|Overall Study||0
1614375|NCT00924560|3948214|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
1614376|NCT00924560|3948215|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
1614377|NCT00924560|3948213|P3|STARTED|Overall Study||455
1614378|NCT00924560|3948214|P2|STARTED|Overall Study||448
1614379|NCT00924560|3948215|P1|STARTED|Overall Study||458
1614380|NCT00924508|3948259|P1|NOT COMPLETED|Overall Study||3
1614381|NCT00924508|3948259|P1|COMPLETED|Overall Study||20
1614382|NCT00924508|3948259|P1|STARTED|Overall Study||23
1614383|NCT00924482|3948266|P1|NOT COMPLETED|Overall Study||0
1614384|NCT00924482|3948266|P1|COMPLETED|Overall Study||261
1614385|NCT00924482|3948266|P1|STARTED|Overall Study||261
1614386|NCT00924469|3948273|P2|NOT COMPLETED|Overall Study||2
1614387|NCT00924469|3948274|P1|NOT COMPLETED|Overall Study||2
1614388|NCT00924469|3948273|P2|COMPLETED|Overall Study||26
1614389|NCT00924469|3948274|P1|COMPLETED|Overall Study||28
1614390|NCT00924469|3948273|P2|STARTED|Overall Study||28
1614391|NCT00924469|3948274|P1|STARTED|Overall Study||30
1614392|NCT00924443|3948296|P1|NOT COMPLETED|Overall Study||3
1614393|NCT00924443|3948296|P1|COMPLETED|Overall Study||66
1614394|NCT00924443|3948296|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
1614395|NCT00924443|3948296|P1|STARTED|Overall Study||69
1614396|NCT00924404|3948306|P2|NOT COMPLETED|Overall Study||4
1614397|NCT00924404|3948307|P1|NOT COMPLETED|Overall Study||6
1614398|NCT00924404|3948306|P2|COMPLETED|Overall Study||22
1614399|NCT00924404|3948307|P1|COMPLETED|Overall Study||21
1614400|NCT00924404|3948306|P2|STARTED|Overall Study||26
1614401|NCT00924404|3948307|P1|STARTED|Overall Study||27
1614402|NCT00924352|3948315|P2|NOT COMPLETED|Overall Study||0
1614403|NCT00924352|3948316|P1|NOT COMPLETED|Overall Study||0
1614404|NCT00924352|3948315|P2|COMPLETED|Overall Study||44
1614405|NCT00924352|3948316|P1|COMPLETED|Overall Study||12
1614406|NCT00924352|3948315|P2|STARTED|Overall Study||44
1614407|NCT00924352|3948316|P1|STARTED|Overall Study||12
1614408|NCT00924313|3948329|P1|NOT COMPLETED|Overall Study||1
1614409|NCT00924313|3948329|P1|COMPLETED|Overall Study||39
1614410|NCT00924313|3948329|P1|STARTED|Overall Study||40
1614411|NCT00924287|3948341|P1|NOT COMPLETED|Overall Study||1
1614412|NCT00924287|3948341|P1|COMPLETED|Overall Study||0
1614413|NCT00924287|3948341|P1|STARTED|Overall Study||1
1614414|NCT00924209|3948347|P1|NOT COMPLETED|Overall Study||0
1614415|NCT00924209|3948347|P1|COMPLETED|Overall Study||7
1614416|NCT00924209|3948347|P1|STARTED|Overall Study||7
1614417|NCT00924170|3948357|P2|NOT COMPLETED|Overall Study||8
1614418|NCT00924170|3948358|P1|NOT COMPLETED|Overall Study||7
1614419|NCT00924170|3948357|P2|COMPLETED|Overall Study||0
1614420|NCT00924170|3948358|P1|COMPLETED|Overall Study||3
1614421|NCT00924170|3948357|P2|STARTED|Overall Study||8
1614422|NCT00924170|3948358|P1|STARTED|Overall Study||10
1614423|NCT00924118|3948398|P2|NOT COMPLETED|Overall Study||0
1614424|NCT00924118|3948399|P1|NOT COMPLETED|Overall Study||0
1614425|NCT00924118|3948398|P2|COMPLETED|Overall Study||15
1614426|NCT00924118|3948399|P1|COMPLETED|Overall Study||15
1614427|NCT00924118|3948398|P2|STARTED|Overall Study||15
1614428|NCT00924118|3948399|P1|STARTED|Overall Study||15
1614429|NCT00924066|3948407|P1|NOT COMPLETED|Overall Study||0
1614430|NCT00924066|3948407|P1|COMPLETED|Overall Study||41
1614431|NCT00924066|3948407|P1|STARTED|Overall Study||41
1614432|NCT00924053|3948416|P4|NOT COMPLETED|Overall Study||0
1614433|NCT00924053|3948417|P3|NOT COMPLETED|Overall Study||0
1614434|NCT00924053|3948418|P2|NOT COMPLETED|Overall Study||0
1614435|NCT00924053|3948419|P1|NOT COMPLETED|Overall Study||0
1614436|NCT00924053|3948416|P4|COMPLETED|Overall Study||6
1614437|NCT00924053|3948417|P3|COMPLETED|Overall Study||6
1614438|NCT00924053|3948418|P2|COMPLETED|Overall Study||6
1614439|NCT00924053|3948419|P1|COMPLETED|Overall Study||6
1614440|NCT00924053|3948416|P4|STARTED|Overall Study||6
1614441|NCT00924053|3948417|P3|STARTED|Overall Study||6
1614442|NCT00924053|3948418|P2|STARTED|Overall Study||6
1614443|NCT00924053|3948419|P1|STARTED|Overall Study||6
1614444|NCT00924040|3948465|P1|NOT COMPLETED|Overall Study||0
1614445|NCT00924040|3948465|P1|COMPLETED|Overall Study||1
1614446|NCT00924040|3948465|P1|STARTED|Overall Study||1
1614447|NCT00924001|3948477|P1|NOT COMPLETED|Overall Study||0
1614448|NCT00924001|3948477|P1|COMPLETED|Overall Study||1
1614449|NCT00924001|3948477|P1|STARTED|Overall Study||1
1614450|NCT00923975|3948483|P1|NOT COMPLETED|Overall Study||1
1614451|NCT00923975|3948483|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
1614452|NCT00923975|3948483|P1|STARTED|Overall Study||51
1614453|NCT00923949|3948490|P1|NOT COMPLETED|Overall Study||0
1614454|NCT00923949|3948490|P1|COMPLETED|Overall Study||1
1614455|NCT00923949|3948490|P1|STARTED|Overall Study||1
1614456|NCT00923936|3948502|P2|NOT COMPLETED|Overall Study||3
1614457|NCT00923936|3948503|P1|NOT COMPLETED|Overall Study||8
1614458|NCT00923936|3948502|P2|COMPLETED|Overall Study||3
1614459|NCT00923936|3948503|P1|COMPLETED|Overall Study||2
1614460|NCT00923936|3948502|P2|STARTED|Overall Study||6
1614461|NCT00923936|3948503|P1|STARTED|Overall Study||10
1614462|NCT00923910|3948519|P2|NOT COMPLETED|Period 2||0
1614463|NCT00923910|3948520|P1|NOT COMPLETED|Period 2||0
1614464|NCT00923910|3948519|P2|COMPLETED|Period 2||5
1614465|NCT00923910|3948520|P1|COMPLETED|Period 2||5
1614466|NCT00923910|3948519|P2|STARTED|Period 2||5
1614467|NCT00923910|3948520|P1|STARTED|Period 2||5
1614468|NCT00923910|3948519|P2|NOT COMPLETED|Period 1||0
1614469|NCT00923910|3948520|P1|NOT COMPLETED|Period 1||0
1614470|NCT00923910|3948519|P2|COMPLETED|Period 1||5
1614471|NCT00923910|3948520|P1|COMPLETED|Period 1||5
1614472|NCT00923910|3948519|P2|STARTED|Period 1||5
1614473|NCT00923910|3948520|P1|STARTED|Period 1||5
1614474|NCT00923845|3948532|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
1614475|NCT00923845|3948533|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
1614476|NCT00923845|3948532|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
1614477|NCT00923845|3948533|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
1614478|NCT00923845|3948532|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
1614479|NCT00923845|3948533|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
1614480|NCT00923845|3948532|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
1614481|NCT00923845|3948533|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
1614482|NCT00923845|3948532|P2|STARTED|Allogeneic Stem Cell Therapy||10
1614483|NCT00923845|3948533|P1|STARTED|Allogeneic Stem Cell Therapy||0
1614484|NCT00923845|3948532|P2|NOT COMPLETED|Induction Therapy||2
1614485|NCT00923845|3948533|P1|NOT COMPLETED|Induction Therapy||0
1614486|NCT00923845|3948532|P2|COMPLETED|Induction Therapy||10
1614487|NCT00923845|3948533|P1|COMPLETED|Induction Therapy||0
1614488|NCT00923845|3948532|P2|STARTED|Induction Therapy||12
1614489|NCT00923845|3948533|P1|STARTED|Induction Therapy||0
1614490|NCT00923845|3948532|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
1614491|NCT00923845|3948533|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
1614492|NCT00923845|3948532|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
1614493|NCT00923845|3948533|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
1614494|NCT00923845|3948532|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
1614495|NCT00923845|3948533|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
1614496|NCT00923845|3948532|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
1614497|NCT00923845|3948533|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
1614498|NCT00923845|3948532|P2|COMPLETED|Donor Lymphocyte Harvest||0
1614499|NCT00923845|3948533|P1|COMPLETED|Donor Lymphocyte Harvest||13
1614500|NCT00923845|3948532|P2|STARTED|Donor Lymphocyte Harvest||0
1614501|NCT00923845|3948533|P1|STARTED|Donor Lymphocyte Harvest||13
1614502|NCT00923481|3948554|P1|NOT COMPLETED|Overall Study||0
1614503|NCT00923481|3948554|P1|COMPLETED|Overall Study||37
1614504|NCT00923481|3948554|P1|STARTED|Overall Study||37
1614505|NCT00923364|3948559|P2|NOT COMPLETED|Overall Study||0
1614506|NCT00923364|3948560|P1|NOT COMPLETED|Overall Study||4
1614507|NCT00923364|3948559|P2|COMPLETED|Overall Study||5
1614508|NCT00923364|3948560|P1|COMPLETED|Overall Study||10
1614509|NCT00923364|3948559|P2|STARTED|Overall Study||5
1614510|NCT00923364|3948560|P1|STARTED|Overall Study||14
1614511|NCT00923351|3948572|P3|NOT COMPLETED|Overall Study||12
1614512|NCT00923351|3948573|P2|NOT COMPLETED|Overall Study||0
1614513|NCT00923351|3948574|P1|NOT COMPLETED|Overall Study||0
1614514|NCT00923351|3948572|P3|COMPLETED|Overall Study||0
1614515|NCT00923351|3948573|P2|COMPLETED|Overall Study||26
1614516|NCT00923351|3948574|P1|COMPLETED|Overall Study||6
1614517|NCT00923351|3948572|P3|STARTED|Overall Study||12
1614518|NCT00923351|3948573|P2|STARTED|Overall Study||26
1614519|NCT00923351|3948574|P1|STARTED|Overall Study||6
1614520|NCT00923273|3948589|P5|NOT COMPLETED|Phase II Treatment Period||0
1614521|NCT00923273|3948590|P4|NOT COMPLETED|Phase II Treatment Period||7
1614522|NCT00923273|3948591|P3|NOT COMPLETED|Phase II Treatment Period||0
1614523|NCT00923273|3948592|P2|NOT COMPLETED|Phase II Treatment Period||0
1614524|NCT00923273|3948593|P1|NOT COMPLETED|Phase II Treatment Period||0
1614525|NCT00923273|3948589|P5|COMPLETED|Phase II Treatment Period||0
1614526|NCT00923273|3948590|P4|COMPLETED|Phase II Treatment Period||20
1614527|NCT00923273|3948591|P3|COMPLETED|Phase II Treatment Period||0
1614528|NCT00923273|3948592|P2|COMPLETED|Phase II Treatment Period||0
1614529|NCT00923273|3948593|P1|COMPLETED|Phase II Treatment Period||0
1614530|NCT00923273|3948589|P5|STARTED|Phase II Treatment Period||0
1614614|NCT00923091|3948859|P11|STARTED|Period VI (Open-Label)||0
1614531|NCT00923273|3948590|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
1614532|NCT00923273|3948591|P3|STARTED|Phase II Treatment Period||0
1614533|NCT00923273|3948592|P2|STARTED|Phase II Treatment Period||0
1614534|NCT00923273|3948593|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
1614535|NCT00923273|3948589|P5|NOT COMPLETED|Phase I Treatment Period||0
1614536|NCT00923273|3948590|P4|NOT COMPLETED|Phase I Treatment Period||0
1614537|NCT00923273|3948591|P3|NOT COMPLETED|Phase I Treatment Period||0
1614538|NCT00923273|3948592|P2|NOT COMPLETED|Phase I Treatment Period||0
1614539|NCT00923273|3948593|P1|NOT COMPLETED|Phase I Treatment Period||0
1614540|NCT00923273|3948589|P5|COMPLETED|Phase I Treatment Period||5
1614541|NCT00923273|3948590|P4|COMPLETED|Phase I Treatment Period||7
1614542|NCT00923273|3948591|P3|COMPLETED|Phase I Treatment Period||3
1614543|NCT00923273|3948592|P2|COMPLETED|Phase I Treatment Period||3
1614544|NCT00923273|3948593|P1|COMPLETED|Phase I Treatment Period||4
1614545|NCT00923273|3948589|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
1614546|NCT00923273|3948590|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
1614547|NCT00923273|3948591|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
1614548|NCT00923273|3948592|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
1614549|NCT00923273|3948593|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
1614550|NCT00923260|3948618|P2|NOT COMPLETED|Overall Study||1
1614551|NCT00923260|3948619|P1|NOT COMPLETED|Overall Study||1
1614552|NCT00923260|3948618|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
1614553|NCT00923260|3948619|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
1614554|NCT00923260|3948618|P2|STARTED|Overall Study||12
1614555|NCT00923260|3948619|P1|STARTED|Overall Study||12
1614556|NCT00923247|3948753|P2|NOT COMPLETED|Overall Study||0
1614557|NCT00923247|3948754|P1|NOT COMPLETED|Overall Study||0
1614558|NCT00923247|3948753|P2|COMPLETED|Overall Study||1
1614559|NCT00923247|3948754|P1|COMPLETED|Overall Study||21
1614560|NCT00923247|3948753|P2|STARTED|Overall Study||1
1614561|NCT00923247|3948754|P1|STARTED|Overall Study||21
1614562|NCT00923195|3948782|P2|NOT COMPLETED|Overall Study||1
1614563|NCT00923195|3948783|P1|NOT COMPLETED|Overall Study||0
1614564|NCT00923195|3948782|P2|COMPLETED|Overall Study||1
1614565|NCT00923195|3948783|P1|COMPLETED|Overall Study||2
1614566|NCT00923195|3948782|P2|STARTED|Overall Study||2
1614567|NCT00923195|3948783|P1|STARTED|Overall Study||2
1614568|NCT00923156|3948794|P3|NOT COMPLETED|Overall Study||3
1614569|NCT00923156|3948795|P2|NOT COMPLETED|Overall Study||4
1614570|NCT00923156|3948796|P1|NOT COMPLETED|Overall Study||0
1614571|NCT00923156|3948794|P3|COMPLETED|Overall Study||38
1614572|NCT00923156|3948795|P2|COMPLETED|Overall Study||38
1614573|NCT00923156|3948796|P1|COMPLETED|Overall Study||40
1614574|NCT00923156|3948794|P3|STARTED|Overall Study||41
1614575|NCT00923156|3948795|P2|STARTED|Overall Study||42
1614576|NCT00923156|3948796|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
1614577|NCT00923130|3948822|P1|NOT COMPLETED|Overall Study||25
1614578|NCT00923130|3948822|P1|COMPLETED|Overall Study||5
1614579|NCT00923130|3948822|P1|STARTED|Overall Study||30
1614580|NCT00923117|3948840|P2|NOT COMPLETED|Overall Study||0
1614581|NCT00923117|3948841|P1|NOT COMPLETED|Overall Study||0
1614582|NCT00923117|3948840|P2|COMPLETED|Overall Study||43
1614583|NCT00923117|3948841|P1|COMPLETED|Overall Study||44
1614584|NCT00923117|3948840|P2|STARTED|Overall Study||43
1614585|NCT00923117|3948841|P1|STARTED|Overall Study||44
1614586|NCT00923091|3948857|P13|NOT COMPLETED|Period VI (Open-Label)||0
1614587|NCT00923091|3948858|P12|NOT COMPLETED|Period VI (Open-Label)||0
1614588|NCT00923091|3948859|P11|NOT COMPLETED|Period VI (Open-Label)||0
1614589|NCT00923091|3948860|P10|NOT COMPLETED|Period VI (Open-Label)||0
1614590|NCT00923091|3948861|P9|NOT COMPLETED|Period VI (Open-Label)||0
1614591|NCT00923091|3948862|P8|NOT COMPLETED|Period VI (Open-Label)||0
1614592|NCT00923091|3948863|P7|NOT COMPLETED|Period VI (Open-Label)||0
1614593|NCT00923091|3948864|P6|NOT COMPLETED|Period VI (Open-Label)||0
1614594|NCT00923091|3948865|P5|NOT COMPLETED|Period VI (Open-Label)||7
1614595|NCT00923091|3948866|P4|NOT COMPLETED|Period VI (Open-Label)||3
1614596|NCT00923091|3948867|P3|NOT COMPLETED|Period VI (Open-Label)||13
1614597|NCT00923091|3948868|P2|NOT COMPLETED|Period VI (Open-Label)||8
1614598|NCT00923091|3948869|P1|NOT COMPLETED|Period VI (Open-Label)||39
1614599|NCT00923091|3948857|P13|COMPLETED|Period VI (Open-Label)||0
1614600|NCT00923091|3948858|P12|COMPLETED|Period VI (Open-Label)||0
1614601|NCT00923091|3948859|P11|COMPLETED|Period VI (Open-Label)||0
1614602|NCT00923091|3948860|P10|COMPLETED|Period VI (Open-Label)||0
1614603|NCT00923091|3948861|P9|COMPLETED|Period VI (Open-Label)||0
1614604|NCT00923091|3948862|P8|COMPLETED|Period VI (Open-Label)||0
1614605|NCT00923091|3948863|P7|COMPLETED|Period VI (Open-Label)||0
1614606|NCT00923091|3948864|P6|COMPLETED|Period VI (Open-Label)||0
1614607|NCT00923091|3948865|P5|COMPLETED|Period VI (Open-Label)||157
1614608|NCT00923091|3948866|P4|COMPLETED|Period VI (Open-Label)||143
1614609|NCT00923091|3948867|P3|COMPLETED|Period VI (Open-Label)||467
1614610|NCT00923091|3948868|P2|COMPLETED|Period VI (Open-Label)||264
1614611|NCT00923091|3948869|P1|COMPLETED|Period VI (Open-Label)||1408
1614612|NCT00923091|3948857|P13|STARTED|Period VI (Open-Label)||0
1614613|NCT00923091|3948858|P12|STARTED|Period VI (Open-Label)||0
1614615|NCT00923091|3948860|P10|STARTED|Period VI (Open-Label)||0
1614616|NCT00923091|3948861|P9|STARTED|Period VI (Open-Label)||0
1614617|NCT00923091|3948862|P8|STARTED|Period VI (Open-Label)||0
1614618|NCT00923091|3948863|P7|STARTED|Period VI (Open-Label)||0
1614619|NCT00923091|3948864|P6|STARTED|Period VI (Open-Label)||0
1614620|NCT00923091|3948865|P5|STARTED|Period VI (Open-Label)||164
1614621|NCT00923091|3948866|P4|STARTED|Period VI (Open-Label)||146
1614622|NCT00923091|3948867|P3|STARTED|Period VI (Open-Label)||480
1614623|NCT00923091|3948868|P2|STARTED|Period VI (Open-Label)||272
1614624|NCT00923091|3948869|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
1614625|NCT00923091|3948857|P13|NOT COMPLETED|Period V (Double -Blind)||2
1614626|NCT00923091|3948858|P12|NOT COMPLETED|Period V (Double -Blind)||0
1614627|NCT00923091|3948859|P11|NOT COMPLETED|Period V (Double -Blind)||1
1614628|NCT00923091|3948860|P10|NOT COMPLETED|Period V (Double -Blind)||0
1614629|NCT00923091|3948861|P9|NOT COMPLETED|Period V (Double -Blind)||1
1614630|NCT00923091|3948862|P8|NOT COMPLETED|Period V (Double -Blind)||0
1614631|NCT00923091|3948863|P7|NOT COMPLETED|Period V (Double -Blind)||0
1614632|NCT00923091|3948864|P6|NOT COMPLETED|Period V (Double -Blind)||0
1614633|NCT00923091|3948865|P5|NOT COMPLETED|Period V (Double -Blind)||0
1614634|NCT00923091|3948866|P4|NOT COMPLETED|Period V (Double -Blind)||0
1614635|NCT00923091|3948867|P3|NOT COMPLETED|Period V (Double -Blind)||0
1614636|NCT00923091|3948868|P2|NOT COMPLETED|Period V (Double -Blind)||0
1614637|NCT00923091|3948869|P1|NOT COMPLETED|Period V (Double -Blind)||0
1614638|NCT00923091|3948857|P13|COMPLETED|Period V (Double -Blind)||73
1614639|NCT00923091|3948858|P12|COMPLETED|Period V (Double -Blind)||151
1614640|NCT00923091|3948859|P11|COMPLETED|Period V (Double -Blind)||193
1614641|NCT00923091|3948860|P10|COMPLETED|Period V (Double -Blind)||119
1614642|NCT00923091|3948861|P9|COMPLETED|Period V (Double -Blind)||134
1614643|NCT00923091|3948862|P8|COMPLETED|Period V (Double -Blind)||0
1614644|NCT00923091|3948863|P7|COMPLETED|Period V (Double -Blind)||0
1614645|NCT00923091|3948864|P6|COMPLETED|Period V (Double -Blind)||0
1614646|NCT00923091|3948865|P5|COMPLETED|Period V (Double -Blind)||0
1614647|NCT00923091|3948866|P4|COMPLETED|Period V (Double -Blind)||0
1614648|NCT00923091|3948867|P3|COMPLETED|Period V (Double -Blind)||0
1614649|NCT00923091|3948868|P2|COMPLETED|Period V (Double -Blind)||0
1614650|NCT00923091|3948869|P1|COMPLETED|Period V (Double -Blind)||0
1614651|NCT00923091|3948857|P13|STARTED|Period V (Double -Blind)||75
1614652|NCT00923091|3948858|P12|STARTED|Period V (Double -Blind)||151
1614653|NCT00923091|3948859|P11|STARTED|Period V (Double -Blind)||194
1614654|NCT00923091|3948860|P10|STARTED|Period V (Double -Blind)||119
1614655|NCT00923091|3948861|P9|STARTED|Period V (Double -Blind)||135
1614656|NCT00923091|3948862|P8|STARTED|Period V (Double -Blind)||0
1614657|NCT00923091|3948863|P7|STARTED|Period V (Double -Blind)||0
1614658|NCT00923091|3948864|P6|STARTED|Period V (Double -Blind)||0
1614659|NCT00923091|3948865|P5|STARTED|Period V (Double -Blind)||0
1614660|NCT00923091|3948866|P4|STARTED|Period V (Double -Blind)||0
1614661|NCT00923091|3948867|P3|STARTED|Period V (Double -Blind)||0
1614662|NCT00923091|3948868|P2|STARTED|Period V (Double -Blind)||0
1614663|NCT00923091|3948869|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
1614664|NCT00923091|3948857|P13|NOT COMPLETED|Period IV (Double-Blind)||0
1614665|NCT00923091|3948858|P12|NOT COMPLETED|Period IV (Double-Blind)||0
1614666|NCT00923091|3948859|P11|NOT COMPLETED|Period IV (Double-Blind)||0
1614667|NCT00923091|3948860|P10|NOT COMPLETED|Period IV (Double-Blind)||0
1614668|NCT00923091|3948861|P9|NOT COMPLETED|Period IV (Double-Blind)||0
1614669|NCT00923091|3948862|P8|NOT COMPLETED|Period IV (Double-Blind)||0
1614670|NCT00923091|3948863|P7|NOT COMPLETED|Period IV (Double-Blind)||0
1614671|NCT00923091|3948864|P6|NOT COMPLETED|Period IV (Double-Blind)||0
1614672|NCT00923091|3948865|P5|NOT COMPLETED|Period IV (Double-Blind)||0
1614673|NCT00923091|3948866|P4|NOT COMPLETED|Period IV (Double-Blind)||0
1614674|NCT00923091|3948867|P3|NOT COMPLETED|Period IV (Double-Blind)||0
1614675|NCT00923091|3948868|P2|NOT COMPLETED|Period IV (Double-Blind)||2
1614676|NCT00923091|3948869|P1|NOT COMPLETED|Period IV (Double-Blind)||2
1614677|NCT00923091|3948857|P13|COMPLETED|Period IV (Double-Blind)||0
1614678|NCT00923091|3948858|P12|COMPLETED|Period IV (Double-Blind)||0
1614679|NCT00923091|3948859|P11|COMPLETED|Period IV (Double-Blind)||0
1614680|NCT00923091|3948860|P10|COMPLETED|Period IV (Double-Blind)||0
1614681|NCT00923091|3948861|P9|COMPLETED|Period IV (Double-Blind)||0
1614682|NCT00923091|3948862|P8|COMPLETED|Period IV (Double-Blind)||0
1614683|NCT00923091|3948863|P7|COMPLETED|Period IV (Double-Blind)||0
1614684|NCT00923091|3948864|P6|COMPLETED|Period IV (Double-Blind)||0
1614685|NCT00923091|3948865|P5|COMPLETED|Period IV (Double-Blind)||0
1614686|NCT00923091|3948866|P4|COMPLETED|Period IV (Double-Blind)||0
1614687|NCT00923091|3948867|P3|COMPLETED|Period IV (Double-Blind)||0
1614688|NCT00923091|3948868|P2|COMPLETED|Period IV (Double-Blind)||451
1614689|NCT00923091|3948869|P1|COMPLETED|Period IV (Double-Blind)||226
1614690|NCT00923091|3948857|P13|STARTED|Period IV (Double-Blind)||0
1614691|NCT00923091|3948858|P12|STARTED|Period IV (Double-Blind)||0
1614692|NCT00923091|3948859|P11|STARTED|Period IV (Double-Blind)||0
1614693|NCT00923091|3948860|P10|STARTED|Period IV (Double-Blind)||0
1614694|NCT00923091|3948861|P9|STARTED|Period IV (Double-Blind)||0
1614695|NCT00923091|3948862|P8|STARTED|Period IV (Double-Blind)||0
1614696|NCT00923091|3948863|P7|STARTED|Period IV (Double-Blind)||0
1614697|NCT00923091|3948864|P6|STARTED|Period IV (Double-Blind)||0
1614698|NCT00923091|3948865|P5|STARTED|Period IV (Double-Blind)||0
1614699|NCT00923091|3948866|P4|STARTED|Period IV (Double-Blind)||0
1614700|NCT00923091|3948867|P3|STARTED|Period IV (Double-Blind)||0
1614701|NCT00923091|3948868|P2|STARTED|Period IV (Double-Blind)||453
1614702|NCT00923091|3948869|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
1614703|NCT00923091|3948857|P13|NOT COMPLETED|Period III (Single-Blind)||0
1614704|NCT00923091|3948858|P12|NOT COMPLETED|Period III (Single-Blind)||0
1614705|NCT00923091|3948859|P11|NOT COMPLETED|Period III (Single-Blind)||0
1614706|NCT00923091|3948860|P10|NOT COMPLETED|Period III (Single-Blind)||0
1614707|NCT00923091|3948861|P9|NOT COMPLETED|Period III (Single-Blind)||0
1614708|NCT00923091|3948862|P8|NOT COMPLETED|Period III (Single-Blind)||0
1614709|NCT00923091|3948863|P7|NOT COMPLETED|Period III (Single-Blind)||0
1614710|NCT00923091|3948864|P6|NOT COMPLETED|Period III (Single-Blind)||0
1614711|NCT00923091|3948865|P5|NOT COMPLETED|Period III (Single-Blind)||0
1614712|NCT00923091|3948866|P4|NOT COMPLETED|Period III (Single-Blind)||0
1614713|NCT00923091|3948867|P3|NOT COMPLETED|Period III (Single-Blind)||0
1614714|NCT00923091|3948868|P2|NOT COMPLETED|Period III (Single-Blind)||0
1614715|NCT00923091|3948869|P1|NOT COMPLETED|Period III (Single-Blind)||20
1614716|NCT00923091|3948857|P13|COMPLETED|Period III (Single-Blind)||0
1614717|NCT00923091|3948858|P12|COMPLETED|Period III (Single-Blind)||0
1614718|NCT00923091|3948859|P11|COMPLETED|Period III (Single-Blind)||0
1614719|NCT00923091|3948860|P10|COMPLETED|Period III (Single-Blind)||0
1614720|NCT00923091|3948861|P9|COMPLETED|Period III (Single-Blind)||0
1614721|NCT00923091|3948862|P8|COMPLETED|Period III (Single-Blind)||0
1614722|NCT00923091|3948863|P7|COMPLETED|Period III (Single-Blind)||0
1614723|NCT00923091|3948864|P6|COMPLETED|Period III (Single-Blind)||0
1614724|NCT00923091|3948865|P5|COMPLETED|Period III (Single-Blind)||0
1614725|NCT00923091|3948866|P4|COMPLETED|Period III (Single-Blind)||0
1614726|NCT00923091|3948867|P3|COMPLETED|Period III (Single-Blind)||0
1614727|NCT00923091|3948868|P2|COMPLETED|Period III (Single-Blind)||0
1614728|NCT00923091|3948869|P1|COMPLETED|Period III (Single-Blind)||2520
1614729|NCT00923091|3948857|P13|STARTED|Period III (Single-Blind)||0
1614730|NCT00923091|3948858|P12|STARTED|Period III (Single-Blind)||0
1614731|NCT00923091|3948859|P11|STARTED|Period III (Single-Blind)||0
1614732|NCT00923091|3948860|P10|STARTED|Period III (Single-Blind)||0
1614733|NCT00923091|3948861|P9|STARTED|Period III (Single-Blind)||0
1614734|NCT00923091|3948862|P8|STARTED|Period III (Single-Blind)||0
1614735|NCT00923091|3948863|P7|STARTED|Period III (Single-Blind)||0
1614736|NCT00923091|3948864|P6|STARTED|Period III (Single-Blind)||0
1614737|NCT00923091|3948865|P5|STARTED|Period III (Single-Blind)||0
1614738|NCT00923091|3948866|P4|STARTED|Period III (Single-Blind)||0
1614739|NCT00923091|3948867|P3|STARTED|Period III (Single-Blind)||0
1614740|NCT00923091|3948868|P2|STARTED|Period III (Single-Blind)||0
1614741|NCT00923091|3948869|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
1614742|NCT00923091|3948857|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614743|NCT00923091|3948858|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614744|NCT00923091|3948859|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614745|NCT00923091|3948860|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614746|NCT00923091|3948861|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614747|NCT00923091|3948862|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
1614748|NCT00923091|3948863|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
1614749|NCT00923091|3948864|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
1614750|NCT00923091|3948865|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
1614751|NCT00923091|3948866|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
1614752|NCT00923091|3948867|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
1614753|NCT00923091|3948868|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
1614754|NCT00923091|3948869|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
1614755|NCT00923091|3948857|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614756|NCT00923091|3948858|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614757|NCT00923091|3948859|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614758|NCT00923091|3948860|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614759|NCT00923091|3948861|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1614760|NCT00923091|3948862|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
1614761|NCT00923091|3948863|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
1614762|NCT00923091|3948864|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
1614763|NCT00923091|3948865|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
1614764|NCT00923091|3948866|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
1614765|NCT00923091|3948867|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
1614766|NCT00923091|3948868|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
1614767|NCT00923091|3948869|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
1614768|NCT00923091|3948857|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1614769|NCT00923091|3948858|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1614770|NCT00923091|3948859|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1614771|NCT00923091|3948860|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1614772|NCT00923091|3948861|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1614773|NCT00923091|3948862|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1614774|NCT00923091|3948863|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
1614775|NCT00923091|3948864|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
1614776|NCT00923091|3948865|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1614777|NCT00923091|3948866|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1614778|NCT00923091|3948867|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1614779|NCT00923091|3948868|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1614780|NCT00923091|3948869|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
1614781|NCT00923078|3948919|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
1614782|NCT00923078|3948920|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
1614783|NCT00923078|3948921|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
1614784|NCT00923078|3948919|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
1614785|NCT00923078|3948920|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
1614786|NCT00923078|3948921|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
1614787|NCT00923078|3948919|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
1614788|NCT00923078|3948920|P2|STARTED|Second Intervention (Weeks 5-8)||19
1614789|NCT00923078|3948921|P1|STARTED|Second Intervention (Weeks 5-8)||19
1614790|NCT00923078|3948919|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
1614791|NCT00923078|3948920|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
1614792|NCT00923078|3948921|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
1614793|NCT00923078|3948919|P3|COMPLETED|First Intervention (Weeks 1-4)||0
1614794|NCT00923078|3948920|P2|COMPLETED|First Intervention (Weeks 1-4)||19
1614795|NCT00923078|3948921|P1|COMPLETED|First Intervention (Weeks 1-4)||19
1614796|NCT00923078|3948919|P3|STARTED|First Intervention (Weeks 1-4)||20
1614797|NCT00923078|3948920|P2|STARTED|First Intervention (Weeks 1-4)||20
1614798|NCT00923078|3948921|P1|STARTED|First Intervention (Weeks 1-4)||20
1614799|NCT00922987|3948940|P1|NOT COMPLETED|Overall Study||4
1614800|NCT00922987|3948940|P1|COMPLETED|Overall Study||277
1614801|NCT00922987|3948940|P1|STARTED|Overall Study||281
1614802|NCT00922935|3948955|P3|NOT COMPLETED|Overall Study||0
1614803|NCT00922935|3948956|P2|NOT COMPLETED|Overall Study||5
1614804|NCT00922935|3948957|P1|NOT COMPLETED|Overall Study||1
1614805|NCT00922935|3948955|P3|COMPLETED|Overall Study||10
1614806|NCT00922935|3948956|P2|COMPLETED|Overall Study||11
1614807|NCT00922935|3948957|P1|COMPLETED|Overall Study||9
1614808|NCT00922935|3948955|P3|STARTED|Overall Study||10
1614809|NCT00922935|3948956|P2|STARTED|Overall Study||16
1614810|NCT00922935|3948957|P1|STARTED|Overall Study||10
1614811|NCT00922883|3948965|P1|NOT COMPLETED|Overall Study||0
1614812|NCT00922883|3948965|P1|COMPLETED|Overall Study||43
1614813|NCT00922883|3948965|P1|STARTED|Overall Study||43
1614814|NCT00922779|3948969|P1|NOT COMPLETED|Overall Study||2327
1614815|NCT00922779|3948969|P1|COMPLETED|Overall Study||4334
1614816|NCT00922779|3948969|P1|STARTED|Overall Study||6661
1614817|NCT00922766|3948976|P1|NOT COMPLETED|Overall Study||7
1614818|NCT00922766|3948976|P1|COMPLETED|Overall Study||610
1614819|NCT00922766|3948976|P1|STARTED|Overall Study||617
1614820|NCT00922701|3948985|P1|NOT COMPLETED|Overall Study||0
1614821|NCT00922701|3948985|P1|COMPLETED|Overall Study||4
1614822|NCT00922701|3948985|P1|STARTED|Overall Study||4
1614823|NCT00922636|3948994|P5|NOT COMPLETED|Overall Study||16
1614824|NCT00922636|3948995|P4|NOT COMPLETED|Overall Study||17
1614825|NCT00922636|3948996|P3|NOT COMPLETED|Overall Study||20
1614826|NCT00922636|3948997|P2|NOT COMPLETED|Overall Study||16
1614827|NCT00922636|3948998|P1|NOT COMPLETED|Overall Study||7
1614828|NCT00922636|3948994|P5|COMPLETED|Overall Study||59
1614829|NCT00922636|3948995|P4|COMPLETED|Overall Study||58
1614830|NCT00922636|3948996|P3|COMPLETED|Overall Study||56
1614831|NCT00922636|3948997|P2|COMPLETED|Overall Study||62
1614832|NCT00922636|3948998|P1|COMPLETED|Overall Study||29
1614833|NCT00922636|3948994|P5|Entered Optional Taper Phase|Overall Study||12
1614834|NCT00922636|3948995|P4|Entered Optional Taper Phase|Overall Study||7
1614835|NCT00922636|3948996|P3|Entered Optional Taper Phase|Overall Study||15
1614836|NCT00922636|3948997|P2|Entered Optional Taper Phase|Overall Study||10
1614837|NCT00922636|3948998|P1|Entered Optional Taper Phase|Overall Study||4
1614838|NCT00922636|3948994|P5|STARTED|Overall Study||75
1614839|NCT00922636|3948995|P4|STARTED|Overall Study||75
1614840|NCT00922636|3948996|P3|STARTED|Overall Study||76
1614841|NCT00922636|3948997|P2|STARTED|Overall Study||78
1614842|NCT00922636|3948998|P1|STARTED|Overall Study||36
1614843|NCT00922623|3949145|P1|NOT COMPLETED|Overall Study||5
1614844|NCT00922623|3949145|P1|COMPLETED|Overall Study||88
1614845|NCT00922623|3949145|P1|STARTED|Overall Study||93
1614846|NCT00922480|3949153|P2|NOT COMPLETED|Extension Study||3
1614847|NCT00922480|3949154|P1|NOT COMPLETED|Extension Study||5
1614848|NCT00922480|3949153|P2|COMPLETED|Extension Study||82
1614849|NCT00922480|3949154|P1|COMPLETED|Extension Study||68
1614850|NCT00922480|3949153|P2|STARTED|Extension Study||85
1614851|NCT00922480|3949154|P1|STARTED|Extension Study||73
1614852|NCT00922480|3949153|P2|NOT COMPLETED|Main Study||29
1614853|NCT00922480|3949154|P1|NOT COMPLETED|Main Study||37
1614854|NCT00922480|3949153|P2|COMPLETED|Main Study||226
1614855|NCT00922480|3949154|P1|COMPLETED|Main Study||213
1614856|NCT00922480|3949153|P2|STARTED|Main Study||255
1614857|NCT00922480|3949154|P1|STARTED|Main Study||250
1614858|NCT00922441|3949165|P3|NOT COMPLETED|Overall Study||3
1614859|NCT00922441|3949166|P2|NOT COMPLETED|Overall Study||0
1614860|NCT00922441|3949167|P1|NOT COMPLETED|Overall Study||0
1614861|NCT00922441|3949165|P3|COMPLETED|Overall Study||29
1614862|NCT00922441|3949166|P2|COMPLETED|Overall Study||30
1614863|NCT00922441|3949167|P1|COMPLETED|Overall Study||30
1614864|NCT00922441|3949165|P3|STARTED|Overall Study||32
1614865|NCT00922441|3949166|P2|STARTED|Overall Study||30
1614866|NCT00922441|3949167|P1|STARTED|Overall Study||30
1614867|NCT00922428|3949175|P1|NOT COMPLETED|Overall Study||15
1614868|NCT00922428|3949175|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
1614869|NCT00922428|3949175|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
1614870|NCT00922272|3949204|P2|NOT COMPLETED|Double-blind Phase||6
1614871|NCT00922272|3949205|P1|NOT COMPLETED|Double-blind Phase||7
1614872|NCT00922272|3949204|P2|COMPLETED|Double-blind Phase||29
1614873|NCT00922272|3949205|P1|COMPLETED|Double-blind Phase||27
1614874|NCT00922272|3949204|P2|STARTED|Double-blind Phase||35
1614875|NCT00922272|3949205|P1|STARTED|Double-blind Phase||34
1614876|NCT00922272|3949204|P2|NOT COMPLETED|Open-label Phase||0
1614877|NCT00922272|3949205|P1|NOT COMPLETED|Open-label Phase||23
1614878|NCT00922272|3949204|P2|COMPLETED|Open-label Phase||0
1614879|NCT00922272|3949205|P1|COMPLETED|Open-label Phase||69
1614880|NCT00922272|3949204|P2|STARTED|Open-label Phase||0
1614881|NCT00922272|3949205|P1|STARTED|Open-label Phase||92
1614882|NCT00922233|3949261|P1|NOT COMPLETED|Overall Study||4
1614883|NCT00922233|3949261|P1|COMPLETED|Overall Study||68
1614884|NCT00922233|3949261|P1|STARTED|Overall Study||72
1614885|NCT00922207|3949270|P3|NOT COMPLETED|Overall Study||4
1614886|NCT00922207|3949271|P2|NOT COMPLETED|Overall Study||7
1614887|NCT00922207|3949272|P1|NOT COMPLETED|Overall Study||6
1614888|NCT00922207|3949270|P3|COMPLETED|Overall Study||90
1614889|NCT00922207|3949271|P2|COMPLETED|Overall Study||88
1614890|NCT00922207|3949272|P1|COMPLETED|Overall Study||85
1614891|NCT00922207|3949270|P3|STARTED|Overall Study||94
1614892|NCT00922207|3949271|P2|STARTED|Overall Study||95
1614893|NCT00922207|3949272|P1|STARTED|Overall Study||91
1614894|NCT00922194|3949298|P1|NOT COMPLETED|Metformin for 12 Months or More||0
1614895|NCT00922194|3949298|P1|COMPLETED|Metformin for 12 Months or More||102
1614896|NCT00922194|3949298|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
1614897|NCT00922194|3949298|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
1614898|NCT00922194|3949298|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
1614899|NCT00922194|3949298|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
1614900|NCT00922116|3949308|P1|NOT COMPLETED|Overall Study||15
1614901|NCT00922116|3949308|P1|COMPLETED|Overall Study||176
1614902|NCT00922116|3949308|P1|STARTED|Overall Study||191
1614903|NCT00921947|3949319|P2|NOT COMPLETED|Day 28||0
1614904|NCT00921947|3949320|P1|NOT COMPLETED|Day 28||0
1614905|NCT00921947|3949319|P2|COMPLETED|Day 28||30
1614906|NCT00921947|3949320|P1|COMPLETED|Day 28||28
1614907|NCT00921947|3949319|P2|STARTED|Day 28||30
1614908|NCT00921947|3949320|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
1614909|NCT00921947|3949319|P2|NOT COMPLETED|Day 0||0
1614910|NCT00921947|3949320|P1|NOT COMPLETED|Day 0||0
1614911|NCT00921947|3949319|P2|COMPLETED|Day 0||30
1614912|NCT00921947|3949320|P1|COMPLETED|Day 0||30
1614913|NCT00921947|3949319|P2|STARTED|Day 0||30
1614914|NCT00921947|3949320|P1|STARTED|Day 0||30
1614915|NCT00921934|3949330|P1|NOT COMPLETED|Overall Study||0
1614916|NCT00921934|3949330|P1|COMPLETED|Overall Study||68
1614917|NCT00921934|3949330|P1|STARTED|Overall Study||68
1614918|NCT00921895|3949334|P1|NOT COMPLETED|Overall Study||0
1614919|NCT00921895|3949334|P1|COMPLETED|Overall Study||128
1614920|NCT00921895|3949334|P1|STARTED|Overall Study||128
1614921|NCT00921687|3949341|P2|NOT COMPLETED|Overall Study||0
1614922|NCT00921687|3949342|P1|NOT COMPLETED|Overall Study||0
1614923|NCT00921687|3949341|P2|COMPLETED|Overall Study||363
1614924|NCT00921687|3949342|P1|COMPLETED|Overall Study||418
1614925|NCT00921687|3949341|P2|STARTED|Overall Study||363
1614926|NCT00921687|3949342|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
1614927|NCT00921557|3949353|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
1614928|NCT00921557|3949354|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
1614929|NCT00921557|3949355|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
1614930|NCT00921557|3949353|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
1614931|NCT00921557|3949354|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
1614932|NCT00921557|3949355|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
1614933|NCT00921557|3949353|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
1614934|NCT00921557|3949354|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
1614935|NCT00921557|3949355|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
1614936|NCT00921557|3949353|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
1614937|NCT00921557|3949354|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
1614938|NCT00921557|3949355|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
1614939|NCT00921557|3949353|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
1614940|NCT00921557|3949354|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
1614941|NCT00921557|3949355|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
1614942|NCT00921557|3949353|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
1614943|NCT00921557|3949354|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
1614944|NCT00921557|3949355|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
1614945|NCT00921557|3949353|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
1614946|NCT00921557|3949354|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
1614947|NCT00921557|3949355|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
1614948|NCT00921557|3949353|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
1614949|NCT00921557|3949354|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
1614950|NCT00921557|3949355|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
1614951|NCT00921557|3949353|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
1614952|NCT00921557|3949354|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
1614953|NCT00921557|3949355|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
1614954|NCT00921518|3949415|P2|NOT COMPLETED|Overall Study||0
1614955|NCT00921518|3949416|P1|NOT COMPLETED|Overall Study||0
1614956|NCT00921518|3949415|P2|COMPLETED|Overall Study||44
1614957|NCT00921518|3949416|P1|COMPLETED|Overall Study||48
1614958|NCT00921518|3949415|P2|STARTED|Overall Study||44
1614959|NCT00921518|3949416|P1|STARTED|Overall Study||48
1614960|NCT00921310|3949424|P3|NOT COMPLETED|Overall Study||0
1614961|NCT00921310|3949425|P2|NOT COMPLETED|Overall Study||0
1614962|NCT00921310|3949426|P1|NOT COMPLETED|Overall Study||0
1614963|NCT00921310|3949424|P3|COMPLETED|Overall Study||4
1614964|NCT00921310|3949425|P2|COMPLETED|Overall Study||6
1614965|NCT00921310|3949426|P1|COMPLETED|Overall Study||2
1614966|NCT00921310|3949424|P3|STARTED|Overall Study||4
1614967|NCT00921310|3949425|P2|STARTED|Overall Study||6
1614968|NCT00921310|3949426|P1|STARTED|Overall Study||2
1614969|NCT00921115|3949451|P1|NOT COMPLETED|Overall Study||0
1614970|NCT00921115|3949451|P1|COMPLETED|Overall Study||42
1614971|NCT00921115|3949451|P1|STARTED|Overall Study||42
1614972|NCT00921024|3949457|P2|NOT COMPLETED|Overall Study||3
1614973|NCT00921024|3949458|P1|NOT COMPLETED|Overall Study||4
1614974|NCT00921024|3949457|P2|COMPLETED|Overall Study||39
1614975|NCT00921024|3949458|P1|COMPLETED|Overall Study||81
1614976|NCT00921024|3949457|P2|STARTED|Overall Study||42
1614977|NCT00921024|3949458|P1|STARTED|Overall Study||85
1614978|NCT00920907|3949468|P2|NOT COMPLETED|Maintenance Period||13
1614979|NCT00920907|3949469|P1|NOT COMPLETED|Maintenance Period||12
1614980|NCT00920907|3949468|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
1614981|NCT00920907|3949469|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
1614982|NCT00920907|3949468|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
1614983|NCT00920907|3949469|P1|STARTED|Maintenance Period||15
1614984|NCT00920907|3949468|P2|NOT COMPLETED|Induction Period||22
1614985|NCT00920907|3949469|P1|NOT COMPLETED|Induction Period||22
1614986|NCT00920907|3949468|P2|COMPLETED|Induction Period||16
1614987|NCT00920907|3949469|P1|COMPLETED|Induction Period||15
1614988|NCT00920907|3949468|P2|STARTED|Induction Period||38
1614989|NCT00920907|3949469|P1|STARTED|Induction Period||37
1614990|NCT00920855|3949510|P3|NOT COMPLETED|Overall Study||22
1614991|NCT00920855|3949511|P2|NOT COMPLETED|Overall Study||3
1614992|NCT00920855|3949512|P1|NOT COMPLETED|Overall Study||5
1614993|NCT00920855|3949510|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
1614994|NCT00920855|3949511|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
1614995|NCT00920855|3949512|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
1614996|NCT00920855|3949510|P3|Safety and Efficacy Populations|Overall Study||31
1614997|NCT00920855|3949511|P2|Safety and Efficacy Populations|Overall Study||4
1614998|NCT00920855|3949512|P1|Safety and Efficacy Populations|Overall Study||5
1614999|NCT00920855|3949510|P3|STARTED|Overall Study||31
1615000|NCT00920855|3949511|P2|STARTED|Overall Study||4
1615001|NCT00920855|3949512|P1|STARTED|Overall Study||5
1615002|NCT00920829|3949538|P4|NOT COMPLETED|Available for Analysis||11
1615003|NCT00920829|3949539|P3|NOT COMPLETED|Available for Analysis||10
1615004|NCT00920829|3949540|P2|NOT COMPLETED|Available for Analysis||11
1615005|NCT00920829|3949541|P1|NOT COMPLETED|Available for Analysis||8
1615006|NCT00920829|3949538|P4|COMPLETED|Available for Analysis||24
1615007|NCT00920829|3949539|P3|COMPLETED|Available for Analysis||28
1615008|NCT00920829|3949540|P2|COMPLETED|Available for Analysis||27
1615009|NCT00920829|3949541|P1|COMPLETED|Available for Analysis||27
1615010|NCT00920829|3949538|P4|STARTED|Available for Analysis||35
1615011|NCT00920829|3949539|P3|STARTED|Available for Analysis||38
1615012|NCT00920829|3949540|P2|STARTED|Available for Analysis||38
1615013|NCT00920829|3949541|P1|STARTED|Available for Analysis||35
1615014|NCT00920829|3949538|P4|NOT COMPLETED|Allocation||2
1615015|NCT00920829|3949539|P3|NOT COMPLETED|Allocation||0
1615016|NCT00920829|3949540|P2|NOT COMPLETED|Allocation||1
1615017|NCT00920829|3949541|P1|NOT COMPLETED|Allocation||3
1615018|NCT00920829|3949538|P4|COMPLETED|Allocation||35
1615019|NCT00920829|3949539|P3|COMPLETED|Allocation||38
1615020|NCT00920829|3949540|P2|COMPLETED|Allocation||38
1615021|NCT00920829|3949541|P1|COMPLETED|Allocation||35
1615022|NCT00920829|3949538|P4|STARTED|Allocation||37
1615023|NCT00920829|3949539|P3|STARTED|Allocation||38
1615024|NCT00920829|3949540|P2|STARTED|Allocation||39
1615025|NCT00920829|3949541|P1|STARTED|Allocation||38
1615026|NCT00920816|3949555|P4|NOT COMPLETED|Overall Study||69
1615027|NCT00920816|3949556|P3|NOT COMPLETED|Overall Study||135
1615028|NCT00920816|3949557|P2|NOT COMPLETED|Overall Study||96
1615029|NCT00920816|3949558|P1|NOT COMPLETED|Overall Study||192
1615030|NCT00920816|3949555|P4|COMPLETED|Overall Study||0
1615031|NCT00920816|3949556|P3|COMPLETED|Overall Study||0
1615032|NCT00920816|3949557|P2|COMPLETED|Overall Study||0
1615033|NCT00920816|3949558|P1|COMPLETED|Overall Study||0
1615034|NCT00920816|3949555|P4|Treated|Overall Study||69
1615035|NCT00920816|3949556|P3|Treated|Overall Study||135
1615036|NCT00920816|3949557|P2|Treated|Overall Study||96
1615037|NCT00920816|3949558|P1|Treated|Overall Study||189
1615038|NCT00920816|3949555|P4|STARTED|Overall Study||69
1615039|NCT00920816|3949556|P3|STARTED|Overall Study||135
1615040|NCT00920816|3949557|P2|STARTED|Overall Study||96
1615041|NCT00920816|3949558|P1|STARTED|Overall Study||192
1615042|NCT00920790|3949596|P1|NOT COMPLETED|Overall Study||14
1615043|NCT00920790|3949596|P1|COMPLETED|Overall Study||13
1615044|NCT00920790|3949596|P1|STARTED|Overall Study||27
1615045|NCT00920699|3949608|P3|NOT COMPLETED|Overall Study||4
1615046|NCT00920699|3949609|P2|NOT COMPLETED|Overall Study||1
1615047|NCT00920699|3949610|P1|NOT COMPLETED|Overall Study||2
1615048|NCT00920699|3949608|P3|COMPLETED|Overall Study||28
1615049|NCT00920699|3949609|P2|COMPLETED|Overall Study||29
1615050|NCT00920699|3949610|P1|COMPLETED|Overall Study||27
1615051|NCT00920699|3949608|P3|STARTED|Overall Study||32
1615052|NCT00920699|3949609|P2|STARTED|Overall Study||30
1615053|NCT00920699|3949610|P1|STARTED|Overall Study||29
1615054|NCT00920686|3949627|P3|NOT COMPLETED|Overall Study||13
1615055|NCT00920686|3949628|P2|NOT COMPLETED|Overall Study||22
1615056|NCT00920686|3949629|P1|NOT COMPLETED|Overall Study||19
1615057|NCT00920686|3949627|P3|COMPLETED|Overall Study||62
1615058|NCT00920686|3949628|P2|COMPLETED|Overall Study||60
1615059|NCT00920686|3949629|P1|COMPLETED|Overall Study||63
1615060|NCT00920686|3949627|P3|STARTED|Overall Study||75
1615061|NCT00920686|3949628|P2|STARTED|Overall Study||82
1615062|NCT00920686|3949629|P1|STARTED|Overall Study||82
1615063|NCT00920647|3949653|P4|NOT COMPLETED|Overall Study||0
1615064|NCT00920647|3949654|P3|NOT COMPLETED|Overall Study||0
1615065|NCT00920647|3949655|P2|NOT COMPLETED|Overall Study||0
1615066|NCT00920647|3949656|P1|NOT COMPLETED|Overall Study||0
1615067|NCT00920647|3949653|P4|COMPLETED|Overall Study||4
1615068|NCT00920647|3949654|P3|COMPLETED|Overall Study||4
1615069|NCT00920647|3949655|P2|COMPLETED|Overall Study||4
1615070|NCT00920647|3949656|P1|COMPLETED|Overall Study||4
1615071|NCT00920647|3949653|P4|STARTED|Overall Study||4
1615072|NCT00920647|3949654|P3|STARTED|Overall Study||4
1615073|NCT00920647|3949655|P2|STARTED|Overall Study||4
1615074|NCT00920647|3949656|P1|STARTED|Overall Study||4
1615075|NCT00920621|3949708|P4|NOT COMPLETED|Overall Study||35
1615076|NCT00920621|3949709|P3|NOT COMPLETED|Overall Study||35
1615077|NCT00920621|3949710|P2|NOT COMPLETED|Overall Study||45
1615078|NCT00920621|3949711|P1|NOT COMPLETED|Overall Study||54
1615079|NCT00920621|3949708|P4|COMPLETED|Overall Study||401
1615080|NCT00920621|3949709|P3|COMPLETED|Overall Study||405
1615081|NCT00920621|3949710|P2|COMPLETED|Overall Study||391
1615082|NCT00920621|3949711|P1|COMPLETED|Overall Study||386
1615083|NCT00920621|3949708|P4|STARTED|Overall Study||436
1615084|NCT00920621|3949709|P3|STARTED|Overall Study||440
1615085|NCT00920621|3949710|P2|STARTED|Overall Study||436
1615086|NCT00920621|3949711|P1|STARTED|Overall Study||440
1615087|NCT00920439|3949735|P1|NOT COMPLETED|Overall Study||0
1615088|NCT00920439|3949735|P1|COMPLETED|Overall Study||25
1615089|NCT00920439|3949735|P1|STARTED|Overall Study||25
1615090|NCT00920426|3949745|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1615091|NCT00920426|3949746|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1615092|NCT00920426|3949747|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1615093|NCT00920426|3949748|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1615094|NCT00920426|3949745|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
1615095|NCT00920426|3949746|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1615096|NCT00920426|3949747|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1615097|NCT00920426|3949748|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
1615098|NCT00920426|3949745|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
1615099|NCT00920426|3949746|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
1615100|NCT00920426|3949747|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
1615101|NCT00920426|3949748|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
1615102|NCT00920426|3949745|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
1615103|NCT00920426|3949746|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
1615104|NCT00920426|3949747|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
1615105|NCT00920426|3949748|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
1615106|NCT00920426|3949745|P4|COMPLETED|ITZ112929: Randomized Regimen||0
1615107|NCT00920426|3949746|P3|COMPLETED|ITZ112929: Randomized Regimen||2
1615108|NCT00920426|3949747|P2|COMPLETED|ITZ112929: Randomized Regimen||7
1615109|NCT00920426|3949748|P1|COMPLETED|ITZ112929: Randomized Regimen||0
1615110|NCT00920426|3949745|P4|STARTED|ITZ112929: Randomized Regimen||0
1615111|NCT00920426|3949746|P3|STARTED|ITZ112929: Randomized Regimen||2
1615112|NCT00920426|3949747|P2|STARTED|ITZ112929: Randomized Regimen||7
1615113|NCT00920426|3949748|P1|STARTED|ITZ112929: Randomized Regimen||0
1615114|NCT00920426|3949745|P4|NOT COMPLETED|ITZ111451||0
1615115|NCT00920426|3949746|P3|NOT COMPLETED|ITZ111451||0
1615116|NCT00920426|3949747|P2|NOT COMPLETED|ITZ111451||0
1615117|NCT00920426|3949748|P1|NOT COMPLETED|ITZ111451||1
1615118|NCT00920426|3949745|P4|COMPLETED|ITZ111451||0
1615119|NCT00920426|3949746|P3|COMPLETED|ITZ111451||0
1615120|NCT00920426|3949747|P2|COMPLETED|ITZ111451||0
1615121|NCT00920426|3949748|P1|COMPLETED|ITZ111451||7
1615122|NCT00920426|3949745|P4|STARTED|ITZ111451||0
1615123|NCT00920426|3949746|P3|STARTED|ITZ111451||0
1615124|NCT00920426|3949747|P2|STARTED|ITZ111451||0
1615125|NCT00920426|3949748|P1|STARTED|ITZ111451||8
1615126|NCT00920374|3949817|P2|NOT COMPLETED|Overall Study||0
1615127|NCT00920374|3949818|P1|NOT COMPLETED|Overall Study||0
1615128|NCT00920374|3949817|P2|COMPLETED|Overall Study||57
1615129|NCT00920374|3949818|P1|COMPLETED|Overall Study||61
1615130|NCT00920374|3949817|P2|STARTED|Overall Study||57
1615131|NCT00920374|3949818|P1|STARTED|Overall Study||61
1615132|NCT00920309|3949844|P2|NOT COMPLETED|Overall Study||0
1615133|NCT00920309|3949845|P1|NOT COMPLETED|Overall Study||0
1615134|NCT00920309|3949844|P2|COMPLETED|Overall Study||7
1615135|NCT00920309|3949845|P1|COMPLETED|Overall Study||14
1615136|NCT00920309|3949844|P2|STARTED|Overall Study||7
1615137|NCT00920309|3949845|P1|STARTED|Overall Study||14
1615138|NCT00920231|3949855|P2|NOT COMPLETED|Overall Study||0
1615139|NCT00920231|3949856|P1|NOT COMPLETED|Overall Study||0
1615140|NCT00920231|3949855|P2|COMPLETED|Overall Study||8
1615141|NCT00920231|3949856|P1|COMPLETED|Overall Study||8
1615142|NCT00920231|3949855|P2|STARTED|Overall Study||8
1615143|NCT00920231|3949856|P1|STARTED|Overall Study||8
1615144|NCT00920218|3949868|P4|NOT COMPLETED|Overall Study||7
1615145|NCT00920218|3949869|P3|NOT COMPLETED|Overall Study||8
1615146|NCT00920218|3949870|P2|NOT COMPLETED|Overall Study||5
1615147|NCT00920218|3949871|P1|NOT COMPLETED|Overall Study||2
1615148|NCT00920218|3949868|P4|COMPLETED|Overall Study||23
1615149|NCT00920218|3949869|P3|COMPLETED|Overall Study||23
1615150|NCT00920218|3949870|P2|COMPLETED|Overall Study||24
1615151|NCT00920218|3949871|P1|COMPLETED|Overall Study||28
1615152|NCT00920218|3949868|P4|STARTED|Overall Study||30
1615153|NCT00920218|3949869|P3|STARTED|Overall Study||31
1615154|NCT00920218|3949870|P2|STARTED|Overall Study||29
1615155|NCT00920218|3949871|P1|STARTED|Overall Study||30
1615156|NCT00920140|3949974|P5|NOT COMPLETED|Phase 2||11
1615157|NCT00920140|3949975|P4|NOT COMPLETED|Phase 2||22
1615158|NCT00920140|3949976|P3|NOT COMPLETED|Phase 2||50
1615159|NCT00920140|3949977|P2|NOT COMPLETED|Phase 2||0
1615160|NCT00920140|3949978|P1|NOT COMPLETED|Phase 2||0
1615161|NCT00920140|3949974|P5|COMPLETED|Phase 2||0
1615162|NCT00920140|3949975|P4|COMPLETED|Phase 2||0
1615163|NCT00920140|3949976|P3|COMPLETED|Phase 2||0
1615164|NCT00920140|3949977|P2|COMPLETED|Phase 2||0
1615165|NCT00920140|3949978|P1|COMPLETED|Phase 2||0
1615166|NCT00920140|3949974|P5|STARTED|Phase 2||11
1615167|NCT00920140|3949975|P4|STARTED|Phase 2||22
1615168|NCT00920140|3949976|P3|STARTED|Phase 2||50
1615169|NCT00920140|3949977|P2|STARTED|Phase 2||0
1615170|NCT00920140|3949978|P1|STARTED|Phase 2||0
1615171|NCT00920140|3949974|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
1615172|NCT00920140|3949975|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
1615173|NCT00920140|3949976|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
1615174|NCT00920140|3949977|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
1615175|NCT00920140|3949978|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
1615176|NCT00920140|3949974|P5|COMPLETED|Phase 1 (Dose Escalation)||0
1615177|NCT00920140|3949975|P4|COMPLETED|Phase 1 (Dose Escalation)||0
1615178|NCT00920140|3949976|P3|COMPLETED|Phase 1 (Dose Escalation)||0
1615179|NCT00920140|3949977|P2|COMPLETED|Phase 1 (Dose Escalation)||0
1615180|NCT00920140|3949978|P1|COMPLETED|Phase 1 (Dose Escalation)||0
1615181|NCT00920140|3949974|P5|STARTED|Phase 1 (Dose Escalation)||0
1615182|NCT00920140|3949975|P4|STARTED|Phase 1 (Dose Escalation)||0
1615183|NCT00920140|3949976|P3|STARTED|Phase 1 (Dose Escalation)||0
1615184|NCT00920140|3949977|P2|STARTED|Phase 1 (Dose Escalation)||9
1615185|NCT00920140|3949978|P1|STARTED|Phase 1 (Dose Escalation)||5
1615186|NCT00920075|3950016|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
1615187|NCT00920075|3950016|P1|COMPLETED|Post Study, 11 Pts Responded||11
1615188|NCT00920075|3950016|P1|STARTED|Post Study, 11 Pts Responded||11
1615189|NCT00920075|3950016|P1|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
1615190|NCT00920075|3950016|P1|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
1615191|NCT00920075|3950016|P1|STARTED|Last Study, 25 Pts Invited,11 Responded||11
1615192|NCT00920023|3950022|P1|NOT COMPLETED|Overall Study||0
1615193|NCT00920023|3950022|P1|COMPLETED|Overall Study||15
1615194|NCT00920023|3950022|P1|STARTED|Overall Study||15
1615195|NCT00919932|3950029|P2|NOT COMPLETED|Overall Study||0
1615196|NCT00919932|3950030|P1|NOT COMPLETED|Overall Study||0
1615197|NCT00919932|3950029|P2|COMPLETED|Overall Study||5
1615198|NCT00919932|3950030|P1|COMPLETED|Overall Study||4
1615199|NCT00919932|3950029|P2|STARTED|Overall Study||5
1615200|NCT00919932|3950030|P1|STARTED|Overall Study||4
1615201|NCT00919893|3950040|P2|NOT COMPLETED|Overall Study||9
1615202|NCT00919893|3950041|P1|NOT COMPLETED|Overall Study||19
1615203|NCT00919893|3950040|P2|COMPLETED|Overall Study||60
1615204|NCT00919893|3950041|P1|COMPLETED|Overall Study||51
1615205|NCT00919893|3950040|P2|STARTED|Overall Study||69
1615206|NCT00919893|3950041|P1|STARTED|Overall Study||70
1615207|NCT00919867|3950053|P6|NOT COMPLETED|Third Intervention||0
1615208|NCT00919867|3950054|P5|NOT COMPLETED|Third Intervention||0
1615209|NCT00919867|3950055|P4|NOT COMPLETED|Third Intervention||0
1615210|NCT00919867|3950056|P3|NOT COMPLETED|Third Intervention||0
1615211|NCT00919867|3950057|P2|NOT COMPLETED|Third Intervention||0
1615212|NCT00919867|3950058|P1|NOT COMPLETED|Third Intervention||0
1615213|NCT00919867|3950053|P6|COMPLETED|Third Intervention||6
1615214|NCT00919867|3950054|P5|COMPLETED|Third Intervention||7
1615215|NCT00919867|3950055|P4|COMPLETED|Third Intervention||7
1615216|NCT00919867|3950056|P3|COMPLETED|Third Intervention||6
1615217|NCT00919867|3950057|P2|COMPLETED|Third Intervention||7
1615218|NCT00919867|3950058|P1|COMPLETED|Third Intervention||7
1615219|NCT00919867|3950053|P6|STARTED|Third Intervention||6
1615220|NCT00919867|3950054|P5|STARTED|Third Intervention||7
1615221|NCT00919867|3950055|P4|STARTED|Third Intervention||7
1615222|NCT00919867|3950056|P3|STARTED|Third Intervention||6
1615223|NCT00919867|3950057|P2|STARTED|Third Intervention||7
1615224|NCT00919867|3950058|P1|STARTED|Third Intervention||7
1615225|NCT00919867|3950053|P6|NOT COMPLETED|Washout||0
1615226|NCT00919867|3950054|P5|NOT COMPLETED|Washout||0
1615227|NCT00919867|3950055|P4|NOT COMPLETED|Washout||0
1615228|NCT00919867|3950056|P3|NOT COMPLETED|Washout||0
1615229|NCT00919867|3950057|P2|NOT COMPLETED|Washout||0
1615230|NCT00919867|3950058|P1|NOT COMPLETED|Washout||0
1615231|NCT00919867|3950053|P6|COMPLETED|Washout||6
1615232|NCT00919867|3950054|P5|COMPLETED|Washout||7
1615233|NCT00919867|3950055|P4|COMPLETED|Washout||7
1615234|NCT00919867|3950056|P3|COMPLETED|Washout||6
1615235|NCT00919867|3950057|P2|COMPLETED|Washout||7
1615236|NCT00919867|3950058|P1|COMPLETED|Washout||7
1615237|NCT00919867|3950053|P6|STARTED|Washout||6
1615238|NCT00919867|3950054|P5|STARTED|Washout||7
1615239|NCT00919867|3950055|P4|STARTED|Washout||7
1615240|NCT00919867|3950056|P3|STARTED|Washout||6
1615241|NCT00919867|3950057|P2|STARTED|Washout||7
1615242|NCT00919867|3950058|P1|STARTED|Washout||7
1615243|NCT00919867|3950053|P6|NOT COMPLETED|Second Intervention||0
1615244|NCT00919867|3950054|P5|NOT COMPLETED|Second Intervention||0
1615245|NCT00919867|3950055|P4|NOT COMPLETED|Second Intervention||0
1615246|NCT00919867|3950056|P3|NOT COMPLETED|Second Intervention||0
1615247|NCT00919867|3950057|P2|NOT COMPLETED|Second Intervention||0
1615248|NCT00919867|3950058|P1|NOT COMPLETED|Second Intervention||0
1615249|NCT00919867|3950053|P6|COMPLETED|Second Intervention||6
1615250|NCT00919867|3950054|P5|COMPLETED|Second Intervention||7
1615251|NCT00919867|3950055|P4|COMPLETED|Second Intervention||7
1615252|NCT00919867|3950056|P3|COMPLETED|Second Intervention||6
1615253|NCT00919867|3950057|P2|COMPLETED|Second Intervention||7
1615254|NCT00919867|3950058|P1|COMPLETED|Second Intervention||7
1615255|NCT00919867|3950053|P6|STARTED|Second Intervention||6
1615256|NCT00919867|3950054|P5|STARTED|Second Intervention||7
1615257|NCT00919867|3950055|P4|STARTED|Second Intervention||7
1615258|NCT00919867|3950056|P3|STARTED|Second Intervention||6
1615259|NCT00919867|3950057|P2|STARTED|Second Intervention||7
1615260|NCT00919867|3950058|P1|STARTED|Second Intervention||7
1615261|NCT00919867|3950053|P6|NOT COMPLETED|Washout||0
1615262|NCT00919867|3950054|P5|NOT COMPLETED|Washout||0
1615263|NCT00919867|3950055|P4|NOT COMPLETED|Washout||0
1615264|NCT00919867|3950056|P3|NOT COMPLETED|Washout||0
1615265|NCT00919867|3950057|P2|NOT COMPLETED|Washout||0
1615266|NCT00919867|3950058|P1|NOT COMPLETED|Washout||0
1615267|NCT00919867|3950053|P6|COMPLETED|Washout||6
1615268|NCT00919867|3950054|P5|COMPLETED|Washout||7
1615269|NCT00919867|3950055|P4|COMPLETED|Washout||7
1615270|NCT00919867|3950056|P3|COMPLETED|Washout||6
1615271|NCT00919867|3950057|P2|COMPLETED|Washout||7
1615272|NCT00919867|3950058|P1|COMPLETED|Washout||7
1615273|NCT00919867|3950053|P6|STARTED|Washout||6
1615274|NCT00919867|3950054|P5|STARTED|Washout||7
1615275|NCT00919867|3950055|P4|STARTED|Washout||7
1615276|NCT00919867|3950056|P3|STARTED|Washout||6
1615277|NCT00919867|3950057|P2|STARTED|Washout||7
1615278|NCT00919867|3950058|P1|STARTED|Washout||7
1615279|NCT00919867|3950053|P6|NOT COMPLETED|First Intervention||1
1615280|NCT00919867|3950054|P5|NOT COMPLETED|First Intervention||0
1615281|NCT00919867|3950055|P4|NOT COMPLETED|First Intervention||0
1615282|NCT00919867|3950056|P3|NOT COMPLETED|First Intervention||1
1615283|NCT00919867|3950057|P2|NOT COMPLETED|First Intervention||0
1615284|NCT00919867|3950058|P1|NOT COMPLETED|First Intervention||0
1615285|NCT00919867|3950053|P6|COMPLETED|First Intervention||6
1615286|NCT00919867|3950054|P5|COMPLETED|First Intervention||7
1615287|NCT00919867|3950055|P4|COMPLETED|First Intervention||7
1615288|NCT00919867|3950056|P3|COMPLETED|First Intervention||6
1615289|NCT00919867|3950057|P2|COMPLETED|First Intervention||7
1615290|NCT00919867|3950058|P1|COMPLETED|First Intervention||7
1615291|NCT00919867|3950053|P6|STARTED|First Intervention||7
1615292|NCT00919867|3950054|P5|STARTED|First Intervention||7
1615293|NCT00919867|3950055|P4|STARTED|First Intervention||7
1615294|NCT00919867|3950056|P3|STARTED|First Intervention||7
1615295|NCT00919867|3950057|P2|STARTED|First Intervention||7
1615296|NCT00919867|3950058|P1|STARTED|First Intervention||7
1615297|NCT00919854|3950079|P1|NOT COMPLETED|Overall Study||1
1615298|NCT00919854|3950079|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
1615299|NCT00919854|3950079|P1|STARTED|Overall Study||21
1615300|NCT00919802|3950088|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
1615301|NCT00919802|3950089|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
1615302|NCT00919802|3950088|P2|COMPLETED|Second Intervention - (24 Hours)||13
1615303|NCT00919802|3950089|P1|COMPLETED|Second Intervention - (24 Hours)||12
1615304|NCT00919802|3950088|P2|STARTED|Second Intervention - (24 Hours)||13
1615305|NCT00919802|3950089|P1|STARTED|Second Intervention - (24 Hours)||12
1615306|NCT00919802|3950088|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
1615307|NCT00919802|3950089|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
1615308|NCT00919802|3950088|P2|COMPLETED|First Intervention - (24 Hours)||13
1615309|NCT00919802|3950089|P1|COMPLETED|First Intervention - (24 Hours)||12
1615310|NCT00919802|3950088|P2|STARTED|First Intervention - (24 Hours)||13
1615311|NCT00919802|3950089|P1|STARTED|First Intervention - (24 Hours)||12
1615312|NCT00919763|3950099|P2|NOT COMPLETED|Overall Study||4
1615313|NCT00919763|3950100|P1|NOT COMPLETED|Overall Study||12
1615314|NCT00919763|3950099|P2|COMPLETED|Overall Study||45
1615315|NCT00919763|3950100|P1|COMPLETED|Overall Study||41
1615316|NCT00919763|3950099|P2|STARTED|Overall Study||49
1615317|NCT00919763|3950100|P1|STARTED|Overall Study||53
1615318|NCT00919724|3950108|P2|NOT COMPLETED|Overall Study||0
1615319|NCT00919724|3950109|P1|NOT COMPLETED|Overall Study||0
1615320|NCT00919724|3950108|P2|COMPLETED|Overall Study||44
1615321|NCT00919724|3950109|P1|COMPLETED|Overall Study||45
1615322|NCT00919724|3950108|P2|STARTED|Overall Study||44
1615323|NCT00919724|3950109|P1|STARTED|Overall Study||45
1615324|NCT00919711|3950117|P2|NOT COMPLETED|Overall Study||13
1615325|NCT00919711|3950118|P1|NOT COMPLETED|Overall Study||33
1615326|NCT00919711|3950117|P2|COMPLETED|Overall Study||422
1615327|NCT00919711|3950118|P1|COMPLETED|Overall Study||402
1615328|NCT00919711|3950117|P2|STARTED|Overall Study||435
1615329|NCT00919711|3950118|P1|STARTED|Overall Study||435
1615330|NCT00919633|3950134|P4|NOT COMPLETED|Overall Study||21
1615331|NCT00919633|3950135|P3|NOT COMPLETED|Overall Study||23
1615332|NCT00919633|3950136|P2|NOT COMPLETED|Overall Study||15
1615333|NCT00919633|3950137|P1|NOT COMPLETED|Overall Study||22
1615334|NCT00919633|3950134|P4|COMPLETED|Overall Study||5
1615335|NCT00919633|3950135|P3|COMPLETED|Overall Study||4
1615336|NCT00919633|3950136|P2|COMPLETED|Overall Study||10
1615337|NCT00919633|3950137|P1|COMPLETED|Overall Study||6
1615338|NCT00919633|3950134|P4|STARTED|Overall Study||26
1615339|NCT00919633|3950135|P3|STARTED|Overall Study||27
1615340|NCT00919633|3950136|P2|STARTED|Overall Study||25
1615341|NCT00919633|3950137|P1|STARTED|Overall Study||28
1615342|NCT00919191|3950155|P1|NOT COMPLETED|Overall Study||0
1615343|NCT00919191|3950155|P1|COMPLETED|Overall Study||26
1615344|NCT00919191|3950155|P1|STARTED|Overall Study||26
1615345|NCT00919126|3950165|P3|NOT COMPLETED|Overall Study||1
1615346|NCT00919126|3950166|P2|NOT COMPLETED|Overall Study||5
1615347|NCT00919126|3950167|P1|NOT COMPLETED|Overall Study||1
1615348|NCT00919126|3950165|P3|COMPLETED|Overall Study||32
1615349|NCT00919126|3950166|P2|COMPLETED|Overall Study||32
1615350|NCT00919126|3950167|P1|COMPLETED|Overall Study||31
1615351|NCT00919126|3950165|P3|STARTED|Overall Study||33
1615352|NCT00919126|3950166|P2|STARTED|Overall Study||37
1615353|NCT00919126|3950167|P1|STARTED|Overall Study||32
1615354|NCT00919113|3950213|P2|NOT COMPLETED|Overall Study||8
1615355|NCT00919113|3950214|P1|NOT COMPLETED|Overall Study||9
1615356|NCT00919113|3950213|P2|COMPLETED|Overall Study||40
1615357|NCT00919113|3950214|P1|COMPLETED|Overall Study||41
1615358|NCT00919113|3950213|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
1615359|NCT00919113|3950214|P1|Received Placebo|Overall Study||0
1615360|NCT00919113|3950213|P2|Received Uracyst|Overall Study||0
1615361|NCT00919113|3950214|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
1615362|NCT00919113|3950213|P2|STARTED|Overall Study||48
1615363|NCT00919113|3950214|P1|STARTED|Overall Study||50
1615364|NCT00919100|3950224|P2|NOT COMPLETED|Overall Study||0
1615365|NCT00919100|3950225|P1|NOT COMPLETED|Overall Study||0
1615366|NCT00919100|3950224|P2|COMPLETED|Overall Study||41
1615367|NCT00919100|3950225|P1|COMPLETED|Overall Study||40
1615368|NCT00919100|3950224|P2|STARTED|Overall Study||41
1615369|NCT00919100|3950225|P1|STARTED|Overall Study||40
1615370|NCT00919061|3950235|P1|NOT COMPLETED|Overall Study||2
1615371|NCT00919061|3950235|P1|COMPLETED|Overall Study||37
1615372|NCT00919061|3950235|P1|STARTED|Overall Study||39
1615373|NCT00919035|3950240|P1|NOT COMPLETED|Overall Study||0
1615374|NCT00919035|3950240|P1|COMPLETED|Overall Study||21
1615375|NCT00919035|3950240|P1|STARTED|Overall Study||21
1615376|NCT00918957|3950248|P2|NOT COMPLETED|Overall Study||0
1615377|NCT00918957|3950249|P1|NOT COMPLETED|Overall Study||3
1615378|NCT00918957|3950248|P2|COMPLETED|Overall Study||30
1615379|NCT00918957|3950249|P1|COMPLETED|Overall Study||29
1615380|NCT00918957|3950248|P2|STARTED|Overall Study||30
1615381|NCT00918957|3950249|P1|STARTED|Overall Study||32
1615382|NCT00918931|3950276|P1|NOT COMPLETED|Overall Study||0
1615383|NCT00918931|3950276|P1|COMPLETED|Overall Study||3
1615384|NCT00918931|3950276|P1|STARTED|Overall Study||3
1615385|NCT00918879|3950282|P2|NOT COMPLETED|Overall Study||6
1615386|NCT00918879|3950283|P1|NOT COMPLETED|Overall Study||6
1615387|NCT00918879|3950282|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
1615388|NCT00918879|3950283|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
1615389|NCT00918879|3950282|P2|STARTED|Overall Study|Randomized and treated|106
1615390|NCT00918879|3950283|P1|STARTED|Overall Study|Randomized and treated|107
1615391|NCT00918866|3950297|P2|NOT COMPLETED|Overall Study||0
1615392|NCT00918866|3950298|P1|NOT COMPLETED|Overall Study||0
1615393|NCT00918866|3950297|P2|COMPLETED|Overall Study||16
1615394|NCT00918866|3950298|P1|COMPLETED|Overall Study||16
1615395|NCT00918866|3950297|P2|STARTED|Overall Study||16
1615396|NCT00918866|3950298|P1|STARTED|Overall Study||16
1615397|NCT00918749|3950315|P3|NOT COMPLETED|Overall Study||7
1615398|NCT00918749|3950316|P2|NOT COMPLETED|Overall Study||3
1615399|NCT00918749|3950317|P1|NOT COMPLETED|Overall Study||7
1615400|NCT00918749|3950315|P3|COMPLETED|Overall Study||62
1615401|NCT00918749|3950316|P2|COMPLETED|Overall Study||63
1615402|NCT00918749|3950317|P1|COMPLETED|Overall Study||63
1615403|NCT00918749|3950315|P3|ITT (Intent to Treat) Population|Overall Study||69
1615404|NCT00918749|3950316|P2|ITT (Intent to Treat) Population|Overall Study||66
1615405|NCT00918749|3950317|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
1615406|NCT00918749|3950315|P3|STARTED|Overall Study||69
1615407|NCT00918749|3950316|P2|STARTED|Overall Study||66
1615408|NCT00918749|3950317|P1|STARTED|Overall Study||70
1615409|NCT00918736|3950349|P1|NOT COMPLETED|Overall Study||4
1615410|NCT00918736|3950349|P1|COMPLETED|Overall Study|October, 2008|46
1615411|NCT00918736|3950349|P1|STARTED|Overall Study|October, 2007|50
1615412|NCT00918723|3950353|P1|NOT COMPLETED|Overall Study||0
1615413|NCT00918723|3950353|P1|COMPLETED|Overall Study||40
1615414|NCT00918723|3950353|P1|STARTED|Overall Study||40
1615415|NCT00918684|3950362|P1|NOT COMPLETED|Treatment Phase||25
1615416|NCT00918684|3950362|P1|COMPLETED|Treatment Phase||65
1615417|NCT00918684|3950362|P1|STARTED|Treatment Phase||90
1615418|NCT00918684|3950362|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
1615419|NCT00918684|3950362|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
1615420|NCT00918684|3950362|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
1615421|NCT00918671|3950368|P1|NOT COMPLETED|Overall Study||0
1615422|NCT00918671|3950368|P1|COMPLETED|Overall Study||60
1615423|NCT00918671|3950368|P1|STARTED|Overall Study||60
1615424|NCT00918645|3950373|P1|NOT COMPLETED|Overall Study||1
1615425|NCT00918645|3950373|P1|COMPLETED|Overall Study||12
1615426|NCT00918645|3950373|P1|STARTED|Overall Study||13
1615427|NCT00918580|3950379|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
1615428|NCT00918580|3950379|P1|COMPLETED|After 6-month FU to 1-year FU||87
1615429|NCT00918580|3950379|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
1615430|NCT00918580|3950379|P1|STARTED|After 6-month FU to 1-year FU||147
1615431|NCT00918580|3950379|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
1615432|NCT00918580|3950379|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
1615433|NCT00918580|3950379|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
1615434|NCT00918580|3950379|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
1615435|NCT00918580|3950379|P1|STARTED|Up to 6-month Follow-up(FU)||158
1615436|NCT00918463|3950397|P1|NOT COMPLETED|Overall Study||2
1615437|NCT00918463|3950397|P1|COMPLETED|Overall Study||0
1615438|NCT00918463|3950397|P1|STARTED|Overall Study||2
1615439|NCT00918385|3950405|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
1615440|NCT00918385|3950406|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
1615441|NCT00918385|3950405|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
1615442|NCT00918385|3950406|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
1615443|NCT00918385|3950405|P2|STARTED|Combination Nilutamide and Dasatinib||11
1615444|NCT00918385|3950406|P1|STARTED|Combination Nilutamide and Dasatinib||12
1615445|NCT00918385|3950405|P2|NOT COMPLETED|Monotherapy||6
1615446|NCT00918385|3950406|P1|NOT COMPLETED|Monotherapy||2
1615447|NCT00918385|3950405|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
1615448|NCT00918385|3950406|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
1615449|NCT00918385|3950405|P2|STARTED|Monotherapy||17
1615450|NCT00918385|3950406|P1|STARTED|Monotherapy||14
1615451|NCT00918346|3950415|P2|NOT COMPLETED|Post Study Period||0
1615452|NCT00918346|3950416|P1|NOT COMPLETED|Post Study Period||0
1615453|NCT00918346|3950415|P2|COMPLETED|Post Study Period||21
1615454|NCT00918346|3950416|P1|COMPLETED|Post Study Period||21
1615455|NCT00918346|3950415|P2|STARTED|Post Study Period||21
1615456|NCT00918346|3950416|P1|STARTED|Post Study Period||21
1615457|NCT00918346|3950415|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
1615458|NCT00918346|3950416|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
1615459|NCT00918346|3950415|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
1615460|NCT00918346|3950416|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
1615461|NCT00918346|3950415|P2|STARTED|Second Treatment Period (4 Weeks)||21
1615462|NCT00918346|3950416|P1|STARTED|Second Treatment Period (4 Weeks)||21
1615463|NCT00918346|3950415|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
1615464|NCT00918346|3950416|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
1615465|NCT00918346|3950415|P2|COMPLETED|Washout (at Least 4 Weeks)||21
1615466|NCT00918346|3950416|P1|COMPLETED|Washout (at Least 4 Weeks)||21
1615467|NCT00918346|3950415|P2|STARTED|Washout (at Least 4 Weeks)||21
1615468|NCT00918346|3950416|P1|STARTED|Washout (at Least 4 Weeks)||21
1615469|NCT00918346|3950415|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
1615470|NCT00918346|3950416|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
1615471|NCT00918346|3950415|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
1615472|NCT00918346|3950416|P1|COMPLETED|First Treatment Period (4 Weeks)||21
1615473|NCT00918346|3950415|P2|STARTED|First Treatment Period (4 Weeks)||22
1615474|NCT00918346|3950416|P1|STARTED|First Treatment Period (4 Weeks)||21
1615475|NCT00918333|3950432|P2|NOT COMPLETED|Overall Study||5
1615476|NCT00918333|3950433|P1|NOT COMPLETED|Overall Study||3
1615477|NCT00918333|3950432|P2|COMPLETED|Overall Study||93
1615478|NCT00918333|3950433|P1|COMPLETED|Overall Study||23
1615479|NCT00918333|3950432|P2|STARTED|Overall Study||98
1615480|NCT00918333|3950433|P1|STARTED|Overall Study||26
1615481|NCT00918281|3950453|P1|NOT COMPLETED|Overall Study||29
1615482|NCT00918281|3950453|P1|COMPLETED|Overall Study||41
1615483|NCT00918281|3950453|P1|STARTED|Overall Study||70
1615484|NCT00918255|3950463|P3|NOT COMPLETED|Overall Study||5
1615485|NCT00918255|3950464|P2|NOT COMPLETED|Overall Study||0
1615486|NCT00918255|3950465|P1|NOT COMPLETED|Overall Study||6
1615487|NCT00918255|3950463|P3|COMPLETED|Overall Study||46
1615488|NCT00918255|3950464|P2|COMPLETED|Overall Study||52
1615489|NCT00918255|3950465|P1|COMPLETED|Overall Study||45
1615490|NCT00918255|3950463|P3|STARTED|Overall Study||51
1615491|NCT00918255|3950464|P2|STARTED|Overall Study||52
1615492|NCT00918255|3950465|P1|STARTED|Overall Study||51
1615493|NCT00918229|3950491|P1|NOT COMPLETED|Overall Study||0
1615494|NCT00918229|3950491|P1|COMPLETED|Overall Study||24
1615495|NCT00918229|3950491|P1|STARTED|Overall Study||24
1615496|NCT00918203|3950498|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
1615497|NCT00918203|3950499|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
1615498|NCT00918203|3950500|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
1615499|NCT00918203|3950498|P3|COMPLETED|Crossover to Olaratumab Monotherapy||18
1615500|NCT00918203|3950499|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
1615501|NCT00918203|3950500|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
1615502|NCT00918203|3950498|P3|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
1615503|NCT00918203|3950499|P2|STARTED|Crossover to Olaratumab Monotherapy||0
1615504|NCT00918203|3950500|P1|STARTED|Crossover to Olaratumab Monotherapy||0
1615505|NCT00918203|3950498|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
1615506|NCT00918203|3950499|P2|NOT COMPLETED|Treatment With or Without Olaratumab||10
1615507|NCT00918203|3950500|P1|NOT COMPLETED|Treatment With or Without Olaratumab||6
1615508|NCT00918203|3950498|P3|COMPLETED|Treatment With or Without Olaratumab||0
1615509|NCT00918203|3950499|P2|COMPLETED|Treatment With or Without Olaratumab||57
1615510|NCT00918203|3950500|P1|COMPLETED|Treatment With or Without Olaratumab||64
1615511|NCT00918203|3950498|P3|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
1615512|NCT00918203|3950499|P2|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
1615513|NCT00918203|3950500|P1|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
1615514|NCT00918203|3950498|P3|Death Due to Any Cause|Treatment With or Without Olaratumab||0
1615515|NCT00918203|3950499|P2|Death Due to Any Cause|Treatment With or Without Olaratumab||47
1615516|NCT00918203|3950500|P1|Death Due to Any Cause|Treatment With or Without Olaratumab||53
1615517|NCT00918203|3950498|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
1615518|NCT00918203|3950499|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
1615519|NCT00918203|3950500|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
1615520|NCT00918203|3950498|P3|STARTED|Treatment With or Without Olaratumab||0
1615521|NCT00918203|3950499|P2|STARTED|Treatment With or Without Olaratumab||67
1615522|NCT00918203|3950500|P1|STARTED|Treatment With or Without Olaratumab||70
1615523|NCT00918138|3950531|P2|NOT COMPLETED|Overall Study||1
1615524|NCT00918138|3950532|P1|NOT COMPLETED|Overall Study||2
1615525|NCT00918138|3950531|P2|COMPLETED|Overall Study||46
1615526|NCT00918138|3950532|P1|COMPLETED|Overall Study||44
1615527|NCT00918138|3950531|P2|STARTED|Overall Study||47
1615528|NCT00918138|3950532|P1|STARTED|Overall Study||46
1615529|NCT00918125|3950548|P2|NOT COMPLETED|Overall Study||0
1615530|NCT00918125|3950549|P1|NOT COMPLETED|Overall Study||0
1615531|NCT00918125|3950548|P2|COMPLETED|Overall Study||39
1615532|NCT00918125|3950549|P1|COMPLETED|Overall Study||20
1615533|NCT00918125|3950548|P2|STARTED|Overall Study||39
1615534|NCT00918125|3950549|P1|STARTED|Overall Study||20
1615535|NCT00917865|3950560|P1|NOT COMPLETED|Overall Study||0
1615536|NCT00917865|3950560|P1|COMPLETED|Overall Study||11
1615537|NCT00917865|3950560|P1|STARTED|Overall Study||11
1615538|NCT00917852|3950571|P1|NOT COMPLETED|Overall Study||6
1615539|NCT00917852|3950571|P1|COMPLETED|Overall Study||45
1615540|NCT00917852|3950571|P1|STARTED|Overall Study||51
1615541|NCT00917735|3950578|P2|NOT COMPLETED|Overall Study||63
1615542|NCT00917735|3950579|P1|NOT COMPLETED|Overall Study||75
1615543|NCT00917735|3950578|P2|COMPLETED|Overall Study||474
1615544|NCT00917735|3950579|P1|COMPLETED|Overall Study||463
1615545|NCT00917735|3950578|P2|STARTED|Overall Study||537
1615546|NCT00917735|3950579|P1|STARTED|Overall Study||538
1615547|NCT00917644|3950589|P2|NOT COMPLETED|Period 2: Second Intervention||0
1615548|NCT00917644|3950590|P1|NOT COMPLETED|Period 2: Second Intervention||1
1615549|NCT00917644|3950589|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
1615550|NCT00917644|3950590|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
1615551|NCT00917644|3950589|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
1615552|NCT00917644|3950590|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
1615553|NCT00917644|3950589|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
1615554|NCT00917644|3950590|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
1615555|NCT00917644|3950589|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
1615556|NCT00917644|3950590|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
1615557|NCT00917644|3950589|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
1615558|NCT00917644|3950590|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
1615559|NCT00917644|3950589|P2|NOT COMPLETED|Period 1: First Intervention||0
1615560|NCT00917644|3950590|P1|NOT COMPLETED|Period 1: First Intervention||0
1615561|NCT00917644|3950589|P2|COMPLETED|Period 1: First Intervention||37
1615562|NCT00917644|3950590|P1|COMPLETED|Period 1: First Intervention||39
1615563|NCT00917644|3950589|P2|STARTED|Period 1: First Intervention||37
1615564|NCT00917644|3950590|P1|STARTED|Period 1: First Intervention||39
1615565|NCT00917579|3950604|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
1615566|NCT00917579|3950605|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
1615567|NCT00917579|3950604|P2|COMPLETED|Period 2: 2nd Intervention||37
1615568|NCT00917579|3950605|P1|COMPLETED|Period 2: 2nd Intervention||37
1615569|NCT00917579|3950604|P2|STARTED|Period 2: 2nd Intervention||37
1615570|NCT00917579|3950605|P1|STARTED|Period 2: 2nd Intervention||37
1615571|NCT00917579|3950604|P2|NOT COMPLETED|Washout >= 2 Weeks||0
1615572|NCT00917579|3950605|P1|NOT COMPLETED|Washout >= 2 Weeks||2
1615573|NCT00917579|3950604|P2|COMPLETED|Washout >= 2 Weeks||37
1615574|NCT00917579|3950605|P1|COMPLETED|Washout >= 2 Weeks||37
1615575|NCT00917579|3950604|P2|STARTED|Washout >= 2 Weeks||37
1615576|NCT00917579|3950605|P1|STARTED|Washout >= 2 Weeks||39
1615577|NCT00917579|3950604|P2|NOT COMPLETED|Period 1: 1st Intervention||0
1615578|NCT00917579|3950605|P1|NOT COMPLETED|Period 1: 1st Intervention||0
1615579|NCT00917579|3950604|P2|COMPLETED|Period 1: 1st Intervention||37
1615580|NCT00917579|3950605|P1|COMPLETED|Period 1: 1st Intervention||39
1615581|NCT00917579|3950604|P2|STARTED|Period 1: 1st Intervention||37
1615582|NCT00917579|3950605|P1|STARTED|Period 1: 1st Intervention||39
1615583|NCT00917553|3950621|P2|NOT COMPLETED|Overall Study||1
1615584|NCT00917553|3950622|P1|NOT COMPLETED|Overall Study||2
1615585|NCT00917553|3950621|P2|COMPLETED|Overall Study||15
1615586|NCT00917553|3950622|P1|COMPLETED|Overall Study||15
1615587|NCT00917553|3950621|P2|STARTED|Overall Study||16
1615588|NCT00917553|3950622|P1|STARTED|Overall Study||17
1615589|NCT00917501|3950638|P2|NOT COMPLETED|Overall Study||5
1615590|NCT00917501|3950639|P1|NOT COMPLETED|Overall Study||8
1615591|NCT00917501|3950638|P2|COMPLETED|Overall Study||21
1615592|NCT00917501|3950639|P1|COMPLETED|Overall Study||21
1615593|NCT00917501|3950638|P2|STARTED|Overall Study||26
1615594|NCT00917501|3950639|P1|STARTED|Overall Study||29
1615595|NCT00917384|3950647|P2|NOT COMPLETED|Overall Study||4
1615596|NCT00917384|3950648|P1|NOT COMPLETED|Overall Study||14
1615597|NCT00917384|3950647|P2|COMPLETED|Overall Study||113
1615598|NCT00917384|3950648|P1|COMPLETED|Overall Study||224
1615599|NCT00917384|3950647|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
1615600|NCT00917384|3950648|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
1615601|NCT00917384|3950647|P2|STARTED|Overall Study||117
1615602|NCT00917384|3950648|P1|STARTED|Overall Study||238
1615603|NCT00917267|3950672|P2|NOT COMPLETED|Overall Study||79
1615604|NCT00917267|3950673|P1|NOT COMPLETED|Overall Study||39
1615605|NCT00917267|3950672|P2|COMPLETED|Overall Study||266
1615606|NCT00917267|3950673|P1|COMPLETED|Overall Study||307
1615607|NCT00917267|3950672|P2|Intent to Treat (ITT)|Overall Study||338
1615608|NCT00917267|3950673|P1|Intent to Treat (ITT)|Overall Study||340
1615609|NCT00917267|3950672|P2|STARTED|Overall Study||345
1615610|NCT00917267|3950673|P1|STARTED|Overall Study||346
1615611|NCT00917124|3950701|P2|NOT COMPLETED|Overall Study||6
1615612|NCT00917124|3950702|P1|NOT COMPLETED|Overall Study||4
1615613|NCT00917124|3950701|P2|COMPLETED|Overall Study||94
1615614|NCT00917124|3950702|P1|COMPLETED|Overall Study||96
1615615|NCT00917124|3950701|P2|STARTED|Overall Study||100
1615616|NCT00917124|3950702|P1|STARTED|Overall Study||100
1615617|NCT00916929|3950712|P2|NOT COMPLETED|Overall Study||29
1615618|NCT00916929|3950713|P1|NOT COMPLETED|Overall Study||10
1615619|NCT00916929|3950712|P2|COMPLETED|Overall Study||53
1615620|NCT00916929|3950713|P1|COMPLETED|Overall Study||70
1615621|NCT00916929|3950712|P2|STARTED|Overall Study||82
1615622|NCT00916929|3950713|P1|STARTED|Overall Study||80
1615623|NCT00916721|3950723|P2|NOT COMPLETED|Overall Study||10
1615624|NCT00916721|3950724|P1|NOT COMPLETED|Overall Study||10
1615625|NCT00916721|3950723|P2|COMPLETED|Overall Study||29
1615626|NCT00916721|3950724|P1|COMPLETED|Overall Study||25
1615627|NCT00916721|3950723|P2|STARTED|Overall Study||39
1615628|NCT00916721|3950724|P1|STARTED|Overall Study||35
1615629|NCT00916643|3950736|P1|NOT COMPLETED|Overall Study||0
1615630|NCT00916643|3950736|P1|COMPLETED|Overall Study||113
1615631|NCT00916643|3950736|P1|STARTED|Overall Study||113
1615632|NCT00916617|3950747|P4|NOT COMPLETED|Overall Study||7
1615633|NCT00916617|3950748|P3|NOT COMPLETED|Overall Study||10
1615634|NCT00916617|3950749|P2|NOT COMPLETED|Overall Study||21
1615635|NCT00916617|3950750|P1|NOT COMPLETED|Overall Study||23
1615636|NCT00916617|3950747|P4|COMPLETED|Overall Study||0
1615637|NCT00916617|3950748|P3|COMPLETED|Overall Study||0
1615638|NCT00916617|3950749|P2|COMPLETED|Overall Study||0
1615639|NCT00916617|3950750|P1|COMPLETED|Overall Study||1
1615640|NCT00916617|3950747|P4|STARTED|Overall Study||7
1615641|NCT00916617|3950748|P3|STARTED|Overall Study||10
1615642|NCT00916617|3950749|P2|STARTED|Overall Study||21
1615643|NCT00916617|3950750|P1|STARTED|Overall Study||24
1615644|NCT00916578|3950764|P1|NOT COMPLETED|Overall Study||7
1615645|NCT00916578|3950764|P1|COMPLETED|Overall Study||26
1615646|NCT00916578|3950764|P1|STARTED|Overall Study||33
1615647|NCT00916539|3950770|P2|NOT COMPLETED|Overall Study||0
1615648|NCT00916539|3950771|P1|NOT COMPLETED|Overall Study||0
1615649|NCT00916539|3950770|P2|COMPLETED|Overall Study||31
1615650|NCT00916539|3950771|P1|COMPLETED|Overall Study||31
1615651|NCT00916539|3950770|P2|STARTED|Overall Study||31
1615652|NCT00916539|3950771|P1|STARTED|Overall Study||31
1615653|NCT00916383|3950793|P1|NOT COMPLETED|Overall Study||3
1615654|NCT00916383|3950793|P1|COMPLETED|Overall Study||46
1615655|NCT00916383|3950793|P1|STARTED|Overall Study||49
1615656|NCT00916370|3950821|P2|NOT COMPLETED|Overall Study||2
1615657|NCT00916370|3950822|P1|NOT COMPLETED|Overall Study||5
1615658|NCT00916370|3950821|P2|COMPLETED|Overall Study||102
1615659|NCT00916370|3950822|P1|COMPLETED|Overall Study||396
1615660|NCT00916370|3950821|P2|STARTED|Overall Study||104
1615661|NCT00916370|3950822|P1|STARTED|Overall Study||401
1615662|NCT00916357|3950996|P6|NOT COMPLETED|Period 3||0
1615663|NCT00916357|3950997|P5|NOT COMPLETED|Period 3||0
1615664|NCT00916357|3950998|P4|NOT COMPLETED|Period 3||0
1615665|NCT00916357|3950999|P3|NOT COMPLETED|Period 3||0
1615666|NCT00916357|3951000|P2|NOT COMPLETED|Period 3||0
1615667|NCT00916357|3951001|P1|NOT COMPLETED|Period 3||0
1615668|NCT00916357|3950996|P6|COMPLETED|Period 3||4
1615669|NCT00916357|3950997|P5|COMPLETED|Period 3||3
1615670|NCT00916357|3950998|P4|COMPLETED|Period 3||3
1615671|NCT00916357|3950999|P3|COMPLETED|Period 3||4
1615672|NCT00916357|3951000|P2|COMPLETED|Period 3||4
1615673|NCT00916357|3951001|P1|COMPLETED|Period 3||3
1615674|NCT00916357|3950996|P6|STARTED|Period 3||4
1615675|NCT00916357|3950997|P5|STARTED|Period 3||3
1615676|NCT00916357|3950998|P4|STARTED|Period 3||3
1615677|NCT00916357|3950999|P3|STARTED|Period 3||4
1615678|NCT00916357|3951000|P2|STARTED|Period 3||4
1615679|NCT00916357|3951001|P1|STARTED|Period 3||3
1615680|NCT00916357|3950996|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
1615681|NCT00916357|3950997|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
1615682|NCT00916357|3950998|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
1615683|NCT00916357|3950999|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
1615684|NCT00916357|3951000|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
1615685|NCT00916357|3951001|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
1615686|NCT00916357|3950996|P6|COMPLETED|Washout (3 to 14 Days)||4
1615687|NCT00916357|3950997|P5|COMPLETED|Washout (3 to 14 Days)||3
1615688|NCT00916357|3950998|P4|COMPLETED|Washout (3 to 14 Days)||3
1615689|NCT00916357|3950999|P3|COMPLETED|Washout (3 to 14 Days)||4
1615690|NCT00916357|3951000|P2|COMPLETED|Washout (3 to 14 Days)||4
1615691|NCT00916357|3951001|P1|COMPLETED|Washout (3 to 14 Days)||3
1615692|NCT00916357|3950996|P6|STARTED|Washout (3 to 14 Days)||4
1615693|NCT00916357|3950997|P5|STARTED|Washout (3 to 14 Days)||3
1615694|NCT00916357|3950998|P4|STARTED|Washout (3 to 14 Days)||3
1615695|NCT00916357|3950999|P3|STARTED|Washout (3 to 14 Days)||4
1615696|NCT00916357|3951000|P2|STARTED|Washout (3 to 14 Days)||4
1615697|NCT00916357|3951001|P1|STARTED|Washout (3 to 14 Days)||3
1615698|NCT00916357|3950996|P6|NOT COMPLETED|Period 2||0
1615699|NCT00916357|3950997|P5|NOT COMPLETED|Period 2||0
1615700|NCT00916357|3950998|P4|NOT COMPLETED|Period 2||1
1615701|NCT00916357|3950999|P3|NOT COMPLETED|Period 2||0
1615702|NCT00916357|3951000|P2|NOT COMPLETED|Period 2||0
1615703|NCT00916357|3951001|P1|NOT COMPLETED|Period 2||0
1615704|NCT00916357|3950996|P6|COMPLETED|Period 2||4
1615705|NCT00916357|3950997|P5|COMPLETED|Period 2||3
1615706|NCT00916357|3950998|P4|COMPLETED|Period 2||3
1615707|NCT00916357|3950999|P3|COMPLETED|Period 2||4
1615708|NCT00916357|3951000|P2|COMPLETED|Period 2||4
1615709|NCT00916357|3951001|P1|COMPLETED|Period 2||3
1615710|NCT00916357|3950996|P6|STARTED|Period 2||4
1615711|NCT00916357|3950997|P5|STARTED|Period 2||3
1615712|NCT00916357|3950998|P4|STARTED|Period 2||4
1615713|NCT00916357|3950999|P3|STARTED|Period 2||4
1615714|NCT00916357|3951000|P2|STARTED|Period 2||4
1615715|NCT00916357|3951001|P1|STARTED|Period 2||3
1615716|NCT00916357|3950996|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
1615717|NCT00916357|3950997|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
1615718|NCT00916357|3950998|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
1615719|NCT00916357|3950999|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
1615720|NCT00916357|3951000|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
1615721|NCT00916357|3951001|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
1615722|NCT00916357|3950996|P6|COMPLETED|Washout (3 to 14 Days)||4
1615723|NCT00916357|3950997|P5|COMPLETED|Washout (3 to 14 Days)||3
1615724|NCT00916357|3950998|P4|COMPLETED|Washout (3 to 14 Days)||4
1615725|NCT00916357|3950999|P3|COMPLETED|Washout (3 to 14 Days)||4
1615726|NCT00916357|3951000|P2|COMPLETED|Washout (3 to 14 Days)||4
1615727|NCT00916357|3951001|P1|COMPLETED|Washout (3 to 14 Days)||3
1615728|NCT00916357|3950996|P6|STARTED|Washout (3 to 14 Days)||4
1615729|NCT00916357|3950997|P5|STARTED|Washout (3 to 14 Days)||3
1615730|NCT00916357|3950998|P4|STARTED|Washout (3 to 14 Days)||4
1615731|NCT00916357|3950999|P3|STARTED|Washout (3 to 14 Days)||4
1615732|NCT00916357|3951000|P2|STARTED|Washout (3 to 14 Days)||4
1615733|NCT00916357|3951001|P1|STARTED|Washout (3 to 14 Days)||3
1615734|NCT00916357|3950996|P6|NOT COMPLETED|Period 1||0
1615735|NCT00916357|3950997|P5|NOT COMPLETED|Period 1||0
1615736|NCT00916357|3950998|P4|NOT COMPLETED|Period 1||0
1615737|NCT00916357|3950999|P3|NOT COMPLETED|Period 1||0
1615738|NCT00916357|3951000|P2|NOT COMPLETED|Period 1||0
1615739|NCT00916357|3951001|P1|NOT COMPLETED|Period 1||1
1615740|NCT00916357|3950996|P6|COMPLETED|Period 1||4
1615741|NCT00916357|3950997|P5|COMPLETED|Period 1||3
1615742|NCT00916357|3950998|P4|COMPLETED|Period 1||4
1615743|NCT00916357|3950999|P3|COMPLETED|Period 1||4
1615744|NCT00916357|3951000|P2|COMPLETED|Period 1||4
1615745|NCT00916357|3951001|P1|COMPLETED|Period 1||3
1615746|NCT00916357|3950996|P6|Received at Least 1 Dose of Study Drug|Period 1||4
1615747|NCT00916357|3950997|P5|Received at Least 1 Dose of Study Drug|Period 1||3
1615748|NCT00916357|3950998|P4|Received at Least 1 Dose of Study Drug|Period 1||4
1615749|NCT00916357|3950999|P3|Received at Least 1 Dose of Study Drug|Period 1||4
1615750|NCT00916357|3951000|P2|Received at Least 1 Dose of Study Drug|Period 1||4
1615751|NCT00916357|3951001|P1|Received at Least 1 Dose of Study Drug|Period 1||4
1615752|NCT00916357|3950996|P6|STARTED|Period 1||4
1615753|NCT00916357|3950997|P5|STARTED|Period 1||3
1615754|NCT00916357|3950998|P4|STARTED|Period 1||4
1615755|NCT00916357|3950999|P3|STARTED|Period 1||4
1615756|NCT00916357|3951000|P2|STARTED|Period 1||4
1615757|NCT00916357|3951001|P1|STARTED|Period 1||4
1615758|NCT00916344|3951039|P1|NOT COMPLETED|Overall Study||8
1615759|NCT00916344|3951039|P1|COMPLETED|Overall Study||167
1615760|NCT00916344|3951039|P1|STARTED|Overall Study||175
1615761|NCT00916305|3951046|P2|NOT COMPLETED|Overall Study||28
1615762|NCT00916305|3951047|P1|NOT COMPLETED|Overall Study||21
1615763|NCT00916305|3951046|P2|COMPLETED|Overall Study||9
1615764|NCT00916305|3951047|P1|COMPLETED|Overall Study||7
1615765|NCT00916305|3951046|P2|STARTED|Overall Study||37
1615766|NCT00916305|3951047|P1|STARTED|Overall Study||28
1615767|NCT00916279|3951055|P1|NOT COMPLETED|Overall Study||4
1615768|NCT00916279|3951055|P1|COMPLETED|Overall Study||37
1615769|NCT00916279|3951055|P1|24 Months|Overall Study||37
1615770|NCT00916279|3951055|P1|6 Months|Overall Study||41
1615771|NCT00916279|3951055|P1|30 Days|Overall Study||41
1615772|NCT00916279|3951055|P1|STARTED|Overall Study||41
1615773|NCT00916149|3951066|P3|NOT COMPLETED|Overall Study||0
1615774|NCT00916149|3951067|P2|NOT COMPLETED|Overall Study||2
1615775|NCT00916149|3951068|P1|NOT COMPLETED|Overall Study||4
1615776|NCT00916149|3951066|P3|COMPLETED|Overall Study||5
1615777|NCT00916149|3951067|P2|COMPLETED|Overall Study||8
1615778|NCT00916149|3951068|P1|COMPLETED|Overall Study||12
1615779|NCT00916149|3951066|P3|STARTED|Overall Study||5
1615780|NCT00916149|3951067|P2|STARTED|Overall Study||10
1615781|NCT00916149|3951068|P1|STARTED|Overall Study||16
1615782|NCT00916136|3951139|P2|NOT COMPLETED|Overall Study||0
1615783|NCT00916136|3951140|P1|NOT COMPLETED|Overall Study||0
1615784|NCT00916136|3951139|P2|COMPLETED|Overall Study||29
1615785|NCT00916136|3951140|P1|COMPLETED|Overall Study||37
1615786|NCT00916136|3951139|P2|STARTED|Overall Study||29
1615787|NCT00916136|3951140|P1|STARTED|Overall Study||37
1615788|NCT00916032|3951148|P2|NOT COMPLETED|Overall Study||0
1615789|NCT00916032|3951149|P1|NOT COMPLETED|Overall Study||0
1615790|NCT00916032|3951148|P2|COMPLETED|Overall Study||11
1615791|NCT00916032|3951149|P1|COMPLETED|Overall Study||12
1615792|NCT00916032|3951148|P2|STARTED|Overall Study||11
1615793|NCT00916032|3951149|P1|STARTED|Overall Study||12
1615794|NCT00916006|3951191|P2|NOT COMPLETED|Overall Study||7
1615795|NCT00916006|3951192|P1|NOT COMPLETED|Overall Study||3
1615796|NCT00916006|3951191|P2|COMPLETED|Overall Study||127
1615797|NCT00916006|3951192|P1|COMPLETED|Overall Study||132
1615798|NCT00916006|3951191|P2|STARTED|Overall Study||134
1615799|NCT00916006|3951192|P1|STARTED|Overall Study||135
1615800|NCT00915902|3951202|P2|NOT COMPLETED|2nd Treatment Period||1
1615801|NCT00915902|3951203|P1|NOT COMPLETED|2nd Treatment Period||0
1615802|NCT00915902|3951202|P2|COMPLETED|2nd Treatment Period||20
1615803|NCT00915902|3951203|P1|COMPLETED|2nd Treatment Period||19
1615804|NCT00915902|3951202|P2|STARTED|2nd Treatment Period||21
1615805|NCT00915902|3951203|P1|STARTED|2nd Treatment Period||19
1615806|NCT00915902|3951202|P2|NOT COMPLETED|Washout (4 Weeks)||1
1615807|NCT00915902|3951203|P1|NOT COMPLETED|Washout (4 Weeks)||0
1615808|NCT00915902|3951202|P2|COMPLETED|Washout (4 Weeks)||21
1615809|NCT00915902|3951203|P1|COMPLETED|Washout (4 Weeks)||19
1615810|NCT00915902|3951202|P2|STARTED|Washout (4 Weeks)||22
1615811|NCT00915902|3951203|P1|STARTED|Washout (4 Weeks)||19
1615812|NCT00915902|3951202|P2|NOT COMPLETED|1st Treatment Period||0
1615813|NCT00915902|3951203|P1|NOT COMPLETED|1st Treatment Period||1
1615814|NCT00915902|3951202|P2|COMPLETED|1st Treatment Period||22
1615815|NCT00915902|3951203|P1|COMPLETED|1st Treatment Period||19
1615816|NCT00915902|3951202|P2|STARTED|1st Treatment Period||22
1615817|NCT00915902|3951203|P1|STARTED|1st Treatment Period||20
1615818|NCT00915876|3951213|P2|NOT COMPLETED|Overall Study||1
1615819|NCT00915876|3951214|P1|NOT COMPLETED|Overall Study||0
1615820|NCT00915876|3951213|P2|COMPLETED|Overall Study||20
1615821|NCT00915876|3951214|P1|COMPLETED|Overall Study||20
1615822|NCT00915876|3951213|P2|Moving Beyond First Dose|Overall Study||20
1615823|NCT00915876|3951214|P1|Moving Beyond First Dose|Overall Study||20
1615824|NCT00915876|3951213|P2|STARTED|Overall Study||21
1615825|NCT00915876|3951214|P1|STARTED|Overall Study||20
1615826|NCT00915798|3951224|P4|NOT COMPLETED|Overall Study||0
1615827|NCT00915798|3951225|P3|NOT COMPLETED|Overall Study||0
1615828|NCT00915798|3951226|P2|NOT COMPLETED|Overall Study||0
1615829|NCT00915798|3951227|P1|NOT COMPLETED|Overall Study||0
1615830|NCT00915798|3951224|P4|COMPLETED|Overall Study||26
1615831|NCT00915798|3951225|P3|COMPLETED|Overall Study||23
1615832|NCT00915798|3951226|P2|COMPLETED|Overall Study||21
1615833|NCT00915798|3951227|P1|COMPLETED|Overall Study||19
1615834|NCT00915798|3951224|P4|STARTED|Overall Study||26
1615835|NCT00915798|3951225|P3|STARTED|Overall Study||23
1615836|NCT00915798|3951226|P2|STARTED|Overall Study||21
1615837|NCT00915798|3951227|P1|STARTED|Overall Study||19
1615838|NCT00915772|3951250|P3|NOT COMPLETED|Overall Study||29
1615839|NCT00915772|3951251|P2|NOT COMPLETED|Overall Study||46
1615840|NCT00915772|3951252|P1|NOT COMPLETED|Overall Study||36
1615841|NCT00915772|3951250|P3|COMPLETED|Overall Study||142
1615842|NCT00915772|3951251|P2|COMPLETED|Overall Study||179
1615843|NCT00915772|3951252|P1|COMPLETED|Overall Study||134
1615844|NCT00915772|3951250|P3|STARTED|Overall Study||171
1615845|NCT00915772|3951251|P2|STARTED|Overall Study||225
1615846|NCT00915772|3951252|P1|STARTED|Overall Study||170
1615847|NCT00915759|3951297|P1|NOT COMPLETED|Overall Study||0
1615848|NCT00915759|3951297|P1|COMPLETED|Overall Study|number of participants|40
1615849|NCT00915759|3951297|P1|STARTED|Overall Study|number of participants|40
1615850|NCT00915655|3951307|P1|NOT COMPLETED|Overall Study||0
1615851|NCT00915655|3951307|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
1615852|NCT00915655|3951307|P1|STARTED|Overall Study||12
1615853|NCT00915603|3951314|P2|NOT COMPLETED|Overall Study||55
1615854|NCT00915603|3951315|P1|NOT COMPLETED|Overall Study||56
1615855|NCT00915603|3951314|P2|COMPLETED|Overall Study||0
1615856|NCT00915603|3951315|P1|COMPLETED|Overall Study||0
1615857|NCT00915603|3951314|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
1615858|NCT00915603|3951315|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
1615859|NCT00915590|3951331|P2|NOT COMPLETED|Overall Study||1
1615860|NCT00915590|3951332|P1|NOT COMPLETED|Overall Study||2
1615861|NCT00915590|3951331|P2|COMPLETED|Overall Study||4
1615862|NCT00915590|3951332|P1|COMPLETED|Overall Study||3
1615863|NCT00915590|3951331|P2|STARTED|Overall Study||5
1615864|NCT00915590|3951332|P1|STARTED|Overall Study||5
1615865|NCT00915551|3951351|P2|NOT COMPLETED|Overall Study||1
1615866|NCT00915551|3951352|P1|NOT COMPLETED|Overall Study||0
1615867|NCT00915551|3951351|P2|COMPLETED|Overall Study||135
1615868|NCT00915551|3951352|P1|COMPLETED|Overall Study||142
1615869|NCT00915551|3951351|P2|STARTED|Overall Study||136
1615870|NCT00915551|3951352|P1|STARTED|Overall Study||142
1615871|NCT00915525|3951362|P2|NOT COMPLETED|Overall Study||135
1615872|NCT00915525|3951363|P1|NOT COMPLETED|Overall Study||265
1615873|NCT00915525|3951362|P2|COMPLETED|Overall Study||151
1615874|NCT00915525|3951363|P1|COMPLETED|Overall Study||278
1615875|NCT00915525|3951362|P2|STARTED|Overall Study||286
1615876|NCT00915525|3951363|P1|STARTED|Overall Study||543
1615877|NCT00915499|3951466|P2|NOT COMPLETED|Overall Study||2
1615878|NCT00915499|3951467|P1|NOT COMPLETED|Overall Study||4
1615879|NCT00915499|3951466|P2|COMPLETED|Overall Study||31
1615880|NCT00915499|3951467|P1|COMPLETED|Overall Study||29
1615881|NCT00915499|3951466|P2|STARTED|Overall Study||33
1615882|NCT00915499|3951467|P1|STARTED|Overall Study||33
1615883|NCT00915473|3951477|P2|NOT COMPLETED|4-week Follow Up||5
1615884|NCT00915473|3951478|P1|NOT COMPLETED|4-week Follow Up||1
1615885|NCT00915473|3951477|P2|COMPLETED|4-week Follow Up||30
1615886|NCT00915473|3951478|P1|COMPLETED|4-week Follow Up||33
1615887|NCT00915473|3951477|P2|STARTED|4-week Follow Up||35
1615888|NCT00915473|3951478|P1|STARTED|4-week Follow Up||34
1615889|NCT00915473|3951477|P2|NOT COMPLETED|Injection||0
1615890|NCT00915473|3951478|P1|NOT COMPLETED|Injection||0
1615891|NCT00915473|3951477|P2|COMPLETED|Injection||35
1615892|NCT00915473|3951478|P1|COMPLETED|Injection||34
1615893|NCT00915473|3951477|P2|STARTED|Injection||35
1615894|NCT00915473|3951478|P1|STARTED|Injection||34
1615895|NCT00915473|3951477|P2|NOT COMPLETED|Screening||0
1615896|NCT00915473|3951478|P1|NOT COMPLETED|Screening||1
1615897|NCT00915473|3951477|P2|COMPLETED|Screening||35
1615898|NCT00915473|3951478|P1|COMPLETED|Screening||34
1615899|NCT00915473|3951477|P2|STARTED|Screening||35
1615900|NCT00915473|3951478|P1|STARTED|Screening||35
1615901|NCT00915356|3951495|P5|NOT COMPLETED|Overall Study||0
1615902|NCT00915356|3951496|P4|NOT COMPLETED|Overall Study||0
1615903|NCT00915356|3951497|P3|NOT COMPLETED|Overall Study||0
1615904|NCT00915356|3951498|P2|NOT COMPLETED|Overall Study||0
1615905|NCT00915356|3951499|P1|NOT COMPLETED|Overall Study||1
1615906|NCT00915356|3951495|P5|COMPLETED|Overall Study||43
1615907|NCT00915356|3951496|P4|COMPLETED|Overall Study||12
1615908|NCT00915356|3951497|P3|COMPLETED|Overall Study||45
1615909|NCT00915356|3951498|P2|COMPLETED|Overall Study||45
1615910|NCT00915356|3951499|P1|COMPLETED|Overall Study||25
1615911|NCT00915356|3951495|P5|STARTED|Overall Study||43
1615912|NCT00915356|3951496|P4|STARTED|Overall Study||12
1615913|NCT00915356|3951497|P3|STARTED|Overall Study||45
1615914|NCT00915356|3951498|P2|STARTED|Overall Study||45
1615915|NCT00915356|3951499|P1|STARTED|Overall Study||26
1615916|NCT00915343|3951561|P3|NOT COMPLETED|Part B - Open Label Period||2
1615917|NCT00915343|3951562|P2|NOT COMPLETED|Part B - Open Label Period||0
1615918|NCT00915343|3951563|P1|NOT COMPLETED|Part B - Open Label Period||0
1615919|NCT00915343|3951561|P3|COMPLETED|Part B - Open Label Period||57
1615920|NCT00915343|3951562|P2|COMPLETED|Part B - Open Label Period||0
1615921|NCT00915343|3951563|P1|COMPLETED|Part B - Open Label Period||0
1615922|NCT00915343|3951561|P3|STARTED|Part B - Open Label Period||59
1615923|NCT00915343|3951562|P2|STARTED|Part B - Open Label Period||0
1615924|NCT00915343|3951563|P1|STARTED|Part B - Open Label Period||0
1615925|NCT00915343|3951561|P3|NOT COMPLETED|Part A - Second Intervention Period||0
1615926|NCT00915343|3951562|P2|NOT COMPLETED|Part A - Second Intervention Period||0
1615927|NCT00915343|3951563|P1|NOT COMPLETED|Part A - Second Intervention Period||0
1615928|NCT00915343|3951561|P3|COMPLETED|Part A - Second Intervention Period||0
1615929|NCT00915343|3951562|P2|COMPLETED|Part A - Second Intervention Period||32
1615930|NCT00915343|3951563|P1|COMPLETED|Part A - Second Intervention Period||32
1615931|NCT00915343|3951561|P3|STARTED|Part A - Second Intervention Period||0
1615932|NCT00915343|3951562|P2|STARTED|Part A - Second Intervention Period||32
1615933|NCT00915343|3951563|P1|STARTED|Part A - Second Intervention Period||32
1615934|NCT00915343|3951561|P3|NOT COMPLETED|Part A - First Intervention Period||0
1615935|NCT00915343|3951562|P2|NOT COMPLETED|Part A - First Intervention Period||0
1615936|NCT00915343|3951563|P1|NOT COMPLETED|Part A - First Intervention Period||0
1615937|NCT00915343|3951561|P3|COMPLETED|Part A - First Intervention Period||0
1615938|NCT00915343|3951562|P2|COMPLETED|Part A - First Intervention Period||32
1615939|NCT00915343|3951563|P1|COMPLETED|Part A - First Intervention Period||32
1615940|NCT00915343|3951561|P3|STARTED|Part A - First Intervention Period||0
1615941|NCT00915343|3951562|P2|STARTED|Part A - First Intervention Period||32
1615942|NCT00915343|3951563|P1|STARTED|Part A - First Intervention Period||32
1615943|NCT00915278|3951648|P6|NOT COMPLETED|Overall Study||8
1615944|NCT00915278|3951649|P5|NOT COMPLETED|Overall Study||2
1615945|NCT00915278|3951650|P4|NOT COMPLETED|Overall Study||3
1615946|NCT00915278|3951651|P3|NOT COMPLETED|Overall Study||1
1615947|NCT00915278|3951652|P2|NOT COMPLETED|Overall Study||3
1615948|NCT00915278|3951653|P1|NOT COMPLETED|Overall Study||5
1615949|NCT00915278|3951648|P6|COMPLETED|Overall Study||1
1615950|NCT00915278|3951649|P5|COMPLETED|Overall Study||1
1615951|NCT00915278|3951650|P4|COMPLETED|Overall Study||2
1615952|NCT00915278|3951651|P3|COMPLETED|Overall Study||2
1615953|NCT00915278|3951652|P2|COMPLETED|Overall Study||2
1615954|NCT00915278|3951653|P1|COMPLETED|Overall Study||3
1615955|NCT00915278|3951648|P6|STARTED|Overall Study||9
1615956|NCT00915278|3951649|P5|STARTED|Overall Study||3
1615957|NCT00915278|3951650|P4|STARTED|Overall Study||5
1615958|NCT00915278|3951651|P3|STARTED|Overall Study||3
1615959|NCT00915278|3951652|P2|STARTED|Overall Study||5
1615960|NCT00915278|3951653|P1|STARTED|Overall Study||8
1615961|NCT00915148|3951799|P1|NOT COMPLETED|Overall Study||0
1615962|NCT00915148|3951799|P1|COMPLETED|Overall Study|August 2010|110
1615963|NCT00915148|3951799|P1|STARTED|Overall Study|October 2009|110
1615964|NCT00915018|3951806|P2|NOT COMPLETED|Overall Study||207
1615965|NCT00915018|3951807|P1|NOT COMPLETED|Overall Study||215
1615966|NCT00915018|3951806|P2|COMPLETED|Overall Study||30
1615967|NCT00915018|3951807|P1|COMPLETED|Overall Study||27
1615968|NCT00915018|3951806|P2|Received Treatment|Overall Study||234
1615969|NCT00915018|3951807|P1|Received Treatment|Overall Study||240
1615970|NCT00915018|3951806|P2|STARTED|Overall Study||237
1615971|NCT00915018|3951807|P1|STARTED|Overall Study||242
1615972|NCT00914966|3951821|P1|NOT COMPLETED|Step 3: 2500 Units||0
1615973|NCT00914966|3951821|P1|COMPLETED|Step 3: 2500 Units||12
1615974|NCT00914966|3951821|P1|STARTED|Step 3: 2500 Units||12
1615975|NCT00914966|3951821|P1|NOT COMPLETED|Step 2: 2000 Units||1
1615976|NCT00914966|3951821|P1|COMPLETED|Step 2: 2000 Units||12
1615977|NCT00914966|3951821|P1|STARTED|Step 2: 2000 Units||13
1615978|NCT00914966|3951821|P1|NOT COMPLETED|Step 1: 1500 Units||2
1615979|NCT00914966|3951821|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
1615980|NCT00914966|3951821|P1|STARTED|Step 1: 1500 Units||20
1615981|NCT00914927|3951840|P7|NOT COMPLETED|Overall Study||0
1615982|NCT00914927|3951841|P6|NOT COMPLETED|Overall Study||0
1615983|NCT00914927|3951842|P5|NOT COMPLETED|Overall Study||2
1615984|NCT00914927|3951843|P4|NOT COMPLETED|Overall Study||2
1615985|NCT00914927|3951844|P3|NOT COMPLETED|Overall Study||0
1615986|NCT00914927|3951845|P2|NOT COMPLETED|Overall Study||2
1615987|NCT00914927|3951846|P1|NOT COMPLETED|Overall Study||2
1615988|NCT00914927|3951840|P7|COMPLETED|Overall Study||21
1615989|NCT00914927|3951841|P6|COMPLETED|Overall Study||21
1615990|NCT00914927|3951842|P5|COMPLETED|Overall Study||19
1615991|NCT00914927|3951843|P4|COMPLETED|Overall Study||14
1615992|NCT00914927|3951844|P3|COMPLETED|Overall Study||17
1615993|NCT00914927|3951845|P2|COMPLETED|Overall Study||14
1615994|NCT00914927|3951846|P1|COMPLETED|Overall Study||16
1615995|NCT00914927|3951840|P7|STARTED|Overall Study||21
1615996|NCT00914927|3951841|P6|STARTED|Overall Study||21
1615997|NCT00914927|3951842|P5|STARTED|Overall Study||21
1615998|NCT00914927|3951843|P4|STARTED|Overall Study||16
1615999|NCT00914927|3951844|P3|STARTED|Overall Study||17
1616000|NCT00914927|3951845|P2|STARTED|Overall Study||16
1616001|NCT00914927|3951846|P1|STARTED|Overall Study||18
1616002|NCT00914862|3951895|P5|NOT COMPLETED|Overall Study||0
1616003|NCT00914862|3951896|P4|NOT COMPLETED|Overall Study||0
1616004|NCT00914862|3951897|P3|NOT COMPLETED|Overall Study||0
1616005|NCT00914862|3951898|P2|NOT COMPLETED|Overall Study||0
1616006|NCT00914862|3951899|P1|NOT COMPLETED|Overall Study||0
1616007|NCT00914862|3951895|P5|COMPLETED|Overall Study||28
1616008|NCT00914862|3951896|P4|COMPLETED|Overall Study||8
1616009|NCT00914862|3951897|P3|COMPLETED|Overall Study||8
1616010|NCT00914862|3951898|P2|COMPLETED|Overall Study||6
1616011|NCT00914862|3951899|P1|COMPLETED|Overall Study||6
1616012|NCT00914862|3951895|P5|STARTED|Overall Study||28
1616013|NCT00914862|3951896|P4|STARTED|Overall Study||8
1616014|NCT00914862|3951897|P3|STARTED|Overall Study||8
1616015|NCT00914862|3951898|P2|STARTED|Overall Study||6
1616016|NCT00914862|3951899|P1|STARTED|Overall Study||6
1616017|NCT00914849|3951973|P2|NOT COMPLETED|Overall Study||1
1616018|NCT00914849|3951974|P1|NOT COMPLETED|Overall Study||1
1616019|NCT00914849|3951973|P2|COMPLETED|Overall Study||33
1616020|NCT00914849|3951974|P1|COMPLETED|Overall Study||33
1616021|NCT00914849|3951973|P2|STARTED|Overall Study||34
1616022|NCT00914849|3951974|P1|STARTED|Overall Study||34
1616023|NCT00914810|3952008|P2|NOT COMPLETED|Overall Study||1
1616024|NCT00914810|3952009|P1|NOT COMPLETED|Overall Study||2
1616025|NCT00914810|3952008|P2|COMPLETED|Overall Study||18
1616026|NCT00914810|3952009|P1|COMPLETED|Overall Study||18
1616027|NCT00914810|3952008|P2|STARTED|Overall Study||19
1616028|NCT00914810|3952009|P1|STARTED|Overall Study||20
1616029|NCT00914589|3952020|P3|NOT COMPLETED|Overall Study||12
1616030|NCT00914589|3952021|P2|NOT COMPLETED|Overall Study||16
1616031|NCT00914589|3952022|P1|NOT COMPLETED|Overall Study||25
1616032|NCT00914589|3952020|P3|COMPLETED|Overall Study||126
1616033|NCT00914589|3952021|P2|COMPLETED|Overall Study||127
1616034|NCT00914589|3952022|P1|COMPLETED|Overall Study||103
1616035|NCT00914589|3952020|P3|STARTED|Overall Study||138
1616036|NCT00914589|3952021|P2|STARTED|Overall Study||143
1616037|NCT00914589|3952022|P1|STARTED|Overall Study||128
1616038|NCT00914485|3952042|P1|NOT COMPLETED|Overall Study||0
1616039|NCT00914485|3952042|P1|COMPLETED|Overall Study||369
1616040|NCT00914485|3952042|P1|STARTED|Overall Study||369
1616041|NCT00914459|3952048|P2|NOT COMPLETED|Overall Study||1
1616042|NCT00914459|3952049|P1|NOT COMPLETED|Overall Study||1
1616043|NCT00914459|3952048|P2|COMPLETED|Overall Study||18
1616044|NCT00914459|3952049|P1|COMPLETED|Overall Study||17
1616045|NCT00914459|3952048|P2|STARTED|Overall Study||19
1616046|NCT00914459|3952049|P1|STARTED|Overall Study||18
1616047|NCT00914316|3952079|P4|NOT COMPLETED|Phase 2||0
1616048|NCT00914316|3952080|P3|NOT COMPLETED|Phase 2||1
1616049|NCT00914316|3952081|P2|NOT COMPLETED|Phase 2||0
1616050|NCT00914316|3952082|P1|NOT COMPLETED|Phase 2||1
1616051|NCT00914316|3952079|P4|COMPLETED|Phase 2||6
1616052|NCT00914316|3952080|P3|COMPLETED|Phase 2||2
1616053|NCT00914316|3952081|P2|COMPLETED|Phase 2||4
1616054|NCT00914316|3952082|P1|COMPLETED|Phase 2||1
1616055|NCT00914316|3952079|P4|STARTED|Phase 2||6
1616056|NCT00914316|3952080|P3|STARTED|Phase 2||3
1616057|NCT00914316|3952081|P2|STARTED|Phase 2||4
1616058|NCT00914316|3952082|P1|STARTED|Phase 2||2
1616059|NCT00914316|3952079|P4|NOT COMPLETED|Phase 1||2
1616060|NCT00914316|3952080|P3|NOT COMPLETED|Phase 1||5
1616061|NCT00914316|3952081|P2|NOT COMPLETED|Phase 1||2
1616062|NCT00914316|3952082|P1|NOT COMPLETED|Phase 1||5
1616063|NCT00914316|3952079|P4|COMPLETED|Phase 1||6
1616064|NCT00914316|3952080|P3|COMPLETED|Phase 1||3
1616065|NCT00914316|3952081|P2|COMPLETED|Phase 1||4
1616066|NCT00914316|3952082|P1|COMPLETED|Phase 1||2
1616067|NCT00914316|3952079|P4|STARTED|Phase 1||8
1616068|NCT00914316|3952080|P3|STARTED|Phase 1||8
1616069|NCT00914316|3952081|P2|STARTED|Phase 1||6
1616070|NCT00914316|3952082|P1|STARTED|Phase 1||7
1616071|NCT00914186|3952100|P4|NOT COMPLETED|Overall Study||10
1616072|NCT00914186|3952101|P3|NOT COMPLETED|Overall Study||2
1616073|NCT00914186|3952102|P2|NOT COMPLETED|Overall Study||2
1616074|NCT00914186|3952103|P1|NOT COMPLETED|Overall Study||3
1616075|NCT00914186|3952100|P4|COMPLETED|Overall Study||20
1616076|NCT00914186|3952101|P3|COMPLETED|Overall Study||29
1616077|NCT00914186|3952102|P2|COMPLETED|Overall Study||28
1616078|NCT00914186|3952103|P1|COMPLETED|Overall Study||28
1616079|NCT00914186|3952100|P4|STARTED|Overall Study||30
1616080|NCT00914186|3952101|P3|STARTED|Overall Study||31
1616081|NCT00914186|3952102|P2|STARTED|Overall Study||30
1616082|NCT00914186|3952103|P1|STARTED|Overall Study||31
1616083|NCT00914069|3952137|P2|NOT COMPLETED|Overall Study||0
1616084|NCT00914069|3952138|P1|NOT COMPLETED|Overall Study||0
1616085|NCT00914069|3952137|P2|COMPLETED|Overall Study||88
1616086|NCT00914069|3952138|P1|COMPLETED|Overall Study||84
1616087|NCT00914069|3952137|P2|STARTED|Overall Study||88
1616088|NCT00914069|3952138|P1|STARTED|Overall Study||84
1616089|NCT00913913|3952152|P1|NOT COMPLETED|Overall Study||8
1616090|NCT00913913|3952152|P1|COMPLETED|Overall Study||0
1616091|NCT00913913|3952152|P1|STARTED|Overall Study||8
1616092|NCT00913835|3952161|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
1616093|NCT00913835|3952162|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
1616094|NCT00913835|3952161|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
1616095|NCT00913835|3952162|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
1616096|NCT00913835|3952161|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
1616097|NCT00913835|3952162|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
1616098|NCT00913835|3952161|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
1616099|NCT00913835|3952162|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
1616100|NCT00913835|3952161|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
1616101|NCT00913835|3952162|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
1616102|NCT00913835|3952161|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
1616103|NCT00913835|3952162|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
1616104|NCT00913835|3952161|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
1616105|NCT00913835|3952162|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
1616106|NCT00913835|3952161|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
1616107|NCT00913835|3952162|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
1616108|NCT00913770|3952201|P3|NOT COMPLETED|Overall Study||21
1616109|NCT00913770|3952202|P2|NOT COMPLETED|Overall Study||29
1616110|NCT00913770|3952203|P1|NOT COMPLETED|Overall Study||35
1616111|NCT00913770|3952201|P3|COMPLETED|Overall Study||93
1616112|NCT00913770|3952202|P2|COMPLETED|Overall Study||82
1616113|NCT00913770|3952203|P1|COMPLETED|Overall Study||69
1616114|NCT00913770|3952201|P3|STARTED|Overall Study||114
1616115|NCT00913770|3952202|P2|STARTED|Overall Study||111
1616116|NCT00913770|3952203|P1|STARTED|Overall Study||104
1616117|NCT00913744|3952216|P2|NOT COMPLETED|Overall Study||1
1616118|NCT00913744|3952217|P1|NOT COMPLETED|Overall Study||5
1616119|NCT00913744|3952216|P2|COMPLETED|Overall Study||24
1616120|NCT00913744|3952217|P1|COMPLETED|Overall Study||70
1616121|NCT00913744|3952216|P2|STARTED|Overall Study||25
1616122|NCT00913744|3952217|P1|STARTED|Overall Study||75
1616123|NCT00913692|3952223|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
1616124|NCT00913692|3952223|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
1616125|NCT00913692|3952223|P1|STARTED|Treatment Phase 2 (5 Months)||1
1616126|NCT00913692|3952223|P1|NOT COMPLETED|Washout (2 Weeks)||0
1616127|NCT00913692|3952223|P1|COMPLETED|Washout (2 Weeks)||1
1616128|NCT00913692|3952223|P1|STARTED|Washout (2 Weeks)||1
1616129|NCT00913692|3952223|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
1616130|NCT00913692|3952223|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
1616131|NCT00913692|3952223|P1|STARTED|Treatment Phase 1 (5 Months)||2
1616132|NCT00913692|3952223|P1|NOT COMPLETED|Screening (4 Months)||9
1616133|NCT00913692|3952223|P1|COMPLETED|Screening (4 Months)||2
1616134|NCT00913692|3952223|P1|STARTED|Screening (4 Months)||11
1616135|NCT00913627|3952237|P4|NOT COMPLETED|Overall Study||0
1616136|NCT00913627|3952238|P3|NOT COMPLETED|Overall Study||0
1616137|NCT00913627|3952239|P2|NOT COMPLETED|Overall Study||0
1616138|NCT00913627|3952240|P1|NOT COMPLETED|Overall Study||0
1616139|NCT00913627|3952237|P4|COMPLETED|Overall Study||58
1616140|NCT00913627|3952238|P3|COMPLETED|Overall Study||56
1616141|NCT00913627|3952239|P2|COMPLETED|Overall Study||53
1616142|NCT00913627|3952240|P1|COMPLETED|Overall Study||29
1616143|NCT00913627|3952237|P4|STARTED|Overall Study||58
1616144|NCT00913627|3952238|P3|STARTED|Overall Study||56
1616145|NCT00913627|3952239|P2|STARTED|Overall Study||53
1616146|NCT00913627|3952240|P1|STARTED|Overall Study||29
1616147|NCT00913523|3952317|P3|NOT COMPLETED|Overall Study||14
1616148|NCT00913523|3952318|P2|NOT COMPLETED|Overall Study||16
1616149|NCT00913523|3952319|P1|NOT COMPLETED|Overall Study||18
1616150|NCT00913523|3952317|P3|COMPLETED|Overall Study||147
1616151|NCT00913523|3952318|P2|COMPLETED|Overall Study||143
1616152|NCT00913523|3952319|P1|COMPLETED|Overall Study||144
1616153|NCT00913523|3952317|P3|STARTED|Overall Study||161
1616154|NCT00913523|3952318|P2|STARTED|Overall Study||159
1616155|NCT00913523|3952319|P1|STARTED|Overall Study||162
1616156|NCT00913510|3952344|P2|NOT COMPLETED|Overall Study||4
1616157|NCT00913510|3952345|P1|NOT COMPLETED|Overall Study||8
1616158|NCT00913510|3952344|P2|COMPLETED|Overall Study||3
1616159|NCT00913510|3952345|P1|COMPLETED|Overall Study||5
1616160|NCT00913510|3952344|P2|STARTED|Overall Study||7
1616161|NCT00913510|3952345|P1|STARTED|Overall Study||13
1616162|NCT00913458|3952351|P7|NOT COMPLETED|Phase 3||8
1616163|NCT00913458|3952352|P6|NOT COMPLETED|Phase 3||18
1616164|NCT00913458|3952353|P5|NOT COMPLETED|Phase 3||22
1616165|NCT00913458|3952354|P4|NOT COMPLETED|Phase 3||0
1616166|NCT00913458|3952355|P3|NOT COMPLETED|Phase 3||0
1616167|NCT00913458|3952356|P2|NOT COMPLETED|Phase 3||0
1616168|NCT00913458|3952357|P1|NOT COMPLETED|Phase 3||0
1616169|NCT00913458|3952351|P7|COMPLETED|Phase 3||24
1616170|NCT00913458|3952352|P6|COMPLETED|Phase 3||28
1616171|NCT00913458|3952353|P5|COMPLETED|Phase 3||31
1616172|NCT00913458|3952354|P4|COMPLETED|Phase 3||0
1616173|NCT00913458|3952355|P3|COMPLETED|Phase 3||0
1616174|NCT00913458|3952356|P2|COMPLETED|Phase 3||0
1616175|NCT00913458|3952357|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
1616176|NCT00913458|3952351|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
1616177|NCT00913458|3952352|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
1616178|NCT00913458|3952353|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
1616179|NCT00913458|3952354|P4|STARTED|Phase 3||0
1616180|NCT00913458|3952355|P3|STARTED|Phase 3||0
1616181|NCT00913458|3952356|P2|STARTED|Phase 3||0
1616182|NCT00913458|3952357|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
1616183|NCT00913458|3952351|P7|NOT COMPLETED|Phase 2||0
1616184|NCT00913458|3952352|P6|NOT COMPLETED|Phase 2||0
1616185|NCT00913458|3952353|P5|NOT COMPLETED|Phase 2||0
1616186|NCT00913458|3952354|P4|NOT COMPLETED|Phase 2||33
1616187|NCT00913458|3952355|P3|NOT COMPLETED|Phase 2||19
1616188|NCT00913458|3952356|P2|NOT COMPLETED|Phase 2||10
1616189|NCT00913458|3952357|P1|NOT COMPLETED|Phase 2||0
1616190|NCT00913458|3952351|P7|COMPLETED|Phase 2||0
1616191|NCT00913458|3952352|P6|COMPLETED|Phase 2||0
1616192|NCT00913458|3952353|P5|COMPLETED|Phase 2||0
1616193|NCT00913458|3952354|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
1616194|NCT00913458|3952355|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
1616195|NCT00913458|3952356|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
1616196|NCT00913458|3952357|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
1616197|NCT00913458|3952351|P7|STARTED|Phase 2||0
1616198|NCT00913458|3952352|P6|STARTED|Phase 2||0
1616199|NCT00913458|3952353|P5|STARTED|Phase 2||0
1616200|NCT00913458|3952354|P4|STARTED|Phase 2||65
1616201|NCT00913458|3952355|P3|STARTED|Phase 2||65
1616202|NCT00913458|3952356|P2|STARTED|Phase 2||63
1616203|NCT00913458|3952357|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
1616204|NCT00913458|3952351|P7|NOT COMPLETED|Phase 1||0
1616205|NCT00913458|3952352|P6|NOT COMPLETED|Phase 1||0
1616206|NCT00913458|3952353|P5|NOT COMPLETED|Phase 1||0
1616207|NCT00913458|3952354|P4|NOT COMPLETED|Phase 1||0
1616208|NCT00913458|3952355|P3|NOT COMPLETED|Phase 1||0
1616209|NCT00913458|3952356|P2|NOT COMPLETED|Phase 1||0
1616210|NCT00913458|3952357|P1|NOT COMPLETED|Phase 1||112
1616211|NCT00913458|3952351|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
1616212|NCT00913458|3952352|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
1616213|NCT00913458|3952353|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
1616214|NCT00913458|3952354|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
1616215|NCT00913458|3952355|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
1616216|NCT00913458|3952356|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
1616217|NCT00913458|3952357|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
1616218|NCT00913458|3952351|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
1616219|NCT00913458|3952352|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
1616220|NCT00913458|3952353|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
1616221|NCT00913458|3952354|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
1616222|NCT00913458|3952355|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
1616223|NCT00913458|3952356|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
1616224|NCT00913458|3952357|P1|STARTED|Phase 1||306
1616225|NCT00913380|3952450|P2|NOT COMPLETED|Clinical Outcomes||6
1616226|NCT00913380|3952451|P1|NOT COMPLETED|Clinical Outcomes||6
1616227|NCT00913380|3952450|P2|COMPLETED|Clinical Outcomes||441
1616228|NCT00913380|3952451|P1|COMPLETED|Clinical Outcomes||438
1616229|NCT00913380|3952450|P2|STARTED|Clinical Outcomes||447
1616230|NCT00913380|3952451|P1|STARTED|Clinical Outcomes||444
1616231|NCT00913380|3952450|P2|NOT COMPLETED|CT Examination||0
1616232|NCT00913380|3952451|P1|NOT COMPLETED|CT Examination||0
1616233|NCT00913380|3952450|P2|COMPLETED|CT Examination||447
1616234|NCT00913380|3952451|P1|COMPLETED|CT Examination||444
1616235|NCT00913380|3952450|P2|STARTED|CT Examination||447
1616236|NCT00913380|3952451|P1|STARTED|CT Examination||444
1616237|NCT00913263|3952477|P1|NOT COMPLETED|Overall Study||0
1616238|NCT00913263|3952477|P1|COMPLETED|Overall Study||24
1616239|NCT00913263|3952477|P1|STARTED|Overall Study||24
1616240|NCT00913133|3952486|P1|NOT COMPLETED|Overall Study||0
1616241|NCT00913133|3952486|P1|COMPLETED|Overall Study||516
1616242|NCT00913133|3952486|P1|STARTED|Overall Study||516
1616243|NCT00913081|3952491|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
1616244|NCT00913081|3952491|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
1616245|NCT00913081|3952491|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
1616246|NCT00913081|3952491|P1|NOT COMPLETED|Washout #3 (7days)||0
1616247|NCT00913081|3952491|P1|COMPLETED|Washout #3 (7days)||17
1616248|NCT00913081|3952491|P1|STARTED|Washout #3 (7days)||17
1616249|NCT00913081|3952491|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
1616250|NCT00913081|3952491|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
1616251|NCT00913081|3952491|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
1616252|NCT00913081|3952491|P1|NOT COMPLETED|Washout #2 (7 Days)||0
1616253|NCT00913081|3952491|P1|COMPLETED|Washout #2 (7 Days)||17
1616254|NCT00913081|3952491|P1|STARTED|Washout #2 (7 Days)||17
1616255|NCT00913081|3952491|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
1616256|NCT00913081|3952491|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
1616257|NCT00913081|3952491|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
1616258|NCT00913081|3952491|P1|NOT COMPLETED|Washout #1 (7 Days)||0
1616259|NCT00913081|3952491|P1|COMPLETED|Washout #1 (7 Days)||17
1616260|NCT00913081|3952491|P1|STARTED|Washout #1 (7 Days)||17
1616261|NCT00913081|3952491|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
1616262|NCT00913081|3952491|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
1616263|NCT00913081|3952491|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
1616264|NCT00913003|3952503|P2|NOT COMPLETED|Overall Study||0
1616265|NCT00913003|3952504|P1|NOT COMPLETED|Overall Study||0
1616266|NCT00913003|3952503|P2|COMPLETED|Overall Study||11
1616267|NCT00913003|3952504|P1|COMPLETED|Overall Study||11
1616268|NCT00913003|3952503|P2|STARTED|Overall Study||11
1616269|NCT00913003|3952504|P1|STARTED|Overall Study||11
1616270|NCT00912964|3952517|P3|NOT COMPLETED|Overall Study||54
1616271|NCT00912964|3952518|P2|NOT COMPLETED|Overall Study||46
1616272|NCT00912964|3952519|P1|NOT COMPLETED|Overall Study||66
1616273|NCT00912964|3952517|P3|COMPLETED|Overall Study||386
1616274|NCT00912964|3952518|P2|COMPLETED|Overall Study||387
1616275|NCT00912964|3952519|P1|COMPLETED|Overall Study||367
1616276|NCT00912964|3952517|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
1616277|NCT00912964|3952518|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
1616278|NCT00912964|3952519|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
1616279|NCT00912964|3952517|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
1616280|NCT00912964|3952518|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
1616281|NCT00912964|3952519|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
1616282|NCT00912964|3952517|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
1616283|NCT00912964|3952518|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
1616284|NCT00912964|3952519|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
1616285|NCT00912964|3952517|P3|STARTED|Overall Study||440
1616286|NCT00912964|3952518|P2|STARTED|Overall Study||433
1616287|NCT00912964|3952519|P1|STARTED|Overall Study||433
1616288|NCT00912925|3952643|P2|NOT COMPLETED|Overall Study||0
1616289|NCT00912925|3952644|P1|NOT COMPLETED|Overall Study||0
1616290|NCT00912925|3952643|P2|COMPLETED|Overall Study||22
1616291|NCT00912925|3952644|P1|COMPLETED|Overall Study||23
1616292|NCT00912925|3952643|P2|STARTED|Overall Study||22
1616293|NCT00912925|3952644|P1|STARTED|Overall Study||23
1616294|NCT00912912|3952662|P1|NOT COMPLETED|Overall Study||4
1616295|NCT00912912|3952662|P1|COMPLETED|Overall Study||1
1616296|NCT00912912|3952662|P1|STARTED|Overall Study||5
1616297|NCT00912808|3952668|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
1616298|NCT00912808|3952669|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
1616299|NCT00912808|3952668|P2|COMPLETED|Second Intervention (6 Weeks)||9
1616300|NCT00912808|3952669|P1|COMPLETED|Second Intervention (6 Weeks)||8
1616301|NCT00912808|3952668|P2|Received Intervention|Second Intervention (6 Weeks)||10
1616302|NCT00912808|3952669|P1|Received Intervention|Second Intervention (6 Weeks)||9
1616303|NCT00912808|3952668|P2|STARTED|Second Intervention (6 Weeks)||10
1616304|NCT00912808|3952669|P1|STARTED|Second Intervention (6 Weeks)||9
1616305|NCT00912808|3952668|P2|NOT COMPLETED|Washout||1
1616306|NCT00912808|3952669|P1|NOT COMPLETED|Washout||0
1616307|NCT00912808|3952668|P2|COMPLETED|Washout||10
1616308|NCT00912808|3952669|P1|COMPLETED|Washout||9
1616309|NCT00912808|3952668|P2|STARTED|Washout||11
1616310|NCT00912808|3952669|P1|STARTED|Washout||9
1616311|NCT00912808|3952668|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
1616312|NCT00912808|3952669|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
1616313|NCT00912808|3952668|P2|COMPLETED|First Intervention (6 Weeks)||11
1616314|NCT00912808|3952669|P1|COMPLETED|First Intervention (6 Weeks)||9
1616315|NCT00912808|3952668|P2|Received Intervention|First Intervention (6 Weeks)||12
1616316|NCT00912808|3952669|P1|Received Intervention|First Intervention (6 Weeks)||11
1616317|NCT00912808|3952668|P2|STARTED|First Intervention (6 Weeks)||12
1616318|NCT00912808|3952669|P1|STARTED|First Intervention (6 Weeks)||11
1616319|NCT00912795|3952679|P2|NOT COMPLETED|Overall Study||58
1616320|NCT00912795|3952680|P1|NOT COMPLETED|Overall Study||47
1616321|NCT00912795|3952679|P2|COMPLETED|Overall Study||17
1616322|NCT00912795|3952680|P1|COMPLETED|Overall Study||29
1616323|NCT00912795|3952679|P2|STARTED|Overall Study||75
1616324|NCT00912795|3952680|P1|STARTED|Overall Study||76
1616325|NCT00912782|3952694|P2|NOT COMPLETED|Overall Study||5
1616326|NCT00912782|3952695|P1|NOT COMPLETED|Overall Study||3
1616327|NCT00912782|3952694|P2|COMPLETED|Overall Study||20
1616328|NCT00912782|3952695|P1|COMPLETED|Overall Study||24
1616329|NCT00912782|3952694|P2|STARTED|Overall Study||25
1616330|NCT00912782|3952695|P1|STARTED|Overall Study||27
1616331|NCT00912743|3952705|P2|NOT COMPLETED|Overall Study||20
1616332|NCT00912743|3952706|P1|NOT COMPLETED|Overall Study||13
1616333|NCT00912743|3952705|P2|COMPLETED|Overall Study||0
1616334|NCT00912743|3952706|P1|COMPLETED|Overall Study||0
1616335|NCT00912743|3952705|P2|STARTED|Overall Study||20
1616336|NCT00912743|3952706|P1|STARTED|Overall Study||13
1616337|NCT00912509|3952718|P2|NOT COMPLETED|Overall Study||3
1616338|NCT00912509|3952719|P1|NOT COMPLETED|Overall Study||5
1616339|NCT00912509|3952718|P2|COMPLETED|Overall Study||7
1616340|NCT00912509|3952719|P1|COMPLETED|Overall Study||15
1616341|NCT00912509|3952718|P2|STARTED|Overall Study||10
1616342|NCT00912509|3952719|P1|STARTED|Overall Study||20
1616343|NCT00912405|3952727|P1|NOT COMPLETED|Overall Study||5
1616344|NCT00912405|3952727|P1|COMPLETED|Overall Study||45
1616345|NCT00912405|3952727|P1|STARTED|Overall Study||50
1616346|NCT00912340|3952737|P3|NOT COMPLETED|Overall Study||4
1616347|NCT00912340|3952738|P2|NOT COMPLETED|Overall Study||4
1616348|NCT00912340|3952739|P1|NOT COMPLETED|Overall Study||2
1616349|NCT00912340|3952737|P3|COMPLETED|Overall Study||0
1616350|NCT00912340|3952738|P2|COMPLETED|Overall Study||26
1616351|NCT00912340|3952739|P1|COMPLETED|Overall Study||22
1616352|NCT00912340|3952737|P3|STARTED|Overall Study||4
1616353|NCT00912340|3952738|P2|STARTED|Overall Study||30
1616354|NCT00912340|3952739|P1|STARTED|Overall Study||24
1616355|NCT00912301|3952753|P3|NOT COMPLETED|Overall Study||0
1616356|NCT00912301|3952754|P2|NOT COMPLETED|Overall Study||0
1616357|NCT00912301|3952755|P1|NOT COMPLETED|Overall Study||0
1616358|NCT00912301|3952753|P3|COMPLETED|Overall Study||13
1616359|NCT00912301|3952754|P2|COMPLETED|Overall Study||12
1616360|NCT00912301|3952755|P1|COMPLETED|Overall Study||11
1616361|NCT00912301|3952753|P3|STARTED|Overall Study||13
1616362|NCT00912301|3952754|P2|STARTED|Overall Study||12
1616363|NCT00912301|3952755|P1|STARTED|Overall Study||11
1616364|NCT00912288|3952777|P2|NOT COMPLETED|Overall Study||40
1616365|NCT00912288|3952778|P1|NOT COMPLETED|Overall Study||41
1616366|NCT00912288|3952777|P2|COMPLETED|Overall Study||2
1616367|NCT00912288|3952778|P1|COMPLETED|Overall Study||3
1616368|NCT00912288|3952777|P2|STARTED|Overall Study||42
1616369|NCT00912288|3952778|P1|STARTED|Overall Study||44
1616370|NCT00912223|3952800|P1|NOT COMPLETED|Overall Study||3
1616371|NCT00912223|3952800|P1|COMPLETED|Overall Study||62
1616372|NCT00912223|3952800|P1|STARTED|Overall Study||65
1616373|NCT00912158|3952819|P3|NOT COMPLETED|Overall Study||0
1616374|NCT00912158|3952820|P2|NOT COMPLETED|Overall Study||0
1616375|NCT00912158|3952821|P1|NOT COMPLETED|Overall Study||0
1616376|NCT00912158|3952819|P3|COMPLETED|Overall Study||41
1616377|NCT00912158|3952820|P2|COMPLETED|Overall Study||44
1616378|NCT00912158|3952821|P1|COMPLETED|Overall Study||44
1616379|NCT00912158|3952819|P3|STARTED|Overall Study||41
1616380|NCT00912158|3952820|P2|STARTED|Overall Study||44
1616381|NCT00912158|3952821|P1|STARTED|Overall Study||44
1616382|NCT00912093|3952831|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1616383|NCT00912093|3952832|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1616384|NCT00912093|3952833|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1616385|NCT00912093|3952834|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1616386|NCT00912093|3952835|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1616387|NCT00912093|3952831|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
1616388|NCT00912093|3952832|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
1616389|NCT00912093|3952833|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
1616390|NCT00912093|3952834|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
1616391|NCT00912093|3952835|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
1616392|NCT00912093|3952831|P5|STARTED|The Open Label Extension (OLE) Phase||4
1616393|NCT00912093|3952832|P4|STARTED|The Open Label Extension (OLE) Phase||2
1616394|NCT00912093|3952833|P3|STARTED|The Open Label Extension (OLE) Phase||3
1616395|NCT00912093|3952834|P2|STARTED|The Open Label Extension (OLE) Phase||35
1616396|NCT00912093|3952835|P1|STARTED|The Open Label Extension (OLE) Phase||38
1616397|NCT00912093|3952831|P5|NOT COMPLETED|The Controlled Phase||1
1616398|NCT00912093|3952832|P4|NOT COMPLETED|The Controlled Phase||0
1616399|NCT00912093|3952833|P3|NOT COMPLETED|The Controlled Phase||0
1616400|NCT00912093|3952834|P2|NOT COMPLETED|The Controlled Phase||2
1616401|NCT00912093|3952835|P1|NOT COMPLETED|The Controlled Phase||0
1616402|NCT00912093|3952831|P5|COMPLETED|The Controlled Phase||4
1616403|NCT00912093|3952832|P4|COMPLETED|The Controlled Phase||2
1616404|NCT00912093|3952833|P3|COMPLETED|The Controlled Phase||3
1616405|NCT00912093|3952834|P2|COMPLETED|The Controlled Phase||43
1616406|NCT00912093|3952835|P1|COMPLETED|The Controlled Phase||43
1616407|NCT00912093|3952831|P5|STARTED|The Controlled Phase||5
1616408|NCT00912093|3952832|P4|STARTED|The Controlled Phase||2
1616409|NCT00912093|3952833|P3|STARTED|The Controlled Phase||3
1616410|NCT00912093|3952834|P2|STARTED|The Controlled Phase||45
1616411|NCT00912093|3952835|P1|STARTED|The Controlled Phase||43
1616412|NCT00912028|3952854|P5|NOT COMPLETED|Overall Study||3
1616413|NCT00912028|3952855|P4|NOT COMPLETED|Overall Study||1
1616414|NCT00912028|3952856|P3|NOT COMPLETED|Overall Study||0
1616415|NCT00912028|3952857|P2|NOT COMPLETED|Overall Study||3
1616416|NCT00912028|3952858|P1|NOT COMPLETED|Overall Study||5
1616417|NCT00912028|3952854|P5|COMPLETED|Overall Study||0
1616418|NCT00912028|3952855|P4|COMPLETED|Overall Study||16
1616419|NCT00912028|3952856|P3|COMPLETED|Overall Study||13
1616420|NCT00912028|3952857|P2|COMPLETED|Overall Study||0
1616421|NCT00912028|3952858|P1|COMPLETED|Overall Study||30
1616422|NCT00912028|3952854|P5|STARTED|Overall Study||3
1616423|NCT00912028|3952855|P4|STARTED|Overall Study||17
1616424|NCT00912028|3952856|P3|STARTED|Overall Study||13
1616425|NCT00912028|3952857|P2|STARTED|Overall Study||3
1616426|NCT00912028|3952858|P1|STARTED|Overall Study||35
1616427|NCT00912015|3952887|P4|NOT COMPLETED|Overall Study||2
1616428|NCT00912015|3952888|P3|NOT COMPLETED|Overall Study||3
1616429|NCT00912015|3952889|P2|NOT COMPLETED|Overall Study||8
1616430|NCT00912015|3952890|P1|NOT COMPLETED|Overall Study||16
1616431|NCT00912015|3952887|P4|COMPLETED|Overall Study||0
1616432|NCT00912015|3952888|P3|COMPLETED|Overall Study||22
1616433|NCT00912015|3952889|P2|COMPLETED|Overall Study||62
1616434|NCT00912015|3952890|P1|COMPLETED|Overall Study||125
1616435|NCT00912015|3952887|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
1616436|NCT00912015|3952888|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
1616437|NCT00912015|3952889|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
1616438|NCT00912015|3952890|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
1616439|NCT00912002|3952900|P1|NOT COMPLETED|Overall Study||0
1616440|NCT00912002|3952900|P1|COMPLETED|Overall Study||6
1616441|NCT00912002|3952900|P1|STARTED|Overall Study||6
1616442|NCT00911989|3952906|P1|NOT COMPLETED|Overall Study||1
1616443|NCT00911989|3952906|P1|COMPLETED|Overall Study||3
1616444|NCT00911989|3952906|P1|STARTED|Overall Study||4
1616445|NCT00911937|3952912|P2|NOT COMPLETED|Overall Study||95
1616446|NCT00911937|3952913|P1|NOT COMPLETED|Overall Study||87
1616447|NCT00911937|3952912|P2|COMPLETED|Overall Study||381
1616448|NCT00911937|3952913|P1|COMPLETED|Overall Study||400
1616449|NCT00911937|3952912|P2|Treated|Overall Study||463
1616450|NCT00911937|3952913|P1|Treated|Overall Study||474
1616451|NCT00911937|3952912|P2|STARTED|Overall Study||476
1616452|NCT00911937|3952913|P1|STARTED|Overall Study||487
1616453|NCT00911898|3952973|P1|NOT COMPLETED|Overall Study||0
1616454|NCT00911898|3952973|P1|COMPLETED|Overall Study||20
1616455|NCT00911898|3952973|P1|STARTED|Overall Study||20
1616456|NCT00911859|3952980|P3|NOT COMPLETED|Follow-up Period||41
1616457|NCT00911859|3952981|P2|NOT COMPLETED|Follow-up Period||46
1616458|NCT00911859|3952982|P1|NOT COMPLETED|Follow-up Period||11
1616459|NCT00911859|3952980|P3|COMPLETED|Follow-up Period||11
1616460|NCT00911859|3952981|P2|COMPLETED|Follow-up Period||7
1616461|NCT00911859|3952982|P1|COMPLETED|Follow-up Period||1
1616462|NCT00911859|3952980|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
1616463|NCT00911859|3952981|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
1616464|NCT00911859|3952982|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
1616465|NCT00911859|3952980|P3|NOT COMPLETED|Maintainance Period||21
1616466|NCT00911859|3952981|P2|NOT COMPLETED|Maintainance Period||0
1616467|NCT00911859|3952982|P1|NOT COMPLETED|Maintainance Period||0
1616468|NCT00911859|3952980|P3|COMPLETED|Maintainance Period||0
1616469|NCT00911859|3952981|P2|COMPLETED|Maintainance Period||0
1616470|NCT00911859|3952982|P1|COMPLETED|Maintainance Period||0
1616471|NCT00911859|3952980|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
1616472|NCT00911859|3952981|P2|STARTED|Maintainance Period||0
1616473|NCT00911859|3952982|P1|STARTED|Maintainance Period||0
1616474|NCT00911859|3952980|P3|NOT COMPLETED|Treatment Period||25
1616475|NCT00911859|3952981|P2|NOT COMPLETED|Treatment Period||21
1616476|NCT00911859|3952982|P1|NOT COMPLETED|Treatment Period||8
1616477|NCT00911859|3952980|P3|COMPLETED|Treatment Period||27
1616478|NCT00911859|3952981|P2|COMPLETED|Treatment Period||33
1616479|NCT00911859|3952982|P1|COMPLETED|Treatment Period||4
1616480|NCT00911859|3952980|P3|Received Treatment|Treatment Period||52
1616481|NCT00911859|3952981|P2|Received Treatment|Treatment Period||53
1616482|NCT00911859|3952982|P1|Received Treatment|Treatment Period||12
1616483|NCT00911859|3952980|P3|STARTED|Treatment Period||52
1616484|NCT00911859|3952981|P2|STARTED|Treatment Period||54
1616485|NCT00911859|3952982|P1|STARTED|Treatment Period||12
1616486|NCT00911820|3953008|P2|NOT COMPLETED|Overall Study||43
1616487|NCT00911820|3953009|P1|NOT COMPLETED|Overall Study||45
1616488|NCT00911820|3953008|P2|COMPLETED|Overall Study||0
1616489|NCT00911820|3953009|P1|COMPLETED|Overall Study||0
1616490|NCT00911820|3953008|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
1616491|NCT00911820|3953009|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
1616492|NCT00911820|3953008|P2|STARTED|Overall Study||43
1616493|NCT00911820|3953009|P1|STARTED|Overall Study||45
1616494|NCT00911807|3953026|P3|NOT COMPLETED|Overall Study||23
1616495|NCT00911807|3953027|P2|NOT COMPLETED|Overall Study||18
1616496|NCT00911807|3953028|P1|NOT COMPLETED|Overall Study||17
1616497|NCT00911807|3953026|P3|COMPLETED|Overall Study||52
1616498|NCT00911807|3953027|P2|COMPLETED|Overall Study||52
1616499|NCT00911807|3953028|P1|COMPLETED|Overall Study||55
1616500|NCT00911807|3953026|P3|STARTED|Overall Study||75
1616501|NCT00911807|3953027|P2|STARTED|Overall Study||70
1616502|NCT00911807|3953028|P1|STARTED|Overall Study||72
1616503|NCT00911768|3953038|P2|NOT COMPLETED|Overall Study||4
1616504|NCT00911768|3953039|P1|NOT COMPLETED|Overall Study||6
1616505|NCT00911768|3953038|P2|COMPLETED|Overall Study||46
1616506|NCT00911768|3953039|P1|COMPLETED|Overall Study||44
1616507|NCT00911768|3953038|P2|STARTED|Overall Study||50
1616508|NCT00911768|3953039|P1|STARTED|Overall Study||50
1616509|NCT00911742|3953051|P2|NOT COMPLETED|Treatment Phase II||0
1616510|NCT00911742|3953052|P1|NOT COMPLETED|Treatment Phase II||0
1616511|NCT00911742|3953051|P2|COMPLETED|Treatment Phase II||13
1616512|NCT00911742|3953052|P1|COMPLETED|Treatment Phase II||13
1616513|NCT00911742|3953051|P2|STARTED|Treatment Phase II||13
1616514|NCT00911742|3953052|P1|STARTED|Treatment Phase II||13
1616515|NCT00911742|3953051|P2|NOT COMPLETED|Treatment Phase I||0
1616516|NCT00911742|3953052|P1|NOT COMPLETED|Treatment Phase I||0
1616517|NCT00911742|3953051|P2|COMPLETED|Treatment Phase I||13
1616518|NCT00911742|3953052|P1|COMPLETED|Treatment Phase I||13
1616519|NCT00911742|3953051|P2|STARTED|Treatment Phase I||13
1616520|NCT00911742|3953052|P1|STARTED|Treatment Phase I||13
1616521|NCT00911625|3953068|P2|NOT COMPLETED|Overall Study||0
1616522|NCT00911625|3953069|P1|NOT COMPLETED|Overall Study||7
1616523|NCT00911625|3953068|P2|COMPLETED|Overall Study||57
1616524|NCT00911625|3953069|P1|COMPLETED|Overall Study||50
1616525|NCT00911625|3953068|P2|STARTED|Overall Study||57
1616526|NCT00911625|3953069|P1|STARTED|Overall Study||57
1616527|NCT00911612|3953079|P2|NOT COMPLETED|Overall Study||0
1616528|NCT00911612|3953080|P1|NOT COMPLETED|Overall Study||0
1616529|NCT00911612|3953079|P2|COMPLETED|Overall Study||12
1616530|NCT00911612|3953080|P1|COMPLETED|Overall Study||12
1616531|NCT00911612|3953079|P2|STARTED|Overall Study||12
1616532|NCT00911612|3953080|P1|STARTED|Overall Study||12
1616533|NCT00911547|3953098|P4|NOT COMPLETED|Overall Study||16
1616534|NCT00911547|3953099|P3|NOT COMPLETED|Overall Study||22
1616535|NCT00911547|3953100|P2|NOT COMPLETED|Overall Study||42
1616536|NCT00911547|3953101|P1|NOT COMPLETED|Overall Study||11
1616537|NCT00911547|3953098|P4|COMPLETED|Overall Study||177
1616538|NCT00911547|3953099|P3|COMPLETED|Overall Study||178
1616539|NCT00911547|3953100|P2|COMPLETED|Overall Study||159
1616540|NCT00911547|3953101|P1|COMPLETED|Overall Study||37
1616541|NCT00911547|3953098|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
1616542|NCT00911547|3953099|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
1616543|NCT00911547|3953100|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
1616544|NCT00911547|3953101|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
1616545|NCT00911534|3953129|P2|NOT COMPLETED|Overall Study||16
1616546|NCT00911534|3953130|P1|NOT COMPLETED|Overall Study||15
1616547|NCT00911534|3953129|P2|COMPLETED|Overall Study||137
1616548|NCT00911534|3953130|P1|COMPLETED|Overall Study||132
1616549|NCT00911534|3953129|P2|STARTED|Overall Study|Randomized (treated)|153
1616550|NCT00911534|3953130|P1|STARTED|Overall Study|Randomized (treated)|147
1616551|NCT00911495|3953142|P1|NOT COMPLETED|Overall Study||1
1616552|NCT00911495|3953142|P1|COMPLETED|Overall Study||14
1616553|NCT00911495|3953142|P1|STARTED|Overall Study||15
1616554|NCT00911443|3953155|P5|NOT COMPLETED|Overall Study||0
1616555|NCT00911443|3953156|P4|NOT COMPLETED|Overall Study||0
1616556|NCT00911443|3953157|P3|NOT COMPLETED|Overall Study||0
1616557|NCT00911443|3953158|P2|NOT COMPLETED|Overall Study||0
1616558|NCT00911443|3953159|P1|NOT COMPLETED|Overall Study||0
1616559|NCT00911443|3953155|P5|COMPLETED|Overall Study||97
1616560|NCT00911443|3953156|P4|COMPLETED|Overall Study||99
1616561|NCT00911443|3953157|P3|COMPLETED|Overall Study||98
1616562|NCT00911443|3953158|P2|COMPLETED|Overall Study||97
1616563|NCT00911443|3953159|P1|COMPLETED|Overall Study||97
1616564|NCT00911443|3953155|P5|STARTED|Overall Study||97
1616565|NCT00911443|3953156|P4|STARTED|Overall Study||99
1616566|NCT00911443|3953157|P3|STARTED|Overall Study||98
1616567|NCT00911443|3953158|P2|STARTED|Overall Study||97
1616568|NCT00911443|3953159|P1|STARTED|Overall Study||97
1616569|NCT00911326|3953176|P1|NOT COMPLETED|Overall Study||16
1616570|NCT00911326|3953176|P1|COMPLETED|Overall Study||85
1616571|NCT00911326|3953176|P1|STARTED|Overall Study||101
1616572|NCT00911300|3953185|P2|NOT COMPLETED|Overall Study||43
1616573|NCT00911300|3953186|P1|NOT COMPLETED|Overall Study||35
1616574|NCT00911300|3953185|P2|COMPLETED|Overall Study||131
1616575|NCT00911300|3953186|P1|COMPLETED|Overall Study||140
1616576|NCT00911300|3953185|P2|STARTED|Overall Study||174
1616577|NCT00911300|3953186|P1|STARTED|Overall Study||175
1616578|NCT00911274|3953212|P2|NOT COMPLETED|Period 2||0
1616579|NCT00911274|3953213|P1|NOT COMPLETED|Period 2||0
1616580|NCT00911274|3953212|P2|COMPLETED|Period 2||26
1616581|NCT00911274|3953213|P1|COMPLETED|Period 2||27
1616582|NCT00911274|3953212|P2|STARTED|Period 2||26
1616583|NCT00911274|3953213|P1|STARTED|Period 2||27
1616584|NCT00911274|3953212|P2|NOT COMPLETED|Period 1||0
1616585|NCT00911274|3953213|P1|NOT COMPLETED|Period 1||0
1616586|NCT00911274|3953212|P2|COMPLETED|Period 1||26
1616587|NCT00911274|3953213|P1|COMPLETED|Period 1||27
1616588|NCT00911274|3953212|P2|STARTED|Period 1||26
1616589|NCT00911274|3953213|P1|STARTED|Period 1||27
1616590|NCT00911170|3953223|P2|NOT COMPLETED|Long Term Follow-Up||422
1616591|NCT00911170|3953224|P1|NOT COMPLETED|Long Term Follow-Up||423
1616592|NCT00911170|3953223|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
1616593|NCT00911170|3953224|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
1616594|NCT00911170|3953223|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
1616595|NCT00911170|3953224|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
1616596|NCT00911170|3953223|P2|NOT COMPLETED|Treatment Period||37
1616597|NCT00911170|3953224|P1|NOT COMPLETED|Treatment Period||27
1616598|NCT00911170|3953223|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
1616599|NCT00911170|3953224|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
1616600|NCT00911170|3953223|P2|Received Investigational Product|Treatment Period||419
1616601|NCT00911170|3953224|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
1616602|NCT00911170|3953223|P2|Received Bevacizumab|Treatment Period||420
1616603|NCT00911170|3953224|P1|Received Bevacizumab|Treatment Period||423
1616604|NCT00911170|3953223|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
1616605|NCT00911170|3953224|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
1616606|NCT00911170|3953223|P2|STARTED|Treatment Period||423
1616607|NCT00911170|3953224|P1|STARTED|Treatment Period||424
1616608|NCT00911157|3953248|P2|NOT COMPLETED|Overall Study||2
1616609|NCT00911157|3953249|P1|NOT COMPLETED|Overall Study||7
1616610|NCT00911157|3953248|P2|COMPLETED|Overall Study||8
1616611|NCT00911157|3953249|P1|COMPLETED|Overall Study||22
1616612|NCT00911157|3953248|P2|STARTED|Overall Study||10
1616613|NCT00911157|3953249|P1|STARTED|Overall Study||29
1616614|NCT00911144|3953265|P2|NOT COMPLETED|Overall Study||5
1616615|NCT00911144|3953266|P1|NOT COMPLETED|Overall Study||16
1616616|NCT00911144|3953265|P2|COMPLETED|Overall Study||108
1616617|NCT00911144|3953266|P1|COMPLETED|Overall Study||319
1616618|NCT00911144|3953265|P2|STARTED|Overall Study||113
1616619|NCT00911144|3953266|P1|STARTED|Overall Study||335
1616620|NCT00910988|3953294|P4|NOT COMPLETED|Overall Study||0
1616621|NCT00910988|3953295|P3|NOT COMPLETED|Overall Study||3
1616622|NCT00910988|3953296|P2|NOT COMPLETED|Overall Study||4
1616623|NCT00910988|3953297|P1|NOT COMPLETED|Overall Study||2
1616624|NCT00910988|3953294|P4|COMPLETED|Overall Study||6
1616625|NCT00910988|3953295|P3|COMPLETED|Overall Study||5
1616626|NCT00910988|3953296|P2|COMPLETED|Overall Study||12
1616627|NCT00910988|3953297|P1|COMPLETED|Overall Study||14
1616628|NCT00910988|3953294|P4|STARTED|Overall Study||6
1616629|NCT00910988|3953295|P3|STARTED|Overall Study||8
1616630|NCT00910988|3953296|P2|STARTED|Overall Study||16
1616631|NCT00910988|3953297|P1|STARTED|Overall Study||16
1616632|NCT00910962|3953342|P3|NOT COMPLETED|Overall Study||76
1616633|NCT00910962|3953343|P2|NOT COMPLETED|Overall Study||78
1616634|NCT00910962|3953344|P1|NOT COMPLETED|Overall Study||43
1616635|NCT00910962|3953342|P3|COMPLETED|Overall Study||116
1616636|NCT00910962|3953343|P2|COMPLETED|Overall Study||121
1616637|NCT00910962|3953344|P1|COMPLETED|Overall Study||92
1616638|NCT00910962|3953342|P3|STARTED|Overall Study||192
1616639|NCT00910962|3953343|P2|STARTED|Overall Study||199
1616640|NCT00910962|3953344|P1|STARTED|Overall Study||135
1616641|NCT00910910|3953436|P2|NOT COMPLETED|Overall Study||224
1616642|NCT00910910|3953437|P1|NOT COMPLETED|Overall Study||225
1616643|NCT00910910|3953436|P2|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|1
1616644|NCT00910910|3953437|P1|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|0
1616645|NCT00910910|3953436|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
1616646|NCT00910910|3953437|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
1616647|NCT00910910|3953436|P2|STARTED|Overall Study||225
1616648|NCT00910910|3953437|P1|STARTED|Overall Study||225
1616649|NCT00910871|3953471|P1|NOT COMPLETED|Overall Study||54
1616650|NCT00910871|3953471|P1|COMPLETED|Overall Study||179
1616651|NCT00910871|3953471|P1|STARTED|Overall Study||233
1616652|NCT00910858|3953479|P3|NOT COMPLETED|Combined Treatment Phase||4
1616653|NCT00910858|3953480|P2|NOT COMPLETED|Combined Treatment Phase||10
1616654|NCT00910858|3953481|P1|NOT COMPLETED|Combined Treatment Phase||9
1616655|NCT00910858|3953479|P3|COMPLETED|Combined Treatment Phase||0
1616656|NCT00910858|3953480|P2|COMPLETED|Combined Treatment Phase||0
1616657|NCT00910858|3953481|P1|COMPLETED|Combined Treatment Phase||0
1616658|NCT00910858|3953479|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
1616659|NCT00910858|3953480|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
1616660|NCT00910858|3953481|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
1616661|NCT00910858|3953479|P3|NOT COMPLETED|Monotherapy Phase||7
1616662|NCT00910858|3953480|P2|NOT COMPLETED|Monotherapy Phase||15
1616663|NCT00910858|3953481|P1|NOT COMPLETED|Monotherapy Phase||17
1616664|NCT00910858|3953479|P3|COMPLETED|Monotherapy Phase||0
1616665|NCT00910858|3953480|P2|COMPLETED|Monotherapy Phase||0
1616666|NCT00910858|3953481|P1|COMPLETED|Monotherapy Phase||0
1616667|NCT00910858|3953479|P3|Pharmacokinetic Population|Monotherapy Phase||7
1616668|NCT00910858|3953480|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
1616669|NCT00910858|3953481|P1|Pharmacokinetic Population|Monotherapy Phase||17
1616670|NCT00910858|3953479|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
1616671|NCT00910858|3953480|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
1616672|NCT00910858|3953481|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
1616673|NCT00910858|3953479|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
1616674|NCT00910858|3953480|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
1616675|NCT00910858|3953481|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
1616676|NCT00910858|3953479|P3|NOT COMPLETED|Pharmacokinetic Phase||0
1616677|NCT00910858|3953480|P2|NOT COMPLETED|Pharmacokinetic Phase||0
1616678|NCT00910858|3953481|P1|NOT COMPLETED|Pharmacokinetic Phase||1
1616679|NCT00910858|3953479|P3|COMPLETED|Pharmacokinetic Phase||3
1616680|NCT00910858|3953480|P2|COMPLETED|Pharmacokinetic Phase||0
1616681|NCT00910858|3953481|P1|COMPLETED|Pharmacokinetic Phase||8
1616682|NCT00910858|3953479|P3|STARTED|Pharmacokinetic Phase||3
1616683|NCT00910858|3953480|P2|STARTED|Pharmacokinetic Phase||0
1616684|NCT00910858|3953481|P1|STARTED|Pharmacokinetic Phase||9
1616685|NCT00910845|3953506|P2|NOT COMPLETED|Treatment Cycle 2||9
1616686|NCT00910845|3953507|P1|NOT COMPLETED|Treatment Cycle 2||5
1616687|NCT00910845|3953506|P2|COMPLETED|Treatment Cycle 2||203
1616688|NCT00910845|3953507|P1|COMPLETED|Treatment Cycle 2||136
1616689|NCT00910845|3953506|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
1616690|NCT00910845|3953507|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
1616691|NCT00910845|3953506|P2|NOT COMPLETED|Treatment Cycle 1||34
1616692|NCT00910845|3953507|P1|NOT COMPLETED|Treatment Cycle 1||31
1616693|NCT00910845|3953506|P2|COMPLETED|Treatment Cycle 1||243
1616694|NCT00910845|3953507|P1|COMPLETED|Treatment Cycle 1||249
1616695|NCT00910845|3953506|P2|STARTED|Treatment Cycle 1||277
1616696|NCT00910845|3953507|P1|STARTED|Treatment Cycle 1||280
1616697|NCT00910728|3953526|P9|NOT COMPLETED|Overall Study||3
1616698|NCT00910728|3953527|P8|NOT COMPLETED|Overall Study||3
1616699|NCT00910728|3953528|P7|NOT COMPLETED|Overall Study||6
1616700|NCT00910728|3953529|P6|NOT COMPLETED|Overall Study||1
1616701|NCT00910728|3953530|P5|NOT COMPLETED|Overall Study||5
1616702|NCT00910728|3953531|P4|NOT COMPLETED|Overall Study||3
1616703|NCT00910728|3953532|P3|NOT COMPLETED|Overall Study||3
1616704|NCT00910728|3953533|P2|NOT COMPLETED|Overall Study||3
1616705|NCT00910728|3953534|P1|NOT COMPLETED|Overall Study||6
1616706|NCT00910728|3953526|P9|COMPLETED|Overall Study||0
1616707|NCT00910728|3953527|P8|COMPLETED|Overall Study||1
1616708|NCT00910728|3953528|P7|COMPLETED|Overall Study||0
1616709|NCT00910728|3953529|P6|COMPLETED|Overall Study||0
1616710|NCT00910728|3953530|P5|COMPLETED|Overall Study||1
1616711|NCT00910728|3953531|P4|COMPLETED|Overall Study||0
1616712|NCT00910728|3953532|P3|COMPLETED|Overall Study||0
1616713|NCT00910728|3953533|P2|COMPLETED|Overall Study||0
1616714|NCT00910728|3953534|P1|COMPLETED|Overall Study||0
1616715|NCT00910728|3953526|P9|STARTED|Overall Study||3
1616716|NCT00910728|3953527|P8|STARTED|Overall Study||4
1616717|NCT00910728|3953528|P7|STARTED|Overall Study||6
1616718|NCT00910728|3953529|P6|STARTED|Overall Study||1
1616719|NCT00910728|3953530|P5|STARTED|Overall Study||6
1616720|NCT00910728|3953531|P4|STARTED|Overall Study||3
1616721|NCT00910728|3953532|P3|STARTED|Overall Study||3
1616722|NCT00910728|3953533|P2|STARTED|Overall Study||3
1616723|NCT00910728|3953534|P1|STARTED|Overall Study||6
1616724|NCT00910715|3953656|P3|NOT COMPLETED|Overall Study||0
1616725|NCT00910715|3953657|P2|NOT COMPLETED|Overall Study||26
1616726|NCT00910715|3953658|P1|NOT COMPLETED|Overall Study||22
1616727|NCT00910715|3953656|P3|COMPLETED|Overall Study||81
1616728|NCT00910715|3953657|P2|COMPLETED|Overall Study||91
1616729|NCT00910715|3953658|P1|COMPLETED|Overall Study||86
1616730|NCT00910715|3953656|P3|STARTED|Overall Study||81
1616731|NCT00910715|3953657|P2|STARTED|Overall Study||117
1616732|NCT00910715|3953658|P1|STARTED|Overall Study||108
1616733|NCT00910689|3953672|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
1616734|NCT00910689|3953673|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
1616735|NCT00910689|3953674|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
1616736|NCT00910689|3953675|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
1616737|NCT00910689|3953672|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
1616738|NCT00910689|3953673|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
1616739|NCT00910689|3953674|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
1616740|NCT00910689|3953675|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
1616741|NCT00910689|3953672|P4|STARTED|Months 11- 16: Evaluation Period II||41
1616742|NCT00910689|3953673|P3|STARTED|Months 11- 16: Evaluation Period II||35
1616743|NCT00910689|3953674|P2|STARTED|Months 11- 16: Evaluation Period II||35
1616744|NCT00910689|3953675|P1|STARTED|Months 11- 16: Evaluation Period II||40
1616745|NCT00910689|3953672|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
1616746|NCT00910689|3953673|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
1616747|NCT00910689|3953674|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
1616748|NCT00910689|3953675|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
1616749|NCT00910689|3953672|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
1616750|NCT00910689|3953673|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
1616751|NCT00910689|3953674|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
1616752|NCT00910689|3953675|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
1616753|NCT00910689|3953672|P4|STARTED|Months 5 - 10: Evaluation Period I||48
1616754|NCT00910689|3953673|P3|STARTED|Months 5 - 10: Evaluation Period I||42
1616755|NCT00910689|3953674|P2|STARTED|Months 5 - 10: Evaluation Period I||42
1616756|NCT00910689|3953675|P1|STARTED|Months 5 - 10: Evaluation Period I||44
1616757|NCT00910689|3953672|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
1616758|NCT00910689|3953673|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
1616759|NCT00910689|3953674|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
1616760|NCT00910689|3953675|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
1616761|NCT00910689|3953672|P4|COMPLETED|Month 2- 4: Treatment Period||48
1616762|NCT00910689|3953673|P3|COMPLETED|Month 2- 4: Treatment Period||42
1616763|NCT00910689|3953674|P2|COMPLETED|Month 2- 4: Treatment Period||42
1616764|NCT00910689|3953675|P1|COMPLETED|Month 2- 4: Treatment Period||44
1616765|NCT00910689|3953672|P4|STARTED|Month 2- 4: Treatment Period||59
1616766|NCT00910689|3953673|P3|STARTED|Month 2- 4: Treatment Period||50
1616767|NCT00910689|3953674|P2|STARTED|Month 2- 4: Treatment Period||52
1616768|NCT00910689|3953675|P1|STARTED|Month 2- 4: Treatment Period||53
1616769|NCT00910689|3953672|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
1616770|NCT00910689|3953673|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
1616771|NCT00910689|3953674|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
1616772|NCT00910689|3953675|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
1616773|NCT00910689|3953672|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
1616774|NCT00910689|3953673|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
1616775|NCT00910689|3953674|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
1616776|NCT00910689|3953675|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
1616777|NCT00910689|3953672|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
1616778|NCT00910689|3953673|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
1616779|NCT00910689|3953674|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
1616780|NCT00910689|3953675|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
1616781|NCT00910663|3953707|P2|NOT COMPLETED|Period 2||0
1616782|NCT00910663|3953708|P1|NOT COMPLETED|Period 2||0
1616783|NCT00910663|3953707|P2|COMPLETED|Period 2||29
1616784|NCT00910663|3953708|P1|COMPLETED|Period 2||30
1616785|NCT00910663|3953707|P2|STARTED|Period 2||29
1616786|NCT00910663|3953708|P1|STARTED|Period 2||30
1616787|NCT00910663|3953707|P2|NOT COMPLETED|Period 1||1
1616788|NCT00910663|3953708|P1|NOT COMPLETED|Period 1||0
1616789|NCT00910663|3953707|P2|COMPLETED|Period 1||29
1616790|NCT00910663|3953708|P1|COMPLETED|Period 1||30
1616791|NCT00910663|3953707|P2|STARTED|Period 1||30
1616792|NCT00910663|3953708|P1|STARTED|Period 1||30
1616793|NCT00910624|3953722|P4|NOT COMPLETED|Follow-Up Phase||0
1616794|NCT00910624|3953723|P3|NOT COMPLETED|Follow-Up Phase||4
1616795|NCT00910624|3953724|P2|NOT COMPLETED|Follow-Up Phase||4
1616796|NCT00910624|3953725|P1|NOT COMPLETED|Follow-Up Phase||6
1616797|NCT00910624|3953722|P4|COMPLETED|Follow-Up Phase||2
1616798|NCT00910624|3953723|P3|COMPLETED|Follow-Up Phase||25
1616799|NCT00910624|3953724|P2|COMPLETED|Follow-Up Phase||76
1616800|NCT00910624|3953725|P1|COMPLETED|Follow-Up Phase||42
1616801|NCT00910624|3953722|P4|STARTED|Follow-Up Phase||2
1616802|NCT00910624|3953723|P3|STARTED|Follow-Up Phase||29
1616803|NCT00910624|3953724|P2|STARTED|Follow-Up Phase||80
1616804|NCT00910624|3953725|P1|STARTED|Follow-Up Phase||48
1616805|NCT00910624|3953722|P4|NOT COMPLETED|Treatment Phase||0
1616806|NCT00910624|3953723|P3|NOT COMPLETED|Treatment Phase||9
1616807|NCT00910624|3953724|P2|NOT COMPLETED|Treatment Phase||21
1616808|NCT00910624|3953725|P1|NOT COMPLETED|Treatment Phase||30
1616809|NCT00910624|3953722|P4|COMPLETED|Treatment Phase||2
1616810|NCT00910624|3953723|P3|COMPLETED|Treatment Phase||20
1616811|NCT00910624|3953724|P2|COMPLETED|Treatment Phase||64
1616812|NCT00910624|3953725|P1|COMPLETED|Treatment Phase||22
1616813|NCT00910624|3953722|P4|STARTED|Treatment Phase||2
1616814|NCT00910624|3953723|P3|STARTED|Treatment Phase||29
1616815|NCT00910624|3953724|P2|STARTED|Treatment Phase||85
1616816|NCT00910624|3953725|P1|STARTED|Treatment Phase||52
1616817|NCT00910520|3953739|P2|NOT COMPLETED|Treatment Cycle 2||8
1616818|NCT00910520|3953740|P1|NOT COMPLETED|Treatment Cycle 2||7
1616819|NCT00910520|3953739|P2|COMPLETED|Treatment Cycle 2||215
1616820|NCT00910520|3953740|P1|COMPLETED|Treatment Cycle 2||156
1616821|NCT00910520|3953739|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
1616822|NCT00910520|3953740|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
1616823|NCT00910520|3953739|P2|NOT COMPLETED|Treatment Cycle 1||24
1616824|NCT00910520|3953740|P1|NOT COMPLETED|Treatment Cycle 1||20
1616825|NCT00910520|3953739|P2|COMPLETED|Treatment Cycle 1||247
1616826|NCT00910520|3953740|P1|COMPLETED|Treatment Cycle 1||257
1616827|NCT00910520|3953739|P2|STARTED|Treatment Cycle 1||271
1616828|NCT00910520|3953740|P1|STARTED|Treatment Cycle 1||277
1616829|NCT00910299|3953752|P2|NOT COMPLETED|Overall Study||74
1616830|NCT00910299|3953753|P1|NOT COMPLETED|Overall Study||76
1616831|NCT00910299|3953752|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
1616832|NCT00910299|3953753|P1|COMPLETED|Overall Study||136
1616833|NCT00910299|3953752|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
1616834|NCT00910299|3953753|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
1616835|NCT00910299|3953752|P2|STARTED|Overall Study||211
1616836|NCT00910299|3953753|P1|STARTED|Overall Study||212
1616837|NCT00910273|3953765|P2|NOT COMPLETED|Overall Study||13
1616838|NCT00910273|3953766|P1|NOT COMPLETED|Overall Study||18
1616839|NCT00910273|3953765|P2|COMPLETED|Overall Study||3
1616840|NCT00910273|3953766|P1|COMPLETED|Overall Study||0
1616841|NCT00910273|3953765|P2|STARTED|Overall Study||16
1616842|NCT00910273|3953766|P1|STARTED|Overall Study||18
1616843|NCT00910247|3953816|P1|NOT COMPLETED|Overall Study||69
1616844|NCT00910247|3953816|P1|COMPLETED|Overall Study||205
1616845|NCT00910247|3953816|P1|STARTED|Overall Study||274
1616846|NCT00910091|3953838|P2|NOT COMPLETED|Treatment and Survival||4
1616847|NCT00910091|3953839|P1|NOT COMPLETED|Treatment and Survival||4
1616848|NCT00910091|3953838|P2|COMPLETED|Treatment and Survival||31
1616849|NCT00910091|3953839|P1|COMPLETED|Treatment and Survival||32
1616850|NCT00910091|3953838|P2|STARTED|Treatment and Survival||35
1616851|NCT00910091|3953839|P1|STARTED|Treatment and Survival||36
1616852|NCT00910091|3953838|P2|NOT COMPLETED|Pre-assignment||2
1616853|NCT00910091|3953839|P1|NOT COMPLETED|Pre-assignment||0
1616854|NCT00910091|3953838|P2|COMPLETED|Pre-assignment||35
1616855|NCT00910091|3953839|P1|COMPLETED|Pre-assignment||36
1616856|NCT00910091|3953838|P2|STARTED|Pre-assignment||37
1616857|NCT00910091|3953839|P1|STARTED|Pre-assignment||36
1616858|NCT00910039|3953867|P1|NOT COMPLETED|Overall Study||1
1616859|NCT00910039|3953867|P1|COMPLETED|Overall Study||13
1616860|NCT00910039|3953867|P1|STARTED|Overall Study||14
1616861|NCT00910000|3953884|P6|NOT COMPLETED|Overall Study||1
1616862|NCT00910000|3953885|P5|NOT COMPLETED|Overall Study||1
1616863|NCT00910000|3953886|P4|NOT COMPLETED|Overall Study||2
1616864|NCT00910000|3953887|P3|NOT COMPLETED|Overall Study||3
1616865|NCT00910000|3953888|P2|NOT COMPLETED|Overall Study||3
1616866|NCT00910000|3953889|P1|NOT COMPLETED|Overall Study||0
1616867|NCT00910000|3953884|P6|COMPLETED|Overall Study||0
1616868|NCT00910000|3953885|P5|COMPLETED|Overall Study||2
1616869|NCT00910000|3953886|P4|COMPLETED|Overall Study||0
1616870|NCT00910000|3953887|P3|COMPLETED|Overall Study||0
1616871|NCT00910000|3953888|P2|COMPLETED|Overall Study||0
1616872|NCT00910000|3953889|P1|COMPLETED|Overall Study||3
1616873|NCT00910000|3953884|P6|STARTED|Overall Study||1
1616874|NCT00910000|3953885|P5|STARTED|Overall Study||3
1616875|NCT00910000|3953886|P4|STARTED|Overall Study||2
1616876|NCT00910000|3953887|P3|STARTED|Overall Study||3
1616877|NCT00910000|3953888|P2|STARTED|Overall Study||3
1616878|NCT00910000|3953889|P1|STARTED|Overall Study||3
1616879|NCT00909870|3953907|P2|NOT COMPLETED|Overall Study||27
1616880|NCT00909870|3953908|P1|NOT COMPLETED|Overall Study||23
1616881|NCT00909870|3953907|P2|COMPLETED|Overall Study||236
1616882|NCT00909870|3953908|P1|COMPLETED|Overall Study||251
1616883|NCT00909870|3953907|P2|STARTED|Overall Study||263
1616884|NCT00909870|3953908|P1|STARTED|Overall Study||274
1616885|NCT00909857|3953920|P2|NOT COMPLETED|Overall Study||45
1616886|NCT00909857|3953921|P1|NOT COMPLETED|Overall Study||36
1616887|NCT00909857|3953920|P2|COMPLETED|Overall Study||209
1616888|NCT00909857|3953921|P1|COMPLETED|Overall Study||217
1616889|NCT00909857|3953920|P2|Treated|Overall Study||230
1616890|NCT00909857|3953921|P1|Treated|Overall Study||234
1616891|NCT00909857|3953920|P2|STARTED|Overall Study||254
1616892|NCT00909857|3953921|P1|STARTED|Overall Study||253
1616893|NCT00909844|3954061|P1|NOT COMPLETED|Overall Study||4
1616894|NCT00909844|3954061|P1|COMPLETED|Overall Study||31
1616895|NCT00909844|3954061|P1|STARTED|Overall Study||35
1616896|NCT00909792|3954079|P2|NOT COMPLETED|Period 2||1
1616897|NCT00909792|3954080|P1|NOT COMPLETED|Period 2||1
1616898|NCT00909792|3954079|P2|COMPLETED|Period 2||124
1616899|NCT00909792|3954080|P1|COMPLETED|Period 2||128
1616900|NCT00909792|3954079|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
1616901|NCT00909792|3954080|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
1616902|NCT00909792|3954079|P2|NOT COMPLETED|Period 1||1
1616903|NCT00909792|3954080|P1|NOT COMPLETED|Period 1||0
1616904|NCT00909792|3954079|P2|COMPLETED|Period 1||127
1616905|NCT00909792|3954080|P1|COMPLETED|Period 1||130
1616906|NCT00909792|3954079|P2|STARTED|Period 1||128
1616907|NCT00909792|3954080|P1|STARTED|Period 1||130
1616908|NCT00909779|3954088|P2|NOT COMPLETED|Overall Study||165
1616909|NCT00909779|3954089|P1|NOT COMPLETED|Overall Study||210
1616910|NCT00909779|3954088|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
1616911|NCT00909779|3954089|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
1616912|NCT00909779|3954088|P2|STARTED|Overall Study||420
1616913|NCT00909779|3954089|P1|STARTED|Overall Study||421
1616914|NCT00909753|3954113|P2|NOT COMPLETED|Period: Second Intervention||0
1616915|NCT00909753|3954114|P1|NOT COMPLETED|Period: Second Intervention||1
1616916|NCT00909753|3954113|P2|COMPLETED|Period: Second Intervention||43
1616917|NCT00909753|3954114|P1|COMPLETED|Period: Second Intervention||43
1616918|NCT00909753|3954113|P2|STARTED|Period: Second Intervention||43
1616919|NCT00909753|3954114|P1|STARTED|Period: Second Intervention||44
1616920|NCT00909753|3954113|P2|NOT COMPLETED|Period: Washout of 28 Days||3
1616921|NCT00909753|3954114|P1|NOT COMPLETED|Period: Washout of 28 Days||2
1616922|NCT00909753|3954113|P2|COMPLETED|Period: Washout of 28 Days||43
1616923|NCT00909753|3954114|P1|COMPLETED|Period: Washout of 28 Days||44
1616924|NCT00909753|3954113|P2|STARTED|Period: Washout of 28 Days||46
1616925|NCT00909753|3954114|P1|STARTED|Period: Washout of 28 Days||46
1616926|NCT00909753|3954113|P2|NOT COMPLETED|Period: First Intervention||0
1616927|NCT00909753|3954114|P1|NOT COMPLETED|Period: First Intervention||0
1616928|NCT00909753|3954113|P2|COMPLETED|Period: First Intervention||46
1616929|NCT00909753|3954114|P1|COMPLETED|Period: First Intervention||46
1616930|NCT00909753|3954113|P2|STARTED|Period: First Intervention||46
1616931|NCT00909753|3954114|P1|STARTED|Period: First Intervention||46
1616932|NCT00909727|3954134|P2|NOT COMPLETED|Overall Study||0
1616933|NCT00909727|3954135|P1|NOT COMPLETED|Overall Study||4
1616934|NCT00909727|3954134|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
1616935|NCT00909727|3954135|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
1616936|NCT00909727|3954134|P2|Completed Treatment Period, Week 24|Overall Study||26
1616937|NCT00909727|3954135|P1|Completed Treatment Period, Week 24|Overall Study||23
1616938|NCT00909727|3954134|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
1616939|NCT00909727|3954135|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
1616940|NCT00909649|3954151|P2|NOT COMPLETED|Overall Study||0
1616941|NCT00909649|3954152|P1|NOT COMPLETED|Overall Study||0
1616942|NCT00909649|3954151|P2|COMPLETED|Overall Study||25
1616943|NCT00909649|3954152|P1|COMPLETED|Overall Study||25
1616944|NCT00909649|3954151|P2|STARTED|Overall Study||25
1616945|NCT00909649|3954152|P1|STARTED|Overall Study||25
1616946|NCT00909610|3954158|P2|NOT COMPLETED|Period: Second Intervention||0
1616947|NCT00909610|3954159|P1|NOT COMPLETED|Period: Second Intervention||1
1616948|NCT00909610|3954158|P2|COMPLETED|Period: Second Intervention||33
1616949|NCT00909610|3954159|P1|COMPLETED|Period: Second Intervention||36
1616950|NCT00909610|3954158|P2|STARTED|Period: Second Intervention||33
1616951|NCT00909610|3954159|P1|STARTED|Period: Second Intervention||37
1616952|NCT00909610|3954158|P2|NOT COMPLETED|Period: Washout of 28 Days||6
1616953|NCT00909610|3954159|P1|NOT COMPLETED|Period: Washout of 28 Days||3
1616954|NCT00909610|3954158|P2|COMPLETED|Period: Washout of 28 Days||33
1616955|NCT00909610|3954159|P1|COMPLETED|Period: Washout of 28 Days||37
1616956|NCT00909610|3954158|P2|STARTED|Period: Washout of 28 Days||39
1616957|NCT00909610|3954159|P1|STARTED|Period: Washout of 28 Days||40
1616958|NCT00909610|3954158|P2|NOT COMPLETED|Period: First Intervention||1
1616959|NCT00909610|3954159|P1|NOT COMPLETED|Period: First Intervention||0
1616960|NCT00909610|3954158|P2|COMPLETED|Period: First Intervention||39
1616961|NCT00909610|3954159|P1|COMPLETED|Period: First Intervention||40
1616962|NCT00909610|3954158|P2|STARTED|Period: First Intervention||40
1616963|NCT00909610|3954159|P1|STARTED|Period: First Intervention||40
1616964|NCT00909545|3954181|P4|NOT COMPLETED|Overall Study||5
1616965|NCT00909545|3954182|P3|NOT COMPLETED|Overall Study||1
1616966|NCT00909545|3954183|P2|NOT COMPLETED|Overall Study||1
1616967|NCT00909545|3954184|P1|NOT COMPLETED|Overall Study||1
1616968|NCT00909545|3954181|P4|COMPLETED|Overall Study||19
1616969|NCT00909545|3954182|P3|COMPLETED|Overall Study||25
1616970|NCT00909545|3954183|P2|COMPLETED|Overall Study||22
1616971|NCT00909545|3954184|P1|COMPLETED|Overall Study||25
1616972|NCT00909545|3954181|P4|STARTED|Overall Study||24
1616973|NCT00909545|3954182|P3|STARTED|Overall Study||26
1616974|NCT00909545|3954183|P2|STARTED|Overall Study||23
1616975|NCT00909545|3954184|P1|STARTED|Overall Study||26
1616976|NCT00909532|3954320|P2|NOT COMPLETED|Overall Study||6
1616977|NCT00909532|3954321|P1|NOT COMPLETED|Overall Study||10
1616978|NCT00909532|3954320|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
1616979|NCT00909532|3954321|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
1616980|NCT00909532|3954320|P2|Completed Treatment Period, Week 24|Overall Study||80
1616981|NCT00909532|3954321|P1|Completed Treatment Period, Week 24|Overall Study||71
1616982|NCT00909532|3954320|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
1616983|NCT00909532|3954321|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
1616984|NCT00909480|3954339|P2|NOT COMPLETED|Overall Study||41
1616985|NCT00909480|3954340|P1|NOT COMPLETED|Overall Study||38
1616986|NCT00909480|3954339|P2|COMPLETED|Overall Study||188
1616987|NCT00909480|3954340|P1|COMPLETED|Overall Study||190
1616988|NCT00909480|3954339|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
1616989|NCT00909480|3954340|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
1616990|NCT00909480|3954339|P2|STARTED|Overall Study||229
1616991|NCT00909480|3954340|P1|STARTED|Overall Study||228
1616992|NCT00909428|3954375|P3|NOT COMPLETED|Overall Study||9
1616993|NCT00909428|3954376|P2|NOT COMPLETED|Overall Study||10
1616994|NCT00909428|3954377|P1|NOT COMPLETED|Overall Study||13
1616995|NCT00909428|3954375|P3|COMPLETED|Overall Study||0
1616996|NCT00909428|3954376|P2|COMPLETED|Overall Study||5
1616997|NCT00909428|3954377|P1|COMPLETED|Overall Study||5
1616998|NCT00909428|3954375|P3|STARTED|Overall Study||9
1616999|NCT00909428|3954376|P2|STARTED|Overall Study||15
1617000|NCT00909428|3954377|P1|STARTED|Overall Study||18
1617001|NCT00909389|3954384|P1|NOT COMPLETED|Overall Study||133
1617002|NCT00909389|3954384|P1|COMPLETED|Overall Study||4615
1617003|NCT00909389|3954384|P1|STARTED|Overall Study||4748
1617004|NCT00909324|3954390|P2|NOT COMPLETED|Overall Study||0
1617005|NCT00909324|3954391|P1|NOT COMPLETED|Overall Study||0
1617006|NCT00909324|3954390|P2|COMPLETED|Overall Study||90
1617007|NCT00909324|3954391|P1|COMPLETED|Overall Study||72
1617008|NCT00909324|3954390|P2|STARTED|Overall Study||90
1617009|NCT00909324|3954391|P1|STARTED|Overall Study||72
1617010|NCT00909220|3954403|P2|NOT COMPLETED|Overall Study||0
1617011|NCT00909220|3954404|P1|NOT COMPLETED|Overall Study||0
1617012|NCT00909220|3954403|P2|COMPLETED|Overall Study||36
1617013|NCT00909220|3954404|P1|COMPLETED|Overall Study||41
1617014|NCT00909220|3954403|P2|Submission for Publication|Overall Study||36
1617015|NCT00909220|3954404|P1|Submission for Publication|Overall Study||41
1617016|NCT00909220|3954403|P2|Data Analyses|Overall Study||36
1617017|NCT00909220|3954404|P1|Data Analyses|Overall Study||41
1617018|NCT00909220|3954403|P2|Data Entry|Overall Study||36
1617019|NCT00909220|3954404|P1|Data Entry|Overall Study||41
1617020|NCT00909220|3954403|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
1617021|NCT00909220|3954404|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
1617022|NCT00909181|3954418|P3|NOT COMPLETED|Overall Study||33
1617023|NCT00909181|3954419|P2|NOT COMPLETED|Overall Study||18
1617024|NCT00909181|3954420|P1|NOT COMPLETED|Overall Study||39
1617025|NCT00909181|3954418|P3|COMPLETED|Overall Study||169
1617026|NCT00909181|3954419|P2|COMPLETED|Overall Study||196
1617027|NCT00909181|3954420|P1|COMPLETED|Overall Study||171
1617028|NCT00909181|3954418|P3|STARTED|Overall Study||202
1617029|NCT00909181|3954419|P2|STARTED|Overall Study||214
1617030|NCT00909181|3954420|P1|STARTED|Overall Study||210
1617031|NCT00909155|3954431|P3|NOT COMPLETED|Overall Study||7
1617032|NCT00909155|3954432|P2|NOT COMPLETED|Overall Study||5
1617033|NCT00909155|3954433|P1|NOT COMPLETED|Overall Study||3
1617034|NCT00909155|3954431|P3|COMPLETED|Overall Study||14
1617035|NCT00909155|3954432|P2|COMPLETED|Overall Study||9
1617036|NCT00909155|3954433|P1|COMPLETED|Overall Study||12
1617037|NCT00909155|3954431|P3|STARTED|Overall Study||21
1617038|NCT00909155|3954432|P2|STARTED|Overall Study||14
1617039|NCT00909155|3954433|P1|STARTED|Overall Study||15
1617040|NCT00909064|3954444|P1|NOT COMPLETED|Overall Study||0
1617041|NCT00909064|3954444|P1|COMPLETED|Overall Study||114
1617042|NCT00909064|3954444|P1|STARTED|Overall Study||114
1617043|NCT00909038|3954450|P1|NOT COMPLETED|Overall Study||417
1617044|NCT00909038|3954450|P1|COMPLETED|Overall Study||1994
1617045|NCT00909038|3954450|P1|STARTED|Overall Study||2411
1617046|NCT00908960|3954462|P3|NOT COMPLETED|Overall Study||2
1617047|NCT00908960|3954463|P2|NOT COMPLETED|Overall Study||1
1617048|NCT00908960|3954464|P1|NOT COMPLETED|Overall Study||1
1617049|NCT00908960|3954462|P3|COMPLETED|Overall Study||32
1617050|NCT00908960|3954463|P2|COMPLETED|Overall Study||11
1617051|NCT00908960|3954464|P1|COMPLETED|Overall Study||23
1617052|NCT00908960|3954462|P3|Evaluable|Overall Study||32
1617053|NCT00908960|3954463|P2|Evaluable|Overall Study||11
1617054|NCT00908960|3954464|P1|Evaluable|Overall Study||23
1617055|NCT00908960|3954462|P3|STARTED|Overall Study||34
1617056|NCT00908960|3954463|P2|STARTED|Overall Study||12
1617057|NCT00908960|3954464|P1|STARTED|Overall Study||24
1617058|NCT00908908|3954478|P1|NOT COMPLETED|Overall Study||0
1617059|NCT00908908|3954478|P1|COMPLETED|Overall Study||6
1617060|NCT00908908|3954478|P1|Physician Decision|Overall Study||0
1617061|NCT00908908|3954478|P1|Administrative/Other|Overall Study||0
1617062|NCT00908908|3954478|P1|Withdrawl by Subject|Overall Study||0
1617063|NCT00908908|3954478|P1|Adverse Event|Overall Study||0
1617064|NCT00908908|3954478|P1|STARTED|Overall Study||6
1617065|NCT00908895|3954486|P2|NOT COMPLETED|Overall Study||6
1617066|NCT00908895|3954487|P1|NOT COMPLETED|Overall Study||4
1617067|NCT00908895|3954486|P2|COMPLETED|Overall Study||57
1617068|NCT00908895|3954487|P1|COMPLETED|Overall Study||53
1617069|NCT00908895|3954486|P2|STARTED|Overall Study||63
1617070|NCT00908895|3954487|P1|STARTED|Overall Study||57
1617071|NCT00908882|3954497|P2|NOT COMPLETED|Overall Study||30
1617072|NCT00908882|3954498|P1|NOT COMPLETED|Overall Study||28
1617073|NCT00908882|3954497|P2|COMPLETED|Overall Study||59
1617074|NCT00908882|3954498|P1|COMPLETED|Overall Study||61
1617075|NCT00908882|3954497|P2|STARTED|Overall Study||89
1617076|NCT00908882|3954498|P1|STARTED|Overall Study||89
1617077|NCT00908830|3954524|P2|NOT COMPLETED|Overall Study||0
1617078|NCT00908830|3954525|P1|NOT COMPLETED|Overall Study||0
1617079|NCT00908830|3954524|P2|COMPLETED|Overall Study||5
1617080|NCT00908830|3954525|P1|COMPLETED|Overall Study||5
1617081|NCT00908830|3954524|P2|STARTED|Overall Study||5
1617082|NCT00908830|3954525|P1|STARTED|Overall Study||5
1617083|NCT00908687|3954539|P6|NOT COMPLETED|Overall Study||6
1617084|NCT00908687|3954540|P5|NOT COMPLETED|Overall Study||4
1617085|NCT00908687|3954541|P4|NOT COMPLETED|Overall Study||3
1617086|NCT00908687|3954542|P3|NOT COMPLETED|Overall Study||3
1617087|NCT00908687|3954543|P2|NOT COMPLETED|Overall Study||1
1617088|NCT00908687|3954544|P1|NOT COMPLETED|Overall Study||1
1617089|NCT00908687|3954539|P6|COMPLETED|Overall Study||94
1617090|NCT00908687|3954540|P5|COMPLETED|Overall Study||94
1617091|NCT00908687|3954541|P4|COMPLETED|Overall Study||47
1617092|NCT00908687|3954542|P3|COMPLETED|Overall Study||99
1617093|NCT00908687|3954543|P2|COMPLETED|Overall Study||99
1617094|NCT00908687|3954544|P1|COMPLETED|Overall Study||49
1617095|NCT00908687|3954539|P6|STARTED|Overall Study||100
1617096|NCT00908687|3954540|P5|STARTED|Overall Study||98
1617097|NCT00908687|3954541|P4|STARTED|Overall Study||50
1617098|NCT00908687|3954542|P3|STARTED|Overall Study||102
1617099|NCT00908687|3954543|P2|STARTED|Overall Study||100
1617100|NCT00908687|3954544|P1|STARTED|Overall Study||50
1617101|NCT00908648|3954560|P2|NOT COMPLETED|Overall Study||0
1617102|NCT00908648|3954561|P1|NOT COMPLETED|Overall Study||0
1617103|NCT00908648|3954560|P2|COMPLETED|Overall Study||103
1617104|NCT00908648|3954561|P1|COMPLETED|Overall Study||108
1617105|NCT00908648|3954560|P2|STARTED|Overall Study||103
1617106|NCT00908648|3954561|P1|STARTED|Overall Study||108
1617107|NCT00908596|3954571|P4|NOT COMPLETED|Overall Study||37
1617108|NCT00908596|3954572|P3|NOT COMPLETED|Overall Study||74
1617109|NCT00908596|3954573|P2|NOT COMPLETED|Overall Study||13
1617110|NCT00908596|3954574|P1|NOT COMPLETED|Overall Study||47
1617111|NCT00908596|3954571|P4|COMPLETED|Overall Study||48
1617112|NCT00908596|3954572|P3|COMPLETED|Overall Study||119
1617113|NCT00908596|3954573|P2|COMPLETED|Overall Study||19
1617114|NCT00908596|3954574|P1|COMPLETED|Overall Study||0
1617115|NCT00908596|3954571|P4|STARTED|Overall Study||85
1617116|NCT00908596|3954572|P3|STARTED|Overall Study||193
1617117|NCT00908596|3954573|P2|STARTED|Overall Study||32
1617118|NCT00908596|3954574|P1|STARTED|Overall Study||47
1617119|NCT00908583|3954604|P1|NOT COMPLETED|Phase 5||3
1617120|NCT00908583|3954604|P1|COMPLETED|Phase 5||2
1617121|NCT00908583|3954604|P1|STARTED|Phase 5||5
1617122|NCT00908583|3954604|P1|NOT COMPLETED|Phase 4||2
1617123|NCT00908583|3954604|P1|COMPLETED|Phase 4||3
1617124|NCT00908583|3954604|P1|STARTED|Phase 4||5
1617125|NCT00908583|3954604|P1|NOT COMPLETED|Phase 3||2
1617126|NCT00908583|3954604|P1|COMPLETED|Phase 3||8
1617127|NCT00908583|3954604|P1|STARTED|Phase 3||10
1617128|NCT00908583|3954604|P1|NOT COMPLETED|Phase 2||2
1617129|NCT00908583|3954604|P1|COMPLETED|Phase 2||10
1617130|NCT00908583|3954604|P1|STARTED|Phase 2||12
1617131|NCT00908583|3954604|P1|NOT COMPLETED|Phase 1||5
1617132|NCT00908583|3954604|P1|COMPLETED|Phase 1||15
1617133|NCT00908583|3954604|P1|STARTED|Phase 1||20
1617134|NCT00908466|3954624|P2|NOT COMPLETED|Overall Study||1
1617135|NCT00908466|3954625|P1|NOT COMPLETED|Overall Study||1
1617136|NCT00908466|3954624|P2|COMPLETED|Overall Study||14
1617137|NCT00908466|3954625|P1|COMPLETED|Overall Study||14
1617138|NCT00908466|3954624|P2|STARTED|Overall Study||15
1617139|NCT00908466|3954625|P1|STARTED|Overall Study||15
1617140|NCT00908388|3954631|P1|NOT COMPLETED|Overall Study||10
1617141|NCT00908388|3954631|P1|COMPLETED|Overall Study||40
1617142|NCT00908388|3954631|P1|STARTED|Overall Study||50
1617143|NCT00908375|3954641|P2|NOT COMPLETED|Overall Study||10
1617144|NCT00908375|3954642|P1|NOT COMPLETED|Overall Study||10
1617145|NCT00908375|3954641|P2|COMPLETED|Overall Study||9
1617146|NCT00908375|3954642|P1|COMPLETED|Overall Study||10
1617147|NCT00908375|3954641|P2|STARTED|Overall Study||19
1617148|NCT00908375|3954642|P1|STARTED|Overall Study||20
1617149|NCT00908349|3954652|P1|NOT COMPLETED|Overall Study||35
1617150|NCT00908349|3954652|P1|COMPLETED|Overall Study||179
1617151|NCT00908349|3954652|P1|STARTED|Overall Study||214
1617152|NCT00908310|3954656|P1|NOT COMPLETED|Overall Study||60
1617153|NCT00908310|3954656|P1|COMPLETED|Overall Study||153
1617154|NCT00908310|3954656|P1|STARTED|Overall Study||213
1617155|NCT00908232|3954660|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
1617156|NCT00908232|3954661|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
1617157|NCT00908232|3954662|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
1617158|NCT00908232|3954663|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
1617159|NCT00908232|3954660|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
1617160|NCT00908232|3954661|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
1617161|NCT00908232|3954662|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
1617162|NCT00908232|3954663|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
1617163|NCT00908232|3954660|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
1617164|NCT00908232|3954661|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
1617165|NCT00908232|3954662|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
1617166|NCT00908232|3954663|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
1617167|NCT00908232|3954660|P4|NOT COMPLETED|Cycle 1 to 4||0
1617168|NCT00908232|3954661|P3|NOT COMPLETED|Cycle 1 to 4||0
1617169|NCT00908232|3954662|P2|NOT COMPLETED|Cycle 1 to 4||0
1617170|NCT00908232|3954663|P1|NOT COMPLETED|Cycle 1 to 4||28
1617171|NCT00908232|3954660|P4|COMPLETED|Cycle 1 to 4||0
1617172|NCT00908232|3954661|P3|COMPLETED|Cycle 1 to 4||0
1617173|NCT00908232|3954662|P2|COMPLETED|Cycle 1 to 4||0
1617174|NCT00908232|3954663|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
1617175|NCT00908232|3954660|P4|STARTED|Cycle 1 to 4||0
1617176|NCT00908232|3954661|P3|STARTED|Cycle 1 to 4||0
1617177|NCT00908232|3954662|P2|STARTED|Cycle 1 to 4||0
1617338|NCT00907907|3954890|P2|NOT COMPLETED|Period 3||0
1617178|NCT00908232|3954663|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
1617179|NCT00908141|3954681|P2|NOT COMPLETED|Overall Study||1
1617180|NCT00908141|3954682|P1|NOT COMPLETED|Overall Study||0
1617181|NCT00908141|3954681|P2|COMPLETED|Overall Study||8
1617182|NCT00908141|3954682|P1|COMPLETED|Overall Study||8
1617183|NCT00908141|3954681|P2|STARTED|Overall Study||9
1617184|NCT00908141|3954682|P1|STARTED|Overall Study||8
1617185|NCT00908128|3954690|P2|NOT COMPLETED|Period 4||0
1617186|NCT00908128|3954691|P1|NOT COMPLETED|Period 4||0
1617187|NCT00908128|3954690|P2|COMPLETED|Period 4||19
1617188|NCT00908128|3954691|P1|COMPLETED|Period 4||20
1617189|NCT00908128|3954690|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
1617190|NCT00908128|3954691|P1|STARTED|Period 4||20
1617191|NCT00908128|3954690|P2|NOT COMPLETED|Period 3||0
1617192|NCT00908128|3954691|P1|NOT COMPLETED|Period 3||0
1617193|NCT00908128|3954690|P2|COMPLETED|Period 3||20
1617194|NCT00908128|3954691|P1|COMPLETED|Period 3||20
1617195|NCT00908128|3954690|P2|STARTED|Period 3||20
1617196|NCT00908128|3954691|P1|STARTED|Period 3||20
1617197|NCT00908128|3954690|P2|NOT COMPLETED|Period 2||0
1617198|NCT00908128|3954691|P1|NOT COMPLETED|Period 2||0
1617199|NCT00908128|3954690|P2|COMPLETED|Period 2||20
1617200|NCT00908128|3954691|P1|COMPLETED|Period 2||20
1617201|NCT00908128|3954690|P2|STARTED|Period 2||20
1617202|NCT00908128|3954691|P1|STARTED|Period 2||20
1617203|NCT00908128|3954690|P2|NOT COMPLETED|Period 1||0
1617204|NCT00908128|3954691|P1|NOT COMPLETED|Period 1||0
1617205|NCT00908128|3954690|P2|COMPLETED|Period 1||20
1617206|NCT00908128|3954691|P1|COMPLETED|Period 1||20
1617207|NCT00908128|3954690|P2|STARTED|Period 1||20
1617208|NCT00908128|3954691|P1|STARTED|Period 1||20
1617209|NCT00908115|3954699|P1|NOT COMPLETED|Overall Study||14
1617210|NCT00908115|3954699|P1|COMPLETED|Overall Study||1244
1617211|NCT00908115|3954699|P1|STARTED|Overall Study||1258
1617212|NCT00908076|3954707|P2|NOT COMPLETED|Overall Study||1
1617213|NCT00908076|3954708|P1|NOT COMPLETED|Overall Study||1
1617214|NCT00908076|3954707|P2|COMPLETED|Overall Study||26
1617215|NCT00908076|3954708|P1|COMPLETED|Overall Study||26
1617216|NCT00908076|3954707|P2|STARTED|Overall Study||27
1617217|NCT00908076|3954708|P1|STARTED|Overall Study||27
1617218|NCT00908037|3954721|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
1617219|NCT00908037|3954722|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
1617220|NCT00908037|3954723|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
1617221|NCT00908037|3954724|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617222|NCT00908037|3954725|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617223|NCT00908037|3954726|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617224|NCT00908037|3954727|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617225|NCT00908037|3954728|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617226|NCT00908037|3954729|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617227|NCT00908037|3954730|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617228|NCT00908037|3954731|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617229|NCT00908037|3954732|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617230|NCT00908037|3954721|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
1617231|NCT00908037|3954722|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
1617232|NCT00908037|3954723|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
1617233|NCT00908037|3954724|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617234|NCT00908037|3954725|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617235|NCT00908037|3954726|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617236|NCT00908037|3954727|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617237|NCT00908037|3954728|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617238|NCT00908037|3954729|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617239|NCT00908037|3954730|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617240|NCT00908037|3954731|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617241|NCT00908037|3954732|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1617242|NCT00908037|3954721|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
1617243|NCT00908037|3954722|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
1617244|NCT00908037|3954723|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
1617245|NCT00908037|3954724|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1617246|NCT00908037|3954725|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1617247|NCT00908037|3954726|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1617248|NCT00908037|3954727|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1617249|NCT00908037|3954728|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1617250|NCT00908037|3954729|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1617251|NCT00908037|3954730|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1617252|NCT00908037|3954731|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1617253|NCT00908037|3954732|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1617254|NCT00908037|3954721|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1617255|NCT00908037|3954722|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1617256|NCT00908037|3954723|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1617257|NCT00908037|3954724|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
1617258|NCT00908037|3954725|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1617259|NCT00908037|3954726|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
1617260|NCT00908037|3954727|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1617261|NCT00908037|3954728|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
1617262|NCT00908037|3954729|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
1617263|NCT00908037|3954730|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1617264|NCT00908037|3954731|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1617265|NCT00908037|3954732|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1617266|NCT00908037|3954721|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
1617267|NCT00908037|3954722|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
1617268|NCT00908037|3954723|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
1617269|NCT00908037|3954724|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
1617270|NCT00908037|3954725|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
1617271|NCT00908037|3954726|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
1617272|NCT00908037|3954727|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
1617273|NCT00908037|3954728|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
1617274|NCT00908037|3954729|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
1617275|NCT00908037|3954730|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
1617276|NCT00908037|3954731|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
1617277|NCT00908037|3954732|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
1617278|NCT00908037|3954721|P12|STARTED|Part 2 (7 Week Randomized Period)||0
1617279|NCT00908037|3954722|P11|STARTED|Part 2 (7 Week Randomized Period)||0
1617280|NCT00908037|3954723|P10|STARTED|Part 2 (7 Week Randomized Period)||0
1617281|NCT00908037|3954724|P9|STARTED|Part 2 (7 Week Randomized Period)||10
1617282|NCT00908037|3954725|P8|STARTED|Part 2 (7 Week Randomized Period)||5
1617283|NCT00908037|3954726|P7|STARTED|Part 2 (7 Week Randomized Period)||19
1617284|NCT00908037|3954727|P6|STARTED|Part 2 (7 Week Randomized Period)||9
1617285|NCT00908037|3954728|P5|STARTED|Part 2 (7 Week Randomized Period)||16
1617286|NCT00908037|3954729|P4|STARTED|Part 2 (7 Week Randomized Period)||8
1617287|NCT00908037|3954730|P3|STARTED|Part 2 (7 Week Randomized Period)||0
1617288|NCT00908037|3954731|P2|STARTED|Part 2 (7 Week Randomized Period)||0
1617289|NCT00908037|3954732|P1|STARTED|Part 2 (7 Week Randomized Period)||0
1617290|NCT00908037|3954721|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617291|NCT00908037|3954722|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617292|NCT00908037|3954723|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617293|NCT00908037|3954724|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617294|NCT00908037|3954725|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617295|NCT00908037|3954726|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617296|NCT00908037|3954727|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617297|NCT00908037|3954728|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617298|NCT00908037|3954729|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617299|NCT00908037|3954730|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617300|NCT00908037|3954731|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617301|NCT00908037|3954732|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617302|NCT00908037|3954721|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617303|NCT00908037|3954722|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617304|NCT00908037|3954723|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617305|NCT00908037|3954724|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617306|NCT00908037|3954725|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617307|NCT00908037|3954726|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617308|NCT00908037|3954727|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617309|NCT00908037|3954728|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617310|NCT00908037|3954729|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1617311|NCT00908037|3954730|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
1617312|NCT00908037|3954731|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
1617313|NCT00908037|3954732|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
1617314|NCT00908037|3954721|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
1617315|NCT00908037|3954722|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
1617316|NCT00908037|3954723|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
1617317|NCT00908037|3954724|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
1617318|NCT00908037|3954725|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
1617319|NCT00908037|3954726|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
1617320|NCT00908037|3954727|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
1617321|NCT00908037|3954728|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
1617322|NCT00908037|3954729|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
1617323|NCT00908037|3954730|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
1617324|NCT00908037|3954731|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
1617325|NCT00908037|3954732|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
1617326|NCT00908011|3954881|P2|NOT COMPLETED|Overall Study||2
1617327|NCT00908011|3954882|P1|NOT COMPLETED|Overall Study||2
1617328|NCT00908011|3954881|P2|COMPLETED|Overall Study||18
1617329|NCT00908011|3954882|P1|COMPLETED|Overall Study||21
1617330|NCT00908011|3954881|P2|STARTED|Overall Study||20
1617331|NCT00908011|3954882|P1|STARTED|Overall Study||23
1617332|NCT00907907|3954890|P2|NOT COMPLETED|Period 4||0
1617333|NCT00907907|3954891|P1|NOT COMPLETED|Period 4||0
1617334|NCT00907907|3954890|P2|COMPLETED|Period 4||18
1617335|NCT00907907|3954891|P1|COMPLETED|Period 4||19
1617336|NCT00907907|3954890|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
1617337|NCT00907907|3954891|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
1617339|NCT00907907|3954891|P1|NOT COMPLETED|Period 3||0
1617340|NCT00907907|3954890|P2|COMPLETED|Period 3||20
1617341|NCT00907907|3954891|P1|COMPLETED|Period 3||20
1617342|NCT00907907|3954890|P2|STARTED|Period 3||20
1617343|NCT00907907|3954891|P1|STARTED|Period 3||20
1617344|NCT00907907|3954890|P2|NOT COMPLETED|Period 2||0
1617345|NCT00907907|3954891|P1|NOT COMPLETED|Period 2||0
1617346|NCT00907907|3954890|P2|COMPLETED|Period 2||20
1617347|NCT00907907|3954891|P1|COMPLETED|Period 2||20
1617348|NCT00907907|3954890|P2|STARTED|Period 2||20
1617349|NCT00907907|3954891|P1|STARTED|Period 2||20
1617350|NCT00907907|3954890|P2|NOT COMPLETED|Period 1||0
1617351|NCT00907907|3954891|P1|NOT COMPLETED|Period 1||0
1617352|NCT00907907|3954890|P2|COMPLETED|Period 1||20
1617353|NCT00907907|3954891|P1|COMPLETED|Period 1||20
1617354|NCT00907907|3954890|P2|STARTED|Period 1||20
1617355|NCT00907907|3954891|P1|STARTED|Period 1||20
1617356|NCT00907881|3954899|P1|NOT COMPLETED|Overall Study||85
1617357|NCT00907881|3954899|P1|COMPLETED|Overall Study||984
1617358|NCT00907881|3954899|P1|STARTED|Overall Study||1069
1617359|NCT00907803|3954909|P3|NOT COMPLETED|Overall Study||0
1617360|NCT00907803|3954910|P2|NOT COMPLETED|Overall Study||3
1617361|NCT00907803|3954911|P1|NOT COMPLETED|Overall Study||3
1617362|NCT00907803|3954909|P3|COMPLETED|Overall Study||16
1617363|NCT00907803|3954910|P2|COMPLETED|Overall Study||43
1617364|NCT00907803|3954911|P1|COMPLETED|Overall Study||42
1617365|NCT00907803|3954909|P3|STARTED|Overall Study||16
1617366|NCT00907803|3954910|P2|STARTED|Overall Study||46
1617367|NCT00907803|3954911|P1|STARTED|Overall Study||45
1617368|NCT00907777|3954942|P2|NOT COMPLETED|Overall Study||1
1617369|NCT00907777|3954943|P1|NOT COMPLETED|Overall Study||0
1617370|NCT00907777|3954942|P2|COMPLETED|Overall Study||26
1617371|NCT00907777|3954943|P1|COMPLETED|Overall Study||25
1617372|NCT00907777|3954942|P2|STARTED|Overall Study||27
1617373|NCT00907777|3954943|P1|STARTED|Overall Study||25
1617374|NCT00907738|3954970|P5|NOT COMPLETED|Overall Study||2
1617375|NCT00907738|3954971|P4|NOT COMPLETED|Overall Study||4
1617376|NCT00907738|3954972|P3|NOT COMPLETED|Overall Study||7
1617377|NCT00907738|3954973|P2|NOT COMPLETED|Overall Study||1
1617378|NCT00907738|3954974|P1|NOT COMPLETED|Overall Study||13
1617379|NCT00907738|3954970|P5|COMPLETED|Overall Study||0
1617380|NCT00907738|3954971|P4|COMPLETED|Overall Study||0
1617381|NCT00907738|3954972|P3|COMPLETED|Overall Study||0
1617382|NCT00907738|3954973|P2|COMPLETED|Overall Study||0
1617383|NCT00907738|3954974|P1|COMPLETED|Overall Study||0
1617384|NCT00907738|3954970|P5|STARTED|Overall Study||2
1617385|NCT00907738|3954971|P4|STARTED|Overall Study||4
1617386|NCT00907738|3954972|P3|STARTED|Overall Study||7
1617387|NCT00907738|3954973|P2|STARTED|Overall Study||1
1617388|NCT00907738|3954974|P1|STARTED|Overall Study||13
1617389|NCT00907621|3954992|P2|NOT COMPLETED|Overall Study||4
1617390|NCT00907621|3954993|P1|NOT COMPLETED|Overall Study||7
1617391|NCT00907621|3954992|P2|COMPLETED|Overall Study||41
1617392|NCT00907621|3954993|P1|COMPLETED|Overall Study||38
1617393|NCT00907621|3954992|P2|STARTED|Overall Study||45
1617394|NCT00907621|3954993|P1|STARTED|Overall Study||45
1617395|NCT00907517|3955006|P5|NOT COMPLETED|Overall Study||5
1617396|NCT00907517|3955007|P4|NOT COMPLETED|Overall Study||4
1617397|NCT00907517|3955008|P3|NOT COMPLETED|Overall Study||4
1617398|NCT00907517|3955009|P2|NOT COMPLETED|Overall Study||3
1617399|NCT00907517|3955010|P1|NOT COMPLETED|Overall Study||3
1617400|NCT00907517|3955006|P5|COMPLETED|Overall Study||1
1617401|NCT00907517|3955007|P4|COMPLETED|Overall Study||2
1617402|NCT00907517|3955008|P3|COMPLETED|Overall Study||2
1617403|NCT00907517|3955009|P2|COMPLETED|Overall Study||0
1617404|NCT00907517|3955010|P1|COMPLETED|Overall Study||0
1617405|NCT00907517|3955006|P5|STARTED|Overall Study||6
1617406|NCT00907517|3955007|P4|STARTED|Overall Study||6
1617407|NCT00907517|3955008|P3|STARTED|Overall Study||6
1617408|NCT00907517|3955009|P2|STARTED|Overall Study||3
1617409|NCT00907517|3955010|P1|STARTED|Overall Study||3
1617410|NCT00907478|3955035|P3|NOT COMPLETED|Overall Study||22
1617411|NCT00907478|3955036|P2|NOT COMPLETED|Overall Study||17
1617412|NCT00907478|3955037|P1|NOT COMPLETED|Overall Study||27
1617413|NCT00907478|3955035|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
1617414|NCT00907478|3955036|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
1617415|NCT00907478|3955037|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
1617416|NCT00907478|3955035|P3|STARTED|Overall Study||69
1617417|NCT00907478|3955036|P2|STARTED|Overall Study||50
1617418|NCT00907478|3955037|P1|STARTED|Overall Study||50
1617419|NCT00907426|3955068|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
1617420|NCT00907426|3955069|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
1617421|NCT00907426|3955070|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
1617422|NCT00907426|3955068|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
1617423|NCT00907426|3955069|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
1617424|NCT00907426|3955070|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
1617425|NCT00907426|3955068|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
1617426|NCT00907426|3955069|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
1617427|NCT00907426|3955070|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
1617428|NCT00907426|3955068|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
1617429|NCT00907426|3955069|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
1617430|NCT00907426|3955070|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
1617431|NCT00907426|3955068|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
1617432|NCT00907426|3955069|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
1617433|NCT00907426|3955070|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
1617434|NCT00907426|3955068|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
1617435|NCT00907426|3955069|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
1617436|NCT00907426|3955070|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
1617437|NCT00907374|3955087|P2|NOT COMPLETED|Overall Study||2
1617438|NCT00907374|3955088|P1|NOT COMPLETED|Overall Study||2
1617439|NCT00907374|3955087|P2|COMPLETED|Overall Study||11
1617440|NCT00907374|3955088|P1|COMPLETED|Overall Study||12
1617441|NCT00907374|3955087|P2|STARTED|Overall Study||13
1617442|NCT00907374|3955088|P1|STARTED|Overall Study||14
1617443|NCT00907335|3955102|P2|NOT COMPLETED|Overall Study||1
1617444|NCT00907335|3955103|P1|NOT COMPLETED|Overall Study||8
1617445|NCT00907335|3955102|P2|COMPLETED|Overall Study||54
1617446|NCT00907335|3955103|P1|COMPLETED|Overall Study||47
1617447|NCT00907335|3955102|P2|STARTED|Overall Study||55
1617448|NCT00907335|3955103|P1|STARTED|Overall Study||55
1617449|NCT00907257|3955121|P2|NOT COMPLETED|Overall Study||12
1617450|NCT00907257|3955122|P1|NOT COMPLETED|Overall Study||13
1617451|NCT00907257|3955121|P2|COMPLETED|Overall Study||112
1617452|NCT00907257|3955122|P1|COMPLETED|Overall Study||110
1617453|NCT00907257|3955121|P2|STARTED|Overall Study||124
1617454|NCT00907257|3955122|P1|STARTED|Overall Study||123
1617455|NCT00907218|3955132|P1|NOT COMPLETED|Overall Study||0
1617456|NCT00907218|3955132|P1|COMPLETED|Overall Study||2
1617457|NCT00907218|3955132|P1|STARTED|Overall Study||2
1617458|NCT00907153|3955144|P2|NOT COMPLETED|Overall Study||4
1617459|NCT00907153|3955145|P1|NOT COMPLETED|Overall Study||2
1617460|NCT00907153|3955144|P2|COMPLETED|Overall Study||11
1617461|NCT00907153|3955145|P1|COMPLETED|Overall Study||11
1617462|NCT00907153|3955144|P2|STARTED|Overall Study||15
1617463|NCT00907153|3955145|P1|STARTED|Overall Study||13
1617464|NCT00907101|3955187|P1|NOT COMPLETED|Overall Study||0
1617465|NCT00907101|3955187|P1|COMPLETED|Overall Study||30
1617466|NCT00907101|3955187|P1|STARTED|Overall Study||30
1617467|NCT00907088|3955197|P2|NOT COMPLETED|Overall Study||30
1617468|NCT00907088|3955198|P1|NOT COMPLETED|Overall Study||20
1617469|NCT00907088|3955197|P2|COMPLETED|Overall Study||99
1617470|NCT00907088|3955198|P1|COMPLETED|Overall Study||102
1617471|NCT00907088|3955197|P2|STARTED|Overall Study||129
1617472|NCT00907088|3955198|P1|STARTED|Overall Study||122
1617473|NCT00906971|3955206|P2|NOT COMPLETED|Overall Study||3
1617474|NCT00906971|3955207|P1|NOT COMPLETED|Overall Study||8
1617475|NCT00906971|3955206|P2|COMPLETED|Overall Study||33
1617476|NCT00906971|3955207|P1|COMPLETED|Overall Study||28
1617477|NCT00906971|3955206|P2|STARTED|Overall Study||36
1617478|NCT00906971|3955207|P1|STARTED|Overall Study||36
1617479|NCT00906945|3955220|P6|NOT COMPLETED|Overall Study||2
1617480|NCT00906945|3955221|P5|NOT COMPLETED|Overall Study||1
1617481|NCT00906945|3955222|P4|NOT COMPLETED|Overall Study||1
1617482|NCT00906945|3955223|P3|NOT COMPLETED|Overall Study||0
1617483|NCT00906945|3955224|P2|NOT COMPLETED|Overall Study||0
1617484|NCT00906945|3955225|P1|NOT COMPLETED|Overall Study||0
1617485|NCT00906945|3955220|P6|COMPLETED|Overall Study||14
1617486|NCT00906945|3955221|P5|COMPLETED|Overall Study||6
1617487|NCT00906945|3955222|P4|COMPLETED|Overall Study||6
1617488|NCT00906945|3955223|P3|COMPLETED|Overall Study||3
1617489|NCT00906945|3955224|P2|COMPLETED|Overall Study||3
1617490|NCT00906945|3955225|P1|COMPLETED|Overall Study||3
1617491|NCT00906945|3955220|P6|STARTED|Overall Study||16
1617492|NCT00906945|3955221|P5|STARTED|Overall Study||7
1617493|NCT00906945|3955222|P4|STARTED|Overall Study||7
1617494|NCT00906945|3955223|P3|STARTED|Overall Study||3
1617495|NCT00906945|3955224|P2|STARTED|Overall Study||3
1617496|NCT00906945|3955225|P1|STARTED|Overall Study||3
1617497|NCT00906789|3955252|P1|NOT COMPLETED|Overall Study||0
1617498|NCT00906789|3955252|P1|COMPLETED|Overall Study||15
1617499|NCT00906789|3955252|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
1617500|NCT00906776|3955262|P2|NOT COMPLETED|Overall Study||0
1617501|NCT00906776|3955263|P1|NOT COMPLETED|Overall Study||0
1617502|NCT00906776|3955262|P2|COMPLETED|Overall Study||8
1617503|NCT00906776|3955263|P1|COMPLETED|Overall Study||11
1617504|NCT00906776|3955262|P2|STARTED|Overall Study||8
1617505|NCT00906776|3955263|P1|STARTED|Overall Study||11
1617506|NCT00906698|3955285|P6|NOT COMPLETED|Overall Study||5
1617507|NCT00906698|3955286|P5|NOT COMPLETED|Overall Study||18
1617508|NCT00906698|3955287|P4|NOT COMPLETED|Overall Study||4
1617509|NCT00906698|3955288|P3|NOT COMPLETED|Overall Study||6
1617510|NCT00906698|3955289|P2|NOT COMPLETED|Overall Study||19
1617511|NCT00906698|3955290|P1|NOT COMPLETED|Overall Study||3
1617512|NCT00906698|3955285|P6|COMPLETED|Overall Study||0
1617513|NCT00906698|3955286|P5|COMPLETED|Overall Study||0
1617514|NCT00906698|3955287|P4|COMPLETED|Overall Study||0
1617515|NCT00906698|3955288|P3|COMPLETED|Overall Study||0
1617516|NCT00906698|3955289|P2|COMPLETED|Overall Study||0
1617517|NCT00906698|3955290|P1|COMPLETED|Overall Study||0
1617518|NCT00906698|3955285|P6|STARTED|Overall Study||5
1617519|NCT00906698|3955286|P5|STARTED|Overall Study||18
1617520|NCT00906698|3955287|P4|STARTED|Overall Study||4
1617521|NCT00906698|3955288|P3|STARTED|Overall Study||6
1617522|NCT00906698|3955289|P2|STARTED|Overall Study||19
1617523|NCT00906698|3955290|P1|STARTED|Overall Study||3
1617524|NCT00906503|3955372|P1|NOT COMPLETED|Overall Study||0
1617525|NCT00906503|3955372|P1|COMPLETED|Overall Study||9
1617526|NCT00906503|3955372|P1|STARTED|Overall Study||9
1617527|NCT00906425|3955378|P2|NOT COMPLETED|Overall Study||72
1617528|NCT00906425|3955379|P1|NOT COMPLETED|Overall Study||73
1617529|NCT00906425|3955378|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
1617530|NCT00906425|3955379|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
1617531|NCT00906425|3955378|P2|2 Year|Overall Study|ITT population|58
1617532|NCT00906425|3955379|P1|2 Year|Overall Study|ITT population|62
1617533|NCT00906425|3955378|P2|1 Year|Overall Study|ITT population|60
1617534|NCT00906425|3955379|P1|1 Year|Overall Study|ITT population|67
1617535|NCT00906425|3955378|P2|6 Months|Overall Study|ITT population|64
1617536|NCT00906425|3955379|P1|6 Months|Overall Study|ITT population|69
1617537|NCT00906425|3955378|P2|STARTED|Overall Study||72
1617538|NCT00906425|3955379|P1|STARTED|Overall Study||73
1617539|NCT00906399|3955392|P7|NOT COMPLETED|Year 2||29
1617540|NCT00906399|3955393|P6|NOT COMPLETED|Year 2||47
1617541|NCT00906399|3955394|P5|NOT COMPLETED|Year 2||35
1617542|NCT00906399|3955395|P4|NOT COMPLETED|Year 2||30
1617543|NCT00906399|3955396|P3|NOT COMPLETED|Year 2||0
1617544|NCT00906399|3955397|P2|NOT COMPLETED|Year 2||0
1617545|NCT00906399|3955398|P1|NOT COMPLETED|Year 2||0
1617546|NCT00906399|3955392|P7|COMPLETED|Year 2||409
1617547|NCT00906399|3955393|P6|COMPLETED|Year 2||391
1617548|NCT00906399|3955394|P5|COMPLETED|Year 2||193
1617549|NCT00906399|3955395|P4|COMPLETED|Year 2||198
1617550|NCT00906399|3955396|P3|COMPLETED|Year 2||0
1617551|NCT00906399|3955397|P2|COMPLETED|Year 2||0
1617552|NCT00906399|3955398|P1|COMPLETED|Year 2||0
1617553|NCT00906399|3955392|P7|Completed Year 2 Study Treatment|Year 2||411
1617554|NCT00906399|3955393|P6|Completed Year 2 Study Treatment|Year 2||391
1617555|NCT00906399|3955394|P5|Completed Year 2 Study Treatment|Year 2||196
1617556|NCT00906399|3955395|P4|Completed Year 2 Study Treatment|Year 2||200
1617557|NCT00906399|3955396|P3|Completed Year 2 Study Treatment|Year 2||0
1617558|NCT00906399|3955397|P2|Completed Year 2 Study Treatment|Year 2||0
1617559|NCT00906399|3955398|P1|Completed Year 2 Study Treatment|Year 2||0
1617560|NCT00906399|3955392|P7|STARTED|Year 2||438
1617561|NCT00906399|3955393|P6|STARTED|Year 2||438
1617562|NCT00906399|3955394|P5|STARTED|Year 2||228
1617563|NCT00906399|3955395|P4|STARTED|Year 2||228
1617564|NCT00906399|3955396|P3|STARTED|Year 2||0
1617565|NCT00906399|3955397|P2|STARTED|Year 2||0
1617566|NCT00906399|3955398|P1|STARTED|Year 2||0
1617567|NCT00906399|3955392|P7|NOT COMPLETED|Year 1||0
1617568|NCT00906399|3955393|P6|NOT COMPLETED|Year 1||0
1617569|NCT00906399|3955394|P5|NOT COMPLETED|Year 1||0
1617570|NCT00906399|3955395|P4|NOT COMPLETED|Year 1||0
1617571|NCT00906399|3955396|P3|NOT COMPLETED|Year 1||76
1617572|NCT00906399|3955397|P2|NOT COMPLETED|Year 1||63
1617573|NCT00906399|3955398|P1|NOT COMPLETED|Year 1||44
1617574|NCT00906399|3955392|P7|COMPLETED|Year 1||0
1617575|NCT00906399|3955393|P6|COMPLETED|Year 1||0
1617576|NCT00906399|3955394|P5|COMPLETED|Year 1||0
1617577|NCT00906399|3955395|P4|COMPLETED|Year 1||0
1617578|NCT00906399|3955396|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
1617579|NCT00906399|3955397|P2|COMPLETED|Year 1||438
1617580|NCT00906399|3955398|P1|COMPLETED|Year 1||456
1617581|NCT00906399|3955392|P7|Completed Year 1 Study Treatment|Year 1||0
1617582|NCT00906399|3955393|P6|Completed Year 1 Study Treatment|Year 1||0
1617583|NCT00906399|3955394|P5|Completed Year 1 Study Treatment|Year 1||0
1617584|NCT00906399|3955395|P4|Completed Year 1 Study Treatment|Year 1||0
1617585|NCT00906399|3955396|P3|Completed Year 1 Study Treatment|Year 1||438
1617586|NCT00906399|3955397|P2|Completed Year 1 Study Treatment|Year 1||438
1617587|NCT00906399|3955398|P1|Completed Year 1 Study Treatment|Year 1||456
1617588|NCT00906399|3955392|P7|STARTED|Year 1||0
1617589|NCT00906399|3955393|P6|STARTED|Year 1||0
1617590|NCT00906399|3955394|P5|STARTED|Year 1||0
1617591|NCT00906399|3955395|P4|STARTED|Year 1||0
1617592|NCT00906399|3955396|P3|STARTED|Year 1||515
1617593|NCT00906399|3955397|P2|STARTED|Year 1||501
1617594|NCT00906399|3955398|P1|STARTED|Year 1||500
1617595|NCT00906373|3955421|P2|NOT COMPLETED|Overall Study||8
1617596|NCT00906373|3955422|P1|NOT COMPLETED|Overall Study||0
1617597|NCT00906373|3955421|P2|COMPLETED|Overall Study||33
1617598|NCT00906373|3955422|P1|COMPLETED|Overall Study||6
1617599|NCT00906373|3955421|P2|Received Any Amount of Study Drug|Overall Study||41
1617600|NCT00906373|3955422|P1|Received Any Amount of Study Drug|Overall Study||6
1617601|NCT00906373|3955421|P2|STARTED|Overall Study||41
1617602|NCT00906373|3955422|P1|STARTED|Overall Study||6
1617603|NCT00906347|3955461|P2|NOT COMPLETED|Received Study Drug||31
1617604|NCT00906347|3955462|P1|NOT COMPLETED|Received Study Drug||40
1617605|NCT00906347|3955461|P2|COMPLETED|Received Study Drug||143
1617606|NCT00906347|3955462|P1|COMPLETED|Received Study Drug||136
1617607|NCT00906347|3955461|P2|STARTED|Received Study Drug||174
1617608|NCT00906347|3955462|P1|STARTED|Received Study Drug||176
1617609|NCT00906347|3955461|P2|NOT COMPLETED|Randomized||0
1617610|NCT00906347|3955462|P1|NOT COMPLETED|Randomized||0
1617611|NCT00906347|3955461|P2|COMPLETED|Randomized||174
1617612|NCT00906347|3955462|P1|COMPLETED|Randomized||176
1617613|NCT00906347|3955461|P2|STARTED|Randomized||174
1617614|NCT00906347|3955462|P1|STARTED|Randomized||176
1617615|NCT00906282|3955482|P1|NOT COMPLETED|Surgical Resection||0
1617616|NCT00906282|3955482|P1|COMPLETED|Surgical Resection||27
1617617|NCT00906282|3955482|P1|STARTED|Surgical Resection||27
1617618|NCT00906282|3955482|P1|NOT COMPLETED|Preoperative Chemotherapy||19
1617619|NCT00906282|3955482|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
1617620|NCT00906282|3955482|P1|STARTED|Preoperative Chemotherapy||46
1617621|NCT00906243|3955490|P1|NOT COMPLETED|Overall Study||0
1617622|NCT00906243|3955490|P1|COMPLETED|Overall Study||6
1617623|NCT00906243|3955490|P1|STARTED|Overall Study||6
1617624|NCT00906204|3955496|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
1617625|NCT00906204|3955497|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
1617626|NCT00906204|3955496|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
1617627|NCT00906204|3955497|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
1617628|NCT00906204|3955496|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
1617629|NCT00906204|3955497|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
1617630|NCT00906204|3955496|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
1617631|NCT00906204|3955497|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
1617632|NCT00906204|3955496|P2|COMPLETED|Primary Endpoint (Early Safety)||51
1617633|NCT00906204|3955497|P1|COMPLETED|Primary Endpoint (Early Safety)||43
1617634|NCT00906204|3955496|P2|STARTED|Primary Endpoint (Early Safety)||52
1617635|NCT00906204|3955497|P1|STARTED|Primary Endpoint (Early Safety)||45
1617636|NCT00906178|3955515|P2|NOT COMPLETED|Overall Study||16
1617637|NCT00906178|3955516|P1|NOT COMPLETED|Overall Study||15
1617638|NCT00906178|3955515|P2|COMPLETED|Overall Study||167
1617639|NCT00906178|3955516|P1|COMPLETED|Overall Study||168
1617640|NCT00906178|3955515|P2|STARTED|Overall Study||183
1617641|NCT00906178|3955516|P1|STARTED|Overall Study||183
1617642|NCT00906087|3955528|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
1617643|NCT00906087|3955528|P1|COMPLETED|Final Washout Period 4 Weeks||12
1617644|NCT00906087|3955528|P1|STARTED|Final Washout Period 4 Weeks||12
1617645|NCT00906087|3955528|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
1617646|NCT00906087|3955528|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
1617647|NCT00906087|3955528|P1|STARTED|Cosopt Treatment 6 Weeks||12
1617648|NCT00906087|3955528|P1|NOT COMPLETED|Initial Washout||2
1617649|NCT00906087|3955528|P1|COMPLETED|Initial Washout||12
1617650|NCT00906087|3955528|P1|Completed Washout and Continue Protocol|Initial Washout||12
1617651|NCT00906087|3955528|P1|Begin Washout|Initial Washout||13
1617652|NCT00906087|3955528|P1|Completed Screening|Initial Washout||14
1617653|NCT00906087|3955528|P1|STARTED|Initial Washout||14
1617654|NCT00906074|3955537|P2|NOT COMPLETED|Overall Study||0
1617655|NCT00906074|3955538|P1|NOT COMPLETED|Overall Study||0
1617656|NCT00906074|3955537|P2|COMPLETED|Overall Study||90
1617657|NCT00906074|3955538|P1|COMPLETED|Overall Study||90
1617658|NCT00906074|3955537|P2|STARTED|Overall Study||90
1617659|NCT00906074|3955538|P1|STARTED|Overall Study||90
1617660|NCT00906035|3955565|P3|NOT COMPLETED|Overall Study||0
1617661|NCT00906035|3955566|P2|NOT COMPLETED|Overall Study||3
1617662|NCT00906035|3955567|P1|NOT COMPLETED|Overall Study||2
1617663|NCT00906035|3955565|P3|COMPLETED|Overall Study||8
1617664|NCT00906035|3955566|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
1617665|NCT00906035|3955567|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
1617666|NCT00906035|3955565|P3|STARTED|Overall Study||8
1617667|NCT00906035|3955566|P2|STARTED|Overall Study||9
1617668|NCT00906035|3955567|P1|STARTED|Overall Study||8
1617669|NCT00905840|3955581|P1|NOT COMPLETED|Overall Study||16
1617670|NCT00905840|3955581|P1|COMPLETED|Overall Study||75
1617671|NCT00905840|3955581|P1|STARTED|Overall Study||91
1617672|NCT00905827|3955593|P3|NOT COMPLETED|Overall Study||0
1617673|NCT00905827|3955594|P2|NOT COMPLETED|Overall Study||0
1617674|NCT00905827|3955595|P1|NOT COMPLETED|Overall Study||0
1617675|NCT00905827|3955593|P3|COMPLETED|Overall Study||73
1617676|NCT00905827|3955594|P2|COMPLETED|Overall Study||69
1617677|NCT00905827|3955595|P1|COMPLETED|Overall Study||70
1617678|NCT00905827|3955593|P3|STARTED|Overall Study||73
1617679|NCT00905827|3955594|P2|STARTED|Overall Study||69
1617680|NCT00905827|3955595|P1|STARTED|Overall Study||70
1617681|NCT00905632|3955612|P7|NOT COMPLETED|Overall Study||4
1617682|NCT00905632|3955613|P6|NOT COMPLETED|Overall Study||1
1617683|NCT00905632|3955614|P5|NOT COMPLETED|Overall Study||0
1617684|NCT00905632|3955615|P4|NOT COMPLETED|Overall Study||0
1617685|NCT00905632|3955616|P3|NOT COMPLETED|Overall Study||0
1617686|NCT00905632|3955617|P2|NOT COMPLETED|Overall Study||0
1617687|NCT00905632|3955618|P1|NOT COMPLETED|Overall Study||0
1617688|NCT00905632|3955612|P7|COMPLETED|Overall Study||7
1617689|NCT00905632|3955613|P6|COMPLETED|Overall Study||8
1617690|NCT00905632|3955614|P5|COMPLETED|Overall Study||10
1617691|NCT00905632|3955615|P4|COMPLETED|Overall Study||6
1617692|NCT00905632|3955616|P3|COMPLETED|Overall Study||7
1617693|NCT00905632|3955617|P2|COMPLETED|Overall Study||6
1617694|NCT00905632|3955618|P1|COMPLETED|Overall Study||8
1617695|NCT00905632|3955612|P7|STARTED|Overall Study||11
1617696|NCT00905632|3955613|P6|STARTED|Overall Study||9
1617697|NCT00905632|3955614|P5|STARTED|Overall Study||10
1617698|NCT00905632|3955615|P4|STARTED|Overall Study||6
1617699|NCT00905632|3955616|P3|STARTED|Overall Study||7
1617700|NCT00905632|3955617|P2|STARTED|Overall Study||6
1617701|NCT00905632|3955618|P1|STARTED|Overall Study||8
1617702|NCT00905606|3955756|P2|NOT COMPLETED|Period 2||0
1617703|NCT00905606|3955757|P1|NOT COMPLETED|Period 2||0
1617704|NCT00905606|3955756|P2|COMPLETED|Period 2||14
1617705|NCT00905606|3955757|P1|COMPLETED|Period 2||14
1617706|NCT00905606|3955756|P2|STARTED|Period 2||14
1617707|NCT00905606|3955757|P1|STARTED|Period 2||14
1617708|NCT00905606|3955756|P2|NOT COMPLETED|Washout||0
1617709|NCT00905606|3955757|P1|NOT COMPLETED|Washout||1
1617710|NCT00905606|3955756|P2|COMPLETED|Washout||14
1617711|NCT00905606|3955757|P1|COMPLETED|Washout||14
1617712|NCT00905606|3955756|P2|STARTED|Washout||14
1617713|NCT00905606|3955757|P1|STARTED|Washout||15
1617714|NCT00905606|3955756|P2|NOT COMPLETED|Period 1||1
1617715|NCT00905606|3955757|P1|NOT COMPLETED|Period 1||0
1617716|NCT00905606|3955756|P2|COMPLETED|Period 1||14
1617717|NCT00905606|3955757|P1|COMPLETED|Period 1||15
1617718|NCT00905606|3955756|P2|STARTED|Period 1||15
1617719|NCT00905606|3955757|P1|STARTED|Period 1||15
1617720|NCT00905580|3955767|P2|NOT COMPLETED|Overall Study||3
1617721|NCT00905580|3955768|P1|NOT COMPLETED|Overall Study||2
1617722|NCT00905580|3955767|P2|COMPLETED|Overall Study||47
1617723|NCT00905580|3955768|P1|COMPLETED|Overall Study||47
1617724|NCT00905580|3955767|P2|STARTED|Overall Study||50
1617725|NCT00905580|3955768|P1|STARTED|Overall Study||49
1617726|NCT00905567|3955782|P2|NOT COMPLETED|Period 2||0
1617727|NCT00905567|3955783|P1|NOT COMPLETED|Period 2||0
1617728|NCT00905567|3955782|P2|COMPLETED|Period 2||11
1617729|NCT00905567|3955783|P1|COMPLETED|Period 2||12
1617730|NCT00905567|3955782|P2|STARTED|Period 2||11
1617731|NCT00905567|3955783|P1|STARTED|Period 2||12
1617732|NCT00905567|3955782|P2|NOT COMPLETED|Washout||1
1617733|NCT00905567|3955783|P1|NOT COMPLETED|Washout||0
1617734|NCT00905567|3955782|P2|COMPLETED|Washout||11
1617735|NCT00905567|3955783|P1|COMPLETED|Washout||12
1617736|NCT00905567|3955782|P2|STARTED|Washout||12
1617737|NCT00905567|3955783|P1|STARTED|Washout||12
1617738|NCT00905567|3955782|P2|NOT COMPLETED|Period 1||0
1617739|NCT00905567|3955783|P1|NOT COMPLETED|Period 1||0
1617740|NCT00905567|3955782|P2|COMPLETED|Period 1||12
1617741|NCT00905567|3955783|P1|COMPLETED|Period 1||12
1617742|NCT00905567|3955782|P2|STARTED|Period 1||12
1617743|NCT00905567|3955783|P1|STARTED|Period 1||12
1617744|NCT00905554|3955793|P2|NOT COMPLETED|Overall Study||0
1617745|NCT00905554|3955794|P1|NOT COMPLETED|Overall Study||0
1617746|NCT00905554|3955793|P2|COMPLETED|Overall Study||114
1617747|NCT00905554|3955794|P1|COMPLETED|Overall Study||116
1617748|NCT00905554|3955793|P2|STARTED|Overall Study||114
1617749|NCT00905554|3955794|P1|STARTED|Overall Study||116
1617750|NCT00905515|3955805|P3|NOT COMPLETED|Overall Study||2
1617751|NCT00905515|3955806|P2|NOT COMPLETED|Overall Study||0
1617752|NCT00905515|3955807|P1|NOT COMPLETED|Overall Study||2
1617753|NCT00905515|3955805|P3|COMPLETED|Overall Study||20
1617754|NCT00905515|3955806|P2|COMPLETED|Overall Study||20
1617755|NCT00905515|3955807|P1|COMPLETED|Overall Study||19
1617756|NCT00905515|3955805|P3|STARTED|Overall Study||22
1617757|NCT00905515|3955806|P2|STARTED|Overall Study||20
1617758|NCT00905515|3955807|P1|STARTED|Overall Study||21
1617759|NCT00905489|3955815|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
1617760|NCT00905489|3955815|P1|COMPLETED|Optional Extension Phase (OEP)||39
1617761|NCT00905489|3955815|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
1617762|NCT00905489|3955815|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
1617763|NCT00905489|3955815|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
1617764|NCT00905489|3955815|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
1617765|NCT00905437|3955864|P2|NOT COMPLETED|Overall Study||10
1617766|NCT00905437|3955865|P1|NOT COMPLETED|Overall Study||8
1617767|NCT00905437|3955864|P2|COMPLETED|Overall Study||27
1617768|NCT00905437|3955865|P1|COMPLETED|Overall Study||27
1617769|NCT00905437|3955864|P2|STARTED|Overall Study||37
1617770|NCT00905437|3955865|P1|STARTED|Overall Study||35
1617771|NCT00905424|3955885|P2|NOT COMPLETED|Overall Study||9
1617772|NCT00905424|3955886|P1|NOT COMPLETED|Overall Study||11
1617773|NCT00905424|3955885|P2|COMPLETED|Overall Study||79
1617774|NCT00905424|3955886|P1|COMPLETED|Overall Study||78
1617775|NCT00905424|3955885|P2|STARTED|Overall Study||88
1617776|NCT00905424|3955886|P1|STARTED|Overall Study||89
1617777|NCT00905359|3955928|P2|NOT COMPLETED|Overall Study||16
1617778|NCT00905359|3955929|P1|NOT COMPLETED|Overall Study||24
1617779|NCT00905359|3955928|P2|COMPLETED|Overall Study||65
1617780|NCT00905359|3955929|P1|COMPLETED|Overall Study||58
1617781|NCT00905359|3955928|P2|24 Months Follow up|Overall Study||65
1617782|NCT00905359|3955929|P1|24 Months Follow up|Overall Study||58
1617783|NCT00905359|3955928|P2|12 Months Follow up|Overall Study||72
1617784|NCT00905359|3955929|P1|12 Months Follow up|Overall Study||68
1617785|NCT00905359|3955928|P2|STARTED|Overall Study||81
1617786|NCT00905359|3955929|P1|STARTED|Overall Study||82
1617787|NCT00905346|3955965|P2|NOT COMPLETED|Period 2||0
1617788|NCT00905346|3955966|P1|NOT COMPLETED|Period 2||0
1617789|NCT00905346|3955965|P2|COMPLETED|Period 2||11
1617790|NCT00905346|3955966|P1|COMPLETED|Period 2||10
1617791|NCT00905346|3955965|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
1617792|NCT00905346|3955966|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
1617793|NCT00905346|3955965|P2|NOT COMPLETED|Period 1||0
1617794|NCT00905346|3955966|P1|NOT COMPLETED|Period 1||1
1617795|NCT00905346|3955965|P2|COMPLETED|Period 1||12
1617796|NCT00905346|3955966|P1|COMPLETED|Period 1||11
1617797|NCT00905346|3955965|P2|STARTED|Period 1||12
1617798|NCT00905346|3955966|P1|STARTED|Period 1||12
1617799|NCT00905307|3955980|P6|NOT COMPLETED|Overall Study||42
1617800|NCT00905307|3955981|P5|NOT COMPLETED|Overall Study||16
1617801|NCT00905307|3955982|P4|NOT COMPLETED|Overall Study||37
1617802|NCT00905307|3955983|P3|NOT COMPLETED|Overall Study||37
1617803|NCT00905307|3955984|P2|NOT COMPLETED|Overall Study||37
1617804|NCT00905307|3955985|P1|NOT COMPLETED|Overall Study||22
1617805|NCT00905307|3955980|P6|COMPLETED|Overall Study||53
1617806|NCT00905307|3955981|P5|COMPLETED|Overall Study||34
1617807|NCT00905307|3955982|P4|COMPLETED|Overall Study||56
1617808|NCT00905307|3955983|P3|COMPLETED|Overall Study||53
1617809|NCT00905307|3955984|P2|COMPLETED|Overall Study||52
1617810|NCT00905307|3955985|P1|COMPLETED|Overall Study||20
1617811|NCT00905307|3955980|P6|STARTED|Overall Study||95
1617812|NCT00905307|3955981|P5|STARTED|Overall Study||50
1617813|NCT00905307|3955982|P4|STARTED|Overall Study||93
1617814|NCT00905307|3955983|P3|STARTED|Overall Study||90
1617815|NCT00905307|3955984|P2|STARTED|Overall Study||89
1617816|NCT00905307|3955985|P1|STARTED|Overall Study||42
1617817|NCT00905268|3956045|P4|NOT COMPLETED|Overall Study||2
1617818|NCT00905268|3956046|P3|NOT COMPLETED|Overall Study||0
1617819|NCT00905268|3956047|P2|NOT COMPLETED|Overall Study||1
1617820|NCT00905268|3956048|P1|NOT COMPLETED|Overall Study||4
1617821|NCT00905268|3956045|P4|COMPLETED|Overall Study||57
1617822|NCT00905268|3956046|P3|COMPLETED|Overall Study||59
1617823|NCT00905268|3956047|P2|COMPLETED|Overall Study||56
1617824|NCT00905268|3956048|P1|COMPLETED|Overall Study||53
1617825|NCT00905268|3956045|P4|STARTED|Overall Study||59
1617826|NCT00905268|3956046|P3|STARTED|Overall Study||59
1617827|NCT00905268|3956047|P2|STARTED|Overall Study||57
1617828|NCT00905268|3956048|P1|STARTED|Overall Study||57
1617829|NCT00905255|3956080|P2|NOT COMPLETED|Overall Study||9
1617830|NCT00905255|3956081|P1|NOT COMPLETED|Overall Study||13
1617831|NCT00905255|3956080|P2|COMPLETED|Overall Study||27
1617832|NCT00905255|3956081|P1|COMPLETED|Overall Study||20
1617833|NCT00905255|3956080|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
1617834|NCT00905255|3956081|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
1617835|NCT00905255|3956080|P2|Safety Population|Overall Study||36
1617836|NCT00905255|3956081|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
1617837|NCT00905255|3956080|P2|STARTED|Overall Study||36
1617838|NCT00905255|3956081|P1|STARTED|Overall Study|Randomized.|33
1617839|NCT00905164|3956099|P2|NOT COMPLETED|Period 2||0
1617840|NCT00905164|3956100|P1|NOT COMPLETED|Period 2||0
1617841|NCT00905164|3956099|P2|COMPLETED|Period 2||11
1617842|NCT00905164|3956100|P1|COMPLETED|Period 2||12
1617843|NCT00905164|3956099|P2|STARTED|Period 2||11
1617844|NCT00905164|3956100|P1|STARTED|Period 2||12
1617845|NCT00905164|3956099|P2|NOT COMPLETED|Period 1||1
1617846|NCT00905164|3956100|P1|NOT COMPLETED|Period 1||0
1617847|NCT00905164|3956099|P2|COMPLETED|Period 1||11
1617848|NCT00905164|3956100|P1|COMPLETED|Period 1||12
1617849|NCT00905164|3956099|P2|STARTED|Period 1||12
1617850|NCT00905164|3956100|P1|STARTED|Period 1||12
1617851|NCT00905151|3956108|P1|NOT COMPLETED|Overall Study||6
1617852|NCT00905151|3956108|P1|COMPLETED|Overall Study||200
1617853|NCT00905151|3956108|P1|STARTED|Overall Study||206
1617854|NCT00905125|3956114|P2|NOT COMPLETED|Overall Study||3
1617855|NCT00905125|3956115|P1|NOT COMPLETED|Overall Study||4
1617856|NCT00905125|3956114|P2|COMPLETED|Overall Study||53
1617857|NCT00905125|3956115|P1|COMPLETED|Overall Study||42
1617858|NCT00905125|3956114|P2|STARTED|Overall Study||56
1617859|NCT00905125|3956115|P1|STARTED|Overall Study||46
1617860|NCT00905034|3956147|P1|NOT COMPLETED|Overall Study||1
1617861|NCT00905034|3956147|P1|COMPLETED|Overall Study||36
1617862|NCT00905034|3956147|P1|STARTED|Overall Study||37
1617863|NCT00905021|3956151|P1|NOT COMPLETED|Overall Study||2
1617864|NCT00905021|3956151|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
1617865|NCT00905021|3956151|P1|STARTED|Overall Study||4
1617866|NCT00904995|3956158|P2|NOT COMPLETED|Overall Study||0
1617867|NCT00904995|3956159|P1|NOT COMPLETED|Overall Study||0
1617868|NCT00904995|3956158|P2|COMPLETED|Overall Study||11
1617869|NCT00904995|3956159|P1|COMPLETED|Overall Study||10
1617870|NCT00904995|3956158|P2|STARTED|Overall Study||11
1617871|NCT00904995|3956159|P1|STARTED|Overall Study||10
1617872|NCT00904982|3956169|P4|NOT COMPLETED|Overall Study||0
1617873|NCT00904982|3956170|P3|NOT COMPLETED|Overall Study||0
1617874|NCT00904982|3956171|P2|NOT COMPLETED|Overall Study||0
1617875|NCT00904982|3956172|P1|NOT COMPLETED|Overall Study||2
1617876|NCT00904982|3956169|P4|COMPLETED|Overall Study||68
1617877|NCT00904982|3956170|P3|COMPLETED|Overall Study||67
1617878|NCT00904982|3956171|P2|COMPLETED|Overall Study||67
1617879|NCT00904982|3956172|P1|COMPLETED|Overall Study||66
1617880|NCT00904982|3956169|P4|STARTED|Overall Study||68
1617881|NCT00904982|3956170|P3|STARTED|Overall Study||67
1617882|NCT00904982|3956171|P2|STARTED|Overall Study||67
1617883|NCT00904982|3956172|P1|STARTED|Overall Study||68
1617884|NCT00904969|3956182|P1|NOT COMPLETED|Overall Study||19
1617885|NCT00904969|3956182|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
1617886|NCT00904969|3956182|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
1617887|NCT00904943|3956234|P2|NOT COMPLETED|Period 2||0
1617888|NCT00904943|3956235|P1|NOT COMPLETED|Period 2||0
1617889|NCT00904943|3956234|P2|COMPLETED|Period 2||8
1617890|NCT00904943|3956235|P1|COMPLETED|Period 2||9
1617891|NCT00904943|3956234|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
1617892|NCT00904943|3956235|P1|STARTED|Period 2||9
1617893|NCT00904943|3956234|P2|NOT COMPLETED|Period 1||0
1617894|NCT00904943|3956235|P1|NOT COMPLETED|Period 1||0
1617895|NCT00904943|3956234|P2|COMPLETED|Period 1||9
1617896|NCT00904943|3956235|P1|COMPLETED|Period 1||9
1617897|NCT00904943|3956234|P2|STARTED|Period 1||9
1617898|NCT00904943|3956235|P1|STARTED|Period 1||9
1617899|NCT00904917|3956247|P4|NOT COMPLETED|Overall Study||2
1617900|NCT00904917|3956248|P3|NOT COMPLETED|Overall Study||2
1617901|NCT00904917|3956249|P2|NOT COMPLETED|Overall Study||2
1617902|NCT00904917|3956250|P1|NOT COMPLETED|Overall Study||2
1617903|NCT00904917|3956247|P4|COMPLETED|Overall Study||6
1617904|NCT00904917|3956248|P3|COMPLETED|Overall Study||6
1617905|NCT00904917|3956249|P2|COMPLETED|Overall Study||9
1617906|NCT00904917|3956250|P1|COMPLETED|Overall Study||5
1617907|NCT00904917|3956247|P4|STARTED|Overall Study||8
1617908|NCT00904917|3956248|P3|STARTED|Overall Study||8
1617909|NCT00904917|3956249|P2|STARTED|Overall Study||11
1617910|NCT00904917|3956250|P1|STARTED|Overall Study||7
1617911|NCT00904839|3956268|P3|NOT COMPLETED|Overall Study||15
1617912|NCT00904839|3956269|P2|NOT COMPLETED|Overall Study||18
1617913|NCT00904839|3956270|P1|NOT COMPLETED|Overall Study||1
1617914|NCT00904839|3956268|P3|COMPLETED|Overall Study||27
1617915|NCT00904839|3956269|P2|COMPLETED|Overall Study||64
1617916|NCT00904839|3956270|P1|COMPLETED|Overall Study||3
1617917|NCT00904839|3956268|P3|STARTED|Overall Study|Randomised|42
1617918|NCT00904839|3956269|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
1617919|NCT00904839|3956270|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
1617920|NCT00904826|3956304|P1|NOT COMPLETED|Overall Study||0
1617921|NCT00904826|3956304|P1|COMPLETED|Overall Study||14
1617922|NCT00904826|3956304|P1|STARTED|Overall Study||14
1617923|NCT00904748|3956316|P6|NOT COMPLETED|Overall Study||0
1617924|NCT00904748|3956317|P5|NOT COMPLETED|Overall Study||1
1617925|NCT00904748|3956318|P4|NOT COMPLETED|Overall Study||2
1617926|NCT00904748|3956319|P3|NOT COMPLETED|Overall Study||1
1617927|NCT00904748|3956320|P2|NOT COMPLETED|Overall Study||1
1617928|NCT00904748|3956321|P1|NOT COMPLETED|Overall Study||1
1617929|NCT00904748|3956316|P6|COMPLETED|Overall Study||8
1617930|NCT00904748|3956317|P5|COMPLETED|Overall Study||7
1617931|NCT00904748|3956318|P4|COMPLETED|Overall Study||6
1617932|NCT00904748|3956319|P3|COMPLETED|Overall Study||7
1617933|NCT00904748|3956320|P2|COMPLETED|Overall Study||7
1617934|NCT00904748|3956321|P1|COMPLETED|Overall Study||7
1617935|NCT00904748|3956316|P6|Received Treatment|Overall Study||8
1617936|NCT00904748|3956317|P5|Received Treatment|Overall Study||7
1617937|NCT00904748|3956318|P4|Received Treatment|Overall Study||8
1617938|NCT00904748|3956319|P3|Received Treatment|Overall Study||8
1617939|NCT00904748|3956320|P2|Received Treatment|Overall Study||8
1617940|NCT00904748|3956321|P1|Received Treatment|Overall Study||8
1617941|NCT00904748|3956316|P6|STARTED|Overall Study||8
1617942|NCT00904748|3956317|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
1617943|NCT00904748|3956318|P4|STARTED|Overall Study||8
1617944|NCT00904748|3956319|P3|STARTED|Overall Study||8
1617945|NCT00904748|3956320|P2|STARTED|Overall Study||8
1617946|NCT00904748|3956321|P1|STARTED|Overall Study||8
1617947|NCT00904722|3956345|P1|NOT COMPLETED|Overall Study||1
1617948|NCT00904722|3956345|P1|COMPLETED|Overall Study||29
1617949|NCT00904722|3956345|P1|STARTED|Overall Study||30
1617950|NCT00904670|3956350|P2|NOT COMPLETED|Second Intervention Period||0
1617951|NCT00904670|3956351|P1|NOT COMPLETED|Second Intervention Period||0
1617952|NCT00904670|3956350|P2|COMPLETED|Second Intervention Period||22
1617953|NCT00904670|3956351|P1|COMPLETED|Second Intervention Period||17
1617954|NCT00904670|3956350|P2|STARTED|Second Intervention Period||22
1617955|NCT00904670|3956351|P1|STARTED|Second Intervention Period||17
1617956|NCT00904670|3956350|P2|NOT COMPLETED|First Intervention Period||0
1617957|NCT00904670|3956351|P1|NOT COMPLETED|First Intervention Period||0
1617958|NCT00904670|3956350|P2|COMPLETED|First Intervention Period||22
1617959|NCT00904670|3956351|P1|COMPLETED|First Intervention Period||17
1617960|NCT00904670|3956350|P2|STARTED|First Intervention Period||22
1617961|NCT00904670|3956351|P1|STARTED|First Intervention Period||17
1617962|NCT00904670|3956350|P2|NOT COMPLETED|Open Label Phase||0
1617963|NCT00904670|3956351|P1|NOT COMPLETED|Open Label Phase||6
1617964|NCT00904670|3956350|P2|COMPLETED|Open Label Phase||22
1617965|NCT00904670|3956351|P1|COMPLETED|Open Label Phase||17
1617966|NCT00904670|3956350|P2|STARTED|Open Label Phase||22
1617967|NCT00904670|3956351|P1|STARTED|Open Label Phase||23
1617968|NCT00904618|3956372|P1|NOT COMPLETED|Overall Study||0
1617969|NCT00904618|3956372|P1|COMPLETED|Overall Study||48
1617970|NCT00904618|3956372|P1|STARTED|Overall Study||48
1617971|NCT00904488|3956382|P2|NOT COMPLETED|Overall Study||0
1617972|NCT00904488|3956383|P1|NOT COMPLETED|Overall Study||0
1617973|NCT00904488|3956382|P2|COMPLETED|Overall Study||6
1617974|NCT00904488|3956383|P1|COMPLETED|Overall Study||5
1617975|NCT00904488|3956382|P2|STARTED|Overall Study||6
1617976|NCT00904488|3956383|P1|STARTED|Overall Study||5
1617977|NCT00904423|3956413|P1|NOT COMPLETED|Overall Study||0
1617978|NCT00904423|3956413|P1|COMPLETED|Overall Study||8
1617979|NCT00904423|3956413|P1|STARTED|Overall Study||8
1617980|NCT00904371|3956421|P1|NOT COMPLETED|Overall Study||9
1617981|NCT00904371|3956421|P1|COMPLETED|Overall Study||202
1617982|NCT00904371|3956421|P1|STARTED|Overall Study||211
1617983|NCT00904215|3956435|P1|NOT COMPLETED|Overall Study||135
1617984|NCT00904215|3956435|P1|COMPLETED|Overall Study||960
1617985|NCT00904215|3956435|P1|STARTED|Overall Study||1095
1617986|NCT00904189|3956442|P1|NOT COMPLETED|Overall Study||0
1617987|NCT00904189|3956442|P1|COMPLETED|Overall Study||2
1617988|NCT00904189|3956442|P1|STARTED|Overall Study||2
1617989|NCT00904150|3956449|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
1617990|NCT00904150|3956450|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
1617991|NCT00904150|3956449|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
1617992|NCT00904150|3956450|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
1617993|NCT00904150|3956449|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
1617994|NCT00904150|3956450|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
1617995|NCT00904150|3956449|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
1617996|NCT00904150|3956450|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
1617997|NCT00904150|3956449|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
1617998|NCT00904150|3956450|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
1617999|NCT00904150|3956449|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
1618000|NCT00904150|3956450|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
1618001|NCT00904150|3956449|P2|NOT COMPLETED|Saliva Samples (DNA)||145
1618002|NCT00904150|3956450|P1|NOT COMPLETED|Saliva Samples (DNA)||3
1618003|NCT00904150|3956449|P2|COMPLETED|Saliva Samples (DNA)||155
1618004|NCT00904150|3956450|P1|COMPLETED|Saliva Samples (DNA)||282
1618005|NCT00904150|3956449|P2|STARTED|Saliva Samples (DNA)||300
1618006|NCT00904150|3956450|P1|STARTED|Saliva Samples (DNA)||285
1618007|NCT00904007|3956470|P2|NOT COMPLETED|Overall Study||0
1618008|NCT00904007|3956471|P1|NOT COMPLETED|Overall Study||0
1618009|NCT00904007|3956470|P2|COMPLETED|Overall Study||56
1618010|NCT00904007|3956471|P1|COMPLETED|Overall Study||55
1618011|NCT00904007|3956470|P2|STARTED|Overall Study||56
1618012|NCT00904007|3956471|P1|STARTED|Overall Study||55
1618013|NCT00903968|3956479|P8|NOT COMPLETED|Overall Study||33
1618014|NCT00903968|3956480|P7|NOT COMPLETED|Overall Study||3
1618015|NCT00903968|3956481|P6|NOT COMPLETED|Overall Study||6
1618016|NCT00903968|3956482|P5|NOT COMPLETED|Overall Study||4
1618017|NCT00903968|3956483|P4|NOT COMPLETED|Overall Study||3
1618018|NCT00903968|3956484|P3|NOT COMPLETED|Overall Study||3
1618019|NCT00903968|3956485|P2|NOT COMPLETED|Overall Study||3
1618020|NCT00903968|3956486|P1|NOT COMPLETED|Overall Study||3
1618021|NCT00903968|3956479|P8|COMPLETED|Overall Study||0
1618022|NCT00903968|3956480|P7|COMPLETED|Overall Study||0
1618023|NCT00903968|3956481|P6|COMPLETED|Overall Study||0
1618024|NCT00903968|3956482|P5|COMPLETED|Overall Study||0
1618025|NCT00903968|3956483|P4|COMPLETED|Overall Study||0
1618026|NCT00903968|3956484|P3|COMPLETED|Overall Study||0
1618027|NCT00903968|3956485|P2|COMPLETED|Overall Study||0
1618028|NCT00903968|3956486|P1|COMPLETED|Overall Study||0
1618029|NCT00903968|3956479|P8|STARTED|Overall Study||33
1618030|NCT00903968|3956480|P7|STARTED|Overall Study||3
1618031|NCT00903968|3956481|P6|STARTED|Overall Study||6
1618032|NCT00903968|3956482|P5|STARTED|Overall Study||4
1618033|NCT00903968|3956483|P4|STARTED|Overall Study||3
1618034|NCT00903968|3956484|P3|STARTED|Overall Study||3
1618035|NCT00903968|3956485|P2|STARTED|Overall Study||3
1618036|NCT00903968|3956486|P1|STARTED|Overall Study||3
1618037|NCT00903929|3956516|P4|NOT COMPLETED|Overall Study||3
1618038|NCT00903929|3956517|P3|NOT COMPLETED|Overall Study||1
1618039|NCT00903929|3956518|P2|NOT COMPLETED|Overall Study||0
1618040|NCT00903929|3956519|P1|NOT COMPLETED|Overall Study||0
1618041|NCT00903929|3956516|P4|COMPLETED|Overall Study||6
1618042|NCT00903929|3956517|P3|COMPLETED|Overall Study||3
1618043|NCT00903929|3956518|P2|COMPLETED|Overall Study||3
1618044|NCT00903929|3956519|P1|COMPLETED|Overall Study||3
1618045|NCT00903929|3956516|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
1618046|NCT00903929|3956517|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
1618047|NCT00903929|3956518|P2|STARTED|Overall Study||3
1618048|NCT00903929|3956519|P1|STARTED|Overall Study||3
1618049|NCT00903877|3956525|P1|NOT COMPLETED|Overall Study||43
1618050|NCT00903877|3956525|P1|COMPLETED|Overall Study||8
1618051|NCT00903877|3956525|P1|STARTED|Overall Study||51
1618052|NCT00903786|3956529|P1|NOT COMPLETED|Overall Study||15
1618053|NCT00903786|3956529|P1|COMPLETED|Overall Study||6
1618054|NCT00903786|3956529|P1|STARTED|Overall Study||21
1618055|NCT00903760|3956539|P2|NOT COMPLETED|Overall Study||16
1618056|NCT00903760|3956540|P1|NOT COMPLETED|Overall Study||19
1618057|NCT00903760|3956539|P2|COMPLETED|Overall Study|Completed all 24 courses|2
1618058|NCT00903760|3956540|P1|COMPLETED|Overall Study|Completed all 24 courses|0
1618059|NCT00903760|3956539|P2|STARTED|Overall Study||18
1618060|NCT00903760|3956540|P1|STARTED|Overall Study||19
1618061|NCT00903695|3956550|P2|NOT COMPLETED|Overall Study||0
1618062|NCT00903695|3956551|P1|NOT COMPLETED|Overall Study||2
1618063|NCT00903695|3956550|P2|COMPLETED|Overall Study||2
1618064|NCT00903695|3956551|P1|COMPLETED|Overall Study||6
1618065|NCT00903695|3956550|P2|STARTED|Overall Study||2
1618066|NCT00903695|3956551|P1|STARTED|Overall Study||8
1618067|NCT00903682|3956573|P2|NOT COMPLETED|Overall Study||15
1618068|NCT00903682|3956574|P1|NOT COMPLETED|Overall Study||16
1618069|NCT00903682|3956573|P2|COMPLETED|Overall Study||63
1618070|NCT00903682|3956574|P1|COMPLETED|Overall Study||63
1618071|NCT00903682|3956573|P2|STARTED|Overall Study||78
1618072|NCT00903682|3956574|P1|STARTED|Overall Study||79
1618073|NCT00903630|3956595|P3|NOT COMPLETED|Phase 2||1
1618074|NCT00903630|3956596|P2|NOT COMPLETED|Phase 2||0
1618075|NCT00903630|3956597|P1|NOT COMPLETED|Phase 2||0
1618168|NCT00903357|3956818|P1|STARTED|Wash Out Period of 2 Weeks||22
1618076|NCT00903630|3956595|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
1618077|NCT00903630|3956596|P2|COMPLETED|Phase 2||0
1618078|NCT00903630|3956597|P1|COMPLETED|Phase 2||6
1618079|NCT00903630|3956595|P3|STARTED|Phase 2||4
1618080|NCT00903630|3956596|P2|STARTED|Phase 2||0
1618081|NCT00903630|3956597|P1|STARTED|Phase 2||6
1618082|NCT00903630|3956595|P3|NOT COMPLETED|Phase l||0
1618083|NCT00903630|3956596|P2|NOT COMPLETED|Phase l||0
1618084|NCT00903630|3956597|P1|NOT COMPLETED|Phase l||0
1618085|NCT00903630|3956595|P3|COMPLETED|Phase l||0
1618086|NCT00903630|3956596|P2|COMPLETED|Phase l||5
1618087|NCT00903630|3956597|P1|COMPLETED|Phase l||6
1618088|NCT00903630|3956595|P3|STARTED|Phase l||0
1618089|NCT00903630|3956596|P2|STARTED|Phase l||5
1618090|NCT00903630|3956597|P1|STARTED|Phase l||6
1618091|NCT00903617|3956615|P4|NOT COMPLETED|Overall Study||1
1618092|NCT00903617|3956616|P3|NOT COMPLETED|Overall Study||5
1618093|NCT00903617|3956617|P2|NOT COMPLETED|Overall Study||5
1618094|NCT00903617|3956618|P1|NOT COMPLETED|Overall Study||3
1618095|NCT00903617|3956615|P4|COMPLETED|Overall Study||20
1618096|NCT00903617|3956616|P3|COMPLETED|Overall Study||15
1618097|NCT00903617|3956617|P2|COMPLETED|Overall Study||15
1618098|NCT00903617|3956618|P1|COMPLETED|Overall Study||16
1618099|NCT00903617|3956615|P4|STARTED|Overall Study||21
1618100|NCT00903617|3956616|P3|STARTED|Overall Study||20
1618101|NCT00903617|3956617|P2|STARTED|Overall Study||20
1618102|NCT00903617|3956618|P1|STARTED|Overall Study||19
1618103|NCT00903448|3956712|P2|NOT COMPLETED|Period 3: 5 Days||0
1618104|NCT00903448|3956713|P1|NOT COMPLETED|Period 3: 5 Days||0
1618105|NCT00903448|3956712|P2|COMPLETED|Period 3: 5 Days||20
1618106|NCT00903448|3956713|P1|COMPLETED|Period 3: 5 Days||20
1618107|NCT00903448|3956712|P2|STARTED|Period 3: 5 Days||20
1618108|NCT00903448|3956713|P1|STARTED|Period 3: 5 Days||20
1618109|NCT00903448|3956712|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
1618110|NCT00903448|3956713|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
1618111|NCT00903448|3956712|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
1618112|NCT00903448|3956713|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
1618113|NCT00903448|3956712|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
1618114|NCT00903448|3956713|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
1618115|NCT00903448|3956712|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
1618116|NCT00903448|3956713|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
1618117|NCT00903448|3956712|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
1618118|NCT00903448|3956713|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
1618119|NCT00903448|3956712|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
1618120|NCT00903448|3956713|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
1618121|NCT00903409|3956721|P2|NOT COMPLETED|Overall Study||27
1618122|NCT00903409|3956722|P1|NOT COMPLETED|Overall Study||26
1618123|NCT00903409|3956721|P2|COMPLETED|Overall Study||73
1618124|NCT00903409|3956722|P1|COMPLETED|Overall Study||62
1618125|NCT00903409|3956721|P2|STARTED|Overall Study||100
1618126|NCT00903409|3956722|P1|STARTED|Overall Study||88
1618127|NCT00903396|3956740|P4|NOT COMPLETED|Overall Study||0
1618128|NCT00903396|3956741|P3|NOT COMPLETED|Overall Study||0
1618129|NCT00903396|3956742|P2|NOT COMPLETED|Overall Study||0
1618130|NCT00903396|3956743|P1|NOT COMPLETED|Overall Study||0
1618131|NCT00903396|3956740|P4|COMPLETED|Overall Study||1
1618132|NCT00903396|3956741|P3|COMPLETED|Overall Study||3
1618133|NCT00903396|3956742|P2|COMPLETED|Overall Study||1
1618134|NCT00903396|3956743|P1|COMPLETED|Overall Study||2
1618135|NCT00903396|3956740|P4|STARTED|Overall Study||1
1618136|NCT00903396|3956741|P3|STARTED|Overall Study||3
1618137|NCT00903396|3956742|P2|STARTED|Overall Study||1
1618138|NCT00903396|3956743|P1|STARTED|Overall Study||2
1618139|NCT00903383|3956773|P4|NOT COMPLETED|Overall Study||5
1618140|NCT00903383|3956774|P3|NOT COMPLETED|Overall Study||3
1618141|NCT00903383|3956775|P2|NOT COMPLETED|Overall Study||6
1618142|NCT00903383|3956776|P1|NOT COMPLETED|Overall Study||7
1618143|NCT00903383|3956773|P4|COMPLETED|Overall Study||44
1618144|NCT00903383|3956774|P3|COMPLETED|Overall Study||47
1618145|NCT00903383|3956775|P2|COMPLETED|Overall Study||48
1618146|NCT00903383|3956776|P1|COMPLETED|Overall Study||48
1618147|NCT00903383|3956773|P4|STARTED|Overall Study||49
1618148|NCT00903383|3956774|P3|STARTED|Overall Study||50
1618149|NCT00903383|3956775|P2|STARTED|Overall Study||54
1618150|NCT00903383|3956776|P1|STARTED|Overall Study||55
1618151|NCT00903370|3956808|P2|NOT COMPLETED|Overall Study||24
1618152|NCT00903370|3956809|P1|NOT COMPLETED|Overall Study||28
1618153|NCT00903370|3956808|P2|COMPLETED|Overall Study||109
1618154|NCT00903370|3956809|P1|COMPLETED|Overall Study||99
1618155|NCT00903370|3956808|P2|STARTED|Overall Study||133
1618156|NCT00903370|3956809|P1|STARTED|Overall Study||127
1618157|NCT00903357|3956817|P2|NOT COMPLETED|Second Intervention||0
1618158|NCT00903357|3956818|P1|NOT COMPLETED|Second Intervention||1
1618159|NCT00903357|3956817|P2|COMPLETED|Second Intervention||22
1618160|NCT00903357|3956818|P1|COMPLETED|Second Intervention||21
1618161|NCT00903357|3956817|P2|STARTED|Second Intervention||22
1618162|NCT00903357|3956818|P1|STARTED|Second Intervention||22
1618163|NCT00903357|3956817|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
1618164|NCT00903357|3956818|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
1618165|NCT00903357|3956817|P2|COMPLETED|Wash Out Period of 2 Weeks||22
1618166|NCT00903357|3956818|P1|COMPLETED|Wash Out Period of 2 Weeks||22
1618167|NCT00903357|3956817|P2|STARTED|Wash Out Period of 2 Weeks||23
1618169|NCT00903357|3956817|P2|NOT COMPLETED|First Intervention||4
1618170|NCT00903357|3956818|P1|NOT COMPLETED|First Intervention||5
1618171|NCT00903357|3956817|P2|COMPLETED|First Intervention||23
1618172|NCT00903357|3956818|P1|COMPLETED|First Intervention||22
1618173|NCT00903357|3956817|P2|STARTED|First Intervention||27
1618174|NCT00903357|3956818|P1|STARTED|First Intervention||27
1618175|NCT00903344|3956830|P2|NOT COMPLETED|Overall Study||3
1618176|NCT00903344|3956831|P1|NOT COMPLETED|Overall Study||5
1618177|NCT00903344|3956830|P2|COMPLETED|Overall Study||7
1618178|NCT00903344|3956831|P1|COMPLETED|Overall Study||7
1618179|NCT00903344|3956830|P2|6 Month Visit|Overall Study||10
1618180|NCT00903344|3956831|P1|6 Month Visit|Overall Study||9
1618181|NCT00903344|3956830|P2|3 Month Visit|Overall Study||10
1618182|NCT00903344|3956831|P1|3 Month Visit|Overall Study||10
1618183|NCT00903344|3956830|P2|STARTED|Overall Study||10
1618184|NCT00903344|3956831|P1|STARTED|Overall Study||12
1618185|NCT00903331|3956849|P2|NOT COMPLETED|Overall Study||18
1618186|NCT00903331|3956850|P1|NOT COMPLETED|Overall Study||5
1618187|NCT00903331|3956849|P2|COMPLETED|Overall Study||101
1618188|NCT00903331|3956850|P1|COMPLETED|Overall Study||54
1618189|NCT00903331|3956849|P2|STARTED|Overall Study||119
1618190|NCT00903331|3956850|P1|STARTED|Overall Study||59
1618191|NCT00903201|3956861|P3|NOT COMPLETED|Overall Study||2
1618192|NCT00903201|3956862|P2|NOT COMPLETED|Overall Study||6
1618193|NCT00903201|3956863|P1|NOT COMPLETED|Overall Study||5
1618194|NCT00903201|3956861|P3|COMPLETED|Overall Study||39
1618195|NCT00903201|3956862|P2|COMPLETED|Overall Study||38
1618196|NCT00903201|3956863|P1|COMPLETED|Overall Study||56
1618197|NCT00903201|3956861|P3|STARTED|Overall Study||41
1618198|NCT00903201|3956862|P2|STARTED|Overall Study||44
1618199|NCT00903201|3956863|P1|STARTED|Overall Study||61
1618200|NCT00903175|3956921|P2|NOT COMPLETED|Period 2 - Second Line||36
1618201|NCT00903175|3956922|P1|NOT COMPLETED|Period 2 - Second Line||49
1618202|NCT00903175|3956921|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
1618203|NCT00903175|3956922|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
1618204|NCT00903175|3956921|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
1618205|NCT00903175|3956922|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
1618206|NCT00903175|3956921|P2|NOT COMPLETED|Period 1 - First Line||89
1618207|NCT00903175|3956922|P1|NOT COMPLETED|Period 1 - First Line||77
1618208|NCT00903175|3956921|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
1618209|NCT00903175|3956922|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
1618210|NCT00903175|3956921|P2|STARTED|Period 1 - First Line||231
1618211|NCT00903175|3956922|P1|STARTED|Period 1 - First Line||238
1618212|NCT00903162|3956952|P1|NOT COMPLETED|Overall Study||4
1618213|NCT00903162|3956952|P1|COMPLETED|Overall Study||12
1618214|NCT00903162|3956952|P1|STARTED|Overall Study||16
1618215|NCT00903032|3956960|P2|NOT COMPLETED|Overall Study||5
1618216|NCT00903032|3956961|P1|NOT COMPLETED|Overall Study||7
1618217|NCT00903032|3956960|P2|COMPLETED|Overall Study||119
1618218|NCT00903032|3956961|P1|COMPLETED|Overall Study||122
1618219|NCT00903032|3956960|P2|STARTED|Overall Study||124
1618220|NCT00903032|3956961|P1|STARTED|Overall Study||129
1618221|NCT00903006|3956971|P4|NOT COMPLETED|Overall Study||0
1618222|NCT00903006|3956972|P3|NOT COMPLETED|Overall Study||1
1618223|NCT00903006|3956973|P2|NOT COMPLETED|Overall Study||3
1618224|NCT00903006|3956974|P1|NOT COMPLETED|Overall Study||2
1618225|NCT00903006|3956971|P4|COMPLETED|Overall Study||0
1618226|NCT00903006|3956972|P3|COMPLETED|Overall Study||0
1618227|NCT00903006|3956973|P2|COMPLETED|Overall Study||0
1618228|NCT00903006|3956974|P1|COMPLETED|Overall Study||0
1618229|NCT00903006|3956971|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
1618230|NCT00903006|3956972|P3|STARTED|Overall Study||1
1618231|NCT00903006|3956973|P2|STARTED|Overall Study||3
1618232|NCT00903006|3956974|P1|STARTED|Overall Study||2
1618233|NCT00902850|3956986|P2|NOT COMPLETED|Overall Study||2
1618234|NCT00902850|3956987|P1|NOT COMPLETED|Overall Study||2
1618235|NCT00902850|3956986|P2|COMPLETED|Overall Study||12
1618236|NCT00902850|3956987|P1|COMPLETED|Overall Study||12
1618237|NCT00902850|3956986|P2|STARTED|Overall Study||14
1618238|NCT00902850|3956987|P1|STARTED|Overall Study||14
1618239|NCT00902746|3956993|P1|NOT COMPLETED|Overall Study||36
1618240|NCT00902746|3956993|P1|COMPLETED|Overall Study||113
1618241|NCT00902746|3956993|P1|Transfer to Step 2|Overall Study||133
1618242|NCT00902746|3956993|P1|Initiation of Study Drug Administration|Overall Study||148
1618243|NCT00902746|3956993|P1|STARTED|Overall Study||149
1618244|NCT00902668|3956998|P1|NOT COMPLETED|Overall Study||3
1618245|NCT00902668|3956998|P1|COMPLETED|Overall Study||0
1618246|NCT00902668|3956998|P1|STARTED|Overall Study||3
1618247|NCT00902564|3957002|P1|NOT COMPLETED|Overall Study||2
1618248|NCT00902564|3957002|P1|COMPLETED|Overall Study||28
1618249|NCT00902564|3957002|P1|STARTED|Overall Study||30
1618250|NCT00902538|3957017|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
1618251|NCT00902538|3957018|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
1618252|NCT00902538|3957019|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
1618253|NCT00902538|3957020|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
1618254|NCT00902538|3957021|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
1618255|NCT00902538|3957022|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
1618256|NCT00902538|3957017|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
1618257|NCT00902538|3957018|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
1618258|NCT00902538|3957019|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
1618259|NCT00902538|3957020|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
1618260|NCT00902538|3957021|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
1618261|NCT00902538|3957022|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
1618262|NCT00902538|3957017|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
1618263|NCT00902538|3957018|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
1618264|NCT00902538|3957019|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
1618265|NCT00902538|3957020|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
1618266|NCT00902538|3957021|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
1618267|NCT00902538|3957022|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
1618268|NCT00902538|3957017|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
1618269|NCT00902538|3957018|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
1618270|NCT00902538|3957019|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
1618271|NCT00902538|3957020|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
1618272|NCT00902538|3957021|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
1618273|NCT00902538|3957022|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
1618274|NCT00902538|3957017|P6|COMPLETED|3-Single-blind, Single Treatment||0
1618275|NCT00902538|3957018|P5|COMPLETED|3-Single-blind, Single Treatment||0
1618276|NCT00902538|3957019|P4|COMPLETED|3-Single-blind, Single Treatment||0
1618277|NCT00902538|3957020|P3|COMPLETED|3-Single-blind, Single Treatment||0
1618278|NCT00902538|3957021|P2|COMPLETED|3-Single-blind, Single Treatment||767
1618279|NCT00902538|3957022|P1|COMPLETED|3-Single-blind, Single Treatment||0
1618280|NCT00902538|3957017|P6|STARTED|3-Single-blind, Single Treatment||0
1618281|NCT00902538|3957018|P5|STARTED|3-Single-blind, Single Treatment||0
1618282|NCT00902538|3957019|P4|STARTED|3-Single-blind, Single Treatment||0
1618283|NCT00902538|3957020|P3|STARTED|3-Single-blind, Single Treatment||0
1618284|NCT00902538|3957021|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
1618285|NCT00902538|3957022|P1|STARTED|3-Single-blind, Single Treatment||0
1618286|NCT00902538|3957017|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
1618287|NCT00902538|3957018|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
1618288|NCT00902538|3957019|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
1618289|NCT00902538|3957020|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
1618290|NCT00902538|3957021|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
1618291|NCT00902538|3957022|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
1618292|NCT00902538|3957017|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
1618293|NCT00902538|3957018|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
1618294|NCT00902538|3957019|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
1618295|NCT00902538|3957020|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
1618296|NCT00902538|3957021|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
1618297|NCT00902538|3957022|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
1618298|NCT00902538|3957017|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
1618299|NCT00902538|3957018|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
1618300|NCT00902538|3957019|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
1618301|NCT00902538|3957020|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
1618302|NCT00902538|3957021|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
1618303|NCT00902538|3957022|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
1618304|NCT00902538|3957017|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618305|NCT00902538|3957018|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618306|NCT00902538|3957019|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618307|NCT00902538|3957020|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618308|NCT00902538|3957021|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618309|NCT00902538|3957022|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
1618310|NCT00902538|3957017|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618311|NCT00902538|3957018|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618312|NCT00902538|3957019|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618313|NCT00902538|3957020|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618314|NCT00902538|3957021|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1618315|NCT00902538|3957022|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
1618316|NCT00902538|3957017|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1618317|NCT00902538|3957018|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1618318|NCT00902538|3957019|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1618319|NCT00902538|3957020|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1618320|NCT00902538|3957021|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1618321|NCT00902538|3957022|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
1618322|NCT00902486|3957056|P6|NOT COMPLETED|Follow-up (After Week 24)||0
1618323|NCT00902486|3957057|P5|NOT COMPLETED|Follow-up (After Week 24)||0
1618324|NCT00902486|3957058|P4|NOT COMPLETED|Follow-up (After Week 24)||1
1618325|NCT00902486|3957059|P3|NOT COMPLETED|Follow-up (After Week 24)||0
1618326|NCT00902486|3957060|P2|NOT COMPLETED|Follow-up (After Week 24)||0
1618327|NCT00902486|3957061|P1|NOT COMPLETED|Follow-up (After Week 24)||0
1618328|NCT00902486|3957056|P6|COMPLETED|Follow-up (After Week 24)||24
1618329|NCT00902486|3957057|P5|COMPLETED|Follow-up (After Week 24)||29
1618330|NCT00902486|3957058|P4|COMPLETED|Follow-up (After Week 24)||26
1618331|NCT00902486|3957059|P3|COMPLETED|Follow-up (After Week 24)||13
1618332|NCT00902486|3957060|P2|COMPLETED|Follow-up (After Week 24)||14
1618333|NCT00902486|3957061|P1|COMPLETED|Follow-up (After Week 24)||0
1618334|NCT00902486|3957056|P6|Safety Evaluable Participants|Follow-up (After Week 24)||27
1618335|NCT00902486|3957057|P5|Safety Evaluable Participants|Follow-up (After Week 24)||30
1618336|NCT00902486|3957058|P4|Safety Evaluable Participants|Follow-up (After Week 24)||29
1618337|NCT00902486|3957059|P3|Safety Evaluable Participants|Follow-up (After Week 24)||15
1618338|NCT00902486|3957060|P2|Safety Evaluable Participants|Follow-up (After Week 24)||14
1618339|NCT00902486|3957061|P1|Safety Evaluable Participants|Follow-up (After Week 24)||0
1618340|NCT00902486|3957056|P6|STARTED|Follow-up (After Week 24)||24
1618341|NCT00902486|3957057|P5|STARTED|Follow-up (After Week 24)||29
1618342|NCT00902486|3957058|P4|STARTED|Follow-up (After Week 24)||27
1618343|NCT00902486|3957059|P3|STARTED|Follow-up (After Week 24)||13
1618344|NCT00902486|3957060|P2|STARTED|Follow-up (After Week 24)||14
1618345|NCT00902486|3957061|P1|STARTED|Follow-up (After Week 24)||0
1618346|NCT00902486|3957056|P6|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
1618347|NCT00902486|3957057|P5|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
1618348|NCT00902486|3957058|P4|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
1618349|NCT00902486|3957059|P3|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
1618350|NCT00902486|3957060|P2|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
1618351|NCT00902486|3957061|P1|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
1618352|NCT00902486|3957056|P6|COMPLETED|Extension Period (Weeks 12 Through 24)||24
1618353|NCT00902486|3957057|P5|COMPLETED|Extension Period (Weeks 12 Through 24)||29
1618354|NCT00902486|3957058|P4|COMPLETED|Extension Period (Weeks 12 Through 24)||27
1618355|NCT00902486|3957059|P3|COMPLETED|Extension Period (Weeks 12 Through 24)||13
1618356|NCT00902486|3957060|P2|COMPLETED|Extension Period (Weeks 12 Through 24)||14
1618357|NCT00902486|3957061|P1|COMPLETED|Extension Period (Weeks 12 Through 24)||0
1618358|NCT00902486|3957056|P6|STARTED|Extension Period (Weeks 12 Through 24)||27
1618359|NCT00902486|3957057|P5|STARTED|Extension Period (Weeks 12 Through 24)||30
1618360|NCT00902486|3957058|P4|STARTED|Extension Period (Weeks 12 Through 24)||29
1618361|NCT00902486|3957059|P3|STARTED|Extension Period (Weeks 12 Through 24)||15
1618362|NCT00902486|3957060|P2|STARTED|Extension Period (Weeks 12 Through 24)||14
1618363|NCT00902486|3957061|P1|STARTED|Extension Period (Weeks 12 Through 24)||0
1618364|NCT00902486|3957056|P6|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
1618365|NCT00902486|3957057|P5|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
1618366|NCT00902486|3957058|P4|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
1618367|NCT00902486|3957059|P3|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
1618368|NCT00902486|3957060|P2|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
1618369|NCT00902486|3957061|P1|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
1618370|NCT00902486|3957056|P6|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
1618371|NCT00902486|3957057|P5|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
1618372|NCT00902486|3957058|P4|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
1618373|NCT00902486|3957059|P3|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
1618374|NCT00902486|3957060|P2|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
1618375|NCT00902486|3957061|P1|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
1618376|NCT00902486|3957056|P6|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
1618377|NCT00902486|3957057|P5|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
1618378|NCT00902486|3957058|P4|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
1618379|NCT00902486|3957059|P3|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
1618380|NCT00902486|3957060|P2|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
1618381|NCT00902486|3957061|P1|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
1618382|NCT00902486|3957056|P6|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
1618383|NCT00902486|3957057|P5|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
1618384|NCT00902486|3957058|P4|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
1618385|NCT00902486|3957059|P3|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
1618386|NCT00902486|3957060|P2|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
1618387|NCT00902486|3957061|P1|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
1618388|NCT00902486|3957056|P6|STARTED|Treatment Period (Weeks 0 Through 12)||32
1618389|NCT00902486|3957057|P5|STARTED|Treatment Period (Weeks 0 Through 12)||32
1618390|NCT00902486|3957058|P4|STARTED|Treatment Period (Weeks 0 Through 12)||32
1618391|NCT00902486|3957059|P3|STARTED|Treatment Period (Weeks 0 Through 12)||0
1618392|NCT00902486|3957060|P2|STARTED|Treatment Period (Weeks 0 Through 12)||0
1618393|NCT00902486|3957061|P1|STARTED|Treatment Period (Weeks 0 Through 12)||31
1618394|NCT00902330|3957199|P2|NOT COMPLETED|Overall Study||5
1618395|NCT00902330|3957200|P1|NOT COMPLETED|Overall Study||4
1618396|NCT00902330|3957199|P2|COMPLETED|Overall Study||75
1618397|NCT00902330|3957200|P1|COMPLETED|Overall Study||77
1618398|NCT00902330|3957199|P2|STARTED|Overall Study||80
1618399|NCT00902330|3957200|P1|STARTED|Overall Study||81
1618400|NCT00902304|3957237|P3|NOT COMPLETED|Overall Study||110
1618401|NCT00902304|3957238|P2|NOT COMPLETED|Overall Study||71
1618402|NCT00902304|3957239|P1|NOT COMPLETED|Overall Study||58
1618403|NCT00902304|3957237|P3|COMPLETED|Overall Study||568
1618404|NCT00902304|3957238|P2|COMPLETED|Overall Study||289
1618405|NCT00902304|3957239|P1|COMPLETED|Overall Study||466
1618406|NCT00902304|3957237|P3|STARTED|Overall Study||678
1618407|NCT00902304|3957238|P2|STARTED|Overall Study||360
1618408|NCT00902304|3957239|P1|STARTED|Overall Study||524
1618409|NCT00902278|3957289|P5|NOT COMPLETED|Overall Study||2
1618410|NCT00902278|3957290|P4|NOT COMPLETED|Overall Study||0
1618411|NCT00902278|3957291|P3|NOT COMPLETED|Overall Study||5
1618412|NCT00902278|3957292|P2|NOT COMPLETED|Overall Study||2
1618413|NCT00902278|3957293|P1|NOT COMPLETED|Overall Study||4
1618414|NCT00902278|3957289|P5|COMPLETED|Overall Study||35
1618415|NCT00902278|3957290|P4|COMPLETED|Overall Study||12
1618416|NCT00902278|3957291|P3|COMPLETED|Overall Study||49
1618417|NCT00902278|3957292|P2|COMPLETED|Overall Study||34
1618418|NCT00902278|3957293|P1|COMPLETED|Overall Study||50
1618419|NCT00902278|3957289|P5|STARTED|Overall Study||37
1618420|NCT00902278|3957290|P4|STARTED|Overall Study||12
1618421|NCT00902278|3957291|P3|STARTED|Overall Study||54
1618422|NCT00902278|3957292|P2|STARTED|Overall Study||36
1618423|NCT00902278|3957293|P1|STARTED|Overall Study||54
1618424|NCT00902265|3957310|P1|NOT COMPLETED|Overall Study||6
1618425|NCT00902265|3957310|P1|COMPLETED|Overall Study||132
1618426|NCT00902265|3957310|P1|Participants Who Received Treatment|Overall Study||137
1618427|NCT00902265|3957310|P1|STARTED|Overall Study||138
1618428|NCT00902226|3957322|P1|NOT COMPLETED|Overall Study||0
1618429|NCT00902226|3957322|P1|COMPLETED|Overall Study||30
1618430|NCT00902226|3957322|P1|STARTED|Overall Study||30
1618431|NCT00902174|3957334|P2|NOT COMPLETED|Overall Study||18
1618432|NCT00902174|3957335|P1|NOT COMPLETED|Overall Study||34
1618433|NCT00902174|3957334|P2|COMPLETED|Overall Study||81
1618434|NCT00902174|3957335|P1|COMPLETED|Overall Study||69
1618435|NCT00902174|3957334|P2|STARTED|Overall Study||99
1618436|NCT00902174|3957335|P1|STARTED|Overall Study||103
1618437|NCT00902161|3957373|P3|NOT COMPLETED|Period 2||0
1618438|NCT00902161|3957374|P2|NOT COMPLETED|Period 2||0
1618439|NCT00902161|3957375|P1|NOT COMPLETED|Period 2||0
1618440|NCT00902161|3957373|P3|COMPLETED|Period 2||0
1618441|NCT00902161|3957374|P2|COMPLETED|Period 2||9
1618442|NCT00902161|3957375|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
1618443|NCT00902161|3957373|P3|STARTED|Period 2||0
1618444|NCT00902161|3957374|P2|STARTED|Period 2||9
1618445|NCT00902161|3957375|P1|STARTED|Period 2||8
1618446|NCT00902161|3957373|P3|NOT COMPLETED|Post-clamp Washout||0
1618447|NCT00902161|3957374|P2|NOT COMPLETED|Post-clamp Washout||0
1618448|NCT00902161|3957375|P1|NOT COMPLETED|Post-clamp Washout||0
1618449|NCT00902161|3957373|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
1618450|NCT00902161|3957374|P2|COMPLETED|Post-clamp Washout||0
1618451|NCT00902161|3957375|P1|COMPLETED|Post-clamp Washout||0
1618452|NCT00902161|3957373|P3|STARTED|Post-clamp Washout||22
1618453|NCT00902161|3957374|P2|STARTED|Post-clamp Washout||0
1618454|NCT00902161|3957375|P1|STARTED|Post-clamp Washout||0
1618455|NCT00902161|3957373|P3|NOT COMPLETED|Period 1||0
1618456|NCT00902161|3957374|P2|NOT COMPLETED|Period 1||0
1618457|NCT00902161|3957375|P1|NOT COMPLETED|Period 1||0
1618458|NCT00902161|3957373|P3|COMPLETED|Period 1||0
1618459|NCT00902161|3957374|P2|COMPLETED|Period 1||10
1618460|NCT00902161|3957375|P1|COMPLETED|Period 1||12
1618461|NCT00902161|3957373|P3|STARTED|Period 1||0
1618462|NCT00902161|3957374|P2|STARTED|Period 1||10
1618463|NCT00902161|3957375|P1|STARTED|Period 1||12
1618464|NCT00902161|3957373|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
1618465|NCT00902161|3957374|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
1618466|NCT00902161|3957375|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
1618467|NCT00902161|3957373|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
1618468|NCT00902161|3957374|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
1618469|NCT00902161|3957375|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
1618470|NCT00902161|3957373|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
1618471|NCT00902161|3957374|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
1618472|NCT00902161|3957375|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
1618473|NCT00901901|3957392|P2|NOT COMPLETED|Follow-up Period||259
1618474|NCT00901901|3957393|P1|NOT COMPLETED|Follow-up Period||246
1618475|NCT00901901|3957392|P2|COMPLETED|Follow-up Period|These participants are ongoing.|65
1618476|NCT00901901|3957393|P1|COMPLETED|Follow-up Period|These participants are ongoing.|76
1618477|NCT00901901|3957392|P2|STARTED|Follow-up Period||324
1618478|NCT00901901|3957393|P1|STARTED|Follow-up Period||322
1618479|NCT00901901|3957392|P2|NOT COMPLETED|Treatment Period||168
1618480|NCT00901901|3957393|P1|NOT COMPLETED|Treatment Period||157
1618481|NCT00901901|3957392|P2|COMPLETED|Treatment Period|17 of these participants are ongoing|190
1618482|NCT00901901|3957393|P1|COMPLETED|Treatment Period|19 of these participants are ongoing|205
1618483|NCT00901901|3957392|P2|Participants Received Treatment|Treatment Period||355
1618484|NCT00901901|3957393|P1|Participants Received Treatment|Treatment Period||362
1618485|NCT00901901|3957392|P2|STARTED|Treatment Period||358
1618486|NCT00901901|3957393|P1|STARTED|Treatment Period||362
1618487|NCT00901628|3957415|P2|NOT COMPLETED|Overall Study||10
1618488|NCT00901628|3957416|P1|NOT COMPLETED|Overall Study||4
1618489|NCT00901628|3957415|P2|COMPLETED|Overall Study||42
1618490|NCT00901628|3957416|P1|COMPLETED|Overall Study||45
1618491|NCT00901628|3957415|P2|STARTED|Overall Study||52
1618492|NCT00901628|3957416|P1|STARTED|Overall Study||49
1618493|NCT00901576|3957438|P6|NOT COMPLETED|Third Intervention||0
1618494|NCT00901576|3957439|P5|NOT COMPLETED|Third Intervention||0
1618495|NCT00901576|3957440|P4|NOT COMPLETED|Third Intervention||0
1618496|NCT00901576|3957441|P3|NOT COMPLETED|Third Intervention||0
1618497|NCT00901576|3957442|P2|NOT COMPLETED|Third Intervention||0
1618498|NCT00901576|3957443|P1|NOT COMPLETED|Third Intervention||0
1618499|NCT00901576|3957438|P6|COMPLETED|Third Intervention||5
1618500|NCT00901576|3957439|P5|COMPLETED|Third Intervention||6
1618501|NCT00901576|3957440|P4|COMPLETED|Third Intervention||5
1618502|NCT00901576|3957441|P3|COMPLETED|Third Intervention||7
1618503|NCT00901576|3957442|P2|COMPLETED|Third Intervention||7
1618504|NCT00901576|3957443|P1|COMPLETED|Third Intervention||5
1618505|NCT00901576|3957438|P6|STARTED|Third Intervention||5
1618506|NCT00901576|3957439|P5|STARTED|Third Intervention||6
1618507|NCT00901576|3957440|P4|STARTED|Third Intervention||5
1618508|NCT00901576|3957441|P3|STARTED|Third Intervention||7
1618509|NCT00901576|3957442|P2|STARTED|Third Intervention||7
1618510|NCT00901576|3957443|P1|STARTED|Third Intervention||5
1618511|NCT00901576|3957438|P6|NOT COMPLETED|Washout||0
1618512|NCT00901576|3957439|P5|NOT COMPLETED|Washout||0
1618513|NCT00901576|3957440|P4|NOT COMPLETED|Washout||0
1618514|NCT00901576|3957441|P3|NOT COMPLETED|Washout||0
1618515|NCT00901576|3957442|P2|NOT COMPLETED|Washout||0
1618516|NCT00901576|3957443|P1|NOT COMPLETED|Washout||0
1618517|NCT00901576|3957438|P6|COMPLETED|Washout||5
1618518|NCT00901576|3957439|P5|COMPLETED|Washout||6
1618519|NCT00901576|3957440|P4|COMPLETED|Washout||5
1618520|NCT00901576|3957441|P3|COMPLETED|Washout||7
1618521|NCT00901576|3957442|P2|COMPLETED|Washout||7
1618522|NCT00901576|3957443|P1|COMPLETED|Washout||5
1618523|NCT00901576|3957438|P6|STARTED|Washout||5
1618524|NCT00901576|3957439|P5|STARTED|Washout||6
1618525|NCT00901576|3957440|P4|STARTED|Washout||5
1618526|NCT00901576|3957441|P3|STARTED|Washout||7
1618527|NCT00901576|3957442|P2|STARTED|Washout||7
1618528|NCT00901576|3957443|P1|STARTED|Washout||5
1618529|NCT00901576|3957438|P6|NOT COMPLETED|Second Intervention||1
1618530|NCT00901576|3957439|P5|NOT COMPLETED|Second Intervention||0
1618531|NCT00901576|3957440|P4|NOT COMPLETED|Second Intervention||1
1618532|NCT00901576|3957441|P3|NOT COMPLETED|Second Intervention||0
1618533|NCT00901576|3957442|P2|NOT COMPLETED|Second Intervention||0
1618534|NCT00901576|3957443|P1|NOT COMPLETED|Second Intervention||1
1618535|NCT00901576|3957438|P6|COMPLETED|Second Intervention||5
1618536|NCT00901576|3957439|P5|COMPLETED|Second Intervention||6
1618537|NCT00901576|3957440|P4|COMPLETED|Second Intervention||5
1618538|NCT00901576|3957441|P3|COMPLETED|Second Intervention||7
1618539|NCT00901576|3957442|P2|COMPLETED|Second Intervention||7
1618540|NCT00901576|3957443|P1|COMPLETED|Second Intervention||5
1618541|NCT00901576|3957438|P6|STARTED|Second Intervention||6
1618542|NCT00901576|3957439|P5|STARTED|Second Intervention||6
1618543|NCT00901576|3957440|P4|STARTED|Second Intervention||6
1618544|NCT00901576|3957441|P3|STARTED|Second Intervention||7
1618545|NCT00901576|3957442|P2|STARTED|Second Intervention||7
1618546|NCT00901576|3957443|P1|STARTED|Second Intervention||6
1618547|NCT00901576|3957438|P6|NOT COMPLETED|Washout||0
1618548|NCT00901576|3957439|P5|NOT COMPLETED|Washout||0
1618549|NCT00901576|3957440|P4|NOT COMPLETED|Washout||0
1618550|NCT00901576|3957441|P3|NOT COMPLETED|Washout||0
1618551|NCT00901576|3957442|P2|NOT COMPLETED|Washout||0
1618552|NCT00901576|3957443|P1|NOT COMPLETED|Washout||0
1618553|NCT00901576|3957438|P6|COMPLETED|Washout||6
1618554|NCT00901576|3957439|P5|COMPLETED|Washout||6
1618555|NCT00901576|3957440|P4|COMPLETED|Washout||6
1618556|NCT00901576|3957441|P3|COMPLETED|Washout||7
1618557|NCT00901576|3957442|P2|COMPLETED|Washout||7
1618558|NCT00901576|3957443|P1|COMPLETED|Washout||6
1618559|NCT00901576|3957438|P6|STARTED|Washout||6
1618560|NCT00901576|3957439|P5|STARTED|Washout||6
1618561|NCT00901576|3957440|P4|STARTED|Washout||6
1618562|NCT00901576|3957441|P3|STARTED|Washout||7
1618563|NCT00901576|3957442|P2|STARTED|Washout||7
1618564|NCT00901576|3957443|P1|STARTED|Washout||6
1618565|NCT00901576|3957438|P6|NOT COMPLETED|First Intervention||0
1618566|NCT00901576|3957439|P5|NOT COMPLETED|First Intervention||0
1618567|NCT00901576|3957440|P4|NOT COMPLETED|First Intervention||0
1618568|NCT00901576|3957441|P3|NOT COMPLETED|First Intervention||0
1618569|NCT00901576|3957442|P2|NOT COMPLETED|First Intervention||0
1618570|NCT00901576|3957443|P1|NOT COMPLETED|First Intervention||0
1618571|NCT00901576|3957438|P6|COMPLETED|First Intervention||6
1618572|NCT00901576|3957439|P5|COMPLETED|First Intervention||6
1618573|NCT00901576|3957440|P4|COMPLETED|First Intervention||6
1618574|NCT00901576|3957441|P3|COMPLETED|First Intervention||7
1618575|NCT00901576|3957442|P2|COMPLETED|First Intervention||7
1618576|NCT00901576|3957443|P1|COMPLETED|First Intervention||6
1618577|NCT00901576|3957438|P6|STARTED|First Intervention||6
1618578|NCT00901576|3957439|P5|STARTED|First Intervention||6
1618579|NCT00901576|3957440|P4|STARTED|First Intervention||6
1618580|NCT00901576|3957441|P3|STARTED|First Intervention||7
1618581|NCT00901576|3957442|P2|STARTED|First Intervention||7
1618582|NCT00901576|3957443|P1|STARTED|First Intervention||6
1618583|NCT00901459|3957464|P1|NOT COMPLETED|Overall Study||6
1618584|NCT00901459|3957464|P1|COMPLETED|Overall Study||15
1618585|NCT00901459|3957464|P1|STARTED|Overall Study||21
1618586|NCT00901342|3957475|P1|NOT COMPLETED|Overall Study||15
1618587|NCT00901342|3957475|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
1618588|NCT00901342|3957475|P1|Received at Least 1 Infusion|Overall Study||98
1618589|NCT00901342|3957475|P1|STARTED|Overall Study||104
1618590|NCT00901316|3957481|P2|NOT COMPLETED|Overall Study||0
1618591|NCT00901316|3957482|P1|NOT COMPLETED|Overall Study||0
1618592|NCT00901316|3957481|P2|COMPLETED|Overall Study||495
1618593|NCT00901316|3957482|P1|COMPLETED|Overall Study||492
1618594|NCT00901316|3957481|P2|STARTED|Overall Study||495
1618595|NCT00901316|3957482|P1|STARTED|Overall Study||492
1618596|NCT00901303|3957490|P2|NOT COMPLETED|Overall Study||0
1618597|NCT00901303|3957491|P1|NOT COMPLETED|Overall Study||0
1618598|NCT00901303|3957490|P2|COMPLETED|Overall Study||1
1618599|NCT00901303|3957491|P1|COMPLETED|Overall Study||5
1618600|NCT00901303|3957490|P2|STARTED|Overall Study||1
1618601|NCT00901303|3957491|P1|STARTED|Overall Study||5
1618602|NCT00901225|3957497|P1|NOT COMPLETED|Overall Study||1
1618603|NCT00901225|3957497|P1|COMPLETED|Overall Study||20
1618604|NCT00901225|3957497|P1|STARTED|Overall Study||21
1618605|NCT00901186|3957508|P2|NOT COMPLETED|Overall Study||11
1618606|NCT00901186|3957509|P1|NOT COMPLETED|Overall Study||9
1618607|NCT00901186|3957508|P2|COMPLETED|Overall Study||32
1618608|NCT00901186|3957509|P1|COMPLETED|Overall Study||31
1618609|NCT00901186|3957508|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
1618610|NCT00901186|3957509|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
1618611|NCT00901186|3957508|P2|Safety Set|Overall Study||43
1618612|NCT00901186|3957509|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
1618613|NCT00901186|3957508|P2|STARTED|Overall Study||43
1618614|NCT00901186|3957509|P1|STARTED|Overall Study||40
1618615|NCT00901017|3957525|P1|NOT COMPLETED|Overall Study||0
1618616|NCT00901017|3957525|P1|COMPLETED|Overall Study||14
1618617|NCT00901017|3957525|P1|STARTED|Overall Study||14
1618618|NCT00900822|3957539|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
1618619|NCT00900822|3957539|P1|COMPLETED|12 Months Clinical Evaluation||11
1618620|NCT00900822|3957539|P1|STARTED|12 Months Clinical Evaluation||11
1618621|NCT00900822|3957539|P1|NOT COMPLETED|9 Months Histological Evaluation||0
1618622|NCT00900822|3957539|P1|COMPLETED|9 Months Histological Evaluation||11
1618623|NCT00900822|3957539|P1|STARTED|9 Months Histological Evaluation||11
1618624|NCT00900796|3957549|P1|NOT COMPLETED|Phase 2||5
1618625|NCT00900796|3957549|P1|COMPLETED|Phase 2||6
1618626|NCT00900796|3957549|P1|STARTED|Phase 2||11
1618627|NCT00900796|3957549|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
1618628|NCT00900796|3957549|P1|COMPLETED|Between Phase 1 and Phase 2||11
1618629|NCT00900796|3957549|P1|STARTED|Between Phase 1 and Phase 2||121
1618630|NCT00900796|3957549|P1|NOT COMPLETED|Phase 1||11
1618631|NCT00900796|3957549|P1|COMPLETED|Phase 1||121
1618632|NCT00900796|3957549|P1|STARTED|Phase 1||132
1618633|NCT00900757|3957559|P1|NOT COMPLETED|Overall Study||19
1618634|NCT00900757|3957559|P1|COMPLETED|Overall Study||38
1618635|NCT00900757|3957559|P1|STARTED|Overall Study||57
1618636|NCT00900731|3957569|P2|NOT COMPLETED|Overall Study||61
1618637|NCT00900731|3957570|P1|NOT COMPLETED|Overall Study||60
1618638|NCT00900731|3957569|P2|COMPLETED|Overall Study||740
1618639|NCT00900731|3957570|P1|COMPLETED|Overall Study||737
1618640|NCT00900731|3957569|P2|Safety Set: Received Study Drug|Overall Study||799
1618641|NCT00900731|3957570|P1|Safety Set: Received Study Drug|Overall Study||794
1618642|NCT00900731|3957569|P2|STARTED|Overall Study||801
1618643|NCT00900731|3957570|P1|STARTED|Overall Study|Randomized participants|797
1618644|NCT00900666|3957592|P2|NOT COMPLETED|Overall Study||0
1618645|NCT00900666|3957593|P1|NOT COMPLETED|Overall Study||0
1618646|NCT00900666|3957592|P2|COMPLETED|Overall Study||9
1618647|NCT00900666|3957593|P1|COMPLETED|Overall Study||10
1618648|NCT00900666|3957592|P2|STARTED|Overall Study||9
1618649|NCT00900666|3957593|P1|STARTED|Overall Study||10
1618650|NCT00900627|3957607|P6|NOT COMPLETED|Overall Study||26
1618651|NCT00900627|3957608|P5|NOT COMPLETED|Overall Study||29
1618652|NCT00900627|3957609|P4|NOT COMPLETED|Overall Study||6
1618653|NCT00900627|3957610|P3|NOT COMPLETED|Overall Study||6
1618654|NCT00900627|3957611|P2|NOT COMPLETED|Overall Study||2
1618655|NCT00900627|3957612|P1|NOT COMPLETED|Overall Study||6
1618656|NCT00900627|3957607|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
1618657|NCT00900627|3957608|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
1618658|NCT00900627|3957609|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1618659|NCT00900627|3957610|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1618660|NCT00900627|3957611|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1618661|NCT00900627|3957612|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1618662|NCT00900627|3957607|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
1618663|NCT00900627|3957608|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
1618664|NCT00900627|3957609|P4|STARTED|Overall Study||6
1618665|NCT00900627|3957610|P3|STARTED|Overall Study||6
1618666|NCT00900627|3957611|P2|STARTED|Overall Study||2
1618667|NCT00900627|3957612|P1|STARTED|Overall Study||6
1618668|NCT00900601|3957630|P1|NOT COMPLETED|Overall Study||1
1618669|NCT00900601|3957630|P1|COMPLETED|Overall Study||8
1618670|NCT00900601|3957630|P1|STARTED|Overall Study||9
1618671|NCT00900237|3957638|P2|NOT COMPLETED|Overall Study||0
1618672|NCT00900237|3957639|P1|NOT COMPLETED|Overall Study||0
1618673|NCT00900237|3957638|P2|COMPLETED|Overall Study||7
1618674|NCT00900237|3957639|P1|COMPLETED|Overall Study||7
1618675|NCT00900237|3957638|P2|STARTED|Overall Study||7
1618676|NCT00900237|3957639|P1|STARTED|Overall Study||7
1618677|NCT00900159|3957649|P2|NOT COMPLETED|Second Intervention||0
1618678|NCT00900159|3957650|P1|NOT COMPLETED|Second Intervention||1
1618679|NCT00900159|3957649|P2|COMPLETED|Second Intervention||13
1618680|NCT00900159|3957650|P1|COMPLETED|Second Intervention||10
1618681|NCT00900159|3957649|P2|STARTED|Second Intervention||13
1618682|NCT00900159|3957650|P1|STARTED|Second Intervention||11
1618683|NCT00900159|3957649|P2|NOT COMPLETED|Washout||0
1618684|NCT00900159|3957650|P1|NOT COMPLETED|Washout||0
1618685|NCT00900159|3957649|P2|COMPLETED|Washout||13
1618686|NCT00900159|3957650|P1|COMPLETED|Washout||11
1618687|NCT00900159|3957649|P2|STARTED|Washout||13
1618688|NCT00900159|3957650|P1|STARTED|Washout||11
1618689|NCT00900159|3957649|P2|NOT COMPLETED|First Intervention||0
1618690|NCT00900159|3957650|P1|NOT COMPLETED|First Intervention||0
1618691|NCT00900159|3957649|P2|COMPLETED|First Intervention||13
1618692|NCT00900159|3957650|P1|COMPLETED|First Intervention||11
1618693|NCT00900159|3957649|P2|STARTED|First Intervention||13
1618694|NCT00900159|3957650|P1|STARTED|First Intervention||11
1618695|NCT00900146|3957669|P5|NOT COMPLETED|Intermediate: Period III||167
1618696|NCT00900146|3957670|P4|NOT COMPLETED|Intermediate: Period III||90
1618697|NCT00900146|3957671|P3|NOT COMPLETED|Intermediate: Period III||84
1618698|NCT00900146|3957672|P2|NOT COMPLETED|Intermediate: Period III||93
1618699|NCT00900146|3957673|P1|NOT COMPLETED|Intermediate: Period III||87
1618700|NCT00900146|3957669|P5|COMPLETED|Intermediate: Period III||0
1618701|NCT00900146|3957670|P4|COMPLETED|Intermediate: Period III||0
1618702|NCT00900146|3957671|P3|COMPLETED|Intermediate: Period III||0
1618703|NCT00900146|3957672|P2|COMPLETED|Intermediate: Period III||0
1618704|NCT00900146|3957673|P1|COMPLETED|Intermediate: Period III||0
1618705|NCT00900146|3957669|P5|Safety Set|Intermediate: Period III||166
1618706|NCT00900146|3957670|P4|Safety Set|Intermediate: Period III||90
1618707|NCT00900146|3957671|P3|Safety Set|Intermediate: Period III||84
1618708|NCT00900146|3957672|P2|Safety Set|Intermediate: Period III||92
1618709|NCT00900146|3957673|P1|Safety Set|Intermediate: Period III||86
1618710|NCT00900146|3957669|P5|STARTED|Intermediate: Period III||167
1618711|NCT00900146|3957670|P4|STARTED|Intermediate: Period III||90
1618712|NCT00900146|3957671|P3|STARTED|Intermediate: Period III||84
1618713|NCT00900146|3957672|P2|STARTED|Intermediate: Period III||93
1618714|NCT00900146|3957673|P1|STARTED|Intermediate: Period III||87
1618715|NCT00900146|3957669|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
1618716|NCT00900146|3957670|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
1618717|NCT00900146|3957671|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
1618718|NCT00900146|3957672|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
1618719|NCT00900146|3957673|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
1618720|NCT00900146|3957669|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
1618721|NCT00900146|3957670|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
1618722|NCT00900146|3957671|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
1618723|NCT00900146|3957672|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
1618724|NCT00900146|3957673|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
1618725|NCT00900146|3957669|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
1618726|NCT00900146|3957670|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
1618727|NCT00900146|3957671|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
1618728|NCT00900146|3957672|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
1618729|NCT00900146|3957673|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
1618730|NCT00900146|3957669|P5|STARTED|Dose Finding: Period II (4 Months)||179
1618731|NCT00900146|3957670|P4|STARTED|Dose Finding: Period II (4 Months)||92
1618732|NCT00900146|3957671|P3|STARTED|Dose Finding: Period II (4 Months)||92
1618733|NCT00900146|3957672|P2|STARTED|Dose Finding: Period II (4 Months)||95
1618734|NCT00900146|3957673|P1|STARTED|Dose Finding: Period II (4 Months)||93
1618735|NCT00900029|3957790|P5|NOT COMPLETED|Overall Study||6
1618736|NCT00900029|3957791|P4|NOT COMPLETED|Overall Study||7
1618737|NCT00900029|3957792|P3|NOT COMPLETED|Overall Study||3
1618738|NCT00900029|3957793|P2|NOT COMPLETED|Overall Study||4
1618739|NCT00900029|3957794|P1|NOT COMPLETED|Overall Study||3
1618740|NCT00900029|3957790|P5|COMPLETED|Overall Study||38
1618741|NCT00900029|3957791|P4|COMPLETED|Overall Study||35
1618742|NCT00900029|3957792|P3|COMPLETED|Overall Study||38
1618743|NCT00900029|3957793|P2|COMPLETED|Overall Study||37
1618744|NCT00900029|3957794|P1|COMPLETED|Overall Study||35
1618745|NCT00900029|3957790|P5|STARTED|Overall Study||44
1618746|NCT00900029|3957791|P4|STARTED|Overall Study||42
1618747|NCT00900029|3957792|P3|STARTED|Overall Study||41
1618748|NCT00900029|3957793|P2|STARTED|Overall Study||41
1618749|NCT00900029|3957794|P1|STARTED|Overall Study||38
1618750|NCT00899847|3957811|P1|NOT COMPLETED|Overall Study||2
1618751|NCT00899847|3957811|P1|COMPLETED|Overall Study||7
1618752|NCT00899847|3957811|P1|STARTED|Overall Study||9
1618753|NCT00899717|3957824|P2|NOT COMPLETED|Overall Study||0
1618754|NCT00899717|3957825|P1|NOT COMPLETED|Overall Study||0
1618755|NCT00899717|3957824|P2|COMPLETED|Overall Study||11
1618756|NCT00899717|3957825|P1|COMPLETED|Overall Study||10
1618757|NCT00899717|3957824|P2|STARTED|Overall Study||11
1618758|NCT00899717|3957825|P1|STARTED|Overall Study||10
1618759|NCT00899678|3957842|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
1618760|NCT00899678|3957843|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
1618761|NCT00899678|3957844|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
1618762|NCT00899678|3957842|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
1618763|NCT00899678|3957843|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
1618764|NCT00899678|3957844|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
1618765|NCT00899678|3957842|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
1618766|NCT00899678|3957843|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
1618767|NCT00899678|3957844|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
1618768|NCT00899678|3957842|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
1618769|NCT00899678|3957843|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
1618770|NCT00899678|3957844|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
1618771|NCT00899678|3957842|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
1618772|NCT00899678|3957843|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
1618773|NCT00899678|3957844|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
1618774|NCT00899678|3957842|P3|STARTED|Induction Period (Weeks 0 to 6)||35
1618775|NCT00899678|3957843|P2|STARTED|Induction Period (Weeks 0 to 6)||37
1618776|NCT00899678|3957844|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
1618777|NCT00899600|3957874|P2|NOT COMPLETED|Overall Study||0
1618778|NCT00899600|3957875|P1|NOT COMPLETED|Overall Study||0
1618779|NCT00899600|3957874|P2|COMPLETED|Overall Study||52
1618780|NCT00899600|3957875|P1|COMPLETED|Overall Study||50
1618781|NCT00899600|3957874|P2|STARTED|Overall Study||52
1618782|NCT00899600|3957875|P1|STARTED|Overall Study||50
1618783|NCT00899574|3957889|P1|NOT COMPLETED|Overall Study||0
1618784|NCT00899574|3957889|P1|COMPLETED|Overall Study||10
1618785|NCT00899574|3957889|P1|STARTED|Overall Study||10
1618786|NCT00899470|3957894|P4|NOT COMPLETED|Fourth Therapy||0
1618787|NCT00899470|3957895|P3|NOT COMPLETED|Fourth Therapy||0
1618788|NCT00899470|3957896|P2|NOT COMPLETED|Fourth Therapy||0
1618789|NCT00899470|3957897|P1|NOT COMPLETED|Fourth Therapy||0
1618790|NCT00899470|3957894|P4|COMPLETED|Fourth Therapy||6
1618791|NCT00899470|3957895|P3|COMPLETED|Fourth Therapy||6
1618792|NCT00899470|3957896|P2|COMPLETED|Fourth Therapy||6
1618793|NCT00899470|3957897|P1|COMPLETED|Fourth Therapy||6
1618794|NCT00899470|3957894|P4|STARTED|Fourth Therapy||6
1618795|NCT00899470|3957895|P3|STARTED|Fourth Therapy||6
1618796|NCT00899470|3957896|P2|STARTED|Fourth Therapy||6
1618797|NCT00899470|3957897|P1|STARTED|Fourth Therapy||6
1618798|NCT00899470|3957894|P4|NOT COMPLETED|Third Washout||0
1618799|NCT00899470|3957895|P3|NOT COMPLETED|Third Washout||0
1618800|NCT00899470|3957896|P2|NOT COMPLETED|Third Washout||0
1618801|NCT00899470|3957897|P1|NOT COMPLETED|Third Washout||0
1618802|NCT00899470|3957894|P4|COMPLETED|Third Washout||6
1618803|NCT00899470|3957895|P3|COMPLETED|Third Washout||6
1618804|NCT00899470|3957896|P2|COMPLETED|Third Washout||6
1618805|NCT00899470|3957897|P1|COMPLETED|Third Washout||6
1618806|NCT00899470|3957894|P4|STARTED|Third Washout||6
1618807|NCT00899470|3957895|P3|STARTED|Third Washout||6
1618808|NCT00899470|3957896|P2|STARTED|Third Washout||6
1618809|NCT00899470|3957897|P1|STARTED|Third Washout||6
1618810|NCT00899470|3957894|P4|NOT COMPLETED|Third Therapy||0
1618811|NCT00899470|3957895|P3|NOT COMPLETED|Third Therapy||0
1618812|NCT00899470|3957896|P2|NOT COMPLETED|Third Therapy||0
1618813|NCT00899470|3957897|P1|NOT COMPLETED|Third Therapy||0
1618814|NCT00899470|3957894|P4|COMPLETED|Third Therapy||6
1618815|NCT00899470|3957895|P3|COMPLETED|Third Therapy||6
1618816|NCT00899470|3957896|P2|COMPLETED|Third Therapy||6
1618817|NCT00899470|3957897|P1|COMPLETED|Third Therapy||6
1618818|NCT00899470|3957894|P4|STARTED|Third Therapy||6
1618819|NCT00899470|3957895|P3|STARTED|Third Therapy||6
1618820|NCT00899470|3957896|P2|STARTED|Third Therapy||6
1618821|NCT00899470|3957897|P1|STARTED|Third Therapy||6
1618822|NCT00899470|3957894|P4|NOT COMPLETED|Second Washout||0
1618823|NCT00899470|3957895|P3|NOT COMPLETED|Second Washout||0
1618824|NCT00899470|3957896|P2|NOT COMPLETED|Second Washout||0
1618825|NCT00899470|3957897|P1|NOT COMPLETED|Second Washout||0
1618826|NCT00899470|3957894|P4|COMPLETED|Second Washout||6
1618827|NCT00899470|3957895|P3|COMPLETED|Second Washout||6
1618828|NCT00899470|3957896|P2|COMPLETED|Second Washout||6
1618829|NCT00899470|3957897|P1|COMPLETED|Second Washout||6
1618830|NCT00899470|3957894|P4|STARTED|Second Washout||6
1618831|NCT00899470|3957895|P3|STARTED|Second Washout||6
1618832|NCT00899470|3957896|P2|STARTED|Second Washout||6
1618833|NCT00899470|3957897|P1|STARTED|Second Washout||6
1618834|NCT00899470|3957894|P4|NOT COMPLETED|Second Therapy||0
1618835|NCT00899470|3957895|P3|NOT COMPLETED|Second Therapy||0
1618836|NCT00899470|3957896|P2|NOT COMPLETED|Second Therapy||0
1618837|NCT00899470|3957897|P1|NOT COMPLETED|Second Therapy||0
1618838|NCT00899470|3957894|P4|COMPLETED|Second Therapy||6
1618839|NCT00899470|3957895|P3|COMPLETED|Second Therapy||6
1618840|NCT00899470|3957896|P2|COMPLETED|Second Therapy||6
1618841|NCT00899470|3957897|P1|COMPLETED|Second Therapy||6
1618842|NCT00899470|3957894|P4|STARTED|Second Therapy||6
1618843|NCT00899470|3957895|P3|STARTED|Second Therapy||6
1618844|NCT00899470|3957896|P2|STARTED|Second Therapy||6
1618845|NCT00899470|3957897|P1|STARTED|Second Therapy||6
1618846|NCT00899470|3957894|P4|NOT COMPLETED|First Washout Period||0
1618847|NCT00899470|3957895|P3|NOT COMPLETED|First Washout Period||0
1618848|NCT00899470|3957896|P2|NOT COMPLETED|First Washout Period||0
1618849|NCT00899470|3957897|P1|NOT COMPLETED|First Washout Period||0
1618850|NCT00899470|3957894|P4|COMPLETED|First Washout Period||6
1618851|NCT00899470|3957895|P3|COMPLETED|First Washout Period||6
1618852|NCT00899470|3957896|P2|COMPLETED|First Washout Period||6
1618853|NCT00899470|3957897|P1|COMPLETED|First Washout Period||6
1618854|NCT00899470|3957894|P4|STARTED|First Washout Period||6
1618855|NCT00899470|3957895|P3|STARTED|First Washout Period||6
1618856|NCT00899470|3957896|P2|STARTED|First Washout Period||6
1618857|NCT00899470|3957897|P1|STARTED|First Washout Period||6
1618858|NCT00899470|3957894|P4|NOT COMPLETED|First Therapy||0
1618859|NCT00899470|3957895|P3|NOT COMPLETED|First Therapy||0
1618860|NCT00899470|3957896|P2|NOT COMPLETED|First Therapy||0
1618861|NCT00899470|3957897|P1|NOT COMPLETED|First Therapy||0
1618862|NCT00899470|3957894|P4|COMPLETED|First Therapy||6
1618863|NCT00899470|3957895|P3|COMPLETED|First Therapy||6
1618864|NCT00899470|3957896|P2|COMPLETED|First Therapy||6
1618865|NCT00899470|3957897|P1|COMPLETED|First Therapy||6
1618866|NCT00899470|3957894|P4|STARTED|First Therapy||6
1618867|NCT00899470|3957895|P3|STARTED|First Therapy||6
1618868|NCT00899470|3957896|P2|STARTED|First Therapy||6
1618869|NCT00899470|3957897|P1|STARTED|First Therapy||6
1618870|NCT00899392|3957975|P2|NOT COMPLETED|Overall Study||24
1618871|NCT00899392|3957976|P1|NOT COMPLETED|Overall Study||21
1618872|NCT00899392|3957975|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
1618873|NCT00899392|3957976|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
1618874|NCT00899392|3957975|P2|STARTED|Overall Study||74
1618875|NCT00899392|3957976|P1|STARTED|Overall Study||68
1618876|NCT00899379|3957993|P5|NOT COMPLETED|Overall Study||31
1618877|NCT00899379|3957994|P4|NOT COMPLETED|Overall Study||37
1618878|NCT00899379|3957995|P3|NOT COMPLETED|Overall Study||29
1618879|NCT00899379|3957996|P2|NOT COMPLETED|Overall Study||29
1618880|NCT00899379|3957997|P1|NOT COMPLETED|Overall Study||34
1618881|NCT00899379|3957993|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
1618882|NCT00899379|3957994|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
1618883|NCT00899379|3957995|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
1618884|NCT00899379|3957996|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
1618885|NCT00899379|3957997|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
1618886|NCT00899379|3957993|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
1618887|NCT00899379|3957994|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
1618888|NCT00899379|3957995|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
1618889|NCT00899379|3957996|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
1618890|NCT00899379|3957997|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
1618891|NCT00899379|3957993|P5|Patients Treated|Overall Study|Patients who took study drug|81
1618892|NCT00899379|3957994|P4|Patients Treated|Overall Study|Patients who took study drug|77
1618893|NCT00899379|3957995|P3|Patients Treated|Overall Study|Patients who took study drug|84
1618894|NCT00899379|3957996|P2|Patients Treated|Overall Study|Patients who took study drug|82
1618895|NCT00899379|3957997|P1|Patients Treated|Overall Study|Patients who took study drug|83
1618896|NCT00899379|3957993|P5|STARTED|Overall Study|Patients who were allocated study drug|94
1618897|NCT00899379|3957994|P4|STARTED|Overall Study|Patients who were allocated study drug|94
1618898|NCT00899379|3957995|P3|STARTED|Overall Study|Patients who were allocated study drug|95
1618899|NCT00899379|3957996|P2|STARTED|Overall Study|Patients who were allocated study drug|95
1618900|NCT00899379|3957997|P1|STARTED|Overall Study|Patients who were allocated study drug|95
1618901|NCT00899353|3958009|P1|NOT COMPLETED|Overall Study||5
1618902|NCT00899353|3958009|P1|COMPLETED|Overall Study||11
1618903|NCT00899353|3958009|P1|STARTED|Overall Study||16
1618904|NCT00898937|3958033|P3|NOT COMPLETED|Overall Study||0
1618905|NCT00898937|3958034|P2|NOT COMPLETED|Overall Study||0
1618906|NCT00898937|3958035|P1|NOT COMPLETED|Overall Study||0
1618907|NCT00898937|3958033|P3|COMPLETED|Overall Study||9
1618908|NCT00898937|3958034|P2|COMPLETED|Overall Study||21
1618909|NCT00898937|3958035|P1|COMPLETED|Overall Study||25
1618910|NCT00898937|3958033|P3|STARTED|Overall Study||9
1618911|NCT00898937|3958034|P2|STARTED|Overall Study||21
1618912|NCT00898937|3958035|P1|STARTED|Overall Study||25
1618913|NCT00898807|3958045|P2|NOT COMPLETED|Overall Study||9
1618914|NCT00898807|3958046|P1|NOT COMPLETED|Overall Study||8
1618915|NCT00898807|3958045|P2|COMPLETED|Overall Study||83
1618916|NCT00898807|3958046|P1|COMPLETED|Overall Study||86
1618917|NCT00898807|3958045|P2|STARTED|Overall Study||92
1618918|NCT00898807|3958046|P1|STARTED|Overall Study||94
1618919|NCT00898677|3958062|P4|NOT COMPLETED|Overall Study||19
1618920|NCT00898677|3958063|P3|NOT COMPLETED|Overall Study||72
1618921|NCT00898677|3958064|P2|NOT COMPLETED|Overall Study||69
1618922|NCT00898677|3958065|P1|NOT COMPLETED|Overall Study||17
1618923|NCT00898677|3958062|P4|COMPLETED|Overall Study||159
1618924|NCT00898677|3958063|P3|COMPLETED|Overall Study||383
1618925|NCT00898677|3958064|P2|COMPLETED|Overall Study||386
1618926|NCT00898677|3958065|P1|COMPLETED|Overall Study||163
1618927|NCT00898677|3958062|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
1618928|NCT00898677|3958063|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
1618929|NCT00898677|3958064|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
1618930|NCT00898677|3958065|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
1618931|NCT00898677|3958062|P4|STARTED|Overall Study||178
1618932|NCT00898677|3958063|P3|STARTED|Overall Study||455
1618933|NCT00898677|3958064|P2|STARTED|Overall Study||455
1618934|NCT00898677|3958065|P1|STARTED|Overall Study||180
1618935|NCT00898560|3958091|P1|NOT COMPLETED|Overall Study||1
1618936|NCT00898560|3958091|P1|COMPLETED|Overall Study||19
1618937|NCT00898560|3958091|P1|STARTED|Overall Study||20
1618938|NCT00898443|3958103|P2|NOT COMPLETED|Overall Study||0
1618939|NCT00898443|3958104|P1|NOT COMPLETED|Overall Study||1
1618940|NCT00898443|3958103|P2|COMPLETED|Overall Study||8
1618941|NCT00898443|3958104|P1|COMPLETED|Overall Study||9
1618942|NCT00898443|3958103|P2|STARTED|Overall Study||8
1618943|NCT00898443|3958104|P1|STARTED|Overall Study||10
1618944|NCT00898222|3958112|P1|NOT COMPLETED|Overall Study||0
1618945|NCT00898222|3958112|P1|COMPLETED|Overall Study||4
1618946|NCT00898222|3958112|P1|STARTED|Overall Study||4
1618947|NCT00897949|3958119|P3|NOT COMPLETED|Overall Study||69
1618948|NCT00897949|3958120|P2|NOT COMPLETED|Overall Study||103
1618949|NCT00897949|3958121|P1|NOT COMPLETED|Overall Study||104
1618950|NCT00897949|3958119|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
1618951|NCT00897949|3958120|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
1618952|NCT00897949|3958121|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
1618953|NCT00897949|3958119|P3|Patients Treated|Overall Study|Patients who took study drug|304
1618954|NCT00897949|3958120|P2|Patients Treated|Overall Study|Patients who took study drug|456
1618955|NCT00897949|3958121|P1|Patients Treated|Overall Study|Patients who took study drug|458
1618956|NCT00897949|3958119|P3|STARTED|Overall Study|Patients who were allocated study drug|370
1618957|NCT00897949|3958120|P2|STARTED|Overall Study|Patients who were allocated study drug|549
1618958|NCT00897949|3958121|P1|STARTED|Overall Study|Patients who were allocated study drug|554
1618959|NCT00897910|3958144|P1|NOT COMPLETED|Overall Study||0
1618960|NCT00897910|3958144|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
1618961|NCT00897910|3958144|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
1618962|NCT00897897|3958148|P1|NOT COMPLETED|Overall Study||0
1618963|NCT00897897|3958148|P1|COMPLETED|Overall Study||33
1618964|NCT00897897|3958148|P1|STARTED|Overall Study||33
1618965|NCT00897715|3958155|P2|NOT COMPLETED|Overall Study||1
1618966|NCT00897715|3958156|P1|NOT COMPLETED|Overall Study||2
1618967|NCT00897715|3958155|P2|COMPLETED|Overall Study||6
1618968|NCT00897715|3958156|P1|COMPLETED|Overall Study||6
1618969|NCT00897715|3958155|P2|STARTED|Overall Study||7
1618970|NCT00897715|3958156|P1|STARTED|Overall Study||8
1618971|NCT00897676|3958164|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
1618972|NCT00897676|3958165|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
1618973|NCT00897676|3958164|P2|COMPLETED|Intervention 2(6 Hours)||7
1618974|NCT00897676|3958165|P1|COMPLETED|Intervention 2(6 Hours)||9
1618975|NCT00897676|3958164|P2|STARTED|Intervention 2(6 Hours)||7
1618976|NCT00897676|3958165|P1|STARTED|Intervention 2(6 Hours)||9
1618977|NCT00897676|3958164|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
1618978|NCT00897676|3958165|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
1618979|NCT00897676|3958164|P2|COMPLETED|Intervention 1(6 Hours)||7
1618980|NCT00897676|3958165|P1|COMPLETED|Intervention 1(6 Hours)||9
1618981|NCT00897676|3958164|P2|STARTED|Intervention 1(6 Hours)||7
1618982|NCT00897676|3958165|P1|STARTED|Intervention 1(6 Hours)||9
1618983|NCT00897390|3958181|P1|NOT COMPLETED|Overall Study||6
1618984|NCT00897390|3958181|P1|COMPLETED|Overall Study||18
1618985|NCT00897390|3958181|P1|STARTED|Overall Study||24
1618986|NCT00897104|3958271|P3|NOT COMPLETED|Overall Study||8
1618987|NCT00897104|3958272|P2|NOT COMPLETED|Overall Study||71
1618988|NCT00897104|3958273|P1|NOT COMPLETED|Overall Study||64
1618989|NCT00897104|3958271|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
1618990|NCT00897104|3958272|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
1618991|NCT00897104|3958273|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
1618992|NCT00897104|3958271|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
1618993|NCT00897104|3958272|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
1618994|NCT00897104|3958273|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
1618995|NCT00897104|3958271|P3|Participants Treated|Overall Study|Participants who took study drug|80
1618996|NCT00897104|3958272|P2|Participants Treated|Overall Study|Participants who took study drug|357
1618997|NCT00897104|3958273|P1|Participants Treated|Overall Study|Participants who took study drug|355
1618998|NCT00897104|3958271|P3|STARTED|Overall Study|Participants who were allocated study drug|87
1618999|NCT00897104|3958272|P2|STARTED|Overall Study|Participants who were allocated study drug|428
1619000|NCT00897104|3958273|P1|STARTED|Overall Study|Participants who were allocated study drug|418
1619001|NCT00896779|3958301|P2|NOT COMPLETED|Overall Study||1
1619002|NCT00896779|3958302|P1|NOT COMPLETED|Overall Study||0
1619003|NCT00896779|3958301|P2|COMPLETED|Overall Study||11
1619004|NCT00896779|3958302|P1|COMPLETED|Overall Study||8
1619005|NCT00896779|3958301|P2|STARTED|Overall Study||12
1619006|NCT00896779|3958302|P1|STARTED|Overall Study||8
1619007|NCT00896649|3958308|P1|NOT COMPLETED|Overall Study||5
1619008|NCT00896649|3958308|P1|COMPLETED|Overall Study||188
1619009|NCT00896649|3958308|P1|STARTED|Overall Study||193
1619010|NCT00896532|3958321|P23|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619011|NCT00896532|3958322|P22|NOT COMPLETED|Months 48-72: Follow-on Phase||2
1619012|NCT00896532|3958323|P21|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619013|NCT00896532|3958324|P20|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619014|NCT00896532|3958325|P19|NOT COMPLETED|Months 48-72: Follow-on Phase||1
1619015|NCT00896532|3958326|P18|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619016|NCT00896532|3958327|P17|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619017|NCT00896532|3958328|P16|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619018|NCT00896532|3958329|P15|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619019|NCT00896532|3958330|P14|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619020|NCT00896532|3958331|P13|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619021|NCT00896532|3958332|P12|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619022|NCT00896532|3958333|P11|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619023|NCT00896532|3958334|P10|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619024|NCT00896532|3958335|P9|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619025|NCT00896532|3958336|P8|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619026|NCT00896532|3958337|P7|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619027|NCT00896532|3958338|P6|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619028|NCT00896532|3958339|P5|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619029|NCT00896532|3958340|P4|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619030|NCT00896532|3958341|P3|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619031|NCT00896532|3958342|P2|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619032|NCT00896532|3958343|P1|NOT COMPLETED|Months 48-72: Follow-on Phase||0
1619033|NCT00896532|3958321|P23|COMPLETED|Months 48-72: Follow-on Phase||8
1619034|NCT00896532|3958322|P22|COMPLETED|Months 48-72: Follow-on Phase||57
1619035|NCT00896532|3958323|P21|COMPLETED|Months 48-72: Follow-on Phase||12
1619036|NCT00896532|3958324|P20|COMPLETED|Months 48-72: Follow-on Phase||11
1619037|NCT00896532|3958325|P19|COMPLETED|Months 48-72: Follow-on Phase||50
1619038|NCT00896532|3958326|P18|COMPLETED|Months 48-72: Follow-on Phase||0
1619039|NCT00896532|3958327|P17|COMPLETED|Months 48-72: Follow-on Phase||0
1619040|NCT00896532|3958328|P16|COMPLETED|Months 48-72: Follow-on Phase||0
1619041|NCT00896532|3958329|P15|COMPLETED|Months 48-72: Follow-on Phase||0
1619042|NCT00896532|3958330|P14|COMPLETED|Months 48-72: Follow-on Phase||0
1619043|NCT00896532|3958331|P13|COMPLETED|Months 48-72: Follow-on Phase||0
1619044|NCT00896532|3958332|P12|COMPLETED|Months 48-72: Follow-on Phase||0
1619045|NCT00896532|3958333|P11|COMPLETED|Months 48-72: Follow-on Phase||0
1619046|NCT00896532|3958334|P10|COMPLETED|Months 48-72: Follow-on Phase||0
1619047|NCT00896532|3958335|P9|COMPLETED|Months 48-72: Follow-on Phase||0
1619048|NCT00896532|3958336|P8|COMPLETED|Months 48-72: Follow-on Phase||0
1619049|NCT00896532|3958337|P7|COMPLETED|Months 48-72: Follow-on Phase||0
1619050|NCT00896532|3958338|P6|COMPLETED|Months 48-72: Follow-on Phase||0
1619051|NCT00896532|3958339|P5|COMPLETED|Months 48-72: Follow-on Phase||0
1619052|NCT00896532|3958340|P4|COMPLETED|Months 48-72: Follow-on Phase||0
1619053|NCT00896532|3958341|P3|COMPLETED|Months 48-72: Follow-on Phase||0
1619054|NCT00896532|3958342|P2|COMPLETED|Months 48-72: Follow-on Phase||0
1619055|NCT00896532|3958343|P1|COMPLETED|Months 48-72: Follow-on Phase||0
1619056|NCT00896532|3958321|P23|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
1619057|NCT00896532|3958322|P22|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
1619058|NCT00896532|3958323|P21|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
1619059|NCT00896532|3958324|P20|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
1619060|NCT00896532|3958325|P19|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619061|NCT00896532|3958326|P18|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619062|NCT00896532|3958327|P17|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619063|NCT00896532|3958328|P16|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619064|NCT00896532|3958329|P15|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619065|NCT00896532|3958330|P14|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619066|NCT00896532|3958331|P13|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619067|NCT00896532|3958332|P12|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619068|NCT00896532|3958333|P11|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619069|NCT00896532|3958334|P10|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619070|NCT00896532|3958335|P9|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619071|NCT00896532|3958336|P8|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619072|NCT00896532|3958337|P7|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619073|NCT00896532|3958338|P6|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619074|NCT00896532|3958339|P5|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619075|NCT00896532|3958340|P4|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619076|NCT00896532|3958341|P3|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619077|NCT00896532|3958342|P2|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619078|NCT00896532|3958343|P1|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
1619079|NCT00896532|3958321|P23|STARTED|Months 48-72: Follow-on Phase||8
1619080|NCT00896532|3958322|P22|STARTED|Months 48-72: Follow-on Phase||59
1619081|NCT00896532|3958323|P21|STARTED|Months 48-72: Follow-on Phase||12
1619082|NCT00896532|3958324|P20|STARTED|Months 48-72: Follow-on Phase||11
1619083|NCT00896532|3958325|P19|STARTED|Months 48-72: Follow-on Phase||51
1619084|NCT00896532|3958326|P18|STARTED|Months 48-72: Follow-on Phase||0
1619085|NCT00896532|3958327|P17|STARTED|Months 48-72: Follow-on Phase||0
1619086|NCT00896532|3958328|P16|STARTED|Months 48-72: Follow-on Phase||0
1619087|NCT00896532|3958329|P15|STARTED|Months 48-72: Follow-on Phase||0
1619088|NCT00896532|3958330|P14|STARTED|Months 48-72: Follow-on Phase||0
1619089|NCT00896532|3958331|P13|STARTED|Months 48-72: Follow-on Phase||0
1619090|NCT00896532|3958332|P12|STARTED|Months 48-72: Follow-on Phase||0
1619091|NCT00896532|3958333|P11|STARTED|Months 48-72: Follow-on Phase||0
1619092|NCT00896532|3958334|P10|STARTED|Months 48-72: Follow-on Phase||0
1619093|NCT00896532|3958335|P9|STARTED|Months 48-72: Follow-on Phase||0
1619094|NCT00896532|3958336|P8|STARTED|Months 48-72: Follow-on Phase||0
1619095|NCT00896532|3958337|P7|STARTED|Months 48-72: Follow-on Phase||0
1619096|NCT00896532|3958338|P6|STARTED|Months 48-72: Follow-on Phase||0
1619097|NCT00896532|3958339|P5|STARTED|Months 48-72: Follow-on Phase||0
1619098|NCT00896532|3958340|P4|STARTED|Months 48-72: Follow-on Phase||0
1619099|NCT00896532|3958341|P3|STARTED|Months 48-72: Follow-on Phase||0
1619100|NCT00896532|3958342|P2|STARTED|Months 48-72: Follow-on Phase||0
1619101|NCT00896532|3958343|P1|STARTED|Months 48-72: Follow-on Phase||0
1619102|NCT00896532|3958321|P23|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619103|NCT00896532|3958322|P22|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619104|NCT00896532|3958323|P21|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619105|NCT00896532|3958324|P20|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619106|NCT00896532|3958325|P19|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619107|NCT00896532|3958326|P18|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
1619108|NCT00896532|3958327|P17|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
1619109|NCT00896532|3958328|P16|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
1619110|NCT00896532|3958329|P15|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619111|NCT00896532|3958330|P14|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619112|NCT00896532|3958331|P13|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619113|NCT00896532|3958332|P12|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619114|NCT00896532|3958333|P11|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619115|NCT00896532|3958334|P10|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619116|NCT00896532|3958335|P9|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619117|NCT00896532|3958336|P8|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619118|NCT00896532|3958337|P7|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619119|NCT00896532|3958338|P6|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619120|NCT00896532|3958339|P5|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619121|NCT00896532|3958340|P4|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619122|NCT00896532|3958341|P3|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619123|NCT00896532|3958342|P2|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619124|NCT00896532|3958343|P1|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619125|NCT00896532|3958321|P23|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619126|NCT00896532|3958322|P22|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619127|NCT00896532|3958323|P21|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619128|NCT00896532|3958324|P20|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619129|NCT00896532|3958325|P19|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619130|NCT00896532|3958326|P18|COMPLETED|Months 36-48: Romosozumab Retreatment||64
1619131|NCT00896532|3958327|P17|COMPLETED|Months 36-48: Romosozumab Retreatment||65
1619132|NCT00896532|3958328|P16|COMPLETED|Months 36-48: Romosozumab Retreatment||14
1619133|NCT00896532|3958329|P15|COMPLETED|Months 36-48: Romosozumab Retreatment||12
1619134|NCT00896532|3958330|P14|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619135|NCT00896532|3958331|P13|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619136|NCT00896532|3958332|P12|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619137|NCT00896532|3958333|P11|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619138|NCT00896532|3958334|P10|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619139|NCT00896532|3958335|P9|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619140|NCT00896532|3958336|P8|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619141|NCT00896532|3958337|P7|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619142|NCT00896532|3958338|P6|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619143|NCT00896532|3958339|P5|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619144|NCT00896532|3958340|P4|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619145|NCT00896532|3958341|P3|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619146|NCT00896532|3958342|P2|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619147|NCT00896532|3958343|P1|COMPLETED|Months 36-48: Romosozumab Retreatment||0
1619148|NCT00896532|3958321|P23|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619149|NCT00896532|3958322|P22|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619150|NCT00896532|3958323|P21|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619151|NCT00896532|3958324|P20|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619152|NCT00896532|3958325|P19|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619153|NCT00896532|3958326|P18|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
1619154|NCT00896532|3958327|P17|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
1619155|NCT00896532|3958328|P16|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
1619156|NCT00896532|3958329|P15|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
1619157|NCT00896532|3958330|P14|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619158|NCT00896532|3958331|P13|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619159|NCT00896532|3958332|P12|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619160|NCT00896532|3958333|P11|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619161|NCT00896532|3958334|P10|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619162|NCT00896532|3958335|P9|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619163|NCT00896532|3958336|P8|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619164|NCT00896532|3958337|P7|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619165|NCT00896532|3958338|P6|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619166|NCT00896532|3958339|P5|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619167|NCT00896532|3958340|P4|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619168|NCT00896532|3958341|P3|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619169|NCT00896532|3958342|P2|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619170|NCT00896532|3958343|P1|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
1619171|NCT00896532|3958321|P23|STARTED|Months 36-48: Romosozumab Retreatment||0
1619172|NCT00896532|3958322|P22|STARTED|Months 36-48: Romosozumab Retreatment||0
1619173|NCT00896532|3958323|P21|STARTED|Months 36-48: Romosozumab Retreatment||0
1619174|NCT00896532|3958324|P20|STARTED|Months 36-48: Romosozumab Retreatment||0
1619175|NCT00896532|3958325|P19|STARTED|Months 36-48: Romosozumab Retreatment||0
1619176|NCT00896532|3958326|P18|STARTED|Months 36-48: Romosozumab Retreatment||67
1619177|NCT00896532|3958327|P17|STARTED|Months 36-48: Romosozumab Retreatment||72
1619178|NCT00896532|3958328|P16|STARTED|Months 36-48: Romosozumab Retreatment||16
1619179|NCT00896532|3958329|P15|STARTED|Months 36-48: Romosozumab Retreatment||12
1619180|NCT00896532|3958330|P14|STARTED|Months 36-48: Romosozumab Retreatment||0
1619181|NCT00896532|3958331|P13|STARTED|Months 36-48: Romosozumab Retreatment||0
1619182|NCT00896532|3958332|P12|STARTED|Months 36-48: Romosozumab Retreatment||0
1619183|NCT00896532|3958333|P11|STARTED|Months 36-48: Romosozumab Retreatment||0
1619184|NCT00896532|3958334|P10|STARTED|Months 36-48: Romosozumab Retreatment||0
1619185|NCT00896532|3958335|P9|STARTED|Months 36-48: Romosozumab Retreatment||0
1619186|NCT00896532|3958336|P8|STARTED|Months 36-48: Romosozumab Retreatment||0
1619187|NCT00896532|3958337|P7|STARTED|Months 36-48: Romosozumab Retreatment||0
1619188|NCT00896532|3958338|P6|STARTED|Months 36-48: Romosozumab Retreatment||0
1619189|NCT00896532|3958339|P5|STARTED|Months 36-48: Romosozumab Retreatment||0
1619190|NCT00896532|3958340|P4|STARTED|Months 36-48: Romosozumab Retreatment||0
1619191|NCT00896532|3958341|P3|STARTED|Months 36-48: Romosozumab Retreatment||0
1619192|NCT00896532|3958342|P2|STARTED|Months 36-48: Romosozumab Retreatment||0
1619193|NCT00896532|3958343|P1|STARTED|Months 36-48: Romosozumab Retreatment||0
1619194|NCT00896532|3958321|P23|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619195|NCT00896532|3958322|P22|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619196|NCT00896532|3958323|P21|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619197|NCT00896532|3958324|P20|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619198|NCT00896532|3958325|P19|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619199|NCT00896532|3958326|P18|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619200|NCT00896532|3958327|P17|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619201|NCT00896532|3958328|P16|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619202|NCT00896532|3958329|P15|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619203|NCT00896532|3958330|P14|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
1619204|NCT00896532|3958331|P13|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
1619205|NCT00896532|3958332|P12|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
1619206|NCT00896532|3958333|P11|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
1619207|NCT00896532|3958334|P10|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619208|NCT00896532|3958335|P9|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
1619209|NCT00896532|3958336|P8|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619210|NCT00896532|3958337|P7|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619211|NCT00896532|3958338|P6|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619212|NCT00896532|3958339|P5|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619213|NCT00896532|3958340|P4|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619214|NCT00896532|3958341|P3|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619215|NCT00896532|3958342|P2|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619216|NCT00896532|3958343|P1|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619217|NCT00896532|3958321|P23|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619218|NCT00896532|3958322|P22|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619219|NCT00896532|3958323|P21|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619220|NCT00896532|3958324|P20|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619221|NCT00896532|3958325|P19|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619222|NCT00896532|3958326|P18|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619223|NCT00896532|3958327|P17|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619224|NCT00896532|3958328|P16|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619225|NCT00896532|3958329|P15|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619226|NCT00896532|3958330|P14|COMPLETED|Months 24-36: Denosumab Extension Phase||88
1619227|NCT00896532|3958331|P13|COMPLETED|Months 24-36: Denosumab Extension Phase||88
1619228|NCT00896532|3958332|P12|COMPLETED|Months 24-36: Denosumab Extension Phase||19
1619229|NCT00896532|3958333|P11|COMPLETED|Months 24-36: Denosumab Extension Phase||18
1619230|NCT00896532|3958334|P10|COMPLETED|Months 24-36: Denosumab Extension Phase||18
1619231|NCT00896532|3958335|P9|COMPLETED|Months 24-36: Denosumab Extension Phase||17
1619232|NCT00896532|3958336|P8|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619233|NCT00896532|3958337|P7|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619234|NCT00896532|3958338|P6|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619235|NCT00896532|3958339|P5|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619236|NCT00896532|3958340|P4|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619237|NCT00896532|3958341|P3|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619238|NCT00896532|3958342|P2|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619239|NCT00896532|3958343|P1|COMPLETED|Months 24-36: Denosumab Extension Phase||0
1619240|NCT00896532|3958321|P23|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619241|NCT00896532|3958322|P22|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619242|NCT00896532|3958323|P21|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619243|NCT00896532|3958324|P20|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619244|NCT00896532|3958325|P19|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619245|NCT00896532|3958326|P18|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619246|NCT00896532|3958327|P17|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619247|NCT00896532|3958328|P16|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619248|NCT00896532|3958329|P15|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619249|NCT00896532|3958330|P14|Received Treatment|Months 24-36: Denosumab Extension Phase||88
1619250|NCT00896532|3958331|P13|Received Treatment|Months 24-36: Denosumab Extension Phase||90
1619251|NCT00896532|3958332|P12|Received Treatment|Months 24-36: Denosumab Extension Phase||19
1619252|NCT00896532|3958333|P11|Received Treatment|Months 24-36: Denosumab Extension Phase||19
1619253|NCT00896532|3958334|P10|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
1619254|NCT00896532|3958335|P9|Received Treatment|Months 24-36: Denosumab Extension Phase||18
1619255|NCT00896532|3958336|P8|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619256|NCT00896532|3958337|P7|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619257|NCT00896532|3958338|P6|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619258|NCT00896532|3958339|P5|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619259|NCT00896532|3958340|P4|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619260|NCT00896532|3958341|P3|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619261|NCT00896532|3958342|P2|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619262|NCT00896532|3958343|P1|Received Treatment|Months 24-36: Denosumab Extension Phase||0
1619263|NCT00896532|3958321|P23|STARTED|Months 24-36: Denosumab Extension Phase||0
1619264|NCT00896532|3958322|P22|STARTED|Months 24-36: Denosumab Extension Phase||0
1619265|NCT00896532|3958323|P21|STARTED|Months 24-36: Denosumab Extension Phase||0
1619266|NCT00896532|3958324|P20|STARTED|Months 24-36: Denosumab Extension Phase||0
1619267|NCT00896532|3958325|P19|STARTED|Months 24-36: Denosumab Extension Phase||0
1619268|NCT00896532|3958326|P18|STARTED|Months 24-36: Denosumab Extension Phase||0
1619269|NCT00896532|3958327|P17|STARTED|Months 24-36: Denosumab Extension Phase||0
1619270|NCT00896532|3958328|P16|STARTED|Months 24-36: Denosumab Extension Phase||0
1619271|NCT00896532|3958329|P15|STARTED|Months 24-36: Denosumab Extension Phase||0
1619272|NCT00896532|3958330|P14|STARTED|Months 24-36: Denosumab Extension Phase||90
1619273|NCT00896532|3958331|P13|STARTED|Months 24-36: Denosumab Extension Phase||93
1619274|NCT00896532|3958332|P12|STARTED|Months 24-36: Denosumab Extension Phase||21
1619275|NCT00896532|3958333|P11|STARTED|Months 24-36: Denosumab Extension Phase||20
1619276|NCT00896532|3958334|P10|STARTED|Months 24-36: Denosumab Extension Phase||18
1619277|NCT00896532|3958335|P9|STARTED|Months 24-36: Denosumab Extension Phase||18
1619278|NCT00896532|3958336|P8|STARTED|Months 24-36: Denosumab Extension Phase||0
1619279|NCT00896532|3958337|P7|STARTED|Months 24-36: Denosumab Extension Phase||0
1619280|NCT00896532|3958338|P6|STARTED|Months 24-36: Denosumab Extension Phase||0
1619281|NCT00896532|3958339|P5|STARTED|Months 24-36: Denosumab Extension Phase||0
1619282|NCT00896532|3958340|P4|STARTED|Months 24-36: Denosumab Extension Phase||0
1619283|NCT00896532|3958341|P3|STARTED|Months 24-36: Denosumab Extension Phase||0
1619284|NCT00896532|3958342|P2|STARTED|Months 24-36: Denosumab Extension Phase||0
1619285|NCT00896532|3958343|P1|STARTED|Months 24-36: Denosumab Extension Phase||0
1619286|NCT00896532|3958321|P23|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619287|NCT00896532|3958322|P22|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619288|NCT00896532|3958323|P21|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619289|NCT00896532|3958324|P20|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619290|NCT00896532|3958325|P19|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619291|NCT00896532|3958326|P18|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619292|NCT00896532|3958327|P17|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619293|NCT00896532|3958328|P16|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619294|NCT00896532|3958329|P15|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619295|NCT00896532|3958330|P14|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619296|NCT00896532|3958331|P13|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619297|NCT00896532|3958332|P12|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619298|NCT00896532|3958333|P11|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619299|NCT00896532|3958334|P10|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619300|NCT00896532|3958335|P9|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619301|NCT00896532|3958336|P8|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
1619302|NCT00896532|3958337|P7|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
1619303|NCT00896532|3958338|P6|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
1619304|NCT00896532|3958339|P5|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
1619305|NCT00896532|3958340|P4|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
1619306|NCT00896532|3958341|P3|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
1619307|NCT00896532|3958342|P2|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
1619308|NCT00896532|3958343|P1|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
1619309|NCT00896532|3958321|P23|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619310|NCT00896532|3958322|P22|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619311|NCT00896532|3958323|P21|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619312|NCT00896532|3958324|P20|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619313|NCT00896532|3958325|P19|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619314|NCT00896532|3958326|P18|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619315|NCT00896532|3958327|P17|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619316|NCT00896532|3958328|P16|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619317|NCT00896532|3958329|P15|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619318|NCT00896532|3958330|P14|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619319|NCT00896532|3958331|P13|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619320|NCT00896532|3958332|P12|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619321|NCT00896532|3958333|P11|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619322|NCT00896532|3958334|P10|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619323|NCT00896532|3958335|P9|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
1619324|NCT00896532|3958336|P8|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
1619325|NCT00896532|3958337|P7|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
1619326|NCT00896532|3958338|P6|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
1619327|NCT00896532|3958339|P5|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
1619328|NCT00896532|3958340|P4|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
1619329|NCT00896532|3958341|P3|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
1619330|NCT00896532|3958342|P2|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
1619331|NCT00896532|3958343|P1|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
1619332|NCT00896532|3958321|P23|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619333|NCT00896532|3958322|P22|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619334|NCT00896532|3958323|P21|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619335|NCT00896532|3958324|P20|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619336|NCT00896532|3958325|P19|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619337|NCT00896532|3958326|P18|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619338|NCT00896532|3958327|P17|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619339|NCT00896532|3958328|P16|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619340|NCT00896532|3958329|P15|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619341|NCT00896532|3958330|P14|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619342|NCT00896532|3958331|P13|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619343|NCT00896532|3958332|P12|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619344|NCT00896532|3958333|P11|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619345|NCT00896532|3958334|P10|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619346|NCT00896532|3958335|P9|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
1619347|NCT00896532|3958336|P8|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
1619348|NCT00896532|3958337|P7|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
1619349|NCT00896532|3958338|P6|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
1619350|NCT00896532|3958339|P5|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
1619351|NCT00896532|3958340|P4|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
1619352|NCT00896532|3958341|P3|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
1619353|NCT00896532|3958342|P2|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
1619354|NCT00896532|3958343|P1|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
1619355|NCT00896532|3958321|P23|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619356|NCT00896532|3958322|P22|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619357|NCT00896532|3958323|P21|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619358|NCT00896532|3958324|P20|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619359|NCT00896532|3958325|P19|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619360|NCT00896532|3958326|P18|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619361|NCT00896532|3958327|P17|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619362|NCT00896532|3958328|P16|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619363|NCT00896532|3958329|P15|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619364|NCT00896532|3958330|P14|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619365|NCT00896532|3958331|P13|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619366|NCT00896532|3958332|P12|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619367|NCT00896532|3958333|P11|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619368|NCT00896532|3958334|P10|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619369|NCT00896532|3958335|P9|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
1619370|NCT00896532|3958336|P8|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
1619371|NCT00896532|3958337|P7|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
1619372|NCT00896532|3958338|P6|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
1619373|NCT00896532|3958339|P5|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
1619374|NCT00896532|3958340|P4|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
1619375|NCT00896532|3958341|P3|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
1619376|NCT00896532|3958342|P2|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
1619377|NCT00896532|3958343|P1|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
1619378|NCT00896532|3958321|P23|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619379|NCT00896532|3958322|P22|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619380|NCT00896532|3958323|P21|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619381|NCT00896532|3958324|P20|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619382|NCT00896532|3958325|P19|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619383|NCT00896532|3958326|P18|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619384|NCT00896532|3958327|P17|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619385|NCT00896532|3958328|P16|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619386|NCT00896532|3958329|P15|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619387|NCT00896532|3958330|P14|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619388|NCT00896532|3958331|P13|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619389|NCT00896532|3958332|P12|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619390|NCT00896532|3958333|P11|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619391|NCT00896532|3958334|P10|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619392|NCT00896532|3958335|P9|STARTED|Months 1-24: Romosozumab Treatment Phase||0
1619393|NCT00896532|3958336|P8|STARTED|Months 1-24: Romosozumab Treatment Phase||52
1619394|NCT00896532|3958337|P7|STARTED|Months 1-24: Romosozumab Treatment Phase||53
1619395|NCT00896532|3958338|P6|STARTED|Months 1-24: Romosozumab Treatment Phase||51
1619396|NCT00896532|3958339|P5|STARTED|Months 1-24: Romosozumab Treatment Phase||54
1619397|NCT00896532|3958340|P4|STARTED|Months 1-24: Romosozumab Treatment Phase||51
1619398|NCT00896532|3958341|P3|STARTED|Months 1-24: Romosozumab Treatment Phase||55
1619399|NCT00896532|3958342|P2|STARTED|Months 1-24: Romosozumab Treatment Phase||51
1619400|NCT00896532|3958343|P1|STARTED|Months 1-24: Romosozumab Treatment Phase||52
1619401|NCT00896454|3958470|P1|NOT COMPLETED|Overall Study||33
1619402|NCT00896454|3958470|P1|COMPLETED|Overall Study||0
1619403|NCT00896454|3958470|P1|STARTED|Overall Study||33
1619404|NCT00896441|3958484|P2|NOT COMPLETED|Overall Study||0
1619405|NCT00896441|3958485|P1|NOT COMPLETED|Overall Study||2
1619406|NCT00896441|3958484|P2|COMPLETED|Overall Study||9
1619407|NCT00896441|3958485|P1|COMPLETED|Overall Study||15
1619408|NCT00896441|3958484|P2|STARTED|Overall Study||9
1619409|NCT00896441|3958485|P1|STARTED|Overall Study||17
1619410|NCT00896389|3958492|P1|NOT COMPLETED|HCTZ High Dose||0
1619411|NCT00896389|3958492|P1|COMPLETED|HCTZ High Dose||25
1619412|NCT00896389|3958492|P1|STARTED|HCTZ High Dose||25
1619413|NCT00896389|3958492|P1|NOT COMPLETED|HCTZ Low Dose||0
1619414|NCT00896389|3958492|P1|COMPLETED|HCTZ Low Dose||28
1619415|NCT00896389|3958492|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
1619416|NCT00896389|3958492|P1|NOT COMPLETED|Salt Loading||0
1619417|NCT00896389|3958492|P1|COMPLETED|Salt Loading||124
1619418|NCT00896389|3958492|P1|STARTED|Salt Loading||124
1619419|NCT00896363|3958509|P3|NOT COMPLETED|Overall Study||8
1619420|NCT00896363|3958510|P2|NOT COMPLETED|Overall Study||11
1619421|NCT00896363|3958511|P1|NOT COMPLETED|Overall Study||6
1619422|NCT00896363|3958509|P3|COMPLETED|Overall Study||24
1619423|NCT00896363|3958510|P2|COMPLETED|Overall Study||25
1619424|NCT00896363|3958511|P1|COMPLETED|Overall Study||25
1619425|NCT00896363|3958509|P3|STARTED|Overall Study||32
1619426|NCT00896363|3958510|P2|STARTED|Overall Study||36
1619427|NCT00896363|3958511|P1|STARTED|Overall Study||31
1619428|NCT00896337|3958563|P1|NOT COMPLETED|Overall Study||25
1619429|NCT00896337|3958563|P1|COMPLETED|Overall Study||100
1619430|NCT00896337|3958563|P1|STARTED|Overall Study||125
1619431|NCT00896233|3958630|P1|NOT COMPLETED|Overall Study||1
1619432|NCT00896233|3958630|P1|COMPLETED|Overall Study||9
1619433|NCT00896233|3958630|P1|STARTED|Overall Study||10
1619434|NCT00896168|3958643|P2|NOT COMPLETED|Overall Study||19
1619435|NCT00896168|3958644|P1|NOT COMPLETED|Overall Study||14
1619436|NCT00896168|3958643|P2|COMPLETED|Overall Study||111
1619437|NCT00896168|3958644|P1|COMPLETED|Overall Study||90
1619438|NCT00896168|3958643|P2|STARTED|Overall Study||130
1619439|NCT00896168|3958644|P1|STARTED|Overall Study||104
1619440|NCT00896064|3958674|P2|NOT COMPLETED|Overall Study||0
1619441|NCT00896064|3958675|P1|NOT COMPLETED|Overall Study||0
1619442|NCT00896064|3958674|P2|COMPLETED|Overall Study||21
1619443|NCT00896064|3958675|P1|COMPLETED|Overall Study||22
1619444|NCT00896064|3958674|P2|STARTED|Overall Study||21
1619445|NCT00896064|3958675|P1|STARTED|Overall Study||22
1619446|NCT00896051|3958705|P2|NOT COMPLETED|Overall Study||9
1619447|NCT00896051|3958706|P1|NOT COMPLETED|Overall Study||10
1619448|NCT00896051|3958705|P2|COMPLETED|Overall Study||16
1619449|NCT00896051|3958706|P1|COMPLETED|Overall Study||15
1619450|NCT00896051|3958705|P2|STARTED|Overall Study||25
1619451|NCT00896051|3958706|P1|STARTED|Overall Study||25
1619452|NCT00896038|3958748|P2|NOT COMPLETED|Overall Study||1
1619453|NCT00896038|3958749|P1|NOT COMPLETED|Overall Study||4
1619454|NCT00896038|3958748|P2|COMPLETED|Overall Study||27
1619455|NCT00896038|3958749|P1|COMPLETED|Overall Study||26
1619456|NCT00896038|3958748|P2|STARTED|Overall Study||28
1619457|NCT00896038|3958749|P1|STARTED|Overall Study||30
1619458|NCT00896025|3958787|P1|NOT COMPLETED|Overall Study||0
1619459|NCT00896025|3958787|P1|COMPLETED|Overall Study||8
1619460|NCT00896025|3958787|P1|STARTED|Overall Study||8
1619461|NCT00895947|3958793|P2|NOT COMPLETED|Overall Study||10
1619462|NCT00895947|3958794|P1|NOT COMPLETED|Overall Study||12
1619463|NCT00895947|3958793|P2|COMPLETED|Overall Study||90
1619464|NCT00895947|3958794|P1|COMPLETED|Overall Study||88
1619465|NCT00895947|3958793|P2|STARTED|Overall Study||100
1619466|NCT00895947|3958794|P1|STARTED|Overall Study||100
1619467|NCT00895934|3958812|P2|NOT COMPLETED|Overall Study||25
1619468|NCT00895934|3958813|P1|NOT COMPLETED|Overall Study||6
1619469|NCT00895934|3958812|P2|COMPLETED|Overall Study||18
1619470|NCT00895934|3958813|P1|COMPLETED|Overall Study||4
1619471|NCT00895934|3958812|P2|STARTED|Overall Study||43
1619472|NCT00895934|3958813|P1|STARTED|Overall Study||10
1619473|NCT00895895|3958824|P5|NOT COMPLETED|Period 2||49
1619474|NCT00895895|3958825|P4|NOT COMPLETED|Period 2||54
1619475|NCT00895895|3958826|P3|NOT COMPLETED|Period 2||49
1619476|NCT00895895|3958827|P2|NOT COMPLETED|Period 2||53
1619477|NCT00895895|3958828|P1|NOT COMPLETED|Period 2||56
1619478|NCT00895895|3958824|P5|COMPLETED|Period 2||35
1619479|NCT00895895|3958825|P4|COMPLETED|Period 2||37
1619480|NCT00895895|3958826|P3|COMPLETED|Period 2||33
1619481|NCT00895895|3958827|P2|COMPLETED|Period 2||31
1619482|NCT00895895|3958828|P1|COMPLETED|Period 2||30
1619483|NCT00895895|3958824|P5|STARTED|Period 2||84
1619484|NCT00895895|3958825|P4|STARTED|Period 2||91
1619485|NCT00895895|3958826|P3|STARTED|Period 2||82
1619486|NCT00895895|3958827|P2|STARTED|Period 2||84
1619487|NCT00895895|3958828|P1|STARTED|Period 2||86
1619488|NCT00895895|3958824|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
1619489|NCT00895895|3958825|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
1619490|NCT00895895|3958826|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
1619491|NCT00895895|3958827|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
1619492|NCT00895895|3958828|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
1619493|NCT00895895|3958824|P5|COMPLETED|After Period 1, Prior to Period 2||84
1619494|NCT00895895|3958825|P4|COMPLETED|After Period 1, Prior to Period 2||91
1619495|NCT00895895|3958826|P3|COMPLETED|After Period 1, Prior to Period 2||82
1619496|NCT00895895|3958827|P2|COMPLETED|After Period 1, Prior to Period 2||84
1619497|NCT00895895|3958828|P1|COMPLETED|After Period 1, Prior to Period 2||86
1619498|NCT00895895|3958824|P5|STARTED|After Period 1, Prior to Period 2||86
1619499|NCT00895895|3958825|P4|STARTED|After Period 1, Prior to Period 2||91
1619500|NCT00895895|3958826|P3|STARTED|After Period 1, Prior to Period 2||84
1619501|NCT00895895|3958827|P2|STARTED|After Period 1, Prior to Period 2||84
1619502|NCT00895895|3958828|P1|STARTED|After Period 1, Prior to Period 2||86
1619503|NCT00895895|3958824|P5|NOT COMPLETED|Period 1||20
1619504|NCT00895895|3958825|P4|NOT COMPLETED|Period 1||13
1619505|NCT00895895|3958826|P3|NOT COMPLETED|Period 1||20
1619506|NCT00895895|3958827|P2|NOT COMPLETED|Period 1||21
1619507|NCT00895895|3958828|P1|NOT COMPLETED|Period 1||21
1619508|NCT00895895|3958824|P5|COMPLETED|Period 1||86
1619509|NCT00895895|3958825|P4|COMPLETED|Period 1||91
1619510|NCT00895895|3958826|P3|COMPLETED|Period 1||84
1619511|NCT00895895|3958827|P2|COMPLETED|Period 1||84
1619512|NCT00895895|3958828|P1|COMPLETED|Period 1||86
1619513|NCT00895895|3958824|P5|Randomized But Not Treated|Period 1||2
1619514|NCT00895895|3958825|P4|Randomized But Not Treated|Period 1||1
1619515|NCT00895895|3958826|P3|Randomized But Not Treated|Period 1||1
1619516|NCT00895895|3958827|P2|Randomized But Not Treated|Period 1||3
1619517|NCT00895895|3958828|P1|Randomized But Not Treated|Period 1||1
1619518|NCT00895895|3958824|P5|STARTED|Period 1||106
1619519|NCT00895895|3958825|P4|STARTED|Period 1||104
1619520|NCT00895895|3958826|P3|STARTED|Period 1||104
1619521|NCT00895895|3958827|P2|STARTED|Period 1||105
1619522|NCT00895895|3958828|P1|STARTED|Period 1||107
1619523|NCT00895843|3958942|P2|NOT COMPLETED|Overall Study||12
1619524|NCT00895843|3958943|P1|NOT COMPLETED|Overall Study||12
1619525|NCT00895843|3958942|P2|COMPLETED|Overall Study||50
1619526|NCT00895843|3958943|P1|COMPLETED|Overall Study||48
1619527|NCT00895843|3958942|P2|STARTED|Overall Study||62
1619528|NCT00895843|3958943|P1|STARTED|Overall Study||60
1619529|NCT00895830|3958954|P5|NOT COMPLETED|Overall Study||0
1619530|NCT00895830|3958955|P4|NOT COMPLETED|Overall Study||0
1619531|NCT00895830|3958956|P3|NOT COMPLETED|Overall Study||0
1619532|NCT00895830|3958957|P2|NOT COMPLETED|Overall Study||0
1619533|NCT00895830|3958958|P1|NOT COMPLETED|Overall Study||0
1619534|NCT00895830|3958954|P5|COMPLETED|Overall Study||55
1619535|NCT00895830|3958955|P4|COMPLETED|Overall Study||52
1619536|NCT00895830|3958956|P3|COMPLETED|Overall Study||49
1619537|NCT00895830|3958957|P2|COMPLETED|Overall Study||50
1619538|NCT00895830|3958958|P1|COMPLETED|Overall Study||51
1619539|NCT00895830|3958954|P5|STARTED|Overall Study||55
1619540|NCT00895830|3958955|P4|STARTED|Overall Study||52
1619541|NCT00895830|3958956|P3|STARTED|Overall Study||49
1619542|NCT00895830|3958957|P2|STARTED|Overall Study||50
1619543|NCT00895830|3958958|P1|STARTED|Overall Study||51
1619544|NCT00895817|3958972|P2|NOT COMPLETED|Overall Study||0
1619545|NCT00895817|3958973|P1|NOT COMPLETED|Overall Study||0
1619546|NCT00895817|3958972|P2|COMPLETED|Overall Study||21
1619547|NCT00895817|3958973|P1|COMPLETED|Overall Study||21
1619548|NCT00895817|3958972|P2|STARTED|Overall Study||21
1619549|NCT00895817|3958973|P1|STARTED|Overall Study||21
1619550|NCT00895752|3958979|P1|NOT COMPLETED|Overall Study||0
1619551|NCT00895752|3958979|P1|COMPLETED|Overall Study||6
1619552|NCT00895752|3958979|P1|STARTED|Overall Study||6
1619553|NCT00895661|3958990|P1|NOT COMPLETED|Overall Study||3
1619554|NCT00895661|3958990|P1|COMPLETED|Overall Study||37
1619555|NCT00895661|3958990|P1|STARTED|Overall Study||40
1619556|NCT00895622|3959000|P3|NOT COMPLETED|Overall Study||4
1619557|NCT00895622|3959001|P2|NOT COMPLETED|Overall Study||4
1619558|NCT00895622|3959002|P1|NOT COMPLETED|Overall Study||5
1619559|NCT00895622|3959000|P3|COMPLETED|Overall Study||53
1619560|NCT00895622|3959001|P2|COMPLETED|Overall Study||52
1619561|NCT00895622|3959002|P1|COMPLETED|Overall Study||60
1619562|NCT00895622|3959000|P3|STARTED|Overall Study||57
1619563|NCT00895622|3959001|P2|STARTED|Overall Study||56
1619564|NCT00895622|3959002|P1|STARTED|Overall Study||65
1619565|NCT00895583|3959025|P2|NOT COMPLETED|Overall Study||12
1619566|NCT00895583|3959026|P1|NOT COMPLETED|Overall Study||44
1619567|NCT00895583|3959025|P2|COMPLETED|Overall Study||111
1619568|NCT00895583|3959026|P1|COMPLETED|Overall Study||87
1619569|NCT00895583|3959025|P2|STARTED|Overall Study||123
1619570|NCT00895583|3959026|P1|STARTED|Overall Study||131
1619571|NCT00895531|3959106|P2|NOT COMPLETED|Overall Study||0
1619572|NCT00895531|3959107|P1|NOT COMPLETED|Overall Study||0
1619573|NCT00895531|3959106|P2|COMPLETED|Overall Study||37
1619574|NCT00895531|3959107|P1|COMPLETED|Overall Study||38
1619575|NCT00895531|3959106|P2|STARTED|Overall Study||37
1619576|NCT00895531|3959107|P1|STARTED|Overall Study||38
1619577|NCT00895453|3959116|P3|NOT COMPLETED|Overall Study||23
1619578|NCT00895453|3959117|P2|NOT COMPLETED|Overall Study||25
1619579|NCT00895453|3959118|P1|NOT COMPLETED|Overall Study||25
1619580|NCT00895453|3959116|P3|COMPLETED|Overall Study||23
1619581|NCT00895453|3959117|P2|COMPLETED|Overall Study||25
1619582|NCT00895453|3959118|P1|COMPLETED|Overall Study||23
1619583|NCT00895453|3959116|P3|STARTED|Overall Study||46
1619584|NCT00895453|3959117|P2|STARTED|Overall Study||50
1619585|NCT00895453|3959118|P1|STARTED|Overall Study||48
1619586|NCT00895310|3959126|P1|NOT COMPLETED|Overall Study||1
1619587|NCT00895310|3959126|P1|COMPLETED|Overall Study||29
1619588|NCT00895310|3959126|P1|STARTED|Overall Study||30
1619589|NCT00895284|3959135|P2|NOT COMPLETED|Overall Study||0
1619590|NCT00895284|3959136|P1|NOT COMPLETED|Overall Study||0
1619591|NCT00895284|3959135|P2|COMPLETED|Overall Study||0
1619592|NCT00895284|3959136|P1|COMPLETED|Overall Study||3
1619593|NCT00895284|3959135|P2|STARTED|Overall Study||0
1619594|NCT00895284|3959136|P1|STARTED|Overall Study||3
1619595|NCT00895245|3959142|P1|NOT COMPLETED|Overall Study||6
1619596|NCT00895245|3959142|P1|COMPLETED|Overall Study||0
1619597|NCT00895245|3959142|P1|STARTED|Overall Study||6
1619598|NCT00895232|3959152|P3|NOT COMPLETED|Overall Study||5
1619599|NCT00895232|3959153|P2|NOT COMPLETED|Overall Study||4
1619600|NCT00895232|3959154|P1|NOT COMPLETED|Overall Study||3
1619601|NCT00895232|3959152|P3|COMPLETED|Overall Study||3
1619602|NCT00895232|3959153|P2|COMPLETED|Overall Study||2
1619603|NCT00895232|3959154|P1|COMPLETED|Overall Study||4
1619604|NCT00895232|3959152|P3|STARTED|Overall Study||8
1619605|NCT00895232|3959153|P2|STARTED|Overall Study||6
1619606|NCT00895232|3959154|P1|STARTED|Overall Study||7
1619607|NCT00895193|3959172|P4|NOT COMPLETED|Overall Study||0
1619608|NCT00895193|3959173|P3|NOT COMPLETED|Overall Study||0
1619609|NCT00895193|3959174|P2|NOT COMPLETED|Overall Study||0
1619610|NCT00895193|3959175|P1|NOT COMPLETED|Overall Study||0
1619611|NCT00895193|3959172|P4|COMPLETED|Overall Study||25
1619612|NCT00895193|3959173|P3|COMPLETED|Overall Study||25
1619613|NCT00895193|3959174|P2|COMPLETED|Overall Study||25
1619614|NCT00895193|3959175|P1|COMPLETED|Overall Study||25
1619615|NCT00895193|3959172|P4|STARTED|Overall Study||25
1619616|NCT00895193|3959173|P3|STARTED|Overall Study||25
1619617|NCT00895193|3959174|P2|STARTED|Overall Study||25
1619618|NCT00895193|3959175|P1|STARTED|Overall Study||25
1619619|NCT00895180|3959199|P2|NOT COMPLETED|Overall Study||0
1619620|NCT00895180|3959200|P1|NOT COMPLETED|Overall Study||0
1619621|NCT00895180|3959199|P2|COMPLETED|Overall Study||40
1619622|NCT00895180|3959200|P1|COMPLETED|Overall Study||40
1619623|NCT00895180|3959199|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
1619624|NCT00895180|3959200|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
1619625|NCT00895180|3959199|P2|STARTED|Overall Study||40
1619626|NCT00895180|3959200|P1|STARTED|Overall Study||40
1619627|NCT00895037|3959221|P3|NOT COMPLETED|Overall Study||1
1619628|NCT00895037|3959222|P2|NOT COMPLETED|Overall Study||2
1619629|NCT00895037|3959223|P1|NOT COMPLETED|Overall Study||0
1619630|NCT00895037|3959221|P3|COMPLETED|Overall Study||1
1619631|NCT00895037|3959222|P2|COMPLETED|Overall Study||75
1619632|NCT00895037|3959223|P1|COMPLETED|Overall Study||22
1619633|NCT00895037|3959221|P3|STARTED|Overall Study||2
1619634|NCT00895037|3959222|P2|STARTED|Overall Study||77
1619635|NCT00895037|3959223|P1|STARTED|Overall Study||22
1619636|NCT00895011|3959254|P3|NOT COMPLETED|Overall Study||8
1619637|NCT00895011|3959255|P2|NOT COMPLETED|Overall Study||14
1619638|NCT00895011|3959256|P1|NOT COMPLETED|Overall Study||24
1619639|NCT00895011|3959254|P3|COMPLETED|Overall Study||91
1619640|NCT00895011|3959255|P2|COMPLETED|Overall Study||85
1619641|NCT00895011|3959256|P1|COMPLETED|Overall Study||76
1619642|NCT00895011|3959254|P3|STARTED|Overall Study||99
1619643|NCT00895011|3959255|P2|STARTED|Overall Study||99
1619644|NCT00895011|3959256|P1|STARTED|Overall Study||100
1619645|NCT00894933|3959270|P1|NOT COMPLETED|Overall Study||4
1619646|NCT00894933|3959270|P1|COMPLETED|Overall Study||29
1619647|NCT00894933|3959270|P1|STARTED|Overall Study||33
1619648|NCT00894803|3959288|P2|NOT COMPLETED|Overall Study||5
1619649|NCT00894803|3959289|P1|NOT COMPLETED|Overall Study||20
1619650|NCT00894803|3959288|P2|COMPLETED|Overall Study||20
1619651|NCT00894803|3959289|P1|COMPLETED|Overall Study||81
1619652|NCT00894803|3959288|P2|STARTED|Overall Study||25
1619653|NCT00894803|3959289|P1|STARTED|Overall Study||101
1619654|NCT00894790|3959325|P2|NOT COMPLETED|Overall Study||2
1619655|NCT00894790|3959326|P1|NOT COMPLETED|Overall Study||1
1619656|NCT00894790|3959325|P2|COMPLETED|Overall Study||2
1619657|NCT00894790|3959326|P1|COMPLETED|Overall Study||3
1619658|NCT00894790|3959325|P2|STARTED|Overall Study||4
1619659|NCT00894790|3959326|P1|STARTED|Overall Study||4
1619660|NCT00894699|3959350|P2|NOT COMPLETED|Overall Study||0
1619661|NCT00894699|3959351|P1|NOT COMPLETED|Overall Study||0
1619662|NCT00894699|3959350|P2|COMPLETED|Overall Study||19
1619663|NCT00894699|3959351|P1|COMPLETED|Overall Study||21
1619664|NCT00894699|3959350|P2|STARTED|Overall Study||19
1619665|NCT00894699|3959351|P1|STARTED|Overall Study||21
1619666|NCT00894686|3959357|P1|NOT COMPLETED|Overall Study||56
1619667|NCT00894686|3959357|P1|COMPLETED|Overall Study||123
1619668|NCT00894686|3959357|P1|STARTED|Overall Study||179
1619669|NCT00894647|3959381|P2|NOT COMPLETED|Overall Study||14
1619670|NCT00894647|3959382|P1|NOT COMPLETED|Overall Study||10
1619671|NCT00894647|3959381|P2|COMPLETED|Overall Study||112
1619672|NCT00894647|3959382|P1|COMPLETED|Overall Study||111
1619673|NCT00894647|3959381|P2|STARTED|Overall Study||126
1619674|NCT00894647|3959382|P1|STARTED|Overall Study||121
1619675|NCT00894556|3959395|P4|NOT COMPLETED|Treatment Phase||0
1619676|NCT00894556|3959396|P3|NOT COMPLETED|Treatment Phase||1
1619677|NCT00894556|3959397|P2|NOT COMPLETED|Treatment Phase||4
1619678|NCT00894556|3959398|P1|NOT COMPLETED|Treatment Phase||4
1619679|NCT00894556|3959395|P4|COMPLETED|Treatment Phase||0
1619680|NCT00894556|3959396|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
1619681|NCT00894556|3959397|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
1619682|NCT00894556|3959398|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
1619683|NCT00894556|3959395|P4|STARTED|Treatment Phase||0
1619684|NCT00894556|3959396|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
1619685|NCT00894556|3959397|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
1619686|NCT00894556|3959398|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
1619687|NCT00894556|3959395|P4|NOT COMPLETED|Baseline Phase||85
1619688|NCT00894556|3959396|P3|NOT COMPLETED|Baseline Phase||0
1619689|NCT00894556|3959397|P2|NOT COMPLETED|Baseline Phase||0
1619690|NCT00894556|3959398|P1|NOT COMPLETED|Baseline Phase||0
1619691|NCT00894556|3959395|P4|COMPLETED|Baseline Phase||109
1619692|NCT00894556|3959396|P3|COMPLETED|Baseline Phase||0
1619693|NCT00894556|3959397|P2|COMPLETED|Baseline Phase||0
1619694|NCT00894556|3959398|P1|COMPLETED|Baseline Phase||0
1619695|NCT00894556|3959395|P4|STARTED|Baseline Phase||194
1619696|NCT00894556|3959396|P3|STARTED|Baseline Phase||0
1619697|NCT00894556|3959397|P2|STARTED|Baseline Phase||0
1619698|NCT00894556|3959398|P1|STARTED|Baseline Phase||0
1619699|NCT00894543|3959409|P2|NOT COMPLETED|Week 4 to Week 8||2
1619700|NCT00894543|3959410|P1|NOT COMPLETED|Week 4 to Week 8||4
1619701|NCT00894543|3959409|P2|COMPLETED|Week 4 to Week 8||97
1619702|NCT00894543|3959410|P1|COMPLETED|Week 4 to Week 8||97
1619703|NCT00894543|3959409|P2|STARTED|Week 4 to Week 8||99
1619704|NCT00894543|3959410|P1|STARTED|Week 4 to Week 8||101
1619705|NCT00894543|3959409|P2|NOT COMPLETED|Baseline to Week 4||2
1619706|NCT00894543|3959410|P1|NOT COMPLETED|Baseline to Week 4||3
1619707|NCT00894543|3959409|P2|COMPLETED|Baseline to Week 4||99
1619708|NCT00894543|3959410|P1|COMPLETED|Baseline to Week 4||101
1619709|NCT00894543|3959409|P2|STARTED|Baseline to Week 4||101
1619710|NCT00894543|3959410|P1|STARTED|Baseline to Week 4||104
1619711|NCT00894543|3959409|P2|NOT COMPLETED|Baseline||0
1619712|NCT00894543|3959410|P1|NOT COMPLETED|Baseline||0
1619713|NCT00894543|3959409|P2|COMPLETED|Baseline||101
1619714|NCT00894543|3959410|P1|COMPLETED|Baseline||104
1619715|NCT00894543|3959409|P2|STARTED|Baseline||101
1619716|NCT00894543|3959410|P1|STARTED|Baseline||104
1619717|NCT00894517|3959434|P2|NOT COMPLETED|Overall Study||5
1619718|NCT00894517|3959435|P1|NOT COMPLETED|Overall Study||2
1619719|NCT00894517|3959434|P2|COMPLETED|Overall Study||26
1619720|NCT00894517|3959435|P1|COMPLETED|Overall Study||28
1619721|NCT00894517|3959434|P2|STARTED|Overall Study||31
1619722|NCT00894517|3959435|P1|STARTED|Overall Study||30
1619723|NCT00894504|3959449|P1|NOT COMPLETED|Overall Study||71
1619724|NCT00894504|3959449|P1|COMPLETED|Overall Study||0
1619725|NCT00894504|3959449|P1|STARTED|Overall Study||71
1619726|NCT00894465|3959465|P2|NOT COMPLETED|Overall Study||0
1619727|NCT00894465|3959466|P1|NOT COMPLETED|Overall Study||0
1619728|NCT00894465|3959465|P2|COMPLETED|Overall Study||22
1619729|NCT00894465|3959466|P1|COMPLETED|Overall Study||22
1619730|NCT00894465|3959465|P2|STARTED|Overall Study||22
1619731|NCT00894465|3959466|P1|STARTED|Overall Study||22
1619732|NCT00894387|3959476|P2|NOT COMPLETED|Overall Study||175
1619733|NCT00894387|3959477|P1|NOT COMPLETED|Overall Study||175
1619734|NCT00894387|3959476|P2|COMPLETED|Overall Study||643
1619735|NCT00894387|3959477|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
1619736|NCT00894387|3959476|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
1619737|NCT00894387|3959477|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
1619738|NCT00894387|3959476|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
1619739|NCT00894387|3959477|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
1619740|NCT00894387|3959476|P2|Full Analysis Set|Overall Study||807
1619741|NCT00894387|3959477|P1|Full Analysis Set|Overall Study||808
1619742|NCT00894387|3959476|P2|Safety Set|Overall Study||810
1619743|NCT00894387|3959477|P1|Safety Set|Overall Study||808
1619744|NCT00894387|3959476|P2|STARTED|Overall Study||818
1619745|NCT00894387|3959477|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
1619746|NCT00894361|3959497|P2|NOT COMPLETED|Overall Study||64
1619747|NCT00894361|3959498|P1|NOT COMPLETED|Overall Study||24
1619748|NCT00894361|3959497|P2|COMPLETED|Overall Study||136
1619749|NCT00894361|3959498|P1|COMPLETED|Overall Study||176
1619750|NCT00894361|3959497|P2|STARTED|Overall Study||200
1619751|NCT00894361|3959498|P1|STARTED|Overall Study||200
1619752|NCT00894322|3959507|P3|NOT COMPLETED|Overall Study||0
1619753|NCT00894322|3959508|P2|NOT COMPLETED|Overall Study||0
1619754|NCT00894322|3959509|P1|NOT COMPLETED|Overall Study||1
1619755|NCT00894322|3959507|P3|COMPLETED|Overall Study||12
1619756|NCT00894322|3959508|P2|COMPLETED|Overall Study||23
1619757|NCT00894322|3959509|P1|COMPLETED|Overall Study||29
1619758|NCT00894322|3959507|P3|STARTED|Overall Study||12
1619759|NCT00894322|3959508|P2|STARTED|Overall Study||23
1619760|NCT00894322|3959509|P1|STARTED|Overall Study||30
1619761|NCT00894244|3959548|P1|NOT COMPLETED|Overall Study||1
1619762|NCT00894244|3959548|P1|COMPLETED|Overall Study||24
1619763|NCT00894244|3959548|P1|STARTED|Overall Study||25
1619764|NCT00894166|3959560|P8|NOT COMPLETED|Overall Study||34
1619765|NCT00894166|3959561|P7|NOT COMPLETED|Overall Study||16
1619766|NCT00894166|3959562|P6|NOT COMPLETED|Overall Study||16
1619767|NCT00894166|3959563|P5|NOT COMPLETED|Overall Study||24
1619768|NCT00894166|3959564|P4|NOT COMPLETED|Overall Study||69
1619769|NCT00894166|3959565|P3|NOT COMPLETED|Overall Study||62
1619770|NCT00894166|3959566|P2|NOT COMPLETED|Overall Study||63
1619771|NCT00894166|3959567|P1|NOT COMPLETED|Overall Study||61
1619772|NCT00894166|3959560|P8|COMPLETED|Overall Study||0
1619773|NCT00894166|3959561|P7|COMPLETED|Overall Study||19
1619774|NCT00894166|3959562|P6|COMPLETED|Overall Study||20
1619775|NCT00894166|3959563|P5|COMPLETED|Overall Study||10
1619776|NCT00894166|3959564|P4|COMPLETED|Overall Study||45
1619777|NCT00894166|3959565|P3|COMPLETED|Overall Study||50
1619778|NCT00894166|3959566|P2|COMPLETED|Overall Study||46
1619779|NCT00894166|3959567|P1|COMPLETED|Overall Study||71
1619780|NCT00894166|3959560|P8|STARTED|Overall Study||34
1619781|NCT00894166|3959561|P7|STARTED|Overall Study||35
1619782|NCT00894166|3959562|P6|STARTED|Overall Study||36
1619783|NCT00894166|3959563|P5|STARTED|Overall Study||34
1619784|NCT00894166|3959564|P4|STARTED|Overall Study||114
1619785|NCT00894166|3959565|P3|STARTED|Overall Study||112
1619786|NCT00894166|3959566|P2|STARTED|Overall Study||109
1619787|NCT00894166|3959567|P1|STARTED|Overall Study||132
1619788|NCT00894127|3959597|P1|NOT COMPLETED|Overall Study||0
1619789|NCT00894127|3959597|P1|COMPLETED|Overall Study||128
1619790|NCT00894127|3959597|P1|STARTED|Overall Study||128
1619791|NCT00893997|3959601|P1|NOT COMPLETED|Overall Study||0
1619792|NCT00893997|3959601|P1|COMPLETED|Overall Study||10
1619793|NCT00893997|3959601|P1|STARTED|Overall Study||10
1619794|NCT00893971|3959606|P1|NOT COMPLETED|Overall Study||3
1619795|NCT00893971|3959606|P1|COMPLETED|Overall Study||13
1619796|NCT00893971|3959606|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
1619797|NCT00893971|3959606|P1|Placebo + FF MDI (PT005)|Overall Study||13
1619798|NCT00893971|3959606|P1|Placebo + GFF MDI (PT003)|Overall Study||15
1619799|NCT00893971|3959606|P1|Placebo + GP MDI (PT001)|Overall Study||15
1619800|NCT00893971|3959606|P1|STARTED|Overall Study||16
1619801|NCT00893789|3959724|P4|NOT COMPLETED|Overall Study||13
1619802|NCT00893789|3959725|P3|NOT COMPLETED|Overall Study||7
1619803|NCT00893789|3959726|P2|NOT COMPLETED|Overall Study||4
1619804|NCT00893789|3959727|P1|NOT COMPLETED|Overall Study||6
1619805|NCT00893789|3959724|P4|COMPLETED|Overall Study||16
1619806|NCT00893789|3959725|P3|COMPLETED|Overall Study||22
1619807|NCT00893789|3959726|P2|COMPLETED|Overall Study||26
1619808|NCT00893789|3959727|P1|COMPLETED|Overall Study||23
1619809|NCT00893789|3959724|P4|Full Analysis Set (FAS)|Overall Study||27
1619810|NCT00893789|3959725|P3|Full Analysis Set (FAS)|Overall Study||28
1619811|NCT00893789|3959726|P2|Full Analysis Set (FAS)|Overall Study||29
1619812|NCT00893789|3959727|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
1619813|NCT00893789|3959724|P4|Safety Analysis Set (SAS)|Overall Study||29
1619814|NCT00893789|3959725|P3|Safety Analysis Set (SAS)|Overall Study||29
1619815|NCT00893789|3959726|P2|Safety Analysis Set (SAS)|Overall Study||30
1619816|NCT00893789|3959727|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
1619817|NCT00893789|3959724|P4|STARTED|Overall Study||29
1619818|NCT00893789|3959725|P3|STARTED|Overall Study||29
1619819|NCT00893789|3959726|P2|STARTED|Overall Study||30
1619820|NCT00893789|3959727|P1|STARTED|Overall Study||29
1619821|NCT00893763|3959811|P2|NOT COMPLETED|Overall Study||110
1619822|NCT00893763|3959812|P1|NOT COMPLETED|Overall Study||110
1619823|NCT00893763|3959811|P2|COMPLETED|Overall Study||47
1619824|NCT00893763|3959812|P1|COMPLETED|Overall Study||47
1619825|NCT00893763|3959811|P2|STARTED|Overall Study||157
1619826|NCT00893763|3959812|P1|STARTED|Overall Study||157
1619827|NCT00893737|3959820|P1|NOT COMPLETED|Overall Study||12
1619828|NCT00893737|3959820|P1|COMPLETED|Overall Study||135
1619829|NCT00893737|3959820|P1|STARTED|Overall Study||147
1619830|NCT00893464|3959834|P8|NOT COMPLETED|Overall Study||2
1619831|NCT00893464|3959835|P7|NOT COMPLETED|Overall Study||2
1619832|NCT00893464|3959836|P6|NOT COMPLETED|Overall Study||0
1619833|NCT00893464|3959837|P5|NOT COMPLETED|Overall Study||0
1619834|NCT00893464|3959838|P4|NOT COMPLETED|Overall Study||0
1619835|NCT00893464|3959839|P3|NOT COMPLETED|Overall Study||0
1619836|NCT00893464|3959840|P2|NOT COMPLETED|Overall Study||0
1619837|NCT00893464|3959841|P1|NOT COMPLETED|Overall Study||0
1619838|NCT00893464|3959834|P8|COMPLETED|Overall Study||3
1619839|NCT00893464|3959835|P7|COMPLETED|Overall Study||8
1619840|NCT00893464|3959836|P6|COMPLETED|Overall Study||7
1619841|NCT00893464|3959837|P5|COMPLETED|Overall Study||4
1619842|NCT00893464|3959838|P4|COMPLETED|Overall Study||1
1619843|NCT00893464|3959839|P3|COMPLETED|Overall Study||1
1619844|NCT00893464|3959840|P2|COMPLETED|Overall Study||1
1619845|NCT00893464|3959841|P1|COMPLETED|Overall Study||1
1619846|NCT00893464|3959834|P8|STARTED|Overall Study||5
1619847|NCT00893464|3959835|P7|STARTED|Overall Study||10
1619848|NCT00893464|3959836|P6|STARTED|Overall Study||7
1619849|NCT00893464|3959837|P5|STARTED|Overall Study||4
1619850|NCT00893464|3959838|P4|STARTED|Overall Study||1
1619851|NCT00893464|3959839|P3|STARTED|Overall Study||1
1619852|NCT00893464|3959840|P2|STARTED|Overall Study||1
1619853|NCT00893464|3959841|P1|STARTED|Overall Study||1
1619854|NCT00893152|3959959|P2|NOT COMPLETED|Overall Study||0
1619855|NCT00893152|3959960|P1|NOT COMPLETED|Overall Study||0
1619856|NCT00893152|3959959|P2|COMPLETED|Overall Study||36
1619857|NCT00893152|3959960|P1|COMPLETED|Overall Study||47
1619858|NCT00893152|3959959|P2|STARTED|Overall Study||36
1619859|NCT00893152|3959960|P1|STARTED|Overall Study||47
1619860|NCT00893113|3959968|P2|NOT COMPLETED|Overall Study||16
1619861|NCT00893113|3959969|P1|NOT COMPLETED|Overall Study||13
1619862|NCT00893113|3959968|P2|COMPLETED|Overall Study||22
1619863|NCT00893113|3959969|P1|COMPLETED|Overall Study||23
1619864|NCT00893113|3959968|P2|STARTED|Overall Study||38
1619865|NCT00893113|3959969|P1|STARTED|Overall Study||36
1619866|NCT00893074|3959979|P1|NOT COMPLETED|Overall Study||11
1619867|NCT00893074|3959979|P1|COMPLETED|Overall Study||13
1619868|NCT00893074|3959979|P1|STARTED|Overall Study||24
1619869|NCT00892957|3959999|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
1619870|NCT00892957|3960000|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
1619871|NCT00892957|3959999|P2|COMPLETED|Postoperative Day 30 Assessment||66
1619872|NCT00892957|3960000|P1|COMPLETED|Postoperative Day 30 Assessment||70
1619873|NCT00892957|3959999|P2|STARTED|Postoperative Day 30 Assessment||66
1619874|NCT00892957|3960000|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
1619875|NCT00892957|3959999|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
1619876|NCT00892957|3960000|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
1619877|NCT00892957|3959999|P2|COMPLETED|Postoperative Day 14 Assessment||66
1619878|NCT00892957|3960000|P1|COMPLETED|Postoperative Day 14 Assessment||68
1619879|NCT00892957|3959999|P2|STARTED|Postoperative Day 14 Assessment||66
1619880|NCT00892957|3960000|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
1619881|NCT00892957|3959999|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
1619882|NCT00892957|3960000|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
1619883|NCT00892957|3959999|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
1619884|NCT00892957|3960000|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
1619885|NCT00892957|3959999|P2|STARTED|Between Postoperative Day 1 and Day 14||70
1619886|NCT00892957|3960000|P1|STARTED|Between Postoperative Day 1 and Day 14||70
1619887|NCT00892957|3959999|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
1619888|NCT00892957|3960000|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
1619889|NCT00892957|3959999|P2|COMPLETED|Postoperative Day 1 Assessment||70
1619890|NCT00892957|3960000|P1|COMPLETED|Postoperative Day 1 Assessment||70
1619891|NCT00892957|3959999|P2|STARTED|Postoperative Day 1 Assessment||70
1619892|NCT00892957|3960000|P1|STARTED|Postoperative Day 1 Assessment||70
1619893|NCT00892957|3959999|P2|NOT COMPLETED|Intraoperative Day 0||0
1619894|NCT00892957|3960000|P1|NOT COMPLETED|Intraoperative Day 0||0
1619895|NCT00892957|3959999|P2|COMPLETED|Intraoperative Day 0||70
1619896|NCT00892957|3960000|P1|COMPLETED|Intraoperative Day 0||70
1619897|NCT00892957|3959999|P2|STARTED|Intraoperative Day 0||70
1619898|NCT00892957|3960000|P1|STARTED|Intraoperative Day 0||70
1619899|NCT00892775|3960088|P2|NOT COMPLETED|Overall Study||1
1619900|NCT00892775|3960089|P1|NOT COMPLETED|Overall Study||5
1619901|NCT00892775|3960088|P2|COMPLETED|Overall Study||165
1619902|NCT00892775|3960089|P1|COMPLETED|Overall Study||327
1619903|NCT00892775|3960088|P2|STARTED|Overall Study||166
1619904|NCT00892775|3960089|P1|STARTED|Overall Study||332
1619905|NCT00892723|3960116|P3|NOT COMPLETED|Overall Study||2
1619906|NCT00892723|3960117|P2|NOT COMPLETED|Overall Study||4
1619907|NCT00892723|3960118|P1|NOT COMPLETED|Overall Study||2
1619908|NCT00892723|3960116|P3|COMPLETED|Overall Study||17
1619909|NCT00892723|3960117|P2|COMPLETED|Overall Study||15
1619910|NCT00892723|3960118|P1|COMPLETED|Overall Study||19
1619911|NCT00892723|3960116|P3|STARTED|Overall Study||19
1619912|NCT00892723|3960117|P2|STARTED|Overall Study||19
1619913|NCT00892723|3960118|P1|STARTED|Overall Study||21
1619914|NCT00892710|3960162|P3|NOT COMPLETED|Overall Study||55
1619915|NCT00892710|3960163|P2|NOT COMPLETED|Overall Study||59
1619916|NCT00892710|3960164|P1|NOT COMPLETED|Overall Study||48
1619917|NCT00892710|3960162|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
1619918|NCT00892710|3960163|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
1620008|NCT00892177|3960243|P4|NOT COMPLETED|Phase I: Dose Level 1||0
1619919|NCT00892710|3960164|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
1619920|NCT00892710|3960162|P3|STARTED|Overall Study||55
1619921|NCT00892710|3960163|P2|STARTED|Overall Study||59
1619922|NCT00892710|3960164|P1|STARTED|Overall Study||48
1619923|NCT00892697|3960187|P1|NOT COMPLETED|Overall Study||0
1619924|NCT00892697|3960187|P1|COMPLETED|Overall Study||15
1619925|NCT00892697|3960187|P1|STARTED|Overall Study||15
1619926|NCT00892606|3960194|P2|NOT COMPLETED|Overall Study||4
1619927|NCT00892606|3960195|P1|NOT COMPLETED|Overall Study||5
1619928|NCT00892606|3960194|P2|COMPLETED|Overall Study||33
1619929|NCT00892606|3960195|P1|COMPLETED|Overall Study||33
1619930|NCT00892606|3960194|P2|STARTED|Overall Study||37
1619931|NCT00892606|3960195|P1|STARTED|Overall Study||38
1619932|NCT00892437|3960207|P2|NOT COMPLETED|Open-Label Extension Phase||4
1619933|NCT00892437|3960208|P1|NOT COMPLETED|Open-Label Extension Phase||12
1619934|NCT00892437|3960207|P2|COMPLETED|Open-Label Extension Phase||15
1619935|NCT00892437|3960208|P1|COMPLETED|Open-Label Extension Phase||32
1619936|NCT00892437|3960207|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
1619937|NCT00892437|3960208|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
1619938|NCT00892437|3960207|P2|NOT COMPLETED|Randomized Phase||5
1619939|NCT00892437|3960208|P1|NOT COMPLETED|Randomized Phase||11
1619940|NCT00892437|3960207|P2|COMPLETED|Randomized Phase||24
1619941|NCT00892437|3960208|P1|COMPLETED|Randomized Phase||45
1619942|NCT00892437|3960207|P2|Randomized and Treated|Randomized Phase||29
1619943|NCT00892437|3960208|P1|Randomized and Treated|Randomized Phase||50
1619944|NCT00892437|3960207|P2|STARTED|Randomized Phase||29
1619945|NCT00892437|3960208|P1|STARTED|Randomized Phase||56
1619946|NCT00892281|3960227|P2|NOT COMPLETED|Overall Study||37
1619947|NCT00892281|3960228|P1|NOT COMPLETED|Overall Study||267
1619948|NCT00892281|3960227|P2|COMPLETED|Overall Study||187
1619949|NCT00892281|3960228|P1|COMPLETED|Overall Study||930
1619950|NCT00892281|3960227|P2|STARTED|Overall Study||224
1619951|NCT00892281|3960228|P1|STARTED|Overall Study||1197
1619952|NCT00892177|3960241|P6|NOT COMPLETED|Phase II||2
1619953|NCT00892177|3960242|P5|NOT COMPLETED|Phase II||5
1619954|NCT00892177|3960243|P4|NOT COMPLETED|Phase II||0
1619955|NCT00892177|3960244|P3|NOT COMPLETED|Phase II||0
1619956|NCT00892177|3960245|P2|NOT COMPLETED|Phase II||0
1619957|NCT00892177|3960246|P1|NOT COMPLETED|Phase II||0
1619958|NCT00892177|3960241|P6|COMPLETED|Phase II||38
1619959|NCT00892177|3960242|P5|COMPLETED|Phase II||83
1619960|NCT00892177|3960243|P4|COMPLETED|Phase II||0
1619961|NCT00892177|3960244|P3|COMPLETED|Phase II||0
1619962|NCT00892177|3960245|P2|COMPLETED|Phase II||0
1619963|NCT00892177|3960246|P1|COMPLETED|Phase II||0
1619964|NCT00892177|3960241|P6|STARTED|Phase II||40
1619965|NCT00892177|3960242|P5|STARTED|Phase II||88
1619966|NCT00892177|3960243|P4|STARTED|Phase II||0
1619967|NCT00892177|3960244|P3|STARTED|Phase II||0
1619968|NCT00892177|3960245|P2|STARTED|Phase II||0
1619969|NCT00892177|3960246|P1|STARTED|Phase II||0
1619970|NCT00892177|3960241|P6|NOT COMPLETED|Phase I: Dose Level 3||0
1619971|NCT00892177|3960242|P5|NOT COMPLETED|Phase I: Dose Level 3||0
1619972|NCT00892177|3960243|P4|NOT COMPLETED|Phase I: Dose Level 3||0
1619973|NCT00892177|3960244|P3|NOT COMPLETED|Phase I: Dose Level 3||0
1619974|NCT00892177|3960245|P2|NOT COMPLETED|Phase I: Dose Level 3||0
1619975|NCT00892177|3960246|P1|NOT COMPLETED|Phase I: Dose Level 3||0
1619976|NCT00892177|3960241|P6|COMPLETED|Phase I: Dose Level 3||0
1619977|NCT00892177|3960242|P5|COMPLETED|Phase I: Dose Level 3||0
1619978|NCT00892177|3960243|P4|COMPLETED|Phase I: Dose Level 3||6
1619979|NCT00892177|3960244|P3|COMPLETED|Phase I: Dose Level 3||0
1619980|NCT00892177|3960245|P2|COMPLETED|Phase I: Dose Level 3||0
1619981|NCT00892177|3960246|P1|COMPLETED|Phase I: Dose Level 3||0
1619982|NCT00892177|3960241|P6|STARTED|Phase I: Dose Level 3||0
1619983|NCT00892177|3960242|P5|STARTED|Phase I: Dose Level 3||0
1619984|NCT00892177|3960243|P4|STARTED|Phase I: Dose Level 3||6
1619985|NCT00892177|3960244|P3|STARTED|Phase I: Dose Level 3||0
1619986|NCT00892177|3960245|P2|STARTED|Phase I: Dose Level 3||0
1619987|NCT00892177|3960246|P1|STARTED|Phase I: Dose Level 3||0
1619988|NCT00892177|3960241|P6|NOT COMPLETED|Phase I: Dose Level 2||0
1619989|NCT00892177|3960242|P5|NOT COMPLETED|Phase I: Dose Level 2||0
1619990|NCT00892177|3960243|P4|NOT COMPLETED|Phase I: Dose Level 2||0
1619991|NCT00892177|3960244|P3|NOT COMPLETED|Phase I: Dose Level 2||0
1619992|NCT00892177|3960245|P2|NOT COMPLETED|Phase I: Dose Level 2||0
1619993|NCT00892177|3960246|P1|NOT COMPLETED|Phase I: Dose Level 2||0
1619994|NCT00892177|3960241|P6|COMPLETED|Phase I: Dose Level 2||0
1619995|NCT00892177|3960242|P5|COMPLETED|Phase I: Dose Level 2||0
1619996|NCT00892177|3960243|P4|COMPLETED|Phase I: Dose Level 2||0
1619997|NCT00892177|3960244|P3|COMPLETED|Phase I: Dose Level 2||3
1619998|NCT00892177|3960245|P2|COMPLETED|Phase I: Dose Level 2||0
1619999|NCT00892177|3960246|P1|COMPLETED|Phase I: Dose Level 2||0
1620000|NCT00892177|3960241|P6|STARTED|Phase I: Dose Level 2||0
1620001|NCT00892177|3960242|P5|STARTED|Phase I: Dose Level 2||0
1620002|NCT00892177|3960243|P4|STARTED|Phase I: Dose Level 2||0
1620003|NCT00892177|3960244|P3|STARTED|Phase I: Dose Level 2||3
1620004|NCT00892177|3960245|P2|STARTED|Phase I: Dose Level 2||0
1620005|NCT00892177|3960246|P1|STARTED|Phase I: Dose Level 2||0
1620006|NCT00892177|3960241|P6|NOT COMPLETED|Phase I: Dose Level 1||0
1620007|NCT00892177|3960242|P5|NOT COMPLETED|Phase I: Dose Level 1||0
1620009|NCT00892177|3960244|P3|NOT COMPLETED|Phase I: Dose Level 1||0
1620010|NCT00892177|3960245|P2|NOT COMPLETED|Phase I: Dose Level 1||0
1620011|NCT00892177|3960246|P1|NOT COMPLETED|Phase I: Dose Level 1||0
1620012|NCT00892177|3960241|P6|COMPLETED|Phase I: Dose Level 1||0
1620013|NCT00892177|3960242|P5|COMPLETED|Phase I: Dose Level 1||0
1620014|NCT00892177|3960243|P4|COMPLETED|Phase I: Dose Level 1||0
1620015|NCT00892177|3960244|P3|COMPLETED|Phase I: Dose Level 1||0
1620016|NCT00892177|3960245|P2|COMPLETED|Phase I: Dose Level 1||4
1620017|NCT00892177|3960246|P1|COMPLETED|Phase I: Dose Level 1||0
1620018|NCT00892177|3960241|P6|STARTED|Phase I: Dose Level 1||0
1620019|NCT00892177|3960242|P5|STARTED|Phase I: Dose Level 1||0
1620020|NCT00892177|3960243|P4|STARTED|Phase I: Dose Level 1||0
1620021|NCT00892177|3960244|P3|STARTED|Phase I: Dose Level 1||0
1620022|NCT00892177|3960245|P2|STARTED|Phase I: Dose Level 1||4
1620023|NCT00892177|3960246|P1|STARTED|Phase I: Dose Level 1||0
1620024|NCT00892177|3960241|P6|NOT COMPLETED|Phase I: Dose Level 0||0
1620025|NCT00892177|3960242|P5|NOT COMPLETED|Phase I: Dose Level 0||0
1620026|NCT00892177|3960243|P4|NOT COMPLETED|Phase I: Dose Level 0||0
1620027|NCT00892177|3960244|P3|NOT COMPLETED|Phase I: Dose Level 0||0
1620028|NCT00892177|3960245|P2|NOT COMPLETED|Phase I: Dose Level 0||0
1620029|NCT00892177|3960246|P1|NOT COMPLETED|Phase I: Dose Level 0||0
1620030|NCT00892177|3960241|P6|COMPLETED|Phase I: Dose Level 0||0
1620031|NCT00892177|3960242|P5|COMPLETED|Phase I: Dose Level 0||0
1620032|NCT00892177|3960243|P4|COMPLETED|Phase I: Dose Level 0||0
1620033|NCT00892177|3960244|P3|COMPLETED|Phase I: Dose Level 0||0
1620034|NCT00892177|3960245|P2|COMPLETED|Phase I: Dose Level 0||0
1620035|NCT00892177|3960246|P1|COMPLETED|Phase I: Dose Level 0||3
1620036|NCT00892177|3960241|P6|STARTED|Phase I: Dose Level 0||0
1620037|NCT00892177|3960242|P5|STARTED|Phase I: Dose Level 0||0
1620038|NCT00892177|3960243|P4|STARTED|Phase I: Dose Level 0||0
1620039|NCT00892177|3960244|P3|STARTED|Phase I: Dose Level 0||0
1620040|NCT00892177|3960245|P2|STARTED|Phase I: Dose Level 0||0
1620041|NCT00892177|3960246|P1|STARTED|Phase I: Dose Level 0||3
1620042|NCT00892151|3960271|P1|NOT COMPLETED|Overall Study||1
1620043|NCT00892151|3960271|P1|COMPLETED|Overall Study||50
1620044|NCT00892151|3960271|P1|STARTED|Overall Study||51
1620045|NCT00892099|3960280|P3|NOT COMPLETED|Overall Study||7
1620046|NCT00892099|3960281|P2|NOT COMPLETED|Overall Study||1
1620047|NCT00892099|3960282|P1|NOT COMPLETED|Overall Study||5
1620048|NCT00892099|3960280|P3|COMPLETED|Overall Study||29
1620049|NCT00892099|3960281|P2|COMPLETED|Overall Study||32
1620050|NCT00892099|3960282|P1|COMPLETED|Overall Study||31
1620051|NCT00892099|3960280|P3|STARTED|Overall Study||36
1620052|NCT00892099|3960281|P2|STARTED|Overall Study||33
1620053|NCT00892099|3960282|P1|STARTED|Overall Study||36
1620054|NCT00892047|3960307|P2|NOT COMPLETED|Overall Study||7
1620055|NCT00892047|3960308|P1|NOT COMPLETED|Overall Study||4
1620056|NCT00892047|3960307|P2|COMPLETED|Overall Study||83
1620057|NCT00892047|3960308|P1|COMPLETED|Overall Study||87
1620058|NCT00892047|3960307|P2|STARTED|Overall Study||90
1620059|NCT00892047|3960308|P1|STARTED|Overall Study||91
1620060|NCT00892008|3960324|P1|NOT COMPLETED|Overall Study||565
1620061|NCT00892008|3960324|P1|COMPLETED|Overall Study||1713
1620062|NCT00892008|3960324|P1|STARTED|Overall Study||2278
1620063|NCT00891995|3960340|P2|NOT COMPLETED|Overall Study||0
1620064|NCT00891995|3960341|P1|NOT COMPLETED|Overall Study||0
1620065|NCT00891995|3960340|P2|COMPLETED|Overall Study||21
1620066|NCT00891995|3960341|P1|COMPLETED|Overall Study||50
1620067|NCT00891995|3960340|P2|STARTED|Overall Study||21
1620068|NCT00891995|3960341|P1|STARTED|Overall Study||50
1620069|NCT00891982|3960365|P2|NOT COMPLETED|Overall Study||1
1620070|NCT00891982|3960366|P1|NOT COMPLETED|Overall Study||2
1620071|NCT00891982|3960365|P2|COMPLETED|Overall Study||30
1620072|NCT00891982|3960366|P1|COMPLETED|Overall Study||28
1620073|NCT00891982|3960365|P2|STARTED|Overall Study||31
1620074|NCT00891982|3960366|P1|STARTED|Overall Study||30
1620075|NCT00891930|3960410|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
1620076|NCT00891930|3960410|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
1620077|NCT00891930|3960410|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
1620078|NCT00891930|3960410|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
1620079|NCT00891930|3960410|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
1620080|NCT00891930|3960410|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
1620081|NCT00891930|3960410|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
1620082|NCT00891904|3960431|P1|NOT COMPLETED|Overall Study||2
1620083|NCT00891904|3960431|P1|COMPLETED|Overall Study||0
1620084|NCT00891904|3960431|P1|STARTED|Overall Study||2
1620085|NCT00891878|3960440|P2|NOT COMPLETED|Overall Study||0
1620086|NCT00891878|3960441|P1|NOT COMPLETED|Overall Study||0
1620087|NCT00891878|3960440|P2|COMPLETED|Overall Study||6
1620088|NCT00891878|3960441|P1|COMPLETED|Overall Study||6
1620089|NCT00891878|3960440|P2|STARTED|Overall Study||6
1620090|NCT00891878|3960441|P1|STARTED|Overall Study||6
1620091|NCT00891839|3960457|P1|NOT COMPLETED|Overall Study||7
1620092|NCT00891839|3960457|P1|COMPLETED|Overall Study|completed treatment|38
1620093|NCT00891839|3960457|P1|STARTED|Overall Study||45
1620094|NCT00891813|3960466|P1|NOT COMPLETED|Overall Study||12
1620095|NCT00891813|3960466|P1|COMPLETED|Overall Study||88
1620096|NCT00891813|3960466|P1|STARTED|Overall Study||100
1620097|NCT00891774|3960472|P1|NOT COMPLETED|Overall Study||14
1620098|NCT00891774|3960472|P1|COMPLETED|Overall Study||158
1620099|NCT00891774|3960472|P1|STARTED|Overall Study||172
1620100|NCT00891735|3960480|P4|NOT COMPLETED|Overall Study||15
1620101|NCT00891735|3960481|P3|NOT COMPLETED|Overall Study||12
1620102|NCT00891735|3960482|P2|NOT COMPLETED|Overall Study||16
1620103|NCT00891735|3960483|P1|NOT COMPLETED|Overall Study||17
1620104|NCT00891735|3960480|P4|COMPLETED|Overall Study||258
1620105|NCT00891735|3960481|P3|COMPLETED|Overall Study||263
1620106|NCT00891735|3960482|P2|COMPLETED|Overall Study||258
1620107|NCT00891735|3960483|P1|COMPLETED|Overall Study||258
1620108|NCT00891735|3960480|P4|STARTED|Overall Study||273
1620109|NCT00891735|3960481|P3|STARTED|Overall Study||275
1620110|NCT00891735|3960482|P2|STARTED|Overall Study||274
1620111|NCT00891735|3960483|P1|STARTED|Overall Study||275
1620112|NCT00891657|3960523|P2|NOT COMPLETED|Overall Study||1
1620113|NCT00891657|3960524|P1|NOT COMPLETED|Overall Study||1
1620114|NCT00891657|3960523|P2|COMPLETED|Overall Study||5
1620115|NCT00891657|3960524|P1|COMPLETED|Overall Study||8
1620116|NCT00891657|3960523|P2|STARTED|Overall Study||6
1620117|NCT00891657|3960524|P1|STARTED|Overall Study||9
1620118|NCT00891618|3960536|P1|NOT COMPLETED|Overall Study||1
1620119|NCT00891618|3960536|P1|COMPLETED|Overall Study||20
1620120|NCT00891618|3960536|P1|STARTED|Overall Study||21
1620121|NCT00891527|3960540|P1|NOT COMPLETED|Overall Study||2
1620122|NCT00891527|3960540|P1|COMPLETED|Overall Study||48
1620123|NCT00891527|3960540|P1|STARTED|Overall Study||50
1620124|NCT00891462|3960549|P3|NOT COMPLETED|Overall Study||24
1620125|NCT00891462|3960550|P2|NOT COMPLETED|Overall Study||33
1620126|NCT00891462|3960551|P1|NOT COMPLETED|Overall Study||37
1620127|NCT00891462|3960549|P3|COMPLETED|Overall Study||166
1620128|NCT00891462|3960550|P2|COMPLETED|Overall Study||152
1620129|NCT00891462|3960551|P1|COMPLETED|Overall Study||149
1620130|NCT00891462|3960549|P3|STARTED|Overall Study||190
1620131|NCT00891462|3960550|P2|STARTED|Overall Study||185
1620132|NCT00891462|3960551|P1|STARTED|Overall Study||186
1620133|NCT00891436|3960564|P2|NOT COMPLETED|Overall Study||0
1620134|NCT00891436|3960565|P1|NOT COMPLETED|Overall Study||0
1620135|NCT00891436|3960564|P2|COMPLETED|Overall Study||10
1620136|NCT00891436|3960565|P1|COMPLETED|Overall Study||10
1620137|NCT00891436|3960564|P2|STARTED|Overall Study||10
1620138|NCT00891436|3960565|P1|STARTED|Overall Study||10
1620139|NCT00891371|3960573|P1|NOT COMPLETED|Treatment||9
1620140|NCT00891371|3960573|P1|COMPLETED|Treatment||27
1620141|NCT00891371|3960573|P1|STARTED|Treatment||36
1620142|NCT00891371|3960573|P1|NOT COMPLETED|Pre-assignment||6
1620143|NCT00891371|3960573|P1|COMPLETED|Pre-assignment||36
1620144|NCT00891371|3960573|P1|STARTED|Pre-assignment||42
1620145|NCT00891319|3960584|P2|NOT COMPLETED|Overall Study||0
1620146|NCT00891319|3960585|P1|NOT COMPLETED|Overall Study||8
1620147|NCT00891319|3960584|P2|COMPLETED|Overall Study||40
1620148|NCT00891319|3960585|P1|COMPLETED|Overall Study||32
1620149|NCT00891319|3960584|P2|STARTED|Overall Study||40
1620150|NCT00891319|3960585|P1|STARTED|Overall Study||40
1620151|NCT00891293|3960595|P1|NOT COMPLETED|Overall Study||84
1620152|NCT00891293|3960595|P1|COMPLETED|Overall Study||9
1620153|NCT00891293|3960595|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
1620154|NCT00891228|3960610|P3|NOT COMPLETED|Overall Study||15
1620155|NCT00891228|3960611|P2|NOT COMPLETED|Overall Study||13
1620156|NCT00891228|3960612|P1|NOT COMPLETED|Overall Study||11
1620157|NCT00891228|3960610|P3|COMPLETED|Overall Study||19
1620158|NCT00891228|3960611|P2|COMPLETED|Overall Study||20
1620159|NCT00891228|3960612|P1|COMPLETED|Overall Study||21
1620160|NCT00891228|3960610|P3|STARTED|Overall Study||34
1620161|NCT00891228|3960611|P2|STARTED|Overall Study||33
1620162|NCT00891228|3960612|P1|STARTED|Overall Study||32
1620163|NCT00891202|3960634|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
1620164|NCT00891202|3960635|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
1620165|NCT00891202|3960636|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1620166|NCT00891202|3960637|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1620167|NCT00891202|3960634|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
1620168|NCT00891202|3960635|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
1620169|NCT00891202|3960636|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1620170|NCT00891202|3960637|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1620171|NCT00891202|3960634|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
1620172|NCT00891202|3960635|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
1620173|NCT00891202|3960636|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
1620174|NCT00891202|3960637|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
1620175|NCT00891202|3960634|P4|NOT COMPLETED|PAP (Up To Week 39)||0
1620176|NCT00891202|3960635|P3|NOT COMPLETED|PAP (Up To Week 39)||0
1620177|NCT00891202|3960636|P2|NOT COMPLETED|PAP (Up To Week 39)||0
1620178|NCT00891202|3960637|P1|NOT COMPLETED|PAP (Up To Week 39)||1
1620179|NCT00891202|3960634|P4|COMPLETED|PAP (Up To Week 39)||0
1620180|NCT00891202|3960635|P3|COMPLETED|PAP (Up To Week 39)||0
1620181|NCT00891202|3960636|P2|COMPLETED|PAP (Up To Week 39)||20
1620182|NCT00891202|3960637|P1|COMPLETED|PAP (Up To Week 39)||19
1620183|NCT00891202|3960634|P4|STARTED|PAP (Up To Week 39)||0
1620184|NCT00891202|3960635|P3|STARTED|PAP (Up To Week 39)||0
1620185|NCT00891202|3960636|P2|STARTED|PAP (Up To Week 39)||20
1620186|NCT00891202|3960637|P1|STARTED|PAP (Up To Week 39)||20
1620187|NCT00891176|3960663|P4|NOT COMPLETED|At 6 Years of Age||0
1620188|NCT00891176|3960664|P3|NOT COMPLETED|At 6 Years of Age||0
1620189|NCT00891176|3960665|P2|NOT COMPLETED|At 6 Years of Age||0
1620190|NCT00891176|3960666|P1|NOT COMPLETED|At 6 Years of Age||0
1620191|NCT00891176|3960663|P4|COMPLETED|At 6 Years of Age||135
1620192|NCT00891176|3960664|P3|COMPLETED|At 6 Years of Age||135
1620193|NCT00891176|3960665|P2|COMPLETED|At 6 Years of Age||138
1620194|NCT00891176|3960666|P1|COMPLETED|At 6 Years of Age||131
1620195|NCT00891176|3960663|P4|STARTED|At 6 Years of Age||135
1620196|NCT00891176|3960664|P3|STARTED|At 6 Years of Age||135
1620197|NCT00891176|3960665|P2|STARTED|At 6 Years of Age||138
1620198|NCT00891176|3960666|P1|STARTED|At 6 Years of Age||131
1620199|NCT00891176|3960663|P4|NOT COMPLETED|At 4 Years of Age||0
1620200|NCT00891176|3960664|P3|NOT COMPLETED|At 4 Years of Age||0
1620201|NCT00891176|3960665|P2|NOT COMPLETED|At 4 Years of Age||0
1620202|NCT00891176|3960666|P1|NOT COMPLETED|At 4 Years of Age||0
1620203|NCT00891176|3960663|P4|COMPLETED|At 4 Years of Age||137
1620204|NCT00891176|3960664|P3|COMPLETED|At 4 Years of Age||142
1620205|NCT00891176|3960665|P2|COMPLETED|At 4 Years of Age||142
1620206|NCT00891176|3960666|P1|COMPLETED|At 4 Years of Age||140
1620207|NCT00891176|3960663|P4|STARTED|At 4 Years of Age||137
1620208|NCT00891176|3960664|P3|STARTED|At 4 Years of Age||142
1620209|NCT00891176|3960665|P2|STARTED|At 4 Years of Age||142
1620210|NCT00891176|3960666|P1|STARTED|At 4 Years of Age||140
1620211|NCT00891176|3960663|P4|NOT COMPLETED|At 3 Years of Age||0
1620212|NCT00891176|3960664|P3|NOT COMPLETED|At 3 Years of Age||0
1620213|NCT00891176|3960665|P2|NOT COMPLETED|At 3 Years of Age||0
1620214|NCT00891176|3960666|P1|NOT COMPLETED|At 3 Years of Age||0
1620215|NCT00891176|3960663|P4|COMPLETED|At 3 Years of Age||141
1620216|NCT00891176|3960664|P3|COMPLETED|At 3 Years of Age||149
1620217|NCT00891176|3960665|P2|COMPLETED|At 3 Years of Age||147
1620218|NCT00891176|3960666|P1|COMPLETED|At 3 Years of Age||144
1620219|NCT00891176|3960663|P4|STARTED|At 3 Years of Age||141
1620220|NCT00891176|3960664|P3|STARTED|At 3 Years of Age||149
1620221|NCT00891176|3960665|P2|STARTED|At 3 Years of Age||147
1620222|NCT00891176|3960666|P1|STARTED|At 3 Years of Age||144
1620223|NCT00891046|3960813|P5|NOT COMPLETED|Overall Study||39
1620224|NCT00891046|3960814|P4|NOT COMPLETED|Overall Study||3
1620225|NCT00891046|3960815|P3|NOT COMPLETED|Overall Study||23
1620226|NCT00891046|3960816|P2|NOT COMPLETED|Overall Study||9
1620227|NCT00891046|3960817|P1|NOT COMPLETED|Overall Study||12
1620228|NCT00891046|3960813|P5|COMPLETED|Overall Study||84
1620229|NCT00891046|3960814|P4|COMPLETED|Overall Study||8
1620230|NCT00891046|3960815|P3|COMPLETED|Overall Study||17
1620231|NCT00891046|3960816|P2|COMPLETED|Overall Study||54
1620232|NCT00891046|3960817|P1|COMPLETED|Overall Study||21
1620233|NCT00891046|3960813|P5|STARTED|Overall Study||123
1620234|NCT00891046|3960814|P4|STARTED|Overall Study||11
1620235|NCT00891046|3960815|P3|STARTED|Overall Study||40
1620236|NCT00891046|3960816|P2|STARTED|Overall Study||63
1620237|NCT00891046|3960817|P1|STARTED|Overall Study||33
1620238|NCT00891020|3960893|P3|NOT COMPLETED|Long-term Extension Period||23
1620239|NCT00891020|3960894|P2|NOT COMPLETED|Long-term Extension Period||24
1620240|NCT00891020|3960895|P1|NOT COMPLETED|Long-term Extension Period||6
1620241|NCT00891020|3960893|P3|COMPLETED|Long-term Extension Period||170
1620242|NCT00891020|3960894|P2|COMPLETED|Long-term Extension Period||172
1620243|NCT00891020|3960895|P1|COMPLETED|Long-term Extension Period||49
1620244|NCT00891020|3960893|P3|STARTED|Long-term Extension Period||193
1620245|NCT00891020|3960894|P2|STARTED|Long-term Extension Period||196
1620246|NCT00891020|3960895|P1|STARTED|Long-term Extension Period||55
1620247|NCT00891020|3960893|P3|NOT COMPLETED|24 Week Treatment Period||58
1620248|NCT00891020|3960894|P2|NOT COMPLETED|24 Week Treatment Period||60
1620249|NCT00891020|3960895|P1|NOT COMPLETED|24 Week Treatment Period||37
1620250|NCT00891020|3960893|P3|COMPLETED|24 Week Treatment Period||302
1620251|NCT00891020|3960894|P2|COMPLETED|24 Week Treatment Period||303
1620252|NCT00891020|3960895|P1|COMPLETED|24 Week Treatment Period||126
1620253|NCT00891020|3960893|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
1620254|NCT00891020|3960894|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
1620255|NCT00891020|3960895|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
1620256|NCT00891020|3960893|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
1620257|NCT00891020|3960894|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
1620258|NCT00891020|3960895|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
1620259|NCT00891020|3960893|P3|STARTED|24 Week Treatment Period||360
1620260|NCT00891020|3960894|P2|STARTED|24 Week Treatment Period||363
1620261|NCT00891020|3960895|P1|STARTED|24 Week Treatment Period||163
1620262|NCT00890981|3960928|P2|NOT COMPLETED|Overall Study||0
1620263|NCT00890981|3960929|P1|NOT COMPLETED|Overall Study||0
1620264|NCT00890981|3960928|P2|COMPLETED|Overall Study||40
1620265|NCT00890981|3960929|P1|COMPLETED|Overall Study||39
1620266|NCT00890981|3960928|P2|STARTED|Overall Study||40
1620267|NCT00890981|3960929|P1|STARTED|Overall Study||39
1620268|NCT00890929|3960959|P1|NOT COMPLETED|Overall Study||6
1620269|NCT00890929|3960959|P1|COMPLETED|Overall Study||39
1620270|NCT00890929|3960959|P1|Initiated Treatment|Overall Study||43
1620271|NCT00890929|3960959|P1|Consented & Enrolled|Overall Study||45
1620272|NCT00890929|3960959|P1|STARTED|Overall Study||45
1620273|NCT00890916|3960971|P1|NOT COMPLETED|"Rehab - NP Off"||0
1620274|NCT00890916|3960971|P1|COMPLETED|"Rehab - NP Off"||10
1620275|NCT00890916|3960971|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
1620276|NCT00890916|3960971|P1|STARTED|"Rehab - NP Off"||10
1620277|NCT00890916|3960971|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
1620278|NCT00890916|3960971|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
1620279|NCT00890916|3960971|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
1620280|NCT00890916|3960971|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
1620281|NCT00890825|3960977|P2|NOT COMPLETED|Overall Study||14
1620282|NCT00890825|3960978|P1|NOT COMPLETED|Overall Study||14
1620283|NCT00890825|3960977|P2|COMPLETED|Overall Study||29
1620284|NCT00890825|3960978|P1|COMPLETED|Overall Study||30
1620285|NCT00890825|3960977|P2|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
1620286|NCT00890825|3960978|P1|STARTED|Overall Study||44
1620287|NCT00890721|3960998|P2|NOT COMPLETED|Overall Study||1
1620288|NCT00890721|3960999|P1|NOT COMPLETED|Overall Study||1
1620289|NCT00890721|3960998|P2|COMPLETED|Overall Study||93
1620290|NCT00890721|3960999|P1|COMPLETED|Overall Study||94
1620291|NCT00890721|3960998|P2|STARTED|Overall Study||94
1620292|NCT00890721|3960999|P1|STARTED|Overall Study||95
1620293|NCT00890695|3961007|P2|NOT COMPLETED|Overall Study||0
1620294|NCT00890695|3961008|P1|NOT COMPLETED|Overall Study||1
1620295|NCT00890695|3961007|P2|COMPLETED|Overall Study||33
1620296|NCT00890695|3961008|P1|COMPLETED|Overall Study||31
1620297|NCT00890695|3961007|P2|STARTED|Overall Study||33
1620298|NCT00890695|3961008|P1|STARTED|Overall Study||32
1620299|NCT00890682|3961026|P2|NOT COMPLETED|Overall Study||2
1620300|NCT00890682|3961027|P1|NOT COMPLETED|Overall Study||4
1620301|NCT00890682|3961026|P2|COMPLETED|Overall Study||94
1620302|NCT00890682|3961027|P1|COMPLETED|Overall Study||93
1620303|NCT00890682|3961026|P2|STARTED|Overall Study||96
1620304|NCT00890682|3961027|P1|STARTED|Overall Study||97
1620305|NCT00890656|3961033|P1|NOT COMPLETED|Overall Study||0
1620306|NCT00890656|3961033|P1|COMPLETED|Overall Study||90
1620307|NCT00890656|3961033|P1|STARTED|Overall Study||90
1620308|NCT00890591|3961037|P1|NOT COMPLETED|Overall Study||20
1620309|NCT00890591|3961037|P1|COMPLETED|Overall Study||124
1620310|NCT00890591|3961037|P1|STARTED|Overall Study||144
1620311|NCT00890552|3961043|P1|NOT COMPLETED|On-treatment||10
1620312|NCT00890552|3961043|P1|COMPLETED|On-treatment||14
1620313|NCT00890552|3961043|P1|STARTED|On-treatment||24
1620314|NCT00890552|3961043|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
1620315|NCT00890552|3961043|P1|COMPLETED|Enrollment and Pre-treatment||24
1620316|NCT00890552|3961043|P1|STARTED|Enrollment and Pre-treatment||25
1620317|NCT00890409|3961052|P2|NOT COMPLETED|Overall Study||21
1620318|NCT00890409|3961053|P1|NOT COMPLETED|Overall Study||20
1620319|NCT00890409|3961052|P2|COMPLETED|Overall Study||119
1620320|NCT00890409|3961053|P1|COMPLETED|Overall Study||96
1620321|NCT00890409|3961052|P2|STARTED|Overall Study||140
1620322|NCT00890409|3961053|P1|STARTED|Overall Study||116
1620323|NCT00890201|3961063|P2|NOT COMPLETED|Overall Study||56
1620324|NCT00890201|3961064|P1|NOT COMPLETED|Overall Study||5
1620325|NCT00890201|3961063|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
1620326|NCT00890201|3961064|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
1620327|NCT00890201|3961063|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
1620328|NCT00890201|3961064|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
1620329|NCT00890097|3961073|P3|NOT COMPLETED|Overall Study||77
1620330|NCT00890097|3961074|P2|NOT COMPLETED|Overall Study||86
1620331|NCT00890097|3961075|P1|NOT COMPLETED|Overall Study||68
1620332|NCT00890097|3961073|P3|COMPLETED|Overall Study||184
1620333|NCT00890097|3961074|P2|COMPLETED|Overall Study||173
1620334|NCT00890097|3961075|P1|COMPLETED|Overall Study||184
1620335|NCT00890097|3961073|P3|STARTED|Overall Study||261
1620336|NCT00890097|3961074|P2|STARTED|Overall Study||259
1620337|NCT00890097|3961075|P1|STARTED|Overall Study||252
1620338|NCT00890084|3961083|P1|NOT COMPLETED|Overall Study||142
1620339|NCT00890084|3961083|P1|COMPLETED|Overall Study||2771
1620340|NCT00890084|3961083|P1|STARTED|Overall Study||2913
1620341|NCT00889928|3961094|P1|NOT COMPLETED|Overall Study||0
1620342|NCT00889928|3961094|P1|COMPLETED|Overall Study||7
1620343|NCT00889928|3961094|P1|STARTED|Overall Study||7
1620344|NCT00889915|3961102|P4|NOT COMPLETED|Overall Study||8
1620345|NCT00889915|3961103|P3|NOT COMPLETED|Overall Study||13
1620346|NCT00889915|3961104|P2|NOT COMPLETED|Overall Study||5
1620347|NCT00889915|3961105|P1|NOT COMPLETED|Overall Study||2
1620348|NCT00889915|3961102|P4|COMPLETED|Overall Study||40
1620349|NCT00889915|3961103|P3|COMPLETED|Overall Study||54
1620350|NCT00889915|3961104|P2|COMPLETED|Overall Study||71
1620351|NCT00889915|3961105|P1|COMPLETED|Overall Study||35
1620352|NCT00889915|3961102|P4|STARTED|Overall Study||48
1620353|NCT00889915|3961103|P3|STARTED|Overall Study||67
1620354|NCT00889915|3961104|P2|STARTED|Overall Study||76
1620355|NCT00889915|3961105|P1|STARTED|Overall Study||37
1620356|NCT00889863|3961123|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
1620357|NCT00889863|3961124|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
1620358|NCT00889863|3961123|P2|COMPLETED|Part II: Randomized Double Blind||24
1620359|NCT00889863|3961124|P1|COMPLETED|Part II: Randomized Double Blind||39
1620360|NCT00889863|3961123|P2|STARTED|Part II: Randomized Double Blind||50
1620361|NCT00889863|3961124|P1|STARTED|Part II: Randomized Double Blind||50
1620362|NCT00889863|3961123|P2|NOT COMPLETED|Part I: Open Label||0
1620363|NCT00889863|3961124|P1|NOT COMPLETED|Part I: Open Label||77
1620364|NCT00889863|3961123|P2|COMPLETED|Part I: Open Label||0
1620365|NCT00889863|3961124|P1|COMPLETED|Part I: Open Label||100
1620366|NCT00889863|3961123|P2|Entered Part 1d|Part I: Open Label||0
1620367|NCT00889863|3961124|P1|Entered Part 1d|Part I: Open Label||103
1620368|NCT00889863|3961123|P2|Entered Part Ic|Part I: Open Label||0
1620369|NCT00889863|3961124|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
1620370|NCT00889863|3961123|P2|Entered Part Ib|Part I: Open Label||0
1620371|NCT00889863|3961124|P1|Entered Part Ib|Part I: Open Label||142
1620372|NCT00889863|3961123|P2|Entered Part Ia|Part I: Open Label||0
1620373|NCT00889863|3961124|P1|Entered Part Ia|Part I: Open Label||145
1620374|NCT00889863|3961123|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
1620375|NCT00889863|3961124|P1|STARTED|Part I: Open Label||177
1620376|NCT00889824|3961146|P1|NOT COMPLETED|Overall Study||0
1620377|NCT00889824|3961146|P1|COMPLETED|Overall Study||5
1620378|NCT00889824|3961146|P1|STARTED|Overall Study||5
1620379|NCT00889720|3961150|P1|NOT COMPLETED|Overall Study||8
1620380|NCT00889720|3961150|P1|COMPLETED|Overall Study||8
1620381|NCT00889720|3961150|P1|Surgical Population|Overall Study||12
1620382|NCT00889720|3961150|P1|STARTED|Overall Study||16
1620383|NCT00889707|3961177|P2|NOT COMPLETED|Overall Study||10
1620384|NCT00889707|3961178|P1|NOT COMPLETED|Overall Study||7
1620385|NCT00889707|3961177|P2|COMPLETED|Overall Study||21
1620386|NCT00889707|3961178|P1|COMPLETED|Overall Study||54
1620387|NCT00889707|3961177|P2|STARTED|Overall Study||31
1620388|NCT00889707|3961178|P1|STARTED|Overall Study||61
1620389|NCT00889681|3961186|P1|NOT COMPLETED|Overall Study||3
1620390|NCT00889681|3961186|P1|COMPLETED|Overall Study||78
1620391|NCT00889681|3961186|P1|Received Treatment|Overall Study||78
1620392|NCT00889681|3961186|P1|STARTED|Overall Study||81
1620393|NCT00889603|3961193|P1|NOT COMPLETED|Overall Study||37
1620394|NCT00889603|3961193|P1|COMPLETED|Overall Study||333
1620395|NCT00889603|3961193|P1|STARTED|Overall Study||370
1620396|NCT00889512|3961208|P2|NOT COMPLETED|Overall Study||0
1620397|NCT00889512|3961209|P1|NOT COMPLETED|Overall Study||0
1620398|NCT00889512|3961208|P2|COMPLETED|Overall Study||9
1620399|NCT00889512|3961209|P1|COMPLETED|Overall Study||5
1620400|NCT00889512|3961208|P2|STARTED|Overall Study||9
1620401|NCT00889512|3961209|P1|STARTED|Overall Study||5
1620402|NCT00889421|3961215|P1|NOT COMPLETED|Overall Study||3
1620403|NCT00889421|3961215|P1|COMPLETED|Overall Study||0
1620404|NCT00889421|3961215|P1|STARTED|Overall Study||3
1620405|NCT00889330|3961225|P2|NOT COMPLETED|Overall Study||0
1620406|NCT00889330|3961226|P1|NOT COMPLETED|Overall Study||0
1620407|NCT00889330|3961225|P2|COMPLETED|Overall Study||30
1620408|NCT00889330|3961226|P1|COMPLETED|Overall Study||30
1620409|NCT00889330|3961225|P2|STARTED|Overall Study||30
1620410|NCT00889330|3961226|P1|STARTED|Overall Study||30
1620411|NCT00889265|3961256|P1|NOT COMPLETED|Overall Study||7
1620412|NCT00889265|3961256|P1|COMPLETED|Overall Study||44
1620413|NCT00889265|3961256|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
1620414|NCT00889252|3961263|P2|NOT COMPLETED|Overall Study||4
1620415|NCT00889252|3961264|P1|NOT COMPLETED|Overall Study||7
1620416|NCT00889252|3961263|P2|COMPLETED|Overall Study||78
1620417|NCT00889252|3961264|P1|COMPLETED|Overall Study||161
1620418|NCT00889252|3961263|P2|STARTED|Overall Study||82
1620419|NCT00889252|3961264|P1|STARTED|Overall Study||168
1620420|NCT00889200|3961306|P1|NOT COMPLETED|Overall Study||0
1620421|NCT00889200|3961306|P1|COMPLETED|Overall Study||12
1620422|NCT00889200|3961306|P1|STARTED|Overall Study||12
1620423|NCT00889187|3961310|P4|NOT COMPLETED|Overall Study||0
1620424|NCT00889187|3961311|P3|NOT COMPLETED|Overall Study||0
1620425|NCT00889187|3961312|P2|NOT COMPLETED|Overall Study||0
1620426|NCT00889187|3961313|P1|NOT COMPLETED|Overall Study||0
1620427|NCT00889187|3961310|P4|COMPLETED|Overall Study||0
1620428|NCT00889187|3961311|P3|COMPLETED|Overall Study||4
1620429|NCT00889187|3961312|P2|COMPLETED|Overall Study||3
1620430|NCT00889187|3961313|P1|COMPLETED|Overall Study||3
1620431|NCT00889187|3961310|P4|STARTED|Overall Study||0
1620432|NCT00889187|3961311|P3|STARTED|Overall Study||4
1620433|NCT00889187|3961312|P2|STARTED|Overall Study||3
1620434|NCT00889187|3961313|P1|STARTED|Overall Study||3
1620435|NCT00889005|3961330|P2|NOT COMPLETED|Overall Study||2
1620436|NCT00889005|3961331|P1|NOT COMPLETED|Overall Study||8
1620437|NCT00889005|3961330|P2|COMPLETED|Overall Study||72
1620438|NCT00889005|3961331|P1|COMPLETED|Overall Study||57
1620439|NCT00889005|3961330|P2|STARTED|Overall Study||74
1620440|NCT00889005|3961331|P1|STARTED|Overall Study||65
1620441|NCT00888979|3961337|P1|NOT COMPLETED|Overall Study||4
1620442|NCT00888979|3961337|P1|COMPLETED|Overall Study||6
1620443|NCT00888979|3961337|P1|Received the Inhaler/Counseling|Overall Study||8
1620444|NCT00888979|3961337|P1|STARTED|Overall Study||10
1620445|NCT00888940|3961345|P2|NOT COMPLETED|Overall Study||21
1620446|NCT00888940|3961346|P1|NOT COMPLETED|Overall Study||28
1620447|NCT00888940|3961345|P2|COMPLETED|Overall Study||101
1620448|NCT00888940|3961346|P1|COMPLETED|Overall Study||92
1620449|NCT00888940|3961345|P2|Completed Therapy|Overall Study||106
1620450|NCT00888940|3961346|P1|Completed Therapy|Overall Study||107
1620451|NCT00888940|3961345|P2|STARTED|Overall Study||122
1620452|NCT00888940|3961346|P1|STARTED|Overall Study||120
1620453|NCT00888849|3961356|P2|NOT COMPLETED|Overall Study||9
1620454|NCT00888849|3961357|P1|NOT COMPLETED|Overall Study||5
1620455|NCT00888849|3961356|P2|COMPLETED|Overall Study||129
1620456|NCT00888849|3961357|P1|COMPLETED|Overall Study||137
1620457|NCT00888849|3961356|P2|STARTED|Overall Study||138
1620458|NCT00888849|3961357|P1|STARTED|Overall Study||142
1620459|NCT00888654|3961367|P1|NOT COMPLETED|Overall Study||10
1620460|NCT00888654|3961367|P1|COMPLETED|Overall Study||31
1620461|NCT00888654|3961367|P1|STARTED|Overall Study||41
1620462|NCT00888628|3961373|P1|NOT COMPLETED|Overall Study||3
1620463|NCT00888628|3961373|P1|COMPLETED|Overall Study||4
1620464|NCT00888628|3961373|P1|Transplanted|Overall Study||4
1620465|NCT00888628|3961373|P1|Withdrawn|Overall Study||1
1620466|NCT00888628|3961373|P1|Screen Failure|Overall Study||2
1620467|NCT00888628|3961373|P1|Enrolled|Overall Study||7
1620468|NCT00888628|3961373|P1|STARTED|Overall Study||7
1620469|NCT00888459|3961387|P2|NOT COMPLETED|Overall Study||0
1620470|NCT00888459|3961388|P1|NOT COMPLETED|Overall Study||0
1620471|NCT00888459|3961387|P2|COMPLETED|Overall Study||30
1620472|NCT00888459|3961388|P1|COMPLETED|Overall Study||30
1620473|NCT00888459|3961387|P2|STARTED|Overall Study||30
1620474|NCT00888459|3961388|P1|STARTED|Overall Study||30
1620475|NCT00888433|3961396|P2|NOT COMPLETED|Overall Study||3
1620476|NCT00888433|3961397|P1|NOT COMPLETED|Overall Study||3
1620477|NCT00888433|3961396|P2|COMPLETED|Overall Study||51
1620478|NCT00888433|3961397|P1|COMPLETED|Overall Study||49
1620479|NCT00888433|3961396|P2|STARTED|Overall Study||54
1620480|NCT00888433|3961397|P1|STARTED|Overall Study||52
1620481|NCT00888381|3961405|P2|NOT COMPLETED|Overall Study||1
1620482|NCT00888381|3961406|P1|NOT COMPLETED|Overall Study||0
1620483|NCT00888381|3961405|P2|COMPLETED|Overall Study||59
1620484|NCT00888381|3961406|P1|COMPLETED|Overall Study||60
1620485|NCT00888381|3961405|P2|STARTED|Overall Study||60
1620486|NCT00888381|3961406|P1|STARTED|Overall Study||60
1620487|NCT00888355|3961426|P4|NOT COMPLETED|Overall Study||10
1620488|NCT00888355|3961427|P3|NOT COMPLETED|Overall Study||12
1620489|NCT00888355|3961428|P2|NOT COMPLETED|Overall Study||9
1620490|NCT00888355|3961429|P1|NOT COMPLETED|Overall Study||22
1620491|NCT00888355|3961426|P4|COMPLETED|Overall Study||96
1620492|NCT00888355|3961427|P3|COMPLETED|Overall Study||94
1620493|NCT00888355|3961428|P2|COMPLETED|Overall Study||99
1620494|NCT00888355|3961429|P1|COMPLETED|Overall Study||86
1620495|NCT00888355|3961426|P4|STARTED|Overall Study||106
1620496|NCT00888355|3961427|P3|STARTED|Overall Study||106
1620497|NCT00888355|3961428|P2|STARTED|Overall Study||108
1620498|NCT00888355|3961429|P1|STARTED|Overall Study||108
1620499|NCT00888329|3961485|P2|NOT COMPLETED|Overall Study||9
1620500|NCT00888329|3961486|P1|NOT COMPLETED|Overall Study||6
1620501|NCT00888329|3961485|P2|COMPLETED|Overall Study||122
1620502|NCT00888329|3961486|P1|COMPLETED|Overall Study||119
1620503|NCT00888329|3961485|P2|STARTED|Overall Study||131
1620504|NCT00888329|3961486|P1|STARTED|Overall Study||125
1620505|NCT00888238|3961492|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
1620506|NCT00888238|3961493|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
1620507|NCT00888238|3961494|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
1620508|NCT00888238|3961492|P3|COMPLETED|Third Period of Treatment Intervention||3
1620509|NCT00888238|3961493|P2|COMPLETED|Third Period of Treatment Intervention||4
1620510|NCT00888238|3961494|P1|COMPLETED|Third Period of Treatment Intervention||4
1620511|NCT00888238|3961492|P3|STARTED|Third Period of Treatment Intervention||3
1620512|NCT00888238|3961493|P2|STARTED|Third Period of Treatment Intervention||4
1620513|NCT00888238|3961494|P1|STARTED|Third Period of Treatment Intervention||4
1620514|NCT00888238|3961492|P3|NOT COMPLETED|Washout Period After Period 2||1
1620515|NCT00888238|3961493|P2|NOT COMPLETED|Washout Period After Period 2||0
1620516|NCT00888238|3961494|P1|NOT COMPLETED|Washout Period After Period 2||0
1620517|NCT00888238|3961492|P3|COMPLETED|Washout Period After Period 2||3
1620518|NCT00888238|3961493|P2|COMPLETED|Washout Period After Period 2||4
1620519|NCT00888238|3961494|P1|COMPLETED|Washout Period After Period 2||4
1620520|NCT00888238|3961492|P3|STARTED|Washout Period After Period 2||4
1620521|NCT00888238|3961493|P2|STARTED|Washout Period After Period 2||4
1620522|NCT00888238|3961494|P1|STARTED|Washout Period After Period 2||4
1620523|NCT00888238|3961492|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
1620524|NCT00888238|3961493|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
1620525|NCT00888238|3961494|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
1620526|NCT00888238|3961492|P3|COMPLETED|Second Period of Treatment Intervention||4
1620527|NCT00888238|3961493|P2|COMPLETED|Second Period of Treatment Intervention||4
1620528|NCT00888238|3961494|P1|COMPLETED|Second Period of Treatment Intervention||4
1620529|NCT00888238|3961492|P3|STARTED|Second Period of Treatment Intervention||4
1620530|NCT00888238|3961493|P2|STARTED|Second Period of Treatment Intervention||4
1620531|NCT00888238|3961494|P1|STARTED|Second Period of Treatment Intervention||4
1620532|NCT00888238|3961492|P3|NOT COMPLETED|Washout Period After Period 1||0
1620533|NCT00888238|3961493|P2|NOT COMPLETED|Washout Period After Period 1||0
1620534|NCT00888238|3961494|P1|NOT COMPLETED|Washout Period After Period 1||0
1620535|NCT00888238|3961492|P3|COMPLETED|Washout Period After Period 1||4
1620536|NCT00888238|3961493|P2|COMPLETED|Washout Period After Period 1||4
1620537|NCT00888238|3961494|P1|COMPLETED|Washout Period After Period 1||4
1620538|NCT00888238|3961492|P3|STARTED|Washout Period After Period 1||4
1620539|NCT00888238|3961493|P2|STARTED|Washout Period After Period 1||4
1620540|NCT00888238|3961494|P1|STARTED|Washout Period After Period 1||4
1620541|NCT00888238|3961492|P3|NOT COMPLETED|First Period of Treatment Intervention||0
1620542|NCT00888238|3961493|P2|NOT COMPLETED|First Period of Treatment Intervention||0
1620543|NCT00888238|3961494|P1|NOT COMPLETED|First Period of Treatment Intervention||0
1620544|NCT00888238|3961492|P3|COMPLETED|First Period of Treatment Intervention||4
1620545|NCT00888238|3961493|P2|COMPLETED|First Period of Treatment Intervention||4
1620546|NCT00888238|3961494|P1|COMPLETED|First Period of Treatment Intervention||4
1620547|NCT00888238|3961492|P3|STARTED|First Period of Treatment Intervention||4
1620548|NCT00888238|3961493|P2|STARTED|First Period of Treatment Intervention||4
1620549|NCT00888238|3961494|P1|STARTED|First Period of Treatment Intervention||4
1620550|NCT00888173|3961502|P1|NOT COMPLETED|Overall Study||2
1620551|NCT00888173|3961502|P1|COMPLETED|Overall Study||43
1620552|NCT00888173|3961502|P1|STARTED|Overall Study||45
1620553|NCT00888134|3961510|P1|NOT COMPLETED|Follow-up||1
1620554|NCT00888134|3961510|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
1620555|NCT00888134|3961510|P1|STARTED|Follow-up||27
1620556|NCT00888134|3961510|P1|NOT COMPLETED|Treatment With Study Drug||1
1620557|NCT00888134|3961510|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
1620558|NCT00888134|3961510|P1|STARTED|Treatment With Study Drug||28
1620559|NCT00887978|3961520|P2|NOT COMPLETED|Overall Study||15
1620560|NCT00887978|3961521|P1|NOT COMPLETED|Overall Study||25
1620561|NCT00887978|3961520|P2|COMPLETED|Overall Study||138
1620562|NCT00887978|3961521|P1|COMPLETED|Overall Study||132
1620563|NCT00887978|3961520|P2|STARTED|Overall Study||153
1620564|NCT00887978|3961521|P1|STARTED|Overall Study||157
1620565|NCT00887965|3961557|P1|NOT COMPLETED|Overall Study||0
1620566|NCT00887965|3961557|P1|COMPLETED|Overall Study||15
1620567|NCT00887965|3961557|P1|STARTED|Overall Study||15
1620568|NCT00887913|3961587|P1|NOT COMPLETED|Overall Study||6
1620569|NCT00887913|3961587|P1|COMPLETED|Overall Study||63
1620570|NCT00887913|3961587|P1|STARTED|Overall Study||69
1620571|NCT00887822|3961595|P2|NOT COMPLETED|Overall Study||102
1620572|NCT00887822|3961596|P1|NOT COMPLETED|Overall Study||97
1620573|NCT00887822|3961595|P2|COMPLETED|Overall Study||0
1620574|NCT00887822|3961596|P1|COMPLETED|Overall Study||3
1620575|NCT00887822|3961595|P2|Treated (Safety Population)|Overall Study||101
1620576|NCT00887822|3961596|P1|Treated (Safety Population)|Overall Study||100
1620577|NCT00887822|3961595|P2|STARTED|Overall Study||102
1620578|NCT00887822|3961596|P1|STARTED|Overall Study||100
1620579|NCT00887809|3961628|P2|NOT COMPLETED|Overall Study||0
1620580|NCT00887809|3961629|P1|NOT COMPLETED|Overall Study||4
1620581|NCT00887809|3961628|P2|COMPLETED|Overall Study||10
1620582|NCT00887809|3961629|P1|COMPLETED|Overall Study||33
1620583|NCT00887809|3961628|P2|STARTED|Overall Study||10
1620584|NCT00887809|3961629|P1|STARTED|Overall Study||37
1620585|NCT00887744|3961635|P1|NOT COMPLETED|Overall Study||34
1620586|NCT00887744|3961635|P1|COMPLETED|Overall Study||128
1620587|NCT00887744|3961635|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
1620588|NCT00887679|3961644|P1|NOT COMPLETED|Overall Study||10
1620589|NCT00887679|3961644|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
1620590|NCT00887679|3961644|P1|STARTED|Overall Study||30
1620591|NCT00887653|3961653|P1|NOT COMPLETED|Overall Study||0
1620592|NCT00887653|3961653|P1|COMPLETED|Overall Study||20
1620593|NCT00887653|3961653|P1|STARTED|Overall Study||20
1620594|NCT00887640|3961659|P1|NOT COMPLETED|Overall Study||0
1620595|NCT00887640|3961659|P1|COMPLETED|Overall Study||11
1620596|NCT00887640|3961659|P1|STARTED|Overall Study||11
1620597|NCT00887588|3961674|P2|NOT COMPLETED|Extension Period||5
1620598|NCT00887588|3961675|P1|NOT COMPLETED|Extension Period||6
1620599|NCT00887588|3961674|P2|COMPLETED|Extension Period||120
1620600|NCT00887588|3961675|P1|COMPLETED|Extension Period||121
1620601|NCT00887588|3961674|P2|Arterial Stiffness Set|Extension Period||94
1620602|NCT00887588|3961675|P1|Arterial Stiffness Set|Extension Period||86
1620603|NCT00887588|3961674|P2|STARTED|Extension Period||125
1620604|NCT00887588|3961675|P1|STARTED|Extension Period||127
1620605|NCT00887588|3961674|P2|NOT COMPLETED|Core Period||21
1620606|NCT00887588|3961675|P1|NOT COMPLETED|Core Period||19
1620607|NCT00887588|3961674|P2|COMPLETED|Core Period||131
1620608|NCT00887588|3961675|P1|COMPLETED|Core Period||130
1620609|NCT00887588|3961674|P2|Arterial Stiffness Set|Core Period||94
1620610|NCT00887588|3961675|P1|Arterial Stiffness Set|Core Period||86
1620611|NCT00887588|3961674|P2|Full Analysis Set|Core Period||146
1620612|NCT00887588|3961675|P1|Full Analysis Set|Core Period||148
1620613|NCT00887588|3961674|P2|Extension Efficacy Set|Core Period||125
1620614|NCT00887588|3961675|P1|Extension Efficacy Set|Core Period||127
1620615|NCT00887588|3961674|P2|STARTED|Core Period||152
1620616|NCT00887588|3961675|P1|STARTED|Core Period||149
1620617|NCT00887575|3961727|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
1620618|NCT00887575|3961728|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
1620619|NCT00887575|3961729|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
1620620|NCT00887575|3961727|P3|COMPLETED|Phase II - Maintenance Therapy||0
1620621|NCT00887575|3961728|P2|COMPLETED|Phase II - Maintenance Therapy||0
1620622|NCT00887575|3961729|P1|COMPLETED|Phase II - Maintenance Therapy||6
1620623|NCT00887575|3961727|P3|STARTED|Phase II - Maintenance Therapy||0
1620624|NCT00887575|3961728|P2|STARTED|Phase II - Maintenance Therapy||0
1620625|NCT00887575|3961729|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
1620626|NCT00887575|3961727|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
1620627|NCT00887575|3961728|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
1620628|NCT00887575|3961729|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
1620629|NCT00887575|3961727|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
1620630|NCT00887575|3961728|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
1620631|NCT00887575|3961729|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
1620632|NCT00887575|3961727|P3|STARTED|Phase II - Neoadjuvant Therapy||0
1620633|NCT00887575|3961728|P2|STARTED|Phase II - Neoadjuvant Therapy||0
1620634|NCT00887575|3961729|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
1620635|NCT00887575|3961727|P3|NOT COMPLETED|Phase I||3
1620636|NCT00887575|3961728|P2|NOT COMPLETED|Phase I||6
1620637|NCT00887575|3961729|P1|NOT COMPLETED|Phase I||0
1620638|NCT00887575|3961727|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1620639|NCT00887575|3961728|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1620640|NCT00887575|3961729|P1|COMPLETED|Phase I||6
1620641|NCT00887575|3961727|P3|STARTED|Phase I||3
1620642|NCT00887575|3961728|P2|STARTED|Phase I||6
1620643|NCT00887575|3961729|P1|STARTED|Phase I||6
1620644|NCT00887562|3961740|P3|NOT COMPLETED|Overall Study||1
1620645|NCT00887562|3961741|P2|NOT COMPLETED|Overall Study||2
1620646|NCT00887562|3961742|P1|NOT COMPLETED|Overall Study||3
1620647|NCT00887562|3961740|P3|COMPLETED|Overall Study||7
1620648|NCT00887562|3961741|P2|COMPLETED|Overall Study||7
1620649|NCT00887562|3961742|P1|COMPLETED|Overall Study||7
1620650|NCT00887562|3961740|P3|STARTED|Overall Study||8
1620651|NCT00887562|3961741|P2|STARTED|Overall Study||9
1620652|NCT00887562|3961742|P1|STARTED|Overall Study||10
1620653|NCT00887549|3961756|P1|NOT COMPLETED|Maintenance Therapy||43
1620654|NCT00887549|3961756|P1|COMPLETED|Maintenance Therapy||0
1620655|NCT00887549|3961756|P1|STARTED|Maintenance Therapy||43
1620656|NCT00887549|3961756|P1|NOT COMPLETED|Induction Therapy||27
1620657|NCT00887549|3961756|P1|COMPLETED|Induction Therapy||43
1620658|NCT00887549|3961756|P1|STARTED|Induction Therapy||70
1620659|NCT00887510|3961765|P2|NOT COMPLETED|Overall Study||0
1620660|NCT00887510|3961766|P1|NOT COMPLETED|Overall Study||0
1620661|NCT00887510|3961765|P2|COMPLETED|Overall Study||12
1620662|NCT00887510|3961766|P1|COMPLETED|Overall Study||12
1620663|NCT00887510|3961765|P2|STARTED|Overall Study||12
1620664|NCT00887510|3961766|P1|STARTED|Overall Study||12
1620665|NCT00887484|3961774|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
1620666|NCT00887484|3961774|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
1620667|NCT00887484|3961774|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
1620668|NCT00887484|3961774|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
1620669|NCT00887484|3961774|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
1620670|NCT00887484|3961774|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
1620671|NCT00887471|3961840|P2|NOT COMPLETED|Overall Study||0
1620672|NCT00887471|3961841|P1|NOT COMPLETED|Overall Study||0
1620673|NCT00887471|3961840|P2|COMPLETED|Overall Study||15
1620674|NCT00887471|3961841|P1|COMPLETED|Overall Study||15
1620675|NCT00887471|3961840|P2|STARTED|Overall Study||15
1620676|NCT00887471|3961841|P1|STARTED|Overall Study||15
1620677|NCT00887458|3961851|P2|NOT COMPLETED|Overall Study||4
1620678|NCT00887458|3961852|P1|NOT COMPLETED|Overall Study||0
1620679|NCT00887458|3961851|P2|COMPLETED|Overall Study||25
1620680|NCT00887458|3961852|P1|COMPLETED|Overall Study||17
1620681|NCT00887458|3961851|P2|STARTED|Overall Study||29
1620682|NCT00887458|3961852|P1|STARTED|Overall Study||17
1620683|NCT00887354|3961862|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
1620684|NCT00887354|3961863|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
1620685|NCT00887354|3961862|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
1620686|NCT00887354|3961863|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
1620687|NCT00887354|3961862|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
1620688|NCT00887354|3961863|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
1620689|NCT00887354|3961862|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
1620690|NCT00887354|3961863|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
1620691|NCT00887354|3961862|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
1620692|NCT00887354|3961863|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
1620693|NCT00887354|3961862|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
1620694|NCT00887354|3961863|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
1620695|NCT00887354|3961862|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
1620696|NCT00887354|3961863|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
1620697|NCT00887354|3961862|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
1620698|NCT00887354|3961863|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
1620699|NCT00887341|3961883|P2|NOT COMPLETED|Overall Study||3
1620700|NCT00887341|3961884|P1|NOT COMPLETED|Overall Study||2
1620701|NCT00887341|3961883|P2|COMPLETED|Overall Study||36
1620702|NCT00887341|3961884|P1|COMPLETED|Overall Study||35
1620703|NCT00887341|3961883|P2|STARTED|Overall Study||39
1620704|NCT00887341|3961884|P1|STARTED|Overall Study||37
1620705|NCT00887315|3961920|P2|NOT COMPLETED|Overall Study||4
1620706|NCT00887315|3961921|P1|NOT COMPLETED|Overall Study||7
1620707|NCT00887315|3961920|P2|COMPLETED|Overall Study||0
1620708|NCT00887315|3961921|P1|COMPLETED|Overall Study||0
1620709|NCT00887315|3961920|P2|STARTED|Overall Study||4
1620710|NCT00887315|3961921|P1|STARTED|Overall Study||7
1620711|NCT00887289|3961929|P1|NOT COMPLETED|Overall Study||95
1620712|NCT00887289|3961929|P1|COMPLETED|Overall Study||1409
1620713|NCT00887289|3961929|P1|STARTED|Overall Study||1504
1620714|NCT00887250|3961941|P3|NOT COMPLETED|Overall Study||13
1620715|NCT00887250|3961942|P2|NOT COMPLETED|Overall Study||12
1620716|NCT00887250|3961943|P1|NOT COMPLETED|Overall Study||18
1620717|NCT00887250|3961941|P3|COMPLETED|Overall Study||110
1620718|NCT00887250|3961942|P2|COMPLETED|Overall Study||115
1620719|NCT00887250|3961943|P1|COMPLETED|Overall Study||98
1620720|NCT00887250|3961941|P3|STARTED|Overall Study||123
1620721|NCT00887250|3961942|P2|STARTED|Overall Study||127
1620722|NCT00887250|3961943|P1|STARTED|Overall Study||116
1620723|NCT00887224|3961966|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
1620724|NCT00887224|3961967|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
1620725|NCT00887224|3961968|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
1620726|NCT00887224|3961966|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
1620727|NCT00887224|3961967|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
1620728|NCT00887224|3961968|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
1620729|NCT00887224|3961966|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
1620730|NCT00887224|3961967|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
1620731|NCT00887224|3961968|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
1620732|NCT00887224|3961966|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
1620733|NCT00887224|3961967|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
1620734|NCT00887224|3961968|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
1620735|NCT00887224|3961966|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
1620736|NCT00887224|3961967|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
1620737|NCT00887224|3961968|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
1620738|NCT00887224|3961966|P3|NOT COMPLETED|Double-blind (DB) Phase||62
1620739|NCT00887224|3961967|P2|NOT COMPLETED|Double-blind (DB) Phase||100
1620740|NCT00887224|3961968|P1|NOT COMPLETED|Double-blind (DB) Phase||0
1620741|NCT00887224|3961966|P3|COMPLETED|Double-blind (DB) Phase||210
1620742|NCT00887224|3961967|P2|COMPLETED|Double-blind (DB) Phase||176
1620743|NCT00887224|3961968|P1|COMPLETED|Double-blind (DB) Phase||0
1620744|NCT00887224|3961966|P3|STARTED|Double-blind (DB) Phase||272
1620745|NCT00887224|3961967|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
1620746|NCT00887224|3961968|P1|STARTED|Double-blind (DB) Phase||0
1620747|NCT00887224|3961966|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
1620748|NCT00887224|3961967|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
1620749|NCT00887224|3961968|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
1620750|NCT00887224|3961966|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
1620751|NCT00887224|3961967|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
1620752|NCT00887224|3961968|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
1620753|NCT00887224|3961966|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
1620754|NCT00887224|3961967|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
1620755|NCT00887224|3961968|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
1620756|NCT00887224|3961966|P3|STARTED|OL Taper Phase / OL Follow Up||0
1620757|NCT00887224|3961967|P2|STARTED|OL Taper Phase / OL Follow Up||0
1620758|NCT00887224|3961968|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
1620759|NCT00887224|3961966|P3|NOT COMPLETED|Between OLS and DB Phases||0
1620760|NCT00887224|3961967|P2|NOT COMPLETED|Between OLS and DB Phases||0
1620761|NCT00887224|3961968|P1|NOT COMPLETED|Between OLS and DB Phases||28
1620762|NCT00887224|3961966|P3|COMPLETED|Between OLS and DB Phases||0
1620763|NCT00887224|3961967|P2|COMPLETED|Between OLS and DB Phases||0
1620764|NCT00887224|3961968|P1|COMPLETED|Between OLS and DB Phases||548
1620765|NCT00887224|3961966|P3|STARTED|Between OLS and DB Phases||0
1620766|NCT00887224|3961967|P2|STARTED|Between OLS and DB Phases||0
1620767|NCT00887224|3961968|P1|STARTED|Between OLS and DB Phases||576
1620768|NCT00887224|3961966|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
1620769|NCT00887224|3961967|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
1620770|NCT00887224|3961968|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
1620771|NCT00887224|3961966|P3|COMPLETED|Open-label Stability (OLS) Phase||0
1620772|NCT00887224|3961967|P2|COMPLETED|Open-label Stability (OLS) Phase||0
1620773|NCT00887224|3961968|P1|COMPLETED|Open-label Stability (OLS) Phase||576
1620774|NCT00887224|3961966|P3|STARTED|Open-label Stability (OLS) Phase||0
1620775|NCT00887224|3961967|P2|STARTED|Open-label Stability (OLS) Phase||0
1620776|NCT00887224|3961968|P1|STARTED|Open-label Stability (OLS) Phase||659
1620777|NCT00887224|3961966|P3|NOT COMPLETED|Between OLR and OLS Phases||0
1620778|NCT00887224|3961967|P2|NOT COMPLETED|Between OLR and OLS Phases||0
1620779|NCT00887224|3961968|P1|NOT COMPLETED|Between OLR and OLS Phases||93
1620780|NCT00887224|3961966|P3|COMPLETED|Between OLR and OLS Phases||0
1620781|NCT00887224|3961967|P2|COMPLETED|Between OLR and OLS Phases||0
1620782|NCT00887224|3961968|P1|COMPLETED|Between OLR and OLS Phases||659
1620783|NCT00887224|3961966|P3|STARTED|Between OLR and OLS Phases||0
1620784|NCT00887224|3961967|P2|STARTED|Between OLR and OLS Phases||0
1620785|NCT00887224|3961968|P1|STARTED|Between OLR and OLS Phases||752
1620786|NCT00887224|3961966|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
1620787|NCT00887224|3961967|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
1620788|NCT00887224|3961968|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
1620789|NCT00887224|3961966|P3|COMPLETED|Open-label Response (OLR) Phase||0
1620790|NCT00887224|3961967|P2|COMPLETED|Open-label Response (OLR) Phase||0
1620791|NCT00887224|3961968|P1|COMPLETED|Open-label Response (OLR) Phase||752
1620792|NCT00887224|3961966|P3|STARTED|Open-label Response (OLR) Phase||0
1620793|NCT00887224|3961967|P2|STARTED|Open-label Response (OLR) Phase||0
1620794|NCT00887224|3961968|P1|STARTED|Open-label Response (OLR) Phase||874
1620795|NCT00887198|3961995|P3|NOT COMPLETED|Cross Over (Placebo to AA)||93
1620796|NCT00887198|3961996|P2|NOT COMPLETED|Cross Over (Placebo to AA)||0
1620797|NCT00887198|3961997|P1|NOT COMPLETED|Cross Over (Placebo to AA)||0
1620798|NCT00887198|3961995|P3|COMPLETED|Cross Over (Placebo to AA)||0
1620799|NCT00887198|3961996|P2|COMPLETED|Cross Over (Placebo to AA)||0
1620800|NCT00887198|3961997|P1|COMPLETED|Cross Over (Placebo to AA)||0
1620801|NCT00887198|3961995|P3|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
1620802|NCT00887198|3961996|P2|STARTED|Cross Over (Placebo to AA)||0
1620803|NCT00887198|3961997|P1|STARTED|Cross Over (Placebo to AA)||0
1620804|NCT00887198|3961995|P3|NOT COMPLETED|Randomized Period||0
1620805|NCT00887198|3961996|P2|NOT COMPLETED|Randomized Period||542
1620806|NCT00887198|3961997|P1|NOT COMPLETED|Randomized Period||546
1620807|NCT00887198|3961995|P3|COMPLETED|Randomized Period||0
1620808|NCT00887198|3961996|P2|COMPLETED|Randomized Period||0
1620809|NCT00887198|3961997|P1|COMPLETED|Randomized Period||0
1620810|NCT00887198|3961995|P3|Treated|Randomized Period||0
1620811|NCT00887198|3961996|P2|Treated|Randomized Period||540
1620812|NCT00887198|3961997|P1|Treated|Randomized Period||542
1620813|NCT00887198|3961995|P3|STARTED|Randomized Period||0
1620814|NCT00887198|3961996|P2|STARTED|Randomized Period||542
1620815|NCT00887198|3961997|P1|STARTED|Randomized Period||546
1620816|NCT00887159|3962028|P3|NOT COMPLETED|Overall Study||56
1620817|NCT00887159|3962029|P2|NOT COMPLETED|Overall Study||56
1620818|NCT00887159|3962030|P1|NOT COMPLETED|Overall Study||29
1620819|NCT00887159|3962028|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
1620820|NCT00887159|3962029|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
1620821|NCT00887159|3962030|P1|COMPLETED|Overall Study||27
1620822|NCT00887159|3962028|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
1620823|NCT00887159|3962029|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
1620824|NCT00887159|3962030|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
1620825|NCT00887159|3962028|P3|Eligible and Treated Patients|Overall Study||52
1620826|NCT00887159|3962029|P2|Eligible and Treated Patients|Overall Study||52
1620827|NCT00887159|3962030|P1|Eligible and Treated Patients|Overall Study||48
1620828|NCT00887159|3962028|P3|Patients Who Started Assigned Treatment|Overall Study||52
1620829|NCT00887159|3962029|P2|Patients Who Started Assigned Treatment|Overall Study||53
1620830|NCT00887159|3962030|P1|Patients Who Started Assigned Treatment|Overall Study||53
1620831|NCT00887159|3962028|P3|STARTED|Overall Study||56
1620832|NCT00887159|3962029|P2|STARTED|Overall Study||56
1620833|NCT00887159|3962030|P1|STARTED|Overall Study||56
1620834|NCT00886938|3962046|P1|NOT COMPLETED|Overall Study||2
1620835|NCT00886938|3962046|P1|COMPLETED|Overall Study||10
1620836|NCT00886938|3962046|P1|STARTED|Overall Study||12
1620837|NCT00886899|3962050|P1|NOT COMPLETED|Overall Study||0
1620838|NCT00886899|3962050|P1|COMPLETED|Overall Study||147
1620839|NCT00886899|3962050|P1|STARTED|Overall Study||147
1620840|NCT00886834|3962059|P2|NOT COMPLETED|Overall Study||3
1620841|NCT00886834|3962060|P1|NOT COMPLETED|Overall Study||0
1620842|NCT00886834|3962059|P2|COMPLETED|Overall Study||51
1620843|NCT00886834|3962060|P1|COMPLETED|Overall Study||54
1620844|NCT00886834|3962059|P2|STARTED|Overall Study||54
1620845|NCT00886834|3962060|P1|STARTED|Overall Study||54
1620846|NCT00886821|3962082|P14|NOT COMPLETED|Stage 2||1
1620847|NCT00886821|3962083|P13|NOT COMPLETED|Stage 2||5
1620848|NCT00886821|3962084|P12|NOT COMPLETED|Stage 2||1
1620849|NCT00886821|3962085|P11|NOT COMPLETED|Stage 2||0
1620850|NCT00886821|3962086|P10|NOT COMPLETED|Stage 2||0
1620851|NCT00886821|3962087|P9|NOT COMPLETED|Stage 2||0
1620852|NCT00886821|3962088|P8|NOT COMPLETED|Stage 2||0
1620853|NCT00886821|3962089|P7|NOT COMPLETED|Stage 2||0
1620854|NCT00886821|3962090|P6|NOT COMPLETED|Stage 2||0
1620855|NCT00886821|3962091|P5|NOT COMPLETED|Stage 2||0
1620856|NCT00886821|3962092|P4|NOT COMPLETED|Stage 2||0
1620857|NCT00886821|3962093|P3|NOT COMPLETED|Stage 2||0
1620858|NCT00886821|3962094|P2|NOT COMPLETED|Stage 2||0
1620859|NCT00886821|3962095|P1|NOT COMPLETED|Stage 2||0
1620860|NCT00886821|3962082|P14|COMPLETED|Stage 2||8
1620861|NCT00886821|3962083|P13|COMPLETED|Stage 2||8
1620862|NCT00886821|3962084|P12|COMPLETED|Stage 2||8
1620863|NCT00886821|3962085|P11|COMPLETED|Stage 2||9
1620864|NCT00886821|3962086|P10|COMPLETED|Stage 2||0
1620865|NCT00886821|3962087|P9|COMPLETED|Stage 2||0
1620866|NCT00886821|3962088|P8|COMPLETED|Stage 2||0
1620867|NCT00886821|3962089|P7|COMPLETED|Stage 2||0
1620868|NCT00886821|3962090|P6|COMPLETED|Stage 2||0
1620869|NCT00886821|3962091|P5|COMPLETED|Stage 2||0
1620870|NCT00886821|3962092|P4|COMPLETED|Stage 2||0
1620871|NCT00886821|3962093|P3|COMPLETED|Stage 2||0
1620872|NCT00886821|3962094|P2|COMPLETED|Stage 2||0
1620873|NCT00886821|3962095|P1|COMPLETED|Stage 2||0
1620874|NCT00886821|3962082|P14|STARTED|Stage 2||9
1620875|NCT00886821|3962083|P13|STARTED|Stage 2||13
1620876|NCT00886821|3962084|P12|STARTED|Stage 2||9
1620877|NCT00886821|3962085|P11|STARTED|Stage 2||9
1620878|NCT00886821|3962086|P10|STARTED|Stage 2||0
1620879|NCT00886821|3962087|P9|STARTED|Stage 2||0
1620880|NCT00886821|3962088|P8|STARTED|Stage 2||0
1620881|NCT00886821|3962089|P7|STARTED|Stage 2||0
1620882|NCT00886821|3962090|P6|STARTED|Stage 2||0
1620883|NCT00886821|3962091|P5|STARTED|Stage 2||0
1620884|NCT00886821|3962092|P4|STARTED|Stage 2||0
1620885|NCT00886821|3962093|P3|STARTED|Stage 2||0
1620886|NCT00886821|3962094|P2|STARTED|Stage 2||0
1620887|NCT00886821|3962095|P1|STARTED|Stage 2||0
1620888|NCT00886821|3962082|P14|NOT COMPLETED|Stage 1||0
1620889|NCT00886821|3962083|P13|NOT COMPLETED|Stage 1||0
1620890|NCT00886821|3962084|P12|NOT COMPLETED|Stage 1||0
1620891|NCT00886821|3962085|P11|NOT COMPLETED|Stage 1||0
1620892|NCT00886821|3962086|P10|NOT COMPLETED|Stage 1||0
1620893|NCT00886821|3962087|P9|NOT COMPLETED|Stage 1||0
1620894|NCT00886821|3962088|P8|NOT COMPLETED|Stage 1||0
1620895|NCT00886821|3962089|P7|NOT COMPLETED|Stage 1||0
1620896|NCT00886821|3962090|P6|NOT COMPLETED|Stage 1||0
1620897|NCT00886821|3962091|P5|NOT COMPLETED|Stage 1||0
1620898|NCT00886821|3962092|P4|NOT COMPLETED|Stage 1||0
1620899|NCT00886821|3962093|P3|NOT COMPLETED|Stage 1||0
1620900|NCT00886821|3962094|P2|NOT COMPLETED|Stage 1||0
1620901|NCT00886821|3962095|P1|NOT COMPLETED|Stage 1||0
1620902|NCT00886821|3962082|P14|COMPLETED|Stage 1||0
1620903|NCT00886821|3962083|P13|COMPLETED|Stage 1||0
1620904|NCT00886821|3962084|P12|COMPLETED|Stage 1||0
1620905|NCT00886821|3962085|P11|COMPLETED|Stage 1||0
1620906|NCT00886821|3962086|P10|COMPLETED|Stage 1||18
1620907|NCT00886821|3962087|P9|COMPLETED|Stage 1||6
1620908|NCT00886821|3962088|P8|COMPLETED|Stage 1||6
1620909|NCT00886821|3962089|P7|COMPLETED|Stage 1||6
1620910|NCT00886821|3962090|P6|COMPLETED|Stage 1||6
1620911|NCT00886821|3962091|P5|COMPLETED|Stage 1||6
1620912|NCT00886821|3962092|P4|COMPLETED|Stage 1||7
1620913|NCT00886821|3962093|P3|COMPLETED|Stage 1||6
1620914|NCT00886821|3962094|P2|COMPLETED|Stage 1||6
1620915|NCT00886821|3962095|P1|COMPLETED|Stage 1||7
1620916|NCT00886821|3962082|P14|STARTED|Stage 1||0
1620917|NCT00886821|3962083|P13|STARTED|Stage 1||0
1620918|NCT00886821|3962084|P12|STARTED|Stage 1||0
1620919|NCT00886821|3962085|P11|STARTED|Stage 1||0
1620920|NCT00886821|3962086|P10|STARTED|Stage 1||18
1620921|NCT00886821|3962087|P9|STARTED|Stage 1||6
1620922|NCT00886821|3962088|P8|STARTED|Stage 1||6
1620923|NCT00886821|3962089|P7|STARTED|Stage 1||6
1620924|NCT00886821|3962090|P6|STARTED|Stage 1||6
1620925|NCT00886821|3962091|P5|STARTED|Stage 1||6
1620926|NCT00886821|3962092|P4|STARTED|Stage 1||7
1620927|NCT00886821|3962093|P3|STARTED|Stage 1||6
1620928|NCT00886821|3962094|P2|STARTED|Stage 1||6
1620929|NCT00886821|3962095|P1|STARTED|Stage 1||7
1620930|NCT00886795|3962320|P1|NOT COMPLETED|Overall Study||1
1620931|NCT00886795|3962320|P1|COMPLETED|Overall Study||3
1620932|NCT00886795|3962320|P1|STARTED|Overall Study||4
1620933|NCT00886769|3962327|P2|NOT COMPLETED|Overall Study||37
1620934|NCT00886769|3962328|P1|NOT COMPLETED|Overall Study||6
1620935|NCT00886769|3962327|P2|COMPLETED|Overall Study||4
1620936|NCT00886769|3962328|P1|COMPLETED|Overall Study||37
1620937|NCT00886769|3962327|P2|STARTED|Overall Study||41
1620938|NCT00886769|3962328|P1|STARTED|Overall Study||43
1620939|NCT00886743|3962352|P1|NOT COMPLETED|Overall Study||4
1620940|NCT00886743|3962352|P1|COMPLETED|Overall Study||15
1620941|NCT00886743|3962352|P1|STARTED|Overall Study|Received treatment|19
1620942|NCT00886704|3962362|P2|NOT COMPLETED|Overall Study||0
1620943|NCT00886704|3962363|P1|NOT COMPLETED|Overall Study||0
1620944|NCT00886704|3962362|P2|COMPLETED|Overall Study||10
1620945|NCT00886704|3962363|P1|COMPLETED|Overall Study||40
1620946|NCT00886704|3962362|P2|STARTED|Overall Study||10
1620947|NCT00886704|3962363|P1|STARTED|Overall Study||40
1620948|NCT00886691|3962373|P2|NOT COMPLETED|Overall Study||0
1620949|NCT00886691|3962374|P1|NOT COMPLETED|Overall Study||0
1620950|NCT00886691|3962373|P2|COMPLETED|Overall Study||75
1620951|NCT00886691|3962374|P1|COMPLETED|Overall Study||75
1620952|NCT00886691|3962373|P2|STARTED|Overall Study||75
1620953|NCT00886691|3962374|P1|STARTED|Overall Study||75
1620954|NCT00886639|3962390|P1|NOT COMPLETED|Overall Study||16
1620955|NCT00886639|3962390|P1|COMPLETED|Overall Study||111
1620956|NCT00886639|3962390|P1|STARTED|Overall Study||127
1620957|NCT00886626|3962394|P2|NOT COMPLETED|Period 2 (90 Days)||0
1620958|NCT00886626|3962395|P1|NOT COMPLETED|Period 2 (90 Days)||0
1620959|NCT00886626|3962394|P2|COMPLETED|Period 2 (90 Days)||6
1620960|NCT00886626|3962395|P1|COMPLETED|Period 2 (90 Days)||5
1620961|NCT00886626|3962394|P2|STARTED|Period 2 (90 Days)||6
1620962|NCT00886626|3962395|P1|STARTED|Period 2 (90 Days)||5
1620963|NCT00886626|3962394|P2|NOT COMPLETED|Period 1 (90 Days)||0
1620964|NCT00886626|3962395|P1|NOT COMPLETED|Period 1 (90 Days)||1
1620965|NCT00886626|3962394|P2|COMPLETED|Period 1 (90 Days)||6
1620966|NCT00886626|3962395|P1|COMPLETED|Period 1 (90 Days)||5
1620967|NCT00886626|3962394|P2|STARTED|Period 1 (90 Days)||6
1620968|NCT00886626|3962395|P1|STARTED|Period 1 (90 Days)||6
1620969|NCT00886613|3962404|P3|NOT COMPLETED|Overall Study||3
1620970|NCT00886613|3962405|P2|NOT COMPLETED|Overall Study||0
1620971|NCT00886613|3962406|P1|NOT COMPLETED|Overall Study||2
1620972|NCT00886613|3962404|P3|COMPLETED|Overall Study||37
1620973|NCT00886613|3962405|P2|COMPLETED|Overall Study||39
1620974|NCT00886613|3962406|P1|COMPLETED|Overall Study||39
1620975|NCT00886613|3962404|P3|STARTED|Overall Study||40
1620976|NCT00886613|3962405|P2|STARTED|Overall Study||39
1620977|NCT00886613|3962406|P1|STARTED|Overall Study||41
1620978|NCT00886600|3962428|P4|NOT COMPLETED|Combination Therapy Period||0
1620979|NCT00886600|3962429|P3|NOT COMPLETED|Combination Therapy Period||2
1620980|NCT00886600|3962430|P2|NOT COMPLETED|Combination Therapy Period||0
1620981|NCT00886600|3962431|P1|NOT COMPLETED|Combination Therapy Period||0
1620982|NCT00886600|3962428|P4|COMPLETED|Combination Therapy Period||23
1620983|NCT00886600|3962429|P3|COMPLETED|Combination Therapy Period||19
1620984|NCT00886600|3962430|P2|COMPLETED|Combination Therapy Period||21
1620985|NCT00886600|3962431|P1|COMPLETED|Combination Therapy Period||28
1620986|NCT00886600|3962428|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
1620987|NCT00886600|3962429|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
1620988|NCT00886600|3962430|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
1620989|NCT00886600|3962431|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
1620990|NCT00886600|3962428|P4|NOT COMPLETED|Double-blind Monotherapy||2
1620991|NCT00886600|3962429|P3|NOT COMPLETED|Double-blind Monotherapy||1
1620992|NCT00886600|3962430|P2|NOT COMPLETED|Double-blind Monotherapy||1
1620993|NCT00886600|3962431|P1|NOT COMPLETED|Double-blind Monotherapy||2
1620994|NCT00886600|3962428|P4|COMPLETED|Double-blind Monotherapy||29
1620995|NCT00886600|3962429|P3|COMPLETED|Double-blind Monotherapy||29
1620996|NCT00886600|3962430|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
1620997|NCT00886600|3962431|P1|COMPLETED|Double-blind Monotherapy||30
1620998|NCT00886600|3962428|P4|STARTED|Double-blind Monotherapy||31
1620999|NCT00886600|3962429|P3|STARTED|Double-blind Monotherapy||30
1621000|NCT00886600|3962430|P2|STARTED|Double-blind Monotherapy||29
1621001|NCT00886600|3962431|P1|STARTED|Double-blind Monotherapy||32
1621002|NCT00886587|3962455|P2|NOT COMPLETED|Overall Study||2
1621003|NCT00886587|3962456|P1|NOT COMPLETED|Overall Study||4
1621004|NCT00886587|3962455|P2|COMPLETED|Overall Study||39
1621005|NCT00886587|3962456|P1|COMPLETED|Overall Study||37
1621006|NCT00886587|3962455|P2|STARTED|Overall Study||41
1621007|NCT00886587|3962456|P1|STARTED|Overall Study||41
1621008|NCT00886483|3962470|P2|NOT COMPLETED|Overall Study||3
1621009|NCT00886483|3962471|P1|NOT COMPLETED|Overall Study||2
1621010|NCT00886483|3962470|P2|COMPLETED|Overall Study||10
1621011|NCT00886483|3962471|P1|COMPLETED|Overall Study||24
1621012|NCT00886483|3962470|P2|Completed 20 Treatments|Overall Study||11
1621013|NCT00886483|3962471|P1|Completed 20 Treatments|Overall Study||25
1621014|NCT00886483|3962470|P2|STARTED|Overall Study||13
1621015|NCT00886483|3962471|P1|STARTED|Overall Study||26
1621016|NCT00886340|3962489|P2|NOT COMPLETED|Overall Study||7
1621017|NCT00886340|3962490|P1|NOT COMPLETED|Overall Study||0
1621018|NCT00886340|3962489|P2|COMPLETED|Overall Study||24
1621019|NCT00886340|3962490|P1|COMPLETED|Overall Study||27
1621020|NCT00886340|3962489|P2|STARTED|Overall Study||31
1621021|NCT00886340|3962490|P1|STARTED|Overall Study||27
1621022|NCT00886288|3962498|P2|NOT COMPLETED|Overall Study||227
1621023|NCT00886288|3962499|P1|NOT COMPLETED|Overall Study||743
1621024|NCT00886288|3962498|P2|COMPLETED|Overall Study||457
1621025|NCT00886288|3962499|P1|COMPLETED|Overall Study||1284
1621026|NCT00886288|3962498|P2|STARTED|Overall Study|Baseline Population|684
1621027|NCT00886288|3962499|P1|STARTED|Overall Study|Baseline Population|2027
1621028|NCT00886262|3962517|P2|NOT COMPLETED|Overall Study||3
1621029|NCT00886262|3962518|P1|NOT COMPLETED|Overall Study||0
1621030|NCT00886262|3962517|P2|COMPLETED|Overall Study||7
1621031|NCT00886262|3962518|P1|COMPLETED|Overall Study||8
1621032|NCT00886262|3962517|P2|STARTED|Overall Study||10
1621033|NCT00886262|3962518|P1|STARTED|Overall Study||8
1621034|NCT00886236|3962533|P3|NOT COMPLETED|Overall Study||4
1621035|NCT00886236|3962534|P2|NOT COMPLETED|Overall Study||4
1621036|NCT00886236|3962535|P1|NOT COMPLETED|Overall Study||2
1621037|NCT00886236|3962533|P3|COMPLETED|Overall Study||17
1621038|NCT00886236|3962534|P2|COMPLETED|Overall Study||17
1621039|NCT00886236|3962535|P1|COMPLETED|Overall Study||18
1621040|NCT00886236|3962533|P3|STARTED|Overall Study||21
1621041|NCT00886236|3962534|P2|STARTED|Overall Study||21
1621042|NCT00886236|3962535|P1|STARTED|Overall Study||20
1621043|NCT00886145|3962549|P1|NOT COMPLETED|Overall Study||0
1621044|NCT00886145|3962549|P1|COMPLETED|Overall Study||1
1621045|NCT00886145|3962549|P1|STARTED|Overall Study||1
1621046|NCT00886119|3962555|P2|NOT COMPLETED|Period 2||0
1621047|NCT00886119|3962556|P1|NOT COMPLETED|Period 2||0
1621048|NCT00886119|3962555|P2|COMPLETED|Period 2||22
1621049|NCT00886119|3962556|P1|COMPLETED|Period 2||23
1621050|NCT00886119|3962555|P2|STARTED|Period 2||22
1621051|NCT00886119|3962556|P1|STARTED|Period 2||23
1621052|NCT00886119|3962555|P2|NOT COMPLETED|Period 1||0
1621053|NCT00886119|3962556|P1|NOT COMPLETED|Period 1||1
1621054|NCT00886119|3962555|P2|COMPLETED|Period 1||22
1621055|NCT00886119|3962556|P1|COMPLETED|Period 1||23
1621056|NCT00886119|3962555|P2|STARTED|Period 1||22
1621057|NCT00886119|3962556|P1|STARTED|Period 1||24
1621058|NCT00886015|3962564|P2|NOT COMPLETED|Overall Study||2
1621059|NCT00886015|3962565|P1|NOT COMPLETED|Overall Study||0
1621060|NCT00886015|3962564|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
1621061|NCT00886015|3962565|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
1621062|NCT00886015|3962564|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
1621063|NCT00886015|3962565|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
1621064|NCT00885846|3962584|P3|NOT COMPLETED|Overall Study||2
1621065|NCT00885846|3962585|P2|NOT COMPLETED|Overall Study||5
1621066|NCT00885846|3962586|P1|NOT COMPLETED|Overall Study||2
1621067|NCT00885846|3962584|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
1621068|NCT00885846|3962585|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
1621069|NCT00885846|3962586|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
1621070|NCT00885846|3962584|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
1621249|NCT00884754|3963143|P1|COMPLETED|Overall Study||30
1621071|NCT00885846|3962585|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
1621072|NCT00885846|3962586|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
1621073|NCT00885768|3962594|P1|NOT COMPLETED|Overall Study||0
1621074|NCT00885768|3962594|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
1621075|NCT00885768|3962594|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
1621076|NCT00885755|3962601|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
1621077|NCT00885755|3962602|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
1621078|NCT00885755|3962603|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
1621079|NCT00885755|3962601|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
1621080|NCT00885755|3962602|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
1621081|NCT00885755|3962603|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
1621082|NCT00885755|3962601|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
1621083|NCT00885755|3962602|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
1621084|NCT00885755|3962603|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
1621085|NCT00885755|3962601|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
1621086|NCT00885755|3962602|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
1621087|NCT00885755|3962603|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
1621088|NCT00885755|3962601|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
1621089|NCT00885755|3962602|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
1621090|NCT00885755|3962603|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
1621091|NCT00885755|3962601|P3|STARTED|Part I: Trastuzumab+Taxane||1
1621092|NCT00885755|3962602|P2|STARTED|Part I: Trastuzumab+Taxane||1
1621093|NCT00885755|3962603|P1|STARTED|Part I: Trastuzumab+Taxane||31
1621094|NCT00885742|3962628|P1|NOT COMPLETED|Overall Study||0
1621095|NCT00885742|3962628|P1|COMPLETED|Overall Study||41
1621096|NCT00885742|3962628|P1|STARTED|Overall Study||41
1621097|NCT00885703|3962646|P7|NOT COMPLETED|Overall Study||6
1621098|NCT00885703|3962647|P6|NOT COMPLETED|Overall Study||13
1621099|NCT00885703|3962648|P5|NOT COMPLETED|Overall Study||12
1621100|NCT00885703|3962649|P4|NOT COMPLETED|Overall Study||9
1621101|NCT00885703|3962650|P3|NOT COMPLETED|Overall Study||11
1621102|NCT00885703|3962651|P2|NOT COMPLETED|Overall Study||10
1621103|NCT00885703|3962652|P1|NOT COMPLETED|Overall Study||10
1621104|NCT00885703|3962646|P7|COMPLETED|Overall Study||18
1621105|NCT00885703|3962647|P6|COMPLETED|Overall Study||11
1621106|NCT00885703|3962648|P5|COMPLETED|Overall Study||12
1621107|NCT00885703|3962649|P4|COMPLETED|Overall Study||15
1621108|NCT00885703|3962650|P3|COMPLETED|Overall Study||13
1621109|NCT00885703|3962651|P2|COMPLETED|Overall Study||16
1621110|NCT00885703|3962652|P1|COMPLETED|Overall Study||12
1621111|NCT00885703|3962646|P7|STARTED|Overall Study||24
1621112|NCT00885703|3962647|P6|STARTED|Overall Study||24
1621113|NCT00885703|3962648|P5|STARTED|Overall Study||24
1621114|NCT00885703|3962649|P4|STARTED|Overall Study||24
1621115|NCT00885703|3962650|P3|STARTED|Overall Study||24
1621116|NCT00885703|3962651|P2|STARTED|Overall Study||26
1621117|NCT00885703|3962652|P1|STARTED|Overall Study||22
1621118|NCT00885677|3962710|P2|NOT COMPLETED|Overall Study||178
1621119|NCT00885677|3962711|P1|NOT COMPLETED|Overall Study||183
1621120|NCT00885677|3962710|P2|COMPLETED|Overall Study||277
1621121|NCT00885677|3962711|P1|COMPLETED|Overall Study||279
1621122|NCT00885677|3962710|P2|Intention To Treat|Overall Study||428
1621123|NCT00885677|3962711|P1|Intention To Treat|Overall Study||437
1621124|NCT00885677|3962710|P2|STARTED|Overall Study||455
1621125|NCT00885677|3962711|P1|STARTED|Overall Study||462
1621126|NCT00885638|3962719|P2|NOT COMPLETED|Overall Study||0
1621127|NCT00885638|3962720|P1|NOT COMPLETED|Overall Study||0
1621128|NCT00885638|3962719|P2|COMPLETED|Overall Study||6
1621129|NCT00885638|3962720|P1|COMPLETED|Overall Study||6
1621130|NCT00885638|3962719|P2|STARTED|Overall Study||6
1621131|NCT00885638|3962720|P1|STARTED|Overall Study||6
1621132|NCT00885534|3962727|P1|NOT COMPLETED|Overall Study||1
1621133|NCT00885534|3962727|P1|COMPLETED|Overall Study||6
1621134|NCT00885534|3962727|P1|STARTED|Overall Study||7
1621135|NCT00885482|3962731|P1|NOT COMPLETED|Overall Study||4
1621136|NCT00885482|3962731|P1|COMPLETED|Overall Study||36
1621137|NCT00885482|3962731|P1|STARTED|Overall Study||40
1621138|NCT00885378|3962737|P2|NOT COMPLETED|Overall Study||8
1621139|NCT00885378|3962738|P1|NOT COMPLETED|Overall Study||8
1621140|NCT00885378|3962737|P2|COMPLETED|Overall Study||78
1621141|NCT00885378|3962738|P1|COMPLETED|Overall Study||66
1621142|NCT00885378|3962737|P2|STARTED|Overall Study|Number randomized.|86
1621143|NCT00885378|3962738|P1|STARTED|Overall Study|Number randomized.|74
1621144|NCT00885365|3962768|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
1621145|NCT00885365|3962769|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
1621146|NCT00885365|3962768|P2|COMPLETED|4 Weeks OFF Treatment||159
1621147|NCT00885365|3962769|P1|COMPLETED|4 Weeks OFF Treatment||155
1621148|NCT00885365|3962768|P2|STARTED|4 Weeks OFF Treatment||159
1621149|NCT00885365|3962769|P1|STARTED|4 Weeks OFF Treatment||155
1621150|NCT00885365|3962768|P2|NOT COMPLETED|4 Weeks ON Treatment||6
1621151|NCT00885365|3962769|P1|NOT COMPLETED|4 Weeks ON Treatment||4
1621152|NCT00885365|3962768|P2|COMPLETED|4 Weeks ON Treatment||159
1621153|NCT00885365|3962769|P1|COMPLETED|4 Weeks ON Treatment||155
1621154|NCT00885365|3962768|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
1621155|NCT00885365|3962769|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
1621156|NCT00885365|3962768|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
1621250|NCT00884754|3963142|P2|STARTED|Overall Study||30
1621157|NCT00885365|3962769|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
1621158|NCT00885365|3962768|P2|STARTED|4 Weeks ON Treatment||165
1621159|NCT00885365|3962769|P1|STARTED|4 Weeks ON Treatment||159
1621160|NCT00885352|3962805|P2|NOT COMPLETED|Overall Study||20
1621161|NCT00885352|3962806|P1|NOT COMPLETED|Overall Study||8
1621162|NCT00885352|3962805|P2|COMPLETED|Overall Study||136
1621163|NCT00885352|3962806|P1|COMPLETED|Overall Study||149
1621164|NCT00885352|3962805|P2|STARTED|Overall Study||156
1621165|NCT00885352|3962806|P1|STARTED|Overall Study||157
1621166|NCT00885170|3962818|P2|NOT COMPLETED|Overall Study||23
1621167|NCT00885170|3962819|P1|NOT COMPLETED|Overall Study||38
1621168|NCT00885170|3962818|P2|COMPLETED|Overall Study||99
1621169|NCT00885170|3962819|P1|COMPLETED|Overall Study||86
1621170|NCT00885170|3962818|P2|Treated|Overall Study||121
1621171|NCT00885170|3962819|P1|Treated|Overall Study||122
1621172|NCT00885170|3962818|P2|STARTED|Overall Study||122
1621173|NCT00885170|3962819|P1|STARTED|Overall Study||124
1621174|NCT00885118|3962878|P5|NOT COMPLETED|Overall Study||1
1621175|NCT00885118|3962879|P4|NOT COMPLETED|Overall Study||0
1621176|NCT00885118|3962880|P3|NOT COMPLETED|Overall Study||1
1621177|NCT00885118|3962881|P2|NOT COMPLETED|Overall Study||0
1621178|NCT00885118|3962882|P1|NOT COMPLETED|Overall Study||1
1621179|NCT00885118|3962878|P5|COMPLETED|Overall Study||18
1621180|NCT00885118|3962879|P4|COMPLETED|Overall Study||20
1621181|NCT00885118|3962880|P3|COMPLETED|Overall Study||20
1621182|NCT00885118|3962881|P2|COMPLETED|Overall Study||19
1621183|NCT00885118|3962882|P1|COMPLETED|Overall Study||20
1621184|NCT00885118|3962878|P5|STARTED|Overall Study||19
1621185|NCT00885118|3962879|P4|STARTED|Overall Study||20
1621186|NCT00885118|3962880|P3|STARTED|Overall Study||21
1621187|NCT00885118|3962881|P2|STARTED|Overall Study||19
1621188|NCT00885118|3962882|P1|STARTED|Overall Study||21
1621189|NCT00885105|3963021|P2|NOT COMPLETED|Overall Study||10
1621190|NCT00885105|3963022|P1|NOT COMPLETED|Overall Study||1
1621191|NCT00885105|3963021|P2|COMPLETED|Overall Study||120
1621192|NCT00885105|3963022|P1|COMPLETED|Overall Study||111
1621193|NCT00885105|3963021|P2|STARTED|Overall Study||130
1621194|NCT00885105|3963022|P1|STARTED|Overall Study||112
1621195|NCT00885092|3963040|P2|NOT COMPLETED|Period 2, 7 Days||0
1621196|NCT00885092|3963041|P1|NOT COMPLETED|Period 2, 7 Days||0
1621197|NCT00885092|3963040|P2|COMPLETED|Period 2, 7 Days||20
1621198|NCT00885092|3963041|P1|COMPLETED|Period 2, 7 Days||20
1621199|NCT00885092|3963040|P2|STARTED|Period 2, 7 Days||20
1621200|NCT00885092|3963041|P1|STARTED|Period 2, 7 Days||20
1621201|NCT00885092|3963040|P2|NOT COMPLETED|Period 1, 7 Days||0
1621202|NCT00885092|3963041|P1|NOT COMPLETED|Period 1, 7 Days||0
1621203|NCT00885092|3963040|P2|COMPLETED|Period 1, 7 Days||20
1621204|NCT00885092|3963041|P1|COMPLETED|Period 1, 7 Days||20
1621205|NCT00885092|3963040|P2|STARTED|Period 1, 7 Days||20
1621206|NCT00885092|3963041|P1|STARTED|Period 1, 7 Days||20
1621207|NCT00885079|3963053|P2|NOT COMPLETED|Overall Study||4
1621208|NCT00885079|3963054|P1|NOT COMPLETED|Overall Study||2
1621209|NCT00885079|3963053|P2|COMPLETED|Overall Study||91
1621210|NCT00885079|3963054|P1|COMPLETED|Overall Study||91
1621211|NCT00885079|3963053|P2|STARTED|Overall Study||95
1621212|NCT00885079|3963054|P1|STARTED|Overall Study||93
1621213|NCT00884949|3963062|P1|NOT COMPLETED|Continuation Period||0
1621214|NCT00884949|3963062|P1|COMPLETED|Continuation Period||18
1621215|NCT00884949|3963062|P1|STARTED|Continuation Period||18
1621216|NCT00884949|3963062|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
1621217|NCT00884949|3963062|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
1621218|NCT00884949|3963062|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
1621219|NCT00884949|3963062|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
1621220|NCT00884949|3963062|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
1621221|NCT00884949|3963062|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
1621222|NCT00884949|3963062|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
1621223|NCT00884949|3963062|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
1621224|NCT00884949|3963062|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
1621225|NCT00884910|3963079|P1|NOT COMPLETED|Overall Study||1
1621226|NCT00884910|3963079|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
1621227|NCT00884910|3963079|P1|STARTED|Overall Study||33
1621228|NCT00884897|3963086|P2|NOT COMPLETED|Overall Study||0
1621229|NCT00884897|3963087|P1|NOT COMPLETED|Overall Study||0
1621230|NCT00884897|3963086|P2|COMPLETED|Overall Study||15
1621231|NCT00884897|3963087|P1|COMPLETED|Overall Study||13
1621232|NCT00884897|3963086|P2|STARTED|Overall Study||15
1621233|NCT00884897|3963087|P1|STARTED|Overall Study||13
1621234|NCT00884832|3963097|P2|NOT COMPLETED|Overall Study||1
1621235|NCT00884832|3963098|P1|NOT COMPLETED|Overall Study||0
1621236|NCT00884832|3963097|P2|COMPLETED|Overall Study||21
1621237|NCT00884832|3963098|P1|COMPLETED|Overall Study||22
1621238|NCT00884832|3963097|P2|STARTED|Overall Study||22
1621239|NCT00884832|3963098|P1|STARTED|Overall Study||22
1621240|NCT00884806|3963128|P1|NOT COMPLETED|Overall Study||0
1621241|NCT00884806|3963128|P1|COMPLETED|Overall Study||110
1621242|NCT00884806|3963128|P1|STARTED|Overall Study||110
1621243|NCT00884793|3963133|P1|NOT COMPLETED|Overall Study||1
1621244|NCT00884793|3963133|P1|COMPLETED|Overall Study||7
1621245|NCT00884793|3963133|P1|STARTED|Overall Study||8
1621246|NCT00884754|3963142|P2|NOT COMPLETED|Overall Study||0
1621247|NCT00884754|3963143|P1|NOT COMPLETED|Overall Study||0
1621248|NCT00884754|3963142|P2|COMPLETED|Overall Study||30
1621251|NCT00884754|3963143|P1|STARTED|Overall Study||30
1621252|NCT00884741|3963152|P4|NOT COMPLETED|Randomization||8
1621253|NCT00884741|3963153|P3|NOT COMPLETED|Randomization||8
1621254|NCT00884741|3963154|P2|NOT COMPLETED|Randomization||0
1621255|NCT00884741|3963155|P1|NOT COMPLETED|Randomization||0
1621256|NCT00884741|3963152|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
1621257|NCT00884741|3963153|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
1621258|NCT00884741|3963154|P2|COMPLETED|Randomization||0
1621259|NCT00884741|3963155|P1|COMPLETED|Randomization||0
1621260|NCT00884741|3963152|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
1621261|NCT00884741|3963153|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
1621262|NCT00884741|3963154|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
1621263|NCT00884741|3963155|P1|STARTED|Randomization||0
1621264|NCT00884741|3963152|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
1621265|NCT00884741|3963153|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
1621266|NCT00884741|3963154|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
1621267|NCT00884741|3963155|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
1621268|NCT00884741|3963152|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
1621269|NCT00884741|3963153|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
1621270|NCT00884741|3963154|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
1621271|NCT00884741|3963155|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
1621272|NCT00884741|3963152|P4|STARTED|Step 2 Registration: Tissue Analysis||0
1621273|NCT00884741|3963153|P3|STARTED|Step 2 Registration: Tissue Analysis||0
1621274|NCT00884741|3963154|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
1621275|NCT00884741|3963155|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
1621276|NCT00884741|3963152|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
1621277|NCT00884741|3963153|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
1621278|NCT00884741|3963154|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
1621279|NCT00884741|3963155|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
1621280|NCT00884741|3963152|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
1621281|NCT00884741|3963153|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
1621282|NCT00884741|3963154|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
1621283|NCT00884741|3963155|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
1621284|NCT00884741|3963152|P4|STARTED|Step 1 Registration: Tissue Screening||0
1621285|NCT00884741|3963153|P3|STARTED|Step 1 Registration: Tissue Screening||0
1621286|NCT00884741|3963154|P2|STARTED|Step 1 Registration: Tissue Screening||0
1621287|NCT00884741|3963155|P1|STARTED|Step 1 Registration: Tissue Screening||978
1621288|NCT00884611|3963166|P1|NOT COMPLETED|Overall Study||1
1621289|NCT00884611|3963166|P1|COMPLETED|Overall Study||19
1621290|NCT00884611|3963166|P1|Enrolled, Not Treated|Overall Study||1
1621291|NCT00884611|3963166|P1|STARTED|Overall Study||20
1621292|NCT00884585|3963190|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
1621293|NCT00884585|3963191|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
1621294|NCT00884585|3963190|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
1621295|NCT00884585|3963191|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
1621296|NCT00884585|3963190|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
1621297|NCT00884585|3963191|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
1621298|NCT00884585|3963190|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
1621299|NCT00884585|3963191|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
1621300|NCT00884585|3963190|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
1621301|NCT00884585|3963191|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
1621302|NCT00884585|3963190|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
1621303|NCT00884585|3963191|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
1621304|NCT00884585|3963190|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
1621305|NCT00884585|3963191|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
1621306|NCT00884585|3963190|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
1621307|NCT00884585|3963191|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
1621308|NCT00884585|3963190|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
1621309|NCT00884585|3963191|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
1621310|NCT00884390|3963205|P2|NOT COMPLETED|Overall Study||8
1621311|NCT00884390|3963206|P1|NOT COMPLETED|Overall Study||23
1621312|NCT00884390|3963205|P2|COMPLETED|Overall Study||54
1621313|NCT00884390|3963206|P1|COMPLETED|Overall Study||123
1621314|NCT00884390|3963205|P2|STARTED|Overall Study||62
1621315|NCT00884390|3963206|P1|STARTED|Overall Study||146
1621316|NCT00884377|3963224|P2|NOT COMPLETED|Overall Study||1
1621317|NCT00884377|3963225|P1|NOT COMPLETED|Overall Study||2
1621318|NCT00884377|3963224|P2|COMPLETED|Overall Study||27
1621319|NCT00884377|3963225|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
1621320|NCT00884377|3963224|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
1621321|NCT00884377|3963225|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
1621322|NCT00884325|3963247|P2|NOT COMPLETED|Overall Study||4
1621323|NCT00884325|3963248|P1|NOT COMPLETED|Overall Study||3
1621324|NCT00884325|3963247|P2|COMPLETED|Overall Study||16
1621325|NCT00884325|3963248|P1|COMPLETED|Overall Study||17
1621326|NCT00884325|3963247|P2|STARTED|Overall Study||20
1621327|NCT00884325|3963248|P1|STARTED|Overall Study||20
1621328|NCT00884312|3963258|P2|NOT COMPLETED|Overall Study||25
1621329|NCT00884312|3963259|P1|NOT COMPLETED|Overall Study||2
1621330|NCT00884312|3963258|P2|COMPLETED|Overall Study||67
1621331|NCT00884312|3963259|P1|COMPLETED|Overall Study||7
1621332|NCT00884312|3963258|P2|Received Treatment|Overall Study||91
1621333|NCT00884312|3963259|P1|Received Treatment|Overall Study||9
1621334|NCT00884312|3963258|P2|STARTED|Overall Study||92
1621335|NCT00884312|3963259|P1|STARTED|Overall Study||9
1621336|NCT00884286|3963275|P2|NOT COMPLETED|Overall Study||33
1621337|NCT00884286|3963276|P1|NOT COMPLETED|Overall Study||32
1621338|NCT00884286|3963275|P2|COMPLETED|Overall Study||0
1621339|NCT00884286|3963276|P1|COMPLETED|Overall Study||2
1621340|NCT00884286|3963275|P2|STARTED|Overall Study||33
1621341|NCT00884286|3963276|P1|STARTED|Overall Study||34
1621342|NCT00884273|3963290|P2|NOT COMPLETED|Overall Study||5
1621343|NCT00884273|3963291|P1|NOT COMPLETED|Overall Study||2
1621344|NCT00884273|3963290|P2|COMPLETED|Overall Study||93
1621345|NCT00884273|3963291|P1|COMPLETED|Overall Study||82
1621346|NCT00884273|3963290|P2|Safety Analysis Set|Overall Study||98
1621347|NCT00884273|3963291|P1|Safety Analysis Set|Overall Study||84
1621348|NCT00884273|3963290|P2|Per Protocol (PP) Analysis Set|Overall Study||92
1621349|NCT00884273|3963291|P1|Per Protocol (PP) Analysis Set|Overall Study||81
1621350|NCT00884273|3963290|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
1621351|NCT00884273|3963291|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
1621352|NCT00884273|3963290|P2|STARTED|Overall Study|ITT population.|98
1621353|NCT00884273|3963291|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
1621354|NCT00884221|3963317|P2|NOT COMPLETED|Overall Study||32
1621355|NCT00884221|3963318|P1|NOT COMPLETED|Overall Study||34
1621356|NCT00884221|3963317|P2|COMPLETED|Overall Study||343
1621357|NCT00884221|3963318|P1|COMPLETED|Overall Study||340
1621358|NCT00884221|3963317|P2|STARTED|Overall Study||375
1621359|NCT00884221|3963318|P1|STARTED|Overall Study||374
1621360|NCT00884117|3963354|P1|NOT COMPLETED|Overall Study||249
1621361|NCT00884117|3963354|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
1621362|NCT00884117|3963354|P1|STARTED|Overall Study||4561
1621363|NCT00884065|3963398|P2|NOT COMPLETED|Overall Study||0
1621364|NCT00884065|3963399|P1|NOT COMPLETED|Overall Study||0
1621365|NCT00884065|3963398|P2|COMPLETED|Overall Study||25
1621366|NCT00884065|3963399|P1|COMPLETED|Overall Study||25
1621367|NCT00884065|3963398|P2|STARTED|Overall Study||25
1621368|NCT00884065|3963399|P1|STARTED|Overall Study||25
1621369|NCT00884039|3963417|P2|NOT COMPLETED|Overall Study||1
1621370|NCT00884039|3963418|P1|NOT COMPLETED|Overall Study||2
1621371|NCT00884039|3963417|P2|COMPLETED|Overall Study||1
1621372|NCT00884039|3963418|P1|COMPLETED|Overall Study||3
1621373|NCT00884039|3963417|P2|STARTED|Overall Study||2
1621374|NCT00884039|3963418|P1|STARTED|Overall Study||5
1621375|NCT00883779|3963426|P2|NOT COMPLETED|Off-study Phase||202
1621376|NCT00883779|3963427|P1|NOT COMPLETED|Off-study Phase||209
1621377|NCT00883779|3963426|P2|COMPLETED|Off-study Phase||0
1621378|NCT00883779|3963427|P1|COMPLETED|Off-study Phase||0
1621379|NCT00883779|3963426|P2|STARTED|Off-study Phase||202
1621380|NCT00883779|3963427|P1|STARTED|Off-study Phase||209
1621381|NCT00883779|3963426|P2|NOT COMPLETED|Post-Study Treatment Phase||135
1621382|NCT00883779|3963427|P1|NOT COMPLETED|Post-Study Treatment Phase||112
1621383|NCT00883779|3963426|P2|COMPLETED|Post-Study Treatment Phase||0
1621384|NCT00883779|3963427|P1|COMPLETED|Post-Study Treatment Phase||0
1621385|NCT00883779|3963426|P2|STARTED|Post-Study Treatment Phase||135
1621386|NCT00883779|3963427|P1|STARTED|Post-Study Treatment Phase||112
1621387|NCT00883779|3963426|P2|NOT COMPLETED|Primary Study Treatment Phase||86
1621388|NCT00883779|3963427|P1|NOT COMPLETED|Primary Study Treatment Phase||105
1621389|NCT00883779|3963426|P2|COMPLETED|Primary Study Treatment Phase||140
1621390|NCT00883779|3963427|P1|COMPLETED|Primary Study Treatment Phase||120
1621391|NCT00883779|3963426|P2|STARTED|Primary Study Treatment Phase||226
1621392|NCT00883779|3963427|P1|STARTED|Primary Study Treatment Phase||225
1621393|NCT00883753|3963463|P1|NOT COMPLETED|Overall Study||107
1621394|NCT00883753|3963463|P1|COMPLETED|Overall Study||827
1621395|NCT00883753|3963463|P1|STARTED|Overall Study||934
1621396|NCT00883740|3963503|P2|NOT COMPLETED|Second Intervention||1
1621397|NCT00883740|3963504|P1|NOT COMPLETED|Second Intervention||1
1621398|NCT00883740|3963503|P2|COMPLETED|Second Intervention||50
1621399|NCT00883740|3963504|P1|COMPLETED|Second Intervention||52
1621400|NCT00883740|3963503|P2|STARTED|Second Intervention||51
1621401|NCT00883740|3963504|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
1621402|NCT00883740|3963503|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
1621403|NCT00883740|3963504|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
1621404|NCT00883740|3963503|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
1621405|NCT00883740|3963504|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
1621406|NCT00883740|3963503|P2|STARTED|Taper and Washout Period (2 Weeks)||51
1621407|NCT00883740|3963504|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
1621408|NCT00883740|3963503|P2|NOT COMPLETED|First Intervention||8
1621409|NCT00883740|3963504|P1|NOT COMPLETED|First Intervention||7
1621410|NCT00883740|3963503|P2|COMPLETED|First Intervention||51
1621411|NCT00883740|3963504|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
1621412|NCT00883740|3963503|P2|STARTED|First Intervention||59
1621413|NCT00883740|3963504|P1|STARTED|First Intervention||60
1621414|NCT00883675|3963544|P1|NOT COMPLETED|Overall Study||0
1621415|NCT00883675|3963544|P1|COMPLETED|Overall Study||133
1621416|NCT00883675|3963544|P1|STARTED|Overall Study||133
1621417|NCT00883558|3963548|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
1621418|NCT00883558|3963549|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
1621419|NCT00883558|3963550|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
1621420|NCT00883558|3963548|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
1621421|NCT00883558|3963549|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
1621422|NCT00883558|3963550|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
1621423|NCT00883558|3963548|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
1621424|NCT00883558|3963549|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
1621425|NCT00883558|3963550|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
1621426|NCT00883558|3963548|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
1621427|NCT00883558|3963549|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
1621428|NCT00883558|3963550|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
1621429|NCT00883558|3963548|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
1621430|NCT00883558|3963549|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
1621431|NCT00883558|3963550|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
1621432|NCT00883558|3963548|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
1621433|NCT00883558|3963549|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
1621434|NCT00883558|3963550|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
1621435|NCT00883558|3963548|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
1621436|NCT00883558|3963549|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
1621437|NCT00883558|3963550|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
1621438|NCT00883558|3963548|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
1621439|NCT00883558|3963549|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
1621440|NCT00883558|3963550|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
1621441|NCT00883558|3963548|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
1621442|NCT00883558|3963549|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
1621443|NCT00883558|3963550|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
1621444|NCT00883558|3963548|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
1621445|NCT00883558|3963549|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
1621446|NCT00883558|3963550|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
1621447|NCT00883558|3963548|P3|STARTED|Titration Period (Weeks 0 to 4)||0
1621448|NCT00883558|3963549|P2|STARTED|Titration Period (Weeks 0 to 4)||0
1621449|NCT00883558|3963550|P1|STARTED|Titration Period (Weeks 0 to 4)||48
1621450|NCT00883493|3963562|P2|NOT COMPLETED|Overall Study||50
1621451|NCT00883493|3963563|P1|NOT COMPLETED|Overall Study||46
1621452|NCT00883493|3963562|P2|COMPLETED|Overall Study||159
1621453|NCT00883493|3963563|P1|COMPLETED|Overall Study||166
1621454|NCT00883493|3963562|P2|Per Protocol Analysis Population|Overall Study||155
1621455|NCT00883493|3963563|P1|Per Protocol Analysis Population|Overall Study||162
1621456|NCT00883493|3963562|P2|Intention To Treat Analysis Population|Overall Study||195
1621457|NCT00883493|3963563|P1|Intention To Treat Analysis Population|Overall Study||204
1621458|NCT00883493|3963562|P2|STARTED|Overall Study||209
1621459|NCT00883493|3963563|P1|STARTED|Overall Study||212
1621460|NCT00883389|3963587|P1|NOT COMPLETED|Overall Study||0
1621461|NCT00883389|3963587|P1|COMPLETED|Overall Study||26
1621462|NCT00883389|3963587|P1|STARTED|Overall Study||26
1621463|NCT00883337|3963594|P3|NOT COMPLETED|Extension Treatment Period||19
1621464|NCT00883337|3963595|P2|NOT COMPLETED|Extension Treatment Period||23
1621465|NCT00883337|3963596|P1|NOT COMPLETED|Extension Treatment Period||28
1621466|NCT00883337|3963594|P3|COMPLETED|Extension Treatment Period||40
1621467|NCT00883337|3963595|P2|COMPLETED|Extension Treatment Period||66
1621468|NCT00883337|3963596|P1|COMPLETED|Extension Treatment Period||61
1621469|NCT00883337|3963594|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
1621470|NCT00883337|3963595|P2|STARTED|Extension Treatment Period||89
1621471|NCT00883337|3963596|P1|STARTED|Extension Treatment Period||89
1621472|NCT00883337|3963594|P3|NOT COMPLETED|Core Treatment Period||33
1621473|NCT00883337|3963595|P2|NOT COMPLETED|Core Treatment Period||22
1621474|NCT00883337|3963596|P1|NOT COMPLETED|Core Treatment Period||20
1621475|NCT00883337|3963594|P3|COMPLETED|Core Treatment Period||71
1621476|NCT00883337|3963595|P2|COMPLETED|Core Treatment Period||89
1621477|NCT00883337|3963596|P1|COMPLETED|Core Treatment Period||89
1621478|NCT00883337|3963594|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
1621479|NCT00883337|3963595|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
1621480|NCT00883337|3963596|P1|Treated|Core Treatment Period||109
1621481|NCT00883337|3963594|P3|STARTED|Core Treatment Period||104
1621482|NCT00883337|3963595|P2|STARTED|Core Treatment Period||111
1621483|NCT00883337|3963596|P1|STARTED|Core Treatment Period||109
1621484|NCT00883246|3963628|P1|NOT COMPLETED|Overall Study||173
1621485|NCT00883246|3963628|P1|COMPLETED|Overall Study||626
1621486|NCT00883246|3963628|P1|STARTED|Overall Study||799
1621487|NCT00883233|3963650|P4|NOT COMPLETED|Overall Study||5
1621488|NCT00883233|3963651|P3|NOT COMPLETED|Overall Study||4
1621489|NCT00883233|3963652|P2|NOT COMPLETED|Overall Study||4
1621490|NCT00883233|3963653|P1|NOT COMPLETED|Overall Study||5
1621491|NCT00883233|3963650|P4|COMPLETED|Overall Study||25
1621492|NCT00883233|3963651|P3|COMPLETED|Overall Study||25
1621493|NCT00883233|3963652|P2|COMPLETED|Overall Study||28
1621494|NCT00883233|3963653|P1|COMPLETED|Overall Study||27
1621495|NCT00883233|3963650|P4|STARTED|Overall Study||30
1621496|NCT00883233|3963651|P3|STARTED|Overall Study||29
1621497|NCT00883233|3963652|P2|STARTED|Overall Study||32
1621498|NCT00883233|3963653|P1|STARTED|Overall Study||32
1621499|NCT00883181|3963663|P1|NOT COMPLETED|Overall Study||278
1621500|NCT00883181|3963663|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
1621501|NCT00883181|3963663|P1|STARTED|Overall Study|Full analysis set|1347
1621502|NCT00883168|3963876|P4|NOT COMPLETED|Overall Study||15
1621503|NCT00883168|3963877|P3|NOT COMPLETED|Overall Study||19
1621504|NCT00883168|3963878|P2|NOT COMPLETED|Overall Study||15
1621505|NCT00883168|3963879|P1|NOT COMPLETED|Overall Study||14
1621506|NCT00883168|3963876|P4|COMPLETED|Overall Study||433
1621507|NCT00883168|3963877|P3|COMPLETED|Overall Study||431
1621508|NCT00883168|3963878|P2|COMPLETED|Overall Study||430
1621509|NCT00883168|3963879|P1|COMPLETED|Overall Study||434
1621510|NCT00883168|3963876|P4|STARTED|Overall Study||448
1621511|NCT00883168|3963877|P3|STARTED|Overall Study||450
1621512|NCT00883168|3963878|P2|STARTED|Overall Study||445
1621513|NCT00883168|3963879|P1|STARTED|Overall Study||448
1621514|NCT00883129|3963899|P2|NOT COMPLETED|Overall Study||36
1621515|NCT00883129|3963900|P1|NOT COMPLETED|Overall Study||20
1621516|NCT00883129|3963899|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
1621517|NCT00883129|3963900|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
1621518|NCT00883129|3963899|P2|STARTED|Overall Study||73
1621519|NCT00883129|3963900|P1|STARTED|Overall Study||69
1621520|NCT00883116|3963924|P2|NOT COMPLETED|Overall Study||219
1621521|NCT00883116|3963925|P1|NOT COMPLETED|Overall Study||209
1621522|NCT00883116|3963924|P2|COMPLETED|Overall Study||29
1621523|NCT00883116|3963925|P1|COMPLETED|Overall Study||39
1621524|NCT00883116|3963924|P2|Received Treatment|Overall Study||239
1621525|NCT00883116|3963925|P1|Received Treatment|Overall Study||248
1621526|NCT00883116|3963924|P2|STARTED|Overall Study||248
1621527|NCT00883116|3963925|P1|STARTED|Overall Study||248
1621528|NCT00883103|3963940|P2|NOT COMPLETED|Overall Study||0
1621529|NCT00883103|3963941|P1|NOT COMPLETED|Overall Study||0
1621530|NCT00883103|3963940|P2|COMPLETED|Overall Study||68
1621531|NCT00883103|3963941|P1|COMPLETED|Overall Study||69
1621532|NCT00883103|3963940|P2|STARTED|Overall Study||68
1621533|NCT00883103|3963941|P1|STARTED|Overall Study||69
1621534|NCT00883090|3963947|P1|NOT COMPLETED|Overall Study||2
1621535|NCT00883090|3963947|P1|COMPLETED|Overall Study||13
1621536|NCT00883090|3963947|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
1621537|NCT00882999|3963969|P7|NOT COMPLETED|Overall Study||8
1621538|NCT00882999|3963970|P6|NOT COMPLETED|Overall Study||7
1621539|NCT00882999|3963971|P5|NOT COMPLETED|Overall Study||8
1621540|NCT00882999|3963972|P4|NOT COMPLETED|Overall Study||5
1621541|NCT00882999|3963973|P3|NOT COMPLETED|Overall Study||4
1621542|NCT00882999|3963974|P2|NOT COMPLETED|Overall Study||8
1621543|NCT00882999|3963975|P1|NOT COMPLETED|Overall Study||8
1621544|NCT00882999|3963969|P7|COMPLETED|Overall Study||27
1621545|NCT00882999|3963970|P6|COMPLETED|Overall Study||28
1621546|NCT00882999|3963971|P5|COMPLETED|Overall Study||28
1621547|NCT00882999|3963972|P4|COMPLETED|Overall Study||31
1621548|NCT00882999|3963973|P3|COMPLETED|Overall Study||30
1621549|NCT00882999|3963974|P2|COMPLETED|Overall Study||26
1621550|NCT00882999|3963975|P1|COMPLETED|Overall Study||27
1621551|NCT00882999|3963969|P7|Completed Study Treatment|Overall Study||31
1621552|NCT00882999|3963970|P6|Completed Study Treatment|Overall Study||30
1621553|NCT00882999|3963971|P5|Completed Study Treatment|Overall Study||29
1621554|NCT00882999|3963972|P4|Completed Study Treatment|Overall Study||33
1621555|NCT00882999|3963973|P3|Completed Study Treatment|Overall Study||31
1621556|NCT00882999|3963974|P2|Completed Study Treatment|Overall Study||29
1621557|NCT00882999|3963975|P1|Completed Study Treatment|Overall Study||29
1621558|NCT00882999|3963969|P7|Received Any Amount of Study Drug|Overall Study||35
1621559|NCT00882999|3963970|P6|Received Any Amount of Study Drug|Overall Study||35
1621560|NCT00882999|3963971|P5|Received Any Amount of Study Drug|Overall Study||36
1621561|NCT00882999|3963972|P4|Received Any Amount of Study Drug|Overall Study||36
1621562|NCT00882999|3963973|P3|Received Any Amount of Study Drug|Overall Study||34
1621563|NCT00882999|3963974|P2|Received Any Amount of Study Drug|Overall Study||34
1621564|NCT00882999|3963975|P1|Received Any Amount of Study Drug|Overall Study||35
1621565|NCT00882999|3963969|P7|STARTED|Overall Study||35
1621566|NCT00882999|3963970|P6|STARTED|Overall Study||35
1621567|NCT00882999|3963971|P5|STARTED|Overall Study||36
1621568|NCT00882999|3963972|P4|STARTED|Overall Study||36
1621569|NCT00882999|3963973|P3|STARTED|Overall Study||34
1621570|NCT00882999|3963974|P2|STARTED|Overall Study||34
1621571|NCT00882999|3963975|P1|STARTED|Overall Study||35
1621572|NCT00882921|3964102|P1|NOT COMPLETED|Overall Study||11
1621573|NCT00882921|3964102|P1|COMPLETED|Overall Study||15
1621574|NCT00882921|3964102|P1|STARTED|Overall Study||26
1621575|NCT00882908|3964112|P5|NOT COMPLETED|Overall Study||6
1621576|NCT00882908|3964113|P4|NOT COMPLETED|Overall Study||7
1621577|NCT00882908|3964114|P3|NOT COMPLETED|Overall Study||7
1621578|NCT00882908|3964115|P2|NOT COMPLETED|Overall Study||6
1621579|NCT00882908|3964116|P1|NOT COMPLETED|Overall Study||3
1621580|NCT00882908|3964112|P5|COMPLETED|Overall Study||71
1621581|NCT00882908|3964113|P4|COMPLETED|Overall Study||72
1621582|NCT00882908|3964114|P3|COMPLETED|Overall Study||70
1621583|NCT00882908|3964115|P2|COMPLETED|Overall Study||69
1621584|NCT00882908|3964116|P1|COMPLETED|Overall Study||75
1621585|NCT00882908|3964112|P5|STARTED|Overall Study||77
1621586|NCT00882908|3964113|P4|STARTED|Overall Study||79
1621587|NCT00882908|3964114|P3|STARTED|Overall Study||77
1621588|NCT00882908|3964115|P2|STARTED|Overall Study||75
1621589|NCT00882908|3964116|P1|STARTED|Overall Study||78
1621590|NCT00882778|3964191|P1|NOT COMPLETED|Overall Study||0
1621591|NCT00882778|3964191|P1|COMPLETED|Overall Study||86
1621592|NCT00882778|3964191|P1|STARTED|Overall Study||86
1621593|NCT00882713|3964222|P1|NOT COMPLETED|Overall Study||22
1621594|NCT00882713|3964222|P1|COMPLETED|Overall Study||172
1621595|NCT00882713|3964222|P1|STARTED|Overall Study||194
1621596|NCT00882687|3964248|P4|NOT COMPLETED|Overall Study||2
1621597|NCT00882687|3964249|P3|NOT COMPLETED|Overall Study||3
1621598|NCT00882687|3964250|P2|NOT COMPLETED|Overall Study||2
1621599|NCT00882687|3964251|P1|NOT COMPLETED|Overall Study||2
1621600|NCT00882687|3964248|P4|COMPLETED|Overall Study||13
1621601|NCT00882687|3964249|P3|COMPLETED|Overall Study||12
1621602|NCT00882687|3964250|P2|COMPLETED|Overall Study||13
1621603|NCT00882687|3964251|P1|COMPLETED|Overall Study||13
1621604|NCT00882687|3964248|P4|STARTED|Overall Study||15
1621605|NCT00882687|3964249|P3|STARTED|Overall Study||15
1621606|NCT00882687|3964250|P2|STARTED|Overall Study||15
1621607|NCT00882687|3964251|P1|STARTED|Overall Study||15
1621608|NCT00882661|3964284|P2|NOT COMPLETED|Treatment||26
1621609|NCT00882661|3964285|P1|NOT COMPLETED|Treatment||10
1621610|NCT00882661|3964284|P2|COMPLETED|Treatment||114
1621611|NCT00882661|3964285|P1|COMPLETED|Treatment||141
1621612|NCT00882661|3964284|P2|STARTED|Treatment||140
1621613|NCT00882661|3964285|P1|STARTED|Treatment||151
1621614|NCT00882661|3964284|P2|NOT COMPLETED|Investigational Training||0
1621615|NCT00882661|3964285|P1|NOT COMPLETED|Investigational Training||10
1621616|NCT00882661|3964284|P2|COMPLETED|Investigational Training||0
1621617|NCT00882661|3964285|P1|COMPLETED|Investigational Training||79
1621618|NCT00882661|3964284|P2|STARTED|Investigational Training||0
1621619|NCT00882661|3964285|P1|STARTED|Investigational Training||89
1621620|NCT00882583|3964315|P2|NOT COMPLETED|Overall Study||1
1621621|NCT00882583|3964316|P1|NOT COMPLETED|Overall Study||1
1621622|NCT00882583|3964315|P2|COMPLETED|Overall Study||11
1621623|NCT00882583|3964316|P1|COMPLETED|Overall Study||6
1621624|NCT00882583|3964315|P2|STARTED|Overall Study||12
1621625|NCT00882583|3964316|P1|STARTED|Overall Study||7
1621626|NCT00882557|3964324|P2|NOT COMPLETED|Overall Study||1
1621627|NCT00882557|3964325|P1|NOT COMPLETED|Overall Study||2
1621628|NCT00882557|3964324|P2|COMPLETED|Overall Study||7
1621629|NCT00882557|3964325|P1|COMPLETED|Overall Study||6
1621630|NCT00882557|3964324|P2|Completed Dose 2|Overall Study||7
1621631|NCT00882557|3964325|P1|Completed Dose 2|Overall Study||6
1621632|NCT00882557|3964324|P2|Completed Dose 1|Overall Study||7
1621633|NCT00882557|3964325|P1|Completed Dose 1|Overall Study||8
1621634|NCT00882557|3964324|P2|STARTED|Overall Study||8
1621635|NCT00882557|3964325|P1|STARTED|Overall Study||8
1621636|NCT00882518|3964345|P2|NOT COMPLETED|Overall Study||44
1621637|NCT00882518|3964346|P1|NOT COMPLETED|Overall Study||38
1621638|NCT00882518|3964345|P2|COMPLETED|Overall Study||148
1621639|NCT00882518|3964346|P1|COMPLETED|Overall Study||158
1621640|NCT00882518|3964345|P2|STARTED|Overall Study||192
1621641|NCT00882518|3964346|P1|STARTED|Overall Study||196
1621642|NCT00882440|3964375|P7|NOT COMPLETED|Overall Study||4
1621643|NCT00882440|3964376|P6|NOT COMPLETED|Overall Study||7
1621644|NCT00882440|3964377|P5|NOT COMPLETED|Overall Study||10
1621645|NCT00882440|3964378|P4|NOT COMPLETED|Overall Study||3
1621646|NCT00882440|3964379|P3|NOT COMPLETED|Overall Study||7
1621647|NCT00882440|3964380|P2|NOT COMPLETED|Overall Study||8
1621648|NCT00882440|3964381|P1|NOT COMPLETED|Overall Study||11
1621649|NCT00882440|3964375|P7|COMPLETED|Overall Study||79
1621650|NCT00882440|3964376|P6|COMPLETED|Overall Study||77
1621651|NCT00882440|3964377|P5|COMPLETED|Overall Study||80
1621652|NCT00882440|3964378|P4|COMPLETED|Overall Study||76
1621653|NCT00882440|3964379|P3|COMPLETED|Overall Study||75
1621654|NCT00882440|3964380|P2|COMPLETED|Overall Study||72
1621655|NCT00882440|3964381|P1|COMPLETED|Overall Study||67
1621656|NCT00882440|3964375|P7|STARTED|Overall Study||83
1621657|NCT00882440|3964376|P6|STARTED|Overall Study||84
1621658|NCT00882440|3964377|P5|STARTED|Overall Study||90
1621659|NCT00882440|3964378|P4|STARTED|Overall Study||79
1621660|NCT00882440|3964379|P3|STARTED|Overall Study||82
1621661|NCT00882440|3964380|P2|STARTED|Overall Study||80
1621662|NCT00882440|3964381|P1|STARTED|Overall Study||78
1621663|NCT00882362|3964406|P2|NOT COMPLETED|Overall Study||23
1621664|NCT00882362|3964407|P1|NOT COMPLETED|Overall Study||49
1621665|NCT00882362|3964406|P2|COMPLETED|Overall Study||10
1621666|NCT00882362|3964407|P1|COMPLETED|Overall Study||73
1621667|NCT00882362|3964406|P2|STARTED|Overall Study||33
1621668|NCT00882362|3964407|P1|STARTED|Overall Study||122
1621669|NCT00882310|3964413|P1|NOT COMPLETED|Overall Study||22
1621670|NCT00882310|3964413|P1|COMPLETED|Overall Study||15
1621671|NCT00882310|3964413|P1|STARTED|Overall Study||37
1621672|NCT00882206|3964419|P1|NOT COMPLETED|Overall Study||0
1621673|NCT00882206|3964419|P1|COMPLETED|Overall Study||13
1621674|NCT00882206|3964419|P1|STARTED|Overall Study||13
1621675|NCT00882115|3964426|P1|NOT COMPLETED|Overall Study||9
1621676|NCT00882115|3964426|P1|COMPLETED|Overall Study||29
1621677|NCT00882115|3964426|P1|STARTED|Overall Study||38
1621678|NCT00882102|3964430|P1|NOT COMPLETED|Overall Study||0
1621679|NCT00882102|3964430|P1|COMPLETED|Overall Study||40
1621680|NCT00882102|3964430|P1|STARTED|Overall Study||40
1621681|NCT00881959|3964436|P2|NOT COMPLETED|Overall Study||4
1621682|NCT00881959|3964437|P1|NOT COMPLETED|Overall Study||2
1621683|NCT00881959|3964436|P2|COMPLETED|Overall Study||38
1621684|NCT00881959|3964437|P1|COMPLETED|Overall Study||36
1621685|NCT00881959|3964436|P2|STARTED|Overall Study||42
1621686|NCT00881959|3964437|P1|STARTED|Overall Study||38
1621687|NCT00881894|3964445|P2|NOT COMPLETED|Overall Study||3
1621688|NCT00881894|3964446|P1|NOT COMPLETED|Overall Study||1
1621689|NCT00881894|3964445|P2|COMPLETED|Overall Study||23
1621690|NCT00881894|3964446|P1|COMPLETED|Overall Study||25
1621691|NCT00881894|3964445|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
1621692|NCT00881894|3964446|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
1621693|NCT00881894|3964445|P2|STARTED|Overall Study||26
1621694|NCT00881894|3964446|P1|STARTED|Overall Study||26
1621695|NCT00881868|3964478|P2|NOT COMPLETED|Overall Study||2
1621696|NCT00881868|3964479|P1|NOT COMPLETED|Overall Study||8
1621697|NCT00881868|3964478|P2|COMPLETED|Overall Study||38
1621698|NCT00881868|3964479|P1|COMPLETED|Overall Study||33
1621699|NCT00881868|3964478|P2|STARTED|Overall Study||40
1621700|NCT00881868|3964479|P1|STARTED|Overall Study||41
1621701|NCT00881751|3964493|P2|NOT COMPLETED|Overall Study||5
1621702|NCT00881751|3964494|P1|NOT COMPLETED|Overall Study||0
1621703|NCT00881751|3964493|P2|COMPLETED|Overall Study||43
1621704|NCT00881751|3964494|P1|COMPLETED|Overall Study||47
1621705|NCT00881751|3964493|P2|STARTED|Overall Study||48
1621706|NCT00881751|3964494|P1|STARTED|Overall Study||47
1621707|NCT00881712|3964509|P3|NOT COMPLETED|Overall Study||0
1621708|NCT00881712|3964510|P2|NOT COMPLETED|Overall Study||0
1621709|NCT00881712|3964511|P1|NOT COMPLETED|Overall Study||2
1621710|NCT00881712|3964509|P3|COMPLETED|Overall Study||0
1621711|NCT00881712|3964510|P2|COMPLETED|Overall Study||0
1621712|NCT00881712|3964511|P1|COMPLETED|Overall Study||13
1621713|NCT00881712|3964509|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
1621714|NCT00881712|3964510|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
1621715|NCT00881712|3964511|P1|STARTED|Overall Study||15
1621716|NCT00881647|3964533|P2|NOT COMPLETED|Overall Study||1
1621717|NCT00881647|3964534|P1|NOT COMPLETED|Overall Study||2
1621718|NCT00881647|3964533|P2|COMPLETED|Overall Study||15
1621719|NCT00881647|3964534|P1|COMPLETED|Overall Study||27
1621720|NCT00881647|3964533|P2|STARTED|Overall Study||16
1621721|NCT00881647|3964534|P1|STARTED|Overall Study||29
1621722|NCT00881621|3964544|P1|NOT COMPLETED|Overall Study||34
1621723|NCT00881621|3964544|P1|COMPLETED|Overall Study||17
1621724|NCT00881621|3964544|P1|STARTED|Overall Study||51
1621725|NCT00881608|3964556|P1|NOT COMPLETED|Overall Study||11
1621726|NCT00881608|3964556|P1|COMPLETED|Overall Study||0
1621727|NCT00881608|3964556|P1|STARTED|Overall Study||11
1621728|NCT00881530|3964579|P6|NOT COMPLETED|Overall Study||5
1621729|NCT00881530|3964580|P5|NOT COMPLETED|Overall Study||14
1621730|NCT00881530|3964581|P4|NOT COMPLETED|Overall Study||9
1621731|NCT00881530|3964582|P3|NOT COMPLETED|Overall Study||5
1621732|NCT00881530|3964583|P2|NOT COMPLETED|Overall Study||5
1621733|NCT00881530|3964584|P1|NOT COMPLETED|Overall Study||14
1621734|NCT00881530|3964579|P6|COMPLETED|Overall Study||51
1621735|NCT00881530|3964580|P5|COMPLETED|Overall Study||152
1621736|NCT00881530|3964581|P4|COMPLETED|Overall Study||157
1621737|NCT00881530|3964582|P3|COMPLETED|Overall Study||51
1621738|NCT00881530|3964583|P2|COMPLETED|Overall Study||104
1621739|NCT00881530|3964584|P1|COMPLETED|Overall Study||92
1621740|NCT00881530|3964579|P6|STARTED|Overall Study||56
1621741|NCT00881530|3964580|P5|STARTED|Overall Study||166
1621742|NCT00881530|3964581|P4|STARTED|Overall Study||166
1621743|NCT00881530|3964582|P3|STARTED|Overall Study||56
1621744|NCT00881530|3964583|P2|STARTED|Overall Study||109
1621745|NCT00881530|3964584|P1|STARTED|Overall Study||106
1621746|NCT00881504|3964640|P1|NOT COMPLETED|Overall Study||1
1621747|NCT00881504|3964640|P1|COMPLETED|Overall Study||8
1621748|NCT00881504|3964640|P1|STARTED|Overall Study||9
1621749|NCT00881465|3964647|P2|NOT COMPLETED|Overall Study||0
1621750|NCT00881465|3964648|P1|NOT COMPLETED|Overall Study||2
1621751|NCT00881465|3964647|P2|COMPLETED|Overall Study||15
1621752|NCT00881465|3964648|P1|COMPLETED|Overall Study||14
1621753|NCT00881465|3964647|P2|STARTED|Overall Study||15
1621754|NCT00881465|3964648|P1|STARTED|Overall Study||16
1621755|NCT00881361|3964660|P3|NOT COMPLETED|Overall Study||2
1621756|NCT00881361|3964661|P2|NOT COMPLETED|Overall Study||9
1621757|NCT00881361|3964662|P1|NOT COMPLETED|Overall Study||44
1621758|NCT00881361|3964660|P3|COMPLETED|Overall Study||0
1621759|NCT00881361|3964661|P2|COMPLETED|Overall Study||38
1621760|NCT00881361|3964662|P1|COMPLETED|Overall Study||663
1621761|NCT00881361|3964660|P3|STARTED|Overall Study||2
1621762|NCT00881361|3964661|P2|STARTED|Overall Study||47
1621763|NCT00881361|3964662|P1|STARTED|Overall Study||707
1621764|NCT00881335|3964677|P2|NOT COMPLETED|Overall Study||2
1621765|NCT00881335|3964678|P1|NOT COMPLETED|Overall Study||3
1621766|NCT00881335|3964677|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
1621767|NCT00881335|3964678|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
1621768|NCT00881335|3964677|P2|STARTED|Overall Study||30
1621769|NCT00881335|3964678|P1|STARTED|Overall Study||30
1621770|NCT00881205|3964698|P2|NOT COMPLETED|Overall Study||7
1621771|NCT00881205|3964699|P1|NOT COMPLETED|Overall Study||11
1621772|NCT00881205|3964698|P2|COMPLETED|Overall Study||34
1621773|NCT00881205|3964699|P1|COMPLETED|Overall Study||34
1621774|NCT00881205|3964698|P2|STARTED|Overall Study||41
1621775|NCT00881205|3964699|P1|STARTED|Overall Study||45
1621776|NCT00880919|3964709|P3|NOT COMPLETED|Overall Study||6
1621777|NCT00880919|3964710|P2|NOT COMPLETED|Overall Study||14
1621778|NCT00880919|3964711|P1|NOT COMPLETED|Overall Study||15
1621779|NCT00880919|3964709|P3|COMPLETED|Overall Study||23
1621780|NCT00880919|3964710|P2|COMPLETED|Overall Study||19
1621781|NCT00880919|3964711|P1|COMPLETED|Overall Study||18
1621782|NCT00880919|3964709|P3|STARTED|Overall Study||29
1621783|NCT00880919|3964710|P2|STARTED|Overall Study||33
1621784|NCT00880919|3964711|P1|STARTED|Overall Study||33
1621785|NCT00880906|3964745|P2|NOT COMPLETED|Overall Study||7
1621786|NCT00880906|3964746|P1|NOT COMPLETED|Overall Study||12
1621787|NCT00880906|3964745|P2|COMPLETED|Overall Study||14
1621788|NCT00880906|3964746|P1|COMPLETED|Overall Study||17
1621789|NCT00880906|3964745|P2|STARTED|Overall Study||21
1621790|NCT00880906|3964746|P1|STARTED|Overall Study||29
1621791|NCT00880763|3964758|P4|NOT COMPLETED|Extension Period (Part 2)||3
1621792|NCT00880763|3964759|P3|NOT COMPLETED|Extension Period (Part 2)||3
1621793|NCT00880763|3964760|P2|NOT COMPLETED|Extension Period (Part 2)||3
1621794|NCT00880763|3964761|P1|NOT COMPLETED|Extension Period (Part 2)||0
1621795|NCT00880763|3964758|P4|COMPLETED|Extension Period (Part 2)||19
1621796|NCT00880763|3964759|P3|COMPLETED|Extension Period (Part 2)||20
1621797|NCT00880763|3964760|P2|COMPLETED|Extension Period (Part 2)||19
1621798|NCT00880763|3964761|P1|COMPLETED|Extension Period (Part 2)||23
1621799|NCT00880763|3964758|P4|STARTED|Extension Period (Part 2)||22
1621800|NCT00880763|3964759|P3|STARTED|Extension Period (Part 2)||23
1621801|NCT00880763|3964760|P2|STARTED|Extension Period (Part 2)||22
1621802|NCT00880763|3964761|P1|STARTED|Extension Period (Part 2)||23
1621803|NCT00880763|3964758|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1621804|NCT00880763|3964759|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1621805|NCT00880763|3964760|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1621806|NCT00880763|3964761|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1621807|NCT00880763|3964758|P4|COMPLETED|Initial Treatment Period (Part 1)||22
1621808|NCT00880763|3964759|P3|COMPLETED|Initial Treatment Period (Part 1)||23
1621809|NCT00880763|3964760|P2|COMPLETED|Initial Treatment Period (Part 1)||22
1621810|NCT00880763|3964761|P1|COMPLETED|Initial Treatment Period (Part 1)||23
1621811|NCT00880763|3964758|P4|STARTED|Initial Treatment Period (Part 1)||22
1621812|NCT00880763|3964759|P3|STARTED|Initial Treatment Period (Part 1)||23
1621813|NCT00880763|3964760|P2|STARTED|Initial Treatment Period (Part 1)||22
1621814|NCT00880763|3964761|P1|STARTED|Initial Treatment Period (Part 1)||23
1621815|NCT00880750|3964793|P2|NOT COMPLETED|Second Intervention||2
1621816|NCT00880750|3964794|P1|NOT COMPLETED|Second Intervention||4
1621817|NCT00880750|3964793|P2|COMPLETED|Second Intervention||30
1621818|NCT00880750|3964794|P1|COMPLETED|Second Intervention||26
1621819|NCT00880750|3964793|P2|STARTED|Second Intervention||32
1621820|NCT00880750|3964794|P1|STARTED|Second Intervention||30
1621821|NCT00880750|3964793|P2|NOT COMPLETED|Washout Period||0
1621822|NCT00880750|3964794|P1|NOT COMPLETED|Washout Period||0
1621823|NCT00880750|3964793|P2|COMPLETED|Washout Period||32
1621824|NCT00880750|3964794|P1|COMPLETED|Washout Period||30
1621825|NCT00880750|3964793|P2|STARTED|Washout Period||32
1621826|NCT00880750|3964794|P1|STARTED|Washout Period||30
1621827|NCT00880750|3964793|P2|NOT COMPLETED|First Intervention||1
1621828|NCT00880750|3964794|P1|NOT COMPLETED|First Intervention||9
1621829|NCT00880750|3964793|P2|COMPLETED|First Intervention||32
1621830|NCT00880750|3964794|P1|COMPLETED|First Intervention||30
1621831|NCT00880750|3964793|P2|STARTED|First Intervention||33
1621832|NCT00880750|3964794|P1|STARTED|First Intervention||39
1621833|NCT00880698|3964812|P4|NOT COMPLETED|Overall Study||3
1621834|NCT00880698|3964813|P3|NOT COMPLETED|Overall Study||1
1621835|NCT00880698|3964814|P2|NOT COMPLETED|Overall Study||3
1621836|NCT00880698|3964815|P1|NOT COMPLETED|Overall Study||1
1621837|NCT00880698|3964812|P4|COMPLETED|Overall Study||36
1621838|NCT00880698|3964813|P3|COMPLETED|Overall Study||36
1621839|NCT00880698|3964814|P2|COMPLETED|Overall Study||61
1621840|NCT00880698|3964815|P1|COMPLETED|Overall Study||61
1621841|NCT00880698|3964812|P4|STARTED|Overall Study||39
1621842|NCT00880698|3964813|P3|STARTED|Overall Study||37
1621843|NCT00880698|3964814|P2|STARTED|Overall Study||64
1621844|NCT00880698|3964815|P1|STARTED|Overall Study||62
1621845|NCT00880685|3964841|P1|NOT COMPLETED|Memantine 30mg||0
1621846|NCT00880685|3964841|P1|COMPLETED|Memantine 30mg||9
1621847|NCT00880685|3964841|P1|STARTED|Memantine 30mg||9
1621848|NCT00880685|3964841|P1|NOT COMPLETED|Memantine 20mg||1
1621849|NCT00880685|3964841|P1|COMPLETED|Memantine 20mg||9
1621850|NCT00880685|3964841|P1|STARTED|Memantine 20mg||10
1621851|NCT00880685|3964841|P1|NOT COMPLETED|Memantine 10mg||2
1621852|NCT00880685|3964841|P1|COMPLETED|Memantine 10mg||10
1621853|NCT00880685|3964841|P1|STARTED|Memantine 10mg||12
1621854|NCT00880620|3964853|P4|NOT COMPLETED|Overall Study||24
1621855|NCT00880620|3964854|P3|NOT COMPLETED|Overall Study||21
1621856|NCT00880620|3964855|P2|NOT COMPLETED|Overall Study||15
1621857|NCT00880620|3964856|P1|NOT COMPLETED|Overall Study||21
1621858|NCT00880620|3964853|P4|COMPLETED|Overall Study||74
1621859|NCT00880620|3964854|P3|COMPLETED|Overall Study||83
1621860|NCT00880620|3964855|P2|COMPLETED|Overall Study||72
1621861|NCT00880620|3964856|P1|COMPLETED|Overall Study||71
1621862|NCT00880620|3964853|P4|Week 23|Overall Study||74
1621863|NCT00880620|3964854|P3|Week 23|Overall Study||85
1621864|NCT00880620|3964855|P2|Week 23|Overall Study||72
1621865|NCT00880620|3964856|P1|Week 23|Overall Study||71
1621866|NCT00880620|3964853|P4|Week 16|Overall Study||74
1621867|NCT00880620|3964854|P3|Week 16|Overall Study||87
1621868|NCT00880620|3964855|P2|Week 16|Overall Study||73
1621869|NCT00880620|3964856|P1|Week 16|Overall Study||74
1621870|NCT00880620|3964853|P4|Week 9|Overall Study||78
1621871|NCT00880620|3964854|P3|Week 9|Overall Study||88
1621872|NCT00880620|3964855|P2|Week 9|Overall Study||73
1621873|NCT00880620|3964856|P1|Week 9|Overall Study||80
1621874|NCT00880620|3964853|P4|Week 4|Overall Study||86
1621875|NCT00880620|3964854|P3|Week 4|Overall Study||94
1621876|NCT00880620|3964855|P2|Week 4|Overall Study||79
1621877|NCT00880620|3964856|P1|Week 4|Overall Study||88
1621878|NCT00880620|3964853|P4|STARTED|Overall Study||98
1621879|NCT00880620|3964854|P3|STARTED|Overall Study||104
1621880|NCT00880620|3964855|P2|STARTED|Overall Study||87
1621881|NCT00880620|3964856|P1|STARTED|Overall Study||92
1621882|NCT00880581|3964870|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
1621883|NCT00880581|3964870|P1|COMPLETED|Cycle 2 Re-treatment||24
1621884|NCT00880581|3964870|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
1621885|NCT00880581|3964870|P1|NOT COMPLETED|Cycle 1||0
1621886|NCT00880581|3964870|P1|COMPLETED|Cycle 1||30
1621887|NCT00880581|3964870|P1|STARTED|Cycle 1||30
1621888|NCT00880568|3964884|P9|NOT COMPLETED|Overall Study||3
1621889|NCT00880568|3964885|P8|NOT COMPLETED|Overall Study||2
1621890|NCT00880568|3964886|P7|NOT COMPLETED|Overall Study||6
1621891|NCT00880568|3964887|P6|NOT COMPLETED|Overall Study||3
1621892|NCT00880568|3964888|P5|NOT COMPLETED|Overall Study||3
1621893|NCT00880568|3964889|P4|NOT COMPLETED|Overall Study||1
1621894|NCT00880568|3964890|P3|NOT COMPLETED|Overall Study||3
1621895|NCT00880568|3964891|P2|NOT COMPLETED|Overall Study||3
1621896|NCT00880568|3964892|P1|NOT COMPLETED|Overall Study||3
1621897|NCT00880568|3964884|P9|COMPLETED|Overall Study||0
1621898|NCT00880568|3964885|P8|COMPLETED|Overall Study||0
1621899|NCT00880568|3964886|P7|COMPLETED|Overall Study||0
1621900|NCT00880568|3964887|P6|COMPLETED|Overall Study||0
1621901|NCT00880568|3964888|P5|COMPLETED|Overall Study||0
1621902|NCT00880568|3964889|P4|COMPLETED|Overall Study||0
1621903|NCT00880568|3964890|P3|COMPLETED|Overall Study||0
1621904|NCT00880568|3964891|P2|COMPLETED|Overall Study||0
1621905|NCT00880568|3964892|P1|COMPLETED|Overall Study||0
1621906|NCT00880568|3964884|P9|STARTED|Overall Study||3
1621907|NCT00880568|3964885|P8|STARTED|Overall Study||2
1621908|NCT00880568|3964886|P7|STARTED|Overall Study||6
1621909|NCT00880568|3964887|P6|STARTED|Overall Study||3
1621910|NCT00880568|3964888|P5|STARTED|Overall Study||3
1621911|NCT00880568|3964889|P4|STARTED|Overall Study||1
1621912|NCT00880568|3964890|P3|STARTED|Overall Study||3
1621913|NCT00880568|3964891|P2|STARTED|Overall Study||3
1621914|NCT00880568|3964892|P1|STARTED|Overall Study||3
1621915|NCT00880555|3964938|P6|NOT COMPLETED|Overall Study||1
1621916|NCT00880555|3964939|P5|NOT COMPLETED|Overall Study||1
1621917|NCT00880555|3964940|P4|NOT COMPLETED|Overall Study||2
1621918|NCT00880555|3964941|P3|NOT COMPLETED|Overall Study||5
1621919|NCT00880555|3964942|P2|NOT COMPLETED|Overall Study||17
1621920|NCT00880555|3964943|P1|NOT COMPLETED|Overall Study||10
1621921|NCT00880555|3964938|P6|COMPLETED|Overall Study||0
1621922|NCT00880555|3964939|P5|COMPLETED|Overall Study||0
1621923|NCT00880555|3964940|P4|COMPLETED|Overall Study||0
1621924|NCT00880555|3964941|P3|COMPLETED|Overall Study||6
1621925|NCT00880555|3964942|P2|COMPLETED|Overall Study||23
1621926|NCT00880555|3964943|P1|COMPLETED|Overall Study||13
1621927|NCT00880555|3964938|P6|STARTED|Overall Study||1
1621928|NCT00880555|3964939|P5|STARTED|Overall Study||1
1621929|NCT00880555|3964940|P4|STARTED|Overall Study||2
1621930|NCT00880555|3964941|P3|STARTED|Overall Study||11
1621931|NCT00880555|3964942|P2|STARTED|Overall Study||40
1621932|NCT00880555|3964943|P1|STARTED|Overall Study||23
1621933|NCT00880542|3964954|P1|NOT COMPLETED|Follow-up Period||0
1621934|NCT00880542|3964954|P1|COMPLETED|Follow-up Period||7
1621935|NCT00880542|3964954|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
1621936|NCT00880542|3964954|P1|NOT COMPLETED|Continued Treatment Period||0
1621937|NCT00880542|3964954|P1|COMPLETED|Continued Treatment Period||0
1621938|NCT00880542|3964954|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
1621939|NCT00880542|3964954|P1|NOT COMPLETED|Post Surgical Evaluation||0
1621940|NCT00880542|3964954|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
1621941|NCT00880542|3964954|P1|STARTED|Post Surgical Evaluation||3
1621942|NCT00880542|3964954|P1|NOT COMPLETED|REP: Surgical Resection||1
1621943|NCT00880542|3964954|P1|COMPLETED|REP: Surgical Resection||3
1621944|NCT00880542|3964954|P1|STARTED|REP: Surgical Resection||4
1621945|NCT00880542|3964954|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
1621946|NCT00880542|3964954|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
1621947|NCT00880542|3964954|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
1621948|NCT00880542|3964954|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
1621949|NCT00880542|3964954|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
1621950|NCT00880542|3964954|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
1621951|NCT00880425|3964959|P2|NOT COMPLETED|Overall Study||0
1621952|NCT00880425|3964960|P1|NOT COMPLETED|Overall Study||0
1621953|NCT00880425|3964959|P2|COMPLETED|Overall Study||27
1621954|NCT00880425|3964960|P1|COMPLETED|Overall Study||18
1621955|NCT00880425|3964959|P2|STARTED|Overall Study||27
1621956|NCT00880425|3964960|P1|STARTED|Overall Study||18
1621957|NCT00880399|3964971|P3|NOT COMPLETED|Overall Study||26
1621958|NCT00880399|3964972|P2|NOT COMPLETED|Overall Study||29
1621959|NCT00880399|3964973|P1|NOT COMPLETED|Overall Study||31
1621960|NCT00880399|3964971|P3|COMPLETED|Overall Study||81
1621961|NCT00880399|3964972|P2|COMPLETED|Overall Study||84
1621962|NCT00880399|3964973|P1|COMPLETED|Overall Study||77
1621963|NCT00880399|3964971|P3|STARTED|Overall Study||107
1621964|NCT00880399|3964972|P2|STARTED|Overall Study||113
1621965|NCT00880399|3964973|P1|STARTED|Overall Study||108
1621966|NCT00880360|3965029|P1|NOT COMPLETED|Overall Study||0
1621967|NCT00880360|3965029|P1|COMPLETED|Overall Study||19
1621968|NCT00880360|3965029|P1|STARTED|Overall Study||19
1621969|NCT00880334|3965036|P2|NOT COMPLETED|Crossover Phase||0
1621970|NCT00880334|3965037|P1|NOT COMPLETED|Crossover Phase||0
1621971|NCT00880334|3965036|P2|COMPLETED|Crossover Phase||37
1621972|NCT00880334|3965037|P1|COMPLETED|Crossover Phase||0
1621973|NCT00880334|3965036|P2|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
1621974|NCT00880334|3965037|P1|STARTED|Crossover Phase||0
1621975|NCT00880334|3965036|P2|NOT COMPLETED|Randomized Phase||40
1621976|NCT00880334|3965037|P1|NOT COMPLETED|Randomized Phase||4
1621977|NCT00880334|3965036|P2|COMPLETED|Randomized Phase||35
1621978|NCT00880334|3965037|P1|COMPLETED|Randomized Phase||70
1621979|NCT00880334|3965036|P2|Eligible & Treated|Randomized Phase||72
1621980|NCT00880334|3965037|P1|Eligible & Treated|Randomized Phase||70
1621981|NCT00880334|3965036|P2|STARTED|Randomized Phase||75
1621982|NCT00880334|3965037|P1|STARTED|Randomized Phase||74
1621983|NCT00880269|3965054|P2|NOT COMPLETED|Overall Study||27
1621984|NCT00880269|3965055|P1|NOT COMPLETED|Overall Study||32
1621985|NCT00880269|3965054|P2|COMPLETED|Overall Study||0
1621986|NCT00880269|3965055|P1|COMPLETED|Overall Study||0
1621987|NCT00880269|3965054|P2|Discontinued Treatment|Overall Study||27
1621988|NCT00880269|3965055|P1|Discontinued Treatment|Overall Study||32
1621989|NCT00880269|3965054|P2|STARTED|Overall Study||27
1621990|NCT00880269|3965055|P1|STARTED|Overall Study||32
1621991|NCT00880256|3965071|P1|NOT COMPLETED|Overall Study||28
1621992|NCT00880256|3965071|P1|COMPLETED|Overall Study||65
1621993|NCT00880256|3965071|P1|STARTED|Overall Study||93
1621994|NCT00880230|3965076|P1|NOT COMPLETED|Overall Study||7
1621995|NCT00880230|3965076|P1|COMPLETED|Overall Study||134
1621996|NCT00880230|3965076|P1|STARTED|Overall Study||141
1621997|NCT00880191|3965098|P2|NOT COMPLETED|Overall Study||8
1621998|NCT00880191|3965099|P1|NOT COMPLETED|Overall Study||13
1621999|NCT00880191|3965098|P2|COMPLETED|Overall Study||198
1622000|NCT00880191|3965099|P1|COMPLETED|Overall Study||194
1622001|NCT00880191|3965098|P2|Available for Primary Endpoint Analysis|Overall Study||206
1622002|NCT00880191|3965099|P1|Available for Primary Endpoint Analysis|Overall Study||207
1622003|NCT00880191|3965098|P2|STARTED|Overall Study||206
1622004|NCT00880191|3965099|P1|STARTED|Overall Study||207
1622005|NCT00880165|3965119|P2|NOT COMPLETED|Overall Study||50
1622006|NCT00880165|3965120|P1|NOT COMPLETED|Overall Study||62
1622007|NCT00880165|3965119|P2|COMPLETED|Overall Study||98
1622008|NCT00880165|3965120|P1|COMPLETED|Overall Study||86
1622009|NCT00880165|3965119|P2|STARTED|Overall Study||148
1622010|NCT00880165|3965120|P1|STARTED|Overall Study||148
1622011|NCT00880100|3965130|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
1622012|NCT00880100|3965130|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
1622013|NCT00880100|3965130|P1|STARTED|Treatment Phase With Ultrase® MT12||48
1622014|NCT00880100|3965130|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
1622015|NCT00880100|3965130|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
1622016|NCT00880100|3965130|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
1622017|NCT00880087|3965143|P2|NOT COMPLETED|Overall Study||2
1622018|NCT00880087|3965144|P1|NOT COMPLETED|Overall Study||0
1622019|NCT00880087|3965143|P2|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
1622020|NCT00880087|3965144|P1|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
1622021|NCT00880087|3965143|P2|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
1622022|NCT00880087|3965144|P1|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
1622023|NCT00880048|3965159|P3|NOT COMPLETED|Overall Study||35
1622024|NCT00880048|3965160|P2|NOT COMPLETED|Overall Study||33
1622025|NCT00880048|3965161|P1|NOT COMPLETED|Overall Study||28
1622026|NCT00880048|3965159|P3|COMPLETED|Overall Study||77
1622027|NCT00880048|3965160|P2|COMPLETED|Overall Study||82
1622028|NCT00880048|3965161|P1|COMPLETED|Overall Study||88
1622029|NCT00880048|3965159|P3|STARTED|Overall Study||112
1622030|NCT00880048|3965160|P2|STARTED|Overall Study||115
1622031|NCT00880048|3965161|P1|STARTED|Overall Study||116
1622032|NCT00880022|3965219|P2|NOT COMPLETED|Overall Study||3
1622033|NCT00880022|3965220|P1|NOT COMPLETED|Overall Study||2
1622034|NCT00880022|3965219|P2|COMPLETED|Overall Study||21
1622035|NCT00880022|3965220|P1|COMPLETED|Overall Study||21
1622036|NCT00880022|3965219|P2|STARTED|Overall Study||24
1622037|NCT00880022|3965220|P1|STARTED|Overall Study||23
1622038|NCT00880009|3965228|P1|NOT COMPLETED|Overall Study||16
1622039|NCT00880009|3965228|P1|COMPLETED|Overall Study||0
1622040|NCT00880009|3965228|P1|STARTED|Overall Study||16
1622041|NCT00879996|3965252|P2|NOT COMPLETED|Overall Study||13
1622042|NCT00879996|3965253|P1|NOT COMPLETED|Overall Study||15
1622043|NCT00879996|3965252|P2|COMPLETED|Overall Study||13
1622044|NCT00879996|3965253|P1|COMPLETED|Overall Study||13
1622045|NCT00879996|3965252|P2|STARTED|Overall Study||26
1622046|NCT00879996|3965253|P1|STARTED|Overall Study||28
1622047|NCT00879970|3965268|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
1622048|NCT00879970|3965269|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
1622049|NCT00879970|3965270|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
1622050|NCT00879970|3965271|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
1622051|NCT00879970|3965272|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
1622052|NCT00879970|3965268|P5|COMPLETED|Period 2 Vitamin D Randomization||600
1622053|NCT00879970|3965269|P4|COMPLETED|Period 2 Vitamin D Randomization||610
1622054|NCT00879970|3965270|P3|COMPLETED|Period 2 Vitamin D Randomization||0
1622055|NCT00879970|3965271|P2|COMPLETED|Period 2 Vitamin D Randomization||0
1622056|NCT00879970|3965272|P1|COMPLETED|Period 2 Vitamin D Randomization||0
1622057|NCT00879970|3965268|P5|STARTED|Period 2 Vitamin D Randomization||607
1622058|NCT00879970|3965269|P4|STARTED|Period 2 Vitamin D Randomization||614
1622059|NCT00879970|3965270|P3|STARTED|Period 2 Vitamin D Randomization||0
1622060|NCT00879970|3965271|P2|STARTED|Period 2 Vitamin D Randomization||0
1622061|NCT00879970|3965272|P1|STARTED|Period 2 Vitamin D Randomization||0
1622062|NCT00879970|3965268|P5|NOT COMPLETED|Period 1 TZD Randomization||0
1622063|NCT00879970|3965269|P4|NOT COMPLETED|Period 1 TZD Randomization||0
1622064|NCT00879970|3965270|P3|NOT COMPLETED|Period 1 TZD Randomization||6
1622065|NCT00879970|3965271|P2|NOT COMPLETED|Period 1 TZD Randomization||4
1622066|NCT00879970|3965272|P1|NOT COMPLETED|Period 1 TZD Randomization||8
1622067|NCT00879970|3965268|P5|COMPLETED|Period 1 TZD Randomization||0
1622068|NCT00879970|3965269|P4|COMPLETED|Period 1 TZD Randomization||0
1622069|NCT00879970|3965270|P3|COMPLETED|Period 1 TZD Randomization||393
1622070|NCT00879970|3965271|P2|COMPLETED|Period 1 TZD Randomization||388
1622071|NCT00879970|3965272|P1|COMPLETED|Period 1 TZD Randomization||533
1622072|NCT00879970|3965268|P5|STARTED|Period 1 TZD Randomization||0
1622073|NCT00879970|3965269|P4|STARTED|Period 1 TZD Randomization||0
1622074|NCT00879970|3965270|P3|STARTED|Period 1 TZD Randomization||399
1622075|NCT00879970|3965271|P2|STARTED|Period 1 TZD Randomization||392
1622076|NCT00879970|3965272|P1|STARTED|Period 1 TZD Randomization||541
1622077|NCT00879879|3965354|P1|NOT COMPLETED|Overall Study||3
1622078|NCT00879879|3965354|P1|COMPLETED|Overall Study||17
1622079|NCT00879879|3965354|P1|STARTED|Overall Study||20
1622080|NCT00879814|3965362|P4|NOT COMPLETED|Overall Study||5
1622081|NCT00879814|3965363|P3|NOT COMPLETED|Overall Study||3
1622082|NCT00879814|3965364|P2|NOT COMPLETED|Overall Study||2
1622083|NCT00879814|3965365|P1|NOT COMPLETED|Overall Study||4
1622084|NCT00879814|3965362|P4|COMPLETED|Overall Study||7
1622085|NCT00879814|3965363|P3|COMPLETED|Overall Study||9
1622086|NCT00879814|3965364|P2|COMPLETED|Overall Study||10
1622087|NCT00879814|3965365|P1|COMPLETED|Overall Study||8
1622088|NCT00879814|3965362|P4|STARTED|Overall Study||12
1622089|NCT00879814|3965363|P3|STARTED|Overall Study||12
1622090|NCT00879814|3965364|P2|STARTED|Overall Study||12
1622091|NCT00879814|3965365|P1|STARTED|Overall Study||12
1622092|NCT00879775|3965473|P2|NOT COMPLETED|Overall Study||1
1622093|NCT00879775|3965474|P1|NOT COMPLETED|Overall Study||2
1622094|NCT00879775|3965473|P2|COMPLETED|Overall Study||20
1622095|NCT00879775|3965474|P1|COMPLETED|Overall Study||18
1622096|NCT00879775|3965473|P2|STARTED|Overall Study||21
1622097|NCT00879775|3965474|P1|STARTED|Overall Study||20
1622098|NCT00879710|3965490|P4|NOT COMPLETED|Phase 2 6 Weeks||0
1622099|NCT00879710|3965491|P3|NOT COMPLETED|Phase 2 6 Weeks||0
1622100|NCT00879710|3965492|P2|NOT COMPLETED|Phase 2 6 Weeks||0
1622101|NCT00879710|3965493|P1|NOT COMPLETED|Phase 2 6 Weeks||0
1622102|NCT00879710|3965490|P4|COMPLETED|Phase 2 6 Weeks||13
1622103|NCT00879710|3965491|P3|COMPLETED|Phase 2 6 Weeks||10
1622104|NCT00879710|3965492|P2|COMPLETED|Phase 2 6 Weeks||14
1622105|NCT00879710|3965493|P1|COMPLETED|Phase 2 6 Weeks||10
1622106|NCT00879710|3965490|P4|STARTED|Phase 2 6 Weeks||13
1622107|NCT00879710|3965491|P3|STARTED|Phase 2 6 Weeks||10
1622108|NCT00879710|3965492|P2|STARTED|Phase 2 6 Weeks||14
1622109|NCT00879710|3965493|P1|STARTED|Phase 2 6 Weeks||10
1622110|NCT00879710|3965490|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1622111|NCT00879710|3965491|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1622112|NCT00879710|3965492|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1622113|NCT00879710|3965493|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1622114|NCT00879710|3965490|P4|COMPLETED|Wash Out Period of 4 Weeks||13
1622115|NCT00879710|3965491|P3|COMPLETED|Wash Out Period of 4 Weeks||10
1622116|NCT00879710|3965492|P2|COMPLETED|Wash Out Period of 4 Weeks||14
1622117|NCT00879710|3965493|P1|COMPLETED|Wash Out Period of 4 Weeks||10
1622118|NCT00879710|3965490|P4|STARTED|Wash Out Period of 4 Weeks||13
1622119|NCT00879710|3965491|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
1622120|NCT00879710|3965492|P2|STARTED|Wash Out Period of 4 Weeks||14
1622121|NCT00879710|3965493|P1|STARTED|Wash Out Period of 4 Weeks||10
1622122|NCT00879710|3965490|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
1622123|NCT00879710|3965491|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
1622124|NCT00879710|3965492|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
1622125|NCT00879710|3965493|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
1622126|NCT00879710|3965490|P4|COMPLETED|Phase 1 - 6 Weeks||13
1622127|NCT00879710|3965491|P3|COMPLETED|Phase 1 - 6 Weeks||9
1622128|NCT00879710|3965492|P2|COMPLETED|Phase 1 - 6 Weeks||14
1622129|NCT00879710|3965493|P1|COMPLETED|Phase 1 - 6 Weeks||10
1622130|NCT00879710|3965490|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
1622131|NCT00879710|3965491|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
1622132|NCT00879710|3965492|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
1622133|NCT00879710|3965493|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
1622134|NCT00879697|3965503|P2|NOT COMPLETED|Overall Study||2
1622135|NCT00879697|3965504|P1|NOT COMPLETED|Overall Study||2
1622136|NCT00879697|3965503|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
1622137|NCT00879697|3965504|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
1622138|NCT00879697|3965503|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
1622139|NCT00879697|3965504|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
1622140|NCT00879684|3965510|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
1622141|NCT00879684|3965511|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
1622142|NCT00879684|3965512|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
1622143|NCT00879684|3965513|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
1622144|NCT00879684|3965514|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
1622145|NCT00879684|3965515|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
1622146|NCT00879684|3965516|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
1622147|NCT00879684|3965510|P7|COMPLETED|Stage 2: Expanded Cohort||0
1622148|NCT00879684|3965511|P6|COMPLETED|Stage 2: Expanded Cohort||0
1622149|NCT00879684|3965512|P5|COMPLETED|Stage 2: Expanded Cohort||0
1622150|NCT00879684|3965513|P4|COMPLETED|Stage 2: Expanded Cohort||0
1622151|NCT00879684|3965514|P3|COMPLETED|Stage 2: Expanded Cohort||0
1622152|NCT00879684|3965515|P2|COMPLETED|Stage 2: Expanded Cohort||0
1622153|NCT00879684|3965516|P1|COMPLETED|Stage 2: Expanded Cohort||0
1622154|NCT00879684|3965510|P7|STARTED|Stage 2: Expanded Cohort||13
1622155|NCT00879684|3965511|P6|STARTED|Stage 2: Expanded Cohort||0
1622156|NCT00879684|3965512|P5|STARTED|Stage 2: Expanded Cohort||0
1622157|NCT00879684|3965513|P4|STARTED|Stage 2: Expanded Cohort||0
1622158|NCT00879684|3965514|P3|STARTED|Stage 2: Expanded Cohort||0
1622159|NCT00879684|3965515|P2|STARTED|Stage 2: Expanded Cohort||0
1622160|NCT00879684|3965516|P1|STARTED|Stage 2: Expanded Cohort||0
1622161|NCT00879684|3965510|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
1622162|NCT00879684|3965511|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
1622163|NCT00879684|3965512|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
1622164|NCT00879684|3965513|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
1622165|NCT00879684|3965514|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
1622166|NCT00879684|3965515|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
1622167|NCT00879684|3965516|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
1622168|NCT00879684|3965510|P7|COMPLETED|Stage 1: Dose Escalation||0
1622169|NCT00879684|3965511|P6|COMPLETED|Stage 1: Dose Escalation||0
1622170|NCT00879684|3965512|P5|COMPLETED|Stage 1: Dose Escalation||0
1622171|NCT00879684|3965513|P4|COMPLETED|Stage 1: Dose Escalation||0
1622172|NCT00879684|3965514|P3|COMPLETED|Stage 1: Dose Escalation||0
1622173|NCT00879684|3965515|P2|COMPLETED|Stage 1: Dose Escalation||0
1622174|NCT00879684|3965516|P1|COMPLETED|Stage 1: Dose Escalation||0
1622175|NCT00879684|3965510|P7|STARTED|Stage 1: Dose Escalation||0
1622176|NCT00879684|3965511|P6|STARTED|Stage 1: Dose Escalation||3
1622177|NCT00879684|3965512|P5|STARTED|Stage 1: Dose Escalation||3
1622178|NCT00879684|3965513|P4|STARTED|Stage 1: Dose Escalation||6
1622179|NCT00879684|3965514|P3|STARTED|Stage 1: Dose Escalation||3
1622180|NCT00879684|3965515|P2|STARTED|Stage 1: Dose Escalation||3
1622181|NCT00879684|3965516|P1|STARTED|Stage 1: Dose Escalation||3
1622182|NCT00879645|3965582|P4|NOT COMPLETED|Overall Study||0
1622183|NCT00879645|3965583|P3|NOT COMPLETED|Overall Study||0
1622184|NCT00879645|3965584|P2|NOT COMPLETED|Overall Study||0
1622185|NCT00879645|3965585|P1|NOT COMPLETED|Overall Study||1
1622186|NCT00879645|3965582|P4|COMPLETED|Overall Study||7
1622187|NCT00879645|3965583|P3|COMPLETED|Overall Study||6
1622188|NCT00879645|3965584|P2|COMPLETED|Overall Study||6
1622189|NCT00879645|3965585|P1|COMPLETED|Overall Study||8
1622190|NCT00879645|3965582|P4|STARTED|Overall Study||7
1622191|NCT00879645|3965583|P3|STARTED|Overall Study||6
1622192|NCT00879645|3965584|P2|STARTED|Overall Study||6
1622193|NCT00879645|3965585|P1|STARTED|Overall Study||9
1622194|NCT00879619|3965603|P1|NOT COMPLETED|Overall Study||0
1622195|NCT00879619|3965603|P1|COMPLETED|Overall Study||4
1622196|NCT00879619|3965603|P1|STARTED|Overall Study||4
1622197|NCT00879411|3965612|P1|NOT COMPLETED|Overall Study||162
1622198|NCT00879411|3965612|P1|COMPLETED|Overall Study||539
1622199|NCT00879411|3965612|P1|STARTED|Overall Study||701
1622200|NCT00879398|3965618|P1|NOT COMPLETED|Overall Study||675
1622201|NCT00879398|3965618|P1|COMPLETED|Overall Study||2434
1622202|NCT00879398|3965618|P1|STARTED|Overall Study||3109
1622203|NCT00879359|3965628|P1|NOT COMPLETED|Overall Study||0
1622204|NCT00879359|3965628|P1|COMPLETED|Overall Study||15
1622205|NCT00879359|3965628|P1|STARTED|Overall Study||15
1622206|NCT00879333|3965636|P2|NOT COMPLETED|Overall Study||217
1622207|NCT00879333|3965637|P1|NOT COMPLETED|Overall Study||428
1622208|NCT00879333|3965636|P2|COMPLETED|Overall Study||0
1622209|NCT00879333|3965637|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
1622210|NCT00879333|3965636|P2|Discontinued Study Treatment|Overall Study||217
1622211|NCT00879333|3965637|P1|Discontinued Study Treatment|Overall Study||428
1622212|NCT00879333|3965636|P2|STARTED|Overall Study||217
1622213|NCT00879333|3965637|P1|STARTED|Overall Study||439
1622214|NCT00879255|3965657|P2|NOT COMPLETED|Overall Study||19
1622215|NCT00879255|3965658|P1|NOT COMPLETED|Overall Study||16
1622216|NCT00879255|3965657|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
1622217|NCT00879255|3965658|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
1622218|NCT00879255|3965657|P2|Completed 3-mo Follow-up|Overall Study||49
1622219|NCT00879255|3965658|P1|Completed 3-mo Follow-up|Overall Study||48
1622220|NCT00879255|3965657|P2|Completed Posttreatment Follow-up|Overall Study||55
1622221|NCT00879255|3965658|P1|Completed Posttreatment Follow-up|Overall Study||50
1622222|NCT00879255|3965657|P2|Received Allocated Intervention:|Overall Study||56
1622223|NCT00879255|3965658|P1|Received Allocated Intervention:|Overall Study||51
1622224|NCT00879255|3965657|P2|STARTED|Overall Study||64
1622225|NCT00879255|3965658|P1|STARTED|Overall Study||61
1622226|NCT00879229|3965670|P2|NOT COMPLETED|Overall Study||14
1622227|NCT00879229|3965671|P1|NOT COMPLETED|Overall Study||22
1622228|NCT00879229|3965670|P2|COMPLETED|Overall Study||1
1622229|NCT00879229|3965671|P1|COMPLETED|Overall Study||3
1622230|NCT00879229|3965670|P2|STARTED|Overall Study||15
1622231|NCT00879229|3965671|P1|STARTED|Overall Study||25
1622232|NCT00879190|3965697|P2|NOT COMPLETED|Overall Study||0
1622233|NCT00879190|3965698|P1|NOT COMPLETED|Overall Study||0
1622234|NCT00879190|3965697|P2|COMPLETED|Overall Study||49
1622235|NCT00879190|3965698|P1|COMPLETED|Overall Study||43
1622236|NCT00879190|3965697|P2|STARTED|Overall Study||49
1622237|NCT00879190|3965698|P1|STARTED|Overall Study||43
1622238|NCT00879034|3965708|P1|NOT COMPLETED|Overall Study||0
1622239|NCT00879034|3965708|P1|COMPLETED|Overall Study||5
1622240|NCT00879034|3965708|P1|Received Treatment|Overall Study||4
1622241|NCT00879034|3965708|P1|STARTED|Overall Study||5
1622242|NCT00878995|3965719|P2|NOT COMPLETED|Midpoint Study - Post Study||0
1622243|NCT00878995|3965720|P1|NOT COMPLETED|Midpoint Study - Post Study||0
1622244|NCT00878995|3965719|P2|COMPLETED|Midpoint Study - Post Study||10
1622245|NCT00878995|3965720|P1|COMPLETED|Midpoint Study - Post Study||12
1622246|NCT00878995|3965719|P2|STARTED|Midpoint Study - Post Study||10
1622247|NCT00878995|3965720|P1|STARTED|Midpoint Study - Post Study||12
1622248|NCT00878995|3965719|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
1622249|NCT00878995|3965720|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
1622250|NCT00878995|3965719|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
1622251|NCT00878995|3965720|P1|COMPLETED|Baseline Study - Midpoint Study||12
1622252|NCT00878995|3965719|P2|Baseline Study|Baseline Study - Midpoint Study||12
1622253|NCT00878995|3965720|P1|Baseline Study|Baseline Study - Midpoint Study||12
1622254|NCT00878995|3965719|P2|STARTED|Baseline Study - Midpoint Study||12
1622255|NCT00878995|3965720|P1|STARTED|Baseline Study - Midpoint Study||12
1622256|NCT00878969|3965821|P3|NOT COMPLETED|Overall Study||11
1622257|NCT00878969|3965822|P2|NOT COMPLETED|Overall Study||15
1622258|NCT00878969|3965823|P1|NOT COMPLETED|Overall Study||15
1622259|NCT00878969|3965821|P3|COMPLETED|Overall Study||15
1622260|NCT00878969|3965822|P2|COMPLETED|Overall Study||12
1622261|NCT00878969|3965823|P1|COMPLETED|Overall Study||10
1622262|NCT00878969|3965821|P3|STARTED|Overall Study||26
1622263|NCT00878969|3965822|P2|STARTED|Overall Study||27
1622264|NCT00878969|3965823|P1|STARTED|Overall Study||25
1622265|NCT00878878|3965833|P2|NOT COMPLETED|Overall Study||0
1622266|NCT00878878|3965834|P1|NOT COMPLETED|Overall Study||0
1622267|NCT00878878|3965833|P2|COMPLETED|Overall Study||15
1622268|NCT00878878|3965834|P1|COMPLETED|Overall Study||15
1622269|NCT00878878|3965833|P2|STARTED|Overall Study||15
1622270|NCT00878878|3965834|P1|STARTED|Overall Study||15
1622271|NCT00878826|3965847|P3|NOT COMPLETED|Overall Study||0
1622272|NCT00878826|3965848|P2|NOT COMPLETED|Overall Study||0
1622273|NCT00878826|3965849|P1|NOT COMPLETED|Overall Study||0
1622274|NCT00878826|3965847|P3|COMPLETED|Overall Study||2
1622275|NCT00878826|3965848|P2|COMPLETED|Overall Study||6
1622276|NCT00878826|3965849|P1|COMPLETED|Overall Study||3
1622277|NCT00878826|3965847|P3|STARTED|Overall Study||2
1622278|NCT00878826|3965848|P2|STARTED|Overall Study||6
1622279|NCT00878826|3965849|P1|STARTED|Overall Study||3
1622280|NCT00878800|3965871|P5|NOT COMPLETED|Overall Study||16
1622281|NCT00878800|3965872|P4|NOT COMPLETED|Overall Study||6
1622282|NCT00878800|3965873|P3|NOT COMPLETED|Overall Study||9
1622283|NCT00878800|3965874|P2|NOT COMPLETED|Overall Study||7
1622284|NCT00878800|3965875|P1|NOT COMPLETED|Overall Study||3
1622285|NCT00878800|3965871|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
1622286|NCT00878800|3965872|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
1622287|NCT00878800|3965873|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
1622288|NCT00878800|3965874|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
1622289|NCT00878800|3965875|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
1622290|NCT00878800|3965871|P5|STARTED|Overall Study||16
1622291|NCT00878800|3965872|P4|STARTED|Overall Study||6
1622292|NCT00878800|3965873|P3|STARTED|Overall Study||9
1622293|NCT00878800|3965874|P2|STARTED|Overall Study||7
1622294|NCT00878800|3965875|P1|STARTED|Overall Study||3
1622295|NCT00878722|3965910|P8|NOT COMPLETED|Overall Study||7
1622296|NCT00878722|3965911|P7|NOT COMPLETED|Overall Study||6
1622297|NCT00878722|3965912|P6|NOT COMPLETED|Overall Study||2
1622298|NCT00878722|3965913|P5|NOT COMPLETED|Overall Study||7
1622299|NCT00878722|3965914|P4|NOT COMPLETED|Overall Study||9
1622300|NCT00878722|3965915|P3|NOT COMPLETED|Overall Study||3
1622301|NCT00878722|3965916|P2|NOT COMPLETED|Overall Study||3
1622302|NCT00878722|3965917|P1|NOT COMPLETED|Overall Study||3
1622303|NCT00878722|3965910|P8|COMPLETED|Overall Study||0
1622304|NCT00878722|3965911|P7|COMPLETED|Overall Study||0
1622305|NCT00878722|3965912|P6|COMPLETED|Overall Study||1
1622306|NCT00878722|3965913|P5|COMPLETED|Overall Study||0
1622307|NCT00878722|3965914|P4|COMPLETED|Overall Study||0
1622308|NCT00878722|3965915|P3|COMPLETED|Overall Study||0
1622309|NCT00878722|3965916|P2|COMPLETED|Overall Study||0
1622310|NCT00878722|3965917|P1|COMPLETED|Overall Study||0
1622311|NCT00878722|3965910|P8|STARTED|Overall Study||7
1622312|NCT00878722|3965911|P7|STARTED|Overall Study||6
1622313|NCT00878722|3965912|P6|STARTED|Overall Study||3
1622314|NCT00878722|3965913|P5|STARTED|Overall Study||7
1622315|NCT00878722|3965914|P4|STARTED|Overall Study||9
1622316|NCT00878722|3965915|P3|STARTED|Overall Study||3
1622317|NCT00878722|3965916|P2|STARTED|Overall Study||3
1622318|NCT00878722|3965917|P1|STARTED|Overall Study||3
1622319|NCT00878709|3966002|P2|NOT COMPLETED|Overall Study||237
1622320|NCT00878709|3966003|P1|NOT COMPLETED|Overall Study||325
1622321|NCT00878709|3966002|P2|COMPLETED|Overall Study||1183
1622322|NCT00878709|3966003|P1|COMPLETED|Overall Study||1095
1622323|NCT00878709|3966002|P2|STARTED|Overall Study||1420
1622324|NCT00878709|3966003|P1|STARTED|Overall Study||1420
1622325|NCT00878644|3966029|P2|NOT COMPLETED|Overall Study||4
1622326|NCT00878644|3966030|P1|NOT COMPLETED|Overall Study||4
1622327|NCT00878644|3966029|P2|COMPLETED|Overall Study||136
1622328|NCT00878644|3966030|P1|COMPLETED|Overall Study||151
1622329|NCT00878644|3966029|P2|STARTED|Overall Study||140
1622330|NCT00878644|3966030|P1|STARTED|Overall Study||155
1622331|NCT00878605|3966046|P4|NOT COMPLETED|Overall Study||3
1622332|NCT00878605|3966047|P3|NOT COMPLETED|Overall Study||1
1622333|NCT00878605|3966048|P2|NOT COMPLETED|Overall Study||3
1622334|NCT00878605|3966049|P1|NOT COMPLETED|Overall Study||3
1622335|NCT00878605|3966046|P4|COMPLETED|Overall Study||6
1622336|NCT00878605|3966047|P3|COMPLETED|Overall Study||8
1622337|NCT00878605|3966048|P2|COMPLETED|Overall Study||7
1622338|NCT00878605|3966049|P1|COMPLETED|Overall Study||7
1622339|NCT00878605|3966046|P4|STARTED|Overall Study||9
1622340|NCT00878605|3966047|P3|STARTED|Overall Study||9
1622341|NCT00878605|3966048|P2|STARTED|Overall Study||10
1622342|NCT00878605|3966049|P1|STARTED|Overall Study||10
1622343|NCT00878553|3966063|P5|NOT COMPLETED|PK Study||0
1622344|NCT00878553|3966064|P4|NOT COMPLETED|PK Study||1
1622345|NCT00878553|3966065|P3|NOT COMPLETED|PK Study||0
1622346|NCT00878553|3966066|P2|NOT COMPLETED|PK Study||0
1622347|NCT00878553|3966067|P1|NOT COMPLETED|PK Study||0
1622348|NCT00878553|3966063|P5|COMPLETED|PK Study||15
1622349|NCT00878553|3966064|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
1622350|NCT00878553|3966065|P3|COMPLETED|PK Study||17
1622351|NCT00878553|3966066|P2|COMPLETED|PK Study||16
1622352|NCT00878553|3966067|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
1622353|NCT00878553|3966063|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
1622354|NCT00878553|3966064|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
1622355|NCT00878553|3966065|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
1622356|NCT00878553|3966066|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
1622357|NCT00878553|3966067|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
1622358|NCT00878553|3966063|P5|NOT COMPLETED|Sleep Study||0
1622359|NCT00878553|3966064|P4|NOT COMPLETED|Sleep Study||0
1622360|NCT00878553|3966065|P3|NOT COMPLETED|Sleep Study||0
1622361|NCT00878553|3966066|P2|NOT COMPLETED|Sleep Study||0
1622362|NCT00878553|3966067|P1|NOT COMPLETED|Sleep Study||5
1622363|NCT00878553|3966063|P5|COMPLETED|Sleep Study||0
1622364|NCT00878553|3966064|P4|COMPLETED|Sleep Study||0
1622365|NCT00878553|3966065|P3|COMPLETED|Sleep Study||0
1622366|NCT00878553|3966066|P2|COMPLETED|Sleep Study||0
1622367|NCT00878553|3966067|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
1622368|NCT00878553|3966063|P5|Number of Patients Receiving 20mg|Sleep Study||0
1622369|NCT00878553|3966064|P4|Number of Patients Receiving 20mg|Sleep Study||0
1622370|NCT00878553|3966065|P3|Number of Patients Receiving 20mg|Sleep Study||0
1622371|NCT00878553|3966066|P2|Number of Patients Receiving 20mg|Sleep Study||0
1622372|NCT00878553|3966067|P1|Number of Patients Receiving 20mg|Sleep Study||65
1622373|NCT00878553|3966063|P5|Number of Patients Receiving 15mg|Sleep Study||0
1622374|NCT00878553|3966064|P4|Number of Patients Receiving 15mg|Sleep Study||0
1622375|NCT00878553|3966065|P3|Number of Patients Receiving 15mg|Sleep Study||0
1622376|NCT00878553|3966066|P2|Number of Patients Receiving 15mg|Sleep Study||0
1622377|NCT00878553|3966067|P1|Number of Patients Receiving 15mg|Sleep Study||65
1622378|NCT00878553|3966063|P5|Number of Patients Receiving 10mg|Sleep Study||0
1622379|NCT00878553|3966064|P4|Number of Patients Receiving 10mg|Sleep Study||0
1622380|NCT00878553|3966065|P3|Number of Patients Receiving 10mg|Sleep Study||0
1622381|NCT00878553|3966066|P2|Number of Patients Receiving 10mg|Sleep Study||0
1622382|NCT00878553|3966067|P1|Number of Patients Receiving 10mg|Sleep Study||65
1622383|NCT00878553|3966063|P5|Number of Patients Receiving Placebo|Sleep Study||0
1622384|NCT00878553|3966064|P4|Number of Patients Receiving Placebo|Sleep Study||0
1622385|NCT00878553|3966065|P3|Number of Patients Receiving Placebo|Sleep Study||0
1622386|NCT00878553|3966066|P2|Number of Patients Receiving Placebo|Sleep Study||0
1622387|NCT00878553|3966067|P1|Number of Patients Receiving Placebo|Sleep Study||66
1622388|NCT00878553|3966063|P5|STARTED|Sleep Study||0
1622389|NCT00878553|3966064|P4|STARTED|Sleep Study||0
1622390|NCT00878553|3966065|P3|STARTED|Sleep Study||0
1622391|NCT00878553|3966066|P2|STARTED|Sleep Study||0
1622392|NCT00878553|3966067|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
1622393|NCT00878501|3966126|P3|NOT COMPLETED|Overall Study||8
1622394|NCT00878501|3966127|P2|NOT COMPLETED|Overall Study||7
1622395|NCT00878501|3966128|P1|NOT COMPLETED|Overall Study||17
1622396|NCT00878501|3966126|P3|COMPLETED|Overall Study||85
1622397|NCT00878501|3966127|P2|COMPLETED|Overall Study||37
1622398|NCT00878501|3966128|P1|COMPLETED|Overall Study||87
1622399|NCT00878501|3966126|P3|Interim Analysis|Overall Study||81
1622400|NCT00878501|3966127|P2|Interim Analysis|Overall Study||37
1622401|NCT00878501|3966128|P1|Interim Analysis|Overall Study||83
1622402|NCT00878501|3966126|P3|STARTED|Overall Study||93
1622403|NCT00878501|3966127|P2|STARTED|Overall Study||44
1622404|NCT00878501|3966128|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
1622405|NCT00878436|3966147|P2|NOT COMPLETED|Overall Study||24
1622406|NCT00878436|3966148|P1|NOT COMPLETED|Overall Study||23
1622407|NCT00878436|3966147|P2|COMPLETED|Overall Study||0
1622408|NCT00878436|3966148|P1|COMPLETED|Overall Study||5
1622409|NCT00878436|3966147|P2|6 Months|Overall Study||0
1622410|NCT00878436|3966148|P1|6 Months|Overall Study||8
1622411|NCT00878436|3966147|P2|Completed 2 Cycles|Overall Study||20
1622412|NCT00878436|3966148|P1|Completed 2 Cycles|Overall Study||21
1622413|NCT00878436|3966147|P2|STARTED|Overall Study||24
1622414|NCT00878436|3966148|P1|STARTED|Overall Study||28
1622415|NCT00878228|3966162|P2|NOT COMPLETED|Overall Study||12
1622416|NCT00878228|3966163|P1|NOT COMPLETED|Overall Study||10
1622417|NCT00878228|3966162|P2|COMPLETED|Overall Study||37
1622418|NCT00878228|3966163|P1|COMPLETED|Overall Study||39
1622419|NCT00878228|3966162|P2|STARTED|Overall Study||49
1622420|NCT00878228|3966163|P1|STARTED|Overall Study||49
1622421|NCT00878215|3966177|P4|NOT COMPLETED|Overall Study||0
1622422|NCT00878215|3966178|P3|NOT COMPLETED|Overall Study||0
1622423|NCT00878215|3966179|P2|NOT COMPLETED|Overall Study||10
1622424|NCT00878215|3966180|P1|NOT COMPLETED|Overall Study||0
1622425|NCT00878215|3966177|P4|COMPLETED|Overall Study||0
1622426|NCT00878215|3966178|P3|COMPLETED|Overall Study||0
1622427|NCT00878215|3966179|P2|COMPLETED|Overall Study||9
1622428|NCT00878215|3966180|P1|COMPLETED|Overall Study||21
1622429|NCT00878215|3966177|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
1622430|NCT00878215|3966178|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
1622431|NCT00878215|3966179|P2|STARTED|Overall Study||19
1622432|NCT00878215|3966180|P1|STARTED|Overall Study||21
1622433|NCT00877929|3966192|P2|NOT COMPLETED|Overall Study||35
1622434|NCT00877929|3966193|P1|NOT COMPLETED|Overall Study||20
1622435|NCT00877929|3966192|P2|COMPLETED|Overall Study||319
1622436|NCT00877929|3966193|P1|COMPLETED|Overall Study||332
1622437|NCT00877929|3966192|P2|STARTED|Overall Study||354
1622438|NCT00877929|3966193|P1|STARTED|Overall Study||352
1622439|NCT00877890|3966281|P2|NOT COMPLETED|Overall Study||30
1622440|NCT00877890|3966282|P1|NOT COMPLETED|Overall Study||20
1622441|NCT00877890|3966281|P2|COMPLETED|Overall Study||95
1622442|NCT00877890|3966282|P1|COMPLETED|Overall Study||109
1622443|NCT00877890|3966281|P2|Intent to Treat (ITT)|Overall Study||123
1622444|NCT00877890|3966282|P1|Intent to Treat (ITT)|Overall Study||129
1622445|NCT00877890|3966281|P2|STARTED|Overall Study||125
1622446|NCT00877890|3966282|P1|STARTED|Overall Study||129
1622447|NCT00877877|3966316|P1|NOT COMPLETED|Year 10||0
1622448|NCT00877877|3966316|P1|COMPLETED|Year 10||495
1622449|NCT00877877|3966316|P1|STARTED|Year 10||495
1622450|NCT00877877|3966316|P1|NOT COMPLETED|Year 9||0
1622451|NCT00877877|3966316|P1|COMPLETED|Year 9||507
1622452|NCT00877877|3966316|P1|STARTED|Year 9||507
1622453|NCT00877877|3966316|P1|NOT COMPLETED|Year 8||0
1622454|NCT00877877|3966316|P1|COMPLETED|Year 8||522
1622455|NCT00877877|3966316|P1|STARTED|Year 8||522
1622456|NCT00877877|3966316|P1|NOT COMPLETED|Year 7||0
1622457|NCT00877877|3966316|P1|COMPLETED|Year 7||523
1622458|NCT00877877|3966316|P1|STARTED|Year 7||523
1622459|NCT00877877|3966316|P1|NOT COMPLETED|Year 6||0
1622460|NCT00877877|3966316|P1|COMPLETED|Year 6||529
1622461|NCT00877877|3966316|P1|STARTED|Year 6||529
1622462|NCT00877877|3966316|P1|NOT COMPLETED|Year 5||0
1622463|NCT00877877|3966316|P1|COMPLETED|Year 5||397
1622464|NCT00877877|3966316|P1|STARTED|Year 5||397
1622465|NCT00877799|3966347|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
1622466|NCT00877799|3966348|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
1622467|NCT00877799|3966349|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1622468|NCT00877799|3966350|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1622469|NCT00877799|3966351|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1622470|NCT00877799|3966347|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
1622471|NCT00877799|3966348|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
1622472|NCT00877799|3966349|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1622473|NCT00877799|3966350|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1622474|NCT00877799|3966351|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1622475|NCT00877799|3966347|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
1622476|NCT00877799|3966348|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
1622477|NCT00877799|3966349|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
1622478|NCT00877799|3966350|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
1622479|NCT00877799|3966351|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
1622480|NCT00877799|3966347|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1622481|NCT00877799|3966348|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1622482|NCT00877799|3966349|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
1622483|NCT00877799|3966350|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
1622484|NCT00877799|3966351|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
1622485|NCT00877799|3966347|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1622486|NCT00877799|3966348|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1622487|NCT00877799|3966349|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
1622488|NCT00877799|3966350|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
1622489|NCT00877799|3966351|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
1622490|NCT00877799|3966347|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1622491|NCT00877799|3966348|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1622492|NCT00877799|3966349|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
1622493|NCT00877799|3966350|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
1622494|NCT00877799|3966351|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
1622495|NCT00877773|3966366|P1|NOT COMPLETED|Overall Study||44
1622496|NCT00877773|3966366|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
1622497|NCT00877773|3966366|P1|STARTED|Overall Study||44
1622498|NCT00877604|3966372|P2|NOT COMPLETED|Overall Study||3
1622499|NCT00877604|3966373|P1|NOT COMPLETED|Overall Study||2
1622500|NCT00877604|3966372|P2|COMPLETED|Overall Study||14
1622501|NCT00877604|3966373|P1|COMPLETED|Overall Study||15
1622502|NCT00877604|3966372|P2|STARTED|Overall Study||17
1622503|NCT00877604|3966373|P1|STARTED|Overall Study||17
1622504|NCT00877487|3966379|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
1622505|NCT00877487|3966380|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
1622506|NCT00877487|3966379|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
1622507|NCT00877487|3966380|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
1622508|NCT00877487|3966379|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
1622509|NCT00877487|3966380|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
1622510|NCT00877487|3966379|P2|NOT COMPLETED|Open-label Treatment Phase||0
1622511|NCT00877487|3966380|P1|NOT COMPLETED|Open-label Treatment Phase||7
1622512|NCT00877487|3966379|P2|COMPLETED|Open-label Treatment Phase||0
1622513|NCT00877487|3966380|P1|COMPLETED|Open-label Treatment Phase||116
1622514|NCT00877487|3966379|P2|STARTED|Open-label Treatment Phase||0
1622515|NCT00877487|3966380|P1|STARTED|Open-label Treatment Phase||123
1622516|NCT00877448|3966397|P7|NOT COMPLETED|Overall Study||0
1622517|NCT00877448|3966398|P6|NOT COMPLETED|Overall Study||1
1622518|NCT00877448|3966399|P5|NOT COMPLETED|Overall Study||0
1622519|NCT00877448|3966400|P4|NOT COMPLETED|Overall Study||1
1622520|NCT00877448|3966401|P3|NOT COMPLETED|Overall Study||0
1622521|NCT00877448|3966402|P2|NOT COMPLETED|Overall Study||1
1622522|NCT00877448|3966403|P1|NOT COMPLETED|Overall Study||0
1622523|NCT00877448|3966397|P7|COMPLETED|Overall Study||3
1622524|NCT00877448|3966398|P6|COMPLETED|Overall Study||9
1622525|NCT00877448|3966399|P5|COMPLETED|Overall Study||10
1622526|NCT00877448|3966400|P4|COMPLETED|Overall Study||9
1622527|NCT00877448|3966401|P3|COMPLETED|Overall Study||10
1622528|NCT00877448|3966402|P2|COMPLETED|Overall Study||9
1622529|NCT00877448|3966403|P1|COMPLETED|Overall Study||10
1622530|NCT00877448|3966397|P7|STARTED|Overall Study||3
1622531|NCT00877448|3966398|P6|STARTED|Overall Study||10
1622532|NCT00877448|3966399|P5|STARTED|Overall Study||10
1622533|NCT00877448|3966400|P4|STARTED|Overall Study||10
1622534|NCT00877448|3966401|P3|STARTED|Overall Study||10
1622535|NCT00877448|3966402|P2|STARTED|Overall Study||10
1622536|NCT00877448|3966403|P1|STARTED|Overall Study||10
1622537|NCT00877383|3966428|P2|NOT COMPLETED|Overall Study||37
1622538|NCT00877383|3966429|P1|NOT COMPLETED|Overall Study||29
1622539|NCT00877383|3966428|P2|COMPLETED|Overall Study||533
1622540|NCT00877383|3966429|P1|COMPLETED|Overall Study||543
1622541|NCT00877383|3966428|P2|STARTED|Overall Study||570
1622542|NCT00877383|3966429|P1|STARTED|Overall Study||572
1622543|NCT00877370|3966445|P1|NOT COMPLETED|Overall Study||0
1622544|NCT00877370|3966445|P1|COMPLETED|Overall Study||8
1622545|NCT00877370|3966445|P1|STARTED|Overall Study||8
1622546|NCT00877071|3966449|P1|NOT COMPLETED|Overall Study||2
1622547|NCT00877071|3966449|P1|COMPLETED|Overall Study||0
1622548|NCT00877071|3966449|P1|STARTED|Overall Study||2
1622549|NCT00877058|3966459|P3|NOT COMPLETED|Overall Study||39
1622550|NCT00877058|3966460|P2|NOT COMPLETED|Overall Study||40
1622551|NCT00877058|3966461|P1|NOT COMPLETED|Overall Study||37
1622552|NCT00877058|3966459|P3|COMPLETED|Overall Study||75
1622553|NCT00877058|3966460|P2|COMPLETED|Overall Study||131
1622554|NCT00877058|3966461|P1|COMPLETED|Overall Study||137
1622555|NCT00877058|3966459|P3|STARTED|Overall Study||114
1622556|NCT00877058|3966460|P2|STARTED|Overall Study||171
1622557|NCT00877058|3966461|P1|STARTED|Overall Study||174
1622558|NCT00877032|3966482|P7|NOT COMPLETED|Overall Study||2
1622559|NCT00877032|3966483|P6|NOT COMPLETED|Overall Study||0
1622560|NCT00877032|3966484|P5|NOT COMPLETED|Overall Study||0
1622561|NCT00877032|3966485|P4|NOT COMPLETED|Overall Study||1
1622562|NCT00877032|3966486|P3|NOT COMPLETED|Overall Study||0
1622563|NCT00877032|3966487|P2|NOT COMPLETED|Overall Study||0
1622564|NCT00877032|3966488|P1|NOT COMPLETED|Overall Study||0
1622565|NCT00877032|3966482|P7|COMPLETED|Overall Study||18
1622566|NCT00877032|3966483|P6|COMPLETED|Overall Study||6
1622567|NCT00877032|3966484|P5|COMPLETED|Overall Study||6
1622568|NCT00877032|3966485|P4|COMPLETED|Overall Study||6
1622569|NCT00877032|3966486|P3|COMPLETED|Overall Study||6
1622570|NCT00877032|3966487|P2|COMPLETED|Overall Study||6
1622571|NCT00877032|3966488|P1|COMPLETED|Overall Study||6
1622572|NCT00877032|3966482|P7|Treated|Overall Study||18
1622573|NCT00877032|3966483|P6|Treated|Overall Study||6
1622574|NCT00877032|3966484|P5|Treated|Overall Study||6
1622575|NCT00877032|3966485|P4|Treated|Overall Study||6
1622576|NCT00877032|3966486|P3|Treated|Overall Study||6
1622577|NCT00877032|3966487|P2|Treated|Overall Study||6
1622578|NCT00877032|3966488|P1|Treated|Overall Study||6
1622579|NCT00877032|3966482|P7|STARTED|Overall Study||20
1622580|NCT00877032|3966483|P6|STARTED|Overall Study||6
1622581|NCT00877032|3966484|P5|STARTED|Overall Study||6
1622582|NCT00877032|3966485|P4|STARTED|Overall Study||7
1622583|NCT00877032|3966486|P3|STARTED|Overall Study||6
1622584|NCT00877032|3966487|P2|STARTED|Overall Study||6
1622585|NCT00877032|3966488|P1|STARTED|Overall Study||6
1622586|NCT00877006|3966589|P2|NOT COMPLETED|Long-Term Follow-up Period||55
1622587|NCT00877006|3966590|P1|NOT COMPLETED|Long-Term Follow-up Period||53
1622588|NCT00877006|3966589|P2|COMPLETED|Long-Term Follow-up Period||154
1622589|NCT00877006|3966590|P1|COMPLETED|Long-Term Follow-up Period||157
1622590|NCT00877006|3966589|P2|STARTED|Long-Term Follow-up Period||209
1622591|NCT00877006|3966590|P1|STARTED|Long-Term Follow-up Period||210
1622592|NCT00877006|3966589|P2|NOT COMPLETED|Treatment Period||27
1622593|NCT00877006|3966590|P1|NOT COMPLETED|Treatment Period||25
1622594|NCT00877006|3966589|P2|COMPLETED|Treatment Period||196
1622595|NCT00877006|3966590|P1|COMPLETED|Treatment Period||199
1622596|NCT00877006|3966589|P2|STARTED|Treatment Period||223
1622597|NCT00877006|3966590|P1|STARTED|Treatment Period||224
1622598|NCT00876928|3966630|P2|NOT COMPLETED|Overall Study||5
1622599|NCT00876928|3966631|P1|NOT COMPLETED|Overall Study||3
1622600|NCT00876928|3966630|P2|COMPLETED|Overall Study||56
1622601|NCT00876928|3966631|P1|COMPLETED|Overall Study||53
1622602|NCT00876928|3966630|P2|STARTED|Overall Study||61
1622603|NCT00876928|3966631|P1|STARTED|Overall Study||56
1622604|NCT00876915|3966642|P3|NOT COMPLETED|Overall Study||0
1622605|NCT00876915|3966643|P2|NOT COMPLETED|Overall Study||14
1622606|NCT00876915|3966644|P1|NOT COMPLETED|Overall Study||19
1622607|NCT00876915|3966642|P3|COMPLETED|Overall Study||101
1622608|NCT00876915|3966643|P2|COMPLETED|Overall Study||34
1622609|NCT00876915|3966644|P1|COMPLETED|Overall Study||31
1622610|NCT00876915|3966642|P3|Week 8|Overall Study||0
1622611|NCT00876915|3966643|P2|Week 8|Overall Study||36
1622612|NCT00876915|3966644|P1|Week 8|Overall Study||33
1622613|NCT00876915|3966642|P3|Week 4|Overall Study||0
1622614|NCT00876915|3966643|P2|Week 4|Overall Study||45
1622615|NCT00876915|3966644|P1|Week 4|Overall Study||38
1622616|NCT00876915|3966642|P3|STARTED|Overall Study||101
1622617|NCT00876915|3966643|P2|STARTED|Overall Study||48
1622618|NCT00876915|3966644|P1|STARTED|Overall Study||50
1622619|NCT00876733|3966668|P4|NOT COMPLETED|Overall Study||7
1622620|NCT00876733|3966669|P3|NOT COMPLETED|Overall Study||30
1622621|NCT00876733|3966670|P2|NOT COMPLETED|Overall Study||42
1622622|NCT00876733|3966671|P1|NOT COMPLETED|Overall Study||91
1622623|NCT00876733|3966668|P4|COMPLETED|Overall Study||14
1622624|NCT00876733|3966669|P3|COMPLETED|Overall Study||63
1622625|NCT00876733|3966670|P2|COMPLETED|Overall Study||161
1622626|NCT00876733|3966671|P1|COMPLETED|Overall Study||197
1622627|NCT00876733|3966668|P4|STARTED|Overall Study||21
1622628|NCT00876733|3966669|P3|STARTED|Overall Study||93
1622629|NCT00876733|3966670|P2|STARTED|Overall Study||203
1622630|NCT00876733|3966671|P1|STARTED|Overall Study||288
1622631|NCT00876694|3966779|P2|NOT COMPLETED|Overall Study||12
1622632|NCT00876694|3966780|P1|NOT COMPLETED|Overall Study||21
1622633|NCT00876694|3966779|P2|COMPLETED|Overall Study||49
1622634|NCT00876694|3966780|P1|COMPLETED|Overall Study||104
1622635|NCT00876694|3966779|P2|STARTED|Overall Study||61
1622636|NCT00876694|3966780|P1|STARTED|Overall Study||125
1622637|NCT00876460|3966806|P8|NOT COMPLETED|Mono Therapy Phase||3
1622638|NCT00876460|3966807|P7|NOT COMPLETED|Mono Therapy Phase||1
1622639|NCT00876460|3966808|P6|NOT COMPLETED|Mono Therapy Phase||0
1622640|NCT00876460|3966809|P5|NOT COMPLETED|Mono Therapy Phase||2
1622641|NCT00876460|3966810|P4|NOT COMPLETED|Mono Therapy Phase||1
1622642|NCT00876460|3966811|P3|NOT COMPLETED|Mono Therapy Phase||0
1622643|NCT00876460|3966812|P2|NOT COMPLETED|Mono Therapy Phase||1
1622644|NCT00876460|3966813|P1|NOT COMPLETED|Mono Therapy Phase||0
1622645|NCT00876460|3966806|P8|COMPLETED|Mono Therapy Phase||0
1622646|NCT00876460|3966807|P7|COMPLETED|Mono Therapy Phase||0
1622647|NCT00876460|3966808|P6|COMPLETED|Mono Therapy Phase||0
1622648|NCT00876460|3966809|P5|COMPLETED|Mono Therapy Phase||0
1622649|NCT00876460|3966810|P4|COMPLETED|Mono Therapy Phase||0
1622650|NCT00876460|3966811|P3|COMPLETED|Mono Therapy Phase||0
1622651|NCT00876460|3966812|P2|COMPLETED|Mono Therapy Phase||0
1622652|NCT00876460|3966813|P1|COMPLETED|Mono Therapy Phase||0
1622653|NCT00876460|3966806|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
1622654|NCT00876460|3966807|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
1622655|NCT00876460|3966808|P6|STARTED|Mono Therapy Phase||0
1622656|NCT00876460|3966809|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
1622657|NCT00876460|3966810|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
1622658|NCT00876460|3966811|P3|STARTED|Mono Therapy Phase||0
1622659|NCT00876460|3966812|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
1622660|NCT00876460|3966813|P1|STARTED|Mono Therapy Phase||0
1622661|NCT00876460|3966806|P8|NOT COMPLETED|Combination Therapy Phase||6
1622662|NCT00876460|3966807|P7|NOT COMPLETED|Combination Therapy Phase||8
1622663|NCT00876460|3966808|P6|NOT COMPLETED|Combination Therapy Phase||3
1622664|NCT00876460|3966809|P5|NOT COMPLETED|Combination Therapy Phase||7
1622665|NCT00876460|3966810|P4|NOT COMPLETED|Combination Therapy Phase||6
1622666|NCT00876460|3966811|P3|NOT COMPLETED|Combination Therapy Phase||3
1622667|NCT00876460|3966812|P2|NOT COMPLETED|Combination Therapy Phase||7
1622668|NCT00876460|3966813|P1|NOT COMPLETED|Combination Therapy Phase||3
1622669|NCT00876460|3966806|P8|COMPLETED|Combination Therapy Phase||0
1622670|NCT00876460|3966807|P7|COMPLETED|Combination Therapy Phase||0
1622671|NCT00876460|3966808|P6|COMPLETED|Combination Therapy Phase||0
1622672|NCT00876460|3966809|P5|COMPLETED|Combination Therapy Phase||0
1622673|NCT00876460|3966810|P4|COMPLETED|Combination Therapy Phase||0
1622674|NCT00876460|3966811|P3|COMPLETED|Combination Therapy Phase||0
1622675|NCT00876460|3966812|P2|COMPLETED|Combination Therapy Phase||0
1622676|NCT00876460|3966813|P1|COMPLETED|Combination Therapy Phase||0
1622677|NCT00876460|3966806|P8|STARTED|Combination Therapy Phase||6
1622678|NCT00876460|3966807|P7|STARTED|Combination Therapy Phase||8
1622679|NCT00876460|3966808|P6|STARTED|Combination Therapy Phase||3
1622680|NCT00876460|3966809|P5|STARTED|Combination Therapy Phase||7
1622681|NCT00876460|3966810|P4|STARTED|Combination Therapy Phase||6
1622682|NCT00876460|3966811|P3|STARTED|Combination Therapy Phase||3
1622683|NCT00876460|3966812|P2|STARTED|Combination Therapy Phase||7
1622684|NCT00876460|3966813|P1|STARTED|Combination Therapy Phase||3
1622685|NCT00876447|3966885|P2|NOT COMPLETED|Overall Study||81
1622686|NCT00876447|3966886|P1|NOT COMPLETED|Overall Study||80
1622687|NCT00876447|3966885|P2|COMPLETED|Overall Study||122
1622688|NCT00876447|3966886|P1|COMPLETED|Overall Study||105
1622689|NCT00876447|3966885|P2|STARTED|Overall Study||203
1622690|NCT00876447|3966886|P1|STARTED|Overall Study||185
1622691|NCT00876395|3966946|P2|NOT COMPLETED|Overall Study||239
1622692|NCT00876395|3966947|P1|NOT COMPLETED|Overall Study||480
1622693|NCT00876395|3966946|P2|COMPLETED|Overall Study||0
1622694|NCT00876395|3966947|P1|COMPLETED|Overall Study||0
1622695|NCT00876395|3966946|P2|Untreated|Overall Study||1
1622696|NCT00876395|3966947|P1|Untreated|Overall Study||8
1622697|NCT00876395|3966946|P2|STARTED|Overall Study||239
1622698|NCT00876395|3966947|P1|STARTED|Overall Study||480
1622699|NCT00876343|3966988|P3|NOT COMPLETED|Overall Study||12
1622700|NCT00876343|3966989|P2|NOT COMPLETED|Overall Study||17
1622701|NCT00876343|3966990|P1|NOT COMPLETED|Overall Study||17
1622702|NCT00876343|3966988|P3|COMPLETED|Overall Study||183
1622703|NCT00876343|3966989|P2|COMPLETED|Overall Study||180
1622704|NCT00876343|3966990|P1|COMPLETED|Overall Study||177
1622705|NCT00876343|3966988|P3|STARTED|Overall Study||195
1622706|NCT00876343|3966989|P2|STARTED|Overall Study||197
1622707|NCT00876343|3966990|P1|STARTED|Overall Study||194
1622708|NCT00876265|3967004|P1|NOT COMPLETED|Overall Study||12
1622709|NCT00876265|3967004|P1|COMPLETED|Overall Study||106
1622710|NCT00876265|3967004|P1|STARTED|Overall Study||118
1622711|NCT00876018|3967013|P3|NOT COMPLETED|Overall Study||3
1622712|NCT00876018|3967014|P2|NOT COMPLETED|Overall Study||5
1622713|NCT00876018|3967015|P1|NOT COMPLETED|Overall Study||5
1622714|NCT00876018|3967013|P3|COMPLETED|Overall Study||97
1622715|NCT00876018|3967014|P2|COMPLETED|Overall Study||95
1622716|NCT00876018|3967015|P1|COMPLETED|Overall Study||95
1622717|NCT00876018|3967013|P3|STARTED|Overall Study||100
1622718|NCT00876018|3967014|P2|STARTED|Overall Study||100
1622719|NCT00876018|3967015|P1|STARTED|Overall Study||100
1622720|NCT00875979|3967070|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
1622721|NCT00875979|3967071|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
1622722|NCT00875979|3967070|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
1622723|NCT00875979|3967071|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
1622724|NCT00875979|3967070|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
1622725|NCT00875979|3967071|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
1622726|NCT00875979|3967070|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
1622727|NCT00875979|3967071|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
1622728|NCT00875979|3967070|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
1622729|NCT00875979|3967071|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
1622730|NCT00875979|3967070|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
1622731|NCT00875979|3967071|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
1622732|NCT00875979|3967070|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
1622733|NCT00875979|3967071|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
1622734|NCT00875979|3967070|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
1622735|NCT00875979|3967071|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
1622736|NCT00875979|3967070|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
1622737|NCT00875979|3967071|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
1622738|NCT00875836|3967083|P2|NOT COMPLETED|Overall Study||40
1622739|NCT00875836|3967084|P1|NOT COMPLETED|Overall Study||43
1622740|NCT00875836|3967083|P2|COMPLETED|Overall Study||47
1622741|NCT00875836|3967084|P1|COMPLETED|Overall Study||45
1622742|NCT00875836|3967083|P2|STARTED|Overall Study||87
1622743|NCT00875836|3967084|P1|STARTED|Overall Study||88
1622744|NCT00875810|3967094|P1|NOT COMPLETED|Overall Study||46
1622745|NCT00875810|3967094|P1|COMPLETED|Overall Study||148
1622746|NCT00875810|3967094|P1|24 Months Follow up|Overall Study||148
1622747|NCT00875810|3967094|P1|12 Months Follow up|Overall Study||112
1622748|NCT00875810|3967094|P1|6 Months Follow up|Overall Study||80
1622749|NCT00875810|3967094|P1|3 Months Follow up|Overall Study||175
1622750|NCT00875810|3967094|P1|Discharged|Overall Study||177
1622751|NCT00875810|3967094|P1|Implanted|Overall Study||190
1622752|NCT00875810|3967094|P1|STARTED|Overall Study||194
1622753|NCT00875797|3967103|P2|NOT COMPLETED|Overall Study||3
1622754|NCT00875797|3967104|P1|NOT COMPLETED|Overall Study||6
1622755|NCT00875797|3967103|P2|COMPLETED|Overall Study||42
1622756|NCT00875797|3967104|P1|COMPLETED|Overall Study||39
1622757|NCT00875797|3967103|P2|STARTED|Overall Study||45
1622758|NCT00875797|3967104|P1|STARTED|Overall Study||45
1622759|NCT00875706|3967117|P3|NOT COMPLETED|Overall Study||0
1622760|NCT00875706|3967118|P2|NOT COMPLETED|Overall Study||0
1622761|NCT00875706|3967119|P1|NOT COMPLETED|Overall Study||1
1622762|NCT00875706|3967117|P3|COMPLETED|Overall Study||13
1622763|NCT00875706|3967118|P2|COMPLETED|Overall Study||24
1622764|NCT00875706|3967119|P1|COMPLETED|Overall Study||7
1622765|NCT00875706|3967117|P3|STARTED|Overall Study||13
1622766|NCT00875706|3967118|P2|STARTED|Overall Study||24
1622767|NCT00875706|3967119|P1|STARTED|Overall Study||8
1622768|NCT00875615|3967136|P1|NOT COMPLETED|Overall Study||1
1622769|NCT00875615|3967136|P1|COMPLETED|Overall Study||10
1622770|NCT00875615|3967136|P1|STARTED|Overall Study||11
1622771|NCT00875589|3967143|P2|NOT COMPLETED|Overall Study||0
1622772|NCT00875589|3967144|P1|NOT COMPLETED|Overall Study||0
1622773|NCT00875589|3967143|P2|COMPLETED|Overall Study||11
1622774|NCT00875589|3967144|P1|COMPLETED|Overall Study||15
1622775|NCT00875589|3967143|P2|STARTED|Overall Study||11
1622776|NCT00875589|3967144|P1|STARTED|Overall Study||15
1622777|NCT00875563|3967150|P1|NOT COMPLETED|Overall Study||24
1622778|NCT00875563|3967150|P1|COMPLETED|Overall Study||18
1622779|NCT00875563|3967150|P1|STARTED|Overall Study||42
1622780|NCT00875550|3967156|P2|NOT COMPLETED|Overall Study||10
1622781|NCT00875550|3967157|P1|NOT COMPLETED|Overall Study||12
1622782|NCT00875550|3967156|P2|COMPLETED|Overall Study||76
1622783|NCT00875550|3967157|P1|COMPLETED|Overall Study||77
1622784|NCT00875550|3967156|P2|STARTED|Overall Study||86
1622785|NCT00875550|3967157|P1|STARTED|Overall Study||89
1622786|NCT00875485|3967175|P2|NOT COMPLETED|Challenge Dose Epoch||0
1622787|NCT00875485|3967176|P1|NOT COMPLETED|Challenge Dose Epoch||1
1622788|NCT00875485|3967175|P2|COMPLETED|Challenge Dose Epoch||11
1622789|NCT00875485|3967176|P1|COMPLETED|Challenge Dose Epoch||7
1622790|NCT00875485|3967175|P2|STARTED|Challenge Dose Epoch||11
1622791|NCT00875485|3967176|P1|STARTED|Challenge Dose Epoch||8
1622792|NCT00875485|3967175|P2|NOT COMPLETED|Year 15||0
1622793|NCT00875485|3967176|P1|NOT COMPLETED|Year 15||0
1622794|NCT00875485|3967175|P2|COMPLETED|Year 15||111
1622795|NCT00875485|3967176|P1|COMPLETED|Year 15||98
1622796|NCT00875485|3967175|P2|STARTED|Year 15||111
1622797|NCT00875485|3967176|P1|STARTED|Year 15||98
1622798|NCT00875485|3967175|P2|NOT COMPLETED|Year 14||0
1622799|NCT00875485|3967176|P1|NOT COMPLETED|Year 14||0
1622800|NCT00875485|3967175|P2|COMPLETED|Year 14||113
1622801|NCT00875485|3967176|P1|COMPLETED|Year 14||100
1622802|NCT00875485|3967175|P2|STARTED|Year 14||113
1622803|NCT00875485|3967176|P1|STARTED|Year 14||100
1622804|NCT00875485|3967175|P2|NOT COMPLETED|Year 13||0
1622805|NCT00875485|3967176|P1|NOT COMPLETED|Year 13||0
1622806|NCT00875485|3967175|P2|COMPLETED|Year 13||113
1622807|NCT00875485|3967176|P1|COMPLETED|Year 13||102
1622808|NCT00875485|3967175|P2|STARTED|Year 13||113
1622809|NCT00875485|3967176|P1|STARTED|Year 13||102
1622810|NCT00875485|3967175|P2|NOT COMPLETED|Year 12||0
1622811|NCT00875485|3967176|P1|NOT COMPLETED|Year 12||0
1622812|NCT00875485|3967175|P2|COMPLETED|Year 12||109
1622813|NCT00875485|3967176|P1|COMPLETED|Year 12||101
1622814|NCT00875485|3967175|P2|STARTED|Year 12||109
1622815|NCT00875485|3967176|P1|STARTED|Year 12||101
1622816|NCT00875485|3967175|P2|NOT COMPLETED|Year 11||0
1622817|NCT00875485|3967176|P1|NOT COMPLETED|Year 11||0
1622818|NCT00875485|3967175|P2|COMPLETED|Year 11||111
1622819|NCT00875485|3967176|P1|COMPLETED|Year 11||99
1622820|NCT00875485|3967175|P2|STARTED|Year 11||111
1622821|NCT00875485|3967176|P1|STARTED|Year 11||99
1622822|NCT00875433|3967216|P1|NOT COMPLETED|Overall Study||60
1622823|NCT00875433|3967216|P1|COMPLETED|Overall Study||0
1622824|NCT00875433|3967216|P1|STARTED|Overall Study|Treated|60
1622825|NCT00875420|3967246|P5|NOT COMPLETED|Overall Study||2
1622826|NCT00875420|3967247|P4|NOT COMPLETED|Overall Study||2
1622827|NCT00875420|3967248|P3|NOT COMPLETED|Overall Study||3
1622828|NCT00875420|3967249|P2|NOT COMPLETED|Overall Study||2
1622829|NCT00875420|3967250|P1|NOT COMPLETED|Overall Study||2
1622830|NCT00875420|3967246|P5|COMPLETED|Overall Study||17
1622831|NCT00875420|3967247|P4|COMPLETED|Overall Study||16
1622832|NCT00875420|3967248|P3|COMPLETED|Overall Study||18
1622833|NCT00875420|3967249|P2|COMPLETED|Overall Study||18
1622834|NCT00875420|3967250|P1|COMPLETED|Overall Study||20
1622835|NCT00875420|3967246|P5|STARTED|Overall Study||19
1622836|NCT00875420|3967247|P4|STARTED|Overall Study||18
1622837|NCT00875420|3967248|P3|STARTED|Overall Study||21
1622838|NCT00875420|3967249|P2|STARTED|Overall Study||20
1622839|NCT00875420|3967250|P1|STARTED|Overall Study||22
1622840|NCT00875394|3967280|P3|NOT COMPLETED|Overall Study||0
1622841|NCT00875394|3967281|P2|NOT COMPLETED|Overall Study||0
1622842|NCT00875394|3967282|P1|NOT COMPLETED|Overall Study||0
1622843|NCT00875394|3967280|P3|COMPLETED|Overall Study||9
1622844|NCT00875394|3967281|P2|COMPLETED|Overall Study||23
1622845|NCT00875394|3967282|P1|COMPLETED|Overall Study||36
1622846|NCT00875394|3967280|P3|STARTED|Overall Study||9
1622847|NCT00875394|3967281|P2|STARTED|Overall Study||23
1622848|NCT00875394|3967282|P1|STARTED|Overall Study||36
1622849|NCT00875329|3967290|P1|NOT COMPLETED|Overall Study||0
1622850|NCT00875329|3967290|P1|COMPLETED|Overall Study||97
1622851|NCT00875329|3967290|P1|STARTED|Overall Study||97
1622852|NCT00875212|3967294|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
1622853|NCT00875212|3967294|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
1622854|NCT00875212|3967294|P1|STARTED|CaGP and Fluoride Dentifrice||12
1622855|NCT00875212|3967294|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
1622856|NCT00875212|3967294|P1|COMPLETED|Fluoride Only Dentifrice||12
1622857|NCT00875212|3967294|P1|STARTED|Fluoride Only Dentifrice||12
1622858|NCT00875212|3967294|P1|NOT COMPLETED|CaGP Only Dentifrice||0
1622859|NCT00875212|3967294|P1|COMPLETED|CaGP Only Dentifrice||12
1622860|NCT00875212|3967294|P1|STARTED|CaGP Only Dentifrice||12
1622861|NCT00875212|3967294|P1|NOT COMPLETED|Placebo Dentifrice||0
1622862|NCT00875212|3967294|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
1622863|NCT00875212|3967294|P1|STARTED|Placebo Dentifrice||12
1622864|NCT00875017|3967311|P6|NOT COMPLETED|Fourth Intervention||1
1622865|NCT00875017|3967312|P5|NOT COMPLETED|Fourth Intervention||0
1622866|NCT00875017|3967313|P4|NOT COMPLETED|Fourth Intervention||0
1622867|NCT00875017|3967314|P3|NOT COMPLETED|Fourth Intervention||0
1622868|NCT00875017|3967315|P2|NOT COMPLETED|Fourth Intervention||0
1622869|NCT00875017|3967316|P1|NOT COMPLETED|Fourth Intervention||0
1622870|NCT00875017|3967311|P6|COMPLETED|Fourth Intervention||4
1622871|NCT00875017|3967312|P5|COMPLETED|Fourth Intervention||3
1622872|NCT00875017|3967313|P4|COMPLETED|Fourth Intervention||4
1622873|NCT00875017|3967314|P3|COMPLETED|Fourth Intervention||2
1622874|NCT00875017|3967315|P2|COMPLETED|Fourth Intervention||3
1622875|NCT00875017|3967316|P1|COMPLETED|Fourth Intervention||3
1622876|NCT00875017|3967311|P6|STARTED|Fourth Intervention||5
1622877|NCT00875017|3967312|P5|STARTED|Fourth Intervention||3
1622878|NCT00875017|3967313|P4|STARTED|Fourth Intervention||4
1622879|NCT00875017|3967314|P3|STARTED|Fourth Intervention||2
1622880|NCT00875017|3967315|P2|STARTED|Fourth Intervention||3
1622881|NCT00875017|3967316|P1|STARTED|Fourth Intervention||3
1622882|NCT00875017|3967311|P6|NOT COMPLETED|Washout||0
1622883|NCT00875017|3967312|P5|NOT COMPLETED|Washout||1
1622884|NCT00875017|3967313|P4|NOT COMPLETED|Washout||0
1622885|NCT00875017|3967314|P3|NOT COMPLETED|Washout||0
1622886|NCT00875017|3967315|P2|NOT COMPLETED|Washout||0
1622887|NCT00875017|3967316|P1|NOT COMPLETED|Washout||0
1622888|NCT00875017|3967311|P6|COMPLETED|Washout||5
1622889|NCT00875017|3967312|P5|COMPLETED|Washout||3
1622890|NCT00875017|3967313|P4|COMPLETED|Washout||4
1622891|NCT00875017|3967314|P3|COMPLETED|Washout||2
1622892|NCT00875017|3967315|P2|COMPLETED|Washout||3
1622893|NCT00875017|3967316|P1|COMPLETED|Washout||3
1622894|NCT00875017|3967311|P6|STARTED|Washout||5
1622895|NCT00875017|3967312|P5|STARTED|Washout||4
1622896|NCT00875017|3967313|P4|STARTED|Washout||4
1622897|NCT00875017|3967314|P3|STARTED|Washout||2
1622898|NCT00875017|3967315|P2|STARTED|Washout||3
1622899|NCT00875017|3967316|P1|STARTED|Washout||3
1622900|NCT00875017|3967311|P6|NOT COMPLETED|Third Intervention||0
1622901|NCT00875017|3967312|P5|NOT COMPLETED|Third Intervention||0
1622902|NCT00875017|3967313|P4|NOT COMPLETED|Third Intervention||0
1622903|NCT00875017|3967314|P3|NOT COMPLETED|Third Intervention||1
1622904|NCT00875017|3967315|P2|NOT COMPLETED|Third Intervention||1
1622905|NCT00875017|3967316|P1|NOT COMPLETED|Third Intervention||0
1622906|NCT00875017|3967311|P6|COMPLETED|Third Intervention||5
1622907|NCT00875017|3967312|P5|COMPLETED|Third Intervention||4
1622908|NCT00875017|3967313|P4|COMPLETED|Third Intervention||4
1622909|NCT00875017|3967314|P3|COMPLETED|Third Intervention||2
1622910|NCT00875017|3967315|P2|COMPLETED|Third Intervention||3
1622911|NCT00875017|3967316|P1|COMPLETED|Third Intervention||3
1622912|NCT00875017|3967311|P6|STARTED|Third Intervention||5
1622913|NCT00875017|3967312|P5|STARTED|Third Intervention||4
1622914|NCT00875017|3967313|P4|STARTED|Third Intervention||4
1622915|NCT00875017|3967314|P3|STARTED|Third Intervention||3
1622916|NCT00875017|3967315|P2|STARTED|Third Intervention||4
1622917|NCT00875017|3967316|P1|STARTED|Third Intervention||3
1622918|NCT00875017|3967311|P6|NOT COMPLETED|Washout||0
1622919|NCT00875017|3967312|P5|NOT COMPLETED|Washout||0
1622920|NCT00875017|3967313|P4|NOT COMPLETED|Washout||0
1622921|NCT00875017|3967314|P3|NOT COMPLETED|Washout||0
1622922|NCT00875017|3967315|P2|NOT COMPLETED|Washout||1
1622923|NCT00875017|3967316|P1|NOT COMPLETED|Washout||0
1622924|NCT00875017|3967311|P6|COMPLETED|Washout||5
1622925|NCT00875017|3967312|P5|COMPLETED|Washout||4
1622926|NCT00875017|3967313|P4|COMPLETED|Washout||4
1622927|NCT00875017|3967314|P3|COMPLETED|Washout||3
1622928|NCT00875017|3967315|P2|COMPLETED|Washout||4
1622929|NCT00875017|3967316|P1|COMPLETED|Washout||3
1622930|NCT00875017|3967311|P6|STARTED|Washout||5
1622931|NCT00875017|3967312|P5|STARTED|Washout||4
1622932|NCT00875017|3967313|P4|STARTED|Washout||4
1622933|NCT00875017|3967314|P3|STARTED|Washout||3
1622934|NCT00875017|3967315|P2|STARTED|Washout||5
1622935|NCT00875017|3967316|P1|STARTED|Washout||3
1622936|NCT00875017|3967311|P6|NOT COMPLETED|Second Intervention||0
1622937|NCT00875017|3967312|P5|NOT COMPLETED|Second Intervention||0
1622938|NCT00875017|3967313|P4|NOT COMPLETED|Second Intervention||1
1622939|NCT00875017|3967314|P3|NOT COMPLETED|Second Intervention||0
1622940|NCT00875017|3967315|P2|NOT COMPLETED|Second Intervention||0
1622941|NCT00875017|3967316|P1|NOT COMPLETED|Second Intervention||0
1622942|NCT00875017|3967311|P6|COMPLETED|Second Intervention||5
1622943|NCT00875017|3967312|P5|COMPLETED|Second Intervention||4
1622944|NCT00875017|3967313|P4|COMPLETED|Second Intervention||4
1622945|NCT00875017|3967314|P3|COMPLETED|Second Intervention||3
1622946|NCT00875017|3967315|P2|COMPLETED|Second Intervention||5
1622947|NCT00875017|3967316|P1|COMPLETED|Second Intervention||3
1622948|NCT00875017|3967311|P6|STARTED|Second Intervention||5
1622949|NCT00875017|3967312|P5|STARTED|Second Intervention||4
1622950|NCT00875017|3967313|P4|STARTED|Second Intervention||5
1622951|NCT00875017|3967314|P3|STARTED|Second Intervention||3
1622952|NCT00875017|3967315|P2|STARTED|Second Intervention||5
1622953|NCT00875017|3967316|P1|STARTED|Second Intervention||3
1622954|NCT00875017|3967311|P6|NOT COMPLETED|Washout||0
1622955|NCT00875017|3967312|P5|NOT COMPLETED|Washout||0
1622956|NCT00875017|3967313|P4|NOT COMPLETED|Washout||0
1622957|NCT00875017|3967314|P3|NOT COMPLETED|Washout||1
1622958|NCT00875017|3967315|P2|NOT COMPLETED|Washout||0
1622959|NCT00875017|3967316|P1|NOT COMPLETED|Washout||0
1622960|NCT00875017|3967311|P6|COMPLETED|Washout||5
1622961|NCT00875017|3967312|P5|COMPLETED|Washout||4
1622962|NCT00875017|3967313|P4|COMPLETED|Washout||5
1622963|NCT00875017|3967314|P3|COMPLETED|Washout||3
1622964|NCT00875017|3967315|P2|COMPLETED|Washout||5
1622965|NCT00875017|3967316|P1|COMPLETED|Washout||3
1622966|NCT00875017|3967311|P6|STARTED|Washout||5
1622967|NCT00875017|3967312|P5|STARTED|Washout||4
1622968|NCT00875017|3967313|P4|STARTED|Washout||5
1622969|NCT00875017|3967314|P3|STARTED|Washout||4
1622970|NCT00875017|3967315|P2|STARTED|Washout||5
1622971|NCT00875017|3967316|P1|STARTED|Washout||3
1622972|NCT00875017|3967311|P6|NOT COMPLETED|First Intervention||0
1622973|NCT00875017|3967312|P5|NOT COMPLETED|First Intervention||1
1622974|NCT00875017|3967313|P4|NOT COMPLETED|First Intervention||1
1622975|NCT00875017|3967314|P3|NOT COMPLETED|First Intervention||1
1622976|NCT00875017|3967315|P2|NOT COMPLETED|First Intervention||0
1622977|NCT00875017|3967316|P1|NOT COMPLETED|First Intervention||2
1622978|NCT00875017|3967311|P6|COMPLETED|First Intervention||5
1622979|NCT00875017|3967312|P5|COMPLETED|First Intervention||4
1622980|NCT00875017|3967313|P4|COMPLETED|First Intervention||5
1622981|NCT00875017|3967314|P3|COMPLETED|First Intervention||4
1622982|NCT00875017|3967315|P2|COMPLETED|First Intervention||5
1622983|NCT00875017|3967316|P1|COMPLETED|First Intervention||3
1622984|NCT00875017|3967311|P6|STARTED|First Intervention||5
1622985|NCT00875017|3967312|P5|STARTED|First Intervention||5
1622986|NCT00875017|3967313|P4|STARTED|First Intervention||6
1622987|NCT00875017|3967314|P3|STARTED|First Intervention||5
1622988|NCT00875017|3967315|P2|STARTED|First Intervention||5
1622989|NCT00875017|3967316|P1|STARTED|First Intervention||5
1622990|NCT00874939|3967330|P1|NOT COMPLETED|Overall Study||4
1622991|NCT00874939|3967330|P1|COMPLETED|Overall Study||0
1622992|NCT00874939|3967330|P1|Treated|Overall Study||0
1622993|NCT00874939|3967330|P1|STARTED|Overall Study||4
1622994|NCT00874887|3967346|P2|NOT COMPLETED|Overall Study||0
1622995|NCT00874887|3967347|P1|NOT COMPLETED|Overall Study||0
1622996|NCT00874887|3967346|P2|COMPLETED|Overall Study||34
1622997|NCT00874887|3967347|P1|COMPLETED|Overall Study||32
1622998|NCT00874887|3967346|P2|STARTED|Overall Study||34
1622999|NCT00874887|3967347|P1|STARTED|Overall Study||32
1623000|NCT00874848|3967363|P2|NOT COMPLETED|Overall Study||28
1623001|NCT00874848|3967364|P1|NOT COMPLETED|Overall Study||59
1623002|NCT00874848|3967363|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
1623003|NCT00874848|3967364|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
1623004|NCT00874848|3967363|P2|Discontinued|Overall Study||28
1623005|NCT00874848|3967364|P1|Discontinued|Overall Study||59
1623006|NCT00874848|3967363|P2|STARTED|Overall Study||29
1623007|NCT00874848|3967364|P1|STARTED|Overall Study||59
1623008|NCT00874822|3967380|P1|NOT COMPLETED|Overall Study||8
1623009|NCT00874822|3967380|P1|COMPLETED|Overall Study||208
1623010|NCT00874822|3967380|P1|STARTED|Overall Study||216
1623011|NCT00874770|3967388|P4|NOT COMPLETED|Overall Study||5
1623012|NCT00874770|3967389|P3|NOT COMPLETED|Overall Study||4
1623013|NCT00874770|3967390|P2|NOT COMPLETED|Overall Study||1
1623014|NCT00874770|3967391|P1|NOT COMPLETED|Overall Study||5
1623015|NCT00874770|3967388|P4|COMPLETED|Overall Study||7
1623016|NCT00874770|3967389|P3|COMPLETED|Overall Study||8
1623017|NCT00874770|3967390|P2|COMPLETED|Overall Study||11
1623018|NCT00874770|3967391|P1|COMPLETED|Overall Study||7
1623019|NCT00874770|3967388|P4|STARTED|Overall Study||12
1623020|NCT00874770|3967389|P3|STARTED|Overall Study||12
1623021|NCT00874770|3967390|P2|STARTED|Overall Study||12
1623022|NCT00874770|3967391|P1|STARTED|Overall Study||12
1623023|NCT00874614|3967425|P1|NOT COMPLETED|Overall Study||58
1623024|NCT00874614|3967425|P1|COMPLETED|Overall Study|As of December 2017|16
1623025|NCT00874614|3967425|P1|Received Two Therapeutic Doses|Overall Study||50
1623026|NCT00874614|3967425|P1|Received at Least One Therapeutic Dose|Overall Study||68
1623027|NCT00874614|3967425|P1|STARTED|Overall Study||74
1623028|NCT00874549|3967437|P4|NOT COMPLETED|Overall Study||2
1623029|NCT00874549|3967438|P3|NOT COMPLETED|Overall Study||4
1623030|NCT00874549|3967439|P2|NOT COMPLETED|Overall Study||1
1623031|NCT00874549|3967440|P1|NOT COMPLETED|Overall Study||1
1623032|NCT00874549|3967437|P4|COMPLETED|Overall Study||56
1623033|NCT00874549|3967438|P3|COMPLETED|Overall Study||47
1623034|NCT00874549|3967439|P2|COMPLETED|Overall Study||55
1623035|NCT00874549|3967440|P1|COMPLETED|Overall Study||50
1623036|NCT00874549|3967437|P4|STARTED|Overall Study||58
1623037|NCT00874549|3967438|P3|STARTED|Overall Study||51
1623038|NCT00874549|3967439|P2|STARTED|Overall Study||56
1623039|NCT00874549|3967440|P1|STARTED|Overall Study||51
1623040|NCT00874510|3967508|P2|NOT COMPLETED|Year 2||0
1623041|NCT00874510|3967509|P1|NOT COMPLETED|Year 2||0
1623042|NCT00874510|3967508|P2|COMPLETED|Year 2||87
1623043|NCT00874510|3967509|P1|COMPLETED|Year 2||92
1623044|NCT00874510|3967508|P2|STARTED|Year 2||87
1623045|NCT00874510|3967509|P1|STARTED|Year 2||92
1623046|NCT00874510|3967508|P2|NOT COMPLETED|Year 1||0
1623047|NCT00874510|3967509|P1|NOT COMPLETED|Year 1||0
1623048|NCT00874510|3967508|P2|COMPLETED|Year 1||85
1623049|NCT00874510|3967509|P1|COMPLETED|Year 1||88
1623050|NCT00874510|3967508|P2|STARTED|Year 1||85
1623051|NCT00874510|3967509|P1|STARTED|Year 1||88
1623052|NCT00874497|3967517|P2|NOT COMPLETED|Overall Study||18
1623053|NCT00874497|3967518|P1|NOT COMPLETED|Overall Study||28
1623054|NCT00874497|3967517|P2|COMPLETED|Overall Study||15
1623055|NCT00874497|3967518|P1|COMPLETED|Overall Study||23
1623056|NCT00874497|3967517|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
1623057|NCT00874497|3967518|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
1623058|NCT00874276|3967558|P2|NOT COMPLETED|Overall Study||1
1623059|NCT00874276|3967559|P1|NOT COMPLETED|Overall Study||1
1623060|NCT00874276|3967558|P2|COMPLETED|Overall Study||7
1623061|NCT00874276|3967559|P1|COMPLETED|Overall Study||5
1623062|NCT00874276|3967558|P2|STARTED|Overall Study||8
1623063|NCT00874276|3967559|P1|STARTED|Overall Study||6
1623064|NCT00874250|3967567|P1|NOT COMPLETED|Overall Study||51
1623065|NCT00874250|3967567|P1|COMPLETED|Overall Study||0
1623066|NCT00874250|3967567|P1|STARTED|Overall Study||51
1623067|NCT00874120|3967581|P2|NOT COMPLETED|Second Intervention||0
1623068|NCT00874120|3967582|P1|NOT COMPLETED|Second Intervention||2
1623069|NCT00874120|3967581|P2|COMPLETED|Second Intervention||56
1623070|NCT00874120|3967582|P1|COMPLETED|Second Intervention||50
1623071|NCT00874120|3967581|P2|STARTED|Second Intervention||56
1623072|NCT00874120|3967582|P1|STARTED|Second Intervention||52
1623073|NCT00874120|3967581|P2|NOT COMPLETED|Wash-out Period||0
1623074|NCT00874120|3967582|P1|NOT COMPLETED|Wash-out Period||0
1623075|NCT00874120|3967581|P2|COMPLETED|Wash-out Period||56
1623076|NCT00874120|3967582|P1|COMPLETED|Wash-out Period||52
1623077|NCT00874120|3967581|P2|STARTED|Wash-out Period||56
1623078|NCT00874120|3967582|P1|STARTED|Wash-out Period||52
1623079|NCT00874120|3967581|P2|NOT COMPLETED|First Intervention||2
1623080|NCT00874120|3967582|P1|NOT COMPLETED|First Intervention||6
1623081|NCT00874120|3967581|P2|COMPLETED|First Intervention||56
1623082|NCT00874120|3967582|P1|COMPLETED|First Intervention||52
1623083|NCT00874120|3967581|P2|STARTED|First Intervention||58
1623084|NCT00874120|3967582|P1|STARTED|First Intervention||58
1623085|NCT00874094|3967588|P1|NOT COMPLETED|Overall Study||0
1623086|NCT00874094|3967588|P1|COMPLETED|Overall Study||15
1623087|NCT00874094|3967588|P1|STARTED|Overall Study||15
1623088|NCT00874029|3967595|P1|NOT COMPLETED|Overall Study||21
1623089|NCT00874029|3967595|P1|COMPLETED|Overall Study||116
1623090|NCT00874029|3967595|P1|STARTED|Overall Study||137
1623091|NCT00873912|3967611|P2|NOT COMPLETED|Overall Study||0
1623092|NCT00873912|3967612|P1|NOT COMPLETED|Overall Study||3
1623093|NCT00873912|3967611|P2|COMPLETED|Overall Study||60
1623094|NCT00873912|3967612|P1|COMPLETED|Overall Study||237
1623095|NCT00873912|3967611|P2|STARTED|Overall Study||60
1623096|NCT00873912|3967612|P1|STARTED|Overall Study||240
1623097|NCT00873873|3967630|P4|NOT COMPLETED|Overall Study||0
1623098|NCT00873873|3967631|P3|NOT COMPLETED|Overall Study||0
1623099|NCT00873873|3967632|P2|NOT COMPLETED|Overall Study||0
1623100|NCT00873873|3967633|P1|NOT COMPLETED|Overall Study||0
1623101|NCT00873873|3967630|P4|COMPLETED|Overall Study||18
1623102|NCT00873873|3967631|P3|COMPLETED|Overall Study||9
1623103|NCT00873873|3967632|P2|COMPLETED|Overall Study||8
1623104|NCT00873873|3967633|P1|COMPLETED|Overall Study||20
1623105|NCT00873873|3967630|P4|STARTED|Overall Study||18
1623106|NCT00873873|3967631|P3|STARTED|Overall Study||9
1623107|NCT00873873|3967632|P2|STARTED|Overall Study||8
1623108|NCT00873873|3967633|P1|STARTED|Overall Study||20
1623109|NCT00873860|3967651|P4|NOT COMPLETED|Overall Study||1
1623110|NCT00873860|3967652|P3|NOT COMPLETED|Overall Study||3
1623111|NCT00873860|3967653|P2|NOT COMPLETED|Overall Study||0
1623112|NCT00873860|3967654|P1|NOT COMPLETED|Overall Study||4
1623113|NCT00873860|3967651|P4|COMPLETED|Overall Study||47
1623114|NCT00873860|3967652|P3|COMPLETED|Overall Study||48
1623115|NCT00873860|3967653|P2|COMPLETED|Overall Study||47
1623116|NCT00873860|3967654|P1|COMPLETED|Overall Study||44
1623117|NCT00873860|3967651|P4|Treated|Overall Study||48
1623118|NCT00873860|3967652|P3|Treated|Overall Study||51
1623119|NCT00873860|3967653|P2|Treated|Overall Study||47
1623120|NCT00873860|3967654|P1|Treated|Overall Study||47
1623121|NCT00873860|3967651|P4|STARTED|Overall Study||48
1623122|NCT00873860|3967652|P3|STARTED|Overall Study||51
1623123|NCT00873860|3967653|P2|STARTED|Overall Study||47
1623124|NCT00873860|3967654|P1|STARTED|Overall Study||48
1623125|NCT00873821|3967725|P2|NOT COMPLETED|Overall Study||0
1623126|NCT00873821|3967726|P1|NOT COMPLETED|Overall Study||0
1623127|NCT00873821|3967725|P2|COMPLETED|Overall Study||22
1623128|NCT00873821|3967726|P1|COMPLETED|Overall Study||22
1623129|NCT00873821|3967725|P2|STARTED|Overall Study||22
1623130|NCT00873821|3967726|P1|STARTED|Overall Study||22
1623131|NCT00873782|3967736|P1|NOT COMPLETED|Overall Study||0
1623132|NCT00873782|3967736|P1|COMPLETED|Overall Study||16
1623133|NCT00873782|3967736|P1|STARTED|Overall Study||16
1623134|NCT00873730|3967742|P2|NOT COMPLETED|Overall Study||5
1623135|NCT00873730|3967743|P1|NOT COMPLETED|Overall Study||6
1623136|NCT00873730|3967742|P2|COMPLETED|Overall Study||49
1623137|NCT00873730|3967743|P1|COMPLETED|Overall Study||48
1623138|NCT00873730|3967742|P2|STARTED|Overall Study||54
1623139|NCT00873730|3967743|P1|STARTED|Overall Study||54
1623140|NCT00873457|3967779|P1|NOT COMPLETED|Overall Study||0
1623141|NCT00873457|3967779|P1|COMPLETED|Overall Study||16
1623142|NCT00873457|3967779|P1|STARTED|Overall Study||16
1623143|NCT00873366|3967786|P1|NOT COMPLETED|Overall Study||6
1623144|NCT00873366|3967786|P1|COMPLETED|Overall Study||71
1623145|NCT00873366|3967786|P1|STARTED|Overall Study||77
1623146|NCT00873327|3967805|P1|NOT COMPLETED|Overall Study||0
1623147|NCT00873327|3967805|P1|COMPLETED|Overall Study||32
1623148|NCT00873327|3967805|P1|STARTED|Overall Study||32
1623149|NCT00873119|3967811|P2|NOT COMPLETED|Overall Study||26
1623150|NCT00873119|3967812|P1|NOT COMPLETED|Overall Study||44
1623151|NCT00873119|3967811|P2|COMPLETED|Overall Study||19
1623152|NCT00873119|3967812|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
1623153|NCT00873119|3967811|P2|STARTED|Overall Study||45
1623154|NCT00873119|3967812|P1|STARTED|Overall Study||44
1623155|NCT00873093|3967833|P5|NOT COMPLETED|Overall Study||2
1623156|NCT00873093|3967834|P4|NOT COMPLETED|Overall Study||11
1623157|NCT00873093|3967835|P3|NOT COMPLETED|Overall Study||16
1623158|NCT00873093|3967836|P2|NOT COMPLETED|Overall Study||27
1623159|NCT00873093|3967837|P1|NOT COMPLETED|Overall Study||1
1623160|NCT00873093|3967833|P5|COMPLETED|Overall Study||8
1623161|NCT00873093|3967834|P4|COMPLETED|Overall Study||12
1623162|NCT00873093|3967835|P3|COMPLETED|Overall Study||33
1623163|NCT00873093|3967836|P2|COMPLETED|Overall Study||35
1623164|NCT00873093|3967837|P1|COMPLETED|Overall Study||3
1623165|NCT00873093|3967833|P5|STARTED|Overall Study||10
1623166|NCT00873093|3967834|P4|STARTED|Overall Study||23
1623167|NCT00873093|3967835|P3|STARTED|Overall Study||49
1623168|NCT00873093|3967836|P2|STARTED|Overall Study||62
1623169|NCT00873093|3967837|P1|STARTED|Overall Study||4
1623170|NCT00873041|3967894|P3|NOT COMPLETED|Extension Study||2
1623171|NCT00873041|3967895|P2|NOT COMPLETED|Extension Study||0
1623172|NCT00873041|3967896|P1|NOT COMPLETED|Extension Study||1
1623173|NCT00873041|3967894|P3|COMPLETED|Extension Study||46
1623174|NCT00873041|3967895|P2|COMPLETED|Extension Study||44
1623175|NCT00873041|3967896|P1|COMPLETED|Extension Study||40
1623176|NCT00873041|3967894|P3|STARTED|Extension Study||48
1623177|NCT00873041|3967895|P2|STARTED|Extension Study||44
1623178|NCT00873041|3967896|P1|STARTED|Extension Study||41
1623179|NCT00873041|3967894|P3|NOT COMPLETED|Core Study||5
1623180|NCT00873041|3967895|P2|NOT COMPLETED|Core Study||6
1623181|NCT00873041|3967896|P1|NOT COMPLETED|Core Study||7
1623182|NCT00873041|3967894|P3|COMPLETED|Core Study||51
1623183|NCT00873041|3967895|P2|COMPLETED|Core Study||49
1623184|NCT00873041|3967896|P1|COMPLETED|Core Study||48
1623185|NCT00873041|3967894|P3|STARTED|Core Study||56
1623186|NCT00873041|3967895|P2|STARTED|Core Study||55
1623187|NCT00873041|3967896|P1|STARTED|Core Study||55
1623188|NCT00873015|3967954|P4|NOT COMPLETED|Overall Study||0
1623189|NCT00873015|3967955|P3|NOT COMPLETED|Overall Study||0
1623190|NCT00873015|3967956|P2|NOT COMPLETED|Overall Study||1
1623191|NCT00873015|3967957|P1|NOT COMPLETED|Overall Study||0
1623192|NCT00873015|3967954|P4|COMPLETED|Overall Study||3
1623193|NCT00873015|3967955|P3|COMPLETED|Overall Study||3
1623194|NCT00873015|3967956|P2|COMPLETED|Overall Study||3
1623195|NCT00873015|3967957|P1|COMPLETED|Overall Study||9
1623196|NCT00873015|3967954|P4|STARTED|Overall Study||3
1623197|NCT00873015|3967955|P3|STARTED|Overall Study||3
1623198|NCT00873015|3967956|P2|STARTED|Overall Study||4
1623199|NCT00873015|3967957|P1|STARTED|Overall Study||9
1623200|NCT00872989|3967966|P2|NOT COMPLETED|Overall Study||63
1623201|NCT00872989|3967967|P1|NOT COMPLETED|Overall Study||65
1623202|NCT00872989|3967966|P2|COMPLETED|Overall Study||0
1623203|NCT00872989|3967967|P1|COMPLETED|Overall Study||1
1623204|NCT00872989|3967966|P2|STARTED|Overall Study||63
1623205|NCT00872989|3967967|P1|STARTED|Overall Study||66
1623206|NCT00872898|3967986|P2|NOT COMPLETED|Part Two - Double Blind||6
1623207|NCT00872898|3967987|P1|NOT COMPLETED|Part Two - Double Blind||11
1623208|NCT00872898|3967986|P2|COMPLETED|Part Two - Double Blind||54
1623209|NCT00872898|3967987|P1|COMPLETED|Part Two - Double Blind||50
1623210|NCT00872898|3967986|P2|STARTED|Part Two - Double Blind||60
1623211|NCT00872898|3967987|P1|STARTED|Part Two - Double Blind||61
1623212|NCT00872898|3967986|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
1623213|NCT00872898|3967987|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
1623214|NCT00872898|3967986|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
1623215|NCT00872898|3967987|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
1623216|NCT00872898|3967986|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
1623217|NCT00872898|3967987|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
1623218|NCT00872833|3968021|P2|NOT COMPLETED|Overall Study||0
1623219|NCT00872833|3968022|P1|NOT COMPLETED|Overall Study||0
1623220|NCT00872833|3968021|P2|COMPLETED|Overall Study||17
1623221|NCT00872833|3968022|P1|COMPLETED|Overall Study||15
1623222|NCT00872833|3968021|P2|STARTED|Overall Study||17
1623223|NCT00872833|3968022|P1|STARTED|Overall Study||15
1623224|NCT00872729|3968031|P1|NOT COMPLETED|Overall Study||0
1623225|NCT00872729|3968031|P1|COMPLETED|Overall Study||9
1623226|NCT00872729|3968031|P1|STARTED|Overall Study||9
1623227|NCT00872599|3968061|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
1623228|NCT00872599|3968062|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
1623229|NCT00872599|3968061|P2|COMPLETED|Second Drug During High Salt Intake||16
1623230|NCT00872599|3968062|P1|COMPLETED|Second Drug During High Salt Intake||15
1623231|NCT00872599|3968061|P2|STARTED|Second Drug During High Salt Intake||16
1623232|NCT00872599|3968062|P1|STARTED|Second Drug During High Salt Intake||15
1623233|NCT00872599|3968061|P2|NOT COMPLETED|Second Washout Period||1
1623234|NCT00872599|3968062|P1|NOT COMPLETED|Second Washout Period||1
1623235|NCT00872599|3968061|P2|COMPLETED|Second Washout Period||16
1623236|NCT00872599|3968062|P1|COMPLETED|Second Washout Period||15
1623237|NCT00872599|3968061|P2|STARTED|Second Washout Period||17
1623238|NCT00872599|3968062|P1|STARTED|Second Washout Period||16
1623239|NCT00872599|3968061|P2|NOT COMPLETED|First Drug During High Salt Intake||0
1623240|NCT00872599|3968062|P1|NOT COMPLETED|First Drug During High Salt Intake||0
1623241|NCT00872599|3968061|P2|COMPLETED|First Drug During High Salt Intake||17
1623242|NCT00872599|3968062|P1|COMPLETED|First Drug During High Salt Intake||16
1623243|NCT00872599|3968061|P2|STARTED|First Drug During High Salt Intake||17
1623244|NCT00872599|3968062|P1|STARTED|First Drug During High Salt Intake||16
1623245|NCT00872599|3968061|P2|NOT COMPLETED|First Washout Period After Low Salt||0
1623246|NCT00872599|3968062|P1|NOT COMPLETED|First Washout Period After Low Salt||0
1623247|NCT00872599|3968061|P2|COMPLETED|First Washout Period After Low Salt||17
1623248|NCT00872599|3968062|P1|COMPLETED|First Washout Period After Low Salt||16
1623249|NCT00872599|3968061|P2|STARTED|First Washout Period After Low Salt||17
1623250|NCT00872599|3968062|P1|STARTED|First Washout Period After Low Salt||16
1623251|NCT00872534|3968072|P2|NOT COMPLETED|Overall Study||3
1623252|NCT00872534|3968073|P1|NOT COMPLETED|Overall Study||3
1623253|NCT00872534|3968072|P2|COMPLETED|Overall Study||101
1623254|NCT00872534|3968073|P1|COMPLETED|Overall Study||97
1623255|NCT00872534|3968072|P2|STARTED|Overall Study||104
1623256|NCT00872534|3968073|P1|STARTED|Overall Study||100
1623257|NCT00872521|3968082|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
1623258|NCT00872521|3968083|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
1623259|NCT00872521|3968084|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
1623260|NCT00872521|3968082|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
1623261|NCT00872521|3968083|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
1623262|NCT00872521|3968084|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
1623263|NCT00872521|3968082|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
1623264|NCT00872521|3968083|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
1623265|NCT00872521|3968084|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
1623266|NCT00872521|3968082|P3|NOT COMPLETED|Completed 3-month Follow up||0
1623267|NCT00872521|3968083|P2|NOT COMPLETED|Completed 3-month Follow up||3
1623268|NCT00872521|3968084|P1|NOT COMPLETED|Completed 3-month Follow up||0
1623269|NCT00872521|3968082|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
1623270|NCT00872521|3968083|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
1623271|NCT00872521|3968084|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
1623272|NCT00872521|3968082|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
1623273|NCT00872521|3968083|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
1623274|NCT00872521|3968084|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
1623275|NCT00872521|3968082|P3|NOT COMPLETED|Primary Endpoint Analysis||1
1623276|NCT00872521|3968083|P2|NOT COMPLETED|Primary Endpoint Analysis||5
1623277|NCT00872521|3968084|P1|NOT COMPLETED|Primary Endpoint Analysis||1
1623278|NCT00872521|3968082|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
1623279|NCT00872521|3968083|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
1623280|NCT00872521|3968084|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
1623281|NCT00872521|3968082|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
1623282|NCT00872521|3968083|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
1623283|NCT00872521|3968084|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
1623284|NCT00872521|3968082|P3|NOT COMPLETED|Completed PAD Induction||0
1623285|NCT00872521|3968083|P2|NOT COMPLETED|Completed PAD Induction||4
1623286|NCT00872521|3968084|P1|NOT COMPLETED|Completed PAD Induction||5
1623287|NCT00872521|3968082|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
1623288|NCT00872521|3968083|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
1623289|NCT00872521|3968084|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
1623290|NCT00872521|3968082|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
1623291|NCT00872521|3968083|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
1623292|NCT00872521|3968084|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
1623293|NCT00872430|3968132|P2|NOT COMPLETED|Second Intervention||0
1623294|NCT00872430|3968133|P1|NOT COMPLETED|Second Intervention||0
1623295|NCT00872430|3968132|P2|COMPLETED|Second Intervention||10
1623296|NCT00872430|3968133|P1|COMPLETED|Second Intervention||10
1623297|NCT00872430|3968132|P2|STARTED|Second Intervention||10
1623298|NCT00872430|3968133|P1|STARTED|Second Intervention||10
1623299|NCT00872430|3968132|P2|NOT COMPLETED|Washout Period||0
1623300|NCT00872430|3968133|P1|NOT COMPLETED|Washout Period||0
1623301|NCT00872430|3968132|P2|COMPLETED|Washout Period||10
1623302|NCT00872430|3968133|P1|COMPLETED|Washout Period||10
1623303|NCT00872430|3968132|P2|STARTED|Washout Period||10
1623304|NCT00872430|3968133|P1|STARTED|Washout Period||10
1623305|NCT00872430|3968132|P2|NOT COMPLETED|First Intervention||0
1623306|NCT00872430|3968133|P1|NOT COMPLETED|First Intervention||0
1623307|NCT00872430|3968132|P2|COMPLETED|First Intervention||10
1623308|NCT00872430|3968133|P1|COMPLETED|First Intervention||10
1623309|NCT00872430|3968132|P2|STARTED|First Intervention||10
1623310|NCT00872430|3968133|P1|STARTED|First Intervention||10
1623311|NCT00872339|3968142|P3|NOT COMPLETED|Overall Study||0
1623312|NCT00872339|3968143|P2|NOT COMPLETED|Overall Study||0
1623313|NCT00872339|3968144|P1|NOT COMPLETED|Overall Study||0
1623314|NCT00872339|3968142|P3|COMPLETED|Overall Study||37
1623315|NCT00872339|3968143|P2|COMPLETED|Overall Study||14
1623316|NCT00872339|3968144|P1|COMPLETED|Overall Study||201
1623317|NCT00872339|3968142|P3|STARTED|Overall Study||37
1623318|NCT00872339|3968143|P2|STARTED|Overall Study||14
1623319|NCT00872339|3968144|P1|STARTED|Overall Study||201
1623320|NCT00872170|3968155|P2|NOT COMPLETED|Overall Study||0
1623321|NCT00872170|3968156|P1|NOT COMPLETED|Overall Study||1
1623322|NCT00872170|3968155|P2|COMPLETED|Overall Study||13
1623323|NCT00872170|3968156|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
1623324|NCT00872170|3968155|P2|STARTED|Overall Study||13
1623325|NCT00872170|3968156|P1|STARTED|Overall Study||14
1623326|NCT00872079|3968171|P1|NOT COMPLETED|Overall Study||0
1623327|NCT00872079|3968171|P1|COMPLETED|Overall Study||175
1623328|NCT00872079|3968171|P1|STARTED|Overall Study||175
1623329|NCT00872027|3968177|P2|NOT COMPLETED|Overall Study||0
1623330|NCT00872027|3968178|P1|NOT COMPLETED|Overall Study||0
1623331|NCT00872027|3968177|P2|COMPLETED|Overall Study||8
1623332|NCT00872027|3968178|P1|COMPLETED|Overall Study||7
1623333|NCT00872027|3968177|P2|STARTED|Overall Study||8
1623334|NCT00872027|3968178|P1|STARTED|Overall Study||7
1623335|NCT00872001|3968186|P2|NOT COMPLETED|Overall Study||131
1623336|NCT00872001|3968187|P1|NOT COMPLETED|Overall Study||136
1623337|NCT00872001|3968186|P2|COMPLETED|Overall Study||1413
1623338|NCT00872001|3968187|P1|COMPLETED|Overall Study||1400
1623339|NCT00872001|3968186|P2|STARTED|Overall Study||1544
1623340|NCT00872001|3968187|P1|STARTED|Overall Study||1536
1623341|NCT00871975|3968195|P1|NOT COMPLETED|Overall Study||22
1623342|NCT00871975|3968195|P1|COMPLETED|Overall Study||133
1623343|NCT00871975|3968195|P1|STARTED|Overall Study||155
1623344|NCT00871871|3968201|P4|NOT COMPLETED|Part II||4
1623345|NCT00871871|3968202|P3|NOT COMPLETED|Part II||4
1623346|NCT00871871|3968203|P2|NOT COMPLETED|Part II||0
1623347|NCT00871871|3968204|P1|NOT COMPLETED|Part II||0
1623348|NCT00871871|3968201|P4|COMPLETED|Part II||11
1623349|NCT00871871|3968202|P3|COMPLETED|Part II||9
1623350|NCT00871871|3968203|P2|COMPLETED|Part II||0
1623351|NCT00871871|3968204|P1|COMPLETED|Part II||0
1623352|NCT00871871|3968201|P4|STARTED|Part II||15
1623353|NCT00871871|3968202|P3|STARTED|Part II||13
1623354|NCT00871871|3968203|P2|STARTED|Part II||0
1623355|NCT00871871|3968204|P1|STARTED|Part II||0
1623356|NCT00871871|3968201|P4|NOT COMPLETED|Part I||0
1623357|NCT00871871|3968202|P3|NOT COMPLETED|Part I||0
1623358|NCT00871871|3968203|P2|NOT COMPLETED|Part I||3
1623359|NCT00871871|3968204|P1|NOT COMPLETED|Part I||3
1623360|NCT00871871|3968201|P4|COMPLETED|Part I||0
1623361|NCT00871871|3968202|P3|COMPLETED|Part I||0
1623362|NCT00871871|3968203|P2|COMPLETED|Part I||15
1623363|NCT00871871|3968204|P1|COMPLETED|Part I||15
1623364|NCT00871871|3968201|P4|STARTED|Part I||0
1623365|NCT00871871|3968202|P3|STARTED|Part I||0
1623366|NCT00871871|3968203|P2|STARTED|Part I||18
1623367|NCT00871871|3968204|P1|STARTED|Part I||18
1623368|NCT00871845|3968226|P2|NOT COMPLETED|Overall Study||0
1623369|NCT00871845|3968227|P1|NOT COMPLETED|Overall Study||0
1623370|NCT00871845|3968226|P2|COMPLETED|Overall Study||25
1623371|NCT00871845|3968227|P1|COMPLETED|Overall Study||11
1623372|NCT00871845|3968226|P2|STARTED|Overall Study||25
1623373|NCT00871845|3968227|P1|STARTED|Overall Study||11
1623374|NCT00871819|3968237|P1|NOT COMPLETED|Overall Study||0
1623375|NCT00871819|3968237|P1|COMPLETED|Overall Study||20
1623376|NCT00871819|3968237|P1|STARTED|Overall Study||20
1623377|NCT00871780|3968241|P1|NOT COMPLETED|Overall Study||27
1623378|NCT00871780|3968241|P1|COMPLETED|Overall Study||197
1623461|NCT00871377|3968442|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
1623379|NCT00871780|3968241|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
1623380|NCT00871780|3968241|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
1623381|NCT00871780|3968241|P1|STARTED|Overall Study|number enrolled|224
1623382|NCT00871741|3968261|P2|NOT COMPLETED|Overall Study||7
1623383|NCT00871741|3968262|P1|NOT COMPLETED|Overall Study||9
1623384|NCT00871741|3968261|P2|COMPLETED|Overall Study||0
1623385|NCT00871741|3968262|P1|COMPLETED|Overall Study||0
1623386|NCT00871741|3968261|P2|STARTED|Overall Study||7
1623387|NCT00871741|3968262|P1|STARTED|Overall Study||9
1623388|NCT00871728|3968276|P1|NOT COMPLETED|Overall Study||20
1623389|NCT00871728|3968276|P1|COMPLETED|Overall Study||112
1623390|NCT00871728|3968276|P1|Treated|Overall Study||130
1623391|NCT00871728|3968276|P1|STARTED|Overall Study||132
1623392|NCT00871715|3968289|P3|NOT COMPLETED|Overall Study||26
1623393|NCT00871715|3968290|P2|NOT COMPLETED|Overall Study||16
1623394|NCT00871715|3968291|P1|NOT COMPLETED|Overall Study||15
1623395|NCT00871715|3968289|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
1623396|NCT00871715|3968290|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
1623397|NCT00871715|3968291|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
1623398|NCT00871715|3968289|P3|6-mo Follow-up|Overall Study||112
1623399|NCT00871715|3968290|P2|6-mo Follow-up|Overall Study||113
1623400|NCT00871715|3968291|P1|6-mo Follow-up|Overall Study||110
1623401|NCT00871715|3968289|P3|Post-Intervention|Overall Study||115
1623402|NCT00871715|3968290|P2|Post-Intervention|Overall Study||115
1623403|NCT00871715|3968291|P1|Post-Intervention|Overall Study||112
1623404|NCT00871715|3968289|P3|STARTED|Overall Study||122
1623405|NCT00871715|3968290|P2|STARTED|Overall Study||120
1623406|NCT00871715|3968291|P1|STARTED|Overall Study||119
1623407|NCT00871689|3968309|P1|NOT COMPLETED|Overall Study||0
1623408|NCT00871689|3968309|P1|COMPLETED|Overall Study||2
1623409|NCT00871689|3968309|P1|STARTED|Overall Study||2
1623410|NCT00871624|3968322|P2|NOT COMPLETED|Overall Study||1
1623411|NCT00871624|3968323|P1|NOT COMPLETED|Overall Study||2
1623412|NCT00871624|3968322|P2|COMPLETED|Overall Study||17
1623413|NCT00871624|3968323|P1|COMPLETED|Overall Study||16
1623414|NCT00871624|3968322|P2|STARTED|Overall Study||18
1623415|NCT00871624|3968323|P1|STARTED|Overall Study||18
1623416|NCT00871572|3968335|P4|NOT COMPLETED|Overall Study||7
1623417|NCT00871572|3968336|P3|NOT COMPLETED|Overall Study||4
1623418|NCT00871572|3968337|P2|NOT COMPLETED|Overall Study||6
1623419|NCT00871572|3968338|P1|NOT COMPLETED|Overall Study||2
1623420|NCT00871572|3968335|P4|COMPLETED|Overall Study||19
1623421|NCT00871572|3968336|P3|COMPLETED|Overall Study||30
1623422|NCT00871572|3968337|P2|COMPLETED|Overall Study||11
1623423|NCT00871572|3968338|P1|COMPLETED|Overall Study||8
1623424|NCT00871572|3968335|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
1623425|NCT00871572|3968336|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
1623426|NCT00871572|3968337|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
1623427|NCT00871572|3968338|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
1623428|NCT00871572|3968335|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
1623429|NCT00871572|3968336|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
1623430|NCT00871572|3968337|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
1623431|NCT00871572|3968338|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
1623432|NCT00871572|3968335|P4|STARTED|Overall Study||26
1623433|NCT00871572|3968336|P3|STARTED|Overall Study||34
1623434|NCT00871572|3968337|P2|STARTED|Overall Study||17
1623435|NCT00871572|3968338|P1|STARTED|Overall Study||10
1623436|NCT00871494|3968408|P1|NOT COMPLETED|Overall Study||14
1623437|NCT00871494|3968408|P1|COMPLETED|Overall Study||62
1623438|NCT00871494|3968408|P1|STARTED|Overall Study||76
1623439|NCT00871429|3968415|P1|NOT COMPLETED|Overall Study||24
1623440|NCT00871429|3968415|P1|COMPLETED|Overall Study||75
1623441|NCT00871429|3968415|P1|STARTED|Overall Study||99
1623442|NCT00871403|3968426|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
1623443|NCT00871403|3968427|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
1623444|NCT00871403|3968428|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
1623445|NCT00871403|3968426|P3|COMPLETED|Monotherapy Treatment Phase||0
1623446|NCT00871403|3968427|P2|COMPLETED|Monotherapy Treatment Phase||0
1623447|NCT00871403|3968428|P1|COMPLETED|Monotherapy Treatment Phase||0
1623448|NCT00871403|3968426|P3|STARTED|Monotherapy Treatment Phase||1
1623449|NCT00871403|3968427|P2|STARTED|Monotherapy Treatment Phase||13
1623450|NCT00871403|3968428|P1|STARTED|Monotherapy Treatment Phase||0
1623451|NCT00871403|3968426|P3|NOT COMPLETED|Combination Treatment Phase||12
1623452|NCT00871403|3968427|P2|NOT COMPLETED|Combination Treatment Phase||49
1623453|NCT00871403|3968428|P1|NOT COMPLETED|Combination Treatment Phase||9
1623454|NCT00871403|3968426|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
1623455|NCT00871403|3968427|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
1623456|NCT00871403|3968428|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
1623457|NCT00871403|3968426|P3|STARTED|Combination Treatment Phase||35
1623458|NCT00871403|3968427|P2|STARTED|Combination Treatment Phase||62
1623459|NCT00871403|3968428|P1|STARTED|Combination Treatment Phase||9
1623460|NCT00871377|3968441|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
1623462|NCT00871377|3968443|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
1623463|NCT00871377|3968444|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
1623464|NCT00871377|3968445|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
1623465|NCT00871377|3968446|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
1623466|NCT00871377|3968441|P6|COMPLETED|Third Intervention (10 Weeks)||3
1623467|NCT00871377|3968442|P5|COMPLETED|Third Intervention (10 Weeks)||4
1623468|NCT00871377|3968443|P4|COMPLETED|Third Intervention (10 Weeks)||3
1623469|NCT00871377|3968444|P3|COMPLETED|Third Intervention (10 Weeks)||3
1623470|NCT00871377|3968445|P2|COMPLETED|Third Intervention (10 Weeks)||4
1623471|NCT00871377|3968446|P1|COMPLETED|Third Intervention (10 Weeks)||2
1623472|NCT00871377|3968441|P6|STARTED|Third Intervention (10 Weeks)||3
1623473|NCT00871377|3968442|P5|STARTED|Third Intervention (10 Weeks)||4
1623474|NCT00871377|3968443|P4|STARTED|Third Intervention (10 Weeks)||4
1623475|NCT00871377|3968444|P3|STARTED|Third Intervention (10 Weeks)||3
1623476|NCT00871377|3968445|P2|STARTED|Third Intervention (10 Weeks)||4
1623477|NCT00871377|3968446|P1|STARTED|Third Intervention (10 Weeks)||2
1623478|NCT00871377|3968441|P6|NOT COMPLETED|Washout (6 Weeks)||1
1623479|NCT00871377|3968442|P5|NOT COMPLETED|Washout (6 Weeks)||0
1623480|NCT00871377|3968443|P4|NOT COMPLETED|Washout (6 Weeks)||0
1623481|NCT00871377|3968444|P3|NOT COMPLETED|Washout (6 Weeks)||0
1623482|NCT00871377|3968445|P2|NOT COMPLETED|Washout (6 Weeks)||0
1623483|NCT00871377|3968446|P1|NOT COMPLETED|Washout (6 Weeks)||0
1623484|NCT00871377|3968441|P6|COMPLETED|Washout (6 Weeks)||3
1623485|NCT00871377|3968442|P5|COMPLETED|Washout (6 Weeks)||4
1623486|NCT00871377|3968443|P4|COMPLETED|Washout (6 Weeks)||4
1623487|NCT00871377|3968444|P3|COMPLETED|Washout (6 Weeks)||3
1623488|NCT00871377|3968445|P2|COMPLETED|Washout (6 Weeks)||4
1623489|NCT00871377|3968446|P1|COMPLETED|Washout (6 Weeks)||2
1623490|NCT00871377|3968441|P6|STARTED|Washout (6 Weeks)||4
1623491|NCT00871377|3968442|P5|STARTED|Washout (6 Weeks)||4
1623492|NCT00871377|3968443|P4|STARTED|Washout (6 Weeks)||4
1623493|NCT00871377|3968444|P3|STARTED|Washout (6 Weeks)||3
1623494|NCT00871377|3968445|P2|STARTED|Washout (6 Weeks)||4
1623495|NCT00871377|3968446|P1|STARTED|Washout (6 Weeks)||2
1623496|NCT00871377|3968441|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
1623497|NCT00871377|3968442|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
1623498|NCT00871377|3968443|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
1623499|NCT00871377|3968444|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
1623500|NCT00871377|3968445|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
1623501|NCT00871377|3968446|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
1623502|NCT00871377|3968441|P6|COMPLETED|Second Intervention (10 Weeks)||4
1623503|NCT00871377|3968442|P5|COMPLETED|Second Intervention (10 Weeks)||4
1623504|NCT00871377|3968443|P4|COMPLETED|Second Intervention (10 Weeks)||4
1623505|NCT00871377|3968444|P3|COMPLETED|Second Intervention (10 Weeks)||3
1623506|NCT00871377|3968445|P2|COMPLETED|Second Intervention (10 Weeks)||4
1623507|NCT00871377|3968446|P1|COMPLETED|Second Intervention (10 Weeks)||2
1623508|NCT00871377|3968441|P6|STARTED|Second Intervention (10 Weeks)||4
1623509|NCT00871377|3968442|P5|STARTED|Second Intervention (10 Weeks)||4
1623510|NCT00871377|3968443|P4|STARTED|Second Intervention (10 Weeks)||4
1623511|NCT00871377|3968444|P3|STARTED|Second Intervention (10 Weeks)||3
1623512|NCT00871377|3968445|P2|STARTED|Second Intervention (10 Weeks)||4
1623513|NCT00871377|3968446|P1|STARTED|Second Intervention (10 Weeks)||2
1623514|NCT00871377|3968441|P6|NOT COMPLETED|Washout (6 Weeks)||0
1623515|NCT00871377|3968442|P5|NOT COMPLETED|Washout (6 Weeks)||0
1623516|NCT00871377|3968443|P4|NOT COMPLETED|Washout (6 Weeks)||0
1623517|NCT00871377|3968444|P3|NOT COMPLETED|Washout (6 Weeks)||0
1623518|NCT00871377|3968445|P2|NOT COMPLETED|Washout (6 Weeks)||0
1623519|NCT00871377|3968446|P1|NOT COMPLETED|Washout (6 Weeks)||1
1623520|NCT00871377|3968441|P6|COMPLETED|Washout (6 Weeks)||4
1623521|NCT00871377|3968442|P5|COMPLETED|Washout (6 Weeks)||4
1623522|NCT00871377|3968443|P4|COMPLETED|Washout (6 Weeks)||4
1623523|NCT00871377|3968444|P3|COMPLETED|Washout (6 Weeks)||3
1623524|NCT00871377|3968445|P2|COMPLETED|Washout (6 Weeks)||4
1623525|NCT00871377|3968446|P1|COMPLETED|Washout (6 Weeks)||2
1623526|NCT00871377|3968441|P6|STARTED|Washout (6 Weeks)||4
1623527|NCT00871377|3968442|P5|STARTED|Washout (6 Weeks)||4
1623528|NCT00871377|3968443|P4|STARTED|Washout (6 Weeks)||4
1623529|NCT00871377|3968444|P3|STARTED|Washout (6 Weeks)||3
1623530|NCT00871377|3968445|P2|STARTED|Washout (6 Weeks)||4
1623531|NCT00871377|3968446|P1|STARTED|Washout (6 Weeks)||3
1623532|NCT00871377|3968441|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
1623533|NCT00871377|3968442|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
1623534|NCT00871377|3968443|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
1623535|NCT00871377|3968444|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
1623536|NCT00871377|3968445|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
1623537|NCT00871377|3968446|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
1623538|NCT00871377|3968441|P6|COMPLETED|First Intervention (10 Weeks)||4
1623539|NCT00871377|3968442|P5|COMPLETED|First Intervention (10 Weeks)||4
1623540|NCT00871377|3968443|P4|COMPLETED|First Intervention (10 Weeks)||4
1623541|NCT00871377|3968444|P3|COMPLETED|First Intervention (10 Weeks)||3
1623542|NCT00871377|3968445|P2|COMPLETED|First Intervention (10 Weeks)||4
1623543|NCT00871377|3968446|P1|COMPLETED|First Intervention (10 Weeks)||3
1623544|NCT00871377|3968441|P6|STARTED|First Intervention (10 Weeks)||5
1623545|NCT00871377|3968442|P5|STARTED|First Intervention (10 Weeks)||4
1623546|NCT00871377|3968443|P4|STARTED|First Intervention (10 Weeks)||4
1623547|NCT00871377|3968444|P3|STARTED|First Intervention (10 Weeks)||4
1623548|NCT00871377|3968445|P2|STARTED|First Intervention (10 Weeks)||4
1623549|NCT00871377|3968446|P1|STARTED|First Intervention (10 Weeks)||3
1623550|NCT00871351|3968457|P3|NOT COMPLETED|Overall Study||0
1623551|NCT00871351|3968458|P2|NOT COMPLETED|Overall Study||1
1623552|NCT00871351|3968459|P1|NOT COMPLETED|Overall Study||4
1623553|NCT00871351|3968457|P3|COMPLETED|Overall Study||32
1623554|NCT00871351|3968458|P2|COMPLETED|Overall Study||45
1623555|NCT00871351|3968459|P1|COMPLETED|Overall Study||43
1623556|NCT00871351|3968457|P3|STARTED|Overall Study||32
1623557|NCT00871351|3968458|P2|STARTED|Overall Study||46
1623558|NCT00871351|3968459|P1|STARTED|Overall Study||47
1623559|NCT00871338|3968481|P2|NOT COMPLETED|After Booster||0
1623560|NCT00871338|3968482|P1|NOT COMPLETED|After Booster||0
1623561|NCT00871338|3968481|P2|COMPLETED|After Booster||135
1623562|NCT00871338|3968482|P1|COMPLETED|After Booster||139
1623563|NCT00871338|3968481|P2|STARTED|After Booster||135
1623564|NCT00871338|3968482|P1|STARTED|After Booster||139
1623565|NCT00871338|3968481|P2|NOT COMPLETED|Prior to Booster||3
1623566|NCT00871338|3968482|P1|NOT COMPLETED|Prior to Booster||2
1623567|NCT00871338|3968481|P2|COMPLETED|Prior to Booster||139
1623568|NCT00871338|3968482|P1|COMPLETED|Prior to Booster||140
1623569|NCT00871338|3968481|P2|STARTED|Prior to Booster||142
1623570|NCT00871338|3968482|P1|STARTED|Prior to Booster||142
1623571|NCT00871286|3968562|P2|NOT COMPLETED|Overall Study||6
1623572|NCT00871286|3968563|P1|NOT COMPLETED|Overall Study||0
1623573|NCT00871286|3968562|P2|COMPLETED|Overall Study||14
1623574|NCT00871286|3968563|P1|COMPLETED|Overall Study||20
1623575|NCT00871286|3968562|P2|STARTED|Overall Study||20
1623576|NCT00871286|3968563|P1|STARTED|Overall Study||20
1623577|NCT00871234|3968571|P1|NOT COMPLETED|Overall Study||5
1623578|NCT00871234|3968571|P1|COMPLETED|Overall Study||23
1623579|NCT00871234|3968571|P1|STARTED|Overall Study||28
1623580|NCT00871169|3968575|P1|NOT COMPLETED|Overall Study||3
1623581|NCT00871169|3968575|P1|COMPLETED|Overall Study||58
1623582|NCT00871169|3968575|P1|STARTED|Overall Study||61
1623583|NCT00871143|3968582|P2|NOT COMPLETED|Overall Study||0
1623584|NCT00871143|3968583|P1|NOT COMPLETED|Overall Study||0
1623585|NCT00871143|3968582|P2|COMPLETED|Overall Study||25
1623586|NCT00871143|3968583|P1|COMPLETED|Overall Study||21
1623587|NCT00871143|3968582|P2|STARTED|Overall Study||25
1623588|NCT00871143|3968583|P1|STARTED|Overall Study||21
1623589|NCT00871117|3968603|P2|NOT COMPLETED|Overall Study||10
1623590|NCT00871117|3968604|P1|NOT COMPLETED|Overall Study||5
1623591|NCT00871117|3968603|P2|COMPLETED|Overall Study||227
1623592|NCT00871117|3968604|P1|COMPLETED|Overall Study||234
1623593|NCT00871117|3968603|P2|STARTED|Overall Study||237
1623594|NCT00871117|3968604|P1|STARTED|Overall Study||239
1623595|NCT00871000|3968638|P2|NOT COMPLETED|Overall Study||0
1623596|NCT00871000|3968639|P1|NOT COMPLETED|Overall Study||1
1623597|NCT00871000|3968638|P2|COMPLETED|Overall Study||152
1623598|NCT00871000|3968639|P1|COMPLETED|Overall Study||150
1623599|NCT00871000|3968638|P2|STARTED|Overall Study||152
1623600|NCT00871000|3968639|P1|STARTED|Overall Study||151
1623601|NCT00870896|3968681|P1|NOT COMPLETED|Overall Study||0
1623602|NCT00870896|3968681|P1|COMPLETED|Overall Study||5
1623603|NCT00870896|3968681|P1|STARTED|Overall Study||5
1623604|NCT00870870|3968691|P4|NOT COMPLETED|Overall Study||5
1623605|NCT00870870|3968692|P3|NOT COMPLETED|Overall Study||3
1623606|NCT00870870|3968693|P2|NOT COMPLETED|Overall Study||1
1623607|NCT00870870|3968694|P1|NOT COMPLETED|Overall Study||0
1623608|NCT00870870|3968691|P4|COMPLETED|Overall Study||20
1623609|NCT00870870|3968692|P3|COMPLETED|Overall Study||26
1623610|NCT00870870|3968693|P2|COMPLETED|Overall Study||5
1623611|NCT00870870|3968694|P1|COMPLETED|Overall Study||4
1623612|NCT00870870|3968691|P4|STARTED|Overall Study||25
1623613|NCT00870870|3968692|P3|STARTED|Overall Study||29
1623614|NCT00870870|3968693|P2|STARTED|Overall Study||6
1623615|NCT00870870|3968694|P1|STARTED|Overall Study||4
1623616|NCT00870740|3968738|P6|NOT COMPLETED|Overall Study||17
1623617|NCT00870740|3968739|P5|NOT COMPLETED|Overall Study||11
1623618|NCT00870740|3968740|P4|NOT COMPLETED|Overall Study||12
1623619|NCT00870740|3968741|P3|NOT COMPLETED|Overall Study||10
1623620|NCT00870740|3968742|P2|NOT COMPLETED|Overall Study||9
1623621|NCT00870740|3968743|P1|NOT COMPLETED|Overall Study||12
1623622|NCT00870740|3968738|P6|COMPLETED|Overall Study||70
1623623|NCT00870740|3968739|P5|COMPLETED|Overall Study||77
1623624|NCT00870740|3968740|P4|COMPLETED|Overall Study||74
1623625|NCT00870740|3968741|P3|COMPLETED|Overall Study||76
1623626|NCT00870740|3968742|P2|COMPLETED|Overall Study||75
1623627|NCT00870740|3968743|P1|COMPLETED|Overall Study||74
1623628|NCT00870740|3968738|P6|STARTED|Overall Study|number randomized and dosed|87
1623629|NCT00870740|3968739|P5|STARTED|Overall Study|number randomized and dosed|88
1623630|NCT00870740|3968740|P4|STARTED|Overall Study|number randomized and dosed|86
1623631|NCT00870740|3968741|P3|STARTED|Overall Study|number randomized and dosed|86
1623632|NCT00870740|3968742|P2|STARTED|Overall Study|number randomized and dosed|84
1623633|NCT00870740|3968743|P1|STARTED|Overall Study|number randomized and dosed|86
1623634|NCT00870727|3968819|P2|NOT COMPLETED|Overall Study||5
1623635|NCT00870727|3968820|P1|NOT COMPLETED|Overall Study||1
1623636|NCT00870727|3968819|P2|COMPLETED|Overall Study||11
1623637|NCT00870727|3968820|P1|COMPLETED|Overall Study||16
1623638|NCT00870727|3968819|P2|STARTED|Overall Study||16
1623639|NCT00870727|3968820|P1|STARTED|Overall Study||17
1623640|NCT00870688|3968836|P1|NOT COMPLETED|Overall Study||4
1623641|NCT00870688|3968836|P1|COMPLETED|Overall Study||78
1623642|NCT00870688|3968836|P1|STARTED|Overall Study||82
1623643|NCT00870584|3968841|P2|NOT COMPLETED|Overall Study||13
1623644|NCT00870584|3968842|P1|NOT COMPLETED|Overall Study||16
1623645|NCT00870584|3968841|P2|COMPLETED|Overall Study||122
1623646|NCT00870584|3968842|P1|COMPLETED|Overall Study||120
1623647|NCT00870584|3968841|P2|STARTED|Overall Study||135
1623648|NCT00870584|3968842|P1|STARTED|Overall Study||136
1623649|NCT00870545|3968850|P1|NOT COMPLETED|Overall Study||17
1623650|NCT00870545|3968850|P1|COMPLETED|Overall Study||69
1623651|NCT00870545|3968850|P1|STARTED|Overall Study||86
1623652|NCT00870467|3968861|P6|NOT COMPLETED|Open-label||3
1623653|NCT00870467|3968862|P5|NOT COMPLETED|Open-label||5
1623654|NCT00870467|3968863|P4|NOT COMPLETED|Open-label||7
1623655|NCT00870467|3968864|P3|NOT COMPLETED|Open-label||13
1623656|NCT00870467|3968865|P2|NOT COMPLETED|Open-label||0
1623657|NCT00870467|3968866|P1|NOT COMPLETED|Open-label||0
1623658|NCT00870467|3968861|P6|COMPLETED|Open-label||21
1623659|NCT00870467|3968862|P5|COMPLETED|Open-label||5
1623660|NCT00870467|3968863|P4|COMPLETED|Open-label||120
1623661|NCT00870467|3968864|P3|COMPLETED|Open-label||132
1623662|NCT00870467|3968865|P2|COMPLETED|Open-label||0
1623663|NCT00870467|3968866|P1|COMPLETED|Open-label||0
1623664|NCT00870467|3968861|P6|STARTED|Open-label||24
1623665|NCT00870467|3968862|P5|STARTED|Open-label||10
1623666|NCT00870467|3968863|P4|STARTED|Open-label||127
1623667|NCT00870467|3968864|P3|STARTED|Open-label||145
1623668|NCT00870467|3968865|P2|STARTED|Open-label||0
1623669|NCT00870467|3968866|P1|STARTED|Open-label||0
1623670|NCT00870467|3968861|P6|NOT COMPLETED|Double-blind||0
1623671|NCT00870467|3968862|P5|NOT COMPLETED|Double-blind||0
1623672|NCT00870467|3968863|P4|NOT COMPLETED|Double-blind||0
1623673|NCT00870467|3968864|P3|NOT COMPLETED|Double-blind||0
1623674|NCT00870467|3968865|P2|NOT COMPLETED|Double-blind||12
1623675|NCT00870467|3968866|P1|NOT COMPLETED|Double-blind||16
1623676|NCT00870467|3968861|P6|COMPLETED|Double-blind||0
1623677|NCT00870467|3968862|P5|COMPLETED|Double-blind||0
1623678|NCT00870467|3968863|P4|COMPLETED|Double-blind||0
1623679|NCT00870467|3968864|P3|COMPLETED|Double-blind||0
1623680|NCT00870467|3968865|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
1623681|NCT00870467|3968866|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
1623682|NCT00870467|3968861|P6|STARTED|Double-blind||0
1623683|NCT00870467|3968862|P5|STARTED|Double-blind||0
1623684|NCT00870467|3968863|P4|STARTED|Double-blind||0
1623685|NCT00870467|3968864|P3|STARTED|Double-blind||0
1623686|NCT00870467|3968865|P2|STARTED|Double-blind||163
1623687|NCT00870467|3968866|P1|STARTED|Double-blind||171
1623688|NCT00870363|3968914|P4|NOT COMPLETED|Overall Study||0
1623689|NCT00870363|3968915|P3|NOT COMPLETED|Overall Study||3
1623690|NCT00870363|3968916|P2|NOT COMPLETED|Overall Study||3
1623691|NCT00870363|3968917|P1|NOT COMPLETED|Overall Study||0
1623692|NCT00870363|3968914|P4|COMPLETED|Overall Study||12
1623693|NCT00870363|3968915|P3|COMPLETED|Overall Study||8
1623694|NCT00870363|3968916|P2|COMPLETED|Overall Study||8
1623695|NCT00870363|3968917|P1|COMPLETED|Overall Study||10
1623696|NCT00870363|3968914|P4|STARTED|Overall Study||12
1623697|NCT00870363|3968915|P3|STARTED|Overall Study||11
1623698|NCT00870363|3968916|P2|STARTED|Overall Study||11
1623699|NCT00870363|3968917|P1|STARTED|Overall Study||10
1623700|NCT00870233|3968951|P1|NOT COMPLETED|Overall Study||24
1623701|NCT00870233|3968951|P1|COMPLETED|Overall Study||96
1623702|NCT00870233|3968951|P1|STARTED|Overall Study||120
1623703|NCT00870194|3968960|P2|NOT COMPLETED|Overall Study||14
1623704|NCT00870194|3968961|P1|NOT COMPLETED|Overall Study||26
1623705|NCT00870194|3968960|P2|COMPLETED|Overall Study||114
1623706|NCT00870194|3968961|P1|COMPLETED|Overall Study||101
1623707|NCT00870194|3968960|P2|Per Protocol Set|Overall Study||111
1623708|NCT00870194|3968961|P1|Per Protocol Set|Overall Study||97
1623709|NCT00870194|3968960|P2|STARTED|Overall Study||128
1623710|NCT00870194|3968961|P1|STARTED|Overall Study||127
1623711|NCT00870103|3968999|P1|NOT COMPLETED|Overall Study||4
1623712|NCT00870103|3968999|P1|COMPLETED|Overall Study||60
1623713|NCT00870103|3968999|P1|STARTED|Overall Study||64
1623714|NCT00869999|3969004|P1|NOT COMPLETED|Overall Study||2
1623715|NCT00869999|3969004|P1|COMPLETED|Overall Study||24
1623716|NCT00869999|3969004|P1|STARTED|Overall Study||26
1623717|NCT00869960|3969010|P1|NOT COMPLETED|Overall Study||2
1623718|NCT00869960|3969010|P1|COMPLETED|Overall Study||22
1623719|NCT00869960|3969010|P1|STARTED|Overall Study||24
1623720|NCT00869947|3969023|P2|NOT COMPLETED|Overall Study||0
1623721|NCT00869947|3969024|P1|NOT COMPLETED|Overall Study||0
1623722|NCT00869947|3969023|P2|COMPLETED|Overall Study||8
1623723|NCT00869947|3969024|P1|COMPLETED|Overall Study||8
1623724|NCT00869947|3969023|P2|STARTED|Overall Study||8
1623725|NCT00869947|3969024|P1|STARTED|Overall Study||8
1623726|NCT00869791|3969037|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
1623727|NCT00869791|3969038|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
1623728|NCT00869791|3969037|P2|COMPLETED|Period 2 Treatment for 7 Days||13
1623729|NCT00869791|3969038|P1|COMPLETED|Period 2 Treatment for 7 Days||14
1623730|NCT00869791|3969037|P2|STARTED|Period 2 Treatment for 7 Days||13
1623731|NCT00869791|3969038|P1|STARTED|Period 2 Treatment for 7 Days||14
1623732|NCT00869791|3969037|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
1623733|NCT00869791|3969038|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
1623734|NCT00869791|3969037|P2|COMPLETED|Period 1 Treatment for 7 Days||13
1623735|NCT00869791|3969038|P1|COMPLETED|Period 1 Treatment for 7 Days||14
1623736|NCT00869791|3969037|P2|STARTED|Period 1 Treatment for 7 Days||13
1623737|NCT00869791|3969038|P1|STARTED|Period 1 Treatment for 7 Days||14
1623738|NCT00869778|3969059|P3|NOT COMPLETED|Overall Study||10
1623739|NCT00869778|3969060|P2|NOT COMPLETED|Overall Study||7
1623740|NCT00869778|3969061|P1|NOT COMPLETED|Overall Study||12
1623741|NCT00869778|3969059|P3|COMPLETED|Overall Study||110
1623742|NCT00869778|3969060|P2|COMPLETED|Overall Study||113
1623743|NCT00869778|3969061|P1|COMPLETED|Overall Study||108
1623744|NCT00869778|3969059|P3|STARTED|Overall Study||120
1623745|NCT00869778|3969060|P2|STARTED|Overall Study||120
1623746|NCT00869778|3969061|P1|STARTED|Overall Study||120
1623747|NCT00869622|3969098|P2|NOT COMPLETED|Overall Study||14
1623748|NCT00869622|3969099|P1|NOT COMPLETED|Overall Study||13
1623749|NCT00869622|3969098|P2|COMPLETED|Overall Study||26
1623750|NCT00869622|3969099|P1|COMPLETED|Overall Study||27
1623751|NCT00869622|3969098|P2|STARTED|Overall Study||40
1623752|NCT00869622|3969099|P1|STARTED|Overall Study||40
1623753|NCT00869609|3969109|P2|NOT COMPLETED|Overall Study||3
1623754|NCT00869609|3969110|P1|NOT COMPLETED|Overall Study||6
1623755|NCT00869609|3969109|P2|COMPLETED|Overall Study||26
1623756|NCT00869609|3969110|P1|COMPLETED|Overall Study||25
1623757|NCT00869609|3969109|P2|STARTED|Overall Study||29
1623758|NCT00869609|3969110|P1|STARTED|Overall Study||31
1623759|NCT00869557|3969136|P2|NOT COMPLETED|Extension Phase||3
1623760|NCT00869557|3969137|P1|NOT COMPLETED|Extension Phase||10
1623761|NCT00869557|3969136|P2|COMPLETED|Extension Phase||11
1623762|NCT00869557|3969137|P1|COMPLETED|Extension Phase||35
1623763|NCT00869557|3969136|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
1623764|NCT00869557|3969137|P1|STARTED|Extension Phase||45
1623765|NCT00869557|3969136|P2|NOT COMPLETED|Randomized Phase||2
1623766|NCT00869557|3969137|P1|NOT COMPLETED|Randomized Phase||3
1623767|NCT00869557|3969136|P2|COMPLETED|Randomized Phase||21
1623768|NCT00869557|3969137|P1|COMPLETED|Randomized Phase||45
1623769|NCT00869557|3969136|P2|STARTED|Randomized Phase||23
1623770|NCT00869557|3969137|P1|STARTED|Randomized Phase||48
1623771|NCT00869518|3969156|P2|NOT COMPLETED|Overall Study||1
1623772|NCT00869518|3969157|P1|NOT COMPLETED|Overall Study||1
1623773|NCT00869518|3969156|P2|COMPLETED|Overall Study||5
1623774|NCT00869518|3969157|P1|COMPLETED|Overall Study||5
1623775|NCT00869518|3969156|P2|STARTED|Overall Study||6
1623776|NCT00869518|3969157|P1|STARTED|Overall Study||6
1623777|NCT00869414|3969169|P3|NOT COMPLETED|Overall Study||0
1623778|NCT00869414|3969170|P2|NOT COMPLETED|Overall Study||0
1623779|NCT00869414|3969171|P1|NOT COMPLETED|Overall Study||0
1623780|NCT00869414|3969169|P3|COMPLETED|Overall Study||0
1623781|NCT00869414|3969170|P2|COMPLETED|Overall Study||0
1623782|NCT00869414|3969171|P1|COMPLETED|Overall Study||0
1623783|NCT00869414|3969169|P3|STARTED|Overall Study||0
1623784|NCT00869414|3969170|P2|STARTED|Overall Study||0
1623785|NCT00869414|3969171|P1|STARTED|Overall Study||0
1623786|NCT00869401|3969185|P5|NOT COMPLETED|Overall Study||3
1623787|NCT00869401|3969186|P4|NOT COMPLETED|Overall Study||5
1623788|NCT00869401|3969187|P3|NOT COMPLETED|Overall Study||0
1623789|NCT00869401|3969188|P2|NOT COMPLETED|Overall Study||0
1623790|NCT00869401|3969189|P1|NOT COMPLETED|Overall Study||0
1623791|NCT00869401|3969185|P5|COMPLETED|Overall Study||63
1623792|NCT00869401|3969186|P4|COMPLETED|Overall Study||133
1623793|NCT00869401|3969187|P3|COMPLETED|Overall Study||7
1623794|NCT00869401|3969188|P2|COMPLETED|Overall Study||3
1623795|NCT00869401|3969189|P1|COMPLETED|Overall Study||3
1623796|NCT00869401|3969185|P5|STARTED|Overall Study||66
1623797|NCT00869401|3969186|P4|STARTED|Overall Study||138
1623798|NCT00869401|3969187|P3|STARTED|Overall Study||7
1623799|NCT00869401|3969188|P2|STARTED|Overall Study||3
1623800|NCT00869401|3969189|P1|STARTED|Overall Study||3
1623801|NCT00869375|3969207|P2|NOT COMPLETED|Overall Study||0
1623802|NCT00869375|3969208|P1|NOT COMPLETED|Overall Study||0
1623803|NCT00869375|3969207|P2|COMPLETED|Overall Study||3
1623804|NCT00869375|3969208|P1|COMPLETED|Overall Study||3
1623805|NCT00869375|3969207|P2|STARTED|Overall Study||3
1623806|NCT00869375|3969208|P1|STARTED|Overall Study||3
1623807|NCT00869362|3969218|P2|NOT COMPLETED|Overall Study||5
1623808|NCT00869362|3969219|P1|NOT COMPLETED|Overall Study||1
1623809|NCT00869362|3969218|P2|COMPLETED|Overall Study||11
1623810|NCT00869362|3969219|P1|COMPLETED|Overall Study||14
1623811|NCT00869362|3969218|P2|STARTED|Overall Study||16
1623812|NCT00869362|3969219|P1|STARTED|Overall Study||15
1623813|NCT00869349|3969229|P2|NOT COMPLETED|Overall Study||4
1623814|NCT00869349|3969230|P1|NOT COMPLETED|Overall Study||7
1623815|NCT00869349|3969229|P2|COMPLETED|Overall Study||36
1623816|NCT00869349|3969230|P1|COMPLETED|Overall Study||32
1623817|NCT00869349|3969229|P2|STARTED|Overall Study||40
1623818|NCT00869349|3969230|P1|STARTED|Overall Study||39
1623819|NCT00869323|3969240|P1|NOT COMPLETED|Maintenance Therapy||1
1623820|NCT00869323|3969240|P1|COMPLETED|Maintenance Therapy||1
1623821|NCT00869323|3969240|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
1623822|NCT00869323|3969240|P1|NOT COMPLETED|Induction Therapy||0
1623823|NCT00869323|3969240|P1|COMPLETED|Induction Therapy||3
1623824|NCT00869323|3969240|P1|STARTED|Induction Therapy||3
1623825|NCT00869258|3969248|P1|NOT COMPLETED|Overall Study||1
1623826|NCT00869258|3969248|P1|COMPLETED|Overall Study||31
1623827|NCT00869258|3969248|P1|STARTED|Overall Study||32
1623828|NCT00869206|3969254|P2|NOT COMPLETED|Overall Study||27
1623829|NCT00869206|3969255|P1|NOT COMPLETED|Overall Study||29
1623830|NCT00869206|3969254|P2|COMPLETED|Overall Study||884
1623831|NCT00869206|3969255|P1|COMPLETED|Overall Study||882
1623832|NCT00869206|3969254|P2|STARTED|Overall Study||911
1623833|NCT00869206|3969255|P1|STARTED|Overall Study||911
1623834|NCT00869167|3969285|P2|NOT COMPLETED|Overall Study||1
1623835|NCT00869167|3969286|P1|NOT COMPLETED|Overall Study||0
1623836|NCT00869167|3969285|P2|COMPLETED|Overall Study||0
1623837|NCT00869167|3969286|P1|COMPLETED|Overall Study||2
1623838|NCT00869167|3969285|P2|STARTED|Overall Study||1
1623839|NCT00869167|3969286|P1|STARTED|Overall Study||2
1623840|NCT00869141|3969302|P2|NOT COMPLETED|Overall Study||0
1623841|NCT00869141|3969303|P1|NOT COMPLETED|Overall Study||0
1623842|NCT00869141|3969302|P2|COMPLETED|Overall Study||26
1623843|NCT00869141|3969303|P1|COMPLETED|Overall Study||26
1623844|NCT00869141|3969302|P2|STARTED|Overall Study||26
1623845|NCT00869141|3969303|P1|STARTED|Overall Study||26
1623846|NCT00869128|3969313|P2|NOT COMPLETED|Overall Study||6
1623847|NCT00869128|3969314|P1|NOT COMPLETED|Overall Study||6
1623848|NCT00869128|3969313|P2|COMPLETED|Overall Study||12
1623849|NCT00869128|3969314|P1|COMPLETED|Overall Study||12
1623850|NCT00869128|3969313|P2|STARTED|Overall Study||18
1623851|NCT00869128|3969314|P1|STARTED|Overall Study||18
1623852|NCT00869089|3969318|P1|NOT COMPLETED|Overall Study||3
1623853|NCT00869089|3969318|P1|COMPLETED|Overall Study||2
1623854|NCT00869089|3969318|P1|STARTED|Overall Study||5
1623855|NCT00869050|3969322|P1|NOT COMPLETED|Overall Study||3
1623856|NCT00869050|3969322|P1|COMPLETED|Overall Study||38
1623857|NCT00869050|3969322|P1|STARTED|Overall Study||41
1623858|NCT00868998|3969327|P1|NOT COMPLETED|Overall Study||5
1623859|NCT00868998|3969327|P1|COMPLETED|Overall Study||0
1623860|NCT00868998|3969327|P1|STARTED|Overall Study||5
1623861|NCT00868959|3969332|P1|NOT COMPLETED|Overall Study||258
1623862|NCT00868959|3969332|P1|COMPLETED|Overall Study||559
1623863|NCT00868959|3969332|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
1623864|NCT00868790|3969338|P14|NOT COMPLETED|Post-study||0
1623865|NCT00868790|3969339|P13|NOT COMPLETED|Post-study||0
1623866|NCT00868790|3969340|P12|NOT COMPLETED|Post-study||0
1623867|NCT00868790|3969341|P11|NOT COMPLETED|Post-study||0
1623868|NCT00868790|3969342|P10|NOT COMPLETED|Post-study||1
1623869|NCT00868790|3969343|P9|NOT COMPLETED|Post-study||0
1623870|NCT00868790|3969344|P8|NOT COMPLETED|Post-study||2
1623871|NCT00868790|3969345|P7|NOT COMPLETED|Post-study||0
1623872|NCT00868790|3969346|P6|NOT COMPLETED|Post-study||0
1623873|NCT00868790|3969347|P5|NOT COMPLETED|Post-study||1
1623874|NCT00868790|3969348|P4|NOT COMPLETED|Post-study||0
1623875|NCT00868790|3969349|P3|NOT COMPLETED|Post-study||0
1623876|NCT00868790|3969350|P2|NOT COMPLETED|Post-study||0
1623877|NCT00868790|3969351|P1|NOT COMPLETED|Post-study||0
1623878|NCT00868790|3969338|P14|COMPLETED|Post-study||7
1623879|NCT00868790|3969339|P13|COMPLETED|Post-study||6
1623880|NCT00868790|3969340|P12|COMPLETED|Post-study||3
1623881|NCT00868790|3969341|P11|COMPLETED|Post-study||5
1623882|NCT00868790|3969342|P10|COMPLETED|Post-study||1
1623883|NCT00868790|3969343|P9|COMPLETED|Post-study||6
1623884|NCT00868790|3969344|P8|COMPLETED|Post-study||12
1623885|NCT00868790|3969345|P7|COMPLETED|Post-study||4
1623886|NCT00868790|3969346|P6|COMPLETED|Post-study||1
1623887|NCT00868790|3969347|P5|COMPLETED|Post-study||17
1623888|NCT00868790|3969348|P4|COMPLETED|Post-study||3
1623889|NCT00868790|3969349|P3|COMPLETED|Post-study||3
1623890|NCT00868790|3969350|P2|COMPLETED|Post-study||6
1623891|NCT00868790|3969351|P1|COMPLETED|Post-study||7
1623892|NCT00868790|3969338|P14|STARTED|Post-study||7
1623893|NCT00868790|3969339|P13|STARTED|Post-study||6
1623894|NCT00868790|3969340|P12|STARTED|Post-study||3
1623895|NCT00868790|3969341|P11|STARTED|Post-study||5
1623896|NCT00868790|3969342|P10|STARTED|Post-study||2
1623897|NCT00868790|3969343|P9|STARTED|Post-study||6
1623898|NCT00868790|3969344|P8|STARTED|Post-study||14
1623899|NCT00868790|3969345|P7|STARTED|Post-study||4
1623900|NCT00868790|3969346|P6|STARTED|Post-study||1
1623901|NCT00868790|3969347|P5|STARTED|Post-study||18
1623902|NCT00868790|3969348|P4|STARTED|Post-study||3
1623903|NCT00868790|3969349|P3|STARTED|Post-study||3
1623904|NCT00868790|3969350|P2|STARTED|Post-study||6
1623905|NCT00868790|3969351|P1|STARTED|Post-study||7
1623906|NCT00868790|3969338|P14|NOT COMPLETED|Period 4||1
1623907|NCT00868790|3969339|P13|NOT COMPLETED|Period 4||1
1623908|NCT00868790|3969340|P12|NOT COMPLETED|Period 4||1
1623909|NCT00868790|3969341|P11|NOT COMPLETED|Period 4||3
1623910|NCT00868790|3969342|P10|NOT COMPLETED|Period 4||0
1623911|NCT00868790|3969343|P9|NOT COMPLETED|Period 4||2
1623912|NCT00868790|3969344|P8|NOT COMPLETED|Period 4||3
1623913|NCT00868790|3969345|P7|NOT COMPLETED|Period 4||0
1623914|NCT00868790|3969346|P6|NOT COMPLETED|Period 4||0
1623915|NCT00868790|3969347|P5|NOT COMPLETED|Period 4||0
1623916|NCT00868790|3969348|P4|NOT COMPLETED|Period 4||0
1623917|NCT00868790|3969349|P3|NOT COMPLETED|Period 4||1
1623918|NCT00868790|3969350|P2|NOT COMPLETED|Period 4||0
1623919|NCT00868790|3969351|P1|NOT COMPLETED|Period 4||2
1623920|NCT00868790|3969338|P14|COMPLETED|Period 4||7
1623921|NCT00868790|3969339|P13|COMPLETED|Period 4||6
1623922|NCT00868790|3969340|P12|COMPLETED|Period 4||3
1623923|NCT00868790|3969341|P11|COMPLETED|Period 4||5
1623924|NCT00868790|3969342|P10|COMPLETED|Period 4||2
1623925|NCT00868790|3969343|P9|COMPLETED|Period 4||6
1623926|NCT00868790|3969344|P8|COMPLETED|Period 4||14
1623927|NCT00868790|3969345|P7|COMPLETED|Period 4||4
1623928|NCT00868790|3969346|P6|COMPLETED|Period 4||1
1623929|NCT00868790|3969347|P5|COMPLETED|Period 4||18
1623930|NCT00868790|3969348|P4|COMPLETED|Period 4||3
1623931|NCT00868790|3969349|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
1623932|NCT00868790|3969350|P2|COMPLETED|Period 4||6
1623933|NCT00868790|3969351|P1|COMPLETED|Period 4||7
1623934|NCT00868790|3969338|P14|STARTED|Period 4||8
1623935|NCT00868790|3969339|P13|STARTED|Period 4||7
1623936|NCT00868790|3969340|P12|STARTED|Period 4||4
1623937|NCT00868790|3969341|P11|STARTED|Period 4||8
1623938|NCT00868790|3969342|P10|STARTED|Period 4||2
1623939|NCT00868790|3969343|P9|STARTED|Period 4||8
1623940|NCT00868790|3969344|P8|STARTED|Period 4||17
1623941|NCT00868790|3969345|P7|STARTED|Period 4||4
1623942|NCT00868790|3969346|P6|STARTED|Period 4||1
1623943|NCT00868790|3969347|P5|STARTED|Period 4||18
1623944|NCT00868790|3969348|P4|STARTED|Period 4||3
1623945|NCT00868790|3969349|P3|STARTED|Period 4||4
1623946|NCT00868790|3969350|P2|STARTED|Period 4||6
1623947|NCT00868790|3969351|P1|STARTED|Period 4||9
1623948|NCT00868790|3969338|P14|NOT COMPLETED|Period 3||0
1623949|NCT00868790|3969339|P13|NOT COMPLETED|Period 3||0
1623950|NCT00868790|3969340|P12|NOT COMPLETED|Period 3||0
1623951|NCT00868790|3969341|P11|NOT COMPLETED|Period 3||1
1623952|NCT00868790|3969342|P10|NOT COMPLETED|Period 3||1
1623953|NCT00868790|3969343|P9|NOT COMPLETED|Period 3||0
1623954|NCT00868790|3969344|P8|NOT COMPLETED|Period 3||0
1623955|NCT00868790|3969345|P7|NOT COMPLETED|Period 3||0
1623956|NCT00868790|3969346|P6|NOT COMPLETED|Period 3||0
1623957|NCT00868790|3969347|P5|NOT COMPLETED|Period 3||0
1623958|NCT00868790|3969348|P4|NOT COMPLETED|Period 3||1
1623959|NCT00868790|3969349|P3|NOT COMPLETED|Period 3||0
1623960|NCT00868790|3969350|P2|NOT COMPLETED|Period 3||0
1623961|NCT00868790|3969351|P1|NOT COMPLETED|Period 3||0
1623962|NCT00868790|3969338|P14|COMPLETED|Period 3||8
1623963|NCT00868790|3969339|P13|COMPLETED|Period 3||7
1623964|NCT00868790|3969340|P12|COMPLETED|Period 3||4
1623965|NCT00868790|3969341|P11|COMPLETED|Period 3||8
1623966|NCT00868790|3969342|P10|COMPLETED|Period 3||2
1623967|NCT00868790|3969343|P9|COMPLETED|Period 3||8
1623968|NCT00868790|3969344|P8|COMPLETED|Period 3||17
1623969|NCT00868790|3969345|P7|COMPLETED|Period 3||4
1623970|NCT00868790|3969346|P6|COMPLETED|Period 3||1
1623971|NCT00868790|3969347|P5|COMPLETED|Period 3||18
1623972|NCT00868790|3969348|P4|COMPLETED|Period 3||3
1623973|NCT00868790|3969349|P3|COMPLETED|Period 3||4
1623974|NCT00868790|3969350|P2|COMPLETED|Period 3||6
1623975|NCT00868790|3969351|P1|COMPLETED|Period 3||9
1623976|NCT00868790|3969338|P14|STARTED|Period 3||8
1623977|NCT00868790|3969339|P13|STARTED|Period 3||7
1623978|NCT00868790|3969340|P12|STARTED|Period 3||4
1623979|NCT00868790|3969341|P11|STARTED|Period 3||9
1623980|NCT00868790|3969342|P10|STARTED|Period 3||3
1623981|NCT00868790|3969343|P9|STARTED|Period 3||8
1623982|NCT00868790|3969344|P8|STARTED|Period 3||17
1623983|NCT00868790|3969345|P7|STARTED|Period 3||4
1623984|NCT00868790|3969346|P6|STARTED|Period 3||1
1623985|NCT00868790|3969347|P5|STARTED|Period 3||18
1623986|NCT00868790|3969348|P4|STARTED|Period 3||4
1623987|NCT00868790|3969349|P3|STARTED|Period 3||4
1623988|NCT00868790|3969350|P2|STARTED|Period 3||6
1623989|NCT00868790|3969351|P1|STARTED|Period 3||9
1623990|NCT00868790|3969338|P14|NOT COMPLETED|Period 2||1
1623991|NCT00868790|3969339|P13|NOT COMPLETED|Period 2||0
1623992|NCT00868790|3969340|P12|NOT COMPLETED|Period 2||0
1623993|NCT00868790|3969341|P11|NOT COMPLETED|Period 2||0
1623994|NCT00868790|3969342|P10|NOT COMPLETED|Period 2||0
1623995|NCT00868790|3969343|P9|NOT COMPLETED|Period 2||2
1623996|NCT00868790|3969344|P8|NOT COMPLETED|Period 2||0
1623997|NCT00868790|3969345|P7|NOT COMPLETED|Period 2||0
1623998|NCT00868790|3969346|P6|NOT COMPLETED|Period 2||1
1623999|NCT00868790|3969347|P5|NOT COMPLETED|Period 2||0
1624000|NCT00868790|3969348|P4|NOT COMPLETED|Period 2||0
1624001|NCT00868790|3969349|P3|NOT COMPLETED|Period 2||0
1624002|NCT00868790|3969350|P2|NOT COMPLETED|Period 2||1
1624003|NCT00868790|3969351|P1|NOT COMPLETED|Period 2||0
1624004|NCT00868790|3969338|P14|COMPLETED|Period 2||8
1624005|NCT00868790|3969339|P13|COMPLETED|Period 2||7
1624006|NCT00868790|3969340|P12|COMPLETED|Period 2||4
1624007|NCT00868790|3969341|P11|COMPLETED|Period 2||9
1624008|NCT00868790|3969342|P10|COMPLETED|Period 2||3
1624009|NCT00868790|3969343|P9|COMPLETED|Period 2||8
1624010|NCT00868790|3969344|P8|COMPLETED|Period 2||17
1624011|NCT00868790|3969345|P7|COMPLETED|Period 2||4
1624012|NCT00868790|3969346|P6|COMPLETED|Period 2||1
1624013|NCT00868790|3969347|P5|COMPLETED|Period 2||18
1624014|NCT00868790|3969348|P4|COMPLETED|Period 2||4
1624015|NCT00868790|3969349|P3|COMPLETED|Period 2||4
1624016|NCT00868790|3969350|P2|COMPLETED|Period 2||6
1624017|NCT00868790|3969351|P1|COMPLETED|Period 2||9
1624018|NCT00868790|3969338|P14|STARTED|Period 2||9
1624019|NCT00868790|3969339|P13|STARTED|Period 2||7
1624020|NCT00868790|3969340|P12|STARTED|Period 2||4
1624021|NCT00868790|3969341|P11|STARTED|Period 2||9
1624022|NCT00868790|3969342|P10|STARTED|Period 2||3
1624023|NCT00868790|3969343|P9|STARTED|Period 2||10
1624024|NCT00868790|3969344|P8|STARTED|Period 2||17
1624025|NCT00868790|3969345|P7|STARTED|Period 2||4
1624026|NCT00868790|3969346|P6|STARTED|Period 2||2
1624027|NCT00868790|3969347|P5|STARTED|Period 2||18
1624028|NCT00868790|3969348|P4|STARTED|Period 2||4
1624029|NCT00868790|3969349|P3|STARTED|Period 2||4
1624030|NCT00868790|3969350|P2|STARTED|Period 2||7
1624031|NCT00868790|3969351|P1|STARTED|Period 2||9
1624032|NCT00868790|3969338|P14|NOT COMPLETED|Period 1||2
1624033|NCT00868790|3969339|P13|NOT COMPLETED|Period 1||0
1624034|NCT00868790|3969340|P12|NOT COMPLETED|Period 1||0
1624035|NCT00868790|3969341|P11|NOT COMPLETED|Period 1||0
1624036|NCT00868790|3969342|P10|NOT COMPLETED|Period 1||0
1624037|NCT00868790|3969343|P9|NOT COMPLETED|Period 1||1
1624038|NCT00868790|3969344|P8|NOT COMPLETED|Period 1||3
1624039|NCT00868790|3969345|P7|NOT COMPLETED|Period 1||0
1624040|NCT00868790|3969346|P6|NOT COMPLETED|Period 1||1
1624041|NCT00868790|3969347|P5|NOT COMPLETED|Period 1||1
1624042|NCT00868790|3969348|P4|NOT COMPLETED|Period 1||0
1624043|NCT00868790|3969349|P3|NOT COMPLETED|Period 1||0
1624044|NCT00868790|3969350|P2|NOT COMPLETED|Period 1||1
1624045|NCT00868790|3969351|P1|NOT COMPLETED|Period 1||2
1624046|NCT00868790|3969338|P14|COMPLETED|Period 1||9
1624047|NCT00868790|3969339|P13|COMPLETED|Period 1||7
1624048|NCT00868790|3969340|P12|COMPLETED|Period 1||4
1624049|NCT00868790|3969341|P11|COMPLETED|Period 1||9
1624050|NCT00868790|3969342|P10|COMPLETED|Period 1||3
1624051|NCT00868790|3969343|P9|COMPLETED|Period 1||10
1624052|NCT00868790|3969344|P8|COMPLETED|Period 1||17
1624053|NCT00868790|3969345|P7|COMPLETED|Period 1||4
1624054|NCT00868790|3969346|P6|COMPLETED|Period 1||2
1624055|NCT00868790|3969347|P5|COMPLETED|Period 1||18
1624056|NCT00868790|3969348|P4|COMPLETED|Period 1||4
1624057|NCT00868790|3969349|P3|COMPLETED|Period 1||4
1624058|NCT00868790|3969350|P2|COMPLETED|Period 1||7
1624059|NCT00868790|3969351|P1|COMPLETED|Period 1||9
1624060|NCT00868790|3969338|P14|STARTED|Period 1||11
1624061|NCT00868790|3969339|P13|STARTED|Period 1||7
1624062|NCT00868790|3969340|P12|STARTED|Period 1||4
1624063|NCT00868790|3969341|P11|STARTED|Period 1||9
1624064|NCT00868790|3969342|P10|STARTED|Period 1||3
1624065|NCT00868790|3969343|P9|STARTED|Period 1||11
1624066|NCT00868790|3969344|P8|STARTED|Period 1||20
1624067|NCT00868790|3969345|P7|STARTED|Period 1||4
1624068|NCT00868790|3969346|P6|STARTED|Period 1||3
1624069|NCT00868790|3969347|P5|STARTED|Period 1||19
1624070|NCT00868790|3969348|P4|STARTED|Period 1||4
1624071|NCT00868790|3969349|P3|STARTED|Period 1||4
1624072|NCT00868790|3969350|P2|STARTED|Period 1||8
1624073|NCT00868790|3969351|P1|STARTED|Period 1||11
1624074|NCT00868751|3969388|P1|NOT COMPLETED|Overall Study||1
1624075|NCT00868751|3969388|P1|COMPLETED|Overall Study||0
1624076|NCT00868751|3969388|P1|STARTED|Overall Study||1
1624077|NCT00868712|3969399|P3|NOT COMPLETED|Overall Study||0
1624078|NCT00868712|3969400|P2|NOT COMPLETED|Overall Study||0
1624079|NCT00868712|3969401|P1|NOT COMPLETED|Overall Study||0
1624080|NCT00868712|3969399|P3|COMPLETED|Overall Study||28
1624081|NCT00868712|3969400|P2|COMPLETED|Overall Study||11
1624082|NCT00868712|3969401|P1|COMPLETED|Overall Study||31
1624083|NCT00868712|3969399|P3|STARTED|Overall Study||28
1624084|NCT00868712|3969400|P2|STARTED|Overall Study||11
1624085|NCT00868712|3969401|P1|STARTED|Overall Study||31
1624086|NCT00868699|3969415|P3|NOT COMPLETED|Overall Study||43
1624087|NCT00868699|3969416|P2|NOT COMPLETED|Overall Study||45
1624088|NCT00868699|3969417|P1|NOT COMPLETED|Overall Study||43
1624089|NCT00868699|3969415|P3|COMPLETED|Overall Study||123
1624090|NCT00868699|3969416|P2|COMPLETED|Overall Study||124
1624091|NCT00868699|3969417|P1|COMPLETED|Overall Study||127
1624092|NCT00868699|3969415|P3|Safety Population|Overall Study||164
1624093|NCT00868699|3969416|P2|Safety Population|Overall Study||167
1624094|NCT00868699|3969417|P1|Safety Population|Overall Study||168
1624095|NCT00868699|3969415|P3|Intent-to-Treat Population|Overall Study||161
1624096|NCT00868699|3969416|P2|Intent-to-Treat Population|Overall Study||162
1624097|NCT00868699|3969417|P1|Intent-to-Treat Population|Overall Study||162
1624098|NCT00868699|3969415|P3|STARTED|Overall Study||166
1624099|NCT00868699|3969416|P2|STARTED|Overall Study||169
1624100|NCT00868699|3969417|P1|STARTED|Overall Study||170
1624101|NCT00868608|3969434|P3|NOT COMPLETED|Overall Study||5
1624102|NCT00868608|3969435|P2|NOT COMPLETED|Overall Study||3
1624103|NCT00868608|3969436|P1|NOT COMPLETED|Overall Study||23
1624104|NCT00868608|3969434|P3|COMPLETED|Overall Study||0
1624105|NCT00868608|3969435|P2|COMPLETED|Overall Study||1
1624106|NCT00868608|3969436|P1|COMPLETED|Overall Study||49
1624107|NCT00868608|3969434|P3|STARTED|Overall Study||5
1624108|NCT00868608|3969435|P2|STARTED|Overall Study||4
1624109|NCT00868608|3969436|P1|STARTED|Overall Study||72
1624110|NCT00868530|3969460|P1|NOT COMPLETED|Overall Study||4
1624111|NCT00868530|3969460|P1|COMPLETED|Overall Study||49
1624112|NCT00868530|3969460|P1|STARTED|Overall Study||53
1624113|NCT00868517|3969475|P3|NOT COMPLETED|Overall Study||2
1624114|NCT00868517|3969476|P2|NOT COMPLETED|Overall Study||4
1624115|NCT00868517|3969477|P1|NOT COMPLETED|Overall Study||4
1624116|NCT00868517|3969475|P3|COMPLETED|Overall Study||9
1624117|NCT00868517|3969476|P2|COMPLETED|Overall Study||8
1624118|NCT00868517|3969477|P1|COMPLETED|Overall Study||8
1624119|NCT00868517|3969475|P3|STARTED|Overall Study||11
1624120|NCT00868517|3969476|P2|STARTED|Overall Study||12
1624121|NCT00868517|3969477|P1|STARTED|Overall Study||12
1624122|NCT00868452|3969502|P2|NOT COMPLETED|Overall Study||29
1624123|NCT00868452|3969503|P1|NOT COMPLETED|Overall Study||40
1624124|NCT00868452|3969502|P2|COMPLETED|Overall Study||136
1624125|NCT00868452|3969503|P1|COMPLETED|Overall Study||143
1624126|NCT00868452|3969502|P2|STARTED|Overall Study||165
1624127|NCT00868452|3969503|P1|STARTED|Overall Study||183
1624128|NCT00868439|3969515|P2|NOT COMPLETED|Overall Study||9
1624129|NCT00868439|3969516|P1|NOT COMPLETED|Overall Study||8
1624130|NCT00868439|3969515|P2|COMPLETED|Overall Study||40
1624131|NCT00868439|3969516|P1|COMPLETED|Overall Study||48
1624132|NCT00868439|3969515|P2|STARTED|Overall Study||49
1624133|NCT00868439|3969516|P1|STARTED|Overall Study||56
1624134|NCT00868374|3969534|P2|NOT COMPLETED|Overall Study||7
1624135|NCT00868374|3969535|P1|NOT COMPLETED|Overall Study||7
1624136|NCT00868374|3969534|P2|COMPLETED|Overall Study||4
1624137|NCT00868374|3969535|P1|COMPLETED|Overall Study||5
1624138|NCT00868374|3969534|P2|STARTED|Overall Study||11
1624139|NCT00868374|3969535|P1|STARTED|Overall Study||12
1624140|NCT00868348|3969543|P2|NOT COMPLETED|Overall Study||0
1624141|NCT00868348|3969544|P1|NOT COMPLETED|Overall Study||0
1624142|NCT00868348|3969543|P2|COMPLETED|Overall Study||30
1624143|NCT00868348|3969544|P1|COMPLETED|Overall Study||30
1624144|NCT00868348|3969543|P2|STARTED|Overall Study||30
1624145|NCT00868348|3969544|P1|STARTED|Overall Study||30
1624146|NCT00868309|3969562|P2|NOT COMPLETED|Overall Study||0
1624147|NCT00868309|3969563|P1|NOT COMPLETED|Overall Study||0
1624148|NCT00868309|3969562|P2|COMPLETED|Overall Study||6
1624149|NCT00868309|3969563|P1|COMPLETED|Overall Study||6
1624150|NCT00868309|3969562|P2|STARTED|Overall Study||6
1624151|NCT00868309|3969563|P1|STARTED|Overall Study||6
1624152|NCT00868296|3969573|P2|NOT COMPLETED|Overall Study||3
1624153|NCT00868296|3969574|P1|NOT COMPLETED|Overall Study||0
1624154|NCT00868296|3969573|P2|COMPLETED|Overall Study||43
1624155|NCT00868296|3969574|P1|COMPLETED|Overall Study||12
1624156|NCT00868296|3969573|P2|STARTED|Overall Study||46
1624157|NCT00868296|3969574|P1|STARTED|Overall Study||12
1624158|NCT00868231|3969582|P6|NOT COMPLETED|Treatment Period 3||0
1624159|NCT00868231|3969583|P5|NOT COMPLETED|Treatment Period 3||0
1624160|NCT00868231|3969584|P4|NOT COMPLETED|Treatment Period 3||0
1624161|NCT00868231|3969585|P3|NOT COMPLETED|Treatment Period 3||1
1624162|NCT00868231|3969586|P2|NOT COMPLETED|Treatment Period 3||0
1624163|NCT00868231|3969587|P1|NOT COMPLETED|Treatment Period 3||0
1624164|NCT00868231|3969582|P6|COMPLETED|Treatment Period 3||5
1624165|NCT00868231|3969583|P5|COMPLETED|Treatment Period 3||4
1624166|NCT00868231|3969584|P4|COMPLETED|Treatment Period 3||5
1624167|NCT00868231|3969585|P3|COMPLETED|Treatment Period 3||4
1624168|NCT00868231|3969586|P2|COMPLETED|Treatment Period 3||5
1624169|NCT00868231|3969587|P1|COMPLETED|Treatment Period 3||4
1624170|NCT00868231|3969582|P6|STARTED|Treatment Period 3||5
1624171|NCT00868231|3969583|P5|STARTED|Treatment Period 3||4
1624172|NCT00868231|3969584|P4|STARTED|Treatment Period 3||5
1624173|NCT00868231|3969585|P3|STARTED|Treatment Period 3||5
1624174|NCT00868231|3969586|P2|STARTED|Treatment Period 3||5
1624175|NCT00868231|3969587|P1|STARTED|Treatment Period 3||4
1624176|NCT00868231|3969582|P6|NOT COMPLETED|Treatment Period 2||0
1624177|NCT00868231|3969583|P5|NOT COMPLETED|Treatment Period 2||0
1624178|NCT00868231|3969584|P4|NOT COMPLETED|Treatment Period 2||0
1624179|NCT00868231|3969585|P3|NOT COMPLETED|Treatment Period 2||0
1624180|NCT00868231|3969586|P2|NOT COMPLETED|Treatment Period 2||0
1624181|NCT00868231|3969587|P1|NOT COMPLETED|Treatment Period 2||1
1624182|NCT00868231|3969582|P6|COMPLETED|Treatment Period 2||5
1624183|NCT00868231|3969583|P5|COMPLETED|Treatment Period 2||4
1624184|NCT00868231|3969584|P4|COMPLETED|Treatment Period 2||5
1624185|NCT00868231|3969585|P3|COMPLETED|Treatment Period 2||5
1624186|NCT00868231|3969586|P2|COMPLETED|Treatment Period 2||5
1624187|NCT00868231|3969587|P1|COMPLETED|Treatment Period 2||4
1624188|NCT00868231|3969582|P6|STARTED|Treatment Period 2||5
1624189|NCT00868231|3969583|P5|STARTED|Treatment Period 2||4
1624190|NCT00868231|3969584|P4|STARTED|Treatment Period 2||5
1624191|NCT00868231|3969585|P3|STARTED|Treatment Period 2||5
1624192|NCT00868231|3969586|P2|STARTED|Treatment Period 2||5
1624193|NCT00868231|3969587|P1|STARTED|Treatment Period 2||5
1624194|NCT00868231|3969582|P6|NOT COMPLETED|Treatment Period 1||0
1624195|NCT00868231|3969583|P5|NOT COMPLETED|Treatment Period 1||1
1624196|NCT00868231|3969584|P4|NOT COMPLETED|Treatment Period 1||0
1624197|NCT00868231|3969585|P3|NOT COMPLETED|Treatment Period 1||0
1624198|NCT00868231|3969586|P2|NOT COMPLETED|Treatment Period 1||0
1624199|NCT00868231|3969587|P1|NOT COMPLETED|Treatment Period 1||0
1624200|NCT00868231|3969582|P6|COMPLETED|Treatment Period 1||5
1624201|NCT00868231|3969583|P5|COMPLETED|Treatment Period 1||4
1624202|NCT00868231|3969584|P4|COMPLETED|Treatment Period 1||5
1624203|NCT00868231|3969585|P3|COMPLETED|Treatment Period 1||5
1624204|NCT00868231|3969586|P2|COMPLETED|Treatment Period 1||5
1624205|NCT00868231|3969587|P1|COMPLETED|Treatment Period 1||5
1624206|NCT00868231|3969582|P6|STARTED|Treatment Period 1||5
1624207|NCT00868231|3969583|P5|STARTED|Treatment Period 1||5
1624208|NCT00868231|3969584|P4|STARTED|Treatment Period 1||5
1624209|NCT00868231|3969585|P3|STARTED|Treatment Period 1||5
1624210|NCT00868231|3969586|P2|STARTED|Treatment Period 1||5
1624211|NCT00868231|3969587|P1|STARTED|Treatment Period 1||5
1624212|NCT00868218|3969632|P4|NOT COMPLETED|Overall Study||0
1624213|NCT00868218|3969633|P3|NOT COMPLETED|Overall Study||0
1624214|NCT00868218|3969634|P2|NOT COMPLETED|Overall Study||0
1624215|NCT00868218|3969635|P1|NOT COMPLETED|Overall Study||0
1624216|NCT00868218|3969632|P4|COMPLETED|Overall Study||15
1624217|NCT00868218|3969633|P3|COMPLETED|Overall Study||15
1624218|NCT00868218|3969634|P2|COMPLETED|Overall Study||15
1624219|NCT00868218|3969635|P1|COMPLETED|Overall Study||15
1624220|NCT00868218|3969632|P4|STARTED|Overall Study||15
1624221|NCT00868218|3969633|P3|STARTED|Overall Study||15
1624222|NCT00868218|3969634|P2|STARTED|Overall Study||15
1624223|NCT00868218|3969635|P1|STARTED|Overall Study||15
1624224|NCT00868192|3969653|P1|NOT COMPLETED|Overall Study||4
1624225|NCT00868192|3969653|P1|COMPLETED|Overall Study||34
1624226|NCT00868192|3969653|P1|STARTED|Overall Study||38
1624227|NCT00868140|3969670|P2|NOT COMPLETED|Overall Study||0
1624228|NCT00868140|3969671|P1|NOT COMPLETED|Overall Study||0
1624229|NCT00868140|3969670|P2|COMPLETED|Overall Study||25
1624230|NCT00868140|3969671|P1|COMPLETED|Overall Study||26
1624231|NCT00868140|3969670|P2|STARTED|Overall Study||25
1624232|NCT00868140|3969671|P1|STARTED|Overall Study||26
1624233|NCT00868101|3969689|P2|NOT COMPLETED|Overall Study||0
1624234|NCT00868101|3969690|P1|NOT COMPLETED|Overall Study||0
1624235|NCT00868101|3969689|P2|COMPLETED|Overall Study||10
1624236|NCT00868101|3969690|P1|COMPLETED|Overall Study||12
1624237|NCT00868101|3969689|P2|STARTED|Overall Study||10
1624238|NCT00868101|3969690|P1|STARTED|Overall Study||12
1624239|NCT00867932|3969702|P1|NOT COMPLETED|Overall Study||0
1624240|NCT00867932|3969702|P1|COMPLETED|Overall Study||7
1624241|NCT00867932|3969702|P1|Intent-to-Treat (ITT) Population|Overall Study||7
1624242|NCT00867932|3969702|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
1624243|NCT00867932|3969702|P1|Maintenance Phase|Overall Study||7
1624244|NCT00867932|3969702|P1|Induction Phase|Overall Study||7
1624245|NCT00867932|3969702|P1|STARTED|Overall Study||7
1624246|NCT00867659|3969710|P1|NOT COMPLETED|Overall Study||0
1624247|NCT00867659|3969710|P1|COMPLETED|Overall Study|January 2010|20
1624248|NCT00867659|3969710|P1|STARTED|Overall Study|October 2009|20
1624249|NCT00867568|3969715|P1|NOT COMPLETED|Overall Study||15
1624250|NCT00867568|3969715|P1|COMPLETED|Overall Study||3
1624251|NCT00867568|3969715|P1|STARTED|Overall Study||18
1624252|NCT00867529|3969724|P1|NOT COMPLETED|Overall Study||0
1624253|NCT00867529|3969724|P1|COMPLETED|Overall Study||63
1624254|NCT00867529|3969724|P1|STARTED|Overall Study||63
1624255|NCT00867503|3969732|P1|NOT COMPLETED|Overall Study||1
1624256|NCT00867503|3969732|P1|COMPLETED|Overall Study||9
1624257|NCT00867503|3969732|P1|STARTED|Overall Study||10
1624258|NCT00867490|3969738|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
1624259|NCT00867490|3969738|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
1624260|NCT00867490|3969738|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
1624261|NCT00867490|3969738|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
1624262|NCT00867490|3969738|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
1624263|NCT00867490|3969738|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
1624264|NCT00867490|3969738|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
1624265|NCT00867490|3969738|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
1624266|NCT00867490|3969738|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
1624267|NCT00867451|3969757|P2|NOT COMPLETED|Overall Study||0
1624268|NCT00867451|3969758|P1|NOT COMPLETED|Overall Study||0
1624269|NCT00867451|3969757|P2|COMPLETED|Overall Study||4
1624270|NCT00867451|3969758|P1|COMPLETED|Overall Study||4
1624271|NCT00867451|3969757|P2|STARTED|Overall Study||4
1624272|NCT00867451|3969758|P1|STARTED|Overall Study||4
1624273|NCT00867360|3969780|P2|NOT COMPLETED|Overall Study||1
1624274|NCT00867360|3969781|P1|NOT COMPLETED|Overall Study||1
1624275|NCT00867360|3969780|P2|COMPLETED|Overall Study||5
1624276|NCT00867360|3969781|P1|COMPLETED|Overall Study||3
1624277|NCT00867360|3969780|P2|STARTED|Overall Study||6
1624278|NCT00867360|3969781|P1|STARTED|Overall Study||4
1624279|NCT00867321|3969794|P6|NOT COMPLETED|Overall Study||0
1624280|NCT00867321|3969795|P5|NOT COMPLETED|Overall Study||0
1624281|NCT00867321|3969796|P4|NOT COMPLETED|Overall Study||0
1624282|NCT00867321|3969797|P3|NOT COMPLETED|Overall Study||0
1624283|NCT00867321|3969798|P2|NOT COMPLETED|Overall Study||1
1624284|NCT00867321|3969799|P1|NOT COMPLETED|Overall Study||0
1624285|NCT00867321|3969794|P6|COMPLETED|Overall Study||3
1624286|NCT00867321|3969795|P5|COMPLETED|Overall Study||5
1624287|NCT00867321|3969796|P4|COMPLETED|Overall Study||6
1624288|NCT00867321|3969797|P3|COMPLETED|Overall Study||3
1624289|NCT00867321|3969798|P2|COMPLETED|Overall Study||2
1624290|NCT00867321|3969799|P1|COMPLETED|Overall Study||4
1624291|NCT00867321|3969794|P6|STARTED|Overall Study||3
1624292|NCT00867321|3969795|P5|STARTED|Overall Study||5
1624293|NCT00867321|3969796|P4|STARTED|Overall Study||6
1624294|NCT00867321|3969797|P3|STARTED|Overall Study||3
1624295|NCT00867321|3969798|P2|STARTED|Overall Study||3
1624296|NCT00867321|3969799|P1|STARTED|Overall Study||4
1624297|NCT00867308|3969819|P2|NOT COMPLETED|Overall Study||18
1624298|NCT00867308|3969820|P1|NOT COMPLETED|Overall Study||9
1624299|NCT00867308|3969819|P2|COMPLETED|Overall Study||0
1624300|NCT00867308|3969820|P1|COMPLETED|Overall Study||0
1624301|NCT00867308|3969819|P2|STARTED|Overall Study||18
1624302|NCT00867308|3969820|P1|STARTED|Overall Study||9
1624303|NCT00867217|3969830|P2|NOT COMPLETED|Overall Study||10
1624304|NCT00867217|3969831|P1|NOT COMPLETED|Overall Study||3
1624305|NCT00867217|3969830|P2|COMPLETED|Overall Study||70
1624306|NCT00867217|3969831|P1|COMPLETED|Overall Study||77
1624307|NCT00867217|3969830|P2|STARTED|Overall Study||80
1624308|NCT00867217|3969831|P1|STARTED|Overall Study||80
1624309|NCT00867165|3969839|P2|NOT COMPLETED|Overall Study||0
1624310|NCT00867165|3969840|P1|NOT COMPLETED|Overall Study||4
1624311|NCT00867165|3969839|P2|COMPLETED|Overall Study||45
1624312|NCT00867165|3969840|P1|COMPLETED|Overall Study||89
1624313|NCT00867165|3969839|P2|STARTED|Overall Study||45
1624314|NCT00867165|3969840|P1|STARTED|Overall Study||93
1624315|NCT00867139|3969945|P3|NOT COMPLETED|Overall Study||1
1624316|NCT00867139|3969946|P2|NOT COMPLETED|Overall Study||0
1624317|NCT00867139|3969947|P1|NOT COMPLETED|Overall Study||0
1624318|NCT00867139|3969945|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
1624319|NCT00867139|3969946|P2|COMPLETED|Overall Study||1
1624320|NCT00867139|3969947|P1|COMPLETED|Overall Study||2
1624321|NCT00867139|3969945|P3|STARTED|Overall Study||4
1624322|NCT00867139|3969946|P2|STARTED|Overall Study||1
1624323|NCT00867139|3969947|P1|STARTED|Overall Study||2
1624324|NCT00867113|3969988|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
1624325|NCT00867113|3969988|P1|COMPLETED|Post Treatment After Survival Follow-up||57
1624326|NCT00867113|3969988|P1|STARTED|Post Treatment After Survival Follow-up||68
1624327|NCT00867113|3969988|P1|NOT COMPLETED|Treatment Period||45
1624328|NCT00867113|3969988|P1|COMPLETED|Treatment Period||46
1624329|NCT00867113|3969988|P1|Full Analysis Set (FAS)|Treatment Period||91
1624330|NCT00867113|3969988|P1|Safety Set|Treatment Period||91
1624331|NCT00867113|3969988|P1|STARTED|Treatment Period||91
1624332|NCT00867087|3969995|P1|NOT COMPLETED|Overall Study||42
1624333|NCT00867087|3969995|P1|COMPLETED|Overall Study||21
1624334|NCT00867087|3969995|P1|STARTED|Overall Study||63
1624335|NCT00867035|3970011|P2|NOT COMPLETED|Baseline to 1 Week||0
1624336|NCT00867035|3970012|P1|NOT COMPLETED|Baseline to 1 Week||1
1624337|NCT00867035|3970011|P2|COMPLETED|Baseline to 1 Week||8
1624338|NCT00867035|3970012|P1|COMPLETED|Baseline to 1 Week||11
1624339|NCT00867035|3970011|P2|STARTED|Baseline to 1 Week||8
1624340|NCT00867035|3970012|P1|STARTED|Baseline to 1 Week||12
1624341|NCT00867035|3970011|P2|NOT COMPLETED|Baseline to 4 Hours||0
1624342|NCT00867035|3970012|P1|NOT COMPLETED|Baseline to 4 Hours||0
1624343|NCT00867035|3970011|P2|COMPLETED|Baseline to 4 Hours||8
1624344|NCT00867035|3970012|P1|COMPLETED|Baseline to 4 Hours||12
1624345|NCT00867035|3970011|P2|STARTED|Baseline to 4 Hours||8
1624346|NCT00867035|3970012|P1|STARTED|Baseline to 4 Hours||12
1624347|NCT00867035|3970011|P2|NOT COMPLETED|Baseline to 2 Hours||0
1624348|NCT00867035|3970012|P1|NOT COMPLETED|Baseline to 2 Hours||0
1624349|NCT00867035|3970011|P2|COMPLETED|Baseline to 2 Hours||8
1624350|NCT00867035|3970012|P1|COMPLETED|Baseline to 2 Hours||12
1624351|NCT00867035|3970011|P2|STARTED|Baseline to 2 Hours||8
1624352|NCT00867035|3970012|P1|STARTED|Baseline to 2 Hours||12
1624353|NCT00867035|3970011|P2|NOT COMPLETED|Baseline to 1 Hour||1
1624354|NCT00867035|3970012|P1|NOT COMPLETED|Baseline to 1 Hour||1
1624355|NCT00867035|3970011|P2|COMPLETED|Baseline to 1 Hour||8
1624356|NCT00867035|3970012|P1|COMPLETED|Baseline to 1 Hour||12
1624357|NCT00867035|3970011|P2|STARTED|Baseline to 1 Hour||9
1624358|NCT00867035|3970012|P1|STARTED|Baseline to 1 Hour||13
1624359|NCT00867009|3970038|P1|NOT COMPLETED|Maintenance Period||4
1624360|NCT00867009|3970038|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
1624361|NCT00867009|3970038|P1|STARTED|Maintenance Period||51
1624362|NCT00867009|3970038|P1|NOT COMPLETED|Induction Period||62
1624363|NCT00867009|3970038|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
1624364|NCT00867009|3970038|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
1624365|NCT00867009|3970038|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
1624366|NCT00867009|3970038|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
1624367|NCT00866918|3970047|P2|NOT COMPLETED|Overall Study||12
1624368|NCT00866918|3970048|P1|NOT COMPLETED|Overall Study||16
1624369|NCT00866918|3970047|P2|COMPLETED|Overall Study||27
1624370|NCT00866918|3970048|P1|COMPLETED|Overall Study||53
1624371|NCT00866918|3970047|P2|STARTED|Overall Study||39
1624372|NCT00866918|3970048|P1|STARTED|Overall Study||69
1624373|NCT00866905|3970060|P1|NOT COMPLETED|Overall Study||33
1624374|NCT00866905|3970060|P1|COMPLETED|Overall Study||135
1624375|NCT00866905|3970060|P1|STARTED|Overall Study||168
1624376|NCT00866814|3970065|P1|NOT COMPLETED|Overall Study||20
1624377|NCT00866814|3970065|P1|COMPLETED|Overall Study||99
1624378|NCT00866814|3970065|P1|STARTED|Overall Study||119
1624379|NCT00866788|3970078|P4|NOT COMPLETED|Overall Study||5
1624380|NCT00866788|3970079|P3|NOT COMPLETED|Overall Study||2
1624381|NCT00866788|3970080|P2|NOT COMPLETED|Overall Study||6
1624382|NCT00866788|3970081|P1|NOT COMPLETED|Overall Study||6
1624383|NCT00866788|3970078|P4|COMPLETED|Overall Study||16
1624384|NCT00866788|3970079|P3|COMPLETED|Overall Study||23
1624385|NCT00866788|3970080|P2|COMPLETED|Overall Study||17
1624386|NCT00866788|3970081|P1|COMPLETED|Overall Study||15
1624387|NCT00866788|3970078|P4|STARTED|Overall Study||21
1624388|NCT00866788|3970079|P3|STARTED|Overall Study||25
1624389|NCT00866788|3970080|P2|STARTED|Overall Study||23
1624390|NCT00866788|3970081|P1|STARTED|Overall Study||21
1624391|NCT00866775|3970129|P2|NOT COMPLETED|Overall Study||52
1624392|NCT00866775|3970130|P1|NOT COMPLETED|Overall Study||36
1624393|NCT00866775|3970129|P2|COMPLETED|Overall Study||76
1624394|NCT00866775|3970130|P1|COMPLETED|Overall Study||29
1624395|NCT00866775|3970129|P2|STARTED|Overall Study||128
1624396|NCT00866775|3970130|P1|STARTED|Overall Study||65
1624397|NCT00866723|3970166|P1|NOT COMPLETED|Overall Study||5
1624398|NCT00866723|3970166|P1|COMPLETED|Overall Study||0
1624399|NCT00866723|3970166|P1|STARTED|Overall Study||5
1624400|NCT00866697|3970173|P2|NOT COMPLETED|Overall Study||228
1624401|NCT00866697|3970174|P1|NOT COMPLETED|Overall Study||214
1624402|NCT00866697|3970173|P2|COMPLETED|Overall Study||244
1624403|NCT00866697|3970174|P1|COMPLETED|Overall Study||254
1624404|NCT00866697|3970173|P2|STARTED|Overall Study||472
1624405|NCT00866697|3970174|P1|STARTED|Overall Study||468
1624406|NCT00866658|3970216|P2|NOT COMPLETED|Overall Study||21
1624407|NCT00866658|3970217|P1|NOT COMPLETED|Overall Study||13
1624408|NCT00866658|3970216|P2|COMPLETED|Overall Study||133
1624409|NCT00866658|3970217|P1|COMPLETED|Overall Study||144
1624410|NCT00866658|3970216|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
1624411|NCT00866658|3970217|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
1624412|NCT00866658|3970216|P2|Safety Population|Overall Study||154
1624413|NCT00866658|3970217|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
1624414|NCT00866658|3970216|P2|STARTED|Overall Study||154
1624415|NCT00866658|3970217|P1|STARTED|Overall Study|Randomized.|157
1624416|NCT00866606|3970245|P1|NOT COMPLETED|Overall Study||4
1624417|NCT00866606|3970245|P1|COMPLETED|Overall Study||31
1624418|NCT00866606|3970245|P1|STARTED|Overall Study||35
1624419|NCT00866359|3970259|P4|NOT COMPLETED|Observational Follow-Up Phase||0
1624420|NCT00866359|3970260|P3|NOT COMPLETED|Observational Follow-Up Phase||0
1624421|NCT00866359|3970261|P2|NOT COMPLETED|Observational Follow-Up Phase||0
1624422|NCT00866359|3970262|P1|NOT COMPLETED|Observational Follow-Up Phase||0
1624423|NCT00866359|3970259|P4|COMPLETED|Observational Follow-Up Phase||54
1624424|NCT00866359|3970260|P3|COMPLETED|Observational Follow-Up Phase||54
1624425|NCT00866359|3970261|P2|COMPLETED|Observational Follow-Up Phase||0
1624426|NCT00866359|3970262|P1|COMPLETED|Observational Follow-Up Phase||0
1624427|NCT00866359|3970259|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
1624428|NCT00866359|3970260|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
1624429|NCT00866359|3970261|P2|STARTED|Observational Follow-Up Phase||0
1624430|NCT00866359|3970262|P1|STARTED|Observational Follow-Up Phase||0
1624431|NCT00866359|3970259|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
1624432|NCT00866359|3970260|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
1624433|NCT00866359|3970261|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
1624434|NCT00866359|3970262|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
1624435|NCT00866359|3970259|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
1624436|NCT00866359|3970260|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
1624437|NCT00866359|3970261|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
1624438|NCT00866359|3970262|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
1624439|NCT00866359|3970259|P4|STARTED|Extension Phase (Day 86 to 169)||50
1624440|NCT00866359|3970260|P3|STARTED|Extension Phase (Day 86 to 169)||45
1624441|NCT00866359|3970261|P2|STARTED|Extension Phase (Day 86 to 169)||0
1624442|NCT00866359|3970262|P1|STARTED|Extension Phase (Day 86 to 169)||0
1624443|NCT00866359|3970259|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
1624444|NCT00866359|3970260|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
1624445|NCT00866359|3970261|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
1624446|NCT00866359|3970262|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
1624447|NCT00866359|3970259|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
1624448|NCT00866359|3970260|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
1624449|NCT00866359|3970261|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
1624450|NCT00866359|3970262|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
1624451|NCT00866359|3970259|P4|STARTED|Treatment Phase (Days 1 to 85)||0
1624452|NCT00866359|3970260|P3|STARTED|Treatment Phase (Days 1 to 85)||0
1624453|NCT00866359|3970261|P2|STARTED|Treatment Phase (Days 1 to 85)||55
1624454|NCT00866359|3970262|P1|STARTED|Treatment Phase (Days 1 to 85)||56
1624455|NCT00866320|3970315|P1|NOT COMPLETED|Overall Study||6
1624456|NCT00866320|3970315|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
1624457|NCT00866320|3970315|P1|STARTED|Overall Study||49
1624458|NCT00866307|3970322|P3|NOT COMPLETED|Consolidation/Maintenance||16
1624459|NCT00866307|3970323|P2|NOT COMPLETED|Consolidation/Maintenance||9
1624460|NCT00866307|3970324|P1|NOT COMPLETED|Consolidation/Maintenance||0
1624461|NCT00866307|3970322|P3|COMPLETED|Consolidation/Maintenance||14
1624462|NCT00866307|3970323|P2|COMPLETED|Consolidation/Maintenance||45
1624463|NCT00866307|3970324|P1|COMPLETED|Consolidation/Maintenance||0
1624464|NCT00866307|3970322|P3|STARTED|Consolidation/Maintenance||30
1624465|NCT00866307|3970323|P2|STARTED|Consolidation/Maintenance||54
1624466|NCT00866307|3970324|P1|STARTED|Consolidation/Maintenance||0
1624467|NCT00866307|3970322|P3|NOT COMPLETED|Induction||0
1624468|NCT00866307|3970323|P2|NOT COMPLETED|Induction||0
1624469|NCT00866307|3970324|P1|NOT COMPLETED|Induction||20
1624470|NCT00866307|3970322|P3|COMPLETED|Induction||0
1624471|NCT00866307|3970323|P2|COMPLETED|Induction||0
1624472|NCT00866307|3970324|P1|COMPLETED|Induction||84
1624473|NCT00866307|3970322|P3|STARTED|Induction||0
1624474|NCT00866307|3970323|P2|STARTED|Induction||0
1624475|NCT00866307|3970324|P1|STARTED|Induction||104
1624476|NCT00866294|3970334|P3|NOT COMPLETED|Overall Study||11
1624477|NCT00866294|3970335|P2|NOT COMPLETED|Overall Study||20
1624478|NCT00866294|3970336|P1|NOT COMPLETED|Overall Study||33
1624479|NCT00866294|3970334|P3|COMPLETED|Overall Study||72
1624480|NCT00866294|3970335|P2|COMPLETED|Overall Study||141
1624481|NCT00866294|3970336|P1|COMPLETED|Overall Study||139
1624482|NCT00866294|3970334|P3|STARTED|Overall Study||83
1624483|NCT00866294|3970335|P2|STARTED|Overall Study||161
1624484|NCT00866294|3970336|P1|STARTED|Overall Study||172
1624485|NCT00866281|3970365|P2|NOT COMPLETED|Overall Study||15
1624486|NCT00866281|3970366|P1|NOT COMPLETED|Overall Study||7
1624487|NCT00866281|3970365|P2|COMPLETED|Overall Study||0
1624488|NCT00866281|3970366|P1|COMPLETED|Overall Study||0
1624489|NCT00866281|3970365|P2|STARTED|Overall Study||15
1624490|NCT00866281|3970366|P1|STARTED|Overall Study||7
1624491|NCT00866177|3970382|P1|NOT COMPLETED|Overall Study||152
1624492|NCT00866177|3970382|P1|COMPLETED|Overall Study||15
1624493|NCT00866177|3970382|P1|STARTED|Overall Study||167
1624494|NCT00866047|3970386|P1|NOT COMPLETED|Follow-up Period||5
1624495|NCT00866047|3970386|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
1624496|NCT00866047|3970386|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
1624497|NCT00866047|3970386|P1|NOT COMPLETED|Treatment Period||48
1624498|NCT00866047|3970386|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
1624499|NCT00866047|3970386|P1|STARTED|Treatment Period||58
1624500|NCT00866034|3970404|P2|NOT COMPLETED|Overall Study||8
1624501|NCT00866034|3970405|P1|NOT COMPLETED|Overall Study||16
1624502|NCT00866034|3970404|P2|COMPLETED|Overall Study||301
1624503|NCT00866034|3970405|P1|COMPLETED|Overall Study||292
1624504|NCT00866034|3970404|P2|STARTED|Overall Study||309
1624505|NCT00866034|3970405|P1|STARTED|Overall Study||308
1624506|NCT00865904|3970418|P5|NOT COMPLETED|Overall Study||1
1624507|NCT00865904|3970419|P4|NOT COMPLETED|Overall Study||1
1624508|NCT00865904|3970420|P3|NOT COMPLETED|Overall Study||0
1624509|NCT00865904|3970421|P2|NOT COMPLETED|Overall Study||0
1624510|NCT00865904|3970422|P1|NOT COMPLETED|Overall Study||2
1624511|NCT00865904|3970418|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
1624512|NCT00865904|3970419|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
1624513|NCT00865904|3970420|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
1624514|NCT00865904|3970421|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
1624515|NCT00865904|3970422|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
1624516|NCT00865904|3970418|P5|STARTED|Overall Study|Randomized.|20
1624517|NCT00865904|3970419|P4|STARTED|Overall Study|Randomized.|18
1624518|NCT00865904|3970420|P3|STARTED|Overall Study|Randomized.|18
1624519|NCT00865904|3970421|P2|STARTED|Overall Study|Randomized.|18
1624520|NCT00865904|3970422|P1|STARTED|Overall Study|Randomized.|19
1624521|NCT00865709|3970479|P2|NOT COMPLETED|Long Term Follow-up||49
1624522|NCT00865709|3970480|P1|NOT COMPLETED|Long Term Follow-up||46
1624523|NCT00865709|3970479|P2|COMPLETED|Long Term Follow-up||33
1624524|NCT00865709|3970480|P1|COMPLETED|Long Term Follow-up||24
1624525|NCT00865709|3970479|P2|STARTED|Long Term Follow-up||82
1624526|NCT00865709|3970480|P1|STARTED|Long Term Follow-up||70
1624527|NCT00865709|3970479|P2|NOT COMPLETED|Active Follow-up||1
1624528|NCT00865709|3970480|P1|NOT COMPLETED|Active Follow-up||8
1624529|NCT00865709|3970479|P2|COMPLETED|Active Follow-up||15
1624530|NCT00865709|3970480|P1|COMPLETED|Active Follow-up||17
1624531|NCT00865709|3970479|P2|STARTED|Active Follow-up||16
1624532|NCT00865709|3970480|P1|STARTED|Active Follow-up||25
1624533|NCT00865709|3970479|P2|NOT COMPLETED|Treatment||18
1624534|NCT00865709|3970480|P1|NOT COMPLETED|Treatment||30
1624535|NCT00865709|3970479|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
1624536|NCT00865709|3970480|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
1624537|NCT00865709|3970479|P2|Received Treatment|Treatment|Safety population|101
1624538|NCT00865709|3970480|P1|Received Treatment|Treatment|Safety population|97
1624539|NCT00865709|3970479|P2|STARTED|Treatment||101
1624540|NCT00865709|3970480|P1|STARTED|Treatment||97
1624541|NCT00865514|3970496|P1|NOT COMPLETED|Overall Study||2
1624542|NCT00865514|3970496|P1|COMPLETED|Overall Study||0
1624543|NCT00865514|3970496|P1|STARTED|Overall Study||2
1624544|NCT00865345|3970501|P1|NOT COMPLETED|Overall Study||2
1624545|NCT00865345|3970501|P1|COMPLETED|Overall Study||61
1624546|NCT00865345|3970501|P1|STARTED|Overall Study||63
1624547|NCT00865306|3970508|P2|NOT COMPLETED|One-Year Follow-Up||0
1624548|NCT00865306|3970509|P1|NOT COMPLETED|One-Year Follow-Up||0
1624549|NCT00865306|3970508|P2|COMPLETED|One-Year Follow-Up||15
1624550|NCT00865306|3970509|P1|COMPLETED|One-Year Follow-Up||29
1624551|NCT00865306|3970508|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
1624552|NCT00865306|3970509|P1|STARTED|One-Year Follow-Up||29
1624553|NCT00865306|3970508|P2|NOT COMPLETED|Controlled Trial||2
1624554|NCT00865306|3970509|P1|NOT COMPLETED|Controlled Trial||5
1624555|NCT00865306|3970508|P2|COMPLETED|Controlled Trial||28
1624556|NCT00865306|3970509|P1|COMPLETED|Controlled Trial||29
1624557|NCT00865306|3970508|P2|STARTED|Controlled Trial||30
1624558|NCT00865306|3970509|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
1624559|NCT00865202|3970521|P2|NOT COMPLETED|Overall Study||0
1624560|NCT00865202|3970522|P1|NOT COMPLETED|Overall Study||0
1624561|NCT00865202|3970521|P2|COMPLETED|Overall Study||149
1624562|NCT00865202|3970522|P1|COMPLETED|Overall Study||152
1624563|NCT00865202|3970521|P2|STARTED|Overall Study||149
1624564|NCT00865202|3970522|P1|STARTED|Overall Study||152
1624565|NCT00865189|3970538|P2|NOT COMPLETED|Overall Study||19
1624566|NCT00865189|3970539|P1|NOT COMPLETED|Overall Study||12
1624567|NCT00865189|3970538|P2|COMPLETED|Overall Study||26
1624568|NCT00865189|3970539|P1|COMPLETED|Overall Study||34
1624569|NCT00865189|3970538|P2|STARTED|Overall Study||45
1624570|NCT00865189|3970539|P1|STARTED|Overall Study||46
1624571|NCT00865124|3970567|P3|NOT COMPLETED|Overall Study||0
1624572|NCT00865124|3970568|P2|NOT COMPLETED|Overall Study||1
1624573|NCT00865124|3970569|P1|NOT COMPLETED|Overall Study||4
1624574|NCT00865124|3970567|P3|COMPLETED|Overall Study||17
1624575|NCT00865124|3970568|P2|COMPLETED|Overall Study||24
1624576|NCT00865124|3970569|P1|COMPLETED|Overall Study||23
1624577|NCT00865124|3970567|P3|STARTED|Overall Study||17
1624578|NCT00865124|3970568|P2|STARTED|Overall Study||25
1624579|NCT00865124|3970569|P1|STARTED|Overall Study||27
1624580|NCT00865098|3970586|P1|NOT COMPLETED|Overall Study||1
1624581|NCT00865098|3970586|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
1624582|NCT00865098|3970586|P1|STARTED|Overall Study||22
1624583|NCT00865046|3970598|P3|NOT COMPLETED|Overall Study||1
1624584|NCT00865046|3970599|P2|NOT COMPLETED|Overall Study||5
1624585|NCT00865046|3970600|P1|NOT COMPLETED|Overall Study||6
1624586|NCT00865046|3970598|P3|COMPLETED|Overall Study||62
1624587|NCT00865046|3970599|P2|COMPLETED|Overall Study||59
1624588|NCT00865046|3970600|P1|COMPLETED|Overall Study||57
1624589|NCT00865046|3970598|P3|STARTED|Overall Study||63
1624590|NCT00865046|3970599|P2|STARTED|Overall Study||64
1624591|NCT00865046|3970600|P1|STARTED|Overall Study||63
1624592|NCT00865020|3970610|P2|NOT COMPLETED|Overall Study||51
1624593|NCT00865020|3970611|P1|NOT COMPLETED|Overall Study||49
1624594|NCT00865020|3970610|P2|COMPLETED|Overall Study||357
1624595|NCT00865020|3970611|P1|COMPLETED|Overall Study||365
1624596|NCT00865020|3970610|P2|STARTED|Overall Study||408
1624597|NCT00865020|3970611|P1|STARTED|Overall Study||414
1624598|NCT00864916|3970627|P2|NOT COMPLETED|Overall Study||4
1624599|NCT00864916|3970628|P1|NOT COMPLETED|Overall Study||6
1624600|NCT00864916|3970627|P2|COMPLETED|Overall Study||5
1624601|NCT00864916|3970628|P1|COMPLETED|Overall Study||4
1624602|NCT00864916|3970627|P2|STARTED|Overall Study||9
1624603|NCT00864916|3970628|P1|STARTED|Overall Study||10
1624604|NCT00864851|3970637|P3|NOT COMPLETED|Overall Study||0
1624605|NCT00864851|3970638|P2|NOT COMPLETED|Overall Study||1
1624606|NCT00864851|3970639|P1|NOT COMPLETED|Overall Study||3
1624607|NCT00864851|3970637|P3|COMPLETED|Overall Study||5
1624608|NCT00864851|3970638|P2|COMPLETED|Overall Study||18
1624609|NCT00864851|3970639|P1|COMPLETED|Overall Study||17
1624610|NCT00864851|3970637|P3|STARTED|Overall Study||5
1624611|NCT00864851|3970638|P2|STARTED|Overall Study||19
1624612|NCT00864851|3970639|P1|STARTED|Overall Study||20
1624613|NCT00864721|3970673|P1|NOT COMPLETED|Overall Study||34
1624614|NCT00864721|3970673|P1|COMPLETED|Overall Study||29
1624615|NCT00864721|3970673|P1|STARTED|Overall Study||63
1624616|NCT00864708|3970681|P1|NOT COMPLETED|Overall Study||0
1624617|NCT00864708|3970681|P1|COMPLETED|Overall Study||1
1624618|NCT00864708|3970681|P1|STARTED|Overall Study||1
1624619|NCT00864682|3970693|P3|NOT COMPLETED|Overall Study||2
1624620|NCT00864682|3970694|P2|NOT COMPLETED|Overall Study||1
1624621|NCT00864682|3970695|P1|NOT COMPLETED|Overall Study||2
1624622|NCT00864682|3970693|P3|COMPLETED|Overall Study||51
1624623|NCT00864682|3970694|P2|COMPLETED|Overall Study||50
1624624|NCT00864682|3970695|P1|COMPLETED|Overall Study||50
1624625|NCT00864682|3970693|P3|STARTED|Overall Study||53
1624626|NCT00864682|3970694|P2|STARTED|Overall Study||51
1624627|NCT00864682|3970695|P1|STARTED|Overall Study||52
1624628|NCT00864539|3970715|P6|NOT COMPLETED|Overall Study||14
1624629|NCT00864539|3970716|P5|NOT COMPLETED|Overall Study||22
1624630|NCT00864539|3970717|P4|NOT COMPLETED|Overall Study||7
1624631|NCT00864539|3970718|P3|NOT COMPLETED|Overall Study||10
1624632|NCT00864539|3970719|P2|NOT COMPLETED|Overall Study||23
1624633|NCT00864539|3970720|P1|NOT COMPLETED|Overall Study||9
1624634|NCT00864539|3970715|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
1624635|NCT00864539|3970716|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
1624636|NCT00864539|3970717|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
1624637|NCT00864539|3970718|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
1624638|NCT00864539|3970719|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
1624639|NCT00864539|3970720|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
1624640|NCT00864539|3970715|P6|STARTED|Overall Study||85
1624641|NCT00864539|3970716|P5|STARTED|Overall Study||103
1624642|NCT00864539|3970717|P4|STARTED|Overall Study||96
1624643|NCT00864539|3970718|P3|STARTED|Overall Study||102
1624644|NCT00864539|3970719|P2|STARTED|Overall Study||95
1624645|NCT00864539|3970720|P1|STARTED|Overall Study||104
1624646|NCT00864513|3970734|P1|NOT COMPLETED|Overall Study||3
1624647|NCT00864513|3970734|P1|COMPLETED|Overall Study||12
1624648|NCT00864513|3970734|P1|STARTED|Overall Study||15
1624649|NCT00864383|3970744|P3|NOT COMPLETED|Modified Intent to Treat||85
1624650|NCT00864383|3970745|P2|NOT COMPLETED|Modified Intent to Treat||87
1624651|NCT00864383|3970746|P1|NOT COMPLETED|Modified Intent to Treat||85
1624652|NCT00864383|3970744|P3|COMPLETED|Modified Intent to Treat||551
1624653|NCT00864383|3970745|P2|COMPLETED|Modified Intent to Treat||568
1624654|NCT00864383|3970746|P1|COMPLETED|Modified Intent to Treat||555
1624655|NCT00864383|3970744|P3|STARTED|Modified Intent to Treat||636
1624656|NCT00864383|3970745|P2|STARTED|Modified Intent to Treat||655
1624657|NCT00864383|3970746|P1|STARTED|Modified Intent to Treat||640
1624658|NCT00864383|3970744|P3|NOT COMPLETED|Per- Protocol||112
1624659|NCT00864383|3970745|P2|NOT COMPLETED|Per- Protocol||141
1624660|NCT00864383|3970746|P1|NOT COMPLETED|Per- Protocol||130
1624661|NCT00864383|3970744|P3|COMPLETED|Per- Protocol||524
1624662|NCT00864383|3970745|P2|COMPLETED|Per- Protocol||514
1624663|NCT00864383|3970746|P1|COMPLETED|Per- Protocol||510
1624664|NCT00864383|3970744|P3|STARTED|Per- Protocol||636
1624665|NCT00864383|3970745|P2|STARTED|Per- Protocol||655
1624666|NCT00864383|3970746|P1|STARTED|Per- Protocol||640
1624667|NCT00864253|3970780|P2|NOT COMPLETED|Overall Study||58
1624668|NCT00864253|3970781|P1|NOT COMPLETED|Overall Study||99
1624669|NCT00864253|3970780|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
1624670|NCT00864253|3970781|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
1624671|NCT00864253|3970780|P2|Treated|Overall Study||258
1624672|NCT00864253|3970781|P1|Treated|Overall Study||257
1624673|NCT00864253|3970780|P2|STARTED|Overall Study||265
1624674|NCT00864253|3970781|P1|STARTED|Overall Study||264
1624675|NCT00864227|3970811|P1|NOT COMPLETED|Overall Study||4
1624676|NCT00864227|3970811|P1|COMPLETED|Overall Study||50
1624677|NCT00864227|3970811|P1|STARTED|Overall Study||54
1624678|NCT00864123|3970828|P2|NOT COMPLETED|Overall Study||0
1624679|NCT00864123|3970829|P1|NOT COMPLETED|Overall Study||0
1624680|NCT00864123|3970828|P2|COMPLETED|Overall Study||15
1624681|NCT00864123|3970829|P1|COMPLETED|Overall Study||15
1624682|NCT00864123|3970828|P2|STARTED|Overall Study||15
1624683|NCT00864123|3970829|P1|STARTED|Overall Study||15
1624684|NCT00864084|3970839|P1|NOT COMPLETED|Overall Study||3
1624685|NCT00864084|3970839|P1|COMPLETED|Overall Study||11
1624686|NCT00864084|3970839|P1|STARTED|Overall Study||14
1624687|NCT00864032|3970862|P3|NOT COMPLETED|Overall Study||0
1624688|NCT00864032|3970863|P2|NOT COMPLETED|Overall Study||0
1624689|NCT00864032|3970864|P1|NOT COMPLETED|Overall Study||0
1624690|NCT00864032|3970862|P3|COMPLETED|Overall Study||0
1624691|NCT00864032|3970863|P2|COMPLETED|Overall Study||5
1624692|NCT00864032|3970864|P1|COMPLETED|Overall Study||3
1624693|NCT00864032|3970862|P3|STARTED|Overall Study||0
1624694|NCT00864032|3970863|P2|STARTED|Overall Study||5
1624695|NCT00864032|3970864|P1|STARTED|Overall Study||3
1624696|NCT00863798|3970873|P3|NOT COMPLETED|Overall Study||25
1624697|NCT00863798|3970874|P2|NOT COMPLETED|Overall Study||30
1624698|NCT00863798|3970875|P1|NOT COMPLETED|Overall Study||32
1624699|NCT00863798|3970873|P3|COMPLETED|Overall Study||202
1624700|NCT00863798|3970874|P2|COMPLETED|Overall Study||198
1624701|NCT00863798|3970875|P1|COMPLETED|Overall Study||195
1624702|NCT00863798|3970873|P3|Treated|Overall Study||224
1624703|NCT00863798|3970874|P2|Treated|Overall Study||226
1624704|NCT00863798|3970875|P1|Treated|Overall Study||223
1624705|NCT00863798|3970873|P3|STARTED|Overall Study||227
1624706|NCT00863798|3970874|P2|STARTED|Overall Study||228
1624707|NCT00863798|3970875|P1|STARTED|Overall Study||227
1624708|NCT00863746|3970927|P2|NOT COMPLETED|Survival Follow up||280
1624709|NCT00863746|3970928|P1|NOT COMPLETED|Survival Follow up||253
1624710|NCT00863746|3970927|P2|COMPLETED|Survival Follow up||51
1624711|NCT00863746|3970928|P1|COMPLETED|Survival Follow up||45
1624712|NCT00863746|3970927|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
1624713|NCT00863746|3970928|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
1624714|NCT00863746|3970927|P2|NOT COMPLETED|Treatment||35
1624715|NCT00863746|3970928|P1|NOT COMPLETED|Treatment||71
1624716|NCT00863746|3970927|P2|COMPLETED|Treatment||318
1624717|NCT00863746|3970928|P1|COMPLETED|Treatment||279
1624718|NCT00863746|3970927|P2|Participants Received Treatment|Treatment|Safety population|351
1624719|NCT00863746|3970928|P1|Participants Received Treatment|Treatment|Safety population|346
1624720|NCT00863746|3970927|P2|STARTED|Treatment||353
1624721|NCT00863746|3970928|P1|STARTED|Treatment||350
1624722|NCT00863707|3970954|P2|NOT COMPLETED|Overall Study||3
1624723|NCT00863707|3970955|P1|NOT COMPLETED|Overall Study||4
1624724|NCT00863707|3970954|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
1624725|NCT00863707|3970955|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
1624726|NCT00863707|3970954|P2|STARTED|Overall Study||337
1624727|NCT00863707|3970955|P1|STARTED|Overall Study||174
1624728|NCT00863655|3970963|P2|NOT COMPLETED|Overall Study||239
1624729|NCT00863655|3970964|P1|NOT COMPLETED|Overall Study||485
1624730|NCT00863655|3970963|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
1624731|NCT00863655|3970964|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
1624732|NCT00863655|3970963|P2|STARTED|Overall Study||239
1624733|NCT00863655|3970964|P1|STARTED|Overall Study||485
1624734|NCT00863551|3970991|P1|NOT COMPLETED|Overall Study||0
1624735|NCT00863551|3970991|P1|COMPLETED|Overall Study||12
1624736|NCT00863551|3970991|P1|STARTED|Overall Study||12
1624737|NCT00863512|3971001|P2|NOT COMPLETED|Overall Study||0
1624738|NCT00863512|3971002|P1|NOT COMPLETED|Overall Study||14
1624739|NCT00863512|3971001|P2|COMPLETED|Overall Study||17
1624740|NCT00863512|3971002|P1|COMPLETED|Overall Study||3
1624741|NCT00863512|3971001|P2|STARTED|Overall Study||17
1624742|NCT00863512|3971002|P1|STARTED|Overall Study||17
1624743|NCT00863434|3971008|P1|NOT COMPLETED|Overall Study||0
1624744|NCT00863434|3971008|P1|COMPLETED|Overall Study||2
1624745|NCT00863434|3971008|P1|STARTED|Overall Study||2
1624746|NCT00863356|3971014|P1|NOT COMPLETED|Overall Study||0
1624747|NCT00863356|3971014|P1|COMPLETED|Overall Study||20
1624748|NCT00863356|3971014|P1|STARTED|Overall Study||20
1624749|NCT00863343|3971020|P2|NOT COMPLETED|Overall Study||0
1624750|NCT00863343|3971021|P1|NOT COMPLETED|Overall Study||0
1624751|NCT00863343|3971020|P2|COMPLETED|Overall Study||374
1624752|NCT00863343|3971021|P1|COMPLETED|Overall Study||17
1624753|NCT00863343|3971020|P2|STARTED|Overall Study||374
1624754|NCT00863343|3971021|P1|STARTED|Overall Study||17
1624755|NCT00863330|3971033|P1|NOT COMPLETED|Overall Study||6
1624756|NCT00863330|3971033|P1|COMPLETED|Overall Study||0
1624757|NCT00863330|3971033|P1|STARTED|Overall Study||6
1624758|NCT00863317|3971039|P2|NOT COMPLETED|Overall Study||9
1624759|NCT00863317|3971040|P1|NOT COMPLETED|Overall Study||8
1624760|NCT00863317|3971039|P2|COMPLETED|Overall Study||64
1624761|NCT00863317|3971040|P1|COMPLETED|Overall Study||60
1624762|NCT00863317|3971039|P2|STARTED|Overall Study||73
1624763|NCT00863317|3971040|P1|STARTED|Overall Study||68
1624764|NCT00863265|3971046|P6|NOT COMPLETED|Overall Study||0
1624765|NCT00863265|3971047|P5|NOT COMPLETED|Overall Study||1
1624766|NCT00863265|3971048|P4|NOT COMPLETED|Overall Study||0
1624767|NCT00863265|3971049|P3|NOT COMPLETED|Overall Study||0
1624768|NCT00863265|3971050|P2|NOT COMPLETED|Overall Study||0
1624769|NCT00863265|3971051|P1|NOT COMPLETED|Overall Study||0
1624770|NCT00863265|3971046|P6|COMPLETED|Overall Study||3
1624771|NCT00863265|3971047|P5|COMPLETED|Overall Study||3
1624772|NCT00863265|3971048|P4|COMPLETED|Overall Study||4
1624773|NCT00863265|3971049|P3|COMPLETED|Overall Study||4
1624774|NCT00863265|3971050|P2|COMPLETED|Overall Study||3
1624775|NCT00863265|3971051|P1|COMPLETED|Overall Study||4
1624776|NCT00863265|3971046|P6|STARTED|Overall Study||3
1624777|NCT00863265|3971047|P5|STARTED|Overall Study||4
1624778|NCT00863265|3971048|P4|STARTED|Overall Study||4
1624779|NCT00863265|3971049|P3|STARTED|Overall Study||4
1624780|NCT00863265|3971050|P2|STARTED|Overall Study||3
1624781|NCT00863265|3971051|P1|STARTED|Overall Study||4
1624782|NCT00863122|3971067|P2|NOT COMPLETED|Overall Study||0
1624783|NCT00863122|3971068|P1|NOT COMPLETED|Overall Study||0
1624784|NCT00863122|3971067|P2|COMPLETED|Overall Study||7
1624785|NCT00863122|3971068|P1|COMPLETED|Overall Study||19
1624786|NCT00863122|3971067|P2|STARTED|Overall Study||7
1624787|NCT00863122|3971068|P1|STARTED|Overall Study||19
1624788|NCT00863109|3971078|P1|NOT COMPLETED|Follow-up Period||11
1624789|NCT00863109|3971078|P1|COMPLETED|Follow-up Period||48
1624790|NCT00863109|3971078|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
1624791|NCT00863109|3971078|P1|NOT COMPLETED|Treatment Period||77
1624792|NCT00863109|3971078|P1|COMPLETED|Treatment Period||53
1624793|NCT00863109|3971078|P1|STARTED|Treatment Period||130
1624794|NCT00863057|3971095|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1624795|NCT00863057|3971096|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1624796|NCT00863057|3971097|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1624797|NCT00863057|3971098|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1624798|NCT00863057|3971095|P4|COMPLETED|Period 4 (Weeks 16-20)||2
1624799|NCT00863057|3971096|P3|COMPLETED|Period 4 (Weeks 16-20)||2
1624800|NCT00863057|3971097|P2|COMPLETED|Period 4 (Weeks 16-20)||1
1624801|NCT00863057|3971098|P1|COMPLETED|Period 4 (Weeks 16-20)||3
1624802|NCT00863057|3971095|P4|STARTED|Period 4 (Weeks 16-20)||2
1624803|NCT00863057|3971096|P3|STARTED|Period 4 (Weeks 16-20)||2
1624804|NCT00863057|3971097|P2|STARTED|Period 4 (Weeks 16-20)||1
1624805|NCT00863057|3971098|P1|STARTED|Period 4 (Weeks 16-20)||3
1624806|NCT00863057|3971095|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1624807|NCT00863057|3971096|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1624808|NCT00863057|3971097|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1624809|NCT00863057|3971098|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1624810|NCT00863057|3971095|P4|COMPLETED|Period 3 (Weeks 11-15)||2
1624811|NCT00863057|3971096|P3|COMPLETED|Period 3 (Weeks 11-15)||2
1624812|NCT00863057|3971097|P2|COMPLETED|Period 3 (Weeks 11-15)||1
1624813|NCT00863057|3971098|P1|COMPLETED|Period 3 (Weeks 11-15)||3
1624814|NCT00863057|3971095|P4|STARTED|Period 3 (Weeks 11-15)||2
1624815|NCT00863057|3971096|P3|STARTED|Period 3 (Weeks 11-15)||2
1624816|NCT00863057|3971097|P2|STARTED|Period 3 (Weeks 11-15)||1
1624817|NCT00863057|3971098|P1|STARTED|Period 3 (Weeks 11-15)||3
1624818|NCT00863057|3971095|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
1624819|NCT00863057|3971096|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
1624820|NCT00863057|3971097|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
1624821|NCT00863057|3971098|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
1624822|NCT00863057|3971095|P4|COMPLETED|Period 2 (Weeks 6-10)||2
1624823|NCT00863057|3971096|P3|COMPLETED|Period 2 (Weeks 6-10)||2
1624824|NCT00863057|3971097|P2|COMPLETED|Period 2 (Weeks 6-10)||1
1624825|NCT00863057|3971098|P1|COMPLETED|Period 2 (Weeks 6-10)||3
1624826|NCT00863057|3971095|P4|STARTED|Period 2 (Weeks 6-10)||3
1624827|NCT00863057|3971096|P3|STARTED|Period 2 (Weeks 6-10)||3
1624828|NCT00863057|3971097|P2|STARTED|Period 2 (Weeks 6-10)||2
1624829|NCT00863057|3971098|P1|STARTED|Period 2 (Weeks 6-10)||3
1624830|NCT00863057|3971095|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
1624831|NCT00863057|3971096|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
1624832|NCT00863057|3971097|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
1624833|NCT00863057|3971098|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
1624834|NCT00863057|3971095|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
1624835|NCT00863057|3971096|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
1624836|NCT00863057|3971097|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
1624837|NCT00863057|3971098|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
1624838|NCT00863057|3971095|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
1624839|NCT00863057|3971096|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
1624840|NCT00863057|3971097|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
1624841|NCT00863057|3971098|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
1624842|NCT00862979|3971148|P2|NOT COMPLETED|Overall Study||7
1624843|NCT00862979|3971149|P1|NOT COMPLETED|Overall Study||8
1624844|NCT00862979|3971148|P2|COMPLETED|Overall Study||71
1624845|NCT00862979|3971149|P1|COMPLETED|Overall Study||76
1624846|NCT00862979|3971148|P2|Full Analysis Set (FAS)|Overall Study||71
1624847|NCT00862979|3971149|P1|Full Analysis Set (FAS)|Overall Study||74
1624848|NCT00862979|3971148|P2|STARTED|Overall Study||78
1624849|NCT00862979|3971149|P1|STARTED|Overall Study||84
1624850|NCT00862940|3971167|P2|NOT COMPLETED|Overall Study||30
1624851|NCT00862940|3971168|P1|NOT COMPLETED|Overall Study||30
1624852|NCT00862940|3971167|P2|COMPLETED|Overall Study||114
1624853|NCT00862940|3971168|P1|COMPLETED|Overall Study||103
1624854|NCT00862940|3971167|P2|STARTED|Overall Study||144
1624855|NCT00862940|3971168|P1|STARTED|Overall Study||133
1624856|NCT00862849|3971180|P6|NOT COMPLETED|Intervention 6||0
1624857|NCT00862849|3971181|P5|NOT COMPLETED|Intervention 6||0
1624858|NCT00862849|3971182|P4|NOT COMPLETED|Intervention 6||0
1624859|NCT00862849|3971183|P3|NOT COMPLETED|Intervention 6||0
1624860|NCT00862849|3971184|P2|NOT COMPLETED|Intervention 6||0
1624861|NCT00862849|3971185|P1|NOT COMPLETED|Intervention 6||0
1624862|NCT00862849|3971180|P6|COMPLETED|Intervention 6||3
1624863|NCT00862849|3971181|P5|COMPLETED|Intervention 6||4
1624864|NCT00862849|3971182|P4|COMPLETED|Intervention 6||4
1624865|NCT00862849|3971183|P3|COMPLETED|Intervention 6||3
1624866|NCT00862849|3971184|P2|COMPLETED|Intervention 6||3
1624867|NCT00862849|3971185|P1|COMPLETED|Intervention 6||3
1624868|NCT00862849|3971180|P6|STARTED|Intervention 6||3
1624869|NCT00862849|3971181|P5|STARTED|Intervention 6||4
1624870|NCT00862849|3971182|P4|STARTED|Intervention 6||4
1624871|NCT00862849|3971183|P3|STARTED|Intervention 6||3
1624872|NCT00862849|3971184|P2|STARTED|Intervention 6||3
1624873|NCT00862849|3971185|P1|STARTED|Intervention 6||3
1624874|NCT00862849|3971180|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1624875|NCT00862849|3971181|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1624876|NCT00862849|3971182|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1624877|NCT00862849|3971183|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1624878|NCT00862849|3971184|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1624879|NCT00862849|3971185|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1624880|NCT00862849|3971180|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
1624881|NCT00862849|3971181|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
1624882|NCT00862849|3971182|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
1624883|NCT00862849|3971183|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
1624884|NCT00862849|3971184|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
1624885|NCT00862849|3971185|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
1624886|NCT00862849|3971180|P6|STARTED|Washout 5 (3 to 14 Days)||3
1624887|NCT00862849|3971181|P5|STARTED|Washout 5 (3 to 14 Days)||4
1624888|NCT00862849|3971182|P4|STARTED|Washout 5 (3 to 14 Days)||4
1624889|NCT00862849|3971183|P3|STARTED|Washout 5 (3 to 14 Days)||3
1624890|NCT00862849|3971184|P2|STARTED|Washout 5 (3 to 14 Days)||3
1624891|NCT00862849|3971185|P1|STARTED|Washout 5 (3 to 14 Days)||3
1624892|NCT00862849|3971180|P6|NOT COMPLETED|Intervention 5||0
1624893|NCT00862849|3971181|P5|NOT COMPLETED|Intervention 5||0
1624894|NCT00862849|3971182|P4|NOT COMPLETED|Intervention 5||0
1624895|NCT00862849|3971183|P3|NOT COMPLETED|Intervention 5||0
1624896|NCT00862849|3971184|P2|NOT COMPLETED|Intervention 5||0
1624897|NCT00862849|3971185|P1|NOT COMPLETED|Intervention 5||0
1624898|NCT00862849|3971180|P6|COMPLETED|Intervention 5||3
1624899|NCT00862849|3971181|P5|COMPLETED|Intervention 5||4
1624900|NCT00862849|3971182|P4|COMPLETED|Intervention 5||4
1624901|NCT00862849|3971183|P3|COMPLETED|Intervention 5||3
1624902|NCT00862849|3971184|P2|COMPLETED|Intervention 5||3
1624903|NCT00862849|3971185|P1|COMPLETED|Intervention 5||3
1624904|NCT00862849|3971180|P6|STARTED|Intervention 5||3
1624905|NCT00862849|3971181|P5|STARTED|Intervention 5||4
1624906|NCT00862849|3971182|P4|STARTED|Intervention 5||4
1624907|NCT00862849|3971183|P3|STARTED|Intervention 5||3
1624908|NCT00862849|3971184|P2|STARTED|Intervention 5||3
1624909|NCT00862849|3971185|P1|STARTED|Intervention 5||3
1624910|NCT00862849|3971180|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1624911|NCT00862849|3971181|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1624912|NCT00862849|3971182|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1624913|NCT00862849|3971183|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1624914|NCT00862849|3971184|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1624915|NCT00862849|3971185|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1624916|NCT00862849|3971180|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
1624917|NCT00862849|3971181|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
1624918|NCT00862849|3971182|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
1624919|NCT00862849|3971183|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
1624920|NCT00862849|3971184|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
1624921|NCT00862849|3971185|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
1624922|NCT00862849|3971180|P6|STARTED|Washout 4 (3 to 14 Days)||3
1624923|NCT00862849|3971181|P5|STARTED|Washout 4 (3 to 14 Days)||4
1624924|NCT00862849|3971182|P4|STARTED|Washout 4 (3 to 14 Days)||4
1624925|NCT00862849|3971183|P3|STARTED|Washout 4 (3 to 14 Days)||3
1624926|NCT00862849|3971184|P2|STARTED|Washout 4 (3 to 14 Days)||3
1624927|NCT00862849|3971185|P1|STARTED|Washout 4 (3 to 14 Days)||3
1624928|NCT00862849|3971180|P6|NOT COMPLETED|Intervention 4||0
1624929|NCT00862849|3971181|P5|NOT COMPLETED|Intervention 4||0
1624930|NCT00862849|3971182|P4|NOT COMPLETED|Intervention 4||0
1624931|NCT00862849|3971183|P3|NOT COMPLETED|Intervention 4||0
1624932|NCT00862849|3971184|P2|NOT COMPLETED|Intervention 4||0
1624933|NCT00862849|3971185|P1|NOT COMPLETED|Intervention 4||0
1624934|NCT00862849|3971180|P6|COMPLETED|Intervention 4||3
1624935|NCT00862849|3971181|P5|COMPLETED|Intervention 4||4
1624936|NCT00862849|3971182|P4|COMPLETED|Intervention 4||4
1624937|NCT00862849|3971183|P3|COMPLETED|Intervention 4||3
1624938|NCT00862849|3971184|P2|COMPLETED|Intervention 4||3
1624939|NCT00862849|3971185|P1|COMPLETED|Intervention 4||3
1624940|NCT00862849|3971180|P6|STARTED|Intervention 4||3
1624941|NCT00862849|3971181|P5|STARTED|Intervention 4||4
1624942|NCT00862849|3971182|P4|STARTED|Intervention 4||4
1624943|NCT00862849|3971183|P3|STARTED|Intervention 4||3
1624944|NCT00862849|3971184|P2|STARTED|Intervention 4||3
1624945|NCT00862849|3971185|P1|STARTED|Intervention 4||3
1624946|NCT00862849|3971180|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1624947|NCT00862849|3971181|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1624948|NCT00862849|3971182|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1624949|NCT00862849|3971183|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1624950|NCT00862849|3971184|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1624951|NCT00862849|3971185|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1624952|NCT00862849|3971180|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
1624953|NCT00862849|3971181|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
1624954|NCT00862849|3971182|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
1624955|NCT00862849|3971183|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
1624956|NCT00862849|3971184|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
1624957|NCT00862849|3971185|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
1624958|NCT00862849|3971180|P6|STARTED|Washout 3 (3 to 14 Days)||3
1624959|NCT00862849|3971181|P5|STARTED|Washout 3 (3 to 14 Days)||4
1624960|NCT00862849|3971182|P4|STARTED|Washout 3 (3 to 14 Days)||4
1624961|NCT00862849|3971183|P3|STARTED|Washout 3 (3 to 14 Days)||3
1624962|NCT00862849|3971184|P2|STARTED|Washout 3 (3 to 14 Days)||3
1624963|NCT00862849|3971185|P1|STARTED|Washout 3 (3 to 14 Days)||3
1624964|NCT00862849|3971180|P6|NOT COMPLETED|Intervention 3||0
1624965|NCT00862849|3971181|P5|NOT COMPLETED|Intervention 3||0
1624966|NCT00862849|3971182|P4|NOT COMPLETED|Intervention 3||0
1624967|NCT00862849|3971183|P3|NOT COMPLETED|Intervention 3||0
1624968|NCT00862849|3971184|P2|NOT COMPLETED|Intervention 3||0
1624969|NCT00862849|3971185|P1|NOT COMPLETED|Intervention 3||0
1624970|NCT00862849|3971180|P6|COMPLETED|Intervention 3||3
1624971|NCT00862849|3971181|P5|COMPLETED|Intervention 3||4
1624972|NCT00862849|3971182|P4|COMPLETED|Intervention 3||4
1624973|NCT00862849|3971183|P3|COMPLETED|Intervention 3||3
1624974|NCT00862849|3971184|P2|COMPLETED|Intervention 3||3
1624975|NCT00862849|3971185|P1|COMPLETED|Intervention 3||3
1624976|NCT00862849|3971180|P6|STARTED|Intervention 3||3
1624977|NCT00862849|3971181|P5|STARTED|Intervention 3||4
1624978|NCT00862849|3971182|P4|STARTED|Intervention 3||4
1624979|NCT00862849|3971183|P3|STARTED|Intervention 3||3
1624980|NCT00862849|3971184|P2|STARTED|Intervention 3||3
1624981|NCT00862849|3971185|P1|STARTED|Intervention 3||3
1624982|NCT00862849|3971180|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1624983|NCT00862849|3971181|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1624984|NCT00862849|3971182|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1624985|NCT00862849|3971183|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1624986|NCT00862849|3971184|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
1624987|NCT00862849|3971185|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1624988|NCT00862849|3971180|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
1624989|NCT00862849|3971181|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
1624990|NCT00862849|3971182|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
1624991|NCT00862849|3971183|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
1624992|NCT00862849|3971184|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
1624993|NCT00862849|3971185|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
1624994|NCT00862849|3971180|P6|STARTED|Washout 2 (3 to 14 Days)||3
1624995|NCT00862849|3971181|P5|STARTED|Washout 2 (3 to 14 Days)||4
1624996|NCT00862849|3971182|P4|STARTED|Washout 2 (3 to 14 Days)||4
1624997|NCT00862849|3971183|P3|STARTED|Washout 2 (3 to 14 Days)||3
1624998|NCT00862849|3971184|P2|STARTED|Washout 2 (3 to 14 Days)||4
1624999|NCT00862849|3971185|P1|STARTED|Washout 2 (3 to 14 Days)||3
1625000|NCT00862849|3971180|P6|NOT COMPLETED|Intervention 2||0
1625001|NCT00862849|3971181|P5|NOT COMPLETED|Intervention 2||0
1625002|NCT00862849|3971182|P4|NOT COMPLETED|Intervention 2||0
1625003|NCT00862849|3971183|P3|NOT COMPLETED|Intervention 2||0
1625004|NCT00862849|3971184|P2|NOT COMPLETED|Intervention 2||0
1625005|NCT00862849|3971185|P1|NOT COMPLETED|Intervention 2||0
1625006|NCT00862849|3971180|P6|COMPLETED|Intervention 2||3
1625007|NCT00862849|3971181|P5|COMPLETED|Intervention 2||4
1625008|NCT00862849|3971182|P4|COMPLETED|Intervention 2||4
1625009|NCT00862849|3971183|P3|COMPLETED|Intervention 2||3
1625010|NCT00862849|3971184|P2|COMPLETED|Intervention 2||4
1625011|NCT00862849|3971185|P1|COMPLETED|Intervention 2||3
1625012|NCT00862849|3971180|P6|STARTED|Intervention 2||3
1625013|NCT00862849|3971181|P5|STARTED|Intervention 2||4
1625014|NCT00862849|3971182|P4|STARTED|Intervention 2||4
1625015|NCT00862849|3971183|P3|STARTED|Intervention 2||3
1625016|NCT00862849|3971184|P2|STARTED|Intervention 2||4
1625017|NCT00862849|3971185|P1|STARTED|Intervention 2||3
1625018|NCT00862849|3971180|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1625019|NCT00862849|3971181|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1625020|NCT00862849|3971182|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1625021|NCT00862849|3971183|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1625022|NCT00862849|3971184|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
1625023|NCT00862849|3971185|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1625024|NCT00862849|3971180|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
1625025|NCT00862849|3971181|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
1625026|NCT00862849|3971182|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
1625027|NCT00862849|3971183|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
1625028|NCT00862849|3971184|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
1625029|NCT00862849|3971185|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
1625030|NCT00862849|3971180|P6|STARTED|Washout 1 (3 to 14 Days)||3
1625031|NCT00862849|3971181|P5|STARTED|Washout 1 (3 to 14 Days)||4
1625032|NCT00862849|3971182|P4|STARTED|Washout 1 (3 to 14 Days)||4
1625033|NCT00862849|3971183|P3|STARTED|Washout 1 (3 to 14 Days)||3
1625034|NCT00862849|3971184|P2|STARTED|Washout 1 (3 to 14 Days)||5
1625035|NCT00862849|3971185|P1|STARTED|Washout 1 (3 to 14 Days)||3
1625036|NCT00862849|3971180|P6|NOT COMPLETED|Intervention 1||0
1625037|NCT00862849|3971181|P5|NOT COMPLETED|Intervention 1||0
1625038|NCT00862849|3971182|P4|NOT COMPLETED|Intervention 1||0
1625039|NCT00862849|3971183|P3|NOT COMPLETED|Intervention 1||0
1625040|NCT00862849|3971184|P2|NOT COMPLETED|Intervention 1||0
1625041|NCT00862849|3971185|P1|NOT COMPLETED|Intervention 1||0
1625042|NCT00862849|3971180|P6|COMPLETED|Intervention 1||3
1625043|NCT00862849|3971181|P5|COMPLETED|Intervention 1||4
1625044|NCT00862849|3971182|P4|COMPLETED|Intervention 1||4
1625045|NCT00862849|3971183|P3|COMPLETED|Intervention 1||3
1625046|NCT00862849|3971184|P2|COMPLETED|Intervention 1||5
1625047|NCT00862849|3971185|P1|COMPLETED|Intervention 1||3
1625048|NCT00862849|3971180|P6|Received at Least One Dose of Study Drug|Intervention 1||3
1625049|NCT00862849|3971181|P5|Received at Least One Dose of Study Drug|Intervention 1||4
1625050|NCT00862849|3971182|P4|Received at Least One Dose of Study Drug|Intervention 1||4
1625051|NCT00862849|3971183|P3|Received at Least One Dose of Study Drug|Intervention 1||3
1625052|NCT00862849|3971184|P2|Received at Least One Dose of Study Drug|Intervention 1||5
1625053|NCT00862849|3971185|P1|Received at Least One Dose of Study Drug|Intervention 1||3
1625054|NCT00862849|3971180|P6|STARTED|Intervention 1||3
1625055|NCT00862849|3971181|P5|STARTED|Intervention 1||4
1625056|NCT00862849|3971182|P4|STARTED|Intervention 1||4
1625057|NCT00862849|3971183|P3|STARTED|Intervention 1||3
1625058|NCT00862849|3971184|P2|STARTED|Intervention 1||5
1625059|NCT00862849|3971185|P1|STARTED|Intervention 1||3
1625060|NCT00862836|3971208|P1|NOT COMPLETED|Overall Study||1
1625061|NCT00862836|3971208|P1|COMPLETED|Overall Study||14
1625062|NCT00862836|3971208|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
1625063|NCT00862836|3971208|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
1625064|NCT00862836|3971208|P1|STARTED|Overall Study||15
1625065|NCT00862823|3971219|P2|NOT COMPLETED|Second Intervention||0
1625066|NCT00862823|3971220|P1|NOT COMPLETED|Second Intervention||0
1625067|NCT00862823|3971219|P2|COMPLETED|Second Intervention||9
1625068|NCT00862823|3971220|P1|COMPLETED|Second Intervention||5
1625069|NCT00862823|3971219|P2|STARTED|Second Intervention||9
1625070|NCT00862823|3971220|P1|STARTED|Second Intervention||5
1625071|NCT00862823|3971219|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1625072|NCT00862823|3971220|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1625073|NCT00862823|3971219|P2|COMPLETED|Washout Period of 2 Weeks||9
1625074|NCT00862823|3971220|P1|COMPLETED|Washout Period of 2 Weeks||5
1625075|NCT00862823|3971219|P2|STARTED|Washout Period of 2 Weeks||9
1625076|NCT00862823|3971220|P1|STARTED|Washout Period of 2 Weeks||5
1625077|NCT00862823|3971219|P2|NOT COMPLETED|First Intervention||1
1625078|NCT00862823|3971220|P1|NOT COMPLETED|First Intervention||1
1625079|NCT00862823|3971219|P2|COMPLETED|First Intervention||9
1625080|NCT00862823|3971220|P1|COMPLETED|First Intervention||5
1625081|NCT00862823|3971219|P2|STARTED|First Intervention||10
1625082|NCT00862823|3971220|P1|STARTED|First Intervention||6
1625083|NCT00862810|3971229|P2|NOT COMPLETED|Overall Study||4
1625084|NCT00862810|3971230|P1|NOT COMPLETED|Overall Study||4
1625085|NCT00862810|3971229|P2|COMPLETED|Overall Study||35
1625086|NCT00862810|3971230|P1|COMPLETED|Overall Study||29
1625087|NCT00862810|3971229|P2|STARTED|Overall Study||39
1625088|NCT00862810|3971230|P1|STARTED|Overall Study||33
1625089|NCT00862784|3971236|P1|NOT COMPLETED|Overall Study||0
1625090|NCT00862784|3971236|P1|COMPLETED|Overall Study||48
1625091|NCT00862784|3971236|P1|Received Any Amount of Study Drug|Overall Study||48
1625092|NCT00862784|3971236|P1|STARTED|Overall Study||48
1625093|NCT00862745|3971258|P2|NOT COMPLETED|Open-label Follow-up||49
1625094|NCT00862745|3971259|P1|NOT COMPLETED|Open-label Follow-up||39
1625095|NCT00862745|3971258|P2|COMPLETED|Open-label Follow-up||225
1625096|NCT00862745|3971259|P1|COMPLETED|Open-label Follow-up||229
1625097|NCT00862745|3971258|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
1625098|NCT00862745|3971259|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
1625099|NCT00862745|3971258|P2|NOT COMPLETED|Randomized Control Trial||39
1625100|NCT00862745|3971259|P1|NOT COMPLETED|Randomized Control Trial||38
1625101|NCT00862745|3971258|P2|COMPLETED|Randomized Control Trial||284
1625102|NCT00862745|3971259|P1|COMPLETED|Randomized Control Trial||284
1625103|NCT00862745|3971258|P2|STARTED|Randomized Control Trial||323
1625104|NCT00862745|3971259|P1|STARTED|Randomized Control Trial||322
1625105|NCT00862719|3971269|P4|NOT COMPLETED|Overall Study||1
1625106|NCT00862719|3971270|P3|NOT COMPLETED|Overall Study||4
1625107|NCT00862719|3971271|P2|NOT COMPLETED|Overall Study||6
1625108|NCT00862719|3971272|P1|NOT COMPLETED|Overall Study||10
1625109|NCT00862719|3971269|P4|COMPLETED|Overall Study||0
1625110|NCT00862719|3971270|P3|COMPLETED|Overall Study||0
1625111|NCT00862719|3971271|P2|COMPLETED|Overall Study||1
1625112|NCT00862719|3971272|P1|COMPLETED|Overall Study||7
1625113|NCT00862719|3971269|P4|STARTED|Overall Study||1
1625114|NCT00862719|3971270|P3|STARTED|Overall Study||4
1625115|NCT00862719|3971271|P2|STARTED|Overall Study||7
1625116|NCT00862719|3971272|P1|STARTED|Overall Study||17
1625117|NCT00862654|3971295|P4|NOT COMPLETED|Overall Study||6
1625118|NCT00862654|3971296|P3|NOT COMPLETED|Overall Study||6
1625119|NCT00862654|3971297|P2|NOT COMPLETED|Overall Study||8
1625120|NCT00862654|3971298|P1|NOT COMPLETED|Overall Study||6
1625121|NCT00862654|3971295|P4|COMPLETED|Overall Study||74
1625122|NCT00862654|3971296|P3|COMPLETED|Overall Study||76
1625123|NCT00862654|3971297|P2|COMPLETED|Overall Study||74
1625124|NCT00862654|3971298|P1|COMPLETED|Overall Study||76
1625125|NCT00862654|3971295|P4|STARTED|Overall Study||80
1625126|NCT00862654|3971296|P3|STARTED|Overall Study||82
1625127|NCT00862654|3971297|P2|STARTED|Overall Study||82
1625128|NCT00862654|3971298|P1|STARTED|Overall Study||82
1625129|NCT00862641|3971312|P4|NOT COMPLETED|Overall Study||4
1625130|NCT00862641|3971313|P3|NOT COMPLETED|Overall Study||1
1625131|NCT00862641|3971314|P2|NOT COMPLETED|Overall Study||4
1625132|NCT00862641|3971315|P1|NOT COMPLETED|Overall Study||1
1625133|NCT00862641|3971312|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
1625134|NCT00862641|3971313|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
1625135|NCT00862641|3971314|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
1625136|NCT00862641|3971315|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
1625137|NCT00862641|3971312|P4|STARTED|Overall Study||320
1625138|NCT00862641|3971313|P3|STARTED|Overall Study||152
1625139|NCT00862641|3971314|P2|STARTED|Overall Study||360
1625140|NCT00862641|3971315|P1|STARTED|Overall Study||177
1625141|NCT00862563|3971361|P4|NOT COMPLETED|Overall Study||5
1625142|NCT00862563|3971362|P3|NOT COMPLETED|Overall Study||6
1625143|NCT00862563|3971363|P2|NOT COMPLETED|Overall Study||4
1625144|NCT00862563|3971364|P1|NOT COMPLETED|Overall Study||4
1625145|NCT00862563|3971361|P4|COMPLETED|Overall Study||19
1625146|NCT00862563|3971362|P3|COMPLETED|Overall Study||15
1625147|NCT00862563|3971363|P2|COMPLETED|Overall Study||17
1625148|NCT00862563|3971364|P1|COMPLETED|Overall Study||15
1625149|NCT00862563|3971361|P4|STARTED|Overall Study||24
1625150|NCT00862563|3971362|P3|STARTED|Overall Study||21
1625151|NCT00862563|3971363|P2|STARTED|Overall Study||21
1625152|NCT00862563|3971364|P1|STARTED|Overall Study||19
1625153|NCT00862537|3971402|P1|NOT COMPLETED|Overall Study||7
1625154|NCT00862537|3971402|P1|COMPLETED|Overall Study||11
1625155|NCT00862537|3971402|P1|STARTED|Overall Study||18
1625156|NCT00862459|3971409|P3|NOT COMPLETED|Overall Study||6
1625157|NCT00862459|3971410|P2|NOT COMPLETED|Overall Study||8
1625158|NCT00862459|3971411|P1|NOT COMPLETED|Overall Study||6
1625159|NCT00862459|3971409|P3|COMPLETED|Overall Study||66
1625160|NCT00862459|3971410|P2|COMPLETED|Overall Study||85
1625161|NCT00862459|3971411|P1|COMPLETED|Overall Study||66
1625162|NCT00862459|3971409|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
1625163|NCT00862459|3971410|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
1625164|NCT00862459|3971411|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
1625165|NCT00862459|3971409|P3|STARTED|Overall Study||72
1625166|NCT00862459|3971410|P2|STARTED|Overall Study||93
1625167|NCT00862459|3971411|P1|STARTED|Overall Study||72
1625168|NCT00862277|3971558|P3|NOT COMPLETED|Overall Study||5
1625169|NCT00862277|3971559|P2|NOT COMPLETED|Overall Study||2
1625170|NCT00862277|3971560|P1|NOT COMPLETED|Overall Study||1
1625171|NCT00862277|3971558|P3|COMPLETED|Overall Study||100
1625172|NCT00862277|3971559|P2|COMPLETED|Overall Study||94
1625173|NCT00862277|3971560|P1|COMPLETED|Overall Study||560
1625174|NCT00862277|3971558|P3|STARTED|Overall Study||105
1625175|NCT00862277|3971559|P2|STARTED|Overall Study||96
1625176|NCT00862277|3971560|P1|STARTED|Overall Study||561
1625177|NCT00862251|3971574|P3|NOT COMPLETED|Overall Study||9
1625178|NCT00862251|3971575|P2|NOT COMPLETED|Overall Study||5
1625179|NCT00862251|3971576|P1|NOT COMPLETED|Overall Study||19
1625180|NCT00862251|3971574|P3|COMPLETED|Overall Study||315
1625181|NCT00862251|3971575|P2|COMPLETED|Overall Study||157
1625182|NCT00862251|3971576|P1|COMPLETED|Overall Study||303
1625183|NCT00862251|3971574|P3|STARTED|Overall Study||324
1625184|NCT00862251|3971575|P2|STARTED|Overall Study||162
1625185|NCT00862251|3971576|P1|STARTED|Overall Study||322
1625186|NCT00862186|3971629|P1|NOT COMPLETED|Overall Study||0
1625187|NCT00862186|3971629|P1|COMPLETED|Overall Study||15
1625188|NCT00862186|3971629|P1|STARTED|Overall Study||15
1625189|NCT00862134|3971636|P2|NOT COMPLETED|Overall Study||12
1625190|NCT00862134|3971637|P1|NOT COMPLETED|Overall Study||11
1625191|NCT00862134|3971636|P2|COMPLETED|Overall Study||11
1625192|NCT00862134|3971637|P1|COMPLETED|Overall Study||8
1625193|NCT00862134|3971636|P2|STARTED|Overall Study||23
1625194|NCT00862134|3971637|P1|STARTED|Overall Study||19
1625195|NCT00862121|3971649|P2|NOT COMPLETED|Overall Study||8
1625196|NCT00862121|3971650|P1|NOT COMPLETED|Overall Study||1
1625197|NCT00862121|3971649|P2|COMPLETED|Overall Study||4
1625198|NCT00862121|3971650|P1|COMPLETED|Overall Study||7
1625199|NCT00862121|3971649|P2|Safety Analysis Set|Overall Study||11
1625200|NCT00862121|3971650|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
1625201|NCT00862121|3971649|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
1625202|NCT00862121|3971650|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
1625203|NCT00862121|3971649|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
1625204|NCT00862121|3971650|P1|STARTED|Overall Study||8
1625205|NCT00862082|3971668|P2|NOT COMPLETED|Overall Study||1
1625206|NCT00862082|3971669|P1|NOT COMPLETED|Overall Study||5
1625207|NCT00862082|3971668|P2|COMPLETED|Overall Study||5
1625208|NCT00862082|3971669|P1|COMPLETED|Overall Study||3
1625209|NCT00862082|3971668|P2|STARTED|Overall Study||6
1625210|NCT00862082|3971669|P1|STARTED|Overall Study||8
1625211|NCT00861913|3971712|P1|NOT COMPLETED|Overall Study||0
1625212|NCT00861913|3971712|P1|COMPLETED|Overall Study||13
1625213|NCT00861913|3971712|P1|STARTED|Overall Study||13
1625214|NCT00861757|3971724|P4|NOT COMPLETED|Overall Study||9
1625215|NCT00861757|3971725|P3|NOT COMPLETED|Overall Study||18
1625216|NCT00861757|3971726|P2|NOT COMPLETED|Overall Study||15
1625217|NCT00861757|3971727|P1|NOT COMPLETED|Overall Study||9
1625218|NCT00861757|3971724|P4|COMPLETED|Overall Study||143
1625219|NCT00861757|3971725|P3|COMPLETED|Overall Study||137
1625220|NCT00861757|3971726|P2|COMPLETED|Overall Study||136
1625221|NCT00861757|3971727|P1|COMPLETED|Overall Study||145
1625222|NCT00861757|3971724|P4|STARTED|Overall Study||152
1625223|NCT00861757|3971725|P3|STARTED|Overall Study||155
1625224|NCT00861757|3971726|P2|STARTED|Overall Study||151
1625225|NCT00861757|3971727|P1|STARTED|Overall Study||154
1625226|NCT00861744|3971785|P4|NOT COMPLETED|Overall Study||33
1625227|NCT00861744|3971786|P3|NOT COMPLETED|Overall Study||24
1625228|NCT00861744|3971787|P2|NOT COMPLETED|Overall Study||29
1625229|NCT00861744|3971788|P1|NOT COMPLETED|Overall Study||17
1625230|NCT00861744|3971785|P4|COMPLETED|Overall Study||275
1625231|NCT00861744|3971786|P3|COMPLETED|Overall Study||280
1625232|NCT00861744|3971787|P2|COMPLETED|Overall Study||275
1625233|NCT00861744|3971788|P1|COMPLETED|Overall Study||287
1625234|NCT00861744|3971785|P4|STARTED|Overall Study||308
1625235|NCT00861744|3971786|P3|STARTED|Overall Study||304
1625236|NCT00861744|3971787|P2|STARTED|Overall Study||304
1625237|NCT00861744|3971788|P1|STARTED|Overall Study||304
1625238|NCT00861705|3971970|P4|NOT COMPLETED|Overall Study||1
1625239|NCT00861705|3971971|P3|NOT COMPLETED|Overall Study||0
1625240|NCT00861705|3971972|P2|NOT COMPLETED|Overall Study||3
1625241|NCT00861705|3971973|P1|NOT COMPLETED|Overall Study||7
1625242|NCT00861705|3971970|P4|COMPLETED|Overall Study||112
1625243|NCT00861705|3971971|P3|COMPLETED|Overall Study||113
1625244|NCT00861705|3971972|P2|COMPLETED|Overall Study||110
1625245|NCT00861705|3971973|P1|COMPLETED|Overall Study||108
1625246|NCT00861705|3971970|P4|STARTED|Overall Study||113
1625247|NCT00861705|3971971|P3|STARTED|Overall Study||113
1625248|NCT00861705|3971972|P2|STARTED|Overall Study||113
1625249|NCT00861705|3971973|P1|STARTED|Overall Study||115
1625250|NCT00861692|3971989|P1|NOT COMPLETED|Overall Study||6
1625251|NCT00861692|3971989|P1|COMPLETED|Overall Study||14
1625252|NCT00861692|3971989|P1|STARTED|Overall Study||20
1625253|NCT00861614|3972001|P2|NOT COMPLETED|Overall Study||368
1625254|NCT00861614|3972002|P1|NOT COMPLETED|Overall Study||371
1625255|NCT00861614|3972001|P2|COMPLETED|Overall Study||28
1625256|NCT00861614|3972002|P1|COMPLETED|Overall Study||22
1625257|NCT00861614|3972001|P2|STARTED|Overall Study||396
1625258|NCT00861614|3972002|P1|STARTED|Overall Study||393
1625259|NCT00861601|3972035|P3|NOT COMPLETED|Overall Study||0
1625260|NCT00861601|3972036|P2|NOT COMPLETED|Overall Study||0
1625261|NCT00861601|3972037|P1|NOT COMPLETED|Overall Study||0
1625262|NCT00861601|3972035|P3|COMPLETED|Overall Study||12
1625263|NCT00861601|3972036|P2|COMPLETED|Overall Study||14
1625264|NCT00861601|3972037|P1|COMPLETED|Overall Study||12
1625265|NCT00861601|3972035|P3|STARTED|Overall Study||12
1625266|NCT00861601|3972036|P2|STARTED|Overall Study||14
1625267|NCT00861601|3972037|P1|STARTED|Overall Study||12
1625268|NCT00861471|3972087|P1|NOT COMPLETED|Overall Study||9
1625269|NCT00861471|3972087|P1|COMPLETED|Overall Study||3
1625270|NCT00861471|3972087|P1|STARTED|Overall Study||12
1625271|NCT00861341|3972095|P1|NOT COMPLETED|Overall Study||2
1625272|NCT00861341|3972095|P1|COMPLETED|Overall Study||38
1625273|NCT00861341|3972095|P1|STARTED|Overall Study||40
1625274|NCT00861263|3972100|P1|NOT COMPLETED|Overall Study||0
1625275|NCT00861263|3972100|P1|COMPLETED|Overall Study||193
1625276|NCT00861263|3972100|P1|STARTED|Overall Study||193
1625277|NCT00861198|3972104|P1|NOT COMPLETED|Overall Study||5
1625278|NCT00861198|3972104|P1|COMPLETED|Overall Study||70
1625279|NCT00861198|3972104|P1|STARTED|Overall Study||75
1625280|NCT00861146|3972110|P2|NOT COMPLETED|Overall Study||8
1625281|NCT00861146|3972111|P1|NOT COMPLETED|Overall Study||20
1625282|NCT00861146|3972110|P2|COMPLETED|Overall Study||38
1625283|NCT00861146|3972111|P1|COMPLETED|Overall Study||85
1625284|NCT00861146|3972110|P2|Week 13 Assessment|Overall Study||38
1625285|NCT00861146|3972111|P1|Week 13 Assessment|Overall Study||85
1625286|NCT00861146|3972110|P2|Week 2 Assessment|Overall Study||45
1625287|NCT00861146|3972111|P1|Week 2 Assessment|Overall Study||97
1625288|NCT00861146|3972110|P2|STARTED|Overall Study||46
1625289|NCT00861146|3972111|P1|STARTED|Overall Study||105
1625290|NCT00860951|3972121|P1|NOT COMPLETED|Overall Study||7
1625291|NCT00860951|3972121|P1|COMPLETED|Overall Study||22
1625292|NCT00860951|3972121|P1|STARTED|Overall Study||29
1625293|NCT00860847|3972129|P2|NOT COMPLETED|Overall Study||5
1625294|NCT00860847|3972130|P1|NOT COMPLETED|Overall Study||4
1625295|NCT00860847|3972129|P2|COMPLETED|Overall Study||28
1625296|NCT00860847|3972130|P1|COMPLETED|Overall Study||28
1625297|NCT00860847|3972129|P2|STARTED|Overall Study||33
1625298|NCT00860847|3972130|P1|STARTED|Overall Study||32
1625299|NCT00860795|3972138|P2|NOT COMPLETED|Overall Study||0
1625300|NCT00860795|3972139|P1|NOT COMPLETED|Overall Study||0
1625301|NCT00860795|3972138|P2|COMPLETED|Overall Study||10
1625302|NCT00860795|3972139|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
1625303|NCT00860795|3972138|P2|Number to Complete Study Medication|Overall Study||10
1625304|NCT00860795|3972139|P1|Number to Complete Study Medication|Overall Study||9
1625305|NCT00860795|3972138|P2|STARTED|Overall Study||10
1625306|NCT00860795|3972139|P1|STARTED|Overall Study||10
1625307|NCT00860743|3972163|P2|NOT COMPLETED|Overall Study||0
1625308|NCT00860743|3972164|P1|NOT COMPLETED|Overall Study||3
1625309|NCT00860743|3972163|P2|COMPLETED|Overall Study||23
1625310|NCT00860743|3972164|P1|COMPLETED|Overall Study||37
1625311|NCT00860743|3972163|P2|STARTED|Overall Study||23
1625312|NCT00860743|3972164|P1|STARTED|Overall Study||40
1625313|NCT00860535|3972170|P1|NOT COMPLETED|Overall Study||1
1625314|NCT00860535|3972170|P1|COMPLETED|Overall Study||8
1625315|NCT00860535|3972170|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
1625316|NCT00860535|3972170|P1|STARTED|Overall Study||9
1625317|NCT00860470|3972177|P2|NOT COMPLETED|Overall Study||59
1625318|NCT00860470|3972178|P1|NOT COMPLETED|Overall Study||48
1625319|NCT00860470|3972177|P2|COMPLETED|Overall Study||22346
1625320|NCT00860470|3972178|P1|COMPLETED|Overall Study||22114
1625321|NCT00860470|3972177|P2|STARTED|Overall Study||22405
1625322|NCT00860470|3972178|P1|STARTED|Overall Study||22162
1625323|NCT00860457|3972202|P1|NOT COMPLETED|Overall Study||11
1625324|NCT00860457|3972202|P1|COMPLETED|Overall Study||11
1625325|NCT00860457|3972202|P1|STARTED|Overall Study||22
1625326|NCT00860405|3972208|P2|NOT COMPLETED|Overall Study||4
1625327|NCT00860405|3972209|P1|NOT COMPLETED|Overall Study||5
1625328|NCT00860405|3972208|P2|COMPLETED|Overall Study||26
1625329|NCT00860405|3972209|P1|COMPLETED|Overall Study|completed overall study|26
1625330|NCT00860405|3972208|P2|Day 28 Follow-up Performed|Overall Study||29
1625331|NCT00860405|3972209|P1|Day 28 Follow-up Performed|Overall Study||31
1625332|NCT00860405|3972208|P2|Completed Treatment|Overall Study||29
1625333|NCT00860405|3972209|P1|Completed Treatment|Overall Study||31
1625334|NCT00860405|3972208|P2|STARTED|Overall Study||30
1625335|NCT00860405|3972209|P1|STARTED|Overall Study||31
1625336|NCT00860314|3972233|P2|NOT COMPLETED|Overall Study||0
1625337|NCT00860314|3972234|P1|NOT COMPLETED|Overall Study||0
1625338|NCT00860314|3972233|P2|COMPLETED|Overall Study||48
1625339|NCT00860314|3972234|P1|COMPLETED|Overall Study||48
1625340|NCT00860314|3972233|P2|STARTED|Overall Study||48
1625341|NCT00860314|3972234|P1|STARTED|Overall Study||48
1625342|NCT00860262|3972249|P3|NOT COMPLETED|Overall Study||18
1625343|NCT00860262|3972250|P2|NOT COMPLETED|Overall Study||22
1625344|NCT00860262|3972251|P1|NOT COMPLETED|Overall Study||20
1625345|NCT00860262|3972249|P3|COMPLETED|Overall Study||202
1625346|NCT00860262|3972250|P2|COMPLETED|Overall Study||195
1625347|NCT00860262|3972251|P1|COMPLETED|Overall Study||401
1625348|NCT00860262|3972249|P3|STARTED|Overall Study||220
1625349|NCT00860262|3972250|P2|STARTED|Overall Study||217
1625350|NCT00860262|3972251|P1|STARTED|Overall Study||421
1625351|NCT00860249|3972364|P3|NOT COMPLETED|Overall Study||21
1625352|NCT00860249|3972365|P2|NOT COMPLETED|Overall Study||18
1625353|NCT00860249|3972366|P1|NOT COMPLETED|Overall Study||21
1625354|NCT00860249|3972364|P3|COMPLETED|Overall Study||0
1625355|NCT00860249|3972365|P2|COMPLETED|Overall Study||0
1625356|NCT00860249|3972366|P1|COMPLETED|Overall Study||0
1625357|NCT00860249|3972364|P3|STARTED|Overall Study||21
1625358|NCT00860249|3972365|P2|STARTED|Overall Study||18
1625359|NCT00860249|3972366|P1|STARTED|Overall Study||21
1625360|NCT00860171|3972377|P1|NOT COMPLETED|Overall Study||0
1625361|NCT00860171|3972377|P1|COMPLETED|Overall Study||16
1625362|NCT00860171|3972377|P1|STARTED|Overall Study||16
1625363|NCT00860158|3972384|P1|NOT COMPLETED|Overall Study||1
1625364|NCT00860158|3972384|P1|COMPLETED|Overall Study||0
1625365|NCT00860158|3972384|P1|STARTED|Overall Study||1
1625366|NCT00860067|3972396|P3|NOT COMPLETED|Overall Study||9
1625367|NCT00860067|3972397|P2|NOT COMPLETED|Overall Study||9
1625368|NCT00860067|3972398|P1|NOT COMPLETED|Overall Study||51
1625369|NCT00860067|3972396|P3|COMPLETED|Overall Study||292
1625370|NCT00860067|3972397|P2|COMPLETED|Overall Study||290
1625371|NCT00860067|3972398|P1|COMPLETED|Overall Study||1149
1625372|NCT00860067|3972396|P3|STARTED|Overall Study||301
1625373|NCT00860067|3972397|P2|STARTED|Overall Study||299
1625374|NCT00860067|3972398|P1|STARTED|Overall Study||1200
1625375|NCT00860028|3972458|P2|NOT COMPLETED|Smoking Cessation Phase||2
1625376|NCT00860028|3972459|P1|NOT COMPLETED|Smoking Cessation Phase||0
1625377|NCT00860028|3972458|P2|COMPLETED|Smoking Cessation Phase||12
1625378|NCT00860028|3972459|P1|COMPLETED|Smoking Cessation Phase||13
1625379|NCT00860028|3972458|P2|STARTED|Smoking Cessation Phase||14
1625380|NCT00860028|3972459|P1|STARTED|Smoking Cessation Phase||13
1625381|NCT00860028|3972458|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
1625382|NCT00860028|3972459|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
1625383|NCT00860028|3972458|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
1625384|NCT00860028|3972459|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
1625385|NCT00860028|3972458|P2|STARTED|Placebo Controlled Pretreatment Period||15
1625386|NCT00860028|3972459|P1|STARTED|Placebo Controlled Pretreatment Period||15
1625387|NCT00859950|3972471|P2|NOT COMPLETED|Overall Study||0
1625388|NCT00859950|3972472|P1|NOT COMPLETED|Overall Study||0
1625389|NCT00859950|3972471|P2|COMPLETED|Overall Study||21
1625390|NCT00859950|3972472|P1|COMPLETED|Overall Study||49
1625391|NCT00859950|3972471|P2|STARTED|Overall Study||21
1625392|NCT00859950|3972472|P1|STARTED|Overall Study||49
1625393|NCT00859937|3972480|P2|NOT COMPLETED|Overall Study||0
1625394|NCT00859937|3972481|P1|NOT COMPLETED|Overall Study||1
1625395|NCT00859937|3972480|P2|COMPLETED|Overall Study||14
1625396|NCT00859937|3972481|P1|COMPLETED|Overall Study||40
1625397|NCT00859937|3972480|P2|STARTED|Overall Study||14
1625398|NCT00859937|3972481|P1|STARTED|Overall Study||41
1625399|NCT00859898|3972496|P3|NOT COMPLETED|Overall Study||27
1625400|NCT00859898|3972497|P2|NOT COMPLETED|Overall Study||31
1625401|NCT00859898|3972498|P1|NOT COMPLETED|Overall Study||28
1625402|NCT00859898|3972496|P3|COMPLETED|Overall Study||181
1625403|NCT00859898|3972497|P2|COMPLETED|Overall Study||188
1625404|NCT00859898|3972498|P1|COMPLETED|Overall Study||183
1625405|NCT00859898|3972496|P3|STARTED|Overall Study||208
1625406|NCT00859898|3972497|P2|STARTED|Overall Study||219
1625407|NCT00859898|3972498|P1|STARTED|Overall Study||211
1625408|NCT00859833|3972539|P1|NOT COMPLETED|Overall Study||0
1625409|NCT00859833|3972539|P1|COMPLETED|Overall Study||30
1625410|NCT00859833|3972539|P1|STARTED|Overall Study||30
1625411|NCT00859651|3972546|P2|NOT COMPLETED|Overall Study||0
1625412|NCT00859651|3972547|P1|NOT COMPLETED|Overall Study||0
1625413|NCT00859651|3972546|P2|COMPLETED|Overall Study||22
1625414|NCT00859651|3972547|P1|COMPLETED|Overall Study||18
1625415|NCT00859651|3972546|P2|STARTED|Overall Study||22
1625416|NCT00859651|3972547|P1|STARTED|Overall Study||18
1625417|NCT00859638|3972557|P2|NOT COMPLETED|Overall Study||4
1625418|NCT00859638|3972558|P1|NOT COMPLETED|Overall Study||10
1625419|NCT00859638|3972557|P2|COMPLETED|Overall Study||55
1625420|NCT00859638|3972558|P1|COMPLETED|Overall Study||55
1625421|NCT00859638|3972557|P2|STARTED|Overall Study||59
1625422|NCT00859638|3972558|P1|STARTED|Overall Study||65
1625423|NCT00859586|3972564|P1|NOT COMPLETED|Overall Study||4
1625424|NCT00859586|3972564|P1|COMPLETED|Overall Study||4
1625425|NCT00859586|3972564|P1|STARTED|Overall Study||8
1625426|NCT00859573|3972570|P2|NOT COMPLETED|Overall Study||2
1625427|NCT00859573|3972571|P1|NOT COMPLETED|Overall Study||5
1625428|NCT00859573|3972570|P2|COMPLETED|Overall Study||1
1625429|NCT00859573|3972571|P1|COMPLETED|Overall Study||1
1625430|NCT00859573|3972570|P2|STARTED|Overall Study||3
1625431|NCT00859573|3972571|P1|STARTED|Overall Study||6
1625432|NCT00859547|3972577|P1|NOT COMPLETED|Overall Study||2
1625433|NCT00859547|3972577|P1|COMPLETED|Overall Study||28
1625434|NCT00859547|3972577|P1|STARTED|Overall Study||30
1625435|NCT00859521|3972590|P2|NOT COMPLETED|Second Intervention||0
1625436|NCT00859521|3972591|P1|NOT COMPLETED|Second Intervention||0
1625437|NCT00859521|3972590|P2|COMPLETED|Second Intervention||14
1625438|NCT00859521|3972591|P1|COMPLETED|Second Intervention||15
1625439|NCT00859521|3972590|P2|STARTED|Second Intervention||14
1625440|NCT00859521|3972591|P1|STARTED|Second Intervention||15
1625441|NCT00859521|3972590|P2|NOT COMPLETED|Washout||1
1625442|NCT00859521|3972591|P1|NOT COMPLETED|Washout||0
1625443|NCT00859521|3972590|P2|COMPLETED|Washout||14
1625444|NCT00859521|3972591|P1|COMPLETED|Washout||15
1625445|NCT00859521|3972590|P2|STARTED|Washout||15
1625446|NCT00859521|3972591|P1|STARTED|Washout||15
1625447|NCT00859521|3972590|P2|NOT COMPLETED|First Intervention||0
1625448|NCT00859521|3972591|P1|NOT COMPLETED|First Intervention||0
1625449|NCT00859521|3972590|P2|COMPLETED|First Intervention||15
1625450|NCT00859521|3972591|P1|COMPLETED|First Intervention||15
1625451|NCT00859521|3972590|P2|STARTED|First Intervention||15
1625452|NCT00859521|3972591|P1|STARTED|First Intervention||15
1625453|NCT00859508|3972601|P2|NOT COMPLETED|Overall Study||0
1625454|NCT00859508|3972602|P1|NOT COMPLETED|Overall Study||6
1625455|NCT00859508|3972601|P2|COMPLETED|Overall Study||37
1625456|NCT00859508|3972602|P1|COMPLETED|Overall Study||62
1625457|NCT00859508|3972601|P2|STARTED|Overall Study||37
1625458|NCT00859508|3972602|P1|STARTED|Overall Study||68
1625459|NCT00859469|3972608|P1|NOT COMPLETED|Overall Study||28
1625460|NCT00859469|3972608|P1|COMPLETED|Overall Study||1
1625461|NCT00859469|3972608|P1|6 Cycles|Overall Study||16
1625462|NCT00859469|3972608|P1|STARTED|Overall Study||29
1625463|NCT00859430|3972616|P2|NOT COMPLETED|Second Intervention||0
1625464|NCT00859430|3972617|P1|NOT COMPLETED|Second Intervention||0
1625465|NCT00859430|3972616|P2|COMPLETED|Second Intervention||10
1625466|NCT00859430|3972617|P1|COMPLETED|Second Intervention||11
1625467|NCT00859430|3972616|P2|STARTED|Second Intervention||10
1625468|NCT00859430|3972617|P1|STARTED|Second Intervention||11
1625469|NCT00859430|3972616|P2|NOT COMPLETED|First Intervention||1
1625470|NCT00859430|3972617|P1|NOT COMPLETED|First Intervention||0
1625471|NCT00859430|3972616|P2|COMPLETED|First Intervention||10
1625472|NCT00859430|3972617|P1|COMPLETED|First Intervention||11
1625473|NCT00859430|3972616|P2|STARTED|First Intervention||11
1625474|NCT00859430|3972617|P1|STARTED|First Intervention||11
1625475|NCT00859339|3972625|P1|NOT COMPLETED|Overall Study||0
1625476|NCT00859339|3972625|P1|COMPLETED|Overall Study||9
1625477|NCT00859339|3972625|P1|STARTED|Overall Study||9
1625478|NCT00859313|3972633|P1|NOT COMPLETED|Overall Study||4
1625479|NCT00859313|3972633|P1|COMPLETED|Overall Study||26
1625480|NCT00859313|3972633|P1|STARTED|Overall Study||30
1625481|NCT00859222|3972640|P5|NOT COMPLETED|Overall Study||15
1625482|NCT00859222|3972641|P4|NOT COMPLETED|Overall Study||24
1625483|NCT00859222|3972642|P3|NOT COMPLETED|Overall Study||6
1625484|NCT00859222|3972643|P2|NOT COMPLETED|Overall Study||3
1625485|NCT00859222|3972644|P1|NOT COMPLETED|Overall Study||3
1625486|NCT00859222|3972640|P5|COMPLETED|Overall Study||0
1625487|NCT00859222|3972641|P4|COMPLETED|Overall Study||0
1625488|NCT00859222|3972642|P3|COMPLETED|Overall Study||0
1625489|NCT00859222|3972643|P2|COMPLETED|Overall Study||0
1625490|NCT00859222|3972644|P1|COMPLETED|Overall Study||0
1625491|NCT00859222|3972640|P5|STARTED|Overall Study||15
1625492|NCT00859222|3972641|P4|STARTED|Overall Study||24
1625493|NCT00859222|3972642|P3|STARTED|Overall Study||6
1625494|NCT00859222|3972643|P2|STARTED|Overall Study||3
1625495|NCT00859222|3972644|P1|STARTED|Overall Study||3
1625496|NCT00859131|3972671|P2|NOT COMPLETED|Overall Study||0
1625497|NCT00859131|3972672|P1|NOT COMPLETED|Overall Study||0
1625498|NCT00859131|3972671|P2|COMPLETED|Overall Study||98
1625499|NCT00859131|3972672|P1|COMPLETED|Overall Study||102
1625500|NCT00859131|3972671|P2|STARTED|Overall Study||98
1625501|NCT00859131|3972672|P1|STARTED|Overall Study||102
1625502|NCT00859053|3972694|P4|NOT COMPLETED|Overall Study||0
1625503|NCT00859053|3972695|P3|NOT COMPLETED|Overall Study||0
1625504|NCT00859053|3972696|P2|NOT COMPLETED|Overall Study||0
1625505|NCT00859053|3972697|P1|NOT COMPLETED|Overall Study||0
1625506|NCT00859053|3972694|P4|COMPLETED|Overall Study||12
1625507|NCT00859053|3972695|P3|COMPLETED|Overall Study||6
1625508|NCT00859053|3972696|P2|COMPLETED|Overall Study||6
1625509|NCT00859053|3972697|P1|COMPLETED|Overall Study||6
1625510|NCT00859053|3972694|P4|STARTED|Overall Study||12
1625511|NCT00859053|3972695|P3|STARTED|Overall Study||6
1625512|NCT00859053|3972696|P2|STARTED|Overall Study||6
1625513|NCT00859053|3972697|P1|STARTED|Overall Study||6
1625514|NCT00859040|3972741|P2|NOT COMPLETED|Overall Study||0
1625515|NCT00859040|3972742|P1|NOT COMPLETED|Overall Study||0
1625516|NCT00859040|3972741|P2|COMPLETED|Overall Study||16
1625517|NCT00859040|3972742|P1|COMPLETED|Overall Study||18
1625518|NCT00859040|3972741|P2|STARTED|Overall Study||16
1625519|NCT00859040|3972742|P1|STARTED|Overall Study||18
1625520|NCT00859027|3972757|P2|NOT COMPLETED|Overall Study||5
1625521|NCT00859027|3972758|P1|NOT COMPLETED|Overall Study||5
1625522|NCT00859027|3972757|P2|COMPLETED|Overall Study||20
1625523|NCT00859027|3972758|P1|COMPLETED|Overall Study||20
1625524|NCT00859027|3972757|P2|STARTED|Overall Study||25
1625525|NCT00859027|3972758|P1|STARTED|Overall Study||25
1625526|NCT00859014|3972766|P1|NOT COMPLETED|Overall Study||5
1625527|NCT00859014|3972766|P1|COMPLETED|Overall Study||20
1625528|NCT00859014|3972766|P1|STARTED|Overall Study||25
1625529|NCT00858962|3972771|P1|NOT COMPLETED|Overall Study||0
1625530|NCT00858962|3972771|P1|COMPLETED|Overall Study||12
1625531|NCT00858962|3972771|P1|STARTED|Overall Study||12
1625532|NCT00858858|3972775|P1|NOT COMPLETED|Overall Study||18
1625533|NCT00858858|3972775|P1|COMPLETED|Overall Study||42
1625534|NCT00858858|3972775|P1|STARTED|Overall Study||60
1625535|NCT00858845|3972781|P2|NOT COMPLETED|Overall Study||1
1625536|NCT00858845|3972782|P1|NOT COMPLETED|Overall Study||0
1625537|NCT00858845|3972781|P2|COMPLETED|Overall Study||5
1625538|NCT00858845|3972782|P1|COMPLETED|Overall Study||5
1625539|NCT00858845|3972781|P2|STARTED|Overall Study||6
1625540|NCT00858845|3972782|P1|STARTED|Overall Study||5
1625541|NCT00858832|3972794|P2|NOT COMPLETED|Overall Study||1
1625542|NCT00858832|3972795|P1|NOT COMPLETED|Overall Study||1
1625543|NCT00858832|3972794|P2|COMPLETED|Overall Study||22
1625544|NCT00858832|3972795|P1|COMPLETED|Overall Study||20
1625545|NCT00858832|3972794|P2|STARTED|Overall Study||23
1625546|NCT00858832|3972795|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
1625547|NCT00858780|3972801|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
1625548|NCT00858780|3972802|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1625549|NCT00858780|3972803|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1625550|NCT00858780|3972804|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1625551|NCT00858780|3972805|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1625552|NCT00858780|3972801|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
1625553|NCT00858780|3972802|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1625554|NCT00858780|3972803|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1625555|NCT00858780|3972804|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1625556|NCT00858780|3972805|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1625557|NCT00858780|3972801|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
1625558|NCT00858780|3972802|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
1625559|NCT00858780|3972803|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
1625560|NCT00858780|3972804|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
1625561|NCT00858780|3972805|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
1625562|NCT00858780|3972801|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1625563|NCT00858780|3972802|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
1625564|NCT00858780|3972803|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
1625565|NCT00858780|3972804|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
1625566|NCT00858780|3972805|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1625567|NCT00858780|3972801|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1625568|NCT00858780|3972802|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
1625569|NCT00858780|3972803|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
1625570|NCT00858780|3972804|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
1625571|NCT00858780|3972805|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1625572|NCT00858780|3972801|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
1625573|NCT00858780|3972802|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
1625574|NCT00858780|3972803|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
1625575|NCT00858780|3972804|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
1625576|NCT00858780|3972805|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
1625577|NCT00858780|3972801|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625578|NCT00858780|3972802|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625579|NCT00858780|3972803|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625580|NCT00858780|3972804|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625581|NCT00858780|3972805|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
1625582|NCT00858780|3972801|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625583|NCT00858780|3972802|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625584|NCT00858780|3972803|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625585|NCT00858780|3972804|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625586|NCT00858780|3972805|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
1625587|NCT00858780|3972801|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625588|NCT00858780|3972802|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625589|NCT00858780|3972803|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625590|NCT00858780|3972804|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1625591|NCT00858780|3972805|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
1625592|NCT00858702|3972880|P2|NOT COMPLETED|Overall Study||2
1625593|NCT00858702|3972881|P1|NOT COMPLETED|Overall Study||5
1625594|NCT00858702|3972880|P2|COMPLETED|Overall Study||50
1625595|NCT00858702|3972881|P1|COMPLETED|Overall Study||48
1625596|NCT00858702|3972880|P2|STARTED|Overall Study||52
1625597|NCT00858702|3972881|P1|STARTED|Overall Study||53
1625598|NCT00858689|3972889|P1|NOT COMPLETED|Overall Study||1
1625599|NCT00858689|3972889|P1|COMPLETED|Overall Study||19
1625600|NCT00858689|3972889|P1|STARTED|Overall Study||20
1625601|NCT00858637|3972896|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
1625602|NCT00858637|3972897|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
1625603|NCT00858637|3972898|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
1625604|NCT00858637|3972899|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
1625605|NCT00858637|3972900|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
1625606|NCT00858637|3972901|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
1625607|NCT00858637|3972896|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
1625608|NCT00858637|3972897|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
1625609|NCT00858637|3972898|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
1625610|NCT00858637|3972899|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
1625611|NCT00858637|3972900|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
1625612|NCT00858637|3972901|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
1625613|NCT00858637|3972896|P6|STARTED|Placebo-controlled Withdrawal Phase||59
1625614|NCT00858637|3972897|P5|STARTED|Placebo-controlled Withdrawal Phase||56
1625615|NCT00858637|3972898|P4|STARTED|Placebo-controlled Withdrawal Phase||0
1625616|NCT00858637|3972899|P3|STARTED|Placebo-controlled Withdrawal Phase||54
1625617|NCT00858637|3972900|P2|STARTED|Placebo-controlled Withdrawal Phase||49
1625618|NCT00858637|3972901|P1|STARTED|Placebo-controlled Withdrawal Phase||0
1625619|NCT00858637|3972896|P6|NOT COMPLETED|Active Comparison Phase||0
1625620|NCT00858637|3972897|P5|NOT COMPLETED|Active Comparison Phase||0
1625621|NCT00858637|3972898|P4|NOT COMPLETED|Active Comparison Phase||18
1625622|NCT00858637|3972899|P3|NOT COMPLETED|Active Comparison Phase||0
1625623|NCT00858637|3972900|P2|NOT COMPLETED|Active Comparison Phase||0
1625624|NCT00858637|3972901|P1|NOT COMPLETED|Active Comparison Phase||24
1625625|NCT00858637|3972896|P6|COMPLETED|Active Comparison Phase||0
1625626|NCT00858637|3972897|P5|COMPLETED|Active Comparison Phase||0
1625627|NCT00858637|3972898|P4|COMPLETED|Active Comparison Phase||115
1625628|NCT00858637|3972899|P3|COMPLETED|Active Comparison Phase||0
1625629|NCT00858637|3972900|P2|COMPLETED|Active Comparison Phase||0
1625630|NCT00858637|3972901|P1|COMPLETED|Active Comparison Phase||103
1625631|NCT00858637|3972896|P6|STARTED|Active Comparison Phase||0
1625632|NCT00858637|3972897|P5|STARTED|Active Comparison Phase||0
1625633|NCT00858637|3972898|P4|STARTED|Active Comparison Phase||133
1625634|NCT00858637|3972899|P3|STARTED|Active Comparison Phase||0
1625635|NCT00858637|3972900|P2|STARTED|Active Comparison Phase||0
1625636|NCT00858637|3972901|P1|STARTED|Active Comparison Phase||127
1625637|NCT00858507|3972913|P2|NOT COMPLETED|Overall Study||15
1625638|NCT00858507|3972914|P1|NOT COMPLETED|Overall Study||22
1625639|NCT00858507|3972913|P2|COMPLETED|Overall Study||101
1625640|NCT00858507|3972914|P1|COMPLETED|Overall Study||83
1625641|NCT00858507|3972913|P2|STARTED|Overall Study||116
1625642|NCT00858507|3972914|P1|STARTED|Overall Study||105
1625643|NCT00858494|3972920|P1|NOT COMPLETED|Overall Study||4
1625644|NCT00858494|3972920|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
1625645|NCT00858494|3972920|P1|STARTED|Overall Study||49
1625646|NCT00858468|3972927|P2|NOT COMPLETED|Overall Study||0
1625647|NCT00858468|3972928|P1|NOT COMPLETED|Overall Study||0
1625648|NCT00858468|3972927|P2|COMPLETED|Overall Study||192
1625649|NCT00858468|3972928|P1|COMPLETED|Overall Study||201
1625650|NCT00858468|3972927|P2|STARTED|Overall Study||192
1625651|NCT00858468|3972928|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
1625652|NCT00858442|3972942|P2|NOT COMPLETED|Compression:Start to Finish||3
1625653|NCT00858442|3972943|P1|NOT COMPLETED|Compression:Start to Finish||1
1625654|NCT00858442|3972942|P2|COMPLETED|Compression:Start to Finish||20
1625655|NCT00858442|3972943|P1|COMPLETED|Compression:Start to Finish||20
1625656|NCT00858442|3972942|P2|STARTED|Compression:Start to Finish||23
1625657|NCT00858442|3972943|P1|STARTED|Compression:Start to Finish||21
1625658|NCT00858442|3972942|P2|NOT COMPLETED|From Surgery to Start Compression;||0
1625659|NCT00858442|3972943|P1|NOT COMPLETED|From Surgery to Start Compression;||0
1625660|NCT00858442|3972942|P2|COMPLETED|From Surgery to Start Compression;||23
1625661|NCT00858442|3972943|P1|COMPLETED|From Surgery to Start Compression;||21
1625662|NCT00858442|3972942|P2|STARTED|From Surgery to Start Compression;||23
1625663|NCT00858442|3972943|P1|STARTED|From Surgery to Start Compression;||21
1625664|NCT00858403|3972953|P1|NOT COMPLETED|Overall Study||5
1625665|NCT00858403|3972953|P1|COMPLETED|Overall Study||2
1625666|NCT00858403|3972953|P1|STARTED|Overall Study||7
1625667|NCT00858390|3972965|P2|NOT COMPLETED|Overall Study||0
1625668|NCT00858390|3972966|P1|NOT COMPLETED|Overall Study||0
1625669|NCT00858390|3972965|P2|COMPLETED|Overall Study||18
1625670|NCT00858390|3972966|P1|COMPLETED|Overall Study||18
1625671|NCT00858390|3972965|P2|STARTED|Overall Study||18
1625672|NCT00858390|3972966|P1|STARTED|Overall Study||18
1625673|NCT00858364|3972974|P2|NOT COMPLETED|Overall Study||457
1625674|NCT00858364|3972975|P1|NOT COMPLETED|Overall Study||204
1625675|NCT00858364|3972974|P2|COMPLETED|Overall Study||1246
1625676|NCT00858364|3972975|P1|COMPLETED|Overall Study||642
1625677|NCT00858364|3972974|P2|Received Study Drug|Overall Study||1681
1625678|NCT00858364|3972975|P1|Received Study Drug|Overall Study||837
1625679|NCT00858364|3972974|P2|STARTED|Overall Study||1703
1625680|NCT00858364|3972975|P1|STARTED|Overall Study||846
1625681|NCT00858247|3972997|P2|NOT COMPLETED|Week 12 Follow-up||1
1625682|NCT00858247|3972998|P1|NOT COMPLETED|Week 12 Follow-up||0
1625683|NCT00858247|3972997|P2|COMPLETED|Week 12 Follow-up||23
1625684|NCT00858247|3972998|P1|COMPLETED|Week 12 Follow-up||23
1625685|NCT00858247|3972997|P2|STARTED|Week 12 Follow-up||24
1625686|NCT00858247|3972998|P1|STARTED|Week 12 Follow-up||23
1625687|NCT00858247|3972997|P2|NOT COMPLETED|Baseline Assessment||2
1625688|NCT00858247|3972998|P1|NOT COMPLETED|Baseline Assessment||2
1625689|NCT00858247|3972997|P2|COMPLETED|Baseline Assessment||24
1625690|NCT00858247|3972998|P1|COMPLETED|Baseline Assessment||23
1625691|NCT00858247|3972997|P2|STARTED|Baseline Assessment||26
1625692|NCT00858247|3972998|P1|STARTED|Baseline Assessment||25
1625693|NCT00858208|3973014|P1|NOT COMPLETED|Overall Study||79
1625694|NCT00858208|3973014|P1|COMPLETED|Overall Study||6
1625695|NCT00858208|3973014|P1|STARTED|Overall Study||85
1625696|NCT00858143|3973031|P1|NOT COMPLETED|Overall Study||50
1625697|NCT00858143|3973031|P1|COMPLETED|Overall Study||261
1625698|NCT00858143|3973031|P1|STARTED|Overall Study|Baseline|311
1625699|NCT00858130|3973080|P1|NOT COMPLETED|Overall Study||0
1625700|NCT00858130|3973080|P1|COMPLETED|Overall Study||12
1625701|NCT00858130|3973080|P1|STARTED|Overall Study||12
1625702|NCT00858013|3973090|P2|NOT COMPLETED|Overall Study||19
1625703|NCT00858013|3973091|P1|NOT COMPLETED|Overall Study||22
1625704|NCT00858013|3973090|P2|COMPLETED|Overall Study||23
1625705|NCT00858013|3973091|P1|COMPLETED|Overall Study||24
1625706|NCT00858013|3973090|P2|STARTED|Overall Study||42
1625707|NCT00858013|3973091|P1|STARTED|Overall Study||46
1625708|NCT00857961|3973105|P1|NOT COMPLETED|Overall Study||0
1625709|NCT00857961|3973105|P1|COMPLETED|Overall Study||21
1625710|NCT00857961|3973105|P1|STARTED|Overall Study||21
1625711|NCT00857948|3973143|P4|NOT COMPLETED|Overall Study||0
1625712|NCT00857948|3973144|P3|NOT COMPLETED|Overall Study||1
1625713|NCT00857948|3973145|P2|NOT COMPLETED|Overall Study||0
1625714|NCT00857948|3973146|P1|NOT COMPLETED|Overall Study||3
1625715|NCT00857948|3973143|P4|COMPLETED|Overall Study||23
1625716|NCT00857948|3973144|P3|COMPLETED|Overall Study||18
1625717|NCT00857948|3973145|P2|COMPLETED|Overall Study||18
1625718|NCT00857948|3973146|P1|COMPLETED|Overall Study||15
1625719|NCT00857948|3973143|P4|STARTED|Overall Study||23
1625720|NCT00857948|3973144|P3|STARTED|Overall Study||19
1625721|NCT00857948|3973145|P2|STARTED|Overall Study||18
1625722|NCT00857948|3973146|P1|STARTED|Overall Study||18
1625723|NCT00857896|3973168|P1|NOT COMPLETED|Week 5 to Week 8||0
1625724|NCT00857896|3973168|P1|COMPLETED|Week 5 to Week 8||20
1625725|NCT00857896|3973168|P1|STARTED|Week 5 to Week 8||20
1625726|NCT00857896|3973168|P1|NOT COMPLETED|Baseline to Week 4||1
1625727|NCT00857896|3973168|P1|COMPLETED|Baseline to Week 4||20
1625728|NCT00857896|3973168|P1|STARTED|Baseline to Week 4||21
1625729|NCT00857857|3973180|P1|NOT COMPLETED|Overall Study||0
1625730|NCT00857857|3973180|P1|COMPLETED|Overall Study||24
1625731|NCT00857857|3973180|P1|STARTED|Overall Study||24
1625732|NCT00857818|3973324|P2|NOT COMPLETED|Overall Study||8
1625733|NCT00857818|3973325|P1|NOT COMPLETED|Overall Study||11
1625734|NCT00857818|3973324|P2|COMPLETED|Overall Study||6
1625735|NCT00857818|3973325|P1|COMPLETED|Overall Study||3
1625736|NCT00857818|3973324|P2|Received Treatment|Overall Study||12
1625737|NCT00857818|3973325|P1|Received Treatment|Overall Study||14
1625738|NCT00857818|3973324|P2|STARTED|Overall Study||14
1625739|NCT00857818|3973325|P1|STARTED|Overall Study||14
1625740|NCT00857792|3973353|P1|NOT COMPLETED|Overall Study||12
1625741|NCT00857792|3973353|P1|COMPLETED|Overall Study||108
1625742|NCT00857792|3973353|P1|STARTED|Overall Study||120
1625743|NCT00857766|3973359|P2|NOT COMPLETED|Overall Study||30
1625744|NCT00857766|3973360|P1|NOT COMPLETED|Overall Study||31
1625745|NCT00857766|3973359|P2|COMPLETED|Overall Study||96
1625746|NCT00857766|3973360|P1|COMPLETED|Overall Study||92
1625747|NCT00857766|3973359|P2|STARTED|Overall Study||126
1625748|NCT00857766|3973360|P1|STARTED|Overall Study||123
1625749|NCT00857727|3973372|P2|NOT COMPLETED|Overall Study||0
1625750|NCT00857727|3973373|P1|NOT COMPLETED|Overall Study||0
1625751|NCT00857727|3973372|P2|COMPLETED|Overall Study||14
1625752|NCT00857727|3973373|P1|COMPLETED|Overall Study||14
1625753|NCT00857727|3973372|P2|STARTED|Overall Study||14
1625754|NCT00857727|3973373|P1|STARTED|Overall Study||14
1625755|NCT00857714|3973395|P1|NOT COMPLETED|Overall Study||0
1625756|NCT00857714|3973395|P1|COMPLETED|Overall Study||1
1625757|NCT00857714|3973395|P1|STARTED|Overall Study||1
1625758|NCT00857649|3973402|P2|NOT COMPLETED|Overall Study||32
1625759|NCT00857649|3973403|P1|NOT COMPLETED|Overall Study||31
1625760|NCT00857649|3973402|P2|COMPLETED|Overall Study||155
1625761|NCT00857649|3973403|P1|COMPLETED|Overall Study||151
1625762|NCT00857649|3973402|P2|STARTED|Overall Study||187
1625763|NCT00857649|3973403|P1|STARTED|Overall Study||182
1625764|NCT00857623|3973419|P2|NOT COMPLETED|Overall Study||10
1625765|NCT00857623|3973420|P1|NOT COMPLETED|Overall Study||14
1625766|NCT00857623|3973419|P2|COMPLETED|Overall Study||55
1625767|NCT00857623|3973420|P1|COMPLETED|Overall Study||48
1625768|NCT00857623|3973419|P2|STARTED|Overall Study||65
1625769|NCT00857623|3973420|P1|STARTED|Overall Study||62
1625770|NCT00857584|3973444|P2|NOT COMPLETED|Overall Study||5
1625771|NCT00857584|3973445|P1|NOT COMPLETED|Overall Study||4
1625772|NCT00857584|3973444|P2|COMPLETED|Overall Study||8
1625773|NCT00857584|3973445|P1|COMPLETED|Overall Study||10
1625774|NCT00857584|3973444|P2|Week 8|Overall Study||8
1625775|NCT00857584|3973445|P1|Week 8|Overall Study||10
1625776|NCT00857584|3973444|P2|Week 4|Overall Study||9
1625777|NCT00857584|3973445|P1|Week 4|Overall Study||11
1625778|NCT00857584|3973444|P2|Week 2|Overall Study||11
1625779|NCT00857584|3973445|P1|Week 2|Overall Study||14
1625780|NCT00857584|3973444|P2|Week 1|Overall Study||13
1625781|NCT00857584|3973445|P1|Week 1|Overall Study||14
1625782|NCT00857584|3973444|P2|STARTED|Overall Study||13
1625783|NCT00857584|3973445|P1|STARTED|Overall Study||14
1625784|NCT00857545|3973487|P2|NOT COMPLETED|Overall Study||0
1625785|NCT00857545|3973488|P1|NOT COMPLETED|Overall Study||0
1625786|NCT00857545|3973487|P2|COMPLETED|Overall Study||85
1625787|NCT00857545|3973488|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
1625788|NCT00857545|3973487|P2|STARTED|Overall Study||85
1625789|NCT00857545|3973488|P1|STARTED|Overall Study||86
1625790|NCT00857532|3973498|P1|NOT COMPLETED|Overall Study||0
1625791|NCT00857532|3973498|P1|COMPLETED|Overall Study||31
1625792|NCT00857532|3973498|P1|STARTED|Overall Study||31
1625793|NCT00857506|3973509|P3|NOT COMPLETED|Overall Study||18
1625794|NCT00857506|3973510|P2|NOT COMPLETED|Overall Study||15
1625795|NCT00857506|3973511|P1|NOT COMPLETED|Overall Study||15
1625796|NCT00857506|3973509|P3|COMPLETED|Overall Study||51
1625797|NCT00857506|3973510|P2|COMPLETED|Overall Study||37
1625798|NCT00857506|3973511|P1|COMPLETED|Overall Study||16
1625799|NCT00857506|3973509|P3|STARTED|Overall Study||69
1625800|NCT00857506|3973510|P2|STARTED|Overall Study||52
1625801|NCT00857506|3973511|P1|STARTED|Overall Study||31
1625802|NCT00857454|3973537|P1|NOT COMPLETED|Overall Study||20
1625803|NCT00857454|3973537|P1|COMPLETED|Overall Study||51
1625804|NCT00857454|3973537|P1|STARTED|Overall Study||71
1625805|NCT00857415|3973550|P2|NOT COMPLETED|Overall Study||0
1625806|NCT00857415|3973551|P1|NOT COMPLETED|Overall Study||117
1625807|NCT00857415|3973550|P2|COMPLETED|Overall Study||74
1625808|NCT00857415|3973551|P1|COMPLETED|Overall Study||35
1625809|NCT00857415|3973550|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
1625810|NCT00857415|3973551|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
1625811|NCT00857415|3973550|P2|STARTED|Overall Study||74
1625812|NCT00857415|3973551|P1|STARTED|Overall Study||152
1625813|NCT00857311|3973562|P4|NOT COMPLETED|Overall Study||0
1625814|NCT00857311|3973563|P3|NOT COMPLETED|Overall Study||0
1625815|NCT00857311|3973564|P2|NOT COMPLETED|Overall Study||0
1625816|NCT00857311|3973565|P1|NOT COMPLETED|Overall Study||1
1625817|NCT00857311|3973562|P4|COMPLETED|Overall Study||0
1625818|NCT00857311|3973563|P3|COMPLETED|Overall Study||8
1625819|NCT00857311|3973564|P2|COMPLETED|Overall Study||0
1625820|NCT00857311|3973565|P1|COMPLETED|Overall Study||8
1625821|NCT00857311|3973562|P4|STARTED|Overall Study||0
1625822|NCT00857311|3973563|P3|STARTED|Overall Study||8
1625823|NCT00857311|3973564|P2|STARTED|Overall Study||0
1625824|NCT00857311|3973565|P1|STARTED|Overall Study||9
1625825|NCT00857285|3973577|P2|NOT COMPLETED|Overall Study||6
1625826|NCT00857285|3973578|P1|NOT COMPLETED|Overall Study||12
1625827|NCT00857285|3973577|P2|COMPLETED|Overall Study||59
1625828|NCT00857285|3973578|P1|COMPLETED|Overall Study||53
1625829|NCT00857285|3973577|P2|STARTED|Overall Study||65
1625830|NCT00857285|3973578|P1|STARTED|Overall Study||65
1625831|NCT00857272|3973584|P2|NOT COMPLETED|Overall Study||9
1625832|NCT00857272|3973585|P1|NOT COMPLETED|Overall Study||9
1625833|NCT00857272|3973584|P2|COMPLETED|Overall Study||145
1625834|NCT00857272|3973585|P1|COMPLETED|Overall Study||145
1625835|NCT00857272|3973584|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
1625836|NCT00857272|3973585|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
1625837|NCT00857259|3973594|P3|NOT COMPLETED|Overall Study||1
1625838|NCT00857259|3973595|P2|NOT COMPLETED|Overall Study||0
1625839|NCT00857259|3973596|P1|NOT COMPLETED|Overall Study||1
1625840|NCT00857259|3973594|P3|COMPLETED|Overall Study||6
1625841|NCT00857259|3973595|P2|COMPLETED|Overall Study||1
1625842|NCT00857259|3973596|P1|COMPLETED|Overall Study||7
1625843|NCT00857259|3973594|P3|STARTED|Overall Study||7
1625844|NCT00857259|3973595|P2|STARTED|Overall Study||1
1625845|NCT00857259|3973596|P1|STARTED|Overall Study||8
1625846|NCT00857246|3973606|P1|NOT COMPLETED|ChemoRT||3
1625847|NCT00857246|3973606|P1|COMPLETED|ChemoRT||12
1625848|NCT00857246|3973606|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
1625849|NCT00857246|3973606|P1|NOT COMPLETED|Surgery (Curative)||6
1625850|NCT00857246|3973606|P1|COMPLETED|Surgery (Curative)||21
1625851|NCT00857246|3973606|P1|STARTED|Surgery (Curative)||27
1625852|NCT00857246|3973606|P1|NOT COMPLETED|Induction Regimen||3
1625853|NCT00857246|3973606|P1|COMPLETED|Induction Regimen||27
1625854|NCT00857246|3973606|P1|STARTED|Induction Regimen||30
1625855|NCT00857233|3973616|P1|NOT COMPLETED|Overall Study||55
1625856|NCT00857233|3973616|P1|COMPLETED|Overall Study||242
1625857|NCT00857233|3973616|P1|STARTED|Overall Study||297
1625858|NCT00857220|3973625|P1|NOT COMPLETED|Overall Study||183
1625859|NCT00857220|3973625|P1|COMPLETED|Overall Study||121
1625860|NCT00857220|3973625|P1|STARTED|Overall Study||304
1625861|NCT00856986|3973647|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
1625862|NCT00856986|3973648|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
1625863|NCT00856986|3973649|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
1625864|NCT00856986|3973650|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
1625865|NCT00856986|3973651|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
1625866|NCT00856986|3973647|P5|COMPLETED|Extension Period, Weeks 26-52||0
1625867|NCT00856986|3973648|P4|COMPLETED|Extension Period, Weeks 26-52||0
1625868|NCT00856986|3973649|P3|COMPLETED|Extension Period, Weeks 26-52||432
1625869|NCT00856986|3973650|P2|COMPLETED|Extension Period, Weeks 26-52||130
1625870|NCT00856986|3973651|P1|COMPLETED|Extension Period, Weeks 26-52||108
1625871|NCT00856986|3973647|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
1625872|NCT00856986|3973648|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
1625873|NCT00856986|3973649|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
1625874|NCT00856986|3973650|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
1625875|NCT00856986|3973651|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
1625876|NCT00856986|3973647|P5|STARTED|Extension Period, Weeks 26-52||0
1625877|NCT00856986|3973648|P4|STARTED|Extension Period, Weeks 26-52||0
1625878|NCT00856986|3973649|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
1625879|NCT00856986|3973650|P2|STARTED|Extension Period, Weeks 26-52||144
1625880|NCT00856986|3973651|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
1625881|NCT00856986|3973647|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
1625882|NCT00856986|3973648|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
1625883|NCT00856986|3973649|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
1625884|NCT00856986|3973650|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
1625885|NCT00856986|3973651|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
1625886|NCT00856986|3973647|P5|COMPLETED|Main Period, Weeks 0-26||0
1625887|NCT00856986|3973648|P4|COMPLETED|Main Period, Weeks 0-26||0
1625888|NCT00856986|3973649|P3|COMPLETED|Main Period, Weeks 0-26||470
1625889|NCT00856986|3973650|P2|COMPLETED|Main Period, Weeks 0-26||144
1625890|NCT00856986|3973651|P1|COMPLETED|Main Period, Weeks 0-26||127
1625891|NCT00856986|3973647|P5|STARTED|Main Period, Weeks 0-26||0
1625892|NCT00856986|3973648|P4|STARTED|Main Period, Weeks 0-26||0
1625893|NCT00856986|3973649|P3|STARTED|Main Period, Weeks 0-26||498
1625894|NCT00856986|3973650|P2|STARTED|Main Period, Weeks 0-26||162
1625895|NCT00856986|3973651|P1|STARTED|Main Period, Weeks 0-26||161
1625896|NCT00856986|3973647|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1625897|NCT00856986|3973648|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
1625898|NCT00856986|3973649|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1625899|NCT00856986|3973650|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1625900|NCT00856986|3973651|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1625901|NCT00856986|3973647|P5|COMPLETED|Run-in Period, Weeks -12-0||0
1625902|NCT00856986|3973648|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
1625903|NCT00856986|3973649|P3|COMPLETED|Run-in Period, Weeks -12-0||498
1625904|NCT00856986|3973650|P2|COMPLETED|Run-in Period, Weeks -12-0||162
1625905|NCT00856986|3973651|P1|COMPLETED|Run-in Period, Weeks -12-0||161
1625906|NCT00856986|3973647|P5|STARTED|Run-in Period, Weeks -12-0||0
1625907|NCT00856986|3973648|P4|STARTED|Run-in Period, Weeks -12-0||167
1625908|NCT00856986|3973649|P3|STARTED|Run-in Period, Weeks -12-0||498
1625909|NCT00856986|3973650|P2|STARTED|Run-in Period, Weeks -12-0||162
1625910|NCT00856986|3973651|P1|STARTED|Run-in Period, Weeks -12-0||161
1625911|NCT00856973|3973821|P3|NOT COMPLETED|Overall Study||38
1625912|NCT00856973|3973822|P2|NOT COMPLETED|Overall Study||41
1625913|NCT00856973|3973823|P1|NOT COMPLETED|Overall Study||36
1625914|NCT00856973|3973821|P3|COMPLETED|Overall Study||123
1625915|NCT00856973|3973822|P2|COMPLETED|Overall Study||122
1625916|NCT00856973|3973823|P1|COMPLETED|Overall Study||126
1625917|NCT00856973|3973821|P3|STARTED|Overall Study||161
1625918|NCT00856973|3973822|P2|STARTED|Overall Study||163
1625919|NCT00856973|3973823|P1|STARTED|Overall Study||162
1625920|NCT00856934|3973891|P3|NOT COMPLETED|Overall Study||0
1625921|NCT00856934|3973892|P2|NOT COMPLETED|Overall Study||0
1625922|NCT00856934|3973893|P1|NOT COMPLETED|Overall Study||0
1625923|NCT00856934|3973891|P3|COMPLETED|Overall Study||15
1625924|NCT00856934|3973892|P2|COMPLETED|Overall Study||15
1625925|NCT00856934|3973893|P1|COMPLETED|Overall Study||15
1625926|NCT00856934|3973891|P3|STARTED|Overall Study||15
1625927|NCT00856934|3973892|P2|STARTED|Overall Study||15
1625928|NCT00856934|3973893|P1|STARTED|Overall Study||15
1625929|NCT00856908|3973903|P2|NOT COMPLETED|Overall Study||0
1625930|NCT00856908|3973904|P1|NOT COMPLETED|Overall Study||1
1625931|NCT00856908|3973903|P2|COMPLETED|Overall Study||5
1625932|NCT00856908|3973904|P1|COMPLETED|Overall Study||14
1625933|NCT00856908|3973903|P2|STARTED|Overall Study||5
1625934|NCT00856908|3973904|P1|STARTED|Overall Study||15
1625935|NCT00856843|3973931|P2|NOT COMPLETED|Overall Study||5
1625936|NCT00856843|3973932|P1|NOT COMPLETED|Overall Study||2
1625937|NCT00856843|3973931|P2|COMPLETED|Overall Study||63
1625938|NCT00856843|3973932|P1|COMPLETED|Overall Study||66
1625939|NCT00856843|3973931|P2|STARTED|Overall Study||68
1625940|NCT00856843|3973932|P1|STARTED|Overall Study||68
1625941|NCT00856830|3973968|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1625942|NCT00856830|3973969|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1625943|NCT00856830|3973970|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1625944|NCT00856830|3973971|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1625945|NCT00856830|3973968|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
1625946|NCT00856830|3973969|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
1625947|NCT00856830|3973970|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
1625948|NCT00856830|3973971|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
1625949|NCT00856830|3973968|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
1625950|NCT00856830|3973969|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
1625951|NCT00856830|3973970|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
1625952|NCT00856830|3973971|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
1625953|NCT00856830|3973968|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
1625954|NCT00856830|3973969|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
1625955|NCT00856830|3973970|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
1625956|NCT00856830|3973971|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
1625957|NCT00856830|3973968|P4|COMPLETED|Irinotecan & Bendamustine||12
1625958|NCT00856830|3973969|P3|COMPLETED|Irinotecan & Bendamustine||6
1625959|NCT00856830|3973970|P2|COMPLETED|Irinotecan & Bendamustine||6
1625960|NCT00856830|3973971|P1|COMPLETED|Irinotecan & Bendamustine||3
1625961|NCT00856830|3973968|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
1625962|NCT00856830|3973969|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
1625963|NCT00856830|3973970|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
1625964|NCT00856830|3973971|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
1625965|NCT00856830|3973968|P4|STARTED|Irinotecan & Bendamustine||15
1625966|NCT00856830|3973969|P3|STARTED|Irinotecan & Bendamustine||6
1625967|NCT00856830|3973970|P2|STARTED|Irinotecan & Bendamustine||6
1625968|NCT00856830|3973971|P1|STARTED|Irinotecan & Bendamustine||3
1625969|NCT00856791|3973977|P1|NOT COMPLETED|Overall Study||0
1625970|NCT00856791|3973977|P1|COMPLETED|Overall Study||1
1625971|NCT00856791|3973977|P1|STARTED|Overall Study||1
1625972|NCT00856778|3973982|P1|NOT COMPLETED|Overall Study||24
1625973|NCT00856778|3973982|P1|COMPLETED|Overall Study||74
1625974|NCT00856778|3973982|P1|STARTED|Overall Study||98
1625975|NCT00856739|3974001|P3|NOT COMPLETED|Overall Study||0
1625976|NCT00856739|3974002|P2|NOT COMPLETED|Overall Study||0
1625977|NCT00856739|3974003|P1|NOT COMPLETED|Overall Study||0
1625978|NCT00856739|3974001|P3|COMPLETED|Overall Study||55
1625979|NCT00856739|3974002|P2|COMPLETED|Overall Study||52
1625980|NCT00856739|3974003|P1|COMPLETED|Overall Study||70
1625981|NCT00856739|3974001|P3|STARTED|Overall Study||55
1625982|NCT00856739|3974002|P2|STARTED|Overall Study||52
1625983|NCT00856739|3974003|P1|STARTED|Overall Study||70
1625984|NCT00856726|3974014|P1|NOT COMPLETED|Overall Study||0
1625985|NCT00856726|3974014|P1|COMPLETED|Overall Study||26
1625986|NCT00856726|3974014|P1|STARTED|Overall Study||26
1625987|NCT00856661|3974025|P2|NOT COMPLETED|Overall Study||29
1625988|NCT00856661|3974026|P1|NOT COMPLETED|Overall Study||27
1625989|NCT00856661|3974025|P2|COMPLETED|Overall Study||106
1625990|NCT00856661|3974026|P1|COMPLETED|Overall Study||108
1625991|NCT00856661|3974025|P2|Randomized Not Treated|Overall Study||4
1625992|NCT00856661|3974026|P1|Randomized Not Treated|Overall Study||9
1625993|NCT00856661|3974025|P2|Treated|Overall Study||131
1625994|NCT00856661|3974026|P1|Treated|Overall Study||126
1625995|NCT00856661|3974025|P2|STARTED|Overall Study|Randomised|135
1625996|NCT00856661|3974026|P1|STARTED|Overall Study|Randomised|135
1625997|NCT00856635|3974040|P2|NOT COMPLETED|Overall Study||8
1625998|NCT00856635|3974041|P1|NOT COMPLETED|Overall Study||10
1625999|NCT00856635|3974040|P2|COMPLETED|Overall Study||14
1626000|NCT00856635|3974041|P1|COMPLETED|Overall Study||12
1626001|NCT00856635|3974040|P2|Received Study Drug|Overall Study||20
1626002|NCT00856635|3974041|P1|Received Study Drug|Overall Study||20
1626003|NCT00856635|3974040|P2|STARTED|Overall Study||22
1626004|NCT00856635|3974041|P1|STARTED|Overall Study||22
1626005|NCT00856609|3974051|P2|NOT COMPLETED|Overall Study||0
1626006|NCT00856609|3974052|P1|NOT COMPLETED|Overall Study||1
1626007|NCT00856609|3974051|P2|COMPLETED|Overall Study||39
1626008|NCT00856609|3974052|P1|COMPLETED|Overall Study||40
1626009|NCT00856609|3974051|P2|STARTED|Overall Study||39
1626010|NCT00856609|3974052|P1|STARTED|Overall Study||41
1626011|NCT00856583|3974064|P2|NOT COMPLETED|Overall Study||2597
1626012|NCT00856583|3974065|P1|NOT COMPLETED|Overall Study||3137
1626013|NCT00856583|3974064|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
1626014|NCT00856583|3974065|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
1626015|NCT00856583|3974064|P2|STARTED|Overall Study|Patients treated|4904
1626016|NCT00856583|3974065|P1|STARTED|Overall Study|Patients treated|4905
1626017|NCT00856557|3974095|P2|NOT COMPLETED|Overall Study||16
1626018|NCT00856557|3974096|P1|NOT COMPLETED|Overall Study||12
1626019|NCT00856557|3974095|P2|COMPLETED|Overall Study||60
1626020|NCT00856557|3974096|P1|COMPLETED|Overall Study||50
1626021|NCT00856557|3974095|P2|With Patients With Contextual Flags|Overall Study||60
1626022|NCT00856557|3974096|P1|With Patients With Contextual Flags|Overall Study||50
1626023|NCT00856557|3974095|P2|Tested With Standardized Patients|Overall Study||76
1626024|NCT00856557|3974096|P1|Tested With Standardized Patients|Overall Study||62
1626025|NCT00856557|3974095|P2|Received Intervention/Control|Overall Study||76
1626026|NCT00856557|3974096|P1|Received Intervention/Control|Overall Study||62
1626027|NCT00856557|3974095|P2|STARTED|Overall Study||76
1626028|NCT00856557|3974096|P1|STARTED|Overall Study||62
1626029|NCT00856544|3974110|P4|NOT COMPLETED|Overall Study||13
1626030|NCT00856544|3974111|P3|NOT COMPLETED|Overall Study||8
1626031|NCT00856544|3974112|P2|NOT COMPLETED|Overall Study||66
1626032|NCT00856544|3974113|P1|NOT COMPLETED|Overall Study||57
1626033|NCT00856544|3974110|P4|COMPLETED|Overall Study||67
1626034|NCT00856544|3974111|P3|COMPLETED|Overall Study||71
1626035|NCT00856544|3974112|P2|COMPLETED|Overall Study||252
1626036|NCT00856544|3974113|P1|COMPLETED|Overall Study||261
1626037|NCT00856544|3974110|P4|Treated|Overall Study||80
1626038|NCT00856544|3974111|P3|Treated|Overall Study||79
1626039|NCT00856544|3974112|P2|Treated|Overall Study||318
1626040|NCT00856544|3974113|P1|Treated|Overall Study||315
1626041|NCT00856544|3974110|P4|STARTED|Overall Study||80
1626042|NCT00856544|3974111|P3|STARTED|Overall Study||79
1626043|NCT00856544|3974112|P2|STARTED|Overall Study||318
1626044|NCT00856544|3974113|P1|STARTED|Overall Study||318
1626045|NCT00856518|3974292|P2|NOT COMPLETED|Overall Study||2
1626046|NCT00856518|3974293|P1|NOT COMPLETED|Overall Study||4
1626047|NCT00856518|3974292|P2|COMPLETED|Overall Study||16
1626048|NCT00856518|3974293|P1|COMPLETED|Overall Study||20
1626049|NCT00856518|3974292|P2|STARTED|Overall Study||18
1626050|NCT00856518|3974293|P1|STARTED|Overall Study||24
1626051|NCT00856492|3974306|P3|NOT COMPLETED|Overall Study||2
1626052|NCT00856492|3974307|P2|NOT COMPLETED|Overall Study||1
1626053|NCT00856492|3974308|P1|NOT COMPLETED|Overall Study||1
1626054|NCT00856492|3974306|P3|COMPLETED|Overall Study||51
1626055|NCT00856492|3974307|P2|COMPLETED|Overall Study||62
1626056|NCT00856492|3974308|P1|COMPLETED|Overall Study||98
1626057|NCT00856492|3974306|P3|Toxicity Eval|Overall Study||51
1626058|NCT00856492|3974307|P2|Toxicity Eval|Overall Study||60
1626059|NCT00856492|3974308|P1|Toxicity Eval|Overall Study||96
1626060|NCT00856492|3974306|P3|STARTED|Overall Study||53
1626061|NCT00856492|3974307|P2|STARTED|Overall Study||63
1626062|NCT00856492|3974308|P1|STARTED|Overall Study||99
1626063|NCT00856414|3974322|P1|NOT COMPLETED|Overall Study||0
1626064|NCT00856414|3974322|P1|COMPLETED|Overall Study||45
1626065|NCT00856414|3974322|P1|STARTED|Overall Study||45
1626066|NCT00856388|3974330|P1|NOT COMPLETED|Overall Study||1
1626067|NCT00856388|3974330|P1|COMPLETED|Overall Study||61
1626068|NCT00856388|3974330|P1|STARTED|Overall Study||62
1626069|NCT00856349|3974341|P1|NOT COMPLETED|Overall Study||1021
1626070|NCT00856349|3974341|P1|COMPLETED|Overall Study||3111
1626071|NCT00856349|3974341|P1|24 Month Follow-up|Overall Study||1698
1626072|NCT00856349|3974341|P1|18 Month Follow-up|Overall Study||2467
1626073|NCT00856349|3974341|P1|12 Month Follow-up|Overall Study||3228
1626074|NCT00856349|3974341|P1|STARTED|Overall Study||4132
1626075|NCT00856323|3974350|P1|NOT COMPLETED|Overall Study||2
1626076|NCT00856323|3974350|P1|COMPLETED|Overall Study||51
1626077|NCT00856323|3974350|P1|STARTED|Overall Study||53
1626078|NCT00856297|3974362|P5|NOT COMPLETED|Overall Study||0
1626079|NCT00856297|3974363|P4|NOT COMPLETED|Overall Study||0
1626080|NCT00856297|3974364|P3|NOT COMPLETED|Overall Study||0
1626081|NCT00856297|3974365|P2|NOT COMPLETED|Overall Study||0
1626082|NCT00856297|3974366|P1|NOT COMPLETED|Overall Study||2
1626083|NCT00856297|3974362|P5|COMPLETED|Overall Study||31
1626084|NCT00856297|3974363|P4|COMPLETED|Overall Study||44
1626085|NCT00856297|3974364|P3|COMPLETED|Overall Study||107
1626086|NCT00856297|3974365|P2|COMPLETED|Overall Study||76
1626087|NCT00856297|3974366|P1|COMPLETED|Overall Study||129
1626088|NCT00856297|3974362|P5|STARTED|Overall Study||31
1626089|NCT00856297|3974363|P4|STARTED|Overall Study||44
1626090|NCT00856297|3974364|P3|STARTED|Overall Study||107
1626091|NCT00856297|3974365|P2|STARTED|Overall Study||76
1626092|NCT00856297|3974366|P1|STARTED|Overall Study||131
1626093|NCT00856284|3974399|P3|NOT COMPLETED|Overall Study||447
1626094|NCT00856284|3974400|P2|NOT COMPLETED|Overall Study||392
1626095|NCT00856284|3974401|P1|NOT COMPLETED|Overall Study||408
1626096|NCT00856284|3974399|P3|COMPLETED|Overall Study||427
1626097|NCT00856284|3974400|P2|COMPLETED|Overall Study||493
1626098|NCT00856284|3974401|P1|COMPLETED|Overall Study||472
1626099|NCT00856284|3974399|P3|Received Study Drug|Overall Study||869
1626100|NCT00856284|3974400|P2|Received Study Drug|Overall Study||878
1626101|NCT00856284|3974401|P1|Received Study Drug|Overall Study||873
1626102|NCT00856284|3974399|P3|STARTED|Overall Study||874
1626103|NCT00856284|3974400|P2|STARTED|Overall Study||885
1626104|NCT00856284|3974401|P1|STARTED|Overall Study||880
1626105|NCT00856245|3974427|P1|NOT COMPLETED|Overall Study||5
1626106|NCT00856245|3974427|P1|COMPLETED|Overall Study||14
1626107|NCT00856245|3974427|P1|STARTED|Overall Study||19
1626108|NCT00856232|3974435|P3|NOT COMPLETED|Overall Study||0
1626109|NCT00856232|3974436|P2|NOT COMPLETED|Overall Study||0
1626110|NCT00856232|3974437|P1|NOT COMPLETED|Overall Study||0
1626111|NCT00856232|3974435|P3|COMPLETED|Overall Study||36
1626112|NCT00856232|3974436|P2|COMPLETED|Overall Study||29
1626113|NCT00856232|3974437|P1|COMPLETED|Overall Study||26
1626114|NCT00856232|3974435|P3|STARTED|Overall Study||36
1626115|NCT00856232|3974436|P2|STARTED|Overall Study||29
1626116|NCT00856232|3974437|P1|STARTED|Overall Study||26
1626117|NCT00856206|3974450|P2|NOT COMPLETED|Overall Study||161
1626118|NCT00856206|3974451|P1|NOT COMPLETED|Overall Study||54
1626119|NCT00856206|3974450|P2|COMPLETED|Overall Study||824
1626120|NCT00856206|3974451|P1|COMPLETED|Overall Study||276
1626121|NCT00856206|3974450|P2|STARTED|Overall Study||985
1626122|NCT00856206|3974451|P1|STARTED|Overall Study||330
1626123|NCT00856193|3974465|P2|NOT COMPLETED|Period 2||2
1626124|NCT00856193|3974466|P1|NOT COMPLETED|Period 2||0
1626125|NCT00856193|3974465|P2|COMPLETED|Period 2||15
1626126|NCT00856193|3974466|P1|COMPLETED|Period 2||16
1626127|NCT00856193|3974465|P2|STARTED|Period 2||17
1626128|NCT00856193|3974466|P1|STARTED|Period 2||16
1626129|NCT00856193|3974465|P2|NOT COMPLETED|Period 1||0
1626130|NCT00856193|3974466|P1|NOT COMPLETED|Period 1||0
1626131|NCT00856193|3974465|P2|COMPLETED|Period 1||17
1626132|NCT00856193|3974466|P1|COMPLETED|Period 1||16
1626133|NCT00856193|3974465|P2|STARTED|Period 1||17
1626134|NCT00856193|3974466|P1|STARTED|Period 1||16
1626135|NCT00856180|3974478|P1|NOT COMPLETED|Overall Study||20
1626136|NCT00856180|3974478|P1|COMPLETED|Overall Study||0
1626137|NCT00856180|3974478|P1|STARTED|Overall Study||20
1626138|NCT00856050|3974487|P1|NOT COMPLETED|Overall Study||0
1626139|NCT00856050|3974487|P1|COMPLETED|Overall Study||26
1626140|NCT00856050|3974487|P1|STARTED|Overall Study||26
1626141|NCT00856024|3974491|P1|NOT COMPLETED|Overall Study||0
1626142|NCT00856024|3974491|P1|COMPLETED|Overall Study||902
1626143|NCT00856024|3974491|P1|STARTED|Overall Study||902
1626144|NCT00855959|3974503|P1|NOT COMPLETED|Overall Study||9
1626145|NCT00855959|3974503|P1|COMPLETED|Overall Study||99
1626146|NCT00855959|3974503|P1|Patients Who Received Pulmicort Respules|Overall Study||105
1626147|NCT00855959|3974503|P1|STARTED|Overall Study||108
1626148|NCT00855933|3974520|P2|NOT COMPLETED|Overall Study||1
1626149|NCT00855933|3974521|P1|NOT COMPLETED|Overall Study||0
1626150|NCT00855933|3974520|P2|COMPLETED|Overall Study||29
1626151|NCT00855933|3974521|P1|COMPLETED|Overall Study||30
1626152|NCT00855933|3974520|P2|STARTED|Overall Study||30
1626153|NCT00855933|3974521|P1|STARTED|Overall Study||30
1626154|NCT00855920|3974530|P3|NOT COMPLETED|Overall Study||11
1626155|NCT00855920|3974531|P2|NOT COMPLETED|Overall Study||9
1626156|NCT00855920|3974532|P1|NOT COMPLETED|Overall Study||8
1626157|NCT00855920|3974530|P3|COMPLETED|Overall Study||64
1626158|NCT00855920|3974531|P2|COMPLETED|Overall Study||65
1626159|NCT00855920|3974532|P1|COMPLETED|Overall Study||68
1626160|NCT00855920|3974530|P3|Safety Population|Overall Study||75
1626161|NCT00855920|3974531|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
1626162|NCT00855920|3974532|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
1626163|NCT00855920|3974530|P3|STARTED|Overall Study||75
1626164|NCT00855920|3974531|P2|STARTED|Overall Study||74
1626165|NCT00855920|3974532|P1|STARTED|Overall Study||76
1626166|NCT00855894|3974549|P1|NOT COMPLETED|Overall Study||33
1626167|NCT00855894|3974549|P1|COMPLETED|Overall Study||8
1626168|NCT00855894|3974549|P1|STARTED|Overall Study||41
1626169|NCT00855868|3974559|P2|NOT COMPLETED|Overall Study||1
1626170|NCT00855868|3974560|P1|NOT COMPLETED|Overall Study||1
1626171|NCT00855868|3974559|P2|COMPLETED|Overall Study||14
1626172|NCT00855868|3974560|P1|COMPLETED|Overall Study||12
1626173|NCT00855868|3974559|P2|STARTED|Overall Study||15
1626174|NCT00855868|3974560|P1|STARTED|Overall Study||13
1626175|NCT00855842|3974566|P1|NOT COMPLETED|Overall Study||0
1626176|NCT00855842|3974566|P1|COMPLETED|Overall Study||4
1626177|NCT00855842|3974566|P1|STARTED|Overall Study||4
1626178|NCT00855816|3974572|P2|NOT COMPLETED|Overall Study||21
1626179|NCT00855816|3974573|P1|NOT COMPLETED|Overall Study||26
1626180|NCT00855816|3974572|P2|COMPLETED|Overall Study||12
1626181|NCT00855816|3974573|P1|COMPLETED|Overall Study||21
1626182|NCT00855816|3974572|P2|STARTED|Overall Study||33
1626183|NCT00855816|3974573|P1|STARTED|Overall Study||47
1626184|NCT00855738|3974579|P1|NOT COMPLETED|Overall Study||5
1626185|NCT00855738|3974579|P1|COMPLETED|Overall Study||106
1626186|NCT00855738|3974579|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
1626187|NCT00855738|3974579|P1|STARTED|Overall Study||111
1626188|NCT00855595|3974607|P2|NOT COMPLETED|Overall Study||7
1626189|NCT00855595|3974608|P1|NOT COMPLETED|Overall Study||6
1626190|NCT00855595|3974607|P2|COMPLETED|Overall Study||94
1626191|NCT00855595|3974608|P1|COMPLETED|Overall Study||100
1626192|NCT00855595|3974607|P2|STARTED|Overall Study||101
1626193|NCT00855595|3974608|P1|STARTED|Overall Study||106
1626194|NCT00855582|3974647|P3|NOT COMPLETED|Overall Study||30
1626195|NCT00855582|3974648|P2|NOT COMPLETED|Overall Study||24
1626196|NCT00855582|3974649|P1|NOT COMPLETED|Overall Study||26
1626197|NCT00855582|3974647|P3|COMPLETED|Overall Study||170
1626198|NCT00855582|3974648|P2|COMPLETED|Overall Study||184
1626199|NCT00855582|3974649|P1|COMPLETED|Overall Study||172
1626200|NCT00855582|3974647|P3|STARTED|Overall Study||200
1626201|NCT00855582|3974648|P2|STARTED|Overall Study||208
1626202|NCT00855582|3974649|P1|STARTED|Overall Study||198
1626203|NCT00855465|3974738|P2|NOT COMPLETED|Follow-up Period (FUP)||2
1626204|NCT00855465|3974739|P1|NOT COMPLETED|Follow-up Period (FUP)||8
1626205|NCT00855465|3974738|P2|COMPLETED|Follow-up Period (FUP)||2
1626206|NCT00855465|3974739|P1|COMPLETED|Follow-up Period (FUP)||9
1626207|NCT00855465|3974738|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
1626208|NCT00855465|3974739|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
1626209|NCT00855465|3974738|P2|NOT COMPLETED|Treatment Period||5
1626210|NCT00855465|3974739|P1|NOT COMPLETED|Treatment Period||14
1626211|NCT00855465|3974738|P2|COMPLETED|Treatment Period||83
1626212|NCT00855465|3974739|P1|COMPLETED|Treatment Period||160
1626213|NCT00855465|3974738|P2|Participants Received Treatment|Treatment Period||88
1626214|NCT00855465|3974739|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
1626215|NCT00855465|3974738|P2|STARTED|Treatment Period||88
1626216|NCT00855465|3974739|P1|STARTED|Treatment Period||174
1626217|NCT00855439|3974829|P2|NOT COMPLETED|Overall Study||0
1626218|NCT00855439|3974830|P1|NOT COMPLETED|Overall Study||3
1626219|NCT00855439|3974829|P2|COMPLETED|Overall Study||24
1626220|NCT00855439|3974830|P1|COMPLETED|Overall Study||19
1626221|NCT00855439|3974829|P2|STARTED|Overall Study||24
1626222|NCT00855439|3974830|P1|STARTED|Overall Study||22
1626223|NCT00855413|3974842|P1|NOT COMPLETED|Overall Study||0
1626224|NCT00855413|3974842|P1|COMPLETED|Overall Study||15
1626225|NCT00855413|3974842|P1|STARTED|Overall Study||15
1626226|NCT00855335|3974888|P5|NOT COMPLETED|Overall Study||1
1626227|NCT00855335|3974889|P4|NOT COMPLETED|Overall Study||7
1626228|NCT00855335|3974890|P3|NOT COMPLETED|Overall Study||5
1626229|NCT00855335|3974891|P2|NOT COMPLETED|Overall Study||2
1626230|NCT00855335|3974892|P1|NOT COMPLETED|Overall Study||5
1626231|NCT00855335|3974888|P5|COMPLETED|Overall Study||6
1626232|NCT00855335|3974889|P4|COMPLETED|Overall Study||12
1626233|NCT00855335|3974890|P3|COMPLETED|Overall Study||10
1626234|NCT00855335|3974891|P2|COMPLETED|Overall Study||16
1626235|NCT00855335|3974892|P1|COMPLETED|Overall Study||13
1626236|NCT00855335|3974888|P5|STARTED|Overall Study||7
1626237|NCT00855335|3974889|P4|STARTED|Overall Study||19
1626238|NCT00855335|3974890|P3|STARTED|Overall Study||15
1626239|NCT00855335|3974891|P2|STARTED|Overall Study||18
1626240|NCT00855335|3974892|P1|STARTED|Overall Study||18
1626241|NCT00855309|3974979|P2|NOT COMPLETED|Overall Study||0
1626242|NCT00855309|3974980|P1|NOT COMPLETED|Overall Study||1
1626243|NCT00855309|3974979|P2|COMPLETED|Overall Study||55
1626244|NCT00855309|3974980|P1|COMPLETED|Overall Study||56
1626245|NCT00855309|3974979|P2|STARTED|Overall Study||55
1626246|NCT00855309|3974980|P1|STARTED|Overall Study||57
1626247|NCT00855218|3974988|P2|NOT COMPLETED|Overall Study||153
1626248|NCT00855218|3974989|P1|NOT COMPLETED|Overall Study||154
1626249|NCT00855218|3974988|P2|COMPLETED|Overall Study||0
1626250|NCT00855218|3974989|P1|COMPLETED|Overall Study||0
1626251|NCT00855218|3974988|P2|Participants Received Treatment|Overall Study||151
1626252|NCT00855218|3974989|P1|Participants Received Treatment|Overall Study||153
1626253|NCT00855218|3974988|P2|STARTED|Overall Study||153
1626254|NCT00855218|3974989|P1|STARTED|Overall Study||154
1626255|NCT00855166|3975007|P2|NOT COMPLETED|Overall Study||8
1626256|NCT00855166|3975008|P1|NOT COMPLETED|Overall Study||5
1626257|NCT00855166|3975007|P2|COMPLETED|Overall Study||83
1626258|NCT00855166|3975008|P1|COMPLETED|Overall Study||86
1626259|NCT00855166|3975007|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
1626260|NCT00855166|3975008|P1|STARTED|Overall Study||91
1626261|NCT00855062|3975028|P2|NOT COMPLETED|Step2||6
1626262|NCT00855062|3975029|P1|NOT COMPLETED|Step2||6
1626263|NCT00855062|3975028|P2|COMPLETED|Step2||15
1626264|NCT00855062|3975029|P1|COMPLETED|Step2||13
1626265|NCT00855062|3975028|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
1626266|NCT00855062|3975029|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
1626267|NCT00855062|3975028|P2|NOT COMPLETED|Step1||11
1626268|NCT00855062|3975029|P1|NOT COMPLETED|Step1||10
1626269|NCT00855062|3975028|P2|COMPLETED|Step1||26
1626270|NCT00855062|3975029|P1|COMPLETED|Step1||26
1626271|NCT00855062|3975028|P2|STARTED|Step1||37
1626272|NCT00855062|3975029|P1|STARTED|Step1||36
1626273|NCT00855010|3975055|P2|NOT COMPLETED|Overall Study||1
1626274|NCT00855010|3975056|P1|NOT COMPLETED|Overall Study||4
1626275|NCT00855010|3975055|P2|COMPLETED|Overall Study||18
1626276|NCT00855010|3975056|P1|COMPLETED|Overall Study||19
1626277|NCT00855010|3975055|P2|STARTED|Overall Study||19
1626278|NCT00855010|3975056|P1|STARTED|Overall Study||23
1626279|NCT00854906|3975078|P1|NOT COMPLETED|Overall Study||1
1626365|NCT00854113|3975237|P11|COMPLETED|Overall Study||6
1626280|NCT00854906|3975078|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
1626281|NCT00854906|3975078|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
1626282|NCT00854724|3975087|P2|NOT COMPLETED|Second Intervention||1
1626283|NCT00854724|3975088|P1|NOT COMPLETED|Second Intervention||1
1626284|NCT00854724|3975087|P2|COMPLETED|Second Intervention||5
1626285|NCT00854724|3975088|P1|COMPLETED|Second Intervention||5
1626286|NCT00854724|3975087|P2|STARTED|Second Intervention||6
1626287|NCT00854724|3975088|P1|STARTED|Second Intervention||6
1626288|NCT00854724|3975087|P2|NOT COMPLETED|Washout||1
1626289|NCT00854724|3975088|P1|NOT COMPLETED|Washout||1
1626290|NCT00854724|3975087|P2|COMPLETED|Washout||6
1626291|NCT00854724|3975088|P1|COMPLETED|Washout||6
1626292|NCT00854724|3975087|P2|STARTED|Washout||7
1626293|NCT00854724|3975088|P1|STARTED|Washout||7
1626294|NCT00854724|3975087|P2|NOT COMPLETED|First Intervention||1
1626295|NCT00854724|3975088|P1|NOT COMPLETED|First Intervention||1
1626296|NCT00854724|3975087|P2|COMPLETED|First Intervention||7
1626297|NCT00854724|3975088|P1|COMPLETED|First Intervention||7
1626298|NCT00854724|3975087|P2|STARTED|First Intervention||8
1626299|NCT00854724|3975088|P1|STARTED|First Intervention||8
1626300|NCT00854620|3975094|P1|NOT COMPLETED|Overall Study||1
1626301|NCT00854620|3975094|P1|COMPLETED|Overall Study||8
1626302|NCT00854620|3975094|P1|STARTED|Overall Study||9
1626303|NCT00854607|3975098|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
1626304|NCT00854607|3975098|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
1626305|NCT00854607|3975098|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
1626306|NCT00854607|3975098|P1|NOT COMPLETED|Enrollment||0
1626307|NCT00854607|3975098|P1|COMPLETED|Enrollment||116
1626308|NCT00854607|3975098|P1|STARTED|Enrollment||116
1626309|NCT00854594|3975133|P2|NOT COMPLETED|Overall Study||0
1626310|NCT00854594|3975134|P1|NOT COMPLETED|Overall Study||0
1626311|NCT00854594|3975133|P2|COMPLETED|Overall Study||69
1626312|NCT00854594|3975134|P1|COMPLETED|Overall Study||48
1626313|NCT00854594|3975133|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
1626314|NCT00854594|3975134|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
1626315|NCT00854581|3975146|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
1626316|NCT00854581|3975146|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
1626317|NCT00854581|3975146|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
1626318|NCT00854581|3975146|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
1626319|NCT00854581|3975146|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
1626320|NCT00854581|3975146|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
1626321|NCT00854581|3975146|P1|NOT COMPLETED|Induction (Up to Day 21)||6
1626322|NCT00854581|3975146|P1|COMPLETED|Induction (Up to Day 21)||7
1626323|NCT00854581|3975146|P1|STARTED|Induction (Up to Day 21)||13
1626324|NCT00854373|3975161|P2|NOT COMPLETED|Overall Study||4
1626325|NCT00854373|3975162|P1|NOT COMPLETED|Overall Study||2
1626326|NCT00854373|3975161|P2|COMPLETED|Overall Study||89
1626327|NCT00854373|3975162|P1|COMPLETED|Overall Study||93
1626328|NCT00854373|3975161|P2|STARTED|Overall Study||93
1626329|NCT00854373|3975162|P1|STARTED|Overall Study||95
1626330|NCT00854360|3975176|P4|NOT COMPLETED|Overall Study||10
1626331|NCT00854360|3975177|P3|NOT COMPLETED|Overall Study||2
1626332|NCT00854360|3975178|P2|NOT COMPLETED|Overall Study||3
1626333|NCT00854360|3975179|P1|NOT COMPLETED|Overall Study||2
1626334|NCT00854360|3975176|P4|COMPLETED|Overall Study||114
1626335|NCT00854360|3975177|P3|COMPLETED|Overall Study||120
1626336|NCT00854360|3975178|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
1626337|NCT00854360|3975179|P1|COMPLETED|Overall Study||116
1626338|NCT00854360|3975176|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
1626339|NCT00854360|3975177|P3|Intent to Treat / Safety Population|Overall Study||122
1626340|NCT00854360|3975178|P2|Intent to Treat / Safety Population|Overall Study||123
1626341|NCT00854360|3975179|P1|Intent to Treat / Safety Population|Overall Study||118
1626342|NCT00854360|3975176|P4|STARTED|Overall Study||124
1626343|NCT00854360|3975177|P3|STARTED|Overall Study||122
1626344|NCT00854360|3975178|P2|STARTED|Overall Study||123
1626345|NCT00854360|3975179|P1|STARTED|Overall Study||118
1626346|NCT00854308|3975211|P2|NOT COMPLETED|Overall Study||67
1626347|NCT00854308|3975212|P1|NOT COMPLETED|Overall Study||62
1626348|NCT00854308|3975211|P2|COMPLETED|Overall Study||1
1626349|NCT00854308|3975212|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
1626350|NCT00854308|3975211|P2|Received Study Drug|Overall Study||67
1626351|NCT00854308|3975212|P1|Received Study Drug|Overall Study||69
1626352|NCT00854308|3975211|P2|STARTED|Overall Study||68
1626353|NCT00854308|3975212|P1|STARTED|Overall Study||69
1626354|NCT00854113|3975237|P11|NOT COMPLETED|Overall Study||0
1626355|NCT00854113|3975238|P10|NOT COMPLETED|Overall Study||0
1626356|NCT00854113|3975239|P9|NOT COMPLETED|Overall Study||1
1626357|NCT00854113|3975240|P8|NOT COMPLETED|Overall Study||3
1626358|NCT00854113|3975241|P7|NOT COMPLETED|Overall Study||0
1626359|NCT00854113|3975242|P6|NOT COMPLETED|Overall Study||0
1626360|NCT00854113|3975243|P5|NOT COMPLETED|Overall Study||0
1626361|NCT00854113|3975244|P4|NOT COMPLETED|Overall Study||0
1626362|NCT00854113|3975245|P3|NOT COMPLETED|Overall Study||0
1626363|NCT00854113|3975246|P2|NOT COMPLETED|Overall Study||0
1626364|NCT00854113|3975247|P1|NOT COMPLETED|Overall Study||0
1626366|NCT00854113|3975238|P10|COMPLETED|Overall Study||8
1626367|NCT00854113|3975239|P9|COMPLETED|Overall Study||7
1626368|NCT00854113|3975240|P8|COMPLETED|Overall Study||5
1626369|NCT00854113|3975241|P7|COMPLETED|Overall Study||12
1626370|NCT00854113|3975242|P6|COMPLETED|Overall Study||6
1626371|NCT00854113|3975243|P5|COMPLETED|Overall Study||6
1626372|NCT00854113|3975244|P4|COMPLETED|Overall Study||6
1626373|NCT00854113|3975245|P3|COMPLETED|Overall Study||6
1626374|NCT00854113|3975246|P2|COMPLETED|Overall Study||6
1626375|NCT00854113|3975247|P1|COMPLETED|Overall Study||6
1626376|NCT00854113|3975237|P11|STARTED|Overall Study||6
1626377|NCT00854113|3975238|P10|STARTED|Overall Study||8
1626378|NCT00854113|3975239|P9|STARTED|Overall Study||8
1626379|NCT00854113|3975240|P8|STARTED|Overall Study||8
1626380|NCT00854113|3975241|P7|STARTED|Overall Study||12
1626381|NCT00854113|3975242|P6|STARTED|Overall Study||6
1626382|NCT00854113|3975243|P5|STARTED|Overall Study||6
1626383|NCT00854113|3975244|P4|STARTED|Overall Study||6
1626384|NCT00854113|3975245|P3|STARTED|Overall Study||6
1626385|NCT00854113|3975246|P2|STARTED|Overall Study||6
1626386|NCT00854113|3975247|P1|STARTED|Overall Study||6
1626387|NCT00854087|3975350|P2|NOT COMPLETED|Overall Study||19
1626388|NCT00854087|3975351|P1|NOT COMPLETED|Overall Study||19
1626389|NCT00854087|3975350|P2|COMPLETED|Overall Study||40
1626390|NCT00854087|3975351|P1|COMPLETED|Overall Study||40
1626391|NCT00854087|3975350|P2|STARTED|Overall Study||59
1626392|NCT00854087|3975351|P1|STARTED|Overall Study||59
1626393|NCT00853996|3975357|P1|NOT COMPLETED|Overall Study||0
1626394|NCT00853996|3975357|P1|COMPLETED|Overall Study||25
1626395|NCT00853996|3975357|P1|STARTED|Overall Study||25
1626396|NCT00853970|3975369|P2|NOT COMPLETED|Overall Study||3
1626397|NCT00853970|3975370|P1|NOT COMPLETED|Overall Study||6
1626398|NCT00853970|3975369|P2|COMPLETED|Overall Study||144
1626399|NCT00853970|3975370|P1|COMPLETED|Overall Study||146
1626400|NCT00853970|3975369|P2|STARTED|Overall Study||147
1626401|NCT00853970|3975370|P1|STARTED|Overall Study||152
1626402|NCT00853957|3975380|P2|NOT COMPLETED|Overall Study||19
1626403|NCT00853957|3975381|P1|NOT COMPLETED|Overall Study||14
1626404|NCT00853957|3975380|P2|COMPLETED|Overall Study||204
1626405|NCT00853957|3975381|P1|COMPLETED|Overall Study||206
1626406|NCT00853957|3975380|P2|STARTED|Overall Study||223
1626407|NCT00853957|3975381|P1|STARTED|Overall Study||220
1626408|NCT00853905|3975399|P2|NOT COMPLETED|Overall Study||4
1626409|NCT00853905|3975400|P1|NOT COMPLETED|Overall Study||2
1626410|NCT00853905|3975399|P2|COMPLETED|Overall Study||36
1626411|NCT00853905|3975400|P1|COMPLETED|Overall Study||35
1626412|NCT00853905|3975399|P2|STARTED|Overall Study||40
1626413|NCT00853905|3975400|P1|STARTED|Overall Study||37
1626414|NCT00853840|3975414|P2|NOT COMPLETED|Period 2||0
1626415|NCT00853840|3975415|P1|NOT COMPLETED|Period 2||0
1626416|NCT00853840|3975414|P2|COMPLETED|Period 2||9
1626417|NCT00853840|3975415|P1|COMPLETED|Period 2||9
1626418|NCT00853840|3975414|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
1626419|NCT00853840|3975415|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
1626420|NCT00853840|3975414|P2|Maraviroc (Days 1 - 3)|Period 2||9
1626421|NCT00853840|3975415|P1|Maraviroc (Days 1 - 3)|Period 2||9
1626422|NCT00853840|3975414|P2|STARTED|Period 2||9
1626423|NCT00853840|3975415|P1|STARTED|Period 2||9
1626424|NCT00853840|3975414|P2|NOT COMPLETED|Period 1||0
1626425|NCT00853840|3975415|P1|NOT COMPLETED|Period 1||0
1626426|NCT00853840|3975414|P2|COMPLETED|Period 1||9
1626427|NCT00853840|3975415|P1|COMPLETED|Period 1||9
1626428|NCT00853840|3975414|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
1626429|NCT00853840|3975415|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
1626430|NCT00853840|3975414|P2|Maraviroc (Days 1 - 4)|Period 1||9
1626431|NCT00853840|3975415|P1|Maraviroc (Days 1 - 4)|Period 1||9
1626432|NCT00853840|3975414|P2|STARTED|Period 1||9
1626433|NCT00853840|3975415|P1|STARTED|Period 1||9
1626434|NCT00853827|3975432|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
1626435|NCT00853827|3975433|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
1626436|NCT00853827|3975432|P2|COMPLETED|Double Blind Period (103 Weeks)||199
1626437|NCT00853827|3975433|P1|COMPLETED|Double Blind Period (103 Weeks)||201
1626438|NCT00853827|3975432|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
1626439|NCT00853827|3975433|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
1626440|NCT00853827|3975432|P2|STARTED|Double Blind Period (103 Weeks)||308
1626441|NCT00853827|3975433|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
1626442|NCT00853827|3975432|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
1626443|NCT00853827|3975433|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
1626444|NCT00853827|3975432|P2|COMPLETED|Single Blind Period (1 Week)||0
1626445|NCT00853827|3975433|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
1626446|NCT00853827|3975432|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
1626447|NCT00853827|3975433|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
1626448|NCT00853762|3975449|P4|NOT COMPLETED|Overall Study||22
1626449|NCT00853762|3975450|P3|NOT COMPLETED|Overall Study||17
1626450|NCT00853762|3975451|P2|NOT COMPLETED|Overall Study||19
1626451|NCT00853762|3975452|P1|NOT COMPLETED|Overall Study||16
1626452|NCT00853762|3975449|P4|COMPLETED|Overall Study||0
1626453|NCT00853762|3975450|P3|COMPLETED|Overall Study||0
1626454|NCT00853762|3975451|P2|COMPLETED|Overall Study||0
1626455|NCT00853762|3975452|P1|COMPLETED|Overall Study||0
1626456|NCT00853762|3975449|P4|STARTED|Overall Study||22
1626457|NCT00853762|3975450|P3|STARTED|Overall Study||17
1626458|NCT00853762|3975451|P2|STARTED|Overall Study||19
1626459|NCT00853762|3975452|P1|STARTED|Overall Study||16
1626460|NCT00853749|3975520|P2|NOT COMPLETED|Overall Study||1
1626461|NCT00853749|3975521|P1|NOT COMPLETED|Overall Study||0
1626462|NCT00853749|3975520|P2|COMPLETED|Overall Study||38
1626463|NCT00853749|3975521|P1|COMPLETED|Overall Study||50
1626464|NCT00853749|3975520|P2|Vaccinated|Overall Study||39
1626465|NCT00853749|3975521|P1|Vaccinated|Overall Study||50
1626466|NCT00853749|3975520|P2|STARTED|Overall Study||39
1626467|NCT00853749|3975521|P1|STARTED|Overall Study||50
1626468|NCT00853723|3975542|P3|NOT COMPLETED|Overall Study||2
1626469|NCT00853723|3975543|P2|NOT COMPLETED|Overall Study||7
1626470|NCT00853723|3975544|P1|NOT COMPLETED|Overall Study||6
1626471|NCT00853723|3975542|P3|COMPLETED|Overall Study||33
1626472|NCT00853723|3975543|P2|COMPLETED|Overall Study||28
1626473|NCT00853723|3975544|P1|COMPLETED|Overall Study||29
1626474|NCT00853723|3975542|P3|STARTED|Overall Study||35
1626475|NCT00853723|3975543|P2|STARTED|Overall Study||35
1626476|NCT00853723|3975544|P1|STARTED|Overall Study||35
1626477|NCT00853671|3975588|P1|NOT COMPLETED|Overall Study||0
1626478|NCT00853671|3975588|P1|COMPLETED|Overall Study||50
1626479|NCT00853671|3975588|P1|STARTED|Overall Study||50
1626480|NCT00853658|3975598|P3|NOT COMPLETED|Overall Study||815
1626481|NCT00853658|3975599|P2|NOT COMPLETED|Overall Study||832
1626482|NCT00853658|3975600|P1|NOT COMPLETED|Overall Study||787
1626483|NCT00853658|3975598|P3|COMPLETED|Overall Study||1539
1626484|NCT00853658|3975599|P2|COMPLETED|Overall Study||1524
1626485|NCT00853658|3975600|P1|COMPLETED|Overall Study||1567
1626486|NCT00853658|3975598|P3|Safety Set|Overall Study||2345
1626487|NCT00853658|3975599|P2|Safety Set|Overall Study||2348
1626488|NCT00853658|3975600|P1|Safety Set|Overall Study||2347
1626489|NCT00853658|3975598|P3|Full Analysis Set (FAS)|Overall Study||2336
1626490|NCT00853658|3975599|P2|Full Analysis Set (FAS)|Overall Study||2340
1626491|NCT00853658|3975600|P1|Full Analysis Set (FAS)|Overall Study||2340
1626492|NCT00853658|3975598|P3|STARTED|Overall Study||2354
1626493|NCT00853658|3975599|P2|STARTED|Overall Study||2356
1626494|NCT00853658|3975600|P1|STARTED|Overall Study||2354
1626495|NCT00853606|3975614|P1|NOT COMPLETED|Overall Study||220
1626496|NCT00853606|3975614|P1|COMPLETED|Overall Study||492
1626497|NCT00853606|3975614|P1|STARTED|Overall Study||712
1626498|NCT00853593|3975620|P1|NOT COMPLETED|Overall Study||45
1626499|NCT00853593|3975620|P1|COMPLETED|Overall Study||152
1626500|NCT00853593|3975620|P1|Model 4396 Lead Attempted|Overall Study||164
1626501|NCT00853593|3975620|P1|Implant Attempted|Overall Study||193
1626502|NCT00853593|3975620|P1|STARTED|Overall Study||197
1626503|NCT00853580|3975647|P2|NOT COMPLETED|Overall Study||16
1626504|NCT00853580|3975648|P1|NOT COMPLETED|Overall Study||7
1626505|NCT00853580|3975647|P2|COMPLETED|Overall Study||56
1626506|NCT00853580|3975648|P1|COMPLETED|Overall Study||67
1626507|NCT00853580|3975647|P2|STARTED|Overall Study||72
1626508|NCT00853580|3975648|P1|STARTED|Overall Study||74
1626509|NCT00853567|3975695|P1|NOT COMPLETED|Overall Study||71
1626510|NCT00853567|3975695|P1|COMPLETED|Overall Study||0
1626511|NCT00853567|3975695|P1|STARTED|Overall Study||71
1626512|NCT00853489|3975705|P2|NOT COMPLETED|Overall Study||2
1626513|NCT00853489|3975706|P1|NOT COMPLETED|Overall Study||5
1626514|NCT00853489|3975705|P2|COMPLETED|Overall Study||12
1626515|NCT00853489|3975706|P1|COMPLETED|Overall Study||11
1626516|NCT00853489|3975705|P2|STARTED|Overall Study||14
1626517|NCT00853489|3975706|P1|STARTED|Overall Study||16
1626518|NCT00853385|3975721|P5|NOT COMPLETED|Overall Study||42
1626519|NCT00853385|3975722|P4|NOT COMPLETED|Overall Study||13
1626520|NCT00853385|3975723|P3|NOT COMPLETED|Overall Study||9
1626521|NCT00853385|3975724|P2|NOT COMPLETED|Overall Study||43
1626522|NCT00853385|3975725|P1|NOT COMPLETED|Overall Study||54
1626523|NCT00853385|3975721|P5|COMPLETED|Overall Study||162
1626524|NCT00853385|3975722|P4|COMPLETED|Overall Study||39
1626525|NCT00853385|3975723|P3|COMPLETED|Overall Study||47
1626526|NCT00853385|3975724|P2|COMPLETED|Overall Study||158
1626527|NCT00853385|3975725|P1|COMPLETED|Overall Study||150
1626528|NCT00853385|3975721|P5|STARTED|Overall Study||204
1626529|NCT00853385|3975722|P4|STARTED|Overall Study||52
1626530|NCT00853385|3975723|P3|STARTED|Overall Study||56
1626531|NCT00853385|3975724|P2|STARTED|Overall Study||201
1626532|NCT00853385|3975725|P1|STARTED|Overall Study||204
1626533|NCT00853333|3975941|P3|NOT COMPLETED|Overall Study||0
1626534|NCT00853333|3975942|P2|NOT COMPLETED|Overall Study||0
1626535|NCT00853333|3975943|P1|NOT COMPLETED|Overall Study||0
1626536|NCT00853333|3975941|P3|COMPLETED|Overall Study||31
1626537|NCT00853333|3975942|P2|COMPLETED|Overall Study||27
1626538|NCT00853333|3975943|P1|COMPLETED|Overall Study||28
1626539|NCT00853333|3975941|P3|STARTED|Overall Study||31
1626540|NCT00853333|3975942|P2|STARTED|Overall Study||27
1626541|NCT00853333|3975943|P1|STARTED|Overall Study||28
1626542|NCT00853307|3975953|P2|NOT COMPLETED|Overall Study||5
1626543|NCT00853307|3975954|P1|NOT COMPLETED|Overall Study||2
1626544|NCT00853307|3975953|P2|COMPLETED|Overall Study||20
1626545|NCT00853307|3975954|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
1626546|NCT00853307|3975953|P2|STARTED|Overall Study||25
1626547|NCT00853307|3975954|P1|STARTED|Overall Study||6
1626548|NCT00853242|3975981|P7|NOT COMPLETED|Overall Study||5
1626549|NCT00853242|3975982|P6|NOT COMPLETED|Overall Study||2
1626550|NCT00853242|3975983|P5|NOT COMPLETED|Overall Study||4
1626551|NCT00853242|3975984|P4|NOT COMPLETED|Overall Study||4
1626552|NCT00853242|3975985|P3|NOT COMPLETED|Overall Study||3
1626553|NCT00853242|3975986|P2|NOT COMPLETED|Overall Study||3
1626554|NCT00853242|3975987|P1|NOT COMPLETED|Overall Study||3
1626555|NCT00853242|3975981|P7|COMPLETED|Overall Study||44
1626556|NCT00853242|3975982|P6|COMPLETED|Overall Study||49
1626557|NCT00853242|3975983|P5|COMPLETED|Overall Study||46
1626558|NCT00853242|3975984|P4|COMPLETED|Overall Study||46
1626559|NCT00853242|3975985|P3|COMPLETED|Overall Study||46
1626560|NCT00853242|3975986|P2|COMPLETED|Overall Study||47
1626561|NCT00853242|3975987|P1|COMPLETED|Overall Study||47
1626562|NCT00853242|3975981|P7|Treated|Overall Study||48
1626563|NCT00853242|3975982|P6|Treated|Overall Study||51
1626564|NCT00853242|3975983|P5|Treated|Overall Study||50
1626565|NCT00853242|3975984|P4|Treated|Overall Study||50
1626566|NCT00853242|3975985|P3|Treated|Overall Study||48
1626567|NCT00853242|3975986|P2|Treated|Overall Study||49
1626568|NCT00853242|3975987|P1|Treated|Overall Study||50
1626569|NCT00853242|3975981|P7|STARTED|Overall Study||49
1626570|NCT00853242|3975982|P6|STARTED|Overall Study||51
1626571|NCT00853242|3975983|P5|STARTED|Overall Study||50
1626572|NCT00853242|3975984|P4|STARTED|Overall Study||50
1626573|NCT00853242|3975985|P3|STARTED|Overall Study||49
1626574|NCT00853242|3975986|P2|STARTED|Overall Study||50
1626575|NCT00853242|3975987|P1|STARTED|Overall Study||50
1626576|NCT00853229|3976029|P2|NOT COMPLETED|Phase 2: Cross Over||0
1626577|NCT00853229|3976030|P1|NOT COMPLETED|Phase 2: Cross Over||0
1626578|NCT00853229|3976029|P2|COMPLETED|Phase 2: Cross Over||0
1626579|NCT00853229|3976030|P1|COMPLETED|Phase 2: Cross Over||0
1626580|NCT00853229|3976029|P2|STARTED|Phase 2: Cross Over||0
1626581|NCT00853229|3976030|P1|STARTED|Phase 2: Cross Over||0
1626582|NCT00853229|3976029|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
1626583|NCT00853229|3976030|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
1626584|NCT00853229|3976029|P2|COMPLETED|Phase 1: Initial Intervention||0
1626585|NCT00853229|3976030|P1|COMPLETED|Phase 1: Initial Intervention||0
1626586|NCT00853229|3976029|P2|STARTED|Phase 1: Initial Intervention||8
1626587|NCT00853229|3976030|P1|STARTED|Phase 1: Initial Intervention||8
1626588|NCT00853151|3976040|P4|NOT COMPLETED|Overall Study||3
1626589|NCT00853151|3976041|P3|NOT COMPLETED|Overall Study||8
1626590|NCT00853151|3976042|P2|NOT COMPLETED|Overall Study||13
1626591|NCT00853151|3976043|P1|NOT COMPLETED|Overall Study||10
1626592|NCT00853151|3976040|P4|COMPLETED|Overall Study||15
1626593|NCT00853151|3976041|P3|COMPLETED|Overall Study||30
1626594|NCT00853151|3976042|P2|COMPLETED|Overall Study||24
1626595|NCT00853151|3976043|P1|COMPLETED|Overall Study||28
1626596|NCT00853151|3976040|P4|STARTED|Overall Study||18
1626597|NCT00853151|3976041|P3|STARTED|Overall Study||38
1626598|NCT00853151|3976042|P2|STARTED|Overall Study||37
1626599|NCT00853151|3976043|P1|STARTED|Overall Study||38
1626600|NCT00853112|3976192|P7|NOT COMPLETED|Overall Study||1
1626601|NCT00853112|3976193|P6|NOT COMPLETED|Overall Study||0
1626602|NCT00853112|3976194|P5|NOT COMPLETED|Overall Study||0
1626603|NCT00853112|3976195|P4|NOT COMPLETED|Overall Study||2
1626604|NCT00853112|3976196|P3|NOT COMPLETED|Overall Study||0
1626605|NCT00853112|3976197|P2|NOT COMPLETED|Overall Study||1
1626606|NCT00853112|3976198|P1|NOT COMPLETED|Overall Study||0
1626607|NCT00853112|3976192|P7|COMPLETED|Overall Study||6
1626608|NCT00853112|3976193|P6|COMPLETED|Overall Study||7
1626609|NCT00853112|3976194|P5|COMPLETED|Overall Study||6
1626610|NCT00853112|3976195|P4|COMPLETED|Overall Study||6
1626611|NCT00853112|3976196|P3|COMPLETED|Overall Study||7
1626612|NCT00853112|3976197|P2|COMPLETED|Overall Study||6
1626613|NCT00853112|3976198|P1|COMPLETED|Overall Study||6
1626614|NCT00853112|3976192|P7|Treated|Overall Study||6
1626615|NCT00853112|3976193|P6|Treated|Overall Study||7
1626616|NCT00853112|3976194|P5|Treated|Overall Study||6
1626617|NCT00853112|3976195|P4|Treated|Overall Study||6
1626618|NCT00853112|3976196|P3|Treated|Overall Study||7
1626619|NCT00853112|3976197|P2|Treated|Overall Study||6
1626620|NCT00853112|3976198|P1|Treated|Overall Study||6
1626621|NCT00853112|3976192|P7|STARTED|Overall Study||7
1626622|NCT00853112|3976193|P6|STARTED|Overall Study||7
1626623|NCT00853112|3976194|P5|STARTED|Overall Study||6
1626624|NCT00853112|3976195|P4|STARTED|Overall Study||8
1626625|NCT00853112|3976196|P3|STARTED|Overall Study||7
1626626|NCT00853112|3976197|P2|STARTED|Overall Study||7
1626627|NCT00853112|3976198|P1|STARTED|Overall Study||6
1626628|NCT00853099|3976308|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
1626629|NCT00853099|3976309|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
1626630|NCT00853099|3976310|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
1626631|NCT00853099|3976311|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
1626632|NCT00853099|3976308|P4|COMPLETED|Double-blind + Open-label Periods||119
1626633|NCT00853099|3976309|P3|COMPLETED|Double-blind + Open-label Periods||0
1626634|NCT00853099|3976310|P2|COMPLETED|Double-blind + Open-label Periods||0
1626635|NCT00853099|3976311|P1|COMPLETED|Double-blind + Open-label Periods||0
1626636|NCT00853099|3976308|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
1626637|NCT00853099|3976309|P3|STARTED|Double-blind + Open-label Periods||0
1626638|NCT00853099|3976310|P2|STARTED|Double-blind + Open-label Periods||0
1626639|NCT00853099|3976311|P1|STARTED|Double-blind + Open-label Periods||0
1626640|NCT00853099|3976308|P4|NOT COMPLETED|Double-blind Period||0
1626641|NCT00853099|3976309|P3|NOT COMPLETED|Double-blind Period||31
1626642|NCT00853099|3976310|P2|NOT COMPLETED|Double-blind Period||29
1626643|NCT00853099|3976311|P1|NOT COMPLETED|Double-blind Period||23
1626644|NCT00853099|3976308|P4|COMPLETED|Double-blind Period||0
1626645|NCT00853099|3976309|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
1626646|NCT00853099|3976310|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
1626647|NCT00853099|3976311|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
1626648|NCT00853099|3976308|P4|Completed Week 8|Double-blind Period||0
1626649|NCT00853099|3976309|P3|Completed Week 8|Double-blind Period||86
1626650|NCT00853099|3976310|P2|Completed Week 8|Double-blind Period||85
1626651|NCT00853099|3976311|P1|Completed Week 8|Double-blind Period||92
1626652|NCT00853099|3976308|P4|Treated|Double-blind Period||0
1626653|NCT00853099|3976309|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
1626654|NCT00853099|3976310|P2|Treated|Double-blind Period||87
1626655|NCT00853099|3976311|P1|Treated|Double-blind Period||96
1626656|NCT00853099|3976308|P4|STARTED|Double-blind Period||0
1626657|NCT00853099|3976309|P3|STARTED|Double-blind Period||91
1626658|NCT00853099|3976310|P2|STARTED|Double-blind Period||87
1626659|NCT00853099|3976311|P1|STARTED|Double-blind Period||96
1626660|NCT00853073|3976353|P2|NOT COMPLETED|Overall Study||2
1626661|NCT00853073|3976354|P1|NOT COMPLETED|Overall Study||3
1626662|NCT00853073|3976353|P2|COMPLETED|Overall Study||29
1626663|NCT00853073|3976354|P1|COMPLETED|Overall Study||29
1626664|NCT00853073|3976353|P2|STARTED|Overall Study||31
1626665|NCT00853073|3976354|P1|STARTED|Overall Study||32
1626666|NCT00853047|3976367|P6|NOT COMPLETED|Open-Label Extension Phase||17
1626667|NCT00853047|3976368|P5|NOT COMPLETED|Open-Label Extension Phase||0
1626668|NCT00853047|3976369|P4|NOT COMPLETED|Open-Label Extension Phase||0
1626669|NCT00853047|3976370|P3|NOT COMPLETED|Open-Label Extension Phase||0
1626670|NCT00853047|3976371|P2|NOT COMPLETED|Open-Label Extension Phase||0
1626671|NCT00853047|3976372|P1|NOT COMPLETED|Open-Label Extension Phase||0
1626672|NCT00853047|3976367|P6|COMPLETED|Open-Label Extension Phase||2
1626673|NCT00853047|3976368|P5|COMPLETED|Open-Label Extension Phase||0
1626674|NCT00853047|3976369|P4|COMPLETED|Open-Label Extension Phase||0
1626675|NCT00853047|3976370|P3|COMPLETED|Open-Label Extension Phase||0
1626676|NCT00853047|3976371|P2|COMPLETED|Open-Label Extension Phase||0
1626677|NCT00853047|3976372|P1|COMPLETED|Open-Label Extension Phase||0
1626678|NCT00853047|3976367|P6|Completed 8-week Extension Period|Open-Label Extension Phase||16
1626679|NCT00853047|3976368|P5|Completed 8-week Extension Period|Open-Label Extension Phase||0
1626680|NCT00853047|3976369|P4|Completed 8-week Extension Period|Open-Label Extension Phase||0
1626681|NCT00853047|3976370|P3|Completed 8-week Extension Period|Open-Label Extension Phase||0
1626682|NCT00853047|3976371|P2|Completed 8-week Extension Period|Open-Label Extension Phase||0
1626683|NCT00853047|3976372|P1|Completed 8-week Extension Period|Open-Label Extension Phase||0
1626684|NCT00853047|3976367|P6|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
1626685|NCT00853047|3976368|P5|STARTED|Open-Label Extension Phase||0
1626686|NCT00853047|3976369|P4|STARTED|Open-Label Extension Phase||0
1626687|NCT00853047|3976370|P3|STARTED|Open-Label Extension Phase||0
1626688|NCT00853047|3976371|P2|STARTED|Open-Label Extension Phase||0
1626689|NCT00853047|3976372|P1|STARTED|Open-Label Extension Phase||0
1626690|NCT00853047|3976367|P6|NOT COMPLETED|Core Phase||0
1626691|NCT00853047|3976368|P5|NOT COMPLETED|Core Phase||0
1626692|NCT00853047|3976369|P4|NOT COMPLETED|Core Phase||1
1626693|NCT00853047|3976370|P3|NOT COMPLETED|Core Phase||0
1626694|NCT00853047|3976371|P2|NOT COMPLETED|Core Phase||0
1626695|NCT00853047|3976372|P1|NOT COMPLETED|Core Phase||0
1626696|NCT00853047|3976367|P6|COMPLETED|Core Phase||0
1626697|NCT00853047|3976368|P5|COMPLETED|Core Phase||9
1626698|NCT00853047|3976369|P4|COMPLETED|Core Phase||2
1626699|NCT00853047|3976370|P3|COMPLETED|Core Phase||3
1626700|NCT00853047|3976371|P2|COMPLETED|Core Phase||3
1626701|NCT00853047|3976372|P1|COMPLETED|Core Phase||5
1626702|NCT00853047|3976367|P6|STARTED|Core Phase||0
1626703|NCT00853047|3976368|P5|STARTED|Core Phase||9
1626704|NCT00853047|3976369|P4|STARTED|Core Phase||3
1626705|NCT00853047|3976370|P3|STARTED|Core Phase||3
1626706|NCT00853047|3976371|P2|STARTED|Core Phase||3
1626707|NCT00853047|3976372|P1|STARTED|Core Phase||5
1626708|NCT00853021|3976438|P1|NOT COMPLETED|Overall Study||5
1626709|NCT00853021|3976438|P1|COMPLETED|Overall Study||21
1626710|NCT00853021|3976438|P1|STARTED|Overall Study||26
1626711|NCT00852995|3976450|P5|NOT COMPLETED|Overall Study||4
1626712|NCT00852995|3976451|P4|NOT COMPLETED|Overall Study||5
1626713|NCT00852995|3976452|P3|NOT COMPLETED|Overall Study||5
1626714|NCT00852995|3976453|P2|NOT COMPLETED|Overall Study||1
1626715|NCT00852995|3976454|P1|NOT COMPLETED|Overall Study||8
1626716|NCT00852995|3976450|P5|COMPLETED|Overall Study||46
1626717|NCT00852995|3976451|P4|COMPLETED|Overall Study||40
1626718|NCT00852995|3976452|P3|COMPLETED|Overall Study||39
1626719|NCT00852995|3976453|P2|COMPLETED|Overall Study||42
1626720|NCT00852995|3976454|P1|COMPLETED|Overall Study||38
1626721|NCT00852995|3976450|P5|STARTED|Overall Study||50
1626722|NCT00852995|3976451|P4|STARTED|Overall Study||45
1626723|NCT00852995|3976452|P3|STARTED|Overall Study||44
1626724|NCT00852995|3976453|P2|STARTED|Overall Study||43
1626725|NCT00852995|3976454|P1|STARTED|Overall Study||46
1626726|NCT00852969|3976498|P2|NOT COMPLETED|Overall Study||2
1626727|NCT00852969|3976499|P1|NOT COMPLETED|Overall Study||0
1626728|NCT00852969|3976498|P2|COMPLETED|Overall Study||13
1626729|NCT00852969|3976499|P1|COMPLETED|Overall Study||15
1626730|NCT00852969|3976498|P2|STARTED|Overall Study||15
1626731|NCT00852969|3976499|P1|STARTED|Overall Study||15
1626732|NCT00852930|3976510|P3|NOT COMPLETED|Overall Study||2
1626733|NCT00852930|3976511|P2|NOT COMPLETED|Overall Study||1
1626734|NCT00852930|3976512|P1|NOT COMPLETED|Overall Study||1
1626735|NCT00852930|3976510|P3|COMPLETED|Overall Study||15
1626736|NCT00852930|3976511|P2|COMPLETED|Overall Study||16
1626737|NCT00852930|3976512|P1|COMPLETED|Overall Study||15
1626738|NCT00852930|3976510|P3|STARTED|Overall Study||17
1626739|NCT00852930|3976511|P2|STARTED|Overall Study||17
1626740|NCT00852930|3976512|P1|STARTED|Overall Study||16
1626741|NCT00852917|3976533|P4|NOT COMPLETED|Overall Study||93
1626742|NCT00852917|3976534|P3|NOT COMPLETED|Overall Study||58
1626743|NCT00852917|3976535|P2|NOT COMPLETED|Overall Study||46
1626744|NCT00852917|3976536|P1|NOT COMPLETED|Overall Study||44
1626745|NCT00852917|3976533|P4|COMPLETED|Overall Study||134
1626746|NCT00852917|3976534|P3|COMPLETED|Overall Study||50
1626747|NCT00852917|3976535|P2|COMPLETED|Overall Study||65
1626748|NCT00852917|3976536|P1|COMPLETED|Overall Study||62
1626749|NCT00852917|3976533|P4|STARTED|Overall Study||227
1626750|NCT00852917|3976534|P3|STARTED|Overall Study||108
1626751|NCT00852917|3976535|P2|STARTED|Overall Study||111
1626752|NCT00852917|3976536|P1|STARTED|Overall Study||106
1626753|NCT00852761|3976576|P2|NOT COMPLETED|Overall Study||0
1626754|NCT00852761|3976577|P1|NOT COMPLETED|Overall Study||0
1626755|NCT00852761|3976576|P2|COMPLETED|Overall Study||17
1626756|NCT00852761|3976577|P1|COMPLETED|Overall Study||17
1626757|NCT00852761|3976576|P2|STARTED|Overall Study||17
1626758|NCT00852761|3976577|P1|STARTED|Overall Study||17
1626759|NCT00852644|3976619|P6|NOT COMPLETED|Overall Study||0
1626760|NCT00852644|3976620|P5|NOT COMPLETED|Overall Study||0
1626761|NCT00852644|3976621|P4|NOT COMPLETED|Overall Study||0
1626762|NCT00852644|3976622|P3|NOT COMPLETED|Overall Study||0
1626763|NCT00852644|3976623|P2|NOT COMPLETED|Overall Study||0
1626764|NCT00852644|3976624|P1|NOT COMPLETED|Overall Study||0
1626765|NCT00852644|3976619|P6|COMPLETED|Overall Study||0
1626766|NCT00852644|3976620|P5|COMPLETED|Overall Study||0
1626767|NCT00852644|3976621|P4|COMPLETED|Overall Study||3
1626768|NCT00852644|3976622|P3|COMPLETED|Overall Study||0
1626769|NCT00852644|3976623|P2|COMPLETED|Overall Study||3
1626770|NCT00852644|3976624|P1|COMPLETED|Overall Study||3
1626771|NCT00852644|3976619|P6|STARTED|Overall Study||0
1626772|NCT00852644|3976620|P5|STARTED|Overall Study||0
1626773|NCT00852644|3976621|P4|STARTED|Overall Study||3
1626774|NCT00852644|3976622|P3|STARTED|Overall Study||0
1626775|NCT00852644|3976623|P2|STARTED|Overall Study||3
1626776|NCT00852644|3976624|P1|STARTED|Overall Study||3
1626777|NCT00852631|3976645|P1|NOT COMPLETED|Overall Study||11
1626778|NCT00852631|3976645|P1|COMPLETED|Overall Study||17
1626779|NCT00852631|3976645|P1|STARTED|Overall Study||28
1626780|NCT00852592|3976653|P2|NOT COMPLETED|Overall Study||4
1626781|NCT00852592|3976654|P1|NOT COMPLETED|Overall Study||3
1626782|NCT00852592|3976653|P2|COMPLETED|Overall Study||19
1626783|NCT00852592|3976654|P1|COMPLETED|Overall Study||20
1626784|NCT00852592|3976653|P2|STARTED|Overall Study||23
1626785|NCT00852592|3976654|P1|STARTED|Overall Study||23
1626786|NCT00852540|3976664|P2|NOT COMPLETED|Overall Study||18
1626787|NCT00852540|3976665|P1|NOT COMPLETED|Overall Study||36
1626788|NCT00852540|3976664|P2|COMPLETED|Overall Study||122
1626789|NCT00852540|3976665|P1|COMPLETED|Overall Study||234
1626790|NCT00852540|3976664|P2|STARTED|Overall Study||140
1626791|NCT00852540|3976665|P1|STARTED|Overall Study||270
1626792|NCT00852527|3976691|P2|NOT COMPLETED|Overall Study||0
1626793|NCT00852527|3976692|P1|NOT COMPLETED|Overall Study||0
1626794|NCT00852527|3976691|P2|COMPLETED|Overall Study||242
1626795|NCT00852527|3976692|P1|COMPLETED|Overall Study||196
1626796|NCT00852527|3976691|P2|STARTED|Overall Study||242
1626797|NCT00852527|3976692|P1|STARTED|Overall Study||196
1626798|NCT00852475|3976699|P2|NOT COMPLETED|Overall Study||4
1626799|NCT00852475|3976700|P1|NOT COMPLETED|Overall Study||3
1626800|NCT00852475|3976699|P2|COMPLETED|Overall Study||16
1626801|NCT00852475|3976700|P1|COMPLETED|Overall Study||23
1626802|NCT00852475|3976699|P2|STARTED|Overall Study||20
1626803|NCT00852475|3976700|P1|STARTED|Overall Study||26
1626804|NCT00852397|3976711|P3|NOT COMPLETED|Overall Study||14
1626805|NCT00852397|3976712|P2|NOT COMPLETED|Overall Study||8
1626806|NCT00852397|3976713|P1|NOT COMPLETED|Overall Study||11
1626807|NCT00852397|3976711|P3|COMPLETED|Overall Study||36
1626808|NCT00852397|3976712|P2|COMPLETED|Overall Study||41
1626809|NCT00852397|3976713|P1|COMPLETED|Overall Study||41
1626810|NCT00852397|3976711|P3|Treated Participants|Overall Study||49
1626811|NCT00852397|3976712|P2|Treated Participants|Overall Study||49
1626812|NCT00852397|3976713|P1|Treated Participants|Overall Study||51
1626813|NCT00852397|3976711|P3|STARTED|Overall Study||50
1626814|NCT00852397|3976712|P2|STARTED|Overall Study||49
1626815|NCT00852397|3976713|P1|STARTED|Overall Study||52
1626816|NCT00852241|3976742|P1|NOT COMPLETED|Overall Study||18
1626817|NCT00852241|3976742|P1|COMPLETED|Overall Study||0
1626818|NCT00852241|3976742|P1|STARTED|Overall Study||18
1626819|NCT00852202|3976749|P3|NOT COMPLETED|Overall Study||26
1626820|NCT00852202|3976750|P2|NOT COMPLETED|Overall Study||12
1626821|NCT00852202|3976751|P1|NOT COMPLETED|Overall Study||17
1626822|NCT00852202|3976749|P3|COMPLETED|Overall Study||49
1626823|NCT00852202|3976750|P2|COMPLETED|Overall Study||63
1626824|NCT00852202|3976751|P1|COMPLETED|Overall Study||60
1626825|NCT00852202|3976749|P3|STARTED|Overall Study||75
1626826|NCT00852202|3976750|P2|STARTED|Overall Study||75
1626827|NCT00852202|3976751|P1|STARTED|Overall Study||77
1626828|NCT00852137|3976764|P2|NOT COMPLETED|Overall Study||0
1626829|NCT00852137|3976765|P1|NOT COMPLETED|Overall Study||0
1626830|NCT00852137|3976764|P2|COMPLETED|Overall Study||3
1626831|NCT00852137|3976765|P1|COMPLETED|Overall Study||13
1626832|NCT00852137|3976764|P2|STARTED|Overall Study||3
1626833|NCT00852137|3976765|P1|STARTED|Overall Study||13
1626834|NCT00852124|3976787|P2|NOT COMPLETED|Overall Study||0
1626835|NCT00852124|3976788|P1|NOT COMPLETED|Overall Study||0
1626836|NCT00852124|3976787|P2|COMPLETED|Overall Study||0
1626837|NCT00852124|3976788|P1|COMPLETED|Overall Study||3
1626838|NCT00852124|3976787|P2|STARTED|Overall Study||0
1626839|NCT00852124|3976788|P1|STARTED|Overall Study||3
1626840|NCT00851903|3976793|P1|NOT COMPLETED|Overall Study||2
1626841|NCT00851903|3976793|P1|COMPLETED|Overall Study||110
1626842|NCT00851903|3976793|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
1626843|NCT00851903|3976793|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
1626844|NCT00851903|3976793|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
1626845|NCT00851903|3976793|P1|STARTED|Overall Study||112
1626846|NCT00851890|3976807|P4|NOT COMPLETED|Overall Study||1
1626847|NCT00851890|3976808|P3|NOT COMPLETED|Overall Study||0
1626848|NCT00851890|3976809|P2|NOT COMPLETED|Overall Study||1
1626849|NCT00851890|3976810|P1|NOT COMPLETED|Overall Study||0
1626850|NCT00851890|3976807|P4|COMPLETED|Overall Study||5
1626851|NCT00851890|3976808|P3|COMPLETED|Overall Study||8
1626852|NCT00851890|3976809|P2|COMPLETED|Overall Study||7
1626853|NCT00851890|3976810|P1|COMPLETED|Overall Study||8
1626854|NCT00851890|3976807|P4|STARTED|Overall Study||6
1626855|NCT00851890|3976808|P3|STARTED|Overall Study||8
1626856|NCT00851890|3976809|P2|STARTED|Overall Study||8
1626857|NCT00851890|3976810|P1|STARTED|Overall Study||8
1626858|NCT00851877|3976867|P3|NOT COMPLETED|Phase II||3
1626859|NCT00851877|3976868|P2|NOT COMPLETED|Phase II||0
1626860|NCT00851877|3976869|P1|NOT COMPLETED|Phase II||0
1626861|NCT00851877|3976867|P3|COMPLETED|Phase II||22
1626862|NCT00851877|3976868|P2|COMPLETED|Phase II||0
1626863|NCT00851877|3976869|P1|COMPLETED|Phase II||0
1626864|NCT00851877|3976867|P3|STARTED|Phase II||25
1626865|NCT00851877|3976868|P2|STARTED|Phase II||0
1626866|NCT00851877|3976869|P1|STARTED|Phase II||0
1626867|NCT00851877|3976867|P3|NOT COMPLETED|Phase I-2||0
1626868|NCT00851877|3976868|P2|NOT COMPLETED|Phase I-2||0
1626869|NCT00851877|3976869|P1|NOT COMPLETED|Phase I-2||0
1626870|NCT00851877|3976867|P3|COMPLETED|Phase I-2||0
1626871|NCT00851877|3976868|P2|COMPLETED|Phase I-2||5
1626872|NCT00851877|3976869|P1|COMPLETED|Phase I-2||0
1626873|NCT00851877|3976867|P3|STARTED|Phase I-2||0
1626874|NCT00851877|3976868|P2|STARTED|Phase I-2||5
1626875|NCT00851877|3976869|P1|STARTED|Phase I-2||0
1626876|NCT00851877|3976867|P3|NOT COMPLETED|Phase I-1||0
1626877|NCT00851877|3976868|P2|NOT COMPLETED|Phase I-1||0
1626878|NCT00851877|3976869|P1|NOT COMPLETED|Phase I-1||1
1626879|NCT00851877|3976867|P3|COMPLETED|Phase I-1||0
1626880|NCT00851877|3976868|P2|COMPLETED|Phase I-1||0
1626881|NCT00851877|3976869|P1|COMPLETED|Phase I-1||6
1626882|NCT00851877|3976867|P3|STARTED|Phase I-1||0
1626883|NCT00851877|3976868|P2|STARTED|Phase I-1||0
1626884|NCT00851877|3976869|P1|STARTED|Phase I-1||7
1626885|NCT00851799|3976879|P3|NOT COMPLETED|Overall Study||24
1626886|NCT00851799|3976880|P2|NOT COMPLETED|Overall Study||13
1626887|NCT00851799|3976881|P1|NOT COMPLETED|Overall Study||16
1626888|NCT00851799|3976879|P3|COMPLETED|Overall Study||89
1626889|NCT00851799|3976880|P2|COMPLETED|Overall Study||93
1626890|NCT00851799|3976881|P1|COMPLETED|Overall Study||93
1626891|NCT00851799|3976879|P3|STARTED|Overall Study||113
1626892|NCT00851799|3976880|P2|STARTED|Overall Study||106
1626893|NCT00851799|3976881|P1|STARTED|Overall Study||109
1626894|NCT00851786|3976969|P2|NOT COMPLETED|Overall Study||2
1626895|NCT00851786|3976970|P1|NOT COMPLETED|Overall Study||5
1626896|NCT00851786|3976969|P2|COMPLETED|Overall Study||97
1626897|NCT00851786|3976970|P1|COMPLETED|Overall Study||291
1626898|NCT00851786|3976969|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
1626899|NCT00851786|3976970|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
1626900|NCT00851747|3976983|P3|NOT COMPLETED|Overall Study||6
1626901|NCT00851747|3976984|P2|NOT COMPLETED|Overall Study||6
1626902|NCT00851747|3976985|P1|NOT COMPLETED|Overall Study||6
1626903|NCT00851747|3976983|P3|COMPLETED|Overall Study||0
1626904|NCT00851747|3976984|P2|COMPLETED|Overall Study||0
1626905|NCT00851747|3976985|P1|COMPLETED|Overall Study||0
1626906|NCT00851747|3976983|P3|STARTED|Overall Study||6
1626907|NCT00851747|3976984|P2|STARTED|Overall Study||6
1626908|NCT00851747|3976985|P1|STARTED|Overall Study||6
1626909|NCT00851721|3976994|P2|NOT COMPLETED|Overall Study||1
1626910|NCT00851721|3976995|P1|NOT COMPLETED|Overall Study||2
1626911|NCT00851721|3976994|P2|COMPLETED|Overall Study||16
1626912|NCT00851721|3976995|P1|COMPLETED|Overall Study||17
1626913|NCT00851721|3976994|P2|STARTED|Overall Study||17
1626914|NCT00851721|3976995|P1|STARTED|Overall Study||19
1626915|NCT00851682|3977085|P2|NOT COMPLETED|Overall Study||0
1626916|NCT00851682|3977086|P1|NOT COMPLETED|Overall Study||5
1626917|NCT00851682|3977085|P2|COMPLETED|Overall Study||5
1626918|NCT00851682|3977086|P1|COMPLETED|Overall Study||55
1626919|NCT00851682|3977085|P2|STARTED|Overall Study||5
1626920|NCT00851682|3977086|P1|STARTED|Overall Study||60
1626921|NCT00851643|3977100|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
1626922|NCT00851643|3977101|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
1626923|NCT00851643|3977102|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
1626924|NCT00851643|3977103|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
1626925|NCT00851643|3977104|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
1626926|NCT00851643|3977105|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
1626927|NCT00851643|3977100|P6|COMPLETED|Extension Study (Up to 36 Months)||14
1626928|NCT00851643|3977101|P5|COMPLETED|Extension Study (Up to 36 Months)||19
1626929|NCT00851643|3977102|P4|COMPLETED|Extension Study (Up to 36 Months)||5
1626930|NCT00851643|3977103|P3|COMPLETED|Extension Study (Up to 36 Months)||14
1626931|NCT00851643|3977104|P2|COMPLETED|Extension Study (Up to 36 Months)||15
1626932|NCT00851643|3977105|P1|COMPLETED|Extension Study (Up to 36 Months)||6
1626933|NCT00851643|3977100|P6|STARTED|Extension Study (Up to 36 Months)||15
1626934|NCT00851643|3977101|P5|STARTED|Extension Study (Up to 36 Months)||21
1626935|NCT00851643|3977102|P4|STARTED|Extension Study (Up to 36 Months)||7
1626936|NCT00851643|3977103|P3|STARTED|Extension Study (Up to 36 Months)||19
1626937|NCT00851643|3977104|P2|STARTED|Extension Study (Up to 36 Months)||19
1626938|NCT00851643|3977105|P1|STARTED|Extension Study (Up to 36 Months)||10
1626939|NCT00851643|3977100|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
1626940|NCT00851643|3977101|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
1626941|NCT00851643|3977102|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
1626942|NCT00851643|3977103|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
1626943|NCT00851643|3977104|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
1626944|NCT00851643|3977105|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
1626945|NCT00851643|3977100|P6|COMPLETED|Base Study (Up to 12 Months)||29
1626946|NCT00851643|3977101|P5|COMPLETED|Base Study (Up to 12 Months)||30
1626947|NCT00851643|3977102|P4|COMPLETED|Base Study (Up to 12 Months)||15
1626948|NCT00851643|3977103|P3|COMPLETED|Base Study (Up to 12 Months)||30
1626949|NCT00851643|3977104|P2|COMPLETED|Base Study (Up to 12 Months)||30
1626950|NCT00851643|3977105|P1|COMPLETED|Base Study (Up to 12 Months)||14
1626951|NCT00851643|3977100|P6|STARTED|Base Study (Up to 12 Months)||30
1626952|NCT00851643|3977101|P5|STARTED|Base Study (Up to 12 Months)||30
1626953|NCT00851643|3977102|P4|STARTED|Base Study (Up to 12 Months)||15
1626954|NCT00851643|3977103|P3|STARTED|Base Study (Up to 12 Months)||30
1626955|NCT00851643|3977104|P2|STARTED|Base Study (Up to 12 Months)||30
1626956|NCT00851643|3977105|P1|STARTED|Base Study (Up to 12 Months)||15
1626957|NCT00851630|3977126|P2|NOT COMPLETED|Overall Study||2
1626958|NCT00851630|3977127|P1|NOT COMPLETED|Overall Study||2
1626959|NCT00851630|3977126|P2|COMPLETED|Overall Study||33
1626960|NCT00851630|3977127|P1|COMPLETED|Overall Study||33
1626961|NCT00851630|3977126|P2|STARTED|Overall Study||35
1626962|NCT00851630|3977127|P1|STARTED|Overall Study||35
1626963|NCT00851591|3977141|P2|NOT COMPLETED|Overall Study||0
1626964|NCT00851591|3977142|P1|NOT COMPLETED|Overall Study||2
1626965|NCT00851591|3977141|P2|COMPLETED|Overall Study||1
1626966|NCT00851591|3977142|P1|COMPLETED|Overall Study||0
1626967|NCT00851591|3977141|P2|STARTED|Overall Study|One received treatment.|1
1626968|NCT00851591|3977142|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
1626969|NCT00851552|3977148|P1|NOT COMPLETED|Overall Study||7
1626970|NCT00851552|3977148|P1|COMPLETED|Overall Study||2
1626971|NCT00851552|3977148|P1|STARTED|Overall Study||9
1626972|NCT00851409|3977153|P1|NOT COMPLETED|Overall Study||0
1626973|NCT00851409|3977153|P1|COMPLETED|Overall Study||25
1626974|NCT00851409|3977153|P1|STARTED|Overall Study||25
1626975|NCT00851318|3977162|P4|NOT COMPLETED|Overall Study||19
1626976|NCT00851318|3977163|P3|NOT COMPLETED|Overall Study||21
1626977|NCT00851318|3977164|P2|NOT COMPLETED|Overall Study||5
1626978|NCT00851318|3977165|P1|NOT COMPLETED|Overall Study||30
1626979|NCT00851318|3977162|P4|COMPLETED|Overall Study||73
1626980|NCT00851318|3977163|P3|COMPLETED|Overall Study||72
1626981|NCT00851318|3977164|P2|COMPLETED|Overall Study||14
1626982|NCT00851318|3977165|P1|COMPLETED|Overall Study||51
1626983|NCT00851318|3977162|P4|Completed Week 52|Overall Study||85
1626984|NCT00851318|3977163|P3|Completed Week 52|Overall Study||87
1626985|NCT00851318|3977164|P2|Completed Week 52|Overall Study||16
1626986|NCT00851318|3977165|P1|Completed Week 52|Overall Study||64
1626987|NCT00851318|3977162|P4|Completed Week 24|Overall Study||87
1626988|NCT00851318|3977163|P3|Completed Week 24|Overall Study||90
1626989|NCT00851318|3977164|P2|Completed Week 24|Overall Study||17
1626990|NCT00851318|3977165|P1|Completed Week 24|Overall Study||69
1626991|NCT00851318|3977162|P4|STARTED|Overall Study||92
1626992|NCT00851318|3977163|P3|STARTED|Overall Study||93
1626993|NCT00851318|3977164|P2|STARTED|Overall Study||19
1626994|NCT00851318|3977165|P1|STARTED|Overall Study||81
1626995|NCT00851279|3977195|P1|NOT COMPLETED|Overall Study||0
1626996|NCT00851279|3977195|P1|COMPLETED|Overall Study||53
1626997|NCT00851279|3977195|P1|STARTED|Overall Study||53
1626998|NCT00851253|3977201|P2|NOT COMPLETED|Overall Study||0
1626999|NCT00851253|3977202|P1|NOT COMPLETED|Overall Study||1
1627000|NCT00851253|3977201|P2|COMPLETED|Overall Study||10
1627001|NCT00851253|3977202|P1|COMPLETED|Overall Study||1
1627002|NCT00851253|3977201|P2|STARTED|Overall Study||10
1627003|NCT00851253|3977202|P1|STARTED|Overall Study||2
1627004|NCT00851084|3977212|P2|NOT COMPLETED|Overall Study||119
1627005|NCT00851084|3977213|P1|NOT COMPLETED|Overall Study||117
1627006|NCT00851084|3977212|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
1627007|NCT00851084|3977213|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
1627008|NCT00851084|3977212|P2|STARTED|Overall Study||119
1627009|NCT00851084|3977213|P1|STARTED|Overall Study||117
1627010|NCT00851006|3977229|P2|NOT COMPLETED|Overall Study||0
1627011|NCT00851006|3977230|P1|NOT COMPLETED|Overall Study||0
1627012|NCT00851006|3977229|P2|COMPLETED|Overall Study||6
1627013|NCT00851006|3977230|P1|COMPLETED|Overall Study||7
1627014|NCT00851006|3977229|P2|STARTED|Overall Study||6
1627015|NCT00851006|3977230|P1|STARTED|Overall Study||7
1627016|NCT00850993|3977241|P4|NOT COMPLETED|Overall Study||0
1627017|NCT00850993|3977242|P3|NOT COMPLETED|Overall Study||0
1627018|NCT00850993|3977243|P2|NOT COMPLETED|Overall Study||1
1627019|NCT00850993|3977244|P1|NOT COMPLETED|Overall Study||0
1627020|NCT00850993|3977241|P4|COMPLETED|Overall Study||8
1627021|NCT00850993|3977242|P3|COMPLETED|Overall Study||18
1627022|NCT00850993|3977243|P2|COMPLETED|Overall Study||16
1627023|NCT00850993|3977244|P1|COMPLETED|Overall Study||15
1627024|NCT00850993|3977241|P4|STARTED|Overall Study||8
1627025|NCT00850993|3977242|P3|STARTED|Overall Study||18
1627026|NCT00850993|3977243|P2|STARTED|Overall Study||17
1627027|NCT00850993|3977244|P1|STARTED|Overall Study||15
1627028|NCT00850889|3977258|P1|NOT COMPLETED|Overall Study||0
1627029|NCT00850889|3977258|P1|COMPLETED|Overall Study||32
1627030|NCT00850889|3977258|P1|STARTED|Overall Study||32
1627031|NCT00850759|3977273|P4|NOT COMPLETED|Overall Study||3
1627032|NCT00850759|3977274|P3|NOT COMPLETED|Overall Study||5
1627033|NCT00850759|3977275|P2|NOT COMPLETED|Overall Study||5
1627034|NCT00850759|3977276|P1|NOT COMPLETED|Overall Study||7
1627035|NCT00850759|3977273|P4|COMPLETED|Overall Study||55
1627036|NCT00850759|3977274|P3|COMPLETED|Overall Study||52
1627037|NCT00850759|3977275|P2|COMPLETED|Overall Study||52
1627038|NCT00850759|3977276|P1|COMPLETED|Overall Study||52
1627039|NCT00850759|3977273|P4|STARTED|Overall Study||58
1627040|NCT00850759|3977274|P3|STARTED|Overall Study||57
1627041|NCT00850759|3977275|P2|STARTED|Overall Study||57
1627042|NCT00850759|3977276|P1|STARTED|Overall Study||59
1627043|NCT00850720|3977286|P1|NOT COMPLETED|Overall Study||0
1627044|NCT00850720|3977286|P1|COMPLETED|Overall Study||0
1627045|NCT00850720|3977286|P1|STARTED|Overall Study||0
1627046|NCT00850642|3977292|P2|NOT COMPLETED|Overall Study||0
1627047|NCT00850642|3977293|P1|NOT COMPLETED|Overall Study||0
1627048|NCT00850642|3977292|P2|COMPLETED|Overall Study||4
1627049|NCT00850642|3977293|P1|COMPLETED|Overall Study||3
1627050|NCT00850642|3977292|P2|STARTED|Overall Study||4
1627051|NCT00850642|3977293|P1|STARTED|Overall Study||3
1627052|NCT00850603|3977331|P5|NOT COMPLETED|Overall Study||0
1627053|NCT00850603|3977332|P4|NOT COMPLETED|Overall Study||0
1627054|NCT00850603|3977333|P3|NOT COMPLETED|Overall Study||0
1627055|NCT00850603|3977334|P2|NOT COMPLETED|Overall Study||0
1627056|NCT00850603|3977335|P1|NOT COMPLETED|Overall Study||0
1627057|NCT00850603|3977331|P5|COMPLETED|Overall Study||34
1627058|NCT00850603|3977332|P4|COMPLETED|Overall Study||34
1627059|NCT00850603|3977333|P3|COMPLETED|Overall Study||34
1627060|NCT00850603|3977334|P2|COMPLETED|Overall Study||34
1627061|NCT00850603|3977335|P1|COMPLETED|Overall Study||34
1627062|NCT00850603|3977331|P5|STARTED|Overall Study||34
1627063|NCT00850603|3977332|P4|STARTED|Overall Study||34
1627064|NCT00850603|3977333|P3|STARTED|Overall Study||34
1627065|NCT00850603|3977334|P2|STARTED|Overall Study||34
1627066|NCT00850603|3977335|P1|STARTED|Overall Study||34
1627067|NCT00850564|3977357|P1|NOT COMPLETED|Overall Study||2
1627068|NCT00850564|3977357|P1|COMPLETED|Overall Study||13
1627069|NCT00850564|3977357|P1|STARTED|Overall Study||15
1627070|NCT00850538|3977362|P1|NOT COMPLETED|Overall Study||41
1627071|NCT00850538|3977362|P1|COMPLETED|Overall Study||60
1627072|NCT00850538|3977362|P1|STARTED|Overall Study||101
1627073|NCT00850499|3977368|P2|NOT COMPLETED|Overall Study||2
1627074|NCT00850499|3977369|P1|NOT COMPLETED|Overall Study||3
1627075|NCT00850499|3977368|P2|COMPLETED|Overall Study||6
1627076|NCT00850499|3977369|P1|COMPLETED|Overall Study||1
1627077|NCT00850499|3977368|P2|STARTED|Overall Study||8
1627078|NCT00850499|3977369|P1|STARTED|Overall Study||4
1627079|NCT00850473|3977377|P1|NOT COMPLETED|Overall Study||0
1627080|NCT00850473|3977377|P1|COMPLETED|Overall Study||3
1627081|NCT00850473|3977377|P1|STARTED|Overall Study||3
1627082|NCT00850460|3977383|P2|NOT COMPLETED|Overall Study||4
1627083|NCT00850460|3977384|P1|NOT COMPLETED|Overall Study||4
1627084|NCT00850460|3977383|P2|COMPLETED|Overall Study||3
1627085|NCT00850460|3977384|P1|COMPLETED|Overall Study||3
1627086|NCT00850460|3977383|P2|Completion - Week 8|Overall Study||3
1627087|NCT00850460|3977384|P1|Completion - Week 8|Overall Study||3
1627088|NCT00850460|3977383|P2|Started - Week 0|Overall Study||7
1627089|NCT00850460|3977384|P1|Started - Week 0|Overall Study||7
1627090|NCT00850460|3977383|P2|STARTED|Overall Study||7
1627091|NCT00850460|3977384|P1|STARTED|Overall Study||7
1627092|NCT00850421|3977392|P1|NOT COMPLETED|Overall Study||17
1627093|NCT00850421|3977392|P1|COMPLETED|Overall Study||18
1627094|NCT00850421|3977392|P1|STARTED|Overall Study||35
1627095|NCT00850395|3977398|P1|NOT COMPLETED|Overall Study||10
1627096|NCT00850395|3977398|P1|COMPLETED|Overall Study||69
1627097|NCT00850395|3977398|P1|STARTED|Overall Study||79
1627098|NCT00850343|3977418|P4|NOT COMPLETED|Overall Study||13
1627099|NCT00850343|3977419|P3|NOT COMPLETED|Overall Study||14
1627100|NCT00850343|3977420|P2|NOT COMPLETED|Overall Study||3
1627101|NCT00850343|3977421|P1|NOT COMPLETED|Overall Study||46
1627102|NCT00850343|3977418|P4|COMPLETED|Overall Study||30
1627103|NCT00850343|3977419|P3|COMPLETED|Overall Study||29
1627104|NCT00850343|3977420|P2|COMPLETED|Overall Study||9
1627105|NCT00850343|3977421|P1|COMPLETED|Overall Study||64
1627106|NCT00850343|3977418|P4|Completed Week 52|Overall Study||37
1627107|NCT00850343|3977419|P3|Completed Week 52|Overall Study||37
1627108|NCT00850343|3977420|P2|Completed Week 52|Overall Study||11
1627109|NCT00850343|3977421|P1|Completed Week 52|Overall Study||88
1627110|NCT00850343|3977418|P4|Completed Week 24|Overall Study||39
1627111|NCT00850343|3977419|P3|Completed Week 24|Overall Study||39
1627112|NCT00850343|3977420|P2|Completed Week 24|Overall Study||12
1627113|NCT00850343|3977421|P1|Completed Week 24|Overall Study||94
1627114|NCT00850343|3977418|P4|STARTED|Overall Study||43
1627115|NCT00850343|3977419|P3|STARTED|Overall Study||43
1627116|NCT00850343|3977420|P2|STARTED|Overall Study||12
1627117|NCT00850343|3977421|P1|STARTED|Overall Study||110
1627118|NCT00850200|3977451|P1|NOT COMPLETED|Overall Study||1
1627119|NCT00850200|3977451|P1|COMPLETED|Overall Study||19
1627120|NCT00850200|3977451|P1|STARTED|Overall Study||20
1627121|NCT00850174|3977459|P2|NOT COMPLETED|Second Intervention||0
1627122|NCT00850174|3977460|P1|NOT COMPLETED|Second Intervention||1
1627123|NCT00850174|3977459|P2|COMPLETED|Second Intervention||28
1627124|NCT00850174|3977460|P1|COMPLETED|Second Intervention||29
1627125|NCT00850174|3977459|P2|STARTED|Second Intervention||28
1627126|NCT00850174|3977460|P1|STARTED|Second Intervention||30
1627127|NCT00850174|3977459|P2|NOT COMPLETED|Washout: One Week||2
1627128|NCT00850174|3977460|P1|NOT COMPLETED|Washout: One Week||0
1627129|NCT00850174|3977459|P2|COMPLETED|Washout: One Week||28
1627130|NCT00850174|3977460|P1|COMPLETED|Washout: One Week||30
1627131|NCT00850174|3977459|P2|STARTED|Washout: One Week||30
1627132|NCT00850174|3977460|P1|STARTED|Washout: One Week||30
1627133|NCT00850174|3977459|P2|NOT COMPLETED|First Intervention||0
1627134|NCT00850174|3977460|P1|NOT COMPLETED|First Intervention||0
1627135|NCT00850174|3977459|P2|COMPLETED|First Intervention||30
1627136|NCT00850174|3977460|P1|COMPLETED|First Intervention||30
1627137|NCT00850174|3977459|P2|STARTED|First Intervention||30
1627138|NCT00850174|3977460|P1|STARTED|First Intervention||30
1627139|NCT00850135|3977474|P1|NOT COMPLETED|Overall Study||1
1627140|NCT00850135|3977474|P1|COMPLETED|Overall Study||56
1627141|NCT00850135|3977474|P1|STARTED|Overall Study||57
1627142|NCT00850096|3977482|P2|NOT COMPLETED|Overall Study||2
1627143|NCT00850096|3977483|P1|NOT COMPLETED|Overall Study||3
1627144|NCT00850096|3977482|P2|COMPLETED|Overall Study||45
1627145|NCT00850096|3977483|P1|COMPLETED|Overall Study||44
1627146|NCT00850096|3977482|P2|STARTED|Overall Study||47
1627147|NCT00850096|3977483|P1|STARTED|Overall Study||47
1627148|NCT00850070|3977493|P2|NOT COMPLETED|Overall Study||1
1627149|NCT00850070|3977494|P1|NOT COMPLETED|Overall Study||3
1627150|NCT00850070|3977493|P2|COMPLETED|Overall Study||22
1627151|NCT00850070|3977494|P1|COMPLETED|Overall Study||20
1627152|NCT00850070|3977493|P2|STARTED|Overall Study||23
1627153|NCT00850070|3977494|P1|STARTED|Overall Study||23
1627154|NCT00850031|3977518|P1|NOT COMPLETED|Overall Study||17
1627155|NCT00850031|3977518|P1|COMPLETED|Overall Study||101
1627156|NCT00850031|3977518|P1|STARTED|Overall Study||118
1627157|NCT00849940|3977523|P1|NOT COMPLETED|Overall Study||4
1627158|NCT00849940|3977523|P1|COMPLETED|Overall Study||68
1627159|NCT00849940|3977523|P1|STARTED|Overall Study||72
1627160|NCT00849901|3977534|P3|NOT COMPLETED|Extension Phase||17
1627161|NCT00849901|3977535|P2|NOT COMPLETED|Extension Phase||26
1627162|NCT00849901|3977536|P1|NOT COMPLETED|Extension Phase||27
1627163|NCT00849901|3977534|P3|COMPLETED|Extension Phase||69
1627164|NCT00849901|3977535|P2|COMPLETED|Extension Phase||65
1627165|NCT00849901|3977536|P1|COMPLETED|Extension Phase||56
1627166|NCT00849901|3977534|P3|STARTED|Extension Phase||86
1627167|NCT00849901|3977535|P2|STARTED|Extension Phase||91
1627168|NCT00849901|3977536|P1|STARTED|Extension Phase||83
1627169|NCT00849901|3977534|P3|NOT COMPLETED|Acute Treatment Phase||16
1627170|NCT00849901|3977535|P2|NOT COMPLETED|Acute Treatment Phase||26
1627171|NCT00849901|3977536|P1|NOT COMPLETED|Acute Treatment Phase||30
1627172|NCT00849901|3977534|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
1627173|NCT00849901|3977535|P2|COMPLETED|Acute Treatment Phase||91
1627174|NCT00849901|3977536|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
1627175|NCT00849901|3977534|P3|STARTED|Acute Treatment Phase||103
1627176|NCT00849901|3977535|P2|STARTED|Acute Treatment Phase||117
1627177|NCT00849901|3977536|P1|STARTED|Acute Treatment Phase||117
1627178|NCT00849875|3977583|P1|NOT COMPLETED|Overall Study||47
1627179|NCT00849875|3977583|P1|COMPLETED|Overall Study||1
1627180|NCT00849875|3977583|P1|STARTED|Overall Study||48
1627181|NCT00849862|3977665|P2|NOT COMPLETED|Second Intervention||0
1627182|NCT00849862|3977666|P1|NOT COMPLETED|Second Intervention||0
1627183|NCT00849862|3977665|P2|COMPLETED|Second Intervention||11
1627184|NCT00849862|3977666|P1|COMPLETED|Second Intervention||11
1627185|NCT00849862|3977665|P2|STARTED|Second Intervention||11
1627186|NCT00849862|3977666|P1|STARTED|Second Intervention||11
1627187|NCT00849862|3977665|P2|NOT COMPLETED|Washout: 7 Days||0
1627188|NCT00849862|3977666|P1|NOT COMPLETED|Washout: 7 Days||0
1627189|NCT00849862|3977665|P2|COMPLETED|Washout: 7 Days||11
1627190|NCT00849862|3977666|P1|COMPLETED|Washout: 7 Days||11
1627191|NCT00849862|3977665|P2|STARTED|Washout: 7 Days||11
1627192|NCT00849862|3977666|P1|STARTED|Washout: 7 Days||11
1627193|NCT00849862|3977665|P2|NOT COMPLETED|First Intervention||0
1627194|NCT00849862|3977666|P1|NOT COMPLETED|First Intervention||0
1627195|NCT00849862|3977665|P2|COMPLETED|First Intervention||11
1627196|NCT00849862|3977666|P1|COMPLETED|First Intervention||11
1627197|NCT00849862|3977665|P2|STARTED|First Intervention||11
1627198|NCT00849862|3977666|P1|STARTED|First Intervention||11
1627199|NCT00849810|3977674|P1|NOT COMPLETED|Overall Study||0
1627200|NCT00849810|3977674|P1|COMPLETED|Overall Study||1
1627201|NCT00849810|3977674|P1|STARTED|Overall Study||1
1627202|NCT00849797|3977680|P2|NOT COMPLETED|Second Intervention||0
1627203|NCT00849797|3977681|P1|NOT COMPLETED|Second Intervention||0
1627204|NCT00849797|3977680|P2|COMPLETED|Second Intervention||57
1627205|NCT00849797|3977681|P1|COMPLETED|Second Intervention||59
1627206|NCT00849797|3977680|P2|STARTED|Second Intervention||57
1627207|NCT00849797|3977681|P1|STARTED|Second Intervention||59
1627208|NCT00849797|3977680|P2|NOT COMPLETED|Washout: One Week||2
1627209|NCT00849797|3977681|P1|NOT COMPLETED|Washout: One Week||0
1627210|NCT00849797|3977680|P2|COMPLETED|Washout: One Week||57
1627211|NCT00849797|3977681|P1|COMPLETED|Washout: One Week||59
1627212|NCT00849797|3977680|P2|STARTED|Washout: One Week||59
1627213|NCT00849797|3977681|P1|STARTED|Washout: One Week||59
1627214|NCT00849797|3977680|P2|NOT COMPLETED|First Intervention||1
1627215|NCT00849797|3977681|P1|NOT COMPLETED|First Intervention||1
1627216|NCT00849797|3977680|P2|COMPLETED|First Intervention||59
1627217|NCT00849797|3977681|P1|COMPLETED|First Intervention||59
1627218|NCT00849797|3977680|P2|STARTED|First Intervention||60
1627219|NCT00849797|3977681|P1|STARTED|First Intervention||60
1627220|NCT00849693|3977699|P4|NOT COMPLETED|Extension Phase||38
1627221|NCT00849693|3977700|P3|NOT COMPLETED|Extension Phase||35
1627222|NCT00849693|3977701|P2|NOT COMPLETED|Extension Phase||30
1627223|NCT00849693|3977702|P1|NOT COMPLETED|Extension Phase||30
1627224|NCT00849693|3977699|P4|COMPLETED|Extension Phase||44
1627225|NCT00849693|3977700|P3|COMPLETED|Extension Phase||49
1627226|NCT00849693|3977701|P2|COMPLETED|Extension Phase||50
1627227|NCT00849693|3977702|P1|COMPLETED|Extension Phase||43
1627228|NCT00849693|3977699|P4|STARTED|Extension Phase||82
1627229|NCT00849693|3977700|P3|STARTED|Extension Phase||84
1627230|NCT00849693|3977701|P2|STARTED|Extension Phase||80
1627231|NCT00849693|3977702|P1|STARTED|Extension Phase||73
1627232|NCT00849693|3977699|P4|NOT COMPLETED|Acute Treatment Phase||37
1627233|NCT00849693|3977700|P3|NOT COMPLETED|Acute Treatment Phase||33
1627234|NCT00849693|3977701|P2|NOT COMPLETED|Acute Treatment Phase||35
1627235|NCT00849693|3977702|P1|NOT COMPLETED|Acute Treatment Phase||33
1627236|NCT00849693|3977699|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
1627237|NCT00849693|3977700|P3|COMPLETED|Acute Treatment Phase||84
1627238|NCT00849693|3977701|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
1627239|NCT00849693|3977702|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
1627240|NCT00849693|3977699|P4|STARTED|Acute Treatment Phase||122
1627241|NCT00849693|3977700|P3|STARTED|Acute Treatment Phase||117
1627242|NCT00849693|3977701|P2|STARTED|Acute Treatment Phase||116
1627243|NCT00849693|3977702|P1|STARTED|Acute Treatment Phase||108
1627244|NCT00849680|3977769|P8|NOT COMPLETED|Overall Study||8
1627245|NCT00849680|3977770|P7|NOT COMPLETED|Overall Study||17
1627246|NCT00849680|3977771|P6|NOT COMPLETED|Overall Study||15
1627247|NCT00849680|3977772|P5|NOT COMPLETED|Overall Study||10
1627248|NCT00849680|3977773|P4|NOT COMPLETED|Overall Study||14
1627249|NCT00849680|3977774|P3|NOT COMPLETED|Overall Study||15
1627250|NCT00849680|3977775|P2|NOT COMPLETED|Overall Study||3
1627251|NCT00849680|3977776|P1|NOT COMPLETED|Overall Study||11
1627252|NCT00849680|3977769|P8|COMPLETED|Overall Study||23
1627253|NCT00849680|3977770|P7|COMPLETED|Overall Study||61
1627254|NCT00849680|3977771|P6|COMPLETED|Overall Study||27
1627255|NCT00849680|3977772|P5|COMPLETED|Overall Study||32
1627256|NCT00849680|3977773|P4|COMPLETED|Overall Study||28
1627257|NCT00849680|3977774|P3|COMPLETED|Overall Study||27
1627258|NCT00849680|3977775|P2|COMPLETED|Overall Study||10
1627259|NCT00849680|3977776|P1|COMPLETED|Overall Study||16
1627260|NCT00849680|3977769|P8|STARTED|Overall Study||31
1627261|NCT00849680|3977770|P7|STARTED|Overall Study||78
1627262|NCT00849680|3977771|P6|STARTED|Overall Study||42
1627263|NCT00849680|3977772|P5|STARTED|Overall Study||42
1627264|NCT00849680|3977773|P4|STARTED|Overall Study||42
1627265|NCT00849680|3977774|P3|STARTED|Overall Study||42
1627266|NCT00849680|3977775|P2|STARTED|Overall Study||13
1627267|NCT00849680|3977776|P1|STARTED|Overall Study||27
1627268|NCT00849524|3977818|P1|NOT COMPLETED|Overall Study||3
1627269|NCT00849524|3977818|P1|COMPLETED|Overall Study||3
1627270|NCT00849524|3977818|P1|STARTED|Overall Study||6
1627271|NCT00849485|3977826|P2|NOT COMPLETED|Second Intervention||0
1627272|NCT00849485|3977827|P1|NOT COMPLETED|Second Intervention||0
1627273|NCT00849485|3977826|P2|COMPLETED|Second Intervention||11
1627274|NCT00849485|3977827|P1|COMPLETED|Second Intervention||11
1627275|NCT00849485|3977826|P2|STARTED|Second Intervention||11
1627276|NCT00849485|3977827|P1|STARTED|Second Intervention||11
1627277|NCT00849485|3977826|P2|NOT COMPLETED|Washout: 7 Days||0
1627278|NCT00849485|3977827|P1|NOT COMPLETED|Washout: 7 Days||0
1627279|NCT00849485|3977826|P2|COMPLETED|Washout: 7 Days||11
1627280|NCT00849485|3977827|P1|COMPLETED|Washout: 7 Days||11
1627281|NCT00849485|3977826|P2|STARTED|Washout: 7 Days||11
1627282|NCT00849485|3977827|P1|STARTED|Washout: 7 Days||11
1627283|NCT00849485|3977826|P2|NOT COMPLETED|First Intervention||0
1627284|NCT00849485|3977827|P1|NOT COMPLETED|First Intervention||0
1627285|NCT00849485|3977826|P2|COMPLETED|First Intervention||11
1627286|NCT00849485|3977827|P1|COMPLETED|First Intervention||11
1627287|NCT00849485|3977826|P2|STARTED|First Intervention||11
1627288|NCT00849485|3977827|P1|STARTED|First Intervention||11
1627289|NCT00849472|3977835|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
1627290|NCT00849472|3977835|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
1627291|NCT00849472|3977835|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
1627292|NCT00849472|3977835|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
1627293|NCT00849472|3977835|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
1627294|NCT00849472|3977835|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
1627295|NCT00849472|3977835|P1|NOT COMPLETED|Weekly Paclitaxel||16
1627296|NCT00849472|3977835|P1|COMPLETED|Weekly Paclitaxel||78
1627297|NCT00849472|3977835|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
1627298|NCT00849472|3977835|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
1627299|NCT00849472|3977835|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
1627300|NCT00849472|3977835|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
1627301|NCT00849381|3977849|P1|NOT COMPLETED|Overall Study||145
1627302|NCT00849381|3977849|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
1627303|NCT00849381|3977849|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
1627304|NCT00849290|3977855|P1|NOT COMPLETED|Overall Study||55
1627305|NCT00849290|3977855|P1|COMPLETED|Overall Study||58
1627306|NCT00849290|3977855|P1|STARTED|Overall Study||113
1627307|NCT00849251|3977859|P2|NOT COMPLETED|Overall Study||1
1627308|NCT00849251|3977860|P1|NOT COMPLETED|Overall Study||1
1627309|NCT00849251|3977859|P2|COMPLETED|Overall Study||24
1627310|NCT00849251|3977860|P1|COMPLETED|Overall Study||5
1627311|NCT00849251|3977859|P2|STARTED|Overall Study||25
1627312|NCT00849251|3977860|P1|STARTED|Overall Study||6
1627313|NCT00849212|3977866|P1|NOT COMPLETED|Overall Study||7
1627314|NCT00849212|3977866|P1|COMPLETED|Overall Study||23
1627315|NCT00849212|3977866|P1|STARTED|Overall Study||30
1627316|NCT00849186|3977871|P1|NOT COMPLETED|Overall Study||10
1627317|NCT00849186|3977871|P1|COMPLETED|Overall Study||16
1627318|NCT00849186|3977871|P1|STARTED|Overall Study||26
1627319|NCT00849147|3977877|P1|NOT COMPLETED|Overall Study||5
1627320|NCT00849147|3977877|P1|COMPLETED|Overall Study||50
1627321|NCT00849147|3977877|P1|STARTED|Overall Study||55
1627322|NCT00849121|3977894|P2|NOT COMPLETED|Overall Study||0
1627323|NCT00849121|3977895|P1|NOT COMPLETED|Overall Study||0
1627324|NCT00849121|3977894|P2|COMPLETED|Overall Study||9
1627325|NCT00849121|3977895|P1|COMPLETED|Overall Study||8
1627326|NCT00849121|3977894|P2|STARTED|Overall Study||9
1627327|NCT00849121|3977895|P1|STARTED|Overall Study||8
1627328|NCT00849108|3977910|P2|NOT COMPLETED|Cohort 2 Efficacy||10
1627329|NCT00849108|3977911|P1|NOT COMPLETED|Cohort 2 Efficacy||0
1627330|NCT00849108|3977910|P2|COMPLETED|Cohort 2 Efficacy||133
1627331|NCT00849108|3977911|P1|COMPLETED|Cohort 2 Efficacy||0
1627332|NCT00849108|3977910|P2|STARTED|Cohort 2 Efficacy||143
1627333|NCT00849108|3977911|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
1627334|NCT00849108|3977910|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
1627335|NCT00849108|3977911|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
1627336|NCT00849108|3977910|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
1627337|NCT00849108|3977911|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
1627338|NCT00849108|3977910|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
1627339|NCT00849108|3977911|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
1627340|NCT00849056|3977921|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
1627341|NCT00849056|3977922|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
1627342|NCT00849056|3977921|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
1627343|NCT00849056|3977922|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
1627344|NCT00849056|3977921|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
1627345|NCT00849056|3977922|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
1627346|NCT00849056|3977921|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
1627347|NCT00849056|3977922|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
1627348|NCT00849056|3977921|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
1627349|NCT00849056|3977922|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
1627350|NCT00849056|3977921|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
1627351|NCT00849056|3977922|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
1627352|NCT00849017|3977947|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
1627353|NCT00849017|3977948|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
1627354|NCT00849017|3977949|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
1627355|NCT00849017|3977947|P3|COMPLETED|Follow-up Period (8 Weeks)||74
1627356|NCT00849017|3977948|P2|COMPLETED|Follow-up Period (8 Weeks)||83
1627357|NCT00849017|3977949|P1|COMPLETED|Follow-up Period (8 Weeks)||76
1627358|NCT00849017|3977947|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
1627359|NCT00849017|3977948|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
1627360|NCT00849017|3977949|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
1627361|NCT00849017|3977947|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
1627362|NCT00849017|3977948|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
1627363|NCT00849017|3977949|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
1627364|NCT00849017|3977947|P3|COMPLETED|Treatment Period (156 Weeks)||57
1627365|NCT00849017|3977948|P2|COMPLETED|Treatment Period (156 Weeks)||68
1627366|NCT00849017|3977949|P1|COMPLETED|Treatment Period (156 Weeks)||58
1627367|NCT00849017|3977947|P3|STARTED|Treatment Period (156 Weeks)||99
1627368|NCT00849017|3977948|P2|STARTED|Treatment Period (156 Weeks)||101
1627369|NCT00849017|3977949|P1|STARTED|Treatment Period (156 Weeks)||101
1627370|NCT00848965|3977992|P1|NOT COMPLETED|Overall Study||2
1627371|NCT00848965|3977992|P1|COMPLETED|Overall Study||57
1627372|NCT00848965|3977992|P1|STARTED|Overall Study||59
1627373|NCT00848926|3978034|P1|NOT COMPLETED|Follow-up Period||12
1627374|NCT00848926|3978034|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
1627375|NCT00848926|3978034|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
1627376|NCT00848926|3978034|P1|NOT COMPLETED|Treatment Period||84
1627377|NCT00848926|3978034|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
1627378|NCT00848926|3978034|P1|STARTED|Treatment Period||102
1627379|NCT00848783|3978053|P3|NOT COMPLETED|Overall Study||0
1627380|NCT00848783|3978054|P2|NOT COMPLETED|Overall Study||2
1627381|NCT00848783|3978055|P1|NOT COMPLETED|Overall Study||3
1627382|NCT00848783|3978053|P3|COMPLETED|Overall Study||1
1627383|NCT00848783|3978054|P2|COMPLETED|Overall Study||1
1627384|NCT00848783|3978055|P1|COMPLETED|Overall Study||1
1627385|NCT00848783|3978053|P3|STARTED|Overall Study||1
1627386|NCT00848783|3978054|P2|STARTED|Overall Study||3
1627387|NCT00848783|3978055|P1|STARTED|Overall Study||4
1627388|NCT00848744|3978064|P1|NOT COMPLETED|Overall Study||0
1627389|NCT00848744|3978064|P1|COMPLETED|Overall Study||10
1627390|NCT00848744|3978064|P1|STARTED|Overall Study||10
1627391|NCT00848549|3978073|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
1627392|NCT00848549|3978074|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
1627393|NCT00848549|3978073|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
1627394|NCT00848549|3978074|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
1627395|NCT00848549|3978073|P2|STARTED|E2090-E044-314 (Extension Study)||158
1627396|NCT00848549|3978074|P1|STARTED|E2090-E044-314 (Extension Study)||137
1627397|NCT00848549|3978073|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
1627398|NCT00848549|3978074|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
1627399|NCT00848549|3978073|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
1627400|NCT00848549|3978074|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
1627401|NCT00848549|3978073|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
1627402|NCT00848549|3978074|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
1627403|NCT00848549|3978073|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
1627404|NCT00848549|3978074|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
1627405|NCT00848549|3978073|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
1627406|NCT00848549|3978074|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
1627407|NCT00848549|3978073|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
1627408|NCT00848549|3978074|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
1627409|NCT00848536|3978092|P2|NOT COMPLETED|Overall Study||7
1627410|NCT00848536|3978093|P1|NOT COMPLETED|Overall Study||4
1627411|NCT00848536|3978092|P2|COMPLETED|Overall Study||179
1627412|NCT00848536|3978093|P1|COMPLETED|Overall Study||181
1627413|NCT00848536|3978092|P2|STARTED|Overall Study||186
1627414|NCT00848536|3978093|P1|STARTED|Overall Study||185
1627415|NCT00848510|3978107|P4|NOT COMPLETED|Overall Study||0
1627416|NCT00848510|3978108|P3|NOT COMPLETED|Overall Study||0
1627417|NCT00848510|3978109|P2|NOT COMPLETED|Overall Study||0
1627418|NCT00848510|3978110|P1|NOT COMPLETED|Overall Study||0
1627419|NCT00848510|3978107|P4|COMPLETED|Overall Study||10
1627420|NCT00848510|3978108|P3|COMPLETED|Overall Study||8
1627421|NCT00848510|3978109|P2|COMPLETED|Overall Study||13
1627422|NCT00848510|3978110|P1|COMPLETED|Overall Study||10
1627423|NCT00848510|3978107|P4|STARTED|Overall Study||10
1627424|NCT00848510|3978108|P3|STARTED|Overall Study||8
1627425|NCT00848510|3978109|P2|STARTED|Overall Study||13
1627426|NCT00848510|3978110|P1|STARTED|Overall Study||10
1627427|NCT00848497|3978158|P2|NOT COMPLETED|Overall Study||1
1627428|NCT00848497|3978159|P1|NOT COMPLETED|Overall Study||2
1627429|NCT00848497|3978158|P2|COMPLETED|Overall Study||0
1627430|NCT00848497|3978159|P1|COMPLETED|Overall Study||0
1627431|NCT00848497|3978158|P2|STARTED|Overall Study|Completed Visit 4|1
1627432|NCT00848497|3978159|P1|STARTED|Overall Study||2
1627433|NCT00848484|3978173|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
1627434|NCT00848484|3978174|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
1627435|NCT00848484|3978173|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
1627436|NCT00848484|3978174|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
1627437|NCT00848484|3978173|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
1627438|NCT00848484|3978174|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
1627439|NCT00848484|3978173|P2|STARTED|Second Intervention (Treatment Period 2)||21
1627440|NCT00848484|3978174|P1|STARTED|Second Intervention (Treatment Period 2)||25
1627441|NCT00848484|3978173|P2|NOT COMPLETED|Washout Period of Two Weeks||3
1627442|NCT00848484|3978174|P1|NOT COMPLETED|Washout Period of Two Weeks||0
1627443|NCT00848484|3978173|P2|COMPLETED|Washout Period of Two Weeks||21
1627444|NCT00848484|3978174|P1|COMPLETED|Washout Period of Two Weeks||25
1627445|NCT00848484|3978173|P2|STARTED|Washout Period of Two Weeks||24
1627446|NCT00848484|3978174|P1|STARTED|Washout Period of Two Weeks||25
1627447|NCT00848484|3978173|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
1627448|NCT00848484|3978174|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
1627449|NCT00848484|3978173|P2|COMPLETED|First Intervention (Treatment Period 1)||24
1627450|NCT00848484|3978174|P1|COMPLETED|First Intervention (Treatment Period 1)||25
1627451|NCT00848484|3978173|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
1627452|NCT00848484|3978174|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
1627453|NCT00848484|3978173|P2|STARTED|First Intervention (Treatment Period 1)||27
1627454|NCT00848484|3978174|P1|STARTED|First Intervention (Treatment Period 1)||27
1627455|NCT00848393|3978193|P3|NOT COMPLETED|Overall Study||3
1627456|NCT00848393|3978194|P2|NOT COMPLETED|Overall Study||0
1627457|NCT00848393|3978195|P1|NOT COMPLETED|Overall Study||0
1627458|NCT00848393|3978193|P3|COMPLETED|Overall Study||15
1627459|NCT00848393|3978194|P2|COMPLETED|Overall Study||16
1627460|NCT00848393|3978195|P1|COMPLETED|Overall Study||17
1627461|NCT00848393|3978193|P3|STARTED|Overall Study||18
1627462|NCT00848393|3978194|P2|STARTED|Overall Study||16
1627463|NCT00848393|3978195|P1|STARTED|Overall Study||17
1627464|NCT00848367|3978223|P2|NOT COMPLETED|Overall Study||9
1627465|NCT00848367|3978224|P1|NOT COMPLETED|Overall Study||9
1627466|NCT00848367|3978223|P2|COMPLETED|Overall Study||41
1627467|NCT00848367|3978224|P1|COMPLETED|Overall Study||43
1627468|NCT00848367|3978223|P2|STARTED|Overall Study||50
1627469|NCT00848367|3978224|P1|STARTED|Overall Study||52
1627470|NCT00848354|3978234|P2|NOT COMPLETED|Phase 2 Year 2||7
1627471|NCT00848354|3978235|P1|NOT COMPLETED|Phase 2 Year 2||23
1627472|NCT00848354|3978234|P2|COMPLETED|Phase 2 Year 2||113
1627473|NCT00848354|3978235|P1|COMPLETED|Phase 2 Year 2||218
1627474|NCT00848354|3978234|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
1627475|NCT00848354|3978235|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
1627476|NCT00848354|3978234|P2|NOT COMPLETED|Phase 2 Year 1||6
1627477|NCT00848354|3978235|P1|NOT COMPLETED|Phase 2 Year 1||18
1627478|NCT00848354|3978234|P2|COMPLETED|Phase 2 Year 1||120
1627479|NCT00848354|3978235|P1|COMPLETED|Phase 2 Year 1||242
1627480|NCT00848354|3978234|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
1627481|NCT00848354|3978235|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
1627482|NCT00848354|3978234|P2|NOT COMPLETED|Phase 1||14
1627483|NCT00848354|3978235|P1|NOT COMPLETED|Phase 1||12
1627484|NCT00848354|3978234|P2|COMPLETED|Phase 1||129
1627485|NCT00848354|3978235|P1|COMPLETED|Phase 1||269
1627486|NCT00848354|3978234|P2|STARTED|Phase 1||143
1627487|NCT00848354|3978235|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
1627488|NCT00848250|3978387|P2|NOT COMPLETED|Overall Study||1
1627489|NCT00848250|3978388|P1|NOT COMPLETED|Overall Study||0
1627490|NCT00848250|3978387|P2|COMPLETED|Overall Study||9
1627491|NCT00848250|3978388|P1|COMPLETED|Overall Study||11
1627492|NCT00848250|3978387|P2|STARTED|Overall Study||10
1627493|NCT00848250|3978388|P1|STARTED|Overall Study||11
1627494|NCT00848237|3978406|P1|NOT COMPLETED|Overall Study||539
1627495|NCT00848237|3978406|P1|COMPLETED|Overall Study||4982
1627496|NCT00848237|3978406|P1|STARTED|Overall Study||5521
1627497|NCT00848211|3978419|P4|NOT COMPLETED|Overall Study||0
1627498|NCT00848211|3978420|P3|NOT COMPLETED|Overall Study||1
1627499|NCT00848211|3978421|P2|NOT COMPLETED|Overall Study||1
1627500|NCT00848211|3978422|P1|NOT COMPLETED|Overall Study||0
1627501|NCT00848211|3978419|P4|COMPLETED|Overall Study||5
1627502|NCT00848211|3978420|P3|COMPLETED|Overall Study||5
1627503|NCT00848211|3978421|P2|COMPLETED|Overall Study||6
1627504|NCT00848211|3978422|P1|COMPLETED|Overall Study||6
1627505|NCT00848211|3978419|P4|STARTED|Overall Study||5
1627506|NCT00848211|3978420|P3|STARTED|Overall Study||6
1627507|NCT00848211|3978421|P2|STARTED|Overall Study||7
1627508|NCT00848211|3978422|P1|STARTED|Overall Study||6
1627509|NCT00848198|3978440|P1|NOT COMPLETED|Overall Study||15
1627510|NCT00848198|3978440|P1|COMPLETED|Overall Study||299
1627511|NCT00848198|3978440|P1|STARTED|Overall Study||314
1627512|NCT00848185|3978481|P3|NOT COMPLETED|Overall Study||0
1627513|NCT00848185|3978482|P2|NOT COMPLETED|Overall Study||0
1627514|NCT00848185|3978483|P1|NOT COMPLETED|Overall Study||0
1627515|NCT00848185|3978481|P3|COMPLETED|Overall Study||32
1627516|NCT00848185|3978482|P2|COMPLETED|Overall Study||32
1627517|NCT00848185|3978483|P1|COMPLETED|Overall Study||32
1627518|NCT00848185|3978481|P3|STARTED|Overall Study||32
1627519|NCT00848185|3978482|P2|STARTED|Overall Study||32
1627520|NCT00848185|3978483|P1|STARTED|Overall Study||32
1627521|NCT00848172|3978493|P2|NOT COMPLETED|Visit 3 - Follow Up||0
1627522|NCT00848172|3978494|P1|NOT COMPLETED|Visit 3 - Follow Up||0
1627523|NCT00848172|3978493|P2|COMPLETED|Visit 3 - Follow Up||8
1627524|NCT00848172|3978494|P1|COMPLETED|Visit 3 - Follow Up||10
1627525|NCT00848172|3978493|P2|STARTED|Visit 3 - Follow Up||8
1627526|NCT00848172|3978494|P1|STARTED|Visit 3 - Follow Up||10
1627527|NCT00848172|3978493|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
1627528|NCT00848172|3978494|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
1627529|NCT00848172|3978493|P2|COMPLETED|Visit 2 - Drug Administration||8
1627530|NCT00848172|3978494|P1|COMPLETED|Visit 2 - Drug Administration||10
1627531|NCT00848172|3978493|P2|STARTED|Visit 2 - Drug Administration||9
1627532|NCT00848172|3978494|P1|STARTED|Visit 2 - Drug Administration||10
1627533|NCT00848120|3978505|P1|NOT COMPLETED|Overall Study||1
1627534|NCT00848120|3978505|P1|COMPLETED|Overall Study||28
1627535|NCT00848120|3978505|P1|STARTED|Overall Study||29
1627536|NCT00848107|3978517|P1|NOT COMPLETED|Overall Study||21
1627537|NCT00848107|3978517|P1|COMPLETED|Overall Study||94
1627538|NCT00848107|3978517|P1|STARTED|Overall Study||115
1627539|NCT00848081|3978527|P2|NOT COMPLETED|Overall Study||18
1627540|NCT00848081|3978528|P1|NOT COMPLETED|Overall Study||20
1627541|NCT00848081|3978527|P2|COMPLETED|Overall Study||140
1627542|NCT00848081|3978528|P1|COMPLETED|Overall Study||140
1627543|NCT00848081|3978527|P2|STARTED|Overall Study||158
1627544|NCT00848081|3978528|P1|STARTED|Overall Study||160
1627545|NCT00848042|3978545|P3|NOT COMPLETED|Overall Study||0
1627546|NCT00848042|3978546|P2|NOT COMPLETED|Overall Study||2
1627547|NCT00848042|3978547|P1|NOT COMPLETED|Overall Study||4
1627548|NCT00848042|3978545|P3|COMPLETED|Overall Study||1
1627549|NCT00848042|3978546|P2|COMPLETED|Overall Study||3
1627550|NCT00848042|3978547|P1|COMPLETED|Overall Study||1
1627551|NCT00848042|3978545|P3|Month 6|Overall Study||1
1627552|NCT00848042|3978546|P2|Month 6|Overall Study||3
1627553|NCT00848042|3978547|P1|Month 6|Overall Study||1
1627554|NCT00848042|3978545|P3|Month 5|Overall Study||1
1627555|NCT00848042|3978546|P2|Month 5|Overall Study||3
1627556|NCT00848042|3978547|P1|Month 5|Overall Study||1
1627557|NCT00848042|3978545|P3|Month 4|Overall Study||1
1627558|NCT00848042|3978546|P2|Month 4|Overall Study||4
1627559|NCT00848042|3978547|P1|Month 4|Overall Study||1
1627560|NCT00848042|3978545|P3|Month 3|Overall Study||1
1627561|NCT00848042|3978546|P2|Month 3|Overall Study||4
1627562|NCT00848042|3978547|P1|Month 3|Overall Study||1
1627563|NCT00848042|3978545|P3|Month 2|Overall Study||1
1627564|NCT00848042|3978546|P2|Month 2|Overall Study||5
1627565|NCT00848042|3978547|P1|Month 2|Overall Study||1
1627566|NCT00848042|3978545|P3|Month 1|Overall Study||1
1627567|NCT00848042|3978546|P2|Month 1|Overall Study||5
1627568|NCT00848042|3978547|P1|Month 1|Overall Study||4
1627569|NCT00848042|3978545|P3|Day 15|Overall Study||1
1627570|NCT00848042|3978546|P2|Day 15|Overall Study||5
1627571|NCT00848042|3978547|P1|Day 15|Overall Study||4
1627572|NCT00848042|3978545|P3|Day 8|Overall Study||1
1627573|NCT00848042|3978546|P2|Day 8|Overall Study||5
1627574|NCT00848042|3978547|P1|Day 8|Overall Study||5
1627575|NCT00848042|3978545|P3|Day 3|Overall Study||1
1627576|NCT00848042|3978546|P2|Day 3|Overall Study||5
1627577|NCT00848042|3978547|P1|Day 3|Overall Study||5
1627578|NCT00848042|3978545|P3|Day 2|Overall Study||1
1627579|NCT00848042|3978546|P2|Day 2|Overall Study||5
1627580|NCT00848042|3978547|P1|Day 2|Overall Study||5
1627581|NCT00848042|3978545|P3|Day 1|Overall Study||1
1627582|NCT00848042|3978546|P2|Day 1|Overall Study||5
1627583|NCT00848042|3978547|P1|Day 1|Overall Study||5
1627584|NCT00848042|3978545|P3|STARTED|Overall Study||1
1627585|NCT00848042|3978546|P2|STARTED|Overall Study||5
1627586|NCT00848042|3978547|P1|STARTED|Overall Study||5
1627587|NCT00848016|3978558|P1|NOT COMPLETED|Overall Study||0
1627588|NCT00848016|3978558|P1|COMPLETED|Overall Study||29
1627589|NCT00848016|3978558|P1|STARTED|Overall Study||29
1627590|NCT00847912|3978566|P2|NOT COMPLETED|Overall Study||13
1627591|NCT00847912|3978567|P1|NOT COMPLETED|Overall Study||9
1627592|NCT00847912|3978566|P2|COMPLETED|Overall Study||464
1627593|NCT00847912|3978567|P1|COMPLETED|Overall Study||468
1627594|NCT00847912|3978566|P2|STARTED|Overall Study||477
1627595|NCT00847912|3978567|P1|STARTED|Overall Study||477
1627596|NCT00847886|3978577|P2|NOT COMPLETED|Overall Study||1
1627597|NCT00847886|3978578|P1|NOT COMPLETED|Overall Study||0
1627598|NCT00847886|3978577|P2|COMPLETED|Overall Study||3
1627599|NCT00847886|3978578|P1|COMPLETED|Overall Study||12
1627600|NCT00847886|3978577|P2|STARTED|Overall Study||4
1627601|NCT00847886|3978578|P1|STARTED|Overall Study||12
1627602|NCT00847808|3978604|P1|NOT COMPLETED|Overall Study||15
1627603|NCT00847808|3978604|P1|COMPLETED|Overall Study||163
1627604|NCT00847808|3978604|P1|STARTED|Overall Study||178
1627605|NCT00847704|3978621|P1|NOT COMPLETED|Overall Study||1
1627606|NCT00847704|3978621|P1|COMPLETED|Overall Study||2
1627607|NCT00847704|3978621|P1|STARTED|Overall Study||3
1627608|NCT00847665|3978632|P2|NOT COMPLETED|Overall Study||0
1627609|NCT00847665|3978633|P1|NOT COMPLETED|Overall Study||1
1627610|NCT00847665|3978632|P2|COMPLETED|Overall Study||165
1627611|NCT00847665|3978633|P1|COMPLETED|Overall Study||164
1627612|NCT00847665|3978632|P2|STARTED|Overall Study||165
1627613|NCT00847665|3978633|P1|STARTED|Overall Study||165
1627614|NCT00847626|3978656|P11|NOT COMPLETED|Overall Study||20
1627615|NCT00847626|3978657|P10|NOT COMPLETED|Overall Study||14
1627616|NCT00847626|3978658|P9|NOT COMPLETED|Overall Study||14
1627617|NCT00847626|3978659|P8|NOT COMPLETED|Overall Study||19
1627618|NCT00847626|3978660|P7|NOT COMPLETED|Overall Study||22
1627619|NCT00847626|3978661|P6|NOT COMPLETED|Overall Study||37
1627620|NCT00847626|3978662|P5|NOT COMPLETED|Overall Study||28
1627621|NCT00847626|3978663|P4|NOT COMPLETED|Overall Study||31
1627622|NCT00847626|3978664|P3|NOT COMPLETED|Overall Study||16
1627623|NCT00847626|3978665|P2|NOT COMPLETED|Overall Study||23
1627624|NCT00847626|3978666|P1|NOT COMPLETED|Overall Study||21
1627625|NCT00847626|3978656|P11|COMPLETED|Overall Study||142
1627626|NCT00847626|3978657|P10|COMPLETED|Overall Study||139
1627627|NCT00847626|3978658|P9|COMPLETED|Overall Study||141
1627628|NCT00847626|3978659|P8|COMPLETED|Overall Study||141
1627629|NCT00847626|3978660|P7|COMPLETED|Overall Study||135
1627630|NCT00847626|3978661|P6|COMPLETED|Overall Study||125
1627631|NCT00847626|3978662|P5|COMPLETED|Overall Study||125
1627632|NCT00847626|3978663|P4|COMPLETED|Overall Study||125
1627633|NCT00847626|3978664|P3|COMPLETED|Overall Study||131
1627634|NCT00847626|3978665|P2|COMPLETED|Overall Study||131
1627635|NCT00847626|3978666|P1|COMPLETED|Overall Study||135
1627636|NCT00847626|3978656|P11|STARTED|Overall Study||162
1627637|NCT00847626|3978657|P10|STARTED|Overall Study||153
1627638|NCT00847626|3978658|P9|STARTED|Overall Study||155
1627639|NCT00847626|3978659|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
1627640|NCT00847626|3978660|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
1627641|NCT00847626|3978661|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
1627642|NCT00847626|3978662|P5|STARTED|Overall Study||153
1627643|NCT00847626|3978663|P4|STARTED|Overall Study||156
1627644|NCT00847626|3978664|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
1627645|NCT00847626|3978665|P2|STARTED|Overall Study||154
1627646|NCT00847626|3978666|P1|STARTED|Overall Study||156
1627647|NCT00847613|3978865|P4|NOT COMPLETED|Overall Study||79
1627648|NCT00847613|3978866|P3|NOT COMPLETED|Overall Study||81
1627649|NCT00847613|3978867|P2|NOT COMPLETED|Overall Study||319
1627650|NCT00847613|3978868|P1|NOT COMPLETED|Overall Study||321
1627651|NCT00847613|3978865|P4|COMPLETED|Overall Study||0
1627652|NCT00847613|3978866|P3|COMPLETED|Overall Study||0
1627653|NCT00847613|3978867|P2|COMPLETED|Overall Study||0
1627654|NCT00847613|3978868|P1|COMPLETED|Overall Study||0
1627655|NCT00847613|3978865|P4|Treated|Overall Study||79
1627656|NCT00847613|3978866|P3|Treated|Overall Study||81
1627657|NCT00847613|3978867|P2|Treated|Overall Study||316
1627658|NCT00847613|3978868|P1|Treated|Overall Study||321
1627659|NCT00847613|3978865|P4|STARTED|Overall Study||79
1627660|NCT00847613|3978866|P3|STARTED|Overall Study||81
1627661|NCT00847613|3978867|P2|STARTED|Overall Study||319
1627662|NCT00847613|3978868|P1|STARTED|Overall Study||321
1627663|NCT00847587|3979108|P2|NOT COMPLETED|Overall Study||0
1627664|NCT00847587|3979109|P1|NOT COMPLETED|Overall Study||1
1627665|NCT00847587|3979108|P2|COMPLETED|Overall Study||34
1627666|NCT00847587|3979109|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
1627667|NCT00847587|3979108|P2|STARTED|Overall Study||34
1627668|NCT00847587|3979109|P1|STARTED|Overall Study||35
1627669|NCT00847561|3979119|P2|NOT COMPLETED|Overall Study||4
1627670|NCT00847561|3979120|P1|NOT COMPLETED|Overall Study||13
1627671|NCT00847561|3979119|P2|COMPLETED|Overall Study||62
1627672|NCT00847561|3979120|P1|COMPLETED|Overall Study||57
1627673|NCT00847561|3979119|P2|STARTED|Overall Study||66
1627674|NCT00847561|3979120|P1|STARTED|Overall Study||70
1627675|NCT00847535|3979126|P3|NOT COMPLETED|Overall Study||1
1627676|NCT00847535|3979127|P2|NOT COMPLETED|Overall Study||2
1627677|NCT00847535|3979128|P1|NOT COMPLETED|Overall Study||2
1627678|NCT00847535|3979126|P3|COMPLETED|Overall Study||15
1627679|NCT00847535|3979127|P2|COMPLETED|Overall Study||22
1627680|NCT00847535|3979128|P1|COMPLETED|Overall Study||22
1627681|NCT00847535|3979126|P3|200 Million AMDC|Overall Study||8
1627682|NCT00847535|3979127|P2|200 Million AMDC|Overall Study||0
1627683|NCT00847535|3979128|P1|200 Million AMDC|Overall Study||0
1627684|NCT00847535|3979126|P3|100 Million AMDC|Overall Study||8
1627685|NCT00847535|3979127|P2|100 Million AMDC|Overall Study||8
1627686|NCT00847535|3979128|P1|100 Million AMDC|Overall Study||8
1627687|NCT00847535|3979126|P3|50 Million AMDC|Overall Study||0
1627688|NCT00847535|3979127|P2|50 Million AMDC|Overall Study||8
1627689|NCT00847535|3979128|P1|50 Million AMDC|Overall Study||8
1627690|NCT00847535|3979126|P3|10 Million AMDC|Overall Study||0
1627691|NCT00847535|3979127|P2|10 Million AMDC|Overall Study||8
1627692|NCT00847535|3979128|P1|10 Million AMDC|Overall Study||8
1627693|NCT00847535|3979126|P3|STARTED|Overall Study||16
1627694|NCT00847535|3979127|P2|STARTED|Overall Study||24
1627695|NCT00847535|3979128|P1|STARTED|Overall Study||24
1627696|NCT00847522|3979136|P1|NOT COMPLETED|Overall Study||0
1627697|NCT00847522|3979136|P1|COMPLETED|Overall Study||90
1627698|NCT00847522|3979136|P1|Phase II|Overall Study||80
1627699|NCT00847522|3979136|P1|Phase I|Overall Study||10
1627700|NCT00847522|3979136|P1|STARTED|Overall Study||90
1627701|NCT00847509|3979141|P1|NOT COMPLETED|Overall Study||11
1627702|NCT00847509|3979141|P1|COMPLETED|Overall Study||38
1627703|NCT00847509|3979141|P1|STARTED|Overall Study||49
1627704|NCT00847405|3979147|P2|NOT COMPLETED|Second Intervention||0
1627705|NCT00847405|3979148|P1|NOT COMPLETED|Second Intervention||0
1627706|NCT00847405|3979147|P2|COMPLETED|Second Intervention||13
1627707|NCT00847405|3979148|P1|COMPLETED|Second Intervention||13
1627708|NCT00847405|3979147|P2|STARTED|Second Intervention||13
1627709|NCT00847405|3979148|P1|STARTED|Second Intervention||13
1627710|NCT00847405|3979147|P2|NOT COMPLETED|Washout of 7 Days||0
1627711|NCT00847405|3979148|P1|NOT COMPLETED|Washout of 7 Days||1
1627712|NCT00847405|3979147|P2|COMPLETED|Washout of 7 Days||13
1627713|NCT00847405|3979148|P1|COMPLETED|Washout of 7 Days||13
1627714|NCT00847405|3979147|P2|STARTED|Washout of 7 Days||13
1627715|NCT00847405|3979148|P1|STARTED|Washout of 7 Days||14
1627716|NCT00847405|3979147|P2|NOT COMPLETED|First Intervention||1
1627717|NCT00847405|3979148|P1|NOT COMPLETED|First Intervention||0
1627718|NCT00847405|3979147|P2|COMPLETED|First Intervention||13
1627719|NCT00847405|3979148|P1|COMPLETED|First Intervention||14
1627720|NCT00847405|3979147|P2|STARTED|First Intervention||14
1627721|NCT00847405|3979148|P1|STARTED|First Intervention||14
1627722|NCT00847301|3979156|P1|NOT COMPLETED|Overall Study||54
1627723|NCT00847301|3979156|P1|COMPLETED|Overall Study||374
1627724|NCT00847301|3979156|P1|STARTED|Overall Study||428
1627725|NCT00847288|3979166|P2|NOT COMPLETED|Overall Study||47
1627726|NCT00847288|3979167|P1|NOT COMPLETED|Overall Study||30
1627727|NCT00847288|3979166|P2|COMPLETED|Overall Study||780
1627728|NCT00847288|3979167|P1|COMPLETED|Overall Study||811
1627729|NCT00847288|3979166|P2|STARTED|Overall Study||827
1627730|NCT00847288|3979167|P1|STARTED|Overall Study||841
1627731|NCT00847210|3979181|P2|NOT COMPLETED|Overall Study||0
1627732|NCT00847210|3979182|P1|NOT COMPLETED|Overall Study||0
1627733|NCT00847210|3979181|P2|COMPLETED|Overall Study||18
1627734|NCT00847210|3979182|P1|COMPLETED|Overall Study||18
1627735|NCT00847210|3979181|P2|STARTED|Overall Study||18
1627736|NCT00847210|3979182|P1|STARTED|Overall Study||18
1627737|NCT00847197|3979204|P2|NOT COMPLETED|Overall Study||5
1627738|NCT00847197|3979205|P1|NOT COMPLETED|Overall Study||24
1627739|NCT00847197|3979204|P2|COMPLETED|Overall Study||70
1627740|NCT00847197|3979205|P1|COMPLETED|Overall Study||92
1627741|NCT00847197|3979204|P2|STARTED|Overall Study||75
1627742|NCT00847197|3979205|P1|STARTED|Overall Study||116
1627743|NCT00847171|3979215|P1|NOT COMPLETED|Overall Study||0
1627744|NCT00847171|3979215|P1|COMPLETED|Overall Study||20
1627745|NCT00847171|3979215|P1|STARTED|Overall Study||20
1627746|NCT00847145|3979229|P8|NOT COMPLETED|Overall Study||4
1627747|NCT00847145|3979230|P7|NOT COMPLETED|Overall Study||9
1627748|NCT00847145|3979231|P6|NOT COMPLETED|Overall Study||4
1627749|NCT00847145|3979232|P5|NOT COMPLETED|Overall Study||6
1627750|NCT00847145|3979233|P4|NOT COMPLETED|Overall Study||1
1627751|NCT00847145|3979234|P3|NOT COMPLETED|Overall Study||11
1627752|NCT00847145|3979235|P2|NOT COMPLETED|Overall Study||6
1627753|NCT00847145|3979236|P1|NOT COMPLETED|Overall Study||6
1627754|NCT00847145|3979229|P8|COMPLETED|Overall Study||136
1627755|NCT00847145|3979230|P7|COMPLETED|Overall Study||143
1627756|NCT00847145|3979231|P6|COMPLETED|Overall Study||152
1627757|NCT00847145|3979232|P5|COMPLETED|Overall Study||131
1627758|NCT00847145|3979233|P4|COMPLETED|Overall Study||116
1627759|NCT00847145|3979234|P3|COMPLETED|Overall Study||274
1627760|NCT00847145|3979235|P2|COMPLETED|Overall Study||627
1627761|NCT00847145|3979236|P1|COMPLETED|Overall Study||623
1627762|NCT00847145|3979229|P8|STARTED|Overall Study||140
1627763|NCT00847145|3979230|P7|STARTED|Overall Study||152
1627764|NCT00847145|3979231|P6|STARTED|Overall Study||156
1627765|NCT00847145|3979232|P5|STARTED|Overall Study||137
1627766|NCT00847145|3979233|P4|STARTED|Overall Study||117
1627767|NCT00847145|3979234|P3|STARTED|Overall Study||285
1627768|NCT00847145|3979235|P2|STARTED|Overall Study||633
1627769|NCT00847145|3979236|P1|STARTED|Overall Study||629
1627770|NCT00847132|3979286|P2|NOT COMPLETED|Overall Study||1
1627771|NCT00847132|3979287|P1|NOT COMPLETED|Overall Study||1
1627772|NCT00847132|3979286|P2|COMPLETED|Overall Study||84
1627773|NCT00847132|3979287|P1|COMPLETED|Overall Study||89
1627774|NCT00847132|3979286|P2|STARTED|Overall Study||85
1627775|NCT00847132|3979287|P1|STARTED|Overall Study||90
1627776|NCT00847015|3979295|P1|NOT COMPLETED|Overall Study||3
1627777|NCT00847015|3979295|P1|COMPLETED|Overall Study||15
1627778|NCT00847015|3979295|P1|STARTED|Overall Study||18
1627779|NCT00847002|3979303|P2|NOT COMPLETED|Overall Study||0
1627780|NCT00847002|3979304|P1|NOT COMPLETED|Overall Study||0
1627781|NCT00847002|3979303|P2|COMPLETED|Overall Study||4
1627782|NCT00847002|3979304|P1|COMPLETED|Overall Study||4
1627783|NCT00847002|3979303|P2|STARTED|Overall Study||4
1627784|NCT00847002|3979304|P1|STARTED|Overall Study||4
1627785|NCT00846885|3979314|P2|NOT COMPLETED|Second Intervention||0
1627786|NCT00846885|3979315|P1|NOT COMPLETED|Second Intervention||0
1627787|NCT00846885|3979314|P2|COMPLETED|Second Intervention||14
1627788|NCT00846885|3979315|P1|COMPLETED|Second Intervention||14
1627789|NCT00846885|3979314|P2|STARTED|Second Intervention||14
1627790|NCT00846885|3979315|P1|STARTED|Second Intervention||14
1627791|NCT00846885|3979314|P2|NOT COMPLETED|Washout of 7 Days||0
1627792|NCT00846885|3979315|P1|NOT COMPLETED|Washout of 7 Days||0
1627793|NCT00846885|3979314|P2|COMPLETED|Washout of 7 Days||14
1627794|NCT00846885|3979315|P1|COMPLETED|Washout of 7 Days||14
1627795|NCT00846885|3979314|P2|STARTED|Washout of 7 Days||14
1627796|NCT00846885|3979315|P1|STARTED|Washout of 7 Days||14
1627797|NCT00846885|3979314|P2|NOT COMPLETED|First Intervention||0
1627798|NCT00846885|3979315|P1|NOT COMPLETED|First Intervention||0
1627799|NCT00846885|3979314|P2|COMPLETED|First Intervention||14
1627800|NCT00846885|3979315|P1|COMPLETED|First Intervention||14
1627801|NCT00846885|3979314|P2|STARTED|First Intervention||14
1627802|NCT00846885|3979315|P1|STARTED|First Intervention||14
1627803|NCT00846846|3979323|P1|NOT COMPLETED|Overall Study||75
1627804|NCT00846846|3979323|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
1627805|NCT00846846|3979323|P1|STARTED|Overall Study||1018
1627806|NCT00846807|3979328|P1|NOT COMPLETED|Overall Study||632
1627807|NCT00846807|3979328|P1|COMPLETED|Overall Study|Completed treatment.|4660
1627808|NCT00846807|3979328|P1|STARTED|Overall Study|Entered and treated.|5292
1627809|NCT00846768|3979336|P4|NOT COMPLETED|Overall Study||0
1627810|NCT00846768|3979337|P3|NOT COMPLETED|Overall Study||0
1627811|NCT00846768|3979338|P2|NOT COMPLETED|Overall Study||1
1627812|NCT00846768|3979339|P1|NOT COMPLETED|Overall Study||0
1627813|NCT00846768|3979336|P4|COMPLETED|Overall Study||12
1627814|NCT00846768|3979337|P3|COMPLETED|Overall Study||12
1627815|NCT00846768|3979338|P2|COMPLETED|Overall Study||11
1627816|NCT00846768|3979339|P1|COMPLETED|Overall Study||11
1627817|NCT00846768|3979336|P4|STARTED|Overall Study||12
1627818|NCT00846768|3979337|P3|STARTED|Overall Study||12
1627819|NCT00846768|3979338|P2|STARTED|Overall Study||12
1627820|NCT00846768|3979339|P1|STARTED|Overall Study||11
1627821|NCT00846651|3979411|P2|NOT COMPLETED|Overall Study||4
1627822|NCT00846651|3979412|P1|NOT COMPLETED|Overall Study||4
1627823|NCT00846651|3979411|P2|COMPLETED|Overall Study||37
1627824|NCT00846651|3979412|P1|COMPLETED|Overall Study||37
1627825|NCT00846651|3979411|P2|STARTED|Overall Study||41
1627826|NCT00846651|3979412|P1|STARTED|Overall Study||41
1627827|NCT00846586|3979430|P2|NOT COMPLETED|Overall Study||35
1627828|NCT00846586|3979431|P1|NOT COMPLETED|Overall Study||39
1627829|NCT00846586|3979430|P2|COMPLETED|Overall Study||529
1627830|NCT00846586|3979431|P1|COMPLETED|Overall Study||531
1627831|NCT00846586|3979430|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
1627832|NCT00846586|3979431|P1|Received Study Drug|Overall Study||570
1627833|NCT00846586|3979430|P2|STARTED|Overall Study||564
1627834|NCT00846586|3979431|P1|STARTED|Overall Study||570
1627835|NCT00846573|3979450|P4|NOT COMPLETED|Overall Study||0
1627836|NCT00846573|3979451|P3|NOT COMPLETED|Overall Study||0
1627837|NCT00846573|3979452|P2|NOT COMPLETED|Overall Study||0
1627838|NCT00846573|3979453|P1|NOT COMPLETED|Overall Study||0
1627839|NCT00846573|3979450|P4|COMPLETED|Overall Study||0
1627840|NCT00846573|3979451|P3|COMPLETED|Overall Study||7
1627841|NCT00846573|3979452|P2|COMPLETED|Overall Study||2
1627842|NCT00846573|3979453|P1|COMPLETED|Overall Study||5
1627843|NCT00846573|3979450|P4|STARTED|Overall Study||0
1627844|NCT00846573|3979451|P3|STARTED|Overall Study||7
1627845|NCT00846573|3979452|P2|STARTED|Overall Study||2
1627846|NCT00846573|3979453|P1|STARTED|Overall Study||5
1627847|NCT00846547|3979461|P1|NOT COMPLETED|Overall Study||7
1627848|NCT00846547|3979461|P1|COMPLETED|Overall Study||25
1627849|NCT00846547|3979461|P1|STARTED|Overall Study||32
1627850|NCT00846521|3979465|P1|NOT COMPLETED|Overall Study||11
1627851|NCT00846521|3979465|P1|COMPLETED|Overall Study||12
1627852|NCT00846521|3979465|P1|STARTED|Overall Study||23
1627853|NCT00846495|3979472|P2|NOT COMPLETED|Overall Study||3
1627854|NCT00846495|3979473|P1|NOT COMPLETED|Overall Study||8
1627855|NCT00846495|3979472|P2|COMPLETED|Overall Study||24
1627856|NCT00846495|3979473|P1|COMPLETED|Overall Study||20
1627857|NCT00846495|3979472|P2|STARTED|Overall Study||27
1627858|NCT00846495|3979473|P1|STARTED|Overall Study||28
1627859|NCT00846391|3979496|P3|NOT COMPLETED|Overall Study||3
1627860|NCT00846391|3979497|P2|NOT COMPLETED|Overall Study||2
1627861|NCT00846391|3979498|P1|NOT COMPLETED|Overall Study||1
1627862|NCT00846391|3979496|P3|COMPLETED|Overall Study||3
1627863|NCT00846391|3979497|P2|COMPLETED|Overall Study||2
1627864|NCT00846391|3979498|P1|COMPLETED|Overall Study||3
1627865|NCT00846391|3979496|P3|STARTED|Overall Study||6
1627866|NCT00846391|3979497|P2|STARTED|Overall Study||4
1627867|NCT00846391|3979498|P1|STARTED|Overall Study||4
1627868|NCT00846365|3979509|P3|NOT COMPLETED|Overall Study||33
1627869|NCT00846365|3979510|P2|NOT COMPLETED|Overall Study||49
1627870|NCT00846365|3979511|P1|NOT COMPLETED|Overall Study||55
1627871|NCT00846365|3979509|P3|COMPLETED|Overall Study||323
1627872|NCT00846365|3979510|P2|COMPLETED|Overall Study||308
1627873|NCT00846365|3979511|P1|COMPLETED|Overall Study||317
1627874|NCT00846365|3979509|P3|STARTED|Overall Study||356
1627875|NCT00846365|3979510|P2|STARTED|Overall Study||357
1627876|NCT00846365|3979511|P1|STARTED|Overall Study||372
1627877|NCT00846287|3979566|P2|NOT COMPLETED|Overall Study||5
1627878|NCT00846287|3979567|P1|NOT COMPLETED|Overall Study||10
1627879|NCT00846287|3979566|P2|COMPLETED|Overall Study||10
1627880|NCT00846287|3979567|P1|COMPLETED|Overall Study||6
1627881|NCT00846287|3979566|P2|STARTED|Overall Study||15
1627882|NCT00846287|3979567|P1|STARTED|Overall Study||16
1627883|NCT00846066|3979577|P2|NOT COMPLETED|Overall Study||0
1627884|NCT00846066|3979578|P1|NOT COMPLETED|Overall Study||0
1627885|NCT00846066|3979577|P2|COMPLETED|Overall Study||29
1627886|NCT00846066|3979578|P1|COMPLETED|Overall Study||27
1627887|NCT00846066|3979577|P2|STARTED|Overall Study||29
1627888|NCT00846066|3979578|P1|STARTED|Overall Study||27
1627889|NCT00846053|3979592|P2|NOT COMPLETED|Overall Study||0
1627890|NCT00846053|3979593|P1|NOT COMPLETED|Overall Study||3
1627891|NCT00846053|3979592|P2|COMPLETED|Overall Study||8
1627892|NCT00846053|3979593|P1|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
1627893|NCT00846053|3979592|P2|STARTED|Overall Study||8
1627894|NCT00846053|3979593|P1|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
1627895|NCT00846027|3979601|P1|NOT COMPLETED|Overall Study||90
1627896|NCT00846027|3979601|P1|COMPLETED|Overall Study||0
1627897|NCT00846027|3979601|P1|Received Treatment|Overall Study||83
1627898|NCT00846027|3979601|P1|STARTED|Overall Study||90
1627899|NCT00845975|3979610|P2|NOT COMPLETED|Overall Study||0
1627900|NCT00845975|3979611|P1|NOT COMPLETED|Overall Study||0
1627901|NCT00845975|3979610|P2|COMPLETED|Overall Study||9
1627902|NCT00845975|3979611|P1|COMPLETED|Overall Study||9
1627903|NCT00845975|3979610|P2|STARTED|Overall Study||9
1627904|NCT00845975|3979611|P1|STARTED|Overall Study||9
1627905|NCT00845897|3979624|P3|NOT COMPLETED|Overall Study||3
1627906|NCT00845897|3979625|P2|NOT COMPLETED|Overall Study||5
1627907|NCT00845897|3979626|P1|NOT COMPLETED|Overall Study||2
1627908|NCT00845897|3979624|P3|COMPLETED|Overall Study||2
1627909|NCT00845897|3979625|P2|COMPLETED|Overall Study||2
1627910|NCT00845897|3979626|P1|COMPLETED|Overall Study||3
1627911|NCT00845897|3979624|P3|STARTED|Overall Study||5
1627912|NCT00845897|3979625|P2|STARTED|Overall Study||7
1627913|NCT00845897|3979626|P1|STARTED|Overall Study||5
1627914|NCT00845858|3979640|P3|NOT COMPLETED|Overall Study||8
1627915|NCT00845858|3979641|P2|NOT COMPLETED|Overall Study||12
1627916|NCT00845858|3979642|P1|NOT COMPLETED|Overall Study||8
1627917|NCT00845858|3979640|P3|COMPLETED|Overall Study||87
1627918|NCT00845858|3979641|P2|COMPLETED|Overall Study||84
1627919|NCT00845858|3979642|P1|COMPLETED|Overall Study||88
1627920|NCT00845858|3979640|P3|STARTED|Overall Study||95
1627921|NCT00845858|3979641|P2|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
1627922|NCT00845858|3979642|P1|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
1627923|NCT00845845|3979655|P2|NOT COMPLETED|Overall Study||4
1627924|NCT00845845|3979656|P1|NOT COMPLETED|Overall Study||0
1627925|NCT00845845|3979655|P2|COMPLETED|Overall Study||2
1627926|NCT00845845|3979656|P1|COMPLETED|Overall Study||3
1627927|NCT00845845|3979655|P2|STARTED|Overall Study||6
1627928|NCT00845845|3979656|P1|STARTED|Overall Study||3
1627929|NCT00845832|3979667|P3|NOT COMPLETED|Extended Safety Follow-Up||7
1627930|NCT00845832|3979668|P2|NOT COMPLETED|Extended Safety Follow-Up||0
1627931|NCT00845832|3979669|P1|NOT COMPLETED|Extended Safety Follow-Up||0
1627932|NCT00845832|3979667|P3|COMPLETED|Extended Safety Follow-Up||0
1627933|NCT00845832|3979668|P2|COMPLETED|Extended Safety Follow-Up||5
1627934|NCT00845832|3979669|P1|COMPLETED|Extended Safety Follow-Up||2
1627935|NCT00845832|3979667|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
1627936|NCT00845832|3979668|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
1627937|NCT00845832|3979669|P1|STARTED|Extended Safety Follow-Up||2
1627938|NCT00845832|3979667|P3|NOT COMPLETED|Safety Follow-Up||0
1627939|NCT00845832|3979668|P2|NOT COMPLETED|Safety Follow-Up||0
1627940|NCT00845832|3979669|P1|NOT COMPLETED|Safety Follow-Up||1
1627941|NCT00845832|3979667|P3|COMPLETED|Safety Follow-Up||12
1627942|NCT00845832|3979668|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
1627943|NCT00845832|3979669|P1|COMPLETED|Safety Follow-Up||2
1627944|NCT00845832|3979667|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
1627945|NCT00845832|3979668|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
1627946|NCT00845832|3979669|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
1627947|NCT00845832|3979667|P3|NOT COMPLETED|Treatment Period||0
1627948|NCT00845832|3979668|P2|NOT COMPLETED|Treatment Period||3
1627949|NCT00845832|3979669|P1|NOT COMPLETED|Treatment Period||1
1627950|NCT00845832|3979667|P3|COMPLETED|Treatment Period||10
1627951|NCT00845832|3979668|P2|COMPLETED|Treatment Period||7
1627952|NCT00845832|3979669|P1|COMPLETED|Treatment Period||3
1627953|NCT00845832|3979667|P3|STARTED|Treatment Period||10
1627954|NCT00845832|3979668|P2|STARTED|Treatment Period||10
1627955|NCT00845832|3979669|P1|STARTED|Treatment Period||4
1627956|NCT00845728|3979715|P2|NOT COMPLETED|Overall Study||342
1627957|NCT00845728|3979716|P1|NOT COMPLETED|Overall Study||386
1627958|NCT00845728|3979715|P2|COMPLETED|Overall Study||1379
1627959|NCT00845728|3979716|P1|COMPLETED|Overall Study||1337
1627960|NCT00845728|3979715|P2|Exposed|Overall Study||1718
1627961|NCT00845728|3979716|P1|Exposed|Overall Study||1721
1627962|NCT00845728|3979715|P2|STARTED|Overall Study||1721
1627963|NCT00845728|3979716|P1|STARTED|Overall Study||1723
1627964|NCT00845702|3979724|P1|NOT COMPLETED|Dotarem MRA||0
1627965|NCT00845702|3979724|P1|COMPLETED|Dotarem MRA||32
1627966|NCT00845702|3979724|P1|STARTED|Dotarem MRA||32
1627967|NCT00845702|3979724|P1|NOT COMPLETED|TOF MRA||1
1627968|NCT00845702|3979724|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
1627969|NCT00845702|3979724|P1|STARTED|TOF MRA||33
1627970|NCT00845676|3979730|P1|NOT COMPLETED|Overall Study||2
1627971|NCT00845676|3979730|P1|COMPLETED|Overall Study||19
1627972|NCT00845676|3979730|P1|STARTED|Overall Study||21
1627973|NCT00845663|3979736|P2|NOT COMPLETED|Overall Study||0
1627974|NCT00845663|3979737|P1|NOT COMPLETED|Overall Study||0
1627975|NCT00845663|3979736|P2|COMPLETED|Overall Study||49
1627976|NCT00845663|3979737|P1|COMPLETED|Overall Study||49
1627977|NCT00845663|3979736|P2|STARTED|Overall Study||49
1627978|NCT00845663|3979737|P1|STARTED|Overall Study||49
1627979|NCT00845650|3979791|P6|NOT COMPLETED|Overall Study||2
1627980|NCT00845650|3979792|P5|NOT COMPLETED|Overall Study||3
1627981|NCT00845650|3979793|P4|NOT COMPLETED|Overall Study||1
1627982|NCT00845650|3979794|P3|NOT COMPLETED|Overall Study||3
1627983|NCT00845650|3979795|P2|NOT COMPLETED|Overall Study||0
1627984|NCT00845650|3979796|P1|NOT COMPLETED|Overall Study||1
1627985|NCT00845650|3979791|P6|COMPLETED|Overall Study||15
1627986|NCT00845650|3979792|P5|COMPLETED|Overall Study||28
1627987|NCT00845650|3979793|P4|COMPLETED|Overall Study||13
1627988|NCT00845650|3979794|P3|COMPLETED|Overall Study||28
1627989|NCT00845650|3979795|P2|COMPLETED|Overall Study||5
1627990|NCT00845650|3979796|P1|COMPLETED|Overall Study||30
1627991|NCT00845650|3979791|P6|STARTED|Overall Study|1 subject not dosed|17
1627992|NCT00845650|3979792|P5|STARTED|Overall Study|2 subjects not dosed|31
1627993|NCT00845650|3979793|P4|STARTED|Overall Study||14
1627994|NCT00845650|3979794|P3|STARTED|Overall Study||31
1627995|NCT00845650|3979795|P2|STARTED|Overall Study||5
1627996|NCT00845650|3979796|P1|STARTED|Overall Study|1 subject not dosed|31
1627997|NCT00845520|3979834|P3|NOT COMPLETED|Overall Study||1
1627998|NCT00845520|3979835|P2|NOT COMPLETED|Overall Study||2
1627999|NCT00845520|3979836|P1|NOT COMPLETED|Overall Study||2
1628000|NCT00845520|3979834|P3|COMPLETED|Overall Study||23
1628001|NCT00845520|3979835|P2|COMPLETED|Overall Study||23
1628002|NCT00845520|3979836|P1|COMPLETED|Overall Study||23
1628003|NCT00845520|3979834|P3|STARTED|Overall Study||24
1628004|NCT00845520|3979835|P2|STARTED|Overall Study||25
1628005|NCT00845520|3979836|P1|STARTED|Overall Study||25
1628006|NCT00845507|3979852|P2|NOT COMPLETED|Overall Study||1
1628007|NCT00845507|3979853|P1|NOT COMPLETED|Overall Study||2
1628008|NCT00845507|3979852|P2|COMPLETED|Overall Study||29
1628009|NCT00845507|3979853|P1|COMPLETED|Overall Study||22
1628010|NCT00845507|3979852|P2|STARTED|Overall Study||30
1628011|NCT00845507|3979853|P1|STARTED|Overall Study||24
1628012|NCT00845481|3979861|P1|NOT COMPLETED|Overall Study||0
1628013|NCT00845481|3979861|P1|COMPLETED|Overall Study||24
1628014|NCT00845481|3979861|P1|STARTED|Overall Study||24
1628015|NCT00845429|3979873|P3|NOT COMPLETED|Overall Study||20
1628016|NCT00845429|3979874|P2|NOT COMPLETED|Overall Study||15
1628017|NCT00845429|3979875|P1|NOT COMPLETED|Overall Study||14
1628018|NCT00845429|3979873|P3|COMPLETED|Overall Study||224
1628019|NCT00845429|3979874|P2|COMPLETED|Overall Study||226
1628020|NCT00845429|3979875|P1|COMPLETED|Overall Study||230
1628021|NCT00845429|3979873|P3|STARTED|Overall Study||244
1628022|NCT00845429|3979874|P2|STARTED|Overall Study||241
1628023|NCT00845429|3979875|P1|STARTED|Overall Study||244
1628024|NCT00845195|3979894|P2|NOT COMPLETED|Overall Study||0
1628025|NCT00845195|3979895|P1|NOT COMPLETED|Overall Study||0
1628026|NCT00845195|3979894|P2|COMPLETED|Overall Study||75
1628027|NCT00845195|3979895|P1|COMPLETED|Overall Study||75
1628028|NCT00845195|3979894|P2|STARTED|Overall Study||75
1628029|NCT00845195|3979895|P1|STARTED|Overall Study||75
1628030|NCT00845182|3979910|P3|NOT COMPLETED|Overall Study||6
1628031|NCT00845182|3979911|P2|NOT COMPLETED|Overall Study||4
1628032|NCT00845182|3979912|P1|NOT COMPLETED|Overall Study||3
1628033|NCT00845182|3979910|P3|COMPLETED|Overall Study||9
1628034|NCT00845182|3979911|P2|COMPLETED|Overall Study||11
1628035|NCT00845182|3979912|P1|COMPLETED|Overall Study||10
1628036|NCT00845182|3979910|P3|STARTED|Overall Study||15
1628037|NCT00845182|3979911|P2|STARTED|Overall Study||15
1628038|NCT00845182|3979912|P1|STARTED|Overall Study||13
1628039|NCT00845130|3979926|P2|NOT COMPLETED|Overall Study||3
1628040|NCT00845130|3979927|P1|NOT COMPLETED|Overall Study||4
1628041|NCT00845130|3979926|P2|COMPLETED|Overall Study||19
1628042|NCT00845130|3979927|P1|COMPLETED|Overall Study||16
1628043|NCT00845130|3979926|P2|STARTED|Overall Study||22
1628044|NCT00845130|3979927|P1|STARTED|Overall Study||20
1628045|NCT00845065|3979937|P2|NOT COMPLETED|Overall Study||55
1628046|NCT00845065|3979938|P1|NOT COMPLETED|Overall Study||47
1628047|NCT00845065|3979937|P2|COMPLETED|Overall Study||79
1628048|NCT00845065|3979938|P1|COMPLETED|Overall Study||20
1628049|NCT00845065|3979937|P2|STARTED|Overall Study||134
1628050|NCT00845065|3979938|P1|STARTED|Overall Study||67
1628051|NCT00845039|3979954|P2|NOT COMPLETED|Overall Study||0
1628052|NCT00845039|3979955|P1|NOT COMPLETED|Overall Study||0
1628053|NCT00845039|3979954|P2|COMPLETED|Overall Study||2
1628054|NCT00845039|3979955|P1|COMPLETED|Overall Study||2
1628055|NCT00845039|3979954|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
1628056|NCT00845039|3979955|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
1628057|NCT00845039|3979954|P2|STARTED|Overall Study||2
1628058|NCT00845039|3979955|P1|STARTED|Overall Study||2
1628059|NCT00845000|3979982|P6|NOT COMPLETED|Period 3||0
1628060|NCT00845000|3979983|P5|NOT COMPLETED|Period 3||0
1628061|NCT00845000|3979984|P4|NOT COMPLETED|Period 3||0
1628062|NCT00845000|3979985|P3|NOT COMPLETED|Period 3||0
1628063|NCT00845000|3979986|P2|NOT COMPLETED|Period 3||0
1628064|NCT00845000|3979987|P1|NOT COMPLETED|Period 3||0
1628065|NCT00845000|3979982|P6|COMPLETED|Period 3||2
1628066|NCT00845000|3979983|P5|COMPLETED|Period 3||2
1628067|NCT00845000|3979984|P4|COMPLETED|Period 3||2
1628068|NCT00845000|3979985|P3|COMPLETED|Period 3||2
1628069|NCT00845000|3979986|P2|COMPLETED|Period 3||2
1628070|NCT00845000|3979987|P1|COMPLETED|Period 3||2
1628071|NCT00845000|3979982|P6|STARTED|Period 3||2
1628072|NCT00845000|3979983|P5|STARTED|Period 3||2
1628073|NCT00845000|3979984|P4|STARTED|Period 3||2
1628074|NCT00845000|3979985|P3|STARTED|Period 3||2
1628075|NCT00845000|3979986|P2|STARTED|Period 3||2
1628076|NCT00845000|3979987|P1|STARTED|Period 3||2
1628077|NCT00845000|3979982|P6|NOT COMPLETED|Period 2||0
1628078|NCT00845000|3979983|P5|NOT COMPLETED|Period 2||0
1628079|NCT00845000|3979984|P4|NOT COMPLETED|Period 2||0
1628080|NCT00845000|3979985|P3|NOT COMPLETED|Period 2||0
1628081|NCT00845000|3979986|P2|NOT COMPLETED|Period 2||0
1628082|NCT00845000|3979987|P1|NOT COMPLETED|Period 2||0
1628083|NCT00845000|3979982|P6|COMPLETED|Period 2||2
1628084|NCT00845000|3979983|P5|COMPLETED|Period 2||2
1628085|NCT00845000|3979984|P4|COMPLETED|Period 2||2
1628086|NCT00845000|3979985|P3|COMPLETED|Period 2||2
1628087|NCT00845000|3979986|P2|COMPLETED|Period 2||2
1628088|NCT00845000|3979987|P1|COMPLETED|Period 2||2
1628089|NCT00845000|3979982|P6|STARTED|Period 2||2
1628090|NCT00845000|3979983|P5|STARTED|Period 2||2
1628091|NCT00845000|3979984|P4|STARTED|Period 2||2
1628092|NCT00845000|3979985|P3|STARTED|Period 2||2
1628093|NCT00845000|3979986|P2|STARTED|Period 2||2
1628094|NCT00845000|3979987|P1|STARTED|Period 2||2
1628095|NCT00845000|3979982|P6|NOT COMPLETED|Period 1||0
1628096|NCT00845000|3979983|P5|NOT COMPLETED|Period 1||0
1628097|NCT00845000|3979984|P4|NOT COMPLETED|Period 1||0
1628098|NCT00845000|3979985|P3|NOT COMPLETED|Period 1||0
1628099|NCT00845000|3979986|P2|NOT COMPLETED|Period 1||0
1628100|NCT00845000|3979987|P1|NOT COMPLETED|Period 1||0
1628101|NCT00845000|3979982|P6|COMPLETED|Period 1||2
1628102|NCT00845000|3979983|P5|COMPLETED|Period 1||2
1628103|NCT00845000|3979984|P4|COMPLETED|Period 1||2
1628104|NCT00845000|3979985|P3|COMPLETED|Period 1||2
1628105|NCT00845000|3979986|P2|COMPLETED|Period 1||2
1628106|NCT00845000|3979987|P1|COMPLETED|Period 1||2
1628107|NCT00845000|3979982|P6|STARTED|Period 1||2
1628108|NCT00845000|3979983|P5|STARTED|Period 1||2
1628109|NCT00845000|3979984|P4|STARTED|Period 1||2
1628110|NCT00845000|3979985|P3|STARTED|Period 1||2
1628111|NCT00845000|3979986|P2|STARTED|Period 1||2
1628112|NCT00845000|3979987|P1|STARTED|Period 1||2
1628113|NCT00844896|3980006|P2|NOT COMPLETED|Overall Study||17
1628114|NCT00844896|3980007|P1|NOT COMPLETED|Overall Study||12
1628115|NCT00844896|3980006|P2|COMPLETED|Overall Study||11
1628116|NCT00844896|3980007|P1|COMPLETED|Overall Study||17
1628117|NCT00844896|3980006|P2|STARTED|Overall Study||28
1628118|NCT00844896|3980007|P1|STARTED|Overall Study||29
1628119|NCT00844883|3980029|P1|NOT COMPLETED|Overall Study||4
1628120|NCT00844883|3980029|P1|COMPLETED|Overall Study||46
1628121|NCT00844883|3980029|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
1628122|NCT00844883|3980029|P1|STARTED|Overall Study||50
1628123|NCT00844857|3980041|P2|NOT COMPLETED|Overall Study||37
1628124|NCT00844857|3980042|P1|NOT COMPLETED|Overall Study||78
1628125|NCT00844857|3980041|P2|COMPLETED|Overall Study||60
1628126|NCT00844857|3980042|P1|COMPLETED|Overall Study||116
1628127|NCT00844857|3980041|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
1628128|NCT00844857|3980042|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
1628129|NCT00844857|3980041|P2|STARTED|Overall Study||97
1628130|NCT00844857|3980042|P1|STARTED|Overall Study||194
1628131|NCT00844844|3980086|P1|NOT COMPLETED|Post Treatment Period||1
1628132|NCT00844844|3980086|P1|COMPLETED|Post Treatment Period||5
1628133|NCT00844844|3980086|P1|STARTED|Post Treatment Period||6
1628134|NCT00844844|3980086|P1|NOT COMPLETED|Extension Treatment Period||2
1628135|NCT00844844|3980086|P1|COMPLETED|Extension Treatment Period||11
1628136|NCT00844844|3980086|P1|STARTED|Extension Treatment Period||13
1628137|NCT00844844|3980086|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
1628138|NCT00844844|3980086|P1|COMPLETED|Treatment Period (26 Weeks)||15
1628139|NCT00844844|3980086|P1|STARTED|Treatment Period (26 Weeks)||17
1628140|NCT00844844|3980086|P1|NOT COMPLETED|Screening Period||0
1628141|NCT00844844|3980086|P1|COMPLETED|Screening Period||17
1628142|NCT00844844|3980086|P1|STARTED|Screening Period||17
1628143|NCT00844831|3980100|P1|NOT COMPLETED|Overall Study||6
1628144|NCT00844831|3980100|P1|COMPLETED|Overall Study||19
1628145|NCT00844831|3980100|P1|STARTED|Overall Study||25
1628146|NCT00844805|3980110|P4|NOT COMPLETED|Follow-Up Phase||9
1628147|NCT00844805|3980111|P3|NOT COMPLETED|Follow-Up Phase||9
1628148|NCT00844805|3980112|P2|NOT COMPLETED|Follow-Up Phase||0
1628149|NCT00844805|3980113|P1|NOT COMPLETED|Follow-Up Phase||0
1628150|NCT00844805|3980110|P4|COMPLETED|Follow-Up Phase||32
1628151|NCT00844805|3980111|P3|COMPLETED|Follow-Up Phase||32
1628152|NCT00844805|3980112|P2|COMPLETED|Follow-Up Phase||0
1628153|NCT00844805|3980113|P1|COMPLETED|Follow-Up Phase||0
1628154|NCT00844805|3980110|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
1628155|NCT00844805|3980111|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
1628156|NCT00844805|3980112|P2|STARTED|Follow-Up Phase||0
1628157|NCT00844805|3980113|P1|STARTED|Follow-Up Phase||0
1628158|NCT00844805|3980110|P4|NOT COMPLETED|Treatment Phase||0
1628159|NCT00844805|3980111|P3|NOT COMPLETED|Treatment Phase||0
1628160|NCT00844805|3980112|P2|NOT COMPLETED|Treatment Phase||7
1628161|NCT00844805|3980113|P1|NOT COMPLETED|Treatment Phase||10
1628162|NCT00844805|3980110|P4|COMPLETED|Treatment Phase||0
1628163|NCT00844805|3980111|P3|COMPLETED|Treatment Phase||0
1628164|NCT00844805|3980112|P2|COMPLETED|Treatment Phase||45
1628165|NCT00844805|3980113|P1|COMPLETED|Treatment Phase||96
1628166|NCT00844805|3980110|P4|STARTED|Treatment Phase||0
1628167|NCT00844805|3980111|P3|STARTED|Treatment Phase||0
1628168|NCT00844805|3980112|P2|STARTED|Treatment Phase||52
1628169|NCT00844805|3980113|P1|STARTED|Treatment Phase||106
1628170|NCT00844753|3980157|P4|NOT COMPLETED|Overall Study||11
1628171|NCT00844753|3980158|P3|NOT COMPLETED|Overall Study||7
1628172|NCT00844753|3980159|P2|NOT COMPLETED|Overall Study||3
1628173|NCT00844753|3980160|P1|NOT COMPLETED|Overall Study||8
1628174|NCT00844753|3980157|P4|COMPLETED|Overall Study||21
1628175|NCT00844753|3980158|P3|COMPLETED|Overall Study||25
1628176|NCT00844753|3980159|P2|COMPLETED|Overall Study||29
1628177|NCT00844753|3980160|P1|COMPLETED|Overall Study||24
1628178|NCT00844753|3980157|P4|STARTED|Overall Study||32
1628179|NCT00844753|3980158|P3|STARTED|Overall Study||32
1628180|NCT00844753|3980159|P2|STARTED|Overall Study||32
1628181|NCT00844753|3980160|P1|STARTED|Overall Study||32
1628182|NCT00844714|3980172|P1|NOT COMPLETED|Overall Study||0
1628183|NCT00844714|3980172|P1|COMPLETED|Overall Study||20
1628184|NCT00844714|3980172|P1|STARTED|Overall Study||20
1628185|NCT00844649|3980178|P2|NOT COMPLETED|Overall Study||418
1628186|NCT00844649|3980179|P1|NOT COMPLETED|Overall Study||405
1628187|NCT00844649|3980178|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
1628188|NCT00844649|3980179|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
1628189|NCT00844649|3980178|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
1628190|NCT00844649|3980179|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
1628191|NCT00844649|3980178|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
1628192|NCT00844649|3980179|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
1628193|NCT00844597|3980203|P6|NOT COMPLETED|Overall Study||0
1628194|NCT00844597|3980204|P5|NOT COMPLETED|Overall Study||0
1628195|NCT00844597|3980205|P4|NOT COMPLETED|Overall Study||1
1628196|NCT00844597|3980206|P3|NOT COMPLETED|Overall Study||0
1628197|NCT00844597|3980207|P2|NOT COMPLETED|Overall Study||0
1628198|NCT00844597|3980208|P1|NOT COMPLETED|Overall Study||0
1628199|NCT00844597|3980203|P6|COMPLETED|Overall Study||4
1628200|NCT00844597|3980204|P5|COMPLETED|Overall Study||4
1628201|NCT00844597|3980205|P4|COMPLETED|Overall Study||2
1628202|NCT00844597|3980206|P3|COMPLETED|Overall Study||2
1628203|NCT00844597|3980207|P2|COMPLETED|Overall Study||2
1628204|NCT00844597|3980208|P1|COMPLETED|Overall Study||4
1628205|NCT00844597|3980203|P6|STARTED|Overall Study||4
1628206|NCT00844597|3980204|P5|STARTED|Overall Study||4
1628207|NCT00844597|3980205|P4|STARTED|Overall Study||3
1628208|NCT00844597|3980206|P3|STARTED|Overall Study||2
1628209|NCT00844597|3980207|P2|STARTED|Overall Study||2
1628210|NCT00844597|3980208|P1|STARTED|Overall Study||4
1628211|NCT00844558|3980228|P2|NOT COMPLETED|Overall Study||4
1628212|NCT00844558|3980229|P1|NOT COMPLETED|Overall Study||12
1628213|NCT00844558|3980228|P2|COMPLETED|Overall Study||18
1628214|NCT00844558|3980229|P1|COMPLETED|Overall Study||24
1628215|NCT00844558|3980228|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
1628216|NCT00844558|3980229|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
1628217|NCT00844558|3980228|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
1628218|NCT00844558|3980229|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
1628219|NCT00844558|3980228|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
1628220|NCT00844558|3980229|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
1628221|NCT00844558|3980228|P2|Received Allocated Intervention|Overall Study||21
1628222|NCT00844558|3980229|P1|Received Allocated Intervention|Overall Study||33
1628223|NCT00844558|3980228|P2|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
1628224|NCT00844558|3980229|P1|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
1628225|NCT00844545|3980245|P1|NOT COMPLETED|Post Treatment Period||1
1628226|NCT00844545|3980245|P1|COMPLETED|Post Treatment Period||5
1628227|NCT00844545|3980245|P1|STARTED|Post Treatment Period||6
1628228|NCT00844545|3980245|P1|NOT COMPLETED|Extension Treatment Period||2
1628229|NCT00844545|3980245|P1|COMPLETED|Extension Treatment Period||11
1628230|NCT00844545|3980245|P1|STARTED|Extension Treatment Period||13
1628231|NCT00844545|3980245|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
1628232|NCT00844545|3980245|P1|COMPLETED|Treatment Period (26 Weeks)||15
1628233|NCT00844545|3980245|P1|STARTED|Treatment Period (26 Weeks)||17
1628234|NCT00844545|3980245|P1|NOT COMPLETED|Screening Period||0
1628235|NCT00844545|3980245|P1|COMPLETED|Screening Period||17
1628236|NCT00844545|3980245|P1|STARTED|Screening Period||17
1628237|NCT00844532|3980259|P1|NOT COMPLETED|Overall Study||39
1628238|NCT00844532|3980259|P1|COMPLETED|Overall Study||112
1628239|NCT00844532|3980259|P1|STARTED|Overall Study||151
1628240|NCT00844519|3980345|P2|NOT COMPLETED|Overall Study||1
1628241|NCT00844519|3980346|P1|NOT COMPLETED|Overall Study||2
1628242|NCT00844519|3980345|P2|COMPLETED|Overall Study||25
1628243|NCT00844519|3980346|P1|COMPLETED|Overall Study||24
1628244|NCT00844519|3980345|P2|STARTED|Overall Study||26
1628245|NCT00844519|3980346|P1|STARTED|Overall Study||26
1628246|NCT00844480|3980354|P2|NOT COMPLETED|Overall Study||3
1628247|NCT00844480|3980355|P1|NOT COMPLETED|Overall Study||2
1628248|NCT00844480|3980354|P2|COMPLETED|Overall Study||6
1628249|NCT00844480|3980355|P1|COMPLETED|Overall Study||6
1628250|NCT00844480|3980354|P2|STARTED|Overall Study||9
1628251|NCT00844480|3980355|P1|STARTED|Overall Study||8
1628252|NCT00844428|3980363|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
1628253|NCT00844428|3980363|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
1628254|NCT00844428|3980363|P1|STARTED|Post Treatment Period (Patients Who Disc||5
1628255|NCT00844428|3980363|P1|NOT COMPLETED|Extension Treatment Period||1
1628256|NCT00844428|3980363|P1|COMPLETED|Extension Treatment Period||18
1628257|NCT00844428|3980363|P1|STARTED|Extension Treatment Period||19
1628258|NCT00844428|3980363|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
1628259|NCT00844428|3980363|P1|COMPLETED|Treatment Period (26 Weeks)||20
1628260|NCT00844428|3980363|P1|STARTED|Treatment Period (26 Weeks)||20
1628261|NCT00844428|3980363|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
1628262|NCT00844428|3980363|P1|COMPLETED|Observation Period (8 Weeks)||20
1628263|NCT00844428|3980363|P1|STARTED|Observation Period (8 Weeks)||20
1628264|NCT00844428|3980363|P1|NOT COMPLETED|Screening Period||3
1628265|NCT00844428|3980363|P1|COMPLETED|Screening Period||20
1628266|NCT00844428|3980363|P1|STARTED|Screening Period||23
1628267|NCT00844415|3980379|P1|NOT COMPLETED|Overall Study||1
1628268|NCT00844415|3980379|P1|COMPLETED|Overall Study|Completed.|8
1628269|NCT00844415|3980379|P1|Pat. Received Single Dose 75mg|Overall Study||1
1628270|NCT00844415|3980379|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
1628271|NCT00844415|3980379|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
1628272|NCT00844415|3980379|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
1628273|NCT00844415|3980379|P1|STARTED|Overall Study|Entered and treated.|9
1628274|NCT00844376|3980393|P2|NOT COMPLETED|Period 2: Second Intervention||0
1628275|NCT00844376|3980394|P1|NOT COMPLETED|Period 2: Second Intervention||0
1628276|NCT00844376|3980393|P2|COMPLETED|Period 2: Second Intervention||6
1628277|NCT00844376|3980394|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
1628278|NCT00844376|3980393|P2|STARTED|Period 2: Second Intervention||6
1628279|NCT00844376|3980394|P1|STARTED|Period 2: Second Intervention||5
1628280|NCT00844376|3980393|P2|NOT COMPLETED|Period 1: First Intervention||0
1628281|NCT00844376|3980394|P1|NOT COMPLETED|Period 1: First Intervention||1
1628282|NCT00844376|3980393|P2|COMPLETED|Period 1: First Intervention||6
1628283|NCT00844376|3980394|P1|COMPLETED|Period 1: First Intervention||5
1628284|NCT00844376|3980393|P2|STARTED|Period 1: First Intervention||6
1628285|NCT00844376|3980394|P1|STARTED|Period 1: First Intervention||6
1628286|NCT00844298|3980412|P1|NOT COMPLETED|Overall Study||0
1628287|NCT00844298|3980412|P1|COMPLETED|Overall Study||91
1628288|NCT00844298|3980412|P1|STARTED|Overall Study||91
1628289|NCT00844194|3980418|P2|NOT COMPLETED|Overall Study||8
1628290|NCT00844194|3980419|P1|NOT COMPLETED|Overall Study||25
1628291|NCT00844194|3980418|P2|COMPLETED|Overall Study||22
1628292|NCT00844194|3980419|P1|COMPLETED|Overall Study||53
1628293|NCT00844194|3980418|P2|STARTED|Overall Study||30
1628294|NCT00844194|3980419|P1|STARTED|Overall Study||78
1628295|NCT00844090|3980625|P2|NOT COMPLETED|Overall Study||8
1628296|NCT00844090|3980626|P1|NOT COMPLETED|Overall Study||6
1628297|NCT00844090|3980625|P2|COMPLETED|Overall Study||46
1628298|NCT00844090|3980626|P1|COMPLETED|Overall Study||46
1628299|NCT00844090|3980625|P2|STARTED|Overall Study||54
1628300|NCT00844090|3980626|P1|STARTED|Overall Study||52
1628301|NCT00844051|3980634|P2|NOT COMPLETED|Overall Study||0
1628302|NCT00844051|3980635|P1|NOT COMPLETED|Overall Study||0
1628303|NCT00844051|3980634|P2|COMPLETED|Overall Study||2368
1628304|NCT00844051|3980635|P1|COMPLETED|Overall Study||2087
1628305|NCT00844051|3980634|P2|STARTED|Overall Study||2368
1628306|NCT00844051|3980635|P1|STARTED|Overall Study||2087
1628307|NCT00843986|3980645|P2|NOT COMPLETED|Overall Study||1
1628308|NCT00843986|3980646|P1|NOT COMPLETED|Overall Study||1
1628309|NCT00843986|3980645|P2|COMPLETED|Overall Study||5
1628310|NCT00843986|3980646|P1|COMPLETED|Overall Study||2
1628311|NCT00843986|3980645|P2|Completed Treatment (Infusion)|Overall Study||6
1628312|NCT00843986|3980646|P1|Completed Treatment (Infusion)|Overall Study||2
1628313|NCT00843986|3980645|P2|STARTED|Overall Study||6
1628314|NCT00843986|3980646|P1|STARTED|Overall Study||3
1628315|NCT00843843|3980674|P2|NOT COMPLETED|Overall Study||2
1628316|NCT00843843|3980675|P1|NOT COMPLETED|Overall Study||2
1628317|NCT00843843|3980674|P2|COMPLETED|Overall Study||6
1628318|NCT00843843|3980675|P1|COMPLETED|Overall Study||6
1628319|NCT00843843|3980674|P2|STARTED|Overall Study||8
1628320|NCT00843843|3980675|P1|STARTED|Overall Study||8
1628321|NCT00843830|3980683|P1|NOT COMPLETED|Overall Study||0
1628322|NCT00843830|3980683|P1|COMPLETED|Overall Study||4
1628323|NCT00843830|3980683|P1|STARTED|Overall Study||4
1628324|NCT00843778|3980688|P1|NOT COMPLETED|Overall Study||35
1628325|NCT00843778|3980688|P1|COMPLETED|Overall Study||96
1628326|NCT00843778|3980688|P1|STARTED|Overall Study||131
1628327|NCT00843713|3980723|P2|NOT COMPLETED|Overall Study||0
1628328|NCT00843713|3980724|P1|NOT COMPLETED|Overall Study||0
1628329|NCT00843713|3980723|P2|COMPLETED|Overall Study||26
1628330|NCT00843713|3980724|P1|COMPLETED|Overall Study||30
1628331|NCT00843713|3980723|P2|STARTED|Overall Study||26
1628332|NCT00843713|3980724|P1|STARTED|Overall Study||30
1628333|NCT00843635|3980733|P3|NOT COMPLETED|Overall Study||0
1628334|NCT00843635|3980734|P2|NOT COMPLETED|Overall Study||2
1628335|NCT00843635|3980735|P1|NOT COMPLETED|Overall Study||2
1628336|NCT00843635|3980733|P3|COMPLETED|Overall Study||5
1628337|NCT00843635|3980734|P2|COMPLETED|Overall Study||13
1628338|NCT00843635|3980735|P1|COMPLETED|Overall Study||13
1628339|NCT00843635|3980733|P3|STARTED|Overall Study||5
1628340|NCT00843635|3980734|P2|STARTED|Overall Study||15
1628341|NCT00843635|3980735|P1|STARTED|Overall Study||15
1628342|NCT00843622|3980755|P2|NOT COMPLETED|Overall Study||55
1628343|NCT00843622|3980756|P1|NOT COMPLETED|Overall Study||43
1628344|NCT00843622|3980755|P2|COMPLETED|Overall Study||70
1628345|NCT00843622|3980756|P1|COMPLETED|Overall Study||82
1628346|NCT00843622|3980755|P2|STARTED|Overall Study||125
1628347|NCT00843622|3980756|P1|STARTED|Overall Study||125
1628348|NCT00843518|3980764|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
1628349|NCT00843518|3980765|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
1628350|NCT00843518|3980764|P2|COMPLETED|Period 3 (Single-blind Washout)||49
1628351|NCT00843518|3980765|P1|COMPLETED|Period 3 (Single-blind Washout)||42
1628352|NCT00843518|3980764|P2|STARTED|Period 3 (Single-blind Washout)||49
1628353|NCT00843518|3980765|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
1628354|NCT00843518|3980764|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
1628355|NCT00843518|3980765|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
1628356|NCT00843518|3980764|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
1628357|NCT00843518|3980765|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
1628358|NCT00843518|3980764|P2|STARTED|Period 2 (Double-blind Treatment)||69
1628359|NCT00843518|3980765|P1|STARTED|Period 2 (Double-blind Treatment)||63
1628360|NCT00843492|3980795|P2|NOT COMPLETED|Overall Study||14
1628361|NCT00843492|3980796|P1|NOT COMPLETED|Overall Study||8
1628362|NCT00843492|3980795|P2|COMPLETED|Overall Study||607
1628363|NCT00843492|3980796|P1|COMPLETED|Overall Study||614
1628364|NCT00843492|3980795|P2|STARTED|Overall Study||621
1628365|NCT00843492|3980796|P1|STARTED|Overall Study||622
1628366|NCT00843479|3980816|P2|NOT COMPLETED|Overall Study||0
1628367|NCT00843479|3980817|P1|NOT COMPLETED|Overall Study||0
1628368|NCT00843479|3980816|P2|COMPLETED|Overall Study||12
1628369|NCT00843479|3980817|P1|COMPLETED|Overall Study||12
1628370|NCT00843479|3980816|P2|STARTED|Overall Study||12
1628371|NCT00843479|3980817|P1|STARTED|Overall Study||12
1628372|NCT00843466|3980835|P2|NOT COMPLETED|Overall Study||0
1628373|NCT00843466|3980836|P1|NOT COMPLETED|Overall Study||0
1628374|NCT00843466|3980835|P2|COMPLETED|Overall Study||18
1628375|NCT00843466|3980836|P1|COMPLETED|Overall Study||24
1628376|NCT00843466|3980835|P2|STARTED|Overall Study||18
1628377|NCT00843466|3980836|P1|STARTED|Overall Study||24
1628378|NCT00843349|3980846|P4|NOT COMPLETED|Overall Study||1
1628379|NCT00843349|3980847|P3|NOT COMPLETED|Overall Study||0
1628380|NCT00843349|3980848|P2|NOT COMPLETED|Overall Study||0
1628381|NCT00843349|3980849|P1|NOT COMPLETED|Overall Study||3
1628382|NCT00843349|3980846|P4|COMPLETED|Overall Study||10
1628383|NCT00843349|3980847|P3|COMPLETED|Overall Study||10
1628384|NCT00843349|3980848|P2|COMPLETED|Overall Study||11
1628385|NCT00843349|3980849|P1|COMPLETED|Overall Study||8
1628386|NCT00843349|3980846|P4|STARTED|Overall Study||11
1628387|NCT00843349|3980847|P3|STARTED|Overall Study||10
1628388|NCT00843349|3980848|P2|STARTED|Overall Study||11
1628389|NCT00843349|3980849|P1|STARTED|Overall Study||11
1628390|NCT00843310|3980863|P1|NOT COMPLETED|Overall Study||7
1628391|NCT00843310|3980863|P1|COMPLETED|Overall Study||1
1628392|NCT00843310|3980863|P1|STARTED|Overall Study||8
1628393|NCT00843284|3980867|P1|NOT COMPLETED|Overall Study||72
1628394|NCT00843284|3980867|P1|COMPLETED|Overall Study||619
1628395|NCT00843284|3980867|P1|STARTED|Overall Study||691
1628396|NCT00843193|3980877|P2|NOT COMPLETED|Overall Study||11
1628397|NCT00843193|3980878|P1|NOT COMPLETED|Overall Study||8
1628398|NCT00843193|3980877|P2|COMPLETED|Overall Study||88
1628399|NCT00843193|3980878|P1|COMPLETED|Overall Study||91
1628400|NCT00843193|3980877|P2|STARTED|Overall Study||99
1628401|NCT00843193|3980878|P1|STARTED|Overall Study||99
1628402|NCT00843180|3980914|P2|NOT COMPLETED|Overall Study||0
1628403|NCT00843180|3980915|P1|NOT COMPLETED|Overall Study||0
1628404|NCT00843180|3980914|P2|COMPLETED|Overall Study||7
1628405|NCT00843180|3980915|P1|COMPLETED|Overall Study||16
1628406|NCT00843180|3980914|P2|STARTED|Overall Study||7
1628407|NCT00843180|3980915|P1|STARTED|Overall Study||16
1628408|NCT00843167|3980929|P2|NOT COMPLETED|Follow-up||0
1628409|NCT00843167|3980930|P1|NOT COMPLETED|Follow-up||0
1628410|NCT00843167|3980929|P2|COMPLETED|Follow-up||24
1628411|NCT00843167|3980930|P1|COMPLETED|Follow-up||24
1628412|NCT00843167|3980929|P2|Completed Final Visit|Follow-up||24
1628413|NCT00843167|3980930|P1|Completed Final Visit|Follow-up||24
1628414|NCT00843167|3980929|P2|STARTED|Follow-up||24
1628415|NCT00843167|3980930|P1|STARTED|Follow-up||24
1628416|NCT00843167|3980929|P2|NOT COMPLETED|Treatment Period||8
1628417|NCT00843167|3980930|P1|NOT COMPLETED|Treatment Period||3
1628418|NCT00843167|3980929|P2|COMPLETED|Treatment Period||19
1628419|NCT00843167|3980930|P1|COMPLETED|Treatment Period||24
1628420|NCT00843167|3980929|P2|STARTED|Treatment Period||27
1628421|NCT00843167|3980930|P1|STARTED|Treatment Period||27
1628422|NCT00843115|3980943|P1|NOT COMPLETED|Overall Study||66
1628423|NCT00843115|3980943|P1|COMPLETED|Overall Study||304
1628424|NCT00843115|3980943|P1|STARTED|Overall Study||370
1628425|NCT00843050|3980989|P1|NOT COMPLETED|Overall Study||13
1628426|NCT00843050|3980989|P1|COMPLETED|Overall Study||0
1628427|NCT00843050|3980989|P1|STARTED|Overall Study||13
1628428|NCT00843024|3980999|P6|NOT COMPLETED|Double-blind Treatment Phase||25
1628429|NCT00843024|3981000|P5|NOT COMPLETED|Double-blind Treatment Phase||20
1628430|NCT00843024|3981001|P4|NOT COMPLETED|Double-blind Treatment Phase||23
1628431|NCT00843024|3981002|P3|NOT COMPLETED|Double-blind Treatment Phase||31
1628432|NCT00843024|3981003|P2|NOT COMPLETED|Double-blind Treatment Phase||0
1628433|NCT00843024|3981004|P1|NOT COMPLETED|Double-blind Treatment Phase||0
1628434|NCT00843024|3980999|P6|COMPLETED|Double-blind Treatment Phase||152
1628435|NCT00843024|3981000|P5|COMPLETED|Double-blind Treatment Phase||97
1628436|NCT00843024|3981001|P4|COMPLETED|Double-blind Treatment Phase||96
1628437|NCT00843024|3981002|P3|COMPLETED|Double-blind Treatment Phase||145
1628438|NCT00843024|3981003|P2|COMPLETED|Double-blind Treatment Phase||0
1628439|NCT00843024|3981004|P1|COMPLETED|Double-blind Treatment Phase||0
1628440|NCT00843024|3980999|P6|STARTED|Double-blind Treatment Phase||177
1628441|NCT00843024|3981000|P5|STARTED|Double-blind Treatment Phase||117
1628442|NCT00843024|3981001|P4|STARTED|Double-blind Treatment Phase||119
1628443|NCT00843024|3981002|P3|STARTED|Double-blind Treatment Phase||176
1628444|NCT00843024|3981003|P2|STARTED|Double-blind Treatment Phase||0
1628445|NCT00843024|3981004|P1|STARTED|Double-blind Treatment Phase||0
1628446|NCT00843024|3980999|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1628447|NCT00843024|3981000|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1628448|NCT00843024|3981001|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1628449|NCT00843024|3981002|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1628450|NCT00843024|3981003|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
1628451|NCT00843024|3981004|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
1628452|NCT00843024|3980999|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
1628453|NCT00843024|3981000|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
1628454|NCT00843024|3981001|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
1628455|NCT00843024|3981002|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
1628456|NCT00843024|3981003|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
1628457|NCT00843024|3981004|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
1628458|NCT00843024|3980999|P6|STARTED|Single-blind Placebo Run-In Phase||0
1628459|NCT00843024|3981000|P5|STARTED|Single-blind Placebo Run-In Phase||0
1628460|NCT00843024|3981001|P4|STARTED|Single-blind Placebo Run-In Phase||0
1628461|NCT00843024|3981002|P3|STARTED|Single-blind Placebo Run-In Phase||0
1628462|NCT00843024|3981003|P2|STARTED|Single-blind Placebo Run-In Phase||457
1628463|NCT00843024|3981004|P1|STARTED|Single-blind Placebo Run-In Phase||408
1628464|NCT00842985|3981069|P1|NOT COMPLETED|Fourth Intervention||0
1628465|NCT00842985|3981069|P1|COMPLETED|Fourth Intervention||15
1628466|NCT00842985|3981069|P1|STARTED|Fourth Intervention||15
1628467|NCT00842985|3981069|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
1628468|NCT00842985|3981069|P1|COMPLETED|Washout Period of GE 4 Days||15
1628469|NCT00842985|3981069|P1|STARTED|Washout Period of GE 4 Days||15
1628470|NCT00842985|3981069|P1|NOT COMPLETED|Third Intervention||0
1628471|NCT00842985|3981069|P1|COMPLETED|Third Intervention||15
1628472|NCT00842985|3981069|P1|STARTED|Third Intervention||15
1628473|NCT00842985|3981069|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
1628474|NCT00842985|3981069|P1|COMPLETED|Washout Period of GE 4 Days||15
1628475|NCT00842985|3981069|P1|STARTED|Washout Period of GE 4 Days||17
1628476|NCT00842985|3981069|P1|NOT COMPLETED|Second Intervention||1
1628477|NCT00842985|3981069|P1|COMPLETED|Second Intervention||17
1628478|NCT00842985|3981069|P1|STARTED|Second Intervention||18
1628479|NCT00842985|3981069|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
1628480|NCT00842985|3981069|P1|COMPLETED|Washout Period of GE 4 Days||18
1628481|NCT00842985|3981069|P1|STARTED|Washout Period of GE 4 Days||20
1628482|NCT00842985|3981069|P1|NOT COMPLETED|First Intervention||6
1628483|NCT00842985|3981069|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
1628484|NCT00842985|3981069|P1|STARTED|First Intervention|Signed Consent|26
1628485|NCT00842985|3981069|P1|NOT COMPLETED|Screening||27
1628486|NCT00842985|3981069|P1|COMPLETED|Screening||26
1628487|NCT00842985|3981069|P1|STARTED|Screening||53
1628488|NCT00842946|3981078|P2|NOT COMPLETED|Overall Study||5
1628489|NCT00842946|3981079|P1|NOT COMPLETED|Overall Study||5
1628490|NCT00842946|3981078|P2|COMPLETED|Overall Study||19
1628491|NCT00842946|3981079|P1|COMPLETED|Overall Study||16
1628492|NCT00842946|3981078|P2|STARTED|Overall Study||24
1628493|NCT00842946|3981079|P1|STARTED|Overall Study||21
1628494|NCT00842829|3981087|P3|NOT COMPLETED|Continuation Period||61
1628495|NCT00842829|3981088|P2|NOT COMPLETED|Continuation Period||0
1628496|NCT00842829|3981089|P1|NOT COMPLETED|Continuation Period||0
1628497|NCT00842829|3981087|P3|COMPLETED|Continuation Period||27
1628498|NCT00842829|3981088|P2|COMPLETED|Continuation Period||0
1628499|NCT00842829|3981089|P1|COMPLETED|Continuation Period||0
1628500|NCT00842829|3981087|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
1628501|NCT00842829|3981088|P2|Continuation Safety Analysis Set|Continuation Period||0
1628502|NCT00842829|3981089|P1|Continuation Safety Analysis Set|Continuation Period||0
1628503|NCT00842829|3981087|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
1628504|NCT00842829|3981088|P2|STARTED|Continuation Period||0
1628505|NCT00842829|3981089|P1|STARTED|Continuation Period||0
1628506|NCT00842829|3981087|P3|NOT COMPLETED|Treatment Period||63
1628507|NCT00842829|3981088|P2|NOT COMPLETED|Treatment Period||0
1628508|NCT00842829|3981089|P1|NOT COMPLETED|Treatment Period||0
1628509|NCT00842829|3981087|P3|COMPLETED|Treatment Period||218
1628510|NCT00842829|3981088|P2|COMPLETED|Treatment Period||0
1628511|NCT00842829|3981089|P1|COMPLETED|Treatment Period||0
1628512|NCT00842829|3981087|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
1628513|NCT00842829|3981088|P2|Safety Analysis Set|Treatment Period||0
1628514|NCT00842829|3981089|P1|Safety Analysis Set|Treatment Period||0
1628515|NCT00842829|3981087|P3|STARTED|Treatment Period||281
1628516|NCT00842829|3981088|P2|STARTED|Treatment Period||0
1628517|NCT00842829|3981089|P1|STARTED|Treatment Period||0
1628518|NCT00842829|3981087|P3|NOT COMPLETED|Dose Titration Period||0
1628519|NCT00842829|3981088|P2|NOT COMPLETED|Dose Titration Period||23
1628520|NCT00842829|3981089|P1|NOT COMPLETED|Dose Titration Period||26
1628521|NCT00842829|3981087|P3|COMPLETED|Dose Titration Period||0
1628522|NCT00842829|3981088|P2|COMPLETED|Dose Titration Period||151
1628523|NCT00842829|3981089|P1|COMPLETED|Dose Titration Period||130
1628524|NCT00842829|3981087|P3|Titration Safety Analysis Set|Dose Titration Period||0
1628525|NCT00842829|3981088|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
1628526|NCT00842829|3981089|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
1628527|NCT00842829|3981087|P3|STARTED|Dose Titration Period||0
1628528|NCT00842829|3981088|P2|STARTED|Dose Titration Period||174
1628529|NCT00842829|3981089|P1|STARTED|Dose Titration Period||156
1628530|NCT00842751|3981123|P1|NOT COMPLETED|Overall Study||0
1628531|NCT00842751|3981123|P1|COMPLETED|Overall Study||11
1628532|NCT00842751|3981123|P1|STARTED|Overall Study||11
1628533|NCT00842712|3981144|P7|NOT COMPLETED|Randomized Part||6
1628534|NCT00842712|3981145|P6|NOT COMPLETED|Randomized Part||1
1628535|NCT00842712|3981146|P5|NOT COMPLETED|Randomized Part||0
1628536|NCT00842712|3981147|P4|NOT COMPLETED|Randomized Part||0
1628537|NCT00842712|3981148|P3|NOT COMPLETED|Randomized Part||0
1628538|NCT00842712|3981149|P2|NOT COMPLETED|Randomized Part||0
1628539|NCT00842712|3981150|P1|NOT COMPLETED|Randomized Part||0
1628540|NCT00842712|3981144|P7|COMPLETED|Randomized Part||78
1628541|NCT00842712|3981145|P6|COMPLETED|Randomized Part||50
1628542|NCT00842712|3981146|P5|COMPLETED|Randomized Part||85
1628543|NCT00842712|3981147|P4|COMPLETED|Randomized Part||0
1628544|NCT00842712|3981148|P3|COMPLETED|Randomized Part||0
1628545|NCT00842712|3981149|P2|COMPLETED|Randomized Part||0
1628546|NCT00842712|3981150|P1|COMPLETED|Randomized Part||0
1628547|NCT00842712|3981144|P7|Treated|Randomized Part||80
1628548|NCT00842712|3981145|P6|Treated|Randomized Part||50
1628549|NCT00842712|3981146|P5|Treated|Randomized Part||85
1628550|NCT00842712|3981147|P4|Treated|Randomized Part||0
1628551|NCT00842712|3981148|P3|Treated|Randomized Part||0
1628552|NCT00842712|3981149|P2|Treated|Randomized Part||0
1628553|NCT00842712|3981150|P1|Treated|Randomized Part||0
1628554|NCT00842712|3981144|P7|STARTED|Randomized Part||84
1628555|NCT00842712|3981145|P6|STARTED|Randomized Part||51
1628556|NCT00842712|3981146|P5|STARTED|Randomized Part||85
1628557|NCT00842712|3981147|P4|STARTED|Randomized Part||0
1628558|NCT00842712|3981148|P3|STARTED|Randomized Part||0
1628559|NCT00842712|3981149|P2|STARTED|Randomized Part||0
1628560|NCT00842712|3981150|P1|STARTED|Randomized Part||0
1628561|NCT00842712|3981144|P7|NOT COMPLETED|Safety Run-in Part||0
1628562|NCT00842712|3981145|P6|NOT COMPLETED|Safety Run-in Part||0
1628563|NCT00842712|3981146|P5|NOT COMPLETED|Safety Run-in Part||0
1628564|NCT00842712|3981147|P4|NOT COMPLETED|Safety Run-in Part||1
1628565|NCT00842712|3981148|P3|NOT COMPLETED|Safety Run-in Part||0
1628566|NCT00842712|3981149|P2|NOT COMPLETED|Safety Run-in Part||2
1628567|NCT00842712|3981150|P1|NOT COMPLETED|Safety Run-in Part||3
1628568|NCT00842712|3981144|P7|COMPLETED|Safety Run-in Part||0
1628569|NCT00842712|3981145|P6|COMPLETED|Safety Run-in Part||0
1628570|NCT00842712|3981146|P5|COMPLETED|Safety Run-in Part||0
1628571|NCT00842712|3981147|P4|COMPLETED|Safety Run-in Part||2
1628572|NCT00842712|3981148|P3|COMPLETED|Safety Run-in Part||3
1628573|NCT00842712|3981149|P2|COMPLETED|Safety Run-in Part||1
1628574|NCT00842712|3981150|P1|COMPLETED|Safety Run-in Part||0
1628575|NCT00842712|3981144|P7|STARTED|Safety Run-in Part||0
1628576|NCT00842712|3981145|P6|STARTED|Safety Run-in Part||0
1628577|NCT00842712|3981146|P5|STARTED|Safety Run-in Part||0
1628578|NCT00842712|3981147|P4|STARTED|Safety Run-in Part||3
1628579|NCT00842712|3981148|P3|STARTED|Safety Run-in Part||3
1628580|NCT00842712|3981149|P2|STARTED|Safety Run-in Part||3
1628581|NCT00842712|3981150|P1|STARTED|Safety Run-in Part||3
1628582|NCT00842608|3981182|P4|NOT COMPLETED|Overall Study||1
1628583|NCT00842608|3981183|P3|NOT COMPLETED|Overall Study||0
1628584|NCT00842608|3981184|P2|NOT COMPLETED|Overall Study||1
1628585|NCT00842608|3981185|P1|NOT COMPLETED|Overall Study||4
1628586|NCT00842608|3981182|P4|COMPLETED|Overall Study||100
1628587|NCT00842608|3981183|P3|COMPLETED|Overall Study||99
1628588|NCT00842608|3981184|P2|COMPLETED|Overall Study||176
1628589|NCT00842608|3981185|P1|COMPLETED|Overall Study||170
1628590|NCT00842608|3981182|P4|STARTED|Overall Study||101
1628591|NCT00842608|3981183|P3|STARTED|Overall Study||99
1628592|NCT00842608|3981184|P2|STARTED|Overall Study||177
1628593|NCT00842608|3981185|P1|STARTED|Overall Study||174
1628594|NCT00842543|3981207|P4|NOT COMPLETED|Overall Study||4
1628595|NCT00842543|3981208|P3|NOT COMPLETED|Overall Study||3
1628596|NCT00842543|3981209|P2|NOT COMPLETED|Overall Study||0
1628597|NCT00842543|3981210|P1|NOT COMPLETED|Overall Study||2
1628598|NCT00842543|3981207|P4|COMPLETED|Overall Study||4
1628599|NCT00842543|3981208|P3|COMPLETED|Overall Study||10
1628600|NCT00842543|3981209|P2|COMPLETED|Overall Study||5
1628601|NCT00842543|3981210|P1|COMPLETED|Overall Study||11
1628602|NCT00842543|3981207|P4|STARTED|Overall Study||8
1628603|NCT00842543|3981208|P3|STARTED|Overall Study||13
1628604|NCT00842543|3981209|P2|STARTED|Overall Study||5
1628605|NCT00842543|3981210|P1|STARTED|Overall Study||13
1628606|NCT00842361|3981224|P2|NOT COMPLETED|Overall Study||2
1628607|NCT00842361|3981225|P1|NOT COMPLETED|Overall Study||1
1628608|NCT00842361|3981224|P2|COMPLETED|Overall Study||31
1628609|NCT00842361|3981225|P1|COMPLETED|Overall Study||32
1628610|NCT00842361|3981224|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
1628611|NCT00842361|3981225|P1|Exposed|Overall Study||33
1628612|NCT00842361|3981224|P2|STARTED|Overall Study||33
1628613|NCT00842361|3981225|P1|STARTED|Overall Study||33
1628614|NCT00842348|3981245|P2|NOT COMPLETED|Study 729||38
1628615|NCT00842348|3981246|P1|NOT COMPLETED|Study 729||26
1628616|NCT00842348|3981245|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
1628617|NCT00842348|3981246|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
1628618|NCT00842348|3981245|P2|STARTED|Study 729||47
1628619|NCT00842348|3981246|P1|STARTED|Study 729||42
1628620|NCT00842348|3981245|P2|NOT COMPLETED|Patients Randomised in Study 726||56
1628621|NCT00842348|3981246|P1|NOT COMPLETED|Patients Randomised in Study 726||59
1628622|NCT00842348|3981245|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
1628623|NCT00842348|3981246|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
1628624|NCT00842348|3981245|P2|STARTED|Patients Randomised in Study 726||103
1628625|NCT00842348|3981246|P1|STARTED|Patients Randomised in Study 726||101
1628626|NCT00842335|3981256|P1|NOT COMPLETED|Overall Study||0
1628627|NCT00842335|3981256|P1|COMPLETED|Overall Study||18
1628628|NCT00842335|3981256|P1|STARTED|Overall Study||18
1628629|NCT00842296|3981263|P1|NOT COMPLETED|Overall Study||0
1628630|NCT00842296|3981263|P1|COMPLETED|Overall Study||326
1628631|NCT00842296|3981263|P1|STARTED|Overall Study||326
1628632|NCT00842257|3981289|P1|NOT COMPLETED|Overall Study||1
1628633|NCT00842257|3981289|P1|COMPLETED|Overall Study||19
1628634|NCT00842257|3981289|P1|STARTED|Overall Study||20
1628635|NCT00842244|3981296|P1|NOT COMPLETED|Overall Study||21
1628636|NCT00842244|3981296|P1|COMPLETED|Overall Study||1
1628637|NCT00842244|3981296|P1|STARTED|Overall Study||22
1628638|NCT00842231|3981315|P1|NOT COMPLETED|Overall Study||0
1628639|NCT00842231|3981315|P1|COMPLETED|Overall Study||40
1628640|NCT00842231|3981315|P1|STARTED|Overall Study||40
1628641|NCT00842153|3981323|P2|NOT COMPLETED|Overall Study||3
1628642|NCT00842153|3981324|P1|NOT COMPLETED|Overall Study||1
1628643|NCT00842153|3981323|P2|COMPLETED|Overall Study||27
1628644|NCT00842153|3981324|P1|COMPLETED|Overall Study||27
1628645|NCT00842153|3981323|P2|STARTED|Overall Study||30
1628646|NCT00842153|3981324|P1|STARTED|Overall Study||28
1628647|NCT00842075|3981364|P2|NOT COMPLETED|Overall Study||0
1628648|NCT00842075|3981365|P1|NOT COMPLETED|Overall Study||0
1628649|NCT00842075|3981364|P2|COMPLETED|Overall Study||5
1628650|NCT00842075|3981365|P1|COMPLETED|Overall Study||5
1628651|NCT00842075|3981364|P2|STARTED|Overall Study||5
1628652|NCT00842075|3981365|P1|STARTED|Overall Study||5
1628653|NCT00842023|3981375|P2|NOT COMPLETED|Overall Study||0
1628654|NCT00842023|3981376|P1|NOT COMPLETED|Overall Study||0
1628655|NCT00842023|3981375|P2|COMPLETED|Overall Study||44
1628656|NCT00842023|3981376|P1|COMPLETED|Overall Study||45
1628657|NCT00842023|3981375|P2|STARTED|Overall Study||44
1628658|NCT00842023|3981376|P1|STARTED|Overall Study||45
1628659|NCT00841971|3981388|P2|NOT COMPLETED|Overall Study||1
1628660|NCT00841971|3981389|P1|NOT COMPLETED|Overall Study||2
1628661|NCT00841971|3981388|P2|COMPLETED|Overall Study||99
1628662|NCT00841971|3981389|P1|COMPLETED|Overall Study||98
1628663|NCT00841971|3981388|P2|STARTED|Overall Study||100
1628664|NCT00841971|3981389|P1|STARTED|Overall Study||100
1628665|NCT00841906|3981399|P2|NOT COMPLETED|Overall Study||0
1628666|NCT00841906|3981400|P1|NOT COMPLETED|Overall Study||2
1628667|NCT00841906|3981399|P2|COMPLETED|Overall Study||14
1628668|NCT00841906|3981400|P1|COMPLETED|Overall Study||16
1628669|NCT00841906|3981399|P2|STARTED|Overall Study||14
1628670|NCT00841906|3981400|P1|STARTED|Overall Study||18
1628671|NCT00841828|3981414|P2|NOT COMPLETED|Overall Study||2
1628672|NCT00841828|3981415|P1|NOT COMPLETED|Overall Study||10
1628673|NCT00841828|3981414|P2|COMPLETED|Overall Study||48
1628674|NCT00841828|3981415|P1|COMPLETED|Overall Study||42
1628675|NCT00841828|3981414|P2|STARTED|Overall Study||50
1628676|NCT00841828|3981415|P1|STARTED|Overall Study||52
1628677|NCT00841815|3981425|P2|NOT COMPLETED|Period 2||0
1628678|NCT00841815|3981426|P1|NOT COMPLETED|Period 2||0
1628679|NCT00841815|3981425|P2|COMPLETED|Period 2||13
1628680|NCT00841815|3981426|P1|COMPLETED|Period 2||14
1628681|NCT00841815|3981425|P2|STARTED|Period 2||13
1628682|NCT00841815|3981426|P1|STARTED|Period 2||14
1628683|NCT00841815|3981425|P2|NOT COMPLETED|Washout||1
1628684|NCT00841815|3981426|P1|NOT COMPLETED|Washout||0
1628685|NCT00841815|3981425|P2|COMPLETED|Washout||13
1628686|NCT00841815|3981426|P1|COMPLETED|Washout||14
1628687|NCT00841815|3981425|P2|STARTED|Washout||14
1628688|NCT00841815|3981426|P1|STARTED|Washout||14
1628689|NCT00841815|3981425|P2|NOT COMPLETED|Period 1||0
1628690|NCT00841815|3981426|P1|NOT COMPLETED|Period 1||0
1628691|NCT00841815|3981425|P2|COMPLETED|Period 1||14
1628692|NCT00841815|3981426|P1|COMPLETED|Period 1||14
1628693|NCT00841815|3981425|P2|STARTED|Period 1||14
1628694|NCT00841815|3981426|P1|STARTED|Period 1||14
1628695|NCT00841776|3981436|P2|NOT COMPLETED|Overall Study||3
1628696|NCT00841776|3981437|P1|NOT COMPLETED|Overall Study||2
1628697|NCT00841776|3981436|P2|COMPLETED|Overall Study||24
1628698|NCT00841776|3981437|P1|COMPLETED|Overall Study||25
1628699|NCT00841776|3981436|P2|STARTED|Overall Study||27
1628700|NCT00841776|3981437|P1|STARTED|Overall Study||27
1628701|NCT00841763|3981455|P4|NOT COMPLETED|Overall Study||3
1628702|NCT00841763|3981456|P3|NOT COMPLETED|Overall Study||8
1628703|NCT00841763|3981457|P2|NOT COMPLETED|Overall Study||57
1628704|NCT00841763|3981458|P1|NOT COMPLETED|Overall Study||162
1628705|NCT00841763|3981455|P4|COMPLETED|Overall Study||53
1628706|NCT00841763|3981456|P3|COMPLETED|Overall Study||211
1628707|NCT00841763|3981457|P2|COMPLETED|Overall Study||624
1628708|NCT00841763|3981458|P1|COMPLETED|Overall Study||2529
1628709|NCT00841763|3981455|P4|STARTED|Overall Study||56
1628710|NCT00841763|3981456|P3|STARTED|Overall Study||219
1628711|NCT00841763|3981457|P2|STARTED|Overall Study||681
1628712|NCT00841763|3981458|P1|STARTED|Overall Study||2691
1628713|NCT00841698|3981520|P2|NOT COMPLETED|Second Intervention||0
1628714|NCT00841698|3981521|P1|NOT COMPLETED|Second Intervention||0
1628715|NCT00841698|3981520|P2|COMPLETED|Second Intervention||25
1628716|NCT00841698|3981521|P1|COMPLETED|Second Intervention||24
1628717|NCT00841698|3981520|P2|STARTED|Second Intervention||25
1628718|NCT00841698|3981521|P1|STARTED|Second Intervention||24
1628719|NCT00841698|3981520|P2|NOT COMPLETED|Washout: 2 Weeks||0
1628720|NCT00841698|3981521|P1|NOT COMPLETED|Washout: 2 Weeks||0
1628721|NCT00841698|3981520|P2|COMPLETED|Washout: 2 Weeks||25
1628722|NCT00841698|3981521|P1|COMPLETED|Washout: 2 Weeks||24
1628723|NCT00841698|3981520|P2|STARTED|Washout: 2 Weeks||25
1628724|NCT00841698|3981521|P1|STARTED|Washout: 2 Weeks||24
1628725|NCT00841698|3981520|P2|NOT COMPLETED|First Intervention||0
1628726|NCT00841698|3981521|P1|NOT COMPLETED|First Intervention||1
1628727|NCT00841698|3981520|P2|COMPLETED|First Intervention||25
1628728|NCT00841698|3981521|P1|COMPLETED|First Intervention||24
1628729|NCT00841698|3981520|P2|STARTED|First Intervention||25
1628730|NCT00841698|3981521|P1|STARTED|First Intervention||25
1628731|NCT00841672|3981531|P2|NOT COMPLETED|Overall Study||32
1628732|NCT00841672|3981532|P1|NOT COMPLETED|Overall Study||20
1628733|NCT00841672|3981531|P2|COMPLETED|Overall Study||209
1628734|NCT00841672|3981532|P1|COMPLETED|Overall Study||224
1628735|NCT00841672|3981531|P2|STARTED|Overall Study||241
1628736|NCT00841672|3981532|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
1628737|NCT00841659|3981548|P2|NOT COMPLETED|Second Intervention||0
1628738|NCT00841659|3981549|P1|NOT COMPLETED|Second Intervention||0
1628739|NCT00841659|3981548|P2|COMPLETED|Second Intervention||12
1628740|NCT00841659|3981549|P1|COMPLETED|Second Intervention||11
1628741|NCT00841659|3981548|P2|STARTED|Second Intervention||12
1628742|NCT00841659|3981549|P1|STARTED|Second Intervention||11
1628743|NCT00841659|3981548|P2|NOT COMPLETED|Washout: 2 Weeks||0
1628744|NCT00841659|3981549|P1|NOT COMPLETED|Washout: 2 Weeks||1
1628745|NCT00841659|3981548|P2|COMPLETED|Washout: 2 Weeks||12
1628746|NCT00841659|3981549|P1|COMPLETED|Washout: 2 Weeks||11
1628747|NCT00841659|3981548|P2|STARTED|Washout: 2 Weeks||12
1628748|NCT00841659|3981549|P1|STARTED|Washout: 2 Weeks||12
1628749|NCT00841659|3981548|P2|NOT COMPLETED|First Intervention||0
1628750|NCT00841659|3981549|P1|NOT COMPLETED|First Intervention||0
1628751|NCT00841659|3981548|P2|COMPLETED|First Intervention||12
1628752|NCT00841659|3981549|P1|COMPLETED|First Intervention||12
1628753|NCT00841659|3981548|P2|STARTED|First Intervention||12
1628754|NCT00841659|3981549|P1|STARTED|First Intervention||12
1628755|NCT00841568|3981557|P1|NOT COMPLETED|Overall Study||5
1628756|NCT00841568|3981557|P1|COMPLETED|Overall Study||12
1628757|NCT00841568|3981557|P1|STARTED|Overall Study||17
1628758|NCT00841555|3981573|P3|NOT COMPLETED|Overall Study||0
1628759|NCT00841555|3981574|P2|NOT COMPLETED|Overall Study||0
1628760|NCT00841555|3981575|P1|NOT COMPLETED|Overall Study||0
1628761|NCT00841555|3981573|P3|COMPLETED|Overall Study||3
1628762|NCT00841555|3981574|P2|COMPLETED|Overall Study||3
1628763|NCT00841555|3981575|P1|COMPLETED|Overall Study||3
1628764|NCT00841555|3981573|P3|STARTED|Overall Study||3
1628765|NCT00841555|3981574|P2|STARTED|Overall Study||3
1628766|NCT00841555|3981575|P1|STARTED|Overall Study||3
1628767|NCT00841542|3981585|P2|NOT COMPLETED|Period 2||0
1628768|NCT00841542|3981586|P1|NOT COMPLETED|Period 2||0
1628769|NCT00841542|3981585|P2|COMPLETED|Period 2||14
1628770|NCT00841542|3981586|P1|COMPLETED|Period 2||13
1628771|NCT00841542|3981585|P2|STARTED|Period 2||14
1628772|NCT00841542|3981586|P1|STARTED|Period 2||13
1628773|NCT00841542|3981585|P2|NOT COMPLETED|Period 1||0
1628774|NCT00841542|3981586|P1|NOT COMPLETED|Period 1||1
1628775|NCT00841542|3981585|P2|COMPLETED|Period 1||14
1628776|NCT00841542|3981586|P1|COMPLETED|Period 1||13
1628777|NCT00841542|3981585|P2|STARTED|Period 1||14
1628778|NCT00841542|3981586|P1|STARTED|Period 1||14
1628779|NCT00841412|3981594|P2|NOT COMPLETED|Overall Study||30
1628780|NCT00841412|3981595|P1|NOT COMPLETED|Overall Study||40
1628781|NCT00841412|3981594|P2|COMPLETED|Overall Study||50
1628782|NCT00841412|3981595|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
1628783|NCT00841412|3981594|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
1628784|NCT00841412|3981595|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
1628785|NCT00841321|3981601|P2|NOT COMPLETED|Overall Study||3
1628786|NCT00841321|3981602|P1|NOT COMPLETED|Overall Study||1
1628787|NCT00841321|3981601|P2|COMPLETED|Overall Study||58
1628788|NCT00841321|3981602|P1|COMPLETED|Overall Study||58
1628789|NCT00841321|3981601|P2|STARTED|Overall Study||61
1628790|NCT00841321|3981602|P1|STARTED|Overall Study||59
1628791|NCT00841269|3981616|P2|NOT COMPLETED|Overall Study||9
1628792|NCT00841269|3981617|P1|NOT COMPLETED|Overall Study||8
1628793|NCT00841269|3981616|P2|COMPLETED|Overall Study||13
1628794|NCT00841269|3981617|P1|COMPLETED|Overall Study||12
1628795|NCT00841269|3981616|P2|STARTED|Overall Study||22
1628796|NCT00841269|3981617|P1|STARTED|Overall Study||20
1628797|NCT00841204|3981628|P2|NOT COMPLETED|Overall Study||0
1628798|NCT00841204|3981629|P1|NOT COMPLETED|Overall Study||0
1628799|NCT00841204|3981628|P2|COMPLETED|Overall Study||25
1628800|NCT00841204|3981629|P1|COMPLETED|Overall Study||25
1628801|NCT00841204|3981628|P2|STARTED|Overall Study||25
1628802|NCT00841204|3981629|P1|STARTED|Overall Study||25
1628803|NCT00841087|3981651|P2|NOT COMPLETED|Overall Study||0
1628804|NCT00841087|3981652|P1|NOT COMPLETED|Overall Study||0
1628805|NCT00841087|3981651|P2|COMPLETED|Overall Study||32
1628806|NCT00841087|3981652|P1|COMPLETED|Overall Study||33
1628807|NCT00841087|3981651|P2|STARTED|Overall Study||32
1628808|NCT00841087|3981652|P1|STARTED|Overall Study||33
1628809|NCT00841035|3981670|P1|NOT COMPLETED|Phase 2 of Overall Study||0
1628810|NCT00841035|3981670|P1|COMPLETED|Phase 2 of Overall Study||6
1628811|NCT00841035|3981670|P1|STARTED|Phase 2 of Overall Study||6
1628812|NCT00841035|3981670|P1|NOT COMPLETED|Phase 1 Overall Study||13
1628813|NCT00841035|3981670|P1|COMPLETED|Phase 1 Overall Study||6
1628814|NCT00841035|3981670|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
1628815|NCT00840996|3981677|P2|NOT COMPLETED|Overall Study||0
1628816|NCT00840996|3981678|P1|NOT COMPLETED|Overall Study||1
1628817|NCT00840996|3981677|P2|COMPLETED|Overall Study||58
1628818|NCT00840996|3981678|P1|COMPLETED|Overall Study||57
1628819|NCT00840996|3981677|P2|STARTED|Overall Study||58
1628820|NCT00840996|3981678|P1|STARTED|Overall Study||58
1628821|NCT00840879|3981698|P2|NOT COMPLETED|Second Intervention||0
1628822|NCT00840879|3981699|P1|NOT COMPLETED|Second Intervention||1
1628823|NCT00840879|3981698|P2|COMPLETED|Second Intervention||14
1628824|NCT00840879|3981699|P1|COMPLETED|Second Intervention||13
1628825|NCT00840879|3981698|P2|STARTED|Second Intervention||14
1628826|NCT00840879|3981699|P1|STARTED|Second Intervention||14
1628827|NCT00840879|3981698|P2|NOT COMPLETED|Washout: 14 Days||0
1628828|NCT00840879|3981699|P1|NOT COMPLETED|Washout: 14 Days||0
1628829|NCT00840879|3981698|P2|COMPLETED|Washout: 14 Days||14
1628830|NCT00840879|3981699|P1|COMPLETED|Washout: 14 Days||14
1628831|NCT00840879|3981698|P2|STARTED|Washout: 14 Days||14
1628832|NCT00840879|3981699|P1|STARTED|Washout: 14 Days||14
1628833|NCT00840879|3981698|P2|NOT COMPLETED|First Intervention||0
1628834|NCT00840879|3981699|P1|NOT COMPLETED|First Intervention||0
1628835|NCT00840879|3981698|P2|COMPLETED|First Intervention||14
1628836|NCT00840879|3981699|P1|COMPLETED|First Intervention||14
1628837|NCT00840879|3981698|P2|STARTED|First Intervention||14
1628838|NCT00840879|3981699|P1|STARTED|First Intervention||14
1628839|NCT00840866|3981709|P2|NOT COMPLETED|Second Intervention||0
1628840|NCT00840866|3981710|P1|NOT COMPLETED|Second Intervention||0
1628841|NCT00840866|3981709|P2|COMPLETED|Second Intervention||19
1628842|NCT00840866|3981710|P1|COMPLETED|Second Intervention||20
1628843|NCT00840866|3981709|P2|STARTED|Second Intervention||19
1628844|NCT00840866|3981710|P1|STARTED|Second Intervention||20
1628845|NCT00840866|3981709|P2|NOT COMPLETED|Washout of 7 Days||0
1628846|NCT00840866|3981710|P1|NOT COMPLETED|Washout of 7 Days||0
1628847|NCT00840866|3981709|P2|COMPLETED|Washout of 7 Days||19
1628848|NCT00840866|3981710|P1|COMPLETED|Washout of 7 Days||20
1628849|NCT00840866|3981709|P2|STARTED|Washout of 7 Days||19
1628850|NCT00840866|3981710|P1|STARTED|Washout of 7 Days||20
1628851|NCT00840866|3981709|P2|NOT COMPLETED|First Intervention||0
1628852|NCT00840866|3981710|P1|NOT COMPLETED|First Intervention||0
1628853|NCT00840866|3981709|P2|COMPLETED|First Intervention||19
1628854|NCT00840866|3981710|P1|COMPLETED|First Intervention||20
1628855|NCT00840866|3981709|P2|STARTED|First Intervention||19
1628856|NCT00840866|3981710|P1|STARTED|First Intervention||20
1628857|NCT00840840|3981720|P2|NOT COMPLETED|Period 2||0
1628858|NCT00840840|3981721|P1|NOT COMPLETED|Period 2||0
1628859|NCT00840840|3981720|P2|COMPLETED|Period 2||24
1628860|NCT00840840|3981721|P1|COMPLETED|Period 2||23
1628861|NCT00840840|3981720|P2|STARTED|Period 2||24
1628862|NCT00840840|3981721|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
1628863|NCT00840840|3981720|P2|NOT COMPLETED|Period 1||0
1628864|NCT00840840|3981721|P1|NOT COMPLETED|Period 1||0
1628865|NCT00840840|3981720|P2|COMPLETED|Period 1||24
1628866|NCT00840840|3981721|P1|COMPLETED|Period 1||24
1628867|NCT00840840|3981720|P2|STARTED|Period 1||24
1628868|NCT00840840|3981721|P1|STARTED|Period 1||24
1628869|NCT00840658|3981739|P4|NOT COMPLETED|Overall Study||4
1628870|NCT00840658|3981740|P3|NOT COMPLETED|Overall Study||5
1628871|NCT00840658|3981741|P2|NOT COMPLETED|Overall Study||3
1628872|NCT00840658|3981742|P1|NOT COMPLETED|Overall Study||5
1628873|NCT00840658|3981739|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
1628874|NCT00840658|3981740|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
1628875|NCT00840658|3981741|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
1628876|NCT00840658|3981742|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
1628877|NCT00840658|3981739|P4|STARTED|Overall Study||146
1628878|NCT00840658|3981740|P3|STARTED|Overall Study||148
1628879|NCT00840658|3981741|P2|STARTED|Overall Study||146
1628880|NCT00840658|3981742|P1|STARTED|Overall Study||144
1628881|NCT00840632|3981754|P2|NOT COMPLETED|Second Intervention||0
1628882|NCT00840632|3981755|P1|NOT COMPLETED|Second Intervention||0
1628883|NCT00840632|3981754|P2|COMPLETED|Second Intervention||18
1628884|NCT00840632|3981755|P1|COMPLETED|Second Intervention||19
1628885|NCT00840632|3981754|P2|STARTED|Second Intervention||18
1628886|NCT00840632|3981755|P1|STARTED|Second Intervention||19
1628887|NCT00840632|3981754|P2|NOT COMPLETED|Washout||1
1628888|NCT00840632|3981755|P1|NOT COMPLETED|Washout||1
1628889|NCT00840632|3981754|P2|COMPLETED|Washout||18
1628890|NCT00840632|3981755|P1|COMPLETED|Washout||19
1628891|NCT00840632|3981754|P2|STARTED|Washout||19
1628892|NCT00840632|3981755|P1|STARTED|Washout||20
1628893|NCT00840632|3981754|P2|NOT COMPLETED|First Intervention||1
1628894|NCT00840632|3981755|P1|NOT COMPLETED|First Intervention||0
1628895|NCT00840632|3981754|P2|COMPLETED|First Intervention||19
1628896|NCT00840632|3981755|P1|COMPLETED|First Intervention||20
1628897|NCT00840632|3981754|P2|STARTED|First Intervention||20
1628898|NCT00840632|3981755|P1|STARTED|First Intervention||20
1628899|NCT00840476|3981771|P2|NOT COMPLETED|Second Intervention||0
1628900|NCT00840476|3981772|P1|NOT COMPLETED|Second Intervention||0
1628901|NCT00840476|3981771|P2|COMPLETED|Second Intervention||14
1628902|NCT00840476|3981772|P1|COMPLETED|Second Intervention||14
1628903|NCT00840476|3981771|P2|STARTED|Second Intervention||14
1628904|NCT00840476|3981772|P1|STARTED|Second Intervention||14
1628905|NCT00840476|3981771|P2|NOT COMPLETED|Washout: 14 Days||0
1628906|NCT00840476|3981772|P1|NOT COMPLETED|Washout: 14 Days||0
1628907|NCT00840476|3981771|P2|COMPLETED|Washout: 14 Days||14
1628908|NCT00840476|3981772|P1|COMPLETED|Washout: 14 Days||14
1628909|NCT00840476|3981771|P2|STARTED|Washout: 14 Days||14
1628910|NCT00840476|3981772|P1|STARTED|Washout: 14 Days||14
1628911|NCT00840476|3981771|P2|NOT COMPLETED|First Intervention||0
1628912|NCT00840476|3981772|P1|NOT COMPLETED|First Intervention||0
1628913|NCT00840476|3981771|P2|COMPLETED|First Intervention||14
1628914|NCT00840476|3981772|P1|COMPLETED|First Intervention||14
1628915|NCT00840476|3981771|P2|STARTED|First Intervention||14
1628916|NCT00840476|3981772|P1|STARTED|First Intervention||14
1628917|NCT00840450|3981780|P1|NOT COMPLETED|Overall Study||3
1628918|NCT00840450|3981780|P1|COMPLETED|Overall Study||9
1628919|NCT00840450|3981780|P1|STARTED|Overall Study||12
1628920|NCT00840411|3981788|P2|NOT COMPLETED|Second Intervention||0
1628921|NCT00840411|3981789|P1|NOT COMPLETED|Second Intervention||0
1628922|NCT00840411|3981788|P2|COMPLETED|Second Intervention||33
1628923|NCT00840411|3981789|P1|COMPLETED|Second Intervention||31
1628924|NCT00840411|3981788|P2|STARTED|Second Intervention||33
1628925|NCT00840411|3981789|P1|STARTED|Second Intervention||31
1628926|NCT00840411|3981788|P2|NOT COMPLETED|Washout||0
1628927|NCT00840411|3981789|P1|NOT COMPLETED|Washout||1
1628928|NCT00840411|3981788|P2|COMPLETED|Washout||33
1628929|NCT00840411|3981789|P1|COMPLETED|Washout||31
1628930|NCT00840411|3981788|P2|STARTED|Washout||33
1628931|NCT00840411|3981789|P1|STARTED|Washout||32
1628932|NCT00840411|3981788|P2|NOT COMPLETED|First Intervention||0
1628933|NCT00840411|3981789|P1|NOT COMPLETED|First Intervention||1
1628934|NCT00840411|3981788|P2|COMPLETED|First Intervention||33
1628935|NCT00840411|3981789|P1|COMPLETED|First Intervention||32
1628936|NCT00840411|3981788|P2|STARTED|First Intervention||33
1628937|NCT00840411|3981789|P1|STARTED|First Intervention||33
1628938|NCT00840307|3981797|P1|NOT COMPLETED|Overall Study||4
1628939|NCT00840307|3981797|P1|COMPLETED|Overall Study||16
1628940|NCT00840307|3981797|P1|STARTED|Overall Study||20
1628941|NCT00840294|3981803|P2|NOT COMPLETED|Overall Study||5
1628942|NCT00840294|3981804|P1|NOT COMPLETED|Overall Study||3
1628943|NCT00840294|3981803|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
1628944|NCT00840294|3981804|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
1628945|NCT00840294|3981803|P2|STARTED|Overall Study||43
1628946|NCT00840294|3981804|P1|STARTED|Overall Study||42
1628947|NCT00840281|3981814|P2|NOT COMPLETED|Second Intervention||0
1628948|NCT00840281|3981815|P1|NOT COMPLETED|Second Intervention||0
1628949|NCT00840281|3981814|P2|COMPLETED|Second Intervention||19
1628950|NCT00840281|3981815|P1|COMPLETED|Second Intervention||19
1628951|NCT00840281|3981814|P2|STARTED|Second Intervention||19
1628952|NCT00840281|3981815|P1|STARTED|Second Intervention||19
1628953|NCT00840281|3981814|P2|NOT COMPLETED|Washout of 7 Days||0
1628954|NCT00840281|3981815|P1|NOT COMPLETED|Washout of 7 Days||0
1628955|NCT00840281|3981814|P2|COMPLETED|Washout of 7 Days||19
1628956|NCT00840281|3981815|P1|COMPLETED|Washout of 7 Days||19
1628957|NCT00840281|3981814|P2|STARTED|Washout of 7 Days||19
1628958|NCT00840281|3981815|P1|STARTED|Washout of 7 Days||19
1628959|NCT00840281|3981814|P2|NOT COMPLETED|First Intervention||0
1628960|NCT00840281|3981815|P1|NOT COMPLETED|First Intervention||0
1628961|NCT00840281|3981814|P2|COMPLETED|First Intervention||19
1628962|NCT00840281|3981815|P1|COMPLETED|First Intervention||19
1628963|NCT00840281|3981814|P2|STARTED|First Intervention||19
1628964|NCT00840281|3981815|P1|STARTED|First Intervention||19
1628965|NCT00840216|3981825|P2|NOT COMPLETED|Second Intervention||0
1628966|NCT00840216|3981826|P1|NOT COMPLETED|Second Intervention||0
1628967|NCT00840216|3981825|P2|COMPLETED|Second Intervention||11
1628968|NCT00840216|3981826|P1|COMPLETED|Second Intervention||10
1628969|NCT00840216|3981825|P2|STARTED|Second Intervention||11
1628970|NCT00840216|3981826|P1|STARTED|Second Intervention||10
1628971|NCT00840216|3981825|P2|NOT COMPLETED|Washout: 7 Days||0
1628972|NCT00840216|3981826|P1|NOT COMPLETED|Washout: 7 Days||1
1628973|NCT00840216|3981825|P2|COMPLETED|Washout: 7 Days||11
1628974|NCT00840216|3981826|P1|COMPLETED|Washout: 7 Days||10
1628975|NCT00840216|3981825|P2|STARTED|Washout: 7 Days||11
1628976|NCT00840216|3981826|P1|STARTED|Washout: 7 Days||11
1628977|NCT00840216|3981825|P2|NOT COMPLETED|First Intervention||0
1628978|NCT00840216|3981826|P1|NOT COMPLETED|First Intervention||0
1628979|NCT00840216|3981825|P2|COMPLETED|First Intervention||11
1628980|NCT00840216|3981826|P1|COMPLETED|First Intervention||11
1628981|NCT00840216|3981825|P2|STARTED|First Intervention||11
1628982|NCT00840216|3981826|P1|STARTED|First Intervention||11
1628983|NCT00840203|3981836|P2|NOT COMPLETED|Second Intervention||0
1628984|NCT00840203|3981837|P1|NOT COMPLETED|Second Intervention||0
1628985|NCT00840203|3981836|P2|COMPLETED|Second Intervention||34
1628986|NCT00840203|3981837|P1|COMPLETED|Second Intervention||35
1628987|NCT00840203|3981836|P2|STARTED|Second Intervention||34
1628988|NCT00840203|3981837|P1|STARTED|Second Intervention||35
1628989|NCT00840203|3981836|P2|NOT COMPLETED|Washout||0
1628990|NCT00840203|3981837|P1|NOT COMPLETED|Washout||1
1628991|NCT00840203|3981836|P2|COMPLETED|Washout||34
1628992|NCT00840203|3981837|P1|COMPLETED|Washout||35
1628993|NCT00840203|3981836|P2|STARTED|Washout||34
1628994|NCT00840203|3981837|P1|STARTED|Washout||36
1628995|NCT00840203|3981836|P2|NOT COMPLETED|First Intervention||1
1628996|NCT00840203|3981837|P1|NOT COMPLETED|First Intervention||1
1628997|NCT00840203|3981836|P2|COMPLETED|First Intervention||34
1628998|NCT00840203|3981837|P1|COMPLETED|First Intervention||36
1628999|NCT00840203|3981836|P2|STARTED|First Intervention||35
1629000|NCT00840203|3981837|P1|STARTED|First Intervention||37
1629001|NCT00840099|3981853|P2|NOT COMPLETED|Period 2||0
1629002|NCT00840099|3981854|P1|NOT COMPLETED|Period 2||0
1629003|NCT00840099|3981853|P2|COMPLETED|Period 2||24
1629004|NCT00840099|3981854|P1|COMPLETED|Period 2||21
1629005|NCT00840099|3981853|P2|STARTED|Period 2||24
1629006|NCT00840099|3981854|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
1629007|NCT00840099|3981853|P2|NOT COMPLETED|Period 1||0
1629008|NCT00840099|3981854|P1|NOT COMPLETED|Period 1||0
1629009|NCT00840099|3981853|P2|COMPLETED|Period 1||24
1629010|NCT00840099|3981854|P1|COMPLETED|Period 1||24
1629011|NCT00840099|3981853|P2|STARTED|Period 1||24
1629012|NCT00840099|3981854|P1|STARTED|Period 1||24
1629013|NCT00840086|3981868|P1|NOT COMPLETED|Overall Study||4
1629014|NCT00840086|3981868|P1|COMPLETED|Overall Study||146
1629015|NCT00840086|3981868|P1|STARTED|Overall Study||150
1629016|NCT00840073|3981877|P2|NOT COMPLETED|Second Intervention||1
1629017|NCT00840073|3981878|P1|NOT COMPLETED|Second Intervention||1
1629018|NCT00840073|3981877|P2|COMPLETED|Second Intervention||24
1629019|NCT00840073|3981878|P1|COMPLETED|Second Intervention||24
1629020|NCT00840073|3981877|P2|STARTED|Second Intervention||25
1629021|NCT00840073|3981878|P1|STARTED|Second Intervention||25
1629022|NCT00840073|3981877|P2|NOT COMPLETED|First Intervention||0
1629023|NCT00840073|3981878|P1|NOT COMPLETED|First Intervention||0
1629024|NCT00840073|3981877|P2|COMPLETED|First Intervention||25
1629025|NCT00840073|3981878|P1|COMPLETED|First Intervention||25
1629026|NCT00840073|3981877|P2|STARTED|First Intervention||25
1629027|NCT00840073|3981878|P1|STARTED|First Intervention||25
1629028|NCT00840060|3981892|P2|NOT COMPLETED|Overall Study||1
1629029|NCT00840060|3981893|P1|NOT COMPLETED|Overall Study||1
1629030|NCT00840060|3981892|P2|COMPLETED|Overall Study||19
1629031|NCT00840060|3981893|P1|COMPLETED|Overall Study||19
1629032|NCT00840060|3981892|P2|STARTED|Overall Study||20
1629033|NCT00840060|3981893|P1|STARTED|Overall Study||20
1629034|NCT00840034|3981903|P2|NOT COMPLETED|Taper Phase||2
1629035|NCT00840034|3981904|P1|NOT COMPLETED|Taper Phase||3
1629036|NCT00840034|3981903|P2|COMPLETED|Taper Phase||80
1629037|NCT00840034|3981904|P1|COMPLETED|Taper Phase||87
1629038|NCT00840034|3981903|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
1629039|NCT00840034|3981904|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
1629040|NCT00840034|3981903|P2|NOT COMPLETED|Acute Treatment Phase||36
1629041|NCT00840034|3981904|P1|NOT COMPLETED|Acute Treatment Phase||21
1629042|NCT00840034|3981903|P2|COMPLETED|Acute Treatment Phase||80
1629043|NCT00840034|3981904|P1|COMPLETED|Acute Treatment Phase||90
1629044|NCT00840034|3981903|P2|STARTED|Acute Treatment Phase||116
1629045|NCT00840034|3981904|P1|STARTED|Acute Treatment Phase||111
1629046|NCT00839982|3981940|P4|NOT COMPLETED|Overall Study||0
1629047|NCT00839982|3981941|P3|NOT COMPLETED|Overall Study||0
1629048|NCT00839982|3981942|P2|NOT COMPLETED|Overall Study||0
1629049|NCT00839982|3981943|P1|NOT COMPLETED|Overall Study||0
1629050|NCT00839982|3981940|P4|COMPLETED|Overall Study||3
1629051|NCT00839982|3981941|P3|COMPLETED|Overall Study||2
1629052|NCT00839982|3981942|P2|COMPLETED|Overall Study||26
1629053|NCT00839982|3981943|P1|COMPLETED|Overall Study||4
1629054|NCT00839982|3981940|P4|STARTED|Overall Study||3
1629055|NCT00839982|3981941|P3|STARTED|Overall Study||2
1629056|NCT00839982|3981942|P2|STARTED|Overall Study||26
1629057|NCT00839982|3981943|P1|STARTED|Overall Study||4
1629058|NCT00839956|3981957|P1|NOT COMPLETED|Overall Study||12
1629059|NCT00839956|3981957|P1|COMPLETED|Overall Study||19
1629060|NCT00839956|3981957|P1|STARTED|Overall Study||31
1629061|NCT00839930|3981966|P2|NOT COMPLETED|Second Intervention||0
1629062|NCT00839930|3981967|P1|NOT COMPLETED|Second Intervention||0
1629063|NCT00839930|3981966|P2|COMPLETED|Second Intervention||15
1629064|NCT00839930|3981967|P1|COMPLETED|Second Intervention||15
1629065|NCT00839930|3981966|P2|STARTED|Second Intervention||15
1629066|NCT00839930|3981967|P1|STARTED|Second Intervention||15
1629067|NCT00839930|3981966|P2|NOT COMPLETED|Washout: 7 Days||0
1629068|NCT00839930|3981967|P1|NOT COMPLETED|Washout: 7 Days||0
1629069|NCT00839930|3981966|P2|COMPLETED|Washout: 7 Days||15
1629070|NCT00839930|3981967|P1|COMPLETED|Washout: 7 Days||15
1629071|NCT00839930|3981966|P2|STARTED|Washout: 7 Days||15
1629072|NCT00839930|3981967|P1|STARTED|Washout: 7 Days||15
1629073|NCT00839930|3981966|P2|NOT COMPLETED|First Intervention||0
1629074|NCT00839930|3981967|P1|NOT COMPLETED|First Intervention||0
1629075|NCT00839930|3981966|P2|COMPLETED|First Intervention||15
1629076|NCT00839930|3981967|P1|COMPLETED|First Intervention||15
1629077|NCT00839930|3981966|P2|STARTED|First Intervention||15
1629078|NCT00839930|3981967|P1|STARTED|First Intervention||15
1629079|NCT00839917|3981977|P2|NOT COMPLETED|Overall Study||1
1629080|NCT00839917|3981978|P1|NOT COMPLETED|Overall Study||1
1629166|NCT00839319|3982191|P2|NOT COMPLETED|Overall Study||1
1629081|NCT00839917|3981977|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
1629082|NCT00839917|3981978|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
1629083|NCT00839917|3981977|P2|STARTED|Overall Study||17
1629084|NCT00839917|3981978|P1|STARTED|Overall Study||13
1629085|NCT00839800|3982016|P2|NOT COMPLETED|Overall Study||110
1629086|NCT00839800|3982017|P1|NOT COMPLETED|Overall Study||93
1629087|NCT00839800|3982016|P2|COMPLETED|Overall Study||932
1629088|NCT00839800|3982017|P1|COMPLETED|Overall Study||956
1629089|NCT00839800|3982016|P2|STARTED|Overall Study||1042
1629090|NCT00839800|3982017|P1|STARTED|Overall Study||1049
1629091|NCT00839540|3982050|P3|NOT COMPLETED|Overall Study||0
1629092|NCT00839540|3982051|P2|NOT COMPLETED|Overall Study||0
1629093|NCT00839540|3982052|P1|NOT COMPLETED|Overall Study||0
1629094|NCT00839540|3982050|P3|COMPLETED|Overall Study||5
1629095|NCT00839540|3982051|P2|COMPLETED|Overall Study||8
1629096|NCT00839540|3982052|P1|COMPLETED|Overall Study||8
1629097|NCT00839540|3982050|P3|STARTED|Overall Study||5
1629098|NCT00839540|3982051|P2|STARTED|Overall Study||8
1629099|NCT00839540|3982052|P1|STARTED|Overall Study||8
1629100|NCT00839527|3982063|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
1629101|NCT00839527|3982064|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
1629102|NCT00839527|3982065|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
1629103|NCT00839527|3982063|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
1629104|NCT00839527|3982064|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
1629105|NCT00839527|3982065|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
1629106|NCT00839527|3982063|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
1629107|NCT00839527|3982064|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
1629108|NCT00839527|3982065|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
1629109|NCT00839527|3982063|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
1629110|NCT00839527|3982064|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
1629111|NCT00839527|3982065|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
1629112|NCT00839527|3982063|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
1629113|NCT00839527|3982064|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
1629114|NCT00839527|3982065|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
1629115|NCT00839527|3982063|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
1629116|NCT00839527|3982064|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
1629117|NCT00839527|3982065|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
1629118|NCT00839436|3982100|P3|NOT COMPLETED|Overall Study||1
1629119|NCT00839436|3982101|P2|NOT COMPLETED|Overall Study||1
1629120|NCT00839436|3982102|P1|NOT COMPLETED|Overall Study||1
1629121|NCT00839436|3982100|P3|COMPLETED|Overall Study||0
1629122|NCT00839436|3982101|P2|COMPLETED|Overall Study||4
1629123|NCT00839436|3982102|P1|COMPLETED|Overall Study||2
1629124|NCT00839436|3982100|P3|STARTED|Overall Study||1
1629125|NCT00839436|3982101|P2|STARTED|Overall Study||5
1629126|NCT00839436|3982102|P1|STARTED|Overall Study||3
1629127|NCT00839423|3982114|P4|NOT COMPLETED|Overall Study||20
1629128|NCT00839423|3982115|P3|NOT COMPLETED|Overall Study||18
1629129|NCT00839423|3982116|P2|NOT COMPLETED|Overall Study||10
1629130|NCT00839423|3982117|P1|NOT COMPLETED|Overall Study||18
1629131|NCT00839423|3982114|P4|COMPLETED|Overall Study||93
1629132|NCT00839423|3982115|P3|COMPLETED|Overall Study||82
1629133|NCT00839423|3982116|P2|COMPLETED|Overall Study||98
1629134|NCT00839423|3982117|P1|COMPLETED|Overall Study||87
1629135|NCT00839423|3982114|P4|STARTED|Overall Study||113
1629136|NCT00839423|3982115|P3|STARTED|Overall Study||100
1629137|NCT00839423|3982116|P2|STARTED|Overall Study||108
1629138|NCT00839423|3982117|P1|STARTED|Overall Study||105
1629139|NCT00839332|3982158|P3|NOT COMPLETED|Phase 2||39
1629140|NCT00839332|3982159|P2|NOT COMPLETED|Phase 2||68
1629141|NCT00839332|3982160|P1|NOT COMPLETED|Phase 2||0
1629142|NCT00839332|3982158|P3|COMPLETED|Phase 2||0
1629143|NCT00839332|3982159|P2|COMPLETED|Phase 2||0
1629144|NCT00839332|3982160|P1|COMPLETED|Phase 2||0
1629145|NCT00839332|3982158|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
1629146|NCT00839332|3982159|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
1629147|NCT00839332|3982160|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
1629148|NCT00839332|3982158|P3|STARTED|Phase 2||39
1629149|NCT00839332|3982159|P2|STARTED|Phase 2||68
1629150|NCT00839332|3982160|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
1629151|NCT00839332|3982158|P3|NOT COMPLETED|Phase 1||0
1629152|NCT00839332|3982159|P2|NOT COMPLETED|Phase 1||0
1629153|NCT00839332|3982160|P1|NOT COMPLETED|Phase 1||50
1629154|NCT00839332|3982158|P3|COMPLETED|Phase 1||0
1629155|NCT00839332|3982159|P2|COMPLETED|Phase 1||0
1629156|NCT00839332|3982160|P1|COMPLETED|Phase 1||0
1629157|NCT00839332|3982158|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
1629158|NCT00839332|3982159|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
1629159|NCT00839332|3982160|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
1629160|NCT00839332|3982158|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
1629161|NCT00839332|3982159|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
1629162|NCT00839332|3982160|P1|STARTED|Phase 1||50
1629163|NCT00839319|3982188|P5|NOT COMPLETED|Overall Study||0
1629164|NCT00839319|3982189|P4|NOT COMPLETED|Overall Study||3
1629165|NCT00839319|3982190|P3|NOT COMPLETED|Overall Study||3
1629167|NCT00839319|3982192|P1|NOT COMPLETED|Overall Study||2
1629168|NCT00839319|3982188|P5|COMPLETED|Overall Study||8
1629169|NCT00839319|3982189|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
1629170|NCT00839319|3982190|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
1629171|NCT00839319|3982191|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
1629172|NCT00839319|3982192|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
1629173|NCT00839319|3982188|P5|STARTED|Overall Study||8
1629174|NCT00839319|3982189|P4|STARTED|Overall Study||8
1629175|NCT00839319|3982190|P3|STARTED|Overall Study||8
1629176|NCT00839319|3982191|P2|STARTED|Overall Study||8
1629177|NCT00839319|3982192|P1|STARTED|Overall Study||8
1629178|NCT00839306|3982221|P2|NOT COMPLETED|Overall Study||43
1629179|NCT00839306|3982222|P1|NOT COMPLETED|Overall Study||25
1629180|NCT00839306|3982221|P2|COMPLETED|Overall Study||134
1629181|NCT00839306|3982222|P1|COMPLETED|Overall Study||35
1629182|NCT00839306|3982221|P2|STARTED|Overall Study|Treated|177
1629183|NCT00839306|3982222|P1|STARTED|Overall Study|Treated|60
1629184|NCT00839241|3982232|P2|NOT COMPLETED|Overall Study||17
1629185|NCT00839241|3982233|P1|NOT COMPLETED|Overall Study||5
1629186|NCT00839241|3982232|P2|COMPLETED|Overall Study||8
1629187|NCT00839241|3982233|P1|COMPLETED|Overall Study||15
1629188|NCT00839241|3982232|P2|STARTED|Overall Study||25
1629189|NCT00839241|3982233|P1|STARTED|Overall Study||20
1629190|NCT00839098|3982320|P3|NOT COMPLETED|Overall Study||7
1629191|NCT00839098|3982321|P2|NOT COMPLETED|Overall Study||1
1629192|NCT00839098|3982322|P1|NOT COMPLETED|Overall Study||2
1629193|NCT00839098|3982320|P3|COMPLETED|Overall Study||6
1629194|NCT00839098|3982321|P2|COMPLETED|Overall Study||11
1629195|NCT00839098|3982322|P1|COMPLETED|Overall Study||1
1629196|NCT00839098|3982320|P3|STARTED|Overall Study||13
1629197|NCT00839098|3982321|P2|STARTED|Overall Study||12
1629198|NCT00839098|3982322|P1|STARTED|Overall Study||3
1629199|NCT00839072|3982348|P2|NOT COMPLETED|Second Intervention Period||0
1629200|NCT00839072|3982349|P1|NOT COMPLETED|Second Intervention Period||1
1629201|NCT00839072|3982348|P2|COMPLETED|Second Intervention Period||11
1629202|NCT00839072|3982349|P1|COMPLETED|Second Intervention Period||9
1629203|NCT00839072|3982348|P2|STARTED|Second Intervention Period||11
1629204|NCT00839072|3982349|P1|STARTED|Second Intervention Period||10
1629205|NCT00839072|3982348|P2|NOT COMPLETED|Washout Period of 7 Days||0
1629206|NCT00839072|3982349|P1|NOT COMPLETED|Washout Period of 7 Days||0
1629207|NCT00839072|3982348|P2|COMPLETED|Washout Period of 7 Days||11
1629208|NCT00839072|3982349|P1|COMPLETED|Washout Period of 7 Days||10
1629209|NCT00839072|3982348|P2|STARTED|Washout Period of 7 Days||11
1629210|NCT00839072|3982349|P1|STARTED|Washout Period of 7 Days||10
1629211|NCT00839072|3982348|P2|NOT COMPLETED|First Intervention Period||1
1629212|NCT00839072|3982349|P1|NOT COMPLETED|First Intervention Period||2
1629213|NCT00839072|3982348|P2|COMPLETED|First Intervention Period||11
1629214|NCT00839072|3982349|P1|COMPLETED|First Intervention Period||10
1629215|NCT00839072|3982348|P2|STARTED|First Intervention Period||12
1629216|NCT00839072|3982349|P1|STARTED|First Intervention Period||12
1629217|NCT00838981|3982369|P4|NOT COMPLETED|Day 4 to Week 11||7
1629218|NCT00838981|3982370|P3|NOT COMPLETED|Day 4 to Week 11||11
1629219|NCT00838981|3982371|P2|NOT COMPLETED|Day 4 to Week 11||8
1629220|NCT00838981|3982372|P1|NOT COMPLETED|Day 4 to Week 11||7
1629221|NCT00838981|3982369|P4|COMPLETED|Day 4 to Week 11||12
1629222|NCT00838981|3982370|P3|COMPLETED|Day 4 to Week 11||16
1629223|NCT00838981|3982371|P2|COMPLETED|Day 4 to Week 11||11
1629224|NCT00838981|3982372|P1|COMPLETED|Day 4 to Week 11||19
1629225|NCT00838981|3982369|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
1629226|NCT00838981|3982370|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
1629227|NCT00838981|3982371|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
1629228|NCT00838981|3982372|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
1629229|NCT00838981|3982369|P4|STARTED|Day 4 to Week 11||19
1629230|NCT00838981|3982370|P3|STARTED|Day 4 to Week 11||27
1629231|NCT00838981|3982371|P2|STARTED|Day 4 to Week 11||19
1629232|NCT00838981|3982372|P1|STARTED|Day 4 to Week 11||26
1629233|NCT00838981|3982369|P4|NOT COMPLETED|Week 1 Days 1-3||0
1629234|NCT00838981|3982370|P3|NOT COMPLETED|Week 1 Days 1-3||0
1629235|NCT00838981|3982371|P2|NOT COMPLETED|Week 1 Days 1-3||0
1629236|NCT00838981|3982372|P1|NOT COMPLETED|Week 1 Days 1-3||0
1629237|NCT00838981|3982369|P4|COMPLETED|Week 1 Days 1-3||19
1629238|NCT00838981|3982370|P3|COMPLETED|Week 1 Days 1-3||27
1629239|NCT00838981|3982371|P2|COMPLETED|Week 1 Days 1-3||19
1629240|NCT00838981|3982372|P1|COMPLETED|Week 1 Days 1-3||26
1629241|NCT00838981|3982369|P4|STARTED|Week 1 Days 1-3||19
1629242|NCT00838981|3982370|P3|STARTED|Week 1 Days 1-3||27
1629243|NCT00838981|3982371|P2|STARTED|Week 1 Days 1-3||19
1629244|NCT00838981|3982372|P1|STARTED|Week 1 Days 1-3||26
1629245|NCT00838929|3982393|P3|NOT COMPLETED|Overall Study||1
1629246|NCT00838929|3982394|P2|NOT COMPLETED|Overall Study||3
1629247|NCT00838929|3982395|P1|NOT COMPLETED|Overall Study||0
1629248|NCT00838929|3982393|P3|COMPLETED|Overall Study||5
1629249|NCT00838929|3982394|P2|COMPLETED|Overall Study||5
1629250|NCT00838929|3982395|P1|COMPLETED|Overall Study||3
1629251|NCT00838929|3982393|P3|STARTED|Overall Study||6
1629252|NCT00838929|3982394|P2|STARTED|Overall Study||8
1629253|NCT00838929|3982395|P1|STARTED|Overall Study||3
1629254|NCT00838916|3982403|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
1629255|NCT00838916|3982404|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
1629256|NCT00838916|3982403|P2|COMPLETED|Follow-up Period (8 Weeks)||190
1629257|NCT00838916|3982404|P1|COMPLETED|Follow-up Period (8 Weeks)||408
1629258|NCT00838916|3982403|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
1629259|NCT00838916|3982404|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
1629260|NCT00838916|3982403|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
1629261|NCT00838916|3982404|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
1629262|NCT00838916|3982403|P2|COMPLETED|Treatment Period (156 Weeks)||164
1629263|NCT00838916|3982404|P1|COMPLETED|Treatment Period (156 Weeks)||308
1629264|NCT00838916|3982403|P2|STARTED|Treatment Period (156 Weeks)||241
1629265|NCT00838916|3982404|P1|STARTED|Treatment Period (156 Weeks)||504
1629266|NCT00838903|3982433|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
1629267|NCT00838903|3982434|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
1629268|NCT00838903|3982435|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
1629269|NCT00838903|3982436|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
1629270|NCT00838903|3982433|P4|COMPLETED|Follow-up Period (8 Weeks)||244
1629271|NCT00838903|3982434|P3|COMPLETED|Follow-up Period (8 Weeks)||243
1629272|NCT00838903|3982435|P2|COMPLETED|Follow-up Period (8 Weeks)||237
1629273|NCT00838903|3982436|P1|COMPLETED|Follow-up Period (8 Weeks)||75
1629274|NCT00838903|3982433|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
1629275|NCT00838903|3982434|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
1629276|NCT00838903|3982435|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
1629277|NCT00838903|3982436|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
1629278|NCT00838903|3982433|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
1629279|NCT00838903|3982434|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
1629280|NCT00838903|3982435|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
1629281|NCT00838903|3982436|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
1629282|NCT00838903|3982433|P4|COMPLETED|Treatment Period (156 Weeks)||192
1629283|NCT00838903|3982434|P3|COMPLETED|Treatment Period (156 Weeks)||191
1629284|NCT00838903|3982435|P2|COMPLETED|Treatment Period (156 Weeks)||190
1629285|NCT00838903|3982436|P1|COMPLETED|Treatment Period (156 Weeks)||55
1629286|NCT00838903|3982433|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
1629287|NCT00838903|3982434|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
1629288|NCT00838903|3982435|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
1629289|NCT00838903|3982436|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
1629290|NCT00838903|3982433|P4|STARTED|Treatment Period (156 Weeks)||302
1629291|NCT00838903|3982434|P3|STARTED|Treatment Period (156 Weeks)||307
1629292|NCT00838903|3982435|P2|STARTED|Treatment Period (156 Weeks)||302
1629293|NCT00838903|3982436|P1|STARTED|Treatment Period (156 Weeks)||101
1629294|NCT00838695|3982480|P2|NOT COMPLETED|Overall Study||0
1629295|NCT00838695|3982481|P1|NOT COMPLETED|Overall Study||0
1629296|NCT00838695|3982480|P2|COMPLETED|Overall Study||64
1629297|NCT00838695|3982481|P1|COMPLETED|Overall Study||42
1629298|NCT00838695|3982480|P2|STARTED|Overall Study||64
1629299|NCT00838695|3982481|P1|STARTED|Overall Study||42
1629300|NCT00838682|3982491|P2|NOT COMPLETED|Overall Study||19
1629301|NCT00838682|3982492|P1|NOT COMPLETED|Overall Study||25
1629302|NCT00838682|3982491|P2|COMPLETED|Overall Study||33
1629303|NCT00838682|3982492|P1|COMPLETED|Overall Study||29
1629304|NCT00838682|3982491|P2|STARTED|Overall Study||52
1629305|NCT00838682|3982492|P1|STARTED|Overall Study||54
1629306|NCT00838630|3982510|P2|NOT COMPLETED|Second Intervention||0
1629307|NCT00838630|3982511|P1|NOT COMPLETED|Second Intervention||0
1629308|NCT00838630|3982510|P2|COMPLETED|Second Intervention||18
1629309|NCT00838630|3982511|P1|COMPLETED|Second Intervention||16
1629310|NCT00838630|3982510|P2|STARTED|Second Intervention||18
1629311|NCT00838630|3982511|P1|STARTED|Second Intervention||16
1629312|NCT00838630|3982510|P2|NOT COMPLETED|Washout: 7 Days||0
1629313|NCT00838630|3982511|P1|NOT COMPLETED|Washout: 7 Days||1
1629314|NCT00838630|3982510|P2|COMPLETED|Washout: 7 Days||18
1629315|NCT00838630|3982511|P1|COMPLETED|Washout: 7 Days||16
1629316|NCT00838630|3982510|P2|STARTED|Washout: 7 Days||18
1629317|NCT00838630|3982511|P1|STARTED|Washout: 7 Days||17
1629318|NCT00838630|3982510|P2|NOT COMPLETED|First Intervention||0
1629319|NCT00838630|3982511|P1|NOT COMPLETED|First Intervention||1
1629320|NCT00838630|3982510|P2|COMPLETED|First Intervention||18
1629321|NCT00838630|3982511|P1|COMPLETED|First Intervention||17
1629322|NCT00838630|3982510|P2|STARTED|First Intervention||18
1629323|NCT00838630|3982511|P1|STARTED|First Intervention||18
1629324|NCT00838578|3982519|P1|NOT COMPLETED|Overall Study||2
1629325|NCT00838578|3982519|P1|COMPLETED|Overall Study||63
1629326|NCT00838578|3982519|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
1629327|NCT00838565|3982533|P6|NOT COMPLETED|Overall Study||2
1629328|NCT00838565|3982534|P5|NOT COMPLETED|Overall Study||0
1629329|NCT00838565|3982535|P4|NOT COMPLETED|Overall Study||0
1629330|NCT00838565|3982536|P3|NOT COMPLETED|Overall Study||1
1629331|NCT00838565|3982537|P2|NOT COMPLETED|Overall Study||3
1629332|NCT00838565|3982538|P1|NOT COMPLETED|Overall Study||0
1629333|NCT00838565|3982533|P6|COMPLETED|Overall Study||5
1629334|NCT00838565|3982534|P5|COMPLETED|Overall Study||6
1629335|NCT00838565|3982535|P4|COMPLETED|Overall Study||6
1629336|NCT00838565|3982536|P3|COMPLETED|Overall Study||5
1629337|NCT00838565|3982537|P2|COMPLETED|Overall Study||4
1629338|NCT00838565|3982538|P1|COMPLETED|Overall Study||9
1629339|NCT00838565|3982533|P6|Treated|Overall Study||7
1629340|NCT00838565|3982534|P5|Treated|Overall Study||6
1629341|NCT00838565|3982535|P4|Treated|Overall Study||6
1629342|NCT00838565|3982536|P3|Treated|Overall Study||6
1629343|NCT00838565|3982537|P2|Treated|Overall Study||6
1629344|NCT00838565|3982538|P1|Treated|Overall Study||9
1629345|NCT00838565|3982533|P6|STARTED|Overall Study||7
1629346|NCT00838565|3982534|P5|STARTED|Overall Study||6
1629347|NCT00838565|3982535|P4|STARTED|Overall Study||6
1629348|NCT00838565|3982536|P3|STARTED|Overall Study||6
1629349|NCT00838565|3982537|P2|STARTED|Overall Study||7
1629350|NCT00838565|3982538|P1|STARTED|Overall Study||9
1629351|NCT00838539|3982643|P12|NOT COMPLETED|Overall Study||4
1629352|NCT00838539|3982644|P11|NOT COMPLETED|Overall Study||5
1629353|NCT00838539|3982645|P10|NOT COMPLETED|Overall Study||8
1629354|NCT00838539|3982646|P9|NOT COMPLETED|Overall Study||5
1629355|NCT00838539|3982647|P8|NOT COMPLETED|Overall Study||6
1629356|NCT00838539|3982648|P7|NOT COMPLETED|Overall Study||5
1629357|NCT00838539|3982649|P6|NOT COMPLETED|Overall Study||4
1629358|NCT00838539|3982650|P5|NOT COMPLETED|Overall Study||6
1629359|NCT00838539|3982651|P4|NOT COMPLETED|Overall Study||4
1629360|NCT00838539|3982652|P3|NOT COMPLETED|Overall Study||5
1629361|NCT00838539|3982653|P2|NOT COMPLETED|Overall Study||6
1629362|NCT00838539|3982654|P1|NOT COMPLETED|Overall Study||3
1629363|NCT00838539|3982643|P12|COMPLETED|Overall Study||0
1629364|NCT00838539|3982644|P11|COMPLETED|Overall Study||0
1629365|NCT00838539|3982645|P10|COMPLETED|Overall Study||0
1629366|NCT00838539|3982646|P9|COMPLETED|Overall Study||0
1629367|NCT00838539|3982647|P8|COMPLETED|Overall Study||0
1629368|NCT00838539|3982648|P7|COMPLETED|Overall Study||2
1629369|NCT00838539|3982649|P6|COMPLETED|Overall Study||0
1629370|NCT00838539|3982650|P5|COMPLETED|Overall Study||0
1629371|NCT00838539|3982651|P4|COMPLETED|Overall Study||0
1629372|NCT00838539|3982652|P3|COMPLETED|Overall Study||0
1629373|NCT00838539|3982653|P2|COMPLETED|Overall Study||0
1629374|NCT00838539|3982654|P1|COMPLETED|Overall Study||0
1629375|NCT00838539|3982643|P12|Received Treatment|Overall Study||4
1629376|NCT00838539|3982644|P11|Received Treatment|Overall Study||5
1629377|NCT00838539|3982645|P10|Received Treatment|Overall Study||8
1629378|NCT00838539|3982646|P9|Received Treatment|Overall Study||5
1629379|NCT00838539|3982647|P8|Received Treatment|Overall Study||6
1629380|NCT00838539|3982648|P7|Received Treatment|Overall Study||7
1629381|NCT00838539|3982649|P6|Received Treatment|Overall Study||4
1629382|NCT00838539|3982650|P5|Received Treatment|Overall Study||4
1629383|NCT00838539|3982651|P4|Received Treatment|Overall Study||4
1629384|NCT00838539|3982652|P3|Received Treatment|Overall Study||5
1629385|NCT00838539|3982653|P2|Received Treatment|Overall Study||5
1629386|NCT00838539|3982654|P1|Received Treatment|Overall Study||3
1629387|NCT00838539|3982643|P12|STARTED|Overall Study||4
1629388|NCT00838539|3982644|P11|STARTED|Overall Study||5
1629389|NCT00838539|3982645|P10|STARTED|Overall Study||8
1629390|NCT00838539|3982646|P9|STARTED|Overall Study||5
1629391|NCT00838539|3982647|P8|STARTED|Overall Study||6
1629392|NCT00838539|3982648|P7|STARTED|Overall Study||7
1629393|NCT00838539|3982649|P6|STARTED|Overall Study||4
1629394|NCT00838539|3982650|P5|STARTED|Overall Study||6
1629395|NCT00838539|3982651|P4|STARTED|Overall Study||4
1629396|NCT00838539|3982652|P3|STARTED|Overall Study||5
1629397|NCT00838539|3982653|P2|STARTED|Overall Study||6
1629398|NCT00838539|3982654|P1|STARTED|Overall Study||3
1629399|NCT00838526|3982704|P2|NOT COMPLETED|Overall Study||39
1629400|NCT00838526|3982705|P1|NOT COMPLETED|Overall Study||24
1629401|NCT00838526|3982704|P2|COMPLETED|Overall Study||137
1629402|NCT00838526|3982705|P1|COMPLETED|Overall Study||35
1629403|NCT00838526|3982704|P2|STARTED|Overall Study|Treated|176
1629404|NCT00838526|3982705|P1|STARTED|Overall Study|Treated|59
1629405|NCT00838513|3982713|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
1629406|NCT00838513|3982713|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
1629407|NCT00838513|3982713|P1|STARTED|Post Treatment Period (Patients Who Disc||5
1629408|NCT00838513|3982713|P1|NOT COMPLETED|Extension Treatment Period||1
1629409|NCT00838513|3982713|P1|COMPLETED|Extension Treatment Period||18
1629410|NCT00838513|3982713|P1|STARTED|Extension Treatment Period||19
1629411|NCT00838513|3982713|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
1629412|NCT00838513|3982713|P1|COMPLETED|Treatment Period (26 Weeks)||20
1629413|NCT00838513|3982713|P1|STARTED|Treatment Period (26 Weeks)||20
1629414|NCT00838513|3982713|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
1629415|NCT00838513|3982713|P1|COMPLETED|Observation Period (8 Weeks)||20
1629416|NCT00838513|3982713|P1|STARTED|Observation Period (8 Weeks)||20
1629417|NCT00838513|3982713|P1|NOT COMPLETED|Screening Period||3
1629418|NCT00838513|3982713|P1|COMPLETED|Screening Period||20
1629419|NCT00838513|3982713|P1|STARTED|Screening Period||23
1629420|NCT00838331|3982729|P1|NOT COMPLETED|Aged Blood Transfusion||9
1629421|NCT00838331|3982729|P1|COMPLETED|Aged Blood Transfusion||8
1629422|NCT00838331|3982729|P1|STARTED|Aged Blood Transfusion||17
1629423|NCT00838331|3982729|P1|NOT COMPLETED|Fresh Blood Transfusion||0
1629424|NCT00838331|3982729|P1|COMPLETED|Fresh Blood Transfusion||17
1629425|NCT00838331|3982729|P1|STARTED|Fresh Blood Transfusion||17
1629426|NCT00838279|3982735|P2|NOT COMPLETED|Second Intervention||0
1629427|NCT00838279|3982736|P1|NOT COMPLETED|Second Intervention||0
1629428|NCT00838279|3982735|P2|COMPLETED|Second Intervention||15
1629429|NCT00838279|3982736|P1|COMPLETED|Second Intervention||15
1629430|NCT00838279|3982735|P2|STARTED|Second Intervention||15
1629431|NCT00838279|3982736|P1|STARTED|Second Intervention||15
1629432|NCT00838279|3982735|P2|NOT COMPLETED|Washout||1
1629433|NCT00838279|3982736|P1|NOT COMPLETED|Washout||1
1629434|NCT00838279|3982735|P2|COMPLETED|Washout||15
1629435|NCT00838279|3982736|P1|COMPLETED|Washout||15
1629436|NCT00838279|3982735|P2|STARTED|Washout||16
1629437|NCT00838279|3982736|P1|STARTED|Washout||16
1629438|NCT00838279|3982735|P2|NOT COMPLETED|First Intervention||0
1629439|NCT00838279|3982736|P1|NOT COMPLETED|First Intervention||0
1629440|NCT00838279|3982735|P2|COMPLETED|First Intervention||16
1629441|NCT00838279|3982736|P1|COMPLETED|First Intervention||16
1629442|NCT00838279|3982735|P2|STARTED|First Intervention||16
1629443|NCT00838279|3982736|P1|STARTED|First Intervention||16
1629444|NCT00838201|3982746|P2|NOT COMPLETED|Overall Study||53
1629445|NCT00838201|3982747|P1|NOT COMPLETED|Overall Study||42
1629446|NCT00838201|3982746|P2|COMPLETED|Overall Study||145
1629447|NCT00838201|3982747|P1|COMPLETED|Overall Study||144
1629448|NCT00838201|3982746|P2|STARTED|Overall Study||198
1629449|NCT00838201|3982747|P1|STARTED|Overall Study||186
1629450|NCT00838162|3982757|P4|NOT COMPLETED|Overall Study||0
1629451|NCT00838162|3982758|P3|NOT COMPLETED|Overall Study||0
1629452|NCT00838162|3982759|P2|NOT COMPLETED|Overall Study||0
1629453|NCT00838162|3982760|P1|NOT COMPLETED|Overall Study||0
1629454|NCT00838162|3982757|P4|COMPLETED|Overall Study||8
1629455|NCT00838162|3982758|P3|COMPLETED|Overall Study||8
1629456|NCT00838162|3982759|P2|COMPLETED|Overall Study||8
1629457|NCT00838162|3982760|P1|COMPLETED|Overall Study||9
1629458|NCT00838162|3982757|P4|STARTED|Overall Study||8
1629459|NCT00838162|3982758|P3|STARTED|Overall Study||8
1629460|NCT00838162|3982759|P2|STARTED|Overall Study||8
1629461|NCT00838162|3982760|P1|STARTED|Overall Study||9
1629462|NCT00838136|3982804|P2|NOT COMPLETED|Second Intervention||1
1629463|NCT00838136|3982805|P1|NOT COMPLETED|Second Intervention||0
1629464|NCT00838136|3982804|P2|COMPLETED|Second Intervention||15
1629465|NCT00838136|3982805|P1|COMPLETED|Second Intervention||16
1629466|NCT00838136|3982804|P2|STARTED|Second Intervention||16
1629467|NCT00838136|3982805|P1|STARTED|Second Intervention||16
1629468|NCT00838136|3982804|P2|NOT COMPLETED|First Intervention||0
1629469|NCT00838136|3982805|P1|NOT COMPLETED|First Intervention||0
1629470|NCT00838136|3982804|P2|COMPLETED|First Intervention||16
1629471|NCT00838136|3982805|P1|COMPLETED|First Intervention||16
1629472|NCT00838136|3982804|P2|STARTED|First Intervention||16
1629473|NCT00838136|3982805|P1|STARTED|First Intervention||16
1629474|NCT00838110|3982815|P4|NOT COMPLETED|Overall Study||18
1629475|NCT00838110|3982816|P3|NOT COMPLETED|Overall Study||17
1629476|NCT00838110|3982817|P2|NOT COMPLETED|Overall Study||22
1629477|NCT00838110|3982818|P1|NOT COMPLETED|Overall Study||22
1629478|NCT00838110|3982815|P4|COMPLETED|Overall Study||226
1629479|NCT00838110|3982816|P3|COMPLETED|Overall Study||226
1629480|NCT00838110|3982817|P2|COMPLETED|Overall Study||106
1629481|NCT00838110|3982818|P1|COMPLETED|Overall Study||105
1629482|NCT00838110|3982815|P4|Treated|Overall Study||244
1629483|NCT00838110|3982816|P3|Treated|Overall Study||243
1629484|NCT00838110|3982817|P2|Treated|Overall Study||127
1629485|NCT00838110|3982818|P1|Treated|Overall Study||127
1629486|NCT00838110|3982815|P4|STARTED|Overall Study||244
1629487|NCT00838110|3982816|P3|STARTED|Overall Study||243
1629488|NCT00838110|3982817|P2|STARTED|Overall Study||128
1629489|NCT00838110|3982818|P1|STARTED|Overall Study||127
1629490|NCT00838097|3982838|P1|NOT COMPLETED|Overall Study||176
1629491|NCT00838097|3982838|P1|COMPLETED|Overall Study||145
1629492|NCT00838097|3982838|P1|Received Darbepoetin Alfa|Overall Study||319
1629493|NCT00838097|3982838|P1|STARTED|Overall Study||321
1629494|NCT00837967|3982846|P2|NOT COMPLETED|Second Intervention||0
1629495|NCT00837967|3982847|P1|NOT COMPLETED|Second Intervention||0
1629496|NCT00837967|3982846|P2|COMPLETED|Second Intervention||12
1629497|NCT00837967|3982847|P1|COMPLETED|Second Intervention||11
1629498|NCT00837967|3982846|P2|STARTED|Second Intervention||12
1629499|NCT00837967|3982847|P1|STARTED|Second Intervention||11
1629500|NCT00837967|3982846|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
1629501|NCT00837967|3982847|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
1629502|NCT00837967|3982846|P2|COMPLETED|Washout Period of 7 - 14 Days||12
1629503|NCT00837967|3982847|P1|COMPLETED|Washout Period of 7 - 14 Days||11
1629504|NCT00837967|3982846|P2|STARTED|Washout Period of 7 - 14 Days||12
1629505|NCT00837967|3982847|P1|STARTED|Washout Period of 7 - 14 Days||13
1629506|NCT00837967|3982846|P2|NOT COMPLETED|First Intervention||0
1629507|NCT00837967|3982847|P1|NOT COMPLETED|First Intervention||0
1629508|NCT00837967|3982846|P2|COMPLETED|First Intervention||12
1629509|NCT00837967|3982847|P1|COMPLETED|First Intervention||13
1629510|NCT00837967|3982846|P2|STARTED|First Intervention||12
1629511|NCT00837967|3982847|P1|STARTED|First Intervention||13
1629512|NCT00837902|3982865|P2|NOT COMPLETED|Overall Study||0
1629513|NCT00837902|3982866|P1|NOT COMPLETED|Overall Study||0
1629514|NCT00837902|3982865|P2|COMPLETED|Overall Study||69
1629515|NCT00837902|3982866|P1|COMPLETED|Overall Study||85
1629516|NCT00837902|3982865|P2|STARTED|Overall Study||69
1629517|NCT00837902|3982866|P1|STARTED|Overall Study||85
1629518|NCT00837876|3982873|P1|NOT COMPLETED|Overall Study||37
1629519|NCT00837876|3982873|P1|COMPLETED|Overall Study||0
1629520|NCT00837876|3982873|P1|STARTED|Overall Study||37
1629521|NCT00837824|3982882|P2|NOT COMPLETED|Overall Study||0
1629522|NCT00837824|3982883|P1|NOT COMPLETED|Overall Study||0
1629523|NCT00837824|3982882|P2|COMPLETED|Overall Study||9
1629524|NCT00837824|3982883|P1|COMPLETED|Overall Study||11
1629525|NCT00837824|3982882|P2|STARTED|Overall Study||9
1629526|NCT00837824|3982883|P1|STARTED|Overall Study||11
1629527|NCT00837811|3982895|P3|NOT COMPLETED|Overall Study||1
1629528|NCT00837811|3982896|P2|NOT COMPLETED|Overall Study||34
1629529|NCT00837811|3982897|P1|NOT COMPLETED|Overall Study||7
1629530|NCT00837811|3982895|P3|COMPLETED|Overall Study||0
1629531|NCT00837811|3982896|P2|COMPLETED|Overall Study||87
1629532|NCT00837811|3982897|P1|COMPLETED|Overall Study||53
1629533|NCT00837811|3982895|P3|Included in Efficacy Analyses|Overall Study||1
1629534|NCT00837811|3982896|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
1629535|NCT00837811|3982897|P1|Included in Efficacy Analyses|Overall Study||59
1629536|NCT00837811|3982895|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
1629537|NCT00837811|3982896|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
1629538|NCT00837811|3982897|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
1629539|NCT00837811|3982895|P3|Received Any Amount of Study Drug|Overall Study||1
1629540|NCT00837811|3982896|P2|Received Any Amount of Study Drug|Overall Study||121
1629541|NCT00837811|3982897|P1|Received Any Amount of Study Drug|Overall Study||60
1629542|NCT00837811|3982895|P3|STARTED|Overall Study||1
1629543|NCT00837811|3982896|P2|STARTED|Overall Study||121
1629544|NCT00837811|3982897|P1|STARTED|Overall Study||60
1629545|NCT00837759|3982982|P1|NOT COMPLETED|Overall Study||4
1629546|NCT00837759|3982982|P1|COMPLETED|Overall Study||3
1629547|NCT00837759|3982982|P1|STARTED|Overall Study||7
1629548|NCT00837616|3982993|P2|NOT COMPLETED|Overall Study||1
1629549|NCT00837616|3982994|P1|NOT COMPLETED|Overall Study||0
1629550|NCT00837616|3982993|P2|COMPLETED|Overall Study||20
1629551|NCT00837616|3982994|P1|COMPLETED|Overall Study||20
1629552|NCT00837616|3982993|P2|STARTED|Overall Study||21
1629553|NCT00837616|3982994|P1|STARTED|Overall Study||20
1629554|NCT00837577|3983020|P2|NOT COMPLETED|Open-label Period||9
1629555|NCT00837577|3983021|P1|NOT COMPLETED|Open-label Period||8
1629556|NCT00837577|3983020|P2|COMPLETED|Open-label Period||54
1629557|NCT00837577|3983021|P1|COMPLETED|Open-label Period||60
1629558|NCT00837577|3983020|P2|STARTED|Open-label Period||63
1629559|NCT00837577|3983021|P1|STARTED|Open-label Period||68
1629560|NCT00837577|3983020|P2|NOT COMPLETED|Double-blind Period||0
1629561|NCT00837577|3983021|P1|NOT COMPLETED|Double-blind Period||2
1629562|NCT00837577|3983020|P2|COMPLETED|Double-blind Period||63
1629563|NCT00837577|3983021|P1|COMPLETED|Double-blind Period||68
1629564|NCT00837577|3983020|P2|STARTED|Double-blind Period||63
1629565|NCT00837577|3983021|P1|STARTED|Double-blind Period||70
1629566|NCT00837512|3983032|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
1629567|NCT00837512|3983033|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
1629568|NCT00837512|3983032|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1629569|NCT00837512|3983033|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1629570|NCT00837512|3983032|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1629571|NCT00837512|3983033|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1629572|NCT00837512|3983032|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
1629573|NCT00837512|3983033|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
1629574|NCT00837512|3983032|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
1629575|NCT00837512|3983033|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
1629576|NCT00837512|3983032|P2|STARTED|Both Arms: Washout (7-28 Days)||8
1629577|NCT00837512|3983033|P1|STARTED|Both Arms: Washout (7-28 Days)||8
1629578|NCT00837512|3983032|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
1629579|NCT00837512|3983033|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
1629580|NCT00837512|3983032|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
1629581|NCT00837512|3983033|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
1629582|NCT00837512|3983032|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
1629583|NCT00837512|3983033|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
1629584|NCT00837486|3983041|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
1629585|NCT00837486|3983042|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
1629586|NCT00837486|3983041|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
1629587|NCT00837486|3983042|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
1629588|NCT00837486|3983041|P2|STARTED|Long-term Follow-up Phase - Open Label||0
1629589|NCT00837486|3983042|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
1629590|NCT00837486|3983041|P2|NOT COMPLETED|Blinded-treatment Phase||0
1629591|NCT00837486|3983042|P1|NOT COMPLETED|Blinded-treatment Phase||1
1629592|NCT00837486|3983041|P2|COMPLETED|Blinded-treatment Phase||14
1629593|NCT00837486|3983042|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
1629594|NCT00837486|3983041|P2|STARTED|Blinded-treatment Phase||14
1629595|NCT00837486|3983042|P1|STARTED|Blinded-treatment Phase||16
1629596|NCT00837473|3983054|P1|NOT COMPLETED|Overall Study||3
1629597|NCT00837473|3983054|P1|COMPLETED|Overall Study||12
1629598|NCT00837473|3983054|P1|STARTED|Overall Study||15
1629599|NCT00837447|3983067|P1|NOT COMPLETED|Overall Study||0
1629600|NCT00837447|3983067|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
1629601|NCT00837447|3983067|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
1629602|NCT00837434|3983074|P2|NOT COMPLETED|Overall Study||1
1629603|NCT00837434|3983075|P1|NOT COMPLETED|Overall Study||9
1629604|NCT00837434|3983074|P2|COMPLETED|Overall Study||19
1629605|NCT00837434|3983075|P1|COMPLETED|Overall Study||34
1629606|NCT00837434|3983074|P2|STARTED|Overall Study||20
1629607|NCT00837434|3983075|P1|STARTED|Overall Study||43
1629608|NCT00837330|3983095|P2|NOT COMPLETED|Overall Study||3
1629609|NCT00837330|3983096|P1|NOT COMPLETED|Overall Study||1
1629610|NCT00837330|3983095|P2|COMPLETED|Overall Study||7
1629611|NCT00837330|3983096|P1|COMPLETED|Overall Study||9
1629612|NCT00837330|3983095|P2|STARTED|Overall Study||10
1629613|NCT00837330|3983096|P1|STARTED|Overall Study||10
1629614|NCT00837252|3983102|P1|NOT COMPLETED|Overall Study||0
1629615|NCT00837252|3983102|P1|COMPLETED|Overall Study||5
1629616|NCT00837252|3983102|P1|STARTED|Overall Study||5
1629617|NCT00837213|3983119|P2|NOT COMPLETED|Overall Study||5
1629618|NCT00837213|3983120|P1|NOT COMPLETED|Overall Study||6
1629619|NCT00837213|3983119|P2|COMPLETED|Overall Study||12
1629620|NCT00837213|3983120|P1|COMPLETED|Overall Study||10
1629621|NCT00837213|3983119|P2|STARTED|Overall Study||17
1629622|NCT00837213|3983120|P1|STARTED|Overall Study||16
1629623|NCT00837200|3983140|P1|NOT COMPLETED|Overall Study||0
1629624|NCT00837200|3983140|P1|COMPLETED|Overall Study||13
1629625|NCT00837200|3983140|P1|STARTED|Overall Study||13
1629626|NCT00837161|3983146|P1|NOT COMPLETED|Overall Study||2
1629627|NCT00837161|3983146|P1|COMPLETED|Overall Study||9
1629628|NCT00837161|3983146|P1|STARTED|Overall Study||11
1629629|NCT00837148|3983154|P1|NOT COMPLETED|Overall Study||2
1629630|NCT00837148|3983154|P1|COMPLETED|Overall Study||35
1629631|NCT00837148|3983154|P1|STARTED|Overall Study||37
1629632|NCT00837096|3983160|P2|NOT COMPLETED|Overall Study||9
1629633|NCT00837096|3983161|P1|NOT COMPLETED|Overall Study||10
1629634|NCT00837096|3983160|P2|COMPLETED|Overall Study||0
1629635|NCT00837096|3983161|P1|COMPLETED|Overall Study||0
1629636|NCT00837096|3983160|P2|STARTED|Overall Study||9
1629637|NCT00837096|3983161|P1|STARTED|Overall Study||10
1629638|NCT00837031|3983167|P1|NOT COMPLETED|Overall Study||0
1629639|NCT00837031|3983167|P1|COMPLETED|Overall Study||72
1629640|NCT00837031|3983167|P1|STARTED|Overall Study||72
1629641|NCT00836953|3983173|P1|NOT COMPLETED|Overall Study||2
1629642|NCT00836953|3983173|P1|COMPLETED|Overall Study||31
1629643|NCT00836953|3983173|P1|STARTED|Overall Study||33
1629644|NCT00836927|3983184|P5|NOT COMPLETED|Overall Study||1
1629645|NCT00836927|3983185|P4|NOT COMPLETED|Overall Study||1
1629646|NCT00836927|3983186|P3|NOT COMPLETED|Overall Study||1
1629647|NCT00836927|3983187|P2|NOT COMPLETED|Overall Study||1
1629648|NCT00836927|3983188|P1|NOT COMPLETED|Overall Study||3
1629649|NCT00836927|3983184|P5|COMPLETED|Overall Study||0
1629650|NCT00836927|3983185|P4|COMPLETED|Overall Study||0
1629651|NCT00836927|3983186|P3|COMPLETED|Overall Study||0
1629652|NCT00836927|3983187|P2|COMPLETED|Overall Study||0
1629653|NCT00836927|3983188|P1|COMPLETED|Overall Study||0
1629654|NCT00836927|3983184|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
1629655|NCT00836927|3983185|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
1629656|NCT00836927|3983186|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continues to receive study drug past the data cut-off date of 03 Apr 2017|1
1629657|NCT00836927|3983187|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continues to receive study drug past the data cut-off date of 03 Apr 2017|1
1629658|NCT00836927|3983188|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
1629659|NCT00836927|3983184|P5|STARTED|Overall Study||1
1629660|NCT00836927|3983185|P4|STARTED|Overall Study||1
1629661|NCT00836927|3983186|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
1629662|NCT00836927|3983187|P2|STARTED|Overall Study||1
1629663|NCT00836927|3983188|P1|STARTED|Overall Study||3
1629664|NCT00836901|3983222|P2|NOT COMPLETED|Second Intervention||0
1629665|NCT00836901|3983223|P1|NOT COMPLETED|Second Intervention||0
1629666|NCT00836901|3983222|P2|COMPLETED|Second Intervention||28
1629667|NCT00836901|3983223|P1|COMPLETED|Second Intervention||23
1629668|NCT00836901|3983222|P2|STARTED|Second Intervention||28
1629669|NCT00836901|3983223|P1|STARTED|Second Intervention||23
1629670|NCT00836901|3983222|P2|NOT COMPLETED|First Intervention||0
1629671|NCT00836901|3983223|P1|NOT COMPLETED|First Intervention||1
1629672|NCT00836901|3983222|P2|COMPLETED|First Intervention||28
1629673|NCT00836901|3983223|P1|COMPLETED|First Intervention||23
1629674|NCT00836901|3983222|P2|STARTED|First Intervention||28
1629675|NCT00836901|3983223|P1|STARTED|First Intervention||24
1629676|NCT00836875|3983239|P2|NOT COMPLETED|Overall Study||3
1629677|NCT00836875|3983240|P1|NOT COMPLETED|Overall Study||3
1629678|NCT00836875|3983239|P2|COMPLETED|Overall Study||17
1629679|NCT00836875|3983240|P1|COMPLETED|Overall Study||8
1629680|NCT00836875|3983239|P2|STARTED|Overall Study||20
1629681|NCT00836875|3983240|P1|STARTED|Overall Study||11
1629682|NCT00836810|3983256|P2|NOT COMPLETED|Overall Study||0
1629683|NCT00836810|3983257|P1|NOT COMPLETED|Overall Study||1
1629684|NCT00836810|3983256|P2|COMPLETED|Overall Study||6
1629685|NCT00836810|3983257|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
1629686|NCT00836810|3983256|P2|STARTED|Overall Study||6
1629687|NCT00836810|3983257|P1|STARTED|Overall Study||5
1629688|NCT00836745|3983273|P1|NOT COMPLETED|Overall Study||21
1629689|NCT00836745|3983273|P1|COMPLETED|Overall Study||15
1629690|NCT00836745|3983273|P1|STARTED|Overall Study||36
1629691|NCT00836719|3983280|P1|NOT COMPLETED|Overall Study||0
1629692|NCT00836719|3983280|P1|COMPLETED|Overall Study||10
1629693|NCT00836719|3983280|P1|STARTED|Overall Study||10
1629694|NCT00836706|3983287|P2|NOT COMPLETED|Second Intervention||0
1629695|NCT00836706|3983288|P1|NOT COMPLETED|Second Intervention||0
1629696|NCT00836706|3983287|P2|COMPLETED|Second Intervention||11
1629697|NCT00836706|3983288|P1|COMPLETED|Second Intervention||11
1629698|NCT00836706|3983287|P2|STARTED|Second Intervention||11
1629699|NCT00836706|3983288|P1|STARTED|Second Intervention||11
1629700|NCT00836706|3983287|P2|NOT COMPLETED|Washout: 7 Days||1
1629701|NCT00836706|3983288|P1|NOT COMPLETED|Washout: 7 Days||0
1629702|NCT00836706|3983287|P2|COMPLETED|Washout: 7 Days||11
1629703|NCT00836706|3983288|P1|COMPLETED|Washout: 7 Days||11
1629704|NCT00836706|3983287|P2|STARTED|Washout: 7 Days||12
1629705|NCT00836706|3983288|P1|STARTED|Washout: 7 Days||11
1629706|NCT00836706|3983287|P2|NOT COMPLETED|First Intervention||0
1629707|NCT00836706|3983288|P1|NOT COMPLETED|First Intervention||0
1629708|NCT00836706|3983287|P2|COMPLETED|First Intervention||12
1629709|NCT00836706|3983288|P1|COMPLETED|First Intervention||11
1629710|NCT00836706|3983287|P2|STARTED|First Intervention||12
1629711|NCT00836706|3983288|P1|STARTED|First Intervention||11
1629712|NCT00836693|3983298|P2|NOT COMPLETED|Overall Study||6
1629713|NCT00836693|3983299|P1|NOT COMPLETED|Overall Study||17
1629714|NCT00836693|3983298|P2|COMPLETED|Overall Study||64
1629715|NCT00836693|3983299|P1|COMPLETED|Overall Study||130
1629716|NCT00836693|3983298|P2|STARTED|Overall Study||70
1629717|NCT00836693|3983299|P1|STARTED|Overall Study||147
1629718|NCT00836641|3983341|P2|NOT COMPLETED|Overall Study||0
1629719|NCT00836641|3983342|P1|NOT COMPLETED|Overall Study||0
1629720|NCT00836641|3983341|P2|COMPLETED|Overall Study||34
1629721|NCT00836641|3983342|P1|COMPLETED|Overall Study||36
1629722|NCT00836641|3983341|P2|STARTED|Overall Study||34
1629723|NCT00836641|3983342|P1|STARTED|Overall Study||36
1629724|NCT00836498|3983351|P2|NOT COMPLETED|Overall Study||1
1629725|NCT00836498|3983352|P1|NOT COMPLETED|Overall Study||4
1629726|NCT00836498|3983351|P2|COMPLETED|Overall Study||21
1629727|NCT00836498|3983352|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
1629728|NCT00836498|3983351|P2|STARTED|Overall Study||22
1629729|NCT00836498|3983352|P1|STARTED|Overall Study||44
1629730|NCT00836472|3983384|P2|NOT COMPLETED|Second Intervention||0
1629731|NCT00836472|3983385|P1|NOT COMPLETED|Second Intervention||0
1629732|NCT00836472|3983384|P2|COMPLETED|Second Intervention||27
1629733|NCT00836472|3983385|P1|COMPLETED|Second Intervention||28
1629734|NCT00836472|3983384|P2|STARTED|Second Intervention||27
1629735|NCT00836472|3983385|P1|STARTED|Second Intervention||28
1629736|NCT00836472|3983384|P2|NOT COMPLETED|Washout||3
1629737|NCT00836472|3983385|P1|NOT COMPLETED|Washout||2
1629738|NCT00836472|3983384|P2|COMPLETED|Washout||27
1629739|NCT00836472|3983385|P1|COMPLETED|Washout||28
1629740|NCT00836472|3983384|P2|STARTED|Washout||30
1629741|NCT00836472|3983385|P1|STARTED|Washout||30
1629742|NCT00836472|3983384|P2|NOT COMPLETED|First Intervention||0
1629743|NCT00836472|3983385|P1|NOT COMPLETED|First Intervention||0
1629744|NCT00836472|3983384|P2|COMPLETED|First Intervention||30
1629745|NCT00836472|3983385|P1|COMPLETED|First Intervention||30
1629746|NCT00836472|3983384|P2|STARTED|First Intervention||30
1629747|NCT00836472|3983385|P1|STARTED|First Intervention||30
1629748|NCT00836433|3983401|P2|NOT COMPLETED|Overall Study||7
1629749|NCT00836433|3983402|P1|NOT COMPLETED|Overall Study||12
1629750|NCT00836433|3983401|P2|COMPLETED|Overall Study||321
1629751|NCT00836433|3983402|P1|COMPLETED|Overall Study||349
1629752|NCT00836433|3983401|P2|STARTED|Overall Study||328
1629753|NCT00836433|3983402|P1|STARTED|Overall Study||361
1629754|NCT00836407|3983412|P2|NOT COMPLETED|Overall Study||8
1629755|NCT00836407|3983413|P1|NOT COMPLETED|Overall Study||11
1629756|NCT00836407|3983412|P2|COMPLETED|Overall Study||7
1629757|NCT00836407|3983413|P1|COMPLETED|Overall Study||4
1629758|NCT00836407|3983412|P2|STARTED|Overall Study||15
1629759|NCT00836407|3983413|P1|STARTED|Overall Study||15
1629760|NCT00836355|3983425|P4|NOT COMPLETED|Overall Study||0
1629761|NCT00836355|3983426|P3|NOT COMPLETED|Overall Study||0
1629762|NCT00836355|3983427|P2|NOT COMPLETED|Overall Study||0
1629763|NCT00836355|3983428|P1|NOT COMPLETED|Overall Study||0
1629764|NCT00836355|3983425|P4|COMPLETED|Overall Study||2
1629765|NCT00836355|3983426|P3|COMPLETED|Overall Study||0
1629766|NCT00836355|3983427|P2|COMPLETED|Overall Study||4
1629767|NCT00836355|3983428|P1|COMPLETED|Overall Study||0
1629768|NCT00836355|3983425|P4|STARTED|Overall Study||2
1629769|NCT00836355|3983426|P3|STARTED|Overall Study||0
1629770|NCT00836355|3983427|P2|STARTED|Overall Study||4
1629771|NCT00836355|3983428|P1|STARTED|Overall Study||0
1629772|NCT00836342|3983449|P3|NOT COMPLETED|Overall Study||0
1629773|NCT00836342|3983450|P2|NOT COMPLETED|Overall Study||0
1629774|NCT00836342|3983451|P1|NOT COMPLETED|Overall Study||0
1629775|NCT00836342|3983449|P3|COMPLETED|Overall Study||36
1629776|NCT00836342|3983450|P2|COMPLETED|Overall Study||23
1629777|NCT00836342|3983451|P1|COMPLETED|Overall Study||22
1629778|NCT00836342|3983449|P3|STARTED|Overall Study||36
1629779|NCT00836342|3983450|P2|STARTED|Overall Study||23
1629780|NCT00836342|3983451|P1|STARTED|Overall Study||22
1629781|NCT00836277|3983462|P1|NOT COMPLETED|Overall Study||6
1629782|NCT00836277|3983462|P1|COMPLETED|Overall Study||18
1629783|NCT00836277|3983462|P1|STARTED|Overall Study||24
1629784|NCT00836095|3983472|P2|NOT COMPLETED|Overall Study||3
1629785|NCT00836095|3983473|P1|NOT COMPLETED|Overall Study||0
1629786|NCT00836095|3983472|P2|COMPLETED|Overall Study||27
1629787|NCT00836095|3983473|P1|COMPLETED|Overall Study||22
1629788|NCT00836095|3983472|P2|STARTED|Overall Study||30
1629789|NCT00836095|3983473|P1|STARTED|Overall Study||22
1629790|NCT00836056|3983483|P2|NOT COMPLETED|Second Intervention||0
1629791|NCT00836056|3983484|P1|NOT COMPLETED|Second Intervention||0
1629792|NCT00836056|3983483|P2|COMPLETED|Second Intervention||12
1629793|NCT00836056|3983484|P1|COMPLETED|Second Intervention||11
1629794|NCT00836056|3983483|P2|STARTED|Second Intervention||12
1629795|NCT00836056|3983484|P1|STARTED|Second Intervention||11
1629796|NCT00836056|3983483|P2|NOT COMPLETED|Washout: 7 Days||0
1629797|NCT00836056|3983484|P1|NOT COMPLETED|Washout: 7 Days||0
1629798|NCT00836056|3983483|P2|COMPLETED|Washout: 7 Days||12
1629799|NCT00836056|3983484|P1|COMPLETED|Washout: 7 Days||11
1629800|NCT00836056|3983483|P2|STARTED|Washout: 7 Days||12
1629801|NCT00836056|3983484|P1|STARTED|Washout: 7 Days||11
1629802|NCT00836056|3983483|P2|NOT COMPLETED|First Intervention||0
1629803|NCT00836056|3983484|P1|NOT COMPLETED|First Intervention||1
1629804|NCT00836056|3983483|P2|COMPLETED|First Intervention||12
1629805|NCT00836056|3983484|P1|COMPLETED|First Intervention||11
1629806|NCT00836056|3983483|P2|STARTED|First Intervention||12
1629807|NCT00836056|3983484|P1|STARTED|First Intervention||12
1629808|NCT00836017|3983492|P1|NOT COMPLETED|Overall Study||544
1629809|NCT00836017|3983492|P1|COMPLETED|Overall Study||502
1629810|NCT00836017|3983492|P1|STARTED|Overall Study||1046
1629811|NCT00836004|3983502|P2|NOT COMPLETED|Second Intervention||0
1629812|NCT00836004|3983503|P1|NOT COMPLETED|Second Intervention||0
1629813|NCT00836004|3983502|P2|COMPLETED|Second Intervention||12
1629814|NCT00836004|3983503|P1|COMPLETED|Second Intervention||12
1629815|NCT00836004|3983502|P2|STARTED|Second Intervention||12
1629816|NCT00836004|3983503|P1|STARTED|Second Intervention||12
1629817|NCT00836004|3983502|P2|NOT COMPLETED|Washout: 7 Days||0
1629818|NCT00836004|3983503|P1|NOT COMPLETED|Washout: 7 Days||0
1629819|NCT00836004|3983502|P2|COMPLETED|Washout: 7 Days||12
1629820|NCT00836004|3983503|P1|COMPLETED|Washout: 7 Days||12
1629821|NCT00836004|3983502|P2|STARTED|Washout: 7 Days||12
1629822|NCT00836004|3983503|P1|STARTED|Washout: 7 Days||12
1629823|NCT00836004|3983502|P2|NOT COMPLETED|First Intervention||0
1629824|NCT00836004|3983503|P1|NOT COMPLETED|First Intervention||0
1629825|NCT00836004|3983502|P2|COMPLETED|First Intervention||12
1629826|NCT00836004|3983503|P1|COMPLETED|First Intervention||12
1629827|NCT00836004|3983502|P2|STARTED|First Intervention||12
1629828|NCT00836004|3983503|P1|STARTED|First Intervention||12
1629829|NCT00835991|3983513|P2|NOT COMPLETED|Second Intervention||0
1629830|NCT00835991|3983514|P1|NOT COMPLETED|Second Intervention||0
1629831|NCT00835991|3983513|P2|COMPLETED|Second Intervention||26
1629832|NCT00835991|3983514|P1|COMPLETED|Second Intervention||27
1629833|NCT00835991|3983513|P2|STARTED|Second Intervention||26
1629834|NCT00835991|3983514|P1|STARTED|Second Intervention||27
1629835|NCT00835991|3983513|P2|NOT COMPLETED|Washout||3
1629836|NCT00835991|3983514|P1|NOT COMPLETED|Washout||3
1629837|NCT00835991|3983513|P2|COMPLETED|Washout||26
1629838|NCT00835991|3983514|P1|COMPLETED|Washout||27
1629839|NCT00835991|3983513|P2|STARTED|Washout||29
1629840|NCT00835991|3983514|P1|STARTED|Washout||30
1629841|NCT00835991|3983513|P2|NOT COMPLETED|First Intervention||1
1629842|NCT00835991|3983514|P1|NOT COMPLETED|First Intervention||0
1629843|NCT00835991|3983513|P2|COMPLETED|First Intervention||29
1629844|NCT00835991|3983514|P1|COMPLETED|First Intervention||30
1629845|NCT00835991|3983513|P2|STARTED|First Intervention||30
1629846|NCT00835991|3983514|P1|STARTED|First Intervention||30
1629847|NCT00835978|3983532|P4|NOT COMPLETED|Overall Study||10
1629848|NCT00835978|3983533|P3|NOT COMPLETED|Overall Study||91
1629849|NCT00835978|3983534|P2|NOT COMPLETED|Overall Study||56
1629850|NCT00835978|3983535|P1|NOT COMPLETED|Overall Study||56
1629851|NCT00835978|3983532|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1629852|NCT00835978|3983533|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1629853|NCT00835978|3983534|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1629854|NCT00835978|3983535|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1629855|NCT00835978|3983532|P4|Treated|Overall Study||10
1629856|NCT00835978|3983533|P3|Treated|Overall Study||91
1629857|NCT00835978|3983534|P2|Treated|Overall Study||56
1629858|NCT00835978|3983535|P1|Treated|Overall Study||56
1629859|NCT00835978|3983532|P4|STARTED|Overall Study||10
1629860|NCT00835978|3983533|P3|STARTED|Overall Study||91
1629861|NCT00835978|3983534|P2|STARTED|Overall Study||56
1629862|NCT00835978|3983535|P1|STARTED|Overall Study||56
1629863|NCT00835926|3983595|P2|NOT COMPLETED|Overall Study||0
1629864|NCT00835926|3983596|P1|NOT COMPLETED|Overall Study||0
1629865|NCT00835926|3983595|P2|COMPLETED|Overall Study||60
1629866|NCT00835926|3983596|P1|COMPLETED|Overall Study||61
1629867|NCT00835926|3983595|P2|STARTED|Overall Study||60
1629868|NCT00835926|3983596|P1|STARTED|Overall Study||61
1629869|NCT00835900|3983610|P2|NOT COMPLETED|Overall Study||6
1629870|NCT00835900|3983611|P1|NOT COMPLETED|Overall Study||5
1629871|NCT00835900|3983610|P2|COMPLETED|Overall Study||22
1629872|NCT00835900|3983611|P1|COMPLETED|Overall Study||27
1629873|NCT00835900|3983610|P2|STARTED|Overall Study||28
1629874|NCT00835900|3983611|P1|STARTED|Overall Study||32
1629875|NCT00835861|3983621|P2|NOT COMPLETED|Overall Study||2
1629876|NCT00835861|3983622|P1|NOT COMPLETED|Overall Study||1
1629877|NCT00835861|3983621|P2|COMPLETED|Overall Study||14
1629878|NCT00835861|3983622|P1|COMPLETED|Overall Study||14
1629879|NCT00835861|3983621|P2|STARTED|Overall Study||16
1629880|NCT00835861|3983622|P1|STARTED|Overall Study||15
1629881|NCT00835796|3983646|P2|NOT COMPLETED|Second Intervention||0
1629882|NCT00835796|3983647|P1|NOT COMPLETED|Second Intervention||0
1629883|NCT00835796|3983646|P2|COMPLETED|Second Intervention||9
1629884|NCT00835796|3983647|P1|COMPLETED|Second Intervention||10
1629885|NCT00835796|3983646|P2|STARTED|Second Intervention||9
1629886|NCT00835796|3983647|P1|STARTED|Second Intervention||10
1629887|NCT00835796|3983646|P2|NOT COMPLETED|Washout||0
1629888|NCT00835796|3983647|P1|NOT COMPLETED|Washout||0
1629889|NCT00835796|3983646|P2|COMPLETED|Washout||9
1629890|NCT00835796|3983647|P1|COMPLETED|Washout||10
1629891|NCT00835796|3983646|P2|STARTED|Washout||9
1629892|NCT00835796|3983647|P1|STARTED|Washout||10
1629893|NCT00835796|3983646|P2|NOT COMPLETED|First Intervention||1
1629894|NCT00835796|3983647|P1|NOT COMPLETED|First Intervention||0
1629895|NCT00835796|3983646|P2|COMPLETED|First Intervention||9
1629896|NCT00835796|3983647|P1|COMPLETED|First Intervention||10
1629897|NCT00835796|3983646|P2|STARTED|First Intervention||10
1629898|NCT00835796|3983647|P1|STARTED|First Intervention||10
1629899|NCT00835731|3983657|P2|NOT COMPLETED|Overall Study||1
1629900|NCT00835731|3983658|P1|NOT COMPLETED|Overall Study||2
1629901|NCT00835731|3983657|P2|COMPLETED|Overall Study||60
1629902|NCT00835731|3983658|P1|COMPLETED|Overall Study||62
1629903|NCT00835731|3983657|P2|STARTED|Overall Study||61
1629904|NCT00835731|3983658|P1|STARTED|Overall Study||64
1629905|NCT00835705|3983678|P2|NOT COMPLETED|Second Intervention||0
1629906|NCT00835705|3983679|P1|NOT COMPLETED|Second Intervention||1
1629907|NCT00835705|3983678|P2|COMPLETED|Second Intervention||28
1629908|NCT00835705|3983679|P1|COMPLETED|Second Intervention||22
1629909|NCT00835705|3983678|P2|STARTED|Second Intervention||28
1629910|NCT00835705|3983679|P1|STARTED|Second Intervention||23
1629911|NCT00835705|3983678|P2|NOT COMPLETED|First Intervention||0
1629912|NCT00835705|3983679|P1|NOT COMPLETED|First Intervention||1
1629913|NCT00835705|3983678|P2|COMPLETED|First Intervention||28
1629914|NCT00835705|3983679|P1|COMPLETED|First Intervention||23
1629915|NCT00835705|3983678|P2|STARTED|First Intervention||28
1629916|NCT00835705|3983679|P1|STARTED|First Intervention||24
1629917|NCT00835692|3983695|P2|NOT COMPLETED|Second Intervention||0
1629918|NCT00835692|3983696|P1|NOT COMPLETED|Second Intervention||0
1629919|NCT00835692|3983695|P2|COMPLETED|Second Intervention||28
1629920|NCT00835692|3983696|P1|COMPLETED|Second Intervention||27
1629921|NCT00835692|3983695|P2|STARTED|Second Intervention||28
1629922|NCT00835692|3983696|P1|STARTED|Second Intervention||27
1629923|NCT00835692|3983695|P2|NOT COMPLETED|Washout||0
1629924|NCT00835692|3983696|P1|NOT COMPLETED|Washout||0
1629925|NCT00835692|3983695|P2|COMPLETED|Washout||28
1629926|NCT00835692|3983696|P1|COMPLETED|Washout||27
1629927|NCT00835692|3983695|P2|STARTED|Washout||28
1629928|NCT00835692|3983696|P1|STARTED|Washout||27
1629929|NCT00835692|3983695|P2|NOT COMPLETED|First Intervention||0
1629930|NCT00835692|3983696|P1|NOT COMPLETED|First Intervention||1
1629931|NCT00835692|3983695|P2|COMPLETED|First Intervention||28
1629932|NCT00835692|3983696|P1|COMPLETED|First Intervention||27
1629933|NCT00835692|3983695|P2|STARTED|First Intervention||28
1629934|NCT00835692|3983696|P1|STARTED|First Intervention||28
1629935|NCT00835679|3983708|P4|NOT COMPLETED|Overall Study||0
1629936|NCT00835679|3983709|P3|NOT COMPLETED|Overall Study||0
1629937|NCT00835679|3983710|P2|NOT COMPLETED|Overall Study||0
1629938|NCT00835679|3983711|P1|NOT COMPLETED|Overall Study||1
1629939|NCT00835679|3983708|P4|COMPLETED|Overall Study||0
1629940|NCT00835679|3983709|P3|COMPLETED|Overall Study||0
1629941|NCT00835679|3983710|P2|COMPLETED|Overall Study||0
1629942|NCT00835679|3983711|P1|COMPLETED|Overall Study||8
1629943|NCT00835679|3983708|P4|STARTED|Overall Study||0
1629944|NCT00835679|3983709|P3|STARTED|Overall Study||0
1629945|NCT00835679|3983710|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
1629946|NCT00835679|3983711|P1|STARTED|Overall Study||9
1629947|NCT00835666|3983735|P2|NOT COMPLETED|Second Intervention||0
1629948|NCT00835666|3983736|P1|NOT COMPLETED|Second Intervention||0
1629949|NCT00835666|3983735|P2|COMPLETED|Second Intervention||16
1629950|NCT00835666|3983736|P1|COMPLETED|Second Intervention||14
1629951|NCT00835666|3983735|P2|STARTED|Second Intervention||16
1629952|NCT00835666|3983736|P1|STARTED|Second Intervention||14
1629953|NCT00835666|3983735|P2|NOT COMPLETED|Washout||0
1629954|NCT00835666|3983736|P1|NOT COMPLETED|Washout||2
1629955|NCT00835666|3983735|P2|COMPLETED|Washout||16
1629956|NCT00835666|3983736|P1|COMPLETED|Washout||14
1629957|NCT00835666|3983735|P2|STARTED|Washout||16
1629958|NCT00835666|3983736|P1|STARTED|Washout||16
1629959|NCT00835666|3983735|P2|NOT COMPLETED|First Intervention||0
1629960|NCT00835666|3983736|P1|NOT COMPLETED|First Intervention||0
1629961|NCT00835666|3983735|P2|COMPLETED|First Intervention||16
1629962|NCT00835666|3983736|P1|COMPLETED|First Intervention||16
1629963|NCT00835666|3983735|P2|STARTED|First Intervention||16
1629964|NCT00835666|3983736|P1|STARTED|First Intervention||16
1629965|NCT00835640|3983746|P2|NOT COMPLETED|Second Intervention||0
1629966|NCT00835640|3983747|P1|NOT COMPLETED|Second Intervention||1
1629967|NCT00835640|3983746|P2|COMPLETED|Second Intervention||12
1629968|NCT00835640|3983747|P1|COMPLETED|Second Intervention||11
1629969|NCT00835640|3983746|P2|STARTED|Second Intervention||12
1629970|NCT00835640|3983747|P1|STARTED|Second Intervention||12
1629971|NCT00835640|3983746|P2|NOT COMPLETED|Washout of 7 Days||0
1629972|NCT00835640|3983747|P1|NOT COMPLETED|Washout of 7 Days||0
1629973|NCT00835640|3983746|P2|COMPLETED|Washout of 7 Days||12
1629974|NCT00835640|3983747|P1|COMPLETED|Washout of 7 Days||12
1629975|NCT00835640|3983746|P2|STARTED|Washout of 7 Days||12
1629976|NCT00835640|3983747|P1|STARTED|Washout of 7 Days||12
1629977|NCT00835640|3983746|P2|NOT COMPLETED|First Intervention||0
1629978|NCT00835640|3983747|P1|NOT COMPLETED|First Intervention||0
1629979|NCT00835640|3983746|P2|COMPLETED|First Intervention||12
1629980|NCT00835640|3983747|P1|COMPLETED|First Intervention||12
1629981|NCT00835640|3983746|P2|STARTED|First Intervention||12
1629982|NCT00835640|3983747|P1|STARTED|First Intervention||12
1629983|NCT00835614|3983757|P2|NOT COMPLETED|Second Intervention||0
1629984|NCT00835614|3983758|P1|NOT COMPLETED|Second Intervention||0
1629985|NCT00835614|3983757|P2|COMPLETED|Second Intervention||13
1629986|NCT00835614|3983758|P1|COMPLETED|Second Intervention||13
1629987|NCT00835614|3983757|P2|STARTED|Second Intervention||13
1629988|NCT00835614|3983758|P1|STARTED|Second Intervention||13
1629989|NCT00835614|3983757|P2|NOT COMPLETED|Washout of 7 Days||0
1629990|NCT00835614|3983758|P1|NOT COMPLETED|Washout of 7 Days||0
1629991|NCT00835614|3983757|P2|COMPLETED|Washout of 7 Days||13
1629992|NCT00835614|3983758|P1|COMPLETED|Washout of 7 Days||13
1629993|NCT00835614|3983757|P2|STARTED|Washout of 7 Days||13
1629994|NCT00835614|3983758|P1|STARTED|Washout of 7 Days||13
1629995|NCT00835614|3983757|P2|NOT COMPLETED|First Intervention||0
1629996|NCT00835614|3983758|P1|NOT COMPLETED|First Intervention||0
1629997|NCT00835614|3983757|P2|COMPLETED|First Intervention||13
1629998|NCT00835614|3983758|P1|COMPLETED|First Intervention||13
1629999|NCT00835614|3983757|P2|STARTED|First Intervention||13
1630000|NCT00835614|3983758|P1|STARTED|First Intervention||13
1630001|NCT00835588|3983768|P2|NOT COMPLETED|Second Intervention||0
1630002|NCT00835588|3983769|P1|NOT COMPLETED|Second Intervention||0
1630003|NCT00835588|3983768|P2|COMPLETED|Second Intervention||50
1630004|NCT00835588|3983769|P1|COMPLETED|Second Intervention||50
1630005|NCT00835588|3983768|P2|STARTED|Second Intervention||50
1630006|NCT00835588|3983769|P1|STARTED|Second Intervention||50
1630007|NCT00835588|3983768|P2|NOT COMPLETED|Washout: 5 Days||0
1630008|NCT00835588|3983769|P1|NOT COMPLETED|Washout: 5 Days||0
1630009|NCT00835588|3983768|P2|COMPLETED|Washout: 5 Days||50
1630010|NCT00835588|3983769|P1|COMPLETED|Washout: 5 Days||50
1630011|NCT00835588|3983768|P2|STARTED|Washout: 5 Days||50
1630012|NCT00835588|3983769|P1|STARTED|Washout: 5 Days||50
1630013|NCT00835588|3983768|P2|NOT COMPLETED|First Intervention||0
1630014|NCT00835588|3983769|P1|NOT COMPLETED|First Intervention||0
1630015|NCT00835588|3983768|P2|COMPLETED|First Intervention||50
1630016|NCT00835588|3983769|P1|COMPLETED|First Intervention||50
1630017|NCT00835588|3983768|P2|STARTED|First Intervention||50
1630018|NCT00835588|3983769|P1|STARTED|First Intervention||50
1630019|NCT00835575|3983779|P2|NOT COMPLETED|Second Intervention||0
1630020|NCT00835575|3983780|P1|NOT COMPLETED|Second Intervention||0
1630021|NCT00835575|3983779|P2|COMPLETED|Second Intervention||16
1630022|NCT00835575|3983780|P1|COMPLETED|Second Intervention||15
1630023|NCT00835575|3983779|P2|STARTED|Second Intervention||16
1630024|NCT00835575|3983780|P1|STARTED|Second Intervention||15
1630025|NCT00835575|3983779|P2|NOT COMPLETED|Washout of 14 Days||0
1630026|NCT00835575|3983780|P1|NOT COMPLETED|Washout of 14 Days||1
1630027|NCT00835575|3983779|P2|COMPLETED|Washout of 14 Days||16
1630028|NCT00835575|3983780|P1|COMPLETED|Washout of 14 Days||15
1630029|NCT00835575|3983779|P2|STARTED|Washout of 14 Days||16
1630030|NCT00835575|3983780|P1|STARTED|Washout of 14 Days||16
1630031|NCT00835575|3983779|P2|NOT COMPLETED|First Intervention||0
1630032|NCT00835575|3983780|P1|NOT COMPLETED|First Intervention||0
1630033|NCT00835575|3983779|P2|COMPLETED|First Intervention||16
1630034|NCT00835575|3983780|P1|COMPLETED|First Intervention||16
1630035|NCT00835575|3983779|P2|STARTED|First Intervention||16
1630036|NCT00835575|3983780|P1|STARTED|First Intervention||16
1630037|NCT00835549|3983790|P2|NOT COMPLETED|Second Intervention||0
1630038|NCT00835549|3983791|P1|NOT COMPLETED|Second Intervention||0
1630039|NCT00835549|3983790|P2|COMPLETED|Second Intervention||16
1630040|NCT00835549|3983791|P1|COMPLETED|Second Intervention||14
1630041|NCT00835549|3983790|P2|STARTED|Second Intervention||16
1630042|NCT00835549|3983791|P1|STARTED|Second Intervention||14
1630043|NCT00835549|3983790|P2|NOT COMPLETED|Washout of 7 Days||0
1630044|NCT00835549|3983791|P1|NOT COMPLETED|Washout of 7 Days||2
1630045|NCT00835549|3983790|P2|COMPLETED|Washout of 7 Days||16
1630046|NCT00835549|3983791|P1|COMPLETED|Washout of 7 Days||14
1630047|NCT00835549|3983790|P2|STARTED|Washout of 7 Days||16
1630048|NCT00835549|3983791|P1|STARTED|Washout of 7 Days||16
1630049|NCT00835549|3983790|P2|NOT COMPLETED|First Intervention||0
1630050|NCT00835549|3983791|P1|NOT COMPLETED|First Intervention||0
1630051|NCT00835549|3983790|P2|COMPLETED|First Intervention||16
1630052|NCT00835549|3983791|P1|COMPLETED|First Intervention||16
1630053|NCT00835549|3983790|P2|STARTED|First Intervention||16
1630054|NCT00835549|3983791|P1|STARTED|First Intervention||16
1630055|NCT00835536|3983801|P2|NOT COMPLETED|Second Intervention||0
1630056|NCT00835536|3983802|P1|NOT COMPLETED|Second Intervention||0
1630057|NCT00835536|3983801|P2|COMPLETED|Second Intervention||14
1630058|NCT00835536|3983802|P1|COMPLETED|Second Intervention||12
1630059|NCT00835536|3983801|P2|STARTED|Second Intervention||14
1630060|NCT00835536|3983802|P1|STARTED|Second Intervention||12
1630061|NCT00835536|3983801|P2|NOT COMPLETED|Washout of 5 Weeks||0
1630062|NCT00835536|3983802|P1|NOT COMPLETED|Washout of 5 Weeks||1
1630063|NCT00835536|3983801|P2|COMPLETED|Washout of 5 Weeks||14
1630064|NCT00835536|3983802|P1|COMPLETED|Washout of 5 Weeks||12
1630065|NCT00835536|3983801|P2|STARTED|Washout of 5 Weeks||14
1630066|NCT00835536|3983802|P1|STARTED|Washout of 5 Weeks||13
1630067|NCT00835536|3983801|P2|NOT COMPLETED|First Intervention||0
1630068|NCT00835536|3983802|P1|NOT COMPLETED|First Intervention||0
1630069|NCT00835536|3983801|P2|COMPLETED|First Intervention||14
1630070|NCT00835536|3983802|P1|COMPLETED|First Intervention||13
1630071|NCT00835536|3983801|P2|STARTED|First Intervention||14
1630072|NCT00835536|3983802|P1|STARTED|First Intervention||13
1630073|NCT00835510|3983811|P3|NOT COMPLETED|Overall Study||38
1630074|NCT00835510|3983812|P2|NOT COMPLETED|Overall Study||69
1630075|NCT00835510|3983813|P1|NOT COMPLETED|Overall Study||76
1630076|NCT00835510|3983811|P3|COMPLETED|Overall Study||70
1630077|NCT00835510|3983812|P2|COMPLETED|Overall Study||152
1630078|NCT00835510|3983813|P1|COMPLETED|Overall Study||143
1630079|NCT00835510|3983811|P3|Positive Fungal Culture|Overall Study||71
1630080|NCT00835510|3983812|P2|Positive Fungal Culture|Overall Study||155
1630081|NCT00835510|3983813|P1|Positive Fungal Culture|Overall Study||149
1630082|NCT00835510|3983811|P3|STARTED|Overall Study||108
1630083|NCT00835510|3983812|P2|STARTED|Overall Study||221
1630084|NCT00835510|3983813|P1|STARTED|Overall Study||219
1630085|NCT00835497|3983835|P2|NOT COMPLETED|Second Intervention||0
1630086|NCT00835497|3983836|P1|NOT COMPLETED|Second Intervention||0
1630087|NCT00835497|3983835|P2|COMPLETED|Second Intervention||20
1630088|NCT00835497|3983836|P1|COMPLETED|Second Intervention||20
1630089|NCT00835497|3983835|P2|STARTED|Second Intervention||20
1630090|NCT00835497|3983836|P1|STARTED|Second Intervention||20
1630091|NCT00835497|3983835|P2|NOT COMPLETED|Washout: 7 Days||0
1630092|NCT00835497|3983836|P1|NOT COMPLETED|Washout: 7 Days||0
1630093|NCT00835497|3983835|P2|COMPLETED|Washout: 7 Days||20
1630094|NCT00835497|3983836|P1|COMPLETED|Washout: 7 Days||20
1630095|NCT00835497|3983835|P2|STARTED|Washout: 7 Days||20
1630096|NCT00835497|3983836|P1|STARTED|Washout: 7 Days||20
1630097|NCT00835497|3983835|P2|NOT COMPLETED|First Intervention||0
1630098|NCT00835497|3983836|P1|NOT COMPLETED|First Intervention||0
1630099|NCT00835497|3983835|P2|COMPLETED|First Intervention||20
1630100|NCT00835497|3983836|P1|COMPLETED|First Intervention||20
1630101|NCT00835497|3983835|P2|STARTED|First Intervention||20
1630102|NCT00835497|3983836|P1|STARTED|First Intervention||20
1630103|NCT00835484|3983852|P2|NOT COMPLETED|Second Intervention||0
1630104|NCT00835484|3983853|P1|NOT COMPLETED|Second Intervention||0
1630105|NCT00835484|3983852|P2|COMPLETED|Second Intervention||16
1630106|NCT00835484|3983853|P1|COMPLETED|Second Intervention||16
1630107|NCT00835484|3983852|P2|STARTED|Second Intervention||16
1630108|NCT00835484|3983853|P1|STARTED|Second Intervention||16
1630109|NCT00835484|3983852|P2|NOT COMPLETED|Washout of 7 Days||0
1630110|NCT00835484|3983853|P1|NOT COMPLETED|Washout of 7 Days||0
1630111|NCT00835484|3983852|P2|COMPLETED|Washout of 7 Days||16
1630112|NCT00835484|3983853|P1|COMPLETED|Washout of 7 Days||16
1630113|NCT00835484|3983852|P2|STARTED|Washout of 7 Days||16
1630114|NCT00835484|3983853|P1|STARTED|Washout of 7 Days||16
1630115|NCT00835484|3983852|P2|NOT COMPLETED|First Intervention||0
1630116|NCT00835484|3983853|P1|NOT COMPLETED|First Intervention||0
1630117|NCT00835484|3983852|P2|COMPLETED|First Intervention||16
1630118|NCT00835484|3983853|P1|COMPLETED|First Intervention||16
1630119|NCT00835484|3983852|P2|STARTED|First Intervention||16
1630120|NCT00835484|3983853|P1|STARTED|First Intervention||16
1630121|NCT00835406|3983863|P2|NOT COMPLETED|Period: Second Intervention||0
1630122|NCT00835406|3983864|P1|NOT COMPLETED|Period: Second Intervention||0
1630123|NCT00835406|3983863|P2|COMPLETED|Period: Second Intervention||67
1630124|NCT00835406|3983864|P1|COMPLETED|Period: Second Intervention||68
1630125|NCT00835406|3983863|P2|STARTED|Period: Second Intervention||67
1630126|NCT00835406|3983864|P1|STARTED|Period: Second Intervention||68
1630127|NCT00835406|3983863|P2|NOT COMPLETED|Period: Washout of 7 Days||2
1630128|NCT00835406|3983864|P1|NOT COMPLETED|Period: Washout of 7 Days||0
1630129|NCT00835406|3983863|P2|COMPLETED|Period: Washout of 7 Days||67
1630130|NCT00835406|3983864|P1|COMPLETED|Period: Washout of 7 Days||68
1630131|NCT00835406|3983863|P2|STARTED|Period: Washout of 7 Days||69
1630132|NCT00835406|3983864|P1|STARTED|Period: Washout of 7 Days||68
1630133|NCT00835406|3983863|P2|NOT COMPLETED|Period: First Intervention||1
1630134|NCT00835406|3983864|P1|NOT COMPLETED|Period: First Intervention||2
1630135|NCT00835406|3983863|P2|COMPLETED|Period: First Intervention||69
1630136|NCT00835406|3983864|P1|COMPLETED|Period: First Intervention||68
1630137|NCT00835406|3983863|P2|STARTED|Period: First Intervention||70
1630138|NCT00835406|3983864|P1|STARTED|Period: First Intervention||70
1630139|NCT00835380|3983870|P1|NOT COMPLETED|Overall Study||2
1630140|NCT00835380|3983870|P1|COMPLETED|Overall Study||78
1630141|NCT00835380|3983870|P1|STARTED|Overall Study||80
1630142|NCT00835367|3983877|P2|NOT COMPLETED|Second Intervention||1
1630143|NCT00835367|3983878|P1|NOT COMPLETED|Second Intervention||1
1630144|NCT00835367|3983877|P2|COMPLETED|Second Intervention||33
1630145|NCT00835367|3983878|P1|COMPLETED|Second Intervention||30
1630146|NCT00835367|3983877|P2|STARTED|Second Intervention||34
1630147|NCT00835367|3983878|P1|STARTED|Second Intervention||31
1630148|NCT00835367|3983877|P2|NOT COMPLETED|Washout||0
1630149|NCT00835367|3983878|P1|NOT COMPLETED|Washout||3
1630150|NCT00835367|3983877|P2|COMPLETED|Washout||34
1630151|NCT00835367|3983878|P1|COMPLETED|Washout||31
1630152|NCT00835367|3983877|P2|STARTED|Washout||34
1630153|NCT00835367|3983878|P1|STARTED|Washout||34
1630154|NCT00835367|3983877|P2|NOT COMPLETED|First Intervention||0
1630155|NCT00835367|3983878|P1|NOT COMPLETED|First Intervention||0
1630156|NCT00835367|3983877|P2|COMPLETED|First Intervention||34
1630157|NCT00835367|3983878|P1|COMPLETED|First Intervention||34
1630158|NCT00835367|3983877|P2|STARTED|First Intervention||34
1630159|NCT00835367|3983878|P1|STARTED|First Intervention||34
1630160|NCT00835354|3983900|P2|NOT COMPLETED|Second Intervention||0
1630161|NCT00835354|3983901|P1|NOT COMPLETED|Second Intervention||0
1630162|NCT00835354|3983900|P2|COMPLETED|Second Intervention||12
1630163|NCT00835354|3983901|P1|COMPLETED|Second Intervention||13
1630164|NCT00835354|3983900|P2|STARTED|Second Intervention||12
1630165|NCT00835354|3983901|P1|STARTED|Second Intervention||13
1630166|NCT00835354|3983900|P2|NOT COMPLETED|Washout of 7 Days||0
1630167|NCT00835354|3983901|P1|NOT COMPLETED|Washout of 7 Days||0
1630168|NCT00835354|3983900|P2|COMPLETED|Washout of 7 Days||12
1630169|NCT00835354|3983901|P1|COMPLETED|Washout of 7 Days||13
1630170|NCT00835354|3983900|P2|STARTED|Washout of 7 Days||12
1630171|NCT00835354|3983901|P1|STARTED|Washout of 7 Days||13
1630172|NCT00835354|3983900|P2|NOT COMPLETED|First Intervention||1
1630173|NCT00835354|3983901|P1|NOT COMPLETED|First Intervention||0
1630174|NCT00835354|3983900|P2|COMPLETED|First Intervention||12
1630175|NCT00835354|3983901|P1|COMPLETED|First Intervention||13
1630176|NCT00835354|3983900|P2|STARTED|First Intervention||13
1630177|NCT00835354|3983901|P1|STARTED|First Intervention||13
1630178|NCT00835341|3983911|P2|NOT COMPLETED|Overall Study||12
1630179|NCT00835341|3983912|P1|NOT COMPLETED|Overall Study||3
1630180|NCT00835341|3983911|P2|COMPLETED|Overall Study||46
1630181|NCT00835341|3983912|P1|COMPLETED|Overall Study||32
1630182|NCT00835341|3983911|P2|STARTED|Overall Study||58
1630183|NCT00835341|3983912|P1|STARTED|Overall Study||35
1630184|NCT00835276|3983920|P2|NOT COMPLETED|Second Intervention||0
1630185|NCT00835276|3983921|P1|NOT COMPLETED|Second Intervention||0
1630186|NCT00835276|3983920|P2|COMPLETED|Second Intervention||24
1630187|NCT00835276|3983921|P1|COMPLETED|Second Intervention||24
1630188|NCT00835276|3983920|P2|STARTED|Second Intervention||24
1630189|NCT00835276|3983921|P1|STARTED|Second Intervention||24
1630190|NCT00835276|3983920|P2|NOT COMPLETED|Washout of 7 Days||0
1630191|NCT00835276|3983921|P1|NOT COMPLETED|Washout of 7 Days||0
1630192|NCT00835276|3983920|P2|COMPLETED|Washout of 7 Days||24
1630193|NCT00835276|3983921|P1|COMPLETED|Washout of 7 Days||24
1630194|NCT00835276|3983920|P2|STARTED|Washout of 7 Days||24
1630195|NCT00835276|3983921|P1|STARTED|Washout of 7 Days||24
1630196|NCT00835276|3983920|P2|NOT COMPLETED|First Intervention||0
1630197|NCT00835276|3983921|P1|NOT COMPLETED|First Intervention||0
1630198|NCT00835276|3983920|P2|COMPLETED|First Intervention||24
1630199|NCT00835276|3983921|P1|COMPLETED|First Intervention||24
1630200|NCT00835276|3983920|P2|STARTED|First Intervention||24
1630201|NCT00835276|3983921|P1|STARTED|First Intervention||24
1630202|NCT00835263|3983931|P2|NOT COMPLETED|Second Intervention||0
1630203|NCT00835263|3983932|P1|NOT COMPLETED|Second Intervention||1
1630204|NCT00835263|3983931|P2|COMPLETED|Second Intervention||16
1630205|NCT00835263|3983932|P1|COMPLETED|Second Intervention||15
1630206|NCT00835263|3983931|P2|STARTED|Second Intervention||16
1630207|NCT00835263|3983932|P1|STARTED|Second Intervention||16
1630208|NCT00835263|3983931|P2|NOT COMPLETED|First Intervention||0
1630209|NCT00835263|3983932|P1|NOT COMPLETED|First Intervention||0
1630210|NCT00835263|3983931|P2|COMPLETED|First Intervention||16
1630211|NCT00835263|3983932|P1|COMPLETED|First Intervention||16
1630212|NCT00835263|3983931|P2|STARTED|First Intervention||16
1630213|NCT00835263|3983932|P1|STARTED|First Intervention||16
1630214|NCT00835237|3983942|P2|NOT COMPLETED|Overall Study||0
1630215|NCT00835237|3983943|P1|NOT COMPLETED|Overall Study||6
1630216|NCT00835237|3983942|P2|COMPLETED|Overall Study||445
1630217|NCT00835237|3983943|P1|COMPLETED|Overall Study||881
1630218|NCT00835237|3983942|P2|STARTED|Overall Study||445
1630219|NCT00835237|3983943|P1|STARTED|Overall Study||887
1630220|NCT00835224|3983967|P1|NOT COMPLETED|Overall Study||10
1630221|NCT00835224|3983967|P1|COMPLETED|Overall Study||24
1630222|NCT00835224|3983967|P1|STARTED|Overall Study||34
1630223|NCT00835211|3983983|P2|NOT COMPLETED|Second Intervention||0
1630224|NCT00835211|3983984|P1|NOT COMPLETED|Second Intervention||0
1630225|NCT00835211|3983983|P2|COMPLETED|Second Intervention||22
1630226|NCT00835211|3983984|P1|COMPLETED|Second Intervention||21
1630227|NCT00835211|3983983|P2|STARTED|Second Intervention||22
1630228|NCT00835211|3983984|P1|STARTED|Second Intervention||21
1630229|NCT00835211|3983983|P2|NOT COMPLETED|Washout: 7 Days||1
1630230|NCT00835211|3983984|P1|NOT COMPLETED|Washout: 7 Days||3
1630231|NCT00835211|3983983|P2|COMPLETED|Washout: 7 Days||22
1630232|NCT00835211|3983984|P1|COMPLETED|Washout: 7 Days||21
1630233|NCT00835211|3983983|P2|STARTED|Washout: 7 Days||23
1630234|NCT00835211|3983984|P1|STARTED|Washout: 7 Days||24
1630235|NCT00835211|3983983|P2|NOT COMPLETED|First Intervention||1
1630236|NCT00835211|3983984|P1|NOT COMPLETED|First Intervention||0
1630237|NCT00835211|3983983|P2|COMPLETED|First Intervention||23
1630238|NCT00835211|3983984|P1|COMPLETED|First Intervention||24
1630239|NCT00835211|3983983|P2|STARTED|First Intervention||24
1630240|NCT00835211|3983984|P1|STARTED|First Intervention||24
1630241|NCT00835198|3983994|P2|NOT COMPLETED|Overall Study||7
1630242|NCT00835198|3983995|P1|NOT COMPLETED|Overall Study||8
1630243|NCT00835198|3983994|P2|COMPLETED|Overall Study||74
1630244|NCT00835198|3983995|P1|COMPLETED|Overall Study||74
1630245|NCT00835198|3983994|P2|STARTED|Overall Study||81
1630246|NCT00835198|3983995|P1|STARTED|Overall Study||82
1630247|NCT00835185|3984007|P1|NOT COMPLETED|Overall Study||0
1630248|NCT00835185|3984007|P1|COMPLETED|Overall Study||44
1630249|NCT00835185|3984007|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
1630250|NCT00835185|3984007|P1|STARTED|Overall Study||44
1630251|NCT00835172|3984030|P2|NOT COMPLETED|Second Intervention||0
1630252|NCT00835172|3984031|P1|NOT COMPLETED|Second Intervention||0
1630253|NCT00835172|3984030|P2|COMPLETED|Second Intervention||15
1630254|NCT00835172|3984031|P1|COMPLETED|Second Intervention||16
1630255|NCT00835172|3984030|P2|STARTED|Second Intervention||15
1630256|NCT00835172|3984031|P1|STARTED|Second Intervention||16
1630257|NCT00835172|3984030|P2|NOT COMPLETED|Washout||1
1630258|NCT00835172|3984031|P1|NOT COMPLETED|Washout||0
1630259|NCT00835172|3984030|P2|COMPLETED|Washout||15
1630260|NCT00835172|3984031|P1|COMPLETED|Washout||16
1630261|NCT00835172|3984030|P2|STARTED|Washout||16
1630262|NCT00835172|3984031|P1|STARTED|Washout||16
1630263|NCT00835172|3984030|P2|NOT COMPLETED|First Intervention||0
1630264|NCT00835172|3984031|P1|NOT COMPLETED|First Intervention||0
1630265|NCT00835172|3984030|P2|COMPLETED|First Intervention||16
1630266|NCT00835172|3984031|P1|COMPLETED|First Intervention||16
1630267|NCT00835172|3984030|P2|STARTED|First Intervention||16
1630268|NCT00835172|3984031|P1|STARTED|First Intervention||16
1630269|NCT00835159|3984041|P2|NOT COMPLETED|Overall Study||0
1630270|NCT00835159|3984042|P1|NOT COMPLETED|Overall Study||0
1630271|NCT00835159|3984041|P2|COMPLETED|Overall Study||17
1630272|NCT00835159|3984042|P1|COMPLETED|Overall Study||11
1630273|NCT00835159|3984041|P2|STARTED|Overall Study||17
1630274|NCT00835159|3984042|P1|STARTED|Overall Study||11
1630275|NCT00835146|3984050|P2|NOT COMPLETED|Second Intervention||0
1630276|NCT00835146|3984051|P1|NOT COMPLETED|Second Intervention||0
1630277|NCT00835146|3984050|P2|COMPLETED|Second Intervention||14
1630278|NCT00835146|3984051|P1|COMPLETED|Second Intervention||14
1630279|NCT00835146|3984050|P2|STARTED|Second Intervention||14
1630280|NCT00835146|3984051|P1|STARTED|Second Intervention||14
1630281|NCT00835146|3984050|P2|NOT COMPLETED|Washout of 5 Weeks||0
1630282|NCT00835146|3984051|P1|NOT COMPLETED|Washout of 5 Weeks||0
1630283|NCT00835146|3984050|P2|COMPLETED|Washout of 5 Weeks||14
1630284|NCT00835146|3984051|P1|COMPLETED|Washout of 5 Weeks||14
1630285|NCT00835146|3984050|P2|STARTED|Washout of 5 Weeks||14
1630286|NCT00835146|3984051|P1|STARTED|Washout of 5 Weeks||14
1630287|NCT00835146|3984050|P2|NOT COMPLETED|First Intervention||0
1630288|NCT00835146|3984051|P1|NOT COMPLETED|First Intervention||0
1630289|NCT00835146|3984050|P2|COMPLETED|First Intervention||14
1630290|NCT00835146|3984051|P1|COMPLETED|First Intervention||14
1630291|NCT00835146|3984050|P2|STARTED|First Intervention||14
1630292|NCT00835146|3984051|P1|STARTED|First Intervention||14
1630293|NCT00835120|3984057|P1|NOT COMPLETED|Overall Study||8
1630294|NCT00835120|3984057|P1|COMPLETED|Overall Study||26
1630295|NCT00835120|3984057|P1|STARTED|Overall Study||34
1630296|NCT00835081|3984067|P2|NOT COMPLETED|Second Intervention||0
1630297|NCT00835081|3984068|P1|NOT COMPLETED|Second Intervention||0
1630298|NCT00835081|3984067|P2|COMPLETED|Second Intervention||13
1630299|NCT00835081|3984068|P1|COMPLETED|Second Intervention||12
1630300|NCT00835081|3984067|P2|STARTED|Second Intervention||13
1630301|NCT00835081|3984068|P1|STARTED|Second Intervention||12
1630302|NCT00835081|3984067|P2|NOT COMPLETED|Washout of 7 Days||0
1630303|NCT00835081|3984068|P1|NOT COMPLETED|Washout of 7 Days||1
1630304|NCT00835081|3984067|P2|COMPLETED|Washout of 7 Days||13
1630305|NCT00835081|3984068|P1|COMPLETED|Washout of 7 Days||12
1630306|NCT00835081|3984067|P2|STARTED|Washout of 7 Days||13
1630307|NCT00835081|3984068|P1|STARTED|Washout of 7 Days||13
1630308|NCT00835081|3984067|P2|NOT COMPLETED|First Intervention||0
1630309|NCT00835081|3984068|P1|NOT COMPLETED|First Intervention||0
1630310|NCT00835081|3984067|P2|COMPLETED|First Intervention||13
1630311|NCT00835081|3984068|P1|COMPLETED|First Intervention||13
1630312|NCT00835081|3984067|P2|STARTED|First Intervention||13
1630313|NCT00835081|3984068|P1|STARTED|First Intervention||13
1630314|NCT00835068|3984078|P2|NOT COMPLETED|Overall Study||1
1630315|NCT00835068|3984079|P1|NOT COMPLETED|Overall Study||10
1630316|NCT00835068|3984078|P2|COMPLETED|Overall Study||0
1630317|NCT00835068|3984079|P1|COMPLETED|Overall Study||47
1630318|NCT00835068|3984078|P2|STARTED|Overall Study||1
1630319|NCT00835068|3984079|P1|STARTED|Overall Study||57
1630320|NCT00835042|3984099|P2|NOT COMPLETED|Second Intervention||0
1630321|NCT00835042|3984100|P1|NOT COMPLETED|Second Intervention||0
1630322|NCT00835042|3984099|P2|COMPLETED|Second Intervention||24
1630323|NCT00835042|3984100|P1|COMPLETED|Second Intervention||26
1630324|NCT00835042|3984099|P2|STARTED|Second Intervention||24
1630325|NCT00835042|3984100|P1|STARTED|Second Intervention||26
1630326|NCT00835042|3984099|P2|NOT COMPLETED|Washout of 21 Days||2
1630327|NCT00835042|3984100|P1|NOT COMPLETED|Washout of 21 Days||0
1630328|NCT00835042|3984099|P2|COMPLETED|Washout of 21 Days||24
1630329|NCT00835042|3984100|P1|COMPLETED|Washout of 21 Days||26
1630330|NCT00835042|3984099|P2|STARTED|Washout of 21 Days||26
1630331|NCT00835042|3984100|P1|STARTED|Washout of 21 Days||26
1630332|NCT00835042|3984099|P2|NOT COMPLETED|First Intervention||2
1630333|NCT00835042|3984100|P1|NOT COMPLETED|First Intervention||4
1630334|NCT00835042|3984099|P2|COMPLETED|First Intervention||26
1630335|NCT00835042|3984100|P1|COMPLETED|First Intervention||26
1630336|NCT00835042|3984099|P2|STARTED|First Intervention||28
1630337|NCT00835042|3984100|P1|STARTED|First Intervention||30
1630338|NCT00835003|3984122|P2|NOT COMPLETED|Overall Study||0
1630339|NCT00835003|3984123|P1|NOT COMPLETED|Overall Study||0
1630340|NCT00835003|3984122|P2|COMPLETED|Overall Study||638
1630341|NCT00835003|3984123|P1|COMPLETED|Overall Study||636
1630342|NCT00835003|3984122|P2|STARTED|Overall Study||638
1630343|NCT00835003|3984123|P1|STARTED|Overall Study||636
1630344|NCT00834990|3984131|P2|NOT COMPLETED|Second Intervention||0
1630345|NCT00834990|3984132|P1|NOT COMPLETED|Second Intervention||0
1630346|NCT00834990|3984131|P2|COMPLETED|Second Intervention||11
1630347|NCT00834990|3984132|P1|COMPLETED|Second Intervention||12
1630348|NCT00834990|3984131|P2|STARTED|Second Intervention||11
1630349|NCT00834990|3984132|P1|STARTED|Second Intervention||12
1630350|NCT00834990|3984131|P2|NOT COMPLETED|Washout of 7 Days||0
1630351|NCT00834990|3984132|P1|NOT COMPLETED|Washout of 7 Days||0
1630352|NCT00834990|3984131|P2|COMPLETED|Washout of 7 Days||11
1630353|NCT00834990|3984132|P1|COMPLETED|Washout of 7 Days||12
1630354|NCT00834990|3984131|P2|STARTED|Washout of 7 Days||11
1630355|NCT00834990|3984132|P1|STARTED|Washout of 7 Days||12
1630356|NCT00834990|3984131|P2|NOT COMPLETED|First Intervention||0
1630357|NCT00834990|3984132|P1|NOT COMPLETED|First Intervention||0
1630358|NCT00834990|3984131|P2|COMPLETED|First Intervention||11
1630359|NCT00834990|3984132|P1|COMPLETED|First Intervention||12
1630360|NCT00834990|3984131|P2|STARTED|First Intervention||11
1630361|NCT00834990|3984132|P1|STARTED|First Intervention||12
1630362|NCT00834977|3984142|P2|NOT COMPLETED|Second Intervention||0
1630363|NCT00834977|3984143|P1|NOT COMPLETED|Second Intervention||0
1630364|NCT00834977|3984142|P2|COMPLETED|Second Intervention||24
1630365|NCT00834977|3984143|P1|COMPLETED|Second Intervention||24
1630366|NCT00834977|3984142|P2|STARTED|Second Intervention||24
1630367|NCT00834977|3984143|P1|STARTED|Second Intervention||24
1630368|NCT00834977|3984142|P2|NOT COMPLETED|First Intervention||0
1630369|NCT00834977|3984143|P1|NOT COMPLETED|First Intervention||0
1630370|NCT00834977|3984142|P2|COMPLETED|First Intervention||24
1630371|NCT00834977|3984143|P1|COMPLETED|First Intervention||24
1630372|NCT00834977|3984142|P2|STARTED|First Intervention||24
1630373|NCT00834977|3984143|P1|STARTED|First Intervention||24
1630374|NCT00834964|3984165|P2|NOT COMPLETED|Second Intervention||0
1630375|NCT00834964|3984166|P1|NOT COMPLETED|Second Intervention||0
1630376|NCT00834964|3984165|P2|COMPLETED|Second Intervention||15
1630377|NCT00834964|3984166|P1|COMPLETED|Second Intervention||15
1630378|NCT00834964|3984165|P2|STARTED|Second Intervention||15
1630379|NCT00834964|3984166|P1|STARTED|Second Intervention||15
1630380|NCT00834964|3984165|P2|NOT COMPLETED|Washout: 7 Days||0
1630381|NCT00834964|3984166|P1|NOT COMPLETED|Washout: 7 Days||0
1630382|NCT00834964|3984165|P2|COMPLETED|Washout: 7 Days||15
1630383|NCT00834964|3984166|P1|COMPLETED|Washout: 7 Days||15
1630384|NCT00834964|3984165|P2|STARTED|Washout: 7 Days||15
1630385|NCT00834964|3984166|P1|STARTED|Washout: 7 Days||15
1630386|NCT00834964|3984165|P2|NOT COMPLETED|First Intervention||0
1630387|NCT00834964|3984166|P1|NOT COMPLETED|First Intervention||0
1630388|NCT00834964|3984165|P2|COMPLETED|First Intervention||15
1630389|NCT00834964|3984166|P1|COMPLETED|First Intervention||15
1630390|NCT00834964|3984165|P2|STARTED|First Intervention||15
1630391|NCT00834964|3984166|P1|STARTED|First Intervention||15
1630392|NCT00834912|3984186|P6|NOT COMPLETED|Treatment Period 3||0
1630393|NCT00834912|3984187|P5|NOT COMPLETED|Treatment Period 3||0
1630394|NCT00834912|3984188|P4|NOT COMPLETED|Treatment Period 3||0
1630395|NCT00834912|3984189|P3|NOT COMPLETED|Treatment Period 3||0
1630396|NCT00834912|3984190|P2|NOT COMPLETED|Treatment Period 3||0
1630397|NCT00834912|3984191|P1|NOT COMPLETED|Treatment Period 3||0
1630398|NCT00834912|3984186|P6|COMPLETED|Treatment Period 3||6
1630399|NCT00834912|3984187|P5|COMPLETED|Treatment Period 3||5
1630400|NCT00834912|3984188|P4|COMPLETED|Treatment Period 3||5
1630401|NCT00834912|3984189|P3|COMPLETED|Treatment Period 3||5
1630402|NCT00834912|3984190|P2|COMPLETED|Treatment Period 3||5
1630403|NCT00834912|3984191|P1|COMPLETED|Treatment Period 3||6
1630404|NCT00834912|3984186|P6|STARTED|Treatment Period 3||6
1630405|NCT00834912|3984187|P5|STARTED|Treatment Period 3||5
1630406|NCT00834912|3984188|P4|STARTED|Treatment Period 3||5
1630407|NCT00834912|3984189|P3|STARTED|Treatment Period 3||5
1630408|NCT00834912|3984190|P2|STARTED|Treatment Period 3||5
1630409|NCT00834912|3984191|P1|STARTED|Treatment Period 3||6
1630410|NCT00834912|3984186|P6|NOT COMPLETED|Treatment Period 2||0
1630411|NCT00834912|3984187|P5|NOT COMPLETED|Treatment Period 2||1
1630412|NCT00834912|3984188|P4|NOT COMPLETED|Treatment Period 2||0
1630413|NCT00834912|3984189|P3|NOT COMPLETED|Treatment Period 2||1
1630414|NCT00834912|3984190|P2|NOT COMPLETED|Treatment Period 2||0
1630415|NCT00834912|3984191|P1|NOT COMPLETED|Treatment Period 2||0
1630416|NCT00834912|3984186|P6|COMPLETED|Treatment Period 2||6
1630417|NCT00834912|3984187|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
1630418|NCT00834912|3984188|P4|COMPLETED|Treatment Period 2||5
1630419|NCT00834912|3984189|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
1630420|NCT00834912|3984190|P2|COMPLETED|Treatment Period 2||5
1630421|NCT00834912|3984191|P1|COMPLETED|Treatment Period 2||6
1630422|NCT00834912|3984186|P6|STARTED|Treatment Period 2||6
1630423|NCT00834912|3984187|P5|STARTED|Treatment Period 2||6
1630424|NCT00834912|3984188|P4|STARTED|Treatment Period 2||5
1630425|NCT00834912|3984189|P3|STARTED|Treatment Period 2||6
1630426|NCT00834912|3984190|P2|STARTED|Treatment Period 2||5
1630427|NCT00834912|3984191|P1|STARTED|Treatment Period 2||6
1630428|NCT00834912|3984186|P6|NOT COMPLETED|Treatment Period 1||0
1630429|NCT00834912|3984187|P5|NOT COMPLETED|Treatment Period 1||0
1630430|NCT00834912|3984188|P4|NOT COMPLETED|Treatment Period 1||1
1630431|NCT00834912|3984189|P3|NOT COMPLETED|Treatment Period 1||0
1630432|NCT00834912|3984190|P2|NOT COMPLETED|Treatment Period 1||1
1630433|NCT00834912|3984191|P1|NOT COMPLETED|Treatment Period 1||0
1630434|NCT00834912|3984186|P6|COMPLETED|Treatment Period 1||6
1630435|NCT00834912|3984187|P5|COMPLETED|Treatment Period 1||6
1630436|NCT00834912|3984188|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
1630437|NCT00834912|3984189|P3|COMPLETED|Treatment Period 1||6
1630438|NCT00834912|3984190|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
1630439|NCT00834912|3984191|P1|COMPLETED|Treatment Period 1||6
1630440|NCT00834912|3984186|P6|STARTED|Treatment Period 1||6
1630441|NCT00834912|3984187|P5|STARTED|Treatment Period 1||6
1630442|NCT00834912|3984188|P4|STARTED|Treatment Period 1||6
1630443|NCT00834912|3984189|P3|STARTED|Treatment Period 1||6
1630444|NCT00834912|3984190|P2|STARTED|Treatment Period 1||6
1630445|NCT00834912|3984191|P1|STARTED|Treatment Period 1||6
1630446|NCT00834899|3984213|P2|NOT COMPLETED|Overall Study||1
1630447|NCT00834899|3984214|P1|NOT COMPLETED|Overall Study||1
1630448|NCT00834899|3984213|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
1630449|NCT00834899|3984214|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
1630450|NCT00834899|3984213|P2|STARTED|Overall Study||4
1630451|NCT00834899|3984214|P1|STARTED|Overall Study||9
1630452|NCT00834886|3984230|P4|NOT COMPLETED|Overall Study||0
1630453|NCT00834886|3984231|P3|NOT COMPLETED|Overall Study||1
1630454|NCT00834886|3984232|P2|NOT COMPLETED|Overall Study||1
1630455|NCT00834886|3984233|P1|NOT COMPLETED|Overall Study||0
1630456|NCT00834886|3984230|P4|COMPLETED|Overall Study||10
1630457|NCT00834886|3984231|P3|COMPLETED|Overall Study||9
1630458|NCT00834886|3984232|P2|COMPLETED|Overall Study||9
1630459|NCT00834886|3984233|P1|COMPLETED|Overall Study||10
1630460|NCT00834886|3984230|P4|STARTED|Overall Study||10
1630461|NCT00834886|3984231|P3|STARTED|Overall Study||10
1630462|NCT00834886|3984232|P2|STARTED|Overall Study||10
1630463|NCT00834886|3984233|P1|STARTED|Overall Study||10
1630464|NCT00834873|3984253|P2|NOT COMPLETED|Second Intervention||0
1630465|NCT00834873|3984254|P1|NOT COMPLETED|Second Intervention||0
1630466|NCT00834873|3984253|P2|COMPLETED|Second Intervention||11
1630467|NCT00834873|3984254|P1|COMPLETED|Second Intervention||12
1630468|NCT00834873|3984253|P2|STARTED|Second Intervention||11
1630469|NCT00834873|3984254|P1|STARTED|Second Intervention||12
1630470|NCT00834873|3984253|P2|NOT COMPLETED|Washout: 7 Days||0
1630471|NCT00834873|3984254|P1|NOT COMPLETED|Washout: 7 Days||0
1630472|NCT00834873|3984253|P2|COMPLETED|Washout: 7 Days||11
1630473|NCT00834873|3984254|P1|COMPLETED|Washout: 7 Days||12
1630474|NCT00834873|3984253|P2|STARTED|Washout: 7 Days||11
1630475|NCT00834873|3984254|P1|STARTED|Washout: 7 Days||12
1630476|NCT00834873|3984253|P2|NOT COMPLETED|First Intervention||1
1630477|NCT00834873|3984254|P1|NOT COMPLETED|First Intervention||0
1630478|NCT00834873|3984253|P2|COMPLETED|First Intervention||11
1630479|NCT00834873|3984254|P1|COMPLETED|First Intervention||12
1630480|NCT00834873|3984253|P2|STARTED|First Intervention||12
1630481|NCT00834873|3984254|P1|STARTED|First Intervention||12
1630482|NCT00834834|3984264|P2|NOT COMPLETED|Overall Study||3
1630483|NCT00834834|3984265|P1|NOT COMPLETED|Overall Study||4
1630484|NCT00834834|3984264|P2|COMPLETED|Overall Study||39
1630485|NCT00834834|3984265|P1|COMPLETED|Overall Study||38
1630486|NCT00834834|3984264|P2|STARTED|Overall Study||42
1630487|NCT00834834|3984265|P1|STARTED|Overall Study||42
1630488|NCT00834808|3984276|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
1630489|NCT00834808|3984277|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
1630490|NCT00834808|3984278|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
1630491|NCT00834808|3984276|P3|COMPLETED|Treatment Period 3 (Day 15)||9
1630492|NCT00834808|3984277|P2|COMPLETED|Treatment Period 3 (Day 15)||9
1630493|NCT00834808|3984278|P1|COMPLETED|Treatment Period 3 (Day 15)||9
1630494|NCT00834808|3984276|P3|STARTED|Treatment Period 3 (Day 15)||9
1630495|NCT00834808|3984277|P2|STARTED|Treatment Period 3 (Day 15)||9
1630496|NCT00834808|3984278|P1|STARTED|Treatment Period 3 (Day 15)||9
1630497|NCT00834808|3984276|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
1630498|NCT00834808|3984277|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
1630499|NCT00834808|3984278|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
1630500|NCT00834808|3984276|P3|COMPLETED|Treatment Period 2 (Day 8)||9
1630501|NCT00834808|3984277|P2|COMPLETED|Treatment Period 2 (Day 8)||9
1630502|NCT00834808|3984278|P1|COMPLETED|Treatment Period 2 (Day 8)||9
1630503|NCT00834808|3984276|P3|STARTED|Treatment Period 2 (Day 8)||9
1630504|NCT00834808|3984277|P2|STARTED|Treatment Period 2 (Day 8)||9
1630505|NCT00834808|3984278|P1|STARTED|Treatment Period 2 (Day 8)||9
1630506|NCT00834808|3984276|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1630507|NCT00834808|3984277|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1630508|NCT00834808|3984278|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1630509|NCT00834808|3984276|P3|COMPLETED|Treatment Period 1 (Day 1)||9
1630510|NCT00834808|3984277|P2|COMPLETED|Treatment Period 1 (Day 1)||9
1630511|NCT00834808|3984278|P1|COMPLETED|Treatment Period 1 (Day 1)||9
1630512|NCT00834808|3984276|P3|STARTED|Treatment Period 1 (Day 1)||9
1630513|NCT00834808|3984277|P2|STARTED|Treatment Period 1 (Day 1)||9
1630514|NCT00834808|3984278|P1|STARTED|Treatment Period 1 (Day 1)||9
1630515|NCT00834795|3984300|P2|NOT COMPLETED|Second Intervention||0
1630516|NCT00834795|3984301|P1|NOT COMPLETED|Second Intervention||1
1630517|NCT00834795|3984300|P2|COMPLETED|Second Intervention||17
1630518|NCT00834795|3984301|P1|COMPLETED|Second Intervention||17
1630519|NCT00834795|3984300|P2|STARTED|Second Intervention||17
1630520|NCT00834795|3984301|P1|STARTED|Second Intervention||18
1630521|NCT00834795|3984300|P2|NOT COMPLETED|Washout: 7 Days||1
1630522|NCT00834795|3984301|P1|NOT COMPLETED|Washout: 7 Days||0
1630523|NCT00834795|3984300|P2|COMPLETED|Washout: 7 Days||17
1630524|NCT00834795|3984301|P1|COMPLETED|Washout: 7 Days||18
1630525|NCT00834795|3984300|P2|STARTED|Washout: 7 Days||18
1630526|NCT00834795|3984301|P1|STARTED|Washout: 7 Days||18
1630527|NCT00834795|3984300|P2|NOT COMPLETED|First Intervention||0
1630528|NCT00834795|3984301|P1|NOT COMPLETED|First Intervention||0
1630529|NCT00834795|3984300|P2|COMPLETED|First Intervention||18
1630530|NCT00834795|3984301|P1|COMPLETED|First Intervention||18
1630531|NCT00834795|3984300|P2|STARTED|First Intervention||18
1630532|NCT00834795|3984301|P1|STARTED|First Intervention||18
1630533|NCT00834756|3984311|P2|NOT COMPLETED|Second Intervention||0
1630534|NCT00834756|3984312|P1|NOT COMPLETED|Second Intervention||0
1630535|NCT00834756|3984311|P2|COMPLETED|Second Intervention||18
1630536|NCT00834756|3984312|P1|COMPLETED|Second Intervention||16
1630537|NCT00834756|3984311|P2|STARTED|Second Intervention||18
1630538|NCT00834756|3984312|P1|STARTED|Second Intervention||16
1630539|NCT00834756|3984311|P2|NOT COMPLETED|Washout: 21 Days||0
1630540|NCT00834756|3984312|P1|NOT COMPLETED|Washout: 21 Days||1
1630541|NCT00834756|3984311|P2|COMPLETED|Washout: 21 Days||18
1630542|NCT00834756|3984312|P1|COMPLETED|Washout: 21 Days||16
1630543|NCT00834756|3984311|P2|STARTED|Washout: 21 Days||18
1630544|NCT00834756|3984312|P1|STARTED|Washout: 21 Days||17
1630545|NCT00834756|3984311|P2|NOT COMPLETED|First Intervention||0
1630546|NCT00834756|3984312|P1|NOT COMPLETED|First Intervention||1
1630547|NCT00834756|3984311|P2|COMPLETED|First Intervention||18
1630548|NCT00834756|3984312|P1|COMPLETED|First Intervention||17
1630549|NCT00834756|3984311|P2|STARTED|First Intervention||18
1630550|NCT00834756|3984312|P1|STARTED|First Intervention||18
1630551|NCT00834743|3984322|P2|NOT COMPLETED|Second Intervention||0
1630552|NCT00834743|3984323|P1|NOT COMPLETED|Second Intervention||1
1630553|NCT00834743|3984322|P2|COMPLETED|Second Intervention||16
1630554|NCT00834743|3984323|P1|COMPLETED|Second Intervention||15
1630555|NCT00834743|3984322|P2|STARTED|Second Intervention||16
1630556|NCT00834743|3984323|P1|STARTED|Second Intervention||16
1630557|NCT00834743|3984322|P2|NOT COMPLETED|Washout of 7 Days||0
1630558|NCT00834743|3984323|P1|NOT COMPLETED|Washout of 7 Days||0
1630559|NCT00834743|3984322|P2|COMPLETED|Washout of 7 Days||16
1630560|NCT00834743|3984323|P1|COMPLETED|Washout of 7 Days||16
1630561|NCT00834743|3984322|P2|STARTED|Washout of 7 Days||16
1630562|NCT00834743|3984323|P1|STARTED|Washout of 7 Days||16
1630563|NCT00834743|3984322|P2|NOT COMPLETED|First Intervention||0
1630564|NCT00834743|3984323|P1|NOT COMPLETED|First Intervention||0
1630565|NCT00834743|3984322|P2|COMPLETED|First Intervention||16
1630566|NCT00834743|3984323|P1|COMPLETED|First Intervention||16
1630567|NCT00834743|3984322|P2|STARTED|First Intervention||16
1630568|NCT00834743|3984323|P1|STARTED|First Intervention||16
1630569|NCT00834717|3984333|P2|NOT COMPLETED|Second Intervention||0
1630570|NCT00834717|3984334|P1|NOT COMPLETED|Second Intervention||0
1630571|NCT00834717|3984333|P2|COMPLETED|Second Intervention||19
1630572|NCT00834717|3984334|P1|COMPLETED|Second Intervention||19
1630573|NCT00834717|3984333|P2|STARTED|Second Intervention||19
1630574|NCT00834717|3984334|P1|STARTED|Second Intervention||19
1630575|NCT00834717|3984333|P2|NOT COMPLETED|First Intervention||1
1630576|NCT00834717|3984334|P1|NOT COMPLETED|First Intervention||1
1630577|NCT00834717|3984333|P2|COMPLETED|First Intervention||19
1630578|NCT00834717|3984334|P1|COMPLETED|First Intervention||19
1630579|NCT00834717|3984333|P2|STARTED|First Intervention||20
1630580|NCT00834717|3984334|P1|STARTED|First Intervention||20
1630581|NCT00834678|3984342|P1|NOT COMPLETED|Overall Study||0
1630582|NCT00834678|3984342|P1|COMPLETED|Overall Study||11
1630583|NCT00834678|3984342|P1|STARTED|Overall Study||11
1630584|NCT00834652|3984356|P2|NOT COMPLETED|Overall Study||40
1630585|NCT00834652|3984357|P1|NOT COMPLETED|Overall Study||38
1630586|NCT00834652|3984356|P2|COMPLETED|Overall Study||62
1630587|NCT00834652|3984357|P1|COMPLETED|Overall Study||66
1630588|NCT00834652|3984356|P2|STARTED|Overall Study||102
1630589|NCT00834652|3984357|P1|STARTED|Overall Study||104
1630590|NCT00834639|3984365|P2|NOT COMPLETED|Second Intervention||2
1630591|NCT00834639|3984366|P1|NOT COMPLETED|Second Intervention||0
1630592|NCT00834639|3984365|P2|COMPLETED|Second Intervention||10
1630593|NCT00834639|3984366|P1|COMPLETED|Second Intervention||12
1630594|NCT00834639|3984365|P2|STARTED|Second Intervention||12
1630595|NCT00834639|3984366|P1|STARTED|Second Intervention||12
1630596|NCT00834639|3984365|P2|NOT COMPLETED|Washout of 7 Days||0
1630597|NCT00834639|3984366|P1|NOT COMPLETED|Washout of 7 Days||0
1630598|NCT00834639|3984365|P2|COMPLETED|Washout of 7 Days||12
1630599|NCT00834639|3984366|P1|COMPLETED|Washout of 7 Days||12
1630600|NCT00834639|3984365|P2|STARTED|Washout of 7 Days||12
1630601|NCT00834639|3984366|P1|STARTED|Washout of 7 Days||12
1630602|NCT00834639|3984365|P2|NOT COMPLETED|First Intervention||0
1630603|NCT00834639|3984366|P1|NOT COMPLETED|First Intervention||0
1630604|NCT00834639|3984365|P2|COMPLETED|First Intervention||12
1630605|NCT00834639|3984366|P1|COMPLETED|First Intervention||12
1630606|NCT00834639|3984365|P2|STARTED|First Intervention||12
1630607|NCT00834639|3984366|P1|STARTED|First Intervention||12
1630608|NCT00834626|3984374|P1|NOT COMPLETED|Overall Study||0
1630609|NCT00834626|3984374|P1|COMPLETED|Overall Study||30
1630610|NCT00834626|3984374|P1|1 Year Follow-up|Overall Study||30
1630611|NCT00834626|3984374|P1|STARTED|Overall Study||30
1630612|NCT00834613|3984383|P2|NOT COMPLETED|Second Intervention||0
1630613|NCT00834613|3984384|P1|NOT COMPLETED|Second Intervention||0
1630614|NCT00834613|3984383|P2|COMPLETED|Second Intervention||16
1630615|NCT00834613|3984384|P1|COMPLETED|Second Intervention||15
1630616|NCT00834613|3984383|P2|STARTED|Second Intervention||16
1630617|NCT00834613|3984384|P1|STARTED|Second Intervention||15
1630618|NCT00834613|3984383|P2|NOT COMPLETED|Washout of 7 Days||0
1630619|NCT00834613|3984384|P1|NOT COMPLETED|Washout of 7 Days||0
1630620|NCT00834613|3984383|P2|COMPLETED|Washout of 7 Days||16
1630621|NCT00834613|3984384|P1|COMPLETED|Washout of 7 Days||15
1630622|NCT00834613|3984383|P2|STARTED|Washout of 7 Days||16
1630623|NCT00834613|3984384|P1|STARTED|Washout of 7 Days||15
1630624|NCT00834613|3984383|P2|NOT COMPLETED|First Intervention||0
1630625|NCT00834613|3984384|P1|NOT COMPLETED|First Intervention||1
1630626|NCT00834613|3984383|P2|COMPLETED|First Intervention||16
1630627|NCT00834613|3984384|P1|COMPLETED|First Intervention||15
1630628|NCT00834613|3984383|P2|STARTED|First Intervention||16
1630629|NCT00834613|3984384|P1|STARTED|First Intervention||16
1630630|NCT00834587|3984394|P2|NOT COMPLETED|Second Intervention||0
1630631|NCT00834587|3984395|P1|NOT COMPLETED|Second Intervention||0
1630632|NCT00834587|3984394|P2|COMPLETED|Second Intervention||20
1630633|NCT00834587|3984395|P1|COMPLETED|Second Intervention||19
1630634|NCT00834587|3984394|P2|STARTED|Second Intervention||20
1630635|NCT00834587|3984395|P1|STARTED|Second Intervention||19
1630636|NCT00834587|3984394|P2|NOT COMPLETED|Washout: 7 Days||0
1630637|NCT00834587|3984395|P1|NOT COMPLETED|Washout: 7 Days||1
1630638|NCT00834587|3984394|P2|COMPLETED|Washout: 7 Days||20
1630639|NCT00834587|3984395|P1|COMPLETED|Washout: 7 Days||19
1630640|NCT00834587|3984394|P2|STARTED|Washout: 7 Days||20
1630641|NCT00834587|3984395|P1|STARTED|Washout: 7 Days||20
1630642|NCT00834587|3984394|P2|NOT COMPLETED|First Intervention||0
1630643|NCT00834587|3984395|P1|NOT COMPLETED|First Intervention||0
1630644|NCT00834587|3984394|P2|COMPLETED|First Intervention||20
1630645|NCT00834587|3984395|P1|COMPLETED|First Intervention||20
1630646|NCT00834587|3984394|P2|STARTED|First Intervention||20
1630647|NCT00834587|3984395|P1|STARTED|First Intervention||20
1630648|NCT00834574|3984411|P2|NOT COMPLETED|Second Intervention||0
1630649|NCT00834574|3984412|P1|NOT COMPLETED|Second Intervention||0
1630650|NCT00834574|3984411|P2|COMPLETED|Second Intervention||16
1630651|NCT00834574|3984412|P1|COMPLETED|Second Intervention||16
1630652|NCT00834574|3984411|P2|STARTED|Second Intervention||16
1630653|NCT00834574|3984412|P1|STARTED|Second Intervention||16
1630654|NCT00834574|3984411|P2|NOT COMPLETED|Washout of 7 Days||0
1630655|NCT00834574|3984412|P1|NOT COMPLETED|Washout of 7 Days||0
1630656|NCT00834574|3984411|P2|COMPLETED|Washout of 7 Days||16
1630657|NCT00834574|3984412|P1|COMPLETED|Washout of 7 Days||16
1630658|NCT00834574|3984411|P2|STARTED|Washout of 7 Days||16
1630659|NCT00834574|3984412|P1|STARTED|Washout of 7 Days||16
1630660|NCT00834574|3984411|P2|NOT COMPLETED|First Intervention||0
1630661|NCT00834574|3984412|P1|NOT COMPLETED|First Intervention||0
1630662|NCT00834574|3984411|P2|COMPLETED|First Intervention||16
1630663|NCT00834574|3984412|P1|COMPLETED|First Intervention||16
1630664|NCT00834574|3984411|P2|STARTED|First Intervention||16
1630665|NCT00834574|3984412|P1|STARTED|First Intervention||16
1630666|NCT00834561|3984422|P2|NOT COMPLETED|Second Intervention||0
1630667|NCT00834561|3984423|P1|NOT COMPLETED|Second Intervention||0
1630668|NCT00834561|3984422|P2|COMPLETED|Second Intervention||16
1630669|NCT00834561|3984423|P1|COMPLETED|Second Intervention||16
1630670|NCT00834561|3984422|P2|STARTED|Second Intervention||16
1630671|NCT00834561|3984423|P1|STARTED|Second Intervention||16
1630672|NCT00834561|3984422|P2|NOT COMPLETED|First Intervention||0
1630673|NCT00834561|3984423|P1|NOT COMPLETED|First Intervention||0
1630674|NCT00834561|3984422|P2|COMPLETED|First Intervention||16
1630675|NCT00834561|3984423|P1|COMPLETED|First Intervention||16
1630676|NCT00834561|3984422|P2|STARTED|First Intervention||16
1630677|NCT00834561|3984423|P1|STARTED|First Intervention||16
1630678|NCT00834535|3984433|P2|NOT COMPLETED|Second Intervention||0
1630679|NCT00834535|3984434|P1|NOT COMPLETED|Second Intervention||0
1630680|NCT00834535|3984433|P2|COMPLETED|Second Intervention||16
1630681|NCT00834535|3984434|P1|COMPLETED|Second Intervention||16
1630682|NCT00834535|3984433|P2|STARTED|Second Intervention||16
1630683|NCT00834535|3984434|P1|STARTED|Second Intervention||16
1630684|NCT00834535|3984433|P2|NOT COMPLETED|Washout of 7 Days||0
1630685|NCT00834535|3984434|P1|NOT COMPLETED|Washout of 7 Days||0
1630686|NCT00834535|3984433|P2|COMPLETED|Washout of 7 Days||16
1630687|NCT00834535|3984434|P1|COMPLETED|Washout of 7 Days||16
1630688|NCT00834535|3984433|P2|STARTED|Washout of 7 Days||16
1630689|NCT00834535|3984434|P1|STARTED|Washout of 7 Days||16
1630690|NCT00834535|3984433|P2|NOT COMPLETED|First Intervention||0
1630691|NCT00834535|3984434|P1|NOT COMPLETED|First Intervention||0
1630692|NCT00834535|3984433|P2|COMPLETED|First Intervention||16
1630693|NCT00834535|3984434|P1|COMPLETED|First Intervention||16
1630694|NCT00834535|3984433|P2|STARTED|First Intervention||16
1630695|NCT00834535|3984434|P1|STARTED|First Intervention||16
1630696|NCT00834522|3984444|P2|NOT COMPLETED|Second Intervention||0
1630697|NCT00834522|3984445|P1|NOT COMPLETED|Second Intervention||0
1630698|NCT00834522|3984444|P2|COMPLETED|Second Intervention||39
1630699|NCT00834522|3984445|P1|COMPLETED|Second Intervention||37
1630700|NCT00834522|3984444|P2|STARTED|Second Intervention||39
1630701|NCT00834522|3984445|P1|STARTED|Second Intervention||37
1630702|NCT00834522|3984444|P2|NOT COMPLETED|Washout||1
1630703|NCT00834522|3984445|P1|NOT COMPLETED|Washout||3
1630704|NCT00834522|3984444|P2|COMPLETED|Washout||39
1630705|NCT00834522|3984445|P1|COMPLETED|Washout||37
1630706|NCT00834522|3984444|P2|STARTED|Washout||40
1630707|NCT00834522|3984445|P1|STARTED|Washout||40
1630708|NCT00834522|3984444|P2|NOT COMPLETED|First Intervention||0
1630709|NCT00834522|3984445|P1|NOT COMPLETED|First Intervention||0
1630710|NCT00834522|3984444|P2|COMPLETED|First Intervention||40
1630711|NCT00834522|3984445|P1|COMPLETED|First Intervention||40
1630712|NCT00834522|3984444|P2|STARTED|First Intervention||40
1630713|NCT00834522|3984445|P1|STARTED|First Intervention||40
1630714|NCT00834483|3984455|P2|NOT COMPLETED|Overall Study||0
1630715|NCT00834483|3984456|P1|NOT COMPLETED|Overall Study||0
1630716|NCT00834483|3984455|P2|COMPLETED|Overall Study||29
1630717|NCT00834483|3984456|P1|COMPLETED|Overall Study||31
1630718|NCT00834483|3984455|P2|STARTED|Overall Study||29
1630719|NCT00834483|3984456|P1|STARTED|Overall Study||31
1630720|NCT00834444|3984468|P2|NOT COMPLETED|Second Intervention||0
1630721|NCT00834444|3984469|P1|NOT COMPLETED|Second Intervention||1
1630722|NCT00834444|3984468|P2|COMPLETED|Second Intervention||16
1630723|NCT00834444|3984469|P1|COMPLETED|Second Intervention||16
1630724|NCT00834444|3984468|P2|STARTED|Second Intervention||16
1630725|NCT00834444|3984469|P1|STARTED|Second Intervention||17
1630726|NCT00834444|3984468|P2|NOT COMPLETED|Washout of 7 Days||1
1630727|NCT00834444|3984469|P1|NOT COMPLETED|Washout of 7 Days||0
1630728|NCT00834444|3984468|P2|COMPLETED|Washout of 7 Days||16
1630729|NCT00834444|3984469|P1|COMPLETED|Washout of 7 Days||17
1630730|NCT00834444|3984468|P2|STARTED|Washout of 7 Days||17
1630731|NCT00834444|3984469|P1|STARTED|Washout of 7 Days||17
1630732|NCT00834444|3984468|P2|NOT COMPLETED|First Intervention||1
1630733|NCT00834444|3984469|P1|NOT COMPLETED|First Intervention||1
1630734|NCT00834444|3984468|P2|COMPLETED|First Intervention||17
1630735|NCT00834444|3984469|P1|COMPLETED|First Intervention||17
1630736|NCT00834444|3984468|P2|STARTED|First Intervention||18
1630737|NCT00834444|3984469|P1|STARTED|First Intervention||18
1630738|NCT00834431|3984479|P2|NOT COMPLETED|Second Intervention||0
1630739|NCT00834431|3984480|P1|NOT COMPLETED|Second Intervention||0
1630740|NCT00834431|3984479|P2|COMPLETED|Second Intervention||16
1630741|NCT00834431|3984480|P1|COMPLETED|Second Intervention||18
1630742|NCT00834431|3984479|P2|STARTED|Second Intervention||16
1630743|NCT00834431|3984480|P1|STARTED|Second Intervention||18
1630744|NCT00834431|3984479|P2|NOT COMPLETED|Washout of 7 Days||1
1630745|NCT00834431|3984480|P1|NOT COMPLETED|Washout of 7 Days||0
1630746|NCT00834431|3984479|P2|COMPLETED|Washout of 7 Days||16
1630747|NCT00834431|3984480|P1|COMPLETED|Washout of 7 Days||18
1630748|NCT00834431|3984479|P2|STARTED|Washout of 7 Days||17
1630749|NCT00834431|3984480|P1|STARTED|Washout of 7 Days||18
1630750|NCT00834431|3984479|P2|NOT COMPLETED|First Intervention||1
1630751|NCT00834431|3984480|P1|NOT COMPLETED|First Intervention||0
1630752|NCT00834431|3984479|P2|COMPLETED|First Intervention||17
1630753|NCT00834431|3984480|P1|COMPLETED|First Intervention||18
1630754|NCT00834431|3984479|P2|STARTED|First Intervention||18
1630755|NCT00834431|3984480|P1|STARTED|First Intervention||18
1630756|NCT00834418|3984490|P2|NOT COMPLETED|Overall Study||2
1630757|NCT00834418|3984491|P1|NOT COMPLETED|Overall Study||0
1630758|NCT00834418|3984490|P2|COMPLETED|Overall Study||40
1630759|NCT00834418|3984491|P1|COMPLETED|Overall Study||42
1630760|NCT00834418|3984490|P2|STARTED|Overall Study||42
1630761|NCT00834418|3984491|P1|STARTED|Overall Study||42
1630762|NCT00834405|3984499|P2|NOT COMPLETED|Overall Study||0
1630763|NCT00834405|3984500|P1|NOT COMPLETED|Overall Study||0
1630764|NCT00834405|3984499|P2|COMPLETED|Overall Study||17
1630765|NCT00834405|3984500|P1|COMPLETED|Overall Study||20
1630766|NCT00834405|3984499|P2|STARTED|Overall Study||17
1630767|NCT00834405|3984500|P1|STARTED|Overall Study||20
1630768|NCT00834366|3984508|P2|NOT COMPLETED|Treatment Period 2||0
1630769|NCT00834366|3984509|P1|NOT COMPLETED|Treatment Period 2||0
1630770|NCT00834366|3984508|P2|COMPLETED|Treatment Period 2||12
1630771|NCT00834366|3984509|P1|COMPLETED|Treatment Period 2||12
1630772|NCT00834366|3984508|P2|STARTED|Treatment Period 2||12
1630773|NCT00834366|3984509|P1|STARTED|Treatment Period 2||12
1630774|NCT00834366|3984508|P2|NOT COMPLETED|Treatment Period 1||1
1630775|NCT00834366|3984509|P1|NOT COMPLETED|Treatment Period 1||1
1630776|NCT00834366|3984508|P2|COMPLETED|Treatment Period 1||12
1630777|NCT00834366|3984509|P1|COMPLETED|Treatment Period 1||12
1630778|NCT00834366|3984508|P2|STARTED|Treatment Period 1||13
1630779|NCT00834366|3984509|P1|STARTED|Treatment Period 1||13
1630780|NCT00834340|3984525|P2|NOT COMPLETED|Second Intervention||0
1630781|NCT00834340|3984526|P1|NOT COMPLETED|Second Intervention||0
1630782|NCT00834340|3984525|P2|COMPLETED|Second Intervention||16
1630783|NCT00834340|3984526|P1|COMPLETED|Second Intervention||14
1630784|NCT00834340|3984525|P2|STARTED|Second Intervention||16
1630785|NCT00834340|3984526|P1|STARTED|Second Intervention||14
1630786|NCT00834340|3984525|P2|NOT COMPLETED|Washout||0
1630787|NCT00834340|3984526|P1|NOT COMPLETED|Washout||2
1630788|NCT00834340|3984525|P2|COMPLETED|Washout||16
1630789|NCT00834340|3984526|P1|COMPLETED|Washout||14
1630790|NCT00834340|3984525|P2|STARTED|Washout||16
1630791|NCT00834340|3984526|P1|STARTED|Washout||16
1630792|NCT00834340|3984525|P2|NOT COMPLETED|First Intervention||0
1630793|NCT00834340|3984526|P1|NOT COMPLETED|First Intervention||0
1630794|NCT00834340|3984525|P2|COMPLETED|First Intervention||16
1630795|NCT00834340|3984526|P1|COMPLETED|First Intervention||16
1630796|NCT00834340|3984525|P2|STARTED|First Intervention||16
1630797|NCT00834340|3984526|P1|STARTED|First Intervention||16
1630798|NCT00834288|3984536|P2|NOT COMPLETED|Treatment Phase II||0
1630799|NCT00834288|3984537|P1|NOT COMPLETED|Treatment Phase II||0
1630800|NCT00834288|3984536|P2|COMPLETED|Treatment Phase II||13
1630801|NCT00834288|3984537|P1|COMPLETED|Treatment Phase II||13
1630802|NCT00834288|3984536|P2|STARTED|Treatment Phase II||13
1630803|NCT00834288|3984537|P1|STARTED|Treatment Phase II||13
1630804|NCT00834288|3984536|P2|NOT COMPLETED|Treatment Phase I||0
1630805|NCT00834288|3984537|P1|NOT COMPLETED|Treatment Phase I||0
1630806|NCT00834288|3984536|P2|COMPLETED|Treatment Phase I||13
1630807|NCT00834288|3984537|P1|COMPLETED|Treatment Phase I||13
1630808|NCT00834288|3984536|P2|STARTED|Treatment Phase I||13
1630809|NCT00834288|3984537|P1|STARTED|Treatment Phase I||13
1630810|NCT00834275|3984559|P2|NOT COMPLETED|Second Intervention||0
1630811|NCT00834275|3984560|P1|NOT COMPLETED|Second Intervention||0
1630812|NCT00834275|3984559|P2|COMPLETED|Second Intervention||13
1630813|NCT00834275|3984560|P1|COMPLETED|Second Intervention||13
1630814|NCT00834275|3984559|P2|STARTED|Second Intervention||13
1630815|NCT00834275|3984560|P1|STARTED|Second Intervention||13
1630816|NCT00834275|3984559|P2|NOT COMPLETED|Washout of 7 Days||0
1630817|NCT00834275|3984560|P1|NOT COMPLETED|Washout of 7 Days||0
1630818|NCT00834275|3984559|P2|COMPLETED|Washout of 7 Days||13
1630819|NCT00834275|3984560|P1|COMPLETED|Washout of 7 Days||13
1630820|NCT00834275|3984559|P2|STARTED|Washout of 7 Days||13
1630821|NCT00834275|3984560|P1|STARTED|Washout of 7 Days||13
1630822|NCT00834275|3984559|P2|NOT COMPLETED|First Intervention||0
1630823|NCT00834275|3984560|P1|NOT COMPLETED|First Intervention||0
1630824|NCT00834275|3984559|P2|COMPLETED|First Intervention||13
1630825|NCT00834275|3984560|P1|COMPLETED|First Intervention||13
1630826|NCT00834275|3984559|P2|STARTED|First Intervention||13
1630827|NCT00834275|3984560|P1|STARTED|First Intervention||13
1630828|NCT00834249|3984570|P2|NOT COMPLETED|Second Intervention||0
1630829|NCT00834249|3984571|P1|NOT COMPLETED|Second Intervention||1
1630830|NCT00834249|3984570|P2|COMPLETED|Second Intervention||8
1630831|NCT00834249|3984571|P1|COMPLETED|Second Intervention||7
1630832|NCT00834249|3984570|P2|STARTED|Second Intervention||8
1630833|NCT00834249|3984571|P1|STARTED|Second Intervention||8
1630834|NCT00834249|3984570|P2|NOT COMPLETED|Washout: 7 Days||1
1630835|NCT00834249|3984571|P1|NOT COMPLETED|Washout: 7 Days||1
1630836|NCT00834249|3984570|P2|COMPLETED|Washout: 7 Days||8
1630837|NCT00834249|3984571|P1|COMPLETED|Washout: 7 Days||8
1630838|NCT00834249|3984570|P2|STARTED|Washout: 7 Days||9
1630839|NCT00834249|3984571|P1|STARTED|Washout: 7 Days||9
1630840|NCT00834249|3984570|P2|NOT COMPLETED|First Intervention||0
1630841|NCT00834249|3984571|P1|NOT COMPLETED|First Intervention||0
1630842|NCT00834249|3984570|P2|COMPLETED|First Intervention||9
1630843|NCT00834249|3984571|P1|COMPLETED|First Intervention||9
1630844|NCT00834249|3984570|P2|STARTED|First Intervention||9
1630845|NCT00834249|3984571|P1|STARTED|First Intervention||9
1630846|NCT00834236|3984587|P2|NOT COMPLETED|Overall Study||0
1630847|NCT00834236|3984588|P1|NOT COMPLETED|Overall Study||0
1630848|NCT00834236|3984587|P2|COMPLETED|Overall Study||47
1630849|NCT00834236|3984588|P1|COMPLETED|Overall Study||29
1630850|NCT00834236|3984587|P2|STARTED|Overall Study||47
1630851|NCT00834236|3984588|P1|STARTED|Overall Study||29
1630852|NCT00834210|3984596|P2|NOT COMPLETED|Overall Study||8
1630853|NCT00834210|3984597|P1|NOT COMPLETED|Overall Study||3
1630854|NCT00834210|3984596|P2|COMPLETED|Overall Study||77
1630855|NCT00834210|3984597|P1|COMPLETED|Overall Study||83
1630856|NCT00834210|3984596|P2|STARTED|Overall Study||85
1630857|NCT00834210|3984597|P1|STARTED|Overall Study||86
1630858|NCT00834197|3984611|P2|NOT COMPLETED|Second Intervention||0
1630859|NCT00834197|3984612|P1|NOT COMPLETED|Second Intervention||0
1630860|NCT00834197|3984611|P2|COMPLETED|Second Intervention||16
1630861|NCT00834197|3984612|P1|COMPLETED|Second Intervention||16
1630862|NCT00834197|3984611|P2|STARTED|Second Intervention||16
1630863|NCT00834197|3984612|P1|STARTED|Second Intervention||16
1630864|NCT00834197|3984611|P2|NOT COMPLETED|Washout of 14 Days||0
1630865|NCT00834197|3984612|P1|NOT COMPLETED|Washout of 14 Days||0
1630866|NCT00834197|3984611|P2|COMPLETED|Washout of 14 Days||16
1630867|NCT00834197|3984612|P1|COMPLETED|Washout of 14 Days||16
1630868|NCT00834197|3984611|P2|STARTED|Washout of 14 Days||16
1630869|NCT00834197|3984612|P1|STARTED|Washout of 14 Days||16
1630870|NCT00834197|3984611|P2|NOT COMPLETED|First Intervention||0
1630871|NCT00834197|3984612|P1|NOT COMPLETED|First Intervention||0
1630872|NCT00834197|3984611|P2|COMPLETED|First Intervention||16
1630873|NCT00834197|3984612|P1|COMPLETED|First Intervention||16
1630874|NCT00834197|3984611|P2|STARTED|First Intervention||16
1630875|NCT00834197|3984612|P1|STARTED|First Intervention||16
1630876|NCT00834171|3984622|P2|NOT COMPLETED|Overall Study||0
1630877|NCT00834171|3984623|P1|NOT COMPLETED|Overall Study||0
1630878|NCT00834171|3984622|P2|COMPLETED|Overall Study||7
1630879|NCT00834171|3984623|P1|COMPLETED|Overall Study||43
1630880|NCT00834171|3984622|P2|STARTED|Overall Study||7
1630881|NCT00834171|3984623|P1|STARTED|Overall Study||43
1630882|NCT00834132|3984631|P2|NOT COMPLETED|Second Intervention||0
1630883|NCT00834132|3984632|P1|NOT COMPLETED|Second Intervention||0
1630884|NCT00834132|3984631|P2|COMPLETED|Second Intervention||12
1630885|NCT00834132|3984632|P1|COMPLETED|Second Intervention||12
1630886|NCT00834132|3984631|P2|STARTED|Second Intervention||12
1630887|NCT00834132|3984632|P1|STARTED|Second Intervention||12
1630888|NCT00834132|3984631|P2|NOT COMPLETED|Washout: 21 Days||0
1630889|NCT00834132|3984632|P1|NOT COMPLETED|Washout: 21 Days||0
1630890|NCT00834132|3984631|P2|COMPLETED|Washout: 21 Days||12
1630891|NCT00834132|3984632|P1|COMPLETED|Washout: 21 Days||12
1630892|NCT00834132|3984631|P2|STARTED|Washout: 21 Days||12
1630893|NCT00834132|3984632|P1|STARTED|Washout: 21 Days||12
1630894|NCT00834132|3984631|P2|NOT COMPLETED|First Intervention||0
1630895|NCT00834132|3984632|P1|NOT COMPLETED|First Intervention||0
1630896|NCT00834132|3984631|P2|COMPLETED|First Intervention||12
1630897|NCT00834132|3984632|P1|COMPLETED|First Intervention||12
1630898|NCT00834132|3984631|P2|STARTED|First Intervention||12
1630899|NCT00834132|3984632|P1|STARTED|First Intervention||12
1630900|NCT00834106|3984642|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
1630901|NCT00834106|3984643|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
1630902|NCT00834106|3984642|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
1630903|NCT00834106|3984643|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
1630904|NCT00834106|3984642|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
1630905|NCT00834106|3984643|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
1630906|NCT00834106|3984642|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
1630907|NCT00834106|3984643|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
1630908|NCT00834106|3984642|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
1630909|NCT00834106|3984643|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
1630910|NCT00834106|3984642|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
1630911|NCT00834106|3984643|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
1630912|NCT00834106|3984642|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
1630913|NCT00834106|3984643|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
1630914|NCT00834106|3984642|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
1630915|NCT00834106|3984643|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
1630916|NCT00834080|3984667|P1|NOT COMPLETED|Overall Study||23
1630917|NCT00834080|3984667|P1|COMPLETED|Overall Study||15
1630918|NCT00834080|3984667|P1|STARTED|Overall Study||38
1630919|NCT00834067|3984673|P2|NOT COMPLETED|Second Intervention||0
1630920|NCT00834067|3984674|P1|NOT COMPLETED|Second Intervention||0
1630921|NCT00834067|3984673|P2|COMPLETED|Second Intervention||29
1630922|NCT00834067|3984674|P1|COMPLETED|Second Intervention||30
1630923|NCT00834067|3984673|P2|STARTED|Second Intervention||29
1630924|NCT00834067|3984674|P1|STARTED|Second Intervention||30
1630925|NCT00834067|3984673|P2|NOT COMPLETED|Washout of 21 Days||1
1630926|NCT00834067|3984674|P1|NOT COMPLETED|Washout of 21 Days||0
1630927|NCT00834067|3984673|P2|COMPLETED|Washout of 21 Days||29
1630928|NCT00834067|3984674|P1|COMPLETED|Washout of 21 Days||30
1630929|NCT00834067|3984673|P2|STARTED|Washout of 21 Days||30
1630930|NCT00834067|3984674|P1|STARTED|Washout of 21 Days||30
1630931|NCT00834067|3984673|P2|NOT COMPLETED|First Intervention||0
1630932|NCT00834067|3984674|P1|NOT COMPLETED|First Intervention||0
1630933|NCT00834067|3984673|P2|COMPLETED|First Intervention||30
1630934|NCT00834067|3984674|P1|COMPLETED|First Intervention||30
1630935|NCT00834067|3984673|P2|STARTED|First Intervention||30
1630936|NCT00834067|3984674|P1|STARTED|First Intervention||30
1630937|NCT00834041|3984696|P2|NOT COMPLETED|Overall Study||1
1630938|NCT00834041|3984697|P1|NOT COMPLETED|Overall Study||1
1630939|NCT00834041|3984696|P2|COMPLETED|Overall Study||19
1630940|NCT00834041|3984697|P1|COMPLETED|Overall Study||18
1630941|NCT00834041|3984696|P2|STARTED|Overall Study||20
1630942|NCT00834041|3984697|P1|STARTED|Overall Study||19
1630943|NCT00833989|3984715|P4|NOT COMPLETED|Overall Study||2
1630944|NCT00833989|3984716|P3|NOT COMPLETED|Overall Study||1
1630945|NCT00833989|3984717|P2|NOT COMPLETED|Overall Study||0
1630946|NCT00833989|3984718|P1|NOT COMPLETED|Overall Study||3
1630947|NCT00833989|3984715|P4|COMPLETED|Overall Study||6
1630948|NCT00833989|3984716|P3|COMPLETED|Overall Study||8
1630949|NCT00833989|3984717|P2|COMPLETED|Overall Study||8
1630950|NCT00833989|3984718|P1|COMPLETED|Overall Study||14
1630951|NCT00833989|3984715|P4|STARTED|Overall Study||8
1630952|NCT00833989|3984716|P3|STARTED|Overall Study||9
1630953|NCT00833989|3984717|P2|STARTED|Overall Study||8
1630954|NCT00833989|3984718|P1|STARTED|Overall Study||17
1630955|NCT00833976|3984822|P1|NOT COMPLETED|Overall Study||51
1630956|NCT00833976|3984822|P1|COMPLETED|Overall Study||14
1630957|NCT00833976|3984822|P1|STARTED|Overall Study||65
1630958|NCT00833937|3984830|P2|NOT COMPLETED|Second Intervention||0
1630959|NCT00833937|3984831|P1|NOT COMPLETED|Second Intervention||0
1630960|NCT00833937|3984830|P2|COMPLETED|Second Intervention||12
1630961|NCT00833937|3984831|P1|COMPLETED|Second Intervention||11
1630962|NCT00833937|3984830|P2|STARTED|Second Intervention||12
1630963|NCT00833937|3984831|P1|STARTED|Second Intervention||11
1630964|NCT00833937|3984830|P2|NOT COMPLETED|Washout||0
1630965|NCT00833937|3984831|P1|NOT COMPLETED|Washout||1
1630966|NCT00833937|3984830|P2|COMPLETED|Washout||12
1630967|NCT00833937|3984831|P1|COMPLETED|Washout||11
1630968|NCT00833937|3984830|P2|STARTED|Washout||12
1630969|NCT00833937|3984831|P1|STARTED|Washout||12
1630970|NCT00833937|3984830|P2|NOT COMPLETED|First Intervention||0
1630971|NCT00833937|3984831|P1|NOT COMPLETED|First Intervention||0
1630972|NCT00833937|3984830|P2|COMPLETED|First Intervention||12
1630973|NCT00833937|3984831|P1|COMPLETED|First Intervention||12
1630974|NCT00833937|3984830|P2|STARTED|First Intervention||12
1630975|NCT00833937|3984831|P1|STARTED|First Intervention||12
1630976|NCT00833924|3984839|P1|NOT COMPLETED|Overall Study||109
1630977|NCT00833924|3984839|P1|COMPLETED|Overall Study||11
1630978|NCT00833924|3984839|P1|12-month|Overall Study||113
1630979|NCT00833924|3984839|P1|30-day|Overall Study||120
1630980|NCT00833924|3984839|P1|STARTED|Overall Study||120
1630981|NCT00833911|3984844|P1|NOT COMPLETED|Maintenance Phase II||10
1630982|NCT00833911|3984844|P1|COMPLETED|Maintenance Phase II||166
1630983|NCT00833911|3984844|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
1630984|NCT00833911|3984844|P1|NOT COMPLETED|Maintenance Phase I||98
1630985|NCT00833911|3984844|P1|COMPLETED|Maintenance Phase I||273
1630986|NCT00833911|3984844|P1|STARTED|Maintenance Phase I||371
1630987|NCT00833911|3984844|P1|NOT COMPLETED|Titration||21
1630988|NCT00833911|3984844|P1|COMPLETED|Titration||371
1630989|NCT00833911|3984844|P1|STARTED|Titration||392
1630990|NCT00833898|3984854|P2|NOT COMPLETED|Overall Study||36
1630991|NCT00833898|3984855|P1|NOT COMPLETED|Overall Study||40
1630992|NCT00833898|3984854|P2|COMPLETED|Overall Study||38
1630993|NCT00833898|3984855|P1|COMPLETED|Overall Study||34
1630994|NCT00833898|3984854|P2|Month 12 (Post Transplantation)|Overall Study||50
1630995|NCT00833898|3984855|P1|Month 12 (Post Transplantation)|Overall Study||50
1630996|NCT00833898|3984854|P2|Month 6 (Post Transplantation)|Overall Study||54
1630997|NCT00833898|3984855|P1|Month 6 (Post Transplantation)|Overall Study||59
1630998|NCT00833898|3984854|P2|Month 3 (Post Transplantation)|Overall Study||64
1630999|NCT00833898|3984855|P1|Month 3 (Post Transplantation)|Overall Study||66
1631000|NCT00833898|3984854|P2|Month 1 (Post Transplantation)|Overall Study||74
1631001|NCT00833898|3984855|P1|Month 1 (Post Transplantation)|Overall Study||72
1631002|NCT00833898|3984854|P2|STARTED|Overall Study||74
1631003|NCT00833898|3984855|P1|STARTED|Overall Study||74
1631004|NCT00833859|3984901|P1|NOT COMPLETED|Overall Study||0
1631005|NCT00833859|3984901|P1|COMPLETED|Overall Study||2
1631006|NCT00833859|3984901|P1|STARTED|Overall Study||2
1631007|NCT00833833|3984914|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
1631008|NCT00833833|3984915|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
1631009|NCT00833833|3984916|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1631010|NCT00833833|3984917|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1631011|NCT00833833|3984918|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1631012|NCT00833833|3984919|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1631013|NCT00833833|3984914|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
1631014|NCT00833833|3984915|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
1631015|NCT00833833|3984916|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
1631016|NCT00833833|3984917|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
1631017|NCT00833833|3984918|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
1631018|NCT00833833|3984919|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
1631019|NCT00833833|3984914|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
1631020|NCT00833833|3984915|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
1631021|NCT00833833|3984916|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
1631022|NCT00833833|3984917|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
1631023|NCT00833833|3984918|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
1631024|NCT00833833|3984919|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
1631025|NCT00833833|3984914|P6|STARTED|Phase 2 (as of 01 April 2011)||108
1631026|NCT00833833|3984915|P5|STARTED|Phase 2 (as of 01 April 2011)||113
1631027|NCT00833833|3984916|P4|STARTED|Phase 2 (as of 01 April 2011)||0
1631028|NCT00833833|3984917|P3|STARTED|Phase 2 (as of 01 April 2011)||0
1631029|NCT00833833|3984918|P2|STARTED|Phase 2 (as of 01 April 2011)||0
1631030|NCT00833833|3984919|P1|STARTED|Phase 2 (as of 01 April 2011)||0
1631031|NCT00833833|3984914|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
1631032|NCT00833833|3984915|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
1631033|NCT00833833|3984916|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
1631034|NCT00833833|3984917|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
1631035|NCT00833833|3984918|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
1631036|NCT00833833|3984919|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
1631037|NCT00833833|3984914|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
1631038|NCT00833833|3984915|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
1631039|NCT00833833|3984916|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
1631040|NCT00833833|3984917|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
1631041|NCT00833833|3984918|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
1631042|NCT00833833|3984919|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
1631043|NCT00833833|3984914|P6|STARTED|Phase 1 (as of 01 April 2011)||0
1631044|NCT00833833|3984915|P5|STARTED|Phase 1 (as of 01 April 2011)||0
1631045|NCT00833833|3984916|P4|STARTED|Phase 1 (as of 01 April 2011)||10
1631046|NCT00833833|3984917|P3|STARTED|Phase 1 (as of 01 April 2011)||14
1631047|NCT00833833|3984918|P2|STARTED|Phase 1 (as of 01 April 2011)||8
1631048|NCT00833833|3984919|P1|STARTED|Phase 1 (as of 01 April 2011)||6
1631049|NCT00833794|3984959|P2|NOT COMPLETED|Double-blind Phase||49
1631050|NCT00833794|3984960|P1|NOT COMPLETED|Double-blind Phase||106
1631051|NCT00833794|3984959|P2|COMPLETED|Double-blind Phase||165
1631052|NCT00833794|3984960|P1|COMPLETED|Double-blind Phase||326
1631053|NCT00833794|3984959|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
1631054|NCT00833794|3984960|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
1631055|NCT00833794|3984959|P2|NOT COMPLETED|Open-label Phase||0
1631056|NCT00833794|3984960|P1|NOT COMPLETED|Open-label Phase||382
1631057|NCT00833794|3984959|P2|COMPLETED|Open-label Phase||0
1631058|NCT00833794|3984960|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
1631059|NCT00833794|3984959|P2|Received Open-Label Treatment|Open-label Phase||0
1631060|NCT00833794|3984960|P1|Received Open-Label Treatment|Open-label Phase||1023
1631061|NCT00833794|3984959|P2|Entered run-in Period|Open-label Phase||0
1631062|NCT00833794|3984960|P1|Entered run-in Period|Open-label Phase||1027
1631063|NCT00833794|3984959|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
1631064|NCT00833794|3984960|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
1631065|NCT00833781|3984988|P2|NOT COMPLETED|Overall Study||0
1631066|NCT00833781|3984989|P1|NOT COMPLETED|Overall Study||0
1631067|NCT00833781|3984988|P2|COMPLETED|Overall Study||5
1631068|NCT00833781|3984989|P1|COMPLETED|Overall Study||10
1631069|NCT00833781|3984988|P2|STARTED|Overall Study||5
1631070|NCT00833781|3984989|P1|STARTED|Overall Study||10
1631071|NCT00833755|3985004|P4|NOT COMPLETED|Overall Study||6
1631072|NCT00833755|3985005|P3|NOT COMPLETED|Overall Study||2
1631073|NCT00833755|3985006|P2|NOT COMPLETED|Overall Study||5
1631074|NCT00833755|3985007|P1|NOT COMPLETED|Overall Study||4
1631075|NCT00833755|3985004|P4|COMPLETED|Overall Study||17
1631076|NCT00833755|3985005|P3|COMPLETED|Overall Study||20
1631077|NCT00833755|3985006|P2|COMPLETED|Overall Study||13
1631078|NCT00833755|3985007|P1|COMPLETED|Overall Study||12
1631079|NCT00833755|3985004|P4|STARTED|Overall Study||23
1631080|NCT00833755|3985005|P3|STARTED|Overall Study||22
1631081|NCT00833755|3985006|P2|STARTED|Overall Study||18
1631082|NCT00833755|3985007|P1|STARTED|Overall Study||16
1631083|NCT00833703|3985027|P2|NOT COMPLETED|Overall Study||1
1631084|NCT00833703|3985028|P1|NOT COMPLETED|Overall Study||0
1631085|NCT00833703|3985027|P2|COMPLETED|Overall Study|Completed follow-up|25
1631086|NCT00833703|3985028|P1|COMPLETED|Overall Study|Completed follow-up|23
1631087|NCT00833703|3985027|P2|Completed Treatment|Overall Study||24
1631088|NCT00833703|3985028|P1|Completed Treatment|Overall Study||22
1631089|NCT00833703|3985027|P2|Treated|Overall Study||26
1631090|NCT00833703|3985028|P1|Treated|Overall Study||23
1631091|NCT00833703|3985027|P2|STARTED|Overall Study|Included|26
1631092|NCT00833703|3985028|P1|STARTED|Overall Study|Included|23
1631093|NCT00833690|3985041|P3|NOT COMPLETED|Overall Study||0
1631094|NCT00833690|3985042|P2|NOT COMPLETED|Overall Study||2
1631095|NCT00833690|3985043|P1|NOT COMPLETED|Overall Study||4
1631096|NCT00833690|3985041|P3|COMPLETED|Overall Study||26
1631097|NCT00833690|3985042|P2|COMPLETED|Overall Study||22
1631098|NCT00833690|3985043|P1|COMPLETED|Overall Study||21
1631099|NCT00833690|3985041|P3|STARTED|Overall Study||26
1631100|NCT00833690|3985042|P2|STARTED|Overall Study||24
1631101|NCT00833690|3985043|P1|STARTED|Overall Study||25
1631102|NCT00833664|3985167|P2|NOT COMPLETED|Second Intervention||0
1631103|NCT00833664|3985168|P1|NOT COMPLETED|Second Intervention||0
1631104|NCT00833664|3985167|P2|COMPLETED|Second Intervention||11
1631105|NCT00833664|3985168|P1|COMPLETED|Second Intervention||10
1631106|NCT00833664|3985167|P2|STARTED|Second Intervention||11
1631107|NCT00833664|3985168|P1|STARTED|Second Intervention||10
1631108|NCT00833664|3985167|P2|NOT COMPLETED|Washout: 14 Days||0
1631109|NCT00833664|3985168|P1|NOT COMPLETED|Washout: 14 Days||1
1631110|NCT00833664|3985167|P2|COMPLETED|Washout: 14 Days||11
1631111|NCT00833664|3985168|P1|COMPLETED|Washout: 14 Days||10
1631112|NCT00833664|3985167|P2|STARTED|Washout: 14 Days||11
1631113|NCT00833664|3985168|P1|STARTED|Washout: 14 Days||11
1631114|NCT00833664|3985167|P2|NOT COMPLETED|First Intervention||0
1631115|NCT00833664|3985168|P1|NOT COMPLETED|First Intervention||0
1631116|NCT00833664|3985167|P2|COMPLETED|First Intervention||11
1631117|NCT00833664|3985168|P1|COMPLETED|First Intervention||11
1631118|NCT00833664|3985167|P2|STARTED|First Intervention||11
1631119|NCT00833664|3985168|P1|STARTED|First Intervention||11
1631120|NCT00833638|3985179|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
1631121|NCT00833638|3985180|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
1631122|NCT00833638|3985181|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
1631123|NCT00833638|3985179|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
1631124|NCT00833638|3985180|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
1631125|NCT00833638|3985181|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
1631126|NCT00833638|3985179|P3|STARTED|Phase 3: Open-label Extension Phase||124
1631127|NCT00833638|3985180|P2|STARTED|Phase 3: Open-label Extension Phase||108
1631128|NCT00833638|3985181|P1|STARTED|Phase 3: Open-label Extension Phase||111
1631129|NCT00833638|3985179|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
1631130|NCT00833638|3985180|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
1631131|NCT00833638|3985181|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
1631132|NCT00833638|3985179|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
1631133|NCT00833638|3985180|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
1631134|NCT00833638|3985181|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
1631135|NCT00833638|3985179|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
1631136|NCT00833638|3985180|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
1631137|NCT00833638|3985181|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
1631138|NCT00833586|3985223|P2|NOT COMPLETED|Second Intervention||0
1631139|NCT00833586|3985224|P1|NOT COMPLETED|Second Intervention||0
1631140|NCT00833586|3985223|P2|COMPLETED|Second Intervention||14
1631141|NCT00833586|3985224|P1|COMPLETED|Second Intervention||14
1631142|NCT00833586|3985223|P2|STARTED|Second Intervention||14
1631143|NCT00833586|3985224|P1|STARTED|Second Intervention||14
1631144|NCT00833586|3985223|P2|NOT COMPLETED|Washout: 14 Days||0
1631145|NCT00833586|3985224|P1|NOT COMPLETED|Washout: 14 Days||0
1631146|NCT00833586|3985223|P2|COMPLETED|Washout: 14 Days||14
1631147|NCT00833586|3985224|P1|COMPLETED|Washout: 14 Days||14
1631148|NCT00833586|3985223|P2|STARTED|Washout: 14 Days||14
1631149|NCT00833586|3985224|P1|STARTED|Washout: 14 Days||14
1631150|NCT00833586|3985223|P2|NOT COMPLETED|First Intervention||0
1631151|NCT00833586|3985224|P1|NOT COMPLETED|First Intervention||0
1631152|NCT00833586|3985223|P2|COMPLETED|First Intervention||14
1631153|NCT00833586|3985224|P1|COMPLETED|First Intervention||14
1631154|NCT00833586|3985223|P2|STARTED|First Intervention||14
1631155|NCT00833586|3985224|P1|STARTED|First Intervention||14
1631156|NCT00833560|3985232|P1|NOT COMPLETED|Overall Study||42
1631157|NCT00833560|3985232|P1|COMPLETED|Overall Study||353
1631158|NCT00833560|3985232|P1|STARTED|Overall Study||395
1631159|NCT00833547|3985241|P2|NOT COMPLETED|Overall Study||2
1631160|NCT00833547|3985242|P1|NOT COMPLETED|Overall Study||2
1631161|NCT00833547|3985241|P2|COMPLETED|Overall Study||10
1631162|NCT00833547|3985242|P1|COMPLETED|Overall Study||11
1631163|NCT00833547|3985241|P2|STARTED|Overall Study||12
1631164|NCT00833547|3985242|P1|STARTED|Overall Study||13
1631165|NCT00833521|3985252|P2|NOT COMPLETED|Second Intervention||0
1631166|NCT00833521|3985253|P1|NOT COMPLETED|Second Intervention||0
1631167|NCT00833521|3985252|P2|COMPLETED|Second Intervention||19
1631168|NCT00833521|3985253|P1|COMPLETED|Second Intervention||19
1631169|NCT00833521|3985252|P2|STARTED|Second Intervention||19
1631170|NCT00833521|3985253|P1|STARTED|Second Intervention||19
1631171|NCT00833521|3985252|P2|NOT COMPLETED|First Intervention||0
1631172|NCT00833521|3985253|P1|NOT COMPLETED|First Intervention||0
1631173|NCT00833521|3985252|P2|COMPLETED|First Intervention||19
1631174|NCT00833521|3985253|P1|COMPLETED|First Intervention||19
1631175|NCT00833521|3985252|P2|STARTED|First Intervention||19
1631176|NCT00833521|3985253|P1|STARTED|First Intervention||19
1631177|NCT00833482|3985263|P6|NOT COMPLETED|Days 21-30||0
1631178|NCT00833482|3985264|P5|NOT COMPLETED|Days 21-30||1
1631179|NCT00833482|3985265|P4|NOT COMPLETED|Days 21-30||0
1631180|NCT00833482|3985266|P3|NOT COMPLETED|Days 21-30||1
1631181|NCT00833482|3985267|P2|NOT COMPLETED|Days 21-30||0
1631182|NCT00833482|3985268|P1|NOT COMPLETED|Days 21-30||0
1631183|NCT00833482|3985263|P6|COMPLETED|Days 21-30||0
1631184|NCT00833482|3985264|P5|COMPLETED|Days 21-30||7
1631185|NCT00833482|3985265|P4|COMPLETED|Days 21-30||0
1631186|NCT00833482|3985266|P3|COMPLETED|Days 21-30||20
1631187|NCT00833482|3985267|P2|COMPLETED|Days 21-30||0
1631188|NCT00833482|3985268|P1|COMPLETED|Days 21-30||0
1631189|NCT00833482|3985263|P6|STARTED|Days 21-30||0
1631190|NCT00833482|3985264|P5|STARTED|Days 21-30||8
1631191|NCT00833482|3985265|P4|STARTED|Days 21-30||0
1631192|NCT00833482|3985266|P3|STARTED|Days 21-30||21
1631193|NCT00833482|3985267|P2|STARTED|Days 21-30||0
1631194|NCT00833482|3985268|P1|STARTED|Days 21-30||0
1631195|NCT00833482|3985263|P6|NOT COMPLETED|Days 11-20||0
1631196|NCT00833482|3985264|P5|NOT COMPLETED|Days 11-20||0
1631197|NCT00833482|3985265|P4|NOT COMPLETED|Days 11-20||0
1631198|NCT00833482|3985266|P3|NOT COMPLETED|Days 11-20||0
1631199|NCT00833482|3985267|P2|NOT COMPLETED|Days 11-20||3
1631200|NCT00833482|3985268|P1|NOT COMPLETED|Days 11-20||0
1631201|NCT00833482|3985263|P6|COMPLETED|Days 11-20||8
1631202|NCT00833482|3985264|P5|COMPLETED|Days 11-20||0
1631203|NCT00833482|3985265|P4|COMPLETED|Days 11-20||0
1631204|NCT00833482|3985266|P3|COMPLETED|Days 11-20||0
1631205|NCT00833482|3985267|P2|COMPLETED|Days 11-20||21
1631206|NCT00833482|3985268|P1|COMPLETED|Days 11-20||0
1631207|NCT00833482|3985263|P6|STARTED|Days 11-20|Participants who received treatment.|8
1631208|NCT00833482|3985264|P5|STARTED|Days 11-20||0
1631209|NCT00833482|3985265|P4|STARTED|Days 11-20||0
1631210|NCT00833482|3985266|P3|STARTED|Days 11-20||0
1631211|NCT00833482|3985267|P2|STARTED|Days 11-20|Participants who received treatment.|24
1631212|NCT00833482|3985268|P1|STARTED|Days 11-20||0
1631213|NCT00833482|3985263|P6|NOT COMPLETED|Days 1-3||0
1631214|NCT00833482|3985264|P5|NOT COMPLETED|Days 1-3||0
1631215|NCT00833482|3985265|P4|NOT COMPLETED|Days 1-3||0
1631216|NCT00833482|3985266|P3|NOT COMPLETED|Days 1-3||0
1631217|NCT00833482|3985267|P2|NOT COMPLETED|Days 1-3||0
1631218|NCT00833482|3985268|P1|NOT COMPLETED|Days 1-3||0
1631219|NCT00833482|3985263|P6|COMPLETED|Days 1-3||0
1631220|NCT00833482|3985264|P5|COMPLETED|Days 1-3||0
1631221|NCT00833482|3985265|P4|COMPLETED|Days 1-3||8
1631222|NCT00833482|3985266|P3|COMPLETED|Days 1-3||0
1631223|NCT00833482|3985267|P2|COMPLETED|Days 1-3||0
1631224|NCT00833482|3985268|P1|COMPLETED|Days 1-3||24
1631225|NCT00833482|3985263|P6|STARTED|Days 1-3||0
1631226|NCT00833482|3985264|P5|STARTED|Days 1-3||0
1631227|NCT00833482|3985265|P4|STARTED|Days 1-3||8
1631228|NCT00833482|3985266|P3|STARTED|Days 1-3||0
1631229|NCT00833482|3985267|P2|STARTED|Days 1-3|Participants who received treatment|0
1631230|NCT00833482|3985268|P1|STARTED|Days 1-3|Participants who received treatment|24
1631231|NCT00833469|3985324|P1|NOT COMPLETED|Overall Study||2
1631232|NCT00833469|3985324|P1|COMPLETED|Overall Study||3
1631233|NCT00833469|3985324|P1|STARTED|Overall Study||5
1631234|NCT00833443|3985332|P2|NOT COMPLETED|Overall Study||28
1631235|NCT00833443|3985333|P1|NOT COMPLETED|Overall Study||20
1631236|NCT00833443|3985332|P2|COMPLETED|Overall Study||15
1631237|NCT00833443|3985333|P1|COMPLETED|Overall Study||21
1631238|NCT00833443|3985332|P2|STARTED|Overall Study||43
1631239|NCT00833443|3985333|P1|STARTED|Overall Study||41
1631240|NCT00833417|3985347|P2|NOT COMPLETED|Overall Study||71
1631241|NCT00833417|3985348|P1|NOT COMPLETED|Overall Study||33
1631242|NCT00833417|3985347|P2|COMPLETED|Overall Study||0
1631243|NCT00833417|3985348|P1|COMPLETED|Overall Study||0
1631244|NCT00833417|3985347|P2|STARTED|Overall Study||71
1631245|NCT00833417|3985348|P1|STARTED|Overall Study||33
1631246|NCT00833365|3985363|P2|NOT COMPLETED|Overall Study||0
1631247|NCT00833365|3985364|P1|NOT COMPLETED|Overall Study||0
1631248|NCT00833365|3985363|P2|COMPLETED|Overall Study||6
1631249|NCT00833365|3985364|P1|COMPLETED|Overall Study||9
1631250|NCT00833365|3985363|P2|STARTED|Overall Study||6
1631251|NCT00833365|3985364|P1|STARTED|Overall Study||9
1631252|NCT00833248|3985374|P2|NOT COMPLETED|Overall Study||3
1631253|NCT00833248|3985375|P1|NOT COMPLETED|Overall Study||4
1631254|NCT00833248|3985374|P2|COMPLETED|Overall Study||62
1631255|NCT00833248|3985375|P1|COMPLETED|Overall Study||177
1631256|NCT00833248|3985374|P2|Safety Analysis Set|Overall Study||64
1631257|NCT00833248|3985375|P1|Safety Analysis Set|Overall Study||181
1631258|NCT00833248|3985374|P2|Per Protocol (PP) Analysis Set|Overall Study||57
1631259|NCT00833248|3985375|P1|Per Protocol (PP) Analysis Set|Overall Study||164
1631260|NCT00833248|3985374|P2|Full Analysis Set (FAS)|Overall Study||64
1631261|NCT00833248|3985375|P1|Full Analysis Set (FAS)|Overall Study||180
1631262|NCT00833248|3985374|P2|STARTED|Overall Study||65
1631263|NCT00833248|3985375|P1|STARTED|Overall Study||181
1631264|NCT00833092|3985399|P2|NOT COMPLETED|Overall Study||7
1631265|NCT00833092|3985400|P1|NOT COMPLETED|Overall Study||4
1631266|NCT00833092|3985399|P2|COMPLETED|Overall Study||50
1631267|NCT00833092|3985400|P1|COMPLETED|Overall Study||50
1631268|NCT00833092|3985399|P2|STARTED|Overall Study||57
1631269|NCT00833092|3985400|P1|STARTED|Overall Study||54
1631270|NCT00833053|3985408|P2|NOT COMPLETED|Overall Study||3
1631271|NCT00833053|3985409|P1|NOT COMPLETED|Overall Study||9
1631272|NCT00833053|3985408|P2|COMPLETED|Overall Study||17
1631273|NCT00833053|3985409|P1|COMPLETED|Overall Study||10
1631274|NCT00833053|3985408|P2|STARTED|Overall Study||20
1631275|NCT00833053|3985409|P1|STARTED|Overall Study||19
1631276|NCT00833040|3985427|P6|NOT COMPLETED|Overall Study||1
1631277|NCT00833040|3985428|P5|NOT COMPLETED|Overall Study||0
1631278|NCT00833040|3985429|P4|NOT COMPLETED|Overall Study||0
1631279|NCT00833040|3985430|P3|NOT COMPLETED|Overall Study||0
1631280|NCT00833040|3985431|P2|NOT COMPLETED|Overall Study||0
1631281|NCT00833040|3985432|P1|NOT COMPLETED|Overall Study||0
1631282|NCT00833040|3985427|P6|COMPLETED|Overall Study||4
1631283|NCT00833040|3985428|P5|COMPLETED|Overall Study||5
1631284|NCT00833040|3985429|P4|COMPLETED|Overall Study||6
1631285|NCT00833040|3985430|P3|COMPLETED|Overall Study||6
1631286|NCT00833040|3985431|P2|COMPLETED|Overall Study||6
1631287|NCT00833040|3985432|P1|COMPLETED|Overall Study||6
1631288|NCT00833040|3985427|P6|STARTED|Overall Study||5
1631289|NCT00833040|3985428|P5|STARTED|Overall Study||5
1631290|NCT00833040|3985429|P4|STARTED|Overall Study||6
1631291|NCT00833040|3985430|P3|STARTED|Overall Study||6
1631292|NCT00833040|3985431|P2|STARTED|Overall Study||6
1631293|NCT00833040|3985432|P1|STARTED|Overall Study||6
1631294|NCT00833027|3985437|P1|NOT COMPLETED|Overall Study||211
1631295|NCT00833027|3985437|P1|COMPLETED|Overall Study||397
1631296|NCT00833027|3985437|P1|STARTED|Overall Study||608
1631297|NCT00832975|3985442|P1|NOT COMPLETED|Overall Study||39
1631298|NCT00832975|3985442|P1|COMPLETED|Overall Study||118
1631299|NCT00832975|3985442|P1|STARTED|Overall Study||157
1631300|NCT00832871|3985447|P1|NOT COMPLETED|Overall Study||0
1631301|NCT00832871|3985447|P1|COMPLETED|Overall Study||4
1631302|NCT00832871|3985447|P1|STARTED|Overall Study||4
1631303|NCT00832819|3985456|P3|NOT COMPLETED|Overall Study||1
1631304|NCT00832819|3985457|P2|NOT COMPLETED|Overall Study||1
1631305|NCT00832819|3985458|P1|NOT COMPLETED|Overall Study||0
1631306|NCT00832819|3985456|P3|COMPLETED|Overall Study||15
1631307|NCT00832819|3985457|P2|COMPLETED|Overall Study||5
1631308|NCT00832819|3985458|P1|COMPLETED|Overall Study||6
1631309|NCT00832819|3985456|P3|STARTED|Overall Study||16
1631310|NCT00832819|3985457|P2|STARTED|Overall Study||6
1631311|NCT00832819|3985458|P1|STARTED|Overall Study||6
1631312|NCT00832780|3985464|P1|NOT COMPLETED|Overall Study||25
1631313|NCT00832780|3985464|P1|COMPLETED|Overall Study||19
1631314|NCT00832780|3985464|P1|STARTED|Overall Study||44
1631315|NCT00832767|3985474|P2|NOT COMPLETED|Overall Study||18
1631316|NCT00832767|3985475|P1|NOT COMPLETED|Overall Study||22
1631317|NCT00832767|3985474|P2|COMPLETED|Overall Study||63
1631318|NCT00832767|3985475|P1|COMPLETED|Overall Study||99
1631319|NCT00832767|3985474|P2|STARTED|Overall Study||81
1631320|NCT00832767|3985475|P1|STARTED|Overall Study||121
1631321|NCT00832650|3985506|P3|NOT COMPLETED|Overall Study||1
1631322|NCT00832650|3985507|P2|NOT COMPLETED|Overall Study||0
1631323|NCT00832650|3985508|P1|NOT COMPLETED|Overall Study||0
1631324|NCT00832650|3985506|P3|COMPLETED|Overall Study||22
1631325|NCT00832650|3985507|P2|COMPLETED|Overall Study||12
1631326|NCT00832650|3985508|P1|COMPLETED|Overall Study||25
1631327|NCT00832650|3985506|P3|Treated|Overall Study||22
1631328|NCT00832650|3985507|P2|Treated|Overall Study||12
1631329|NCT00832650|3985508|P1|Treated|Overall Study||25
1631330|NCT00832650|3985506|P3|STARTED|Overall Study||23
1631331|NCT00832650|3985507|P2|STARTED|Overall Study||12
1631332|NCT00832650|3985508|P1|STARTED|Overall Study||25
1631333|NCT00832637|3985540|P1|NOT COMPLETED|Overall Study||0
1631334|NCT00832637|3985540|P1|COMPLETED|Overall Study||33
1631335|NCT00832637|3985540|P1|STARTED|Overall Study||33
1631336|NCT00832624|3985548|P1|NOT COMPLETED|Overall Study||10
1631337|NCT00832624|3985548|P1|COMPLETED|Overall Study||0
1631338|NCT00832624|3985548|P1|STARTED|Overall Study||10
1631339|NCT00832598|3985552|P1|NOT COMPLETED|Overall Study||0
1631340|NCT00832598|3985552|P1|COMPLETED|Overall Study||13
1631341|NCT00832598|3985552|P1|STARTED|Overall Study||13
1631342|NCT00832585|3985558|P1|NOT COMPLETED|Overall Study||2
1631343|NCT00832585|3985558|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
1631344|NCT00832585|3985558|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
1631345|NCT00832572|3985565|P2|NOT COMPLETED|Period 2||0
1631346|NCT00832572|3985566|P1|NOT COMPLETED|Period 2||0
1631347|NCT00832572|3985565|P2|COMPLETED|Period 2||2
1631348|NCT00832572|3985566|P1|COMPLETED|Period 2||3
1631349|NCT00832572|3985565|P2|STARTED|Period 2||2
1631350|NCT00832572|3985566|P1|STARTED|Period 2||3
1631351|NCT00832572|3985565|P2|NOT COMPLETED|Period 1||0
1631352|NCT00832572|3985566|P1|NOT COMPLETED|Period 1||0
1631353|NCT00832572|3985565|P2|COMPLETED|Period 1||2
1631354|NCT00832572|3985566|P1|COMPLETED|Period 1||3
1631355|NCT00832572|3985565|P2|STARTED|Period 1||2
1631356|NCT00832572|3985566|P1|STARTED|Period 1||3
1631357|NCT00832520|3985578|P1|NOT COMPLETED|Overall Study||0
1631358|NCT00832520|3985578|P1|COMPLETED|Overall Study||13
1631359|NCT00832520|3985578|P1|STARTED|Overall Study||13
1631360|NCT00832455|3985583|P1|NOT COMPLETED|Overall Study||72
1631361|NCT00832455|3985583|P1|COMPLETED|Overall Study||373
1631362|NCT00832455|3985583|P1|Week 12|Overall Study||373
1631363|NCT00832455|3985583|P1|Week 8 (Optional)|Overall Study||247
1631364|NCT00832455|3985583|P1|Week 4|Overall Study||411
1631365|NCT00832455|3985583|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
1631366|NCT00832455|3985583|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
1631367|NCT00832416|3985607|P4|NOT COMPLETED|Overall Study||83
1631368|NCT00832416|3985608|P3|NOT COMPLETED|Overall Study||61
1631369|NCT00832416|3985609|P2|NOT COMPLETED|Overall Study||53
1631370|NCT00832416|3985610|P1|NOT COMPLETED|Overall Study||46
1631371|NCT00832416|3985607|P4|COMPLETED|Overall Study||144
1631372|NCT00832416|3985608|P3|COMPLETED|Overall Study||54
1631373|NCT00832416|3985609|P2|COMPLETED|Overall Study||60
1631374|NCT00832416|3985610|P1|COMPLETED|Overall Study||64
1631375|NCT00832416|3985607|P4|STARTED|Overall Study||227
1631376|NCT00832416|3985608|P3|STARTED|Overall Study||115
1631377|NCT00832416|3985609|P2|STARTED|Overall Study||113
1631378|NCT00832416|3985610|P1|STARTED|Overall Study||110
1631379|NCT00832390|3985651|P3|NOT COMPLETED|Overall Study||0
1631380|NCT00832390|3985652|P2|NOT COMPLETED|Overall Study||0
1631381|NCT00832390|3985653|P1|NOT COMPLETED|Overall Study||0
1631382|NCT00832390|3985651|P3|COMPLETED|Overall Study||1
1631383|NCT00832390|3985652|P2|COMPLETED|Overall Study||16
1631384|NCT00832390|3985653|P1|COMPLETED|Overall Study||12
1631385|NCT00832390|3985651|P3|STARTED|Overall Study||1
1631386|NCT00832390|3985652|P2|STARTED|Overall Study||16
1631387|NCT00832390|3985653|P1|STARTED|Overall Study||12
1631388|NCT00832377|3985661|P1|NOT COMPLETED|Overall Study||1
1631389|NCT00832377|3985661|P1|COMPLETED|Overall Study||36
1631390|NCT00832377|3985661|P1|STARTED|Overall Study||37
1631391|NCT00832338|3985668|P1|NOT COMPLETED|Overall Study||0
1631392|NCT00832338|3985668|P1|COMPLETED|Overall Study||23
1631393|NCT00832338|3985668|P1|STARTED|Overall Study||23
1631394|NCT00832299|3985672|P1|NOT COMPLETED|Overall Study||0
1631395|NCT00832299|3985672|P1|COMPLETED|Overall Study||2
1631396|NCT00832299|3985672|P1|STARTED|Overall Study||2
1631397|NCT00832260|3985677|P1|NOT COMPLETED|Overall Study||0
1631398|NCT00832260|3985677|P1|COMPLETED|Overall Study||70
1631399|NCT00832260|3985677|P1|STARTED|Overall Study||70
1631400|NCT00832130|3985684|P2|NOT COMPLETED|Overall Study||0
1631401|NCT00832130|3985685|P1|NOT COMPLETED|Overall Study||0
1631402|NCT00832130|3985684|P2|COMPLETED|Overall Study||70
1631403|NCT00832130|3985685|P1|COMPLETED|Overall Study||69
1631404|NCT00832130|3985684|P2|STARTED|Overall Study||70
1631405|NCT00832130|3985685|P1|STARTED|Overall Study||69
1631406|NCT00832117|3985707|P1|NOT COMPLETED|Overall Study||12
1631407|NCT00832117|3985707|P1|COMPLETED|Overall Study||17
1631408|NCT00832117|3985707|P1|STARTED|Overall Study||29
1631409|NCT00832091|3985726|P2|NOT COMPLETED|Overall Study||2
1631410|NCT00832091|3985727|P1|NOT COMPLETED|Overall Study||5
1631411|NCT00832091|3985726|P2|COMPLETED|Overall Study||53
1631412|NCT00832091|3985727|P1|COMPLETED|Overall Study||12
1631413|NCT00832091|3985726|P2|STARTED|Overall Study||55
1631414|NCT00832091|3985727|P1|STARTED|Overall Study||17
1631415|NCT00832078|3985735|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
1631416|NCT00832078|3985736|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
1631417|NCT00832078|3985735|P2|COMPLETED|Test Day 2 - 2 Period||10
1631418|NCT00832078|3985736|P1|COMPLETED|Test Day 2 - 2 Period||12
1631419|NCT00832078|3985735|P2|STARTED|Test Day 2 - 2 Period||10
1631420|NCT00832078|3985736|P1|STARTED|Test Day 2 - 2 Period||13
1631421|NCT00832078|3985735|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
1631422|NCT00832078|3985736|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
1631423|NCT00832078|3985735|P2|COMPLETED|Test Day 2 - 1 Period||10
1631424|NCT00832078|3985736|P1|COMPLETED|Test Day 2 - 1 Period||13
1631425|NCT00832078|3985735|P2|STARTED|Test Day 2 - 1 Period||10
1631426|NCT00832078|3985736|P1|STARTED|Test Day 2 - 1 Period||13
1631427|NCT00832078|3985735|P2|NOT COMPLETED|Test Day 1-2 Period||2
1631428|NCT00832078|3985736|P1|NOT COMPLETED|Test Day 1-2 Period||0
1631429|NCT00832078|3985735|P2|COMPLETED|Test Day 1-2 Period||10
1631430|NCT00832078|3985736|P1|COMPLETED|Test Day 1-2 Period||13
1631431|NCT00832078|3985735|P2|STARTED|Test Day 1-2 Period||12
1631432|NCT00832078|3985736|P1|STARTED|Test Day 1-2 Period||13
1631433|NCT00832078|3985735|P2|NOT COMPLETED|Test Day 1- 1 Period||0
1631434|NCT00832078|3985736|P1|NOT COMPLETED|Test Day 1- 1 Period||0
1631435|NCT00832078|3985735|P2|COMPLETED|Test Day 1- 1 Period||12
1631436|NCT00832078|3985736|P1|COMPLETED|Test Day 1- 1 Period||13
1631437|NCT00832078|3985735|P2|STARTED|Test Day 1- 1 Period||12
1631438|NCT00832078|3985736|P1|STARTED|Test Day 1- 1 Period||13
1631439|NCT00832000|3985742|P2|NOT COMPLETED|Overall Study||1
1631440|NCT00832000|3985743|P1|NOT COMPLETED|Overall Study||6
1631441|NCT00832000|3985742|P2|COMPLETED|Overall Study||29
1631442|NCT00832000|3985743|P1|COMPLETED|Overall Study||23
1631443|NCT00832000|3985742|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
1631444|NCT00832000|3985743|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
1631445|NCT00832000|3985742|P2|STARTED|Overall Study|Placebo|30
1631446|NCT00832000|3985743|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
1631447|NCT00831987|3985781|P2|NOT COMPLETED|Overall Study||0
1631448|NCT00831987|3985782|P1|NOT COMPLETED|Overall Study||0
1631449|NCT00831987|3985781|P2|COMPLETED|Overall Study||60
1631450|NCT00831987|3985782|P1|COMPLETED|Overall Study||60
1631451|NCT00831987|3985781|P2|STARTED|Overall Study||60
1631452|NCT00831987|3985782|P1|STARTED|Overall Study||60
1631453|NCT00831844|3985804|P10|NOT COMPLETED|Overall Study||0
1631454|NCT00831844|3985805|P9|NOT COMPLETED|Overall Study||9
1631455|NCT00831844|3985806|P8|NOT COMPLETED|Overall Study||10
1631456|NCT00831844|3985807|P7|NOT COMPLETED|Overall Study||10
1631457|NCT00831844|3985808|P6|NOT COMPLETED|Overall Study||19
1631458|NCT00831844|3985809|P5|NOT COMPLETED|Overall Study||14
1631459|NCT00831844|3985810|P4|NOT COMPLETED|Overall Study||10
1631460|NCT00831844|3985811|P3|NOT COMPLETED|Overall Study||20
1631461|NCT00831844|3985812|P2|NOT COMPLETED|Overall Study||12
1631462|NCT00831844|3985813|P1|NOT COMPLETED|Overall Study||10
1631463|NCT00831844|3985804|P10|COMPLETED|Overall Study||0
1631464|NCT00831844|3985805|P9|COMPLETED|Overall Study||0
1631465|NCT00831844|3985806|P8|COMPLETED|Overall Study||0
1631466|NCT00831844|3985807|P7|COMPLETED|Overall Study||0
1631467|NCT00831844|3985808|P6|COMPLETED|Overall Study||1
1631468|NCT00831844|3985809|P5|COMPLETED|Overall Study||0
1631469|NCT00831844|3985810|P4|COMPLETED|Overall Study||0
1631470|NCT00831844|3985811|P3|COMPLETED|Overall Study||1
1631471|NCT00831844|3985812|P2|COMPLETED|Overall Study||0
1631472|NCT00831844|3985813|P1|COMPLETED|Overall Study||0
1631473|NCT00831844|3985804|P10|STARTED|Overall Study||0
1631474|NCT00831844|3985805|P9|STARTED|Overall Study||9
1631475|NCT00831844|3985806|P8|STARTED|Overall Study||10
1631476|NCT00831844|3985807|P7|STARTED|Overall Study||10
1631477|NCT00831844|3985808|P6|STARTED|Overall Study||20
1631478|NCT00831844|3985809|P5|STARTED|Overall Study||14
1631479|NCT00831844|3985810|P4|STARTED|Overall Study||10
1631480|NCT00831844|3985811|P3|STARTED|Overall Study||21
1631481|NCT00831844|3985812|P2|STARTED|Overall Study||12
1631482|NCT00831844|3985813|P1|STARTED|Overall Study||10
1631483|NCT00831779|3985837|P2|NOT COMPLETED|Overall Study||1
1631484|NCT00831779|3985838|P1|NOT COMPLETED|Overall Study||1
1631485|NCT00831779|3985837|P2|COMPLETED|Overall Study||22
1631486|NCT00831779|3985838|P1|COMPLETED|Overall Study||20
1631487|NCT00831779|3985837|P2|STARTED|Overall Study||23
1631488|NCT00831779|3985838|P1|STARTED|Overall Study||21
1631489|NCT00831766|3985848|P2|NOT COMPLETED|Overall Study||0
1631490|NCT00831766|3985849|P1|NOT COMPLETED|Overall Study||0
1631491|NCT00831766|3985848|P2|COMPLETED|Overall Study||28
1631492|NCT00831766|3985849|P1|COMPLETED|Overall Study||23
1631493|NCT00831766|3985848|P2|STARTED|Overall Study||28
1631494|NCT00831766|3985849|P1|STARTED|Overall Study||23
1631495|NCT00831753|3985860|P2|NOT COMPLETED|Overall Study||0
1631496|NCT00831753|3985861|P1|NOT COMPLETED|Overall Study||0
1631497|NCT00831753|3985860|P2|COMPLETED|Overall Study||131
1631498|NCT00831753|3985861|P1|COMPLETED|Overall Study||132
1631499|NCT00831753|3985860|P2|STARTED|Overall Study||131
1631500|NCT00831753|3985861|P1|STARTED|Overall Study||132
1631501|NCT00831701|3985875|P2|NOT COMPLETED|Overall Study||5
1631502|NCT00831701|3985876|P1|NOT COMPLETED|Overall Study||5
1631503|NCT00831701|3985875|P2|COMPLETED|Overall Study||45
1631504|NCT00831701|3985876|P1|COMPLETED|Overall Study||45
1631505|NCT00831701|3985875|P2|STARTED|Overall Study||50
1631506|NCT00831701|3985876|P1|STARTED|Overall Study||50
1631507|NCT00831675|3985892|P2|NOT COMPLETED|Overall Study||0
1631508|NCT00831675|3985893|P1|NOT COMPLETED|Overall Study||0
1631509|NCT00831675|3985892|P2|COMPLETED|Overall Study||18
1631510|NCT00831675|3985893|P1|COMPLETED|Overall Study||12
1631511|NCT00831675|3985892|P2|STARTED|Overall Study||18
1631512|NCT00831675|3985893|P1|STARTED|Overall Study||12
1631513|NCT00831493|3985905|P1|NOT COMPLETED|Overall Study||1
1631514|NCT00831493|3985905|P1|COMPLETED|Overall Study||2
1631515|NCT00831493|3985905|P1|STARTED|Overall Study||3
1631516|NCT00831480|3985909|P1|NOT COMPLETED|Overall Study||2
1631517|NCT00831480|3985909|P1|COMPLETED|Overall Study||7
1631518|NCT00831480|3985909|P1|STARTED|Overall Study||9
1631519|NCT00831441|3985915|P2|NOT COMPLETED|Follow Up (30 Days)||174
1631520|NCT00831441|3985916|P1|NOT COMPLETED|Follow Up (30 Days)||133
1631521|NCT00831441|3985915|P2|COMPLETED|Follow Up (30 Days)||3355
1631522|NCT00831441|3985916|P1|COMPLETED|Follow Up (30 Days)||3375
1631523|NCT00831441|3985915|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
1631524|NCT00831441|3985916|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
1631525|NCT00831441|3985915|P2|NOT COMPLETED|Randomized||3705
1631526|NCT00831441|3985916|P1|NOT COMPLETED|Randomized||3687
1631527|NCT00831441|3985915|P2|COMPLETED|Randomized||0
1631528|NCT00831441|3985916|P1|COMPLETED|Randomized||0
1631529|NCT00831441|3985915|P2|Treated|Randomized||3672
1631530|NCT00831441|3985916|P1|Treated|Randomized||3643
1631531|NCT00831441|3985915|P2|STARTED|Randomized||3705
1631532|NCT00831441|3985916|P1|STARTED|Randomized||3687
1631533|NCT00831428|3985944|P1|NOT COMPLETED|Overall Study||0
1631534|NCT00831428|3985944|P1|COMPLETED|Overall Study||97
1631535|NCT00831428|3985944|P1|STARTED|Overall Study||97
1631536|NCT00831415|3985948|P1|NOT COMPLETED|Overall Study||75
1631537|NCT00831415|3985948|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
1631538|NCT00831415|3985948|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
1631539|NCT00831415|3985948|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
1631540|NCT00831415|3985948|P1|STARTED|Overall Study||304
1631541|NCT00831389|3985957|P2|NOT COMPLETED|Overall Study||1
1631542|NCT00831389|3985958|P1|NOT COMPLETED|Overall Study||0
1631543|NCT00831389|3985957|P2|COMPLETED|Overall Study||6
1631544|NCT00831389|3985958|P1|COMPLETED|Overall Study||6
1631545|NCT00831389|3985957|P2|STARTED|Overall Study||7
1631546|NCT00831389|3985958|P1|STARTED|Overall Study||6
1631547|NCT00831311|3985984|P2|NOT COMPLETED|Overall Study||8
1631548|NCT00831311|3985985|P1|NOT COMPLETED|Overall Study||12
1631549|NCT00831311|3985984|P2|COMPLETED|Overall Study||304
1631550|NCT00831311|3985985|P1|COMPLETED|Overall Study||300
1631551|NCT00831311|3985984|P2|STARTED|Overall Study||312
1631552|NCT00831311|3985985|P1|STARTED|Overall Study||312
1631553|NCT00831272|3986007|P4|NOT COMPLETED|Overall Study||10
1631554|NCT00831272|3986008|P3|NOT COMPLETED|Overall Study||10
1631555|NCT00831272|3986009|P2|NOT COMPLETED|Overall Study||7
1631556|NCT00831272|3986010|P1|NOT COMPLETED|Overall Study||8
1631557|NCT00831272|3986007|P4|COMPLETED|Overall Study||56
1631558|NCT00831272|3986008|P3|COMPLETED|Overall Study||63
1631559|NCT00831272|3986009|P2|COMPLETED|Overall Study||37
1631560|NCT00831272|3986010|P1|COMPLETED|Overall Study||30
1631561|NCT00831272|3986007|P4|STARTED|Overall Study||66
1631562|NCT00831272|3986008|P3|STARTED|Overall Study||73
1631563|NCT00831272|3986009|P2|STARTED|Overall Study||44
1631564|NCT00831272|3986010|P1|STARTED|Overall Study||38
1631565|NCT00831233|3986022|P2|NOT COMPLETED|Overall Study||1
1631566|NCT00831233|3986023|P1|NOT COMPLETED|Overall Study||3
1631567|NCT00831233|3986022|P2|COMPLETED|Overall Study||12
1631568|NCT00831233|3986023|P1|COMPLETED|Overall Study||26
1631569|NCT00831233|3986022|P2|Per Protocol (PP) Analysis Set|Overall Study||11
1631570|NCT00831233|3986023|P1|Per Protocol (PP) Analysis Set|Overall Study||26
1631571|NCT00831233|3986022|P2|Full Analysis Set (FAS)|Overall Study||13
1631572|NCT00831233|3986023|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
1631573|NCT00831233|3986022|P2|STARTED|Overall Study|ITT population.|13
1631574|NCT00831233|3986023|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
1631575|NCT00831181|3986047|P1|NOT COMPLETED|Overall Study||12
1631576|NCT00831181|3986047|P1|COMPLETED|Overall Study||15
1631577|NCT00831181|3986047|P1|STARTED|Overall Study||27
1631578|NCT00831129|3986060|P2|NOT COMPLETED|Overall Study||10
1631579|NCT00831129|3986061|P1|NOT COMPLETED|Overall Study||0
1631580|NCT00831129|3986060|P2|COMPLETED|Overall Study||23
1631581|NCT00831129|3986061|P1|COMPLETED|Overall Study||20
1631582|NCT00831129|3986060|P2|STARTED|Overall Study||33
1631583|NCT00831129|3986061|P1|STARTED|Overall Study||20
1631584|NCT00830960|3986103|P6|NOT COMPLETED|Overall Study||37
1631585|NCT00830960|3986104|P5|NOT COMPLETED|Overall Study||32
1631586|NCT00830960|3986105|P4|NOT COMPLETED|Overall Study||32
1631587|NCT00830960|3986106|P3|NOT COMPLETED|Overall Study||29
1631588|NCT00830960|3986107|P2|NOT COMPLETED|Overall Study||28
1631589|NCT00830960|3986108|P1|NOT COMPLETED|Overall Study||33
1631590|NCT00830960|3986103|P6|COMPLETED|Overall Study||63
1631591|NCT00830960|3986104|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
1631592|NCT00830960|3986105|P4|COMPLETED|Overall Study||106
1631593|NCT00830960|3986106|P3|COMPLETED|Overall Study||108
1631594|NCT00830960|3986107|P2|COMPLETED|Overall Study||96
1631595|NCT00830960|3986108|P1|COMPLETED|Overall Study||91
1631596|NCT00830960|3986103|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
1631597|NCT00830960|3986104|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
1631598|NCT00830960|3986105|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
1631599|NCT00830960|3986106|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
1631600|NCT00830960|3986107|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
1631601|NCT00830960|3986108|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
1631602|NCT00830960|3986103|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
1631603|NCT00830960|3986104|P5|STARTED|Overall Study||96
1631604|NCT00830960|3986105|P4|STARTED|Overall Study||138
1631605|NCT00830960|3986106|P3|STARTED|Overall Study||137
1631606|NCT00830960|3986107|P2|STARTED|Overall Study||124
1631607|NCT00830960|3986108|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
1631608|NCT00830947|3986224|P2|NOT COMPLETED|Overall Study||4
1631609|NCT00830947|3986225|P1|NOT COMPLETED|Overall Study||4
1631610|NCT00830947|3986224|P2|COMPLETED|Overall Study||18
1631611|NCT00830947|3986225|P1|COMPLETED|Overall Study||19
1631612|NCT00830947|3986224|P2|STARTED|Overall Study||22
1631613|NCT00830947|3986225|P1|STARTED|Overall Study||23
1631614|NCT00830804|3986231|P1|NOT COMPLETED|Overall Study||15
1631615|NCT00830804|3986231|P1|COMPLETED|Overall Study||97
1631616|NCT00830804|3986231|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
1631617|NCT00830791|3986257|P6|NOT COMPLETED|Overall Study||0
1631618|NCT00830791|3986258|P5|NOT COMPLETED|Overall Study||0
1631619|NCT00830791|3986259|P4|NOT COMPLETED|Overall Study||0
1631620|NCT00830791|3986260|P3|NOT COMPLETED|Overall Study||0
1631621|NCT00830791|3986261|P2|NOT COMPLETED|Overall Study||0
1631622|NCT00830791|3986262|P1|NOT COMPLETED|Overall Study||0
1631623|NCT00830791|3986257|P6|COMPLETED|Overall Study||0
1631624|NCT00830791|3986258|P5|COMPLETED|Overall Study||0
1631625|NCT00830791|3986259|P4|COMPLETED|Overall Study||8
1631626|NCT00830791|3986260|P3|COMPLETED|Overall Study||8
1631627|NCT00830791|3986261|P2|COMPLETED|Overall Study||8
1631628|NCT00830791|3986262|P1|COMPLETED|Overall Study||8
1631629|NCT00830791|3986257|P6|STARTED|Overall Study||0
1631630|NCT00830791|3986258|P5|STARTED|Overall Study||0
1631631|NCT00830791|3986259|P4|STARTED|Overall Study||8
1631632|NCT00830791|3986260|P3|STARTED|Overall Study||8
1631633|NCT00830791|3986261|P2|STARTED|Overall Study||8
1631634|NCT00830791|3986262|P1|STARTED|Overall Study||8
1631635|NCT00830765|3986311|P2|NOT COMPLETED|Overall Study||2
1631636|NCT00830765|3986312|P1|NOT COMPLETED|Overall Study||3
1631637|NCT00830765|3986311|P2|COMPLETED|Overall Study||69
1631638|NCT00830765|3986312|P1|COMPLETED|Overall Study||70
1631639|NCT00830765|3986311|P2|STARTED|Overall Study||71
1631640|NCT00830765|3986312|P1|STARTED|Overall Study||73
1631641|NCT00830596|3986321|P3|NOT COMPLETED|Overall Study||6
1631642|NCT00830596|3986322|P2|NOT COMPLETED|Overall Study||2
1631643|NCT00830596|3986323|P1|NOT COMPLETED|Overall Study||2
1631644|NCT00830596|3986321|P3|COMPLETED|Overall Study||67
1631645|NCT00830596|3986322|P2|COMPLETED|Overall Study||72
1631646|NCT00830596|3986323|P1|COMPLETED|Overall Study||72
1631647|NCT00830596|3986321|P3|STARTED|Overall Study||73
1631648|NCT00830596|3986322|P2|STARTED|Overall Study||74
1631649|NCT00830596|3986323|P1|STARTED|Overall Study||74
1631650|NCT00830518|3986345|P2|NOT COMPLETED|Overall Study||11
1631651|NCT00830518|3986346|P1|NOT COMPLETED|Overall Study||46
1631652|NCT00830518|3986345|P2|COMPLETED|Overall Study||0
1631653|NCT00830518|3986346|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
1631654|NCT00830518|3986345|P2|STARTED|Overall Study||11
1631655|NCT00830518|3986346|P1|STARTED|Overall Study||46
1631656|NCT00830440|3986365|P2|NOT COMPLETED|Overall Study||0
1631657|NCT00830440|3986366|P1|NOT COMPLETED|Overall Study||8
1631658|NCT00830440|3986365|P2|COMPLETED|Overall Study||11
1631659|NCT00830440|3986366|P1|COMPLETED|Overall Study||24
1631660|NCT00830440|3986365|P2|Completed 24 Week Follow up|Overall Study||0
1631661|NCT00830440|3986366|P1|Completed 24 Week Follow up|Overall Study||3
1631662|NCT00830440|3986365|P2|Completed 16 Week Follow up|Overall Study||0
1631663|NCT00830440|3986366|P1|Completed 16 Week Follow up|Overall Study||4
1631664|NCT00830440|3986365|P2|Completed 12 Week Follow up|Overall Study||11
1631665|NCT00830440|3986366|P1|Completed 12 Week Follow up|Overall Study||24
1631666|NCT00830440|3986365|P2|Received Device|Overall Study||0
1631667|NCT00830440|3986366|P1|Received Device|Overall Study||26
1631668|NCT00830440|3986365|P2|STARTED|Overall Study||11
1631669|NCT00830440|3986366|P1|STARTED|Overall Study||32
1631670|NCT00830388|3986376|P1|NOT COMPLETED|Overall Study||0
1631671|NCT00830388|3986376|P1|COMPLETED|Overall Study||11
1631672|NCT00830388|3986376|P1|STARTED|Overall Study||11
1631673|NCT00830375|3986381|P1|NOT COMPLETED|Overall Study||1
1631674|NCT00830375|3986381|P1|COMPLETED|Overall Study||9
1631675|NCT00830375|3986381|P1|STARTED|Overall Study||10
1631676|NCT00830362|3986387|P2|NOT COMPLETED|Overall Study||4
1631677|NCT00830362|3986388|P1|NOT COMPLETED|Overall Study||4
1631678|NCT00830362|3986387|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
1631679|NCT00830362|3986388|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
1631680|NCT00830362|3986387|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
1631681|NCT00830362|3986388|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
1631682|NCT00830362|3986387|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
1631683|NCT00830362|3986388|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
1631684|NCT00830336|3986396|P2|NOT COMPLETED|Second Intervention||0
1631685|NCT00830336|3986397|P1|NOT COMPLETED|Second Intervention||0
1631686|NCT00830336|3986396|P2|COMPLETED|Second Intervention||40
1631687|NCT00830336|3986397|P1|COMPLETED|Second Intervention||39
1631688|NCT00830336|3986396|P2|STARTED|Second Intervention||40
1631689|NCT00830336|3986397|P1|STARTED|Second Intervention||39
1631690|NCT00830336|3986396|P2|NOT COMPLETED|Washout: 21 Days||0
1631691|NCT00830336|3986397|P1|NOT COMPLETED|Washout: 21 Days||1
1631692|NCT00830336|3986396|P2|COMPLETED|Washout: 21 Days||40
1631693|NCT00830336|3986397|P1|COMPLETED|Washout: 21 Days||39
1631694|NCT00830336|3986396|P2|STARTED|Washout: 21 Days||40
1631695|NCT00830336|3986397|P1|STARTED|Washout: 21 Days||40
1631696|NCT00830336|3986396|P2|NOT COMPLETED|First Intervention||0
1631697|NCT00830336|3986397|P1|NOT COMPLETED|First Intervention||0
1631698|NCT00830336|3986396|P2|COMPLETED|First Intervention||40
1631699|NCT00830336|3986397|P1|COMPLETED|First Intervention||40
1631700|NCT00830336|3986396|P2|STARTED|First Intervention||40
1631701|NCT00830336|3986397|P1|STARTED|First Intervention||40
1631702|NCT00830310|3986405|P1|NOT COMPLETED|Overall Study||13
1631703|NCT00830310|3986405|P1|COMPLETED|Overall Study||30
1631704|NCT00830310|3986405|P1|STARTED|Overall Study||43
1631705|NCT00830284|3986417|P1|NOT COMPLETED|Overall Study||2
1631706|NCT00830284|3986417|P1|COMPLETED|Overall Study||10
1631707|NCT00830284|3986417|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
1631708|NCT00830258|3986424|P2|NOT COMPLETED|Second Intervention||0
1631709|NCT00830258|3986425|P1|NOT COMPLETED|Second Intervention||0
1631710|NCT00830258|3986424|P2|COMPLETED|Second Intervention||30
1631711|NCT00830258|3986425|P1|COMPLETED|Second Intervention||28
1631712|NCT00830258|3986424|P2|STARTED|Second Intervention||30
1631713|NCT00830258|3986425|P1|STARTED|Second Intervention||28
1631714|NCT00830258|3986424|P2|NOT COMPLETED|Washout: 7 Days||0
1631715|NCT00830258|3986425|P1|NOT COMPLETED|Washout: 7 Days||1
1631716|NCT00830258|3986424|P2|COMPLETED|Washout: 7 Days||30
1631717|NCT00830258|3986425|P1|COMPLETED|Washout: 7 Days||28
1631718|NCT00830258|3986424|P2|STARTED|Washout: 7 Days||30
1631719|NCT00830258|3986425|P1|STARTED|Washout: 7 Days||29
1631720|NCT00830258|3986424|P2|NOT COMPLETED|First Intervention||0
1631721|NCT00830258|3986425|P1|NOT COMPLETED|First Intervention||1
1631722|NCT00830258|3986424|P2|COMPLETED|First Intervention||30
1631723|NCT00830258|3986425|P1|COMPLETED|First Intervention||29
1631724|NCT00830258|3986424|P2|STARTED|First Intervention||30
1631725|NCT00830258|3986425|P1|STARTED|First Intervention||30
1631726|NCT00830232|3986435|P2|NOT COMPLETED|Overall Study||0
1631727|NCT00830232|3986436|P1|NOT COMPLETED|Overall Study||0
1631728|NCT00830232|3986435|P2|COMPLETED|Overall Study||20
1631729|NCT00830232|3986436|P1|COMPLETED|Overall Study||20
1631730|NCT00830232|3986435|P2|STARTED|Overall Study||20
1631731|NCT00830232|3986436|P1|STARTED|Overall Study||20
1631732|NCT00830219|3986444|P2|NOT COMPLETED|Second Intervention||0
1631733|NCT00830219|3986445|P1|NOT COMPLETED|Second Intervention||0
1631734|NCT00830219|3986444|P2|COMPLETED|Second Intervention||22
1631735|NCT00830219|3986445|P1|COMPLETED|Second Intervention||22
1631736|NCT00830219|3986444|P2|STARTED|Second Intervention||22
1631737|NCT00830219|3986445|P1|STARTED|Second Intervention||22
1631738|NCT00830219|3986444|P2|NOT COMPLETED|Washout of 7 Days||1
1631739|NCT00830219|3986445|P1|NOT COMPLETED|Washout of 7 Days||1
1631740|NCT00830219|3986444|P2|COMPLETED|Washout of 7 Days||22
1631741|NCT00830219|3986445|P1|COMPLETED|Washout of 7 Days||22
1631742|NCT00830219|3986444|P2|STARTED|Washout of 7 Days||23
1631743|NCT00830219|3986445|P1|STARTED|Washout of 7 Days||23
1631744|NCT00830219|3986444|P2|NOT COMPLETED|First Intervention||0
1631745|NCT00830219|3986445|P1|NOT COMPLETED|First Intervention||0
1631746|NCT00830219|3986444|P2|COMPLETED|First Intervention||23
1631747|NCT00830219|3986445|P1|COMPLETED|First Intervention||23
1631748|NCT00830219|3986444|P2|STARTED|First Intervention||23
1631749|NCT00830219|3986445|P1|STARTED|First Intervention||23
1631750|NCT00830206|3986455|P2|NOT COMPLETED|Second Intervention||0
1631751|NCT00830206|3986456|P1|NOT COMPLETED|Second Intervention||0
1631752|NCT00830206|3986455|P2|COMPLETED|Second Intervention||39
1631753|NCT00830206|3986456|P1|COMPLETED|Second Intervention||39
1631754|NCT00830206|3986455|P2|STARTED|Second Intervention||39
1631755|NCT00830206|3986456|P1|STARTED|Second Intervention||39
1631756|NCT00830206|3986455|P2|NOT COMPLETED|Washout: 21 Days||1
1631757|NCT00830206|3986456|P1|NOT COMPLETED|Washout: 21 Days||1
1631758|NCT00830206|3986455|P2|COMPLETED|Washout: 21 Days||39
1631759|NCT00830206|3986456|P1|COMPLETED|Washout: 21 Days||39
1631760|NCT00830206|3986455|P2|STARTED|Washout: 21 Days||40
1631761|NCT00830206|3986456|P1|STARTED|Washout: 21 Days||40
1631762|NCT00830206|3986455|P2|NOT COMPLETED|First Intervention||0
1631763|NCT00830206|3986456|P1|NOT COMPLETED|First Intervention||0
1631764|NCT00830206|3986455|P2|COMPLETED|First Intervention||40
1631765|NCT00830206|3986456|P1|COMPLETED|First Intervention||40
1631766|NCT00830206|3986455|P2|STARTED|First Intervention||40
1631767|NCT00830206|3986456|P1|STARTED|First Intervention||40
1631768|NCT00830167|3986466|P2|NOT COMPLETED|Overall Study||43
1631769|NCT00830167|3986467|P1|NOT COMPLETED|Overall Study||40
1631770|NCT00830167|3986466|P2|COMPLETED|Overall Study||207
1631771|NCT00830167|3986467|P1|COMPLETED|Overall Study||208
1631772|NCT00830167|3986466|P2|STARTED|Overall Study|Treated|250
1631773|NCT00830167|3986467|P1|STARTED|Overall Study|Treated|248
1631774|NCT00830128|3986537|P1|NOT COMPLETED|Overall Study||19
1631775|NCT00830128|3986537|P1|COMPLETED|Overall Study||87
1631776|NCT00830128|3986537|P1|STARTED|Overall Study||106
1631777|NCT00830115|3986552|P1|NOT COMPLETED|Overall Study||3
1631778|NCT00830115|3986552|P1|COMPLETED|Overall Study||1042
1631779|NCT00830115|3986552|P1|STARTED|Overall Study||1045
1631780|NCT00830076|3986568|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
1631781|NCT00830076|3986568|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
1631782|NCT00830076|3986568|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
1631783|NCT00830076|3986568|P1|NOT COMPLETED|7-day Washout||0
1631784|NCT00830076|3986568|P1|COMPLETED|7-day Washout||18
1631785|NCT00830076|3986568|P1|STARTED|7-day Washout||18
1631786|NCT00830076|3986568|P1|NOT COMPLETED|Sitagliptin + Metformin||0
1631787|NCT00830076|3986568|P1|COMPLETED|Sitagliptin + Metformin||18
1631788|NCT00830076|3986568|P1|STARTED|Sitagliptin + Metformin||18
1631789|NCT00830076|3986568|P1|NOT COMPLETED|7-day Washout||0
1631790|NCT00830076|3986568|P1|COMPLETED|7-day Washout||18
1631791|NCT00830076|3986568|P1|STARTED|7-day Washout||18
1631792|NCT00830076|3986568|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
1631793|NCT00830076|3986568|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
1631794|NCT00830076|3986568|P1|STARTED|Metformin + Placebo Sitagliptin||18
1631795|NCT00830076|3986568|P1|NOT COMPLETED|7-day Washout||0
1631796|NCT00830076|3986568|P1|COMPLETED|7-day Washout||18
1631797|NCT00830076|3986568|P1|STARTED|7-day Washout||18
1631798|NCT00830076|3986568|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
1631799|NCT00830076|3986568|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
1631800|NCT00830076|3986568|P1|STARTED|Sitagliptin + Placebo Metformin||18
1631801|NCT00830037|3986579|P2|NOT COMPLETED|Overall Study||19
1631802|NCT00830037|3986580|P1|NOT COMPLETED|Overall Study||18
1631803|NCT00830037|3986579|P2|COMPLETED|Overall Study||50
1631804|NCT00830037|3986580|P1|COMPLETED|Overall Study||49
1631805|NCT00830037|3986579|P2|STARTED|Overall Study||69
1631806|NCT00830037|3986580|P1|STARTED|Overall Study||67
1631807|NCT00830024|3986590|P2|NOT COMPLETED|Second Intervention||0
1631808|NCT00830024|3986591|P1|NOT COMPLETED|Second Intervention||0
1631809|NCT00830024|3986590|P2|COMPLETED|Second Intervention||18
1631810|NCT00830024|3986591|P1|COMPLETED|Second Intervention||17
1631811|NCT00830024|3986590|P2|STARTED|Second Intervention||18
1631812|NCT00830024|3986591|P1|STARTED|Second Intervention||17
1631813|NCT00830024|3986590|P2|NOT COMPLETED|Washout: 7 Days||0
1631814|NCT00830024|3986591|P1|NOT COMPLETED|Washout: 7 Days||1
1631815|NCT00830024|3986590|P2|COMPLETED|Washout: 7 Days||18
1631816|NCT00830024|3986591|P1|COMPLETED|Washout: 7 Days||17
1631817|NCT00830024|3986590|P2|STARTED|Washout: 7 Days||18
1631818|NCT00830024|3986591|P1|STARTED|Washout: 7 Days||18
1631819|NCT00830024|3986590|P2|NOT COMPLETED|First Intervention||0
1631820|NCT00830024|3986591|P1|NOT COMPLETED|First Intervention||0
1631821|NCT00830024|3986590|P2|COMPLETED|First Intervention||18
1631822|NCT00830024|3986591|P1|COMPLETED|First Intervention||18
1631823|NCT00830024|3986590|P2|STARTED|First Intervention||18
1631824|NCT00830024|3986591|P1|STARTED|First Intervention||18
1631825|NCT00829998|3986601|P2|NOT COMPLETED|Second Intervention||0
1631826|NCT00829998|3986602|P1|NOT COMPLETED|Second Intervention||0
1631827|NCT00829998|3986601|P2|COMPLETED|Second Intervention||19
1631828|NCT00829998|3986602|P1|COMPLETED|Second Intervention||21
1631829|NCT00829998|3986601|P2|STARTED|Second Intervention||19
1631830|NCT00829998|3986602|P1|STARTED|Second Intervention||21
1631831|NCT00829998|3986601|P2|NOT COMPLETED|Washout||1
1631832|NCT00829998|3986602|P1|NOT COMPLETED|Washout||0
1631833|NCT00829998|3986601|P2|COMPLETED|Washout||19
1631834|NCT00829998|3986602|P1|COMPLETED|Washout||21
1631835|NCT00829998|3986601|P2|STARTED|Washout||20
1631836|NCT00829998|3986602|P1|STARTED|Washout||21
1631837|NCT00829998|3986601|P2|NOT COMPLETED|First Intervention||0
1631838|NCT00829998|3986602|P1|NOT COMPLETED|First Intervention||0
1631839|NCT00829998|3986601|P2|COMPLETED|First Intervention||20
1631840|NCT00829998|3986602|P1|COMPLETED|First Intervention||21
1631841|NCT00829998|3986601|P2|STARTED|First Intervention||20
1631842|NCT00829998|3986602|P1|STARTED|First Intervention||21
1631843|NCT00829985|3986612|P2|NOT COMPLETED|Overall Study||4
1631844|NCT00829985|3986613|P1|NOT COMPLETED|Overall Study||9
1631845|NCT00829985|3986612|P2|COMPLETED|Overall Study||22
1631846|NCT00829985|3986613|P1|COMPLETED|Overall Study||19
1631847|NCT00829985|3986612|P2|STARTED|Overall Study||26
1631848|NCT00829985|3986613|P1|STARTED|Overall Study||28
1631849|NCT00829933|3986631|P4|NOT COMPLETED|Overall Study||14
1631850|NCT00829933|3986632|P3|NOT COMPLETED|Overall Study||13
1631851|NCT00829933|3986633|P2|NOT COMPLETED|Overall Study||13
1631852|NCT00829933|3986634|P1|NOT COMPLETED|Overall Study||14
1631853|NCT00829933|3986631|P4|COMPLETED|Overall Study||120
1631854|NCT00829933|3986632|P3|COMPLETED|Overall Study||119
1631855|NCT00829933|3986633|P2|COMPLETED|Overall Study||122
1631856|NCT00829933|3986634|P1|COMPLETED|Overall Study||121
1631857|NCT00829933|3986631|P4|Baseline Analysis Population|Overall Study||129
1631858|NCT00829933|3986632|P3|Baseline Analysis Population|Overall Study||131
1631859|NCT00829933|3986633|P2|Baseline Analysis Population|Overall Study||134
1631860|NCT00829933|3986634|P1|Baseline Analysis Population|Overall Study||131
1631861|NCT00829933|3986631|P4|STARTED|Overall Study||134
1631862|NCT00829933|3986632|P3|STARTED|Overall Study||132
1631863|NCT00829933|3986633|P2|STARTED|Overall Study||135
1631864|NCT00829933|3986634|P1|STARTED|Overall Study||135
1631865|NCT00829868|3986646|P2|NOT COMPLETED|Second Intervention||0
1631866|NCT00829868|3986647|P1|NOT COMPLETED|Second Intervention||0
1631867|NCT00829868|3986646|P2|COMPLETED|Second Intervention||21
1631868|NCT00829868|3986647|P1|COMPLETED|Second Intervention||20
1631869|NCT00829868|3986646|P2|STARTED|Second Intervention||21
1631870|NCT00829868|3986647|P1|STARTED|Second Intervention||20
1631871|NCT00829868|3986646|P2|NOT COMPLETED|Washout||0
1631872|NCT00829868|3986647|P1|NOT COMPLETED|Washout||1
1631873|NCT00829868|3986646|P2|COMPLETED|Washout||21
1631874|NCT00829868|3986647|P1|COMPLETED|Washout||20
1631875|NCT00829868|3986646|P2|STARTED|Washout||21
1631876|NCT00829868|3986647|P1|STARTED|Washout||21
1631877|NCT00829868|3986646|P2|NOT COMPLETED|First Intervention||0
1631878|NCT00829868|3986647|P1|NOT COMPLETED|First Intervention||0
1631879|NCT00829868|3986646|P2|COMPLETED|First Intervention||21
1631880|NCT00829868|3986647|P1|COMPLETED|First Intervention||21
1631881|NCT00829868|3986646|P2|STARTED|First Intervention||21
1631882|NCT00829868|3986647|P1|STARTED|First Intervention||21
1631883|NCT00829829|3986658|P3|NOT COMPLETED|Overall Study||11
1631884|NCT00829829|3986659|P2|NOT COMPLETED|Overall Study||16
1631885|NCT00829829|3986660|P1|NOT COMPLETED|Overall Study||22
1631886|NCT00829829|3986658|P3|COMPLETED|Overall Study||70
1631887|NCT00829829|3986659|P2|COMPLETED|Overall Study||64
1631888|NCT00829829|3986660|P1|COMPLETED|Overall Study||58
1631889|NCT00829829|3986658|P3|Treated|Overall Study||81
1631890|NCT00829829|3986659|P2|Treated|Overall Study||80
1631891|NCT00829829|3986660|P1|Treated|Overall Study||79
1631892|NCT00829829|3986658|P3|STARTED|Overall Study||81
1631893|NCT00829829|3986659|P2|STARTED|Overall Study||80
1631894|NCT00829829|3986660|P1|STARTED|Overall Study||80
1631895|NCT00829790|3986685|P2|NOT COMPLETED|Second Intervention||0
1631896|NCT00829790|3986686|P1|NOT COMPLETED|Second Intervention||0
1631897|NCT00829790|3986685|P2|COMPLETED|Second Intervention||14
1631898|NCT00829790|3986686|P1|COMPLETED|Second Intervention||15
1631899|NCT00829790|3986685|P2|STARTED|Second Intervention||14
1631900|NCT00829790|3986686|P1|STARTED|Second Intervention||15
1631901|NCT00829790|3986685|P2|NOT COMPLETED|Washout of 14 Days||1
1631902|NCT00829790|3986686|P1|NOT COMPLETED|Washout of 14 Days||0
1631903|NCT00829790|3986685|P2|COMPLETED|Washout of 14 Days||14
1631904|NCT00829790|3986686|P1|COMPLETED|Washout of 14 Days||15
1631905|NCT00829790|3986685|P2|STARTED|Washout of 14 Days||15
1631906|NCT00829790|3986686|P1|STARTED|Washout of 14 Days||15
1631907|NCT00829790|3986685|P2|NOT COMPLETED|First Intervention||0
1631908|NCT00829790|3986686|P1|NOT COMPLETED|First Intervention||0
1631909|NCT00829790|3986685|P2|COMPLETED|First Intervention||15
1631910|NCT00829790|3986686|P1|COMPLETED|First Intervention||15
1631911|NCT00829790|3986685|P2|STARTED|First Intervention||15
1631912|NCT00829790|3986686|P1|STARTED|First Intervention||15
1631913|NCT00829764|3986696|P2|NOT COMPLETED|Second Intervention||0
1631914|NCT00829764|3986697|P1|NOT COMPLETED|Second Intervention||0
1631915|NCT00829764|3986696|P2|COMPLETED|Second Intervention||14
1631916|NCT00829764|3986697|P1|COMPLETED|Second Intervention||13
1631917|NCT00829764|3986696|P2|STARTED|Second Intervention||14
1631918|NCT00829764|3986697|P1|STARTED|Second Intervention||13
1631919|NCT00829764|3986696|P2|NOT COMPLETED|Washout of 14 Days||0
1631920|NCT00829764|3986697|P1|NOT COMPLETED|Washout of 14 Days||0
1631921|NCT00829764|3986696|P2|COMPLETED|Washout of 14 Days||14
1631922|NCT00829764|3986697|P1|COMPLETED|Washout of 14 Days||13
1631923|NCT00829764|3986696|P2|STARTED|Washout of 14 Days||14
1631924|NCT00829764|3986697|P1|STARTED|Washout of 14 Days||13
1631925|NCT00829764|3986696|P2|NOT COMPLETED|First Intervention||1
1631926|NCT00829764|3986697|P1|NOT COMPLETED|First Intervention||2
1631927|NCT00829764|3986696|P2|COMPLETED|First Intervention||14
1631928|NCT00829764|3986697|P1|COMPLETED|First Intervention||13
1631929|NCT00829764|3986696|P2|STARTED|First Intervention||15
1631930|NCT00829764|3986697|P1|STARTED|First Intervention||15
1631931|NCT00829738|3986705|P1|NOT COMPLETED|Overall Study||8
1631932|NCT00829738|3986705|P1|COMPLETED|Overall Study||4180
1631933|NCT00829738|3986705|P1|STARTED|Overall Study||4188
1631934|NCT00829712|3986723|P2|NOT COMPLETED|Second Intervention||0
1631935|NCT00829712|3986724|P1|NOT COMPLETED|Second Intervention||0
1631936|NCT00829712|3986723|P2|COMPLETED|Second Intervention||11
1631937|NCT00829712|3986724|P1|COMPLETED|Second Intervention||12
1631938|NCT00829712|3986723|P2|STARTED|Second Intervention||11
1631939|NCT00829712|3986724|P1|STARTED|Second Intervention||12
1631940|NCT00829712|3986723|P2|NOT COMPLETED|Washout of 7 Days||1
1631941|NCT00829712|3986724|P1|NOT COMPLETED|Washout of 7 Days||0
1631942|NCT00829712|3986723|P2|COMPLETED|Washout of 7 Days||11
1631943|NCT00829712|3986724|P1|COMPLETED|Washout of 7 Days||12
1631944|NCT00829712|3986723|P2|STARTED|Washout of 7 Days||12
1631945|NCT00829712|3986724|P1|STARTED|Washout of 7 Days||12
1631946|NCT00829712|3986723|P2|NOT COMPLETED|First Intervention||0
1631947|NCT00829712|3986724|P1|NOT COMPLETED|First Intervention||0
1631948|NCT00829712|3986723|P2|COMPLETED|First Intervention||12
1631949|NCT00829712|3986724|P1|COMPLETED|First Intervention||12
1631950|NCT00829712|3986723|P2|STARTED|First Intervention||12
1631951|NCT00829712|3986724|P1|STARTED|First Intervention||12
1631952|NCT00829686|3986734|P2|NOT COMPLETED|Overall Study||0
1631953|NCT00829686|3986735|P1|NOT COMPLETED|Overall Study||0
1631954|NCT00829686|3986734|P2|COMPLETED|Overall Study||18
1631955|NCT00829686|3986735|P1|COMPLETED|Overall Study||13
1631956|NCT00829686|3986734|P2|STARTED|Overall Study||18
1631957|NCT00829686|3986735|P1|STARTED|Overall Study||13
1631958|NCT00829673|3986743|P2|NOT COMPLETED|Second Intervention||0
1631959|NCT00829673|3986744|P1|NOT COMPLETED|Second Intervention||0
1631960|NCT00829673|3986743|P2|COMPLETED|Second Intervention||12
1631961|NCT00829673|3986744|P1|COMPLETED|Second Intervention||11
1631962|NCT00829673|3986743|P2|STARTED|Second Intervention||12
1631963|NCT00829673|3986744|P1|STARTED|Second Intervention||11
1631964|NCT00829673|3986743|P2|NOT COMPLETED|Washout of 7 Days||0
1631965|NCT00829673|3986744|P1|NOT COMPLETED|Washout of 7 Days||1
1631966|NCT00829673|3986743|P2|COMPLETED|Washout of 7 Days||12
1631967|NCT00829673|3986744|P1|COMPLETED|Washout of 7 Days||11
1631968|NCT00829673|3986743|P2|STARTED|Washout of 7 Days||12
1631969|NCT00829673|3986744|P1|STARTED|Washout of 7 Days||12
1631970|NCT00829673|3986743|P2|NOT COMPLETED|First Intervention||0
1631971|NCT00829673|3986744|P1|NOT COMPLETED|First Intervention||0
1631972|NCT00829673|3986743|P2|COMPLETED|First Intervention||12
1631973|NCT00829673|3986744|P1|COMPLETED|First Intervention||12
1631974|NCT00829673|3986743|P2|STARTED|First Intervention||12
1631975|NCT00829673|3986744|P1|STARTED|First Intervention||12
1631976|NCT00829621|3986754|P2|NOT COMPLETED|Overall Study||4
1631977|NCT00829621|3986755|P1|NOT COMPLETED|Overall Study||4
1631978|NCT00829621|3986754|P2|COMPLETED|Overall Study||8
1631979|NCT00829621|3986755|P1|COMPLETED|Overall Study||4
1631980|NCT00829621|3986754|P2|STARTED|Overall Study||12
1631981|NCT00829621|3986755|P1|STARTED|Overall Study||8
1631982|NCT00829530|3986763|P2|NOT COMPLETED|Second Intervention||0
1631983|NCT00829530|3986764|P1|NOT COMPLETED|Second Intervention||1
1631984|NCT00829530|3986763|P2|COMPLETED|Second Intervention||18
1631985|NCT00829530|3986764|P1|COMPLETED|Second Intervention||19
1631986|NCT00829530|3986763|P2|STARTED|Second Intervention||18
1631987|NCT00829530|3986764|P1|STARTED|Second Intervention||20
1631988|NCT00829530|3986763|P2|NOT COMPLETED|Washout of 42 Days||0
1631989|NCT00829530|3986764|P1|NOT COMPLETED|Washout of 42 Days||0
1631990|NCT00829530|3986763|P2|COMPLETED|Washout of 42 Days||18
1631991|NCT00829530|3986764|P1|COMPLETED|Washout of 42 Days||20
1631992|NCT00829530|3986763|P2|STARTED|Washout of 42 Days||18
1631993|NCT00829530|3986764|P1|STARTED|Washout of 42 Days||20
1631994|NCT00829530|3986763|P2|NOT COMPLETED|First Intervention||2
1631995|NCT00829530|3986764|P1|NOT COMPLETED|First Intervention||0
1631996|NCT00829530|3986763|P2|COMPLETED|First Intervention||18
1631997|NCT00829530|3986764|P1|COMPLETED|First Intervention||20
1631998|NCT00829530|3986763|P2|STARTED|First Intervention||20
1631999|NCT00829530|3986764|P1|STARTED|First Intervention||20
1632000|NCT00829504|3986778|P2|NOT COMPLETED|Second Intervention||0
1632001|NCT00829504|3986779|P1|NOT COMPLETED|Second Intervention||1
1632002|NCT00829504|3986778|P2|COMPLETED|Second Intervention||22
1632003|NCT00829504|3986779|P1|COMPLETED|Second Intervention||19
1632004|NCT00829504|3986778|P2|STARTED|Second Intervention||22
1632005|NCT00829504|3986779|P1|STARTED|Second Intervention||20
1632006|NCT00829504|3986778|P2|NOT COMPLETED|Washout of 7 Days||0
1632007|NCT00829504|3986779|P1|NOT COMPLETED|Washout of 7 Days||1
1632008|NCT00829504|3986778|P2|COMPLETED|Washout of 7 Days||22
1632009|NCT00829504|3986779|P1|COMPLETED|Washout of 7 Days||20
1632010|NCT00829504|3986778|P2|STARTED|Washout of 7 Days||22
1632011|NCT00829504|3986779|P1|STARTED|Washout of 7 Days||21
1632012|NCT00829504|3986778|P2|NOT COMPLETED|First Intervention||0
1632013|NCT00829504|3986779|P1|NOT COMPLETED|First Intervention||1
1632014|NCT00829504|3986778|P2|COMPLETED|First Intervention||22
1632015|NCT00829504|3986779|P1|COMPLETED|First Intervention||21
1632016|NCT00829504|3986778|P2|STARTED|First Intervention||22
1632017|NCT00829504|3986779|P1|STARTED|First Intervention||22
1632018|NCT00829452|3986789|P2|NOT COMPLETED|Second Intervention||1
1632019|NCT00829452|3986790|P1|NOT COMPLETED|Second Intervention||0
1632020|NCT00829452|3986789|P2|COMPLETED|Second Intervention||17
1632021|NCT00829452|3986790|P1|COMPLETED|Second Intervention||20
1632022|NCT00829452|3986789|P2|STARTED|Second Intervention||18
1632023|NCT00829452|3986790|P1|STARTED|Second Intervention||20
1632024|NCT00829452|3986789|P2|NOT COMPLETED|Washout of 42 Days||1
1632025|NCT00829452|3986790|P1|NOT COMPLETED|Washout of 42 Days||0
1632026|NCT00829452|3986789|P2|COMPLETED|Washout of 42 Days||18
1632027|NCT00829452|3986790|P1|COMPLETED|Washout of 42 Days||20
1632028|NCT00829452|3986789|P2|STARTED|Washout of 42 Days||19
1632029|NCT00829452|3986790|P1|STARTED|Washout of 42 Days||20
1632030|NCT00829452|3986789|P2|NOT COMPLETED|First Intervention||1
1632031|NCT00829452|3986790|P1|NOT COMPLETED|First Intervention||0
1632032|NCT00829452|3986789|P2|COMPLETED|First Intervention||19
1632033|NCT00829452|3986790|P1|COMPLETED|First Intervention||20
1632034|NCT00829452|3986789|P2|STARTED|First Intervention||20
1632035|NCT00829452|3986790|P1|STARTED|First Intervention||20
1632036|NCT00829439|3986802|P4|NOT COMPLETED|Overall Study||0
1632037|NCT00829439|3986803|P3|NOT COMPLETED|Overall Study||1
1632038|NCT00829439|3986804|P2|NOT COMPLETED|Overall Study||0
1632039|NCT00829439|3986805|P1|NOT COMPLETED|Overall Study||0
1632040|NCT00829439|3986802|P4|COMPLETED|Overall Study||4
1632041|NCT00829439|3986803|P3|COMPLETED|Overall Study||5
1632042|NCT00829439|3986804|P2|COMPLETED|Overall Study||3
1632043|NCT00829439|3986805|P1|COMPLETED|Overall Study||3
1632044|NCT00829439|3986802|P4|STARTED|Overall Study||4
1632045|NCT00829439|3986803|P3|STARTED|Overall Study||6
1632046|NCT00829439|3986804|P2|STARTED|Overall Study||3
1632047|NCT00829439|3986805|P1|STARTED|Overall Study||3
1632048|NCT00829426|3986811|P2|NOT COMPLETED|Second Intervention||0
1632049|NCT00829426|3986812|P1|NOT COMPLETED|Second Intervention||0
1632050|NCT00829426|3986811|P2|COMPLETED|Second Intervention||16
1632051|NCT00829426|3986812|P1|COMPLETED|Second Intervention||15
1632052|NCT00829426|3986811|P2|STARTED|Second Intervention||16
1632053|NCT00829426|3986812|P1|STARTED|Second Intervention||15
1632054|NCT00829426|3986811|P2|NOT COMPLETED|Washout: 7 Days||0
1632055|NCT00829426|3986812|P1|NOT COMPLETED|Washout: 7 Days||1
1632056|NCT00829426|3986811|P2|COMPLETED|Washout: 7 Days||16
1632057|NCT00829426|3986812|P1|COMPLETED|Washout: 7 Days||15
1632058|NCT00829426|3986811|P2|STARTED|Washout: 7 Days||16
1632059|NCT00829426|3986812|P1|STARTED|Washout: 7 Days||16
1632060|NCT00829426|3986811|P2|NOT COMPLETED|First Intervention||0
1632061|NCT00829426|3986812|P1|NOT COMPLETED|First Intervention||0
1632062|NCT00829426|3986811|P2|COMPLETED|First Intervention||16
1632063|NCT00829426|3986812|P1|COMPLETED|First Intervention||16
1632064|NCT00829426|3986811|P2|STARTED|First Intervention||16
1632065|NCT00829426|3986812|P1|STARTED|First Intervention||16
1632066|NCT00829413|3986820|P1|NOT COMPLETED|Overall Study||94
1632067|NCT00829413|3986820|P1|COMPLETED|Overall Study||259
1632068|NCT00829413|3986820|P1|STARTED|Overall Study||353
1632069|NCT00829387|3986869|P2|NOT COMPLETED|Overall Study||3
1632070|NCT00829387|3986870|P1|NOT COMPLETED|Overall Study||3
1632071|NCT00829387|3986869|P2|COMPLETED|Overall Study||21
1632072|NCT00829387|3986870|P1|COMPLETED|Overall Study||20
1632073|NCT00829387|3986869|P2|STARTED|Overall Study||24
1632074|NCT00829387|3986870|P1|STARTED|Overall Study||23
1632075|NCT00829309|3986888|P2|NOT COMPLETED|Second Intervention||0
1632076|NCT00829309|3986889|P1|NOT COMPLETED|Second Intervention||0
1632077|NCT00829309|3986888|P2|COMPLETED|Second Intervention||8
1632078|NCT00829309|3986889|P1|COMPLETED|Second Intervention||7
1632079|NCT00829309|3986888|P2|STARTED|Second Intervention||8
1632080|NCT00829309|3986889|P1|STARTED|Second Intervention||7
1632081|NCT00829309|3986888|P2|NOT COMPLETED|Washout: 7 Days||0
1632082|NCT00829309|3986889|P1|NOT COMPLETED|Washout: 7 Days||1
1632083|NCT00829309|3986888|P2|COMPLETED|Washout: 7 Days||8
1632084|NCT00829309|3986889|P1|COMPLETED|Washout: 7 Days||7
1632085|NCT00829309|3986888|P2|STARTED|Washout: 7 Days||8
1632086|NCT00829309|3986889|P1|STARTED|Washout: 7 Days||8
1632087|NCT00829309|3986888|P2|NOT COMPLETED|First Intervention||0
1632088|NCT00829309|3986889|P1|NOT COMPLETED|First Intervention||0
1632089|NCT00829309|3986888|P2|COMPLETED|First Intervention||8
1632090|NCT00829309|3986889|P1|COMPLETED|First Intervention||8
1632091|NCT00829309|3986888|P2|STARTED|First Intervention||8
1632092|NCT00829309|3986889|P1|STARTED|First Intervention||8
1632093|NCT00829296|3986899|P2|NOT COMPLETED|Overall Study||4
1632094|NCT00829296|3986900|P1|NOT COMPLETED|Overall Study||5
1632095|NCT00829296|3986899|P2|COMPLETED|Overall Study||32
1632096|NCT00829296|3986900|P1|COMPLETED|Overall Study||29
1632097|NCT00829296|3986899|P2|STARTED|Overall Study||36
1632098|NCT00829296|3986900|P1|STARTED|Overall Study||34
1632099|NCT00829283|3986914|P2|NOT COMPLETED|Overall Study||25
1632100|NCT00829283|3986915|P1|NOT COMPLETED|Overall Study||7
1632101|NCT00829283|3986914|P2|COMPLETED|Overall Study||127
1632102|NCT00829283|3986915|P1|COMPLETED|Overall Study||32
1632103|NCT00829283|3986914|P2|STARTED|Overall Study||152
1632104|NCT00829283|3986915|P1|STARTED|Overall Study||39
1632105|NCT00829244|3986925|P2|NOT COMPLETED|Overall Study||21
1632106|NCT00829244|3986926|P1|NOT COMPLETED|Overall Study||14
1632107|NCT00829244|3986925|P2|COMPLETED|Overall Study||83
1632108|NCT00829244|3986926|P1|COMPLETED|Overall Study||82
1632109|NCT00829244|3986925|P2|STARTED|Overall Study||104
1632110|NCT00829244|3986926|P1|STARTED|Overall Study||96
1632111|NCT00829179|3986956|P1|NOT COMPLETED|Overall Study||1
1632112|NCT00829179|3986956|P1|COMPLETED|Overall Study||19
1632113|NCT00829179|3986956|P1|STARTED|Overall Study||20
1632114|NCT00829166|3986962|P2|NOT COMPLETED|Overall Study||496
1632115|NCT00829166|3986963|P1|NOT COMPLETED|Overall Study||495
1632116|NCT00829166|3986962|P2|COMPLETED|Overall Study||0
1632117|NCT00829166|3986963|P1|COMPLETED|Overall Study||0
1632118|NCT00829166|3986962|P2|Treated|Overall Study||488
1632119|NCT00829166|3986963|P1|Treated|Overall Study||490
1632120|NCT00829166|3986962|P2|STARTED|Overall Study||496
1632121|NCT00829166|3986963|P1|STARTED|Overall Study||495
1632122|NCT00829049|3987004|P2|NOT COMPLETED|Overall Study||20
1632123|NCT00829049|3987005|P1|NOT COMPLETED|Overall Study||17
1632124|NCT00829049|3987004|P2|COMPLETED|Overall Study||68
1632125|NCT00829049|3987005|P1|COMPLETED|Overall Study||60
1632126|NCT00829049|3987004|P2|STARTED|Overall Study||88
1632127|NCT00829049|3987005|P1|STARTED|Overall Study||77
1632128|NCT00829036|3987017|P1|NOT COMPLETED|Overall Study||0
1632129|NCT00829036|3987017|P1|COMPLETED|Overall Study||24
1632130|NCT00829036|3987017|P1|STARTED|Overall Study||24
1632131|NCT00829010|3987026|P5|NOT COMPLETED|Overall Study||2
1632132|NCT00829010|3987027|P4|NOT COMPLETED|Overall Study||8
1632133|NCT00829010|3987028|P3|NOT COMPLETED|Overall Study||3
1632134|NCT00829010|3987029|P2|NOT COMPLETED|Overall Study||9
1632135|NCT00829010|3987030|P1|NOT COMPLETED|Overall Study||10
1632136|NCT00829010|3987026|P5|COMPLETED|Overall Study||98
1632137|NCT00829010|3987027|P4|COMPLETED|Overall Study||92
1632138|NCT00829010|3987028|P3|COMPLETED|Overall Study||97
1632139|NCT00829010|3987029|P2|COMPLETED|Overall Study||92
1632140|NCT00829010|3987030|P1|COMPLETED|Overall Study||73
1632141|NCT00829010|3987026|P5|STARTED|Overall Study||100
1632142|NCT00829010|3987027|P4|STARTED|Overall Study||100
1632143|NCT00829010|3987028|P3|STARTED|Overall Study||100
1632144|NCT00829010|3987029|P2|STARTED|Overall Study||101
1632145|NCT00829010|3987030|P1|STARTED|Overall Study||83
1632146|NCT00828984|3987195|P3|NOT COMPLETED|Overall Study||9
1632147|NCT00828984|3987196|P2|NOT COMPLETED|Overall Study||16
1632148|NCT00828984|3987197|P1|NOT COMPLETED|Overall Study||14
1632149|NCT00828984|3987195|P3|COMPLETED|Overall Study||19
1632150|NCT00828984|3987196|P2|COMPLETED|Overall Study||15
1632151|NCT00828984|3987197|P1|COMPLETED|Overall Study||14
1632152|NCT00828984|3987195|P3|Post Intervention Follow-Up|Overall Study||19
1632153|NCT00828984|3987196|P2|Post Intervention Follow-Up|Overall Study||16
1632154|NCT00828984|3987197|P1|Post Intervention Follow-Up|Overall Study||15
1632155|NCT00828984|3987195|P3|Flexible Sigmoidoscopy|Overall Study||19
1632156|NCT00828984|3987196|P2|Flexible Sigmoidoscopy|Overall Study||19
1632157|NCT00828984|3987197|P1|Flexible Sigmoidoscopy|Overall Study||20
1632158|NCT00828984|3987195|P3|Treatment|Overall Study||24
1632159|NCT00828984|3987196|P2|Treatment|Overall Study||26
1632160|NCT00828984|3987197|P1|Treatment|Overall Study||24
1632161|NCT00828984|3987195|P3|Randomization|Overall Study||28
1632162|NCT00828984|3987196|P2|Randomization|Overall Study||31
1632163|NCT00828984|3987197|P1|Randomization|Overall Study||28
1632164|NCT00828984|3987195|P3|STARTED|Overall Study||28
1632165|NCT00828984|3987196|P2|STARTED|Overall Study||31
1632166|NCT00828984|3987197|P1|STARTED|Overall Study||28
1632167|NCT00828945|3987220|P1|NOT COMPLETED|Overall Study||41
1632168|NCT00828945|3987220|P1|COMPLETED|Overall Study||216
1632169|NCT00828945|3987220|P1|STARTED|Overall Study||257
1632170|NCT00828841|3987237|P3|NOT COMPLETED|Overall Study||4
1632171|NCT00828841|3987238|P2|NOT COMPLETED|Overall Study||4
1632172|NCT00828841|3987239|P1|NOT COMPLETED|Overall Study||4
1632173|NCT00828841|3987237|P3|COMPLETED|Overall Study||126
1632174|NCT00828841|3987238|P2|COMPLETED|Overall Study||232
1632175|NCT00828841|3987239|P1|COMPLETED|Overall Study||231
1632176|NCT00828841|3987237|P3|STARTED|Overall Study||130
1632177|NCT00828841|3987238|P2|STARTED|Overall Study||236
1632178|NCT00828841|3987239|P1|STARTED|Overall Study||235
1632179|NCT00828750|3987252|P1|NOT COMPLETED|Overall Study||4
1632180|NCT00828750|3987252|P1|COMPLETED|Overall Study||15
1632181|NCT00828750|3987252|P1|STARTED|Overall Study||19
1632182|NCT00828711|3987266|P3|NOT COMPLETED|Overall Study||0
1632183|NCT00828711|3987267|P2|NOT COMPLETED|Overall Study||0
1632184|NCT00828711|3987268|P1|NOT COMPLETED|Overall Study||1
1632185|NCT00828711|3987266|P3|COMPLETED|Overall Study||131
1632186|NCT00828711|3987267|P2|COMPLETED|Overall Study||125
1632187|NCT00828711|3987268|P1|COMPLETED|Overall Study||117
1632188|NCT00828711|3987266|P3|STARTED|Overall Study||131
1632189|NCT00828711|3987267|P2|STARTED|Overall Study||125
1632190|NCT00828711|3987268|P1|STARTED|Overall Study||118
1632191|NCT00828568|3987300|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
1632192|NCT00828568|3987301|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
1632193|NCT00828568|3987302|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
1632194|NCT00828568|3987300|P3|COMPLETED|Treated - Received at Least One Dose||55
1632195|NCT00828568|3987301|P2|COMPLETED|Treated - Received at Least One Dose||150
1632196|NCT00828568|3987302|P1|COMPLETED|Treated - Received at Least One Dose||153
1632197|NCT00828568|3987300|P3|STARTED|Treated - Received at Least One Dose||60
1632198|NCT00828568|3987301|P2|STARTED|Treated - Received at Least One Dose||179
1632199|NCT00828568|3987302|P1|STARTED|Treated - Received at Least One Dose||183
1632200|NCT00828568|3987300|P3|NOT COMPLETED|Randomized||2
1632201|NCT00828568|3987301|P2|NOT COMPLETED|Randomized||0
1632202|NCT00828568|3987302|P1|NOT COMPLETED|Randomized||1
1632203|NCT00828568|3987300|P3|COMPLETED|Randomized||60
1632204|NCT00828568|3987301|P2|COMPLETED|Randomized||179
1632205|NCT00828568|3987302|P1|COMPLETED|Randomized||183
1632206|NCT00828568|3987300|P3|STARTED|Randomized||62
1632207|NCT00828568|3987301|P2|STARTED|Randomized||179
1632208|NCT00828568|3987302|P1|STARTED|Randomized||184
1632209|NCT00828542|3987317|P2|NOT COMPLETED|Overall Study||3
1632210|NCT00828542|3987318|P1|NOT COMPLETED|Overall Study||3
1632211|NCT00828542|3987317|P2|COMPLETED|Overall Study||20
1632212|NCT00828542|3987318|P1|COMPLETED|Overall Study||20
1632213|NCT00828542|3987317|P2|STARTED|Overall Study||23
1632214|NCT00828542|3987318|P1|STARTED|Overall Study||23
1632215|NCT00828516|3987324|P1|NOT COMPLETED|Clinical Phase: Series 2||0
1632216|NCT00828516|3987324|P1|COMPLETED|Clinical Phase: Series 2||30
1632217|NCT00828516|3987324|P1|STARTED|Clinical Phase: Series 2||30
1632218|NCT00828516|3987324|P1|NOT COMPLETED|Clinical Phase: Series 1||2
1632219|NCT00828516|3987324|P1|COMPLETED|Clinical Phase: Series 1||33
1632220|NCT00828516|3987324|P1|STARTED|Clinical Phase: Series 1||35
1632221|NCT00828464|3987329|P1|NOT COMPLETED|Overall Study||1
1632222|NCT00828464|3987329|P1|COMPLETED|Overall Study||29
1632223|NCT00828464|3987329|P1|STARTED|Overall Study||30
1632224|NCT00828451|3987346|P1|NOT COMPLETED|Overall Study||11
1632225|NCT00828451|3987346|P1|COMPLETED|Overall Study||18
1632226|NCT00828451|3987346|P1|STARTED|Overall Study||29
1632227|NCT00828412|3987354|P2|NOT COMPLETED|Overall Study||2
1632228|NCT00828412|3987355|P1|NOT COMPLETED|Overall Study||9
1632229|NCT00828412|3987354|P2|COMPLETED|Overall Study||48
1632230|NCT00828412|3987355|P1|COMPLETED|Overall Study||41
1632231|NCT00828412|3987354|P2|STARTED|Overall Study||50
1632232|NCT00828412|3987355|P1|STARTED|Overall Study||50
1632233|NCT00828347|3987363|P2|NOT COMPLETED|Overall Study||0
1632234|NCT00828347|3987364|P1|NOT COMPLETED|Overall Study||0
1632235|NCT00828347|3987363|P2|COMPLETED|Overall Study||11
1632236|NCT00828347|3987364|P1|COMPLETED|Overall Study||12
1632237|NCT00828347|3987363|P2|STARTED|Overall Study||11
1632238|NCT00828347|3987364|P1|STARTED|Overall Study||12
1632239|NCT00828321|3987372|P2|NOT COMPLETED|Second Intervention||1
1632240|NCT00828321|3987373|P1|NOT COMPLETED|Second Intervention||0
1632241|NCT00828321|3987372|P2|COMPLETED|Second Intervention||19
1632242|NCT00828321|3987373|P1|COMPLETED|Second Intervention||18
1632243|NCT00828321|3987372|P2|STARTED|Second Intervention||20
1632244|NCT00828321|3987373|P1|STARTED|Second Intervention||18
1632245|NCT00828321|3987372|P2|NOT COMPLETED|Washout of 42 Days||0
1632246|NCT00828321|3987373|P1|NOT COMPLETED|Washout of 42 Days||2
1632247|NCT00828321|3987372|P2|COMPLETED|Washout of 42 Days||20
1632248|NCT00828321|3987373|P1|COMPLETED|Washout of 42 Days||18
1632249|NCT00828321|3987372|P2|STARTED|Washout of 42 Days||20
1632250|NCT00828321|3987373|P1|STARTED|Washout of 42 Days||20
1632251|NCT00828321|3987372|P2|NOT COMPLETED|First Intervention||0
1632252|NCT00828321|3987373|P1|NOT COMPLETED|First Intervention||0
1632253|NCT00828321|3987372|P2|COMPLETED|First Intervention||20
1632254|NCT00828321|3987373|P1|COMPLETED|First Intervention||20
1632255|NCT00828321|3987372|P2|STARTED|First Intervention||20
1632256|NCT00828321|3987373|P1|STARTED|First Intervention||20
1632257|NCT00828308|3987385|P1|NOT COMPLETED|Overall Study||0
1632258|NCT00828308|3987385|P1|COMPLETED|Overall Study||16
1632259|NCT00828308|3987385|P1|STARTED|Overall Study||16
1632260|NCT00828295|3987391|P2|NOT COMPLETED|Overall Study||0
1632261|NCT00828295|3987392|P1|NOT COMPLETED|Overall Study||0
1632262|NCT00828295|3987391|P2|COMPLETED|Overall Study||75
1632263|NCT00828295|3987392|P1|COMPLETED|Overall Study||75
1632264|NCT00828295|3987391|P2|STARTED|Overall Study||75
1632265|NCT00828295|3987392|P1|STARTED|Overall Study||75
1632266|NCT00828204|3987402|P2|NOT COMPLETED|Extension Study||3
1632267|NCT00828204|3987403|P1|NOT COMPLETED|Extension Study||0
1632268|NCT00828204|3987402|P2|COMPLETED|Extension Study||61
1632269|NCT00828204|3987403|P1|COMPLETED|Extension Study||0
1632270|NCT00828204|3987402|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
1632271|NCT00828204|3987403|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
1632272|NCT00828204|3987402|P2|NOT COMPLETED|Main Study: After Study Restart||3
1632273|NCT00828204|3987403|P1|NOT COMPLETED|Main Study: After Study Restart||0
1632274|NCT00828204|3987402|P2|COMPLETED|Main Study: After Study Restart||71
1632275|NCT00828204|3987403|P1|COMPLETED|Main Study: After Study Restart||0
1632276|NCT00828204|3987402|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
1632277|NCT00828204|3987403|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
1632278|NCT00828204|3987402|P2|Completed Manual Injection|Main Study: After Study Restart||74
1632279|NCT00828204|3987403|P1|Completed Manual Injection|Main Study: After Study Restart||0
1632280|NCT00828204|3987402|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
1632281|NCT00828204|3987403|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
1632282|NCT00828204|3987402|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
1632283|NCT00828204|3987403|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
1632284|NCT00828204|3987402|P2|COMPLETED|Main Study: Prior to Study Suspension||0
1632285|NCT00828204|3987403|P1|COMPLETED|Main Study: Prior to Study Suspension||7
1632286|NCT00828204|3987402|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
1632287|NCT00828204|3987403|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
1632288|NCT00828204|3987402|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
1632289|NCT00828204|3987403|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
1632290|NCT00828204|3987402|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
1632291|NCT00828204|3987403|P1|STARTED|Main Study: Prior to Study Suspension||21
1632292|NCT00828191|3987422|P2|NOT COMPLETED|Overall Study||10
1632293|NCT00828191|3987423|P1|NOT COMPLETED|Overall Study||8
1632294|NCT00828191|3987422|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
1632295|NCT00828191|3987423|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
1632296|NCT00828191|3987422|P2|STARTED|Overall Study|Randomized patients|400
1632297|NCT00828191|3987423|P1|STARTED|Overall Study|Randomized patients|400
1632298|NCT00828178|3987435|P2|NOT COMPLETED|Overall Study||2
1632299|NCT00828178|3987436|P1|NOT COMPLETED|Overall Study||0
1632300|NCT00828178|3987435|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
1632301|NCT00828178|3987436|P1|COMPLETED|Overall Study||42
1632302|NCT00828178|3987435|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
1632303|NCT00828178|3987436|P1|STARTED|Overall Study||42
1632304|NCT00828139|3987450|P4|NOT COMPLETED|Overall Study||51
1632305|NCT00828139|3987451|P3|NOT COMPLETED|Overall Study||55
1632306|NCT00828139|3987452|P2|NOT COMPLETED|Overall Study||41
1632307|NCT00828139|3987453|P1|NOT COMPLETED|Overall Study||41
1632308|NCT00828139|3987450|P4|COMPLETED|Overall Study||0
1632309|NCT00828139|3987451|P3|COMPLETED|Overall Study||0
1632310|NCT00828139|3987452|P2|COMPLETED|Overall Study||0
1632311|NCT00828139|3987453|P1|COMPLETED|Overall Study||1
1632312|NCT00828139|3987450|P4|STARTED|Overall Study||51
1632313|NCT00828139|3987451|P3|STARTED|Overall Study||55
1632314|NCT00828139|3987452|P2|STARTED|Overall Study||41
1632315|NCT00828139|3987453|P1|STARTED|Overall Study||42
1632316|NCT00828113|3987473|P2|NOT COMPLETED|Overall Study||31
1632317|NCT00828113|3987474|P1|NOT COMPLETED|Overall Study||30
1632318|NCT00828113|3987473|P2|COMPLETED|Overall Study||20
1632319|NCT00828113|3987474|P1|COMPLETED|Overall Study||20
1632320|NCT00828113|3987473|P2|STARTED|Overall Study||51
1632321|NCT00828113|3987474|P1|STARTED|Overall Study||50
1632322|NCT00828074|3987482|P3|NOT COMPLETED|Overall Study||0
1632323|NCT00828074|3987483|P2|NOT COMPLETED|Overall Study||0
1632324|NCT00828074|3987484|P1|NOT COMPLETED|Overall Study||0
1632325|NCT00828074|3987482|P3|COMPLETED|Overall Study||35
1632326|NCT00828074|3987483|P2|COMPLETED|Overall Study||5
1632327|NCT00828074|3987484|P1|COMPLETED|Overall Study||6
1632328|NCT00828074|3987482|P3|STARTED|Overall Study||35
1632329|NCT00828074|3987483|P2|STARTED|Overall Study||5
1632330|NCT00828074|3987484|P1|STARTED|Overall Study||6
1632331|NCT00828061|3987496|P6|NOT COMPLETED|Period 3||0
1632332|NCT00828061|3987497|P5|NOT COMPLETED|Period 3||0
1632333|NCT00828061|3987498|P4|NOT COMPLETED|Period 3||0
1632334|NCT00828061|3987499|P3|NOT COMPLETED|Period 3||0
1632335|NCT00828061|3987500|P2|NOT COMPLETED|Period 3||0
1632336|NCT00828061|3987501|P1|NOT COMPLETED|Period 3||0
1632337|NCT00828061|3987496|P6|COMPLETED|Period 3||3
1632338|NCT00828061|3987497|P5|COMPLETED|Period 3||3
1632339|NCT00828061|3987498|P4|COMPLETED|Period 3||3
1632340|NCT00828061|3987499|P3|COMPLETED|Period 3||3
1632341|NCT00828061|3987500|P2|COMPLETED|Period 3||3
1632342|NCT00828061|3987501|P1|COMPLETED|Period 3||4
1632343|NCT00828061|3987496|P6|STARTED|Period 3||3
1632344|NCT00828061|3987497|P5|STARTED|Period 3||3
1632345|NCT00828061|3987498|P4|STARTED|Period 3||3
1632346|NCT00828061|3987499|P3|STARTED|Period 3||3
1632347|NCT00828061|3987500|P2|STARTED|Period 3||3
1632348|NCT00828061|3987501|P1|STARTED|Period 3||4
1632349|NCT00828061|3987496|P6|NOT COMPLETED|Period 2||0
1632350|NCT00828061|3987497|P5|NOT COMPLETED|Period 2||0
1632351|NCT00828061|3987498|P4|NOT COMPLETED|Period 2||0
1632352|NCT00828061|3987499|P3|NOT COMPLETED|Period 2||0
1632353|NCT00828061|3987500|P2|NOT COMPLETED|Period 2||0
1632354|NCT00828061|3987501|P1|NOT COMPLETED|Period 2||0
1632355|NCT00828061|3987496|P6|COMPLETED|Period 2||3
1632356|NCT00828061|3987497|P5|COMPLETED|Period 2||3
1632357|NCT00828061|3987498|P4|COMPLETED|Period 2||3
1632358|NCT00828061|3987499|P3|COMPLETED|Period 2||3
1632359|NCT00828061|3987500|P2|COMPLETED|Period 2||3
1632360|NCT00828061|3987501|P1|COMPLETED|Period 2||4
1632361|NCT00828061|3987496|P6|STARTED|Period 2||3
1632362|NCT00828061|3987497|P5|STARTED|Period 2||3
1632363|NCT00828061|3987498|P4|STARTED|Period 2||3
1632364|NCT00828061|3987499|P3|STARTED|Period 2||3
1632365|NCT00828061|3987500|P2|STARTED|Period 2||3
1632366|NCT00828061|3987501|P1|STARTED|Period 2||4
1632367|NCT00828061|3987496|P6|NOT COMPLETED|Period 1||0
1632368|NCT00828061|3987497|P5|NOT COMPLETED|Period 1||0
1632369|NCT00828061|3987498|P4|NOT COMPLETED|Period 1||0
1632370|NCT00828061|3987499|P3|NOT COMPLETED|Period 1||0
1632371|NCT00828061|3987500|P2|NOT COMPLETED|Period 1||0
1632372|NCT00828061|3987501|P1|NOT COMPLETED|Period 1||0
1632373|NCT00828061|3987496|P6|COMPLETED|Period 1||3
1632374|NCT00828061|3987497|P5|COMPLETED|Period 1||3
1632375|NCT00828061|3987498|P4|COMPLETED|Period 1||3
1632376|NCT00828061|3987499|P3|COMPLETED|Period 1||3
1632377|NCT00828061|3987500|P2|COMPLETED|Period 1||3
1632378|NCT00828061|3987501|P1|COMPLETED|Period 1||4
1632379|NCT00828061|3987496|P6|STARTED|Period 1||3
1632380|NCT00828061|3987497|P5|STARTED|Period 1||3
1632381|NCT00828061|3987498|P4|STARTED|Period 1||3
1632382|NCT00828061|3987499|P3|STARTED|Period 1||3
1632383|NCT00828061|3987500|P2|STARTED|Period 1||3
1632384|NCT00828061|3987501|P1|STARTED|Period 1||4
1632385|NCT00827983|3987514|P2|NOT COMPLETED|Overall Study||16
1632386|NCT00827983|3987515|P1|NOT COMPLETED|Overall Study||18
1632387|NCT00827983|3987514|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
1632388|NCT00827983|3987515|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
1632389|NCT00827983|3987514|P2|STARTED|Overall Study|all randomised patients|344
1632390|NCT00827983|3987515|P1|STARTED|Overall Study|All randomised patients|339
1632391|NCT00827944|3987527|P2|NOT COMPLETED|Overall Study||59
1632392|NCT00827944|3987528|P1|NOT COMPLETED|Overall Study||63
1632393|NCT00827944|3987527|P2|COMPLETED|Overall Study||240
1632394|NCT00827944|3987528|P1|COMPLETED|Overall Study||241
1632395|NCT00827944|3987527|P2|STARTED|Overall Study||299
1632396|NCT00827944|3987528|P1|STARTED|Overall Study||304
1632397|NCT00827931|3987548|P2|NOT COMPLETED|Overall Study||6
1632398|NCT00827931|3987549|P1|NOT COMPLETED|Overall Study||6
1632399|NCT00827931|3987548|P2|COMPLETED|Overall Study||39
1632400|NCT00827931|3987549|P1|COMPLETED|Overall Study||43
1632401|NCT00827931|3987548|P2|STARTED|Overall Study||45
1632402|NCT00827931|3987549|P1|STARTED|Overall Study||49
1632403|NCT00827918|3987570|P3|NOT COMPLETED|Overall Study||21
1632404|NCT00827918|3987571|P2|NOT COMPLETED|Overall Study||9
1632405|NCT00827918|3987572|P1|NOT COMPLETED|Overall Study||28
1632406|NCT00827918|3987570|P3|COMPLETED|Overall Study||62
1632407|NCT00827918|3987571|P2|COMPLETED|Overall Study||38
1632408|NCT00827918|3987572|P1|COMPLETED|Overall Study||58
1632409|NCT00827918|3987570|P3|STARTED|Overall Study||83
1632410|NCT00827918|3987571|P2|STARTED|Overall Study||47
1632411|NCT00827918|3987572|P1|STARTED|Overall Study||86
1632412|NCT00827827|3987600|P2|NOT COMPLETED|Overall Study||0
1632413|NCT00827827|3987601|P1|NOT COMPLETED|Overall Study||8
1632414|NCT00827827|3987600|P2|COMPLETED|Overall Study||16
1632415|NCT00827827|3987601|P1|COMPLETED|Overall Study||14
1632416|NCT00827827|3987600|P2|STARTED|Overall Study||16
1632417|NCT00827827|3987601|P1|STARTED|Overall Study||22
1632418|NCT00827632|3987645|P2|NOT COMPLETED|Overall Study||23
1632419|NCT00827632|3987646|P1|NOT COMPLETED|Overall Study||22
1632420|NCT00827632|3987645|P2|COMPLETED|Overall Study||75
1632421|NCT00827632|3987646|P1|COMPLETED|Overall Study||106
1632422|NCT00827632|3987645|P2|STARTED|Overall Study||98
1632423|NCT00827632|3987646|P1|STARTED|Overall Study||128
1632424|NCT00827606|3987654|P2|NOT COMPLETED|Overall Study||38
1632425|NCT00827606|3987655|P1|NOT COMPLETED|Overall Study||27
1632426|NCT00827606|3987654|P2|COMPLETED|Overall Study||94
1632427|NCT00827606|3987655|P1|COMPLETED|Overall Study||112
1632428|NCT00827606|3987654|P2|STARTED|Overall Study||132
1632429|NCT00827606|3987655|P1|STARTED|Overall Study||139
1632430|NCT00827567|3987716|P1|NOT COMPLETED|Overall Study||4
1632431|NCT00827567|3987716|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
1632432|NCT00827567|3987716|P1|STARTED|Overall Study||4
1632433|NCT00827541|3987722|P2|NOT COMPLETED|Overall Study||11
1632434|NCT00827541|3987723|P1|NOT COMPLETED|Overall Study||4
1632435|NCT00827541|3987722|P2|COMPLETED|Overall Study||85
1632436|NCT00827541|3987723|P1|COMPLETED|Overall Study||15
1632437|NCT00827541|3987722|P2|STARTED|Overall Study||96
1632438|NCT00827541|3987723|P1|STARTED|Overall Study||19
1632439|NCT00827502|3987735|P1|NOT COMPLETED|Overall Study||21
1632440|NCT00827502|3987735|P1|COMPLETED|Overall Study||400
1632441|NCT00827502|3987735|P1|Received Treatment (Number Treated)|Overall Study||410
1632442|NCT00827502|3987735|P1|STARTED|Overall Study||421
1632443|NCT00827372|3987741|P1|NOT COMPLETED|Overall Study||8
1632444|NCT00827372|3987741|P1|COMPLETED|Overall Study||2
1632445|NCT00827372|3987741|P1|STARTED|Overall Study||10
1632446|NCT00827255|3987749|P1|NOT COMPLETED|Overall Study||0
1632447|NCT00827255|3987749|P1|COMPLETED|Overall Study||35
1632448|NCT00827255|3987749|P1|STARTED|Overall Study||35
1632449|NCT00827242|3987756|P2|NOT COMPLETED|Overall Study||12
1632450|NCT00827242|3987757|P1|NOT COMPLETED|Overall Study||13
1632451|NCT00827242|3987756|P2|COMPLETED|Overall Study||152
1632452|NCT00827242|3987757|P1|COMPLETED|Overall Study||148
1632453|NCT00827242|3987756|P2|STARTED|Overall Study||164
1632454|NCT00827242|3987757|P1|STARTED|Overall Study||161
1632455|NCT00827112|3987795|P2|NOT COMPLETED|Overall Study||12
1632456|NCT00827112|3987796|P1|NOT COMPLETED|Overall Study||15
1632457|NCT00827112|3987795|P2|COMPLETED|Overall Study||52
1632458|NCT00827112|3987796|P1|COMPLETED|Overall Study||50
1632459|NCT00827112|3987795|P2|Treated|Overall Study||61
1632460|NCT00827112|3987796|P1|Treated|Overall Study||60
1632461|NCT00827112|3987795|P2|STARTED|Overall Study||64
1632462|NCT00827112|3987796|P1|STARTED|Overall Study||65
1632463|NCT00827099|3987829|P1|NOT COMPLETED|Overall Study||0
1632464|NCT00827099|3987829|P1|COMPLETED|Overall Study||5
1632465|NCT00827099|3987829|P1|STARTED|Overall Study||5
1632466|NCT00827073|3987840|P2|NOT COMPLETED|Overall Study||0
1632467|NCT00827073|3987841|P1|NOT COMPLETED|Overall Study||0
1632468|NCT00827073|3987840|P2|COMPLETED|Overall Study||20
1632469|NCT00827073|3987841|P1|COMPLETED|Overall Study||20
1632470|NCT00827073|3987840|P2|STARTED|Overall Study||20
1632471|NCT00827073|3987841|P1|STARTED|Overall Study||20
1632472|NCT00826943|3987849|P6|NOT COMPLETED|Overall Study||0
1632473|NCT00826943|3987850|P5|NOT COMPLETED|Overall Study||1
1632474|NCT00826943|3987851|P4|NOT COMPLETED|Overall Study||0
1632475|NCT00826943|3987852|P3|NOT COMPLETED|Overall Study||0
1632476|NCT00826943|3987853|P2|NOT COMPLETED|Overall Study||0
1632477|NCT00826943|3987854|P1|NOT COMPLETED|Overall Study||0
1632478|NCT00826943|3987849|P6|COMPLETED|Overall Study||2
1632479|NCT00826943|3987850|P5|COMPLETED|Overall Study||6
1632480|NCT00826943|3987851|P4|COMPLETED|Overall Study||5
1632481|NCT00826943|3987852|P3|COMPLETED|Overall Study||4
1632482|NCT00826943|3987853|P2|COMPLETED|Overall Study||6
1632483|NCT00826943|3987854|P1|COMPLETED|Overall Study||6
1632484|NCT00826943|3987849|P6|STARTED|Overall Study||2
1632485|NCT00826943|3987850|P5|STARTED|Overall Study||7
1632486|NCT00826943|3987851|P4|STARTED|Overall Study||5
1632487|NCT00826943|3987852|P3|STARTED|Overall Study||4
1632488|NCT00826943|3987853|P2|STARTED|Overall Study||6
1632489|NCT00826943|3987854|P1|STARTED|Overall Study||6
1632490|NCT00826800|3987868|P1|NOT COMPLETED|Overall Study||0
1632491|NCT00826800|3987868|P1|COMPLETED|Overall Study||2
1632492|NCT00826800|3987868|P1|STARTED|Overall Study||2
1632493|NCT00826748|3987875|P3|NOT COMPLETED|Overall Study||4
1632494|NCT00826748|3987876|P2|NOT COMPLETED|Overall Study||0
1632495|NCT00826748|3987877|P1|NOT COMPLETED|Overall Study||0
1632496|NCT00826748|3987875|P3|COMPLETED|Overall Study||8
1632497|NCT00826748|3987876|P2|COMPLETED|Overall Study||4
1632498|NCT00826748|3987877|P1|COMPLETED|Overall Study||6
1632499|NCT00826748|3987875|P3|STARTED|Overall Study||12
1632500|NCT00826748|3987876|P2|STARTED|Overall Study||4
1632501|NCT00826748|3987877|P1|STARTED|Overall Study||6
1632502|NCT00826618|3987885|P1|NOT COMPLETED|Overall Study||1
1632503|NCT00826618|3987885|P1|COMPLETED|Overall Study||5
1632504|NCT00826618|3987885|P1|STARTED|Overall Study||6
1632505|NCT00826540|3987889|P1|NOT COMPLETED|Overall Study||4
1632506|NCT00826540|3987889|P1|COMPLETED|Overall Study||79
1632507|NCT00826540|3987889|P1|STARTED|Overall Study||83
1632508|NCT00826449|3987895|P1|NOT COMPLETED|Overall Study||5
1632509|NCT00826449|3987895|P1|COMPLETED|Overall Study||42
1632510|NCT00826449|3987895|P1|Phase II|Overall Study||35
1632511|NCT00826449|3987895|P1|Phase I|Overall Study||12
1632512|NCT00826449|3987895|P1|STARTED|Overall Study||47
1632513|NCT00826280|3987904|P3|NOT COMPLETED|Overall Study||46
1632514|NCT00826280|3987905|P2|NOT COMPLETED|Overall Study||46
1632515|NCT00826280|3987906|P1|NOT COMPLETED|Overall Study||48
1632516|NCT00826280|3987904|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
1632517|NCT00826280|3987905|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
1632518|NCT00826280|3987906|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
1632683|NCT00825812|3988096|P1|STARTED|Overall Study||29
1632519|NCT00826280|3987904|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
1632520|NCT00826280|3987905|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
1632521|NCT00826280|3987906|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
1632522|NCT00826280|3987904|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
1632523|NCT00826280|3987905|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
1632524|NCT00826280|3987906|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
1632525|NCT00826280|3987904|P3|STARTED|Overall Study||117
1632526|NCT00826280|3987905|P2|STARTED|Overall Study||116
1632527|NCT00826280|3987906|P1|STARTED|Overall Study||114
1632528|NCT00826267|3987935|P3|NOT COMPLETED|Overall Study||0
1632529|NCT00826267|3987936|P2|NOT COMPLETED|Overall Study||0
1632530|NCT00826267|3987937|P1|NOT COMPLETED|Overall Study||1
1632531|NCT00826267|3987935|P3|COMPLETED|Overall Study||11
1632532|NCT00826267|3987936|P2|COMPLETED|Overall Study||8
1632533|NCT00826267|3987937|P1|COMPLETED|Overall Study||9
1632534|NCT00826267|3987935|P3|STARTED|Overall Study||11
1632535|NCT00826267|3987936|P2|STARTED|Overall Study||8
1632536|NCT00826267|3987937|P1|STARTED|Overall Study||10
1632537|NCT00826228|3987955|P1|NOT COMPLETED|Overall Study||1
1632538|NCT00826228|3987955|P1|COMPLETED|Overall Study||11
1632539|NCT00826228|3987955|P1|STARTED|Overall Study||12
1632540|NCT00826202|3987962|P2|NOT COMPLETED|Overall Study||13
1632541|NCT00826202|3987963|P1|NOT COMPLETED|Overall Study||10
1632542|NCT00826202|3987962|P2|COMPLETED|Overall Study||11
1632543|NCT00826202|3987963|P1|COMPLETED|Overall Study||10
1632544|NCT00826202|3987962|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
1632545|NCT00826202|3987963|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
1632546|NCT00826202|3987962|P2|STARTED|Overall Study||24
1632547|NCT00826202|3987963|P1|STARTED|Overall Study||20
1632548|NCT00826176|3987977|P2|NOT COMPLETED|Overall Study||0
1632549|NCT00826176|3987978|P1|NOT COMPLETED|Overall Study||13
1632550|NCT00826176|3987977|P2|COMPLETED|Overall Study|treated and completed|36
1632551|NCT00826176|3987978|P1|COMPLETED|Overall Study|treated and completed|115
1632552|NCT00826176|3987977|P2|STARTED|Overall Study|enrolled|36
1632553|NCT00826176|3987978|P1|STARTED|Overall Study|enrolled|128
1632554|NCT00826111|3987990|P2|NOT COMPLETED|Overall Study||2
1632555|NCT00826111|3987991|P1|NOT COMPLETED|Overall Study||7
1632556|NCT00826111|3987990|P2|COMPLETED|Overall Study||3
1632557|NCT00826111|3987991|P1|COMPLETED|Overall Study||7
1632558|NCT00826111|3987990|P2|STARTED|Overall Study||5
1632559|NCT00826111|3987991|P1|STARTED|Overall Study||14
1632560|NCT00826007|3988015|P2|NOT COMPLETED|Overall Study||0
1632561|NCT00826007|3988016|P1|NOT COMPLETED|Overall Study||0
1632562|NCT00826007|3988015|P2|COMPLETED|Overall Study||279
1632563|NCT00826007|3988016|P1|COMPLETED|Overall Study|Retrospective review|308
1632564|NCT00826007|3988015|P2|STARTED|Overall Study||279
1632565|NCT00826007|3988016|P1|STARTED|Overall Study|Retrospective review|308
1632566|NCT00825994|3988021|P1|NOT COMPLETED|Overall Study||5
1632567|NCT00825994|3988021|P1|COMPLETED|Overall Study||19
1632568|NCT00825994|3988021|P1|STARTED|Overall Study||24
1632569|NCT00825916|3988029|P3|NOT COMPLETED|Overall Study||1
1632570|NCT00825916|3988030|P2|NOT COMPLETED|Overall Study||2
1632571|NCT00825916|3988031|P1|NOT COMPLETED|Overall Study||4
1632572|NCT00825916|3988029|P3|COMPLETED|Overall Study||19
1632573|NCT00825916|3988030|P2|COMPLETED|Overall Study||18
1632574|NCT00825916|3988031|P1|COMPLETED|Overall Study||15
1632575|NCT00825916|3988029|P3|STARTED|Overall Study||20
1632576|NCT00825916|3988030|P2|STARTED|Overall Study||20
1632577|NCT00825916|3988031|P1|STARTED|Overall Study||19
1632578|NCT00825825|3988072|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
1632579|NCT00825825|3988073|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
1632580|NCT00825825|3988074|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
1632581|NCT00825825|3988075|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
1632582|NCT00825825|3988076|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
1632583|NCT00825825|3988077|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
1632584|NCT00825825|3988072|P6|COMPLETED|Third Medication Period (14 Days)||1
1632585|NCT00825825|3988073|P5|COMPLETED|Third Medication Period (14 Days)||3
1632586|NCT00825825|3988074|P4|COMPLETED|Third Medication Period (14 Days)||3
1632587|NCT00825825|3988075|P3|COMPLETED|Third Medication Period (14 Days)||2
1632588|NCT00825825|3988076|P2|COMPLETED|Third Medication Period (14 Days)||2
1632589|NCT00825825|3988077|P1|COMPLETED|Third Medication Period (14 Days)||1
1632590|NCT00825825|3988072|P6|STARTED|Third Medication Period (14 Days)||3
1632591|NCT00825825|3988073|P5|STARTED|Third Medication Period (14 Days)||3
1632592|NCT00825825|3988074|P4|STARTED|Third Medication Period (14 Days)||3
1632593|NCT00825825|3988075|P3|STARTED|Third Medication Period (14 Days)||2
1632594|NCT00825825|3988076|P2|STARTED|Third Medication Period (14 Days)||4
1632595|NCT00825825|3988077|P1|STARTED|Third Medication Period (14 Days)||1
1632596|NCT00825825|3988072|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
1632597|NCT00825825|3988073|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
1632598|NCT00825825|3988074|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
1632599|NCT00825825|3988075|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
1632600|NCT00825825|3988076|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
1632601|NCT00825825|3988077|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
1632602|NCT00825825|3988072|P6|COMPLETED|Second Washout Period (14 Days)||3
1632603|NCT00825825|3988073|P5|COMPLETED|Second Washout Period (14 Days)||3
1632604|NCT00825825|3988074|P4|COMPLETED|Second Washout Period (14 Days)||3
1632605|NCT00825825|3988075|P3|COMPLETED|Second Washout Period (14 Days)||2
1632606|NCT00825825|3988076|P2|COMPLETED|Second Washout Period (14 Days)||4
1632607|NCT00825825|3988077|P1|COMPLETED|Second Washout Period (14 Days)||1
1632608|NCT00825825|3988072|P6|STARTED|Second Washout Period (14 Days)||3
1632609|NCT00825825|3988073|P5|STARTED|Second Washout Period (14 Days)||3
1632610|NCT00825825|3988074|P4|STARTED|Second Washout Period (14 Days)||3
1632611|NCT00825825|3988075|P3|STARTED|Second Washout Period (14 Days)||2
1632612|NCT00825825|3988076|P2|STARTED|Second Washout Period (14 Days)||4
1632613|NCT00825825|3988077|P1|STARTED|Second Washout Period (14 Days)||1
1632614|NCT00825825|3988072|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
1632615|NCT00825825|3988073|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
1632616|NCT00825825|3988074|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
1632617|NCT00825825|3988075|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
1632618|NCT00825825|3988076|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
1632619|NCT00825825|3988077|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
1632620|NCT00825825|3988072|P6|COMPLETED|Second Medication Period (14 Days)||3
1632621|NCT00825825|3988073|P5|COMPLETED|Second Medication Period (14 Days)||3
1632622|NCT00825825|3988074|P4|COMPLETED|Second Medication Period (14 Days)||3
1632623|NCT00825825|3988075|P3|COMPLETED|Second Medication Period (14 Days)||2
1632624|NCT00825825|3988076|P2|COMPLETED|Second Medication Period (14 Days)||4
1632625|NCT00825825|3988077|P1|COMPLETED|Second Medication Period (14 Days)||1
1632626|NCT00825825|3988072|P6|STARTED|Second Medication Period (14 Days)||3
1632627|NCT00825825|3988073|P5|STARTED|Second Medication Period (14 Days)||4
1632628|NCT00825825|3988074|P4|STARTED|Second Medication Period (14 Days)||5
1632629|NCT00825825|3988075|P3|STARTED|Second Medication Period (14 Days)||2
1632630|NCT00825825|3988076|P2|STARTED|Second Medication Period (14 Days)||4
1632631|NCT00825825|3988077|P1|STARTED|Second Medication Period (14 Days)||3
1632632|NCT00825825|3988072|P6|NOT COMPLETED|First Washout Period (14 Days)||0
1632633|NCT00825825|3988073|P5|NOT COMPLETED|First Washout Period (14 Days)||0
1632634|NCT00825825|3988074|P4|NOT COMPLETED|First Washout Period (14 Days)||0
1632635|NCT00825825|3988075|P3|NOT COMPLETED|First Washout Period (14 Days)||0
1632636|NCT00825825|3988076|P2|NOT COMPLETED|First Washout Period (14 Days)||0
1632637|NCT00825825|3988077|P1|NOT COMPLETED|First Washout Period (14 Days)||0
1632638|NCT00825825|3988072|P6|COMPLETED|First Washout Period (14 Days)||3
1632639|NCT00825825|3988073|P5|COMPLETED|First Washout Period (14 Days)||4
1632640|NCT00825825|3988074|P4|COMPLETED|First Washout Period (14 Days)||5
1632641|NCT00825825|3988075|P3|COMPLETED|First Washout Period (14 Days)||2
1632642|NCT00825825|3988076|P2|COMPLETED|First Washout Period (14 Days)||4
1632643|NCT00825825|3988077|P1|COMPLETED|First Washout Period (14 Days)||3
1632644|NCT00825825|3988072|P6|STARTED|First Washout Period (14 Days)||3
1632645|NCT00825825|3988073|P5|STARTED|First Washout Period (14 Days)||4
1632646|NCT00825825|3988074|P4|STARTED|First Washout Period (14 Days)||5
1632647|NCT00825825|3988075|P3|STARTED|First Washout Period (14 Days)||2
1632648|NCT00825825|3988076|P2|STARTED|First Washout Period (14 Days)||4
1632649|NCT00825825|3988077|P1|STARTED|First Washout Period (14 Days)||3
1632650|NCT00825825|3988072|P6|NOT COMPLETED|First Medication Period (14 Days)||2
1632651|NCT00825825|3988073|P5|NOT COMPLETED|First Medication Period (14 Days)||0
1632652|NCT00825825|3988074|P4|NOT COMPLETED|First Medication Period (14 Days)||0
1632653|NCT00825825|3988075|P3|NOT COMPLETED|First Medication Period (14 Days)||1
1632654|NCT00825825|3988076|P2|NOT COMPLETED|First Medication Period (14 Days)||0
1632655|NCT00825825|3988077|P1|NOT COMPLETED|First Medication Period (14 Days)||3
1632656|NCT00825825|3988072|P6|COMPLETED|First Medication Period (14 Days)||3
1632657|NCT00825825|3988073|P5|COMPLETED|First Medication Period (14 Days)||4
1632658|NCT00825825|3988074|P4|COMPLETED|First Medication Period (14 Days)||5
1632659|NCT00825825|3988075|P3|COMPLETED|First Medication Period (14 Days)||2
1632660|NCT00825825|3988076|P2|COMPLETED|First Medication Period (14 Days)||4
1632661|NCT00825825|3988077|P1|COMPLETED|First Medication Period (14 Days)||3
1632662|NCT00825825|3988072|P6|STARTED|First Medication Period (14 Days)||5
1632663|NCT00825825|3988073|P5|STARTED|First Medication Period (14 Days)||4
1632664|NCT00825825|3988074|P4|STARTED|First Medication Period (14 Days)||5
1632665|NCT00825825|3988075|P3|STARTED|First Medication Period (14 Days)||3
1632666|NCT00825825|3988076|P2|STARTED|First Medication Period (14 Days)||4
1632667|NCT00825825|3988077|P1|STARTED|First Medication Period (14 Days)||6
1632668|NCT00825812|3988093|P4|NOT COMPLETED|Overall Study||10
1632669|NCT00825812|3988094|P3|NOT COMPLETED|Overall Study||6
1632670|NCT00825812|3988095|P2|NOT COMPLETED|Overall Study||1
1632671|NCT00825812|3988096|P1|NOT COMPLETED|Overall Study||0
1632672|NCT00825812|3988093|P4|COMPLETED|Overall Study||111
1632673|NCT00825812|3988094|P3|COMPLETED|Overall Study||120
1632674|NCT00825812|3988095|P2|COMPLETED|Overall Study||31
1632675|NCT00825812|3988096|P1|COMPLETED|Overall Study||29
1632676|NCT00825812|3988093|P4|TREATED|Overall Study||111
1632677|NCT00825812|3988094|P3|TREATED|Overall Study||120
1632678|NCT00825812|3988095|P2|TREATED|Overall Study||31
1632679|NCT00825812|3988096|P1|TREATED|Overall Study||29
1632680|NCT00825812|3988093|P4|STARTED|Overall Study||121
1632681|NCT00825812|3988094|P3|STARTED|Overall Study||126
1632682|NCT00825812|3988095|P2|STARTED|Overall Study||32
1632684|NCT00825786|3988112|P2|NOT COMPLETED|Overall Study||0
1632685|NCT00825786|3988113|P1|NOT COMPLETED|Overall Study||0
1632686|NCT00825786|3988112|P2|COMPLETED|Overall Study||51
1632687|NCT00825786|3988113|P1|COMPLETED|Overall Study||52
1632688|NCT00825786|3988112|P2|STARTED|Overall Study||51
1632689|NCT00825786|3988113|P1|STARTED|Overall Study||52
1632690|NCT00825734|3988131|P3|NOT COMPLETED|Phase II||76
1632691|NCT00825734|3988132|P2|NOT COMPLETED|Phase II||0
1632692|NCT00825734|3988133|P1|NOT COMPLETED|Phase II||0
1632693|NCT00825734|3988131|P3|COMPLETED|Phase II||0
1632694|NCT00825734|3988132|P2|COMPLETED|Phase II||0
1632695|NCT00825734|3988133|P1|COMPLETED|Phase II||0
1632696|NCT00825734|3988131|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
1632697|NCT00825734|3988132|P2|STARTED|Phase II||0
1632698|NCT00825734|3988133|P1|STARTED|Phase II||0
1632699|NCT00825734|3988131|P3|NOT COMPLETED|Phase I||0
1632700|NCT00825734|3988132|P2|NOT COMPLETED|Phase I||3
1632701|NCT00825734|3988133|P1|NOT COMPLETED|Phase I||4
1632702|NCT00825734|3988131|P3|COMPLETED|Phase I||3
1632703|NCT00825734|3988132|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1632704|NCT00825734|3988133|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1632705|NCT00825734|3988131|P3|STARTED|Phase I||3
1632706|NCT00825734|3988132|P2|STARTED|Phase I||3
1632707|NCT00825734|3988133|P1|STARTED|Phase I||4
1632708|NCT00825682|3988143|P2|NOT COMPLETED|Overall Study||5
1632709|NCT00825682|3988144|P1|NOT COMPLETED|Overall Study||13
1632710|NCT00825682|3988143|P2|COMPLETED|Overall Study||20
1632711|NCT00825682|3988144|P1|COMPLETED|Overall Study||34
1632712|NCT00825682|3988143|P2|STARTED|Overall Study||25
1632713|NCT00825682|3988144|P1|STARTED|Overall Study||47
1632714|NCT00825630|3988158|P4|NOT COMPLETED|Overall Study||0
1632715|NCT00825630|3988159|P3|NOT COMPLETED|Overall Study||0
1632716|NCT00825630|3988160|P2|NOT COMPLETED|Overall Study||0
1632717|NCT00825630|3988161|P1|NOT COMPLETED|Overall Study||0
1632718|NCT00825630|3988158|P4|COMPLETED|Overall Study||13
1632719|NCT00825630|3988159|P3|COMPLETED|Overall Study||19
1632720|NCT00825630|3988160|P2|COMPLETED|Overall Study||62
1632721|NCT00825630|3988161|P1|COMPLETED|Overall Study||29
1632722|NCT00825630|3988158|P4|STARTED|Overall Study||13
1632723|NCT00825630|3988159|P3|STARTED|Overall Study||19
1632724|NCT00825630|3988160|P2|STARTED|Overall Study||62
1632725|NCT00825630|3988161|P1|STARTED|Overall Study||29
1632726|NCT00825565|3988171|P1|NOT COMPLETED|Overall Study||0
1632727|NCT00825565|3988171|P1|COMPLETED|Overall Study||8
1632728|NCT00825565|3988171|P1|STARTED|Overall Study||8
1632729|NCT00825500|3988184|P3|NOT COMPLETED|Overall Study||0
1632730|NCT00825500|3988185|P2|NOT COMPLETED|Overall Study||0
1632731|NCT00825500|3988186|P1|NOT COMPLETED|Overall Study||0
1632732|NCT00825500|3988184|P3|COMPLETED|Overall Study||120
1632733|NCT00825500|3988185|P2|COMPLETED|Overall Study||121
1632734|NCT00825500|3988186|P1|COMPLETED|Overall Study||125
1632735|NCT00825500|3988184|P3|STARTED|Overall Study||120
1632736|NCT00825500|3988185|P2|STARTED|Overall Study||121
1632737|NCT00825500|3988186|P1|STARTED|Overall Study||125
1632738|NCT00825370|3988199|P2|NOT COMPLETED|Overall Study||0
1632739|NCT00825370|3988200|P1|NOT COMPLETED|Overall Study||0
1632740|NCT00825370|3988199|P2|COMPLETED|Overall Study||175
1632741|NCT00825370|3988200|P1|COMPLETED|Overall Study||175
1632742|NCT00825370|3988199|P2|STARTED|Overall Study||175
1632743|NCT00825370|3988200|P1|STARTED|Overall Study||175
1632744|NCT00825344|3988214|P2|NOT COMPLETED|Overall Study||1
1632745|NCT00825344|3988215|P1|NOT COMPLETED|Overall Study||1
1632746|NCT00825344|3988214|P2|COMPLETED|Overall Study||42
1632747|NCT00825344|3988215|P1|COMPLETED|Overall Study||33
1632748|NCT00825344|3988214|P2|STARTED|Overall Study||43
1632749|NCT00825344|3988215|P1|STARTED|Overall Study||34
1632750|NCT00825318|3988225|P1|NOT COMPLETED|Overall Study||1
1632751|NCT00825318|3988225|P1|COMPLETED|Overall Study||12
1632752|NCT00825318|3988225|P1|STARTED|Overall Study||13
1632753|NCT00825305|3988235|P2|NOT COMPLETED|Overall Study||23
1632754|NCT00825305|3988236|P1|NOT COMPLETED|Overall Study||17
1632755|NCT00825305|3988235|P2|COMPLETED|Overall Study||252
1632756|NCT00825305|3988236|P1|COMPLETED|Overall Study||533
1632757|NCT00825305|3988235|P2|STARTED|Overall Study||275
1632758|NCT00825305|3988236|P1|STARTED|Overall Study||550
1632759|NCT00825266|3988250|P2|NOT COMPLETED|Overall Study||0
1632760|NCT00825266|3988251|P1|NOT COMPLETED|Overall Study||0
1632761|NCT00825266|3988250|P2|COMPLETED|Overall Study||1
1632762|NCT00825266|3988251|P1|COMPLETED|Overall Study||1
1632763|NCT00825266|3988250|P2|STARTED|Overall Study||1
1632764|NCT00825266|3988251|P1|STARTED|Overall Study||1
1632765|NCT00825227|3988263|P2|NOT COMPLETED|Overall Study||0
1632766|NCT00825227|3988264|P1|NOT COMPLETED|Overall Study||0
1632767|NCT00825227|3988263|P2|COMPLETED|Overall Study||4
1632768|NCT00825227|3988264|P1|COMPLETED|Overall Study||6
1632769|NCT00825227|3988263|P2|STARTED|Overall Study||4
1632770|NCT00825227|3988264|P1|STARTED|Overall Study||6
1632771|NCT00825175|3988276|P2|NOT COMPLETED|Overall Study||5
1632772|NCT00825175|3988277|P1|NOT COMPLETED|Overall Study||0
1632773|NCT00825175|3988276|P2|COMPLETED|Overall Study||7
1632774|NCT00825175|3988277|P1|COMPLETED|Overall Study||10
1632775|NCT00825175|3988276|P2|STARTED|Overall Study||12
1632776|NCT00825175|3988277|P1|STARTED|Overall Study||10
1632777|NCT00825162|3988286|P3|NOT COMPLETED|Overall Study||6
1632778|NCT00825162|3988287|P2|NOT COMPLETED|Overall Study||21
1632779|NCT00825162|3988288|P1|NOT COMPLETED|Overall Study||28
1632780|NCT00825162|3988286|P3|COMPLETED|Overall Study||396
1632781|NCT00825162|3988287|P2|COMPLETED|Overall Study||859
1632782|NCT00825162|3988288|P1|COMPLETED|Overall Study||682
1632783|NCT00825162|3988286|P3|STARTED|Overall Study||402
1632784|NCT00825162|3988287|P2|STARTED|Overall Study||880
1632785|NCT00825162|3988288|P1|STARTED|Overall Study||710
1632786|NCT00824993|3988314|P2|NOT COMPLETED|Overall Study||17
1632787|NCT00824993|3988315|P1|NOT COMPLETED|Overall Study||14
1632788|NCT00824993|3988314|P2|COMPLETED|Overall Study||22
1632789|NCT00824993|3988315|P1|COMPLETED|Overall Study||25
1632790|NCT00824993|3988314|P2|6 Month Follow up|Overall Study||27
1632791|NCT00824993|3988315|P1|6 Month Follow up|Overall Study||33
1632792|NCT00824993|3988314|P2|STARTED|Overall Study||39
1632793|NCT00824993|3988315|P1|STARTED|Overall Study||39
1632794|NCT00824850|3988323|P2|NOT COMPLETED|Overall Study||1
1632795|NCT00824850|3988324|P1|NOT COMPLETED|Overall Study||0
1632796|NCT00824850|3988323|P2|COMPLETED|Overall Study||36
1632797|NCT00824850|3988324|P1|COMPLETED|Overall Study||38
1632798|NCT00824850|3988323|P2|Received Vaccination 13vPnC|Overall Study||36
1632799|NCT00824850|3988324|P1|Received Vaccination 13vPnC|Overall Study||38
1632800|NCT00824850|3988323|P2|STARTED|Overall Study||37
1632801|NCT00824850|3988324|P1|STARTED|Overall Study||38
1632802|NCT00824824|3988370|P2|NOT COMPLETED|Overall Study||0
1632803|NCT00824824|3988371|P1|NOT COMPLETED|Overall Study||0
1632804|NCT00824824|3988370|P2|COMPLETED|Overall Study||3
1632805|NCT00824824|3988371|P1|COMPLETED|Overall Study||4
1632806|NCT00824824|3988370|P2|STARTED|Overall Study||3
1632807|NCT00824824|3988371|P1|STARTED|Overall Study||4
1632808|NCT00824772|3988377|P1|NOT COMPLETED|Overall Study||8
1632809|NCT00824772|3988377|P1|COMPLETED|Overall Study||196
1632810|NCT00824772|3988377|P1|STARTED|Overall Study||204
1632811|NCT00824746|3988382|P1|NOT COMPLETED|Overall Study||0
1632812|NCT00824746|3988382|P1|COMPLETED|Overall Study||23
1632813|NCT00824746|3988382|P1|STARTED|Overall Study||23
1632814|NCT00824733|3988388|P1|NOT COMPLETED|Overall Study||0
1632815|NCT00824733|3988388|P1|COMPLETED|Overall Study||6
1632816|NCT00824733|3988388|P1|STARTED|Overall Study||6
1632817|NCT00824720|3988397|P3|NOT COMPLETED|Overall Study||1
1632818|NCT00824720|3988398|P2|NOT COMPLETED|Overall Study||1
1632819|NCT00824720|3988399|P1|NOT COMPLETED|Overall Study||3
1632820|NCT00824720|3988397|P3|COMPLETED|Overall Study||19
1632821|NCT00824720|3988398|P2|COMPLETED|Overall Study||15
1632822|NCT00824720|3988399|P1|COMPLETED|Overall Study||16
1632823|NCT00824720|3988397|P3|STARTED|Overall Study||20
1632824|NCT00824720|3988398|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
1632825|NCT00824720|3988399|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
1632826|NCT00824655|3988415|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
1632827|NCT00824655|3988416|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
1632828|NCT00824655|3988415|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
1632829|NCT00824655|3988416|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
1632830|NCT00824655|3988415|P2|STARTED|Toddler Dose (12 Months of Age)||116
1632831|NCT00824655|3988416|P1|STARTED|Toddler Dose (12 Months of Age)||118
1632832|NCT00824655|3988415|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
1632833|NCT00824655|3988416|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
1632834|NCT00824655|3988415|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
1632835|NCT00824655|3988416|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
1632836|NCT00824655|3988415|P2|STARTED|After Infant Dose (6 Months of Age)||0
1632837|NCT00824655|3988416|P1|STARTED|After Infant Dose (6 Months of Age)||118
1632838|NCT00824655|3988415|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
1632839|NCT00824655|3988416|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
1632840|NCT00824655|3988415|P2|COMPLETED|Infant Series (5 Months of Age)||0
1632841|NCT00824655|3988416|P1|COMPLETED|Infant Series (5 Months of Age)||118
1632842|NCT00824655|3988415|P2|STARTED|Infant Series (5 Months of Age)||0
1632843|NCT00824655|3988416|P1|STARTED|Infant Series (5 Months of Age)||118
1632844|NCT00824616|3988436|P2|NOT COMPLETED|Overall Study||7
1632845|NCT00824616|3988437|P1|NOT COMPLETED|Overall Study||6
1632846|NCT00824616|3988436|P2|COMPLETED|Overall Study||27
1632847|NCT00824616|3988437|P1|COMPLETED|Overall Study||28
1632848|NCT00824616|3988436|P2|STARTED|Overall Study||34
1632849|NCT00824616|3988437|P1|STARTED|Overall Study||34
1632850|NCT00824564|3988447|P2|NOT COMPLETED|Overall Study||10
1632851|NCT00824564|3988448|P1|NOT COMPLETED|Overall Study||8
1632852|NCT00824564|3988447|P2|COMPLETED|Overall Study||30
1632853|NCT00824564|3988448|P1|COMPLETED|Overall Study||34
1632854|NCT00824564|3988447|P2|Treated|Overall Study||40
1632855|NCT00824564|3988448|P1|Treated|Overall Study||41
1632856|NCT00824564|3988447|P2|STARTED|Overall Study||40
1632857|NCT00824564|3988448|P1|STARTED|Overall Study||42
1632858|NCT00824538|3988466|P1|NOT COMPLETED|Overall Study||2
1632859|NCT00824538|3988466|P1|COMPLETED|Overall Study||11
1632860|NCT00824538|3988466|P1|STARTED|Overall Study|13 patients entered the study|13
1632861|NCT00824512|3988476|P2|NOT COMPLETED|Overall Study||0
1632862|NCT00824512|3988477|P1|NOT COMPLETED|Overall Study||0
1632863|NCT00824512|3988476|P2|COMPLETED|Overall Study||11
1632864|NCT00824512|3988477|P1|COMPLETED|Overall Study||11
1632865|NCT00824512|3988476|P2|STARTED|Overall Study||11
1632866|NCT00824512|3988477|P1|STARTED|Overall Study||11
1632867|NCT00824473|3988527|P2|NOT COMPLETED|Overall Study||13
1632868|NCT00824473|3988528|P1|NOT COMPLETED|Overall Study||15
1632869|NCT00824473|3988527|P2|COMPLETED|Overall Study||238
1632870|NCT00824473|3988528|P1|COMPLETED|Overall Study||240
1632871|NCT00824473|3988527|P2|STARTED|Overall Study||251
1632872|NCT00824473|3988528|P1|STARTED|Overall Study|1 subject was randomized in error|255
1632873|NCT00824460|3988550|P6|NOT COMPLETED|Overall Study||8
1632874|NCT00824460|3988551|P5|NOT COMPLETED|Overall Study||9
1632875|NCT00824460|3988552|P4|NOT COMPLETED|Overall Study||12
1632876|NCT00824460|3988553|P3|NOT COMPLETED|Overall Study||5
1632877|NCT00824460|3988554|P2|NOT COMPLETED|Overall Study||9
1632878|NCT00824460|3988555|P1|NOT COMPLETED|Overall Study||8
1632879|NCT00824460|3988550|P6|COMPLETED|Overall Study||18
1632880|NCT00824460|3988551|P5|COMPLETED|Overall Study||15
1632881|NCT00824460|3988552|P4|COMPLETED|Overall Study||15
1632882|NCT00824460|3988553|P3|COMPLETED|Overall Study||20
1632883|NCT00824460|3988554|P2|COMPLETED|Overall Study||17
1632884|NCT00824460|3988555|P1|COMPLETED|Overall Study||18
1632885|NCT00824460|3988550|P6|STARTED|Overall Study||26
1632886|NCT00824460|3988551|P5|STARTED|Overall Study||24
1632887|NCT00824460|3988552|P4|STARTED|Overall Study||27
1632888|NCT00824460|3988553|P3|STARTED|Overall Study||25
1632889|NCT00824460|3988554|P2|STARTED|Overall Study||26
1632890|NCT00824460|3988555|P1|STARTED|Overall Study||26
1632891|NCT00824434|3988587|P1|NOT COMPLETED|Overall Study||0
1632892|NCT00824434|3988587|P1|COMPLETED|Overall Study||100
1632893|NCT00824434|3988587|P1|STARTED|Overall Study||100
1632894|NCT00824421|3988609|P3|NOT COMPLETED|Overall Study||14
1632895|NCT00824421|3988610|P2|NOT COMPLETED|Overall Study||22
1632896|NCT00824421|3988611|P1|NOT COMPLETED|Overall Study||17
1632897|NCT00824421|3988609|P3|COMPLETED|Overall Study||49
1632898|NCT00824421|3988610|P2|COMPLETED|Overall Study||44
1632899|NCT00824421|3988611|P1|COMPLETED|Overall Study||49
1632900|NCT00824421|3988609|P3|Treated|Overall Study||63
1632901|NCT00824421|3988610|P2|Treated|Overall Study||65
1632902|NCT00824421|3988611|P1|Treated|Overall Study||65
1632903|NCT00824421|3988609|P3|STARTED|Overall Study||63
1632904|NCT00824421|3988610|P2|STARTED|Overall Study||66
1632905|NCT00824421|3988611|P1|STARTED|Overall Study||66
1632906|NCT00824408|3988662|P5|NOT COMPLETED|Randomized Phase||46
1632907|NCT00824408|3988663|P4|NOT COMPLETED|Randomized Phase||46
1632908|NCT00824408|3988664|P3|NOT COMPLETED|Randomized Phase||36
1632909|NCT00824408|3988665|P2|NOT COMPLETED|Randomized Phase||0
1632910|NCT00824408|3988666|P1|NOT COMPLETED|Randomized Phase||0
1632911|NCT00824408|3988662|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
1632912|NCT00824408|3988663|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
1632913|NCT00824408|3988664|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
1632914|NCT00824408|3988665|P2|COMPLETED|Randomized Phase||0
1632915|NCT00824408|3988666|P1|COMPLETED|Randomized Phase||0
1632916|NCT00824408|3988662|P5|STARTED|Randomized Phase||47
1632917|NCT00824408|3988663|P4|STARTED|Randomized Phase||47
1632918|NCT00824408|3988664|P3|STARTED|Randomized Phase||37
1632919|NCT00824408|3988665|P2|STARTED|Randomized Phase||0
1632920|NCT00824408|3988666|P1|STARTED|Randomized Phase||0
1632921|NCT00824408|3988662|P5|NOT COMPLETED|Run-in Phase||0
1632922|NCT00824408|3988663|P4|NOT COMPLETED|Run-in Phase||0
1632923|NCT00824408|3988664|P3|NOT COMPLETED|Run-in Phase||0
1632924|NCT00824408|3988665|P2|NOT COMPLETED|Run-in Phase||6
1632925|NCT00824408|3988666|P1|NOT COMPLETED|Run-in Phase||6
1632926|NCT00824408|3988662|P5|COMPLETED|Run-in Phase||0
1632927|NCT00824408|3988663|P4|COMPLETED|Run-in Phase||0
1632928|NCT00824408|3988664|P3|COMPLETED|Run-in Phase||0
1632929|NCT00824408|3988665|P2|COMPLETED|Run-in Phase||0
1632930|NCT00824408|3988666|P1|COMPLETED|Run-in Phase||0
1632931|NCT00824408|3988662|P5|STARTED|Run-in Phase||0
1632932|NCT00824408|3988663|P4|STARTED|Run-in Phase||0
1632933|NCT00824408|3988664|P3|STARTED|Run-in Phase||0
1632934|NCT00824408|3988665|P2|STARTED|Run-in Phase||6
1632935|NCT00824408|3988666|P1|STARTED|Run-in Phase||6
1632936|NCT00824382|3988718|P4|NOT COMPLETED|Overall Study||5
1632937|NCT00824382|3988719|P3|NOT COMPLETED|Overall Study||3
1632938|NCT00824382|3988720|P2|NOT COMPLETED|Overall Study||2
1632939|NCT00824382|3988721|P1|NOT COMPLETED|Overall Study||5
1632940|NCT00824382|3988718|P4|COMPLETED|Overall Study||81
1632941|NCT00824382|3988719|P3|COMPLETED|Overall Study||76
1632942|NCT00824382|3988720|P2|COMPLETED|Overall Study||82
1632943|NCT00824382|3988721|P1|COMPLETED|Overall Study||74
1632944|NCT00824382|3988718|P4|STARTED|Overall Study||86
1632945|NCT00824382|3988719|P3|STARTED|Overall Study||79
1632946|NCT00824382|3988720|P2|STARTED|Overall Study||84
1632947|NCT00824382|3988721|P1|STARTED|Overall Study||79
1632948|NCT00824369|3988797|P6|NOT COMPLETED|Overall Study||1
1632949|NCT00824369|3988798|P5|NOT COMPLETED|Overall Study||1
1632950|NCT00824369|3988799|P4|NOT COMPLETED|Overall Study||2
1632951|NCT00824369|3988800|P3|NOT COMPLETED|Overall Study||1
1632952|NCT00824369|3988801|P2|NOT COMPLETED|Overall Study||0
1632953|NCT00824369|3988802|P1|NOT COMPLETED|Overall Study||1
1632954|NCT00824369|3988797|P6|COMPLETED|Overall Study||16
1632955|NCT00824369|3988798|P5|COMPLETED|Overall Study||11
1632956|NCT00824369|3988799|P4|COMPLETED|Overall Study||9
1632957|NCT00824369|3988800|P3|COMPLETED|Overall Study||2
1632958|NCT00824369|3988801|P2|COMPLETED|Overall Study||4
1632959|NCT00824369|3988802|P1|COMPLETED|Overall Study||4
1632960|NCT00824369|3988797|P6|STARTED|Overall Study||17
1632961|NCT00824369|3988798|P5|STARTED|Overall Study||12
1632962|NCT00824369|3988799|P4|STARTED|Overall Study||11
1632963|NCT00824369|3988800|P3|STARTED|Overall Study||3
1632964|NCT00824369|3988801|P2|STARTED|Overall Study||4
1632965|NCT00824369|3988802|P1|STARTED|Overall Study||5
1632966|NCT00824291|3988842|P2|NOT COMPLETED|Overall Study||35
1632967|NCT00824291|3988843|P1|NOT COMPLETED|Overall Study||54
1632968|NCT00824291|3988842|P2|COMPLETED|Overall Study||107
1632969|NCT00824291|3988843|P1|COMPLETED|Overall Study||231
1632970|NCT00824291|3988842|P2|STARTED|Overall Study||142
1632971|NCT00824291|3988843|P1|STARTED|Overall Study||285
1632972|NCT00824265|3988865|P2|NOT COMPLETED|Survival Follow-up Phase||16
1632973|NCT00824265|3988866|P1|NOT COMPLETED|Survival Follow-up Phase||9
1632974|NCT00824265|3988865|P2|COMPLETED|Survival Follow-up Phase||73
1632975|NCT00824265|3988866|P1|COMPLETED|Survival Follow-up Phase||87
1632976|NCT00824265|3988865|P2|STARTED|Survival Follow-up Phase||89
1632977|NCT00824265|3988866|P1|STARTED|Survival Follow-up Phase||96
1632978|NCT00824265|3988865|P2|NOT COMPLETED|Follow-up Phase||31
1632979|NCT00824265|3988866|P1|NOT COMPLETED|Follow-up Phase||18
1632980|NCT00824265|3988865|P2|COMPLETED|Follow-up Phase||129
1632981|NCT00824265|3988866|P1|COMPLETED|Follow-up Phase||154
1632982|NCT00824265|3988865|P2|STARTED|Follow-up Phase||160
1632983|NCT00824265|3988866|P1|STARTED|Follow-up Phase||172
1632984|NCT00824265|3988865|P2|NOT COMPLETED|Treatment Phase||80
1632985|NCT00824265|3988866|P1|NOT COMPLETED|Treatment Phase||64
1632986|NCT00824265|3988865|P2|COMPLETED|Treatment Phase||102
1632987|NCT00824265|3988866|P1|COMPLETED|Treatment Phase||119
1632988|NCT00824265|3988865|P2|STARTED|Treatment Phase||182
1632989|NCT00824265|3988866|P1|STARTED|Treatment Phase||183
1632990|NCT00824161|3988927|P1|NOT COMPLETED|Overall Study||2
1632991|NCT00824161|3988927|P1|COMPLETED|Overall Study||26
1632992|NCT00824161|3988927|P1|STARTED|Overall Study||28
1632993|NCT00824070|3988936|P3|NOT COMPLETED|Overall Study||0
1632994|NCT00824070|3988937|P2|NOT COMPLETED|Overall Study||0
1632995|NCT00824070|3988938|P1|NOT COMPLETED|Overall Study||0
1632996|NCT00824070|3988936|P3|COMPLETED|Overall Study||36
1632997|NCT00824070|3988937|P2|COMPLETED|Overall Study||35
1632998|NCT00824070|3988938|P1|COMPLETED|Overall Study||34
1632999|NCT00824070|3988936|P3|STARTED|Overall Study||36
1633000|NCT00824070|3988937|P2|STARTED|Overall Study||35
1633001|NCT00824070|3988938|P1|STARTED|Overall Study||34
1633002|NCT00824044|3988948|P2|NOT COMPLETED|Overall Study||6
1633003|NCT00824044|3988949|P1|NOT COMPLETED|Overall Study||9
1633004|NCT00824044|3988948|P2|COMPLETED|Overall Study||10
1633005|NCT00824044|3988949|P1|COMPLETED|Overall Study||14
1633006|NCT00824044|3988948|P2|STARTED|Overall Study||16
1633007|NCT00824044|3988949|P1|STARTED|Overall Study||23
1633008|NCT00824005|3988993|P2|NOT COMPLETED|Overall Study||2
1633009|NCT00824005|3988994|P1|NOT COMPLETED|Overall Study||0
1633010|NCT00824005|3988993|P2|COMPLETED|Overall Study||59
1633011|NCT00824005|3988994|P1|COMPLETED|Overall Study||31
1633012|NCT00824005|3988993|P2|STARTED|Overall Study||61
1633013|NCT00824005|3988994|P1|STARTED|Overall Study||31
1633014|NCT00823979|3989029|P3|NOT COMPLETED|Overall Study||24
1633015|NCT00823979|3989030|P2|NOT COMPLETED|Overall Study||32
1633016|NCT00823979|3989031|P1|NOT COMPLETED|Overall Study||29
1633017|NCT00823979|3989029|P3|COMPLETED|Overall Study||11
1633018|NCT00823979|3989030|P2|COMPLETED|Overall Study||3
1633019|NCT00823979|3989031|P1|COMPLETED|Overall Study||6
1633020|NCT00823979|3989029|P3|Treated|Overall Study||34
1633021|NCT00823979|3989030|P2|Treated|Overall Study||32
1633022|NCT00823979|3989031|P1|Treated|Overall Study||31
1633023|NCT00823979|3989029|P3|STARTED|Overall Study||35
1633024|NCT00823979|3989030|P2|STARTED|Overall Study||35
1633025|NCT00823979|3989031|P1|STARTED|Overall Study||35
1633026|NCT00823966|3989069|P1|NOT COMPLETED|Overall Study||0
1633027|NCT00823966|3989069|P1|COMPLETED|Overall Study||3
1633028|NCT00823966|3989069|P1|STARTED|Overall Study||3
1633029|NCT00823901|3989076|P2|NOT COMPLETED|Overall Study||2
1633030|NCT00823901|3989077|P1|NOT COMPLETED|Overall Study||4
1633031|NCT00823901|3989076|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
1633032|NCT00823901|3989077|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
1633033|NCT00823901|3989076|P2|STARTED|Overall Study|Randomized to placebo gel|40
1633034|NCT00823901|3989077|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
1633035|NCT00823836|3989085|P2|NOT COMPLETED|Long-term Phase||5
1633036|NCT00823836|3989086|P1|NOT COMPLETED|Long-term Phase||5
1633037|NCT00823836|3989085|P2|COMPLETED|Long-term Phase||79
1633038|NCT00823836|3989086|P1|COMPLETED|Long-term Phase||68
1633039|NCT00823836|3989085|P2|STARTED|Long-term Phase||84
1633040|NCT00823836|3989086|P1|STARTED|Long-term Phase||73
1633041|NCT00823836|3989085|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
1633042|NCT00823836|3989086|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
1633043|NCT00823836|3989085|P2|COMPLETED|NV and PR/XR Switching Phases||117
1633044|NCT00823836|3989086|P1|COMPLETED|NV and PR/XR Switching Phases||124
1633045|NCT00823836|3989085|P2|STARTED|NV and PR/XR Switching Phases||146
1633046|NCT00823836|3989086|P1|STARTED|NV and PR/XR Switching Phases||156
1633047|NCT00823823|3989192|P2|NOT COMPLETED|Overall Study||6
1633048|NCT00823823|3989193|P1|NOT COMPLETED|Overall Study||8
1633049|NCT00823823|3989192|P2|COMPLETED|Overall Study||101
1633050|NCT00823823|3989193|P1|COMPLETED|Overall Study||101
1633051|NCT00823823|3989192|P2|STARTED|Overall Study||107
1633052|NCT00823823|3989193|P1|STARTED|Overall Study||109
1633053|NCT00823797|3989203|P2|NOT COMPLETED|Overall Study||0
1633054|NCT00823797|3989204|P1|NOT COMPLETED|Overall Study||0
1633055|NCT00823797|3989203|P2|COMPLETED|Overall Study||16
1633056|NCT00823797|3989204|P1|COMPLETED|Overall Study||29
1633057|NCT00823797|3989203|P2|STARTED|Overall Study||16
1633058|NCT00823797|3989204|P1|STARTED|Overall Study||29
1633059|NCT00823719|3989217|P2|NOT COMPLETED|Overall Study||11
1633060|NCT00823719|3989218|P1|NOT COMPLETED|Overall Study||6
1633061|NCT00823719|3989217|P2|COMPLETED|Overall Study||24
1633062|NCT00823719|3989218|P1|COMPLETED|Overall Study||20
1633063|NCT00823719|3989217|P2|STARTED|Overall Study||35
1633064|NCT00823719|3989218|P1|STARTED|Overall Study||26
1633065|NCT00823615|3989271|P2|NOT COMPLETED|Period 2||2
1633066|NCT00823615|3989272|P1|NOT COMPLETED|Period 2||3
1633067|NCT00823615|3989271|P2|COMPLETED|Period 2||17
1633068|NCT00823615|3989272|P1|COMPLETED|Period 2||16
1633069|NCT00823615|3989271|P2|STARTED|Period 2||19
1633070|NCT00823615|3989272|P1|STARTED|Period 2||19
1633071|NCT00823615|3989271|P2|NOT COMPLETED|Period 1||0
1633072|NCT00823615|3989272|P1|NOT COMPLETED|Period 1||0
1633073|NCT00823615|3989271|P2|COMPLETED|Period 1||19
1633074|NCT00823615|3989272|P1|COMPLETED|Period 1||19
1633075|NCT00823615|3989271|P2|STARTED|Period 1||19
1633076|NCT00823615|3989272|P1|STARTED|Period 1||19
1633077|NCT00823472|3989282|P2|NOT COMPLETED|Overall Study||28
1633078|NCT00823472|3989283|P1|NOT COMPLETED|Overall Study||24
1633079|NCT00823472|3989282|P2|COMPLETED|Overall Study||39
1633080|NCT00823472|3989283|P1|COMPLETED|Overall Study||56
1633081|NCT00823472|3989282|P2|STARTED|Overall Study||67
1633082|NCT00823472|3989283|P1|STARTED|Overall Study||80
1633083|NCT00823303|3989293|P2|NOT COMPLETED|Overall Study||11
1633084|NCT00823303|3989294|P1|NOT COMPLETED|Overall Study||9
1633085|NCT00823303|3989293|P2|COMPLETED|Overall Study||45
1633086|NCT00823303|3989294|P1|COMPLETED|Overall Study||45
1633087|NCT00823303|3989293|P2|STARTED|Overall Study||56
1633088|NCT00823303|3989294|P1|STARTED|Overall Study||54
1633089|NCT00823264|3989302|P2|NOT COMPLETED|Overall Study||0
1633090|NCT00823264|3989303|P1|NOT COMPLETED|Overall Study||2
1633091|NCT00823264|3989302|P2|COMPLETED|Overall Study||7
1633092|NCT00823264|3989303|P1|COMPLETED|Overall Study||8
1633093|NCT00823264|3989302|P2|STARTED|Overall Study||7
1633094|NCT00823264|3989303|P1|STARTED|Overall Study||10
1633095|NCT00823212|3989311|P2|NOT COMPLETED|Overall Study||33
1633096|NCT00823212|3989312|P1|NOT COMPLETED|Overall Study||35
1633097|NCT00823212|3989311|P2|COMPLETED|Overall Study|12-month follow-up|735
1633098|NCT00823212|3989312|P1|COMPLETED|Overall Study|12-month follow-up|727
1633099|NCT00823212|3989311|P2|STARTED|Overall Study||768
1633100|NCT00823212|3989312|P1|STARTED|Overall Study||762
1633101|NCT00823199|3989394|P1|NOT COMPLETED|Overall Study||2
1633102|NCT00823199|3989394|P1|COMPLETED|Overall Study||8
1633103|NCT00823199|3989394|P1|STARTED|Overall Study||10
1633104|NCT00823095|3989400|P1|NOT COMPLETED|Overall Study||0
1633105|NCT00823095|3989400|P1|COMPLETED|Overall Study||7
1633106|NCT00823095|3989400|P1|STARTED|Overall Study||7
1633107|NCT00823082|3989407|P2|NOT COMPLETED|Overall Study||1
1633108|NCT00823082|3989408|P1|NOT COMPLETED|Overall Study||0
1633109|NCT00823082|3989407|P2|COMPLETED|Overall Study||99
1633110|NCT00823082|3989408|P1|COMPLETED|Overall Study||100
1633111|NCT00823082|3989407|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
1633112|NCT00823082|3989408|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
1633113|NCT00823082|3989407|P2|Safety Population|Overall Study||99
1633114|NCT00823082|3989408|P1|Safety Population|Overall Study||100
1633115|NCT00823082|3989407|P2|STARTED|Overall Study||100
1633116|NCT00823082|3989408|P1|STARTED|Overall Study||100
1633117|NCT00823069|3989442|P1|NOT COMPLETED|Overall Study||0
1633118|NCT00823069|3989442|P1|COMPLETED|Overall Study||60
1633119|NCT00823069|3989442|P1|STARTED|Overall Study||60
1633120|NCT00823043|3989449|P2|NOT COMPLETED|Overall Study||0
1633121|NCT00823043|3989450|P1|NOT COMPLETED|Overall Study||0
1633122|NCT00823043|3989449|P2|COMPLETED|Overall Study||39
1633123|NCT00823043|3989450|P1|COMPLETED|Overall Study||64
1633124|NCT00823043|3989449|P2|STARTED|Overall Study||39
1633125|NCT00823043|3989450|P1|STARTED|Overall Study||64
1633126|NCT00822926|3989463|P2|NOT COMPLETED|Second Injection Visit||1
1633127|NCT00822926|3989464|P1|NOT COMPLETED|Second Injection Visit||1
1633128|NCT00822926|3989463|P2|COMPLETED|Second Injection Visit||2
1633129|NCT00822926|3989464|P1|COMPLETED|Second Injection Visit||1
1633130|NCT00822926|3989463|P2|STARTED|Second Injection Visit||3
1633131|NCT00822926|3989464|P1|STARTED|Second Injection Visit||2
1633132|NCT00822926|3989463|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
1633133|NCT00822926|3989464|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
1633134|NCT00822926|3989463|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
1633135|NCT00822926|3989464|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
1633136|NCT00822926|3989463|P2|STARTED|Washout (Varies Based on Scheduling)||3
1633137|NCT00822926|3989464|P1|STARTED|Washout (Varies Based on Scheduling)||2
1633138|NCT00822926|3989463|P2|NOT COMPLETED|First Injection Visit||0
1633139|NCT00822926|3989464|P1|NOT COMPLETED|First Injection Visit||0
1633140|NCT00822926|3989463|P2|COMPLETED|First Injection Visit||3
1633141|NCT00822926|3989464|P1|COMPLETED|First Injection Visit||2
1633142|NCT00822926|3989463|P2|STARTED|First Injection Visit||3
1633143|NCT00822926|3989464|P1|STARTED|First Injection Visit||2
1633144|NCT00822900|3989478|P2|NOT COMPLETED|Overall Study||93
1633145|NCT00822900|3989479|P1|NOT COMPLETED|Overall Study||108
1633146|NCT00822900|3989478|P2|COMPLETED|Overall Study||347
1633147|NCT00822900|3989479|P1|COMPLETED|Overall Study||334
1633148|NCT00822900|3989478|P2|STARTED|Overall Study||440
1633149|NCT00822900|3989479|P1|STARTED|Overall Study||442
1633150|NCT00822770|3989507|P1|NOT COMPLETED|Overall Study||0
1633151|NCT00822770|3989507|P1|COMPLETED|Overall Study||47
1633152|NCT00822770|3989507|P1|STARTED|Overall Study||47
1633153|NCT00822757|3989513|P2|NOT COMPLETED|Overall Study||0
1633154|NCT00822757|3989514|P1|NOT COMPLETED|Overall Study||0
1633155|NCT00822757|3989513|P2|COMPLETED|Overall Study||10
1633156|NCT00822757|3989514|P1|COMPLETED|Overall Study||41
1633157|NCT00822757|3989513|P2|STARTED|Overall Study||10
1633158|NCT00822757|3989514|P1|STARTED|Overall Study||41
1633159|NCT00822692|3989526|P2|NOT COMPLETED|Overall Study||25
1633160|NCT00822692|3989527|P1|NOT COMPLETED|Overall Study||17
1633161|NCT00822692|3989526|P2|COMPLETED|Overall Study|June 1 , 2009|51
1633162|NCT00822692|3989527|P1|COMPLETED|Overall Study|June 1, 2009|46
1633163|NCT00822692|3989526|P2|STARTED|Overall Study|July 1, 2008|76
1633164|NCT00822692|3989527|P1|STARTED|Overall Study|July 1, 2008|63
1633165|NCT00822679|3989535|P2|NOT COMPLETED|Overall Study||0
1633166|NCT00822679|3989536|P1|NOT COMPLETED|Overall Study||0
1633167|NCT00822679|3989535|P2|COMPLETED|Overall Study||0
1633168|NCT00822679|3989536|P1|COMPLETED|Overall Study||0
1633169|NCT00822679|3989535|P2|STARTED|Overall Study||0
1633170|NCT00822679|3989536|P1|STARTED|Overall Study||0
1633171|NCT00822588|3989544|P2|NOT COMPLETED|Overall Study||4
1633172|NCT00822588|3989545|P1|NOT COMPLETED|Overall Study||7
1633173|NCT00822588|3989544|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
1633174|NCT00822588|3989545|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
1633175|NCT00822588|3989544|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
1633176|NCT00822588|3989545|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
1633177|NCT00822523|3989554|P3|NOT COMPLETED|Overall Study||0
1633178|NCT00822523|3989555|P2|NOT COMPLETED|Overall Study||0
1633179|NCT00822523|3989556|P1|NOT COMPLETED|Overall Study||0
1633180|NCT00822523|3989554|P3|COMPLETED|Overall Study||4
1633181|NCT00822523|3989555|P2|COMPLETED|Overall Study||4
1633182|NCT00822523|3989556|P1|COMPLETED|Overall Study||5
1633183|NCT00822523|3989554|P3|STARTED|Overall Study||4
1633184|NCT00822523|3989555|P2|STARTED|Overall Study||4
1633185|NCT00822523|3989556|P1|STARTED|Overall Study||5
1633186|NCT00822510|3989602|P2|NOT COMPLETED|Overall Study||5
1633187|NCT00822510|3989603|P1|NOT COMPLETED|Overall Study||3
1633188|NCT00822510|3989602|P2|COMPLETED|Overall Study||36
1633189|NCT00822510|3989603|P1|COMPLETED|Overall Study||35
1633190|NCT00822510|3989602|P2|STARTED|Overall Study||41
1633191|NCT00822510|3989603|P1|STARTED|Overall Study||38
1633192|NCT00822354|3989623|P2|NOT COMPLETED|Second Intervention (28 Days)||0
1633193|NCT00822354|3989624|P1|NOT COMPLETED|Second Intervention (28 Days)||1
1633194|NCT00822354|3989623|P2|COMPLETED|Second Intervention (28 Days)||5
1633195|NCT00822354|3989624|P1|COMPLETED|Second Intervention (28 Days)||3
1633196|NCT00822354|3989623|P2|STARTED|Second Intervention (28 Days)||5
1633197|NCT00822354|3989624|P1|STARTED|Second Intervention (28 Days)||4
1633198|NCT00822354|3989623|P2|NOT COMPLETED|Washout (7 Days)||0
1633199|NCT00822354|3989624|P1|NOT COMPLETED|Washout (7 Days)||0
1633200|NCT00822354|3989623|P2|COMPLETED|Washout (7 Days)||5
1633201|NCT00822354|3989624|P1|COMPLETED|Washout (7 Days)||4
1633202|NCT00822354|3989623|P2|STARTED|Washout (7 Days)||5
1633203|NCT00822354|3989624|P1|STARTED|Washout (7 Days)||4
1633204|NCT00822354|3989623|P2|NOT COMPLETED|First Intervention (28 Days)||0
1633205|NCT00822354|3989624|P1|NOT COMPLETED|First Intervention (28 Days)||1
1633206|NCT00822354|3989623|P2|COMPLETED|First Intervention (28 Days)||5
1633207|NCT00822354|3989624|P1|COMPLETED|First Intervention (28 Days)||4
1633208|NCT00822354|3989623|P2|STARTED|First Intervention (28 Days)||5
1633209|NCT00822354|3989624|P1|STARTED|First Intervention (28 Days)||5
1633210|NCT00822328|3989654|P2|NOT COMPLETED|Overall Study||0
1633211|NCT00822328|3989655|P1|NOT COMPLETED|Overall Study||0
1633212|NCT00822328|3989654|P2|COMPLETED|Overall Study||12
1633213|NCT00822328|3989655|P1|COMPLETED|Overall Study||12
1633214|NCT00822328|3989654|P2|STARTED|Overall Study||12
1633215|NCT00822328|3989655|P1|STARTED|Overall Study||12
1633216|NCT00822237|3989665|P2|NOT COMPLETED|Dose 2 Vaccination||11
1633217|NCT00822237|3989666|P1|NOT COMPLETED|Dose 2 Vaccination||4
1633218|NCT00822237|3989665|P2|COMPLETED|Dose 2 Vaccination||262
1633219|NCT00822237|3989666|P1|COMPLETED|Dose 2 Vaccination||270
1633220|NCT00822237|3989665|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
1633221|NCT00822237|3989666|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
1633222|NCT00822237|3989665|P2|NOT COMPLETED|Dose 1 Vaccination||26
1633223|NCT00822237|3989666|P1|NOT COMPLETED|Dose 1 Vaccination||25
1633224|NCT00822237|3989665|P2|COMPLETED|Dose 1 Vaccination||273
1633225|NCT00822237|3989666|P1|COMPLETED|Dose 1 Vaccination||274
1633226|NCT00822237|3989665|P2|STARTED|Dose 1 Vaccination|Number randomized|299
1633227|NCT00822237|3989666|P1|STARTED|Dose 1 Vaccination|Number randomized|299
1633228|NCT00822185|3989676|P5|NOT COMPLETED|Overall Study||0
1633229|NCT00822185|3989677|P4|NOT COMPLETED|Overall Study||0
1633230|NCT00822185|3989678|P3|NOT COMPLETED|Overall Study||0
1633231|NCT00822185|3989679|P2|NOT COMPLETED|Overall Study||0
1633232|NCT00822185|3989680|P1|NOT COMPLETED|Overall Study||0
1633233|NCT00822185|3989676|P5|COMPLETED|Overall Study||8
1633234|NCT00822185|3989677|P4|COMPLETED|Overall Study||6
1633235|NCT00822185|3989678|P3|COMPLETED|Overall Study||6
1633236|NCT00822185|3989679|P2|COMPLETED|Overall Study||6
1633237|NCT00822185|3989680|P1|COMPLETED|Overall Study||6
1633238|NCT00822185|3989676|P5|STARTED|Overall Study||8
1633239|NCT00822185|3989677|P4|STARTED|Overall Study||6
1633240|NCT00822185|3989678|P3|STARTED|Overall Study||6
1633241|NCT00822185|3989679|P2|STARTED|Overall Study||6
1633242|NCT00822185|3989680|P1|STARTED|Overall Study||6
1633243|NCT00822172|3989747|P2|NOT COMPLETED|Overall Study||19
1633244|NCT00822172|3989748|P1|NOT COMPLETED|Overall Study||15
1633245|NCT00822172|3989747|P2|COMPLETED|Overall Study||64
1633246|NCT00822172|3989748|P1|COMPLETED|Overall Study||65
1633247|NCT00822172|3989747|P2|STARTED|Overall Study||83
1633248|NCT00822172|3989748|P1|STARTED|Overall Study||80
1633249|NCT00822120|3989756|P6|NOT COMPLETED|PET-directed Therapy||0
1633250|NCT00822120|3989757|P5|NOT COMPLETED|PET-directed Therapy||0
1633251|NCT00822120|3989758|P4|NOT COMPLETED|PET-directed Therapy||10
1633252|NCT00822120|3989759|P3|NOT COMPLETED|PET-directed Therapy||0
1633253|NCT00822120|3989760|P2|NOT COMPLETED|PET-directed Therapy||0
1633254|NCT00822120|3989761|P1|NOT COMPLETED|PET-directed Therapy||0
1633255|NCT00822120|3989756|P6|COMPLETED|PET-directed Therapy||1
1633256|NCT00822120|3989757|P5|COMPLETED|PET-directed Therapy||10
1633257|NCT00822120|3989758|P4|COMPLETED|PET-directed Therapy||45
1633258|NCT00822120|3989759|P3|COMPLETED|PET-directed Therapy||270
1633259|NCT00822120|3989760|P2|COMPLETED|PET-directed Therapy||0
1633260|NCT00822120|3989761|P1|COMPLETED|PET-directed Therapy||0
1633261|NCT00822120|3989756|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
1633262|NCT00822120|3989757|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
1633263|NCT00822120|3989758|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
1633264|NCT00822120|3989759|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
1633265|NCT00822120|3989760|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
1633266|NCT00822120|3989761|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
1633267|NCT00822120|3989756|P6|STARTED|PET-directed Therapy||1
1633268|NCT00822120|3989757|P5|STARTED|PET-directed Therapy||10
1633269|NCT00822120|3989758|P4|STARTED|PET-directed Therapy||55
1633270|NCT00822120|3989759|P3|STARTED|PET-directed Therapy||270
1633271|NCT00822120|3989760|P2|STARTED|PET-directed Therapy||0
1633272|NCT00822120|3989761|P1|STARTED|PET-directed Therapy||0
1633273|NCT00822120|3989756|P6|NOT COMPLETED|Initial Registration||0
1633274|NCT00822120|3989757|P5|NOT COMPLETED|Initial Registration||0
1633275|NCT00822120|3989758|P4|NOT COMPLETED|Initial Registration||0
1633276|NCT00822120|3989759|P3|NOT COMPLETED|Initial Registration||0
1633277|NCT00822120|3989760|P2|NOT COMPLETED|Initial Registration||1
1633278|NCT00822120|3989761|P1|NOT COMPLETED|Initial Registration||26
1633279|NCT00822120|3989756|P6|COMPLETED|Initial Registration||0
1633280|NCT00822120|3989757|P5|COMPLETED|Initial Registration||0
1633281|NCT00822120|3989758|P4|COMPLETED|Initial Registration||0
1633282|NCT00822120|3989759|P3|COMPLETED|Initial Registration||0
1633283|NCT00822120|3989760|P2|COMPLETED|Initial Registration||12
1633284|NCT00822120|3989761|P1|COMPLETED|Initial Registration||332
1633285|NCT00822120|3989756|P6|Eligible and Evaluable Patients|Initial Registration||0
1633286|NCT00822120|3989757|P5|Eligible and Evaluable Patients|Initial Registration||0
1633287|NCT00822120|3989758|P4|Eligible and Evaluable Patients|Initial Registration||0
1633288|NCT00822120|3989759|P3|Eligible and Evaluable Patients|Initial Registration||0
1633289|NCT00822120|3989760|P2|Eligible and Evaluable Patients|Initial Registration||12
1633290|NCT00822120|3989761|P1|Eligible and Evaluable Patients|Initial Registration||336
1633291|NCT00822120|3989756|P6|STARTED|Initial Registration||0
1633292|NCT00822120|3989757|P5|STARTED|Initial Registration||0
1633293|NCT00822120|3989758|P4|STARTED|Initial Registration||0
1633294|NCT00822120|3989759|P3|STARTED|Initial Registration||0
1633295|NCT00822120|3989760|P2|STARTED|Initial Registration||13
1633296|NCT00822120|3989761|P1|STARTED|Initial Registration||358
1633297|NCT00822094|3989786|P2|NOT COMPLETED|Overall Study||25
1633298|NCT00822094|3989787|P1|NOT COMPLETED|Overall Study||44
1633299|NCT00822094|3989786|P2|COMPLETED|Overall Study||20
1633300|NCT00822094|3989787|P1|COMPLETED|Overall Study||37
1633301|NCT00822094|3989786|P2|STARTED|Overall Study||45
1633302|NCT00822094|3989787|P1|STARTED|Overall Study||81
1633303|NCT00821964|3989803|P1|NOT COMPLETED|Overall Study||6
1633304|NCT00821964|3989803|P1|COMPLETED|Overall Study||9
1633305|NCT00821964|3989803|P1|Evaluable for Pathologic Response|Overall Study||7
1633306|NCT00821964|3989803|P1|Evaluable for Clinical Response|Overall Study||14
1633307|NCT00821964|3989803|P1|STARTED|Overall Study||15
1633308|NCT00821951|3989812|P1|NOT COMPLETED|Overall Study||5
1633309|NCT00821951|3989812|P1|COMPLETED|Overall Study||12
1633310|NCT00821951|3989812|P1|STARTED|Overall Study||17
1633311|NCT00821886|3989816|P1|NOT COMPLETED|Overall Study||9
1633312|NCT00821886|3989816|P1|COMPLETED|Overall Study||49
1633313|NCT00821886|3989816|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
1633314|NCT00821873|3989823|P1|NOT COMPLETED|Overall Study||4
1633315|NCT00821873|3989823|P1|COMPLETED|Overall Study||5
1633316|NCT00821873|3989823|P1|STARTED|Overall Study||9
1633317|NCT00821821|3989830|P3|NOT COMPLETED|Overall Study||0
1633318|NCT00821821|3989831|P2|NOT COMPLETED|Overall Study||0
1633319|NCT00821821|3989832|P1|NOT COMPLETED|Overall Study||0
1633320|NCT00821821|3989830|P3|COMPLETED|Overall Study||11
1633321|NCT00821821|3989831|P2|COMPLETED|Overall Study||13
1633322|NCT00821821|3989832|P1|COMPLETED|Overall Study||12
1633323|NCT00821821|3989830|P3|STARTED|Overall Study||11
1633324|NCT00821821|3989831|P2|STARTED|Overall Study||13
1633325|NCT00821821|3989832|P1|STARTED|Overall Study||12
1633326|NCT00821678|3989844|P2|NOT COMPLETED|Overall Study||14
1633327|NCT00821678|3989845|P1|NOT COMPLETED|Overall Study||21
1633328|NCT00821678|3989844|P2|COMPLETED|Overall Study||118
1633329|NCT00821678|3989845|P1|COMPLETED|Overall Study||112
1633330|NCT00821678|3989844|P2|STARTED|Overall Study||132
1633331|NCT00821678|3989845|P1|STARTED|Overall Study||133
1633332|NCT00821587|3989867|P2|NOT COMPLETED|Overall Study||1
1633333|NCT00821587|3989868|P1|NOT COMPLETED|Overall Study||0
1633334|NCT00821587|3989867|P2|COMPLETED|Overall Study||18
1633335|NCT00821587|3989868|P1|COMPLETED|Overall Study||20
1633336|NCT00821587|3989867|P2|STARTED|Overall Study||19
1633337|NCT00821587|3989868|P1|STARTED|Overall Study||20
1633338|NCT00821509|3989877|P3|NOT COMPLETED|Overall Study||34
1633339|NCT00821509|3989878|P2|NOT COMPLETED|Overall Study||11
1633340|NCT00821509|3989879|P1|NOT COMPLETED|Overall Study||12
1633341|NCT00821509|3989877|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
1633342|NCT00821509|3989878|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
1633343|NCT00821509|3989879|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
1633344|NCT00821509|3989877|P3|STARTED|Overall Study||224
1633345|NCT00821509|3989878|P2|STARTED|Overall Study||202
1633346|NCT00821509|3989879|P1|STARTED|Overall Study||257
1633347|NCT00821431|3989892|P2|NOT COMPLETED|Overall Study||5
1633348|NCT00821431|3989893|P1|NOT COMPLETED|Overall Study||15
1633349|NCT00821431|3989892|P2|COMPLETED|Overall Study||47
1633350|NCT00821431|3989893|P1|COMPLETED|Overall Study||23
1633351|NCT00821431|3989892|P2|STARTED|Overall Study||52
1633352|NCT00821431|3989893|P1|STARTED|Overall Study||38
1633353|NCT00821327|3989901|P1|NOT COMPLETED|Overall Study||35
1633354|NCT00821327|3989901|P1|COMPLETED|Overall Study||1
1633355|NCT00821327|3989901|P1|STARTED|Overall Study||36
1633356|NCT00821236|3989910|P1|NOT COMPLETED|Overall Study||3
1633357|NCT00821236|3989910|P1|COMPLETED|Overall Study||37
1633358|NCT00821236|3989910|P1|STARTED|Overall Study||40
1633359|NCT00821184|3989926|P2|NOT COMPLETED|Overall Study||0
1633360|NCT00821184|3989927|P1|NOT COMPLETED|Overall Study||0
1633361|NCT00821184|3989926|P2|COMPLETED|Overall Study||6
1633362|NCT00821184|3989927|P1|COMPLETED|Overall Study||6
1633363|NCT00821184|3989926|P2|STARTED|Overall Study||6
1633364|NCT00821184|3989927|P1|STARTED|Overall Study||6
1633365|NCT00821119|3989937|P2|NOT COMPLETED|Overall Study||0
1633366|NCT00821119|3989938|P1|NOT COMPLETED|Overall Study||0
1633367|NCT00821119|3989937|P2|COMPLETED|Overall Study||100
1633368|NCT00821119|3989938|P1|COMPLETED|Overall Study||100
1633369|NCT00821119|3989937|P2|STARTED|Overall Study||100
1633370|NCT00821119|3989938|P1|STARTED|Overall Study||100
1633371|NCT00821093|3989950|P2|NOT COMPLETED|Overall Study||40
1633372|NCT00821093|3989951|P1|NOT COMPLETED|Overall Study||49
1633373|NCT00821093|3989950|P2|COMPLETED|Overall Study||523
1633374|NCT00821093|3989951|P1|COMPLETED|Overall Study||511
1633375|NCT00821093|3989950|P2|Exposed to Drug|Overall Study||562
1633376|NCT00821093|3989951|P1|Exposed to Drug|Overall Study||559
1633377|NCT00821093|3989950|P2|STARTED|Overall Study||563
1633378|NCT00821093|3989951|P1|STARTED|Overall Study||560
1633379|NCT00821041|3989961|P2|NOT COMPLETED|Overall Study||0
1633380|NCT00821041|3989962|P1|NOT COMPLETED|Overall Study||0
1633381|NCT00821041|3989961|P2|COMPLETED|Overall Study||59
1633382|NCT00821041|3989962|P1|COMPLETED|Overall Study||59
1633383|NCT00821041|3989961|P2|STARTED|Overall Study||59
1633384|NCT00821041|3989962|P1|STARTED|Overall Study||59
1633385|NCT00820898|3989970|P1|NOT COMPLETED|Overall Study||1
1633386|NCT00820898|3989970|P1|COMPLETED|Overall Study||23
1633387|NCT00820898|3989970|P1|STARTED|Overall Study||24
1633388|NCT00820872|3989980|P1|NOT COMPLETED|Overall Study||0
1633389|NCT00820872|3989980|P1|COMPLETED|Overall Study||30
1633390|NCT00820872|3989980|P1|STARTED|Overall Study||30
1633391|NCT00820755|3989984|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
1633392|NCT00820755|3989985|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
1633393|NCT00820755|3989986|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
1633394|NCT00820755|3989984|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
1633395|NCT00820755|3989985|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
1633396|NCT00820755|3989986|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
1633397|NCT00820755|3989984|P3|STARTED|Period 2: Maintenance Therapy Phase||154
1633398|NCT00820755|3989985|P2|STARTED|Period 2: Maintenance Therapy Phase||157
1633399|NCT00820755|3989986|P1|STARTED|Period 2: Maintenance Therapy Phase||0
1633400|NCT00820755|3989984|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
1633401|NCT00820755|3989985|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
1633402|NCT00820755|3989986|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
1633403|NCT00820755|3989984|P3|COMPLETED|Period 1: Combination Therapy Phase||0
1633404|NCT00820755|3989985|P2|COMPLETED|Period 1: Combination Therapy Phase||0
1633405|NCT00820755|3989986|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
1633406|NCT00820755|3989984|P3|STARTED|Period 1: Combination Therapy Phase||0
1633407|NCT00820755|3989985|P2|STARTED|Period 1: Combination Therapy Phase||0
1633408|NCT00820755|3989986|P1|STARTED|Period 1: Combination Therapy Phase||583
1633409|NCT00820664|3990010|P3|NOT COMPLETED|Overall Study||0
1633410|NCT00820664|3990011|P2|NOT COMPLETED|Overall Study||0
1633411|NCT00820664|3990012|P1|NOT COMPLETED|Overall Study||0
1633412|NCT00820664|3990010|P3|COMPLETED|Overall Study||9
1633413|NCT00820664|3990011|P2|COMPLETED|Overall Study||11
1633414|NCT00820664|3990012|P1|COMPLETED|Overall Study||9
1633415|NCT00820664|3990010|P3|STARTED|Overall Study||9
1633416|NCT00820664|3990011|P2|STARTED|Overall Study||11
1633417|NCT00820664|3990012|P1|STARTED|Overall Study||9
1633418|NCT00820612|3990022|P2|NOT COMPLETED|Overall Study||0
1633419|NCT00820612|3990023|P1|NOT COMPLETED|Overall Study||0
1633420|NCT00820612|3990022|P2|COMPLETED|Overall Study||295
1633421|NCT00820612|3990023|P1|COMPLETED|Overall Study||307
1633422|NCT00820612|3990022|P2|STARTED|Overall Study||295
1633423|NCT00820612|3990023|P1|STARTED|Overall Study||307
1633424|NCT00820573|3990033|P4|NOT COMPLETED|Overall Study||0
1633425|NCT00820573|3990034|P3|NOT COMPLETED|Overall Study||0
1633426|NCT00820573|3990035|P2|NOT COMPLETED|Overall Study||0
1633427|NCT00820573|3990036|P1|NOT COMPLETED|Overall Study||0
1633428|NCT00820573|3990033|P4|COMPLETED|Overall Study||4
1633429|NCT00820573|3990034|P3|COMPLETED|Overall Study||4
1633430|NCT00820573|3990035|P2|COMPLETED|Overall Study||4
1633431|NCT00820573|3990036|P1|COMPLETED|Overall Study||4
1633432|NCT00820573|3990033|P4|STARTED|Overall Study||4
1633433|NCT00820573|3990034|P3|STARTED|Overall Study||4
1633434|NCT00820573|3990035|P2|STARTED|Overall Study||4
1633435|NCT00820573|3990036|P1|STARTED|Overall Study||4
1633436|NCT00820534|3990060|P2|NOT COMPLETED|Overall Study||0
1633437|NCT00820534|3990061|P1|NOT COMPLETED|Overall Study||0
1633438|NCT00820534|3990060|P2|COMPLETED|Overall Study||62
1633439|NCT00820534|3990061|P1|COMPLETED|Overall Study||64
1633440|NCT00820534|3990060|P2|STARTED|Overall Study||62
1633441|NCT00820534|3990061|P1|STARTED|Overall Study||64
1633442|NCT00820443|3990069|P1|NOT COMPLETED|24 Month||43
1633443|NCT00820443|3990069|P1|COMPLETED|24 Month||202
1633444|NCT00820443|3990069|P1|STARTED|24 Month||245
1633445|NCT00820443|3990069|P1|NOT COMPLETED|12 Month||24
1633446|NCT00820443|3990069|P1|COMPLETED|12 Month||226
1633447|NCT00820443|3990069|P1|STARTED|12 Month||250
1633448|NCT00820443|3990069|P1|NOT COMPLETED|6 Month||20
1633449|NCT00820443|3990069|P1|COMPLETED|6 Month||233
1633450|NCT00820443|3990069|P1|STARTED|6 Month||253
1633451|NCT00820443|3990069|P1|NOT COMPLETED|3 Month||9
1633452|NCT00820443|3990069|P1|COMPLETED|3 Month||244
1633453|NCT00820443|3990069|P1|STARTED|3 Month||253
1633454|NCT00820443|3990069|P1|NOT COMPLETED|Immediately||5
1633455|NCT00820443|3990069|P1|COMPLETED|Immediately||248
1633456|NCT00820443|3990069|P1|STARTED|Immediately||253
1633457|NCT00820443|3990069|P1|NOT COMPLETED|Op||0
1633458|NCT00820443|3990069|P1|COMPLETED|Op||253
1633459|NCT00820443|3990069|P1|STARTED|Op||253
1633460|NCT00820443|3990069|P1|NOT COMPLETED|Pre-Op||0
1633461|NCT00820443|3990069|P1|COMPLETED|Pre-Op||253
1633462|NCT00820443|3990069|P1|STARTED|Pre-Op||253
1633463|NCT00820248|3990079|P2|NOT COMPLETED|Overall Study||1
1633464|NCT00820248|3990080|P1|NOT COMPLETED|Overall Study||4
1633465|NCT00820248|3990079|P2|COMPLETED|Overall Study||159
1633466|NCT00820248|3990080|P1|COMPLETED|Overall Study||156
1633467|NCT00820248|3990079|P2|Received Protocol Treatment|Overall Study||159
1633468|NCT00820248|3990080|P1|Received Protocol Treatment|Overall Study||156
1633469|NCT00820248|3990079|P2|STARTED|Overall Study||160
1633470|NCT00820248|3990080|P1|STARTED|Overall Study||160
1633471|NCT00820222|3990090|P2|NOT COMPLETED|Overall Study||211
1633472|NCT00820222|3990091|P1|NOT COMPLETED|Overall Study||201
1633473|NCT00820222|3990090|P2|COMPLETED|Overall Study||58
1633474|NCT00820222|3990091|P1|COMPLETED|Overall Study||70
1633475|NCT00820222|3990090|P2|Ongoing|Overall Study||191
1633476|NCT00820222|3990091|P1|Ongoing|Overall Study||185
1633477|NCT00820222|3990090|P2|STARTED|Overall Study||269
1633478|NCT00820222|3990091|P1|STARTED|Overall Study||271
1633479|NCT00819910|3990121|P4|NOT COMPLETED|Overall Study||1
1633480|NCT00819910|3990122|P3|NOT COMPLETED|Overall Study||3
1633481|NCT00819910|3990123|P2|NOT COMPLETED|Overall Study||1
1633482|NCT00819910|3990124|P1|NOT COMPLETED|Overall Study||2
1633483|NCT00819910|3990121|P4|COMPLETED|Overall Study||10
1633484|NCT00819910|3990122|P3|COMPLETED|Overall Study||7
1633485|NCT00819910|3990123|P2|COMPLETED|Overall Study||9
1633486|NCT00819910|3990124|P1|COMPLETED|Overall Study||8
1633487|NCT00819910|3990121|P4|STARTED|Overall Study||11
1633488|NCT00819910|3990122|P3|STARTED|Overall Study||10
1633489|NCT00819910|3990123|P2|STARTED|Overall Study||10
1633490|NCT00819910|3990124|P1|STARTED|Overall Study||10
1633491|NCT00819832|3990156|P6|NOT COMPLETED|Overall Study||0
1633492|NCT00819832|3990157|P5|NOT COMPLETED|Overall Study||0
1633493|NCT00819832|3990158|P4|NOT COMPLETED|Overall Study||0
1633494|NCT00819832|3990159|P3|NOT COMPLETED|Overall Study||0
1633495|NCT00819832|3990160|P2|NOT COMPLETED|Overall Study||0
1633496|NCT00819832|3990161|P1|NOT COMPLETED|Overall Study||3
1633497|NCT00819832|3990156|P6|COMPLETED|Overall Study||0
1633498|NCT00819832|3990157|P5|COMPLETED|Overall Study||0
1633499|NCT00819832|3990158|P4|COMPLETED|Overall Study||0
1633500|NCT00819832|3990159|P3|COMPLETED|Overall Study||0
1633501|NCT00819832|3990160|P2|COMPLETED|Overall Study||0
1633502|NCT00819832|3990161|P1|COMPLETED|Overall Study||0
1633503|NCT00819832|3990156|P6|STARTED|Overall Study||0
1633504|NCT00819832|3990157|P5|STARTED|Overall Study||0
1633505|NCT00819832|3990158|P4|STARTED|Overall Study||0
1633506|NCT00819832|3990159|P3|STARTED|Overall Study||0
1633507|NCT00819832|3990160|P2|STARTED|Overall Study||0
1633508|NCT00819832|3990161|P1|STARTED|Overall Study|No patient data analysis.|3
1633509|NCT00819780|3990177|P2|NOT COMPLETED|Overall Study||21
1633510|NCT00819780|3990178|P1|NOT COMPLETED|Overall Study||28
1633511|NCT00819780|3990177|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
1633512|NCT00819780|3990178|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
1633513|NCT00819780|3990177|P2|Received Study Treatment|Overall Study||139
1633514|NCT00819780|3990178|P1|Received Study Treatment|Overall Study||139
1633515|NCT00819780|3990177|P2|STARTED|Overall Study||143
1633516|NCT00819780|3990178|P1|STARTED|Overall Study||142
1633517|NCT00819767|3990212|P2|NOT COMPLETED|Overall Study||2
1633518|NCT00819767|3990213|P1|NOT COMPLETED|Overall Study||1
1633519|NCT00819767|3990212|P2|COMPLETED|Overall Study||33
1633520|NCT00819767|3990213|P1|COMPLETED|Overall Study||32
1633521|NCT00819767|3990212|P2|STARTED|Overall Study||35
1633522|NCT00819767|3990213|P1|STARTED|Overall Study||33
1633523|NCT00819741|3990225|P2|NOT COMPLETED|Overall Study||14
1633524|NCT00819741|3990226|P1|NOT COMPLETED|Overall Study||22
1633525|NCT00819741|3990225|P2|COMPLETED|Overall Study||201
1633526|NCT00819741|3990226|P1|COMPLETED|Overall Study||196
1633527|NCT00819741|3990225|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
1633528|NCT00819741|3990226|P1|Exposed to Drug|Overall Study||218
1633529|NCT00819741|3990225|P2|STARTED|Overall Study||215
1633530|NCT00819741|3990226|P1|STARTED|Overall Study||218
1633531|NCT00819637|3990263|P3|NOT COMPLETED|Overall Study||0
1633532|NCT00819637|3990264|P2|NOT COMPLETED|Overall Study||0
1633533|NCT00819637|3990265|P1|NOT COMPLETED|Overall Study||0
1633534|NCT00819637|3990263|P3|COMPLETED|Overall Study||0
1633535|NCT00819637|3990264|P2|COMPLETED|Overall Study||0
1633536|NCT00819637|3990265|P1|COMPLETED|Overall Study||2
1633537|NCT00819637|3990263|P3|STARTED|Overall Study||0
1633538|NCT00819637|3990264|P2|STARTED|Overall Study||0
1633539|NCT00819637|3990265|P1|STARTED|Overall Study||2
1633540|NCT00819585|3990280|P11|NOT COMPLETED|Extension Study||2
1633541|NCT00819585|3990281|P10|NOT COMPLETED|Extension Study||1
1633542|NCT00819585|3990282|P9|NOT COMPLETED|Extension Study||8
1633543|NCT00819585|3990283|P8|NOT COMPLETED|Extension Study||0
1633544|NCT00819585|3990284|P7|NOT COMPLETED|Extension Study||0
1633545|NCT00819585|3990285|P6|NOT COMPLETED|Extension Study||0
1633546|NCT00819585|3990286|P5|NOT COMPLETED|Extension Study||0
1633547|NCT00819585|3990287|P4|NOT COMPLETED|Extension Study||0
1633548|NCT00819585|3990288|P3|NOT COMPLETED|Extension Study||0
1633549|NCT00819585|3990289|P2|NOT COMPLETED|Extension Study||0
1633550|NCT00819585|3990290|P1|NOT COMPLETED|Extension Study||0
1633551|NCT00819585|3990280|P11|COMPLETED|Extension Study||58
1633552|NCT00819585|3990281|P10|COMPLETED|Extension Study||24
1633553|NCT00819585|3990282|P9|COMPLETED|Extension Study||173
1633554|NCT00819585|3990283|P8|COMPLETED|Extension Study||75
1633555|NCT00819585|3990284|P7|COMPLETED|Extension Study||0
1633556|NCT00819585|3990285|P6|COMPLETED|Extension Study||0
1633557|NCT00819585|3990286|P5|COMPLETED|Extension Study||0
1633558|NCT00819585|3990287|P4|COMPLETED|Extension Study||0
1633559|NCT00819585|3990288|P3|COMPLETED|Extension Study||0
1633560|NCT00819585|3990289|P2|COMPLETED|Extension Study||0
1633561|NCT00819585|3990290|P1|COMPLETED|Extension Study||0
1633562|NCT00819585|3990280|P11|STARTED|Extension Study||60
1633563|NCT00819585|3990281|P10|STARTED|Extension Study||25
1633564|NCT00819585|3990282|P9|STARTED|Extension Study||181
1633565|NCT00819585|3990283|P8|STARTED|Extension Study||75
1633566|NCT00819585|3990284|P7|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1633567|NCT00819585|3990285|P6|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1633568|NCT00819585|3990286|P5|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1633569|NCT00819585|3990287|P4|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1633570|NCT00819585|3990288|P3|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1633571|NCT00819585|3990289|P2|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1633572|NCT00819585|3990290|P1|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
1633573|NCT00819585|3990280|P11|NOT COMPLETED|Core Study||0
1633574|NCT00819585|3990281|P10|NOT COMPLETED|Core Study||0
1633575|NCT00819585|3990282|P9|NOT COMPLETED|Core Study||0
1633576|NCT00819585|3990283|P8|NOT COMPLETED|Core Study||0
1633577|NCT00819585|3990284|P7|NOT COMPLETED|Core Study||13
1633578|NCT00819585|3990285|P6|NOT COMPLETED|Core Study||2
1633579|NCT00819585|3990286|P5|NOT COMPLETED|Core Study||3
1633580|NCT00819585|3990287|P4|NOT COMPLETED|Core Study||5
1633581|NCT00819585|3990288|P3|NOT COMPLETED|Core Study||6
1633582|NCT00819585|3990289|P2|NOT COMPLETED|Core Study||6
1633583|NCT00819585|3990290|P1|NOT COMPLETED|Core Study||6
1633584|NCT00819585|3990280|P11|COMPLETED|Core Study||0
1633585|NCT00819585|3990281|P10|COMPLETED|Core Study||0
1633586|NCT00819585|3990282|P9|COMPLETED|Core Study||0
1633587|NCT00819585|3990283|P8|COMPLETED|Core Study||0
1633588|NCT00819585|3990284|P7|COMPLETED|Core Study||95
1633589|NCT00819585|3990285|P6|COMPLETED|Core Study||52
1633590|NCT00819585|3990286|P5|COMPLETED|Core Study||50
1633591|NCT00819585|3990287|P4|COMPLETED|Core Study||49
1633592|NCT00819585|3990288|P3|COMPLETED|Core Study||48
1633593|NCT00819585|3990289|P2|COMPLETED|Core Study||48
1633594|NCT00819585|3990290|P1|COMPLETED|Core Study||49
1633595|NCT00819585|3990280|P11|Received Study Medication|Core Study||0
1633596|NCT00819585|3990281|P10|Received Study Medication|Core Study||0
1633597|NCT00819585|3990282|P9|Received Study Medication|Core Study||0
1633598|NCT00819585|3990283|P8|Received Study Medication|Core Study||0
1633599|NCT00819585|3990284|P7|Received Study Medication|Core Study||108
1633600|NCT00819585|3990285|P6|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
1633601|NCT00819585|3990286|P5|Received Study Medication|Core Study||53
1633602|NCT00819585|3990287|P4|Received Study Medication|Core Study||54
1633603|NCT00819585|3990288|P3|Received Study Medication|Core Study||54
1633604|NCT00819585|3990289|P2|Received Study Medication|Core Study||54
1633605|NCT00819585|3990290|P1|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
1633606|NCT00819585|3990280|P11|STARTED|Core Study|There were no participants in this arm during the core study.|0
1633607|NCT00819585|3990281|P10|STARTED|Core Study|There were no participants in this arm during the core study.|0
1633608|NCT00819585|3990282|P9|STARTED|Core Study|There were no participants in this arm during the core study.|0
1633609|NCT00819585|3990283|P8|STARTED|Core Study|There were no participants in this arm during the core study.|0
1633610|NCT00819585|3990284|P7|STARTED|Core Study||108
1633611|NCT00819585|3990285|P6|STARTED|Core Study||54
1633612|NCT00819585|3990286|P5|STARTED|Core Study||53
1633613|NCT00819585|3990287|P4|STARTED|Core Study||54
1633614|NCT00819585|3990288|P3|STARTED|Core Study||54
1633615|NCT00819585|3990289|P2|STARTED|Core Study||54
1633616|NCT00819585|3990290|P1|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
1633617|NCT00819507|3990361|P1|NOT COMPLETED|Overall Study||0
1633618|NCT00819507|3990361|P1|COMPLETED|Overall Study||25
1633619|NCT00819507|3990361|P1|STARTED|Overall Study||25
1633620|NCT00819403|3990368|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1633621|NCT00819403|3990369|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1633622|NCT00819403|3990368|P2|COMPLETED|Second Intervention (6 Weeks)||8
1633623|NCT00819403|3990369|P1|COMPLETED|Second Intervention (6 Weeks)||7
1633624|NCT00819403|3990368|P2|STARTED|Second Intervention (6 Weeks)||8
1633625|NCT00819403|3990369|P1|STARTED|Second Intervention (6 Weeks)||7
1633626|NCT00819403|3990368|P2|NOT COMPLETED|Washout (14 Days)||0
1633627|NCT00819403|3990369|P1|NOT COMPLETED|Washout (14 Days)||0
1633628|NCT00819403|3990368|P2|COMPLETED|Washout (14 Days)||8
1633629|NCT00819403|3990369|P1|COMPLETED|Washout (14 Days)||7
1633630|NCT00819403|3990368|P2|STARTED|Washout (14 Days)||8
1633631|NCT00819403|3990369|P1|STARTED|Washout (14 Days)||7
1633632|NCT00819403|3990368|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
1633633|NCT00819403|3990369|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
1633634|NCT00819403|3990368|P2|COMPLETED|First Intervention (6 Weeks)||8
1633635|NCT00819403|3990369|P1|COMPLETED|First Intervention (6 Weeks)||7
1633636|NCT00819403|3990368|P2|STARTED|First Intervention (6 Weeks)||8
1633637|NCT00819403|3990369|P1|STARTED|First Intervention (6 Weeks)||7
1633638|NCT00819390|3990381|P4|NOT COMPLETED|Overall Study||0
1633639|NCT00819390|3990382|P3|NOT COMPLETED|Overall Study||1
1633640|NCT00819390|3990383|P2|NOT COMPLETED|Overall Study||1
1633641|NCT00819390|3990384|P1|NOT COMPLETED|Overall Study||3
1633642|NCT00819390|3990381|P4|COMPLETED|Overall Study||19
1633643|NCT00819390|3990382|P3|COMPLETED|Overall Study||17
1633644|NCT00819390|3990383|P2|COMPLETED|Overall Study||16
1633645|NCT00819390|3990384|P1|COMPLETED|Overall Study||13
1633646|NCT00819390|3990381|P4|STARTED|Overall Study||19
1633647|NCT00819390|3990382|P3|STARTED|Overall Study||18
1633648|NCT00819390|3990383|P2|STARTED|Overall Study||17
1633649|NCT00819390|3990384|P1|STARTED|Overall Study||16
1633650|NCT00819286|3990496|P2|NOT COMPLETED|Overall Study||25
1633651|NCT00819286|3990497|P1|NOT COMPLETED|Overall Study||14
1633652|NCT00819286|3990496|P2|COMPLETED|Overall Study||45
1633653|NCT00819286|3990497|P1|COMPLETED|Overall Study||56
1633654|NCT00819286|3990496|P2|STARTED|Overall Study||70
1633655|NCT00819286|3990497|P1|STARTED|Overall Study||70
1633656|NCT00819260|3990505|P1|NOT COMPLETED|Overall Study||0
1633657|NCT00819260|3990505|P1|COMPLETED|Overall Study||31
1633658|NCT00819260|3990505|P1|STARTED|Overall Study||31
1633659|NCT00819247|3990520|P3|NOT COMPLETED|Overall Study||14
1633660|NCT00819247|3990521|P2|NOT COMPLETED|Overall Study||16
1633661|NCT00819247|3990522|P1|NOT COMPLETED|Overall Study||11
1633662|NCT00819247|3990520|P3|COMPLETED|Overall Study||26
1633663|NCT00819247|3990521|P2|COMPLETED|Overall Study||30
1633664|NCT00819247|3990522|P1|COMPLETED|Overall Study||32
1633665|NCT00819247|3990520|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
1633666|NCT00819247|3990521|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
1633667|NCT00819247|3990522|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
1633668|NCT00819247|3990520|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
1633669|NCT00819247|3990521|P2|Intent-to-treat Population|Overall Study||46
1633670|NCT00819247|3990522|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
1633671|NCT00819247|3990520|P3|Randomized|Overall Study||40
1633672|NCT00819247|3990521|P2|Randomized|Overall Study||46
1633673|NCT00819247|3990522|P1|Randomized|Overall Study||43
1633674|NCT00819247|3990520|P3|STARTED|Overall Study||40
1633675|NCT00819247|3990521|P2|STARTED|Overall Study||46
1633676|NCT00819247|3990522|P1|STARTED|Overall Study||43
1633677|NCT00819234|3990548|P10|NOT COMPLETED|Overall Study||7
1633678|NCT00819234|3990549|P9|NOT COMPLETED|Overall Study||6
1633679|NCT00819234|3990550|P8|NOT COMPLETED|Overall Study||9
1633680|NCT00819234|3990551|P7|NOT COMPLETED|Overall Study||5
1633681|NCT00819234|3990552|P6|NOT COMPLETED|Overall Study||7
1633682|NCT00819234|3990553|P5|NOT COMPLETED|Overall Study||1
1633683|NCT00819234|3990554|P4|NOT COMPLETED|Overall Study||6
1633684|NCT00819234|3990555|P3|NOT COMPLETED|Overall Study||8
1633685|NCT00819234|3990556|P2|NOT COMPLETED|Overall Study||15
1633686|NCT00819234|3990557|P1|NOT COMPLETED|Overall Study||10
1633687|NCT00819234|3990548|P10|COMPLETED|Overall Study||30
1633688|NCT00819234|3990549|P9|COMPLETED|Overall Study||31
1633689|NCT00819234|3990550|P8|COMPLETED|Overall Study||20
1633690|NCT00819234|3990551|P7|COMPLETED|Overall Study||8
1633691|NCT00819234|3990552|P6|COMPLETED|Overall Study||7
1633692|NCT00819234|3990553|P5|COMPLETED|Overall Study||12
1633693|NCT00819234|3990554|P4|COMPLETED|Overall Study||22
1633694|NCT00819234|3990555|P3|COMPLETED|Overall Study||28
1633695|NCT00819234|3990556|P2|COMPLETED|Overall Study||20
1633696|NCT00819234|3990557|P1|COMPLETED|Overall Study||21
1633697|NCT00819234|3990548|P10|STARTED|Overall Study||37
1633698|NCT00819234|3990549|P9|STARTED|Overall Study||37
1633699|NCT00819234|3990550|P8|STARTED|Overall Study||29
1633700|NCT00819234|3990551|P7|STARTED|Overall Study||13
1633701|NCT00819234|3990552|P6|STARTED|Overall Study||14
1633702|NCT00819234|3990553|P5|STARTED|Overall Study||13
1633703|NCT00819234|3990554|P4|STARTED|Overall Study||28
1633704|NCT00819234|3990555|P3|STARTED|Overall Study||36
1633705|NCT00819234|3990556|P2|STARTED|Overall Study||35
1633706|NCT00819234|3990557|P1|STARTED|Overall Study||31
1633707|NCT00819182|3990718|P3|NOT COMPLETED|Overall Study||1
1633708|NCT00819182|3990719|P2|NOT COMPLETED|Overall Study||8
1633709|NCT00819182|3990720|P1|NOT COMPLETED|Overall Study||13
1633710|NCT00819182|3990718|P3|COMPLETED|Overall Study||43
1633711|NCT00819182|3990719|P2|COMPLETED|Overall Study||78
1633712|NCT00819182|3990720|P1|COMPLETED|Overall Study||75
1633713|NCT00819182|3990718|P3|Week 16 Visit|Overall Study||43
1633714|NCT00819182|3990719|P2|Week 16 Visit|Overall Study||78
1633715|NCT00819182|3990720|P1|Week 16 Visit|Overall Study||75
1633716|NCT00819182|3990718|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
1633717|NCT00819182|3990719|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
1633718|NCT00819182|3990720|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
1633719|NCT00819156|3990756|P6|NOT COMPLETED|Overall Study||8
1633720|NCT00819156|3990757|P5|NOT COMPLETED|Overall Study||6
1633721|NCT00819156|3990758|P4|NOT COMPLETED|Overall Study||2
1633722|NCT00819156|3990759|P3|NOT COMPLETED|Overall Study||6
1633723|NCT00819156|3990760|P2|NOT COMPLETED|Overall Study||10
1633724|NCT00819156|3990761|P1|NOT COMPLETED|Overall Study||10
1633725|NCT00819156|3990756|P6|COMPLETED|Overall Study||23
1633726|NCT00819156|3990757|P5|COMPLETED|Overall Study||27
1633727|NCT00819156|3990758|P4|COMPLETED|Overall Study||28
1633728|NCT00819156|3990759|P3|COMPLETED|Overall Study||26
1633729|NCT00819156|3990760|P2|COMPLETED|Overall Study||23
1633730|NCT00819156|3990761|P1|COMPLETED|Overall Study||20
1633731|NCT00819156|3990756|P6|Randomised and Treated (ITT Population)|Overall Study||30
1633732|NCT00819156|3990757|P5|Randomised and Treated (ITT Population)|Overall Study||33
1633733|NCT00819156|3990758|P4|Randomised and Treated (ITT Population)|Overall Study||30
1633734|NCT00819156|3990759|P3|Randomised and Treated (ITT Population)|Overall Study||32
1633735|NCT00819156|3990760|P2|Randomised and Treated (ITT Population)|Overall Study||32
1633736|NCT00819156|3990761|P1|Randomised and Treated (ITT Population)|Overall Study||30
1633737|NCT00819156|3990756|P6|STARTED|Overall Study||31
1633738|NCT00819156|3990757|P5|STARTED|Overall Study||33
1633739|NCT00819156|3990758|P4|STARTED|Overall Study||30
1633740|NCT00819156|3990759|P3|STARTED|Overall Study||32
1633741|NCT00819156|3990760|P2|STARTED|Overall Study||33
1633742|NCT00819156|3990761|P1|STARTED|Overall Study||30
1633743|NCT00819091|3990851|P2|NOT COMPLETED|Overall Study||10
1633744|NCT00819091|3990852|P1|NOT COMPLETED|Overall Study||7
1633745|NCT00819091|3990851|P2|COMPLETED|Overall Study||151
1633746|NCT00819091|3990852|P1|COMPLETED|Overall Study||77
1633747|NCT00819091|3990851|P2|STARTED|Overall Study||161
1633748|NCT00819091|3990852|P1|STARTED|Overall Study||84
1633749|NCT00819052|3990878|P2|NOT COMPLETED|Overall Study||14
1633750|NCT00819052|3990879|P1|NOT COMPLETED|Overall Study||6
1633751|NCT00819052|3990878|P2|COMPLETED|Overall Study||281
1633752|NCT00819052|3990879|P1|COMPLETED|Overall Study||142
1633753|NCT00819052|3990878|P2|STARTED|Overall Study||295
1633754|NCT00819052|3990879|P1|STARTED|Overall Study||148
1633755|NCT00819039|3990994|P3|NOT COMPLETED|Overall Study||1
1633756|NCT00819039|3990995|P2|NOT COMPLETED|Overall Study||0
1633757|NCT00819039|3990996|P1|NOT COMPLETED|Overall Study||2
1633758|NCT00819039|3990994|P3|COMPLETED|Overall Study||24
1633759|NCT00819039|3990995|P2|COMPLETED|Overall Study||27
1633760|NCT00819039|3990996|P1|COMPLETED|Overall Study||44
1633761|NCT00819039|3990994|P3|STARTED|Overall Study||25
1633762|NCT00819039|3990995|P2|STARTED|Overall Study||27
1633763|NCT00819039|3990996|P1|STARTED|Overall Study||46
1633764|NCT00819013|3991026|P4|NOT COMPLETED|Overall Study||4
1633765|NCT00819013|3991027|P3|NOT COMPLETED|Overall Study||5
1633766|NCT00819013|3991028|P2|NOT COMPLETED|Overall Study||1
1633767|NCT00819013|3991029|P1|NOT COMPLETED|Overall Study||3
1633768|NCT00819013|3991026|P4|COMPLETED|Overall Study||17
1633769|NCT00819013|3991027|P3|COMPLETED|Overall Study||16
1633770|NCT00819013|3991028|P2|COMPLETED|Overall Study||22
1633771|NCT00819013|3991029|P1|COMPLETED|Overall Study||19
1633772|NCT00819013|3991026|P4|STARTED|Overall Study||21
1633773|NCT00819013|3991027|P3|STARTED|Overall Study||21
1633774|NCT00819013|3991028|P2|STARTED|Overall Study||23
1633775|NCT00819013|3991029|P1|STARTED|Overall Study||22
1633776|NCT00818961|3991079|P1|NOT COMPLETED|Overall Study||0
1633777|NCT00818961|3991079|P1|COMPLETED|Overall Study||36
1633778|NCT00818961|3991079|P1|STARTED|Overall Study||36
1633779|NCT00818883|3991095|P2|NOT COMPLETED|Overall Study||46
1633780|NCT00818883|3991096|P1|NOT COMPLETED|Overall Study||51
1633781|NCT00818883|3991095|P2|COMPLETED|Overall Study||260
1633782|NCT00818883|3991096|P1|COMPLETED|Overall Study||252
1633783|NCT00818883|3991095|P2|STARTED|Overall Study||306
1633784|NCT00818883|3991096|P1|STARTED|Overall Study||303
1633785|NCT00818805|3991130|P2|NOT COMPLETED|Second Intervention||0
1633786|NCT00818805|3991131|P1|NOT COMPLETED|Second Intervention||0
1633787|NCT00818805|3991130|P2|COMPLETED|Second Intervention||25
1633788|NCT00818805|3991131|P1|COMPLETED|Second Intervention||25
1633789|NCT00818805|3991130|P2|STARTED|Second Intervention||25
1633790|NCT00818805|3991131|P1|STARTED|Second Intervention||25
1633791|NCT00818805|3991130|P2|NOT COMPLETED|First Intervention||0
1633792|NCT00818805|3991131|P1|NOT COMPLETED|First Intervention||0
1633793|NCT00818805|3991130|P2|COMPLETED|First Intervention||25
1633794|NCT00818805|3991131|P1|COMPLETED|First Intervention||25
1633795|NCT00818805|3991130|P2|STARTED|First Intervention||25
1633796|NCT00818805|3991131|P1|STARTED|First Intervention||25
1633797|NCT00818779|3991143|P2|NOT COMPLETED|Overall Study||1
1633798|NCT00818779|3991144|P1|NOT COMPLETED|Overall Study||6
1633799|NCT00818779|3991143|P2|COMPLETED|Overall Study||15
1633800|NCT00818779|3991144|P1|COMPLETED|Overall Study||16
1633801|NCT00818779|3991143|P2|STARTED|Overall Study||16
1633802|NCT00818779|3991144|P1|STARTED|Overall Study||22
1633803|NCT00818766|3991160|P2|NOT COMPLETED|Overall Study||10
1633804|NCT00818766|3991161|P1|NOT COMPLETED|Overall Study||15
1633805|NCT00818766|3991160|P2|COMPLETED|Overall Study||116
1633806|NCT00818766|3991161|P1|COMPLETED|Overall Study||110
1633807|NCT00818766|3991160|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
1633808|NCT00818766|3991161|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
1633809|NCT00818766|3991160|P2|Received Allocated Intervention|Overall Study||126
1633810|NCT00818766|3991161|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
1633811|NCT00818766|3991160|P2|STARTED|Overall Study||126
1633812|NCT00818766|3991161|P1|STARTED|Overall Study||125
1633813|NCT00818753|3991190|P3|NOT COMPLETED|Overall Study||1
1633814|NCT00818753|3991191|P2|NOT COMPLETED|Overall Study||0
1633815|NCT00818753|3991192|P1|NOT COMPLETED|Overall Study||3
1633816|NCT00818753|3991190|P3|COMPLETED|Overall Study||9
1633817|NCT00818753|3991191|P2|COMPLETED|Overall Study||21
1633818|NCT00818753|3991192|P1|COMPLETED|Overall Study||19
1633819|NCT00818753|3991190|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
1633820|NCT00818753|3991191|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
1633821|NCT00818753|3991192|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
1633822|NCT00818662|3991216|P4|NOT COMPLETED|Overall Study||16
1633823|NCT00818662|3991217|P3|NOT COMPLETED|Overall Study||9
1633824|NCT00818662|3991218|P2|NOT COMPLETED|Overall Study||33
1633825|NCT00818662|3991219|P1|NOT COMPLETED|Overall Study||23
1633826|NCT00818662|3991216|P4|COMPLETED|Overall Study||47
1633827|NCT00818662|3991217|P3|COMPLETED|Overall Study||49
1633828|NCT00818662|3991218|P2|COMPLETED|Overall Study||102
1633829|NCT00818662|3991219|P1|COMPLETED|Overall Study||104
1633830|NCT00818662|3991216|P4|STARTED|Overall Study||63
1633831|NCT00818662|3991217|P3|STARTED|Overall Study||58
1633832|NCT00818662|3991218|P2|STARTED|Overall Study||135
1633833|NCT00818662|3991219|P1|STARTED|Overall Study||127
1633834|NCT00818649|3991305|P1|NOT COMPLETED|Overall Study||4
1633835|NCT00818649|3991305|P1|COMPLETED|Overall Study||12
1633836|NCT00818649|3991305|P1|STARTED|Overall Study||16
1633837|NCT00818623|3991319|P8|NOT COMPLETED|Overall Study||1
1633838|NCT00818623|3991320|P7|NOT COMPLETED|Overall Study||4
1633839|NCT00818623|3991321|P6|NOT COMPLETED|Overall Study||3
1633840|NCT00818623|3991322|P5|NOT COMPLETED|Overall Study||4
1633841|NCT00818623|3991323|P4|NOT COMPLETED|Overall Study||5
1633842|NCT00818623|3991324|P3|NOT COMPLETED|Overall Study||4
1633843|NCT00818623|3991325|P2|NOT COMPLETED|Overall Study||4
1633844|NCT00818623|3991326|P1|NOT COMPLETED|Overall Study||2
1633845|NCT00818623|3991319|P8|COMPLETED|Overall Study||26
1633846|NCT00818623|3991320|P7|COMPLETED|Overall Study||23
1633847|NCT00818623|3991321|P6|COMPLETED|Overall Study||21
1633848|NCT00818623|3991322|P5|COMPLETED|Overall Study||23
1633849|NCT00818623|3991323|P4|COMPLETED|Overall Study||19
1633850|NCT00818623|3991324|P3|COMPLETED|Overall Study||9
1633851|NCT00818623|3991325|P2|COMPLETED|Overall Study||8
1633852|NCT00818623|3991326|P1|COMPLETED|Overall Study||24
1633853|NCT00818623|3991319|P8|Intent-to-treat (ITT) Population|Overall Study||27
1633854|NCT00818623|3991320|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
1633855|NCT00818623|3991321|P6|Intent-to-treat (ITT) Population|Overall Study||24
1633856|NCT00818623|3991322|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
1633857|NCT00818623|3991323|P4|Intent-to-treat (ITT) Population|Overall Study||24
1633858|NCT00818623|3991324|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
1633859|NCT00818623|3991325|P2|Intent-to-treat (ITT) Population|Overall Study||12
1633860|NCT00818623|3991326|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
1633861|NCT00818623|3991319|P8|STARTED|Overall Study||27
1633862|NCT00818623|3991320|P7|STARTED|Overall Study||27
1633863|NCT00818623|3991321|P6|STARTED|Overall Study||24
1633864|NCT00818623|3991322|P5|STARTED|Overall Study||27
1633865|NCT00818623|3991323|P4|STARTED|Overall Study||24
1633866|NCT00818623|3991324|P3|STARTED|Overall Study||13
1633867|NCT00818623|3991325|P2|STARTED|Overall Study||12
1633868|NCT00818623|3991326|P1|STARTED|Overall Study||26
1633869|NCT00818519|3991402|P2|NOT COMPLETED|Overall Study||19
1633870|NCT00818519|3991403|P1|NOT COMPLETED|Overall Study||14
1633871|NCT00818519|3991402|P2|COMPLETED|Overall Study||71
1633872|NCT00818519|3991403|P1|COMPLETED|Overall Study||75
1633873|NCT00818519|3991402|P2|Participants Received Treatment|Overall Study|= Baseline|86
1633874|NCT00818519|3991403|P1|Participants Received Treatment|Overall Study|= Baseline|87
1633875|NCT00818519|3991402|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
1633876|NCT00818519|3991403|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
1633877|NCT00818454|3991433|P4|NOT COMPLETED|Treatment Period 3||1
1633878|NCT00818454|3991434|P3|NOT COMPLETED|Treatment Period 3||0
1633879|NCT00818454|3991435|P2|NOT COMPLETED|Treatment Period 3||0
1633880|NCT00818454|3991436|P1|NOT COMPLETED|Treatment Period 3||0
1633881|NCT00818454|3991433|P4|COMPLETED|Treatment Period 3||138
1633882|NCT00818454|3991434|P3|COMPLETED|Treatment Period 3||26
1633883|NCT00818454|3991435|P2|COMPLETED|Treatment Period 3||0
1633884|NCT00818454|3991436|P1|COMPLETED|Treatment Period 3||0
1633885|NCT00818454|3991433|P4|STARTED|Treatment Period 3||139
1633886|NCT00818454|3991434|P3|STARTED|Treatment Period 3||26
1633887|NCT00818454|3991435|P2|STARTED|Treatment Period 3||0
1633888|NCT00818454|3991436|P1|STARTED|Treatment Period 3||0
1633889|NCT00818454|3991433|P4|NOT COMPLETED|Treatment Period 2||0
1633890|NCT00818454|3991434|P3|NOT COMPLETED|Treatment Period 2||0
1633891|NCT00818454|3991435|P2|NOT COMPLETED|Treatment Period 2||1
1633892|NCT00818454|3991436|P1|NOT COMPLETED|Treatment Period 2||2
1633893|NCT00818454|3991433|P4|COMPLETED|Treatment Period 2||0
1633894|NCT00818454|3991434|P3|COMPLETED|Treatment Period 2||0
1633895|NCT00818454|3991435|P2|COMPLETED|Treatment Period 2||106
1633896|NCT00818454|3991436|P1|COMPLETED|Treatment Period 2||106
1633897|NCT00818454|3991433|P4|STARTED|Treatment Period 2||0
1633898|NCT00818454|3991434|P3|STARTED|Treatment Period 2||0
1633899|NCT00818454|3991435|P2|STARTED|Treatment Period 2||107
1633900|NCT00818454|3991436|P1|STARTED|Treatment Period 2||108
1633901|NCT00818454|3991433|P4|NOT COMPLETED|Washout Period of 1 Week||0
1633902|NCT00818454|3991434|P3|NOT COMPLETED|Washout Period of 1 Week||0
1633903|NCT00818454|3991435|P2|NOT COMPLETED|Washout Period of 1 Week||3
1633904|NCT00818454|3991436|P1|NOT COMPLETED|Washout Period of 1 Week||4
1633905|NCT00818454|3991433|P4|COMPLETED|Washout Period of 1 Week||0
1633906|NCT00818454|3991434|P3|COMPLETED|Washout Period of 1 Week||0
1633907|NCT00818454|3991435|P2|COMPLETED|Washout Period of 1 Week||107
1633908|NCT00818454|3991436|P1|COMPLETED|Washout Period of 1 Week||108
1633909|NCT00818454|3991433|P4|STARTED|Washout Period of 1 Week||0
1633910|NCT00818454|3991434|P3|STARTED|Washout Period of 1 Week||0
1633911|NCT00818454|3991435|P2|STARTED|Washout Period of 1 Week||110
1633912|NCT00818454|3991436|P1|STARTED|Washout Period of 1 Week||112
1633913|NCT00818454|3991433|P4|NOT COMPLETED|Treatment Period 1||0
1633914|NCT00818454|3991434|P3|NOT COMPLETED|Treatment Period 1||0
1633915|NCT00818454|3991435|P2|NOT COMPLETED|Treatment Period 1||1
1633916|NCT00818454|3991436|P1|NOT COMPLETED|Treatment Period 1||3
1633917|NCT00818454|3991433|P4|COMPLETED|Treatment Period 1||0
1633918|NCT00818454|3991434|P3|COMPLETED|Treatment Period 1||0
1633919|NCT00818454|3991435|P2|COMPLETED|Treatment Period 1||110
1633920|NCT00818454|3991436|P1|COMPLETED|Treatment Period 1||112
1633921|NCT00818454|3991433|P4|STARTED|Treatment Period 1||0
1633922|NCT00818454|3991434|P3|STARTED|Treatment Period 1||0
1633923|NCT00818454|3991435|P2|STARTED|Treatment Period 1||111
1633924|NCT00818454|3991436|P1|STARTED|Treatment Period 1||115
1633925|NCT00818441|3991464|P2|NOT COMPLETED|Overall Study||30
1633926|NCT00818441|3991465|P1|NOT COMPLETED|Overall Study||89
1633927|NCT00818441|3991464|P2|COMPLETED|Overall Study||0
1633928|NCT00818441|3991465|P1|COMPLETED|Overall Study||0
1633929|NCT00818441|3991464|P2|STARTED|Overall Study||30
1633930|NCT00818441|3991465|P1|STARTED|Overall Study||89
1633931|NCT00818389|3991487|P2|NOT COMPLETED|Overall Study||6
1633932|NCT00818389|3991488|P1|NOT COMPLETED|Overall Study||4
1633933|NCT00818389|3991487|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
1633934|NCT00818389|3991488|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
1633935|NCT00818389|3991487|P2|STARTED|Overall Study||44
1633936|NCT00818389|3991488|P1|STARTED|Overall Study||40
1633937|NCT00818337|3991498|P1|NOT COMPLETED|Overall Study||0
1633938|NCT00818337|3991498|P1|COMPLETED|Overall Study||36
1633939|NCT00818337|3991498|P1|STARTED|Overall Study||36
1633940|NCT00818324|3991503|P1|NOT COMPLETED|Overall Study||27
1633941|NCT00818324|3991503|P1|COMPLETED|Overall Study||127
1633942|NCT00818324|3991503|P1|STARTED|Overall Study||154
1633943|NCT00818272|3991508|P1|NOT COMPLETED|Overall Study||74
1633944|NCT00818272|3991508|P1|COMPLETED|Overall Study||74
1633945|NCT00818272|3991508|P1|STARTED|Overall Study||148
1633946|NCT00818259|3991523|P9|NOT COMPLETED|Part V||0
1633947|NCT00818259|3991524|P8|NOT COMPLETED|Part V||1
1633948|NCT00818259|3991525|P7|NOT COMPLETED|Part V||0
1633949|NCT00818259|3991526|P6|NOT COMPLETED|Part V||0
1633950|NCT00818259|3991527|P5|NOT COMPLETED|Part V||0
1633951|NCT00818259|3991528|P4|NOT COMPLETED|Part V||0
1633952|NCT00818259|3991529|P3|NOT COMPLETED|Part V||0
1633953|NCT00818259|3991530|P2|NOT COMPLETED|Part V||0
1633954|NCT00818259|3991531|P1|NOT COMPLETED|Part V||0
1633955|NCT00818259|3991523|P9|COMPLETED|Part V||6
1633956|NCT00818259|3991524|P8|COMPLETED|Part V||16
1633957|NCT00818259|3991525|P7|COMPLETED|Part V||0
1633958|NCT00818259|3991526|P6|COMPLETED|Part V||0
1633959|NCT00818259|3991527|P5|COMPLETED|Part V||0
1633960|NCT00818259|3991528|P4|COMPLETED|Part V||0
1633961|NCT00818259|3991529|P3|COMPLETED|Part V||0
1633962|NCT00818259|3991530|P2|COMPLETED|Part V||0
1633963|NCT00818259|3991531|P1|COMPLETED|Part V||0
1633964|NCT00818259|3991523|P9|STARTED|Part V|Newly enrolled participants|6
1633965|NCT00818259|3991524|P8|STARTED|Part V|Participants continuing from Part IV|17
1633966|NCT00818259|3991525|P7|STARTED|Part V||0
1633967|NCT00818259|3991526|P6|STARTED|Part V||0
1633968|NCT00818259|3991527|P5|STARTED|Part V||0
1633969|NCT00818259|3991528|P4|STARTED|Part V||0
1633970|NCT00818259|3991529|P3|STARTED|Part V||0
1633971|NCT00818259|3991530|P2|STARTED|Part V||0
1633972|NCT00818259|3991531|P1|STARTED|Part V||0
1633973|NCT00818259|3991523|P9|NOT COMPLETED|Part IV||0
1633974|NCT00818259|3991524|P8|NOT COMPLETED|Part IV||0
1633975|NCT00818259|3991525|P7|NOT COMPLETED|Part IV||0
1633976|NCT00818259|3991526|P6|NOT COMPLETED|Part IV||1
1633977|NCT00818259|3991527|P5|NOT COMPLETED|Part IV||0
1633978|NCT00818259|3991528|P4|NOT COMPLETED|Part IV||0
1633979|NCT00818259|3991529|P3|NOT COMPLETED|Part IV||0
1633980|NCT00818259|3991530|P2|NOT COMPLETED|Part IV||0
1633981|NCT00818259|3991531|P1|NOT COMPLETED|Part IV||0
1633982|NCT00818259|3991523|P9|COMPLETED|Part IV||0
1633983|NCT00818259|3991524|P8|COMPLETED|Part IV||0
1633984|NCT00818259|3991525|P7|COMPLETED|Part IV||5
1633985|NCT00818259|3991526|P6|COMPLETED|Part IV||14
1633986|NCT00818259|3991527|P5|COMPLETED|Part IV||0
1633987|NCT00818259|3991528|P4|COMPLETED|Part IV||0
1633988|NCT00818259|3991529|P3|COMPLETED|Part IV||0
1633989|NCT00818259|3991530|P2|COMPLETED|Part IV||0
1633990|NCT00818259|3991531|P1|COMPLETED|Part IV||0
1633991|NCT00818259|3991523|P9|STARTED|Part IV||0
1633992|NCT00818259|3991524|P8|STARTED|Part IV||0
1633993|NCT00818259|3991525|P7|STARTED|Part IV|Newly enrolled participants|5
1633994|NCT00818259|3991526|P6|STARTED|Part IV|Participants continuing from Part III|15
1633995|NCT00818259|3991527|P5|STARTED|Part IV||0
1633996|NCT00818259|3991528|P4|STARTED|Part IV||0
1633997|NCT00818259|3991529|P3|STARTED|Part IV||0
1633998|NCT00818259|3991530|P2|STARTED|Part IV||0
1633999|NCT00818259|3991531|P1|STARTED|Part IV||0
1634000|NCT00818259|3991523|P9|NOT COMPLETED|Part III||0
1634001|NCT00818259|3991524|P8|NOT COMPLETED|Part III||0
1634002|NCT00818259|3991525|P7|NOT COMPLETED|Part III||0
1634003|NCT00818259|3991526|P6|NOT COMPLETED|Part III||0
1634004|NCT00818259|3991527|P5|NOT COMPLETED|Part III||0
1634005|NCT00818259|3991528|P4|NOT COMPLETED|Part III||0
1634006|NCT00818259|3991529|P3|NOT COMPLETED|Part III||0
1634007|NCT00818259|3991530|P2|NOT COMPLETED|Part III||0
1634008|NCT00818259|3991531|P1|NOT COMPLETED|Part III||0
1634009|NCT00818259|3991523|P9|COMPLETED|Part III||0
1634010|NCT00818259|3991524|P8|COMPLETED|Part III||0
1634011|NCT00818259|3991525|P7|COMPLETED|Part III||0
1634012|NCT00818259|3991526|P6|COMPLETED|Part III||0
1634013|NCT00818259|3991527|P5|COMPLETED|Part III||19
1634014|NCT00818259|3991528|P4|COMPLETED|Part III||0
1634015|NCT00818259|3991529|P3|COMPLETED|Part III||0
1634016|NCT00818259|3991530|P2|COMPLETED|Part III||0
1634017|NCT00818259|3991531|P1|COMPLETED|Part III||0
1634018|NCT00818259|3991523|P9|STARTED|Part III||0
1634019|NCT00818259|3991524|P8|STARTED|Part III||0
1634020|NCT00818259|3991525|P7|STARTED|Part III||0
1634021|NCT00818259|3991526|P6|STARTED|Part III||0
1634022|NCT00818259|3991527|P5|STARTED|Part III|Newly enrolled participants|19
1634023|NCT00818259|3991528|P4|STARTED|Part III||0
1634024|NCT00818259|3991529|P3|STARTED|Part III||0
1634025|NCT00818259|3991530|P2|STARTED|Part III||0
1634026|NCT00818259|3991531|P1|STARTED|Part III||0
1634027|NCT00818259|3991523|P9|NOT COMPLETED|Part II||0
1634028|NCT00818259|3991524|P8|NOT COMPLETED|Part II||0
1634029|NCT00818259|3991525|P7|NOT COMPLETED|Part II||0
1634030|NCT00818259|3991526|P6|NOT COMPLETED|Part II||0
1634031|NCT00818259|3991527|P5|NOT COMPLETED|Part II||0
1634032|NCT00818259|3991528|P4|NOT COMPLETED|Part II||2
1634033|NCT00818259|3991529|P3|NOT COMPLETED|Part II||1
1634034|NCT00818259|3991530|P2|NOT COMPLETED|Part II||0
1634035|NCT00818259|3991531|P1|NOT COMPLETED|Part II||0
1634036|NCT00818259|3991523|P9|COMPLETED|Part II||0
1634037|NCT00818259|3991524|P8|COMPLETED|Part II||0
1634038|NCT00818259|3991525|P7|COMPLETED|Part II||0
1634039|NCT00818259|3991526|P6|COMPLETED|Part II||0
1634040|NCT00818259|3991527|P5|COMPLETED|Part II||0
1634041|NCT00818259|3991528|P4|COMPLETED|Part II||18
1634042|NCT00818259|3991529|P3|COMPLETED|Part II||18
1634043|NCT00818259|3991530|P2|COMPLETED|Part II||0
1634044|NCT00818259|3991531|P1|COMPLETED|Part II||0
1634045|NCT00818259|3991523|P9|Treated|Part II||0
1634046|NCT00818259|3991524|P8|Treated|Part II||0
1634047|NCT00818259|3991525|P7|Treated|Part II||0
1634048|NCT00818259|3991526|P6|Treated|Part II||0
1634049|NCT00818259|3991527|P5|Treated|Part II||0
1634050|NCT00818259|3991528|P4|Treated|Part II||19
1634051|NCT00818259|3991529|P3|Treated|Part II||19
1634052|NCT00818259|3991530|P2|Treated|Part II||0
1634053|NCT00818259|3991531|P1|Treated|Part II||0
1634054|NCT00818259|3991523|P9|STARTED|Part II||0
1634055|NCT00818259|3991524|P8|STARTED|Part II||0
1634056|NCT00818259|3991525|P7|STARTED|Part II||0
1634057|NCT00818259|3991526|P6|STARTED|Part II||0
1634058|NCT00818259|3991527|P5|STARTED|Part II||0
1634059|NCT00818259|3991528|P4|STARTED|Part II|Newly enrolled participants|20
1634060|NCT00818259|3991529|P3|STARTED|Part II|Newly enrolled participants|19
1634061|NCT00818259|3991530|P2|STARTED|Part II||0
1634062|NCT00818259|3991531|P1|STARTED|Part II||0
1634063|NCT00818259|3991523|P9|NOT COMPLETED|Part I||0
1634064|NCT00818259|3991524|P8|NOT COMPLETED|Part I||0
1634065|NCT00818259|3991525|P7|NOT COMPLETED|Part I||0
1634066|NCT00818259|3991526|P6|NOT COMPLETED|Part I||0
1634067|NCT00818259|3991527|P5|NOT COMPLETED|Part I||0
1634068|NCT00818259|3991528|P4|NOT COMPLETED|Part I||0
1634069|NCT00818259|3991529|P3|NOT COMPLETED|Part I||0
1634070|NCT00818259|3991530|P2|NOT COMPLETED|Part I||0
1634071|NCT00818259|3991531|P1|NOT COMPLETED|Part I||1
1634072|NCT00818259|3991523|P9|COMPLETED|Part I||0
1634073|NCT00818259|3991524|P8|COMPLETED|Part I||0
1634074|NCT00818259|3991525|P7|COMPLETED|Part I||0
1634075|NCT00818259|3991526|P6|COMPLETED|Part I||0
1634076|NCT00818259|3991527|P5|COMPLETED|Part I||0
1634077|NCT00818259|3991528|P4|COMPLETED|Part I||0
1634078|NCT00818259|3991529|P3|COMPLETED|Part I||0
1634079|NCT00818259|3991530|P2|COMPLETED|Part I||11
1634080|NCT00818259|3991531|P1|COMPLETED|Part I||11
1634081|NCT00818259|3991523|P9|STARTED|Part I||0
1634082|NCT00818259|3991524|P8|STARTED|Part I||0
1634083|NCT00818259|3991525|P7|STARTED|Part I||0
1634084|NCT00818259|3991526|P6|STARTED|Part I||0
1634085|NCT00818259|3991527|P5|STARTED|Part I||0
1634086|NCT00818259|3991528|P4|STARTED|Part I||0
1634087|NCT00818259|3991529|P3|STARTED|Part I||0
1634088|NCT00818259|3991530|P2|STARTED|Part I|Newly enrolled participants|11
1634089|NCT00818259|3991531|P1|STARTED|Part I|Newly enrolled participants|12
1634090|NCT00818259|3991523|P9|NOT COMPLETED|Randomization||0
1634091|NCT00818259|3991524|P8|NOT COMPLETED|Randomization||0
1634092|NCT00818259|3991525|P7|NOT COMPLETED|Randomization||0
1634093|NCT00818259|3991526|P6|NOT COMPLETED|Randomization||0
1634094|NCT00818259|3991527|P5|NOT COMPLETED|Randomization||0
1634095|NCT00818259|3991528|P4|NOT COMPLETED|Randomization||0
1634096|NCT00818259|3991529|P3|NOT COMPLETED|Randomization||0
1634097|NCT00818259|3991530|P2|NOT COMPLETED|Randomization||0
1634098|NCT00818259|3991531|P1|NOT COMPLETED|Randomization||0
1634099|NCT00818259|3991523|P9|COMPLETED|Randomization||6
1634100|NCT00818259|3991524|P8|COMPLETED|Randomization||0
1634101|NCT00818259|3991525|P7|COMPLETED|Randomization||5
1634102|NCT00818259|3991526|P6|COMPLETED|Randomization||0
1634103|NCT00818259|3991527|P5|COMPLETED|Randomization||19
1634104|NCT00818259|3991528|P4|COMPLETED|Randomization||20
1634105|NCT00818259|3991529|P3|COMPLETED|Randomization||19
1634106|NCT00818259|3991530|P2|COMPLETED|Randomization||11
1634107|NCT00818259|3991531|P1|COMPLETED|Randomization||12
1634108|NCT00818259|3991523|P9|STARTED|Randomization||6
1634109|NCT00818259|3991524|P8|STARTED|Randomization||0
1634110|NCT00818259|3991525|P7|STARTED|Randomization||5
1634111|NCT00818259|3991526|P6|STARTED|Randomization||0
1634112|NCT00818259|3991527|P5|STARTED|Randomization||19
1634113|NCT00818259|3991528|P4|STARTED|Randomization||20
1634114|NCT00818259|3991529|P3|STARTED|Randomization||19
1634115|NCT00818259|3991530|P2|STARTED|Randomization||11
1634116|NCT00818259|3991531|P1|STARTED|Randomization||12
1634117|NCT00818246|3991603|P1|NOT COMPLETED|Overall Study||5
1634118|NCT00818246|3991603|P1|COMPLETED|Overall Study|split-face study|35
1634119|NCT00818246|3991603|P1|STARTED|Overall Study||40
1634120|NCT00818207|3991612|P2|NOT COMPLETED|Overall Study||267
1634121|NCT00818207|3991613|P1|NOT COMPLETED|Overall Study||222
1634122|NCT00818207|3991612|P2|COMPLETED|Overall Study||417
1634123|NCT00818207|3991613|P1|COMPLETED|Overall Study||474
1634124|NCT00818207|3991612|P2|STARTED|Overall Study||684
1634125|NCT00818207|3991613|P1|STARTED|Overall Study||696
1634126|NCT00818168|3991627|P1|NOT COMPLETED|Overall Study||70
1634127|NCT00818168|3991627|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
1634128|NCT00818168|3991627|P1|STARTED|Overall Study||320
1634129|NCT00818116|3991635|P1|NOT COMPLETED|Overall Study||0
1634130|NCT00818116|3991635|P1|COMPLETED|Overall Study||34
1634131|NCT00818116|3991635|P1|STARTED|Overall Study||34
1634132|NCT00817999|3991641|P2|NOT COMPLETED|No Grapefruit Juice||0
1634133|NCT00817999|3991642|P1|NOT COMPLETED|No Grapefruit Juice||0
1634134|NCT00817999|3991641|P2|COMPLETED|No Grapefruit Juice||17
1634135|NCT00817999|3991642|P1|COMPLETED|No Grapefruit Juice||15
1634136|NCT00817999|3991641|P2|STARTED|No Grapefruit Juice||17
1634137|NCT00817999|3991642|P1|STARTED|No Grapefruit Juice||15
1634138|NCT00817999|3991641|P2|NOT COMPLETED|Grapefruit Juice||0
1634139|NCT00817999|3991642|P1|NOT COMPLETED|Grapefruit Juice||0
1634140|NCT00817999|3991641|P2|COMPLETED|Grapefruit Juice||17
1634141|NCT00817999|3991642|P1|COMPLETED|Grapefruit Juice||15
1634142|NCT00817999|3991641|P2|STARTED|Grapefruit Juice||17
1634143|NCT00817999|3991642|P1|STARTED|Grapefruit Juice||15
1634144|NCT00817843|3991650|P2|NOT COMPLETED|Second Period (6 Weeks)||1
1634145|NCT00817843|3991651|P1|NOT COMPLETED|Second Period (6 Weeks)||0
1634146|NCT00817843|3991650|P2|COMPLETED|Second Period (6 Weeks)||44
1634147|NCT00817843|3991651|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
1634148|NCT00817843|3991650|P2|STARTED|Second Period (6 Weeks)||45
1634149|NCT00817843|3991651|P1|STARTED|Second Period (6 Weeks)||41
1634150|NCT00817843|3991650|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
1634151|NCT00817843|3991651|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
1634152|NCT00817843|3991650|P2|COMPLETED|Washout Period (6 Weeks)||45
1634153|NCT00817843|3991651|P1|COMPLETED|Washout Period (6 Weeks)||41
1634154|NCT00817843|3991650|P2|STARTED|Washout Period (6 Weeks)||46
1634155|NCT00817843|3991651|P1|STARTED|Washout Period (6 Weeks)||42
1634156|NCT00817843|3991650|P2|NOT COMPLETED|First Period (6 Weeks)||4
1634157|NCT00817843|3991651|P1|NOT COMPLETED|First Period (6 Weeks)||8
1634158|NCT00817843|3991650|P2|COMPLETED|First Period (6 Weeks)||46
1634159|NCT00817843|3991651|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
1634160|NCT00817843|3991650|P2|STARTED|First Period (6 Weeks)||50
1634161|NCT00817843|3991651|P1|STARTED|First Period (6 Weeks)||50
1634162|NCT00817804|3991658|P2|NOT COMPLETED|Overall Study||0
1634163|NCT00817804|3991659|P1|NOT COMPLETED|Overall Study||0
1634164|NCT00817804|3991658|P2|COMPLETED|Overall Study||2
1634165|NCT00817804|3991659|P1|COMPLETED|Overall Study||1
1634166|NCT00817804|3991658|P2|STARTED|Overall Study||2
1634167|NCT00817804|3991659|P1|STARTED|Overall Study||1
1634168|NCT00817778|3991667|P2|NOT COMPLETED|Overall Study||3
1634169|NCT00817778|3991668|P1|NOT COMPLETED|Overall Study||3
1634170|NCT00817778|3991667|P2|COMPLETED|Overall Study||5
1634171|NCT00817778|3991668|P1|COMPLETED|Overall Study||16
1634172|NCT00817778|3991667|P2|STARTED|Overall Study||8
1634173|NCT00817778|3991668|P1|STARTED|Overall Study||19
1634174|NCT00817596|3991693|P1|NOT COMPLETED|Overall Study||48
1634175|NCT00817596|3991693|P1|COMPLETED|Overall Study||62
1634176|NCT00817596|3991693|P1|STARTED|Overall Study||110
1634177|NCT00817531|3991697|P1|NOT COMPLETED|Overall Study||2
1634178|NCT00817531|3991697|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
1634179|NCT00817531|3991697|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
1634180|NCT00817479|3991703|P2|NOT COMPLETED|Overall Study||1
1634181|NCT00817479|3991704|P1|NOT COMPLETED|Overall Study||1
1634182|NCT00817479|3991703|P2|COMPLETED|Overall Study||13
1634183|NCT00817479|3991704|P1|COMPLETED|Overall Study||5
1634184|NCT00817479|3991703|P2|STARTED|Overall Study||14
1634185|NCT00817479|3991704|P1|STARTED|Overall Study||6
1634186|NCT00817336|3991714|P2|NOT COMPLETED|Overall Study||1
1634187|NCT00817336|3991715|P1|NOT COMPLETED|Overall Study||1
1634188|NCT00817336|3991714|P2|COMPLETED|Overall Study||7
1634189|NCT00817336|3991715|P1|COMPLETED|Overall Study||7
1634190|NCT00817336|3991714|P2|STARTED|Overall Study||8
1634191|NCT00817336|3991715|P1|STARTED|Overall Study||8
1634192|NCT00817219|3991726|P1|NOT COMPLETED|Overall Study||0
1634193|NCT00817219|3991726|P1|COMPLETED|Overall Study||33
1634194|NCT00817219|3991726|P1|STARTED|Overall Study||33
1634195|NCT00817206|3991741|P2|NOT COMPLETED|Overall Study||9
1634196|NCT00817206|3991742|P1|NOT COMPLETED|Overall Study||21
1634197|NCT00817206|3991741|P2|COMPLETED|Overall Study||154
1634198|NCT00817206|3991742|P1|COMPLETED|Overall Study||142
1634199|NCT00817206|3991741|P2|STARTED|Overall Study||163
1634200|NCT00817206|3991742|P1|STARTED|Overall Study||163
1634201|NCT00817063|3991750|P2|NOT COMPLETED|Overall Study||170
1634202|NCT00817063|3991751|P1|NOT COMPLETED|Overall Study||137
1634203|NCT00817063|3991750|P2|COMPLETED|Overall Study||128
1634204|NCT00817063|3991751|P1|COMPLETED|Overall Study||161
1634205|NCT00817063|3991750|P2|STARTED|Overall Study||298
1634206|NCT00817063|3991751|P1|STARTED|Overall Study||298
1634207|NCT00816907|3991795|P2|NOT COMPLETED|Overall Study||17
1634208|NCT00816907|3991796|P1|NOT COMPLETED|Overall Study||13
1634209|NCT00816907|3991795|P2|COMPLETED|Overall Study||58
1634210|NCT00816907|3991796|P1|COMPLETED|Overall Study||58
1634211|NCT00816907|3991795|P2|STARTED|Overall Study||75
1634212|NCT00816907|3991796|P1|STARTED|Overall Study||71
1634213|NCT00816829|3991818|P2|NOT COMPLETED|Overall Study||0
1634214|NCT00816829|3991819|P1|NOT COMPLETED|Overall Study||0
1634215|NCT00816829|3991818|P2|COMPLETED|Overall Study||18
1634216|NCT00816829|3991819|P1|COMPLETED|Overall Study||16
1634217|NCT00816829|3991818|P2|STARTED|Overall Study||18
1634218|NCT00816829|3991819|P1|STARTED|Overall Study||16
1634219|NCT00816777|3991845|P2|NOT COMPLETED|Overall Study||0
1634220|NCT00816777|3991846|P1|NOT COMPLETED|Overall Study||0
1634221|NCT00816777|3991845|P2|COMPLETED|Overall Study||2
1634222|NCT00816777|3991846|P1|COMPLETED|Overall Study||2
1634223|NCT00816777|3991845|P2|STARTED|Overall Study||2
1634224|NCT00816777|3991846|P1|STARTED|Overall Study||2
1634225|NCT00816595|3991868|P2|NOT COMPLETED|Overall Study||0
1634226|NCT00816595|3991869|P1|NOT COMPLETED|Overall Study||2
1634227|NCT00816595|3991868|P2|COMPLETED|Overall Study||33
1634228|NCT00816595|3991869|P1|COMPLETED|Overall Study||33
1634229|NCT00816595|3991868|P2|STARTED|Overall Study||33
1634230|NCT00816595|3991869|P1|STARTED|Overall Study||35
1634231|NCT00816556|3991882|P3|NOT COMPLETED|Overall Study||3
1634232|NCT00816556|3991883|P2|NOT COMPLETED|Overall Study||2
1634233|NCT00816556|3991884|P1|NOT COMPLETED|Overall Study||2
1634234|NCT00816556|3991882|P3|COMPLETED|Overall Study||19
1634235|NCT00816556|3991883|P2|COMPLETED|Overall Study||19
1634236|NCT00816556|3991884|P1|COMPLETED|Overall Study||18
1634237|NCT00816556|3991882|P3|STARTED|Overall Study||22
1634238|NCT00816556|3991883|P2|STARTED|Overall Study||21
1634239|NCT00816556|3991884|P1|STARTED|Overall Study||20
1634240|NCT00816400|3991907|P9|NOT COMPLETED|Overall Study||6
1634241|NCT00816400|3991908|P8|NOT COMPLETED|Overall Study||5
1634242|NCT00816400|3991909|P7|NOT COMPLETED|Overall Study||2
1634243|NCT00816400|3991910|P6|NOT COMPLETED|Overall Study||3
1634244|NCT00816400|3991911|P5|NOT COMPLETED|Overall Study||2
1634245|NCT00816400|3991912|P4|NOT COMPLETED|Overall Study||3
1634246|NCT00816400|3991913|P3|NOT COMPLETED|Overall Study||5
1634247|NCT00816400|3991914|P2|NOT COMPLETED|Overall Study||3
1634248|NCT00816400|3991915|P1|NOT COMPLETED|Overall Study||2
1634249|NCT00816400|3991907|P9|COMPLETED|Overall Study||0
1634250|NCT00816400|3991908|P8|COMPLETED|Overall Study||1
1634251|NCT00816400|3991909|P7|COMPLETED|Overall Study||1
1634252|NCT00816400|3991910|P6|COMPLETED|Overall Study||0
1634253|NCT00816400|3991911|P5|COMPLETED|Overall Study||1
1634254|NCT00816400|3991912|P4|COMPLETED|Overall Study||0
1634255|NCT00816400|3991913|P3|COMPLETED|Overall Study||0
1634256|NCT00816400|3991914|P2|COMPLETED|Overall Study||0
1634257|NCT00816400|3991915|P1|COMPLETED|Overall Study||1
1634258|NCT00816400|3991907|P9|STARTED|Overall Study||6
1634259|NCT00816400|3991908|P8|STARTED|Overall Study||6
1634260|NCT00816400|3991909|P7|STARTED|Overall Study||3
1634261|NCT00816400|3991910|P6|STARTED|Overall Study||3
1634262|NCT00816400|3991911|P5|STARTED|Overall Study||3
1634263|NCT00816400|3991912|P4|STARTED|Overall Study||3
1634264|NCT00816400|3991913|P3|STARTED|Overall Study||5
1634265|NCT00816400|3991914|P2|STARTED|Overall Study||3
1634266|NCT00816400|3991915|P1|STARTED|Overall Study||3
1634267|NCT00816348|3992099|P1|NOT COMPLETED|Overall Study||0
1634268|NCT00816348|3992099|P1|COMPLETED|Overall Study||15
1634269|NCT00816348|3992099|P1|STARTED|Overall Study||15
1634270|NCT00816166|3992105|P2|NOT COMPLETED|Overall Study||12
1634271|NCT00816166|3992106|P1|NOT COMPLETED|Overall Study||10
1634272|NCT00816166|3992105|P2|COMPLETED|Overall Study||41
1634273|NCT00816166|3992106|P1|COMPLETED|Overall Study||49
1634274|NCT00816166|3992105|P2|ITT Population (Met Eligibility)|Overall Study||53
1634275|NCT00816166|3992106|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
1634276|NCT00816166|3992105|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
1634277|NCT00816166|3992106|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
1634278|NCT00816101|3992115|P3|NOT COMPLETED|Overall Study||0
1634279|NCT00816101|3992116|P2|NOT COMPLETED|Overall Study||0
1634280|NCT00816101|3992117|P1|NOT COMPLETED|Overall Study||0
1634281|NCT00816101|3992115|P3|COMPLETED|Overall Study||5
1634282|NCT00816101|3992116|P2|COMPLETED|Overall Study||8
1634283|NCT00816101|3992117|P1|COMPLETED|Overall Study||13
1634284|NCT00816101|3992115|P3|STARTED|Overall Study||5
1634285|NCT00816101|3992116|P2|STARTED|Overall Study||8
1634286|NCT00816101|3992117|P1|STARTED|Overall Study||13
1634287|NCT00816062|3992131|P1|NOT COMPLETED|Overall Study||127
1634288|NCT00816062|3992131|P1|COMPLETED|Overall Study||133
1634289|NCT00816062|3992131|P1|STARTED|Overall Study||260
1634290|NCT00816036|3992138|P2|NOT COMPLETED|Overall Study||108
1634291|NCT00816036|3992139|P1|NOT COMPLETED|Overall Study||176
1634292|NCT00816036|3992138|P2|COMPLETED|Overall Study||287
1634293|NCT00816036|3992139|P1|COMPLETED|Overall Study||327
1634294|NCT00816036|3992138|P2|STARTED|Overall Study||395
1634295|NCT00816036|3992139|P1|STARTED|Overall Study||503
1634296|NCT00816023|3992153|P4|NOT COMPLETED|Overall Study||12
1634297|NCT00816023|3992154|P3|NOT COMPLETED|Overall Study||9
1634298|NCT00816023|3992155|P2|NOT COMPLETED|Overall Study||6
1634299|NCT00816023|3992156|P1|NOT COMPLETED|Overall Study||9
1634300|NCT00816023|3992153|P4|COMPLETED|Overall Study||62
1634301|NCT00816023|3992154|P3|COMPLETED|Overall Study||60
1634302|NCT00816023|3992155|P2|COMPLETED|Overall Study||56
1634303|NCT00816023|3992156|P1|COMPLETED|Overall Study||62
1634304|NCT00816023|3992153|P4|Completed Therapy|Overall Study||63
1634305|NCT00816023|3992154|P3|Completed Therapy|Overall Study||61
1634306|NCT00816023|3992155|P2|Completed Therapy|Overall Study||59
1634307|NCT00816023|3992156|P1|Completed Therapy|Overall Study||65
1634308|NCT00816023|3992153|P4|STARTED|Overall Study||74
1634309|NCT00816023|3992154|P3|STARTED|Overall Study||69
1634310|NCT00816023|3992155|P2|STARTED|Overall Study||62
1634311|NCT00816023|3992156|P1|STARTED|Overall Study||71
1634312|NCT00815919|3992170|P1|NOT COMPLETED|Overall Study||4
1634313|NCT00815919|3992170|P1|COMPLETED|Overall Study||18
1634314|NCT00815919|3992170|P1|STARTED|Overall Study||22
1634315|NCT00815776|3992181|P3|NOT COMPLETED|Overall Study||6
1634316|NCT00815776|3992182|P2|NOT COMPLETED|Overall Study||8
1634317|NCT00815776|3992183|P1|NOT COMPLETED|Overall Study||8
1634318|NCT00815776|3992181|P3|COMPLETED|Overall Study||22
1634319|NCT00815776|3992182|P2|COMPLETED|Overall Study||56
1634320|NCT00815776|3992183|P1|COMPLETED|Overall Study||52
1634321|NCT00815776|3992181|P3|STARTED|Overall Study||28
1634322|NCT00815776|3992182|P2|STARTED|Overall Study||64
1634323|NCT00815776|3992183|P1|STARTED|Overall Study||60
1634324|NCT00815698|3992199|P2|NOT COMPLETED|Overall Study||0
1634325|NCT00815698|3992200|P1|NOT COMPLETED|Overall Study||0
1634326|NCT00815698|3992199|P2|COMPLETED|Overall Study||171
1634327|NCT00815698|3992200|P1|COMPLETED|Overall Study||163
1634328|NCT00815698|3992199|P2|STARTED|Overall Study||171
1634329|NCT00815698|3992200|P1|STARTED|Overall Study||163
1634330|NCT00815685|3992208|P1|NOT COMPLETED|Overall Study||22
1634331|NCT00815685|3992208|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
1634332|NCT00815685|3992208|P1|STARTED|Overall Study||36
1634333|NCT00815659|3992213|P1|NOT COMPLETED|Overall Study||23
1634334|NCT00815659|3992213|P1|COMPLETED|Overall Study||74
1634335|NCT00815659|3992213|P1|STARTED|Overall Study||97
1634336|NCT00815633|3992256|P1|NOT COMPLETED|Overall Study||1
1634337|NCT00815633|3992256|P1|COMPLETED|Overall Study||0
1634338|NCT00815633|3992256|P1|STARTED|Overall Study||1
1634339|NCT00815516|3992263|P2|NOT COMPLETED|Overall Study||1
1634340|NCT00815516|3992264|P1|NOT COMPLETED|Overall Study||4
1634341|NCT00815516|3992263|P2|COMPLETED|Overall Study||9
1634342|NCT00815516|3992264|P1|COMPLETED|Overall Study||16
1634343|NCT00815516|3992263|P2|STARTED|Overall Study||10
1634344|NCT00815516|3992264|P1|STARTED|Overall Study||20
1634345|NCT00815490|3992295|P2|NOT COMPLETED|Overall Study||0
1634346|NCT00815490|3992296|P1|NOT COMPLETED|Overall Study||0
1634347|NCT00815490|3992295|P2|COMPLETED|Overall Study||9
1634348|NCT00815490|3992296|P1|COMPLETED|Overall Study||9
1634349|NCT00815490|3992295|P2|STARTED|Overall Study||9
1634350|NCT00815490|3992296|P1|STARTED|Overall Study||9
1634351|NCT00815360|3992304|P2|NOT COMPLETED|Overall Study||0
1634352|NCT00815360|3992305|P1|NOT COMPLETED|Overall Study||0
1634353|NCT00815360|3992304|P2|COMPLETED|Overall Study||11
1634354|NCT00815360|3992305|P1|COMPLETED|Overall Study||11
1634355|NCT00815360|3992304|P2|STARTED|Overall Study||11
1634356|NCT00815360|3992305|P1|STARTED|Overall Study||11
1634357|NCT00815347|3992313|P1|NOT COMPLETED|Overall Study||4
1634358|NCT00815347|3992313|P1|COMPLETED|Overall Study||7
1634359|NCT00815347|3992313|P1|STARTED|Overall Study||11
1634360|NCT00815308|3992329|P1|NOT COMPLETED|Overall Study||10
1634361|NCT00815308|3992329|P1|COMPLETED|Overall Study||45
1634362|NCT00815308|3992329|P1|STARTED|Overall Study||55
1634363|NCT00815295|3992338|P3|NOT COMPLETED|Overall Study||3
1634364|NCT00815295|3992339|P2|NOT COMPLETED|Overall Study||1
1634365|NCT00815295|3992340|P1|NOT COMPLETED|Overall Study||0
1634366|NCT00815295|3992338|P3|COMPLETED|Overall Study||9
1634367|NCT00815295|3992339|P2|COMPLETED|Overall Study||7
1634368|NCT00815295|3992340|P1|COMPLETED|Overall Study||8
1634369|NCT00815295|3992338|P3|STARTED|Overall Study||12
1634370|NCT00815295|3992339|P2|STARTED|Overall Study||8
1634371|NCT00815295|3992340|P1|STARTED|Overall Study||8
1634372|NCT00815191|3992352|P2|NOT COMPLETED|Overall Study||1
1634373|NCT00815191|3992353|P1|NOT COMPLETED|Overall Study||1
1634374|NCT00815191|3992352|P2|COMPLETED|Overall Study||34
1634375|NCT00815191|3992353|P1|COMPLETED|Overall Study||37
1634376|NCT00815191|3992352|P2|STARTED|Overall Study||35
1634377|NCT00815191|3992353|P1|STARTED|Overall Study||38
1634378|NCT00815087|3992361|P2|NOT COMPLETED|Overall Study||0
1634379|NCT00815087|3992362|P1|NOT COMPLETED|Overall Study||0
1634380|NCT00815087|3992361|P2|COMPLETED|Overall Study||10
1634381|NCT00815087|3992362|P1|COMPLETED|Overall Study||10
1634382|NCT00815087|3992361|P2|STARTED|Overall Study||10
1634383|NCT00815087|3992362|P1|STARTED|Overall Study||10
1634384|NCT00815035|3992370|P3|NOT COMPLETED|Open Label Extension Phase||6
1634385|NCT00815035|3992371|P2|NOT COMPLETED|Open Label Extension Phase||0
1634386|NCT00815035|3992372|P1|NOT COMPLETED|Open Label Extension Phase||0
1634387|NCT00815035|3992370|P3|COMPLETED|Open Label Extension Phase||9
1634388|NCT00815035|3992371|P2|COMPLETED|Open Label Extension Phase||0
1634389|NCT00815035|3992372|P1|COMPLETED|Open Label Extension Phase||0
1634390|NCT00815035|3992370|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
1634391|NCT00815035|3992371|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
1634392|NCT00815035|3992372|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
1634393|NCT00815035|3992370|P3|NOT COMPLETED|Blinded Phase||0
1634394|NCT00815035|3992371|P2|NOT COMPLETED|Blinded Phase||0
1634395|NCT00815035|3992372|P1|NOT COMPLETED|Blinded Phase||1
1634396|NCT00815035|3992370|P3|COMPLETED|Blinded Phase||0
1634397|NCT00815035|3992371|P2|COMPLETED|Blinded Phase||6
1634398|NCT00815035|3992372|P1|COMPLETED|Blinded Phase||9
1634399|NCT00815035|3992370|P3|STARTED|Blinded Phase||0
1634400|NCT00815035|3992371|P2|STARTED|Blinded Phase||6
1634401|NCT00815035|3992372|P1|STARTED|Blinded Phase||10
1634402|NCT00814983|3992390|P2|NOT COMPLETED|Overall Study||0
1634403|NCT00814983|3992391|P1|NOT COMPLETED|Overall Study||3
1634404|NCT00814983|3992390|P2|COMPLETED|Overall Study||0
1634405|NCT00814983|3992391|P1|COMPLETED|Overall Study||12
1634406|NCT00814983|3992390|P2|STARTED|Overall Study||0
1634407|NCT00814983|3992391|P1|STARTED|Overall Study||15
1634408|NCT00814970|3992401|P1|NOT COMPLETED|Overall Study||50
1634409|NCT00814970|3992401|P1|COMPLETED|Overall Study||146
1634410|NCT00814970|3992401|P1|STARTED|Overall Study||196
1634411|NCT00814892|3992422|P1|NOT COMPLETED|Overall Study||2
1634412|NCT00814892|3992422|P1|COMPLETED|Overall Study||0
1634413|NCT00814892|3992422|P1|STARTED|Overall Study||2
1634414|NCT00814879|3992434|P2|NOT COMPLETED|By Week 48||3
1634415|NCT00814879|3992435|P1|NOT COMPLETED|By Week 48||2
1634416|NCT00814879|3992434|P2|COMPLETED|By Week 48||26
1634417|NCT00814879|3992435|P1|COMPLETED|By Week 48||25
1634418|NCT00814879|3992434|P2|STARTED|By Week 48||29
1634419|NCT00814879|3992435|P1|STARTED|By Week 48||27
1634420|NCT00814879|3992434|P2|NOT COMPLETED|By Week 24||1
1634421|NCT00814879|3992435|P1|NOT COMPLETED|By Week 24||1
1634422|NCT00814879|3992434|P2|COMPLETED|By Week 24||29
1634423|NCT00814879|3992435|P1|COMPLETED|By Week 24||27
1634424|NCT00814879|3992434|P2|STARTED|By Week 24||30
1634425|NCT00814879|3992435|P1|STARTED|By Week 24||28
1634426|NCT00814801|3992454|P3|NOT COMPLETED|Overall Study||43
1634427|NCT00814801|3992455|P2|NOT COMPLETED|Overall Study||38
1634428|NCT00814801|3992456|P1|NOT COMPLETED|Overall Study||34
1634429|NCT00814801|3992454|P3|COMPLETED|Overall Study||151
1634430|NCT00814801|3992455|P2|COMPLETED|Overall Study||154
1634431|NCT00814801|3992456|P1|COMPLETED|Overall Study||160
1634432|NCT00814801|3992454|P3|STARTED|Overall Study||194
1634433|NCT00814801|3992455|P2|STARTED|Overall Study||192
1634434|NCT00814801|3992456|P1|STARTED|Overall Study||194
1634435|NCT00814788|3992476|P1|NOT COMPLETED|Overall Study||0
1634436|NCT00814788|3992476|P1|COMPLETED|Overall Study||24
1634437|NCT00814788|3992476|P1|STARTED|Overall Study||24
1634438|NCT00814775|3992484|P2|NOT COMPLETED|Overall Study||0
1634439|NCT00814775|3992485|P1|NOT COMPLETED|Overall Study||0
1634440|NCT00814775|3992484|P2|COMPLETED|Overall Study||20
1634441|NCT00814775|3992485|P1|COMPLETED|Overall Study||23
1634442|NCT00814775|3992484|P2|STARTED|Overall Study||20
1634443|NCT00814775|3992485|P1|STARTED|Overall Study||23
1634444|NCT00814710|3992495|P2|NOT COMPLETED|Overall Study||3
1634445|NCT00814710|3992496|P1|NOT COMPLETED|Overall Study||8
1634446|NCT00814710|3992495|P2|COMPLETED|Overall Study||117
1634447|NCT00814710|3992496|P1|COMPLETED|Overall Study||232
1634448|NCT00814710|3992495|P2|STARTED|Overall Study||120
1634449|NCT00814710|3992496|P1|STARTED|Overall Study||240
1634450|NCT00814697|3992534|P1|NOT COMPLETED|Overall Study||0
1634451|NCT00814697|3992534|P1|COMPLETED|Overall Study||12
1634452|NCT00814697|3992534|P1|STARTED|Overall Study||12
1634453|NCT00814671|3992541|P3|NOT COMPLETED|Overall Study||2
1634454|NCT00814671|3992542|P2|NOT COMPLETED|Overall Study||4
1634455|NCT00814671|3992543|P1|NOT COMPLETED|Overall Study||7
1634456|NCT00814671|3992541|P3|COMPLETED|Overall Study||49
1634457|NCT00814671|3992542|P2|COMPLETED|Overall Study||44
1634458|NCT00814671|3992543|P1|COMPLETED|Overall Study||47
1634459|NCT00814671|3992541|P3|STARTED|Overall Study||51
1634460|NCT00814671|3992542|P2|STARTED|Overall Study||48
1634461|NCT00814671|3992543|P1|STARTED|Overall Study||54
1634462|NCT00814658|3992564|P2|NOT COMPLETED|Overall Study||4
1634463|NCT00814658|3992565|P1|NOT COMPLETED|Overall Study||4
1634464|NCT00814658|3992564|P2|COMPLETED|Overall Study||8
1634465|NCT00814658|3992565|P1|COMPLETED|Overall Study||5
1634466|NCT00814658|3992564|P2|STARTED|Overall Study||12
1634467|NCT00814658|3992565|P1|STARTED|Overall Study||9
1634468|NCT00814632|3992631|P1|NOT COMPLETED|Overall Study||2
1634469|NCT00814632|3992631|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
1634470|NCT00814632|3992631|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
1634471|NCT00814580|3992637|P2|NOT COMPLETED|Overall Study||47
1634472|NCT00814580|3992638|P1|NOT COMPLETED|Overall Study||31
1634473|NCT00814580|3992637|P2|COMPLETED|Overall Study||141
1634474|NCT00814580|3992638|P1|COMPLETED|Overall Study||163
1634475|NCT00814580|3992637|P2|STARTED|Overall Study||188
1634476|NCT00814580|3992638|P1|STARTED|Overall Study||194
1634477|NCT00814502|3992768|P2|NOT COMPLETED|Overall Study||2
1634478|NCT00814502|3992769|P1|NOT COMPLETED|Overall Study||1
1634479|NCT00814502|3992768|P2|COMPLETED|Overall Study||7
1634480|NCT00814502|3992769|P1|COMPLETED|Overall Study||7
1634481|NCT00814502|3992768|P2|STARTED|Overall Study||9
1634482|NCT00814502|3992769|P1|STARTED|Overall Study||8
1634483|NCT00814489|3992782|P3|NOT COMPLETED|Overall Study||1
1634484|NCT00814489|3992783|P2|NOT COMPLETED|Overall Study||0
1634485|NCT00814489|3992784|P1|NOT COMPLETED|Overall Study||2
1634486|NCT00814489|3992782|P3|COMPLETED|Overall Study||7
1634487|NCT00814489|3992783|P2|COMPLETED|Overall Study||17
1634488|NCT00814489|3992784|P1|COMPLETED|Overall Study||13
1634489|NCT00814489|3992782|P3|STARTED|Overall Study||8
1634490|NCT00814489|3992783|P2|STARTED|Overall Study||17
1634491|NCT00814489|3992784|P1|STARTED|Overall Study||15
1634492|NCT00814463|3992816|P1|NOT COMPLETED|Overall Study||1
1634493|NCT00814463|3992816|P1|COMPLETED|Overall Study||0
1634494|NCT00814463|3992816|P1|STARTED|Overall Study||1
1634495|NCT00814346|3992822|P2|NOT COMPLETED|Open Phase (17 Months)||0
1634496|NCT00814346|3992823|P1|NOT COMPLETED|Open Phase (17 Months)||10
1634497|NCT00814346|3992822|P2|COMPLETED|Open Phase (17 Months)||0
1634498|NCT00814346|3992823|P1|COMPLETED|Open Phase (17 Months)||31
1634499|NCT00814346|3992822|P2|AD|Open Phase (17 Months)||0
1634500|NCT00814346|3992823|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
1634501|NCT00814346|3992822|P2|MC|Open Phase (17 Months)||0
1634502|NCT00814346|3992823|P1|MC|Open Phase (17 Months)||20
1634503|NCT00814346|3992822|P2|CNE|Open Phase (17 Months)||0
1634504|NCT00814346|3992823|P1|CNE|Open Phase (17 Months)||21
1634505|NCT00814346|3992822|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
1634506|NCT00814346|3992823|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
1634507|NCT00814346|3992822|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
1634508|NCT00814346|3992823|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
1634509|NCT00814346|3992822|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
1634510|NCT00814346|3992823|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
1634511|NCT00814346|3992822|P2|AD|Double-blind Phase (4 Weeks)||2
1634512|NCT00814346|3992823|P1|AD|Double-blind Phase (4 Weeks)||3
1634513|NCT00814346|3992822|P2|MC|Double-blind Phase (4 Weeks)||11
1634514|NCT00814346|3992823|P1|MC|Double-blind Phase (4 Weeks)||10
1634515|NCT00814346|3992822|P2|CNE|Double-blind Phase (4 Weeks)||13
1634516|NCT00814346|3992823|P1|CNE|Double-blind Phase (4 Weeks)||10
1634517|NCT00814346|3992822|P2|STARTED|Double-blind Phase (4 Weeks)||26
1634518|NCT00814346|3992823|P1|STARTED|Double-blind Phase (4 Weeks)||23
1634519|NCT00814333|3992889|P2|NOT COMPLETED|Treatment Period||0
1634520|NCT00814333|3992890|P1|NOT COMPLETED|Treatment Period||0
1634521|NCT00814333|3992889|P2|COMPLETED|Treatment Period||0
1634522|NCT00814333|3992890|P1|COMPLETED|Treatment Period||0
1634523|NCT00814333|3992889|P2|STARTED|Treatment Period||0
1634524|NCT00814333|3992890|P1|STARTED|Treatment Period||0
1634525|NCT00814333|3992889|P2|NOT COMPLETED|Enrollment||0
1634526|NCT00814333|3992890|P1|NOT COMPLETED|Enrollment||1
1634527|NCT00814333|3992889|P2|COMPLETED|Enrollment||0
1634528|NCT00814333|3992890|P1|COMPLETED|Enrollment||0
1634529|NCT00814333|3992889|P2|STARTED|Enrollment||0
1634530|NCT00814333|3992890|P1|STARTED|Enrollment||1
1634531|NCT00814320|3992898|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
1634532|NCT00814320|3992899|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
1634533|NCT00814320|3992898|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
1634534|NCT00814320|3992899|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
1634535|NCT00814320|3992898|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
1634536|NCT00814320|3992899|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
1634537|NCT00814320|3992898|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
1634538|NCT00814320|3992899|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
1634539|NCT00814320|3992898|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
1634540|NCT00814320|3992899|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
1634541|NCT00814320|3992898|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
1634542|NCT00814320|3992899|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
1634543|NCT00814320|3992898|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
1634544|NCT00814320|3992899|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
1634545|NCT00814320|3992898|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
1634546|NCT00814320|3992899|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
1634547|NCT00814320|3992898|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
1634548|NCT00814320|3992899|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
1634549|NCT00814320|3992898|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
1634550|NCT00814320|3992899|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
1634551|NCT00814320|3992898|P2|COMPLETED|Epoch 1 (IV Treatment)||71
1634552|NCT00814320|3992899|P1|COMPLETED|Epoch 1 (IV Treatment)||13
1634553|NCT00814320|3992898|P2|STARTED|Epoch 1 (IV Treatment)||73
1634554|NCT00814320|3992899|P1|STARTED|Epoch 1 (IV Treatment)||14
1634555|NCT00814307|3993031|P4|NOT COMPLETED|Overall Study||10
1634556|NCT00814307|3993032|P3|NOT COMPLETED|Overall Study||7
1634557|NCT00814307|3993033|P2|NOT COMPLETED|Overall Study||27
1634558|NCT00814307|3993034|P1|NOT COMPLETED|Overall Study||12
1634559|NCT00814307|3993031|P4|COMPLETED|Overall Study||51
1634560|NCT00814307|3993032|P3|COMPLETED|Overall Study||54
1634561|NCT00814307|3993033|P2|COMPLETED|Overall Study||218
1634562|NCT00814307|3993034|P1|COMPLETED|Overall Study||232
1634563|NCT00814307|3993031|P4|Treated|Overall Study||61
1634564|NCT00814307|3993032|P3|Treated|Overall Study||61
1634565|NCT00814307|3993033|P2|Treated|Overall Study||245
1634566|NCT00814307|3993034|P1|Treated|Overall Study||243
1634567|NCT00814307|3993031|P4|STARTED|Overall Study||61
1634568|NCT00814307|3993032|P3|STARTED|Overall Study||61
1634569|NCT00814307|3993033|P2|STARTED|Overall Study||245
1634570|NCT00814307|3993034|P1|STARTED|Overall Study||244
1634571|NCT00814255|3993199|P3|NOT COMPLETED|Overall Study||1
1634572|NCT00814255|3993200|P2|NOT COMPLETED|Overall Study||0
1634573|NCT00814255|3993201|P1|NOT COMPLETED|Overall Study||1
1634574|NCT00814255|3993199|P3|COMPLETED|Overall Study||7
1634575|NCT00814255|3993200|P2|COMPLETED|Overall Study||7
1634576|NCT00814255|3993201|P1|COMPLETED|Overall Study||7
1634577|NCT00814255|3993199|P3|STARTED|Overall Study||8
1634578|NCT00814255|3993200|P2|STARTED|Overall Study||7
1634579|NCT00814255|3993201|P1|STARTED|Overall Study||8
1634580|NCT00814177|3993223|P2|NOT COMPLETED|Overall Study||0
1634581|NCT00814177|3993224|P1|NOT COMPLETED|Overall Study||0
1634582|NCT00814177|3993223|P2|COMPLETED|Overall Study||80
1634583|NCT00814177|3993224|P1|COMPLETED|Overall Study||80
1634584|NCT00814177|3993223|P2|STARTED|Overall Study||80
1634585|NCT00814177|3993224|P1|STARTED|Overall Study||80
1634586|NCT00814164|3993230|P1|NOT COMPLETED|Overall Study||19
1634587|NCT00814164|3993230|P1|COMPLETED|Overall Study||2
1634588|NCT00814164|3993230|P1|STARTED|Overall Study||21
1634589|NCT00814138|3993243|P2|NOT COMPLETED|Overall Study||7
1634590|NCT00814138|3993244|P1|NOT COMPLETED|Overall Study||1
1634591|NCT00814138|3993243|P2|COMPLETED|Overall Study||18
1634592|NCT00814138|3993244|P1|COMPLETED|Overall Study||24
1634593|NCT00814138|3993243|P2|STARTED|Overall Study||25
1634594|NCT00814138|3993244|P1|STARTED|Overall Study||25
1634595|NCT00813995|3993264|P2|NOT COMPLETED|Overall Study||16
1634596|NCT00813995|3993265|P1|NOT COMPLETED|Overall Study||23
1634597|NCT00813995|3993264|P2|COMPLETED|Overall Study||182
1634598|NCT00813995|3993265|P1|COMPLETED|Overall Study||174
1634599|NCT00813995|3993264|P2|STARTED|Overall Study||198
1634600|NCT00813995|3993265|P1|STARTED|Overall Study||197
1634601|NCT00813982|3993279|P1|NOT COMPLETED|Overall Study||0
1634602|NCT00813982|3993279|P1|COMPLETED|Overall Study||59
1634603|NCT00813982|3993279|P1|STARTED|Overall Study||59
1634604|NCT00813943|3993288|P3|NOT COMPLETED|Overall Study||3
1634605|NCT00813943|3993289|P2|NOT COMPLETED|Overall Study||5
1634606|NCT00813943|3993290|P1|NOT COMPLETED|Overall Study||5
1634607|NCT00813943|3993288|P3|COMPLETED|Overall Study||86
1634608|NCT00813943|3993289|P2|COMPLETED|Overall Study||83
1634609|NCT00813943|3993290|P1|COMPLETED|Overall Study||83
1634610|NCT00813943|3993288|P3|STARTED|Overall Study||89
1634611|NCT00813943|3993289|P2|STARTED|Overall Study||88
1634612|NCT00813943|3993290|P1|STARTED|Overall Study||88
1634613|NCT00813917|3993320|P2|NOT COMPLETED|Overall Study||6
1634614|NCT00813917|3993321|P1|NOT COMPLETED|Overall Study||6
1634615|NCT00813917|3993320|P2|COMPLETED|Overall Study||32
1634616|NCT00813917|3993321|P1|COMPLETED|Overall Study||32
1634617|NCT00813917|3993320|P2|STARTED|Overall Study||38
1634618|NCT00813917|3993321|P1|STARTED|Overall Study||38
1634619|NCT00813904|3993327|P1|NOT COMPLETED|Overall Study||1
1634620|NCT00813904|3993327|P1|COMPLETED|Overall Study||30
1634621|NCT00813904|3993327|P1|STARTED|Overall Study||31
1634622|NCT00813865|3993333|P1|NOT COMPLETED|Overall Study||7
1634623|NCT00813865|3993333|P1|COMPLETED|Overall Study||1
1634624|NCT00813865|3993333|P1|Pharmacodynamic (PD) Population|Overall Study||8
1634625|NCT00813865|3993333|P1|Safety Population|Overall Study||8
1634626|NCT00813865|3993333|P1|STARTED|Overall Study||8
1634627|NCT00813813|3993341|P2|NOT COMPLETED|Overall Study||9
1634628|NCT00813813|3993342|P1|NOT COMPLETED|Overall Study||3
1634629|NCT00813813|3993341|P2|COMPLETED|Overall Study||16
1634630|NCT00813813|3993342|P1|COMPLETED|Overall Study||4
1634631|NCT00813813|3993341|P2|STARTED|Overall Study||25
1634632|NCT00813813|3993342|P1|STARTED|Overall Study||7
1634633|NCT00813800|3993358|P1|NOT COMPLETED|Overall Study||6
1634634|NCT00813800|3993358|P1|COMPLETED|Overall Study||5
1634635|NCT00813800|3993358|P1|STARTED|Overall Study||11
1634636|NCT00813761|3993366|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
1634637|NCT00813761|3993367|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
1634638|NCT00813761|3993368|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
1634639|NCT00813761|3993369|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
1634640|NCT00813761|3993366|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
1634641|NCT00813761|3993367|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
1634642|NCT00813761|3993368|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
1634643|NCT00813761|3993369|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
1634644|NCT00813761|3993366|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
1634645|NCT00813761|3993367|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
1634646|NCT00813761|3993368|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
1634647|NCT00813761|3993369|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
1634648|NCT00813761|3993366|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
1634649|NCT00813761|3993367|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
1634650|NCT00813761|3993368|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
1634651|NCT00813761|3993369|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
1634652|NCT00813761|3993366|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
1634653|NCT00813761|3993367|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
1634654|NCT00813761|3993368|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
1634655|NCT00813761|3993369|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
1634656|NCT00813761|3993366|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
1634657|NCT00813761|3993367|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
1634658|NCT00813761|3993368|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
1634659|NCT00813761|3993369|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
1634660|NCT00813748|3993419|P2|NOT COMPLETED|Skin Test Substudy||1
1634661|NCT00813748|3993420|P1|NOT COMPLETED|Skin Test Substudy||0
1634662|NCT00813748|3993419|P2|COMPLETED|Skin Test Substudy||7
1634663|NCT00813748|3993420|P1|COMPLETED|Skin Test Substudy||3
1634664|NCT00813748|3993419|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
1634665|NCT00813748|3993420|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
1634666|NCT00813748|3993419|P2|NOT COMPLETED|Main Observational Study||0
1634667|NCT00813748|3993420|P1|NOT COMPLETED|Main Observational Study||0
1634668|NCT00813748|3993419|P2|COMPLETED|Main Observational Study||88
1634669|NCT00813748|3993420|P1|COMPLETED|Main Observational Study||30
1634670|NCT00813748|3993419|P2|STARTED|Main Observational Study||88
1634671|NCT00813748|3993420|P1|STARTED|Main Observational Study||30
1634672|NCT00813709|3993449|P6|NOT COMPLETED|Open Label Period||11
1634673|NCT00813709|3993450|P5|NOT COMPLETED|Open Label Period||10
1634674|NCT00813709|3993451|P4|NOT COMPLETED|Open Label Period||20
1634675|NCT00813709|3993452|P3|NOT COMPLETED|Open Label Period||0
1634676|NCT00813709|3993453|P2|NOT COMPLETED|Open Label Period||0
1634677|NCT00813709|3993454|P1|NOT COMPLETED|Open Label Period||0
1634678|NCT00813709|3993449|P6|COMPLETED|Open Label Period||35
1634679|NCT00813709|3993450|P5|COMPLETED|Open Label Period||41
1634680|NCT00813709|3993451|P4|COMPLETED|Open Label Period||38
1634681|NCT00813709|3993452|P3|COMPLETED|Open Label Period||0
1634682|NCT00813709|3993453|P2|COMPLETED|Open Label Period||0
1634683|NCT00813709|3993454|P1|COMPLETED|Open Label Period||0
1634684|NCT00813709|3993449|P6|Treated|Open Label Period||45
1634685|NCT00813709|3993450|P5|Treated|Open Label Period||51
1634686|NCT00813709|3993451|P4|Treated|Open Label Period||57
1634687|NCT00813709|3993452|P3|Treated|Open Label Period||0
1634688|NCT00813709|3993453|P2|Treated|Open Label Period||0
1634689|NCT00813709|3993454|P1|Treated|Open Label Period||0
1634690|NCT00813709|3993449|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
1634691|NCT00813709|3993450|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
1634692|NCT00813709|3993451|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
1634693|NCT00813709|3993452|P3|STARTED|Open Label Period||0
1634694|NCT00813709|3993453|P2|STARTED|Open Label Period||0
1634695|NCT00813709|3993454|P1|STARTED|Open Label Period||0
1634696|NCT00813709|3993449|P6|NOT COMPLETED|Double Blind Period||0
1634697|NCT00813709|3993450|P5|NOT COMPLETED|Double Blind Period||0
1634698|NCT00813709|3993451|P4|NOT COMPLETED|Double Blind Period||0
1634699|NCT00813709|3993452|P3|NOT COMPLETED|Double Blind Period||31
1634700|NCT00813709|3993453|P2|NOT COMPLETED|Double Blind Period||41
1634701|NCT00813709|3993454|P1|NOT COMPLETED|Double Blind Period||31
1634702|NCT00813709|3993449|P6|COMPLETED|Double Blind Period||0
1634703|NCT00813709|3993450|P5|COMPLETED|Double Blind Period||0
1634704|NCT00813709|3993451|P4|COMPLETED|Double Blind Period||0
1634705|NCT00813709|3993452|P3|COMPLETED|Double Blind Period||68
1634706|NCT00813709|3993453|P2|COMPLETED|Double Blind Period||76
1634707|NCT00813709|3993454|P1|COMPLETED|Double Blind Period||53
1634708|NCT00813709|3993449|P6|Treated|Double Blind Period||0
1634709|NCT00813709|3993450|P5|Treated|Double Blind Period||0
1634710|NCT00813709|3993451|P4|Treated|Double Blind Period||0
1634711|NCT00813709|3993452|P3|Treated|Double Blind Period||98
1634712|NCT00813709|3993453|P2|Treated|Double Blind Period||114
1634713|NCT00813709|3993454|P1|Treated|Double Blind Period||83
1634714|NCT00813709|3993449|P6|STARTED|Double Blind Period||0
1634715|NCT00813709|3993450|P5|STARTED|Double Blind Period||0
1634716|NCT00813709|3993451|P4|STARTED|Double Blind Period||0
1634717|NCT00813709|3993452|P3|STARTED|Double Blind Period||99
1634718|NCT00813709|3993453|P2|STARTED|Double Blind Period||117
1634719|NCT00813709|3993454|P1|STARTED|Double Blind Period||84
1634720|NCT00813592|3993534|P1|NOT COMPLETED|Overall Study||2
1634721|NCT00813592|3993534|P1|COMPLETED|Overall Study||0
1634722|NCT00813592|3993534|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
1634723|NCT00813592|3993534|P1|Treated|Overall Study|Two patients were treated.|2
1634724|NCT00813592|3993534|P1|STARTED|Overall Study||2
1634725|NCT00813488|3993543|P2|NOT COMPLETED|Open-label Extension||7
1634726|NCT00813488|3993544|P1|NOT COMPLETED|Open-label Extension||12
1634727|NCT00813488|3993543|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
1634728|NCT00813488|3993544|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
1634729|NCT00813488|3993543|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
1634730|NCT00813488|3993544|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
1634731|NCT00813488|3993543|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
1634732|NCT00813488|3993544|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
1634733|NCT00813488|3993543|P2|COMPLETED|Double-blind Treatment Period 2||65
1634734|NCT00813488|3993544|P1|COMPLETED|Double-blind Treatment Period 2||66
1634735|NCT00813488|3993543|P2|STARTED|Double-blind Treatment Period 2||66
1634736|NCT00813488|3993544|P1|STARTED|Double-blind Treatment Period 2||71
1634737|NCT00813488|3993543|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
1634738|NCT00813488|3993544|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
1634739|NCT00813488|3993543|P2|COMPLETED|Double-blind Treatment Period 1||66
1634740|NCT00813488|3993544|P1|COMPLETED|Double-blind Treatment Period 1||71
1634741|NCT00813488|3993543|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
1634742|NCT00813488|3993544|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
1634743|NCT00813488|3993543|P2|NOT COMPLETED|Titration Period 2||10
1634744|NCT00813488|3993544|P1|NOT COMPLETED|Titration Period 2||16
1634745|NCT00813488|3993543|P2|COMPLETED|Titration Period 2||79
1634746|NCT00813488|3993544|P1|COMPLETED|Titration Period 2||64
1634747|NCT00813488|3993543|P2|STARTED|Titration Period 2||89
1634748|NCT00813488|3993544|P1|STARTED|Titration Period 2||80
1634749|NCT00813488|3993543|P2|NOT COMPLETED|Titration Period 1||17
1634750|NCT00813488|3993544|P1|NOT COMPLETED|Titration Period 1||27
1634751|NCT00813488|3993543|P2|COMPLETED|Titration Period 1||89
1634752|NCT00813488|3993544|P1|COMPLETED|Titration Period 1||80
1634753|NCT00813488|3993543|P2|STARTED|Titration Period 1||106
1634754|NCT00813488|3993544|P1|STARTED|Titration Period 1||107
1634755|NCT00813319|3993642|P2|NOT COMPLETED|Overall Study||0
1634756|NCT00813319|3993643|P1|NOT COMPLETED|Overall Study||0
1634757|NCT00813319|3993642|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
1634758|NCT00813319|3993643|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
1634759|NCT00813319|3993642|P2|STARTED|Overall Study||108
1634760|NCT00813319|3993643|P1|STARTED|Overall Study||108
1634761|NCT00813176|3993655|P2|NOT COMPLETED|Overall Study||0
1634762|NCT00813176|3993656|P1|NOT COMPLETED|Overall Study||0
1634763|NCT00813176|3993655|P2|COMPLETED|Overall Study||25
1634764|NCT00813176|3993656|P1|COMPLETED|Overall Study||25
1634765|NCT00813176|3993655|P2|STARTED|Overall Study||25
1634766|NCT00813176|3993656|P1|STARTED|Overall Study||25
1634767|NCT00813150|3993674|P2|NOT COMPLETED|Long Term Follow-up||31
1634768|NCT00813150|3993675|P1|NOT COMPLETED|Long Term Follow-up||24
1634769|NCT00813150|3993674|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
1634770|NCT00813150|3993675|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
1634771|NCT00813150|3993674|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
1634772|NCT00813150|3993675|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
1634773|NCT00813150|3993674|P2|NOT COMPLETED|Treatment Period||32
1634774|NCT00813150|3993675|P1|NOT COMPLETED|Treatment Period||32
1634775|NCT00813150|3993674|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
1634776|NCT00813150|3993675|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
1634777|NCT00813150|3993674|P2|Intent-to-treat Participants|Treatment Period||47
1634778|NCT00813150|3993675|P1|Intent-to-treat Participants|Treatment Period||43
1634779|NCT00813150|3993674|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
1634780|NCT00813150|3993675|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
1634781|NCT00813111|3993689|P2|NOT COMPLETED|Overall Study||0
1634782|NCT00813111|3993690|P1|NOT COMPLETED|Overall Study||2
1634783|NCT00813111|3993689|P2|COMPLETED|Overall Study||70
1634784|NCT00813111|3993690|P1|COMPLETED|Overall Study||64
1634785|NCT00813111|3993689|P2|STARTED|Overall Study||70
1634786|NCT00813111|3993690|P1|STARTED|Overall Study||66
1634787|NCT00813098|3993699|P3|NOT COMPLETED|Overall Study||2
1634788|NCT00813098|3993700|P2|NOT COMPLETED|Overall Study||8
1634789|NCT00813098|3993701|P1|NOT COMPLETED|Overall Study||3
1634790|NCT00813098|3993699|P3|COMPLETED|Overall Study||50
1634791|NCT00813098|3993700|P2|COMPLETED|Overall Study||46
1634792|NCT00813098|3993701|P1|COMPLETED|Overall Study||46
1634793|NCT00813098|3993699|P3|STARTED|Overall Study||52
1634794|NCT00813098|3993700|P2|STARTED|Overall Study||54
1634795|NCT00813098|3993701|P1|STARTED|Overall Study||49
1634796|NCT00812981|3993726|P2|NOT COMPLETED|Overall Study||1
1634797|NCT00812981|3993727|P1|NOT COMPLETED|Overall Study||0
1634798|NCT00812981|3993726|P2|COMPLETED|Overall Study||159
1634799|NCT00812981|3993727|P1|COMPLETED|Overall Study||160
1634800|NCT00812981|3993726|P2|STARTED|Overall Study||160
1634801|NCT00812981|3993727|P1|STARTED|Overall Study||160
1634802|NCT00812968|3993765|P1|NOT COMPLETED|Overall Study||11
1634803|NCT00812968|3993765|P1|COMPLETED|Overall Study||0
1634804|NCT00812968|3993765|P1|STARTED|Overall Study||11
1634805|NCT00812955|3993800|P4|NOT COMPLETED|Overall Study||8
1634806|NCT00812955|3993801|P3|NOT COMPLETED|Overall Study||6
1634807|NCT00812955|3993802|P2|NOT COMPLETED|Overall Study||7
1634808|NCT00812955|3993803|P1|NOT COMPLETED|Overall Study||10
1634809|NCT00812955|3993800|P4|COMPLETED|Overall Study||110
1634810|NCT00812955|3993801|P3|COMPLETED|Overall Study||113
1634811|NCT00812955|3993802|P2|COMPLETED|Overall Study||111
1634812|NCT00812955|3993803|P1|COMPLETED|Overall Study||109
1634813|NCT00812955|3993800|P4|STARTED|Overall Study||118
1634814|NCT00812955|3993801|P3|STARTED|Overall Study||119
1634815|NCT00812955|3993802|P2|STARTED|Overall Study||118
1634816|NCT00812955|3993803|P1|STARTED|Overall Study||119
1634817|NCT00812929|3993823|P10|NOT COMPLETED|Treatment Period 5||0
1634818|NCT00812929|3993824|P9|NOT COMPLETED|Treatment Period 5||0
1634819|NCT00812929|3993825|P8|NOT COMPLETED|Treatment Period 5||0
1634820|NCT00812929|3993826|P7|NOT COMPLETED|Treatment Period 5||0
1634821|NCT00812929|3993827|P6|NOT COMPLETED|Treatment Period 5||0
1634822|NCT00812929|3993828|P5|NOT COMPLETED|Treatment Period 5||0
1634823|NCT00812929|3993829|P4|NOT COMPLETED|Treatment Period 5||0
1634824|NCT00812929|3993830|P3|NOT COMPLETED|Treatment Period 5||0
1634825|NCT00812929|3993831|P2|NOT COMPLETED|Treatment Period 5||0
1634826|NCT00812929|3993832|P1|NOT COMPLETED|Treatment Period 5||0
1634827|NCT00812929|3993823|P10|COMPLETED|Treatment Period 5||4
1634828|NCT00812929|3993824|P9|COMPLETED|Treatment Period 5||4
1634829|NCT00812929|3993825|P8|COMPLETED|Treatment Period 5||5
1634830|NCT00812929|3993826|P7|COMPLETED|Treatment Period 5||5
1634831|NCT00812929|3993827|P6|COMPLETED|Treatment Period 5||4
1634832|NCT00812929|3993828|P5|COMPLETED|Treatment Period 5||5
1634833|NCT00812929|3993829|P4|COMPLETED|Treatment Period 5||4
1634834|NCT00812929|3993830|P3|COMPLETED|Treatment Period 5||4
1634835|NCT00812929|3993831|P2|COMPLETED|Treatment Period 5||4
1634836|NCT00812929|3993832|P1|COMPLETED|Treatment Period 5||5
1634837|NCT00812929|3993823|P10|STARTED|Treatment Period 5||4
1634838|NCT00812929|3993824|P9|STARTED|Treatment Period 5||4
1634839|NCT00812929|3993825|P8|STARTED|Treatment Period 5||5
1634840|NCT00812929|3993826|P7|STARTED|Treatment Period 5||5
1634841|NCT00812929|3993827|P6|STARTED|Treatment Period 5||4
1634842|NCT00812929|3993828|P5|STARTED|Treatment Period 5||5
1634843|NCT00812929|3993829|P4|STARTED|Treatment Period 5||4
1634844|NCT00812929|3993830|P3|STARTED|Treatment Period 5||4
1634845|NCT00812929|3993831|P2|STARTED|Treatment Period 5||4
1634846|NCT00812929|3993832|P1|STARTED|Treatment Period 5||5
1634847|NCT00812929|3993823|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634848|NCT00812929|3993824|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634849|NCT00812929|3993825|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634850|NCT00812929|3993826|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634851|NCT00812929|3993827|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634852|NCT00812929|3993828|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634853|NCT00812929|3993829|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634854|NCT00812929|3993830|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634855|NCT00812929|3993831|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634856|NCT00812929|3993832|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
1634857|NCT00812929|3993823|P10|COMPLETED|Washout Period 4 (7 Days)||4
1634858|NCT00812929|3993824|P9|COMPLETED|Washout Period 4 (7 Days)||4
1634859|NCT00812929|3993825|P8|COMPLETED|Washout Period 4 (7 Days)||5
1634860|NCT00812929|3993826|P7|COMPLETED|Washout Period 4 (7 Days)||5
1634861|NCT00812929|3993827|P6|COMPLETED|Washout Period 4 (7 Days)||4
1634862|NCT00812929|3993828|P5|COMPLETED|Washout Period 4 (7 Days)||5
1634863|NCT00812929|3993829|P4|COMPLETED|Washout Period 4 (7 Days)||4
1634864|NCT00812929|3993830|P3|COMPLETED|Washout Period 4 (7 Days)||4
1634865|NCT00812929|3993831|P2|COMPLETED|Washout Period 4 (7 Days)||4
1634866|NCT00812929|3993832|P1|COMPLETED|Washout Period 4 (7 Days)||5
1634867|NCT00812929|3993823|P10|STARTED|Washout Period 4 (7 Days)||4
1634868|NCT00812929|3993824|P9|STARTED|Washout Period 4 (7 Days)||4
1634869|NCT00812929|3993825|P8|STARTED|Washout Period 4 (7 Days)||5
1634870|NCT00812929|3993826|P7|STARTED|Washout Period 4 (7 Days)||5
1634871|NCT00812929|3993827|P6|STARTED|Washout Period 4 (7 Days)||4
1634872|NCT00812929|3993828|P5|STARTED|Washout Period 4 (7 Days)||5
1634873|NCT00812929|3993829|P4|STARTED|Washout Period 4 (7 Days)||4
1634874|NCT00812929|3993830|P3|STARTED|Washout Period 4 (7 Days)||4
1634875|NCT00812929|3993831|P2|STARTED|Washout Period 4 (7 Days)||4
1634876|NCT00812929|3993832|P1|STARTED|Washout Period 4 (7 Days)||5
1634877|NCT00812929|3993823|P10|NOT COMPLETED|Treatment Period 4||0
1634878|NCT00812929|3993824|P9|NOT COMPLETED|Treatment Period 4||0
1634879|NCT00812929|3993825|P8|NOT COMPLETED|Treatment Period 4||0
1634880|NCT00812929|3993826|P7|NOT COMPLETED|Treatment Period 4||0
1634881|NCT00812929|3993827|P6|NOT COMPLETED|Treatment Period 4||0
1634882|NCT00812929|3993828|P5|NOT COMPLETED|Treatment Period 4||0
1634883|NCT00812929|3993829|P4|NOT COMPLETED|Treatment Period 4||0
1634884|NCT00812929|3993830|P3|NOT COMPLETED|Treatment Period 4||0
1634885|NCT00812929|3993831|P2|NOT COMPLETED|Treatment Period 4||0
1634886|NCT00812929|3993832|P1|NOT COMPLETED|Treatment Period 4||0
1634887|NCT00812929|3993823|P10|COMPLETED|Treatment Period 4||4
1634888|NCT00812929|3993824|P9|COMPLETED|Treatment Period 4||4
1634889|NCT00812929|3993825|P8|COMPLETED|Treatment Period 4||5
1634890|NCT00812929|3993826|P7|COMPLETED|Treatment Period 4||5
1634891|NCT00812929|3993827|P6|COMPLETED|Treatment Period 4||4
1634892|NCT00812929|3993828|P5|COMPLETED|Treatment Period 4||5
1634893|NCT00812929|3993829|P4|COMPLETED|Treatment Period 4||4
1634894|NCT00812929|3993830|P3|COMPLETED|Treatment Period 4||4
1634895|NCT00812929|3993831|P2|COMPLETED|Treatment Period 4||4
1634896|NCT00812929|3993832|P1|COMPLETED|Treatment Period 4||5
1634897|NCT00812929|3993823|P10|STARTED|Treatment Period 4||4
1634898|NCT00812929|3993824|P9|STARTED|Treatment Period 4||4
1634899|NCT00812929|3993825|P8|STARTED|Treatment Period 4||5
1634900|NCT00812929|3993826|P7|STARTED|Treatment Period 4||5
1634901|NCT00812929|3993827|P6|STARTED|Treatment Period 4||4
1634902|NCT00812929|3993828|P5|STARTED|Treatment Period 4||5
1634903|NCT00812929|3993829|P4|STARTED|Treatment Period 4||4
1634904|NCT00812929|3993830|P3|STARTED|Treatment Period 4||4
1634905|NCT00812929|3993831|P2|STARTED|Treatment Period 4||4
1634906|NCT00812929|3993832|P1|STARTED|Treatment Period 4||5
1634907|NCT00812929|3993823|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
1634908|NCT00812929|3993824|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
1634909|NCT00812929|3993825|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
1634910|NCT00812929|3993826|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
1634911|NCT00812929|3993827|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
1634912|NCT00812929|3993828|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
1634913|NCT00812929|3993829|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
1634914|NCT00812929|3993830|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
1634915|NCT00812929|3993831|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
1634916|NCT00812929|3993832|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
1634917|NCT00812929|3993823|P10|COMPLETED|Washout Period 3 (7 Days)||4
1634918|NCT00812929|3993824|P9|COMPLETED|Washout Period 3 (7 Days)||4
1634919|NCT00812929|3993825|P8|COMPLETED|Washout Period 3 (7 Days)||5
1634920|NCT00812929|3993826|P7|COMPLETED|Washout Period 3 (7 Days)||5
1634921|NCT00812929|3993827|P6|COMPLETED|Washout Period 3 (7 Days)||4
1634922|NCT00812929|3993828|P5|COMPLETED|Washout Period 3 (7 Days)||5
1634923|NCT00812929|3993829|P4|COMPLETED|Washout Period 3 (7 Days)||4
1634924|NCT00812929|3993830|P3|COMPLETED|Washout Period 3 (7 Days)||4
1634925|NCT00812929|3993831|P2|COMPLETED|Washout Period 3 (7 Days)||4
1634926|NCT00812929|3993832|P1|COMPLETED|Washout Period 3 (7 Days)||5
1634927|NCT00812929|3993823|P10|STARTED|Washout Period 3 (7 Days)||4
1634928|NCT00812929|3993824|P9|STARTED|Washout Period 3 (7 Days)||4
1634929|NCT00812929|3993825|P8|STARTED|Washout Period 3 (7 Days)||5
1634930|NCT00812929|3993826|P7|STARTED|Washout Period 3 (7 Days)||5
1634931|NCT00812929|3993827|P6|STARTED|Washout Period 3 (7 Days)||5
1634932|NCT00812929|3993828|P5|STARTED|Washout Period 3 (7 Days)||5
1634933|NCT00812929|3993829|P4|STARTED|Washout Period 3 (7 Days)||4
1634934|NCT00812929|3993830|P3|STARTED|Washout Period 3 (7 Days)||4
1634935|NCT00812929|3993831|P2|STARTED|Washout Period 3 (7 Days)||4
1634936|NCT00812929|3993832|P1|STARTED|Washout Period 3 (7 Days)||5
1634937|NCT00812929|3993823|P10|NOT COMPLETED|Treatment Period 3||0
1634938|NCT00812929|3993824|P9|NOT COMPLETED|Treatment Period 3||0
1634939|NCT00812929|3993825|P8|NOT COMPLETED|Treatment Period 3||0
1634940|NCT00812929|3993826|P7|NOT COMPLETED|Treatment Period 3||0
1634941|NCT00812929|3993827|P6|NOT COMPLETED|Treatment Period 3||0
1634942|NCT00812929|3993828|P5|NOT COMPLETED|Treatment Period 3||0
1634943|NCT00812929|3993829|P4|NOT COMPLETED|Treatment Period 3||0
1634944|NCT00812929|3993830|P3|NOT COMPLETED|Treatment Period 3||0
1634945|NCT00812929|3993831|P2|NOT COMPLETED|Treatment Period 3||0
1634946|NCT00812929|3993832|P1|NOT COMPLETED|Treatment Period 3||0
1634947|NCT00812929|3993823|P10|COMPLETED|Treatment Period 3||4
1634948|NCT00812929|3993824|P9|COMPLETED|Treatment Period 3||4
1634949|NCT00812929|3993825|P8|COMPLETED|Treatment Period 3||5
1634950|NCT00812929|3993826|P7|COMPLETED|Treatment Period 3||5
1634951|NCT00812929|3993827|P6|COMPLETED|Treatment Period 3||5
1634952|NCT00812929|3993828|P5|COMPLETED|Treatment Period 3||5
1634953|NCT00812929|3993829|P4|COMPLETED|Treatment Period 3||4
1634954|NCT00812929|3993830|P3|COMPLETED|Treatment Period 3||4
1634955|NCT00812929|3993831|P2|COMPLETED|Treatment Period 3||4
1634956|NCT00812929|3993832|P1|COMPLETED|Treatment Period 3||5
1634957|NCT00812929|3993823|P10|STARTED|Treatment Period 3||4
1634958|NCT00812929|3993824|P9|STARTED|Treatment Period 3||4
1634959|NCT00812929|3993825|P8|STARTED|Treatment Period 3||5
1634960|NCT00812929|3993826|P7|STARTED|Treatment Period 3||5
1634961|NCT00812929|3993827|P6|STARTED|Treatment Period 3||5
1634962|NCT00812929|3993828|P5|STARTED|Treatment Period 3||5
1634963|NCT00812929|3993829|P4|STARTED|Treatment Period 3||4
1634964|NCT00812929|3993830|P3|STARTED|Treatment Period 3||4
1634965|NCT00812929|3993831|P2|STARTED|Treatment Period 3||4
1634966|NCT00812929|3993832|P1|STARTED|Treatment Period 3||5
1634967|NCT00812929|3993823|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
1634968|NCT00812929|3993824|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
1634969|NCT00812929|3993825|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
1634970|NCT00812929|3993826|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
1634971|NCT00812929|3993827|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1634972|NCT00812929|3993828|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1634973|NCT00812929|3993829|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1634974|NCT00812929|3993830|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1634975|NCT00812929|3993831|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1634976|NCT00812929|3993832|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1634977|NCT00812929|3993823|P10|COMPLETED|Washout Period 2 (7 Days)||4
1634978|NCT00812929|3993824|P9|COMPLETED|Washout Period 2 (7 Days)||4
1634979|NCT00812929|3993825|P8|COMPLETED|Washout Period 2 (7 Days)||5
1634980|NCT00812929|3993826|P7|COMPLETED|Washout Period 2 (7 Days)||5
1634981|NCT00812929|3993827|P6|COMPLETED|Washout Period 2 (7 Days)||5
1634982|NCT00812929|3993828|P5|COMPLETED|Washout Period 2 (7 Days)||5
1634983|NCT00812929|3993829|P4|COMPLETED|Washout Period 2 (7 Days)||4
1634984|NCT00812929|3993830|P3|COMPLETED|Washout Period 2 (7 Days)||4
1634985|NCT00812929|3993831|P2|COMPLETED|Washout Period 2 (7 Days)||4
1634986|NCT00812929|3993832|P1|COMPLETED|Washout Period 2 (7 Days)||5
1634987|NCT00812929|3993823|P10|STARTED|Washout Period 2 (7 Days)||5
1634988|NCT00812929|3993824|P9|STARTED|Washout Period 2 (7 Days)||4
1634989|NCT00812929|3993825|P8|STARTED|Washout Period 2 (7 Days)||5
1634990|NCT00812929|3993826|P7|STARTED|Washout Period 2 (7 Days)||5
1634991|NCT00812929|3993827|P6|STARTED|Washout Period 2 (7 Days)||5
1634992|NCT00812929|3993828|P5|STARTED|Washout Period 2 (7 Days)||5
1634993|NCT00812929|3993829|P4|STARTED|Washout Period 2 (7 Days)||4
1634994|NCT00812929|3993830|P3|STARTED|Washout Period 2 (7 Days)||4
1634995|NCT00812929|3993831|P2|STARTED|Washout Period 2 (7 Days)||4
1634996|NCT00812929|3993832|P1|STARTED|Washout Period 2 (7 Days)||5
1634997|NCT00812929|3993823|P10|NOT COMPLETED|Treatment Period 2||0
1634998|NCT00812929|3993824|P9|NOT COMPLETED|Treatment Period 2||0
1634999|NCT00812929|3993825|P8|NOT COMPLETED|Treatment Period 2||0
1635000|NCT00812929|3993826|P7|NOT COMPLETED|Treatment Period 2||0
1635001|NCT00812929|3993827|P6|NOT COMPLETED|Treatment Period 2||0
1635002|NCT00812929|3993828|P5|NOT COMPLETED|Treatment Period 2||0
1635003|NCT00812929|3993829|P4|NOT COMPLETED|Treatment Period 2||0
1635004|NCT00812929|3993830|P3|NOT COMPLETED|Treatment Period 2||0
1635005|NCT00812929|3993831|P2|NOT COMPLETED|Treatment Period 2||0
1635006|NCT00812929|3993832|P1|NOT COMPLETED|Treatment Period 2||0
1635007|NCT00812929|3993823|P10|COMPLETED|Treatment Period 2||5
1635008|NCT00812929|3993824|P9|COMPLETED|Treatment Period 2||4
1635009|NCT00812929|3993825|P8|COMPLETED|Treatment Period 2||5
1635010|NCT00812929|3993826|P7|COMPLETED|Treatment Period 2||5
1635011|NCT00812929|3993827|P6|COMPLETED|Treatment Period 2||5
1635012|NCT00812929|3993828|P5|COMPLETED|Treatment Period 2||5
1635013|NCT00812929|3993829|P4|COMPLETED|Treatment Period 2||4
1635014|NCT00812929|3993830|P3|COMPLETED|Treatment Period 2||4
1635015|NCT00812929|3993831|P2|COMPLETED|Treatment Period 2||4
1635016|NCT00812929|3993832|P1|COMPLETED|Treatment Period 2||5
1635017|NCT00812929|3993823|P10|STARTED|Treatment Period 2||5
1635018|NCT00812929|3993824|P9|STARTED|Treatment Period 2||4
1635019|NCT00812929|3993825|P8|STARTED|Treatment Period 2||5
1635020|NCT00812929|3993826|P7|STARTED|Treatment Period 2||5
1635021|NCT00812929|3993827|P6|STARTED|Treatment Period 2||5
1635022|NCT00812929|3993828|P5|STARTED|Treatment Period 2||5
1635023|NCT00812929|3993829|P4|STARTED|Treatment Period 2||4
1635024|NCT00812929|3993830|P3|STARTED|Treatment Period 2||4
1635025|NCT00812929|3993831|P2|STARTED|Treatment Period 2||4
1635026|NCT00812929|3993832|P1|STARTED|Treatment Period 2||5
1635027|NCT00812929|3993823|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
1635028|NCT00812929|3993824|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
1635029|NCT00812929|3993825|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
1635030|NCT00812929|3993826|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
1635031|NCT00812929|3993827|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1635032|NCT00812929|3993828|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1635033|NCT00812929|3993829|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1635034|NCT00812929|3993830|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
1635035|NCT00812929|3993831|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1635036|NCT00812929|3993832|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1635037|NCT00812929|3993823|P10|COMPLETED|Washout Period 1 (7 Days)||5
1635038|NCT00812929|3993824|P9|COMPLETED|Washout Period 1 (7 Days)||4
1635039|NCT00812929|3993825|P8|COMPLETED|Washout Period 1 (7 Days)||5
1635040|NCT00812929|3993826|P7|COMPLETED|Washout Period 1 (7 Days)||5
1635041|NCT00812929|3993827|P6|COMPLETED|Washout Period 1 (7 Days)||5
1635042|NCT00812929|3993828|P5|COMPLETED|Washout Period 1 (7 Days)||5
1635043|NCT00812929|3993829|P4|COMPLETED|Washout Period 1 (7 Days)||4
1635044|NCT00812929|3993830|P3|COMPLETED|Washout Period 1 (7 Days)||4
1635045|NCT00812929|3993831|P2|COMPLETED|Washout Period 1 (7 Days)||4
1635046|NCT00812929|3993832|P1|COMPLETED|Washout Period 1 (7 Days)||5
1635047|NCT00812929|3993823|P10|STARTED|Washout Period 1 (7 Days)||5
1635048|NCT00812929|3993824|P9|STARTED|Washout Period 1 (7 Days)||4
1635049|NCT00812929|3993825|P8|STARTED|Washout Period 1 (7 Days)||5
1635050|NCT00812929|3993826|P7|STARTED|Washout Period 1 (7 Days)||5
1635051|NCT00812929|3993827|P6|STARTED|Washout Period 1 (7 Days)||5
1635052|NCT00812929|3993828|P5|STARTED|Washout Period 1 (7 Days)||5
1635053|NCT00812929|3993829|P4|STARTED|Washout Period 1 (7 Days)||4
1635054|NCT00812929|3993830|P3|STARTED|Washout Period 1 (7 Days)||5
1635055|NCT00812929|3993831|P2|STARTED|Washout Period 1 (7 Days)||4
1635056|NCT00812929|3993832|P1|STARTED|Washout Period 1 (7 Days)||5
1635057|NCT00812929|3993823|P10|NOT COMPLETED|Treatment Period 1||0
1635058|NCT00812929|3993824|P9|NOT COMPLETED|Treatment Period 1||0
1635059|NCT00812929|3993825|P8|NOT COMPLETED|Treatment Period 1||0
1635060|NCT00812929|3993826|P7|NOT COMPLETED|Treatment Period 1||0
1635061|NCT00812929|3993827|P6|NOT COMPLETED|Treatment Period 1||0
1635062|NCT00812929|3993828|P5|NOT COMPLETED|Treatment Period 1||0
1635063|NCT00812929|3993829|P4|NOT COMPLETED|Treatment Period 1||0
1635064|NCT00812929|3993830|P3|NOT COMPLETED|Treatment Period 1||0
1635065|NCT00812929|3993831|P2|NOT COMPLETED|Treatment Period 1||0
1635066|NCT00812929|3993832|P1|NOT COMPLETED|Treatment Period 1||0
1635067|NCT00812929|3993823|P10|COMPLETED|Treatment Period 1||5
1635068|NCT00812929|3993824|P9|COMPLETED|Treatment Period 1||4
1635069|NCT00812929|3993825|P8|COMPLETED|Treatment Period 1||5
1635070|NCT00812929|3993826|P7|COMPLETED|Treatment Period 1||5
1635071|NCT00812929|3993827|P6|COMPLETED|Treatment Period 1||5
1635072|NCT00812929|3993828|P5|COMPLETED|Treatment Period 1||5
1635073|NCT00812929|3993829|P4|COMPLETED|Treatment Period 1||4
1635074|NCT00812929|3993830|P3|COMPLETED|Treatment Period 1||5
1635075|NCT00812929|3993831|P2|COMPLETED|Treatment Period 1||4
1635076|NCT00812929|3993832|P1|COMPLETED|Treatment Period 1||5
1635077|NCT00812929|3993823|P10|STARTED|Treatment Period 1||5
1635078|NCT00812929|3993824|P9|STARTED|Treatment Period 1||4
1635079|NCT00812929|3993825|P8|STARTED|Treatment Period 1||5
1635080|NCT00812929|3993826|P7|STARTED|Treatment Period 1||5
1635081|NCT00812929|3993827|P6|STARTED|Treatment Period 1||5
1635082|NCT00812929|3993828|P5|STARTED|Treatment Period 1||5
1635083|NCT00812929|3993829|P4|STARTED|Treatment Period 1||4
1635084|NCT00812929|3993830|P3|STARTED|Treatment Period 1||5
1635085|NCT00812929|3993831|P2|STARTED|Treatment Period 1||4
1635086|NCT00812929|3993832|P1|STARTED|Treatment Period 1||5
1635087|NCT00812916|3993948|P1|NOT COMPLETED|Overall Study||3
1635088|NCT00812916|3993948|P1|COMPLETED|Overall Study||203
1635089|NCT00812916|3993948|P1|CFAE - Guided Ablation|Overall Study||203
1635090|NCT00812916|3993948|P1|Data Available|Overall Study||205
1635091|NCT00812916|3993948|P1|STARTED|Overall Study|206 enrolled (consented)|206
1635092|NCT00812877|3993959|P2|NOT COMPLETED|Overall Study||51
1635093|NCT00812877|3993960|P1|NOT COMPLETED|Overall Study||37
1635094|NCT00812877|3993959|P2|COMPLETED|Overall Study||130
1635095|NCT00812877|3993960|P1|COMPLETED|Overall Study||158
1635096|NCT00812877|3993959|P2|STARTED|Overall Study||181
1635097|NCT00812877|3993960|P1|STARTED|Overall Study||195
1635098|NCT00812812|3993970|P2|NOT COMPLETED|Overall Study||4
1635099|NCT00812812|3993971|P1|NOT COMPLETED|Overall Study||3
1635100|NCT00812812|3993970|P2|COMPLETED|Overall Study||25
1635101|NCT00812812|3993971|P1|COMPLETED|Overall Study||24
1635102|NCT00812812|3993970|P2|STARTED|Overall Study||29
1635103|NCT00812812|3993971|P1|STARTED|Overall Study||27
1635104|NCT00812708|3993984|P1|NOT COMPLETED|Overall Study||8
1635105|NCT00812708|3993984|P1|COMPLETED|Overall Study||64
1635106|NCT00812708|3993984|P1|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
1635107|NCT00812708|3993984|P1|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
1635108|NCT00812604|3993995|P2|NOT COMPLETED|Overall Study||5
1635109|NCT00812604|3993996|P1|NOT COMPLETED|Overall Study||5
1635110|NCT00812604|3993995|P2|COMPLETED|Overall Study||22
1635111|NCT00812604|3993996|P1|COMPLETED|Overall Study||23
1635112|NCT00812604|3993995|P2|STARTED|Overall Study||27
1635113|NCT00812604|3993996|P1|STARTED|Overall Study||28
1635114|NCT00812565|3994012|P8|NOT COMPLETED|Overall Study||1
1635115|NCT00812565|3994013|P7|NOT COMPLETED|Overall Study||0
1635116|NCT00812565|3994014|P6|NOT COMPLETED|Overall Study||1
1635117|NCT00812565|3994015|P5|NOT COMPLETED|Overall Study||1
1635118|NCT00812565|3994016|P4|NOT COMPLETED|Overall Study||2
1635119|NCT00812565|3994017|P3|NOT COMPLETED|Overall Study||0
1635120|NCT00812565|3994018|P2|NOT COMPLETED|Overall Study||1
1635121|NCT00812565|3994019|P1|NOT COMPLETED|Overall Study||3
1635122|NCT00812565|3994012|P8|COMPLETED|Overall Study||6
1635123|NCT00812565|3994013|P7|COMPLETED|Overall Study||8
1635124|NCT00812565|3994014|P6|COMPLETED|Overall Study||6
1635125|NCT00812565|3994015|P5|COMPLETED|Overall Study||6
1635126|NCT00812565|3994016|P4|COMPLETED|Overall Study||5
1635127|NCT00812565|3994017|P3|COMPLETED|Overall Study||7
1635128|NCT00812565|3994018|P2|COMPLETED|Overall Study||6
1635129|NCT00812565|3994019|P1|COMPLETED|Overall Study||5
1635130|NCT00812565|3994012|P8|STARTED|Overall Study||7
1635131|NCT00812565|3994013|P7|STARTED|Overall Study||8
1635132|NCT00812565|3994014|P6|STARTED|Overall Study||7
1635133|NCT00812565|3994015|P5|STARTED|Overall Study||7
1635134|NCT00812565|3994016|P4|STARTED|Overall Study||7
1635135|NCT00812565|3994017|P3|STARTED|Overall Study||7
1635136|NCT00812565|3994018|P2|STARTED|Overall Study||7
1635137|NCT00812565|3994019|P1|STARTED|Overall Study||8
1635138|NCT00812487|3994143|P2|NOT COMPLETED|Overall Study||3
1635139|NCT00812487|3994144|P1|NOT COMPLETED|Overall Study||6
1635140|NCT00812487|3994143|P2|COMPLETED|Overall Study||39
1635141|NCT00812487|3994144|P1|COMPLETED|Overall Study||26
1635142|NCT00812487|3994143|P2|STARTED|Overall Study||42
1635143|NCT00812487|3994144|P1|STARTED|Overall Study||32
1635144|NCT00812461|3994170|P2|NOT COMPLETED|All Treated Patients||147
1635145|NCT00812461|3994171|P1|NOT COMPLETED|All Treated Patients||132
1635146|NCT00812461|3994170|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
1635147|NCT00812461|3994171|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
1635148|NCT00812461|3994170|P2|STARTED|All Treated Patients||341
1635149|NCT00812461|3994171|P1|STARTED|All Treated Patients||337
1635150|NCT00812461|3994170|P2|NOT COMPLETED|All Randomised Patients||17
1635151|NCT00812461|3994171|P1|NOT COMPLETED|All Randomised Patients||23
1635152|NCT00812461|3994170|P2|COMPLETED|All Randomised Patients||341
1635153|NCT00812461|3994171|P1|COMPLETED|All Randomised Patients||337
1635154|NCT00812461|3994170|P2|STARTED|All Randomised Patients||358
1635155|NCT00812461|3994171|P1|STARTED|All Randomised Patients||360
1635156|NCT00812331|3994194|P5|NOT COMPLETED|Overall Study||0
1635157|NCT00812331|3994195|P4|NOT COMPLETED|Overall Study||0
1635158|NCT00812331|3994196|P3|NOT COMPLETED|Overall Study||0
1635159|NCT00812331|3994197|P2|NOT COMPLETED|Overall Study||0
1635160|NCT00812331|3994198|P1|NOT COMPLETED|Overall Study||1
1635161|NCT00812331|3994194|P5|COMPLETED|Overall Study||8
1635162|NCT00812331|3994195|P4|COMPLETED|Overall Study||7
1635163|NCT00812331|3994196|P3|COMPLETED|Overall Study||8
1635164|NCT00812331|3994197|P2|COMPLETED|Overall Study||8
1635165|NCT00812331|3994198|P1|COMPLETED|Overall Study||5
1635166|NCT00812331|3994194|P5|STARTED|Overall Study||8
1635167|NCT00812331|3994195|P4|STARTED|Overall Study||7
1635168|NCT00812331|3994196|P3|STARTED|Overall Study||8
1635169|NCT00812331|3994197|P2|STARTED|Overall Study||8
1635170|NCT00812331|3994198|P1|STARTED|Overall Study||6
1635171|NCT00812253|3994273|P2|NOT COMPLETED|Overall Study||3
1635172|NCT00812253|3994274|P1|NOT COMPLETED|Overall Study||6
1635173|NCT00812253|3994273|P2|COMPLETED|Overall Study||39
1635174|NCT00812253|3994274|P1|COMPLETED|Overall Study||26
1635175|NCT00812253|3994273|P2|STARTED|Overall Study||42
1635176|NCT00812253|3994274|P1|STARTED|Overall Study||32
1635177|NCT00812110|3994290|P1|NOT COMPLETED|Overall Study||0
1635178|NCT00812110|3994290|P1|COMPLETED|Overall Study||292
1635179|NCT00812110|3994290|P1|STARTED|Overall Study||292
1635180|NCT00812097|3994299|P4|NOT COMPLETED|Overall Study||35
1635181|NCT00812097|3994300|P3|NOT COMPLETED|Overall Study||57
1635182|NCT00812097|3994301|P2|NOT COMPLETED|Overall Study||89
1635183|NCT00812097|3994302|P1|NOT COMPLETED|Overall Study||245
1635184|NCT00812097|3994299|P4|COMPLETED|Overall Study||34
1635185|NCT00812097|3994300|P3|COMPLETED|Overall Study||67
1635186|NCT00812097|3994301|P2|COMPLETED|Overall Study||101
1635187|NCT00812097|3994302|P1|COMPLETED|Overall Study||327
1635188|NCT00812097|3994299|P4|STARTED|Overall Study||69
1635189|NCT00812097|3994300|P3|STARTED|Overall Study||124
1635190|NCT00812097|3994301|P2|STARTED|Overall Study||190
1635191|NCT00812097|3994302|P1|STARTED|Overall Study||572
1635192|NCT00812006|3994331|P3|NOT COMPLETED|Overall Study||6
1635193|NCT00812006|3994332|P2|NOT COMPLETED|Overall Study||3
1635194|NCT00812006|3994333|P1|NOT COMPLETED|Overall Study||6
1635195|NCT00812006|3994331|P3|COMPLETED|Overall Study||30
1635196|NCT00812006|3994332|P2|COMPLETED|Overall Study||33
1635197|NCT00812006|3994333|P1|COMPLETED|Overall Study||30
1635198|NCT00812006|3994331|P3|STARTED|Overall Study||36
1635199|NCT00812006|3994332|P2|STARTED|Overall Study||36
1635200|NCT00812006|3994333|P1|STARTED|Overall Study||36
1635201|NCT00811954|3994350|P3|NOT COMPLETED|Overall Study||101
1635202|NCT00811954|3994351|P2|NOT COMPLETED|Overall Study||72
1635203|NCT00811954|3994352|P1|NOT COMPLETED|Overall Study||89
1635204|NCT00811954|3994350|P3|COMPLETED|Overall Study||500
1635205|NCT00811954|3994351|P2|COMPLETED|Overall Study||531
1635206|NCT00811954|3994352|P1|COMPLETED|Overall Study||516
1635207|NCT00811954|3994350|P3|STARTED|Overall Study||601
1635208|NCT00811954|3994351|P2|STARTED|Overall Study||603
1635209|NCT00811954|3994352|P1|STARTED|Overall Study||605
1635210|NCT00811941|3994416|P2|NOT COMPLETED|All Treated Patients||191
1635211|NCT00811941|3994417|P1|NOT COMPLETED|All Treated Patients||52
1635212|NCT00811941|3994416|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
1635300|NCT00811434|3994675|P1|COMPLETED|First Intervention||4
1635213|NCT00811941|3994417|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
1635214|NCT00811941|3994416|P2|STARTED|All Treated Patients||501
1635215|NCT00811941|3994417|P1|STARTED|All Treated Patients||164
1635216|NCT00811941|3994416|P2|NOT COMPLETED|All Randomised Patients||8
1635217|NCT00811941|3994417|P1|NOT COMPLETED|All Randomised Patients||2
1635218|NCT00811941|3994416|P2|COMPLETED|All Randomised Patients||501
1635219|NCT00811941|3994417|P1|COMPLETED|All Randomised Patients||164
1635220|NCT00811941|3994416|P2|STARTED|All Randomised Patients||509
1635221|NCT00811941|3994417|P1|STARTED|All Randomised Patients||166
1635222|NCT00811928|3994455|P2|NOT COMPLETED|Overall Study||33
1635223|NCT00811928|3994456|P1|NOT COMPLETED|Overall Study||39
1635224|NCT00811928|3994455|P2|COMPLETED|Overall Study||90
1635225|NCT00811928|3994456|P1|COMPLETED|Overall Study||90
1635226|NCT00811928|3994455|P2|STARTED|Overall Study||123
1635227|NCT00811928|3994456|P1|STARTED|Overall Study||129
1635228|NCT00811850|3994474|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
1635229|NCT00811850|3994474|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
1635230|NCT00811850|3994474|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
1635231|NCT00811850|3994474|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
1635232|NCT00811850|3994474|P1|COMPLETED|Treatment Period 2: Wash Out||15
1635233|NCT00811850|3994474|P1|STARTED|Treatment Period 2: Wash Out||15
1635234|NCT00811850|3994474|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
1635235|NCT00811850|3994474|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
1635236|NCT00811850|3994474|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
1635237|NCT00811798|3994494|P1|NOT COMPLETED|Overall Study||0
1635238|NCT00811798|3994494|P1|COMPLETED|Overall Study||92
1635239|NCT00811798|3994494|P1|STARTED|Overall Study||92
1635240|NCT00811733|3994500|P2|NOT COMPLETED|Overall Study||10
1635241|NCT00811733|3994501|P1|NOT COMPLETED|Overall Study||11
1635242|NCT00811733|3994500|P2|COMPLETED|Overall Study||12
1635243|NCT00811733|3994501|P1|COMPLETED|Overall Study||4
1635244|NCT00811733|3994500|P2|STARTED|Overall Study||22
1635245|NCT00811733|3994501|P1|STARTED|Overall Study||15
1635246|NCT00811720|3994549|P2|NOT COMPLETED|All Treated Patients||164
1635247|NCT00811720|3994550|P1|NOT COMPLETED|All Treated Patients||96
1635248|NCT00811720|3994549|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
1635249|NCT00811720|3994550|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
1635250|NCT00811720|3994549|P2|STARTED|All Treated Patients||302
1635251|NCT00811720|3994550|P1|STARTED|All Treated Patients||296
1635252|NCT00811720|3994549|P2|NOT COMPLETED|All Randomised Patients||4
1635253|NCT00811720|3994550|P1|NOT COMPLETED|All Randomised Patients||2
1635254|NCT00811720|3994549|P2|COMPLETED|All Randomised Patients||302
1635255|NCT00811720|3994550|P1|COMPLETED|All Randomised Patients||296
1635256|NCT00811720|3994549|P2|STARTED|All Randomised Patients||306
1635257|NCT00811720|3994550|P1|STARTED|All Randomised Patients||298
1635258|NCT00811655|3994568|P1|NOT COMPLETED|Overall Study||1
1635259|NCT00811655|3994568|P1|COMPLETED|Overall Study||5
1635260|NCT00811655|3994568|P1|STARTED|Overall Study||6
1635261|NCT00811642|3994580|P1|NOT COMPLETED|Overall Study||15
1635262|NCT00811642|3994580|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
1635263|NCT00811642|3994580|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
1635264|NCT00811590|3994590|P1|NOT COMPLETED|Overall Study||0
1635265|NCT00811590|3994590|P1|COMPLETED|Overall Study||3
1635266|NCT00811590|3994590|P1|STARTED|Overall Study||3
1635267|NCT00811577|3994596|P2|NOT COMPLETED|Overall Study||1
1635268|NCT00811577|3994597|P1|NOT COMPLETED|Overall Study||10
1635269|NCT00811577|3994596|P2|COMPLETED|Overall Study||23
1635270|NCT00811577|3994597|P1|COMPLETED|Overall Study||116
1635271|NCT00811577|3994596|P2|STARTED|Overall Study||24
1635272|NCT00811577|3994597|P1|STARTED|Overall Study||126
1635273|NCT00811564|3994648|P2|NOT COMPLETED|Overall Study||2
1635274|NCT00811564|3994649|P1|NOT COMPLETED|Overall Study||9
1635275|NCT00811564|3994648|P2|COMPLETED|Overall Study||73
1635276|NCT00811564|3994649|P1|COMPLETED|Overall Study||64
1635277|NCT00811564|3994648|P2|STARTED|Overall Study||75
1635278|NCT00811564|3994649|P1|STARTED|Overall Study||73
1635279|NCT00811473|3994657|P2|NOT COMPLETED|Overall Study||26
1635280|NCT00811473|3994658|P1|NOT COMPLETED|Overall Study||23
1635281|NCT00811473|3994657|P2|COMPLETED|Overall Study||74
1635282|NCT00811473|3994658|P1|COMPLETED|Overall Study||70
1635283|NCT00811473|3994657|P2|STARTED|Overall Study||100
1635284|NCT00811473|3994658|P1|STARTED|Overall Study||93
1635285|NCT00811434|3994674|P2|NOT COMPLETED|Second Intervention||0
1635286|NCT00811434|3994675|P1|NOT COMPLETED|Second Intervention||0
1635287|NCT00811434|3994674|P2|COMPLETED|Second Intervention||5
1635288|NCT00811434|3994675|P1|COMPLETED|Second Intervention||4
1635289|NCT00811434|3994674|P2|STARTED|Second Intervention||5
1635290|NCT00811434|3994675|P1|STARTED|Second Intervention||4
1635291|NCT00811434|3994674|P2|NOT COMPLETED|Washout (1 Month)||0
1635292|NCT00811434|3994675|P1|NOT COMPLETED|Washout (1 Month)||0
1635293|NCT00811434|3994674|P2|COMPLETED|Washout (1 Month)||5
1635294|NCT00811434|3994675|P1|COMPLETED|Washout (1 Month)||4
1635295|NCT00811434|3994674|P2|STARTED|Washout (1 Month)||5
1635296|NCT00811434|3994675|P1|STARTED|Washout (1 Month)||4
1635297|NCT00811434|3994674|P2|NOT COMPLETED|First Intervention||0
1635298|NCT00811434|3994675|P1|NOT COMPLETED|First Intervention||3
1635299|NCT00811434|3994674|P2|COMPLETED|First Intervention||5
1635301|NCT00811434|3994674|P2|STARTED|First Intervention||5
1635302|NCT00811434|3994675|P1|STARTED|First Intervention||7
1635303|NCT00811395|3994689|P6|NOT COMPLETED|Extension Treatment||2
1635304|NCT00811395|3994690|P5|NOT COMPLETED|Extension Treatment||0
1635305|NCT00811395|3994691|P4|NOT COMPLETED|Extension Treatment||3
1635306|NCT00811395|3994692|P3|NOT COMPLETED|Extension Treatment||3
1635307|NCT00811395|3994693|P2|NOT COMPLETED|Extension Treatment||6
1635308|NCT00811395|3994694|P1|NOT COMPLETED|Extension Treatment||2
1635309|NCT00811395|3994689|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
1635310|NCT00811395|3994690|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
1635311|NCT00811395|3994691|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
1635312|NCT00811395|3994692|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
1635313|NCT00811395|3994693|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
1635314|NCT00811395|3994694|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
1635315|NCT00811395|3994689|P6|STARTED|Extension Treatment|continued initial treatment|29
1635316|NCT00811395|3994690|P5|STARTED|Extension Treatment|continued initial treatment|30
1635317|NCT00811395|3994691|P4|STARTED|Extension Treatment|continued initial treatment|37
1635318|NCT00811395|3994692|P3|STARTED|Extension Treatment|continued initial treatment|27
1635319|NCT00811395|3994693|P2|STARTED|Extension Treatment|continued initial treatment|28
1635320|NCT00811395|3994694|P1|STARTED|Extension Treatment|continued initial treatment|31
1635321|NCT00811395|3994689|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
1635322|NCT00811395|3994690|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
1635323|NCT00811395|3994691|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
1635324|NCT00811395|3994692|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
1635325|NCT00811395|3994693|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
1635326|NCT00811395|3994694|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
1635327|NCT00811395|3994689|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
1635328|NCT00811395|3994690|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
1635329|NCT00811395|3994691|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
1635330|NCT00811395|3994692|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
1635331|NCT00811395|3994693|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
1635332|NCT00811395|3994694|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
1635333|NCT00811395|3994689|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
1635334|NCT00811395|3994690|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
1635335|NCT00811395|3994691|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
1635336|NCT00811395|3994692|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
1635337|NCT00811395|3994693|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
1635338|NCT00811395|3994694|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
1635339|NCT00811382|3994758|P2|NOT COMPLETED|Overall Study||0
1635340|NCT00811382|3994759|P1|NOT COMPLETED|Overall Study||0
1635341|NCT00811382|3994758|P2|COMPLETED|Overall Study||75
1635342|NCT00811382|3994759|P1|COMPLETED|Overall Study||88
1635343|NCT00811382|3994758|P2|STARTED|Overall Study||75
1635344|NCT00811382|3994759|P1|STARTED|Overall Study||88
1635345|NCT00811317|3994771|P1|NOT COMPLETED|Overall Study||0
1635346|NCT00811317|3994771|P1|COMPLETED|Overall Study||11
1635347|NCT00811317|3994771|P1|STARTED|Overall Study||11
1635348|NCT00811252|3994800|P3|NOT COMPLETED|Overall Study||23
1635349|NCT00811252|3994801|P2|NOT COMPLETED|Overall Study||20
1635350|NCT00811252|3994802|P1|NOT COMPLETED|Overall Study||17
1635351|NCT00811252|3994800|P3|COMPLETED|Overall Study||128
1635352|NCT00811252|3994801|P2|COMPLETED|Overall Study||136
1635353|NCT00811252|3994802|P1|COMPLETED|Overall Study||128
1635354|NCT00811252|3994800|P3|STARTED|Overall Study||151
1635355|NCT00811252|3994801|P2|STARTED|Overall Study||156
1635356|NCT00811252|3994802|P1|STARTED|Overall Study||145
1635357|NCT00811174|3994846|P1|NOT COMPLETED|Overall Study||3
1635358|NCT00811174|3994846|P1|COMPLETED|Overall Study||2
1635359|NCT00811174|3994846|P1|STARTED|Overall Study||5
1635360|NCT00811135|3994857|P1|NOT COMPLETED|Overall Study||88
1635361|NCT00811135|3994857|P1|COMPLETED|Overall Study||0
1635362|NCT00811135|3994857|P1|STARTED|Overall Study||88
1635363|NCT00811070|3994875|P6|NOT COMPLETED|Overall Study||1
1635364|NCT00811070|3994876|P5|NOT COMPLETED|Overall Study||5
1635365|NCT00811070|3994877|P4|NOT COMPLETED|Overall Study||2
1635366|NCT00811070|3994878|P3|NOT COMPLETED|Overall Study||0
1635367|NCT00811070|3994879|P2|NOT COMPLETED|Overall Study||1
1635368|NCT00811070|3994880|P1|NOT COMPLETED|Overall Study||1
1635369|NCT00811070|3994875|P6|COMPLETED|Overall Study||10
1635370|NCT00811070|3994876|P5|COMPLETED|Overall Study||2
1635371|NCT00811070|3994877|P4|COMPLETED|Overall Study||26
1635372|NCT00811070|3994878|P3|COMPLETED|Overall Study||3
1635373|NCT00811070|3994879|P2|COMPLETED|Overall Study||6
1635374|NCT00811070|3994880|P1|COMPLETED|Overall Study||6
1635375|NCT00811070|3994875|P6|STARTED|Overall Study||11
1635376|NCT00811070|3994876|P5|STARTED|Overall Study||7
1635377|NCT00811070|3994877|P4|STARTED|Overall Study||28
1635378|NCT00811070|3994878|P3|STARTED|Overall Study||3
1635379|NCT00811070|3994879|P2|STARTED|Overall Study||7
1635380|NCT00811070|3994880|P1|STARTED|Overall Study||7
1635381|NCT00811057|3994940|P3|NOT COMPLETED|Overall Study||10
1635382|NCT00811057|3994941|P2|NOT COMPLETED|Overall Study||10
1635383|NCT00811057|3994942|P1|NOT COMPLETED|Overall Study||5
1635384|NCT00811057|3994940|P3|COMPLETED|Overall Study||87
1635385|NCT00811057|3994941|P2|COMPLETED|Overall Study||104
1635386|NCT00811057|3994942|P1|COMPLETED|Overall Study||85
1635387|NCT00811057|3994940|P3|STARTED|Overall Study||97
1635388|NCT00811057|3994941|P2|STARTED|Overall Study||114
1635389|NCT00811057|3994942|P1|STARTED|Overall Study||90
1635390|NCT00811018|3994953|P1|NOT COMPLETED|Overall Study||968
1635391|NCT00811018|3994953|P1|COMPLETED|Overall Study||224
1635392|NCT00811018|3994953|P1|STARTED|Overall Study||1192
1635393|NCT00810901|3994971|P2|NOT COMPLETED|Overall Study||58
1635394|NCT00810901|3994972|P1|NOT COMPLETED|Overall Study||88
1635395|NCT00810901|3994971|P2|COMPLETED|Overall Study||118
1635396|NCT00810901|3994972|P1|COMPLETED|Overall Study||165
1635397|NCT00810901|3994971|P2|6-month Follow-up|Overall Study||122
1635398|NCT00810901|3994972|P1|6-month Follow-up|Overall Study||181
1635399|NCT00810901|3994971|P2|1-month Follow up|Overall Study||146
1635400|NCT00810901|3994972|P1|1-month Follow up|Overall Study||242
1635401|NCT00810901|3994971|P2|STARTED|Overall Study||176
1635402|NCT00810901|3994972|P1|STARTED|Overall Study||253
1635403|NCT00810888|3994983|P3|NOT COMPLETED|Overall Study||0
1635404|NCT00810888|3994984|P2|NOT COMPLETED|Overall Study||0
1635405|NCT00810888|3994985|P1|NOT COMPLETED|Overall Study||0
1635406|NCT00810888|3994983|P3|COMPLETED|Overall Study||73
1635407|NCT00810888|3994984|P2|COMPLETED|Overall Study||9
1635408|NCT00810888|3994985|P1|COMPLETED|Overall Study||10
1635409|NCT00810888|3994983|P3|STARTED|Overall Study||73
1635410|NCT00810888|3994984|P2|STARTED|Overall Study||9
1635411|NCT00810888|3994985|P1|STARTED|Overall Study||10
1635412|NCT00810810|3995018|P4|NOT COMPLETED|Overall Study||13
1635413|NCT00810810|3995019|P3|NOT COMPLETED|Overall Study||11
1635414|NCT00810810|3995020|P2|NOT COMPLETED|Overall Study||11
1635415|NCT00810810|3995021|P1|NOT COMPLETED|Overall Study||0
1635416|NCT00810810|3995018|P4|COMPLETED|Overall Study||38
1635417|NCT00810810|3995019|P3|COMPLETED|Overall Study||45
1635418|NCT00810810|3995020|P2|COMPLETED|Overall Study||38
1635419|NCT00810810|3995021|P1|COMPLETED|Overall Study||124
1635420|NCT00810810|3995018|P4|STARTED|Overall Study||51
1635421|NCT00810810|3995019|P3|STARTED|Overall Study||56
1635422|NCT00810810|3995020|P2|STARTED|Overall Study||49
1635423|NCT00810810|3995021|P1|STARTED|Overall Study||124
1635424|NCT00810771|3995038|P3|NOT COMPLETED|Overall Study||0
1635425|NCT00810771|3995039|P2|NOT COMPLETED|Overall Study||0
1635426|NCT00810771|3995040|P1|NOT COMPLETED|Overall Study||0
1635427|NCT00810771|3995038|P3|COMPLETED|Overall Study||84
1635428|NCT00810771|3995039|P2|COMPLETED|Overall Study||234
1635429|NCT00810771|3995040|P1|COMPLETED|Overall Study||232
1635430|NCT00810771|3995038|P3|STARTED|Overall Study||84
1635431|NCT00810771|3995039|P2|STARTED|Overall Study||234
1635432|NCT00810771|3995040|P1|STARTED|Overall Study||232
1635433|NCT00810719|3995060|P1|NOT COMPLETED|Overall Study||0
1635434|NCT00810719|3995060|P1|COMPLETED|Overall Study||30
1635435|NCT00810719|3995060|P1|STARTED|Overall Study||30
1635436|NCT00810693|3995069|P3|NOT COMPLETED|Follow-up Period (FUP)||4
1635437|NCT00810693|3995070|P2|NOT COMPLETED|Follow-up Period (FUP)||3
1635438|NCT00810693|3995071|P1|NOT COMPLETED|Follow-up Period (FUP)||8
1635439|NCT00810693|3995069|P3|COMPLETED|Follow-up Period (FUP)||12
1635440|NCT00810693|3995070|P2|COMPLETED|Follow-up Period (FUP)||4
1635441|NCT00810693|3995071|P1|COMPLETED|Follow-up Period (FUP)||15
1635442|NCT00810693|3995069|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
1635443|NCT00810693|3995070|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
1635444|NCT00810693|3995071|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
1635445|NCT00810693|3995069|P3|NOT COMPLETED|Treatment Period||16
1635446|NCT00810693|3995070|P2|NOT COMPLETED|Treatment Period||7
1635447|NCT00810693|3995071|P1|NOT COMPLETED|Treatment Period||17
1635448|NCT00810693|3995069|P3|COMPLETED|Treatment Period||111
1635449|NCT00810693|3995070|P2|COMPLETED|Treatment Period||57
1635450|NCT00810693|3995071|P1|COMPLETED|Treatment Period||237
1635451|NCT00810693|3995069|P3|Participants Received Treatment|Treatment Period||126
1635452|NCT00810693|3995070|P2|Participants Received Treatment|Treatment Period||63
1635453|NCT00810693|3995071|P1|Participants Received Treatment|Treatment Period||254
1635454|NCT00810693|3995069|P3|STARTED|Treatment Period|1 randomized but not treated|127
1635455|NCT00810693|3995070|P2|STARTED|Treatment Period|1 randomized but not treated|64
1635456|NCT00810693|3995071|P1|STARTED|Treatment Period||254
1635457|NCT00810641|3995103|P3|NOT COMPLETED|Overall Study||2
1635458|NCT00810641|3995104|P2|NOT COMPLETED|Overall Study||1
1635459|NCT00810641|3995105|P1|NOT COMPLETED|Overall Study||0
1635460|NCT00810641|3995103|P3|COMPLETED|Overall Study||49
1635461|NCT00810641|3995104|P2|COMPLETED|Overall Study||53
1635462|NCT00810641|3995105|P1|COMPLETED|Overall Study||52
1635463|NCT00810641|3995103|P3|STARTED|Overall Study||51
1635464|NCT00810641|3995104|P2|STARTED|Overall Study||54
1635465|NCT00810641|3995105|P1|STARTED|Overall Study||52
1635466|NCT00810615|3995115|P2|NOT COMPLETED|Overall Study||1
1635467|NCT00810615|3995116|P1|NOT COMPLETED|Overall Study||1
1635468|NCT00810615|3995115|P2|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
1635560|NCT00810108|3995363|P2|STARTED|Overall Study||7
1635469|NCT00810615|3995116|P1|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
1635470|NCT00810615|3995115|P2|STARTED|Overall Study||25
1635471|NCT00810615|3995116|P1|STARTED|Overall Study||25
1635472|NCT00810602|3995166|P2|NOT COMPLETED|Overall Study||3
1635473|NCT00810602|3995167|P1|NOT COMPLETED|Overall Study||8
1635474|NCT00810602|3995166|P2|COMPLETED|Overall Study||31
1635475|NCT00810602|3995167|P1|COMPLETED|Overall Study||19
1635476|NCT00810602|3995166|P2|STARTED|Overall Study||34
1635477|NCT00810602|3995167|P1|STARTED|Overall Study||27
1635478|NCT00810576|3995174|P1|NOT COMPLETED|Overall Study||0
1635479|NCT00810576|3995174|P1|COMPLETED|Overall Study||1
1635480|NCT00810576|3995174|P1|STARTED|Overall Study||1
1635481|NCT00810511|3995180|P2|NOT COMPLETED|Overall Study||4
1635482|NCT00810511|3995181|P1|NOT COMPLETED|Overall Study||10
1635483|NCT00810511|3995180|P2|COMPLETED|Overall Study||102
1635484|NCT00810511|3995181|P1|COMPLETED|Overall Study||97
1635485|NCT00810511|3995180|P2|STARTED|Overall Study||106
1635486|NCT00810511|3995181|P1|STARTED|Overall Study||107
1635487|NCT00810394|3995187|P1|NOT COMPLETED|Overall Study||3
1635488|NCT00810394|3995187|P1|COMPLETED|Overall Study||47
1635489|NCT00810394|3995187|P1|Cycle 3 400mg Twice Daily|Overall Study||5
1635490|NCT00810394|3995187|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
1635491|NCT00810394|3995187|P1|Cycle 2 400mg Once Daily|Overall Study||22
1635492|NCT00810394|3995187|P1|Cycle 2 600mg Twice Daily|Overall Study||13
1635493|NCT00810394|3995187|P1|STARTED|Overall Study||50
1635494|NCT00810368|3995195|P2|NOT COMPLETED|Overall Study||2
1635495|NCT00810368|3995196|P1|NOT COMPLETED|Overall Study||6
1635496|NCT00810368|3995195|P2|COMPLETED|Overall Study||13
1635497|NCT00810368|3995196|P1|COMPLETED|Overall Study||12
1635498|NCT00810368|3995195|P2|STARTED|Overall Study||15
1635499|NCT00810368|3995196|P1|STARTED|Overall Study||18
1635500|NCT00810355|3995217|P3|NOT COMPLETED|Overall Study||11
1635501|NCT00810355|3995218|P2|NOT COMPLETED|Overall Study||17
1635502|NCT00810355|3995219|P1|NOT COMPLETED|Overall Study||14
1635503|NCT00810355|3995217|P3|COMPLETED|Overall Study||14
1635504|NCT00810355|3995218|P2|COMPLETED|Overall Study||8
1635505|NCT00810355|3995219|P1|COMPLETED|Overall Study||11
1635506|NCT00810355|3995217|P3|STARTED|Overall Study||25
1635507|NCT00810355|3995218|P2|STARTED|Overall Study||25
1635508|NCT00810355|3995219|P1|STARTED|Overall Study||25
1635509|NCT00810342|3995235|P2|NOT COMPLETED|12-month Followup||11
1635510|NCT00810342|3995236|P1|NOT COMPLETED|12-month Followup||12
1635511|NCT00810342|3995235|P2|COMPLETED|12-month Followup||136
1635512|NCT00810342|3995236|P1|COMPLETED|12-month Followup||113
1635513|NCT00810342|3995235|P2|STARTED|12-month Followup||147
1635514|NCT00810342|3995236|P1|STARTED|12-month Followup||125
1635515|NCT00810342|3995235|P2|NOT COMPLETED|6-month Follow-up||8
1635516|NCT00810342|3995236|P1|NOT COMPLETED|6-month Follow-up||24
1635517|NCT00810342|3995235|P2|COMPLETED|6-month Follow-up||147
1635518|NCT00810342|3995236|P1|COMPLETED|6-month Follow-up||125
1635519|NCT00810342|3995235|P2|STARTED|6-month Follow-up||155
1635520|NCT00810342|3995236|P1|STARTED|6-month Follow-up||149
1635521|NCT00810342|3995235|P2|NOT COMPLETED|Month 1 Follow-up||2
1635522|NCT00810342|3995236|P1|NOT COMPLETED|Month 1 Follow-up||5
1635523|NCT00810342|3995235|P2|COMPLETED|Month 1 Follow-up||155
1635524|NCT00810342|3995236|P1|COMPLETED|Month 1 Follow-up||149
1635525|NCT00810342|3995235|P2|STARTED|Month 1 Follow-up||157
1635526|NCT00810342|3995236|P1|STARTED|Month 1 Follow-up||154
1635527|NCT00810303|3995244|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
1635528|NCT00810303|3995244|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
1635529|NCT00810303|3995244|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
1635530|NCT00810303|3995244|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
1635531|NCT00810303|3995244|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
1635532|NCT00810303|3995244|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
1635533|NCT00810303|3995244|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
1635534|NCT00810303|3995244|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
1635535|NCT00810303|3995244|P1|STARTED|Ezetimibe Alone - Day 6-15||12
1635536|NCT00810303|3995244|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
1635537|NCT00810303|3995244|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
1635538|NCT00810303|3995244|P1|STARTED|Efavirenz Alone - Day 1-5||12
1635539|NCT00810277|3995269|P1|NOT COMPLETED|Overall Study||1
1635540|NCT00810277|3995269|P1|COMPLETED|Overall Study||13
1635541|NCT00810277|3995269|P1|STARTED|Overall Study||14
1635542|NCT00810199|3995284|P2|NOT COMPLETED|Overall Study||82
1635543|NCT00810199|3995285|P1|NOT COMPLETED|Overall Study||59
1635544|NCT00810199|3995284|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
1635545|NCT00810199|3995285|P1|COMPLETED|Overall Study||220
1635546|NCT00810199|3995284|P2|Completed Week 104|Overall Study||201
1635547|NCT00810199|3995285|P1|Completed Week 104|Overall Study||222
1635548|NCT00810199|3995284|P2|Completed Week 52|Overall Study||229
1635549|NCT00810199|3995285|P1|Completed Week 52|Overall Study||243
1635550|NCT00810199|3995284|P2|Completed Week 24|Overall Study||250
1635551|NCT00810199|3995285|P1|Completed Week 24|Overall Study||259
1635552|NCT00810199|3995284|P2|Received Study Drug|Overall Study||276
1635553|NCT00810199|3995285|P1|Received Study Drug|Overall Study||277
1635554|NCT00810199|3995284|P2|STARTED|Overall Study||277
1635555|NCT00810199|3995285|P1|STARTED|Overall Study||279
1635556|NCT00810108|3995363|P2|NOT COMPLETED|Overall Study||0
1635557|NCT00810108|3995364|P1|NOT COMPLETED|Overall Study||1
1635558|NCT00810108|3995363|P2|COMPLETED|Overall Study||7
1635559|NCT00810108|3995364|P1|COMPLETED|Overall Study||5
1635561|NCT00810108|3995364|P1|STARTED|Overall Study||6
1635562|NCT00810095|3995369|P1|NOT COMPLETED|Overall Study||0
1635563|NCT00810095|3995369|P1|COMPLETED|Overall Study||40
1635564|NCT00810095|3995369|P1|STARTED|Overall Study||40
1635565|NCT00810082|3995378|P2|NOT COMPLETED|Overall Study||4
1635566|NCT00810082|3995379|P1|NOT COMPLETED|Overall Study||0
1635567|NCT00810082|3995378|P2|COMPLETED|Overall Study||27
1635568|NCT00810082|3995379|P1|COMPLETED|Overall Study||34
1635569|NCT00810082|3995378|P2|STARTED|Overall Study||31
1635570|NCT00810082|3995379|P1|STARTED|Overall Study||34
1635571|NCT00810069|3995387|P3|NOT COMPLETED|Double-Blind Period II||72
1635572|NCT00810069|3995388|P2|NOT COMPLETED|Double-Blind Period II||56
1635573|NCT00810069|3995389|P1|NOT COMPLETED|Double-Blind Period II||0
1635574|NCT00810069|3995387|P3|COMPLETED|Double-Blind Period II||212
1635575|NCT00810069|3995388|P2|COMPLETED|Double-Blind Period II||226
1635576|NCT00810069|3995389|P1|COMPLETED|Double-Blind Period II||0
1635577|NCT00810069|3995387|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
1635578|NCT00810069|3995388|P2|STARTED|Double-Blind Period II||282
1635579|NCT00810069|3995389|P1|STARTED|Double-Blind Period II||0
1635580|NCT00810069|3995387|P3|NOT COMPLETED|Lead-in Period I||0
1635581|NCT00810069|3995388|P2|NOT COMPLETED|Lead-in Period I||0
1635582|NCT00810069|3995389|P1|NOT COMPLETED|Lead-in Period I||274
1635583|NCT00810069|3995387|P3|COMPLETED|Lead-in Period I||0
1635584|NCT00810069|3995388|P2|COMPLETED|Lead-in Period I||0
1635585|NCT00810069|3995389|P1|COMPLETED|Lead-in Period I||566
1635586|NCT00810069|3995387|P3|STARTED|Lead-in Period I||0
1635587|NCT00810069|3995388|P2|STARTED|Lead-in Period I||0
1635588|NCT00810069|3995389|P1|STARTED|Lead-in Period I||840
1635589|NCT00810043|3995434|P3|NOT COMPLETED|Overall Study||8
1635590|NCT00810043|3995435|P2|NOT COMPLETED|Overall Study||1
1635591|NCT00810043|3995436|P1|NOT COMPLETED|Overall Study||4
1635592|NCT00810043|3995434|P3|COMPLETED|Overall Study||0
1635593|NCT00810043|3995435|P2|COMPLETED|Overall Study||54
1635594|NCT00810043|3995436|P1|COMPLETED|Overall Study||53
1635595|NCT00810043|3995434|P3|STARTED|Overall Study||8
1635596|NCT00810043|3995435|P2|STARTED|Overall Study||55
1635597|NCT00810043|3995436|P1|STARTED|Overall Study||57
1635598|NCT00809965|3995458|P3|NOT COMPLETED|Overall Study||844
1635599|NCT00809965|3995459|P2|NOT COMPLETED|Overall Study||775
1635600|NCT00809965|3995460|P1|NOT COMPLETED|Overall Study||783
1635601|NCT00809965|3995458|P3|COMPLETED|Overall Study||4332
1635602|NCT00809965|3995459|P2|COMPLETED|Overall Study||4399
1635603|NCT00809965|3995460|P1|COMPLETED|Overall Study||4393
1635604|NCT00809965|3995458|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
1635605|NCT00809965|3995459|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
1635606|NCT00809965|3995460|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
1635607|NCT00809965|3995458|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
1635608|NCT00809965|3995459|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
1635609|NCT00809965|3995460|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
1635610|NCT00809965|3995458|P3|STARTED|Overall Study||5176
1635611|NCT00809965|3995459|P2|STARTED|Overall Study||5174
1635612|NCT00809965|3995460|P1|STARTED|Overall Study||5176
1635613|NCT00809926|3995482|P2|NOT COMPLETED|Overall Study||23
1635614|NCT00809926|3995483|P1|NOT COMPLETED|Overall Study||31
1635615|NCT00809926|3995482|P2|COMPLETED|Overall Study||196
1635616|NCT00809926|3995483|P1|COMPLETED|Overall Study||201
1635617|NCT00809926|3995482|P2|STARTED|Overall Study||219
1635618|NCT00809926|3995483|P1|STARTED|Overall Study||232
1635619|NCT00809848|3995512|P5|NOT COMPLETED|Overall Study||3
1635620|NCT00809848|3995513|P4|NOT COMPLETED|Overall Study||1
1635621|NCT00809848|3995514|P3|NOT COMPLETED|Overall Study||0
1635622|NCT00809848|3995515|P2|NOT COMPLETED|Overall Study||0
1635623|NCT00809848|3995516|P1|NOT COMPLETED|Overall Study||0
1635624|NCT00809848|3995512|P5|COMPLETED|Overall Study||34
1635625|NCT00809848|3995513|P4|COMPLETED|Overall Study||30
1635626|NCT00809848|3995514|P3|COMPLETED|Overall Study||34
1635627|NCT00809848|3995515|P2|COMPLETED|Overall Study||34
1635628|NCT00809848|3995516|P1|COMPLETED|Overall Study||36
1635629|NCT00809848|3995512|P5|STARTED|Overall Study||37
1635630|NCT00809848|3995513|P4|STARTED|Overall Study||31
1635631|NCT00809848|3995514|P3|STARTED|Overall Study||34
1635632|NCT00809848|3995515|P2|STARTED|Overall Study||34
1635633|NCT00809848|3995516|P1|STARTED|Overall Study||36
1635634|NCT00809835|3995537|P4|NOT COMPLETED|Overall Study||2
1635635|NCT00809835|3995538|P3|NOT COMPLETED|Overall Study||11
1635636|NCT00809835|3995539|P2|NOT COMPLETED|Overall Study||7
1635637|NCT00809835|3995540|P1|NOT COMPLETED|Overall Study||8
1635638|NCT00809835|3995537|P4|COMPLETED|Overall Study||25
1635639|NCT00809835|3995538|P3|COMPLETED|Overall Study||27
1635640|NCT00809835|3995539|P2|COMPLETED|Overall Study||20
1635641|NCT00809835|3995540|P1|COMPLETED|Overall Study||20
1635642|NCT00809835|3995537|P4|STARTED|Overall Study||27
1635643|NCT00809835|3995538|P3|STARTED|Overall Study||38
1635644|NCT00809835|3995539|P2|STARTED|Overall Study||27
1635645|NCT00809835|3995540|P1|STARTED|Overall Study||28
1635646|NCT00809809|3995560|P2|NOT COMPLETED|Overall Study||2
1635647|NCT00809809|3995561|P1|NOT COMPLETED|Overall Study||3
1635648|NCT00809809|3995560|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
1635649|NCT00809809|3995561|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
1635650|NCT00809809|3995560|P2|STARTED|Overall Study||79
1635651|NCT00809809|3995561|P1|STARTED|Overall Study||78
1635652|NCT00809757|3995570|P3|NOT COMPLETED|Overall Study||11
1635653|NCT00809757|3995571|P2|NOT COMPLETED|Overall Study||5
1635654|NCT00809757|3995572|P1|NOT COMPLETED|Overall Study||6
1635655|NCT00809757|3995570|P3|COMPLETED|Overall Study||53
1635656|NCT00809757|3995571|P2|COMPLETED|Overall Study||60
1635657|NCT00809757|3995572|P1|COMPLETED|Overall Study||62
1635658|NCT00809757|3995570|P3|STARTED|Overall Study||64
1635659|NCT00809757|3995571|P2|STARTED|Overall Study||65
1635660|NCT00809757|3995572|P1|STARTED|Overall Study||68
1635661|NCT00809614|3995657|P2|NOT COMPLETED|Overall Study||4
1635662|NCT00809614|3995658|P1|NOT COMPLETED|Overall Study||3
1635663|NCT00809614|3995657|P2|COMPLETED|Overall Study||10
1635664|NCT00809614|3995658|P1|COMPLETED|Overall Study||25
1635665|NCT00809614|3995657|P2|Pharmacodynamic (PD) Set|Overall Study||13
1635666|NCT00809614|3995658|P1|Pharmacodynamic (PD) Set|Overall Study||24
1635667|NCT00809614|3995657|P2|Pharmacokinetic Safety Set|Overall Study||14
1635668|NCT00809614|3995658|P1|Pharmacokinetic Safety Set|Overall Study||27
1635669|NCT00809614|3995657|P2|STARTED|Overall Study||14
1635670|NCT00809614|3995658|P1|STARTED|Overall Study||28
1635671|NCT00809523|3995688|P2|NOT COMPLETED|Overall Study||4
1635672|NCT00809523|3995689|P1|NOT COMPLETED|Overall Study||7
1635673|NCT00809523|3995688|P2|COMPLETED|Overall Study||48
1635674|NCT00809523|3995689|P1|COMPLETED|Overall Study||47
1635675|NCT00809523|3995688|P2|STARTED|Overall Study||52
1635676|NCT00809523|3995689|P1|STARTED|Overall Study||54
1635677|NCT00809471|3995702|P3|NOT COMPLETED|Overall Study||17
1635678|NCT00809471|3995703|P2|NOT COMPLETED|Overall Study||20
1635679|NCT00809471|3995704|P1|NOT COMPLETED|Overall Study||20
1635680|NCT00809471|3995702|P3|COMPLETED|Overall Study||114
1635681|NCT00809471|3995703|P2|COMPLETED|Overall Study||109
1635682|NCT00809471|3995704|P1|COMPLETED|Overall Study||110
1635683|NCT00809471|3995702|P3|STARTED|Overall Study||131
1635684|NCT00809471|3995703|P2|STARTED|Overall Study||129
1635685|NCT00809471|3995704|P1|STARTED|Overall Study||130
1635686|NCT00809458|3995720|P2|NOT COMPLETED|Overall Study||1
1635687|NCT00809458|3995721|P1|NOT COMPLETED|Overall Study||1
1635688|NCT00809458|3995720|P2|COMPLETED|Overall Study||5
1635689|NCT00809458|3995721|P1|COMPLETED|Overall Study||8
1635690|NCT00809458|3995720|P2|STARTED|Overall Study||6
1635691|NCT00809458|3995721|P1|STARTED|Overall Study||9
1635692|NCT00809445|3995734|P3|NOT COMPLETED|6 Month Follow-up||24
1635693|NCT00809445|3995735|P2|NOT COMPLETED|6 Month Follow-up||23
1635694|NCT00809445|3995736|P1|NOT COMPLETED|6 Month Follow-up||24
1635695|NCT00809445|3995734|P3|COMPLETED|6 Month Follow-up||395
1635696|NCT00809445|3995735|P2|COMPLETED|6 Month Follow-up||410
1635697|NCT00809445|3995736|P1|COMPLETED|6 Month Follow-up||405
1635698|NCT00809445|3995734|P3|STARTED|6 Month Follow-up||419
1635699|NCT00809445|3995735|P2|STARTED|6 Month Follow-up||433
1635700|NCT00809445|3995736|P1|STARTED|6 Month Follow-up||429
1635701|NCT00809445|3995734|P3|NOT COMPLETED|1 Month Follow-up||4
1635702|NCT00809445|3995735|P2|NOT COMPLETED|1 Month Follow-up||4
1635703|NCT00809445|3995736|P1|NOT COMPLETED|1 Month Follow-up||2
1635704|NCT00809445|3995734|P3|COMPLETED|1 Month Follow-up||415
1635705|NCT00809445|3995735|P2|COMPLETED|1 Month Follow-up||429
1635706|NCT00809445|3995736|P1|COMPLETED|1 Month Follow-up||427
1635707|NCT00809445|3995734|P3|STARTED|1 Month Follow-up||419
1635708|NCT00809445|3995735|P2|STARTED|1 Month Follow-up||433
1635709|NCT00809445|3995736|P1|STARTED|1 Month Follow-up||429
1635710|NCT00809341|3995755|P2|NOT COMPLETED|Overall Study||1
1635711|NCT00809341|3995756|P1|NOT COMPLETED|Overall Study||0
1635712|NCT00809341|3995755|P2|COMPLETED|Overall Study||4
1635713|NCT00809341|3995756|P1|COMPLETED|Overall Study||20
1635714|NCT00809341|3995755|P2|STARTED|Overall Study||5
1635715|NCT00809341|3995756|P1|STARTED|Overall Study||20
1635716|NCT00809328|3995764|P1|NOT COMPLETED|Overall Study||29
1635717|NCT00809328|3995764|P1|COMPLETED|Overall Study||73
1635718|NCT00809328|3995764|P1|STARTED|Overall Study||102
1635719|NCT00809276|3995772|P1|NOT COMPLETED|Overall Study||0
1635720|NCT00809276|3995772|P1|COMPLETED|Overall Study||92
1635721|NCT00809276|3995772|P1|STARTED|Overall Study||92
1635722|NCT00809185|3995776|P1|NOT COMPLETED|Overall Study||0
1635723|NCT00809185|3995776|P1|COMPLETED|Overall Study||7
1635724|NCT00809185|3995776|P1|STARTED|Overall Study||7
1635725|NCT00809159|3995784|P6|NOT COMPLETED|Part 1 and 2||3
1635726|NCT00809159|3995785|P5|NOT COMPLETED|Part 1 and 2||6
1635727|NCT00809159|3995786|P4|NOT COMPLETED|Part 1 and 2||5
1635728|NCT00809159|3995787|P3|NOT COMPLETED|Part 1 and 2||10
1635729|NCT00809159|3995788|P2|NOT COMPLETED|Part 1 and 2||0
1635730|NCT00809159|3995789|P1|NOT COMPLETED|Part 1 and 2||0
1635731|NCT00809159|3995784|P6|COMPLETED|Part 1 and 2||3
1635732|NCT00809159|3995785|P5|COMPLETED|Part 1 and 2||6
1635733|NCT00809159|3995786|P4|COMPLETED|Part 1 and 2||7
1635734|NCT00809159|3995787|P3|COMPLETED|Part 1 and 2||20
1635735|NCT00809159|3995788|P2|COMPLETED|Part 1 and 2||0
1635736|NCT00809159|3995789|P1|COMPLETED|Part 1 and 2||0
1635737|NCT00809159|3995784|P6|PD Analysis Set|Part 1 and 2||6
1635738|NCT00809159|3995785|P5|PD Analysis Set|Part 1 and 2||12
1635739|NCT00809159|3995786|P4|PD Analysis Set|Part 1 and 2||12
1635740|NCT00809159|3995787|P3|PD Analysis Set|Part 1 and 2||28
1635741|NCT00809159|3995788|P2|PD Analysis Set|Part 1 and 2||0
1635742|NCT00809159|3995789|P1|PD Analysis Set|Part 1 and 2||0
1635743|NCT00809159|3995784|P6|PK Analysis Set|Part 1 and 2||6
1635744|NCT00809159|3995785|P5|PK Analysis Set|Part 1 and 2||12
1635745|NCT00809159|3995786|P4|PK Analysis Set|Part 1 and 2||12
1635746|NCT00809159|3995787|P3|PK Analysis Set|Part 1 and 2||30
1635747|NCT00809159|3995788|P2|PK Analysis Set|Part 1 and 2||0
1635748|NCT00809159|3995789|P1|PK Analysis Set|Part 1 and 2||0
1635749|NCT00809159|3995784|P6|STARTED|Part 1 and 2||6
1635750|NCT00809159|3995785|P5|STARTED|Part 1 and 2||12
1635751|NCT00809159|3995786|P4|STARTED|Part 1 and 2||12
1635752|NCT00809159|3995787|P3|STARTED|Part 1 and 2||30
1635753|NCT00809159|3995788|P2|STARTED|Part 1 and 2||0
1635754|NCT00809159|3995789|P1|STARTED|Part 1 and 2||0
1635755|NCT00809159|3995784|P6|NOT COMPLETED|Part 1||0
1635756|NCT00809159|3995785|P5|NOT COMPLETED|Part 1||0
1635757|NCT00809159|3995786|P4|NOT COMPLETED|Part 1||0
1635758|NCT00809159|3995787|P3|NOT COMPLETED|Part 1||0
1635759|NCT00809159|3995788|P2|NOT COMPLETED|Part 1||3
1635760|NCT00809159|3995789|P1|NOT COMPLETED|Part 1||8
1635761|NCT00809159|3995784|P6|COMPLETED|Part 1||0
1635762|NCT00809159|3995785|P5|COMPLETED|Part 1||0
1635763|NCT00809159|3995786|P4|COMPLETED|Part 1||0
1635764|NCT00809159|3995787|P3|COMPLETED|Part 1||0
1635765|NCT00809159|3995788|P2|COMPLETED|Part 1||3
1635766|NCT00809159|3995789|P1|COMPLETED|Part 1||16
1635767|NCT00809159|3995784|P6|PD Analysis Set|Part 1||0
1635768|NCT00809159|3995785|P5|PD Analysis Set|Part 1||0
1635769|NCT00809159|3995786|P4|PD Analysis Set|Part 1||0
1635770|NCT00809159|3995787|P3|PD Analysis Set|Part 1||0
1635771|NCT00809159|3995788|P2|PD Analysis Set|Part 1||6
1635772|NCT00809159|3995789|P1|PD Analysis Set|Part 1||23
1635773|NCT00809159|3995784|P6|PK Analysis Set|Part 1||0
1635774|NCT00809159|3995785|P5|PK Analysis Set|Part 1||0
1635775|NCT00809159|3995786|P4|PK Analysis Set|Part 1||0
1635776|NCT00809159|3995787|P3|PK Analysis Set|Part 1||0
1635777|NCT00809159|3995788|P2|PK Analysis Set|Part 1||6
1635778|NCT00809159|3995789|P1|PK Analysis Set|Part 1||24
1635779|NCT00809159|3995784|P6|STARTED|Part 1||0
1635780|NCT00809159|3995785|P5|STARTED|Part 1||0
1635781|NCT00809159|3995786|P4|STARTED|Part 1||0
1635782|NCT00809159|3995787|P3|STARTED|Part 1||0
1635783|NCT00809159|3995788|P2|STARTED|Part 1||6
1635784|NCT00809159|3995789|P1|STARTED|Part 1||24
1635785|NCT00809146|3995855|P2|NOT COMPLETED|Overall Study||0
1635786|NCT00809146|3995856|P1|NOT COMPLETED|Overall Study||0
1635787|NCT00809146|3995855|P2|COMPLETED|Overall Study||445
1635788|NCT00809146|3995856|P1|COMPLETED|Overall Study||448
1635789|NCT00809146|3995855|P2|STARTED|Overall Study||445
1635790|NCT00809146|3995856|P1|STARTED|Overall Study||448
1635791|NCT00809133|3995894|P14|NOT COMPLETED|Overall Study||7
1635792|NCT00809133|3995895|P13|NOT COMPLETED|Overall Study||5
1635793|NCT00809133|3995896|P12|NOT COMPLETED|Overall Study||8
1635794|NCT00809133|3995897|P11|NOT COMPLETED|Overall Study||6
1635795|NCT00809133|3995898|P10|NOT COMPLETED|Overall Study||9
1635796|NCT00809133|3995899|P9|NOT COMPLETED|Overall Study||3
1635797|NCT00809133|3995900|P8|NOT COMPLETED|Overall Study||8
1635798|NCT00809133|3995901|P7|NOT COMPLETED|Overall Study||6
1635799|NCT00809133|3995902|P6|NOT COMPLETED|Overall Study||7
1635800|NCT00809133|3995903|P5|NOT COMPLETED|Overall Study||5
1635801|NCT00809133|3995904|P4|NOT COMPLETED|Overall Study||3
1635802|NCT00809133|3995905|P3|NOT COMPLETED|Overall Study||6
1635803|NCT00809133|3995906|P2|NOT COMPLETED|Overall Study||7
1635804|NCT00809133|3995907|P1|NOT COMPLETED|Overall Study||3
1635805|NCT00809133|3995894|P14|COMPLETED|Overall Study||0
1635806|NCT00809133|3995895|P13|COMPLETED|Overall Study||0
1635807|NCT00809133|3995896|P12|COMPLETED|Overall Study||0
1635808|NCT00809133|3995897|P11|COMPLETED|Overall Study||0
1635809|NCT00809133|3995898|P10|COMPLETED|Overall Study||0
1635810|NCT00809133|3995899|P9|COMPLETED|Overall Study||0
1635811|NCT00809133|3995900|P8|COMPLETED|Overall Study||0
1635812|NCT00809133|3995901|P7|COMPLETED|Overall Study||0
1635813|NCT00809133|3995902|P6|COMPLETED|Overall Study||0
1635814|NCT00809133|3995903|P5|COMPLETED|Overall Study||0
1635815|NCT00809133|3995904|P4|COMPLETED|Overall Study||0
1635816|NCT00809133|3995905|P3|COMPLETED|Overall Study||0
1635817|NCT00809133|3995906|P2|COMPLETED|Overall Study||0
1635818|NCT00809133|3995907|P1|COMPLETED|Overall Study||0
1635819|NCT00809133|3995894|P14|STARTED|Overall Study||7
1635820|NCT00809133|3995895|P13|STARTED|Overall Study||5
1635821|NCT00809133|3995896|P12|STARTED|Overall Study||8
1635822|NCT00809133|3995897|P11|STARTED|Overall Study||6
1635823|NCT00809133|3995898|P10|STARTED|Overall Study||9
1635824|NCT00809133|3995899|P9|STARTED|Overall Study||3
1635825|NCT00809133|3995900|P8|STARTED|Overall Study||8
1635826|NCT00809133|3995901|P7|STARTED|Overall Study||6
1635827|NCT00809133|3995902|P6|STARTED|Overall Study||7
1635828|NCT00809133|3995903|P5|STARTED|Overall Study||5
1635829|NCT00809133|3995904|P4|STARTED|Overall Study||3
1635830|NCT00809133|3995905|P3|STARTED|Overall Study||6
1635831|NCT00809133|3995906|P2|STARTED|Overall Study||7
1635832|NCT00809133|3995907|P1|STARTED|Overall Study||3
1635833|NCT00809094|3996061|P2|NOT COMPLETED|Overall Study||1
1635834|NCT00809094|3996062|P1|NOT COMPLETED|Overall Study||0
1635835|NCT00809094|3996061|P2|COMPLETED|Overall Study||33
1635836|NCT00809094|3996062|P1|COMPLETED|Overall Study||36
1635837|NCT00809094|3996061|P2|STARTED|Overall Study||34
1635838|NCT00809094|3996062|P1|STARTED|Overall Study||36
1635839|NCT00809055|3996082|P2|NOT COMPLETED|Overall Study||7
1635840|NCT00809055|3996083|P1|NOT COMPLETED|Overall Study||9
1635841|NCT00809055|3996082|P2|COMPLETED|Overall Study||30
1635842|NCT00809055|3996083|P1|COMPLETED|Overall Study||28
1635843|NCT00809055|3996082|P2|STARTED|Overall Study||37
1635844|NCT00809055|3996083|P1|STARTED|Overall Study||37
1635845|NCT00808899|3996107|P1|NOT COMPLETED|Overall Study||4
1635846|NCT00808899|3996107|P1|COMPLETED|Overall Study||0
1635847|NCT00808899|3996107|P1|STARTED|Overall Study||4
1635848|NCT00808834|3996111|P2|NOT COMPLETED|Period 2||0
1635849|NCT00808834|3996112|P1|NOT COMPLETED|Period 2||0
1635850|NCT00808834|3996111|P2|COMPLETED|Period 2||99
1635851|NCT00808834|3996112|P1|COMPLETED|Period 2||97
1635852|NCT00808834|3996111|P2|STARTED|Period 2||99
1635853|NCT00808834|3996112|P1|STARTED|Period 2||97
1635854|NCT00808834|3996111|P2|NOT COMPLETED|Period 1||0
1635855|NCT00808834|3996112|P1|NOT COMPLETED|Period 1||0
1635856|NCT00808834|3996111|P2|COMPLETED|Period 1||99
1635857|NCT00808834|3996112|P1|COMPLETED|Period 1||97
1635858|NCT00808834|3996111|P2|STARTED|Period 1||99
1635859|NCT00808834|3996112|P1|STARTED|Period 1||97
1635860|NCT00808808|3996121|P3|NOT COMPLETED|Overall Study||2557
1635861|NCT00808808|3996122|P2|NOT COMPLETED|Overall Study||2437
1635862|NCT00808808|3996123|P1|NOT COMPLETED|Overall Study||2817
1635863|NCT00808808|3996121|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
1635864|NCT00808808|3996122|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
1635865|NCT00808808|3996123|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
1635866|NCT00808808|3996121|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
1635867|NCT00808808|3996122|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
1635868|NCT00808808|3996123|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
1635869|NCT00808808|3996121|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
1635870|NCT00808808|3996122|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
1635871|NCT00808808|3996123|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
1635872|NCT00808769|3996149|P2|NOT COMPLETED|Second Intervention||0
1635873|NCT00808769|3996150|P1|NOT COMPLETED|Second Intervention||0
1635874|NCT00808769|3996149|P2|COMPLETED|Second Intervention||15
1635875|NCT00808769|3996150|P1|COMPLETED|Second Intervention||15
1635876|NCT00808769|3996149|P2|STARTED|Second Intervention||15
1635877|NCT00808769|3996150|P1|STARTED|Second Intervention||15
1635878|NCT00808769|3996149|P2|NOT COMPLETED|First Intervention||0
1635879|NCT00808769|3996150|P1|NOT COMPLETED|First Intervention||0
1635880|NCT00808769|3996149|P2|COMPLETED|First Intervention||15
1635881|NCT00808769|3996150|P1|COMPLETED|First Intervention||15
1635882|NCT00808769|3996149|P2|STARTED|First Intervention||15
1635883|NCT00808769|3996150|P1|STARTED|First Intervention||15
1635884|NCT00808665|3996158|P2|NOT COMPLETED|Overall Study||3
1635885|NCT00808665|3996159|P1|NOT COMPLETED|Overall Study||6
1635886|NCT00808665|3996158|P2|COMPLETED|Overall Study||29
1635887|NCT00808665|3996159|P1|COMPLETED|Overall Study||25
1635888|NCT00808665|3996158|P2|Completed Post Operative Doses|Overall Study||29
1635889|NCT00808665|3996159|P1|Completed Post Operative Doses|Overall Study||25
1635890|NCT00808665|3996158|P2|Completed Intra-operative Dose|Overall Study||32
1635891|NCT00808665|3996159|P1|Completed Intra-operative Dose|Overall Study||26
1635892|NCT00808665|3996158|P2|Medication Started|Overall Study||32
1635893|NCT00808665|3996159|P1|Medication Started|Overall Study||30
1635894|NCT00808665|3996158|P2|STARTED|Overall Study||32
1635895|NCT00808665|3996159|P1|STARTED|Overall Study||31
1635896|NCT00808639|3996165|P1|NOT COMPLETED|Overall Study||1
1635897|NCT00808639|3996165|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
1635898|NCT00808639|3996165|P1|STARTED|Overall Study||39
1635899|NCT00808509|3996173|P2|NOT COMPLETED|Observation Phase||0
1635900|NCT00808509|3996174|P1|NOT COMPLETED|Observation Phase||0
1635901|NCT00808509|3996173|P2|COMPLETED|Observation Phase||15
1635902|NCT00808509|3996174|P1|COMPLETED|Observation Phase||16
1635903|NCT00808509|3996173|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
1635904|NCT00808509|3996174|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
1635905|NCT00808509|3996173|P2|NOT COMPLETED|Randomized Phase||5
1635906|NCT00808509|3996174|P1|NOT COMPLETED|Randomized Phase||2
1635907|NCT00808509|3996173|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
1635908|NCT00808509|3996174|P1|COMPLETED|Randomized Phase||15
1635909|NCT00808509|3996173|P2|Received Rescue Therapy|Randomized Phase||9
1635910|NCT00808509|3996174|P1|Received Rescue Therapy|Randomized Phase||0
1635911|NCT00808509|3996173|P2|STARTED|Randomized Phase||16
1635912|NCT00808509|3996174|P1|STARTED|Randomized Phase||17
1635913|NCT00808483|3996272|P2|NOT COMPLETED|From 5 Months to 12 Months||0
1635914|NCT00808483|3996273|P1|NOT COMPLETED|From 5 Months to 12 Months||1
1635915|NCT00808483|3996272|P2|COMPLETED|From 5 Months to 12 Months||32
1635916|NCT00808483|3996273|P1|COMPLETED|From 5 Months to 12 Months||32
1635917|NCT00808483|3996272|P2|STARTED|From 5 Months to 12 Months||32
1635918|NCT00808483|3996273|P1|STARTED|From 5 Months to 12 Months||33
1635919|NCT00808483|3996272|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
1635920|NCT00808483|3996273|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
1635921|NCT00808483|3996272|P2|COMPLETED|From 3 to 5 Months After Surgery||32
1635922|NCT00808483|3996273|P1|COMPLETED|From 3 to 5 Months After Surgery||33
1635923|NCT00808483|3996272|P2|STARTED|From 3 to 5 Months After Surgery||33
1635924|NCT00808483|3996273|P1|STARTED|From 3 to 5 Months After Surgery||35
1635925|NCT00808470|3996295|P2|NOT COMPLETED|Overall Study||0
1635926|NCT00808470|3996296|P1|NOT COMPLETED|Overall Study||2
1635927|NCT00808470|3996295|P2|COMPLETED|Overall Study||35
1635928|NCT00808470|3996296|P1|COMPLETED|Overall Study||35
1635929|NCT00808470|3996295|P2|STARTED|Overall Study||35
1635930|NCT00808470|3996296|P1|STARTED|Overall Study||37
1635931|NCT00808444|3996310|P2|NOT COMPLETED|Overall Study||1
1635932|NCT00808444|3996311|P1|NOT COMPLETED|Overall Study||1
1635933|NCT00808444|3996310|P2|COMPLETED|Overall Study||232
1635934|NCT00808444|3996311|P1|COMPLETED|Overall Study||232
1635935|NCT00808444|3996310|P2|STARTED|Overall Study||233
1635936|NCT00808444|3996311|P1|STARTED|Overall Study||233
1635937|NCT00808405|3996351|P2|NOT COMPLETED|Overall Study||0
1635938|NCT00808405|3996352|P1|NOT COMPLETED|Overall Study||0
1635939|NCT00808405|3996351|P2|COMPLETED|Overall Study||27
1635940|NCT00808405|3996352|P1|COMPLETED|Overall Study||61
1635941|NCT00808405|3996351|P2|STARTED|Overall Study||27
1635942|NCT00808405|3996352|P1|STARTED|Overall Study||61
1635943|NCT00808340|3996360|P6|NOT COMPLETED|Third Intervention||0
1635944|NCT00808340|3996361|P5|NOT COMPLETED|Third Intervention||0
1635945|NCT00808340|3996362|P4|NOT COMPLETED|Third Intervention||0
1635946|NCT00808340|3996363|P3|NOT COMPLETED|Third Intervention||0
1635947|NCT00808340|3996364|P2|NOT COMPLETED|Third Intervention||0
1635948|NCT00808340|3996365|P1|NOT COMPLETED|Third Intervention||0
1635949|NCT00808340|3996360|P6|COMPLETED|Third Intervention||6
1635950|NCT00808340|3996361|P5|COMPLETED|Third Intervention||5
1635951|NCT00808340|3996362|P4|COMPLETED|Third Intervention||3
1635952|NCT00808340|3996363|P3|COMPLETED|Third Intervention||7
1635953|NCT00808340|3996364|P2|COMPLETED|Third Intervention||9
1635954|NCT00808340|3996365|P1|COMPLETED|Third Intervention||4
1635955|NCT00808340|3996360|P6|STARTED|Third Intervention||6
1635956|NCT00808340|3996361|P5|STARTED|Third Intervention||5
1635957|NCT00808340|3996362|P4|STARTED|Third Intervention||3
1635958|NCT00808340|3996363|P3|STARTED|Third Intervention||7
1635959|NCT00808340|3996364|P2|STARTED|Third Intervention||9
1635960|NCT00808340|3996365|P1|STARTED|Third Intervention||4
1635961|NCT00808340|3996360|P6|NOT COMPLETED|Second Intervention||0
1635962|NCT00808340|3996361|P5|NOT COMPLETED|Second Intervention||0
1635963|NCT00808340|3996362|P4|NOT COMPLETED|Second Intervention||0
1635964|NCT00808340|3996363|P3|NOT COMPLETED|Second Intervention||0
1635965|NCT00808340|3996364|P2|NOT COMPLETED|Second Intervention||0
1635966|NCT00808340|3996365|P1|NOT COMPLETED|Second Intervention||0
1635967|NCT00808340|3996360|P6|COMPLETED|Second Intervention||6
1635968|NCT00808340|3996361|P5|COMPLETED|Second Intervention||5
1635969|NCT00808340|3996362|P4|COMPLETED|Second Intervention||3
1635970|NCT00808340|3996363|P3|COMPLETED|Second Intervention||7
1635971|NCT00808340|3996364|P2|COMPLETED|Second Intervention||9
1635972|NCT00808340|3996365|P1|COMPLETED|Second Intervention||4
1635973|NCT00808340|3996360|P6|STARTED|Second Intervention||6
1635974|NCT00808340|3996361|P5|STARTED|Second Intervention||5
1635975|NCT00808340|3996362|P4|STARTED|Second Intervention||3
1635976|NCT00808340|3996363|P3|STARTED|Second Intervention||7
1635977|NCT00808340|3996364|P2|STARTED|Second Intervention||9
1635978|NCT00808340|3996365|P1|STARTED|Second Intervention||4
1635979|NCT00808340|3996360|P6|NOT COMPLETED|First Intervention||0
1635980|NCT00808340|3996361|P5|NOT COMPLETED|First Intervention||0
1635981|NCT00808340|3996362|P4|NOT COMPLETED|First Intervention||0
1635982|NCT00808340|3996363|P3|NOT COMPLETED|First Intervention||0
1635983|NCT00808340|3996364|P2|NOT COMPLETED|First Intervention||0
1635984|NCT00808340|3996365|P1|NOT COMPLETED|First Intervention||0
1635985|NCT00808340|3996360|P6|COMPLETED|First Intervention||6
1635986|NCT00808340|3996361|P5|COMPLETED|First Intervention||5
1635987|NCT00808340|3996362|P4|COMPLETED|First Intervention||3
1635988|NCT00808340|3996363|P3|COMPLETED|First Intervention||7
1635989|NCT00808340|3996364|P2|COMPLETED|First Intervention||9
1635990|NCT00808340|3996365|P1|COMPLETED|First Intervention||4
1635991|NCT00808340|3996360|P6|STARTED|First Intervention||6
1635992|NCT00808340|3996361|P5|STARTED|First Intervention||5
1635993|NCT00808340|3996362|P4|STARTED|First Intervention||3
1635994|NCT00808340|3996363|P3|STARTED|First Intervention||7
1635995|NCT00808340|3996364|P2|STARTED|First Intervention||9
1635996|NCT00808340|3996365|P1|STARTED|First Intervention||4
1635997|NCT00808249|3996386|P4|NOT COMPLETED|Overall Study||16
1635998|NCT00808249|3996387|P3|NOT COMPLETED|Overall Study||22
1635999|NCT00808249|3996388|P2|NOT COMPLETED|Overall Study||15
1636000|NCT00808249|3996389|P1|NOT COMPLETED|Overall Study||17
1636001|NCT00808249|3996386|P4|COMPLETED|Overall Study||90
1636002|NCT00808249|3996387|P3|COMPLETED|Overall Study||83
1636003|NCT00808249|3996388|P2|COMPLETED|Overall Study||91
1636004|NCT00808249|3996389|P1|COMPLETED|Overall Study||90
1636005|NCT00808249|3996386|P4|STARTED|Overall Study||106
1636006|NCT00808249|3996387|P3|STARTED|Overall Study||105
1636007|NCT00808249|3996388|P2|STARTED|Overall Study||106
1636008|NCT00808249|3996389|P1|STARTED|Overall Study||107
1636009|NCT00808236|3996417|P2|NOT COMPLETED|Overall Study||91
1636010|NCT00808236|3996418|P1|NOT COMPLETED|Overall Study||82
1636011|NCT00808236|3996417|P2|COMPLETED|Overall Study||13
1636012|NCT00808236|3996418|P1|COMPLETED|Overall Study||14
1636013|NCT00808236|3996417|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
1636014|NCT00808236|3996418|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
1636015|NCT00808236|3996417|P2|Achieved ROSC|Overall Study||43
1636016|NCT00808236|3996418|P1|Achieved ROSC|Overall Study||33
1636017|NCT00808236|3996417|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
1636018|NCT00808236|3996418|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
1636019|NCT00808236|3996417|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
1636020|NCT00808236|3996418|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
1636021|NCT00808236|3996417|P2|STARTED|Overall Study||104
1636022|NCT00808236|3996418|P1|STARTED|Overall Study||96
1636023|NCT00808132|3996451|P5|NOT COMPLETED|Overall Study||100
1636024|NCT00808132|3996452|P4|NOT COMPLETED|Overall Study||69
1636025|NCT00808132|3996453|P3|NOT COMPLETED|Overall Study||54
1636026|NCT00808132|3996454|P2|NOT COMPLETED|Overall Study||88
1636027|NCT00808132|3996455|P1|NOT COMPLETED|Overall Study||98
1636028|NCT00808132|3996451|P5|COMPLETED|Overall Study||383
1636029|NCT00808132|3996452|P4|COMPLETED|Overall Study||159
1636030|NCT00808132|3996453|P3|COMPLETED|Overall Study||185
1636031|NCT00808132|3996454|P2|COMPLETED|Overall Study||393
1636032|NCT00808132|3996455|P1|COMPLETED|Overall Study||357
1636033|NCT00808132|3996451|P5|Treated|Overall Study||474
1636034|NCT00808132|3996452|P4|Treated|Overall Study||220
1636035|NCT00808132|3996453|P3|Treated|Overall Study||230
1636036|NCT00808132|3996454|P2|Treated|Overall Study||474
1636037|NCT00808132|3996455|P1|Treated|Overall Study||445
1636038|NCT00808132|3996451|P5|STARTED|Overall Study||483
1636039|NCT00808132|3996452|P4|STARTED|Overall Study||228
1636040|NCT00808132|3996453|P3|STARTED|Overall Study||239
1636041|NCT00808132|3996454|P2|STARTED|Overall Study||481
1636042|NCT00808132|3996455|P1|STARTED|Overall Study||455
1636043|NCT00808080|3996527|P1|NOT COMPLETED|Overall Study||6
1636044|NCT00808080|3996527|P1|COMPLETED|Overall Study||0
1636045|NCT00808080|3996527|P1|STARTED|Overall Study||6
1636046|NCT00808067|3996533|P2|NOT COMPLETED|Overall Study||518
1636047|NCT00808067|3996534|P1|NOT COMPLETED|Overall Study||481
1636048|NCT00808067|3996533|P2|COMPLETED|Overall Study||2438
1636049|NCT00808067|3996534|P1|COMPLETED|Overall Study||2446
1636050|NCT00808067|3996533|P2|STARTED|Overall Study|Number of patients which are treated.|2956
1636051|NCT00808067|3996534|P1|STARTED|Overall Study|Number of patients which are treated.|2927
1636052|NCT00808028|3996570|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
1636053|NCT00808028|3996571|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
1636054|NCT00808028|3996572|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
1636055|NCT00808028|3996573|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
1636056|NCT00808028|3996570|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
1636057|NCT00808028|3996571|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
1636058|NCT00808028|3996572|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
1636059|NCT00808028|3996573|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
1636060|NCT00808028|3996570|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
1636061|NCT00808028|3996571|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
1636062|NCT00808028|3996572|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
1636063|NCT00808028|3996573|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
1636064|NCT00808028|3996570|P4|NOT COMPLETED|Stage 1 (6 Months)||15
1636065|NCT00808028|3996571|P3|NOT COMPLETED|Stage 1 (6 Months)||7
1636066|NCT00808028|3996572|P2|NOT COMPLETED|Stage 1 (6 Months)||1
1636067|NCT00808028|3996573|P1|NOT COMPLETED|Stage 1 (6 Months)||5
1636068|NCT00808028|3996570|P4|COMPLETED|Stage 1 (6 Months)||183
1636069|NCT00808028|3996571|P3|COMPLETED|Stage 1 (6 Months)||191
1636070|NCT00808028|3996572|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
1636071|NCT00808028|3996573|P1|COMPLETED|Stage 1 (6 Months)||116
1636072|NCT00808028|3996570|P4|STARTED|Stage 1 (6 Months)||198
1636073|NCT00808028|3996571|P3|STARTED|Stage 1 (6 Months)||198
1636074|NCT00808028|3996572|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
1636075|NCT00808028|3996573|P1|STARTED|Stage 1 (6 Months)||121
1636076|NCT00808015|3996609|P1|NOT COMPLETED|Overall Study||344
1636077|NCT00808015|3996609|P1|COMPLETED|Overall Study||1033
1636078|NCT00808015|3996609|P1|Treated|Overall Study||1373
1636079|NCT00808015|3996609|P1|STARTED|Overall Study||1377
1636080|NCT00807989|3996623|P2|NOT COMPLETED|Overall Study||2
1636081|NCT00807989|3996624|P1|NOT COMPLETED|Overall Study||3
1636082|NCT00807989|3996623|P2|COMPLETED|Overall Study||98
1636083|NCT00807989|3996624|P1|COMPLETED|Overall Study||104
1636084|NCT00807989|3996623|P2|STARTED|Overall Study||100
1636085|NCT00807989|3996624|P1|STARTED|Overall Study||107
1636086|NCT00807937|3996638|P4|NOT COMPLETED|Overall Study||15
1636087|NCT00807937|3996639|P3|NOT COMPLETED|Overall Study||14
1636088|NCT00807937|3996640|P2|NOT COMPLETED|Overall Study||25
1636089|NCT00807937|3996641|P1|NOT COMPLETED|Overall Study||27
1636090|NCT00807937|3996638|P4|COMPLETED|Overall Study||77
1636091|NCT00807937|3996639|P3|COMPLETED|Overall Study||78
1636092|NCT00807937|3996640|P2|COMPLETED|Overall Study||67
1636093|NCT00807937|3996641|P1|COMPLETED|Overall Study||66
1636094|NCT00807937|3996638|P4|STARTED|Overall Study||92
1636095|NCT00807937|3996639|P3|STARTED|Overall Study||92
1636096|NCT00807937|3996640|P2|STARTED|Overall Study||92
1636097|NCT00807937|3996641|P1|STARTED|Overall Study||93
1636098|NCT00807885|3996676|P9|NOT COMPLETED|Overall Study||0
1636099|NCT00807885|3996677|P8|NOT COMPLETED|Overall Study||0
1636100|NCT00807885|3996678|P7|NOT COMPLETED|Overall Study||0
1636101|NCT00807885|3996679|P6|NOT COMPLETED|Overall Study||1
1636102|NCT00807885|3996680|P5|NOT COMPLETED|Overall Study||0
1636103|NCT00807885|3996681|P4|NOT COMPLETED|Overall Study||0
1636104|NCT00807885|3996682|P3|NOT COMPLETED|Overall Study||0
1636105|NCT00807885|3996683|P2|NOT COMPLETED|Overall Study||0
1636106|NCT00807885|3996684|P1|NOT COMPLETED|Overall Study||0
1636107|NCT00807885|3996676|P9|COMPLETED|Overall Study||11
1636108|NCT00807885|3996677|P8|COMPLETED|Overall Study||11
1636109|NCT00807885|3996678|P7|COMPLETED|Overall Study||12
1636110|NCT00807885|3996679|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
1636111|NCT00807885|3996680|P5|COMPLETED|Overall Study||12
1636112|NCT00807885|3996681|P4|COMPLETED|Overall Study||10
1636113|NCT00807885|3996682|P3|COMPLETED|Overall Study||11
1636114|NCT00807885|3996683|P2|COMPLETED|Overall Study||11
1636115|NCT00807885|3996684|P1|COMPLETED|Overall Study||10
1636116|NCT00807885|3996676|P9|STARTED|Overall Study||11
1636117|NCT00807885|3996677|P8|STARTED|Overall Study||11
1636118|NCT00807885|3996678|P7|STARTED|Overall Study||12
1636119|NCT00807885|3996679|P6|STARTED|Overall Study||12
1636120|NCT00807885|3996680|P5|STARTED|Overall Study||12
1636121|NCT00807885|3996681|P4|STARTED|Overall Study||10
1636122|NCT00807885|3996682|P3|STARTED|Overall Study||11
1636123|NCT00807885|3996683|P2|STARTED|Overall Study||11
1636124|NCT00807885|3996684|P1|STARTED|Overall Study||10
1636125|NCT00807846|3996733|P2|NOT COMPLETED|Overall Study||4
1636126|NCT00807846|3996734|P1|NOT COMPLETED|Overall Study||12
1636127|NCT00807846|3996733|P2|COMPLETED|Overall Study||94
1636128|NCT00807846|3996734|P1|COMPLETED|Overall Study||88
1636129|NCT00807846|3996733|P2|STARTED|Overall Study||98
1636130|NCT00807846|3996734|P1|STARTED|Overall Study||100
1636131|NCT00807768|3996768|P2|NOT COMPLETED|Overall Study||0
1636132|NCT00807768|3996769|P1|NOT COMPLETED|Overall Study||0
1636133|NCT00807768|3996768|P2|COMPLETED|Overall Study||300
1636134|NCT00807768|3996769|P1|COMPLETED|Overall Study||301
1636135|NCT00807768|3996768|P2|STARTED|Overall Study||300
1636136|NCT00807768|3996769|P1|STARTED|Overall Study||301
1636137|NCT00807664|3996787|P2|NOT COMPLETED|Overall Study||19
1636138|NCT00807664|3996788|P1|NOT COMPLETED|Overall Study||11
1636139|NCT00807664|3996787|P2|COMPLETED|Overall Study||75
1636140|NCT00807664|3996788|P1|COMPLETED|Overall Study||77
1636141|NCT00807664|3996787|P2|STARTED|Overall Study||94
1636142|NCT00807664|3996788|P1|STARTED|Overall Study||88
1636143|NCT00807573|3996798|P1|NOT COMPLETED|Overall Study||2
1636144|NCT00807573|3996798|P1|COMPLETED|Overall Study||42
1636145|NCT00807573|3996798|P1|STARTED|Overall Study||44
1636146|NCT00807560|3996804|P2|NOT COMPLETED|Overall Study||0
1636147|NCT00807560|3996805|P1|NOT COMPLETED|Overall Study||0
1636148|NCT00807560|3996804|P2|COMPLETED|Overall Study||39
1636149|NCT00807560|3996805|P1|COMPLETED|Overall Study||38
1636150|NCT00807560|3996804|P2|STARTED|Overall Study||39
1636151|NCT00807560|3996805|P1|STARTED|Overall Study||38
1636152|NCT00807495|3996844|P5|NOT COMPLETED|Overall Study||5
1636153|NCT00807495|3996845|P4|NOT COMPLETED|Overall Study||1
1636154|NCT00807495|3996846|P3|NOT COMPLETED|Overall Study||4
1636155|NCT00807495|3996847|P2|NOT COMPLETED|Overall Study||6
1636156|NCT00807495|3996848|P1|NOT COMPLETED|Overall Study||8
1636157|NCT00807495|3996844|P5|COMPLETED|Overall Study||2
1636158|NCT00807495|3996845|P4|COMPLETED|Overall Study||0
1636159|NCT00807495|3996846|P3|COMPLETED|Overall Study||1
1636160|NCT00807495|3996847|P2|COMPLETED|Overall Study||7
1636161|NCT00807495|3996848|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
1636162|NCT00807495|3996844|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
1636163|NCT00807495|3996845|P4|STARTED|Overall Study||1
1636164|NCT00807495|3996846|P3|STARTED|Overall Study||5
1636165|NCT00807495|3996847|P2|STARTED|Overall Study||13
1636166|NCT00807495|3996848|P1|STARTED|Overall Study||22
1636167|NCT00807456|3996890|P1|NOT COMPLETED|Overall Study||0
1636168|NCT00807456|3996890|P1|COMPLETED|Overall Study||65
1636169|NCT00807456|3996890|P1|STARTED|Overall Study||65
1636170|NCT00807365|3996894|P1|NOT COMPLETED|Overall Study||5
1636171|NCT00807365|3996894|P1|COMPLETED|Overall Study||0
1636172|NCT00807365|3996894|P1|STARTED|Overall Study||5
1636173|NCT00807248|3996902|P4|NOT COMPLETED|Overall Study||14
1636174|NCT00807248|3996903|P3|NOT COMPLETED|Overall Study||18
1636175|NCT00807248|3996904|P2|NOT COMPLETED|Overall Study||12
1636176|NCT00807248|3996905|P1|NOT COMPLETED|Overall Study||21
1636177|NCT00807248|3996902|P4|COMPLETED|Overall Study||126
1636178|NCT00807248|3996903|P3|COMPLETED|Overall Study||121
1636179|NCT00807248|3996904|P2|COMPLETED|Overall Study||128
1636180|NCT00807248|3996905|P1|COMPLETED|Overall Study||50
1636181|NCT00807248|3996902|P4|STARTED|Overall Study||140
1636182|NCT00807248|3996903|P3|STARTED|Overall Study||139
1636183|NCT00807248|3996904|P2|STARTED|Overall Study||140
1636184|NCT00807248|3996905|P1|STARTED|Overall Study||71
1636185|NCT00807235|3996949|P2|NOT COMPLETED|Overall Study||0
1636186|NCT00807235|3996950|P1|NOT COMPLETED|Overall Study||1
1636187|NCT00807235|3996949|P2|COMPLETED|Overall Study||6
1636188|NCT00807235|3996950|P1|COMPLETED|Overall Study||10
1636189|NCT00807235|3996949|P2|STARTED|Overall Study||6
1636190|NCT00807235|3996950|P1|STARTED|Overall Study||11
1636191|NCT00807209|3996983|P3|NOT COMPLETED|Overall Study||0
1636192|NCT00807209|3996984|P2|NOT COMPLETED|Overall Study||0
1636193|NCT00807209|3996985|P1|NOT COMPLETED|Overall Study||0
1636194|NCT00807209|3996983|P3|COMPLETED|Overall Study||1
1636195|NCT00807209|3996984|P2|COMPLETED|Overall Study||1
1636196|NCT00807209|3996985|P1|COMPLETED|Overall Study||1
1636197|NCT00807209|3996983|P3|STARTED|Overall Study||1
1636198|NCT00807209|3996984|P2|STARTED|Overall Study||1
1636199|NCT00807209|3996985|P1|STARTED|Overall Study||1
1636200|NCT00807092|3996995|P2|NOT COMPLETED|Overall Study||4
1636201|NCT00807092|3996996|P1|NOT COMPLETED|Overall Study||1
1636202|NCT00807092|3996995|P2|COMPLETED|Overall Study||69
1636203|NCT00807092|3996996|P1|COMPLETED|Overall Study||71
1636204|NCT00807092|3996995|P2|Exposed to Drug|Overall Study||73
1636205|NCT00807092|3996996|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
1636206|NCT00807092|3996995|P2|STARTED|Overall Study||73
1636207|NCT00807092|3996996|P1|STARTED|Overall Study||72
1636208|NCT00807040|3997026|P2|NOT COMPLETED|Overall Study||41
1636209|NCT00807040|3997027|P1|NOT COMPLETED|Overall Study||36
1636210|NCT00807040|3997026|P2|COMPLETED|Overall Study||84
1636211|NCT00807040|3997027|P1|COMPLETED|Overall Study||90
1636212|NCT00807040|3997026|P2|STARTED|Overall Study||125
1636213|NCT00807040|3997027|P1|STARTED|Overall Study||126
1636214|NCT00807014|3997037|P2|NOT COMPLETED|Overall Study||27
1636215|NCT00807014|3997038|P1|NOT COMPLETED|Overall Study||27
1636216|NCT00807014|3997037|P2|COMPLETED|Overall Study||58
1636217|NCT00807014|3997038|P1|COMPLETED|Overall Study||56
1636218|NCT00807014|3997037|P2|STARTED|Overall Study||85
1636219|NCT00807014|3997038|P1|STARTED|Overall Study||83
1636220|NCT00807001|3997069|P5|NOT COMPLETED|Overall Study||0
1636221|NCT00807001|3997070|P4|NOT COMPLETED|Overall Study||0
1636222|NCT00807001|3997071|P3|NOT COMPLETED|Overall Study||0
1636223|NCT00807001|3997072|P2|NOT COMPLETED|Overall Study||1
1636224|NCT00807001|3997073|P1|NOT COMPLETED|Overall Study||0
1636225|NCT00807001|3997069|P5|COMPLETED|Overall Study||9
1636226|NCT00807001|3997070|P4|COMPLETED|Overall Study||8
1636227|NCT00807001|3997071|P3|COMPLETED|Overall Study||8
1636228|NCT00807001|3997072|P2|COMPLETED|Overall Study||7
1636229|NCT00807001|3997073|P1|COMPLETED|Overall Study||8
1636230|NCT00807001|3997069|P5|STARTED|Overall Study||9
1636231|NCT00807001|3997070|P4|STARTED|Overall Study||8
1636232|NCT00807001|3997071|P3|STARTED|Overall Study||8
1636233|NCT00807001|3997072|P2|STARTED|Overall Study||8
1636234|NCT00807001|3997073|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
1636235|NCT00806988|3997092|P2|NOT COMPLETED|Overall Study||43
1636236|NCT00806988|3997093|P1|NOT COMPLETED|Overall Study||27
1636237|NCT00806988|3997092|P2|COMPLETED|Overall Study||108
1636238|NCT00806988|3997093|P1|COMPLETED|Overall Study||123
1636239|NCT00806988|3997092|P2|STARTED|Overall Study||151
1636240|NCT00806988|3997093|P1|STARTED|Overall Study||150
1636241|NCT00806819|3997103|P2|NOT COMPLETED|Overall Study||358
1636242|NCT00806819|3997104|P1|NOT COMPLETED|Overall Study||346
1636243|NCT00806819|3997103|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
1636244|NCT00806819|3997104|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
1636245|NCT00806819|3997103|P2|STARTED|Overall Study|randomised patients|360
1636246|NCT00806819|3997104|P1|STARTED|Overall Study|randomised patients|353
1636247|NCT00806676|3997139|P3|NOT COMPLETED|Overall Study||6
1636248|NCT00806676|3997140|P2|NOT COMPLETED|Overall Study||0
1636249|NCT00806676|3997141|P1|NOT COMPLETED|Overall Study||4
1636250|NCT00806676|3997139|P3|COMPLETED|Overall Study||23
1636251|NCT00806676|3997140|P2|COMPLETED|Overall Study||9
1636252|NCT00806676|3997141|P1|COMPLETED|Overall Study||25
1636253|NCT00806676|3997139|P3|STARTED|Overall Study||29
1636254|NCT00806676|3997140|P2|STARTED|Overall Study||9
1636255|NCT00806676|3997141|P1|STARTED|Overall Study||29
1636256|NCT00806624|3997173|P3|NOT COMPLETED|Overall Study||6
1636257|NCT00806624|3997174|P2|NOT COMPLETED|Overall Study||12
1636258|NCT00806624|3997175|P1|NOT COMPLETED|Overall Study||9
1636259|NCT00806624|3997173|P3|COMPLETED|Overall Study||69
1636260|NCT00806624|3997174|P2|COMPLETED|Overall Study||68
1636261|NCT00806624|3997175|P1|COMPLETED|Overall Study||70
1636262|NCT00806624|3997173|P3|STARTED|Overall Study||75
1636263|NCT00806624|3997174|P2|STARTED|Overall Study||80
1636264|NCT00806624|3997175|P1|STARTED|Overall Study||79
1636265|NCT00806598|3997183|P1|NOT COMPLETED|Overall Study||0
1636266|NCT00806598|3997183|P1|COMPLETED|Overall Study||48
1636267|NCT00806598|3997183|P1|STARTED|Overall Study||48
1636268|NCT00806585|3997192|P5|NOT COMPLETED|Overall Study||31
1636269|NCT00806585|3997193|P4|NOT COMPLETED|Overall Study||15
1636270|NCT00806585|3997194|P3|NOT COMPLETED|Overall Study||32
1636271|NCT00806585|3997195|P2|NOT COMPLETED|Overall Study||31
1636272|NCT00806585|3997196|P1|NOT COMPLETED|Overall Study||32
1636273|NCT00806585|3997192|P5|COMPLETED|Overall Study||106
1636274|NCT00806585|3997193|P4|COMPLETED|Overall Study||56
1636275|NCT00806585|3997194|P3|COMPLETED|Overall Study||109
1636276|NCT00806585|3997195|P2|COMPLETED|Overall Study||103
1636277|NCT00806585|3997196|P1|COMPLETED|Overall Study||105
1636278|NCT00806585|3997192|P5|STARTED|Overall Study||137
1636279|NCT00806585|3997193|P4|STARTED|Overall Study||71
1636280|NCT00806585|3997194|P3|STARTED|Overall Study||141
1636281|NCT00806585|3997195|P2|STARTED|Overall Study||134
1636282|NCT00806585|3997196|P1|STARTED|Overall Study||137
1636283|NCT00806546|3997228|P1|NOT COMPLETED|Overall Study||307
1636284|NCT00806546|3997228|P1|COMPLETED|Overall Study||207
1636285|NCT00806546|3997228|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
1636286|NCT00806494|3997232|P1|NOT COMPLETED|Overall Study||80
1636287|NCT00806494|3997232|P1|COMPLETED|Overall Study||251
1636288|NCT00806494|3997232|P1|STARTED|Overall Study||331
1636289|NCT00806442|3997256|P2|NOT COMPLETED|Overall Study||7
1636290|NCT00806442|3997257|P1|NOT COMPLETED|Overall Study||4
1636291|NCT00806442|3997256|P2|COMPLETED|Overall Study||14
1636292|NCT00806442|3997257|P1|COMPLETED|Overall Study||14
1636293|NCT00806442|3997256|P2|Second Intervention (3 Wks)|Overall Study||14
1636294|NCT00806442|3997257|P1|Second Intervention (3 Wks)|Overall Study||15
1636295|NCT00806442|3997256|P2|Washout (3 Wks)|Overall Study||14
1636296|NCT00806442|3997257|P1|Washout (3 Wks)|Overall Study||15
1636297|NCT00806442|3997256|P2|First Intervention (3 Wks)|Overall Study||21
1636298|NCT00806442|3997257|P1|First Intervention (3 Wks)|Overall Study||18
1636299|NCT00806442|3997256|P2|STARTED|Overall Study||21
1636300|NCT00806442|3997257|P1|STARTED|Overall Study||18
1636301|NCT00806416|3997279|P4|NOT COMPLETED|Period 2 - Part II||0
1636302|NCT00806416|3997280|P3|NOT COMPLETED|Period 2 - Part II||0
1636303|NCT00806416|3997281|P2|NOT COMPLETED|Period 2 - Part II||0
1636304|NCT00806416|3997282|P1|NOT COMPLETED|Period 2 - Part II||0
1636305|NCT00806416|3997279|P4|COMPLETED|Period 2 - Part II||14
1636306|NCT00806416|3997280|P3|COMPLETED|Period 2 - Part II||14
1636307|NCT00806416|3997281|P2|COMPLETED|Period 2 - Part II||0
1636308|NCT00806416|3997282|P1|COMPLETED|Period 2 - Part II||0
1636309|NCT00806416|3997279|P4|STARTED|Period 2 - Part II||14
1636310|NCT00806416|3997280|P3|STARTED|Period 2 - Part II||14
1636311|NCT00806416|3997281|P2|STARTED|Period 2 - Part II||0
1636312|NCT00806416|3997282|P1|STARTED|Period 2 - Part II||0
1636313|NCT00806416|3997279|P4|NOT COMPLETED|Period 1 - Part II||2
1636314|NCT00806416|3997280|P3|NOT COMPLETED|Period 1 - Part II||0
1636315|NCT00806416|3997281|P2|NOT COMPLETED|Period 1 - Part II||0
1636316|NCT00806416|3997282|P1|NOT COMPLETED|Period 1 - Part II||0
1636317|NCT00806416|3997279|P4|COMPLETED|Period 1 - Part II||14
1636318|NCT00806416|3997280|P3|COMPLETED|Period 1 - Part II||14
1636319|NCT00806416|3997281|P2|COMPLETED|Period 1 - Part II||0
1636320|NCT00806416|3997282|P1|COMPLETED|Period 1 - Part II||0
1636321|NCT00806416|3997279|P4|STARTED|Period 1 - Part II||16
1636322|NCT00806416|3997280|P3|STARTED|Period 1 - Part II||14
1636323|NCT00806416|3997281|P2|STARTED|Period 1 - Part II||0
1636324|NCT00806416|3997282|P1|STARTED|Period 1 - Part II||0
1636325|NCT00806416|3997279|P4|NOT COMPLETED|Period 2 - Part I||0
1636326|NCT00806416|3997280|P3|NOT COMPLETED|Period 2 - Part I||0
1636327|NCT00806416|3997281|P2|NOT COMPLETED|Period 2 - Part I||0
1636328|NCT00806416|3997282|P1|NOT COMPLETED|Period 2 - Part I||0
1636329|NCT00806416|3997279|P4|COMPLETED|Period 2 - Part I||0
1636330|NCT00806416|3997280|P3|COMPLETED|Period 2 - Part I||0
1636331|NCT00806416|3997281|P2|COMPLETED|Period 2 - Part I||103
1636332|NCT00806416|3997282|P1|COMPLETED|Period 2 - Part I||104
1636333|NCT00806416|3997279|P4|STARTED|Period 2 - Part I||0
1636334|NCT00806416|3997280|P3|STARTED|Period 2 - Part I||0
1636335|NCT00806416|3997281|P2|STARTED|Period 2 - Part I||103
1636336|NCT00806416|3997282|P1|STARTED|Period 2 - Part I||104
1636337|NCT00806416|3997279|P4|NOT COMPLETED|Period 1 - Part I||0
1636338|NCT00806416|3997280|P3|NOT COMPLETED|Period 1 - Part I||0
1636339|NCT00806416|3997281|P2|NOT COMPLETED|Period 1 - Part I||4
1636340|NCT00806416|3997282|P1|NOT COMPLETED|Period 1 - Part I||3
1636341|NCT00806416|3997279|P4|COMPLETED|Period 1 - Part I||0
1636342|NCT00806416|3997280|P3|COMPLETED|Period 1 - Part I||0
1636343|NCT00806416|3997281|P2|COMPLETED|Period 1 - Part I||103
1636344|NCT00806416|3997282|P1|COMPLETED|Period 1 - Part I||104
1636345|NCT00806416|3997279|P4|STARTED|Period 1 - Part I||0
1636346|NCT00806416|3997280|P3|STARTED|Period 1 - Part I||0
1636347|NCT00806416|3997281|P2|STARTED|Period 1 - Part I||107
1636348|NCT00806416|3997282|P1|STARTED|Period 1 - Part I||107
1636349|NCT00806403|3997295|P2|NOT COMPLETED|Overall Study||3
1636350|NCT00806403|3997296|P1|NOT COMPLETED|Overall Study||4
1636351|NCT00806403|3997295|P2|COMPLETED|Overall Study||98
1636352|NCT00806403|3997296|P1|COMPLETED|Overall Study||100
1636353|NCT00806403|3997295|P2|STARTED|Overall Study||101
1636354|NCT00806403|3997296|P1|STARTED|Overall Study||104
1636355|NCT00806390|3997310|P2|NOT COMPLETED|Overall Study||0
1636356|NCT00806390|3997311|P1|NOT COMPLETED|Overall Study||0
1636357|NCT00806390|3997310|P2|COMPLETED|Overall Study||8
1636358|NCT00806390|3997311|P1|COMPLETED|Overall Study||7
1636359|NCT00806390|3997310|P2|STARTED|Overall Study||8
1636360|NCT00806390|3997311|P1|STARTED|Overall Study||7
1636361|NCT00806351|3997319|P2|NOT COMPLETED|Overall Study||4
1636362|NCT00806351|3997320|P1|NOT COMPLETED|Overall Study||5
1636363|NCT00806351|3997319|P2|COMPLETED|Overall Study||2
1636364|NCT00806351|3997320|P1|COMPLETED|Overall Study||10
1636365|NCT00806351|3997319|P2|STARTED|Overall Study||6
1636366|NCT00806351|3997320|P1|STARTED|Overall Study||15
1636367|NCT00806260|3997357|P6|NOT COMPLETED|Period 3||0
1636368|NCT00806260|3997358|P5|NOT COMPLETED|Period 3||0
1636369|NCT00806260|3997359|P4|NOT COMPLETED|Period 3||0
1636370|NCT00806260|3997360|P3|NOT COMPLETED|Period 3||1
1636371|NCT00806260|3997361|P2|NOT COMPLETED|Period 3||1
1636372|NCT00806260|3997362|P1|NOT COMPLETED|Period 3||1
1636373|NCT00806260|3997357|P6|COMPLETED|Period 3||0
1636374|NCT00806260|3997358|P5|COMPLETED|Period 3||0
1636375|NCT00806260|3997359|P4|COMPLETED|Period 3||12
1636376|NCT00806260|3997360|P3|COMPLETED|Period 3||5
1636377|NCT00806260|3997361|P2|COMPLETED|Period 3||7
1636378|NCT00806260|3997362|P1|COMPLETED|Period 3||12
1636379|NCT00806260|3997357|P6|STARTED|Period 3||0
1636380|NCT00806260|3997358|P5|STARTED|Period 3||0
1636381|NCT00806260|3997359|P4|STARTED|Period 3||12
1636382|NCT00806260|3997360|P3|STARTED|Period 3||6
1636383|NCT00806260|3997361|P2|STARTED|Period 3||8
1636384|NCT00806260|3997362|P1|STARTED|Period 3||13
1636385|NCT00806260|3997357|P6|NOT COMPLETED|Period 2||0
1636386|NCT00806260|3997358|P5|NOT COMPLETED|Period 2||0
1636387|NCT00806260|3997359|P4|NOT COMPLETED|Period 2||2
1636388|NCT00806260|3997360|P3|NOT COMPLETED|Period 2||2
1636389|NCT00806260|3997361|P2|NOT COMPLETED|Period 2||0
1636390|NCT00806260|3997362|P1|NOT COMPLETED|Period 2||2
1636391|NCT00806260|3997357|P6|COMPLETED|Period 2||0
1636392|NCT00806260|3997358|P5|COMPLETED|Period 2||0
1636393|NCT00806260|3997359|P4|COMPLETED|Period 2||12
1636394|NCT00806260|3997360|P3|COMPLETED|Period 2||6
1636395|NCT00806260|3997361|P2|COMPLETED|Period 2||8
1636396|NCT00806260|3997362|P1|COMPLETED|Period 2||13
1636397|NCT00806260|3997357|P6|STARTED|Period 2||0
1636398|NCT00806260|3997358|P5|STARTED|Period 2||0
1636399|NCT00806260|3997359|P4|STARTED|Period 2||14
1636400|NCT00806260|3997360|P3|STARTED|Period 2||8
1636401|NCT00806260|3997361|P2|STARTED|Period 2||8
1636402|NCT00806260|3997362|P1|STARTED|Period 2||15
1636403|NCT00806260|3997357|P6|NOT COMPLETED|Period 1 (1 Day)||0
1636404|NCT00806260|3997358|P5|NOT COMPLETED|Period 1 (1 Day)||3
1636405|NCT00806260|3997359|P4|NOT COMPLETED|Period 1 (1 Day)||0
1636406|NCT00806260|3997360|P3|NOT COMPLETED|Period 1 (1 Day)||0
1636407|NCT00806260|3997361|P2|NOT COMPLETED|Period 1 (1 Day)||0
1636408|NCT00806260|3997362|P1|NOT COMPLETED|Period 1 (1 Day)||0
1636409|NCT00806260|3997357|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
1636410|NCT00806260|3997358|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
1636411|NCT00806260|3997359|P4|COMPLETED|Period 1 (1 Day)||14
1636412|NCT00806260|3997360|P3|COMPLETED|Period 1 (1 Day)||8
1636413|NCT00806260|3997361|P2|COMPLETED|Period 1 (1 Day)||8
1636414|NCT00806260|3997362|P1|COMPLETED|Period 1 (1 Day)||15
1636415|NCT00806260|3997357|P6|STARTED|Period 1 (1 Day)||17
1636416|NCT00806260|3997358|P5|STARTED|Period 1 (1 Day)||18
1636417|NCT00806260|3997359|P4|STARTED|Period 1 (1 Day)||14
1636418|NCT00806260|3997360|P3|STARTED|Period 1 (1 Day)||8
1636419|NCT00806260|3997361|P2|STARTED|Period 1 (1 Day)||8
1636420|NCT00806260|3997362|P1|STARTED|Period 1 (1 Day)||15
1636421|NCT00806234|3997377|P3|NOT COMPLETED|Overall Study||12
1636422|NCT00806234|3997378|P2|NOT COMPLETED|Overall Study||12
1636423|NCT00806234|3997379|P1|NOT COMPLETED|Overall Study||13
1636424|NCT00806234|3997377|P3|COMPLETED|Overall Study||37
1636425|NCT00806234|3997378|P2|COMPLETED|Overall Study||19
1636426|NCT00806234|3997379|P1|COMPLETED|Overall Study||34
1636427|NCT00806234|3997377|P3|STARTED|Overall Study||49
1636428|NCT00806234|3997378|P2|STARTED|Overall Study||31
1636429|NCT00806234|3997379|P1|STARTED|Overall Study||47
1636430|NCT00806221|3997396|P1|NOT COMPLETED|Overall Study||2
1636431|NCT00806221|3997396|P1|COMPLETED|Overall Study||20
1636432|NCT00806221|3997396|P1|STARTED|Overall Study||22
1636433|NCT00806195|3997407|P4|NOT COMPLETED|Overall Study||106
1636434|NCT00806195|3997408|P3|NOT COMPLETED|Overall Study||270
1636435|NCT00806195|3997409|P2|NOT COMPLETED|Overall Study||162
1636436|NCT00806195|3997410|P1|NOT COMPLETED|Overall Study||514
1636437|NCT00806195|3997407|P4|COMPLETED|Overall Study||383
1636438|NCT00806195|3997408|P3|COMPLETED|Overall Study||1139
1636439|NCT00806195|3997409|P2|COMPLETED|Overall Study||1321
1636440|NCT00806195|3997410|P1|COMPLETED|Overall Study||3849
1636441|NCT00806195|3997407|P4|STARTED|Overall Study||489
1636442|NCT00806195|3997408|P3|STARTED|Overall Study||1409
1636443|NCT00806195|3997409|P2|STARTED|Overall Study||1483
1636444|NCT00806195|3997410|P1|STARTED|Overall Study||4363
1636445|NCT00806078|3997424|P2|NOT COMPLETED|Second Intervention||0
1636446|NCT00806078|3997425|P1|NOT COMPLETED|Second Intervention||0
1636447|NCT00806078|3997424|P2|COMPLETED|Second Intervention||9
1636448|NCT00806078|3997425|P1|COMPLETED|Second Intervention||9
1636449|NCT00806078|3997424|P2|STARTED|Second Intervention||9
1636450|NCT00806078|3997425|P1|STARTED|Second Intervention||9
1636451|NCT00806078|3997424|P2|NOT COMPLETED|7 Day Washout Period||0
1636452|NCT00806078|3997425|P1|NOT COMPLETED|7 Day Washout Period||0
1636453|NCT00806078|3997424|P2|COMPLETED|7 Day Washout Period||9
1636454|NCT00806078|3997425|P1|COMPLETED|7 Day Washout Period||9
1636455|NCT00806078|3997424|P2|STARTED|7 Day Washout Period||9
1636456|NCT00806078|3997425|P1|STARTED|7 Day Washout Period||9
1636457|NCT00806078|3997424|P2|NOT COMPLETED|First Intervention||0
1636458|NCT00806078|3997425|P1|NOT COMPLETED|First Intervention||0
1636459|NCT00806078|3997424|P2|COMPLETED|First Intervention||9
1636460|NCT00806078|3997425|P1|COMPLETED|First Intervention||9
1636461|NCT00806078|3997424|P2|STARTED|First Intervention||9
1636462|NCT00806078|3997425|P1|STARTED|First Intervention||9
1636463|NCT00806026|3997441|P6|NOT COMPLETED|Overall Study||32
1636464|NCT00806026|3997442|P5|NOT COMPLETED|Overall Study||30
1636465|NCT00806026|3997443|P4|NOT COMPLETED|Overall Study||29
1636466|NCT00806026|3997444|P3|NOT COMPLETED|Overall Study||93
1636467|NCT00806026|3997445|P2|NOT COMPLETED|Overall Study||101
1636468|NCT00806026|3997446|P1|NOT COMPLETED|Overall Study||92
1636469|NCT00806026|3997441|P6|COMPLETED|Overall Study||29
1636470|NCT00806026|3997442|P5|COMPLETED|Overall Study||29
1636471|NCT00806026|3997443|P4|COMPLETED|Overall Study||32
1636472|NCT00806026|3997444|P3|COMPLETED|Overall Study||89
1636473|NCT00806026|3997445|P2|COMPLETED|Overall Study||82
1636474|NCT00806026|3997446|P1|COMPLETED|Overall Study||93
1636475|NCT00806026|3997441|P6|Treated|Overall Study||61
1636476|NCT00806026|3997442|P5|Treated|Overall Study||59
1636477|NCT00806026|3997443|P4|Treated|Overall Study||59
1636478|NCT00806026|3997444|P3|Treated|Overall Study||180
1636479|NCT00806026|3997445|P2|Treated|Overall Study||178
1636480|NCT00806026|3997446|P1|Treated|Overall Study||182
1636481|NCT00806026|3997441|P6|STARTED|Overall Study||61
1636482|NCT00806026|3997442|P5|STARTED|Overall Study||59
1636483|NCT00806026|3997443|P4|STARTED|Overall Study||61
1636484|NCT00806026|3997444|P3|STARTED|Overall Study||182
1636485|NCT00806026|3997445|P2|STARTED|Overall Study||183
1636486|NCT00806026|3997446|P1|STARTED|Overall Study||185
1636487|NCT00805961|3997541|P1|NOT COMPLETED|Maintenance Treatment||34
1636488|NCT00805961|3997541|P1|COMPLETED|Maintenance Treatment||23
1636489|NCT00805961|3997541|P1|STARTED|Maintenance Treatment||57
1636490|NCT00805961|3997541|P1|NOT COMPLETED|Treatment-Free Interval||7
1636491|NCT00805961|3997541|P1|COMPLETED|Treatment-Free Interval||57
1636492|NCT00805961|3997541|P1|STARTED|Treatment-Free Interval||64
1636493|NCT00805961|3997541|P1|NOT COMPLETED|Modality Therapy||4
1636494|NCT00805961|3997541|P1|COMPLETED|Modality Therapy||64
1636495|NCT00805961|3997541|P1|STARTED|Modality Therapy||68
1636496|NCT00805935|3997551|P4|NOT COMPLETED|Overall Study||11
1636497|NCT00805935|3997552|P3|NOT COMPLETED|Overall Study||15
1636498|NCT00805935|3997553|P2|NOT COMPLETED|Overall Study||19
1636499|NCT00805935|3997554|P1|NOT COMPLETED|Overall Study||13
1636500|NCT00805935|3997551|P4|COMPLETED|Overall Study||19
1636501|NCT00805935|3997552|P3|COMPLETED|Overall Study||13
1636502|NCT00805935|3997553|P2|COMPLETED|Overall Study||8
1636503|NCT00805935|3997554|P1|COMPLETED|Overall Study||12
1636504|NCT00805935|3997551|P4|STARTED|Overall Study||30
1636505|NCT00805935|3997552|P3|STARTED|Overall Study||28
1636506|NCT00805935|3997553|P2|STARTED|Overall Study||27
1636507|NCT00805935|3997554|P1|STARTED|Overall Study||25
1636508|NCT00805870|3997608|P2|NOT COMPLETED|Overall Study||0
1636509|NCT00805870|3997609|P1|NOT COMPLETED|Overall Study||0
1636510|NCT00805870|3997608|P2|COMPLETED|Overall Study||10
1636511|NCT00805870|3997609|P1|COMPLETED|Overall Study||10
1636512|NCT00805870|3997608|P2|STARTED|Overall Study||10
1636513|NCT00805870|3997609|P1|STARTED|Overall Study||10
1636514|NCT00805792|3997621|P1|NOT COMPLETED|Overall Study||5
1636515|NCT00805792|3997621|P1|COMPLETED|Overall Study||28
1636516|NCT00805792|3997621|P1|STARTED|Overall Study||33
1636517|NCT00805766|3997629|P1|NOT COMPLETED|Increased Dose Period||13
1636518|NCT00805766|3997629|P1|COMPLETED|Increased Dose Period||26
1636519|NCT00805766|3997629|P1|STARTED|Increased Dose Period||39
1636520|NCT00805766|3997629|P1|NOT COMPLETED|Screening Period||6
1636521|NCT00805766|3997629|P1|COMPLETED|Screening Period||39
1636522|NCT00805766|3997629|P1|STARTED|Screening Period||45
1636523|NCT00805740|3997643|P2|NOT COMPLETED|Overall Study||4
1636524|NCT00805740|3997644|P1|NOT COMPLETED|Overall Study||11
1636525|NCT00805740|3997643|P2|COMPLETED|Overall Study||9
1636526|NCT00805740|3997644|P1|COMPLETED|Overall Study||17
1636527|NCT00805740|3997643|P2|Treated|Overall Study||13
1636528|NCT00805740|3997644|P1|Treated|Overall Study||26
1636529|NCT00805740|3997643|P2|STARTED|Overall Study||13
1636530|NCT00805740|3997644|P1|STARTED|Overall Study||28
1636531|NCT00805675|3997669|P3|NOT COMPLETED|Overall Study||1
1636532|NCT00805675|3997670|P2|NOT COMPLETED|Overall Study||0
1636533|NCT00805675|3997671|P1|NOT COMPLETED|Overall Study||0
1636534|NCT00805675|3997669|P3|COMPLETED|Overall Study||15
1636535|NCT00805675|3997670|P2|COMPLETED|Overall Study||14
1636536|NCT00805675|3997671|P1|COMPLETED|Overall Study||16
1636537|NCT00805675|3997669|P3|STARTED|Overall Study||16
1636538|NCT00805675|3997670|P2|STARTED|Overall Study||14
1636539|NCT00805675|3997671|P1|STARTED|Overall Study||16
1636540|NCT00805545|3997705|P2|NOT COMPLETED|Overall Study||3
1636541|NCT00805545|3997706|P1|NOT COMPLETED|Overall Study||6
1636542|NCT00805545|3997705|P2|COMPLETED|Overall Study||197
1636543|NCT00805545|3997706|P1|COMPLETED|Overall Study||194
1636544|NCT00805545|3997705|P2|STARTED|Overall Study||200
1636545|NCT00805545|3997706|P1|STARTED|Overall Study||200
1636546|NCT00805532|3997714|P2|NOT COMPLETED|Overall Study||1
1636547|NCT00805532|3997715|P1|NOT COMPLETED|Overall Study||0
1636548|NCT00805532|3997714|P2|COMPLETED|Overall Study||38
1636549|NCT00805532|3997715|P1|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
1636550|NCT00805532|3997714|P2|STARTED|Overall Study||39
1636551|NCT00805532|3997715|P1|STARTED|Overall Study||42
1636552|NCT00805493|3997732|P3|NOT COMPLETED|Overall Study||1
1636553|NCT00805493|3997733|P2|NOT COMPLETED|Overall Study||0
1636554|NCT00805493|3997734|P1|NOT COMPLETED|Overall Study||2
1636555|NCT00805493|3997732|P3|COMPLETED|Overall Study||0
1636556|NCT00805493|3997733|P2|COMPLETED|Overall Study||2
1636557|NCT00805493|3997734|P1|COMPLETED|Overall Study||1
1636558|NCT00805493|3997732|P3|STARTED|Overall Study||1
1636559|NCT00805493|3997733|P2|STARTED|Overall Study||2
1636560|NCT00805493|3997734|P1|STARTED|Overall Study||3
1636561|NCT00805480|3997749|P4|NOT COMPLETED|Overall Study||5
1636562|NCT00805480|3997750|P3|NOT COMPLETED|Overall Study||12
1636563|NCT00805480|3997751|P2|NOT COMPLETED|Overall Study||7
1636564|NCT00805480|3997752|P1|NOT COMPLETED|Overall Study||14
1636565|NCT00805480|3997749|P4|COMPLETED|Overall Study||5
1636566|NCT00805480|3997750|P3|COMPLETED|Overall Study||19
1636567|NCT00805480|3997751|P2|COMPLETED|Overall Study||22
1636568|NCT00805480|3997752|P1|COMPLETED|Overall Study||16
1636569|NCT00805480|3997749|P4|Pharmacodynamic Analysis Set|Overall Study||10
1636570|NCT00805480|3997750|P3|Pharmacodynamic Analysis Set|Overall Study||29
1636571|NCT00805480|3997751|P2|Pharmacodynamic Analysis Set|Overall Study||25
1636572|NCT00805480|3997752|P1|Pharmacodynamic Analysis Set|Overall Study||30
1636573|NCT00805480|3997749|P4|STARTED|Overall Study||10
1636574|NCT00805480|3997750|P3|STARTED|Overall Study||31
1636575|NCT00805480|3997751|P2|STARTED|Overall Study||29
1636576|NCT00805480|3997752|P1|STARTED|Overall Study||30
1636577|NCT00805467|3997781|P4|NOT COMPLETED|Overall Study||237
1636578|NCT00805467|3997782|P3|NOT COMPLETED|Overall Study||103
1636579|NCT00805467|3997783|P2|NOT COMPLETED|Overall Study||34
1636580|NCT00805467|3997784|P1|NOT COMPLETED|Overall Study||0
1636581|NCT00805467|3997781|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
1636582|NCT00805467|3997782|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
1636583|NCT00805467|3997783|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
1636584|NCT00805467|3997784|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
1636585|NCT00805467|3997781|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
1636586|NCT00805467|3997782|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
1636587|NCT00805467|3997783|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
1636588|NCT00805467|3997784|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
1636589|NCT00805467|3997781|P4|STARTED|Overall Study|Patients who received treatment|381
1636590|NCT00805467|3997782|P3|STARTED|Overall Study|Patients who received treatment|183
1636591|NCT00805467|3997783|P2|STARTED|Overall Study|Patients who received treatment|59
1636592|NCT00805467|3997784|P1|STARTED|Overall Study|Patients who received treatment|1
1636593|NCT00805441|3997804|P2|NOT COMPLETED|Overall Study||36
1636594|NCT00805441|3997805|P1|NOT COMPLETED|Overall Study||34
1636595|NCT00805441|3997804|P2|COMPLETED|Overall Study||60
1636596|NCT00805441|3997805|P1|COMPLETED|Overall Study||60
1636597|NCT00805441|3997804|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
1636598|NCT00805441|3997805|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
1636599|NCT00805441|3997804|P2|STARTED|Overall Study||96
1636600|NCT00805441|3997805|P1|STARTED|Overall Study||94
1636601|NCT00805389|3997840|P5|NOT COMPLETED|Overall Study||13
1636602|NCT00805389|3997841|P4|NOT COMPLETED|Overall Study||17
1636603|NCT00805389|3997842|P3|NOT COMPLETED|Overall Study||12
1636604|NCT00805389|3997843|P2|NOT COMPLETED|Overall Study||5
1636605|NCT00805389|3997844|P1|NOT COMPLETED|Overall Study||7
1636606|NCT00805389|3997840|P5|COMPLETED|Overall Study||129
1636607|NCT00805389|3997841|P4|COMPLETED|Overall Study||128
1636608|NCT00805389|3997842|P3|COMPLETED|Overall Study||129
1636609|NCT00805389|3997843|P2|COMPLETED|Overall Study||137
1636610|NCT00805389|3997844|P1|COMPLETED|Overall Study||136
1636611|NCT00805389|3997840|P5|STARTED|Overall Study||142
1636612|NCT00805389|3997841|P4|STARTED|Overall Study||145
1636613|NCT00805389|3997842|P3|STARTED|Overall Study||141
1636614|NCT00805389|3997843|P2|STARTED|Overall Study||142
1636615|NCT00805389|3997844|P1|STARTED|Overall Study||143
1636616|NCT00805285|3998091|P1|NOT COMPLETED|Overall Study||1
1636617|NCT00805285|3998091|P1|COMPLETED|Overall Study||0
1636618|NCT00805285|3998091|P1|STARTED|Overall Study||1
1636619|NCT00805207|3998108|P9|NOT COMPLETED|Overall Study||0
1636620|NCT00805207|3998109|P8|NOT COMPLETED|Overall Study||0
1636621|NCT00805207|3998110|P7|NOT COMPLETED|Overall Study||0
1636622|NCT00805207|3998111|P6|NOT COMPLETED|Overall Study||3
1636623|NCT00805207|3998112|P5|NOT COMPLETED|Overall Study||1
1636624|NCT00805207|3998113|P4|NOT COMPLETED|Overall Study||0
1636625|NCT00805207|3998114|P3|NOT COMPLETED|Overall Study||1
1636626|NCT00805207|3998115|P2|NOT COMPLETED|Overall Study||2
1636627|NCT00805207|3998116|P1|NOT COMPLETED|Overall Study||0
1636628|NCT00805207|3998108|P9|COMPLETED|Overall Study||6
1636629|NCT00805207|3998109|P8|COMPLETED|Overall Study||6
1636630|NCT00805207|3998110|P7|COMPLETED|Overall Study||6
1636631|NCT00805207|3998111|P6|COMPLETED|Overall Study||9
1636632|NCT00805207|3998112|P5|COMPLETED|Overall Study||2
1636633|NCT00805207|3998113|P4|COMPLETED|Overall Study||6
1636634|NCT00805207|3998114|P3|COMPLETED|Overall Study||11
1636635|NCT00805207|3998115|P2|COMPLETED|Overall Study||7
1636636|NCT00805207|3998116|P1|COMPLETED|Overall Study||1
1636637|NCT00805207|3998108|P9|STARTED|Overall Study||6
1636638|NCT00805207|3998109|P8|STARTED|Overall Study||6
1636639|NCT00805207|3998110|P7|STARTED|Overall Study||6
1636640|NCT00805207|3998111|P6|STARTED|Overall Study||12
1636641|NCT00805207|3998112|P5|STARTED|Overall Study||3
1636642|NCT00805207|3998113|P4|STARTED|Overall Study||6
1636643|NCT00805207|3998114|P3|STARTED|Overall Study||12
1636644|NCT00805207|3998115|P2|STARTED|Overall Study||9
1636645|NCT00805207|3998116|P1|STARTED|Overall Study||1
1636646|NCT00805194|3998174|P2|NOT COMPLETED|Overall Study||654
1636647|NCT00805194|3998175|P1|NOT COMPLETED|Overall Study||649
1636648|NCT00805194|3998174|P2|COMPLETED|Overall Study||5
1636649|NCT00805194|3998175|P1|COMPLETED|Overall Study||6
1636650|NCT00805194|3998174|P2|STARTED|Overall Study|randomised patients|659
1636651|NCT00805194|3998175|P1|STARTED|Overall Study|randomised patients|655
1636652|NCT00805142|3998209|P2|NOT COMPLETED|Maintenance Period||2
1636653|NCT00805142|3998210|P1|NOT COMPLETED|Maintenance Period||0
1636654|NCT00805142|3998209|P2|COMPLETED|Maintenance Period||30
1636655|NCT00805142|3998210|P1|COMPLETED|Maintenance Period||30
1636656|NCT00805142|3998209|P2|STARTED|Maintenance Period||32
1636657|NCT00805142|3998210|P1|STARTED|Maintenance Period||30
1636658|NCT00805142|3998209|P2|NOT COMPLETED|Titration Period||10
1636659|NCT00805142|3998210|P1|NOT COMPLETED|Titration Period||6
1636660|NCT00805142|3998209|P2|COMPLETED|Titration Period||32
1636661|NCT00805142|3998210|P1|COMPLETED|Titration Period||30
1636662|NCT00805142|3998209|P2|STARTED|Titration Period||42
1636663|NCT00805142|3998210|P1|STARTED|Titration Period||36
1636664|NCT00805038|3998236|P2|NOT COMPLETED|Overall Study||0
1636665|NCT00805038|3998237|P1|NOT COMPLETED|Overall Study||0
1636666|NCT00805038|3998236|P2|COMPLETED|Overall Study||92
1636667|NCT00805038|3998237|P1|COMPLETED|Overall Study||75
1636668|NCT00805038|3998236|P2|STARTED|Overall Study||92
1636669|NCT00805038|3998237|P1|STARTED|Overall Study||75
1636670|NCT00805025|3998243|P1|NOT COMPLETED|Overall Study||49
1636671|NCT00805025|3998243|P1|COMPLETED|Overall Study||82
1636672|NCT00805025|3998243|P1|Enrolled and Treated|Overall Study||89
1636673|NCT00805025|3998243|P1|STARTED|Overall Study||131
1636674|NCT00804999|3998253|P4|NOT COMPLETED|Overall Study||0
1636675|NCT00804999|3998254|P3|NOT COMPLETED|Overall Study||0
1636676|NCT00804999|3998255|P2|NOT COMPLETED|Overall Study||0
1636677|NCT00804999|3998256|P1|NOT COMPLETED|Overall Study||0
1636678|NCT00804999|3998253|P4|COMPLETED|Overall Study||10
1636679|NCT00804999|3998254|P3|COMPLETED|Overall Study||14
1636680|NCT00804999|3998255|P2|COMPLETED|Overall Study||12
1636681|NCT00804999|3998256|P1|COMPLETED|Overall Study||15
1636682|NCT00804999|3998253|P4|STARTED|Overall Study||10
1636683|NCT00804999|3998254|P3|STARTED|Overall Study||14
1636684|NCT00804999|3998255|P2|STARTED|Overall Study||12
1636685|NCT00804999|3998256|P1|STARTED|Overall Study||15
1636686|NCT00804986|3998272|P6|NOT COMPLETED|Overall Study||10
1636687|NCT00804986|3998273|P5|NOT COMPLETED|Overall Study||9
1636688|NCT00804986|3998274|P4|NOT COMPLETED|Overall Study||8
1636689|NCT00804986|3998275|P3|NOT COMPLETED|Overall Study||2
1636690|NCT00804986|3998276|P2|NOT COMPLETED|Overall Study||8
1636691|NCT00804986|3998277|P1|NOT COMPLETED|Overall Study||1
1636692|NCT00804986|3998272|P6|COMPLETED|Overall Study||31
1636693|NCT00804986|3998273|P5|COMPLETED|Overall Study||34
1636694|NCT00804986|3998274|P4|COMPLETED|Overall Study||34
1636695|NCT00804986|3998275|P3|COMPLETED|Overall Study||40
1636696|NCT00804986|3998276|P2|COMPLETED|Overall Study||35
1636697|NCT00804986|3998277|P1|COMPLETED|Overall Study||35
1636698|NCT00804986|3998272|P6|STARTED|Overall Study||41
1636699|NCT00804986|3998273|P5|STARTED|Overall Study||43
1636700|NCT00804986|3998274|P4|STARTED|Overall Study||42
1636701|NCT00804986|3998275|P3|STARTED|Overall Study||42
1636702|NCT00804986|3998276|P2|STARTED|Overall Study||43
1636703|NCT00804986|3998277|P1|STARTED|Overall Study||36
1636704|NCT00804908|3998372|P3|NOT COMPLETED|Overall Study||114
1636705|NCT00804908|3998373|P2|NOT COMPLETED|Overall Study||116
1636706|NCT00804908|3998374|P1|NOT COMPLETED|Overall Study||115
1636707|NCT00804908|3998372|P3|COMPLETED|Overall Study||1
1636708|NCT00804908|3998373|P2|COMPLETED|Overall Study||0
1636709|NCT00804908|3998374|P1|COMPLETED|Overall Study||0
1636710|NCT00804908|3998372|P3|STARTED|Overall Study||115
1636711|NCT00804908|3998373|P2|STARTED|Overall Study||116
1636712|NCT00804908|3998374|P1|STARTED|Overall Study||115
1636713|NCT00804843|3998405|P2|NOT COMPLETED|Overall Study||7
1636714|NCT00804843|3998406|P1|NOT COMPLETED|Overall Study||10
1636715|NCT00804843|3998405|P2|COMPLETED|Overall Study||43
1636716|NCT00804843|3998406|P1|COMPLETED|Overall Study||40
1636717|NCT00804843|3998405|P2|STARTED|Overall Study||50
1636718|NCT00804843|3998406|P1|STARTED|Overall Study||50
1636719|NCT00804713|3998416|P1|NOT COMPLETED|Overall Study||0
1636720|NCT00804713|3998416|P1|COMPLETED|Overall Study||1978
1636721|NCT00804713|3998416|P1|STARTED|Overall Study||1978
1636722|NCT00804687|3998424|P6|NOT COMPLETED|Period 5: Treatment Period||0
1636723|NCT00804687|3998425|P5|NOT COMPLETED|Period 5: Treatment Period||1
1636724|NCT00804687|3998426|P4|NOT COMPLETED|Period 5: Treatment Period||0
1636725|NCT00804687|3998427|P3|NOT COMPLETED|Period 5: Treatment Period||1
1636726|NCT00804687|3998428|P2|NOT COMPLETED|Period 5: Treatment Period||0
1636727|NCT00804687|3998429|P1|NOT COMPLETED|Period 5: Treatment Period||1
1636728|NCT00804687|3998424|P6|COMPLETED|Period 5: Treatment Period||8
1636729|NCT00804687|3998425|P5|COMPLETED|Period 5: Treatment Period||8
1636730|NCT00804687|3998426|P4|COMPLETED|Period 5: Treatment Period||8
1636731|NCT00804687|3998427|P3|COMPLETED|Period 5: Treatment Period||8
1636732|NCT00804687|3998428|P2|COMPLETED|Period 5: Treatment Period||9
1636733|NCT00804687|3998429|P1|COMPLETED|Period 5: Treatment Period||8
1636734|NCT00804687|3998424|P6|STARTED|Period 5: Treatment Period||8
1636735|NCT00804687|3998425|P5|STARTED|Period 5: Treatment Period||9
1636736|NCT00804687|3998426|P4|STARTED|Period 5: Treatment Period||8
1636737|NCT00804687|3998427|P3|STARTED|Period 5: Treatment Period||9
1636738|NCT00804687|3998428|P2|STARTED|Period 5: Treatment Period||9
1636739|NCT00804687|3998429|P1|STARTED|Period 5: Treatment Period||9
1636740|NCT00804687|3998424|P6|NOT COMPLETED|Period 4: Washout Period||0
1636741|NCT00804687|3998425|P5|NOT COMPLETED|Period 4: Washout Period||0
1636742|NCT00804687|3998426|P4|NOT COMPLETED|Period 4: Washout Period||0
1636743|NCT00804687|3998427|P3|NOT COMPLETED|Period 4: Washout Period||0
1636744|NCT00804687|3998428|P2|NOT COMPLETED|Period 4: Washout Period||0
1636745|NCT00804687|3998429|P1|NOT COMPLETED|Period 4: Washout Period||0
1636746|NCT00804687|3998424|P6|COMPLETED|Period 4: Washout Period||8
1636747|NCT00804687|3998425|P5|COMPLETED|Period 4: Washout Period||9
1636748|NCT00804687|3998426|P4|COMPLETED|Period 4: Washout Period||8
1636749|NCT00804687|3998427|P3|COMPLETED|Period 4: Washout Period||9
1636750|NCT00804687|3998428|P2|COMPLETED|Period 4: Washout Period||9
1636751|NCT00804687|3998429|P1|COMPLETED|Period 4: Washout Period||9
1636752|NCT00804687|3998424|P6|STARTED|Period 4: Washout Period||8
1636753|NCT00804687|3998425|P5|STARTED|Period 4: Washout Period||9
1636754|NCT00804687|3998426|P4|STARTED|Period 4: Washout Period||8
1636755|NCT00804687|3998427|P3|STARTED|Period 4: Washout Period||9
1636756|NCT00804687|3998428|P2|STARTED|Period 4: Washout Period||9
1636757|NCT00804687|3998429|P1|STARTED|Period 4: Washout Period||9
1636758|NCT00804687|3998424|P6|NOT COMPLETED|Period 3: Treatment Period||0
1636759|NCT00804687|3998425|P5|NOT COMPLETED|Period 3: Treatment Period||0
1636760|NCT00804687|3998426|P4|NOT COMPLETED|Period 3: Treatment Period||1
1636761|NCT00804687|3998427|P3|NOT COMPLETED|Period 3: Treatment Period||0
1636762|NCT00804687|3998428|P2|NOT COMPLETED|Period 3: Treatment Period||0
1636763|NCT00804687|3998429|P1|NOT COMPLETED|Period 3: Treatment Period||0
1636764|NCT00804687|3998424|P6|COMPLETED|Period 3: Treatment Period||8
1636765|NCT00804687|3998425|P5|COMPLETED|Period 3: Treatment Period||9
1636766|NCT00804687|3998426|P4|COMPLETED|Period 3: Treatment Period||8
1636767|NCT00804687|3998427|P3|COMPLETED|Period 3: Treatment Period||9
1636768|NCT00804687|3998428|P2|COMPLETED|Period 3: Treatment Period||9
1636769|NCT00804687|3998429|P1|COMPLETED|Period 3: Treatment Period||9
1636770|NCT00804687|3998424|P6|STARTED|Period 3: Treatment Period||8
1636771|NCT00804687|3998425|P5|STARTED|Period 3: Treatment Period||9
1636772|NCT00804687|3998426|P4|STARTED|Period 3: Treatment Period||9
1636773|NCT00804687|3998427|P3|STARTED|Period 3: Treatment Period||9
1636774|NCT00804687|3998428|P2|STARTED|Period 3: Treatment Period||9
1636775|NCT00804687|3998429|P1|STARTED|Period 3: Treatment Period||9
1636776|NCT00804687|3998424|P6|NOT COMPLETED|Period 2: Washout Period||0
1636777|NCT00804687|3998425|P5|NOT COMPLETED|Period 2: Washout Period||0
1636778|NCT00804687|3998426|P4|NOT COMPLETED|Period 2: Washout Period||0
1636779|NCT00804687|3998427|P3|NOT COMPLETED|Period 2: Washout Period||0
1636780|NCT00804687|3998428|P2|NOT COMPLETED|Period 2: Washout Period||0
1636781|NCT00804687|3998429|P1|NOT COMPLETED|Period 2: Washout Period||0
1636782|NCT00804687|3998424|P6|COMPLETED|Period 2: Washout Period||8
1636783|NCT00804687|3998425|P5|COMPLETED|Period 2: Washout Period||9
1636784|NCT00804687|3998426|P4|COMPLETED|Period 2: Washout Period||9
1636785|NCT00804687|3998427|P3|COMPLETED|Period 2: Washout Period||9
1636786|NCT00804687|3998428|P2|COMPLETED|Period 2: Washout Period||9
1636787|NCT00804687|3998429|P1|COMPLETED|Period 2: Washout Period||9
1636788|NCT00804687|3998424|P6|STARTED|Period 2: Washout Period||8
1636789|NCT00804687|3998425|P5|STARTED|Period 2: Washout Period||9
1636790|NCT00804687|3998426|P4|STARTED|Period 2: Washout Period||9
1636791|NCT00804687|3998427|P3|STARTED|Period 2: Washout Period||9
1636792|NCT00804687|3998428|P2|STARTED|Period 2: Washout Period||9
1636793|NCT00804687|3998429|P1|STARTED|Period 2: Washout Period||9
1636794|NCT00804687|3998424|P6|NOT COMPLETED|Period 1: Treatment Period||0
1636795|NCT00804687|3998425|P5|NOT COMPLETED|Period 1: Treatment Period||0
1636796|NCT00804687|3998426|P4|NOT COMPLETED|Period 1: Treatment Period||0
1636797|NCT00804687|3998427|P3|NOT COMPLETED|Period 1: Treatment Period||0
1636798|NCT00804687|3998428|P2|NOT COMPLETED|Period 1: Treatment Period||0
1636799|NCT00804687|3998429|P1|NOT COMPLETED|Period 1: Treatment Period||0
1636800|NCT00804687|3998424|P6|COMPLETED|Period 1: Treatment Period||8
1636801|NCT00804687|3998425|P5|COMPLETED|Period 1: Treatment Period||9
1636802|NCT00804687|3998426|P4|COMPLETED|Period 1: Treatment Period||9
1636803|NCT00804687|3998427|P3|COMPLETED|Period 1: Treatment Period||9
1636804|NCT00804687|3998428|P2|COMPLETED|Period 1: Treatment Period||9
1636805|NCT00804687|3998429|P1|COMPLETED|Period 1: Treatment Period||9
1636806|NCT00804687|3998424|P6|STARTED|Period 1: Treatment Period||8
1636807|NCT00804687|3998425|P5|STARTED|Period 1: Treatment Period||9
1636808|NCT00804687|3998426|P4|STARTED|Period 1: Treatment Period||9
1636809|NCT00804687|3998427|P3|STARTED|Period 1: Treatment Period||9
1636810|NCT00804687|3998428|P2|STARTED|Period 1: Treatment Period||9
1636811|NCT00804687|3998429|P1|STARTED|Period 1: Treatment Period||9
1636812|NCT00804648|3998446|P6|NOT COMPLETED|Third Invervention||0
1636813|NCT00804648|3998447|P5|NOT COMPLETED|Third Invervention||0
1636814|NCT00804648|3998448|P4|NOT COMPLETED|Third Invervention||0
1636815|NCT00804648|3998449|P3|NOT COMPLETED|Third Invervention||0
1636816|NCT00804648|3998450|P2|NOT COMPLETED|Third Invervention||0
1636817|NCT00804648|3998451|P1|NOT COMPLETED|Third Invervention||0
1636818|NCT00804648|3998446|P6|COMPLETED|Third Invervention||8
1636819|NCT00804648|3998447|P5|COMPLETED|Third Invervention||4
1636820|NCT00804648|3998448|P4|COMPLETED|Third Invervention||4
1636821|NCT00804648|3998449|P3|COMPLETED|Third Invervention||6
1636822|NCT00804648|3998450|P2|COMPLETED|Third Invervention||5
1636823|NCT00804648|3998451|P1|COMPLETED|Third Invervention||3
1636824|NCT00804648|3998446|P6|STARTED|Third Invervention||8
1636825|NCT00804648|3998447|P5|STARTED|Third Invervention||4
1636826|NCT00804648|3998448|P4|STARTED|Third Invervention||4
1636827|NCT00804648|3998449|P3|STARTED|Third Invervention||6
1636828|NCT00804648|3998450|P2|STARTED|Third Invervention||5
1636829|NCT00804648|3998451|P1|STARTED|Third Invervention||3
1636830|NCT00804648|3998446|P6|NOT COMPLETED|Second Intervention||0
1636831|NCT00804648|3998447|P5|NOT COMPLETED|Second Intervention||0
1636832|NCT00804648|3998448|P4|NOT COMPLETED|Second Intervention||0
1636833|NCT00804648|3998449|P3|NOT COMPLETED|Second Intervention||0
1636834|NCT00804648|3998450|P2|NOT COMPLETED|Second Intervention||0
1636835|NCT00804648|3998451|P1|NOT COMPLETED|Second Intervention||0
1636836|NCT00804648|3998446|P6|COMPLETED|Second Intervention||8
1636837|NCT00804648|3998447|P5|COMPLETED|Second Intervention||4
1636838|NCT00804648|3998448|P4|COMPLETED|Second Intervention||4
1636839|NCT00804648|3998449|P3|COMPLETED|Second Intervention||6
1636840|NCT00804648|3998450|P2|COMPLETED|Second Intervention||5
1636841|NCT00804648|3998451|P1|COMPLETED|Second Intervention||3
1636842|NCT00804648|3998446|P6|STARTED|Second Intervention||8
1636843|NCT00804648|3998447|P5|STARTED|Second Intervention||4
1636844|NCT00804648|3998448|P4|STARTED|Second Intervention||4
1636845|NCT00804648|3998449|P3|STARTED|Second Intervention||6
1636846|NCT00804648|3998450|P2|STARTED|Second Intervention||5
1636847|NCT00804648|3998451|P1|STARTED|Second Intervention||3
1636848|NCT00804648|3998446|P6|NOT COMPLETED|First Intervention||0
1636849|NCT00804648|3998447|P5|NOT COMPLETED|First Intervention||0
1636850|NCT00804648|3998448|P4|NOT COMPLETED|First Intervention||0
1636851|NCT00804648|3998449|P3|NOT COMPLETED|First Intervention||0
1636852|NCT00804648|3998450|P2|NOT COMPLETED|First Intervention||0
1636853|NCT00804648|3998451|P1|NOT COMPLETED|First Intervention||0
1636854|NCT00804648|3998446|P6|COMPLETED|First Intervention||8
1636855|NCT00804648|3998447|P5|COMPLETED|First Intervention||4
1636856|NCT00804648|3998448|P4|COMPLETED|First Intervention||4
1636857|NCT00804648|3998449|P3|COMPLETED|First Intervention||6
1636858|NCT00804648|3998450|P2|COMPLETED|First Intervention||5
1636859|NCT00804648|3998451|P1|COMPLETED|First Intervention||3
1636860|NCT00804648|3998446|P6|STARTED|First Intervention||8
1636861|NCT00804648|3998447|P5|STARTED|First Intervention||4
1636862|NCT00804648|3998448|P4|STARTED|First Intervention||4
1636863|NCT00804648|3998449|P3|STARTED|First Intervention||6
1636864|NCT00804648|3998450|P2|STARTED|First Intervention||5
1636865|NCT00804648|3998451|P1|STARTED|First Intervention||3
1636866|NCT00804609|3998494|P2|NOT COMPLETED|Overall Study||1
1636867|NCT00804609|3998495|P1|NOT COMPLETED|Overall Study||0
1636868|NCT00804609|3998494|P2|COMPLETED|Overall Study||14
1636869|NCT00804609|3998495|P1|COMPLETED|Overall Study||15
1636870|NCT00804609|3998494|P2|STARTED|Overall Study||15
1636871|NCT00804609|3998495|P1|STARTED|Overall Study||15
1636872|NCT00804596|3998501|P1|NOT COMPLETED|Overall Study||0
1636873|NCT00804596|3998501|P1|COMPLETED|Overall Study||74
1636874|NCT00804596|3998501|P1|STARTED|Overall Study||74
1636875|NCT00804570|3998508|P2|NOT COMPLETED|Overall Study||94
1636876|NCT00804570|3998509|P1|NOT COMPLETED|Overall Study||72
1636877|NCT00804570|3998508|P2|COMPLETED|Overall Study||94
1636878|NCT00804570|3998509|P1|COMPLETED|Overall Study||115
1636879|NCT00804570|3998508|P2|STARTED|Overall Study||188
1636880|NCT00804570|3998509|P1|STARTED|Overall Study||187
1636881|NCT00804193|3998568|P3|NOT COMPLETED|Overall Study||32
1636882|NCT00804193|3998569|P2|NOT COMPLETED|Overall Study||44
1636883|NCT00804193|3998570|P1|NOT COMPLETED|Overall Study||39
1636884|NCT00804193|3998568|P3|COMPLETED|Overall Study||77
1636885|NCT00804193|3998569|P2|COMPLETED|Overall Study||180
1636886|NCT00804193|3998570|P1|COMPLETED|Overall Study||181
1636887|NCT00804193|3998568|P3|STARTED|Overall Study||109
1636888|NCT00804193|3998569|P2|STARTED|Overall Study||224
1636889|NCT00804193|3998570|P1|STARTED|Overall Study||220
1636890|NCT00803959|3998586|P2|NOT COMPLETED|Overall Study||51
1636891|NCT00803959|3998587|P1|NOT COMPLETED|Overall Study||56
1636892|NCT00803959|3998586|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
1636893|NCT00803959|3998587|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
1636894|NCT00803959|3998586|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
1636895|NCT00803959|3998587|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
1636896|NCT00803959|3998586|P2|STARTED|Overall Study||315
1636897|NCT00803959|3998587|P1|STARTED|Overall Study||315
1636898|NCT00803790|3998619|P4|NOT COMPLETED|Period 2||1
1636899|NCT00803790|3998620|P3|NOT COMPLETED|Period 2||1
1636900|NCT00803790|3998621|P2|NOT COMPLETED|Period 2||0
1636901|NCT00803790|3998622|P1|NOT COMPLETED|Period 2||2
1636902|NCT00803790|3998619|P4|COMPLETED|Period 2||30
1636903|NCT00803790|3998620|P3|COMPLETED|Period 2||30
1636904|NCT00803790|3998621|P2|COMPLETED|Period 2||114
1636905|NCT00803790|3998622|P1|COMPLETED|Period 2||114
1636906|NCT00803790|3998619|P4|STARTED|Period 2||31
1636907|NCT00803790|3998620|P3|STARTED|Period 2||31
1636908|NCT00803790|3998621|P2|STARTED|Period 2||114
1636909|NCT00803790|3998622|P1|STARTED|Period 2||116
1636910|NCT00803790|3998619|P4|NOT COMPLETED|Period 1||4
1636911|NCT00803790|3998620|P3|NOT COMPLETED|Period 1||1
1636912|NCT00803790|3998621|P2|NOT COMPLETED|Period 1||12
1636913|NCT00803790|3998622|P1|NOT COMPLETED|Period 1||9
1636914|NCT00803790|3998619|P4|COMPLETED|Period 1||31
1636915|NCT00803790|3998620|P3|COMPLETED|Period 1||31
1636916|NCT00803790|3998621|P2|COMPLETED|Period 1||114
1636917|NCT00803790|3998622|P1|COMPLETED|Period 1||116
1636918|NCT00803790|3998619|P4|STARTED|Period 1||35
1636919|NCT00803790|3998620|P3|STARTED|Period 1||32
1636920|NCT00803790|3998621|P2|STARTED|Period 1||126
1636921|NCT00803790|3998622|P1|STARTED|Period 1||125
1636922|NCT00803777|3998633|P1|NOT COMPLETED|Overall Study||0
1636923|NCT00803777|3998633|P1|COMPLETED|Overall Study||147
1636924|NCT00803777|3998633|P1|STARTED|Overall Study||147
1636925|NCT00803751|3998643|P2|NOT COMPLETED|Overall Study||0
1636926|NCT00803751|3998644|P1|NOT COMPLETED|Overall Study||0
1636927|NCT00803751|3998643|P2|COMPLETED|Overall Study||23
1636928|NCT00803751|3998644|P1|COMPLETED|Overall Study||26
1636929|NCT00803751|3998643|P2|STARTED|Overall Study||23
1636930|NCT00803751|3998644|P1|STARTED|Overall Study||26
1636931|NCT00803738|3998662|P2|NOT COMPLETED|Overall Study||110
1636932|NCT00803738|3998663|P1|NOT COMPLETED|Overall Study||94
1636933|NCT00803738|3998662|P2|COMPLETED|Overall Study||176
1636934|NCT00803738|3998663|P1|COMPLETED|Overall Study||192
1636935|NCT00803738|3998662|P2|STARTED|Overall Study||286
1636936|NCT00803738|3998663|P1|STARTED|Overall Study||286
1636937|NCT00803712|3998675|P2|NOT COMPLETED|Overall Study||27
1636938|NCT00803712|3998676|P1|NOT COMPLETED|Overall Study||36
1636939|NCT00803712|3998675|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
1636940|NCT00803712|3998676|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
1636941|NCT00803712|3998675|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
1636942|NCT00803712|3998676|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
1636943|NCT00803712|3998675|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
1636944|NCT00803712|3998676|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
1636945|NCT00803712|3998675|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
1636946|NCT00803712|3998676|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
1636947|NCT00803686|3998744|P4|NOT COMPLETED|Part 2, Period 3||0
1636948|NCT00803686|3998745|P3|NOT COMPLETED|Part 2, Period 3||0
1636949|NCT00803686|3998746|P2|NOT COMPLETED|Part 2, Period 3||0
1636950|NCT00803686|3998747|P1|NOT COMPLETED|Part 2, Period 3||0
1636951|NCT00803686|3998744|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
1636952|NCT00803686|3998745|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
1636953|NCT00803686|3998746|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
1636954|NCT00803686|3998747|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
1636955|NCT00803686|3998744|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
1636956|NCT00803686|3998745|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
1636957|NCT00803686|3998746|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
1636958|NCT00803686|3998747|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
1636959|NCT00803686|3998744|P4|NOT COMPLETED|Part 1, Period 2||0
1636960|NCT00803686|3998745|P3|NOT COMPLETED|Part 1, Period 2||0
1636961|NCT00803686|3998746|P2|NOT COMPLETED|Part 1, Period 2||0
1636962|NCT00803686|3998747|P1|NOT COMPLETED|Part 1, Period 2||0
1636963|NCT00803686|3998744|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
1636964|NCT00803686|3998745|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
1636965|NCT00803686|3998746|P2|COMPLETED|Part 1, Period 2||6
1636966|NCT00803686|3998747|P1|COMPLETED|Part 1, Period 2||6
1636967|NCT00803686|3998744|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
1636968|NCT00803686|3998745|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
1636969|NCT00803686|3998746|P2|STARTED|Part 1, Period 2||6
1636970|NCT00803686|3998747|P1|STARTED|Part 1, Period 2||6
1636971|NCT00803686|3998744|P4|NOT COMPLETED|Part 1, Period 1||0
1636972|NCT00803686|3998745|P3|NOT COMPLETED|Part 1, Period 1||0
1636973|NCT00803686|3998746|P2|NOT COMPLETED|Part 1, Period 1||0
1636974|NCT00803686|3998747|P1|NOT COMPLETED|Part 1, Period 1||0
1636975|NCT00803686|3998744|P4|COMPLETED|Part 1, Period 1||0
1636976|NCT00803686|3998745|P3|COMPLETED|Part 1, Period 1||0
1636977|NCT00803686|3998746|P2|COMPLETED|Part 1, Period 1||6
1636978|NCT00803686|3998747|P1|COMPLETED|Part 1, Period 1||6
1636979|NCT00803686|3998744|P4|STARTED|Part 1, Period 1||0
1636980|NCT00803686|3998745|P3|STARTED|Part 1, Period 1||0
1636981|NCT00803686|3998746|P2|STARTED|Part 1, Period 1||6
1636982|NCT00803686|3998747|P1|STARTED|Part 1, Period 1||6
1636983|NCT00803647|3998765|P1|NOT COMPLETED|Overall Study||0
1636984|NCT00803647|3998765|P1|COMPLETED|Overall Study||20
1636985|NCT00803647|3998765|P1|STARTED|Overall Study||20
1636986|NCT00803634|3998775|P2|NOT COMPLETED|Overall Study||5
1636987|NCT00803634|3998776|P1|NOT COMPLETED|Overall Study||6
1636988|NCT00803634|3998775|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
1636989|NCT00803634|3998776|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
1636990|NCT00803634|3998775|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
1636991|NCT00803634|3998776|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
1636992|NCT00803634|3998775|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
1636993|NCT00803634|3998776|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
1636994|NCT00803595|3998805|P3|NOT COMPLETED|Overall Study||16
1636995|NCT00803595|3998806|P2|NOT COMPLETED|Overall Study||8
1636996|NCT00803595|3998807|P1|NOT COMPLETED|Overall Study||15
1636997|NCT00803595|3998805|P3|COMPLETED|Overall Study||322
1636998|NCT00803595|3998806|P2|COMPLETED|Overall Study||319
1636999|NCT00803595|3998807|P1|COMPLETED|Overall Study||322
1637000|NCT00803595|3998805|P3|STARTED|Overall Study||338
1637001|NCT00803595|3998806|P2|STARTED|Overall Study||327
1637002|NCT00803595|3998807|P1|STARTED|Overall Study||337
1637003|NCT00803543|3998820|P2|NOT COMPLETED|Overall Study||12
1637004|NCT00803543|3998821|P1|NOT COMPLETED|Overall Study||24
1637005|NCT00803543|3998820|P2|COMPLETED|Overall Study||22
1637006|NCT00803543|3998821|P1|COMPLETED|Overall Study||45
1637007|NCT00803543|3998820|P2|STARTED|Overall Study||34
1637008|NCT00803543|3998821|P1|STARTED|Overall Study||69
1637009|NCT00803517|3998835|P2|NOT COMPLETED|Overall Study||0
1637010|NCT00803517|3998836|P1|NOT COMPLETED|Overall Study||0
1637011|NCT00803517|3998835|P2|COMPLETED|Overall Study||12
1637012|NCT00803517|3998836|P1|COMPLETED|Overall Study||12
1637013|NCT00803517|3998835|P2|STARTED|Overall Study||12
1637014|NCT00803517|3998836|P1|STARTED|Overall Study||12
1637015|NCT00803452|3998844|P2|NOT COMPLETED|Overall Study||5
1637016|NCT00803452|3998845|P1|NOT COMPLETED|Overall Study||0
1637017|NCT00803452|3998844|P2|COMPLETED|Overall Study||17
1637018|NCT00803452|3998845|P1|COMPLETED|Overall Study||9
1637019|NCT00803452|3998844|P2|STARTED|Overall Study||22
1637020|NCT00803452|3998845|P1|STARTED|Overall Study||9
1637021|NCT00803413|3998855|P4|NOT COMPLETED|Overall Period||0
1637022|NCT00803413|3998856|P3|NOT COMPLETED|Overall Period||0
1637023|NCT00803413|3998857|P2|NOT COMPLETED|Overall Period||0
1637024|NCT00803413|3998858|P1|NOT COMPLETED|Overall Period||0
1637025|NCT00803413|3998855|P4|COMPLETED|Overall Period||30
1637026|NCT00803413|3998856|P3|COMPLETED|Overall Period||29
1637027|NCT00803413|3998857|P2|COMPLETED|Overall Period||32
1637028|NCT00803413|3998858|P1|COMPLETED|Overall Period||28
1637029|NCT00803413|3998855|P4|STARTED|Overall Period||30
1637030|NCT00803413|3998856|P3|STARTED|Overall Period||29
1637031|NCT00803413|3998857|P2|STARTED|Overall Period||32
1637032|NCT00803413|3998858|P1|STARTED|Overall Period||28
1637033|NCT00803400|3998870|P2|NOT COMPLETED|Overall Study||24
1637034|NCT00803400|3998871|P1|NOT COMPLETED|Overall Study||20
1637035|NCT00803400|3998870|P2|COMPLETED|Overall Study||51
1637036|NCT00803400|3998871|P1|COMPLETED|Overall Study||55
1637037|NCT00803400|3998870|P2|STARTED|Overall Study||75
1637038|NCT00803400|3998871|P1|STARTED|Overall Study||75
1637039|NCT00803361|3998883|P2|NOT COMPLETED|Overall Study||28
1637040|NCT00803361|3998884|P1|NOT COMPLETED|Overall Study||26
1637041|NCT00803361|3998883|P2|COMPLETED|Overall Study||74
1637042|NCT00803361|3998884|P1|COMPLETED|Overall Study||82
1637043|NCT00803361|3998883|P2|STARTED|Overall Study||102
1637044|NCT00803361|3998884|P1|STARTED|Overall Study||108
1637045|NCT00803283|3998904|P2|NOT COMPLETED|Overall Study||0
1637046|NCT00803283|3998905|P1|NOT COMPLETED|Overall Study||0
1637047|NCT00803283|3998904|P2|COMPLETED|Overall Study||1
1637048|NCT00803283|3998905|P1|COMPLETED|Overall Study||1
1637049|NCT00803283|3998904|P2|STARTED|Overall Study||1
1637050|NCT00803283|3998905|P1|STARTED|Overall Study||1
1637051|NCT00803270|3998931|P2|NOT COMPLETED|Overall Study||2
1637052|NCT00803270|3998932|P1|NOT COMPLETED|Overall Study||1
1637053|NCT00803270|3998931|P2|COMPLETED|Overall Study||12
1637054|NCT00803270|3998932|P1|COMPLETED|Overall Study||12
1637055|NCT00803270|3998931|P2|STARTED|Overall Study||14
1637056|NCT00803270|3998932|P1|STARTED|Overall Study||13
1637057|NCT00803244|3998942|P2|NOT COMPLETED|Overall Study||15
1637058|NCT00803244|3998943|P1|NOT COMPLETED|Overall Study||7
1637059|NCT00803244|3998942|P2|COMPLETED|Overall Study||178
1637060|NCT00803244|3998943|P1|COMPLETED|Overall Study||181
1637061|NCT00803244|3998942|P2|STARTED|Overall Study||193
1637062|NCT00803244|3998943|P1|STARTED|Overall Study||188
1637063|NCT00803179|3998951|P1|NOT COMPLETED|Overall Study||3
1637064|NCT00803179|3998951|P1|COMPLETED|Overall Study||2
1637065|NCT00803179|3998951|P1|STARTED|Overall Study||5
1637066|NCT00803114|3998957|P2|NOT COMPLETED|Overall Study||0
1637067|NCT00803114|3998958|P1|NOT COMPLETED|Overall Study||0
1637068|NCT00803114|3998957|P2|COMPLETED|Overall Study||115
1637069|NCT00803114|3998958|P1|COMPLETED|Overall Study||113
1637070|NCT00803114|3998957|P2|STARTED|Overall Study||115
1637071|NCT00803114|3998958|P1|STARTED|Overall Study||113
1637072|NCT00803101|3998970|P2|NOT COMPLETED|Overall Study||22
1637073|NCT00803101|3998971|P1|NOT COMPLETED|Overall Study||18
1637074|NCT00803101|3998970|P2|COMPLETED|Overall Study||66
1637075|NCT00803101|3998971|P1|COMPLETED|Overall Study||70
1637076|NCT00803101|3998970|P2|STARTED|Overall Study||88
1637077|NCT00803101|3998971|P1|STARTED|Overall Study||88
1637078|NCT00803062|3998993|P4|NOT COMPLETED|Overall Study||0
1637079|NCT00803062|3998994|P3|NOT COMPLETED|Overall Study||0
1637080|NCT00803062|3998995|P2|NOT COMPLETED|Overall Study||0
1637081|NCT00803062|3998996|P1|NOT COMPLETED|Overall Study||0
1637082|NCT00803062|3998993|P4|COMPLETED|Overall Study||112
1637083|NCT00803062|3998994|P3|COMPLETED|Overall Study||111
1637084|NCT00803062|3998995|P2|COMPLETED|Overall Study||115
1637085|NCT00803062|3998996|P1|COMPLETED|Overall Study||114
1637086|NCT00803062|3998993|P4|STARTED|Overall Study||112
1637087|NCT00803062|3998994|P3|STARTED|Overall Study||111
1637088|NCT00803062|3998995|P2|STARTED|Overall Study||115
1637089|NCT00803062|3998996|P1|STARTED|Overall Study||114
1637090|NCT00803049|3999022|P4|NOT COMPLETED|Overall Study||102
1637091|NCT00803049|3999023|P3|NOT COMPLETED|Overall Study||44
1637092|NCT00803049|3999024|P2|NOT COMPLETED|Overall Study||118
1637093|NCT00803049|3999025|P1|NOT COMPLETED|Overall Study||61
1637094|NCT00803049|3999022|P4|COMPLETED|Overall Study||151
1637095|NCT00803049|3999023|P3|COMPLETED|Overall Study||64
1637096|NCT00803049|3999024|P2|COMPLETED|Overall Study||134
1637097|NCT00803049|3999025|P1|COMPLETED|Overall Study||68
1637098|NCT00803049|3999022|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
1637099|NCT00803049|3999023|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
1637100|NCT00803049|3999024|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
1637101|NCT00803049|3999025|P1|Safety Population|Overall Study||129
1637102|NCT00803049|3999022|P4|Treated|Overall Study||251
1637103|NCT00803049|3999023|P3|Treated|Overall Study||108
1637104|NCT00803049|3999024|P2|Treated|Overall Study||252
1637105|NCT00803049|3999025|P1|Treated|Overall Study||129
1637106|NCT00803049|3999022|P4|STARTED|Overall Study|Randomized in extension study|253
1637107|NCT00803049|3999023|P3|STARTED|Overall Study|Randomized in extension study|108
1637108|NCT00803049|3999024|P2|STARTED|Overall Study|Randomized in extension study|252
1637109|NCT00803049|3999025|P1|STARTED|Overall Study|Randomized in extension study|129
1637110|NCT00803023|3999059|P4|NOT COMPLETED|Overall Study||8
1637111|NCT00803023|3999060|P3|NOT COMPLETED|Overall Study||11
1637112|NCT00803023|3999061|P2|NOT COMPLETED|Overall Study||8
1637113|NCT00803023|3999062|P1|NOT COMPLETED|Overall Study||5
1637114|NCT00803023|3999059|P4|COMPLETED|Overall Study||25
1637115|NCT00803023|3999060|P3|COMPLETED|Overall Study||20
1637116|NCT00803023|3999061|P2|COMPLETED|Overall Study||25
1637117|NCT00803023|3999062|P1|COMPLETED|Overall Study||27
1637118|NCT00803023|3999059|P4|STARTED|Overall Study||33
1637119|NCT00803023|3999060|P3|STARTED|Overall Study||31
1637120|NCT00803023|3999061|P2|STARTED|Overall Study||33
1637121|NCT00803023|3999062|P1|STARTED|Overall Study||32
1637122|NCT00803010|3999074|P2|NOT COMPLETED|Overall Study||0
1637123|NCT00803010|3999075|P1|NOT COMPLETED|Overall Study||0
1637124|NCT00803010|3999074|P2|COMPLETED|Overall Study||37
1637125|NCT00803010|3999075|P1|COMPLETED|Overall Study||37
1637126|NCT00803010|3999074|P2|STARTED|Overall Study||37
1637127|NCT00803010|3999075|P1|STARTED|Overall Study||37
1637128|NCT00802997|3999087|P2|NOT COMPLETED|6 Month to 9 Months||0
1637129|NCT00802997|3999088|P1|NOT COMPLETED|6 Month to 9 Months||2
1637130|NCT00802997|3999087|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1637131|NCT00802997|3999088|P1|COMPLETED|6 Month to 9 Months||25
1637132|NCT00802997|3999087|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1637133|NCT00802997|3999088|P1|STARTED|6 Month to 9 Months||27
1637134|NCT00802997|3999087|P2|NOT COMPLETED|3 Months to 6 Months||0
1637135|NCT00802997|3999088|P1|NOT COMPLETED|3 Months to 6 Months||7
1637136|NCT00802997|3999087|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1637137|NCT00802997|3999088|P1|COMPLETED|3 Months to 6 Months||27
1637138|NCT00802997|3999087|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1637139|NCT00802997|3999088|P1|STARTED|3 Months to 6 Months||34
1637140|NCT00802997|3999087|P2|NOT COMPLETED|Baseline to 3 Months||0
1637141|NCT00802997|3999088|P1|NOT COMPLETED|Baseline to 3 Months||0
1637142|NCT00802997|3999087|P2|COMPLETED|Baseline to 3 Months||17
1637143|NCT00802997|3999088|P1|COMPLETED|Baseline to 3 Months||34
1637144|NCT00802997|3999087|P2|STARTED|Baseline to 3 Months||17
1637145|NCT00802997|3999088|P1|STARTED|Baseline to 3 Months||34
1637146|NCT00802945|3999100|P2|NOT COMPLETED|Overall Study||35
1637147|NCT00802945|3999101|P1|NOT COMPLETED|Overall Study||35
1637148|NCT00802945|3999100|P2|COMPLETED|Overall Study||0
1637149|NCT00802945|3999101|P1|COMPLETED|Overall Study||0
1637150|NCT00802945|3999100|P2|STARTED|Overall Study||35
1637151|NCT00802945|3999101|P1|STARTED|Overall Study||35
1637152|NCT00802919|3999119|P2|NOT COMPLETED|Overall Study||1
1637153|NCT00802919|3999120|P1|NOT COMPLETED|Overall Study||3
1637154|NCT00802919|3999119|P2|COMPLETED|Overall Study||45
1637155|NCT00802919|3999120|P1|COMPLETED|Overall Study||42
1637156|NCT00802919|3999119|P2|STARTED|Overall Study||46
1637157|NCT00802919|3999120|P1|STARTED|Overall Study||45
1637158|NCT00802893|3999132|P1|NOT COMPLETED|Overall Study||3
1637159|NCT00802893|3999132|P1|COMPLETED|Overall Study||0
1637160|NCT00802893|3999132|P1|STARTED|Overall Study||3
1637161|NCT00802880|3999137|P1|NOT COMPLETED|Overall Study||0
1637162|NCT00802880|3999137|P1|COMPLETED|Overall Study||80
1637163|NCT00802880|3999137|P1|STARTED|Overall Study||80
1637164|NCT00802867|3999156|P1|NOT COMPLETED|Overall Study||13
1637165|NCT00802867|3999156|P1|COMPLETED|Overall Study||976
1637166|NCT00802867|3999156|P1|STARTED|Overall Study||989
1637167|NCT00802854|3999164|P1|NOT COMPLETED|Overall Study||0
1637168|NCT00802854|3999164|P1|COMPLETED|Overall Study||244
1637169|NCT00802854|3999164|P1|STARTED|Overall Study||244
1637170|NCT00802841|3999179|P2|NOT COMPLETED|Overall Study||95
1637171|NCT00802841|3999180|P1|NOT COMPLETED|Overall Study||96
1637172|NCT00802841|3999179|P2|COMPLETED|Overall Study||0
1637173|NCT00802841|3999180|P1|COMPLETED|Overall Study||0
1637174|NCT00802841|3999179|P2|Cross-over Set|Overall Study||56
1637175|NCT00802841|3999180|P1|Cross-over Set|Overall Study||13
1637176|NCT00802841|3999179|P2|Safety Set|Overall Study||93
1637177|NCT00802841|3999180|P1|Safety Set|Overall Study||96
1637178|NCT00802841|3999179|P2|Full Analysis Set|Overall Study||95
1637179|NCT00802841|3999180|P1|Full Analysis Set|Overall Study||96
1637180|NCT00802841|3999179|P2|STARTED|Overall Study||95
1637181|NCT00802841|3999180|P1|STARTED|Overall Study||96
1637182|NCT00802737|3999205|P3|NOT COMPLETED|Overall Study||1
1637183|NCT00802737|3999206|P2|NOT COMPLETED|Overall Study||11
1637184|NCT00802737|3999207|P1|NOT COMPLETED|Overall Study||17
1637185|NCT00802737|3999205|P3|COMPLETED|Overall Study||0
1637186|NCT00802737|3999206|P2|COMPLETED|Overall Study||0
1637187|NCT00802737|3999207|P1|COMPLETED|Overall Study||0
1637188|NCT00802737|3999205|P3|STARTED|Overall Study||1
1637189|NCT00802737|3999206|P2|STARTED|Overall Study||11
1637190|NCT00802737|3999207|P1|STARTED|Overall Study||17
1637191|NCT00802685|3999255|P2|NOT COMPLETED|Overall Study||0
1637192|NCT00802685|3999256|P1|NOT COMPLETED|Overall Study||0
1637193|NCT00802685|3999255|P2|COMPLETED|Overall Study||51
1637194|NCT00802685|3999256|P1|COMPLETED|Overall Study||54
1637195|NCT00802685|3999255|P2|STARTED|Overall Study||51
1637196|NCT00802685|3999256|P1|STARTED|Overall Study||54
1637197|NCT00802672|3999267|P3|NOT COMPLETED|Overall Study||34
1637198|NCT00802672|3999268|P2|NOT COMPLETED|Overall Study||52
1637199|NCT00802672|3999269|P1|NOT COMPLETED|Overall Study||68
1637200|NCT00802672|3999267|P3|COMPLETED|Overall Study||77
1637201|NCT00802672|3999268|P2|COMPLETED|Overall Study||174
1637202|NCT00802672|3999269|P1|COMPLETED|Overall Study||156
1637203|NCT00802672|3999267|P3|STARTED|Overall Study||111
1637204|NCT00802672|3999268|P2|STARTED|Overall Study||226
1637205|NCT00802672|3999269|P1|STARTED|Overall Study||224
1637206|NCT00802659|3999287|P4|NOT COMPLETED|Overall Study||0
1637207|NCT00802659|3999288|P3|NOT COMPLETED|Overall Study||0
1637208|NCT00802659|3999289|P2|NOT COMPLETED|Overall Study||1
1637209|NCT00802659|3999290|P1|NOT COMPLETED|Overall Study||0
1637210|NCT00802659|3999287|P4|COMPLETED|Overall Study||0
1637211|NCT00802659|3999288|P3|COMPLETED|Overall Study||0
1637212|NCT00802659|3999289|P2|COMPLETED|Overall Study||1
1637213|NCT00802659|3999290|P1|COMPLETED|Overall Study||0
1637214|NCT00802659|3999287|P4|STARTED|Overall Study||0
1637215|NCT00802659|3999288|P3|STARTED|Overall Study||0
1637216|NCT00802659|3999289|P2|STARTED|Overall Study||2
1637217|NCT00802659|3999290|P1|STARTED|Overall Study||0
1637218|NCT00802633|3999318|P2|NOT COMPLETED|Overall Study||0
1637219|NCT00802633|3999319|P1|NOT COMPLETED|Overall Study||0
1637220|NCT00802633|3999318|P2|COMPLETED|Overall Study||40
1637221|NCT00802633|3999319|P1|COMPLETED|Overall Study||40
1637222|NCT00802633|3999318|P2|STARTED|Overall Study||40
1637223|NCT00802633|3999319|P1|STARTED|Overall Study||40
1637224|NCT00802529|3999329|P2|NOT COMPLETED|Overall Study||1
1637225|NCT00802529|3999330|P1|NOT COMPLETED|Overall Study||0
1637226|NCT00802529|3999329|P2|COMPLETED|Overall Study||29
1637227|NCT00802529|3999330|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
1637228|NCT00802529|3999329|P2|STARTED|Overall Study||30
1637229|NCT00802529|3999330|P1|STARTED|Overall Study||30
1637230|NCT00802503|3999342|P2|NOT COMPLETED|Overall Study||20
1637231|NCT00802503|3999343|P1|NOT COMPLETED|Overall Study||10
1637232|NCT00802503|3999342|P2|COMPLETED|Overall Study||133
1637233|NCT00802503|3999343|P1|COMPLETED|Overall Study||142
1637234|NCT00802503|3999342|P2|STARTED|Overall Study||153
1637235|NCT00802503|3999343|P1|STARTED|Overall Study||152
1637236|NCT00802464|3999369|P4|NOT COMPLETED|Month 8 - Month 14||0
1637237|NCT00802464|3999370|P3|NOT COMPLETED|Month 8 - Month 14||1
1637238|NCT00802464|3999371|P2|NOT COMPLETED|Month 8 - Month 14||2
1637239|NCT00802464|3999372|P1|NOT COMPLETED|Month 8 - Month 14||1
1637240|NCT00802464|3999369|P4|COMPLETED|Month 8 - Month 14||126
1637241|NCT00802464|3999370|P3|COMPLETED|Month 8 - Month 14||129
1637242|NCT00802464|3999371|P2|COMPLETED|Month 8 - Month 14||63
1637243|NCT00802464|3999372|P1|COMPLETED|Month 8 - Month 14||33
1637244|NCT00802464|3999369|P4|STARTED|Month 8 - Month 14||126
1637245|NCT00802464|3999370|P3|STARTED|Month 8 - Month 14||130
1637246|NCT00802464|3999371|P2|STARTED|Month 8 - Month 14||65
1637247|NCT00802464|3999372|P1|STARTED|Month 8 - Month 14||34
1637248|NCT00802464|3999369|P4|NOT COMPLETED|Month 0 - Month 8||9
1637249|NCT00802464|3999370|P3|NOT COMPLETED|Month 0 - Month 8||7
1637250|NCT00802464|3999371|P2|NOT COMPLETED|Month 0 - Month 8||3
1637251|NCT00802464|3999372|P1|NOT COMPLETED|Month 0 - Month 8||0
1637252|NCT00802464|3999369|P4|COMPLETED|Month 0 - Month 8||141
1637253|NCT00802464|3999370|P3|COMPLETED|Month 0 - Month 8||142
1637254|NCT00802464|3999371|P2|COMPLETED|Month 0 - Month 8||70
1637255|NCT00802464|3999372|P1|COMPLETED|Month 0 - Month 8||38
1637256|NCT00802464|3999369|P4|STARTED|Month 0 - Month 8||150
1637257|NCT00802464|3999370|P3|STARTED|Month 0 - Month 8||149
1637258|NCT00802464|3999371|P2|STARTED|Month 0 - Month 8||73
1637259|NCT00802464|3999372|P1|STARTED|Month 0 - Month 8||38
1637260|NCT00802438|3999458|P1|NOT COMPLETED|Overall Study||28
1637261|NCT00802438|3999458|P1|COMPLETED|Overall Study||10
1637262|NCT00802438|3999458|P1|STARTED|Overall Study||38
1637263|NCT00802412|3999465|P2|NOT COMPLETED|Overall Study||1
1637264|NCT00802412|3999466|P1|NOT COMPLETED|Overall Study||2
1637265|NCT00802412|3999465|P2|COMPLETED|Overall Study||66
1637266|NCT00802412|3999466|P1|COMPLETED|Overall Study||63
1637267|NCT00802412|3999465|P2|STARTED|Overall Study||67
1637268|NCT00802412|3999466|P1|STARTED|Overall Study||65
1637269|NCT00802360|3999478|P4|NOT COMPLETED|Overall Study||22
1637270|NCT00802360|3999479|P3|NOT COMPLETED|Overall Study||25
1637271|NCT00802360|3999480|P2|NOT COMPLETED|Overall Study||26
1637272|NCT00802360|3999481|P1|NOT COMPLETED|Overall Study||24
1637273|NCT00802360|3999478|P4|COMPLETED|Overall Study||17
1637274|NCT00802360|3999479|P3|COMPLETED|Overall Study||17
1637275|NCT00802360|3999480|P2|COMPLETED|Overall Study||16
1637276|NCT00802360|3999481|P1|COMPLETED|Overall Study||18
1637277|NCT00802360|3999478|P4|STARTED|Overall Study||39
1637278|NCT00802360|3999479|P3|STARTED|Overall Study||42
1637279|NCT00802360|3999480|P2|STARTED|Overall Study||42
1637280|NCT00802360|3999481|P1|STARTED|Overall Study||42
1637281|NCT00802204|3999523|P2|NOT COMPLETED|Overall Study||1
1637282|NCT00802204|3999524|P1|NOT COMPLETED|Overall Study||1
1637283|NCT00802204|3999523|P2|COMPLETED|Overall Study||18
1637284|NCT00802204|3999524|P1|COMPLETED|Overall Study||8
1637285|NCT00802204|3999523|P2|STARTED|Overall Study||19
1637286|NCT00802204|3999524|P1|STARTED|Overall Study||9
1637287|NCT00802178|3999548|P1|NOT COMPLETED|Overall Study||113
1637288|NCT00802178|3999548|P1|COMPLETED|Overall Study||2335
1637289|NCT00802178|3999548|P1|STARTED|Overall Study||2448
1637290|NCT00802100|3999558|P3|NOT COMPLETED|Overall Study||4
1637291|NCT00802100|3999559|P2|NOT COMPLETED|Overall Study||7
1637292|NCT00802100|3999560|P1|NOT COMPLETED|Overall Study||6
1637293|NCT00802100|3999558|P3|COMPLETED|Overall Study||2
1637294|NCT00802100|3999559|P2|COMPLETED|Overall Study||2
1637295|NCT00802100|3999560|P1|COMPLETED|Overall Study||0
1637296|NCT00802100|3999558|P3|STARTED|Overall Study||6
1637297|NCT00802100|3999559|P2|STARTED|Overall Study||9
1637298|NCT00802100|3999560|P1|STARTED|Overall Study||6
1637299|NCT00802074|3999575|P6|NOT COMPLETED|Overall Study||0
1637300|NCT00802074|3999576|P5|NOT COMPLETED|Overall Study||0
1637301|NCT00802074|3999577|P4|NOT COMPLETED|Overall Study||0
1637302|NCT00802074|3999578|P3|NOT COMPLETED|Overall Study||1
1637303|NCT00802074|3999579|P2|NOT COMPLETED|Overall Study||1
1637304|NCT00802074|3999580|P1|NOT COMPLETED|Overall Study||2
1637305|NCT00802074|3999575|P6|COMPLETED|Overall Study||7
1637306|NCT00802074|3999576|P5|COMPLETED|Overall Study||7
1637307|NCT00802074|3999577|P4|COMPLETED|Overall Study||7
1637308|NCT00802074|3999578|P3|COMPLETED|Overall Study||6
1637309|NCT00802074|3999579|P2|COMPLETED|Overall Study||7
1637310|NCT00802074|3999580|P1|COMPLETED|Overall Study||7
1637311|NCT00802074|3999575|P6|STARTED|Overall Study||7
1637312|NCT00802074|3999576|P5|STARTED|Overall Study||7
1637313|NCT00802074|3999577|P4|STARTED|Overall Study||7
1637314|NCT00802074|3999578|P3|STARTED|Overall Study||7
1637315|NCT00802074|3999579|P2|STARTED|Overall Study||8
1637316|NCT00802074|3999580|P1|STARTED|Overall Study||9
1637317|NCT00801983|3999614|P2|NOT COMPLETED|Period 2||1
1637318|NCT00801983|3999615|P1|NOT COMPLETED|Period 2||2
1637319|NCT00801983|3999614|P2|COMPLETED|Period 2||32
1637320|NCT00801983|3999615|P1|COMPLETED|Period 2||38
1637321|NCT00801983|3999614|P2|STARTED|Period 2||33
1637322|NCT00801983|3999615|P1|STARTED|Period 2||40
1637323|NCT00801983|3999614|P2|NOT COMPLETED|Period 1||8
1637324|NCT00801983|3999615|P1|NOT COMPLETED|Period 1||4
1637325|NCT00801983|3999614|P2|COMPLETED|Period 1||33
1637326|NCT00801983|3999615|P1|COMPLETED|Period 1||40
1637327|NCT00801983|3999614|P2|STARTED|Period 1||41
1637328|NCT00801983|3999615|P1|STARTED|Period 1||44
1637329|NCT00801892|3999623|P2|NOT COMPLETED|Sham Crossover Period||2
1637330|NCT00801892|3999624|P1|NOT COMPLETED|Sham Crossover Period||0
1637331|NCT00801892|3999623|P2|COMPLETED|Sham Crossover Period||5
1637332|NCT00801892|3999624|P1|COMPLETED|Sham Crossover Period||0
1637333|NCT00801892|3999623|P2|STARTED|Sham Crossover Period||7
1637334|NCT00801892|3999624|P1|STARTED|Sham Crossover Period||0
1637335|NCT00801892|3999623|P2|NOT COMPLETED|Main Study Period||1
1637336|NCT00801892|3999624|P1|NOT COMPLETED|Main Study Period||0
1637337|NCT00801892|3999623|P2|COMPLETED|Main Study Period||10
1637338|NCT00801892|3999624|P1|COMPLETED|Main Study Period||12
1637339|NCT00801892|3999623|P2|STARTED|Main Study Period||11
1637340|NCT00801892|3999624|P1|STARTED|Main Study Period||12
1637341|NCT00801827|3999640|P1|NOT COMPLETED|Overall Study||0
1637342|NCT00801827|3999640|P1|COMPLETED|Overall Study||5
1637343|NCT00801827|3999640|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
1637344|NCT00801801|3999644|P1|NOT COMPLETED|Overall Study||0
1637345|NCT00801801|3999644|P1|COMPLETED|Overall Study||5
1637346|NCT00801801|3999644|P1|STARTED|Overall Study||5
1637347|NCT00801684|3999649|P1|NOT COMPLETED|Overall Study||0
1637348|NCT00801684|3999649|P1|COMPLETED|Overall Study||24
1637349|NCT00801684|3999649|P1|STARTED|Overall Study||24
1637350|NCT00801632|3999671|P1|NOT COMPLETED|Overall Study||1
1637351|NCT00801632|3999671|P1|COMPLETED|Overall Study||4
1637352|NCT00801632|3999671|P1|STARTED|Overall Study||5
1637353|NCT00801242|3999682|P1|NOT COMPLETED|Overall Study||52
1637354|NCT00801242|3999682|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
1637355|NCT00801242|3999682|P1|Started Cycle 3|Overall Study||2
1637356|NCT00801242|3999682|P1|Started Cycle 2|Overall Study||35
1637357|NCT00801242|3999682|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
1637358|NCT00801242|3999682|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
1637359|NCT00801242|3999682|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
1637360|NCT00801242|3999682|P1|STARTED|Overall Study|Randomized participants.|220
1637361|NCT00801229|3999695|P2|NOT COMPLETED|Received Study Drug/Placebo||4
1637362|NCT00801229|3999696|P1|NOT COMPLETED|Received Study Drug/Placebo||4
1637363|NCT00801229|3999695|P2|COMPLETED|Received Study Drug/Placebo||30
1637364|NCT00801229|3999696|P1|COMPLETED|Received Study Drug/Placebo||31
1637365|NCT00801229|3999695|P2|STARTED|Received Study Drug/Placebo||34
1637366|NCT00801229|3999696|P1|STARTED|Received Study Drug/Placebo||35
1637367|NCT00801229|3999695|P2|NOT COMPLETED|Signed Consent||3
1637368|NCT00801229|3999696|P1|NOT COMPLETED|Signed Consent||3
1637369|NCT00801229|3999695|P2|COMPLETED|Signed Consent||34
1637370|NCT00801229|3999696|P1|COMPLETED|Signed Consent||35
1637371|NCT00801229|3999695|P2|STARTED|Signed Consent||37
1637372|NCT00801229|3999696|P1|STARTED|Signed Consent||38
1637373|NCT00801138|3999706|P4|NOT COMPLETED|Overall Study||0
1637374|NCT00801138|3999707|P3|NOT COMPLETED|Overall Study||0
1637375|NCT00801138|3999708|P2|NOT COMPLETED|Overall Study||0
1637376|NCT00801138|3999709|P1|NOT COMPLETED|Overall Study||0
1637377|NCT00801138|3999706|P4|COMPLETED|Overall Study||54
1637378|NCT00801138|3999707|P3|COMPLETED|Overall Study||54
1637379|NCT00801138|3999708|P2|COMPLETED|Overall Study||56
1637380|NCT00801138|3999709|P1|COMPLETED|Overall Study||54
1637381|NCT00801138|3999706|P4|STARTED|Overall Study||54
1637382|NCT00801138|3999707|P3|STARTED|Overall Study||54
1637383|NCT00801138|3999708|P2|STARTED|Overall Study||56
1637384|NCT00801138|3999709|P1|STARTED|Overall Study||54
1637385|NCT00801099|3999731|P1|NOT COMPLETED|Overall Study||101
1637386|NCT00801099|3999731|P1|COMPLETED|Overall Study||175
1637387|NCT00801099|3999731|P1|STARTED|Overall Study||276
1637388|NCT00800982|3999737|P2|NOT COMPLETED|Overall Study||3
1637389|NCT00800982|3999738|P1|NOT COMPLETED|Overall Study||2
1637390|NCT00800982|3999737|P2|COMPLETED|Overall Study||12
1637391|NCT00800982|3999738|P1|COMPLETED|Overall Study||13
1637392|NCT00800982|3999737|P2|STARTED|Overall Study||15
1637393|NCT00800982|3999738|P1|STARTED|Overall Study||15
1637394|NCT00800865|3999746|P2|NOT COMPLETED|Overall Study||0
1637395|NCT00800865|3999747|P1|NOT COMPLETED|Overall Study||0
1637396|NCT00800865|3999746|P2|COMPLETED|Overall Study||16
1637397|NCT00800865|3999747|P1|COMPLETED|Overall Study||15
1637398|NCT00800865|3999746|P2|STARTED|Overall Study||16
1637399|NCT00800865|3999747|P1|STARTED|Overall Study||15
1637400|NCT00800839|3999755|P1|NOT COMPLETED|Overall Study||7
1637401|NCT00800839|3999755|P1|COMPLETED|Overall Study||49
1637402|NCT00800839|3999755|P1|STARTED|Overall Study||56
1637403|NCT00800735|3999764|P1|NOT COMPLETED|Overall Study||14
1637404|NCT00800735|3999764|P1|COMPLETED|Overall Study||16
1637405|NCT00800735|3999764|P1|STARTED|Overall Study||30
1637406|NCT00800683|3999770|P2|NOT COMPLETED|Overall Study||19
1637407|NCT00800683|3999771|P1|NOT COMPLETED|Overall Study||17
1637408|NCT00800683|3999770|P2|COMPLETED|Overall Study|Number who completed treatment|49
1637409|NCT00800683|3999771|P1|COMPLETED|Overall Study|Number who completed treatment|48
1637410|NCT00800683|3999770|P2|STARTED|Overall Study|Number who started treatment|68
1637411|NCT00800683|3999771|P1|STARTED|Overall Study|Number who started treatment|65
1637412|NCT00800540|3999817|P2|NOT COMPLETED|Period 2: 6 Weeks||1
1637413|NCT00800540|3999818|P1|NOT COMPLETED|Period 2: 6 Weeks||0
1637414|NCT00800540|3999817|P2|COMPLETED|Period 2: 6 Weeks||16
1637415|NCT00800540|3999818|P1|COMPLETED|Period 2: 6 Weeks||16
1637416|NCT00800540|3999817|P2|STARTED|Period 2: 6 Weeks||17
1637417|NCT00800540|3999818|P1|STARTED|Period 2: 6 Weeks||16
1637418|NCT00800540|3999817|P2|NOT COMPLETED|Washout: 4 Weeks||0
1637419|NCT00800540|3999818|P1|NOT COMPLETED|Washout: 4 Weeks||0
1637420|NCT00800540|3999817|P2|COMPLETED|Washout: 4 Weeks||17
1637421|NCT00800540|3999818|P1|COMPLETED|Washout: 4 Weeks||16
1637422|NCT00800540|3999817|P2|STARTED|Washout: 4 Weeks||17
1637423|NCT00800540|3999818|P1|STARTED|Washout: 4 Weeks||16
1637424|NCT00800540|3999817|P2|NOT COMPLETED|Period One: 6 Weeks||1
1637425|NCT00800540|3999818|P1|NOT COMPLETED|Period One: 6 Weeks||1
1637426|NCT00800540|3999817|P2|COMPLETED|Period One: 6 Weeks||17
1637427|NCT00800540|3999818|P1|COMPLETED|Period One: 6 Weeks||16
1637428|NCT00800540|3999817|P2|STARTED|Period One: 6 Weeks||18
1637429|NCT00800540|3999818|P1|STARTED|Period One: 6 Weeks||17
1637430|NCT00800436|3999853|P7|NOT COMPLETED|Overall Study||0
1637431|NCT00800436|3999854|P6|NOT COMPLETED|Overall Study||0
1637432|NCT00800436|3999855|P5|NOT COMPLETED|Overall Study||0
1637433|NCT00800436|3999856|P4|NOT COMPLETED|Overall Study||1
1637434|NCT00800436|3999857|P3|NOT COMPLETED|Overall Study||1
1637435|NCT00800436|3999858|P2|NOT COMPLETED|Overall Study||0
1637436|NCT00800436|3999859|P1|NOT COMPLETED|Overall Study||0
1637437|NCT00800436|3999853|P7|COMPLETED|Overall Study||20
1637438|NCT00800436|3999854|P6|COMPLETED|Overall Study||20
1637439|NCT00800436|3999855|P5|COMPLETED|Overall Study||6
1637440|NCT00800436|3999856|P4|COMPLETED|Overall Study||5
1637441|NCT00800436|3999857|P3|COMPLETED|Overall Study||5
1637442|NCT00800436|3999858|P2|COMPLETED|Overall Study||6
1637443|NCT00800436|3999859|P1|COMPLETED|Overall Study||6
1637444|NCT00800436|3999853|P7|STARTED|Overall Study||20
1637445|NCT00800436|3999854|P6|STARTED|Overall Study||20
1637446|NCT00800436|3999855|P5|STARTED|Overall Study||6
1637447|NCT00800436|3999856|P4|STARTED|Overall Study||6
1637448|NCT00800436|3999857|P3|STARTED|Overall Study||6
1637449|NCT00800436|3999858|P2|STARTED|Overall Study||6
1637450|NCT00800436|3999859|P1|STARTED|Overall Study||6
1637451|NCT00800384|3999905|P2|NOT COMPLETED|Overall Study||43
1637452|NCT00800384|3999906|P1|NOT COMPLETED|Overall Study||41
1637453|NCT00800384|3999905|P2|COMPLETED|Overall Study||1210
1637454|NCT00800384|3999906|P1|COMPLETED|Overall Study||1206
1637455|NCT00800384|3999905|P2|STARTED|Overall Study||1253
1637456|NCT00800384|3999906|P1|STARTED|Overall Study||1247
1637457|NCT00800345|3999914|P1|NOT COMPLETED|Overall Study||0
1637458|NCT00800345|3999914|P1|COMPLETED|Overall Study||33
1637459|NCT00800345|3999914|P1|STARTED|Overall Study||33
1637460|NCT00800254|3999921|P2|NOT COMPLETED|Overall Study||6
1637461|NCT00800254|3999922|P1|NOT COMPLETED|Overall Study||5
1637462|NCT00800254|3999921|P2|COMPLETED|Overall Study||25
1637463|NCT00800254|3999922|P1|COMPLETED|Overall Study||30
1637464|NCT00800254|3999921|P2|3.5 Weeks Post-operatively|Overall Study||31
1637465|NCT00800254|3999922|P1|3.5 Weeks Post-operatively|Overall Study||31
1637466|NCT00800254|3999921|P2|STARTED|Overall Study||31
1637467|NCT00800254|3999922|P1|STARTED|Overall Study||35
1637468|NCT00800202|3999944|P2|NOT COMPLETED|Overall Study||24
1637469|NCT00800202|3999945|P1|NOT COMPLETED|Overall Study||67
1637470|NCT00800202|3999944|P2|COMPLETED|Overall Study||0
1637471|NCT00800202|3999945|P1|COMPLETED|Overall Study||0
1637472|NCT00800202|3999944|P2|STARTED|Overall Study||24
1637473|NCT00800202|3999945|P1|STARTED|Overall Study||67
1637474|NCT00799903|3999965|P2|NOT COMPLETED|Overall Study||278
1637475|NCT00799903|3999966|P1|NOT COMPLETED|Overall Study||273
1637476|NCT00799903|3999965|P2|COMPLETED|Overall Study||7646
1637477|NCT00799903|3999966|P1|COMPLETED|Overall Study||7631
1637478|NCT00799903|3999965|P2|STARTED|Overall Study||7924
1637479|NCT00799903|3999966|P1|STARTED|Overall Study||7904
1637480|NCT00799825|3999986|P1|NOT COMPLETED|Overall Study||48
1637481|NCT00799825|3999986|P1|COMPLETED|Overall Study||296
1637482|NCT00799825|3999986|P1|STARTED|Overall Study||344
1637483|NCT00799773|3999994|P2|NOT COMPLETED|Overall Study||0
1637484|NCT00799773|3999995|P1|NOT COMPLETED|Overall Study||0
1637485|NCT00799773|3999994|P2|COMPLETED|Overall Study||1
1637486|NCT00799773|3999995|P1|COMPLETED|Overall Study||2
1637487|NCT00799773|3999994|P2|STARTED|Overall Study||1
1637488|NCT00799773|3999995|P1|STARTED|Overall Study||2
1637489|NCT00799708|4000026|P3|NOT COMPLETED|Overall Study||0
1637490|NCT00799708|4000027|P2|NOT COMPLETED|Overall Study||0
1637491|NCT00799708|4000028|P1|NOT COMPLETED|Overall Study||1
1637492|NCT00799708|4000026|P3|COMPLETED|Overall Study||11
1637493|NCT00799708|4000027|P2|COMPLETED|Overall Study||6
1637494|NCT00799708|4000028|P1|COMPLETED|Overall Study||9
1637495|NCT00799708|4000026|P3|STARTED|Overall Study||11
1637496|NCT00799708|4000027|P2|STARTED|Overall Study||6
1637497|NCT00799708|4000028|P1|STARTED|Overall Study||10
1637498|NCT00799643|4000040|P2|NOT COMPLETED|Overall Study||27
1637499|NCT00799643|4000041|P1|NOT COMPLETED|Overall Study||25
1637500|NCT00799643|4000040|P2|COMPLETED|Overall Study||119
1637501|NCT00799643|4000041|P1|COMPLETED|Overall Study||115
1637502|NCT00799643|4000040|P2|STARTED|Overall Study||146
1637503|NCT00799643|4000041|P1|STARTED|Overall Study||140
1637504|NCT00799617|4000051|P2|NOT COMPLETED|Anemia Trial||3
1637505|NCT00799617|4000052|P1|NOT COMPLETED|Anemia Trial||3
1637506|NCT00799617|4000051|P2|COMPLETED|Anemia Trial||32
1637507|NCT00799617|4000052|P1|COMPLETED|Anemia Trial||24
1637508|NCT00799617|4000051|P2|STARTED|Anemia Trial||35
1637509|NCT00799617|4000052|P1|STARTED|Anemia Trial||27
1637510|NCT00799617|4000051|P2|NOT COMPLETED|Cognitive Function Trial||1
1637511|NCT00799617|4000052|P1|NOT COMPLETED|Cognitive Function Trial||0
1637512|NCT00799617|4000051|P2|COMPLETED|Cognitive Function Trial||245
1637513|NCT00799617|4000052|P1|COMPLETED|Cognitive Function Trial||247
1637514|NCT00799617|4000051|P2|STARTED|Cognitive Function Trial||246
1637515|NCT00799617|4000052|P1|STARTED|Cognitive Function Trial||247
1637516|NCT00799617|4000051|P2|NOT COMPLETED|Bone Trial||16
1637517|NCT00799617|4000052|P1|NOT COMPLETED|Bone Trial||6
1637518|NCT00799617|4000051|P2|COMPLETED|Bone Trial||85
1637519|NCT00799617|4000052|P1|COMPLETED|Bone Trial||104
1637520|NCT00799617|4000051|P2|STARTED|Bone Trial||101
1637521|NCT00799617|4000052|P1|STARTED|Bone Trial||110
1637522|NCT00799617|4000051|P2|NOT COMPLETED|Cardiovascular Trial||17
1637523|NCT00799617|4000052|P1|NOT COMPLETED|Cardiovascular Trial||15
1637524|NCT00799617|4000051|P2|COMPLETED|Cardiovascular Trial||65
1637525|NCT00799617|4000052|P1|COMPLETED|Cardiovascular Trial||73
1637526|NCT00799617|4000051|P2|STARTED|Cardiovascular Trial||82
1637527|NCT00799617|4000052|P1|STARTED|Cardiovascular Trial||88
1637528|NCT00799617|4000051|P2|NOT COMPLETED|Vitality Trial||22
1637529|NCT00799617|4000052|P1|NOT COMPLETED|Vitality Trial||7
1637530|NCT00799617|4000051|P2|COMPLETED|Vitality Trial||216
1637531|NCT00799617|4000052|P1|COMPLETED|Vitality Trial||229
1637532|NCT00799617|4000051|P2|STARTED|Vitality Trial||238
1637533|NCT00799617|4000052|P1|STARTED|Vitality Trial||236
1637534|NCT00799617|4000051|P2|NOT COMPLETED|Physical Function Trial||11
1637535|NCT00799617|4000052|P1|NOT COMPLETED|Physical Function Trial||6
1637536|NCT00799617|4000051|P2|COMPLETED|Physical Function Trial||185
1637537|NCT00799617|4000052|P1|COMPLETED|Physical Function Trial||185
1637538|NCT00799617|4000051|P2|STARTED|Physical Function Trial||196
1637539|NCT00799617|4000052|P1|STARTED|Physical Function Trial||191
1637540|NCT00799617|4000051|P2|NOT COMPLETED|Sexual Funtion Trial||21
1637541|NCT00799617|4000052|P1|NOT COMPLETED|Sexual Funtion Trial||16
1637542|NCT00799617|4000051|P2|COMPLETED|Sexual Funtion Trial||215
1637543|NCT00799617|4000052|P1|COMPLETED|Sexual Funtion Trial||218
1637544|NCT00799617|4000051|P2|STARTED|Sexual Funtion Trial||236
1637545|NCT00799617|4000052|P1|STARTED|Sexual Funtion Trial||234
1637546|NCT00799617|4000051|P2|NOT COMPLETED|Main Testosterone Trial||21
1637547|NCT00799617|4000052|P1|NOT COMPLETED|Main Testosterone Trial||19
1637548|NCT00799617|4000051|P2|COMPLETED|Main Testosterone Trial||374
1637549|NCT00799617|4000052|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
1637550|NCT00799617|4000051|P2|STARTED|Main Testosterone Trial||395
1637551|NCT00799617|4000052|P1|STARTED|Main Testosterone Trial||395
1637552|NCT00799604|4000133|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
1637553|NCT00799604|4000134|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
1637554|NCT00799604|4000135|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
1637555|NCT00799604|4000133|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
1637556|NCT00799604|4000134|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
1637557|NCT00799604|4000135|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
1637558|NCT00799604|4000133|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
1637559|NCT00799604|4000134|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
1637560|NCT00799604|4000135|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
1637561|NCT00799604|4000133|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
1637562|NCT00799604|4000134|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
1637563|NCT00799604|4000135|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
1637564|NCT00799604|4000133|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
1637565|NCT00799604|4000134|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
1637566|NCT00799604|4000135|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
1637567|NCT00799604|4000133|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
1637568|NCT00799604|4000134|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
1637569|NCT00799604|4000135|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
1637570|NCT00799591|4000159|P1|NOT COMPLETED|Overall Study||66
1637571|NCT00799591|4000159|P1|COMPLETED|Overall Study||90
1637572|NCT00799591|4000159|P1|STARTED|Overall Study||156
1637573|NCT00799578|4000170|P1|NOT COMPLETED|Overall Study||2
1637574|NCT00799578|4000170|P1|COMPLETED|Overall Study||11
1637575|NCT00799578|4000170|P1|STARTED|Overall Study||13
1637576|NCT00799487|4000177|P3|NOT COMPLETED|Double-Blind Assessment Period||2
1637577|NCT00799487|4000178|P2|NOT COMPLETED|Double-Blind Assessment Period||1
1637578|NCT00799487|4000179|P1|NOT COMPLETED|Double-Blind Assessment Period||0
1637579|NCT00799487|4000177|P3|COMPLETED|Double-Blind Assessment Period||32
1637580|NCT00799487|4000178|P2|COMPLETED|Double-Blind Assessment Period||33
1637581|NCT00799487|4000179|P1|COMPLETED|Double-Blind Assessment Period||0
1637582|NCT00799487|4000177|P3|STARTED|Double-Blind Assessment Period||34
1637583|NCT00799487|4000178|P2|STARTED|Double-Blind Assessment Period||34
1637584|NCT00799487|4000179|P1|STARTED|Double-Blind Assessment Period||0
1637585|NCT00799487|4000177|P3|NOT COMPLETED|Dose Adjustment Period||0
1637586|NCT00799487|4000178|P2|NOT COMPLETED|Dose Adjustment Period||0
1637587|NCT00799487|4000179|P1|NOT COMPLETED|Dose Adjustment Period||21
1637588|NCT00799487|4000177|P3|COMPLETED|Dose Adjustment Period||34
1637589|NCT00799487|4000178|P2|COMPLETED|Dose Adjustment Period||34
1637590|NCT00799487|4000179|P1|COMPLETED|Dose Adjustment Period||0
1637591|NCT00799487|4000177|P3|STARTED|Dose Adjustment Period||34
1637592|NCT00799487|4000178|P2|STARTED|Dose Adjustment Period||34
1637593|NCT00799487|4000179|P1|STARTED|Dose Adjustment Period||21
1637594|NCT00799474|4000259|P1|NOT COMPLETED|Overall Study||0
1637595|NCT00799474|4000259|P1|COMPLETED|Overall Study||609
1637596|NCT00799474|4000259|P1|STARTED|Overall Study||609
1637597|NCT00799435|4000267|P2|NOT COMPLETED|Overall Study||0
1637598|NCT00799435|4000268|P1|NOT COMPLETED|Overall Study||0
1637599|NCT00799435|4000267|P2|COMPLETED|Overall Study||1
1637600|NCT00799435|4000268|P1|COMPLETED|Overall Study||1
1637601|NCT00799435|4000267|P2|STARTED|Overall Study||1
1637602|NCT00799435|4000268|P1|STARTED|Overall Study||1
1637603|NCT00799422|4000274|P6|NOT COMPLETED|Third Week of Wear||0
1637604|NCT00799422|4000275|P5|NOT COMPLETED|Third Week of Wear||0
1637605|NCT00799422|4000276|P4|NOT COMPLETED|Third Week of Wear||0
1637606|NCT00799422|4000277|P3|NOT COMPLETED|Third Week of Wear||0
1637607|NCT00799422|4000278|P2|NOT COMPLETED|Third Week of Wear||0
1637608|NCT00799422|4000279|P1|NOT COMPLETED|Third Week of Wear||0
1637609|NCT00799422|4000274|P6|COMPLETED|Third Week of Wear||4
1637610|NCT00799422|4000275|P5|COMPLETED|Third Week of Wear||4
1637611|NCT00799422|4000276|P4|COMPLETED|Third Week of Wear||3
1637612|NCT00799422|4000277|P3|COMPLETED|Third Week of Wear||3
1637613|NCT00799422|4000278|P2|COMPLETED|Third Week of Wear||4
1637614|NCT00799422|4000279|P1|COMPLETED|Third Week of Wear||4
1637615|NCT00799422|4000274|P6|STARTED|Third Week of Wear||4
1637616|NCT00799422|4000275|P5|STARTED|Third Week of Wear||4
1637617|NCT00799422|4000276|P4|STARTED|Third Week of Wear||3
1637618|NCT00799422|4000277|P3|STARTED|Third Week of Wear||3
1637619|NCT00799422|4000278|P2|STARTED|Third Week of Wear||4
1637620|NCT00799422|4000279|P1|STARTED|Third Week of Wear||4
1637621|NCT00799422|4000274|P6|NOT COMPLETED|Second Week of Wear||0
1637622|NCT00799422|4000275|P5|NOT COMPLETED|Second Week of Wear||0
1637623|NCT00799422|4000276|P4|NOT COMPLETED|Second Week of Wear||0
1637624|NCT00799422|4000277|P3|NOT COMPLETED|Second Week of Wear||0
1637625|NCT00799422|4000278|P2|NOT COMPLETED|Second Week of Wear||0
1637626|NCT00799422|4000279|P1|NOT COMPLETED|Second Week of Wear||0
1637627|NCT00799422|4000274|P6|COMPLETED|Second Week of Wear||4
1637628|NCT00799422|4000275|P5|COMPLETED|Second Week of Wear||4
1637629|NCT00799422|4000276|P4|COMPLETED|Second Week of Wear||3
1637630|NCT00799422|4000277|P3|COMPLETED|Second Week of Wear||3
1637631|NCT00799422|4000278|P2|COMPLETED|Second Week of Wear||4
1637632|NCT00799422|4000279|P1|COMPLETED|Second Week of Wear||4
1637633|NCT00799422|4000274|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
1637634|NCT00799422|4000275|P5|STARTED|Second Week of Wear||4
1637635|NCT00799422|4000276|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
1637636|NCT00799422|4000277|P3|STARTED|Second Week of Wear||3
1637637|NCT00799422|4000278|P2|STARTED|Second Week of Wear||4
1637638|NCT00799422|4000279|P1|STARTED|Second Week of Wear||4
1637639|NCT00799422|4000274|P6|NOT COMPLETED|First Week of Wear||0
1637640|NCT00799422|4000275|P5|NOT COMPLETED|First Week of Wear||0
1637641|NCT00799422|4000276|P4|NOT COMPLETED|First Week of Wear||1
1637642|NCT00799422|4000277|P3|NOT COMPLETED|First Week of Wear||1
1637643|NCT00799422|4000278|P2|NOT COMPLETED|First Week of Wear||0
1637644|NCT00799422|4000279|P1|NOT COMPLETED|First Week of Wear||0
1637645|NCT00799422|4000274|P6|COMPLETED|First Week of Wear||5
1637646|NCT00799422|4000275|P5|COMPLETED|First Week of Wear||4
1637647|NCT00799422|4000276|P4|COMPLETED|First Week of Wear||4
1637648|NCT00799422|4000277|P3|COMPLETED|First Week of Wear||3
1637649|NCT00799422|4000278|P2|COMPLETED|First Week of Wear||4
1637650|NCT00799422|4000279|P1|COMPLETED|First Week of Wear||4
1637651|NCT00799422|4000274|P6|STARTED|First Week of Wear||5
1637652|NCT00799422|4000275|P5|STARTED|First Week of Wear||4
1637653|NCT00799422|4000276|P4|STARTED|First Week of Wear||5
1637654|NCT00799422|4000277|P3|STARTED|First Week of Wear||4
1637655|NCT00799422|4000278|P2|STARTED|First Week of Wear||4
1637656|NCT00799422|4000279|P1|STARTED|First Week of Wear||4
1637657|NCT00799409|4000296|P3|NOT COMPLETED|Overall Study||0
1637658|NCT00799409|4000297|P2|NOT COMPLETED|Overall Study||0
1637659|NCT00799409|4000298|P1|NOT COMPLETED|Overall Study||7
1637660|NCT00799409|4000296|P3|COMPLETED|Overall Study||35
1637661|NCT00799409|4000297|P2|COMPLETED|Overall Study||36
1637662|NCT00799409|4000298|P1|COMPLETED|Overall Study||0
1637663|NCT00799409|4000296|P3|STARTED|Overall Study||35
1637664|NCT00799409|4000297|P2|STARTED|Overall Study||36
1637665|NCT00799409|4000298|P1|STARTED|Overall Study||7
1637666|NCT00799396|4000378|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
1637667|NCT00799396|4000378|P1|COMPLETED|Clopidogrel Plus Aspirin||663
1637668|NCT00799396|4000378|P1|STARTED|Clopidogrel Plus Aspirin||669
1637669|NCT00799396|4000378|P1|NOT COMPLETED|Clopidogrel Treatment||13
1637670|NCT00799396|4000378|P1|COMPLETED|Clopidogrel Treatment||669
1637671|NCT00799396|4000378|P1|STARTED|Clopidogrel Treatment||682
1637672|NCT00799383|4000385|P2|NOT COMPLETED|Overall Study||6
1637673|NCT00799383|4000386|P1|NOT COMPLETED|Overall Study||3
1637674|NCT00799383|4000385|P2|COMPLETED|Overall Study||18
1637675|NCT00799383|4000386|P1|COMPLETED|Overall Study||20
1637676|NCT00799383|4000385|P2|STARTED|Overall Study||24
1637677|NCT00799383|4000386|P1|STARTED|Overall Study||23
1637678|NCT00799292|4000408|P2|NOT COMPLETED|Overall Study||0
1637679|NCT00799292|4000409|P1|NOT COMPLETED|Overall Study||0
1637680|NCT00799292|4000408|P2|COMPLETED|Overall Study||29
1637681|NCT00799292|4000409|P1|COMPLETED|Overall Study||29
1637682|NCT00799292|4000408|P2|STARTED|Overall Study||29
1637683|NCT00799292|4000409|P1|STARTED|Overall Study||29
1637684|NCT00799227|4000413|P1|NOT COMPLETED|Overall Study||3
1637685|NCT00799227|4000413|P1|COMPLETED|Overall Study||53
1637686|NCT00799227|4000413|P1|STARTED|Overall Study||56
1637687|NCT00798967|4000422|P2|NOT COMPLETED|Overall Study||4
1637688|NCT00798967|4000423|P1|NOT COMPLETED|Overall Study||4
1637689|NCT00798967|4000422|P2|COMPLETED|Overall Study||39
1637690|NCT00798967|4000423|P1|COMPLETED|Overall Study||39
1637691|NCT00798967|4000422|P2|Discontinued During Dosing Period|Overall Study||4
1637692|NCT00798967|4000423|P1|Discontinued During Dosing Period|Overall Study||4
1637693|NCT00798967|4000422|P2|STARTED|Overall Study||43
1637694|NCT00798967|4000423|P1|STARTED|Overall Study||43
1637695|NCT00798889|4000431|P1|NOT COMPLETED|Overall Study||314
1637696|NCT00798889|4000431|P1|COMPLETED|Overall Study||0
1637697|NCT00798889|4000431|P1|Treated|Overall Study||311
1637698|NCT00798889|4000431|P1|STARTED|Overall Study||314
1637699|NCT00798759|4000437|P2|NOT COMPLETED|Overall Study||13
1637700|NCT00798759|4000438|P1|NOT COMPLETED|Overall Study||8
1637701|NCT00798759|4000437|P2|COMPLETED|Overall Study||106
1637702|NCT00798759|4000438|P1|COMPLETED|Overall Study||109
1637703|NCT00798759|4000437|P2|STARTED|Overall Study||119
1637704|NCT00798759|4000438|P1|STARTED|Overall Study||117
1637705|NCT00798720|4000446|P1|NOT COMPLETED|Overall Study||0
1637706|NCT00798720|4000446|P1|COMPLETED|Overall Study||18
1637707|NCT00798720|4000446|P1|STARTED|Overall Study||18
1637708|NCT00798707|4000456|P3|NOT COMPLETED|Overall Study||22
1637709|NCT00798707|4000457|P2|NOT COMPLETED|Overall Study||33
1637710|NCT00798707|4000458|P1|NOT COMPLETED|Overall Study||26
1637711|NCT00798707|4000456|P3|COMPLETED|Overall Study||215
1637712|NCT00798707|4000457|P2|COMPLETED|Overall Study||204
1637713|NCT00798707|4000458|P1|COMPLETED|Overall Study||209
1637714|NCT00798707|4000456|P3|Treated|Overall Study||236
1637715|NCT00798707|4000457|P2|Treated|Overall Study||232
1637716|NCT00798707|4000458|P1|Treated|Overall Study||231
1637717|NCT00798707|4000456|P3|STARTED|Overall Study||237
1637718|NCT00798707|4000457|P2|STARTED|Overall Study||237
1637719|NCT00798707|4000458|P1|STARTED|Overall Study||235
1637720|NCT00798694|4000510|P2|NOT COMPLETED|Overall Study||1
1637721|NCT00798694|4000511|P1|NOT COMPLETED|Overall Study||2
1637722|NCT00798694|4000510|P2|COMPLETED|Overall Study||27
1637723|NCT00798694|4000511|P1|COMPLETED|Overall Study||28
1637724|NCT00798694|4000510|P2|STARTED|Overall Study||28
1637725|NCT00798694|4000511|P1|STARTED|Overall Study||30
1637726|NCT00798655|4000535|P1|NOT COMPLETED|Overall Study||2
1637727|NCT00798655|4000535|P1|COMPLETED|Overall Study||44
1637728|NCT00798655|4000535|P1|STARTED|Overall Study||46
1637729|NCT00798603|4000540|P1|NOT COMPLETED|Overall Study||35
1637730|NCT00798603|4000540|P1|COMPLETED|Overall Study||27
1637731|NCT00798603|4000540|P1|STARTED|Overall Study||62
1637732|NCT00798590|4000562|P2|NOT COMPLETED|Overall Study||8
1637733|NCT00798590|4000563|P1|NOT COMPLETED|Overall Study||11
1637734|NCT00798590|4000562|P2|COMPLETED|Overall Study||0
1637735|NCT00798590|4000563|P1|COMPLETED|Overall Study||0
1637736|NCT00798590|4000562|P2|STARTED|Overall Study||8
1637737|NCT00798590|4000563|P1|STARTED|Overall Study||11
1637738|NCT00798577|4000573|P2|NOT COMPLETED|Overall Study||0
1637739|NCT00798577|4000574|P1|NOT COMPLETED|Overall Study||0
1637740|NCT00798577|4000573|P2|COMPLETED|Overall Study||7
1637741|NCT00798577|4000574|P1|COMPLETED|Overall Study||17
1637742|NCT00798577|4000573|P2|STARTED|Overall Study||7
1637743|NCT00798577|4000574|P1|STARTED|Overall Study||17
1637744|NCT00798486|4000588|P1|NOT COMPLETED|Overall Study||0
1637745|NCT00798486|4000588|P1|COMPLETED|Overall Study||110
1637746|NCT00798486|4000588|P1|STARTED|Overall Study||110
1637747|NCT00798434|4000597|P2|NOT COMPLETED|Open-Label||32
1637748|NCT00798434|4000598|P1|NOT COMPLETED|Open-Label||42
1637749|NCT00798434|4000597|P2|COMPLETED|Open-Label||282
1637750|NCT00798434|4000598|P1|COMPLETED|Open-Label||299
1637751|NCT00798434|4000597|P2|Received Treatment|Open-Label||313
1637752|NCT00798434|4000598|P1|Received Treatment|Open-Label||341
1637753|NCT00798434|4000597|P2|STARTED|Open-Label||314
1637754|NCT00798434|4000598|P1|STARTED|Open-Label||341
1637755|NCT00798434|4000597|P2|NOT COMPLETED|Double-Blind||84
1637756|NCT00798434|4000598|P1|NOT COMPLETED|Double-Blind||55
1637757|NCT00798434|4000597|P2|COMPLETED|Double-Blind||314
1637758|NCT00798434|4000598|P1|COMPLETED|Double-Blind||341
1637759|NCT00798434|4000597|P2|Received Treatment|Double-Blind||392
1637760|NCT00798434|4000598|P1|Received Treatment|Double-Blind||393
1637761|NCT00798434|4000597|P2|STARTED|Double-Blind||398
1637762|NCT00798434|4000598|P1|STARTED|Double-Blind||396
1637763|NCT00798369|4000684|P6|NOT COMPLETED|Overall Study||3
1637764|NCT00798369|4000685|P5|NOT COMPLETED|Overall Study||1
1637765|NCT00798369|4000686|P4|NOT COMPLETED|Overall Study||1
1637766|NCT00798369|4000687|P3|NOT COMPLETED|Overall Study||2
1637767|NCT00798369|4000688|P2|NOT COMPLETED|Overall Study||1
1637768|NCT00798369|4000689|P1|NOT COMPLETED|Overall Study||1
1637769|NCT00798369|4000684|P6|COMPLETED|Overall Study||54
1637770|NCT00798369|4000685|P5|COMPLETED|Overall Study||27
1637771|NCT00798369|4000686|P4|COMPLETED|Overall Study||28
1637772|NCT00798369|4000687|P3|COMPLETED|Overall Study||27
1637773|NCT00798369|4000688|P2|COMPLETED|Overall Study||28
1637774|NCT00798369|4000689|P1|COMPLETED|Overall Study||27
1637775|NCT00798369|4000684|P6|STARTED|Overall Study||57
1637776|NCT00798369|4000685|P5|STARTED|Overall Study||28
1637777|NCT00798369|4000686|P4|STARTED|Overall Study||29
1637778|NCT00798369|4000687|P3|STARTED|Overall Study||29
1637779|NCT00798369|4000688|P2|STARTED|Overall Study||29
1637780|NCT00798369|4000689|P1|STARTED|Overall Study||28
1637781|NCT00798317|4000736|P2|NOT COMPLETED|Overall Study||7
1637782|NCT00798317|4000737|P1|NOT COMPLETED|Overall Study||10
1637783|NCT00798317|4000736|P2|COMPLETED|Overall Study||74
1637784|NCT00798317|4000737|P1|COMPLETED|Overall Study||235
1637785|NCT00798317|4000736|P2|STARTED|Overall Study||81
1637786|NCT00798317|4000737|P1|STARTED|Overall Study||245
1637787|NCT00798304|4000748|P3|NOT COMPLETED|Overall Study||10
1637788|NCT00798304|4000749|P2|NOT COMPLETED|Overall Study||22
1637789|NCT00798304|4000750|P1|NOT COMPLETED|Overall Study||14
1637790|NCT00798304|4000748|P3|COMPLETED|Overall Study||0
1637791|NCT00798304|4000749|P2|COMPLETED|Overall Study||0
1637792|NCT00798304|4000750|P1|COMPLETED|Overall Study||0
1637793|NCT00798304|4000748|P3|STARTED|Overall Study||10
1637794|NCT00798304|4000749|P2|STARTED|Overall Study||22
1637795|NCT00798304|4000750|P1|STARTED|Overall Study||14
1637796|NCT00798174|4000776|P2|NOT COMPLETED|Overall Study||3
1637797|NCT00798174|4000777|P1|NOT COMPLETED|Overall Study||4
1637798|NCT00798174|4000776|P2|COMPLETED|Overall Study||13
1637799|NCT00798174|4000777|P1|COMPLETED|Overall Study||12
1637800|NCT00798174|4000776|P2|STARTED|Overall Study||16
1637801|NCT00798174|4000777|P1|STARTED|Overall Study||16
1637802|NCT00798161|4000788|P7|NOT COMPLETED|Overall Study||10
1637803|NCT00798161|4000789|P6|NOT COMPLETED|Overall Study||11
1637804|NCT00798161|4000790|P5|NOT COMPLETED|Overall Study||16
1637805|NCT00798161|4000791|P4|NOT COMPLETED|Overall Study||21
1637806|NCT00798161|4000792|P3|NOT COMPLETED|Overall Study||21
1637807|NCT00798161|4000793|P2|NOT COMPLETED|Overall Study||17
1637808|NCT00798161|4000794|P1|NOT COMPLETED|Overall Study||18
1637809|NCT00798161|4000788|P7|COMPLETED|Overall Study||56
1637810|NCT00798161|4000789|P6|COMPLETED|Overall Study||132
1637811|NCT00798161|4000790|P5|COMPLETED|Overall Study||127
1637812|NCT00798161|4000791|P4|COMPLETED|Overall Study||121
1637813|NCT00798161|4000792|P3|COMPLETED|Overall Study||126
1637814|NCT00798161|4000793|P2|COMPLETED|Overall Study||127
1637815|NCT00798161|4000794|P1|COMPLETED|Overall Study||54
1637816|NCT00798161|4000788|P7|STARTED|Overall Study||66
1637817|NCT00798161|4000789|P6|STARTED|Overall Study||143
1637818|NCT00798161|4000790|P5|STARTED|Overall Study||143
1637819|NCT00798161|4000791|P4|STARTED|Overall Study||142
1637820|NCT00798161|4000792|P3|STARTED|Overall Study||147
1637821|NCT00798161|4000793|P2|STARTED|Overall Study||144
1637822|NCT00798161|4000794|P1|STARTED|Overall Study||72
1637823|NCT00798135|4000901|P1|NOT COMPLETED|Overall Study||13
1637824|NCT00798135|4000901|P1|COMPLETED|Overall Study||0
1637825|NCT00798135|4000901|P1|STARTED|Overall Study||13
1637826|NCT00798096|4000907|P1|NOT COMPLETED|Overall Study||2
1637917|NCT00797823|4001037|P2|NOT COMPLETED|First Period (Initial Randomization)||0
1637827|NCT00798096|4000907|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
1637828|NCT00798096|4000907|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
1637829|NCT00798018|4000918|P4|NOT COMPLETED|Overall Study||0
1637830|NCT00798018|4000919|P3|NOT COMPLETED|Overall Study||0
1637831|NCT00798018|4000920|P2|NOT COMPLETED|Overall Study||0
1637832|NCT00798018|4000921|P1|NOT COMPLETED|Overall Study||0
1637833|NCT00798018|4000918|P4|COMPLETED|Overall Study||25
1637834|NCT00798018|4000919|P3|COMPLETED|Overall Study||25
1637835|NCT00798018|4000920|P2|COMPLETED|Overall Study||25
1637836|NCT00798018|4000921|P1|COMPLETED|Overall Study||25
1637837|NCT00798018|4000918|P4|STARTED|Overall Study||25
1637838|NCT00798018|4000919|P3|STARTED|Overall Study||25
1637839|NCT00798018|4000920|P2|STARTED|Overall Study||25
1637840|NCT00798018|4000921|P1|STARTED|Overall Study||25
1637841|NCT00797966|4000935|P6|NOT COMPLETED|Phase A+||28
1637842|NCT00797966|4000936|P5|NOT COMPLETED|Phase A+||0
1637843|NCT00797966|4000937|P4|NOT COMPLETED|Phase A+||0
1637844|NCT00797966|4000938|P3|NOT COMPLETED|Phase A+||0
1637845|NCT00797966|4000939|P2|NOT COMPLETED|Phase A+||0
1637846|NCT00797966|4000940|P1|NOT COMPLETED|Phase A+||0
1637847|NCT00797966|4000935|P6|COMPLETED|Phase A+||207
1637848|NCT00797966|4000936|P5|COMPLETED|Phase A+||0
1637849|NCT00797966|4000937|P4|COMPLETED|Phase A+||0
1637850|NCT00797966|4000938|P3|COMPLETED|Phase A+||0
1637851|NCT00797966|4000939|P2|COMPLETED|Phase A+||0
1637852|NCT00797966|4000940|P1|COMPLETED|Phase A+||0
1637853|NCT00797966|4000935|P6|STARTED|Phase A+||235
1637854|NCT00797966|4000936|P5|STARTED|Phase A+||0
1637855|NCT00797966|4000937|P4|STARTED|Phase A+||0
1637856|NCT00797966|4000938|P3|STARTED|Phase A+||0
1637857|NCT00797966|4000939|P2|STARTED|Phase A+||0
1637858|NCT00797966|4000940|P1|STARTED|Phase A+||0
1637859|NCT00797966|4000935|P6|NOT COMPLETED|Phase B||0
1637860|NCT00797966|4000936|P5|NOT COMPLETED|Phase B||0
1637861|NCT00797966|4000937|P4|NOT COMPLETED|Phase B||16
1637862|NCT00797966|4000938|P3|NOT COMPLETED|Phase B||21
1637863|NCT00797966|4000939|P2|NOT COMPLETED|Phase B||18
1637864|NCT00797966|4000940|P1|NOT COMPLETED|Phase B||11
1637865|NCT00797966|4000935|P6|COMPLETED|Phase B||0
1637866|NCT00797966|4000936|P5|COMPLETED|Phase B||0
1637867|NCT00797966|4000937|P4|COMPLETED|Phase B||110
1637868|NCT00797966|4000938|P3|COMPLETED|Phase B||100
1637869|NCT00797966|4000939|P2|COMPLETED|Phase B||102
1637870|NCT00797966|4000940|P1|COMPLETED|Phase B||51
1637871|NCT00797966|4000935|P6|STARTED|Phase B||0
1637872|NCT00797966|4000936|P5|STARTED|Phase B||0
1637873|NCT00797966|4000937|P4|STARTED|Phase B|Randomized participants.|126
1637874|NCT00797966|4000938|P3|STARTED|Phase B|Randomized participants.|121
1637875|NCT00797966|4000939|P2|STARTED|Phase B|Randomized participants.|120
1637876|NCT00797966|4000940|P1|STARTED|Phase B|Randomized participants.|62
1637877|NCT00797966|4000935|P6|NOT COMPLETED|Phase A||0
1637878|NCT00797966|4000936|P5|NOT COMPLETED|Phase A||185
1637879|NCT00797966|4000937|P4|NOT COMPLETED|Phase A||0
1637880|NCT00797966|4000938|P3|NOT COMPLETED|Phase A||0
1637881|NCT00797966|4000939|P2|NOT COMPLETED|Phase A||0
1637882|NCT00797966|4000940|P1|NOT COMPLETED|Phase A||0
1637883|NCT00797966|4000935|P6|COMPLETED|Phase A||0
1637884|NCT00797966|4000936|P5|COMPLETED|Phase A||664
1637885|NCT00797966|4000937|P4|COMPLETED|Phase A||0
1637886|NCT00797966|4000938|P3|COMPLETED|Phase A||0
1637887|NCT00797966|4000939|P2|COMPLETED|Phase A||0
1637888|NCT00797966|4000940|P1|COMPLETED|Phase A||0
1637889|NCT00797966|4000935|P6|STARTED|Phase A||0
1637890|NCT00797966|4000936|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
1637891|NCT00797966|4000937|P4|STARTED|Phase A||0
1637892|NCT00797966|4000938|P3|STARTED|Phase A||0
1637893|NCT00797966|4000939|P2|STARTED|Phase A||0
1637894|NCT00797966|4000940|P1|STARTED|Phase A||0
1637895|NCT00797862|4001005|P3|NOT COMPLETED|Overall Study||86
1637896|NCT00797862|4001006|P2|NOT COMPLETED|Overall Study||68
1637897|NCT00797862|4001007|P1|NOT COMPLETED|Overall Study||124
1637898|NCT00797862|4001005|P3|COMPLETED|Overall Study||230
1637899|NCT00797862|4001006|P2|COMPLETED|Overall Study||250
1637900|NCT00797862|4001007|P1|COMPLETED|Overall Study||496
1637901|NCT00797862|4001005|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
1637902|NCT00797862|4001006|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
1637903|NCT00797862|4001007|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
1637904|NCT00797862|4001005|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
1637905|NCT00797862|4001006|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
1637906|NCT00797862|4001007|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
1637907|NCT00797823|4001036|P3|NOT COMPLETED|Second Period (Crossover)||0
1637908|NCT00797823|4001037|P2|NOT COMPLETED|Second Period (Crossover)||0
1637909|NCT00797823|4001038|P1|NOT COMPLETED|Second Period (Crossover)||0
1637910|NCT00797823|4001036|P3|COMPLETED|Second Period (Crossover)||0
1637911|NCT00797823|4001037|P2|COMPLETED|Second Period (Crossover)||4
1637912|NCT00797823|4001038|P1|COMPLETED|Second Period (Crossover)||3
1637913|NCT00797823|4001036|P3|STARTED|Second Period (Crossover)||0
1637914|NCT00797823|4001037|P2|STARTED|Second Period (Crossover)||4
1637915|NCT00797823|4001038|P1|STARTED|Second Period (Crossover)||3
1637916|NCT00797823|4001036|P3|NOT COMPLETED|First Period (Initial Randomization)||0
1637918|NCT00797823|4001038|P1|NOT COMPLETED|First Period (Initial Randomization)||1
1637919|NCT00797823|4001036|P3|COMPLETED|First Period (Initial Randomization)||0
1637920|NCT00797823|4001037|P2|COMPLETED|First Period (Initial Randomization)||4
1637921|NCT00797823|4001038|P1|COMPLETED|First Period (Initial Randomization)||3
1637922|NCT00797823|4001036|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
1637923|NCT00797823|4001037|P2|STARTED|First Period (Initial Randomization)||4
1637924|NCT00797823|4001038|P1|STARTED|First Period (Initial Randomization)||4
1637925|NCT00797823|4001036|P3|NOT COMPLETED|Pilot Studies||0
1637926|NCT00797823|4001037|P2|NOT COMPLETED|Pilot Studies||0
1637927|NCT00797823|4001038|P1|NOT COMPLETED|Pilot Studies||0
1637928|NCT00797823|4001036|P3|COMPLETED|Pilot Studies||6
1637929|NCT00797823|4001037|P2|COMPLETED|Pilot Studies||0
1637930|NCT00797823|4001038|P1|COMPLETED|Pilot Studies||0
1637931|NCT00797823|4001036|P3|STARTED|Pilot Studies||6
1637932|NCT00797823|4001037|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
1637933|NCT00797823|4001038|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
1637934|NCT00797797|4001049|P2|NOT COMPLETED|Overall Study||43
1637935|NCT00797797|4001050|P1|NOT COMPLETED|Overall Study||55
1637936|NCT00797797|4001049|P2|COMPLETED|Overall Study||141
1637937|NCT00797797|4001050|P1|COMPLETED|Overall Study||123
1637938|NCT00797797|4001049|P2|STARTED|Overall Study||184
1637939|NCT00797797|4001050|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
1637940|NCT00797732|4001060|P3|NOT COMPLETED|Overall Study||154
1637941|NCT00797732|4001061|P2|NOT COMPLETED|Overall Study||3
1637942|NCT00797732|4001062|P1|NOT COMPLETED|Overall Study||5
1637943|NCT00797732|4001060|P3|COMPLETED|Overall Study||0
1637944|NCT00797732|4001061|P2|COMPLETED|Overall Study||18
1637945|NCT00797732|4001062|P1|COMPLETED|Overall Study||16
1637946|NCT00797732|4001060|P3|Evaluable at 12 Months|Overall Study||0
1637947|NCT00797732|4001061|P2|Evaluable at 12 Months|Overall Study||18
1637948|NCT00797732|4001062|P1|Evaluable at 12 Months|Overall Study||17
1637949|NCT00797732|4001060|P3|Evaluable at 20 Weeks|Overall Study||0
1637950|NCT00797732|4001061|P2|Evaluable at 20 Weeks|Overall Study||18
1637951|NCT00797732|4001062|P1|Evaluable at 20 Weeks|Overall Study||17
1637952|NCT00797732|4001060|P3|Evaluable at Baseline|Overall Study||0
1637953|NCT00797732|4001061|P2|Evaluable at Baseline|Overall Study||18
1637954|NCT00797732|4001062|P1|Evaluable at Baseline|Overall Study||18
1637955|NCT00797732|4001060|P3|STARTED|Overall Study||154
1637956|NCT00797732|4001061|P2|STARTED|Overall Study||21
1637957|NCT00797732|4001062|P1|STARTED|Overall Study||21
1637958|NCT00797667|4001077|P3|NOT COMPLETED|Overall Study||127
1637959|NCT00797667|4001078|P2|NOT COMPLETED|Overall Study||259
1637960|NCT00797667|4001079|P1|NOT COMPLETED|Overall Study||260
1637961|NCT00797667|4001077|P3|COMPLETED|Overall Study||4
1637962|NCT00797667|4001078|P2|COMPLETED|Overall Study||5
1637963|NCT00797667|4001079|P1|COMPLETED|Overall Study||5
1637964|NCT00797667|4001077|P3|Treated|Overall Study||130
1637965|NCT00797667|4001078|P2|Treated|Overall Study||263
1637966|NCT00797667|4001079|P1|Treated|Overall Study||263
1637967|NCT00797667|4001077|P3|STARTED|Overall Study||131
1637968|NCT00797667|4001078|P2|STARTED|Overall Study||264
1637969|NCT00797667|4001079|P1|STARTED|Overall Study||265
1637970|NCT00797563|4001105|P1|NOT COMPLETED|Overall Study||1
1637971|NCT00797563|4001105|P1|COMPLETED|Overall Study||101
1637972|NCT00797563|4001105|P1|STARTED|Overall Study|number of subjects|102
1637973|NCT00797511|4001111|P1|NOT COMPLETED|Overall Study||1
1637974|NCT00797511|4001111|P1|COMPLETED|Overall Study||131
1637975|NCT00797511|4001111|P1|STARTED|Overall Study||132
1637976|NCT00797459|4001119|P1|NOT COMPLETED|Overall Study||0
1637977|NCT00797459|4001119|P1|COMPLETED|Overall Study||60
1637978|NCT00797459|4001119|P1|STARTED|Overall Study||60
1637979|NCT00797316|4001129|P2|NOT COMPLETED|Overall Study||32
1637980|NCT00797316|4001130|P1|NOT COMPLETED|Overall Study||23
1637981|NCT00797316|4001129|P2|COMPLETED|Overall Study||233
1637982|NCT00797316|4001130|P1|COMPLETED|Overall Study||244
1637983|NCT00797316|4001129|P2|STARTED|Overall Study||265
1637984|NCT00797316|4001130|P1|STARTED|Overall Study||267
1637985|NCT00797277|4001146|P2|NOT COMPLETED|Overall Study||0
1637986|NCT00797277|4001147|P1|NOT COMPLETED|Overall Study||0
1637987|NCT00797277|4001146|P2|COMPLETED|Overall Study||30
1637988|NCT00797277|4001147|P1|COMPLETED|Overall Study||37
1637989|NCT00797277|4001146|P2|STARTED|Overall Study||30
1637990|NCT00797277|4001147|P1|STARTED|Overall Study||37
1637991|NCT00797225|4001159|P8|NOT COMPLETED|Weeks 13 to 24||0
1637992|NCT00797225|4001160|P7|NOT COMPLETED|Weeks 13 to 24||2
1637993|NCT00797225|4001161|P6|NOT COMPLETED|Weeks 13 to 24||0
1637994|NCT00797225|4001162|P5|NOT COMPLETED|Weeks 13 to 24||1
1637995|NCT00797225|4001163|P4|NOT COMPLETED|Weeks 13 to 24||0
1637996|NCT00797225|4001164|P3|NOT COMPLETED|Weeks 13 to 24||2
1637997|NCT00797225|4001165|P2|NOT COMPLETED|Weeks 13 to 24||4
1637998|NCT00797225|4001166|P1|NOT COMPLETED|Weeks 13 to 24||0
1637999|NCT00797225|4001159|P8|COMPLETED|Weeks 13 to 24||22
1638000|NCT00797225|4001160|P7|COMPLETED|Weeks 13 to 24||20
1638001|NCT00797225|4001161|P6|COMPLETED|Weeks 13 to 24||21
1638002|NCT00797225|4001162|P5|COMPLETED|Weeks 13 to 24||19
1638003|NCT00797225|4001163|P4|COMPLETED|Weeks 13 to 24||0
1638004|NCT00797225|4001164|P3|COMPLETED|Weeks 13 to 24||41
1638005|NCT00797225|4001165|P2|COMPLETED|Weeks 13 to 24||38
1638006|NCT00797225|4001166|P1|COMPLETED|Weeks 13 to 24||0
1638007|NCT00797225|4001159|P8|STARTED|Weeks 13 to 24||22
1638008|NCT00797225|4001160|P7|STARTED|Weeks 13 to 24||22
1638009|NCT00797225|4001161|P6|STARTED|Weeks 13 to 24||21
1638010|NCT00797225|4001162|P5|STARTED|Weeks 13 to 24||20
1638011|NCT00797225|4001163|P4|STARTED|Weeks 13 to 24||0
1638012|NCT00797225|4001164|P3|STARTED|Weeks 13 to 24||43
1638013|NCT00797225|4001165|P2|STARTED|Weeks 13 to 24||42
1638014|NCT00797225|4001166|P1|STARTED|Weeks 13 to 24||0
1638015|NCT00797225|4001159|P8|NOT COMPLETED|Weeks 1 to 12||0
1638016|NCT00797225|4001160|P7|NOT COMPLETED|Weeks 1 to 12||0
1638017|NCT00797225|4001161|P6|NOT COMPLETED|Weeks 1 to 12||0
1638018|NCT00797225|4001162|P5|NOT COMPLETED|Weeks 1 to 12||0
1638019|NCT00797225|4001163|P4|NOT COMPLETED|Weeks 1 to 12||0
1638020|NCT00797225|4001164|P3|NOT COMPLETED|Weeks 1 to 12||1
1638021|NCT00797225|4001165|P2|NOT COMPLETED|Weeks 1 to 12||1
1638022|NCT00797225|4001166|P1|NOT COMPLETED|Weeks 1 to 12||2
1638023|NCT00797225|4001159|P8|COMPLETED|Weeks 1 to 12||0
1638024|NCT00797225|4001160|P7|COMPLETED|Weeks 1 to 12||0
1638025|NCT00797225|4001161|P6|COMPLETED|Weeks 1 to 12||0
1638026|NCT00797225|4001162|P5|COMPLETED|Weeks 1 to 12||0
1638027|NCT00797225|4001163|P4|COMPLETED|Weeks 1 to 12||44
1638028|NCT00797225|4001164|P3|COMPLETED|Weeks 1 to 12||43
1638029|NCT00797225|4001165|P2|COMPLETED|Weeks 1 to 12||42
1638030|NCT00797225|4001166|P1|COMPLETED|Weeks 1 to 12||41
1638031|NCT00797225|4001159|P8|Received Study Drug|Weeks 1 to 12||0
1638032|NCT00797225|4001160|P7|Received Study Drug|Weeks 1 to 12||0
1638033|NCT00797225|4001161|P6|Received Study Drug|Weeks 1 to 12||0
1638034|NCT00797225|4001162|P5|Received Study Drug|Weeks 1 to 12||0
1638035|NCT00797225|4001163|P4|Received Study Drug|Weeks 1 to 12||44
1638036|NCT00797225|4001164|P3|Received Study Drug|Weeks 1 to 12||44
1638037|NCT00797225|4001165|P2|Received Study Drug|Weeks 1 to 12||43
1638038|NCT00797225|4001166|P1|Received Study Drug|Weeks 1 to 12||43
1638039|NCT00797225|4001159|P8|STARTED|Weeks 1 to 12||0
1638040|NCT00797225|4001160|P7|STARTED|Weeks 1 to 12||0
1638041|NCT00797225|4001161|P6|STARTED|Weeks 1 to 12||0
1638042|NCT00797225|4001162|P5|STARTED|Weeks 1 to 12||0
1638043|NCT00797225|4001163|P4|STARTED|Weeks 1 to 12||44
1638044|NCT00797225|4001164|P3|STARTED|Weeks 1 to 12||44
1638045|NCT00797225|4001165|P2|STARTED|Weeks 1 to 12||43
1638046|NCT00797225|4001166|P1|STARTED|Weeks 1 to 12||43
1638047|NCT00797212|4001274|P1|NOT COMPLETED|Overall Study||0
1638048|NCT00797212|4001274|P1|COMPLETED|Overall Study||50
1638049|NCT00797212|4001274|P1|STARTED|Overall Study||50
1638050|NCT00797108|4001283|P3|NOT COMPLETED|Overall Study||6
1638051|NCT00797108|4001284|P2|NOT COMPLETED|Overall Study||2
1638052|NCT00797108|4001285|P1|NOT COMPLETED|Overall Study||4
1638053|NCT00797108|4001283|P3|COMPLETED|Overall Study||6
1638054|NCT00797108|4001284|P2|COMPLETED|Overall Study||9
1638055|NCT00797108|4001285|P1|COMPLETED|Overall Study||8
1638056|NCT00797108|4001283|P3|Treated|Overall Study||12
1638057|NCT00797108|4001284|P2|Treated|Overall Study||11
1638058|NCT00797108|4001285|P1|Treated|Overall Study||10
1638059|NCT00797108|4001283|P3|STARTED|Overall Study||12
1638060|NCT00797108|4001284|P2|STARTED|Overall Study||11
1638061|NCT00797108|4001285|P1|STARTED|Overall Study||12
1638062|NCT00796991|4001320|P3|NOT COMPLETED|Overall Study||14
1638063|NCT00796991|4001321|P2|NOT COMPLETED|Overall Study||12
1638064|NCT00796991|4001322|P1|NOT COMPLETED|Overall Study||15
1638065|NCT00796991|4001320|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
1638066|NCT00796991|4001321|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
1638067|NCT00796991|4001322|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
1638068|NCT00796991|4001320|P3|STARTED|Overall Study||20
1638069|NCT00796991|4001321|P2|STARTED|Overall Study||19
1638070|NCT00796991|4001322|P1|STARTED|Overall Study||20
1638071|NCT00796926|4001422|P2|NOT COMPLETED|Overall Study||0
1638072|NCT00796926|4001423|P1|NOT COMPLETED|Overall Study||1
1638073|NCT00796926|4001422|P2|COMPLETED|Overall Study||15
1638074|NCT00796926|4001423|P1|COMPLETED|Overall Study||14
1638075|NCT00796926|4001422|P2|STARTED|Overall Study||15
1638076|NCT00796926|4001423|P1|STARTED|Overall Study||15
1638077|NCT00796861|4001429|P1|NOT COMPLETED|Overall Study||4
1638078|NCT00796861|4001429|P1|COMPLETED|Overall Study||0
1638079|NCT00796861|4001429|P1|STARTED|Overall Study||4
1638080|NCT00796822|4001435|P2|NOT COMPLETED|Overall Study||0
1638081|NCT00796822|4001436|P1|NOT COMPLETED|Overall Study||3
1638082|NCT00796822|4001435|P2|COMPLETED|Overall Study||13
1638083|NCT00796822|4001436|P1|COMPLETED|Overall Study||10
1638084|NCT00796822|4001435|P2|STARTED|Overall Study||13
1638085|NCT00796822|4001436|P1|STARTED|Overall Study||13
1638086|NCT00796757|4001444|P1|NOT COMPLETED|Overall Study||86
1638087|NCT00796757|4001444|P1|COMPLETED|Overall Study||60
1638088|NCT00796757|4001444|P1|STARTED|Overall Study||146
1638089|NCT00796744|4001459|P3|NOT COMPLETED|Overall Study||1
1638090|NCT00796744|4001460|P2|NOT COMPLETED|Overall Study||0
1638091|NCT00796744|4001461|P1|NOT COMPLETED|Overall Study||0
1638092|NCT00796744|4001459|P3|COMPLETED|Overall Study||27
1638093|NCT00796744|4001460|P2|COMPLETED|Overall Study||26
1638094|NCT00796744|4001461|P1|COMPLETED|Overall Study||24
1638095|NCT00796744|4001459|P3|STARTED|Overall Study||28
1638096|NCT00796744|4001460|P2|STARTED|Overall Study||26
1638097|NCT00796744|4001461|P1|STARTED|Overall Study||24
1638098|NCT00796718|4001478|P1|NOT COMPLETED|Overall Study||9
1638099|NCT00796718|4001478|P1|COMPLETED|Overall Study||53
1638100|NCT00796718|4001478|P1|STARTED|Overall Study||62
1638101|NCT00796705|4001489|P4|NOT COMPLETED|Overall Study||0
1638102|NCT00796705|4001490|P3|NOT COMPLETED|Overall Study||0
1638103|NCT00796705|4001491|P2|NOT COMPLETED|Overall Study||0
1638104|NCT00796705|4001492|P1|NOT COMPLETED|Overall Study||0
1638105|NCT00796705|4001489|P4|COMPLETED|Overall Study||2
1638106|NCT00796705|4001490|P3|COMPLETED|Overall Study||4
1638107|NCT00796705|4001491|P2|COMPLETED|Overall Study||4
1638108|NCT00796705|4001492|P1|COMPLETED|Overall Study||3
1638109|NCT00796705|4001489|P4|STARTED|Overall Study||2
1638110|NCT00796705|4001490|P3|STARTED|Overall Study||4
1638111|NCT00796705|4001491|P2|STARTED|Overall Study||4
1638112|NCT00796705|4001492|P1|STARTED|Overall Study||3
1638113|NCT00796666|4001530|P2|NOT COMPLETED|Overall Study||64
1638114|NCT00796666|4001531|P1|NOT COMPLETED|Overall Study||67
1638115|NCT00796666|4001530|P2|COMPLETED|Overall Study||0
1638116|NCT00796666|4001531|P1|COMPLETED|Overall Study||0
1638117|NCT00796666|4001530|P2|Randomized and Not Treated|Overall Study||0
1638118|NCT00796666|4001531|P1|Randomized and Not Treated|Overall Study||1
1638119|NCT00796666|4001530|P2|Treated|Overall Study||64
1638120|NCT00796666|4001531|P1|Treated|Overall Study||66
1638121|NCT00796666|4001530|P2|STARTED|Overall Study||64
1638122|NCT00796666|4001531|P1|STARTED|Overall Study||67
1638123|NCT00796653|4001565|P4|NOT COMPLETED|Overall Study||40
1638124|NCT00796653|4001566|P3|NOT COMPLETED|Overall Study||36
1638125|NCT00796653|4001567|P2|NOT COMPLETED|Overall Study||37
1638126|NCT00796653|4001568|P1|NOT COMPLETED|Overall Study||51
1638127|NCT00796653|4001565|P4|COMPLETED|Overall Study||193
1638128|NCT00796653|4001566|P3|COMPLETED|Overall Study||198
1638129|NCT00796653|4001567|P2|COMPLETED|Overall Study||195
1638130|NCT00796653|4001568|P1|COMPLETED|Overall Study||184
1638131|NCT00796653|4001565|P4|STARTED|Overall Study||233
1638132|NCT00796653|4001566|P3|STARTED|Overall Study||234
1638133|NCT00796653|4001567|P2|STARTED|Overall Study||232
1638134|NCT00796653|4001568|P1|STARTED|Overall Study||235
1638135|NCT00796627|4001836|P2|NOT COMPLETED|Overall Study||0
1638136|NCT00796627|4001837|P1|NOT COMPLETED|Overall Study||0
1638137|NCT00796627|4001836|P2|COMPLETED|Overall Study||31
1638138|NCT00796627|4001837|P1|COMPLETED|Overall Study||10
1638139|NCT00796627|4001836|P2|STARTED|Overall Study||31
1638140|NCT00796627|4001837|P1|STARTED|Overall Study||10
1638141|NCT00796614|4001853|P4|NOT COMPLETED|Overall Study||1
1638142|NCT00796614|4001854|P3|NOT COMPLETED|Overall Study||3
1638143|NCT00796614|4001855|P2|NOT COMPLETED|Overall Study||4
1638144|NCT00796614|4001856|P1|NOT COMPLETED|Overall Study||5
1638145|NCT00796614|4001853|P4|COMPLETED|Overall Study||40
1638146|NCT00796614|4001854|P3|COMPLETED|Overall Study||36
1638147|NCT00796614|4001855|P2|COMPLETED|Overall Study||36
1638148|NCT00796614|4001856|P1|COMPLETED|Overall Study||36
1638149|NCT00796614|4001853|P4|Not Treated|Overall Study||0
1638150|NCT00796614|4001854|P3|Not Treated|Overall Study||1
1638151|NCT00796614|4001855|P2|Not Treated|Overall Study||0
1638152|NCT00796614|4001856|P1|Not Treated|Overall Study||0
1638153|NCT00796614|4001853|P4|STARTED|Overall Study||41
1638154|NCT00796614|4001854|P3|STARTED|Overall Study||39
1638155|NCT00796614|4001855|P2|STARTED|Overall Study||40
1638156|NCT00796614|4001856|P1|STARTED|Overall Study||41
1638157|NCT00796549|4001898|P1|NOT COMPLETED|Overall Study||218
1638158|NCT00796549|4001898|P1|COMPLETED|Overall Study||0
1638159|NCT00796549|4001898|P1|Entered|Overall Study|entered and treated|69
1638160|NCT00796549|4001898|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
1638161|NCT00796523|4001915|P2|NOT COMPLETED|Overall Study||7
1638162|NCT00796523|4001916|P1|NOT COMPLETED|Overall Study||9
1638163|NCT00796523|4001915|P2|COMPLETED|Overall Study||17
1638164|NCT00796523|4001916|P1|COMPLETED|Overall Study||18
1638165|NCT00796523|4001915|P2|STARTED|Overall Study||24
1638166|NCT00796523|4001916|P1|STARTED|Overall Study||27
1638167|NCT00796510|4001926|P2|NOT COMPLETED|Overall Study||0
1638168|NCT00796510|4001927|P1|NOT COMPLETED|Overall Study||3
1638169|NCT00796510|4001926|P2|COMPLETED|Overall Study||0
1638170|NCT00796510|4001927|P1|COMPLETED|Overall Study||0
1638171|NCT00796510|4001926|P2|STARTED|Overall Study||0
1638172|NCT00796510|4001927|P1|STARTED|Overall Study||3
1638173|NCT00796419|4001939|P2|NOT COMPLETED|Overall Study||1
1638174|NCT00796419|4001940|P1|NOT COMPLETED|Overall Study||0
1638175|NCT00796419|4001939|P2|COMPLETED|Overall Study||13
1638176|NCT00796419|4001940|P1|COMPLETED|Overall Study||13
1638177|NCT00796419|4001939|P2|STARTED|Overall Study||14
1638178|NCT00796419|4001940|P1|STARTED|Overall Study||13
1638179|NCT00796367|4001953|P3|NOT COMPLETED|Overall Study||47
1638180|NCT00796367|4001954|P2|NOT COMPLETED|Overall Study||25
1638181|NCT00796367|4001955|P1|NOT COMPLETED|Overall Study||30
1638182|NCT00796367|4001953|P3|COMPLETED|Overall Study||248
1638183|NCT00796367|4001954|P2|COMPLETED|Overall Study||129
1638184|NCT00796367|4001955|P1|COMPLETED|Overall Study||197
1638185|NCT00796367|4001953|P3|STARTED|Overall Study||295
1638186|NCT00796367|4001954|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
1638187|NCT00796367|4001955|P1|STARTED|Overall Study||227
1638188|NCT00796328|4001966|P1|NOT COMPLETED|Overall Study||6
1638189|NCT00796328|4001966|P1|COMPLETED|Overall Study||40
1638190|NCT00796328|4001966|P1|STARTED|Overall Study||46
1638191|NCT00796315|4001970|P3|NOT COMPLETED|Overall Study||0
1638192|NCT00796315|4001971|P2|NOT COMPLETED|Overall Study||1
1638193|NCT00796315|4001972|P1|NOT COMPLETED|Overall Study||0
1638194|NCT00796315|4001970|P3|COMPLETED|Overall Study||15
1638195|NCT00796315|4001971|P2|COMPLETED|Overall Study||16
1638196|NCT00796315|4001972|P1|COMPLETED|Overall Study||9
1638197|NCT00796315|4001970|P3|STARTED|Overall Study||15
1638198|NCT00796315|4001971|P2|STARTED|Overall Study||17
1638199|NCT00796315|4001972|P1|STARTED|Overall Study||9
1638200|NCT00796302|4001985|P2|NOT COMPLETED|Overall Study||18
1638201|NCT00796302|4001986|P1|NOT COMPLETED|Overall Study||13
1638202|NCT00796302|4001985|P2|COMPLETED|Overall Study||66
1638203|NCT00796302|4001986|P1|COMPLETED|Overall Study||71
1638204|NCT00796302|4001985|P2|STARTED|Overall Study||84
1638205|NCT00796302|4001986|P1|STARTED|Overall Study||84
1638206|NCT00796224|4002000|P2|NOT COMPLETED|Overall Study||1
1638207|NCT00796224|4002001|P1|NOT COMPLETED|Overall Study||1
1638208|NCT00796224|4002000|P2|COMPLETED|Overall Study||18
1638209|NCT00796224|4002001|P1|COMPLETED|Overall Study||18
1638210|NCT00796224|4002000|P2|STARTED|Overall Study||19
1638211|NCT00796224|4002001|P1|STARTED|Overall Study||19
1638212|NCT00796120|4002021|P2|NOT COMPLETED|Overall Study||60
1638213|NCT00796120|4002022|P1|NOT COMPLETED|Overall Study||61
1638214|NCT00796120|4002021|P2|COMPLETED|Overall Study||0
1638215|NCT00796120|4002022|P1|COMPLETED|Overall Study||0
1638216|NCT00796120|4002021|P2|Treated|Overall Study||57
1638217|NCT00796120|4002022|P1|Treated|Overall Study||61
1638218|NCT00796120|4002021|P2|STARTED|Overall Study||60
1638219|NCT00796120|4002022|P1|STARTED|Overall Study||61
1638220|NCT00796003|4002038|P2|NOT COMPLETED|Overall Study||29
1638221|NCT00796003|4002039|P1|NOT COMPLETED|Overall Study||3
1638222|NCT00796003|4002038|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
1638223|NCT00796003|4002039|P1|COMPLETED|Overall Study||0
1638224|NCT00796003|4002038|P2|Treated|Overall Study|Number of participants treated|34
1638225|NCT00796003|4002039|P1|Treated|Overall Study|Number of participants treated|3
1638226|NCT00796003|4002038|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
1638227|NCT00796003|4002039|P1|STARTED|Overall Study|Number of participants enrolled|3
1638228|NCT00795951|4002060|P1|NOT COMPLETED|Overall Study||2
1638229|NCT00795951|4002060|P1|COMPLETED|Overall Study||100
1638230|NCT00795951|4002060|P1|STARTED|Overall Study||102
1638231|NCT00795886|4002097|P1|NOT COMPLETED|Overall Study||10
1638232|NCT00795886|4002097|P1|COMPLETED|Overall Study||53
1638233|NCT00795886|4002097|P1|STARTED|Overall Study||63
1638234|NCT00795821|4002105|P2|NOT COMPLETED|Taper Phase||0
1638235|NCT00795821|4002106|P1|NOT COMPLETED|Taper Phase||9
1638236|NCT00795821|4002105|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
1638237|NCT00795821|4002106|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
1638238|NCT00795821|4002105|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
1638239|NCT00795821|4002106|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
1638240|NCT00795821|4002105|P2|NOT COMPLETED|Long-term Extension Phase||92
1638241|NCT00795821|4002106|P1|NOT COMPLETED|Long-term Extension Phase||90
1638242|NCT00795821|4002105|P2|COMPLETED|Long-term Extension Phase||115
1638243|NCT00795821|4002106|P1|COMPLETED|Long-term Extension Phase||100
1638244|NCT00795821|4002105|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
1638245|NCT00795821|4002106|P1|STARTED|Long-term Extension Phase||190
1638246|NCT00795821|4002105|P2|NOT COMPLETED|Acute Treatment Phase||31
1638247|NCT00795821|4002106|P1|NOT COMPLETED|Acute Treatment Phase||56
1638248|NCT00795821|4002105|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
1638249|NCT00795821|4002106|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
1638250|NCT00795821|4002105|P2|STARTED|Acute Treatment Phase||245
1638251|NCT00795821|4002106|P1|STARTED|Acute Treatment Phase||250
1638252|NCT00795769|4002175|P1|NOT COMPLETED|Overall Study||0
1638253|NCT00795769|4002175|P1|COMPLETED|Overall Study||49
1638254|NCT00795769|4002175|P1|STARTED|Overall Study||49
1638255|NCT00795717|4002181|P2|NOT COMPLETED|Phase II||1
1638256|NCT00795717|4002182|P1|NOT COMPLETED|Phase II||0
1638257|NCT00795717|4002181|P2|COMPLETED|Phase II||18
1638258|NCT00795717|4002182|P1|COMPLETED|Phase II||18
1638259|NCT00795717|4002181|P2|STARTED|Phase II||19
1638260|NCT00795717|4002182|P1|STARTED|Phase II||18
1638261|NCT00795717|4002181|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
1638262|NCT00795717|4002182|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
1638263|NCT00795717|4002181|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
1638264|NCT00795717|4002182|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
1638265|NCT00795717|4002181|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
1638266|NCT00795717|4002182|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
1638267|NCT00795704|4002194|P2|NOT COMPLETED|Overall Study||3
1638268|NCT00795704|4002195|P1|NOT COMPLETED|Overall Study||4
1638269|NCT00795704|4002194|P2|COMPLETED|Overall Study||9
1638270|NCT00795704|4002195|P1|COMPLETED|Overall Study||8
1638271|NCT00795704|4002194|P2|STARTED|Overall Study||12
1638272|NCT00795704|4002195|P1|STARTED|Overall Study||12
1638273|NCT00795639|4002207|P2|NOT COMPLETED|Overall Study||26
1638274|NCT00795639|4002208|P1|NOT COMPLETED|Overall Study||21
1638275|NCT00795639|4002207|P2|COMPLETED|Overall Study||66
1638276|NCT00795639|4002208|P1|COMPLETED|Overall Study||70
1638277|NCT00795639|4002207|P2|Randomized and Not Treated|Overall Study||1
1638278|NCT00795639|4002208|P1|Randomized and Not Treated|Overall Study||0
1638279|NCT00795639|4002207|P2|STARTED|Overall Study||92
1638280|NCT00795639|4002208|P1|STARTED|Overall Study||91
1638281|NCT00795600|4002220|P2|NOT COMPLETED|Overall Study||4
1638282|NCT00795600|4002221|P1|NOT COMPLETED|Overall Study||4
1638283|NCT00795600|4002220|P2|COMPLETED|Overall Study||31
1638284|NCT00795600|4002221|P1|COMPLETED|Overall Study||21
1638285|NCT00795600|4002220|P2|Exposed to Drug|Overall Study||35
1638286|NCT00795600|4002221|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
1638287|NCT00795600|4002220|P2|STARTED|Overall Study||35
1638288|NCT00795600|4002221|P1|STARTED|Overall Study||25
1638289|NCT00795535|4002341|P1|NOT COMPLETED|Overall Study||20
1638290|NCT00795535|4002341|P1|COMPLETED|Overall Study||75
1638291|NCT00795535|4002341|P1|STARTED|Overall Study||95
1638292|NCT00795509|4002348|P1|NOT COMPLETED|Overall Study||31
1638293|NCT00795509|4002348|P1|COMPLETED|Overall Study||343
1638294|NCT00795509|4002348|P1|STARTED|Overall Study||374
1638295|NCT00795366|4002355|P2|NOT COMPLETED|Overall Study||0
1638296|NCT00795366|4002356|P1|NOT COMPLETED|Overall Study||0
1638297|NCT00795366|4002355|P2|COMPLETED|Overall Study||54
1638298|NCT00795366|4002356|P1|COMPLETED|Overall Study||42
1638299|NCT00795366|4002355|P2|STARTED|Overall Study||54
1638300|NCT00795366|4002356|P1|STARTED|Overall Study||42
1638301|NCT00795340|4002364|P2|NOT COMPLETED|Overall Study||0
1638302|NCT00795340|4002365|P1|NOT COMPLETED|Overall Study||7
1638303|NCT00795340|4002364|P2|COMPLETED|Overall Study||153
1638304|NCT00795340|4002365|P1|COMPLETED|Overall Study||146
1638305|NCT00795340|4002364|P2|STARTED|Overall Study||153
1638306|NCT00795340|4002365|P1|STARTED|Overall Study||153
1638307|NCT00795288|4002377|P2|NOT COMPLETED|Overall Study||0
1638308|NCT00795288|4002378|P1|NOT COMPLETED|Overall Study||0
1638309|NCT00795288|4002377|P2|COMPLETED|Overall Study||21
1638310|NCT00795288|4002378|P1|COMPLETED|Overall Study||21
1638311|NCT00795288|4002377|P2|STARTED|Overall Study||21
1638312|NCT00795288|4002378|P1|STARTED|Overall Study||21
1638313|NCT00795210|4002391|P3|NOT COMPLETED|Overall Study||2
1638314|NCT00795210|4002392|P2|NOT COMPLETED|Overall Study||1
1638315|NCT00795210|4002393|P1|NOT COMPLETED|Overall Study||0
1638316|NCT00795210|4002391|P3|COMPLETED|Overall Study||3
1638317|NCT00795210|4002392|P2|COMPLETED|Overall Study||11
1638318|NCT00795210|4002393|P1|COMPLETED|Overall Study||8
1638319|NCT00795210|4002391|P3|STARTED|Overall Study||5
1638320|NCT00795210|4002392|P2|STARTED|Overall Study||12
1638321|NCT00795210|4002393|P1|STARTED|Overall Study||8
1638322|NCT00795184|4002404|P2|NOT COMPLETED|Overall Study||13
1638323|NCT00795184|4002405|P1|NOT COMPLETED|Overall Study||8
1638324|NCT00795184|4002404|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
1638325|NCT00795184|4002405|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
1638326|NCT00795184|4002404|P2|STARTED|Overall Study||57
1638327|NCT00795184|4002405|P1|STARTED|Overall Study||65
1638328|NCT00795145|4002416|P7|NOT COMPLETED|Cohort 2||0
1638329|NCT00795145|4002417|P6|NOT COMPLETED|Cohort 2||0
1638330|NCT00795145|4002418|P5|NOT COMPLETED|Cohort 2||0
1638331|NCT00795145|4002419|P4|NOT COMPLETED|Cohort 2||0
1638332|NCT00795145|4002420|P3|NOT COMPLETED|Cohort 2||0
1638333|NCT00795145|4002421|P2|NOT COMPLETED|Cohort 2||0
1638334|NCT00795145|4002422|P1|NOT COMPLETED|Cohort 2||0
1638335|NCT00795145|4002416|P7|COMPLETED|Cohort 2||10
1638336|NCT00795145|4002417|P6|COMPLETED|Cohort 2||10
1638337|NCT00795145|4002418|P5|COMPLETED|Cohort 2||10
1638338|NCT00795145|4002419|P4|COMPLETED|Cohort 2||10
1638339|NCT00795145|4002420|P3|COMPLETED|Cohort 2||0
1638340|NCT00795145|4002421|P2|COMPLETED|Cohort 2||0
1638341|NCT00795145|4002422|P1|COMPLETED|Cohort 2||0
1638342|NCT00795145|4002416|P7|STARTED|Cohort 2||10
1638343|NCT00795145|4002417|P6|STARTED|Cohort 2||10
1638344|NCT00795145|4002418|P5|STARTED|Cohort 2||10
1638345|NCT00795145|4002419|P4|STARTED|Cohort 2||10
1638346|NCT00795145|4002420|P3|STARTED|Cohort 2||0
1638347|NCT00795145|4002421|P2|STARTED|Cohort 2||0
1638348|NCT00795145|4002422|P1|STARTED|Cohort 2||0
1638349|NCT00795145|4002416|P7|NOT COMPLETED|Cohort 1||0
1638350|NCT00795145|4002417|P6|NOT COMPLETED|Cohort 1||0
1638351|NCT00795145|4002418|P5|NOT COMPLETED|Cohort 1||0
1638352|NCT00795145|4002419|P4|NOT COMPLETED|Cohort 1||0
1638353|NCT00795145|4002420|P3|NOT COMPLETED|Cohort 1||0
1638354|NCT00795145|4002421|P2|NOT COMPLETED|Cohort 1||0
1638355|NCT00795145|4002422|P1|NOT COMPLETED|Cohort 1||0
1638356|NCT00795145|4002416|P7|COMPLETED|Cohort 1||0
1638357|NCT00795145|4002417|P6|COMPLETED|Cohort 1||0
1638358|NCT00795145|4002418|P5|COMPLETED|Cohort 1||0
1638359|NCT00795145|4002419|P4|COMPLETED|Cohort 1||0
1638360|NCT00795145|4002420|P3|COMPLETED|Cohort 1||3
1638361|NCT00795145|4002421|P2|COMPLETED|Cohort 1||3
1638362|NCT00795145|4002422|P1|COMPLETED|Cohort 1||3
1638363|NCT00795145|4002416|P7|STARTED|Cohort 1||0
1638364|NCT00795145|4002417|P6|STARTED|Cohort 1||0
1638365|NCT00795145|4002418|P5|STARTED|Cohort 1||0
1638366|NCT00795145|4002419|P4|STARTED|Cohort 1||0
1638367|NCT00795145|4002420|P3|STARTED|Cohort 1||3
1638368|NCT00795145|4002421|P2|STARTED|Cohort 1||3
1638369|NCT00795145|4002422|P1|STARTED|Cohort 1||3
1638370|NCT00795132|4002466|P1|NOT COMPLETED|Overall Study||3
1638371|NCT00795132|4002466|P1|COMPLETED|Overall Study||44
1638372|NCT00795132|4002466|P1|STARTED|Overall Study||47
1638373|NCT00795002|4002480|P2|NOT COMPLETED|Overall Study||0
1638374|NCT00795002|4002481|P1|NOT COMPLETED|Overall Study||0
1638375|NCT00795002|4002480|P2|COMPLETED|Overall Study||37
1638376|NCT00795002|4002481|P1|COMPLETED|Overall Study||37
1638377|NCT00795002|4002480|P2|STARTED|Overall Study||37
1638378|NCT00795002|4002481|P1|STARTED|Overall Study||37
1638379|NCT00794963|4002493|P2|NOT COMPLETED|Overall Study||4
1638380|NCT00794963|4002494|P1|NOT COMPLETED|Overall Study||1
1638381|NCT00794963|4002493|P2|COMPLETED|Overall Study||0
1638382|NCT00794963|4002494|P1|COMPLETED|Overall Study||3
1638383|NCT00794963|4002493|P2|STARTED|Overall Study||4
1638384|NCT00794963|4002494|P1|STARTED|Overall Study||4
1638385|NCT00794924|4002502|P2|NOT COMPLETED|Overall Study||70
1638386|NCT00794924|4002503|P1|NOT COMPLETED|Overall Study||60
1638387|NCT00794924|4002502|P2|COMPLETED|Overall Study||101
1638388|NCT00794924|4002503|P1|COMPLETED|Overall Study||114
1638389|NCT00794924|4002502|P2|STARTED|Overall Study|14 patients refused to start the study|171
1638390|NCT00794924|4002503|P1|STARTED|Overall Study|14 patients refused to start the study|174
1638391|NCT00794820|4002507|P1|NOT COMPLETED|Overall Study||16
1638392|NCT00794820|4002507|P1|COMPLETED|Overall Study||50
1638393|NCT00794820|4002507|P1|STARTED|Overall Study||66
1638394|NCT00794677|4002515|P2|NOT COMPLETED|Second Intervention||0
1638395|NCT00794677|4002516|P1|NOT COMPLETED|Second Intervention||0
1638396|NCT00794677|4002515|P2|COMPLETED|Second Intervention||13
1638397|NCT00794677|4002516|P1|COMPLETED|Second Intervention||11
1638398|NCT00794677|4002515|P2|STARTED|Second Intervention||13
1638399|NCT00794677|4002516|P1|STARTED|Second Intervention||11
1638400|NCT00794677|4002515|P2|NOT COMPLETED|First Intervention||0
1638401|NCT00794677|4002516|P1|NOT COMPLETED|First Intervention||2
1638402|NCT00794677|4002515|P2|COMPLETED|First Intervention||13
1638403|NCT00794677|4002516|P1|COMPLETED|First Intervention||11
1638404|NCT00794677|4002515|P2|STARTED|First Intervention||13
1638405|NCT00794677|4002516|P1|STARTED|First Intervention||13
1638406|NCT00794664|4002538|P2|NOT COMPLETED|Follow-up Period||5
1638407|NCT00794664|4002539|P1|NOT COMPLETED|Follow-up Period||1
1638408|NCT00794664|4002538|P2|COMPLETED|Follow-up Period||28
1638409|NCT00794664|4002539|P1|COMPLETED|Follow-up Period||15
1638410|NCT00794664|4002538|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
1638411|NCT00794664|4002539|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
1638412|NCT00794664|4002538|P2|NOT COMPLETED|Treatment Period||12
1638413|NCT00794664|4002539|P1|NOT COMPLETED|Treatment Period||1
1638414|NCT00794664|4002538|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
1638415|NCT00794664|4002539|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
1638416|NCT00794664|4002538|P2|STARTED|Treatment Period||39
1638417|NCT00794664|4002539|P1|STARTED|Treatment Period||19
1638418|NCT00794560|4002587|P4|NOT COMPLETED|Overall Study||4
1638419|NCT00794560|4002588|P3|NOT COMPLETED|Overall Study||4
1638420|NCT00794560|4002589|P2|NOT COMPLETED|Overall Study||4
1638421|NCT00794560|4002590|P1|NOT COMPLETED|Overall Study||3
1638422|NCT00794560|4002587|P4|COMPLETED|Overall Study||34
1638423|NCT00794560|4002588|P3|COMPLETED|Overall Study||40
1638424|NCT00794560|4002589|P2|COMPLETED|Overall Study||32
1638425|NCT00794560|4002590|P1|COMPLETED|Overall Study||33
1638426|NCT00794560|4002587|P4|STARTED|Overall Study||38
1638427|NCT00794560|4002588|P3|STARTED|Overall Study||44
1638428|NCT00794560|4002589|P2|STARTED|Overall Study||36
1638429|NCT00794560|4002590|P1|STARTED|Overall Study||36
1638430|NCT00794547|4002604|P2|NOT COMPLETED|Overall Study||0
1638431|NCT00794547|4002605|P1|NOT COMPLETED|Overall Study||0
1638432|NCT00794547|4002604|P2|COMPLETED|Overall Study||16
1638433|NCT00794547|4002605|P1|COMPLETED|Overall Study||18
1638434|NCT00794547|4002604|P2|STARTED|Overall Study||16
1638435|NCT00794547|4002605|P1|STARTED|Overall Study||18
1638436|NCT00794508|4002613|P1|NOT COMPLETED|Overall Study||0
1638437|NCT00794508|4002613|P1|COMPLETED|Overall Study||10
1638438|NCT00794508|4002613|P1|STARTED|Overall Study||10
1638439|NCT00794469|4002619|P1|NOT COMPLETED|Overall Study||0
1638440|NCT00794469|4002619|P1|COMPLETED|Overall Study||21
1638441|NCT00794469|4002619|P1|STARTED|Overall Study||21
1638442|NCT00794365|4002624|P1|NOT COMPLETED|Overall Study||79
1638443|NCT00794365|4002624|P1|COMPLETED|Overall Study||251
1638444|NCT00794365|4002624|P1|STARTED|Overall Study||330
1638445|NCT00794313|4002630|P3|NOT COMPLETED|Overall Study||0
1638446|NCT00794313|4002631|P2|NOT COMPLETED|Overall Study||0
1638447|NCT00794313|4002632|P1|NOT COMPLETED|Overall Study||0
1638448|NCT00794313|4002630|P3|COMPLETED|Overall Study||1
1638449|NCT00794313|4002631|P2|COMPLETED|Overall Study||1
1638450|NCT00794313|4002632|P1|COMPLETED|Overall Study||1
1638451|NCT00794313|4002630|P3|STARTED|Overall Study||1
1638452|NCT00794313|4002631|P2|STARTED|Overall Study||1
1638453|NCT00794313|4002632|P1|STARTED|Overall Study||1
1638454|NCT00794196|4002645|P2|NOT COMPLETED|Overall Study||23
1638455|NCT00794196|4002646|P1|NOT COMPLETED|Overall Study||5
1638456|NCT00794196|4002645|P2|COMPLETED|Overall Study||64
1638457|NCT00794196|4002646|P1|COMPLETED|Overall Study||87
1638458|NCT00794196|4002645|P2|STARTED|Overall Study||87
1638459|NCT00794196|4002646|P1|STARTED|Overall Study||92
1638460|NCT00794170|4002656|P2|NOT COMPLETED|Overall Study||3
1638461|NCT00794170|4002657|P1|NOT COMPLETED|Overall Study||7
1638462|NCT00794170|4002656|P2|COMPLETED|Overall Study||152
1638463|NCT00794170|4002657|P1|COMPLETED|Overall Study||150
1638464|NCT00794170|4002656|P2|STARTED|Overall Study||155
1638465|NCT00794170|4002657|P1|STARTED|Overall Study||157
1638466|NCT00794157|4002666|P3|NOT COMPLETED|Overall Study||19
1638467|NCT00794157|4002667|P2|NOT COMPLETED|Overall Study||10
1638468|NCT00794157|4002668|P1|NOT COMPLETED|Overall Study||10
1638469|NCT00794157|4002666|P3|COMPLETED|Overall Study||98
1638470|NCT00794157|4002667|P2|COMPLETED|Overall Study||106
1638471|NCT00794157|4002668|P1|COMPLETED|Overall Study||104
1638472|NCT00794157|4002666|P3|STARTED|Overall Study||117
1638473|NCT00794157|4002667|P2|STARTED|Overall Study||116
1638474|NCT00794157|4002668|P1|STARTED|Overall Study||114
1638475|NCT00794144|4002690|P2|NOT COMPLETED|Overall Study||3
1638476|NCT00794144|4002691|P1|NOT COMPLETED|Overall Study||3
1638477|NCT00794144|4002690|P2|COMPLETED|Overall Study||63
1638478|NCT00794144|4002691|P1|COMPLETED|Overall Study||63
1638479|NCT00794144|4002690|P2|STARTED|Overall Study||66
1638480|NCT00794144|4002691|P1|STARTED|Overall Study||66
1638481|NCT00794118|4002697|P1|NOT COMPLETED|Overall Study||27
1638482|NCT00794118|4002697|P1|COMPLETED|Overall Study||272
1638483|NCT00794118|4002697|P1|STARTED|Overall Study||299
1638484|NCT00793910|4002755|P2|NOT COMPLETED|Overall Study||7
1638485|NCT00793910|4002756|P1|NOT COMPLETED|Overall Study||5
1638486|NCT00793910|4002755|P2|COMPLETED|Overall Study||46
1638487|NCT00793910|4002756|P1|COMPLETED|Overall Study||48
1638488|NCT00793910|4002755|P2|STARTED|Overall Study||53
1638489|NCT00793910|4002756|P1|STARTED|Overall Study||53
1638490|NCT00793871|4002770|P1|NOT COMPLETED|Overall Study||60
1638491|NCT00793871|4002770|P1|COMPLETED|Overall Study||0
1638492|NCT00793871|4002770|P1|Received Treatment|Overall Study||59
1638493|NCT00793871|4002770|P1|STARTED|Overall Study||60
1638494|NCT00793819|4002784|P2|NOT COMPLETED|Overall Study||9
1638495|NCT00793819|4002785|P1|NOT COMPLETED|Overall Study||14
1638496|NCT00793819|4002784|P2|COMPLETED|Overall Study||89
1638497|NCT00793819|4002785|P1|COMPLETED|Overall Study||97
1638498|NCT00793819|4002784|P2|STARTED|Overall Study||98
1638499|NCT00793819|4002785|P1|STARTED|Overall Study||111
1638500|NCT00793793|4002803|P12|NOT COMPLETED|Overall Study||6
1638501|NCT00793793|4002804|P11|NOT COMPLETED|Overall Study||3
1638502|NCT00793793|4002805|P10|NOT COMPLETED|Overall Study||9
1638503|NCT00793793|4002806|P9|NOT COMPLETED|Overall Study||9
1638504|NCT00793793|4002807|P8|NOT COMPLETED|Overall Study||0
1638505|NCT00793793|4002808|P7|NOT COMPLETED|Overall Study||4
1638506|NCT00793793|4002809|P6|NOT COMPLETED|Overall Study||2
1638507|NCT00793793|4002810|P5|NOT COMPLETED|Overall Study||2
1638508|NCT00793793|4002811|P4|NOT COMPLETED|Overall Study||3
1638509|NCT00793793|4002812|P3|NOT COMPLETED|Overall Study||2
1638510|NCT00793793|4002813|P2|NOT COMPLETED|Overall Study||1
1638511|NCT00793793|4002814|P1|NOT COMPLETED|Overall Study||0
1638512|NCT00793793|4002803|P12|COMPLETED|Overall Study||1
1638513|NCT00793793|4002804|P11|COMPLETED|Overall Study||3
1638514|NCT00793793|4002805|P10|COMPLETED|Overall Study||6
1638515|NCT00793793|4002806|P9|COMPLETED|Overall Study||6
1638516|NCT00793793|4002807|P8|COMPLETED|Overall Study||6
1638517|NCT00793793|4002808|P7|COMPLETED|Overall Study||3
1638518|NCT00793793|4002809|P6|COMPLETED|Overall Study||4
1638519|NCT00793793|4002810|P5|COMPLETED|Overall Study||4
1638520|NCT00793793|4002811|P4|COMPLETED|Overall Study||4
1638521|NCT00793793|4002812|P3|COMPLETED|Overall Study||5
1638522|NCT00793793|4002813|P2|COMPLETED|Overall Study||5
1638523|NCT00793793|4002814|P1|COMPLETED|Overall Study||8
1638524|NCT00793793|4002803|P12|STARTED|Overall Study||7
1638525|NCT00793793|4002804|P11|STARTED|Overall Study||6
1638526|NCT00793793|4002805|P10|STARTED|Overall Study||15
1638527|NCT00793793|4002806|P9|STARTED|Overall Study||15
1638528|NCT00793793|4002807|P8|STARTED|Overall Study||6
1638529|NCT00793793|4002808|P7|STARTED|Overall Study||7
1638530|NCT00793793|4002809|P6|STARTED|Overall Study||6
1638531|NCT00793793|4002810|P5|STARTED|Overall Study||6
1638532|NCT00793793|4002811|P4|STARTED|Overall Study||7
1638533|NCT00793793|4002812|P3|STARTED|Overall Study||7
1638534|NCT00793793|4002813|P2|STARTED|Overall Study||6
1638535|NCT00793793|4002814|P1|STARTED|Overall Study||8
1638536|NCT00793780|4003189|P2|NOT COMPLETED|Overall Study||1
1638537|NCT00793780|4003190|P1|NOT COMPLETED|Overall Study||2
1638538|NCT00793780|4003189|P2|COMPLETED|Overall Study||11
1638539|NCT00793780|4003190|P1|COMPLETED|Overall Study||10
1638540|NCT00793780|4003189|P2|Collected Baseline Data|Overall Study||12
1638541|NCT00793780|4003190|P1|Collected Baseline Data|Overall Study||11
1638542|NCT00793780|4003189|P2|Randomization|Overall Study||12
1638543|NCT00793780|4003190|P1|Randomization|Overall Study||12
1638544|NCT00793780|4003189|P2|STARTED|Overall Study||12
1638545|NCT00793780|4003190|P1|STARTED|Overall Study||12
1638546|NCT00793650|4003208|P2|NOT COMPLETED|Overall Study||0
1638547|NCT00793650|4003209|P1|NOT COMPLETED|Overall Study||0
1638548|NCT00793650|4003208|P2|COMPLETED|Overall Study||20
1638549|NCT00793650|4003209|P1|COMPLETED|Overall Study||19
1638550|NCT00793650|4003208|P2|STARTED|Overall Study||20
1638551|NCT00793650|4003209|P1|STARTED|Overall Study||19
1638552|NCT00793624|4003221|P4|NOT COMPLETED|Overall Study||43
1638553|NCT00793624|4003222|P3|NOT COMPLETED|Overall Study||39
1638554|NCT00793624|4003223|P2|NOT COMPLETED|Overall Study||36
1638555|NCT00793624|4003224|P1|NOT COMPLETED|Overall Study||57
1638556|NCT00793624|4003221|P4|COMPLETED|Overall Study||184
1638557|NCT00793624|4003222|P3|COMPLETED|Overall Study||186
1638558|NCT00793624|4003223|P2|COMPLETED|Overall Study||191
1638559|NCT00793624|4003224|P1|COMPLETED|Overall Study||168
1638560|NCT00793624|4003221|P4|STARTED|Overall Study||227
1638561|NCT00793624|4003222|P3|STARTED|Overall Study||225
1638562|NCT00793624|4003223|P2|STARTED|Overall Study||227
1638563|NCT00793624|4003224|P1|STARTED|Overall Study||225
1638564|NCT00793611|4003492|P2|NOT COMPLETED|Overall Study||0
1638565|NCT00793611|4003493|P1|NOT COMPLETED|Overall Study||0
1638566|NCT00793611|4003492|P2|COMPLETED|Overall Study||10
1638567|NCT00793611|4003493|P1|COMPLETED|Overall Study||10
1638568|NCT00793611|4003492|P2|STARTED|Overall Study||10
1638569|NCT00793611|4003493|P1|STARTED|Overall Study||10
1638570|NCT00793585|4003505|P2|NOT COMPLETED|Overall Study||3
1638571|NCT00793585|4003506|P1|NOT COMPLETED|Overall Study||2
1638572|NCT00793585|4003505|P2|COMPLETED|Overall Study||18
1638573|NCT00793585|4003506|P1|COMPLETED|Overall Study||17
1638574|NCT00793585|4003505|P2|STARTED|Overall Study||21
1638575|NCT00793585|4003506|P1|STARTED|Overall Study||19
1638576|NCT00793572|4003514|P1|NOT COMPLETED|Overall Study||0
1638577|NCT00793572|4003514|P1|COMPLETED|Overall Study||32
1638578|NCT00793572|4003514|P1|STARTED|Overall Study||32
1638579|NCT00793546|4003525|P2|NOT COMPLETED|Overall Study||28
1638580|NCT00793546|4003526|P1|NOT COMPLETED|Overall Study||14
1638581|NCT00793546|4003525|P2|COMPLETED|Overall Study||0
1638582|NCT00793546|4003526|P1|COMPLETED|Overall Study||0
1638583|NCT00793546|4003525|P2|STARTED|Overall Study||28
1638584|NCT00793546|4003526|P1|STARTED|Overall Study||14
1638585|NCT00793520|4003556|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
1638586|NCT00793520|4003557|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
1638587|NCT00793520|4003556|P2|COMPLETED|Placebo Crossover to Milnacipran||0
1638588|NCT00793520|4003557|P1|COMPLETED|Placebo Crossover to Milnacipran||0
1638589|NCT00793520|4003556|P2|STARTED|Placebo Crossover to Milnacipran||1
1638590|NCT00793520|4003557|P1|STARTED|Placebo Crossover to Milnacipran||0
1638591|NCT00793520|4003556|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
1638592|NCT00793520|4003557|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
1638593|NCT00793520|4003556|P2|COMPLETED|Milnacipran Crossover to Placebo||0
1638594|NCT00793520|4003557|P1|COMPLETED|Milnacipran Crossover to Placebo||0
1638595|NCT00793520|4003556|P2|STARTED|Milnacipran Crossover to Placebo||0
1638596|NCT00793520|4003557|P1|STARTED|Milnacipran Crossover to Placebo||1
1638597|NCT00793455|4003567|P2|NOT COMPLETED|Overall Study||0
1638598|NCT00793455|4003568|P1|NOT COMPLETED|Overall Study||0
1638599|NCT00793455|4003567|P2|COMPLETED|Overall Study||314
1638600|NCT00793455|4003568|P1|COMPLETED|Overall Study||314
1638601|NCT00793455|4003567|P2|STARTED|Overall Study||314
1638602|NCT00793455|4003568|P1|STARTED|Overall Study||314
1638603|NCT00793403|4003576|P1|NOT COMPLETED|Overall Study||73
1638604|NCT00793403|4003576|P1|COMPLETED|Overall Study||220
1638605|NCT00793403|4003576|P1|STARTED|Overall Study||293
1638606|NCT00793325|4003623|P1|NOT COMPLETED|Overall Study||19
1638607|NCT00793325|4003623|P1|COMPLETED|Overall Study||890
1638608|NCT00793325|4003623|P1|STARTED|Overall Study||909
1638609|NCT00793182|4003647|P1|NOT COMPLETED|Overall Study||1
1638610|NCT00793182|4003647|P1|COMPLETED|Overall Study||5
1638611|NCT00793182|4003647|P1|STARTED|Overall Study||6
1638612|NCT00793169|4003651|P1|NOT COMPLETED|Overall Study||0
1638613|NCT00793169|4003651|P1|COMPLETED|Overall Study||19
1638614|NCT00793169|4003651|P1|STARTED|Overall Study||19
1638615|NCT00793104|4003655|P1|NOT COMPLETED|Overall Study||1
1638616|NCT00793104|4003655|P1|COMPLETED|Overall Study||9
1638617|NCT00793104|4003655|P1|STARTED|Overall Study||10
1638618|NCT00792948|4003663|P1|NOT COMPLETED|Overall Study||28
1638619|NCT00792948|4003663|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
1638620|NCT00792948|4003663|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
1638621|NCT00792935|4003674|P2|NOT COMPLETED|Overall Study||3
1638622|NCT00792935|4003675|P1|NOT COMPLETED|Overall Study||4
1638623|NCT00792935|4003674|P2|COMPLETED|Overall Study||68
1638624|NCT00792935|4003675|P1|COMPLETED|Overall Study||68
1638625|NCT00792935|4003674|P2|STARTED|Overall Study||71
1638626|NCT00792935|4003675|P1|STARTED|Overall Study||72
1638627|NCT00792922|4003687|P4|NOT COMPLETED|At 3 Years||0
1638628|NCT00792922|4003688|P3|NOT COMPLETED|At 3 Years||0
1638629|NCT00792922|4003689|P2|NOT COMPLETED|At 3 Years||0
1638630|NCT00792922|4003690|P1|NOT COMPLETED|At 3 Years||0
1638631|NCT00792922|4003687|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638632|NCT00792922|4003688|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638633|NCT00792922|4003689|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638634|NCT00792922|4003690|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638635|NCT00792922|4003687|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638636|NCT00792922|4003688|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638637|NCT00792922|4003689|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638638|NCT00792922|4003690|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638639|NCT00792922|4003687|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638640|NCT00792922|4003688|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638641|NCT00792922|4003689|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638642|NCT00792922|4003690|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638643|NCT00792922|4003687|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638644|NCT00792922|4003688|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638645|NCT00792922|4003689|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638646|NCT00792922|4003690|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1638647|NCT00792922|4003687|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
1638648|NCT00792922|4003688|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
1638649|NCT00792922|4003689|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
1638650|NCT00792922|4003690|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
1638651|NCT00792922|4003687|P4|NOT COMPLETED|At Baseline||0
1638652|NCT00792922|4003688|P3|NOT COMPLETED|At Baseline||0
1638653|NCT00792922|4003689|P2|NOT COMPLETED|At Baseline||0
1638654|NCT00792922|4003690|P1|NOT COMPLETED|At Baseline||0
1638655|NCT00792922|4003687|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638656|NCT00792922|4003688|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638657|NCT00792922|4003689|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638658|NCT00792922|4003690|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638659|NCT00792922|4003687|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638660|NCT00792922|4003688|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638661|NCT00792922|4003689|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638662|NCT00792922|4003690|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638663|NCT00792922|4003687|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638664|NCT00792922|4003688|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638665|NCT00792922|4003689|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638666|NCT00792922|4003690|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638667|NCT00792922|4003687|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638668|NCT00792922|4003688|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638669|NCT00792922|4003689|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638670|NCT00792922|4003690|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638671|NCT00792922|4003687|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638672|NCT00792922|4003688|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638673|NCT00792922|4003689|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638674|NCT00792922|4003690|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1638675|NCT00792909|4003707|P3|NOT COMPLETED|Overall Study||0
1638676|NCT00792909|4003708|P2|NOT COMPLETED|Overall Study||1
1638677|NCT00792909|4003709|P1|NOT COMPLETED|Overall Study||0
1638678|NCT00792909|4003707|P3|COMPLETED|Overall Study||62
1638679|NCT00792909|4003708|P2|COMPLETED|Overall Study||58
1638680|NCT00792909|4003709|P1|COMPLETED|Overall Study||51
1638681|NCT00792909|4003707|P3|STARTED|Overall Study||62
1638682|NCT00792909|4003708|P2|STARTED|Overall Study||59
1638683|NCT00792909|4003709|P1|STARTED|Overall Study||51
1638684|NCT00792805|4003765|P3|NOT COMPLETED|Overall Study||33
1638685|NCT00792805|4003766|P2|NOT COMPLETED|Overall Study||26
1638686|NCT00792805|4003767|P1|NOT COMPLETED|Overall Study||22
1638687|NCT00792805|4003765|P3|COMPLETED|Overall Study||154
1638688|NCT00792805|4003766|P2|COMPLETED|Overall Study||162
1638689|NCT00792805|4003767|P1|COMPLETED|Overall Study||166
1638690|NCT00792805|4003765|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
1638691|NCT00792805|4003766|P2|Exposed to Study Medication or Placebo|Overall Study||188
1638692|NCT00792805|4003767|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
1638693|NCT00792805|4003765|P3|STARTED|Overall Study||187
1638694|NCT00792805|4003766|P2|STARTED|Overall Study||188
1638695|NCT00792805|4003767|P1|STARTED|Overall Study||188
1638696|NCT00792701|4003777|P2|NOT COMPLETED|Overall Study||44
1638697|NCT00792701|4003778|P1|NOT COMPLETED|Overall Study||19
1638698|NCT00792701|4003777|P2|COMPLETED|Overall Study||22
1638699|NCT00792701|4003778|P1|COMPLETED|Overall Study||0
1638700|NCT00792701|4003777|P2|Eligible and Analyzable|Overall Study||44
1638701|NCT00792701|4003778|P1|Eligible and Analyzable|Overall Study||17
1638702|NCT00792701|4003777|P2|Eligible|Overall Study||63
1638703|NCT00792701|4003778|P1|Eligible|Overall Study||18
1638704|NCT00792701|4003777|P2|STARTED|Overall Study||66
1638705|NCT00792701|4003778|P1|STARTED|Overall Study||19
1638706|NCT00792688|4003792|P3|NOT COMPLETED|Overall Study||0
1638707|NCT00792688|4003793|P2|NOT COMPLETED|Overall Study||0
1638708|NCT00792688|4003794|P1|NOT COMPLETED|Overall Study||0
1638709|NCT00792688|4003792|P3|COMPLETED|Overall Study||9
1638710|NCT00792688|4003793|P2|COMPLETED|Overall Study||8
1638711|NCT00792688|4003794|P1|COMPLETED|Overall Study||9
1638712|NCT00792688|4003792|P3|STARTED|Overall Study||9
1638713|NCT00792688|4003793|P2|STARTED|Overall Study||8
1638714|NCT00792688|4003794|P1|STARTED|Overall Study||9
1638715|NCT00792636|4003808|P3|NOT COMPLETED|Overall Study||81
1638716|NCT00792636|4003809|P2|NOT COMPLETED|Overall Study||81
1638717|NCT00792636|4003810|P1|NOT COMPLETED|Overall Study||68
1638718|NCT00792636|4003808|P3|COMPLETED|Overall Study||55
1638719|NCT00792636|4003809|P2|COMPLETED|Overall Study||55
1638720|NCT00792636|4003810|P1|COMPLETED|Overall Study||67
1638721|NCT00792636|4003808|P3|STARTED|Overall Study||136
1638722|NCT00792636|4003809|P2|STARTED|Overall Study||136
1638723|NCT00792636|4003810|P1|STARTED|Overall Study||135
1638724|NCT00792623|4003847|P1|NOT COMPLETED|Overall Study||7
1638725|NCT00792623|4003847|P1|COMPLETED|Overall Study||22
1638726|NCT00792623|4003847|P1|STARTED|Overall Study||29
1638727|NCT00792610|4003860|P1|NOT COMPLETED|Overall Study||0
1638728|NCT00792610|4003860|P1|COMPLETED|Overall Study||127
1638729|NCT00792610|4003860|P1|Youths|Overall Study||127
1638730|NCT00792610|4003860|P1|STARTED|Overall Study||127
1638731|NCT00792428|4003866|P2|NOT COMPLETED|Overall Study||0
1638732|NCT00792428|4003867|P1|NOT COMPLETED|Overall Study||0
1638733|NCT00792428|4003866|P2|COMPLETED|Overall Study||10
1638734|NCT00792428|4003867|P1|COMPLETED|Overall Study||10
1638735|NCT00792428|4003866|P2|STARTED|Overall Study||10
1638736|NCT00792428|4003867|P1|STARTED|Overall Study||10
1638737|NCT00792298|4003875|P8|NOT COMPLETED|Treatment Period 2||2
1638738|NCT00792298|4003876|P7|NOT COMPLETED|Treatment Period 2||1
1638739|NCT00792298|4003877|P6|NOT COMPLETED|Treatment Period 2||0
1638740|NCT00792298|4003878|P5|NOT COMPLETED|Treatment Period 2||2
1638741|NCT00792298|4003879|P4|NOT COMPLETED|Treatment Period 2||2
1638742|NCT00792298|4003880|P3|NOT COMPLETED|Treatment Period 2||1
1638743|NCT00792298|4003881|P2|NOT COMPLETED|Treatment Period 2||1
1638744|NCT00792298|4003882|P1|NOT COMPLETED|Treatment Period 2||1
1638745|NCT00792298|4003875|P8|COMPLETED|Treatment Period 2||28
1638746|NCT00792298|4003876|P7|COMPLETED|Treatment Period 2||28
1638747|NCT00792298|4003877|P6|COMPLETED|Treatment Period 2||27
1638748|NCT00792298|4003878|P5|COMPLETED|Treatment Period 2||30
1638749|NCT00792298|4003879|P4|COMPLETED|Treatment Period 2||26
1638750|NCT00792298|4003880|P3|COMPLETED|Treatment Period 2||30
1638751|NCT00792298|4003881|P2|COMPLETED|Treatment Period 2||30
1638752|NCT00792298|4003882|P1|COMPLETED|Treatment Period 2||29
1638753|NCT00792298|4003875|P8|STARTED|Treatment Period 2||30
1638754|NCT00792298|4003876|P7|STARTED|Treatment Period 2||29
1638755|NCT00792298|4003877|P6|STARTED|Treatment Period 2||27
1638756|NCT00792298|4003878|P5|STARTED|Treatment Period 2||32
1638757|NCT00792298|4003879|P4|STARTED|Treatment Period 2||28
1638758|NCT00792298|4003880|P3|STARTED|Treatment Period 2||31
1638759|NCT00792298|4003881|P2|STARTED|Treatment Period 2||31
1638760|NCT00792298|4003882|P1|STARTED|Treatment Period 2||30
1638761|NCT00792298|4003875|P8|NOT COMPLETED|Washout||0
1638762|NCT00792298|4003876|P7|NOT COMPLETED|Washout||0
1638763|NCT00792298|4003877|P6|NOT COMPLETED|Washout||2
1638764|NCT00792298|4003878|P5|NOT COMPLETED|Washout||0
1638765|NCT00792298|4003879|P4|NOT COMPLETED|Washout||0
1638766|NCT00792298|4003880|P3|NOT COMPLETED|Washout||1
1638767|NCT00792298|4003881|P2|NOT COMPLETED|Washout||0
1638768|NCT00792298|4003882|P1|NOT COMPLETED|Washout||0
1638769|NCT00792298|4003875|P8|COMPLETED|Washout||30
1638770|NCT00792298|4003876|P7|COMPLETED|Washout||29
1638771|NCT00792298|4003877|P6|COMPLETED|Washout||27
1638772|NCT00792298|4003878|P5|COMPLETED|Washout||32
1638773|NCT00792298|4003879|P4|COMPLETED|Washout||28
1638774|NCT00792298|4003880|P3|COMPLETED|Washout||31
1638775|NCT00792298|4003881|P2|COMPLETED|Washout||31
1638776|NCT00792298|4003882|P1|COMPLETED|Washout||30
1638777|NCT00792298|4003875|P8|STARTED|Washout||30
1638778|NCT00792298|4003876|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
1638779|NCT00792298|4003877|P6|STARTED|Washout||29
1638780|NCT00792298|4003878|P5|STARTED|Washout||32
1638781|NCT00792298|4003879|P4|STARTED|Washout||28
1638782|NCT00792298|4003880|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
1638783|NCT00792298|4003881|P2|STARTED|Washout||31
1638784|NCT00792298|4003882|P1|STARTED|Washout||30
1638785|NCT00792298|4003875|P8|NOT COMPLETED|Treatment Period 1||1
1638786|NCT00792298|4003876|P7|NOT COMPLETED|Treatment Period 1||4
1638787|NCT00792298|4003877|P6|NOT COMPLETED|Treatment Period 1||3
1638788|NCT00792298|4003878|P5|NOT COMPLETED|Treatment Period 1||0
1638789|NCT00792298|4003879|P4|NOT COMPLETED|Treatment Period 1||4
1638790|NCT00792298|4003880|P3|NOT COMPLETED|Treatment Period 1||2
1638791|NCT00792298|4003881|P2|NOT COMPLETED|Treatment Period 1||1
1638792|NCT00792298|4003882|P1|NOT COMPLETED|Treatment Period 1||1
1638793|NCT00792298|4003875|P8|COMPLETED|Treatment Period 1||30
1638794|NCT00792298|4003876|P7|COMPLETED|Treatment Period 1||27
1638795|NCT00792298|4003877|P6|COMPLETED|Treatment Period 1||29
1638796|NCT00792298|4003878|P5|COMPLETED|Treatment Period 1||32
1638797|NCT00792298|4003879|P4|COMPLETED|Treatment Period 1||28
1638798|NCT00792298|4003880|P3|COMPLETED|Treatment Period 1||31
1638799|NCT00792298|4003881|P2|COMPLETED|Treatment Period 1||31
1638800|NCT00792298|4003882|P1|COMPLETED|Treatment Period 1||30
1638801|NCT00792298|4003875|P8|STARTED|Treatment Period 1||31
1638802|NCT00792298|4003876|P7|STARTED|Treatment Period 1||31
1638803|NCT00792298|4003877|P6|STARTED|Treatment Period 1||32
1638804|NCT00792298|4003878|P5|STARTED|Treatment Period 1||32
1638805|NCT00792298|4003879|P4|STARTED|Treatment Period 1||32
1638806|NCT00792298|4003880|P3|STARTED|Treatment Period 1||33
1638807|NCT00792298|4003881|P2|STARTED|Treatment Period 1||32
1638808|NCT00792298|4003882|P1|STARTED|Treatment Period 1||31
1638809|NCT00792259|4003912|P3|NOT COMPLETED|Overall Study||0
1638810|NCT00792259|4003913|P2|NOT COMPLETED|Overall Study||0
1638811|NCT00792259|4003914|P1|NOT COMPLETED|Overall Study||1
1638812|NCT00792259|4003912|P3|COMPLETED|Overall Study||13
1638813|NCT00792259|4003913|P2|COMPLETED|Overall Study||20
1638814|NCT00792259|4003914|P1|COMPLETED|Overall Study||14
1638815|NCT00792259|4003912|P3|STARTED|Overall Study||13
1638816|NCT00792259|4003913|P2|STARTED|Overall Study||20
1638817|NCT00792259|4003914|P1|STARTED|Overall Study||15
1638818|NCT00792116|4003924|P2|NOT COMPLETED|Overall Study||1
1638819|NCT00792116|4003925|P1|NOT COMPLETED|Overall Study||1
1638820|NCT00792116|4003924|P2|COMPLETED|Overall Study||54
1638821|NCT00792116|4003925|P1|COMPLETED|Overall Study||52
1638822|NCT00792116|4003924|P2|STARTED|Overall Study||55
1638823|NCT00792116|4003925|P1|STARTED|Overall Study||53
1638824|NCT00792103|4003935|P1|NOT COMPLETED|Overall Study||133
1638825|NCT00792103|4003935|P1|COMPLETED|Overall Study||65
1638826|NCT00792103|4003935|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
1638827|NCT00791999|4003947|P4|NOT COMPLETED|Overall Study||52
1638828|NCT00791999|4003948|P3|NOT COMPLETED|Overall Study||20
1638829|NCT00791999|4003949|P2|NOT COMPLETED|Overall Study||16
1638830|NCT00791999|4003950|P1|NOT COMPLETED|Overall Study||21
1638831|NCT00791999|4003947|P4|COMPLETED|Overall Study||25
1638832|NCT00791999|4003948|P3|COMPLETED|Overall Study||65
1638833|NCT00791999|4003949|P2|COMPLETED|Overall Study||66
1638834|NCT00791999|4003950|P1|COMPLETED|Overall Study||51
1638835|NCT00791999|4003947|P4|STARTED|Overall Study||77
1638836|NCT00791999|4003948|P3|STARTED|Overall Study||85
1638837|NCT00791999|4003949|P2|STARTED|Overall Study||82
1638838|NCT00791999|4003950|P1|STARTED|Overall Study||72
1638839|NCT00791973|4003966|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1638840|NCT00791973|4003967|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1638841|NCT00791973|4003966|P2|COMPLETED|Second Intervention (1 Week)||7
1638842|NCT00791973|4003967|P1|COMPLETED|Second Intervention (1 Week)||8
1638843|NCT00791973|4003966|P2|STARTED|Second Intervention (1 Week)||7
1638844|NCT00791973|4003967|P1|STARTED|Second Intervention (1 Week)||8
1638845|NCT00791973|4003966|P2|NOT COMPLETED|Washout (1 Week)||0
1638846|NCT00791973|4003967|P1|NOT COMPLETED|Washout (1 Week)||0
1638847|NCT00791973|4003966|P2|COMPLETED|Washout (1 Week)||7
1638848|NCT00791973|4003967|P1|COMPLETED|Washout (1 Week)||8
1638849|NCT00791973|4003966|P2|STARTED|Washout (1 Week)||7
1638850|NCT00791973|4003967|P1|STARTED|Washout (1 Week)||8
1638851|NCT00791973|4003966|P2|NOT COMPLETED|First Intervention (1 Week)||0
1638852|NCT00791973|4003967|P1|NOT COMPLETED|First Intervention (1 Week)||0
1638853|NCT00791973|4003966|P2|COMPLETED|First Intervention (1 Week)||7
1638854|NCT00791973|4003967|P1|COMPLETED|First Intervention (1 Week)||8
1638855|NCT00791973|4003966|P2|STARTED|First Intervention (1 Week)||7
1638856|NCT00791973|4003967|P1|STARTED|First Intervention (1 Week)||8
1638857|NCT00791934|4003975|P1|NOT COMPLETED|Overall Study||15
1638858|NCT00791934|4003975|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
1638859|NCT00791934|4003975|P1|STARTED|Overall Study||63
1638860|NCT00791921|4003985|P2|NOT COMPLETED|Overall Study||96
1638861|NCT00791921|4003986|P1|NOT COMPLETED|Overall Study||34
1638862|NCT00791921|4003985|P2|COMPLETED|Overall Study||18
1638863|NCT00791921|4003986|P1|COMPLETED|Overall Study||82
1638864|NCT00791921|4003985|P2|STARTED|Overall Study||114
1638865|NCT00791921|4003986|P1|STARTED|Overall Study||116
1638866|NCT00791908|4003994|P1|NOT COMPLETED|Overall Study||0
1638867|NCT00791908|4003994|P1|COMPLETED|Overall Study||15
1638868|NCT00791908|4003994|P1|STARTED|Overall Study||15
1638869|NCT00791817|4004004|P2|NOT COMPLETED|2: Single Dose||0
1638870|NCT00791817|4004005|P1|NOT COMPLETED|2: Single Dose||0
1638871|NCT00791817|4004004|P2|COMPLETED|2: Single Dose||5
1638872|NCT00791817|4004005|P1|COMPLETED|2: Single Dose||5
1638873|NCT00791817|4004004|P2|STARTED|2: Single Dose||5
1638874|NCT00791817|4004005|P1|STARTED|2: Single Dose||5
1638875|NCT00791817|4004004|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
1638876|NCT00791817|4004005|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
1638877|NCT00791817|4004004|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
1638878|NCT00791817|4004005|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
1638879|NCT00791817|4004004|P2|STARTED|1: Single Dose Followed by Week Washout||5
1638880|NCT00791817|4004005|P1|STARTED|1: Single Dose Followed by Week Washout||5
1638881|NCT00791778|4004013|P2|NOT COMPLETED|Follow-up||1
1638882|NCT00791778|4004014|P1|NOT COMPLETED|Follow-up||5
1638883|NCT00791778|4004013|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
1638884|NCT00791778|4004014|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
1638885|NCT00791778|4004013|P2|STARTED|Follow-up||91
1638886|NCT00791778|4004014|P1|STARTED|Follow-up||100
1638887|NCT00791778|4004013|P2|NOT COMPLETED|Double-blind Treatment||48
1638888|NCT00791778|4004014|P1|NOT COMPLETED|Double-blind Treatment||77
1638889|NCT00791778|4004013|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
1638890|NCT00791778|4004014|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
1638891|NCT00791778|4004013|P2|STARTED|Double-blind Treatment||123
1638892|NCT00791778|4004014|P1|STARTED|Double-blind Treatment||123
1638893|NCT00791765|4004068|P2|NOT COMPLETED|Weeks 13 to 24||8
1638894|NCT00791765|4004069|P1|NOT COMPLETED|Weeks 13 to 24||5
1638895|NCT00791765|4004068|P2|COMPLETED|Weeks 13 to 24||49
1638896|NCT00791765|4004069|P1|COMPLETED|Weeks 13 to 24||49
1638897|NCT00791765|4004068|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
1638898|NCT00791765|4004069|P1|STARTED|Weeks 13 to 24||54
1638899|NCT00791765|4004068|P2|NOT COMPLETED|Weeks 1 to 12||4
1638900|NCT00791765|4004069|P1|NOT COMPLETED|Weeks 1 to 12||8
1638901|NCT00791765|4004068|P2|COMPLETED|Weeks 1 to 12||58
1638902|NCT00791765|4004069|P1|COMPLETED|Weeks 1 to 12||54
1638903|NCT00791765|4004068|P2|Treated|Weeks 1 to 12||59
1638904|NCT00791765|4004069|P1|Treated|Weeks 1 to 12||62
1638905|NCT00791765|4004068|P2|STARTED|Weeks 1 to 12||62
1638906|NCT00791765|4004069|P1|STARTED|Weeks 1 to 12||62
1638907|NCT00791700|4004084|P4|NOT COMPLETED|Overall Study||18
1638908|NCT00791700|4004085|P3|NOT COMPLETED|Overall Study||4
1638909|NCT00791700|4004086|P2|NOT COMPLETED|Overall Study||5
1638910|NCT00791700|4004087|P1|NOT COMPLETED|Overall Study||4
1638911|NCT00791700|4004084|P4|COMPLETED|Overall Study|Two participants discontinued treatment after the lower bound (days 313 and 314) of Week 48 window.|25
1638912|NCT00791700|4004085|P3|COMPLETED|Overall Study||9
1638913|NCT00791700|4004086|P2|COMPLETED|Overall Study||26
1638914|NCT00791700|4004087|P1|COMPLETED|Overall Study||12
1638915|NCT00791700|4004084|P4|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|43
1638916|NCT00791700|4004085|P3|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|13
1638917|NCT00791700|4004086|P2|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|31
1638918|NCT00791700|4004087|P1|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|16
1638919|NCT00791661|4004175|P3|NOT COMPLETED|Period 3||0
1638920|NCT00791661|4004176|P2|NOT COMPLETED|Period 3||0
1638921|NCT00791661|4004177|P1|NOT COMPLETED|Period 3||0
1638922|NCT00791661|4004175|P3|COMPLETED|Period 3||6
1638923|NCT00791661|4004176|P2|COMPLETED|Period 3||8
1638924|NCT00791661|4004177|P1|COMPLETED|Period 3||8
1638925|NCT00791661|4004175|P3|Received Matching Placebo to MK-1006|Period 3||1
1638926|NCT00791661|4004176|P2|Received Matching Placebo to MK-1006|Period 3||2
1638927|NCT00791661|4004177|P1|Received Matching Placebo to MK-1006|Period 3||2
1638928|NCT00791661|4004175|P3|Received MK-1006|Period 3||5
1638929|NCT00791661|4004176|P2|Received MK-1006|Period 3||6
1638930|NCT00791661|4004177|P1|Received MK-1006|Period 3||6
1638931|NCT00791661|4004175|P3|STARTED|Period 3||6
1638932|NCT00791661|4004176|P2|STARTED|Period 3||8
1638933|NCT00791661|4004177|P1|STARTED|Period 3||8
1638934|NCT00791661|4004175|P3|NOT COMPLETED|7 Day Wash-out||0
1638935|NCT00791661|4004176|P2|NOT COMPLETED|7 Day Wash-out||0
1638936|NCT00791661|4004177|P1|NOT COMPLETED|7 Day Wash-out||0
1638937|NCT00791661|4004175|P3|COMPLETED|7 Day Wash-out||6
1638938|NCT00791661|4004176|P2|COMPLETED|7 Day Wash-out||8
1638939|NCT00791661|4004177|P1|COMPLETED|7 Day Wash-out||8
1638940|NCT00791661|4004175|P3|STARTED|7 Day Wash-out||6
1638941|NCT00791661|4004176|P2|STARTED|7 Day Wash-out||8
1638942|NCT00791661|4004177|P1|STARTED|7 Day Wash-out||8
1638943|NCT00791661|4004175|P3|NOT COMPLETED|Period 2||0
1638944|NCT00791661|4004176|P2|NOT COMPLETED|Period 2||0
1638945|NCT00791661|4004177|P1|NOT COMPLETED|Period 2||0
1638946|NCT00791661|4004175|P3|COMPLETED|Period 2||6
1638947|NCT00791661|4004176|P2|COMPLETED|Period 2||8
1638948|NCT00791661|4004177|P1|COMPLETED|Period 2||8
1638949|NCT00791661|4004175|P3|Received Matching Placebo to MK-1006|Period 2||2
1638950|NCT00791661|4004176|P2|Received Matching Placebo to MK-1006|Period 2||2
1638951|NCT00791661|4004177|P1|Received Matching Placebo to MK-1006|Period 2||2
1638952|NCT00791661|4004175|P3|Received MK-1006|Period 2||4
1638953|NCT00791661|4004176|P2|Received MK-1006|Period 2||6
1638954|NCT00791661|4004177|P1|Received MK-1006|Period 2||6
1638955|NCT00791661|4004175|P3|STARTED|Period 2||6
1638956|NCT00791661|4004176|P2|STARTED|Period 2||8
1638957|NCT00791661|4004177|P1|STARTED|Period 2||8
1638958|NCT00791661|4004175|P3|NOT COMPLETED|7 Day Wash-out||2
1638959|NCT00791661|4004176|P2|NOT COMPLETED|7 Day Wash-out||0
1638960|NCT00791661|4004177|P1|NOT COMPLETED|7 Day Wash-out||0
1638961|NCT00791661|4004175|P3|COMPLETED|7 Day Wash-out||6
1638962|NCT00791661|4004176|P2|COMPLETED|7 Day Wash-out||8
1638963|NCT00791661|4004177|P1|COMPLETED|7 Day Wash-out||8
1638964|NCT00791661|4004175|P3|STARTED|7 Day Wash-out||8
1638965|NCT00791661|4004176|P2|STARTED|7 Day Wash-out||8
1638966|NCT00791661|4004177|P1|STARTED|7 Day Wash-out||8
1638967|NCT00791661|4004175|P3|NOT COMPLETED|Period 1||0
1638968|NCT00791661|4004176|P2|NOT COMPLETED|Period 1||0
1638969|NCT00791661|4004177|P1|NOT COMPLETED|Period 1||0
1638970|NCT00791661|4004175|P3|COMPLETED|Period 1||8
1638971|NCT00791661|4004176|P2|COMPLETED|Period 1||8
1638972|NCT00791661|4004177|P1|COMPLETED|Period 1||8
1638973|NCT00791661|4004175|P3|Received Matching Placebo to MK-1006|Period 1||2
1638974|NCT00791661|4004176|P2|Received Matching Placebo to MK-1006|Period 1||2
1638975|NCT00791661|4004177|P1|Received Matching Placebo to MK-1006|Period 1||2
1638976|NCT00791661|4004175|P3|Received MK-1006|Period 1||6
1638977|NCT00791661|4004176|P2|Received MK-1006|Period 1||6
1638978|NCT00791661|4004177|P1|Received MK-1006|Period 1||6
1638979|NCT00791661|4004175|P3|STARTED|Period 1||8
1638980|NCT00791661|4004176|P2|STARTED|Period 1||8
1638981|NCT00791661|4004177|P1|STARTED|Period 1||8
1638982|NCT00791648|4004270|P2|NOT COMPLETED|Overall Study||2
1638983|NCT00791648|4004271|P1|NOT COMPLETED|Overall Study||0
1638984|NCT00791648|4004270|P2|COMPLETED|Overall Study||307
1638985|NCT00791648|4004271|P1|COMPLETED|Overall Study||308
1638986|NCT00791648|4004270|P2|STARTED|Overall Study||309
1638987|NCT00791648|4004271|P1|STARTED|Overall Study||308
1638988|NCT00791557|4004287|P1|NOT COMPLETED|Overall Study||1
1638989|NCT00791557|4004287|P1|COMPLETED|Overall Study||1
1638990|NCT00791557|4004287|P1|STARTED|Overall Study||2
1638991|NCT00791518|4004291|P1|NOT COMPLETED|Overall Study||93
1638992|NCT00791518|4004291|P1|COMPLETED|Overall Study||991
1638993|NCT00791518|4004291|P1|STARTED|Overall Study||1084
1638994|NCT00791492|4004319|P2|NOT COMPLETED|Overall Study||3
1638995|NCT00791492|4004320|P1|NOT COMPLETED|Overall Study||6
1638996|NCT00791492|4004319|P2|COMPLETED|Overall Study||38
1638997|NCT00791492|4004320|P1|COMPLETED|Overall Study||39
1638998|NCT00791492|4004319|P2|TREATED|Overall Study||41
1638999|NCT00791492|4004320|P1|TREATED|Overall Study||44
1639000|NCT00791492|4004319|P2|STARTED|Overall Study||41
1639001|NCT00791492|4004320|P1|STARTED|Overall Study||45
1639002|NCT00791479|4004368|P6|NOT COMPLETED|Overall Study||3
1639003|NCT00791479|4004369|P5|NOT COMPLETED|Overall Study||3
1639004|NCT00791479|4004370|P4|NOT COMPLETED|Overall Study||4
1639005|NCT00791479|4004371|P3|NOT COMPLETED|Overall Study||0
1639006|NCT00791479|4004372|P2|NOT COMPLETED|Overall Study||3
1639007|NCT00791479|4004373|P1|NOT COMPLETED|Overall Study||2
1639008|NCT00791479|4004368|P6|COMPLETED|Overall Study||29
1639009|NCT00791479|4004369|P5|COMPLETED|Overall Study||0
1639010|NCT00791479|4004370|P4|COMPLETED|Overall Study||25
1639011|NCT00791479|4004371|P3|COMPLETED|Overall Study||34
1639012|NCT00791479|4004372|P2|COMPLETED|Overall Study||31
1639013|NCT00791479|4004373|P1|COMPLETED|Overall Study||33
1639014|NCT00791479|4004368|P6|Received at Least One Dose of Study Drug|Overall Study||32
1639015|NCT00791479|4004369|P5|Received at Least One Dose of Study Drug|Overall Study||3
1639016|NCT00791479|4004370|P4|Received at Least One Dose of Study Drug|Overall Study||29
1639017|NCT00791479|4004371|P3|Received at Least One Dose of Study Drug|Overall Study||34
1639018|NCT00791479|4004372|P2|Received at Least One Dose of Study Drug|Overall Study||34
1639019|NCT00791479|4004373|P1|Received at Least One Dose of Study Drug|Overall Study||35
1639020|NCT00791479|4004368|P6|STARTED|Overall Study||32
1639021|NCT00791479|4004369|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
1639022|NCT00791479|4004370|P4|STARTED|Overall Study||29
1639023|NCT00791479|4004371|P3|STARTED|Overall Study||34
1639024|NCT00791479|4004372|P2|STARTED|Overall Study||34
1639025|NCT00791479|4004373|P1|STARTED|Overall Study||35
1639026|NCT00791388|4004472|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
1639027|NCT00791388|4004473|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1639028|NCT00791388|4004474|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1639029|NCT00791388|4004475|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1639030|NCT00791388|4004476|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1639031|NCT00791388|4004472|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
1639032|NCT00791388|4004473|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
1639033|NCT00791388|4004474|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
1639034|NCT00791388|4004475|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
1639035|NCT00791388|4004476|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
1639036|NCT00791388|4004472|P5|STARTED|Period 4 - 400 mg Dose Group||8
1639037|NCT00791388|4004473|P4|STARTED|Period 4 - 400 mg Dose Group||0
1639038|NCT00791388|4004474|P3|STARTED|Period 4 - 400 mg Dose Group||0
1639039|NCT00791388|4004475|P2|STARTED|Period 4 - 400 mg Dose Group||0
1639040|NCT00791388|4004476|P1|STARTED|Period 4 - 400 mg Dose Group||4
1639041|NCT00791388|4004472|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1639042|NCT00791388|4004473|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1639043|NCT00791388|4004474|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1639044|NCT00791388|4004475|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1639045|NCT00791388|4004476|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1639046|NCT00791388|4004472|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
1639047|NCT00791388|4004473|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
1639048|NCT00791388|4004474|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
1639049|NCT00791388|4004475|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
1639050|NCT00791388|4004476|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
1639051|NCT00791388|4004472|P5|STARTED|Period 3 - 200 mg Dose Group||0
1639052|NCT00791388|4004473|P4|STARTED|Period 3 - 200 mg Dose Group||8
1639053|NCT00791388|4004474|P3|STARTED|Period 3 - 200 mg Dose Group||0
1639054|NCT00791388|4004475|P2|STARTED|Period 3 - 200 mg Dose Group||0
1639055|NCT00791388|4004476|P1|STARTED|Period 3 - 200 mg Dose Group||3
1639056|NCT00791388|4004472|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1639057|NCT00791388|4004473|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1639058|NCT00791388|4004474|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1639059|NCT00791388|4004475|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1639060|NCT00791388|4004476|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
1639061|NCT00791388|4004472|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
1639062|NCT00791388|4004473|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
1639063|NCT00791388|4004474|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
1639064|NCT00791388|4004475|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
1639065|NCT00791388|4004476|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
1639066|NCT00791388|4004472|P5|STARTED|Period 2 - 100 mg Dose Group||0
1639067|NCT00791388|4004473|P4|STARTED|Period 2 - 100 mg Dose Group||0
1639068|NCT00791388|4004474|P3|STARTED|Period 2 - 100 mg Dose Group||8
1639069|NCT00791388|4004475|P2|STARTED|Period 2 - 100 mg Dose Group||0
1639070|NCT00791388|4004476|P1|STARTED|Period 2 - 100 mg Dose Group||3
1639071|NCT00791388|4004472|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1639072|NCT00791388|4004473|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1639073|NCT00791388|4004474|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1639074|NCT00791388|4004475|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
1639075|NCT00791388|4004476|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1639076|NCT00791388|4004472|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
1639077|NCT00791388|4004473|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
1639078|NCT00791388|4004474|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
1639079|NCT00791388|4004475|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
1639080|NCT00791388|4004476|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
1639081|NCT00791388|4004472|P5|STARTED|Period 1 - 50 mg Dose Group||0
1639082|NCT00791388|4004473|P4|STARTED|Period 1 - 50 mg Dose Group||0
1639083|NCT00791388|4004474|P3|STARTED|Period 1 - 50 mg Dose Group||0
1639084|NCT00791388|4004475|P2|STARTED|Period 1 - 50 mg Dose Group||8
1639085|NCT00791388|4004476|P1|STARTED|Period 1 - 50 mg Dose Group||3
1639086|NCT00791336|4004503|P1|NOT COMPLETED|Overall Study||0
1639087|NCT00791336|4004503|P1|COMPLETED|Overall Study||1
1639088|NCT00791336|4004503|P1|STARTED|Overall Study||1
1639089|NCT00791323|4004511|P2|NOT COMPLETED|Overall Study||0
1639090|NCT00791323|4004512|P1|NOT COMPLETED|Overall Study||0
1639091|NCT00791323|4004511|P2|COMPLETED|Overall Study||3
1639092|NCT00791323|4004512|P1|COMPLETED|Overall Study||6
1639093|NCT00791323|4004511|P2|STARTED|Overall Study||3
1639094|NCT00791323|4004512|P1|STARTED|Overall Study||6
1639095|NCT00791258|4004518|P1|NOT COMPLETED|Overall Study||263
1639096|NCT00791258|4004518|P1|COMPLETED|Overall Study||736
1639097|NCT00791258|4004518|P1|STARTED|Overall Study||999
1639098|NCT00791128|4004580|P1|NOT COMPLETED|Overall Study||9
1639099|NCT00791128|4004580|P1|COMPLETED|Overall Study||13
1639100|NCT00791128|4004580|P1|STARTED|Overall Study||22
1639101|NCT00791102|4004585|P2|NOT COMPLETED|Period 2||0
1639102|NCT00791102|4004586|P1|NOT COMPLETED|Period 2||0
1639103|NCT00791102|4004585|P2|COMPLETED|Period 2||10
1639104|NCT00791102|4004586|P1|COMPLETED|Period 2||10
1639105|NCT00791102|4004585|P2|STARTED|Period 2||10
1639106|NCT00791102|4004586|P1|STARTED|Period 2||10
1639107|NCT00791102|4004585|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1639108|NCT00791102|4004586|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1639109|NCT00791102|4004585|P2|COMPLETED|Washout Period of 2 Weeks||10
1639110|NCT00791102|4004586|P1|COMPLETED|Washout Period of 2 Weeks||10
1639111|NCT00791102|4004585|P2|STARTED|Washout Period of 2 Weeks||10
1639112|NCT00791102|4004586|P1|STARTED|Washout Period of 2 Weeks||10
1639113|NCT00791102|4004585|P2|NOT COMPLETED|Period 1||0
1639114|NCT00791102|4004586|P1|NOT COMPLETED|Period 1||0
1639115|NCT00791102|4004585|P2|COMPLETED|Period 1||10
1639116|NCT00791102|4004586|P1|COMPLETED|Period 1||10
1639117|NCT00791102|4004585|P2|STARTED|Period 1||10
1639118|NCT00791102|4004586|P1|STARTED|Period 1||10
1639119|NCT00791089|4004604|P2|NOT COMPLETED|Overall Study||6
1639120|NCT00791089|4004605|P1|NOT COMPLETED|Overall Study||6
1639121|NCT00791089|4004604|P2|COMPLETED|Overall Study||0
1639122|NCT00791089|4004605|P1|COMPLETED|Overall Study||0
1639123|NCT00791089|4004604|P2|Six-month Data Collected|Overall Study||5
1639124|NCT00791089|4004605|P1|Six-month Data Collected|Overall Study||6
1639125|NCT00791089|4004604|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
1639126|NCT00791089|4004605|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
1639127|NCT00791089|4004604|P2|STARTED|Overall Study||6
1639128|NCT00791089|4004605|P1|STARTED|Overall Study||6
1639129|NCT00791076|4004611|P1|NOT COMPLETED|Overall Study||8
1639130|NCT00791076|4004611|P1|COMPLETED|Overall Study||0
1639131|NCT00791076|4004611|P1|STARTED|Overall Study||8
1639132|NCT00791037|4004619|P1|NOT COMPLETED|Overall Study||0
1639133|NCT00791037|4004619|P1|COMPLETED|Overall Study||23
1639134|NCT00791037|4004619|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
1639135|NCT00791037|4004619|P1|Primary Outcome|Overall Study||19
1639136|NCT00791037|4004619|P1|STARTED|Overall Study||23
1639137|NCT00790907|4004629|P3|NOT COMPLETED|Overall Study||339
1639138|NCT00790907|4004630|P2|NOT COMPLETED|Overall Study||340
1639139|NCT00790907|4004631|P1|NOT COMPLETED|Overall Study||455
1639140|NCT00790907|4004629|P3|COMPLETED|Overall Study||663
1639141|NCT00790907|4004630|P2|COMPLETED|Overall Study||684
1639142|NCT00790907|4004631|P1|COMPLETED|Overall Study||754
1639143|NCT00790907|4004629|P3|STARTED|Overall Study||1002
1639144|NCT00790907|4004630|P2|STARTED|Overall Study||1024
1639145|NCT00790907|4004631|P1|STARTED|Overall Study||1209
1639146|NCT00790868|4004654|P2|NOT COMPLETED|Overall Study||17
1639147|NCT00790868|4004655|P1|NOT COMPLETED|Overall Study||6
1639148|NCT00790868|4004654|P2|COMPLETED|Overall Study||75
1639149|NCT00790868|4004655|P1|COMPLETED|Overall Study||82
1639150|NCT00790868|4004654|P2|STARTED|Overall Study||92
1639151|NCT00790868|4004655|P1|STARTED|Overall Study||88
1639152|NCT00790855|4004669|P1|NOT COMPLETED|Overall Study||0
1639153|NCT00790855|4004669|P1|COMPLETED|Overall Study||25
1639154|NCT00790855|4004669|P1|STARTED|Overall Study||25
1639155|NCT00790842|4004677|P11|NOT COMPLETED|Expansion Cohort||0
1639156|NCT00790842|4004678|P10|NOT COMPLETED|Expansion Cohort||0
1639157|NCT00790842|4004679|P9|NOT COMPLETED|Expansion Cohort||0
1639158|NCT00790842|4004680|P8|NOT COMPLETED|Expansion Cohort||0
1639159|NCT00790842|4004681|P7|NOT COMPLETED|Expansion Cohort||1
1639160|NCT00790842|4004682|P6|NOT COMPLETED|Expansion Cohort||0
1639161|NCT00790842|4004683|P5|NOT COMPLETED|Expansion Cohort||0
1639162|NCT00790842|4004684|P4|NOT COMPLETED|Expansion Cohort||0
1639163|NCT00790842|4004685|P3|NOT COMPLETED|Expansion Cohort||7
1639164|NCT00790842|4004686|P2|NOT COMPLETED|Expansion Cohort||0
1639165|NCT00790842|4004687|P1|NOT COMPLETED|Expansion Cohort||0
1639166|NCT00790842|4004677|P11|COMPLETED|Expansion Cohort||0
1639167|NCT00790842|4004678|P10|COMPLETED|Expansion Cohort||0
1639168|NCT00790842|4004679|P9|COMPLETED|Expansion Cohort||0
1639169|NCT00790842|4004680|P8|COMPLETED|Expansion Cohort||0
1639170|NCT00790842|4004681|P7|COMPLETED|Expansion Cohort||1
1639171|NCT00790842|4004682|P6|COMPLETED|Expansion Cohort||0
1639172|NCT00790842|4004683|P5|COMPLETED|Expansion Cohort||0
1639173|NCT00790842|4004684|P4|COMPLETED|Expansion Cohort||0
1639174|NCT00790842|4004685|P3|COMPLETED|Expansion Cohort||7
1639175|NCT00790842|4004686|P2|COMPLETED|Expansion Cohort||0
1639176|NCT00790842|4004687|P1|COMPLETED|Expansion Cohort||0
1639177|NCT00790842|4004677|P11|Began Treatment|Expansion Cohort||0
1639178|NCT00790842|4004678|P10|Began Treatment|Expansion Cohort||0
1639179|NCT00790842|4004679|P9|Began Treatment|Expansion Cohort||0
1639180|NCT00790842|4004680|P8|Began Treatment|Expansion Cohort||0
1639181|NCT00790842|4004681|P7|Began Treatment|Expansion Cohort||2
1639182|NCT00790842|4004682|P6|Began Treatment|Expansion Cohort||0
1639183|NCT00790842|4004683|P5|Began Treatment|Expansion Cohort||0
1639184|NCT00790842|4004684|P4|Began Treatment|Expansion Cohort||0
1639185|NCT00790842|4004685|P3|Began Treatment|Expansion Cohort||14
1639186|NCT00790842|4004686|P2|Began Treatment|Expansion Cohort||0
1639187|NCT00790842|4004687|P1|Began Treatment|Expansion Cohort||0
1639188|NCT00790842|4004677|P11|STARTED|Expansion Cohort||0
1639189|NCT00790842|4004678|P10|STARTED|Expansion Cohort||0
1639190|NCT00790842|4004679|P9|STARTED|Expansion Cohort||0
1639191|NCT00790842|4004680|P8|STARTED|Expansion Cohort||0
1639192|NCT00790842|4004681|P7|STARTED|Expansion Cohort||2
1639193|NCT00790842|4004682|P6|STARTED|Expansion Cohort||0
1639194|NCT00790842|4004683|P5|STARTED|Expansion Cohort||0
1639195|NCT00790842|4004684|P4|STARTED|Expansion Cohort||0
1639196|NCT00790842|4004685|P3|STARTED|Expansion Cohort||14
1639197|NCT00790842|4004686|P2|STARTED|Expansion Cohort||0
1639198|NCT00790842|4004687|P1|STARTED|Expansion Cohort||0
1639199|NCT00790842|4004677|P11|NOT COMPLETED|Dose Level 4||2
1639200|NCT00790842|4004678|P10|NOT COMPLETED|Dose Level 4||0
1639201|NCT00790842|4004679|P9|NOT COMPLETED|Dose Level 4||0
1639202|NCT00790842|4004680|P8|NOT COMPLETED|Dose Level 4||0
1639203|NCT00790842|4004681|P7|NOT COMPLETED|Dose Level 4||2
1639204|NCT00790842|4004682|P6|NOT COMPLETED|Dose Level 4||0
1639205|NCT00790842|4004683|P5|NOT COMPLETED|Dose Level 4||0
1639206|NCT00790842|4004684|P4|NOT COMPLETED|Dose Level 4||0
1639207|NCT00790842|4004685|P3|NOT COMPLETED|Dose Level 4||0
1639208|NCT00790842|4004686|P2|NOT COMPLETED|Dose Level 4||0
1639209|NCT00790842|4004687|P1|NOT COMPLETED|Dose Level 4||0
1639210|NCT00790842|4004677|P11|COMPLETED|Dose Level 4||3
1639211|NCT00790842|4004678|P10|COMPLETED|Dose Level 4||0
1639212|NCT00790842|4004679|P9|COMPLETED|Dose Level 4||0
1639213|NCT00790842|4004680|P8|COMPLETED|Dose Level 4||0
1639214|NCT00790842|4004681|P7|COMPLETED|Dose Level 4||6
1639215|NCT00790842|4004682|P6|COMPLETED|Dose Level 4||0
1639216|NCT00790842|4004683|P5|COMPLETED|Dose Level 4||0
1639217|NCT00790842|4004684|P4|COMPLETED|Dose Level 4||0
1639218|NCT00790842|4004685|P3|COMPLETED|Dose Level 4||0
1639219|NCT00790842|4004686|P2|COMPLETED|Dose Level 4||0
1639220|NCT00790842|4004687|P1|COMPLETED|Dose Level 4||0
1639221|NCT00790842|4004677|P11|Began Treatment|Dose Level 4||5
1639222|NCT00790842|4004678|P10|Began Treatment|Dose Level 4||0
1639223|NCT00790842|4004679|P9|Began Treatment|Dose Level 4||0
1639224|NCT00790842|4004680|P8|Began Treatment|Dose Level 4||0
1639225|NCT00790842|4004681|P7|Began Treatment|Dose Level 4||8
1639226|NCT00790842|4004682|P6|Began Treatment|Dose Level 4||0
1639227|NCT00790842|4004683|P5|Began Treatment|Dose Level 4||0
1639228|NCT00790842|4004684|P4|Began Treatment|Dose Level 4||0
1639229|NCT00790842|4004685|P3|Began Treatment|Dose Level 4||0
1639230|NCT00790842|4004686|P2|Began Treatment|Dose Level 4||0
1639231|NCT00790842|4004687|P1|Began Treatment|Dose Level 4||0
1639232|NCT00790842|4004677|P11|STARTED|Dose Level 4||5
1639233|NCT00790842|4004678|P10|STARTED|Dose Level 4||0
1639234|NCT00790842|4004679|P9|STARTED|Dose Level 4||0
1639235|NCT00790842|4004680|P8|STARTED|Dose Level 4||0
1639236|NCT00790842|4004681|P7|STARTED|Dose Level 4||8
1639237|NCT00790842|4004682|P6|STARTED|Dose Level 4||0
1639238|NCT00790842|4004683|P5|STARTED|Dose Level 4||0
1639239|NCT00790842|4004684|P4|STARTED|Dose Level 4||0
1639240|NCT00790842|4004685|P3|STARTED|Dose Level 4||0
1639241|NCT00790842|4004686|P2|STARTED|Dose Level 4||0
1639242|NCT00790842|4004687|P1|STARTED|Dose Level 4||0
1639243|NCT00790842|4004677|P11|NOT COMPLETED|Dose Level 3||0
1639244|NCT00790842|4004678|P10|NOT COMPLETED|Dose Level 3||2
1639245|NCT00790842|4004679|P9|NOT COMPLETED|Dose Level 3||0
1639246|NCT00790842|4004680|P8|NOT COMPLETED|Dose Level 3||0
1639247|NCT00790842|4004681|P7|NOT COMPLETED|Dose Level 3||0
1639248|NCT00790842|4004682|P6|NOT COMPLETED|Dose Level 3||1
1639249|NCT00790842|4004683|P5|NOT COMPLETED|Dose Level 3||0
1639250|NCT00790842|4004684|P4|NOT COMPLETED|Dose Level 3||0
1639251|NCT00790842|4004685|P3|NOT COMPLETED|Dose Level 3||5
1639252|NCT00790842|4004686|P2|NOT COMPLETED|Dose Level 3||0
1639253|NCT00790842|4004687|P1|NOT COMPLETED|Dose Level 3||0
1639254|NCT00790842|4004677|P11|COMPLETED|Dose Level 3||0
1639255|NCT00790842|4004678|P10|COMPLETED|Dose Level 3||1
1639256|NCT00790842|4004679|P9|COMPLETED|Dose Level 3||0
1639257|NCT00790842|4004680|P8|COMPLETED|Dose Level 3||0
1639258|NCT00790842|4004681|P7|COMPLETED|Dose Level 3||0
1639259|NCT00790842|4004682|P6|COMPLETED|Dose Level 3||2
1639260|NCT00790842|4004683|P5|COMPLETED|Dose Level 3||0
1639261|NCT00790842|4004684|P4|COMPLETED|Dose Level 3||0
1639262|NCT00790842|4004685|P3|COMPLETED|Dose Level 3||2
1639263|NCT00790842|4004686|P2|COMPLETED|Dose Level 3||0
1639264|NCT00790842|4004687|P1|COMPLETED|Dose Level 3||0
1639265|NCT00790842|4004677|P11|Began Treatment|Dose Level 3||0
1639266|NCT00790842|4004678|P10|Began Treatment|Dose Level 3||3
1639267|NCT00790842|4004679|P9|Began Treatment|Dose Level 3||0
1639268|NCT00790842|4004680|P8|Began Treatment|Dose Level 3||0
1639269|NCT00790842|4004681|P7|Began Treatment|Dose Level 3||0
1639270|NCT00790842|4004682|P6|Began Treatment|Dose Level 3||3
1639271|NCT00790842|4004683|P5|Began Treatment|Dose Level 3||0
1639272|NCT00790842|4004684|P4|Began Treatment|Dose Level 3||0
1639273|NCT00790842|4004685|P3|Began Treatment|Dose Level 3||6
1639274|NCT00790842|4004686|P2|Began Treatment|Dose Level 3||0
1639275|NCT00790842|4004687|P1|Began Treatment|Dose Level 3||0
1639276|NCT00790842|4004677|P11|STARTED|Dose Level 3||0
1639277|NCT00790842|4004678|P10|STARTED|Dose Level 3||3
1639278|NCT00790842|4004679|P9|STARTED|Dose Level 3||0
1639279|NCT00790842|4004680|P8|STARTED|Dose Level 3||0
1639280|NCT00790842|4004681|P7|STARTED|Dose Level 3||0
1639281|NCT00790842|4004682|P6|STARTED|Dose Level 3||3
1639282|NCT00790842|4004683|P5|STARTED|Dose Level 3||0
1639283|NCT00790842|4004684|P4|STARTED|Dose Level 3||0
1639284|NCT00790842|4004685|P3|STARTED|Dose Level 3||7
1639285|NCT00790842|4004686|P2|STARTED|Dose Level 3||0
1639286|NCT00790842|4004687|P1|STARTED|Dose Level 3||0
1639287|NCT00790842|4004677|P11|NOT COMPLETED|Dose Level 2||0
1639288|NCT00790842|4004678|P10|NOT COMPLETED|Dose Level 2||0
1639289|NCT00790842|4004679|P9|NOT COMPLETED|Dose Level 2||2
1639290|NCT00790842|4004680|P8|NOT COMPLETED|Dose Level 2||0
1639291|NCT00790842|4004681|P7|NOT COMPLETED|Dose Level 2||0
1639292|NCT00790842|4004682|P6|NOT COMPLETED|Dose Level 2||0
1639293|NCT00790842|4004683|P5|NOT COMPLETED|Dose Level 2||1
1639294|NCT00790842|4004684|P4|NOT COMPLETED|Dose Level 2||0
1639295|NCT00790842|4004685|P3|NOT COMPLETED|Dose Level 2||0
1639296|NCT00790842|4004686|P2|NOT COMPLETED|Dose Level 2||3
1639297|NCT00790842|4004687|P1|NOT COMPLETED|Dose Level 2||0
1639298|NCT00790842|4004677|P11|COMPLETED|Dose Level 2||0
1639299|NCT00790842|4004678|P10|COMPLETED|Dose Level 2||0
1639300|NCT00790842|4004679|P9|COMPLETED|Dose Level 2||1
1639301|NCT00790842|4004680|P8|COMPLETED|Dose Level 2||0
1639302|NCT00790842|4004681|P7|COMPLETED|Dose Level 2||0
1639303|NCT00790842|4004682|P6|COMPLETED|Dose Level 2||0
1639304|NCT00790842|4004683|P5|COMPLETED|Dose Level 2||2
1639305|NCT00790842|4004684|P4|COMPLETED|Dose Level 2||0
1639306|NCT00790842|4004685|P3|COMPLETED|Dose Level 2||0
1639307|NCT00790842|4004686|P2|COMPLETED|Dose Level 2||0
1639308|NCT00790842|4004687|P1|COMPLETED|Dose Level 2||0
1639309|NCT00790842|4004677|P11|Began Treatment|Dose Level 2||0
1639310|NCT00790842|4004678|P10|Began Treatment|Dose Level 2||0
1639311|NCT00790842|4004679|P9|Began Treatment|Dose Level 2||3
1639312|NCT00790842|4004680|P8|Began Treatment|Dose Level 2||0
1639313|NCT00790842|4004681|P7|Began Treatment|Dose Level 2||0
1639314|NCT00790842|4004682|P6|Began Treatment|Dose Level 2||0
1639315|NCT00790842|4004683|P5|Began Treatment|Dose Level 2||3
1639316|NCT00790842|4004684|P4|Began Treatment|Dose Level 2||0
1639317|NCT00790842|4004685|P3|Began Treatment|Dose Level 2||0
1639318|NCT00790842|4004686|P2|Began Treatment|Dose Level 2||3
1639319|NCT00790842|4004687|P1|Began Treatment|Dose Level 2||0
1639320|NCT00790842|4004677|P11|STARTED|Dose Level 2||0
1639321|NCT00790842|4004678|P10|STARTED|Dose Level 2||0
1639322|NCT00790842|4004679|P9|STARTED|Dose Level 2||3
1639323|NCT00790842|4004680|P8|STARTED|Dose Level 2||0
1639324|NCT00790842|4004681|P7|STARTED|Dose Level 2||0
1639325|NCT00790842|4004682|P6|STARTED|Dose Level 2||0
1639326|NCT00790842|4004683|P5|STARTED|Dose Level 2||3
1639327|NCT00790842|4004684|P4|STARTED|Dose Level 2||0
1639328|NCT00790842|4004685|P3|STARTED|Dose Level 2||0
1639329|NCT00790842|4004686|P2|STARTED|Dose Level 2||3
1639330|NCT00790842|4004687|P1|STARTED|Dose Level 2||0
1639331|NCT00790842|4004677|P11|NOT COMPLETED|Dose Level 1||0
1639332|NCT00790842|4004678|P10|NOT COMPLETED|Dose Level 1||0
1639333|NCT00790842|4004679|P9|NOT COMPLETED|Dose Level 1||0
1639334|NCT00790842|4004680|P8|NOT COMPLETED|Dose Level 1||2
1639335|NCT00790842|4004681|P7|NOT COMPLETED|Dose Level 1||0
1639336|NCT00790842|4004682|P6|NOT COMPLETED|Dose Level 1||0
1639337|NCT00790842|4004683|P5|NOT COMPLETED|Dose Level 1||0
1639338|NCT00790842|4004684|P4|NOT COMPLETED|Dose Level 1||2
1639339|NCT00790842|4004685|P3|NOT COMPLETED|Dose Level 1||0
1639340|NCT00790842|4004686|P2|NOT COMPLETED|Dose Level 1||0
1639341|NCT00790842|4004687|P1|NOT COMPLETED|Dose Level 1||3
1639342|NCT00790842|4004677|P11|COMPLETED|Dose Level 1||0
1639343|NCT00790842|4004678|P10|COMPLETED|Dose Level 1||0
1639344|NCT00790842|4004679|P9|COMPLETED|Dose Level 1||0
1639345|NCT00790842|4004680|P8|COMPLETED|Dose Level 1||1
1639346|NCT00790842|4004681|P7|COMPLETED|Dose Level 1||0
1639347|NCT00790842|4004682|P6|COMPLETED|Dose Level 1||0
1639348|NCT00790842|4004683|P5|COMPLETED|Dose Level 1||0
1639349|NCT00790842|4004684|P4|COMPLETED|Dose Level 1||1
1639350|NCT00790842|4004685|P3|COMPLETED|Dose Level 1||0
1639351|NCT00790842|4004686|P2|COMPLETED|Dose Level 1||0
1639352|NCT00790842|4004687|P1|COMPLETED|Dose Level 1||3
1639353|NCT00790842|4004677|P11|Began Treatment|Dose Level 1||0
1639354|NCT00790842|4004678|P10|Began Treatment|Dose Level 1||0
1639355|NCT00790842|4004679|P9|Began Treatment|Dose Level 1||0
1639356|NCT00790842|4004680|P8|Began Treatment|Dose Level 1||3
1639357|NCT00790842|4004681|P7|Began Treatment|Dose Level 1||0
1639358|NCT00790842|4004682|P6|Began Treatment|Dose Level 1||0
1639359|NCT00790842|4004683|P5|Began Treatment|Dose Level 1||0
1639360|NCT00790842|4004684|P4|Began Treatment|Dose Level 1||3
1639361|NCT00790842|4004685|P3|Began Treatment|Dose Level 1||0
1639362|NCT00790842|4004686|P2|Began Treatment|Dose Level 1||0
1639363|NCT00790842|4004687|P1|Began Treatment|Dose Level 1||6
1639364|NCT00790842|4004677|P11|STARTED|Dose Level 1||0
1639365|NCT00790842|4004678|P10|STARTED|Dose Level 1||0
1639366|NCT00790842|4004679|P9|STARTED|Dose Level 1||0
1639367|NCT00790842|4004680|P8|STARTED|Dose Level 1||3
1639368|NCT00790842|4004681|P7|STARTED|Dose Level 1||0
1639369|NCT00790842|4004682|P6|STARTED|Dose Level 1||0
1639370|NCT00790842|4004683|P5|STARTED|Dose Level 1||0
1639371|NCT00790842|4004684|P4|STARTED|Dose Level 1||3
1639372|NCT00790842|4004685|P3|STARTED|Dose Level 1||0
1639373|NCT00790842|4004686|P2|STARTED|Dose Level 1||0
1639374|NCT00790842|4004687|P1|STARTED|Dose Level 1||6
1639375|NCT00790803|4004744|P1|NOT COMPLETED|Overall Study||0
1639376|NCT00790803|4004744|P1|COMPLETED|Overall Study||5
1639377|NCT00790803|4004744|P1|STARTED|Overall Study||5
1639378|NCT00790790|4004755|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1639379|NCT00790790|4004756|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1639380|NCT00790790|4004757|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1639381|NCT00790790|4004755|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
1639382|NCT00790790|4004756|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
1639383|NCT00790790|4004757|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
1639384|NCT00790790|4004755|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
1639385|NCT00790790|4004756|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
1639386|NCT00790790|4004757|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
1639387|NCT00790790|4004755|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
1639388|NCT00790790|4004756|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
1639389|NCT00790790|4004757|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
1639390|NCT00790790|4004755|P3|COMPLETED|Study Period 2: Therapy Phase||27
1639391|NCT00790790|4004756|P2|COMPLETED|Study Period 2: Therapy Phase||32
1639392|NCT00790790|4004757|P1|COMPLETED|Study Period 2: Therapy Phase||37
1639393|NCT00790790|4004755|P3|STARTED|Study Period 2: Therapy Phase||48
1639394|NCT00790790|4004756|P2|STARTED|Study Period 2: Therapy Phase||50
1639395|NCT00790790|4004757|P1|STARTED|Study Period 2: Therapy Phase||49
1639396|NCT00790751|4004834|P4|NOT COMPLETED|Overall Study||21
1639397|NCT00790751|4004835|P3|NOT COMPLETED|Overall Study||20
1639398|NCT00790751|4004836|P2|NOT COMPLETED|Overall Study||30
1639399|NCT00790751|4004837|P1|NOT COMPLETED|Overall Study||25
1639400|NCT00790751|4004834|P4|COMPLETED|Overall Study||141
1639401|NCT00790751|4004835|P3|COMPLETED|Overall Study||141
1639402|NCT00790751|4004836|P2|COMPLETED|Overall Study||131
1639403|NCT00790751|4004837|P1|COMPLETED|Overall Study||137
1639404|NCT00790751|4004834|P4|STARTED|Overall Study||162
1639405|NCT00790751|4004835|P3|STARTED|Overall Study||161
1639406|NCT00790751|4004836|P2|STARTED|Overall Study||161
1639407|NCT00790751|4004837|P1|STARTED|Overall Study||162
1639408|NCT00790738|4004857|P2|NOT COMPLETED|Overall Study||3
1639409|NCT00790738|4004858|P1|NOT COMPLETED|Overall Study||2
1639410|NCT00790738|4004857|P2|COMPLETED|Overall Study||3
1639411|NCT00790738|4004858|P1|COMPLETED|Overall Study||3
1639412|NCT00790738|4004857|P2|STARTED|Overall Study||6
1639413|NCT00790738|4004858|P1|STARTED|Overall Study||5
1639414|NCT00790673|4004872|P4|NOT COMPLETED|Overall Study||0
1639415|NCT00790673|4004873|P3|NOT COMPLETED|Overall Study||0
1639416|NCT00790673|4004874|P2|NOT COMPLETED|Overall Study||0
1639417|NCT00790673|4004875|P1|NOT COMPLETED|Overall Study||0
1639418|NCT00790673|4004872|P4|COMPLETED|Overall Study||8
1639419|NCT00790673|4004873|P3|COMPLETED|Overall Study||12
1639420|NCT00790673|4004874|P2|COMPLETED|Overall Study||6
1639421|NCT00790673|4004875|P1|COMPLETED|Overall Study||6
1639422|NCT00790673|4004872|P4|STARTED|Overall Study||8
1639423|NCT00790673|4004873|P3|STARTED|Overall Study||12
1639424|NCT00790673|4004874|P2|STARTED|Overall Study||6
1639425|NCT00790673|4004875|P1|STARTED|Overall Study||6
1639426|NCT00790647|4004885|P1|NOT COMPLETED|Overall Study||1
1639427|NCT00790647|4004885|P1|COMPLETED|Overall Study||9
1639428|NCT00790647|4004885|P1|STARTED|Overall Study||10
1639429|NCT00790569|4004895|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
1639430|NCT00790569|4004896|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
1639431|NCT00790569|4004897|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
1639432|NCT00790569|4004895|P3|COMPLETED|End of Study (12 Month Interview)||83
1639433|NCT00790569|4004896|P2|COMPLETED|End of Study (12 Month Interview)||26
1639434|NCT00790569|4004897|P1|COMPLETED|End of Study (12 Month Interview)||71
1639435|NCT00790569|4004895|P3|STARTED|End of Study (12 Month Interview)||133
1639436|NCT00790569|4004896|P2|STARTED|End of Study (12 Month Interview)||45
1639437|NCT00790569|4004897|P1|STARTED|End of Study (12 Month Interview)||137
1639438|NCT00790569|4004895|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
1639439|NCT00790569|4004896|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
1639440|NCT00790569|4004897|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
1639441|NCT00790569|4004895|P3|COMPLETED|End of Treatment (6 Month Interview)||107
1639442|NCT00790569|4004896|P2|COMPLETED|End of Treatment (6 Month Interview)||35
1639443|NCT00790569|4004897|P1|COMPLETED|End of Treatment (6 Month Interview)||115
1639444|NCT00790569|4004895|P3|STARTED|End of Treatment (6 Month Interview)||133
1639445|NCT00790569|4004896|P2|STARTED|End of Treatment (6 Month Interview)||45
1639446|NCT00790569|4004897|P1|STARTED|End of Treatment (6 Month Interview)||137
1639447|NCT00790556|4004938|P2|NOT COMPLETED|Treatment Period 2||0
1639448|NCT00790556|4004939|P1|NOT COMPLETED|Treatment Period 2||0
1639449|NCT00790556|4004938|P2|COMPLETED|Treatment Period 2||6
1639450|NCT00790556|4004939|P1|COMPLETED|Treatment Period 2||6
1639451|NCT00790556|4004938|P2|STARTED|Treatment Period 2||6
1639452|NCT00790556|4004939|P1|STARTED|Treatment Period 2||6
1639453|NCT00790556|4004938|P2|NOT COMPLETED|Washout After Period 1||0
1639454|NCT00790556|4004939|P1|NOT COMPLETED|Washout After Period 1||0
1639455|NCT00790556|4004938|P2|COMPLETED|Washout After Period 1||6
1639456|NCT00790556|4004939|P1|COMPLETED|Washout After Period 1||6
1639457|NCT00790556|4004938|P2|STARTED|Washout After Period 1||6
1639458|NCT00790556|4004939|P1|STARTED|Washout After Period 1||6
1639459|NCT00790556|4004938|P2|NOT COMPLETED|Treatment Period 1||0
1639460|NCT00790556|4004939|P1|NOT COMPLETED|Treatment Period 1||2
1639461|NCT00790556|4004938|P2|COMPLETED|Treatment Period 1||6
1639462|NCT00790556|4004939|P1|COMPLETED|Treatment Period 1||6
1639463|NCT00790556|4004938|P2|STARTED|Treatment Period 1||6
1639464|NCT00790556|4004939|P1|STARTED|Treatment Period 1||8
1639465|NCT00790452|4004951|P2|NOT COMPLETED|Overall Study||0
1639466|NCT00790452|4004952|P1|NOT COMPLETED|Overall Study||1
1639467|NCT00790452|4004951|P2|COMPLETED|Overall Study||0
1639468|NCT00790452|4004952|P1|COMPLETED|Overall Study||0
1639469|NCT00790452|4004951|P2|STARTED|Overall Study||0
1639470|NCT00790452|4004952|P1|STARTED|Overall Study||1
1639471|NCT00790400|4004960|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
1639472|NCT00790400|4004961|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
1639473|NCT00790400|4004960|P2|COMPLETED|Everolimus Period (Core or Extension)||0
1639474|NCT00790400|4004961|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
1639475|NCT00790400|4004960|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
1639476|NCT00790400|4004961|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
1639477|NCT00790400|4004960|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
1639478|NCT00790400|4004961|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
1639479|NCT00790400|4004960|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
1639480|NCT00790400|4004961|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
1639481|NCT00790400|4004960|P2|STARTED|Double-blind Period (Core Phase)||39
1639482|NCT00790400|4004961|P1|STARTED|Double-blind Period (Core Phase)||79
1639483|NCT00790335|4004990|P2|NOT COMPLETED|Overall Study||112
1639484|NCT00790335|4004991|P1|NOT COMPLETED|Overall Study||80
1639485|NCT00790335|4004990|P2|COMPLETED|Overall Study||243
1639486|NCT00790335|4004991|P1|COMPLETED|Overall Study||257
1639487|NCT00790335|4004990|P2|STARTED|Overall Study||355
1639488|NCT00790335|4004991|P1|STARTED|Overall Study||337
1639489|NCT00790296|4005051|P2|NOT COMPLETED|Overall Study||2
1639490|NCT00790296|4005052|P1|NOT COMPLETED|Overall Study||1
1639491|NCT00790296|4005051|P2|COMPLETED|Overall Study||4
1639492|NCT00790296|4005052|P1|COMPLETED|Overall Study||4
1639493|NCT00790296|4005051|P2|STARTED|Overall Study||6
1639494|NCT00790296|4005052|P1|STARTED|Overall Study||5
1639495|NCT00790270|4005061|P3|NOT COMPLETED|Overall Study||0
1639496|NCT00790270|4005062|P2|NOT COMPLETED|Overall Study||0
1639497|NCT00790270|4005063|P1|NOT COMPLETED|Overall Study||0
1639498|NCT00790270|4005061|P3|COMPLETED|Overall Study||20
1639499|NCT00790270|4005062|P2|COMPLETED|Overall Study||20
1639500|NCT00790270|4005063|P1|COMPLETED|Overall Study||21
1639501|NCT00790270|4005061|P3|STARTED|Overall Study||20
1639502|NCT00790270|4005062|P2|STARTED|Overall Study||20
1639503|NCT00790270|4005063|P1|STARTED|Overall Study||21
1639504|NCT00790218|4005074|P3|NOT COMPLETED|Overall Study||0
1639505|NCT00790218|4005075|P2|NOT COMPLETED|Overall Study||0
1639506|NCT00790218|4005076|P1|NOT COMPLETED|Overall Study||1
1639507|NCT00790218|4005074|P3|COMPLETED|Overall Study||7
1639508|NCT00790218|4005075|P2|COMPLETED|Overall Study||6
1639509|NCT00790218|4005076|P1|COMPLETED|Overall Study||5
1639510|NCT00790218|4005074|P3|STARTED|Overall Study||7
1639511|NCT00790218|4005075|P2|STARTED|Overall Study||6
1639512|NCT00790218|4005076|P1|STARTED|Overall Study||6
1639513|NCT00790205|4005086|P2|NOT COMPLETED|Overall Study||434
1639514|NCT00790205|4005087|P1|NOT COMPLETED|Overall Study||360
1639515|NCT00790205|4005086|P2|COMPLETED|Overall Study||6905
1639516|NCT00790205|4005087|P1|COMPLETED|Overall Study||6972
1639517|NCT00790205|4005086|P2|Treated|Overall Study||7274
1639518|NCT00790205|4005087|P1|Treated|Overall Study||7266
1639519|NCT00790205|4005086|P2|STARTED|Overall Study||7339
1639520|NCT00790205|4005087|P1|STARTED|Overall Study||7332
1639521|NCT00790192|4005131|P4|NOT COMPLETED|Overall Study||48
1639522|NCT00790192|4005132|P3|NOT COMPLETED|Overall Study||23
1639523|NCT00790192|4005133|P2|NOT COMPLETED|Overall Study||28
1639524|NCT00790192|4005134|P1|NOT COMPLETED|Overall Study||36
1639525|NCT00790192|4005131|P4|COMPLETED|Overall Study||74
1639526|NCT00790192|4005132|P3|COMPLETED|Overall Study||97
1639527|NCT00790192|4005133|P2|COMPLETED|Overall Study||93
1639528|NCT00790192|4005134|P1|COMPLETED|Overall Study||89
1639529|NCT00790192|4005131|P4|STARTED|Overall Study||122
1639530|NCT00790192|4005132|P3|STARTED|Overall Study||120
1639531|NCT00790192|4005133|P2|STARTED|Overall Study||121
1639532|NCT00790192|4005134|P1|STARTED|Overall Study||125
1639533|NCT00790062|4005151|P3|NOT COMPLETED|Overall Study||0
1639534|NCT00790062|4005152|P2|NOT COMPLETED|Overall Study||0
1639535|NCT00790062|4005153|P1|NOT COMPLETED|Overall Study||0
1639536|NCT00790062|4005151|P3|COMPLETED|Overall Study||658
1639537|NCT00790062|4005152|P2|COMPLETED|Overall Study||481
1639538|NCT00790062|4005153|P1|COMPLETED|Overall Study||659
1639539|NCT00790062|4005151|P3|STARTED|Overall Study||658
1639540|NCT00790062|4005152|P2|STARTED|Overall Study||481
1639541|NCT00790062|4005153|P1|STARTED|Overall Study||659
1639542|NCT00790036|4005184|P2|NOT COMPLETED|Overall Study||121
1639543|NCT00790036|4005185|P1|NOT COMPLETED|Overall Study||195
1639544|NCT00790036|4005184|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
1639545|NCT00790036|4005185|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
1639546|NCT00790036|4005184|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
1639547|NCT00790036|4005185|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
1639548|NCT00790036|4005184|P2|STARTED|Overall Study||370
1639549|NCT00790036|4005185|P1|STARTED|Overall Study||372
1639550|NCT00790023|4005199|P3|NOT COMPLETED|Overall Study||21
1639551|NCT00790023|4005200|P2|NOT COMPLETED|Overall Study||10
1639552|NCT00790023|4005201|P1|NOT COMPLETED|Overall Study||11
1639553|NCT00790023|4005199|P3|COMPLETED|Overall Study||214
1639554|NCT00790023|4005200|P2|COMPLETED|Overall Study||225
1639555|NCT00790023|4005201|P1|COMPLETED|Overall Study||226
1639556|NCT00790023|4005199|P3|STARTED|Overall Study||235
1639557|NCT00790023|4005200|P2|STARTED|Overall Study||235
1639558|NCT00790023|4005201|P1|STARTED|Overall Study||237
1639559|NCT00789997|4005291|P2|NOT COMPLETED|Overall Study||2
1639560|NCT00789997|4005292|P1|NOT COMPLETED|Overall Study||1
1639561|NCT00789997|4005291|P2|COMPLETED|Overall Study||38
1639562|NCT00789997|4005292|P1|COMPLETED|Overall Study||40
1639563|NCT00789997|4005291|P2|STARTED|Overall Study||40
1639564|NCT00789997|4005292|P1|STARTED|Overall Study||41
1639565|NCT00789958|4005300|P1|NOT COMPLETED|Overall Study||37
1639566|NCT00789958|4005300|P1|COMPLETED|Overall Study||68
1639567|NCT00789958|4005300|P1|Eligible and Analyzable|Overall Study||79
1639568|NCT00789958|4005300|P1|STARTED|Overall Study||105
1639569|NCT00789880|4005319|P6|NOT COMPLETED|Overall Study||0
1639570|NCT00789880|4005320|P5|NOT COMPLETED|Overall Study||3
1639571|NCT00789880|4005321|P4|NOT COMPLETED|Overall Study||1
1639572|NCT00789880|4005322|P3|NOT COMPLETED|Overall Study||0
1639573|NCT00789880|4005323|P2|NOT COMPLETED|Overall Study||1
1639574|NCT00789880|4005324|P1|NOT COMPLETED|Overall Study||1
1639575|NCT00789880|4005319|P6|COMPLETED|Overall Study||8
1639576|NCT00789880|4005320|P5|COMPLETED|Overall Study||15
1639577|NCT00789880|4005321|P4|COMPLETED|Overall Study||15
1639578|NCT00789880|4005322|P3|COMPLETED|Overall Study||8
1639579|NCT00789880|4005323|P2|COMPLETED|Overall Study||15
1639580|NCT00789880|4005324|P1|COMPLETED|Overall Study||15
1639581|NCT00789880|4005319|P6|STARTED|Overall Study||8
1639582|NCT00789880|4005320|P5|STARTED|Overall Study||18
1639583|NCT00789880|4005321|P4|STARTED|Overall Study||16
1639584|NCT00789880|4005322|P3|STARTED|Overall Study||8
1639585|NCT00789880|4005323|P2|STARTED|Overall Study||16
1639586|NCT00789880|4005324|P1|STARTED|Overall Study||16
1639587|NCT00789854|4005353|P3|NOT COMPLETED|Overall Study||47
1639588|NCT00789854|4005354|P2|NOT COMPLETED|Overall Study||35
1639589|NCT00789854|4005355|P1|NOT COMPLETED|Overall Study||49
1639590|NCT00789854|4005353|P3|COMPLETED|Overall Study||182
1639591|NCT00789854|4005354|P2|COMPLETED|Overall Study||196
1639592|NCT00789854|4005355|P1|COMPLETED|Overall Study||179
1639593|NCT00789854|4005353|P3|STARTED|Overall Study||229
1639594|NCT00789854|4005354|P2|STARTED|Overall Study||231
1639595|NCT00789854|4005355|P1|STARTED|Overall Study||228
1639596|NCT00789828|4005452|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
1639597|NCT00789828|4005453|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
1639598|NCT00789828|4005452|P2|COMPLETED|Open-label Extension Period (4 Years)||0
1639599|NCT00789828|4005453|P1|COMPLETED|Open-label Extension Period (4 Years)||82
1639600|NCT00789828|4005452|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
1639601|NCT00789828|4005453|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
1639602|NCT00789828|4005452|P2|NOT COMPLETED|Core Period (48 Weeks)||6
1639603|NCT00789828|4005453|P1|NOT COMPLETED|Core Period (48 Weeks)||0
1639604|NCT00789828|4005452|P2|COMPLETED|Core Period (48 Weeks)||33
1639605|NCT00789828|4005453|P1|COMPLETED|Core Period (48 Weeks)||78
1639606|NCT00789828|4005452|P2|STARTED|Core Period (48 Weeks)||39
1639607|NCT00789828|4005453|P1|STARTED|Core Period (48 Weeks)||78
1639608|NCT00789815|4005487|P2|NOT COMPLETED|Overall Study||1
1639609|NCT00789815|4005488|P1|NOT COMPLETED|Overall Study||7
1639610|NCT00789815|4005487|P2|COMPLETED|Overall Study||249
1639611|NCT00789815|4005488|P1|COMPLETED|Overall Study||243
1639612|NCT00789815|4005487|P2|STARTED|Overall Study||250
1639613|NCT00789815|4005488|P1|STARTED|Overall Study||250
1639614|NCT00789802|4005511|P3|NOT COMPLETED|Overall Study||6
1639615|NCT00789802|4005512|P2|NOT COMPLETED|Overall Study||7
1639616|NCT00789802|4005513|P1|NOT COMPLETED|Overall Study||10
1639617|NCT00789802|4005511|P3|COMPLETED|Overall Study||37
1639618|NCT00789802|4005512|P2|COMPLETED|Overall Study||35
1639619|NCT00789802|4005513|P1|COMPLETED|Overall Study||34
1639620|NCT00789802|4005511|P3|STARTED|Overall Study||43
1639621|NCT00789802|4005512|P2|STARTED|Overall Study||42
1639622|NCT00789802|4005513|P1|STARTED|Overall Study||44
1639623|NCT00789776|4005532|P2|NOT COMPLETED|Overall Study||1
1639624|NCT00789776|4005533|P1|NOT COMPLETED|Overall Study||0
1639625|NCT00789776|4005532|P2|COMPLETED|Overall Study||35
1639626|NCT00789776|4005533|P1|COMPLETED|Overall Study||5
1639627|NCT00789776|4005532|P2|STARTED|Overall Study||36
1639628|NCT00789776|4005533|P1|STARTED|Overall Study||5
1639629|NCT00789750|4005553|P2|NOT COMPLETED|Overall Study||60
1639630|NCT00789750|4005554|P1|NOT COMPLETED|Overall Study||59
1639631|NCT00789750|4005553|P2|COMPLETED|Overall Study||222
1639632|NCT00789750|4005554|P1|COMPLETED|Overall Study||221
1639633|NCT00789750|4005553|P2|Intent to Treat Set|Overall Study||276
1639634|NCT00789750|4005554|P1|Intent to Treat Set|Overall Study||271
1639635|NCT00789750|4005553|P2|Safety Set|Overall Study||277
1639636|NCT00789750|4005554|P1|Safety Set|Overall Study||274
1639637|NCT00789750|4005553|P2|Dropped During run-in Period|Overall Study||5
1639638|NCT00789750|4005554|P1|Dropped During run-in Period|Overall Study||6
1639639|NCT00789750|4005553|P2|STARTED|Overall Study||282
1639640|NCT00789750|4005554|P1|STARTED|Overall Study||280
1639641|NCT00789737|4005598|P2|NOT COMPLETED|Overall Study||55
1639642|NCT00789737|4005599|P1|NOT COMPLETED|Overall Study||48
1639643|NCT00789737|4005598|P2|COMPLETED|Overall Study||126
1639644|NCT00789737|4005599|P1|COMPLETED|Overall Study||128
1639645|NCT00789737|4005598|P2|STARTED|Overall Study||181
1639646|NCT00789737|4005599|P1|STARTED|Overall Study||176
1639647|NCT00789724|4005631|P2|NOT COMPLETED|Overall Study||0
1639648|NCT00789724|4005632|P1|NOT COMPLETED|Overall Study||0
1639649|NCT00789724|4005631|P2|COMPLETED|Overall Study||5
1639650|NCT00789724|4005632|P1|COMPLETED|Overall Study||5
1639651|NCT00789724|4005631|P2|STARTED|Overall Study||5
1639652|NCT00789724|4005632|P1|STARTED|Overall Study||5
1639653|NCT00789698|4005642|P4|NOT COMPLETED|Overall Study||52
1639654|NCT00789698|4005643|P3|NOT COMPLETED|Overall Study||27
1639655|NCT00789698|4005644|P2|NOT COMPLETED|Overall Study||33
1639656|NCT00789698|4005645|P1|NOT COMPLETED|Overall Study||40
1639657|NCT00789698|4005642|P4|COMPLETED|Overall Study||33
1639658|NCT00789698|4005643|P3|COMPLETED|Overall Study||29
1639659|NCT00789698|4005644|P2|COMPLETED|Overall Study||46
1639660|NCT00789698|4005645|P1|COMPLETED|Overall Study||32
1639661|NCT00789698|4005642|P4|STARTED|Overall Study||85
1639662|NCT00789698|4005643|P3|STARTED|Overall Study||56
1639663|NCT00789698|4005644|P2|STARTED|Overall Study||79
1639664|NCT00789698|4005645|P1|STARTED|Overall Study||72
1639665|NCT00789685|4005659|P1|NOT COMPLETED|Overall Study||12
1639666|NCT00789685|4005659|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
1639667|NCT00789685|4005659|P1|STARTED|Overall Study||37
1639668|NCT00789672|4005667|P2|NOT COMPLETED|Overall Study||0
1639669|NCT00789672|4005668|P1|NOT COMPLETED|Overall Study||0
1639670|NCT00789672|4005667|P2|COMPLETED|Overall Study||17
1639671|NCT00789672|4005668|P1|COMPLETED|Overall Study||16
1639672|NCT00789672|4005667|P2|STARTED|Overall Study||17
1639673|NCT00789672|4005668|P1|STARTED|Overall Study||16
1639674|NCT00789581|4005700|P2|NOT COMPLETED|Adjuvant Therapy||57
1639675|NCT00789581|4005701|P1|NOT COMPLETED|Adjuvant Therapy||40
1639676|NCT00789581|4005700|P2|COMPLETED|Adjuvant Therapy||234
1639677|NCT00789581|4005701|P1|COMPLETED|Adjuvant Therapy||255
1639678|NCT00789581|4005700|P2|STARTED|Adjuvant Therapy||291
1639679|NCT00789581|4005701|P1|STARTED|Adjuvant Therapy||295
1639680|NCT00789581|4005700|P2|NOT COMPLETED|AC Therapy||17
1639681|NCT00789581|4005701|P1|NOT COMPLETED|AC Therapy||11
1639682|NCT00789581|4005700|P2|COMPLETED|AC Therapy||291
1639683|NCT00789581|4005701|P1|COMPLETED|AC Therapy||295
1639684|NCT00789581|4005700|P2|STARTED|AC Therapy||308
1639685|NCT00789581|4005701|P1|STARTED|AC Therapy||306
1639686|NCT00789555|4005712|P3|NOT COMPLETED|Overall Study||159
1639687|NCT00789555|4005713|P2|NOT COMPLETED|Overall Study||139
1639688|NCT00789555|4005714|P1|NOT COMPLETED|Overall Study||159
1639689|NCT00789555|4005712|P3|COMPLETED|Overall Study||263
1639690|NCT00789555|4005713|P2|COMPLETED|Overall Study||278
1639691|NCT00789555|4005714|P1|COMPLETED|Overall Study||262
1639692|NCT00789555|4005712|P3|STARTED|Overall Study||422
1639693|NCT00789555|4005713|P2|STARTED|Overall Study||417
1639694|NCT00789555|4005714|P1|STARTED|Overall Study||421
1639695|NCT00789529|4005739|P2|NOT COMPLETED|Overall Study||1
1639696|NCT00789529|4005740|P1|NOT COMPLETED|Overall Study||1
1639697|NCT00789529|4005739|P2|COMPLETED|Overall Study||15
1639698|NCT00789529|4005740|P1|COMPLETED|Overall Study||15
1639699|NCT00789529|4005739|P2|STARTED|Overall Study||16
1639700|NCT00789529|4005740|P1|STARTED|Overall Study||16
1639701|NCT00789477|4005753|P5|NOT COMPLETED|Overall Study||7
1639702|NCT00789477|4005754|P4|NOT COMPLETED|Overall Study||10
1639703|NCT00789477|4005755|P3|NOT COMPLETED|Overall Study||11
1639704|NCT00789477|4005756|P2|NOT COMPLETED|Overall Study||6
1639705|NCT00789477|4005757|P1|NOT COMPLETED|Overall Study||11
1639706|NCT00789477|4005753|P5|COMPLETED|Overall Study||38
1639707|NCT00789477|4005754|P4|COMPLETED|Overall Study||34
1639708|NCT00789477|4005755|P3|COMPLETED|Overall Study||33
1639709|NCT00789477|4005756|P2|COMPLETED|Overall Study||38
1639710|NCT00789477|4005757|P1|COMPLETED|Overall Study||33
1639711|NCT00789477|4005753|P5|Participants Received Treatment|Overall Study|SAF|45
1639712|NCT00789477|4005754|P4|Participants Received Treatment|Overall Study|SAF|42
1639713|NCT00789477|4005755|P3|Participants Received Treatment|Overall Study|SAF|44
1639714|NCT00789477|4005756|P2|Participants Received Treatment|Overall Study|SAF|44
1639715|NCT00789477|4005757|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
1639716|NCT00789477|4005753|P5|STARTED|Overall Study|randomized|45
1639717|NCT00789477|4005754|P4|STARTED|Overall Study|randomized|44
1639718|NCT00789477|4005755|P3|STARTED|Overall Study|randomized|44
1639719|NCT00789477|4005756|P2|STARTED|Overall Study|randomized|44
1639720|NCT00789477|4005757|P1|STARTED|Overall Study|randomized|44
1639721|NCT00789438|4005792|P3|NOT COMPLETED|Overall Study||0
1639722|NCT00789438|4005793|P2|NOT COMPLETED|Overall Study||0
1639723|NCT00789438|4005794|P1|NOT COMPLETED|Overall Study||0
1639724|NCT00789438|4005792|P3|COMPLETED|Overall Study||28
1639725|NCT00789438|4005793|P2|COMPLETED|Overall Study||20
1639726|NCT00789438|4005794|P1|COMPLETED|Overall Study||21
1639727|NCT00789438|4005792|P3|STARTED|Overall Study||28
1639728|NCT00789438|4005793|P2|STARTED|Overall Study||20
1639729|NCT00789438|4005794|P1|STARTED|Overall Study||21
1639730|NCT00789373|4005802|P3|NOT COMPLETED|Maintenance||180
1639731|NCT00789373|4005803|P2|NOT COMPLETED|Maintenance||359
1639732|NCT00789373|4005804|P1|NOT COMPLETED|Maintenance||0
1639733|NCT00789373|4005802|P3|COMPLETED|Maintenance||0
1639734|NCT00789373|4005803|P2|COMPLETED|Maintenance||0
1639735|NCT00789373|4005804|P1|COMPLETED|Maintenance||0
1639736|NCT00789373|4005802|P3|STARTED|Maintenance||180
1639737|NCT00789373|4005803|P2|STARTED|Maintenance||359
1639738|NCT00789373|4005804|P1|STARTED|Maintenance||0
1639739|NCT00789373|4005802|P3|NOT COMPLETED|Induction||0
1639740|NCT00789373|4005803|P2|NOT COMPLETED|Induction||0
1639741|NCT00789373|4005804|P1|NOT COMPLETED|Induction||399
1639742|NCT00789373|4005802|P3|COMPLETED|Induction||0
1639743|NCT00789373|4005803|P2|COMPLETED|Induction||0
1639744|NCT00789373|4005804|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
1639745|NCT00789373|4005802|P3|STARTED|Induction||0
1639746|NCT00789373|4005803|P2|STARTED|Induction||0
1639747|NCT00789373|4005804|P1|STARTED|Induction||939
1639748|NCT00789321|4005831|P2|NOT COMPLETED|Overall Study||1
1639749|NCT00789321|4005832|P1|NOT COMPLETED|Overall Study||0
1639750|NCT00789321|4005831|P2|COMPLETED|Overall Study||22
1639751|NCT00789321|4005832|P1|COMPLETED|Overall Study||24
1639752|NCT00789321|4005831|P2|STARTED|Overall Study||23
1639753|NCT00789321|4005832|P1|STARTED|Overall Study||24
1639754|NCT00789256|4005842|P2|NOT COMPLETED|Overall Study||0
1639755|NCT00789256|4005843|P1|NOT COMPLETED|Overall Study||0
1639756|NCT00789256|4005842|P2|COMPLETED|Overall Study||12
1639757|NCT00789256|4005843|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
1639758|NCT00789256|4005842|P2|STARTED|Overall Study||12
1639759|NCT00789256|4005843|P1|STARTED|Overall Study||14
1639760|NCT00789191|4005854|P2|NOT COMPLETED|Overall Study||19
1639761|NCT00789191|4005855|P1|NOT COMPLETED|Overall Study||14
1639762|NCT00789191|4005854|P2|COMPLETED|Overall Study||92
1639763|NCT00789191|4005855|P1|COMPLETED|Overall Study||97
1639764|NCT00789191|4005854|P2|Exposed|Overall Study|1 non-compliance|110
1639765|NCT00789191|4005855|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
1639766|NCT00789191|4005854|P2|STARTED|Overall Study||111
1639767|NCT00789191|4005855|P1|STARTED|Overall Study||111
1639768|NCT00789113|4005883|P1|NOT COMPLETED|Overall Study||0
1639769|NCT00789113|4005883|P1|COMPLETED|Overall Study||12
1639770|NCT00789113|4005883|P1|STARTED|Overall Study||12
1639771|NCT00789074|4005890|P2|NOT COMPLETED|Overall Study||13
1639772|NCT00789074|4005891|P1|NOT COMPLETED|Overall Study||11
1639773|NCT00789074|4005890|P2|COMPLETED|Overall Study||35
1639774|NCT00789074|4005891|P1|COMPLETED|Overall Study||42
1639775|NCT00789074|4005890|P2|STARTED|Overall Study||48
1639776|NCT00789074|4005891|P1|STARTED|Overall Study||53
1639777|NCT00789035|4005912|P5|NOT COMPLETED|Overall Study||6
1639778|NCT00789035|4005913|P4|NOT COMPLETED|Overall Study||1
1639779|NCT00789035|4005914|P3|NOT COMPLETED|Overall Study||1
1639780|NCT00789035|4005915|P2|NOT COMPLETED|Overall Study||7
1639781|NCT00789035|4005916|P1|NOT COMPLETED|Overall Study||6
1639782|NCT00789035|4005912|P5|COMPLETED|Overall Study||74
1639783|NCT00789035|4005913|P4|COMPLETED|Overall Study||81
1639784|NCT00789035|4005914|P3|COMPLETED|Overall Study||80
1639785|NCT00789035|4005915|P2|COMPLETED|Overall Study||74
1639786|NCT00789035|4005916|P1|COMPLETED|Overall Study||76
1639787|NCT00789035|4005912|P5|STARTED|Overall Study||80
1639788|NCT00789035|4005913|P4|STARTED|Overall Study||82
1639789|NCT00789035|4005914|P3|STARTED|Overall Study||81
1639790|NCT00789035|4005915|P2|STARTED|Overall Study||81
1639791|NCT00789035|4005916|P1|STARTED|Overall Study||82
1639792|NCT00788957|4005975|P6|NOT COMPLETED|Part 3||11
1639793|NCT00788957|4005976|P5|NOT COMPLETED|Part 3||9
1639794|NCT00788957|4005977|P4|NOT COMPLETED|Part 3||0
1639795|NCT00788957|4005978|P3|NOT COMPLETED|Part 3||0
1639796|NCT00788957|4005979|P2|NOT COMPLETED|Part 3||0
1639797|NCT00788957|4005980|P1|NOT COMPLETED|Part 3||0
1639798|NCT00788957|4005975|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
1639799|NCT00788957|4005976|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
1639800|NCT00788957|4005977|P4|COMPLETED|Part 3||0
1639801|NCT00788957|4005978|P3|COMPLETED|Part 3||0
1639802|NCT00788957|4005979|P2|COMPLETED|Part 3||0
1639803|NCT00788957|4005980|P1|COMPLETED|Part 3||0
1639804|NCT00788957|4005975|P6|STARTED|Part 3||12
1639805|NCT00788957|4005976|P5|STARTED|Part 3||13
1639806|NCT00788957|4005977|P4|STARTED|Part 3||0
1639807|NCT00788957|4005978|P3|STARTED|Part 3||0
1639808|NCT00788957|4005979|P2|STARTED|Part 3||0
1639809|NCT00788957|4005980|P1|STARTED|Part 3||0
1639810|NCT00788957|4005975|P6|NOT COMPLETED|Part 2||0
1639811|NCT00788957|4005976|P5|NOT COMPLETED|Part 2||0
1639812|NCT00788957|4005977|P4|NOT COMPLETED|Part 2||41
1639813|NCT00788957|4005978|P3|NOT COMPLETED|Part 2||44
1639814|NCT00788957|4005979|P2|NOT COMPLETED|Part 2||42
1639815|NCT00788957|4005980|P1|NOT COMPLETED|Part 2||0
1639816|NCT00788957|4005975|P6|COMPLETED|Part 2||0
1639817|NCT00788957|4005976|P5|COMPLETED|Part 2||0
1639818|NCT00788957|4005977|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
1639819|NCT00788957|4005978|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
1639820|NCT00788957|4005979|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
1639821|NCT00788957|4005980|P1|COMPLETED|Part 2||0
1639822|NCT00788957|4005975|P6|STARTED|Part 2||0
1639823|NCT00788957|4005976|P5|STARTED|Part 2||0
1639824|NCT00788957|4005977|P4|STARTED|Part 2||46
1639825|NCT00788957|4005978|P3|STARTED|Part 2||48
1639826|NCT00788957|4005979|P2|STARTED|Part 2||48
1639827|NCT00788957|4005980|P1|STARTED|Part 2||0
1639828|NCT00788957|4005975|P6|NOT COMPLETED|Part 1||0
1639829|NCT00788957|4005976|P5|NOT COMPLETED|Part 1||0
1639830|NCT00788957|4005977|P4|NOT COMPLETED|Part 1||0
1639831|NCT00788957|4005978|P3|NOT COMPLETED|Part 1||0
1639832|NCT00788957|4005979|P2|NOT COMPLETED|Part 1||0
1639833|NCT00788957|4005980|P1|NOT COMPLETED|Part 1||9
1639834|NCT00788957|4005975|P6|COMPLETED|Part 1||0
1639835|NCT00788957|4005976|P5|COMPLETED|Part 1||0
1639836|NCT00788957|4005977|P4|COMPLETED|Part 1||0
1639837|NCT00788957|4005978|P3|COMPLETED|Part 1||0
1639838|NCT00788957|4005979|P2|COMPLETED|Part 1||0
1639839|NCT00788957|4005980|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
1639840|NCT00788957|4005975|P6|STARTED|Part 1||0
1639841|NCT00788957|4005976|P5|STARTED|Part 1||0
1639842|NCT00788957|4005977|P4|STARTED|Part 1||0
1639843|NCT00788957|4005978|P3|STARTED|Part 1||0
1639844|NCT00788957|4005979|P2|STARTED|Part 1||0
1639845|NCT00788957|4005980|P1|STARTED|Part 1||11
1639846|NCT00788892|4006036|P2|NOT COMPLETED|Overall Study||23
1639847|NCT00788892|4006037|P1|NOT COMPLETED|Overall Study||49
1639848|NCT00788892|4006036|P2|COMPLETED|Overall Study||18
1639849|NCT00788892|4006037|P1|COMPLETED|Overall Study||36
1639850|NCT00788892|4006036|P2|STARTED|Overall Study||41
1639851|NCT00788892|4006037|P1|STARTED|Overall Study||85
1639852|NCT00788775|4006055|P2|NOT COMPLETED|Overall Study||8
1639853|NCT00788775|4006056|P1|NOT COMPLETED|Overall Study||10
1639854|NCT00788775|4006055|P2|COMPLETED|Overall Study||1
1639855|NCT00788775|4006056|P1|COMPLETED|Overall Study||1
1639856|NCT00788775|4006055|P2|Treated|Overall Study||8
1639857|NCT00788775|4006056|P1|Treated|Overall Study||11
1639858|NCT00788775|4006055|P2|STARTED|Overall Study||9
1639859|NCT00788775|4006056|P1|STARTED|Overall Study||11
1639860|NCT00788710|4006071|P3|NOT COMPLETED|Overall Study||6
1639861|NCT00788710|4006072|P2|NOT COMPLETED|Overall Study||8
1639862|NCT00788710|4006073|P1|NOT COMPLETED|Overall Study||5
1639863|NCT00788710|4006071|P3|COMPLETED|Overall Study||138
1639864|NCT00788710|4006072|P2|COMPLETED|Overall Study||134
1639865|NCT00788710|4006073|P1|COMPLETED|Overall Study||139
1639866|NCT00788710|4006071|P3|STARTED|Overall Study||144
1639867|NCT00788710|4006072|P2|STARTED|Overall Study||142
1639868|NCT00788710|4006073|P1|STARTED|Overall Study||144
1639869|NCT00788697|4006087|P1|NOT COMPLETED|Overall Study||109
1639870|NCT00788697|4006087|P1|COMPLETED|Overall Study||240
1639871|NCT00788697|4006087|P1|STARTED|Overall Study||349
1639872|NCT00788593|4006134|P3|NOT COMPLETED|Second Intervention Period||1
1639873|NCT00788593|4006135|P2|NOT COMPLETED|Second Intervention Period||1
1639874|NCT00788593|4006136|P1|NOT COMPLETED|Second Intervention Period||0
1639875|NCT00788593|4006134|P3|COMPLETED|Second Intervention Period||36
1639876|NCT00788593|4006135|P2|COMPLETED|Second Intervention Period||37
1639877|NCT00788593|4006136|P1|COMPLETED|Second Intervention Period||0
1639878|NCT00788593|4006134|P3|STARTED|Second Intervention Period||37
1639879|NCT00788593|4006135|P2|STARTED|Second Intervention Period||38
1639880|NCT00788593|4006136|P1|STARTED|Second Intervention Period||0
1639881|NCT00788593|4006134|P3|NOT COMPLETED|First Intervention Period||0
1639882|NCT00788593|4006135|P2|NOT COMPLETED|First Intervention Period||1
1639883|NCT00788593|4006136|P1|NOT COMPLETED|First Intervention Period||0
1639884|NCT00788593|4006134|P3|COMPLETED|First Intervention Period||37
1639885|NCT00788593|4006135|P2|COMPLETED|First Intervention Period||38
1639886|NCT00788593|4006136|P1|COMPLETED|First Intervention Period||0
1639887|NCT00788593|4006134|P3|STARTED|First Intervention Period||37
1639888|NCT00788593|4006135|P2|STARTED|First Intervention Period||39
1639889|NCT00788593|4006136|P1|STARTED|First Intervention Period||0
1639890|NCT00788593|4006134|P3|NOT COMPLETED|Placebo Run-in Phase||0
1639891|NCT00788593|4006135|P2|NOT COMPLETED|Placebo Run-in Phase||0
1639892|NCT00788593|4006136|P1|NOT COMPLETED|Placebo Run-in Phase||6
1639893|NCT00788593|4006134|P3|COMPLETED|Placebo Run-in Phase||0
1639894|NCT00788593|4006135|P2|COMPLETED|Placebo Run-in Phase||0
1639895|NCT00788593|4006136|P1|COMPLETED|Placebo Run-in Phase||76
1639896|NCT00788593|4006134|P3|STARTED|Placebo Run-in Phase||0
1639897|NCT00788593|4006135|P2|STARTED|Placebo Run-in Phase||0
1639898|NCT00788593|4006136|P1|STARTED|Placebo Run-in Phase||82
1639899|NCT00788372|4006153|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
1639900|NCT00788372|4006153|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
1639901|NCT00788372|4006153|P1|STARTED|Period 2 (Week 4 to Week 52)||111
1639902|NCT00788372|4006153|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
1639903|NCT00788372|4006153|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
1639904|NCT00788372|4006153|P1|STARTED|Period 1 (up to 4 Weeks)||142
1639905|NCT00788255|4006167|P1|NOT COMPLETED|Overall Study||0
1639906|NCT00788255|4006167|P1|COMPLETED|Overall Study||25
1639907|NCT00788255|4006167|P1|Oxytocin: 0 μU/mL|Overall Study||25
1639908|NCT00788255|4006167|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
1639909|NCT00788255|4006167|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
1639910|NCT00788255|4006167|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
1639911|NCT00788255|4006167|P1|STARTED|Overall Study||25
1639912|NCT00788073|4006182|P2|NOT COMPLETED|Placebo Then STX209||1
1639913|NCT00788073|4006183|P1|NOT COMPLETED|Placebo Then STX209||2
1639914|NCT00788073|4006182|P2|COMPLETED|Placebo Then STX209||29
1639915|NCT00788073|4006183|P1|COMPLETED|Placebo Then STX209||27
1639916|NCT00788073|4006182|P2|STARTED|Placebo Then STX209||30
1639917|NCT00788073|4006183|P1|STARTED|Placebo Then STX209||29
1639918|NCT00788073|4006182|P2|NOT COMPLETED|STX209 Then Placebo||3
1639919|NCT00788073|4006183|P1|NOT COMPLETED|STX209 Then Placebo||1
1639920|NCT00788073|4006182|P2|COMPLETED|STX209 Then Placebo||30
1639921|NCT00788073|4006183|P1|COMPLETED|STX209 Then Placebo||29
1639922|NCT00788073|4006182|P2|STARTED|STX209 Then Placebo||33
1639923|NCT00788073|4006183|P1|STARTED|STX209 Then Placebo||30
1639924|NCT00788008|4006193|P2|NOT COMPLETED|Overall Study||0
1639925|NCT00788008|4006194|P1|NOT COMPLETED|Overall Study||0
1639926|NCT00788008|4006193|P2|COMPLETED|Overall Study||101
1639927|NCT00788008|4006194|P1|COMPLETED|Overall Study||98
1639928|NCT00788008|4006193|P2|STARTED|Overall Study||101
1639929|NCT00788008|4006194|P1|STARTED|Overall Study||98
1639930|NCT00787943|4006200|P1|NOT COMPLETED|Overall Study||0
1639931|NCT00787943|4006200|P1|COMPLETED|Overall Study||10
1639932|NCT00787943|4006200|P1|STARTED|Overall Study||10
1639933|NCT00787930|4006208|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
1639934|NCT00787930|4006208|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
1639935|NCT00787930|4006208|P1|STARTED|Continuation Treatment -- up to 12 Month||19
1639936|NCT00787930|4006208|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
1639937|NCT00787930|4006208|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
1639938|NCT00787930|4006208|P1|STARTED|Acute Treatment -- 3 Weeks||19
1639939|NCT00787917|4006223|P2|NOT COMPLETED|Open Label||0
1639940|NCT00787917|4006224|P1|NOT COMPLETED|Open Label||4
1639941|NCT00787917|4006223|P2|COMPLETED|Open Label||0
1639942|NCT00787917|4006224|P1|COMPLETED|Open Label||3
1639943|NCT00787917|4006223|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
1639944|NCT00787917|4006224|P1|STARTED|Open Label||7
1639945|NCT00787917|4006223|P2|NOT COMPLETED|Blinded Treatment||2
1639946|NCT00787917|4006224|P1|NOT COMPLETED|Blinded Treatment||5
1639947|NCT00787917|4006223|P2|COMPLETED|Blinded Treatment||3
1639948|NCT00787917|4006224|P1|COMPLETED|Blinded Treatment||4
1639949|NCT00787917|4006223|P2|STARTED|Blinded Treatment||5
1639950|NCT00787917|4006224|P1|STARTED|Blinded Treatment||9
1639951|NCT00787904|4006243|P2|NOT COMPLETED|Overall Study||0
1639952|NCT00787904|4006244|P1|NOT COMPLETED|Overall Study||0
1639953|NCT00787904|4006243|P2|COMPLETED|Overall Study||13
1639954|NCT00787904|4006244|P1|COMPLETED|Overall Study||6
1639955|NCT00787904|4006243|P2|STARTED|Overall Study||13
1639956|NCT00787904|4006244|P1|STARTED|Overall Study||6
1639957|NCT00787891|4006254|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
1639958|NCT00787891|4006255|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
1639959|NCT00787891|4006254|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
1639960|NCT00787891|4006255|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
1639961|NCT00787891|4006254|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
1639962|NCT00787891|4006255|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
1639963|NCT00787891|4006254|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
1639964|NCT00787891|4006255|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
1639965|NCT00787891|4006254|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
1639966|NCT00787891|4006255|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
1639967|NCT00787891|4006254|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
1639968|NCT00787891|4006255|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
1639969|NCT00787852|4006275|P2|NOT COMPLETED|Overall Study||0
1639970|NCT00787852|4006276|P1|NOT COMPLETED|Overall Study||1
1639971|NCT00787852|4006275|P2|COMPLETED|Overall Study||5
1639972|NCT00787852|4006276|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
1639973|NCT00787852|4006275|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
1639974|NCT00787852|4006276|P1|STARTED|Overall Study||6
1639975|NCT00787839|4006282|P1|NOT COMPLETED|Overall Study||404
1639976|NCT00787839|4006282|P1|COMPLETED|Overall Study||1535
1639977|NCT00787839|4006282|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
1639978|NCT00787839|4006282|P1|Completed GCT Screening|Overall Study||1876
1639979|NCT00787839|4006282|P1|Consented|Overall Study|consented|1939
1639980|NCT00787839|4006282|P1|STARTED|Overall Study||1939
1639981|NCT00787800|4006305|P2|NOT COMPLETED|Overall Study||7
1639982|NCT00787800|4006306|P1|NOT COMPLETED|Overall Study||3
1639983|NCT00787800|4006305|P2|COMPLETED|Overall Study||43
1639984|NCT00787800|4006306|P1|COMPLETED|Overall Study||47
1639985|NCT00787800|4006305|P2|STARTED|Overall Study||50
1639986|NCT00787800|4006306|P1|STARTED|Overall Study||50
1639987|NCT00787787|4006322|P1|NOT COMPLETED|Overall Study||7
1639988|NCT00787787|4006322|P1|COMPLETED|Overall Study||0
1639989|NCT00787787|4006322|P1|STARTED|Overall Study||7
1639990|NCT00787761|4006328|P1|NOT COMPLETED|Overall Study||0
1639991|NCT00787761|4006328|P1|COMPLETED|Overall Study||24
1639992|NCT00787761|4006328|P1|STARTED|Overall Study||24
1639993|NCT00787644|4006341|P2|NOT COMPLETED|Overall Study||2
1639994|NCT00787644|4006342|P1|NOT COMPLETED|Overall Study||2
1639995|NCT00787644|4006341|P2|COMPLETED|Overall Study||9
1639996|NCT00787644|4006342|P1|COMPLETED|Overall Study||10
1639997|NCT00787644|4006341|P2|STARTED|Overall Study||11
1639998|NCT00787644|4006342|P1|STARTED|Overall Study||12
1639999|NCT00787618|4006351|P3|NOT COMPLETED|Overall Study||0
1640000|NCT00787618|4006352|P2|NOT COMPLETED|Overall Study||0
1640001|NCT00787618|4006353|P1|NOT COMPLETED|Overall Study||0
1640002|NCT00787618|4006351|P3|COMPLETED|Overall Study||3
1640003|NCT00787618|4006352|P2|COMPLETED|Overall Study||0
1640004|NCT00787618|4006353|P1|COMPLETED|Overall Study||3
1640005|NCT00787618|4006351|P3|STARTED|Overall Study||3
1640006|NCT00787618|4006352|P2|STARTED|Overall Study||0
1640007|NCT00787618|4006353|P1|STARTED|Overall Study||3
1640008|NCT00787605|4006363|P2|NOT COMPLETED|Overall Study||56
1640009|NCT00787605|4006364|P1|NOT COMPLETED|Overall Study||46
1640010|NCT00787605|4006363|P2|COMPLETED|Overall Study||376
1640011|NCT00787605|4006364|P1|COMPLETED|Overall Study||382
1640012|NCT00787605|4006363|P2|STARTED|Overall Study||432
1640013|NCT00787605|4006364|P1|STARTED|Overall Study||428
1640014|NCT00787566|4006383|P3|NOT COMPLETED|Overall Study||0
1640015|NCT00787566|4006384|P2|NOT COMPLETED|Overall Study||1
1640016|NCT00787566|4006385|P1|NOT COMPLETED|Overall Study||0
1640017|NCT00787566|4006383|P3|COMPLETED|Overall Study||22
1640018|NCT00787566|4006384|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
1640019|NCT00787566|4006385|P1|COMPLETED|Overall Study||21
1640020|NCT00787566|4006383|P3|STARTED|Overall Study||22
1640021|NCT00787566|4006384|P2|STARTED|Overall Study||25
1640022|NCT00787566|4006385|P1|STARTED|Overall Study||21
1640023|NCT00787527|4006393|P1|NOT COMPLETED|Overall Study||3
1640024|NCT00787527|4006393|P1|COMPLETED|Overall Study||11
1640025|NCT00787527|4006393|P1|STARTED|Overall Study||14
1640026|NCT00787332|4006403|P2|NOT COMPLETED|Overall Study||0
1640027|NCT00787332|4006404|P1|NOT COMPLETED|Overall Study||0
1640028|NCT00787332|4006403|P2|COMPLETED|Overall Study||8
1640029|NCT00787332|4006404|P1|COMPLETED|Overall Study||8
1640030|NCT00787332|4006403|P2|STARTED|Overall Study||8
1640031|NCT00787332|4006404|P1|STARTED|Overall Study||8
1640032|NCT00787319|4006410|P1|NOT COMPLETED|Overall Study||63
1640033|NCT00787319|4006410|P1|COMPLETED|Overall Study||45
1640034|NCT00787319|4006410|P1|STARTED|Overall Study||108
1640035|NCT00787267|4006422|P1|NOT COMPLETED|Overall Study||12
1640036|NCT00787267|4006422|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
1640037|NCT00787267|4006422|P1|STARTED|Overall Study|Signed a consent form|37
1640038|NCT00787254|4006432|P2|NOT COMPLETED|Overall Study||82
1640039|NCT00787254|4006433|P1|NOT COMPLETED|Overall Study||76
1640040|NCT00787254|4006432|P2|COMPLETED|Overall Study||99
1640041|NCT00787254|4006433|P1|COMPLETED|Overall Study||109
1640042|NCT00787254|4006432|P2|STARTED|Overall Study||181
1640043|NCT00787254|4006433|P1|STARTED|Overall Study||185
1640044|NCT00787241|4006536|P3|NOT COMPLETED|Overall Study||0
1640045|NCT00787241|4006537|P2|NOT COMPLETED|Overall Study||0
1640046|NCT00787241|4006538|P1|NOT COMPLETED|Overall Study||0
1640047|NCT00787241|4006536|P3|COMPLETED|Overall Study||41
1640048|NCT00787241|4006537|P2|COMPLETED|Overall Study||143
1640049|NCT00787241|4006538|P1|COMPLETED|Overall Study||261
1640050|NCT00787241|4006536|P3|STARTED|Overall Study||41
1640051|NCT00787241|4006537|P2|STARTED|Overall Study||143
1640052|NCT00787241|4006538|P1|STARTED|Overall Study||261
1640053|NCT00787202|4006557|P5|NOT COMPLETED|Overall Study||4
1640054|NCT00787202|4006558|P4|NOT COMPLETED|Overall Study||2
1640055|NCT00787202|4006559|P3|NOT COMPLETED|Overall Study||7
1640056|NCT00787202|4006560|P2|NOT COMPLETED|Overall Study||11
1640057|NCT00787202|4006561|P1|NOT COMPLETED|Overall Study||14
1640058|NCT00787202|4006557|P5|COMPLETED|Overall Study||45
1640059|NCT00787202|4006558|P4|COMPLETED|Overall Study||31
1640060|NCT00787202|4006559|P3|COMPLETED|Overall Study||26
1640061|NCT00787202|4006560|P2|COMPLETED|Overall Study||20
1640062|NCT00787202|4006561|P1|COMPLETED|Overall Study||35
1640063|NCT00787202|4006557|P5|Treated|Overall Study||49
1640064|NCT00787202|4006558|P4|Treated|Overall Study||33
1640065|NCT00787202|4006559|P3|Treated|Overall Study||33
1640066|NCT00787202|4006560|P2|Treated|Overall Study||31
1640067|NCT00787202|4006561|P1|Treated|Overall Study||48
1640068|NCT00787202|4006557|P5|STARTED|Overall Study||49
1640069|NCT00787202|4006558|P4|STARTED|Overall Study||33
1640070|NCT00787202|4006559|P3|STARTED|Overall Study||33
1640071|NCT00787202|4006560|P2|STARTED|Overall Study||31
1640072|NCT00787202|4006561|P1|STARTED|Overall Study||49
1640073|NCT00787189|4006614|P2|NOT COMPLETED|Overall Study||2
1640074|NCT00787189|4006615|P1|NOT COMPLETED|Overall Study||2
1640075|NCT00787189|4006614|P2|COMPLETED|Overall Study|To study end point.|30
1640076|NCT00787189|4006615|P1|COMPLETED|Overall Study|To study end point.|30
1640077|NCT00787189|4006614|P2|STARTED|Overall Study||32
1640078|NCT00787189|4006615|P1|STARTED|Overall Study||32
1640079|NCT00787150|4006624|P3|NOT COMPLETED|Overall Study||5
1640080|NCT00787150|4006625|P2|NOT COMPLETED|Overall Study||7
1640081|NCT00787150|4006626|P1|NOT COMPLETED|Overall Study||9
1640082|NCT00787150|4006624|P3|COMPLETED|Overall Study||66
1640083|NCT00787150|4006625|P2|COMPLETED|Overall Study||65
1640084|NCT00787150|4006626|P1|COMPLETED|Overall Study||66
1640085|NCT00787150|4006624|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
1640086|NCT00787150|4006625|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
1640087|NCT00787150|4006626|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
1640088|NCT00787137|4006671|P3|NOT COMPLETED|Overall Study||1
1640089|NCT00787137|4006672|P2|NOT COMPLETED|Overall Study||0
1640090|NCT00787137|4006673|P1|NOT COMPLETED|Overall Study||0
1640091|NCT00787137|4006671|P3|COMPLETED|Overall Study||4
1640092|NCT00787137|4006672|P2|COMPLETED|Overall Study||6
1640093|NCT00787137|4006673|P1|COMPLETED|Overall Study||6
1640094|NCT00787137|4006671|P3|STARTED|Overall Study||5
1640095|NCT00787137|4006672|P2|STARTED|Overall Study||6
1640096|NCT00787137|4006673|P1|STARTED|Overall Study||6
1640097|NCT00787124|4006695|P2|NOT COMPLETED|Overall Study||0
1640098|NCT00787124|4006696|P1|NOT COMPLETED|Overall Study||0
1640099|NCT00787124|4006695|P2|COMPLETED|Overall Study||4
1640100|NCT00787124|4006696|P1|COMPLETED|Overall Study||4
1640101|NCT00787124|4006695|P2|STARTED|Overall Study||4
1640102|NCT00787124|4006696|P1|STARTED|Overall Study||4
1640103|NCT00787020|4006706|P2|NOT COMPLETED|Overall Study||0
1640104|NCT00787020|4006707|P1|NOT COMPLETED|Overall Study||0
1640105|NCT00787020|4006706|P2|COMPLETED|Overall Study||13
1640106|NCT00787020|4006707|P1|COMPLETED|Overall Study||24
1640107|NCT00787020|4006706|P2|STARTED|Overall Study||13
1640108|NCT00787020|4006707|P1|STARTED|Overall Study||24
1640109|NCT00786994|4006721|P4|NOT COMPLETED|Overall Study||6
1640110|NCT00786994|4006722|P3|NOT COMPLETED|Overall Study||2
1640111|NCT00786994|4006723|P2|NOT COMPLETED|Overall Study||15
1640112|NCT00786994|4006724|P1|NOT COMPLETED|Overall Study||10
1640113|NCT00786994|4006721|P4|COMPLETED|Overall Study||22
1640114|NCT00786994|4006722|P3|COMPLETED|Overall Study||24
1640115|NCT00786994|4006723|P2|COMPLETED|Overall Study||39
1640116|NCT00786994|4006724|P1|COMPLETED|Overall Study||47
1640117|NCT00786994|4006721|P4|ITT|Overall Study||28
1640118|NCT00786994|4006722|P3|ITT|Overall Study||25
1640119|NCT00786994|4006723|P2|ITT|Overall Study||51
1640120|NCT00786994|4006724|P1|ITT|Overall Study||53
1640121|NCT00786994|4006721|P4|STARTED|Overall Study||28
1640122|NCT00786994|4006722|P3|STARTED|Overall Study||26
1640123|NCT00786994|4006723|P2|STARTED|Overall Study||54
1640124|NCT00786994|4006724|P1|STARTED|Overall Study||57
1640125|NCT00786916|4006736|P3|NOT COMPLETED|Overall Study||0
1640126|NCT00786916|4006737|P2|NOT COMPLETED|Overall Study||0
1640127|NCT00786916|4006738|P1|NOT COMPLETED|Overall Study||0
1640128|NCT00786916|4006736|P3|COMPLETED|Overall Study||34
1640129|NCT00786916|4006737|P2|COMPLETED|Overall Study||36
1640130|NCT00786916|4006738|P1|COMPLETED|Overall Study||39
1640131|NCT00786916|4006736|P3|STARTED|Overall Study||34
1640132|NCT00786916|4006737|P2|STARTED|Overall Study||36
1640133|NCT00786916|4006738|P1|STARTED|Overall Study||39
1640134|NCT00786864|4006748|P2|NOT COMPLETED|Overall Study||1
1640135|NCT00786864|4006749|P1|NOT COMPLETED|Overall Study||1
1640136|NCT00786864|4006748|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
1640137|NCT00786864|4006749|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
1640138|NCT00786864|4006748|P2|STARTED|Overall Study||33
1640139|NCT00786864|4006749|P1|STARTED|Overall Study||39
1640140|NCT00786838|4006761|P1|NOT COMPLETED|Overall Study||49
1640141|NCT00786838|4006761|P1|COMPLETED|Overall Study||26
1640142|NCT00786838|4006761|P1|STARTED|Overall Study||75
1640143|NCT00786799|4006788|P2|NOT COMPLETED|Overall Study||1
1640144|NCT00786799|4006789|P1|NOT COMPLETED|Overall Study||1
1640145|NCT00786799|4006788|P2|COMPLETED|Overall Study||12
1640146|NCT00786799|4006789|P1|COMPLETED|Overall Study||13
1640147|NCT00786799|4006788|P2|STARTED|Overall Study||13
1640148|NCT00786799|4006789|P1|STARTED|Overall Study||14
1640149|NCT00786682|4006800|P1|NOT COMPLETED|Overall Study||0
1640150|NCT00786682|4006800|P1|COMPLETED|Overall Study||11
1640151|NCT00786682|4006800|P1|STARTED|Overall Study||11
1640152|NCT00786643|4006808|P2|NOT COMPLETED|Overall Study||0
1640153|NCT00786643|4006809|P1|NOT COMPLETED|Overall Study||0
1640154|NCT00786643|4006808|P2|COMPLETED|Overall Study||28
1640155|NCT00786643|4006809|P1|COMPLETED|Overall Study||20
1640156|NCT00786643|4006808|P2|STARTED|Overall Study||28
1640157|NCT00786643|4006809|P1|STARTED|Overall Study||20
1640158|NCT00786565|4006819|P1|NOT COMPLETED|Post Surgery||2
1640159|NCT00786565|4006819|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
1640160|NCT00786565|4006819|P1|STARTED|Post Surgery||69
1640161|NCT00786565|4006819|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
1640162|NCT00786565|4006819|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
1640163|NCT00786565|4006819|P1|STARTED|Enrollment Prior to Surgery||75
1640164|NCT00786487|4006861|P4|NOT COMPLETED|Overall Study||0
1640165|NCT00786487|4006862|P3|NOT COMPLETED|Overall Study||0
1640166|NCT00786487|4006863|P2|NOT COMPLETED|Overall Study||0
1640167|NCT00786487|4006864|P1|NOT COMPLETED|Overall Study||0
1640168|NCT00786487|4006861|P4|COMPLETED|Overall Study||7
1640169|NCT00786487|4006862|P3|COMPLETED|Overall Study||9
1640170|NCT00786487|4006863|P2|COMPLETED|Overall Study||7
1640171|NCT00786487|4006864|P1|COMPLETED|Overall Study||10
1640172|NCT00786487|4006861|P4|STARTED|Overall Study||7
1640173|NCT00786487|4006862|P3|STARTED|Overall Study||9
1640174|NCT00786487|4006863|P2|STARTED|Overall Study||7
1640175|NCT00786487|4006864|P1|STARTED|Overall Study||10
1640176|NCT00786474|4006876|P2|NOT COMPLETED|Overall Study||43
1640177|NCT00786474|4006877|P1|NOT COMPLETED|Overall Study||37
1640178|NCT00786474|4006876|P2|COMPLETED|Overall Study||891
1640179|NCT00786474|4006877|P1|COMPLETED|Overall Study||913
1640180|NCT00786474|4006876|P2|STARTED|Overall Study||934
1640181|NCT00786474|4006877|P1|STARTED|Overall Study||950
1640182|NCT00786422|4006889|P1|NOT COMPLETED|Follow-up Period||3
1640183|NCT00786422|4006889|P1|COMPLETED|Follow-up Period||17
1640184|NCT00786422|4006889|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
1640185|NCT00786422|4006889|P1|NOT COMPLETED|Rivaroxaban Treatment||11
1640186|NCT00786422|4006889|P1|COMPLETED|Rivaroxaban Treatment||14
1640187|NCT00786422|4006889|P1|STARTED|Rivaroxaban Treatment||25
1640188|NCT00786409|4006905|P1|NOT COMPLETED|Overall Study||7
1640189|NCT00786409|4006905|P1|COMPLETED|Overall Study||20
1640190|NCT00786409|4006905|P1|STARTED|Overall Study||27
1640191|NCT00786188|4006922|P2|NOT COMPLETED|Overall Study||1
1640192|NCT00786188|4006923|P1|NOT COMPLETED|Overall Study||5
1640193|NCT00786188|4006922|P2|COMPLETED|Overall Study||51
1640194|NCT00786188|4006923|P1|COMPLETED|Overall Study||45
1640195|NCT00786188|4006922|P2|STARTED|Overall Study||52
1640196|NCT00786188|4006923|P1|STARTED|Overall Study||50
1640197|NCT00786032|4006949|P1|NOT COMPLETED|Overall Study||24
1640198|NCT00786032|4006949|P1|COMPLETED|Overall Study||3
1640199|NCT00786032|4006949|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
1640200|NCT00786032|4006949|P1|STARTED|Overall Study||27
1640201|NCT00786019|4006961|P2|NOT COMPLETED|Overall Study||10
1640202|NCT00786019|4006962|P1|NOT COMPLETED|Overall Study||5
1640203|NCT00786019|4006961|P2|COMPLETED|Overall Study||17
1640204|NCT00786019|4006962|P1|COMPLETED|Overall Study||15
1640205|NCT00786019|4006961|P2|STARTED|Overall Study||27
1640206|NCT00786019|4006962|P1|STARTED|Overall Study||20
1640207|NCT00785980|4006970|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
1640208|NCT00785980|4006970|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
1640209|NCT00785980|4006970|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
1640210|NCT00785980|4006970|P1|NOT COMPLETED|Ciprofloxacin Alone||0
1640211|NCT00785980|4006970|P1|COMPLETED|Ciprofloxacin Alone||21
1640212|NCT00785980|4006970|P1|STARTED|Ciprofloxacin Alone||21
1640213|NCT00785980|4006970|P1|NOT COMPLETED|7 Day Washout Period||3
1640214|NCT00785980|4006970|P1|COMPLETED|7 Day Washout Period||21
1640215|NCT00785980|4006970|P1|STARTED|7 Day Washout Period||24
1640216|NCT00785980|4006970|P1|NOT COMPLETED|Quinine Sulfate Alone||0
1640217|NCT00785980|4006970|P1|COMPLETED|Quinine Sulfate Alone||24
1640218|NCT00785980|4006970|P1|STARTED|Quinine Sulfate Alone||24
1640219|NCT00785928|4006988|P7|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
1640220|NCT00785928|4006989|P6|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
1640221|NCT00785928|4006990|P5|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
1640222|NCT00785928|4006991|P4|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
1640223|NCT00785928|4006992|P3|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
1640224|NCT00785928|4006993|P2|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
1640225|NCT00785928|4006994|P1|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
1640226|NCT00785928|4006988|P7|COMPLETED|Follow-up Phases (Weeks 24-72)||9
1640227|NCT00785928|4006989|P6|COMPLETED|Follow-up Phases (Weeks 24-72)||0
1640228|NCT00785928|4006990|P5|COMPLETED|Follow-up Phases (Weeks 24-72)||4
1640229|NCT00785928|4006991|P4|COMPLETED|Follow-up Phases (Weeks 24-72)||4
1640230|NCT00785928|4006992|P3|COMPLETED|Follow-up Phases (Weeks 24-72)||4
1640231|NCT00785928|4006993|P2|COMPLETED|Follow-up Phases (Weeks 24-72)||5
1640232|NCT00785928|4006994|P1|COMPLETED|Follow-up Phases (Weeks 24-72)||7
1640233|NCT00785928|4006988|P7|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
1640234|NCT00785928|4006989|P6|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
1640235|NCT00785928|4006990|P5|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
1640236|NCT00785928|4006991|P4|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
1640237|NCT00785928|4006992|P3|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
1640238|NCT00785928|4006993|P2|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
1640323|NCT00785577|4007185|P1|STARTED|Study Period 2: Therapy Phase||89
1640239|NCT00785928|4006994|P1|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
1640240|NCT00785928|4006988|P7|NOT COMPLETED|Treatment Phase||3
1640241|NCT00785928|4006989|P6|NOT COMPLETED|Treatment Phase||0
1640242|NCT00785928|4006990|P5|NOT COMPLETED|Treatment Phase||2
1640243|NCT00785928|4006991|P4|NOT COMPLETED|Treatment Phase||0
1640244|NCT00785928|4006992|P3|NOT COMPLETED|Treatment Phase||3
1640245|NCT00785928|4006993|P2|NOT COMPLETED|Treatment Phase||5
1640246|NCT00785928|4006994|P1|NOT COMPLETED|Treatment Phase||3
1640247|NCT00785928|4006988|P7|COMPLETED|Treatment Phase||23
1640248|NCT00785928|4006989|P6|COMPLETED|Treatment Phase||13
1640249|NCT00785928|4006990|P5|COMPLETED|Treatment Phase||16
1640250|NCT00785928|4006991|P4|COMPLETED|Treatment Phase||15
1640251|NCT00785928|4006992|P3|COMPLETED|Treatment Phase||17
1640252|NCT00785928|4006993|P2|COMPLETED|Treatment Phase||25
1640253|NCT00785928|4006994|P1|COMPLETED|Treatment Phase||33
1640254|NCT00785928|4006988|P7|STARTED|Treatment Phase||26
1640255|NCT00785928|4006989|P6|STARTED|Treatment Phase||13
1640256|NCT00785928|4006990|P5|STARTED|Treatment Phase||18
1640257|NCT00785928|4006991|P4|STARTED|Treatment Phase||15
1640258|NCT00785928|4006992|P3|STARTED|Treatment Phase||20
1640259|NCT00785928|4006993|P2|STARTED|Treatment Phase||30
1640260|NCT00785928|4006994|P1|STARTED|Treatment Phase||36
1640261|NCT00785798|4007134|P1|NOT COMPLETED|Overall Study||1
1640262|NCT00785798|4007134|P1|COMPLETED|Overall Study||16
1640263|NCT00785798|4007134|P1|STARTED|Overall Study||17
1640264|NCT00785785|4007141|P2|NOT COMPLETED|Optional Extension Phase||125
1640265|NCT00785785|4007142|P1|NOT COMPLETED|Optional Extension Phase||39
1640266|NCT00785785|4007141|P2|COMPLETED|Optional Extension Phase||0
1640267|NCT00785785|4007142|P1|COMPLETED|Optional Extension Phase||0
1640268|NCT00785785|4007141|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
1640269|NCT00785785|4007142|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
1640270|NCT00785785|4007141|P2|NOT COMPLETED|Core Phase up to 36 Months||320
1640271|NCT00785785|4007142|P1|NOT COMPLETED|Core Phase up to 36 Months||324
1640272|NCT00785785|4007141|P2|COMPLETED|Core Phase up to 36 Months||0
1640273|NCT00785785|4007142|P1|COMPLETED|Core Phase up to 36 Months||0
1640274|NCT00785785|4007141|P2|STARTED|Core Phase up to 36 Months||320
1640275|NCT00785785|4007142|P1|STARTED|Core Phase up to 36 Months||324
1640276|NCT00785772|4007150|P1|NOT COMPLETED|Overall Study||0
1640277|NCT00785772|4007150|P1|COMPLETED|Overall Study||1
1640278|NCT00785772|4007150|P1|STARTED|Overall Study||1
1640279|NCT00785707|4007156|P1|NOT COMPLETED|Overall Study||7
1640280|NCT00785707|4007156|P1|COMPLETED|Overall Study||24
1640281|NCT00785707|4007156|P1|STARTED|Overall Study||31
1640282|NCT00785629|4007165|P4|NOT COMPLETED|Overall Study||16
1640283|NCT00785629|4007166|P3|NOT COMPLETED|Overall Study||10
1640284|NCT00785629|4007167|P2|NOT COMPLETED|Overall Study||5
1640285|NCT00785629|4007168|P1|NOT COMPLETED|Overall Study||8
1640286|NCT00785629|4007165|P4|COMPLETED|Overall Study|16 not completed|41
1640287|NCT00785629|4007166|P3|COMPLETED|Overall Study|10 not completed|18
1640288|NCT00785629|4007167|P2|COMPLETED|Overall Study|5 not completed|25
1640289|NCT00785629|4007168|P1|COMPLETED|Overall Study|8 not completed|22
1640290|NCT00785629|4007165|P4|STARTED|Overall Study||57
1640291|NCT00785629|4007166|P3|STARTED|Overall Study||28
1640292|NCT00785629|4007167|P2|STARTED|Overall Study||30
1640293|NCT00785629|4007168|P1|STARTED|Overall Study||30
1640294|NCT00785577|4007181|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1640295|NCT00785577|4007182|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1640296|NCT00785577|4007183|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1640297|NCT00785577|4007184|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1640298|NCT00785577|4007185|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1640299|NCT00785577|4007181|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
1640300|NCT00785577|4007182|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
1640301|NCT00785577|4007183|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
1640302|NCT00785577|4007184|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
1640303|NCT00785577|4007185|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
1640304|NCT00785577|4007181|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
1640305|NCT00785577|4007182|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
1640306|NCT00785577|4007183|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
1640307|NCT00785577|4007184|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
1640308|NCT00785577|4007185|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
1640309|NCT00785577|4007181|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
1640310|NCT00785577|4007182|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
1640311|NCT00785577|4007183|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
1640312|NCT00785577|4007184|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
1640313|NCT00785577|4007185|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
1640314|NCT00785577|4007181|P5|COMPLETED|Study Period 2: Therapy Phase||27
1640315|NCT00785577|4007182|P4|COMPLETED|Study Period 2: Therapy Phase||36
1640316|NCT00785577|4007183|P3|COMPLETED|Study Period 2: Therapy Phase||25
1640317|NCT00785577|4007184|P2|COMPLETED|Study Period 2: Therapy Phase||36
1640318|NCT00785577|4007185|P1|COMPLETED|Study Period 2: Therapy Phase||78
1640319|NCT00785577|4007181|P5|STARTED|Study Period 2: Therapy Phase||47
1640320|NCT00785577|4007182|P4|STARTED|Study Period 2: Therapy Phase||49
1640321|NCT00785577|4007183|P3|STARTED|Study Period 2: Therapy Phase||43
1640322|NCT00785577|4007184|P2|STARTED|Study Period 2: Therapy Phase||45
1640324|NCT00785538|4007325|P4|NOT COMPLETED|Treatment Period||1
1640325|NCT00785538|4007326|P3|NOT COMPLETED|Treatment Period||2
1640326|NCT00785538|4007327|P2|NOT COMPLETED|Treatment Period||2
1640327|NCT00785538|4007328|P1|NOT COMPLETED|Treatment Period||1
1640328|NCT00785538|4007325|P4|COMPLETED|Treatment Period||1
1640329|NCT00785538|4007326|P3|COMPLETED|Treatment Period||4
1640330|NCT00785538|4007327|P2|COMPLETED|Treatment Period||7
1640331|NCT00785538|4007328|P1|COMPLETED|Treatment Period||6
1640332|NCT00785538|4007325|P4|Received at Least 1 Dose of Study Drug|Treatment Period||2
1640333|NCT00785538|4007326|P3|Received at Least 1 Dose of Study Drug|Treatment Period||6
1640334|NCT00785538|4007327|P2|Received at Least 1 Dose of Study Drug|Treatment Period||9
1640335|NCT00785538|4007328|P1|Received at Least 1 Dose of Study Drug|Treatment Period||7
1640336|NCT00785538|4007325|P4|STARTED|Treatment Period||2
1640337|NCT00785538|4007326|P3|STARTED|Treatment Period||6
1640338|NCT00785538|4007327|P2|STARTED|Treatment Period||9
1640339|NCT00785538|4007328|P1|STARTED|Treatment Period||7
1640340|NCT00785538|4007325|P4|NOT COMPLETED|PK Period||0
1640341|NCT00785538|4007326|P3|NOT COMPLETED|PK Period||0
1640342|NCT00785538|4007327|P2|NOT COMPLETED|PK Period||0
1640343|NCT00785538|4007328|P1|NOT COMPLETED|PK Period||0
1640344|NCT00785538|4007325|P4|COMPLETED|PK Period||0
1640345|NCT00785538|4007326|P3|COMPLETED|PK Period||1
1640346|NCT00785538|4007327|P2|COMPLETED|PK Period||1
1640347|NCT00785538|4007328|P1|COMPLETED|PK Period||7
1640348|NCT00785538|4007325|P4|STARTED|PK Period||0
1640349|NCT00785538|4007326|P3|STARTED|PK Period||1
1640350|NCT00785538|4007327|P2|STARTED|PK Period||1
1640351|NCT00785538|4007328|P1|STARTED|PK Period||7
1640352|NCT00785512|4007376|P2|NOT COMPLETED|Overall Study||4
1640353|NCT00785512|4007377|P1|NOT COMPLETED|Overall Study||3
1640354|NCT00785512|4007376|P2|COMPLETED|Overall Study||101
1640355|NCT00785512|4007377|P1|COMPLETED|Overall Study||99
1640356|NCT00785512|4007376|P2|STARTED|Overall Study||105
1640357|NCT00785512|4007377|P1|STARTED|Overall Study||102
1640358|NCT00785486|4007386|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
1640359|NCT00785486|4007386|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
1640360|NCT00785486|4007386|P1|STARTED|Midazolam With Qualaquin at Steady State||23
1640361|NCT00785486|4007386|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
1640362|NCT00785486|4007386|P1|COMPLETED|Qualaquin Alone at Steady State||23
1640363|NCT00785486|4007386|P1|STARTED|Qualaquin Alone at Steady State||23
1640364|NCT00785486|4007386|P1|NOT COMPLETED|3 Day Washout||0
1640365|NCT00785486|4007386|P1|COMPLETED|3 Day Washout||23
1640366|NCT00785486|4007386|P1|STARTED|3 Day Washout||23
1640367|NCT00785486|4007386|P1|NOT COMPLETED|Midazolam Alone||1
1640368|NCT00785486|4007386|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
1640369|NCT00785486|4007386|P1|STARTED|Midazolam Alone||24
1640370|NCT00785356|4007410|P1|NOT COMPLETED|Overall Study||8
1640371|NCT00785356|4007410|P1|COMPLETED|Overall Study||0
1640372|NCT00785356|4007410|P1|STARTED|Overall Study||8
1640373|NCT00785291|4007421|P3|NOT COMPLETED|Overall Study||106
1640374|NCT00785291|4007422|P2|NOT COMPLETED|Overall Study||149
1640375|NCT00785291|4007423|P1|NOT COMPLETED|Overall Study||136
1640376|NCT00785291|4007421|P3|COMPLETED|Overall Study||139
1640377|NCT00785291|4007422|P2|COMPLETED|Overall Study||122
1640378|NCT00785291|4007423|P1|COMPLETED|Overall Study||147
1640379|NCT00785291|4007421|P3|STARTED|Overall Study||245
1640380|NCT00785291|4007422|P2|STARTED|Overall Study||271
1640381|NCT00785291|4007423|P1|STARTED|Overall Study||283
1640382|NCT00785213|4007443|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
1640383|NCT00785213|4007443|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
1640384|NCT00785213|4007443|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
1640385|NCT00785213|4007443|P1|NOT COMPLETED|Quinine Sulfate Alone||4
1640386|NCT00785213|4007443|P1|COMPLETED|Quinine Sulfate Alone||19
1640387|NCT00785213|4007443|P1|STARTED|Quinine Sulfate Alone||23
1640388|NCT00785213|4007443|P1|NOT COMPLETED|2 Day Washout Period||0
1640389|NCT00785213|4007443|P1|COMPLETED|2 Day Washout Period||23
1640390|NCT00785213|4007443|P1|STARTED|2 Day Washout Period||23
1640391|NCT00785213|4007443|P1|NOT COMPLETED|Rosiglitazone Alone||0
1640392|NCT00785213|4007443|P1|COMPLETED|Rosiglitazone Alone||23
1640393|NCT00785213|4007443|P1|STARTED|Rosiglitazone Alone||23
1640394|NCT00785044|4007454|P1|NOT COMPLETED|Overall Study||496
1640395|NCT00785044|4007454|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
1640396|NCT00785044|4007454|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
1640397|NCT00785044|4007454|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
1640398|NCT00784979|4007459|P1|NOT COMPLETED|Overall Study||6
1640399|NCT00784979|4007459|P1|COMPLETED|Overall Study||20
1640400|NCT00784979|4007459|P1|STARTED|Overall Study||26
1640401|NCT00784927|4007463|P1|NOT COMPLETED|Overall Study||3
1640402|NCT00784927|4007463|P1|COMPLETED|Overall Study||33
1640403|NCT00784927|4007463|P1|STARTED|Overall Study||36
1640404|NCT00784875|4007475|P4|NOT COMPLETED|Period D||1
1640405|NCT00784875|4007476|P3|NOT COMPLETED|Period D||6
1640406|NCT00784875|4007477|P2|NOT COMPLETED|Period D||4
1640407|NCT00784875|4007478|P1|NOT COMPLETED|Period D||5
1640408|NCT00784875|4007475|P4|COMPLETED|Period D||87
1640409|NCT00784875|4007476|P3|COMPLETED|Period D||88
1640410|NCT00784875|4007477|P2|COMPLETED|Period D||85
1640411|NCT00784875|4007478|P1|COMPLETED|Period D||86
1640412|NCT00784875|4007475|P4|STARTED|Period D||88
1640413|NCT00784875|4007476|P3|STARTED|Period D||94
1640414|NCT00784875|4007477|P2|STARTED|Period D||89
1640415|NCT00784875|4007478|P1|STARTED|Period D||91
1640416|NCT00784875|4007475|P4|NOT COMPLETED|Period C||7
1640417|NCT00784875|4007476|P3|NOT COMPLETED|Period C||13
1640418|NCT00784875|4007477|P2|NOT COMPLETED|Period C||6
1640419|NCT00784875|4007478|P1|NOT COMPLETED|Period C||7
1640420|NCT00784875|4007475|P4|COMPLETED|Period C||91
1640421|NCT00784875|4007476|P3|COMPLETED|Period C||84
1640422|NCT00784875|4007477|P2|COMPLETED|Period C||91
1640423|NCT00784875|4007478|P1|COMPLETED|Period C||96
1640424|NCT00784875|4007475|P4|STARTED|Period C||98
1640425|NCT00784875|4007476|P3|STARTED|Period C||97
1640426|NCT00784875|4007477|P2|STARTED|Period C||97
1640427|NCT00784875|4007478|P1|STARTED|Period C||103
1640428|NCT00784875|4007475|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
1640429|NCT00784875|4007476|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
1640430|NCT00784875|4007477|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
1640431|NCT00784875|4007478|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
1640432|NCT00784875|4007475|P4|COMPLETED|Period B - Efficacy Endpoint||98
1640433|NCT00784875|4007476|P3|COMPLETED|Period B - Efficacy Endpoint||96
1640434|NCT00784875|4007477|P2|COMPLETED|Period B - Efficacy Endpoint||101
1640435|NCT00784875|4007478|P1|COMPLETED|Period B - Efficacy Endpoint||100
1640436|NCT00784875|4007475|P4|Cohort 2|Period B - Efficacy Endpoint||101
1640437|NCT00784875|4007476|P3|Cohort 2|Period B - Efficacy Endpoint||102
1640438|NCT00784875|4007477|P2|Cohort 2|Period B - Efficacy Endpoint||102
1640439|NCT00784875|4007478|P1|Cohort 2|Period B - Efficacy Endpoint||102
1640440|NCT00784875|4007475|P4|STARTED|Period B - Efficacy Endpoint||117
1640441|NCT00784875|4007476|P3|STARTED|Period B - Efficacy Endpoint||117
1640442|NCT00784875|4007477|P2|STARTED|Period B - Efficacy Endpoint||113
1640443|NCT00784875|4007478|P1|STARTED|Period B - Efficacy Endpoint||114
1640444|NCT00784875|4007475|P4|NOT COMPLETED|Period A - Baseline||182
1640445|NCT00784875|4007476|P3|NOT COMPLETED|Period A - Baseline||0
1640446|NCT00784875|4007477|P2|NOT COMPLETED|Period A - Baseline||0
1640447|NCT00784875|4007478|P1|NOT COMPLETED|Period A - Baseline||0
1640448|NCT00784875|4007475|P4|COMPLETED|Period A - Baseline||461
1640449|NCT00784875|4007476|P3|COMPLETED|Period A - Baseline||0
1640450|NCT00784875|4007477|P2|COMPLETED|Period A - Baseline||0
1640451|NCT00784875|4007478|P1|COMPLETED|Period A - Baseline||0
1640452|NCT00784875|4007475|P4|STARTED|Period A - Baseline||643
1640453|NCT00784875|4007476|P3|STARTED|Period A - Baseline||0
1640454|NCT00784875|4007477|P2|STARTED|Period A - Baseline||0
1640455|NCT00784875|4007478|P1|STARTED|Period A - Baseline||0
1640456|NCT00784849|4007592|P1|NOT COMPLETED|Overall Study||0
1640457|NCT00784849|4007592|P1|COMPLETED|Overall Study||62
1640458|NCT00784849|4007592|P1|STARTED|Overall Study||62
1640459|NCT00784836|4007598|P1|NOT COMPLETED|Overall Study||3
1640460|NCT00784836|4007598|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
1640461|NCT00784836|4007598|P1|STARTED|Overall Study||3
1640462|NCT00784810|4007605|P2|NOT COMPLETED|Overall Study||49
1640463|NCT00784810|4007606|P1|NOT COMPLETED|Overall Study||63
1640464|NCT00784810|4007605|P2|COMPLETED|Overall Study||74
1640465|NCT00784810|4007606|P1|COMPLETED|Overall Study||61
1640466|NCT00784810|4007605|P2|STARTED|Overall Study||123
1640467|NCT00784810|4007606|P1|STARTED|Overall Study||124
1640468|NCT00784784|4007616|P2|NOT COMPLETED|Overall Study||2
1640469|NCT00784784|4007617|P1|NOT COMPLETED|Overall Study||2
1640470|NCT00784784|4007616|P2|COMPLETED|Overall Study||40
1640471|NCT00784784|4007617|P1|COMPLETED|Overall Study||20
1640472|NCT00784784|4007616|P2|STARTED|Overall Study||42
1640473|NCT00784784|4007617|P1|STARTED|Overall Study||22
1640474|NCT00784719|4007632|P7|NOT COMPLETED|Overall Study||5
1640475|NCT00784719|4007633|P6|NOT COMPLETED|Overall Study||3
1640476|NCT00784719|4007634|P5|NOT COMPLETED|Overall Study||6
1640477|NCT00784719|4007635|P4|NOT COMPLETED|Overall Study||0
1640478|NCT00784719|4007636|P3|NOT COMPLETED|Overall Study||1
1640479|NCT00784719|4007637|P2|NOT COMPLETED|Overall Study||3
1640480|NCT00784719|4007638|P1|NOT COMPLETED|Overall Study||3
1640481|NCT00784719|4007632|P7|COMPLETED|Overall Study||42
1640482|NCT00784719|4007633|P6|COMPLETED|Overall Study||41
1640483|NCT00784719|4007634|P5|COMPLETED|Overall Study||42
1640484|NCT00784719|4007635|P4|COMPLETED|Overall Study||48
1640485|NCT00784719|4007636|P3|COMPLETED|Overall Study||46
1640486|NCT00784719|4007637|P2|COMPLETED|Overall Study||43
1640487|NCT00784719|4007638|P1|COMPLETED|Overall Study||44
1640488|NCT00784719|4007632|P7|STARTED|Overall Study||47
1640489|NCT00784719|4007633|P6|STARTED|Overall Study||44
1640490|NCT00784719|4007634|P5|STARTED|Overall Study||48
1640491|NCT00784719|4007635|P4|STARTED|Overall Study||48
1640492|NCT00784719|4007636|P3|STARTED|Overall Study||47
1640493|NCT00784719|4007637|P2|STARTED|Overall Study||46
1640494|NCT00784719|4007638|P1|STARTED|Overall Study||47
1640495|NCT00784654|4007808|P3|NOT COMPLETED|Randomized Withdrawal Period||63
1640496|NCT00784654|4007809|P2|NOT COMPLETED|Randomized Withdrawal Period||18
1640497|NCT00784654|4007810|P1|NOT COMPLETED|Randomized Withdrawal Period||0
1640498|NCT00784654|4007808|P3|COMPLETED|Randomized Withdrawal Period||16
1640499|NCT00784654|4007809|P2|COMPLETED|Randomized Withdrawal Period||60
1640500|NCT00784654|4007810|P1|COMPLETED|Randomized Withdrawal Period||0
1640501|NCT00784654|4007808|P3|STARTED|Randomized Withdrawal Period||79
1640502|NCT00784654|4007809|P2|STARTED|Randomized Withdrawal Period||78
1640503|NCT00784654|4007810|P1|STARTED|Randomized Withdrawal Period||0
1640504|NCT00784654|4007808|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
1640505|NCT00784654|4007809|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
1640506|NCT00784654|4007810|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
1640507|NCT00784654|4007808|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
1640508|NCT00784654|4007809|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
1640509|NCT00784654|4007810|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
1640510|NCT00784654|4007808|P3|STARTED|Open-Label Period (Non-Randomized)||0
1640511|NCT00784654|4007809|P2|STARTED|Open-Label Period (Non-Randomized)||0
1640512|NCT00784654|4007810|P1|STARTED|Open-Label Period (Non-Randomized)||276
1640513|NCT00784563|4007845|P3|NOT COMPLETED|Year 3||3
1640514|NCT00784563|4007846|P2|NOT COMPLETED|Year 3||0
1640515|NCT00784563|4007847|P1|NOT COMPLETED|Year 3||0
1640516|NCT00784563|4007845|P3|COMPLETED|Year 3||14
1640517|NCT00784563|4007846|P2|COMPLETED|Year 3||0
1640518|NCT00784563|4007847|P1|COMPLETED|Year 3||0
1640519|NCT00784563|4007845|P3|STARTED|Year 3||17
1640520|NCT00784563|4007846|P2|STARTED|Year 3||0
1640521|NCT00784563|4007847|P1|STARTED|Year 3||0
1640522|NCT00784563|4007845|P3|NOT COMPLETED|Years 1 & 2||0
1640523|NCT00784563|4007846|P2|NOT COMPLETED|Years 1 & 2||5
1640524|NCT00784563|4007847|P1|NOT COMPLETED|Years 1 & 2||3
1640525|NCT00784563|4007845|P3|COMPLETED|Years 1 & 2||0
1640526|NCT00784563|4007846|P2|COMPLETED|Years 1 & 2||17
1640527|NCT00784563|4007847|P1|COMPLETED|Years 1 & 2||18
1640528|NCT00784563|4007845|P3|STARTED|Years 1 & 2||0
1640529|NCT00784563|4007846|P2|STARTED|Years 1 & 2||22
1640530|NCT00784563|4007847|P1|STARTED|Years 1 & 2||21
1640531|NCT00784550|4007865|P2|NOT COMPLETED|Overall Study||42
1640532|NCT00784550|4007866|P1|NOT COMPLETED|Overall Study||36
1640533|NCT00784550|4007865|P2|COMPLETED|Overall Study||127
1640534|NCT00784550|4007866|P1|COMPLETED|Overall Study||137
1640535|NCT00784550|4007865|P2|STARTED|Overall Study||169
1640536|NCT00784550|4007866|P1|STARTED|Overall Study||173
1640537|NCT00784459|4007884|P2|NOT COMPLETED|Overall Study||2
1640538|NCT00784459|4007885|P1|NOT COMPLETED|Overall Study||0
1640539|NCT00784459|4007884|P2|COMPLETED|Overall Study||11
1640540|NCT00784459|4007885|P1|COMPLETED|Overall Study||11
1640541|NCT00784459|4007884|P2|STARTED|Overall Study||13
1640542|NCT00784459|4007885|P1|STARTED|Overall Study||11
1640543|NCT00784368|4007896|P3|NOT COMPLETED|Overall Study||11
1640544|NCT00784368|4007897|P2|NOT COMPLETED|Overall Study||11
1640545|NCT00784368|4007898|P1|NOT COMPLETED|Overall Study||8
1640546|NCT00784368|4007896|P3|COMPLETED|Overall Study||12
1640547|NCT00784368|4007897|P2|COMPLETED|Overall Study||5
1640548|NCT00784368|4007898|P1|COMPLETED|Overall Study||8
1640549|NCT00784368|4007896|P3|STARTED|Overall Study||23
1640550|NCT00784368|4007897|P2|STARTED|Overall Study||16
1640551|NCT00784368|4007898|P1|STARTED|Overall Study||16
1640552|NCT00784277|4007936|P7|NOT COMPLETED|ER Treatment||15
1640553|NCT00784277|4007937|P6|NOT COMPLETED|ER Treatment||24
1640554|NCT00784277|4007938|P5|NOT COMPLETED|ER Treatment||9
1640555|NCT00784277|4007939|P4|NOT COMPLETED|ER Treatment||0
1640556|NCT00784277|4007940|P3|NOT COMPLETED|ER Treatment||0
1640557|NCT00784277|4007941|P2|NOT COMPLETED|ER Treatment||0
1640558|NCT00784277|4007942|P1|NOT COMPLETED|ER Treatment||0
1640559|NCT00784277|4007936|P7|COMPLETED|ER Treatment||76
1640560|NCT00784277|4007937|P6|COMPLETED|ER Treatment||226
1640561|NCT00784277|4007938|P5|COMPLETED|ER Treatment||113
1640562|NCT00784277|4007939|P4|COMPLETED|ER Treatment||0
1640563|NCT00784277|4007940|P3|COMPLETED|ER Treatment||0
1640564|NCT00784277|4007941|P2|COMPLETED|ER Treatment||0
1640565|NCT00784277|4007942|P1|COMPLETED|ER Treatment||0
1640566|NCT00784277|4007936|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
1640567|NCT00784277|4007937|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
1640568|NCT00784277|4007938|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
1640569|NCT00784277|4007939|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1640570|NCT00784277|4007940|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1640571|NCT00784277|4007941|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1640572|NCT00784277|4007942|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1640573|NCT00784277|4007936|P7|NOT COMPLETED|IR Treatment||0
1640574|NCT00784277|4007937|P6|NOT COMPLETED|IR Treatment||0
1640575|NCT00784277|4007938|P5|NOT COMPLETED|IR Treatment||0
1640576|NCT00784277|4007939|P4|NOT COMPLETED|IR Treatment||43
1640577|NCT00784277|4007940|P3|NOT COMPLETED|IR Treatment||28
1640578|NCT00784277|4007941|P2|NOT COMPLETED|IR Treatment||17
1640579|NCT00784277|4007942|P1|NOT COMPLETED|IR Treatment||16
1640580|NCT00784277|4007936|P7|COMPLETED|IR Treatment||0
1640581|NCT00784277|4007937|P6|COMPLETED|IR Treatment||0
1640582|NCT00784277|4007938|P5|COMPLETED|IR Treatment||0
1640583|NCT00784277|4007939|P4|COMPLETED|IR Treatment||100
1640584|NCT00784277|4007940|P3|COMPLETED|IR Treatment||126
1640585|NCT00784277|4007941|P2|COMPLETED|IR Treatment||134
1640586|NCT00784277|4007942|P1|COMPLETED|IR Treatment||132
1640587|NCT00784277|4007936|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
1640588|NCT00784277|4007937|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
1640589|NCT00784277|4007938|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
1640590|NCT00784277|4007939|P4|STARTED|IR Treatment||143
1640591|NCT00784277|4007940|P3|STARTED|IR Treatment||154
1640592|NCT00784277|4007941|P2|STARTED|IR Treatment||151
1640593|NCT00784277|4007942|P1|STARTED|IR Treatment||148
1640594|NCT00784238|4007959|P1|NOT COMPLETED|Overall Study||119
1640595|NCT00784238|4007959|P1|COMPLETED|Overall Study||170
1640596|NCT00784238|4007959|P1|STARTED|Overall Study||289
1640597|NCT00784147|4008002|P2|NOT COMPLETED|Overall Study||9
1640598|NCT00784147|4008003|P1|NOT COMPLETED|Overall Study||8
1640599|NCT00784147|4008002|P2|COMPLETED|Overall Study||45
1640600|NCT00784147|4008003|P1|COMPLETED|Overall Study||51
1640601|NCT00784147|4008002|P2|STARTED|Overall Study||54
1640602|NCT00784147|4008003|P1|STARTED|Overall Study||59
1640603|NCT00784134|4008023|P2|NOT COMPLETED|Overall Study||6
1640604|NCT00784134|4008024|P1|NOT COMPLETED|Overall Study||3
1640605|NCT00784134|4008023|P2|COMPLETED|Overall Study||245
1640606|NCT00784134|4008024|P1|COMPLETED|Overall Study||246
1640607|NCT00784134|4008023|P2|STARTED|Overall Study||251
1640608|NCT00784134|4008024|P1|STARTED|Overall Study||249
1640609|NCT00784095|4008123|P3|NOT COMPLETED|Overall Study||1
1640610|NCT00784095|4008124|P2|NOT COMPLETED|Overall Study||1
1640611|NCT00784095|4008125|P1|NOT COMPLETED|Overall Study||0
1640612|NCT00784095|4008123|P3|COMPLETED|Overall Study||11
1640613|NCT00784095|4008124|P2|COMPLETED|Overall Study||11
1640614|NCT00784095|4008125|P1|COMPLETED|Overall Study||12
1640615|NCT00784095|4008123|P3|STARTED|Overall Study||12
1640616|NCT00784095|4008124|P2|STARTED|Overall Study||12
1640617|NCT00784095|4008125|P1|STARTED|Overall Study||12
1640618|NCT00784043|4008147|P2|NOT COMPLETED|Overall Study||6
1640619|NCT00784043|4008148|P1|NOT COMPLETED|Overall Study||31
1640620|NCT00784043|4008147|P2|COMPLETED|Overall Study||0
1640621|NCT00784043|4008148|P1|COMPLETED|Overall Study||0
1640622|NCT00784043|4008147|P2|STARTED|Overall Study||6
1640623|NCT00784043|4008148|P1|STARTED|Overall Study||31
1640624|NCT00784030|4008160|P2|NOT COMPLETED|Overall Study||0
1640625|NCT00784030|4008161|P1|NOT COMPLETED|Overall Study||0
1640626|NCT00784030|4008160|P2|COMPLETED|Overall Study||10
1640627|NCT00784030|4008161|P1|COMPLETED|Overall Study||13
1640628|NCT00784030|4008160|P2|STARTED|Overall Study||10
1640629|NCT00784030|4008161|P1|STARTED|Overall Study||13
1640630|NCT00783965|4008169|P2|NOT COMPLETED|Second Intervention (24 Months)||9
1640631|NCT00783965|4008170|P1|NOT COMPLETED|Second Intervention (24 Months)||0
1640632|NCT00783965|4008169|P2|COMPLETED|Second Intervention (24 Months)||16
1640633|NCT00783965|4008170|P1|COMPLETED|Second Intervention (24 Months)||2
1640634|NCT00783965|4008169|P2|STARTED|Second Intervention (24 Months)||25
1640635|NCT00783965|4008170|P1|STARTED|Second Intervention (24 Months)||2
1640636|NCT00783965|4008169|P2|NOT COMPLETED|First Intervention (12 Months)||4
1640637|NCT00783965|4008170|P1|NOT COMPLETED|First Intervention (12 Months)||3
1640638|NCT00783965|4008169|P2|COMPLETED|First Intervention (12 Months)||25
1640639|NCT00783965|4008170|P1|COMPLETED|First Intervention (12 Months)||2
1640640|NCT00783965|4008169|P2|STARTED|First Intervention (12 Months)||29
1640641|NCT00783965|4008170|P1|STARTED|First Intervention (12 Months)||5
1640642|NCT00783952|4008178|P1|NOT COMPLETED|Overall Study||0
1640643|NCT00783952|4008178|P1|COMPLETED|Overall Study||8
1640644|NCT00783952|4008178|P1|STARTED|Overall Study||8
1640645|NCT00783835|4008183|P1|NOT COMPLETED|Overall Study||10
1640646|NCT00783835|4008183|P1|COMPLETED|Overall Study||50
1640647|NCT00783835|4008183|P1|STARTED|Overall Study||60
1640648|NCT00783796|4008195|P1|NOT COMPLETED|Overall Study||6
1640649|NCT00783796|4008195|P1|COMPLETED|Overall Study||144
1640650|NCT00783796|4008195|P1|STARTED|Overall Study||150
1640651|NCT00783718|4008300|P7|NOT COMPLETED|Maintenance Phase||195
1640652|NCT00783718|4008301|P6|NOT COMPLETED|Maintenance Phase||41
1640653|NCT00783718|4008302|P5|NOT COMPLETED|Maintenance Phase||45
1640654|NCT00783718|4008303|P4|NOT COMPLETED|Maintenance Phase||78
1640655|NCT00783718|4008304|P3|NOT COMPLETED|Maintenance Phase||0
1640656|NCT00783718|4008305|P2|NOT COMPLETED|Maintenance Phase||0
1640657|NCT00783718|4008306|P1|NOT COMPLETED|Maintenance Phase||105
1640658|NCT00783718|4008300|P7|COMPLETED|Maintenance Phase||135
1640659|NCT00783718|4008301|P6|COMPLETED|Maintenance Phase||84
1640660|NCT00783718|4008302|P5|COMPLETED|Maintenance Phase||77
1640661|NCT00783718|4008303|P4|COMPLETED|Maintenance Phase||48
1640662|NCT00783718|4008304|P3|COMPLETED|Maintenance Phase||0
1640663|NCT00783718|4008305|P2|COMPLETED|Maintenance Phase||0
1640664|NCT00783718|4008306|P1|COMPLETED|Maintenance Phase||30
1640665|NCT00783718|4008300|P7|STARTED|Maintenance Phase||330
1640666|NCT00783718|4008301|P6|STARTED|Maintenance Phase||125
1640667|NCT00783718|4008302|P5|STARTED|Maintenance Phase||122
1640668|NCT00783718|4008303|P4|STARTED|Maintenance Phase||126
1640669|NCT00783718|4008304|P3|STARTED|Maintenance Phase||0
1640670|NCT00783718|4008305|P2|STARTED|Maintenance Phase||0
1640671|NCT00783718|4008306|P1|STARTED|Maintenance Phase||135
1640672|NCT00783718|4008300|P7|NOT COMPLETED|Induction Phase||0
1640673|NCT00783718|4008301|P6|NOT COMPLETED|Induction Phase||0
1640674|NCT00783718|4008302|P5|NOT COMPLETED|Induction Phase||0
1640675|NCT00783718|4008303|P4|NOT COMPLETED|Induction Phase||0
1640676|NCT00783718|4008304|P3|NOT COMPLETED|Induction Phase||36
1640677|NCT00783718|4008305|P2|NOT COMPLETED|Induction Phase||7
1640678|NCT00783718|4008306|P1|NOT COMPLETED|Induction Phase||14
1640679|NCT00783718|4008300|P7|COMPLETED|Induction Phase||0
1640680|NCT00783718|4008301|P6|COMPLETED|Induction Phase||0
1640681|NCT00783718|4008302|P5|COMPLETED|Induction Phase||0
1640682|NCT00783718|4008303|P4|COMPLETED|Induction Phase||0
1640683|NCT00783718|4008304|P3|COMPLETED|Induction Phase||485
1640684|NCT00783718|4008305|P2|COMPLETED|Induction Phase||218
1640685|NCT00783718|4008306|P1|COMPLETED|Induction Phase||135
1640686|NCT00783718|4008300|P7|STARTED|Induction Phase||0
1640687|NCT00783718|4008301|P6|STARTED|Induction Phase||0
1640688|NCT00783718|4008302|P5|STARTED|Induction Phase||0
1640689|NCT00783718|4008303|P4|STARTED|Induction Phase||0
1640690|NCT00783718|4008304|P3|STARTED|Induction Phase||521
1640691|NCT00783718|4008305|P2|STARTED|Induction Phase||225
1640692|NCT00783718|4008306|P1|STARTED|Induction Phase||149
1640693|NCT00783705|4008334|P2|NOT COMPLETED|Overall Study||5
1640694|NCT00783705|4008335|P1|NOT COMPLETED|Overall Study||6
1640695|NCT00783705|4008334|P2|COMPLETED|Overall Study||36
1640696|NCT00783705|4008335|P1|COMPLETED|Overall Study||38
1640697|NCT00783705|4008334|P2|STARTED|Overall Study||41
1640698|NCT00783705|4008335|P1|STARTED|Overall Study||44
1640699|NCT00783692|4008382|P7|NOT COMPLETED|Maintenance Phase||249
1640700|NCT00783692|4008383|P6|NOT COMPLETED|Maintenance Phase||72
1640701|NCT00783692|4008384|P5|NOT COMPLETED|Maintenance Phase||81
1640702|NCT00783692|4008385|P4|NOT COMPLETED|Maintenance Phase||89
1640703|NCT00783692|4008386|P3|NOT COMPLETED|Maintenance Phase||0
1640704|NCT00783692|4008387|P2|NOT COMPLETED|Maintenance Phase||0
1640705|NCT00783692|4008388|P1|NOT COMPLETED|Maintenance Phase||95
1640706|NCT00783692|4008382|P7|COMPLETED|Maintenance Phase||163
1640707|NCT00783692|4008383|P6|COMPLETED|Maintenance Phase||82
1640708|NCT00783692|4008384|P5|COMPLETED|Maintenance Phase||73
1640709|NCT00783692|4008385|P4|COMPLETED|Maintenance Phase||64
1640710|NCT00783692|4008386|P3|COMPLETED|Maintenance Phase||0
1640711|NCT00783692|4008387|P2|COMPLETED|Maintenance Phase||0
1640712|NCT00783692|4008388|P1|COMPLETED|Maintenance Phase||42
1640713|NCT00783692|4008382|P7|STARTED|Maintenance Phase||412
1640714|NCT00783692|4008383|P6|STARTED|Maintenance Phase||154
1640715|NCT00783692|4008384|P5|STARTED|Maintenance Phase||154
1640716|NCT00783692|4008385|P4|STARTED|Maintenance Phase||153
1640717|NCT00783692|4008386|P3|STARTED|Maintenance Phase||0
1640718|NCT00783692|4008387|P2|STARTED|Maintenance Phase||0
1640719|NCT00783692|4008388|P1|STARTED|Maintenance Phase||137
1640720|NCT00783692|4008382|P7|NOT COMPLETED|Induction Phase||0
1640721|NCT00783692|4008383|P6|NOT COMPLETED|Induction Phase||0
1640722|NCT00783692|4008384|P5|NOT COMPLETED|Induction Phase||0
1640723|NCT00783692|4008385|P4|NOT COMPLETED|Induction Phase||0
1640724|NCT00783692|4008386|P3|NOT COMPLETED|Induction Phase||74
1640725|NCT00783692|4008387|P2|NOT COMPLETED|Induction Phase||21
1640726|NCT00783692|4008388|P1|NOT COMPLETED|Induction Phase||11
1640727|NCT00783692|4008382|P7|COMPLETED|Induction Phase||0
1640728|NCT00783692|4008383|P6|COMPLETED|Induction Phase||0
1640729|NCT00783692|4008384|P5|COMPLETED|Induction Phase||0
1640730|NCT00783692|4008385|P4|COMPLETED|Induction Phase||0
1640731|NCT00783692|4008386|P3|COMPLETED|Induction Phase||674
1640732|NCT00783692|4008387|P2|COMPLETED|Induction Phase||199
1640733|NCT00783692|4008388|P1|COMPLETED|Induction Phase||137
1640734|NCT00783692|4008382|P7|Treated|Induction Phase||0
1640735|NCT00783692|4008383|P6|Treated|Induction Phase||0
1640736|NCT00783692|4008384|P5|Treated|Induction Phase||0
1640737|NCT00783692|4008385|P4|Treated|Induction Phase||0
1640738|NCT00783692|4008386|P3|Treated|Induction Phase||747
1640739|NCT00783692|4008387|P2|Treated|Induction Phase||220
1640740|NCT00783692|4008388|P1|Treated|Induction Phase||148
1640741|NCT00783692|4008382|P7|STARTED|Induction Phase||0
1640742|NCT00783692|4008383|P6|STARTED|Induction Phase||0
1640743|NCT00783692|4008384|P5|STARTED|Induction Phase||0
1640744|NCT00783692|4008385|P4|STARTED|Induction Phase||0
1640745|NCT00783692|4008386|P3|STARTED|Induction Phase||748
1640746|NCT00783692|4008387|P2|STARTED|Induction Phase||220
1640747|NCT00783692|4008388|P1|STARTED|Induction Phase||148
1640748|NCT00783614|4008415|P4|NOT COMPLETED|Overall Study||0
1640749|NCT00783614|4008416|P3|NOT COMPLETED|Overall Study||0
1640750|NCT00783614|4008417|P2|NOT COMPLETED|Overall Study||0
1640751|NCT00783614|4008418|P1|NOT COMPLETED|Overall Study||0
1640752|NCT00783614|4008415|P4|COMPLETED|Overall Study||5
1640753|NCT00783614|4008416|P3|COMPLETED|Overall Study||5
1640754|NCT00783614|4008417|P2|COMPLETED|Overall Study||6
1640755|NCT00783614|4008418|P1|COMPLETED|Overall Study||6
1640756|NCT00783614|4008415|P4|STARTED|Overall Study||5
1640757|NCT00783614|4008416|P3|STARTED|Overall Study||5
1640758|NCT00783614|4008417|P2|STARTED|Overall Study||6
1640759|NCT00783614|4008418|P1|STARTED|Overall Study||6
1640760|NCT00783432|4008434|P2|NOT COMPLETED|Overall Study||78
1640761|NCT00783432|4008435|P1|NOT COMPLETED|Overall Study||85
1640762|NCT00783432|4008434|P2|COMPLETED|Overall Study||354
1640763|NCT00783432|4008435|P1|COMPLETED|Overall Study||345
1640764|NCT00783432|4008434|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
1640765|NCT00783432|4008435|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
1640766|NCT00783302|4008445|P1|NOT COMPLETED|Overall Study||35
1640767|NCT00783302|4008445|P1|COMPLETED|Overall Study||850
1640768|NCT00783302|4008445|P1|STARTED|Overall Study||885
1640769|NCT00783263|4008467|P4|NOT COMPLETED|Overall Study||3
1640770|NCT00783263|4008468|P3|NOT COMPLETED|Overall Study||3
1640771|NCT00783263|4008469|P2|NOT COMPLETED|Overall Study||2
1640772|NCT00783263|4008470|P1|NOT COMPLETED|Overall Study||4
1640773|NCT00783263|4008467|P4|COMPLETED|Overall Study||118
1640774|NCT00783263|4008468|P3|COMPLETED|Overall Study||119
1640775|NCT00783263|4008469|P2|COMPLETED|Overall Study||96
1640776|NCT00783263|4008470|P1|COMPLETED|Overall Study||95
1640777|NCT00783263|4008467|P4|STARTED|Overall Study||121
1640778|NCT00783263|4008468|P3|STARTED|Overall Study||122
1640779|NCT00783263|4008469|P2|STARTED|Overall Study||98
1640780|NCT00783263|4008470|P1|STARTED|Overall Study||99
1640781|NCT00783224|4008500|P4|NOT COMPLETED|Overall Study||2
1640782|NCT00783224|4008501|P3|NOT COMPLETED|Overall Study||1
1640783|NCT00783224|4008502|P2|NOT COMPLETED|Overall Study||0
1640784|NCT00783224|4008503|P1|NOT COMPLETED|Overall Study||0
1640785|NCT00783224|4008500|P4|COMPLETED|Overall Study||140
1640786|NCT00783224|4008501|P3|COMPLETED|Overall Study||142
1640787|NCT00783224|4008502|P2|COMPLETED|Overall Study||34
1640788|NCT00783224|4008503|P1|COMPLETED|Overall Study||32
1640789|NCT00783224|4008500|P4|STARTED|Overall Study||142
1640790|NCT00783224|4008501|P3|STARTED|Overall Study||143
1640791|NCT00783224|4008502|P2|STARTED|Overall Study||34
1640792|NCT00783224|4008503|P1|STARTED|Overall Study||32
1640793|NCT00783198|4008515|P3|NOT COMPLETED|Overall Study||42
1640794|NCT00783198|4008516|P2|NOT COMPLETED|Overall Study||43
1640795|NCT00783198|4008517|P1|NOT COMPLETED|Overall Study||57
1640796|NCT00783198|4008515|P3|COMPLETED|Overall Study||146
1640797|NCT00783198|4008516|P2|COMPLETED|Overall Study||144
1640798|NCT00783198|4008517|P1|COMPLETED|Overall Study||133
1640799|NCT00783198|4008515|P3|STARTED|Overall Study||188
1640800|NCT00783198|4008516|P2|STARTED|Overall Study||187
1640801|NCT00783198|4008517|P1|STARTED|Overall Study||190
1640802|NCT00783094|4008540|P3|NOT COMPLETED|Open-Label Extension Period||30
1640803|NCT00783094|4008541|P2|NOT COMPLETED|Open-Label Extension Period||19
1640804|NCT00783094|4008542|P1|NOT COMPLETED|Open-Label Extension Period||22
1640805|NCT00783094|4008540|P3|COMPLETED|Open-Label Extension Period||101
1640806|NCT00783094|4008541|P2|COMPLETED|Open-Label Extension Period||109
1640807|NCT00783094|4008542|P1|COMPLETED|Open-Label Extension Period||113
1640808|NCT00783094|4008540|P3|STARTED|Open-Label Extension Period||131
1640809|NCT00783094|4008541|P2|STARTED|Open-Label Extension Period||128
1640810|NCT00783094|4008542|P1|STARTED|Open-Label Extension Period||135
1640811|NCT00783094|4008540|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
1640812|NCT00783094|4008541|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
1640813|NCT00783094|4008542|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
1640814|NCT00783094|4008540|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
1640815|NCT00783094|4008541|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
1640816|NCT00783094|4008542|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
1640817|NCT00783094|4008540|P3|STARTED|Randomized Double-Blind Treatment Period||140
1640818|NCT00783094|4008541|P2|STARTED|Randomized Double-Blind Treatment Period||140
1640819|NCT00783094|4008542|P1|STARTED|Randomized Double-Blind Treatment Period||142
1640820|NCT00782834|4008618|P1|NOT COMPLETED|Treatment Phase||1
1640821|NCT00782834|4008618|P1|COMPLETED|Treatment Phase||13
1640822|NCT00782834|4008618|P1|STARTED|Treatment Phase||14
1640823|NCT00782834|4008618|P1|NOT COMPLETED|Screened Patients||1
1640824|NCT00782834|4008618|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
1640825|NCT00782834|4008618|P1|STARTED|Screened Patients||15
1640826|NCT00782821|4008627|P4|NOT COMPLETED|Overall Study||2
1640827|NCT00782821|4008628|P3|NOT COMPLETED|Overall Study||1
1640828|NCT00782821|4008629|P2|NOT COMPLETED|Overall Study||0
1640829|NCT00782821|4008630|P1|NOT COMPLETED|Overall Study||0
1640830|NCT00782821|4008627|P4|COMPLETED|Overall Study||8
1640831|NCT00782821|4008628|P3|COMPLETED|Overall Study||9
1640832|NCT00782821|4008629|P2|COMPLETED|Overall Study||10
1640833|NCT00782821|4008630|P1|COMPLETED|Overall Study||10
1640834|NCT00782821|4008627|P4|STARTED|Overall Study||10
1640835|NCT00782821|4008628|P3|STARTED|Overall Study||10
1640836|NCT00782821|4008629|P2|STARTED|Overall Study||10
1640837|NCT00782821|4008630|P1|STARTED|Overall Study||10
1640838|NCT00782795|4008658|P2|NOT COMPLETED|Overall Study||2
1640839|NCT00782795|4008659|P1|NOT COMPLETED|Overall Study||1
1640840|NCT00782795|4008658|P2|COMPLETED|Overall Study||6
1640841|NCT00782795|4008659|P1|COMPLETED|Overall Study||16
1640842|NCT00782795|4008658|P2|24 Week Appointment|Overall Study||7
1640843|NCT00782795|4008659|P1|24 Week Appointment|Overall Study||16
1640844|NCT00782795|4008658|P2|6 Weeks (1st Apptment)|Overall Study||7
1640845|NCT00782795|4008659|P1|6 Weeks (1st Apptment)|Overall Study||16
1640846|NCT00782795|4008658|P2|STARTED|Overall Study||8
1640847|NCT00782795|4008659|P1|STARTED|Overall Study||17
1640848|NCT00782756|4008691|P1|NOT COMPLETED|Overall Study||0
1640849|NCT00782756|4008691|P1|COMPLETED|Overall Study||40
1640850|NCT00782756|4008691|P1|STARTED|Overall Study||40
1640851|NCT00782717|4008699|P2|NOT COMPLETED|Overall Study||28
1640852|NCT00782717|4008700|P1|NOT COMPLETED|Overall Study||15
1640853|NCT00782717|4008699|P2|COMPLETED|Overall Study||102
1640854|NCT00782717|4008700|P1|COMPLETED|Overall Study||118
1640855|NCT00782717|4008699|P2|STARTED|Overall Study||130
1640856|NCT00782717|4008700|P1|STARTED|Overall Study||133
1640857|NCT00782639|4008710|P2|NOT COMPLETED|Overall Study||0
1640858|NCT00782639|4008711|P1|NOT COMPLETED|Overall Study||0
1640859|NCT00782639|4008710|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
1640860|NCT00782639|4008711|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
1640861|NCT00782639|4008710|P2|STARTED|Overall Study||11
1640862|NCT00782639|4008711|P1|STARTED|Overall Study||12
1640863|NCT00782626|4008727|P1|NOT COMPLETED|Overall Study||7
1640864|NCT00782626|4008727|P1|COMPLETED|Overall Study||16
1640865|NCT00782626|4008727|P1|STARTED|Overall Study||23
1640866|NCT00782509|4008734|P3|NOT COMPLETED|Overall Study||36
1640867|NCT00782509|4008735|P2|NOT COMPLETED|Overall Study||24
1640868|NCT00782509|4008736|P1|NOT COMPLETED|Overall Study||41
1640869|NCT00782509|4008734|P3|COMPLETED|Overall Study||181
1640870|NCT00782509|4008735|P2|COMPLETED|Overall Study||185
1640871|NCT00782509|4008736|P1|COMPLETED|Overall Study||175
1640872|NCT00782509|4008734|P3|STARTED|Overall Study||217
1640873|NCT00782509|4008735|P2|STARTED|Overall Study||209
1640874|NCT00782509|4008736|P1|STARTED|Overall Study||216
1640875|NCT00782496|4008929|P2|NOT COMPLETED|Overall Study||15
1640876|NCT00782496|4008930|P1|NOT COMPLETED|Overall Study||14
1640877|NCT00782496|4008929|P2|COMPLETED|Overall Study||90
1640878|NCT00782496|4008930|P1|COMPLETED|Overall Study||92
1640879|NCT00782496|4008929|P2|STARTED|Overall Study||105
1640880|NCT00782496|4008930|P1|STARTED|Overall Study||106
1640881|NCT00782483|4008937|P1|NOT COMPLETED|Overall Study||6
1640882|NCT00782483|4008937|P1|COMPLETED|Overall Study||0
1640883|NCT00782483|4008937|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
1640884|NCT00782418|4008941|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1640885|NCT00782418|4008942|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1640886|NCT00782418|4008943|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1640887|NCT00782418|4008944|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1640888|NCT00782418|4008945|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1640889|NCT00782418|4008946|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1640890|NCT00782418|4008947|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1640891|NCT00782418|4008941|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
1640892|NCT00782418|4008942|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
1640893|NCT00782418|4008943|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
1640894|NCT00782418|4008944|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
1640895|NCT00782418|4008945|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
1640896|NCT00782418|4008946|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
1640897|NCT00782418|4008947|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
1640898|NCT00782418|4008941|P7|STARTED|Period 2 Procedure/Treatment Groups||4
1640899|NCT00782418|4008942|P6|STARTED|Period 2 Procedure/Treatment Groups||4
1640900|NCT00782418|4008943|P5|STARTED|Period 2 Procedure/Treatment Groups||3
1640901|NCT00782418|4008944|P4|STARTED|Period 2 Procedure/Treatment Groups||1
1640902|NCT00782418|4008945|P3|STARTED|Period 2 Procedure/Treatment Groups||4
1640903|NCT00782418|4008946|P2|STARTED|Period 2 Procedure/Treatment Groups||4
1640904|NCT00782418|4008947|P1|STARTED|Period 2 Procedure/Treatment Groups||3
1640905|NCT00782418|4008941|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1640906|NCT00782418|4008942|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
1640907|NCT00782418|4008943|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
1640908|NCT00782418|4008944|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1640909|NCT00782418|4008945|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1640910|NCT00782418|4008946|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1640911|NCT00782418|4008947|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
1640912|NCT00782418|4008941|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
1640913|NCT00782418|4008942|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
1640914|NCT00782418|4008943|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
1640915|NCT00782418|4008944|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
1640916|NCT00782418|4008945|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
1640917|NCT00782418|4008946|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
1640918|NCT00782418|4008947|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
1640919|NCT00782418|4008941|P7|STARTED|Period 1 Procedure/Treatment Groups||4
1640920|NCT00782418|4008942|P6|STARTED|Period 1 Procedure/Treatment Groups||5
1640921|NCT00782418|4008943|P5|STARTED|Period 1 Procedure/Treatment Groups||5
1640922|NCT00782418|4008944|P4|STARTED|Period 1 Procedure/Treatment Groups||2
1640923|NCT00782418|4008945|P3|STARTED|Period 1 Procedure/Treatment Groups||4
1640924|NCT00782418|4008946|P2|STARTED|Period 1 Procedure/Treatment Groups||4
1640925|NCT00782418|4008947|P1|STARTED|Period 1 Procedure/Treatment Groups||3
1640926|NCT00782379|4008967|P1|NOT COMPLETED|Overall Study||0
1640927|NCT00782379|4008967|P1|COMPLETED|Overall Study||20
1640928|NCT00782379|4008967|P1|STARTED|Overall Study||20
1640929|NCT00782340|4008984|P3|NOT COMPLETED|Randomized Double Blind||0
1640930|NCT00782340|4008985|P2|NOT COMPLETED|Randomized Double Blind||0
1640931|NCT00782340|4008986|P1|NOT COMPLETED|Randomized Double Blind||0
1640932|NCT00782340|4008984|P3|COMPLETED|Randomized Double Blind||80
1640933|NCT00782340|4008985|P2|COMPLETED|Randomized Double Blind||82
1640934|NCT00782340|4008986|P1|COMPLETED|Randomized Double Blind||0
1640935|NCT00782340|4008984|P3|STARTED|Randomized Double Blind||80
1640936|NCT00782340|4008985|P2|STARTED|Randomized Double Blind||82
1640937|NCT00782340|4008986|P1|STARTED|Randomized Double Blind||0
1640938|NCT00782340|4008984|P3|NOT COMPLETED|Open Label Titration||0
1640939|NCT00782340|4008985|P2|NOT COMPLETED|Open Label Titration||0
1640940|NCT00782340|4008986|P1|NOT COMPLETED|Open Label Titration||101
1640941|NCT00782340|4008984|P3|COMPLETED|Open Label Titration||0
1640942|NCT00782340|4008985|P2|COMPLETED|Open Label Titration||0
1640943|NCT00782340|4008986|P1|COMPLETED|Open Label Titration||162
1640944|NCT00782340|4008984|P3|STARTED|Open Label Titration||0
1640945|NCT00782340|4008985|P2|STARTED|Open Label Titration||0
1640946|NCT00782340|4008986|P1|STARTED|Open Label Titration||263
1640947|NCT00782288|4009012|P3|NOT COMPLETED|Overall Study||0
1640948|NCT00782288|4009013|P2|NOT COMPLETED|Overall Study||0
1640949|NCT00782288|4009014|P1|NOT COMPLETED|Overall Study||0
1640950|NCT00782288|4009012|P3|COMPLETED|Overall Study||8
1640951|NCT00782288|4009013|P2|COMPLETED|Overall Study||8
1640952|NCT00782288|4009014|P1|COMPLETED|Overall Study||8
1640953|NCT00782288|4009012|P3|STARTED|Overall Study||8
1640954|NCT00782288|4009013|P2|STARTED|Overall Study||8
1640955|NCT00782288|4009014|P1|STARTED|Overall Study||8
1640956|NCT00782275|4009056|P1|NOT COMPLETED|Overall Study||41
1640957|NCT00782275|4009056|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1640958|NCT00782275|4009056|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
1640959|NCT00782275|4009056|P1|Treated|Overall Study||40
1640960|NCT00782275|4009056|P1|STARTED|Overall Study||41
1640961|NCT00782210|4009065|P3|NOT COMPLETED|Overall Study||35
1640962|NCT00782210|4009066|P2|NOT COMPLETED|Overall Study||35
1640963|NCT00782210|4009067|P1|NOT COMPLETED|Overall Study||50
1640964|NCT00782210|4009065|P3|COMPLETED|Overall Study||172
1640965|NCT00782210|4009066|P2|COMPLETED|Overall Study||173
1640966|NCT00782210|4009067|P1|COMPLETED|Overall Study||159
1640967|NCT00782210|4009065|P3|STARTED|Overall Study||207
1640968|NCT00782210|4009066|P2|STARTED|Overall Study||208
1640969|NCT00782210|4009067|P1|STARTED|Overall Study||209
1640970|NCT00782184|4009260|P2|NOT COMPLETED|Overall Study||5
1640971|NCT00782184|4009261|P1|NOT COMPLETED|Overall Study||4
1640972|NCT00782184|4009260|P2|COMPLETED|Overall Study||125
1640973|NCT00782184|4009261|P1|COMPLETED|Overall Study||116
1640974|NCT00782184|4009260|P2|STARTED|Overall Study||130
1640975|NCT00782184|4009261|P1|STARTED|Overall Study||120
1640976|NCT00782171|4009298|P2|NOT COMPLETED|Overall Study||19
1640977|NCT00782171|4009299|P1|NOT COMPLETED|Overall Study||22
1640978|NCT00782171|4009298|P2|COMPLETED|Overall Study||115
1640979|NCT00782171|4009299|P1|COMPLETED|Overall Study||124
1640980|NCT00782171|4009298|P2|Surgery (Baseline)|Overall Study||128
1640981|NCT00782171|4009299|P1|Surgery (Baseline)|Overall Study||138
1640982|NCT00782171|4009298|P2|1 Year|Overall Study||120
1640983|NCT00782171|4009299|P1|1 Year|Overall Study||131
1640984|NCT00782171|4009298|P2|20-23 Weeks|Overall Study||124
1640985|NCT00782171|4009299|P1|20-23 Weeks|Overall Study||135
1640986|NCT00782171|4009298|P2|STARTED|Overall Study||134
1640987|NCT00782171|4009299|P1|STARTED|Overall Study||146
1640988|NCT00782067|4009331|P1|NOT COMPLETED|Overall Study||116
1640989|NCT00782067|4009331|P1|COMPLETED|Overall Study||0
1640990|NCT00782067|4009331|P1|Primary Efficacy Population (PEP)|Overall Study||89
1640991|NCT00782067|4009331|P1|Safety Set (SS)|Overall Study||116
1640992|NCT00782067|4009331|P1|STARTED|Overall Study||116
1640993|NCT00781963|4009344|P3|NOT COMPLETED|Overall Study||2
1640994|NCT00781963|4009345|P2|NOT COMPLETED|Overall Study||9
1640995|NCT00781963|4009346|P1|NOT COMPLETED|Overall Study||8
1640996|NCT00781963|4009344|P3|COMPLETED|Overall Study||51
1640997|NCT00781963|4009345|P2|COMPLETED|Overall Study||43
1640998|NCT00781963|4009346|P1|COMPLETED|Overall Study||46
1640999|NCT00781963|4009344|P3|6-month Follow-up|Overall Study||52
1641000|NCT00781963|4009345|P2|6-month Follow-up|Overall Study||44
1641001|NCT00781963|4009346|P1|6-month Follow-up|Overall Study||48
1641002|NCT00781963|4009344|P3|Post-treatment|Overall Study||53
1641003|NCT00781963|4009345|P2|Post-treatment|Overall Study||45
1641004|NCT00781963|4009346|P1|Post-treatment|Overall Study||52
1641005|NCT00781963|4009344|P3|STARTED|Overall Study||53
1641006|NCT00781963|4009345|P2|STARTED|Overall Study||52
1641007|NCT00781963|4009346|P1|STARTED|Overall Study||54
1641008|NCT00781950|4009356|P2|NOT COMPLETED|Overall Study||13
1641009|NCT00781950|4009357|P1|NOT COMPLETED|Overall Study||11
1641010|NCT00781950|4009356|P2|COMPLETED|Overall Study||45
1641011|NCT00781950|4009357|P1|COMPLETED|Overall Study||41
1641012|NCT00781950|4009356|P2|STARTED|Overall Study||58
1641013|NCT00781950|4009357|P1|STARTED|Overall Study||52
1641014|NCT00781937|4009367|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
1641015|NCT00781937|4009368|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
1641016|NCT00781937|4009367|P2|COMPLETED|Follow up Period (Week 56-68)||141
1641017|NCT00781937|4009368|P1|COMPLETED|Follow up Period (Week 56-68)||153
1641018|NCT00781937|4009367|P2|STARTED|Follow up Period (Week 56-68)||146
1641019|NCT00781937|4009368|P1|STARTED|Follow up Period (Week 56-68)||159
1641020|NCT00781937|4009367|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
1641021|NCT00781937|4009368|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
1641022|NCT00781937|4009367|P2|COMPLETED|Main Trial Period Through Week 56||146
1641023|NCT00781937|4009368|P1|COMPLETED|Main Trial Period Through Week 56||159
1641024|NCT00781937|4009367|P2|STARTED|Main Trial Period Through Week 56||210
1641025|NCT00781937|4009368|P1|STARTED|Main Trial Period Through Week 56||212
1641026|NCT00781911|4009426|P2|NOT COMPLETED|Overall Study||8
1641027|NCT00781911|4009427|P1|NOT COMPLETED|Overall Study||6
1641028|NCT00781911|4009426|P2|COMPLETED|Overall Study||4
1641029|NCT00781911|4009427|P1|COMPLETED|Overall Study||25
1641030|NCT00781911|4009426|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
1641031|NCT00781911|4009427|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
1641032|NCT00781911|4009426|P2|STARTED|Overall Study||12
1641033|NCT00781911|4009427|P1|STARTED|Overall Study||31
1641034|NCT00781898|4009455|P2|NOT COMPLETED|Overall Study||29
1641035|NCT00781898|4009456|P1|NOT COMPLETED|Overall Study||34
1641036|NCT00781898|4009455|P2|COMPLETED|Overall Study||126
1641037|NCT00781898|4009456|P1|COMPLETED|Overall Study||119
1641038|NCT00781898|4009455|P2|STARTED|Overall Study||155
1641039|NCT00781898|4009456|P1|STARTED|Overall Study||153
1641040|NCT00781859|4009464|P2|NOT COMPLETED|Overall Study||9
1641041|NCT00781859|4009465|P1|NOT COMPLETED|Overall Study||19
1641042|NCT00781859|4009464|P2|COMPLETED|Overall Study||98
1641043|NCT00781859|4009465|P1|COMPLETED|Overall Study||200
1641044|NCT00781859|4009464|P2|STARTED|Overall Study||107
1641045|NCT00781859|4009465|P1|STARTED|Overall Study||219
1641046|NCT00781768|4009475|P2|NOT COMPLETED|Overall Study||2
1641047|NCT00781768|4009476|P1|NOT COMPLETED|Overall Study||0
1641048|NCT00781768|4009475|P2|COMPLETED|Overall Study||90
1641049|NCT00781768|4009476|P1|COMPLETED|Overall Study||89
1641050|NCT00781768|4009475|P2|STARTED|Overall Study||92
1641051|NCT00781768|4009476|P1|STARTED|Overall Study||89
1641052|NCT00781599|4009484|P2|NOT COMPLETED|Overall Study||4
1641053|NCT00781599|4009485|P1|NOT COMPLETED|Overall Study||7
1641054|NCT00781599|4009484|P2|COMPLETED|Overall Study||32
1641055|NCT00781599|4009485|P1|COMPLETED|Overall Study||29
1641056|NCT00781599|4009484|P2|STARTED|Overall Study||36
1641057|NCT00781599|4009485|P1|STARTED|Overall Study||36
1641058|NCT00781508|4009499|P2|NOT COMPLETED|Overall Study||0
1641059|NCT00781508|4009500|P1|NOT COMPLETED|Overall Study||0
1641060|NCT00781508|4009499|P2|COMPLETED|Overall Study||5
1641061|NCT00781508|4009500|P1|COMPLETED|Overall Study||5
1641062|NCT00781508|4009499|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
1641063|NCT00781508|4009500|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
1641064|NCT00781456|4009510|P2|NOT COMPLETED|Overall Study||16
1641065|NCT00781456|4009511|P1|NOT COMPLETED|Overall Study||21
1641066|NCT00781456|4009510|P2|COMPLETED|Overall Study||35
1641067|NCT00781456|4009511|P1|COMPLETED|Overall Study||37
1641068|NCT00781456|4009510|P2|Received Study Drug|Overall Study||49
1641069|NCT00781456|4009511|P1|Received Study Drug|Overall Study||57
1641070|NCT00781456|4009510|P2|STARTED|Overall Study||51
1641071|NCT00781456|4009511|P1|STARTED|Overall Study||58
1641072|NCT00781391|4009534|P3|NOT COMPLETED|Overall Study||784
1641073|NCT00781391|4009535|P2|NOT COMPLETED|Overall Study||807
1641074|NCT00781391|4009536|P1|NOT COMPLETED|Overall Study||879
1641075|NCT00781391|4009534|P3|COMPLETED|Overall Study||6250
1641076|NCT00781391|4009535|P2|COMPLETED|Overall Study||6228
1641077|NCT00781391|4009536|P1|COMPLETED|Overall Study||6157
1641078|NCT00781391|4009534|P3|Per Protocol Analysis Set|Overall Study||6982
1641079|NCT00781391|4009535|P2|Per Protocol Analysis Set|Overall Study||6995
1641080|NCT00781391|4009536|P1|Per Protocol Analysis Set|Overall Study||6993
1641081|NCT00781391|4009534|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
1641082|NCT00781391|4009535|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
1641083|NCT00781391|4009536|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
1641084|NCT00781391|4009534|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
1641085|NCT00781391|4009535|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
1641086|NCT00781391|4009536|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
1641087|NCT00781391|4009534|P3|STARTED|Overall Study||7034
1641088|NCT00781391|4009535|P2|STARTED|Overall Study||7035
1641089|NCT00781391|4009536|P1|STARTED|Overall Study||7036
1641090|NCT00781365|4009570|P2|NOT COMPLETED|Overall Study||36
1641091|NCT00781365|4009571|P1|NOT COMPLETED|Overall Study||34
1641092|NCT00781365|4009570|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
1641093|NCT00781365|4009571|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
1641094|NCT00781365|4009570|P2|STARTED|Overall Study||222
1641095|NCT00781365|4009571|P1|STARTED|Overall Study||228
1641096|NCT00781326|4009581|P1|NOT COMPLETED|Phase 2||0
1641097|NCT00781326|4009581|P1|COMPLETED|Phase 2||0
1641098|NCT00781326|4009581|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
1641099|NCT00781326|4009581|P1|NOT COMPLETED|Phase I||4
1641100|NCT00781326|4009581|P1|COMPLETED|Phase I||2
1641101|NCT00781326|4009581|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
1641102|NCT00781274|4009585|P1|NOT COMPLETED|Overall Study||2
1641103|NCT00781274|4009585|P1|COMPLETED|Overall Study||30
1641104|NCT00781274|4009585|P1|STARTED|Overall Study||32
1641105|NCT00781079|4009591|P2|NOT COMPLETED|Overall Study||17
1641106|NCT00781079|4009592|P1|NOT COMPLETED|Overall Study||27
1641107|NCT00781079|4009591|P2|COMPLETED|Overall Study||116
1641108|NCT00781079|4009592|P1|COMPLETED|Overall Study||122
1641109|NCT00781079|4009591|P2|STARTED|Overall Study||133
1641110|NCT00781079|4009592|P1|STARTED|Overall Study||149
1641111|NCT00780962|4009610|P2|NOT COMPLETED|Overall Study||27
1641112|NCT00780962|4009611|P1|NOT COMPLETED|Overall Study||15
1641113|NCT00780962|4009610|P2|COMPLETED|Overall Study||172
1641114|NCT00780962|4009611|P1|COMPLETED|Overall Study||185
1641115|NCT00780962|4009610|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
1641116|NCT00780962|4009611|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
1641117|NCT00780962|4009610|P2|STARTED|Overall Study||199
1641118|NCT00780962|4009611|P1|STARTED|Overall Study||200
1641119|NCT00780910|4009617|P1|NOT COMPLETED|Overall Study||2
1641120|NCT00780910|4009617|P1|COMPLETED|Overall Study||107
1641121|NCT00780910|4009617|P1|STARTED|Overall Study||109
1641122|NCT00780741|4009623|P2|NOT COMPLETED|Overall Study||10
1641123|NCT00780741|4009624|P1|NOT COMPLETED|Overall Study||7
1641124|NCT00780741|4009623|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
1641125|NCT00780741|4009624|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
1641126|NCT00780741|4009623|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
1641127|NCT00780741|4009624|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
1641128|NCT00780741|4009623|P2|STARTED|Overall Study|randomized|81
1641129|NCT00780741|4009624|P1|STARTED|Overall Study|randomized|82
1641130|NCT00780715|4009640|P4|NOT COMPLETED|Overall Study||0
1641131|NCT00780715|4009641|P3|NOT COMPLETED|Overall Study||0
1641132|NCT00780715|4009642|P2|NOT COMPLETED|Overall Study||0
1641133|NCT00780715|4009643|P1|NOT COMPLETED|Overall Study||0
1641134|NCT00780715|4009640|P4|COMPLETED|Overall Study||11
1641135|NCT00780715|4009641|P3|COMPLETED|Overall Study||6
1641136|NCT00780715|4009642|P2|COMPLETED|Overall Study||6
1641137|NCT00780715|4009643|P1|COMPLETED|Overall Study||6
1641138|NCT00780715|4009640|P4|STARTED|Overall Study||11
1641139|NCT00780715|4009641|P3|STARTED|Overall Study||6
1641140|NCT00780715|4009642|P2|STARTED|Overall Study||6
1641141|NCT00780715|4009643|P1|STARTED|Overall Study||6
1641142|NCT00780676|4009658|P5|NOT COMPLETED|Overall Study||0
1641143|NCT00780676|4009659|P4|NOT COMPLETED|Overall Study||0
1641144|NCT00780676|4009660|P3|NOT COMPLETED|Overall Study||0
1641145|NCT00780676|4009661|P2|NOT COMPLETED|Overall Study||0
1641146|NCT00780676|4009662|P1|NOT COMPLETED|Overall Study||0
1641147|NCT00780676|4009658|P5|COMPLETED|Overall Study||0
1641148|NCT00780676|4009659|P4|COMPLETED|Overall Study||0
1641149|NCT00780676|4009660|P3|COMPLETED|Overall Study||13
1641150|NCT00780676|4009661|P2|COMPLETED|Overall Study||8
1641151|NCT00780676|4009662|P1|COMPLETED|Overall Study||9
1641152|NCT00780676|4009658|P5|STARTED|Overall Study||0
1641153|NCT00780676|4009659|P4|STARTED|Overall Study||0
1641154|NCT00780676|4009660|P3|STARTED|Overall Study||13
1641155|NCT00780676|4009661|P2|STARTED|Overall Study||8
1641156|NCT00780676|4009662|P1|STARTED|Overall Study||9
1641157|NCT00780572|4009670|P2|NOT COMPLETED|Overall Study||0
1641158|NCT00780572|4009671|P1|NOT COMPLETED|Overall Study||0
1641159|NCT00780572|4009670|P2|COMPLETED|Overall Study||298
1641160|NCT00780572|4009671|P1|COMPLETED|Overall Study||297
1641161|NCT00780572|4009670|P2|STARTED|Overall Study||298
1641162|NCT00780572|4009671|P1|STARTED|Overall Study||297
1641163|NCT00780481|4009677|P1|NOT COMPLETED|Overall Study||0
1641164|NCT00780481|4009677|P1|COMPLETED|Overall Study||13
1641165|NCT00780481|4009677|P1|STARTED|Overall Study||13
1641166|NCT00780455|4009686|P2|NOT COMPLETED|Overall Study||0
1641167|NCT00780455|4009687|P1|NOT COMPLETED|Overall Study||0
1641168|NCT00780455|4009686|P2|COMPLETED|Overall Study||2
1641169|NCT00780455|4009687|P1|COMPLETED|Overall Study||2
1641170|NCT00780455|4009686|P2|STARTED|Overall Study||2
1641171|NCT00780455|4009687|P1|STARTED|Overall Study||2
1641172|NCT00780442|4009713|P2|NOT COMPLETED|Overall Study||0
1641173|NCT00780442|4009714|P1|NOT COMPLETED|Overall Study||0
1641174|NCT00780442|4009713|P2|COMPLETED|Overall Study||15
1641175|NCT00780442|4009714|P1|COMPLETED|Overall Study||12
1641176|NCT00780442|4009713|P2|STARTED|Overall Study||15
1641177|NCT00780442|4009714|P1|STARTED|Overall Study||12
1641178|NCT00780416|4009722|P2|NOT COMPLETED|Overall Study||9
1641179|NCT00780416|4009723|P1|NOT COMPLETED|Overall Study||12
1641180|NCT00780416|4009722|P2|COMPLETED|Overall Study||54
1641181|NCT00780416|4009723|P1|COMPLETED|Overall Study||114
1641182|NCT00780416|4009722|P2|STARTED|Overall Study||63
1641183|NCT00780416|4009723|P1|STARTED|Overall Study||126
1641184|NCT00780403|4009729|P2|NOT COMPLETED|Second Intervention||0
1641185|NCT00780403|4009730|P1|NOT COMPLETED|Second Intervention||0
1641186|NCT00780403|4009729|P2|COMPLETED|Second Intervention||111
1641187|NCT00780403|4009730|P1|COMPLETED|Second Intervention||109
1641188|NCT00780403|4009729|P2|STARTED|Second Intervention||111
1641189|NCT00780403|4009730|P1|STARTED|Second Intervention||109
1641190|NCT00780403|4009729|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1641191|NCT00780403|4009730|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1641192|NCT00780403|4009729|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
1641193|NCT00780403|4009730|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
1641194|NCT00780403|4009729|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
1641195|NCT00780403|4009730|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
1641196|NCT00780403|4009729|P2|NOT COMPLETED|First Intervention||0
1641197|NCT00780403|4009730|P1|NOT COMPLETED|First Intervention||0
1641198|NCT00780403|4009729|P2|COMPLETED|First Intervention||111
1641199|NCT00780403|4009730|P1|COMPLETED|First Intervention||109
1641200|NCT00780403|4009729|P2|STARTED|First Intervention||111
1641201|NCT00780403|4009730|P1|STARTED|First Intervention||109
1641202|NCT00780338|4009739|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
1641203|NCT00780338|4009740|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
1641204|NCT00780338|4009739|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
1641205|NCT00780338|4009740|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
1641206|NCT00780338|4009739|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
1641207|NCT00780338|4009740|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
1641208|NCT00780338|4009739|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
1641209|NCT00780338|4009740|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
1641210|NCT00780338|4009739|P2|COMPLETED|Baseline to Mid (1 Year)||164
1641211|NCT00780338|4009740|P1|COMPLETED|Baseline to Mid (1 Year)||169
1641212|NCT00780338|4009739|P2|STARTED|Baseline to Mid (1 Year)||202
1641213|NCT00780338|4009740|P1|STARTED|Baseline to Mid (1 Year)||174
1641214|NCT00780273|4009768|P1|NOT COMPLETED|Overall Study||2
1641215|NCT00780273|4009768|P1|COMPLETED|Overall Study||17
1641216|NCT00780273|4009768|P1|STARTED|Overall Study||19
1641217|NCT00780208|4009777|P1|NOT COMPLETED|Overall Study||6
1641218|NCT00780208|4009777|P1|COMPLETED|Overall Study||8
1641219|NCT00780208|4009777|P1|STARTED|Overall Study||14
1641220|NCT00780143|4009782|P1|NOT COMPLETED|Overall Study||3
1641221|NCT00780143|4009782|P1|COMPLETED|Overall Study||0
1641222|NCT00780143|4009782|P1|STARTED|Overall Study||3
1641223|NCT00780026|4009790|P2|NOT COMPLETED|Overall Study||0
1641224|NCT00780026|4009791|P1|NOT COMPLETED|Overall Study||0
1641225|NCT00780026|4009790|P2|COMPLETED|Overall Study||44
1641226|NCT00780026|4009791|P1|COMPLETED|Overall Study||42
1641227|NCT00780026|4009790|P2|STARTED|Overall Study||44
1641228|NCT00780026|4009791|P1|STARTED|Overall Study||42
1641229|NCT00779909|4009813|P4|NOT COMPLETED|Overall Study||1
1641230|NCT00779909|4009814|P3|NOT COMPLETED|Overall Study||0
1641231|NCT00779909|4009815|P2|NOT COMPLETED|Overall Study||1
1641232|NCT00779909|4009816|P1|NOT COMPLETED|Overall Study||1
1641233|NCT00779909|4009813|P4|COMPLETED|Overall Study||7
1641234|NCT00779909|4009814|P3|COMPLETED|Overall Study||8
1641235|NCT00779909|4009815|P2|COMPLETED|Overall Study||8
1641236|NCT00779909|4009816|P1|COMPLETED|Overall Study||9
1641237|NCT00779909|4009813|P4|STARTED|Overall Study||8
1641238|NCT00779909|4009814|P3|STARTED|Overall Study||8
1641239|NCT00779909|4009815|P2|STARTED|Overall Study||9
1641240|NCT00779909|4009816|P1|STARTED|Overall Study||10
1641241|NCT00779857|4009858|P1|NOT COMPLETED|Overall Study||6
1641242|NCT00779857|4009858|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
1641243|NCT00779857|4009858|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
1641244|NCT00779857|4009858|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
1641245|NCT00779857|4009858|P1|STARTED|Overall Study|70 patients treated|70
1641246|NCT00779779|4009863|P1|NOT COMPLETED|Overall Study||24
1641247|NCT00779779|4009863|P1|COMPLETED|Overall Study||498
1641248|NCT00779779|4009863|P1|STARTED|Overall Study||522
1641249|NCT00779766|4009872|P2|NOT COMPLETED|Overall Study||68
1641250|NCT00779766|4009873|P1|NOT COMPLETED|Overall Study||85
1641251|NCT00779766|4009872|P2|COMPLETED|Overall Study|Among those 2814 subjects, 1408 completed the study and 1406 had an unknown completion status.|2957
1641252|NCT00779766|4009873|P1|COMPLETED|Overall Study|Among those 2831 subjects, 1432 completed the study and 1399 had an unknown completion status.|2941
1641253|NCT00779766|4009872|P2|STARTED|Overall Study||3025
1641254|NCT00779766|4009873|P1|STARTED|Overall Study||3026
1641255|NCT00779701|4009951|P1|NOT COMPLETED|Overall Study||0
1641256|NCT00779701|4009951|P1|COMPLETED|Overall Study||27
1641257|NCT00779701|4009951|P1|STARTED|Overall Study||27
1641258|NCT00779675|4009955|P1|NOT COMPLETED|Extended Treatment Period||46
1641259|NCT00779675|4009955|P1|COMPLETED|Extended Treatment Period||147
1641260|NCT00779675|4009955|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
1641261|NCT00779675|4009955|P1|NOT COMPLETED|Treatment Period||332
1641262|NCT00779675|4009955|P1|COMPLETED|Treatment Period||328
1641263|NCT00779675|4009955|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
1641264|NCT00779584|4009983|P9|NOT COMPLETED|Overall Study||2
1641265|NCT00779584|4009984|P8|NOT COMPLETED|Overall Study||3
1641266|NCT00779584|4009985|P7|NOT COMPLETED|Overall Study||8
1641267|NCT00779584|4009986|P6|NOT COMPLETED|Overall Study||6
1641268|NCT00779584|4009987|P5|NOT COMPLETED|Overall Study||7
1641269|NCT00779584|4009988|P4|NOT COMPLETED|Overall Study||6
1641270|NCT00779584|4009989|P3|NOT COMPLETED|Overall Study||7
1641271|NCT00779584|4009990|P2|NOT COMPLETED|Overall Study||3
1641272|NCT00779584|4009991|P1|NOT COMPLETED|Overall Study||3
1641273|NCT00779584|4009983|P9|COMPLETED|Overall Study||0
1641274|NCT00779584|4009984|P8|COMPLETED|Overall Study||0
1641275|NCT00779584|4009985|P7|COMPLETED|Overall Study||0
1641276|NCT00779584|4009986|P6|COMPLETED|Overall Study||0
1641277|NCT00779584|4009987|P5|COMPLETED|Overall Study||0
1641278|NCT00779584|4009988|P4|COMPLETED|Overall Study||0
1641279|NCT00779584|4009989|P3|COMPLETED|Overall Study||0
1641280|NCT00779584|4009990|P2|COMPLETED|Overall Study||0
1641281|NCT00779584|4009991|P1|COMPLETED|Overall Study||0
1641282|NCT00779584|4009983|P9|Treated|Overall Study||2
1641283|NCT00779584|4009984|P8|Treated|Overall Study||3
1641284|NCT00779584|4009985|P7|Treated|Overall Study||8
1641285|NCT00779584|4009986|P6|Treated|Overall Study||4
1641286|NCT00779584|4009987|P5|Treated|Overall Study||7
1641287|NCT00779584|4009988|P4|Treated|Overall Study||6
1641288|NCT00779584|4009989|P3|Treated|Overall Study||7
1641289|NCT00779584|4009990|P2|Treated|Overall Study||3
1641290|NCT00779584|4009991|P1|Treated|Overall Study||3
1641291|NCT00779584|4009983|P9|STARTED|Overall Study||2
1641292|NCT00779584|4009984|P8|STARTED|Overall Study||3
1641293|NCT00779584|4009985|P7|STARTED|Overall Study||8
1641294|NCT00779584|4009986|P6|STARTED|Overall Study||6
1641295|NCT00779584|4009987|P5|STARTED|Overall Study||7
1641296|NCT00779584|4009988|P4|STARTED|Overall Study||6
1641297|NCT00779584|4009989|P3|STARTED|Overall Study||7
1641298|NCT00779584|4009990|P2|STARTED|Overall Study||3
1641299|NCT00779584|4009991|P1|STARTED|Overall Study||3
1641300|NCT00779558|4010067|P2|NOT COMPLETED|Overall Study||7
1641301|NCT00779558|4010068|P1|NOT COMPLETED|Overall Study||4
1641302|NCT00779558|4010067|P2|COMPLETED|Overall Study||37
1641303|NCT00779558|4010068|P1|COMPLETED|Overall Study||53
1641304|NCT00779558|4010067|P2|STARTED|Overall Study||44
1641305|NCT00779558|4010068|P1|STARTED|Overall Study||57
1641306|NCT00779506|4010082|P1|NOT COMPLETED|Overall Study||29
1641307|NCT00779506|4010082|P1|COMPLETED|Overall Study||67
1641308|NCT00779506|4010082|P1|Withdrawal Treatment|Overall Study||27
1641309|NCT00779506|4010082|P1|Treatment Complete|Overall Study||67
1641310|NCT00779506|4010082|P1|MITT|Overall Study||89
1641311|NCT00779506|4010082|P1|Assigned|Overall Study||94
1641312|NCT00779506|4010082|P1|Screen Failed|Overall Study||2
1641313|NCT00779506|4010082|P1|Enrolled|Overall Study||96
1641314|NCT00779506|4010082|P1|STARTED|Overall Study||96
1641315|NCT00779467|4010096|P4|NOT COMPLETED|Overall Study||19
1641316|NCT00779467|4010097|P3|NOT COMPLETED|Overall Study||10
1641317|NCT00779467|4010098|P2|NOT COMPLETED|Overall Study||5
1641318|NCT00779467|4010099|P1|NOT COMPLETED|Overall Study||15
1641319|NCT00779467|4010096|P4|COMPLETED|Overall Study||35
1641320|NCT00779467|4010097|P3|COMPLETED|Overall Study||38
1641321|NCT00779467|4010098|P2|COMPLETED|Overall Study||40
1641322|NCT00779467|4010099|P1|COMPLETED|Overall Study||38
1641323|NCT00779467|4010096|P4|STARTED|Overall Study||54
1641324|NCT00779467|4010097|P3|STARTED|Overall Study||48
1641325|NCT00779467|4010098|P2|STARTED|Overall Study||45
1641326|NCT00779467|4010099|P1|STARTED|Overall Study||53
1641327|NCT00779402|4010139|P2|NOT COMPLETED|Long-term Follow-up||6
1641328|NCT00779402|4010140|P1|NOT COMPLETED|Long-term Follow-up||21
1641329|NCT00779402|4010139|P2|COMPLETED|Long-term Follow-up||7
1641330|NCT00779402|4010140|P1|COMPLETED|Long-term Follow-up||20
1641331|NCT00779402|4010139|P2|STARTED|Long-term Follow-up||13
1641332|NCT00779402|4010140|P1|STARTED|Long-term Follow-up||41
1641333|NCT00779402|4010139|P2|NOT COMPLETED|Surveillance Phase||31
1641334|NCT00779402|4010140|P1|NOT COMPLETED|Surveillance Phase||43
1641335|NCT00779402|4010139|P2|COMPLETED|Surveillance Phase||13
1641336|NCT00779402|4010140|P1|COMPLETED|Surveillance Phase||41
1641337|NCT00779402|4010139|P2|STARTED|Surveillance Phase||44
1641338|NCT00779402|4010140|P1|STARTED|Surveillance Phase||84
1641339|NCT00779402|4010139|P2|NOT COMPLETED|Treatment Phase 1||15
1641340|NCT00779402|4010140|P1|NOT COMPLETED|Treatment Phase 1||33
1641341|NCT00779402|4010139|P2|COMPLETED|Treatment Phase 1||44
1641342|NCT00779402|4010140|P1|COMPLETED|Treatment Phase 1||84
1641343|NCT00779402|4010139|P2|Received Booster Infusion|Treatment Phase 1||30
1641344|NCT00779402|4010140|P1|Received Booster Infusion|Treatment Phase 1||50
1641345|NCT00779402|4010139|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
1641346|NCT00779402|4010140|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
1641347|NCT00779402|4010139|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
1641348|NCT00779402|4010140|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
1641349|NCT00779402|4010139|P2|STARTED|Treatment Phase 1||59
1641350|NCT00779402|4010140|P1|STARTED|Treatment Phase 1||117
1641351|NCT00779311|4010153|P5|NOT COMPLETED|Overall Study||0
1641352|NCT00779311|4010154|P4|NOT COMPLETED|Overall Study||0
1641353|NCT00779311|4010155|P3|NOT COMPLETED|Overall Study||0
1641354|NCT00779311|4010156|P2|NOT COMPLETED|Overall Study||0
1641355|NCT00779311|4010157|P1|NOT COMPLETED|Overall Study||0
1641356|NCT00779311|4010153|P5|COMPLETED|Overall Study||0
1641357|NCT00779311|4010154|P4|COMPLETED|Overall Study||0
1641358|NCT00779311|4010155|P3|COMPLETED|Overall Study||0
1641359|NCT00779311|4010156|P2|COMPLETED|Overall Study||0
1641360|NCT00779311|4010157|P1|COMPLETED|Overall Study||8
1641361|NCT00779311|4010153|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1641362|NCT00779311|4010154|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1641363|NCT00779311|4010155|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1641364|NCT00779311|4010156|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1641365|NCT00779311|4010157|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
1641366|NCT00779311|4010153|P5|STARTED|Overall Study||0
1641367|NCT00779311|4010154|P4|STARTED|Overall Study||0
1641368|NCT00779311|4010155|P3|STARTED|Overall Study||0
1641369|NCT00779311|4010156|P2|STARTED|Overall Study||0
1641370|NCT00779311|4010157|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
1641371|NCT00779285|4010179|P1|NOT COMPLETED|Overall Study||0
1641372|NCT00779285|4010179|P1|COMPLETED|Overall Study||1
1641373|NCT00779285|4010179|P1|STARTED|Overall Study||1
1641374|NCT00779259|4010183|P1|NOT COMPLETED|Theophylline With Quinine||0
1641375|NCT00779259|4010183|P1|COMPLETED|Theophylline With Quinine||22
1641376|NCT00779259|4010183|P1|STARTED|Theophylline With Quinine||22
1641377|NCT00779259|4010183|P1|NOT COMPLETED|Quinine Alone||2
1641378|NCT00779259|4010183|P1|COMPLETED|Quinine Alone||22
1641379|NCT00779259|4010183|P1|STARTED|Quinine Alone||24
1641380|NCT00779259|4010183|P1|NOT COMPLETED|4 Day Washout Period||0
1641381|NCT00779259|4010183|P1|COMPLETED|4 Day Washout Period||24
1641382|NCT00779259|4010183|P1|STARTED|4 Day Washout Period||24
1641383|NCT00779259|4010183|P1|NOT COMPLETED|Theophylline Alone||0
1641384|NCT00779259|4010183|P1|COMPLETED|Theophylline Alone||24
1641385|NCT00779259|4010183|P1|STARTED|Theophylline Alone||24
1641386|NCT00779246|4010204|P2|NOT COMPLETED|Overall Study||53
1641387|NCT00779246|4010205|P1|NOT COMPLETED|Overall Study||33
1641388|NCT00779246|4010204|P2|COMPLETED|Overall Study||715
1641389|NCT00779246|4010205|P1|COMPLETED|Overall Study||717
1641390|NCT00779246|4010204|P2|STARTED|Overall Study||768
1641391|NCT00779246|4010205|P1|STARTED|Overall Study||750
1641392|NCT00779155|4010217|P2|NOT COMPLETED|Overall Study||0
1641393|NCT00779155|4010218|P1|NOT COMPLETED|Overall Study||0
1641394|NCT00779155|4010217|P2|COMPLETED|Overall Study||6
1641395|NCT00779155|4010218|P1|COMPLETED|Overall Study||6
1641396|NCT00779155|4010217|P2|STARTED|Overall Study||6
1641397|NCT00779155|4010218|P1|STARTED|Overall Study||6
1641398|NCT00779142|4010224|P1|NOT COMPLETED|Overall Study||3
1641399|NCT00779142|4010224|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
1641400|NCT00779142|4010224|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
1641401|NCT00779116|4010230|P2|NOT COMPLETED|Second Intervention||0
1641402|NCT00779116|4010231|P1|NOT COMPLETED|Second Intervention||0
1641403|NCT00779116|4010230|P2|COMPLETED|Second Intervention||108
1641404|NCT00779116|4010231|P1|COMPLETED|Second Intervention||109
1641405|NCT00779116|4010230|P2|STARTED|Second Intervention||108
1641406|NCT00779116|4010231|P1|STARTED|Second Intervention||109
1641407|NCT00779116|4010230|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1641408|NCT00779116|4010231|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1641409|NCT00779116|4010230|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
1641410|NCT00779116|4010231|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
1641411|NCT00779116|4010230|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
1641412|NCT00779116|4010231|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
1641413|NCT00779116|4010230|P2|NOT COMPLETED|First Intervention||0
1641414|NCT00779116|4010231|P1|NOT COMPLETED|First Intervention||0
1641415|NCT00779116|4010230|P2|COMPLETED|First Intervention||108
1641416|NCT00779116|4010231|P1|COMPLETED|First Intervention||109
1641417|NCT00779116|4010230|P2|STARTED|First Intervention||108
1641418|NCT00779116|4010231|P1|STARTED|First Intervention||109
1641419|NCT00779038|4010238|P1|NOT COMPLETED|Overall Study||13
1641420|NCT00779038|4010238|P1|COMPLETED|Overall Study||0
1641421|NCT00779038|4010238|P1|STARTED|Overall Study||13
1641422|NCT00779025|4010247|P1|NOT COMPLETED|Overall Study||1
1641423|NCT00779025|4010247|P1|COMPLETED|Overall Study||81
1641424|NCT00779025|4010247|P1|STARTED|Overall Study||82
1641425|NCT00778999|4010258|P2|NOT COMPLETED|Overall Study||34
1641426|NCT00778999|4010259|P1|NOT COMPLETED|Overall Study||28
1641427|NCT00778999|4010258|P2|COMPLETED|Overall Study||185
1641428|NCT00778999|4010259|P1|COMPLETED|Overall Study||195
1641429|NCT00778999|4010258|P2|STARTED|Overall Study||219
1641430|NCT00778999|4010259|P1|STARTED|Overall Study||223
1641431|NCT00778921|4010268|P3|NOT COMPLETED|Overall Study||28
1641432|NCT00778921|4010269|P2|NOT COMPLETED|Overall Study||19
1641433|NCT00778921|4010270|P1|NOT COMPLETED|Overall Study||18
1641434|NCT00778921|4010268|P3|COMPLETED|Overall Study||255
1641435|NCT00778921|4010269|P2|COMPLETED|Overall Study||266
1641436|NCT00778921|4010270|P1|COMPLETED|Overall Study||261
1641437|NCT00778921|4010268|P3|STARTED|Overall Study||283
1641438|NCT00778921|4010269|P2|STARTED|Overall Study||285
1641439|NCT00778921|4010270|P1|STARTED|Overall Study||279
1641440|NCT00778895|4010287|P3|NOT COMPLETED|ESFU Phase||2
1641441|NCT00778895|4010288|P2|NOT COMPLETED|ESFU Phase||12
1641442|NCT00778895|4010289|P1|NOT COMPLETED|ESFU Phase||11
1641443|NCT00778895|4010287|P3|COMPLETED|ESFU Phase||41
1641444|NCT00778895|4010288|P2|COMPLETED|ESFU Phase||155
1641445|NCT00778895|4010289|P1|COMPLETED|ESFU Phase||153
1641446|NCT00778895|4010287|P3|STARTED|ESFU Phase||43
1641447|NCT00778895|4010288|P2|STARTED|ESFU Phase||167
1641448|NCT00778895|4010289|P1|STARTED|ESFU Phase||164
1641449|NCT00778895|4010287|P3|NOT COMPLETED|Active Phase||0
1641450|NCT00778895|4010288|P2|NOT COMPLETED|Active Phase||6
1641451|NCT00778895|4010289|P1|NOT COMPLETED|Active Phase||7
1641452|NCT00778895|4010287|P3|COMPLETED|Active Phase||43
1641453|NCT00778895|4010288|P2|COMPLETED|Active Phase||161
1641454|NCT00778895|4010289|P1|COMPLETED|Active Phase||157
1641455|NCT00778895|4010287|P3|STARTED|Active Phase||43
1641456|NCT00778895|4010288|P2|STARTED|Active Phase||167
1641457|NCT00778895|4010289|P1|STARTED|Active Phase||164
1641458|NCT00778869|4010327|P1|NOT COMPLETED|Overall Study||0
1641459|NCT00778869|4010327|P1|COMPLETED|Overall Study||10
1641460|NCT00778869|4010327|P1|STARTED|Overall Study||10
1641461|NCT00778830|4010333|P2|NOT COMPLETED|Overall Study||1
1641462|NCT00778830|4010334|P1|NOT COMPLETED|Overall Study||0
1641463|NCT00778830|4010333|P2|COMPLETED|Overall Study||187
1641464|NCT00778830|4010334|P1|COMPLETED|Overall Study||101
1641465|NCT00778830|4010333|P2|STARTED|Overall Study||188
1641466|NCT00778830|4010334|P1|STARTED|Overall Study||101
1641467|NCT00778817|4010346|P1|NOT COMPLETED|Overall Study||4
1641468|NCT00778817|4010346|P1|COMPLETED|Overall Study||16
1641469|NCT00778817|4010346|P1|STARTED|Overall Study||20
1641470|NCT00778648|4010363|P2|NOT COMPLETED|Overall Study||5
1641471|NCT00778648|4010364|P1|NOT COMPLETED|Overall Study||9
1641472|NCT00778648|4010363|P2|COMPLETED|Overall Study||266
1641473|NCT00778648|4010364|P1|COMPLETED|Overall Study||263
1641474|NCT00778648|4010363|P2|STARTED|Overall Study||271
1641475|NCT00778648|4010364|P1|STARTED|Overall Study||272
1641476|NCT00778622|4010373|P3|NOT COMPLETED|Overall Study||15
1641477|NCT00778622|4010374|P2|NOT COMPLETED|Overall Study||15
1641478|NCT00778622|4010375|P1|NOT COMPLETED|Overall Study||16
1641479|NCT00778622|4010373|P3|COMPLETED|Overall Study||109
1641480|NCT00778622|4010374|P2|COMPLETED|Overall Study||107
1641481|NCT00778622|4010375|P1|COMPLETED|Overall Study||109
1641482|NCT00778622|4010373|P3|STARTED|Overall Study||124
1641483|NCT00778622|4010374|P2|STARTED|Overall Study||122
1641484|NCT00778622|4010375|P1|STARTED|Overall Study||125
1641485|NCT00778375|4010428|P1|NOT COMPLETED|Overall Study||3
1641486|NCT00778375|4010428|P1|COMPLETED|Overall Study||119
1641487|NCT00778375|4010428|P1|STARTED|Overall Study||122
1641488|NCT00778336|4010442|P4|NOT COMPLETED|3 Month Follow Up||0
1641489|NCT00778336|4010443|P3|NOT COMPLETED|3 Month Follow Up||5
1641490|NCT00778336|4010444|P2|NOT COMPLETED|3 Month Follow Up||23
1641491|NCT00778336|4010445|P1|NOT COMPLETED|3 Month Follow Up||23
1641492|NCT00778336|4010442|P4|COMPLETED|3 Month Follow Up||12
1641493|NCT00778336|4010443|P3|COMPLETED|3 Month Follow Up||65
1641494|NCT00778336|4010444|P2|COMPLETED|3 Month Follow Up||144
1641495|NCT00778336|4010445|P1|COMPLETED|3 Month Follow Up||169
1641496|NCT00778336|4010442|P4|STARTED|3 Month Follow Up||12
1641497|NCT00778336|4010443|P3|STARTED|3 Month Follow Up||70
1641498|NCT00778336|4010444|P2|STARTED|3 Month Follow Up||167
1641499|NCT00778336|4010445|P1|STARTED|3 Month Follow Up||192
1641500|NCT00778336|4010442|P4|NOT COMPLETED|Index Procedure-Discharge||0
1641501|NCT00778336|4010443|P3|NOT COMPLETED|Index Procedure-Discharge||2
1641502|NCT00778336|4010444|P2|NOT COMPLETED|Index Procedure-Discharge||3
1641503|NCT00778336|4010445|P1|NOT COMPLETED|Index Procedure-Discharge||6
1641504|NCT00778336|4010442|P4|COMPLETED|Index Procedure-Discharge||12
1641505|NCT00778336|4010443|P3|COMPLETED|Index Procedure-Discharge||70
1641506|NCT00778336|4010444|P2|COMPLETED|Index Procedure-Discharge||167
1641507|NCT00778336|4010445|P1|COMPLETED|Index Procedure-Discharge||192
1641508|NCT00778336|4010442|P4|STARTED|Index Procedure-Discharge||12
1641509|NCT00778336|4010443|P3|STARTED|Index Procedure-Discharge||72
1641510|NCT00778336|4010444|P2|STARTED|Index Procedure-Discharge||170
1641511|NCT00778336|4010445|P1|STARTED|Index Procedure-Discharge||198
1641512|NCT00778310|4010465|P2|NOT COMPLETED|Overall Study||0
1641513|NCT00778310|4010466|P1|NOT COMPLETED|Overall Study||0
1641514|NCT00778310|4010465|P2|COMPLETED|Overall Study||26
1641515|NCT00778310|4010466|P1|COMPLETED|Overall Study||17
1641516|NCT00778310|4010465|P2|Usable Data|Overall Study||21
1641517|NCT00778310|4010466|P1|Usable Data|Overall Study||14
1641518|NCT00778310|4010465|P2|STARTED|Overall Study||26
1641519|NCT00778310|4010466|P1|STARTED|Overall Study||17
1641520|NCT00778258|4010483|P9|NOT COMPLETED|Overall Study||4
1641521|NCT00778258|4010484|P8|NOT COMPLETED|Overall Study||15
1641522|NCT00778258|4010485|P7|NOT COMPLETED|Overall Study||15
1641523|NCT00778258|4010486|P6|NOT COMPLETED|Overall Study||10
1641524|NCT00778258|4010487|P5|NOT COMPLETED|Overall Study||0
1641525|NCT00778258|4010488|P4|NOT COMPLETED|Overall Study||3
1641526|NCT00778258|4010489|P3|NOT COMPLETED|Overall Study||10
1641527|NCT00778258|4010490|P2|NOT COMPLETED|Overall Study||2
1641528|NCT00778258|4010491|P1|NOT COMPLETED|Overall Study||7
1641529|NCT00778258|4010483|P9|COMPLETED|Overall Study||6
1641530|NCT00778258|4010484|P8|COMPLETED|Overall Study||26
1641531|NCT00778258|4010485|P7|COMPLETED|Overall Study||19
1641532|NCT00778258|4010486|P6|COMPLETED|Overall Study||13
1641533|NCT00778258|4010487|P5|COMPLETED|Overall Study||6
1641534|NCT00778258|4010488|P4|COMPLETED|Overall Study||12
1641535|NCT00778258|4010489|P3|COMPLETED|Overall Study||10
1641536|NCT00778258|4010490|P2|COMPLETED|Overall Study||3
1641537|NCT00778258|4010491|P1|COMPLETED|Overall Study||9
1641538|NCT00778258|4010483|P9|STARTED|Overall Study||10
1641539|NCT00778258|4010484|P8|STARTED|Overall Study||41
1641540|NCT00778258|4010485|P7|STARTED|Overall Study||34
1641541|NCT00778258|4010486|P6|STARTED|Overall Study||23
1641542|NCT00778258|4010487|P5|STARTED|Overall Study||6
1641543|NCT00778258|4010488|P4|STARTED|Overall Study||15
1641544|NCT00778258|4010489|P3|STARTED|Overall Study||20
1641545|NCT00778258|4010490|P2|STARTED|Overall Study||5
1641546|NCT00778258|4010491|P1|STARTED|Overall Study||16
1641547|NCT00778167|4010546|P3|NOT COMPLETED|Overall Study||0
1641548|NCT00778167|4010547|P2|NOT COMPLETED|Overall Study||0
1641549|NCT00778167|4010548|P1|NOT COMPLETED|Overall Study||0
1641550|NCT00778167|4010546|P3|COMPLETED|Overall Study||4
1641551|NCT00778167|4010547|P2|COMPLETED|Overall Study||8
1641552|NCT00778167|4010548|P1|COMPLETED|Overall Study||6
1641553|NCT00778167|4010546|P3|STARTED|Overall Study||4
1641554|NCT00778167|4010547|P2|STARTED|Overall Study||8
1641555|NCT00778167|4010548|P1|STARTED|Overall Study||6
1641556|NCT00778102|4010558|P2|NOT COMPLETED|Overall Study||22
1641557|NCT00778102|4010559|P1|NOT COMPLETED|Overall Study||21
1641558|NCT00778102|4010558|P2|COMPLETED|Overall Study||19
1641559|NCT00778102|4010559|P1|COMPLETED|Overall Study||18
1641560|NCT00778102|4010558|P2|STARTED|Overall Study||41
1641561|NCT00778102|4010559|P1|STARTED|Overall Study||39
1641562|NCT00777946|4010594|P3|NOT COMPLETED|Overall Study||16
1641563|NCT00777946|4010595|P2|NOT COMPLETED|Overall Study||6
1641564|NCT00777946|4010596|P1|NOT COMPLETED|Overall Study||21
1641565|NCT00777946|4010594|P3|COMPLETED|Overall Study||244
1641566|NCT00777946|4010595|P2|COMPLETED|Overall Study||271
1641567|NCT00777946|4010596|P1|COMPLETED|Overall Study||262
1641568|NCT00777946|4010594|P3|Safety & Full Analysis Sets|Overall Study||260
1641569|NCT00777946|4010595|P2|Safety & Full Analysis Sets|Overall Study||276
1641570|NCT00777946|4010596|P1|Safety & Full Analysis Sets|Overall Study||282
1641571|NCT00777946|4010594|P3|STARTED|Overall Study||260
1641572|NCT00777946|4010595|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
1641573|NCT00777946|4010596|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
1641574|NCT00777855|4010619|P2|NOT COMPLETED|Second Intervention||0
1641575|NCT00777855|4010620|P1|NOT COMPLETED|Second Intervention||0
1641576|NCT00777855|4010619|P2|COMPLETED|Second Intervention||5
1641577|NCT00777855|4010620|P1|COMPLETED|Second Intervention||5
1641578|NCT00777855|4010619|P2|STARTED|Second Intervention||5
1641579|NCT00777855|4010620|P1|STARTED|Second Intervention||5
1641580|NCT00777855|4010619|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
1641581|NCT00777855|4010620|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
1641582|NCT00777855|4010619|P2|COMPLETED|Washout Period (>= 14 Days)||5
1641583|NCT00777855|4010620|P1|COMPLETED|Washout Period (>= 14 Days)||5
1641584|NCT00777855|4010619|P2|STARTED|Washout Period (>= 14 Days)||5
1641585|NCT00777855|4010620|P1|STARTED|Washout Period (>= 14 Days)||5
1641586|NCT00777855|4010619|P2|NOT COMPLETED|First Intervention||0
1641587|NCT00777855|4010620|P1|NOT COMPLETED|First Intervention||0
1641588|NCT00777855|4010619|P2|COMPLETED|First Intervention||5
1641589|NCT00777855|4010620|P1|COMPLETED|First Intervention||5
1641590|NCT00777855|4010619|P2|STARTED|First Intervention||5
1641591|NCT00777855|4010620|P1|STARTED|First Intervention||5
1641592|NCT00777803|4010631|P2|NOT COMPLETED|Overall Study||7
1641593|NCT00777803|4010632|P1|NOT COMPLETED|Overall Study||15
1641594|NCT00777803|4010631|P2|COMPLETED|Overall Study||90
1641595|NCT00777803|4010632|P1|COMPLETED|Overall Study||269
1641596|NCT00777803|4010631|P2|STARTED|Overall Study||97
1641597|NCT00777803|4010632|P1|STARTED|Overall Study||284
1641598|NCT00777790|4010667|P3|NOT COMPLETED|Overall Study||0
1641599|NCT00777790|4010668|P2|NOT COMPLETED|Overall Study||0
1641600|NCT00777790|4010669|P1|NOT COMPLETED|Overall Study||0
1641601|NCT00777790|4010667|P3|COMPLETED|Overall Study||88
1641602|NCT00777790|4010668|P2|COMPLETED|Overall Study||77
1641603|NCT00777790|4010669|P1|COMPLETED|Overall Study||76
1641604|NCT00777790|4010667|P3|STARTED|Overall Study||88
1641605|NCT00777790|4010668|P2|STARTED|Overall Study||77
1641606|NCT00777790|4010669|P1|STARTED|Overall Study||76
1641607|NCT00777764|4010679|P2|NOT COMPLETED|Overall Study||1
1641608|NCT00777764|4010680|P1|NOT COMPLETED|Overall Study||0
1641609|NCT00777764|4010679|P2|COMPLETED|Overall Study||29
1641610|NCT00777764|4010680|P1|COMPLETED|Overall Study||30
1641611|NCT00777764|4010679|P2|STARTED|Overall Study||30
1641612|NCT00777764|4010680|P1|STARTED|Overall Study||30
1641613|NCT00777634|4010692|P2|NOT COMPLETED|Overall Study||1
1641614|NCT00777634|4010693|P1|NOT COMPLETED|Overall Study||5
1641615|NCT00777634|4010692|P2|COMPLETED|Overall Study||133
1641616|NCT00777634|4010693|P1|COMPLETED|Overall Study||129
1641617|NCT00777634|4010692|P2|STARTED|Overall Study||134
1641618|NCT00777634|4010693|P1|STARTED|Overall Study||134
1641619|NCT00777608|4010711|P2|NOT COMPLETED|Overall Study||6
1641620|NCT00777608|4010712|P1|NOT COMPLETED|Overall Study||4
1641621|NCT00777608|4010711|P2|COMPLETED|Overall Study||47
1641622|NCT00777608|4010712|P1|COMPLETED|Overall Study||49
1641623|NCT00777608|4010711|P2|STARTED|Overall Study||53
1641624|NCT00777608|4010712|P1|STARTED|Overall Study||53
1641625|NCT00777556|4010722|P1|NOT COMPLETED|Overall Study||66
1641626|NCT00777556|4010722|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
1641627|NCT00777556|4010722|P1|Used Product|Overall Study||297
1641628|NCT00777556|4010722|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
1641629|NCT00777556|4010722|P1|Dispensed Product|Overall Study||307
1641630|NCT00777556|4010722|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
1641631|NCT00777335|4010731|P2|NOT COMPLETED|Overall Study||0
1641632|NCT00777335|4010732|P1|NOT COMPLETED|Overall Study||0
1641633|NCT00777335|4010731|P2|COMPLETED|Overall Study||2
1641634|NCT00777335|4010732|P1|COMPLETED|Overall Study||2
1641635|NCT00777335|4010731|P2|STARTED|Overall Study||2
1641636|NCT00777335|4010732|P1|STARTED|Overall Study||2
1641637|NCT00777257|4010743|P3|NOT COMPLETED|Overall Study||9
1641638|NCT00777257|4010744|P2|NOT COMPLETED|Overall Study||12
1641639|NCT00777257|4010745|P1|NOT COMPLETED|Overall Study||11
1641640|NCT00777257|4010743|P3|COMPLETED|Overall Study||442
1641641|NCT00777257|4010744|P2|COMPLETED|Overall Study||438
1641642|NCT00777257|4010745|P1|COMPLETED|Overall Study||433
1641643|NCT00777257|4010743|P3|STARTED|Overall Study||451
1641644|NCT00777257|4010744|P2|STARTED|Overall Study||450
1641645|NCT00777257|4010745|P1|STARTED|Overall Study||444
1641646|NCT00777205|4010764|P2|NOT COMPLETED|Overall Study||71
1641647|NCT00777205|4010765|P1|NOT COMPLETED|Overall Study||31
1641648|NCT00777205|4010764|P2|COMPLETED|Overall Study||129
1641649|NCT00777205|4010765|P1|COMPLETED|Overall Study||212
1641650|NCT00777205|4010764|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
1641651|NCT00777205|4010765|P1|Intervention Interruption|Overall Study||0
1641652|NCT00777205|4010764|P2|STARTED|Overall Study||200
1641653|NCT00777205|4010765|P1|STARTED|Overall Study||243
1641654|NCT00777179|4010781|P2|NOT COMPLETED|Overall Study||0
1641655|NCT00777179|4010782|P1|NOT COMPLETED|Overall Study||0
1641656|NCT00777179|4010781|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
1641657|NCT00777179|4010782|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
1641658|NCT00777179|4010781|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
1641659|NCT00777179|4010782|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
1641660|NCT00777153|4010799|P3|NOT COMPLETED|Overall Study||37
1641661|NCT00777153|4010800|P2|NOT COMPLETED|Overall Study||83
1641662|NCT00777153|4010801|P1|NOT COMPLETED|Overall Study||90
1641663|NCT00777153|4010799|P3|COMPLETED|Overall Study||28
1641664|NCT00777153|4010800|P2|COMPLETED|Overall Study||46
1641665|NCT00777153|4010801|P1|COMPLETED|Overall Study||41
1641666|NCT00777153|4010799|P3|STARTED|Overall Study||65
1641667|NCT00777153|4010800|P2|STARTED|Overall Study||129
1641668|NCT00777153|4010801|P1|STARTED|Overall Study||131
1641669|NCT00777101|4010826|P2|NOT COMPLETED|Overall Study||51
1641670|NCT00777101|4010827|P1|NOT COMPLETED|Overall Study||62
1641671|NCT00777101|4010826|P2|COMPLETED|Overall Study||65
1641672|NCT00777101|4010827|P1|COMPLETED|Overall Study||55
1641673|NCT00777101|4010826|P2|Treated|Overall Study||115
1641674|NCT00777101|4010827|P1|Treated|Overall Study||116
1641675|NCT00777101|4010826|P2|STARTED|Overall Study||116
1641676|NCT00777101|4010827|P1|STARTED|Overall Study||117
1641677|NCT00777088|4010845|P1|NOT COMPLETED|Overall Study||1
1641678|NCT00777088|4010845|P1|COMPLETED|Overall Study||107
1641679|NCT00777088|4010845|P1|STARTED|Overall Study||108
1641680|NCT00777062|4010859|P2|NOT COMPLETED|Overall Study||5
1641681|NCT00777062|4010860|P1|NOT COMPLETED|Overall Study||3
1641682|NCT00777062|4010859|P2|COMPLETED|Overall Study||36
1641683|NCT00777062|4010860|P1|COMPLETED|Overall Study||36
1641684|NCT00777062|4010859|P2|STARTED|Overall Study||41
1641685|NCT00777062|4010860|P1|STARTED|Overall Study||39
1641686|NCT00777049|4010870|P2|NOT COMPLETED|Overall Study||1
1641687|NCT00777049|4010871|P1|NOT COMPLETED|Overall Study||1
1641688|NCT00777049|4010870|P2|COMPLETED|Overall Study||20
1641689|NCT00777049|4010871|P1|COMPLETED|Overall Study||32
1641690|NCT00777049|4010870|P2|STARTED|Overall Study||21
1641691|NCT00777049|4010871|P1|STARTED|Overall Study||33
1641692|NCT00777036|4010880|P3|NOT COMPLETED|Follow-Up||4
1641693|NCT00777036|4010881|P2|NOT COMPLETED|Follow-Up||8
1641694|NCT00777036|4010882|P1|NOT COMPLETED|Follow-Up||5
1641695|NCT00777036|4010880|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
1641696|NCT00777036|4010881|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
1641697|NCT00777036|4010882|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
1641698|NCT00777036|4010880|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
1641699|NCT00777036|4010881|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
1641700|NCT00777036|4010882|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
1641701|NCT00777036|4010880|P3|NOT COMPLETED|On Treatment||23
1641702|NCT00777036|4010881|P2|NOT COMPLETED|On Treatment||16
1641703|NCT00777036|4010882|P1|NOT COMPLETED|On Treatment||15
1641704|NCT00777036|4010880|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
1641705|NCT00777036|4010881|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
1641706|NCT00777036|4010882|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
1641707|NCT00777036|4010880|P3|STARTED|On Treatment||84
1641708|NCT00777036|4010881|P2|STARTED|On Treatment||17
1641709|NCT00777036|4010882|P1|STARTED|On Treatment||29
1641710|NCT00777023|4010978|P3|NOT COMPLETED|Overall Study||37
1641711|NCT00777023|4010979|P2|NOT COMPLETED|Overall Study||41
1641712|NCT00777023|4010980|P1|NOT COMPLETED|Overall Study||35
1641713|NCT00777023|4010978|P3|COMPLETED|Overall Study||146
1641714|NCT00777023|4010979|P2|COMPLETED|Overall Study||149
1641715|NCT00777023|4010980|P1|COMPLETED|Overall Study||151
1641716|NCT00777023|4010978|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
1641717|NCT00777023|4010979|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
1641718|NCT00777023|4010980|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
1641719|NCT00776997|4010997|P1|NOT COMPLETED|Overall Study||2
1641720|NCT00776997|4010997|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
1641721|NCT00776997|4010997|P1|STARTED|Overall Study||100
1641722|NCT00776984|4011006|P2|NOT COMPLETED|Overall Study||21
1641723|NCT00776984|4011007|P1|NOT COMPLETED|Overall Study||31
1641724|NCT00776984|4011006|P2|COMPLETED|Overall Study||198
1641725|NCT00776984|4011007|P1|COMPLETED|Overall Study||203
1641726|NCT00776984|4011006|P2|STARTED|Overall Study||219
1641727|NCT00776984|4011007|P1|STARTED|Overall Study||234
1641728|NCT00776919|4011081|P4|NOT COMPLETED|Overall Study||39
1641729|NCT00776919|4011082|P3|NOT COMPLETED|Overall Study||32
1641730|NCT00776919|4011083|P2|NOT COMPLETED|Overall Study||33
1641731|NCT00776919|4011084|P1|NOT COMPLETED|Overall Study||27
1641732|NCT00776919|4011081|P4|COMPLETED|Overall Study||293
1641733|NCT00776919|4011082|P3|COMPLETED|Overall Study||296
1641734|NCT00776919|4011083|P2|COMPLETED|Overall Study||295
1641735|NCT00776919|4011084|P1|COMPLETED|Overall Study||300
1641736|NCT00776919|4011081|P4|STARTED|Overall Study||332
1641737|NCT00776919|4011082|P3|STARTED|Overall Study||328
1641738|NCT00776919|4011083|P2|STARTED|Overall Study||328
1641739|NCT00776919|4011084|P1|STARTED|Overall Study||327
1641740|NCT00776789|4011148|P2|NOT COMPLETED|Overall Study||3
1641741|NCT00776789|4011149|P1|NOT COMPLETED|Overall Study||3
1641742|NCT00776789|4011148|P2|COMPLETED|Overall Study||18
1641743|NCT00776789|4011149|P1|COMPLETED|Overall Study||17
1641744|NCT00776789|4011148|P2|STARTED|Overall Study||21
1641745|NCT00776789|4011149|P1|STARTED|Overall Study||20
1641746|NCT00776659|4011161|P1|NOT COMPLETED|Overall Study||26
1641747|NCT00776659|4011161|P1|COMPLETED|Overall Study||13
1641748|NCT00776659|4011161|P1|STARTED|Overall Study||39
1641749|NCT00776594|4011173|P2|NOT COMPLETED|Overall Study||2
1641750|NCT00776594|4011174|P1|NOT COMPLETED|Overall Study||4
1641751|NCT00776594|4011173|P2|COMPLETED|Overall Study||34
1641752|NCT00776594|4011174|P1|COMPLETED|Overall Study||62
1641753|NCT00776594|4011173|P2|STARTED|Overall Study||36
1641754|NCT00776594|4011174|P1|STARTED|Overall Study||66
1641755|NCT00776555|4011188|P2|NOT COMPLETED|Overall Study||0
1641756|NCT00776555|4011189|P1|NOT COMPLETED|Overall Study||3
1641757|NCT00776555|4011188|P2|COMPLETED|Overall Study||0
1641758|NCT00776555|4011189|P1|COMPLETED|Overall Study||0
1641759|NCT00776555|4011188|P2|STARTED|Overall Study||0
1641760|NCT00776555|4011189|P1|STARTED|Overall Study||3
1641761|NCT00776295|4011199|P1|NOT COMPLETED|Overall Study||0
1641762|NCT00776295|4011199|P1|COMPLETED|Overall Study||2
1641763|NCT00776295|4011199|P1|STARTED|Overall Study||2
1641764|NCT00776230|4011207|P3|NOT COMPLETED|Overall Study||5
1641765|NCT00776230|4011208|P2|NOT COMPLETED|Overall Study||3
1641766|NCT00776230|4011209|P1|NOT COMPLETED|Overall Study||3
1641767|NCT00776230|4011207|P3|COMPLETED|Overall Study||97
1641768|NCT00776230|4011208|P2|COMPLETED|Overall Study||100
1641769|NCT00776230|4011209|P1|COMPLETED|Overall Study||96
1641770|NCT00776230|4011207|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
1641771|NCT00776230|4011208|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
1641772|NCT00776230|4011209|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
1641773|NCT00776230|4011207|P3|STARTED|Overall Study||102
1641774|NCT00776230|4011208|P2|STARTED|Overall Study||103
1641775|NCT00776230|4011209|P1|STARTED|Overall Study||99
1641776|NCT00776100|4011219|P2|NOT COMPLETED|Overall Study||0
1641777|NCT00776100|4011220|P1|NOT COMPLETED|Overall Study||1
1641778|NCT00776100|4011219|P2|COMPLETED|Overall Study||1
1641779|NCT00776100|4011220|P1|COMPLETED|Overall Study||0
1641780|NCT00776100|4011219|P2|STARTED|Overall Study||1
1641781|NCT00776100|4011220|P1|STARTED|Overall Study||1
1641782|NCT00776009|4011242|P6|NOT COMPLETED|Period 3: Third Intervention||0
1641783|NCT00776009|4011243|P5|NOT COMPLETED|Period 3: Third Intervention||0
1641784|NCT00776009|4011244|P4|NOT COMPLETED|Period 3: Third Intervention||0
1641785|NCT00776009|4011245|P3|NOT COMPLETED|Period 3: Third Intervention||0
1641786|NCT00776009|4011246|P2|NOT COMPLETED|Period 3: Third Intervention||0
1641787|NCT00776009|4011247|P1|NOT COMPLETED|Period 3: Third Intervention||1
1641788|NCT00776009|4011242|P6|COMPLETED|Period 3: Third Intervention||26
1641789|NCT00776009|4011243|P5|COMPLETED|Period 3: Third Intervention||26
1641790|NCT00776009|4011244|P4|COMPLETED|Period 3: Third Intervention||27
1641791|NCT00776009|4011245|P3|COMPLETED|Period 3: Third Intervention||27
1641792|NCT00776009|4011246|P2|COMPLETED|Period 3: Third Intervention||27
1641793|NCT00776009|4011247|P1|COMPLETED|Period 3: Third Intervention||24
1641794|NCT00776009|4011242|P6|STARTED|Period 3: Third Intervention||26
1641795|NCT00776009|4011243|P5|STARTED|Period 3: Third Intervention||26
1641796|NCT00776009|4011244|P4|STARTED|Period 3: Third Intervention||27
1641797|NCT00776009|4011245|P3|STARTED|Period 3: Third Intervention||27
1641798|NCT00776009|4011246|P2|STARTED|Period 3: Third Intervention||27
1641799|NCT00776009|4011247|P1|STARTED|Period 3: Third Intervention||25
1641800|NCT00776009|4011242|P6|NOT COMPLETED|Period 2: Second Intervention||1
1641801|NCT00776009|4011243|P5|NOT COMPLETED|Period 2: Second Intervention||0
1641802|NCT00776009|4011244|P4|NOT COMPLETED|Period 2: Second Intervention||0
1641803|NCT00776009|4011245|P3|NOT COMPLETED|Period 2: Second Intervention||1
1641804|NCT00776009|4011246|P2|NOT COMPLETED|Period 2: Second Intervention||0
1641805|NCT00776009|4011247|P1|NOT COMPLETED|Period 2: Second Intervention||1
1641806|NCT00776009|4011242|P6|COMPLETED|Period 2: Second Intervention||26
1641807|NCT00776009|4011243|P5|COMPLETED|Period 2: Second Intervention||26
1641808|NCT00776009|4011244|P4|COMPLETED|Period 2: Second Intervention||27
1641809|NCT00776009|4011245|P3|COMPLETED|Period 2: Second Intervention||27
1641810|NCT00776009|4011246|P2|COMPLETED|Period 2: Second Intervention||27
1641811|NCT00776009|4011247|P1|COMPLETED|Period 2: Second Intervention||25
1641812|NCT00776009|4011242|P6|STARTED|Period 2: Second Intervention||27
1641813|NCT00776009|4011243|P5|STARTED|Period 2: Second Intervention||26
1641814|NCT00776009|4011244|P4|STARTED|Period 2: Second Intervention||27
1641815|NCT00776009|4011245|P3|STARTED|Period 2: Second Intervention||28
1641816|NCT00776009|4011246|P2|STARTED|Period 2: Second Intervention||27
1641817|NCT00776009|4011247|P1|STARTED|Period 2: Second Intervention||26
1641818|NCT00776009|4011242|P6|NOT COMPLETED|Period 1: First Intervention||0
1641819|NCT00776009|4011243|P5|NOT COMPLETED|Period 1: First Intervention||2
1641820|NCT00776009|4011244|P4|NOT COMPLETED|Period 1: First Intervention||0
1641821|NCT00776009|4011245|P3|NOT COMPLETED|Period 1: First Intervention||1
1641822|NCT00776009|4011246|P2|NOT COMPLETED|Period 1: First Intervention||1
1641823|NCT00776009|4011247|P1|NOT COMPLETED|Period 1: First Intervention||0
1641824|NCT00776009|4011242|P6|COMPLETED|Period 1: First Intervention||27
1641825|NCT00776009|4011243|P5|COMPLETED|Period 1: First Intervention||26
1641826|NCT00776009|4011244|P4|COMPLETED|Period 1: First Intervention||27
1641827|NCT00776009|4011245|P3|COMPLETED|Period 1: First Intervention||28
1641828|NCT00776009|4011246|P2|COMPLETED|Period 1: First Intervention||27
1641829|NCT00776009|4011247|P1|COMPLETED|Period 1: First Intervention||26
1641830|NCT00776009|4011242|P6|STARTED|Period 1: First Intervention||27
1641831|NCT00776009|4011243|P5|STARTED|Period 1: First Intervention||28
1641832|NCT00776009|4011244|P4|STARTED|Period 1: First Intervention||27
1641833|NCT00776009|4011245|P3|STARTED|Period 1: First Intervention||29
1641834|NCT00776009|4011246|P2|STARTED|Period 1: First Intervention||28
1641835|NCT00776009|4011247|P1|STARTED|Period 1: First Intervention||26
1641836|NCT00775983|4011269|P2|NOT COMPLETED|Overall Study||2
1641837|NCT00775983|4011270|P1|NOT COMPLETED|Overall Study||1
1641838|NCT00775983|4011269|P2|COMPLETED|Overall Study||34
1641839|NCT00775983|4011270|P1|COMPLETED|Overall Study||35
1641840|NCT00775983|4011269|P2|STARTED|Overall Study||36
1641841|NCT00775983|4011270|P1|STARTED|Overall Study||36
1641842|NCT00775944|4011282|P4|NOT COMPLETED|Overall Study||16
1641843|NCT00775944|4011283|P3|NOT COMPLETED|Overall Study||16
1641844|NCT00775944|4011284|P2|NOT COMPLETED|Overall Study||9
1641845|NCT00775944|4011285|P1|NOT COMPLETED|Overall Study||15
1641846|NCT00775944|4011282|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
1641847|NCT00775944|4011283|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
1641848|NCT00775944|4011284|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
1641849|NCT00775944|4011285|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
1641850|NCT00775944|4011282|P4|STARTED|Overall Study||648
1641851|NCT00775944|4011283|P3|STARTED|Overall Study||648
1641852|NCT00775944|4011284|P2|STARTED|Overall Study||647
1641853|NCT00775944|4011285|P1|STARTED|Overall Study||648
1641854|NCT00775684|4011314|P3|NOT COMPLETED|Overall Study||3
1641855|NCT00775684|4011315|P2|NOT COMPLETED|Overall Study||1
1641856|NCT00775684|4011316|P1|NOT COMPLETED|Overall Study||3
1641857|NCT00775684|4011314|P3|COMPLETED|Overall Study||14
1641858|NCT00775684|4011315|P2|COMPLETED|Overall Study||12
1641859|NCT00775684|4011316|P1|COMPLETED|Overall Study||14
1641860|NCT00775684|4011314|P3|STARTED|Overall Study||17
1641861|NCT00775684|4011315|P2|STARTED|Overall Study||13
1641862|NCT00775684|4011316|P1|STARTED|Overall Study||17
1641863|NCT00775671|4011338|P2|NOT COMPLETED|Overall Study||0
1641864|NCT00775671|4011339|P1|NOT COMPLETED|Overall Study||0
1641865|NCT00775671|4011338|P2|COMPLETED|Overall Study||23
1641866|NCT00775671|4011339|P1|COMPLETED|Overall Study||23
1641867|NCT00775671|4011338|P2|STARTED|Overall Study||23
1641868|NCT00775671|4011339|P1|STARTED|Overall Study||23
1641869|NCT00775658|4011347|P2|NOT COMPLETED|Second Intervention||0
1641870|NCT00775658|4011348|P1|NOT COMPLETED|Second Intervention||0
1641871|NCT00775658|4011347|P2|COMPLETED|Second Intervention||11
1641872|NCT00775658|4011348|P1|COMPLETED|Second Intervention||10
1641873|NCT00775658|4011347|P2|STARTED|Second Intervention||11
1641874|NCT00775658|4011348|P1|STARTED|Second Intervention||10
1641875|NCT00775658|4011347|P2|NOT COMPLETED|First Intervention||0
1641876|NCT00775658|4011348|P1|NOT COMPLETED|First Intervention||0
1641877|NCT00775658|4011347|P2|COMPLETED|First Intervention||11
1641878|NCT00775658|4011348|P1|COMPLETED|First Intervention||10
1641879|NCT00775658|4011347|P2|STARTED|First Intervention||11
1641880|NCT00775658|4011348|P1|STARTED|First Intervention||10
1641881|NCT00775645|4011358|P2|NOT COMPLETED|Overall Study||20
1641882|NCT00775645|4011359|P1|NOT COMPLETED|Overall Study||17
1641883|NCT00775645|4011358|P2|COMPLETED|Overall Study||181
1641884|NCT00775645|4011359|P1|COMPLETED|Overall Study||191
1641885|NCT00775645|4011358|P2|STARTED|Overall Study||201
1641886|NCT00775645|4011359|P1|STARTED|Overall Study||208
1641887|NCT00775606|4011381|P2|NOT COMPLETED|Overall Study||0
1641888|NCT00775606|4011382|P1|NOT COMPLETED|Overall Study||3
1641889|NCT00775606|4011381|P2|COMPLETED|Overall Study||5
1641890|NCT00775606|4011382|P1|COMPLETED|Overall Study||5
1641891|NCT00775606|4011381|P2|STARTED|Overall Study||5
1641892|NCT00775606|4011382|P1|STARTED|Overall Study||8
1641893|NCT00775593|4011392|P1|NOT COMPLETED|Overall Study||7
1641894|NCT00775593|4011392|P1|COMPLETED|Overall Study||53
1641895|NCT00775593|4011392|P1|STARTED|Overall Study||60
1641896|NCT00775528|4011399|P1|NOT COMPLETED|Overall Study||1
1641897|NCT00775528|4011399|P1|COMPLETED|Overall Study||18
1641898|NCT00775528|4011399|P1|STARTED|Overall Study|Started means number of patients who consented|19
1641899|NCT00775463|4011408|P2|NOT COMPLETED|Overall Study||13
1641900|NCT00775463|4011409|P1|NOT COMPLETED|Overall Study||11
1641901|NCT00775463|4011408|P2|COMPLETED|Overall Study||59
1641902|NCT00775463|4011409|P1|COMPLETED|Overall Study||65
1641903|NCT00775463|4011408|P2|STARTED|Overall Study||72
1641904|NCT00775463|4011409|P1|STARTED|Overall Study||76
1641905|NCT00775450|4011446|P5|NOT COMPLETED|Overall Study||2
1641906|NCT00775450|4011447|P4|NOT COMPLETED|Overall Study||0
1641907|NCT00775450|4011448|P3|NOT COMPLETED|Overall Study||0
1641908|NCT00775450|4011449|P2|NOT COMPLETED|Overall Study||0
1641909|NCT00775450|4011450|P1|NOT COMPLETED|Overall Study||3
1641910|NCT00775450|4011446|P5|COMPLETED|Overall Study||199
1641911|NCT00775450|4011447|P4|COMPLETED|Overall Study||108
1641912|NCT00775450|4011448|P3|COMPLETED|Overall Study||105
1641913|NCT00775450|4011449|P2|COMPLETED|Overall Study||98
1641914|NCT00775450|4011450|P1|COMPLETED|Overall Study||292
1641915|NCT00775450|4011446|P5|STARTED|Overall Study||201
1641916|NCT00775450|4011447|P4|STARTED|Overall Study||108
1641917|NCT00775450|4011448|P3|STARTED|Overall Study||105
1641918|NCT00775450|4011449|P2|STARTED|Overall Study||98
1641919|NCT00775450|4011450|P1|STARTED|Overall Study||295
1641920|NCT00775437|4011477|P1|NOT COMPLETED|Overall Study||6
1641921|NCT00775437|4011477|P1|COMPLETED|Overall Study||26
1641922|NCT00775437|4011477|P1|STARTED|Overall Study||32
1641923|NCT00775411|4011527|P1|NOT COMPLETED|Overall Study||1
1641924|NCT00775411|4011527|P1|COMPLETED|Overall Study||43
1641925|NCT00775411|4011527|P1|STARTED|Overall Study||44
1641926|NCT00775346|4011533|P1|NOT COMPLETED|Overall Study||0
1641927|NCT00775346|4011533|P1|COMPLETED|Overall Study||92
1641928|NCT00775346|4011533|P1|STARTED|Overall Study||92
1641929|NCT00775229|4011539|P2|NOT COMPLETED|Overall Study||2
1641930|NCT00775229|4011540|P1|NOT COMPLETED|Overall Study||5
1641931|NCT00775229|4011539|P2|COMPLETED|Overall Study||24
1641932|NCT00775229|4011540|P1|COMPLETED|Overall Study||20
1641933|NCT00775229|4011539|P2|STARTED|Overall Study||26
1641934|NCT00775229|4011540|P1|STARTED|Overall Study||25
1641935|NCT00775203|4011552|P2|NOT COMPLETED|Overall Study||43
1641936|NCT00775203|4011553|P1|NOT COMPLETED|Overall Study||62
1641937|NCT00775203|4011552|P2|COMPLETED|Overall Study||163
1641938|NCT00775203|4011553|P1|COMPLETED|Overall Study||144
1641939|NCT00775203|4011552|P2|Received Study Medication|Overall Study||204
1641940|NCT00775203|4011553|P1|Received Study Medication|Overall Study||202
1641941|NCT00775203|4011552|P2|STARTED|Overall Study||206
1641942|NCT00775203|4011553|P1|STARTED|Overall Study||206
1641943|NCT00775190|4011587|P2|NOT COMPLETED|Overall Study||5
1641944|NCT00775190|4011588|P1|NOT COMPLETED|Overall Study||4
1641945|NCT00775190|4011587|P2|COMPLETED|Overall Study||0
1641946|NCT00775190|4011588|P1|COMPLETED|Overall Study||3
1641947|NCT00775190|4011587|P2|STARTED|Overall Study||5
1641948|NCT00775190|4011588|P1|STARTED|Overall Study||7
1641949|NCT00775021|4011610|P2|NOT COMPLETED|Second Intervention||1
1641950|NCT00775021|4011611|P1|NOT COMPLETED|Second Intervention||0
1641951|NCT00775021|4011610|P2|COMPLETED|Second Intervention||59
1641952|NCT00775021|4011611|P1|COMPLETED|Second Intervention||62
1641953|NCT00775021|4011610|P2|STARTED|Second Intervention||60
1641954|NCT00775021|4011611|P1|STARTED|Second Intervention||62
1641955|NCT00775021|4011610|P2|NOT COMPLETED|First Intervention||0
1641956|NCT00775021|4011611|P1|NOT COMPLETED|First Intervention||1
1641957|NCT00775021|4011610|P2|COMPLETED|First Intervention||60
1641958|NCT00775021|4011611|P1|COMPLETED|First Intervention||62
1641959|NCT00775021|4011610|P2|STARTED|First Intervention||60
1641960|NCT00775021|4011611|P1|STARTED|First Intervention||63
1641961|NCT00774995|4011629|P4|NOT COMPLETED|Overall Study||0
1641962|NCT00774995|4011630|P3|NOT COMPLETED|Overall Study||1
1641963|NCT00774995|4011631|P2|NOT COMPLETED|Overall Study||0
1641964|NCT00774995|4011632|P1|NOT COMPLETED|Overall Study||0
1641965|NCT00774995|4011629|P4|COMPLETED|Overall Study||16
1641966|NCT00774995|4011630|P3|COMPLETED|Overall Study||7
1641967|NCT00774995|4011631|P2|COMPLETED|Overall Study||16
1641968|NCT00774995|4011632|P1|COMPLETED|Overall Study||9
1641969|NCT00774995|4011629|P4|STARTED|Overall Study||16
1641970|NCT00774995|4011630|P3|STARTED|Overall Study||8
1641971|NCT00774995|4011631|P2|STARTED|Overall Study||16
1641972|NCT00774995|4011632|P1|STARTED|Overall Study||9
1641973|NCT00774930|4011672|P2|NOT COMPLETED|LTOLE Phase||17
1641974|NCT00774930|4011673|P1|NOT COMPLETED|LTOLE Phase||15
1641975|NCT00774930|4011672|P2|COMPLETED|LTOLE Phase||8
1641976|NCT00774930|4011673|P1|COMPLETED|LTOLE Phase||17
1641977|NCT00774930|4011672|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
1641978|NCT00774930|4011673|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
1641979|NCT00774930|4011672|P2|NOT COMPLETED|IOL Phase||9
1641980|NCT00774930|4011673|P1|NOT COMPLETED|IOL Phase||13
1641981|NCT00774930|4011672|P2|COMPLETED|IOL Phase||37
1641982|NCT00774930|4011673|P1|COMPLETED|IOL Phase||43
1641983|NCT00774930|4011672|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
1641984|NCT00774930|4011673|P1|STARTED|IOL Phase||56
1641985|NCT00774930|4011672|P2|NOT COMPLETED|DB Phase||22
1641986|NCT00774930|4011673|P1|NOT COMPLETED|DB Phase||14
1641987|NCT00774930|4011672|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
1641988|NCT00774930|4011673|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
1641989|NCT00774930|4011672|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
1641990|NCT00774930|4011673|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
1641991|NCT00774852|4011701|P2|NOT COMPLETED|Overall Study||41
1641992|NCT00774852|4011702|P1|NOT COMPLETED|Overall Study||45
1641993|NCT00774852|4011701|P2|COMPLETED|Overall Study||27
1641994|NCT00774852|4011702|P1|COMPLETED|Overall Study||24
1641995|NCT00774852|4011701|P2|STARTED|Overall Study||68
1641996|NCT00774852|4011702|P1|STARTED|Overall Study||69
1641997|NCT00774800|4011750|P1|NOT COMPLETED|Intervention 4||1
1641998|NCT00774800|4011750|P1|COMPLETED|Intervention 4||21
1641999|NCT00774800|4011750|P1|Received at Least One Dose of Study Drug|Intervention 4||21
1642000|NCT00774800|4011750|P1|STARTED|Intervention 4||22
1642001|NCT00774800|4011750|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
1642002|NCT00774800|4011750|P1|COMPLETED|Washout (3 to 10 Days)||22
1642003|NCT00774800|4011750|P1|STARTED|Washout (3 to 10 Days)||22
1642004|NCT00774800|4011750|P1|NOT COMPLETED|Intervention 3||0
1642005|NCT00774800|4011750|P1|COMPLETED|Intervention 3||22
1642006|NCT00774800|4011750|P1|Received at Least One Dose of Study Drug|Intervention 3||22
1642007|NCT00774800|4011750|P1|STARTED|Intervention 3||22
1642008|NCT00774800|4011750|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
1642009|NCT00774800|4011750|P1|COMPLETED|Washout (3 to 10 Days)||22
1642010|NCT00774800|4011750|P1|STARTED|Washout (3 to 10 Days)||22
1642011|NCT00774800|4011750|P1|NOT COMPLETED|Intervention 2||0
1642012|NCT00774800|4011750|P1|COMPLETED|Intervention 2||22
1642013|NCT00774800|4011750|P1|Received at Least One Dose of Study Drug|Intervention 2||22
1642014|NCT00774800|4011750|P1|STARTED|Intervention 2||22
1642015|NCT00774800|4011750|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
1642016|NCT00774800|4011750|P1|COMPLETED|Washout (3 to 10 Days)||22
1642017|NCT00774800|4011750|P1|STARTED|Washout (3 to 10 Days)||22
1642018|NCT00774800|4011750|P1|NOT COMPLETED|Intervention 1||0
1642019|NCT00774800|4011750|P1|COMPLETED|Intervention 1||22
1642020|NCT00774800|4011750|P1|Received at Least One Dose of Study Drug|Intervention 1||22
1642021|NCT00774800|4011750|P1|STARTED|Intervention 1||22
1642022|NCT00774787|4011772|P1|NOT COMPLETED|Overall Study||1
1642023|NCT00774787|4011772|P1|COMPLETED|Overall Study||26
1642024|NCT00774787|4011772|P1|STARTED|Overall Study||27
1642025|NCT00774748|4011779|P1|NOT COMPLETED|Overall Study||3
1642026|NCT00774748|4011779|P1|COMPLETED|Overall Study||18
1642027|NCT00774748|4011779|P1|STARTED|Overall Study||21
1642028|NCT00774397|4011794|P7|NOT COMPLETED|Overall Study||30
1642029|NCT00774397|4011795|P6|NOT COMPLETED|Overall Study||22
1642030|NCT00774397|4011796|P5|NOT COMPLETED|Overall Study||46
1642031|NCT00774397|4011797|P4|NOT COMPLETED|Overall Study||17
1642032|NCT00774397|4011798|P3|NOT COMPLETED|Overall Study||30
1642033|NCT00774397|4011799|P2|NOT COMPLETED|Overall Study||13
1642034|NCT00774397|4011800|P1|NOT COMPLETED|Overall Study||14
1642035|NCT00774397|4011794|P7|COMPLETED|Overall Study||41
1642036|NCT00774397|4011795|P6|COMPLETED|Overall Study||54
1642037|NCT00774397|4011796|P5|COMPLETED|Overall Study||97
1642038|NCT00774397|4011797|P4|COMPLETED|Overall Study||129
1642039|NCT00774397|4011798|P3|COMPLETED|Overall Study||113
1642040|NCT00774397|4011799|P2|COMPLETED|Overall Study||56
1642041|NCT00774397|4011800|P1|COMPLETED|Overall Study||57
1642042|NCT00774397|4011794|P7|STARTED|Overall Study||71
1642043|NCT00774397|4011795|P6|STARTED|Overall Study||76
1642044|NCT00774397|4011796|P5|STARTED|Overall Study||143
1642045|NCT00774397|4011797|P4|STARTED|Overall Study||146
1642046|NCT00774397|4011798|P3|STARTED|Overall Study||143
1642047|NCT00774397|4011799|P2|STARTED|Overall Study||69
1642048|NCT00774397|4011800|P1|STARTED|Overall Study||71
1642049|NCT00774306|4012036|P4|NOT COMPLETED|Overall Study||5
1642050|NCT00774306|4012037|P3|NOT COMPLETED|Overall Study||8
1642051|NCT00774306|4012038|P2|NOT COMPLETED|Overall Study||2
1642052|NCT00774306|4012039|P1|NOT COMPLETED|Overall Study||18
1642053|NCT00774306|4012036|P4|COMPLETED|Overall Study||2
1642054|NCT00774306|4012037|P3|COMPLETED|Overall Study||8
1642055|NCT00774306|4012038|P2|COMPLETED|Overall Study||3
1642056|NCT00774306|4012039|P1|COMPLETED|Overall Study||6
1642057|NCT00774306|4012036|P4|STARTED|Overall Study||7
1642058|NCT00774306|4012037|P3|STARTED|Overall Study||16
1642059|NCT00774306|4012038|P2|STARTED|Overall Study||5
1642060|NCT00774306|4012039|P1|STARTED|Overall Study||24
1642061|NCT00774267|4012053|P4|NOT COMPLETED|Overall Study||0
1642062|NCT00774267|4012054|P3|NOT COMPLETED|Overall Study||0
1642063|NCT00774267|4012055|P2|NOT COMPLETED|Overall Study||0
1642064|NCT00774267|4012056|P1|NOT COMPLETED|Overall Study||0
1642065|NCT00774267|4012053|P4|COMPLETED|Overall Study||135
1642066|NCT00774267|4012054|P3|COMPLETED|Overall Study||129
1642067|NCT00774267|4012055|P2|COMPLETED|Overall Study||111
1642068|NCT00774267|4012056|P1|COMPLETED|Overall Study||132
1642069|NCT00774267|4012053|P4|STARTED|Overall Study||135
1642070|NCT00774267|4012054|P3|STARTED|Overall Study||129
1642071|NCT00774267|4012055|P2|STARTED|Overall Study||111
1642072|NCT00774267|4012056|P1|STARTED|Overall Study||132
1642073|NCT00774202|4012068|P2|NOT COMPLETED|Overall Study||0
1642074|NCT00774202|4012069|P1|NOT COMPLETED|Overall Study||0
1642075|NCT00774202|4012068|P2|COMPLETED|Overall Study||8
1642076|NCT00774202|4012069|P1|COMPLETED|Overall Study||9
1642077|NCT00774202|4012068|P2|STARTED|Overall Study||8
1642078|NCT00774202|4012069|P1|STARTED|Overall Study||9
1642079|NCT00774163|4012081|P2|NOT COMPLETED|Overall Study||0
1642080|NCT00774163|4012082|P1|NOT COMPLETED|Overall Study||0
1642081|NCT00774163|4012081|P2|COMPLETED|Overall Study||15
1642082|NCT00774163|4012082|P1|COMPLETED|Overall Study||30
1642083|NCT00774163|4012081|P2|STARTED|Overall Study||15
1642084|NCT00774163|4012082|P1|STARTED|Overall Study||30
1642085|NCT00774046|4012120|P1|NOT COMPLETED|Autologous Transplant||0
1642086|NCT00774046|4012120|P1|COMPLETED|Autologous Transplant||4
1642087|NCT00774046|4012120|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
1642088|NCT00774046|4012120|P1|NOT COMPLETED|Stem Cell Mobilization||3
1642089|NCT00774046|4012120|P1|COMPLETED|Stem Cell Mobilization||7
1642090|NCT00774046|4012120|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
1642091|NCT00774046|4012120|P1|NOT COMPLETED|Induction Therapy||0
1642092|NCT00774046|4012120|P1|COMPLETED|Induction Therapy||32
1642093|NCT00774046|4012120|P1|STARTED|Induction Therapy||32
1642094|NCT00774046|4012120|P1|NOT COMPLETED|Enrollment||28
1642095|NCT00774046|4012120|P1|COMPLETED|Enrollment||32
1642096|NCT00774046|4012120|P1|STARTED|Enrollment||60
1642097|NCT00774046|4012120|P1|NOT COMPLETED|Screening||56
1642098|NCT00774046|4012120|P1|COMPLETED|Screening||60
1642099|NCT00774046|4012120|P1|STARTED|Screening||116
1642100|NCT00773968|4012130|P1|NOT COMPLETED|Overall Study||45
1642101|NCT00773968|4012130|P1|COMPLETED|Overall Study||95
1642102|NCT00773968|4012130|P1|Treated|Overall Study||111
1642103|NCT00773968|4012130|P1|STARTED|Overall Study||140
1642104|NCT00773955|4012139|P1|NOT COMPLETED|Overall Study||0
1642105|NCT00773955|4012139|P1|COMPLETED|Overall Study||15
1642106|NCT00773955|4012139|P1|STARTED|Overall Study||15
1642107|NCT00773786|4012146|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1642108|NCT00773786|4012147|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1642109|NCT00773786|4012146|P2|COMPLETED|Second Intervention (1 Week)||10
1642110|NCT00773786|4012147|P1|COMPLETED|Second Intervention (1 Week)||10
1642111|NCT00773786|4012146|P2|STARTED|Second Intervention (1 Week)||10
1642112|NCT00773786|4012147|P1|STARTED|Second Intervention (1 Week)||10
1642113|NCT00773786|4012146|P2|NOT COMPLETED|Washout (1 Week)||0
1642114|NCT00773786|4012147|P1|NOT COMPLETED|Washout (1 Week)||0
1642115|NCT00773786|4012146|P2|COMPLETED|Washout (1 Week)||10
1642116|NCT00773786|4012147|P1|COMPLETED|Washout (1 Week)||10
1642117|NCT00773786|4012146|P2|STARTED|Washout (1 Week)||10
1642118|NCT00773786|4012147|P1|STARTED|Washout (1 Week)||10
1642119|NCT00773786|4012146|P2|NOT COMPLETED|First Intervention (1 Week)||0
1642120|NCT00773786|4012147|P1|NOT COMPLETED|First Intervention (1 Week)||0
1642121|NCT00773786|4012146|P2|COMPLETED|First Intervention (1 Week)||10
1642122|NCT00773786|4012147|P1|COMPLETED|First Intervention (1 Week)||10
1642123|NCT00773786|4012146|P2|STARTED|First Intervention (1 Week)||10
1642124|NCT00773786|4012147|P1|STARTED|First Intervention (1 Week)||10
1642125|NCT00773734|4012161|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1642126|NCT00773734|4012162|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1642127|NCT00773734|4012163|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
1642128|NCT00773734|4012164|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
1642129|NCT00773734|4012165|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1642130|NCT00773734|4012166|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1642131|NCT00773734|4012161|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
1642132|NCT00773734|4012162|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
1642133|NCT00773734|4012163|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
1642134|NCT00773734|4012164|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
1642135|NCT00773734|4012165|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
1642136|NCT00773734|4012166|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
1642137|NCT00773734|4012161|P6|STARTED|LTE Period: Week 52 to 6 Years||0
1642138|NCT00773734|4012162|P5|STARTED|LTE Period: Week 52 to 6 Years||0
1642139|NCT00773734|4012163|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
1642140|NCT00773734|4012164|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
1642141|NCT00773734|4012165|P2|STARTED|LTE Period: Week 52 to 6 Years||0
1642142|NCT00773734|4012166|P1|STARTED|LTE Period: Week 52 to 6 Years||0
1642143|NCT00773734|4012161|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
1642144|NCT00773734|4012162|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
1642145|NCT00773734|4012163|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
1642146|NCT00773734|4012164|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
1642147|NCT00773734|4012165|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
1642148|NCT00773734|4012166|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
1642149|NCT00773734|4012161|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
1642150|NCT00773734|4012162|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
1642151|NCT00773734|4012163|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
1642152|NCT00773734|4012164|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
1642153|NCT00773734|4012165|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
1642154|NCT00773734|4012166|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
1642155|NCT00773734|4012161|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
1642156|NCT00773734|4012162|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
1642157|NCT00773734|4012163|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
1642158|NCT00773734|4012164|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
1642159|NCT00773734|4012165|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
1642160|NCT00773734|4012166|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
1642161|NCT00773734|4012161|P6|STARTED|Extension: Active Treatment Week 24-52||27
1642162|NCT00773734|4012162|P5|STARTED|Extension: Active Treatment Week 24-52||27
1642163|NCT00773734|4012163|P4|STARTED|Extension: Active Treatment Week 24-52||58
1642164|NCT00773734|4012164|P3|STARTED|Extension: Active Treatment Week 24-52||50
1642165|NCT00773734|4012165|P2|STARTED|Extension: Active Treatment Week 24-52||47
1642166|NCT00773734|4012166|P1|STARTED|Extension: Active Treatment Week 24-52||0
1642167|NCT00773734|4012161|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
1642168|NCT00773734|4012162|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
1642169|NCT00773734|4012163|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
1642170|NCT00773734|4012164|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
1642171|NCT00773734|4012165|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
1642172|NCT00773734|4012166|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
1642173|NCT00773734|4012161|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
1642174|NCT00773734|4012162|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
1642175|NCT00773734|4012163|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
1642176|NCT00773734|4012164|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
1642177|NCT00773734|4012165|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
1642178|NCT00773734|4012166|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
1642179|NCT00773734|4012161|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
1642180|NCT00773734|4012162|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
1642181|NCT00773734|4012163|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
1642182|NCT00773734|4012164|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
1642183|NCT00773734|4012165|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
1642184|NCT00773734|4012166|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
1642185|NCT00773734|4012161|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1642186|NCT00773734|4012162|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1642187|NCT00773734|4012163|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
1642188|NCT00773734|4012164|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
1642189|NCT00773734|4012165|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
1642190|NCT00773734|4012166|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
1642191|NCT00773734|4012161|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1642192|NCT00773734|4012162|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1642193|NCT00773734|4012163|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
1642194|NCT00773734|4012164|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
1642195|NCT00773734|4012165|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
1642196|NCT00773734|4012166|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
1642197|NCT00773734|4012161|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
1642198|NCT00773734|4012162|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
1642199|NCT00773734|4012163|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
1642200|NCT00773734|4012164|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
1642201|NCT00773734|4012165|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
1642202|NCT00773734|4012166|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
1642203|NCT00773513|4012730|P2|NOT COMPLETED|Overall Study||1109
1642204|NCT00773513|4012731|P1|NOT COMPLETED|Overall Study||1101
1642205|NCT00773513|4012730|P2|COMPLETED|Overall Study||303
1642206|NCT00773513|4012731|P1|COMPLETED|Overall Study||312
1642207|NCT00773513|4012730|P2|Received Study Treatment|Overall Study||1409
1642208|NCT00773513|4012731|P1|Received Study Treatment|Overall Study||1409
1642209|NCT00773513|4012730|P2|STARTED|Overall Study||1412
1642210|NCT00773513|4012731|P1|STARTED|Overall Study||1413
1642211|NCT00773474|4012751|P1|NOT COMPLETED|Overall Study||0
1642212|NCT00773474|4012751|P1|COMPLETED|Overall Study||29
1642213|NCT00773474|4012751|P1|STARTED|Overall Study||29
1642214|NCT00773461|4012760|P2|NOT COMPLETED|Overall Study||4
1642215|NCT00773461|4012761|P1|NOT COMPLETED|Overall Study||5
1642216|NCT00773461|4012760|P2|COMPLETED|Overall Study||135
1642217|NCT00773461|4012761|P1|COMPLETED|Overall Study||65
1642218|NCT00773461|4012760|P2|STARTED|Overall Study||139
1642219|NCT00773461|4012761|P1|STARTED|Overall Study||70
1642220|NCT00773422|4012802|P3|NOT COMPLETED|Overall Study||0
1642221|NCT00773422|4012803|P2|NOT COMPLETED|Overall Study||0
1642222|NCT00773422|4012804|P1|NOT COMPLETED|Overall Study||0
1642223|NCT00773422|4012802|P3|COMPLETED|Overall Study||10
1642224|NCT00773422|4012803|P2|COMPLETED|Overall Study||9
1642225|NCT00773422|4012804|P1|COMPLETED|Overall Study||11
1642226|NCT00773422|4012802|P3|STARTED|Overall Study||10
1642227|NCT00773422|4012803|P2|STARTED|Overall Study||9
1642228|NCT00773422|4012804|P1|STARTED|Overall Study||11
1642229|NCT00773383|4012815|P1|NOT COMPLETED|Overall Study||31
1642230|NCT00773383|4012815|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
1642231|NCT00773383|4012815|P1|Received Study Drug|Overall Study||34
1642232|NCT00773383|4012815|P1|STARTED|Overall Study||35
1642233|NCT00773370|4012837|P2|NOT COMPLETED|Overall Study||10
1642234|NCT00773370|4012838|P1|NOT COMPLETED|Overall Study||18
1642235|NCT00773370|4012837|P2|COMPLETED|Overall Study||23
1642236|NCT00773370|4012838|P1|COMPLETED|Overall Study||25
1642237|NCT00773370|4012837|P2|STARTED|Overall Study||33
1642238|NCT00773370|4012838|P1|STARTED|Overall Study||43
1642239|NCT00773279|4012850|P2|NOT COMPLETED|Period 2||6
1642240|NCT00773279|4012851|P1|NOT COMPLETED|Period 2||3
1642241|NCT00773279|4012850|P2|COMPLETED|Period 2||111
1642242|NCT00773279|4012851|P1|COMPLETED|Period 2||111
1642243|NCT00773279|4012850|P2|STARTED|Period 2||117
1642244|NCT00773279|4012851|P1|STARTED|Period 2||114
1642245|NCT00773279|4012850|P2|NOT COMPLETED|Period 1||4
1642246|NCT00773279|4012851|P1|NOT COMPLETED|Period 1||7
1642247|NCT00773279|4012850|P2|COMPLETED|Period 1||117
1642248|NCT00773279|4012851|P1|COMPLETED|Period 1||114
1642249|NCT00773279|4012850|P2|STARTED|Period 1||121
1642250|NCT00773279|4012851|P1|STARTED|Period 1||121
1642251|NCT00773253|4012872|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
1642252|NCT00773253|4012873|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
1642253|NCT00773253|4012872|P2|COMPLETED|Second Intervention (Week 24-48)||4
1642254|NCT00773253|4012873|P1|COMPLETED|Second Intervention (Week 24-48)||5
1642255|NCT00773253|4012872|P2|STARTED|Second Intervention (Week 24-48)||4
1642256|NCT00773253|4012873|P1|STARTED|Second Intervention (Week 24-48)||5
1642257|NCT00773253|4012872|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
1642258|NCT00773253|4012873|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
1642259|NCT00773253|4012872|P2|COMPLETED|First Intervention (Week 0-24)||4
1642260|NCT00773253|4012873|P1|COMPLETED|First Intervention (Week 0-24)||5
1642261|NCT00773253|4012872|P2|STARTED|First Intervention (Week 0-24)||5
1642262|NCT00773253|4012873|P1|STARTED|First Intervention (Week 0-24)||5
1642263|NCT00773175|4012881|P2|NOT COMPLETED|Overall Study||2
1642264|NCT00773175|4012882|P1|NOT COMPLETED|Overall Study||2
1642265|NCT00773175|4012881|P2|COMPLETED|Overall Study||73
1642266|NCT00773175|4012882|P1|COMPLETED|Overall Study||71
1642267|NCT00773175|4012881|P2|No Fluids Received|Overall Study||1
1642268|NCT00773175|4012882|P1|No Fluids Received|Overall Study||0
1642269|NCT00773175|4012881|P2|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
1642270|NCT00773175|4012882|P1|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
1642271|NCT00773175|4012881|P2|Initial Fluids Via Randomized Route|Overall Study||59
1642272|NCT00773175|4012882|P1|Initial Fluids Via Randomized Route|Overall Study||73
1642273|NCT00773175|4012881|P2|STARTED|Overall Study||75
1642274|NCT00773175|4012882|P1|STARTED|Overall Study||73
1642275|NCT00773136|4012974|P1|NOT COMPLETED|Overall Study||2
1642276|NCT00773136|4012974|P1|COMPLETED|Overall Study||19
1642277|NCT00773136|4012974|P1|STARTED|Overall Study||21
1642278|NCT00773097|4012979|P1|NOT COMPLETED|Overall Study||7
1642279|NCT00773097|4012979|P1|COMPLETED|Overall Study||39
1642280|NCT00773097|4012979|P1|STARTED|Overall Study||46
1642281|NCT00772967|4012985|P6|NOT COMPLETED|Crossover Treatment 3||0
1642282|NCT00772967|4012986|P5|NOT COMPLETED|Crossover Treatment 3||1
1642283|NCT00772967|4012987|P4|NOT COMPLETED|Crossover Treatment 3||0
1642284|NCT00772967|4012988|P3|NOT COMPLETED|Crossover Treatment 3||0
1642285|NCT00772967|4012989|P2|NOT COMPLETED|Crossover Treatment 3||0
1642286|NCT00772967|4012990|P1|NOT COMPLETED|Crossover Treatment 3||0
1642287|NCT00772967|4012985|P6|COMPLETED|Crossover Treatment 3||3
1642288|NCT00772967|4012986|P5|COMPLETED|Crossover Treatment 3||3
1642289|NCT00772967|4012987|P4|COMPLETED|Crossover Treatment 3||3
1642290|NCT00772967|4012988|P3|COMPLETED|Crossover Treatment 3||3
1642291|NCT00772967|4012989|P2|COMPLETED|Crossover Treatment 3||4
1642292|NCT00772967|4012990|P1|COMPLETED|Crossover Treatment 3||3
1642293|NCT00772967|4012985|P6|STARTED|Crossover Treatment 3||3
1642294|NCT00772967|4012986|P5|STARTED|Crossover Treatment 3||4
1642295|NCT00772967|4012987|P4|STARTED|Crossover Treatment 3||3
1642296|NCT00772967|4012988|P3|STARTED|Crossover Treatment 3||3
1642297|NCT00772967|4012989|P2|STARTED|Crossover Treatment 3||4
1642298|NCT00772967|4012990|P1|STARTED|Crossover Treatment 3||3
1642299|NCT00772967|4012985|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
1642300|NCT00772967|4012986|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
1642301|NCT00772967|4012987|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
1642302|NCT00772967|4012988|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
1642303|NCT00772967|4012989|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
1642304|NCT00772967|4012990|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
1642305|NCT00772967|4012985|P6|COMPLETED|Break 2 (4-7 Days)||3
1642306|NCT00772967|4012986|P5|COMPLETED|Break 2 (4-7 Days)||4
1642307|NCT00772967|4012987|P4|COMPLETED|Break 2 (4-7 Days)||3
1642308|NCT00772967|4012988|P3|COMPLETED|Break 2 (4-7 Days)||3
1642309|NCT00772967|4012989|P2|COMPLETED|Break 2 (4-7 Days)||4
1642310|NCT00772967|4012990|P1|COMPLETED|Break 2 (4-7 Days)||3
1642311|NCT00772967|4012985|P6|STARTED|Break 2 (4-7 Days)||3
1642312|NCT00772967|4012986|P5|STARTED|Break 2 (4-7 Days)||4
1642313|NCT00772967|4012987|P4|STARTED|Break 2 (4-7 Days)||3
1642314|NCT00772967|4012988|P3|STARTED|Break 2 (4-7 Days)||3
1642315|NCT00772967|4012989|P2|STARTED|Break 2 (4-7 Days)||4
1642316|NCT00772967|4012990|P1|STARTED|Break 2 (4-7 Days)||3
1642317|NCT00772967|4012985|P6|NOT COMPLETED|Crossover Treatment 2||0
1642318|NCT00772967|4012986|P5|NOT COMPLETED|Crossover Treatment 2||0
1642319|NCT00772967|4012987|P4|NOT COMPLETED|Crossover Treatment 2||0
1642320|NCT00772967|4012988|P3|NOT COMPLETED|Crossover Treatment 2||0
1642321|NCT00772967|4012989|P2|NOT COMPLETED|Crossover Treatment 2||0
1642322|NCT00772967|4012990|P1|NOT COMPLETED|Crossover Treatment 2||0
1642323|NCT00772967|4012985|P6|COMPLETED|Crossover Treatment 2||3
1642324|NCT00772967|4012986|P5|COMPLETED|Crossover Treatment 2||4
1642325|NCT00772967|4012987|P4|COMPLETED|Crossover Treatment 2||3
1642326|NCT00772967|4012988|P3|COMPLETED|Crossover Treatment 2||3
1642327|NCT00772967|4012989|P2|COMPLETED|Crossover Treatment 2||4
1642328|NCT00772967|4012990|P1|COMPLETED|Crossover Treatment 2||3
1642329|NCT00772967|4012985|P6|STARTED|Crossover Treatment 2||3
1642330|NCT00772967|4012986|P5|STARTED|Crossover Treatment 2||4
1642331|NCT00772967|4012987|P4|STARTED|Crossover Treatment 2||3
1642332|NCT00772967|4012988|P3|STARTED|Crossover Treatment 2||3
1642333|NCT00772967|4012989|P2|STARTED|Crossover Treatment 2||4
1642334|NCT00772967|4012990|P1|STARTED|Crossover Treatment 2||3
1642335|NCT00772967|4012985|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
1642336|NCT00772967|4012986|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
1642337|NCT00772967|4012987|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
1642338|NCT00772967|4012988|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
1642339|NCT00772967|4012989|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
1642340|NCT00772967|4012990|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
1642341|NCT00772967|4012985|P6|COMPLETED|Break 1 (4-7 Days)||3
1642342|NCT00772967|4012986|P5|COMPLETED|Break 1 (4-7 Days)||4
1642343|NCT00772967|4012987|P4|COMPLETED|Break 1 (4-7 Days)||3
1642344|NCT00772967|4012988|P3|COMPLETED|Break 1 (4-7 Days)||3
1642345|NCT00772967|4012989|P2|COMPLETED|Break 1 (4-7 Days)||4
1642346|NCT00772967|4012990|P1|COMPLETED|Break 1 (4-7 Days)||3
1642347|NCT00772967|4012985|P6|STARTED|Break 1 (4-7 Days)||3
1642348|NCT00772967|4012986|P5|STARTED|Break 1 (4-7 Days)||4
1642349|NCT00772967|4012987|P4|STARTED|Break 1 (4-7 Days)||3
1642350|NCT00772967|4012988|P3|STARTED|Break 1 (4-7 Days)||3
1642351|NCT00772967|4012989|P2|STARTED|Break 1 (4-7 Days)||5
1642352|NCT00772967|4012990|P1|STARTED|Break 1 (4-7 Days)||3
1642353|NCT00772967|4012985|P6|NOT COMPLETED|Crossover Treatment 1||0
1642354|NCT00772967|4012986|P5|NOT COMPLETED|Crossover Treatment 1||0
1642355|NCT00772967|4012987|P4|NOT COMPLETED|Crossover Treatment 1||1
1642356|NCT00772967|4012988|P3|NOT COMPLETED|Crossover Treatment 1||0
1642357|NCT00772967|4012989|P2|NOT COMPLETED|Crossover Treatment 1||0
1642358|NCT00772967|4012990|P1|NOT COMPLETED|Crossover Treatment 1||0
1642359|NCT00772967|4012985|P6|COMPLETED|Crossover Treatment 1||3
1642360|NCT00772967|4012986|P5|COMPLETED|Crossover Treatment 1||4
1642361|NCT00772967|4012987|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
1642362|NCT00772967|4012988|P3|COMPLETED|Crossover Treatment 1||3
1642363|NCT00772967|4012989|P2|COMPLETED|Crossover Treatment 1||5
1642364|NCT00772967|4012990|P1|COMPLETED|Crossover Treatment 1||3
1642365|NCT00772967|4012985|P6|STARTED|Crossover Treatment 1||3
1642366|NCT00772967|4012986|P5|STARTED|Crossover Treatment 1||4
1642367|NCT00772967|4012987|P4|STARTED|Crossover Treatment 1||4
1642368|NCT00772967|4012988|P3|STARTED|Crossover Treatment 1||3
1642369|NCT00772967|4012989|P2|STARTED|Crossover Treatment 1||5
1642370|NCT00772967|4012990|P1|STARTED|Crossover Treatment 1||3
1642371|NCT00772954|4013010|P3|NOT COMPLETED|Overall Study||1
1642372|NCT00772954|4013011|P2|NOT COMPLETED|Overall Study||0
1642373|NCT00772954|4013012|P1|NOT COMPLETED|Overall Study||0
1642374|NCT00772954|4013010|P3|COMPLETED|Overall Study||11
1642375|NCT00772954|4013011|P2|COMPLETED|Overall Study||12
1642376|NCT00772954|4013012|P1|COMPLETED|Overall Study||12
1642377|NCT00772954|4013010|P3|STARTED|Overall Study||12
1642378|NCT00772954|4013011|P2|STARTED|Overall Study||12
1642379|NCT00772954|4013012|P1|STARTED|Overall Study||12
1642380|NCT00772941|4013020|P1|NOT COMPLETED|Overall Study||682
1642381|NCT00772941|4013020|P1|COMPLETED|Overall Study||3257
1642382|NCT00772941|4013020|P1|STARTED|Overall Study||3939
1642383|NCT00772928|4013051|P2|NOT COMPLETED|Overall Study||41
1642384|NCT00772928|4013052|P1|NOT COMPLETED|Overall Study||44
1642385|NCT00772928|4013051|P2|COMPLETED|Overall Study||538
1642386|NCT00772928|4013052|P1|COMPLETED|Overall Study||543
1642387|NCT00772928|4013051|P2|STARTED|Overall Study||579
1642388|NCT00772928|4013052|P1|STARTED|Overall Study||587
1642389|NCT00772915|4013062|P1|NOT COMPLETED|Overall Study||15
1642390|NCT00772915|4013062|P1|COMPLETED|Overall Study||23
1642391|NCT00772915|4013062|P1|STARTED|Overall Study||38
1642392|NCT00772889|4013069|P3|NOT COMPLETED|Overall Study||16
1642393|NCT00772889|4013070|P2|NOT COMPLETED|Overall Study||18
1642394|NCT00772889|4013071|P1|NOT COMPLETED|Overall Study||22
1642395|NCT00772889|4013069|P3|COMPLETED|Overall Study||187
1642396|NCT00772889|4013070|P2|COMPLETED|Overall Study||375
1642397|NCT00772889|4013071|P1|COMPLETED|Overall Study||353
1642398|NCT00772889|4013069|P3|Completed at Day 21|Overall Study||203
1642399|NCT00772889|4013070|P2|Completed at Day 21|Overall Study||390
1642400|NCT00772889|4013071|P1|Completed at Day 21|Overall Study||374
1642401|NCT00772889|4013069|P3|STARTED|Overall Study||203
1642402|NCT00772889|4013070|P2|STARTED|Overall Study||393
1642403|NCT00772889|4013071|P1|STARTED|Overall Study||375
1642404|NCT00772772|4013124|P1|NOT COMPLETED|Overall Study||0
1642405|NCT00772772|4013124|P1|COMPLETED|Overall Study||12
1642406|NCT00772772|4013124|P1|STARTED|Overall Study||12
1642407|NCT00772707|4013129|P1|NOT COMPLETED|Overall Study||3
1642408|NCT00772707|4013129|P1|COMPLETED|Overall Study||111
1642409|NCT00772707|4013129|P1|STARTED|Overall Study||114
1642410|NCT00772668|4013134|P1|NOT COMPLETED|Overall Study||3
1642411|NCT00772668|4013134|P1|COMPLETED|Overall Study||0
1642412|NCT00772668|4013134|P1|STARTED|Overall Study||3
1642413|NCT00772629|4013143|P2|NOT COMPLETED|Overall Study||0
1642414|NCT00772629|4013144|P1|NOT COMPLETED|Overall Study||1
1642415|NCT00772629|4013143|P2|COMPLETED|Overall Study||1
1642416|NCT00772629|4013144|P1|COMPLETED|Overall Study||16
1642417|NCT00772629|4013143|P2|STARTED|Overall Study||1
1642418|NCT00772629|4013144|P1|STARTED|Overall Study||17
1642419|NCT00772603|4013153|P3|NOT COMPLETED|Overall Study||26
1642420|NCT00772603|4013154|P2|NOT COMPLETED|Overall Study||40
1642421|NCT00772603|4013155|P1|NOT COMPLETED|Overall Study||52
1642422|NCT00772603|4013153|P3|COMPLETED|Overall Study||95
1642423|NCT00772603|4013154|P2|COMPLETED|Overall Study||82
1642424|NCT00772603|4013155|P1|COMPLETED|Overall Study||71
1642425|NCT00772603|4013153|P3|STARTED|Overall Study||121
1642426|NCT00772603|4013154|P2|STARTED|Overall Study||122
1642427|NCT00772603|4013155|P1|STARTED|Overall Study||123
1642428|NCT00772590|4013179|P4|NOT COMPLETED|Overall Study||0
1642429|NCT00772590|4013180|P3|NOT COMPLETED|Overall Study||0
1642430|NCT00772590|4013181|P2|NOT COMPLETED|Overall Study||0
1642431|NCT00772590|4013182|P1|NOT COMPLETED|Overall Study||0
1642432|NCT00772590|4013179|P4|COMPLETED|Overall Study||17
1642433|NCT00772590|4013180|P3|COMPLETED|Overall Study||18
1642434|NCT00772590|4013181|P2|COMPLETED|Overall Study||19
1642435|NCT00772590|4013182|P1|COMPLETED|Overall Study||19
1642436|NCT00772590|4013179|P4|STARTED|Overall Study||17
1642437|NCT00772590|4013180|P3|STARTED|Overall Study||18
1642438|NCT00772590|4013181|P2|STARTED|Overall Study||19
1642439|NCT00772590|4013182|P1|STARTED|Overall Study||19
1642440|NCT00772577|4013194|P2|NOT COMPLETED|Overall Study||23
1642441|NCT00772577|4013195|P1|NOT COMPLETED|Overall Study||23
1642442|NCT00772577|4013194|P2|COMPLETED|Overall Study||170
1642443|NCT00772577|4013195|P1|COMPLETED|Overall Study||170
1642444|NCT00772577|4013194|P2|STARTED|Overall Study||193
1642445|NCT00772577|4013195|P1|STARTED|Overall Study||193
1642446|NCT00772538|4013211|P2|NOT COMPLETED|Overall Study||26
1642447|NCT00772538|4013212|P1|NOT COMPLETED|Overall Study||20
1642448|NCT00772538|4013211|P2|COMPLETED|Overall Study||211
1642449|NCT00772538|4013212|P1|COMPLETED|Overall Study||202
1642450|NCT00772538|4013211|P2|STARTED|Overall Study||237
1642451|NCT00772538|4013212|P1|STARTED|Overall Study||222
1642452|NCT00772447|4013284|P2|NOT COMPLETED|Overall Study||24
1642453|NCT00772447|4013285|P1|NOT COMPLETED|Overall Study||20
1642454|NCT00772447|4013284|P2|COMPLETED|Overall Study||110
1642455|NCT00772447|4013285|P1|COMPLETED|Overall Study||111
1642456|NCT00772447|4013284|P2|STARTED|Overall Study||134
1642457|NCT00772447|4013285|P1|STARTED|Overall Study||131
1642458|NCT00772382|4013313|P1|NOT COMPLETED|Overall Study||55
1642459|NCT00772382|4013313|P1|COMPLETED|Overall Study||61
1642460|NCT00772382|4013313|P1|STARTED|Overall Study||116
1642461|NCT00772369|4013318|P1|NOT COMPLETED|Overall Study||1
1642462|NCT00772369|4013318|P1|COMPLETED|Overall Study||3213
1642463|NCT00772369|4013318|P1|STARTED|Overall Study||3214
1642464|NCT00772304|4013323|P1|NOT COMPLETED|Overall Study||0
1642465|NCT00772304|4013323|P1|COMPLETED|Overall Study||102
1642466|NCT00772304|4013323|P1|STARTED|Overall Study||102
1642467|NCT00772148|4013329|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
1642468|NCT00772148|4013330|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
1642469|NCT00772148|4013329|P2|COMPLETED|Maintenance Phase (Week 52)||18
1642470|NCT00772148|4013330|P1|COMPLETED|Maintenance Phase (Week 52)||17
1642471|NCT00772148|4013329|P2|STARTED|Maintenance Phase (Week 52)||23
1642472|NCT00772148|4013330|P1|STARTED|Maintenance Phase (Week 52)||21
1642473|NCT00772148|4013329|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
1642474|NCT00772148|4013330|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
1642475|NCT00772148|4013329|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
1642476|NCT00772148|4013330|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
1642477|NCT00772148|4013329|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
1642478|NCT00772148|4013330|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
1642479|NCT00772109|4013350|P4|NOT COMPLETED|Overall Study||31
1642480|NCT00772109|4013351|P3|NOT COMPLETED|Overall Study||19
1642481|NCT00772109|4013352|P2|NOT COMPLETED|Overall Study||19
1642482|NCT00772109|4013353|P1|NOT COMPLETED|Overall Study||21
1642483|NCT00772109|4013350|P4|COMPLETED|Overall Study||1397
1642484|NCT00772109|4013351|P3|COMPLETED|Overall Study||936
1642485|NCT00772109|4013352|P2|COMPLETED|Overall Study||934
1642486|NCT00772109|4013353|P1|COMPLETED|Overall Study||935
1642487|NCT00772109|4013350|P4|STARTED|Overall Study||1428
1642488|NCT00772109|4013351|P3|STARTED|Overall Study||955
1642489|NCT00772109|4013352|P2|STARTED|Overall Study||953
1642490|NCT00772109|4013353|P1|STARTED|Overall Study||956
1642491|NCT00772070|4013377|P2|NOT COMPLETED|Overall Study||10
1642492|NCT00772070|4013378|P1|NOT COMPLETED|Overall Study||2
1642493|NCT00772070|4013377|P2|COMPLETED|Overall Study||61
1642494|NCT00772070|4013378|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
1642495|NCT00772070|4013377|P2|STARTED|Overall Study||71
1642496|NCT00772070|4013378|P1|STARTED|Overall Study||102
1642497|NCT00772031|4013390|P2|NOT COMPLETED|Overall Study||43
1642498|NCT00772031|4013391|P1|NOT COMPLETED|Overall Study||32
1642499|NCT00772031|4013390|P2|COMPLETED|Overall Study||52
1642500|NCT00772031|4013391|P1|COMPLETED|Overall Study||64
1642501|NCT00772031|4013390|P2|STARTED|Overall Study||95
1642502|NCT00772031|4013391|P1|STARTED|Overall Study||96
1642503|NCT00772005|4013417|P4|NOT COMPLETED|Overall Study||26
1642504|NCT00772005|4013418|P3|NOT COMPLETED|Overall Study||28
1642505|NCT00772005|4013419|P2|NOT COMPLETED|Overall Study||30
1642506|NCT00772005|4013420|P1|NOT COMPLETED|Overall Study||25
1642507|NCT00772005|4013417|P4|COMPLETED|Overall Study||46
1642508|NCT00772005|4013418|P3|COMPLETED|Overall Study||44
1642509|NCT00772005|4013419|P2|COMPLETED|Overall Study||40
1642510|NCT00772005|4013420|P1|COMPLETED|Overall Study||46
1642511|NCT00772005|4013417|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
1642512|NCT00772005|4013418|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
1642513|NCT00772005|4013419|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
1642514|NCT00772005|4013420|P1|STARTED|Overall Study||71
1642515|NCT00771953|4014108|P2|NOT COMPLETED|Overall Study||10
1642516|NCT00771953|4014109|P1|NOT COMPLETED|Overall Study||10
1642517|NCT00771953|4014108|P2|COMPLETED|Overall Study||26
1642518|NCT00771953|4014109|P1|COMPLETED|Overall Study||26
1642519|NCT00771953|4014108|P2|STARTED|Overall Study||36
1642520|NCT00771953|4014109|P1|STARTED|Overall Study||36
1642521|NCT00771927|4014119|P2|NOT COMPLETED|Overall Study||237
1642522|NCT00771927|4014120|P1|NOT COMPLETED|Overall Study||255
1642523|NCT00771927|4014119|P2|COMPLETED|Overall Study||256
1642524|NCT00771927|4014120|P1|COMPLETED|Overall Study||256
1642525|NCT00771927|4014119|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
1642526|NCT00771927|4014120|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
1642527|NCT00771914|4014132|P4|NOT COMPLETED|Overall Study||2
1642528|NCT00771914|4014133|P3|NOT COMPLETED|Overall Study||0
1642529|NCT00771914|4014134|P2|NOT COMPLETED|Overall Study||0
1642530|NCT00771914|4014135|P1|NOT COMPLETED|Overall Study||0
1642531|NCT00771914|4014132|P4|COMPLETED|Overall Study||6
1642532|NCT00771914|4014133|P3|COMPLETED|Overall Study||6
1642533|NCT00771914|4014134|P2|COMPLETED|Overall Study||6
1642534|NCT00771914|4014135|P1|COMPLETED|Overall Study||7
1642535|NCT00771914|4014132|P4|STARTED|Overall Study||8
1642536|NCT00771914|4014133|P3|STARTED|Overall Study||6
1642537|NCT00771914|4014134|P2|STARTED|Overall Study||6
1642538|NCT00771914|4014135|P1|STARTED|Overall Study||7
1642539|NCT00771901|4014148|P3|NOT COMPLETED|Overall Study||4
1642540|NCT00771901|4014149|P2|NOT COMPLETED|Overall Study||0
1642541|NCT00771901|4014150|P1|NOT COMPLETED|Overall Study||0
1642542|NCT00771901|4014148|P3|COMPLETED|Overall Study||6
1642543|NCT00771901|4014149|P2|COMPLETED|Overall Study||10
1642544|NCT00771901|4014150|P1|COMPLETED|Overall Study||10
1642545|NCT00771901|4014148|P3|STARTED|Overall Study||10
1642546|NCT00771901|4014149|P2|STARTED|Overall Study||10
1642547|NCT00771901|4014150|P1|STARTED|Overall Study||10
1642548|NCT00771875|4014167|P3|NOT COMPLETED|Overall Study||0
1642549|NCT00771875|4014168|P2|NOT COMPLETED|Overall Study||1
1642550|NCT00771875|4014169|P1|NOT COMPLETED|Overall Study||0
1642551|NCT00771875|4014167|P3|COMPLETED|Overall Study||10
1642552|NCT00771875|4014168|P2|COMPLETED|Overall Study||9
1642553|NCT00771875|4014169|P1|COMPLETED|Overall Study||10
1642554|NCT00771875|4014167|P3|STARTED|Overall Study||10
1642555|NCT00771875|4014168|P2|STARTED|Overall Study||10
1642556|NCT00771875|4014169|P1|STARTED|Overall Study||10
1642557|NCT00771849|4014197|P2|NOT COMPLETED|Overall Study||4
1642558|NCT00771849|4014198|P1|NOT COMPLETED|Overall Study||2
1642559|NCT00771849|4014197|P2|COMPLETED|Overall Study||47
1642560|NCT00771849|4014198|P1|COMPLETED|Overall Study||50
1642561|NCT00771849|4014197|P2|STARTED|Overall Study|One subject was not vaccinated|51
1642562|NCT00771849|4014198|P1|STARTED|Overall Study||52
1642563|NCT00771810|4014209|P3|NOT COMPLETED|Overall Study||7
1642564|NCT00771810|4014210|P2|NOT COMPLETED|Overall Study||5
1642565|NCT00771810|4014211|P1|NOT COMPLETED|Overall Study||5
1642566|NCT00771810|4014209|P3|COMPLETED|Overall Study||6
1642567|NCT00771810|4014210|P2|COMPLETED|Overall Study||6
1642568|NCT00771810|4014211|P1|COMPLETED|Overall Study||5
1642569|NCT00771810|4014209|P3|STARTED|Overall Study||13
1642570|NCT00771810|4014210|P2|STARTED|Overall Study||11
1642571|NCT00771810|4014211|P1|STARTED|Overall Study||10
1642572|NCT00771758|4014249|P3|NOT COMPLETED|Overall Study||2
1642573|NCT00771758|4014250|P2|NOT COMPLETED|Overall Study||12
1642574|NCT00771758|4014251|P1|NOT COMPLETED|Overall Study||8
1642575|NCT00771758|4014249|P3|COMPLETED|Overall Study||19
1642576|NCT00771758|4014250|P2|COMPLETED|Overall Study||31
1642577|NCT00771758|4014251|P1|COMPLETED|Overall Study||36
1642578|NCT00771758|4014249|P3|STARTED|Overall Study||21
1642579|NCT00771758|4014250|P2|STARTED|Overall Study||43
1642580|NCT00771758|4014251|P1|STARTED|Overall Study||44
1642581|NCT00771745|4014401|P2|NOT COMPLETED|Overall Study||0
1642582|NCT00771745|4014402|P1|NOT COMPLETED|Overall Study||0
1642583|NCT00771745|4014401|P2|COMPLETED|Overall Study||5
1642584|NCT00771745|4014402|P1|COMPLETED|Overall Study||6
1642585|NCT00771745|4014401|P2|STARTED|Overall Study||5
1642586|NCT00771745|4014402|P1|STARTED|Overall Study||6
1642587|NCT00771667|4014412|P10|NOT COMPLETED|Maintenance Phase||17
1642588|NCT00771667|4014413|P9|NOT COMPLETED|Maintenance Phase||22
1642589|NCT00771667|4014414|P8|NOT COMPLETED|Maintenance Phase||5
1642590|NCT00771667|4014415|P7|NOT COMPLETED|Maintenance Phase||10
1642591|NCT00771667|4014416|P6|NOT COMPLETED|Maintenance Phase||7
1642592|NCT00771667|4014417|P5|NOT COMPLETED|Maintenance Phase||2
1642593|NCT00771667|4014418|P4|NOT COMPLETED|Maintenance Phase||0
1642594|NCT00771667|4014419|P3|NOT COMPLETED|Maintenance Phase||0
1642595|NCT00771667|4014420|P2|NOT COMPLETED|Maintenance Phase||0
1642596|NCT00771667|4014421|P1|NOT COMPLETED|Maintenance Phase||0
1642597|NCT00771667|4014412|P10|COMPLETED|Maintenance Phase||92
1642598|NCT00771667|4014413|P9|COMPLETED|Maintenance Phase||88
1642599|NCT00771667|4014414|P8|COMPLETED|Maintenance Phase||67
1642600|NCT00771667|4014415|P7|COMPLETED|Maintenance Phase||63
1642601|NCT00771667|4014416|P6|COMPLETED|Maintenance Phase||78
1642602|NCT00771667|4014417|P5|COMPLETED|Maintenance Phase||26
1642603|NCT00771667|4014418|P4|COMPLETED|Maintenance Phase||0
1642604|NCT00771667|4014419|P3|COMPLETED|Maintenance Phase||0
1642605|NCT00771667|4014420|P2|COMPLETED|Maintenance Phase||0
1642606|NCT00771667|4014421|P1|COMPLETED|Maintenance Phase||0
1642607|NCT00771667|4014412|P10|STARTED|Maintenance Phase||109
1642608|NCT00771667|4014413|P9|STARTED|Maintenance Phase||110
1642609|NCT00771667|4014414|P8|STARTED|Maintenance Phase||72
1642610|NCT00771667|4014415|P7|STARTED|Maintenance Phase||73
1642611|NCT00771667|4014416|P6|STARTED|Maintenance Phase||85
1642612|NCT00771667|4014417|P5|STARTED|Maintenance Phase||28
1642613|NCT00771667|4014418|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1642614|NCT00771667|4014419|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1642615|NCT00771667|4014420|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1642616|NCT00771667|4014421|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1642617|NCT00771667|4014412|P10|NOT COMPLETED|Induction Phase||0
1642618|NCT00771667|4014413|P9|NOT COMPLETED|Induction Phase||0
1642619|NCT00771667|4014414|P8|NOT COMPLETED|Induction Phase||0
1642620|NCT00771667|4014415|P7|NOT COMPLETED|Induction Phase||0
1642621|NCT00771667|4014416|P6|NOT COMPLETED|Induction Phase||0
1642622|NCT00771667|4014417|P5|NOT COMPLETED|Induction Phase||0
1642623|NCT00771667|4014418|P4|NOT COMPLETED|Induction Phase||8
1642624|NCT00771667|4014419|P3|NOT COMPLETED|Induction Phase||12
1642625|NCT00771667|4014420|P2|NOT COMPLETED|Induction Phase||10
1642626|NCT00771667|4014421|P1|NOT COMPLETED|Induction Phase||19
1642627|NCT00771667|4014412|P10|COMPLETED|Induction Phase||0
1642628|NCT00771667|4014413|P9|COMPLETED|Induction Phase||0
1642629|NCT00771667|4014414|P8|COMPLETED|Induction Phase||0
1642630|NCT00771667|4014415|P7|COMPLETED|Induction Phase||0
1642631|NCT00771667|4014416|P6|COMPLETED|Induction Phase||0
1642632|NCT00771667|4014417|P5|COMPLETED|Induction Phase||0
1642633|NCT00771667|4014418|P4|COMPLETED|Induction Phase||123
1642634|NCT00771667|4014419|P3|COMPLETED|Induction Phase||120
1642635|NCT00771667|4014420|P2|COMPLETED|Induction Phase||121
1642636|NCT00771667|4014421|P1|COMPLETED|Induction Phase||113
1642637|NCT00771667|4014412|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1642638|NCT00771667|4014413|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1642639|NCT00771667|4014414|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1642640|NCT00771667|4014415|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1642641|NCT00771667|4014416|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1642642|NCT00771667|4014417|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1642643|NCT00771667|4014418|P4|STARTED|Induction Phase||131
1642644|NCT00771667|4014419|P3|STARTED|Induction Phase||132
1642645|NCT00771667|4014420|P2|STARTED|Induction Phase||131
1642646|NCT00771667|4014421|P1|STARTED|Induction Phase||132
1642647|NCT00771615|4014466|P9|NOT COMPLETED|Overall Study||0
1642648|NCT00771615|4014467|P8|NOT COMPLETED|Overall Study||1
1642649|NCT00771615|4014468|P7|NOT COMPLETED|Overall Study||1
1642650|NCT00771615|4014469|P6|NOT COMPLETED|Overall Study||1
1642651|NCT00771615|4014470|P5|NOT COMPLETED|Overall Study||0
1642652|NCT00771615|4014471|P4|NOT COMPLETED|Overall Study||1
1642653|NCT00771615|4014472|P3|NOT COMPLETED|Overall Study||1
1642654|NCT00771615|4014473|P2|NOT COMPLETED|Overall Study||2
1642655|NCT00771615|4014474|P1|NOT COMPLETED|Overall Study||1
1642656|NCT00771615|4014466|P9|COMPLETED|Overall Study|Up to Day 364|41
1642657|NCT00771615|4014467|P8|COMPLETED|Overall Study|Up to Day 364|58
1642658|NCT00771615|4014468|P7|COMPLETED|Overall Study|Up to Day 364|45
1642659|NCT00771615|4014469|P6|COMPLETED|Overall Study|Up to Day 364|60
1642660|NCT00771615|4014470|P5|COMPLETED|Overall Study|Up to Day 364|40
1642661|NCT00771615|4014471|P4|COMPLETED|Overall Study|Up to Day 364|59
1642662|NCT00771615|4014472|P3|COMPLETED|Overall Study|Up to Day 364|40
1642663|NCT00771615|4014473|P2|COMPLETED|Overall Study|Up to Day 364|70
1642664|NCT00771615|4014474|P1|COMPLETED|Overall Study|Up to Day 364|48
1642665|NCT00771615|4014466|P9|STARTED|Overall Study||41
1642666|NCT00771615|4014467|P8|STARTED|Overall Study||59
1642667|NCT00771615|4014468|P7|STARTED|Overall Study||46
1642668|NCT00771615|4014469|P6|STARTED|Overall Study||61
1642669|NCT00771615|4014470|P5|STARTED|Overall Study||40
1642670|NCT00771615|4014471|P4|STARTED|Overall Study||60
1642671|NCT00771615|4014472|P3|STARTED|Overall Study||41
1642672|NCT00771615|4014473|P2|STARTED|Overall Study||72
1642673|NCT00771615|4014474|P1|STARTED|Overall Study||49
1642674|NCT00771602|4014668|P3|NOT COMPLETED|Overall Study||0
1642675|NCT00771602|4014669|P2|NOT COMPLETED|Overall Study||0
1642676|NCT00771602|4014670|P1|NOT COMPLETED|Overall Study||0
1642677|NCT00771602|4014668|P3|COMPLETED|Overall Study||0
1642678|NCT00771602|4014669|P2|COMPLETED|Overall Study||0
1642679|NCT00771602|4014670|P1|COMPLETED|Overall Study||1
1642680|NCT00771602|4014668|P3|STARTED|Overall Study||0
1642681|NCT00771602|4014669|P2|STARTED|Overall Study||0
1642682|NCT00771602|4014670|P1|STARTED|Overall Study||1
1642683|NCT00771537|4014694|P16|NOT COMPLETED|Overall Study||0
1642684|NCT00771537|4014695|P15|NOT COMPLETED|Overall Study||0
1642685|NCT00771537|4014696|P14|NOT COMPLETED|Overall Study||0
1642686|NCT00771537|4014697|P13|NOT COMPLETED|Overall Study||0
1642687|NCT00771537|4014698|P12|NOT COMPLETED|Overall Study||0
1642688|NCT00771537|4014699|P11|NOT COMPLETED|Overall Study||0
1642689|NCT00771537|4014700|P10|NOT COMPLETED|Overall Study||0
1642690|NCT00771537|4014701|P9|NOT COMPLETED|Overall Study||0
1642691|NCT00771537|4014702|P8|NOT COMPLETED|Overall Study||0
1642692|NCT00771537|4014703|P7|NOT COMPLETED|Overall Study||0
1642693|NCT00771537|4014704|P6|NOT COMPLETED|Overall Study||0
1642694|NCT00771537|4014705|P5|NOT COMPLETED|Overall Study||0
1642695|NCT00771537|4014706|P4|NOT COMPLETED|Overall Study||0
1642696|NCT00771537|4014707|P3|NOT COMPLETED|Overall Study||0
1642697|NCT00771537|4014708|P2|NOT COMPLETED|Overall Study||0
1642698|NCT00771537|4014709|P1|NOT COMPLETED|Overall Study||0
1642699|NCT00771537|4014694|P16|COMPLETED|Overall Study||122
1642700|NCT00771537|4014695|P15|COMPLETED|Overall Study||124
1642701|NCT00771537|4014696|P14|COMPLETED|Overall Study||124
1642702|NCT00771537|4014697|P13|COMPLETED|Overall Study||128
1642703|NCT00771537|4014698|P12|COMPLETED|Overall Study||137
1642704|NCT00771537|4014699|P11|COMPLETED|Overall Study||133
1642705|NCT00771537|4014700|P10|COMPLETED|Overall Study||119
1642706|NCT00771537|4014701|P9|COMPLETED|Overall Study||115
1642707|NCT00771537|4014702|P8|COMPLETED|Overall Study||132
1642708|NCT00771537|4014703|P7|COMPLETED|Overall Study||128
1642709|NCT00771537|4014704|P6|COMPLETED|Overall Study||118
1642710|NCT00771537|4014705|P5|COMPLETED|Overall Study||127
1642711|NCT00771537|4014706|P4|COMPLETED|Overall Study||114
1642712|NCT00771537|4014707|P3|COMPLETED|Overall Study||151
1642713|NCT00771537|4014708|P2|COMPLETED|Overall Study||124
1642714|NCT00771537|4014709|P1|COMPLETED|Overall Study||135
1642715|NCT00771537|4014694|P16|STARTED|Overall Study||122
1642716|NCT00771537|4014695|P15|STARTED|Overall Study||124
1642717|NCT00771537|4014696|P14|STARTED|Overall Study||124
1642718|NCT00771537|4014697|P13|STARTED|Overall Study||128
1642719|NCT00771537|4014698|P12|STARTED|Overall Study||137
1642720|NCT00771537|4014699|P11|STARTED|Overall Study||133
1642721|NCT00771537|4014700|P10|STARTED|Overall Study||119
1642722|NCT00771537|4014701|P9|STARTED|Overall Study||115
1642723|NCT00771537|4014702|P8|STARTED|Overall Study||132
1642724|NCT00771537|4014703|P7|STARTED|Overall Study||128
1642725|NCT00771537|4014704|P6|STARTED|Overall Study||118
1642726|NCT00771537|4014705|P5|STARTED|Overall Study||127
1642727|NCT00771537|4014706|P4|STARTED|Overall Study||114
1642728|NCT00771537|4014707|P3|STARTED|Overall Study||151
1642729|NCT00771537|4014708|P2|STARTED|Overall Study||124
1642730|NCT00771537|4014709|P1|STARTED|Overall Study||135
1642731|NCT00771472|4014735|P2|NOT COMPLETED|Overall Study||4
1642732|NCT00771472|4014736|P1|NOT COMPLETED|Overall Study||6
1642733|NCT00771472|4014735|P2|COMPLETED|Overall Study||0
1642734|NCT00771472|4014736|P1|COMPLETED|Overall Study||0
1642735|NCT00771472|4014735|P2|STARTED|Overall Study||4
1642736|NCT00771472|4014736|P1|STARTED|Overall Study||6
1642737|NCT00771407|4014747|P2|NOT COMPLETED|Overall Study||25
1642738|NCT00771407|4014748|P1|NOT COMPLETED|Overall Study||20
1642739|NCT00771407|4014747|P2|COMPLETED|Overall Study||35
1642740|NCT00771407|4014748|P1|COMPLETED|Overall Study||40
1642741|NCT00771407|4014747|P2|STARTED|Overall Study||60
1642742|NCT00771407|4014748|P1|STARTED|Overall Study||60
1642743|NCT00771316|4014756|P2|NOT COMPLETED|Overall Study||1
1642744|NCT00771316|4014757|P1|NOT COMPLETED|Overall Study||2
1642745|NCT00771316|4014756|P2|COMPLETED|Overall Study||1
1642746|NCT00771316|4014757|P1|COMPLETED|Overall Study||2
1642747|NCT00771316|4014756|P2|STARTED|Overall Study||2
1642748|NCT00771316|4014757|P1|STARTED|Overall Study||4
1642749|NCT00771277|4014767|P1|NOT COMPLETED|Overall Study||0
1642750|NCT00771277|4014767|P1|COMPLETED|Overall Study||6
1642751|NCT00771277|4014767|P1|STARTED|Overall Study||6
1642752|NCT00771264|4014775|P2|NOT COMPLETED|Overall Study||5
1642753|NCT00771264|4014776|P1|NOT COMPLETED|Overall Study||7
1642754|NCT00771264|4014775|P2|COMPLETED|Overall Study||105
1642755|NCT00771264|4014776|P1|COMPLETED|Overall Study||103
1642756|NCT00771264|4014775|P2|STARTED|Overall Study||110
1642757|NCT00771264|4014776|P1|STARTED|Overall Study||110
1642758|NCT00771238|4014784|P2|NOT COMPLETED|Overall Study||0
1642759|NCT00771238|4014785|P1|NOT COMPLETED|Overall Study||0
1642760|NCT00771238|4014784|P2|COMPLETED|Overall Study||21
1642761|NCT00771238|4014785|P1|COMPLETED|Overall Study||31
1642762|NCT00771238|4014784|P2|STARTED|Overall Study||21
1642763|NCT00771238|4014785|P1|STARTED|Overall Study||31
1642764|NCT00771173|4014795|P2|NOT COMPLETED|Overall Study||17
1642765|NCT00771173|4014796|P1|NOT COMPLETED|Overall Study||22
1642766|NCT00771173|4014795|P2|COMPLETED|Overall Study||112
1642767|NCT00771173|4014796|P1|COMPLETED|Overall Study||107
1642768|NCT00771173|4014795|P2|STARTED|Overall Study||129
1642769|NCT00771173|4014796|P1|STARTED|Overall Study||129
1642770|NCT00771056|4014802|P1|NOT COMPLETED|Overall Study||5
1642771|NCT00771056|4014802|P1|COMPLETED|Overall Study||18
1642772|NCT00771056|4014802|P1|STARTED|Overall Study||23
1642773|NCT00770991|4014809|P2|NOT COMPLETED|Overall Study||5
1642774|NCT00770991|4014810|P1|NOT COMPLETED|Overall Study||5
1642775|NCT00770991|4014809|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
1642776|NCT00770991|4014810|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
1642777|NCT00770991|4014809|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
1642778|NCT00770991|4014810|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
1642779|NCT00770965|4014826|P4|NOT COMPLETED|Excluded Set||13
1642780|NCT00770965|4014827|P3|NOT COMPLETED|Excluded Set||14
1642781|NCT00770965|4014828|P2|NOT COMPLETED|Excluded Set||13
1642782|NCT00770965|4014829|P1|NOT COMPLETED|Excluded Set||15
1642783|NCT00770965|4014826|P4|COMPLETED|Excluded Set||2
1642784|NCT00770965|4014827|P3|COMPLETED|Excluded Set||2
1642785|NCT00770965|4014828|P2|COMPLETED|Excluded Set||3
1642786|NCT00770965|4014829|P1|COMPLETED|Excluded Set||3
1642787|NCT00770965|4014826|P4|STARTED|Excluded Set||15
1642788|NCT00770965|4014827|P3|STARTED|Excluded Set||16
1642789|NCT00770965|4014828|P2|STARTED|Excluded Set||16
1642790|NCT00770965|4014829|P1|STARTED|Excluded Set||18
1642791|NCT00770965|4014826|P4|NOT COMPLETED|Safety Set||1
1642792|NCT00770965|4014827|P3|NOT COMPLETED|Safety Set||1
1642793|NCT00770965|4014828|P2|NOT COMPLETED|Safety Set||0
1642794|NCT00770965|4014829|P1|NOT COMPLETED|Safety Set||0
1642795|NCT00770965|4014826|P4|COMPLETED|Safety Set||4
1642796|NCT00770965|4014827|P3|COMPLETED|Safety Set||3
1642797|NCT00770965|4014828|P2|COMPLETED|Safety Set||4
1642798|NCT00770965|4014829|P1|COMPLETED|Safety Set||2
1642799|NCT00770965|4014826|P4|STARTED|Safety Set||5
1642800|NCT00770965|4014827|P3|STARTED|Safety Set||4
1642801|NCT00770965|4014828|P2|STARTED|Safety Set||4
1642802|NCT00770965|4014829|P1|STARTED|Safety Set||2
1642803|NCT00770913|4014850|P3|NOT COMPLETED|Overall Study||13
1642804|NCT00770913|4014851|P2|NOT COMPLETED|Overall Study||8
1642805|NCT00770913|4014852|P1|NOT COMPLETED|Overall Study||11
1642806|NCT00770913|4014850|P3|COMPLETED|Overall Study||100
1642807|NCT00770913|4014851|P2|COMPLETED|Overall Study||103
1642808|NCT00770913|4014852|P1|COMPLETED|Overall Study||102
1642809|NCT00770913|4014850|P3|STARTED|Overall Study||113
1642810|NCT00770913|4014851|P2|STARTED|Overall Study||111
1642811|NCT00770913|4014852|P1|STARTED|Overall Study||113
1642812|NCT00770861|4014862|P2|NOT COMPLETED|Overall Study||16
1642813|NCT00770861|4014863|P1|NOT COMPLETED|Overall Study||10
1642814|NCT00770861|4014862|P2|COMPLETED|Overall Study||120
1642815|NCT00770861|4014863|P1|COMPLETED|Overall Study||131
1642816|NCT00770861|4014862|P2|STARTED|Overall Study||136
1642817|NCT00770861|4014863|P1|STARTED|Overall Study||141
1642818|NCT00770809|4014874|P3|NOT COMPLETED|Overall Study||23
1642819|NCT00770809|4014875|P2|NOT COMPLETED|Overall Study||10
1642820|NCT00770809|4014876|P1|NOT COMPLETED|Overall Study||17
1642821|NCT00770809|4014874|P3|COMPLETED|Overall Study||44
1642822|NCT00770809|4014875|P2|COMPLETED|Overall Study||110
1642823|NCT00770809|4014876|P1|COMPLETED|Overall Study||101
1642824|NCT00770809|4014874|P3|STARTED|Overall Study||67
1642825|NCT00770809|4014875|P2|STARTED|Overall Study||120
1642826|NCT00770809|4014876|P1|STARTED|Overall Study||118
1642827|NCT00770770|4014886|P2|NOT COMPLETED|Overall Study||1
1642828|NCT00770770|4014887|P1|NOT COMPLETED|Overall Study||10
1642829|NCT00770770|4014886|P2|COMPLETED|Overall Study||5
1642830|NCT00770770|4014887|P1|COMPLETED|Overall Study||4
1642831|NCT00770770|4014886|P2|STARTED|Overall Study||6
1642832|NCT00770770|4014887|P1|STARTED|Overall Study||14
1642833|NCT00770757|4014893|P1|NOT COMPLETED|Overall Study||0
1642834|NCT00770757|4014893|P1|COMPLETED|Overall Study||13
1642835|NCT00770757|4014893|P1|STARTED|Overall Study||13
1642836|NCT00770692|4014905|P4|NOT COMPLETED|Overall Study||11
1642837|NCT00770692|4014906|P3|NOT COMPLETED|Overall Study||14
1642838|NCT00770692|4014907|P2|NOT COMPLETED|Overall Study||9
1642839|NCT00770692|4014908|P1|NOT COMPLETED|Overall Study||12
1642840|NCT00770692|4014905|P4|COMPLETED|Overall Study||66
1642841|NCT00770692|4014906|P3|COMPLETED|Overall Study||70
1642842|NCT00770692|4014907|P2|COMPLETED|Overall Study||74
1642843|NCT00770692|4014908|P1|COMPLETED|Overall Study||69
1642844|NCT00770692|4014905|P4|STARTED|Overall Study||77
1642845|NCT00770692|4014906|P3|STARTED|Overall Study||84
1642846|NCT00770692|4014907|P2|STARTED|Overall Study||83
1642847|NCT00770692|4014908|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
1642848|NCT00770679|4014934|P1|NOT COMPLETED|Overall Study||6
1642849|NCT00770679|4014934|P1|COMPLETED|Overall Study||10
1642850|NCT00770679|4014934|P1|STARTED|Overall Study||16
1642851|NCT00770653|4014942|P2|NOT COMPLETED|Overall Study||29
1642852|NCT00770653|4014943|P1|NOT COMPLETED|Overall Study||32
1642853|NCT00770653|4014942|P2|COMPLETED|Overall Study||121
1642854|NCT00770653|4014943|P1|COMPLETED|Overall Study||123
1642855|NCT00770653|4014942|P2|STARTED|Overall Study||150
1642856|NCT00770653|4014943|P1|STARTED|Overall Study||155
1642857|NCT00770588|4015013|P2|NOT COMPLETED|Overall Study||95
1642858|NCT00770588|4015014|P1|NOT COMPLETED|Overall Study||81
1642859|NCT00770588|4015013|P2|COMPLETED|Overall Study||53
1642860|NCT00770588|4015014|P1|COMPLETED|Overall Study||67
1642861|NCT00770588|4015013|P2|STARTED|Overall Study||148
1642862|NCT00770588|4015014|P1|STARTED|Overall Study||148
1642863|NCT00770562|4015030|P2|NOT COMPLETED|Overall Study||1
1642864|NCT00770562|4015031|P1|NOT COMPLETED|Overall Study||1
1642865|NCT00770562|4015030|P2|COMPLETED|Overall Study||49
1642866|NCT00770562|4015031|P1|COMPLETED|Overall Study||52
1642867|NCT00770562|4015030|P2|STARTED|Overall Study||50
1642868|NCT00770562|4015031|P1|STARTED|Overall Study||53
1642869|NCT00770510|4015042|P1|NOT COMPLETED|Overall Study||5
1642870|NCT00770510|4015042|P1|COMPLETED|Overall Study||67
1642871|NCT00770510|4015042|P1|STARTED|Overall Study||72
1642872|NCT00770484|4015081|P2|NOT COMPLETED|Overall Study||0
1642873|NCT00770484|4015082|P1|NOT COMPLETED|Overall Study||1
1642874|NCT00770484|4015081|P2|COMPLETED|Overall Study||4
1642875|NCT00770484|4015082|P1|COMPLETED|Overall Study||7
1642876|NCT00770484|4015081|P2|STARTED|Overall Study||4
1642877|NCT00770484|4015082|P1|STARTED|Overall Study||8
1642878|NCT00770432|4015090|P2|NOT COMPLETED|Overall Study||7
1642879|NCT00770432|4015091|P1|NOT COMPLETED|Overall Study||4
1642880|NCT00770432|4015090|P2|COMPLETED|Overall Study||94
1642881|NCT00770432|4015091|P1|COMPLETED|Overall Study||98
1642882|NCT00770432|4015090|P2|STARTED|Overall Study||101
1642883|NCT00770432|4015091|P1|STARTED|Overall Study||102
1642884|NCT00770367|4015099|P2|NOT COMPLETED|Second Intervention||0
1642885|NCT00770367|4015100|P1|NOT COMPLETED|Second Intervention||2
1642886|NCT00770367|4015099|P2|COMPLETED|Second Intervention||15
1642887|NCT00770367|4015100|P1|COMPLETED|Second Intervention||16
1642888|NCT00770367|4015099|P2|STARTED|Second Intervention||15
1642889|NCT00770367|4015100|P1|STARTED|Second Intervention||18
1642890|NCT00770367|4015099|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
1642891|NCT00770367|4015100|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
1642892|NCT00770367|4015099|P2|COMPLETED|Washout Period of 4 Weeks||15
1642893|NCT00770367|4015100|P1|COMPLETED|Washout Period of 4 Weeks||18
1642894|NCT00770367|4015099|P2|STARTED|Washout Period of 4 Weeks||16
1642895|NCT00770367|4015100|P1|STARTED|Washout Period of 4 Weeks||18
1642896|NCT00770367|4015099|P2|NOT COMPLETED|First Intervention||2
1642897|NCT00770367|4015100|P1|NOT COMPLETED|First Intervention||0
1642898|NCT00770367|4015099|P2|COMPLETED|First Intervention||16
1642899|NCT00770367|4015100|P1|COMPLETED|First Intervention||18
1642900|NCT00770367|4015099|P2|STARTED|First Intervention||18
1642901|NCT00770367|4015100|P1|STARTED|First Intervention||18
1642902|NCT00770341|4015111|P3|NOT COMPLETED|Overall Study||3
1642903|NCT00770341|4015112|P2|NOT COMPLETED|Overall Study||5
1642904|NCT00770341|4015113|P1|NOT COMPLETED|Overall Study||12
1642905|NCT00770341|4015111|P3|COMPLETED|Overall Study||8
1642906|NCT00770341|4015112|P2|COMPLETED|Overall Study||17
1642907|NCT00770341|4015113|P1|COMPLETED|Overall Study||77
1642908|NCT00770341|4015111|P3|STARTED|Overall Study|Number randomized|11
1642909|NCT00770341|4015112|P2|STARTED|Overall Study|Number randomized|22
1642910|NCT00770341|4015113|P1|STARTED|Overall Study|Number randomized|89
1642911|NCT00770328|4015139|P2|NOT COMPLETED|Overall Study||4
1642912|NCT00770328|4015140|P1|NOT COMPLETED|Overall Study||13
1642913|NCT00770328|4015139|P2|COMPLETED|Overall Study||11
1642914|NCT00770328|4015140|P1|COMPLETED|Overall Study||9
1642915|NCT00770328|4015139|P2|STARTED|Overall Study||15
1642916|NCT00770328|4015140|P1|STARTED|Overall Study||22
1642917|NCT00770315|4015156|P4|NOT COMPLETED|Overall Study||38
1642918|NCT00770315|4015157|P3|NOT COMPLETED|Overall Study||57
1642919|NCT00770315|4015158|P2|NOT COMPLETED|Overall Study||43
1642920|NCT00770315|4015159|P1|NOT COMPLETED|Overall Study||40
1642921|NCT00770315|4015156|P4|COMPLETED|Overall Study||160
1642922|NCT00770315|4015157|P3|COMPLETED|Overall Study||137
1642923|NCT00770315|4015158|P2|COMPLETED|Overall Study||152
1642924|NCT00770315|4015159|P1|COMPLETED|Overall Study||157
1642925|NCT00770315|4015156|P4|STARTED|Overall Study||198
1642926|NCT00770315|4015157|P3|STARTED|Overall Study||194
1642927|NCT00770315|4015158|P2|STARTED|Overall Study||195
1642928|NCT00770315|4015159|P1|STARTED|Overall Study||197
1642929|NCT00770289|4015185|P1|NOT COMPLETED|Overall Study||6
1642930|NCT00770289|4015185|P1|COMPLETED|Overall Study||845
1642931|NCT00770289|4015185|P1|STARTED|Overall Study||851
1642932|NCT00770224|4015194|P2|NOT COMPLETED|Step 2: Maintenance||30
1642933|NCT00770224|4015195|P1|NOT COMPLETED|Step 2: Maintenance||0
1642934|NCT00770224|4015194|P2|COMPLETED|Step 2: Maintenance||41
1642935|NCT00770224|4015195|P1|COMPLETED|Step 2: Maintenance||0
1642936|NCT00770224|4015194|P2|Eligible and Evaluable|Step 2: Maintenance||69
1642937|NCT00770224|4015195|P1|Eligible and Evaluable|Step 2: Maintenance||0
1642938|NCT00770224|4015194|P2|STARTED|Step 2: Maintenance||71
1642939|NCT00770224|4015195|P1|STARTED|Step 2: Maintenance||0
1642940|NCT00770224|4015194|P2|NOT COMPLETED|Step 1: Induction||0
1642941|NCT00770224|4015195|P1|NOT COMPLETED|Step 1: Induction||14
1642942|NCT00770224|4015194|P2|COMPLETED|Step 1: Induction||0
1642943|NCT00770224|4015195|P1|COMPLETED|Step 1: Induction||73
1642944|NCT00770224|4015194|P2|Eligible and Evaluable|Step 1: Induction||0
1642945|NCT00770224|4015195|P1|Eligible and Evaluable|Step 1: Induction||84
1642946|NCT00770224|4015194|P2|STARTED|Step 1: Induction||0
1642947|NCT00770224|4015195|P1|STARTED|Step 1: Induction||87
1642948|NCT00770211|4015207|P2|NOT COMPLETED|Overall Study||2
1642949|NCT00770211|4015208|P1|NOT COMPLETED|Overall Study||1
1642950|NCT00770211|4015207|P2|COMPLETED|Overall Study||87
1642951|NCT00770211|4015208|P1|COMPLETED|Overall Study||181
1642952|NCT00770211|4015207|P2|STARTED|Overall Study||89
1642953|NCT00770211|4015208|P1|STARTED|Overall Study||182
1642954|NCT00770146|4015224|P2|NOT COMPLETED|Follow-up Period||20
1642955|NCT00770146|4015225|P1|NOT COMPLETED|Follow-up Period||11
1642956|NCT00770146|4015224|P2|COMPLETED|Follow-up Period||85
1642957|NCT00770146|4015225|P1|COMPLETED|Follow-up Period||42
1642958|NCT00770146|4015224|P2|STARTED|Follow-up Period||105
1642959|NCT00770146|4015225|P1|STARTED|Follow-up Period||53
1642960|NCT00770146|4015224|P2|NOT COMPLETED|Treatment Period||45
1642961|NCT00770146|4015225|P1|NOT COMPLETED|Treatment Period||9
1642962|NCT00770146|4015224|P2|COMPLETED|Treatment Period||60
1642963|NCT00770146|4015225|P1|COMPLETED|Treatment Period||44
1642964|NCT00770146|4015224|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
1642965|NCT00770146|4015225|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
1642966|NCT00770146|4015224|P2|Treated|Treatment Period||105
1642967|NCT00770146|4015225|P1|Treated|Treatment Period||52
1642968|NCT00770146|4015224|P2|STARTED|Treatment Period||105
1642969|NCT00770146|4015225|P1|STARTED|Treatment Period||53
1642970|NCT00770120|4015269|P1|NOT COMPLETED|Overall Study||61
1642971|NCT00770120|4015269|P1|COMPLETED|Overall Study||0
1642972|NCT00770120|4015269|P1|Not Analyzable|Overall Study||1
1642973|NCT00770120|4015269|P1|Eligible|Overall Study||60
1642974|NCT00770120|4015269|P1|STARTED|Overall Study||61
1642975|NCT00770029|4015278|P2|NOT COMPLETED|Overall Study||3
1642976|NCT00770029|4015279|P1|NOT COMPLETED|Overall Study||6
1642977|NCT00770029|4015278|P2|COMPLETED|Overall Study||89
1642978|NCT00770029|4015279|P1|COMPLETED|Overall Study||178
1642979|NCT00770029|4015278|P2|STARTED|Overall Study||92
1642980|NCT00770029|4015279|P1|STARTED|Overall Study||184
1642981|NCT00769860|4015295|P2|NOT COMPLETED|Overall Study||0
1642982|NCT00769860|4015296|P1|NOT COMPLETED|Overall Study||2
1642983|NCT00769860|4015295|P2|COMPLETED|Overall Study||8
1642984|NCT00769860|4015296|P1|COMPLETED|Overall Study||14
1642985|NCT00769860|4015295|P2|Month 8|Overall Study||8
1642986|NCT00769860|4015296|P1|Month 8|Overall Study||14
1642987|NCT00769860|4015295|P2|Month 4|Overall Study||8
1642988|NCT00769860|4015296|P1|Month 4|Overall Study||16
1642989|NCT00769860|4015295|P2|STARTED|Overall Study||8
1642990|NCT00769860|4015296|P1|STARTED|Overall Study||16
1642991|NCT00769704|4015324|P2|NOT COMPLETED|Overall Study||199
1642992|NCT00769704|4015325|P1|NOT COMPLETED|Overall Study||111
1642993|NCT00769704|4015324|P2|COMPLETED|Overall Study||97
1642994|NCT00769704|4015325|P1|COMPLETED|Overall Study||30
1642995|NCT00769704|4015324|P2|Received Treatment|Overall Study||292
1642996|NCT00769704|4015325|P1|Received Treatment|Overall Study||127
1642997|NCT00769704|4015324|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
1642998|NCT00769704|4015325|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
1642999|NCT00769704|4015324|P2|STARTED|Overall Study||296
1643000|NCT00769704|4015325|P1|STARTED|Overall Study||141
1643001|NCT00769652|4015345|P2|NOT COMPLETED|Overall Study||0
1643002|NCT00769652|4015346|P1|NOT COMPLETED|Overall Study||0
1643003|NCT00769652|4015345|P2|COMPLETED|Overall Study||1
1643004|NCT00769652|4015346|P1|COMPLETED|Overall Study||6
1643005|NCT00769652|4015345|P2|STARTED|Overall Study||1
1643006|NCT00769652|4015346|P1|STARTED|Overall Study||6
1643007|NCT00769561|4015358|P2|NOT COMPLETED|Overall Study||5
1643008|NCT00769561|4015359|P1|NOT COMPLETED|Overall Study||3
1643009|NCT00769561|4015358|P2|COMPLETED|Overall Study||24
1643010|NCT00769561|4015359|P1|COMPLETED|Overall Study||26
1643011|NCT00769561|4015358|P2|STARTED|Overall Study||29
1643012|NCT00769561|4015359|P1|STARTED|Overall Study||29
1643013|NCT00769314|4015381|P2|NOT COMPLETED|Overall Study||13
1643014|NCT00769314|4015382|P1|NOT COMPLETED|Overall Study||17
1643015|NCT00769314|4015381|P2|COMPLETED|Overall Study||384
1643016|NCT00769314|4015382|P1|COMPLETED|Overall Study||361
1643017|NCT00769314|4015381|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
1643018|NCT00769314|4015382|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
1643019|NCT00769184|4015408|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
1643020|NCT00769184|4015409|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
1643021|NCT00769184|4015408|P2|COMPLETED|No Treatment (6 Weeks)||6
1643022|NCT00769184|4015409|P1|COMPLETED|No Treatment (6 Weeks)||5
1643023|NCT00769184|4015408|P2|STARTED|No Treatment (6 Weeks)||7
1643024|NCT00769184|4015409|P1|STARTED|No Treatment (6 Weeks)||6
1643025|NCT00769184|4015408|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
1643026|NCT00769184|4015409|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
1643027|NCT00769184|4015408|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
1643028|NCT00769184|4015409|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
1643029|NCT00769184|4015408|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
1643030|NCT00769184|4015409|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
1643031|NCT00769184|4015408|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
1643032|NCT00769184|4015409|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
1643033|NCT00769184|4015408|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
1643034|NCT00769184|4015409|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
1643035|NCT00769184|4015408|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
1643036|NCT00769184|4015409|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
1643037|NCT00769132|4015417|P4|NOT COMPLETED|Period 4||0
1643038|NCT00769132|4015418|P3|NOT COMPLETED|Period 4||0
1643039|NCT00769132|4015419|P2|NOT COMPLETED|Period 4||1
1643040|NCT00769132|4015420|P1|NOT COMPLETED|Period 4||0
1643041|NCT00769132|4015417|P4|COMPLETED|Period 4||5
1643042|NCT00769132|4015418|P3|COMPLETED|Period 4||6
1643043|NCT00769132|4015419|P2|COMPLETED|Period 4||5
1643044|NCT00769132|4015420|P1|COMPLETED|Period 4||5
1643045|NCT00769132|4015417|P4|STARTED|Period 4||5
1643046|NCT00769132|4015418|P3|STARTED|Period 4||6
1643047|NCT00769132|4015419|P2|STARTED|Period 4||6
1643048|NCT00769132|4015420|P1|STARTED|Period 4||5
1643049|NCT00769132|4015417|P4|NOT COMPLETED|Period 3||0
1643050|NCT00769132|4015418|P3|NOT COMPLETED|Period 3||0
1643051|NCT00769132|4015419|P2|NOT COMPLETED|Period 3||0
1643052|NCT00769132|4015420|P1|NOT COMPLETED|Period 3||1
1643053|NCT00769132|4015417|P4|COMPLETED|Period 3||5
1643054|NCT00769132|4015418|P3|COMPLETED|Period 3||6
1643055|NCT00769132|4015419|P2|COMPLETED|Period 3||6
1643056|NCT00769132|4015420|P1|COMPLETED|Period 3||5
1643057|NCT00769132|4015417|P4|STARTED|Period 3||5
1643058|NCT00769132|4015418|P3|STARTED|Period 3||6
1643059|NCT00769132|4015419|P2|STARTED|Period 3||6
1643060|NCT00769132|4015420|P1|STARTED|Period 3||6
1643061|NCT00769132|4015417|P4|NOT COMPLETED|Period 2||1
1643062|NCT00769132|4015418|P3|NOT COMPLETED|Period 2||0
1643063|NCT00769132|4015419|P2|NOT COMPLETED|Period 2||0
1643064|NCT00769132|4015420|P1|NOT COMPLETED|Period 2||0
1643065|NCT00769132|4015417|P4|COMPLETED|Period 2||5
1643066|NCT00769132|4015418|P3|COMPLETED|Period 2||6
1643067|NCT00769132|4015419|P2|COMPLETED|Period 2||6
1643068|NCT00769132|4015420|P1|COMPLETED|Period 2||6
1643069|NCT00769132|4015417|P4|STARTED|Period 2||6
1643070|NCT00769132|4015418|P3|STARTED|Period 2||6
1643071|NCT00769132|4015419|P2|STARTED|Period 2||6
1643072|NCT00769132|4015420|P1|STARTED|Period 2||6
1643073|NCT00769132|4015417|P4|NOT COMPLETED|Period 1||1
1643074|NCT00769132|4015418|P3|NOT COMPLETED|Period 1||0
1643075|NCT00769132|4015419|P2|NOT COMPLETED|Period 1||0
1643076|NCT00769132|4015420|P1|NOT COMPLETED|Period 1||1
1643077|NCT00769132|4015417|P4|COMPLETED|Period 1||6
1643078|NCT00769132|4015418|P3|COMPLETED|Period 1||6
1643079|NCT00769132|4015419|P2|COMPLETED|Period 1||6
1643080|NCT00769132|4015420|P1|COMPLETED|Period 1||6
1643081|NCT00769132|4015417|P4|STARTED|Period 1||7
1643082|NCT00769132|4015418|P3|STARTED|Period 1||6
1643083|NCT00769132|4015419|P2|STARTED|Period 1||6
1643084|NCT00769132|4015420|P1|STARTED|Period 1||7
1643085|NCT00769119|4015436|P2|NOT COMPLETED|Overall Study||3
1643086|NCT00769119|4015437|P1|NOT COMPLETED|Overall Study||2
1643087|NCT00769119|4015436|P2|COMPLETED|Overall Study||13
1643088|NCT00769119|4015437|P1|COMPLETED|Overall Study||20
1643089|NCT00769119|4015436|P2|STARTED|Overall Study||16
1643090|NCT00769119|4015437|P1|STARTED|Overall Study||22
1643091|NCT00769067|4015483|P2|NOT COMPLETED|Overall Study||94
1643092|NCT00769067|4015484|P1|NOT COMPLETED|Overall Study||94
1643093|NCT00769067|4015483|P2|COMPLETED|Overall Study||0
1643094|NCT00769067|4015484|P1|COMPLETED|Overall Study||0
1643095|NCT00769067|4015483|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
1643096|NCT00769067|4015484|P1|Treated|Overall Study||94
1643097|NCT00769067|4015483|P2|STARTED|Overall Study||94
1643098|NCT00769067|4015484|P1|STARTED|Overall Study||94
1643099|NCT00769015|4015511|P2|NOT COMPLETED|Overall Study||16
1643100|NCT00769015|4015512|P1|NOT COMPLETED|Overall Study||9
1643101|NCT00769015|4015511|P2|COMPLETED|Overall Study||76
1643102|NCT00769015|4015512|P1|COMPLETED|Overall Study||87
1643103|NCT00769015|4015511|P2|STARTED|Overall Study||92
1643104|NCT00769015|4015512|P1|STARTED|Overall Study||96
1643105|NCT00768989|4015532|P2|NOT COMPLETED|On or After Week 36||27
1643106|NCT00768989|4015533|P1|NOT COMPLETED|On or After Week 36||51
1643107|NCT00768989|4015532|P2|COMPLETED|On or After Week 36||0
1643108|NCT00768989|4015533|P1|COMPLETED|On or After Week 36||0
1643109|NCT00768989|4015532|P2|STARTED|On or After Week 36||27
1643110|NCT00768989|4015533|P1|STARTED|On or After Week 36||51
1643111|NCT00768989|4015532|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
1643112|NCT00768989|4015533|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
1643113|NCT00768989|4015532|P2|COMPLETED|Week 24 to Prior to Week 36||27
1643114|NCT00768989|4015533|P1|COMPLETED|Week 24 to Prior to Week 36||51
1643115|NCT00768989|4015532|P2|STARTED|Week 24 to Prior to Week 36||27
1643116|NCT00768989|4015533|P1|STARTED|Week 24 to Prior to Week 36||59
1643117|NCT00768989|4015532|P2|NOT COMPLETED|Prior to Week 24||3
1643118|NCT00768989|4015533|P1|NOT COMPLETED|Prior to Week 24||4
1643119|NCT00768989|4015532|P2|COMPLETED|Prior to Week 24||27
1643120|NCT00768989|4015533|P1|COMPLETED|Prior to Week 24||59
1643121|NCT00768989|4015532|P2|STARTED|Prior to Week 24||30
1643122|NCT00768989|4015533|P1|STARTED|Prior to Week 24||63
1643123|NCT00768898|4015581|P1|NOT COMPLETED|Overall Study||2
1643124|NCT00768898|4015581|P1|COMPLETED|Overall Study||28
1643125|NCT00768898|4015581|P1|STARTED|Overall Study||30
1643126|NCT00768755|4015605|P4|NOT COMPLETED|Phase 2||57
1643127|NCT00768755|4015606|P3|NOT COMPLETED|Phase 2||58
1643128|NCT00768755|4015607|P2|NOT COMPLETED|Phase 2||55
1643129|NCT00768755|4015608|P1|NOT COMPLETED|Phase 2||0
1643130|NCT00768755|4015605|P4|COMPLETED|Phase 2||0
1643131|NCT00768755|4015606|P3|COMPLETED|Phase 2||0
1643132|NCT00768755|4015607|P2|COMPLETED|Phase 2||0
1643133|NCT00768755|4015608|P1|COMPLETED|Phase 2||0
1643134|NCT00768755|4015605|P4|Treated|Phase 2||55
1643135|NCT00768755|4015606|P3|Treated|Phase 2||58
1643136|NCT00768755|4015607|P2|Treated|Phase 2||55
1643137|NCT00768755|4015608|P1|Treated|Phase 2||0
1643138|NCT00768755|4015605|P4|STARTED|Phase 2||57
1643139|NCT00768755|4015606|P3|STARTED|Phase 2||58
1643140|NCT00768755|4015607|P2|STARTED|Phase 2||55
1643141|NCT00768755|4015608|P1|STARTED|Phase 2||0
1643142|NCT00768755|4015605|P4|NOT COMPLETED|Phase 1||0
1643143|NCT00768755|4015606|P3|NOT COMPLETED|Phase 1||0
1643144|NCT00768755|4015607|P2|NOT COMPLETED|Phase 1||0
1643145|NCT00768755|4015608|P1|NOT COMPLETED|Phase 1||10
1643146|NCT00768755|4015605|P4|COMPLETED|Phase 1||0
1643147|NCT00768755|4015606|P3|COMPLETED|Phase 1||0
1643148|NCT00768755|4015607|P2|COMPLETED|Phase 1||0
1643149|NCT00768755|4015608|P1|COMPLETED|Phase 1||0
1643150|NCT00768755|4015605|P4|STARTED|Phase 1||0
1643151|NCT00768755|4015606|P3|STARTED|Phase 1||0
1643152|NCT00768755|4015607|P2|STARTED|Phase 1||0
1643153|NCT00768755|4015608|P1|STARTED|Phase 1||10
1643154|NCT00768651|4015632|P1|NOT COMPLETED|Overall Study||1
1643155|NCT00768651|4015632|P1|COMPLETED|Overall Study||7
1643156|NCT00768651|4015632|P1|STARTED|Overall Study||8
1643157|NCT00768599|4015640|P3|NOT COMPLETED|Overall Study||12
1643158|NCT00768599|4015641|P2|NOT COMPLETED|Overall Study||16
1643159|NCT00768599|4015642|P1|NOT COMPLETED|Overall Study||11
1643160|NCT00768599|4015640|P3|COMPLETED|Overall Study||35
1643161|NCT00768599|4015641|P2|COMPLETED|Overall Study||27
1643162|NCT00768599|4015642|P1|COMPLETED|Overall Study||34
1643163|NCT00768599|4015640|P3|STARTED|Overall Study||47
1643164|NCT00768599|4015641|P2|STARTED|Overall Study||43
1643165|NCT00768599|4015642|P1|STARTED|Overall Study||45
1643166|NCT00768560|4015671|P6|NOT COMPLETED|Intervention Set 3||0
1643167|NCT00768560|4015672|P5|NOT COMPLETED|Intervention Set 3||0
1643168|NCT00768560|4015673|P4|NOT COMPLETED|Intervention Set 3||0
1643169|NCT00768560|4015674|P3|NOT COMPLETED|Intervention Set 3||0
1643170|NCT00768560|4015675|P2|NOT COMPLETED|Intervention Set 3||0
1643171|NCT00768560|4015676|P1|NOT COMPLETED|Intervention Set 3||0
1643172|NCT00768560|4015671|P6|COMPLETED|Intervention Set 3||6
1643173|NCT00768560|4015672|P5|COMPLETED|Intervention Set 3||6
1643174|NCT00768560|4015673|P4|COMPLETED|Intervention Set 3||6
1643175|NCT00768560|4015674|P3|COMPLETED|Intervention Set 3||6
1643176|NCT00768560|4015675|P2|COMPLETED|Intervention Set 3||5
1643177|NCT00768560|4015676|P1|COMPLETED|Intervention Set 3||5
1643178|NCT00768560|4015671|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
1643179|NCT00768560|4015672|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
1643180|NCT00768560|4015673|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
1643181|NCT00768560|4015674|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
1643182|NCT00768560|4015675|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
1643183|NCT00768560|4015676|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
1643184|NCT00768560|4015671|P6|NOT COMPLETED|Intervention Set 2||0
1643185|NCT00768560|4015672|P5|NOT COMPLETED|Intervention Set 2||0
1643186|NCT00768560|4015673|P4|NOT COMPLETED|Intervention Set 2||0
1643187|NCT00768560|4015674|P3|NOT COMPLETED|Intervention Set 2||0
1643188|NCT00768560|4015675|P2|NOT COMPLETED|Intervention Set 2||0
1643189|NCT00768560|4015676|P1|NOT COMPLETED|Intervention Set 2||0
1643190|NCT00768560|4015671|P6|COMPLETED|Intervention Set 2||6
1643191|NCT00768560|4015672|P5|COMPLETED|Intervention Set 2||6
1643192|NCT00768560|4015673|P4|COMPLETED|Intervention Set 2||6
1643193|NCT00768560|4015674|P3|COMPLETED|Intervention Set 2||6
1643194|NCT00768560|4015675|P2|COMPLETED|Intervention Set 2||5
1643195|NCT00768560|4015676|P1|COMPLETED|Intervention Set 2||5
1643196|NCT00768560|4015671|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
1643197|NCT00768560|4015672|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
1643198|NCT00768560|4015673|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
1643199|NCT00768560|4015674|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
1643200|NCT00768560|4015675|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
1643201|NCT00768560|4015676|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
1643202|NCT00768560|4015671|P6|NOT COMPLETED|Intervention Set 1||0
1643203|NCT00768560|4015672|P5|NOT COMPLETED|Intervention Set 1||0
1643204|NCT00768560|4015673|P4|NOT COMPLETED|Intervention Set 1||0
1643205|NCT00768560|4015674|P3|NOT COMPLETED|Intervention Set 1||0
1643206|NCT00768560|4015675|P2|NOT COMPLETED|Intervention Set 1||1
1643207|NCT00768560|4015676|P1|NOT COMPLETED|Intervention Set 1||0
1643208|NCT00768560|4015671|P6|COMPLETED|Intervention Set 1||6
1643209|NCT00768560|4015672|P5|COMPLETED|Intervention Set 1||6
1643210|NCT00768560|4015673|P4|COMPLETED|Intervention Set 1||6
1643211|NCT00768560|4015674|P3|COMPLETED|Intervention Set 1||6
1643212|NCT00768560|4015675|P2|COMPLETED|Intervention Set 1||5
1643213|NCT00768560|4015676|P1|COMPLETED|Intervention Set 1||5
1643214|NCT00768560|4015671|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
1643215|NCT00768560|4015672|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
1643216|NCT00768560|4015673|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
1643217|NCT00768560|4015674|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
1643218|NCT00768560|4015675|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
1643219|NCT00768560|4015676|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
1643220|NCT00768560|4015671|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
1643221|NCT00768560|4015672|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
1643222|NCT00768560|4015673|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
1643223|NCT00768560|4015674|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
1643224|NCT00768560|4015675|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
1643225|NCT00768560|4015676|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
1643226|NCT00768521|4015702|P2|NOT COMPLETED|Period 2||0
1643227|NCT00768521|4015703|P1|NOT COMPLETED|Period 2||0
1643228|NCT00768521|4015702|P2|COMPLETED|Period 2||11
1643229|NCT00768521|4015703|P1|COMPLETED|Period 2||9
1643230|NCT00768521|4015702|P2|STARTED|Period 2||11
1643231|NCT00768521|4015703|P1|STARTED|Period 2||9
1643232|NCT00768521|4015702|P2|NOT COMPLETED|Period 1||0
1643233|NCT00768521|4015703|P1|NOT COMPLETED|Period 1||0
1643234|NCT00768521|4015702|P2|COMPLETED|Period 1||11
1643235|NCT00768521|4015703|P1|COMPLETED|Period 1||9
1643236|NCT00768521|4015702|P2|STARTED|Period 1||11
1643237|NCT00768521|4015703|P1|STARTED|Period 1||9
1643238|NCT00768469|4015713|P2|NOT COMPLETED|Overall Study||7
1643239|NCT00768469|4015714|P1|NOT COMPLETED|Overall Study||3
1643240|NCT00768469|4015713|P2|COMPLETED|Overall Study||0
1643241|NCT00768469|4015714|P1|COMPLETED|Overall Study||0
1643242|NCT00768469|4015713|P2|STARTED|Overall Study||7
1643243|NCT00768469|4015714|P1|STARTED|Overall Study||3
1643244|NCT00768430|4015729|P2|NOT COMPLETED|7 Day Endpoint||3
1643245|NCT00768430|4015730|P1|NOT COMPLETED|7 Day Endpoint||2
1643246|NCT00768430|4015729|P2|COMPLETED|7 Day Endpoint||22
1643247|NCT00768430|4015730|P1|COMPLETED|7 Day Endpoint||45
1643248|NCT00768430|4015729|P2|STARTED|7 Day Endpoint||25
1643249|NCT00768430|4015730|P1|STARTED|7 Day Endpoint||47
1643250|NCT00768430|4015729|P2|NOT COMPLETED|24 Hour Endpoint||0
1643251|NCT00768430|4015730|P1|NOT COMPLETED|24 Hour Endpoint||1
1643252|NCT00768430|4015729|P2|COMPLETED|24 Hour Endpoint||25
1643253|NCT00768430|4015730|P1|COMPLETED|24 Hour Endpoint||47
1643254|NCT00768430|4015729|P2|STARTED|24 Hour Endpoint||25
1643255|NCT00768430|4015730|P1|STARTED|24 Hour Endpoint||48
1643256|NCT00768300|4015738|P2|NOT COMPLETED|Overall Study||163
1643257|NCT00768300|4015739|P1|NOT COMPLETED|Overall Study||329
1643258|NCT00768300|4015738|P2|COMPLETED|Overall Study||1
1643259|NCT00768300|4015739|P1|COMPLETED|Overall Study||1
1643260|NCT00768300|4015738|P2|Randomized and Treated|Overall Study||163
1643261|NCT00768300|4015739|P1|Randomized and Treated|Overall Study||329
1643262|NCT00768300|4015738|P2|STARTED|Overall Study||164
1643263|NCT00768300|4015739|P1|STARTED|Overall Study||330
1643264|NCT00768287|4015761|P6|NOT COMPLETED|Surgical Sub-study||0
1643265|NCT00768287|4015762|P5|NOT COMPLETED|Surgical Sub-study||0
1643266|NCT00768287|4015763|P4|NOT COMPLETED|Surgical Sub-study||0
1643267|NCT00768287|4015764|P3|NOT COMPLETED|Surgical Sub-study||0
1643268|NCT00768287|4015765|P2|NOT COMPLETED|Surgical Sub-study||0
1643269|NCT00768287|4015766|P1|NOT COMPLETED|Surgical Sub-study||0
1643270|NCT00768287|4015761|P6|COMPLETED|Surgical Sub-study||17
1643271|NCT00768287|4015762|P5|COMPLETED|Surgical Sub-study||0
1643272|NCT00768287|4015763|P4|COMPLETED|Surgical Sub-study||0
1643273|NCT00768287|4015764|P3|COMPLETED|Surgical Sub-study||0
1643274|NCT00768287|4015765|P2|COMPLETED|Surgical Sub-study||0
1643275|NCT00768287|4015766|P1|COMPLETED|Surgical Sub-study||0
1643276|NCT00768287|4015761|P6|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
1643277|NCT00768287|4015762|P5|STARTED|Surgical Sub-study||0
1643278|NCT00768287|4015763|P4|STARTED|Surgical Sub-study||0
1643279|NCT00768287|4015764|P3|STARTED|Surgical Sub-study||0
1643280|NCT00768287|4015765|P2|STARTED|Surgical Sub-study||0
1643281|NCT00768287|4015766|P1|STARTED|Surgical Sub-study||0
1643282|NCT00768287|4015761|P6|NOT COMPLETED|Treatment Study||0
1643283|NCT00768287|4015762|P5|NOT COMPLETED|Treatment Study||0
1643284|NCT00768287|4015763|P4|NOT COMPLETED|Treatment Study||0
1643285|NCT00768287|4015764|P3|NOT COMPLETED|Treatment Study||0
1643286|NCT00768287|4015765|P2|NOT COMPLETED|Treatment Study||0
1643287|NCT00768287|4015766|P1|NOT COMPLETED|Treatment Study||0
1643288|NCT00768287|4015761|P6|COMPLETED|Treatment Study||0
1643289|NCT00768287|4015762|P5|COMPLETED|Treatment Study||9
1643290|NCT00768287|4015763|P4|COMPLETED|Treatment Study||58
1643291|NCT00768287|4015764|P3|COMPLETED|Treatment Study||0
1643292|NCT00768287|4015765|P2|COMPLETED|Treatment Study||0
1643293|NCT00768287|4015766|P1|COMPLETED|Treatment Study||0
1643294|NCT00768287|4015761|P6|Treated|Treatment Study||0
1643295|NCT00768287|4015762|P5|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
1643296|NCT00768287|4015763|P4|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
1643297|NCT00768287|4015764|P3|Treated|Treatment Study||0
1643298|NCT00768287|4015765|P2|Treated|Treatment Study||0
1643299|NCT00768287|4015766|P1|Treated|Treatment Study||0
1643300|NCT00768287|4015761|P6|STARTED|Treatment Study||0
1643301|NCT00768287|4015762|P5|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
1643302|NCT00768287|4015763|P4|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
1643303|NCT00768287|4015764|P3|STARTED|Treatment Study||0
1643304|NCT00768287|4015765|P2|STARTED|Treatment Study||0
1643305|NCT00768287|4015766|P1|STARTED|Treatment Study||0
1643306|NCT00768287|4015761|P6|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1643307|NCT00768287|4015762|P5|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1643308|NCT00768287|4015763|P4|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1643309|NCT00768287|4015764|P3|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1643310|NCT00768287|4015765|P2|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1643311|NCT00768287|4015766|P1|NOT COMPLETED|Repeat Pharmacokinetic Study||0
1643312|NCT00768287|4015761|P6|COMPLETED|Repeat Pharmacokinetic Study||0
1643313|NCT00768287|4015762|P5|COMPLETED|Repeat Pharmacokinetic Study||0
1643314|NCT00768287|4015763|P4|COMPLETED|Repeat Pharmacokinetic Study||0
1643315|NCT00768287|4015764|P3|COMPLETED|Repeat Pharmacokinetic Study||14
1643316|NCT00768287|4015765|P2|COMPLETED|Repeat Pharmacokinetic Study||0
1643317|NCT00768287|4015766|P1|COMPLETED|Repeat Pharmacokinetic Study||0
1643318|NCT00768287|4015761|P6|STARTED|Repeat Pharmacokinetic Study||0
1643319|NCT00768287|4015762|P5|STARTED|Repeat Pharmacokinetic Study||0
1643320|NCT00768287|4015763|P4|STARTED|Repeat Pharmacokinetic Study||0
1643321|NCT00768287|4015764|P3|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
1643322|NCT00768287|4015765|P2|STARTED|Repeat Pharmacokinetic Study||0
1643323|NCT00768287|4015766|P1|STARTED|Repeat Pharmacokinetic Study||0
1643324|NCT00768287|4015761|P6|NOT COMPLETED|Pharmacokinetic Study||0
1643325|NCT00768287|4015762|P5|NOT COMPLETED|Pharmacokinetic Study||0
1643326|NCT00768287|4015763|P4|NOT COMPLETED|Pharmacokinetic Study||0
1643327|NCT00768287|4015764|P3|NOT COMPLETED|Pharmacokinetic Study||0
1643328|NCT00768287|4015765|P2|NOT COMPLETED|Pharmacokinetic Study||0
1643329|NCT00768287|4015766|P1|NOT COMPLETED|Pharmacokinetic Study||0
1643330|NCT00768287|4015761|P6|COMPLETED|Pharmacokinetic Study||0
1643331|NCT00768287|4015762|P5|COMPLETED|Pharmacokinetic Study||0
1643332|NCT00768287|4015763|P4|COMPLETED|Pharmacokinetic Study||0
1643333|NCT00768287|4015764|P3|COMPLETED|Pharmacokinetic Study||0
1643334|NCT00768287|4015765|P2|COMPLETED|Pharmacokinetic Study||16
1643335|NCT00768287|4015766|P1|COMPLETED|Pharmacokinetic Study||16
1643336|NCT00768287|4015761|P6|STARTED|Pharmacokinetic Study||0
1643337|NCT00768287|4015762|P5|STARTED|Pharmacokinetic Study||0
1643338|NCT00768287|4015763|P4|STARTED|Pharmacokinetic Study||0
1643339|NCT00768287|4015764|P3|STARTED|Pharmacokinetic Study||0
1643340|NCT00768287|4015765|P2|STARTED|Pharmacokinetic Study||16
1643341|NCT00768287|4015766|P1|STARTED|Pharmacokinetic Study||16
1643342|NCT00768261|4015805|P4|NOT COMPLETED|Overall Study||0
1643343|NCT00768261|4015806|P3|NOT COMPLETED|Overall Study||25
1643344|NCT00768261|4015807|P2|NOT COMPLETED|Overall Study||0
1643345|NCT00768261|4015808|P1|NOT COMPLETED|Overall Study||0
1643346|NCT00768261|4015805|P4|COMPLETED|Overall Study||56
1643347|NCT00768261|4015806|P3|COMPLETED|Overall Study||14
1643348|NCT00768261|4015807|P2|COMPLETED|Overall Study||18
1643349|NCT00768261|4015808|P1|COMPLETED|Overall Study||14
1643350|NCT00768261|4015805|P4|STARTED|Overall Study||56
1643351|NCT00768261|4015806|P3|STARTED|Overall Study||39
1643352|NCT00768261|4015807|P2|STARTED|Overall Study||18
1643353|NCT00768261|4015808|P1|STARTED|Overall Study||14
1643354|NCT00768222|4015823|P2|NOT COMPLETED|Overall Study||4
1643355|NCT00768222|4015824|P1|NOT COMPLETED|Overall Study||4
1643356|NCT00768222|4015823|P2|COMPLETED|Overall Study||47
1643357|NCT00768222|4015824|P1|COMPLETED|Overall Study||46
1643358|NCT00768222|4015823|P2|STARTED|Overall Study||51
1643359|NCT00768222|4015824|P1|STARTED|Overall Study||50
1643360|NCT00768144|4015846|P1|NOT COMPLETED|Overall Study||36
1643361|NCT00768144|4015846|P1|COMPLETED|Overall Study||0
1643362|NCT00768144|4015846|P1|STARTED|Overall Study||36
1643363|NCT00768118|4015852|P1|NOT COMPLETED|Overall Study||0
1643364|NCT00768118|4015852|P1|COMPLETED|Overall Study||11
1643365|NCT00768118|4015852|P1|STARTED|Overall Study||11
1643366|NCT00768066|4015859|P3|NOT COMPLETED|Overall Study||0
1643367|NCT00768066|4015860|P2|NOT COMPLETED|Overall Study||3
1643368|NCT00768066|4015861|P1|NOT COMPLETED|Overall Study||3
1643369|NCT00768066|4015859|P3|COMPLETED|Overall Study||21
1643370|NCT00768066|4015860|P2|COMPLETED|Overall Study||19
1643371|NCT00768066|4015861|P1|COMPLETED|Overall Study||19
1643372|NCT00768066|4015859|P3|STARTED|Overall Study||21
1643373|NCT00768066|4015860|P2|STARTED|Overall Study||22
1643374|NCT00768066|4015861|P1|STARTED|Overall Study||22
1643375|NCT00768053|4015893|P1|NOT COMPLETED|Overall Study||11
1643376|NCT00768053|4015893|P1|COMPLETED|Overall Study||97
1643377|NCT00768053|4015893|P1|STARTED|Overall Study||108
1643378|NCT00768040|4015924|P2|NOT COMPLETED|Overall Study||3
1643379|NCT00768040|4015925|P1|NOT COMPLETED|Overall Study||4
1643380|NCT00768040|4015924|P2|COMPLETED|Overall Study||16
1643381|NCT00768040|4015925|P1|COMPLETED|Overall Study||16
1643382|NCT00768040|4015924|P2|STARTED|Overall Study||19
1643383|NCT00768040|4015925|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
1643384|NCT00767806|4015933|P2|NOT COMPLETED|Overall Study||47
1643385|NCT00767806|4015934|P1|NOT COMPLETED|Overall Study||51
1643386|NCT00767806|4015933|P2|COMPLETED|Overall Study||156
1643387|NCT00767806|4015934|P1|COMPLETED|Overall Study||147
1643388|NCT00767806|4015933|P2|STARTED|Overall Study||203
1643389|NCT00767806|4015934|P1|STARTED|Overall Study||198
1643390|NCT00767767|4015995|P5|NOT COMPLETED|Overall Study||0
1643391|NCT00767767|4015996|P4|NOT COMPLETED|Overall Study||0
1643392|NCT00767767|4015997|P3|NOT COMPLETED|Overall Study||0
1643393|NCT00767767|4015998|P2|NOT COMPLETED|Overall Study||0
1643394|NCT00767767|4015999|P1|NOT COMPLETED|Overall Study||0
1643395|NCT00767767|4015995|P5|COMPLETED|Overall Study||3
1643396|NCT00767767|4015996|P4|COMPLETED|Overall Study||3
1643397|NCT00767767|4015997|P3|COMPLETED|Overall Study||20
1643398|NCT00767767|4015998|P2|COMPLETED|Overall Study||20
1643399|NCT00767767|4015999|P1|COMPLETED|Overall Study||21
1643400|NCT00767767|4015995|P5|STARTED|Overall Study||3
1643401|NCT00767767|4015996|P4|STARTED|Overall Study||3
1643402|NCT00767767|4015997|P3|STARTED|Overall Study||20
1643403|NCT00767767|4015998|P2|STARTED|Overall Study||20
1643404|NCT00767767|4015999|P1|STARTED|Overall Study||21
1643405|NCT00767676|4016011|P1|NOT COMPLETED|Overall Study||54
1643406|NCT00767676|4016011|P1|COMPLETED|Overall Study||205
1643407|NCT00767676|4016011|P1|STARTED|Overall Study||259
1643408|NCT00767624|4016017|P2|NOT COMPLETED|Overall Study||17
1643409|NCT00767624|4016018|P1|NOT COMPLETED|Overall Study||24
1643410|NCT00767624|4016017|P2|COMPLETED|Overall Study||58
1643411|NCT00767624|4016018|P1|COMPLETED|Overall Study||51
1643412|NCT00767624|4016017|P2|STARTED|Overall Study||75
1643413|NCT00767624|4016018|P1|STARTED|Overall Study||75
1643414|NCT00767572|4016026|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
1643415|NCT00767572|4016026|P1|COMPLETED|Second Intervention (12 Weeks)||12
1643416|NCT00767572|4016026|P1|STARTED|Second Intervention (12 Weeks)||12
1643417|NCT00767572|4016026|P1|NOT COMPLETED|Washout (4 Weeks)||0
1643418|NCT00767572|4016026|P1|COMPLETED|Washout (4 Weeks)||12
1643419|NCT00767572|4016026|P1|STARTED|Washout (4 Weeks)||12
1643420|NCT00767572|4016026|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
1643421|NCT00767572|4016026|P1|COMPLETED|First Intervention (12 Weeks)||12
1643422|NCT00767572|4016026|P1|STARTED|First Intervention (12 Weeks)||12
1643423|NCT00767520|4016034|P2|NOT COMPLETED|Overall Study||17
1643424|NCT00767520|4016035|P1|NOT COMPLETED|Overall Study||11
1643425|NCT00767520|4016034|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
1643426|NCT00767520|4016035|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
1643427|NCT00767520|4016034|P2|STARTED|Overall Study||78
1643428|NCT00767520|4016035|P1|STARTED|Overall Study||79
1643429|NCT00767507|4016061|P4|NOT COMPLETED|Overall Study||3
1643430|NCT00767507|4016062|P3|NOT COMPLETED|Overall Study||0
1643431|NCT00767507|4016063|P2|NOT COMPLETED|Overall Study||0
1643432|NCT00767507|4016064|P1|NOT COMPLETED|Overall Study||0
1643433|NCT00767507|4016061|P4|COMPLETED|Overall Study||101
1643434|NCT00767507|4016062|P3|COMPLETED|Overall Study||106
1643435|NCT00767507|4016063|P2|COMPLETED|Overall Study||6
1643436|NCT00767507|4016064|P1|COMPLETED|Overall Study||5
1643437|NCT00767507|4016061|P4|STARTED|Overall Study||104
1643438|NCT00767507|4016062|P3|STARTED|Overall Study||106
1643439|NCT00767507|4016063|P2|STARTED|Overall Study||6
1643440|NCT00767507|4016064|P1|STARTED|Overall Study||5
1643441|NCT00767455|4016088|P1|NOT COMPLETED|Overall Study||19
1643442|NCT00767455|4016088|P1|COMPLETED|Overall Study||40
1643443|NCT00767455|4016088|P1|STARTED|Overall Study||59
1643444|NCT00767364|4016096|P2|NOT COMPLETED|Overall Study||0
1643445|NCT00767364|4016097|P1|NOT COMPLETED|Overall Study||0
1643446|NCT00767364|4016096|P2|COMPLETED|Overall Study||3
1643447|NCT00767364|4016097|P1|COMPLETED|Overall Study||5
1643448|NCT00767364|4016096|P2|STARTED|Overall Study||3
1643449|NCT00767364|4016097|P1|STARTED|Overall Study||5
1643450|NCT00767338|4016109|P4|NOT COMPLETED|Overall Study||0
1643451|NCT00767338|4016110|P3|NOT COMPLETED|Overall Study||0
1643452|NCT00767338|4016111|P2|NOT COMPLETED|Overall Study||2
1643453|NCT00767338|4016112|P1|NOT COMPLETED|Overall Study||1
1643454|NCT00767338|4016109|P4|COMPLETED|Overall Study||0
1643455|NCT00767338|4016110|P3|COMPLETED|Overall Study||0
1643456|NCT00767338|4016111|P2|COMPLETED|Overall Study||0
1643457|NCT00767338|4016112|P1|COMPLETED|Overall Study||0
1643458|NCT00767338|4016109|P4|STARTED|Overall Study||0
1643459|NCT00767338|4016110|P3|STARTED|Overall Study||0
1643460|NCT00767338|4016111|P2|STARTED|Overall Study||2
1643461|NCT00767338|4016112|P1|STARTED|Overall Study||1
1643462|NCT00767325|4016122|P1|NOT COMPLETED|Overall Study||15
1643463|NCT00767325|4016122|P1|COMPLETED|Overall Study||89
1643464|NCT00767325|4016122|P1|STARTED|Overall Study||104
1643465|NCT00767104|4016133|P2|NOT COMPLETED|Overall Study||2
1643466|NCT00767104|4016134|P1|NOT COMPLETED|Overall Study||1
1643467|NCT00767104|4016133|P2|COMPLETED|Overall Study||18
1643468|NCT00767104|4016134|P1|COMPLETED|Overall Study||19
1643469|NCT00767104|4016133|P2|STARTED|Overall Study||20
1643470|NCT00767104|4016134|P1|STARTED|Overall Study||20
1643471|NCT00767039|4016144|P2|NOT COMPLETED|Overall Study||2
1643472|NCT00767039|4016145|P1|NOT COMPLETED|Overall Study||5
1643473|NCT00767039|4016144|P2|COMPLETED|Overall Study||23
1643474|NCT00767039|4016145|P1|COMPLETED|Overall Study||22
1643475|NCT00767039|4016144|P2|STARTED|Overall Study||25
1643476|NCT00767039|4016145|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
1643477|NCT00767000|4016176|P5|NOT COMPLETED|Optional 104-week Extension||4
1643478|NCT00767000|4016177|P4|NOT COMPLETED|Optional 104-week Extension||2
1643479|NCT00767000|4016178|P3|NOT COMPLETED|Optional 104-week Extension||7
1643480|NCT00767000|4016179|P2|NOT COMPLETED|Optional 104-week Extension||3
1643481|NCT00767000|4016180|P1|NOT COMPLETED|Optional 104-week Extension||7
1643482|NCT00767000|4016176|P5|COMPLETED|Optional 104-week Extension||0
1643483|NCT00767000|4016177|P4|COMPLETED|Optional 104-week Extension||0
1643484|NCT00767000|4016178|P3|COMPLETED|Optional 104-week Extension||0
1643485|NCT00767000|4016179|P2|COMPLETED|Optional 104-week Extension||0
1643486|NCT00767000|4016180|P1|COMPLETED|Optional 104-week Extension||0
1643487|NCT00767000|4016176|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
1643488|NCT00767000|4016177|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
1643489|NCT00767000|4016178|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
1643490|NCT00767000|4016179|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
1643491|NCT00767000|4016180|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
1643492|NCT00767000|4016176|P5|NOT COMPLETED|54-week Study||224
1643493|NCT00767000|4016177|P4|NOT COMPLETED|54-week Study||225
1643494|NCT00767000|4016178|P3|NOT COMPLETED|54-week Study||109
1643495|NCT00767000|4016179|P2|NOT COMPLETED|54-week Study||113
1643496|NCT00767000|4016180|P1|NOT COMPLETED|54-week Study||108
1643497|NCT00767000|4016176|P5|COMPLETED|54-week Study||7
1643498|NCT00767000|4016177|P4|COMPLETED|54-week Study||4
1643499|NCT00767000|4016178|P3|COMPLETED|54-week Study||8
1643500|NCT00767000|4016179|P2|COMPLETED|54-week Study||4
1643501|NCT00767000|4016180|P1|COMPLETED|54-week Study||11
1643502|NCT00767000|4016176|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
1643503|NCT00767000|4016177|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
1643504|NCT00767000|4016178|P3|STARTED|54-week Study||117
1643505|NCT00767000|4016179|P2|STARTED|54-week Study||117
1643506|NCT00767000|4016180|P1|STARTED|54-week Study||119
1643507|NCT00766831|4016222|P1|NOT COMPLETED|Overall Study||115
1643508|NCT00766831|4016222|P1|COMPLETED|Overall Study||75
1643509|NCT00766831|4016222|P1|STARTED|Overall Study||190
1643510|NCT00766753|4016240|P2|NOT COMPLETED|Overall Study||0
1643511|NCT00766753|4016241|P1|NOT COMPLETED|Overall Study||0
1643512|NCT00766753|4016240|P2|COMPLETED|Overall Study||11
1643513|NCT00766753|4016241|P1|COMPLETED|Overall Study||11
1643514|NCT00766753|4016240|P2|Completed at Least Four Vaccines|Overall Study||9
1643515|NCT00766753|4016241|P1|Completed at Least Four Vaccines|Overall Study||10
1643516|NCT00766753|4016240|P2|Received at Least One Vaccine|Overall Study||11
1643517|NCT00766753|4016241|P1|Received at Least One Vaccine|Overall Study||11
1643518|NCT00766753|4016240|P2|STARTED|Overall Study||11
1643519|NCT00766753|4016241|P1|STARTED|Overall Study||11
1643520|NCT00766675|4016252|P1|NOT COMPLETED|Overall Study||40
1643521|NCT00766675|4016252|P1|COMPLETED|Overall Study||40
1643522|NCT00766675|4016252|P1|STARTED|Overall Study||80
1643523|NCT00766649|4016265|P1|NOT COMPLETED|Overall Study||10
1643524|NCT00766649|4016265|P1|COMPLETED|Overall Study||1
1643525|NCT00766649|4016265|P1|STARTED|Overall Study||11
1643526|NCT00766636|4016279|P2|NOT COMPLETED|Overall Study||2
1643527|NCT00766636|4016280|P1|NOT COMPLETED|Overall Study||3
1643528|NCT00766636|4016279|P2|COMPLETED|Overall Study||0
1643529|NCT00766636|4016280|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
1643530|NCT00766636|4016279|P2|STARTED|Overall Study||2
1643531|NCT00766636|4016280|P1|STARTED|Overall Study||3
1643532|NCT00766597|4016286|P1|NOT COMPLETED|Overall Study||9
1643533|NCT00766597|4016286|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
1643534|NCT00766597|4016286|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
1643535|NCT00766597|4016286|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
1643536|NCT00766597|4016286|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
1643537|NCT00766597|4016286|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
1643538|NCT00766597|4016286|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
1643539|NCT00766532|4016298|P1|NOT COMPLETED|Overall Study||2
1643540|NCT00766532|4016298|P1|COMPLETED|Overall Study||10
1643541|NCT00766532|4016298|P1|STARTED|Overall Study||12
1643542|NCT00766506|4016304|P2|NOT COMPLETED|Overall Study||2
1643543|NCT00766506|4016305|P1|NOT COMPLETED|Overall Study||5
1643544|NCT00766506|4016304|P2|COMPLETED|Overall Study||48
1643545|NCT00766506|4016305|P1|COMPLETED|Overall Study||53
1643546|NCT00766506|4016304|P2|STARTED|Overall Study||50
1643547|NCT00766506|4016305|P1|STARTED|Overall Study||58
1643548|NCT00766493|4016329|P1|NOT COMPLETED|30 Days Post-Procedure||12
1643549|NCT00766493|4016329|P1|COMPLETED|30 Days Post-Procedure||238
1643550|NCT00766493|4016329|P1|STARTED|30 Days Post-Procedure||250
1643551|NCT00766493|4016329|P1|NOT COMPLETED|Pre-Discharge||0
1643552|NCT00766493|4016329|P1|COMPLETED|Pre-Discharge||250
1643553|NCT00766493|4016329|P1|STARTED|Pre-Discharge||250
1643554|NCT00766467|4016339|P2|NOT COMPLETED|Overall Study||8
1643555|NCT00766467|4016340|P1|NOT COMPLETED|Overall Study||11
1643556|NCT00766467|4016339|P2|COMPLETED|Overall Study||31
1643557|NCT00766467|4016340|P1|COMPLETED|Overall Study||31
1643558|NCT00766467|4016339|P2|Initiated Treatment|Overall Study||38
1643559|NCT00766467|4016340|P1|Initiated Treatment|Overall Study||39
1643560|NCT00766467|4016339|P2|STARTED|Overall Study||39
1643561|NCT00766467|4016340|P1|STARTED|Overall Study||42
1643562|NCT00766415|4016352|P2|NOT COMPLETED|Overall Study||1
1643563|NCT00766415|4016353|P1|NOT COMPLETED|Overall Study||0
1643564|NCT00766415|4016352|P2|COMPLETED|Overall Study||26
1643565|NCT00766415|4016353|P1|COMPLETED|Overall Study||25
1643566|NCT00766415|4016352|P2|STARTED|Overall Study||27
1643567|NCT00766415|4016353|P1|STARTED|Overall Study||25
1643568|NCT00766376|4016401|P1|NOT COMPLETED|Overall Study||27
1643569|NCT00766376|4016401|P1|COMPLETED|Overall Study||124
1643570|NCT00766376|4016401|P1|STARTED|Overall Study||151
1643571|NCT00766363|4016410|P4|NOT COMPLETED|Overall Study||0
1643572|NCT00766363|4016411|P3|NOT COMPLETED|Overall Study||0
1643573|NCT00766363|4016412|P2|NOT COMPLETED|Overall Study||1
1643574|NCT00766363|4016413|P1|NOT COMPLETED|Overall Study||1
1643575|NCT00766363|4016410|P4|COMPLETED|Overall Study||12
1643576|NCT00766363|4016411|P3|COMPLETED|Overall Study||12
1643577|NCT00766363|4016412|P2|COMPLETED|Overall Study||12
1643578|NCT00766363|4016413|P1|COMPLETED|Overall Study||11
1643579|NCT00766363|4016410|P4|PK POPULATION|Overall Study||13
1643580|NCT00766363|4016411|P3|PK POPULATION|Overall Study||10
1643581|NCT00766363|4016412|P2|PK POPULATION|Overall Study||13
1643582|NCT00766363|4016413|P1|PK POPULATION|Overall Study||12
1643583|NCT00766363|4016410|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
1643584|NCT00766363|4016411|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
1643585|NCT00766363|4016412|P2|SAFETY POPULATION|Overall Study||13
1643586|NCT00766363|4016413|P1|SAFETY POPULATION|Overall Study||12
1643587|NCT00766363|4016410|P4|STARTED|Overall Study|Number randomized.|12
1643588|NCT00766363|4016411|P3|STARTED|Overall Study|Number randomized.|12
1643589|NCT00766363|4016412|P2|STARTED|Overall Study||13
1643590|NCT00766363|4016413|P1|STARTED|Overall Study||12
1643591|NCT00766090|4016452|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1643592|NCT00766090|4016453|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1643593|NCT00766090|4016454|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1643594|NCT00766090|4016455|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1643595|NCT00766090|4016456|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1643596|NCT00766090|4016457|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1643597|NCT00766090|4016458|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1643598|NCT00766090|4016459|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1643599|NCT00766090|4016460|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1643600|NCT00766090|4016461|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1643601|NCT00766090|4016462|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1643602|NCT00766090|4016463|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1643603|NCT00766090|4016452|P12|COMPLETED|Treatment Period 3 (28 Days)||6
1643604|NCT00766090|4016453|P11|COMPLETED|Treatment Period 3 (28 Days)||7
1643605|NCT00766090|4016454|P10|COMPLETED|Treatment Period 3 (28 Days)||8
1643606|NCT00766090|4016455|P9|COMPLETED|Treatment Period 3 (28 Days)||6
1643607|NCT00766090|4016456|P8|COMPLETED|Treatment Period 3 (28 Days)||8
1643608|NCT00766090|4016457|P7|COMPLETED|Treatment Period 3 (28 Days)||6
1643609|NCT00766090|4016458|P6|COMPLETED|Treatment Period 3 (28 Days)||22
1643610|NCT00766090|4016459|P5|COMPLETED|Treatment Period 3 (28 Days)||20
1643611|NCT00766090|4016460|P4|COMPLETED|Treatment Period 3 (28 Days)||24
1643612|NCT00766090|4016461|P3|COMPLETED|Treatment Period 3 (28 Days)||20
1643613|NCT00766090|4016462|P2|COMPLETED|Treatment Period 3 (28 Days)||26
1643614|NCT00766090|4016463|P1|COMPLETED|Treatment Period 3 (28 Days)||22
1643615|NCT00766090|4016452|P12|STARTED|Treatment Period 3 (28 Days)||7
1643616|NCT00766090|4016453|P11|STARTED|Treatment Period 3 (28 Days)||7
1643617|NCT00766090|4016454|P10|STARTED|Treatment Period 3 (28 Days)||8
1643618|NCT00766090|4016455|P9|STARTED|Treatment Period 3 (28 Days)||6
1643619|NCT00766090|4016456|P8|STARTED|Treatment Period 3 (28 Days)||8
1643620|NCT00766090|4016457|P7|STARTED|Treatment Period 3 (28 Days)||6
1643621|NCT00766090|4016458|P6|STARTED|Treatment Period 3 (28 Days)||23
1643622|NCT00766090|4016459|P5|STARTED|Treatment Period 3 (28 Days)||21
1643623|NCT00766090|4016460|P4|STARTED|Treatment Period 3 (28 Days)||25
1643624|NCT00766090|4016461|P3|STARTED|Treatment Period 3 (28 Days)||20
1643625|NCT00766090|4016462|P2|STARTED|Treatment Period 3 (28 Days)||27
1643626|NCT00766090|4016463|P1|STARTED|Treatment Period 3 (28 Days)||22
1643627|NCT00766090|4016452|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643628|NCT00766090|4016453|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643629|NCT00766090|4016454|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643630|NCT00766090|4016455|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643631|NCT00766090|4016456|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643632|NCT00766090|4016457|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643633|NCT00766090|4016458|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643634|NCT00766090|4016459|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643635|NCT00766090|4016460|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643636|NCT00766090|4016461|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
1643637|NCT00766090|4016462|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643638|NCT00766090|4016463|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
1643639|NCT00766090|4016452|P12|COMPLETED|Washout Period 2 (14 Days)||7
1643640|NCT00766090|4016453|P11|COMPLETED|Washout Period 2 (14 Days)||7
1643641|NCT00766090|4016454|P10|COMPLETED|Washout Period 2 (14 Days)||8
1643642|NCT00766090|4016455|P9|COMPLETED|Washout Period 2 (14 Days)||6
1643643|NCT00766090|4016456|P8|COMPLETED|Washout Period 2 (14 Days)||8
1643644|NCT00766090|4016457|P7|COMPLETED|Washout Period 2 (14 Days)||6
1643645|NCT00766090|4016458|P6|COMPLETED|Washout Period 2 (14 Days)||23
1643646|NCT00766090|4016459|P5|COMPLETED|Washout Period 2 (14 Days)||21
1643647|NCT00766090|4016460|P4|COMPLETED|Washout Period 2 (14 Days)||25
1643648|NCT00766090|4016461|P3|COMPLETED|Washout Period 2 (14 Days)||20
1643649|NCT00766090|4016462|P2|COMPLETED|Washout Period 2 (14 Days)||27
1643650|NCT00766090|4016463|P1|COMPLETED|Washout Period 2 (14 Days)||22
1643651|NCT00766090|4016452|P12|STARTED|Washout Period 2 (14 Days)||7
1643652|NCT00766090|4016453|P11|STARTED|Washout Period 2 (14 Days)||7
1643653|NCT00766090|4016454|P10|STARTED|Washout Period 2 (14 Days)||8
1643654|NCT00766090|4016455|P9|STARTED|Washout Period 2 (14 Days)||6
1643655|NCT00766090|4016456|P8|STARTED|Washout Period 2 (14 Days)||8
1643656|NCT00766090|4016457|P7|STARTED|Washout Period 2 (14 Days)||6
1643657|NCT00766090|4016458|P6|STARTED|Washout Period 2 (14 Days)||23
1643658|NCT00766090|4016459|P5|STARTED|Washout Period 2 (14 Days)||21
1643659|NCT00766090|4016460|P4|STARTED|Washout Period 2 (14 Days)||25
1643660|NCT00766090|4016461|P3|STARTED|Washout Period 2 (14 Days)||21
1643661|NCT00766090|4016462|P2|STARTED|Washout Period 2 (14 Days)||27
1643662|NCT00766090|4016463|P1|STARTED|Washout Period 2 (14 Days)||22
1643663|NCT00766090|4016452|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643664|NCT00766090|4016453|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643665|NCT00766090|4016454|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643666|NCT00766090|4016455|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643667|NCT00766090|4016456|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643668|NCT00766090|4016457|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643669|NCT00766090|4016458|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643670|NCT00766090|4016459|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
1643671|NCT00766090|4016460|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643672|NCT00766090|4016461|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1643673|NCT00766090|4016462|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643674|NCT00766090|4016463|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1643675|NCT00766090|4016452|P12|COMPLETED|Treatment Period 2 (28 Days)||7
1643676|NCT00766090|4016453|P11|COMPLETED|Treatment Period 2 (28 Days)||7
1643677|NCT00766090|4016454|P10|COMPLETED|Treatment Period 2 (28 Days)||8
1643678|NCT00766090|4016455|P9|COMPLETED|Treatment Period 2 (28 Days)||6
1643679|NCT00766090|4016456|P8|COMPLETED|Treatment Period 2 (28 Days)||8
1643680|NCT00766090|4016457|P7|COMPLETED|Treatment Period 2 (28 Days)||6
1643681|NCT00766090|4016458|P6|COMPLETED|Treatment Period 2 (28 Days)||23
1643682|NCT00766090|4016459|P5|COMPLETED|Treatment Period 2 (28 Days)||21
1643683|NCT00766090|4016460|P4|COMPLETED|Treatment Period 2 (28 Days)||25
1643684|NCT00766090|4016461|P3|COMPLETED|Treatment Period 2 (28 Days)||21
1643685|NCT00766090|4016462|P2|COMPLETED|Treatment Period 2 (28 Days)||27
1643686|NCT00766090|4016463|P1|COMPLETED|Treatment Period 2 (28 Days)||22
1643687|NCT00766090|4016452|P12|STARTED|Treatment Period 2 (28 Days)||7
1643688|NCT00766090|4016453|P11|STARTED|Treatment Period 2 (28 Days)||7
1643689|NCT00766090|4016454|P10|STARTED|Treatment Period 2 (28 Days)||8
1643690|NCT00766090|4016455|P9|STARTED|Treatment Period 2 (28 Days)||6
1643691|NCT00766090|4016456|P8|STARTED|Treatment Period 2 (28 Days)||8
1643692|NCT00766090|4016457|P7|STARTED|Treatment Period 2 (28 Days)||6
1643693|NCT00766090|4016458|P6|STARTED|Treatment Period 2 (28 Days)||23
1643694|NCT00766090|4016459|P5|STARTED|Treatment Period 2 (28 Days)||23
1643695|NCT00766090|4016460|P4|STARTED|Treatment Period 2 (28 Days)||25
1643696|NCT00766090|4016461|P3|STARTED|Treatment Period 2 (28 Days)||22
1643697|NCT00766090|4016462|P2|STARTED|Treatment Period 2 (28 Days)||27
1643698|NCT00766090|4016463|P1|STARTED|Treatment Period 2 (28 Days)||22
1643699|NCT00766090|4016452|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643700|NCT00766090|4016453|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643701|NCT00766090|4016454|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643702|NCT00766090|4016455|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643703|NCT00766090|4016456|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643704|NCT00766090|4016457|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643705|NCT00766090|4016458|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643706|NCT00766090|4016459|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643707|NCT00766090|4016460|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643708|NCT00766090|4016461|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
1643709|NCT00766090|4016462|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643710|NCT00766090|4016463|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
1643711|NCT00766090|4016452|P12|COMPLETED|Washout Period 1 (14 Days)||7
1643712|NCT00766090|4016453|P11|COMPLETED|Washout Period 1 (14 Days)||7
1643713|NCT00766090|4016454|P10|COMPLETED|Washout Period 1 (14 Days)||8
1643714|NCT00766090|4016455|P9|COMPLETED|Washout Period 1 (14 Days)||6
1643715|NCT00766090|4016456|P8|COMPLETED|Washout Period 1 (14 Days)||8
1643716|NCT00766090|4016457|P7|COMPLETED|Washout Period 1 (14 Days)||6
1643717|NCT00766090|4016458|P6|COMPLETED|Washout Period 1 (14 Days)||23
1643718|NCT00766090|4016459|P5|COMPLETED|Washout Period 1 (14 Days)||23
1643719|NCT00766090|4016460|P4|COMPLETED|Washout Period 1 (14 Days)||25
1643720|NCT00766090|4016461|P3|COMPLETED|Washout Period 1 (14 Days)||22
1643721|NCT00766090|4016462|P2|COMPLETED|Washout Period 1 (14 Days)||27
1643722|NCT00766090|4016463|P1|COMPLETED|Washout Period 1 (14 Days)||22
1643723|NCT00766090|4016452|P12|STARTED|Washout Period 1 (14 Days)||7
1643724|NCT00766090|4016453|P11|STARTED|Washout Period 1 (14 Days)||7
1643725|NCT00766090|4016454|P10|STARTED|Washout Period 1 (14 Days)||8
1643726|NCT00766090|4016455|P9|STARTED|Washout Period 1 (14 Days)||6
1643727|NCT00766090|4016456|P8|STARTED|Washout Period 1 (14 Days)||8
1643728|NCT00766090|4016457|P7|STARTED|Washout Period 1 (14 Days)||6
1643729|NCT00766090|4016458|P6|STARTED|Washout Period 1 (14 Days)||23
1643730|NCT00766090|4016459|P5|STARTED|Washout Period 1 (14 Days)||23
1643731|NCT00766090|4016460|P4|STARTED|Washout Period 1 (14 Days)||25
1643732|NCT00766090|4016461|P3|STARTED|Washout Period 1 (14 Days)||23
1643733|NCT00766090|4016462|P2|STARTED|Washout Period 1 (14 Days)||27
1643734|NCT00766090|4016463|P1|STARTED|Washout Period 1 (14 Days)||22
1643735|NCT00766090|4016452|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1643736|NCT00766090|4016453|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1643737|NCT00766090|4016454|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1643738|NCT00766090|4016455|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1643739|NCT00766090|4016456|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1643740|NCT00766090|4016457|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1643741|NCT00766090|4016458|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1643742|NCT00766090|4016459|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1643743|NCT00766090|4016460|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1643744|NCT00766090|4016461|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1643745|NCT00766090|4016462|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1643746|NCT00766090|4016463|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
1643747|NCT00766090|4016452|P12|COMPLETED|Treatment Period 1 (28 Days)||7
1643748|NCT00766090|4016453|P11|COMPLETED|Treatment Period 1 (28 Days)||7
1643749|NCT00766090|4016454|P10|COMPLETED|Treatment Period 1 (28 Days)||8
1643750|NCT00766090|4016455|P9|COMPLETED|Treatment Period 1 (28 Days)||6
1643751|NCT00766090|4016456|P8|COMPLETED|Treatment Period 1 (28 Days)||8
1643752|NCT00766090|4016457|P7|COMPLETED|Treatment Period 1 (28 Days)||6
1643753|NCT00766090|4016458|P6|COMPLETED|Treatment Period 1 (28 Days)||23
1643754|NCT00766090|4016459|P5|COMPLETED|Treatment Period 1 (28 Days)||23
1643755|NCT00766090|4016460|P4|COMPLETED|Treatment Period 1 (28 Days)||25
1643756|NCT00766090|4016461|P3|COMPLETED|Treatment Period 1 (28 Days)||23
1643757|NCT00766090|4016462|P2|COMPLETED|Treatment Period 1 (28 Days)||27
1643758|NCT00766090|4016463|P1|COMPLETED|Treatment Period 1 (28 Days)||22
1643759|NCT00766090|4016452|P12|STARTED|Treatment Period 1 (28 Days)||7
1643760|NCT00766090|4016453|P11|STARTED|Treatment Period 1 (28 Days)||7
1643761|NCT00766090|4016454|P10|STARTED|Treatment Period 1 (28 Days)||8
1643762|NCT00766090|4016455|P9|STARTED|Treatment Period 1 (28 Days)||7
1643763|NCT00766090|4016456|P8|STARTED|Treatment Period 1 (28 Days)||8
1643764|NCT00766090|4016457|P7|STARTED|Treatment Period 1 (28 Days)||6
1643765|NCT00766090|4016458|P6|STARTED|Treatment Period 1 (28 Days)||23
1643766|NCT00766090|4016459|P5|STARTED|Treatment Period 1 (28 Days)||23
1643767|NCT00766090|4016460|P4|STARTED|Treatment Period 1 (28 Days)||26
1643768|NCT00766090|4016461|P3|STARTED|Treatment Period 1 (28 Days)||23
1643769|NCT00766090|4016462|P2|STARTED|Treatment Period 1 (28 Days)||27
1643770|NCT00766090|4016463|P1|STARTED|Treatment Period 1 (28 Days)||25
1643771|NCT00766051|4016504|P2|NOT COMPLETED|Overall Study||0
1643772|NCT00766051|4016505|P1|NOT COMPLETED|Overall Study||2
1643773|NCT00766051|4016504|P2|COMPLETED|Overall Study||10
1643774|NCT00766051|4016505|P1|COMPLETED|Overall Study||10
1643775|NCT00766051|4016504|P2|STARTED|Overall Study||10
1643776|NCT00766051|4016505|P1|STARTED|Overall Study||12
1643777|NCT00765947|4016515|P1|NOT COMPLETED|Overall Study||24
1643778|NCT00765947|4016515|P1|COMPLETED|Overall Study||232
1643779|NCT00765947|4016515|P1|STARTED|Overall Study||256
1643780|NCT00765895|4016526|P2|NOT COMPLETED|Overall Study||0
1643781|NCT00765895|4016527|P1|NOT COMPLETED|Overall Study||0
1643782|NCT00765895|4016526|P2|COMPLETED|Overall Study||65
1643783|NCT00765895|4016527|P1|COMPLETED|Overall Study||65
1643784|NCT00765895|4016526|P2|STARTED|Overall Study||65
1643785|NCT00765895|4016527|P1|STARTED|Overall Study||65
1643786|NCT00765882|4016536|P3|NOT COMPLETED|Overall Study||36
1643787|NCT00765882|4016537|P2|NOT COMPLETED|Overall Study||40
1643788|NCT00765882|4016538|P1|NOT COMPLETED|Overall Study||24
1643789|NCT00765882|4016536|P3|COMPLETED|Overall Study||169
1643790|NCT00765882|4016537|P2|COMPLETED|Overall Study||173
1643791|NCT00765882|4016538|P1|COMPLETED|Overall Study||191
1643792|NCT00765882|4016536|P3|STARTED|Overall Study||205
1643793|NCT00765882|4016537|P2|STARTED|Overall Study||213
1643794|NCT00765882|4016538|P1|STARTED|Overall Study||215
1643795|NCT00765843|4016570|P3|NOT COMPLETED|Overall Study||3
1643796|NCT00765843|4016571|P2|NOT COMPLETED|Overall Study||4
1643797|NCT00765843|4016572|P1|NOT COMPLETED|Overall Study||1
1643798|NCT00765843|4016570|P3|COMPLETED|Overall Study||23
1643799|NCT00765843|4016571|P2|COMPLETED|Overall Study||21
1643800|NCT00765843|4016572|P1|COMPLETED|Overall Study||25
1643801|NCT00765843|4016570|P3|STARTED|Overall Study||26
1643802|NCT00765843|4016571|P2|STARTED|Overall Study||25
1643803|NCT00765843|4016572|P1|STARTED|Overall Study||26
1643804|NCT00765817|4016582|P2|NOT COMPLETED|Overall Study||22
1643805|NCT00765817|4016583|P1|NOT COMPLETED|Overall Study||26
1643806|NCT00765817|4016582|P2|COMPLETED|Overall Study||101
1643807|NCT00765817|4016583|P1|COMPLETED|Overall Study||112
1643808|NCT00765817|4016582|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
1643809|NCT00765817|4016583|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
1643810|NCT00765765|4016621|P1|NOT COMPLETED|Overall Study||0
1643811|NCT00765765|4016621|P1|COMPLETED|Overall Study||6
1643812|NCT00765765|4016621|P1|STARTED|Overall Study||6
1643813|NCT00765726|4016631|P1|NOT COMPLETED|Overall Study||9
1643814|NCT00765726|4016631|P1|COMPLETED|Overall Study||3
1643815|NCT00765726|4016631|P1|STARTED|Overall Study||12
1643816|NCT00765674|4016639|P4|NOT COMPLETED|Overall Study||25
1643817|NCT00765674|4016640|P3|NOT COMPLETED|Overall Study||17
1643818|NCT00765674|4016641|P2|NOT COMPLETED|Overall Study||22
1643819|NCT00765674|4016642|P1|NOT COMPLETED|Overall Study||21
1643820|NCT00765674|4016639|P4|COMPLETED|Overall Study||285
1643821|NCT00765674|4016640|P3|COMPLETED|Overall Study||279
1643822|NCT00765674|4016641|P2|COMPLETED|Overall Study||276
1643823|NCT00765674|4016642|P1|COMPLETED|Overall Study||266
1643824|NCT00765674|4016639|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
1643825|NCT00765674|4016640|P3|STARTED|Overall Study||296
1643826|NCT00765674|4016641|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
1643827|NCT00765674|4016642|P1|STARTED|Overall Study||287
1643828|NCT00765661|4016666|P2|NOT COMPLETED|Overall Study||0
1643829|NCT00765661|4016667|P1|NOT COMPLETED|Overall Study||0
1643830|NCT00765661|4016666|P2|COMPLETED|Overall Study||31
1643831|NCT00765661|4016667|P1|COMPLETED|Overall Study||32
1643832|NCT00765661|4016666|P2|STARTED|Overall Study||31
1643833|NCT00765661|4016667|P1|STARTED|Overall Study||32
1643834|NCT00765648|4016681|P2|NOT COMPLETED|Overall Study||2
1643835|NCT00765648|4016682|P1|NOT COMPLETED|Overall Study||1
1643836|NCT00765648|4016681|P2|COMPLETED|Overall Study||114
1643837|NCT00765648|4016682|P1|COMPLETED|Overall Study||109
1643838|NCT00765648|4016681|P2|STARTED|Overall Study||116
1643839|NCT00765648|4016682|P1|STARTED|Overall Study||110
1643840|NCT00765570|4016700|P2|NOT COMPLETED|Overall Study||0
1643841|NCT00765570|4016701|P1|NOT COMPLETED|Overall Study||2
1643842|NCT00765570|4016700|P2|COMPLETED|Overall Study||3
1643843|NCT00765570|4016701|P1|COMPLETED|Overall Study||7
1643844|NCT00765570|4016700|P2|STARTED|Overall Study||3
1643845|NCT00765570|4016701|P1|STARTED|Overall Study||9
1643846|NCT00765388|4016709|P2|NOT COMPLETED|Period 2||0
1643847|NCT00765388|4016710|P1|NOT COMPLETED|Period 2||0
1643848|NCT00765388|4016709|P2|COMPLETED|Period 2||6
1643849|NCT00765388|4016710|P1|COMPLETED|Period 2||15
1643850|NCT00765388|4016709|P2|STARTED|Period 2||6
1643851|NCT00765388|4016710|P1|STARTED|Period 2||15
1643852|NCT00765388|4016709|P2|NOT COMPLETED|Period 1||5
1643853|NCT00765388|4016710|P1|NOT COMPLETED|Period 1||1
1643854|NCT00765388|4016709|P2|COMPLETED|Period 1||6
1643855|NCT00765388|4016710|P1|COMPLETED|Period 1||15
1643856|NCT00765388|4016709|P2|STARTED|Period 1||11
1643857|NCT00765388|4016710|P1|STARTED|Period 1|A cross-over study|16
1643858|NCT00765375|4016738|P1|NOT COMPLETED|Overall Study||0
1643859|NCT00765375|4016738|P1|COMPLETED|Overall Study||5
1643860|NCT00765375|4016738|P1|STARTED|Overall Study||5
1643861|NCT00765362|4016744|P1|NOT COMPLETED|Overall Study||137
1643862|NCT00765362|4016744|P1|COMPLETED|Overall Study||282
1643863|NCT00765362|4016744|P1|STARTED|Overall Study||419
1643864|NCT00765336|4016752|P2|NOT COMPLETED|Overall Study||16
1643865|NCT00765336|4016753|P1|NOT COMPLETED|Overall Study||19
1643866|NCT00765336|4016752|P2|COMPLETED|Overall Study||73
1643867|NCT00765336|4016753|P1|COMPLETED|Overall Study||72
1643868|NCT00765336|4016752|P2|STARTED|Overall Study||89
1643869|NCT00765336|4016753|P1|STARTED|Overall Study||91
1643870|NCT00765245|4016761|P2|NOT COMPLETED|Overall Study||2
1643871|NCT00765245|4016762|P1|NOT COMPLETED|Overall Study||13
1643872|NCT00765245|4016761|P2|COMPLETED|Overall Study||20
1643873|NCT00765245|4016762|P1|COMPLETED|Overall Study||9
1643874|NCT00765245|4016761|P2|STARTED|Overall Study||22
1643875|NCT00765245|4016762|P1|STARTED|Overall Study||22
1643876|NCT00765232|4016774|P2|NOT COMPLETED|Overall Study||0
1643877|NCT00765232|4016775|P1|NOT COMPLETED|Overall Study||0
1643878|NCT00765232|4016774|P2|COMPLETED|Overall Study||54
1643879|NCT00765232|4016775|P1|COMPLETED|Overall Study||57
1643880|NCT00765232|4016774|P2|STARTED|Overall Study||54
1643881|NCT00765232|4016775|P1|STARTED|Overall Study||57
1643882|NCT00765206|4016783|P4|NOT COMPLETED|Second Intervention||0
1643883|NCT00765206|4016784|P3|NOT COMPLETED|Second Intervention||0
1643884|NCT00765206|4016785|P2|NOT COMPLETED|Second Intervention||0
1643885|NCT00765206|4016786|P1|NOT COMPLETED|Second Intervention||0
1643886|NCT00765206|4016783|P4|COMPLETED|Second Intervention||15
1643887|NCT00765206|4016784|P3|COMPLETED|Second Intervention||15
1643888|NCT00765206|4016785|P2|COMPLETED|Second Intervention||15
1643889|NCT00765206|4016786|P1|COMPLETED|Second Intervention||15
1643890|NCT00765206|4016783|P4|STARTED|Second Intervention||15
1643891|NCT00765206|4016784|P3|STARTED|Second Intervention||15
1643892|NCT00765206|4016785|P2|STARTED|Second Intervention||15
1643893|NCT00765206|4016786|P1|STARTED|Second Intervention||15
1643894|NCT00765206|4016783|P4|NOT COMPLETED|Washout Period of 14 Days||0
1643895|NCT00765206|4016784|P3|NOT COMPLETED|Washout Period of 14 Days||0
1643896|NCT00765206|4016785|P2|NOT COMPLETED|Washout Period of 14 Days||0
1643897|NCT00765206|4016786|P1|NOT COMPLETED|Washout Period of 14 Days||0
1643898|NCT00765206|4016783|P4|COMPLETED|Washout Period of 14 Days||15
1643899|NCT00765206|4016784|P3|COMPLETED|Washout Period of 14 Days||15
1643900|NCT00765206|4016785|P2|COMPLETED|Washout Period of 14 Days||15
1643901|NCT00765206|4016786|P1|COMPLETED|Washout Period of 14 Days||15
1643902|NCT00765206|4016783|P4|STARTED|Washout Period of 14 Days||15
1643903|NCT00765206|4016784|P3|STARTED|Washout Period of 14 Days||15
1643904|NCT00765206|4016785|P2|STARTED|Washout Period of 14 Days||15
1643905|NCT00765206|4016786|P1|STARTED|Washout Period of 14 Days||15
1643906|NCT00765206|4016783|P4|NOT COMPLETED|First Intervention||0
1643907|NCT00765206|4016784|P3|NOT COMPLETED|First Intervention||0
1643908|NCT00765206|4016785|P2|NOT COMPLETED|First Intervention||0
1643909|NCT00765206|4016786|P1|NOT COMPLETED|First Intervention||0
1643910|NCT00765206|4016783|P4|COMPLETED|First Intervention||15
1643911|NCT00765206|4016784|P3|COMPLETED|First Intervention||15
1643912|NCT00765206|4016785|P2|COMPLETED|First Intervention||15
1643913|NCT00765206|4016786|P1|COMPLETED|First Intervention||15
1643914|NCT00765206|4016783|P4|STARTED|First Intervention||15
1643915|NCT00765206|4016784|P3|STARTED|First Intervention||15
1643916|NCT00765206|4016785|P2|STARTED|First Intervention||15
1643917|NCT00765206|4016786|P1|STARTED|First Intervention||15
1643918|NCT00765193|4016792|P1|NOT COMPLETED|Full Body Examination||0
1643919|NCT00765193|4016792|P1|COMPLETED|Full Body Examination||14381
1643920|NCT00765193|4016792|P1|STARTED|Full Body Examination||14381
1643921|NCT00765193|4016792|P1|NOT COMPLETED|Problem Area Examination||0
1643922|NCT00765193|4016792|P1|COMPLETED|Problem Area Examination||14381
1643923|NCT00765193|4016792|P1|STARTED|Problem Area Examination||14381
1643924|NCT00765128|4016799|P2|NOT COMPLETED|Overall Study||0
1643925|NCT00765128|4016800|P1|NOT COMPLETED|Overall Study||0
1643926|NCT00765128|4016799|P2|COMPLETED|Overall Study||9
1643927|NCT00765128|4016800|P1|COMPLETED|Overall Study||8
1643928|NCT00765128|4016799|P2|STARTED|Overall Study||9
1643929|NCT00765128|4016800|P1|STARTED|Overall Study||8
1643930|NCT00765102|4016808|P1|NOT COMPLETED|Overall Study||31
1643931|NCT00765102|4016808|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
1643932|NCT00765102|4016808|P1|STARTED|Overall Study||32
1643933|NCT00765076|4016833|P3|NOT COMPLETED|Overall Study||1
1643934|NCT00765076|4016834|P2|NOT COMPLETED|Overall Study||0
1643935|NCT00765076|4016835|P1|NOT COMPLETED|Overall Study||1
1643936|NCT00765076|4016833|P3|COMPLETED|Overall Study||49
1643937|NCT00765076|4016834|P2|COMPLETED|Overall Study||73
1643938|NCT00765076|4016835|P1|COMPLETED|Overall Study||68
1643939|NCT00765076|4016833|P3|STARTED|Overall Study||50
1643940|NCT00765076|4016834|P2|STARTED|Overall Study||73
1643941|NCT00765076|4016835|P1|STARTED|Overall Study||69
1643942|NCT00765063|4016888|P1|NOT COMPLETED|Overall Study||32
1643943|NCT00765063|4016888|P1|COMPLETED|Overall Study||30
1643944|NCT00765063|4016888|P1|STARTED|Overall Study||62
1643945|NCT00765037|4016904|P1|NOT COMPLETED|Overall Study||6
1643946|NCT00765037|4016904|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
1643947|NCT00765037|4016904|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
1643948|NCT00764946|4016911|P3|NOT COMPLETED|Overall Study||4
1643949|NCT00764946|4016912|P2|NOT COMPLETED|Overall Study||17
1643950|NCT00764946|4016913|P1|NOT COMPLETED|Overall Study||13
1643951|NCT00764946|4016911|P3|COMPLETED|Overall Study||18
1643952|NCT00764946|4016912|P2|COMPLETED|Overall Study||72
1643953|NCT00764946|4016913|P1|COMPLETED|Overall Study||85
1643954|NCT00764946|4016911|P3|TREATED|Overall Study||21
1643955|NCT00764946|4016912|P2|TREATED|Overall Study||88
1643956|NCT00764946|4016913|P1|TREATED|Overall Study||97
1643957|NCT00764946|4016911|P3|STARTED|Overall Study||22
1643958|NCT00764946|4016912|P2|STARTED|Overall Study||89
1643959|NCT00764946|4016913|P1|STARTED|Overall Study||98
1643960|NCT00764881|4016941|P2|NOT COMPLETED|Overall Study||10
1643961|NCT00764881|4016942|P1|NOT COMPLETED|Overall Study||16
1643962|NCT00764881|4016941|P2|COMPLETED|Overall Study||99
1643963|NCT00764881|4016942|P1|COMPLETED|Overall Study||92
1643964|NCT00764881|4016941|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
1643965|NCT00764881|4016942|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
1643966|NCT00764881|4016941|P2|STARTED|Overall Study||109
1643967|NCT00764881|4016942|P1|STARTED|Overall Study||108
1643968|NCT00764868|4017166|P1|NOT COMPLETED|Overall Study||113
1643969|NCT00764868|4017166|P1|COMPLETED|Overall Study||156
1643970|NCT00764868|4017166|P1|STARTED|Overall Study||269
1643971|NCT00764790|4017175|P3|NOT COMPLETED|Overall Study||30
1643972|NCT00764790|4017176|P2|NOT COMPLETED|Overall Study||41
1643973|NCT00764790|4017177|P1|NOT COMPLETED|Overall Study||38
1643974|NCT00764790|4017175|P3|COMPLETED|Overall Study||1074
1643975|NCT00764790|4017176|P2|COMPLETED|Overall Study||1065
1643976|NCT00764790|4017177|P1|COMPLETED|Overall Study||1069
1643977|NCT00764790|4017175|P3|STARTED|Overall Study||1104
1643978|NCT00764790|4017176|P2|STARTED|Overall Study||1106
1643979|NCT00764790|4017177|P1|STARTED|Overall Study||1107
1643980|NCT00764699|4017209|P1|NOT COMPLETED|Overall Study||3
1643981|NCT00764699|4017209|P1|COMPLETED|Overall Study||0
1643982|NCT00764699|4017209|P1|STARTED|Overall Study||3
1643983|NCT00764673|4017213|P1|NOT COMPLETED|Overall Study||12
1643984|NCT00764673|4017213|P1|COMPLETED|Overall Study||59
1643985|NCT00764673|4017213|P1|STARTED|Overall Study||71
1643986|NCT00764660|4017223|P2|NOT COMPLETED|Overall Study||11
1643987|NCT00764660|4017224|P1|NOT COMPLETED|Overall Study||22
1643988|NCT00764660|4017223|P2|COMPLETED|Overall Study||55
1643989|NCT00764660|4017224|P1|COMPLETED|Overall Study||53
1643990|NCT00764660|4017223|P2|STARTED|Overall Study||66
1643991|NCT00764660|4017224|P1|STARTED|Overall Study||75
1643992|NCT00764517|4017258|P2|NOT COMPLETED|Overall Study||14
1643993|NCT00764517|4017259|P1|NOT COMPLETED|Overall Study||15
1643994|NCT00764517|4017258|P2|COMPLETED|Overall Study||4
1643995|NCT00764517|4017259|P1|COMPLETED|Overall Study||24
1643996|NCT00764517|4017258|P2|STARTED|Overall Study||18
1643997|NCT00764517|4017259|P1|STARTED|Overall Study||39
1643998|NCT00764504|4017280|P3|NOT COMPLETED|Overall Study||103
1643999|NCT00764504|4017281|P2|NOT COMPLETED|Overall Study||70
1644000|NCT00764504|4017282|P1|NOT COMPLETED|Overall Study||66
1644001|NCT00764504|4017280|P3|COMPLETED|Overall Study||131
1644002|NCT00764504|4017281|P2|COMPLETED|Overall Study||71
1644003|NCT00764504|4017282|P1|COMPLETED|Overall Study||75
1644004|NCT00764504|4017280|P3|STARTED|Overall Study||234
1644005|NCT00764504|4017281|P2|STARTED|Overall Study||141
1644006|NCT00764504|4017282|P1|STARTED|Overall Study||141
1644007|NCT00764478|4017311|P3|NOT COMPLETED|Overall Study||8
1644008|NCT00764478|4017312|P2|NOT COMPLETED|Overall Study||22
1644009|NCT00764478|4017313|P1|NOT COMPLETED|Overall Study||15
1644010|NCT00764478|4017311|P3|COMPLETED|Overall Study||118
1644011|NCT00764478|4017312|P2|COMPLETED|Overall Study||97
1644012|NCT00764478|4017313|P1|COMPLETED|Overall Study||107
1644013|NCT00764478|4017311|P3|STARTED|Overall Study||126
1644014|NCT00764478|4017312|P2|STARTED|Overall Study||119
1644015|NCT00764478|4017313|P1|STARTED|Overall Study||122
1644016|NCT00764465|4017393|P6|NOT COMPLETED|Overall Study||1
1644017|NCT00764465|4017394|P5|NOT COMPLETED|Overall Study||1
1644018|NCT00764465|4017395|P4|NOT COMPLETED|Overall Study||1
1644019|NCT00764465|4017396|P3|NOT COMPLETED|Overall Study||1
1644020|NCT00764465|4017397|P2|NOT COMPLETED|Overall Study||1
1644021|NCT00764465|4017398|P1|NOT COMPLETED|Overall Study||2
1644022|NCT00764465|4017393|P6|COMPLETED|Overall Study||7
1644023|NCT00764465|4017394|P5|COMPLETED|Overall Study||6
1644024|NCT00764465|4017395|P4|COMPLETED|Overall Study||6
1644025|NCT00764465|4017396|P3|COMPLETED|Overall Study||6
1644026|NCT00764465|4017397|P2|COMPLETED|Overall Study||6
1644027|NCT00764465|4017398|P1|COMPLETED|Overall Study||7
1644028|NCT00764465|4017393|P6|STARTED|Overall Study||8
1644029|NCT00764465|4017394|P5|STARTED|Overall Study||7
1644030|NCT00764465|4017395|P4|STARTED|Overall Study||7
1644031|NCT00764465|4017396|P3|STARTED|Overall Study||7
1644032|NCT00764465|4017397|P2|STARTED|Overall Study||7
1644033|NCT00764465|4017398|P1|STARTED|Overall Study||9
1644034|NCT00764361|4017426|P2|NOT COMPLETED|Overall Study||4
1644035|NCT00764361|4017427|P1|NOT COMPLETED|Overall Study||2
1644036|NCT00764361|4017426|P2|COMPLETED|Overall Study||3
1644037|NCT00764361|4017427|P1|COMPLETED|Overall Study||6
1644038|NCT00764361|4017426|P2|STARTED|Overall Study||7
1644039|NCT00764361|4017427|P1|STARTED|Overall Study||8
1644040|NCT00764322|4017435|P1|NOT COMPLETED|Overall Study||20
1644041|NCT00764322|4017435|P1|COMPLETED|Overall Study||480
1644042|NCT00764322|4017435|P1|STARTED|Overall Study||500
1644043|NCT00764309|4017452|P1|NOT COMPLETED|Overall Study||0
1644044|NCT00764309|4017452|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
1644045|NCT00764309|4017452|P1|STARTED|Overall Study|Number of participants treated.|31
1644046|NCT00763971|4017462|P3|NOT COMPLETED|Overall Study||69
1644047|NCT00763971|4017463|P2|NOT COMPLETED|Overall Study||38
1644048|NCT00763971|4017464|P1|NOT COMPLETED|Overall Study||33
1644049|NCT00763971|4017462|P3|COMPLETED|Overall Study||42
1644050|NCT00763971|4017463|P2|COMPLETED|Overall Study||74
1644051|NCT00763971|4017464|P1|COMPLETED|Overall Study||80
1644052|NCT00763971|4017462|P3|STARTED|Overall Study||111
1644053|NCT00763971|4017463|P2|STARTED|Overall Study||112
1644054|NCT00763971|4017464|P1|STARTED|Overall Study||113
1644055|NCT00763958|4017495|P2|NOT COMPLETED|Overall Study||11
1644056|NCT00763958|4017496|P1|NOT COMPLETED|Overall Study||14
1644057|NCT00763958|4017495|P2|COMPLETED|Overall Study||5
1644058|NCT00763958|4017496|P1|COMPLETED|Overall Study||14
1644059|NCT00763958|4017495|P2|STARTED|Overall Study||16
1644060|NCT00763958|4017496|P1|STARTED|Overall Study||28
1644061|NCT00763919|4017506|P1|NOT COMPLETED|Overall Study||13
1644062|NCT00763919|4017506|P1|COMPLETED|Overall Study||30
1644063|NCT00763919|4017506|P1|STARTED|Overall Study||43
1644064|NCT00763867|4017534|P2|NOT COMPLETED|Overall Study||12
1644065|NCT00763867|4017535|P1|NOT COMPLETED|Overall Study||5
1644066|NCT00763867|4017534|P2|COMPLETED|Overall Study||101
1644067|NCT00763867|4017535|P1|COMPLETED|Overall Study||98
1644068|NCT00763867|4017534|P2|STARTED|Overall Study||113
1644069|NCT00763867|4017535|P1|STARTED|Overall Study||103
1644070|NCT00763815|4017631|P2|NOT COMPLETED|Overall Study||84
1644071|NCT00763815|4017632|P1|NOT COMPLETED|Overall Study||52
1644072|NCT00763815|4017631|P2|COMPLETED|Overall Study||239
1644073|NCT00763815|4017632|P1|COMPLETED|Overall Study||109
1644074|NCT00763815|4017631|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
1644075|NCT00763815|4017632|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
1644076|NCT00763815|4017631|P2|Treated/Safety Population|Overall Study||323
1644077|NCT00763815|4017632|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
1644078|NCT00763815|4017631|P2|STARTED|Overall Study||323
1644079|NCT00763815|4017632|P1|STARTED|Overall Study|Randomized.|161
1644080|NCT00763750|4017656|P1|NOT COMPLETED|Overall Study||0
1644081|NCT00763750|4017656|P1|COMPLETED|Overall Study||25
1644082|NCT00763750|4017656|P1|STARTED|Overall Study||25
1644083|NCT00763698|4017660|P1|NOT COMPLETED|Overall Study||10
1644084|NCT00763698|4017660|P1|COMPLETED|Overall Study||76
1644085|NCT00763698|4017660|P1|STARTED|Overall Study||86
1644086|NCT00763490|4017666|P1|NOT COMPLETED|Overall Study||0
1644087|NCT00763490|4017666|P1|COMPLETED|Overall Study||20
1644088|NCT00763490|4017666|P1|STARTED|Overall Study||20
1644089|NCT00763451|4017677|P4|NOT COMPLETED|Overall Study||30
1644090|NCT00763451|4017678|P3|NOT COMPLETED|Overall Study||40
1644091|NCT00763451|4017679|P2|NOT COMPLETED|Overall Study||22
1644092|NCT00763451|4017680|P1|NOT COMPLETED|Overall Study||13
1644093|NCT00763451|4017677|P4|COMPLETED|Overall Study||131
1644094|NCT00763451|4017678|P3|COMPLETED|Overall Study||121
1644095|NCT00763451|4017679|P2|COMPLETED|Overall Study||60
1644096|NCT00763451|4017680|P1|COMPLETED|Overall Study||67
1644097|NCT00763451|4017677|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
1644098|NCT00763451|4017678|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
1644099|NCT00763451|4017679|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
1644100|NCT00763451|4017680|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
1644101|NCT00763451|4017677|P4|Treated/Safety Population|Overall Study||161
1644102|NCT00763451|4017678|P3|Treated/Safety Population|Overall Study||161
1644103|NCT00763451|4017679|P2|Treated/Safety Population|Overall Study||81
1644104|NCT00763451|4017680|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
1644105|NCT00763451|4017677|P4|STARTED|Overall Study||161
1644106|NCT00763451|4017678|P3|STARTED|Overall Study||161
1644107|NCT00763451|4017679|P2|STARTED|Overall Study||82
1644108|NCT00763451|4017680|P1|STARTED|Overall Study|Randomized.|80
1644109|NCT00763412|4017714|P2|NOT COMPLETED|Overall Study||4
1644110|NCT00763412|4017715|P1|NOT COMPLETED|Overall Study||4
1644111|NCT00763412|4017714|P2|COMPLETED|Overall Study||4
1644112|NCT00763412|4017715|P1|COMPLETED|Overall Study||4
1644113|NCT00763412|4017714|P2|STARTED|Overall Study||8
1644114|NCT00763412|4017715|P1|STARTED|Overall Study||8
1644115|NCT00763386|4017739|P2|NOT COMPLETED|Overall Study||40
1644116|NCT00763386|4017740|P1|NOT COMPLETED|Overall Study||48
1644117|NCT00763386|4017739|P2|COMPLETED|Overall Study||127
1644118|NCT00763386|4017740|P1|COMPLETED|Overall Study||116
1644119|NCT00763386|4017739|P2|STARTED|Overall Study||167
1644120|NCT00763386|4017740|P1|STARTED|Overall Study||164
1644121|NCT00763360|4017751|P3|NOT COMPLETED|Overall Study||0
1644122|NCT00763360|4017752|P2|NOT COMPLETED|Overall Study||2
1644123|NCT00763360|4017753|P1|NOT COMPLETED|Overall Study||0
1644124|NCT00763360|4017751|P3|COMPLETED|Overall Study||63
1644125|NCT00763360|4017752|P2|COMPLETED|Overall Study||58
1644126|NCT00763360|4017753|P1|COMPLETED|Overall Study||61
1644127|NCT00763360|4017751|P3|STARTED|Overall Study||63
1644128|NCT00763360|4017752|P2|STARTED|Overall Study||60
1644129|NCT00763360|4017753|P1|STARTED|Overall Study||61
1644130|NCT00763321|4017773|P3|NOT COMPLETED|Double-blind Period||29
1644131|NCT00763321|4017774|P2|NOT COMPLETED|Double-blind Period||21
1644132|NCT00763321|4017775|P1|NOT COMPLETED|Double-blind Period||0
1644133|NCT00763321|4017773|P3|COMPLETED|Double-blind Period||84
1644134|NCT00763321|4017774|P2|COMPLETED|Double-blind Period||88
1644135|NCT00763321|4017775|P1|COMPLETED|Double-blind Period||0
1644136|NCT00763321|4017773|P3|STARTED|Double-blind Period||113
1644137|NCT00763321|4017774|P2|STARTED|Double-blind Period||109
1644138|NCT00763321|4017775|P1|STARTED|Double-blind Period||0
1644139|NCT00763321|4017773|P3|NOT COMPLETED|Open-label Period||0
1644140|NCT00763321|4017774|P2|NOT COMPLETED|Open-label Period||0
1644141|NCT00763321|4017775|P1|NOT COMPLETED|Open-label Period||63
1644142|NCT00763321|4017773|P3|COMPLETED|Open-label Period||0
1644143|NCT00763321|4017774|P2|COMPLETED|Open-label Period||0
1644144|NCT00763321|4017775|P1|COMPLETED|Open-label Period||222
1644145|NCT00763321|4017773|P3|STARTED|Open-label Period||0
1644146|NCT00763321|4017774|P2|STARTED|Open-label Period||0
1644147|NCT00763321|4017775|P1|STARTED|Open-label Period||285
1644148|NCT00763282|4017786|P2|NOT COMPLETED|Overall Study||34
1644149|NCT00763282|4017787|P1|NOT COMPLETED|Overall Study||32
1644150|NCT00763282|4017786|P2|COMPLETED|Overall Study||38
1644151|NCT00763282|4017787|P1|COMPLETED|Overall Study||40
1644152|NCT00763282|4017786|P2|STARTED|Overall Study||72
1644153|NCT00763282|4017787|P1|STARTED|Overall Study||72
1644154|NCT00763269|4017803|P2|NOT COMPLETED|Overall Study||13
1644155|NCT00763269|4017804|P1|NOT COMPLETED|Overall Study||12
1644156|NCT00763269|4017803|P2|COMPLETED|Overall Study||299
1644157|NCT00763269|4017804|P1|COMPLETED|Overall Study||302
1644158|NCT00763269|4017803|P2|STARTED|Overall Study||312
1644159|NCT00763269|4017804|P1|STARTED|Overall Study||314
1644160|NCT00763256|4017818|P2|NOT COMPLETED|Overall Study||10
1644161|NCT00763256|4017819|P1|NOT COMPLETED|Overall Study||7
1644162|NCT00763256|4017818|P2|COMPLETED|Overall Study||8
1644163|NCT00763256|4017819|P1|COMPLETED|Overall Study||8
1644164|NCT00763256|4017818|P2|STARTED|Overall Study||18
1644165|NCT00763256|4017819|P1|STARTED|Overall Study||15
1644166|NCT00763243|4017833|P1|NOT COMPLETED|6-Month Follow-Up Period||0
1644167|NCT00763243|4017833|P1|COMPLETED|6-Month Follow-Up Period||9
1644168|NCT00763243|4017833|P1|STARTED|6-Month Follow-Up Period||9
1644169|NCT00763243|4017833|P1|NOT COMPLETED|1-Month Follow-Up Period||0
1644170|NCT00763243|4017833|P1|COMPLETED|1-Month Follow-Up Period||9
1644171|NCT00763243|4017833|P1|STARTED|1-Month Follow-Up Period||9
1644172|NCT00763243|4017833|P1|NOT COMPLETED|Training Period||0
1644173|NCT00763243|4017833|P1|COMPLETED|Training Period||9
1644174|NCT00763243|4017833|P1|STARTED|Training Period||9
1644175|NCT00763243|4017833|P1|NOT COMPLETED|Waiting Period||0
1644176|NCT00763243|4017833|P1|COMPLETED|Waiting Period||9
1644177|NCT00763243|4017833|P1|STARTED|Waiting Period||9
1644178|NCT00763139|4017855|P2|NOT COMPLETED|Overall Study||3
1644179|NCT00763139|4017856|P1|NOT COMPLETED|Overall Study||5
1644180|NCT00763139|4017855|P2|COMPLETED|Overall Study||14
1644181|NCT00763139|4017856|P1|COMPLETED|Overall Study||12
1644182|NCT00763139|4017855|P2|STARTED|Overall Study||17
1644183|NCT00763139|4017856|P1|STARTED|Overall Study||17
1644184|NCT00763061|4017878|P2|NOT COMPLETED|Overall Study||13
1644185|NCT00763061|4017879|P1|NOT COMPLETED|Overall Study||5
1644186|NCT00763061|4017878|P2|COMPLETED|Overall Study||44
1644187|NCT00763061|4017879|P1|COMPLETED|Overall Study||49
1644188|NCT00763061|4017878|P2|STARTED|Overall Study||57
1644189|NCT00763061|4017879|P1|STARTED|Overall Study||54
1644190|NCT00763048|4017893|P2|NOT COMPLETED|Overall Study||0
1644191|NCT00763048|4017894|P1|NOT COMPLETED|Overall Study||0
1644192|NCT00763048|4017893|P2|COMPLETED|Overall Study||18
1644193|NCT00763048|4017894|P1|COMPLETED|Overall Study||21
1644194|NCT00763048|4017893|P2|STARTED|Overall Study||18
1644195|NCT00763048|4017894|P1|STARTED|Overall Study||21
1644196|NCT00763035|4017918|P2|NOT COMPLETED|Second Intervention||0
1644197|NCT00763035|4017919|P1|NOT COMPLETED|Second Intervention||3
1644198|NCT00763035|4017918|P2|COMPLETED|Second Intervention||3
1644199|NCT00763035|4017919|P1|COMPLETED|Second Intervention||6
1644200|NCT00763035|4017918|P2|STARTED|Second Intervention||3
1644201|NCT00763035|4017919|P1|STARTED|Second Intervention||9
1644202|NCT00763035|4017918|P2|NOT COMPLETED|First Intervention||1
1644203|NCT00763035|4017919|P1|NOT COMPLETED|First Intervention||1
1644204|NCT00763035|4017918|P2|COMPLETED|First Intervention||3
1644205|NCT00763035|4017919|P1|COMPLETED|First Intervention||9
1644206|NCT00763035|4017918|P2|STARTED|First Intervention||4
1644207|NCT00763035|4017919|P1|STARTED|First Intervention||10
1644208|NCT00763009|4017937|P1|NOT COMPLETED|Overall Study||1
1644209|NCT00763009|4017937|P1|COMPLETED|Overall Study||7
1644210|NCT00763009|4017937|P1|STARTED|Overall Study||8
1644211|NCT00762996|4017942|P4|NOT COMPLETED|Period Two||0
1644212|NCT00762996|4017943|P3|NOT COMPLETED|Period Two||0
1644213|NCT00762996|4017944|P2|NOT COMPLETED|Period Two||0
1644214|NCT00762996|4017945|P1|NOT COMPLETED|Period Two||0
1644215|NCT00762996|4017942|P4|COMPLETED|Period Two||16
1644216|NCT00762996|4017943|P3|COMPLETED|Period Two||13
1644217|NCT00762996|4017944|P2|COMPLETED|Period Two||16
1644218|NCT00762996|4017945|P1|COMPLETED|Period Two||15
1644219|NCT00762996|4017942|P4|STARTED|Period Two||16
1644220|NCT00762996|4017943|P3|STARTED|Period Two||13
1644221|NCT00762996|4017944|P2|STARTED|Period Two||16
1644222|NCT00762996|4017945|P1|STARTED|Period Two||15
1644223|NCT00762996|4017942|P4|NOT COMPLETED|Period One||1
1644224|NCT00762996|4017943|P3|NOT COMPLETED|Period One||4
1644225|NCT00762996|4017944|P2|NOT COMPLETED|Period One||0
1644226|NCT00762996|4017945|P1|NOT COMPLETED|Period One||0
1644227|NCT00762996|4017942|P4|COMPLETED|Period One||16
1644228|NCT00762996|4017943|P3|COMPLETED|Period One||13
1644229|NCT00762996|4017944|P2|COMPLETED|Period One||16
1644230|NCT00762996|4017945|P1|COMPLETED|Period One||15
1644231|NCT00762996|4017942|P4|STARTED|Period One||17
1644232|NCT00762996|4017943|P3|STARTED|Period One||17
1644233|NCT00762996|4017944|P2|STARTED|Period One||16
1644234|NCT00762996|4017945|P1|STARTED|Period One||15
1644235|NCT00762970|4017958|P3|NOT COMPLETED|Overall Study||1
1644236|NCT00762970|4017959|P2|NOT COMPLETED|Overall Study||9
1644237|NCT00762970|4017960|P1|NOT COMPLETED|Overall Study||12
1644238|NCT00762970|4017958|P3|COMPLETED|Overall Study||46
1644239|NCT00762970|4017959|P2|COMPLETED|Overall Study||35
1644240|NCT00762970|4017960|P1|COMPLETED|Overall Study||34
1644241|NCT00762970|4017958|P3|STARTED|Overall Study||47
1644242|NCT00762970|4017959|P2|STARTED|Overall Study||44
1644243|NCT00762970|4017960|P1|STARTED|Overall Study||46
1644244|NCT00762931|4017971|P1|NOT COMPLETED|Overall Study||2
1644245|NCT00762931|4017971|P1|COMPLETED|Overall Study||23
1644246|NCT00762931|4017971|P1|STARTED|Overall Study||25
1644247|NCT00762892|4017978|P2|NOT COMPLETED|Overall Study||6
1644248|NCT00762892|4017979|P1|NOT COMPLETED|Overall Study||5
1644249|NCT00762892|4017978|P2|COMPLETED|Overall Study||8
1644250|NCT00762892|4017979|P1|COMPLETED|Overall Study||9
1644251|NCT00762892|4017978|P2|STARTED|Overall Study||14
1644252|NCT00762892|4017979|P1|STARTED|Overall Study||14
1644253|NCT00762853|4017995|P2|NOT COMPLETED|Second Treatment Period||0
1644254|NCT00762853|4017996|P1|NOT COMPLETED|Second Treatment Period||0
1644255|NCT00762853|4017995|P2|COMPLETED|Second Treatment Period||10
1644256|NCT00762853|4017996|P1|COMPLETED|Second Treatment Period||10
1644257|NCT00762853|4017995|P2|STARTED|Second Treatment Period||10
1644258|NCT00762853|4017996|P1|STARTED|Second Treatment Period||10
1644259|NCT00762853|4017995|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
1644260|NCT00762853|4017996|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
1644261|NCT00762853|4017995|P2|COMPLETED|1 Week Washout After Treatment 1||10
1644262|NCT00762853|4017996|P1|COMPLETED|1 Week Washout After Treatment 1||10
1644263|NCT00762853|4017995|P2|STARTED|1 Week Washout After Treatment 1||10
1644264|NCT00762853|4017996|P1|STARTED|1 Week Washout After Treatment 1||10
1644265|NCT00762853|4017995|P2|NOT COMPLETED|First Treatment Period||0
1644266|NCT00762853|4017996|P1|NOT COMPLETED|First Treatment Period||0
1644267|NCT00762853|4017995|P2|COMPLETED|First Treatment Period||10
1644268|NCT00762853|4017996|P1|COMPLETED|First Treatment Period||10
1644269|NCT00762853|4017995|P2|STARTED|First Treatment Period||10
1644270|NCT00762853|4017996|P1|STARTED|First Treatment Period||10
1644271|NCT00762788|4018008|P6|NOT COMPLETED|Overall Study||21
1644272|NCT00762788|4018009|P5|NOT COMPLETED|Overall Study||13
1644273|NCT00762788|4018010|P4|NOT COMPLETED|Overall Study||26
1644274|NCT00762788|4018011|P3|NOT COMPLETED|Overall Study||21
1644275|NCT00762788|4018012|P2|NOT COMPLETED|Overall Study||37
1644276|NCT00762788|4018013|P1|NOT COMPLETED|Overall Study||26
1644277|NCT00762788|4018008|P6|COMPLETED|Overall Study||31
1644278|NCT00762788|4018009|P5|COMPLETED|Overall Study||30
1644279|NCT00762788|4018010|P4|COMPLETED|Overall Study||38
1644280|NCT00762788|4018011|P3|COMPLETED|Overall Study||21
1644281|NCT00762788|4018012|P2|COMPLETED|Overall Study||21
1644282|NCT00762788|4018013|P1|COMPLETED|Overall Study||29
1644283|NCT00762788|4018008|P6|STARTED|Overall Study||52
1644284|NCT00762788|4018009|P5|STARTED|Overall Study||43
1644285|NCT00762788|4018010|P4|STARTED|Overall Study||64
1644286|NCT00762788|4018011|P3|STARTED|Overall Study||42
1644287|NCT00762788|4018012|P2|STARTED|Overall Study||58
1644288|NCT00762788|4018013|P1|STARTED|Overall Study||55
1644289|NCT00762762|4018035|P2|NOT COMPLETED|Overall Study||10
1644290|NCT00762762|4018036|P1|NOT COMPLETED|Overall Study||8
1644291|NCT00762762|4018035|P2|COMPLETED|Overall Study||20
1644292|NCT00762762|4018036|P1|COMPLETED|Overall Study||22
1644293|NCT00762762|4018035|P2|STARTED|Overall Study||30
1644294|NCT00762762|4018036|P1|STARTED|Overall Study||30
1644295|NCT00762723|4018053|P3|NOT COMPLETED|Overall Study||3
1644296|NCT00762723|4018054|P2|NOT COMPLETED|Overall Study||5
1644297|NCT00762723|4018055|P1|NOT COMPLETED|Overall Study||5
1644298|NCT00762723|4018053|P3|COMPLETED|Overall Study||0
1644299|NCT00762723|4018054|P2|COMPLETED|Overall Study||6
1644300|NCT00762723|4018055|P1|COMPLETED|Overall Study||0
1644301|NCT00762723|4018053|P3|STARTED|Overall Study||3
1644302|NCT00762723|4018054|P2|STARTED|Overall Study||11
1644303|NCT00762723|4018055|P1|STARTED|Overall Study||5
1644304|NCT00762645|4018065|P2|NOT COMPLETED|Overall Study||2
1644305|NCT00762645|4018066|P1|NOT COMPLETED|Overall Study||4
1644306|NCT00762645|4018065|P2|COMPLETED|Overall Study||12
1644307|NCT00762645|4018066|P1|COMPLETED|Overall Study||12
1644308|NCT00762645|4018065|P2|STARTED|Overall Study||14
1644309|NCT00762645|4018066|P1|STARTED|Overall Study||16
1644310|NCT00762619|4018076|P2|NOT COMPLETED|Overall Study||0
1644311|NCT00762619|4018077|P1|NOT COMPLETED|Overall Study||0
1644312|NCT00762619|4018076|P2|COMPLETED|Overall Study||50
1644313|NCT00762619|4018077|P1|COMPLETED|Overall Study||55
1644314|NCT00762619|4018076|P2|STARTED|Overall Study||50
1644315|NCT00762619|4018077|P1|STARTED|Overall Study||55
1644316|NCT00762606|4018219|P2|NOT COMPLETED|Overall Study||13
1644317|NCT00762606|4018220|P1|NOT COMPLETED|Overall Study||18
1644318|NCT00762606|4018219|P2|COMPLETED|Overall Study||38
1644319|NCT00762606|4018220|P1|COMPLETED|Overall Study||37
1644320|NCT00762606|4018219|P2|STARTED|Overall Study||51
1644321|NCT00762606|4018220|P1|STARTED|Overall Study||55
1644322|NCT00762528|4018230|P2|NOT COMPLETED|Overall Study||0
1644323|NCT00762528|4018231|P1|NOT COMPLETED|Overall Study||0
1644324|NCT00762528|4018230|P2|COMPLETED|Overall Study||25
1644325|NCT00762528|4018231|P1|COMPLETED|Overall Study||24
1644326|NCT00762528|4018230|P2|STARTED|Overall Study||25
1644327|NCT00762528|4018231|P1|STARTED|Overall Study||24
1644328|NCT00762515|4018253|P2|NOT COMPLETED|Overall Study||0
1644329|NCT00762515|4018254|P1|NOT COMPLETED|Overall Study||0
1644330|NCT00762515|4018253|P2|COMPLETED|Overall Study||22
1644331|NCT00762515|4018254|P1|COMPLETED|Overall Study||22
1644332|NCT00762515|4018253|P2|STARTED|Overall Study||22
1644333|NCT00762515|4018254|P1|STARTED|Overall Study||22
1644334|NCT00762502|4018265|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
1644335|NCT00762502|4018266|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
1644336|NCT00762502|4018267|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
1644337|NCT00762502|4018265|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
1644338|NCT00762502|4018266|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
1644339|NCT00762502|4018267|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
1644340|NCT00762502|4018265|P3|STARTED|Month 3 to Month 6 (Period 2)||23
1644341|NCT00762502|4018266|P2|STARTED|Month 3 to Month 6 (Period 2)||5
1644342|NCT00762502|4018267|P1|STARTED|Month 3 to Month 6 (Period 2)||9
1644343|NCT00762502|4018265|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
1644344|NCT00762502|4018266|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
1644345|NCT00762502|4018267|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
1644346|NCT00762502|4018265|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
1644347|NCT00762502|4018266|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
1644348|NCT00762502|4018267|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
1644349|NCT00762502|4018265|P3|STARTED|Baseline to Month 3 (Period 1)||51
1644350|NCT00762502|4018266|P2|STARTED|Baseline to Month 3 (Period 1)||25
1644351|NCT00762502|4018267|P1|STARTED|Baseline to Month 3 (Period 1)||36
1644352|NCT00762476|4018281|P2|NOT COMPLETED|Overall Study||36
1644353|NCT00762476|4018282|P1|NOT COMPLETED|Overall Study||23
1644354|NCT00762476|4018281|P2|COMPLETED|Overall Study||169
1644355|NCT00762476|4018282|P1|COMPLETED|Overall Study||183
1644356|NCT00762476|4018281|P2|STARTED|Overall Study||205
1644357|NCT00762476|4018282|P1|STARTED|Overall Study||206
1644358|NCT00762463|4018294|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
1644359|NCT00762463|4018295|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
1644360|NCT00762463|4018296|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
1644361|NCT00762463|4018297|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
1644362|NCT00762463|4018294|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
1644363|NCT00762463|4018295|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
1644364|NCT00762463|4018296|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
1644365|NCT00762463|4018297|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
1644366|NCT00762463|4018294|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
1644367|NCT00762463|4018295|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
1644368|NCT00762463|4018296|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
1644369|NCT00762463|4018297|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
1644370|NCT00762463|4018294|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
1644371|NCT00762463|4018295|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
1644372|NCT00762463|4018296|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
1644373|NCT00762463|4018297|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
1644374|NCT00762463|4018294|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
1644375|NCT00762463|4018295|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
1644376|NCT00762463|4018296|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
1644377|NCT00762463|4018297|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
1644378|NCT00762463|4018294|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
1644379|NCT00762463|4018295|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
1644380|NCT00762463|4018296|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
1644381|NCT00762463|4018297|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
1644382|NCT00762463|4018294|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1644383|NCT00762463|4018295|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1644384|NCT00762463|4018296|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
1644385|NCT00762463|4018297|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
1644386|NCT00762463|4018294|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1644387|NCT00762463|4018295|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1644388|NCT00762463|4018296|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
1644389|NCT00762463|4018297|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
1644390|NCT00762463|4018294|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
1644391|NCT00762463|4018295|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
1644392|NCT00762463|4018296|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
1644393|NCT00762463|4018297|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
1644394|NCT00762450|4018382|P3|NOT COMPLETED|3rd Treatment Period||0
1644395|NCT00762450|4018383|P2|NOT COMPLETED|3rd Treatment Period||0
1644396|NCT00762450|4018384|P1|NOT COMPLETED|3rd Treatment Period||0
1644397|NCT00762450|4018382|P3|COMPLETED|3rd Treatment Period||2
1644398|NCT00762450|4018383|P2|COMPLETED|3rd Treatment Period||2
1644399|NCT00762450|4018384|P1|COMPLETED|3rd Treatment Period||2
1644400|NCT00762450|4018382|P3|STARTED|3rd Treatment Period||2
1644401|NCT00762450|4018383|P2|STARTED|3rd Treatment Period||2
1644402|NCT00762450|4018384|P1|STARTED|3rd Treatment Period||2
1644403|NCT00762450|4018382|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
1644404|NCT00762450|4018383|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
1644405|NCT00762450|4018384|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
1644406|NCT00762450|4018382|P3|COMPLETED|Washout After 2nd Treatment Period||2
1644407|NCT00762450|4018383|P2|COMPLETED|Washout After 2nd Treatment Period||2
1644408|NCT00762450|4018384|P1|COMPLETED|Washout After 2nd Treatment Period||2
1644409|NCT00762450|4018382|P3|STARTED|Washout After 2nd Treatment Period||2
1644410|NCT00762450|4018383|P2|STARTED|Washout After 2nd Treatment Period||2
1644411|NCT00762450|4018384|P1|STARTED|Washout After 2nd Treatment Period||2
1644412|NCT00762450|4018382|P3|NOT COMPLETED|2nd Treatment Period||0
1644413|NCT00762450|4018383|P2|NOT COMPLETED|2nd Treatment Period||0
1644414|NCT00762450|4018384|P1|NOT COMPLETED|2nd Treatment Period||0
1644415|NCT00762450|4018382|P3|COMPLETED|2nd Treatment Period||2
1644416|NCT00762450|4018383|P2|COMPLETED|2nd Treatment Period||2
1644417|NCT00762450|4018384|P1|COMPLETED|2nd Treatment Period||2
1644418|NCT00762450|4018382|P3|STARTED|2nd Treatment Period||2
1644419|NCT00762450|4018383|P2|STARTED|2nd Treatment Period||2
1644420|NCT00762450|4018384|P1|STARTED|2nd Treatment Period||2
1644421|NCT00762450|4018382|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
1644422|NCT00762450|4018383|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
1644423|NCT00762450|4018384|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
1644424|NCT00762450|4018382|P3|COMPLETED|Washout After 1st Treatment Period||2
1644425|NCT00762450|4018383|P2|COMPLETED|Washout After 1st Treatment Period||2
1644426|NCT00762450|4018384|P1|COMPLETED|Washout After 1st Treatment Period||2
1644427|NCT00762450|4018382|P3|STARTED|Washout After 1st Treatment Period||2
1644428|NCT00762450|4018383|P2|STARTED|Washout After 1st Treatment Period||2
1644429|NCT00762450|4018384|P1|STARTED|Washout After 1st Treatment Period||2
1644430|NCT00762450|4018382|P3|NOT COMPLETED|1st Treatment Period||0
1644431|NCT00762450|4018383|P2|NOT COMPLETED|1st Treatment Period||0
1644432|NCT00762450|4018384|P1|NOT COMPLETED|1st Treatment Period||0
1644433|NCT00762450|4018382|P3|COMPLETED|1st Treatment Period||2
1644434|NCT00762450|4018383|P2|COMPLETED|1st Treatment Period||2
1644435|NCT00762450|4018384|P1|COMPLETED|1st Treatment Period||2
1644436|NCT00762450|4018382|P3|STARTED|1st Treatment Period||2
1644437|NCT00762450|4018383|P2|STARTED|1st Treatment Period||2
1644438|NCT00762450|4018384|P1|STARTED|1st Treatment Period||2
1644439|NCT00762424|4018394|P2|NOT COMPLETED|Overall Study||0
1644440|NCT00762424|4018395|P1|NOT COMPLETED|Overall Study||0
1644441|NCT00762424|4018394|P2|COMPLETED|Overall Study||25
1644442|NCT00762424|4018395|P1|COMPLETED|Overall Study||28
1644443|NCT00762424|4018394|P2|STARTED|Overall Study||25
1644444|NCT00762424|4018395|P1|STARTED|Overall Study||28
1644445|NCT00762411|4018403|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
1644446|NCT00762411|4018404|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
1644447|NCT00762411|4018403|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
1644448|NCT00762411|4018404|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
1644449|NCT00762411|4018403|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
1644450|NCT00762411|4018404|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
1644451|NCT00762411|4018403|P2|NOT COMPLETED|Delayed Start||26
1644452|NCT00762411|4018404|P1|NOT COMPLETED|Delayed Start||17
1644453|NCT00762411|4018403|P2|COMPLETED|Delayed Start||8
1644454|NCT00762411|4018404|P1|COMPLETED|Delayed Start||5
1644455|NCT00762411|4018403|P2|STARTED|Delayed Start||34
1644456|NCT00762411|4018404|P1|STARTED|Delayed Start||22
1644457|NCT00762411|4018403|P2|NOT COMPLETED|Initial Treatment||521
1644458|NCT00762411|4018404|P1|NOT COMPLETED|Initial Treatment||534
1644459|NCT00762411|4018403|P2|COMPLETED|Initial Treatment||34
1644460|NCT00762411|4018404|P1|COMPLETED|Initial Treatment||22
1644461|NCT00762411|4018403|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
1644462|NCT00762411|4018404|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
1644463|NCT00762411|4018403|P2|STARTED|Initial Treatment||555
1644464|NCT00762411|4018404|P1|STARTED|Initial Treatment||556
1644465|NCT00762385|4018468|P2|NOT COMPLETED|Second Intervention||3
1644466|NCT00762385|4018469|P1|NOT COMPLETED|Second Intervention||3
1644467|NCT00762385|4018468|P2|COMPLETED|Second Intervention||39
1644468|NCT00762385|4018469|P1|COMPLETED|Second Intervention||46
1644469|NCT00762385|4018468|P2|STARTED|Second Intervention||42
1644470|NCT00762385|4018469|P1|STARTED|Second Intervention||49
1644471|NCT00762385|4018468|P2|NOT COMPLETED|First Intervention||4
1644472|NCT00762385|4018469|P1|NOT COMPLETED|First Intervention||2
1644473|NCT00762385|4018468|P2|COMPLETED|First Intervention||42
1644474|NCT00762385|4018469|P1|COMPLETED|First Intervention||49
1644475|NCT00762385|4018468|P2|STARTED|First Intervention||46
1644476|NCT00762385|4018469|P1|STARTED|First Intervention||51
1644477|NCT00762359|4018481|P2|NOT COMPLETED|Overall Study||57
1644478|NCT00762359|4018482|P1|NOT COMPLETED|Overall Study||59
1644479|NCT00762359|4018481|P2|COMPLETED|Overall Study||178
1644480|NCT00762359|4018482|P1|COMPLETED|Overall Study||167
1644481|NCT00762359|4018481|P2|STARTED|Overall Study||235
1644482|NCT00762359|4018482|P1|STARTED|Overall Study||226
1644483|NCT00762320|4018582|P1|NOT COMPLETED|Overall Study||0
1644484|NCT00762320|4018582|P1|COMPLETED|Overall Study||8
1644485|NCT00762320|4018582|P1|STARTED|Overall Study||8
1644486|NCT00762268|4018599|P2|NOT COMPLETED|Overall Study||2
1644487|NCT00762268|4018600|P1|NOT COMPLETED|Overall Study||1
1644488|NCT00762268|4018599|P2|COMPLETED|Overall Study||8
1644489|NCT00762268|4018600|P1|COMPLETED|Overall Study||9
1644490|NCT00762268|4018599|P2|STARTED|Overall Study||10
1644491|NCT00762268|4018600|P1|STARTED|Overall Study||10
1644492|NCT00762229|4018608|P2|NOT COMPLETED|Overall Study||2
1644493|NCT00762229|4018609|P1|NOT COMPLETED|Overall Study||1
1644494|NCT00762229|4018608|P2|COMPLETED|Overall Study||22
1644495|NCT00762229|4018609|P1|COMPLETED|Overall Study||14
1644496|NCT00762229|4018608|P2|STARTED|Overall Study||24
1644497|NCT00762229|4018609|P1|STARTED|Overall Study||15
1644498|NCT00762216|4018617|P1|NOT COMPLETED|Overall Study||0
1644499|NCT00762216|4018617|P1|COMPLETED|Overall Study||71
1644500|NCT00762216|4018617|P1|STARTED|Overall Study||71
1644501|NCT00762177|4018625|P3|NOT COMPLETED|3rd Treatment Period||0
1644502|NCT00762177|4018626|P2|NOT COMPLETED|3rd Treatment Period||0
1644503|NCT00762177|4018627|P1|NOT COMPLETED|3rd Treatment Period||0
1644504|NCT00762177|4018625|P3|COMPLETED|3rd Treatment Period||8
1644505|NCT00762177|4018626|P2|COMPLETED|3rd Treatment Period||8
1644506|NCT00762177|4018627|P1|COMPLETED|3rd Treatment Period||8
1644507|NCT00762177|4018625|P3|STARTED|3rd Treatment Period||8
1644508|NCT00762177|4018626|P2|STARTED|3rd Treatment Period||8
1644509|NCT00762177|4018627|P1|STARTED|3rd Treatment Period||8
1644510|NCT00762177|4018625|P3|NOT COMPLETED|Washout After 2nd Treatment||0
1644511|NCT00762177|4018626|P2|NOT COMPLETED|Washout After 2nd Treatment||0
1644512|NCT00762177|4018627|P1|NOT COMPLETED|Washout After 2nd Treatment||0
1644513|NCT00762177|4018625|P3|COMPLETED|Washout After 2nd Treatment||8
1644514|NCT00762177|4018626|P2|COMPLETED|Washout After 2nd Treatment||8
1644515|NCT00762177|4018627|P1|COMPLETED|Washout After 2nd Treatment||8
1644516|NCT00762177|4018625|P3|STARTED|Washout After 2nd Treatment||8
1644517|NCT00762177|4018626|P2|STARTED|Washout After 2nd Treatment||8
1644518|NCT00762177|4018627|P1|STARTED|Washout After 2nd Treatment||8
1644519|NCT00762177|4018625|P3|NOT COMPLETED|2nd Treatment Period||0
1644520|NCT00762177|4018626|P2|NOT COMPLETED|2nd Treatment Period||0
1644521|NCT00762177|4018627|P1|NOT COMPLETED|2nd Treatment Period||0
1644522|NCT00762177|4018625|P3|COMPLETED|2nd Treatment Period||8
1644523|NCT00762177|4018626|P2|COMPLETED|2nd Treatment Period||8
1644524|NCT00762177|4018627|P1|COMPLETED|2nd Treatment Period||8
1644525|NCT00762177|4018625|P3|STARTED|2nd Treatment Period||8
1644526|NCT00762177|4018626|P2|STARTED|2nd Treatment Period||8
1644527|NCT00762177|4018627|P1|STARTED|2nd Treatment Period||8
1644528|NCT00762177|4018625|P3|NOT COMPLETED|Washout After 1st Treatment||0
1644529|NCT00762177|4018626|P2|NOT COMPLETED|Washout After 1st Treatment||0
1644530|NCT00762177|4018627|P1|NOT COMPLETED|Washout After 1st Treatment||0
1644531|NCT00762177|4018625|P3|COMPLETED|Washout After 1st Treatment||8
1644532|NCT00762177|4018626|P2|COMPLETED|Washout After 1st Treatment||8
1644533|NCT00762177|4018627|P1|COMPLETED|Washout After 1st Treatment||8
1644534|NCT00762177|4018625|P3|STARTED|Washout After 1st Treatment||8
1644535|NCT00762177|4018626|P2|STARTED|Washout After 1st Treatment||8
1644536|NCT00762177|4018627|P1|STARTED|Washout After 1st Treatment||8
1644537|NCT00762177|4018625|P3|NOT COMPLETED|1st Treatment Period||0
1644538|NCT00762177|4018626|P2|NOT COMPLETED|1st Treatment Period||0
1644539|NCT00762177|4018627|P1|NOT COMPLETED|1st Treatment Period||0
1644540|NCT00762177|4018625|P3|COMPLETED|1st Treatment Period||8
1644541|NCT00762177|4018626|P2|COMPLETED|1st Treatment Period||8
1644542|NCT00762177|4018627|P1|COMPLETED|1st Treatment Period||8
1644543|NCT00762177|4018625|P3|STARTED|1st Treatment Period||8
1644544|NCT00762177|4018626|P2|STARTED|1st Treatment Period||8
1644545|NCT00762177|4018627|P1|STARTED|1st Treatment Period||8
1644546|NCT00762164|4018706|P2|NOT COMPLETED|Overall Study||2
1644547|NCT00762164|4018707|P1|NOT COMPLETED|Overall Study||3
1644548|NCT00762164|4018706|P2|COMPLETED|Overall Study||15
1644549|NCT00762164|4018707|P1|COMPLETED|Overall Study||14
1644550|NCT00762164|4018706|P2|STARTED|Overall Study||17
1644551|NCT00762164|4018707|P1|STARTED|Overall Study||17
1644552|NCT00762086|4018717|P2|NOT COMPLETED|Overall Study||4
1644553|NCT00762086|4018718|P1|NOT COMPLETED|Overall Study||6
1644554|NCT00762086|4018717|P2|COMPLETED|Overall Study||24
1644555|NCT00762086|4018718|P1|COMPLETED|Overall Study||33
1644556|NCT00762086|4018717|P2|STARTED|Overall Study||28
1644557|NCT00762086|4018718|P1|STARTED|Overall Study||39
1644558|NCT00762073|4018728|P4|NOT COMPLETED|Overall Study||3
1644559|NCT00762073|4018729|P3|NOT COMPLETED|Overall Study||2
1644560|NCT00762073|4018730|P2|NOT COMPLETED|Overall Study||4
1644561|NCT00762073|4018731|P1|NOT COMPLETED|Overall Study||4
1644562|NCT00762073|4018728|P4|COMPLETED|Overall Study||17
1644563|NCT00762073|4018729|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
1644564|NCT00762073|4018730|P2|COMPLETED|Overall Study||17
1644565|NCT00762073|4018731|P1|COMPLETED|Overall Study||17
1644566|NCT00762073|4018728|P4|STARTED|Overall Study||20
1644567|NCT00762073|4018729|P3|STARTED|Overall Study||20
1644568|NCT00762073|4018730|P2|STARTED|Overall Study||21
1644569|NCT00762073|4018731|P1|STARTED|Overall Study||21
1644570|NCT00762034|4018795|P2|NOT COMPLETED|Maintenance Period||298
1644571|NCT00762034|4018796|P1|NOT COMPLETED|Maintenance Period||294
1644572|NCT00762034|4018795|P2|COMPLETED|Maintenance Period||0
1644573|NCT00762034|4018796|P1|COMPLETED|Maintenance Period||0
1644574|NCT00762034|4018795|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
1644575|NCT00762034|4018796|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
1644576|NCT00762034|4018795|P2|STARTED|Maintenance Period||298
1644577|NCT00762034|4018796|P1|STARTED|Maintenance Period||294
1644578|NCT00762034|4018795|P2|NOT COMPLETED|Induction Period||169
1644579|NCT00762034|4018796|P1|NOT COMPLETED|Induction Period||178
1644580|NCT00762034|4018795|P2|COMPLETED|Induction Period||298
1644581|NCT00762034|4018796|P1|COMPLETED|Induction Period||294
1644582|NCT00762034|4018795|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
1644583|NCT00762034|4018796|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
1644584|NCT00762034|4018795|P2|STARTED|Induction Period||467
1644585|NCT00762034|4018796|P1|STARTED|Induction Period||472
1644586|NCT00762021|4018855|P2|NOT COMPLETED|Overall Study||8
1644587|NCT00762021|4018856|P1|NOT COMPLETED|Overall Study||8
1644588|NCT00762021|4018855|P2|COMPLETED|Overall Study||44
1644589|NCT00762021|4018856|P1|COMPLETED|Overall Study||44
1644590|NCT00762021|4018855|P2|STARTED|Overall Study||52
1644591|NCT00762021|4018856|P1|STARTED|Overall Study||52
1644592|NCT00761969|4018868|P2|NOT COMPLETED|Overall Study||140
1644593|NCT00761969|4018869|P1|NOT COMPLETED|Overall Study||200
1644594|NCT00761969|4018868|P2|COMPLETED|Overall Study||573
1644595|NCT00761969|4018869|P1|COMPLETED|Overall Study||542
1644596|NCT00761969|4018868|P2|STARTED|Overall Study||713
1644597|NCT00761969|4018869|P1|STARTED|Overall Study||742
1644598|NCT00761956|4018879|P2|NOT COMPLETED|Overall Study||54
1644599|NCT00761956|4018880|P1|NOT COMPLETED|Overall Study||35
1644600|NCT00761956|4018879|P2|COMPLETED|Overall Study||48
1644601|NCT00761956|4018880|P1|COMPLETED|Overall Study||52
1644602|NCT00761956|4018879|P2|STARTED|Overall Study||102
1644603|NCT00761956|4018880|P1|STARTED|Overall Study||87
1644604|NCT00761930|4018891|P3|NOT COMPLETED|Overall Study||0
1644605|NCT00761930|4018892|P2|NOT COMPLETED|Overall Study||0
1644606|NCT00761930|4018893|P1|NOT COMPLETED|Overall Study||0
1644607|NCT00761930|4018891|P3|COMPLETED|Overall Study||35
1644608|NCT00761930|4018892|P2|COMPLETED|Overall Study||34
1644609|NCT00761930|4018893|P1|COMPLETED|Overall Study||34
1644610|NCT00761930|4018891|P3|STARTED|Overall Study||35
1644611|NCT00761930|4018892|P2|STARTED|Overall Study||34
1644612|NCT00761930|4018893|P1|STARTED|Overall Study||34
1644613|NCT00761865|4018909|P2|NOT COMPLETED|Overall Study||7
1644614|NCT00761865|4018910|P1|NOT COMPLETED|Overall Study||8
1644615|NCT00761865|4018909|P2|COMPLETED|Overall Study||11
1644616|NCT00761865|4018910|P1|COMPLETED|Overall Study||8
1644617|NCT00761865|4018909|P2|STARTED|Overall Study||18
1644618|NCT00761865|4018910|P1|STARTED|Overall Study||16
1644619|NCT00761813|4018920|P2|NOT COMPLETED|Overall Study||14
1644620|NCT00761813|4018921|P1|NOT COMPLETED|Overall Study||15
1644621|NCT00761813|4018920|P2|COMPLETED|Overall Study||537
1644622|NCT00761813|4018921|P1|COMPLETED|Overall Study||542
1644623|NCT00761813|4018920|P2|STARTED|Overall Study||551
1644624|NCT00761813|4018921|P1|STARTED|Overall Study||557
1644625|NCT00761774|4018931|P1|NOT COMPLETED|Overall Study||79
1644626|NCT00761774|4018931|P1|COMPLETED|Overall Study||29
1644627|NCT00761774|4018931|P1|STARTED|Overall Study||108
1644628|NCT00761761|4018942|P2|NOT COMPLETED|Overall Study||1
1644629|NCT00761761|4018943|P1|NOT COMPLETED|Overall Study||6
1644630|NCT00761761|4018942|P2|COMPLETED|Overall Study||29
1644631|NCT00761761|4018943|P1|COMPLETED|Overall Study||24
1644632|NCT00761761|4018942|P2|STARTED|Overall Study||30
1644633|NCT00761761|4018943|P1|STARTED|Overall Study||30
1644634|NCT00761748|4018955|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
1644635|NCT00761748|4018956|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
1644636|NCT00761748|4018955|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
1644637|NCT00761748|4018956|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
1644638|NCT00761748|4018955|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
1644639|NCT00761748|4018956|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
1644640|NCT00761748|4018955|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
1644641|NCT00761748|4018956|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
1644642|NCT00761748|4018955|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
1644643|NCT00761748|4018956|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
1644644|NCT00761748|4018955|P2|STARTED|First Intervention (21 +/- 3 Days)||10
1644645|NCT00761748|4018956|P1|STARTED|First Intervention (21 +/- 3 Days)||20
1644646|NCT00761735|4018962|P1|NOT COMPLETED|Overall Study||14
1644647|NCT00761735|4018962|P1|COMPLETED|Overall Study||80
1644648|NCT00761735|4018962|P1|STARTED|Overall Study||94
1644649|NCT00761631|4018978|P6|NOT COMPLETED|Overall Study||5
1644650|NCT00761631|4018979|P5|NOT COMPLETED|Overall Study||22
1644651|NCT00761631|4018980|P4|NOT COMPLETED|Overall Study||3
1644652|NCT00761631|4018981|P3|NOT COMPLETED|Overall Study||16
1644653|NCT00761631|4018982|P2|NOT COMPLETED|Overall Study||7
1644654|NCT00761631|4018983|P1|NOT COMPLETED|Overall Study||15
1644655|NCT00761631|4018978|P6|COMPLETED|Overall Study||294
1644656|NCT00761631|4018979|P5|COMPLETED|Overall Study||277
1644657|NCT00761631|4018980|P4|COMPLETED|Overall Study||116
1644658|NCT00761631|4018981|P3|COMPLETED|Overall Study||160
1644659|NCT00761631|4018982|P2|COMPLETED|Overall Study||174
1644660|NCT00761631|4018983|P1|COMPLETED|Overall Study||111
1644661|NCT00761631|4018978|P6|Vaccinated Dose 2|Overall Study||0
1644662|NCT00761631|4018979|P5|Vaccinated Dose 2|Overall Study||0
1644663|NCT00761631|4018980|P4|Vaccinated Dose 2|Overall Study||0
1644664|NCT00761631|4018981|P3|Vaccinated Dose 2|Overall Study||165
1644665|NCT00761631|4018982|P2|Vaccinated Dose 2|Overall Study||0
1644666|NCT00761631|4018983|P1|Vaccinated Dose 2|Overall Study||112
1644667|NCT00761631|4018978|P6|Vaccinated Dose 1|Overall Study||298
1644668|NCT00761631|4018979|P5|Vaccinated Dose 1|Overall Study||294
1644669|NCT00761631|4018980|P4|Vaccinated Dose 1|Overall Study||118
1644670|NCT00761631|4018981|P3|Vaccinated Dose 1|Overall Study||175
1644671|NCT00761631|4018982|P2|Vaccinated Dose 1|Overall Study||179
1644672|NCT00761631|4018983|P1|Vaccinated Dose 1|Overall Study||124
1644673|NCT00761631|4018978|P6|STARTED|Overall Study||299
1644674|NCT00761631|4018979|P5|STARTED|Overall Study||299
1644675|NCT00761631|4018980|P4|STARTED|Overall Study||119
1644676|NCT00761631|4018981|P3|STARTED|Overall Study||176
1644677|NCT00761631|4018982|P2|STARTED|Overall Study||181
1644678|NCT00761631|4018983|P1|STARTED|Overall Study||126
1644679|NCT00761605|4019018|P1|NOT COMPLETED|Overall Study||141
1644680|NCT00761605|4019018|P1|COMPLETED|Overall Study||246
1644681|NCT00761605|4019018|P1|STARTED|Overall Study||387
1644682|NCT00761592|4019047|P2|NOT COMPLETED|Overall Study||1
1644683|NCT00761592|4019048|P1|NOT COMPLETED|Overall Study||1
1644684|NCT00761592|4019047|P2|COMPLETED|Overall Study||32
1644685|NCT00761592|4019048|P1|COMPLETED|Overall Study||31
1644686|NCT00761592|4019047|P2|STARTED|Overall Study||33
1644687|NCT00761592|4019048|P1|STARTED|Overall Study||32
1644688|NCT00761579|4019062|P1|NOT COMPLETED|Overall Study||92
1644689|NCT00761579|4019062|P1|COMPLETED|Overall Study||98
1644690|NCT00761579|4019062|P1|STARTED|Overall Study||190
1644691|NCT00761527|4019095|P1|NOT COMPLETED|Overall Study||22
1644692|NCT00761527|4019095|P1|COMPLETED|Overall Study||2958
1644693|NCT00761527|4019095|P1|Received One Dose of Study Medication|Overall Study||2978
1644694|NCT00761527|4019095|P1|STARTED|Overall Study||2980
1644695|NCT00761514|4019102|P1|NOT COMPLETED|Overall Study||7
1644696|NCT00761514|4019102|P1|COMPLETED|Overall Study||7
1644697|NCT00761514|4019102|P1|STARTED|Overall Study||14
1644698|NCT00761462|4019109|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
1644699|NCT00761462|4019110|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
1644700|NCT00761462|4019109|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
1644701|NCT00761462|4019110|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
1644702|NCT00761462|4019109|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
1644703|NCT00761462|4019110|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
1644704|NCT00761462|4019109|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
1644705|NCT00761462|4019110|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
1644706|NCT00761462|4019109|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
1644707|NCT00761462|4019110|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
1644708|NCT00761462|4019109|P2|NOT COMPLETED|Treatment||12
1644709|NCT00761462|4019110|P1|NOT COMPLETED|Treatment||23
1644710|NCT00761462|4019109|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
1644711|NCT00761462|4019110|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
1644712|NCT00761462|4019109|P2|STARTED|Treatment|Patients enrolled in study group|519
1644713|NCT00761462|4019110|P1|STARTED|Treatment|Patients enrolled in study group|510
1644714|NCT00761345|4019118|P1|NOT COMPLETED|Overall Study||3
1644715|NCT00761345|4019118|P1|COMPLETED|Overall Study||24
1644716|NCT00761345|4019118|P1|STARTED|Overall Study||27
1644717|NCT00761319|4019124|P2|NOT COMPLETED|Overall Study||34
1644718|NCT00761319|4019125|P1|NOT COMPLETED|Overall Study||48
1644719|NCT00761319|4019124|P2|COMPLETED|Overall Study||318
1644720|NCT00761319|4019125|P1|COMPLETED|Overall Study||305
1644721|NCT00761319|4019124|P2|STARTED|Overall Study||352
1644722|NCT00761319|4019125|P1|STARTED|Overall Study||353
1644723|NCT00761306|4019133|P1|NOT COMPLETED|Overall Study||20
1644724|NCT00761306|4019133|P1|COMPLETED|Overall Study||54
1644725|NCT00761306|4019133|P1|STARTED|Overall Study||74
1644726|NCT00761280|4019144|P2|NOT COMPLETED|First Dose to End of Study||11
1644727|NCT00761280|4019145|P1|NOT COMPLETED|First Dose to End of Study||12
1644728|NCT00761280|4019144|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
1644729|NCT00761280|4019145|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
1644730|NCT00761280|4019144|P2|STARTED|First Dose to End of Study||11
1644731|NCT00761280|4019145|P1|STARTED|First Dose to End of Study||12
1644732|NCT00761280|4019144|P2|NOT COMPLETED|Randomization to First Dose||2
1644733|NCT00761280|4019145|P1|NOT COMPLETED|Randomization to First Dose||2
1644734|NCT00761280|4019144|P2|COMPLETED|Randomization to First Dose||11
1644735|NCT00761280|4019145|P1|COMPLETED|Randomization to First Dose||12
1644736|NCT00761280|4019144|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
1644737|NCT00761280|4019145|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
1644738|NCT00761280|4019144|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
1644739|NCT00761280|4019145|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
1644740|NCT00761280|4019144|P2|STARTED|Randomization to First Dose||13
1644741|NCT00761280|4019145|P1|STARTED|Randomization to First Dose||14
1644742|NCT00761267|4019176|P3|NOT COMPLETED|Overall Study||6
1644743|NCT00761267|4019177|P2|NOT COMPLETED|Overall Study||4
1644744|NCT00761267|4019178|P1|NOT COMPLETED|Overall Study||2
1644745|NCT00761267|4019176|P3|COMPLETED|Overall Study||24
1644746|NCT00761267|4019177|P2|COMPLETED|Overall Study||16
1644747|NCT00761267|4019178|P1|COMPLETED|Overall Study||18
1644748|NCT00761267|4019176|P3|Treated|Overall Study||30
1644749|NCT00761267|4019177|P2|Treated|Overall Study||19
1644750|NCT00761267|4019178|P1|Treated|Overall Study||19
1644751|NCT00761267|4019176|P3|STARTED|Overall Study||30
1644752|NCT00761267|4019177|P2|STARTED|Overall Study||20
1644753|NCT00761267|4019178|P1|STARTED|Overall Study||20
1644754|NCT00761215|4019208|P3|NOT COMPLETED|Overall Study||8
1644755|NCT00761215|4019209|P2|NOT COMPLETED|Overall Study||4
1644756|NCT00761215|4019210|P1|NOT COMPLETED|Overall Study||9
1644757|NCT00761215|4019208|P3|COMPLETED|Overall Study||56
1644758|NCT00761215|4019209|P2|COMPLETED|Overall Study||60
1644759|NCT00761215|4019210|P1|COMPLETED|Overall Study||55
1644760|NCT00761215|4019208|P3|STARTED|Overall Study||64
1644761|NCT00761215|4019209|P2|STARTED|Overall Study||64
1644762|NCT00761215|4019210|P1|STARTED|Overall Study||64
1644763|NCT00761202|4019235|P2|NOT COMPLETED|Overall Study||2
1644764|NCT00761202|4019236|P1|NOT COMPLETED|Overall Study||1
1644765|NCT00761202|4019235|P2|COMPLETED|Overall Study||26
1644766|NCT00761202|4019236|P1|COMPLETED|Overall Study||21
1644767|NCT00761202|4019235|P2|STARTED|Overall Study||28
1644768|NCT00761202|4019236|P1|STARTED|Overall Study||22
1644769|NCT00761189|4019252|P1|NOT COMPLETED|Overall Study||185
1644770|NCT00761189|4019252|P1|COMPLETED|Overall Study||306
1644771|NCT00761189|4019252|P1|STARTED|Overall Study||491
1644772|NCT00761176|4019269|P2|NOT COMPLETED|Overall Study||1
1644773|NCT00761176|4019270|P1|NOT COMPLETED|Overall Study||2
1644774|NCT00761176|4019269|P2|COMPLETED|Overall Study||3
1644775|NCT00761176|4019270|P1|COMPLETED|Overall Study||2
1644776|NCT00761176|4019269|P2|STARTED|Overall Study||4
1644777|NCT00761176|4019270|P1|STARTED|Overall Study||4
1644778|NCT00761150|4019279|P3|NOT COMPLETED|Double-blind Period||29
1644779|NCT00761150|4019280|P2|NOT COMPLETED|Double-blind Period||14
1644780|NCT00761150|4019281|P1|NOT COMPLETED|Double-blind Period||0
1644781|NCT00761150|4019279|P3|COMPLETED|Double-blind Period||89
1644782|NCT00761150|4019280|P2|COMPLETED|Double-blind Period||106
1644783|NCT00761150|4019281|P1|COMPLETED|Double-blind Period||0
1644784|NCT00761150|4019279|P3|STARTED|Double-blind Period||118
1644785|NCT00761150|4019280|P2|STARTED|Double-blind Period||120
1644786|NCT00761150|4019281|P1|STARTED|Double-blind Period||0
1644787|NCT00761150|4019279|P3|NOT COMPLETED|Open-label Period||0
1644788|NCT00761150|4019280|P2|NOT COMPLETED|Open-label Period||0
1644789|NCT00761150|4019281|P1|NOT COMPLETED|Open-label Period||70
1644790|NCT00761150|4019279|P3|COMPLETED|Open-label Period||0
1644791|NCT00761150|4019280|P2|COMPLETED|Open-label Period||0
1644792|NCT00761150|4019281|P1|COMPLETED|Open-label Period||238
1644793|NCT00761150|4019279|P3|STARTED|Open-label Period||0
1644794|NCT00761150|4019280|P2|STARTED|Open-label Period||0
1644795|NCT00761150|4019281|P1|STARTED|Open-label Period||308
1644796|NCT00761137|4019290|P1|NOT COMPLETED|Overall Study||0
1644797|NCT00761137|4019290|P1|COMPLETED|Overall Study||19
1644798|NCT00761137|4019290|P1|3 mg Tropicamide|Overall Study||19
1644799|NCT00761137|4019290|P1|1 mg Tropicamide|Overall Study||19
1644800|NCT00761137|4019290|P1|0.3 mg Tropicamide|Overall Study||19
1644801|NCT00761137|4019290|P1|Placebo|Overall Study||19
1644802|NCT00761137|4019290|P1|STARTED|Overall Study||19
1644803|NCT00761007|4019305|P4|NOT COMPLETED|Overall Study||7
1644804|NCT00761007|4019306|P3|NOT COMPLETED|Overall Study||18
1644805|NCT00761007|4019307|P2|NOT COMPLETED|Overall Study||11
1644806|NCT00761007|4019308|P1|NOT COMPLETED|Overall Study||13
1644807|NCT00761007|4019305|P4|COMPLETED|Overall Study||131
1644808|NCT00761007|4019306|P3|COMPLETED|Overall Study||121
1644809|NCT00761007|4019307|P2|COMPLETED|Overall Study||124
1644810|NCT00761007|4019308|P1|COMPLETED|Overall Study||129
1644811|NCT00761007|4019305|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
1644812|NCT00761007|4019306|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
1644813|NCT00761007|4019307|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
1644814|NCT00761007|4019308|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
1644815|NCT00761007|4019305|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
1644816|NCT00761007|4019306|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
1644817|NCT00761007|4019307|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
1644818|NCT00761007|4019308|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
1644819|NCT00761007|4019305|P4|STARTED|Overall Study||138
1644820|NCT00761007|4019306|P3|STARTED|Overall Study||139
1644821|NCT00761007|4019307|P2|STARTED|Overall Study||135
1644822|NCT00761007|4019308|P1|STARTED|Overall Study||142
1644823|NCT00760877|4019332|P2|NOT COMPLETED|Overall Study||26
1644824|NCT00760877|4019333|P1|NOT COMPLETED|Overall Study||45
1644825|NCT00760877|4019332|P2|COMPLETED|Overall Study||77
1644826|NCT00760877|4019333|P1|COMPLETED|Overall Study||59
1644827|NCT00760877|4019332|P2|Safety Set|Overall Study||103
1644828|NCT00760877|4019333|P1|Safety Set|Overall Study||101
1644829|NCT00760877|4019332|P2|Cross-over to Nilotinib|Overall Study||46
1644830|NCT00760877|4019333|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
1644831|NCT00760877|4019332|P2|STARTED|Overall Study||103
1644832|NCT00760877|4019333|P1|STARTED|Overall Study||104
1644833|NCT00760838|4019351|P2|NOT COMPLETED|Overall Study||2
1644834|NCT00760838|4019352|P1|NOT COMPLETED|Overall Study||5
1644835|NCT00760838|4019351|P2|COMPLETED|Overall Study||53
1644836|NCT00760838|4019352|P1|COMPLETED|Overall Study||49
1644837|NCT00760838|4019351|P2|STARTED|Overall Study||55
1644838|NCT00760838|4019352|P1|STARTED|Overall Study||54
1644839|NCT00760747|4019370|P2|NOT COMPLETED|Study Period III||3
1644840|NCT00760747|4019371|P1|NOT COMPLETED|Study Period III||3
1644841|NCT00760747|4019370|P2|COMPLETED|Study Period III||38
1644842|NCT00760747|4019371|P1|COMPLETED|Study Period III||41
1644843|NCT00760747|4019370|P2|STARTED|Study Period III||41
1644844|NCT00760747|4019371|P1|STARTED|Study Period III||44
1644845|NCT00760747|4019370|P2|NOT COMPLETED|Study Period II||14
1644846|NCT00760747|4019371|P1|NOT COMPLETED|Study Period II||13
1644847|NCT00760747|4019370|P2|COMPLETED|Study Period II||41
1644848|NCT00760747|4019371|P1|COMPLETED|Study Period II||44
1644849|NCT00760747|4019370|P2|Received at Least One Dose of Study Drug|Study Period II||54
1644850|NCT00760747|4019371|P1|Received at Least One Dose of Study Drug|Study Period II||57
1644851|NCT00760747|4019370|P2|STARTED|Study Period II||55
1644852|NCT00760747|4019371|P1|STARTED|Study Period II||57
1644853|NCT00760669|4019399|P1|NOT COMPLETED|Overall Study||30
1644854|NCT00760669|4019399|P1|COMPLETED|Overall Study||1031
1644855|NCT00760669|4019399|P1|STARTED|Overall Study||1061
1644856|NCT00760617|4019416|P3|NOT COMPLETED|Overall Study||5
1644857|NCT00760617|4019417|P2|NOT COMPLETED|Overall Study||2
1644858|NCT00760617|4019418|P1|NOT COMPLETED|Overall Study||5
1644859|NCT00760617|4019416|P3|COMPLETED|Overall Study||111
1644860|NCT00760617|4019417|P2|COMPLETED|Overall Study||142
1644861|NCT00760617|4019418|P1|COMPLETED|Overall Study||261
1644862|NCT00760617|4019416|P3|STARTED|Overall Study||116
1644863|NCT00760617|4019417|P2|STARTED|Overall Study||144
1644864|NCT00760617|4019418|P1|STARTED|Overall Study||266
1644865|NCT00760578|4019493|P4|NOT COMPLETED|Overall Study||4
1644866|NCT00760578|4019494|P3|NOT COMPLETED|Overall Study||5
1644867|NCT00760578|4019495|P2|NOT COMPLETED|Overall Study||2
1644868|NCT00760578|4019496|P1|NOT COMPLETED|Overall Study||3
1644869|NCT00760578|4019493|P4|COMPLETED|Overall Study||18
1644870|NCT00760578|4019494|P3|COMPLETED|Overall Study||16
1644871|NCT00760578|4019495|P2|COMPLETED|Overall Study||19
1644872|NCT00760578|4019496|P1|COMPLETED|Overall Study||19
1644873|NCT00760578|4019493|P4|Entered Drug Treatment Period|Overall Study||22
1644874|NCT00760578|4019494|P3|Entered Drug Treatment Period|Overall Study||19
1644875|NCT00760578|4019495|P2|Entered Drug Treatment Period|Overall Study||20
1644876|NCT00760578|4019496|P1|Entered Drug Treatment Period|Overall Study||21
1644877|NCT00760578|4019493|P4|STARTED|Overall Study||22
1644878|NCT00760578|4019494|P3|STARTED|Overall Study||21
1644879|NCT00760578|4019495|P2|STARTED|Overall Study||21
1644880|NCT00760578|4019496|P1|STARTED|Overall Study||22
1644881|NCT00760552|4019532|P2|NOT COMPLETED|Overall Study||10
1644882|NCT00760552|4019533|P1|NOT COMPLETED|Overall Study||13
1644883|NCT00760552|4019532|P2|COMPLETED|Overall Study||52
1644884|NCT00760552|4019533|P1|COMPLETED|Overall Study||48
1644885|NCT00760552|4019532|P2|STARTED|Overall Study||62
1644886|NCT00760552|4019533|P1|STARTED|Overall Study||61
1644887|NCT00760526|4019541|P2|NOT COMPLETED|Overall Study||4
1644888|NCT00760526|4019542|P1|NOT COMPLETED|Overall Study||5
1644889|NCT00760526|4019541|P2|COMPLETED|Overall Study||68
1644890|NCT00760526|4019542|P1|COMPLETED|Overall Study||69
1644891|NCT00760526|4019541|P2|STARTED|Overall Study||72
1644892|NCT00760526|4019542|P1|STARTED|Overall Study||74
1644893|NCT00760487|4019567|P1|NOT COMPLETED|Overall Study||3
1644894|NCT00760487|4019567|P1|COMPLETED|Overall Study||117
1644895|NCT00760487|4019567|P1|STARTED|Overall Study||120
1644896|NCT00760474|4019573|P2|NOT COMPLETED|Period 2 (P2)||1
1644897|NCT00760474|4019574|P1|NOT COMPLETED|Period 2 (P2)||1
1644898|NCT00760474|4019573|P2|COMPLETED|Period 2 (P2)||11
1644899|NCT00760474|4019574|P1|COMPLETED|Period 2 (P2)||11
1644900|NCT00760474|4019573|P2|STARTED|Period 2 (P2)||12
1644901|NCT00760474|4019574|P1|STARTED|Period 2 (P2)||12
1644902|NCT00760474|4019573|P2|NOT COMPLETED|Placebo Washout Period||1
1644903|NCT00760474|4019574|P1|NOT COMPLETED|Placebo Washout Period||0
1644904|NCT00760474|4019573|P2|COMPLETED|Placebo Washout Period||12
1644905|NCT00760474|4019574|P1|COMPLETED|Placebo Washout Period||12
1644906|NCT00760474|4019573|P2|STARTED|Placebo Washout Period||13
1644907|NCT00760474|4019574|P1|STARTED|Placebo Washout Period||12
1644908|NCT00760474|4019573|P2|NOT COMPLETED|Period 1 (P1)||1
1644909|NCT00760474|4019574|P1|NOT COMPLETED|Period 1 (P1)||1
1644910|NCT00760474|4019573|P2|COMPLETED|Period 1 (P1)||13
1644911|NCT00760474|4019574|P1|COMPLETED|Period 1 (P1)||12
1644912|NCT00760474|4019573|P2|Overall Number of Unique Participants|Period 1 (P1)||13
1644913|NCT00760474|4019574|P1|Overall Number of Unique Participants|Period 1 (P1)||12
1644914|NCT00760474|4019573|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
1644915|NCT00760474|4019574|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
1644916|NCT00760474|4019573|P2|STARTED|Period 1 (P1)||14
1644917|NCT00760474|4019574|P1|STARTED|Period 1 (P1)||13
1644918|NCT00760461|4019610|P1|NOT COMPLETED|Overall Study||44
1644919|NCT00760461|4019610|P1|COMPLETED|Overall Study||0
1644920|NCT00760461|4019610|P1|STARTED|Overall Study||44
1644921|NCT00760435|4019616|P2|NOT COMPLETED|Overall Study||5
1644922|NCT00760435|4019617|P1|NOT COMPLETED|Overall Study||4
1644923|NCT00760435|4019616|P2|COMPLETED|Overall Study||93
1644924|NCT00760435|4019617|P1|COMPLETED|Overall Study||94
1644925|NCT00760435|4019616|P2|STARTED|Overall Study||98
1644926|NCT00760435|4019617|P1|STARTED|Overall Study||98
1644927|NCT00760383|4019631|P2|NOT COMPLETED|Overall Study||7
1644928|NCT00760383|4019632|P1|NOT COMPLETED|Overall Study||5
1644929|NCT00760383|4019631|P2|COMPLETED|Overall Study||12
1644930|NCT00760383|4019632|P1|COMPLETED|Overall Study||16
1644931|NCT00760383|4019631|P2|STARTED|Overall Study||19
1644932|NCT00760383|4019632|P1|STARTED|Overall Study||21
1644933|NCT00760266|4019644|P2|NOT COMPLETED|Overall Study||18
1644934|NCT00760266|4019645|P1|NOT COMPLETED|Overall Study||24
1644935|NCT00760266|4019644|P2|COMPLETED|Overall Study||205
1644936|NCT00760266|4019645|P1|COMPLETED|Overall Study||204
1644937|NCT00760266|4019644|P2|STARTED|Overall Study||223
1644938|NCT00760266|4019645|P1|STARTED|Overall Study||228
1644939|NCT00760214|4019662|P3|NOT COMPLETED|Overall Study||41
1644940|NCT00760214|4019663|P2|NOT COMPLETED|Overall Study||30
1644941|NCT00760214|4019664|P1|NOT COMPLETED|Overall Study||30
1644942|NCT00760214|4019662|P3|COMPLETED|Overall Study||255
1644943|NCT00760214|4019663|P2|COMPLETED|Overall Study||264
1644944|NCT00760214|4019664|P1|COMPLETED|Overall Study||265
1644945|NCT00760214|4019662|P3|STARTED|Overall Study||296
1644946|NCT00760214|4019663|P2|STARTED|Overall Study||294
1644947|NCT00760214|4019664|P1|STARTED|Overall Study||295
1644948|NCT00760084|4019705|P1|NOT COMPLETED|Overall Study||10
1644949|NCT00760084|4019705|P1|COMPLETED|Overall Study||0
1644950|NCT00760084|4019705|P1|STARTED|Overall Study||10
1644951|NCT00760019|4019711|P4|NOT COMPLETED|Overall Study||0
1644952|NCT00760019|4019712|P3|NOT COMPLETED|Overall Study||0
1644953|NCT00760019|4019713|P2|NOT COMPLETED|Overall Study||0
1644954|NCT00760019|4019714|P1|NOT COMPLETED|Overall Study||0
1644955|NCT00760019|4019711|P4|COMPLETED|Overall Study||14
1644956|NCT00760019|4019712|P3|COMPLETED|Overall Study||14
1644957|NCT00760019|4019713|P2|COMPLETED|Overall Study||15
1644958|NCT00760019|4019714|P1|COMPLETED|Overall Study||15
1644959|NCT00760019|4019711|P4|STARTED|Overall Study||14
1644960|NCT00760019|4019712|P3|STARTED|Overall Study||14
1644961|NCT00760019|4019713|P2|STARTED|Overall Study||15
1644962|NCT00760019|4019714|P1|STARTED|Overall Study||15
1644963|NCT00760006|4019722|P2|NOT COMPLETED|Overall Study||0
1644964|NCT00760006|4019723|P1|NOT COMPLETED|Overall Study||0
1644965|NCT00760006|4019722|P2|COMPLETED|Overall Study||138
1644966|NCT00760006|4019723|P1|COMPLETED|Overall Study||86
1644967|NCT00760006|4019722|P2|STARTED|Overall Study||138
1644968|NCT00760006|4019723|P1|STARTED|Overall Study||86
1644969|NCT00759967|4019729|P2|NOT COMPLETED|Second Intervention||0
1644970|NCT00759967|4019730|P1|NOT COMPLETED|Second Intervention||2
1644971|NCT00759967|4019729|P2|COMPLETED|Second Intervention||9
1644972|NCT00759967|4019730|P1|COMPLETED|Second Intervention||8
1644973|NCT00759967|4019729|P2|STARTED|Second Intervention||9
1644974|NCT00759967|4019730|P1|STARTED|Second Intervention||10
1644975|NCT00759967|4019729|P2|NOT COMPLETED|First Intervention||0
1644976|NCT00759967|4019730|P1|NOT COMPLETED|First Intervention||0
1644977|NCT00759967|4019729|P2|COMPLETED|First Intervention||9
1644978|NCT00759967|4019730|P1|COMPLETED|First Intervention||10
1644979|NCT00759967|4019729|P2|STARTED|First Intervention||9
1644980|NCT00759967|4019730|P1|STARTED|First Intervention||10
1644981|NCT00759954|4019748|P2|NOT COMPLETED|Overall Study||2
1644982|NCT00759954|4019749|P1|NOT COMPLETED|Overall Study||2
1644983|NCT00759954|4019748|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
1644984|NCT00759954|4019749|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
1644985|NCT00759954|4019748|P2|STARTED|Overall Study|All assigned participants entered trial|18
1644986|NCT00759954|4019749|P1|STARTED|Overall Study|All assigned participants entered trial|18
1644987|NCT00759941|4019763|P2|NOT COMPLETED|Overall Study||1
1644988|NCT00759941|4019764|P1|NOT COMPLETED|Overall Study||3
1644989|NCT00759941|4019763|P2|COMPLETED|Overall Study||43
1644990|NCT00759941|4019764|P1|COMPLETED|Overall Study||39
1644991|NCT00759941|4019763|P2|STARTED|Overall Study||44
1644992|NCT00759941|4019764|P1|STARTED|Overall Study||42
1644993|NCT00759915|4019778|P2|NOT COMPLETED|Overall Study||1
1644994|NCT00759915|4019779|P1|NOT COMPLETED|Overall Study||1
1644995|NCT00759915|4019778|P2|COMPLETED|Overall Study||17
1644996|NCT00759915|4019779|P1|COMPLETED|Overall Study||17
1644997|NCT00759915|4019778|P2|STARTED|Overall Study||18
1644998|NCT00759915|4019779|P1|STARTED|Overall Study||18
1644999|NCT00759902|4019793|P2|NOT COMPLETED|Overall Study||1
1645000|NCT00759902|4019794|P1|NOT COMPLETED|Overall Study||0
1645001|NCT00759902|4019793|P2|COMPLETED|Overall Study||17
1645002|NCT00759902|4019794|P1|COMPLETED|Overall Study||18
1645003|NCT00759902|4019793|P2|STARTED|Overall Study||18
1645004|NCT00759902|4019794|P1|STARTED|Overall Study||18
1645005|NCT00759863|4019808|P2|NOT COMPLETED|Overall Study||18
1645006|NCT00759863|4019809|P1|NOT COMPLETED|Overall Study||20
1645007|NCT00759863|4019808|P2|COMPLETED|Overall Study||80
1645008|NCT00759863|4019809|P1|COMPLETED|Overall Study||124
1645009|NCT00759863|4019808|P2|STARTED|Overall Study||98
1645010|NCT00759863|4019809|P1|STARTED|Overall Study||144
1645011|NCT00759811|4019821|P2|NOT COMPLETED|Overall Study||1
1645012|NCT00759811|4019822|P1|NOT COMPLETED|Overall Study||2
1645013|NCT00759811|4019821|P2|COMPLETED|Overall Study||24
1645014|NCT00759811|4019822|P1|COMPLETED|Overall Study||23
1645015|NCT00759811|4019821|P2|STARTED|Overall Study||25
1645016|NCT00759811|4019822|P1|STARTED|Overall Study||25
1645017|NCT00759785|4019830|P2|NOT COMPLETED|Overall Study||5
1645018|NCT00759785|4019831|P1|NOT COMPLETED|Overall Study||12
1645019|NCT00759785|4019830|P2|COMPLETED|Overall Study||17
1645020|NCT00759785|4019831|P1|COMPLETED|Overall Study||14
1645021|NCT00759785|4019830|P2|Treated|Overall Study||20
1645022|NCT00759785|4019831|P1|Treated|Overall Study||25
1645023|NCT00759785|4019830|P2|STARTED|Overall Study||22
1645024|NCT00759785|4019831|P1|STARTED|Overall Study||26
1645025|NCT00759772|4019845|P2|NOT COMPLETED|Overall Study||0
1645026|NCT00759772|4019846|P1|NOT COMPLETED|Overall Study||0
1645027|NCT00759772|4019845|P2|COMPLETED|Overall Study||11
1645028|NCT00759772|4019846|P1|COMPLETED|Overall Study||12
1645029|NCT00759772|4019845|P2|STARTED|Overall Study||11
1645030|NCT00759772|4019846|P1|STARTED|Overall Study||12
1645031|NCT00759759|4019854|P2|NOT COMPLETED|Overall Study||1
1645032|NCT00759759|4019855|P1|NOT COMPLETED|Overall Study||4
1645033|NCT00759759|4019854|P2|COMPLETED|Overall Study||17
1645034|NCT00759759|4019855|P1|COMPLETED|Overall Study||14
1645035|NCT00759759|4019854|P2|STARTED|Overall Study||18
1645036|NCT00759759|4019855|P1|STARTED|Overall Study||18
1645037|NCT00759707|4019867|P1|NOT COMPLETED|Overall Study||0
1645038|NCT00759707|4019867|P1|COMPLETED|Overall Study||19
1645039|NCT00759707|4019867|P1|STARTED|Overall Study||19
1645040|NCT00759681|4019873|P2|NOT COMPLETED|Overall Study||10
1645041|NCT00759681|4019874|P1|NOT COMPLETED|Overall Study||10
1645042|NCT00759681|4019873|P2|COMPLETED|Overall Study||100
1645043|NCT00759681|4019874|P1|COMPLETED|Overall Study||97
1645044|NCT00759681|4019873|P2|STARTED|Overall Study||110
1645045|NCT00759681|4019874|P1|STARTED|Overall Study||107
1645046|NCT00759668|4019884|P2|NOT COMPLETED|Overall Study||3
1645047|NCT00759668|4019885|P1|NOT COMPLETED|Overall Study||1
1645048|NCT00759668|4019884|P2|COMPLETED|Overall Study||15
1645049|NCT00759668|4019885|P1|COMPLETED|Overall Study||16
1645050|NCT00759668|4019884|P2|STARTED|Overall Study||18
1645051|NCT00759668|4019885|P1|STARTED|Overall Study||17
1645052|NCT00759655|4019901|P1|NOT COMPLETED|Overall Study||1
1645053|NCT00759655|4019901|P1|COMPLETED|Overall Study||0
1645054|NCT00759655|4019901|P1|STARTED|Overall Study||1
1645055|NCT00759642|4019912|P1|NOT COMPLETED|Overall Study||0
1645056|NCT00759642|4019912|P1|COMPLETED|Overall Study||33
1645057|NCT00759642|4019912|P1|STARTED|Overall Study||33
1645058|NCT00759603|4019916|P1|NOT COMPLETED|Overall Study||0
1645059|NCT00759603|4019916|P1|COMPLETED|Overall Study||59
1645060|NCT00759603|4019916|P1|STARTED|Overall Study||59
1645061|NCT00759577|4019920|P1|NOT COMPLETED|Overall Study||0
1645062|NCT00759577|4019920|P1|COMPLETED|Overall Study||36
1645063|NCT00759577|4019920|P1|STARTED|Overall Study||36
1645064|NCT00759564|4019929|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
1645065|NCT00759564|4019930|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
1645066|NCT00759564|4019931|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
1645067|NCT00759564|4019932|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
1645068|NCT00759564|4019933|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
1645069|NCT00759564|4019929|P5|COMPLETED|Second Intervention Period (4 Days)||3
1645070|NCT00759564|4019930|P4|COMPLETED|Second Intervention Period (4 Days)||1
1645071|NCT00759564|4019931|P3|COMPLETED|Second Intervention Period (4 Days)||8
1645072|NCT00759564|4019932|P2|COMPLETED|Second Intervention Period (4 Days)||8
1645073|NCT00759564|4019933|P1|COMPLETED|Second Intervention Period (4 Days)||8
1645074|NCT00759564|4019929|P5|STARTED|Second Intervention Period (4 Days)||3
1645075|NCT00759564|4019930|P4|STARTED|Second Intervention Period (4 Days)||1
1645076|NCT00759564|4019931|P3|STARTED|Second Intervention Period (4 Days)||8
1645077|NCT00759564|4019932|P2|STARTED|Second Intervention Period (4 Days)||8
1645078|NCT00759564|4019933|P1|STARTED|Second Intervention Period (4 Days)||8
1645079|NCT00759564|4019929|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
1645080|NCT00759564|4019930|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1645081|NCT00759564|4019931|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1645082|NCT00759564|4019932|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1645083|NCT00759564|4019933|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1645084|NCT00759564|4019929|P5|COMPLETED|Washout Period (at Least 14 Days)||3
1645085|NCT00759564|4019930|P4|COMPLETED|Washout Period (at Least 14 Days)||1
1645086|NCT00759564|4019931|P3|COMPLETED|Washout Period (at Least 14 Days)||8
1645087|NCT00759564|4019932|P2|COMPLETED|Washout Period (at Least 14 Days)||8
1645088|NCT00759564|4019933|P1|COMPLETED|Washout Period (at Least 14 Days)||8
1645089|NCT00759564|4019929|P5|STARTED|Washout Period (at Least 14 Days)||4
1645090|NCT00759564|4019930|P4|STARTED|Washout Period (at Least 14 Days)||1
1645091|NCT00759564|4019931|P3|STARTED|Washout Period (at Least 14 Days)||8
1645092|NCT00759564|4019932|P2|STARTED|Washout Period (at Least 14 Days)||8
1645093|NCT00759564|4019933|P1|STARTED|Washout Period (at Least 14 Days)||8
1645094|NCT00759564|4019929|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
1645095|NCT00759564|4019930|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
1645096|NCT00759564|4019931|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
1645097|NCT00759564|4019932|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
1645098|NCT00759564|4019933|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
1645099|NCT00759564|4019929|P5|COMPLETED|First Intervention Period (4 Days)||4
1645100|NCT00759564|4019930|P4|COMPLETED|First Intervention Period (4 Days)||1
1645101|NCT00759564|4019931|P3|COMPLETED|First Intervention Period (4 Days)||8
1645102|NCT00759564|4019932|P2|COMPLETED|First Intervention Period (4 Days)||8
1645103|NCT00759564|4019933|P1|COMPLETED|First Intervention Period (4 Days)||8
1645104|NCT00759564|4019929|P5|STARTED|First Intervention Period (4 Days)||4
1645105|NCT00759564|4019930|P4|STARTED|First Intervention Period (4 Days)||1
1645106|NCT00759564|4019931|P3|STARTED|First Intervention Period (4 Days)||8
1645107|NCT00759564|4019932|P2|STARTED|First Intervention Period (4 Days)||8
1645108|NCT00759564|4019933|P1|STARTED|First Intervention Period (4 Days)||8
1645109|NCT00759525|4020073|P2|NOT COMPLETED|Second Intervention (14 Days)||0
1645110|NCT00759525|4020074|P1|NOT COMPLETED|Second Intervention (14 Days)||0
1645111|NCT00759525|4020073|P2|COMPLETED|Second Intervention (14 Days)||8
1645112|NCT00759525|4020074|P1|COMPLETED|Second Intervention (14 Days)||7
1645113|NCT00759525|4020073|P2|STARTED|Second Intervention (14 Days)||8
1645114|NCT00759525|4020074|P1|STARTED|Second Intervention (14 Days)||7
1645115|NCT00759525|4020073|P2|NOT COMPLETED|Washout (14 Days)||0
1645116|NCT00759525|4020074|P1|NOT COMPLETED|Washout (14 Days)||0
1645117|NCT00759525|4020073|P2|COMPLETED|Washout (14 Days)||8
1645118|NCT00759525|4020074|P1|COMPLETED|Washout (14 Days)||7
1645119|NCT00759525|4020073|P2|STARTED|Washout (14 Days)||8
1645120|NCT00759525|4020074|P1|STARTED|Washout (14 Days)||7
1645121|NCT00759525|4020073|P2|NOT COMPLETED|First Intervention (14 Days)||0
1645122|NCT00759525|4020074|P1|NOT COMPLETED|First Intervention (14 Days)||0
1645123|NCT00759525|4020073|P2|COMPLETED|First Intervention (14 Days)||8
1645124|NCT00759525|4020074|P1|COMPLETED|First Intervention (14 Days)||7
1645125|NCT00759525|4020073|P2|STARTED|First Intervention (14 Days)||8
1645126|NCT00759525|4020074|P1|STARTED|First Intervention (14 Days)||7
1645127|NCT00759473|4020085|P5|NOT COMPLETED|Overall Study||0
1645128|NCT00759473|4020086|P4|NOT COMPLETED|Overall Study||0
1645129|NCT00759473|4020087|P3|NOT COMPLETED|Overall Study||0
1645130|NCT00759473|4020088|P2|NOT COMPLETED|Overall Study||0
1645131|NCT00759473|4020089|P1|NOT COMPLETED|Overall Study||0
1645132|NCT00759473|4020085|P5|COMPLETED|Overall Study||24
1645133|NCT00759473|4020086|P4|COMPLETED|Overall Study||23
1645134|NCT00759473|4020087|P3|COMPLETED|Overall Study||12
1645135|NCT00759473|4020088|P2|COMPLETED|Overall Study||10
1645136|NCT00759473|4020089|P1|COMPLETED|Overall Study||10
1645137|NCT00759473|4020085|P5|STARTED|Overall Study||24
1645138|NCT00759473|4020086|P4|STARTED|Overall Study||23
1645139|NCT00759473|4020087|P3|STARTED|Overall Study||12
1645140|NCT00759473|4020088|P2|STARTED|Overall Study||10
1645141|NCT00759473|4020089|P1|STARTED|Overall Study||10
1645142|NCT00759408|4020101|P1|NOT COMPLETED|Overall Study||19
1645143|NCT00759408|4020101|P1|COMPLETED|Overall Study||19
1645144|NCT00759408|4020101|P1|STARTED|Overall Study||38
1645145|NCT00759395|4020110|P2|NOT COMPLETED|Overall Study||2
1645146|NCT00759395|4020111|P1|NOT COMPLETED|Overall Study||2
1645147|NCT00759395|4020110|P2|COMPLETED|Overall Study||7
1645148|NCT00759395|4020111|P1|COMPLETED|Overall Study||11
1645149|NCT00759395|4020110|P2|STARTED|Overall Study||9
1645150|NCT00759395|4020111|P1|STARTED|Overall Study||13
1645151|NCT00759356|4020127|P2|NOT COMPLETED|Overall Study||3
1645152|NCT00759356|4020128|P1|NOT COMPLETED|Overall Study||1
1645153|NCT00759356|4020127|P2|COMPLETED|Overall Study||15
1645154|NCT00759356|4020128|P1|COMPLETED|Overall Study||17
1645155|NCT00759356|4020127|P2|STARTED|Overall Study||18
1645156|NCT00759356|4020128|P1|STARTED|Overall Study||18
1645157|NCT00759330|4020144|P4|NOT COMPLETED|Overall Study||2
1645158|NCT00759330|4020145|P3|NOT COMPLETED|Overall Study||0
1645159|NCT00759330|4020146|P2|NOT COMPLETED|Overall Study||1
1645160|NCT00759330|4020147|P1|NOT COMPLETED|Overall Study||1
1645161|NCT00759330|4020144|P4|COMPLETED|Overall Study||41
1645162|NCT00759330|4020145|P3|COMPLETED|Overall Study||22
1645163|NCT00759330|4020146|P2|COMPLETED|Overall Study||41
1645164|NCT00759330|4020147|P1|COMPLETED|Overall Study||19
1645165|NCT00759330|4020144|P4|STARTED|Overall Study||43
1645166|NCT00759330|4020145|P3|STARTED|Overall Study||22
1645167|NCT00759330|4020146|P2|STARTED|Overall Study||42
1645168|NCT00759330|4020147|P1|STARTED|Overall Study||20
1645169|NCT00759187|4020196|P3|NOT COMPLETED|Overall Study||0
1645170|NCT00759187|4020197|P2|NOT COMPLETED|Overall Study||0
1645171|NCT00759187|4020198|P1|NOT COMPLETED|Overall Study||0
1645172|NCT00759187|4020196|P3|COMPLETED|Overall Study||9
1645173|NCT00759187|4020197|P2|COMPLETED|Overall Study||8
1645174|NCT00759187|4020198|P1|COMPLETED|Overall Study||8
1645175|NCT00759187|4020196|P3|STARTED|Overall Study||9
1645176|NCT00759187|4020197|P2|STARTED|Overall Study||8
1645177|NCT00759187|4020198|P1|STARTED|Overall Study||8
1645178|NCT00759174|4020208|P2|NOT COMPLETED|Overall Study||2
1645179|NCT00759174|4020209|P1|NOT COMPLETED|Overall Study||0
1645180|NCT00759174|4020208|P2|COMPLETED|Overall Study||595
1645181|NCT00759174|4020209|P1|COMPLETED|Overall Study||76
1645182|NCT00759174|4020208|P2|STARTED|Overall Study||597
1645183|NCT00759174|4020209|P1|STARTED|Overall Study||76
1645184|NCT00759161|4020218|P1|NOT COMPLETED|Overall Study||0
1645185|NCT00759161|4020218|P1|COMPLETED|Overall Study||35
1645186|NCT00759161|4020218|P1|STARTED|Overall Study||35
1645187|NCT00759148|4020233|P2|NOT COMPLETED|Overall Study||32
1645188|NCT00759148|4020234|P1|NOT COMPLETED|Overall Study||14
1645189|NCT00759148|4020233|P2|COMPLETED|Overall Study||554
1645190|NCT00759148|4020234|P1|COMPLETED|Overall Study||579
1645191|NCT00759148|4020233|P2|STARTED|Overall Study||586
1645192|NCT00759148|4020234|P1|STARTED|Overall Study||593
1645193|NCT00759109|4020244|P2|NOT COMPLETED|Overall Study||35
1645194|NCT00759109|4020245|P1|NOT COMPLETED|Overall Study||39
1645195|NCT00759109|4020244|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
1645196|NCT00759109|4020245|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
1645197|NCT00759109|4020244|P2|STARTED|Overall Study||76
1645198|NCT00759109|4020245|P1|STARTED|Overall Study||74
1645199|NCT00759096|4020261|P1|NOT COMPLETED|Overall Study||0
1645200|NCT00759096|4020261|P1|COMPLETED|Overall Study||30
1645201|NCT00759096|4020261|P1|STARTED|Overall Study||30
1645202|NCT00759031|4020267|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1645203|NCT00759031|4020268|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1645204|NCT00759031|4020267|P2|COMPLETED|Second Intervention (1 Day)||8
1645205|NCT00759031|4020268|P1|COMPLETED|Second Intervention (1 Day)||8
1645206|NCT00759031|4020267|P2|STARTED|Second Intervention (1 Day)||8
1645207|NCT00759031|4020268|P1|STARTED|Second Intervention (1 Day)||8
1645208|NCT00759031|4020267|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
1645209|NCT00759031|4020268|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
1645210|NCT00759031|4020267|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
1645211|NCT00759031|4020268|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
1645212|NCT00759031|4020267|P2|STARTED|Washout After 1st Intervention (1 Week)||8
1645213|NCT00759031|4020268|P1|STARTED|Washout After 1st Intervention (1 Week)||8
1645214|NCT00759031|4020267|P2|NOT COMPLETED|First Intervention (1 Day)||1
1645215|NCT00759031|4020268|P1|NOT COMPLETED|First Intervention (1 Day)||2
1645216|NCT00759031|4020267|P2|COMPLETED|First Intervention (1 Day)||8
1645217|NCT00759031|4020268|P1|COMPLETED|First Intervention (1 Day)||8
1645218|NCT00759031|4020267|P2|STARTED|First Intervention (1 Day)||9
1645219|NCT00759031|4020268|P1|STARTED|First Intervention (1 Day)||10
1645220|NCT00758862|4020274|P1|NOT COMPLETED|Overall Study||1
1645221|NCT00758862|4020274|P1|COMPLETED|Overall Study||19
1645222|NCT00758862|4020274|P1|STARTED|Overall Study||20
1645223|NCT00758836|4020294|P4|NOT COMPLETED|Overall Study||32
1645224|NCT00758836|4020295|P3|NOT COMPLETED|Overall Study||38
1645225|NCT00758836|4020296|P2|NOT COMPLETED|Overall Study||26
1645226|NCT00758836|4020297|P1|NOT COMPLETED|Overall Study||24
1645227|NCT00758836|4020294|P4|COMPLETED|Overall Study||138
1645228|NCT00758836|4020295|P3|COMPLETED|Overall Study||133
1645229|NCT00758836|4020296|P2|COMPLETED|Overall Study||145
1645230|NCT00758836|4020297|P1|COMPLETED|Overall Study||147
1645231|NCT00758836|4020294|P4|Treated|Overall Study||138
1645232|NCT00758836|4020295|P3|Treated|Overall Study||133
1645233|NCT00758836|4020296|P2|Treated|Overall Study||145
1645234|NCT00758836|4020297|P1|Treated|Overall Study||147
1645235|NCT00758836|4020294|P4|STARTED|Overall Study||170
1645236|NCT00758836|4020295|P3|STARTED|Overall Study||171
1645237|NCT00758836|4020296|P2|STARTED|Overall Study||171
1645238|NCT00758836|4020297|P1|STARTED|Overall Study||171
1645239|NCT00758771|4020321|P2|NOT COMPLETED|Overall Study||5
1645240|NCT00758771|4020322|P1|NOT COMPLETED|Overall Study||3
1645241|NCT00758771|4020321|P2|COMPLETED|Overall Study||15
1645242|NCT00758771|4020322|P1|COMPLETED|Overall Study||15
1645243|NCT00758771|4020321|P2|STARTED|Overall Study||20
1645244|NCT00758771|4020322|P1|STARTED|Overall Study||18
1645245|NCT00758758|4020336|P8|NOT COMPLETED|Overall Study||0
1645246|NCT00758758|4020337|P7|NOT COMPLETED|Overall Study||14
1645247|NCT00758758|4020338|P6|NOT COMPLETED|Overall Study||14
1645248|NCT00758758|4020339|P5|NOT COMPLETED|Overall Study||2
1645249|NCT00758758|4020340|P4|NOT COMPLETED|Overall Study||2
1645250|NCT00758758|4020341|P3|NOT COMPLETED|Overall Study||18
1645251|NCT00758758|4020342|P2|NOT COMPLETED|Overall Study||25
1645252|NCT00758758|4020343|P1|NOT COMPLETED|Overall Study||3
1645253|NCT00758758|4020336|P8|COMPLETED|Overall Study||0
1645254|NCT00758758|4020337|P7|COMPLETED|Overall Study||17
1645255|NCT00758758|4020338|P6|COMPLETED|Overall Study||36
1645256|NCT00758758|4020339|P5|COMPLETED|Overall Study||1
1645257|NCT00758758|4020340|P4|COMPLETED|Overall Study||4
1645258|NCT00758758|4020341|P3|COMPLETED|Overall Study||35
1645259|NCT00758758|4020342|P2|COMPLETED|Overall Study||49
1645260|NCT00758758|4020343|P1|COMPLETED|Overall Study||11
1645261|NCT00758758|4020336|P8|STARTED|Overall Study||0
1645262|NCT00758758|4020337|P7|STARTED|Overall Study||31
1645263|NCT00758758|4020338|P6|STARTED|Overall Study||50
1645264|NCT00758758|4020339|P5|STARTED|Overall Study||3
1645265|NCT00758758|4020340|P4|STARTED|Overall Study||6
1645266|NCT00758758|4020341|P3|STARTED|Overall Study||53
1645267|NCT00758758|4020342|P2|STARTED|Overall Study||74
1645268|NCT00758758|4020343|P1|STARTED|Overall Study||14
1645269|NCT00758745|4020371|P2|NOT COMPLETED|Overall Study||21
1645270|NCT00758745|4020372|P1|NOT COMPLETED|Overall Study||21
1645271|NCT00758745|4020371|P2|COMPLETED|Overall Study||60
1645272|NCT00758745|4020372|P1|COMPLETED|Overall Study||60
1645273|NCT00758745|4020371|P2|STARTED|Overall Study||81
1645274|NCT00758745|4020372|P1|STARTED|Overall Study||81
1645275|NCT00758706|4020380|P2|NOT COMPLETED|Overall Study||4
1645276|NCT00758706|4020381|P1|NOT COMPLETED|Overall Study||4
1645277|NCT00758706|4020380|P2|COMPLETED|Overall Study||25
1645278|NCT00758706|4020381|P1|COMPLETED|Overall Study||22
1645279|NCT00758706|4020380|P2|STARTED|Overall Study||29
1645280|NCT00758706|4020381|P1|STARTED|Overall Study||26
1645281|NCT00758680|4020417|P10|NOT COMPLETED|Overall Study||1
1645282|NCT00758680|4020418|P9|NOT COMPLETED|Overall Study||2
1645283|NCT00758680|4020419|P8|NOT COMPLETED|Overall Study||1
1645284|NCT00758680|4020420|P7|NOT COMPLETED|Overall Study||1
1645285|NCT00758680|4020421|P6|NOT COMPLETED|Overall Study||0
1645286|NCT00758680|4020422|P5|NOT COMPLETED|Overall Study||0
1645287|NCT00758680|4020423|P4|NOT COMPLETED|Overall Study||0
1645288|NCT00758680|4020424|P3|NOT COMPLETED|Overall Study||0
1645289|NCT00758680|4020425|P2|NOT COMPLETED|Overall Study||0
1645290|NCT00758680|4020426|P1|NOT COMPLETED|Overall Study||0
1645291|NCT00758680|4020417|P10|COMPLETED|Overall Study||28
1645292|NCT00758680|4020418|P9|COMPLETED|Overall Study||18
1645293|NCT00758680|4020419|P8|COMPLETED|Overall Study||19
1645294|NCT00758680|4020420|P7|COMPLETED|Overall Study||6
1645295|NCT00758680|4020421|P6|COMPLETED|Overall Study||6
1645296|NCT00758680|4020422|P5|COMPLETED|Overall Study||6
1645297|NCT00758680|4020423|P4|COMPLETED|Overall Study||6
1645298|NCT00758680|4020424|P3|COMPLETED|Overall Study||6
1645299|NCT00758680|4020425|P2|COMPLETED|Overall Study||6
1645300|NCT00758680|4020426|P1|COMPLETED|Overall Study||6
1645301|NCT00758680|4020417|P10|STARTED|Overall Study||29
1645302|NCT00758680|4020418|P9|STARTED|Overall Study||20
1645303|NCT00758680|4020419|P8|STARTED|Overall Study||20
1645304|NCT00758680|4020420|P7|STARTED|Overall Study||7
1645305|NCT00758680|4020421|P6|STARTED|Overall Study||6
1645306|NCT00758680|4020422|P5|STARTED|Overall Study||6
1645307|NCT00758680|4020423|P4|STARTED|Overall Study||6
1645308|NCT00758680|4020424|P3|STARTED|Overall Study||6
1645309|NCT00758680|4020425|P2|STARTED|Overall Study||6
1645310|NCT00758680|4020426|P1|STARTED|Overall Study||6
1645311|NCT00758667|4020468|P2|NOT COMPLETED|Overall Study||0
1645312|NCT00758667|4020469|P1|NOT COMPLETED|Overall Study||0
1645313|NCT00758667|4020468|P2|COMPLETED|Overall Study||11
1645314|NCT00758667|4020469|P1|COMPLETED|Overall Study||9
1645315|NCT00758667|4020468|P2|STARTED|Overall Study||11
1645316|NCT00758667|4020469|P1|STARTED|Overall Study||9
1645317|NCT00758602|4020479|P2|NOT COMPLETED|Overall Study||22
1645318|NCT00758602|4020480|P1|NOT COMPLETED|Overall Study||19
1645319|NCT00758602|4020479|P2|COMPLETED|Overall Study||84
1645320|NCT00758602|4020480|P1|COMPLETED|Overall Study||85
1645321|NCT00758602|4020479|P2|STARTED|Overall Study||106
1645322|NCT00758602|4020480|P1|STARTED|Overall Study||104
1645323|NCT00758589|4020506|P4|NOT COMPLETED|Overall Study||6
1645324|NCT00758589|4020507|P3|NOT COMPLETED|Overall Study||6
1645325|NCT00758589|4020508|P2|NOT COMPLETED|Overall Study||3
1645326|NCT00758589|4020509|P1|NOT COMPLETED|Overall Study||3
1645327|NCT00758589|4020506|P4|COMPLETED|Overall Study||85
1645328|NCT00758589|4020507|P3|COMPLETED|Overall Study||86
1645329|NCT00758589|4020508|P2|COMPLETED|Overall Study||87
1645330|NCT00758589|4020509|P1|COMPLETED|Overall Study||92
1645331|NCT00758589|4020506|P4|STARTED|Overall Study||91
1645332|NCT00758589|4020507|P3|STARTED|Overall Study||92
1645333|NCT00758589|4020508|P2|STARTED|Overall Study||90
1645334|NCT00758589|4020509|P1|STARTED|Overall Study||95
1645335|NCT00758576|4020575|P1|NOT COMPLETED|Overall Study||1
1645336|NCT00758576|4020575|P1|COMPLETED|Overall Study||63
1645337|NCT00758576|4020575|P1|STARTED|Overall Study||64
1645338|NCT00758563|4020583|P2|NOT COMPLETED|Overall Study||0
1645339|NCT00758563|4020584|P1|NOT COMPLETED|Overall Study||0
1645340|NCT00758563|4020583|P2|COMPLETED|Overall Study||8
1645341|NCT00758563|4020584|P1|COMPLETED|Overall Study||7
1645342|NCT00758563|4020583|P2|STARTED|Overall Study||8
1645343|NCT00758563|4020584|P1|STARTED|Overall Study||7
1645344|NCT00758550|4020590|P2|NOT COMPLETED|Overall Study||0
1645345|NCT00758550|4020591|P1|NOT COMPLETED|Overall Study||0
1645346|NCT00758550|4020590|P2|COMPLETED|Overall Study||30
1645347|NCT00758550|4020591|P1|COMPLETED|Overall Study||30
1645348|NCT00758550|4020590|P2|STARTED|Overall Study||30
1645349|NCT00758550|4020591|P1|STARTED|Overall Study||30
1645350|NCT00758498|4020602|P3|NOT COMPLETED|Overall Study||5
1645351|NCT00758498|4020603|P2|NOT COMPLETED|Overall Study||2
1645352|NCT00758498|4020604|P1|NOT COMPLETED|Overall Study||3
1645353|NCT00758498|4020602|P3|COMPLETED|Overall Study||137
1645354|NCT00758498|4020603|P2|COMPLETED|Overall Study||141
1645355|NCT00758498|4020604|P1|COMPLETED|Overall Study||139
1645356|NCT00758498|4020602|P3|STARTED|Overall Study||142
1645357|NCT00758498|4020603|P2|STARTED|Overall Study||143
1645358|NCT00758498|4020604|P1|STARTED|Overall Study||142
1645359|NCT00758485|4020689|P2|NOT COMPLETED|Overall Study||3
1645360|NCT00758485|4020690|P1|NOT COMPLETED|Overall Study||1
1645361|NCT00758485|4020689|P2|COMPLETED|Overall Study||67
1645362|NCT00758485|4020690|P1|COMPLETED|Overall Study||69
1645363|NCT00758485|4020689|P2|TREATED|Overall Study||68
1645364|NCT00758485|4020690|P1|TREATED|Overall Study||69
1645365|NCT00758485|4020689|P2|STARTED|Overall Study||70
1645366|NCT00758485|4020690|P1|STARTED|Overall Study||70
1645367|NCT00758459|4020702|P2|NOT COMPLETED|Overall Study||4
1645368|NCT00758459|4020703|P1|NOT COMPLETED|Overall Study||3
1645369|NCT00758459|4020702|P2|COMPLETED|Overall Study||35
1645370|NCT00758459|4020703|P1|COMPLETED|Overall Study||32
1645371|NCT00758459|4020702|P2|STARTED|Overall Study||39
1645372|NCT00758459|4020703|P1|STARTED|Overall Study||35
1645373|NCT00758420|4020737|P2|NOT COMPLETED|Overall Study||0
1645374|NCT00758420|4020738|P1|NOT COMPLETED|Overall Study||0
1645375|NCT00758420|4020737|P2|COMPLETED|Overall Study||38
1645376|NCT00758420|4020738|P1|COMPLETED|Overall Study||39
1645377|NCT00758420|4020737|P2|STARTED|Overall Study||38
1645378|NCT00758420|4020738|P1|STARTED|Overall Study||39
1645379|NCT00758394|4020748|P4|NOT COMPLETED|4th Intervention||0
1645380|NCT00758394|4020749|P3|NOT COMPLETED|4th Intervention||0
1645381|NCT00758394|4020750|P2|NOT COMPLETED|4th Intervention||0
1645382|NCT00758394|4020751|P1|NOT COMPLETED|4th Intervention||0
1645383|NCT00758394|4020748|P4|COMPLETED|4th Intervention||7
1645384|NCT00758394|4020749|P3|COMPLETED|4th Intervention||6
1645385|NCT00758394|4020750|P2|COMPLETED|4th Intervention||6
1645386|NCT00758394|4020751|P1|COMPLETED|4th Intervention||7
1645387|NCT00758394|4020748|P4|STARTED|4th Intervention||7
1645388|NCT00758394|4020749|P3|STARTED|4th Intervention||6
1645389|NCT00758394|4020750|P2|STARTED|4th Intervention||6
1645390|NCT00758394|4020751|P1|STARTED|4th Intervention||7
1645391|NCT00758394|4020748|P4|NOT COMPLETED|Washout After 3rd Intervention||0
1645392|NCT00758394|4020749|P3|NOT COMPLETED|Washout After 3rd Intervention||0
1645393|NCT00758394|4020750|P2|NOT COMPLETED|Washout After 3rd Intervention||0
1645394|NCT00758394|4020751|P1|NOT COMPLETED|Washout After 3rd Intervention||0
1645395|NCT00758394|4020748|P4|COMPLETED|Washout After 3rd Intervention||7
1645396|NCT00758394|4020749|P3|COMPLETED|Washout After 3rd Intervention||6
1645397|NCT00758394|4020750|P2|COMPLETED|Washout After 3rd Intervention||6
1645398|NCT00758394|4020751|P1|COMPLETED|Washout After 3rd Intervention||7
1645399|NCT00758394|4020748|P4|STARTED|Washout After 3rd Intervention||7
1645400|NCT00758394|4020749|P3|STARTED|Washout After 3rd Intervention||6
1645401|NCT00758394|4020750|P2|STARTED|Washout After 3rd Intervention||6
1645402|NCT00758394|4020751|P1|STARTED|Washout After 3rd Intervention||7
1645403|NCT00758394|4020748|P4|NOT COMPLETED|3rd Intervention||1
1645404|NCT00758394|4020749|P3|NOT COMPLETED|3rd Intervention||0
1645405|NCT00758394|4020750|P2|NOT COMPLETED|3rd Intervention||0
1645406|NCT00758394|4020751|P1|NOT COMPLETED|3rd Intervention||1
1645407|NCT00758394|4020748|P4|COMPLETED|3rd Intervention||7
1645408|NCT00758394|4020749|P3|COMPLETED|3rd Intervention||6
1645409|NCT00758394|4020750|P2|COMPLETED|3rd Intervention||6
1645410|NCT00758394|4020751|P1|COMPLETED|3rd Intervention||7
1645411|NCT00758394|4020748|P4|STARTED|3rd Intervention||8
1645412|NCT00758394|4020749|P3|STARTED|3rd Intervention||6
1645413|NCT00758394|4020750|P2|STARTED|3rd Intervention||6
1645414|NCT00758394|4020751|P1|STARTED|3rd Intervention||8
1645415|NCT00758394|4020748|P4|NOT COMPLETED|Washout After 2nd Intervention||0
1645416|NCT00758394|4020749|P3|NOT COMPLETED|Washout After 2nd Intervention||0
1645417|NCT00758394|4020750|P2|NOT COMPLETED|Washout After 2nd Intervention||0
1645418|NCT00758394|4020751|P1|NOT COMPLETED|Washout After 2nd Intervention||0
1645419|NCT00758394|4020748|P4|COMPLETED|Washout After 2nd Intervention||8
1645420|NCT00758394|4020749|P3|COMPLETED|Washout After 2nd Intervention||6
1645421|NCT00758394|4020750|P2|COMPLETED|Washout After 2nd Intervention||6
1645422|NCT00758394|4020751|P1|COMPLETED|Washout After 2nd Intervention||8
1645423|NCT00758394|4020748|P4|STARTED|Washout After 2nd Intervention||8
1645424|NCT00758394|4020749|P3|STARTED|Washout After 2nd Intervention||6
1645425|NCT00758394|4020750|P2|STARTED|Washout After 2nd Intervention||6
1645426|NCT00758394|4020751|P1|STARTED|Washout After 2nd Intervention||8
1645427|NCT00758394|4020748|P4|NOT COMPLETED|2nd Intervention Order||0
1645428|NCT00758394|4020749|P3|NOT COMPLETED|2nd Intervention Order||0
1645429|NCT00758394|4020750|P2|NOT COMPLETED|2nd Intervention Order||1
1645430|NCT00758394|4020751|P1|NOT COMPLETED|2nd Intervention Order||0
1645431|NCT00758394|4020748|P4|COMPLETED|2nd Intervention Order||8
1645432|NCT00758394|4020749|P3|COMPLETED|2nd Intervention Order||6
1645433|NCT00758394|4020750|P2|COMPLETED|2nd Intervention Order||6
1645434|NCT00758394|4020751|P1|COMPLETED|2nd Intervention Order||8
1645435|NCT00758394|4020748|P4|STARTED|2nd Intervention Order||8
1645436|NCT00758394|4020749|P3|STARTED|2nd Intervention Order||6
1645437|NCT00758394|4020750|P2|STARTED|2nd Intervention Order||7
1645438|NCT00758394|4020751|P1|STARTED|2nd Intervention Order||8
1645439|NCT00758394|4020748|P4|NOT COMPLETED|Washout After 1st Intervention||0
1645440|NCT00758394|4020749|P3|NOT COMPLETED|Washout After 1st Intervention||0
1645441|NCT00758394|4020750|P2|NOT COMPLETED|Washout After 1st Intervention||0
1645442|NCT00758394|4020751|P1|NOT COMPLETED|Washout After 1st Intervention||0
1645443|NCT00758394|4020748|P4|COMPLETED|Washout After 1st Intervention||8
1645444|NCT00758394|4020749|P3|COMPLETED|Washout After 1st Intervention||6
1645445|NCT00758394|4020750|P2|COMPLETED|Washout After 1st Intervention||7
1645446|NCT00758394|4020751|P1|COMPLETED|Washout After 1st Intervention||8
1645447|NCT00758394|4020748|P4|STARTED|Washout After 1st Intervention||8
1645448|NCT00758394|4020749|P3|STARTED|Washout After 1st Intervention||6
1645449|NCT00758394|4020750|P2|STARTED|Washout After 1st Intervention||7
1645450|NCT00758394|4020751|P1|STARTED|Washout After 1st Intervention||8
1645451|NCT00758394|4020748|P4|NOT COMPLETED|1st Intervention||0
1645452|NCT00758394|4020749|P3|NOT COMPLETED|1st Intervention||0
1645453|NCT00758394|4020750|P2|NOT COMPLETED|1st Intervention||0
1645454|NCT00758394|4020751|P1|NOT COMPLETED|1st Intervention||0
1645455|NCT00758394|4020748|P4|COMPLETED|1st Intervention||8
1645456|NCT00758394|4020749|P3|COMPLETED|1st Intervention||6
1645457|NCT00758394|4020750|P2|COMPLETED|1st Intervention||7
1645458|NCT00758394|4020751|P1|COMPLETED|1st Intervention||8
1645459|NCT00758394|4020748|P4|STARTED|1st Intervention||8
1645460|NCT00758394|4020749|P3|STARTED|1st Intervention||6
1645461|NCT00758394|4020750|P2|STARTED|1st Intervention||7
1645462|NCT00758394|4020751|P1|STARTED|1st Intervention||8
1645463|NCT00758342|4020763|P2|NOT COMPLETED|Overall Study||1
1645464|NCT00758342|4020764|P1|NOT COMPLETED|Overall Study||4
1645465|NCT00758342|4020763|P2|COMPLETED|Overall Study||17
1645466|NCT00758342|4020764|P1|COMPLETED|Overall Study||15
1645467|NCT00758342|4020763|P2|STARTED|Overall Study||18
1645468|NCT00758342|4020764|P1|STARTED|Overall Study||19
1645469|NCT00758290|4020772|P2|NOT COMPLETED|Overall Study||0
1645470|NCT00758290|4020773|P1|NOT COMPLETED|Overall Study||0
1645471|NCT00758290|4020772|P2|COMPLETED|Overall Study||12
1645472|NCT00758290|4020773|P1|COMPLETED|Overall Study||11
1645473|NCT00758290|4020772|P2|STARTED|Overall Study||12
1645474|NCT00758290|4020773|P1|STARTED|Overall Study||11
1645475|NCT00758264|4020780|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
1645476|NCT00758264|4020781|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
1645477|NCT00758264|4020782|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
1645478|NCT00758264|4020780|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
1645479|NCT00758264|4020781|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
1645480|NCT00758264|4020782|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
1645481|NCT00758264|4020780|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
1645482|NCT00758264|4020781|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
1645483|NCT00758264|4020782|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
1645484|NCT00758264|4020780|P3|NOT COMPLETED|Active Phase||5
1645485|NCT00758264|4020781|P2|NOT COMPLETED|Active Phase||0
1645486|NCT00758264|4020782|P1|NOT COMPLETED|Active Phase||1
1645487|NCT00758264|4020780|P3|COMPLETED|Active Phase||85
1645488|NCT00758264|4020781|P2|COMPLETED|Active Phase||91
1645489|NCT00758264|4020782|P1|COMPLETED|Active Phase||181
1645490|NCT00758264|4020780|P3|STARTED|Active Phase||90
1645491|NCT00758264|4020781|P2|STARTED|Active Phase||91
1645492|NCT00758264|4020782|P1|STARTED|Active Phase||182
1645493|NCT00758160|4020841|P1|NOT COMPLETED|Overall Study||66
1645494|NCT00758160|4020841|P1|COMPLETED|Overall Study||230
1645495|NCT00758160|4020841|P1|STARTED|Overall Study||296
1645496|NCT00758069|4020862|P3|NOT COMPLETED|Overall Study||1
1645497|NCT00758069|4020863|P2|NOT COMPLETED|Overall Study||0
1645498|NCT00758069|4020864|P1|NOT COMPLETED|Overall Study||1
1645499|NCT00758069|4020862|P3|COMPLETED|Overall Study||27
1645500|NCT00758069|4020863|P2|COMPLETED|Overall Study||25
1645501|NCT00758069|4020864|P1|COMPLETED|Overall Study||26
1645502|NCT00758069|4020862|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
1645503|NCT00758069|4020863|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
1645504|NCT00758069|4020864|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
1645505|NCT00758043|4020879|P4|NOT COMPLETED|Overall Study||100
1645506|NCT00758043|4020880|P3|NOT COMPLETED|Overall Study||39
1645507|NCT00758043|4020881|P2|NOT COMPLETED|Overall Study||41
1645508|NCT00758043|4020882|P1|NOT COMPLETED|Overall Study||1
1645509|NCT00758043|4020879|P4|COMPLETED|Overall Study||0
1645510|NCT00758043|4020880|P3|COMPLETED|Overall Study||79
1645511|NCT00758043|4020881|P2|COMPLETED|Overall Study||119
1645512|NCT00758043|4020882|P1|COMPLETED|Overall Study||161
1645513|NCT00758043|4020879|P4|STARTED|Overall Study||100
1645514|NCT00758043|4020880|P3|STARTED|Overall Study||118
1645515|NCT00758043|4020881|P2|STARTED|Overall Study||160
1645516|NCT00758043|4020882|P1|STARTED|Overall Study||162
1645517|NCT00757848|4020910|P2|NOT COMPLETED|Overall Study||2
1645518|NCT00757848|4020911|P1|NOT COMPLETED|Overall Study||3
1645519|NCT00757848|4020910|P2|COMPLETED|Overall Study||27
1645520|NCT00757848|4020911|P1|COMPLETED|Overall Study||24
1645521|NCT00757848|4020910|P2|STARTED|Overall Study||29
1645522|NCT00757848|4020911|P1|STARTED|Overall Study||27
1645523|NCT00757822|4020957|P2|NOT COMPLETED|Overall Study||31
1645524|NCT00757822|4020958|P1|NOT COMPLETED|Overall Study||28
1645525|NCT00757822|4020957|P2|COMPLETED|Overall Study||57
1645526|NCT00757822|4020958|P1|COMPLETED|Overall Study||64
1645527|NCT00757822|4020957|P2|Data Lock, Unblinding Analysis|Overall Study||57
1645528|NCT00757822|4020958|P1|Data Lock, Unblinding Analysis|Overall Study||64
1645529|NCT00757822|4020957|P2|Withdrawn-protocol Deviation|Overall Study||8
1645530|NCT00757822|4020958|P1|Withdrawn-protocol Deviation|Overall Study||9
1645531|NCT00757822|4020957|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
1645532|NCT00757822|4020958|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
1645533|NCT00757822|4020957|P2|Data Entry, QC Assessment|Overall Study||74
1645534|NCT00757822|4020958|P1|Data Entry, QC Assessment|Overall Study||85
1645535|NCT00757822|4020957|P2|2-6 wk Post-op Assessment|Overall Study||74
1645536|NCT00757822|4020958|P1|2-6 wk Post-op Assessment|Overall Study||85
1645537|NCT00757822|4020957|P2|24-48 hr Telephone Assessment|Overall Study||74
1645538|NCT00757822|4020958|P1|24-48 hr Telephone Assessment|Overall Study||85
1645539|NCT00757822|4020957|P2|DOS: Post-operative Assessments|Overall Study||74
1645540|NCT00757822|4020958|P1|DOS: Post-operative Assessments|Overall Study||85
1645541|NCT00757822|4020957|P2|Received Study Intervention|Overall Study||74
1645542|NCT00757822|4020958|P1|Received Study Intervention|Overall Study||85
1645543|NCT00757822|4020957|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
1645544|NCT00757822|4020958|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
1645545|NCT00757822|4020957|P2|Withdrawal by Subject-no Intervention|Overall Study||3
1645546|NCT00757822|4020958|P1|Withdrawal by Subject-no Intervention|Overall Study||1
1645547|NCT00757822|4020957|P2|Day of Surgery (DOS) Assessment|Overall Study||88
1645548|NCT00757822|4020958|P1|Day of Surgery (DOS) Assessment|Overall Study||92
1645549|NCT00757822|4020957|P2|STARTED|Overall Study||88
1645550|NCT00757822|4020958|P1|STARTED|Overall Study||92
1645551|NCT00757783|4020980|P2|NOT COMPLETED|Overall Study||6
1645552|NCT00757783|4020981|P1|NOT COMPLETED|Overall Study||5
1645553|NCT00757783|4020980|P2|COMPLETED|Overall Study||25
1645554|NCT00757783|4020981|P1|COMPLETED|Overall Study||29
1645555|NCT00757783|4020980|P2|STARTED|Overall Study||31
1645556|NCT00757783|4020981|P1|STARTED|Overall Study||34
1645557|NCT00757705|4021017|P1|NOT COMPLETED|Overall Study||121
1645558|NCT00757705|4021017|P1|COMPLETED|Overall Study||178
1645559|NCT00757705|4021017|P1|STARTED|Overall Study||299
1645560|NCT00757666|4021031|P2|NOT COMPLETED|Overall Study||23
1645561|NCT00757666|4021032|P1|NOT COMPLETED|Overall Study||22
1645562|NCT00757666|4021031|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
1645563|NCT00757666|4021032|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
1645564|NCT00757666|4021031|P2|STARTED|Overall Study||34
1645565|NCT00757666|4021032|P1|STARTED|Overall Study||34
1645566|NCT00757627|4021046|P1|NOT COMPLETED|Overall Study||81
1645567|NCT00757627|4021046|P1|COMPLETED|Overall Study||419
1645568|NCT00757627|4021046|P1|STARTED|Overall Study||500
1645569|NCT00757601|4021059|P12|NOT COMPLETED|Period 5||0
1645570|NCT00757601|4021060|P11|NOT COMPLETED|Period 5||0
1645571|NCT00757601|4021061|P10|NOT COMPLETED|Period 5||0
1645572|NCT00757601|4021062|P9|NOT COMPLETED|Period 5||0
1645573|NCT00757601|4021063|P8|NOT COMPLETED|Period 5||0
1645574|NCT00757601|4021064|P7|NOT COMPLETED|Period 5||0
1645575|NCT00757601|4021065|P6|NOT COMPLETED|Period 5||0
1645576|NCT00757601|4021066|P5|NOT COMPLETED|Period 5||0
1645577|NCT00757601|4021067|P4|NOT COMPLETED|Period 5||0
1645578|NCT00757601|4021068|P3|NOT COMPLETED|Period 5||0
1645579|NCT00757601|4021069|P2|NOT COMPLETED|Period 5||0
1645580|NCT00757601|4021070|P1|NOT COMPLETED|Period 5||0
1645581|NCT00757601|4021059|P12|COMPLETED|Period 5||1
1645582|NCT00757601|4021060|P11|COMPLETED|Period 5||2
1645583|NCT00757601|4021061|P10|COMPLETED|Period 5||1
1645584|NCT00757601|4021062|P9|COMPLETED|Period 5||2
1645585|NCT00757601|4021063|P8|COMPLETED|Period 5||2
1645586|NCT00757601|4021064|P7|COMPLETED|Period 5||2
1645587|NCT00757601|4021065|P6|COMPLETED|Period 5||2
1645588|NCT00757601|4021066|P5|COMPLETED|Period 5||2
1645589|NCT00757601|4021067|P4|COMPLETED|Period 5||2
1645590|NCT00757601|4021068|P3|COMPLETED|Period 5||2
1645591|NCT00757601|4021069|P2|COMPLETED|Period 5||2
1645592|NCT00757601|4021070|P1|COMPLETED|Period 5||2
1645593|NCT00757601|4021059|P12|STARTED|Period 5||1
1645594|NCT00757601|4021060|P11|STARTED|Period 5||2
1645595|NCT00757601|4021061|P10|STARTED|Period 5||1
1645596|NCT00757601|4021062|P9|STARTED|Period 5||2
1645597|NCT00757601|4021063|P8|STARTED|Period 5||2
1645598|NCT00757601|4021064|P7|STARTED|Period 5||2
1645599|NCT00757601|4021065|P6|STARTED|Period 5||2
1645600|NCT00757601|4021066|P5|STARTED|Period 5||2
1645601|NCT00757601|4021067|P4|STARTED|Period 5||2
1645602|NCT00757601|4021068|P3|STARTED|Period 5||2
1645603|NCT00757601|4021069|P2|STARTED|Period 5||2
1645604|NCT00757601|4021070|P1|STARTED|Period 5||2
1645605|NCT00757601|4021059|P12|NOT COMPLETED|Period 4||1
1645606|NCT00757601|4021060|P11|NOT COMPLETED|Period 4||0
1645607|NCT00757601|4021061|P10|NOT COMPLETED|Period 4||1
1645608|NCT00757601|4021062|P9|NOT COMPLETED|Period 4||0
1645609|NCT00757601|4021063|P8|NOT COMPLETED|Period 4||0
1645610|NCT00757601|4021064|P7|NOT COMPLETED|Period 4||0
1645611|NCT00757601|4021065|P6|NOT COMPLETED|Period 4||0
1645612|NCT00757601|4021066|P5|NOT COMPLETED|Period 4||0
1645613|NCT00757601|4021067|P4|NOT COMPLETED|Period 4||0
1645614|NCT00757601|4021068|P3|NOT COMPLETED|Period 4||0
1645615|NCT00757601|4021069|P2|NOT COMPLETED|Period 4||0
1645616|NCT00757601|4021070|P1|NOT COMPLETED|Period 4||0
1645617|NCT00757601|4021059|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
1645618|NCT00757601|4021060|P11|COMPLETED|Period 4||2
1645619|NCT00757601|4021061|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
1645620|NCT00757601|4021062|P9|COMPLETED|Period 4||2
1645621|NCT00757601|4021063|P8|COMPLETED|Period 4||2
1645622|NCT00757601|4021064|P7|COMPLETED|Period 4||2
1645623|NCT00757601|4021065|P6|COMPLETED|Period 4||2
1645624|NCT00757601|4021066|P5|COMPLETED|Period 4||2
1645625|NCT00757601|4021067|P4|COMPLETED|Period 4||2
1645626|NCT00757601|4021068|P3|COMPLETED|Period 4||2
1645627|NCT00757601|4021069|P2|COMPLETED|Period 4||2
1645628|NCT00757601|4021070|P1|COMPLETED|Period 4||2
1645629|NCT00757601|4021059|P12|STARTED|Period 4||2
1645630|NCT00757601|4021060|P11|STARTED|Period 4||2
1645631|NCT00757601|4021061|P10|STARTED|Period 4||2
1645632|NCT00757601|4021062|P9|STARTED|Period 4||2
1645633|NCT00757601|4021063|P8|STARTED|Period 4||2
1645634|NCT00757601|4021064|P7|STARTED|Period 4||2
1645635|NCT00757601|4021065|P6|STARTED|Period 4||2
1645636|NCT00757601|4021066|P5|STARTED|Period 4||2
1645637|NCT00757601|4021067|P4|STARTED|Period 4||2
1645638|NCT00757601|4021068|P3|STARTED|Period 4||2
1645639|NCT00757601|4021069|P2|STARTED|Period 4||2
1645640|NCT00757601|4021070|P1|STARTED|Period 4||2
1645641|NCT00757601|4021059|P12|NOT COMPLETED|Period 3||0
1645642|NCT00757601|4021060|P11|NOT COMPLETED|Period 3||0
1645643|NCT00757601|4021061|P10|NOT COMPLETED|Period 3||0
1645644|NCT00757601|4021062|P9|NOT COMPLETED|Period 3||0
1645645|NCT00757601|4021063|P8|NOT COMPLETED|Period 3||0
1645646|NCT00757601|4021064|P7|NOT COMPLETED|Period 3||0
1645647|NCT00757601|4021065|P6|NOT COMPLETED|Period 3||0
1645648|NCT00757601|4021066|P5|NOT COMPLETED|Period 3||0
1645649|NCT00757601|4021067|P4|NOT COMPLETED|Period 3||0
1645650|NCT00757601|4021068|P3|NOT COMPLETED|Period 3||0
1645651|NCT00757601|4021069|P2|NOT COMPLETED|Period 3||0
1645652|NCT00757601|4021070|P1|NOT COMPLETED|Period 3||0
1645653|NCT00757601|4021059|P12|COMPLETED|Period 3||2
1645654|NCT00757601|4021060|P11|COMPLETED|Period 3||2
1645655|NCT00757601|4021061|P10|COMPLETED|Period 3||2
1645656|NCT00757601|4021062|P9|COMPLETED|Period 3||2
1645657|NCT00757601|4021063|P8|COMPLETED|Period 3||2
1645658|NCT00757601|4021064|P7|COMPLETED|Period 3||2
1645659|NCT00757601|4021065|P6|COMPLETED|Period 3||2
1645660|NCT00757601|4021066|P5|COMPLETED|Period 3||2
1645661|NCT00757601|4021067|P4|COMPLETED|Period 3||2
1645662|NCT00757601|4021068|P3|COMPLETED|Period 3||2
1645663|NCT00757601|4021069|P2|COMPLETED|Period 3||2
1645664|NCT00757601|4021070|P1|COMPLETED|Period 3||2
1645665|NCT00757601|4021059|P12|STARTED|Period 3||2
1645666|NCT00757601|4021060|P11|STARTED|Period 3||2
1645667|NCT00757601|4021061|P10|STARTED|Period 3||2
1645668|NCT00757601|4021062|P9|STARTED|Period 3||2
1645669|NCT00757601|4021063|P8|STARTED|Period 3||2
1645670|NCT00757601|4021064|P7|STARTED|Period 3||2
1645671|NCT00757601|4021065|P6|STARTED|Period 3||2
1645672|NCT00757601|4021066|P5|STARTED|Period 3||2
1645673|NCT00757601|4021067|P4|STARTED|Period 3||2
1645674|NCT00757601|4021068|P3|STARTED|Period 3||2
1645675|NCT00757601|4021069|P2|STARTED|Period 3||2
1645676|NCT00757601|4021070|P1|STARTED|Period 3||2
1645677|NCT00757601|4021059|P12|NOT COMPLETED|Period 2||1
1645678|NCT00757601|4021060|P11|NOT COMPLETED|Period 2||0
1645679|NCT00757601|4021061|P10|NOT COMPLETED|Period 2||0
1645680|NCT00757601|4021062|P9|NOT COMPLETED|Period 2||0
1645681|NCT00757601|4021063|P8|NOT COMPLETED|Period 2||0
1645682|NCT00757601|4021064|P7|NOT COMPLETED|Period 2||0
1645683|NCT00757601|4021065|P6|NOT COMPLETED|Period 2||0
1645684|NCT00757601|4021066|P5|NOT COMPLETED|Period 2||0
1645685|NCT00757601|4021067|P4|NOT COMPLETED|Period 2||0
1645686|NCT00757601|4021068|P3|NOT COMPLETED|Period 2||0
1645687|NCT00757601|4021069|P2|NOT COMPLETED|Period 2||0
1645688|NCT00757601|4021070|P1|NOT COMPLETED|Period 2||0
1645689|NCT00757601|4021059|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
1645690|NCT00757601|4021060|P11|COMPLETED|Period 2||2
1645691|NCT00757601|4021061|P10|COMPLETED|Period 2||2
1645692|NCT00757601|4021062|P9|COMPLETED|Period 2||2
1645693|NCT00757601|4021063|P8|COMPLETED|Period 2||2
1645694|NCT00757601|4021064|P7|COMPLETED|Period 2||2
1645695|NCT00757601|4021065|P6|COMPLETED|Period 2||2
1645696|NCT00757601|4021066|P5|COMPLETED|Period 2||2
1645697|NCT00757601|4021067|P4|COMPLETED|Period 2||2
1645698|NCT00757601|4021068|P3|COMPLETED|Period 2||2
1645699|NCT00757601|4021069|P2|COMPLETED|Period 2||2
1645700|NCT00757601|4021070|P1|COMPLETED|Period 2||2
1645701|NCT00757601|4021059|P12|STARTED|Period 2||3
1645702|NCT00757601|4021060|P11|STARTED|Period 2||2
1645703|NCT00757601|4021061|P10|STARTED|Period 2||2
1645704|NCT00757601|4021062|P9|STARTED|Period 2||2
1645705|NCT00757601|4021063|P8|STARTED|Period 2||2
1645706|NCT00757601|4021064|P7|STARTED|Period 2||2
1645707|NCT00757601|4021065|P6|STARTED|Period 2||2
1645708|NCT00757601|4021066|P5|STARTED|Period 2||2
1645709|NCT00757601|4021067|P4|STARTED|Period 2||2
1645710|NCT00757601|4021068|P3|STARTED|Period 2||2
1645711|NCT00757601|4021069|P2|STARTED|Period 2||2
1645712|NCT00757601|4021070|P1|STARTED|Period 2||2
1645713|NCT00757601|4021059|P12|NOT COMPLETED|Period 1||0
1645714|NCT00757601|4021060|P11|NOT COMPLETED|Period 1||0
1645715|NCT00757601|4021061|P10|NOT COMPLETED|Period 1||0
1645716|NCT00757601|4021062|P9|NOT COMPLETED|Period 1||0
1645717|NCT00757601|4021063|P8|NOT COMPLETED|Period 1||0
1645718|NCT00757601|4021064|P7|NOT COMPLETED|Period 1||0
1645719|NCT00757601|4021065|P6|NOT COMPLETED|Period 1||0
1645720|NCT00757601|4021066|P5|NOT COMPLETED|Period 1||0
1645721|NCT00757601|4021067|P4|NOT COMPLETED|Period 1||0
1645722|NCT00757601|4021068|P3|NOT COMPLETED|Period 1||0
1645723|NCT00757601|4021069|P2|NOT COMPLETED|Period 1||0
1645724|NCT00757601|4021070|P1|NOT COMPLETED|Period 1||0
1645725|NCT00757601|4021059|P12|COMPLETED|Period 1||3
1645726|NCT00757601|4021060|P11|COMPLETED|Period 1||2
1645727|NCT00757601|4021061|P10|COMPLETED|Period 1||2
1645728|NCT00757601|4021062|P9|COMPLETED|Period 1||2
1645729|NCT00757601|4021063|P8|COMPLETED|Period 1||2
1645730|NCT00757601|4021064|P7|COMPLETED|Period 1||2
1645731|NCT00757601|4021065|P6|COMPLETED|Period 1||2
1645732|NCT00757601|4021066|P5|COMPLETED|Period 1||2
1645733|NCT00757601|4021067|P4|COMPLETED|Period 1||2
1645734|NCT00757601|4021068|P3|COMPLETED|Period 1||2
1645735|NCT00757601|4021069|P2|COMPLETED|Period 1||2
1645736|NCT00757601|4021070|P1|COMPLETED|Period 1||2
1645737|NCT00757601|4021059|P12|STARTED|Period 1||3
1645738|NCT00757601|4021060|P11|STARTED|Period 1||2
1645739|NCT00757601|4021061|P10|STARTED|Period 1||2
1645740|NCT00757601|4021062|P9|STARTED|Period 1||2
1645741|NCT00757601|4021063|P8|STARTED|Period 1||2
1645742|NCT00757601|4021064|P7|STARTED|Period 1||2
1645743|NCT00757601|4021065|P6|STARTED|Period 1||2
1645744|NCT00757601|4021066|P5|STARTED|Period 1||2
1645745|NCT00757601|4021067|P4|STARTED|Period 1||2
1645746|NCT00757601|4021068|P3|STARTED|Period 1||2
1645747|NCT00757601|4021069|P2|STARTED|Period 1||2
1645748|NCT00757601|4021070|P1|STARTED|Period 1||2
1645749|NCT00757588|4021181|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
1645750|NCT00757588|4021182|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
1645751|NCT00757588|4021181|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
1645752|NCT00757588|4021182|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
1645753|NCT00757588|4021181|P2|STARTED|Period 2: Long-term (52-week) Phase||134
1645754|NCT00757588|4021182|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
1645755|NCT00757588|4021181|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
1645756|NCT00757588|4021182|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
1645757|NCT00757588|4021181|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
1645758|NCT00757588|4021182|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
1645759|NCT00757588|4021181|P2|STARTED|Period 1: Short-term (24-week) Phase||151
1645760|NCT00757588|4021182|P1|STARTED|Period 1: Short-term (24-week) Phase||304
1645761|NCT00757484|4021214|P1|NOT COMPLETED|Overall Study||0
1645762|NCT00757484|4021214|P1|COMPLETED|Overall Study||491
1645763|NCT00757484|4021214|P1|STARTED|Overall Study||491
1645764|NCT00757237|4021223|P2|NOT COMPLETED|Overall Study||25
1645765|NCT00757237|4021224|P1|NOT COMPLETED|Overall Study||13
1645766|NCT00757237|4021223|P2|COMPLETED|Overall Study||111
1645767|NCT00757237|4021224|P1|COMPLETED|Overall Study||124
1645768|NCT00757237|4021223|P2|Treated|Overall Study||132
1645769|NCT00757237|4021224|P1|Treated|Overall Study||136
1645770|NCT00757237|4021223|P2|STARTED|Overall Study||136
1645771|NCT00757237|4021224|P1|STARTED|Overall Study||137
1645772|NCT00757172|4021252|P1|NOT COMPLETED|Overall Study||11
1645773|NCT00757172|4021252|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
1645774|NCT00757172|4021252|P1|STARTED|Overall Study||65
1645775|NCT00757003|4021260|P1|NOT COMPLETED|Overall Study||49
1645776|NCT00757003|4021260|P1|COMPLETED|Overall Study||51
1645777|NCT00757003|4021260|P1|STARTED|Overall Study||100
1645778|NCT00756977|4021268|P2|NOT COMPLETED|Overall Study||11
1645779|NCT00756977|4021269|P1|NOT COMPLETED|Overall Study||21
1645780|NCT00756977|4021268|P2|COMPLETED|Overall Study||187
1645781|NCT00756977|4021269|P1|COMPLETED|Overall Study||175
1645782|NCT00756977|4021268|P2|STARTED|Overall Study||198
1645783|NCT00756977|4021269|P1|STARTED|Overall Study||196
1645784|NCT00756964|4021297|P2|NOT COMPLETED|Overall Study||0
1645785|NCT00756964|4021298|P1|NOT COMPLETED|Overall Study||0
1645786|NCT00756964|4021297|P2|COMPLETED|Overall Study||13
1645787|NCT00756964|4021298|P1|COMPLETED|Overall Study||13
1645788|NCT00756964|4021297|P2|STARTED|Overall Study||13
1645789|NCT00756964|4021298|P1|STARTED|Overall Study||13
1645790|NCT00756938|4021307|P4|NOT COMPLETED|Optional Extension||37
1645791|NCT00756938|4021308|P3|NOT COMPLETED|Optional Extension||0
1645792|NCT00756938|4021309|P2|NOT COMPLETED|Optional Extension||0
1645793|NCT00756938|4021310|P1|NOT COMPLETED|Optional Extension||0
1645794|NCT00756938|4021307|P4|COMPLETED|Optional Extension||53
1645795|NCT00756938|4021308|P3|COMPLETED|Optional Extension||0
1645796|NCT00756938|4021309|P2|COMPLETED|Optional Extension||0
1645797|NCT00756938|4021310|P1|COMPLETED|Optional Extension||0
1645798|NCT00756938|4021307|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
1645799|NCT00756938|4021308|P3|STARTED|Optional Extension||0
1645800|NCT00756938|4021309|P2|STARTED|Optional Extension||0
1645801|NCT00756938|4021310|P1|STARTED|Optional Extension||0
1645802|NCT00756938|4021307|P4|NOT COMPLETED|12-week Base Study||0
1645803|NCT00756938|4021308|P3|NOT COMPLETED|12-week Base Study||2
1645804|NCT00756938|4021309|P2|NOT COMPLETED|12-week Base Study||0
1645805|NCT00756938|4021310|P1|NOT COMPLETED|12-week Base Study||2
1645806|NCT00756938|4021307|P4|COMPLETED|12-week Base Study||0
1645807|NCT00756938|4021308|P3|COMPLETED|12-week Base Study||32
1645808|NCT00756938|4021309|P2|COMPLETED|12-week Base Study||34
1645809|NCT00756938|4021310|P1|COMPLETED|12-week Base Study||31
1645810|NCT00756938|4021307|P4|STARTED|12-week Base Study||0
1645811|NCT00756938|4021308|P3|STARTED|12-week Base Study||34
1645812|NCT00756938|4021309|P2|STARTED|12-week Base Study||34
1645813|NCT00756938|4021310|P1|STARTED|12-week Base Study||33
1645814|NCT00756886|4021338|P2|NOT COMPLETED|Overall Study||7
1645815|NCT00756886|4021339|P1|NOT COMPLETED|Overall Study||11
1645816|NCT00756886|4021338|P2|COMPLETED|Overall Study||25
1645817|NCT00756886|4021339|P1|COMPLETED|Overall Study||30
1645818|NCT00756886|4021338|P2|STARTED|Overall Study||32
1645819|NCT00756886|4021339|P1|STARTED|Overall Study||41
1645820|NCT00756730|4021347|P2|NOT COMPLETED|Overall Study||2
1645821|NCT00756730|4021348|P1|NOT COMPLETED|Overall Study||0
1645822|NCT00756730|4021347|P2|COMPLETED|Overall Study||22
1645823|NCT00756730|4021348|P1|COMPLETED|Overall Study||25
1645824|NCT00756730|4021347|P2|STARTED|Overall Study||24
1645825|NCT00756730|4021348|P1|STARTED|Overall Study||25
1645826|NCT00756678|4021368|P1|NOT COMPLETED|Overall Study||1
1645827|NCT00756678|4021368|P1|COMPLETED|Overall Study||50
1645828|NCT00756678|4021368|P1|STARTED|Overall Study||51
1645829|NCT00756574|4021381|P2|NOT COMPLETED|Overall Study||11
1645830|NCT00756574|4021382|P1|NOT COMPLETED|Overall Study||13
1645831|NCT00756574|4021381|P2|COMPLETED|Overall Study||210
1645832|NCT00756574|4021382|P1|COMPLETED|Overall Study||212
1645833|NCT00756574|4021381|P2|STARTED|Overall Study||221
1645834|NCT00756574|4021382|P1|STARTED|Overall Study||225
1645835|NCT00756561|4021392|P1|NOT COMPLETED|Overall Study||0
1645836|NCT00756561|4021392|P1|COMPLETED|Overall Study||10
1645837|NCT00756561|4021392|P1|STARTED|Overall Study||10
1645838|NCT00756548|4021399|P2|NOT COMPLETED|Overall Study||0
1645839|NCT00756548|4021400|P1|NOT COMPLETED|Overall Study||2
1645840|NCT00756548|4021399|P2|COMPLETED|Overall Study||185
1645841|NCT00756548|4021400|P1|COMPLETED|Overall Study||184
1645842|NCT00756548|4021399|P2|STARTED|Overall Study||185
1645843|NCT00756548|4021400|P1|STARTED|Overall Study||186
1645844|NCT00756470|4021426|P1|NOT COMPLETED|Overall Study||5
1645845|NCT00756470|4021426|P1|COMPLETED|Overall Study||10
1645846|NCT00756470|4021426|P1|STARTED|Overall Study||15
1645847|NCT00756457|4021433|P2|NOT COMPLETED|Overall Study||2
1645848|NCT00756457|4021434|P1|NOT COMPLETED|Overall Study||1
1645849|NCT00756457|4021433|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
1645850|NCT00756457|4021434|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
1645851|NCT00756457|4021433|P2|STARTED|Overall Study||19
1645852|NCT00756457|4021434|P1|STARTED|Overall Study||20
1645853|NCT00756444|4021464|P2|NOT COMPLETED|Overall Study||21
1645854|NCT00756444|4021465|P1|NOT COMPLETED|Overall Study||15
1645855|NCT00756444|4021464|P2|COMPLETED|Overall Study||13
1645856|NCT00756444|4021465|P1|COMPLETED|Overall Study||18
1645857|NCT00756444|4021464|P2|STARTED|Overall Study||34
1645858|NCT00756444|4021465|P1|STARTED|Overall Study||33
1645859|NCT00756314|4021476|P2|NOT COMPLETED|Overall Study||59
1645860|NCT00756314|4021477|P1|NOT COMPLETED|Overall Study||2
1645861|NCT00756314|4021476|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
1645862|NCT00756314|4021477|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
1645863|NCT00756314|4021476|P2|STARTED|Overall Study||123
1645864|NCT00756314|4021477|P1|STARTED|Overall Study||123
1645865|NCT00756275|4021493|P2|NOT COMPLETED|Overall Study||28
1645866|NCT00756275|4021494|P1|NOT COMPLETED|Overall Study||29
1645867|NCT00756275|4021493|P2|COMPLETED|Overall Study||49
1645868|NCT00756275|4021494|P1|COMPLETED|Overall Study||31
1645869|NCT00756275|4021493|P2|STARTED|Overall Study||77
1645870|NCT00756275|4021494|P1|STARTED|Overall Study||60
1645871|NCT00756236|4021521|P3|NOT COMPLETED|Overall Study||0
1645872|NCT00756236|4021522|P2|NOT COMPLETED|Overall Study||0
1645873|NCT00756236|4021523|P1|NOT COMPLETED|Overall Study||0
1645874|NCT00756236|4021521|P3|COMPLETED|Overall Study||20
1645875|NCT00756236|4021522|P2|COMPLETED|Overall Study||20
1645876|NCT00756236|4021523|P1|COMPLETED|Overall Study||20
1645877|NCT00756236|4021521|P3|STARTED|Overall Study||20
1645878|NCT00756236|4021522|P2|STARTED|Overall Study||20
1645879|NCT00756236|4021523|P1|STARTED|Overall Study||20
1645880|NCT00756093|4021531|P4|NOT COMPLETED|Fourth Intervention||0
1645881|NCT00756093|4021532|P3|NOT COMPLETED|Fourth Intervention||0
1645882|NCT00756093|4021533|P2|NOT COMPLETED|Fourth Intervention||0
1645883|NCT00756093|4021534|P1|NOT COMPLETED|Fourth Intervention||0
1645884|NCT00756093|4021531|P4|COMPLETED|Fourth Intervention||5
1645885|NCT00756093|4021532|P3|COMPLETED|Fourth Intervention||5
1645886|NCT00756093|4021533|P2|COMPLETED|Fourth Intervention||5
1645887|NCT00756093|4021534|P1|COMPLETED|Fourth Intervention||5
1645888|NCT00756093|4021531|P4|STARTED|Fourth Intervention||5
1645889|NCT00756093|4021532|P3|STARTED|Fourth Intervention||5
1645890|NCT00756093|4021533|P2|STARTED|Fourth Intervention||5
1645891|NCT00756093|4021534|P1|STARTED|Fourth Intervention||5
1645892|NCT00756093|4021531|P4|NOT COMPLETED|Third Intervention||0
1645893|NCT00756093|4021532|P3|NOT COMPLETED|Third Intervention||0
1645894|NCT00756093|4021533|P2|NOT COMPLETED|Third Intervention||0
1645895|NCT00756093|4021534|P1|NOT COMPLETED|Third Intervention||0
1645896|NCT00756093|4021531|P4|COMPLETED|Third Intervention||5
1645897|NCT00756093|4021532|P3|COMPLETED|Third Intervention||5
1645898|NCT00756093|4021533|P2|COMPLETED|Third Intervention||5
1645899|NCT00756093|4021534|P1|COMPLETED|Third Intervention||5
1645900|NCT00756093|4021531|P4|STARTED|Third Intervention||5
1645901|NCT00756093|4021532|P3|STARTED|Third Intervention||5
1645902|NCT00756093|4021533|P2|STARTED|Third Intervention||5
1645903|NCT00756093|4021534|P1|STARTED|Third Intervention||5
1645904|NCT00756093|4021531|P4|NOT COMPLETED|Second Intervention||0
1645905|NCT00756093|4021532|P3|NOT COMPLETED|Second Intervention||0
1645906|NCT00756093|4021533|P2|NOT COMPLETED|Second Intervention||0
1645907|NCT00756093|4021534|P1|NOT COMPLETED|Second Intervention||0
1645908|NCT00756093|4021531|P4|COMPLETED|Second Intervention||5
1645909|NCT00756093|4021532|P3|COMPLETED|Second Intervention||5
1645910|NCT00756093|4021533|P2|COMPLETED|Second Intervention||5
1645911|NCT00756093|4021534|P1|COMPLETED|Second Intervention||5
1645912|NCT00756093|4021531|P4|STARTED|Second Intervention||5
1645913|NCT00756093|4021532|P3|STARTED|Second Intervention||5
1645914|NCT00756093|4021533|P2|STARTED|Second Intervention||5
1645915|NCT00756093|4021534|P1|STARTED|Second Intervention||5
1645916|NCT00756093|4021531|P4|NOT COMPLETED|First Intervention||0
1645917|NCT00756093|4021532|P3|NOT COMPLETED|First Intervention||0
1645918|NCT00756093|4021533|P2|NOT COMPLETED|First Intervention||0
1645919|NCT00756093|4021534|P1|NOT COMPLETED|First Intervention||0
1645920|NCT00756093|4021531|P4|COMPLETED|First Intervention||5
1645921|NCT00756093|4021532|P3|COMPLETED|First Intervention||5
1645922|NCT00756093|4021533|P2|COMPLETED|First Intervention||5
1645923|NCT00756093|4021534|P1|COMPLETED|First Intervention||5
1645924|NCT00756093|4021531|P4|STARTED|First Intervention||5
1645925|NCT00756093|4021532|P3|STARTED|First Intervention||5
1645926|NCT00756093|4021533|P2|STARTED|First Intervention||5
1645927|NCT00756093|4021534|P1|STARTED|First Intervention||5
1645928|NCT00756002|4021546|P2|NOT COMPLETED|Placebo Run-out||0
1645929|NCT00756002|4021547|P1|NOT COMPLETED|Placebo Run-out||0
1645930|NCT00756002|4021546|P2|COMPLETED|Placebo Run-out||0
1645931|NCT00756002|4021547|P1|COMPLETED|Placebo Run-out||114
1645932|NCT00756002|4021546|P2|STARTED|Placebo Run-out||0
1645933|NCT00756002|4021547|P1|STARTED|Placebo Run-out||114
1645934|NCT00756002|4021546|P2|NOT COMPLETED|Double-Blind Treatment Period||15
1645935|NCT00756002|4021547|P1|NOT COMPLETED|Double-Blind Treatment Period||15
1645936|NCT00756002|4021546|P2|COMPLETED|Double-Blind Treatment Period||115
1645937|NCT00756002|4021547|P1|COMPLETED|Double-Blind Treatment Period||114
1645938|NCT00756002|4021546|P2|STARTED|Double-Blind Treatment Period||130
1645939|NCT00756002|4021547|P1|STARTED|Double-Blind Treatment Period||129
1645940|NCT00756002|4021546|P2|NOT COMPLETED|Placebo Run-in||0
1645941|NCT00756002|4021547|P1|NOT COMPLETED|Placebo Run-in||229
1645942|NCT00756002|4021546|P2|COMPLETED|Placebo Run-in||0
1645943|NCT00756002|4021547|P1|COMPLETED|Placebo Run-in||259
1645944|NCT00756002|4021546|P2|STARTED|Placebo Run-in||0
1645945|NCT00756002|4021547|P1|STARTED|Placebo Run-in||488
1645946|NCT00755937|4021641|P1|NOT COMPLETED|Observational Follow-up||148
1645947|NCT00755937|4021641|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
1645948|NCT00755937|4021641|P1|STARTED|Observational Follow-up||392
1645949|NCT00755937|4021641|P1|NOT COMPLETED|Recruitment||164
1645950|NCT00755937|4021641|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
1645951|NCT00755937|4021641|P1|STARTED|Recruitment|Subjects registered in the program|556
1645952|NCT00755911|4021653|P2|NOT COMPLETED|Overall Study||0
1645953|NCT00755911|4021654|P1|NOT COMPLETED|Overall Study||0
1645954|NCT00755911|4021653|P2|COMPLETED|Overall Study||12
1645955|NCT00755911|4021654|P1|COMPLETED|Overall Study||12
1645956|NCT00755911|4021653|P2|STARTED|Overall Study||12
1645957|NCT00755911|4021654|P1|STARTED|Overall Study||12
1645958|NCT00755846|4021668|P6|NOT COMPLETED|Overall Study||14
1645959|NCT00755846|4021669|P5|NOT COMPLETED|Overall Study||17
1645960|NCT00755846|4021670|P4|NOT COMPLETED|Overall Study||13
1645961|NCT00755846|4021671|P3|NOT COMPLETED|Overall Study||12
1645962|NCT00755846|4021672|P2|NOT COMPLETED|Overall Study||17
1645963|NCT00755846|4021673|P1|NOT COMPLETED|Overall Study||25
1645964|NCT00755846|4021668|P6|COMPLETED|Overall Study||31
1645965|NCT00755846|4021669|P5|COMPLETED|Overall Study||27
1645966|NCT00755846|4021670|P4|COMPLETED|Overall Study||32
1645967|NCT00755846|4021671|P3|COMPLETED|Overall Study||32
1645968|NCT00755846|4021672|P2|COMPLETED|Overall Study||27
1645969|NCT00755846|4021673|P1|COMPLETED|Overall Study||18
1645970|NCT00755846|4021668|P6|STARTED|Overall Study||45
1645971|NCT00755846|4021669|P5|STARTED|Overall Study||44
1645972|NCT00755846|4021670|P4|STARTED|Overall Study||45
1645973|NCT00755846|4021671|P3|STARTED|Overall Study||44
1645974|NCT00755846|4021672|P2|STARTED|Overall Study||44
1645975|NCT00755846|4021673|P1|STARTED|Overall Study||43
1645976|NCT00755807|4021773|P2|NOT COMPLETED|Open-label Extension Phase||16
1645977|NCT00755807|4021774|P1|NOT COMPLETED|Open-label Extension Phase||18
1645978|NCT00755807|4021773|P2|COMPLETED|Open-label Extension Phase||93
1645979|NCT00755807|4021774|P1|COMPLETED|Open-label Extension Phase||82
1645980|NCT00755807|4021773|P2|STARTED|Open-label Extension Phase||109
1645981|NCT00755807|4021774|P1|STARTED|Open-label Extension Phase||100
1645982|NCT00755807|4021773|P2|NOT COMPLETED|Acute Phase||12
1645983|NCT00755807|4021774|P1|NOT COMPLETED|Acute Phase||18
1645984|NCT00755807|4021773|P2|COMPLETED|Acute Phase||109
1645985|NCT00755807|4021774|P1|COMPLETED|Acute Phase||100
1645986|NCT00755807|4021773|P2|STARTED|Acute Phase||121
1645987|NCT00755807|4021774|P1|STARTED|Acute Phase||118
1645988|NCT00755755|4021838|P3|NOT COMPLETED|Overall Study||3
1645989|NCT00755755|4021839|P2|NOT COMPLETED|Overall Study||8
1645990|NCT00755755|4021840|P1|NOT COMPLETED|Overall Study||6
1645991|NCT00755755|4021838|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
1645992|NCT00755755|4021839|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
1645993|NCT00755755|4021840|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
1645994|NCT00755755|4021838|P3|STARTED|Overall Study|Safety population|48
1645995|NCT00755755|4021839|P2|STARTED|Overall Study|Safety population|98
1645996|NCT00755755|4021840|P1|STARTED|Overall Study|Safety population|95
1645997|NCT00755716|4021854|P3|NOT COMPLETED|Overall Study||3
1645998|NCT00755716|4021855|P2|NOT COMPLETED|Overall Study||8
1645999|NCT00755716|4021856|P1|NOT COMPLETED|Overall Study||8
1646000|NCT00755716|4021854|P3|COMPLETED|Overall Study||16
1646001|NCT00755716|4021855|P2|COMPLETED|Overall Study||11
1646002|NCT00755716|4021856|P1|COMPLETED|Overall Study||11
1646003|NCT00755716|4021854|P3|STARTED|Overall Study||19
1646004|NCT00755716|4021855|P2|STARTED|Overall Study||19
1646005|NCT00755716|4021856|P1|STARTED|Overall Study||19
1646006|NCT00755417|4021870|P3|NOT COMPLETED|Overall Study||42
1646007|NCT00755417|4021871|P2|NOT COMPLETED|Overall Study||55
1646008|NCT00755417|4021872|P1|NOT COMPLETED|Overall Study||62
1646009|NCT00755417|4021870|P3|COMPLETED|Overall Study||135
1646010|NCT00755417|4021871|P2|COMPLETED|Overall Study||126
1646011|NCT00755417|4021872|P1|COMPLETED|Overall Study||112
1646012|NCT00755417|4021870|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
1646013|NCT00755417|4021871|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
1646014|NCT00755417|4021872|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
1646015|NCT00755274|4021891|P2|NOT COMPLETED|Overall Study||0
1646016|NCT00755274|4021892|P1|NOT COMPLETED|Overall Study||0
1646017|NCT00755274|4021891|P2|COMPLETED|Overall Study||8
1646018|NCT00755274|4021892|P1|COMPLETED|Overall Study||24
1646019|NCT00755274|4021891|P2|STARTED|Overall Study||8
1646020|NCT00755274|4021892|P1|STARTED|Overall Study||24
1646021|NCT00755261|4021912|P1|NOT COMPLETED|Overall Study||2
1646022|NCT00755261|4021912|P1|COMPLETED|Overall Study||4
1646023|NCT00755261|4021912|P1|STARTED|Overall Study||6
1646024|NCT00755235|4021918|P2|NOT COMPLETED|Overall Study||9
1646025|NCT00755235|4021919|P1|NOT COMPLETED|Overall Study||2
1646026|NCT00755235|4021918|P2|COMPLETED|Overall Study||93
1646027|NCT00755235|4021919|P1|COMPLETED|Overall Study||104
1646028|NCT00755235|4021918|P2|STARTED|Overall Study||102
1646029|NCT00755235|4021919|P1|STARTED|Overall Study||106
1646030|NCT00755222|4021929|P2|NOT COMPLETED|Overall Study||2
1646031|NCT00755222|4021930|P1|NOT COMPLETED|Overall Study||8
1646032|NCT00755222|4021929|P2|COMPLETED|Overall Study||34
1646033|NCT00755222|4021930|P1|COMPLETED|Overall Study||103
1646034|NCT00755222|4021929|P2|STARTED|Overall Study||36
1646035|NCT00755222|4021930|P1|STARTED|Overall Study||111
1646036|NCT00755196|4021944|P1|NOT COMPLETED|Overall Study||2
1646037|NCT00755196|4021944|P1|COMPLETED|Overall Study||28
1646038|NCT00755196|4021944|P1|STARTED|Overall Study||30
1646039|NCT00755131|4021951|P2|NOT COMPLETED|Overall Study||0
1646040|NCT00755131|4021952|P1|NOT COMPLETED|Overall Study||0
1646041|NCT00755131|4021951|P2|COMPLETED|Overall Study||38
1646042|NCT00755131|4021952|P1|COMPLETED|Overall Study||37
1646043|NCT00755131|4021951|P2|STARTED|Overall Study||38
1646044|NCT00755131|4021952|P1|STARTED|Overall Study||37
1646045|NCT00755105|4021965|P3|NOT COMPLETED|Overall Study||4
1646046|NCT00755105|4021966|P2|NOT COMPLETED|Overall Study||11
1646047|NCT00755105|4021967|P1|NOT COMPLETED|Overall Study||9
1646048|NCT00755105|4021965|P3|COMPLETED|Overall Study||5
1646049|NCT00755105|4021966|P2|COMPLETED|Overall Study||19
1646050|NCT00755105|4021967|P1|COMPLETED|Overall Study||29
1646051|NCT00755105|4021965|P3|STARTED|Overall Study||9
1646052|NCT00755105|4021966|P2|STARTED|Overall Study||30
1646053|NCT00755105|4021967|P1|STARTED|Overall Study||38
1646054|NCT00755079|4021977|P2|NOT COMPLETED|Overall Study||6
1646055|NCT00755079|4021978|P1|NOT COMPLETED|Overall Study||1
1646056|NCT00755079|4021977|P2|COMPLETED|Overall Study||16
1646057|NCT00755079|4021978|P1|COMPLETED|Overall Study||17
1646058|NCT00755079|4021977|P2|STARTED|Overall Study||22
1646059|NCT00755079|4021978|P1|STARTED|Overall Study||18
1646060|NCT00755040|4021988|P2|NOT COMPLETED|Overall Study||34
1646061|NCT00755040|4021989|P1|NOT COMPLETED|Overall Study||43
1646062|NCT00755040|4021988|P2|COMPLETED|Overall Study||47
1646063|NCT00755040|4021989|P1|COMPLETED|Overall Study||40
1646064|NCT00755040|4021988|P2|STARTED|Overall Study||81
1646065|NCT00755040|4021989|P1|STARTED|Overall Study||83
1646066|NCT00754923|4021997|P1|NOT COMPLETED|Overall Study||0
1646067|NCT00754923|4021997|P1|COMPLETED|Overall Study||11
1646068|NCT00754923|4021997|P1|STARTED|Overall Study||11
1646069|NCT00754845|4022004|P2|NOT COMPLETED|Overall Study||0
1646070|NCT00754845|4022005|P1|NOT COMPLETED|Overall Study||0
1646071|NCT00754845|4022004|P2|COMPLETED|Overall Study||959
1646072|NCT00754845|4022005|P1|COMPLETED|Overall Study||959
1646073|NCT00754845|4022004|P2|STARTED|Overall Study||959
1646074|NCT00754845|4022005|P1|STARTED|Overall Study||959
1646075|NCT00754832|4022017|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
1646076|NCT00754832|4022018|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
1646077|NCT00754832|4022017|P2|COMPLETED|Second 6 Weeks Intervention||24
1646078|NCT00754832|4022018|P1|COMPLETED|Second 6 Weeks Intervention||17
1646079|NCT00754832|4022017|P2|STARTED|Second 6 Weeks Intervention||26
1646080|NCT00754832|4022018|P1|STARTED|Second 6 Weeks Intervention||17
1646081|NCT00754832|4022017|P2|NOT COMPLETED|2 Weeks Washout||2
1646082|NCT00754832|4022018|P1|NOT COMPLETED|2 Weeks Washout||1
1646083|NCT00754832|4022017|P2|COMPLETED|2 Weeks Washout||26
1646084|NCT00754832|4022018|P1|COMPLETED|2 Weeks Washout||17
1646085|NCT00754832|4022017|P2|STARTED|2 Weeks Washout||28
1646086|NCT00754832|4022018|P1|STARTED|2 Weeks Washout||18
1646087|NCT00754832|4022017|P2|NOT COMPLETED|First 6 Weeks Intervention||2
1646088|NCT00754832|4022018|P1|NOT COMPLETED|First 6 Weeks Intervention||8
1646089|NCT00754832|4022017|P2|COMPLETED|First 6 Weeks Intervention||28
1646090|NCT00754832|4022018|P1|COMPLETED|First 6 Weeks Intervention||18
1646091|NCT00754832|4022017|P2|STARTED|First 6 Weeks Intervention||30
1646092|NCT00754832|4022018|P1|STARTED|First 6 Weeks Intervention||26
1646093|NCT00754793|4022030|P2|NOT COMPLETED|Overall Study||1
1646094|NCT00754793|4022031|P1|NOT COMPLETED|Overall Study||0
1646095|NCT00754793|4022030|P2|COMPLETED|Overall Study||1
1646096|NCT00754793|4022031|P1|COMPLETED|Overall Study||1
1646097|NCT00754793|4022030|P2|STARTED|Overall Study||2
1646098|NCT00754793|4022031|P1|STARTED|Overall Study||1
1646099|NCT00754767|4022039|P2|NOT COMPLETED|Overall Study||0
1646100|NCT00754767|4022040|P1|NOT COMPLETED|Overall Study||0
1646101|NCT00754767|4022039|P2|COMPLETED|Overall Study||0
1646102|NCT00754767|4022040|P1|COMPLETED|Overall Study||2
1646103|NCT00754767|4022039|P2|STARTED|Overall Study||0
1646104|NCT00754767|4022040|P1|STARTED|Overall Study||2
1646105|NCT00754741|4022049|P3|NOT COMPLETED|Overall Study||54
1646106|NCT00754741|4022050|P2|NOT COMPLETED|Overall Study||69
1646107|NCT00754741|4022051|P1|NOT COMPLETED|Overall Study||57
1646108|NCT00754741|4022049|P3|COMPLETED|Overall Study||502
1646109|NCT00754741|4022050|P2|COMPLETED|Overall Study||500
1646110|NCT00754741|4022051|P1|COMPLETED|Overall Study||510
1646111|NCT00754741|4022049|P3|STARTED|Overall Study||556
1646112|NCT00754741|4022050|P2|STARTED|Overall Study||569
1646113|NCT00754741|4022051|P1|STARTED|Overall Study||567
1646114|NCT00754650|4022098|P1|NOT COMPLETED|Overall Study||2
1646115|NCT00754650|4022098|P1|COMPLETED|Overall Study||0
1646116|NCT00754650|4022098|P1|STARTED|Overall Study||2
1646117|NCT00754624|4022103|P1|NOT COMPLETED|Overall Study||69
1646118|NCT00754624|4022103|P1|COMPLETED|Overall Study||160
1646119|NCT00754624|4022103|P1|STARTED|Overall Study||229
1646120|NCT00754572|4022113|P1|NOT COMPLETED|Overall Study||71
1646121|NCT00754572|4022113|P1|COMPLETED|Overall Study||347
1646122|NCT00754572|4022113|P1|STARTED|Overall Study||418
1646123|NCT00754559|4022140|P1|NOT COMPLETED|Overall Study||47
1646124|NCT00754559|4022140|P1|COMPLETED|Overall Study||239
1646125|NCT00754559|4022140|P1|STARTED|Overall Study||286
1646126|NCT00754546|4022164|P1|NOT COMPLETED|Overall Study||0
1646127|NCT00754546|4022164|P1|COMPLETED|Overall Study||20
1646128|NCT00754546|4022164|P1|STARTED|Overall Study||20
1646129|NCT00754494|4022181|P3|NOT COMPLETED|Overall Study||1
1646130|NCT00754494|4022182|P2|NOT COMPLETED|Overall Study||0
1646131|NCT00754494|4022183|P1|NOT COMPLETED|Overall Study||2
1646132|NCT00754494|4022181|P3|COMPLETED|Overall Study||14
1646133|NCT00754494|4022182|P2|COMPLETED|Overall Study||15
1646134|NCT00754494|4022183|P1|COMPLETED|Overall Study||13
1646135|NCT00754494|4022181|P3|STARTED|Overall Study||15
1646136|NCT00754494|4022182|P2|STARTED|Overall Study||15
1646137|NCT00754494|4022183|P1|STARTED|Overall Study||15
1646138|NCT00754468|4022229|P2|NOT COMPLETED|Overall Study||0
1646139|NCT00754468|4022230|P1|NOT COMPLETED|Overall Study||0
1646140|NCT00754468|4022229|P2|COMPLETED|Overall Study||3
1646141|NCT00754468|4022230|P1|COMPLETED|Overall Study||4
1646142|NCT00754468|4022229|P2|STARTED|Overall Study||3
1646143|NCT00754468|4022230|P1|STARTED|Overall Study||4
1646144|NCT00754442|4022240|P2|NOT COMPLETED|Overall Study||3
1646145|NCT00754442|4022241|P1|NOT COMPLETED|Overall Study||5
1646146|NCT00754442|4022240|P2|COMPLETED|Overall Study||6
1646147|NCT00754442|4022241|P1|COMPLETED|Overall Study||6
1646148|NCT00754442|4022240|P2|STARTED|Overall Study|patients 9|9
1646149|NCT00754442|4022241|P1|STARTED|Overall Study|controls 11|11
1646150|NCT00754390|4022248|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
1646151|NCT00754390|4022248|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
1646152|NCT00754390|4022248|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
1646153|NCT00754390|4022248|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
1646154|NCT00754390|4022248|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
1646155|NCT00754390|4022248|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
1646156|NCT00754390|4022248|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
1646157|NCT00754390|4022248|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
1646158|NCT00754390|4022248|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
1646159|NCT00754390|4022248|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
1646160|NCT00754390|4022248|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
1646161|NCT00754390|4022248|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
1646162|NCT00754377|4022257|P2|NOT COMPLETED|Overall Study||0
1646163|NCT00754377|4022258|P1|NOT COMPLETED|Overall Study||0
1646164|NCT00754377|4022257|P2|COMPLETED|Overall Study||42
1646165|NCT00754377|4022258|P1|COMPLETED|Overall Study||50
1646166|NCT00754377|4022257|P2|STARTED|Overall Study||42
1646167|NCT00754377|4022258|P1|STARTED|Overall Study||50
1646168|NCT00754338|4022270|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
1646169|NCT00754338|4022271|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
1646170|NCT00754338|4022272|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
1646171|NCT00754338|4022273|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
1646172|NCT00754338|4022270|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
1646173|NCT00754338|4022271|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
1646174|NCT00754338|4022272|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
1646175|NCT00754338|4022273|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
1646176|NCT00754338|4022270|P4|STARTED|Second Intervention for Phase1&Phase2||19
1646177|NCT00754338|4022271|P3|STARTED|Second Intervention for Phase1&Phase2||16
1646178|NCT00754338|4022272|P2|STARTED|Second Intervention for Phase1&Phase2||18
1646179|NCT00754338|4022273|P1|STARTED|Second Intervention for Phase1&Phase2||17
1646180|NCT00754338|4022270|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
1646181|NCT00754338|4022271|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
1646182|NCT00754338|4022272|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
1646183|NCT00754338|4022273|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
1646184|NCT00754338|4022270|P4|COMPLETED|First Intervention for Phase1&Phase2||19
1646185|NCT00754338|4022271|P3|COMPLETED|First Intervention for Phase1&Phase2||16
1646186|NCT00754338|4022272|P2|COMPLETED|First Intervention for Phase1&Phase2||18
1646187|NCT00754338|4022273|P1|COMPLETED|First Intervention for Phase1&Phase2||17
1646188|NCT00754338|4022270|P4|STARTED|First Intervention for Phase1&Phase2||19
1646189|NCT00754338|4022271|P3|STARTED|First Intervention for Phase1&Phase2||19
1646190|NCT00754338|4022272|P2|STARTED|First Intervention for Phase1&Phase2||21
1646191|NCT00754338|4022273|P1|STARTED|First Intervention for Phase1&Phase2||17
1646192|NCT00754325|4022305|P2|NOT COMPLETED|Progression and Cross-over||21
1646193|NCT00754325|4022306|P1|NOT COMPLETED|Progression and Cross-over||0
1646194|NCT00754325|4022305|P2|COMPLETED|Progression and Cross-over||0
1646195|NCT00754325|4022306|P1|COMPLETED|Progression and Cross-over||0
1646196|NCT00754325|4022305|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
1646197|NCT00754325|4022306|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
1646198|NCT00754325|4022305|P2|NOT COMPLETED|Initial Treatment||49
1646199|NCT00754325|4022306|P1|NOT COMPLETED|Initial Treatment||50
1646200|NCT00754325|4022305|P2|COMPLETED|Initial Treatment||0
1646201|NCT00754325|4022306|P1|COMPLETED|Initial Treatment||0
1646202|NCT00754325|4022305|P2|STARTED|Initial Treatment||49
1646203|NCT00754325|4022306|P1|STARTED|Initial Treatment||50
1646204|NCT00754234|4022325|P1|NOT COMPLETED|Overall Study||3
1646205|NCT00754234|4022325|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
1646206|NCT00754234|4022325|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
1646207|NCT00754208|4022329|P1|NOT COMPLETED|Overall Study||0
1646208|NCT00754208|4022329|P1|COMPLETED|Overall Study||7
1646209|NCT00754208|4022329|P1|STARTED|Overall Study||7
1646210|NCT00754156|4022338|P2|NOT COMPLETED|Overall Study||0
1646211|NCT00754156|4022339|P1|NOT COMPLETED|Overall Study||0
1646212|NCT00754156|4022338|P2|COMPLETED|Overall Study||6
1646213|NCT00754156|4022339|P1|COMPLETED|Overall Study||8
1646214|NCT00754156|4022338|P2|STARTED|Overall Study||6
1646215|NCT00754156|4022339|P1|STARTED|Overall Study||8
1646216|NCT00754130|4022363|P6|NOT COMPLETED|Period 2 (5 Days)||0
1646217|NCT00754130|4022364|P5|NOT COMPLETED|Period 2 (5 Days)||0
1646218|NCT00754130|4022365|P4|NOT COMPLETED|Period 2 (5 Days)||0
1646219|NCT00754130|4022366|P3|NOT COMPLETED|Period 2 (5 Days)||0
1646220|NCT00754130|4022367|P2|NOT COMPLETED|Period 2 (5 Days)||0
1646221|NCT00754130|4022368|P1|NOT COMPLETED|Period 2 (5 Days)||0
1646222|NCT00754130|4022363|P6|COMPLETED|Period 2 (5 Days)||4
1646223|NCT00754130|4022364|P5|COMPLETED|Period 2 (5 Days)||2
1646224|NCT00754130|4022365|P4|COMPLETED|Period 2 (5 Days)||2
1646225|NCT00754130|4022366|P3|COMPLETED|Period 2 (5 Days)||4
1646226|NCT00754130|4022367|P2|COMPLETED|Period 2 (5 Days)||2
1646227|NCT00754130|4022368|P1|COMPLETED|Period 2 (5 Days)||2
1646228|NCT00754130|4022363|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
1646229|NCT00754130|4022364|P5|STARTED|Period 2 (5 Days)||2
1646230|NCT00754130|4022365|P4|STARTED|Period 2 (5 Days)||2
1646231|NCT00754130|4022366|P3|STARTED|Period 2 (5 Days)||4
1646232|NCT00754130|4022367|P2|STARTED|Period 2 (5 Days)||2
1646233|NCT00754130|4022368|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
1646234|NCT00754130|4022363|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
1646235|NCT00754130|4022364|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
1646236|NCT00754130|4022365|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
1646237|NCT00754130|4022366|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
1646238|NCT00754130|4022367|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
1646239|NCT00754130|4022368|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
1646240|NCT00754130|4022363|P6|COMPLETED|Washout Period (>=8 Days)||4
1646241|NCT00754130|4022364|P5|COMPLETED|Washout Period (>=8 Days)||2
1646242|NCT00754130|4022365|P4|COMPLETED|Washout Period (>=8 Days)||2
1646243|NCT00754130|4022366|P3|COMPLETED|Washout Period (>=8 Days)||4
1646244|NCT00754130|4022367|P2|COMPLETED|Washout Period (>=8 Days)||2
1646245|NCT00754130|4022368|P1|COMPLETED|Washout Period (>=8 Days)||2
1646246|NCT00754130|4022363|P6|STARTED|Washout Period (>=8 Days)||4
1646247|NCT00754130|4022364|P5|STARTED|Washout Period (>=8 Days)||2
1646248|NCT00754130|4022365|P4|STARTED|Washout Period (>=8 Days)||2
1646249|NCT00754130|4022366|P3|STARTED|Washout Period (>=8 Days)||4
1646250|NCT00754130|4022367|P2|STARTED|Washout Period (>=8 Days)||2
1646251|NCT00754130|4022368|P1|STARTED|Washout Period (>=8 Days)||2
1646252|NCT00754130|4022363|P6|NOT COMPLETED|Period 1 (5 Days)||0
1646253|NCT00754130|4022364|P5|NOT COMPLETED|Period 1 (5 Days)||0
1646254|NCT00754130|4022365|P4|NOT COMPLETED|Period 1 (5 Days)||0
1646255|NCT00754130|4022366|P3|NOT COMPLETED|Period 1 (5 Days)||0
1646256|NCT00754130|4022367|P2|NOT COMPLETED|Period 1 (5 Days)||0
1646257|NCT00754130|4022368|P1|NOT COMPLETED|Period 1 (5 Days)||0
1646258|NCT00754130|4022363|P6|COMPLETED|Period 1 (5 Days)||4
1646259|NCT00754130|4022364|P5|COMPLETED|Period 1 (5 Days)||2
1646260|NCT00754130|4022365|P4|COMPLETED|Period 1 (5 Days)||2
1646261|NCT00754130|4022366|P3|COMPLETED|Period 1 (5 Days)||4
1646262|NCT00754130|4022367|P2|COMPLETED|Period 1 (5 Days)||2
1646263|NCT00754130|4022368|P1|COMPLETED|Period 1 (5 Days)||2
1646264|NCT00754130|4022363|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
1646265|NCT00754130|4022364|P5|STARTED|Period 1 (5 Days)||2
1646266|NCT00754130|4022365|P4|STARTED|Period 1 (5 Days)||2
1646267|NCT00754130|4022366|P3|STARTED|Period 1 (5 Days)||4
1646268|NCT00754130|4022367|P2|STARTED|Period 1 (5 Days)||2
1646269|NCT00754130|4022368|P1|STARTED|Period 1 (5 Days)||2
1646270|NCT00754065|4022411|P2|NOT COMPLETED|Overall Study||80
1646271|NCT00754065|4022412|P1|NOT COMPLETED|Overall Study||81
1646272|NCT00754065|4022411|P2|COMPLETED|Overall Study||126
1646273|NCT00754065|4022412|P1|COMPLETED|Overall Study||122
1646274|NCT00754065|4022411|P2|Cycle 6|Overall Study||153
1646275|NCT00754065|4022412|P1|Cycle 6|Overall Study||141
1646276|NCT00754065|4022411|P2|Participants Received Treatment|Overall Study||204
1646277|NCT00754065|4022412|P1|Participants Received Treatment|Overall Study||191
1646278|NCT00754065|4022411|P2|STARTED|Overall Study||206
1646279|NCT00754065|4022412|P1|STARTED|Overall Study||203
1646280|NCT00754052|4022652|P2|NOT COMPLETED|Overall Study||3
1646281|NCT00754052|4022653|P1|NOT COMPLETED|Overall Study||5
1646282|NCT00754052|4022652|P2|COMPLETED|Overall Study||0
1646283|NCT00754052|4022653|P1|COMPLETED|Overall Study||0
1646284|NCT00754052|4022652|P2|STARTED|Overall Study||3
1646285|NCT00754052|4022653|P1|STARTED|Overall Study||5
1646286|NCT00754013|4022667|P2|NOT COMPLETED|Overall Study||5
1646287|NCT00754013|4022668|P1|NOT COMPLETED|Overall Study||4
1646288|NCT00754013|4022667|P2|COMPLETED|Overall Study||0
1646289|NCT00754013|4022668|P1|COMPLETED|Overall Study||0
1646290|NCT00754013|4022667|P2|STARTED|Overall Study||5
1646291|NCT00754013|4022668|P1|STARTED|Overall Study||4
1646292|NCT00753948|4022679|P3|NOT COMPLETED|Overall Study||0
1646293|NCT00753948|4022680|P2|NOT COMPLETED|Overall Study||0
1646294|NCT00753948|4022681|P1|NOT COMPLETED|Overall Study||0
1646295|NCT00753948|4022679|P3|COMPLETED|Overall Study||7
1646296|NCT00753948|4022680|P2|COMPLETED|Overall Study||7
1646297|NCT00753948|4022681|P1|COMPLETED|Overall Study||9
1646298|NCT00753948|4022679|P3|STARTED|Overall Study||7
1646299|NCT00753948|4022680|P2|STARTED|Overall Study||7
1646300|NCT00753948|4022681|P1|STARTED|Overall Study||9
1646301|NCT00753935|4022691|P2|NOT COMPLETED|Overall Study||0
1646302|NCT00753935|4022692|P1|NOT COMPLETED|Overall Study||0
1646303|NCT00753935|4022691|P2|COMPLETED|Overall Study||47
1646304|NCT00753935|4022692|P1|COMPLETED|Overall Study||45
1646305|NCT00753935|4022691|P2|STARTED|Overall Study||47
1646306|NCT00753935|4022692|P1|STARTED|Overall Study||45
1646307|NCT00753922|4022702|P4|NOT COMPLETED|Overall Study||23
1646308|NCT00753922|4022703|P3|NOT COMPLETED|Overall Study||63
1646309|NCT00753922|4022704|P2|NOT COMPLETED|Overall Study||94
1646310|NCT00753922|4022705|P1|NOT COMPLETED|Overall Study||246
1646311|NCT00753922|4022702|P4|COMPLETED|Overall Study||37
1646312|NCT00753922|4022703|P3|COMPLETED|Overall Study||82
1646313|NCT00753922|4022704|P2|COMPLETED|Overall Study||157
1646314|NCT00753922|4022705|P1|COMPLETED|Overall Study||306
1646315|NCT00753922|4022702|P4|STARTED|Overall Study||60
1646316|NCT00753922|4022703|P3|STARTED|Overall Study||145
1646317|NCT00753922|4022704|P2|STARTED|Overall Study||251
1646318|NCT00753922|4022705|P1|STARTED|Overall Study||552
1646319|NCT00753896|4022735|P1|NOT COMPLETED|Overall Study||16
1646320|NCT00753896|4022735|P1|COMPLETED|Overall Study||118
1646321|NCT00753896|4022735|P1|STARTED|Overall Study||134
1646322|NCT00753766|4022751|P2|NOT COMPLETED|Overall Study||0
1646323|NCT00753766|4022752|P1|NOT COMPLETED|Overall Study||1
1646324|NCT00753766|4022751|P2|COMPLETED|Overall Study||0
1646325|NCT00753766|4022752|P1|COMPLETED|Overall Study||0
1646326|NCT00753766|4022751|P2|STARTED|Overall Study||0
1646327|NCT00753766|4022752|P1|STARTED|Overall Study||1
1646328|NCT00753714|4022762|P2|NOT COMPLETED|Overall Study||62
1646329|NCT00753714|4022763|P1|NOT COMPLETED|Overall Study||60
1646330|NCT00753714|4022762|P2|COMPLETED|Overall Study||1
1646331|NCT00753714|4022763|P1|COMPLETED|Overall Study||1
1646332|NCT00753714|4022762|P2|STARTED|Overall Study||63
1646333|NCT00753714|4022763|P1|STARTED|Overall Study||61
1646334|NCT00753688|4022779|P2|NOT COMPLETED|Overall Study||246
1646335|NCT00753688|4022780|P1|NOT COMPLETED|Overall Study||123
1646336|NCT00753688|4022779|P2|COMPLETED|Overall Study||0
1646337|NCT00753688|4022780|P1|COMPLETED|Overall Study||0
1646338|NCT00753688|4022779|P2|Ongoing - in Follow-up|Overall Study||31
1646339|NCT00753688|4022780|P1|Ongoing - in Follow-up|Overall Study||15
1646340|NCT00753688|4022779|P2|STARTED|Overall Study||246
1646341|NCT00753688|4022780|P1|STARTED|Overall Study||123
1646342|NCT00753675|4022809|P3|NOT COMPLETED|Overall Study||56
1646343|NCT00753675|4022810|P2|NOT COMPLETED|Overall Study||59
1646344|NCT00753675|4022811|P1|NOT COMPLETED|Overall Study||59
1646345|NCT00753675|4022809|P3|COMPLETED|Overall Study||0
1646346|NCT00753675|4022810|P2|COMPLETED|Overall Study||0
1646347|NCT00753675|4022811|P1|COMPLETED|Overall Study||0
1646348|NCT00753675|4022809|P3|STARTED|Overall Study||56
1646349|NCT00753675|4022810|P2|STARTED|Overall Study||59
1646350|NCT00753675|4022811|P1|STARTED|Overall Study||59
1646351|NCT00753649|4022833|P2|NOT COMPLETED|Overall Study||0
1646352|NCT00753649|4022834|P1|NOT COMPLETED|Overall Study||7
1646353|NCT00753649|4022833|P2|COMPLETED|Overall Study||112
1646354|NCT00753649|4022834|P1|COMPLETED|Overall Study||105
1646355|NCT00753649|4022833|P2|STARTED|Overall Study||112
1646356|NCT00753649|4022834|P1|STARTED|Overall Study||112
1646357|NCT00753636|4022854|P1|NOT COMPLETED|Overall Study||6
1646358|NCT00753636|4022854|P1|COMPLETED|Overall Study||25
1646359|NCT00753636|4022854|P1|STARTED|Overall Study||31
1646360|NCT00753623|4022866|P2|NOT COMPLETED|Phase II (14 Days)||1
1646361|NCT00753623|4022867|P1|NOT COMPLETED|Phase II (14 Days)||0
1646362|NCT00753623|4022866|P2|COMPLETED|Phase II (14 Days)||7
1646363|NCT00753623|4022867|P1|COMPLETED|Phase II (14 Days)||8
1646364|NCT00753623|4022866|P2|STARTED|Phase II (14 Days)||8
1646365|NCT00753623|4022867|P1|STARTED|Phase II (14 Days)||8
1646366|NCT00753623|4022866|P2|NOT COMPLETED|Washout (7 Days)||0
1646367|NCT00753623|4022867|P1|NOT COMPLETED|Washout (7 Days)||1
1646368|NCT00753623|4022866|P2|COMPLETED|Washout (7 Days)||8
1646369|NCT00753623|4022867|P1|COMPLETED|Washout (7 Days)||8
1646370|NCT00753623|4022866|P2|STARTED|Washout (7 Days)||8
1646371|NCT00753623|4022867|P1|STARTED|Washout (7 Days)||9
1646372|NCT00753623|4022866|P2|NOT COMPLETED|Phase I (14 Days)||4
1646373|NCT00753623|4022867|P1|NOT COMPLETED|Phase I (14 Days)||2
1646374|NCT00753623|4022866|P2|COMPLETED|Phase I (14 Days)||8
1646375|NCT00753623|4022867|P1|COMPLETED|Phase I (14 Days)||9
1646376|NCT00753623|4022866|P2|STARTED|Phase I (14 Days)||12
1646377|NCT00753623|4022867|P1|STARTED|Phase I (14 Days)||11
1646378|NCT00753545|4022875|P2|NOT COMPLETED|Overall Study||118
1646379|NCT00753545|4022876|P1|NOT COMPLETED|Overall Study||108
1646380|NCT00753545|4022875|P2|COMPLETED|Overall Study|Patients completing the Study|11
1646381|NCT00753545|4022876|P1|COMPLETED|Overall Study|Patients completing the Study|28
1646382|NCT00753545|4022875|P2|STARTED|Overall Study|Patients randomized|129
1646383|NCT00753545|4022876|P1|STARTED|Overall Study|Patients randomized|136
1646384|NCT00753519|4022914|P2|NOT COMPLETED|Overall Study||2
1646385|NCT00753519|4022915|P1|NOT COMPLETED|Overall Study||0
1646386|NCT00753519|4022914|P2|COMPLETED|Overall Study||13
1646387|NCT00753519|4022915|P1|COMPLETED|Overall Study||13
1646388|NCT00753519|4022914|P2|STARTED|Overall Study||15
1646389|NCT00753519|4022915|P1|STARTED|Overall Study||13
1646390|NCT00753506|4022937|P2|NOT COMPLETED|Overall Study||2
1646391|NCT00753506|4022938|P1|NOT COMPLETED|Overall Study||7
1646392|NCT00753506|4022937|P2|COMPLETED|Overall Study||31
1646393|NCT00753506|4022938|P1|COMPLETED|Overall Study||26
1646394|NCT00753506|4022937|P2|STARTED|Overall Study||33
1646395|NCT00753506|4022938|P1|STARTED|Overall Study||33
1646396|NCT00753454|4022944|P1|NOT COMPLETED|Overall Study||14
1646397|NCT00753454|4022944|P1|COMPLETED|Overall Study||154
1646398|NCT00753454|4022944|P1|STARTED|Overall Study||168
1646399|NCT00753415|4022978|P10|NOT COMPLETED|Part B||1
1646400|NCT00753415|4022979|P9|NOT COMPLETED|Part B||3
1646401|NCT00753415|4022980|P8|NOT COMPLETED|Part B||1
1646402|NCT00753415|4022981|P7|NOT COMPLETED|Part B||0
1646403|NCT00753415|4022982|P6|NOT COMPLETED|Part B||0
1646404|NCT00753415|4022983|P5|NOT COMPLETED|Part B||0
1646405|NCT00753415|4022984|P4|NOT COMPLETED|Part B||0
1646406|NCT00753415|4022985|P3|NOT COMPLETED|Part B||0
1646407|NCT00753415|4022986|P2|NOT COMPLETED|Part B||0
1646408|NCT00753415|4022987|P1|NOT COMPLETED|Part B||0
1646409|NCT00753415|4022978|P10|COMPLETED|Part B||8
1646410|NCT00753415|4022979|P9|COMPLETED|Part B||6
1646411|NCT00753415|4022980|P8|COMPLETED|Part B||6
1646412|NCT00753415|4022981|P7|COMPLETED|Part B||2
1646413|NCT00753415|4022982|P6|COMPLETED|Part B||1
1646414|NCT00753415|4022983|P5|COMPLETED|Part B||0
1646415|NCT00753415|4022984|P4|COMPLETED|Part B||0
1646416|NCT00753415|4022985|P3|COMPLETED|Part B||0
1646417|NCT00753415|4022986|P2|COMPLETED|Part B||0
1646418|NCT00753415|4022987|P1|COMPLETED|Part B||0
1646419|NCT00753415|4022978|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
1646420|NCT00753415|4022979|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
1646421|NCT00753415|4022980|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
1646422|NCT00753415|4022981|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
1646423|NCT00753415|4022982|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
1646424|NCT00753415|4022983|P5|STARTED|Part B||0
1646425|NCT00753415|4022984|P4|STARTED|Part B||0
1646426|NCT00753415|4022985|P3|STARTED|Part B||0
1646427|NCT00753415|4022986|P2|STARTED|Part B||0
1646428|NCT00753415|4022987|P1|STARTED|Part B||0
1646429|NCT00753415|4022978|P10|NOT COMPLETED|Part A||0
1646430|NCT00753415|4022979|P9|NOT COMPLETED|Part A||0
1646431|NCT00753415|4022980|P8|NOT COMPLETED|Part A||0
1646432|NCT00753415|4022981|P7|NOT COMPLETED|Part A||0
1646433|NCT00753415|4022982|P6|NOT COMPLETED|Part A||0
1646434|NCT00753415|4022983|P5|NOT COMPLETED|Part A||0
1646435|NCT00753415|4022984|P4|NOT COMPLETED|Part A||2
1646436|NCT00753415|4022985|P3|NOT COMPLETED|Part A||2
1646437|NCT00753415|4022986|P2|NOT COMPLETED|Part A||0
1646438|NCT00753415|4022987|P1|NOT COMPLETED|Part A||1
1646439|NCT00753415|4022978|P10|COMPLETED|Part A||0
1646440|NCT00753415|4022979|P9|COMPLETED|Part A||0
1646441|NCT00753415|4022980|P8|COMPLETED|Part A||0
1646442|NCT00753415|4022981|P7|COMPLETED|Part A||0
1646443|NCT00753415|4022982|P6|COMPLETED|Part A||0
1646444|NCT00753415|4022983|P5|COMPLETED|Part A||10
1646445|NCT00753415|4022984|P4|COMPLETED|Part A||9
1646446|NCT00753415|4022985|P3|COMPLETED|Part A||8
1646447|NCT00753415|4022986|P2|COMPLETED|Part A||3
1646448|NCT00753415|4022987|P1|COMPLETED|Part A||2
1646449|NCT00753415|4022978|P10|STARTED|Part A||0
1646450|NCT00753415|4022979|P9|STARTED|Part A||0
1646451|NCT00753415|4022980|P8|STARTED|Part A||0
1646452|NCT00753415|4022981|P7|STARTED|Part A||0
1646453|NCT00753415|4022982|P6|STARTED|Part A||0
1646454|NCT00753415|4022983|P5|STARTED|Part A||10
1646455|NCT00753415|4022984|P4|STARTED|Part A||11
1646456|NCT00753415|4022985|P3|STARTED|Part A||10
1646457|NCT00753415|4022986|P2|STARTED|Part A||3
1646458|NCT00753415|4022987|P1|STARTED|Part A||3
1646459|NCT00753363|4023031|P2|NOT COMPLETED|Overall Study||39
1646460|NCT00753363|4023032|P1|NOT COMPLETED|Overall Study||40
1646461|NCT00753363|4023031|P2|COMPLETED|Overall Study||21
1646462|NCT00753363|4023032|P1|COMPLETED|Overall Study||19
1646463|NCT00753363|4023031|P2|STARTED|Overall Study||60
1646464|NCT00753363|4023032|P1|STARTED|Overall Study||59
1646465|NCT00753337|4023042|P1|NOT COMPLETED|Overall Study||0
1646466|NCT00753337|4023042|P1|COMPLETED|Overall Study||123
1646467|NCT00753337|4023042|P1|STARTED|Overall Study||123
1646468|NCT00753298|4023058|P2|NOT COMPLETED|Overall Study||4
1646469|NCT00753298|4023059|P1|NOT COMPLETED|Overall Study||8
1646470|NCT00753298|4023058|P2|COMPLETED|Overall Study||94
1646471|NCT00753298|4023059|P1|COMPLETED|Overall Study||89
1646472|NCT00753298|4023058|P2|STARTED|Overall Study||98
1646473|NCT00753298|4023059|P1|STARTED|Overall Study||97
1646474|NCT00753272|4023077|P2|NOT COMPLETED|Overall Study||4907
1646475|NCT00753272|4023078|P1|NOT COMPLETED|Overall Study||4982
1646476|NCT00753272|4023077|P2|COMPLETED|Overall Study||16895
1646477|NCT00753272|4023078|P1|COMPLETED|Overall Study||16911
1646478|NCT00753272|4023077|P2|STARTED|Overall Study||21802
1646479|NCT00753272|4023078|P1|STARTED|Overall Study||21893
1646480|NCT00753220|4023140|P1|NOT COMPLETED|Overall Study||5
1646481|NCT00753220|4023140|P1|COMPLETED|Overall Study||2
1646482|NCT00753220|4023140|P1|STARTED|Overall Study||7
1646483|NCT00753142|4023147|P3|NOT COMPLETED|Overall Study||0
1646484|NCT00753142|4023148|P2|NOT COMPLETED|Overall Study||0
1646485|NCT00753142|4023149|P1|NOT COMPLETED|Overall Study||0
1646486|NCT00753142|4023147|P3|COMPLETED|Overall Study||13
1646487|NCT00753142|4023148|P2|COMPLETED|Overall Study||7
1646488|NCT00753142|4023149|P1|COMPLETED|Overall Study||8
1646489|NCT00753142|4023147|P3|STARTED|Overall Study||13
1646490|NCT00753142|4023148|P2|STARTED|Overall Study||7
1646491|NCT00753142|4023149|P1|STARTED|Overall Study||8
1646492|NCT00753012|4023162|P2|NOT COMPLETED|Overall Study||1
1646493|NCT00753012|4023163|P1|NOT COMPLETED|Overall Study||8
1646494|NCT00753012|4023162|P2|COMPLETED|Overall Study||8
1646495|NCT00753012|4023163|P1|COMPLETED|Overall Study||7
1646496|NCT00753012|4023162|P2|STARTED|Overall Study||9
1646497|NCT00753012|4023163|P1|STARTED|Overall Study||15
1646498|NCT00752986|4023176|P3|NOT COMPLETED|Overall Study||2
1646499|NCT00752986|4023177|P2|NOT COMPLETED|Overall Study||1
1646500|NCT00752986|4023178|P1|NOT COMPLETED|Overall Study||5
1646501|NCT00752986|4023176|P3|COMPLETED|Overall Study||9
1646502|NCT00752986|4023177|P2|COMPLETED|Overall Study||11
1646503|NCT00752986|4023178|P1|COMPLETED|Overall Study||11
1646504|NCT00752986|4023176|P3|STARTED|Overall Study||11
1646505|NCT00752986|4023177|P2|STARTED|Overall Study||12
1646506|NCT00752986|4023178|P1|STARTED|Overall Study||16
1646507|NCT00752973|4023195|P1|NOT COMPLETED|Overall Study||0
1646508|NCT00752973|4023195|P1|COMPLETED|Overall Study||12
1646509|NCT00752973|4023195|P1|STARTED|Overall Study||12
1646510|NCT00752895|4023207|P2|NOT COMPLETED|Overall Study||3
1646511|NCT00752895|4023208|P1|NOT COMPLETED|Overall Study||8
1646512|NCT00752895|4023207|P2|COMPLETED|Overall Study||143
1646513|NCT00752895|4023208|P1|COMPLETED|Overall Study||139
1646514|NCT00752895|4023207|P2|STARTED|Overall Study||146
1646515|NCT00752895|4023208|P1|STARTED|Overall Study||147
1646516|NCT00752791|4023216|P1|NOT COMPLETED|Overall Study||16
1646517|NCT00752791|4023216|P1|COMPLETED|Overall Study||43
1646518|NCT00752791|4023216|P1|STARTED|Overall Study||59
1646519|NCT00752726|4023228|P2|NOT COMPLETED|Overall Study||13
1646520|NCT00752726|4023229|P1|NOT COMPLETED|Overall Study||11
1646521|NCT00752726|4023228|P2|COMPLETED|Overall Study||53
1646522|NCT00752726|4023229|P1|COMPLETED|Overall Study||54
1646523|NCT00752726|4023228|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
1646524|NCT00752726|4023229|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
1646525|NCT00752726|4023228|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
1646526|NCT00752726|4023229|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
1646527|NCT00752726|4023228|P2|STARTED|Overall Study||66
1646528|NCT00752726|4023229|P1|STARTED|Overall Study||65
1646529|NCT00752622|4023254|P1|NOT COMPLETED|Interventional Phase||8
1646530|NCT00752622|4023254|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
1646531|NCT00752622|4023254|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
1646532|NCT00752622|4023254|P1|NOT COMPLETED|Observational Phase||43
1646533|NCT00752622|4023254|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
1646534|NCT00752622|4023254|P1|STARTED|Observational Phase||65
1646535|NCT00752622|4023254|P1|NOT COMPLETED|Induction Phase||35
1646536|NCT00752622|4023254|P1|COMPLETED|Induction Phase||65
1646537|NCT00752622|4023254|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
1646538|NCT00752609|4023267|P2|NOT COMPLETED|Overall Study||2
1646539|NCT00752609|4023268|P1|NOT COMPLETED|Overall Study||9
1646540|NCT00752609|4023267|P2|COMPLETED|Overall Study||47
1646541|NCT00752609|4023268|P1|COMPLETED|Overall Study||44
1646542|NCT00752609|4023267|P2|Full Analysis Set|Overall Study||49
1646543|NCT00752609|4023268|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
1646544|NCT00752609|4023267|P2|STARTED|Overall Study||49
1646545|NCT00752609|4023268|P1|STARTED|Overall Study||53
1646546|NCT00752232|4023294|P7|NOT COMPLETED|Overall Study||0
1646547|NCT00752232|4023295|P6|NOT COMPLETED|Overall Study||1
1646548|NCT00752232|4023296|P5|NOT COMPLETED|Overall Study||3
1646549|NCT00752232|4023297|P4|NOT COMPLETED|Overall Study||1
1646550|NCT00752232|4023298|P3|NOT COMPLETED|Overall Study||1
1646551|NCT00752232|4023299|P2|NOT COMPLETED|Overall Study||0
1646552|NCT00752232|4023300|P1|NOT COMPLETED|Overall Study||2
1646553|NCT00752232|4023294|P7|COMPLETED|Overall Study||4
1646554|NCT00752232|4023295|P6|COMPLETED|Overall Study||5
1646555|NCT00752232|4023296|P5|COMPLETED|Overall Study||3
1646556|NCT00752232|4023297|P4|COMPLETED|Overall Study||5
1646557|NCT00752232|4023298|P3|COMPLETED|Overall Study||5
1646558|NCT00752232|4023299|P2|COMPLETED|Overall Study||6
1646559|NCT00752232|4023300|P1|COMPLETED|Overall Study||4
1646560|NCT00752232|4023294|P7|STARTED|Overall Study||4
1646561|NCT00752232|4023295|P6|STARTED|Overall Study||6
1646562|NCT00752232|4023296|P5|STARTED|Overall Study||6
1646563|NCT00752232|4023297|P4|STARTED|Overall Study||6
1646564|NCT00752232|4023298|P3|STARTED|Overall Study||6
1646565|NCT00752232|4023299|P2|STARTED|Overall Study||6
1646566|NCT00752232|4023300|P1|STARTED|Overall Study||6
1646567|NCT00752219|4023374|P2|NOT COMPLETED|Overall Study||6
1646568|NCT00752219|4023375|P1|NOT COMPLETED|Overall Study||11
1646569|NCT00752219|4023374|P2|COMPLETED|Overall Study||96
1646570|NCT00752219|4023375|P1|COMPLETED|Overall Study||91
1646571|NCT00752219|4023374|P2|Treated|Overall Study||102
1646572|NCT00752219|4023375|P1|Treated|Overall Study||101
1646573|NCT00752219|4023374|P2|STARTED|Overall Study||102
1646574|NCT00752219|4023375|P1|STARTED|Overall Study||102
1646575|NCT00752128|4023399|P1|NOT COMPLETED|Overall Study||4
1646576|NCT00752128|4023399|P1|COMPLETED|Overall Study||2345
1646577|NCT00752128|4023399|P1|STARTED|Overall Study||2349
1646578|NCT00752102|4023406|P2|NOT COMPLETED|Overall Study||1
1646579|NCT00752102|4023407|P1|NOT COMPLETED|Overall Study||3
1646580|NCT00752102|4023406|P2|COMPLETED|Overall Study||21
1646581|NCT00752102|4023407|P1|COMPLETED|Overall Study||19
1646582|NCT00752102|4023406|P2|STARTED|Overall Study||22
1646583|NCT00752102|4023407|P1|STARTED|Overall Study||22
1646584|NCT00752089|4023413|P1|NOT COMPLETED|Overall Study||6
1646585|NCT00752089|4023413|P1|COMPLETED|Overall Study||14
1646586|NCT00752089|4023413|P1|Received Placebo|Overall Study||18
1646587|NCT00752089|4023413|P1|Received NaF|Overall Study||18
1646588|NCT00752089|4023413|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
1646589|NCT00752089|4023413|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
1646590|NCT00752089|4023413|P1|STARTED|Overall Study||20
1646591|NCT00751998|4023427|P1|NOT COMPLETED|Overall Study||20
1646592|NCT00751998|4023427|P1|COMPLETED|Overall Study||277
1646593|NCT00751998|4023427|P1|STARTED|Overall Study||297
1646594|NCT00751972|4023433|P2|NOT COMPLETED|Overall Study||0
1646595|NCT00751972|4023434|P1|NOT COMPLETED|Overall Study||0
1646596|NCT00751972|4023433|P2|COMPLETED|Overall Study||499
1646597|NCT00751972|4023434|P1|COMPLETED|Overall Study||140
1646598|NCT00751972|4023433|P2|STARTED|Overall Study||499
1646599|NCT00751972|4023434|P1|STARTED|Overall Study||140
1646600|NCT00751933|4023446|P4|NOT COMPLETED|Overall Study||1
1646601|NCT00751933|4023447|P3|NOT COMPLETED|Overall Study||1
1646602|NCT00751933|4023448|P2|NOT COMPLETED|Overall Study||1
1646603|NCT00751933|4023449|P1|NOT COMPLETED|Overall Study||0
1646604|NCT00751933|4023446|P4|COMPLETED|Overall Study||0
1646605|NCT00751933|4023447|P3|COMPLETED|Overall Study||0
1646606|NCT00751933|4023448|P2|COMPLETED|Overall Study||0
1646607|NCT00751933|4023449|P1|COMPLETED|Overall Study||0
1646608|NCT00751933|4023446|P4|STARTED|Overall Study||1
1646609|NCT00751933|4023447|P3|STARTED|Overall Study||1
1646610|NCT00751933|4023448|P2|STARTED|Overall Study||1
1646611|NCT00751933|4023449|P1|STARTED|Overall Study||0
1646612|NCT00751881|4023457|P3|NOT COMPLETED|Extension Study Period||66
1646613|NCT00751881|4023458|P2|NOT COMPLETED|Extension Study Period||71
1646614|NCT00751881|4023459|P1|NOT COMPLETED|Extension Study Period||65
1646615|NCT00751881|4023457|P3|COMPLETED|Extension Study Period||167
1646616|NCT00751881|4023458|P2|COMPLETED|Extension Study Period||194
1646617|NCT00751881|4023459|P1|COMPLETED|Extension Study Period||188
1646618|NCT00751881|4023457|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
1646619|NCT00751881|4023458|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
1646620|NCT00751881|4023459|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
1646621|NCT00751881|4023457|P3|NOT COMPLETED|Core Treatment Period||128
1646622|NCT00751881|4023458|P2|NOT COMPLETED|Core Treatment Period||135
1646623|NCT00751881|4023459|P1|NOT COMPLETED|Core Treatment Period||126
1646624|NCT00751881|4023457|P3|COMPLETED|Core Treatment Period||244
1646625|NCT00751881|4023458|P2|COMPLETED|Core Treatment Period||273
1646626|NCT00751881|4023459|P1|COMPLETED|Core Treatment Period||263
1646627|NCT00751881|4023457|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
1646628|NCT00751881|4023458|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
1646629|NCT00751881|4023459|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
1646630|NCT00751881|4023457|P3|STARTED|Core Treatment Period|Randomized|372
1646631|NCT00751881|4023458|P2|STARTED|Core Treatment Period|Randomized|408
1646632|NCT00751881|4023459|P1|STARTED|Core Treatment Period|Randomized|389
1646633|NCT00751790|4023506|P1|NOT COMPLETED|Overall Study||5
1646634|NCT00751790|4023506|P1|COMPLETED|Overall Study||115
1646635|NCT00751790|4023506|P1|STARTED|Overall Study||120
1646636|NCT00751777|4023512|P2|NOT COMPLETED|Overall Study||3
1646637|NCT00751777|4023513|P1|NOT COMPLETED|Overall Study||11
1646638|NCT00751777|4023512|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
1646639|NCT00751777|4023513|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
1646640|NCT00751777|4023512|P2|STARTED|Overall Study||39
1646641|NCT00751777|4023513|P1|STARTED|Overall Study||81
1646642|NCT00751634|4023523|P1|NOT COMPLETED|Overall Study||0
1646643|NCT00751634|4023523|P1|COMPLETED|Overall Study||20
1646644|NCT00751634|4023523|P1|STARTED|Overall Study||20
1646645|NCT00751621|4023531|P1|NOT COMPLETED|Overall Study||4
1646646|NCT00751621|4023531|P1|COMPLETED|Overall Study||36
1646647|NCT00751621|4023531|P1|STARTED|Overall Study||40
1646648|NCT00751530|4023550|P2|NOT COMPLETED|Overall Study||0
1646649|NCT00751530|4023551|P1|NOT COMPLETED|Overall Study||0
1646650|NCT00751530|4023550|P2|COMPLETED|Overall Study||110
1646651|NCT00751530|4023551|P1|COMPLETED|Overall Study||332
1646652|NCT00751530|4023550|P2|STARTED|Overall Study||110
1646653|NCT00751530|4023551|P1|STARTED|Overall Study||332
1646654|NCT00751400|4023565|P1|NOT COMPLETED|Overall Study||10
1646655|NCT00751400|4023565|P1|COMPLETED|Overall Study||487
1646656|NCT00751400|4023565|P1|Subjects Provided Detailed Use Data|Overall Study||467
1646657|NCT00751400|4023565|P1|Subjects Consumed Drug|Overall Study||485
1646658|NCT00751400|4023565|P1|Subjects Provided Drug|Overall Study||497
1646659|NCT00751400|4023565|P1|STARTED|Overall Study||497
1646660|NCT00751348|4023580|P2|NOT COMPLETED|Overall Study||2
1646661|NCT00751348|4023581|P1|NOT COMPLETED|Overall Study||6
1646662|NCT00751348|4023580|P2|COMPLETED|Overall Study||159
1646663|NCT00751348|4023581|P1|COMPLETED|Overall Study||307
1646664|NCT00751348|4023580|P2|STARTED|Overall Study||161
1646665|NCT00751348|4023581|P1|STARTED|Overall Study||313
1646666|NCT00751296|4023603|P1|NOT COMPLETED|Overall Study||2
1646667|NCT00751296|4023603|P1|COMPLETED|Overall Study||25
1646668|NCT00751296|4023603|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
1646669|NCT00751179|4023610|P2|NOT COMPLETED|Overall Study||15
1646670|NCT00751179|4023611|P1|NOT COMPLETED|Overall Study||14
1646671|NCT00751179|4023610|P2|COMPLETED|Overall Study||70
1646672|NCT00751179|4023611|P1|COMPLETED|Overall Study||62
1646673|NCT00751179|4023610|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
1646674|NCT00751179|4023611|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
1646675|NCT00751140|4023631|P1|NOT COMPLETED|Overall Study||1
1646676|NCT00751140|4023631|P1|COMPLETED|Overall Study||19
1646677|NCT00751140|4023631|P1|STARTED|Overall Study||20
1646678|NCT00751114|4023641|P2|NOT COMPLETED|Overall Study||32
1646679|NCT00751114|4023642|P1|NOT COMPLETED|Overall Study||38
1646680|NCT00751114|4023641|P2|COMPLETED|Overall Study||233
1646681|NCT00751114|4023642|P1|COMPLETED|Overall Study||212
1646682|NCT00751114|4023641|P2|mITT Population|Overall Study||253
1646683|NCT00751114|4023642|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
1646684|NCT00751114|4023641|P2|TREATED = Safety Population|Overall Study||264
1646685|NCT00751114|4023642|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
1646686|NCT00751114|4023641|P2|STARTED|Overall Study||265
1646687|NCT00751114|4023642|P1|STARTED|Overall Study|randomized|250
1646688|NCT00751036|4023667|P2|NOT COMPLETED|Overall Study||46
1646689|NCT00751036|4023668|P1|NOT COMPLETED|Overall Study||48
1646690|NCT00751036|4023667|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
1646691|NCT00751036|4023668|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
1646692|NCT00751036|4023667|P2|STARTED|Overall Study|Started = Treated|46
1646693|NCT00751036|4023668|P1|STARTED|Overall Study|Started = Treated|48
1646694|NCT00750919|4023680|P1|NOT COMPLETED|Overall Study||58
1646695|NCT00750919|4023680|P1|COMPLETED|Overall Study||126
1646696|NCT00750919|4023680|P1|STARTED|Overall Study||184
1646697|NCT00750893|4023688|P1|NOT COMPLETED|Overall Study||542
1646698|NCT00750893|4023688|P1|COMPLETED|Overall Study||2569
1646699|NCT00750893|4023688|P1|STARTED|Overall Study||3111
1646700|NCT00750880|4023703|P1|NOT COMPLETED|Overall Study||215
1646701|NCT00750880|4023703|P1|COMPLETED|Overall Study||1466
1646702|NCT00750880|4023703|P1|STARTED|Overall Study||1681
1646703|NCT00750867|4023726|P1|NOT COMPLETED|Overall Study||2
1646704|NCT00750867|4023726|P1|COMPLETED|Overall Study||7
1646705|NCT00750867|4023726|P1|STARTED|Overall Study||9
1646706|NCT00750815|4023733|P2|NOT COMPLETED|Overall Study||0
1646707|NCT00750815|4023734|P1|NOT COMPLETED|Overall Study||0
1646708|NCT00750815|4023733|P2|COMPLETED|Overall Study||46
1646709|NCT00750815|4023734|P1|COMPLETED|Overall Study||12
1646710|NCT00750815|4023733|P2|STARTED|Overall Study||46
1646711|NCT00750815|4023734|P1|STARTED|Overall Study||12
1646712|NCT00750737|4023747|P2|NOT COMPLETED|Overall Study||3
1646713|NCT00750737|4023748|P1|NOT COMPLETED|Overall Study||3
1646714|NCT00750737|4023747|P2|COMPLETED|Overall Study||19
1646715|NCT00750737|4023748|P1|COMPLETED|Overall Study||21
1646716|NCT00750737|4023747|P2|STARTED|Overall Study||22
1646717|NCT00750737|4023748|P1|STARTED|Overall Study||24
1646718|NCT00750373|4023758|P2|NOT COMPLETED|Overall Study||0
1646719|NCT00750373|4023759|P1|NOT COMPLETED|Overall Study||0
1646720|NCT00750373|4023758|P2|COMPLETED|Overall Study||37
1646721|NCT00750373|4023759|P1|COMPLETED|Overall Study||39
1646722|NCT00750373|4023758|P2|STARTED|Overall Study||37
1646723|NCT00750373|4023759|P1|STARTED|Overall Study||39
1646724|NCT00750360|4023771|P6|NOT COMPLETED|Overall Study||0
1646725|NCT00750360|4023772|P5|NOT COMPLETED|Overall Study||0
1646726|NCT00750360|4023773|P4|NOT COMPLETED|Overall Study||0
1646727|NCT00750360|4023774|P3|NOT COMPLETED|Overall Study||0
1646728|NCT00750360|4023775|P2|NOT COMPLETED|Overall Study||0
1646729|NCT00750360|4023776|P1|NOT COMPLETED|Overall Study||0
1646730|NCT00750360|4023771|P6|COMPLETED|Overall Study||71
1646731|NCT00750360|4023772|P5|COMPLETED|Overall Study||46
1646732|NCT00750360|4023773|P4|COMPLETED|Overall Study||79
1646733|NCT00750360|4023774|P3|COMPLETED|Overall Study||384
1646734|NCT00750360|4023775|P2|COMPLETED|Overall Study||1
1646735|NCT00750360|4023776|P1|COMPLETED|Overall Study||294
1646736|NCT00750360|4023771|P6|STARTED|Overall Study||71
1646737|NCT00750360|4023772|P5|STARTED|Overall Study||46
1646738|NCT00750360|4023773|P4|STARTED|Overall Study||79
1646739|NCT00750360|4023774|P3|STARTED|Overall Study||384
1646740|NCT00750360|4023775|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
1646741|NCT00750360|4023776|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
1646742|NCT00750308|4023808|P12|NOT COMPLETED|Fourth Treatment||0
1646743|NCT00750308|4023809|P11|NOT COMPLETED|Fourth Treatment||0
1646744|NCT00750308|4023810|P10|NOT COMPLETED|Fourth Treatment||0
1646745|NCT00750308|4023811|P9|NOT COMPLETED|Fourth Treatment||0
1646746|NCT00750308|4023812|P8|NOT COMPLETED|Fourth Treatment||0
1646747|NCT00750308|4023813|P7|NOT COMPLETED|Fourth Treatment||0
1646748|NCT00750308|4023814|P6|NOT COMPLETED|Fourth Treatment||0
1646749|NCT00750308|4023815|P5|NOT COMPLETED|Fourth Treatment||0
1646750|NCT00750308|4023816|P4|NOT COMPLETED|Fourth Treatment||0
1646751|NCT00750308|4023817|P3|NOT COMPLETED|Fourth Treatment||0
1646752|NCT00750308|4023818|P2|NOT COMPLETED|Fourth Treatment||0
1646753|NCT00750308|4023819|P1|NOT COMPLETED|Fourth Treatment||0
1646754|NCT00750308|4023808|P12|COMPLETED|Fourth Treatment||1
1646755|NCT00750308|4023809|P11|COMPLETED|Fourth Treatment||1
1646756|NCT00750308|4023810|P10|COMPLETED|Fourth Treatment||2
1646757|NCT00750308|4023811|P9|COMPLETED|Fourth Treatment||1
1646758|NCT00750308|4023812|P8|COMPLETED|Fourth Treatment||2
1646759|NCT00750308|4023813|P7|COMPLETED|Fourth Treatment||2
1646760|NCT00750308|4023814|P6|COMPLETED|Fourth Treatment||2
1646761|NCT00750308|4023815|P5|COMPLETED|Fourth Treatment||1
1646762|NCT00750308|4023816|P4|COMPLETED|Fourth Treatment||1
1646763|NCT00750308|4023817|P3|COMPLETED|Fourth Treatment||2
1646764|NCT00750308|4023818|P2|COMPLETED|Fourth Treatment||1
1646765|NCT00750308|4023819|P1|COMPLETED|Fourth Treatment||2
1646766|NCT00750308|4023808|P12|STARTED|Fourth Treatment||1
1646767|NCT00750308|4023809|P11|STARTED|Fourth Treatment||1
1646768|NCT00750308|4023810|P10|STARTED|Fourth Treatment||2
1646769|NCT00750308|4023811|P9|STARTED|Fourth Treatment||1
1646770|NCT00750308|4023812|P8|STARTED|Fourth Treatment||2
1646771|NCT00750308|4023813|P7|STARTED|Fourth Treatment||2
1646772|NCT00750308|4023814|P6|STARTED|Fourth Treatment||2
1646773|NCT00750308|4023815|P5|STARTED|Fourth Treatment||1
1646774|NCT00750308|4023816|P4|STARTED|Fourth Treatment||1
1646775|NCT00750308|4023817|P3|STARTED|Fourth Treatment||2
1646776|NCT00750308|4023818|P2|STARTED|Fourth Treatment||1
1646777|NCT00750308|4023819|P1|STARTED|Fourth Treatment||2
1646778|NCT00750308|4023808|P12|NOT COMPLETED|Washout||0
1646779|NCT00750308|4023809|P11|NOT COMPLETED|Washout||0
1646780|NCT00750308|4023810|P10|NOT COMPLETED|Washout||0
1646781|NCT00750308|4023811|P9|NOT COMPLETED|Washout||0
1646782|NCT00750308|4023812|P8|NOT COMPLETED|Washout||0
1646783|NCT00750308|4023813|P7|NOT COMPLETED|Washout||0
1646784|NCT00750308|4023814|P6|NOT COMPLETED|Washout||0
1646785|NCT00750308|4023815|P5|NOT COMPLETED|Washout||0
1646786|NCT00750308|4023816|P4|NOT COMPLETED|Washout||0
1646787|NCT00750308|4023817|P3|NOT COMPLETED|Washout||0
1646788|NCT00750308|4023818|P2|NOT COMPLETED|Washout||0
1646789|NCT00750308|4023819|P1|NOT COMPLETED|Washout||0
1646790|NCT00750308|4023808|P12|COMPLETED|Washout||1
1646791|NCT00750308|4023809|P11|COMPLETED|Washout||1
1646792|NCT00750308|4023810|P10|COMPLETED|Washout||2
1646793|NCT00750308|4023811|P9|COMPLETED|Washout||1
1646794|NCT00750308|4023812|P8|COMPLETED|Washout||2
1646795|NCT00750308|4023813|P7|COMPLETED|Washout||2
1646796|NCT00750308|4023814|P6|COMPLETED|Washout||2
1646797|NCT00750308|4023815|P5|COMPLETED|Washout||1
1646798|NCT00750308|4023816|P4|COMPLETED|Washout||1
1646799|NCT00750308|4023817|P3|COMPLETED|Washout||2
1646800|NCT00750308|4023818|P2|COMPLETED|Washout||1
1646801|NCT00750308|4023819|P1|COMPLETED|Washout||2
1646802|NCT00750308|4023808|P12|STARTED|Washout||1
1646803|NCT00750308|4023809|P11|STARTED|Washout||1
1646804|NCT00750308|4023810|P10|STARTED|Washout||2
1646805|NCT00750308|4023811|P9|STARTED|Washout||1
1646806|NCT00750308|4023812|P8|STARTED|Washout||2
1646807|NCT00750308|4023813|P7|STARTED|Washout||2
1646808|NCT00750308|4023814|P6|STARTED|Washout||2
1646809|NCT00750308|4023815|P5|STARTED|Washout||1
1646810|NCT00750308|4023816|P4|STARTED|Washout||1
1646811|NCT00750308|4023817|P3|STARTED|Washout||2
1646812|NCT00750308|4023818|P2|STARTED|Washout||1
1646813|NCT00750308|4023819|P1|STARTED|Washout||2
1646814|NCT00750308|4023808|P12|NOT COMPLETED|Third Treatment||0
1646815|NCT00750308|4023809|P11|NOT COMPLETED|Third Treatment||0
1646816|NCT00750308|4023810|P10|NOT COMPLETED|Third Treatment||0
1646817|NCT00750308|4023811|P9|NOT COMPLETED|Third Treatment||0
1646818|NCT00750308|4023812|P8|NOT COMPLETED|Third Treatment||0
1646819|NCT00750308|4023813|P7|NOT COMPLETED|Third Treatment||0
1646820|NCT00750308|4023814|P6|NOT COMPLETED|Third Treatment||0
1646821|NCT00750308|4023815|P5|NOT COMPLETED|Third Treatment||0
1646822|NCT00750308|4023816|P4|NOT COMPLETED|Third Treatment||0
1646823|NCT00750308|4023817|P3|NOT COMPLETED|Third Treatment||0
1646824|NCT00750308|4023818|P2|NOT COMPLETED|Third Treatment||1
1646825|NCT00750308|4023819|P1|NOT COMPLETED|Third Treatment||0
1646826|NCT00750308|4023808|P12|COMPLETED|Third Treatment||1
1646827|NCT00750308|4023809|P11|COMPLETED|Third Treatment||1
1646828|NCT00750308|4023810|P10|COMPLETED|Third Treatment||2
1646829|NCT00750308|4023811|P9|COMPLETED|Third Treatment||1
1646830|NCT00750308|4023812|P8|COMPLETED|Third Treatment||2
1646831|NCT00750308|4023813|P7|COMPLETED|Third Treatment||2
1646832|NCT00750308|4023814|P6|COMPLETED|Third Treatment||2
1646833|NCT00750308|4023815|P5|COMPLETED|Third Treatment||1
1646834|NCT00750308|4023816|P4|COMPLETED|Third Treatment||1
1646835|NCT00750308|4023817|P3|COMPLETED|Third Treatment||2
1646836|NCT00750308|4023818|P2|COMPLETED|Third Treatment||1
1646837|NCT00750308|4023819|P1|COMPLETED|Third Treatment||2
1646838|NCT00750308|4023808|P12|STARTED|Third Treatment||1
1646839|NCT00750308|4023809|P11|STARTED|Third Treatment||1
1646840|NCT00750308|4023810|P10|STARTED|Third Treatment||2
1646841|NCT00750308|4023811|P9|STARTED|Third Treatment||1
1646842|NCT00750308|4023812|P8|STARTED|Third Treatment||2
1646843|NCT00750308|4023813|P7|STARTED|Third Treatment||2
1646844|NCT00750308|4023814|P6|STARTED|Third Treatment||2
1646845|NCT00750308|4023815|P5|STARTED|Third Treatment||1
1646846|NCT00750308|4023816|P4|STARTED|Third Treatment||1
1646847|NCT00750308|4023817|P3|STARTED|Third Treatment||2
1646848|NCT00750308|4023818|P2|STARTED|Third Treatment||2
1646849|NCT00750308|4023819|P1|STARTED|Third Treatment||2
1646850|NCT00750308|4023808|P12|NOT COMPLETED|Washout||0
1646851|NCT00750308|4023809|P11|NOT COMPLETED|Washout||0
1646852|NCT00750308|4023810|P10|NOT COMPLETED|Washout||0
1646853|NCT00750308|4023811|P9|NOT COMPLETED|Washout||0
1646854|NCT00750308|4023812|P8|NOT COMPLETED|Washout||0
1646855|NCT00750308|4023813|P7|NOT COMPLETED|Washout||0
1646856|NCT00750308|4023814|P6|NOT COMPLETED|Washout||0
1646857|NCT00750308|4023815|P5|NOT COMPLETED|Washout||0
1646858|NCT00750308|4023816|P4|NOT COMPLETED|Washout||0
1646859|NCT00750308|4023817|P3|NOT COMPLETED|Washout||0
1646860|NCT00750308|4023818|P2|NOT COMPLETED|Washout||0
1646861|NCT00750308|4023819|P1|NOT COMPLETED|Washout||0
1646862|NCT00750308|4023808|P12|COMPLETED|Washout||1
1646863|NCT00750308|4023809|P11|COMPLETED|Washout||1
1646864|NCT00750308|4023810|P10|COMPLETED|Washout||2
1646865|NCT00750308|4023811|P9|COMPLETED|Washout||1
1646866|NCT00750308|4023812|P8|COMPLETED|Washout||2
1646867|NCT00750308|4023813|P7|COMPLETED|Washout||2
1646868|NCT00750308|4023814|P6|COMPLETED|Washout||2
1646869|NCT00750308|4023815|P5|COMPLETED|Washout||1
1646870|NCT00750308|4023816|P4|COMPLETED|Washout||1
1646871|NCT00750308|4023817|P3|COMPLETED|Washout||2
1646872|NCT00750308|4023818|P2|COMPLETED|Washout||2
1646873|NCT00750308|4023819|P1|COMPLETED|Washout||2
1646874|NCT00750308|4023808|P12|STARTED|Washout||1
1646875|NCT00750308|4023809|P11|STARTED|Washout||1
1646876|NCT00750308|4023810|P10|STARTED|Washout||2
1646877|NCT00750308|4023811|P9|STARTED|Washout||1
1646878|NCT00750308|4023812|P8|STARTED|Washout||2
1646879|NCT00750308|4023813|P7|STARTED|Washout||2
1646880|NCT00750308|4023814|P6|STARTED|Washout||2
1646881|NCT00750308|4023815|P5|STARTED|Washout||1
1646882|NCT00750308|4023816|P4|STARTED|Washout||1
1646883|NCT00750308|4023817|P3|STARTED|Washout||2
1646884|NCT00750308|4023818|P2|STARTED|Washout||2
1646885|NCT00750308|4023819|P1|STARTED|Washout||2
1646886|NCT00750308|4023808|P12|NOT COMPLETED|Second Treatment||0
1646887|NCT00750308|4023809|P11|NOT COMPLETED|Second Treatment||0
1646888|NCT00750308|4023810|P10|NOT COMPLETED|Second Treatment||0
1646889|NCT00750308|4023811|P9|NOT COMPLETED|Second Treatment||1
1646890|NCT00750308|4023812|P8|NOT COMPLETED|Second Treatment||0
1646891|NCT00750308|4023813|P7|NOT COMPLETED|Second Treatment||0
1646892|NCT00750308|4023814|P6|NOT COMPLETED|Second Treatment||1
1646893|NCT00750308|4023815|P5|NOT COMPLETED|Second Treatment||1
1646894|NCT00750308|4023816|P4|NOT COMPLETED|Second Treatment||0
1646895|NCT00750308|4023817|P3|NOT COMPLETED|Second Treatment||0
1646896|NCT00750308|4023818|P2|NOT COMPLETED|Second Treatment||0
1646897|NCT00750308|4023819|P1|NOT COMPLETED|Second Treatment||0
1646898|NCT00750308|4023808|P12|COMPLETED|Second Treatment||1
1646899|NCT00750308|4023809|P11|COMPLETED|Second Treatment||1
1646900|NCT00750308|4023810|P10|COMPLETED|Second Treatment||2
1646901|NCT00750308|4023811|P9|COMPLETED|Second Treatment||1
1646902|NCT00750308|4023812|P8|COMPLETED|Second Treatment||2
1646903|NCT00750308|4023813|P7|COMPLETED|Second Treatment||2
1646904|NCT00750308|4023814|P6|COMPLETED|Second Treatment||2
1646905|NCT00750308|4023815|P5|COMPLETED|Second Treatment||1
1646906|NCT00750308|4023816|P4|COMPLETED|Second Treatment||1
1646907|NCT00750308|4023817|P3|COMPLETED|Second Treatment||2
1646908|NCT00750308|4023818|P2|COMPLETED|Second Treatment||2
1646909|NCT00750308|4023819|P1|COMPLETED|Second Treatment||2
1646910|NCT00750308|4023808|P12|STARTED|Second Treatment||1
1646911|NCT00750308|4023809|P11|STARTED|Second Treatment||1
1646912|NCT00750308|4023810|P10|STARTED|Second Treatment||2
1646913|NCT00750308|4023811|P9|STARTED|Second Treatment||2
1646914|NCT00750308|4023812|P8|STARTED|Second Treatment||2
1646915|NCT00750308|4023813|P7|STARTED|Second Treatment||2
1646916|NCT00750308|4023814|P6|STARTED|Second Treatment||3
1646917|NCT00750308|4023815|P5|STARTED|Second Treatment||2
1646918|NCT00750308|4023816|P4|STARTED|Second Treatment||1
1646919|NCT00750308|4023817|P3|STARTED|Second Treatment||2
1646920|NCT00750308|4023818|P2|STARTED|Second Treatment||2
1646921|NCT00750308|4023819|P1|STARTED|Second Treatment||2
1646922|NCT00750308|4023808|P12|NOT COMPLETED|Washout||0
1646923|NCT00750308|4023809|P11|NOT COMPLETED|Washout||0
1646924|NCT00750308|4023810|P10|NOT COMPLETED|Washout||0
1646925|NCT00750308|4023811|P9|NOT COMPLETED|Washout||0
1646926|NCT00750308|4023812|P8|NOT COMPLETED|Washout||0
1646927|NCT00750308|4023813|P7|NOT COMPLETED|Washout||0
1646928|NCT00750308|4023814|P6|NOT COMPLETED|Washout||0
1646929|NCT00750308|4023815|P5|NOT COMPLETED|Washout||0
1646930|NCT00750308|4023816|P4|NOT COMPLETED|Washout||0
1646931|NCT00750308|4023817|P3|NOT COMPLETED|Washout||0
1646932|NCT00750308|4023818|P2|NOT COMPLETED|Washout||0
1646933|NCT00750308|4023819|P1|NOT COMPLETED|Washout||0
1646934|NCT00750308|4023808|P12|COMPLETED|Washout||1
1646935|NCT00750308|4023809|P11|COMPLETED|Washout||1
1646936|NCT00750308|4023810|P10|COMPLETED|Washout||2
1646937|NCT00750308|4023811|P9|COMPLETED|Washout||2
1646938|NCT00750308|4023812|P8|COMPLETED|Washout||2
1646939|NCT00750308|4023813|P7|COMPLETED|Washout||2
1646940|NCT00750308|4023814|P6|COMPLETED|Washout||3
1646941|NCT00750308|4023815|P5|COMPLETED|Washout||2
1646942|NCT00750308|4023816|P4|COMPLETED|Washout||1
1646943|NCT00750308|4023817|P3|COMPLETED|Washout||2
1646944|NCT00750308|4023818|P2|COMPLETED|Washout||2
1646945|NCT00750308|4023819|P1|COMPLETED|Washout||2
1646946|NCT00750308|4023808|P12|STARTED|Washout||1
1646947|NCT00750308|4023809|P11|STARTED|Washout||1
1646948|NCT00750308|4023810|P10|STARTED|Washout||2
1646949|NCT00750308|4023811|P9|STARTED|Washout||2
1646950|NCT00750308|4023812|P8|STARTED|Washout||2
1646951|NCT00750308|4023813|P7|STARTED|Washout||2
1646952|NCT00750308|4023814|P6|STARTED|Washout||3
1646953|NCT00750308|4023815|P5|STARTED|Washout||2
1646954|NCT00750308|4023816|P4|STARTED|Washout||1
1646955|NCT00750308|4023817|P3|STARTED|Washout||2
1646956|NCT00750308|4023818|P2|STARTED|Washout||2
1646957|NCT00750308|4023819|P1|STARTED|Washout||2
1646958|NCT00750308|4023808|P12|NOT COMPLETED|First Treatment||1
1646959|NCT00750308|4023809|P11|NOT COMPLETED|First Treatment||1
1646960|NCT00750308|4023810|P10|NOT COMPLETED|First Treatment||0
1646961|NCT00750308|4023811|P9|NOT COMPLETED|First Treatment||0
1646962|NCT00750308|4023812|P8|NOT COMPLETED|First Treatment||1
1646963|NCT00750308|4023813|P7|NOT COMPLETED|First Treatment||0
1646964|NCT00750308|4023814|P6|NOT COMPLETED|First Treatment||0
1646965|NCT00750308|4023815|P5|NOT COMPLETED|First Treatment||0
1646966|NCT00750308|4023816|P4|NOT COMPLETED|First Treatment||1
1646967|NCT00750308|4023817|P3|NOT COMPLETED|First Treatment||0
1646968|NCT00750308|4023818|P2|NOT COMPLETED|First Treatment||1
1646969|NCT00750308|4023819|P1|NOT COMPLETED|First Treatment||0
1646970|NCT00750308|4023808|P12|COMPLETED|First Treatment||1
1646971|NCT00750308|4023809|P11|COMPLETED|First Treatment||1
1646972|NCT00750308|4023810|P10|COMPLETED|First Treatment||2
1646973|NCT00750308|4023811|P9|COMPLETED|First Treatment||2
1646974|NCT00750308|4023812|P8|COMPLETED|First Treatment||2
1646975|NCT00750308|4023813|P7|COMPLETED|First Treatment||2
1646976|NCT00750308|4023814|P6|COMPLETED|First Treatment||3
1646977|NCT00750308|4023815|P5|COMPLETED|First Treatment||2
1646978|NCT00750308|4023816|P4|COMPLETED|First Treatment||1
1646979|NCT00750308|4023817|P3|COMPLETED|First Treatment||2
1646980|NCT00750308|4023818|P2|COMPLETED|First Treatment||2
1646981|NCT00750308|4023819|P1|COMPLETED|First Treatment||2
1646982|NCT00750308|4023808|P12|STARTED|First Treatment||2
1646983|NCT00750308|4023809|P11|STARTED|First Treatment||2
1646984|NCT00750308|4023810|P10|STARTED|First Treatment||2
1646985|NCT00750308|4023811|P9|STARTED|First Treatment||2
1646986|NCT00750308|4023812|P8|STARTED|First Treatment||3
1646987|NCT00750308|4023813|P7|STARTED|First Treatment||2
1646988|NCT00750308|4023814|P6|STARTED|First Treatment||3
1646989|NCT00750308|4023815|P5|STARTED|First Treatment||2
1646990|NCT00750308|4023816|P4|STARTED|First Treatment||2
1646991|NCT00750308|4023817|P3|STARTED|First Treatment||2
1646992|NCT00750308|4023818|P2|STARTED|First Treatment||3
1646993|NCT00750308|4023819|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
1646994|NCT00750282|4023837|P4|NOT COMPLETED|Overall Study||1
1646995|NCT00750282|4023838|P3|NOT COMPLETED|Overall Study||1
1646996|NCT00750282|4023839|P2|NOT COMPLETED|Overall Study||1
1646997|NCT00750282|4023840|P1|NOT COMPLETED|Overall Study||0
1646998|NCT00750282|4023837|P4|COMPLETED|Overall Study||147
1646999|NCT00750282|4023838|P3|COMPLETED|Overall Study||125
1647000|NCT00750282|4023839|P2|COMPLETED|Overall Study||81
1647001|NCT00750282|4023840|P1|COMPLETED|Overall Study||69
1647002|NCT00750282|4023837|P4|STARTED|Overall Study||148
1647003|NCT00750282|4023838|P3|STARTED|Overall Study||126
1647004|NCT00750282|4023839|P2|STARTED|Overall Study||82
1647005|NCT00750282|4023840|P1|STARTED|Overall Study||69
1647006|NCT00750269|4023869|P5|NOT COMPLETED|Overall Study||10
1647007|NCT00750269|4023870|P4|NOT COMPLETED|Overall Study||5
1647008|NCT00750269|4023871|P3|NOT COMPLETED|Overall Study||4
1647009|NCT00750269|4023872|P2|NOT COMPLETED|Overall Study||1
1647010|NCT00750269|4023873|P1|NOT COMPLETED|Overall Study||0
1647011|NCT00750269|4023869|P5|COMPLETED|Overall Study||33
1647012|NCT00750269|4023870|P4|COMPLETED|Overall Study||38
1647013|NCT00750269|4023871|P3|COMPLETED|Overall Study||14
1647014|NCT00750269|4023872|P2|COMPLETED|Overall Study||7
1647015|NCT00750269|4023873|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
1647016|NCT00750269|4023869|P5|STARTED|Overall Study||43
1647017|NCT00750269|4023870|P4|STARTED|Overall Study||43
1647018|NCT00750269|4023871|P3|STARTED|Overall Study||18
1647019|NCT00750269|4023872|P2|STARTED|Overall Study||8
1647020|NCT00750269|4023873|P1|STARTED|Overall Study||8
1647021|NCT00750204|4023920|P2|NOT COMPLETED|Overall Study||1
1647022|NCT00750204|4023921|P1|NOT COMPLETED|Overall Study||1
1647023|NCT00750204|4023920|P2|COMPLETED|Overall Study||0
1647024|NCT00750204|4023921|P1|COMPLETED|Overall Study||0
1647025|NCT00750204|4023920|P2|STARTED|Overall Study||1
1647026|NCT00750204|4023921|P1|STARTED|Overall Study||1
1647027|NCT00750191|4023929|P2|NOT COMPLETED|Overall Study||10
1647028|NCT00750191|4023930|P1|NOT COMPLETED|Overall Study||5
1647029|NCT00750191|4023929|P2|COMPLETED|Overall Study||20
1647030|NCT00750191|4023930|P1|COMPLETED|Overall Study||22
1647031|NCT00750191|4023929|P2|STARTED|Overall Study||30
1647032|NCT00750191|4023930|P1|STARTED|Overall Study||27
1647033|NCT00750152|4023944|P2|NOT COMPLETED|Overall Study||27
1647034|NCT00750152|4023945|P1|NOT COMPLETED|Overall Study||22
1647035|NCT00750152|4023944|P2|COMPLETED|Overall Study||141
1647036|NCT00750152|4023945|P1|COMPLETED|Overall Study||144
1647037|NCT00750152|4023944|P2|STARTED|Overall Study||168
1647038|NCT00750152|4023945|P1|STARTED|Overall Study||166
1647039|NCT00750139|4023957|P4|NOT COMPLETED|Overall Study||46
1647040|NCT00750139|4023958|P3|NOT COMPLETED|Overall Study||101
1647041|NCT00750139|4023959|P2|NOT COMPLETED|Overall Study||59
1647042|NCT00750139|4023960|P1|NOT COMPLETED|Overall Study||89
1647043|NCT00750139|4023957|P4|COMPLETED|Overall Study||73
1647044|NCT00750139|4023958|P3|COMPLETED|Overall Study||135
1647045|NCT00750139|4023959|P2|COMPLETED|Overall Study||59
1647046|NCT00750139|4023960|P1|COMPLETED|Overall Study||145
1647047|NCT00750139|4023957|P4|STARTED|Overall Study||119
1647048|NCT00750139|4023958|P3|STARTED|Overall Study||236
1647049|NCT00750139|4023959|P2|STARTED|Overall Study||118
1647050|NCT00750139|4023960|P1|STARTED|Overall Study||234
1647051|NCT00750061|4023976|P2|NOT COMPLETED|Overall Study||2
1647052|NCT00750061|4023977|P1|NOT COMPLETED|Overall Study||2
1647053|NCT00750061|4023976|P2|COMPLETED|Overall Study||18
1647054|NCT00750061|4023977|P1|COMPLETED|Overall Study||18
1647055|NCT00750061|4023976|P2|STARTED|Overall Study||20
1647056|NCT00750061|4023977|P1|STARTED|Overall Study||20
1647057|NCT00749996|4023987|P2|NOT COMPLETED|Overall Study||13
1647058|NCT00749996|4023988|P1|NOT COMPLETED|Overall Study||18
1647059|NCT00749996|4023987|P2|COMPLETED|Overall Study||58
1647060|NCT00749996|4023988|P1|COMPLETED|Overall Study||57
1647061|NCT00749996|4023987|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
1647062|NCT00749996|4023988|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
1647063|NCT00749996|4023987|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
1647064|NCT00749996|4023988|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
1647065|NCT00749996|4023987|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
1647066|NCT00749996|4023988|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
1647067|NCT00749996|4023987|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
1647068|NCT00749996|4023988|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
1647069|NCT00749996|4023987|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
1647070|NCT00749996|4023988|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
1647071|NCT00749996|4023987|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
1647072|NCT00749996|4023988|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
1647073|NCT00749957|4023998|P2|NOT COMPLETED|Overall Study||0
1647074|NCT00749957|4023999|P1|NOT COMPLETED|Overall Study||0
1647075|NCT00749957|4023998|P2|COMPLETED|Overall Study||6
1647076|NCT00749957|4023999|P1|COMPLETED|Overall Study||6
1647077|NCT00749957|4023998|P2|STARTED|Overall Study||6
1647078|NCT00749957|4023999|P1|STARTED|Overall Study||6
1647079|NCT00749944|4024011|P2|NOT COMPLETED|Overall Study||1
1647080|NCT00749944|4024012|P1|NOT COMPLETED|Overall Study||5
1647081|NCT00749944|4024011|P2|COMPLETED|Overall Study||54
1647082|NCT00749944|4024012|P1|COMPLETED|Overall Study||50
1647083|NCT00749944|4024011|P2|STARTED|Overall Study||55
1647084|NCT00749944|4024012|P1|STARTED|Overall Study||55
1647085|NCT00749931|4024080|P3|NOT COMPLETED|Overall Study||0
1647086|NCT00749931|4024081|P2|NOT COMPLETED|Overall Study||0
1647087|NCT00749931|4024082|P1|NOT COMPLETED|Overall Study||0
1647088|NCT00749931|4024080|P3|COMPLETED|Overall Study||68
1647089|NCT00749931|4024081|P2|COMPLETED|Overall Study||298
1647090|NCT00749931|4024082|P1|COMPLETED|Overall Study||298
1647091|NCT00749931|4024080|P3|STARTED|Overall Study||68
1647092|NCT00749931|4024081|P2|STARTED|Overall Study||298
1647093|NCT00749931|4024082|P1|STARTED|Overall Study||298
1647094|NCT00749775|4024091|P1|NOT COMPLETED|Overall Study||107
1647095|NCT00749775|4024091|P1|COMPLETED|Overall Study||3210
1647096|NCT00749775|4024091|P1|STARTED|Overall Study||3317
1647097|NCT00749684|4024107|P1|NOT COMPLETED|Overall Study||82
1647098|NCT00749684|4024107|P1|COMPLETED|Overall Study||56
1647099|NCT00749684|4024107|P1|STARTED|Overall Study||138
1647100|NCT00749671|4024114|P2|NOT COMPLETED|Overall Study||0
1647101|NCT00749671|4024115|P1|NOT COMPLETED|Overall Study||0
1647102|NCT00749671|4024114|P2|COMPLETED|Overall Study||9
1647103|NCT00749671|4024115|P1|COMPLETED|Overall Study||11
1647104|NCT00749671|4024114|P2|STARTED|Overall Study||9
1647105|NCT00749671|4024115|P1|STARTED|Overall Study||11
1647106|NCT00749606|4024125|P2|NOT COMPLETED|Year 3 (Observation)||3
1647107|NCT00749606|4024126|P1|NOT COMPLETED|Year 3 (Observation)||0
1647108|NCT00749606|4024125|P2|COMPLETED|Year 3 (Observation)||69
1647109|NCT00749606|4024126|P1|COMPLETED|Year 3 (Observation)||63
1647110|NCT00749606|4024125|P2|STARTED|Year 3 (Observation)||72
1647111|NCT00749606|4024126|P1|STARTED|Year 3 (Observation)||63
1647112|NCT00749606|4024125|P2|NOT COMPLETED|Year 2||8
1647113|NCT00749606|4024126|P1|NOT COMPLETED|Year 2||11
1647114|NCT00749606|4024125|P2|COMPLETED|Year 2||72
1647115|NCT00749606|4024126|P1|COMPLETED|Year 2||63
1647116|NCT00749606|4024125|P2|STARTED|Year 2||80
1647117|NCT00749606|4024126|P1|STARTED|Year 2||74
1647118|NCT00749606|4024125|P2|NOT COMPLETED|Year 1||48
1647119|NCT00749606|4024126|P1|NOT COMPLETED|Year 1||55
1647120|NCT00749606|4024125|P2|COMPLETED|Year 1||80
1647121|NCT00749606|4024126|P1|COMPLETED|Year 1||74
1647122|NCT00749606|4024125|P2|STARTED|Year 1||128
1647123|NCT00749606|4024126|P1|STARTED|Year 1||129
1647124|NCT00749580|4024146|P2|NOT COMPLETED|Overall Study||9
1647125|NCT00749580|4024147|P1|NOT COMPLETED|Overall Study||4
1647126|NCT00749580|4024146|P2|COMPLETED|Overall Study||16
1647127|NCT00749580|4024147|P1|COMPLETED|Overall Study|December 2010|17
1647128|NCT00749580|4024146|P2|STARTED|Overall Study||25
1647129|NCT00749580|4024147|P1|STARTED|Overall Study|September 2008|21
1647130|NCT00749476|4024155|P1|NOT COMPLETED|Overall Study||0
1647131|NCT00749476|4024155|P1|COMPLETED|Overall Study||1
1647132|NCT00749476|4024155|P1|STARTED|Overall Study||1
1647133|NCT00749463|4024162|P3|NOT COMPLETED|Overall Study||1
1647134|NCT00749463|4024163|P2|NOT COMPLETED|Overall Study||4
1647135|NCT00749463|4024164|P1|NOT COMPLETED|Overall Study||1
1647136|NCT00749463|4024162|P3|COMPLETED|Overall Study||149
1647137|NCT00749463|4024163|P2|COMPLETED|Overall Study||60
1647138|NCT00749463|4024164|P1|COMPLETED|Overall Study||85
1647139|NCT00749463|4024162|P3|STARTED|Overall Study||150
1647140|NCT00749463|4024163|P2|STARTED|Overall Study||64
1647141|NCT00749463|4024164|P1|STARTED|Overall Study||86
1647142|NCT00749398|4024190|P1|NOT COMPLETED|Overall Study||53
1647143|NCT00749398|4024190|P1|COMPLETED|Overall Study||71
1647144|NCT00749398|4024190|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
1647145|NCT00749268|4024208|P2|NOT COMPLETED|Overall Study||36
1647146|NCT00749268|4024209|P1|NOT COMPLETED|Overall Study||34
1647147|NCT00749268|4024208|P2|COMPLETED|Overall Study||74
1647148|NCT00749268|4024209|P1|COMPLETED|Overall Study||72
1647149|NCT00749268|4024208|P2|STARTED|Overall Study||110
1647150|NCT00749268|4024209|P1|STARTED|Overall Study||106
1647151|NCT00749203|4024233|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
1647152|NCT00749203|4024234|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
1647153|NCT00749203|4024233|P2|COMPLETED|Second Infusion at 2 Weeks||13
1647154|NCT00749203|4024234|P1|COMPLETED|Second Infusion at 2 Weeks||16
1647155|NCT00749203|4024233|P2|STARTED|Second Infusion at 2 Weeks||15
1647156|NCT00749203|4024234|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
1647157|NCT00749203|4024233|P2|NOT COMPLETED|no Infusion at Week 1||4
1647158|NCT00749203|4024234|P1|NOT COMPLETED|no Infusion at Week 1||0
1647159|NCT00749203|4024233|P2|COMPLETED|no Infusion at Week 1||15
1647160|NCT00749203|4024234|P1|COMPLETED|no Infusion at Week 1||22
1647161|NCT00749203|4024233|P2|STARTED|no Infusion at Week 1||19
1647162|NCT00749203|4024234|P1|STARTED|no Infusion at Week 1||22
1647163|NCT00749203|4024233|P2|NOT COMPLETED|First Infusion Day 1||0
1647164|NCT00749203|4024234|P1|NOT COMPLETED|First Infusion Day 1||0
1647165|NCT00749203|4024233|P2|COMPLETED|First Infusion Day 1||19
1647166|NCT00749203|4024234|P1|COMPLETED|First Infusion Day 1||22
1647167|NCT00749203|4024233|P2|STARTED|First Infusion Day 1||19
1647168|NCT00749203|4024234|P1|STARTED|First Infusion Day 1||22
1647169|NCT00749190|4024255|P7|NOT COMPLETED|Overall Study||1
1647170|NCT00749190|4024256|P6|NOT COMPLETED|Overall Study||5
1647171|NCT00749190|4024257|P5|NOT COMPLETED|Overall Study||0
1647172|NCT00749190|4024258|P4|NOT COMPLETED|Overall Study||5
1647173|NCT00749190|4024259|P3|NOT COMPLETED|Overall Study||1
1647174|NCT00749190|4024260|P2|NOT COMPLETED|Overall Study||5
1647175|NCT00749190|4024261|P1|NOT COMPLETED|Overall Study||5
1647176|NCT00749190|4024255|P7|COMPLETED|Overall Study||70
1647177|NCT00749190|4024256|P6|COMPLETED|Overall Study||65
1647178|NCT00749190|4024257|P5|COMPLETED|Overall Study||70
1647179|NCT00749190|4024258|P4|COMPLETED|Overall Study||66
1647180|NCT00749190|4024259|P3|COMPLETED|Overall Study||70
1647181|NCT00749190|4024260|P2|COMPLETED|Overall Study||66
1647182|NCT00749190|4024261|P1|COMPLETED|Overall Study||66
1647183|NCT00749190|4024255|P7|STARTED|Overall Study||71
1647184|NCT00749190|4024256|P6|STARTED|Overall Study||70
1647185|NCT00749190|4024257|P5|STARTED|Overall Study||70
1647186|NCT00749190|4024258|P4|STARTED|Overall Study||71
1647187|NCT00749190|4024259|P3|STARTED|Overall Study||71
1647188|NCT00749190|4024260|P2|STARTED|Overall Study||71
1647189|NCT00749190|4024261|P1|STARTED|Overall Study||71
1647190|NCT00749125|4024340|P2|NOT COMPLETED|Overall Study||18
1647191|NCT00749125|4024341|P1|NOT COMPLETED|Overall Study||11
1647192|NCT00749125|4024340|P2|COMPLETED|Overall Study||34
1647193|NCT00749125|4024341|P1|COMPLETED|Overall Study||36
1647194|NCT00749125|4024340|P2|STARTED|Overall Study||52
1647195|NCT00749125|4024341|P1|STARTED|Overall Study||47
1647196|NCT00749073|4024347|P1|NOT COMPLETED|Overall Study||0
1647197|NCT00749073|4024347|P1|COMPLETED|Overall Study||10
1647198|NCT00749073|4024347|P1|STARTED|Overall Study||10
1647199|NCT00748982|4024355|P2|NOT COMPLETED|Overall Study||0
1647200|NCT00748982|4024356|P1|NOT COMPLETED|Overall Study||0
1647201|NCT00748982|4024355|P2|COMPLETED|Overall Study||4
1647202|NCT00748982|4024356|P1|COMPLETED|Overall Study||12
1647203|NCT00748982|4024355|P2|STARTED|Overall Study||4
1647204|NCT00748982|4024356|P1|STARTED|Overall Study||12
1647205|NCT00748969|4024370|P2|NOT COMPLETED|Overall Study||1
1647206|NCT00748969|4024371|P1|NOT COMPLETED|Overall Study||1
1647207|NCT00748969|4024370|P2|COMPLETED|Overall Study||0
1647208|NCT00748969|4024371|P1|COMPLETED|Overall Study||0
1647209|NCT00748969|4024370|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
1647210|NCT00748969|4024371|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
1647211|NCT00748956|4024382|P3|NOT COMPLETED|Overall Study||0
1647212|NCT00748956|4024383|P2|NOT COMPLETED|Overall Study||0
1647213|NCT00748956|4024384|P1|NOT COMPLETED|Overall Study||0
1647214|NCT00748956|4024382|P3|COMPLETED|Overall Study||5
1647215|NCT00748956|4024383|P2|COMPLETED|Overall Study||5
1647216|NCT00748956|4024384|P1|COMPLETED|Overall Study||0
1647217|NCT00748956|4024382|P3|STARTED|Overall Study||5
1647218|NCT00748956|4024383|P2|STARTED|Overall Study||5
1647219|NCT00748956|4024384|P1|STARTED|Overall Study||0
1647220|NCT00748865|4024407|P2|NOT COMPLETED|Overall Study||0
1647221|NCT00748865|4024408|P1|NOT COMPLETED|Overall Study||0
1647222|NCT00748865|4024407|P2|COMPLETED|Overall Study||10
1647223|NCT00748865|4024408|P1|COMPLETED|Overall Study||10
1647224|NCT00748865|4024407|P2|STARTED|Overall Study||10
1647225|NCT00748865|4024408|P1|STARTED|Overall Study||10
1647226|NCT00748826|4024414|P1|NOT COMPLETED|Overall Study||301
1647227|NCT00748826|4024414|P1|COMPLETED|Overall Study||207
1647228|NCT00748826|4024414|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
1647229|NCT00748709|4024421|P1|NOT COMPLETED|Overall Study||20
1647230|NCT00748709|4024421|P1|COMPLETED|Overall Study||0
1647231|NCT00748709|4024421|P1|STARTED|Overall Study|Treated|20
1647232|NCT00748657|4024433|P1|NOT COMPLETED|Overall Study||0
1647233|NCT00748657|4024433|P1|COMPLETED|Overall Study||36
1647234|NCT00748657|4024433|P1|STARTED|Overall Study||36
1647235|NCT00748579|4024447|P2|NOT COMPLETED|Overall Study||0
1647236|NCT00748579|4024448|P1|NOT COMPLETED|Overall Study||0
1647237|NCT00748579|4024447|P2|COMPLETED|Overall Study||0
1647238|NCT00748579|4024448|P1|COMPLETED|Overall Study||2
1647239|NCT00748579|4024447|P2|STARTED|Overall Study||0
1647240|NCT00748579|4024448|P1|STARTED|Overall Study||2
1647241|NCT00748566|4024454|P1|NOT COMPLETED|Overall Study||112
1647242|NCT00748566|4024454|P1|COMPLETED|Overall Study||60
1647243|NCT00748566|4024454|P1|STARTED|Overall Study||172
1647244|NCT00748553|4024484|P2|NOT COMPLETED|Overall Study||1
1647245|NCT00748553|4024485|P1|NOT COMPLETED|Overall Study||3
1647246|NCT00748553|4024484|P2|COMPLETED|Overall Study||13
1647247|NCT00748553|4024485|P1|COMPLETED|Overall Study||13
1647248|NCT00748553|4024484|P2|STARTED|Overall Study||14
1647249|NCT00748553|4024485|P1|STARTED|Overall Study||16
1647250|NCT00748540|4024492|P1|NOT COMPLETED|Overall Study||1
1647251|NCT00748540|4024492|P1|COMPLETED|Overall Study||49
1647252|NCT00748540|4024492|P1|STARTED|Overall Study||50
1647253|NCT00748410|4024501|P2|NOT COMPLETED|Overall Study||0
1647254|NCT00748410|4024502|P1|NOT COMPLETED|Overall Study||0
1647255|NCT00748410|4024501|P2|COMPLETED|Overall Study||2
1647256|NCT00748410|4024502|P1|COMPLETED|Overall Study||1
1647257|NCT00748410|4024501|P2|STARTED|Overall Study||2
1647258|NCT00748410|4024502|P1|STARTED|Overall Study||1
1647259|NCT00748241|4024518|P1|NOT COMPLETED|Overall Study||8
1647260|NCT00748241|4024518|P1|COMPLETED|Overall Study||11
1647261|NCT00748241|4024518|P1|STARTED|Overall Study||19
1647262|NCT00748189|4024528|P2|NOT COMPLETED|Overall Study||221
1647263|NCT00748189|4024529|P1|NOT COMPLETED|Overall Study||225
1647264|NCT00748189|4024528|P2|COMPLETED|Overall Study||0
1647265|NCT00748189|4024529|P1|COMPLETED|Overall Study|This participant was entered incorrectly by the site and has not completed the 5 year follow-up.|1
1647266|NCT00748189|4024528|P2|Ongoing|Overall Study|One par. was incorrectly recorded as withdrawn due to “Study Terminated by Sponsor” and is ongoing.|162
1647267|NCT00748189|4024529|P1|Ongoing|Overall Study||155
1647268|NCT00748189|4024528|P2|STARTED|Overall Study||221
1647269|NCT00748189|4024529|P1|STARTED|Overall Study||226
1647270|NCT00748098|4024583|P2|NOT COMPLETED|Second Taper Period||0
1647271|NCT00748098|4024584|P1|NOT COMPLETED|Second Taper Period||0
1647272|NCT00748098|4024583|P2|COMPLETED|Second Taper Period||61
1647273|NCT00748098|4024584|P1|COMPLETED|Second Taper Period||53
1647274|NCT00748098|4024583|P2|STARTED|Second Taper Period||61
1647275|NCT00748098|4024584|P1|STARTED|Second Taper Period||53
1647276|NCT00748098|4024583|P2|NOT COMPLETED|Second Treatment Intervention Period||3
1647277|NCT00748098|4024584|P1|NOT COMPLETED|Second Treatment Intervention Period||6
1647278|NCT00748098|4024583|P2|COMPLETED|Second Treatment Intervention Period||61
1647279|NCT00748098|4024584|P1|COMPLETED|Second Treatment Intervention Period||53
1647280|NCT00748098|4024583|P2|STARTED|Second Treatment Intervention Period||64
1647281|NCT00748098|4024584|P1|STARTED|Second Treatment Intervention Period||59
1647282|NCT00748098|4024583|P2|NOT COMPLETED|1-Week Washout Period||1
1647283|NCT00748098|4024584|P1|NOT COMPLETED|1-Week Washout Period||2
1647284|NCT00748098|4024583|P2|COMPLETED|1-Week Washout Period||64
1647285|NCT00748098|4024584|P1|COMPLETED|1-Week Washout Period||59
1647286|NCT00748098|4024583|P2|STARTED|1-Week Washout Period||65
1647287|NCT00748098|4024584|P1|STARTED|1-Week Washout Period||61
1647288|NCT00748098|4024583|P2|NOT COMPLETED|First Taper Period||1
1647289|NCT00748098|4024584|P1|NOT COMPLETED|First Taper Period||3
1647290|NCT00748098|4024583|P2|COMPLETED|First Taper Period||65
1647291|NCT00748098|4024584|P1|COMPLETED|First Taper Period||61
1647292|NCT00748098|4024583|P2|STARTED|First Taper Period||66
1647293|NCT00748098|4024584|P1|STARTED|First Taper Period||64
1647294|NCT00748098|4024583|P2|NOT COMPLETED|First Treatment Intervention Period||1
1647295|NCT00748098|4024584|P1|NOT COMPLETED|First Treatment Intervention Period||5
1647296|NCT00748098|4024583|P2|COMPLETED|First Treatment Intervention Period||66
1647297|NCT00748098|4024584|P1|COMPLETED|First Treatment Intervention Period||64
1647298|NCT00748098|4024583|P2|STARTED|First Treatment Intervention Period||67
1647299|NCT00748098|4024584|P1|STARTED|First Treatment Intervention Period||69
1647300|NCT00748085|4024644|P1|NOT COMPLETED|Overall Study||0
1647301|NCT00748085|4024644|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
1647302|NCT00748085|4024644|P1|STARTED|Overall Study||5
1647303|NCT00748072|4024651|P2|NOT COMPLETED|Overall Study||0
1647304|NCT00748072|4024652|P1|NOT COMPLETED|Overall Study||0
1647305|NCT00748072|4024651|P2|COMPLETED|Overall Study||80
1647306|NCT00748072|4024652|P1|COMPLETED|Overall Study||82
1647307|NCT00748072|4024651|P2|STARTED|Overall Study||80
1647308|NCT00748072|4024652|P1|STARTED|Overall Study||82
1647309|NCT00747916|4024658|P1|NOT COMPLETED|Overall Study||0
1647310|NCT00747916|4024658|P1|COMPLETED|Overall Study||3
1647311|NCT00747916|4024658|P1|STARTED|Overall Study||3
1647312|NCT00747812|4024665|P2|NOT COMPLETED|Overall Study||3
1647313|NCT00747812|4024666|P1|NOT COMPLETED|Overall Study||5
1647314|NCT00747812|4024665|P2|COMPLETED|Overall Study||0
1647315|NCT00747812|4024666|P1|COMPLETED|Overall Study||0
1647316|NCT00747812|4024665|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
1647317|NCT00747812|4024666|P1|STARTED|Overall Study||5
1647318|NCT00747747|4024677|P3|NOT COMPLETED|Overall Study||0
1647319|NCT00747747|4024678|P2|NOT COMPLETED|Overall Study||0
1647320|NCT00747747|4024679|P1|NOT COMPLETED|Overall Study||0
1647321|NCT00747747|4024677|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
1647322|NCT00747747|4024678|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
1647323|NCT00747747|4024679|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
1647324|NCT00747747|4024677|P3|STARTED|Overall Study||21
1647325|NCT00747747|4024678|P2|STARTED|Overall Study||14
1647326|NCT00747747|4024679|P1|STARTED|Overall Study||14
1647327|NCT00747643|4024704|P2|NOT COMPLETED|Overall Study||27
1647328|NCT00747643|4024705|P1|NOT COMPLETED|Overall Study||36
1647329|NCT00747643|4024704|P2|COMPLETED|Overall Study||54
1647330|NCT00747643|4024705|P1|COMPLETED|Overall Study||46
1647331|NCT00747643|4024704|P2|STARTED|Overall Study||81
1647332|NCT00747643|4024705|P1|STARTED|Overall Study||82
1647333|NCT00747617|4024719|P2|NOT COMPLETED|Overall Study||1
1647334|NCT00747617|4024720|P1|NOT COMPLETED|Overall Study||3
1647335|NCT00747617|4024719|P2|COMPLETED|Overall Study||11
1647336|NCT00747617|4024720|P1|COMPLETED|Overall Study||10
1647337|NCT00747617|4024719|P2|STARTED|Overall Study||12
1647338|NCT00747617|4024720|P1|STARTED|Overall Study||13
1647339|NCT00747565|4024730|P2|NOT COMPLETED|Overall Study||7
1647340|NCT00747565|4024731|P1|NOT COMPLETED|Overall Study||14
1647341|NCT00747565|4024730|P2|COMPLETED|Overall Study||116
1647342|NCT00747565|4024731|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
1647343|NCT00747565|4024730|P2|STARTED|Overall Study||123
1647344|NCT00747565|4024731|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
1647345|NCT00747552|4024739|P1|NOT COMPLETED|Overall Study||0
1647346|NCT00747552|4024739|P1|COMPLETED|Overall Study||30
1647347|NCT00747552|4024739|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
1647348|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647349|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647350|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647351|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647352|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647353|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647354|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647355|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647356|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647357|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647358|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647359|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647360|NCT00747474|4024744|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
1647361|NCT00747474|4024745|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647362|NCT00747474|4024746|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647363|NCT00747474|4024747|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647364|NCT00747474|4024748|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647365|NCT00747474|4024749|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647366|NCT00747474|4024750|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647367|NCT00747474|4024751|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647368|NCT00747474|4024752|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647369|NCT00747474|4024753|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647370|NCT00747474|4024754|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647371|NCT00747474|4024755|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1647372|NCT00747474|4024744|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
1647373|NCT00747474|4024745|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647374|NCT00747474|4024746|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647375|NCT00747474|4024747|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647376|NCT00747474|4024748|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647377|NCT00747474|4024749|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647378|NCT00747474|4024750|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647379|NCT00747474|4024751|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647380|NCT00747474|4024752|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647381|NCT00747474|4024753|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647382|NCT00747474|4024754|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647383|NCT00747474|4024755|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
1647384|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647385|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647386|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647387|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647388|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647389|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647390|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647391|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647392|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647393|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647394|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647395|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647396|NCT00747474|4024744|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647397|NCT00747474|4024745|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
1647398|NCT00747474|4024746|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647399|NCT00747474|4024747|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647400|NCT00747474|4024748|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647401|NCT00747474|4024749|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647402|NCT00747474|4024750|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647403|NCT00747474|4024751|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647404|NCT00747474|4024752|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647405|NCT00747474|4024753|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647406|NCT00747474|4024754|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647407|NCT00747474|4024755|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1647408|NCT00747474|4024744|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647409|NCT00747474|4024745|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
1647410|NCT00747474|4024746|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647411|NCT00747474|4024747|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647412|NCT00747474|4024748|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647413|NCT00747474|4024749|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647414|NCT00747474|4024750|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647415|NCT00747474|4024751|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647416|NCT00747474|4024752|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647417|NCT00747474|4024753|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647418|NCT00747474|4024754|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647419|NCT00747474|4024755|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
1647420|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647421|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647422|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647423|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647424|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647425|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647426|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647427|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647428|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647429|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647430|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647431|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647432|NCT00747474|4024744|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647433|NCT00747474|4024745|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647434|NCT00747474|4024746|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
1647435|NCT00747474|4024747|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647436|NCT00747474|4024748|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647437|NCT00747474|4024749|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647438|NCT00747474|4024750|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647439|NCT00747474|4024751|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647440|NCT00747474|4024752|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647441|NCT00747474|4024753|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647442|NCT00747474|4024754|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647443|NCT00747474|4024755|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1647444|NCT00747474|4024744|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647445|NCT00747474|4024745|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647446|NCT00747474|4024746|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
1647447|NCT00747474|4024747|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647448|NCT00747474|4024748|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647449|NCT00747474|4024749|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647450|NCT00747474|4024750|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647451|NCT00747474|4024751|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647452|NCT00747474|4024752|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647453|NCT00747474|4024753|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647454|NCT00747474|4024754|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647455|NCT00747474|4024755|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
1647456|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647457|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647458|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647459|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647460|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647461|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647462|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647463|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647464|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647465|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647466|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647467|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647468|NCT00747474|4024744|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647469|NCT00747474|4024745|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647470|NCT00747474|4024746|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647471|NCT00747474|4024747|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
1647472|NCT00747474|4024748|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647473|NCT00747474|4024749|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647474|NCT00747474|4024750|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647475|NCT00747474|4024751|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647476|NCT00747474|4024752|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647477|NCT00747474|4024753|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647478|NCT00747474|4024754|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647479|NCT00747474|4024755|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1647480|NCT00747474|4024744|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647481|NCT00747474|4024745|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647482|NCT00747474|4024746|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647483|NCT00747474|4024747|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
1647484|NCT00747474|4024748|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647485|NCT00747474|4024749|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647486|NCT00747474|4024750|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647487|NCT00747474|4024751|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647488|NCT00747474|4024752|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647489|NCT00747474|4024753|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647490|NCT00747474|4024754|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647491|NCT00747474|4024755|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
1647492|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647493|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647494|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647495|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647496|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
1647497|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647498|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647499|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647500|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647501|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647502|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647503|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647504|NCT00747474|4024744|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647505|NCT00747474|4024745|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647506|NCT00747474|4024746|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647507|NCT00747474|4024747|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647508|NCT00747474|4024748|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
1647509|NCT00747474|4024749|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647510|NCT00747474|4024750|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647511|NCT00747474|4024751|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647512|NCT00747474|4024752|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647513|NCT00747474|4024753|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647514|NCT00747474|4024754|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647515|NCT00747474|4024755|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1647516|NCT00747474|4024744|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647517|NCT00747474|4024745|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647518|NCT00747474|4024746|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647519|NCT00747474|4024747|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647520|NCT00747474|4024748|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
1647521|NCT00747474|4024749|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647522|NCT00747474|4024750|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647523|NCT00747474|4024751|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647524|NCT00747474|4024752|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647525|NCT00747474|4024753|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647526|NCT00747474|4024754|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647527|NCT00747474|4024755|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
1647528|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647529|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647530|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647531|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647532|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647533|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647534|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647535|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647536|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647537|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647538|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647539|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647540|NCT00747474|4024744|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647541|NCT00747474|4024745|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647542|NCT00747474|4024746|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647543|NCT00747474|4024747|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647544|NCT00747474|4024748|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647545|NCT00747474|4024749|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
1647546|NCT00747474|4024750|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647547|NCT00747474|4024751|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647548|NCT00747474|4024752|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647549|NCT00747474|4024753|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647550|NCT00747474|4024754|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647551|NCT00747474|4024755|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1647552|NCT00747474|4024744|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647553|NCT00747474|4024745|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647554|NCT00747474|4024746|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647555|NCT00747474|4024747|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647556|NCT00747474|4024748|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647557|NCT00747474|4024749|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
1647558|NCT00747474|4024750|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647559|NCT00747474|4024751|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647560|NCT00747474|4024752|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647561|NCT00747474|4024753|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647562|NCT00747474|4024754|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647563|NCT00747474|4024755|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
1647564|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647565|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647566|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647567|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647568|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647569|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647570|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647571|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647572|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647573|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647574|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647575|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647576|NCT00747474|4024744|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647577|NCT00747474|4024745|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647578|NCT00747474|4024746|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647579|NCT00747474|4024747|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647580|NCT00747474|4024748|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647581|NCT00747474|4024749|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647582|NCT00747474|4024750|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
1647583|NCT00747474|4024751|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647584|NCT00747474|4024752|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647585|NCT00747474|4024753|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647586|NCT00747474|4024754|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647587|NCT00747474|4024755|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1647588|NCT00747474|4024744|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647589|NCT00747474|4024745|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647590|NCT00747474|4024746|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647591|NCT00747474|4024747|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647592|NCT00747474|4024748|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647593|NCT00747474|4024749|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647594|NCT00747474|4024750|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
1647595|NCT00747474|4024751|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647596|NCT00747474|4024752|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647597|NCT00747474|4024753|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647598|NCT00747474|4024754|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647599|NCT00747474|4024755|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
1647600|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647601|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647602|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647603|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647604|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647605|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647606|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647607|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647608|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647609|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647610|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647611|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647612|NCT00747474|4024744|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647613|NCT00747474|4024745|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647614|NCT00747474|4024746|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647615|NCT00747474|4024747|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647616|NCT00747474|4024748|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647617|NCT00747474|4024749|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647618|NCT00747474|4024750|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647619|NCT00747474|4024751|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
1647620|NCT00747474|4024752|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647621|NCT00747474|4024753|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647622|NCT00747474|4024754|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647623|NCT00747474|4024755|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1647624|NCT00747474|4024744|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647625|NCT00747474|4024745|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647626|NCT00747474|4024746|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647627|NCT00747474|4024747|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647628|NCT00747474|4024748|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647629|NCT00747474|4024749|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647630|NCT00747474|4024750|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647631|NCT00747474|4024751|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
1647632|NCT00747474|4024752|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647633|NCT00747474|4024753|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647634|NCT00747474|4024754|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647635|NCT00747474|4024755|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1647636|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647637|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647638|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647639|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647640|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647641|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647642|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647643|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647644|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647645|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647646|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647647|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647648|NCT00747474|4024744|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647649|NCT00747474|4024745|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647650|NCT00747474|4024746|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647651|NCT00747474|4024747|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647652|NCT00747474|4024748|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647653|NCT00747474|4024749|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647654|NCT00747474|4024750|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647655|NCT00747474|4024751|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647656|NCT00747474|4024752|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
1647657|NCT00747474|4024753|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647658|NCT00747474|4024754|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647659|NCT00747474|4024755|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1647660|NCT00747474|4024744|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647661|NCT00747474|4024745|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647662|NCT00747474|4024746|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647663|NCT00747474|4024747|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647664|NCT00747474|4024748|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647665|NCT00747474|4024749|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647666|NCT00747474|4024750|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647667|NCT00747474|4024751|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647668|NCT00747474|4024752|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
1647669|NCT00747474|4024753|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647670|NCT00747474|4024754|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647671|NCT00747474|4024755|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
1647672|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647673|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647674|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647675|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647676|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647677|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647678|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647679|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647680|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647681|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647682|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647683|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647684|NCT00747474|4024744|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647685|NCT00747474|4024745|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647686|NCT00747474|4024746|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647687|NCT00747474|4024747|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647688|NCT00747474|4024748|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647689|NCT00747474|4024749|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647690|NCT00747474|4024750|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647691|NCT00747474|4024751|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647692|NCT00747474|4024752|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647693|NCT00747474|4024753|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
1647694|NCT00747474|4024754|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647695|NCT00747474|4024755|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1647696|NCT00747474|4024744|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647697|NCT00747474|4024745|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647698|NCT00747474|4024746|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647699|NCT00747474|4024747|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647700|NCT00747474|4024748|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647701|NCT00747474|4024749|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647702|NCT00747474|4024750|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647703|NCT00747474|4024751|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647704|NCT00747474|4024752|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647705|NCT00747474|4024753|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
1647706|NCT00747474|4024754|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647707|NCT00747474|4024755|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
1647708|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647709|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647710|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647711|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647712|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647713|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647714|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647715|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647716|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647717|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647718|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647719|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647720|NCT00747474|4024744|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647721|NCT00747474|4024745|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647722|NCT00747474|4024746|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647723|NCT00747474|4024747|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647724|NCT00747474|4024748|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647725|NCT00747474|4024749|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647726|NCT00747474|4024750|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647727|NCT00747474|4024751|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647728|NCT00747474|4024752|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647729|NCT00747474|4024753|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647730|NCT00747474|4024754|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
1647731|NCT00747474|4024755|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1647732|NCT00747474|4024744|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647733|NCT00747474|4024745|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647734|NCT00747474|4024746|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647735|NCT00747474|4024747|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647736|NCT00747474|4024748|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647737|NCT00747474|4024749|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647738|NCT00747474|4024750|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647739|NCT00747474|4024751|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647740|NCT00747474|4024752|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647741|NCT00747474|4024753|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647742|NCT00747474|4024754|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
1647743|NCT00747474|4024755|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
1647744|NCT00747474|4024744|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647745|NCT00747474|4024745|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647746|NCT00747474|4024746|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647747|NCT00747474|4024747|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647748|NCT00747474|4024748|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647749|NCT00747474|4024749|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647750|NCT00747474|4024750|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647751|NCT00747474|4024751|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647752|NCT00747474|4024752|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647753|NCT00747474|4024753|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647754|NCT00747474|4024754|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647755|NCT00747474|4024755|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647756|NCT00747474|4024744|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647757|NCT00747474|4024745|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647758|NCT00747474|4024746|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647759|NCT00747474|4024747|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647760|NCT00747474|4024748|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647761|NCT00747474|4024749|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647762|NCT00747474|4024750|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647763|NCT00747474|4024751|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647764|NCT00747474|4024752|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647765|NCT00747474|4024753|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647766|NCT00747474|4024754|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1647767|NCT00747474|4024755|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
1647768|NCT00747474|4024744|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647769|NCT00747474|4024745|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647770|NCT00747474|4024746|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647771|NCT00747474|4024747|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647772|NCT00747474|4024748|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647773|NCT00747474|4024749|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647774|NCT00747474|4024750|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647775|NCT00747474|4024751|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647776|NCT00747474|4024752|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647777|NCT00747474|4024753|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647778|NCT00747474|4024754|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1647779|NCT00747474|4024755|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
1647780|NCT00747461|4024781|P1|NOT COMPLETED|Overall Study||5
1647781|NCT00747461|4024781|P1|COMPLETED|Overall Study||0
1647782|NCT00747461|4024781|P1|STARTED|Overall Study||5
1647783|NCT00747435|4024786|P1|NOT COMPLETED|Overall Study||6
1647784|NCT00747435|4024786|P1|COMPLETED|Overall Study||67
1647785|NCT00747435|4024786|P1|STARTED|Overall Study||73
1647786|NCT00747344|4024796|P4|NOT COMPLETED|After Controlled Period||1
1647787|NCT00747344|4024797|P3|NOT COMPLETED|After Controlled Period||0
1647788|NCT00747344|4024798|P2|NOT COMPLETED|After Controlled Period||0
1647789|NCT00747344|4024799|P1|NOT COMPLETED|After Controlled Period||0
1647790|NCT00747344|4024796|P4|COMPLETED|After Controlled Period||56
1647791|NCT00747344|4024797|P3|COMPLETED|After Controlled Period||55
1647792|NCT00747344|4024798|P2|COMPLETED|After Controlled Period||0
1647793|NCT00747344|4024799|P1|COMPLETED|After Controlled Period||0
1647794|NCT00747344|4024796|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
1647795|NCT00747344|4024797|P3|STARTED|After Controlled Period||55
1647796|NCT00747344|4024798|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1647797|NCT00747344|4024799|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1647798|NCT00747344|4024796|P4|NOT COMPLETED|Controlled Period||0
1647799|NCT00747344|4024797|P3|NOT COMPLETED|Controlled Period||0
1647800|NCT00747344|4024798|P2|NOT COMPLETED|Controlled Period||4
1647801|NCT00747344|4024799|P1|NOT COMPLETED|Controlled Period||5
1647802|NCT00747344|4024796|P4|COMPLETED|Controlled Period||0
1647803|NCT00747344|4024797|P3|COMPLETED|Controlled Period||0
1647804|NCT00747344|4024798|P2|COMPLETED|Controlled Period||57
1647805|NCT00747344|4024799|P1|COMPLETED|Controlled Period||55
1647806|NCT00747344|4024796|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1647807|NCT00747344|4024797|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1647808|NCT00747344|4024798|P2|STARTED|Controlled Period||61
1647809|NCT00747344|4024799|P1|STARTED|Controlled Period||60
1647810|NCT00747227|4024813|P2|NOT COMPLETED|Overall Study||4
1647811|NCT00747227|4024814|P1|NOT COMPLETED|Overall Study||6
1647812|NCT00747227|4024813|P2|COMPLETED|Overall Study||120
1647813|NCT00747227|4024814|P1|COMPLETED|Overall Study||120
1647814|NCT00747227|4024813|P2|STARTED|Overall Study||124
1647815|NCT00747227|4024814|P1|STARTED|Overall Study||126
1647816|NCT00747214|4024828|P2|NOT COMPLETED|Overall Study||3
1647817|NCT00747214|4024829|P1|NOT COMPLETED|Overall Study||8
1647818|NCT00747214|4024828|P2|COMPLETED|Overall Study||29
1647819|NCT00747214|4024829|P1|COMPLETED|Overall Study||19
1647820|NCT00747214|4024828|P2|STARTED|Overall Study||32
1647821|NCT00747214|4024829|P1|STARTED|Overall Study||27
1647822|NCT00747149|4024843|P2|NOT COMPLETED|Overall Study||43
1647823|NCT00747149|4024844|P1|NOT COMPLETED|Overall Study||1
1647824|NCT00747149|4024843|P2|COMPLETED|Overall Study||401
1647825|NCT00747149|4024844|P1|COMPLETED|Overall Study||153
1647826|NCT00747149|4024843|P2|STARTED|Overall Study||444
1647827|NCT00747149|4024844|P1|STARTED|Overall Study||154
1647828|NCT00747006|4024859|P3|NOT COMPLETED|Overall Study||1
1647829|NCT00747006|4024860|P2|NOT COMPLETED|Overall Study||1
1647830|NCT00747006|4024861|P1|NOT COMPLETED|Overall Study||3
1647831|NCT00747006|4024859|P3|COMPLETED|Overall Study||2
1647832|NCT00747006|4024860|P2|COMPLETED|Overall Study||7
1647833|NCT00747006|4024861|P1|COMPLETED|Overall Study||4
1647834|NCT00747006|4024859|P3|STARTED|Overall Study||3
1647835|NCT00747006|4024860|P2|STARTED|Overall Study||8
1647836|NCT00747006|4024861|P1|STARTED|Overall Study||7
1647837|NCT00746954|4024927|P3|NOT COMPLETED|Overall Study||0
1647838|NCT00746954|4024928|P2|NOT COMPLETED|Overall Study||0
1647839|NCT00746954|4024929|P1|NOT COMPLETED|Overall Study||0
1647840|NCT00746954|4024927|P3|COMPLETED|Overall Study||2
1647841|NCT00746954|4024928|P2|COMPLETED|Overall Study||3
1647842|NCT00746954|4024929|P1|COMPLETED|Overall Study||3
1647843|NCT00746954|4024927|P3|STARTED|Overall Study||2
1647844|NCT00746954|4024928|P2|STARTED|Overall Study||3
1647845|NCT00746954|4024929|P1|STARTED|Overall Study||3
1647846|NCT00746941|4024939|P4|NOT COMPLETED|Overall Study||13
1647847|NCT00746941|4024940|P3|NOT COMPLETED|Overall Study||2
1647848|NCT00746941|4024941|P2|NOT COMPLETED|Overall Study||4
1647849|NCT00746941|4024942|P1|NOT COMPLETED|Overall Study||7
1647850|NCT00746941|4024939|P4|COMPLETED|Overall Study||7
1647851|NCT00746941|4024940|P3|COMPLETED|Overall Study||3
1647852|NCT00746941|4024941|P2|COMPLETED|Overall Study||1
1647853|NCT00746941|4024942|P1|COMPLETED|Overall Study||0
1647854|NCT00746941|4024939|P4|STARTED|Overall Study||20
1647855|NCT00746941|4024940|P3|STARTED|Overall Study||5
1647856|NCT00746941|4024941|P2|STARTED|Overall Study||5
1647857|NCT00746941|4024942|P1|STARTED|Overall Study||7
1647858|NCT00746889|4024970|P2|NOT COMPLETED|Overall Study||4
1647859|NCT00746889|4024971|P1|NOT COMPLETED|Overall Study||4
1647860|NCT00746889|4024970|P2|COMPLETED|Overall Study||35
1647861|NCT00746889|4024971|P1|COMPLETED|Overall Study||36
1647862|NCT00746889|4024970|P2|STARTED|Overall Study||39
1647863|NCT00746889|4024971|P1|STARTED|Overall Study||40
1647864|NCT00746863|4024981|P2|NOT COMPLETED|Overall Study||0
1647865|NCT00746863|4024982|P1|NOT COMPLETED|Overall Study||0
1647866|NCT00746863|4024981|P2|COMPLETED|Overall Study||21
1647867|NCT00746863|4024982|P1|COMPLETED|Overall Study||21
1647868|NCT00746863|4024981|P2|STARTED|Overall Study||21
1647869|NCT00746863|4024982|P1|STARTED|Overall Study||21
1647870|NCT00746798|4025000|P4|NOT COMPLETED|Overall Study||0
1647871|NCT00746798|4025001|P3|NOT COMPLETED|Overall Study||3
1647872|NCT00746798|4025002|P2|NOT COMPLETED|Overall Study||2
1647873|NCT00746798|4025003|P1|NOT COMPLETED|Overall Study||1
1647874|NCT00746798|4025000|P4|COMPLETED|Overall Study||120
1647875|NCT00746798|4025001|P3|COMPLETED|Overall Study||110
1647876|NCT00746798|4025002|P2|COMPLETED|Overall Study||122
1647877|NCT00746798|4025003|P1|COMPLETED|Overall Study||121
1647878|NCT00746798|4025000|P4|STARTED|Overall Study||120
1647879|NCT00746798|4025001|P3|STARTED|Overall Study||113
1647880|NCT00746798|4025002|P2|STARTED|Overall Study||124
1647881|NCT00746798|4025003|P1|STARTED|Overall Study||122
1647882|NCT00746785|4025028|P3|NOT COMPLETED|Overall Study||27
1647883|NCT00746785|4025029|P2|NOT COMPLETED|Overall Study||25
1647884|NCT00746785|4025030|P1|NOT COMPLETED|Overall Study||29
1647885|NCT00746785|4025028|P3|COMPLETED|Overall Study||13
1647886|NCT00746785|4025029|P2|COMPLETED|Overall Study||21
1647887|NCT00746785|4025030|P1|COMPLETED|Overall Study||14
1647888|NCT00746785|4025028|P3|STARTED|Overall Study||40
1647889|NCT00746785|4025029|P2|STARTED|Overall Study||46
1647890|NCT00746785|4025030|P1|STARTED|Overall Study||43
1647891|NCT00746733|4025038|P2|NOT COMPLETED|Fourth Intervention||0
1647892|NCT00746733|4025039|P1|NOT COMPLETED|Fourth Intervention||0
1647893|NCT00746733|4025038|P2|COMPLETED|Fourth Intervention||11
1647894|NCT00746733|4025039|P1|COMPLETED|Fourth Intervention||10
1647895|NCT00746733|4025038|P2|STARTED|Fourth Intervention||11
1647896|NCT00746733|4025039|P1|STARTED|Fourth Intervention||10
1647897|NCT00746733|4025038|P2|NOT COMPLETED|Third Intervention||1
1647898|NCT00746733|4025039|P1|NOT COMPLETED|Third Intervention||1
1647899|NCT00746733|4025038|P2|COMPLETED|Third Intervention||11
1647900|NCT00746733|4025039|P1|COMPLETED|Third Intervention||10
1647901|NCT00746733|4025038|P2|STARTED|Third Intervention||12
1647902|NCT00746733|4025039|P1|STARTED|Third Intervention||11
1647903|NCT00746733|4025038|P2|NOT COMPLETED|Second Intervention||0
1647904|NCT00746733|4025039|P1|NOT COMPLETED|Second Intervention||1
1647905|NCT00746733|4025038|P2|COMPLETED|Second Intervention||12
1647906|NCT00746733|4025039|P1|COMPLETED|Second Intervention||11
1647907|NCT00746733|4025038|P2|STARTED|Second Intervention||12
1647908|NCT00746733|4025039|P1|STARTED|Second Intervention||12
1647909|NCT00746733|4025038|P2|NOT COMPLETED|First Intervention||0
1647910|NCT00746733|4025039|P1|NOT COMPLETED|First Intervention||0
1647911|NCT00746733|4025038|P2|COMPLETED|First Intervention||12
1647912|NCT00746733|4025039|P1|COMPLETED|First Intervention||12
1647913|NCT00746733|4025038|P2|STARTED|First Intervention||12
1647914|NCT00746733|4025039|P1|STARTED|First Intervention||12
1647915|NCT00746694|4025099|P1|NOT COMPLETED|Overall Study||0
1647916|NCT00746694|4025099|P1|COMPLETED|Overall Study||154
1647917|NCT00746694|4025099|P1|STARTED|Overall Study||154
1647918|NCT00746668|4025104|P7|NOT COMPLETED|Overall Study||0
1647919|NCT00746668|4025105|P6|NOT COMPLETED|Overall Study||0
1647920|NCT00746668|4025106|P5|NOT COMPLETED|Overall Study||0
1647921|NCT00746668|4025107|P4|NOT COMPLETED|Overall Study||0
1647922|NCT00746668|4025108|P3|NOT COMPLETED|Overall Study||0
1647923|NCT00746668|4025109|P2|NOT COMPLETED|Overall Study||0
1647924|NCT00746668|4025110|P1|NOT COMPLETED|Overall Study||0
1647925|NCT00746668|4025104|P7|COMPLETED|Overall Study||5
1647926|NCT00746668|4025105|P6|COMPLETED|Overall Study||5
1647927|NCT00746668|4025106|P5|COMPLETED|Overall Study||5
1647928|NCT00746668|4025107|P4|COMPLETED|Overall Study||5
1647929|NCT00746668|4025108|P3|COMPLETED|Overall Study||5
1647930|NCT00746668|4025109|P2|COMPLETED|Overall Study||5
1647931|NCT00746668|4025110|P1|COMPLETED|Overall Study||6
1647932|NCT00746668|4025104|P7|STARTED|Overall Study||5
1647933|NCT00746668|4025105|P6|STARTED|Overall Study||5
1647934|NCT00746668|4025106|P5|STARTED|Overall Study||5
1647935|NCT00746668|4025107|P4|STARTED|Overall Study||5
1647936|NCT00746668|4025108|P3|STARTED|Overall Study||5
1647937|NCT00746668|4025109|P2|STARTED|Overall Study||5
1647938|NCT00746668|4025110|P1|STARTED|Overall Study||6
1647939|NCT00746590|4025123|P1|NOT COMPLETED|Overall Study||1
1647940|NCT00746590|4025123|P1|COMPLETED|Overall Study||0
1647941|NCT00746590|4025123|P1|STARTED|Overall Study||1
1647942|NCT00746564|4025127|P1|NOT COMPLETED|Overall Study||2
1647943|NCT00746564|4025127|P1|COMPLETED|Overall Study||73
1647944|NCT00746564|4025127|P1|STARTED|Overall Study||75
1647945|NCT00746551|4025142|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
1647946|NCT00746551|4025143|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
1647947|NCT00746551|4025142|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
1647948|NCT00746551|4025143|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
1647949|NCT00746551|4025142|P2|STARTED|At Delivery (GA of 39 Weeks)||40
1647950|NCT00746551|4025143|P1|STARTED|At Delivery (GA of 39 Weeks)||40
1647951|NCT00746551|4025142|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
1647952|NCT00746551|4025143|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
1647953|NCT00746551|4025142|P2|COMPLETED|At Gestational Age of 36 Weeks||36
1647954|NCT00746551|4025143|P1|COMPLETED|At Gestational Age of 36 Weeks||38
1647955|NCT00746551|4025142|P2|STARTED|At Gestational Age of 36 Weeks||40
1647956|NCT00746551|4025143|P1|STARTED|At Gestational Age of 36 Weeks||40
1647957|NCT00746512|4025155|P4|NOT COMPLETED|Overall Study||0
1647958|NCT00746512|4025156|P3|NOT COMPLETED|Overall Study||0
1647959|NCT00746512|4025157|P2|NOT COMPLETED|Overall Study||0
1647960|NCT00746512|4025158|P1|NOT COMPLETED|Overall Study||0
1647961|NCT00746512|4025155|P4|COMPLETED|Overall Study||9
1647962|NCT00746512|4025156|P3|COMPLETED|Overall Study||18
1647963|NCT00746512|4025157|P2|COMPLETED|Overall Study||10
1647964|NCT00746512|4025158|P1|COMPLETED|Overall Study||8
1647965|NCT00746512|4025155|P4|STARTED|Overall Study||9
1647966|NCT00746512|4025156|P3|STARTED|Overall Study||18
1647967|NCT00746512|4025157|P2|STARTED|Overall Study||10
1647968|NCT00746512|4025158|P1|STARTED|Overall Study||8
1647969|NCT00746421|4025174|P2|NOT COMPLETED|Overall Study||2
1647970|NCT00746421|4025175|P1|NOT COMPLETED|Overall Study||7
1647971|NCT00746421|4025174|P2|COMPLETED|Overall Study||9
1647972|NCT00746421|4025175|P1|COMPLETED|Overall Study||5
1647973|NCT00746421|4025174|P2|STARTED|Overall Study||11
1647974|NCT00746421|4025175|P1|STARTED|Overall Study||12
1647975|NCT00746395|4025185|P2|NOT COMPLETED|Overall Study||0
1647976|NCT00746395|4025186|P1|NOT COMPLETED|Overall Study||0
1647977|NCT00746395|4025185|P2|COMPLETED|Overall Study||20
1647978|NCT00746395|4025186|P1|COMPLETED|Overall Study||20
1647979|NCT00746395|4025185|P2|STARTED|Overall Study||20
1647980|NCT00746395|4025186|P1|STARTED|Overall Study||20
1647981|NCT00746356|4025194|P2|NOT COMPLETED|Overall Study||7
1647982|NCT00746356|4025195|P1|NOT COMPLETED|Overall Study||11
1647983|NCT00746356|4025194|P2|COMPLETED|Overall Study||40
1647984|NCT00746356|4025195|P1|COMPLETED|Overall Study||70
1647985|NCT00746356|4025194|P2|STARTED|Overall Study||47
1647986|NCT00746356|4025195|P1|STARTED|Overall Study||81
1647987|NCT00746330|4025207|P4|NOT COMPLETED|Period 4||0
1647988|NCT00746330|4025208|P3|NOT COMPLETED|Period 4||0
1647989|NCT00746330|4025209|P2|NOT COMPLETED|Period 4||0
1647990|NCT00746330|4025210|P1|NOT COMPLETED|Period 4||0
1647991|NCT00746330|4025207|P4|COMPLETED|Period 4||7
1647992|NCT00746330|4025208|P3|COMPLETED|Period 4||8
1647993|NCT00746330|4025209|P2|COMPLETED|Period 4||9
1647994|NCT00746330|4025210|P1|COMPLETED|Period 4||7
1647995|NCT00746330|4025207|P4|STARTED|Period 4||7
1647996|NCT00746330|4025208|P3|STARTED|Period 4||8
1647997|NCT00746330|4025209|P2|STARTED|Period 4||9
1647998|NCT00746330|4025210|P1|STARTED|Period 4||7
1647999|NCT00746330|4025207|P4|NOT COMPLETED|Period 3||0
1648000|NCT00746330|4025208|P3|NOT COMPLETED|Period 3||0
1648001|NCT00746330|4025209|P2|NOT COMPLETED|Period 3||0
1648002|NCT00746330|4025210|P1|NOT COMPLETED|Period 3||0
1648003|NCT00746330|4025207|P4|COMPLETED|Period 3||7
1648004|NCT00746330|4025208|P3|COMPLETED|Period 3||8
1648005|NCT00746330|4025209|P2|COMPLETED|Period 3||9
1648006|NCT00746330|4025210|P1|COMPLETED|Period 3||7
1648007|NCT00746330|4025207|P4|STARTED|Period 3||7
1648008|NCT00746330|4025208|P3|STARTED|Period 3||8
1648009|NCT00746330|4025209|P2|STARTED|Period 3||9
1648010|NCT00746330|4025210|P1|STARTED|Period 3||7
1648011|NCT00746330|4025207|P4|NOT COMPLETED|Period 2||0
1648012|NCT00746330|4025208|P3|NOT COMPLETED|Period 2||0
1648013|NCT00746330|4025209|P2|NOT COMPLETED|Period 2||0
1648014|NCT00746330|4025210|P1|NOT COMPLETED|Period 2||0
1648015|NCT00746330|4025207|P4|COMPLETED|Period 2||7
1648016|NCT00746330|4025208|P3|COMPLETED|Period 2||8
1648017|NCT00746330|4025209|P2|COMPLETED|Period 2||9
1648018|NCT00746330|4025210|P1|COMPLETED|Period 2||7
1648019|NCT00746330|4025207|P4|STARTED|Period 2||7
1648020|NCT00746330|4025208|P3|STARTED|Period 2||8
1648021|NCT00746330|4025209|P2|STARTED|Period 2||9
1648022|NCT00746330|4025210|P1|STARTED|Period 2||7
1648023|NCT00746330|4025207|P4|NOT COMPLETED|Period 1||0
1648024|NCT00746330|4025208|P3|NOT COMPLETED|Period 1||1
1648025|NCT00746330|4025209|P2|NOT COMPLETED|Period 1||0
1648026|NCT00746330|4025210|P1|NOT COMPLETED|Period 1||0
1648027|NCT00746330|4025207|P4|COMPLETED|Period 1||7
1648028|NCT00746330|4025208|P3|COMPLETED|Period 1||8
1648029|NCT00746330|4025209|P2|COMPLETED|Period 1||9
1648030|NCT00746330|4025210|P1|COMPLETED|Period 1||7
1648031|NCT00746330|4025207|P4|STARTED|Period 1||7
1648032|NCT00746330|4025208|P3|STARTED|Period 1||9
1648033|NCT00746330|4025209|P2|STARTED|Period 1||9
1648034|NCT00746330|4025210|P1|STARTED|Period 1||7
1648035|NCT00746252|4025240|P2|NOT COMPLETED|Overall Study||2
1648036|NCT00746252|4025241|P1|NOT COMPLETED|Overall Study||1
1648037|NCT00746252|4025240|P2|COMPLETED|Overall Study||0
1648038|NCT00746252|4025241|P1|COMPLETED|Overall Study||0
1648039|NCT00746252|4025240|P2|STARTED|Overall Study||2
1648040|NCT00746252|4025241|P1|STARTED|Overall Study||1
1648041|NCT00746239|4025247|P1|NOT COMPLETED|Overall Study||6
1648042|NCT00746239|4025247|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
1648043|NCT00746239|4025247|P1|STARTED|Overall Study||11
1648044|NCT00746187|4025254|P2|NOT COMPLETED|Overall Study||2
1648045|NCT00746187|4025255|P1|NOT COMPLETED|Overall Study||3
1648046|NCT00746187|4025254|P2|COMPLETED|Overall Study||16
1648047|NCT00746187|4025255|P1|COMPLETED|Overall Study||15
1648048|NCT00746187|4025254|P2|STARTED|Overall Study||18
1648049|NCT00746187|4025255|P1|STARTED|Overall Study||18
1648050|NCT00746096|4025263|P2|NOT COMPLETED|Overall Study||3
1648051|NCT00746096|4025264|P1|NOT COMPLETED|Overall Study||10
1648052|NCT00746096|4025263|P2|COMPLETED|Overall Study||54
1648053|NCT00746096|4025264|P1|COMPLETED|Overall Study||48
1648054|NCT00746096|4025263|P2|STARTED|Overall Study||57
1648055|NCT00746096|4025264|P1|STARTED|Overall Study||58
1648056|NCT00746018|4025272|P1|NOT COMPLETED|Overall Study||0
1648057|NCT00746018|4025272|P1|COMPLETED|Overall Study||39
1648058|NCT00746018|4025272|P1|STARTED|Overall Study||39
1648059|NCT00745940|4025278|P2|NOT COMPLETED|Overall Study||10
1648060|NCT00745940|4025279|P1|NOT COMPLETED|Overall Study||19
1648061|NCT00745940|4025278|P2|COMPLETED|Overall Study||38
1648062|NCT00745940|4025279|P1|COMPLETED|Overall Study||38
1648063|NCT00745940|4025278|P2|STARTED|Overall Study||48
1648064|NCT00745940|4025279|P1|STARTED|Overall Study||57
1648065|NCT00745901|4025295|P2|NOT COMPLETED|Overall Study||21
1648066|NCT00745901|4025296|P1|NOT COMPLETED|Overall Study||24
1648067|NCT00745901|4025295|P2|COMPLETED|Overall Study||156
1648068|NCT00745901|4025296|P1|COMPLETED|Overall Study||154
1648069|NCT00745901|4025295|P2|STARTED|Overall Study|Number of Patients Randomized|177
1648070|NCT00745901|4025296|P1|STARTED|Overall Study|Number of Patients Randomized|178
1648071|NCT00745875|4025342|P2|NOT COMPLETED|Overall Study||4
1648072|NCT00745875|4025343|P1|NOT COMPLETED|Overall Study||4
1648073|NCT00745875|4025342|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
1648074|NCT00745875|4025343|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
1648075|NCT00745875|4025342|P2|STARTED|Overall Study|Started – Number of patients randomised|30
1648076|NCT00745875|4025343|P1|STARTED|Overall Study|Started – Number of patients randomised|36
1648077|NCT00745823|4025353|P2|NOT COMPLETED|Overall Study||386
1648078|NCT00745823|4025354|P1|NOT COMPLETED|Overall Study||385
1648079|NCT00745823|4025353|P2|COMPLETED|Overall Study||3
1648080|NCT00745823|4025354|P1|COMPLETED|Overall Study||1
1648081|NCT00745823|4025353|P2|TREATED Week 0 - 96|Overall Study||388
1648082|NCT00745823|4025354|P1|TREATED Week 0 - 96|Overall Study||382
1648083|NCT00745823|4025353|P2|STARTED|Overall Study||389
1648084|NCT00745823|4025354|P1|STARTED|Overall Study||386
1648085|NCT00745498|4025381|P3|NOT COMPLETED|Overall Study||8
1648086|NCT00745498|4025382|P2|NOT COMPLETED|Overall Study||6
1648087|NCT00745498|4025383|P1|NOT COMPLETED|Overall Study||5
1648088|NCT00745498|4025381|P3|COMPLETED|Overall Study||34
1648089|NCT00745498|4025382|P2|COMPLETED|Overall Study||37
1648090|NCT00745498|4025383|P1|COMPLETED|Overall Study||36
1648091|NCT00745498|4025381|P3|STARTED|Overall Study||42
1648092|NCT00745498|4025382|P2|STARTED|Overall Study||43
1648093|NCT00745498|4025383|P1|STARTED|Overall Study||41
1648094|NCT00745420|4025397|P1|NOT COMPLETED|Overall Study||1
1648095|NCT00745420|4025397|P1|COMPLETED|Overall Study||29
1648096|NCT00745420|4025397|P1|STARTED|Overall Study||30
1648097|NCT00745368|4025414|P1|NOT COMPLETED|Overall Study||3
1648098|NCT00745368|4025414|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
1648099|NCT00745368|4025414|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
1648100|NCT00745290|4025427|P2|NOT COMPLETED|Overall Study||0
1648101|NCT00745290|4025428|P1|NOT COMPLETED|Overall Study||0
1648102|NCT00745290|4025427|P2|COMPLETED|Overall Study||122
1648103|NCT00745290|4025428|P1|COMPLETED|Overall Study||123
1648104|NCT00745290|4025427|P2|STARTED|Overall Study||122
1648105|NCT00745290|4025428|P1|STARTED|Overall Study||123
1648106|NCT00745251|4025436|P2|NOT COMPLETED|Overall Study||3
1648107|NCT00745251|4025437|P1|NOT COMPLETED|Overall Study||2
1648108|NCT00745251|4025436|P2|COMPLETED|Overall Study||19
1648109|NCT00745251|4025437|P1|COMPLETED|Overall Study||21
1648110|NCT00745251|4025436|P2|STARTED|Overall Study||22
1648111|NCT00745251|4025437|P1|STARTED|Overall Study||23
1648112|NCT00745095|4025451|P6|NOT COMPLETED|Overall Study||123
1648113|NCT00745095|4025452|P5|NOT COMPLETED|Overall Study||122
1648114|NCT00745095|4025453|P4|NOT COMPLETED|Overall Study||3
1648115|NCT00745095|4025454|P3|NOT COMPLETED|Overall Study||3
1648116|NCT00745095|4025455|P2|NOT COMPLETED|Overall Study||2
1648117|NCT00745095|4025456|P1|NOT COMPLETED|Overall Study||1
1648118|NCT00745095|4025451|P6|COMPLETED|Overall Study||27
1648119|NCT00745095|4025452|P5|COMPLETED|Overall Study||28
1648120|NCT00745095|4025453|P4|COMPLETED|Overall Study||12
1648121|NCT00745095|4025454|P3|COMPLETED|Overall Study||12
1648122|NCT00745095|4025455|P2|COMPLETED|Overall Study||13
1648123|NCT00745095|4025456|P1|COMPLETED|Overall Study||14
1648124|NCT00745095|4025451|P6|STARTED|Overall Study||150
1648125|NCT00745095|4025452|P5|STARTED|Overall Study||150
1648126|NCT00745095|4025453|P4|STARTED|Overall Study||15
1648127|NCT00745095|4025454|P3|STARTED|Overall Study||15
1648128|NCT00745095|4025455|P2|STARTED|Overall Study||15
1648129|NCT00745095|4025456|P1|STARTED|Overall Study||15
1648130|NCT00745030|4025478|P2|NOT COMPLETED|Overall Study||0
1648131|NCT00745030|4025479|P1|NOT COMPLETED|Overall Study||0
1648132|NCT00745030|4025478|P2|COMPLETED|Overall Study||2
1648133|NCT00745030|4025479|P1|COMPLETED|Overall Study||1
1648134|NCT00745030|4025478|P2|STARTED|Overall Study||2
1648135|NCT00745030|4025479|P1|STARTED|Overall Study||1
1648136|NCT00744978|4025487|P2|NOT COMPLETED|Period 2||1
1648137|NCT00744978|4025488|P1|NOT COMPLETED|Period 2||0
1648138|NCT00744978|4025487|P2|COMPLETED|Period 2||28
1648139|NCT00744978|4025488|P1|COMPLETED|Period 2||26
1648140|NCT00744978|4025487|P2|STARTED|Period 2||29
1648141|NCT00744978|4025488|P1|STARTED|Period 2||26
1648142|NCT00744978|4025487|P2|NOT COMPLETED|Placebo Washout||0
1648143|NCT00744978|4025488|P1|NOT COMPLETED|Placebo Washout||0
1648144|NCT00744978|4025487|P2|COMPLETED|Placebo Washout||29
1648145|NCT00744978|4025488|P1|COMPLETED|Placebo Washout||26
1648146|NCT00744978|4025487|P2|STARTED|Placebo Washout||29
1648147|NCT00744978|4025488|P1|STARTED|Placebo Washout||26
1648148|NCT00744978|4025487|P2|NOT COMPLETED|Period 1||5
1648149|NCT00744978|4025488|P1|NOT COMPLETED|Period 1||6
1648150|NCT00744978|4025487|P2|COMPLETED|Period 1||29
1648151|NCT00744978|4025488|P1|COMPLETED|Period 1||26
1648152|NCT00744978|4025487|P2|Treated|Period 1||33
1648153|NCT00744978|4025488|P1|Treated|Period 1||31
1648154|NCT00744978|4025487|P2|STARTED|Period 1||34
1648155|NCT00744978|4025488|P1|STARTED|Period 1||32
1648156|NCT00744939|4025540|P1|NOT COMPLETED|Overall Study||91
1648157|NCT00744939|4025540|P1|COMPLETED|Overall Study||77
1648158|NCT00744939|4025540|P1|Treatment Received|Overall Study||141
1648159|NCT00744939|4025540|P1|STARTED|Overall Study||168
1648160|NCT00744874|4025576|P1|NOT COMPLETED|Overall Study||4
1648161|NCT00744874|4025576|P1|COMPLETED|Overall Study||51
1648162|NCT00744874|4025576|P1|STARTED|Overall Study||55
1648163|NCT00744848|4025594|P2|NOT COMPLETED|Overall Study||0
1648164|NCT00744848|4025595|P1|NOT COMPLETED|Overall Study||0
1648165|NCT00744848|4025594|P2|COMPLETED|Overall Study||101
1648166|NCT00744848|4025595|P1|COMPLETED|Overall Study||103
1648167|NCT00744848|4025594|P2|STARTED|Overall Study||101
1648168|NCT00744848|4025595|P1|STARTED|Overall Study||103
1648169|NCT00744757|4025601|P1|NOT COMPLETED|Overall Study||21
1648170|NCT00744757|4025601|P1|COMPLETED|Overall Study||16
1648171|NCT00744757|4025601|P1|STARTED|Overall Study||37
1648172|NCT00744692|4025614|P1|NOT COMPLETED|Overall Study||0
1648173|NCT00744692|4025614|P1|COMPLETED|Overall Study||22
1648174|NCT00744692|4025614|P1|STARTED|Overall Study||22
1648175|NCT00744653|4025626|P1|NOT COMPLETED|Overall Study||16
1648176|NCT00744653|4025626|P1|COMPLETED|Overall Study||1
1648177|NCT00744653|4025626|P1|STARTED|Overall Study||17
1648178|NCT00744627|4025634|P2|NOT COMPLETED|Overall Study||22
1648179|NCT00744627|4025635|P1|NOT COMPLETED|Overall Study||25
1648180|NCT00744627|4025634|P2|COMPLETED|Overall Study||128
1648181|NCT00744627|4025635|P1|COMPLETED|Overall Study||126
1648182|NCT00744627|4025634|P2|Treated|Overall Study||150
1648183|NCT00744627|4025635|P1|Treated|Overall Study||150
1648184|NCT00744627|4025634|P2|STARTED|Overall Study||150
1648185|NCT00744627|4025635|P1|STARTED|Overall Study||151
1648186|NCT00744523|4025691|P2|NOT COMPLETED|30 Days After the Procedure||5
1648187|NCT00744523|4025692|P1|NOT COMPLETED|30 Days After the Procedure||0
1648188|NCT00744523|4025691|P2|COMPLETED|30 Days After the Procedure||220
1648189|NCT00744523|4025692|P1|COMPLETED|30 Days After the Procedure||37
1648190|NCT00744523|4025691|P2|STARTED|30 Days After the Procedure||225
1648191|NCT00744523|4025692|P1|STARTED|30 Days After the Procedure||37
1648192|NCT00744523|4025691|P2|NOT COMPLETED|Procedure||0
1648193|NCT00744523|4025692|P1|NOT COMPLETED|Procedure||0
1648194|NCT00744523|4025691|P2|COMPLETED|Procedure||225
1648195|NCT00744523|4025692|P1|COMPLETED|Procedure||37
1648196|NCT00744523|4025691|P2|STARTED|Procedure||225
1648197|NCT00744523|4025692|P1|STARTED|Procedure||37
1648198|NCT00744497|4025712|P2|NOT COMPLETED|Overall Study||762
1648199|NCT00744497|4025713|P1|NOT COMPLETED|Overall Study||760
1648200|NCT00744497|4025712|P2|COMPLETED|Overall Study||0
1648201|NCT00744497|4025713|P1|COMPLETED|Overall Study||0
1648202|NCT00744497|4025712|P2|Received Treatment|Overall Study||761
1648203|NCT00744497|4025713|P1|Received Treatment|Overall Study||757
1648204|NCT00744497|4025712|P2|STARTED|Overall Study|Randomized|762
1648205|NCT00744497|4025713|P1|STARTED|Overall Study|Randomized|760
1648206|NCT00744380|4025749|P2|NOT COMPLETED|Overall Study||0
1648207|NCT00744380|4025750|P1|NOT COMPLETED|Overall Study||0
1648208|NCT00744380|4025749|P2|COMPLETED|Overall Study||11
1648209|NCT00744380|4025750|P1|COMPLETED|Overall Study||12
1648210|NCT00744380|4025749|P2|STARTED|Overall Study||11
1648211|NCT00744380|4025750|P1|STARTED|Overall Study||12
1648212|NCT00744328|4025773|P3|NOT COMPLETED|Overall Study||8
1648213|NCT00744328|4025774|P2|NOT COMPLETED|Overall Study||8
1648214|NCT00744328|4025775|P1|NOT COMPLETED|Overall Study||7
1648215|NCT00744328|4025773|P3|COMPLETED|Overall Study||21
1648216|NCT00744328|4025774|P2|COMPLETED|Overall Study||22
1648217|NCT00744328|4025775|P1|COMPLETED|Overall Study||19
1648218|NCT00744328|4025773|P3|STARTED|Overall Study||29
1648219|NCT00744328|4025774|P2|STARTED|Overall Study||30
1648220|NCT00744328|4025775|P1|STARTED|Overall Study||26
1648221|NCT00744263|4025785|P2|NOT COMPLETED|Overall Study||5320
1648222|NCT00744263|4025786|P1|NOT COMPLETED|Overall Study||5236
1648223|NCT00744263|4025785|P2|COMPLETED|Overall Study||36936
1648224|NCT00744263|4025786|P1|COMPLETED|Overall Study||37004
1648225|NCT00744263|4025785|P2|STARTED|Overall Study||42256
1648226|NCT00744263|4025786|P1|STARTED|Overall Study||42240
1648227|NCT00744237|4025809|P3|NOT COMPLETED|Overall Study||15
1648228|NCT00744237|4025810|P2|NOT COMPLETED|Overall Study||27
1648229|NCT00744237|4025811|P1|NOT COMPLETED|Overall Study||27
1648230|NCT00744237|4025809|P3|COMPLETED|Overall Study||59
1648231|NCT00744237|4025810|P2|COMPLETED|Overall Study||46
1648232|NCT00744237|4025811|P1|COMPLETED|Overall Study||56
1648233|NCT00744237|4025809|P3|STARTED|Overall Study||74
1648234|NCT00744237|4025810|P2|STARTED|Overall Study||73
1648235|NCT00744237|4025811|P1|STARTED|Overall Study||83
1648236|NCT00744211|4025825|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
1648237|NCT00744211|4025826|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
1648238|NCT00744211|4025827|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
1648239|NCT00744211|4025825|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
1648240|NCT00744211|4025826|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
1648241|NCT00744211|4025827|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
1648242|NCT00744211|4025825|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
1648243|NCT00744211|4025826|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
1648244|NCT00744211|4025827|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
1648245|NCT00744211|4025825|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
1648246|NCT00744211|4025826|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
1648247|NCT00744211|4025827|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
1648248|NCT00744211|4025825|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
1648249|NCT00744211|4025826|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
1648250|NCT00744211|4025827|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
1648251|NCT00744211|4025825|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
1648252|NCT00744211|4025826|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
1648253|NCT00744211|4025827|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
1648254|NCT00744211|4025825|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
1648255|NCT00744211|4025826|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
1648256|NCT00744211|4025827|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
1648257|NCT00744211|4025825|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
1648258|NCT00744211|4025826|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
1648259|NCT00744211|4025827|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
1648260|NCT00744211|4025825|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
1648261|NCT00744211|4025826|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
1648262|NCT00744211|4025827|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
1648263|NCT00744211|4025825|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
1648264|NCT00744211|4025826|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
1648265|NCT00744211|4025827|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
1648266|NCT00744211|4025825|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
1648267|NCT00744211|4025826|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
1648268|NCT00744211|4025827|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
1648269|NCT00744211|4025825|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
1648270|NCT00744211|4025826|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
1648271|NCT00744211|4025827|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
1648272|NCT00744211|4025825|P3|NOT COMPLETED|Baseline||0
1648273|NCT00744211|4025826|P2|NOT COMPLETED|Baseline||0
1648274|NCT00744211|4025827|P1|NOT COMPLETED|Baseline||0
1648275|NCT00744211|4025825|P3|COMPLETED|Baseline||10
1648276|NCT00744211|4025826|P2|COMPLETED|Baseline||9
1648277|NCT00744211|4025827|P1|COMPLETED|Baseline||10
1648278|NCT00744211|4025825|P3|STARTED|Baseline||10
1648279|NCT00744211|4025826|P2|STARTED|Baseline||9
1648280|NCT00744211|4025827|P1|STARTED|Baseline||10
1648281|NCT00744055|4025845|P2|NOT COMPLETED|Overall Study||14
1648282|NCT00744055|4025846|P1|NOT COMPLETED|Overall Study||7
1648283|NCT00744055|4025845|P2|COMPLETED|Overall Study||32
1648284|NCT00744055|4025846|P1|COMPLETED|Overall Study||43
1648285|NCT00744055|4025845|P2|STARTED|Overall Study||46
1648286|NCT00744055|4025846|P1|STARTED|Overall Study||50
1648287|NCT00744042|4025854|P1|NOT COMPLETED|Overall Study||1
1648288|NCT00744042|4025854|P1|COMPLETED|Overall Study||10
1648289|NCT00744042|4025854|P1|STARTED|Overall Study||11
1648290|NCT00743730|4025870|P3|NOT COMPLETED|Overall Study||5
1648291|NCT00743730|4025871|P2|NOT COMPLETED|Overall Study||4
1648292|NCT00743730|4025872|P1|NOT COMPLETED|Overall Study||5
1648293|NCT00743730|4025870|P3|COMPLETED|Overall Study||28
1648294|NCT00743730|4025871|P2|COMPLETED|Overall Study||30
1648295|NCT00743730|4025872|P1|COMPLETED|Overall Study||22
1648296|NCT00743730|4025870|P3|STARTED|Overall Study||33
1648297|NCT00743730|4025871|P2|STARTED|Overall Study||34
1648298|NCT00743730|4025872|P1|STARTED|Overall Study||27
1648299|NCT00743717|4025888|P2|NOT COMPLETED|Overall Study||0
1648300|NCT00743717|4025889|P1|NOT COMPLETED|Overall Study||0
1648301|NCT00743717|4025888|P2|COMPLETED|Overall Study||2
1648302|NCT00743717|4025889|P1|COMPLETED|Overall Study||2
1648303|NCT00743717|4025888|P2|STARTED|Overall Study||2
1648304|NCT00743717|4025889|P1|STARTED|Overall Study||2
1648305|NCT00743652|4025900|P5|NOT COMPLETED|Overall Study||0
1648306|NCT00743652|4025901|P4|NOT COMPLETED|Overall Study||4
1648307|NCT00743652|4025902|P3|NOT COMPLETED|Overall Study||2
1648308|NCT00743652|4025903|P2|NOT COMPLETED|Overall Study||3
1648309|NCT00743652|4025904|P1|NOT COMPLETED|Overall Study||10
1648310|NCT00743652|4025900|P5|COMPLETED|Overall Study||79
1648311|NCT00743652|4025901|P4|COMPLETED|Overall Study||63
1648312|NCT00743652|4025902|P3|COMPLETED|Overall Study||23
1648313|NCT00743652|4025903|P2|COMPLETED|Overall Study||48
1648314|NCT00743652|4025904|P1|COMPLETED|Overall Study||141
1648315|NCT00743652|4025900|P5|Toddler Dose|Overall Study||0
1648316|NCT00743652|4025901|P4|Toddler Dose|Overall Study||0
1648317|NCT00743652|4025902|P3|Toddler Dose|Overall Study||16
1648318|NCT00743652|4025903|P2|Toddler Dose|Overall Study||23
1648319|NCT00743652|4025904|P1|Toddler Dose|Overall Study||15
1648320|NCT00743652|4025900|P5|Vaccinated Dose 3|Overall Study||0
1648321|NCT00743652|4025901|P4|Vaccinated Dose 3|Overall Study||0
1648322|NCT00743652|4025902|P3|Vaccinated Dose 3|Overall Study||0
1648323|NCT00743652|4025903|P2|Vaccinated Dose 3|Overall Study||0
1648324|NCT00743652|4025904|P1|Vaccinated Dose 3|Overall Study||74
1648325|NCT00743652|4025900|P5|Vaccinated Dose 2|Overall Study||0
1648326|NCT00743652|4025901|P4|Vaccinated Dose 2|Overall Study||49
1648327|NCT00743652|4025902|P3|Vaccinated Dose 2|Overall Study||0
1648328|NCT00743652|4025903|P2|Vaccinated Dose 2|Overall Study||41
1648329|NCT00743652|4025904|P1|Vaccinated Dose 2|Overall Study||112
1648330|NCT00743652|4025900|P5|Vaccinated Dose 1|Overall Study||79
1648331|NCT00743652|4025901|P4|Vaccinated Dose 1|Overall Study||66
1648332|NCT00743652|4025902|P3|Vaccinated Dose 1|Overall Study||25
1648333|NCT00743652|4025903|P2|Vaccinated Dose 1|Overall Study||51
1648334|NCT00743652|4025904|P1|Vaccinated Dose 1|Overall Study||151
1648335|NCT00743652|4025900|P5|STARTED|Overall Study||79
1648336|NCT00743652|4025901|P4|STARTED|Overall Study||67
1648337|NCT00743652|4025902|P3|STARTED|Overall Study||25
1648338|NCT00743652|4025903|P2|STARTED|Overall Study||51
1648339|NCT00743652|4025904|P1|STARTED|Overall Study||151
1648340|NCT00743574|4025979|P1|NOT COMPLETED|Overall Study||24
1648341|NCT00743574|4025979|P1|COMPLETED|Overall Study||12
1648342|NCT00743574|4025979|P1|Dropped Out After Initiating Trial|Overall Study||3
1648343|NCT00743574|4025979|P1|Further Exclusions|Overall Study||8
1648344|NCT00743574|4025979|P1|Dropped Out Before Eligibility Testing|Overall Study||13
1648345|NCT00743574|4025979|P1|STARTED|Overall Study||36
1648346|NCT00743509|4025988|P1|NOT COMPLETED|Overall Study||2
1648347|NCT00743509|4025988|P1|COMPLETED|Overall Study||47
1648348|NCT00743509|4025988|P1|STARTED|Overall Study||49
1648349|NCT00743483|4025993|P1|NOT COMPLETED|Treatment Period||1
1648350|NCT00743483|4025993|P1|COMPLETED|Treatment Period||13
1648351|NCT00743483|4025993|P1|STARTED|Treatment Period||14
1648352|NCT00743483|4025993|P1|NOT COMPLETED|Baseline Period||1
1648353|NCT00743483|4025993|P1|COMPLETED|Baseline Period||14
1648354|NCT00743483|4025993|P1|STARTED|Baseline Period||15
1648355|NCT00743444|4025997|P2|NOT COMPLETED|Second Intervention||0
1648356|NCT00743444|4025998|P1|NOT COMPLETED|Second Intervention||0
1648357|NCT00743444|4025997|P2|COMPLETED|Second Intervention||11
1648358|NCT00743444|4025998|P1|COMPLETED|Second Intervention||14
1648359|NCT00743444|4025997|P2|STARTED|Second Intervention||11
1648360|NCT00743444|4025998|P1|STARTED|Second Intervention||14
1648361|NCT00743444|4025997|P2|NOT COMPLETED|Washout Period||1
1648362|NCT00743444|4025998|P1|NOT COMPLETED|Washout Period||0
1648363|NCT00743444|4025997|P2|COMPLETED|Washout Period||11
1648364|NCT00743444|4025998|P1|COMPLETED|Washout Period||14
1648365|NCT00743444|4025997|P2|STARTED|Washout Period||12
1648366|NCT00743444|4025998|P1|STARTED|Washout Period||14
1648367|NCT00743444|4025997|P2|NOT COMPLETED|First Intervention||1
1648368|NCT00743444|4025998|P1|NOT COMPLETED|First Intervention||0
1648369|NCT00743444|4025997|P2|COMPLETED|First Intervention||12
1648370|NCT00743444|4025998|P1|COMPLETED|First Intervention||14
1648371|NCT00743444|4025997|P2|STARTED|First Intervention||13
1648372|NCT00743444|4025998|P1|STARTED|First Intervention||14
1648373|NCT00743431|4026007|P1|NOT COMPLETED|Overall Study||126
1648374|NCT00743431|4026007|P1|COMPLETED|Overall Study||98
1648375|NCT00743431|4026007|P1|STARTED|Overall Study||224
1648376|NCT00743366|4026011|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
1648377|NCT00743366|4026012|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
1648378|NCT00743366|4026011|P2|COMPLETED|Intervention 2 (8 Days)||7
1648379|NCT00743366|4026012|P1|COMPLETED|Intervention 2 (8 Days)||7
1648380|NCT00743366|4026011|P2|STARTED|Intervention 2 (8 Days)||7
1648381|NCT00743366|4026012|P1|STARTED|Intervention 2 (8 Days)||7
1648382|NCT00743366|4026011|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
1648383|NCT00743366|4026012|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
1648384|NCT00743366|4026011|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
1648385|NCT00743366|4026012|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
1648386|NCT00743366|4026011|P2|STARTED|Intervention 1 (8 Days)||10
1648387|NCT00743366|4026012|P1|STARTED|Intervention 1 (8 Days)||10
1648388|NCT00743340|4026018|P1|NOT COMPLETED|Overall Study||41
1648389|NCT00743340|4026018|P1|COMPLETED|Overall Study||9
1648390|NCT00743340|4026018|P1|STARTED|Overall Study||50
1648391|NCT00743288|4026022|P7|NOT COMPLETED|Overall Study||9
1648392|NCT00743288|4026023|P6|NOT COMPLETED|Overall Study||5
1648393|NCT00743288|4026024|P5|NOT COMPLETED|Overall Study||6
1648394|NCT00743288|4026025|P4|NOT COMPLETED|Overall Study||7
1648395|NCT00743288|4026026|P3|NOT COMPLETED|Overall Study||5
1648396|NCT00743288|4026027|P2|NOT COMPLETED|Overall Study||3
1648397|NCT00743288|4026028|P1|NOT COMPLETED|Overall Study||3
1648398|NCT00743288|4026022|P7|COMPLETED|Overall Study||0
1648399|NCT00743288|4026023|P6|COMPLETED|Overall Study||1
1648400|NCT00743288|4026024|P5|COMPLETED|Overall Study||0
1648401|NCT00743288|4026025|P4|COMPLETED|Overall Study||0
1648402|NCT00743288|4026026|P3|COMPLETED|Overall Study||1
1648403|NCT00743288|4026027|P2|COMPLETED|Overall Study||0
1648404|NCT00743288|4026028|P1|COMPLETED|Overall Study||0
1648405|NCT00743288|4026022|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
1648406|NCT00743288|4026023|P6|STARTED|Overall Study||6
1648407|NCT00743288|4026024|P5|STARTED|Overall Study||6
1648408|NCT00743288|4026025|P4|STARTED|Overall Study||7
1648409|NCT00743288|4026026|P3|STARTED|Overall Study||6
1648410|NCT00743288|4026027|P2|STARTED|Overall Study||3
1648411|NCT00743288|4026028|P1|STARTED|Overall Study||3
1648412|NCT00743275|4026042|P2|NOT COMPLETED|Overall Study||1
1648413|NCT00743275|4026043|P1|NOT COMPLETED|Overall Study||0
1648414|NCT00743275|4026042|P2|COMPLETED|Overall Study||60
1648415|NCT00743275|4026043|P1|COMPLETED|Overall Study||59
1648416|NCT00743275|4026042|P2|STARTED|Overall Study||61
1648417|NCT00743275|4026043|P1|STARTED|Overall Study||59
1648418|NCT00743262|4026055|P1|NOT COMPLETED|Overall Study||0
1648419|NCT00743262|4026055|P1|COMPLETED|Overall Study||15
1648420|NCT00743262|4026055|P1|STARTED|Overall Study||15
1648421|NCT00743249|4026063|P2|NOT COMPLETED|Overall Study||6
1648422|NCT00743249|4026064|P1|NOT COMPLETED|Overall Study||2
1648423|NCT00743249|4026063|P2|COMPLETED|Overall Study||24
1648424|NCT00743249|4026064|P1|COMPLETED|Overall Study||28
1648425|NCT00743249|4026063|P2|STARTED|Overall Study||30
1648426|NCT00743249|4026064|P1|STARTED|Overall Study||30
1648427|NCT00743197|4026074|P2|NOT COMPLETED|Overall Study||2
1648428|NCT00743197|4026075|P1|NOT COMPLETED|Overall Study||1
1648429|NCT00743197|4026074|P2|COMPLETED|Overall Study||0
1648430|NCT00743197|4026075|P1|COMPLETED|Overall Study||0
1648431|NCT00743197|4026074|P2|STARTED|Overall Study||2
1648432|NCT00743197|4026075|P1|STARTED|Overall Study||1
1648433|NCT00743145|4026081|P1|NOT COMPLETED|Overall Study||4
1648434|NCT00743145|4026081|P1|COMPLETED|Overall Study||19
1648435|NCT00743145|4026081|P1|STARTED|Overall Study||23
1648436|NCT00743119|4026095|P1|NOT COMPLETED|Overall Study||4
1648437|NCT00743119|4026095|P1|COMPLETED|Overall Study||30
1648438|NCT00743119|4026095|P1|STARTED|Overall Study||34
1648439|NCT00743106|4026109|P2|NOT COMPLETED|Overall Study||5
1648440|NCT00743106|4026110|P1|NOT COMPLETED|Overall Study||8
1648441|NCT00743106|4026109|P2|COMPLETED|Overall Study||43
1648442|NCT00743106|4026110|P1|COMPLETED|Overall Study||34
1648443|NCT00743106|4026109|P2|STARTED|Overall Study||48
1648444|NCT00743106|4026110|P1|STARTED|Overall Study||42
1648445|NCT00743093|4026120|P2|NOT COMPLETED|Extended Dosing Period||0
1648446|NCT00743093|4026121|P1|NOT COMPLETED|Extended Dosing Period||3
1648447|NCT00743093|4026120|P2|COMPLETED|Extended Dosing Period||1
1648448|NCT00743093|4026121|P1|COMPLETED|Extended Dosing Period||48
1648449|NCT00743093|4026120|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
1648450|NCT00743093|4026121|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
1648451|NCT00743093|4026120|P2|NOT COMPLETED|Base Study Period||5
1648452|NCT00743093|4026121|P1|NOT COMPLETED|Base Study Period||19
1648453|NCT00743093|4026120|P2|COMPLETED|Base Study Period||47
1648454|NCT00743093|4026121|P1|COMPLETED|Base Study Period||205
1648455|NCT00743093|4026120|P2|STARTED|Base Study Period||52
1648456|NCT00743093|4026121|P1|STARTED|Base Study Period||224
1648457|NCT00742963|4026129|P1|NOT COMPLETED|Overall Study||33
1648458|NCT00742963|4026129|P1|COMPLETED|Overall Study||68
1648459|NCT00742963|4026129|P1|Completed All Treatment Cycles|Overall Study||68
1648460|NCT00742963|4026129|P1|STARTED|Overall Study||101
1648461|NCT00742924|4026137|P4|NOT COMPLETED|Overall Study||6
1648462|NCT00742924|4026138|P3|NOT COMPLETED|Overall Study||4
1648463|NCT00742924|4026139|P2|NOT COMPLETED|Overall Study||2
1648464|NCT00742924|4026140|P1|NOT COMPLETED|Overall Study||5
1648465|NCT00742924|4026137|P4|COMPLETED|Overall Study||0
1648466|NCT00742924|4026138|P3|COMPLETED|Overall Study||2
1648467|NCT00742924|4026139|P2|COMPLETED|Overall Study||4
1648468|NCT00742924|4026140|P1|COMPLETED|Overall Study||1
1648469|NCT00742924|4026137|P4|STARTED|Overall Study||6
1648470|NCT00742924|4026138|P3|STARTED|Overall Study||6
1648471|NCT00742924|4026139|P2|STARTED|Overall Study||6
1648472|NCT00742924|4026140|P1|STARTED|Overall Study||6
1648473|NCT00742885|4026152|P2|NOT COMPLETED|Overall Study||0
1648474|NCT00742885|4026153|P1|NOT COMPLETED|Overall Study||1
1648475|NCT00742885|4026152|P2|COMPLETED|Overall Study|to Day 182|50
1648476|NCT00742885|4026153|P1|COMPLETED|Overall Study|to Day 182|49
1648477|NCT00742885|4026152|P2|STARTED|Overall Study||50
1648478|NCT00742885|4026153|P1|STARTED|Overall Study||50
1648479|NCT00742872|4026201|P2|NOT COMPLETED|Overall Study||8
1648480|NCT00742872|4026202|P1|NOT COMPLETED|Overall Study||12
1648481|NCT00742872|4026201|P2|COMPLETED|Overall Study||12
1648482|NCT00742872|4026202|P1|COMPLETED|Overall Study||9
1648483|NCT00742872|4026201|P2|STARTED|Overall Study||20
1648484|NCT00742872|4026202|P1|STARTED|Overall Study||21
1648485|NCT00742859|4026212|P4|NOT COMPLETED|Overall Study||8
1648486|NCT00742859|4026213|P3|NOT COMPLETED|Overall Study||11
1648487|NCT00742859|4026214|P2|NOT COMPLETED|Overall Study||12
1648488|NCT00742859|4026215|P1|NOT COMPLETED|Overall Study||11
1648489|NCT00742859|4026212|P4|COMPLETED|Overall Study||119
1648490|NCT00742859|4026213|P3|COMPLETED|Overall Study||116
1648491|NCT00742859|4026214|P2|COMPLETED|Overall Study||115
1648492|NCT00742859|4026215|P1|COMPLETED|Overall Study||116
1648493|NCT00742859|4026212|P4|STARTED|Overall Study||127
1648494|NCT00742859|4026213|P3|STARTED|Overall Study||127
1648495|NCT00742859|4026214|P2|STARTED|Overall Study||127
1648496|NCT00742859|4026215|P1|STARTED|Overall Study||127
1648497|NCT00742781|4026229|P1|NOT COMPLETED|Overall Study||3
1648498|NCT00742781|4026229|P1|COMPLETED|Overall Study||18
1648499|NCT00742781|4026229|P1|STARTED|Overall Study||21
1648500|NCT00742625|4026238|P1|NOT COMPLETED|Consolidation||21
1648501|NCT00742625|4026238|P1|COMPLETED|Consolidation||20
1648502|NCT00742625|4026238|P1|STARTED|Consolidation||41
1648503|NCT00742625|4026238|P1|NOT COMPLETED|Remission Induction||54
1648504|NCT00742625|4026238|P1|COMPLETED|Remission Induction||41
1648505|NCT00742625|4026238|P1|STARTED|Remission Induction||95
1648506|NCT00742560|4026252|P5|NOT COMPLETED|Overall Study||37
1648507|NCT00742560|4026253|P4|NOT COMPLETED|Overall Study||36
1648508|NCT00742560|4026254|P3|NOT COMPLETED|Overall Study||22
1648509|NCT00742560|4026255|P2|NOT COMPLETED|Overall Study||3
1648510|NCT00742560|4026256|P1|NOT COMPLETED|Overall Study||3
1648511|NCT00742560|4026252|P5|COMPLETED|Overall Study||0
1648512|NCT00742560|4026253|P4|COMPLETED|Overall Study||0
1648513|NCT00742560|4026254|P3|COMPLETED|Overall Study||0
1648514|NCT00742560|4026255|P2|COMPLETED|Overall Study||0
1648515|NCT00742560|4026256|P1|COMPLETED|Overall Study||0
1648516|NCT00742560|4026252|P5|STARTED|Overall Study||37
1648517|NCT00742560|4026253|P4|STARTED|Overall Study||36
1648518|NCT00742560|4026254|P3|STARTED|Overall Study||22
1648519|NCT00742560|4026255|P2|STARTED|Overall Study||3
1648520|NCT00742560|4026256|P1|STARTED|Overall Study||3
1648521|NCT00742508|4026330|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
1648522|NCT00742508|4026331|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
1648523|NCT00742508|4026330|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
1648524|NCT00742508|4026331|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
1648525|NCT00742508|4026330|P2|STARTED|4-Week Exploratory Evaluation Period||8
1648526|NCT00742508|4026331|P1|STARTED|4-Week Exploratory Evaluation Period||0
1648527|NCT00742508|4026330|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
1648528|NCT00742508|4026331|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
1648529|NCT00742508|4026330|P2|COMPLETED|8-Week Primary Evaluation Period||8
1648530|NCT00742508|4026331|P1|COMPLETED|8-Week Primary Evaluation Period||11
1648531|NCT00742508|4026330|P2|STARTED|8-Week Primary Evaluation Period||19
1648532|NCT00742508|4026331|P1|STARTED|8-Week Primary Evaluation Period||22
1648533|NCT00742417|4026395|P2|NOT COMPLETED|Maintenance II||0
1648534|NCT00742417|4026396|P1|NOT COMPLETED|Maintenance II||0
1648535|NCT00742417|4026395|P2|COMPLETED|Maintenance II||19
1648536|NCT00742417|4026396|P1|COMPLETED|Maintenance II||16
1648537|NCT00742417|4026395|P2|STARTED|Maintenance II||19
1648538|NCT00742417|4026396|P1|STARTED|Maintenance II||16
1648539|NCT00742417|4026395|P2|NOT COMPLETED|Maintenance I||0
1648540|NCT00742417|4026396|P1|NOT COMPLETED|Maintenance I||0
1648541|NCT00742417|4026395|P2|COMPLETED|Maintenance I||19
1648542|NCT00742417|4026396|P1|COMPLETED|Maintenance I||16
1648543|NCT00742417|4026395|P2|STARTED|Maintenance I||19
1648544|NCT00742417|4026396|P1|STARTED|Maintenance I||16
1648545|NCT00742417|4026395|P2|NOT COMPLETED|Intensive Period||1
1648546|NCT00742417|4026396|P1|NOT COMPLETED|Intensive Period||3
1648547|NCT00742417|4026395|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
1648548|NCT00742417|4026396|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
1648549|NCT00742417|4026395|P2|STARTED|Intensive Period||20
1648550|NCT00742417|4026396|P1|STARTED|Intensive Period||19
1648551|NCT00742417|4026395|P2|NOT COMPLETED|Randomized||1
1648552|NCT00742417|4026396|P1|NOT COMPLETED|Randomized||2
1648553|NCT00742417|4026395|P2|COMPLETED|Randomized||20
1648554|NCT00742417|4026396|P1|COMPLETED|Randomized||19
1648555|NCT00742417|4026395|P2|STARTED|Randomized||21
1648556|NCT00742417|4026396|P1|STARTED|Randomized||21
1648557|NCT00742391|4026420|P2|NOT COMPLETED|Overall Study||1
1648558|NCT00742391|4026421|P1|NOT COMPLETED|Overall Study||4
1648559|NCT00742391|4026420|P2|COMPLETED|Overall Study||128
1648560|NCT00742391|4026421|P1|COMPLETED|Overall Study||122
1648561|NCT00742391|4026420|P2|STARTED|Overall Study||129
1648562|NCT00742391|4026421|P1|STARTED|Overall Study||126
1648563|NCT00742326|4026431|P2|NOT COMPLETED|Overall Study||1
1648564|NCT00742326|4026432|P1|NOT COMPLETED|Overall Study||0
1648565|NCT00742326|4026431|P2|COMPLETED|Overall Study||6
1648566|NCT00742326|4026432|P1|COMPLETED|Overall Study||6
1648567|NCT00742326|4026431|P2|STARTED|Overall Study||7
1648568|NCT00742326|4026432|P1|STARTED|Overall Study||6
1648569|NCT00742313|4026442|P2|NOT COMPLETED|Overall Study||0
1648570|NCT00742313|4026443|P1|NOT COMPLETED|Overall Study||1
1648571|NCT00742313|4026442|P2|COMPLETED|Overall Study||19
1648572|NCT00742313|4026443|P1|COMPLETED|Overall Study||24
1648573|NCT00742313|4026442|P2|STARTED|Overall Study||19
1648574|NCT00742313|4026443|P1|STARTED|Overall Study||25
1648575|NCT00742274|4026451|P2|NOT COMPLETED|Overall Study||3
1648576|NCT00742274|4026452|P1|NOT COMPLETED|Overall Study||3
1648577|NCT00742274|4026451|P2|COMPLETED|Overall Study||28
1648578|NCT00742274|4026452|P1|COMPLETED|Overall Study||27
1648579|NCT00742274|4026451|P2|STARTED|Overall Study||31
1648580|NCT00742274|4026452|P1|STARTED|Overall Study||30
1648581|NCT00742235|4026460|P2|NOT COMPLETED|Overall Study||31
1648582|NCT00742235|4026461|P1|NOT COMPLETED|Overall Study||0
1648583|NCT00742235|4026460|P2|COMPLETED|Overall Study||36
1648584|NCT00742235|4026461|P1|COMPLETED|Overall Study||32
1648585|NCT00742235|4026460|P2|STARTED|Overall Study||67
1648586|NCT00742235|4026461|P1|STARTED|Overall Study||32
1648587|NCT00742209|4026474|P5|NOT COMPLETED|Overall Study||25
1648588|NCT00742209|4026475|P4|NOT COMPLETED|Overall Study||37
1648589|NCT00742209|4026476|P3|NOT COMPLETED|Overall Study||46
1648590|NCT00742209|4026477|P2|NOT COMPLETED|Overall Study||18
1648591|NCT00742209|4026478|P1|NOT COMPLETED|Overall Study||34
1648592|NCT00742209|4026474|P5|COMPLETED|Overall Study||37
1648593|NCT00742209|4026475|P4|COMPLETED|Overall Study||97
1648594|NCT00742209|4026476|P3|COMPLETED|Overall Study||88
1648595|NCT00742209|4026477|P2|COMPLETED|Overall Study||49
1648596|NCT00742209|4026478|P1|COMPLETED|Overall Study||95
1648597|NCT00742209|4026474|P5|STARTED|Overall Study||62
1648598|NCT00742209|4026475|P4|STARTED|Overall Study||134
1648599|NCT00742209|4026476|P3|STARTED|Overall Study||134
1648600|NCT00742209|4026477|P2|STARTED|Overall Study||67
1648601|NCT00742209|4026478|P1|STARTED|Overall Study||129
1648602|NCT00742183|4026581|P2|NOT COMPLETED|Overall Study||12
1648603|NCT00742183|4026582|P1|NOT COMPLETED|Overall Study||9
1648604|NCT00742183|4026581|P2|COMPLETED|Overall Study||39
1648605|NCT00742183|4026582|P1|COMPLETED|Overall Study||40
1648606|NCT00742183|4026581|P2|STARTED|Overall Study||51
1648607|NCT00742183|4026582|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
1648608|NCT00742170|4026590|P2|NOT COMPLETED|Overall Study||5
1648609|NCT00742170|4026591|P1|NOT COMPLETED|Overall Study||2
1648610|NCT00742170|4026590|P2|COMPLETED|Overall Study||24
1648611|NCT00742170|4026591|P1|COMPLETED|Overall Study||24
1648612|NCT00742170|4026590|P2|STARTED|Overall Study||29
1648613|NCT00742170|4026591|P1|STARTED|Overall Study||26
1648614|NCT00742079|4026601|P2|NOT COMPLETED|Overall Study||1
1648615|NCT00742079|4026602|P1|NOT COMPLETED|Overall Study||0
1648616|NCT00742079|4026601|P2|COMPLETED|Overall Study||9
1648617|NCT00742079|4026602|P1|COMPLETED|Overall Study||11
1648618|NCT00742079|4026601|P2|Week 2 (Received Dose 2)|Overall Study||9
1648619|NCT00742079|4026602|P1|Week 2 (Received Dose 2)|Overall Study||11
1648620|NCT00742079|4026601|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
1648621|NCT00742079|4026602|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
1648622|NCT00742079|4026601|P2|STARTED|Overall Study||10
1648623|NCT00742079|4026602|P1|STARTED|Overall Study||11
1648624|NCT00742053|4026616|P1|NOT COMPLETED|Overall Study||0
1648625|NCT00742053|4026616|P1|COMPLETED|Overall Study||7
1648626|NCT00742053|4026616|P1|STARTED|Overall Study||7
1648627|NCT00741988|4026622|P2|NOT COMPLETED|Overall Study||4
1648628|NCT00741988|4026623|P1|NOT COMPLETED|Overall Study||4
1648629|NCT00741988|4026622|P2|COMPLETED|Overall Study||36
1648630|NCT00741988|4026623|P1|COMPLETED|Overall Study||38
1648631|NCT00741988|4026622|P2|STARTED|Overall Study||40
1648632|NCT00741988|4026623|P1|STARTED|Overall Study||42
1648633|NCT00741936|4026635|P2|NOT COMPLETED|Overall Study||8
1648634|NCT00741936|4026636|P1|NOT COMPLETED|Overall Study||9
1648635|NCT00741936|4026635|P2|COMPLETED|Overall Study||52
1648636|NCT00741936|4026636|P1|COMPLETED|Overall Study||51
1648637|NCT00741936|4026635|P2|STARTED|Overall Study||60
1648638|NCT00741936|4026636|P1|STARTED|Overall Study||60
1648639|NCT00741858|4026664|P2|NOT COMPLETED|Overall Study||0
1648640|NCT00741858|4026665|P1|NOT COMPLETED|Overall Study||0
1648641|NCT00741858|4026664|P2|COMPLETED|Overall Study||18
1648642|NCT00741858|4026665|P1|COMPLETED|Overall Study||16
1648643|NCT00741858|4026664|P2|STARTED|Overall Study||18
1648644|NCT00741858|4026665|P1|STARTED|Overall Study||16
1648645|NCT00741819|4026671|P1|NOT COMPLETED|Overall Study||8
1648646|NCT00741819|4026671|P1|COMPLETED|Overall Study||65
1648647|NCT00741819|4026671|P1|STARTED|Overall Study||73
1648648|NCT00741611|4026685|P3|NOT COMPLETED|Overall Study||3
1648649|NCT00741611|4026686|P2|NOT COMPLETED|Overall Study||2
1648650|NCT00741611|4026687|P1|NOT COMPLETED|Overall Study||0
1648651|NCT00741611|4026685|P3|COMPLETED|Overall Study||26
1648652|NCT00741611|4026686|P2|COMPLETED|Overall Study||1
1648653|NCT00741611|4026687|P1|COMPLETED|Overall Study||4
1648654|NCT00741611|4026685|P3|STARTED|Overall Study||29
1648655|NCT00741611|4026686|P2|STARTED|Overall Study||3
1648656|NCT00741611|4026687|P1|STARTED|Overall Study||4
1648657|NCT00741598|4026706|P2|NOT COMPLETED|Overall Study||9
1648658|NCT00741598|4026707|P1|NOT COMPLETED|Overall Study||9
1648659|NCT00741598|4026706|P2|COMPLETED|Overall Study||30
1648660|NCT00741598|4026707|P1|COMPLETED|Overall Study||24
1648661|NCT00741598|4026706|P2|STARTED|Overall Study||39
1648662|NCT00741598|4026707|P1|STARTED|Overall Study||33
1648663|NCT00741468|4026721|P1|NOT COMPLETED|Overall Study||0
1648664|NCT00741468|4026721|P1|COMPLETED|Overall Study||18
1648665|NCT00741468|4026721|P1|STARTED|Overall Study||18
1648666|NCT00741390|4026729|P4|NOT COMPLETED|Visit 2||1
1648667|NCT00741390|4026730|P3|NOT COMPLETED|Visit 2||1
1648668|NCT00741390|4026731|P2|NOT COMPLETED|Visit 2||0
1648669|NCT00741390|4026732|P1|NOT COMPLETED|Visit 2||0
1648670|NCT00741390|4026729|P4|COMPLETED|Visit 2||60
1648671|NCT00741390|4026730|P3|COMPLETED|Visit 2||54
1648672|NCT00741390|4026731|P2|COMPLETED|Visit 2||61
1648673|NCT00741390|4026732|P1|COMPLETED|Visit 2||59
1648674|NCT00741390|4026729|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
1648675|NCT00741390|4026730|P3|STARTED|Visit 2||55
1648676|NCT00741390|4026731|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
1648677|NCT00741390|4026732|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
1648678|NCT00741390|4026729|P4|NOT COMPLETED|Visit 1||1
1648679|NCT00741390|4026730|P3|NOT COMPLETED|Visit 1||7
1648680|NCT00741390|4026731|P2|NOT COMPLETED|Visit 1||0
1648681|NCT00741390|4026732|P1|NOT COMPLETED|Visit 1||2
1648682|NCT00741390|4026729|P4|COMPLETED|Visit 1||62
1648683|NCT00741390|4026730|P3|COMPLETED|Visit 1||55
1648684|NCT00741390|4026731|P2|COMPLETED|Visit 1||63
1648685|NCT00741390|4026732|P1|COMPLETED|Visit 1||60
1648686|NCT00741390|4026729|P4|STARTED|Visit 1||63
1648687|NCT00741390|4026730|P3|STARTED|Visit 1||62
1648688|NCT00741390|4026731|P2|STARTED|Visit 1||63
1648689|NCT00741390|4026732|P1|STARTED|Visit 1||62
1648690|NCT00741338|4026753|P2|NOT COMPLETED|Overall Study||1
1648691|NCT00741338|4026754|P1|NOT COMPLETED|Overall Study||0
1648692|NCT00741338|4026753|P2|COMPLETED|Overall Study||2
1648693|NCT00741338|4026754|P1|COMPLETED|Overall Study||3
1648694|NCT00741338|4026753|P2|STARTED|Overall Study||3
1648695|NCT00741338|4026754|P1|STARTED|Overall Study||3
1648696|NCT00741286|4026764|P2|NOT COMPLETED|Overall Study||19
1648697|NCT00741286|4026765|P1|NOT COMPLETED|Overall Study||20
1648698|NCT00741286|4026764|P2|COMPLETED|Overall Study||81
1648699|NCT00741286|4026765|P1|COMPLETED|Overall Study||83
1648700|NCT00741286|4026764|P2|STARTED|Overall Study||100
1648701|NCT00741286|4026765|P1|STARTED|Overall Study||103
1648702|NCT00741273|4026775|P2|NOT COMPLETED|Overall Study||0
1648703|NCT00741273|4026776|P1|NOT COMPLETED|Overall Study||0
1648704|NCT00741273|4026775|P2|COMPLETED|Overall Study||8
1648705|NCT00741273|4026776|P1|COMPLETED|Overall Study||8
1648706|NCT00741273|4026775|P2|STARTED|Overall Study||8
1648707|NCT00741273|4026776|P1|STARTED|Overall Study||8
1648708|NCT00741260|4026799|P7|NOT COMPLETED|Overall Study||7
1648709|NCT00741260|4026800|P6|NOT COMPLETED|Overall Study||45
1648710|NCT00741260|4026801|P5|NOT COMPLETED|Overall Study||9
1648711|NCT00741260|4026802|P4|NOT COMPLETED|Overall Study||6
1648712|NCT00741260|4026803|P3|NOT COMPLETED|Overall Study||4
1648713|NCT00741260|4026804|P2|NOT COMPLETED|Overall Study||8
1648714|NCT00741260|4026805|P1|NOT COMPLETED|Overall Study||6
1648715|NCT00741260|4026799|P7|COMPLETED|Overall Study||0
1648716|NCT00741260|4026800|P6|COMPLETED|Overall Study||20
1648717|NCT00741260|4026801|P5|COMPLETED|Overall Study||0
1648718|NCT00741260|4026802|P4|COMPLETED|Overall Study||0
1648719|NCT00741260|4026803|P3|COMPLETED|Overall Study||0
1648720|NCT00741260|4026804|P2|COMPLETED|Overall Study||0
1648721|NCT00741260|4026805|P1|COMPLETED|Overall Study||0
1648722|NCT00741260|4026799|P7|STARTED|Overall Study||7
1648723|NCT00741260|4026800|P6|STARTED|Overall Study||65
1648724|NCT00741260|4026801|P5|STARTED|Overall Study||9
1648725|NCT00741260|4026802|P4|STARTED|Overall Study||6
1648726|NCT00741260|4026803|P3|STARTED|Overall Study||4
1648727|NCT00741260|4026804|P2|STARTED|Overall Study||8
1648728|NCT00741260|4026805|P1|STARTED|Overall Study||6
1648729|NCT00741156|4026832|P1|NOT COMPLETED|Overall Study||0
1648730|NCT00741156|4026832|P1|COMPLETED|Overall Study||12
1648731|NCT00741156|4026832|P1|STARTED|Overall Study||12
1648732|NCT00741104|4026847|P1|NOT COMPLETED|Overall Study||0
1648733|NCT00741104|4026847|P1|COMPLETED|Overall Study||363
1648734|NCT00741104|4026847|P1|STARTED|Overall Study||363
1648735|NCT00741091|4026854|P1|NOT COMPLETED|Overall Study||57
1648736|NCT00741091|4026854|P1|COMPLETED|Overall Study||1040
1648737|NCT00741091|4026854|P1|STARTED|Overall Study||1097
1648738|NCT00741039|4026864|P2|NOT COMPLETED|Overall Study||0
1648739|NCT00741039|4026865|P1|NOT COMPLETED|Overall Study||2
1648740|NCT00741039|4026864|P2|COMPLETED|Overall Study||25
1648741|NCT00741039|4026865|P1|COMPLETED|Overall Study||100
1648742|NCT00741039|4026864|P2|STARTED|Overall Study||25
1648743|NCT00741039|4026865|P1|STARTED|Overall Study||102
1648744|NCT00741026|4026871|P1|NOT COMPLETED|Overall Study||0
1648745|NCT00741026|4026871|P1|COMPLETED|Overall Study||15
1648746|NCT00741026|4026871|P1|STARTED|Overall Study||15
1648747|NCT00741013|4026902|P3|NOT COMPLETED|Overall Study||1
1648748|NCT00741013|4026903|P2|NOT COMPLETED|Overall Study||2
1648749|NCT00741013|4026904|P1|NOT COMPLETED|Overall Study||1
1648750|NCT00741013|4026902|P3|COMPLETED|Overall Study||6
1648751|NCT00741013|4026903|P2|COMPLETED|Overall Study||6
1648752|NCT00741013|4026904|P1|COMPLETED|Overall Study||6
1648753|NCT00741013|4026902|P3|STARTED|Overall Study||7
1648754|NCT00741013|4026903|P2|STARTED|Overall Study||8
1648755|NCT00741013|4026904|P1|STARTED|Overall Study||7
1648756|NCT00740870|4026915|P1|NOT COMPLETED|Overall Study||21
1648757|NCT00740870|4026915|P1|COMPLETED|Overall Study||150
1648758|NCT00740870|4026915|P1|STARTED|Overall Study||171
1648759|NCT00740857|4026930|P3|NOT COMPLETED|Overall Study||0
1648760|NCT00740857|4026931|P2|NOT COMPLETED|Overall Study||0
1648761|NCT00740857|4026932|P1|NOT COMPLETED|Overall Study||1
1648762|NCT00740857|4026930|P3|COMPLETED|Overall Study||90
1648763|NCT00740857|4026931|P2|COMPLETED|Overall Study||88
1648764|NCT00740857|4026932|P1|COMPLETED|Overall Study||32
1648765|NCT00740857|4026930|P3|STARTED|Overall Study||90
1648766|NCT00740857|4026931|P2|STARTED|Overall Study||88
1648767|NCT00740857|4026932|P1|STARTED|Overall Study||33
1648768|NCT00740831|4026964|P3|NOT COMPLETED|Overall Study||6
1648769|NCT00740831|4026965|P2|NOT COMPLETED|Overall Study||3
1648770|NCT00740831|4026966|P1|NOT COMPLETED|Overall Study||4
1648771|NCT00740831|4026964|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
1648772|NCT00740831|4026965|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
1648773|NCT00740831|4026966|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
1648774|NCT00740831|4026964|P3|STARTED|Overall Study|Safety population|101
1648775|NCT00740831|4026965|P2|STARTED|Overall Study|Safety population|103
1648776|NCT00740831|4026966|P1|STARTED|Overall Study|Safety population|97
1648777|NCT00740792|4026987|P4|NOT COMPLETED|Overall Study||10
1648778|NCT00740792|4026988|P3|NOT COMPLETED|Overall Study||9
1648779|NCT00740792|4026989|P2|NOT COMPLETED|Overall Study||8
1648780|NCT00740792|4026990|P1|NOT COMPLETED|Overall Study||10
1648781|NCT00740792|4026987|P4|COMPLETED|Overall Study||190
1648782|NCT00740792|4026988|P3|COMPLETED|Overall Study||180
1648783|NCT00740792|4026989|P2|COMPLETED|Overall Study||186
1648784|NCT00740792|4026990|P1|COMPLETED|Overall Study||183
1648785|NCT00740792|4026987|P4|STARTED|Overall Study||200
1648786|NCT00740792|4026988|P3|STARTED|Overall Study||189
1648787|NCT00740792|4026989|P2|STARTED|Overall Study||194
1648788|NCT00740792|4026990|P1|STARTED|Overall Study||193
1648789|NCT00740779|4027011|P3|NOT COMPLETED|Overall Study||13
1648790|NCT00740779|4027012|P2|NOT COMPLETED|Overall Study||14
1648791|NCT00740779|4027013|P1|NOT COMPLETED|Overall Study||9
1648792|NCT00740779|4027011|P3|COMPLETED|Overall Study||41
1648793|NCT00740779|4027012|P2|COMPLETED|Overall Study||31
1648794|NCT00740779|4027013|P1|COMPLETED|Overall Study||43
1648795|NCT00740779|4027011|P3|STARTED|Overall Study||54
1648796|NCT00740779|4027012|P2|STARTED|Overall Study||45
1648797|NCT00740779|4027013|P1|STARTED|Overall Study||52
1648798|NCT00740727|4027021|P1|NOT COMPLETED|Overall Study||0
1648799|NCT00740727|4027021|P1|COMPLETED|Overall Study||18
1648800|NCT00740727|4027021|P1|STARTED|Overall Study||18
1648801|NCT00740714|4027030|P3|NOT COMPLETED|Overall Study||29
1648802|NCT00740714|4027031|P2|NOT COMPLETED|Overall Study||19
1648803|NCT00740714|4027032|P1|NOT COMPLETED|Overall Study||17
1648804|NCT00740714|4027030|P3|COMPLETED|Overall Study||174
1648805|NCT00740714|4027031|P2|COMPLETED|Overall Study||182
1648806|NCT00740714|4027032|P1|COMPLETED|Overall Study||179
1648807|NCT00740714|4027030|P3|Active Patients at Study Termination|Overall Study||33
1648808|NCT00740714|4027031|P2|Active Patients at Study Termination|Overall Study||12
1648809|NCT00740714|4027032|P1|Active Patients at Study Termination|Overall Study||24
1648810|NCT00740714|4027030|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
1648811|NCT00740714|4027031|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
1648812|NCT00740714|4027032|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
1648813|NCT00740714|4027030|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
1648814|NCT00740714|4027031|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
1648815|NCT00740714|4027032|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
1648816|NCT00740636|4027108|P2|NOT COMPLETED|Overall Study||4
1648817|NCT00740636|4027109|P1|NOT COMPLETED|Overall Study||2
1648818|NCT00740636|4027108|P2|COMPLETED|Overall Study||63
1648819|NCT00740636|4027109|P1|COMPLETED|Overall Study||23
1648820|NCT00740636|4027108|P2|STARTED|Overall Study||67
1648821|NCT00740636|4027109|P1|STARTED|Overall Study||25
1648822|NCT00740597|4027115|P1|NOT COMPLETED|Overall Study||1
1648823|NCT00740597|4027115|P1|COMPLETED|Overall Study||0
1648824|NCT00740597|4027115|P1|STARTED|Overall Study||1
1648825|NCT00740584|4027119|P1|NOT COMPLETED|Overall Study||1
1648826|NCT00740584|4027119|P1|COMPLETED|Overall Study||11
1648827|NCT00740584|4027119|P1|STARTED|Overall Study||12
1648828|NCT00740480|4027124|P1|NOT COMPLETED|Overall Study||2
1648829|NCT00740480|4027124|P1|COMPLETED|Overall Study||23
1648830|NCT00740480|4027124|P1|STARTED|Overall Study||25
1648831|NCT00740220|4027128|P1|NOT COMPLETED|Overall Study||9
1648832|NCT00740220|4027128|P1|COMPLETED|Overall Study||88
1648833|NCT00740220|4027128|P1|STARTED|Overall Study||97
1648834|NCT00740207|4027134|P2|NOT COMPLETED|Overall Study||0
1648835|NCT00740207|4027135|P1|NOT COMPLETED|Overall Study||0
1648836|NCT00740207|4027134|P2|COMPLETED|Overall Study||16
1648837|NCT00740207|4027135|P1|COMPLETED|Overall Study||17
1648838|NCT00740207|4027134|P2|STARTED|Overall Study||16
1648839|NCT00740207|4027135|P1|STARTED|Overall Study||17
1648840|NCT00740181|4027147|P1|NOT COMPLETED|Overall Study||0
1648841|NCT00740181|4027147|P1|COMPLETED|Overall Study||9
1648842|NCT00740181|4027147|P1|STARTED|Overall Study||9
1648843|NCT00740051|4027153|P2|NOT COMPLETED|Overall Study||32
1648844|NCT00740051|4027154|P1|NOT COMPLETED|Overall Study||18
1648845|NCT00740051|4027153|P2|COMPLETED|Overall Study||119
1648846|NCT00740051|4027154|P1|COMPLETED|Overall Study||58
1648847|NCT00740051|4027153|P2|STARTED|Overall Study||151
1648848|NCT00740051|4027154|P1|STARTED|Overall Study||76
1648849|NCT00739999|4027176|P2|NOT COMPLETED|Overall Study||0
1648850|NCT00739999|4027177|P1|NOT COMPLETED|Overall Study||0
1648851|NCT00739999|4027176|P2|COMPLETED|Overall Study||24
1648852|NCT00739999|4027177|P1|COMPLETED|Overall Study||15
1648853|NCT00739999|4027176|P2|STARTED|Overall Study||24
1648854|NCT00739999|4027177|P1|STARTED|Overall Study||15
1648855|NCT00739973|4027257|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
1648856|NCT00739973|4027258|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
1648857|NCT00739973|4027259|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
1648858|NCT00739973|4027260|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
1648859|NCT00739973|4027261|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
1648860|NCT00739973|4027262|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
1648861|NCT00739973|4027263|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
1648862|NCT00739973|4027264|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
1648863|NCT00739973|4027265|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
1648864|NCT00739973|4027257|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
1648865|NCT00739973|4027258|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
1648866|NCT00739973|4027259|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
1648867|NCT00739973|4027260|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
1648868|NCT00739973|4027261|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
1648869|NCT00739973|4027262|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
1648870|NCT00739973|4027263|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
1648871|NCT00739973|4027264|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
1648872|NCT00739973|4027265|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
1648873|NCT00739973|4027257|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
1648874|NCT00739973|4027258|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
1648875|NCT00739973|4027259|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
1648876|NCT00739973|4027260|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
1648877|NCT00739973|4027261|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
1648878|NCT00739973|4027262|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
1648879|NCT00739973|4027263|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
1648880|NCT00739973|4027264|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
1648881|NCT00739973|4027265|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
1648882|NCT00739973|4027257|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648883|NCT00739973|4027258|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648884|NCT00739973|4027259|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648885|NCT00739973|4027260|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648886|NCT00739973|4027261|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648887|NCT00739973|4027262|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648888|NCT00739973|4027263|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648889|NCT00739973|4027264|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648890|NCT00739973|4027265|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
1648891|NCT00739973|4027257|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648892|NCT00739973|4027258|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648893|NCT00739973|4027259|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648894|NCT00739973|4027260|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648895|NCT00739973|4027261|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648896|NCT00739973|4027262|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648897|NCT00739973|4027263|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648898|NCT00739973|4027264|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1648899|NCT00739973|4027265|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
1648900|NCT00739973|4027257|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
1648901|NCT00739973|4027258|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
1648902|NCT00739973|4027259|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
1648903|NCT00739973|4027260|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
1648904|NCT00739973|4027261|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
1648905|NCT00739973|4027262|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
1648906|NCT00739973|4027263|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
1648907|NCT00739973|4027264|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
1648908|NCT00739973|4027265|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
1648909|NCT00739934|4027351|P1|NOT COMPLETED|Voriconazole Oral||3
1648910|NCT00739934|4027351|P1|COMPLETED|Voriconazole Oral||31
1648911|NCT00739934|4027351|P1|STARTED|Voriconazole Oral||34
1648912|NCT00739934|4027351|P1|NOT COMPLETED|Voriconazole IV||6
1648913|NCT00739934|4027351|P1|COMPLETED|Voriconazole IV||34
1648914|NCT00739934|4027351|P1|STARTED|Voriconazole IV||40
1648915|NCT00739908|4027373|P2|NOT COMPLETED|Overall Study||25
1648916|NCT00739908|4027374|P1|NOT COMPLETED|Overall Study||25
1648917|NCT00739908|4027373|P2|COMPLETED|Overall Study||118
1648918|NCT00739908|4027374|P1|COMPLETED|Overall Study||117
1648919|NCT00739908|4027373|P2|STARTED|Overall Study||143
1648920|NCT00739908|4027374|P1|STARTED|Overall Study||142
1648921|NCT00739882|4027394|P2|NOT COMPLETED|Open-label Period||5
1648922|NCT00739882|4027395|P1|NOT COMPLETED|Open-label Period||10
1648923|NCT00739882|4027394|P2|COMPLETED|Open-label Period||9
1648924|NCT00739882|4027395|P1|COMPLETED|Open-label Period||7
1648925|NCT00739882|4027394|P2|STARTED|Open-label Period||14
1648926|NCT00739882|4027395|P1|STARTED|Open-label Period||17
1648927|NCT00739882|4027394|P2|NOT COMPLETED|Double-blind Period||11
1648928|NCT00739882|4027395|P1|NOT COMPLETED|Double-blind Period||19
1648929|NCT00739882|4027394|P2|COMPLETED|Double-blind Period||14
1648930|NCT00739882|4027395|P1|COMPLETED|Double-blind Period||32
1648931|NCT00739882|4027394|P2|STARTED|Double-blind Period||25
1648932|NCT00739882|4027395|P1|STARTED|Double-blind Period||51
1648933|NCT00739765|4027416|P3|NOT COMPLETED|Overall Study||11
1648934|NCT00739765|4027417|P2|NOT COMPLETED|Overall Study||11
1648935|NCT00739765|4027418|P1|NOT COMPLETED|Overall Study||6
1648936|NCT00739765|4027416|P3|COMPLETED|Overall Study||21
1648937|NCT00739765|4027417|P2|COMPLETED|Overall Study||27
1648938|NCT00739765|4027418|P1|COMPLETED|Overall Study||34
1648939|NCT00739765|4027416|P3|STARTED|Overall Study||32
1648940|NCT00739765|4027417|P2|STARTED|Overall Study||38
1648941|NCT00739765|4027418|P1|STARTED|Overall Study||40
1648942|NCT00739752|4027435|P6|NOT COMPLETED|Overall Study||0
1648943|NCT00739752|4027436|P5|NOT COMPLETED|Overall Study||0
1648944|NCT00739752|4027437|P4|NOT COMPLETED|Overall Study||0
1648945|NCT00739752|4027438|P3|NOT COMPLETED|Overall Study||0
1648946|NCT00739752|4027439|P2|NOT COMPLETED|Overall Study||0
1648947|NCT00739752|4027440|P1|NOT COMPLETED|Overall Study||0
1648948|NCT00739752|4027435|P6|COMPLETED|Overall Study||293
1648949|NCT00739752|4027436|P5|COMPLETED|Overall Study||291
1648950|NCT00739752|4027437|P4|COMPLETED|Overall Study||288
1648951|NCT00739752|4027438|P3|COMPLETED|Overall Study||292
1648952|NCT00739752|4027439|P2|COMPLETED|Overall Study||284
1648953|NCT00739752|4027440|P1|COMPLETED|Overall Study||299
1648954|NCT00739752|4027435|P6|STARTED|Overall Study||293
1648955|NCT00739752|4027436|P5|STARTED|Overall Study||291
1648956|NCT00739752|4027437|P4|STARTED|Overall Study||288
1648957|NCT00739752|4027438|P3|STARTED|Overall Study||292
1648958|NCT00739752|4027439|P2|STARTED|Overall Study||284
1648959|NCT00739752|4027440|P1|STARTED|Overall Study||299
1648960|NCT00739674|4027456|P2|NOT COMPLETED|Overall Study||122
1648961|NCT00739674|4027457|P1|NOT COMPLETED|Overall Study||181
1648962|NCT00739674|4027456|P2|COMPLETED|Overall Study||335
1648963|NCT00739674|4027457|P1|COMPLETED|Overall Study||354
1648964|NCT00739674|4027456|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
1648965|NCT00739674|4027457|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
1648966|NCT00739674|4027456|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
1648967|NCT00739674|4027457|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
1648968|NCT00739674|4027456|P2|No Follow-up Data|Overall Study||18
1648969|NCT00739674|4027457|P1|No Follow-up Data|Overall Study||33
1648970|NCT00739674|4027456|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
1648971|NCT00739674|4027457|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
1648972|NCT00739674|4027456|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
1648973|NCT00739674|4027457|P1|Screening Failures|Overall Study||19
1648974|NCT00739674|4027456|P2|STARTED|Overall Study||457
1648975|NCT00739674|4027457|P1|STARTED|Overall Study||535
1648976|NCT00739661|4027485|P2|NOT COMPLETED|Overall Study||42
1648977|NCT00739661|4027486|P1|NOT COMPLETED|Overall Study||46
1648978|NCT00739661|4027485|P2|COMPLETED|Overall Study||10
1648979|NCT00739661|4027486|P1|COMPLETED|Overall Study||6
1648980|NCT00739661|4027485|P2|STARTED|Overall Study||52
1648981|NCT00739661|4027486|P1|STARTED|Overall Study||52
1648982|NCT00739648|4027498|P2|NOT COMPLETED|Overall Study||53
1648983|NCT00739648|4027499|P1|NOT COMPLETED|Overall Study||26
1648984|NCT00739648|4027498|P2|COMPLETED|Overall Study||161
1648985|NCT00739648|4027499|P1|COMPLETED|Overall Study||82
1648986|NCT00739648|4027498|P2|STARTED|Overall Study||214
1648987|NCT00739648|4027499|P1|STARTED|Overall Study||108
1648988|NCT00739596|4027513|P2|NOT COMPLETED|Overall Study||17
1648989|NCT00739596|4027514|P1|NOT COMPLETED|Overall Study||25
1648990|NCT00739596|4027513|P2|COMPLETED|Overall Study||149
1648991|NCT00739596|4027514|P1|COMPLETED|Overall Study||141
1648992|NCT00739596|4027513|P2|STARTED|Overall Study||166
1648993|NCT00739596|4027514|P1|STARTED|Overall Study||166
1648994|NCT00739583|4027530|P2|NOT COMPLETED|Overall Study||0
1648995|NCT00739583|4027531|P1|NOT COMPLETED|Overall Study||0
1648996|NCT00739583|4027530|P2|COMPLETED|Overall Study||10
1648997|NCT00739583|4027531|P1|COMPLETED|Overall Study||10
1648998|NCT00739583|4027530|P2|STARTED|Overall Study||10
1648999|NCT00739583|4027531|P1|STARTED|Overall Study||10
1649000|NCT00739336|4027543|P2|NOT COMPLETED|Overall Study||0
1649001|NCT00739336|4027544|P1|NOT COMPLETED|Overall Study||4
1649002|NCT00739336|4027543|P2|COMPLETED|Overall Study||24
1649003|NCT00739336|4027544|P1|COMPLETED|Overall Study||17
1649004|NCT00739336|4027543|P2|STARTED|Overall Study||24
1649005|NCT00739336|4027544|P1|STARTED|Overall Study||21
1649006|NCT00739310|4027556|P1|NOT COMPLETED|Overall Study||7
1649007|NCT00739310|4027556|P1|COMPLETED|Overall Study||22
1649008|NCT00739310|4027556|P1|STARTED|Overall Study||29
1649009|NCT00739297|4027561|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
1649010|NCT00739297|4027562|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
1649011|NCT00739297|4027563|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1649012|NCT00739297|4027564|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1649013|NCT00739297|4027565|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1649014|NCT00739297|4027566|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1649015|NCT00739297|4027567|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1649016|NCT00739297|4027561|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
1649017|NCT00739297|4027562|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
1649018|NCT00739297|4027563|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
1649019|NCT00739297|4027564|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
1649020|NCT00739297|4027565|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
1649021|NCT00739297|4027566|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
1649022|NCT00739297|4027567|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
1649023|NCT00739297|4027561|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
1649024|NCT00739297|4027562|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
1649025|NCT00739297|4027563|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
1649026|NCT00739297|4027564|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
1649027|NCT00739297|4027565|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
1649028|NCT00739297|4027566|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
1649029|NCT00739297|4027567|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
1649030|NCT00739297|4027561|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1649031|NCT00739297|4027562|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1649032|NCT00739297|4027563|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1649033|NCT00739297|4027564|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1649034|NCT00739297|4027565|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1649035|NCT00739297|4027566|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1649036|NCT00739297|4027567|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1649037|NCT00739297|4027561|P7|COMPLETED|Third Washout Period of 4-7 Days||66
1649038|NCT00739297|4027562|P6|COMPLETED|Third Washout Period of 4-7 Days||8
1649039|NCT00739297|4027563|P5|COMPLETED|Third Washout Period of 4-7 Days||6
1649040|NCT00739297|4027564|P4|COMPLETED|Third Washout Period of 4-7 Days||18
1649041|NCT00739297|4027565|P3|COMPLETED|Third Washout Period of 4-7 Days||6
1649042|NCT00739297|4027566|P2|COMPLETED|Third Washout Period of 4-7 Days||12
1649043|NCT00739297|4027567|P1|COMPLETED|Third Washout Period of 4-7 Days||16
1649044|NCT00739297|4027561|P7|STARTED|Third Washout Period of 4-7 Days||66
1649045|NCT00739297|4027562|P6|STARTED|Third Washout Period of 4-7 Days||8
1649046|NCT00739297|4027563|P5|STARTED|Third Washout Period of 4-7 Days||6
1649047|NCT00739297|4027564|P4|STARTED|Third Washout Period of 4-7 Days||18
1649048|NCT00739297|4027565|P3|STARTED|Third Washout Period of 4-7 Days||6
1649049|NCT00739297|4027566|P2|STARTED|Third Washout Period of 4-7 Days||12
1649050|NCT00739297|4027567|P1|STARTED|Third Washout Period of 4-7 Days||16
1649051|NCT00739297|4027561|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1649052|NCT00739297|4027562|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1649053|NCT00739297|4027563|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1649054|NCT00739297|4027564|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1649055|NCT00739297|4027565|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1649056|NCT00739297|4027566|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1649057|NCT00739297|4027567|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1649058|NCT00739297|4027561|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
1649059|NCT00739297|4027562|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
1649060|NCT00739297|4027563|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
1649061|NCT00739297|4027564|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
1649062|NCT00739297|4027565|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
1649063|NCT00739297|4027566|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
1649064|NCT00739297|4027567|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
1649065|NCT00739297|4027561|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
1649066|NCT00739297|4027562|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
1649067|NCT00739297|4027563|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
1649068|NCT00739297|4027564|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
1649069|NCT00739297|4027565|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
1649070|NCT00739297|4027566|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
1649071|NCT00739297|4027567|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
1649072|NCT00739297|4027561|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1649073|NCT00739297|4027562|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1649074|NCT00739297|4027563|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1649075|NCT00739297|4027564|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1649076|NCT00739297|4027565|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1649077|NCT00739297|4027566|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1649078|NCT00739297|4027567|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1649079|NCT00739297|4027561|P7|COMPLETED|Second Washout Period of 4-7 Days||66
1649080|NCT00739297|4027562|P6|COMPLETED|Second Washout Period of 4-7 Days||10
1649081|NCT00739297|4027563|P5|COMPLETED|Second Washout Period of 4-7 Days||6
1649082|NCT00739297|4027564|P4|COMPLETED|Second Washout Period of 4-7 Days||14
1649083|NCT00739297|4027565|P3|COMPLETED|Second Washout Period of 4-7 Days||10
1649084|NCT00739297|4027566|P2|COMPLETED|Second Washout Period of 4-7 Days||8
1649085|NCT00739297|4027567|P1|COMPLETED|Second Washout Period of 4-7 Days||18
1649086|NCT00739297|4027561|P7|STARTED|Second Washout Period of 4-7 Days||66
1649087|NCT00739297|4027562|P6|STARTED|Second Washout Period of 4-7 Days||10
1649088|NCT00739297|4027563|P5|STARTED|Second Washout Period of 4-7 Days||6
1649089|NCT00739297|4027564|P4|STARTED|Second Washout Period of 4-7 Days||14
1649090|NCT00739297|4027565|P3|STARTED|Second Washout Period of 4-7 Days||10
1649091|NCT00739297|4027566|P2|STARTED|Second Washout Period of 4-7 Days||8
1649092|NCT00739297|4027567|P1|STARTED|Second Washout Period of 4-7 Days||18
1649093|NCT00739297|4027561|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1649094|NCT00739297|4027562|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1649095|NCT00739297|4027563|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1649096|NCT00739297|4027564|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1649097|NCT00739297|4027565|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1649098|NCT00739297|4027566|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1649099|NCT00739297|4027567|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1649100|NCT00739297|4027561|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
1649101|NCT00739297|4027562|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
1649102|NCT00739297|4027563|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
1649103|NCT00739297|4027564|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
1649104|NCT00739297|4027565|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
1649105|NCT00739297|4027566|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
1649106|NCT00739297|4027567|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
1649107|NCT00739297|4027561|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
1649108|NCT00739297|4027562|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
1649109|NCT00739297|4027563|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
1649110|NCT00739297|4027564|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
1649111|NCT00739297|4027565|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
1649112|NCT00739297|4027566|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
1649113|NCT00739297|4027567|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
1649114|NCT00739297|4027561|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
1649115|NCT00739297|4027562|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
1649116|NCT00739297|4027563|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
1649117|NCT00739297|4027564|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
1649118|NCT00739297|4027565|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
1649119|NCT00739297|4027566|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
1649120|NCT00739297|4027567|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
1649121|NCT00739297|4027561|P7|COMPLETED|First Washout Period of 4-7 Days||66
1649122|NCT00739297|4027562|P6|COMPLETED|First Washout Period of 4-7 Days||9
1649123|NCT00739297|4027563|P5|COMPLETED|First Washout Period of 4-7 Days||6
1649124|NCT00739297|4027564|P4|COMPLETED|First Washout Period of 4-7 Days||17
1649125|NCT00739297|4027565|P3|COMPLETED|First Washout Period of 4-7 Days||6
1649126|NCT00739297|4027566|P2|COMPLETED|First Washout Period of 4-7 Days||11
1649127|NCT00739297|4027567|P1|COMPLETED|First Washout Period of 4-7 Days||17
1649128|NCT00739297|4027561|P7|STARTED|First Washout Period of 4-7 Days||68
1649129|NCT00739297|4027562|P6|STARTED|First Washout Period of 4-7 Days||9
1649130|NCT00739297|4027563|P5|STARTED|First Washout Period of 4-7 Days||6
1649131|NCT00739297|4027564|P4|STARTED|First Washout Period of 4-7 Days||19
1649132|NCT00739297|4027565|P3|STARTED|First Washout Period of 4-7 Days||6
1649133|NCT00739297|4027566|P2|STARTED|First Washout Period of 4-7 Days||11
1649134|NCT00739297|4027567|P1|STARTED|First Washout Period of 4-7 Days||17
1649135|NCT00739297|4027561|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1649136|NCT00739297|4027562|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1649137|NCT00739297|4027563|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1649138|NCT00739297|4027564|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1649139|NCT00739297|4027565|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1649140|NCT00739297|4027566|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1649141|NCT00739297|4027567|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1649142|NCT00739297|4027561|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
1649143|NCT00739297|4027562|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
1649144|NCT00739297|4027563|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
1649145|NCT00739297|4027564|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
1649146|NCT00739297|4027565|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
1649147|NCT00739297|4027566|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
1649148|NCT00739297|4027567|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
1649149|NCT00739297|4027561|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
1649150|NCT00739297|4027562|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
1649151|NCT00739297|4027563|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
1649152|NCT00739297|4027564|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
1649153|NCT00739297|4027565|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
1649154|NCT00739297|4027566|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
1649155|NCT00739297|4027567|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
1649156|NCT00739102|4027595|P1|NOT COMPLETED|Overall Study||15
1649157|NCT00739102|4027595|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
1649158|NCT00739102|4027595|P1|STARTED|Overall Study||250
1649159|NCT00739063|4027611|P1|NOT COMPLETED|Overall Study||8
1649160|NCT00739063|4027611|P1|COMPLETED|Overall Study||3
1649161|NCT00739063|4027611|P1|STARTED|Overall Study||11
1649162|NCT00739050|4027615|P2|NOT COMPLETED|Overall Study||0
1649163|NCT00739050|4027616|P1|NOT COMPLETED|Overall Study||1
1649164|NCT00739050|4027615|P2|COMPLETED|Overall Study||0
1649165|NCT00739050|4027616|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
1649166|NCT00739050|4027615|P2|STARTED|Overall Study||0
1649167|NCT00739050|4027616|P1|STARTED|Overall Study||4
1649168|NCT00739024|4027630|P2|NOT COMPLETED|Overall Study||0
1649169|NCT00739024|4027631|P1|NOT COMPLETED|Overall Study||0
1649170|NCT00739024|4027630|P2|COMPLETED|Overall Study||6
1649171|NCT00739024|4027631|P1|COMPLETED|Overall Study||7
1649172|NCT00739024|4027630|P2|STARTED|Overall Study||6
1649173|NCT00739024|4027631|P1|STARTED|Overall Study||7
1649174|NCT00738972|4027641|P4|NOT COMPLETED|Overall Study||1
1649175|NCT00738972|4027642|P3|NOT COMPLETED|Overall Study||0
1649176|NCT00738972|4027643|P2|NOT COMPLETED|Overall Study||0
1649177|NCT00738972|4027644|P1|NOT COMPLETED|Overall Study||0
1649178|NCT00738972|4027641|P4|COMPLETED|Overall Study||2
1649179|NCT00738972|4027642|P3|COMPLETED|Overall Study||3
1649180|NCT00738972|4027643|P2|COMPLETED|Overall Study||3
1649181|NCT00738972|4027644|P1|COMPLETED|Overall Study||3
1649182|NCT00738972|4027641|P4|STARTED|Overall Study||3
1649183|NCT00738972|4027642|P3|STARTED|Overall Study||3
1649184|NCT00738972|4027643|P2|STARTED|Overall Study||3
1649185|NCT00738972|4027644|P1|STARTED|Overall Study||3
1649186|NCT00738894|4027656|P2|NOT COMPLETED|Overall Study||33
1649187|NCT00738894|4027657|P1|NOT COMPLETED|Overall Study||39
1649188|NCT00738894|4027656|P2|COMPLETED|Overall Study||190
1649189|NCT00738894|4027657|P1|COMPLETED|Overall Study||402
1649190|NCT00738894|4027656|P2|STARTED|Overall Study||223
1649191|NCT00738894|4027657|P1|STARTED|Overall Study||441
1649192|NCT00738881|4027670|P2|NOT COMPLETED|Overall Study||2
1649193|NCT00738881|4027671|P1|NOT COMPLETED|Overall Study||0
1649194|NCT00738881|4027670|P2|COMPLETED|Overall Study||10
1649195|NCT00738881|4027671|P1|COMPLETED|Overall Study||11
1649196|NCT00738881|4027670|P2|STARTED|Overall Study||12
1649197|NCT00738881|4027671|P1|STARTED|Overall Study||11
1649198|NCT00738699|4027685|P2|NOT COMPLETED|Overall Study||140
1649199|NCT00738699|4027686|P1|NOT COMPLETED|Overall Study||275
1649200|NCT00738699|4027685|P2|COMPLETED|Overall Study||0
1649201|NCT00738699|4027686|P1|COMPLETED|Overall Study||0
1649202|NCT00738699|4027685|P2|Participants Treated|Overall Study||139
1649203|NCT00738699|4027686|P1|Participants Treated|Overall Study||273
1649204|NCT00738699|4027685|P2|Participants Not Treated|Overall Study||1
1649205|NCT00738699|4027686|P1|Participants Not Treated|Overall Study||2
1649206|NCT00738699|4027685|P2|STARTED|Overall Study||140
1649207|NCT00738699|4027686|P1|STARTED|Overall Study||275
1649208|NCT00738673|4027704|P2|NOT COMPLETED|Overall Study||11
1649209|NCT00738673|4027705|P1|NOT COMPLETED|Overall Study||24
1649210|NCT00738673|4027704|P2|COMPLETED|Overall Study||1
1649211|NCT00738673|4027705|P1|COMPLETED|Overall Study||1
1649212|NCT00738673|4027704|P2|Intent to Treat Population|Overall Study||12
1649213|NCT00738673|4027705|P1|Intent to Treat Population|Overall Study||24
1649214|NCT00738673|4027704|P2|STARTED|Overall Study||12
1649215|NCT00738673|4027705|P1|STARTED|Overall Study||25
1649216|NCT00738543|4027733|P1|NOT COMPLETED|Control||0
1649217|NCT00738543|4027733|P1|COMPLETED|Control||48
1649218|NCT00738543|4027733|P1|STARTED|Control||48
1649219|NCT00738543|4027733|P1|NOT COMPLETED|Sodium Hypochlorite||0
1649220|NCT00738543|4027733|P1|COMPLETED|Sodium Hypochlorite||48
1649221|NCT00738543|4027733|P1|STARTED|Sodium Hypochlorite||48
1649222|NCT00738543|4027733|P1|NOT COMPLETED|Povidone Iodine||0
1649223|NCT00738543|4027733|P1|COMPLETED|Povidone Iodine||48
1649224|NCT00738543|4027733|P1|STARTED|Povidone Iodine||48
1649225|NCT00738530|4027743|P2|NOT COMPLETED|Overall Study||238
1649226|NCT00738530|4027744|P1|NOT COMPLETED|Overall Study||234
1649227|NCT00738530|4027743|P2|COMPLETED|Overall Study||84
1649228|NCT00738530|4027744|P1|COMPLETED|Overall Study||93
1649229|NCT00738530|4027743|P2|Treated|Overall Study||316
1649230|NCT00738530|4027744|P1|Treated|Overall Study||325
1649231|NCT00738530|4027743|P2|STARTED|Overall Study||322
1649232|NCT00738530|4027744|P1|STARTED|Overall Study||327
1649233|NCT00738426|4027770|P2|NOT COMPLETED|Overall Study||3
1649234|NCT00738426|4027771|P1|NOT COMPLETED|Overall Study||2
1649235|NCT00738426|4027770|P2|COMPLETED|Overall Study||32
1649236|NCT00738426|4027771|P1|COMPLETED|Overall Study||35
1649237|NCT00738426|4027770|P2|STARTED|Overall Study||35
1649238|NCT00738426|4027771|P1|STARTED|Overall Study||37
1649239|NCT00738400|4027779|P2|NOT COMPLETED|Overall Study||7
1649240|NCT00738400|4027780|P1|NOT COMPLETED|Overall Study||4
1649241|NCT00738400|4027779|P2|COMPLETED|Overall Study||67
1649242|NCT00738400|4027780|P1|COMPLETED|Overall Study||72
1649243|NCT00738400|4027779|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
1649244|NCT00738400|4027780|P1|ITT (Intent To Treatment) Population|Overall Study||75
1649245|NCT00738400|4027779|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
1649246|NCT00738400|4027780|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
1649247|NCT00738400|4027779|P2|STARTED|Overall Study||74
1649248|NCT00738400|4027780|P1|STARTED|Overall Study||76
1649249|NCT00738374|4027801|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
1649250|NCT00738374|4027802|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
1649251|NCT00738374|4027803|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
1649252|NCT00738374|4027804|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
1649253|NCT00738374|4027801|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
1649254|NCT00738374|4027802|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
1649255|NCT00738374|4027803|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
1649256|NCT00738374|4027804|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
1649257|NCT00738374|4027801|P4|STARTED|Maintenance Treatment/Observation Phase||32
1649258|NCT00738374|4027802|P3|STARTED|Maintenance Treatment/Observation Phase||34
1649259|NCT00738374|4027803|P2|STARTED|Maintenance Treatment/Observation Phase||7
1649260|NCT00738374|4027804|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
1649261|NCT00738374|4027801|P4|NOT COMPLETED|Induction Treatment Phase||0
1649262|NCT00738374|4027802|P3|NOT COMPLETED|Induction Treatment Phase||0
1649263|NCT00738374|4027803|P2|NOT COMPLETED|Induction Treatment Phase||0
1649264|NCT00738374|4027804|P1|NOT COMPLETED|Induction Treatment Phase||24
1649265|NCT00738374|4027801|P4|COMPLETED|Induction Treatment Phase||0
1649266|NCT00738374|4027802|P3|COMPLETED|Induction Treatment Phase||0
1649267|NCT00738374|4027803|P2|COMPLETED|Induction Treatment Phase||0
1649268|NCT00738374|4027804|P1|COMPLETED|Induction Treatment Phase||73
1649269|NCT00738374|4027801|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
1649270|NCT00738374|4027802|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
1649271|NCT00738374|4027803|P2|STARTED|Induction Treatment Phase||0
1649272|NCT00738374|4027804|P1|STARTED|Induction Treatment Phase||97
1649273|NCT00738361|4027836|P1|NOT COMPLETED|Overall Study||0
1649274|NCT00738361|4027836|P1|COMPLETED|Overall Study||4
1649275|NCT00738361|4027836|P1|STARTED|Overall Study||4
1649276|NCT00738283|4027842|P1|NOT COMPLETED|Overall Study||4
1649277|NCT00738283|4027842|P1|COMPLETED|Overall Study||13
1649278|NCT00738283|4027842|P1|STARTED|Overall Study||17
1649279|NCT00738062|4027849|P3|NOT COMPLETED|Open-Label Extension||0
1649280|NCT00738062|4027850|P2|NOT COMPLETED|Open-Label Extension||0
1649281|NCT00738062|4027851|P1|NOT COMPLETED|Open-Label Extension||17
1649282|NCT00738062|4027849|P3|COMPLETED|Open-Label Extension||0
1649283|NCT00738062|4027850|P2|COMPLETED|Open-Label Extension||0
1649284|NCT00738062|4027851|P1|COMPLETED|Open-Label Extension||57
1649285|NCT00738062|4027849|P3|STARTED|Open-Label Extension||0
1649286|NCT00738062|4027850|P2|STARTED|Open-Label Extension||0
1649287|NCT00738062|4027851|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
1649288|NCT00738062|4027849|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
1649289|NCT00738062|4027850|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
1649290|NCT00738062|4027851|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
1649291|NCT00738062|4027849|P3|COMPLETED|2 Week Randomized Withdrawal||37
1649292|NCT00738062|4027850|P2|COMPLETED|2 Week Randomized Withdrawal||38
1649293|NCT00738062|4027851|P1|COMPLETED|2 Week Randomized Withdrawal||0
1649294|NCT00738062|4027849|P3|STARTED|2 Week Randomized Withdrawal||37
1649295|NCT00738062|4027850|P2|STARTED|2 Week Randomized Withdrawal||38
1649296|NCT00738062|4027851|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
1649297|NCT00738062|4027849|P3|NOT COMPLETED|Open Label Treatment||0
1649298|NCT00738062|4027850|P2|NOT COMPLETED|Open Label Treatment||0
1649299|NCT00738062|4027851|P1|NOT COMPLETED|Open Label Treatment||28
1649300|NCT00738062|4027849|P3|COMPLETED|Open Label Treatment||0
1649301|NCT00738062|4027850|P2|COMPLETED|Open Label Treatment||0
1649302|NCT00738062|4027851|P1|COMPLETED|Open Label Treatment||75
1649303|NCT00738062|4027849|P3|STARTED|Open Label Treatment||0
1649304|NCT00738062|4027850|P2|STARTED|Open Label Treatment||0
1649305|NCT00738062|4027851|P1|STARTED|Open Label Treatment||103
1649306|NCT00738049|4027878|P2|NOT COMPLETED|Washout||0
1649307|NCT00738049|4027879|P1|NOT COMPLETED|Washout||0
1649308|NCT00738049|4027878|P2|COMPLETED|Washout||7
1649309|NCT00738049|4027879|P1|COMPLETED|Washout||13
1649310|NCT00738049|4027878|P2|STARTED|Washout||7
1649311|NCT00738049|4027879|P1|STARTED|Washout||13
1649312|NCT00738049|4027878|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
1649313|NCT00738049|4027879|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
1649314|NCT00738049|4027878|P2|COMPLETED|2nd Intervention(14 Days)||7
1649315|NCT00738049|4027879|P1|COMPLETED|2nd Intervention(14 Days)||13
1649316|NCT00738049|4027878|P2|STARTED|2nd Intervention(14 Days)||7
1649317|NCT00738049|4027879|P1|STARTED|2nd Intervention(14 Days)||13
1649318|NCT00738049|4027878|P2|NOT COMPLETED|1st Intervention(14 Days)||0
1649319|NCT00738049|4027879|P1|NOT COMPLETED|1st Intervention(14 Days)||0
1649320|NCT00738049|4027878|P2|COMPLETED|1st Intervention(14 Days)||7
1649321|NCT00738049|4027879|P1|COMPLETED|1st Intervention(14 Days)||13
1649322|NCT00738049|4027878|P2|STARTED|1st Intervention(14 Days)||7
1649323|NCT00738049|4027879|P1|STARTED|1st Intervention(14 Days)||13
1649324|NCT00738023|4027893|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
1649325|NCT00738023|4027894|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
1649326|NCT00738023|4027893|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
1649327|NCT00738023|4027894|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
1649328|NCT00738023|4027893|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
1649329|NCT00738023|4027894|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
1649330|NCT00738023|4027893|P2|NOT COMPLETED|Saline Infusion||0
1649331|NCT00738023|4027894|P1|NOT COMPLETED|Saline Infusion||0
1649332|NCT00738023|4027893|P2|COMPLETED|Saline Infusion||0
1649333|NCT00738023|4027894|P1|COMPLETED|Saline Infusion||19
1649334|NCT00738023|4027893|P2|STARTED|Saline Infusion||0
1649335|NCT00738023|4027894|P1|STARTED|Saline Infusion||19
1649336|NCT00738023|4027893|P2|NOT COMPLETED|Intralipid Infusion||0
1649337|NCT00738023|4027894|P1|NOT COMPLETED|Intralipid Infusion||0
1649338|NCT00738023|4027893|P2|COMPLETED|Intralipid Infusion||13
1649339|NCT00738023|4027894|P1|COMPLETED|Intralipid Infusion||19
1649340|NCT00738023|4027893|P2|STARTED|Intralipid Infusion||13
1649341|NCT00738023|4027894|P1|STARTED|Intralipid Infusion||19
1649342|NCT00737737|4027904|P2|NOT COMPLETED|Overall Study||0
1649343|NCT00737737|4027905|P1|NOT COMPLETED|Overall Study||0
1649344|NCT00737737|4027904|P2|COMPLETED|Overall Study||2
1649345|NCT00737737|4027905|P1|COMPLETED|Overall Study||2
1649346|NCT00737737|4027904|P2|STARTED|Overall Study||2
1649347|NCT00737737|4027905|P1|STARTED|Overall Study||2
1649348|NCT00737711|4027913|P1|NOT COMPLETED|Overall Study||31
1649349|NCT00737711|4027913|P1|COMPLETED|Overall Study||158
1649350|NCT00737711|4027913|P1|STARTED|Overall Study||189
1649351|NCT00737672|4027946|P2|NOT COMPLETED|Overall Study||83
1649352|NCT00737672|4027947|P1|NOT COMPLETED|Overall Study||80
1649353|NCT00737672|4027946|P2|COMPLETED|Overall Study||65
1649354|NCT00737672|4027947|P1|COMPLETED|Overall Study||65
1649355|NCT00737672|4027946|P2|Per Protocol Population|Overall Study||138
1649356|NCT00737672|4027947|P1|Per Protocol Population|Overall Study||131
1649357|NCT00737672|4027946|P2|Exclusions Due to Protocol Deviations|Overall Study||10
1649358|NCT00737672|4027947|P1|Exclusions Due to Protocol Deviations|Overall Study||14
1649359|NCT00737672|4027946|P2|STARTED|Overall Study||148
1649360|NCT00737672|4027947|P1|STARTED|Overall Study||145
1649361|NCT00737633|4027985|P2|NOT COMPLETED|Overall Study||57
1649362|NCT00737633|4027986|P1|NOT COMPLETED|Overall Study||44
1649363|NCT00737633|4027985|P2|COMPLETED|Overall Study||0
1649364|NCT00737633|4027986|P1|COMPLETED|Overall Study||0
1649365|NCT00737633|4027985|P2|STARTED|Overall Study||57
1649366|NCT00737633|4027986|P1|STARTED|Overall Study||44
1649367|NCT00737594|4027997|P3|NOT COMPLETED|Overall Study||0
1649368|NCT00737594|4027998|P2|NOT COMPLETED|Overall Study||0
1649369|NCT00737594|4027999|P1|NOT COMPLETED|Overall Study||0
1649370|NCT00737594|4027997|P3|COMPLETED|Overall Study||0
1649371|NCT00737594|4027998|P2|COMPLETED|Overall Study||0
1649372|NCT00737594|4027999|P1|COMPLETED|Overall Study||0
1649373|NCT00737594|4027997|P3|STARTED|Overall Study||0
1649374|NCT00737594|4027998|P2|STARTED|Overall Study||0
1649375|NCT00737594|4027999|P1|STARTED|Overall Study||0
1649376|NCT00737568|4028009|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
1649377|NCT00737568|4028010|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
1649378|NCT00737568|4028009|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
1649379|NCT00737568|4028010|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
1649380|NCT00737568|4028009|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
1649381|NCT00737568|4028010|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
1649382|NCT00737568|4028009|P2|NOT COMPLETED|Treatment Period Through Week 240||21
1649383|NCT00737568|4028010|P1|NOT COMPLETED|Treatment Period Through Week 240||20
1649384|NCT00737568|4028009|P2|COMPLETED|Treatment Period Through Week 240||118
1649385|NCT00737568|4028010|P1|COMPLETED|Treatment Period Through Week 240||121
1649386|NCT00737568|4028009|P2|STARTED|Treatment Period Through Week 240||139
1649387|NCT00737568|4028010|P1|STARTED|Treatment Period Through Week 240||141
1649388|NCT00737529|4028040|P1|NOT COMPLETED|Overall Study||133
1649389|NCT00737529|4028040|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
1649390|NCT00737529|4028040|P1|STARTED|Overall Study||134
1649391|NCT00737477|4028054|P1|NOT COMPLETED|Overall Study||34
1649392|NCT00737477|4028054|P1|COMPLETED|Overall Study||62
1649393|NCT00737477|4028054|P1|STARTED|Overall Study||96
1649394|NCT00737464|4028070|P1|NOT COMPLETED|Overall Study||18
1649395|NCT00737464|4028070|P1|COMPLETED|Overall Study||114
1649396|NCT00737464|4028070|P1|STARTED|Overall Study||132
1649397|NCT00737438|4028091|P1|NOT COMPLETED|Overall Study||3
1649398|NCT00737438|4028091|P1|COMPLETED|Overall Study||20
1649399|NCT00737438|4028091|P1|STARTED|Overall Study||23
1649400|NCT00737360|4028095|P1|NOT COMPLETED|Overall Study||0
1649401|NCT00737360|4028095|P1|COMPLETED|Overall Study||27
1649402|NCT00737360|4028095|P1|STARTED|Overall Study||27
1649403|NCT00737282|4028104|P1|NOT COMPLETED|Overall Study||175
1649404|NCT00737282|4028104|P1|COMPLETED|Overall Study||0
1649405|NCT00737282|4028104|P1|STARTED|Overall Study||175
1649406|NCT00737243|4028110|P1|NOT COMPLETED|Overall Study||95
1649407|NCT00737243|4028110|P1|COMPLETED|Overall Study||194
1649408|NCT00737243|4028110|P1|Empiric CUP Therapy|Overall Study||29
1649409|NCT00737243|4028110|P1|Site Specific Therapy Less Responsive|Overall Study||79
1649410|NCT00737243|4028110|P1|Site Specific Therapy More Responsive|Overall Study||115
1649411|NCT00737243|4028110|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
1649412|NCT00737243|4028110|P1|Treated|Overall Study||223
1649413|NCT00737243|4028110|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
1649414|NCT00737243|4028110|P1|Successful Assay Performed|Overall Study||252
1649415|NCT00737243|4028110|P1|STARTED|Overall Study||289
1649416|NCT00737204|4028118|P2|NOT COMPLETED|Overall Study||6
1649417|NCT00737204|4028119|P1|NOT COMPLETED|Overall Study||0
1649418|NCT00737204|4028118|P2|COMPLETED|Overall Study||28
1649419|NCT00737204|4028119|P1|COMPLETED|Overall Study||36
1649420|NCT00737204|4028118|P2|STARTED|Overall Study||34
1649421|NCT00737204|4028119|P1|STARTED|Overall Study||36
1649422|NCT00737178|4028133|P2|NOT COMPLETED|Overall Study||9
1649423|NCT00737178|4028134|P1|NOT COMPLETED|Overall Study||5
1649424|NCT00737178|4028133|P2|COMPLETED|Overall Study||76
1649425|NCT00737178|4028134|P1|COMPLETED|Overall Study||66
1649426|NCT00737178|4028133|P2|STARTED|Overall Study||85
1649427|NCT00737178|4028134|P1|STARTED|Overall Study||71
1649428|NCT00737100|4028147|P3|NOT COMPLETED|Overall Study||7
1649429|NCT00737100|4028148|P2|NOT COMPLETED|Overall Study||7
1649430|NCT00737100|4028149|P1|NOT COMPLETED|Overall Study||7
1649431|NCT00737100|4028147|P3|COMPLETED|Overall Study||169
1649432|NCT00737100|4028148|P2|COMPLETED|Overall Study||159
1649433|NCT00737100|4028149|P1|COMPLETED|Overall Study||161
1649434|NCT00737100|4028147|P3|STARTED|Overall Study||176
1649435|NCT00737100|4028148|P2|STARTED|Overall Study||166
1649436|NCT00737100|4028149|P1|STARTED|Overall Study||168
1649437|NCT00737061|4028193|P1|NOT COMPLETED|1 Year Wearing Period||17
1649438|NCT00737061|4028193|P1|COMPLETED|1 Year Wearing Period||553
1649439|NCT00737061|4028193|P1|STARTED|1 Year Wearing Period||570
1649440|NCT00737061|4028193|P1|NOT COMPLETED|Waiting Period||75
1649441|NCT00737061|4028193|P1|COMPLETED|Waiting Period||570
1649442|NCT00737061|4028193|P1|STARTED|Waiting Period||645
1649443|NCT00737048|4028210|P3|NOT COMPLETED|Overall Study||4
1649444|NCT00737048|4028211|P2|NOT COMPLETED|Overall Study||6
1649445|NCT00737048|4028212|P1|NOT COMPLETED|Overall Study||3
1649446|NCT00737048|4028210|P3|COMPLETED|Overall Study||126
1649447|NCT00737048|4028211|P2|COMPLETED|Overall Study||60
1649448|NCT00737048|4028212|P1|COMPLETED|Overall Study||129
1649449|NCT00737048|4028210|P3|STARTED|Overall Study||130
1649450|NCT00737048|4028211|P2|STARTED|Overall Study||66
1649451|NCT00737048|4028212|P1|STARTED|Overall Study||132
1649452|NCT00736996|4028256|P3|NOT COMPLETED|Overall Study||2
1649453|NCT00736996|4028257|P2|NOT COMPLETED|Overall Study||9
1649454|NCT00736996|4028258|P1|NOT COMPLETED|Overall Study||1
1649455|NCT00736996|4028256|P3|COMPLETED|Overall Study||25
1649456|NCT00736996|4028257|P2|COMPLETED|Overall Study||17
1649457|NCT00736996|4028258|P1|COMPLETED|Overall Study||24
1649458|NCT00736996|4028256|P3|STARTED|Overall Study||27
1649459|NCT00736996|4028257|P2|STARTED|Overall Study||26
1649460|NCT00736996|4028258|P1|STARTED|Overall Study||25
1649461|NCT00736957|4028272|P1|NOT COMPLETED|Overall Study||122
1649462|NCT00736957|4028272|P1|COMPLETED|Overall Study||97
1649463|NCT00736957|4028272|P1|Treated|Overall Study||190
1649464|NCT00736957|4028272|P1|STARTED|Overall Study||219
1649465|NCT00736944|4028282|P1|NOT COMPLETED|Definitive Treatment||1
1649466|NCT00736944|4028282|P1|COMPLETED|Definitive Treatment||28
1649467|NCT00736944|4028282|P1|STARTED|Definitive Treatment||29
1649468|NCT00736944|4028282|P1|NOT COMPLETED|Induction||1
1649469|NCT00736944|4028282|P1|COMPLETED|Induction||29
1649470|NCT00736944|4028282|P1|STARTED|Induction||30
1649471|NCT00736879|4028313|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
1649472|NCT00736879|4028314|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
1649473|NCT00736879|4028315|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
1649474|NCT00736879|4028316|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
1649475|NCT00736879|4028313|P4|COMPLETED|Follow up Period - No Drug Treatment||62
1649476|NCT00736879|4028314|P3|COMPLETED|Follow up Period - No Drug Treatment||66
1649477|NCT00736879|4028315|P2|COMPLETED|Follow up Period - No Drug Treatment||67
1649478|NCT00736879|4028316|P1|COMPLETED|Follow up Period - No Drug Treatment||65
1649479|NCT00736879|4028313|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
1649480|NCT00736879|4028314|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
1649481|NCT00736879|4028315|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
1649482|NCT00736879|4028316|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
1649483|NCT00736879|4028313|P4|NOT COMPLETED|Double Blind Treatment Period||5
1649484|NCT00736879|4028314|P3|NOT COMPLETED|Double Blind Treatment Period||7
1649485|NCT00736879|4028315|P2|NOT COMPLETED|Double Blind Treatment Period||4
1649486|NCT00736879|4028316|P1|NOT COMPLETED|Double Blind Treatment Period||3
1649487|NCT00736879|4028313|P4|COMPLETED|Double Blind Treatment Period||63
1649488|NCT00736879|4028314|P3|COMPLETED|Double Blind Treatment Period||67
1649489|NCT00736879|4028315|P2|COMPLETED|Double Blind Treatment Period||68
1649490|NCT00736879|4028316|P1|COMPLETED|Double Blind Treatment Period||65
1649491|NCT00736879|4028313|P4|STARTED|Double Blind Treatment Period||68
1649492|NCT00736879|4028314|P3|STARTED|Double Blind Treatment Period||74
1649493|NCT00736879|4028315|P2|STARTED|Double Blind Treatment Period||72
1649494|NCT00736879|4028316|P1|STARTED|Double Blind Treatment Period||68
1649495|NCT00736853|4028370|P3|NOT COMPLETED|Double-Blind Period||48
1649496|NCT00736853|4028371|P2|NOT COMPLETED|Double-Blind Period||24
1649497|NCT00736853|4028372|P1|NOT COMPLETED|Double-Blind Period||0
1649498|NCT00736853|4028370|P3|COMPLETED|Double-Blind Period||45
1649499|NCT00736853|4028371|P2|COMPLETED|Double-Blind Period||70
1649500|NCT00736853|4028372|P1|COMPLETED|Double-Blind Period||0
1649501|NCT00736853|4028370|P3|STARTED|Double-Blind Period||93
1649502|NCT00736853|4028371|P2|STARTED|Double-Blind Period||94
1649503|NCT00736853|4028372|P1|STARTED|Double-Blind Period||0
1649504|NCT00736853|4028370|P3|NOT COMPLETED|Open-Label Period||0
1649505|NCT00736853|4028371|P2|NOT COMPLETED|Open-Label Period||0
1649506|NCT00736853|4028372|P1|NOT COMPLETED|Open-Label Period||132
1649507|NCT00736853|4028370|P3|COMPLETED|Open-Label Period||0
1649508|NCT00736853|4028371|P2|COMPLETED|Open-Label Period||0
1649509|NCT00736853|4028372|P1|COMPLETED|Open-Label Period||187
1649510|NCT00736853|4028370|P3|Treated|Open-Label Period||0
1649511|NCT00736853|4028371|P2|Treated|Open-Label Period||0
1649512|NCT00736853|4028372|P1|Treated|Open-Label Period||277
1649513|NCT00736853|4028370|P3|STARTED|Open-Label Period||0
1649514|NCT00736853|4028371|P2|STARTED|Open-Label Period||0
1649515|NCT00736853|4028372|P1|STARTED|Open-Label Period||319
1649516|NCT00736840|4028412|P1|NOT COMPLETED|Overall Study||13
1649517|NCT00736840|4028412|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
1649518|NCT00736840|4028412|P1|STARTED|Overall Study||414
1649519|NCT00736723|4028419|P2|NOT COMPLETED|Overall Study||3
1649520|NCT00736723|4028420|P1|NOT COMPLETED|Overall Study||4
1649521|NCT00736723|4028419|P2|COMPLETED|Overall Study||18
1649522|NCT00736723|4028420|P1|COMPLETED|Overall Study||26
1649523|NCT00736723|4028419|P2|STARTED|Overall Study||21
1649524|NCT00736723|4028420|P1|STARTED|Overall Study||30
1649525|NCT00736645|4028430|P4|NOT COMPLETED|Overall Study||0
1649526|NCT00736645|4028431|P3|NOT COMPLETED|Overall Study||0
1649527|NCT00736645|4028432|P2|NOT COMPLETED|Overall Study||2
1649528|NCT00736645|4028433|P1|NOT COMPLETED|Overall Study||0
1649529|NCT00736645|4028430|P4|COMPLETED|Overall Study||13
1649530|NCT00736645|4028431|P3|COMPLETED|Overall Study||14
1649531|NCT00736645|4028432|P2|COMPLETED|Overall Study||13
1649532|NCT00736645|4028433|P1|COMPLETED|Overall Study||13
1649533|NCT00736645|4028430|P4|STARTED|Overall Study||13
1649534|NCT00736645|4028431|P3|STARTED|Overall Study||14
1649535|NCT00736645|4028432|P2|STARTED|Overall Study||15
1649536|NCT00736645|4028433|P1|STARTED|Overall Study||13
1649537|NCT00736580|4028449|P2|NOT COMPLETED|Overall Study||0
1649538|NCT00736580|4028450|P1|NOT COMPLETED|Overall Study||0
1649539|NCT00736580|4028449|P2|COMPLETED|Overall Study||123
1649540|NCT00736580|4028450|P1|COMPLETED|Overall Study||117
1649541|NCT00736580|4028449|P2|STARTED|Overall Study||123
1649542|NCT00736580|4028450|P1|STARTED|Overall Study||117
1649543|NCT00736502|4028456|P1|NOT COMPLETED|Overall Study||65
1649544|NCT00736502|4028456|P1|COMPLETED|Overall Study||213
1649545|NCT00736502|4028456|P1|STARTED|Overall Study|Entered and treated.|278
1649546|NCT00736489|4028462|P6|NOT COMPLETED|Period 6||0
1649547|NCT00736489|4028463|P5|NOT COMPLETED|Period 6||0
1649548|NCT00736489|4028464|P4|NOT COMPLETED|Period 6||0
1649549|NCT00736489|4028465|P3|NOT COMPLETED|Period 6||0
1649550|NCT00736489|4028466|P2|NOT COMPLETED|Period 6||0
1649551|NCT00736489|4028467|P1|NOT COMPLETED|Period 6||0
1649552|NCT00736489|4028462|P6|COMPLETED|Period 6||5
1649553|NCT00736489|4028463|P5|COMPLETED|Period 6||7
1649554|NCT00736489|4028464|P4|COMPLETED|Period 6||7
1649555|NCT00736489|4028465|P3|COMPLETED|Period 6||6
1649556|NCT00736489|4028466|P2|COMPLETED|Period 6||5
1649557|NCT00736489|4028467|P1|COMPLETED|Period 6||5
1649558|NCT00736489|4028462|P6|STARTED|Period 6||5
1649559|NCT00736489|4028463|P5|STARTED|Period 6||7
1649560|NCT00736489|4028464|P4|STARTED|Period 6||7
1649561|NCT00736489|4028465|P3|STARTED|Period 6||6
1649562|NCT00736489|4028466|P2|STARTED|Period 6||5
1649563|NCT00736489|4028467|P1|STARTED|Period 6||5
1649564|NCT00736489|4028462|P6|NOT COMPLETED|Period 5||0
1649565|NCT00736489|4028463|P5|NOT COMPLETED|Period 5||0
1649566|NCT00736489|4028464|P4|NOT COMPLETED|Period 5||0
1649567|NCT00736489|4028465|P3|NOT COMPLETED|Period 5||0
1649568|NCT00736489|4028466|P2|NOT COMPLETED|Period 5||0
1649569|NCT00736489|4028467|P1|NOT COMPLETED|Period 5||0
1649570|NCT00736489|4028462|P6|COMPLETED|Period 5||5
1649571|NCT00736489|4028463|P5|COMPLETED|Period 5||7
1649572|NCT00736489|4028464|P4|COMPLETED|Period 5||7
1649573|NCT00736489|4028465|P3|COMPLETED|Period 5||6
1649574|NCT00736489|4028466|P2|COMPLETED|Period 5||5
1649575|NCT00736489|4028467|P1|COMPLETED|Period 5||5
1649576|NCT00736489|4028462|P6|STARTED|Period 5||5
1649577|NCT00736489|4028463|P5|STARTED|Period 5||7
1649578|NCT00736489|4028464|P4|STARTED|Period 5||7
1649579|NCT00736489|4028465|P3|STARTED|Period 5||6
1649580|NCT00736489|4028466|P2|STARTED|Period 5||5
1649581|NCT00736489|4028467|P1|STARTED|Period 5||5
1649582|NCT00736489|4028462|P6|NOT COMPLETED|Period 4||0
1649583|NCT00736489|4028463|P5|NOT COMPLETED|Period 4||0
1649584|NCT00736489|4028464|P4|NOT COMPLETED|Period 4||0
1649585|NCT00736489|4028465|P3|NOT COMPLETED|Period 4||0
1649586|NCT00736489|4028466|P2|NOT COMPLETED|Period 4||0
1649587|NCT00736489|4028467|P1|NOT COMPLETED|Period 4||0
1649588|NCT00736489|4028462|P6|COMPLETED|Period 4||5
1649589|NCT00736489|4028463|P5|COMPLETED|Period 4||7
1649590|NCT00736489|4028464|P4|COMPLETED|Period 4||7
1649591|NCT00736489|4028465|P3|COMPLETED|Period 4||6
1649592|NCT00736489|4028466|P2|COMPLETED|Period 4||5
1649593|NCT00736489|4028467|P1|COMPLETED|Period 4||5
1649594|NCT00736489|4028462|P6|STARTED|Period 4||5
1649595|NCT00736489|4028463|P5|STARTED|Period 4||7
1649596|NCT00736489|4028464|P4|STARTED|Period 4||7
1649597|NCT00736489|4028465|P3|STARTED|Period 4||6
1649598|NCT00736489|4028466|P2|STARTED|Period 4||5
1649599|NCT00736489|4028467|P1|STARTED|Period 4||5
1649600|NCT00736489|4028462|P6|NOT COMPLETED|Period 3||0
1649601|NCT00736489|4028463|P5|NOT COMPLETED|Period 3||0
1649602|NCT00736489|4028464|P4|NOT COMPLETED|Period 3||0
1649603|NCT00736489|4028465|P3|NOT COMPLETED|Period 3||0
1649604|NCT00736489|4028466|P2|NOT COMPLETED|Period 3||0
1649605|NCT00736489|4028467|P1|NOT COMPLETED|Period 3||0
1649606|NCT00736489|4028462|P6|COMPLETED|Period 3||5
1649607|NCT00736489|4028463|P5|COMPLETED|Period 3||7
1649608|NCT00736489|4028464|P4|COMPLETED|Period 3||7
1649609|NCT00736489|4028465|P3|COMPLETED|Period 3||6
1649610|NCT00736489|4028466|P2|COMPLETED|Period 3||5
1649611|NCT00736489|4028467|P1|COMPLETED|Period 3||5
1649612|NCT00736489|4028462|P6|STARTED|Period 3||5
1649613|NCT00736489|4028463|P5|STARTED|Period 3||7
1649614|NCT00736489|4028464|P4|STARTED|Period 3||7
1649615|NCT00736489|4028465|P3|STARTED|Period 3||6
1649616|NCT00736489|4028466|P2|STARTED|Period 3||5
1649617|NCT00736489|4028467|P1|STARTED|Period 3||5
1649618|NCT00736489|4028462|P6|NOT COMPLETED|Period 2||0
1649619|NCT00736489|4028463|P5|NOT COMPLETED|Period 2||0
1649620|NCT00736489|4028464|P4|NOT COMPLETED|Period 2||0
1649621|NCT00736489|4028465|P3|NOT COMPLETED|Period 2||0
1649622|NCT00736489|4028466|P2|NOT COMPLETED|Period 2||0
1649623|NCT00736489|4028467|P1|NOT COMPLETED|Period 2||0
1649624|NCT00736489|4028462|P6|COMPLETED|Period 2||5
1649625|NCT00736489|4028463|P5|COMPLETED|Period 2||7
1649626|NCT00736489|4028464|P4|COMPLETED|Period 2||7
1649627|NCT00736489|4028465|P3|COMPLETED|Period 2||6
1649628|NCT00736489|4028466|P2|COMPLETED|Period 2||5
1649629|NCT00736489|4028467|P1|COMPLETED|Period 2||5
1649630|NCT00736489|4028462|P6|STARTED|Period 2||5
1649631|NCT00736489|4028463|P5|STARTED|Period 2||7
1649632|NCT00736489|4028464|P4|STARTED|Period 2||7
1649633|NCT00736489|4028465|P3|STARTED|Period 2||6
1649634|NCT00736489|4028466|P2|STARTED|Period 2||5
1649635|NCT00736489|4028467|P1|STARTED|Period 2||5
1649636|NCT00736489|4028462|P6|NOT COMPLETED|Period 1||1
1649637|NCT00736489|4028463|P5|NOT COMPLETED|Period 1||0
1649638|NCT00736489|4028464|P4|NOT COMPLETED|Period 1||0
1649639|NCT00736489|4028465|P3|NOT COMPLETED|Period 1||0
1649640|NCT00736489|4028466|P2|NOT COMPLETED|Period 1||0
1649641|NCT00736489|4028467|P1|NOT COMPLETED|Period 1||1
1649642|NCT00736489|4028462|P6|COMPLETED|Period 1||5
1649643|NCT00736489|4028463|P5|COMPLETED|Period 1||7
1649644|NCT00736489|4028464|P4|COMPLETED|Period 1||7
1649645|NCT00736489|4028465|P3|COMPLETED|Period 1||6
1649646|NCT00736489|4028466|P2|COMPLETED|Period 1||5
1649647|NCT00736489|4028467|P1|COMPLETED|Period 1||5
1649648|NCT00736489|4028462|P6|STARTED|Period 1||6
1649649|NCT00736489|4028463|P5|STARTED|Period 1||7
1649650|NCT00736489|4028464|P4|STARTED|Period 1||7
1649651|NCT00736489|4028465|P3|STARTED|Period 1||6
1649652|NCT00736489|4028466|P2|STARTED|Period 1||5
1649653|NCT00736489|4028467|P1|STARTED|Period 1|Cross-over study|6
1649654|NCT00736476|4028621|P2|NOT COMPLETED|Overall Study||0
1649655|NCT00736476|4028622|P1|NOT COMPLETED|Overall Study||1
1649656|NCT00736476|4028621|P2|COMPLETED|Overall Study||27
1649657|NCT00736476|4028622|P1|COMPLETED|Overall Study||35
1649658|NCT00736476|4028621|P2|STARTED|Overall Study||27
1649659|NCT00736476|4028622|P1|STARTED|Overall Study||36
1649660|NCT00736450|4028642|P1|NOT COMPLETED|Overall Study||25
1649661|NCT00736450|4028642|P1|COMPLETED|Overall Study||12
1649662|NCT00736450|4028642|P1|STARTED|Overall Study||37
1649663|NCT00736385|4028650|P2|NOT COMPLETED|Overall Study||3
1649664|NCT00736385|4028651|P1|NOT COMPLETED|Overall Study||2
1649665|NCT00736385|4028650|P2|COMPLETED|Overall Study||2
1649666|NCT00736385|4028651|P1|COMPLETED|Overall Study||2
1649667|NCT00736385|4028650|P2|STARTED|Overall Study||5
1649668|NCT00736385|4028651|P1|STARTED|Overall Study||4
1649669|NCT00736333|4028663|P1|NOT COMPLETED|Overall Study||111
1649670|NCT00736333|4028663|P1|COMPLETED|Overall Study||56
1649671|NCT00736333|4028663|P1|STARTED|Overall Study||167
1649672|NCT00736255|4028674|P2|NOT COMPLETED|Overall Study||1
1649673|NCT00736255|4028675|P1|NOT COMPLETED|Overall Study||3
1649674|NCT00736255|4028674|P2|COMPLETED|Overall Study||14
1649675|NCT00736255|4028675|P1|COMPLETED|Overall Study||14
1649676|NCT00736255|4028674|P2|STARTED|Overall Study||15
1649677|NCT00736255|4028675|P1|STARTED|Overall Study||17
1649678|NCT00736242|4028693|P1|NOT COMPLETED|Overall Study||125
1649679|NCT00736242|4028693|P1|COMPLETED|Overall Study||107
1649680|NCT00736242|4028693|P1|Participants in Safety Analysis Set|Overall Study||229
1649681|NCT00736242|4028693|P1|STARTED|Overall Study||232
1649682|NCT00736229|4028707|P3|NOT COMPLETED|Overall Study||0
1649683|NCT00736229|4028708|P2|NOT COMPLETED|Overall Study||0
1649684|NCT00736229|4028709|P1|NOT COMPLETED|Overall Study||0
1649685|NCT00736229|4028707|P3|COMPLETED|Overall Study||84
1649686|NCT00736229|4028708|P2|COMPLETED|Overall Study||71
1649687|NCT00736229|4028709|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
1649688|NCT00736229|4028707|P3|STARTED|Overall Study|Historic Control|84
1649689|NCT00736229|4028708|P2|STARTED|Overall Study|Historic control|71
1649690|NCT00736229|4028709|P1|STARTED|Overall Study|Actively Enrolled|40
1649691|NCT00736190|4028722|P1|NOT COMPLETED|Overall Study||3
1649692|NCT00736190|4028722|P1|COMPLETED|Overall Study||87
1649693|NCT00736190|4028722|P1|STARTED|Overall Study||90
1649694|NCT00736125|4028737|P2|NOT COMPLETED|Overall Study||2
1649695|NCT00736125|4028738|P1|NOT COMPLETED|Overall Study||1
1649696|NCT00736125|4028737|P2|COMPLETED|Overall Study||8
1649697|NCT00736125|4028738|P1|COMPLETED|Overall Study||9
1649698|NCT00736125|4028737|P2|STARTED|Overall Study||10
1649699|NCT00736125|4028738|P1|STARTED|Overall Study||10
1649700|NCT00736099|4028748|P2|NOT COMPLETED|Overall Study||58
1649701|NCT00736099|4028749|P1|NOT COMPLETED|Overall Study||183
1649702|NCT00736099|4028748|P2|COMPLETED|Overall Study|Number who completed treatment.|531
1649703|NCT00736099|4028749|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
1649704|NCT00736099|4028748|P2|STARTED|Overall Study|Number who started treatment.|589
1649705|NCT00736099|4028749|P1|STARTED|Overall Study|Number who started treatment.|1532
1649706|NCT00736073|4028847|P2|NOT COMPLETED|Overall Study||0
1649707|NCT00736073|4028848|P1|NOT COMPLETED|Overall Study||0
1649708|NCT00736073|4028847|P2|COMPLETED|Overall Study||39
1649709|NCT00736073|4028848|P1|COMPLETED|Overall Study||34
1649710|NCT00736073|4028847|P2|STARTED|Overall Study||39
1649711|NCT00736073|4028848|P1|STARTED|Overall Study||34
1649712|NCT00736034|4028858|P1|NOT COMPLETED|Overall Study||2
1649713|NCT00736034|4028858|P1|COMPLETED|Overall Study||16
1649714|NCT00736034|4028858|P1|STARTED|Overall Study||18
1649715|NCT00735969|4028862|P1|NOT COMPLETED|Overall Study||0
1649716|NCT00735969|4028862|P1|COMPLETED|Overall Study||21
1649717|NCT00735969|4028862|P1|STARTED|Overall Study||21
1649718|NCT00735943|4028866|P1|NOT COMPLETED|Overall Study||2
1649719|NCT00735943|4028866|P1|COMPLETED|Overall Study||20
1649720|NCT00735943|4028866|P1|STARTED|Overall Study||22
1649721|NCT00735917|4028883|P1|NOT COMPLETED|Overall Study||0
1649722|NCT00735917|4028883|P1|COMPLETED|Overall Study||19
1649723|NCT00735917|4028883|P1|STARTED|Overall Study||19
1649724|NCT00735904|4028891|P1|NOT COMPLETED|Overall Study||38
1649725|NCT00735904|4028891|P1|COMPLETED|Overall Study||0
1649726|NCT00735904|4028891|P1|STARTED|Overall Study||38
1649727|NCT00735878|4028901|P3|NOT COMPLETED|Phase II- Determined Dose||0
1649728|NCT00735878|4028902|P2|NOT COMPLETED|Phase II- Determined Dose||0
1649729|NCT00735878|4028903|P1|NOT COMPLETED|Phase II- Determined Dose||0
1649730|NCT00735878|4028901|P3|COMPLETED|Phase II- Determined Dose||0
1649731|NCT00735878|4028902|P2|COMPLETED|Phase II- Determined Dose||7
1649732|NCT00735878|4028903|P1|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
1649733|NCT00735878|4028901|P3|STARTED|Phase II- Determined Dose||0
1649734|NCT00735878|4028902|P2|STARTED|Phase II- Determined Dose||7
1649735|NCT00735878|4028903|P1|STARTED|Phase II- Determined Dose||0
1649736|NCT00735878|4028901|P3|NOT COMPLETED|Phase I- Dose Determination||1
1649737|NCT00735878|4028902|P2|NOT COMPLETED|Phase I- Dose Determination||0
1649738|NCT00735878|4028903|P1|NOT COMPLETED|Phase I- Dose Determination||0
1649739|NCT00735878|4028901|P3|COMPLETED|Phase I- Dose Determination||4
1649740|NCT00735878|4028902|P2|COMPLETED|Phase I- Dose Determination||7
1649741|NCT00735878|4028903|P1|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
1649742|NCT00735878|4028901|P3|STARTED|Phase I- Dose Determination||5
1649743|NCT00735878|4028902|P2|STARTED|Phase I- Dose Determination||7
1649744|NCT00735878|4028903|P1|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
1649745|NCT00735839|4028916|P2|NOT COMPLETED|Overall Study||0
1649746|NCT00735839|4028917|P1|NOT COMPLETED|Overall Study||0
1649747|NCT00735839|4028916|P2|COMPLETED|Overall Study||10
1649748|NCT00735839|4028917|P1|COMPLETED|Overall Study||30
1649749|NCT00735839|4028916|P2|STARTED|Overall Study||10
1649750|NCT00735839|4028917|P1|STARTED|Overall Study||30
1649751|NCT00735826|4028925|P1|NOT COMPLETED|Overall Study||0
1649752|NCT00735826|4028925|P1|COMPLETED|Overall Study||10
1649753|NCT00735826|4028925|P1|STARTED|Overall Study||10
1649754|NCT00735787|4028933|P2|NOT COMPLETED|Period 2||1
1649755|NCT00735787|4028934|P1|NOT COMPLETED|Period 2||5
1649756|NCT00735787|4028933|P2|COMPLETED|Period 2||40
1649757|NCT00735787|4028934|P1|COMPLETED|Period 2||13
1649758|NCT00735787|4028933|P2|STARTED|Period 2||41
1649759|NCT00735787|4028934|P1|STARTED|Period 2||18
1649760|NCT00735787|4028933|P2|NOT COMPLETED|Period 1||8
1649761|NCT00735787|4028934|P1|NOT COMPLETED|Period 1||6
1649762|NCT00735787|4028933|P2|COMPLETED|Period 1||41
1649763|NCT00735787|4028934|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
1649764|NCT00735787|4028933|P2|STARTED|Period 1||49
1649765|NCT00735787|4028934|P1|STARTED|Period 1||23
1649766|NCT00735709|4028982|P4|NOT COMPLETED|Overall Study||18
1649767|NCT00735709|4028983|P3|NOT COMPLETED|Overall Study||11
1649768|NCT00735709|4028984|P2|NOT COMPLETED|Overall Study||13
1649769|NCT00735709|4028985|P1|NOT COMPLETED|Overall Study||13
1649770|NCT00735709|4028982|P4|COMPLETED|Overall Study||122
1649771|NCT00735709|4028983|P3|COMPLETED|Overall Study||129
1649772|NCT00735709|4028984|P2|COMPLETED|Overall Study||127
1649773|NCT00735709|4028985|P1|COMPLETED|Overall Study||127
1649774|NCT00735709|4028982|P4|Treated|Overall Study||139
1649775|NCT00735709|4028983|P3|Treated|Overall Study||140
1649776|NCT00735709|4028984|P2|Treated|Overall Study||140
1649777|NCT00735709|4028985|P1|Treated|Overall Study||140
1649778|NCT00735709|4028982|P4|STARTED|Overall Study||140
1649779|NCT00735709|4028983|P3|STARTED|Overall Study||140
1649780|NCT00735709|4028984|P2|STARTED|Overall Study||140
1649781|NCT00735709|4028985|P1|STARTED|Overall Study||140
1649782|NCT00735696|4029095|P1|NOT COMPLETED|Overall Study||2
1649783|NCT00735696|4029095|P1|COMPLETED|Overall Study||39
1649784|NCT00735696|4029095|P1|Received Any Quantity of Study Drug|Overall Study||40
1649785|NCT00735696|4029095|P1|STARTED|Overall Study||41
1649786|NCT00735670|4029109|P2|NOT COMPLETED|Overall Study||5
1649787|NCT00735670|4029110|P1|NOT COMPLETED|Overall Study||4
1649788|NCT00735670|4029109|P2|COMPLETED|Overall Study||6
1649789|NCT00735670|4029110|P1|COMPLETED|Overall Study||6
1649790|NCT00735670|4029109|P2|STARTED|Overall Study||11
1649791|NCT00735670|4029110|P1|STARTED|Overall Study||10
1649792|NCT00735644|4029123|P5|NOT COMPLETED|Overall Study||0
1649793|NCT00735644|4029124|P4|NOT COMPLETED|Overall Study||1
1649794|NCT00735644|4029125|P3|NOT COMPLETED|Overall Study||1
1649795|NCT00735644|4029126|P2|NOT COMPLETED|Overall Study||2
1649796|NCT00735644|4029127|P1|NOT COMPLETED|Overall Study||0
1649797|NCT00735644|4029123|P5|COMPLETED|Overall Study||102
1649798|NCT00735644|4029124|P4|COMPLETED|Overall Study||198
1649799|NCT00735644|4029125|P3|COMPLETED|Overall Study||295
1649800|NCT00735644|4029126|P2|COMPLETED|Overall Study||298
1649801|NCT00735644|4029127|P1|COMPLETED|Overall Study||303
1649802|NCT00735644|4029123|P5|STARTED|Overall Study||102
1649803|NCT00735644|4029124|P4|STARTED|Overall Study||199
1649804|NCT00735644|4029125|P3|STARTED|Overall Study||296
1649805|NCT00735644|4029126|P2|STARTED|Overall Study||300
1649806|NCT00735644|4029127|P1|STARTED|Overall Study||303
1649807|NCT00735618|4029164|P1|NOT COMPLETED|Overall Study||0
1649808|NCT00735618|4029164|P1|COMPLETED|Overall Study||19
1649809|NCT00735618|4029164|P1|STARTED|Overall Study||19
1649810|NCT00735553|4029171|P1|NOT COMPLETED|Overall Study||77
1649811|NCT00735553|4029171|P1|COMPLETED|Overall Study||0
1649812|NCT00735553|4029171|P1|STARTED|Overall Study||77
1649813|NCT00735475|4029181|P2|NOT COMPLETED|Overall Study||11
1649814|NCT00735475|4029182|P1|NOT COMPLETED|Overall Study||8
1649815|NCT00735475|4029181|P2|COMPLETED|Overall Study||626
1649816|NCT00735475|4029182|P1|COMPLETED|Overall Study||623
1649817|NCT00735475|4029181|P2|STARTED|Overall Study||637
1649818|NCT00735475|4029182|P1|STARTED|Overall Study||631
1649819|NCT00735462|4029203|P3|NOT COMPLETED|Overall Study||28
1649820|NCT00735462|4029204|P2|NOT COMPLETED|Overall Study||55
1649821|NCT00735462|4029205|P1|NOT COMPLETED|Overall Study||63
1649822|NCT00735462|4029203|P3|COMPLETED|Overall Study||77
1649823|NCT00735462|4029204|P2|COMPLETED|Overall Study||149
1649824|NCT00735462|4029205|P1|COMPLETED|Overall Study||139
1649825|NCT00735462|4029203|P3|STARTED|Overall Study||105
1649826|NCT00735462|4029204|P2|STARTED|Overall Study||204
1649827|NCT00735462|4029205|P1|STARTED|Overall Study||202
1649828|NCT00735449|4029218|P2|NOT COMPLETED|Overall Study||6
1649829|NCT00735449|4029219|P1|NOT COMPLETED|Overall Study||7
1649830|NCT00735449|4029218|P2|COMPLETED|Overall Study||96
1649831|NCT00735449|4029219|P1|COMPLETED|Overall Study||95
1649832|NCT00735449|4029218|P2|STARTED|Overall Study||102
1649833|NCT00735449|4029219|P1|STARTED|Overall Study||102
1649834|NCT00735436|4029233|P1|NOT COMPLETED|Overall Study||0
1649835|NCT00735436|4029233|P1|COMPLETED|Overall Study||18
1649836|NCT00735436|4029233|P1|STARTED|Overall Study||18
1649837|NCT00735397|4029242|P1|NOT COMPLETED|Overall Study||1183
1649838|NCT00735397|4029242|P1|COMPLETED|Overall Study||35
1649839|NCT00735397|4029242|P1|STARTED|Overall Study||1218
1649840|NCT00735371|4029256|P4|NOT COMPLETED|Overall Study||10
1649841|NCT00735371|4029257|P3|NOT COMPLETED|Overall Study||11
1649842|NCT00735371|4029258|P2|NOT COMPLETED|Overall Study||13
1649843|NCT00735371|4029259|P1|NOT COMPLETED|Overall Study||15
1649844|NCT00735371|4029256|P4|COMPLETED|Overall Study||69
1649845|NCT00735371|4029257|P3|COMPLETED|Overall Study||67
1649846|NCT00735371|4029258|P2|COMPLETED|Overall Study||66
1649847|NCT00735371|4029259|P1|COMPLETED|Overall Study||63
1649848|NCT00735371|4029256|P4|STARTED|Overall Study||79
1649849|NCT00735371|4029257|P3|STARTED|Overall Study||78
1649850|NCT00735371|4029258|P2|STARTED|Overall Study||79
1649851|NCT00735371|4029259|P1|STARTED|Overall Study||78
1649852|NCT00735306|4029277|P1|NOT COMPLETED|Overall Study||0
1649853|NCT00735306|4029277|P1|COMPLETED|Overall Study||12
1649854|NCT00735306|4029277|P1|STARTED|Overall Study||12
1649855|NCT00735254|4029287|P4|NOT COMPLETED|Overall Study||0
1649856|NCT00735254|4029288|P3|NOT COMPLETED|Overall Study||1
1649857|NCT00735254|4029289|P2|NOT COMPLETED|Overall Study||1
1649858|NCT00735254|4029290|P1|NOT COMPLETED|Overall Study||1
1649859|NCT00735254|4029287|P4|COMPLETED|Overall Study||0
1649860|NCT00735254|4029288|P3|COMPLETED|Overall Study||0
1649861|NCT00735254|4029289|P2|COMPLETED|Overall Study||0
1649862|NCT00735254|4029290|P1|COMPLETED|Overall Study||0
1649863|NCT00735254|4029287|P4|STARTED|Overall Study||0
1649864|NCT00735254|4029288|P3|STARTED|Overall Study||1
1649865|NCT00735254|4029289|P2|STARTED|Overall Study||1
1649866|NCT00735254|4029290|P1|STARTED|Overall Study||1
1649867|NCT00735072|4029302|P2|NOT COMPLETED|Overall Study||1
1649868|NCT00735072|4029303|P1|NOT COMPLETED|Overall Study||1
1649869|NCT00735072|4029302|P2|COMPLETED|Overall Study||21
1649870|NCT00735072|4029303|P1|COMPLETED|Overall Study||22
1649871|NCT00735072|4029302|P2|STARTED|Overall Study||22
1649872|NCT00735072|4029303|P1|STARTED|Overall Study||23
1649873|NCT00735007|4029309|P1|NOT COMPLETED|Overall Study||5
1649874|NCT00735007|4029309|P1|COMPLETED|Overall Study||101
1649875|NCT00735007|4029309|P1|STARTED|Overall Study||106
1649876|NCT00734994|4029334|P1|NOT COMPLETED|Overall Study||1
1649877|NCT00734994|4029334|P1|COMPLETED|Overall Study||14
1649878|NCT00734994|4029334|P1|STARTED|Overall Study||15
1649879|NCT00734968|4029341|P2|NOT COMPLETED|Overall Study||1
1649880|NCT00734968|4029342|P1|NOT COMPLETED|Overall Study||1
1649881|NCT00734968|4029341|P2|COMPLETED|Overall Study||75
1649882|NCT00734968|4029342|P1|COMPLETED|Overall Study||76
1649883|NCT00734968|4029341|P2|STARTED|Overall Study||76
1649884|NCT00734968|4029342|P1|STARTED|Overall Study||77
1649885|NCT00734929|4029354|P2|NOT COMPLETED|Overall Study||5
1649886|NCT00734929|4029355|P1|NOT COMPLETED|Overall Study||6
1649887|NCT00734929|4029354|P2|COMPLETED|Overall Study||53
1649888|NCT00734929|4029355|P1|COMPLETED|Overall Study||51
1649889|NCT00734929|4029354|P2|STARTED|Overall Study||58
1649890|NCT00734929|4029355|P1|STARTED|Overall Study||57
1649891|NCT00734903|4029385|P2|NOT COMPLETED|Overall Study||1
1649892|NCT00734903|4029386|P1|NOT COMPLETED|Overall Study||3
1649893|NCT00734903|4029385|P2|COMPLETED|Overall Study||32
1649894|NCT00734903|4029386|P1|COMPLETED|Overall Study||30
1649895|NCT00734903|4029385|P2|Completed 3-month Followup|Overall Study||15
1649896|NCT00734903|4029386|P1|Completed 3-month Followup|Overall Study||14
1649897|NCT00734903|4029385|P2|Completed End of Treatment Assessment|Overall Study||23
1649898|NCT00734903|4029386|P1|Completed End of Treatment Assessment|Overall Study||21
1649899|NCT00734903|4029385|P2|STARTED|Overall Study||33
1649900|NCT00734903|4029386|P1|STARTED|Overall Study||33
1649901|NCT00734851|4029412|P1|NOT COMPLETED|Overall Study||21
1649902|NCT00734851|4029412|P1|COMPLETED|Overall Study||13
1649903|NCT00734851|4029412|P1|STARTED|Overall Study||34
1649904|NCT00734799|4029424|P2|NOT COMPLETED|Overall Study||4
1649905|NCT00734799|4029425|P1|NOT COMPLETED|Overall Study||0
1649906|NCT00734799|4029424|P2|COMPLETED|Overall Study||9
1649907|NCT00734799|4029425|P1|COMPLETED|Overall Study||9
1649908|NCT00734799|4029424|P2|STARTED|Overall Study||13
1649909|NCT00734799|4029425|P1|STARTED|Overall Study||9
1649910|NCT00734747|4029433|P1|NOT COMPLETED|6 Month Follow-up||3
1649911|NCT00734747|4029433|P1|COMPLETED|6 Month Follow-up||66
1649912|NCT00734747|4029433|P1|STARTED|6 Month Follow-up||69
1649913|NCT00734747|4029433|P1|NOT COMPLETED|SRS Procedure||3
1649914|NCT00734747|4029433|P1|COMPLETED|SRS Procedure||69
1649915|NCT00734747|4029433|P1|STARTED|SRS Procedure||72
1649916|NCT00734734|4029440|P1|NOT COMPLETED|Overall Study||0
1649917|NCT00734734|4029440|P1|COMPLETED|Overall Study||64
1649918|NCT00734734|4029440|P1|STARTED|Overall Study||64
1649919|NCT00734656|4029447|P4|NOT COMPLETED|Lab Session 4||1
1649920|NCT00734656|4029448|P3|NOT COMPLETED|Lab Session 4||0
1649921|NCT00734656|4029449|P2|NOT COMPLETED|Lab Session 4||0
1649922|NCT00734656|4029450|P1|NOT COMPLETED|Lab Session 4||0
1649923|NCT00734656|4029447|P4|COMPLETED|Lab Session 4||19
1649924|NCT00734656|4029448|P3|COMPLETED|Lab Session 4||16
1649925|NCT00734656|4029449|P2|COMPLETED|Lab Session 4||18
1649926|NCT00734656|4029450|P1|COMPLETED|Lab Session 4||20
1649927|NCT00734656|4029447|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1649928|NCT00734656|4029448|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
1649929|NCT00734656|4029449|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
1649930|NCT00734656|4029450|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1649931|NCT00734656|4029447|P4|NOT COMPLETED|Washout 3||1
1649932|NCT00734656|4029448|P3|NOT COMPLETED|Washout 3||0
1649933|NCT00734656|4029449|P2|NOT COMPLETED|Washout 3||0
1649934|NCT00734656|4029450|P1|NOT COMPLETED|Washout 3||1
1649935|NCT00734656|4029447|P4|COMPLETED|Washout 3||18
1649936|NCT00734656|4029448|P3|COMPLETED|Washout 3||20
1649937|NCT00734656|4029449|P2|COMPLETED|Washout 3||19
1649938|NCT00734656|4029450|P1|COMPLETED|Washout 3||17
1649939|NCT00734656|4029447|P4|STARTED|Washout 3||19
1649940|NCT00734656|4029448|P3|STARTED|Washout 3||20
1649941|NCT00734656|4029449|P2|STARTED|Washout 3||19
1649942|NCT00734656|4029450|P1|STARTED|Washout 3||18
1649943|NCT00734656|4029447|P4|NOT COMPLETED|Lab Session 3||0
1649944|NCT00734656|4029448|P3|NOT COMPLETED|Lab Session 3||0
1649945|NCT00734656|4029449|P2|NOT COMPLETED|Lab Session 3||0
1649946|NCT00734656|4029450|P1|NOT COMPLETED|Lab Session 3||0
1649947|NCT00734656|4029447|P4|COMPLETED|Lab Session 3||19
1649948|NCT00734656|4029448|P3|COMPLETED|Lab Session 3||20
1649949|NCT00734656|4029449|P2|COMPLETED|Lab Session 3||19
1649950|NCT00734656|4029450|P1|COMPLETED|Lab Session 3||18
1649951|NCT00734656|4029447|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
1649952|NCT00734656|4029448|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1649953|NCT00734656|4029449|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
1649954|NCT00734656|4029450|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
1649955|NCT00734656|4029447|P4|NOT COMPLETED|Washout 2||0
1649956|NCT00734656|4029448|P3|NOT COMPLETED|Washout 2||1
1649957|NCT00734656|4029449|P2|NOT COMPLETED|Washout 2||1
1649958|NCT00734656|4029450|P1|NOT COMPLETED|Washout 2||1
1649959|NCT00734656|4029447|P4|COMPLETED|Washout 2||19
1649960|NCT00734656|4029448|P3|COMPLETED|Washout 2||20
1649961|NCT00734656|4029449|P2|COMPLETED|Washout 2||20
1649962|NCT00734656|4029450|P1|COMPLETED|Washout 2||17
1649963|NCT00734656|4029447|P4|STARTED|Washout 2||19
1649964|NCT00734656|4029448|P3|STARTED|Washout 2||21
1649965|NCT00734656|4029449|P2|STARTED|Washout 2||21
1649966|NCT00734656|4029450|P1|STARTED|Washout 2||18
1649967|NCT00734656|4029447|P4|NOT COMPLETED|Lab Session 2||1
1649968|NCT00734656|4029448|P3|NOT COMPLETED|Lab Session 2||0
1649969|NCT00734656|4029449|P2|NOT COMPLETED|Lab Session 2||0
1649970|NCT00734656|4029450|P1|NOT COMPLETED|Lab Session 2||1
1649971|NCT00734656|4029447|P4|COMPLETED|Lab Session 2||19
1649972|NCT00734656|4029448|P3|COMPLETED|Lab Session 2||21
1649973|NCT00734656|4029449|P2|COMPLETED|Lab Session 2||21
1649974|NCT00734656|4029450|P1|COMPLETED|Lab Session 2||18
1650064|NCT00734539|4029605|P2|STARTED|Long Term Follow up||138
1649975|NCT00734656|4029447|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1649976|NCT00734656|4029448|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
1649977|NCT00734656|4029449|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
1649978|NCT00734656|4029450|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
1649979|NCT00734656|4029447|P4|NOT COMPLETED|Washout 1||3
1649980|NCT00734656|4029448|P3|NOT COMPLETED|Washout 1||2
1649981|NCT00734656|4029449|P2|NOT COMPLETED|Washout 1||5
1649982|NCT00734656|4029450|P1|NOT COMPLETED|Washout 1||1
1649983|NCT00734656|4029447|P4|COMPLETED|Washout 1||18
1649984|NCT00734656|4029448|P3|COMPLETED|Washout 1||24
1649985|NCT00734656|4029449|P2|COMPLETED|Washout 1||18
1649986|NCT00734656|4029450|P1|COMPLETED|Washout 1||21
1649987|NCT00734656|4029447|P4|STARTED|Washout 1||21
1649988|NCT00734656|4029448|P3|STARTED|Washout 1||26
1649989|NCT00734656|4029449|P2|STARTED|Washout 1||23
1649990|NCT00734656|4029450|P1|STARTED|Washout 1||22
1649991|NCT00734656|4029447|P4|NOT COMPLETED|Lab Session 1||0
1649992|NCT00734656|4029448|P3|NOT COMPLETED|Lab Session 1||0
1649993|NCT00734656|4029449|P2|NOT COMPLETED|Lab Session 1||0
1649994|NCT00734656|4029450|P1|NOT COMPLETED|Lab Session 1||2
1649995|NCT00734656|4029447|P4|COMPLETED|Lab Session 1||21
1649996|NCT00734656|4029448|P3|COMPLETED|Lab Session 1||26
1649997|NCT00734656|4029449|P2|COMPLETED|Lab Session 1||23
1649998|NCT00734656|4029450|P1|COMPLETED|Lab Session 1||22
1649999|NCT00734656|4029447|P4|STARTED|Lab Session 1||21
1650000|NCT00734656|4029448|P3|STARTED|Lab Session 1||26
1650001|NCT00734656|4029449|P2|STARTED|Lab Session 1||23
1650002|NCT00734656|4029450|P1|STARTED|Lab Session 1||24
1650003|NCT00734630|4029474|P2|NOT COMPLETED|Overall Study||33
1650004|NCT00734630|4029475|P1|NOT COMPLETED|Overall Study||29
1650005|NCT00734630|4029474|P2|COMPLETED|Overall Study||200
1650006|NCT00734630|4029475|P1|COMPLETED|Overall Study||229
1650007|NCT00734630|4029474|P2|STARTED|Overall Study||233
1650008|NCT00734630|4029475|P1|STARTED|Overall Study||258
1650009|NCT00734617|4029485|P2|NOT COMPLETED|Overall Study||102
1650010|NCT00734617|4029486|P1|NOT COMPLETED|Overall Study||107
1650011|NCT00734617|4029485|P2|COMPLETED|Overall Study||128
1650012|NCT00734617|4029486|P1|COMPLETED|Overall Study||142
1650013|NCT00734617|4029485|P2|STARTED|Overall Study||230
1650014|NCT00734617|4029486|P1|STARTED|Overall Study||249
1650015|NCT00734604|4029498|P6|NOT COMPLETED|Overall Study||6
1650016|NCT00734604|4029499|P5|NOT COMPLETED|Overall Study||8
1650017|NCT00734604|4029500|P4|NOT COMPLETED|Overall Study||9
1650018|NCT00734604|4029501|P3|NOT COMPLETED|Overall Study||6
1650019|NCT00734604|4029502|P2|NOT COMPLETED|Overall Study||12
1650020|NCT00734604|4029503|P1|NOT COMPLETED|Overall Study||3
1650021|NCT00734604|4029498|P6|COMPLETED|Overall Study||58
1650022|NCT00734604|4029499|P5|COMPLETED|Overall Study||55
1650023|NCT00734604|4029500|P4|COMPLETED|Overall Study||54
1650024|NCT00734604|4029501|P3|COMPLETED|Overall Study||57
1650025|NCT00734604|4029502|P2|COMPLETED|Overall Study||51
1650026|NCT00734604|4029503|P1|COMPLETED|Overall Study||59
1650027|NCT00734604|4029498|P6|STARTED|Overall Study||64
1650028|NCT00734604|4029499|P5|STARTED|Overall Study||63
1650029|NCT00734604|4029500|P4|STARTED|Overall Study||63
1650030|NCT00734604|4029501|P3|STARTED|Overall Study||63
1650031|NCT00734604|4029502|P2|STARTED|Overall Study||63
1650032|NCT00734604|4029503|P1|STARTED|Overall Study||62
1650033|NCT00734591|4029553|P2|NOT COMPLETED|Prospective Period||44
1650034|NCT00734591|4029554|P1|NOT COMPLETED|Prospective Period||51
1650035|NCT00734591|4029553|P2|COMPLETED|Prospective Period||1229
1650036|NCT00734591|4029554|P1|COMPLETED|Prospective Period||1307
1650037|NCT00734591|4029553|P2|STARTED|Prospective Period||1273
1650038|NCT00734591|4029554|P1|STARTED|Prospective Period||1358
1650039|NCT00734591|4029553|P2|NOT COMPLETED|Screening for Prospective Period||2291
1650040|NCT00734591|4029554|P1|NOT COMPLETED|Screening for Prospective Period||2517
1650041|NCT00734591|4029553|P2|COMPLETED|Screening for Prospective Period||1273
1650042|NCT00734591|4029554|P1|COMPLETED|Screening for Prospective Period||1358
1650043|NCT00734591|4029553|P2|STARTED|Screening for Prospective Period||3564
1650044|NCT00734591|4029554|P1|STARTED|Screening for Prospective Period||3875
1650045|NCT00734591|4029553|P2|NOT COMPLETED|Retrospective Period||0
1650046|NCT00734591|4029554|P1|NOT COMPLETED|Retrospective Period||0
1650047|NCT00734591|4029553|P2|COMPLETED|Retrospective Period||3564
1650048|NCT00734591|4029554|P1|COMPLETED|Retrospective Period||3875
1650049|NCT00734591|4029553|P2|STARTED|Retrospective Period||3564
1650050|NCT00734591|4029554|P1|STARTED|Retrospective Period||3875
1650051|NCT00734578|4029569|P3|NOT COMPLETED|Overall Study||25
1650052|NCT00734578|4029570|P2|NOT COMPLETED|Overall Study||25
1650053|NCT00734578|4029571|P1|NOT COMPLETED|Overall Study||33
1650054|NCT00734578|4029569|P3|COMPLETED|Overall Study||129
1650055|NCT00734578|4029570|P2|COMPLETED|Overall Study||128
1650056|NCT00734578|4029571|P1|COMPLETED|Overall Study||121
1650057|NCT00734578|4029569|P3|STARTED|Overall Study||154
1650058|NCT00734578|4029570|P2|STARTED|Overall Study||153
1650059|NCT00734578|4029571|P1|STARTED|Overall Study||154
1650060|NCT00734539|4029605|P2|NOT COMPLETED|Long Term Follow up||31
1650061|NCT00734539|4029606|P1|NOT COMPLETED|Long Term Follow up||34
1650062|NCT00734539|4029605|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
1650063|NCT00734539|4029606|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
1650065|NCT00734539|4029606|P1|STARTED|Long Term Follow up||152
1650066|NCT00734539|4029605|P2|NOT COMPLETED|Main Study||35
1650067|NCT00734539|4029606|P1|NOT COMPLETED|Main Study||37
1650068|NCT00734539|4029605|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
1650069|NCT00734539|4029606|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
1650070|NCT00734539|4029605|P2|STARTED|Main Study||173
1650071|NCT00734539|4029606|P1|STARTED|Main Study||189
1650072|NCT00734500|4029634|P1|NOT COMPLETED|Overall Study||1
1650073|NCT00734500|4029634|P1|COMPLETED|Overall Study||14
1650074|NCT00734500|4029634|P1|STARTED|Overall Study||15
1650075|NCT00734474|4029648|P9|NOT COMPLETED|Overall Study||82
1650076|NCT00734474|4029649|P8|NOT COMPLETED|Overall Study||129
1650077|NCT00734474|4029650|P7|NOT COMPLETED|Overall Study||24
1650078|NCT00734474|4029651|P6|NOT COMPLETED|Overall Study||25
1650079|NCT00734474|4029652|P5|NOT COMPLETED|Overall Study||118
1650080|NCT00734474|4029653|P4|NOT COMPLETED|Overall Study||10
1650081|NCT00734474|4029654|P3|NOT COMPLETED|Overall Study||112
1650082|NCT00734474|4029655|P2|NOT COMPLETED|Overall Study||30
1650083|NCT00734474|4029656|P1|NOT COMPLETED|Overall Study||15
1650084|NCT00734474|4029648|P9|COMPLETED|Overall Study||95
1650085|NCT00734474|4029649|P8|COMPLETED|Overall Study||186
1650086|NCT00734474|4029650|P7|COMPLETED|Overall Study||0
1650087|NCT00734474|4029651|P6|COMPLETED|Overall Study||0
1650088|NCT00734474|4029652|P5|COMPLETED|Overall Study||184
1650089|NCT00734474|4029653|P4|COMPLETED|Overall Study||0
1650090|NCT00734474|4029654|P3|COMPLETED|Overall Study||192
1650091|NCT00734474|4029655|P2|COMPLETED|Overall Study||0
1650092|NCT00734474|4029656|P1|COMPLETED|Overall Study||0
1650093|NCT00734474|4029648|P9|Completed 52-Week Visit|Overall Study||112
1650094|NCT00734474|4029649|P8|Completed 52-Week Visit|Overall Study||238
1650095|NCT00734474|4029650|P7|Completed 52-Week Visit|Overall Study||0
1650096|NCT00734474|4029651|P6|Completed 52-Week Visit|Overall Study||0
1650097|NCT00734474|4029652|P5|Completed 52-Week Visit|Overall Study||243
1650098|NCT00734474|4029653|P4|Completed 52-Week Visit|Overall Study||0
1650099|NCT00734474|4029654|P3|Completed 52-Week Visit|Overall Study||238
1650100|NCT00734474|4029655|P2|Completed 52-Week Visit|Overall Study||0
1650101|NCT00734474|4029656|P1|Completed 52-Week Visit|Overall Study||0
1650102|NCT00734474|4029648|P9|Completed 26-Week Visit|Overall Study||124
1650103|NCT00734474|4029649|P8|Completed 26-Week Visit|Overall Study||270
1650104|NCT00734474|4029650|P7|Completed 26-Week Visit|Overall Study||2
1650105|NCT00734474|4029651|P6|Completed 26-Week Visit|Overall Study||2
1650106|NCT00734474|4029652|P5|Completed 26-Week Visit|Overall Study||268
1650107|NCT00734474|4029653|P4|Completed 26-Week Visit|Overall Study||2
1650108|NCT00734474|4029654|P3|Completed 26-Week Visit|Overall Study||258
1650109|NCT00734474|4029655|P2|Completed 26-Week Visit|Overall Study||0
1650110|NCT00734474|4029656|P1|Completed 26-Week Visit|Overall Study||0
1650111|NCT00734474|4029648|P9|Entered Study After Dose Decision Point|Overall Study||139
1650112|NCT00734474|4029649|P8|Entered Study After Dose Decision Point|Overall Study||273
1650113|NCT00734474|4029650|P7|Entered Study After Dose Decision Point|Overall Study||0
1650114|NCT00734474|4029651|P6|Entered Study After Dose Decision Point|Overall Study||0
1650115|NCT00734474|4029652|P5|Entered Study After Dose Decision Point|Overall Study||281
1650116|NCT00734474|4029653|P4|Entered Study After Dose Decision Point|Overall Study||0
1650117|NCT00734474|4029654|P3|Entered Study After Dose Decision Point|Overall Study||279
1650118|NCT00734474|4029655|P2|Entered Study After Dose Decision Point|Overall Study||0
1650119|NCT00734474|4029656|P1|Entered Study After Dose Decision Point|Overall Study||0
1650120|NCT00734474|4029648|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
1650121|NCT00734474|4029649|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
1650122|NCT00734474|4029650|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
1650123|NCT00734474|4029651|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
1650124|NCT00734474|4029652|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
1650125|NCT00734474|4029653|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
1650126|NCT00734474|4029654|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
1650127|NCT00734474|4029655|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
1650128|NCT00734474|4029656|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
1650129|NCT00734474|4029648|P9|Entered Study Before Dose Decision Point|Overall Study||38
1650130|NCT00734474|4029649|P8|Entered Study Before Dose Decision Point|Overall Study||42
1650131|NCT00734474|4029650|P7|Entered Study Before Dose Decision Point|Overall Study||24
1650132|NCT00734474|4029651|P6|Entered Study Before Dose Decision Point|Overall Study||25
1650133|NCT00734474|4029652|P5|Entered Study Before Dose Decision Point|Overall Study||21
1650134|NCT00734474|4029653|P4|Entered Study Before Dose Decision Point|Overall Study||10
1650135|NCT00734474|4029654|P3|Entered Study Before Dose Decision Point|Overall Study||25
1650136|NCT00734474|4029655|P2|Entered Study Before Dose Decision Point|Overall Study||30
1650137|NCT00734474|4029656|P1|Entered Study Before Dose Decision Point|Overall Study||15
1650138|NCT00734474|4029648|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
1650139|NCT00734474|4029649|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
1650140|NCT00734474|4029650|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
1650141|NCT00734474|4029651|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
1650142|NCT00734474|4029652|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
1650143|NCT00734474|4029653|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
1650144|NCT00734474|4029654|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
1650145|NCT00734474|4029655|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
1650146|NCT00734474|4029656|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
1650147|NCT00734474|4029648|P9|STARTED|Overall Study||177
1650148|NCT00734474|4029649|P8|STARTED|Overall Study||315
1650149|NCT00734474|4029650|P7|STARTED|Overall Study||24
1650150|NCT00734474|4029651|P6|STARTED|Overall Study||25
1650151|NCT00734474|4029652|P5|STARTED|Overall Study||302
1650152|NCT00734474|4029653|P4|STARTED|Overall Study||10
1650153|NCT00734474|4029654|P3|STARTED|Overall Study||304
1650154|NCT00734474|4029655|P2|STARTED|Overall Study||30
1650155|NCT00734474|4029656|P1|STARTED|Overall Study||15
1650156|NCT00734409|4029825|P2|NOT COMPLETED|Overall Study||0
1650157|NCT00734409|4029826|P1|NOT COMPLETED|Overall Study||0
1650158|NCT00734409|4029825|P2|COMPLETED|Overall Study||145
1650159|NCT00734409|4029826|P1|COMPLETED|Overall Study||155
1650160|NCT00734409|4029825|P2|STARTED|Overall Study||145
1650161|NCT00734409|4029826|P1|STARTED|Overall Study||155
1650162|NCT00734344|4029838|P2|NOT COMPLETED|Overall Study||0
1650163|NCT00734344|4029839|P1|NOT COMPLETED|Overall Study||0
1650164|NCT00734344|4029838|P2|COMPLETED|Overall Study||9
1650165|NCT00734344|4029839|P1|COMPLETED|Overall Study||9
1650166|NCT00734344|4029838|P2|STARTED|Overall Study||9
1650167|NCT00734344|4029839|P1|STARTED|Overall Study||9
1650168|NCT00734305|4029909|P7|NOT COMPLETED|Overall Study||0
1650169|NCT00734305|4029910|P6|NOT COMPLETED|Overall Study||0
1650170|NCT00734305|4029911|P5|NOT COMPLETED|Overall Study||0
1650171|NCT00734305|4029912|P4|NOT COMPLETED|Overall Study||0
1650172|NCT00734305|4029913|P3|NOT COMPLETED|Overall Study||0
1650173|NCT00734305|4029914|P2|NOT COMPLETED|Overall Study||0
1650174|NCT00734305|4029915|P1|NOT COMPLETED|Overall Study||1
1650175|NCT00734305|4029909|P7|COMPLETED|Overall Study||18
1650176|NCT00734305|4029910|P6|COMPLETED|Overall Study||4
1650177|NCT00734305|4029911|P5|COMPLETED|Overall Study||5
1650178|NCT00734305|4029912|P4|COMPLETED|Overall Study||3
1650179|NCT00734305|4029913|P3|COMPLETED|Overall Study||4
1650180|NCT00734305|4029914|P2|COMPLETED|Overall Study||3
1650181|NCT00734305|4029915|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
1650182|NCT00734305|4029909|P7|STARTED|Overall Study||18
1650183|NCT00734305|4029910|P6|STARTED|Overall Study||4
1650184|NCT00734305|4029911|P5|STARTED|Overall Study||5
1650185|NCT00734305|4029912|P4|STARTED|Overall Study||3
1650186|NCT00734305|4029913|P3|STARTED|Overall Study||4
1650187|NCT00734305|4029914|P2|STARTED|Overall Study||3
1650188|NCT00734305|4029915|P1|STARTED|Overall Study||7
1650189|NCT00734214|4029946|P2|NOT COMPLETED|Overall Study||4
1650190|NCT00734214|4029947|P1|NOT COMPLETED|Overall Study||4
1650191|NCT00734214|4029946|P2|COMPLETED|Overall Study||126
1650192|NCT00734214|4029947|P1|COMPLETED|Overall Study||124
1650193|NCT00734214|4029946|P2|STARTED|Overall Study||130
1650194|NCT00734214|4029947|P1|STARTED|Overall Study||128
1650195|NCT00734162|4029957|P4|NOT COMPLETED|Open-Label Phase||3
1650196|NCT00734162|4029958|P3|NOT COMPLETED|Open-Label Phase||1
1650197|NCT00734162|4029959|P2|NOT COMPLETED|Open-Label Phase||2
1650198|NCT00734162|4029960|P1|NOT COMPLETED|Open-Label Phase||3
1650199|NCT00734162|4029957|P4|COMPLETED|Open-Label Phase||36
1650200|NCT00734162|4029958|P3|COMPLETED|Open-Label Phase||12
1650201|NCT00734162|4029959|P2|COMPLETED|Open-Label Phase||39
1650202|NCT00734162|4029960|P1|COMPLETED|Open-Label Phase||7
1650203|NCT00734162|4029957|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
1650204|NCT00734162|4029958|P3|STARTED|Open-Label Phase||13
1650205|NCT00734162|4029959|P2|STARTED|Open-Label Phase||41
1650206|NCT00734162|4029960|P1|STARTED|Open-Label Phase||10
1650207|NCT00734162|4029957|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
1650208|NCT00734162|4029958|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
1650209|NCT00734162|4029959|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
1650210|NCT00734162|4029960|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
1650211|NCT00734162|4029957|P4|COMPLETED|Randomized Phase (Through Week 72)||37
1650212|NCT00734162|4029958|P3|COMPLETED|Randomized Phase (Through Week 72)||13
1650213|NCT00734162|4029959|P2|COMPLETED|Randomized Phase (Through Week 72)||41
1650214|NCT00734162|4029960|P1|COMPLETED|Randomized Phase (Through Week 72)||10
1650215|NCT00734162|4029957|P4|STARTED|Randomized Phase (Through Week 72)||41
1650216|NCT00734162|4029958|P3|STARTED|Randomized Phase (Through Week 72)||13
1650217|NCT00734162|4029959|P2|STARTED|Randomized Phase (Through Week 72)||42
1650218|NCT00734162|4029960|P1|STARTED|Randomized Phase (Through Week 72)||10
1650219|NCT00734149|4030184|P1|NOT COMPLETED|Overall Study||1
1650220|NCT00734149|4030184|P1|COMPLETED|Overall Study||44
1650221|NCT00734149|4030184|P1|STARTED|Overall Study||45
1650222|NCT00734097|4030191|P1|NOT COMPLETED|Open Label||16
1650223|NCT00734097|4030191|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
1650224|NCT00734097|4030191|P1|Per Protocol|Open Label||301
1650225|NCT00734097|4030191|P1|Full Analysis|Open Label||311
1650226|NCT00734097|4030191|P1|Safety Analysis|Open Label||317
1650227|NCT00734097|4030191|P1|STARTED|Open Label|Full analysis performed in 311|317
1650228|NCT00734097|4030191|P1|NOT COMPLETED|Screening||20
1650229|NCT00734097|4030191|P1|COMPLETED|Screening|20 participants were screening failure.|317
1650230|NCT00734097|4030191|P1|STARTED|Screening||337
1650231|NCT00734071|4030208|P2|NOT COMPLETED|Overall Study||27
1650232|NCT00734071|4030209|P1|NOT COMPLETED|Overall Study||38
1650233|NCT00734071|4030208|P2|COMPLETED|Overall Study||125
1650234|NCT00734071|4030209|P1|COMPLETED|Overall Study||114
1650235|NCT00734071|4030208|P2|Treated|Overall Study||148
1650236|NCT00734071|4030209|P1|Treated|Overall Study||151
1650237|NCT00734071|4030208|P2|STARTED|Overall Study||152
1650238|NCT00734071|4030209|P1|STARTED|Overall Study||152
1650239|NCT00734032|4030267|P4|NOT COMPLETED|Overall Study||0
1650240|NCT00734032|4030268|P3|NOT COMPLETED|Overall Study||0
1650241|NCT00734032|4030269|P2|NOT COMPLETED|Overall Study||1
1650242|NCT00734032|4030270|P1|NOT COMPLETED|Overall Study||0
1650243|NCT00734032|4030267|P4|COMPLETED|Overall Study||26
1650244|NCT00734032|4030268|P3|COMPLETED|Overall Study||28
1650245|NCT00734032|4030269|P2|COMPLETED|Overall Study||27
1650246|NCT00734032|4030270|P1|COMPLETED|Overall Study||25
1650247|NCT00734032|4030267|P4|STARTED|Overall Study||26
1650248|NCT00734032|4030268|P3|STARTED|Overall Study||28
1650249|NCT00734032|4030269|P2|STARTED|Overall Study||28
1650250|NCT00734032|4030270|P1|STARTED|Overall Study||25
1650251|NCT00733993|4030290|P2|NOT COMPLETED|Overall Study||0
1650252|NCT00733993|4030291|P1|NOT COMPLETED|Overall Study||0
1650253|NCT00733993|4030290|P2|COMPLETED|Overall Study||10
1650254|NCT00733993|4030291|P1|COMPLETED|Overall Study||13
1650255|NCT00733993|4030290|P2|STARTED|Overall Study||10
1650256|NCT00733993|4030291|P1|STARTED|Overall Study||13
1650257|NCT00733980|4030326|P2|NOT COMPLETED|Overall Study||21
1650258|NCT00733980|4030327|P1|NOT COMPLETED|Overall Study||22
1650259|NCT00733980|4030326|P2|COMPLETED|Overall Study||55
1650260|NCT00733980|4030327|P1|COMPLETED|Overall Study||52
1650261|NCT00733980|4030326|P2|STARTED|Overall Study||76
1650262|NCT00733980|4030327|P1|STARTED|Overall Study||74
1650263|NCT00733954|4030371|P2|NOT COMPLETED|Overall Study||2
1650264|NCT00733954|4030372|P1|NOT COMPLETED|Overall Study||8
1650265|NCT00733954|4030371|P2|COMPLETED|Overall Study||123
1650266|NCT00733954|4030372|P1|COMPLETED|Overall Study||116
1650267|NCT00733954|4030371|P2|STARTED|Overall Study||125
1650268|NCT00733954|4030372|P1|STARTED|Overall Study||124
1650269|NCT00733824|4030419|P5|NOT COMPLETED|Phase II||0
1650270|NCT00733824|4030420|P4|NOT COMPLETED|Phase II||0
1650271|NCT00733824|4030421|P3|NOT COMPLETED|Phase II||0
1650272|NCT00733824|4030422|P2|NOT COMPLETED|Phase II||0
1650273|NCT00733824|4030423|P1|NOT COMPLETED|Phase II||0
1650274|NCT00733824|4030419|P5|COMPLETED|Phase II||36
1650275|NCT00733824|4030420|P4|COMPLETED|Phase II||0
1650276|NCT00733824|4030421|P3|COMPLETED|Phase II||0
1650277|NCT00733824|4030422|P2|COMPLETED|Phase II||0
1650278|NCT00733824|4030423|P1|COMPLETED|Phase II||0
1650279|NCT00733824|4030419|P5|STARTED|Phase II||36
1650280|NCT00733824|4030420|P4|STARTED|Phase II||0
1650281|NCT00733824|4030421|P3|STARTED|Phase II||0
1650282|NCT00733824|4030422|P2|STARTED|Phase II||0
1650283|NCT00733824|4030423|P1|STARTED|Phase II||0
1650284|NCT00733824|4030419|P5|NOT COMPLETED|Phase I||0
1650285|NCT00733824|4030420|P4|NOT COMPLETED|Phase I||0
1650286|NCT00733824|4030421|P3|NOT COMPLETED|Phase I||0
1650287|NCT00733824|4030422|P2|NOT COMPLETED|Phase I||0
1650288|NCT00733824|4030423|P1|NOT COMPLETED|Phase I||1
1650289|NCT00733824|4030419|P5|COMPLETED|Phase I||0
1650290|NCT00733824|4030420|P4|COMPLETED|Phase I||6
1650291|NCT00733824|4030421|P3|COMPLETED|Phase I||6
1650292|NCT00733824|4030422|P2|COMPLETED|Phase I||3
1650293|NCT00733824|4030423|P1|COMPLETED|Phase I||9
1650294|NCT00733824|4030419|P5|STARTED|Phase I||0
1650295|NCT00733824|4030420|P4|STARTED|Phase I||6
1650296|NCT00733824|4030421|P3|STARTED|Phase I||6
1650297|NCT00733824|4030422|P2|STARTED|Phase I||3
1650298|NCT00733824|4030423|P1|STARTED|Phase I||10
1650299|NCT00733746|4030442|P1|NOT COMPLETED|Overall Study||5
1650300|NCT00733746|4030442|P1|COMPLETED|Overall Study||114
1650301|NCT00733746|4030442|P1|STARTED|Overall Study||119
1650302|NCT00733512|4030450|P1|NOT COMPLETED|Overall Study||0
1650303|NCT00733512|4030450|P1|COMPLETED|Overall Study||146
1650304|NCT00733512|4030450|P1|STARTED|Overall Study||146
1650305|NCT00733499|4030457|P2|NOT COMPLETED|24 Months Follow-up||1
1650306|NCT00733499|4030458|P1|NOT COMPLETED|24 Months Follow-up||0
1650307|NCT00733499|4030457|P2|COMPLETED|24 Months Follow-up||95
1650308|NCT00733499|4030458|P1|COMPLETED|24 Months Follow-up||99
1650309|NCT00733499|4030457|P2|STARTED|24 Months Follow-up||96
1650310|NCT00733499|4030458|P1|STARTED|24 Months Follow-up||99
1650311|NCT00733499|4030457|P2|NOT COMPLETED|12 Months Follow-up||1
1650312|NCT00733499|4030458|P1|NOT COMPLETED|12 Months Follow-up||2
1650313|NCT00733499|4030457|P2|COMPLETED|12 Months Follow-up||96
1650314|NCT00733499|4030458|P1|COMPLETED|12 Months Follow-up||99
1650315|NCT00733499|4030457|P2|STARTED|12 Months Follow-up||97
1650316|NCT00733499|4030458|P1|STARTED|12 Months Follow-up||101
1650317|NCT00733499|4030457|P2|NOT COMPLETED|6 Months Follow-up||3
1650318|NCT00733499|4030458|P1|NOT COMPLETED|6 Months Follow-up||0
1650319|NCT00733499|4030457|P2|COMPLETED|6 Months Follow-up||97
1650320|NCT00733499|4030458|P1|COMPLETED|6 Months Follow-up||101
1650321|NCT00733499|4030457|P2|STARTED|6 Months Follow-up||100
1650322|NCT00733499|4030458|P1|STARTED|6 Months Follow-up||101
1650323|NCT00733499|4030457|P2|NOT COMPLETED|3 Months Follow-up||2
1650324|NCT00733499|4030458|P1|NOT COMPLETED|3 Months Follow-up||1
1650325|NCT00733499|4030457|P2|COMPLETED|3 Months Follow-up||100
1650326|NCT00733499|4030458|P1|COMPLETED|3 Months Follow-up||101
1650327|NCT00733499|4030457|P2|STARTED|3 Months Follow-up||102
1650328|NCT00733499|4030458|P1|STARTED|3 Months Follow-up||102
1650329|NCT00733499|4030457|P2|NOT COMPLETED|Pre-operative||1
1650330|NCT00733499|4030458|P1|NOT COMPLETED|Pre-operative||0
1650331|NCT00733499|4030457|P2|COMPLETED|Pre-operative||102
1650332|NCT00733499|4030458|P1|COMPLETED|Pre-operative||102
1650333|NCT00733499|4030457|P2|STARTED|Pre-operative||103
1650334|NCT00733499|4030458|P1|STARTED|Pre-operative||102
1650335|NCT00733421|4030466|P2|NOT COMPLETED|Overall Study||1
1650336|NCT00733421|4030467|P1|NOT COMPLETED|Overall Study||1
1650337|NCT00733421|4030466|P2|COMPLETED|Overall Study|All but one randomised patient|49
1650338|NCT00733421|4030467|P1|COMPLETED|Overall Study|All but one randomsied patient|49
1650339|NCT00733421|4030466|P2|STARTED|Overall Study|November 2008|50
1650340|NCT00733421|4030467|P1|STARTED|Overall Study|November 2008|50
1650341|NCT00733408|4030489|P1|NOT COMPLETED|Overall Study||4
1650342|NCT00733408|4030489|P1|COMPLETED|Overall Study||55
1650343|NCT00733408|4030489|P1|STARTED|Overall Study||59
1650344|NCT00733369|4030501|P2|NOT COMPLETED|Overall Study||9
1650345|NCT00733369|4030502|P1|NOT COMPLETED|Overall Study||10
1650346|NCT00733369|4030501|P2|COMPLETED|Overall Study||47
1650347|NCT00733369|4030502|P1|COMPLETED|Overall Study||40
1650348|NCT00733369|4030501|P2|STARTED|Overall Study||56
1650349|NCT00733369|4030502|P1|STARTED|Overall Study||50
1650350|NCT00733356|4030618|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
1650351|NCT00733356|4030618|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
1650352|NCT00733356|4030618|P1|STARTED|Modified Lab School, Reading Evaluation||26
1650353|NCT00733356|4030618|P1|NOT COMPLETED|Vyvanse Dose Titration||2
1650354|NCT00733356|4030618|P1|COMPLETED|Vyvanse Dose Titration||26
1650355|NCT00733356|4030618|P1|STARTED|Vyvanse Dose Titration||28
1650356|NCT00733330|4030624|P2|NOT COMPLETED|Overall Study||4
1650357|NCT00733330|4030625|P1|NOT COMPLETED|Overall Study||2
1650358|NCT00733330|4030624|P2|COMPLETED|Overall Study||48
1650359|NCT00733330|4030625|P1|COMPLETED|Overall Study||30
1650360|NCT00733330|4030624|P2|STARTED|Overall Study||52
1650361|NCT00733330|4030625|P1|STARTED|Overall Study||32
1650362|NCT00733304|4030710|P3|NOT COMPLETED|Overall Study||5
1650363|NCT00733304|4030711|P2|NOT COMPLETED|Overall Study||3
1650364|NCT00733304|4030712|P1|NOT COMPLETED|Overall Study||7
1650365|NCT00733304|4030710|P3|COMPLETED|Overall Study||3
1650366|NCT00733304|4030711|P2|COMPLETED|Overall Study||12
1650367|NCT00733304|4030712|P1|COMPLETED|Overall Study||12
1650368|NCT00733304|4030710|P3|STARTED|Overall Study||8
1650369|NCT00733304|4030711|P2|STARTED|Overall Study||15
1650370|NCT00733304|4030712|P1|STARTED|Overall Study||19
1650371|NCT00733291|4030794|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1650372|NCT00733291|4030795|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1650373|NCT00733291|4030796|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1650374|NCT00733291|4030797|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1650375|NCT00733291|4030794|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1650376|NCT00733291|4030795|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1650377|NCT00733291|4030796|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1650378|NCT00733291|4030797|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
1650379|NCT00733291|4030794|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1650380|NCT00733291|4030795|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1650381|NCT00733291|4030796|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1650382|NCT00733291|4030797|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
1650383|NCT00733291|4030794|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
1650384|NCT00733291|4030795|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
1650385|NCT00733291|4030796|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
1650386|NCT00733291|4030797|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
1650387|NCT00733291|4030794|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
1650388|NCT00733291|4030795|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
1650389|NCT00733291|4030796|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
1650390|NCT00733291|4030797|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
1650391|NCT00733291|4030794|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
1650392|NCT00733291|4030795|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
1650393|NCT00733291|4030796|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
1650394|NCT00733291|4030797|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
1650395|NCT00733291|4030794|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1650396|NCT00733291|4030795|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1650397|NCT00733291|4030796|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1650398|NCT00733291|4030797|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1650399|NCT00733291|4030794|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
1650400|NCT00733291|4030795|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
1650401|NCT00733291|4030796|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
1650402|NCT00733291|4030797|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
1650403|NCT00733291|4030794|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
1650404|NCT00733291|4030795|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
1650405|NCT00733291|4030796|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
1650406|NCT00733291|4030797|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
1650407|NCT00733278|4030819|P1|NOT COMPLETED|Overall Study||0
1650408|NCT00733278|4030819|P1|COMPLETED|Overall Study||7
1650409|NCT00733278|4030819|P1|STARTED|Overall Study||7
1650410|NCT00733226|4030826|P2|NOT COMPLETED|Overall Study||0
1650411|NCT00733226|4030827|P1|NOT COMPLETED|Overall Study||5
1650412|NCT00733226|4030826|P2|COMPLETED|Overall Study||40
1650413|NCT00733226|4030827|P1|COMPLETED|Overall Study||35
1650414|NCT00733226|4030826|P2|STARTED|Overall Study||40
1650415|NCT00733226|4030827|P1|STARTED|Overall Study||40
1650416|NCT00733135|4030843|P1|NOT COMPLETED|Overall Study||2
1650417|NCT00733135|4030843|P1|COMPLETED|Overall Study||131
1650418|NCT00733135|4030843|P1|STARTED|Overall Study||133
1650419|NCT00733096|4030855|P3|NOT COMPLETED|Overall Study||0
1650420|NCT00733096|4030856|P2|NOT COMPLETED|Overall Study||0
1650421|NCT00733096|4030857|P1|NOT COMPLETED|Overall Study||0
1650422|NCT00733096|4030855|P3|COMPLETED|Overall Study||30
1650423|NCT00733096|4030856|P2|COMPLETED|Overall Study||26
1650424|NCT00733096|4030857|P1|COMPLETED|Overall Study||28
1650425|NCT00733096|4030855|P3|STARTED|Overall Study||30
1650426|NCT00733096|4030856|P2|STARTED|Overall Study||26
1650427|NCT00733096|4030857|P1|STARTED|Overall Study||28
1650428|NCT00733005|4030876|P2|NOT COMPLETED|Overall Study||3
1650429|NCT00733005|4030877|P1|NOT COMPLETED|Overall Study||2
1650430|NCT00733005|4030876|P2|COMPLETED|Overall Study||159
1650431|NCT00733005|4030877|P1|COMPLETED|Overall Study||160
1650432|NCT00733005|4030876|P2|STARTED|Overall Study||162
1650433|NCT00733005|4030877|P1|STARTED|Overall Study||162
1650434|NCT00732992|4030887|P2|NOT COMPLETED|Overall Study||6
1650435|NCT00732992|4030888|P1|NOT COMPLETED|Overall Study||6
1650436|NCT00732992|4030887|P2|COMPLETED|Overall Study||0
1650437|NCT00732992|4030888|P1|COMPLETED|Overall Study||0
1650438|NCT00732992|4030887|P2|STARTED|Overall Study||6
1650439|NCT00732992|4030888|P1|STARTED|Overall Study||6
1650440|NCT00732940|4030907|P2|NOT COMPLETED|Overall Study||3
1650441|NCT00732940|4030908|P1|NOT COMPLETED|Overall Study||2
1650442|NCT00732940|4030907|P2|COMPLETED|Overall Study||25
1650443|NCT00732940|4030908|P1|COMPLETED|Overall Study||26
1650444|NCT00732940|4030907|P2|STARTED|Overall Study||28
1650445|NCT00732940|4030908|P1|STARTED|Overall Study||28
1650446|NCT00732901|4030978|P2|NOT COMPLETED|Overall Study||0
1650447|NCT00732901|4030979|P1|NOT COMPLETED|Overall Study||0
1650448|NCT00732901|4030978|P2|COMPLETED|Overall Study||12
1650449|NCT00732901|4030979|P1|COMPLETED|Overall Study||11
1650450|NCT00732901|4030978|P2|STARTED|Overall Study||12
1650451|NCT00732901|4030979|P1|STARTED|Overall Study||11
1650452|NCT00732875|4030989|P1|NOT COMPLETED|Overall Study||35
1650453|NCT00732875|4030989|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
1650454|NCT00732875|4030989|P1|STARTED|Overall Study||92
1650455|NCT00732758|4030997|P2|NOT COMPLETED|Overall Study||16
1650456|NCT00732758|4030998|P1|NOT COMPLETED|Overall Study||8
1650457|NCT00732758|4030997|P2|COMPLETED|Overall Study||63
1650458|NCT00732758|4030998|P1|COMPLETED|Overall Study||70
1650459|NCT00732758|4030997|P2|STARTED|Overall Study||79
1650460|NCT00732758|4030998|P1|STARTED|Overall Study||78
1650461|NCT00732680|4031010|P1|NOT COMPLETED|Overall Study||0
1650462|NCT00732680|4031010|P1|COMPLETED|Overall Study||9
1650463|NCT00732680|4031010|P1|STARTED|Overall Study||9
1650464|NCT00732654|4031017|P3|NOT COMPLETED|Overall Study||0
1650465|NCT00732654|4031018|P2|NOT COMPLETED|Overall Study||1
1650466|NCT00732654|4031019|P1|NOT COMPLETED|Overall Study||0
1650467|NCT00732654|4031017|P3|COMPLETED|Overall Study||10
1650468|NCT00732654|4031018|P2|COMPLETED|Overall Study||9
1650469|NCT00732654|4031019|P1|COMPLETED|Overall Study||10
1650470|NCT00732654|4031017|P3|STARTED|Overall Study||10
1650471|NCT00732654|4031018|P2|STARTED|Overall Study||10
1650472|NCT00732654|4031019|P1|STARTED|Overall Study||10
1650473|NCT00732641|4031038|P2|NOT COMPLETED|Overall Study||112
1650474|NCT00732641|4031039|P1|NOT COMPLETED|Overall Study||106
1650475|NCT00732641|4031038|P2|COMPLETED|Overall Study||9
1650476|NCT00732641|4031039|P1|COMPLETED|Overall Study||17
1650477|NCT00732641|4031038|P2|STARTED|Overall Study||121
1650478|NCT00732641|4031039|P1|STARTED|Overall Study||123
1650479|NCT00732615|4031059|P2|NOT COMPLETED|Overall Study||5
1650480|NCT00732615|4031060|P1|NOT COMPLETED|Overall Study||7
1650481|NCT00732615|4031059|P2|COMPLETED|Overall Study||79
1650482|NCT00732615|4031060|P1|COMPLETED|Overall Study||33
1650483|NCT00732615|4031059|P2|STARTED|Overall Study||84
1650484|NCT00732615|4031060|P1|STARTED|Overall Study||40
1650485|NCT00732472|4031076|P4|NOT COMPLETED|Overall Study||3
1650486|NCT00732472|4031077|P3|NOT COMPLETED|Overall Study||1
1650487|NCT00732472|4031078|P2|NOT COMPLETED|Overall Study||3
1650488|NCT00732472|4031079|P1|NOT COMPLETED|Overall Study||0
1650489|NCT00732472|4031076|P4|COMPLETED|Overall Study||6
1650490|NCT00732472|4031077|P3|COMPLETED|Overall Study||9
1650491|NCT00732472|4031078|P2|COMPLETED|Overall Study||7
1650492|NCT00732472|4031079|P1|COMPLETED|Overall Study||9
1650493|NCT00732472|4031076|P4|STARTED|Overall Study||9
1650494|NCT00732472|4031077|P3|STARTED|Overall Study||10
1650495|NCT00732472|4031078|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
1650496|NCT00732472|4031079|P1|STARTED|Overall Study||9
1650497|NCT00732381|4031179|P2|NOT COMPLETED|Overall Study||1
1650498|NCT00732381|4031180|P1|NOT COMPLETED|Overall Study||2
1650499|NCT00732381|4031179|P2|COMPLETED|Overall Study||174
1650500|NCT00732381|4031180|P1|COMPLETED|Overall Study||174
1650501|NCT00732381|4031179|P2|STARTED|Overall Study||175
1650502|NCT00732381|4031180|P1|STARTED|Overall Study||176
1650503|NCT00732303|4031188|P1|NOT COMPLETED|Overall Study||2
1650504|NCT00732303|4031188|P1|COMPLETED|Overall Study||6
1650505|NCT00732303|4031188|P1|STARTED|Overall Study||8
1650506|NCT00732251|4031194|P1|NOT COMPLETED|Overall Study||7
1650507|NCT00732251|4031194|P1|COMPLETED|Overall Study||1
1650508|NCT00732251|4031194|P1|STARTED|Overall Study||8
1650509|NCT00732238|4031200|P2|NOT COMPLETED|Overall Study||1
1650510|NCT00732238|4031201|P1|NOT COMPLETED|Overall Study||5
1650511|NCT00732238|4031200|P2|COMPLETED|Overall Study||27
1650512|NCT00732238|4031201|P1|COMPLETED|Overall Study||28
1650513|NCT00732238|4031200|P2|STARTED|Overall Study||28
1650514|NCT00732238|4031201|P1|STARTED|Overall Study||33
1650515|NCT00732225|4031214|P5|NOT COMPLETED|Overall Study||6
1650516|NCT00732225|4031215|P4|NOT COMPLETED|Overall Study||4
1650517|NCT00732225|4031216|P3|NOT COMPLETED|Overall Study||3
1650518|NCT00732225|4031217|P2|NOT COMPLETED|Overall Study||8
1650519|NCT00732225|4031218|P1|NOT COMPLETED|Overall Study||11
1650520|NCT00732225|4031214|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
1650521|NCT00732225|4031215|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
1650522|NCT00732225|4031216|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
1650523|NCT00732225|4031217|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
1650524|NCT00732225|4031218|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
1650525|NCT00732225|4031214|P5|STARTED|Overall Study|55 eyes of 54 patients|54
1650526|NCT00732225|4031215|P4|STARTED|Overall Study|33 eyes of 33 patients|33
1650527|NCT00732225|4031216|P3|STARTED|Overall Study|26 eyes of 26 patients|26
1650528|NCT00732225|4031217|P2|STARTED|Overall Study|41 eyes of 40 patients|40
1650529|NCT00732225|4031218|P1|STARTED|Overall Study|76 eyes of 71 patients|71
1650530|NCT00732212|4031269|P2|NOT COMPLETED|Overall Study||0
1650531|NCT00732212|4031270|P1|NOT COMPLETED|Overall Study||0
1650532|NCT00732212|4031269|P2|COMPLETED|Overall Study||123
1650533|NCT00732212|4031270|P1|COMPLETED|Overall Study||112
1650534|NCT00732212|4031269|P2|Temporarily Suspended|Overall Study||50
1650535|NCT00732212|4031270|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
1650536|NCT00732212|4031269|P2|STARTED|Overall Study||123
1650537|NCT00732212|4031270|P1|STARTED|Overall Study||112
1650538|NCT00732199|4031302|P2|NOT COMPLETED|Overall Study||26
1650539|NCT00732199|4031303|P1|NOT COMPLETED|Overall Study||34
1650540|NCT00732199|4031302|P2|COMPLETED|Overall Study||16
1650541|NCT00732199|4031303|P1|COMPLETED|Overall Study||16
1650542|NCT00732199|4031302|P2|STARTED|Overall Study||42
1650543|NCT00732199|4031303|P1|STARTED|Overall Study||50
1650544|NCT00732160|4031318|P4|NOT COMPLETED|Overall Study||2
1650545|NCT00732160|4031319|P3|NOT COMPLETED|Overall Study||3
1650546|NCT00732160|4031320|P2|NOT COMPLETED|Overall Study||4
1650547|NCT00732160|4031321|P1|NOT COMPLETED|Overall Study||5
1650548|NCT00732160|4031318|P4|COMPLETED|Overall Study||3
1650549|NCT00732160|4031319|P3|COMPLETED|Overall Study||3
1650550|NCT00732160|4031320|P2|COMPLETED|Overall Study||1
1650551|NCT00732160|4031321|P1|COMPLETED|Overall Study||2
1650552|NCT00732160|4031318|P4|LS Aldosterone|Overall Study||5
1650553|NCT00732160|4031319|P3|LS Aldosterone|Overall Study||6
1650554|NCT00732160|4031320|P2|LS Aldosterone|Overall Study||1
1650555|NCT00732160|4031321|P1|LS Aldosterone|Overall Study||2
1650556|NCT00732160|4031318|P4|LS Vehicle|Overall Study||5
1650557|NCT00732160|4031319|P3|LS Vehicle|Overall Study||6
1650558|NCT00732160|4031320|P2|LS Vehicle|Overall Study||1
1650559|NCT00732160|4031321|P1|LS Vehicle|Overall Study||2
1650560|NCT00732160|4031318|P4|HS Aldosterone|Overall Study||3
1650561|NCT00732160|4031319|P3|HS Aldosterone|Overall Study||3
1650562|NCT00732160|4031320|P2|HS Aldosterone|Overall Study||5
1650563|NCT00732160|4031321|P1|HS Aldosterone|Overall Study||7
1650564|NCT00732160|4031318|P4|HS Vehicle|Overall Study||3
1650565|NCT00732160|4031319|P3|HS Vehicle|Overall Study||3
1650566|NCT00732160|4031320|P2|HS Vehicle|Overall Study||5
1650567|NCT00732160|4031321|P1|HS Vehicle|Overall Study||7
1650568|NCT00732160|4031318|P4|STARTED|Overall Study||5
1650569|NCT00732160|4031319|P3|STARTED|Overall Study||6
1650570|NCT00732160|4031320|P2|STARTED|Overall Study||5
1650571|NCT00732160|4031321|P1|STARTED|Overall Study||7
1650572|NCT00732069|4031335|P6|NOT COMPLETED|Third Study Drug||0
1650573|NCT00732069|4031336|P5|NOT COMPLETED|Third Study Drug||0
1650574|NCT00732069|4031337|P4|NOT COMPLETED|Third Study Drug||0
1650575|NCT00732069|4031338|P3|NOT COMPLETED|Third Study Drug||0
1650576|NCT00732069|4031339|P2|NOT COMPLETED|Third Study Drug||0
1650577|NCT00732069|4031340|P1|NOT COMPLETED|Third Study Drug||0
1650578|NCT00732069|4031335|P6|COMPLETED|Third Study Drug||2
1650579|NCT00732069|4031336|P5|COMPLETED|Third Study Drug||3
1650580|NCT00732069|4031337|P4|COMPLETED|Third Study Drug||2
1650581|NCT00732069|4031338|P3|COMPLETED|Third Study Drug||3
1650582|NCT00732069|4031339|P2|COMPLETED|Third Study Drug||3
1650583|NCT00732069|4031340|P1|COMPLETED|Third Study Drug||2
1650584|NCT00732069|4031335|P6|STARTED|Third Study Drug||2
1650585|NCT00732069|4031336|P5|STARTED|Third Study Drug||3
1650586|NCT00732069|4031337|P4|STARTED|Third Study Drug||2
1650587|NCT00732069|4031338|P3|STARTED|Third Study Drug||3
1650588|NCT00732069|4031339|P2|STARTED|Third Study Drug||3
1650589|NCT00732069|4031340|P1|STARTED|Third Study Drug||2
1650590|NCT00732069|4031335|P6|NOT COMPLETED|Washout After Second Study Drug||0
1650591|NCT00732069|4031336|P5|NOT COMPLETED|Washout After Second Study Drug||0
1650592|NCT00732069|4031337|P4|NOT COMPLETED|Washout After Second Study Drug||0
1650593|NCT00732069|4031338|P3|NOT COMPLETED|Washout After Second Study Drug||0
1650594|NCT00732069|4031339|P2|NOT COMPLETED|Washout After Second Study Drug||0
1650595|NCT00732069|4031340|P1|NOT COMPLETED|Washout After Second Study Drug||0
1650596|NCT00732069|4031335|P6|COMPLETED|Washout After Second Study Drug||2
1650597|NCT00732069|4031336|P5|COMPLETED|Washout After Second Study Drug||3
1650598|NCT00732069|4031337|P4|COMPLETED|Washout After Second Study Drug||2
1650599|NCT00732069|4031338|P3|COMPLETED|Washout After Second Study Drug||3
1650600|NCT00732069|4031339|P2|COMPLETED|Washout After Second Study Drug||3
1650601|NCT00732069|4031340|P1|COMPLETED|Washout After Second Study Drug||2
1650602|NCT00732069|4031335|P6|STARTED|Washout After Second Study Drug||2
1650603|NCT00732069|4031336|P5|STARTED|Washout After Second Study Drug||3
1650604|NCT00732069|4031337|P4|STARTED|Washout After Second Study Drug||2
1650605|NCT00732069|4031338|P3|STARTED|Washout After Second Study Drug||3
1650606|NCT00732069|4031339|P2|STARTED|Washout After Second Study Drug||3
1650607|NCT00732069|4031340|P1|STARTED|Washout After Second Study Drug||2
1650608|NCT00732069|4031335|P6|NOT COMPLETED|Second Study Drug||0
1650609|NCT00732069|4031336|P5|NOT COMPLETED|Second Study Drug||0
1650610|NCT00732069|4031337|P4|NOT COMPLETED|Second Study Drug||0
1650611|NCT00732069|4031338|P3|NOT COMPLETED|Second Study Drug||0
1650612|NCT00732069|4031339|P2|NOT COMPLETED|Second Study Drug||0
1650613|NCT00732069|4031340|P1|NOT COMPLETED|Second Study Drug||0
1650614|NCT00732069|4031335|P6|COMPLETED|Second Study Drug||2
1650615|NCT00732069|4031336|P5|COMPLETED|Second Study Drug||3
1650616|NCT00732069|4031337|P4|COMPLETED|Second Study Drug||2
1650617|NCT00732069|4031338|P3|COMPLETED|Second Study Drug||3
1650618|NCT00732069|4031339|P2|COMPLETED|Second Study Drug||3
1650619|NCT00732069|4031340|P1|COMPLETED|Second Study Drug||2
1650620|NCT00732069|4031335|P6|STARTED|Second Study Drug||2
1650621|NCT00732069|4031336|P5|STARTED|Second Study Drug||3
1650622|NCT00732069|4031337|P4|STARTED|Second Study Drug||2
1650623|NCT00732069|4031338|P3|STARTED|Second Study Drug||3
1650624|NCT00732069|4031339|P2|STARTED|Second Study Drug||3
1650625|NCT00732069|4031340|P1|STARTED|Second Study Drug||2
1650626|NCT00732069|4031335|P6|NOT COMPLETED|Washout After First Study Drug||0
1650627|NCT00732069|4031336|P5|NOT COMPLETED|Washout After First Study Drug||0
1650628|NCT00732069|4031337|P4|NOT COMPLETED|Washout After First Study Drug||0
1650629|NCT00732069|4031338|P3|NOT COMPLETED|Washout After First Study Drug||0
1650630|NCT00732069|4031339|P2|NOT COMPLETED|Washout After First Study Drug||0
1650631|NCT00732069|4031340|P1|NOT COMPLETED|Washout After First Study Drug||1
1650632|NCT00732069|4031335|P6|COMPLETED|Washout After First Study Drug||2
1650633|NCT00732069|4031336|P5|COMPLETED|Washout After First Study Drug||3
1650634|NCT00732069|4031337|P4|COMPLETED|Washout After First Study Drug||2
1650635|NCT00732069|4031338|P3|COMPLETED|Washout After First Study Drug||3
1650636|NCT00732069|4031339|P2|COMPLETED|Washout After First Study Drug||3
1650637|NCT00732069|4031340|P1|COMPLETED|Washout After First Study Drug||2
1650638|NCT00732069|4031335|P6|STARTED|Washout After First Study Drug||2
1650639|NCT00732069|4031336|P5|STARTED|Washout After First Study Drug||3
1650640|NCT00732069|4031337|P4|STARTED|Washout After First Study Drug||2
1650641|NCT00732069|4031338|P3|STARTED|Washout After First Study Drug||3
1650642|NCT00732069|4031339|P2|STARTED|Washout After First Study Drug||3
1650643|NCT00732069|4031340|P1|STARTED|Washout After First Study Drug||3
1650644|NCT00732069|4031335|P6|NOT COMPLETED|First Study Drug||0
1650645|NCT00732069|4031336|P5|NOT COMPLETED|First Study Drug||0
1650646|NCT00732069|4031337|P4|NOT COMPLETED|First Study Drug||0
1650647|NCT00732069|4031338|P3|NOT COMPLETED|First Study Drug||0
1650648|NCT00732069|4031339|P2|NOT COMPLETED|First Study Drug||0
1650649|NCT00732069|4031340|P1|NOT COMPLETED|First Study Drug||0
1650650|NCT00732069|4031335|P6|COMPLETED|First Study Drug||2
1650651|NCT00732069|4031336|P5|COMPLETED|First Study Drug||3
1650652|NCT00732069|4031337|P4|COMPLETED|First Study Drug||2
1650653|NCT00732069|4031338|P3|COMPLETED|First Study Drug||3
1650654|NCT00732069|4031339|P2|COMPLETED|First Study Drug||3
1650655|NCT00732069|4031340|P1|COMPLETED|First Study Drug||3
1650656|NCT00732069|4031335|P6|STARTED|First Study Drug||2
1650657|NCT00732069|4031336|P5|STARTED|First Study Drug||3
1650658|NCT00732069|4031337|P4|STARTED|First Study Drug||2
1650659|NCT00732069|4031338|P3|STARTED|First Study Drug||3
1650660|NCT00732069|4031339|P2|STARTED|First Study Drug||3
1650661|NCT00732069|4031340|P1|STARTED|First Study Drug||3
1650662|NCT00732030|4031351|P1|NOT COMPLETED|Overall Study||2
1650663|NCT00732030|4031351|P1|COMPLETED|Overall Study||24
1650664|NCT00732030|4031351|P1|STARTED|Overall Study||26
1650665|NCT00731939|4031358|P1|NOT COMPLETED|Overall Study||34
1650666|NCT00731939|4031358|P1|COMPLETED|Overall Study||90
1650667|NCT00731939|4031358|P1|STARTED|Overall Study||124
1650668|NCT00731874|4031408|P2|NOT COMPLETED|Overall Study||0
1650669|NCT00731874|4031409|P1|NOT COMPLETED|Overall Study||0
1650670|NCT00731874|4031408|P2|COMPLETED|Overall Study||13
1650671|NCT00731874|4031409|P1|COMPLETED|Overall Study||10
1650672|NCT00731874|4031408|P2|STARTED|Overall Study||13
1650673|NCT00731874|4031409|P1|STARTED|Overall Study||10
1650674|NCT00731822|4031435|P2|NOT COMPLETED|Overall Study||1
1650675|NCT00731822|4031436|P1|NOT COMPLETED|Overall Study||4
1650676|NCT00731822|4031435|P2|COMPLETED|Overall Study||39
1650677|NCT00731822|4031436|P1|COMPLETED|Overall Study||16
1650678|NCT00731822|4031435|P2|STARTED|Overall Study||40
1650679|NCT00731822|4031436|P1|STARTED|Overall Study||20
1650680|NCT00731783|4031450|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
1650681|NCT00731783|4031451|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
1650682|NCT00731783|4031450|P2|COMPLETED|12 Month Follow-Up Visit||58
1650683|NCT00731783|4031451|P1|COMPLETED|12 Month Follow-Up Visit||68
1650684|NCT00731783|4031450|P2|STARTED|12 Month Follow-Up Visit||65
1650685|NCT00731783|4031451|P1|STARTED|12 Month Follow-Up Visit||74
1650686|NCT00731783|4031450|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
1650687|NCT00731783|4031451|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
1650688|NCT00731783|4031450|P2|COMPLETED|Six Month Follow-Up Visit||64
1650689|NCT00731783|4031451|P1|COMPLETED|Six Month Follow-Up Visit||71
1650690|NCT00731783|4031450|P2|STARTED|Six Month Follow-Up Visit||67
1650691|NCT00731783|4031451|P1|STARTED|Six Month Follow-Up Visit||77
1650692|NCT00731783|4031450|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
1650693|NCT00731783|4031451|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
1650694|NCT00731783|4031450|P2|COMPLETED|Three Month Follow-Up Visit||57
1650695|NCT00731783|4031451|P1|COMPLETED|Three Month Follow-Up Visit||72
1650696|NCT00731783|4031450|P2|STARTED|Three Month Follow-Up Visit||73
1650697|NCT00731783|4031451|P1|STARTED|Three Month Follow-Up Visit||79
1650698|NCT00731783|4031450|P2|NOT COMPLETED|One Month Follow-Up Visit||22
1650699|NCT00731783|4031451|P1|NOT COMPLETED|One Month Follow-Up Visit||14
1650700|NCT00731783|4031450|P2|COMPLETED|One Month Follow-Up Visit||69
1650701|NCT00731783|4031451|P1|COMPLETED|One Month Follow-Up Visit||78
1650702|NCT00731783|4031450|P2|STARTED|One Month Follow-Up Visit||91
1650703|NCT00731783|4031451|P1|STARTED|One Month Follow-Up Visit||92
1650704|NCT00731731|4031474|P3|NOT COMPLETED|Overall Study||3
1650705|NCT00731731|4031475|P2|NOT COMPLETED|Overall Study||0
1650706|NCT00731731|4031476|P1|NOT COMPLETED|Overall Study||0
1650707|NCT00731731|4031474|P3|COMPLETED|Overall Study||107
1650708|NCT00731731|4031475|P2|COMPLETED|Overall Study||3
1650709|NCT00731731|4031476|P1|COMPLETED|Overall Study||12
1650710|NCT00731731|4031474|P3|STARTED|Overall Study||110
1650711|NCT00731731|4031475|P2|STARTED|Overall Study||3
1650712|NCT00731731|4031476|P1|STARTED|Overall Study||12
1650713|NCT00731692|4031494|P3|NOT COMPLETED|Extension Phase||301
1650714|NCT00731692|4031495|P2|NOT COMPLETED|Extension Phase||196
1650715|NCT00731692|4031496|P1|NOT COMPLETED|Extension Phase||74
1650716|NCT00731692|4031494|P3|COMPLETED|Extension Phase||0
1650717|NCT00731692|4031495|P2|COMPLETED|Extension Phase||0
1650718|NCT00731692|4031496|P1|COMPLETED|Extension Phase||0
1650719|NCT00731692|4031494|P3|STARTED|Extension Phase||301
1650720|NCT00731692|4031495|P2|STARTED|Extension Phase||196
1650721|NCT00731692|4031496|P1|STARTED|Extension Phase||74
1650722|NCT00731692|4031494|P3|NOT COMPLETED|Core Study (36 Months)||170
1650723|NCT00731692|4031495|P2|NOT COMPLETED|Core Study (36 Months)||116
1650724|NCT00731692|4031496|P1|NOT COMPLETED|Core Study (36 Months)||68
1650725|NCT00731692|4031494|P3|COMPLETED|Core Study (36 Months)||317
1650726|NCT00731692|4031495|P2|COMPLETED|Core Study (36 Months)||220
1650727|NCT00731692|4031496|P1|COMPLETED|Core Study (36 Months)||79
1650728|NCT00731692|4031494|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
1650729|NCT00731692|4031495|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
1650730|NCT00731692|4031496|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
1650731|NCT00731692|4031494|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
1650732|NCT00731692|4031495|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
1650733|NCT00731692|4031496|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
1650734|NCT00731692|4031494|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
1650735|NCT00731692|4031495|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
1650736|NCT00731692|4031496|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
1650737|NCT00731692|4031494|P3|Safety Set (SAF)|Core Study (36 Months)||487
1650738|NCT00731692|4031495|P2|Safety Set (SAF)|Core Study (36 Months)||336
1650739|NCT00731692|4031496|P1|Safety Set (SAF)|Core Study (36 Months)||0
1650740|NCT00731692|4031494|P3|STARTED|Core Study (36 Months)||487
1650741|NCT00731692|4031495|P2|STARTED|Core Study (36 Months)||336
1650742|NCT00731692|4031496|P1|STARTED|Core Study (36 Months)||147
1650743|NCT00731679|4031542|P2|NOT COMPLETED|Overall Study||26
1650744|NCT00731679|4031543|P1|NOT COMPLETED|Overall Study||22
1650745|NCT00731679|4031542|P2|COMPLETED|Overall Study||283
1650746|NCT00731679|4031543|P1|COMPLETED|Overall Study||292
1650747|NCT00731679|4031542|P2|STARTED|Overall Study||309
1650748|NCT00731679|4031543|P1|STARTED|Overall Study||314
1650749|NCT00731666|4031551|P1|NOT COMPLETED|Overall Study||12
1650750|NCT00731666|4031551|P1|COMPLETED|Overall Study||28
1650751|NCT00731666|4031551|P1|STARTED|Overall Study||40
1650752|NCT00731653|4031557|P1|NOT COMPLETED|Overall Study||9
1650753|NCT00731653|4031557|P1|COMPLETED|Overall Study||72
1650754|NCT00731653|4031557|P1|STARTED|Overall Study||81
1650755|NCT00731640|4031563|P2|NOT COMPLETED|Overall Study||0
1650756|NCT00731640|4031564|P1|NOT COMPLETED|Overall Study||0
1650757|NCT00731640|4031563|P2|COMPLETED|Overall Study||32
1650758|NCT00731640|4031564|P1|COMPLETED|Overall Study||20
1650759|NCT00731640|4031563|P2|STARTED|Overall Study||32
1650760|NCT00731640|4031564|P1|STARTED|Overall Study||20
1650761|NCT00731614|4031578|P2|NOT COMPLETED|Overall Study||13
1650762|NCT00731614|4031579|P1|NOT COMPLETED|Overall Study||7
1650763|NCT00731614|4031578|P2|COMPLETED|Overall Study||18
1650764|NCT00731614|4031579|P1|COMPLETED|Overall Study||16
1650765|NCT00731614|4031578|P2|12 Weeks Posttreatment|Overall Study||23
1650766|NCT00731614|4031579|P1|12 Weeks Posttreatment|Overall Study||18
1650767|NCT00731614|4031578|P2|End of Treatment|Overall Study||24
1650768|NCT00731614|4031579|P1|End of Treatment|Overall Study||16
1650769|NCT00731614|4031578|P2|STARTED|Overall Study||31
1650770|NCT00731614|4031579|P1|STARTED|Overall Study||23
1650771|NCT00731549|4031585|P1|NOT COMPLETED|Overall Study||223
1650772|NCT00731549|4031585|P1|COMPLETED|Overall Study||858
1650773|NCT00731549|4031585|P1|STARTED|Overall Study||1081
1650774|NCT00731484|4031598|P1|NOT COMPLETED|Overall Study||0
1650775|NCT00731484|4031598|P1|COMPLETED|Overall Study||233
1650776|NCT00731484|4031598|P1|STARTED|Overall Study||233
1650777|NCT00731341|4031602|P1|NOT COMPLETED|Overall Study||0
1650778|NCT00731341|4031602|P1|COMPLETED|Overall Study||3
1650779|NCT00731341|4031602|P1|STARTED|Overall Study||3
1650780|NCT00731211|4031611|P1|NOT COMPLETED|Overall Study||0
1650781|NCT00731211|4031611|P1|COMPLETED|Overall Study||55
1650782|NCT00731211|4031611|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
1650783|NCT00731198|4031618|P2|NOT COMPLETED|Overall Study||6
1650784|NCT00731198|4031619|P1|NOT COMPLETED|Overall Study||6
1650785|NCT00731198|4031618|P2|COMPLETED|Overall Study||319
1650786|NCT00731198|4031619|P1|COMPLETED|Overall Study||319
1650787|NCT00731198|4031618|P2|STARTED|Overall Study||325
1650788|NCT00731198|4031619|P1|STARTED|Overall Study||325
1650789|NCT00731133|4031625|P1|NOT COMPLETED|Overall Study||10
1650790|NCT00731133|4031625|P1|COMPLETED|Overall Study||5
1650791|NCT00731133|4031625|P1|STARTED|Overall Study||15
1650792|NCT00731120|4031633|P3|NOT COMPLETED|Overall Study||36
1650793|NCT00731120|4031634|P2|NOT COMPLETED|Overall Study||43
1650794|NCT00731120|4031635|P1|NOT COMPLETED|Overall Study||42
1650795|NCT00731120|4031633|P3|COMPLETED|Overall Study||116
1650796|NCT00731120|4031634|P2|COMPLETED|Overall Study||109
1650797|NCT00731120|4031635|P1|COMPLETED|Overall Study||111
1650798|NCT00731120|4031633|P3|Treated|Overall Study||152
1650799|NCT00731120|4031634|P2|Treated|Overall Study||151
1650800|NCT00731120|4031635|P1|Treated|Overall Study||153
1650801|NCT00731120|4031633|P3|STARTED|Overall Study||152
1650802|NCT00731120|4031634|P2|STARTED|Overall Study||152
1650803|NCT00731120|4031635|P1|STARTED|Overall Study||153
1650804|NCT00731094|4031672|P2|NOT COMPLETED|Overall Study||11
1650805|NCT00731094|4031673|P1|NOT COMPLETED|Overall Study||18
1650806|NCT00731094|4031672|P2|COMPLETED|Overall Study||105
1650807|NCT00731094|4031673|P1|COMPLETED|Overall Study||98
1650808|NCT00731094|4031672|P2|Month 6|Overall Study||107
1650809|NCT00731094|4031673|P1|Month 6|Overall Study||101
1650810|NCT00731094|4031672|P2|STARTED|Overall Study||116
1650811|NCT00731094|4031673|P1|STARTED|Overall Study||116
1650812|NCT00731055|4031743|P1|NOT COMPLETED|Overall Study||0
1650813|NCT00731055|4031743|P1|COMPLETED|Overall Study||16
1650814|NCT00731055|4031743|P1|Received Varenicline 2.0 mg|Overall Study||16
1650815|NCT00731055|4031743|P1|Received Varenicline 1.0 mg|Overall Study||16
1650816|NCT00731055|4031743|P1|Received Varenicline 0.5 mg|Overall Study||16
1650817|NCT00731055|4031743|P1|Received Placebo|Overall Study||16
1650818|NCT00731055|4031743|P1|STARTED|Overall Study|This is a within-subjects study design.|16
1650819|NCT00731042|4031752|P2|NOT COMPLETED|Second Intervention||2
1650820|NCT00731042|4031753|P1|NOT COMPLETED|Second Intervention||0
1650821|NCT00731042|4031752|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
1650822|NCT00731042|4031753|P1|COMPLETED|Second Intervention||16
1650823|NCT00731042|4031752|P2|STARTED|Second Intervention||17
1650824|NCT00731042|4031753|P1|STARTED|Second Intervention||16
1650825|NCT00731042|4031752|P2|NOT COMPLETED|Wash-out||0
1650826|NCT00731042|4031753|P1|NOT COMPLETED|Wash-out||0
1650827|NCT00731042|4031752|P2|COMPLETED|Wash-out||17
1650828|NCT00731042|4031753|P1|COMPLETED|Wash-out||16
1650829|NCT00731042|4031752|P2|STARTED|Wash-out||17
1650830|NCT00731042|4031753|P1|STARTED|Wash-out||16
1650831|NCT00731042|4031752|P2|NOT COMPLETED|First Intervention||0
1650832|NCT00731042|4031753|P1|NOT COMPLETED|First Intervention||0
1650833|NCT00731042|4031752|P2|COMPLETED|First Intervention||17
1650834|NCT00731042|4031753|P1|COMPLETED|First Intervention||16
1650835|NCT00731042|4031752|P2|STARTED|First Intervention||17
1650836|NCT00731042|4031753|P1|STARTED|First Intervention||16
1650837|NCT00730964|4031759|P1|NOT COMPLETED|Overall Study||0
1650838|NCT00730964|4031759|P1|COMPLETED|Overall Study||1039
1650839|NCT00730964|4031759|P1|STARTED|Overall Study||1039
1650840|NCT00730925|4031764|P1|NOT COMPLETED|Overall Study||41
1650841|NCT00730925|4031764|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
1650842|NCT00730925|4031764|P1|STARTED|Overall Study||41
1650843|NCT00730912|4031774|P3|NOT COMPLETED|Overall Study||1
1650844|NCT00730912|4031775|P2|NOT COMPLETED|Overall Study||0
1650845|NCT00730912|4031776|P1|NOT COMPLETED|Overall Study||0
1650846|NCT00730912|4031774|P3|COMPLETED|Overall Study||103
1650847|NCT00730912|4031775|P2|COMPLETED|Overall Study||104
1650848|NCT00730912|4031776|P1|COMPLETED|Overall Study||53
1650849|NCT00730912|4031774|P3|STARTED|Overall Study||104
1650850|NCT00730912|4031775|P2|STARTED|Overall Study||104
1650851|NCT00730912|4031776|P1|STARTED|Overall Study||53
1650852|NCT00730886|4031789|P2|NOT COMPLETED|Overall Study||0
1650853|NCT00730886|4031790|P1|NOT COMPLETED|Overall Study||2
1650854|NCT00730886|4031789|P2|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
1650855|NCT00730886|4031790|P1|COMPLETED|Overall Study||0
1650856|NCT00730886|4031789|P2|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
1650857|NCT00730886|4031790|P1|STARTED|Overall Study||2
1650858|NCT00730847|4031814|P1|NOT COMPLETED|Overall Study||131
1650859|NCT00730847|4031814|P1|COMPLETED|Overall Study||465
1650860|NCT00730847|4031814|P1|STARTED|Overall Study||596
1650861|NCT00730756|4031823|P2|NOT COMPLETED|Overall Study||5
1650862|NCT00730756|4031824|P1|NOT COMPLETED|Overall Study||4
1650863|NCT00730756|4031823|P2|COMPLETED|Overall Study||48
1650864|NCT00730756|4031824|P1|COMPLETED|Overall Study||45
1650865|NCT00730756|4031823|P2|STARTED|Overall Study||53
1650866|NCT00730756|4031824|P1|STARTED|Overall Study||49
1650867|NCT00730730|4031846|P1|NOT COMPLETED|Overall Study||0
1650868|NCT00730730|4031846|P1|COMPLETED|Overall Study||50
1650869|NCT00730730|4031846|P1|STARTED|Overall Study||50
1650870|NCT00730691|4031858|P5|NOT COMPLETED|Overall Study||50
1650871|NCT00730691|4031859|P4|NOT COMPLETED|Overall Study||45
1650872|NCT00730691|4031860|P3|NOT COMPLETED|Overall Study||39
1650873|NCT00730691|4031861|P2|NOT COMPLETED|Overall Study||36
1650874|NCT00730691|4031862|P1|NOT COMPLETED|Overall Study||36
1650875|NCT00730691|4031858|P5|COMPLETED|Overall Study||106
1650876|NCT00730691|4031859|P4|COMPLETED|Overall Study||111
1650877|NCT00730691|4031860|P3|COMPLETED|Overall Study||117
1650878|NCT00730691|4031861|P2|COMPLETED|Overall Study||120
1650879|NCT00730691|4031862|P1|COMPLETED|Overall Study||121
1650880|NCT00730691|4031858|P5|STARTED|Overall Study||156
1650881|NCT00730691|4031859|P4|STARTED|Overall Study||156
1650882|NCT00730691|4031860|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
1650883|NCT00730691|4031861|P2|STARTED|Overall Study||156
1650884|NCT00730691|4031862|P1|STARTED|Overall Study||157
1650885|NCT00730639|4031954|P5|NOT COMPLETED|Overall Study||131
1650886|NCT00730639|4031955|P4|NOT COMPLETED|Overall Study||54
1650887|NCT00730639|4031956|P3|NOT COMPLETED|Overall Study||86
1650888|NCT00730639|4031957|P2|NOT COMPLETED|Overall Study||18
1650889|NCT00730639|4031958|P1|NOT COMPLETED|Overall Study||17
1650890|NCT00730639|4031954|P5|COMPLETED|Overall Study||0
1650891|NCT00730639|4031955|P4|COMPLETED|Overall Study||0
1650892|NCT00730639|4031956|P3|COMPLETED|Overall Study||0
1650893|NCT00730639|4031957|P2|COMPLETED|Overall Study||0
1650894|NCT00730639|4031958|P1|COMPLETED|Overall Study||0
1650895|NCT00730639|4031954|P5|STARTED|Overall Study||131
1650896|NCT00730639|4031955|P4|STARTED|Overall Study||54
1650897|NCT00730639|4031956|P3|STARTED|Overall Study||86
1650898|NCT00730639|4031957|P2|STARTED|Overall Study||18
1650899|NCT00730639|4031958|P1|STARTED|Overall Study||17
1650900|NCT00730483|4032022|P1|NOT COMPLETED|Overall Study||7
1650901|NCT00730483|4032022|P1|COMPLETED|Overall Study||6
1650902|NCT00730483|4032022|P1|6 Months After First DEB-TACE|Overall Study||10
1650903|NCT00730483|4032022|P1|1 Month After First DEB-TACE|Overall Study||13
1650904|NCT00730483|4032022|P1|STARTED|Overall Study||13
1650905|NCT00730405|4032035|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
1650906|NCT00730405|4032036|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
1650907|NCT00730405|4032037|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
1650908|NCT00730405|4032038|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
1650909|NCT00730405|4032039|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
1650910|NCT00730405|4032035|P5|COMPLETED|Overall Study-follow-up Phase||93
1650911|NCT00730405|4032036|P4|COMPLETED|Overall Study-follow-up Phase||100
1650912|NCT00730405|4032037|P3|COMPLETED|Overall Study-follow-up Phase||94
1650913|NCT00730405|4032038|P2|COMPLETED|Overall Study-follow-up Phase||96
1650914|NCT00730405|4032039|P1|COMPLETED|Overall Study-follow-up Phase||95
1650915|NCT00730405|4032035|P5|STARTED|Overall Study-follow-up Phase||115
1650916|NCT00730405|4032036|P4|STARTED|Overall Study-follow-up Phase||117
1650917|NCT00730405|4032037|P3|STARTED|Overall Study-follow-up Phase||117
1650918|NCT00730405|4032038|P2|STARTED|Overall Study-follow-up Phase||117
1650919|NCT00730405|4032039|P1|STARTED|Overall Study-follow-up Phase||116
1650920|NCT00730405|4032035|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
1650921|NCT00730405|4032036|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
1650922|NCT00730405|4032037|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
1650923|NCT00730405|4032038|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
1650924|NCT00730405|4032039|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
1650925|NCT00730405|4032035|P5|COMPLETED|Overall Study-Treatment Phase||95
1650926|NCT00730405|4032036|P4|COMPLETED|Overall Study-Treatment Phase||98
1650927|NCT00730405|4032037|P3|COMPLETED|Overall Study-Treatment Phase||96
1650928|NCT00730405|4032038|P2|COMPLETED|Overall Study-Treatment Phase||96
1650929|NCT00730405|4032039|P1|COMPLETED|Overall Study-Treatment Phase||97
1650930|NCT00730405|4032035|P5|STARTED|Overall Study-Treatment Phase||115
1650931|NCT00730405|4032036|P4|STARTED|Overall Study-Treatment Phase||117
1650932|NCT00730405|4032037|P3|STARTED|Overall Study-Treatment Phase||117
1650933|NCT00730405|4032038|P2|STARTED|Overall Study-Treatment Phase||117
1650934|NCT00730405|4032039|P1|STARTED|Overall Study-Treatment Phase||116
1650935|NCT00730353|4032076|P1|NOT COMPLETED|Overall Study||0
1650936|NCT00730353|4032076|P1|COMPLETED|Overall Study||28
1650937|NCT00730353|4032076|P1|STARTED|Overall Study||28
1650938|NCT00730327|4032086|P2|NOT COMPLETED|Overall Study||37
1650939|NCT00730327|4032087|P1|NOT COMPLETED|Overall Study||27
1650940|NCT00730327|4032086|P2|COMPLETED|Overall Study||93
1650941|NCT00730327|4032087|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
1650942|NCT00730327|4032086|P2|Completed Week 26|Overall Study||99
1650943|NCT00730327|4032087|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
1650944|NCT00730327|4032086|P2|STARTED|Overall Study||130
1650945|NCT00730327|4032087|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
1650946|NCT00730275|4032112|P4|NOT COMPLETED|Overall Study||1
1650947|NCT00730275|4032113|P3|NOT COMPLETED|Overall Study||0
1650948|NCT00730275|4032114|P2|NOT COMPLETED|Overall Study||0
1650949|NCT00730275|4032115|P1|NOT COMPLETED|Overall Study||0
1650950|NCT00730275|4032112|P4|COMPLETED|Overall Study||8
1650951|NCT00730275|4032113|P3|COMPLETED|Overall Study||8
1650952|NCT00730275|4032114|P2|COMPLETED|Overall Study||9
1650953|NCT00730275|4032115|P1|COMPLETED|Overall Study||9
1650954|NCT00730275|4032112|P4|STARTED|Overall Study||9
1650955|NCT00730275|4032113|P3|STARTED|Overall Study||8
1650956|NCT00730275|4032114|P2|STARTED|Overall Study||9
1650957|NCT00730275|4032115|P1|STARTED|Overall Study||9
1650958|NCT00730236|4032141|P1|NOT COMPLETED|Overall Study||6
1650959|NCT00730236|4032141|P1|COMPLETED|Overall Study||23
1650960|NCT00730236|4032141|P1|STARTED|Overall Study||29
1650961|NCT00730171|4032156|P1|NOT COMPLETED|Overall Study||771
1650962|NCT00730171|4032156|P1|COMPLETED|Overall Study||954
1650963|NCT00730171|4032156|P1|IBS-C Safety Population|Overall Study||1119
1650964|NCT00730171|4032156|P1|CC Safety Population|Overall Study||607
1650965|NCT00730171|4032156|P1|STARTED|Overall Study||1725
1650966|NCT00730132|4032164|P1|NOT COMPLETED|Overall Study||155
1650967|NCT00730132|4032164|P1|COMPLETED|Overall Study||557
1650968|NCT00730132|4032164|P1|STARTED|Overall Study||712
1650969|NCT00730041|4032182|P2|NOT COMPLETED|Overall Study||2
1650970|NCT00730041|4032183|P1|NOT COMPLETED|Overall Study||0
1650971|NCT00730041|4032182|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
1650972|NCT00730041|4032183|P1|COMPLETED|Overall Study||26
1650973|NCT00730041|4032182|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
1650974|NCT00730041|4032183|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
1650975|NCT00730028|4032206|P5|NOT COMPLETED|Overall Study||82
1650976|NCT00730028|4032207|P4|NOT COMPLETED|Overall Study||56
1650977|NCT00730028|4032208|P3|NOT COMPLETED|Overall Study||45
1650978|NCT00730028|4032209|P2|NOT COMPLETED|Overall Study||66
1650979|NCT00730028|4032210|P1|NOT COMPLETED|Overall Study||60
1650980|NCT00730028|4032206|P5|COMPLETED|Overall Study||175
1650981|NCT00730028|4032207|P4|COMPLETED|Overall Study||207
1650982|NCT00730028|4032208|P3|COMPLETED|Overall Study||221
1650983|NCT00730028|4032209|P2|COMPLETED|Overall Study||194
1650984|NCT00730028|4032210|P1|COMPLETED|Overall Study||204
1650985|NCT00730028|4032206|P5|STARTED|Overall Study||257
1650986|NCT00730028|4032207|P4|STARTED|Overall Study||263
1650987|NCT00730028|4032208|P3|STARTED|Overall Study||266
1650988|NCT00730028|4032209|P2|STARTED|Overall Study||260
1650989|NCT00730028|4032210|P1|STARTED|Overall Study||264
1650990|NCT00730015|4032260|P3|NOT COMPLETED|Overall Study||32
1650991|NCT00730015|4032261|P2|NOT COMPLETED|Overall Study||40
1650992|NCT00730015|4032262|P1|NOT COMPLETED|Overall Study||31
1650993|NCT00730015|4032260|P3|COMPLETED|Overall Study||177
1650994|NCT00730015|4032261|P2|COMPLETED|Overall Study||177
1650995|NCT00730015|4032262|P1|COMPLETED|Overall Study||186
1650996|NCT00730015|4032260|P3|STARTED|Overall Study||209
1650997|NCT00730015|4032261|P2|STARTED|Overall Study||217
1650998|NCT00730015|4032262|P1|STARTED|Overall Study||217
1650999|NCT00729937|4032302|P6|NOT COMPLETED|Overall Study||37
1651000|NCT00729937|4032303|P5|NOT COMPLETED|Overall Study||28
1651001|NCT00729937|4032304|P4|NOT COMPLETED|Overall Study||34
1651002|NCT00729937|4032305|P3|NOT COMPLETED|Overall Study||29
1651003|NCT00729937|4032306|P2|NOT COMPLETED|Overall Study||88
1651004|NCT00729937|4032307|P1|NOT COMPLETED|Overall Study||74
1651005|NCT00729937|4032302|P6|COMPLETED|Overall Study||214
1651006|NCT00729937|4032303|P5|COMPLETED|Overall Study||221
1651007|NCT00729937|4032304|P4|COMPLETED|Overall Study||215
1651008|NCT00729937|4032305|P3|COMPLETED|Overall Study||222
1651009|NCT00729937|4032306|P2|COMPLETED|Overall Study||548
1651010|NCT00729937|4032307|P1|COMPLETED|Overall Study||555
1651011|NCT00729937|4032302|P6|STARTED|Overall Study||251
1651012|NCT00729937|4032303|P5|STARTED|Overall Study||249
1651013|NCT00729937|4032304|P4|STARTED|Overall Study||249
1651014|NCT00729937|4032305|P3|STARTED|Overall Study||251
1651015|NCT00729937|4032306|P2|STARTED|Overall Study||636
1651016|NCT00729937|4032307|P1|STARTED|Overall Study||629
1651017|NCT00729924|4032501|P1|NOT COMPLETED|Overall Study||0
1651018|NCT00729924|4032501|P1|COMPLETED|Overall Study||40
1651019|NCT00729924|4032501|P1|STARTED|Overall Study||40
1651020|NCT00729859|4032511|P3|NOT COMPLETED|Overall Study||0
1651021|NCT00729859|4032512|P2|NOT COMPLETED|Overall Study||2
1651022|NCT00729859|4032513|P1|NOT COMPLETED|Overall Study||0
1651023|NCT00729859|4032511|P3|COMPLETED|Overall Study||8
1651024|NCT00729859|4032512|P2|COMPLETED|Overall Study||6
1651025|NCT00729859|4032513|P1|COMPLETED|Overall Study||8
1651026|NCT00729859|4032511|P3|STARTED|Overall Study||8
1651027|NCT00729859|4032512|P2|STARTED|Overall Study||8
1651028|NCT00729859|4032513|P1|STARTED|Overall Study||8
1651029|NCT00729846|4032550|P2|NOT COMPLETED|Overall Study||0
1651030|NCT00729846|4032551|P1|NOT COMPLETED|Overall Study||0
1651031|NCT00729846|4032550|P2|COMPLETED|Overall Study||11
1651032|NCT00729846|4032551|P1|COMPLETED|Overall Study||11
1651033|NCT00729846|4032550|P2|STARTED|Overall Study||11
1651034|NCT00729846|4032551|P1|STARTED|Overall Study||11
1651035|NCT00729833|4032557|P4|NOT COMPLETED|Overall Study||6
1651036|NCT00729833|4032558|P3|NOT COMPLETED|Overall Study||12
1651037|NCT00729833|4032559|P2|NOT COMPLETED|Overall Study||7
1651038|NCT00729833|4032560|P1|NOT COMPLETED|Overall Study||20
1651039|NCT00729833|4032557|P4|COMPLETED|Overall Study||0
1651040|NCT00729833|4032558|P3|COMPLETED|Overall Study||0
1651041|NCT00729833|4032559|P2|COMPLETED|Overall Study||0
1651042|NCT00729833|4032560|P1|COMPLETED|Overall Study||0
1651043|NCT00729833|4032557|P4|STARTED|Overall Study||6
1651044|NCT00729833|4032558|P3|STARTED|Overall Study||12
1651045|NCT00729833|4032559|P2|STARTED|Overall Study||7
1651046|NCT00729833|4032560|P1|STARTED|Overall Study||20
1651047|NCT00729807|4032599|P1|NOT COMPLETED|Overall Study||0
1651048|NCT00729807|4032599|P1|COMPLETED|Overall Study||6
1651049|NCT00729807|4032599|P1|STARTED|Overall Study||6
1651050|NCT00729781|4032603|P1|NOT COMPLETED|Long-term Follow-up Study||0
1651051|NCT00729781|4032603|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
1651052|NCT00729781|4032603|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
1651053|NCT00729781|4032603|P1|NOT COMPLETED|Original Study||0
1651054|NCT00729781|4032603|P1|COMPLETED|Original Study||45
1651055|NCT00729781|4032603|P1|STARTED|Original Study||45
1651056|NCT00729690|4032612|P3|NOT COMPLETED|Overall Study||2
1651057|NCT00729690|4032613|P2|NOT COMPLETED|Overall Study||2
1651058|NCT00729690|4032614|P1|NOT COMPLETED|Overall Study||0
1651059|NCT00729690|4032612|P3|COMPLETED|Overall Study||14
1651060|NCT00729690|4032613|P2|COMPLETED|Overall Study||14
1651061|NCT00729690|4032614|P1|COMPLETED|Overall Study||16
1651062|NCT00729690|4032612|P3|STARTED|Overall Study||16
1651063|NCT00729690|4032613|P2|STARTED|Overall Study||16
1651064|NCT00729690|4032614|P1|STARTED|Overall Study||16
1651065|NCT00729677|4032631|P1|NOT COMPLETED|Overall Study||0
1651066|NCT00729677|4032631|P1|COMPLETED|Overall Study||64
1651067|NCT00729677|4032631|P1|STARTED|Overall Study||64
1651068|NCT00729651|4032644|P2|NOT COMPLETED|Overall Study||18
1651069|NCT00729651|4032645|P1|NOT COMPLETED|Overall Study||19
1651070|NCT00729651|4032644|P2|COMPLETED|Overall Study||152
1651071|NCT00729651|4032645|P1|COMPLETED|Overall Study||154
1651072|NCT00729651|4032644|P2|STARTED|Overall Study||170
1651073|NCT00729651|4032645|P1|STARTED|Overall Study||173
1651074|NCT00729612|4032657|P1|NOT COMPLETED|Overall Study||10
1651075|NCT00729612|4032657|P1|COMPLETED|Overall Study||53
1651076|NCT00729612|4032657|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
1651077|NCT00729612|4032657|P1|Received Cycle 2|Overall Study||54
1651078|NCT00729612|4032657|P1|Did Not Receive Cycle 2|Overall Study||7
1651079|NCT00729612|4032657|P1|Received Cycle 1|Overall Study||62
1651080|NCT00729612|4032657|P1|Died Before Cycle 1|Overall Study||1
1651081|NCT00729612|4032657|P1|STARTED|Overall Study||63
1651082|NCT00729586|4032666|P2|NOT COMPLETED|Overall Study||1
1651083|NCT00729586|4032667|P1|NOT COMPLETED|Overall Study||1
1651084|NCT00729586|4032666|P2|COMPLETED|Overall Study|Eligible and treated patients|21
1651085|NCT00729586|4032667|P1|COMPLETED|Overall Study|Eligible and treated patients|50
1651086|NCT00729586|4032666|P2|STARTED|Overall Study||22
1651087|NCT00729586|4032667|P1|STARTED|Overall Study||51
1651088|NCT00729560|4032680|P1|NOT COMPLETED|Overall Study||3
1651089|NCT00729560|4032680|P1|COMPLETED|Overall Study||5
1651090|NCT00729560|4032680|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
1651091|NCT00729521|4032687|P3|NOT COMPLETED|Overall Study||0
1651092|NCT00729521|4032688|P2|NOT COMPLETED|Overall Study||0
1651093|NCT00729521|4032689|P1|NOT COMPLETED|Overall Study||0
1651094|NCT00729521|4032687|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
1651095|NCT00729521|4032688|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
1651096|NCT00729521|4032689|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
1651097|NCT00729521|4032687|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
1651098|NCT00729521|4032688|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
1651099|NCT00729521|4032689|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
1651100|NCT00729482|4032697|P1|NOT COMPLETED|Overall Study||0
1651101|NCT00729482|4032697|P1|COMPLETED|Overall Study||54
1651102|NCT00729482|4032697|P1|STARTED|Overall Study||54
1651103|NCT00729469|4032706|P2|NOT COMPLETED|Overall Study||47
1651104|NCT00729469|4032707|P1|NOT COMPLETED|Overall Study||53
1651105|NCT00729469|4032706|P2|COMPLETED|Overall Study||416
1651106|NCT00729469|4032707|P1|COMPLETED|Overall Study||403
1651107|NCT00729469|4032706|P2|STARTED|Overall Study||463
1651108|NCT00729469|4032707|P1|STARTED|Overall Study||456
1651109|NCT00729430|4032745|P2|NOT COMPLETED|Overall Study||50
1651110|NCT00729430|4032746|P1|NOT COMPLETED|Overall Study||47
1651111|NCT00729430|4032745|P2|COMPLETED|Overall Study||128
1651112|NCT00729430|4032746|P1|COMPLETED|Overall Study||133
1651113|NCT00729430|4032745|P2|STARTED|Overall Study||178
1651114|NCT00729430|4032746|P1|STARTED|Overall Study||180
1651115|NCT00729378|4032760|P2|NOT COMPLETED|36-months||6
1651116|NCT00729378|4032761|P1|NOT COMPLETED|36-months||15
1651117|NCT00729378|4032760|P2|COMPLETED|36-months||95
1651118|NCT00729378|4032761|P1|COMPLETED|36-months||105
1651119|NCT00729378|4032760|P2|STARTED|36-months||101
1651120|NCT00729378|4032761|P1|STARTED|36-months||120
1651121|NCT00729378|4032760|P2|NOT COMPLETED|24-months||51
1651122|NCT00729378|4032761|P1|NOT COMPLETED|24-months||72
1651123|NCT00729378|4032760|P2|COMPLETED|24-months||101
1651124|NCT00729378|4032761|P1|COMPLETED|24-months||120
1651125|NCT00729378|4032760|P2|STARTED|24-months||152
1651126|NCT00729378|4032761|P1|STARTED|24-months||192
1651127|NCT00729378|4032760|P2|NOT COMPLETED|12-months||65
1651128|NCT00729378|4032761|P1|NOT COMPLETED|12-months||100
1651129|NCT00729378|4032760|P2|COMPLETED|12-months||152
1651130|NCT00729378|4032761|P1|COMPLETED|12-months||192
1651131|NCT00729378|4032760|P2|STARTED|12-months||217
1651132|NCT00729378|4032761|P1|STARTED|12-months||292
1651133|NCT00729378|4032760|P2|NOT COMPLETED|Baseline||92
1651134|NCT00729378|4032761|P1|NOT COMPLETED|Baseline||138
1651135|NCT00729378|4032760|P2|COMPLETED|Baseline||217
1651136|NCT00729378|4032761|P1|COMPLETED|Baseline||292
1651137|NCT00729378|4032760|P2|STARTED|Baseline||309
1651138|NCT00729378|4032761|P1|STARTED|Baseline||430
1651139|NCT00729365|4032960|P3|NOT COMPLETED|Overall Study||7
1651140|NCT00729365|4032961|P2|NOT COMPLETED|Overall Study||6
1651141|NCT00729365|4032962|P1|NOT COMPLETED|Overall Study||33
1651142|NCT00729365|4032960|P3|COMPLETED|Overall Study|Study terminated|0
1651143|NCT00729365|4032961|P2|COMPLETED|Overall Study|Study Terminated|0
1651144|NCT00729365|4032962|P1|COMPLETED|Overall Study|Study terminated|0
1651145|NCT00729365|4032960|P3|STARTED|Overall Study||7
1651146|NCT00729365|4032961|P2|STARTED|Overall Study||6
1651147|NCT00729365|4032962|P1|STARTED|Overall Study||33
1651148|NCT00729326|4032975|P2|NOT COMPLETED|Overall Study||9
1651149|NCT00729326|4032976|P1|NOT COMPLETED|Overall Study||10
1651150|NCT00729326|4032975|P2|COMPLETED|Overall Study||33
1651151|NCT00729326|4032976|P1|COMPLETED|Overall Study||31
1651152|NCT00729326|4032975|P2|STARTED|Overall Study||42
1651153|NCT00729326|4032976|P1|STARTED|Overall Study||41
1651154|NCT00729248|4033018|P1|NOT COMPLETED|Overall Study||2
1651155|NCT00729248|4033018|P1|COMPLETED|Overall Study||10
1651156|NCT00729248|4033018|P1|STARTED|Overall Study||12
1651157|NCT00729183|4033025|P2|NOT COMPLETED|Overall Study||15
1651158|NCT00729183|4033026|P1|NOT COMPLETED|Overall Study||25
1651159|NCT00729183|4033025|P2|COMPLETED|Overall Study|Completed 24 month visit|90
1651160|NCT00729183|4033026|P1|COMPLETED|Overall Study|Completed 24 month visit|84
1651161|NCT00729183|4033025|P2|STARTED|Overall Study||105
1651162|NCT00729183|4033026|P1|STARTED|Overall Study||109
1651163|NCT00729157|4033058|P1|NOT COMPLETED|Overall Study||1
1651164|NCT00729157|4033058|P1|COMPLETED|Overall Study||40
1651165|NCT00729157|4033058|P1|STARTED|Overall Study||41
1651166|NCT00729053|4033070|P4|NOT COMPLETED|Overall Study||0
1651167|NCT00729053|4033071|P3|NOT COMPLETED|Overall Study||0
1651168|NCT00729053|4033072|P2|NOT COMPLETED|Overall Study||0
1651169|NCT00729053|4033073|P1|NOT COMPLETED|Overall Study||0
1651170|NCT00729053|4033070|P4|COMPLETED|Overall Study||23
1651171|NCT00729053|4033071|P3|COMPLETED|Overall Study||23
1651172|NCT00729053|4033072|P2|COMPLETED|Overall Study||23
1651173|NCT00729053|4033073|P1|COMPLETED|Overall Study||23
1651174|NCT00729053|4033070|P4|STARTED|Overall Study||23
1651175|NCT00729053|4033071|P3|STARTED|Overall Study||23
1651176|NCT00729053|4033072|P2|STARTED|Overall Study||23
1651177|NCT00729053|4033073|P1|STARTED|Overall Study||23
1651178|NCT00728988|4033101|P2|NOT COMPLETED|Overall Study||88
1651179|NCT00728988|4033102|P1|NOT COMPLETED|Overall Study||93
1651180|NCT00728988|4033101|P2|COMPLETED|Overall Study||164
1651181|NCT00728988|4033102|P1|COMPLETED|Overall Study||154
1651182|NCT00728988|4033101|P2|Full Analysis Set|Overall Study||172
1651183|NCT00728988|4033102|P1|Full Analysis Set|Overall Study||163
1651184|NCT00728988|4033101|P2|Treated|Overall Study||250
1651185|NCT00728988|4033102|P1|Treated|Overall Study||245
1651186|NCT00728988|4033101|P2|STARTED|Overall Study||252
1651187|NCT00728988|4033102|P1|STARTED|Overall Study||247
1651188|NCT00728962|4033120|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
1651189|NCT00728962|4033120|P1|COMPLETED|Two Year Post Placement Follow-up||59
1651190|NCT00728962|4033120|P1|STARTED|Two Year Post Placement Follow-up||62
1651191|NCT00728962|4033120|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
1651192|NCT00728962|4033120|P1|COMPLETED|One Year Post Placement Follow-up||62
1651193|NCT00728962|4033120|P1|STARTED|One Year Post Placement Follow-up||62
1651194|NCT00728962|4033120|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
1651195|NCT00728962|4033120|P1|COMPLETED|Permanent Prosthesis Placement||62
1651196|NCT00728962|4033120|P1|STARTED|Permanent Prosthesis Placement||65
1651197|NCT00728962|4033120|P1|NOT COMPLETED|Implant Placement Surgery||10
1651198|NCT00728962|4033120|P1|COMPLETED|Implant Placement Surgery||65
1651199|NCT00728962|4033120|P1|STARTED|Implant Placement Surgery||75
1651200|NCT00728949|4033126|P2|NOT COMPLETED|Overall Study||4
1651201|NCT00728949|4033127|P1|NOT COMPLETED|Overall Study||11
1651202|NCT00728949|4033126|P2|COMPLETED|Overall Study||27
1651203|NCT00728949|4033127|P1|COMPLETED|Overall Study||51
1651204|NCT00728949|4033126|P2|STARTED|Overall Study||31
1651205|NCT00728949|4033127|P1|STARTED|Overall Study||62
1651206|NCT00728923|4033145|P1|NOT COMPLETED|Overall Study||0
1651207|NCT00728923|4033145|P1|COMPLETED|Overall Study||9
1651208|NCT00728923|4033145|P1|STARTED|Overall Study||9
1651209|NCT00728910|4033150|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
1651210|NCT00728910|4033150|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
1651211|NCT00728910|4033150|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
1651212|NCT00728910|4033150|P1|NOT COMPLETED|Atorvastatin+ABT335||0
1651213|NCT00728910|4033150|P1|COMPLETED|Atorvastatin+ABT335||22
1651214|NCT00728910|4033150|P1|STARTED|Atorvastatin+ABT335||22
1651215|NCT00728910|4033150|P1|NOT COMPLETED|Atorvastatin||3
1651216|NCT00728910|4033150|P1|COMPLETED|Atorvastatin||22
1651217|NCT00728910|4033150|P1|STARTED|Atorvastatin||25
1651218|NCT00728884|4033162|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
1651219|NCT00728884|4033162|P1|COMPLETED|Two Year Post Placement Follow-up||145
1651220|NCT00728884|4033162|P1|STARTED|Two Year Post Placement Follow-up||145
1651221|NCT00728884|4033162|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
1651222|NCT00728884|4033162|P1|COMPLETED|One Year Post Placement Follow-up||145
1651223|NCT00728884|4033162|P1|STARTED|One Year Post Placement Follow-up||149
1651224|NCT00728884|4033162|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
1651225|NCT00728884|4033162|P1|COMPLETED|Permanent Prosthesis Placement||149
1651226|NCT00728884|4033162|P1|STARTED|Permanent Prosthesis Placement||162
1651227|NCT00728884|4033162|P1|NOT COMPLETED|Implant Placement Surgery||0
1651228|NCT00728884|4033162|P1|COMPLETED|Implant Placement Surgery||162
1651229|NCT00728884|4033162|P1|STARTED|Implant Placement Surgery||162
1651230|NCT00728845|4033168|P2|NOT COMPLETED|Overall Study||0
1651231|NCT00728845|4033169|P1|NOT COMPLETED|Overall Study||0
1651232|NCT00728845|4033168|P2|COMPLETED|Overall Study||0
1651233|NCT00728845|4033169|P1|COMPLETED|Overall Study||8
1651234|NCT00728845|4033168|P2|STARTED|Overall Study||0
1651235|NCT00728845|4033169|P1|STARTED|Overall Study||8
1651236|NCT00728819|4033185|P2|NOT COMPLETED|Overall Study||29
1651237|NCT00728819|4033186|P1|NOT COMPLETED|Overall Study||36
1651238|NCT00728819|4033185|P2|COMPLETED|Overall Study||139
1651239|NCT00728819|4033186|P1|COMPLETED|Overall Study||135
1651240|NCT00728819|4033185|P2|STARTED|Overall Study||168
1651241|NCT00728819|4033186|P1|STARTED|Overall Study||171
1651242|NCT00728754|4033198|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
1651243|NCT00728754|4033199|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
1651244|NCT00728754|4033198|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
1651245|NCT00728754|4033199|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
1651246|NCT00728754|4033198|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
1651247|NCT00728754|4033199|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
1651248|NCT00728754|4033198|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
1651249|NCT00728754|4033199|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
1651250|NCT00728754|4033198|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
1651251|NCT00728754|4033199|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
1651252|NCT00728754|4033198|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
1651253|NCT00728754|4033199|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
1651254|NCT00728754|4033198|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
1651255|NCT00728754|4033199|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
1651256|NCT00728754|4033198|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
1651257|NCT00728754|4033199|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
1651258|NCT00728754|4033198|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
1651259|NCT00728754|4033199|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
1651260|NCT00728754|4033198|P2|NOT COMPLETED|Implant Placement Surgery||0
1651261|NCT00728754|4033199|P1|NOT COMPLETED|Implant Placement Surgery||0
1651262|NCT00728754|4033198|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
1651263|NCT00728754|4033199|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
1651264|NCT00728754|4033198|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
1651265|NCT00728754|4033199|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
1651266|NCT00728728|4033207|P2|NOT COMPLETED|Overall Study||12
1651267|NCT00728728|4033208|P1|NOT COMPLETED|Overall Study||4
1651268|NCT00728728|4033207|P2|COMPLETED|Overall Study||34
1651269|NCT00728728|4033208|P1|COMPLETED|Overall Study||38
1651270|NCT00728728|4033207|P2|STARTED|Overall Study||46
1651271|NCT00728728|4033208|P1|STARTED|Overall Study||42
1651272|NCT00728689|4033228|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
1651273|NCT00728689|4033229|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
1651274|NCT00728689|4033228|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
1651275|NCT00728689|4033229|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
1651276|NCT00728689|4033228|P2|STARTED|Second Intervention (Days 11 - 13)||6
1651277|NCT00728689|4033229|P1|STARTED|Second Intervention (Days 11 - 13)||5
1651278|NCT00728689|4033228|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
1651279|NCT00728689|4033229|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
1651280|NCT00728689|4033228|P2|COMPLETED|Washout Period (Days 4 - 10)||6
1651281|NCT00728689|4033229|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
1651282|NCT00728689|4033228|P2|STARTED|Washout Period (Days 4 - 10)||6
1651283|NCT00728689|4033229|P1|STARTED|Washout Period (Days 4 - 10)||6
1651284|NCT00728689|4033228|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
1651285|NCT00728689|4033229|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
1651286|NCT00728689|4033228|P2|COMPLETED|First Intervention (Days 1 - 3)||6
1651287|NCT00728689|4033229|P1|COMPLETED|First Intervention (Days 1 - 3)||6
1651288|NCT00728689|4033228|P2|STARTED|First Intervention (Days 1 - 3)||6
1651289|NCT00728689|4033229|P1|STARTED|First Intervention (Days 1 - 3)||6
1651290|NCT00728507|4033247|P2|NOT COMPLETED|Overall Study||8
1651291|NCT00728507|4033248|P1|NOT COMPLETED|Overall Study||2
1651292|NCT00728507|4033247|P2|COMPLETED|Overall Study||51
1651293|NCT00728507|4033248|P1|COMPLETED|Overall Study||60
1651294|NCT00728507|4033247|P2|STARTED|Overall Study||59
1651295|NCT00728507|4033248|P1|STARTED|Overall Study||62
1651296|NCT00728494|4033258|P2|NOT COMPLETED|Overall Study||7
1651297|NCT00728494|4033259|P1|NOT COMPLETED|Overall Study||9
1651298|NCT00728494|4033258|P2|COMPLETED|Overall Study||32
1651299|NCT00728494|4033259|P1|COMPLETED|Overall Study||51
1651300|NCT00728494|4033258|P2|STARTED|Overall Study||39
1651301|NCT00728494|4033259|P1|STARTED|Overall Study||60
1651302|NCT00728481|4033277|P2|NOT COMPLETED|Overall Study||4
1651303|NCT00728481|4033278|P1|NOT COMPLETED|Overall Study||1
1651304|NCT00728481|4033277|P2|COMPLETED|Overall Study||28
1651305|NCT00728481|4033278|P1|COMPLETED|Overall Study||18
1651306|NCT00728481|4033277|P2|STARTED|Overall Study||32
1651307|NCT00728481|4033278|P1|STARTED|Overall Study||19
1651308|NCT00728468|4033294|P1|NOT COMPLETED|Overall Study||16
1651309|NCT00728468|4033294|P1|COMPLETED|Overall Study||0
1651310|NCT00728468|4033294|P1|Treated|Overall Study||15
1651311|NCT00728468|4033294|P1|STARTED|Overall Study||16
1651312|NCT00728416|4033318|P2|NOT COMPLETED|Overall Study||2
1651313|NCT00728416|4033319|P1|NOT COMPLETED|Overall Study||2
1651314|NCT00728416|4033318|P2|COMPLETED|Overall Study||163
1651315|NCT00728416|4033319|P1|COMPLETED|Overall Study||166
1651316|NCT00728416|4033318|P2|STARTED|Overall Study||165
1651317|NCT00728416|4033319|P1|STARTED|Overall Study||168
1651318|NCT00728260|4033327|P1|NOT COMPLETED|Overall Study||0
1651319|NCT00728260|4033327|P1|COMPLETED|Overall Study||1421
1651320|NCT00728260|4033327|P1|STARTED|Overall Study||1421
1651321|NCT00728182|4033335|P2|NOT COMPLETED|Overall Study||3
1651322|NCT00728182|4033336|P1|NOT COMPLETED|Overall Study||3
1651323|NCT00728182|4033335|P2|COMPLETED|Overall Study||90
1651324|NCT00728182|4033336|P1|COMPLETED|Overall Study||89
1651325|NCT00728182|4033335|P2|STARTED|Overall Study||93
1651326|NCT00728182|4033336|P1|STARTED|Overall Study||92
1651327|NCT00728130|4033364|P1|NOT COMPLETED|Overall Study||3
1651328|NCT00728130|4033364|P1|COMPLETED|Overall Study||19
1651329|NCT00728130|4033364|P1|STARTED|Overall Study||22
1651330|NCT00727961|4033369|P1|NOT COMPLETED|Overall Study||37
1651331|NCT00727961|4033369|P1|COMPLETED|Overall Study||21
1651332|NCT00727961|4033369|P1|STARTED|Overall Study||58
1651333|NCT00727909|4033379|P4|NOT COMPLETED|Overall Study||5
1651334|NCT00727909|4033380|P3|NOT COMPLETED|Overall Study||9
1651335|NCT00727909|4033381|P2|NOT COMPLETED|Overall Study||11
1651336|NCT00727909|4033382|P1|NOT COMPLETED|Overall Study||5
1651337|NCT00727909|4033379|P4|COMPLETED|Overall Study||70
1651338|NCT00727909|4033380|P3|COMPLETED|Overall Study||58
1651339|NCT00727909|4033381|P2|COMPLETED|Overall Study||61
1651340|NCT00727909|4033382|P1|COMPLETED|Overall Study||60
1651341|NCT00727909|4033379|P4|STARTED|Overall Study||75
1651342|NCT00727909|4033380|P3|STARTED|Overall Study||67
1651343|NCT00727909|4033381|P2|STARTED|Overall Study||72
1651344|NCT00727909|4033382|P1|STARTED|Overall Study||65
1651345|NCT00727857|4033389|P3|NOT COMPLETED|Overall Study||68
1651346|NCT00727857|4033390|P2|NOT COMPLETED|Overall Study||64
1651347|NCT00727857|4033391|P1|NOT COMPLETED|Overall Study||44
1651348|NCT00727857|4033389|P3|COMPLETED|Overall Study||142
1651349|NCT00727857|4033390|P2|COMPLETED|Overall Study||125
1651350|NCT00727857|4033391|P1|COMPLETED|Overall Study||157
1651351|NCT00727857|4033389|P3|STARTED|Overall Study||210
1651352|NCT00727857|4033390|P2|STARTED|Overall Study||189
1651353|NCT00727857|4033391|P1|STARTED|Overall Study||201
1651354|NCT00727844|4033479|P4|NOT COMPLETED|Second Randomization||0
1651355|NCT00727844|4033480|P3|NOT COMPLETED|Second Randomization||0
1651356|NCT00727844|4033481|P2|NOT COMPLETED|Second Randomization||0
1651357|NCT00727844|4033482|P1|NOT COMPLETED|Second Randomization||0
1651358|NCT00727844|4033479|P4|COMPLETED|Second Randomization||16
1651359|NCT00727844|4033480|P3|COMPLETED|Second Randomization||17
1651360|NCT00727844|4033481|P2|COMPLETED|Second Randomization||0
1651361|NCT00727844|4033482|P1|COMPLETED|Second Randomization||0
1651362|NCT00727844|4033479|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
1651363|NCT00727844|4033480|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
1651364|NCT00727844|4033481|P2|STARTED|Second Randomization||0
1651365|NCT00727844|4033482|P1|STARTED|Second Randomization||0
1651366|NCT00727844|4033479|P4|NOT COMPLETED|Initial Randomization||0
1651367|NCT00727844|4033480|P3|NOT COMPLETED|Initial Randomization||0
1651368|NCT00727844|4033481|P2|NOT COMPLETED|Initial Randomization||0
1651369|NCT00727844|4033482|P1|NOT COMPLETED|Initial Randomization||2
1651370|NCT00727844|4033479|P4|COMPLETED|Initial Randomization||0
1651371|NCT00727844|4033480|P3|COMPLETED|Initial Randomization||0
1651372|NCT00727844|4033481|P2|COMPLETED|Initial Randomization||20
1651373|NCT00727844|4033482|P1|COMPLETED|Initial Randomization||19
1651374|NCT00727844|4033479|P4|Included in MITT Analysis|Initial Randomization||0
1651375|NCT00727844|4033480|P3|Included in MITT Analysis|Initial Randomization||0
1651376|NCT00727844|4033481|P2|Included in MITT Analysis|Initial Randomization||20
1651377|NCT00727844|4033482|P1|Included in MITT Analysis|Initial Randomization||19
1651378|NCT00727844|4033479|P4|STARTED|Initial Randomization||0
1651379|NCT00727844|4033480|P3|STARTED|Initial Randomization||0
1651380|NCT00727844|4033481|P2|STARTED|Initial Randomization||20
1651381|NCT00727844|4033482|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
1651382|NCT00727740|4033489|P2|NOT COMPLETED|Overall Study||0
1651383|NCT00727740|4033490|P1|NOT COMPLETED|Overall Study||0
1651384|NCT00727740|4033489|P2|COMPLETED|Overall Study||61
1651385|NCT00727740|4033490|P1|COMPLETED|Overall Study||56
1651386|NCT00727740|4033489|P2|STARTED|Overall Study||61
1651387|NCT00727740|4033490|P1|STARTED|Overall Study||56
1651388|NCT00727714|4033496|P1|NOT COMPLETED|Overall Study||2
1651389|NCT00727714|4033496|P1|COMPLETED|Overall Study||93
1651390|NCT00727714|4033496|P1|STARTED|Overall Study||95
1651391|NCT00727649|4033506|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
1651392|NCT00727649|4033507|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
1651393|NCT00727649|4033506|P2|COMPLETED|Second Intervention (4-weeks)||34
1651394|NCT00727649|4033507|P1|COMPLETED|Second Intervention (4-weeks)||29
1651395|NCT00727649|4033506|P2|STARTED|Second Intervention (4-weeks)||37
1651396|NCT00727649|4033507|P1|STARTED|Second Intervention (4-weeks)||30
1651397|NCT00727649|4033506|P2|NOT COMPLETED|Wash-out (2-weeks)||3
1651398|NCT00727649|4033507|P1|NOT COMPLETED|Wash-out (2-weeks)||4
1651399|NCT00727649|4033506|P2|COMPLETED|Wash-out (2-weeks)||37
1651400|NCT00727649|4033507|P1|COMPLETED|Wash-out (2-weeks)||30
1651401|NCT00727649|4033506|P2|STARTED|Wash-out (2-weeks)||40
1651402|NCT00727649|4033507|P1|STARTED|Wash-out (2-weeks)||34
1651403|NCT00727649|4033506|P2|NOT COMPLETED|First Intervention (4-weeks)||3
1651404|NCT00727649|4033507|P1|NOT COMPLETED|First Intervention (4-weeks)||3
1651405|NCT00727649|4033506|P2|COMPLETED|First Intervention (4-weeks)||40
1651406|NCT00727649|4033507|P1|COMPLETED|First Intervention (4-weeks)||34
1651407|NCT00727649|4033506|P2|STARTED|First Intervention (4-weeks)||43
1651408|NCT00727649|4033507|P1|STARTED|First Intervention (4-weeks)||37
1651409|NCT00727636|4033521|P2|NOT COMPLETED|Overall Study||0
1651410|NCT00727636|4033522|P1|NOT COMPLETED|Overall Study||4
1651411|NCT00727636|4033521|P2|COMPLETED|Overall Study||15
1651412|NCT00727636|4033522|P1|COMPLETED|Overall Study||33
1651413|NCT00727636|4033521|P2|STARTED|Overall Study||15
1651414|NCT00727636|4033522|P1|STARTED|Overall Study||37
1651415|NCT00727597|4033536|P2|NOT COMPLETED|Overall Study||0
1651416|NCT00727597|4033537|P1|NOT COMPLETED|Overall Study||0
1651417|NCT00727597|4033536|P2|COMPLETED|Overall Study||50
1651418|NCT00727597|4033537|P1|COMPLETED|Overall Study||51
1651419|NCT00727597|4033536|P2|STARTED|Overall Study||50
1651420|NCT00727597|4033537|P1|STARTED|Overall Study||51
1651421|NCT00727571|4033549|P4|NOT COMPLETED|Overall Study||6
1651422|NCT00727571|4033550|P3|NOT COMPLETED|Overall Study||30
1651423|NCT00727571|4033551|P2|NOT COMPLETED|Overall Study||55
1651424|NCT00727571|4033552|P1|NOT COMPLETED|Overall Study||1
1651425|NCT00727571|4033549|P4|COMPLETED|Overall Study||163
1651426|NCT00727571|4033550|P3|COMPLETED|Overall Study||135
1651427|NCT00727571|4033551|P2|COMPLETED|Overall Study||173
1651428|NCT00727571|4033552|P1|COMPLETED|Overall Study||231
1651429|NCT00727571|4033549|P4|STARTED|Overall Study||169
1651430|NCT00727571|4033550|P3|STARTED|Overall Study||165
1651431|NCT00727571|4033551|P2|STARTED|Overall Study||228
1651432|NCT00727571|4033552|P1|STARTED|Overall Study||232
1651433|NCT00727558|4033579|P2|NOT COMPLETED|Overall Study||3
1651434|NCT00727558|4033580|P1|NOT COMPLETED|Overall Study||2
1651435|NCT00727558|4033579|P2|COMPLETED|Overall Study||118
1651436|NCT00727558|4033580|P1|COMPLETED|Overall Study||125
1651437|NCT00727558|4033579|P2|STARTED|Overall Study||121
1651438|NCT00727558|4033580|P1|STARTED|Overall Study||127
1651439|NCT00727506|4033604|P6|NOT COMPLETED|Overall Study||39
1651440|NCT00727506|4033605|P5|NOT COMPLETED|Overall Study||41
1651441|NCT00727506|4033606|P4|NOT COMPLETED|Overall Study||39
1651442|NCT00727506|4033607|P3|NOT COMPLETED|Overall Study||18
1651443|NCT00727506|4033608|P2|NOT COMPLETED|Overall Study||8
1651444|NCT00727506|4033609|P1|NOT COMPLETED|Overall Study||6
1651445|NCT00727506|4033604|P6|COMPLETED|Overall Study||0
1651446|NCT00727506|4033605|P5|COMPLETED|Overall Study||0
1651447|NCT00727506|4033606|P4|COMPLETED|Overall Study||0
1651448|NCT00727506|4033607|P3|COMPLETED|Overall Study||0
1651449|NCT00727506|4033608|P2|COMPLETED|Overall Study||0
1651450|NCT00727506|4033609|P1|COMPLETED|Overall Study||0
1651451|NCT00727506|4033604|P6|STARTED|Overall Study|Randomized|39
1651452|NCT00727506|4033605|P5|STARTED|Overall Study|Randomized|41
1651453|NCT00727506|4033606|P4|STARTED|Overall Study|Randomized|39
1651454|NCT00727506|4033607|P3|STARTED|Overall Study|Entered|18
1651455|NCT00727506|4033608|P2|STARTED|Overall Study|Entered|8
1651456|NCT00727506|4033609|P1|STARTED|Overall Study|Entered|6
1651457|NCT00727402|4033702|P1|NOT COMPLETED|Overall Study||116
1651458|NCT00727402|4033702|P1|COMPLETED|Overall Study||89
1651459|NCT00727402|4033702|P1|STARTED|Overall Study||205
1651460|NCT00727337|4033710|P4|NOT COMPLETED|Overall Study||9
1651461|NCT00727337|4033711|P3|NOT COMPLETED|Overall Study||10
1651462|NCT00727337|4033712|P2|NOT COMPLETED|Overall Study||10
1651463|NCT00727337|4033713|P1|NOT COMPLETED|Overall Study||7
1651464|NCT00727337|4033710|P4|COMPLETED|Overall Study||64
1651465|NCT00727337|4033711|P3|COMPLETED|Overall Study||63
1651466|NCT00727337|4033712|P2|COMPLETED|Overall Study||55
1651467|NCT00727337|4033713|P1|COMPLETED|Overall Study||61
1651468|NCT00727337|4033710|P4|STARTED|Overall Study||73
1651469|NCT00727337|4033711|P3|STARTED|Overall Study||73
1651470|NCT00727337|4033712|P2|STARTED|Overall Study||65
1651471|NCT00727337|4033713|P1|STARTED|Overall Study||68
1651472|NCT00727311|4033731|P1|NOT COMPLETED|Overall Study||1107
1651473|NCT00727311|4033731|P1|COMPLETED|Overall Study||1195
1651474|NCT00727311|4033731|P1|STARTED|Overall Study||2302
1651475|NCT00727298|4033738|P1|NOT COMPLETED|Overall Study||1257
1651476|NCT00727298|4033738|P1|COMPLETED|Overall Study||3228
1651477|NCT00727298|4033738|P1|STARTED|Overall Study||4485
1651478|NCT00727272|4033744|P3|NOT COMPLETED|Period III||0
1651479|NCT00727272|4033745|P2|NOT COMPLETED|Period III||0
1651480|NCT00727272|4033746|P1|NOT COMPLETED|Period III||0
1651481|NCT00727272|4033744|P3|COMPLETED|Period III||7
1651482|NCT00727272|4033745|P2|COMPLETED|Period III||9
1651483|NCT00727272|4033746|P1|COMPLETED|Period III||9
1651484|NCT00727272|4033744|P3|STARTED|Period III||7
1651485|NCT00727272|4033745|P2|STARTED|Period III||9
1651486|NCT00727272|4033746|P1|STARTED|Period III||9
1651487|NCT00727272|4033744|P3|NOT COMPLETED|Washout Period B||1
1651488|NCT00727272|4033745|P2|NOT COMPLETED|Washout Period B||0
1651489|NCT00727272|4033746|P1|NOT COMPLETED|Washout Period B||0
1651490|NCT00727272|4033744|P3|COMPLETED|Washout Period B|personal reasons|7
1651491|NCT00727272|4033745|P2|COMPLETED|Washout Period B||9
1651492|NCT00727272|4033746|P1|COMPLETED|Washout Period B||9
1651493|NCT00727272|4033744|P3|STARTED|Washout Period B||8
1651494|NCT00727272|4033745|P2|STARTED|Washout Period B||9
1651495|NCT00727272|4033746|P1|STARTED|Washout Period B||9
1651496|NCT00727272|4033744|P3|NOT COMPLETED|Period II||0
1651497|NCT00727272|4033745|P2|NOT COMPLETED|Period II||0
1651498|NCT00727272|4033746|P1|NOT COMPLETED|Period II||0
1651499|NCT00727272|4033744|P3|COMPLETED|Period II||8
1651500|NCT00727272|4033745|P2|COMPLETED|Period II||9
1651501|NCT00727272|4033746|P1|COMPLETED|Period II||9
1651502|NCT00727272|4033744|P3|STARTED|Period II||8
1651503|NCT00727272|4033745|P2|STARTED|Period II||9
1651504|NCT00727272|4033746|P1|STARTED|Period II||9
1651505|NCT00727272|4033744|P3|NOT COMPLETED|Washout Period A||1
1651506|NCT00727272|4033745|P2|NOT COMPLETED|Washout Period A||0
1651507|NCT00727272|4033746|P1|NOT COMPLETED|Washout Period A||0
1651508|NCT00727272|4033744|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
1651509|NCT00727272|4033745|P2|COMPLETED|Washout Period A||9
1651510|NCT00727272|4033746|P1|COMPLETED|Washout Period A||9
1651511|NCT00727272|4033744|P3|STARTED|Washout Period A||9
1651512|NCT00727272|4033745|P2|STARTED|Washout Period A||9
1651513|NCT00727272|4033746|P1|STARTED|Washout Period A||9
1651514|NCT00727272|4033744|P3|NOT COMPLETED|Period I||0
1651515|NCT00727272|4033745|P2|NOT COMPLETED|Period I||0
1651516|NCT00727272|4033746|P1|NOT COMPLETED|Period I||0
1651517|NCT00727272|4033744|P3|COMPLETED|Period I||9
1651518|NCT00727272|4033745|P2|COMPLETED|Period I||9
1651519|NCT00727272|4033746|P1|COMPLETED|Period I||9
1651520|NCT00727272|4033744|P3|STARTED|Period I||9
1651521|NCT00727272|4033745|P2|STARTED|Period I||9
1651522|NCT00727272|4033746|P1|STARTED|Period I||9
1651523|NCT00727259|4033763|P1|NOT COMPLETED|Overall Study||1055
1651524|NCT00727259|4033763|P1|COMPLETED|Overall Study||940
1651525|NCT00727259|4033763|P1|STARTED|Overall Study||1995
1651526|NCT00727246|4033772|P4|NOT COMPLETED|Overall Study||2
1651527|NCT00727246|4033773|P3|NOT COMPLETED|Overall Study||1
1651528|NCT00727246|4033774|P2|NOT COMPLETED|Overall Study||1
1651529|NCT00727246|4033775|P1|NOT COMPLETED|Overall Study||0
1651530|NCT00727246|4033772|P4|COMPLETED|Overall Study||3
1651531|NCT00727246|4033773|P3|COMPLETED|Overall Study||7
1651532|NCT00727246|4033774|P2|COMPLETED|Overall Study||2
1651533|NCT00727246|4033775|P1|COMPLETED|Overall Study||3
1651534|NCT00727246|4033772|P4|STARTED|Overall Study||5
1651535|NCT00727246|4033773|P3|STARTED|Overall Study||8
1651536|NCT00727246|4033774|P2|STARTED|Overall Study||3
1651537|NCT00727246|4033775|P1|STARTED|Overall Study||3
1651538|NCT00727220|4033791|P2|NOT COMPLETED|Overall Study||4
1651539|NCT00727220|4033792|P1|NOT COMPLETED|Overall Study||1
1651540|NCT00727220|4033791|P2|COMPLETED|Overall Study||17
1651541|NCT00727220|4033792|P1|COMPLETED|Overall Study||20
1651542|NCT00727220|4033791|P2|STARTED|Overall Study||21
1651543|NCT00727220|4033792|P1|STARTED|Overall Study||21
1651544|NCT00727194|4033798|P3|NOT COMPLETED|Treatment Period 2||0
1651545|NCT00727194|4033799|P2|NOT COMPLETED|Treatment Period 2||1
1651546|NCT00727194|4033800|P1|NOT COMPLETED|Treatment Period 2||0
1651547|NCT00727194|4033798|P3|COMPLETED|Treatment Period 2||0
1651548|NCT00727194|4033799|P2|COMPLETED|Treatment Period 2||5
1651549|NCT00727194|4033800|P1|COMPLETED|Treatment Period 2||6
1651550|NCT00727194|4033798|P3|STARTED|Treatment Period 2||0
1651551|NCT00727194|4033799|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
1651552|NCT00727194|4033800|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
1651553|NCT00727194|4033798|P3|NOT COMPLETED|Washout Period||0
1651554|NCT00727194|4033799|P2|NOT COMPLETED|Washout Period||0
1651555|NCT00727194|4033800|P1|NOT COMPLETED|Washout Period||0
1651556|NCT00727194|4033798|P3|COMPLETED|Washout Period||0
1651557|NCT00727194|4033799|P2|COMPLETED|Washout Period||7
1651558|NCT00727194|4033800|P1|COMPLETED|Washout Period||7
1651559|NCT00727194|4033798|P3|STARTED|Washout Period||0
1651560|NCT00727194|4033799|P2|STARTED|Washout Period||7
1651561|NCT00727194|4033800|P1|STARTED|Washout Period||7
1651562|NCT00727194|4033798|P3|NOT COMPLETED|Treatment Period 1||0
1651563|NCT00727194|4033799|P2|NOT COMPLETED|Treatment Period 1||0
1651564|NCT00727194|4033800|P1|NOT COMPLETED|Treatment Period 1||0
1651565|NCT00727194|4033798|P3|COMPLETED|Treatment Period 1||0
1651566|NCT00727194|4033799|P2|COMPLETED|Treatment Period 1||7
1651567|NCT00727194|4033800|P1|COMPLETED|Treatment Period 1||7
1651568|NCT00727194|4033798|P3|STARTED|Treatment Period 1||0
1651569|NCT00727194|4033799|P2|STARTED|Treatment Period 1||7
1651570|NCT00727194|4033800|P1|STARTED|Treatment Period 1||7
1651571|NCT00727194|4033798|P3|NOT COMPLETED|Screening Period||16
1651572|NCT00727194|4033799|P2|NOT COMPLETED|Screening Period||0
1651573|NCT00727194|4033800|P1|NOT COMPLETED|Screening Period||0
1651574|NCT00727194|4033798|P3|COMPLETED|Screening Period||0
1651575|NCT00727194|4033799|P2|COMPLETED|Screening Period||7
1651576|NCT00727194|4033800|P1|COMPLETED|Screening Period||7
1651577|NCT00727194|4033798|P3|STARTED|Screening Period||16
1651578|NCT00727194|4033799|P2|STARTED|Screening Period||7
1651579|NCT00727194|4033800|P1|STARTED|Screening Period||7
1651580|NCT00727090|4033836|P2|NOT COMPLETED|Overall Study||0
1651581|NCT00727090|4033837|P1|NOT COMPLETED|Overall Study||0
1651582|NCT00727090|4033836|P2|COMPLETED|Overall Study||3
1651583|NCT00727090|4033837|P1|COMPLETED|Overall Study||3
1651584|NCT00727090|4033836|P2|STARTED|Overall Study||3
1651585|NCT00727090|4033837|P1|STARTED|Overall Study||3
1651586|NCT00727064|4033855|P2|NOT COMPLETED|Overall Study||0
1651587|NCT00727064|4033856|P1|NOT COMPLETED|Overall Study||0
1651588|NCT00727064|4033855|P2|COMPLETED|Overall Study||7
1651589|NCT00727064|4033856|P1|COMPLETED|Overall Study||7
1651590|NCT00727064|4033855|P2|STARTED|Overall Study||7
1651591|NCT00727064|4033856|P1|STARTED|Overall Study||7
1651592|NCT00727025|4033872|P1|NOT COMPLETED|Overall Study||23
1651593|NCT00727025|4033872|P1|COMPLETED|Overall Study||51
1651594|NCT00727025|4033872|P1|STARTED|Overall Study||74
1651595|NCT00726999|4033884|P2|NOT COMPLETED|Overall Study||1
1651596|NCT00726999|4033885|P1|NOT COMPLETED|Overall Study||3
1651597|NCT00726999|4033884|P2|COMPLETED|Overall Study||30
1651598|NCT00726999|4033885|P1|COMPLETED|Overall Study||29
1651599|NCT00726999|4033884|P2|STARTED|Overall Study||31
1651600|NCT00726999|4033885|P1|STARTED|Overall Study||32
1651601|NCT00726986|4033895|P1|NOT COMPLETED|Maintenance Phase||3
1651602|NCT00726986|4033895|P1|COMPLETED|Maintenance Phase||0
1651603|NCT00726986|4033895|P1|STARTED|Maintenance Phase||3
1651604|NCT00726986|4033895|P1|NOT COMPLETED|Induction Phase||15
1651605|NCT00726986|4033895|P1|COMPLETED|Induction Phase||3
1651606|NCT00726986|4033895|P1|Maintance|Induction Phase||3
1651607|NCT00726986|4033895|P1|STARTED|Induction Phase||18
1651608|NCT00726895|4033902|P2|NOT COMPLETED|Second Intervention||0
1651609|NCT00726895|4033903|P1|NOT COMPLETED|Second Intervention||0
1651610|NCT00726895|4033902|P2|COMPLETED|Second Intervention||11
1651611|NCT00726895|4033903|P1|COMPLETED|Second Intervention||12
1651612|NCT00726895|4033902|P2|STARTED|Second Intervention||11
1651613|NCT00726895|4033903|P1|STARTED|Second Intervention||12
1651614|NCT00726895|4033902|P2|NOT COMPLETED|Washout Period of 7 Days||1
1651615|NCT00726895|4033903|P1|NOT COMPLETED|Washout Period of 7 Days||0
1651616|NCT00726895|4033902|P2|COMPLETED|Washout Period of 7 Days||11
1651617|NCT00726895|4033903|P1|COMPLETED|Washout Period of 7 Days||12
1651618|NCT00726895|4033902|P2|STARTED|Washout Period of 7 Days||12
1651619|NCT00726895|4033903|P1|STARTED|Washout Period of 7 Days||12
1651620|NCT00726895|4033902|P2|NOT COMPLETED|First Intervention||0
1651621|NCT00726895|4033903|P1|NOT COMPLETED|First Intervention||0
1651622|NCT00726895|4033902|P2|COMPLETED|First Intervention||12
1651623|NCT00726895|4033903|P1|COMPLETED|First Intervention||12
1651624|NCT00726895|4033902|P2|STARTED|First Intervention||12
1651625|NCT00726895|4033903|P1|STARTED|First Intervention||12
1651626|NCT00726882|4033916|P1|NOT COMPLETED|Overall Study||22
1651627|NCT00726882|4033916|P1|COMPLETED|Overall Study||13
1651628|NCT00726882|4033916|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
1651629|NCT00726882|4033916|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
1651630|NCT00726882|4033916|P1|STARTED|Overall Study||35
1651631|NCT00726830|4033924|P2|NOT COMPLETED|Overall Study||0
1651632|NCT00726830|4033925|P1|NOT COMPLETED|Overall Study||0
1651633|NCT00726830|4033924|P2|COMPLETED|Overall Study||0
1651634|NCT00726830|4033925|P1|COMPLETED|Overall Study||1
1651635|NCT00726830|4033924|P2|STARTED|Overall Study||0
1651636|NCT00726830|4033925|P1|STARTED|Overall Study||1
1651637|NCT00726752|4033931|P1|NOT COMPLETED|Overall Study||6
1651638|NCT00726752|4033931|P1|COMPLETED|Overall Study||0
1651639|NCT00726752|4033931|P1|STARTED|Overall Study||6
1651640|NCT00726739|4033947|P2|NOT COMPLETED|Overall Study||0
1651641|NCT00726739|4033948|P1|NOT COMPLETED|Overall Study||1
1651642|NCT00726739|4033947|P2|COMPLETED|Overall Study||10
1651643|NCT00726739|4033948|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
1651644|NCT00726739|4033947|P2|STARTED|Overall Study||10
1651645|NCT00726739|4033948|P1|STARTED|Overall Study||11
1651646|NCT00726713|4033964|P2|NOT COMPLETED|Overall Study||7
1651647|NCT00726713|4033965|P1|NOT COMPLETED|Overall Study||7
1651648|NCT00726713|4033964|P2|COMPLETED|Overall Study||101
1651649|NCT00726713|4033965|P1|COMPLETED|Overall Study||99
1651650|NCT00726713|4033964|P2|STARTED|Overall Study||108
1651651|NCT00726713|4033965|P1|STARTED|Overall Study||106
1651652|NCT00726661|4033993|P2|NOT COMPLETED|Overall Study||418
1651653|NCT00726661|4033994|P1|NOT COMPLETED|Overall Study||814
1651654|NCT00726661|4033993|P2|COMPLETED|Overall Study||17
1651655|NCT00726661|4033994|P1|COMPLETED|Overall Study||18
1651656|NCT00726661|4033993|P2|STARTED|Overall Study||435
1651657|NCT00726661|4033994|P1|STARTED|Overall Study||832
1651658|NCT00726622|4034011|P2|NOT COMPLETED|Overall Study||3
1651659|NCT00726622|4034012|P1|NOT COMPLETED|Overall Study||18
1651660|NCT00726622|4034011|P2|COMPLETED|Overall Study||240
1651661|NCT00726622|4034012|P1|COMPLETED|Overall Study||225
1651662|NCT00726622|4034011|P2|STARTED|Overall Study||243
1651663|NCT00726622|4034012|P1|STARTED|Overall Study||243
1651664|NCT00726609|4034030|P1|NOT COMPLETED|Overall Study||98
1651835|NCT00725985|4034171|P12|STARTED|OLMP||0
1651665|NCT00726609|4034030|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
1651666|NCT00726609|4034030|P1|STARTED|Overall Study||214
1651667|NCT00726557|4034034|P1|NOT COMPLETED|Overall Study||128
1651668|NCT00726557|4034034|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
1651669|NCT00726557|4034034|P1|STARTED|Overall Study||246
1651670|NCT00726453|4034041|P2|NOT COMPLETED|38 mm Length Group||3
1651671|NCT00726453|4034042|P1|NOT COMPLETED|38 mm Length Group||0
1651672|NCT00726453|4034041|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
1651673|NCT00726453|4034042|P1|COMPLETED|38 mm Length Group||0
1651674|NCT00726453|4034041|P2|STARTED|38 mm Length Group||114
1651675|NCT00726453|4034042|P1|STARTED|38 mm Length Group||0
1651676|NCT00726453|4034041|P2|NOT COMPLETED|Primary Enrollment Group||0
1651677|NCT00726453|4034042|P1|NOT COMPLETED|Primary Enrollment Group||31
1651678|NCT00726453|4034041|P2|COMPLETED|Primary Enrollment Group||0
1651679|NCT00726453|4034042|P1|COMPLETED|Primary Enrollment Group||1371
1651680|NCT00726453|4034041|P2|STARTED|Primary Enrollment Group||0
1651681|NCT00726453|4034042|P1|STARTED|Primary Enrollment Group||1402
1651682|NCT00726414|4034052|P2|NOT COMPLETED|Second Intervention||0
1651683|NCT00726414|4034053|P1|NOT COMPLETED|Second Intervention||0
1651684|NCT00726414|4034052|P2|COMPLETED|Second Intervention||11
1651685|NCT00726414|4034053|P1|COMPLETED|Second Intervention||11
1651686|NCT00726414|4034052|P2|STARTED|Second Intervention||11
1651687|NCT00726414|4034053|P1|STARTED|Second Intervention||11
1651688|NCT00726414|4034052|P2|NOT COMPLETED|Washout Period of 7 Days||0
1651689|NCT00726414|4034053|P1|NOT COMPLETED|Washout Period of 7 Days||0
1651690|NCT00726414|4034052|P2|COMPLETED|Washout Period of 7 Days||11
1651691|NCT00726414|4034053|P1|COMPLETED|Washout Period of 7 Days||11
1651692|NCT00726414|4034052|P2|STARTED|Washout Period of 7 Days||11
1651693|NCT00726414|4034053|P1|STARTED|Washout Period of 7 Days||11
1651694|NCT00726414|4034052|P2|NOT COMPLETED|First Intervention||0
1651695|NCT00726414|4034053|P1|NOT COMPLETED|First Intervention||0
1651696|NCT00726414|4034052|P2|COMPLETED|First Intervention||11
1651697|NCT00726414|4034053|P1|COMPLETED|First Intervention||11
1651698|NCT00726414|4034052|P2|STARTED|First Intervention||11
1651699|NCT00726414|4034053|P1|STARTED|First Intervention||11
1651700|NCT00726375|4034063|P1|NOT COMPLETED|Overall Study||0
1651701|NCT00726375|4034063|P1|COMPLETED|Overall Study||34
1651702|NCT00726375|4034063|P1|STARTED|Overall Study||34
1651703|NCT00726323|4034070|P2|NOT COMPLETED|Overall Study||31
1651704|NCT00726323|4034071|P1|NOT COMPLETED|Overall Study||37
1651705|NCT00726323|4034070|P2|COMPLETED|Overall Study||6
1651706|NCT00726323|4034071|P1|COMPLETED|Overall Study||0
1651707|NCT00726323|4034070|P2|STARTED|Overall Study||37
1651708|NCT00726323|4034071|P1|STARTED|Overall Study||37
1651709|NCT00726232|4034101|P6|NOT COMPLETED|Overall Study||4
1651710|NCT00726232|4034102|P5|NOT COMPLETED|Overall Study||5
1651711|NCT00726232|4034103|P4|NOT COMPLETED|Overall Study||1
1651712|NCT00726232|4034104|P3|NOT COMPLETED|Overall Study||0
1651713|NCT00726232|4034105|P2|NOT COMPLETED|Overall Study||1
1651714|NCT00726232|4034106|P1|NOT COMPLETED|Overall Study||5
1651715|NCT00726232|4034101|P6|COMPLETED|Overall Study||5
1651716|NCT00726232|4034102|P5|COMPLETED|Overall Study||17
1651717|NCT00726232|4034103|P4|COMPLETED|Overall Study||7
1651718|NCT00726232|4034104|P3|COMPLETED|Overall Study||7
1651719|NCT00726232|4034105|P2|COMPLETED|Overall Study||7
1651720|NCT00726232|4034106|P1|COMPLETED|Overall Study|Represents patients ongoing in the study as of the data cut-off date of 18 June 2010.|14
1651721|NCT00726232|4034101|P6|STARTED|Overall Study||9
1651722|NCT00726232|4034102|P5|STARTED|Overall Study|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
1651723|NCT00726232|4034103|P4|STARTED|Overall Study||8
1651724|NCT00726232|4034104|P3|STARTED|Overall Study||7
1651725|NCT00726232|4034105|P2|STARTED|Overall Study||8
1651726|NCT00726232|4034106|P1|STARTED|Overall Study|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
1651727|NCT00726180|4034150|P1|NOT COMPLETED|Overall Study||0
1651728|NCT00726180|4034150|P1|COMPLETED|Overall Study||1
1651729|NCT00726180|4034150|P1|STARTED|Overall Study||1
1651730|NCT00726063|4034156|P2|NOT COMPLETED|Overall Study||7
1651731|NCT00726063|4034157|P1|NOT COMPLETED|Overall Study||9
1651732|NCT00726063|4034156|P2|COMPLETED|Overall Study|Number of implants = 239|112
1651733|NCT00726063|4034157|P1|COMPLETED|Overall Study|Number of implants =230|113
1651734|NCT00726063|4034156|P2|STARTED|Overall Study|Number of implants= 246|119
1651735|NCT00726063|4034157|P1|STARTED|Overall Study|Number of implants= 239|122
1651736|NCT00726037|4034163|P1|NOT COMPLETED|Overall Study||0
1651737|NCT00726037|4034163|P1|COMPLETED|Overall Study||7
1651738|NCT00726037|4034163|P1|STARTED|Overall Study||7
1651739|NCT00725985|4034171|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
1651740|NCT00725985|4034172|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
1651741|NCT00725985|4034173|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
1651742|NCT00725985|4034174|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1651743|NCT00725985|4034175|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1651744|NCT00725985|4034176|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1651745|NCT00725985|4034177|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1651746|NCT00725985|4034178|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1651747|NCT00725985|4034179|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1651748|NCT00725985|4034180|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1651749|NCT00725985|4034181|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1651750|NCT00725985|4034182|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1651751|NCT00725985|4034171|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
1651752|NCT00725985|4034172|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
1651753|NCT00725985|4034173|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
1651754|NCT00725985|4034174|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
1651755|NCT00725985|4034175|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
1651756|NCT00725985|4034176|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
1651757|NCT00725985|4034177|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
1651758|NCT00725985|4034178|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
1651759|NCT00725985|4034179|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
1651760|NCT00725985|4034180|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
1651761|NCT00725985|4034181|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
1651762|NCT00725985|4034182|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
1651763|NCT00725985|4034171|P12|STARTED|LTFU (No Cladribine Treatment)||14
1651764|NCT00725985|4034172|P11|STARTED|LTFU (No Cladribine Treatment)||36
1651765|NCT00725985|4034173|P10|STARTED|LTFU (No Cladribine Treatment)||34
1651766|NCT00725985|4034174|P9|STARTED|LTFU (No Cladribine Treatment)||0
1651767|NCT00725985|4034175|P8|STARTED|LTFU (No Cladribine Treatment)||0
1651768|NCT00725985|4034176|P7|STARTED|LTFU (No Cladribine Treatment)||0
1651769|NCT00725985|4034177|P6|STARTED|LTFU (No Cladribine Treatment)||0
1651770|NCT00725985|4034178|P5|STARTED|LTFU (No Cladribine Treatment)||0
1651771|NCT00725985|4034179|P4|STARTED|LTFU (No Cladribine Treatment)||0
1651772|NCT00725985|4034180|P3|STARTED|LTFU (No Cladribine Treatment)||0
1651773|NCT00725985|4034181|P2|STARTED|LTFU (No Cladribine Treatment)||0
1651774|NCT00725985|4034182|P1|STARTED|LTFU (No Cladribine Treatment)||0
1651775|NCT00725985|4034171|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1651776|NCT00725985|4034172|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1651777|NCT00725985|4034173|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1651778|NCT00725985|4034174|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
1651779|NCT00725985|4034175|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
1651780|NCT00725985|4034176|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
1651781|NCT00725985|4034177|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1651782|NCT00725985|4034178|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1651783|NCT00725985|4034179|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1651784|NCT00725985|4034180|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1651785|NCT00725985|4034181|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1651786|NCT00725985|4034182|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1651787|NCT00725985|4034171|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
1651788|NCT00725985|4034172|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
1651789|NCT00725985|4034173|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
1651790|NCT00725985|4034174|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
1651791|NCT00725985|4034175|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
1651792|NCT00725985|4034176|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
1651793|NCT00725985|4034177|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
1651794|NCT00725985|4034178|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
1651795|NCT00725985|4034179|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
1651796|NCT00725985|4034180|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
1651797|NCT00725985|4034181|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
1651798|NCT00725985|4034182|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
1651799|NCT00725985|4034171|P12|STARTED|LTFU (With Cladribine Treatment)||0
1651800|NCT00725985|4034172|P11|STARTED|LTFU (With Cladribine Treatment)||0
1651801|NCT00725985|4034173|P10|STARTED|LTFU (With Cladribine Treatment)||0
1651802|NCT00725985|4034174|P9|STARTED|LTFU (With Cladribine Treatment)||17
1651803|NCT00725985|4034175|P8|STARTED|LTFU (With Cladribine Treatment)||9
1651804|NCT00725985|4034176|P7|STARTED|LTFU (With Cladribine Treatment)||9
1651805|NCT00725985|4034177|P6|STARTED|LTFU (With Cladribine Treatment)||0
1651806|NCT00725985|4034178|P5|STARTED|LTFU (With Cladribine Treatment)||0
1651807|NCT00725985|4034179|P4|STARTED|LTFU (With Cladribine Treatment)||0
1651808|NCT00725985|4034180|P3|STARTED|LTFU (With Cladribine Treatment)||0
1651809|NCT00725985|4034181|P2|STARTED|LTFU (With Cladribine Treatment)||0
1651810|NCT00725985|4034182|P1|STARTED|LTFU (With Cladribine Treatment)||0
1651811|NCT00725985|4034171|P12|NOT COMPLETED|OLMP||0
1651812|NCT00725985|4034172|P11|NOT COMPLETED|OLMP||0
1651813|NCT00725985|4034173|P10|NOT COMPLETED|OLMP||0
1651814|NCT00725985|4034174|P9|NOT COMPLETED|OLMP||0
1651815|NCT00725985|4034175|P8|NOT COMPLETED|OLMP||0
1651816|NCT00725985|4034176|P7|NOT COMPLETED|OLMP||0
1651817|NCT00725985|4034177|P6|NOT COMPLETED|OLMP||53
1651818|NCT00725985|4034178|P5|NOT COMPLETED|OLMP||23
1651819|NCT00725985|4034179|P4|NOT COMPLETED|OLMP||18
1651820|NCT00725985|4034180|P3|NOT COMPLETED|OLMP||0
1651821|NCT00725985|4034181|P2|NOT COMPLETED|OLMP||0
1651822|NCT00725985|4034182|P1|NOT COMPLETED|OLMP||0
1651823|NCT00725985|4034171|P12|COMPLETED|OLMP||0
1651824|NCT00725985|4034172|P11|COMPLETED|OLMP||0
1651825|NCT00725985|4034173|P10|COMPLETED|OLMP||0
1651826|NCT00725985|4034174|P9|COMPLETED|OLMP||0
1651827|NCT00725985|4034175|P8|COMPLETED|OLMP||0
1651828|NCT00725985|4034176|P7|COMPLETED|OLMP||0
1651829|NCT00725985|4034177|P6|COMPLETED|OLMP||7
1651830|NCT00725985|4034178|P5|COMPLETED|OLMP||2
1651831|NCT00725985|4034179|P4|COMPLETED|OLMP||6
1651832|NCT00725985|4034180|P3|COMPLETED|OLMP||0
1651833|NCT00725985|4034181|P2|COMPLETED|OLMP||0
1651834|NCT00725985|4034182|P1|COMPLETED|OLMP||0
1651836|NCT00725985|4034172|P11|STARTED|OLMP||0
1651837|NCT00725985|4034173|P10|STARTED|OLMP||0
1651838|NCT00725985|4034174|P9|STARTED|OLMP||0
1651839|NCT00725985|4034175|P8|STARTED|OLMP||0
1651840|NCT00725985|4034176|P7|STARTED|OLMP||0
1651841|NCT00725985|4034177|P6|STARTED|OLMP||60
1651842|NCT00725985|4034178|P5|STARTED|OLMP||25
1651843|NCT00725985|4034179|P4|STARTED|OLMP||24
1651844|NCT00725985|4034180|P3|STARTED|OLMP||0
1651845|NCT00725985|4034181|P2|STARTED|OLMP||0
1651846|NCT00725985|4034182|P1|STARTED|OLMP||0
1651847|NCT00725985|4034171|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1651848|NCT00725985|4034172|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1651849|NCT00725985|4034173|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1651850|NCT00725985|4034174|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1651851|NCT00725985|4034175|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1651852|NCT00725985|4034176|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1651853|NCT00725985|4034177|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1651854|NCT00725985|4034178|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1651855|NCT00725985|4034179|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1651856|NCT00725985|4034180|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
1651857|NCT00725985|4034181|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
1651858|NCT00725985|4034182|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
1651859|NCT00725985|4034171|P12|COMPLETED|ITP (Up to 96 Weeks)||0
1651860|NCT00725985|4034172|P11|COMPLETED|ITP (Up to 96 Weeks)||0
1651861|NCT00725985|4034173|P10|COMPLETED|ITP (Up to 96 Weeks)||0
1651862|NCT00725985|4034174|P9|COMPLETED|ITP (Up to 96 Weeks)||0
1651863|NCT00725985|4034175|P8|COMPLETED|ITP (Up to 96 Weeks)||0
1651864|NCT00725985|4034176|P7|COMPLETED|ITP (Up to 96 Weeks)||0
1651865|NCT00725985|4034177|P6|COMPLETED|ITP (Up to 96 Weeks)||0
1651866|NCT00725985|4034178|P5|COMPLETED|ITP (Up to 96 Weeks)||0
1651867|NCT00725985|4034179|P4|COMPLETED|ITP (Up to 96 Weeks)||0
1651868|NCT00725985|4034180|P3|COMPLETED|ITP (Up to 96 Weeks)||104
1651869|NCT00725985|4034181|P2|COMPLETED|ITP (Up to 96 Weeks)||131
1651870|NCT00725985|4034182|P1|COMPLETED|ITP (Up to 96 Weeks)||104
1651871|NCT00725985|4034171|P12|Treated|ITP (Up to 96 Weeks)||0
1651872|NCT00725985|4034172|P11|Treated|ITP (Up to 96 Weeks)||0
1651873|NCT00725985|4034173|P10|Treated|ITP (Up to 96 Weeks)||0
1651874|NCT00725985|4034174|P9|Treated|ITP (Up to 96 Weeks)||0
1651875|NCT00725985|4034175|P8|Treated|ITP (Up to 96 Weeks)||0
1651876|NCT00725985|4034176|P7|Treated|ITP (Up to 96 Weeks)||0
1651877|NCT00725985|4034177|P6|Treated|ITP (Up to 96 Weeks)||0
1651878|NCT00725985|4034178|P5|Treated|ITP (Up to 96 Weeks)||0
1651879|NCT00725985|4034179|P4|Treated|ITP (Up to 96 Weeks)||0
1651880|NCT00725985|4034180|P3|Treated|ITP (Up to 96 Weeks)||206
1651881|NCT00725985|4034181|P2|Treated|ITP (Up to 96 Weeks)||206
1651882|NCT00725985|4034182|P1|Treated|ITP (Up to 96 Weeks)||204
1651883|NCT00725985|4034171|P12|STARTED|ITP (Up to 96 Weeks)||0
1651884|NCT00725985|4034172|P11|STARTED|ITP (Up to 96 Weeks)||0
1651885|NCT00725985|4034173|P10|STARTED|ITP (Up to 96 Weeks)||0
1651886|NCT00725985|4034174|P9|STARTED|ITP (Up to 96 Weeks)||0
1651887|NCT00725985|4034175|P8|STARTED|ITP (Up to 96 Weeks)||0
1651888|NCT00725985|4034176|P7|STARTED|ITP (Up to 96 Weeks)||0
1651889|NCT00725985|4034177|P6|STARTED|ITP (Up to 96 Weeks)||0
1651890|NCT00725985|4034178|P5|STARTED|ITP (Up to 96 Weeks)||0
1651891|NCT00725985|4034179|P4|STARTED|ITP (Up to 96 Weeks)||0
1651892|NCT00725985|4034180|P3|STARTED|ITP (Up to 96 Weeks)||206
1651893|NCT00725985|4034181|P2|STARTED|ITP (Up to 96 Weeks)||206
1651894|NCT00725985|4034182|P1|STARTED|ITP (Up to 96 Weeks)||205
1651895|NCT00725959|4034210|P2|NOT COMPLETED|Overall Study||197
1651896|NCT00725959|4034211|P1|NOT COMPLETED|Overall Study||289
1651897|NCT00725959|4034210|P2|COMPLETED|Overall Study||439
1651898|NCT00725959|4034211|P1|COMPLETED|Overall Study||653
1651899|NCT00725959|4034210|P2|STARTED|Overall Study||636
1651900|NCT00725959|4034211|P1|STARTED|Overall Study||942
1651901|NCT00725920|4034219|P2|NOT COMPLETED|Overall Study||6
1651902|NCT00725920|4034220|P1|NOT COMPLETED|Overall Study||3
1651903|NCT00725920|4034219|P2|COMPLETED|Overall Study||12
1651904|NCT00725920|4034220|P1|COMPLETED|Overall Study||14
1651905|NCT00725920|4034219|P2|STARTED|Overall Study||18
1651906|NCT00725920|4034220|P1|STARTED|Overall Study||17
1651907|NCT00725842|4034226|P1|NOT COMPLETED|Overall Study||40
1651908|NCT00725842|4034226|P1|COMPLETED|Overall Study||57
1651909|NCT00725842|4034226|P1|Participants Eligible for Analysis|Overall Study||90
1651910|NCT00725842|4034226|P1|STARTED|Overall Study||97
1651911|NCT00725764|4034233|P1|NOT COMPLETED|Overall Study||14
1651912|NCT00725764|4034233|P1|COMPLETED|Overall Study||0
1651913|NCT00725764|4034233|P1|STARTED|Overall Study||14
1651914|NCT00725751|4034253|P2|NOT COMPLETED|Overall Study||108
1651915|NCT00725751|4034254|P1|NOT COMPLETED|Overall Study||34
1651916|NCT00725751|4034253|P2|COMPLETED|Overall Study||150
1651917|NCT00725751|4034254|P1|COMPLETED|Overall Study||56
1651918|NCT00725751|4034253|P2|STARTED|Overall Study||258
1651919|NCT00725751|4034254|P1|STARTED|Overall Study||90
1651920|NCT00725725|4034266|P3|NOT COMPLETED|Overall Study||5
1651921|NCT00725725|4034267|P2|NOT COMPLETED|Overall Study||4
1651922|NCT00725725|4034268|P1|NOT COMPLETED|Overall Study||4
1651923|NCT00725725|4034266|P3|COMPLETED|Overall Study||12
1651924|NCT00725725|4034267|P2|COMPLETED|Overall Study||11
1651925|NCT00725725|4034268|P1|COMPLETED|Overall Study||10
1651926|NCT00725725|4034266|P3|Treated|Overall Study||14
1651927|NCT00725725|4034267|P2|Treated|Overall Study||15
1651928|NCT00725725|4034268|P1|Treated|Overall Study||11
1651929|NCT00725725|4034266|P3|STARTED|Overall Study||17
1651930|NCT00725725|4034267|P2|STARTED|Overall Study||15
1651931|NCT00725725|4034268|P1|STARTED|Overall Study||14
1651932|NCT00725712|4034311|P2|NOT COMPLETED|Overall Study||26
1651933|NCT00725712|4034312|P1|NOT COMPLETED|Overall Study||48
1651934|NCT00725712|4034311|P2|COMPLETED|Overall Study||0
1651935|NCT00725712|4034312|P1|COMPLETED|Overall Study||0
1651936|NCT00725712|4034311|P2|STARTED|Overall Study||26
1651937|NCT00725712|4034312|P1|STARTED|Overall Study||48
1651938|NCT00725621|4034348|P1|NOT COMPLETED|Overall Study||271
1651939|NCT00725621|4034348|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
1651940|NCT00725621|4034348|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
1651941|NCT00725608|4034371|P1|NOT COMPLETED|Overall Study||167
1651942|NCT00725608|4034371|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
1651943|NCT00725608|4034371|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
1651944|NCT00725543|4034377|P1|NOT COMPLETED|Overall Study||153
1651945|NCT00725543|4034377|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
1651946|NCT00725543|4034377|P1|STARTED|Overall Study||358
1651947|NCT00725530|4034386|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
1651948|NCT00725530|4034387|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
1651949|NCT00725530|4034386|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
1651950|NCT00725530|4034387|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
1651951|NCT00725530|4034386|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
1651952|NCT00725530|4034387|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
1651953|NCT00725530|4034386|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
1651954|NCT00725530|4034387|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
1651955|NCT00725530|4034386|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
1651956|NCT00725530|4034387|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
1651957|NCT00725530|4034386|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
1651958|NCT00725530|4034387|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
1651959|NCT00725504|4034393|P1|NOT COMPLETED|Overall Study||0
1651960|NCT00725504|4034393|P1|COMPLETED|Overall Study||71
1651961|NCT00725504|4034393|P1|STARTED|Overall Study||71
1651962|NCT00725491|4034402|P2|NOT COMPLETED|Overall Study||18
1651963|NCT00725491|4034403|P1|NOT COMPLETED|Overall Study||9
1651964|NCT00725491|4034402|P2|COMPLETED|Overall Study||102
1651965|NCT00725491|4034403|P1|COMPLETED|Overall Study||104
1651966|NCT00725491|4034402|P2|STARTED|Overall Study|Intent-to-Treat Group|120
1651967|NCT00725491|4034403|P1|STARTED|Overall Study|Intent-to-Treat Group|113
1651968|NCT00725452|4034409|P1|NOT COMPLETED|Overall Study||11
1651969|NCT00725452|4034409|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
1651970|NCT00725452|4034409|P1|STARTED|Overall Study||26
1651971|NCT00725361|4034418|P1|NOT COMPLETED|Overall Study||4
1651972|NCT00725361|4034418|P1|COMPLETED|Overall Study||16
1651973|NCT00725361|4034418|P1|STARTED|Overall Study||20
1651974|NCT00725322|4034428|P2|NOT COMPLETED|Second Injection Visit||0
1651975|NCT00725322|4034429|P1|NOT COMPLETED|Second Injection Visit||0
1651976|NCT00725322|4034428|P2|COMPLETED|Second Injection Visit||14
1651977|NCT00725322|4034429|P1|COMPLETED|Second Injection Visit||13
1651978|NCT00725322|4034428|P2|STARTED|Second Injection Visit||14
1651979|NCT00725322|4034429|P1|STARTED|Second Injection Visit||13
1651980|NCT00725322|4034428|P2|NOT COMPLETED|Washout (28 Days)||1
1651981|NCT00725322|4034429|P1|NOT COMPLETED|Washout (28 Days)||2
1651982|NCT00725322|4034428|P2|COMPLETED|Washout (28 Days)||14
1651983|NCT00725322|4034429|P1|COMPLETED|Washout (28 Days)||13
1651984|NCT00725322|4034428|P2|STARTED|Washout (28 Days)||15
1651985|NCT00725322|4034429|P1|STARTED|Washout (28 Days)||15
1651986|NCT00725322|4034428|P2|NOT COMPLETED|First Injection Visit||0
1651987|NCT00725322|4034429|P1|NOT COMPLETED|First Injection Visit||0
1651988|NCT00725322|4034428|P2|COMPLETED|First Injection Visit||15
1651989|NCT00725322|4034429|P1|COMPLETED|First Injection Visit||15
1651990|NCT00725322|4034428|P2|STARTED|First Injection Visit||15
1651991|NCT00725322|4034429|P1|STARTED|First Injection Visit||15
1651992|NCT00725296|4034437|P1|NOT COMPLETED|Overall Study||62
1651993|NCT00725296|4034437|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
1651994|NCT00725296|4034437|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
1651995|NCT00725283|4034446|P1|NOT COMPLETED|Overall Study||24
1651996|NCT00725283|4034446|P1|COMPLETED|Overall Study||10
1651997|NCT00725283|4034446|P1|STARTED|Overall Study||34
1651998|NCT00725270|4034458|P2|NOT COMPLETED|Overall Study||0
1651999|NCT00725270|4034459|P1|NOT COMPLETED|Overall Study||0
1652000|NCT00725270|4034458|P2|COMPLETED|Overall Study||7
1652001|NCT00725270|4034459|P1|COMPLETED|Overall Study||5
1652002|NCT00725270|4034458|P2|STARTED|Overall Study||7
1652003|NCT00725270|4034459|P1|STARTED|Overall Study||5
1652004|NCT00725205|4034467|P1|NOT COMPLETED|Overall Study||87
1652005|NCT00725205|4034467|P1|COMPLETED|Overall Study||207
1652006|NCT00725205|4034467|P1|STARTED|Overall Study||294
1652007|NCT00725153|4034473|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
1652008|NCT00725153|4034474|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
1652009|NCT00725153|4034473|P2|COMPLETED|Period Two, 10 Hours of Wear||28
1652010|NCT00725153|4034474|P1|COMPLETED|Period Two, 10 Hours of Wear||27
1652011|NCT00725153|4034473|P2|STARTED|Period Two, 10 Hours of Wear||28
1652012|NCT00725153|4034474|P1|STARTED|Period Two, 10 Hours of Wear||27
1652013|NCT00725153|4034473|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
1652014|NCT00725153|4034474|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
1652015|NCT00725153|4034473|P2|COMPLETED|Period One, 10 Hours of Wear||28
1652016|NCT00725153|4034474|P1|COMPLETED|Period One, 10 Hours of Wear||27
1652017|NCT00725153|4034473|P2|STARTED|Period One, 10 Hours of Wear||28
1652018|NCT00725153|4034474|P1|STARTED|Period One, 10 Hours of Wear||27
1652019|NCT00725101|4034480|P1|NOT COMPLETED|Overall Study||495
1652020|NCT00725101|4034480|P1|COMPLETED|Overall Study||1205
1652021|NCT00725101|4034480|P1|STARTED|Overall Study||1700
1652022|NCT00725075|4034503|P3|NOT COMPLETED|Overall Study||9
1652023|NCT00725075|4034504|P2|NOT COMPLETED|Overall Study||8
1652024|NCT00725075|4034505|P1|NOT COMPLETED|Overall Study||11
1652025|NCT00725075|4034503|P3|COMPLETED|Overall Study||61
1652026|NCT00725075|4034504|P2|COMPLETED|Overall Study||65
1652027|NCT00725075|4034505|P1|COMPLETED|Overall Study||61
1652028|NCT00725075|4034503|P3|Treated|Overall Study||70
1652029|NCT00725075|4034504|P2|Treated|Overall Study||73
1652030|NCT00725075|4034505|P1|Treated|Overall Study||71
1652031|NCT00725075|4034503|P3|STARTED|Overall Study||70
1652032|NCT00725075|4034504|P2|STARTED|Overall Study||73
1652033|NCT00725075|4034505|P1|STARTED|Overall Study||72
1652034|NCT00725049|4034551|P2|NOT COMPLETED|Overall Study||0
1652035|NCT00725049|4034552|P1|NOT COMPLETED|Overall Study||0
1652036|NCT00725049|4034551|P2|COMPLETED|Overall Study||20
1652037|NCT00725049|4034552|P1|COMPLETED|Overall Study||17
1652038|NCT00725049|4034551|P2|STARTED|Overall Study||20
1652039|NCT00725049|4034552|P1|STARTED|Overall Study||17
1652040|NCT00725010|4034558|P1|NOT COMPLETED|Overall Study||25
1652041|NCT00725010|4034558|P1|COMPLETED|Overall Study||25
1652042|NCT00725010|4034558|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
1652043|NCT00724984|4034572|P6|NOT COMPLETED|Overall Study||5
1652044|NCT00724984|4034573|P5|NOT COMPLETED|Overall Study||4
1652045|NCT00724984|4034574|P4|NOT COMPLETED|Overall Study||2
1652046|NCT00724984|4034575|P3|NOT COMPLETED|Overall Study||0
1652047|NCT00724984|4034576|P2|NOT COMPLETED|Overall Study||1
1652048|NCT00724984|4034577|P1|NOT COMPLETED|Overall Study||1
1652049|NCT00724984|4034572|P6|COMPLETED|Overall Study||9
1652050|NCT00724984|4034573|P5|COMPLETED|Overall Study||12
1652051|NCT00724984|4034574|P4|COMPLETED|Overall Study||7
1652052|NCT00724984|4034575|P3|COMPLETED|Overall Study||3
1652053|NCT00724984|4034576|P2|COMPLETED|Overall Study||7
1652054|NCT00724984|4034577|P1|COMPLETED|Overall Study||4
1652055|NCT00724984|4034572|P6|STARTED|Overall Study||14
1652056|NCT00724984|4034573|P5|STARTED|Overall Study||16
1652057|NCT00724984|4034574|P4|STARTED|Overall Study||9
1652058|NCT00724984|4034575|P3|STARTED|Overall Study||3
1652059|NCT00724984|4034576|P2|STARTED|Overall Study||8
1652060|NCT00724984|4034577|P1|STARTED|Overall Study||5
1652061|NCT00724958|4034591|P1|NOT COMPLETED|Overall Study||182
1652062|NCT00724958|4034591|P1|COMPLETED|Overall Study||166
1652063|NCT00724958|4034591|P1|STARTED|Overall Study||348
1652064|NCT00724945|4034600|P2|NOT COMPLETED|Period 2||0
1652065|NCT00724945|4034601|P1|NOT COMPLETED|Period 2||4
1652066|NCT00724945|4034600|P2|COMPLETED|Period 2||54
1652067|NCT00724945|4034601|P1|COMPLETED|Period 2||51
1652068|NCT00724945|4034600|P2|STARTED|Period 2||54
1652069|NCT00724945|4034601|P1|STARTED|Period 2||55
1652070|NCT00724945|4034600|P2|NOT COMPLETED|Period 1||1
1652071|NCT00724945|4034601|P1|NOT COMPLETED|Period 1||3
1652072|NCT00724945|4034600|P2|COMPLETED|Period 1||54
1652073|NCT00724945|4034601|P1|COMPLETED|Period 1||55
1652074|NCT00724945|4034600|P2|STARTED|Period 1||55
1652075|NCT00724945|4034601|P1|STARTED|Period 1||58
1652076|NCT00724932|4034613|P2|NOT COMPLETED|Overall Study||3
1652077|NCT00724932|4034614|P1|NOT COMPLETED|Overall Study||5
1652078|NCT00724932|4034613|P2|COMPLETED|Overall Study||67
1652079|NCT00724932|4034614|P1|COMPLETED|Overall Study||65
1652080|NCT00724932|4034613|P2|STARTED|Overall Study||70
1652081|NCT00724932|4034614|P1|STARTED|Overall Study||70
1652082|NCT00724893|4034685|P2|NOT COMPLETED|Overall Study||458
1652083|NCT00724893|4034686|P1|NOT COMPLETED|Overall Study||364
1652084|NCT00724893|4034685|P2|COMPLETED|Overall Study||670
1652085|NCT00724893|4034686|P1|COMPLETED|Overall Study||938
1652086|NCT00724893|4034685|P2|STARTED|Overall Study||1128
1652087|NCT00724893|4034686|P1|STARTED|Overall Study||1302
1652088|NCT00724867|4034754|P1|NOT COMPLETED|Overall Study||128
1652089|NCT00724867|4034754|P1|COMPLETED|Overall Study||140
1652090|NCT00724867|4034754|P1|STARTED|Overall Study||268
1652091|NCT00724854|4034794|P2|NOT COMPLETED|Overall Study||31
1652092|NCT00724854|4034795|P1|NOT COMPLETED|Overall Study||403
1652093|NCT00724854|4034794|P2|COMPLETED|Overall Study||41
1652094|NCT00724854|4034795|P1|COMPLETED|Overall Study||607
1652095|NCT00724854|4034794|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
1652096|NCT00724854|4034795|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
1652097|NCT00724815|4034812|P2|NOT COMPLETED|Overall Study||39
1652098|NCT00724815|4034813|P1|NOT COMPLETED|Overall Study||43
1652099|NCT00724815|4034812|P2|COMPLETED|Overall Study||226
1652100|NCT00724815|4034813|P1|COMPLETED|Overall Study||222
1652101|NCT00724815|4034812|P2|STARTED|Overall Study|subjects randomized|265
1652102|NCT00724815|4034813|P1|STARTED|Overall Study|subjects randomized|265
1652103|NCT00724750|4034827|P2|NOT COMPLETED|Overall Study||0
1652104|NCT00724750|4034828|P1|NOT COMPLETED|Overall Study||0
1652105|NCT00724750|4034827|P2|COMPLETED|Overall Study||42
1652106|NCT00724750|4034828|P1|COMPLETED|Overall Study||45
1652107|NCT00724750|4034827|P2|STARTED|Overall Study||42
1652108|NCT00724750|4034828|P1|STARTED|Overall Study||45
1652109|NCT00724711|4034846|P2|NOT COMPLETED|Overall Study||17
1652110|NCT00724711|4034847|P1|NOT COMPLETED|Overall Study||17
1652111|NCT00724711|4034846|P2|COMPLETED|Overall Study||139
1652112|NCT00724711|4034847|P1|COMPLETED|Overall Study||138
1652113|NCT00724711|4034846|P2|STARTED|Overall Study||156
1652114|NCT00724711|4034847|P1|STARTED|Overall Study||155
1652115|NCT00724698|4034879|P1|NOT COMPLETED|Overall Study||90
1652116|NCT00724698|4034879|P1|COMPLETED|Overall Study||2921
1652117|NCT00724698|4034879|P1|STARTED|Overall Study||3011
1652118|NCT00724594|4034886|P4|NOT COMPLETED|Overall Study||1
1652119|NCT00724594|4034887|P3|NOT COMPLETED|Overall Study||0
1652120|NCT00724594|4034888|P2|NOT COMPLETED|Overall Study||0
1652121|NCT00724594|4034889|P1|NOT COMPLETED|Overall Study||0
1652122|NCT00724594|4034886|P4|COMPLETED|Overall Study||10
1652123|NCT00724594|4034887|P3|COMPLETED|Overall Study||11
1652124|NCT00724594|4034888|P2|COMPLETED|Overall Study||12
1652125|NCT00724594|4034889|P1|COMPLETED|Overall Study||12
1652126|NCT00724594|4034886|P4|STARTED|Overall Study||11
1652127|NCT00724594|4034887|P3|STARTED|Overall Study||11
1652128|NCT00724594|4034888|P2|STARTED|Overall Study||12
1652129|NCT00724594|4034889|P1|STARTED|Overall Study||12
1652130|NCT00724568|4034924|P2|NOT COMPLETED|Overall Study||0
1652131|NCT00724568|4034925|P1|NOT COMPLETED|Overall Study||0
1652132|NCT00724568|4034924|P2|COMPLETED|Overall Study||32
1652133|NCT00724568|4034925|P1|COMPLETED|Overall Study||42
1652134|NCT00724568|4034924|P2|STARTED|Overall Study||32
1652135|NCT00724568|4034925|P1|STARTED|Overall Study||42
1652136|NCT00724477|4034930|P1|NOT COMPLETED|Overall Study||0
1652137|NCT00724477|4034930|P1|COMPLETED|Overall Study||1663
1652138|NCT00724477|4034930|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
1652139|NCT00724464|4034934|P1|NOT COMPLETED|Overall Study||23
1652140|NCT00724464|4034934|P1|COMPLETED|Overall Study||309
1652141|NCT00724464|4034934|P1|STARTED|Overall Study||332
1652142|NCT00724451|4034946|P1|NOT COMPLETED|Overall Study||802
1652143|NCT00724451|4034946|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
1652144|NCT00724451|4034946|P1|Received Antiviral Treatment|Overall Study||500
1652145|NCT00724451|4034946|P1|STARTED|Overall Study||1128
1652146|NCT00724373|4034952|P1|NOT COMPLETED|Overall Study||171
1652147|NCT00724373|4034952|P1|COMPLETED|Overall Study||271
1652148|NCT00724373|4034952|P1|STARTED|Overall Study||442
1652149|NCT00724347|4034956|P1|NOT COMPLETED|Overall Study||2
1652150|NCT00724347|4034956|P1|COMPLETED|Overall Study||16
1652151|NCT00724347|4034956|P1|Baseline Testing|Overall Study||18
1652152|NCT00724347|4034956|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
1652153|NCT00724308|4034962|P2|NOT COMPLETED|Overall Study||97
1652154|NCT00724308|4034963|P1|NOT COMPLETED|Overall Study||80
1652155|NCT00724308|4034962|P2|COMPLETED|Overall Study||210
1652156|NCT00724308|4034963|P1|COMPLETED|Overall Study||190
1652157|NCT00724308|4034962|P2|STARTED|Overall Study||307
1652158|NCT00724308|4034963|P1|STARTED|Overall Study||270
1652159|NCT00724282|4034969|P1|NOT COMPLETED|Overall Study||4
1652160|NCT00724282|4034969|P1|COMPLETED|Overall Study||16
1652161|NCT00724282|4034969|P1|STARTED|Overall Study||20
1652162|NCT00724243|4034973|P1|NOT COMPLETED|Overall Study||15
1652163|NCT00724243|4034973|P1|COMPLETED|Overall Study||18
1652164|NCT00724243|4034973|P1|STARTED|Overall Study||33
1652165|NCT00724152|4034983|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
1652166|NCT00724152|4034984|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
1652167|NCT00724152|4034985|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
1652168|NCT00724152|4034983|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
1652169|NCT00724152|4034984|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
1652170|NCT00724152|4034985|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
1652171|NCT00724152|4034983|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
1652172|NCT00724152|4034984|P2|STARTED|Three-arm Study Period (+Standard Care)||2
1652173|NCT00724152|4034985|P1|STARTED|Three-arm Study Period (+Standard Care)||4
1652174|NCT00724152|4034983|P3|NOT COMPLETED|Two-arm Study Period||0
1652175|NCT00724152|4034984|P2|NOT COMPLETED|Two-arm Study Period||2
1652176|NCT00724152|4034985|P1|NOT COMPLETED|Two-arm Study Period||3
1652177|NCT00724152|4034983|P3|COMPLETED|Two-arm Study Period||0
1652178|NCT00724152|4034984|P2|COMPLETED|Two-arm Study Period||9
1652179|NCT00724152|4034985|P1|COMPLETED|Two-arm Study Period||11
1652180|NCT00724152|4034983|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
1652181|NCT00724152|4034984|P2|STARTED|Two-arm Study Period||11
1652182|NCT00724152|4034985|P1|STARTED|Two-arm Study Period||14
1652183|NCT00724126|4035002|P2|NOT COMPLETED|Overall Study||15
1652184|NCT00724126|4035003|P1|NOT COMPLETED|Overall Study||19
1652185|NCT00724126|4035002|P2|COMPLETED|Overall Study||301
1652186|NCT00724126|4035003|P1|COMPLETED|Overall Study||302
1652187|NCT00724126|4035002|P2|STARTED|Overall Study||316
1652188|NCT00724126|4035003|P1|STARTED|Overall Study||321
1652189|NCT00724061|4035011|P1|NOT COMPLETED|Maintenance Therapy||0
1652190|NCT00724061|4035011|P1|COMPLETED|Maintenance Therapy||2
1652191|NCT00724061|4035011|P1|STARTED|Maintenance Therapy||2
1652192|NCT00724061|4035011|P1|NOT COMPLETED|Dose Escalation Phase||5
1652193|NCT00724061|4035011|P1|COMPLETED|Dose Escalation Phase||2
1652194|NCT00724061|4035011|P1|STARTED|Dose Escalation Phase||7
1652195|NCT00724009|4035018|P1|NOT COMPLETED|Overall Study||0
1652196|NCT00724009|4035018|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
1652197|NCT00724009|4035018|P1|STARTED|Overall Study||29
1652198|NCT00723957|4035031|P2|NOT COMPLETED|Overall Study||53
1652199|NCT00723957|4035032|P1|NOT COMPLETED|Overall Study||51
1652200|NCT00723957|4035031|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
1652201|NCT00723957|4035032|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
1652202|NCT00723957|4035031|P2|STARTED|Overall Study|Randomized|99
1652203|NCT00723957|4035032|P1|STARTED|Overall Study|Randomized|98
1652204|NCT00723944|4035056|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
1652205|NCT00723944|4035057|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
1652206|NCT00723944|4035056|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
1652207|NCT00723944|4035057|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
1652208|NCT00723944|4035056|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
1652209|NCT00723944|4035057|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
1652210|NCT00723944|4035056|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
1652211|NCT00723944|4035057|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
1652212|NCT00723944|4035056|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
1652213|NCT00723944|4035057|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
1652214|NCT00723944|4035056|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
1652215|NCT00723944|4035057|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
1652216|NCT00723944|4035056|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
1652217|NCT00723944|4035057|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
1652218|NCT00723944|4035056|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
1652219|NCT00723944|4035057|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
1652220|NCT00723944|4035056|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
1652221|NCT00723944|4035057|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
1652222|NCT00723944|4035056|P2|NOT COMPLETED|Implant Placement Surgery||0
1652223|NCT00723944|4035057|P1|NOT COMPLETED|Implant Placement Surgery||0
1652224|NCT00723944|4035056|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
1652225|NCT00723944|4035057|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
1652226|NCT00723944|4035056|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
1652227|NCT00723944|4035057|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
1652228|NCT00723931|4035063|P1|NOT COMPLETED|Overall Study||0
1652229|NCT00723931|4035063|P1|COMPLETED|Overall Study||1267
1652230|NCT00723931|4035063|P1|STARTED|Overall Study||1267
1652231|NCT00723892|4035070|P2|NOT COMPLETED|Overall Study||87
1652232|NCT00723892|4035071|P1|NOT COMPLETED|Overall Study||107
1652233|NCT00723892|4035070|P2|COMPLETED|Overall Study||168
1652234|NCT00723892|4035071|P1|COMPLETED|Overall Study||206
1652235|NCT00723892|4035070|P2|STARTED|Overall Study||255
1652236|NCT00723892|4035071|P1|STARTED|Overall Study||313
1652237|NCT00723840|4035078|P1|NOT COMPLETED|Overall Study||82
1652238|NCT00723840|4035078|P1|COMPLETED|Overall Study||163
1652239|NCT00723840|4035078|P1|STARTED|Overall Study||245
1652240|NCT00723827|4035089|P1|NOT COMPLETED|Overall Study||0
1652241|NCT00723827|4035089|P1|COMPLETED|Overall Study||682
1652242|NCT00723827|4035089|P1|STARTED|Overall Study||682
1652243|NCT00723801|4035099|P2|NOT COMPLETED|Overall Study||3
1652244|NCT00723801|4035100|P1|NOT COMPLETED|Overall Study||3
1652245|NCT00723801|4035099|P2|COMPLETED|Overall Study||17
1652246|NCT00723801|4035100|P1|COMPLETED|Overall Study||17
1652247|NCT00723801|4035099|P2|STARTED|Overall Study||20
1652248|NCT00723801|4035100|P1|STARTED|Overall Study||20
1652249|NCT00723788|4035108|P1|NOT COMPLETED|Overall Study||0
1652250|NCT00723788|4035108|P1|COMPLETED|Overall Study||21
1652251|NCT00723788|4035108|P1|STARTED|Overall Study||21
1652252|NCT00723749|4035114|P1|NOT COMPLETED|Overall Study||163
1652253|NCT00723749|4035114|P1|COMPLETED|Overall Study||182
1652254|NCT00723749|4035114|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
1652255|NCT00723736|4035121|P1|NOT COMPLETED|Overall Study||1
1652256|NCT00723736|4035121|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
1652257|NCT00723736|4035121|P1|STARTED|Overall Study||100
1652258|NCT00723710|4035125|P1|NOT COMPLETED|Overall Study||174
1652259|NCT00723710|4035125|P1|COMPLETED|Overall Study||120
1652260|NCT00723710|4035125|P1|STARTED|Overall Study||294
1652261|NCT00723697|4035129|P1|NOT COMPLETED|Overall Study||18
1652262|NCT00723697|4035129|P1|COMPLETED|Overall Study||1289
1652263|NCT00723697|4035129|P1|STARTED|Overall Study||1307
1652264|NCT00723645|4035137|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
1652265|NCT00723645|4035137|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
1652266|NCT00723645|4035137|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
1652267|NCT00723645|4035137|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
1652268|NCT00723645|4035137|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
1652269|NCT00723645|4035137|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
1652270|NCT00723645|4035137|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
1652271|NCT00723645|4035137|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
1652272|NCT00723645|4035137|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
1652273|NCT00723632|4035142|P1|NOT COMPLETED|Overall Study||203
1652274|NCT00723632|4035142|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
1652275|NCT00723632|4035142|P1|STARTED|Overall Study||901
1652276|NCT00723606|4035150|P2|NOT COMPLETED|Overall Study||7
1652277|NCT00723606|4035151|P1|NOT COMPLETED|Overall Study||4
1652278|NCT00723606|4035150|P2|COMPLETED|Overall Study||180
1652279|NCT00723606|4035151|P1|COMPLETED|Overall Study||185
1652280|NCT00723606|4035150|P2|STARTED|Overall Study||187
1652281|NCT00723606|4035151|P1|STARTED|Overall Study||189
1652282|NCT00723580|4035167|P1|NOT COMPLETED|Overall Study||0
1652283|NCT00723580|4035167|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
1652284|NCT00723580|4035167|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
1652285|NCT00723580|4035167|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
1652286|NCT00723554|4035171|P1|NOT COMPLETED|Overall Study||29
1652287|NCT00723554|4035171|P1|COMPLETED|Overall Study||34
1652288|NCT00723554|4035171|P1|STARTED|Overall Study||63
1652289|NCT00723528|4035221|P7|NOT COMPLETED|Period 2: After Controlled Period||4
1652290|NCT00723528|4035222|P6|NOT COMPLETED|Period 2: After Controlled Period||6
1652291|NCT00723528|4035223|P5|NOT COMPLETED|Period 2: After Controlled Period||2
1652292|NCT00723528|4035224|P4|NOT COMPLETED|Period 2: After Controlled Period||1
1652293|NCT00723528|4035225|P3|NOT COMPLETED|Period 2: After Controlled Period||0
1652294|NCT00723528|4035226|P2|NOT COMPLETED|Period 2: After Controlled Period||0
1652295|NCT00723528|4035227|P1|NOT COMPLETED|Period 2: After Controlled Period||0
1652296|NCT00723528|4035221|P7|COMPLETED|Period 2: After Controlled Period||54
1652297|NCT00723528|4035222|P6|COMPLETED|Period 2: After Controlled Period||58
1652298|NCT00723528|4035223|P5|COMPLETED|Period 2: After Controlled Period||11
1652299|NCT00723528|4035224|P4|COMPLETED|Period 2: After Controlled Period||14
1652300|NCT00723528|4035225|P3|COMPLETED|Period 2: After Controlled Period||0
1652301|NCT00723528|4035226|P2|COMPLETED|Period 2: After Controlled Period||0
1652302|NCT00723528|4035227|P1|COMPLETED|Period 2: After Controlled Period||0
1652303|NCT00723528|4035221|P7|STARTED|Period 2: After Controlled Period||58
1652304|NCT00723528|4035222|P6|STARTED|Period 2: After Controlled Period||64
1652305|NCT00723528|4035223|P5|STARTED|Period 2: After Controlled Period||13
1652306|NCT00723528|4035224|P4|STARTED|Period 2: After Controlled Period||15
1652307|NCT00723528|4035225|P3|STARTED|Period 2: After Controlled Period||0
1652308|NCT00723528|4035226|P2|STARTED|Period 2: After Controlled Period||0
1652309|NCT00723528|4035227|P1|STARTED|Period 2: After Controlled Period||0
1652310|NCT00723528|4035221|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1652311|NCT00723528|4035222|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1652312|NCT00723528|4035223|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1652313|NCT00723528|4035224|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1652314|NCT00723528|4035225|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
1652315|NCT00723528|4035226|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1652316|NCT00723528|4035227|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
1652317|NCT00723528|4035221|P7|COMPLETED|Period 1: Controlled Period (CP)||0
1652318|NCT00723528|4035222|P6|COMPLETED|Period 1: Controlled Period (CP)||0
1652319|NCT00723528|4035223|P5|COMPLETED|Period 1: Controlled Period (CP)||0
1652320|NCT00723528|4035224|P4|COMPLETED|Period 1: Controlled Period (CP)||0
1652321|NCT00723528|4035225|P3|COMPLETED|Period 1: Controlled Period (CP)||58
1652322|NCT00723528|4035226|P2|COMPLETED|Period 1: Controlled Period (CP)||64
1652323|NCT00723528|4035227|P1|COMPLETED|Period 1: Controlled Period (CP)||28
1652324|NCT00723528|4035221|P7|STARTED|Period 1: Controlled Period (CP)||0
1652325|NCT00723528|4035222|P6|STARTED|Period 1: Controlled Period (CP)||0
1652326|NCT00723528|4035223|P5|STARTED|Period 1: Controlled Period (CP)||0
1652327|NCT00723528|4035224|P4|STARTED|Period 1: Controlled Period (CP)||0
1652328|NCT00723528|4035225|P3|STARTED|Period 1: Controlled Period (CP)||62
1652329|NCT00723528|4035226|P2|STARTED|Period 1: Controlled Period (CP)||64
1652330|NCT00723528|4035227|P1|STARTED|Period 1: Controlled Period (CP)||32
1652331|NCT00723489|4035289|P4|NOT COMPLETED|Overall Study||3
1652332|NCT00723489|4035290|P3|NOT COMPLETED|Overall Study||0
1652333|NCT00723489|4035291|P2|NOT COMPLETED|Overall Study||4
1652334|NCT00723489|4035292|P1|NOT COMPLETED|Overall Study||1
1652335|NCT00723489|4035289|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
1652336|NCT00723489|4035290|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
1652337|NCT00723489|4035291|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
1652338|NCT00723489|4035292|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
1652339|NCT00723489|4035289|P4|STARTED|Overall Study||23
1652340|NCT00723489|4035290|P3|STARTED|Overall Study||19
1652341|NCT00723489|4035291|P2|STARTED|Overall Study||19
1652342|NCT00723489|4035292|P1|STARTED|Overall Study||21
1652343|NCT00723450|4035320|P3|NOT COMPLETED|Randomized Phase||67
1652344|NCT00723450|4035321|P2|NOT COMPLETED|Randomized Phase||65
1652345|NCT00723450|4035322|P1|NOT COMPLETED|Randomized Phase||0
1652346|NCT00723450|4035320|P3|COMPLETED|Randomized Phase||20
1652347|NCT00723450|4035321|P2|COMPLETED|Randomized Phase||21
1652348|NCT00723450|4035322|P1|COMPLETED|Randomized Phase||0
1652349|NCT00723450|4035320|P3|STARTED|Randomized Phase||87
1652350|NCT00723450|4035321|P2|STARTED|Randomized Phase||86
1652351|NCT00723450|4035322|P1|STARTED|Randomized Phase||0
1652352|NCT00723450|4035320|P3|NOT COMPLETED|Open-Label Phase||0
1652353|NCT00723450|4035321|P2|NOT COMPLETED|Open-Label Phase||0
1652354|NCT00723450|4035322|P1|NOT COMPLETED|Open-Label Phase||125
1652355|NCT00723450|4035320|P3|COMPLETED|Open-Label Phase||0
1652356|NCT00723450|4035321|P2|COMPLETED|Open-Label Phase||0
1652357|NCT00723450|4035322|P1|COMPLETED|Open-Label Phase||173
1652358|NCT00723450|4035320|P3|STARTED|Open-Label Phase||0
1652359|NCT00723450|4035321|P2|STARTED|Open-Label Phase||0
1652360|NCT00723450|4035322|P1|STARTED|Open-Label Phase||298
1652361|NCT00723398|4035368|P5|NOT COMPLETED|Overall Study||9
1652362|NCT00723398|4035369|P4|NOT COMPLETED|Overall Study||5
1652363|NCT00723398|4035370|P3|NOT COMPLETED|Overall Study||17
1652364|NCT00723398|4035371|P2|NOT COMPLETED|Overall Study||15
1652365|NCT00723398|4035372|P1|NOT COMPLETED|Overall Study||6
1652366|NCT00723398|4035368|P5|COMPLETED|Overall Study||44
1652367|NCT00723398|4035369|P4|COMPLETED|Overall Study||49
1652368|NCT00723398|4035370|P3|COMPLETED|Overall Study||36
1652369|NCT00723398|4035371|P2|COMPLETED|Overall Study||38
1652370|NCT00723398|4035372|P1|COMPLETED|Overall Study||47
1652371|NCT00723398|4035368|P5|STARTED|Overall Study||53
1652372|NCT00723398|4035369|P4|STARTED|Overall Study||54
1652373|NCT00723398|4035370|P3|STARTED|Overall Study||53
1652374|NCT00723398|4035371|P2|STARTED|Overall Study||53
1652375|NCT00723398|4035372|P1|STARTED|Overall Study||53
1652376|NCT00723294|4035434|P1|NOT COMPLETED|Overall Study||13
1652377|NCT00723294|4035434|P1|COMPLETED|Overall Study||86
1652378|NCT00723294|4035434|P1|STARTED|Overall Study||99
1652379|NCT00723255|4035439|P1|NOT COMPLETED|Overall Study||4
1652380|NCT00723255|4035439|P1|COMPLETED|Overall Study|Eligible and treated patients|49
1652381|NCT00723255|4035439|P1|STARTED|Overall Study||53
1652382|NCT00723229|4035466|P2|NOT COMPLETED|Second Intervention||0
1652383|NCT00723229|4035467|P1|NOT COMPLETED|Second Intervention||0
1652384|NCT00723229|4035466|P2|COMPLETED|Second Intervention||20
1652385|NCT00723229|4035467|P1|COMPLETED|Second Intervention||18
1652386|NCT00723229|4035466|P2|STARTED|Second Intervention||20
1652387|NCT00723229|4035467|P1|STARTED|Second Intervention||18
1652388|NCT00723229|4035466|P2|NOT COMPLETED|First Intervention||3
1652389|NCT00723229|4035467|P1|NOT COMPLETED|First Intervention||7
1652390|NCT00723229|4035466|P2|COMPLETED|First Intervention||20
1652391|NCT00723229|4035467|P1|COMPLETED|First Intervention||18
1652392|NCT00723229|4035466|P2|STARTED|First Intervention||23
1652393|NCT00723229|4035467|P1|STARTED|First Intervention||25
1652394|NCT00723203|4035479|P1|NOT COMPLETED|Overall Study||3
1652395|NCT00723203|4035479|P1|COMPLETED|Overall Study||13
1652396|NCT00723203|4035479|P1|STARTED|Overall Study||16
1652397|NCT00723190|4035483|P1|NOT COMPLETED|Overall Study||142
1652398|NCT00723190|4035483|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
1652399|NCT00723190|4035483|P1|SAFETY POPULATION|Overall Study||301
1652400|NCT00723190|4035483|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
1652401|NCT00723177|4035501|P3|NOT COMPLETED|Overall Study||5
1652402|NCT00723177|4035502|P2|NOT COMPLETED|Overall Study||4
1652403|NCT00723177|4035503|P1|NOT COMPLETED|Overall Study||5
1652404|NCT00723177|4035501|P3|COMPLETED|Overall Study||10
1652405|NCT00723177|4035502|P2|COMPLETED|Overall Study||10
1652406|NCT00723177|4035503|P1|COMPLETED|Overall Study||10
1652407|NCT00723177|4035501|P3|STARTED|Overall Study||15
1652408|NCT00723177|4035502|P2|STARTED|Overall Study||14
1652409|NCT00723177|4035503|P1|STARTED|Overall Study||15
1652410|NCT00723125|4035516|P2|NOT COMPLETED|Overall Study||6
1652411|NCT00723125|4035517|P1|NOT COMPLETED|Overall Study||18
1652412|NCT00723125|4035516|P2|COMPLETED|Overall Study||21
1652413|NCT00723125|4035517|P1|COMPLETED|Overall Study||15
1652414|NCT00723125|4035516|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
1652415|NCT00723125|4035517|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
1652416|NCT00723073|4035529|P2|NOT COMPLETED|Overall Study||0
1652417|NCT00723073|4035530|P1|NOT COMPLETED|Overall Study||0
1652418|NCT00723073|4035529|P2|COMPLETED|Overall Study||174
1652419|NCT00723073|4035530|P1|COMPLETED|Overall Study||149
1652420|NCT00723073|4035529|P2|STARTED|Overall Study||174
1652421|NCT00723073|4035530|P1|STARTED|Overall Study||149
1652422|NCT00723021|4035554|P5|NOT COMPLETED|Intervention Period 5||0
1652423|NCT00723021|4035555|P4|NOT COMPLETED|Intervention Period 5||0
1652424|NCT00723021|4035556|P3|NOT COMPLETED|Intervention Period 5||0
1652425|NCT00723021|4035557|P2|NOT COMPLETED|Intervention Period 5||0
1652426|NCT00723021|4035558|P1|NOT COMPLETED|Intervention Period 5||0
1652427|NCT00723021|4035554|P5|COMPLETED|Intervention Period 5||2
1652428|NCT00723021|4035555|P4|COMPLETED|Intervention Period 5||3
1652429|NCT00723021|4035556|P3|COMPLETED|Intervention Period 5||3
1652430|NCT00723021|4035557|P2|COMPLETED|Intervention Period 5||3
1652431|NCT00723021|4035558|P1|COMPLETED|Intervention Period 5||3
1652432|NCT00723021|4035554|P5|STARTED|Intervention Period 5||2
1652433|NCT00723021|4035555|P4|STARTED|Intervention Period 5||3
1652434|NCT00723021|4035556|P3|STARTED|Intervention Period 5||3
1652435|NCT00723021|4035557|P2|STARTED|Intervention Period 5||3
1652436|NCT00723021|4035558|P1|STARTED|Intervention Period 5||3
1652437|NCT00723021|4035554|P5|NOT COMPLETED|Intervention Period 4||1
1652438|NCT00723021|4035555|P4|NOT COMPLETED|Intervention Period 4||0
1652439|NCT00723021|4035556|P3|NOT COMPLETED|Intervention Period 4||0
1652440|NCT00723021|4035557|P2|NOT COMPLETED|Intervention Period 4||0
1652441|NCT00723021|4035558|P1|NOT COMPLETED|Intervention Period 4||0
1652442|NCT00723021|4035554|P5|COMPLETED|Intervention Period 4||2
1652443|NCT00723021|4035555|P4|COMPLETED|Intervention Period 4||3
1652444|NCT00723021|4035556|P3|COMPLETED|Intervention Period 4||3
1652445|NCT00723021|4035557|P2|COMPLETED|Intervention Period 4||3
1652446|NCT00723021|4035558|P1|COMPLETED|Intervention Period 4||3
1652447|NCT00723021|4035554|P5|STARTED|Intervention Period 4||3
1652448|NCT00723021|4035555|P4|STARTED|Intervention Period 4||3
1652449|NCT00723021|4035556|P3|STARTED|Intervention Period 4||3
1652450|NCT00723021|4035557|P2|STARTED|Intervention Period 4||3
1652451|NCT00723021|4035558|P1|STARTED|Intervention Period 4||3
1652452|NCT00723021|4035554|P5|NOT COMPLETED|Intervention Period 3||0
1652453|NCT00723021|4035555|P4|NOT COMPLETED|Intervention Period 3||0
1652454|NCT00723021|4035556|P3|NOT COMPLETED|Intervention Period 3||0
1652455|NCT00723021|4035557|P2|NOT COMPLETED|Intervention Period 3||0
1652456|NCT00723021|4035558|P1|NOT COMPLETED|Intervention Period 3||0
1652457|NCT00723021|4035554|P5|COMPLETED|Intervention Period 3||3
1652458|NCT00723021|4035555|P4|COMPLETED|Intervention Period 3||3
1652459|NCT00723021|4035556|P3|COMPLETED|Intervention Period 3||3
1652460|NCT00723021|4035557|P2|COMPLETED|Intervention Period 3||3
1652461|NCT00723021|4035558|P1|COMPLETED|Intervention Period 3||3
1652462|NCT00723021|4035554|P5|STARTED|Intervention Period 3||3
1652463|NCT00723021|4035555|P4|STARTED|Intervention Period 3||3
1652464|NCT00723021|4035556|P3|STARTED|Intervention Period 3||3
1652465|NCT00723021|4035557|P2|STARTED|Intervention Period 3||3
1652466|NCT00723021|4035558|P1|STARTED|Intervention Period 3||3
1652467|NCT00723021|4035554|P5|NOT COMPLETED|Intervention Period 2||0
1652468|NCT00723021|4035555|P4|NOT COMPLETED|Intervention Period 2||0
1652469|NCT00723021|4035556|P3|NOT COMPLETED|Intervention Period 2||0
1652470|NCT00723021|4035557|P2|NOT COMPLETED|Intervention Period 2||0
1652471|NCT00723021|4035558|P1|NOT COMPLETED|Intervention Period 2||0
1652472|NCT00723021|4035554|P5|COMPLETED|Intervention Period 2||3
1652473|NCT00723021|4035555|P4|COMPLETED|Intervention Period 2||3
1652474|NCT00723021|4035556|P3|COMPLETED|Intervention Period 2||3
1652475|NCT00723021|4035557|P2|COMPLETED|Intervention Period 2||3
1652476|NCT00723021|4035558|P1|COMPLETED|Intervention Period 2||3
1652477|NCT00723021|4035554|P5|STARTED|Intervention Period 2||3
1652478|NCT00723021|4035555|P4|STARTED|Intervention Period 2||3
1652479|NCT00723021|4035556|P3|STARTED|Intervention Period 2||3
1652480|NCT00723021|4035557|P2|STARTED|Intervention Period 2||3
1652481|NCT00723021|4035558|P1|STARTED|Intervention Period 2||3
1652482|NCT00723021|4035554|P5|NOT COMPLETED|Intervention Period 1||0
1652483|NCT00723021|4035555|P4|NOT COMPLETED|Intervention Period 1||0
1652484|NCT00723021|4035556|P3|NOT COMPLETED|Intervention Period 1||0
1652485|NCT00723021|4035557|P2|NOT COMPLETED|Intervention Period 1||0
1652486|NCT00723021|4035558|P1|NOT COMPLETED|Intervention Period 1||0
1652487|NCT00723021|4035554|P5|COMPLETED|Intervention Period 1||3
1652488|NCT00723021|4035555|P4|COMPLETED|Intervention Period 1||3
1652489|NCT00723021|4035556|P3|COMPLETED|Intervention Period 1||3
1652490|NCT00723021|4035557|P2|COMPLETED|Intervention Period 1||3
1652491|NCT00723021|4035558|P1|COMPLETED|Intervention Period 1||3
1652492|NCT00723021|4035554|P5|STARTED|Intervention Period 1||3
1652493|NCT00723021|4035555|P4|STARTED|Intervention Period 1||3
1652494|NCT00723021|4035556|P3|STARTED|Intervention Period 1||3
1652495|NCT00723021|4035557|P2|STARTED|Intervention Period 1||3
1652496|NCT00723021|4035558|P1|STARTED|Intervention Period 1||3
1652497|NCT00723008|4035612|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
1652498|NCT00723008|4035613|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
1652499|NCT00723008|4035612|P2|COMPLETED|4-Week Unblinded Treatment||3
1652500|NCT00723008|4035613|P1|COMPLETED|4-Week Unblinded Treatment||4
1652501|NCT00723008|4035612|P2|STARTED|4-Week Unblinded Treatment||4
1652502|NCT00723008|4035613|P1|STARTED|4-Week Unblinded Treatment||5
1652503|NCT00723008|4035612|P2|NOT COMPLETED|4-Week Double Blinded||5
1652504|NCT00723008|4035613|P1|NOT COMPLETED|4-Week Double Blinded||5
1652505|NCT00723008|4035612|P2|COMPLETED|4-Week Double Blinded||4
1652506|NCT00723008|4035613|P1|COMPLETED|4-Week Double Blinded||5
1652507|NCT00723008|4035612|P2|STARTED|4-Week Double Blinded||9
1652508|NCT00723008|4035613|P1|STARTED|4-Week Double Blinded||10
1652509|NCT00723008|4035612|P2|NOT COMPLETED|Enrollment||0
1652510|NCT00723008|4035613|P1|NOT COMPLETED|Enrollment||1
1652511|NCT00723008|4035612|P2|COMPLETED|Enrollment||9
1652512|NCT00723008|4035613|P1|COMPLETED|Enrollment||10
1652513|NCT00723008|4035612|P2|STARTED|Enrollment||9
1652514|NCT00723008|4035613|P1|STARTED|Enrollment||11
1652515|NCT00722865|4035635|P1|NOT COMPLETED|Overall Study||2
1652516|NCT00722865|4035635|P1|COMPLETED|Overall Study||23
1652517|NCT00722865|4035635|P1|STARTED|Overall Study||25
1652518|NCT00722800|4035645|P2|NOT COMPLETED|Overall Study||0
1652519|NCT00722800|4035646|P1|NOT COMPLETED|Overall Study||2
1652520|NCT00722800|4035645|P2|COMPLETED|Overall Study||2
1652521|NCT00722800|4035646|P1|COMPLETED|Overall Study||0
1652522|NCT00722800|4035645|P2|STARTED|Overall Study||2
1652523|NCT00722800|4035646|P1|STARTED|Overall Study||2
1652524|NCT00722761|4035658|P2|NOT COMPLETED|Overall Study||6
1652525|NCT00722761|4035659|P1|NOT COMPLETED|Overall Study||6
1652526|NCT00722761|4035658|P2|COMPLETED|Overall Study||8
1652527|NCT00722761|4035659|P1|COMPLETED|Overall Study||10
1652528|NCT00722761|4035658|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
1652529|NCT00722761|4035659|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
1652530|NCT00722761|4035658|P2|STARTED|Overall Study||14
1652531|NCT00722761|4035659|P1|STARTED|Overall Study||16
1652532|NCT00722722|4035670|P3|NOT COMPLETED|Overall Study||0
1652533|NCT00722722|4035671|P2|NOT COMPLETED|Overall Study||0
1652534|NCT00722722|4035672|P1|NOT COMPLETED|Overall Study||0
1652535|NCT00722722|4035670|P3|COMPLETED|Overall Study||10
1652536|NCT00722722|4035671|P2|COMPLETED|Overall Study||5
1652537|NCT00722722|4035672|P1|COMPLETED|Overall Study||3
1652538|NCT00722722|4035670|P3|STARTED|Overall Study||10
1652539|NCT00722722|4035671|P2|STARTED|Overall Study||5
1652540|NCT00722722|4035672|P1|STARTED|Overall Study||3
1652541|NCT00722566|4035682|P2|NOT COMPLETED|Overall Study||35
1652542|NCT00722566|4035683|P1|NOT COMPLETED|Overall Study||67
1652543|NCT00722566|4035682|P2|COMPLETED|Overall Study|Completed 8 cycles|39
1652544|NCT00722566|4035683|P1|COMPLETED|Overall Study|Completed 8 cycles|81
1652545|NCT00722566|4035682|P2|STARTED|Overall Study||74
1652546|NCT00722566|4035683|P1|STARTED|Overall Study|One patient randomized and not dosed|148
1652547|NCT00722553|4035691|P1|NOT COMPLETED|Overall Study||0
1652548|NCT00722553|4035691|P1|COMPLETED|Overall Study||30
1652549|NCT00722553|4035691|P1|STARTED|Overall Study||30
1652550|NCT00722436|4035701|P2|NOT COMPLETED|Overall Study||0
1652551|NCT00722436|4035702|P1|NOT COMPLETED|Overall Study||0
1652552|NCT00722436|4035701|P2|COMPLETED|Overall Study||11
1652553|NCT00722436|4035702|P1|COMPLETED|Overall Study||9
1652554|NCT00722436|4035701|P2|STARTED|Overall Study||11
1652555|NCT00722436|4035702|P1|STARTED|Overall Study||9
1652556|NCT00722423|4035716|P2|NOT COMPLETED|Overall Study||1
1652557|NCT00722423|4035717|P1|NOT COMPLETED|Overall Study||0
1652558|NCT00722423|4035716|P2|COMPLETED|Overall Study||181
1652559|NCT00722423|4035717|P1|COMPLETED|Overall Study||182
1652560|NCT00722423|4035716|P2|STARTED|Overall Study||182
1652561|NCT00722423|4035717|P1|STARTED|Overall Study||182
1652562|NCT00722371|4035732|P7|NOT COMPLETED|Overall Study||51
1652563|NCT00722371|4035733|P6|NOT COMPLETED|Overall Study||53
1652564|NCT00722371|4035734|P5|NOT COMPLETED|Overall Study||48
1652565|NCT00722371|4035735|P4|NOT COMPLETED|Overall Study||63
1652566|NCT00722371|4035736|P3|NOT COMPLETED|Overall Study||65
1652567|NCT00722371|4035737|P2|NOT COMPLETED|Overall Study||72
1652568|NCT00722371|4035738|P1|NOT COMPLETED|Overall Study||56
1652569|NCT00722371|4035732|P7|COMPLETED|Overall Study||179
1652570|NCT00722371|4035733|P6|COMPLETED|Overall Study||178
1652571|NCT00722371|4035734|P5|COMPLETED|Overall Study||182
1652572|NCT00722371|4035735|P4|COMPLETED|Overall Study||167
1652573|NCT00722371|4035736|P3|COMPLETED|Overall Study||168
1652574|NCT00722371|4035737|P2|COMPLETED|Overall Study||158
1652575|NCT00722371|4035738|P1|COMPLETED|Overall Study||175
1652576|NCT00722371|4035732|P7|STARTED|Overall Study||230
1652577|NCT00722371|4035733|P6|STARTED|Overall Study||231
1652578|NCT00722371|4035734|P5|STARTED|Overall Study||230
1652579|NCT00722371|4035735|P4|STARTED|Overall Study||230
1652580|NCT00722371|4035736|P3|STARTED|Overall Study||233
1652581|NCT00722371|4035737|P2|STARTED|Overall Study||230
1652582|NCT00722371|4035738|P1|STARTED|Overall Study||231
1652583|NCT00722137|4035791|P2|NOT COMPLETED|Overall Study||48
1652584|NCT00722137|4035792|P1|NOT COMPLETED|Overall Study||45
1652585|NCT00722137|4035791|P2|COMPLETED|Overall Study||195
1652586|NCT00722137|4035792|P1|COMPLETED|Overall Study||199
1652587|NCT00722137|4035791|P2|STARTED|Overall Study||243
1652588|NCT00722137|4035792|P1|STARTED|Overall Study||244
1652589|NCT00722124|4035821|P3|NOT COMPLETED|Overall Study||20
1652590|NCT00722124|4035822|P2|NOT COMPLETED|Overall Study||14
1652591|NCT00722124|4035823|P1|NOT COMPLETED|Overall Study||17
1652592|NCT00722124|4035821|P3|COMPLETED|Overall Study||20
1652593|NCT00722124|4035822|P2|COMPLETED|Overall Study||26
1652594|NCT00722124|4035823|P1|COMPLETED|Overall Study||23
1652595|NCT00722124|4035821|P3|STARTED|Overall Study||40
1652596|NCT00722124|4035822|P2|STARTED|Overall Study||40
1652597|NCT00722124|4035823|P1|STARTED|Overall Study||40
1652598|NCT00722111|4035833|P2|NOT COMPLETED|Overall Study||0
1652599|NCT00722111|4035834|P1|NOT COMPLETED|Overall Study||0
1652600|NCT00722111|4035833|P2|COMPLETED|Overall Study||72
1652601|NCT00722111|4035834|P1|COMPLETED|Overall Study||11
1652602|NCT00722111|4035833|P2|STARTED|Overall Study||72
1652603|NCT00722111|4035834|P1|STARTED|Overall Study||11
1652604|NCT00722072|4035841|P1|NOT COMPLETED|Overall Study||3
1652605|NCT00722072|4035841|P1|COMPLETED|Overall Study||9
1652606|NCT00722072|4035841|P1|STARTED|Overall Study||12
1652607|NCT00722020|4035851|P2|NOT COMPLETED|Overall Study||0
1652608|NCT00722020|4035852|P1|NOT COMPLETED|Overall Study||0
1652609|NCT00722020|4035851|P2|COMPLETED|Overall Study||24
1652610|NCT00722020|4035852|P1|COMPLETED|Overall Study||19
1652611|NCT00722020|4035851|P2|STARTED|Overall Study||24
1652612|NCT00722020|4035852|P1|STARTED|Overall Study||19
1652613|NCT00721968|4035862|P2|NOT COMPLETED|Overall Study||0
1652614|NCT00721968|4035863|P1|NOT COMPLETED|Overall Study||2
1652615|NCT00721968|4035862|P2|COMPLETED|Overall Study||17
1652616|NCT00721968|4035863|P1|COMPLETED|Overall Study||25
1652617|NCT00721968|4035862|P2|STARTED|Overall Study||17
1652618|NCT00721968|4035863|P1|STARTED|Overall Study||27
1652619|NCT00721955|4035874|P3|NOT COMPLETED|Overall Study||2
1652620|NCT00721955|4035875|P2|NOT COMPLETED|Overall Study||0
1652621|NCT00721955|4035876|P1|NOT COMPLETED|Overall Study||0
1652622|NCT00721955|4035874|P3|COMPLETED|Overall Study||103
1652623|NCT00721955|4035875|P2|COMPLETED|Overall Study||104
1652624|NCT00721955|4035876|P1|COMPLETED|Overall Study||105
1652625|NCT00721955|4035874|P3|STARTED|Overall Study||105
1652626|NCT00721955|4035875|P2|STARTED|Overall Study||104
1652627|NCT00721955|4035876|P1|STARTED|Overall Study||105
1652628|NCT00721799|4035890|P1|NOT COMPLETED|Overall Study||8
1652629|NCT00721799|4035890|P1|COMPLETED|Overall Study||25
1652630|NCT00721799|4035890|P1|Received FLT PET Scan #2|Overall Study||25
1652631|NCT00721799|4035890|P1|Recieved FLT PET Scan 1|Overall Study||26
1652632|NCT00721799|4035890|P1|STARTED|Overall Study||33
1652633|NCT00721734|4035930|P5|NOT COMPLETED|Overall Study||6
1652634|NCT00721734|4035931|P4|NOT COMPLETED|Overall Study||6
1652635|NCT00721734|4035932|P3|NOT COMPLETED|Overall Study||8
1652636|NCT00721734|4035933|P2|NOT COMPLETED|Overall Study||12
1652637|NCT00721734|4035934|P1|NOT COMPLETED|Overall Study||8
1652638|NCT00721734|4035930|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
1652639|NCT00721734|4035931|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
1652640|NCT00721734|4035932|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
1652641|NCT00721734|4035933|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
1652642|NCT00721734|4035934|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
1652643|NCT00721734|4035930|P5|STARTED|Overall Study||8
1652644|NCT00721734|4035931|P4|STARTED|Overall Study||8
1652645|NCT00721734|4035932|P3|STARTED|Overall Study||10
1652646|NCT00721734|4035933|P2|STARTED|Overall Study||12
1652647|NCT00721734|4035934|P1|STARTED|Overall Study||12
1652648|NCT00721630|4036046|P1|NOT COMPLETED|Overall Study||1
1652649|NCT00721630|4036046|P1|COMPLETED|Overall Study||23
1652650|NCT00721630|4036046|P1|STARTED|Overall Study||24
1652651|NCT00721617|4036051|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
1652652|NCT00721617|4036051|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
1652653|NCT00721617|4036051|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
1652654|NCT00721617|4036051|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
1652655|NCT00721617|4036051|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
1652656|NCT00721617|4036051|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
1652657|NCT00721617|4036051|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
1652658|NCT00721617|4036051|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
1652659|NCT00721617|4036051|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
1652660|NCT00721617|4036051|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
1652661|NCT00721617|4036051|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
1652662|NCT00721617|4036051|P1|STARTED|8 Hours Into Dextrose Infusion||12
1652663|NCT00721617|4036051|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
1652664|NCT00721617|4036051|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
1652665|NCT00721617|4036051|P1|STARTED|4 Hours Into Dextrose Infusion||12
1652666|NCT00721617|4036051|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
1652667|NCT00721617|4036051|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
1652668|NCT00721617|4036051|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
1652669|NCT00721617|4036051|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
1652670|NCT00721617|4036051|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
1652671|NCT00721617|4036051|P1|STARTED|8 Hours Into Intralipid Infusion||12
1652672|NCT00721617|4036051|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
1652673|NCT00721617|4036051|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
1652674|NCT00721617|4036051|P1|STARTED|4 Hours Into Intralipid Infusion||12
1652675|NCT00721617|4036051|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
1652676|NCT00721617|4036051|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
1652677|NCT00721617|4036051|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
1652678|NCT00721617|4036051|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
1652679|NCT00721617|4036051|P1|COMPLETED|8 Hours Into Saline Infusion||12
1652680|NCT00721617|4036051|P1|STARTED|8 Hours Into Saline Infusion||12
1652681|NCT00721617|4036051|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
1652682|NCT00721617|4036051|P1|COMPLETED|4 Hours Into Saline Infusion||12
1652683|NCT00721617|4036051|P1|STARTED|4 Hours Into Saline Infusion||12
1652684|NCT00721617|4036051|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
1652685|NCT00721617|4036051|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
1652686|NCT00721617|4036051|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
1652687|NCT00721578|4036075|P2|NOT COMPLETED|Overall Study||2
1652688|NCT00721578|4036076|P1|NOT COMPLETED|Overall Study||2
1652689|NCT00721578|4036075|P2|COMPLETED|Overall Study||9
1652690|NCT00721578|4036076|P1|COMPLETED|Overall Study||10
1652691|NCT00721578|4036075|P2|STARTED|Overall Study||11
1652692|NCT00721578|4036076|P1|STARTED|Overall Study||12
1652693|NCT00721539|4036088|P1|NOT COMPLETED|Overall Study||0
1652694|NCT00721539|4036088|P1|COMPLETED|Overall Study||9
1652695|NCT00721539|4036088|P1|STARTED|Overall Study||9
1652696|NCT00721500|4036095|P4|NOT COMPLETED|Period Three||0
1652697|NCT00721500|4036096|P3|NOT COMPLETED|Period Three||0
1652698|NCT00721500|4036097|P2|NOT COMPLETED|Period Three||0
1652699|NCT00721500|4036098|P1|NOT COMPLETED|Period Three||0
1652700|NCT00721500|4036095|P4|COMPLETED|Period Three||6
1652701|NCT00721500|4036096|P3|COMPLETED|Period Three||6
1652702|NCT00721500|4036097|P2|COMPLETED|Period Three||7
1652703|NCT00721500|4036098|P1|COMPLETED|Period Three||6
1652704|NCT00721500|4036095|P4|STARTED|Period Three||6
1652705|NCT00721500|4036096|P3|STARTED|Period Three||6
1652706|NCT00721500|4036097|P2|STARTED|Period Three||7
1652707|NCT00721500|4036098|P1|STARTED|Period Three||6
1652708|NCT00721500|4036095|P4|NOT COMPLETED|Period Two||0
1652709|NCT00721500|4036096|P3|NOT COMPLETED|Period Two||0
1652710|NCT00721500|4036097|P2|NOT COMPLETED|Period Two||0
1652711|NCT00721500|4036098|P1|NOT COMPLETED|Period Two||0
1652712|NCT00721500|4036095|P4|COMPLETED|Period Two||6
1652713|NCT00721500|4036096|P3|COMPLETED|Period Two||6
1652714|NCT00721500|4036097|P2|COMPLETED|Period Two||7
1652715|NCT00721500|4036098|P1|COMPLETED|Period Two||6
1652716|NCT00721500|4036095|P4|STARTED|Period Two||6
1652717|NCT00721500|4036096|P3|STARTED|Period Two||6
1652718|NCT00721500|4036097|P2|STARTED|Period Two||7
1652719|NCT00721500|4036098|P1|STARTED|Period Two||6
1652720|NCT00721500|4036095|P4|NOT COMPLETED|Period One||0
1652721|NCT00721500|4036096|P3|NOT COMPLETED|Period One||0
1652722|NCT00721500|4036097|P2|NOT COMPLETED|Period One||0
1652723|NCT00721500|4036098|P1|NOT COMPLETED|Period One||0
1652724|NCT00721500|4036095|P4|COMPLETED|Period One||6
1652725|NCT00721500|4036096|P3|COMPLETED|Period One||6
1652726|NCT00721500|4036097|P2|COMPLETED|Period One||7
1652727|NCT00721500|4036098|P1|COMPLETED|Period One||6
1652728|NCT00721500|4036095|P4|STARTED|Period One||6
1652729|NCT00721500|4036096|P3|STARTED|Period One||6
1652730|NCT00721500|4036097|P2|STARTED|Period One||7
1652731|NCT00721500|4036098|P1|STARTED|Period One||6
1652732|NCT00721409|4036119|P3|NOT COMPLETED|Overall Study||79
1652733|NCT00721409|4036120|P2|NOT COMPLETED|Overall Study||82
1652734|NCT00721409|4036121|P1|NOT COMPLETED|Overall Study||12
1652735|NCT00721409|4036119|P3|COMPLETED|Overall Study||2
1652736|NCT00721409|4036120|P2|COMPLETED|Overall Study||2
1652737|NCT00721409|4036121|P1|COMPLETED|Overall Study||0
1652738|NCT00721409|4036119|P3|Treated|Overall Study||77
1652739|NCT00721409|4036120|P2|Treated|Overall Study||83
1652740|NCT00721409|4036121|P1|Treated|Overall Study||12
1652741|NCT00721409|4036119|P3|STARTED|Overall Study||81
1652742|NCT00721409|4036120|P2|STARTED|Overall Study||84
1652743|NCT00721409|4036121|P1|STARTED|Overall Study||12
1652744|NCT00721396|4036248|P4|NOT COMPLETED|Overall Study||10
1652745|NCT00721396|4036249|P3|NOT COMPLETED|Overall Study||10
1652746|NCT00721396|4036250|P2|NOT COMPLETED|Overall Study||36
1652747|NCT00721396|4036251|P1|NOT COMPLETED|Overall Study||30
1652748|NCT00721396|4036248|P4|COMPLETED|Overall Study||302
1652749|NCT00721396|4036249|P3|COMPLETED|Overall Study||308
1652750|NCT00721396|4036250|P2|COMPLETED|Overall Study||592
1652751|NCT00721396|4036251|P1|COMPLETED|Overall Study||597
1652752|NCT00721396|4036248|P4|STARTED|Overall Study||312
1652753|NCT00721396|4036249|P3|STARTED|Overall Study||318
1652754|NCT00721396|4036250|P2|STARTED|Overall Study||628
1652755|NCT00721396|4036251|P1|STARTED|Overall Study||627
1652756|NCT00721357|4036289|P2|NOT COMPLETED|Overall Study||0
1652757|NCT00721357|4036290|P1|NOT COMPLETED|Overall Study||0
1652758|NCT00721357|4036289|P2|COMPLETED|Overall Study||15
1652759|NCT00721357|4036290|P1|COMPLETED|Overall Study||15
1652760|NCT00721357|4036289|P2|STARTED|Overall Study||15
1652761|NCT00721357|4036290|P1|STARTED|Overall Study||15
1652762|NCT00721279|4036298|P2|NOT COMPLETED|Overall Study||24
1652763|NCT00721279|4036299|P1|NOT COMPLETED|Overall Study||36
1652764|NCT00721279|4036298|P2|COMPLETED|Overall Study||73
1652765|NCT00721279|4036299|P1|COMPLETED|Overall Study||416
1652766|NCT00721279|4036298|P2|STARTED|Overall Study||97
1652767|NCT00721279|4036299|P1|STARTED|Overall Study||452
1652768|NCT00721253|4036313|P3|NOT COMPLETED|Overall Study||0
1652769|NCT00721253|4036314|P2|NOT COMPLETED|Overall Study||0
1652770|NCT00721253|4036315|P1|NOT COMPLETED|Overall Study||0
1652771|NCT00721253|4036313|P3|COMPLETED|Overall Study||0
1652772|NCT00721253|4036314|P2|COMPLETED|Overall Study||22
1652773|NCT00721253|4036315|P1|COMPLETED|Overall Study||20
1652774|NCT00721253|4036313|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
1652775|NCT00721253|4036314|P2|STARTED|Overall Study||22
1652776|NCT00721253|4036315|P1|STARTED|Overall Study||20
1652777|NCT00721227|4036327|P2|NOT COMPLETED|Overall Study||0
1652778|NCT00721227|4036328|P1|NOT COMPLETED|Overall Study||4
1652779|NCT00721227|4036327|P2|COMPLETED|Overall Study||6
1652780|NCT00721227|4036328|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
1652781|NCT00721227|4036327|P2|STARTED|Overall Study||6
1652782|NCT00721227|4036328|P1|STARTED|Overall Study||9
1652783|NCT00721214|4036338|P1|NOT COMPLETED|Overall Study||4
1652784|NCT00721214|4036338|P1|COMPLETED|Overall Study||12
1652785|NCT00721214|4036338|P1|STARTED|Overall Study||16
1652786|NCT00721188|4036349|P1|NOT COMPLETED|Overall Study||0
1652787|NCT00721188|4036349|P1|COMPLETED|Overall Study||11
1652788|NCT00721188|4036349|P1|STARTED|Overall Study||11
1652789|NCT00721175|4036366|P2|NOT COMPLETED|Overall Study||0
1652790|NCT00721175|4036367|P1|NOT COMPLETED|Overall Study||0
1652791|NCT00721175|4036366|P2|COMPLETED|Overall Study||54
1652792|NCT00721175|4036367|P1|COMPLETED|Overall Study||54
1652793|NCT00721175|4036366|P2|STARTED|Overall Study||54
1652794|NCT00721175|4036367|P1|STARTED|Overall Study||54
1652795|NCT00721162|4036379|P1|NOT COMPLETED|Overall Study||0
1652796|NCT00721162|4036379|P1|COMPLETED|Overall Study||60
1652797|NCT00721162|4036379|P1|Received Any Amount of Study Drug|Overall Study||60
1652798|NCT00721162|4036379|P1|STARTED|Overall Study||60
1652799|NCT00721149|4036388|P1|NOT COMPLETED|Overall Study||1
1652800|NCT00721149|4036388|P1|COMPLETED|Overall Study||9
1652801|NCT00721149|4036388|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
1652802|NCT00721136|4036401|P4|NOT COMPLETED|Overall Study||0
1652803|NCT00721136|4036402|P3|NOT COMPLETED|Overall Study||0
1652804|NCT00721136|4036403|P2|NOT COMPLETED|Overall Study||0
1652805|NCT00721136|4036404|P1|NOT COMPLETED|Overall Study||0
1652806|NCT00721136|4036401|P4|COMPLETED|Overall Study||8
1652807|NCT00721136|4036402|P3|COMPLETED|Overall Study||8
1652808|NCT00721136|4036403|P2|COMPLETED|Overall Study||42
1652809|NCT00721136|4036404|P1|COMPLETED|Overall Study||42
1652810|NCT00721136|4036401|P4|STARTED|Overall Study||8
1652811|NCT00721136|4036402|P3|STARTED|Overall Study||8
1652812|NCT00721136|4036403|P2|STARTED|Overall Study||42
1652813|NCT00721136|4036404|P1|STARTED|Overall Study||42
1652814|NCT00721123|4036422|P1|NOT COMPLETED|Overall Study||183
1652815|NCT00721123|4036422|P1|COMPLETED|Overall Study||355
1652816|NCT00721123|4036422|P1|STARTED|Overall Study||538
1652817|NCT00721110|4036500|P4|NOT COMPLETED|Overall Study||0
1652818|NCT00721110|4036501|P3|NOT COMPLETED|Overall Study||1
1652819|NCT00721110|4036502|P2|NOT COMPLETED|Overall Study||0
1652820|NCT00721110|4036503|P1|NOT COMPLETED|Overall Study||1
1652821|NCT00721110|4036500|P4|COMPLETED|Overall Study||16
1652822|NCT00721110|4036501|P3|COMPLETED|Overall Study||15
1652823|NCT00721110|4036502|P2|COMPLETED|Overall Study||16
1652824|NCT00721110|4036503|P1|COMPLETED|Overall Study||15
1652825|NCT00721110|4036500|P4|STARTED|Overall Study||16
1652826|NCT00721110|4036501|P3|STARTED|Overall Study||16
1652827|NCT00721110|4036502|P2|STARTED|Overall Study||16
1652828|NCT00721110|4036503|P1|STARTED|Overall Study||16
1652829|NCT00720941|4036531|P2|NOT COMPLETED|Overall Study||415
1652830|NCT00720941|4036532|P1|NOT COMPLETED|Overall Study||413
1652831|NCT00720941|4036531|P2|COMPLETED|Overall Study||138
1652832|NCT00720941|4036532|P1|COMPLETED|Overall Study||144
1652833|NCT00720941|4036531|P2|Ongoing|Overall Study||23
1652834|NCT00720941|4036532|P1|Ongoing|Overall Study||34
1652835|NCT00720941|4036531|P2|STARTED|Overall Study||553
1652836|NCT00720941|4036532|P1|STARTED|Overall Study||557
1652837|NCT00720876|4036572|P1|NOT COMPLETED|Overall Study||2
1652838|NCT00720876|4036572|P1|COMPLETED|Overall Study||28
1652839|NCT00720876|4036572|P1|STARTED|Overall Study||30
1652840|NCT00720798|4036578|P1|NOT COMPLETED|Overall Study||756
1652841|NCT00720798|4036578|P1|COMPLETED|Overall Study||1311
1652842|NCT00720798|4036578|P1|STARTED|Overall Study||2067
1652843|NCT00720759|4036601|P4|NOT COMPLETED|Overall Study||0
1652844|NCT00720759|4036602|P3|NOT COMPLETED|Overall Study||1
1652845|NCT00720759|4036603|P2|NOT COMPLETED|Overall Study||1
1652846|NCT00720759|4036604|P1|NOT COMPLETED|Overall Study||0
1652847|NCT00720759|4036601|P4|COMPLETED|Overall Study||6
1652848|NCT00720759|4036602|P3|COMPLETED|Overall Study||5
1652849|NCT00720759|4036603|P2|COMPLETED|Overall Study||5
1652850|NCT00720759|4036604|P1|COMPLETED|Overall Study||6
1652851|NCT00720759|4036601|P4|STARTED|Overall Study||6
1652852|NCT00720759|4036602|P3|STARTED|Overall Study||6
1652853|NCT00720759|4036603|P2|STARTED|Overall Study||6
1652854|NCT00720759|4036604|P1|STARTED|Overall Study||6
1652855|NCT00720629|4036614|P1|NOT COMPLETED|Overall Study||0
1652856|NCT00720629|4036614|P1|COMPLETED|Overall Study||8
1652857|NCT00720629|4036614|P1|STARTED|Overall Study||8
1652858|NCT00720499|4036624|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
1652859|NCT00720499|4036625|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
1652860|NCT00720499|4036624|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
1652861|NCT00720499|4036625|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
1652862|NCT00720499|4036624|P2|STARTED|Treatment Period 2 (4 Weeks)||70
1652863|NCT00720499|4036625|P1|STARTED|Treatment Period 2 (4 Weeks)||66
1652864|NCT00720499|4036624|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
1652865|NCT00720499|4036625|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
1652866|NCT00720499|4036624|P2|COMPLETED|Washout Period (2 Weeks)||70
1652867|NCT00720499|4036625|P1|COMPLETED|Washout Period (2 Weeks)||66
1652868|NCT00720499|4036624|P2|STARTED|Washout Period (2 Weeks)||70
1652869|NCT00720499|4036625|P1|STARTED|Washout Period (2 Weeks)||66
1652870|NCT00720499|4036624|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
1652871|NCT00720499|4036625|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
1652872|NCT00720499|4036624|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
1652873|NCT00720499|4036625|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
1652874|NCT00720499|4036624|P2|STARTED|Treatment Period 1 (4 Weeks)||72
1652875|NCT00720499|4036625|P1|STARTED|Treatment Period 1 (4 Weeks)||69
1652876|NCT00720473|4036689|P2|NOT COMPLETED|Overall Study||8
1652877|NCT00720473|4036690|P1|NOT COMPLETED|Overall Study||30
1652878|NCT00720473|4036689|P2|COMPLETED|Overall Study||16
1652879|NCT00720473|4036690|P1|COMPLETED|Overall Study||15
1652880|NCT00720473|4036689|P2|STARTED|Overall Study||24
1652881|NCT00720473|4036690|P1|STARTED|Overall Study||45
1652882|NCT00720434|4036718|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
1652883|NCT00720434|4036719|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
1652884|NCT00720434|4036720|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
1652885|NCT00720434|4036721|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
1652886|NCT00720434|4036718|P4|COMPLETED|Open-Label Period (Week 5-72)||4
1652887|NCT00720434|4036719|P3|COMPLETED|Open-Label Period (Week 5-72)||4
1652888|NCT00720434|4036720|P2|COMPLETED|Open-Label Period (Week 5-72)||5
1652889|NCT00720434|4036721|P1|COMPLETED|Open-Label Period (Week 5-72)||4
1652890|NCT00720434|4036718|P4|STARTED|Open-Label Period (Week 5-72)||8
1652891|NCT00720434|4036719|P3|STARTED|Open-Label Period (Week 5-72)||8
1652892|NCT00720434|4036720|P2|STARTED|Open-Label Period (Week 5-72)||8
1652893|NCT00720434|4036721|P1|STARTED|Open-Label Period (Week 5-72)||10
1652894|NCT00720434|4036718|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
1652895|NCT00720434|4036719|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
1652896|NCT00720434|4036720|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
1652897|NCT00720434|4036721|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
1652898|NCT00720434|4036718|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
1652899|NCT00720434|4036719|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
1652900|NCT00720434|4036720|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
1652901|NCT00720434|4036721|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
1652902|NCT00720434|4036718|P4|STARTED|Double-Blind Period (Week 1-4)||8
1652903|NCT00720434|4036719|P3|STARTED|Double-Blind Period (Week 1-4)||8
1652904|NCT00720434|4036720|P2|STARTED|Double-Blind Period (Week 1-4)||9
1652905|NCT00720434|4036721|P1|STARTED|Double-Blind Period (Week 1-4)||10
1652906|NCT00720382|4036745|P2|NOT COMPLETED|Overall Study||59
1652907|NCT00720382|4036746|P1|NOT COMPLETED|Overall Study||176
1652908|NCT00720382|4036745|P2|COMPLETED|Overall Study||178
1652909|NCT00720382|4036746|P1|COMPLETED|Overall Study||290
1652910|NCT00720382|4036745|P2|STARTED|Overall Study||237
1652911|NCT00720382|4036746|P1|STARTED|Overall Study||466
1652912|NCT00720369|4036756|P2|NOT COMPLETED|Overall Study||0
1652913|NCT00720369|4036757|P1|NOT COMPLETED|Overall Study||1
1652914|NCT00720369|4036756|P2|COMPLETED|Overall Study||8
1652915|NCT00720369|4036757|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
1652916|NCT00720369|4036756|P2|STARTED|Overall Study||8
1652917|NCT00720369|4036757|P1|STARTED|Overall Study||11
1652918|NCT00720356|4036765|P1|NOT COMPLETED|Follow up Until Death||5
1652919|NCT00720356|4036765|P1|COMPLETED|Follow up Until Death||43
1652920|NCT00720356|4036765|P1|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
1652921|NCT00720356|4036765|P1|NOT COMPLETED|Went on to be Treated Cycle 3||2
1652922|NCT00720356|4036765|P1|COMPLETED|Went on to be Treated Cycle 3||44
1652923|NCT00720356|4036765|P1|STARTED|Went on to be Treated Cycle 3||46
1652924|NCT00720356|4036765|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
1652925|NCT00720356|4036765|P1|COMPLETED|Reached 1st Response/2 Cycles||46
1652926|NCT00720356|4036765|P1|STARTED|Reached 1st Response/2 Cycles||48
1652927|NCT00720356|4036765|P1|NOT COMPLETED|Registration to Study||67
1652928|NCT00720356|4036765|P1|COMPLETED|Registration to Study||48
1652929|NCT00720356|4036765|P1|Completed Registration Step 2|Registration to Study||48
1652930|NCT00720356|4036765|P1|Completed Registration Step 1|Registration to Study||115
1652931|NCT00720356|4036765|P1|STARTED|Registration to Study||115
1652932|NCT00720343|4036779|P1|NOT COMPLETED|Overall Study||6
1652933|NCT00720343|4036779|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
1652934|NCT00720343|4036779|P1|STARTED|Overall Study||54
1652935|NCT00720330|4036788|P3|NOT COMPLETED|Overall Study||0
1652936|NCT00720330|4036789|P2|NOT COMPLETED|Overall Study||0
1652937|NCT00720330|4036790|P1|NOT COMPLETED|Overall Study||0
1652938|NCT00720330|4036788|P3|COMPLETED|Overall Study||3
1652939|NCT00720330|4036789|P2|COMPLETED|Overall Study||4
1652940|NCT00720330|4036790|P1|COMPLETED|Overall Study||5
1652941|NCT00720330|4036788|P3|STARTED|Overall Study||3
1652942|NCT00720330|4036789|P2|STARTED|Overall Study||4
1652943|NCT00720330|4036790|P1|STARTED|Overall Study||5
1652944|NCT00720278|4036813|P3|NOT COMPLETED|Overall Study||6
1652945|NCT00720278|4036814|P2|NOT COMPLETED|Overall Study||4
1652946|NCT00720278|4036815|P1|NOT COMPLETED|Overall Study||7
1652947|NCT00720278|4036813|P3|COMPLETED|Overall Study||172
1652948|NCT00720278|4036814|P2|COMPLETED|Overall Study||166
1652949|NCT00720278|4036815|P1|COMPLETED|Overall Study||171
1652950|NCT00720278|4036813|P3|STARTED|Overall Study|1 subject was randomized in error|178
1652951|NCT00720278|4036814|P2|STARTED|Overall Study|1 subject was randomized in error|170
1652952|NCT00720278|4036815|P1|STARTED|Overall Study|1 subject was randomized in error|178
1652953|NCT00720226|4036837|P2|NOT COMPLETED|Overall Study||4
1652954|NCT00720226|4036838|P1|NOT COMPLETED|Overall Study||7
1652955|NCT00720226|4036837|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
1652956|NCT00720226|4036838|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
1652957|NCT00720226|4036837|P2|STARTED|Overall Study||52
1652958|NCT00720226|4036838|P1|STARTED|Overall Study||54
1652959|NCT00720122|4036846|P1|NOT COMPLETED|Overall Study||9
1652960|NCT00720122|4036846|P1|COMPLETED|Overall Study||19
1652961|NCT00720122|4036846|P1|STARTED|Overall Study||28
1652962|NCT00720109|4036850|P3|NOT COMPLETED|Risk Stratification Period||8
1652963|NCT00720109|4036851|P2|NOT COMPLETED|Risk Stratification Period||15
1652964|NCT00720109|4036852|P1|NOT COMPLETED|Risk Stratification Period||0
1652965|NCT00720109|4036850|P3|COMPLETED|Risk Stratification Period||1
1652966|NCT00720109|4036851|P2|COMPLETED|Risk Stratification Period||33
1652967|NCT00720109|4036852|P1|COMPLETED|Risk Stratification Period||0
1652968|NCT00720109|4036850|P3|STARTED|Risk Stratification Period||9
1652969|NCT00720109|4036851|P2|STARTED|Risk Stratification Period||48
1652970|NCT00720109|4036852|P1|STARTED|Risk Stratification Period||0
1652971|NCT00720109|4036850|P3|NOT COMPLETED|Induction Period||0
1652972|NCT00720109|4036851|P2|NOT COMPLETED|Induction Period||0
1652973|NCT00720109|4036852|P1|NOT COMPLETED|Induction Period||6
1652974|NCT00720109|4036850|P3|COMPLETED|Induction Period||0
1652975|NCT00720109|4036851|P2|COMPLETED|Induction Period||0
1652976|NCT00720109|4036852|P1|COMPLETED|Induction Period||57
1652977|NCT00720109|4036850|P3|STARTED|Induction Period||0
1652978|NCT00720109|4036851|P2|STARTED|Induction Period||0
1652979|NCT00720109|4036852|P1|STARTED|Induction Period||63
1652980|NCT00720096|4036872|P2|NOT COMPLETED|Overall Study||2
1652981|NCT00720096|4036873|P1|NOT COMPLETED|Overall Study||0
1652982|NCT00720096|4036872|P2|COMPLETED|Overall Study||0
1652983|NCT00720096|4036873|P1|COMPLETED|Overall Study||2
1652984|NCT00720096|4036872|P2|STARTED|Overall Study||2
1652985|NCT00720096|4036873|P1|STARTED|Overall Study||2
1652986|NCT00720083|4036885|P2|NOT COMPLETED|Overall Study||2
1652987|NCT00720083|4036886|P1|NOT COMPLETED|Overall Study||1
1652988|NCT00720083|4036885|P2|COMPLETED|Overall Study||13
1652989|NCT00720083|4036886|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
1652990|NCT00720083|4036885|P2|STARTED|Overall Study||15
1652991|NCT00720083|4036886|P1|STARTED|Overall Study||17
1652992|NCT00720057|4036894|P2|NOT COMPLETED|Overall Study||3
1652993|NCT00720057|4036895|P1|NOT COMPLETED|Overall Study||1
1652994|NCT00720057|4036894|P2|COMPLETED|Overall Study||156
1652995|NCT00720057|4036895|P1|COMPLETED|Overall Study||152
1652996|NCT00720057|4036894|P2|STARTED|Overall Study||159
1652997|NCT00720057|4036895|P1|STARTED|Overall Study||153
1652998|NCT00719953|4036911|P1|NOT COMPLETED|Overall Study||4
1652999|NCT00719953|4036911|P1|COMPLETED|Overall Study||26
1653000|NCT00719953|4036911|P1|STARTED|Overall Study||30
1653001|NCT00719914|4036917|P2|NOT COMPLETED|Overall Study||0
1653002|NCT00719914|4036918|P1|NOT COMPLETED|Overall Study||0
1653003|NCT00719914|4036917|P2|COMPLETED|Overall Study||7
1653004|NCT00719914|4036918|P1|COMPLETED|Overall Study||10
1653005|NCT00719914|4036917|P2|STARTED|Overall Study||7
1653006|NCT00719914|4036918|P1|STARTED|Overall Study||10
1653007|NCT00719901|4036924|P1|NOT COMPLETED|Overall Study||11
1653008|NCT00719901|4036924|P1|COMPLETED|Overall Study||0
1653009|NCT00719901|4036924|P1|STARTED|Overall Study||11
1653010|NCT00719862|4036936|P2|NOT COMPLETED|Overall Study||6
1653011|NCT00719862|4036937|P1|NOT COMPLETED|Overall Study||8
1653012|NCT00719862|4036936|P2|COMPLETED|Overall Study||233
1653013|NCT00719862|4036937|P1|COMPLETED|Overall Study||234
1653014|NCT00719862|4036936|P2|STARTED|Overall Study|1 subject was randomized in error|239
1653015|NCT00719862|4036937|P1|STARTED|Overall Study||242
1653016|NCT00719849|4036955|P2|NOT COMPLETED|Overall Study||1
1653017|NCT00719849|4036956|P1|NOT COMPLETED|Overall Study||0
1653018|NCT00719849|4036955|P2|COMPLETED|Overall Study||8
1653019|NCT00719849|4036956|P1|COMPLETED|Overall Study||4
1653020|NCT00719849|4036955|P2|STARTED|Overall Study||9
1653021|NCT00719849|4036956|P1|STARTED|Overall Study||4
1653022|NCT00719810|4036995|P3|NOT COMPLETED|Overall Study||8
1653023|NCT00719810|4036996|P2|NOT COMPLETED|Overall Study||4
1653024|NCT00719810|4036997|P1|NOT COMPLETED|Overall Study||3
1653025|NCT00719810|4036995|P3|COMPLETED|Overall Study||42
1653026|NCT00719810|4036996|P2|COMPLETED|Overall Study||47
1653027|NCT00719810|4036997|P1|COMPLETED|Overall Study||46
1653028|NCT00719810|4036995|P3|STARTED|Overall Study||50
1653029|NCT00719810|4036996|P2|STARTED|Overall Study||51
1653030|NCT00719810|4036997|P1|STARTED|Overall Study||49
1653031|NCT00719732|4037008|P1|NOT COMPLETED|Overall Study||22
1653032|NCT00719732|4037008|P1|COMPLETED|Overall Study||196
1653033|NCT00719732|4037008|P1|STARTED|Overall Study||218
1653034|NCT00719706|4037014|P2|NOT COMPLETED|Overall Study||6
1653035|NCT00719706|4037015|P1|NOT COMPLETED|Overall Study||9
1653036|NCT00719706|4037014|P2|COMPLETED|Overall Study||14
1653037|NCT00719706|4037015|P1|COMPLETED|Overall Study||11
1653038|NCT00719706|4037014|P2|STARTED|Overall Study||20
1653039|NCT00719706|4037015|P1|STARTED|Overall Study||20
1653040|NCT00719680|4037029|P1|NOT COMPLETED|Overall Study||5
1653041|NCT00719680|4037029|P1|COMPLETED|Overall Study||16
1653042|NCT00719680|4037029|P1|STARTED|Overall Study||21
1653043|NCT00719615|4037052|P3|NOT COMPLETED|Overall Study||0
1653044|NCT00719615|4037053|P2|NOT COMPLETED|Overall Study||0
1653045|NCT00719615|4037054|P1|NOT COMPLETED|Overall Study||0
1653046|NCT00719615|4037052|P3|COMPLETED|Overall Study||24
1653047|NCT00719615|4037053|P2|COMPLETED|Overall Study||45
1653048|NCT00719615|4037054|P1|COMPLETED|Overall Study||42
1653049|NCT00719615|4037052|P3|STARTED|Overall Study||24
1653050|NCT00719615|4037053|P2|STARTED|Overall Study||45
1653051|NCT00719615|4037054|P1|STARTED|Overall Study||42
1653052|NCT00719576|4037064|P2|NOT COMPLETED|Overall Study||5
1653053|NCT00719576|4037065|P1|NOT COMPLETED|Overall Study||2
1653054|NCT00719576|4037064|P2|COMPLETED|Overall Study||67
1653055|NCT00719576|4037065|P1|COMPLETED|Overall Study||70
1653056|NCT00719576|4037064|P2|STARTED|Overall Study||72
1653057|NCT00719576|4037065|P1|STARTED|Overall Study||72
1653058|NCT00719563|4037085|P2|NOT COMPLETED|Overall Study||42
1653059|NCT00719563|4037086|P1|NOT COMPLETED|Overall Study||38
1653060|NCT00719563|4037085|P2|COMPLETED|Overall Study||128
1653061|NCT00719563|4037086|P1|COMPLETED|Overall Study||133
1653062|NCT00719563|4037085|P2|STARTED|Overall Study||170
1653063|NCT00719563|4037086|P1|STARTED|Overall Study||171
1653064|NCT00719537|4037118|P2|NOT COMPLETED|Overall Study||1
1653065|NCT00719537|4037119|P1|NOT COMPLETED|Overall Study||1
1653066|NCT00719537|4037118|P2|COMPLETED|Overall Study||0
1653067|NCT00719537|4037119|P1|COMPLETED|Overall Study||1
1653068|NCT00719537|4037118|P2|STARTED|Overall Study||1
1653069|NCT00719537|4037119|P1|STARTED|Overall Study||2
1653070|NCT00719472|4037125|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
1653071|NCT00719472|4037125|P1|COMPLETED|Received Cycle 2 Treatment||304
1653072|NCT00719472|4037125|P1|STARTED|Received Cycle 2 Treatment||372
1653073|NCT00719472|4037125|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
1653074|NCT00719472|4037125|P1|COMPLETED|Received Cycle 1 Treatment||372
1653075|NCT00719472|4037125|P1|STARTED|Received Cycle 1 Treatment||425
1653076|NCT00719472|4037125|P1|NOT COMPLETED|Enrolled in Study||26
1653077|NCT00719472|4037125|P1|COMPLETED|Enrolled in Study||425
1653078|NCT00719472|4037125|P1|STARTED|Enrolled in Study||451
1653079|NCT00719355|4037136|P2|NOT COMPLETED|Overall Study||13
1653080|NCT00719355|4037137|P1|NOT COMPLETED|Overall Study||18
1653081|NCT00719355|4037136|P2|COMPLETED|Overall Study||39
1653082|NCT00719355|4037137|P1|COMPLETED|Overall Study||33
1653083|NCT00719355|4037136|P2|Completed 32 Weeks|Overall Study||39
1653084|NCT00719355|4037137|P1|Completed 32 Weeks|Overall Study||33
1653085|NCT00719355|4037136|P2|Completed 24 Weeks|Overall Study||43
1653086|NCT00719355|4037137|P1|Completed 24 Weeks|Overall Study||34
1653087|NCT00719355|4037136|P2|Completed 12 Weeks|Overall Study||46
1653088|NCT00719355|4037137|P1|Completed 12 Weeks|Overall Study||43
1653089|NCT00719355|4037136|P2|Completed 6 Weeks|Overall Study||48
1653090|NCT00719355|4037137|P1|Completed 6 Weeks|Overall Study||49
1653091|NCT00719355|4037136|P2|STARTED|Overall Study||52
1653092|NCT00719355|4037137|P1|STARTED|Overall Study||51
1653093|NCT00719329|4037148|P3|NOT COMPLETED|Overall Study||1
1653094|NCT00719329|4037149|P2|NOT COMPLETED|Overall Study||2
1653095|NCT00719329|4037150|P1|NOT COMPLETED|Overall Study||0
1653096|NCT00719329|4037148|P3|COMPLETED|Overall Study||646
1653097|NCT00719329|4037149|P2|COMPLETED|Overall Study||569
1653098|NCT00719329|4037150|P1|COMPLETED|Overall Study||705
1653099|NCT00719329|4037148|P3|Day 7 Swab|Overall Study||561
1653100|NCT00719329|4037149|P2|Day 7 Swab|Overall Study||467
1653101|NCT00719329|4037150|P1|Day 7 Swab|Overall Study||593
1653102|NCT00719329|4037148|P3|Day 3 Swab|Overall Study||578
1653103|NCT00719329|4037149|P2|Day 3 Swab|Overall Study||501
1653104|NCT00719329|4037150|P1|Day 3 Swab|Overall Study||614
1653105|NCT00719329|4037148|P3|Day 1 Swab|Overall Study||646
1653106|NCT00719329|4037149|P2|Day 1 Swab|Overall Study||569
1653107|NCT00719329|4037150|P1|Day 1 Swab|Overall Study||705
1653108|NCT00719329|4037148|P3|STARTED|Overall Study||647
1653109|NCT00719329|4037149|P2|STARTED|Overall Study||571
1653110|NCT00719329|4037150|P1|STARTED|Overall Study||705
1653111|NCT00719264|4037166|P2|NOT COMPLETED|Overall Study||183
1653112|NCT00719264|4037167|P1|NOT COMPLETED|Overall Study||182
1653113|NCT00719264|4037166|P2|COMPLETED|Overall Study||0
1653114|NCT00719264|4037167|P1|COMPLETED|Overall Study||0
1653115|NCT00719264|4037166|P2|Safety Set|Overall Study||181
1653116|NCT00719264|4037167|P1|Safety Set|Overall Study||180
1653117|NCT00719264|4037166|P2|Full Analysis Set|Overall Study||183
1653118|NCT00719264|4037167|P1|Full Analysis Set|Overall Study||182
1653119|NCT00719264|4037166|P2|STARTED|Overall Study||183
1653120|NCT00719264|4037167|P1|STARTED|Overall Study||182
1653121|NCT00719212|4037186|P1|NOT COMPLETED|Overall Study||44
1653122|NCT00719212|4037186|P1|COMPLETED|Overall Study||17
1653123|NCT00719212|4037186|P1|STARTED|Overall Study||61
1653124|NCT00719186|4037198|P2|NOT COMPLETED|Overall Study||0
1653125|NCT00719186|4037199|P1|NOT COMPLETED|Overall Study||0
1653126|NCT00719186|4037198|P2|COMPLETED|Overall Study||374
1653127|NCT00719186|4037199|P1|COMPLETED|Overall Study||376
1653128|NCT00719186|4037198|P2|STARTED|Overall Study||374
1653129|NCT00719186|4037199|P1|STARTED|Overall Study||376
1653130|NCT00719160|4037213|P2|NOT COMPLETED|Overall Study||0
1653131|NCT00719160|4037214|P1|NOT COMPLETED|Overall Study||0
1653132|NCT00719160|4037213|P2|COMPLETED|Overall Study||6
1653133|NCT00719160|4037214|P1|COMPLETED|Overall Study||6
1653134|NCT00719160|4037213|P2|STARTED|Overall Study||6
1653135|NCT00719160|4037214|P1|STARTED|Overall Study||6
1653136|NCT00719134|4037221|P1|NOT COMPLETED|Overall Study||10
1653137|NCT00719134|4037221|P1|COMPLETED|Overall Study||66
1653138|NCT00719134|4037221|P1|STARTED|Overall Study||76
1653139|NCT00719043|4037234|P7|NOT COMPLETED|Overall Study||28
1653140|NCT00719043|4037235|P6|NOT COMPLETED|Overall Study||34
1653141|NCT00719043|4037236|P5|NOT COMPLETED|Overall Study||27
1653142|NCT00719043|4037237|P4|NOT COMPLETED|Overall Study||23
1653143|NCT00719043|4037238|P3|NOT COMPLETED|Overall Study||20
1653144|NCT00719043|4037239|P2|NOT COMPLETED|Overall Study||25
1653145|NCT00719043|4037240|P1|NOT COMPLETED|Overall Study||32
1653146|NCT00719043|4037234|P7|COMPLETED|Overall Study|Up to Day 909|92
1653147|NCT00719043|4037235|P6|COMPLETED|Overall Study|Up to Day 909|86
1653148|NCT00719043|4037236|P5|COMPLETED|Overall Study|Up to Day 909|95
1653149|NCT00719043|4037237|P4|COMPLETED|Overall Study|Up to Day 909|96
1653150|NCT00719043|4037238|P3|COMPLETED|Overall Study|Up to Day 909|99
1653151|NCT00719043|4037239|P2|COMPLETED|Overall Study|Up to Day 909|96
1653152|NCT00719043|4037240|P1|COMPLETED|Overall Study|Up to Day 909|88
1653153|NCT00719043|4037234|P7|STARTED|Overall Study||120
1653154|NCT00719043|4037235|P6|STARTED|Overall Study||120
1653155|NCT00719043|4037236|P5|STARTED|Overall Study||122
1653156|NCT00719043|4037237|P4|STARTED|Overall Study||119
1653157|NCT00719043|4037238|P3|STARTED|Overall Study||119
1653158|NCT00719043|4037239|P2|STARTED|Overall Study||121
1653159|NCT00719043|4037240|P1|STARTED|Overall Study||120
1653160|NCT00718887|4037364|P2|NOT COMPLETED|Overall Study||9
1653161|NCT00718887|4037365|P1|NOT COMPLETED|Overall Study||5
1653162|NCT00718887|4037364|P2|COMPLETED|Overall Study||68
1653163|NCT00718887|4037365|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
1653164|NCT00718887|4037364|P2|STARTED|Overall Study|Participants who received treatment.|77
1653165|NCT00718887|4037365|P1|STARTED|Overall Study|Participants who received treatment.|89
1653166|NCT00718861|4037389|P2|NOT COMPLETED|Overall Study||18
1653167|NCT00718861|4037390|P1|NOT COMPLETED|Overall Study||21
1653168|NCT00718861|4037389|P2|COMPLETED|Overall Study||77
1653169|NCT00718861|4037390|P1|COMPLETED|Overall Study||74
1653170|NCT00718861|4037389|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
1653171|NCT00718861|4037390|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
1653172|NCT00718861|4037389|P2|Safety Set|Overall Study||95
1653173|NCT00718861|4037390|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
1653174|NCT00718861|4037389|P2|STARTED|Overall Study||95
1653175|NCT00718861|4037390|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
1653176|NCT00718809|4037418|P2|NOT COMPLETED|Overall Study||9
1653177|NCT00718809|4037419|P1|NOT COMPLETED|Overall Study||12
1653178|NCT00718809|4037418|P2|COMPLETED|Overall Study||0
1653179|NCT00718809|4037419|P1|COMPLETED|Overall Study||0
1653180|NCT00718809|4037418|P2|STARTED|Overall Study||9
1653181|NCT00718809|4037419|P1|STARTED|Overall Study||12
1653182|NCT00718770|4037433|P1|NOT COMPLETED|Overall Study||8
1653183|NCT00718770|4037433|P1|COMPLETED|Overall Study||2
1653184|NCT00718770|4037433|P1|STARTED|Overall Study||10
1653185|NCT00718718|4037444|P10|NOT COMPLETED|Week 12 to End of Study||0
1653186|NCT00718718|4037445|P9|NOT COMPLETED|Week 12 to End of Study||1
1653187|NCT00718718|4037446|P8|NOT COMPLETED|Week 12 to End of Study||1
1653188|NCT00718718|4037447|P7|NOT COMPLETED|Week 12 to End of Study||2
1653189|NCT00718718|4037448|P6|NOT COMPLETED|Week 12 to End of Study||3
1653190|NCT00718718|4037449|P5|NOT COMPLETED|Week 12 to End of Study||0
1653191|NCT00718718|4037450|P4|NOT COMPLETED|Week 12 to End of Study||1
1653192|NCT00718718|4037451|P3|NOT COMPLETED|Week 12 to End of Study||0
1653193|NCT00718718|4037452|P2|NOT COMPLETED|Week 12 to End of Study||1
1653194|NCT00718718|4037453|P1|NOT COMPLETED|Week 12 to End of Study||0
1653195|NCT00718718|4037444|P10|COMPLETED|Week 12 to End of Study||31
1653196|NCT00718718|4037445|P9|COMPLETED|Week 12 to End of Study||27
1653197|NCT00718718|4037446|P8|COMPLETED|Week 12 to End of Study||27
1653198|NCT00718718|4037447|P7|COMPLETED|Week 12 to End of Study||27
1653199|NCT00718718|4037448|P6|COMPLETED|Week 12 to End of Study||24
1653200|NCT00718718|4037449|P5|COMPLETED|Week 12 to End of Study||0
1653201|NCT00718718|4037450|P4|COMPLETED|Week 12 to End of Study||15
1653202|NCT00718718|4037451|P3|COMPLETED|Week 12 to End of Study||0
1653203|NCT00718718|4037452|P2|COMPLETED|Week 12 to End of Study||17
1653204|NCT00718718|4037453|P1|COMPLETED|Week 12 to End of Study||0
1653205|NCT00718718|4037444|P10|Treated|Week 12 to End of Study||31
1653206|NCT00718718|4037445|P9|Treated|Week 12 to End of Study||28
1653207|NCT00718718|4037446|P8|Treated|Week 12 to End of Study||28
1653208|NCT00718718|4037447|P7|Treated|Week 12 to End of Study||29
1653209|NCT00718718|4037448|P6|Treated|Week 12 to End of Study||26
1653210|NCT00718718|4037449|P5|Treated|Week 12 to End of Study||0
1653211|NCT00718718|4037450|P4|Treated|Week 12 to End of Study||16
1653212|NCT00718718|4037451|P3|Treated|Week 12 to End of Study||0
1653213|NCT00718718|4037452|P2|Treated|Week 12 to End of Study||18
1653214|NCT00718718|4037453|P1|Treated|Week 12 to End of Study||0
1653215|NCT00718718|4037444|P10|STARTED|Week 12 to End of Study||31
1653216|NCT00718718|4037445|P9|STARTED|Week 12 to End of Study||28
1653217|NCT00718718|4037446|P8|STARTED|Week 12 to End of Study||28
1653218|NCT00718718|4037447|P7|STARTED|Week 12 to End of Study||29
1653219|NCT00718718|4037448|P6|STARTED|Week 12 to End of Study||27
1653220|NCT00718718|4037449|P5|STARTED|Week 12 to End of Study||0
1653221|NCT00718718|4037450|P4|STARTED|Week 12 to End of Study||16
1653222|NCT00718718|4037451|P3|STARTED|Week 12 to End of Study||0
1653223|NCT00718718|4037452|P2|STARTED|Week 12 to End of Study||18
1653224|NCT00718718|4037453|P1|STARTED|Week 12 to End of Study||0
1653225|NCT00718718|4037444|P10|NOT COMPLETED|Prior to Week 12||0
1653226|NCT00718718|4037445|P9|NOT COMPLETED|Prior to Week 12||2
1653227|NCT00718718|4037446|P8|NOT COMPLETED|Prior to Week 12||2
1653228|NCT00718718|4037447|P7|NOT COMPLETED|Prior to Week 12||1
1653229|NCT00718718|4037448|P6|NOT COMPLETED|Prior to Week 12||0
1653230|NCT00718718|4037449|P5|NOT COMPLETED|Prior to Week 12||3
1653231|NCT00718718|4037450|P4|NOT COMPLETED|Prior to Week 12||0
1653232|NCT00718718|4037451|P3|NOT COMPLETED|Prior to Week 12||1
1653233|NCT00718718|4037452|P2|NOT COMPLETED|Prior to Week 12||0
1653234|NCT00718718|4037453|P1|NOT COMPLETED|Prior to Week 12||1
1653235|NCT00718718|4037444|P10|COMPLETED|Prior to Week 12||31
1653236|NCT00718718|4037445|P9|COMPLETED|Prior to Week 12||28
1653237|NCT00718718|4037446|P8|COMPLETED|Prior to Week 12||28
1653238|NCT00718718|4037447|P7|COMPLETED|Prior to Week 12||29
1653239|NCT00718718|4037448|P6|COMPLETED|Prior to Week 12||0
1653240|NCT00718718|4037449|P5|COMPLETED|Prior to Week 12||27
1653241|NCT00718718|4037450|P4|COMPLETED|Prior to Week 12||0
1653242|NCT00718718|4037451|P3|COMPLETED|Prior to Week 12||16
1653243|NCT00718718|4037452|P2|COMPLETED|Prior to Week 12||0
1653244|NCT00718718|4037453|P1|COMPLETED|Prior to Week 12||18
1653245|NCT00718718|4037444|P10|STARTED|Prior to Week 12||31
1653246|NCT00718718|4037445|P9|STARTED|Prior to Week 12||30
1653247|NCT00718718|4037446|P8|STARTED|Prior to Week 12||30
1653248|NCT00718718|4037447|P7|STARTED|Prior to Week 12||30
1653249|NCT00718718|4037448|P6|STARTED|Prior to Week 12||0
1653250|NCT00718718|4037449|P5|STARTED|Prior to Week 12||30
1653251|NCT00718718|4037450|P4|STARTED|Prior to Week 12||0
1653252|NCT00718718|4037451|P3|STARTED|Prior to Week 12||17
1653253|NCT00718718|4037452|P2|STARTED|Prior to Week 12||0
1653254|NCT00718718|4037453|P1|STARTED|Prior to Week 12||19
1653255|NCT00718666|4037496|P3|NOT COMPLETED|Booster Phase Year 5||6
1653256|NCT00718666|4037497|P2|NOT COMPLETED|Booster Phase Year 5||0
1653257|NCT00718666|4037498|P1|NOT COMPLETED|Booster Phase Year 5||2
1653258|NCT00718666|4037496|P3|COMPLETED|Booster Phase Year 5||94
1653259|NCT00718666|4037497|P2|COMPLETED|Booster Phase Year 5||46
1653260|NCT00718666|4037498|P1|COMPLETED|Booster Phase Year 5||36
1653261|NCT00718666|4037496|P3|STARTED|Booster Phase Year 5||100
1653262|NCT00718666|4037497|P2|STARTED|Booster Phase Year 5||46
1653263|NCT00718666|4037498|P1|STARTED|Booster Phase Year 5||38
1653264|NCT00718666|4037496|P3|NOT COMPLETED|Persistence Phase Year 5||0
1653265|NCT00718666|4037497|P2|NOT COMPLETED|Persistence Phase Year 5||0
1653266|NCT00718666|4037498|P1|NOT COMPLETED|Persistence Phase Year 5||0
1653267|NCT00718666|4037496|P3|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
1653268|NCT00718666|4037497|P2|COMPLETED|Persistence Phase Year 5||82
1653269|NCT00718666|4037498|P1|COMPLETED|Persistence Phase Year 5||70
1653270|NCT00718666|4037496|P3|STARTED|Persistence Phase Year 5||0
1653271|NCT00718666|4037497|P2|STARTED|Persistence Phase Year 5||82
1653272|NCT00718666|4037498|P1|STARTED|Persistence Phase Year 5||70
1653273|NCT00718666|4037496|P3|NOT COMPLETED|Persistence Phase Year 3||0
1653274|NCT00718666|4037497|P2|NOT COMPLETED|Persistence Phase Year 3||0
1653275|NCT00718666|4037498|P1|NOT COMPLETED|Persistence Phase Year 3||0
1653276|NCT00718666|4037496|P3|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
1653277|NCT00718666|4037497|P2|COMPLETED|Persistence Phase Year 3||104
1653278|NCT00718666|4037498|P1|COMPLETED|Persistence Phase Year 3||98
1653279|NCT00718666|4037496|P3|STARTED|Persistence Phase Year 3||0
1653280|NCT00718666|4037497|P2|STARTED|Persistence Phase Year 3||104
1653281|NCT00718666|4037498|P1|STARTED|Persistence Phase Year 3||98
1653282|NCT00718666|4037496|P3|NOT COMPLETED|Persistence Phase Year 1||0
1653283|NCT00718666|4037497|P2|NOT COMPLETED|Persistence Phase Year 1||0
1653284|NCT00718666|4037498|P1|NOT COMPLETED|Persistence Phase Year 1||0
1653285|NCT00718666|4037496|P3|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
1653286|NCT00718666|4037497|P2|COMPLETED|Persistence Phase Year 1||130
1653287|NCT00718666|4037498|P1|COMPLETED|Persistence Phase Year 1||118
1653288|NCT00718666|4037496|P3|STARTED|Persistence Phase Year 1||0
1653289|NCT00718666|4037497|P2|STARTED|Persistence Phase Year 1||130
1653290|NCT00718666|4037498|P1|STARTED|Persistence Phase Year 1||118
1653291|NCT00718640|4037582|P1|NOT COMPLETED|Overall Study||7
1653292|NCT00718640|4037582|P1|COMPLETED|Overall Study||3
1653293|NCT00718640|4037582|P1|STARTED|Overall Study||10
1653294|NCT00718549|4037594|P3|NOT COMPLETED|Maintenance/ Observation Phase||30
1653295|NCT00718549|4037595|P2|NOT COMPLETED|Maintenance/ Observation Phase||28
1653296|NCT00718549|4037596|P1|NOT COMPLETED|Maintenance/ Observation Phase||0
1653297|NCT00718549|4037594|P3|COMPLETED|Maintenance/ Observation Phase||3
1653298|NCT00718549|4037595|P2|COMPLETED|Maintenance/ Observation Phase||5
1653299|NCT00718549|4037596|P1|COMPLETED|Maintenance/ Observation Phase||0
1653300|NCT00718549|4037594|P3|STARTED|Maintenance/ Observation Phase||33
1653301|NCT00718549|4037595|P2|STARTED|Maintenance/ Observation Phase||33
1653302|NCT00718549|4037596|P1|STARTED|Maintenance/ Observation Phase||0
1653303|NCT00718549|4037594|P3|NOT COMPLETED|Induction Phase||0
1653304|NCT00718549|4037595|P2|NOT COMPLETED|Induction Phase||0
1653305|NCT00718549|4037596|P1|NOT COMPLETED|Induction Phase||62
1653306|NCT00718549|4037594|P3|COMPLETED|Induction Phase||0
1653307|NCT00718549|4037595|P2|COMPLETED|Induction Phase||0
1653308|NCT00718549|4037596|P1|COMPLETED|Induction Phase||66
1653309|NCT00718549|4037594|P3|STARTED|Induction Phase||0
1653310|NCT00718549|4037595|P2|STARTED|Induction Phase||0
1653311|NCT00718549|4037596|P1|STARTED|Induction Phase||128
1653312|NCT00718523|4037621|P2|NOT COMPLETED|Overall Study||24
1653313|NCT00718523|4037622|P1|NOT COMPLETED|Overall Study||18
1653314|NCT00718523|4037621|P2|COMPLETED|Overall Study||62
1653315|NCT00718523|4037622|P1|COMPLETED|Overall Study||66
1653316|NCT00718523|4037621|P2|STARTED|Overall Study||86
1653317|NCT00718523|4037622|P1|STARTED|Overall Study||84
1653318|NCT00718510|4037634|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
1653319|NCT00718510|4037635|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
1653320|NCT00718510|4037634|P2|COMPLETED|Second Intervention (3 Weeks)||7
1653321|NCT00718510|4037635|P1|COMPLETED|Second Intervention (3 Weeks)||6
1653322|NCT00718510|4037634|P2|STARTED|Second Intervention (3 Weeks)||7
1653323|NCT00718510|4037635|P1|STARTED|Second Intervention (3 Weeks)||7
1653324|NCT00718510|4037634|P2|NOT COMPLETED|Washout (5 Days)||0
1653325|NCT00718510|4037635|P1|NOT COMPLETED|Washout (5 Days)||0
1653326|NCT00718510|4037634|P2|COMPLETED|Washout (5 Days)||7
1653327|NCT00718510|4037635|P1|COMPLETED|Washout (5 Days)||7
1653328|NCT00718510|4037634|P2|STARTED|Washout (5 Days)||7
1653329|NCT00718510|4037635|P1|STARTED|Washout (5 Days)||7
1653330|NCT00718510|4037634|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
1653331|NCT00718510|4037635|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
1653332|NCT00718510|4037634|P2|COMPLETED|First Intervention (3 Weeks)||7
1653333|NCT00718510|4037635|P1|COMPLETED|First Intervention (3 Weeks)||7
1653334|NCT00718510|4037634|P2|Received Intervention|First Intervention (3 Weeks)||7
1653335|NCT00718510|4037635|P1|Received Intervention|First Intervention (3 Weeks)||7
1653336|NCT00718510|4037634|P2|STARTED|First Intervention (3 Weeks)||8
1653337|NCT00718510|4037635|P1|STARTED|First Intervention (3 Weeks)||7
1653338|NCT00718328|4037647|P2|NOT COMPLETED|Overall Study||0
1653339|NCT00718328|4037648|P1|NOT COMPLETED|Overall Study||1
1653340|NCT00718328|4037647|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
1653341|NCT00718328|4037648|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
1653342|NCT00718328|4037647|P2|STARTED|Overall Study||0
1653343|NCT00718328|4037648|P1|STARTED|Overall Study||1
1653344|NCT00718315|4037657|P3|NOT COMPLETED|Overall Study||21
1653345|NCT00718315|4037658|P2|NOT COMPLETED|Overall Study||22
1653346|NCT00718315|4037659|P1|NOT COMPLETED|Overall Study||19
1653347|NCT00718315|4037657|P3|COMPLETED|Overall Study||46
1653348|NCT00718315|4037658|P2|COMPLETED|Overall Study||45
1653349|NCT00718315|4037659|P1|COMPLETED|Overall Study||48
1653350|NCT00718315|4037657|P3|STARTED|Overall Study||67
1653351|NCT00718315|4037658|P2|STARTED|Overall Study||67
1653352|NCT00718315|4037659|P1|STARTED|Overall Study||67
1653353|NCT00718302|4037693|P2|NOT COMPLETED|Overall Study||0
1653354|NCT00718302|4037694|P1|NOT COMPLETED|Overall Study||0
1653355|NCT00718302|4037693|P2|COMPLETED|Overall Study||114
1653356|NCT00718302|4037694|P1|COMPLETED|Overall Study||119
1653357|NCT00718302|4037693|P2|STARTED|Overall Study||114
1653358|NCT00718302|4037694|P1|STARTED|Overall Study||119
1653359|NCT00718237|4037710|P2|NOT COMPLETED|Overall Study||15
1653360|NCT00718237|4037711|P1|NOT COMPLETED|Overall Study||13
1653361|NCT00718237|4037710|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
1653362|NCT00718237|4037711|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
1653363|NCT00718237|4037710|P2|Vaccinated at Visit 3|Overall Study||369
1653364|NCT00718237|4037711|P1|Vaccinated at Visit 3|Overall Study||371
1653365|NCT00718237|4037710|P2|Vaccinated at Visit 2|Overall Study||374
1653366|NCT00718237|4037711|P1|Vaccinated at Visit 2|Overall Study||373
1653367|NCT00718237|4037710|P2|Vaccinated at Visit 1|Overall Study||381
1653368|NCT00718237|4037711|P1|Vaccinated at Visit 1|Overall Study||380
1653369|NCT00718237|4037710|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
1653370|NCT00718237|4037711|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
1653371|NCT00718159|4037728|P7|NOT COMPLETED|Overall Study||1
1653372|NCT00718159|4037729|P6|NOT COMPLETED|Overall Study||1
1653373|NCT00718159|4037730|P5|NOT COMPLETED|Overall Study||8
1653374|NCT00718159|4037731|P4|NOT COMPLETED|Overall Study||4
1653375|NCT00718159|4037732|P3|NOT COMPLETED|Overall Study||3
1653376|NCT00718159|4037733|P2|NOT COMPLETED|Overall Study||3
1653377|NCT00718159|4037734|P1|NOT COMPLETED|Overall Study||3
1653378|NCT00718159|4037728|P7|COMPLETED|Overall Study||0
1653379|NCT00718159|4037729|P6|COMPLETED|Overall Study||0
1653380|NCT00718159|4037730|P5|COMPLETED|Overall Study||0
1653381|NCT00718159|4037731|P4|COMPLETED|Overall Study||0
1653382|NCT00718159|4037732|P3|COMPLETED|Overall Study||0
1653383|NCT00718159|4037733|P2|COMPLETED|Overall Study||0
1653384|NCT00718159|4037734|P1|COMPLETED|Overall Study||0
1653385|NCT00718159|4037728|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
1653386|NCT00718159|4037729|P6|Received at Least 1 Dose of Study Drug|Overall Study||1
1653387|NCT00718159|4037730|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
1653388|NCT00718159|4037731|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
1653389|NCT00718159|4037732|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
1653390|NCT00718159|4037733|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
1653391|NCT00718159|4037734|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1653392|NCT00718159|4037728|P7|STARTED|Overall Study||1
1653393|NCT00718159|4037729|P6|STARTED|Overall Study||1
1653394|NCT00718159|4037730|P5|STARTED|Overall Study||8
1653395|NCT00718159|4037731|P4|STARTED|Overall Study||4
1653396|NCT00718159|4037732|P3|STARTED|Overall Study||3
1653397|NCT00718159|4037733|P2|STARTED|Overall Study||3
1653398|NCT00718159|4037734|P1|STARTED|Overall Study||3
1653399|NCT00718120|4037760|P2|NOT COMPLETED|Overall Study||0
1653400|NCT00718120|4037761|P1|NOT COMPLETED|Overall Study||0
1653401|NCT00718120|4037760|P2|COMPLETED|Overall Study||55
1653402|NCT00718120|4037761|P1|COMPLETED|Overall Study||55
1653403|NCT00718120|4037760|P2|STARTED|Overall Study||55
1653404|NCT00718120|4037761|P1|STARTED|Overall Study||55
1653405|NCT00718094|4037781|P2|NOT COMPLETED|Overall Study||0
1653406|NCT00718094|4037782|P1|NOT COMPLETED|Overall Study||0
1653407|NCT00718094|4037781|P2|COMPLETED|Overall Study||5
1653408|NCT00718094|4037782|P1|COMPLETED|Overall Study||15
1653409|NCT00718094|4037781|P2|STARTED|Overall Study||5
1653410|NCT00718094|4037782|P1|STARTED|Overall Study||15
1653411|NCT00718081|4037791|P3|NOT COMPLETED|Overall Study||21
1653412|NCT00718081|4037792|P2|NOT COMPLETED|Overall Study||4
1653413|NCT00718081|4037793|P1|NOT COMPLETED|Overall Study||7
1653414|NCT00718081|4037791|P3|COMPLETED|Overall Study||9
1653415|NCT00718081|4037792|P2|COMPLETED|Overall Study||25
1653416|NCT00718081|4037793|P1|COMPLETED|Overall Study||22
1653417|NCT00718081|4037791|P3|STARTED|Overall Study||30
1653418|NCT00718081|4037792|P2|STARTED|Overall Study||29
1653419|NCT00718081|4037793|P1|STARTED|Overall Study||29
1653420|NCT00718042|4037810|P6|NOT COMPLETED|Donor Follow-up||0
1653421|NCT00718042|4037811|P5|NOT COMPLETED|Donor Follow-up||19
1653422|NCT00718042|4037812|P4|NOT COMPLETED|Donor Follow-up||0
1653423|NCT00718042|4037813|P3|NOT COMPLETED|Donor Follow-up||0
1653424|NCT00718042|4037814|P2|NOT COMPLETED|Donor Follow-up||0
1653425|NCT00718042|4037815|P1|NOT COMPLETED|Donor Follow-up||13
1653426|NCT00718042|4037810|P6|COMPLETED|Donor Follow-up||0
1653427|NCT00718042|4037811|P5|COMPLETED|Donor Follow-up||24
1653428|NCT00718042|4037812|P4|COMPLETED|Donor Follow-up||0
1653429|NCT00718042|4037813|P3|COMPLETED|Donor Follow-up||0
1653430|NCT00718042|4037814|P2|COMPLETED|Donor Follow-up||0
1653431|NCT00718042|4037815|P1|COMPLETED|Donor Follow-up||23
1653432|NCT00718042|4037810|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1653433|NCT00718042|4037811|P5|STARTED|Donor Follow-up||43
1653434|NCT00718042|4037812|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1653435|NCT00718042|4037813|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1653436|NCT00718042|4037814|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1653437|NCT00718042|4037815|P1|STARTED|Donor Follow-up||36
1653438|NCT00718042|4037810|P6|NOT COMPLETED|ESA Chagas Testing||0
1653439|NCT00718042|4037811|P5|NOT COMPLETED|ESA Chagas Testing||0
1653440|NCT00718042|4037812|P4|NOT COMPLETED|ESA Chagas Testing||0
1653441|NCT00718042|4037813|P3|NOT COMPLETED|ESA Chagas Testing||0
1653442|NCT00718042|4037814|P2|NOT COMPLETED|ESA Chagas Testing||0
1653443|NCT00718042|4037815|P1|NOT COMPLETED|ESA Chagas Testing||0
1653444|NCT00718042|4037810|P6|COMPLETED|ESA Chagas Testing||330
1653445|NCT00718042|4037811|P5|COMPLETED|ESA Chagas Testing||43
1653446|NCT00718042|4037812|P4|COMPLETED|ESA Chagas Testing||110
1653447|NCT00718042|4037813|P3|COMPLETED|ESA Chagas Testing||524
1653448|NCT00718042|4037814|P2|COMPLETED|ESA Chagas Testing||287
1653449|NCT00718042|4037815|P1|COMPLETED|ESA Chagas Testing||36
1653450|NCT00718042|4037810|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
1653451|NCT00718042|4037811|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
1653452|NCT00718042|4037812|P4|STARTED|ESA Chagas Testing||110
1653453|NCT00718042|4037813|P3|STARTED|ESA Chagas Testing||524
1653454|NCT00718042|4037814|P2|STARTED|ESA Chagas Testing||287
1653455|NCT00718042|4037815|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
1653456|NCT00718042|4037810|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
1653457|NCT00718042|4037811|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
1653458|NCT00718042|4037812|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
1653459|NCT00718042|4037813|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
1653460|NCT00718042|4037814|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
1653461|NCT00718042|4037815|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
1653462|NCT00718042|4037810|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
1653463|NCT00718042|4037811|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
1653464|NCT00718042|4037812|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
1653465|NCT00718042|4037813|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
1653466|NCT00718042|4037814|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
1653467|NCT00718042|4037815|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
1653468|NCT00718042|4037810|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
1653469|NCT00718042|4037811|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
1653470|NCT00718042|4037812|P4|STARTED|ABBOTT PRISM Chagas Testing||110
1653471|NCT00718042|4037813|P3|STARTED|ABBOTT PRISM Chagas Testing||525
1653472|NCT00718042|4037814|P2|STARTED|ABBOTT PRISM Chagas Testing||289
1653473|NCT00718042|4037815|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
1653474|NCT00717977|4037827|P1|NOT COMPLETED|Overall Study||0
1653475|NCT00717977|4037827|P1|COMPLETED|Overall Study||74
1653476|NCT00717977|4037827|P1|STARTED|Overall Study||74
1653477|NCT00717912|4037855|P6|NOT COMPLETED|Overall Study||0
1653478|NCT00717912|4037856|P5|NOT COMPLETED|Overall Study||0
1653479|NCT00717912|4037857|P4|NOT COMPLETED|Overall Study||0
1653480|NCT00717912|4037858|P3|NOT COMPLETED|Overall Study||0
1653481|NCT00717912|4037859|P2|NOT COMPLETED|Overall Study||0
1653482|NCT00717912|4037860|P1|NOT COMPLETED|Overall Study||0
1653483|NCT00717912|4037855|P6|COMPLETED|Overall Study||1
1653484|NCT00717912|4037856|P5|COMPLETED|Overall Study||1
1653485|NCT00717912|4037857|P4|COMPLETED|Overall Study||1
1653486|NCT00717912|4037858|P3|COMPLETED|Overall Study||1
1653487|NCT00717912|4037859|P2|COMPLETED|Overall Study||1
1653488|NCT00717912|4037860|P1|COMPLETED|Overall Study||1
1653489|NCT00717912|4037855|P6|STARTED|Overall Study||1
1653490|NCT00717912|4037856|P5|STARTED|Overall Study||1
1653491|NCT00717912|4037857|P4|STARTED|Overall Study||1
1653492|NCT00717912|4037858|P3|STARTED|Overall Study||1
1653493|NCT00717912|4037859|P2|STARTED|Overall Study||1
1653494|NCT00717912|4037860|P1|STARTED|Overall Study||1
1653495|NCT00717886|4037871|P1|NOT COMPLETED|Overall Study||4
1653496|NCT00717886|4037871|P1|COMPLETED|Overall Study||9
1653497|NCT00717886|4037871|P1|STARTED|Overall Study||13
1653498|NCT00717873|4037877|P2|NOT COMPLETED|Overall Study||0
1653499|NCT00717873|4037878|P1|NOT COMPLETED|Overall Study||0
1653500|NCT00717873|4037877|P2|COMPLETED|Overall Study||59
1653501|NCT00717873|4037878|P1|COMPLETED|Overall Study||46
1653502|NCT00717873|4037877|P2|STARTED|Overall Study||59
1653503|NCT00717873|4037878|P1|STARTED|Overall Study||46
1653504|NCT00717860|4037886|P2|NOT COMPLETED|Overall Study||28
1653505|NCT00717860|4037887|P1|NOT COMPLETED|Overall Study||27
1653506|NCT00717860|4037886|P2|COMPLETED|Overall Study||32
1653507|NCT00717860|4037887|P1|COMPLETED|Overall Study||34
1653508|NCT00717860|4037886|P2|STARTED|Overall Study||60
1653509|NCT00717860|4037887|P1|STARTED|Overall Study||61
1653510|NCT00717756|4037897|P1|NOT COMPLETED|Overall Study||1
1653511|NCT00717756|4037897|P1|COMPLETED|Overall Study||40
1653512|NCT00717756|4037897|P1|STARTED|Overall Study||41
1653513|NCT00717574|4037903|P2|NOT COMPLETED|Overall Study||2
1653514|NCT00717574|4037904|P1|NOT COMPLETED|Overall Study||2
1653515|NCT00717574|4037903|P2|COMPLETED|Overall Study||14
1653516|NCT00717574|4037904|P1|COMPLETED|Overall Study||14
1653517|NCT00717574|4037903|P2|STARTED|Overall Study||16
1653518|NCT00717574|4037904|P1|STARTED|Overall Study||16
1653519|NCT00717522|4037910|P1|NOT COMPLETED|Overall Study||7
1653520|NCT00717522|4037910|P1|COMPLETED|Overall Study||0
1653521|NCT00717522|4037910|P1|STARTED|Overall Study||7
1653522|NCT00717418|4037919|P4|NOT COMPLETED|1-Year Follow-Up||4
1653523|NCT00717418|4037920|P3|NOT COMPLETED|1-Year Follow-Up||434
1653524|NCT00717418|4037921|P2|NOT COMPLETED|1-Year Follow-Up||51
1653525|NCT00717418|4037922|P1|NOT COMPLETED|1-Year Follow-Up||147
1653526|NCT00717418|4037919|P4|COMPLETED|1-Year Follow-Up||0
1653527|NCT00717418|4037920|P3|COMPLETED|1-Year Follow-Up||74
1653528|NCT00717418|4037921|P2|COMPLETED|1-Year Follow-Up||23
1653529|NCT00717418|4037922|P1|COMPLETED|1-Year Follow-Up||33
1653530|NCT00717418|4037919|P4|STARTED|1-Year Follow-Up||4
1653531|NCT00717418|4037920|P3|STARTED|1-Year Follow-Up||508
1653532|NCT00717418|4037921|P2|STARTED|1-Year Follow-Up||74
1653533|NCT00717418|4037922|P1|STARTED|1-Year Follow-Up||180
1653534|NCT00717418|4037919|P4|NOT COMPLETED|Baseline||15
1653535|NCT00717418|4037920|P3|NOT COMPLETED|Baseline||0
1653536|NCT00717418|4037921|P2|NOT COMPLETED|Baseline||0
1653537|NCT00717418|4037922|P1|NOT COMPLETED|Baseline||0
1653538|NCT00717418|4037919|P4|COMPLETED|Baseline||4
1653539|NCT00717418|4037920|P3|COMPLETED|Baseline||508
1653540|NCT00717418|4037921|P2|COMPLETED|Baseline||74
1653541|NCT00717418|4037922|P1|COMPLETED|Baseline||180
1653542|NCT00717418|4037919|P4|STARTED|Baseline||19
1653543|NCT00717418|4037920|P3|STARTED|Baseline||508
1653544|NCT00717418|4037921|P2|STARTED|Baseline||74
1653545|NCT00717418|4037922|P1|STARTED|Baseline||180
1653546|NCT00717405|4037927|P1|NOT COMPLETED|Overall Study||0
1653547|NCT00717405|4037927|P1|COMPLETED|Overall Study||52
1653548|NCT00717405|4037927|P1|STARTED|Overall Study||52
1653549|NCT00717366|4037946|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
1653550|NCT00717366|4037947|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
1653551|NCT00717366|4037946|P2|COMPLETED|Extension Period (52 Weeks)||12
1653552|NCT00717366|4037947|P1|COMPLETED|Extension Period (52 Weeks)||5
1653553|NCT00717366|4037946|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
1653554|NCT00717366|4037947|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
1653555|NCT00717366|4037946|P2|STARTED|Extension Period (52 Weeks)||28
1653556|NCT00717366|4037947|P1|STARTED|Extension Period (52 Weeks)||9
1653557|NCT00717366|4037946|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
1653558|NCT00717366|4037947|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
1653559|NCT00717366|4037946|P2|COMPLETED|Core Study Period (20 Weeks)||35
1653560|NCT00717366|4037947|P1|COMPLETED|Core Study Period (20 Weeks)||12
1653561|NCT00717366|4037946|P2|STARTED|Core Study Period (20 Weeks)||48
1653562|NCT00717366|4037947|P1|STARTED|Core Study Period (20 Weeks)||16
1653563|NCT00717314|4037971|P2|NOT COMPLETED|Overall Study||10
1653564|NCT00717314|4037972|P1|NOT COMPLETED|Overall Study||6
1653565|NCT00717314|4037971|P2|COMPLETED|Overall Study||34
1653566|NCT00717314|4037972|P1|COMPLETED|Overall Study||37
1653567|NCT00717314|4037971|P2|STARTED|Overall Study||44
1653568|NCT00717314|4037972|P1|STARTED|Overall Study||43
1653569|NCT00717288|4037993|P3|NOT COMPLETED|Overall Study||0
1653570|NCT00717288|4037994|P2|NOT COMPLETED|Overall Study||0
1653571|NCT00717288|4037995|P1|NOT COMPLETED|Overall Study||0
1653572|NCT00717288|4037993|P3|COMPLETED|Overall Study||25
1653573|NCT00717288|4037994|P2|COMPLETED|Overall Study||29
1653574|NCT00717288|4037995|P1|COMPLETED|Overall Study||28
1653575|NCT00717288|4037993|P3|STARTED|Overall Study||25
1653576|NCT00717288|4037994|P2|STARTED|Overall Study||29
1653577|NCT00717288|4037995|P1|STARTED|Overall Study||28
1653578|NCT00717275|4038009|P1|NOT COMPLETED|Overall Study||3
1653579|NCT00717275|4038009|P1|COMPLETED|Overall Study||0
1653580|NCT00717275|4038009|P1|STARTED|Overall Study||3
1653581|NCT00717249|4038015|P2|NOT COMPLETED|Overall Study||15
1653582|NCT00717249|4038016|P1|NOT COMPLETED|Overall Study||22
1653583|NCT00717249|4038015|P2|COMPLETED|Overall Study||150
1653584|NCT00717249|4038016|P1|COMPLETED|Overall Study||304
1653585|NCT00717249|4038015|P2|STARTED|Overall Study||165
1653586|NCT00717249|4038016|P1|STARTED|Overall Study||326
1653587|NCT00717236|4038030|P2|NOT COMPLETED|Open-Label Period||21
1653588|NCT00717236|4038031|P1|NOT COMPLETED|Open-Label Period||125
1653589|NCT00717236|4038030|P2|COMPLETED|Open-Label Period||163
1653590|NCT00717236|4038031|P1|COMPLETED|Open-Label Period||646
1653591|NCT00717236|4038030|P2|STARTED|Open-Label Period||184
1653592|NCT00717236|4038031|P1|STARTED|Open-Label Period||771
1653593|NCT00717236|4038030|P2|NOT COMPLETED|Double-Blind Period||28
1653594|NCT00717236|4038031|P1|NOT COMPLETED|Double-Blind Period||80
1653595|NCT00717236|4038030|P2|COMPLETED|Double-Blind Period||184
1653596|NCT00717236|4038031|P1|COMPLETED|Double-Blind Period||771
1653597|NCT00717236|4038030|P2|STARTED|Double-Blind Period||212
1653598|NCT00717236|4038031|P1|STARTED|Double-Blind Period||851
1653599|NCT00717197|4038100|P1|NOT COMPLETED|Overall Study||7
1653600|NCT00717197|4038100|P1|COMPLETED|Overall Study||23
1653601|NCT00717197|4038100|P1|STARTED|Overall Study||30
1653602|NCT00717093|4038106|P2|NOT COMPLETED|Overall Study||48
1653603|NCT00717093|4038107|P1|NOT COMPLETED|Overall Study||44
1653604|NCT00717093|4038106|P2|COMPLETED|Overall Study||170
1653605|NCT00717093|4038107|P1|COMPLETED|Overall Study||170
1653606|NCT00717093|4038106|P2|Received Treatment|Overall Study||218
1653607|NCT00717093|4038107|P1|Received Treatment|Overall Study||213
1653608|NCT00717093|4038106|P2|STARTED|Overall Study||218
1653609|NCT00717093|4038107|P1|STARTED|Overall Study||214
1653610|NCT00717067|4038124|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1653611|NCT00717067|4038125|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1653612|NCT00717067|4038126|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1653613|NCT00717067|4038127|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1653614|NCT00717067|4038128|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1653615|NCT00717067|4038124|P5|COMPLETED|Part 2: End Stage Renal Disease||6
1653616|NCT00717067|4038125|P4|COMPLETED|Part 2: End Stage Renal Disease||0
1653617|NCT00717067|4038126|P3|COMPLETED|Part 2: End Stage Renal Disease||0
1653618|NCT00717067|4038127|P2|COMPLETED|Part 2: End Stage Renal Disease||0
1653619|NCT00717067|4038128|P1|COMPLETED|Part 2: End Stage Renal Disease||0
1653620|NCT00717067|4038124|P5|STARTED|Part 2: End Stage Renal Disease||6
1653621|NCT00717067|4038125|P4|STARTED|Part 2: End Stage Renal Disease||0
1653622|NCT00717067|4038126|P3|STARTED|Part 2: End Stage Renal Disease||0
1653623|NCT00717067|4038127|P2|STARTED|Part 2: End Stage Renal Disease||0
1653624|NCT00717067|4038128|P1|STARTED|Part 2: End Stage Renal Disease||0
1653625|NCT00717067|4038124|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1653626|NCT00717067|4038125|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1653627|NCT00717067|4038126|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1653628|NCT00717067|4038127|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1653629|NCT00717067|4038128|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1653630|NCT00717067|4038124|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
1653631|NCT00717067|4038125|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
1653632|NCT00717067|4038126|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
1653633|NCT00717067|4038127|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
1653634|NCT00717067|4038128|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
1653635|NCT00717067|4038124|P5|STARTED|Part 1b: Severe Renal Impairment||0
1653636|NCT00717067|4038125|P4|STARTED|Part 1b: Severe Renal Impairment||6
1653637|NCT00717067|4038126|P3|STARTED|Part 1b: Severe Renal Impairment||0
1653638|NCT00717067|4038127|P2|STARTED|Part 1b: Severe Renal Impairment||0
1653639|NCT00717067|4038128|P1|STARTED|Part 1b: Severe Renal Impairment||0
1653640|NCT00717067|4038124|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1653641|NCT00717067|4038125|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1653642|NCT00717067|4038126|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
1653643|NCT00717067|4038127|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1653644|NCT00717067|4038128|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1653645|NCT00717067|4038124|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1653646|NCT00717067|4038125|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1653647|NCT00717067|4038126|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
1653648|NCT00717067|4038127|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
1653649|NCT00717067|4038128|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
1653650|NCT00717067|4038124|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
1653651|NCT00717067|4038125|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
1653652|NCT00717067|4038126|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
1653653|NCT00717067|4038127|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
1653654|NCT00717067|4038128|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
1653655|NCT00717054|4038212|P2|NOT COMPLETED|Overall Study||0
1653656|NCT00717054|4038213|P1|NOT COMPLETED|Overall Study||0
1653657|NCT00717054|4038212|P2|COMPLETED|Overall Study||57
1653658|NCT00717054|4038213|P1|COMPLETED|Overall Study||58
1653659|NCT00717054|4038212|P2|STARTED|Overall Study||57
1653660|NCT00717054|4038213|P1|STARTED|Overall Study||58
1653661|NCT00717041|4038225|P1|NOT COMPLETED|Overall Study||0
1653662|NCT00717041|4038225|P1|COMPLETED|Overall Study||1206
1653663|NCT00717041|4038225|P1|STARTED|Overall Study||1206
1653664|NCT00716976|4038235|P2|NOT COMPLETED|Overall Study||9
1653665|NCT00716976|4038236|P1|NOT COMPLETED|Overall Study||20
1653666|NCT00716976|4038235|P2|COMPLETED|Overall Study||57
1653667|NCT00716976|4038236|P1|COMPLETED|Overall Study||45
1653668|NCT00716976|4038235|P2|STARTED|Overall Study||66
1653669|NCT00716976|4038236|P1|STARTED|Overall Study||65
1653670|NCT00716963|4038258|P6|NOT COMPLETED|Overall Study||0
1653671|NCT00716963|4038259|P5|NOT COMPLETED|Overall Study||0
1653672|NCT00716963|4038260|P4|NOT COMPLETED|Overall Study||0
1653673|NCT00716963|4038261|P3|NOT COMPLETED|Overall Study||0
1653674|NCT00716963|4038262|P2|NOT COMPLETED|Overall Study||0
1653675|NCT00716963|4038263|P1|NOT COMPLETED|Overall Study||1
1653676|NCT00716963|4038258|P6|COMPLETED|Overall Study||1
1653677|NCT00716963|4038259|P5|COMPLETED|Overall Study||1
1653678|NCT00716963|4038260|P4|COMPLETED|Overall Study||1
1653679|NCT00716963|4038261|P3|COMPLETED|Overall Study||1
1653680|NCT00716963|4038262|P2|COMPLETED|Overall Study||1
1653681|NCT00716963|4038263|P1|COMPLETED|Overall Study||1
1653682|NCT00716963|4038258|P6|STARTED|Overall Study||1
1653683|NCT00716963|4038259|P5|STARTED|Overall Study||1
1653684|NCT00716963|4038260|P4|STARTED|Overall Study||1
1653685|NCT00716963|4038261|P3|STARTED|Overall Study||1
1653686|NCT00716963|4038262|P2|STARTED|Overall Study||1
1653687|NCT00716963|4038263|P1|STARTED|Overall Study||2
1653688|NCT00716859|4038276|P2|NOT COMPLETED|Overall Study||5
1653689|NCT00716859|4038277|P1|NOT COMPLETED|Overall Study||9
1653690|NCT00716859|4038276|P2|COMPLETED|Overall Study||64
1653691|NCT00716859|4038277|P1|COMPLETED|Overall Study||61
1653692|NCT00716859|4038276|P2|Received Treatment|Overall Study||68
1653693|NCT00716859|4038277|P1|Received Treatment|Overall Study||69
1653694|NCT00716859|4038276|P2|STARTED|Overall Study||69
1653695|NCT00716859|4038277|P1|STARTED|Overall Study||70
1653696|NCT00716820|4038301|P1|NOT COMPLETED|Overall Study||0
1653697|NCT00716820|4038301|P1|COMPLETED|Overall Study||472
1653698|NCT00716820|4038301|P1|STARTED|Overall Study||472
1653699|NCT00716807|4038336|P4|NOT COMPLETED|Overall Study||0
1653700|NCT00716807|4038337|P3|NOT COMPLETED|Overall Study||0
1653701|NCT00716807|4038338|P2|NOT COMPLETED|Overall Study||0
1653702|NCT00716807|4038339|P1|NOT COMPLETED|Overall Study||0
1653703|NCT00716807|4038336|P4|COMPLETED|Overall Study||15
1653704|NCT00716807|4038337|P3|COMPLETED|Overall Study||18
1653705|NCT00716807|4038338|P2|COMPLETED|Overall Study||5
1653706|NCT00716807|4038339|P1|COMPLETED|Overall Study||8
1653707|NCT00716807|4038336|P4|STARTED|Overall Study||15
1653708|NCT00716807|4038337|P3|STARTED|Overall Study||18
1653709|NCT00716807|4038338|P2|STARTED|Overall Study||5
1653710|NCT00716807|4038339|P1|STARTED|Overall Study||8
1653711|NCT00716742|4038352|P3|NOT COMPLETED|3 Year Follow-up||21
1653712|NCT00716742|4038353|P2|NOT COMPLETED|3 Year Follow-up||32
1653713|NCT00716742|4038354|P1|NOT COMPLETED|3 Year Follow-up||30
1653714|NCT00716742|4038352|P3|COMPLETED|3 Year Follow-up||29
1653715|NCT00716742|4038353|P2|COMPLETED|3 Year Follow-up||35
1653716|NCT00716742|4038354|P1|COMPLETED|3 Year Follow-up||26
1653717|NCT00716742|4038352|P3|STARTED|3 Year Follow-up||50
1653718|NCT00716742|4038353|P2|STARTED|3 Year Follow-up||67
1653719|NCT00716742|4038354|P1|STARTED|3 Year Follow-up||56
1653720|NCT00716742|4038352|P3|NOT COMPLETED|2 Year Follow-up||102
1653721|NCT00716742|4038353|P2|NOT COMPLETED|2 Year Follow-up||96
1653722|NCT00716742|4038354|P1|NOT COMPLETED|2 Year Follow-up||104
1653723|NCT00716742|4038352|P3|COMPLETED|2 Year Follow-up||50
1653724|NCT00716742|4038353|P2|COMPLETED|2 Year Follow-up||67
1653725|NCT00716742|4038354|P1|COMPLETED|2 Year Follow-up||56
1653726|NCT00716742|4038352|P3|STARTED|2 Year Follow-up||152
1653727|NCT00716742|4038353|P2|STARTED|2 Year Follow-up||163
1653728|NCT00716742|4038354|P1|STARTED|2 Year Follow-up||160
1653729|NCT00716742|4038352|P3|NOT COMPLETED|1 Year Follow-up||200
1653730|NCT00716742|4038353|P2|NOT COMPLETED|1 Year Follow-up||193
1653731|NCT00716742|4038354|P1|NOT COMPLETED|1 Year Follow-up||187
1653732|NCT00716742|4038352|P3|COMPLETED|1 Year Follow-up||152
1653733|NCT00716742|4038353|P2|COMPLETED|1 Year Follow-up||163
1653734|NCT00716742|4038354|P1|COMPLETED|1 Year Follow-up||160
1653735|NCT00716742|4038352|P3|STARTED|1 Year Follow-up||352
1653736|NCT00716742|4038353|P2|STARTED|1 Year Follow-up||356
1653737|NCT00716742|4038354|P1|STARTED|1 Year Follow-up||347
1653738|NCT00716742|4038352|P3|NOT COMPLETED|Baseline||13
1653739|NCT00716742|4038353|P2|NOT COMPLETED|Baseline||14
1653740|NCT00716742|4038354|P1|NOT COMPLETED|Baseline||17
1653741|NCT00716742|4038352|P3|COMPLETED|Baseline||352
1653742|NCT00716742|4038353|P2|COMPLETED|Baseline||356
1653743|NCT00716742|4038354|P1|COMPLETED|Baseline||347
1653744|NCT00716742|4038352|P3|STARTED|Baseline||365
1653745|NCT00716742|4038353|P2|STARTED|Baseline||370
1653746|NCT00716742|4038354|P1|STARTED|Baseline||364
1653747|NCT00716625|4038362|P1|NOT COMPLETED|Overall Study||1
1653748|NCT00716625|4038362|P1|COMPLETED|Overall Study||1673
1653749|NCT00716625|4038362|P1|STARTED|Overall Study||1674
1653750|NCT00716482|4038387|P1|NOT COMPLETED|Overall Study||119
1653751|NCT00716482|4038387|P1|COMPLETED|Overall Study||1562
1653752|NCT00716482|4038387|P1|STARTED|Overall Study||1681
1653753|NCT00716456|4038400|P3|NOT COMPLETED|Overall Study||0
1653754|NCT00716456|4038401|P2|NOT COMPLETED|Overall Study||2
1653755|NCT00716456|4038402|P1|NOT COMPLETED|Overall Study||0
1653756|NCT00716456|4038400|P3|COMPLETED|Overall Study||13
1653757|NCT00716456|4038401|P2|COMPLETED|Overall Study||3
1653758|NCT00716456|4038402|P1|COMPLETED|Overall Study||3
1653759|NCT00716456|4038400|P3|STARTED|Overall Study||13
1653760|NCT00716456|4038401|P2|STARTED|Overall Study||5
1653761|NCT00716456|4038402|P1|STARTED|Overall Study||3
1653762|NCT00716443|4038410|P1|NOT COMPLETED|Overall Study||0
1653763|NCT00716443|4038410|P1|COMPLETED|Overall Study||51
1653764|NCT00716443|4038410|P1|STARTED|Overall Study||51
1653765|NCT00716417|4038453|P10|NOT COMPLETED|Overall Study||3
1653766|NCT00716417|4038454|P9|NOT COMPLETED|Overall Study||5
1653767|NCT00716417|4038455|P8|NOT COMPLETED|Overall Study||3
1653768|NCT00716417|4038456|P7|NOT COMPLETED|Overall Study||7
1653769|NCT00716417|4038457|P6|NOT COMPLETED|Overall Study||3
1653770|NCT00716417|4038458|P5|NOT COMPLETED|Overall Study||1
1653771|NCT00716417|4038459|P4|NOT COMPLETED|Overall Study||11
1653772|NCT00716417|4038460|P3|NOT COMPLETED|Overall Study||5
1653773|NCT00716417|4038461|P2|NOT COMPLETED|Overall Study||6
1653774|NCT00716417|4038462|P1|NOT COMPLETED|Overall Study||3
1653775|NCT00716417|4038453|P10|COMPLETED|Overall Study||0
1653776|NCT00716417|4038454|P9|COMPLETED|Overall Study||0
1653777|NCT00716417|4038455|P8|COMPLETED|Overall Study||0
1653778|NCT00716417|4038456|P7|COMPLETED|Overall Study||0
1653779|NCT00716417|4038457|P6|COMPLETED|Overall Study||0
1653780|NCT00716417|4038458|P5|COMPLETED|Overall Study||0
1653781|NCT00716417|4038459|P4|COMPLETED|Overall Study||0
1653782|NCT00716417|4038460|P3|COMPLETED|Overall Study||0
1653783|NCT00716417|4038461|P2|COMPLETED|Overall Study||0
1653784|NCT00716417|4038462|P1|COMPLETED|Overall Study||0
1653785|NCT00716417|4038453|P10|STARTED|Overall Study||3
1653786|NCT00716417|4038454|P9|STARTED|Overall Study||5
1653787|NCT00716417|4038455|P8|STARTED|Overall Study||3
1653788|NCT00716417|4038456|P7|STARTED|Overall Study||7
1653789|NCT00716417|4038457|P6|STARTED|Overall Study||3
1653790|NCT00716417|4038458|P5|STARTED|Overall Study||1
1653791|NCT00716417|4038459|P4|STARTED|Overall Study||11
1653792|NCT00716417|4038460|P3|STARTED|Overall Study||5
1653793|NCT00716417|4038461|P2|STARTED|Overall Study||6
1653794|NCT00716417|4038462|P1|STARTED|Overall Study||3
1653795|NCT00716274|4038509|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
1653796|NCT00716274|4038510|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
1653797|NCT00716274|4038511|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
1653798|NCT00716274|4038512|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
1653799|NCT00716274|4038513|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
1653800|NCT00716274|4038514|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
1653801|NCT00716274|4038509|P6|COMPLETED|Study Period III (16-Weeks)||19
1653802|NCT00716274|4038510|P5|COMPLETED|Study Period III (16-Weeks)||32
1653803|NCT00716274|4038511|P4|COMPLETED|Study Period III (16-Weeks)||17
1653804|NCT00716274|4038512|P3|COMPLETED|Study Period III (16-Weeks)||16
1653805|NCT00716274|4038513|P2|COMPLETED|Study Period III (16-Weeks)||0
1653806|NCT00716274|4038514|P1|COMPLETED|Study Period III (16-Weeks)||0
1653807|NCT00716274|4038509|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
1653808|NCT00716274|4038510|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
1653809|NCT00716274|4038511|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
1653810|NCT00716274|4038512|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
1653811|NCT00716274|4038513|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
1653812|NCT00716274|4038514|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
1653813|NCT00716274|4038509|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
1653814|NCT00716274|4038510|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
1653815|NCT00716274|4038511|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
1653816|NCT00716274|4038512|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
1653817|NCT00716274|4038513|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
1653818|NCT00716274|4038514|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
1653819|NCT00716274|4038509|P6|COMPLETED|Study Period II (16-Weeks)||19
1653820|NCT00716274|4038510|P5|COMPLETED|Study Period II (16-Weeks)||0
1653821|NCT00716274|4038511|P4|COMPLETED|Study Period II (16-Weeks)||0
1653822|NCT00716274|4038512|P3|COMPLETED|Study Period II (16-Weeks)||0
1653823|NCT00716274|4038513|P2|COMPLETED|Study Period II (16-Weeks)||35
1653824|NCT00716274|4038514|P1|COMPLETED|Study Period II (16-Weeks)||36
1653825|NCT00716274|4038509|P6|STARTED|Study Period II (16-Weeks)||21
1653826|NCT00716274|4038510|P5|STARTED|Study Period II (16-Weeks)||0
1653827|NCT00716274|4038511|P4|STARTED|Study Period II (16-Weeks)||0
1653828|NCT00716274|4038512|P3|STARTED|Study Period II (16-Weeks)||0
1653829|NCT00716274|4038513|P2|STARTED|Study Period II (16-Weeks)||44
1653830|NCT00716274|4038514|P1|STARTED|Study Period II (16-Weeks)||45
1653831|NCT00716144|4038648|P4|NOT COMPLETED|Overall Study||12
1653832|NCT00716144|4038649|P3|NOT COMPLETED|Overall Study||12
1653833|NCT00716144|4038650|P2|NOT COMPLETED|Overall Study||7
1653834|NCT00716144|4038651|P1|NOT COMPLETED|Overall Study||9
1653835|NCT00716144|4038648|P4|COMPLETED|Overall Study||33
1653836|NCT00716144|4038649|P3|COMPLETED|Overall Study||33
1653837|NCT00716144|4038650|P2|COMPLETED|Overall Study||38
1653838|NCT00716144|4038651|P1|COMPLETED|Overall Study||32
1653839|NCT00716144|4038648|P4|STARTED|Overall Study||45
1653840|NCT00716144|4038649|P3|STARTED|Overall Study||45
1653841|NCT00716144|4038650|P2|STARTED|Overall Study||45
1653842|NCT00716144|4038651|P1|STARTED|Overall Study||41
1653843|NCT00716092|4038676|P3|NOT COMPLETED|Overall Study||0
1653844|NCT00716092|4038677|P2|NOT COMPLETED|Overall Study||1
1653845|NCT00716092|4038678|P1|NOT COMPLETED|Overall Study||2
1653846|NCT00716092|4038676|P3|COMPLETED|Overall Study||41
1653847|NCT00716092|4038677|P2|COMPLETED|Overall Study||39
1653848|NCT00716092|4038678|P1|COMPLETED|Overall Study||38
1653849|NCT00716092|4038676|P3|STARTED|Overall Study||41
1653850|NCT00716092|4038677|P2|STARTED|Overall Study||40
1653851|NCT00716092|4038678|P1|STARTED|Overall Study||40
1653852|NCT00716079|4038709|P2|NOT COMPLETED|Overall Study||15
1653853|NCT00716079|4038710|P1|NOT COMPLETED|Overall Study||9
1653854|NCT00716079|4038709|P2|COMPLETED|Overall Study||1421
1653855|NCT00716079|4038710|P1|COMPLETED|Overall Study||1394
1653856|NCT00716079|4038709|P2|STARTED|Overall Study||1436
1653857|NCT00716079|4038710|P1|STARTED|Overall Study||1403
1653858|NCT00715962|4038720|P2|NOT COMPLETED|Overall Study||2
1653859|NCT00715962|4038721|P1|NOT COMPLETED|Overall Study||6
1653860|NCT00715962|4038720|P2|COMPLETED|Overall Study||48
1653861|NCT00715962|4038721|P1|COMPLETED|Overall Study||44
1653862|NCT00715962|4038720|P2|STARTED|Overall Study||50
1653863|NCT00715962|4038721|P1|STARTED|Overall Study||50
1653864|NCT00715949|4038731|P1|NOT COMPLETED|Overall Study||4
1653865|NCT00715949|4038731|P1|COMPLETED|Overall Study|116 patients completed first test|116
1653866|NCT00715949|4038731|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
1653867|NCT00715910|4038739|P6|NOT COMPLETED|Booster and ESFU Phase||13
1653868|NCT00715910|4038740|P5|NOT COMPLETED|Booster and ESFU Phase||2
1653869|NCT00715910|4038741|P4|NOT COMPLETED|Booster and ESFU Phase||11
1653870|NCT00715910|4038742|P3|NOT COMPLETED|Booster and ESFU Phase||0
1653871|NCT00715910|4038743|P2|NOT COMPLETED|Booster and ESFU Phase||0
1653872|NCT00715910|4038744|P1|NOT COMPLETED|Booster and ESFU Phase||0
1653873|NCT00715910|4038739|P6|COMPLETED|Booster and ESFU Phase||88
1653874|NCT00715910|4038740|P5|COMPLETED|Booster and ESFU Phase||36
1653875|NCT00715910|4038741|P4|COMPLETED|Booster and ESFU Phase||172
1653876|NCT00715910|4038742|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
1653877|NCT00715910|4038743|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
1653878|NCT00715910|4038744|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
1653879|NCT00715910|4038739|P6|STARTED|Booster and ESFU Phase||101
1653880|NCT00715910|4038740|P5|STARTED|Booster and ESFU Phase||38
1653881|NCT00715910|4038741|P4|STARTED|Booster and ESFU Phase||183
1653882|NCT00715910|4038742|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
1653883|NCT00715910|4038743|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
1653884|NCT00715910|4038744|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
1653885|NCT00715910|4038739|P6|NOT COMPLETED|Year 5||0
1653886|NCT00715910|4038740|P5|NOT COMPLETED|Year 5||0
1653887|NCT00715910|4038741|P4|NOT COMPLETED|Year 5||0
1653888|NCT00715910|4038742|P3|NOT COMPLETED|Year 5||0
1653889|NCT00715910|4038743|P2|NOT COMPLETED|Year 5||0
1653890|NCT00715910|4038744|P1|NOT COMPLETED|Year 5||0
1653891|NCT00715910|4038739|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
1653892|NCT00715910|4038740|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
1653893|NCT00715910|4038741|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
1653894|NCT00715910|4038742|P3|COMPLETED|Year 5||38
1653895|NCT00715910|4038743|P2|COMPLETED|Year 5||56
1653896|NCT00715910|4038744|P1|COMPLETED|Year 5||218
1653897|NCT00715910|4038739|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
1653898|NCT00715910|4038740|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
1653899|NCT00715910|4038741|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
1653900|NCT00715910|4038742|P3|STARTED|Year 5||38
1653901|NCT00715910|4038743|P2|STARTED|Year 5||56
1653902|NCT00715910|4038744|P1|STARTED|Year 5||218
1653903|NCT00715910|4038739|P6|NOT COMPLETED|Year 3||0
1653904|NCT00715910|4038740|P5|NOT COMPLETED|Year 3||0
1653905|NCT00715910|4038741|P4|NOT COMPLETED|Year 3||0
1653906|NCT00715910|4038742|P3|NOT COMPLETED|Year 3||0
1653907|NCT00715910|4038743|P2|NOT COMPLETED|Year 3||0
1653908|NCT00715910|4038744|P1|NOT COMPLETED|Year 3||0
1653909|NCT00715910|4038739|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
1653910|NCT00715910|4038740|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
1653911|NCT00715910|4038741|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
1653912|NCT00715910|4038742|P3|COMPLETED|Year 3||56
1653913|NCT00715910|4038743|P2|COMPLETED|Year 3||86
1653914|NCT00715910|4038744|P1|COMPLETED|Year 3||345
1653915|NCT00715910|4038739|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
1653916|NCT00715910|4038740|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
1653917|NCT00715910|4038741|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
1653918|NCT00715910|4038742|P3|STARTED|Year 3||56
1653919|NCT00715910|4038743|P2|STARTED|Year 3||86
1653920|NCT00715910|4038744|P1|STARTED|Year 3||345
1653921|NCT00715910|4038739|P6|NOT COMPLETED|Year 1||0
1653922|NCT00715910|4038740|P5|NOT COMPLETED|Year 1||0
1653923|NCT00715910|4038741|P4|NOT COMPLETED|Year 1||0
1653924|NCT00715910|4038742|P3|NOT COMPLETED|Year 1||0
1653925|NCT00715910|4038743|P2|NOT COMPLETED|Year 1||0
1653926|NCT00715910|4038744|P1|NOT COMPLETED|Year 1||0
1653927|NCT00715910|4038739|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
1653928|NCT00715910|4038740|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
1653929|NCT00715910|4038741|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
1653930|NCT00715910|4038742|P3|COMPLETED|Year 1||68
1653931|NCT00715910|4038743|P2|COMPLETED|Year 1||147
1653932|NCT00715910|4038744|P1|COMPLETED|Year 1||433
1653933|NCT00715910|4038739|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
1653934|NCT00715910|4038740|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
1653935|NCT00715910|4038741|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
1653936|NCT00715910|4038742|P3|STARTED|Year 1||68
1653937|NCT00715910|4038743|P2|STARTED|Year 1||147
1653938|NCT00715910|4038744|P1|STARTED|Year 1||433
1653939|NCT00715884|4038820|P2|NOT COMPLETED|Overall Study||1
1653940|NCT00715884|4038821|P1|NOT COMPLETED|Overall Study||8
1653941|NCT00715884|4038820|P2|COMPLETED|Overall Study||225
1653942|NCT00715884|4038821|P1|COMPLETED|Overall Study||444
1653943|NCT00715884|4038820|P2|STARTED|Overall Study||226
1653944|NCT00715884|4038821|P1|STARTED|Overall Study||452
1653945|NCT00715793|4038863|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
1653946|NCT00715793|4038864|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
1653947|NCT00715793|4038863|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
1653948|NCT00715793|4038864|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
1653949|NCT00715793|4038863|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
1653950|NCT00715793|4038864|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
1653951|NCT00715793|4038863|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
1653952|NCT00715793|4038864|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
1653953|NCT00715793|4038863|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
1653954|NCT00715793|4038864|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
1653955|NCT00715793|4038863|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
1653956|NCT00715793|4038864|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
1653957|NCT00715754|4038876|P1|NOT COMPLETED|Overall Study||0
1653958|NCT00715754|4038876|P1|COMPLETED|Overall Study||47
1653959|NCT00715754|4038876|P1|STARTED|Overall Study||47
1653960|NCT00715741|4038886|P4|NOT COMPLETED|Overall Study||0
1653961|NCT00715741|4038887|P3|NOT COMPLETED|Overall Study||0
1653962|NCT00715741|4038888|P2|NOT COMPLETED|Overall Study||0
1653963|NCT00715741|4038889|P1|NOT COMPLETED|Overall Study||0
1653964|NCT00715741|4038886|P4|COMPLETED|Overall Study||25
1653965|NCT00715741|4038887|P3|COMPLETED|Overall Study||25
1653966|NCT00715741|4038888|P2|COMPLETED|Overall Study||25
1653967|NCT00715741|4038889|P1|COMPLETED|Overall Study||25
1653968|NCT00715741|4038886|P4|STARTED|Overall Study||25
1653969|NCT00715741|4038887|P3|STARTED|Overall Study||25
1653970|NCT00715741|4038888|P2|STARTED|Overall Study||25
1653971|NCT00715741|4038889|P1|STARTED|Overall Study||25
1653972|NCT00715728|4038913|P2|NOT COMPLETED|Overall Study||0
1653973|NCT00715728|4038914|P1|NOT COMPLETED|Overall Study||0
1653974|NCT00715728|4038913|P2|COMPLETED|Overall Study||14
1653975|NCT00715728|4038914|P1|COMPLETED|Overall Study||14
1653976|NCT00715728|4038913|P2|STARTED|Overall Study||14
1653977|NCT00715728|4038914|P1|STARTED|Overall Study||14
1653978|NCT00715676|4038925|P3|NOT COMPLETED|Overall Study||32
1653979|NCT00715676|4038926|P2|NOT COMPLETED|Overall Study||11
1653980|NCT00715676|4038927|P1|NOT COMPLETED|Overall Study||6
1653981|NCT00715676|4038925|P3|COMPLETED|Overall Study||21
1653982|NCT00715676|4038926|P2|COMPLETED|Overall Study||43
1653983|NCT00715676|4038927|P1|COMPLETED|Overall Study||43
1653984|NCT00715676|4038925|P3|STARTED|Overall Study||53
1653985|NCT00715676|4038926|P2|STARTED|Overall Study||54
1653986|NCT00715676|4038927|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
1653987|NCT00715650|4038955|P2|NOT COMPLETED|Follow-up||5
1653988|NCT00715650|4038956|P1|NOT COMPLETED|Follow-up||13
1653989|NCT00715650|4038955|P2|COMPLETED|Follow-up||37
1653990|NCT00715650|4038956|P1|COMPLETED|Follow-up||29
1653991|NCT00715650|4038955|P2|Completed Month 6 Follow-up|Follow-up||37
1653992|NCT00715650|4038956|P1|Completed Month 6 Follow-up|Follow-up||29
1653993|NCT00715650|4038955|P2|Completed Month 3 Follow-up|Follow-up||40
1653994|NCT00715650|4038956|P1|Completed Month 3 Follow-up|Follow-up||35
1653995|NCT00715650|4038955|P2|Completed Month 1 Follow-up|Follow-up||38
1653996|NCT00715650|4038956|P1|Completed Month 1 Follow-up|Follow-up||40
1653997|NCT00715650|4038955|P2|STARTED|Follow-up||42
1653998|NCT00715650|4038956|P1|STARTED|Follow-up||42
1653999|NCT00715650|4038955|P2|NOT COMPLETED|Intervention||3
1654000|NCT00715650|4038956|P1|NOT COMPLETED|Intervention||5
1654001|NCT00715650|4038955|P2|COMPLETED|Intervention||42
1654002|NCT00715650|4038956|P1|COMPLETED|Intervention||42
1654003|NCT00715650|4038955|P2|Attended ≥ 3 Sessions|Intervention||17
1654004|NCT00715650|4038956|P1|Attended ≥ 3 Sessions|Intervention||23
1654005|NCT00715650|4038955|P2|Attended ≥ 2 Sessions|Intervention||33
1654006|NCT00715650|4038956|P1|Attended ≥ 2 Sessions|Intervention||36
1654007|NCT00715650|4038955|P2|Received Any Session|Intervention||38
1654008|NCT00715650|4038956|P1|Received Any Session|Intervention||39
1654009|NCT00715650|4038955|P2|STARTED|Intervention||45
1654010|NCT00715650|4038956|P1|STARTED|Intervention||47
1654011|NCT00715624|4038970|P2|NOT COMPLETED|Overall Study||116
1654012|NCT00715624|4038971|P1|NOT COMPLETED|Overall Study||52
1654013|NCT00715624|4038970|P2|COMPLETED|Overall Study||213
1654014|NCT00715624|4038971|P1|COMPLETED|Overall Study||115
1654015|NCT00715624|4038970|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
1654016|NCT00715624|4038971|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
1654017|NCT00715624|4038970|P2|Treated/Safety Population|Overall Study||328
1654018|NCT00715624|4038971|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
1654019|NCT00715624|4038970|P2|STARTED|Overall Study||329
1654020|NCT00715624|4038971|P1|STARTED|Overall Study|Randomized|167
1654021|NCT00715559|4038999|P1|NOT COMPLETED|Overall Study||1
1654022|NCT00715559|4038999|P1|COMPLETED|Overall Study||2
1654023|NCT00715559|4038999|P1|STARTED|Overall Study||3
1654024|NCT00715520|4039009|P3|NOT COMPLETED|Overall Study||2
1654025|NCT00715520|4039010|P2|NOT COMPLETED|Overall Study||1
1654026|NCT00715520|4039011|P1|NOT COMPLETED|Overall Study||10
1654027|NCT00715520|4039009|P3|COMPLETED|Overall Study||1
1654028|NCT00715520|4039010|P2|COMPLETED|Overall Study||9
1654029|NCT00715520|4039011|P1|COMPLETED|Overall Study||10
1654030|NCT00715520|4039009|P3|STARTED|Overall Study||3
1654031|NCT00715520|4039010|P2|STARTED|Overall Study||10
1654032|NCT00715520|4039011|P1|STARTED|Overall Study||20
1654033|NCT00715403|4039031|P7|NOT COMPLETED|Overall Study||1
1654034|NCT00715403|4039032|P6|NOT COMPLETED|Overall Study||19
1654035|NCT00715403|4039033|P5|NOT COMPLETED|Overall Study||6
1654036|NCT00715403|4039034|P4|NOT COMPLETED|Overall Study||9
1654037|NCT00715403|4039035|P3|NOT COMPLETED|Overall Study||4
1654038|NCT00715403|4039036|P2|NOT COMPLETED|Overall Study||1
1654039|NCT00715403|4039037|P1|NOT COMPLETED|Overall Study||1
1654040|NCT00715403|4039031|P7|COMPLETED|Overall Study||0
1654041|NCT00715403|4039032|P6|COMPLETED|Overall Study||0
1654042|NCT00715403|4039033|P5|COMPLETED|Overall Study||0
1654043|NCT00715403|4039034|P4|COMPLETED|Overall Study||0
1654044|NCT00715403|4039035|P3|COMPLETED|Overall Study||0
1654045|NCT00715403|4039036|P2|COMPLETED|Overall Study||0
1654046|NCT00715403|4039037|P1|COMPLETED|Overall Study||0
1654047|NCT00715403|4039031|P7|STARTED|Overall Study||1
1654048|NCT00715403|4039032|P6|STARTED|Overall Study||19
1654049|NCT00715403|4039033|P5|STARTED|Overall Study||6
1654050|NCT00715403|4039034|P4|STARTED|Overall Study||9
1654051|NCT00715403|4039035|P3|STARTED|Overall Study||4
1654052|NCT00715403|4039036|P2|STARTED|Overall Study||1
1654053|NCT00715403|4039037|P1|STARTED|Overall Study||1
1654054|NCT00715390|4039172|P1|NOT COMPLETED|Overall Study||0
1654055|NCT00715390|4039172|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
1654056|NCT00715390|4039172|P1|Eligible|Overall Study||234
1654057|NCT00715390|4039172|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
1654058|NCT00715299|4039176|P1|NOT COMPLETED|Overall Study||6
1654059|NCT00715299|4039176|P1|COMPLETED|Overall Study||30
1654060|NCT00715299|4039176|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
1654061|NCT00715208|4039182|P2|NOT COMPLETED|Overall Study||9
1654062|NCT00715208|4039183|P1|NOT COMPLETED|Overall Study||1
1654063|NCT00715208|4039182|P2|COMPLETED|Overall Study||39
1654064|NCT00715208|4039183|P1|COMPLETED|Overall Study||6
1654065|NCT00715208|4039182|P2|STARTED|Overall Study||48
1654066|NCT00715208|4039183|P1|STARTED|Overall Study||7
1654067|NCT00715117|4039199|P2|NOT COMPLETED|Overall Study||1
1654068|NCT00715117|4039200|P1|NOT COMPLETED|Overall Study||0
1654069|NCT00715117|4039199|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
1654070|NCT00715117|4039200|P1|COMPLETED|Overall Study||6
1654071|NCT00715117|4039199|P2|Completion fo 8 Week Study|Overall Study||6
1654072|NCT00715117|4039200|P1|Completion fo 8 Week Study|Overall Study||6
1654073|NCT00715117|4039199|P2|STARTED|Overall Study||6
1654074|NCT00715117|4039200|P1|STARTED|Overall Study||6
1654075|NCT00715104|4039214|P3|NOT COMPLETED|Overall Study||0
1654076|NCT00715104|4039215|P2|NOT COMPLETED|Overall Study||0
1654077|NCT00715104|4039216|P1|NOT COMPLETED|Overall Study||0
1654078|NCT00715104|4039214|P3|COMPLETED|Overall Study||8
1654079|NCT00715104|4039215|P2|COMPLETED|Overall Study||16
1654080|NCT00715104|4039216|P1|COMPLETED|Overall Study||18
1654081|NCT00715104|4039214|P3|STARTED|Overall Study||8
1654082|NCT00715104|4039215|P2|STARTED|Overall Study||16
1654083|NCT00715104|4039216|P1|STARTED|Overall Study||18
1654084|NCT00715078|4039268|P3|NOT COMPLETED|Overall Study||38
1654085|NCT00715078|4039269|P2|NOT COMPLETED|Overall Study||36
1654086|NCT00715078|4039270|P1|NOT COMPLETED|Overall Study||30
1654087|NCT00715078|4039268|P3|COMPLETED|Overall Study||3
1654088|NCT00715078|4039269|P2|COMPLETED|Overall Study||4
1654089|NCT00715078|4039270|P1|COMPLETED|Overall Study||11
1654090|NCT00715078|4039268|P3|Received ≥ 1 Leukapheresis|Overall Study||40
1654091|NCT00715078|4039269|P2|Received ≥ 1 Leukapheresis|Overall Study||40
1654092|NCT00715078|4039270|P1|Received ≥ 1 Leukapheresis|Overall Study||40
1654093|NCT00715078|4039268|P3|Received ≥ 1 Study Infusion|Overall Study||39
1654094|NCT00715078|4039269|P2|Received ≥ 1 Study Infusion|Overall Study||40
1654095|NCT00715078|4039270|P1|Received ≥ 1 Study Infusion|Overall Study||40
1654096|NCT00715078|4039268|P3|STARTED|Overall Study||41
1654097|NCT00715078|4039269|P2|STARTED|Overall Study||40
1654098|NCT00715078|4039270|P1|STARTED|Overall Study||41
1654099|NCT00715026|4039278|P1|NOT COMPLETED|Overall Study||10
1654100|NCT00715026|4039278|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
1654101|NCT00715026|4039278|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
1654102|NCT00715026|4039278|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
1654103|NCT00714948|4039283|P1|NOT COMPLETED|Overall Study||2
1654104|NCT00714948|4039283|P1|COMPLETED|Overall Study||0
1654105|NCT00714948|4039283|P1|STARTED|Overall Study||2
1654106|NCT00714870|4039289|P2|NOT COMPLETED|Overall Study||5
1654107|NCT00714870|4039290|P1|NOT COMPLETED|Overall Study||27
1654108|NCT00714870|4039289|P2|COMPLETED|Overall Study||22
1654109|NCT00714870|4039290|P1|COMPLETED|Overall Study||22
1654110|NCT00714870|4039289|P2|STARTED|Overall Study||27
1654111|NCT00714870|4039290|P1|STARTED|Overall Study||49
1654112|NCT00714792|4039298|P2|NOT COMPLETED|Overall Study||0
1654113|NCT00714792|4039299|P1|NOT COMPLETED|Overall Study||0
1654114|NCT00714792|4039298|P2|COMPLETED|Overall Study||8
1654115|NCT00714792|4039299|P1|COMPLETED|Overall Study||10
1654116|NCT00714792|4039298|P2|STARTED|Overall Study||8
1654117|NCT00714792|4039299|P1|STARTED|Overall Study||10
1654118|NCT00714753|4039305|P1|NOT COMPLETED|Overall Study||0
1654119|NCT00714753|4039305|P1|COMPLETED|Overall Study||5
1654120|NCT00714753|4039305|P1|STARTED|Overall Study||5
1654121|NCT00714714|4039314|P1|NOT COMPLETED|Overall Study||1
1654122|NCT00714714|4039314|P1|COMPLETED|Overall Study||24
1654123|NCT00714714|4039314|P1|STARTED|Overall Study||25
1654124|NCT00714688|4039323|P3|NOT COMPLETED|Overall Study||37
1654125|NCT00714688|4039324|P2|NOT COMPLETED|Overall Study||35
1654126|NCT00714688|4039325|P1|NOT COMPLETED|Overall Study||29
1654127|NCT00714688|4039323|P3|COMPLETED|Overall Study||55
1654128|NCT00714688|4039324|P2|COMPLETED|Overall Study||55
1654129|NCT00714688|4039325|P1|COMPLETED|Overall Study||68
1654130|NCT00714688|4039323|P3|STARTED|Overall Study||92
1654131|NCT00714688|4039324|P2|STARTED|Overall Study||90
1654132|NCT00714688|4039325|P1|STARTED|Overall Study||97
1654133|NCT00714571|4039348|P6|NOT COMPLETED|Stage 2||0
1654134|NCT00714571|4039349|P5|NOT COMPLETED|Stage 2||0
1654135|NCT00714571|4039350|P4|NOT COMPLETED|Stage 2||0
1654136|NCT00714571|4039351|P3|NOT COMPLETED|Stage 2||0
1654137|NCT00714571|4039352|P2|NOT COMPLETED|Stage 2||0
1654138|NCT00714571|4039353|P1|NOT COMPLETED|Stage 2||0
1654139|NCT00714571|4039348|P6|COMPLETED|Stage 2||15
1654140|NCT00714571|4039349|P5|COMPLETED|Stage 2||15
1654141|NCT00714571|4039350|P4|COMPLETED|Stage 2||0
1654142|NCT00714571|4039351|P3|COMPLETED|Stage 2||0
1654143|NCT00714571|4039352|P2|COMPLETED|Stage 2||0
1654144|NCT00714571|4039353|P1|COMPLETED|Stage 2||0
1654145|NCT00714571|4039348|P6|STARTED|Stage 2||15
1654146|NCT00714571|4039349|P5|STARTED|Stage 2||15
1654147|NCT00714571|4039350|P4|STARTED|Stage 2||0
1654148|NCT00714571|4039351|P3|STARTED|Stage 2||0
1654149|NCT00714571|4039352|P2|STARTED|Stage 2||0
1654150|NCT00714571|4039353|P1|STARTED|Stage 2||0
1654151|NCT00714571|4039348|P6|NOT COMPLETED|Stage 1||0
1654152|NCT00714571|4039349|P5|NOT COMPLETED|Stage 1||0
1654153|NCT00714571|4039350|P4|NOT COMPLETED|Stage 1||0
1654154|NCT00714571|4039351|P3|NOT COMPLETED|Stage 1||1
1654155|NCT00714571|4039352|P2|NOT COMPLETED|Stage 1||0
1654156|NCT00714571|4039353|P1|NOT COMPLETED|Stage 1||0
1654157|NCT00714571|4039348|P6|COMPLETED|Stage 1||0
1654158|NCT00714571|4039349|P5|COMPLETED|Stage 1||0
1654159|NCT00714571|4039350|P4|COMPLETED|Stage 1||14
1654160|NCT00714571|4039351|P3|COMPLETED|Stage 1||10
1654161|NCT00714571|4039352|P2|COMPLETED|Stage 1||15
1654162|NCT00714571|4039353|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
1654163|NCT00714571|4039348|P6|STARTED|Stage 1||0
1654164|NCT00714571|4039349|P5|STARTED|Stage 1||0
1654165|NCT00714571|4039350|P4|STARTED|Stage 1||14
1654166|NCT00714571|4039351|P3|STARTED|Stage 1||11
1654167|NCT00714571|4039352|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
1654168|NCT00714571|4039353|P1|STARTED|Stage 1||12
1654169|NCT00714493|4039367|P1|NOT COMPLETED|Overall Study||49
1654170|NCT00714493|4039367|P1|COMPLETED|Overall Study||154
1654171|NCT00714493|4039367|P1|STARTED|Overall Study||203
1654172|NCT00714415|4039379|P2|NOT COMPLETED|Overall Study||0
1654173|NCT00714415|4039380|P1|NOT COMPLETED|Overall Study||2
1654174|NCT00714415|4039379|P2|COMPLETED|Overall Study||55
1654175|NCT00714415|4039380|P1|COMPLETED|Overall Study||23
1654176|NCT00714415|4039379|P2|STARTED|Overall Study||55
1654177|NCT00714415|4039380|P1|STARTED|Overall Study||25
1654178|NCT00714389|4039412|P1|NOT COMPLETED|Overall Study||0
1654179|NCT00714389|4039412|P1|COMPLETED|Overall Study||12
1654180|NCT00714389|4039412|P1|STARTED|Overall Study||12
1654181|NCT00714311|4039419|P2|NOT COMPLETED|Overall Study||22
1654182|NCT00714311|4039420|P1|NOT COMPLETED|Overall Study||13
1654183|NCT00714311|4039419|P2|COMPLETED|Overall Study||30
1654184|NCT00714311|4039420|P1|COMPLETED|Overall Study||39
1654185|NCT00714311|4039419|P2|STARTED|Overall Study||52
1654186|NCT00714311|4039420|P1|STARTED|Overall Study||52
1654187|NCT00714285|4039430|P4|NOT COMPLETED|Overall Study||1
1654188|NCT00714285|4039431|P3|NOT COMPLETED|Overall Study||0
1654189|NCT00714285|4039432|P2|NOT COMPLETED|Overall Study||3
1654190|NCT00714285|4039433|P1|NOT COMPLETED|Overall Study||0
1654191|NCT00714285|4039430|P4|COMPLETED|Overall Study|Completed upto Day 180|104
1654192|NCT00714285|4039431|P3|COMPLETED|Overall Study|Completed upto Day 180|105
1654193|NCT00714285|4039432|P2|COMPLETED|Overall Study|Completed upto Day 180|102
1654194|NCT00714285|4039433|P1|COMPLETED|Overall Study|Completed upto Day 180|105
1654195|NCT00714285|4039430|P4|STARTED|Overall Study||105
1654196|NCT00714285|4039431|P3|STARTED|Overall Study||105
1654197|NCT00714285|4039432|P2|STARTED|Overall Study||105
1654198|NCT00714285|4039433|P1|STARTED|Overall Study||105
1654199|NCT00714259|4039483|P1|NOT COMPLETED|Overall Study||2
1654200|NCT00714259|4039483|P1|COMPLETED|Overall Study||3
1654201|NCT00714259|4039483|P1|STARTED|Overall Study||5
1654202|NCT00714233|4039497|P4|NOT COMPLETED|Overall Study||4
1654203|NCT00714233|4039498|P3|NOT COMPLETED|Overall Study||1
1654204|NCT00714233|4039499|P2|NOT COMPLETED|Overall Study||1
1654205|NCT00714233|4039500|P1|NOT COMPLETED|Overall Study||4
1654206|NCT00714233|4039497|P4|COMPLETED|Overall Study||6
1654207|NCT00714233|4039498|P3|COMPLETED|Overall Study||10
1654208|NCT00714233|4039499|P2|COMPLETED|Overall Study||10
1654209|NCT00714233|4039500|P1|COMPLETED|Overall Study||6
1654210|NCT00714233|4039497|P4|STARTED|Overall Study||10
1654211|NCT00714233|4039498|P3|STARTED|Overall Study||11
1654212|NCT00714233|4039499|P2|STARTED|Overall Study||11
1654213|NCT00714233|4039500|P1|STARTED|Overall Study||10
1654214|NCT00714168|4039529|P2|NOT COMPLETED|Overall Study||59
1654215|NCT00714168|4039530|P1|NOT COMPLETED|Overall Study||44
1654216|NCT00714168|4039529|P2|COMPLETED|Overall Study||139
1654217|NCT00714168|4039530|P1|COMPLETED|Overall Study||121
1654218|NCT00714168|4039529|P2|STARTED|Overall Study||198
1654219|NCT00714168|4039530|P1|STARTED|Overall Study||165
1654220|NCT00714051|4039546|P2|NOT COMPLETED|Overall Study||1
1654221|NCT00714051|4039547|P1|NOT COMPLETED|Overall Study||1
1654222|NCT00714051|4039546|P2|COMPLETED|Overall Study||27
1654223|NCT00714051|4039547|P1|COMPLETED|Overall Study||26
1654224|NCT00714051|4039546|P2|STARTED|Overall Study||28
1654225|NCT00714051|4039547|P1|STARTED|Overall Study||27
1654226|NCT00713830|4039555|P2|NOT COMPLETED|Overall Study||177
1654227|NCT00713830|4039556|P1|NOT COMPLETED|Overall Study||82
1654228|NCT00713830|4039555|P2|COMPLETED|Overall Study||396
1654229|NCT00713830|4039556|P1|COMPLETED|Overall Study||204
1654230|NCT00713830|4039555|P2|Subgroup for Standardized Meal Test|Overall Study||313
1654319|NCT00713479|4039763|P2|NOT COMPLETED|Washout||0
1654320|NCT00713479|4039764|P1|NOT COMPLETED|Washout||0
1654231|NCT00713830|4039556|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
1654232|NCT00713830|4039555|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
1654233|NCT00713830|4039556|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
1654234|NCT00713830|4039555|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
1654235|NCT00713830|4039556|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
1654236|NCT00713830|4039555|P2|STARTED|Overall Study||573
1654237|NCT00713830|4039556|P1|STARTED|Overall Study|Randomized.|286
1654238|NCT00713817|4039594|P2|NOT COMPLETED|Overall Study||0
1654239|NCT00713817|4039595|P1|NOT COMPLETED|Overall Study||0
1654240|NCT00713817|4039594|P2|COMPLETED|Overall Study||9
1654241|NCT00713817|4039595|P1|COMPLETED|Overall Study||10
1654242|NCT00713817|4039594|P2|STARTED|Overall Study||9
1654243|NCT00713817|4039595|P1|STARTED|Overall Study||10
1654244|NCT00713700|4039613|P1|NOT COMPLETED|Overall Study||4
1654245|NCT00713700|4039613|P1|COMPLETED|Overall Study||188
1654246|NCT00713700|4039613|P1|STARTED|Overall Study||192
1654247|NCT00713661|4039622|P4|NOT COMPLETED|Overall Study||0
1654248|NCT00713661|4039623|P3|NOT COMPLETED|Overall Study||0
1654249|NCT00713661|4039624|P2|NOT COMPLETED|Overall Study||0
1654250|NCT00713661|4039625|P1|NOT COMPLETED|Overall Study||0
1654251|NCT00713661|4039622|P4|COMPLETED|Overall Study||5
1654252|NCT00713661|4039623|P3|COMPLETED|Overall Study||4
1654253|NCT00713661|4039624|P2|COMPLETED|Overall Study||9
1654254|NCT00713661|4039625|P1|COMPLETED|Overall Study||7
1654255|NCT00713661|4039622|P4|STARTED|Overall Study||5
1654256|NCT00713661|4039623|P3|STARTED|Overall Study||4
1654257|NCT00713661|4039624|P2|STARTED|Overall Study||9
1654258|NCT00713661|4039625|P1|STARTED|Overall Study||7
1654259|NCT00713648|4039639|P1|NOT COMPLETED|Overall Study||8
1654260|NCT00713648|4039639|P1|COMPLETED|Overall Study||33
1654261|NCT00713648|4039639|P1|STARTED|Overall Study||41
1654262|NCT00713609|4039652|P6|NOT COMPLETED|Overall Study||8
1654263|NCT00713609|4039653|P5|NOT COMPLETED|Overall Study||19
1654264|NCT00713609|4039654|P4|NOT COMPLETED|Overall Study||9
1654265|NCT00713609|4039655|P3|NOT COMPLETED|Overall Study||15
1654266|NCT00713609|4039656|P2|NOT COMPLETED|Overall Study||15
1654267|NCT00713609|4039657|P1|NOT COMPLETED|Overall Study||21
1654268|NCT00713609|4039652|P6|COMPLETED|Overall Study||47
1654269|NCT00713609|4039653|P5|COMPLETED|Overall Study||87
1654270|NCT00713609|4039654|P4|COMPLETED|Overall Study||99
1654271|NCT00713609|4039655|P3|COMPLETED|Overall Study||92
1654272|NCT00713609|4039656|P2|COMPLETED|Overall Study||90
1654273|NCT00713609|4039657|P1|COMPLETED|Overall Study||85
1654274|NCT00713609|4039652|P6|STARTED|Overall Study||55
1654275|NCT00713609|4039653|P5|STARTED|Overall Study||106
1654276|NCT00713609|4039654|P4|STARTED|Overall Study||108
1654277|NCT00713609|4039655|P3|STARTED|Overall Study||107
1654278|NCT00713609|4039656|P2|STARTED|Overall Study||105
1654279|NCT00713609|4039657|P1|STARTED|Overall Study||106
1654280|NCT00713596|4039692|P3|NOT COMPLETED|Overall Study||2
1654281|NCT00713596|4039693|P2|NOT COMPLETED|Overall Study||3
1654282|NCT00713596|4039694|P1|NOT COMPLETED|Overall Study||2
1654283|NCT00713596|4039692|P3|COMPLETED|Overall Study||6
1654284|NCT00713596|4039693|P2|COMPLETED|Overall Study||5
1654285|NCT00713596|4039694|P1|COMPLETED|Overall Study||7
1654286|NCT00713596|4039692|P3|STARTED|Overall Study||8
1654287|NCT00713596|4039693|P2|STARTED|Overall Study||8
1654288|NCT00713596|4039694|P1|STARTED|Overall Study||9
1654289|NCT00713583|4039707|P2|NOT COMPLETED|Overall Study||0
1654290|NCT00713583|4039708|P1|NOT COMPLETED|Overall Study||0
1654291|NCT00713583|4039707|P2|COMPLETED|Overall Study||40
1654292|NCT00713583|4039708|P1|COMPLETED|Overall Study||45
1654293|NCT00713583|4039707|P2|STARTED|Overall Study||40
1654294|NCT00713583|4039708|P1|STARTED|Overall Study||45
1654295|NCT00713544|4039720|P6|NOT COMPLETED|Overall Study||9
1654296|NCT00713544|4039721|P5|NOT COMPLETED|Overall Study||8
1654297|NCT00713544|4039722|P4|NOT COMPLETED|Overall Study||10
1654298|NCT00713544|4039723|P3|NOT COMPLETED|Overall Study||11
1654299|NCT00713544|4039724|P2|NOT COMPLETED|Overall Study||6
1654300|NCT00713544|4039725|P1|NOT COMPLETED|Overall Study||7
1654301|NCT00713544|4039720|P6|COMPLETED|Overall Study||67
1654302|NCT00713544|4039721|P5|COMPLETED|Overall Study||57
1654303|NCT00713544|4039722|P4|COMPLETED|Overall Study||66
1654304|NCT00713544|4039723|P3|COMPLETED|Overall Study||41
1654305|NCT00713544|4039724|P2|COMPLETED|Overall Study||46
1654306|NCT00713544|4039725|P1|COMPLETED|Overall Study||45
1654307|NCT00713544|4039720|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
1654308|NCT00713544|4039721|P5|STARTED|Overall Study||65
1654309|NCT00713544|4039722|P4|STARTED|Overall Study||76
1654310|NCT00713544|4039723|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
1654311|NCT00713544|4039724|P2|STARTED|Overall Study||52
1654312|NCT00713544|4039725|P1|STARTED|Overall Study||52
1654313|NCT00713479|4039763|P2|NOT COMPLETED|Next Medication Condition||0
1654314|NCT00713479|4039764|P1|NOT COMPLETED|Next Medication Condition||0
1654315|NCT00713479|4039763|P2|COMPLETED|Next Medication Condition||6
1654316|NCT00713479|4039764|P1|COMPLETED|Next Medication Condition||2
1654317|NCT00713479|4039763|P2|STARTED|Next Medication Condition||6
1654318|NCT00713479|4039764|P1|STARTED|Next Medication Condition||2
1654321|NCT00713479|4039763|P2|COMPLETED|Washout||6
1654322|NCT00713479|4039764|P1|COMPLETED|Washout||2
1654323|NCT00713479|4039763|P2|STARTED|Washout||6
1654324|NCT00713479|4039764|P1|STARTED|Washout||2
1654325|NCT00713479|4039763|P2|NOT COMPLETED|First Medication Condition||0
1654326|NCT00713479|4039764|P1|NOT COMPLETED|First Medication Condition||4
1654327|NCT00713479|4039763|P2|COMPLETED|First Medication Condition||6
1654328|NCT00713479|4039764|P1|COMPLETED|First Medication Condition||2
1654329|NCT00713479|4039763|P2|STARTED|First Medication Condition||6
1654330|NCT00713479|4039764|P1|STARTED|First Medication Condition||6
1654331|NCT00713349|4039776|P1|NOT COMPLETED|Overall Study||1
1654332|NCT00713349|4039776|P1|COMPLETED|Overall Study||24
1654333|NCT00713349|4039776|P1|STARTED|Overall Study||25
1654334|NCT00713323|4039782|P1|NOT COMPLETED|Overall Study||146
1654335|NCT00713323|4039782|P1|COMPLETED|Overall Study||234
1654336|NCT00713323|4039782|P1|STARTED|Overall Study||380
1654337|NCT00713310|4039795|P2|NOT COMPLETED|Overall Study||6
1654338|NCT00713310|4039796|P1|NOT COMPLETED|Overall Study||5
1654339|NCT00713310|4039795|P2|COMPLETED|Overall Study||36
1654340|NCT00713310|4039796|P1|COMPLETED|Overall Study||36
1654341|NCT00713310|4039795|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
1654342|NCT00713310|4039796|P1|mITT Population|Overall Study||41
1654343|NCT00713310|4039795|P2|STARTED|Overall Study||42
1654344|NCT00713310|4039796|P1|STARTED|Overall Study||41
1654345|NCT00713258|4039806|P2|NOT COMPLETED|Overall Study||6
1654346|NCT00713258|4039807|P1|NOT COMPLETED|Overall Study||5
1654347|NCT00713258|4039806|P2|COMPLETED|Overall Study||28
1654348|NCT00713258|4039807|P1|COMPLETED|Overall Study||36
1654349|NCT00713258|4039806|P2|STARTED|Overall Study||34
1654350|NCT00713258|4039807|P1|STARTED|Overall Study||41
1654351|NCT00713219|4039815|P1|NOT COMPLETED|Overall Study||2
1654352|NCT00713219|4039815|P1|COMPLETED|Overall Study||12
1654353|NCT00713219|4039815|P1|STARTED|Overall Study||14
1654354|NCT00713206|4039821|P2|NOT COMPLETED|Overall Study||3
1654355|NCT00713206|4039822|P1|NOT COMPLETED|Overall Study||7
1654356|NCT00713206|4039821|P2|COMPLETED|Overall Study||27
1654357|NCT00713206|4039822|P1|COMPLETED|Overall Study||55
1654358|NCT00713206|4039821|P2|STARTED|Overall Study||30
1654359|NCT00713206|4039822|P1|STARTED|Overall Study||62
1654360|NCT00712985|4039828|P1|NOT COMPLETED|Overall Study||5
1654361|NCT00712985|4039828|P1|COMPLETED|Overall Study||13
1654362|NCT00712985|4039828|P1|STARTED|Overall Study||18
1654363|NCT00712959|4039834|P2|NOT COMPLETED|Overall Study||3
1654364|NCT00712959|4039835|P1|NOT COMPLETED|Overall Study||19
1654365|NCT00712959|4039834|P2|COMPLETED|Overall Study||404
1654366|NCT00712959|4039835|P1|COMPLETED|Overall Study||342
1654367|NCT00712959|4039834|P2|STARTED|Overall Study||407
1654368|NCT00712959|4039835|P1|STARTED|Overall Study||361
1654369|NCT00712933|4039853|P1|NOT COMPLETED|Overall Study||367
1654370|NCT00712933|4039853|P1|COMPLETED|Overall Study||368
1654371|NCT00712933|4039853|P1|STARTED|Overall Study||735
1654372|NCT00712920|4039883|P3|NOT COMPLETED|Overall Study||12
1654373|NCT00712920|4039884|P2|NOT COMPLETED|Overall Study||17
1654374|NCT00712920|4039885|P1|NOT COMPLETED|Overall Study||17
1654375|NCT00712920|4039883|P3|COMPLETED|Overall Study||180
1654376|NCT00712920|4039884|P2|COMPLETED|Overall Study||180
1654377|NCT00712920|4039885|P1|COMPLETED|Overall Study||175
1654378|NCT00712920|4039883|P3|STARTED|Overall Study||192
1654379|NCT00712920|4039884|P2|STARTED|Overall Study|3 subjects were randomized in error|197
1654380|NCT00712920|4039885|P1|STARTED|Overall Study||192
1654381|NCT00712725|4039913|P8|NOT COMPLETED|Overall Study||11
1654382|NCT00712725|4039914|P7|NOT COMPLETED|Overall Study||22
1654383|NCT00712725|4039915|P6|NOT COMPLETED|Overall Study||16
1654384|NCT00712725|4039916|P5|NOT COMPLETED|Overall Study||19
1654385|NCT00712725|4039917|P4|NOT COMPLETED|Overall Study||17
1654386|NCT00712725|4039918|P3|NOT COMPLETED|Overall Study||10
1654387|NCT00712725|4039919|P2|NOT COMPLETED|Overall Study||6
1654388|NCT00712725|4039920|P1|NOT COMPLETED|Overall Study||29
1654389|NCT00712725|4039913|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
1654390|NCT00712725|4039914|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
1654391|NCT00712725|4039915|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
1654392|NCT00712725|4039916|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
1654393|NCT00712725|4039917|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
1654394|NCT00712725|4039918|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
1654395|NCT00712725|4039919|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
1654396|NCT00712725|4039920|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
1654397|NCT00712725|4039913|P8|STARTED|Overall Study||74
1654398|NCT00712725|4039914|P7|STARTED|Overall Study||83
1654399|NCT00712725|4039915|P6|STARTED|Overall Study||84
1654400|NCT00712725|4039916|P5|STARTED|Overall Study||86
1654401|NCT00712725|4039917|P4|STARTED|Overall Study||84
1654402|NCT00712725|4039918|P3|STARTED|Overall Study||57
1654403|NCT00712725|4039919|P2|STARTED|Overall Study||39
1654404|NCT00712725|4039920|P1|STARTED|Overall Study||169
1654405|NCT00712673|4039981|P4|NOT COMPLETED|Overall Study||70
1654406|NCT00712673|4039982|P3|NOT COMPLETED|Overall Study||57
1654407|NCT00712673|4039983|P2|NOT COMPLETED|Overall Study||21
1654408|NCT00712673|4039984|P1|NOT COMPLETED|Overall Study||21
1654409|NCT00712673|4039981|P4|COMPLETED|Overall Study||185
1654410|NCT00712673|4039982|P3|COMPLETED|Overall Study||198
1654411|NCT00712673|4039983|P2|COMPLETED|Overall Study||64
1654412|NCT00712673|4039984|P1|COMPLETED|Overall Study||64
1654413|NCT00712673|4039981|P4|Subgroup for Standardized Meal Test|Overall Study||0
1654414|NCT00712673|4039982|P3|Subgroup for Standardized Meal Test|Overall Study||255
1654415|NCT00712673|4039983|P2|Subgroup for Standardized Meal Test|Overall Study||0
1654416|NCT00712673|4039984|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
1654417|NCT00712673|4039981|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
1654418|NCT00712673|4039982|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
1654419|NCT00712673|4039983|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
1654420|NCT00712673|4039984|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
1654421|NCT00712673|4039981|P4|Safety Population|Overall Study||255
1654422|NCT00712673|4039982|P3|Safety Population|Overall Study||255
1654423|NCT00712673|4039983|P2|Safety Population|Overall Study||85
1654424|NCT00712673|4039984|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
1654425|NCT00712673|4039981|P4|STARTED|Overall Study||255
1654426|NCT00712673|4039982|P3|STARTED|Overall Study||255
1654427|NCT00712673|4039983|P2|STARTED|Overall Study||85
1654428|NCT00712673|4039984|P1|STARTED|Overall Study|Randomized.|85
1654429|NCT00712543|4040048|P2|NOT COMPLETED|Day 8-14||2
1654430|NCT00712543|4040049|P1|NOT COMPLETED|Day 8-14||0
1654431|NCT00712543|4040048|P2|COMPLETED|Day 8-14||25
1654432|NCT00712543|4040049|P1|COMPLETED|Day 8-14||23
1654433|NCT00712543|4040048|P2|STARTED|Day 8-14||27
1654434|NCT00712543|4040049|P1|STARTED|Day 8-14||23
1654435|NCT00712543|4040048|P2|NOT COMPLETED|Day 1-7||0
1654436|NCT00712543|4040049|P1|NOT COMPLETED|Day 1-7||0
1654437|NCT00712543|4040048|P2|COMPLETED|Day 1-7||27
1654438|NCT00712543|4040049|P1|COMPLETED|Day 1-7||23
1654439|NCT00712543|4040048|P2|STARTED|Day 1-7||27
1654440|NCT00712543|4040049|P1|STARTED|Day 1-7||23
1654441|NCT00712530|4040058|P3|NOT COMPLETED|Overall Study||0
1654442|NCT00712530|4040059|P2|NOT COMPLETED|Overall Study||0
1654443|NCT00712530|4040060|P1|NOT COMPLETED|Overall Study||0
1654444|NCT00712530|4040058|P3|COMPLETED|Overall Study||3
1654445|NCT00712530|4040059|P2|COMPLETED|Overall Study||3
1654446|NCT00712530|4040060|P1|COMPLETED|Overall Study||3
1654447|NCT00712530|4040058|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
1654448|NCT00712530|4040059|P2|STARTED|Overall Study||3
1654449|NCT00712530|4040060|P1|STARTED|Overall Study||3
1654450|NCT00712348|4040083|P1|NOT COMPLETED|Overall Study||1
1654451|NCT00712348|4040083|P1|COMPLETED|Overall Study||30
1654452|NCT00712348|4040083|P1|STARTED|Overall Study||31
1654453|NCT00712335|4040095|P5|NOT COMPLETED|Overall Study||0
1654454|NCT00712335|4040096|P4|NOT COMPLETED|Overall Study||5
1654455|NCT00712335|4040097|P3|NOT COMPLETED|Overall Study||5
1654456|NCT00712335|4040098|P2|NOT COMPLETED|Overall Study||17
1654457|NCT00712335|4040099|P1|NOT COMPLETED|Overall Study||3
1654458|NCT00712335|4040095|P5|COMPLETED|Overall Study||30
1654459|NCT00712335|4040096|P4|COMPLETED|Overall Study||19
1654460|NCT00712335|4040097|P3|COMPLETED|Overall Study||6
1654461|NCT00712335|4040098|P2|COMPLETED|Overall Study||15
1654462|NCT00712335|4040099|P1|COMPLETED|Overall Study||5
1654463|NCT00712335|4040095|P5|STARTED|Overall Study||30
1654464|NCT00712335|4040096|P4|STARTED|Overall Study||24
1654465|NCT00712335|4040097|P3|STARTED|Overall Study||11
1654466|NCT00712335|4040098|P2|STARTED|Overall Study||32
1654467|NCT00712335|4040099|P1|STARTED|Overall Study||8
1654468|NCT00712270|4040144|P1|NOT COMPLETED|Overall Study||14
1654469|NCT00712270|4040144|P1|COMPLETED|Overall Study||7
1654470|NCT00712270|4040144|P1|STARTED|Overall Study||21
1654471|NCT00712244|4040157|P4|NOT COMPLETED|Overall Study||1
1654472|NCT00712244|4040158|P3|NOT COMPLETED|Overall Study||2
1654473|NCT00712244|4040159|P2|NOT COMPLETED|Overall Study||1
1654474|NCT00712244|4040160|P1|NOT COMPLETED|Overall Study||4
1654475|NCT00712244|4040157|P4|COMPLETED|Overall Study||26
1654476|NCT00712244|4040158|P3|COMPLETED|Overall Study||25
1654477|NCT00712244|4040159|P2|COMPLETED|Overall Study||28
1654478|NCT00712244|4040160|P1|COMPLETED|Overall Study||25
1654479|NCT00712244|4040157|P4|STARTED|Overall Study||27
1654480|NCT00712244|4040158|P3|STARTED|Overall Study||27
1654481|NCT00712244|4040159|P2|STARTED|Overall Study||29
1654482|NCT00712244|4040160|P1|STARTED|Overall Study||29
1654483|NCT00712179|4040202|P1|NOT COMPLETED|Overall Study||12
1654484|NCT00712179|4040202|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
1654485|NCT00712179|4040202|P1|STARTED|Overall Study||49
1654486|NCT00712166|4040208|P2|NOT COMPLETED|Overall Study||1
1654487|NCT00712166|4040209|P1|NOT COMPLETED|Overall Study||0
1654488|NCT00712166|4040208|P2|COMPLETED|Overall Study||75
1654489|NCT00712166|4040209|P1|COMPLETED|Overall Study||81
1654490|NCT00712166|4040208|P2|STARTED|Overall Study||76
1654491|NCT00712166|4040209|P1|STARTED|Overall Study||81
1654492|NCT00712075|4040236|P3|NOT COMPLETED|Overall Study||11
1654493|NCT00712075|4040237|P2|NOT COMPLETED|Overall Study||4
1654494|NCT00712075|4040238|P1|NOT COMPLETED|Overall Study||5
1654495|NCT00712075|4040236|P3|COMPLETED|Overall Study||14
1654496|NCT00712075|4040237|P2|COMPLETED|Overall Study||26
1654497|NCT00712075|4040238|P1|COMPLETED|Overall Study||17
1654498|NCT00712075|4040236|P3|STARTED|Overall Study||25
1654499|NCT00712075|4040237|P2|STARTED|Overall Study||30
1654500|NCT00712075|4040238|P1|STARTED|Overall Study||22
1654501|NCT00712010|4040252|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
1654502|NCT00712010|4040252|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
1654503|NCT00712010|4040252|P1|STARTED|7th and Last Protein Testing (1 Day)||23
1654504|NCT00712010|4040252|P1|NOT COMPLETED|Washout (7 Days)||0
1654505|NCT00712010|4040252|P1|COMPLETED|Washout (7 Days)||23
1654506|NCT00712010|4040252|P1|STARTED|Washout (7 Days)||23
1654507|NCT00712010|4040252|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
1654508|NCT00712010|4040252|P1|COMPLETED|6th Protein Testing (1 Day)||23
1654509|NCT00712010|4040252|P1|STARTED|6th Protein Testing (1 Day)||23
1654510|NCT00712010|4040252|P1|NOT COMPLETED|Washout (7 Days)||0
1654511|NCT00712010|4040252|P1|COMPLETED|Washout (7 Days)||23
1654512|NCT00712010|4040252|P1|STARTED|Washout (7 Days)||23
1654513|NCT00712010|4040252|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
1654514|NCT00712010|4040252|P1|COMPLETED|5th Protein Testing (1 Day)||23
1654515|NCT00712010|4040252|P1|STARTED|5th Protein Testing (1 Day)||23
1654516|NCT00712010|4040252|P1|NOT COMPLETED|Washout (7 Days)||1
1654517|NCT00712010|4040252|P1|COMPLETED|Washout (7 Days)||23
1654518|NCT00712010|4040252|P1|STARTED|Washout (7 Days)||24
1654519|NCT00712010|4040252|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
1654520|NCT00712010|4040252|P1|COMPLETED|4th Protein Testing (1 Day)||24
1654521|NCT00712010|4040252|P1|STARTED|4th Protein Testing (1 Day)||24
1654522|NCT00712010|4040252|P1|NOT COMPLETED|Washout (7 Days)||0
1654523|NCT00712010|4040252|P1|COMPLETED|Washout (7 Days)||24
1654524|NCT00712010|4040252|P1|STARTED|Washout (7 Days)||24
1654525|NCT00712010|4040252|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
1654526|NCT00712010|4040252|P1|COMPLETED|3rd Protein Testing (1 Day)||24
1654527|NCT00712010|4040252|P1|STARTED|3rd Protein Testing (1 Day)||24
1654528|NCT00712010|4040252|P1|NOT COMPLETED|Washout (7 Days)||0
1654529|NCT00712010|4040252|P1|COMPLETED|Washout (7 Days)||24
1654530|NCT00712010|4040252|P1|STARTED|Washout (7 Days)||24
1654531|NCT00712010|4040252|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
1654532|NCT00712010|4040252|P1|COMPLETED|2nd Protein Testing (1 Day)||24
1654533|NCT00712010|4040252|P1|STARTED|2nd Protein Testing (1 Day)||24
1654534|NCT00712010|4040252|P1|NOT COMPLETED|Washout (7 Days)||0
1654535|NCT00712010|4040252|P1|COMPLETED|Washout (7 Days)||24
1654536|NCT00712010|4040252|P1|STARTED|Washout (7 Days)||24
1654537|NCT00712010|4040252|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
1654538|NCT00712010|4040252|P1|COMPLETED|1st Protein Testing (1 Day)||24
1654539|NCT00712010|4040252|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
1654540|NCT00711997|4040277|P2|NOT COMPLETED|Overall Study||0
1654541|NCT00711997|4040278|P1|NOT COMPLETED|Overall Study||0
1654542|NCT00711997|4040277|P2|COMPLETED|Overall Study||6
1654543|NCT00711997|4040278|P1|COMPLETED|Overall Study||3
1654544|NCT00711997|4040277|P2|STARTED|Overall Study||6
1654545|NCT00711997|4040278|P1|STARTED|Overall Study||3
1654546|NCT00711971|4040291|P3|NOT COMPLETED|Overall Study||1
1654547|NCT00711971|4040292|P2|NOT COMPLETED|Overall Study||4
1654548|NCT00711971|4040293|P1|NOT COMPLETED|Overall Study||3
1654549|NCT00711971|4040291|P3|COMPLETED|Overall Study||41
1654550|NCT00711971|4040292|P2|COMPLETED|Overall Study||38
1654551|NCT00711971|4040293|P1|COMPLETED|Overall Study||39
1654552|NCT00711971|4040291|P3|STARTED|Overall Study||42
1654553|NCT00711971|4040292|P2|STARTED|Overall Study||42
1654554|NCT00711971|4040293|P1|STARTED|Overall Study||42
1654555|NCT00711958|4040327|P2|NOT COMPLETED|Overall Study||23
1654556|NCT00711958|4040328|P1|NOT COMPLETED|Overall Study||33
1654557|NCT00711958|4040327|P2|COMPLETED|Overall Study||17
1654558|NCT00711958|4040328|P1|COMPLETED|Overall Study||41
1654559|NCT00711958|4040327|P2|STARTED|Overall Study||40
1654560|NCT00711958|4040328|P1|STARTED|Overall Study||74
1654561|NCT00711880|4040336|P2|NOT COMPLETED|Overall Study||7
1654562|NCT00711880|4040337|P1|NOT COMPLETED|Overall Study||13
1654563|NCT00711880|4040336|P2|COMPLETED|Overall Study||55
1654564|NCT00711880|4040337|P1|COMPLETED|Overall Study||50
1654565|NCT00711880|4040336|P2|STARTED|Overall Study||62
1654566|NCT00711880|4040337|P1|STARTED|Overall Study||63
1654567|NCT00711867|4040375|P2|NOT COMPLETED|Overall Study||4
1654568|NCT00711867|4040376|P1|NOT COMPLETED|Overall Study||5
1654569|NCT00711867|4040375|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
1654570|NCT00711867|4040376|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
1654571|NCT00711867|4040375|P2|STARTED|Overall Study||25
1654572|NCT00711867|4040376|P1|STARTED|Overall Study||30
1654573|NCT00711828|4040382|P1|NOT COMPLETED|Overall Study||0
1654574|NCT00711828|4040382|P1|COMPLETED|Overall Study||21
1654575|NCT00711828|4040382|P1|STARTED|Overall Study||21
1654576|NCT00711802|4040399|P8|NOT COMPLETED|Overall Study||2
1654577|NCT00711802|4040400|P7|NOT COMPLETED|Overall Study||5
1654578|NCT00711802|4040401|P6|NOT COMPLETED|Overall Study||8
1654579|NCT00711802|4040402|P5|NOT COMPLETED|Overall Study||14
1654580|NCT00711802|4040403|P4|NOT COMPLETED|Overall Study||3
1654581|NCT00711802|4040404|P3|NOT COMPLETED|Overall Study||6
1654582|NCT00711802|4040405|P2|NOT COMPLETED|Overall Study||6
1654583|NCT00711802|4040406|P1|NOT COMPLETED|Overall Study||2
1654584|NCT00711802|4040399|P8|COMPLETED|Overall Study||13
1654585|NCT00711802|4040400|P7|COMPLETED|Overall Study||25
1654586|NCT00711802|4040401|P6|COMPLETED|Overall Study||34
1654587|NCT00711802|4040402|P5|COMPLETED|Overall Study||69
1654588|NCT00711802|4040403|P4|COMPLETED|Overall Study||35
1654589|NCT00711802|4040404|P3|COMPLETED|Overall Study||69
1654590|NCT00711802|4040405|P2|COMPLETED|Overall Study||32
1654591|NCT00711802|4040406|P1|COMPLETED|Overall Study||73
1654592|NCT00711802|4040399|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
1654593|NCT00711802|4040400|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
1654594|NCT00711802|4040401|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
1654595|NCT00711802|4040402|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
1654596|NCT00711802|4040403|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
1654597|NCT00711802|4040404|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
1654598|NCT00711802|4040405|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
1654599|NCT00711802|4040406|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
1654600|NCT00711802|4040399|P8|STARTED|Overall Study||15
1654601|NCT00711802|4040400|P7|STARTED|Overall Study||30
1654602|NCT00711802|4040401|P6|STARTED|Overall Study||42
1654603|NCT00711802|4040402|P5|STARTED|Overall Study||83
1654604|NCT00711802|4040403|P4|STARTED|Overall Study||38
1654605|NCT00711802|4040404|P3|STARTED|Overall Study||75
1654606|NCT00711802|4040405|P2|STARTED|Overall Study||38
1654607|NCT00711802|4040406|P1|STARTED|Overall Study||75
1654608|NCT00711646|4040438|P2|NOT COMPLETED|Overall Study||3
1654609|NCT00711646|4040439|P1|NOT COMPLETED|Overall Study||12
1654610|NCT00711646|4040438|P2|COMPLETED|Overall Study||62
1654611|NCT00711646|4040439|P1|COMPLETED|Overall Study||112
1654612|NCT00711646|4040438|P2|STARTED|Overall Study||65
1654613|NCT00711646|4040439|P1|STARTED|Overall Study||124
1654614|NCT00711594|4040461|P4|NOT COMPLETED|Overall Study||62
1654615|NCT00711594|4040462|P3|NOT COMPLETED|Overall Study||6
1654616|NCT00711594|4040463|P2|NOT COMPLETED|Overall Study||3
1654617|NCT00711594|4040464|P1|NOT COMPLETED|Overall Study||3
1654618|NCT00711594|4040461|P4|COMPLETED|Overall Study||0
1654619|NCT00711594|4040462|P3|COMPLETED|Overall Study||0
1654620|NCT00711594|4040463|P2|COMPLETED|Overall Study||0
1654621|NCT00711594|4040464|P1|COMPLETED|Overall Study||0
1654622|NCT00711594|4040461|P4|STARTED|Overall Study||62
1654623|NCT00711594|4040462|P3|STARTED|Overall Study||6
1654624|NCT00711594|4040463|P2|STARTED|Overall Study||3
1654625|NCT00711594|4040464|P1|STARTED|Overall Study||3
1654626|NCT00711555|4040501|P1|NOT COMPLETED|Overall Study||3
1654627|NCT00711555|4040501|P1|COMPLETED|Overall Study||19
1654628|NCT00711555|4040501|P1|STARTED|Overall Study||22
1654629|NCT00711529|4040510|P2|NOT COMPLETED|Overall Study||6
1654630|NCT00711529|4040511|P1|NOT COMPLETED|Overall Study||4
1654631|NCT00711529|4040510|P2|COMPLETED|Overall Study||8
1654632|NCT00711529|4040511|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
1654633|NCT00711529|4040510|P2|STARTED|Overall Study||14
1654634|NCT00711529|4040511|P1|STARTED|Overall Study||13
1654635|NCT00711516|4040535|P2|NOT COMPLETED|Overall Study||3
1654636|NCT00711516|4040536|P1|NOT COMPLETED|Overall Study||1
1654637|NCT00711516|4040535|P2|COMPLETED|Overall Study||16
1654638|NCT00711516|4040536|P1|COMPLETED|Overall Study||20
1654639|NCT00711516|4040535|P2|STARTED|Overall Study||19
1654640|NCT00711516|4040536|P1|STARTED|Overall Study||21
1654641|NCT00711490|4040630|P1|NOT COMPLETED|Overall Study||0
1654642|NCT00711490|4040630|P1|COMPLETED|Overall Study||5
1654643|NCT00711490|4040630|P1|STARTED|Overall Study||5
1654644|NCT00711477|4040643|P2|NOT COMPLETED|Overall Study||3
1654645|NCT00711477|4040644|P1|NOT COMPLETED|Overall Study||3
1654646|NCT00711477|4040643|P2|COMPLETED|Overall Study||20
1654647|NCT00711477|4040644|P1|COMPLETED|Overall Study||20
1654648|NCT00711477|4040643|P2|STARTED|Overall Study||23
1654649|NCT00711477|4040644|P1|STARTED|Overall Study||23
1654650|NCT00711464|4040672|P1|NOT COMPLETED|Overall Study||0
1654651|NCT00711464|4040672|P1|COMPLETED|Overall Study||29
1654652|NCT00711464|4040672|P1|STARTED|Overall Study||29
1654653|NCT00711425|4040690|P1|NOT COMPLETED|Overall Study||4
1654654|NCT00711425|4040690|P1|COMPLETED|Overall Study||41
1654655|NCT00711425|4040690|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
1654656|NCT00711412|4040696|P1|NOT COMPLETED|Survival Follow up Until Death||12
1654657|NCT00711412|4040696|P1|COMPLETED|Survival Follow up Until Death||26
1654658|NCT00711412|4040696|P1|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
1654659|NCT00711412|4040696|P1|NOT COMPLETED|Evaluation for Response and Surgery||6
1654660|NCT00711412|4040696|P1|COMPLETED|Evaluation for Response and Surgery||28
1654661|NCT00711412|4040696|P1|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
1654662|NCT00711412|4040696|P1|NOT COMPLETED|Combination Treatment||1
1654663|NCT00711412|4040696|P1|COMPLETED|Combination Treatment||33
1654664|NCT00711412|4040696|P1|STARTED|Combination Treatment||34
1654665|NCT00711412|4040696|P1|NOT COMPLETED|Evaluated for Combination Treatment||6
1654666|NCT00711412|4040696|P1|COMPLETED|Evaluated for Combination Treatment||34
1654667|NCT00711412|4040696|P1|STARTED|Evaluated for Combination Treatment||40
1654668|NCT00711412|4040696|P1|NOT COMPLETED|Induction Treatment||4
1654669|NCT00711412|4040696|P1|COMPLETED|Induction Treatment||40
1654670|NCT00711412|4040696|P1|Started Induction Treatment|Induction Treatment||43
1654671|NCT00711412|4040696|P1|Registered to Study|Induction Treatment||44
1654672|NCT00711412|4040696|P1|STARTED|Induction Treatment||44
1654673|NCT00711347|4040710|P2|NOT COMPLETED|Overall Study||0
1654674|NCT00711347|4040711|P1|NOT COMPLETED|Overall Study||0
1654675|NCT00711347|4040710|P2|COMPLETED|Overall Study||14
1654676|NCT00711347|4040711|P1|COMPLETED|Overall Study||14
1654677|NCT00711347|4040710|P2|STARTED|Overall Study||14
1654678|NCT00711347|4040711|P1|STARTED|Overall Study||14
1654679|NCT00711269|4040731|P4|NOT COMPLETED|Overall Study||14
1654680|NCT00711269|4040732|P3|NOT COMPLETED|Overall Study||50
1654681|NCT00711269|4040733|P2|NOT COMPLETED|Overall Study||48
1654682|NCT00711269|4040734|P1|NOT COMPLETED|Overall Study||44
1654683|NCT00711269|4040731|P4|COMPLETED|Overall Study||51
1654684|NCT00711269|4040732|P3|COMPLETED|Overall Study||83
1654685|NCT00711269|4040733|P2|COMPLETED|Overall Study||83
1654686|NCT00711269|4040734|P1|COMPLETED|Overall Study||87
1654687|NCT00711269|4040731|P4|STARTED|Overall Study||65
1654688|NCT00711269|4040732|P3|STARTED|Overall Study||133
1654689|NCT00711269|4040733|P2|STARTED|Overall Study||131
1654690|NCT00711269|4040734|P1|STARTED|Overall Study||131
1654691|NCT00711243|4040774|P6|NOT COMPLETED|Follow up Every 3 Months Until Death||2
1654692|NCT00711243|4040775|P5|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1654693|NCT00711243|4040776|P4|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1654694|NCT00711243|4040777|P3|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1654695|NCT00711243|4040778|P2|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1654696|NCT00711243|4040779|P1|NOT COMPLETED|Follow up Every 3 Months Until Death||0
1654697|NCT00711243|4040774|P6|COMPLETED|Follow up Every 3 Months Until Death||37
1654698|NCT00711243|4040775|P5|COMPLETED|Follow up Every 3 Months Until Death||3
1654699|NCT00711243|4040776|P4|COMPLETED|Follow up Every 3 Months Until Death||3
1654700|NCT00711243|4040777|P3|COMPLETED|Follow up Every 3 Months Until Death||3
1654701|NCT00711243|4040778|P2|COMPLETED|Follow up Every 3 Months Until Death||3
1654702|NCT00711243|4040779|P1|COMPLETED|Follow up Every 3 Months Until Death||3
1654703|NCT00711243|4040774|P6|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
1654704|NCT00711243|4040775|P5|STARTED|Follow up Every 3 Months Until Death||3
1654705|NCT00711243|4040776|P4|STARTED|Follow up Every 3 Months Until Death||3
1654706|NCT00711243|4040777|P3|STARTED|Follow up Every 3 Months Until Death||3
1654707|NCT00711243|4040778|P2|STARTED|Follow up Every 3 Months Until Death||3
1654708|NCT00711243|4040779|P1|STARTED|Follow up Every 3 Months Until Death||3
1654709|NCT00711243|4040774|P6|NOT COMPLETED|Treated Cycle 5 After First Response||4
1654710|NCT00711243|4040775|P5|NOT COMPLETED|Treated Cycle 5 After First Response||1
1654711|NCT00711243|4040776|P4|NOT COMPLETED|Treated Cycle 5 After First Response||0
1654712|NCT00711243|4040777|P3|NOT COMPLETED|Treated Cycle 5 After First Response||0
1654713|NCT00711243|4040778|P2|NOT COMPLETED|Treated Cycle 5 After First Response||2
1654714|NCT00711243|4040779|P1|NOT COMPLETED|Treated Cycle 5 After First Response||1
1654715|NCT00711243|4040774|P6|COMPLETED|Treated Cycle 5 After First Response||37
1654716|NCT00711243|4040775|P5|COMPLETED|Treated Cycle 5 After First Response||2
1654717|NCT00711243|4040776|P4|COMPLETED|Treated Cycle 5 After First Response||2
1654718|NCT00711243|4040777|P3|COMPLETED|Treated Cycle 5 After First Response||3
1654719|NCT00711243|4040778|P2|COMPLETED|Treated Cycle 5 After First Response||1
1654720|NCT00711243|4040779|P1|COMPLETED|Treated Cycle 5 After First Response||2
1654721|NCT00711243|4040774|P6|STARTED|Treated Cycle 5 After First Response||41
1654722|NCT00711243|4040775|P5|STARTED|Treated Cycle 5 After First Response||3
1654723|NCT00711243|4040776|P4|STARTED|Treated Cycle 5 After First Response||2
1654724|NCT00711243|4040777|P3|STARTED|Treated Cycle 5 After First Response||3
1654725|NCT00711243|4040778|P2|STARTED|Treated Cycle 5 After First Response||3
1654726|NCT00711243|4040779|P1|STARTED|Treated Cycle 5 After First Response||3
1654727|NCT00711243|4040774|P6|NOT COMPLETED|Reached First Response/4 Cycles||2
1654728|NCT00711243|4040775|P5|NOT COMPLETED|Reached First Response/4 Cycles||0
1654729|NCT00711243|4040776|P4|NOT COMPLETED|Reached First Response/4 Cycles||1
1654730|NCT00711243|4040777|P3|NOT COMPLETED|Reached First Response/4 Cycles||0
1654731|NCT00711243|4040778|P2|NOT COMPLETED|Reached First Response/4 Cycles||0
1654732|NCT00711243|4040779|P1|NOT COMPLETED|Reached First Response/4 Cycles||0
1654733|NCT00711243|4040774|P6|COMPLETED|Reached First Response/4 Cycles||41
1654734|NCT00711243|4040775|P5|COMPLETED|Reached First Response/4 Cycles||3
1654735|NCT00711243|4040776|P4|COMPLETED|Reached First Response/4 Cycles||2
1654736|NCT00711243|4040777|P3|COMPLETED|Reached First Response/4 Cycles||3
1654737|NCT00711243|4040778|P2|COMPLETED|Reached First Response/4 Cycles||3
1654738|NCT00711243|4040779|P1|COMPLETED|Reached First Response/4 Cycles||3
1654739|NCT00711243|4040774|P6|STARTED|Reached First Response/4 Cycles||43
1654740|NCT00711243|4040775|P5|STARTED|Reached First Response/4 Cycles||3
1654741|NCT00711243|4040776|P4|STARTED|Reached First Response/4 Cycles||3
1654742|NCT00711243|4040777|P3|STARTED|Reached First Response/4 Cycles||3
1654743|NCT00711243|4040778|P2|STARTED|Reached First Response/4 Cycles||3
1654744|NCT00711243|4040779|P1|STARTED|Reached First Response/4 Cycles||3
1654745|NCT00711243|4040774|P6|NOT COMPLETED|Registed and Started Treatment||1
1654746|NCT00711243|4040775|P5|NOT COMPLETED|Registed and Started Treatment||0
1654747|NCT00711243|4040776|P4|NOT COMPLETED|Registed and Started Treatment||0
1654748|NCT00711243|4040777|P3|NOT COMPLETED|Registed and Started Treatment||0
1654749|NCT00711243|4040778|P2|NOT COMPLETED|Registed and Started Treatment||0
1654750|NCT00711243|4040779|P1|NOT COMPLETED|Registed and Started Treatment||0
1654751|NCT00711243|4040774|P6|COMPLETED|Registed and Started Treatment||43
1654752|NCT00711243|4040775|P5|COMPLETED|Registed and Started Treatment||3
1654753|NCT00711243|4040776|P4|COMPLETED|Registed and Started Treatment||3
1654754|NCT00711243|4040777|P3|COMPLETED|Registed and Started Treatment||3
1654755|NCT00711243|4040778|P2|COMPLETED|Registed and Started Treatment||3
1654756|NCT00711243|4040779|P1|COMPLETED|Registed and Started Treatment||3
1654757|NCT00711243|4040774|P6|Started Treatment|Registed and Started Treatment||43
1654758|NCT00711243|4040775|P5|Started Treatment|Registed and Started Treatment||3
1654759|NCT00711243|4040776|P4|Started Treatment|Registed and Started Treatment||3
1654760|NCT00711243|4040777|P3|Started Treatment|Registed and Started Treatment||3
1654761|NCT00711243|4040778|P2|Started Treatment|Registed and Started Treatment||3
1654762|NCT00711243|4040779|P1|Started Treatment|Registed and Started Treatment||3
1654763|NCT00711243|4040774|P6|Registered to Study|Registed and Started Treatment||44
1654764|NCT00711243|4040775|P5|Registered to Study|Registed and Started Treatment||3
1654765|NCT00711243|4040776|P4|Registered to Study|Registed and Started Treatment||3
1654766|NCT00711243|4040777|P3|Registered to Study|Registed and Started Treatment||3
1654767|NCT00711243|4040778|P2|Registered to Study|Registed and Started Treatment||3
1654768|NCT00711243|4040779|P1|Registered to Study|Registed and Started Treatment||3
1654769|NCT00711243|4040774|P6|STARTED|Registed and Started Treatment||44
1654770|NCT00711243|4040775|P5|STARTED|Registed and Started Treatment||3
1654771|NCT00711243|4040776|P4|STARTED|Registed and Started Treatment||3
1654772|NCT00711243|4040777|P3|STARTED|Registed and Started Treatment||3
1654773|NCT00711243|4040778|P2|STARTED|Registed and Started Treatment||3
1654774|NCT00711243|4040779|P1|STARTED|Registed and Started Treatment||3
1654775|NCT00711191|4040802|P3|NOT COMPLETED|Overall Study||12
1654776|NCT00711191|4040803|P2|NOT COMPLETED|Overall Study||5
1654777|NCT00711191|4040804|P1|NOT COMPLETED|Overall Study||3
1654778|NCT00711191|4040802|P3|COMPLETED|Overall Study||1
1654779|NCT00711191|4040803|P2|COMPLETED|Overall Study||1
1654780|NCT00711191|4040804|P1|COMPLETED|Overall Study||0
1654781|NCT00711191|4040802|P3|STARTED|Overall Study||13
1654782|NCT00711191|4040803|P2|STARTED|Overall Study||6
1654783|NCT00711191|4040804|P1|STARTED|Overall Study||3
1654784|NCT00711113|4040841|P1|NOT COMPLETED|Overall Study||11
1654785|NCT00711113|4040841|P1|COMPLETED|Overall Study||36
1654786|NCT00711113|4040841|P1|STARTED|Overall Study||47
1654787|NCT00711100|4040847|P1|NOT COMPLETED|Overall Study||13
1654788|NCT00711100|4040847|P1|COMPLETED|Overall Study||91
1654789|NCT00711100|4040847|P1|STARTED|Overall Study||104
1654790|NCT00711087|4040865|P2|NOT COMPLETED|Overall Study||0
1654791|NCT00711087|4040866|P1|NOT COMPLETED|Overall Study||1
1654792|NCT00711087|4040865|P2|COMPLETED|Overall Study||0
1654793|NCT00711087|4040866|P1|COMPLETED|Overall Study||0
1654794|NCT00711087|4040865|P2|STARTED|Overall Study||0
1654795|NCT00711087|4040866|P1|STARTED|Overall Study||1
1654796|NCT00711022|4040872|P1|NOT COMPLETED|Overall Study||11
1654797|NCT00711022|4040872|P1|COMPLETED|Overall Study||40
1654798|NCT00711022|4040872|P1|STARTED|Overall Study||51
1654799|NCT00711009|4040878|P2|NOT COMPLETED|Overall Study||19
1654800|NCT00711009|4040879|P1|NOT COMPLETED|Overall Study||15
1654801|NCT00711009|4040878|P2|COMPLETED|Overall Study||82
1654802|NCT00711009|4040879|P1|COMPLETED|Overall Study||90
1654803|NCT00711009|4040878|P2|STARTED|Overall Study||101
1654804|NCT00711009|4040879|P1|STARTED|Overall Study||105
1654805|NCT00710996|4041050|P3|NOT COMPLETED|Overall Study||0
1654806|NCT00710996|4041051|P2|NOT COMPLETED|Overall Study||4
1654807|NCT00710996|4041052|P1|NOT COMPLETED|Overall Study||1
1654808|NCT00710996|4041050|P3|COMPLETED|Overall Study||21
1654809|NCT00710996|4041051|P2|COMPLETED|Overall Study||16
1654810|NCT00710996|4041052|P1|COMPLETED|Overall Study||16
1654811|NCT00710996|4041050|P3|STARTED|Overall Study||21
1654812|NCT00710996|4041051|P2|STARTED|Overall Study||20
1654813|NCT00710996|4041052|P1|STARTED|Overall Study||17
1654814|NCT00710970|4041060|P1|NOT COMPLETED|Overall Study||10
1654815|NCT00710970|4041060|P1|COMPLETED|Overall Study||18
1654816|NCT00710970|4041060|P1|STARTED|Overall Study||28
1654817|NCT00710944|4041067|P3|NOT COMPLETED|Overall Study||2
1654818|NCT00710944|4041068|P2|NOT COMPLETED|Overall Study||9
1654819|NCT00710944|4041069|P1|NOT COMPLETED|Overall Study||10
1654820|NCT00710944|4041067|P3|COMPLETED|Overall Study||17
1654821|NCT00710944|4041068|P2|COMPLETED|Overall Study||49
1654822|NCT00710944|4041069|P1|COMPLETED|Overall Study||45
1654823|NCT00710944|4041067|P3|STARTED|Overall Study||19
1654824|NCT00710944|4041068|P2|STARTED|Overall Study||58
1654825|NCT00710944|4041069|P1|STARTED|Overall Study||55
1654826|NCT00710931|4041077|P1|NOT COMPLETED|Overall Study||5
1654827|NCT00710931|4041077|P1|COMPLETED|Overall Study||29
1654828|NCT00710931|4041077|P1|STARTED|Overall Study||34
1654829|NCT00710905|4041081|P1|NOT COMPLETED|Overall Study||16
1654830|NCT00710905|4041081|P1|COMPLETED|Overall Study||34
1654831|NCT00710905|4041081|P1|STARTED|Overall Study||50
1654832|NCT00710879|4041087|P2|NOT COMPLETED|Overall Study||4
1654833|NCT00710879|4041088|P1|NOT COMPLETED|Overall Study||2
1654834|NCT00710879|4041087|P2|COMPLETED|Overall Study||113
1654835|NCT00710879|4041088|P1|COMPLETED|Overall Study||58
1654836|NCT00710879|4041087|P2|STARTED|Overall Study||117
1654837|NCT00710879|4041088|P1|STARTED|Overall Study||60
1654838|NCT00710866|4041100|P2|NOT COMPLETED|Overall Study||6
1654839|NCT00710866|4041101|P1|NOT COMPLETED|Overall Study||9
1654840|NCT00710866|4041100|P2|COMPLETED|Overall Study||128
1654841|NCT00710866|4041101|P1|COMPLETED|Overall Study||124
1654842|NCT00710866|4041100|P2|STARTED|Overall Study||134
1654843|NCT00710866|4041101|P1|STARTED|Overall Study||133
1654844|NCT00710840|4041123|P2|NOT COMPLETED|Overall Study||3
1654845|NCT00710840|4041124|P1|NOT COMPLETED|Overall Study||0
1654846|NCT00710840|4041123|P2|COMPLETED|Overall Study||19
1654847|NCT00710840|4041124|P1|COMPLETED|Overall Study||22
1654848|NCT00710840|4041123|P2|STARTED|Overall Study||22
1654849|NCT00710840|4041124|P1|STARTED|Overall Study||22
1654850|NCT00710814|4041138|P2|NOT COMPLETED|Overall Study||3
1654851|NCT00710814|4041139|P1|NOT COMPLETED|Overall Study||1
1654852|NCT00710814|4041138|P2|COMPLETED|Overall Study||13
1654853|NCT00710814|4041139|P1|COMPLETED|Overall Study||14
1654854|NCT00710814|4041138|P2|STARTED|Overall Study||16
1654855|NCT00710814|4041139|P1|STARTED|Overall Study||15
1654856|NCT00710762|4041147|P2|NOT COMPLETED|Overall Study||40
1654857|NCT00710762|4041148|P1|NOT COMPLETED|Overall Study||39
1654858|NCT00710762|4041147|P2|COMPLETED|Overall Study||0
1654859|NCT00710762|4041148|P1|COMPLETED|Overall Study||5
1654860|NCT00710762|4041147|P2|STARTED|Overall Study||40
1654861|NCT00710762|4041148|P1|STARTED|Overall Study||44
1654862|NCT00710749|4041164|P2|NOT COMPLETED|Second Intervention||0
1654863|NCT00710749|4041165|P1|NOT COMPLETED|Second Intervention||0
1654864|NCT00710749|4041164|P2|COMPLETED|Second Intervention||30
1654865|NCT00710749|4041165|P1|COMPLETED|Second Intervention||29
1654866|NCT00710749|4041164|P2|STARTED|Second Intervention||30
1654867|NCT00710749|4041165|P1|STARTED|Second Intervention||29
1654868|NCT00710749|4041164|P2|NOT COMPLETED|First Intervention||0
1654869|NCT00710749|4041165|P1|NOT COMPLETED|First Intervention||1
1654870|NCT00710749|4041164|P2|COMPLETED|First Intervention||30
1654871|NCT00710749|4041165|P1|COMPLETED|First Intervention||29
1654872|NCT00710749|4041164|P2|STARTED|First Intervention||30
1654873|NCT00710749|4041165|P1|STARTED|First Intervention||30
1654874|NCT00710749|4041164|P2|NOT COMPLETED|Clinic Baseline Recording||0
1654875|NCT00710749|4041165|P1|NOT COMPLETED|Clinic Baseline Recording||0
1654876|NCT00710749|4041164|P2|COMPLETED|Clinic Baseline Recording||30
1654877|NCT00710749|4041165|P1|COMPLETED|Clinic Baseline Recording||30
1654878|NCT00710749|4041164|P2|STARTED|Clinic Baseline Recording||30
1654879|NCT00710749|4041165|P1|STARTED|Clinic Baseline Recording||30
1654880|NCT00710684|4041176|P3|NOT COMPLETED|Overall Study||64
1654881|NCT00710684|4041177|P2|NOT COMPLETED|Overall Study||74
1654882|NCT00710684|4041178|P1|NOT COMPLETED|Overall Study||74
1654883|NCT00710684|4041176|P3|COMPLETED|Overall Study||172
1654884|NCT00710684|4041177|P2|COMPLETED|Overall Study||147
1654885|NCT00710684|4041178|P1|COMPLETED|Overall Study||151
1654886|NCT00710684|4041176|P3|STARTED|Overall Study||236
1654887|NCT00710684|4041177|P2|STARTED|Overall Study||221
1654888|NCT00710684|4041178|P1|STARTED|Overall Study||225
1654889|NCT00710606|4041235|P2|NOT COMPLETED|Overall Study||2
1654890|NCT00710606|4041236|P1|NOT COMPLETED|Overall Study||0
1654891|NCT00710606|4041235|P2|COMPLETED|Overall Study||18
1654892|NCT00710606|4041236|P1|COMPLETED|Overall Study||20
1654893|NCT00710606|4041235|P2|STARTED|Overall Study||20
1654894|NCT00710606|4041236|P1|STARTED|Overall Study||20
1654895|NCT00710593|4041248|P2|NOT COMPLETED|Overall Study||5
1654896|NCT00710593|4041249|P1|NOT COMPLETED|Overall Study||15
1654897|NCT00710593|4041248|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
1654898|NCT00710593|4041249|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
1654899|NCT00710593|4041248|P2|STARTED|Overall Study||30
1654900|NCT00710593|4041249|P1|STARTED|Overall Study||69
1654901|NCT00710554|4041292|P2|NOT COMPLETED|Overall Study||24
1654902|NCT00710554|4041293|P1|NOT COMPLETED|Overall Study||49
1654903|NCT00710554|4041292|P2|COMPLETED|Overall Study||94
1654904|NCT00710554|4041293|P1|COMPLETED|Overall Study||79
1654905|NCT00710554|4041292|P2|STARTED|Overall Study||118
1654906|NCT00710554|4041293|P1|STARTED|Overall Study||128
1654907|NCT00710424|4041321|P2|NOT COMPLETED|Overall Study||23
1654908|NCT00710424|4041322|P1|NOT COMPLETED|Overall Study||44
1654909|NCT00710424|4041321|P2|COMPLETED|Overall Study||125
1654910|NCT00710424|4041322|P1|COMPLETED|Overall Study||105
1654911|NCT00710424|4041321|P2|STARTED|Overall Study||148
1654912|NCT00710424|4041322|P1|STARTED|Overall Study||149
1654913|NCT00710385|4041346|P1|NOT COMPLETED|Overall Study||5
1654914|NCT00710385|4041346|P1|COMPLETED|Overall Study||12
1654915|NCT00710385|4041346|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
1654916|NCT00710203|4041363|P1|NOT COMPLETED|Overall Study||0
1654917|NCT00710203|4041363|P1|COMPLETED|Overall Study||10
1654918|NCT00710203|4041363|P1|STARTED|Overall Study||10
1654919|NCT00710034|4041391|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
1654920|NCT00710034|4041392|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
1654921|NCT00710034|4041391|P2|COMPLETED|Completed 12 Weeks of Treatment||138
1654922|NCT00710034|4041392|P1|COMPLETED|Completed 12 Weeks of Treatment||141
1654923|NCT00710034|4041391|P2|STARTED|Completed 12 Weeks of Treatment||149
1654924|NCT00710034|4041392|P1|STARTED|Completed 12 Weeks of Treatment||154
1654925|NCT00710034|4041391|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
1654926|NCT00710034|4041392|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
1654927|NCT00710034|4041391|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
1654928|NCT00710034|4041392|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
1654929|NCT00710034|4041391|P2|STARTED|Completed 6 Weeks of Treatment||196
1654930|NCT00710034|4041392|P1|STARTED|Completed 6 Weeks of Treatment||195
1654931|NCT00710021|4041409|P3|NOT COMPLETED|Overall Study||1
1654932|NCT00710021|4041410|P2|NOT COMPLETED|Overall Study||3
1654933|NCT00710021|4041411|P1|NOT COMPLETED|Overall Study||1
1654934|NCT00710021|4041409|P3|COMPLETED|Overall Study||18
1654935|NCT00710021|4041410|P2|COMPLETED|Overall Study||16
1654936|NCT00710021|4041411|P1|COMPLETED|Overall Study||18
1654937|NCT00710021|4041409|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
1654938|NCT00710021|4041410|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
1654939|NCT00710021|4041411|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
1654940|NCT00710021|4041409|P3|STARTED|Overall Study||19
1654941|NCT00710021|4041410|P2|STARTED|Overall Study||19
1654942|NCT00710021|4041411|P1|STARTED|Overall Study||19
1654943|NCT00709956|4041526|P2|NOT COMPLETED|Overall Study||4
1654944|NCT00709956|4041527|P1|NOT COMPLETED|Overall Study||3
1654945|NCT00709956|4041526|P2|COMPLETED|Overall Study||33
1654946|NCT00709956|4041527|P1|COMPLETED|Overall Study||30
1654947|NCT00709956|4041526|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
1654948|NCT00709956|4041527|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
1654949|NCT00709956|4041526|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
1654950|NCT00709956|4041527|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
1654951|NCT00709891|4041535|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
1654952|NCT00709891|4041535|P1|COMPLETED|Longitudinal Follow-up Phase||5020
1654953|NCT00709891|4041535|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
1654954|NCT00709891|4041535|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
1654955|NCT00709891|4041535|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
1654956|NCT00709891|4041535|P1|STARTED|Baseline, Cross-sectional Phase||47208
1654957|NCT00709878|4041544|P4|NOT COMPLETED|Overall Study||0
1654958|NCT00709878|4041545|P3|NOT COMPLETED|Overall Study||0
1654959|NCT00709878|4041546|P2|NOT COMPLETED|Overall Study||0
1654960|NCT00709878|4041547|P1|NOT COMPLETED|Overall Study||0
1654961|NCT00709878|4041544|P4|COMPLETED|Overall Study||8
1654962|NCT00709878|4041545|P3|COMPLETED|Overall Study||8
1654963|NCT00709878|4041546|P2|COMPLETED|Overall Study||8
1654964|NCT00709878|4041547|P1|COMPLETED|Overall Study||8
1654965|NCT00709878|4041544|P4|STARTED|Overall Study||8
1654966|NCT00709878|4041545|P3|STARTED|Overall Study||8
1654967|NCT00709878|4041546|P2|STARTED|Overall Study||8
1654968|NCT00709878|4041547|P1|STARTED|Overall Study||8
1654969|NCT00709852|4041557|P2|NOT COMPLETED|Period 2||2
1654970|NCT00709852|4041558|P1|NOT COMPLETED|Period 2||9
1654971|NCT00709852|4041557|P2|COMPLETED|Period 2||169
1654972|NCT00709852|4041558|P1|COMPLETED|Period 2||211
1654973|NCT00709852|4041557|P2|STARTED|Period 2||171
1654974|NCT00709852|4041558|P1|STARTED|Period 2||220
1654975|NCT00709852|4041557|P2|NOT COMPLETED|Period 1||3
1654976|NCT00709852|4041558|P1|NOT COMPLETED|Period 1||8
1654977|NCT00709852|4041557|P2|COMPLETED|Period 1||171
1654978|NCT00709852|4041558|P1|COMPLETED|Period 1||220
1654979|NCT00709852|4041557|P2|STARTED|Period 1||174
1654980|NCT00709852|4041558|P1|STARTED|Period 1||228
1654981|NCT00709826|4041713|P2|NOT COMPLETED|Overall Study||1
1654982|NCT00709826|4041714|P1|NOT COMPLETED|Overall Study||2
1654983|NCT00709826|4041713|P2|COMPLETED|Overall Study||38
1654984|NCT00709826|4041714|P1|COMPLETED|Overall Study||68
1654985|NCT00709826|4041713|P2|STARTED|Overall Study||39
1654986|NCT00709826|4041714|P1|STARTED|Overall Study||70
1654987|NCT00709761|4041722|P1|NOT COMPLETED|Overall Study||47
1654988|NCT00709761|4041722|P1|COMPLETED|Overall Study||13
1654989|NCT00709761|4041722|P1|Ongoing|Overall Study|At time of clinical data cut off, 11 participants were on study treatment; 29 were in follow up.|40
1654990|NCT00709761|4041722|P1|STARTED|Overall Study||60
1654991|NCT00709735|4041733|P2|NOT COMPLETED|Overall Study||2
1654992|NCT00709735|4041734|P1|NOT COMPLETED|Overall Study||3
1654993|NCT00709735|4041733|P2|COMPLETED|Overall Study||10
1654994|NCT00709735|4041734|P1|COMPLETED|Overall Study||8
1654995|NCT00709735|4041733|P2|STARTED|Overall Study||12
1654996|NCT00709735|4041734|P1|STARTED|Overall Study||11
1654997|NCT00709722|4041742|P1|NOT COMPLETED|Overall Study||1
1654998|NCT00709722|4041742|P1|COMPLETED|Overall Study||20
1654999|NCT00709722|4041742|P1|STARTED|Overall Study||21
1655000|NCT00709696|4041750|P2|NOT COMPLETED|Overall Study||0
1655001|NCT00709696|4041751|P1|NOT COMPLETED|Overall Study||0
1655002|NCT00709696|4041750|P2|COMPLETED|Overall Study||3
1655003|NCT00709696|4041751|P1|COMPLETED|Overall Study||4
1655004|NCT00709696|4041750|P2|STARTED|Overall Study||3
1655005|NCT00709696|4041751|P1|STARTED|Overall Study||4
1655006|NCT00709618|4041757|P1|NOT COMPLETED|Overall Study||30
1655007|NCT00709618|4041757|P1|COMPLETED|Overall Study||14
1655008|NCT00709618|4041757|P1|STARTED|Overall Study||44
1655009|NCT00709592|4041769|P2|NOT COMPLETED|Overall Study||1
1655010|NCT00709592|4041770|P1|NOT COMPLETED|Overall Study||0
1655011|NCT00709592|4041769|P2|COMPLETED|Overall Study||22
1655012|NCT00709592|4041770|P1|COMPLETED|Overall Study||19
1655013|NCT00709592|4041769|P2|STARTED|Overall Study||23
1655014|NCT00709592|4041770|P1|STARTED|Overall Study||19
1655015|NCT00709319|4041792|P1|NOT COMPLETED|Overall Study||6
1655016|NCT00709319|4041792|P1|COMPLETED|Overall Study||81
1655017|NCT00709319|4041792|P1|STARTED|Overall Study||87
1655018|NCT00709306|4041804|P4|NOT COMPLETED|Overall Study||10
1655019|NCT00709306|4041805|P3|NOT COMPLETED|Overall Study||10
1655020|NCT00709306|4041806|P2|NOT COMPLETED|Overall Study||14
1655021|NCT00709306|4041807|P1|NOT COMPLETED|Overall Study||9
1655022|NCT00709306|4041804|P4|COMPLETED|Overall Study||37
1655023|NCT00709306|4041805|P3|COMPLETED|Overall Study||48
1655024|NCT00709306|4041806|P2|COMPLETED|Overall Study||30
1655025|NCT00709306|4041807|P1|COMPLETED|Overall Study||39
1655026|NCT00709306|4041804|P4|STARTED|Overall Study||47
1655027|NCT00709306|4041805|P3|STARTED|Overall Study||58
1655028|NCT00709306|4041806|P2|STARTED|Overall Study||44
1655029|NCT00709306|4041807|P1|STARTED|Overall Study||48
1655030|NCT00709228|4041821|P1|NOT COMPLETED|Overall Study||332
1655031|NCT00709228|4041821|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
1655032|NCT00709228|4041821|P1|STARTED|Overall Study||496
1655033|NCT00709124|4041827|P2|NOT COMPLETED|Overall Study||1
1655034|NCT00709124|4041828|P1|NOT COMPLETED|Overall Study||4
1655035|NCT00709124|4041827|P2|COMPLETED|Overall Study||17
1655036|NCT00709124|4041828|P1|COMPLETED|Overall Study||12
1655037|NCT00709124|4041827|P2|STARTED|Overall Study||18
1655038|NCT00709124|4041828|P1|STARTED|Overall Study||16
1655039|NCT00709111|4041862|P1|NOT COMPLETED|Overall Study||2
1655040|NCT00709111|4041862|P1|COMPLETED|Overall Study||32
1655041|NCT00709111|4041862|P1|Week 22/24|Overall Study||33
1655042|NCT00709111|4041862|P1|STARTED|Overall Study||34
1655043|NCT00709098|4041903|P3|NOT COMPLETED|Open-label Period||14
1655044|NCT00709098|4041904|P2|NOT COMPLETED|Open-label Period||0
1655045|NCT00709098|4041905|P1|NOT COMPLETED|Open-label Period||0
1655046|NCT00709098|4041903|P3|COMPLETED|Open-label Period||18
1655047|NCT00709098|4041904|P2|COMPLETED|Open-label Period||0
1655048|NCT00709098|4041905|P1|COMPLETED|Open-label Period||0
1655049|NCT00709098|4041903|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
1655050|NCT00709098|4041904|P2|STARTED|Open-label Period||0
1655051|NCT00709098|4041905|P1|STARTED|Open-label Period||0
1655052|NCT00709098|4041903|P3|NOT COMPLETED|Double-blind Period||0
1655053|NCT00709098|4041904|P2|NOT COMPLETED|Double-blind Period||8
1655054|NCT00709098|4041905|P1|NOT COMPLETED|Double-blind Period||6
1655055|NCT00709098|4041903|P3|COMPLETED|Double-blind Period||0
1655056|NCT00709098|4041904|P2|COMPLETED|Double-blind Period||16
1655057|NCT00709098|4041905|P1|COMPLETED|Double-blind Period||19
1655058|NCT00709098|4041903|P3|STARTED|Double-blind Period||0
1655059|NCT00709098|4041904|P2|STARTED|Double-blind Period||24
1655060|NCT00709098|4041905|P1|STARTED|Double-blind Period||25
1655061|NCT00709059|4041924|P1|NOT COMPLETED|Overall Study||94
1655062|NCT00709059|4041924|P1|COMPLETED|Overall Study||444
1655063|NCT00709059|4041924|P1|STARTED|Overall Study||538
1655064|NCT00708942|4041933|P5|NOT COMPLETED|Overall Study||1
1655065|NCT00708942|4041934|P4|NOT COMPLETED|Overall Study||0
1655066|NCT00708942|4041935|P3|NOT COMPLETED|Overall Study||2
1655067|NCT00708942|4041936|P2|NOT COMPLETED|Overall Study||1
1655068|NCT00708942|4041937|P1|NOT COMPLETED|Overall Study||7
1655069|NCT00708942|4041933|P5|COMPLETED|Overall Study||2
1655070|NCT00708942|4041934|P4|COMPLETED|Overall Study||10
1655071|NCT00708942|4041935|P3|COMPLETED|Overall Study||9
1655072|NCT00708942|4041936|P2|COMPLETED|Overall Study||11
1655073|NCT00708942|4041937|P1|COMPLETED|Overall Study||40
1655074|NCT00708942|4041933|P5|STARTED|Overall Study||3
1655075|NCT00708942|4041934|P4|STARTED|Overall Study||10
1655076|NCT00708942|4041935|P3|STARTED|Overall Study||11
1655077|NCT00708942|4041936|P2|STARTED|Overall Study||12
1655078|NCT00708942|4041937|P1|STARTED|Overall Study||47
1655079|NCT00708877|4041959|P1|NOT COMPLETED|Overall Study||0
1655080|NCT00708877|4041959|P1|COMPLETED|Overall Study||5
1655081|NCT00708877|4041959|P1|STARTED|Overall Study||5
1655082|NCT00708851|4041963|P1|NOT COMPLETED|Overall Study||0
1655083|NCT00708851|4041963|P1|COMPLETED|Overall Study||12
1655084|NCT00708851|4041963|P1|STARTED|Overall Study||12
1655085|NCT00708734|4041971|P1|NOT COMPLETED|Overall Study||7
1655086|NCT00708734|4041971|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
1655087|NCT00708734|4041971|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
1655088|NCT00708721|4041975|P4|NOT COMPLETED|Overall Study||0
1655089|NCT00708721|4041976|P3|NOT COMPLETED|Overall Study||0
1655090|NCT00708721|4041977|P2|NOT COMPLETED|Overall Study||0
1655091|NCT00708721|4041978|P1|NOT COMPLETED|Overall Study||0
1655092|NCT00708721|4041975|P4|COMPLETED|Overall Study||2
1655093|NCT00708721|4041976|P3|COMPLETED|Overall Study||3
1655094|NCT00708721|4041977|P2|COMPLETED|Overall Study||4
1655095|NCT00708721|4041978|P1|COMPLETED|Overall Study||2
1655096|NCT00708721|4041975|P4|STARTED|Overall Study||2
1655097|NCT00708721|4041976|P3|STARTED|Overall Study||3
1655098|NCT00708721|4041977|P2|STARTED|Overall Study||4
1655099|NCT00708721|4041978|P1|STARTED|Overall Study||2
1655100|NCT00708708|4041991|P1|NOT COMPLETED|Overall Study||742
1655101|NCT00708708|4041991|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
1655102|NCT00708708|4041991|P1|STARTED|Overall Study||955
1655103|NCT00708682|4042039|P1|NOT COMPLETED|Toddler Dose||8
1655104|NCT00708682|4042039|P1|COMPLETED|Toddler Dose||183
1655105|NCT00708682|4042039|P1|STARTED|Toddler Dose||191
1655106|NCT00708682|4042039|P1|NOT COMPLETED|After Infant Series||1
1655107|NCT00708682|4042039|P1|COMPLETED|After Infant Series||191
1655108|NCT00708682|4042039|P1|STARTED|After Infant Series||192
1655109|NCT00708682|4042039|P1|NOT COMPLETED|Infant Series||33
1655110|NCT00708682|4042039|P1|COMPLETED|Infant Series||192
1655111|NCT00708682|4042039|P1|Vaccinated Dose 3|Infant Series||194
1655112|NCT00708682|4042039|P1|Vaccinated Dose 2|Infant Series||214
1655113|NCT00708682|4042039|P1|Vaccinated Dose 1|Infant Series||223
1655114|NCT00708682|4042039|P1|STARTED|Infant Series||225
1655115|NCT00708643|4042060|P2|NOT COMPLETED|Overall Study||1
1655116|NCT00708643|4042061|P1|NOT COMPLETED|Overall Study||0
1655117|NCT00708643|4042060|P2|COMPLETED|Overall Study||39
1655118|NCT00708643|4042061|P1|COMPLETED|Overall Study||40
1655119|NCT00708643|4042060|P2|STARTED|Overall Study||40
1655120|NCT00708643|4042061|P1|STARTED|Overall Study||40
1655121|NCT00708552|4042081|P4|NOT COMPLETED|Overall Study||21
1655122|NCT00708552|4042082|P3|NOT COMPLETED|Overall Study||15
1655123|NCT00708552|4042083|P2|NOT COMPLETED|Overall Study||18
1655124|NCT00708552|4042084|P1|NOT COMPLETED|Overall Study||27
1655125|NCT00708552|4042081|P4|COMPLETED|Overall Study||130
1655126|NCT00708552|4042082|P3|COMPLETED|Overall Study||118
1655127|NCT00708552|4042083|P2|COMPLETED|Overall Study||127
1655128|NCT00708552|4042084|P1|COMPLETED|Overall Study||118
1655129|NCT00708552|4042081|P4|STARTED|Overall Study||151
1655130|NCT00708552|4042082|P3|STARTED|Overall Study||133
1655131|NCT00708552|4042083|P2|STARTED|Overall Study||145
1655132|NCT00708552|4042084|P1|STARTED|Overall Study||145
1655133|NCT00708526|4042234|P2|NOT COMPLETED|Return of Cognitive Function||0
1655134|NCT00708526|4042235|P1|NOT COMPLETED|Return of Cognitive Function||0
1655135|NCT00708526|4042234|P2|COMPLETED|Return of Cognitive Function||11
1655136|NCT00708526|4042235|P1|COMPLETED|Return of Cognitive Function||11
1655137|NCT00708526|4042234|P2|STARTED|Return of Cognitive Function||11
1655138|NCT00708526|4042235|P1|STARTED|Return of Cognitive Function||11
1655139|NCT00708526|4042234|P2|NOT COMPLETED|Wake up After Anesthesia||0
1655140|NCT00708526|4042235|P1|NOT COMPLETED|Wake up After Anesthesia||0
1655141|NCT00708526|4042234|P2|COMPLETED|Wake up After Anesthesia||11
1655142|NCT00708526|4042235|P1|COMPLETED|Wake up After Anesthesia||11
1655143|NCT00708526|4042234|P2|STARTED|Wake up After Anesthesia||11
1655144|NCT00708526|4042235|P1|STARTED|Wake up After Anesthesia||11
1655145|NCT00708500|4042246|P3|NOT COMPLETED|FOLLOWUP||15
1655146|NCT00708500|4042247|P2|NOT COMPLETED|FOLLOWUP||15
1655147|NCT00708500|4042248|P1|NOT COMPLETED|FOLLOWUP||40
1655148|NCT00708500|4042246|P3|COMPLETED|FOLLOWUP||143
1655149|NCT00708500|4042247|P2|COMPLETED|FOLLOWUP||136
1655150|NCT00708500|4042248|P1|COMPLETED|FOLLOWUP||37
1655151|NCT00708500|4042246|P3|STARTED|FOLLOWUP||158
1655152|NCT00708500|4042247|P2|STARTED|FOLLOWUP||151
1655153|NCT00708500|4042248|P1|STARTED|FOLLOWUP||77
1655154|NCT00708500|4042246|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
1655155|NCT00708500|4042247|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
1655156|NCT00708500|4042248|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
1655157|NCT00708500|4042246|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
1655158|NCT00708500|4042247|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
1655159|NCT00708500|4042248|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
1655160|NCT00708500|4042246|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
1655161|NCT00708500|4042247|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
1655162|NCT00708500|4042248|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
1655163|NCT00708500|4042246|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
1655164|NCT00708500|4042247|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
1655165|NCT00708500|4042248|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
1655166|NCT00708500|4042246|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
1655167|NCT00708500|4042247|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
1655168|NCT00708500|4042248|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
1655169|NCT00708500|4042246|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
1655170|NCT00708500|4042247|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
1655171|NCT00708500|4042248|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
1655172|NCT00708500|4042246|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
1655173|NCT00708500|4042247|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
1655174|NCT00708500|4042248|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
1655175|NCT00708461|4042267|P2|NOT COMPLETED|Overall Study||200
1655176|NCT00708461|4042268|P1|NOT COMPLETED|Overall Study||141
1655177|NCT00708461|4042267|P2|COMPLETED|Overall Study||795
1655178|NCT00708461|4042268|P1|COMPLETED|Overall Study||611
1655179|NCT00708461|4042267|P2|STARTED|Overall Study||995
1655180|NCT00708461|4042268|P1|STARTED|Overall Study||752
1655181|NCT00708435|4042276|P2|NOT COMPLETED|Overall Study||17
1655182|NCT00708435|4042277|P1|NOT COMPLETED|Overall Study||25
1655183|NCT00708435|4042276|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
1655184|NCT00708435|4042277|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
1655185|NCT00708435|4042276|P2|STARTED|Overall Study||109
1655186|NCT00708435|4042277|P1|STARTED|Overall Study||107
1655187|NCT00708422|4042304|P2|NOT COMPLETED|Overall Study||1
1655188|NCT00708422|4042305|P1|NOT COMPLETED|Overall Study||4
1655189|NCT00708422|4042304|P2|COMPLETED|Overall Study||114
1655190|NCT00708422|4042305|P1|COMPLETED|Overall Study||112
1655191|NCT00708422|4042304|P2|STARTED|Overall Study||115
1655192|NCT00708422|4042305|P1|STARTED|Overall Study||116
1655193|NCT00708305|4042313|P4|NOT COMPLETED|Period 4||0
1655194|NCT00708305|4042314|P3|NOT COMPLETED|Period 4||0
1655195|NCT00708305|4042315|P2|NOT COMPLETED|Period 4||0
1655196|NCT00708305|4042316|P1|NOT COMPLETED|Period 4||0
1655197|NCT00708305|4042313|P4|COMPLETED|Period 4||14
1655198|NCT00708305|4042314|P3|COMPLETED|Period 4||14
1655199|NCT00708305|4042315|P2|COMPLETED|Period 4||14
1655200|NCT00708305|4042316|P1|COMPLETED|Period 4||12
1655201|NCT00708305|4042313|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
1655202|NCT00708305|4042314|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
1655203|NCT00708305|4042315|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
1655204|NCT00708305|4042316|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
1655205|NCT00708305|4042313|P4|NOT COMPLETED|Period 3||0
1655206|NCT00708305|4042314|P3|NOT COMPLETED|Period 3||0
1655207|NCT00708305|4042315|P2|NOT COMPLETED|Period 3||2
1655208|NCT00708305|4042316|P1|NOT COMPLETED|Period 3||1
1655209|NCT00708305|4042313|P4|COMPLETED|Period 3||14
1655210|NCT00708305|4042314|P3|COMPLETED|Period 3||14
1655211|NCT00708305|4042315|P2|COMPLETED|Period 3||12
1655212|NCT00708305|4042316|P1|COMPLETED|Period 3||14
1655213|NCT00708305|4042313|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
1655214|NCT00708305|4042314|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
1655215|NCT00708305|4042315|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
1655216|NCT00708305|4042316|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
1655217|NCT00708305|4042313|P4|NOT COMPLETED|Period 2||1
1655218|NCT00708305|4042314|P3|NOT COMPLETED|Period 2||0
1655219|NCT00708305|4042315|P2|NOT COMPLETED|Period 2||2
1655220|NCT00708305|4042316|P1|NOT COMPLETED|Period 2||1
1655221|NCT00708305|4042313|P4|COMPLETED|Period 2||14
1655222|NCT00708305|4042314|P3|COMPLETED|Period 2||16
1655223|NCT00708305|4042315|P2|COMPLETED|Period 2||13
1655224|NCT00708305|4042316|P1|COMPLETED|Period 2||14
1655225|NCT00708305|4042313|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
1655226|NCT00708305|4042314|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
1655227|NCT00708305|4042315|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
1655228|NCT00708305|4042316|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
1655229|NCT00708305|4042313|P4|NOT COMPLETED|Period 1||2
1655230|NCT00708305|4042314|P3|NOT COMPLETED|Period 1||1
1655231|NCT00708305|4042315|P2|NOT COMPLETED|Period 1||0
1655232|NCT00708305|4042316|P1|NOT COMPLETED|Period 1||1
1655233|NCT00708305|4042313|P4|COMPLETED|Period 1||14
1655234|NCT00708305|4042314|P3|COMPLETED|Period 1||16
1655235|NCT00708305|4042315|P2|COMPLETED|Period 1||16
1655236|NCT00708305|4042316|P1|COMPLETED|Period 1||15
1655237|NCT00708305|4042313|P4|STARTED|Period 1||16
1655238|NCT00708305|4042314|P3|STARTED|Period 1||17
1655239|NCT00708305|4042315|P2|STARTED|Period 1||16
1655240|NCT00708305|4042316|P1|STARTED|Period 1||16
1655241|NCT00708227|4042352|P4|NOT COMPLETED|Overall Study||3
1655242|NCT00708227|4042353|P3|NOT COMPLETED|Overall Study||1
1655243|NCT00708227|4042354|P2|NOT COMPLETED|Overall Study||5
1655244|NCT00708227|4042355|P1|NOT COMPLETED|Overall Study||1
1655245|NCT00708227|4042352|P4|COMPLETED|Overall Study||22
1655246|NCT00708227|4042353|P3|COMPLETED|Overall Study||17
1655247|NCT00708227|4042354|P2|COMPLETED|Overall Study||21
1655248|NCT00708227|4042355|P1|COMPLETED|Overall Study||18
1655249|NCT00708227|4042352|P4|STARTED|Overall Study||25
1655250|NCT00708227|4042353|P3|STARTED|Overall Study||18
1655251|NCT00708227|4042354|P2|STARTED|Overall Study||26
1655252|NCT00708227|4042355|P1|STARTED|Overall Study||19
1655253|NCT00708214|4042388|P3|NOT COMPLETED|Overall Study||8
1655254|NCT00708214|4042389|P2|NOT COMPLETED|Overall Study||13
1655255|NCT00708214|4042390|P1|NOT COMPLETED|Overall Study||7
1655256|NCT00708214|4042388|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
1655257|NCT00708214|4042389|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
1655258|NCT00708214|4042390|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
1655259|NCT00708214|4042388|P3|STARTED|Overall Study||8
1655260|NCT00708214|4042389|P2|STARTED|Overall Study||13
1655261|NCT00708214|4042390|P1|STARTED|Overall Study||7
1655262|NCT00708201|4042433|P2|NOT COMPLETED|Overall Study||6
1655263|NCT00708201|4042434|P1|NOT COMPLETED|Overall Study||7
1655264|NCT00708201|4042433|P2|COMPLETED|Overall Study||137
1655265|NCT00708201|4042434|P1|COMPLETED|Overall Study||130
1655266|NCT00708201|4042433|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
1655267|NCT00708201|4042434|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
1655268|NCT00708201|4042433|P2|STARTED|Overall Study||143
1655269|NCT00708201|4042434|P1|STARTED|Overall Study||137
1655270|NCT00708175|4042458|P2|NOT COMPLETED|Overall Study||21
1655271|NCT00708175|4042459|P1|NOT COMPLETED|Overall Study||18
1655272|NCT00708175|4042458|P2|COMPLETED|Overall Study||57
1655273|NCT00708175|4042459|P1|COMPLETED|Overall Study||60
1655274|NCT00708175|4042458|P2|STARTED|Overall Study||78
1655275|NCT00708175|4042459|P1|STARTED|Overall Study||78
1655276|NCT00708162|4042475|P2|NOT COMPLETED|Open-Label Phase||30
1655277|NCT00708162|4042476|P1|NOT COMPLETED|Open-Label Phase||44
1655278|NCT00708162|4042475|P2|COMPLETED|Open-Label Phase||121
1655279|NCT00708162|4042476|P1|COMPLETED|Open-Label Phase||152
1655280|NCT00708162|4042475|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
1655357|NCT00708123|4042519|P3|COMPLETED|Period 1||11
1655281|NCT00708162|4042476|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
1655282|NCT00708162|4042475|P2|NOT COMPLETED|Randomized Phase||154
1655283|NCT00708162|4042476|P1|NOT COMPLETED|Randomized Phase||156
1655284|NCT00708162|4042475|P2|COMPLETED|Randomized Phase||209
1655285|NCT00708162|4042476|P1|COMPLETED|Randomized Phase||205
1655286|NCT00708162|4042475|P2|Randomized and Treated|Randomized Phase||358
1655287|NCT00708162|4042476|P1|Randomized and Treated|Randomized Phase||354
1655288|NCT00708162|4042475|P2|STARTED|Randomized Phase||363
1655289|NCT00708162|4042476|P1|STARTED|Randomized Phase||361
1655290|NCT00708123|4042517|P5|NOT COMPLETED|Period 5||0
1655291|NCT00708123|4042518|P4|NOT COMPLETED|Period 5||0
1655292|NCT00708123|4042519|P3|NOT COMPLETED|Period 5||0
1655293|NCT00708123|4042520|P2|NOT COMPLETED|Period 5||0
1655294|NCT00708123|4042521|P1|NOT COMPLETED|Period 5||0
1655295|NCT00708123|4042517|P5|COMPLETED|Period 5||10
1655296|NCT00708123|4042518|P4|COMPLETED|Period 5||11
1655297|NCT00708123|4042519|P3|COMPLETED|Period 5||11
1655298|NCT00708123|4042520|P2|COMPLETED|Period 5||10
1655299|NCT00708123|4042521|P1|COMPLETED|Period 5||10
1655300|NCT00708123|4042517|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
1655301|NCT00708123|4042518|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
1655302|NCT00708123|4042519|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
1655303|NCT00708123|4042520|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
1655304|NCT00708123|4042521|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
1655305|NCT00708123|4042517|P5|NOT COMPLETED|Period 4||0
1655306|NCT00708123|4042518|P4|NOT COMPLETED|Period 4||0
1655307|NCT00708123|4042519|P3|NOT COMPLETED|Period 4||0
1655308|NCT00708123|4042520|P2|NOT COMPLETED|Period 4||1
1655309|NCT00708123|4042521|P1|NOT COMPLETED|Period 4||0
1655310|NCT00708123|4042517|P5|COMPLETED|Period 4||11
1655311|NCT00708123|4042518|P4|COMPLETED|Period 4||10
1655312|NCT00708123|4042519|P3|COMPLETED|Period 4||10
1655313|NCT00708123|4042520|P2|COMPLETED|Period 4||11
1655314|NCT00708123|4042521|P1|COMPLETED|Period 4||10
1655315|NCT00708123|4042517|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
1655316|NCT00708123|4042518|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
1655317|NCT00708123|4042519|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
1655318|NCT00708123|4042520|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
1655319|NCT00708123|4042521|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
1655320|NCT00708123|4042517|P5|NOT COMPLETED|Period 3||0
1655321|NCT00708123|4042518|P4|NOT COMPLETED|Period 3||1
1655322|NCT00708123|4042519|P3|NOT COMPLETED|Period 3||1
1655323|NCT00708123|4042520|P2|NOT COMPLETED|Period 3||0
1655324|NCT00708123|4042521|P1|NOT COMPLETED|Period 3||0
1655325|NCT00708123|4042517|P5|COMPLETED|Period 3||10
1655326|NCT00708123|4042518|P4|COMPLETED|Period 3||11
1655327|NCT00708123|4042519|P3|COMPLETED|Period 3||10
1655328|NCT00708123|4042520|P2|COMPLETED|Period 3||10
1655329|NCT00708123|4042521|P1|COMPLETED|Period 3||12
1655330|NCT00708123|4042517|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
1655331|NCT00708123|4042518|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
1655332|NCT00708123|4042519|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
1655333|NCT00708123|4042520|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
1655334|NCT00708123|4042521|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
1655335|NCT00708123|4042517|P5|NOT COMPLETED|Period 2||0
1655336|NCT00708123|4042518|P4|NOT COMPLETED|Period 2||1
1655337|NCT00708123|4042519|P3|NOT COMPLETED|Period 2||0
1655338|NCT00708123|4042520|P2|NOT COMPLETED|Period 2||0
1655339|NCT00708123|4042521|P1|NOT COMPLETED|Period 2||1
1655340|NCT00708123|4042517|P5|COMPLETED|Period 2||11
1655341|NCT00708123|4042518|P4|COMPLETED|Period 2||10
1655342|NCT00708123|4042519|P3|COMPLETED|Period 2||12
1655343|NCT00708123|4042520|P2|COMPLETED|Period 2||12
1655344|NCT00708123|4042521|P1|COMPLETED|Period 2||10
1655345|NCT00708123|4042517|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
1655346|NCT00708123|4042518|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
1655347|NCT00708123|4042519|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
1655348|NCT00708123|4042520|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
1655349|NCT00708123|4042521|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
1655350|NCT00708123|4042517|P5|NOT COMPLETED|Period 1||0
1655351|NCT00708123|4042518|P4|NOT COMPLETED|Period 1||1
1655352|NCT00708123|4042519|P3|NOT COMPLETED|Period 1||1
1655353|NCT00708123|4042520|P2|NOT COMPLETED|Period 1||1
1655354|NCT00708123|4042521|P1|NOT COMPLETED|Period 1||0
1655355|NCT00708123|4042517|P5|COMPLETED|Period 1||12
1655356|NCT00708123|4042518|P4|COMPLETED|Period 1||11
1655358|NCT00708123|4042520|P2|COMPLETED|Period 1||11
1655359|NCT00708123|4042521|P1|COMPLETED|Period 1||12
1655360|NCT00708123|4042517|P5|STARTED|Period 1||12
1655361|NCT00708123|4042518|P4|STARTED|Period 1||12
1655362|NCT00708123|4042519|P3|STARTED|Period 1||12
1655363|NCT00708123|4042520|P2|STARTED|Period 1||12
1655364|NCT00708123|4042521|P1|STARTED|Period 1||12
1655365|NCT00708110|4042545|P4|NOT COMPLETED|Overall Study||0
1655366|NCT00708110|4042546|P3|NOT COMPLETED|Overall Study||0
1655367|NCT00708110|4042547|P2|NOT COMPLETED|Overall Study||0
1655368|NCT00708110|4042548|P1|NOT COMPLETED|Overall Study||0
1655369|NCT00708110|4042545|P4|COMPLETED|Overall Study||10
1655370|NCT00708110|4042546|P3|COMPLETED|Overall Study||9
1655371|NCT00708110|4042547|P2|COMPLETED|Overall Study||9
1655372|NCT00708110|4042548|P1|COMPLETED|Overall Study||7
1655373|NCT00708110|4042545|P4|STARTED|Overall Study||10
1655374|NCT00708110|4042546|P3|STARTED|Overall Study||9
1655375|NCT00708110|4042547|P2|STARTED|Overall Study||9
1655376|NCT00708110|4042548|P1|STARTED|Overall Study||7
1655377|NCT00708097|4042654|P5|NOT COMPLETED|Period 5||0
1655378|NCT00708097|4042655|P4|NOT COMPLETED|Period 5||0
1655379|NCT00708097|4042656|P3|NOT COMPLETED|Period 5||0
1655380|NCT00708097|4042657|P2|NOT COMPLETED|Period 5||0
1655381|NCT00708097|4042658|P1|NOT COMPLETED|Period 5||0
1655382|NCT00708097|4042654|P5|COMPLETED|Period 5||12
1655383|NCT00708097|4042655|P4|COMPLETED|Period 5||10
1655384|NCT00708097|4042656|P3|COMPLETED|Period 5||11
1655385|NCT00708097|4042657|P2|COMPLETED|Period 5||9
1655386|NCT00708097|4042658|P1|COMPLETED|Period 5||8
1655387|NCT00708097|4042654|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
1655388|NCT00708097|4042655|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
1655389|NCT00708097|4042656|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
1655390|NCT00708097|4042657|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
1655391|NCT00708097|4042658|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
1655392|NCT00708097|4042654|P5|NOT COMPLETED|Period 4||0
1655393|NCT00708097|4042655|P4|NOT COMPLETED|Period 4||0
1655394|NCT00708097|4042656|P3|NOT COMPLETED|Period 4||0
1655395|NCT00708097|4042657|P2|NOT COMPLETED|Period 4||0
1655396|NCT00708097|4042658|P1|NOT COMPLETED|Period 4||0
1655397|NCT00708097|4042654|P5|COMPLETED|Period 4||8
1655398|NCT00708097|4042655|P4|COMPLETED|Period 4||11
1655399|NCT00708097|4042656|P3|COMPLETED|Period 4||10
1655400|NCT00708097|4042657|P2|COMPLETED|Period 4||9
1655401|NCT00708097|4042658|P1|COMPLETED|Period 4||12
1655402|NCT00708097|4042654|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
1655403|NCT00708097|4042655|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
1655404|NCT00708097|4042656|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
1655405|NCT00708097|4042657|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
1655406|NCT00708097|4042658|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
1655407|NCT00708097|4042654|P5|NOT COMPLETED|Period 3||0
1655408|NCT00708097|4042655|P4|NOT COMPLETED|Period 3||0
1655409|NCT00708097|4042656|P3|NOT COMPLETED|Period 3||0
1655410|NCT00708097|4042657|P2|NOT COMPLETED|Period 3||0
1655411|NCT00708097|4042658|P1|NOT COMPLETED|Period 3||0
1655412|NCT00708097|4042654|P5|COMPLETED|Period 3||10
1655413|NCT00708097|4042655|P4|COMPLETED|Period 3||10
1655414|NCT00708097|4042656|P3|COMPLETED|Period 3||10
1655415|NCT00708097|4042657|P2|COMPLETED|Period 3||11
1655416|NCT00708097|4042658|P1|COMPLETED|Period 3||9
1655417|NCT00708097|4042654|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
1655418|NCT00708097|4042655|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
1655419|NCT00708097|4042656|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
1655420|NCT00708097|4042657|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
1655421|NCT00708097|4042658|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
1655422|NCT00708097|4042654|P5|NOT COMPLETED|Period 2||0
1655423|NCT00708097|4042655|P4|NOT COMPLETED|Period 2||1
1655424|NCT00708097|4042656|P3|NOT COMPLETED|Period 2||1
1655425|NCT00708097|4042657|P2|NOT COMPLETED|Period 2||1
1655426|NCT00708097|4042658|P1|NOT COMPLETED|Period 2||0
1655427|NCT00708097|4042654|P5|COMPLETED|Period 2||10
1655428|NCT00708097|4042655|P4|COMPLETED|Period 2||10
1655429|NCT00708097|4042656|P3|COMPLETED|Period 2||9
1655430|NCT00708097|4042657|P2|COMPLETED|Period 2||11
1655431|NCT00708097|4042658|P1|COMPLETED|Period 2||10
1655432|NCT00708097|4042654|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
1655433|NCT00708097|4042655|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
1655434|NCT00708097|4042656|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
1655435|NCT00708097|4042657|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
1655529|NCT00707746|4042968|P2|STARTED|Treatment Period||22
1655436|NCT00708097|4042658|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
1655437|NCT00708097|4042654|P5|NOT COMPLETED|Period 1||1
1655438|NCT00708097|4042655|P4|NOT COMPLETED|Period 1||2
1655439|NCT00708097|4042656|P3|NOT COMPLETED|Period 1||0
1655440|NCT00708097|4042657|P2|NOT COMPLETED|Period 1||1
1655441|NCT00708097|4042658|P1|NOT COMPLETED|Period 1||0
1655442|NCT00708097|4042654|P5|COMPLETED|Period 1||10
1655443|NCT00708097|4042655|P4|COMPLETED|Period 1||9
1655444|NCT00708097|4042656|P3|COMPLETED|Period 1||12
1655445|NCT00708097|4042657|P2|COMPLETED|Period 1||11
1655446|NCT00708097|4042658|P1|COMPLETED|Period 1||11
1655447|NCT00708097|4042654|P5|STARTED|Period 1||11
1655448|NCT00708097|4042655|P4|STARTED|Period 1||11
1655449|NCT00708097|4042656|P3|STARTED|Period 1||12
1655450|NCT00708097|4042657|P2|STARTED|Period 1||12
1655451|NCT00708097|4042658|P1|STARTED|Period 1||11
1655452|NCT00708071|4042688|P1|NOT COMPLETED|Overall Study||0
1655453|NCT00708071|4042688|P1|COMPLETED|Overall Study||45
1655454|NCT00708071|4042688|P1|STARTED|Overall Study|Randomized and treated|45
1655455|NCT00708032|4042768|P2|NOT COMPLETED|Overall Study||16
1655456|NCT00708032|4042769|P1|NOT COMPLETED|Overall Study||10
1655457|NCT00708032|4042768|P2|COMPLETED|Overall Study||22
1655458|NCT00708032|4042769|P1|COMPLETED|Overall Study||26
1655459|NCT00708032|4042768|P2|STARTED|Overall Study||38
1655460|NCT00708032|4042769|P1|STARTED|Overall Study||36
1655461|NCT00708019|4042785|P2|NOT COMPLETED|Overall Study||15
1655462|NCT00708019|4042786|P1|NOT COMPLETED|Overall Study||15
1655463|NCT00708019|4042785|P2|COMPLETED|Overall Study||78
1655464|NCT00708019|4042786|P1|COMPLETED|Overall Study||77
1655465|NCT00708019|4042785|P2|STARTED|Overall Study||93
1655466|NCT00708019|4042786|P1|STARTED|Overall Study||92
1655467|NCT00707993|4042796|P2|NOT COMPLETED|Overall Study||94
1655468|NCT00707993|4042797|P1|NOT COMPLETED|Overall Study||89
1655469|NCT00707993|4042796|P2|COMPLETED|Overall Study||125
1655470|NCT00707993|4042797|P1|COMPLETED|Overall Study||133
1655471|NCT00707993|4042796|P2|STARTED|Overall Study||219
1655472|NCT00707993|4042797|P1|STARTED|Overall Study||222
1655473|NCT00707980|4042839|P1|NOT COMPLETED|Overall Study||310
1655474|NCT00707980|4042839|P1|COMPLETED|Overall Study||526
1655475|NCT00707980|4042839|P1|Received Treatment|Overall Study||834
1655476|NCT00707980|4042839|P1|STARTED|Overall Study||836
1655477|NCT00707967|4042857|P3|NOT COMPLETED|Overall Study||0
1655478|NCT00707967|4042858|P2|NOT COMPLETED|Overall Study||0
1655479|NCT00707967|4042859|P1|NOT COMPLETED|Overall Study||0
1655480|NCT00707967|4042857|P3|COMPLETED|Overall Study||7
1655481|NCT00707967|4042858|P2|COMPLETED|Overall Study||8
1655482|NCT00707967|4042859|P1|COMPLETED|Overall Study||22
1655483|NCT00707967|4042857|P3|STARTED|Overall Study||7
1655484|NCT00707967|4042858|P2|STARTED|Overall Study||8
1655485|NCT00707967|4042859|P1|STARTED|Overall Study||22
1655486|NCT00707954|4042923|P5|NOT COMPLETED|Overall Study||1
1655487|NCT00707954|4042924|P4|NOT COMPLETED|Overall Study||0
1655488|NCT00707954|4042925|P3|NOT COMPLETED|Overall Study||0
1655489|NCT00707954|4042926|P2|NOT COMPLETED|Overall Study||0
1655490|NCT00707954|4042927|P1|NOT COMPLETED|Overall Study||0
1655491|NCT00707954|4042923|P5|COMPLETED|Overall Study||9
1655492|NCT00707954|4042924|P4|COMPLETED|Overall Study||13
1655493|NCT00707954|4042925|P3|COMPLETED|Overall Study||14
1655494|NCT00707954|4042926|P2|COMPLETED|Overall Study||12
1655495|NCT00707954|4042927|P1|COMPLETED|Overall Study||12
1655496|NCT00707954|4042923|P5|STARTED|Overall Study||10
1655497|NCT00707954|4042924|P4|STARTED|Overall Study||13
1655498|NCT00707954|4042925|P3|STARTED|Overall Study||14
1655499|NCT00707954|4042926|P2|STARTED|Overall Study||12
1655500|NCT00707954|4042927|P1|STARTED|Overall Study||12
1655501|NCT00707915|4042939|P1|NOT COMPLETED|Overall Study||0
1655502|NCT00707915|4042939|P1|COMPLETED|Overall Study||30
1655503|NCT00707915|4042939|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
1655504|NCT00707915|4042939|P1|STARTED|Overall Study||30
1655505|NCT00707863|4042950|P2|NOT COMPLETED|Overall Study||3
1655506|NCT00707863|4042951|P1|NOT COMPLETED|Overall Study||0
1655507|NCT00707863|4042950|P2|COMPLETED|Overall Study||8
1655508|NCT00707863|4042951|P1|COMPLETED|Overall Study||6
1655509|NCT00707863|4042950|P2|STARTED|Overall Study||11
1655510|NCT00707863|4042951|P1|STARTED|Overall Study||6
1655511|NCT00707759|4042959|P2|NOT COMPLETED|Overall Study||2
1655512|NCT00707759|4042960|P1|NOT COMPLETED|Overall Study||2
1655513|NCT00707759|4042959|P2|COMPLETED|Overall Study||12
1655514|NCT00707759|4042960|P1|COMPLETED|Overall Study||12
1655515|NCT00707759|4042959|P2|STARTED|Overall Study||14
1655516|NCT00707759|4042960|P1|STARTED|Overall Study||14
1655517|NCT00707746|4042968|P2|NOT COMPLETED|Follow-up Period||0
1655518|NCT00707746|4042969|P1|NOT COMPLETED|Follow-up Period||0
1655519|NCT00707746|4042968|P2|COMPLETED|Follow-up Period||21
1655520|NCT00707746|4042969|P1|COMPLETED|Follow-up Period||12
1655521|NCT00707746|4042968|P2|STARTED|Follow-up Period||21
1655522|NCT00707746|4042969|P1|STARTED|Follow-up Period||12
1655523|NCT00707746|4042968|P2|NOT COMPLETED|Treatment Period||5
1655524|NCT00707746|4042969|P1|NOT COMPLETED|Treatment Period||2
1655525|NCT00707746|4042968|P2|COMPLETED|Treatment Period||17
1655526|NCT00707746|4042969|P1|COMPLETED|Treatment Period||10
1655527|NCT00707746|4042968|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
1655528|NCT00707746|4042969|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
1655530|NCT00707746|4042969|P1|STARTED|Treatment Period||12
1655531|NCT00707655|4043017|P2|NOT COMPLETED|Overall Study||2
1655532|NCT00707655|4043018|P1|NOT COMPLETED|Overall Study||0
1655533|NCT00707655|4043017|P2|COMPLETED|Overall Study||3
1655534|NCT00707655|4043018|P1|COMPLETED|Overall Study||3
1655535|NCT00707655|4043017|P2|STARTED|Overall Study||5
1655536|NCT00707655|4043018|P1|STARTED|Overall Study||3
1655537|NCT00707577|4043030|P2|NOT COMPLETED|Overall Study||38
1655538|NCT00707577|4043031|P1|NOT COMPLETED|Overall Study||54
1655539|NCT00707577|4043030|P2|COMPLETED|Overall Study||118
1655540|NCT00707577|4043031|P1|COMPLETED|Overall Study||120
1655541|NCT00707577|4043030|P2|STARTED|Overall Study||156
1655542|NCT00707577|4043031|P1|STARTED|Overall Study||174
1655543|NCT00707486|4043037|P1|NOT COMPLETED|Overall Study||1
1655544|NCT00707486|4043037|P1|COMPLETED|Overall Study||71
1655545|NCT00707486|4043037|P1|STARTED|Overall Study||72
1655546|NCT00707447|4043048|P2|NOT COMPLETED|Overall Study||8
1655547|NCT00707447|4043049|P1|NOT COMPLETED|Overall Study||8
1655548|NCT00707447|4043048|P2|COMPLETED|Overall Study||85
1655549|NCT00707447|4043049|P1|COMPLETED|Overall Study||81
1655550|NCT00707447|4043048|P2|STARTED|Overall Study||93
1655551|NCT00707447|4043049|P1|STARTED|Overall Study||89
1655552|NCT00707343|4043073|P1|NOT COMPLETED|Overall Study||0
1655553|NCT00707343|4043073|P1|COMPLETED|Overall Study||15
1655554|NCT00707343|4043073|P1|STARTED|Overall Study||15
1655555|NCT00707239|4043080|P3|NOT COMPLETED|Overall Study||14
1655556|NCT00707239|4043081|P2|NOT COMPLETED|Overall Study||11
1655557|NCT00707239|4043082|P1|NOT COMPLETED|Overall Study||19
1655558|NCT00707239|4043080|P3|COMPLETED|Overall Study||21
1655559|NCT00707239|4043081|P2|COMPLETED|Overall Study||25
1655560|NCT00707239|4043082|P1|COMPLETED|Overall Study||18
1655561|NCT00707239|4043080|P3|Treated|Overall Study||34
1655562|NCT00707239|4043081|P2|Treated|Overall Study||35
1655563|NCT00707239|4043082|P1|Treated|Overall Study||36
1655564|NCT00707239|4043080|P3|STARTED|Overall Study||35
1655565|NCT00707239|4043081|P2|STARTED|Overall Study||36
1655566|NCT00707239|4043082|P1|STARTED|Overall Study||37
1655567|NCT00707174|4043130|P2|NOT COMPLETED|Overall Study||7
1655568|NCT00707174|4043131|P1|NOT COMPLETED|Overall Study||5
1655569|NCT00707174|4043130|P2|COMPLETED|Overall Study||37
1655570|NCT00707174|4043131|P1|COMPLETED|Overall Study||41
1655571|NCT00707174|4043130|P2|STARTED|Overall Study||44
1655572|NCT00707174|4043131|P1|STARTED|Overall Study||46
1655573|NCT00707161|4043137|P1|NOT COMPLETED|Overall Study||6
1655574|NCT00707161|4043137|P1|COMPLETED|Overall Study||0
1655575|NCT00707161|4043137|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
1655576|NCT00707057|4043143|P2|NOT COMPLETED|Overall Study||4
1655577|NCT00707057|4043144|P1|NOT COMPLETED|Overall Study||8
1655578|NCT00707057|4043143|P2|COMPLETED|Overall Study||83
1655579|NCT00707057|4043144|P1|COMPLETED|Overall Study||161
1655580|NCT00707057|4043143|P2|STARTED|Overall Study||87
1655581|NCT00707057|4043144|P1|STARTED|Overall Study||169
1655582|NCT00707031|4043178|P2|NOT COMPLETED|Overall Study||99
1655583|NCT00707031|4043179|P1|NOT COMPLETED|Overall Study||104
1655584|NCT00707031|4043178|P2|COMPLETED|Overall Study||220
1655585|NCT00707031|4043179|P1|COMPLETED|Overall Study||216
1655586|NCT00707031|4043178|P2|Modified Intent-to-Treat Population|Overall Study||315
1655587|NCT00707031|4043179|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
1655588|NCT00707031|4043178|P2|Treated/Safety Population|Overall Study||316
1655589|NCT00707031|4043179|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
1655590|NCT00707031|4043178|P2|STARTED|Overall Study||319
1655591|NCT00707031|4043179|P1|STARTED|Overall Study|Randomized|320
1655592|NCT00706992|4043208|P7|NOT COMPLETED|Overall Study||3
1655593|NCT00706992|4043209|P6|NOT COMPLETED|Overall Study||2
1655594|NCT00706992|4043210|P5|NOT COMPLETED|Overall Study||4
1655595|NCT00706992|4043211|P4|NOT COMPLETED|Overall Study||2
1655596|NCT00706992|4043212|P3|NOT COMPLETED|Overall Study||6
1655597|NCT00706992|4043213|P2|NOT COMPLETED|Overall Study||5
1655598|NCT00706992|4043214|P1|NOT COMPLETED|Overall Study||5
1655599|NCT00706992|4043208|P7|COMPLETED|Overall Study||3
1655600|NCT00706992|4043209|P6|COMPLETED|Overall Study||3
1655601|NCT00706992|4043210|P5|COMPLETED|Overall Study||2
1655602|NCT00706992|4043211|P4|COMPLETED|Overall Study||6
1655603|NCT00706992|4043212|P3|COMPLETED|Overall Study||3
1655604|NCT00706992|4043213|P2|COMPLETED|Overall Study||3
1655605|NCT00706992|4043214|P1|COMPLETED|Overall Study||3
1655606|NCT00706992|4043208|P7|STARTED|Overall Study||6
1655607|NCT00706992|4043209|P6|STARTED|Overall Study||5
1655608|NCT00706992|4043210|P5|STARTED|Overall Study||6
1655609|NCT00706992|4043211|P4|STARTED|Overall Study||8
1655610|NCT00706992|4043212|P3|STARTED|Overall Study||9
1655611|NCT00706992|4043213|P2|STARTED|Overall Study||8
1655612|NCT00706992|4043214|P1|STARTED|Overall Study||8
1655613|NCT00706979|4043233|P2|NOT COMPLETED|Overall Study||0
1655614|NCT00706979|4043234|P1|NOT COMPLETED|Overall Study||0
1655615|NCT00706979|4043233|P2|COMPLETED|Overall Study||423
1655616|NCT00706979|4043234|P1|COMPLETED|Overall Study||426
1655617|NCT00706979|4043233|P2|STARTED|Overall Study||423
1655618|NCT00706979|4043234|P1|STARTED|Overall Study||426
1655619|NCT00706966|4043246|P1|NOT COMPLETED|Overall Study||1
1655620|NCT00706966|4043246|P1|COMPLETED|Overall Study||9
1655621|NCT00706966|4043246|P1|STARTED|Overall Study||10
1655622|NCT00706914|4043282|P3|NOT COMPLETED|Overall Study||1
1655623|NCT00706914|4043283|P2|NOT COMPLETED|Overall Study||4
1655624|NCT00706914|4043284|P1|NOT COMPLETED|Overall Study||6
1655625|NCT00706914|4043282|P3|COMPLETED|Overall Study||30
1655626|NCT00706914|4043283|P2|COMPLETED|Overall Study||58
1655627|NCT00706914|4043284|P1|COMPLETED|Overall Study||57
1655628|NCT00706914|4043282|P3|STARTED|Overall Study||31
1655629|NCT00706914|4043283|P2|STARTED|Overall Study||62
1655630|NCT00706914|4043284|P1|STARTED|Overall Study||63
1655631|NCT00706901|4043307|P3|NOT COMPLETED|Overall Study||8
1655632|NCT00706901|4043308|P2|NOT COMPLETED|Overall Study||5
1655633|NCT00706901|4043309|P1|NOT COMPLETED|Overall Study||8
1655634|NCT00706901|4043307|P3|COMPLETED|Overall Study||51
1655635|NCT00706901|4043308|P2|COMPLETED|Overall Study||57
1655636|NCT00706901|4043309|P1|COMPLETED|Overall Study||51
1655637|NCT00706901|4043307|P3|STARTED|Overall Study||59
1655638|NCT00706901|4043308|P2|STARTED|Overall Study||62
1655639|NCT00706901|4043309|P1|STARTED|Overall Study||59
1655640|NCT00706849|4043334|P2|NOT COMPLETED|Follow-up Period||3
1655641|NCT00706849|4043335|P1|NOT COMPLETED|Follow-up Period||0
1655642|NCT00706849|4043334|P2|COMPLETED|Follow-up Period||25
1655643|NCT00706849|4043335|P1|COMPLETED|Follow-up Period||3
1655644|NCT00706849|4043334|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
1655645|NCT00706849|4043335|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
1655646|NCT00706849|4043334|P2|NOT COMPLETED|Treatment Period||10
1655647|NCT00706849|4043335|P1|NOT COMPLETED|Treatment Period||0
1655648|NCT00706849|4043334|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
1655649|NCT00706849|4043335|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
1655650|NCT00706849|4043334|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
1655651|NCT00706849|4043335|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
1655652|NCT00706849|4043334|P2|STARTED|Treatment Period||83
1655653|NCT00706849|4043335|P1|STARTED|Treatment Period||41
1655654|NCT00706836|4043379|P1|NOT COMPLETED|Overall Study||0
1655655|NCT00706836|4043379|P1|COMPLETED|Overall Study||16
1655656|NCT00706836|4043379|P1|STARTED|Overall Study||16
1655657|NCT00706823|4043389|P2|NOT COMPLETED|Overall Study||0
1655658|NCT00706823|4043390|P1|NOT COMPLETED|Overall Study||0
1655659|NCT00706823|4043389|P2|COMPLETED|Overall Study||25
1655660|NCT00706823|4043390|P1|COMPLETED|Overall Study||25
1655661|NCT00706823|4043389|P2|STARTED|Overall Study||25
1655662|NCT00706823|4043390|P1|STARTED|Overall Study||25
1655663|NCT00706810|4043406|P1|NOT COMPLETED|Overall Study||1
1655664|NCT00706810|4043406|P1|COMPLETED|Overall Study||7
1655665|NCT00706810|4043406|P1|STARTED|Overall Study||8
1655666|NCT00706797|4043413|P2|NOT COMPLETED|Overall Study||71
1655667|NCT00706797|4043414|P1|NOT COMPLETED|Overall Study||69
1655668|NCT00706797|4043413|P2|COMPLETED|Overall Study||0
1655669|NCT00706797|4043414|P1|COMPLETED|Overall Study||1
1655670|NCT00706797|4043413|P2|Safety Population|Overall Study||71
1655671|NCT00706797|4043414|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
1655672|NCT00706797|4043413|P2|STARTED|Overall Study||71
1655673|NCT00706797|4043414|P1|STARTED|Overall Study||70
1655674|NCT00706784|4043456|P2|NOT COMPLETED|Overall Study||0
1655675|NCT00706784|4043457|P1|NOT COMPLETED|Overall Study||0
1655676|NCT00706784|4043456|P2|COMPLETED|Overall Study||3
1655677|NCT00706784|4043457|P1|COMPLETED|Overall Study||3
1655678|NCT00706784|4043456|P2|STARTED|Overall Study||3
1655679|NCT00706784|4043457|P1|STARTED|Overall Study||3
1655680|NCT00706719|4043466|P3|NOT COMPLETED|Overall Study||4
1655681|NCT00706719|4043467|P2|NOT COMPLETED|Overall Study||1
1655682|NCT00706719|4043468|P1|NOT COMPLETED|Overall Study||0
1655683|NCT00706719|4043466|P3|COMPLETED|Overall Study||1
1655684|NCT00706719|4043467|P2|COMPLETED|Overall Study||6
1655685|NCT00706719|4043468|P1|COMPLETED|Overall Study||5
1655686|NCT00706719|4043466|P3|STARTED|Overall Study||5
1655687|NCT00706719|4043467|P2|STARTED|Overall Study||7
1655688|NCT00706719|4043468|P1|STARTED|Overall Study||5
1655689|NCT00706706|4043483|P1|NOT COMPLETED|Overall Study||105
1655690|NCT00706706|4043483|P1|COMPLETED|Overall Study||0
1655691|NCT00706706|4043483|P1|STARTED|Overall Study||105
1655692|NCT00706654|4043493|P4|NOT COMPLETED|Depot Maintenance Phase||70
1655693|NCT00706654|4043494|P3|NOT COMPLETED|Depot Maintenance Phase||88
1655694|NCT00706654|4043495|P2|NOT COMPLETED|Depot Maintenance Phase||69
1655695|NCT00706654|4043496|P1|NOT COMPLETED|Depot Maintenance Phase||0
1655696|NCT00706654|4043493|P4|COMPLETED|Depot Maintenance Phase||61
1655697|NCT00706654|4043494|P3|COMPLETED|Depot Maintenance Phase||178
1655698|NCT00706654|4043495|P2|COMPLETED|Depot Maintenance Phase||196
1655699|NCT00706654|4043496|P1|COMPLETED|Depot Maintenance Phase||0
1655700|NCT00706654|4043493|P4|STARTED|Depot Maintenance Phase||131
1655701|NCT00706654|4043494|P3|STARTED|Depot Maintenance Phase||266
1655702|NCT00706654|4043495|P2|STARTED|Depot Maintenance Phase||265
1655703|NCT00706654|4043496|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
1655704|NCT00706654|4043493|P4|NOT COMPLETED|Oral Stabilization Phase||0
1655705|NCT00706654|4043494|P3|NOT COMPLETED|Oral Stabilization Phase||0
1655706|NCT00706654|4043495|P2|NOT COMPLETED|Oral Stabilization Phase||0
1655707|NCT00706654|4043496|P1|NOT COMPLETED|Oral Stabilization Phase||180
1655708|NCT00706654|4043493|P4|COMPLETED|Oral Stabilization Phase||0
1655709|NCT00706654|4043494|P3|COMPLETED|Oral Stabilization Phase||0
1655710|NCT00706654|4043495|P2|COMPLETED|Oral Stabilization Phase||0
1655711|NCT00706654|4043496|P1|COMPLETED|Oral Stabilization Phase||662
1655712|NCT00706654|4043493|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1655713|NCT00706654|4043494|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1655714|NCT00706654|4043495|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1655715|NCT00706654|4043496|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
1655716|NCT00706654|4043493|P4|NOT COMPLETED|Conversion Phase||0
1655717|NCT00706654|4043494|P3|NOT COMPLETED|Conversion Phase||0
1655718|NCT00706654|4043495|P2|NOT COMPLETED|Conversion Phase||0
1655719|NCT00706654|4043496|P1|NOT COMPLETED|Conversion Phase||95
1655720|NCT00706654|4043493|P4|COMPLETED|Conversion Phase||0
1655721|NCT00706654|4043494|P3|COMPLETED|Conversion Phase||0
1655722|NCT00706654|4043495|P2|COMPLETED|Conversion Phase||0
1655723|NCT00706654|4043496|P1|COMPLETED|Conversion Phase||614
1655724|NCT00706654|4043493|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1655725|NCT00706654|4043494|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1655726|NCT00706654|4043495|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1655727|NCT00706654|4043496|P1|STARTED|Conversion Phase||709
1655728|NCT00706641|4043515|P1|NOT COMPLETED|Radical Cystectomy||1
1655729|NCT00706641|4043515|P1|COMPLETED|Radical Cystectomy||22
1655730|NCT00706641|4043515|P1|STARTED|Radical Cystectomy||23
1655731|NCT00706641|4043515|P1|NOT COMPLETED|Dasatinib Administration||2
1655732|NCT00706641|4043515|P1|COMPLETED|Dasatinib Administration||23
1655733|NCT00706641|4043515|P1|Toxicity Evaluation|Dasatinib Administration||24
1655734|NCT00706641|4043515|P1|STARTED|Dasatinib Administration||25
1655735|NCT00706628|4043529|P4|NOT COMPLETED|Overall Study||3
1655736|NCT00706628|4043530|P3|NOT COMPLETED|Overall Study||16
1655737|NCT00706628|4043531|P2|NOT COMPLETED|Overall Study||21
1655738|NCT00706628|4043532|P1|NOT COMPLETED|Overall Study||47
1655739|NCT00706628|4043529|P4|COMPLETED|Overall Study||0
1655740|NCT00706628|4043530|P3|COMPLETED|Overall Study||0
1655741|NCT00706628|4043531|P2|COMPLETED|Overall Study||0
1655742|NCT00706628|4043532|P1|COMPLETED|Overall Study||0
1655743|NCT00706628|4043529|P4|STARTED|Overall Study||3
1655744|NCT00706628|4043530|P3|STARTED|Overall Study||16
1655745|NCT00706628|4043531|P2|STARTED|Overall Study||21
1655746|NCT00706628|4043532|P1|STARTED|Overall Study||47
1655747|NCT00706589|4043582|P2|NOT COMPLETED|Overall Study||4
1655748|NCT00706589|4043583|P1|NOT COMPLETED|Overall Study||3
1655749|NCT00706589|4043582|P2|COMPLETED|Overall Study||25
1655750|NCT00706589|4043583|P1|COMPLETED|Overall Study||29
1655751|NCT00706589|4043582|P2|STARTED|Overall Study||29
1655752|NCT00706589|4043583|P1|STARTED|Overall Study||32
1655753|NCT00706563|4043591|P2|NOT COMPLETED|Overall Study||0
1655754|NCT00706563|4043592|P1|NOT COMPLETED|Overall Study||0
1655755|NCT00706563|4043591|P2|COMPLETED|Overall Study||59
1655756|NCT00706563|4043592|P1|COMPLETED|Overall Study||61
1655757|NCT00706563|4043591|P2|STARTED|Overall Study||59
1655758|NCT00706563|4043592|P1|STARTED|Overall Study||61
1655759|NCT00706550|4043616|P2|NOT COMPLETED|Overall Study||28
1655760|NCT00706550|4043617|P1|NOT COMPLETED|Overall Study||7
1655761|NCT00706550|4043616|P2|COMPLETED|Overall Study||36
1655762|NCT00706550|4043617|P1|COMPLETED|Overall Study||36
1655763|NCT00706550|4043616|P2|STARTED|Overall Study||64
1655764|NCT00706550|4043617|P1|STARTED|Overall Study||43
1655765|NCT00706485|4043633|P1|NOT COMPLETED|Overall Study||0
1655766|NCT00706485|4043633|P1|COMPLETED|Overall Study||5
1655767|NCT00706485|4043633|P1|STARTED|Overall Study||5
1655768|NCT00706446|4043645|P6|NOT COMPLETED|Overall Study||38
1655769|NCT00706446|4043646|P5|NOT COMPLETED|Overall Study||44
1655770|NCT00706446|4043647|P4|NOT COMPLETED|Overall Study||22
1655771|NCT00706446|4043648|P3|NOT COMPLETED|Overall Study||37
1655772|NCT00706446|4043649|P2|NOT COMPLETED|Overall Study||49
1655773|NCT00706446|4043650|P1|NOT COMPLETED|Overall Study||26
1655774|NCT00706446|4043645|P6|COMPLETED|Overall Study||7
1655775|NCT00706446|4043646|P5|COMPLETED|Overall Study||10
1655776|NCT00706446|4043647|P4|COMPLETED|Overall Study||4
1655777|NCT00706446|4043648|P3|COMPLETED|Overall Study||7
1655778|NCT00706446|4043649|P2|COMPLETED|Overall Study||8
1655779|NCT00706446|4043650|P1|COMPLETED|Overall Study||3
1655780|NCT00706446|4043645|P6|STARTED|Overall Study||45
1655781|NCT00706446|4043646|P5|STARTED|Overall Study||54
1655782|NCT00706446|4043647|P4|STARTED|Overall Study||26
1655783|NCT00706446|4043648|P3|STARTED|Overall Study||44
1655784|NCT00706446|4043649|P2|STARTED|Overall Study||57
1655785|NCT00706446|4043650|P1|STARTED|Overall Study||29
1655786|NCT00706433|4043692|P4|NOT COMPLETED|Overall Study||2
1655787|NCT00706433|4043693|P3|NOT COMPLETED|Overall Study||10
1655788|NCT00706433|4043694|P2|NOT COMPLETED|Overall Study||3
1655789|NCT00706433|4043695|P1|NOT COMPLETED|Overall Study||5
1655790|NCT00706433|4043692|P4|COMPLETED|Overall Study||64
1655791|NCT00706433|4043693|P3|COMPLETED|Overall Study||57
1655792|NCT00706433|4043694|P2|COMPLETED|Overall Study||62
1655793|NCT00706433|4043695|P1|COMPLETED|Overall Study||63
1655794|NCT00706433|4043692|P4|STARTED|Overall Study||66
1655795|NCT00706433|4043693|P3|STARTED|Overall Study||67
1655796|NCT00706433|4043694|P2|STARTED|Overall Study||65
1655797|NCT00706433|4043695|P1|STARTED|Overall Study||68
1655798|NCT00706407|4044011|P1|NOT COMPLETED|Overall Study||9
1655799|NCT00706407|4044011|P1|COMPLETED|Overall Study||33
1655800|NCT00706407|4044011|P1|STARTED|Overall Study||42
1655801|NCT00706355|4044022|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
1655802|NCT00706355|4044023|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
1655803|NCT00706355|4044024|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
1655804|NCT00706355|4044025|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
1655805|NCT00706355|4044022|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
1655806|NCT00706355|4044023|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
1655807|NCT00706355|4044024|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
1655808|NCT00706355|4044025|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
1655809|NCT00706355|4044022|P4|STARTED|Period 4: PF-04217903 150 mg||4
1655810|NCT00706355|4044023|P3|STARTED|Period 4: PF-04217903 150 mg||0
1655811|NCT00706355|4044024|P2|STARTED|Period 4: PF-04217903 150 mg||0
1655812|NCT00706355|4044025|P1|STARTED|Period 4: PF-04217903 150 mg||0
1655813|NCT00706355|4044022|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
1655814|NCT00706355|4044023|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
1655815|NCT00706355|4044024|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
1655816|NCT00706355|4044025|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
1655817|NCT00706355|4044022|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
1655818|NCT00706355|4044023|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
1655819|NCT00706355|4044024|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
1655820|NCT00706355|4044025|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
1655821|NCT00706355|4044022|P4|STARTED|Period 3: PF-04217903 200 mg||0
1655822|NCT00706355|4044023|P3|STARTED|Period 3: PF-04217903 200 mg||2
1655823|NCT00706355|4044024|P2|STARTED|Period 3: PF-04217903 200 mg||0
1655824|NCT00706355|4044025|P1|STARTED|Period 3: PF-04217903 200 mg||0
1655825|NCT00706355|4044022|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
1655826|NCT00706355|4044023|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
1655827|NCT00706355|4044024|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
1655828|NCT00706355|4044025|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
1655829|NCT00706355|4044022|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
1655830|NCT00706355|4044023|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
1655831|NCT00706355|4044024|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
1655832|NCT00706355|4044025|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
1655833|NCT00706355|4044022|P4|STARTED|Period 2: PF-04217903 100 mg||0
1655834|NCT00706355|4044023|P3|STARTED|Period 2: PF-04217903 100 mg||0
1655835|NCT00706355|4044024|P2|STARTED|Period 2: PF-04217903 100 mg||7
1655836|NCT00706355|4044025|P1|STARTED|Period 2: PF-04217903 100 mg||0
1655837|NCT00706355|4044022|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
1655838|NCT00706355|4044023|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
1655839|NCT00706355|4044024|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
1655840|NCT00706355|4044025|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
1655841|NCT00706355|4044022|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
1655842|NCT00706355|4044023|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
1655843|NCT00706355|4044024|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
1655844|NCT00706355|4044025|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
1655845|NCT00706355|4044022|P4|STARTED|Period 1: PF-04217903 50 mg||0
1655846|NCT00706355|4044023|P3|STARTED|Period 1: PF-04217903 50 mg||0
1655847|NCT00706355|4044024|P2|STARTED|Period 1: PF-04217903 50 mg||0
1655848|NCT00706355|4044025|P1|STARTED|Period 1: PF-04217903 50 mg||3
1655849|NCT00706342|4044077|P1|NOT COMPLETED|Overall Study||18
1655850|NCT00706342|4044077|P1|COMPLETED|Overall Study||0
1655851|NCT00706342|4044077|P1|STARTED|Overall Study||18
1655852|NCT00706329|4044086|P1|NOT COMPLETED|Overall Study||0
1655853|NCT00706329|4044086|P1|COMPLETED|Overall Study||25
1655854|NCT00706329|4044086|P1|STARTED|Overall Study||25
1655855|NCT00706134|4044094|P4|NOT COMPLETED|Overall Study||11
1655856|NCT00706134|4044095|P3|NOT COMPLETED|Overall Study||6
1655857|NCT00706134|4044096|P2|NOT COMPLETED|Overall Study||19
1655858|NCT00706134|4044097|P1|NOT COMPLETED|Overall Study||20
1655859|NCT00706134|4044094|P4|COMPLETED|Overall Study||175
1655860|NCT00706134|4044095|P3|COMPLETED|Overall Study||183
1655861|NCT00706134|4044096|P2|COMPLETED|Overall Study||173
1655862|NCT00706134|4044097|P1|COMPLETED|Overall Study||169
1655863|NCT00706134|4044094|P4|Entered Double-blind Period|Overall Study||186
1655864|NCT00706134|4044095|P3|Entered Double-blind Period|Overall Study||189
1655865|NCT00706134|4044096|P2|Entered Double-blind Period|Overall Study||192
1655866|NCT00706134|4044097|P1|Entered Double-blind Period|Overall Study||187
1655867|NCT00706134|4044094|P4|STARTED|Overall Study||186
1655868|NCT00706134|4044095|P3|STARTED|Overall Study||189
1655869|NCT00706134|4044096|P2|STARTED|Overall Study||192
1655870|NCT00706134|4044097|P1|STARTED|Overall Study||189
1655871|NCT00706121|4044131|P4|NOT COMPLETED|Overall Study||352
1655872|NCT00706121|4044132|P3|NOT COMPLETED|Overall Study||404
1655873|NCT00706121|4044133|P2|NOT COMPLETED|Overall Study||396
1655874|NCT00706121|4044134|P1|NOT COMPLETED|Overall Study||396
1655875|NCT00706121|4044131|P4|COMPLETED|Overall Study||1577
1655876|NCT00706121|4044132|P3|COMPLETED|Overall Study||1626
1655877|NCT00706121|4044133|P2|COMPLETED|Overall Study||1700
1655878|NCT00706121|4044134|P1|COMPLETED|Overall Study||1643
1655879|NCT00706121|4044131|P4|STARTED|Overall Study||1929
1655880|NCT00706121|4044132|P3|STARTED|Overall Study||2030
1655881|NCT00706121|4044133|P2|STARTED|Overall Study||2096
1655882|NCT00706121|4044134|P1|STARTED|Overall Study||2039
1655883|NCT00706095|4044163|P3|NOT COMPLETED|Overall Study||5
1655884|NCT00706095|4044164|P2|NOT COMPLETED|Overall Study||7
1655885|NCT00706095|4044165|P1|NOT COMPLETED|Overall Study||6
1655886|NCT00706095|4044163|P3|COMPLETED|Overall Study||0
1655887|NCT00706095|4044164|P2|COMPLETED|Overall Study||0
1655888|NCT00706095|4044165|P1|COMPLETED|Overall Study||0
1655889|NCT00706095|4044163|P3|STARTED|Overall Study||5
1655890|NCT00706095|4044164|P2|STARTED|Overall Study||7
1655891|NCT00706095|4044165|P1|STARTED|Overall Study||6
1655892|NCT00706030|4044183|P4|NOT COMPLETED|Overall Study||16
1655893|NCT00706030|4044184|P3|NOT COMPLETED|Overall Study||60
1655894|NCT00706030|4044185|P2|NOT COMPLETED|Overall Study||6
1655895|NCT00706030|4044186|P1|NOT COMPLETED|Overall Study||6
1655896|NCT00706030|4044183|P4|COMPLETED|Overall Study||0
1655897|NCT00706030|4044184|P3|COMPLETED|Overall Study||4
1655898|NCT00706030|4044185|P2|COMPLETED|Overall Study||0
1655899|NCT00706030|4044186|P1|COMPLETED|Overall Study||0
1655900|NCT00706030|4044183|P4|Treated|Overall Study||15
1655901|NCT00706030|4044184|P3|Treated|Overall Study||64
1655902|NCT00706030|4044185|P2|Treated|Overall Study||6
1655903|NCT00706030|4044186|P1|Treated|Overall Study||6
1655904|NCT00706030|4044183|P4|STARTED|Overall Study||16
1655905|NCT00706030|4044184|P3|STARTED|Overall Study||64
1655906|NCT00706030|4044185|P2|STARTED|Overall Study||6
1655907|NCT00706030|4044186|P1|STARTED|Overall Study||6
1655908|NCT00706004|4044201|P1|NOT COMPLETED|Overall Study||2
1655909|NCT00706004|4044201|P1|COMPLETED|Overall Study||7
1655910|NCT00706004|4044201|P1|STARTED|Overall Study||9
1655911|NCT00705939|4044229|P3|NOT COMPLETED|Overall Study||4
1655912|NCT00705939|4044230|P2|NOT COMPLETED|Overall Study||2
1655913|NCT00705939|4044231|P1|NOT COMPLETED|Overall Study||0
1655914|NCT00705939|4044229|P3|COMPLETED|Overall Study||14
1655915|NCT00705939|4044230|P2|COMPLETED|Overall Study||12
1655916|NCT00705939|4044231|P1|COMPLETED|Overall Study||12
1655917|NCT00705939|4044229|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
1655918|NCT00705939|4044230|P2|STARTED|Overall Study||14
1655919|NCT00705939|4044231|P1|STARTED|Overall Study||12
1655920|NCT00705874|4044261|P7|NOT COMPLETED|Overall Study||0
1655921|NCT00705874|4044262|P6|NOT COMPLETED|Overall Study||4
1655922|NCT00705874|4044263|P5|NOT COMPLETED|Overall Study||12
1655923|NCT00705874|4044264|P4|NOT COMPLETED|Overall Study||1
1655924|NCT00705874|4044265|P3|NOT COMPLETED|Overall Study||2
1655925|NCT00705874|4044266|P2|NOT COMPLETED|Overall Study||1
1655926|NCT00705874|4044267|P1|NOT COMPLETED|Overall Study||2
1655927|NCT00705874|4044261|P7|COMPLETED|Overall Study||3
1655928|NCT00705874|4044262|P6|COMPLETED|Overall Study||28
1655929|NCT00705874|4044263|P5|COMPLETED|Overall Study||36
1655930|NCT00705874|4044264|P4|COMPLETED|Overall Study||33
1655931|NCT00705874|4044265|P3|COMPLETED|Overall Study||32
1655932|NCT00705874|4044266|P2|COMPLETED|Overall Study||8
1655933|NCT00705874|4044267|P1|COMPLETED|Overall Study||10
1655934|NCT00705874|4044261|P7|STARTED|Overall Study||3
1655935|NCT00705874|4044262|P6|STARTED|Overall Study||32
1655936|NCT00705874|4044263|P5|STARTED|Overall Study||48
1655937|NCT00705874|4044264|P4|STARTED|Overall Study||34
1655938|NCT00705874|4044265|P3|STARTED|Overall Study||34
1655939|NCT00705874|4044266|P2|STARTED|Overall Study||9
1655940|NCT00705874|4044267|P1|STARTED|Overall Study||12
1655941|NCT00705783|4044285|P3|NOT COMPLETED|Depot Maintenance Phase||131
1655942|NCT00705783|4044286|P2|NOT COMPLETED|Depot Maintenance Phase||246
1655943|NCT00705783|4044287|P1|NOT COMPLETED|Depot Maintenance Phase||0
1655944|NCT00705783|4044285|P3|COMPLETED|Depot Maintenance Phase||3
1655945|NCT00705783|4044286|P2|COMPLETED|Depot Maintenance Phase||23
1655946|NCT00705783|4044287|P1|COMPLETED|Depot Maintenance Phase||0
1655947|NCT00705783|4044285|P3|STARTED|Depot Maintenance Phase||134
1655948|NCT00705783|4044286|P2|STARTED|Depot Maintenance Phase||269
1655949|NCT00705783|4044287|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
1655950|NCT00705783|4044285|P3|NOT COMPLETED|Depot Stabilization Phase||0
1655951|NCT00705783|4044286|P2|NOT COMPLETED|Depot Stabilization Phase||0
1655952|NCT00705783|4044287|P1|NOT COMPLETED|Depot Stabilization Phase||173
1655953|NCT00705783|4044285|P3|COMPLETED|Depot Stabilization Phase||0
1655954|NCT00705783|4044286|P2|COMPLETED|Depot Stabilization Phase||0
1655955|NCT00705783|4044287|P1|COMPLETED|Depot Stabilization Phase||403
1655956|NCT00705783|4044285|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1655957|NCT00705783|4044286|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1655958|NCT00705783|4044287|P1|STARTED|Depot Stabilization Phase||576
1655959|NCT00705783|4044285|P3|NOT COMPLETED|Oral Stabilization Phase||0
1655960|NCT00705783|4044286|P2|NOT COMPLETED|Oral Stabilization Phase||0
1655961|NCT00705783|4044287|P1|NOT COMPLETED|Oral Stabilization Phase||134
1655962|NCT00705783|4044285|P3|COMPLETED|Oral Stabilization Phase||0
1655963|NCT00705783|4044286|P2|COMPLETED|Oral Stabilization Phase||0
1655964|NCT00705783|4044287|P1|COMPLETED|Oral Stabilization Phase||576
1655965|NCT00705783|4044285|P3|Received Study Medication|Oral Stabilization Phase||0
1655966|NCT00705783|4044286|P2|Received Study Medication|Oral Stabilization Phase||0
1655967|NCT00705783|4044287|P1|Received Study Medication|Oral Stabilization Phase||709
1655968|NCT00705783|4044285|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1655969|NCT00705783|4044286|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1655970|NCT00705783|4044287|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
1655971|NCT00705783|4044285|P3|NOT COMPLETED|Conversion Phase||0
1655972|NCT00705783|4044286|P2|NOT COMPLETED|Conversion Phase||0
1655973|NCT00705783|4044287|P1|NOT COMPLETED|Conversion Phase||133
1655974|NCT00705783|4044285|P3|COMPLETED|Conversion Phase||0
1655975|NCT00705783|4044286|P2|COMPLETED|Conversion Phase||0
1655976|NCT00705783|4044287|P1|COMPLETED|Conversion Phase||500
1655977|NCT00705783|4044285|P3|Received Study Medication|Conversion Phase||0
1655978|NCT00705783|4044286|P2|Received Study Medication|Conversion Phase||0
1655979|NCT00705783|4044287|P1|Received Study Medication|Conversion Phase||632
1655980|NCT00705783|4044285|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1655981|NCT00705783|4044286|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1655982|NCT00705783|4044287|P1|STARTED|Conversion Phase||633
1655983|NCT00705757|4044317|P3|NOT COMPLETED|Overall Study||11
1655984|NCT00705757|4044318|P2|NOT COMPLETED|Overall Study||8
1655985|NCT00705757|4044319|P1|NOT COMPLETED|Overall Study||13
1655986|NCT00705757|4044317|P3|COMPLETED|Overall Study||17
1655987|NCT00705757|4044318|P2|COMPLETED|Overall Study||21
1655988|NCT00705757|4044319|P1|COMPLETED|Overall Study||19
1655989|NCT00705757|4044317|P3|STARTED|Overall Study||28
1655990|NCT00705757|4044318|P2|STARTED|Overall Study||29
1655991|NCT00705757|4044319|P1|STARTED|Overall Study||32
1655992|NCT00705718|4044329|P2|NOT COMPLETED|Overall Study||22
1655993|NCT00705718|4044330|P1|NOT COMPLETED|Overall Study||7
1655994|NCT00705718|4044329|P2|COMPLETED|Overall Study||128
1655995|NCT00705718|4044330|P1|COMPLETED|Overall Study||37
1655996|NCT00705718|4044329|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
1655997|NCT00705718|4044330|P1|12 Month Follow up|Overall Study|2 Deaths|37
1655998|NCT00705718|4044329|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
1655999|NCT00705718|4044330|P1|6 Month Follow up|Overall Study|3 Deaths|40
1656000|NCT00705718|4044329|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
1656001|NCT00705718|4044330|P1|1 Month Follow up|Overall Study|1 Death|43
1656002|NCT00705718|4044329|P2|STARTED|Overall Study||150
1656003|NCT00705718|4044330|P1|STARTED|Overall Study||44
1656004|NCT00705679|4044351|P5|NOT COMPLETED|Overall Study||69
1656005|NCT00705679|4044352|P4|NOT COMPLETED|Overall Study||80
1656006|NCT00705679|4044353|P3|NOT COMPLETED|Overall Study||115
1656007|NCT00705679|4044354|P2|NOT COMPLETED|Overall Study||139
1656008|NCT00705679|4044355|P1|NOT COMPLETED|Overall Study||65
1656009|NCT00705679|4044351|P5|COMPLETED|Overall Study||934
1656010|NCT00705679|4044352|P4|COMPLETED|Overall Study||927
1656011|NCT00705679|4044353|P3|COMPLETED|Overall Study||894
1656012|NCT00705679|4044354|P2|COMPLETED|Overall Study||864
1656013|NCT00705679|4044355|P1|COMPLETED|Overall Study||942
1656014|NCT00705679|4044351|P5|STARTED|Overall Study||1003
1656015|NCT00705679|4044352|P4|STARTED|Overall Study||1007
1656016|NCT00705679|4044353|P3|STARTED|Overall Study||1009
1656017|NCT00705679|4044354|P2|STARTED|Overall Study||1003
1656018|NCT00705679|4044355|P1|STARTED|Overall Study||1007
1656019|NCT00705666|4044390|P1|NOT COMPLETED|Overall Study||339
1656020|NCT00705666|4044390|P1|COMPLETED|Overall Study||450
1656021|NCT00705666|4044390|P1|STARTED|Overall Study||789
1656022|NCT00705653|4044394|P1|NOT COMPLETED|Overall Study||0
1656023|NCT00705653|4044394|P1|COMPLETED|Overall Study||46
1656024|NCT00705653|4044394|P1|STARTED|Overall Study||46
1656025|NCT00705614|4044401|P2|NOT COMPLETED|Switch to Remicade||49
1656026|NCT00705614|4044402|P1|NOT COMPLETED|Switch to Remicade||0
1656027|NCT00705614|4044401|P2|COMPLETED|Switch to Remicade||249
1656028|NCT00705614|4044402|P1|COMPLETED|Switch to Remicade||0
1656029|NCT00705614|4044401|P2|STARTED|Switch to Remicade||298
1656030|NCT00705614|4044402|P1|STARTED|Switch to Remicade||0
1656031|NCT00705614|4044401|P2|NOT COMPLETED|Initial Intervention||321
1656032|NCT00705614|4044402|P1|NOT COMPLETED|Initial Intervention||518
1656033|NCT00705614|4044401|P2|COMPLETED|Initial Intervention||800
1656034|NCT00705614|4044402|P1|COMPLETED|Initial Intervention||1023
1656035|NCT00705614|4044401|P2|STARTED|Initial Intervention||1121
1656036|NCT00705614|4044402|P1|STARTED|Initial Intervention||1541
1656037|NCT00705575|4044451|P2|NOT COMPLETED|Overall Study||46
1656038|NCT00705575|4044452|P1|NOT COMPLETED|Overall Study||23
1656039|NCT00705575|4044451|P2|COMPLETED|Overall Study||293
1656040|NCT00705575|4044452|P1|COMPLETED|Overall Study||326
1656041|NCT00705575|4044451|P2|STARTED|Overall Study||339
1656042|NCT00705575|4044452|P1|STARTED|Overall Study||349
1656043|NCT00705536|4044466|P4|NOT COMPLETED|Completed Study||0
1656044|NCT00705536|4044467|P3|NOT COMPLETED|Completed Study||0
1656045|NCT00705536|4044468|P2|NOT COMPLETED|Completed Study||0
1656046|NCT00705536|4044469|P1|NOT COMPLETED|Completed Study||0
1656047|NCT00705536|4044466|P4|COMPLETED|Completed Study||6
1656048|NCT00705536|4044467|P3|COMPLETED|Completed Study||7
1656049|NCT00705536|4044468|P2|COMPLETED|Completed Study||6
1656050|NCT00705536|4044469|P1|COMPLETED|Completed Study||6
1656051|NCT00705536|4044466|P4|STARTED|Completed Study||6
1656052|NCT00705536|4044467|P3|STARTED|Completed Study||7
1656053|NCT00705536|4044468|P2|STARTED|Completed Study||6
1656054|NCT00705536|4044469|P1|STARTED|Completed Study||6
1656055|NCT00705536|4044466|P4|NOT COMPLETED|Start Period 2||0
1656056|NCT00705536|4044467|P3|NOT COMPLETED|Start Period 2||0
1656057|NCT00705536|4044468|P2|NOT COMPLETED|Start Period 2||0
1656058|NCT00705536|4044469|P1|NOT COMPLETED|Start Period 2||0
1656059|NCT00705536|4044466|P4|COMPLETED|Start Period 2||6
1656060|NCT00705536|4044467|P3|COMPLETED|Start Period 2||7
1656061|NCT00705536|4044468|P2|COMPLETED|Start Period 2||6
1656062|NCT00705536|4044469|P1|COMPLETED|Start Period 2||6
1656063|NCT00705536|4044466|P4|STARTED|Start Period 2||6
1656064|NCT00705536|4044467|P3|STARTED|Start Period 2||7
1656065|NCT00705536|4044468|P2|STARTED|Start Period 2||6
1656066|NCT00705536|4044469|P1|STARTED|Start Period 2||6
1656067|NCT00705536|4044466|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
1656068|NCT00705536|4044467|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
1656069|NCT00705536|4044468|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
1656070|NCT00705536|4044469|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
1656071|NCT00705536|4044466|P4|COMPLETED|Washout Period of at Least 6 Days||6
1656072|NCT00705536|4044467|P3|COMPLETED|Washout Period of at Least 6 Days||7
1656073|NCT00705536|4044468|P2|COMPLETED|Washout Period of at Least 6 Days||6
1656074|NCT00705536|4044469|P1|COMPLETED|Washout Period of at Least 6 Days||6
1656075|NCT00705536|4044466|P4|STARTED|Washout Period of at Least 6 Days||6
1656076|NCT00705536|4044467|P3|STARTED|Washout Period of at Least 6 Days||7
1656077|NCT00705536|4044468|P2|STARTED|Washout Period of at Least 6 Days||6
1656078|NCT00705536|4044469|P1|STARTED|Washout Period of at Least 6 Days||6
1656079|NCT00705536|4044466|P4|NOT COMPLETED|Start Period 1||1
1656080|NCT00705536|4044467|P3|NOT COMPLETED|Start Period 1||0
1656081|NCT00705536|4044468|P2|NOT COMPLETED|Start Period 1||0
1656082|NCT00705536|4044469|P1|NOT COMPLETED|Start Period 1||0
1656083|NCT00705536|4044466|P4|COMPLETED|Start Period 1||6
1656084|NCT00705536|4044467|P3|COMPLETED|Start Period 1||7
1656085|NCT00705536|4044468|P2|COMPLETED|Start Period 1||6
1656086|NCT00705536|4044469|P1|COMPLETED|Start Period 1||6
1656087|NCT00705536|4044466|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
1656088|NCT00705536|4044467|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
1656089|NCT00705536|4044468|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
1656090|NCT00705536|4044469|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
1656091|NCT00705536|4044466|P4|STARTED|Start Period 1||7
1656092|NCT00705536|4044467|P3|STARTED|Start Period 1||7
1656093|NCT00705536|4044468|P2|STARTED|Start Period 1||6
1656094|NCT00705536|4044469|P1|STARTED|Start Period 1||6
1656095|NCT00705523|4044530|P2|NOT COMPLETED|Overall Study||3
1656096|NCT00705523|4044531|P1|NOT COMPLETED|Overall Study||2
1656097|NCT00705523|4044530|P2|COMPLETED|Overall Study||18
1656098|NCT00705523|4044531|P1|COMPLETED|Overall Study||17
1656099|NCT00705523|4044530|P2|STARTED|Overall Study||21
1656100|NCT00705523|4044531|P1|STARTED|Overall Study||19
1656101|NCT00705484|4044541|P2|NOT COMPLETED|Overall Study||408
1656102|NCT00705484|4044542|P1|NOT COMPLETED|Overall Study||382
1656103|NCT00705484|4044541|P2|COMPLETED|Overall Study||772
1656104|NCT00705484|4044542|P1|COMPLETED|Overall Study||677
1656105|NCT00705484|4044541|P2|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
1656106|NCT00705484|4044542|P1|Follow-up Period|Overall Study||1059
1656107|NCT00705484|4044541|P2|STARTED|Overall Study|Number Enrolled|1180
1656108|NCT00705484|4044542|P1|STARTED|Overall Study|Number Enrolled|1059
1656109|NCT00705432|4044556|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
1656110|NCT00705432|4044557|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
1656111|NCT00705432|4044558|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
1656112|NCT00705432|4044559|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
1656113|NCT00705432|4044560|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
1656114|NCT00705432|4044561|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
1656115|NCT00705432|4044556|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
1656116|NCT00705432|4044557|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
1656117|NCT00705432|4044558|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
1656118|NCT00705432|4044559|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
1656119|NCT00705432|4044560|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
1656120|NCT00705432|4044561|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
1656121|NCT00705432|4044556|P6|STARTED|Follow-up Period (Upto Week 72)||53
1656122|NCT00705432|4044557|P5|STARTED|Follow-up Period (Upto Week 72)||44
1656123|NCT00705432|4044558|P4|STARTED|Follow-up Period (Upto Week 72)||42
1656124|NCT00705432|4044559|P3|STARTED|Follow-up Period (Upto Week 72)||291
1656125|NCT00705432|4044560|P2|STARTED|Follow-up Period (Upto Week 72)||295
1656126|NCT00705432|4044561|P1|STARTED|Follow-up Period (Upto Week 72)||278
1656127|NCT00705432|4044556|P6|NOT COMPLETED|Treatment Period||30
1656128|NCT00705432|4044557|P5|NOT COMPLETED|Treatment Period||28
1656129|NCT00705432|4044558|P4|NOT COMPLETED|Treatment Period||41
1656130|NCT00705432|4044559|P3|NOT COMPLETED|Treatment Period||121
1656131|NCT00705432|4044560|P2|NOT COMPLETED|Treatment Period||111
1656132|NCT00705432|4044561|P1|NOT COMPLETED|Treatment Period||163
1656133|NCT00705432|4044556|P6|COMPLETED|Treatment Period||25
1656134|NCT00705432|4044557|P5|COMPLETED|Treatment Period||24
1656135|NCT00705432|4044558|P4|COMPLETED|Treatment Period||11
1656136|NCT00705432|4044559|P3|COMPLETED|Treatment Period||190
1656137|NCT00705432|4044560|P2|COMPLETED|Treatment Period||205
1656138|NCT00705432|4044561|P1|COMPLETED|Treatment Period||148
1656139|NCT00705432|4044556|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
1656140|NCT00705432|4044557|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
1656141|NCT00705432|4044558|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
1656142|NCT00705432|4044559|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
1656143|NCT00705432|4044560|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
1656144|NCT00705432|4044561|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
1656145|NCT00705432|4044556|P6|STARTED|Treatment Period||55
1656146|NCT00705432|4044557|P5|STARTED|Treatment Period||52
1656147|NCT00705432|4044558|P4|STARTED|Treatment Period||52
1656148|NCT00705432|4044559|P3|STARTED|Treatment Period||311
1656149|NCT00705432|4044560|P2|STARTED|Treatment Period||316
1656150|NCT00705432|4044561|P1|STARTED|Treatment Period||311
1656151|NCT00705406|4044598|P2|NOT COMPLETED|Overall Study||5
1656152|NCT00705406|4044599|P1|NOT COMPLETED|Overall Study||4
1656153|NCT00705406|4044598|P2|COMPLETED|Overall Study||197
1656154|NCT00705406|4044599|P1|COMPLETED|Overall Study||199
1656155|NCT00705406|4044598|P2|STARTED|Overall Study||202
1656156|NCT00705406|4044599|P1|STARTED|Overall Study||203
1656157|NCT00705367|4044623|P2|NOT COMPLETED|Long-term Extension Period||0
1656158|NCT00705367|4044624|P1|NOT COMPLETED|Long-term Extension Period||9
1656159|NCT00705367|4044623|P2|COMPLETED|Long-term Extension Period||0
1656160|NCT00705367|4044624|P1|COMPLETED|Long-term Extension Period||0
1656161|NCT00705367|4044623|P2|STARTED|Long-term Extension Period||0
1656162|NCT00705367|4044624|P1|STARTED|Long-term Extension Period||9
1656163|NCT00705367|4044623|P2|NOT COMPLETED|Short-term Period||0
1656164|NCT00705367|4044624|P1|NOT COMPLETED|Short-term Period||0
1656165|NCT00705367|4044623|P2|COMPLETED|Short-term Period||3
1656166|NCT00705367|4044624|P1|COMPLETED|Short-term Period||6
1656167|NCT00705367|4044623|P2|STARTED|Short-term Period||3
1656168|NCT00705367|4044624|P1|STARTED|Short-term Period||6
1656169|NCT00705341|4044651|P4|NOT COMPLETED|Phase 2: Trial||4
1656170|NCT00705341|4044652|P3|NOT COMPLETED|Phase 2: Trial||7
1656171|NCT00705341|4044653|P2|NOT COMPLETED|Phase 2: Trial||0
1656172|NCT00705341|4044654|P1|NOT COMPLETED|Phase 2: Trial||0
1656173|NCT00705341|4044651|P4|COMPLETED|Phase 2: Trial||28
1656174|NCT00705341|4044652|P3|COMPLETED|Phase 2: Trial||23
1656175|NCT00705341|4044653|P2|COMPLETED|Phase 2: Trial||0
1656176|NCT00705341|4044654|P1|COMPLETED|Phase 2: Trial||0
1656177|NCT00705341|4044651|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
1656178|NCT00705341|4044652|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
1656179|NCT00705341|4044653|P2|STARTED|Phase 2: Trial||0
1656180|NCT00705341|4044654|P1|STARTED|Phase 2: Trial||0
1656181|NCT00705341|4044651|P4|NOT COMPLETED|Phase 1:Control Challenge||0
1656182|NCT00705341|4044652|P3|NOT COMPLETED|Phase 1:Control Challenge||0
1656183|NCT00705341|4044653|P2|NOT COMPLETED|Phase 1:Control Challenge||0
1656184|NCT00705341|4044654|P1|NOT COMPLETED|Phase 1:Control Challenge||0
1656185|NCT00705341|4044651|P4|COMPLETED|Phase 1:Control Challenge||0
1656186|NCT00705341|4044652|P3|COMPLETED|Phase 1:Control Challenge||0
1656187|NCT00705341|4044653|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
1656188|NCT00705341|4044654|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
1656189|NCT00705341|4044651|P4|STARTED|Phase 1:Control Challenge||0
1656190|NCT00705341|4044652|P3|STARTED|Phase 1:Control Challenge||0
1656191|NCT00705341|4044653|P2|STARTED|Phase 1:Control Challenge||93
1656192|NCT00705341|4044654|P1|STARTED|Phase 1:Control Challenge||126
1656193|NCT00705289|4044662|P1|NOT COMPLETED|Overall Study||131
1656194|NCT00705289|4044662|P1|COMPLETED|Overall Study||597
1656195|NCT00705289|4044662|P1|STARTED|Overall Study||728
1656196|NCT00705263|4044686|P1|NOT COMPLETED|Overall Study||2
1656197|NCT00705263|4044686|P1|COMPLETED|Overall Study||108
1656198|NCT00705263|4044686|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
1656199|NCT00705250|4044690|P1|NOT COMPLETED|Overall Study||2
1656200|NCT00705250|4044690|P1|COMPLETED|Overall Study||34
1656201|NCT00705250|4044690|P1|STARTED|Overall Study||36
1656202|NCT00705224|4044694|P1|NOT COMPLETED|Overall Study||11
1656203|NCT00705224|4044694|P1|COMPLETED|Overall Study||239
1656204|NCT00705224|4044694|P1|STARTED|Overall Study||250
1656205|NCT00705159|4044710|P4|NOT COMPLETED|Overall Study||4
1656206|NCT00705159|4044711|P3|NOT COMPLETED|Overall Study||5
1656207|NCT00705159|4044712|P2|NOT COMPLETED|Overall Study||2
1656208|NCT00705159|4044713|P1|NOT COMPLETED|Overall Study||0
1656209|NCT00705159|4044710|P4|COMPLETED|Overall Study||30
1656210|NCT00705159|4044711|P3|COMPLETED|Overall Study||29
1656211|NCT00705159|4044712|P2|COMPLETED|Overall Study||33
1656212|NCT00705159|4044713|P1|COMPLETED|Overall Study||34
1656213|NCT00705159|4044710|P4|STARTED|Overall Study||34
1656214|NCT00705159|4044711|P3|STARTED|Overall Study||34
1656215|NCT00705159|4044712|P2|STARTED|Overall Study||35
1656216|NCT00705159|4044713|P1|STARTED|Overall Study||34
1656217|NCT00705146|4044733|P2|NOT COMPLETED|Overall Study||1
1656218|NCT00705146|4044734|P1|NOT COMPLETED|Overall Study||1
1656219|NCT00705146|4044733|P2|COMPLETED|Overall Study||23
1656220|NCT00705146|4044734|P1|COMPLETED|Overall Study||31
1656221|NCT00705146|4044733|P2|STARTED|Overall Study||24
1656222|NCT00705146|4044734|P1|STARTED|Overall Study||32
1656223|NCT00705107|4044742|P1|NOT COMPLETED|Overall Study||49
1656224|NCT00705107|4044742|P1|COMPLETED|Overall Study||218
1656225|NCT00705107|4044742|P1|STARTED|Overall Study||267
1656226|NCT00705081|4044749|P2|NOT COMPLETED|Overall Study||0
1656227|NCT00705081|4044750|P1|NOT COMPLETED|Overall Study||0
1656228|NCT00705081|4044749|P2|COMPLETED|Overall Study||198
1656229|NCT00705081|4044750|P1|COMPLETED|Overall Study||255
1656230|NCT00705081|4044749|P2|STARTED|Overall Study||198
1656231|NCT00705081|4044750|P1|STARTED|Overall Study||255
1656232|NCT00705016|4044763|P3|NOT COMPLETED|Overall Study||58
1656233|NCT00705016|4044764|P2|NOT COMPLETED|Overall Study||58
1656234|NCT00705016|4044765|P1|NOT COMPLETED|Overall Study||60
1656235|NCT00705016|4044763|P3|COMPLETED|Overall Study||4
1656236|NCT00705016|4044764|P2|COMPLETED|Overall Study||2
1656237|NCT00705016|4044765|P1|COMPLETED|Overall Study||2
1656238|NCT00705016|4044763|P3|STARTED|Overall Study||62
1656239|NCT00705016|4044764|P2|STARTED|Overall Study||60
1656240|NCT00705016|4044765|P1|STARTED|Overall Study||62
1656241|NCT00705003|4044794|P3|NOT COMPLETED|Treated||3
1656242|NCT00705003|4044795|P2|NOT COMPLETED|Treated||6
1656243|NCT00705003|4044796|P1|NOT COMPLETED|Treated||13
1656244|NCT00705003|4044794|P3|COMPLETED|Treated||30
1656245|NCT00705003|4044795|P2|COMPLETED|Treated||28
1656246|NCT00705003|4044796|P1|COMPLETED|Treated||54
1656247|NCT00705003|4044794|P3|STARTED|Treated||33
1656248|NCT00705003|4044795|P2|STARTED|Treated||34
1656249|NCT00705003|4044796|P1|STARTED|Treated||67
1656250|NCT00705003|4044794|P3|NOT COMPLETED|Enrolled||1
1656251|NCT00705003|4044795|P2|NOT COMPLETED|Enrolled||3
1656252|NCT00705003|4044796|P1|NOT COMPLETED|Enrolled||4
1656253|NCT00705003|4044794|P3|COMPLETED|Enrolled||33
1656254|NCT00705003|4044795|P2|COMPLETED|Enrolled||34
1656255|NCT00705003|4044796|P1|COMPLETED|Enrolled||67
1656256|NCT00705003|4044794|P3|STARTED|Enrolled||34
1656257|NCT00705003|4044795|P2|STARTED|Enrolled||37
1656258|NCT00705003|4044796|P1|STARTED|Enrolled||71
1656259|NCT00704964|4044816|P1|NOT COMPLETED|Overall Study||328
1656260|NCT00704964|4044816|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
1656261|NCT00704964|4044816|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
1656262|NCT00704938|4044823|P2|NOT COMPLETED|Overall Study||0
1656263|NCT00704938|4044824|P1|NOT COMPLETED|Overall Study||0
1656264|NCT00704938|4044823|P2|COMPLETED|Overall Study||1
1656265|NCT00704938|4044824|P1|COMPLETED|Overall Study||2
1656266|NCT00704938|4044823|P2|STARTED|Overall Study||1
1656267|NCT00704938|4044824|P1|STARTED|Overall Study||2
1656268|NCT00704912|4044835|P3|NOT COMPLETED|Overall Study||7
1656269|NCT00704912|4044836|P2|NOT COMPLETED|Overall Study||4
1656270|NCT00704912|4044837|P1|NOT COMPLETED|Overall Study||6
1656271|NCT00704912|4044835|P3|COMPLETED|Overall Study||43
1656272|NCT00704912|4044836|P2|COMPLETED|Overall Study||45
1656273|NCT00704912|4044837|P1|COMPLETED|Overall Study||44
1656274|NCT00704912|4044835|P3|STARTED|Overall Study||50
1656275|NCT00704912|4044836|P2|STARTED|Overall Study||49
1656276|NCT00704912|4044837|P1|STARTED|Overall Study||50
1656277|NCT00704847|4044856|P2|NOT COMPLETED|Overall Study||170
1656278|NCT00704847|4044857|P1|NOT COMPLETED|Overall Study||221
1656279|NCT00704847|4044856|P2|COMPLETED|Overall Study||339
1656280|NCT00704847|4044857|P1|COMPLETED|Overall Study||300
1656281|NCT00704847|4044856|P2|STARTED|Overall Study||509
1656282|NCT00704847|4044857|P1|STARTED|Overall Study||521
1656283|NCT00704808|4044865|P1|NOT COMPLETED|Overall Study||131
1656284|NCT00704808|4044865|P1|COMPLETED|Overall Study||49
1656285|NCT00704808|4044865|P1|STARTED|Overall Study||180
1656286|NCT00704769|4044869|P1|NOT COMPLETED|Overall Study||0
1656287|NCT00704769|4044869|P1|COMPLETED|Overall Study||591
1656288|NCT00704769|4044869|P1|STARTED|Overall Study||591
1656289|NCT00704730|4044876|P2|NOT COMPLETED|Overall Study||96
1656290|NCT00704730|4044877|P1|NOT COMPLETED|Overall Study||121
1656291|NCT00704730|4044876|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
1656292|NCT00704730|4044877|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
1656293|NCT00704730|4044876|P2|STARTED|Overall Study|Randomized|111
1656294|NCT00704730|4044877|P1|STARTED|Overall Study|Randomized|219
1656295|NCT00704717|4044893|P1|NOT COMPLETED|Overall Study||0
1656296|NCT00704717|4044893|P1|COMPLETED|Overall Study||185
1656297|NCT00704717|4044893|P1|STARTED|Overall Study||185
1656298|NCT00704535|4044897|P1|NOT COMPLETED|Overall Study||146
1656299|NCT00704535|4044897|P1|COMPLETED|Overall Study||3959
1656300|NCT00704535|4044897|P1|STARTED|Overall Study||4105
1656301|NCT00704522|4044910|P2|NOT COMPLETED|Overall Study||45
1656302|NCT00704522|4044911|P1|NOT COMPLETED|Overall Study||183
1656303|NCT00704522|4044910|P2|COMPLETED|Overall Study||75
1656304|NCT00704522|4044911|P1|COMPLETED|Overall Study||298
1656305|NCT00704522|4044910|P2|STARTED|Overall Study||120
1656306|NCT00704522|4044911|P1|STARTED|Overall Study||481
1656307|NCT00704496|4044920|P2|NOT COMPLETED|Overall Study||0
1656308|NCT00704496|4044921|P1|NOT COMPLETED|Overall Study||0
1656309|NCT00704496|4044920|P2|COMPLETED|Overall Study||0
1656310|NCT00704496|4044921|P1|COMPLETED|Overall Study||0
1656311|NCT00704496|4044920|P2|STARTED|Overall Study||0
1656312|NCT00704496|4044921|P1|STARTED|Overall Study||0
1656313|NCT00704418|4044931|P2|NOT COMPLETED|Overall Study||6
1656314|NCT00704418|4044932|P1|NOT COMPLETED|Overall Study||5
1656315|NCT00704418|4044931|P2|COMPLETED|Overall Study||72
1656316|NCT00704418|4044932|P1|COMPLETED|Overall Study||73
1656317|NCT00704418|4044931|P2|STARTED|Overall Study||78
1656318|NCT00704418|4044932|P1|STARTED|Overall Study||78
1656319|NCT00704405|4044945|P5|NOT COMPLETED|Overall Study (C Population)||0
1656320|NCT00704405|4044946|P4|NOT COMPLETED|Overall Study (C Population)||1
1656321|NCT00704405|4044947|P3|NOT COMPLETED|Overall Study (C Population)||1
1656322|NCT00704405|4044948|P2|NOT COMPLETED|Overall Study (C Population)||3
1656323|NCT00704405|4044949|P1|NOT COMPLETED|Overall Study (C Population)||1
1656324|NCT00704405|4044945|P5|COMPLETED|Overall Study (C Population)||14
1656325|NCT00704405|4044946|P4|COMPLETED|Overall Study (C Population)||14
1656326|NCT00704405|4044947|P3|COMPLETED|Overall Study (C Population)||14
1656327|NCT00704405|4044948|P2|COMPLETED|Overall Study (C Population)||11
1656328|NCT00704405|4044949|P1|COMPLETED|Overall Study (C Population)||15
1656329|NCT00704405|4044945|P5|STARTED|Overall Study (C Population)||14
1656330|NCT00704405|4044946|P4|STARTED|Overall Study (C Population)||15
1656331|NCT00704405|4044947|P3|STARTED|Overall Study (C Population)||15
1656332|NCT00704405|4044948|P2|STARTED|Overall Study (C Population)||14
1656333|NCT00704405|4044949|P1|STARTED|Overall Study (C Population)||16
1656334|NCT00704405|4044945|P5|NOT COMPLETED|Overall Study (NC Population)||5
1656335|NCT00704405|4044946|P4|NOT COMPLETED|Overall Study (NC Population)||4
1656336|NCT00704405|4044947|P3|NOT COMPLETED|Overall Study (NC Population)||3
1656337|NCT00704405|4044948|P2|NOT COMPLETED|Overall Study (NC Population)||4
1656338|NCT00704405|4044949|P1|NOT COMPLETED|Overall Study (NC Population)||5
1656339|NCT00704405|4044945|P5|COMPLETED|Overall Study (NC Population)||37
1656340|NCT00704405|4044946|P4|COMPLETED|Overall Study (NC Population)||38
1656341|NCT00704405|4044947|P3|COMPLETED|Overall Study (NC Population)||38
1656342|NCT00704405|4044948|P2|COMPLETED|Overall Study (NC Population)||40
1656343|NCT00704405|4044949|P1|COMPLETED|Overall Study (NC Population)||37
1656344|NCT00704405|4044945|P5|STARTED|Overall Study (NC Population)||42
1656345|NCT00704405|4044946|P4|STARTED|Overall Study (NC Population)||42
1656346|NCT00704405|4044947|P3|STARTED|Overall Study (NC Population)||41
1656347|NCT00704405|4044948|P2|STARTED|Overall Study (NC Population)||44
1656348|NCT00704405|4044949|P1|STARTED|Overall Study (NC Population)||42
1656349|NCT00704379|4044979|P2|NOT COMPLETED|Overall Study||7
1656350|NCT00704379|4044980|P1|NOT COMPLETED|Overall Study||7
1656351|NCT00704379|4044979|P2|COMPLETED|Overall Study||41
1656352|NCT00704379|4044980|P1|COMPLETED|Overall Study||39
1656353|NCT00704379|4044979|P2|STARTED|Overall Study||48
1656354|NCT00704379|4044980|P1|STARTED|Overall Study||46
1656355|NCT00704353|4044998|P2|NOT COMPLETED|Overall Study||114
1656356|NCT00704353|4044999|P1|NOT COMPLETED|Overall Study||98
1656357|NCT00704353|4044998|P2|COMPLETED|Overall Study||255
1656358|NCT00704353|4044999|P1|COMPLETED|Overall Study||268
1656359|NCT00704353|4044998|P2|STARTED|Overall Study||369
1656360|NCT00704353|4044999|P1|STARTED|Overall Study||366
1656361|NCT00704340|4045007|P2|NOT COMPLETED|Overall Study||2
1656362|NCT00704340|4045008|P1|NOT COMPLETED|Overall Study||2
1656363|NCT00704340|4045007|P2|COMPLETED|Overall Study||115
1656364|NCT00704340|4045008|P1|COMPLETED|Overall Study||118
1656365|NCT00704340|4045007|P2|STARTED|Overall Study||117
1656366|NCT00704340|4045008|P1|STARTED|Overall Study||120
1656367|NCT00704184|4045023|P5|NOT COMPLETED|Open-Label Treatment||3
1656368|NCT00704184|4045024|P4|NOT COMPLETED|Open-Label Treatment||5
1656369|NCT00704184|4045025|P3|NOT COMPLETED|Open-Label Treatment||4
1656370|NCT00704184|4045026|P2|NOT COMPLETED|Open-Label Treatment||2
1656371|NCT00704184|4045027|P1|NOT COMPLETED|Open-Label Treatment||1
1656372|NCT00704184|4045023|P5|COMPLETED|Open-Label Treatment||16
1656373|NCT00704184|4045024|P4|COMPLETED|Open-Label Treatment||13
1656374|NCT00704184|4045025|P3|COMPLETED|Open-Label Treatment||16
1656375|NCT00704184|4045026|P2|COMPLETED|Open-Label Treatment||16
1656376|NCT00704184|4045027|P1|COMPLETED|Open-Label Treatment||18
1656377|NCT00704184|4045023|P5|STARTED|Open-Label Treatment||19
1656378|NCT00704184|4045024|P4|STARTED|Open-Label Treatment||18
1656379|NCT00704184|4045025|P3|STARTED|Open-Label Treatment||20
1656380|NCT00704184|4045026|P2|STARTED|Open-Label Treatment||18
1656381|NCT00704184|4045027|P1|STARTED|Open-Label Treatment||19
1656382|NCT00704184|4045023|P5|NOT COMPLETED|Double-Blind Treatment||0
1656383|NCT00704184|4045024|P4|NOT COMPLETED|Double-Blind Treatment||0
1656384|NCT00704184|4045025|P3|NOT COMPLETED|Double-Blind Treatment||0
1656385|NCT00704184|4045026|P2|NOT COMPLETED|Double-Blind Treatment||0
1656386|NCT00704184|4045027|P1|NOT COMPLETED|Double-Blind Treatment||1
1656387|NCT00704184|4045023|P5|COMPLETED|Double-Blind Treatment||19
1656388|NCT00704184|4045024|P4|COMPLETED|Double-Blind Treatment||18
1656389|NCT00704184|4045025|P3|COMPLETED|Double-Blind Treatment||20
1656390|NCT00704184|4045026|P2|COMPLETED|Double-Blind Treatment||18
1656391|NCT00704184|4045027|P1|COMPLETED|Double-Blind Treatment||19
1656392|NCT00704184|4045023|P5|Treated|Double-Blind Treatment||19
1656393|NCT00704184|4045024|P4|Treated|Double-Blind Treatment||18
1656394|NCT00704184|4045025|P3|Treated|Double-Blind Treatment||20
1656395|NCT00704184|4045026|P2|Treated|Double-Blind Treatment||18
1656396|NCT00704184|4045027|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
1656397|NCT00704184|4045023|P5|STARTED|Double-Blind Treatment||19
1656398|NCT00704184|4045024|P4|STARTED|Double-Blind Treatment||18
1656399|NCT00704184|4045025|P3|STARTED|Double-Blind Treatment||20
1656400|NCT00704184|4045026|P2|STARTED|Double-Blind Treatment||18
1656401|NCT00704184|4045027|P1|STARTED|Double-Blind Treatment||20
1656402|NCT00704171|4045066|P2|NOT COMPLETED|Overall Study||0
1656403|NCT00704171|4045067|P1|NOT COMPLETED|Overall Study||1
1656404|NCT00704171|4045066|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
1656405|NCT00704171|4045067|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
1656406|NCT00704171|4045066|P2|STARTED|Overall Study||59
1656407|NCT00704171|4045067|P1|STARTED|Overall Study||62
1656408|NCT00704132|4045085|P2|NOT COMPLETED|Overall Study||2
1656409|NCT00704132|4045086|P1|NOT COMPLETED|Overall Study||1
1656410|NCT00704132|4045085|P2|COMPLETED|Overall Study||22
1656411|NCT00704132|4045086|P1|COMPLETED|Overall Study||25
1656412|NCT00704132|4045085|P2|STARTED|Overall Study||24
1656413|NCT00704132|4045086|P1|STARTED|Overall Study||26
1656414|NCT00704028|4045094|P2|NOT COMPLETED|Overall Study||21
1656415|NCT00704028|4045095|P1|NOT COMPLETED|Overall Study||12
1656416|NCT00704028|4045094|P2|COMPLETED|Overall Study||57
1656417|NCT00704028|4045095|P1|COMPLETED|Overall Study||70
1656418|NCT00704028|4045094|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
1656419|NCT00704028|4045095|P1|STARTED|Overall Study||82
1656420|NCT00703976|4045103|P2|NOT COMPLETED|Overall Study||0
1656421|NCT00703976|4045104|P1|NOT COMPLETED|Overall Study||0
1656422|NCT00703976|4045103|P2|COMPLETED|Overall Study||41
1656423|NCT00703976|4045104|P1|COMPLETED|Overall Study||37
1656424|NCT00703976|4045103|P2|STARTED|Overall Study||41
1656425|NCT00703976|4045104|P1|STARTED|Overall Study||37
1656426|NCT00703963|4045114|P2|NOT COMPLETED|Overall Study||14
1656427|NCT00703963|4045115|P1|NOT COMPLETED|Overall Study||7
1656428|NCT00703963|4045114|P2|COMPLETED|Overall Study||86
1656429|NCT00703963|4045115|P1|COMPLETED|Overall Study||93
1656430|NCT00703963|4045114|P2|STARTED|Overall Study||100
1656431|NCT00703963|4045115|P1|STARTED|Overall Study||100
1656432|NCT00703937|4045127|P2|NOT COMPLETED|Overall Study||93
1656433|NCT00703937|4045128|P1|NOT COMPLETED|Overall Study||65
1656434|NCT00703937|4045127|P2|COMPLETED|Overall Study||267
1656435|NCT00703937|4045128|P1|COMPLETED|Overall Study||278
1656436|NCT00703937|4045127|P2|STARTED|Overall Study||360
1656437|NCT00703937|4045128|P1|STARTED|Overall Study||343
1656438|NCT00703924|4045136|P2|NOT COMPLETED|Overall Study||1
1656439|NCT00703924|4045137|P1|NOT COMPLETED|Overall Study||1
1656440|NCT00703924|4045136|P2|COMPLETED|Overall Study||41
1656441|NCT00703924|4045137|P1|COMPLETED|Overall Study||49
1656442|NCT00703924|4045136|P2|STARTED|Overall Study||42
1656443|NCT00703924|4045137|P1|STARTED|Overall Study||50
1656444|NCT00703911|4045153|P1|NOT COMPLETED|Overall Study||10
1656445|NCT00703911|4045153|P1|COMPLETED|Overall Study||92
1656446|NCT00703911|4045153|P1|STARTED|Overall Study||102
1656447|NCT00703885|4045181|P1|NOT COMPLETED|Overall Study||0
1656448|NCT00703885|4045181|P1|COMPLETED|Overall Study||16
1656449|NCT00703885|4045181|P1|STARTED|Overall Study||16
1656450|NCT00703846|4045186|P1|NOT COMPLETED|Overall Study||137
1656451|NCT00703846|4045186|P1|COMPLETED|Overall Study||363
1656452|NCT00703846|4045186|P1|STARTED|Overall Study||500
1656453|NCT00703820|4045202|P2|NOT COMPLETED|Overall Study||34
1656454|NCT00703820|4045203|P1|NOT COMPLETED|Overall Study||35
1656455|NCT00703820|4045202|P2|COMPLETED|Overall Study||95
1656456|NCT00703820|4045203|P1|COMPLETED|Overall Study||98
1656457|NCT00703820|4045202|P2|STARTED|Overall Study||129
1656458|NCT00703820|4045203|P1|STARTED|Overall Study||133
1656459|NCT00703781|4045212|P2|NOT COMPLETED|Overall Study||2
1656460|NCT00703781|4045213|P1|NOT COMPLETED|Overall Study||2
1656461|NCT00703781|4045212|P2|COMPLETED|Overall Study||61
1656462|NCT00703781|4045213|P1|COMPLETED|Overall Study||61
1656463|NCT00703781|4045212|P2|STARTED|Overall Study||63
1656464|NCT00703781|4045213|P1|STARTED|Overall Study||63
1656465|NCT00703729|4045223|P2|NOT COMPLETED|Overall Study||3
1656466|NCT00703729|4045224|P1|NOT COMPLETED|Overall Study||0
1656467|NCT00703729|4045223|P2|COMPLETED|Overall Study||21
1656468|NCT00703729|4045224|P1|COMPLETED|Overall Study||25
1656469|NCT00703729|4045223|P2|STARTED|Overall Study||24
1656470|NCT00703729|4045224|P1|STARTED|Overall Study||25
1656471|NCT00703677|4045258|P1|NOT COMPLETED|Overall Study||3
1656472|NCT00703677|4045258|P1|COMPLETED|Overall Study||14
1656473|NCT00703677|4045258|P1|STARTED|Overall Study||17
1656474|NCT00703664|4045274|P3|NOT COMPLETED|Overall Study||0
1656475|NCT00703664|4045275|P2|NOT COMPLETED|Overall Study||0
1656476|NCT00703664|4045276|P1|NOT COMPLETED|Overall Study||0
1656477|NCT00703664|4045274|P3|COMPLETED|Overall Study||39
1656478|NCT00703664|4045275|P2|COMPLETED|Overall Study||4
1656479|NCT00703664|4045276|P1|COMPLETED|Overall Study||22
1656480|NCT00703664|4045274|P3|STARTED|Overall Study||39
1656481|NCT00703664|4045275|P2|STARTED|Overall Study||4
1656482|NCT00703664|4045276|P1|STARTED|Overall Study||22
1656483|NCT00703534|4045298|P2|NOT COMPLETED|Overall Study||25
1656484|NCT00703534|4045299|P1|NOT COMPLETED|Overall Study||30
1656485|NCT00703534|4045298|P2|COMPLETED|Overall Study||218
1656486|NCT00703534|4045299|P1|COMPLETED|Overall Study||205
1656487|NCT00703534|4045298|P2|STARTED|Overall Study||243
1656488|NCT00703534|4045299|P1|STARTED|Overall Study||235
1656489|NCT00703508|4045305|P1|NOT COMPLETED|Overall Study||0
1656490|NCT00703508|4045305|P1|COMPLETED|Overall Study||26
1656491|NCT00703508|4045305|P1|STARTED|Overall Study||26
1656492|NCT00703391|4045319|P2|NOT COMPLETED|Overall Study||0
1656493|NCT00703391|4045320|P1|NOT COMPLETED|Overall Study||0
1656494|NCT00703391|4045319|P2|COMPLETED|Overall Study||6
1656495|NCT00703391|4045320|P1|COMPLETED|Overall Study||12
1656496|NCT00703391|4045319|P2|STARTED|Overall Study||6
1656497|NCT00703391|4045320|P1|STARTED|Overall Study||12
1656498|NCT00703339|4045364|P1|NOT COMPLETED|Overall Study||0
1656499|NCT00703339|4045364|P1|COMPLETED|Overall Study||1
1656500|NCT00703339|4045364|P1|STARTED|Overall Study||1
1656501|NCT00703326|4045371|P2|NOT COMPLETED|Overall Study||225
1656502|NCT00703326|4045372|P1|NOT COMPLETED|Overall Study||447
1656503|NCT00703326|4045371|P2|COMPLETED|Overall Study||160
1656504|NCT00703326|4045372|P1|COMPLETED|Overall Study||312
1656505|NCT00703326|4045371|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
1656506|NCT00703326|4045372|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
1656507|NCT00703326|4045371|P2|STARTED|Overall Study||385
1656508|NCT00703326|4045372|P1|STARTED|Overall Study||759
1656509|NCT00703261|4045394|P2|NOT COMPLETED|Overall Study||6
1656510|NCT00703261|4045395|P1|NOT COMPLETED|Overall Study||6
1656511|NCT00703261|4045394|P2|COMPLETED|Overall Study||35
1656512|NCT00703261|4045395|P1|COMPLETED|Overall Study||36
1656513|NCT00703261|4045394|P2|STARTED|Overall Study||41
1656514|NCT00703261|4045395|P1|STARTED|Overall Study||42
1656515|NCT00703157|4045404|P2|NOT COMPLETED|Overall Study||2
1656516|NCT00703157|4045405|P1|NOT COMPLETED|Overall Study||4
1656517|NCT00703157|4045404|P2|COMPLETED|Overall Study||24
1656518|NCT00703157|4045405|P1|COMPLETED|Overall Study||22
1656519|NCT00703157|4045404|P2|24 Months FU|Overall Study||24
1656520|NCT00703157|4045405|P1|24 Months FU|Overall Study||22
1656521|NCT00703157|4045404|P2|6 Months FU|Overall Study||25
1656522|NCT00703157|4045405|P1|6 Months FU|Overall Study||25
1656523|NCT00703157|4045404|P2|STARTED|Overall Study||26
1656524|NCT00703157|4045405|P1|STARTED|Overall Study||26
1656525|NCT00703118|4045439|P3|NOT COMPLETED|Overall Study||22
1656526|NCT00703118|4045440|P2|NOT COMPLETED|Overall Study||16
1656527|NCT00703118|4045441|P1|NOT COMPLETED|Overall Study||21
1656528|NCT00703118|4045439|P3|COMPLETED|Overall Study||110
1656529|NCT00703118|4045440|P2|COMPLETED|Overall Study||248
1656530|NCT00703118|4045441|P1|COMPLETED|Overall Study||245
1656531|NCT00703118|4045439|P3|STARTED|Overall Study||132
1656532|NCT00703118|4045440|P2|STARTED|Overall Study||264
1656533|NCT00703118|4045441|P1|STARTED|Overall Study||266
1656534|NCT00703092|4045472|P1|NOT COMPLETED|Overall Study||2
1656535|NCT00703092|4045472|P1|COMPLETED|Overall Study||0
1656536|NCT00703092|4045472|P1|STARTED|Overall Study||2
1656537|NCT00703053|4045486|P9|NOT COMPLETED|Overall Study||1
1656538|NCT00703053|4045487|P8|NOT COMPLETED|Overall Study||6
1656539|NCT00703053|4045488|P7|NOT COMPLETED|Overall Study||7
1656540|NCT00703053|4045489|P6|NOT COMPLETED|Overall Study||6
1656541|NCT00703053|4045490|P5|NOT COMPLETED|Overall Study||1
1656542|NCT00703053|4045491|P4|NOT COMPLETED|Overall Study||3
1656543|NCT00703053|4045492|P3|NOT COMPLETED|Overall Study||3
1656544|NCT00703053|4045493|P2|NOT COMPLETED|Overall Study||2
1656545|NCT00703053|4045494|P1|NOT COMPLETED|Overall Study||1
1656546|NCT00703053|4045486|P9|COMPLETED|Overall Study||102
1656547|NCT00703053|4045487|P8|COMPLETED|Overall Study||91
1656548|NCT00703053|4045488|P7|COMPLETED|Overall Study||45
1656549|NCT00703053|4045489|P6|COMPLETED|Overall Study||43
1656550|NCT00703053|4045490|P5|COMPLETED|Overall Study||50
1656551|NCT00703053|4045491|P4|COMPLETED|Overall Study||46
1656552|NCT00703053|4045492|P3|COMPLETED|Overall Study||48
1656553|NCT00703053|4045493|P2|COMPLETED|Overall Study||24
1656554|NCT00703053|4045494|P1|COMPLETED|Overall Study||26
1656555|NCT00703053|4045486|P9|STARTED|Overall Study||103
1656556|NCT00703053|4045487|P8|STARTED|Overall Study||97
1656557|NCT00703053|4045488|P7|STARTED|Overall Study||52
1656558|NCT00703053|4045489|P6|STARTED|Overall Study||49
1656559|NCT00703053|4045490|P5|STARTED|Overall Study||51
1656560|NCT00703053|4045491|P4|STARTED|Overall Study||49
1656561|NCT00703053|4045492|P3|STARTED|Overall Study||51
1656562|NCT00703053|4045493|P2|STARTED|Overall Study||26
1656563|NCT00703053|4045494|P1|STARTED|Overall Study||27
1656564|NCT00703014|4045680|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
1656565|NCT00703014|4045681|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
1656566|NCT00703014|4045682|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1656567|NCT00703014|4045683|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1656568|NCT00703014|4045680|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
1656569|NCT00703014|4045681|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
1656570|NCT00703014|4045682|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1656571|NCT00703014|4045683|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1656572|NCT00703014|4045680|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
1656573|NCT00703014|4045681|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
1656574|NCT00703014|4045682|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
1656575|NCT00703014|4045683|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
1656576|NCT00703014|4045680|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
1656577|NCT00703014|4045681|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
1656578|NCT00703014|4045682|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
1656579|NCT00703014|4045683|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
1656580|NCT00703014|4045680|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
1656581|NCT00703014|4045681|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
1656582|NCT00703014|4045682|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
1656583|NCT00703014|4045683|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
1656584|NCT00703014|4045680|P4|COMPLETED|Mothers Follow Up Trial P05712||0
1656585|NCT00703014|4045681|P3|COMPLETED|Mothers Follow Up Trial P05712||0
1656586|NCT00703014|4045682|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
1656587|NCT00703014|4045683|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
1656588|NCT00703014|4045680|P4|STARTED|Mothers Follow Up Trial P05712||0
1656589|NCT00703014|4045681|P3|STARTED|Mothers Follow Up Trial P05712||0
1656590|NCT00703014|4045682|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
1656591|NCT00703014|4045683|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
1656592|NCT00703014|4045680|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1656593|NCT00703014|4045681|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1656594|NCT00703014|4045682|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
1656595|NCT00703014|4045683|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
1656596|NCT00703014|4045680|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1656597|NCT00703014|4045681|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1656598|NCT00703014|4045682|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
1656599|NCT00703014|4045683|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
1656600|NCT00703014|4045680|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
1656601|NCT00703014|4045681|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
1656602|NCT00703014|4045682|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
1656603|NCT00703014|4045683|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
1656604|NCT00703014|4045680|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
1656605|NCT00703014|4045681|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
1656606|NCT00703014|4045682|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
1656607|NCT00703014|4045683|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
1656608|NCT00703014|4045680|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
1656609|NCT00703014|4045681|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
1656610|NCT00703014|4045682|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
1656611|NCT00703014|4045683|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
1656612|NCT00702962|4045703|P2|NOT COMPLETED|Overall Study||1
1656613|NCT00702962|4045704|P1|NOT COMPLETED|Overall Study||1
1656614|NCT00702962|4045703|P2|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
1656615|NCT00702962|4045704|P1|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
1656616|NCT00702962|4045703|P2|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
1656617|NCT00702962|4045704|P1|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
1656618|NCT00702949|4045715|P3|NOT COMPLETED|Overall Study||8
1656619|NCT00702949|4045716|P2|NOT COMPLETED|Overall Study||9
1656620|NCT00702949|4045717|P1|NOT COMPLETED|Overall Study||5
1656621|NCT00702949|4045715|P3|COMPLETED|Overall Study||54
1656622|NCT00702949|4045716|P2|COMPLETED|Overall Study||57
1656623|NCT00702949|4045717|P1|COMPLETED|Overall Study||58
1656624|NCT00702949|4045715|P3|Evaluable for Primary Endpoint|Overall Study||51
1656625|NCT00702949|4045716|P2|Evaluable for Primary Endpoint|Overall Study||56
1656626|NCT00702949|4045717|P1|Evaluable for Primary Endpoint|Overall Study||56
1656627|NCT00702949|4045715|P3|STARTED|Overall Study||62
1656628|NCT00702949|4045716|P2|STARTED|Overall Study||66
1656629|NCT00702949|4045717|P1|STARTED|Overall Study||63
1656630|NCT00702923|4045742|P1|NOT COMPLETED|Overall Study||1
1656631|NCT00702923|4045742|P1|COMPLETED|Overall Study||11
1656632|NCT00702923|4045742|P1|STARTED|Overall Study||12
1656633|NCT00702884|4045751|P1|NOT COMPLETED|Overall Study||0
1656634|NCT00702884|4045751|P1|COMPLETED|Overall Study||25
1656635|NCT00702884|4045751|P1|STARTED|Overall Study||25
1656636|NCT00702845|4045765|P2|NOT COMPLETED|Overall Study||8
1656637|NCT00702845|4045766|P1|NOT COMPLETED|Overall Study||22
1656638|NCT00702845|4045765|P2|COMPLETED|Overall Study||121
1656639|NCT00702845|4045766|P1|COMPLETED|Overall Study||246
1656640|NCT00702845|4045765|P2|Randomized|Overall Study||128
1656641|NCT00702845|4045766|P1|Randomized|Overall Study||268
1656642|NCT00702845|4045765|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
1656643|NCT00702845|4045766|P1|STARTED|Overall Study||268
1656644|NCT00702780|4045806|P2|NOT COMPLETED|Overall Study||8
1656645|NCT00702780|4045807|P1|NOT COMPLETED|Overall Study||9
1656646|NCT00702780|4045806|P2|COMPLETED|Overall Study||29
1656647|NCT00702780|4045807|P1|COMPLETED|Overall Study||28
1656648|NCT00702780|4045806|P2|STARTED|Overall Study||37
1656649|NCT00702780|4045807|P1|STARTED|Overall Study||37
1656650|NCT00702754|4045815|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
1656651|NCT00702754|4045815|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
1656652|NCT00702754|4045815|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
1656653|NCT00702754|4045815|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
1656654|NCT00702754|4045815|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
1656655|NCT00702754|4045815|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
1656656|NCT00702754|4045815|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
1656657|NCT00702754|4045815|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
1656658|NCT00702754|4045815|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
1656659|NCT00702754|4045815|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
1656660|NCT00702754|4045815|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
1656661|NCT00702754|4045815|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
1656662|NCT00702754|4045815|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
1656663|NCT00702754|4045815|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
1656664|NCT00702754|4045815|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
1656665|NCT00702754|4045815|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
1656666|NCT00702754|4045815|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
1656667|NCT00702754|4045815|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
1656668|NCT00702754|4045815|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
1656669|NCT00702754|4045815|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
1656670|NCT00702754|4045815|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
1656671|NCT00702754|4045815|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
1656672|NCT00702754|4045815|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
1656673|NCT00702754|4045815|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
1656674|NCT00702715|4045828|P2|NOT COMPLETED|Overall Study||0
1656675|NCT00702715|4045829|P1|NOT COMPLETED|Overall Study||1
1656676|NCT00702715|4045828|P2|COMPLETED|Overall Study||33
1656677|NCT00702715|4045829|P1|COMPLETED|Overall Study||34
1656678|NCT00702715|4045828|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
1656679|NCT00702715|4045829|P1|STARTED|Overall Study||35
1656680|NCT00702702|4045842|P1|NOT COMPLETED|Overall Study||56
1656681|NCT00702702|4045842|P1|COMPLETED|Overall Study||0
1656682|NCT00702702|4045842|P1|STARTED|Overall Study||56
1656683|NCT00702689|4045850|P1|NOT COMPLETED|Overall Study||6
1656684|NCT00702689|4045850|P1|COMPLETED|Overall Study||14
1656685|NCT00702689|4045850|P1|STARTED|Overall Study||20
1656686|NCT00702650|4045861|P1|NOT COMPLETED|Overall Study||20
1656687|NCT00702650|4045861|P1|COMPLETED|Overall Study||135
1656688|NCT00702650|4045861|P1|STARTED|Overall Study||155
1656689|NCT00702624|4045881|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
1656690|NCT00702624|4045882|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
1656691|NCT00702624|4045883|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
1656692|NCT00702624|4045884|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
1656693|NCT00702624|4045881|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
1656694|NCT00702624|4045882|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
1656695|NCT00702624|4045883|P2|COMPLETED|Fetuses/Infant Follow-up||0
1656696|NCT00702624|4045884|P1|COMPLETED|Fetuses/Infant Follow-up||0
1656697|NCT00702624|4045881|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
1656698|NCT00702624|4045882|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
1656699|NCT00702624|4045883|P2|Live Born Infants|Fetuses/Infant Follow-up||0
1656700|NCT00702624|4045884|P1|Live Born Infants|Fetuses/Infant Follow-up||0
1656701|NCT00702624|4045881|P4|STARTED|Fetuses/Infant Follow-up||55
1656702|NCT00702624|4045882|P3|STARTED|Fetuses/Infant Follow-up||88
1656703|NCT00702624|4045883|P2|STARTED|Fetuses/Infant Follow-up||0
1656704|NCT00702624|4045884|P1|STARTED|Fetuses/Infant Follow-up||0
1656705|NCT00702624|4045881|P4|NOT COMPLETED|Expectant Mother Follow-up||0
1656706|NCT00702624|4045882|P3|NOT COMPLETED|Expectant Mother Follow-up||0
1656707|NCT00702624|4045883|P2|NOT COMPLETED|Expectant Mother Follow-up||0
1656708|NCT00702624|4045884|P1|NOT COMPLETED|Expectant Mother Follow-up||7
1656709|NCT00702624|4045881|P4|COMPLETED|Expectant Mother Follow-up||0
1656710|NCT00702624|4045882|P3|COMPLETED|Expectant Mother Follow-up||0
1656711|NCT00702624|4045883|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
1656712|NCT00702624|4045884|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
1656713|NCT00702624|4045881|P4|STARTED|Expectant Mother Follow-up||0
1656714|NCT00702624|4045882|P3|STARTED|Expectant Mother Follow-up||0
1656715|NCT00702624|4045883|P2|STARTED|Expectant Mother Follow-up||45
1656716|NCT00702624|4045884|P1|STARTED|Expectant Mother Follow-up||68
1656717|NCT00702624|4045881|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
1656718|NCT00702624|4045882|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
1656719|NCT00702624|4045883|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
1656720|NCT00702624|4045884|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
1656721|NCT00702624|4045881|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
1656722|NCT00702624|4045882|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
1656723|NCT00702624|4045883|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
1656724|NCT00702624|4045884|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
1656725|NCT00702624|4045881|P4|STARTED|Base Study P05690 (NCT00702845)||0
1656726|NCT00702624|4045882|P3|STARTED|Base Study P05690 (NCT00702845)||0
1656727|NCT00702624|4045883|P2|STARTED|Base Study P05690 (NCT00702845)||128
1656728|NCT00702624|4045884|P1|STARTED|Base Study P05690 (NCT00702845)||268
1656729|NCT00702546|4045902|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
1656730|NCT00702546|4045903|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
1656731|NCT00702546|4045902|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
1656732|NCT00702546|4045903|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
1656733|NCT00702546|4045902|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
1656734|NCT00702546|4045903|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
1656735|NCT00702546|4045902|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
1656736|NCT00702546|4045903|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
1656737|NCT00702546|4045902|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
1656738|NCT00702546|4045903|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
1656739|NCT00702546|4045902|P2|STARTED|Base Study P05690 (NCT00702845)||128
1656740|NCT00702546|4045903|P1|STARTED|Base Study P05690 (NCT00702845)||268
1656741|NCT00702520|4045923|P4|NOT COMPLETED|Follow-up Study P05783||0
1656742|NCT00702520|4045924|P3|NOT COMPLETED|Follow-up Study P05783||0
1656743|NCT00702520|4045925|P2|NOT COMPLETED|Follow-up Study P05783||0
1656744|NCT00702520|4045926|P1|NOT COMPLETED|Follow-up Study P05783||0
1656745|NCT00702520|4045923|P4|COMPLETED|Follow-up Study P05783||11
1656746|NCT00702520|4045924|P3|COMPLETED|Follow-up Study P05783||8
1656747|NCT00702520|4045925|P2|COMPLETED|Follow-up Study P05783||8
1656748|NCT00702520|4045926|P1|COMPLETED|Follow-up Study P05783||7
1656749|NCT00702520|4045923|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
1656750|NCT00702520|4045924|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
1656751|NCT00702520|4045925|P2|STARTED|Follow-up Study P05783||8
1656752|NCT00702520|4045926|P1|STARTED|Follow-up Study P05783||7
1656753|NCT00702520|4045923|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
1656754|NCT00702520|4045924|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
1656755|NCT00702520|4045925|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
1656756|NCT00702520|4045926|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
1656757|NCT00702520|4045923|P4|COMPLETED|Base Study P05788 - Follow-Up||0
1656758|NCT00702520|4045924|P3|COMPLETED|Base Study P05788 - Follow-Up||0
1656759|NCT00702520|4045925|P2|COMPLETED|Base Study P05788 - Follow-Up||8
1656760|NCT00702520|4045926|P1|COMPLETED|Base Study P05788 - Follow-Up||7
1656761|NCT00702520|4045923|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
1656762|NCT00702520|4045924|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
1656763|NCT00702520|4045925|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
1656764|NCT00702520|4045926|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
1656765|NCT00702520|4045923|P4|STARTED|Base Study P05788 - Follow-Up||0
1656766|NCT00702520|4045924|P3|STARTED|Base Study P05788 - Follow-Up||0
1656767|NCT00702520|4045925|P2|STARTED|Base Study P05788 - Follow-Up||18
1656768|NCT00702520|4045926|P1|STARTED|Base Study P05788 - Follow-Up||22
1656769|NCT00702520|4045923|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
1656770|NCT00702520|4045924|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
1656771|NCT00702520|4045925|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
1656772|NCT00702520|4045926|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
1656773|NCT00702520|4045923|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
1656774|NCT00702520|4045924|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
1656775|NCT00702520|4045925|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
1656776|NCT00702520|4045926|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
1656777|NCT00702520|4045923|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
1656778|NCT00702520|4045924|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
1656779|NCT00702520|4045925|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
1656780|NCT00702520|4045926|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
1656781|NCT00702520|4045923|P4|STARTED|Base Study P05788 - Embryo Transfer||0
1656782|NCT00702520|4045924|P3|STARTED|Base Study P05788 - Embryo Transfer||0
1656783|NCT00702520|4045925|P2|STARTED|Base Study P05788 - Embryo Transfer||24
1656784|NCT00702520|4045926|P1|STARTED|Base Study P05788 - Embryo Transfer||25
1656785|NCT00702520|4045923|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
1656786|NCT00702520|4045924|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
1656787|NCT00702520|4045925|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
1656788|NCT00702520|4045926|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
1656789|NCT00702520|4045923|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
1656790|NCT00702520|4045924|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
1656791|NCT00702520|4045925|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
1656792|NCT00702520|4045926|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
1656793|NCT00702520|4045923|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
1656794|NCT00702520|4045924|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
1656795|NCT00702520|4045925|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
1656796|NCT00702520|4045926|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
1656797|NCT00702520|4045923|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
1656798|NCT00702520|4045924|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
1656799|NCT00702520|4045925|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
1656800|NCT00702520|4045926|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
1656801|NCT00702520|4045923|P4|STARTED|Base Study P05788 - Assigned Treatment||0
1656802|NCT00702520|4045924|P3|STARTED|Base Study P05788 - Assigned Treatment||0
1656803|NCT00702520|4045925|P2|STARTED|Base Study P05788 - Assigned Treatment||25
1656804|NCT00702520|4045926|P1|STARTED|Base Study P05788 - Assigned Treatment||25
1656805|NCT00702507|4045942|P1|NOT COMPLETED|Follow-up Phase||27
1656806|NCT00702507|4045942|P1|COMPLETED|Follow-up Phase||132
1656807|NCT00702507|4045942|P1|STARTED|Follow-up Phase||159
1656808|NCT00702507|4045942|P1|NOT COMPLETED|Initial Treatment Phase||41
1656809|NCT00702507|4045942|P1|COMPLETED|Initial Treatment Phase||159
1656810|NCT00702507|4045942|P1|STARTED|Initial Treatment Phase||200
1656811|NCT00702468|4045956|P2|NOT COMPLETED|Overall Study||16
1656812|NCT00702468|4045957|P1|NOT COMPLETED|Overall Study||3
1656813|NCT00702468|4045956|P2|COMPLETED|Overall Study||2
1656814|NCT00702468|4045957|P1|COMPLETED|Overall Study||15
1656815|NCT00702468|4045956|P2|STARTED|Overall Study||18
1656816|NCT00702468|4045957|P1|STARTED|Overall Study||18
1656817|NCT00702403|4045979|P1|NOT COMPLETED|From Engraftment to Study Completion||27
1656818|NCT00702403|4045979|P1|COMPLETED|From Engraftment to Study Completion||13
1656819|NCT00702403|4045979|P1|Patient Drop-outs|From Engraftment to Study Completion||27
1656820|NCT00702403|4045979|P1|STARTED|From Engraftment to Study Completion||40
1656821|NCT00702403|4045979|P1|NOT COMPLETED|From Consent to Engraftment||17
1656822|NCT00702403|4045979|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
1656823|NCT00702403|4045979|P1|Ineligible for Study Drug|From Consent to Engraftment||17
1656824|NCT00702403|4045979|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
1656825|NCT00702377|4045989|P2|NOT COMPLETED|Overall Study||3
1656826|NCT00702377|4045990|P1|NOT COMPLETED|Overall Study||1
1656827|NCT00702377|4045989|P2|COMPLETED|Overall Study||53
1656828|NCT00702377|4045990|P1|COMPLETED|Overall Study||52
1656829|NCT00702377|4045989|P2|STARTED|Overall Study||56
1656830|NCT00702377|4045990|P1|STARTED|Overall Study||53
1656831|NCT00702364|4046002|P2|NOT COMPLETED|Overall Study||4
1656832|NCT00702364|4046003|P1|NOT COMPLETED|Overall Study||2
1656833|NCT00702364|4046002|P2|COMPLETED|Overall Study||25
1656834|NCT00702364|4046003|P1|COMPLETED|Overall Study||24
1656835|NCT00702364|4046002|P2|STARTED|Overall Study||29
1656836|NCT00702364|4046003|P1|STARTED|Overall Study||26
1656837|NCT00702338|4046015|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
1656838|NCT00702338|4046016|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
1656839|NCT00702338|4046017|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
1656840|NCT00702338|4046015|P3|COMPLETED|Follow-up Study: Infant FU||0
1656841|NCT00702338|4046016|P2|COMPLETED|Follow-up Study: Infant FU||0
1656842|NCT00702338|4046017|P1|COMPLETED|Follow-up Study: Infant FU||0
1656843|NCT00702338|4046015|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
1656844|NCT00702338|4046016|P2|STARTED|Follow-up Study: Infant FU||0
1656845|NCT00702338|4046017|P1|STARTED|Follow-up Study: Infant FU||0
1656846|NCT00702338|4046015|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
1656847|NCT00702338|4046016|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
1656848|NCT00702338|4046017|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
1656849|NCT00702338|4046015|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
1656850|NCT00702338|4046016|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
1656851|NCT00702338|4046017|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
1656852|NCT00702338|4046015|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
1656853|NCT00702338|4046016|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
1656854|NCT00702338|4046017|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
1656855|NCT00702338|4046015|P3|NOT COMPLETED|Base Study (NCT00697255)||0
1656856|NCT00702338|4046016|P2|NOT COMPLETED|Base Study (NCT00697255)||2
1656857|NCT00702338|4046017|P1|NOT COMPLETED|Base Study (NCT00697255)||3
1656858|NCT00702338|4046015|P3|COMPLETED|Base Study (NCT00697255)||0
1656859|NCT00702338|4046016|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
1656860|NCT00702338|4046017|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
1656861|NCT00702338|4046015|P3|STARTED|Base Study (NCT00697255)||0
1656862|NCT00702338|4046016|P2|STARTED|Base Study (NCT00697255)||3
1656863|NCT00702338|4046017|P1|STARTED|Base Study (NCT00697255)||5
1656864|NCT00702325|4046033|P2|NOT COMPLETED|Overall Study||53
1656865|NCT00702325|4046034|P1|NOT COMPLETED|Overall Study||38
1656866|NCT00702325|4046033|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
1656867|NCT00702325|4046034|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
1656868|NCT00702325|4046033|P2|STARTED|Overall Study|Randomized|155
1656869|NCT00702325|4046034|P1|STARTED|Overall Study|Randomized|156
1656870|NCT00702299|4046086|P1|NOT COMPLETED|Overall Study||0
1656871|NCT00702299|4046086|P1|COMPLETED|Overall Study||15
1656872|NCT00702299|4046086|P1|STARTED|Overall Study||15
1656873|NCT00702273|4046099|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
1656874|NCT00702273|4046100|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
1656875|NCT00702273|4046099|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
1656876|NCT00702273|4046100|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
1656877|NCT00702273|4046099|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
1656878|NCT00702273|4046100|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
1656879|NCT00702273|4046099|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
1656880|NCT00702273|4046100|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
1656881|NCT00702273|4046099|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
1656882|NCT00702273|4046100|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
1656883|NCT00702273|4046099|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
1656884|NCT00702273|4046100|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
1656885|NCT00702273|4046099|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
1656886|NCT00702273|4046100|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
1656887|NCT00702234|4046118|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
1656888|NCT00702234|4046119|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
1656889|NCT00702234|4046118|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
1656890|NCT00702234|4046119|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
1656891|NCT00702234|4046118|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
1656892|NCT00702234|4046119|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
1656893|NCT00702234|4046118|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
1656894|NCT00702234|4046119|P1|STARTED|Follow-up Study: Fetuses/Infants||0
1656895|NCT00702234|4046118|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
1656896|NCT00702234|4046119|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
1656897|NCT00702234|4046118|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
1656898|NCT00702234|4046119|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
1656899|NCT00702234|4046118|P2|STARTED|Follow-up Study: Expectant Mothers||0
1656900|NCT00702234|4046119|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
1656901|NCT00702234|4046118|P2|NOT COMPLETED|Base Study (NCT00696878)||0
1656902|NCT00702234|4046119|P1|NOT COMPLETED|Base Study (NCT00696878)||504
1656903|NCT00702234|4046118|P2|COMPLETED|Base Study (NCT00696878)||0
1656904|NCT00702234|4046119|P1|COMPLETED|Base Study (NCT00696878)||178
1656905|NCT00702234|4046118|P2|STARTED|Base Study (NCT00696878)||0
1656906|NCT00702234|4046119|P1|STARTED|Base Study (NCT00696878)||682
1656907|NCT00702221|4046130|P2|NOT COMPLETED|Overall Study||3
1656908|NCT00702221|4046131|P1|NOT COMPLETED|Overall Study||4
1656909|NCT00702221|4046130|P2|COMPLETED|Overall Study||7
1656910|NCT00702221|4046131|P1|COMPLETED|Overall Study||6
1656911|NCT00702221|4046130|P2|STARTED|Overall Study||10
1656912|NCT00702221|4046131|P1|STARTED|Overall Study||10
1656913|NCT00702208|4046137|P1|NOT COMPLETED|Overall Study||31
1656914|NCT00702208|4046137|P1|COMPLETED|Overall Study||167
1656915|NCT00702208|4046137|P1|STARTED|Overall Study||198
1656916|NCT00702143|4046146|P3|NOT COMPLETED|Overall Study||1
1656917|NCT00702143|4046147|P2|NOT COMPLETED|Overall Study||0
1656918|NCT00702143|4046148|P1|NOT COMPLETED|Overall Study||0
1656919|NCT00702143|4046146|P3|COMPLETED|Overall Study||78
1656920|NCT00702143|4046147|P2|COMPLETED|Overall Study||60
1656921|NCT00702143|4046148|P1|COMPLETED|Overall Study||45
1656922|NCT00702143|4046146|P3|STARTED|Overall Study||79
1656923|NCT00702143|4046147|P2|STARTED|Overall Study||60
1656924|NCT00702143|4046148|P1|STARTED|Overall Study||45
1656925|NCT00701935|4046162|P2|NOT COMPLETED|Overall Study||11
1656926|NCT00701935|4046163|P1|NOT COMPLETED|Overall Study||16
1656927|NCT00701935|4046162|P2|COMPLETED|Overall Study||26
1656928|NCT00701935|4046163|P1|COMPLETED|Overall Study||27
1656929|NCT00701935|4046162|P2|STARTED|Overall Study||37
1656930|NCT00701935|4046163|P1|STARTED|Overall Study||43
1656931|NCT00701805|4046197|P4|NOT COMPLETED|Overall Study||4
1656932|NCT00701805|4046198|P3|NOT COMPLETED|Overall Study||7
1656933|NCT00701805|4046199|P2|NOT COMPLETED|Overall Study||4
1656934|NCT00701805|4046200|P1|NOT COMPLETED|Overall Study||3
1656935|NCT00701805|4046197|P4|COMPLETED|Overall Study||22
1656936|NCT00701805|4046198|P3|COMPLETED|Overall Study||16
1656937|NCT00701805|4046199|P2|COMPLETED|Overall Study||25
1656938|NCT00701805|4046200|P1|COMPLETED|Overall Study||23
1656939|NCT00701805|4046197|P4|STARTED|Overall Study||26
1656940|NCT00701805|4046198|P3|STARTED|Overall Study||23
1656941|NCT00701805|4046199|P2|STARTED|Overall Study||29
1656942|NCT00701805|4046200|P1|STARTED|Overall Study||26
1656943|NCT00701779|4046250|P1|NOT COMPLETED|Overall Study||9
1656944|NCT00701779|4046250|P1|COMPLETED|Overall Study||54
1656945|NCT00701779|4046250|P1|12 Month|Overall Study||54
1656946|NCT00701779|4046250|P1|9 Month|Overall Study||56
1656947|NCT00701779|4046250|P1|6 Month|Overall Study||58
1656948|NCT00701779|4046250|P1|3 Month|Overall Study||60
1656949|NCT00701779|4046250|P1|STARTED|Overall Study||63
1656950|NCT00701727|4046262|P2|NOT COMPLETED|Second Treatment Period||0
1656951|NCT00701727|4046263|P1|NOT COMPLETED|Second Treatment Period||2
1656952|NCT00701727|4046262|P2|COMPLETED|Second Treatment Period||13
1656953|NCT00701727|4046263|P1|COMPLETED|Second Treatment Period||13
1656954|NCT00701727|4046262|P2|STARTED|Second Treatment Period||13
1656955|NCT00701727|4046263|P1|STARTED|Second Treatment Period||15
1656956|NCT00701727|4046262|P2|NOT COMPLETED|First Treatment Period||2
1656957|NCT00701727|4046263|P1|NOT COMPLETED|First Treatment Period||1
1656958|NCT00701727|4046262|P2|COMPLETED|First Treatment Period||13
1656959|NCT00701727|4046263|P1|COMPLETED|First Treatment Period||15
1656960|NCT00701727|4046262|P2|STARTED|First Treatment Period||15
1656961|NCT00701727|4046263|P1|STARTED|First Treatment Period||16
1656962|NCT00701714|4046283|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
1656963|NCT00701714|4046284|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
1656964|NCT00701714|4046283|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
1656965|NCT00701714|4046284|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
1656966|NCT00701714|4046283|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
1656967|NCT00701714|4046284|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
1656968|NCT00701714|4046283|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
1656969|NCT00701714|4046284|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
1656970|NCT00701714|4046283|P2|COMPLETED|Treatment Period (up to 1 Year)||29
1656971|NCT00701714|4046284|P1|COMPLETED|Treatment Period (up to 1 Year)||37
1656972|NCT00701714|4046283|P2|STARTED|Treatment Period (up to 1 Year)||163
1656973|NCT00701714|4046284|P1|STARTED|Treatment Period (up to 1 Year)||174
1656974|NCT00701675|4046299|P3|NOT COMPLETED|Overall Study||7
1656975|NCT00701675|4046300|P2|NOT COMPLETED|Overall Study||8
1656976|NCT00701675|4046301|P1|NOT COMPLETED|Overall Study||4
1656977|NCT00701675|4046299|P3|COMPLETED|Overall Study||7
1656978|NCT00701675|4046300|P2|COMPLETED|Overall Study||6
1656979|NCT00701675|4046301|P1|COMPLETED|Overall Study||10
1656980|NCT00701675|4046299|P3|STARTED|Overall Study||14
1656981|NCT00701675|4046300|P2|STARTED|Overall Study||14
1656982|NCT00701675|4046301|P1|STARTED|Overall Study||14
1656983|NCT00701662|4046309|P1|NOT COMPLETED|Overall Study||1
1656984|NCT00701662|4046309|P1|COMPLETED|Overall Study||7
1656985|NCT00701662|4046309|P1|STARTED|Overall Study||8
1656986|NCT00701636|4046328|P2|NOT COMPLETED|Overall Study||0
1656987|NCT00701636|4046329|P1|NOT COMPLETED|Overall Study||0
1656988|NCT00701636|4046328|P2|COMPLETED|Overall Study||15
1656989|NCT00701636|4046329|P1|COMPLETED|Overall Study||15
1656990|NCT00701636|4046328|P2|STARTED|Overall Study||15
1656991|NCT00701636|4046329|P1|STARTED|Overall Study||15
1656992|NCT00701558|4046334|P1|NOT COMPLETED|Overall Study||15
1656993|NCT00701558|4046334|P1|COMPLETED|Overall Study||4
1656994|NCT00701558|4046334|P1|STARTED|Overall Study||19
1656995|NCT00701441|4046342|P2|NOT COMPLETED|Overall Study||4
1656996|NCT00701441|4046343|P1|NOT COMPLETED|Overall Study||0
1656997|NCT00701441|4046342|P2|COMPLETED|Overall Study||12
1656998|NCT00701441|4046343|P1|COMPLETED|Overall Study||9
1656999|NCT00701441|4046342|P2|STARTED|Overall Study||16
1657000|NCT00701441|4046343|P1|STARTED|Overall Study||9
1657001|NCT00701415|4046355|P2|NOT COMPLETED|Overall Study||1
1657002|NCT00701415|4046356|P1|NOT COMPLETED|Overall Study||1
1657003|NCT00701415|4046355|P2|COMPLETED|Overall Study||14
1657004|NCT00701415|4046356|P1|COMPLETED|Overall Study||15
1657005|NCT00701415|4046355|P2|STARTED|Overall Study||15
1657006|NCT00701415|4046356|P1|STARTED|Overall Study||16
1657007|NCT00701389|4046366|P4|NOT COMPLETED|Period 4||0
1657008|NCT00701389|4046367|P3|NOT COMPLETED|Period 4||0
1657009|NCT00701389|4046368|P2|NOT COMPLETED|Period 4||0
1657010|NCT00701389|4046369|P1|NOT COMPLETED|Period 4||0
1657011|NCT00701389|4046366|P4|COMPLETED|Period 4||6
1657012|NCT00701389|4046367|P3|COMPLETED|Period 4||6
1657013|NCT00701389|4046368|P2|COMPLETED|Period 4||6
1657014|NCT00701389|4046369|P1|COMPLETED|Period 4||6
1657015|NCT00701389|4046366|P4|STARTED|Period 4||6
1657016|NCT00701389|4046367|P3|STARTED|Period 4||6
1657017|NCT00701389|4046368|P2|STARTED|Period 4||6
1657018|NCT00701389|4046369|P1|STARTED|Period 4||6
1657019|NCT00701389|4046366|P4|NOT COMPLETED|Period 3||0
1657020|NCT00701389|4046367|P3|NOT COMPLETED|Period 3||0
1657021|NCT00701389|4046368|P2|NOT COMPLETED|Period 3||0
1657022|NCT00701389|4046369|P1|NOT COMPLETED|Period 3||0
1657023|NCT00701389|4046366|P4|COMPLETED|Period 3||6
1657024|NCT00701389|4046367|P3|COMPLETED|Period 3||6
1657025|NCT00701389|4046368|P2|COMPLETED|Period 3||6
1657026|NCT00701389|4046369|P1|COMPLETED|Period 3||6
1657027|NCT00701389|4046366|P4|STARTED|Period 3||6
1657028|NCT00701389|4046367|P3|STARTED|Period 3||6
1657029|NCT00701389|4046368|P2|STARTED|Period 3||6
1657030|NCT00701389|4046369|P1|STARTED|Period 3||6
1657031|NCT00701389|4046366|P4|NOT COMPLETED|Period 2||0
1657032|NCT00701389|4046367|P3|NOT COMPLETED|Period 2||0
1657033|NCT00701389|4046368|P2|NOT COMPLETED|Period 2||0
1657034|NCT00701389|4046369|P1|NOT COMPLETED|Period 2||0
1657035|NCT00701389|4046366|P4|COMPLETED|Period 2||6
1657036|NCT00701389|4046367|P3|COMPLETED|Period 2||6
1657037|NCT00701389|4046368|P2|COMPLETED|Period 2||6
1657038|NCT00701389|4046369|P1|COMPLETED|Period 2||6
1657039|NCT00701389|4046366|P4|STARTED|Period 2||6
1657040|NCT00701389|4046367|P3|STARTED|Period 2||6
1657041|NCT00701389|4046368|P2|STARTED|Period 2||6
1657042|NCT00701389|4046369|P1|STARTED|Period 2||6
1657043|NCT00701389|4046366|P4|NOT COMPLETED|Period 1||0
1657044|NCT00701389|4046367|P3|NOT COMPLETED|Period 1||0
1657045|NCT00701389|4046368|P2|NOT COMPLETED|Period 1||0
1657046|NCT00701389|4046369|P1|NOT COMPLETED|Period 1||0
1657047|NCT00701389|4046366|P4|COMPLETED|Period 1||6
1657048|NCT00701389|4046367|P3|COMPLETED|Period 1||6
1657049|NCT00701389|4046368|P2|COMPLETED|Period 1||6
1657050|NCT00701389|4046369|P1|COMPLETED|Period 1||6
1657051|NCT00701389|4046366|P4|STARTED|Period 1||6
1657052|NCT00701389|4046367|P3|STARTED|Period 1||6
1657053|NCT00701389|4046368|P2|STARTED|Period 1||6
1657054|NCT00701389|4046369|P1|STARTED|Period 1||6
1657055|NCT00701363|4046391|P4|NOT COMPLETED|Treatment Phase 2||0
1657056|NCT00701363|4046392|P3|NOT COMPLETED|Treatment Phase 2||2
1657057|NCT00701363|4046393|P2|NOT COMPLETED|Treatment Phase 2||0
1657058|NCT00701363|4046394|P1|NOT COMPLETED|Treatment Phase 2||0
1657059|NCT00701363|4046391|P4|COMPLETED|Treatment Phase 2||26
1657060|NCT00701363|4046392|P3|COMPLETED|Treatment Phase 2||68
1657061|NCT00701363|4046393|P2|COMPLETED|Treatment Phase 2||13
1657062|NCT00701363|4046394|P1|COMPLETED|Treatment Phase 2||0
1657063|NCT00701363|4046391|P4|STARTED|Treatment Phase 2||26
1657064|NCT00701363|4046392|P3|STARTED|Treatment Phase 2||70
1657065|NCT00701363|4046393|P2|STARTED|Treatment Phase 2||13
1657066|NCT00701363|4046394|P1|STARTED|Treatment Phase 2||0
1657067|NCT00701363|4046391|P4|NOT COMPLETED|Treatment Phase 1||0
1657068|NCT00701363|4046392|P3|NOT COMPLETED|Treatment Phase 1||0
1657069|NCT00701363|4046393|P2|NOT COMPLETED|Treatment Phase 1||0
1657070|NCT00701363|4046394|P1|NOT COMPLETED|Treatment Phase 1||15
1657071|NCT00701363|4046391|P4|COMPLETED|Treatment Phase 1||0
1657072|NCT00701363|4046392|P3|COMPLETED|Treatment Phase 1||0
1657073|NCT00701363|4046393|P2|COMPLETED|Treatment Phase 1||0
1657074|NCT00701363|4046394|P1|COMPLETED|Treatment Phase 1||109
1657075|NCT00701363|4046391|P4|STARTED|Treatment Phase 1||0
1657076|NCT00701363|4046392|P3|STARTED|Treatment Phase 1||0
1657077|NCT00701363|4046393|P2|STARTED|Treatment Phase 1||0
1657078|NCT00701363|4046394|P1|STARTED|Treatment Phase 1||124
1657079|NCT00701363|4046391|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
1657080|NCT00701363|4046392|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
1657081|NCT00701363|4046393|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
1657082|NCT00701363|4046394|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
1657083|NCT00701363|4046391|P4|COMPLETED|Screening (Pre-assignment) Phase||0
1657084|NCT00701363|4046392|P3|COMPLETED|Screening (Pre-assignment) Phase||0
1657085|NCT00701363|4046393|P2|COMPLETED|Screening (Pre-assignment) Phase||0
1657086|NCT00701363|4046394|P1|COMPLETED|Screening (Pre-assignment) Phase||124
1657087|NCT00701363|4046391|P4|STARTED|Screening (Pre-assignment) Phase||0
1657088|NCT00701363|4046392|P3|STARTED|Screening (Pre-assignment) Phase||0
1657089|NCT00701363|4046393|P2|STARTED|Screening (Pre-assignment) Phase||0
1657090|NCT00701363|4046394|P1|STARTED|Screening (Pre-assignment) Phase||128
1657091|NCT00701311|4046434|P1|NOT COMPLETED|Overall Study||8
1657092|NCT00701311|4046434|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
1657093|NCT00701311|4046434|P1|STARTED|Overall Study||17
1657094|NCT00701129|4046438|P1|NOT COMPLETED|Overall Study||2
1657095|NCT00701129|4046438|P1|COMPLETED|Overall Study||2
1657096|NCT00701129|4046438|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
1657097|NCT00701129|4046438|P1|STARTED|Overall Study||4
1657098|NCT00701103|4046460|P11|NOT COMPLETED|Overall Study||11
1657099|NCT00701103|4046461|P10|NOT COMPLETED|Overall Study||11
1657100|NCT00701103|4046462|P9|NOT COMPLETED|Overall Study||9
1657101|NCT00701103|4046463|P8|NOT COMPLETED|Overall Study||7
1657102|NCT00701103|4046464|P7|NOT COMPLETED|Overall Study||8
1657103|NCT00701103|4046465|P6|NOT COMPLETED|Overall Study||6
1657104|NCT00701103|4046466|P5|NOT COMPLETED|Overall Study||6
1657105|NCT00701103|4046467|P4|NOT COMPLETED|Overall Study||6
1657106|NCT00701103|4046468|P3|NOT COMPLETED|Overall Study||8
1657107|NCT00701103|4046469|P2|NOT COMPLETED|Overall Study||3
1657108|NCT00701103|4046470|P1|NOT COMPLETED|Overall Study||5
1657109|NCT00701103|4046460|P11|COMPLETED|Overall Study||0
1657110|NCT00701103|4046461|P10|COMPLETED|Overall Study||0
1657111|NCT00701103|4046462|P9|COMPLETED|Overall Study||0
1657112|NCT00701103|4046463|P8|COMPLETED|Overall Study||0
1657113|NCT00701103|4046464|P7|COMPLETED|Overall Study||0
1657114|NCT00701103|4046465|P6|COMPLETED|Overall Study||0
1657115|NCT00701103|4046466|P5|COMPLETED|Overall Study||0
1657116|NCT00701103|4046467|P4|COMPLETED|Overall Study||0
1657117|NCT00701103|4046468|P3|COMPLETED|Overall Study||0
1657118|NCT00701103|4046469|P2|COMPLETED|Overall Study||0
1657119|NCT00701103|4046470|P1|COMPLETED|Overall Study||0
1657120|NCT00701103|4046460|P11|STARTED|Overall Study||11
1657121|NCT00701103|4046461|P10|STARTED|Overall Study||11
1657122|NCT00701103|4046462|P9|STARTED|Overall Study||9
1657123|NCT00701103|4046463|P8|STARTED|Overall Study||7
1657124|NCT00701103|4046464|P7|STARTED|Overall Study||8
1657125|NCT00701103|4046465|P6|STARTED|Overall Study||6
1657126|NCT00701103|4046466|P5|STARTED|Overall Study||6
1657127|NCT00701103|4046467|P4|STARTED|Overall Study||6
1657128|NCT00701103|4046468|P3|STARTED|Overall Study||8
1657129|NCT00701103|4046469|P2|STARTED|Overall Study||3
1657130|NCT00701103|4046470|P1|STARTED|Overall Study||5
1657131|NCT00701090|4046576|P2|NOT COMPLETED|Overall Study||51
1657132|NCT00701090|4046577|P1|NOT COMPLETED|Overall Study||48
1657133|NCT00701090|4046576|P2|COMPLETED|Overall Study||468
1657134|NCT00701090|4046577|P1|COMPLETED|Overall Study||468
1657135|NCT00701090|4046576|P2|STARTED|Overall Study||519
1657136|NCT00701090|4046577|P1|STARTED|Overall Study||516
1657137|NCT00701064|4046595|P2|NOT COMPLETED|Overall Study||4
1657138|NCT00701064|4046596|P1|NOT COMPLETED|Overall Study||4
1657139|NCT00701064|4046595|P2|COMPLETED|Overall Study||32
1657140|NCT00701064|4046596|P1|COMPLETED|Overall Study||31
1657141|NCT00701064|4046595|P2|STARTED|Overall Study||36
1657142|NCT00701064|4046596|P1|STARTED|Overall Study||35
1657143|NCT00701051|4046608|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
1657144|NCT00701051|4046609|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
1657145|NCT00701051|4046610|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
1657146|NCT00701051|4046608|P3|COMPLETED|Detraining Intervention (Optional)||6
1657147|NCT00701051|4046609|P2|COMPLETED|Detraining Intervention (Optional)||6
1657148|NCT00701051|4046610|P1|COMPLETED|Detraining Intervention (Optional)||0
1657149|NCT00701051|4046608|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
1657150|NCT00701051|4046609|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
1657151|NCT00701051|4046610|P1|STARTED|Detraining Intervention (Optional)||0
1657152|NCT00701051|4046608|P3|NOT COMPLETED|Exercise Intervention||3
1657153|NCT00701051|4046609|P2|NOT COMPLETED|Exercise Intervention||5
1657154|NCT00701051|4046610|P1|NOT COMPLETED|Exercise Intervention||0
1657155|NCT00701051|4046608|P3|COMPLETED|Exercise Intervention||9
1657156|NCT00701051|4046609|P2|COMPLETED|Exercise Intervention||14
1657157|NCT00701051|4046610|P1|COMPLETED|Exercise Intervention||0
1657158|NCT00701051|4046608|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
1657159|NCT00701051|4046609|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
1657160|NCT00701051|4046610|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
1657161|NCT00701051|4046608|P3|NOT COMPLETED|Screening||0
1657162|NCT00701051|4046609|P2|NOT COMPLETED|Screening||0
1657163|NCT00701051|4046610|P1|NOT COMPLETED|Screening||59
1657164|NCT00701051|4046608|P3|COMPLETED|Screening||0
1657165|NCT00701051|4046609|P2|COMPLETED|Screening||0
1657166|NCT00701051|4046610|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
1657167|NCT00701051|4046608|P3|STARTED|Screening||0
1657168|NCT00701051|4046609|P2|STARTED|Screening||0
1657169|NCT00701051|4046610|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
1657170|NCT00701038|4046628|P2|NOT COMPLETED|Overall Study||4
1657171|NCT00701038|4046629|P1|NOT COMPLETED|Overall Study||4
1657172|NCT00701038|4046628|P2|COMPLETED|Overall Study||23
1657173|NCT00701038|4046629|P1|COMPLETED|Overall Study||23
1657174|NCT00701038|4046628|P2|STARTED|Overall Study||27
1657175|NCT00701038|4046629|P1|STARTED|Overall Study||27
1657176|NCT00700999|4046637|P2|NOT COMPLETED|Overall Study||9
1657177|NCT00700999|4046638|P1|NOT COMPLETED|Overall Study||15
1657178|NCT00700999|4046637|P2|COMPLETED|Overall Study||20
1657179|NCT00700999|4046638|P1|COMPLETED|Overall Study||21
1657180|NCT00700999|4046637|P2|Second MRI Scan|Overall Study||18
1657181|NCT00700999|4046638|P1|Second MRI Scan|Overall Study||19
1657182|NCT00700999|4046637|P2|First MRI Scan|Overall Study||22
1657183|NCT00700999|4046638|P1|First MRI Scan|Overall Study||29
1657184|NCT00700999|4046637|P2|STARTED|Overall Study||29
1657185|NCT00700999|4046638|P1|STARTED|Overall Study||36
1657186|NCT00700973|4046646|P2|NOT COMPLETED|Overall Study||7
1657187|NCT00700973|4046647|P1|NOT COMPLETED|Overall Study||8
1657188|NCT00700973|4046646|P2|COMPLETED|Overall Study||63
1657189|NCT00700973|4046647|P1|COMPLETED|Overall Study||63
1657190|NCT00700973|4046646|P2|STARTED|Overall Study||70
1657191|NCT00700973|4046647|P1|STARTED|Overall Study||71
1657192|NCT00700817|4046658|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
1657193|NCT00700817|4046659|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
1657194|NCT00700817|4046660|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
1657195|NCT00700817|4046661|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
1657196|NCT00700817|4046662|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
1657197|NCT00700817|4046658|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
1657198|NCT00700817|4046659|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
1657199|NCT00700817|4046660|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
1657200|NCT00700817|4046661|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
1657201|NCT00700817|4046662|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
1657202|NCT00700817|4046658|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
1657203|NCT00700817|4046659|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
1657204|NCT00700817|4046660|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
1657205|NCT00700817|4046661|P2|STARTED|Week 52-78 (Extension Period 2)||150
1657206|NCT00700817|4046662|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
1657207|NCT00700817|4046658|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
1657208|NCT00700817|4046659|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
1657209|NCT00700817|4046660|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
1657210|NCT00700817|4046661|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
1657211|NCT00700817|4046662|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
1657212|NCT00700817|4046658|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
1657213|NCT00700817|4046659|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
1657214|NCT00700817|4046660|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
1657215|NCT00700817|4046661|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
1657216|NCT00700817|4046662|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
1657217|NCT00700817|4046658|P5|STARTED|Week 26-52 (Extension Period 1)||0
1657218|NCT00700817|4046659|P4|STARTED|Week 26-52 (Extension Period 1)||0
1657219|NCT00700817|4046660|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
1657220|NCT00700817|4046661|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
1657221|NCT00700817|4046662|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
1657222|NCT00700817|4046658|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
1657223|NCT00700817|4046659|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
1657224|NCT00700817|4046660|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
1657225|NCT00700817|4046661|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
1657226|NCT00700817|4046662|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
1657227|NCT00700817|4046658|P5|COMPLETED|Week 0-26 (Main Period)||0
1657228|NCT00700817|4046659|P4|COMPLETED|Week 0-26 (Main Period)||0
1657229|NCT00700817|4046660|P3|COMPLETED|Week 0-26 (Main Period)||194
1657230|NCT00700817|4046661|P2|COMPLETED|Week 0-26 (Main Period)||191
1657231|NCT00700817|4046662|P1|COMPLETED|Week 0-26 (Main Period)||169
1657232|NCT00700817|4046658|P5|Exposed|Week 0-26 (Main Period)||0
1657233|NCT00700817|4046659|P4|Exposed|Week 0-26 (Main Period)||0
1657234|NCT00700817|4046660|P3|Exposed|Week 0-26 (Main Period)||219
1657235|NCT00700817|4046661|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
1657236|NCT00700817|4046662|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
1657237|NCT00700817|4046658|P5|STARTED|Week 0-26 (Main Period)||0
1657238|NCT00700817|4046659|P4|STARTED|Week 0-26 (Main Period)||0
1657239|NCT00700817|4046660|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
1657240|NCT00700817|4046661|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
1657241|NCT00700817|4046662|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
1657242|NCT00700804|4047044|P2|NOT COMPLETED|Overall Study||4
1657243|NCT00700804|4047045|P1|NOT COMPLETED|Overall Study||3
1657244|NCT00700804|4047044|P2|COMPLETED|Overall Study||13
1657245|NCT00700804|4047045|P1|COMPLETED|Overall Study||14
1657246|NCT00700804|4047044|P2|STARTED|Overall Study||17
1657247|NCT00700804|4047045|P1|STARTED|Overall Study||17
1657248|NCT00700752|4047053|P2|NOT COMPLETED|Second Intervention||0
1657249|NCT00700752|4047054|P1|NOT COMPLETED|Second Intervention||0
1657250|NCT00700752|4047053|P2|COMPLETED|Second Intervention||18
1657251|NCT00700752|4047054|P1|COMPLETED|Second Intervention||20
1657252|NCT00700752|4047053|P2|STARTED|Second Intervention||18
1657253|NCT00700752|4047054|P1|STARTED|Second Intervention||20
1657254|NCT00700752|4047053|P2|NOT COMPLETED|First Intervention||2
1657255|NCT00700752|4047054|P1|NOT COMPLETED|First Intervention||0
1657256|NCT00700752|4047053|P2|COMPLETED|First Intervention||18
1657257|NCT00700752|4047054|P1|COMPLETED|First Intervention||20
1657258|NCT00700752|4047053|P2|STARTED|First Intervention||20
1657259|NCT00700752|4047054|P1|STARTED|First Intervention||20
1657260|NCT00700739|4047062|P2|NOT COMPLETED|Overall Study||4
1657261|NCT00700739|4047063|P1|NOT COMPLETED|Overall Study||4
1657262|NCT00700739|4047062|P2|COMPLETED|Overall Study||12
1657263|NCT00700739|4047063|P1|COMPLETED|Overall Study||18
1657264|NCT00700739|4047062|P2|STARTED|Overall Study||16
1657265|NCT00700739|4047063|P1|STARTED|Overall Study||22
1657266|NCT00700713|4047102|P3|NOT COMPLETED|Overall Study||2
1657267|NCT00700713|4047103|P2|NOT COMPLETED|Overall Study||0
1657268|NCT00700713|4047104|P1|NOT COMPLETED|Overall Study||1
1657269|NCT00700713|4047102|P3|COMPLETED|Overall Study||65
1657270|NCT00700713|4047103|P2|COMPLETED|Overall Study||66
1657271|NCT00700713|4047104|P1|COMPLETED|Overall Study||47
1657272|NCT00700713|4047102|P3|STARTED|Overall Study||67
1657273|NCT00700713|4047103|P2|STARTED|Overall Study||66
1657274|NCT00700713|4047104|P1|STARTED|Overall Study||48
1657275|NCT00700635|4047121|P3|NOT COMPLETED|Overall Study||1
1657276|NCT00700635|4047122|P2|NOT COMPLETED|Overall Study||8
1657277|NCT00700635|4047123|P1|NOT COMPLETED|Overall Study||11
1657278|NCT00700635|4047121|P3|COMPLETED|Overall Study||110
1657279|NCT00700635|4047122|P2|COMPLETED|Overall Study||103
1657280|NCT00700635|4047123|P1|COMPLETED|Overall Study||100
1657281|NCT00700635|4047121|P3|STARTED|Overall Study||111
1657282|NCT00700635|4047122|P2|STARTED|Overall Study||111
1657283|NCT00700635|4047123|P1|STARTED|Overall Study||111
1657284|NCT00700622|4047145|P2|NOT COMPLETED|Overall Study||5
1657285|NCT00700622|4047146|P1|NOT COMPLETED|Overall Study||13
1657286|NCT00700622|4047145|P2|COMPLETED|Overall Study||60
1657287|NCT00700622|4047146|P1|COMPLETED|Overall Study||52
1657288|NCT00700622|4047145|P2|STARTED|Overall Study||65
1657289|NCT00700622|4047146|P1|STARTED|Overall Study||65
1657290|NCT00700570|4047154|P2|NOT COMPLETED|Overall Study||26
1657291|NCT00700570|4047155|P1|NOT COMPLETED|Overall Study||11
1657292|NCT00700570|4047154|P2|COMPLETED|Overall Study||0
1657293|NCT00700570|4047155|P1|COMPLETED|Overall Study||8
1657294|NCT00700570|4047154|P2|STARTED|Overall Study||26
1657295|NCT00700570|4047155|P1|STARTED|Overall Study||19
1657296|NCT00700440|4047167|P1|NOT COMPLETED|Overall Study||0
1657297|NCT00700440|4047167|P1|COMPLETED|Overall Study||100
1657298|NCT00700440|4047167|P1|STARTED|Overall Study||100
1657299|NCT00700427|4047171|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
1657300|NCT00700427|4047172|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1657301|NCT00700427|4047173|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1657302|NCT00700427|4047174|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1657303|NCT00700427|4047175|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1657304|NCT00700427|4047171|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
1657305|NCT00700427|4047172|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
1657306|NCT00700427|4047173|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
1657307|NCT00700427|4047174|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
1657308|NCT00700427|4047175|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
1657309|NCT00700427|4047171|P5|STARTED|Study Period 4 (Open-Label Extension)||180
1657310|NCT00700427|4047172|P4|STARTED|Study Period 4 (Open-Label Extension)||0
1657311|NCT00700427|4047173|P3|STARTED|Study Period 4 (Open-Label Extension)||0
1657312|NCT00700427|4047174|P2|STARTED|Study Period 4 (Open-Label Extension)||0
1657313|NCT00700427|4047175|P1|STARTED|Study Period 4 (Open-Label Extension)||0
1657314|NCT00700427|4047171|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1657315|NCT00700427|4047172|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
1657316|NCT00700427|4047173|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
1657317|NCT00700427|4047174|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1657318|NCT00700427|4047175|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1657319|NCT00700427|4047171|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1657320|NCT00700427|4047172|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
1657321|NCT00700427|4047173|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
1657322|NCT00700427|4047174|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1657323|NCT00700427|4047175|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1657324|NCT00700427|4047171|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
1657325|NCT00700427|4047172|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
1657326|NCT00700427|4047173|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
1657327|NCT00700427|4047174|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
1657328|NCT00700427|4047175|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
1657329|NCT00700427|4047171|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1657330|NCT00700427|4047172|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1657331|NCT00700427|4047173|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1657332|NCT00700427|4047174|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
1657333|NCT00700427|4047175|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1657334|NCT00700427|4047171|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1657335|NCT00700427|4047172|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1657336|NCT00700427|4047173|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1657337|NCT00700427|4047174|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
1657338|NCT00700427|4047175|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1657339|NCT00700427|4047171|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
1657340|NCT00700427|4047172|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
1657341|NCT00700427|4047173|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
1657342|NCT00700427|4047174|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
1657343|NCT00700427|4047175|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
1657344|NCT00700427|4047171|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1657345|NCT00700427|4047172|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1657346|NCT00700427|4047173|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1657347|NCT00700427|4047174|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1657348|NCT00700427|4047175|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
1657349|NCT00700427|4047171|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1657350|NCT00700427|4047172|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1657351|NCT00700427|4047173|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1657352|NCT00700427|4047174|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1657353|NCT00700427|4047175|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
1657354|NCT00700427|4047171|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1657355|NCT00700427|4047172|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1657356|NCT00700427|4047173|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1657357|NCT00700427|4047174|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1657358|NCT00700427|4047175|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
1657359|NCT00700427|4047171|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1657360|NCT00700427|4047172|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1657361|NCT00700427|4047173|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1657362|NCT00700427|4047174|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1657363|NCT00700427|4047175|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
1657364|NCT00700401|4047197|P1|NOT COMPLETED|Overall Study||94
1657365|NCT00700401|4047197|P1|COMPLETED|Overall Study||168
1657366|NCT00700401|4047197|P1|STARTED|Overall Study||262
1657367|NCT00700375|4047210|P2|NOT COMPLETED|Overall Study||0
1657368|NCT00700375|4047211|P1|NOT COMPLETED|Overall Study||0
1657369|NCT00700375|4047210|P2|COMPLETED|Overall Study||29
1657370|NCT00700375|4047211|P1|COMPLETED|Overall Study||30
1657371|NCT00700375|4047210|P2|2 Days After Creatinine Mesurement|Overall Study||29
1657372|NCT00700375|4047211|P1|2 Days After Creatinine Mesurement|Overall Study||30
1657373|NCT00700375|4047210|P2|STARTED|Overall Study||29
1657374|NCT00700375|4047211|P1|STARTED|Overall Study||30
1657375|NCT00700310|4047221|P4|NOT COMPLETED|Overall Study||26
1657376|NCT00700310|4047222|P3|NOT COMPLETED|Overall Study||16
1657377|NCT00700310|4047223|P2|NOT COMPLETED|Overall Study||26
1657378|NCT00700310|4047224|P1|NOT COMPLETED|Overall Study||21
1657379|NCT00700310|4047221|P4|COMPLETED|Overall Study||145
1657380|NCT00700310|4047222|P3|COMPLETED|Overall Study||158
1657381|NCT00700310|4047223|P2|COMPLETED|Overall Study||154
1657382|NCT00700310|4047224|P1|COMPLETED|Overall Study||166
1657383|NCT00700310|4047221|P4|STARTED|Overall Study||171
1657384|NCT00700310|4047222|P3|STARTED|Overall Study||174
1657385|NCT00700310|4047223|P2|STARTED|Overall Study||180
1657386|NCT00700310|4047224|P1|STARTED|Overall Study||187
1657387|NCT00700271|4047244|P2|NOT COMPLETED|Overall Study||12
1657388|NCT00700271|4047245|P1|NOT COMPLETED|Overall Study||14
1657389|NCT00700271|4047244|P2|COMPLETED|Overall Study||256
1657390|NCT00700271|4047245|P1|COMPLETED|Overall Study||264
1657391|NCT00700271|4047244|P2|STARTED|Overall Study||268
1657392|NCT00700271|4047245|P1|STARTED|Overall Study||278
1657393|NCT00700180|4047273|P2|NOT COMPLETED|Overall Study||149
1657394|NCT00700180|4047274|P1|NOT COMPLETED|Overall Study||154
1657395|NCT00700180|4047273|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
1657396|NCT00700180|4047274|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
1657397|NCT00700180|4047273|P2|STARTED|Overall Study||149
1657398|NCT00700180|4047274|P1|STARTED|Overall Study||154
1657399|NCT00700141|4047296|P1|NOT COMPLETED|Overall Study||0
1657400|NCT00700141|4047296|P1|COMPLETED|Overall Study||482
1657401|NCT00700141|4047296|P1|STARTED|Overall Study||482
1657402|NCT00700115|4047303|P2|NOT COMPLETED|Overall Study||1
1657403|NCT00700115|4047304|P1|NOT COMPLETED|Overall Study||1
1657404|NCT00700115|4047303|P2|COMPLETED|Overall Study||19
1657405|NCT00700115|4047304|P1|COMPLETED|Overall Study||39
1657406|NCT00700115|4047303|P2|STARTED|Overall Study||20
1657407|NCT00700115|4047304|P1|STARTED|Overall Study||40
1657408|NCT00700102|4047314|P2|NOT COMPLETED|Overall Study||395
1657409|NCT00700102|4047315|P1|NOT COMPLETED|Overall Study||402
1657410|NCT00700102|4047314|P2|COMPLETED|Overall Study||14
1657411|NCT00700102|4047315|P1|COMPLETED|Overall Study||9
1657412|NCT00700102|4047314|P2|Received at Least One Dose|Overall Study||403
1657413|NCT00700102|4047315|P1|Received at Least One Dose|Overall Study||407
1657414|NCT00700102|4047314|P2|Intention to Treat|Overall Study||409
1657415|NCT00700102|4047315|P1|Intention to Treat|Overall Study||410
1657416|NCT00700102|4047314|P2|STARTED|Overall Study||409
1657417|NCT00700102|4047315|P1|STARTED|Overall Study||411
1657418|NCT00700063|4047339|P8|NOT COMPLETED|Overall Study||0
1657419|NCT00700063|4047340|P7|NOT COMPLETED|Overall Study||0
1657420|NCT00700063|4047341|P6|NOT COMPLETED|Overall Study||0
1657421|NCT00700063|4047342|P5|NOT COMPLETED|Overall Study||2
1657422|NCT00700063|4047343|P4|NOT COMPLETED|Overall Study||2
1657423|NCT00700063|4047344|P3|NOT COMPLETED|Overall Study||0
1657424|NCT00700063|4047345|P2|NOT COMPLETED|Overall Study||0
1657425|NCT00700063|4047346|P1|NOT COMPLETED|Overall Study||1
1657426|NCT00700063|4047339|P8|COMPLETED|Overall Study||33
1657427|NCT00700063|4047340|P7|COMPLETED|Overall Study||32
1657428|NCT00700063|4047341|P6|COMPLETED|Overall Study||34
1657429|NCT00700063|4047342|P5|COMPLETED|Overall Study||31
1657430|NCT00700063|4047343|P4|COMPLETED|Overall Study||31
1657431|NCT00700063|4047344|P3|COMPLETED|Overall Study||33
1657432|NCT00700063|4047345|P2|COMPLETED|Overall Study||34
1657433|NCT00700063|4047346|P1|COMPLETED|Overall Study||32
1657434|NCT00700063|4047339|P8|STARTED|Overall Study||33
1657435|NCT00700063|4047340|P7|STARTED|Overall Study||32
1657436|NCT00700063|4047341|P6|STARTED|Overall Study||34
1657437|NCT00700063|4047342|P5|STARTED|Overall Study||33
1657438|NCT00700063|4047343|P4|STARTED|Overall Study||33
1657439|NCT00700063|4047344|P3|STARTED|Overall Study||33
1657440|NCT00700063|4047345|P2|STARTED|Overall Study||34
1657441|NCT00700063|4047346|P1|STARTED|Overall Study||33
1657442|NCT00700011|4047454|P2|NOT COMPLETED|Overall Study||1
1657443|NCT00700011|4047455|P1|NOT COMPLETED|Overall Study||0
1657444|NCT00700011|4047454|P2|COMPLETED|Overall Study||1
1657445|NCT00700011|4047455|P1|COMPLETED|Overall Study||8
1657446|NCT00700011|4047454|P2|STARTED|Overall Study||2
1657447|NCT00700011|4047455|P1|STARTED|Overall Study||8
1657448|NCT00699998|4047471|P4|NOT COMPLETED|Overall Study||82
1657449|NCT00699998|4047472|P3|NOT COMPLETED|Overall Study||206
1657450|NCT00699998|4047473|P2|NOT COMPLETED|Overall Study||86
1657451|NCT00699998|4047474|P1|NOT COMPLETED|Overall Study||199
1657452|NCT00699998|4047471|P4|COMPLETED|Overall Study||958
1657453|NCT00699998|4047472|P3|COMPLETED|Overall Study||3417
1657454|NCT00699998|4047473|P2|COMPLETED|Overall Study||957
1657455|NCT00699998|4047474|P1|COMPLETED|Overall Study||3421
1657456|NCT00699998|4047471|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
1657457|NCT00699998|4047472|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
1657458|NCT00699998|4047473|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
1657459|NCT00699998|4047474|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
1657460|NCT00699998|4047471|P4|STARTED|Overall Study||1040
1657461|NCT00699998|4047472|P3|STARTED|Overall Study||3623
1657462|NCT00699998|4047473|P2|STARTED|Overall Study||1043
1657463|NCT00699998|4047474|P1|STARTED|Overall Study||3620
1657464|NCT00699972|4047519|P3|NOT COMPLETED|Overall Study||35
1657465|NCT00699972|4047520|P2|NOT COMPLETED|Overall Study||19
1657466|NCT00699972|4047521|P1|NOT COMPLETED|Overall Study||16
1657467|NCT00699972|4047519|P3|COMPLETED|Overall Study||100
1657468|NCT00699972|4047520|P2|COMPLETED|Overall Study||114
1657469|NCT00699972|4047521|P1|COMPLETED|Overall Study||106
1657470|NCT00699972|4047519|P3|STARTED|Overall Study||135
1657471|NCT00699972|4047520|P2|STARTED|Overall Study||133
1657472|NCT00699972|4047521|P1|STARTED|Overall Study||122
1657473|NCT00699907|4047538|P3|NOT COMPLETED|Overall Study||8
1657474|NCT00699907|4047539|P2|NOT COMPLETED|Overall Study||10
1657475|NCT00699907|4047540|P1|NOT COMPLETED|Overall Study||2
1657476|NCT00699907|4047538|P3|COMPLETED|Overall Study||48
1657477|NCT00699907|4047539|P2|COMPLETED|Overall Study||47
1657478|NCT00699907|4047540|P1|COMPLETED|Overall Study||12
1657479|NCT00699907|4047538|P3|STARTED|Overall Study||56
1657480|NCT00699907|4047539|P2|STARTED|Overall Study||57
1657481|NCT00699907|4047540|P1|STARTED|Overall Study||14
1657482|NCT00699842|4047575|P3|NOT COMPLETED|Overall Study||0
1657483|NCT00699842|4047576|P2|NOT COMPLETED|Overall Study||1
1657484|NCT00699842|4047577|P1|NOT COMPLETED|Overall Study||0
1657485|NCT00699842|4047575|P3|COMPLETED|Overall Study||0
1657486|NCT00699842|4047576|P2|COMPLETED|Overall Study||4
1657487|NCT00699842|4047577|P1|COMPLETED|Overall Study||3
1657488|NCT00699842|4047575|P3|STARTED|Overall Study||0
1657489|NCT00699842|4047576|P2|STARTED|Overall Study||5
1657490|NCT00699842|4047577|P1|STARTED|Overall Study||3
1657491|NCT00699816|4047590|P2|NOT COMPLETED|Overall Study||3
1657492|NCT00699816|4047591|P1|NOT COMPLETED|Overall Study||1
1657493|NCT00699816|4047590|P2|COMPLETED|Overall Study||112
1657494|NCT00699816|4047591|P1|COMPLETED|Overall Study||114
1657495|NCT00699816|4047590|P2|STARTED|Overall Study||115
1657496|NCT00699816|4047591|P1|STARTED|Overall Study||115
1657497|NCT00699751|4047609|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
1657498|NCT00699751|4047610|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
1657499|NCT00699751|4047609|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
1657500|NCT00699751|4047610|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
1657501|NCT00699751|4047609|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
1657502|NCT00699751|4047610|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
1657503|NCT00699751|4047609|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
1657504|NCT00699751|4047610|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
1657505|NCT00699751|4047609|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
1657506|NCT00699751|4047610|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
1657507|NCT00699751|4047609|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
1657508|NCT00699751|4047610|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
1657509|NCT00699751|4047609|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
1657510|NCT00699751|4047610|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
1657511|NCT00699751|4047609|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
1657512|NCT00699751|4047610|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
1657513|NCT00699751|4047609|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
1657514|NCT00699751|4047610|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
1657515|NCT00699751|4047609|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
1657516|NCT00699751|4047610|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
1657517|NCT00699751|4047609|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
1657518|NCT00699751|4047610|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
1657519|NCT00699751|4047609|P2|STARTED|Period 1: Without/Before Drug Switch||307
1657520|NCT00699751|4047610|P1|STARTED|Period 1: Without/Before Drug Switch||614
1657521|NCT00699699|4047695|P1|NOT COMPLETED|Overall Study||57
1657522|NCT00699699|4047695|P1|COMPLETED|Overall Study||1223
1657523|NCT00699699|4047695|P1|STARTED|Overall Study||1280
1657524|NCT00699660|4047704|P2|NOT COMPLETED|Overall Study||8
1657525|NCT00699660|4047705|P1|NOT COMPLETED|Overall Study||14
1657526|NCT00699660|4047704|P2|COMPLETED|Overall Study||208
1657527|NCT00699660|4047705|P1|COMPLETED|Overall Study||176
1657528|NCT00699660|4047704|P2|STARTED|Overall Study||216
1657529|NCT00699660|4047705|P1|STARTED|Overall Study||190
1657530|NCT00699608|4047717|P6|NOT COMPLETED|Third Intervention||0
1657531|NCT00699608|4047718|P5|NOT COMPLETED|Third Intervention||0
1657532|NCT00699608|4047719|P4|NOT COMPLETED|Third Intervention||0
1657533|NCT00699608|4047720|P3|NOT COMPLETED|Third Intervention||0
1657534|NCT00699608|4047721|P2|NOT COMPLETED|Third Intervention||0
1657535|NCT00699608|4047722|P1|NOT COMPLETED|Third Intervention||0
1657536|NCT00699608|4047717|P6|COMPLETED|Third Intervention||15
1657537|NCT00699608|4047718|P5|COMPLETED|Third Intervention||14
1657538|NCT00699608|4047719|P4|COMPLETED|Third Intervention||14
1657539|NCT00699608|4047720|P3|COMPLETED|Third Intervention||13
1657540|NCT00699608|4047721|P2|COMPLETED|Third Intervention||15
1657541|NCT00699608|4047722|P1|COMPLETED|Third Intervention||16
1657542|NCT00699608|4047717|P6|STARTED|Third Intervention||15
1657543|NCT00699608|4047718|P5|STARTED|Third Intervention||14
1657544|NCT00699608|4047719|P4|STARTED|Third Intervention||14
1657545|NCT00699608|4047720|P3|STARTED|Third Intervention||13
1657546|NCT00699608|4047721|P2|STARTED|Third Intervention||15
1657547|NCT00699608|4047722|P1|STARTED|Third Intervention||16
1657548|NCT00699608|4047717|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
1657549|NCT00699608|4047718|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
1657550|NCT00699608|4047719|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
1657551|NCT00699608|4047720|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
1657552|NCT00699608|4047721|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
1657553|NCT00699608|4047722|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
1657554|NCT00699608|4047717|P6|COMPLETED|Second 4-14 Day Washout Period||15
1657555|NCT00699608|4047718|P5|COMPLETED|Second 4-14 Day Washout Period||14
1657556|NCT00699608|4047719|P4|COMPLETED|Second 4-14 Day Washout Period||14
1657557|NCT00699608|4047720|P3|COMPLETED|Second 4-14 Day Washout Period||13
1657558|NCT00699608|4047721|P2|COMPLETED|Second 4-14 Day Washout Period||15
1657559|NCT00699608|4047722|P1|COMPLETED|Second 4-14 Day Washout Period||16
1657560|NCT00699608|4047717|P6|STARTED|Second 4-14 Day Washout Period||15
1657561|NCT00699608|4047718|P5|STARTED|Second 4-14 Day Washout Period||14
1657562|NCT00699608|4047719|P4|STARTED|Second 4-14 Day Washout Period||14
1657563|NCT00699608|4047720|P3|STARTED|Second 4-14 Day Washout Period||13
1657564|NCT00699608|4047721|P2|STARTED|Second 4-14 Day Washout Period||15
1657565|NCT00699608|4047722|P1|STARTED|Second 4-14 Day Washout Period||16
1657566|NCT00699608|4047717|P6|NOT COMPLETED|Second Intervention||0
1657567|NCT00699608|4047718|P5|NOT COMPLETED|Second Intervention||0
1657568|NCT00699608|4047719|P4|NOT COMPLETED|Second Intervention||1
1657569|NCT00699608|4047720|P3|NOT COMPLETED|Second Intervention||1
1657570|NCT00699608|4047721|P2|NOT COMPLETED|Second Intervention||0
1657571|NCT00699608|4047722|P1|NOT COMPLETED|Second Intervention||0
1657572|NCT00699608|4047717|P6|COMPLETED|Second Intervention||15
1657573|NCT00699608|4047718|P5|COMPLETED|Second Intervention||14
1657574|NCT00699608|4047719|P4|COMPLETED|Second Intervention||14
1657575|NCT00699608|4047720|P3|COMPLETED|Second Intervention||13
1657576|NCT00699608|4047721|P2|COMPLETED|Second Intervention||15
1657577|NCT00699608|4047722|P1|COMPLETED|Second Intervention||16
1657578|NCT00699608|4047717|P6|STARTED|Second Intervention||15
1657579|NCT00699608|4047718|P5|STARTED|Second Intervention||14
1657580|NCT00699608|4047719|P4|STARTED|Second Intervention||15
1657581|NCT00699608|4047720|P3|STARTED|Second Intervention||14
1657582|NCT00699608|4047721|P2|STARTED|Second Intervention||15
1657583|NCT00699608|4047722|P1|STARTED|Second Intervention||16
1657584|NCT00699608|4047717|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
1657585|NCT00699608|4047718|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
1657586|NCT00699608|4047719|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
1657587|NCT00699608|4047720|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
1657588|NCT00699608|4047721|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
1657589|NCT00699608|4047722|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
1657590|NCT00699608|4047717|P6|COMPLETED|First 4-14 Day Washout Period||15
1657591|NCT00699608|4047718|P5|COMPLETED|First 4-14 Day Washout Period||14
1657592|NCT00699608|4047719|P4|COMPLETED|First 4-14 Day Washout Period||15
1657593|NCT00699608|4047720|P3|COMPLETED|First 4-14 Day Washout Period||14
1657594|NCT00699608|4047721|P2|COMPLETED|First 4-14 Day Washout Period||15
1657595|NCT00699608|4047722|P1|COMPLETED|First 4-14 Day Washout Period||16
1657596|NCT00699608|4047717|P6|STARTED|First 4-14 Day Washout Period||15
1657597|NCT00699608|4047718|P5|STARTED|First 4-14 Day Washout Period||14
1657598|NCT00699608|4047719|P4|STARTED|First 4-14 Day Washout Period||15
1657599|NCT00699608|4047720|P3|STARTED|First 4-14 Day Washout Period||14
1657600|NCT00699608|4047721|P2|STARTED|First 4-14 Day Washout Period||15
1657601|NCT00699608|4047722|P1|STARTED|First 4-14 Day Washout Period||16
1657602|NCT00699608|4047717|P6|NOT COMPLETED|First Intervention||0
1657603|NCT00699608|4047718|P5|NOT COMPLETED|First Intervention||1
1657604|NCT00699608|4047719|P4|NOT COMPLETED|First Intervention||0
1657605|NCT00699608|4047720|P3|NOT COMPLETED|First Intervention||1
1657606|NCT00699608|4047721|P2|NOT COMPLETED|First Intervention||0
1657607|NCT00699608|4047722|P1|NOT COMPLETED|First Intervention||0
1657608|NCT00699608|4047717|P6|COMPLETED|First Intervention||15
1657609|NCT00699608|4047718|P5|COMPLETED|First Intervention||14
1657610|NCT00699608|4047719|P4|COMPLETED|First Intervention||15
1657611|NCT00699608|4047720|P3|COMPLETED|First Intervention||14
1657612|NCT00699608|4047721|P2|COMPLETED|First Intervention||15
1657613|NCT00699608|4047722|P1|COMPLETED|First Intervention||16
1657614|NCT00699608|4047717|P6|STARTED|First Intervention||15
1657615|NCT00699608|4047718|P5|STARTED|First Intervention||15
1657616|NCT00699608|4047719|P4|STARTED|First Intervention||15
1657617|NCT00699608|4047720|P3|STARTED|First Intervention||15
1657618|NCT00699608|4047721|P2|STARTED|First Intervention||15
1657619|NCT00699608|4047722|P1|STARTED|First Intervention||16
1657620|NCT00699582|4047775|P3|NOT COMPLETED|Overall Study||28
1657621|NCT00699582|4047776|P2|NOT COMPLETED|Overall Study||22
1657622|NCT00699582|4047777|P1|NOT COMPLETED|Overall Study||18
1657623|NCT00699582|4047775|P3|COMPLETED|Overall Study||93
1657624|NCT00699582|4047776|P2|COMPLETED|Overall Study||108
1657625|NCT00699582|4047777|P1|COMPLETED|Overall Study||120
1657626|NCT00699582|4047775|P3|STARTED|Overall Study||121
1657627|NCT00699582|4047776|P2|STARTED|Overall Study||130
1657628|NCT00699582|4047777|P1|STARTED|Overall Study||138
1657629|NCT00699556|4047791|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1657630|NCT00699556|4047792|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1657631|NCT00699556|4047791|P2|COMPLETED|Second Intervention (1 Day)||11
1657632|NCT00699556|4047792|P1|COMPLETED|Second Intervention (1 Day)||11
1657633|NCT00699556|4047791|P2|STARTED|Second Intervention (1 Day)||11
1657634|NCT00699556|4047792|P1|STARTED|Second Intervention (1 Day)||11
1657635|NCT00699556|4047791|P2|NOT COMPLETED|First Intervention (1 Day)||0
1657636|NCT00699556|4047792|P1|NOT COMPLETED|First Intervention (1 Day)||0
1657637|NCT00699556|4047791|P2|COMPLETED|First Intervention (1 Day)||11
1657638|NCT00699556|4047792|P1|COMPLETED|First Intervention (1 Day)||11
1657639|NCT00699556|4047791|P2|STARTED|First Intervention (1 Day)||11
1657640|NCT00699556|4047792|P1|STARTED|First Intervention (1 Day)||11
1657641|NCT00699491|4047806|P6|NOT COMPLETED|Overall Study||0
1657642|NCT00699491|4047807|P5|NOT COMPLETED|Overall Study||0
1657643|NCT00699491|4047808|P4|NOT COMPLETED|Overall Study||0
1657644|NCT00699491|4047809|P3|NOT COMPLETED|Overall Study||0
1657645|NCT00699491|4047810|P2|NOT COMPLETED|Overall Study||0
1657646|NCT00699491|4047811|P1|NOT COMPLETED|Overall Study||0
1657647|NCT00699491|4047806|P6|COMPLETED|Overall Study||22
1657648|NCT00699491|4047807|P5|COMPLETED|Overall Study||8
1657649|NCT00699491|4047808|P4|COMPLETED|Overall Study||6
1657650|NCT00699491|4047809|P3|COMPLETED|Overall Study||7
1657651|NCT00699491|4047810|P2|COMPLETED|Overall Study||2
1657652|NCT00699491|4047811|P1|COMPLETED|Overall Study||3
1657653|NCT00699491|4047806|P6|STARTED|Overall Study||22
1657654|NCT00699491|4047807|P5|STARTED|Overall Study||8
1657655|NCT00699491|4047808|P4|STARTED|Overall Study||6
1657656|NCT00699491|4047809|P3|STARTED|Overall Study||7
1657657|NCT00699491|4047810|P2|STARTED|Overall Study||2
1657658|NCT00699491|4047811|P1|STARTED|Overall Study||3
1657659|NCT00699413|4047832|P2|NOT COMPLETED|Overall Study||2
1657660|NCT00699413|4047833|P1|NOT COMPLETED|Overall Study||0
1657661|NCT00699413|4047832|P2|COMPLETED|Overall Study||2
1657662|NCT00699413|4047833|P1|COMPLETED|Overall Study||4
1657663|NCT00699413|4047832|P2|STARTED|Overall Study||4
1657664|NCT00699413|4047833|P1|STARTED|Overall Study||4
1657665|NCT00699400|4047842|P6|NOT COMPLETED|Overall Study||11
1657666|NCT00699400|4047843|P5|NOT COMPLETED|Overall Study||0
1657667|NCT00699400|4047844|P4|NOT COMPLETED|Overall Study||0
1657668|NCT00699400|4047845|P3|NOT COMPLETED|Overall Study||0
1657669|NCT00699400|4047846|P2|NOT COMPLETED|Overall Study||0
1657670|NCT00699400|4047847|P1|NOT COMPLETED|Overall Study||0
1657671|NCT00699400|4047842|P6|COMPLETED|Overall Study||0
1657672|NCT00699400|4047843|P5|COMPLETED|Overall Study||4
1657673|NCT00699400|4047844|P4|COMPLETED|Overall Study||6
1657674|NCT00699400|4047845|P3|COMPLETED|Overall Study||138
1657675|NCT00699400|4047846|P2|COMPLETED|Overall Study||3
1657676|NCT00699400|4047847|P1|COMPLETED|Overall Study||42
1657677|NCT00699400|4047842|P6|STARTED|Overall Study||11
1657678|NCT00699400|4047843|P5|STARTED|Overall Study||4
1657679|NCT00699400|4047844|P4|STARTED|Overall Study||6
1657680|NCT00699400|4047845|P3|STARTED|Overall Study||138
1657681|NCT00699400|4047846|P2|STARTED|Overall Study||3
1657682|NCT00699400|4047847|P1|STARTED|Overall Study||42
1657683|NCT00699374|4047881|P2|NOT COMPLETED|Overall Study||544
1657684|NCT00699374|4047882|P1|NOT COMPLETED|Overall Study||530
1657685|NCT00699374|4047881|P2|COMPLETED|Overall Study||0
1657686|NCT00699374|4047882|P1|COMPLETED|Overall Study||0
1657687|NCT00699374|4047881|P2|Treated|Overall Study||542
1657688|NCT00699374|4047882|P1|Treated|Overall Study||526
1657689|NCT00699374|4047881|P2|STARTED|Overall Study||544
1657690|NCT00699374|4047882|P1|STARTED|Overall Study||530
1657691|NCT00699348|4047894|P1|NOT COMPLETED|Overall Study||90
1657692|NCT00699348|4047894|P1|COMPLETED|Overall Study||261
1657693|NCT00699348|4047894|P1|STARTED|Overall Study||351
1657694|NCT00699335|4047903|P1|NOT COMPLETED|Overall Study||228
1657695|NCT00699335|4047903|P1|COMPLETED|Overall Study||5080
1657696|NCT00699335|4047903|P1|STARTED|Overall Study||5308
1657697|NCT00699283|4047936|P2|NOT COMPLETED|Overall Study||8
1657698|NCT00699283|4047937|P1|NOT COMPLETED|Overall Study||33
1657699|NCT00699283|4047936|P2|COMPLETED|Overall Study||7
1657700|NCT00699283|4047937|P1|COMPLETED|Overall Study||14
1657701|NCT00699283|4047936|P2|STARTED|Overall Study||15
1657702|NCT00699283|4047937|P1|STARTED|Overall Study||47
1657703|NCT00699218|4047942|P1|NOT COMPLETED|Overall Study||0
1657704|NCT00699218|4047942|P1|COMPLETED|Overall Study||15
1657705|NCT00699218|4047942|P1|STARTED|Overall Study||15
1657706|NCT00699192|4047950|P3|NOT COMPLETED|Overall Study||11
1657707|NCT00699192|4047951|P2|NOT COMPLETED|Overall Study||12
1657708|NCT00699192|4047952|P1|NOT COMPLETED|Overall Study||16
1657709|NCT00699192|4047950|P3|COMPLETED|Overall Study||261
1657710|NCT00699192|4047951|P2|COMPLETED|Overall Study||260
1657711|NCT00699192|4047952|P1|COMPLETED|Overall Study||259
1657712|NCT00699192|4047950|P3|STARTED|Overall Study||272
1657713|NCT00699192|4047951|P2|STARTED|Overall Study||272
1657714|NCT00699192|4047952|P1|STARTED|Overall Study||275
1657715|NCT00699153|4047974|P2|NOT COMPLETED|Overall Study||2
1657716|NCT00699153|4047975|P1|NOT COMPLETED|Overall Study||3
1657717|NCT00699153|4047974|P2|COMPLETED|Overall Study||200
1657718|NCT00699153|4047975|P1|COMPLETED|Overall Study||200
1657719|NCT00699153|4047974|P2|STARTED|Overall Study|Intent to treat population|202
1657720|NCT00699153|4047975|P1|STARTED|Overall Study|Intent to treat population|203
1657721|NCT00699140|4047987|P1|NOT COMPLETED|Overall Study||0
1657722|NCT00699140|4047987|P1|COMPLETED|Overall Study||18
1657723|NCT00699140|4047987|P1|STARTED|Overall Study||18
1657724|NCT00699010|4048001|P2|NOT COMPLETED|Overall Study||0
1657725|NCT00699010|4048002|P1|NOT COMPLETED|Overall Study||0
1657726|NCT00699010|4048001|P2|COMPLETED|Overall Study||15
1657727|NCT00699010|4048002|P1|COMPLETED|Overall Study||15
1657728|NCT00699010|4048001|P2|STARTED|Overall Study||15
1657729|NCT00699010|4048002|P1|STARTED|Overall Study||15
1657730|NCT00698932|4048010|P2|NOT COMPLETED|Overall Study||36
1657731|NCT00698932|4048011|P1|NOT COMPLETED|Overall Study||22
1657732|NCT00698932|4048010|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
1657733|NCT00698932|4048011|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
1657734|NCT00698932|4048010|P2|STARTED|Overall Study|Randomized and treated|284
1657735|NCT00698932|4048011|P1|STARTED|Overall Study|Randomized and treated|284
1657736|NCT00698867|4048027|P1|NOT COMPLETED|Overall Study||91
1657737|NCT00698867|4048027|P1|COMPLETED|Overall Study||27
1657738|NCT00698867|4048027|P1|Subjects With 4 Year Data|Overall Study||34
1657739|NCT00698867|4048027|P1|Subjects With 3 Year Data|Overall Study||35
1657740|NCT00698867|4048027|P1|Subjects With 2 Year Data|Overall Study||55
1657741|NCT00698867|4048027|P1|Subjects With 1 Year Data|Overall Study||68
1657742|NCT00698867|4048027|P1|STARTED|Overall Study||118
1657743|NCT00698841|4048037|P1|NOT COMPLETED|Overall Study||18
1657744|NCT00698841|4048037|P1|COMPLETED|Overall Study||33
1657745|NCT00698841|4048037|P1|STARTED|Overall Study||51
1657746|NCT00698815|4048051|P3|NOT COMPLETED|Overall Study||10
1657747|NCT00698815|4048052|P2|NOT COMPLETED|Overall Study||14
1657748|NCT00698815|4048053|P1|NOT COMPLETED|Overall Study||10
1657749|NCT00698815|4048051|P3|COMPLETED|Overall Study||31
1657750|NCT00698815|4048052|P2|COMPLETED|Overall Study||33
1657751|NCT00698815|4048053|P1|COMPLETED|Overall Study||32
1657752|NCT00698815|4048051|P3|STARTED|Overall Study||41
1657753|NCT00698815|4048052|P2|STARTED|Overall Study||47
1657754|NCT00698815|4048053|P1|STARTED|Overall Study||42
1657755|NCT00698685|4048070|P1|NOT COMPLETED|Overall Study||2
1657756|NCT00698685|4048070|P1|COMPLETED|Overall Study||12
1657757|NCT00698685|4048070|P1|STARTED|Overall Study||14
1657758|NCT00698646|4048078|P3|NOT COMPLETED|Overall Study||29
1657759|NCT00698646|4048079|P2|NOT COMPLETED|Overall Study||31
1657760|NCT00698646|4048080|P1|NOT COMPLETED|Overall Study||36
1657761|NCT00698646|4048078|P3|COMPLETED|Overall Study||99
1657762|NCT00698646|4048079|P2|COMPLETED|Overall Study||97
1657763|NCT00698646|4048080|P1|COMPLETED|Overall Study||92
1657764|NCT00698646|4048078|P3|STARTED|Overall Study||128
1657765|NCT00698646|4048079|P2|STARTED|Overall Study||128
1657766|NCT00698646|4048080|P1|STARTED|Overall Study||128
1657767|NCT00698581|4048105|P2|NOT COMPLETED|Overall Study||12
1657768|NCT00698581|4048106|P1|NOT COMPLETED|Overall Study||45
1657769|NCT00698581|4048105|P2|COMPLETED|Overall Study||8
1657770|NCT00698581|4048106|P1|COMPLETED|Overall Study||23
1657771|NCT00698581|4048105|P2|STARTED|Overall Study||20
1657772|NCT00698581|4048106|P1|STARTED|Overall Study||68
1657773|NCT00698516|4048117|P1|NOT COMPLETED|Overall Study||5
1657774|NCT00698516|4048117|P1|COMPLETED|Overall Study||45
1657775|NCT00698516|4048117|P1|STARTED|Overall Study||50
1657776|NCT00698451|4048135|P1|NOT COMPLETED|Overall Study||39
1657777|NCT00698451|4048135|P1|COMPLETED|Overall Study||15
1657778|NCT00698451|4048135|P1|STARTED|Overall Study||54
1657779|NCT00698204|4048142|P2|NOT COMPLETED|Overall Study||0
1657780|NCT00698204|4048143|P1|NOT COMPLETED|Overall Study||1
1657781|NCT00698204|4048142|P2|COMPLETED|Overall Study||20
1657782|NCT00698204|4048143|P1|COMPLETED|Overall Study||19
1657783|NCT00698204|4048142|P2|STARTED|Overall Study||20
1657784|NCT00698204|4048143|P1|STARTED|Overall Study||20
1657785|NCT00698139|4048154|P3|NOT COMPLETED|Overall Study||0
1657786|NCT00698139|4048155|P2|NOT COMPLETED|Overall Study||0
1657787|NCT00698139|4048156|P1|NOT COMPLETED|Overall Study||0
1657788|NCT00698139|4048154|P3|COMPLETED|Overall Study||1
1657789|NCT00698139|4048155|P2|COMPLETED|Overall Study||1
1657790|NCT00698139|4048156|P1|COMPLETED|Overall Study||1
1657791|NCT00698139|4048154|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
1657792|NCT00698139|4048155|P2|2nd Visit|Overall Study||1
1657793|NCT00698139|4048156|P1|2nd Visit|Overall Study||1
1657794|NCT00698139|4048154|P3|STARTED|Overall Study||1
1657795|NCT00698139|4048155|P2|STARTED|Overall Study||1
1657796|NCT00698139|4048156|P1|STARTED|Overall Study||1
1657797|NCT00698035|4048172|P2|NOT COMPLETED|Overall Study||2
1657798|NCT00698035|4048173|P1|NOT COMPLETED|Overall Study||4
1657799|NCT00698035|4048172|P2|COMPLETED|Overall Study||34
1657800|NCT00698035|4048173|P1|COMPLETED|Overall Study||35
1657801|NCT00698035|4048172|P2|STARTED|Overall Study||36
1657802|NCT00698035|4048173|P1|STARTED|Overall Study||39
1657803|NCT00698022|4048193|P3|NOT COMPLETED|Overall Study||2
1657804|NCT00698022|4048194|P2|NOT COMPLETED|Overall Study||10
1657805|NCT00698022|4048195|P1|NOT COMPLETED|Overall Study||16
1657806|NCT00698022|4048193|P3|COMPLETED|Overall Study||14
1657807|NCT00698022|4048194|P2|COMPLETED|Overall Study||20
1657808|NCT00698022|4048195|P1|COMPLETED|Overall Study||14
1657809|NCT00698022|4048193|P3|STARTED|Overall Study||16
1657810|NCT00698022|4048194|P2|STARTED|Overall Study||30
1657811|NCT00698022|4048195|P1|STARTED|Overall Study||30
1657812|NCT00698009|4048203|P1|NOT COMPLETED|Overall Study||1
1657813|NCT00698009|4048203|P1|COMPLETED|Overall Study||0
1657814|NCT00698009|4048203|P1|STARTED|Overall Study||1
1657815|NCT00697827|4048209|P2|NOT COMPLETED|Overall Study||1
1657816|NCT00697827|4048210|P1|NOT COMPLETED|Overall Study||2
1657817|NCT00697827|4048209|P2|COMPLETED|Overall Study||15
1657818|NCT00697827|4048210|P1|COMPLETED|Overall Study||26
1657819|NCT00697827|4048209|P2|STARTED|Overall Study||16
1657820|NCT00697827|4048210|P1|STARTED|Overall Study||28
1657821|NCT00697801|4048221|P3|NOT COMPLETED|Overall Study||24
1657822|NCT00697801|4048222|P2|NOT COMPLETED|Overall Study||12
1657823|NCT00697801|4048223|P1|NOT COMPLETED|Overall Study||12
1657824|NCT00697801|4048221|P3|COMPLETED|Overall Study||45
1657825|NCT00697801|4048222|P2|COMPLETED|Overall Study||58
1657826|NCT00697801|4048223|P1|COMPLETED|Overall Study||57
1657827|NCT00697801|4048221|P3|STARTED|Overall Study||69
1657828|NCT00697801|4048222|P2|STARTED|Overall Study||70
1657829|NCT00697801|4048223|P1|STARTED|Overall Study||69
1657830|NCT00697788|4048237|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657831|NCT00697788|4048238|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657832|NCT00697788|4048239|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657833|NCT00697788|4048240|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657834|NCT00697788|4048241|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657835|NCT00697788|4048242|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657836|NCT00697788|4048243|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657837|NCT00697788|4048244|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657838|NCT00697788|4048237|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
1657839|NCT00697788|4048238|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657840|NCT00697788|4048239|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657841|NCT00697788|4048240|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657842|NCT00697788|4048241|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657843|NCT00697788|4048242|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657844|NCT00697788|4048243|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657845|NCT00697788|4048244|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657846|NCT00697788|4048237|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
1657847|NCT00697788|4048238|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657848|NCT00697788|4048239|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657849|NCT00697788|4048240|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657850|NCT00697788|4048241|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657851|NCT00697788|4048242|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657852|NCT00697788|4048243|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657853|NCT00697788|4048244|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1657854|NCT00697788|4048237|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657855|NCT00697788|4048238|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657856|NCT00697788|4048239|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657857|NCT00697788|4048240|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657858|NCT00697788|4048241|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657859|NCT00697788|4048242|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657860|NCT00697788|4048243|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657861|NCT00697788|4048244|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657862|NCT00697788|4048237|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657863|NCT00697788|4048238|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
1657864|NCT00697788|4048239|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657865|NCT00697788|4048240|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657866|NCT00697788|4048241|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657867|NCT00697788|4048242|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657868|NCT00697788|4048243|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657869|NCT00697788|4048244|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657870|NCT00697788|4048237|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657871|NCT00697788|4048238|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
1657872|NCT00697788|4048239|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657873|NCT00697788|4048240|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657874|NCT00697788|4048241|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657875|NCT00697788|4048242|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657876|NCT00697788|4048243|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657877|NCT00697788|4048244|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1657878|NCT00697788|4048237|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657879|NCT00697788|4048238|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657880|NCT00697788|4048239|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657881|NCT00697788|4048240|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657882|NCT00697788|4048241|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657883|NCT00697788|4048242|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657884|NCT00697788|4048243|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657885|NCT00697788|4048244|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657886|NCT00697788|4048237|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657887|NCT00697788|4048238|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657888|NCT00697788|4048239|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
1657889|NCT00697788|4048240|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657890|NCT00697788|4048241|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657891|NCT00697788|4048242|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657892|NCT00697788|4048243|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657893|NCT00697788|4048244|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657894|NCT00697788|4048237|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657895|NCT00697788|4048238|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657896|NCT00697788|4048239|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
1657897|NCT00697788|4048240|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657898|NCT00697788|4048241|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657899|NCT00697788|4048242|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657900|NCT00697788|4048243|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657901|NCT00697788|4048244|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1657902|NCT00697788|4048237|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657903|NCT00697788|4048238|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657904|NCT00697788|4048239|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657905|NCT00697788|4048240|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
1657906|NCT00697788|4048241|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657907|NCT00697788|4048242|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657908|NCT00697788|4048243|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657909|NCT00697788|4048244|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657910|NCT00697788|4048237|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657911|NCT00697788|4048238|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657912|NCT00697788|4048239|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657913|NCT00697788|4048240|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
1657914|NCT00697788|4048241|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657915|NCT00697788|4048242|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657916|NCT00697788|4048243|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657917|NCT00697788|4048244|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657918|NCT00697788|4048237|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657919|NCT00697788|4048238|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657920|NCT00697788|4048239|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657921|NCT00697788|4048240|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
1657922|NCT00697788|4048241|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657923|NCT00697788|4048242|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657924|NCT00697788|4048243|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657925|NCT00697788|4048244|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1657926|NCT00697788|4048237|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657927|NCT00697788|4048238|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657928|NCT00697788|4048239|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657929|NCT00697788|4048240|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657930|NCT00697788|4048241|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657931|NCT00697788|4048242|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657932|NCT00697788|4048243|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657933|NCT00697788|4048244|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657934|NCT00697788|4048237|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657935|NCT00697788|4048238|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657936|NCT00697788|4048239|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657937|NCT00697788|4048240|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657938|NCT00697788|4048241|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
1657939|NCT00697788|4048242|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657940|NCT00697788|4048243|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657941|NCT00697788|4048244|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657942|NCT00697788|4048237|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657943|NCT00697788|4048238|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657944|NCT00697788|4048239|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657945|NCT00697788|4048240|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657946|NCT00697788|4048241|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
1657947|NCT00697788|4048242|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657948|NCT00697788|4048243|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657949|NCT00697788|4048244|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1657950|NCT00697788|4048237|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657951|NCT00697788|4048238|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657952|NCT00697788|4048239|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657953|NCT00697788|4048240|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657954|NCT00697788|4048241|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657955|NCT00697788|4048242|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657956|NCT00697788|4048243|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657957|NCT00697788|4048244|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657958|NCT00697788|4048237|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657959|NCT00697788|4048238|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657960|NCT00697788|4048239|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657961|NCT00697788|4048240|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657962|NCT00697788|4048241|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657963|NCT00697788|4048242|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
1657964|NCT00697788|4048243|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657965|NCT00697788|4048244|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657966|NCT00697788|4048237|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657967|NCT00697788|4048238|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657968|NCT00697788|4048239|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657969|NCT00697788|4048240|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657970|NCT00697788|4048241|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657971|NCT00697788|4048242|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
1657972|NCT00697788|4048243|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657973|NCT00697788|4048244|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1657974|NCT00697788|4048237|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657975|NCT00697788|4048238|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657976|NCT00697788|4048239|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657977|NCT00697788|4048240|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657978|NCT00697788|4048241|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657979|NCT00697788|4048242|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657980|NCT00697788|4048243|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
1657981|NCT00697788|4048244|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657982|NCT00697788|4048237|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657983|NCT00697788|4048238|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657984|NCT00697788|4048239|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657985|NCT00697788|4048240|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657986|NCT00697788|4048241|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657987|NCT00697788|4048242|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657988|NCT00697788|4048243|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
1657989|NCT00697788|4048244|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657990|NCT00697788|4048237|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657991|NCT00697788|4048238|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657992|NCT00697788|4048239|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657993|NCT00697788|4048240|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657994|NCT00697788|4048241|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657995|NCT00697788|4048242|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657996|NCT00697788|4048243|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
1657997|NCT00697788|4048244|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1657998|NCT00697788|4048237|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1657999|NCT00697788|4048238|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658000|NCT00697788|4048239|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658001|NCT00697788|4048240|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658002|NCT00697788|4048241|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658003|NCT00697788|4048242|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658004|NCT00697788|4048243|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658005|NCT00697788|4048244|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658006|NCT00697788|4048237|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658007|NCT00697788|4048238|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658008|NCT00697788|4048239|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658009|NCT00697788|4048240|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658010|NCT00697788|4048241|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658011|NCT00697788|4048242|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658012|NCT00697788|4048243|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1658013|NCT00697788|4048244|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
1658014|NCT00697788|4048237|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1658015|NCT00697788|4048238|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1658016|NCT00697788|4048239|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1658017|NCT00697788|4048240|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1658018|NCT00697788|4048241|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1658019|NCT00697788|4048242|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
1658020|NCT00697788|4048243|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
1658021|NCT00697788|4048244|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
1658022|NCT00697697|4048288|P2|NOT COMPLETED|Overall Study||54
1658023|NCT00697697|4048289|P1|NOT COMPLETED|Overall Study||49
1658024|NCT00697697|4048288|P2|COMPLETED|Overall Study||44
1658025|NCT00697697|4048289|P1|COMPLETED|Overall Study||45
1658026|NCT00697697|4048288|P2|STARTED|Overall Study||98
1658027|NCT00697697|4048289|P1|STARTED|Overall Study||94
1658028|NCT00697619|4048299|P2|NOT COMPLETED|Overall Study||8
1658029|NCT00697619|4048300|P1|NOT COMPLETED|Overall Study||6
1658030|NCT00697619|4048299|P2|COMPLETED|Overall Study||22
1658031|NCT00697619|4048300|P1|COMPLETED|Overall Study||24
1658032|NCT00697619|4048299|P2|STARTED|Overall Study||30
1658033|NCT00697619|4048300|P1|STARTED|Overall Study||30
1658034|NCT00697593|4048306|P1|NOT COMPLETED|Overall Study||19
1658035|NCT00697593|4048306|P1|COMPLETED|Overall Study||51
1658036|NCT00697593|4048306|P1|STARTED|Overall Study||70
1658037|NCT00697541|4048339|P2|NOT COMPLETED|Overall Study||1
1658038|NCT00697541|4048340|P1|NOT COMPLETED|Overall Study||2
1658039|NCT00697541|4048339|P2|COMPLETED|Overall Study||9
1658040|NCT00697541|4048340|P1|COMPLETED|Overall Study||8
1658041|NCT00697541|4048339|P2|STARTED|Overall Study||10
1658042|NCT00697541|4048340|P1|STARTED|Overall Study||10
1658043|NCT00697515|4048350|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
1658044|NCT00697515|4048351|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
1658045|NCT00697515|4048350|P2|COMPLETED|Second Intervention (Crossover Period)||51
1658046|NCT00697515|4048351|P1|COMPLETED|Second Intervention (Crossover Period)||52
1658047|NCT00697515|4048350|P2|STARTED|Second Intervention (Crossover Period)||52
1658048|NCT00697515|4048351|P1|STARTED|Second Intervention (Crossover Period)||53
1658049|NCT00697515|4048350|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
1658050|NCT00697515|4048351|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
1658051|NCT00697515|4048350|P2|COMPLETED|First Intervention (Crossover Period)||52
1658052|NCT00697515|4048351|P1|COMPLETED|First Intervention (Crossover Period)||53
1658053|NCT00697515|4048350|P2|STARTED|First Intervention (Crossover Period)||64
1658054|NCT00697515|4048351|P1|STARTED|First Intervention (Crossover Period)||63
1658055|NCT00697515|4048350|P2|NOT COMPLETED|Dose Optimization Period||0
1658056|NCT00697515|4048351|P1|NOT COMPLETED|Dose Optimization Period||15
1658057|NCT00697515|4048350|P2|COMPLETED|Dose Optimization Period||0
1658058|NCT00697515|4048351|P1|COMPLETED|Dose Optimization Period||127
1658059|NCT00697515|4048350|P2|STARTED|Dose Optimization Period||0
1658060|NCT00697515|4048351|P1|STARTED|Dose Optimization Period||142
1658061|NCT00697463|4048379|P1|NOT COMPLETED|Overall Study||1
1658062|NCT00697463|4048379|P1|COMPLETED|Overall Study||21
1658063|NCT00697463|4048379|P1|STARTED|Overall Study||22
1658064|NCT00697255|4048385|P2|NOT COMPLETED|Stage 1b||2
1658065|NCT00697255|4048386|P1|NOT COMPLETED|Stage 1b||0
1658066|NCT00697255|4048385|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
1658067|NCT00697255|4048386|P1|COMPLETED|Stage 1b||0
1658068|NCT00697255|4048385|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
1658069|NCT00697255|4048386|P1|STARTED|Stage 1b||0
1658070|NCT00697255|4048385|P2|NOT COMPLETED|Stage 1a||0
1658071|NCT00697255|4048386|P1|NOT COMPLETED|Stage 1a||3
1658072|NCT00697255|4048385|P2|COMPLETED|Stage 1a||0
1658073|NCT00697255|4048386|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
1658074|NCT00697255|4048385|P2|STARTED|Stage 1a||0
1658075|NCT00697255|4048386|P1|STARTED|Stage 1a||5
1658076|NCT00697190|4048402|P2|NOT COMPLETED|Second Intervention||0
1658077|NCT00697190|4048403|P1|NOT COMPLETED|Second Intervention||0
1658078|NCT00697190|4048402|P2|COMPLETED|Second Intervention||20
1658079|NCT00697190|4048403|P1|COMPLETED|Second Intervention||18
1658080|NCT00697190|4048402|P2|STARTED|Second Intervention||20
1658081|NCT00697190|4048403|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
1658082|NCT00697190|4048402|P2|NOT COMPLETED|First Intervention||0
1658083|NCT00697190|4048403|P1|NOT COMPLETED|First Intervention||0
1658084|NCT00697190|4048402|P2|COMPLETED|First Intervention||20
1658085|NCT00697190|4048403|P1|COMPLETED|First Intervention||19
1658086|NCT00697190|4048402|P2|STARTED|First Intervention||20
1658087|NCT00697190|4048403|P1|STARTED|First Intervention||19
1658088|NCT00697112|4048437|P1|NOT COMPLETED|Overall Study||10
1658089|NCT00697112|4048437|P1|COMPLETED|Overall Study||43
1658090|NCT00697112|4048437|P1|Met the Inclusion Criteria|Overall Study||52
1658091|NCT00697112|4048437|P1|STARTED|Overall Study||53
1658092|NCT00697073|4048461|P1|NOT COMPLETED|Overall Study||9
1658093|NCT00697073|4048461|P1|COMPLETED|Overall Study||59
1658094|NCT00697073|4048461|P1|STARTED|Overall Study||68
1658095|NCT00696878|4048465|P1|NOT COMPLETED|Overall Study||504
1658096|NCT00696878|4048465|P1|COMPLETED|Overall Study||178
1658097|NCT00696878|4048465|P1|STARTED|Overall Study||682
1658098|NCT00696800|4048539|P2|NOT COMPLETED|Overall Study||48
1658099|NCT00696800|4048540|P1|NOT COMPLETED|Overall Study||85
1658100|NCT00696800|4048539|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
1658101|NCT00696800|4048540|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
1658102|NCT00696800|4048539|P2|Treated (ITT)|Overall Study|The ITT group|750
1658103|NCT00696800|4048540|P1|Treated (ITT)|Overall Study|The ITT group|756
1658104|NCT00696800|4048539|P2|STARTED|Overall Study||752
1658105|NCT00696800|4048540|P1|STARTED|Overall Study||757
1658106|NCT00696787|4048593|P3|NOT COMPLETED|Overall Study||26
1658107|NCT00696787|4048594|P2|NOT COMPLETED|Overall Study||20
1658108|NCT00696787|4048595|P1|NOT COMPLETED|Overall Study||15
1658109|NCT00696787|4048593|P3|COMPLETED|Overall Study||17
1658110|NCT00696787|4048594|P2|COMPLETED|Overall Study||22
1658111|NCT00696787|4048595|P1|COMPLETED|Overall Study||25
1658112|NCT00696787|4048593|P3|STARTED|Overall Study||43
1658113|NCT00696787|4048594|P2|STARTED|Overall Study||42
1658114|NCT00696787|4048595|P1|STARTED|Overall Study||40
1658115|NCT00696774|4048609|P3|NOT COMPLETED|Period III||0
1658116|NCT00696774|4048610|P2|NOT COMPLETED|Period III||7
1658117|NCT00696774|4048611|P1|NOT COMPLETED|Period III||7
1658118|NCT00696774|4048609|P3|COMPLETED|Period III||0
1658119|NCT00696774|4048610|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
1658120|NCT00696774|4048611|P1|COMPLETED|Period III||106
1658121|NCT00696774|4048609|P3|STARTED|Period III||0
1658122|NCT00696774|4048610|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
1658123|NCT00696774|4048611|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
1658124|NCT00696774|4048609|P3|NOT COMPLETED|Period II||36
1658125|NCT00696774|4048610|P2|NOT COMPLETED|Period II||0
1658126|NCT00696774|4048611|P1|NOT COMPLETED|Period II||0
1658127|NCT00696774|4048609|P3|COMPLETED|Period II||0
1658128|NCT00696774|4048610|P2|COMPLETED|Period II||91
1658129|NCT00696774|4048611|P1|COMPLETED|Period II||115
1658130|NCT00696774|4048609|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
1658131|NCT00696774|4048610|P2|STARTED|Period II||91
1658132|NCT00696774|4048611|P1|STARTED|Period II||115
1658133|NCT00696761|4048649|P4|NOT COMPLETED|Overall Study||10
1658134|NCT00696761|4048650|P3|NOT COMPLETED|Overall Study||11
1658135|NCT00696761|4048651|P2|NOT COMPLETED|Overall Study||26
1658136|NCT00696761|4048652|P1|NOT COMPLETED|Overall Study||20
1658137|NCT00696761|4048649|P4|COMPLETED|Overall Study||44
1658138|NCT00696761|4048650|P3|COMPLETED|Overall Study||30
1658139|NCT00696761|4048651|P2|COMPLETED|Overall Study||50
1658140|NCT00696761|4048652|P1|COMPLETED|Overall Study||41
1658141|NCT00696761|4048649|P4|STARTED|Overall Study||54
1658142|NCT00696761|4048650|P3|STARTED|Overall Study||41
1658143|NCT00696761|4048651|P2|STARTED|Overall Study||76
1658144|NCT00696761|4048652|P1|STARTED|Overall Study||61
1658145|NCT00696696|4048666|P1|NOT COMPLETED|Overall Study||18
1658146|NCT00696696|4048666|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
1658147|NCT00696696|4048666|P1|STARTED|Overall Study||44
1658148|NCT00696657|4048681|P9|NOT COMPLETED|Overall Study||9
1658149|NCT00696657|4048682|P8|NOT COMPLETED|Overall Study||3
1658150|NCT00696657|4048683|P7|NOT COMPLETED|Overall Study||15
1658151|NCT00696657|4048684|P6|NOT COMPLETED|Overall Study||12
1658152|NCT00696657|4048685|P5|NOT COMPLETED|Overall Study||10
1658153|NCT00696657|4048686|P4|NOT COMPLETED|Overall Study||11
1658154|NCT00696657|4048687|P3|NOT COMPLETED|Overall Study||8
1658155|NCT00696657|4048688|P2|NOT COMPLETED|Overall Study||5
1658156|NCT00696657|4048689|P1|NOT COMPLETED|Overall Study||1
1658157|NCT00696657|4048681|P9|COMPLETED|Overall Study||41
1658158|NCT00696657|4048682|P8|COMPLETED|Overall Study||42
1658159|NCT00696657|4048683|P7|COMPLETED|Overall Study||30
1658160|NCT00696657|4048684|P6|COMPLETED|Overall Study||33
1658161|NCT00696657|4048685|P5|COMPLETED|Overall Study||34
1658162|NCT00696657|4048686|P4|COMPLETED|Overall Study||38
1658163|NCT00696657|4048687|P3|COMPLETED|Overall Study||36
1658164|NCT00696657|4048688|P2|COMPLETED|Overall Study||42
1658165|NCT00696657|4048689|P1|COMPLETED|Overall Study||45
1658166|NCT00696657|4048681|P9|EXPOSED|Overall Study||50
1658167|NCT00696657|4048682|P8|EXPOSED|Overall Study||45
1658168|NCT00696657|4048683|P7|EXPOSED|Overall Study||45
1658169|NCT00696657|4048684|P6|EXPOSED|Overall Study||43
1658170|NCT00696657|4048685|P5|EXPOSED|Overall Study||44
1658171|NCT00696657|4048686|P4|EXPOSED|Overall Study||48
1658172|NCT00696657|4048687|P3|EXPOSED|Overall Study||43
1658173|NCT00696657|4048688|P2|EXPOSED|Overall Study||47
1658174|NCT00696657|4048689|P1|EXPOSED|Overall Study||46
1658175|NCT00696657|4048681|P9|STARTED|Overall Study||50
1658176|NCT00696657|4048682|P8|STARTED|Overall Study||45
1658177|NCT00696657|4048683|P7|STARTED|Overall Study||45
1658178|NCT00696657|4048684|P6|STARTED|Overall Study||45
1658179|NCT00696657|4048685|P5|STARTED|Overall Study||44
1658180|NCT00696657|4048686|P4|STARTED|Overall Study||49
1658181|NCT00696657|4048687|P3|STARTED|Overall Study||44
1658182|NCT00696657|4048688|P2|STARTED|Overall Study||47
1658183|NCT00696657|4048689|P1|STARTED|Overall Study||46
1658184|NCT00696618|4049016|P3|NOT COMPLETED|Overall Study||0
1658185|NCT00696618|4049017|P2|NOT COMPLETED|Overall Study||0
1658186|NCT00696618|4049018|P1|NOT COMPLETED|Overall Study||0
1658187|NCT00696618|4049016|P3|COMPLETED|Overall Study||3
1658188|NCT00696618|4049017|P2|COMPLETED|Overall Study||3
1658189|NCT00696618|4049018|P1|COMPLETED|Overall Study||3
1658190|NCT00696618|4049016|P3|STARTED|Overall Study||3
1658191|NCT00696618|4049017|P2|STARTED|Overall Study||3
1658192|NCT00696618|4049018|P1|STARTED|Overall Study||3
1658193|NCT00696488|4049032|P1|NOT COMPLETED|Overall Study||0
1658194|NCT00696488|4049032|P1|COMPLETED|Overall Study||20
1658195|NCT00696488|4049032|P1|STARTED|Overall Study||20
1658196|NCT00696449|4049040|P4|NOT COMPLETED|Overall Study||3
1658197|NCT00696449|4049041|P3|NOT COMPLETED|Overall Study||1
1658198|NCT00696449|4049042|P2|NOT COMPLETED|Overall Study||6
1658199|NCT00696449|4049043|P1|NOT COMPLETED|Overall Study||3
1658200|NCT00696449|4049040|P4|COMPLETED|Overall Study||13
1658201|NCT00696449|4049041|P3|COMPLETED|Overall Study||14
1658202|NCT00696449|4049042|P2|COMPLETED|Overall Study||9
1658203|NCT00696449|4049043|P1|COMPLETED|Overall Study||12
1658204|NCT00696449|4049040|P4|STARTED|Overall Study||16
1658205|NCT00696449|4049041|P3|STARTED|Overall Study||15
1658206|NCT00696449|4049042|P2|STARTED|Overall Study||15
1658207|NCT00696449|4049043|P1|STARTED|Overall Study||15
1658208|NCT00696436|4049058|P5|NOT COMPLETED|Overall Study||13
1658209|NCT00696436|4049059|P4|NOT COMPLETED|Overall Study||22
1658210|NCT00696436|4049060|P3|NOT COMPLETED|Overall Study||28
1658211|NCT00696436|4049061|P2|NOT COMPLETED|Overall Study||30
1658212|NCT00696436|4049062|P1|NOT COMPLETED|Overall Study||23
1658213|NCT00696436|4049058|P5|COMPLETED|Overall Study||141
1658214|NCT00696436|4049059|P4|COMPLETED|Overall Study||268
1658215|NCT00696436|4049060|P3|COMPLETED|Overall Study||254
1658216|NCT00696436|4049061|P2|COMPLETED|Overall Study||255
1658217|NCT00696436|4049062|P1|COMPLETED|Overall Study||257
1658218|NCT00696436|4049058|P5|STARTED|Overall Study|Randomized participants only.|154
1658219|NCT00696436|4049059|P4|STARTED|Overall Study|Randomized participants only.|290
1658220|NCT00696436|4049060|P3|STARTED|Overall Study|Randomized participants only.|282
1658221|NCT00696436|4049061|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
1658222|NCT00696436|4049062|P1|STARTED|Overall Study|Randomized participants only.|280
1658223|NCT00696423|4049146|P2|NOT COMPLETED|Overall Study||5
1658224|NCT00696423|4049147|P1|NOT COMPLETED|Overall Study||0
1658225|NCT00696423|4049146|P2|COMPLETED|Overall Study||218
1658226|NCT00696423|4049147|P1|COMPLETED|Overall Study||244
1658227|NCT00696423|4049146|P2|STARTED|Overall Study||223
1658228|NCT00696423|4049147|P1|STARTED|Overall Study||244
1658229|NCT00696410|4049179|P2|NOT COMPLETED|Overall Study||0
1658230|NCT00696410|4049180|P1|NOT COMPLETED|Overall Study||13
1658231|NCT00696410|4049179|P2|COMPLETED|Overall Study||10
1658232|NCT00696410|4049180|P1|COMPLETED|Overall Study||25
1658233|NCT00696410|4049179|P2|STARTED|Overall Study||10
1658234|NCT00696410|4049180|P1|STARTED|Overall Study||38
1658235|NCT00696384|4049194|P3|NOT COMPLETED|Double Blind Phase||6
1658236|NCT00696384|4049195|P2|NOT COMPLETED|Double Blind Phase||11
1658237|NCT00696384|4049196|P1|NOT COMPLETED|Double Blind Phase||0
1658238|NCT00696384|4049194|P3|COMPLETED|Double Blind Phase||145
1658239|NCT00696384|4049195|P2|COMPLETED|Double Blind Phase||137
1658240|NCT00696384|4049196|P1|COMPLETED|Double Blind Phase||0
1658241|NCT00696384|4049194|P3|STARTED|Double Blind Phase||151
1658242|NCT00696384|4049195|P2|STARTED|Double Blind Phase||148
1658243|NCT00696384|4049196|P1|STARTED|Double Blind Phase||0
1658244|NCT00696384|4049194|P3|NOT COMPLETED|Open Label Phase||0
1658245|NCT00696384|4049195|P2|NOT COMPLETED|Open Label Phase||0
1658246|NCT00696384|4049196|P1|NOT COMPLETED|Open Label Phase||119
1658247|NCT00696384|4049194|P3|COMPLETED|Open Label Phase||0
1658248|NCT00696384|4049195|P2|COMPLETED|Open Label Phase||0
1658249|NCT00696384|4049196|P1|COMPLETED|Open Label Phase||299
1658250|NCT00696384|4049194|P3|STARTED|Open Label Phase||0
1658251|NCT00696384|4049195|P2|STARTED|Open Label Phase||0
1658252|NCT00696384|4049196|P1|STARTED|Open Label Phase||418
1658253|NCT00696293|4049210|P1|NOT COMPLETED|Overall Study||2
1658254|NCT00696293|4049210|P1|COMPLETED|Overall Study||28
1658255|NCT00696293|4049210|P1|STARTED|Overall Study||30
1658256|NCT00696241|4049220|P5|NOT COMPLETED|Overall Study||12
1658257|NCT00696241|4049221|P4|NOT COMPLETED|Overall Study||14
1658258|NCT00696241|4049222|P3|NOT COMPLETED|Overall Study||24
1658259|NCT00696241|4049223|P2|NOT COMPLETED|Overall Study||22
1658260|NCT00696241|4049224|P1|NOT COMPLETED|Overall Study||24
1658261|NCT00696241|4049220|P5|COMPLETED|Overall Study||130
1658262|NCT00696241|4049221|P4|COMPLETED|Overall Study||268
1658263|NCT00696241|4049222|P3|COMPLETED|Overall Study||261
1658264|NCT00696241|4049223|P2|COMPLETED|Overall Study||261
1658265|NCT00696241|4049224|P1|COMPLETED|Overall Study||259
1658266|NCT00696241|4049220|P5|STARTED|Overall Study||142
1658267|NCT00696241|4049221|P4|STARTED|Overall Study||282
1658268|NCT00696241|4049222|P3|STARTED|Overall Study||285
1658269|NCT00696241|4049223|P2|STARTED|Overall Study||283
1658270|NCT00696241|4049224|P1|STARTED|Overall Study||283
1658271|NCT00696137|4049306|P1|NOT COMPLETED|Overall Study||2
1658272|NCT00696137|4049306|P1|COMPLETED|Overall Study||3
1658273|NCT00696137|4049306|P1|STARTED|Overall Study||5
1658274|NCT00696072|4049312|P2|NOT COMPLETED|Overall Study||63
1658275|NCT00696072|4049313|P1|NOT COMPLETED|Overall Study||57
1658276|NCT00696072|4049312|P2|COMPLETED|Overall Study||0
1658277|NCT00696072|4049313|P1|COMPLETED|Overall Study||0
1658278|NCT00696072|4049312|P2|STARTED|Overall Study||63
1658279|NCT00696072|4049313|P1|STARTED|Overall Study||57
1658280|NCT00696020|4049334|P4|NOT COMPLETED|Overall Study||4
1658281|NCT00696020|4049335|P3|NOT COMPLETED|Overall Study||3
1658282|NCT00696020|4049336|P2|NOT COMPLETED|Overall Study||2
1658283|NCT00696020|4049337|P1|NOT COMPLETED|Overall Study||4
1658284|NCT00696020|4049334|P4|COMPLETED|Overall Study||84
1658285|NCT00696020|4049335|P3|COMPLETED|Overall Study||90
1658286|NCT00696020|4049336|P2|COMPLETED|Overall Study||87
1658287|NCT00696020|4049337|P1|COMPLETED|Overall Study||86
1658288|NCT00696020|4049334|P4|STARTED|Overall Study||88
1658289|NCT00696020|4049335|P3|STARTED|Overall Study||93
1658290|NCT00696020|4049336|P2|STARTED|Overall Study||89
1658291|NCT00696020|4049337|P1|STARTED|Overall Study||90
1658292|NCT00695955|4049445|P1|NOT COMPLETED|Cohort 2||104
1658293|NCT00695955|4049445|P1|COMPLETED|Cohort 2||203
1658294|NCT00695955|4049445|P1|STARTED|Cohort 2||307
1658295|NCT00695955|4049445|P1|NOT COMPLETED|Cohort 1||102
1658296|NCT00695955|4049445|P1|COMPLETED|Cohort 1||260
1658297|NCT00695955|4049445|P1|STARTED|Cohort 1||362
1658298|NCT00695903|4049457|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
1658299|NCT00695903|4049458|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
1658300|NCT00695903|4049457|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
1658301|NCT00695903|4049458|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
1658302|NCT00695903|4049457|P2|STARTED|Had Test of Cure (TOC) Assessment||4
1658303|NCT00695903|4049458|P1|STARTED|Had Test of Cure (TOC) Assessment||7
1658304|NCT00695903|4049457|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
1658305|NCT00695903|4049458|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
1658306|NCT00695903|4049457|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
1658307|NCT00695903|4049458|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
1658308|NCT00695903|4049457|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
1658309|NCT00695903|4049458|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
1658310|NCT00695903|4049457|P2|STARTED|Had End of Therapy (EOT) Assessment||19
1658311|NCT00695903|4049458|P1|STARTED|Had End of Therapy (EOT) Assessment||19
1658312|NCT00695864|4049470|P1|NOT COMPLETED|Ondansetron||5
1658313|NCT00695864|4049470|P1|COMPLETED|Ondansetron||9
1658314|NCT00695864|4049470|P1|STARTED|Ondansetron||14
1658315|NCT00695864|4049470|P1|NOT COMPLETED|Placebo||5
1658316|NCT00695864|4049470|P1|COMPLETED|Placebo||9
1658317|NCT00695864|4049470|P1|STARTED|Placebo||14
1658318|NCT00695669|4049480|P4|NOT COMPLETED|Overall Study||4
1658319|NCT00695669|4049481|P3|NOT COMPLETED|Overall Study||3
1658320|NCT00695669|4049482|P2|NOT COMPLETED|Overall Study||4
1658321|NCT00695669|4049483|P1|NOT COMPLETED|Overall Study||4
1658322|NCT00695669|4049480|P4|COMPLETED|Overall Study||74
1658323|NCT00695669|4049481|P3|COMPLETED|Overall Study||75
1658324|NCT00695669|4049482|P2|COMPLETED|Overall Study||74
1658325|NCT00695669|4049483|P1|COMPLETED|Overall Study||74
1658326|NCT00695669|4049480|P4|STARTED|Overall Study||78
1658327|NCT00695669|4049481|P3|STARTED|Overall Study||78
1658328|NCT00695669|4049482|P2|STARTED|Overall Study||78
1658329|NCT00695669|4049483|P1|STARTED|Overall Study||78
1658330|NCT00695578|4049559|P2|NOT COMPLETED|Overall Study||0
1658331|NCT00695578|4049560|P1|NOT COMPLETED|Overall Study||0
1658332|NCT00695578|4049559|P2|COMPLETED|Overall Study||10
1658333|NCT00695578|4049560|P1|COMPLETED|Overall Study||10
1658334|NCT00695578|4049559|P2|STARTED|Overall Study||10
1658335|NCT00695578|4049560|P1|STARTED|Overall Study||10
1658336|NCT00695565|4049568|P2|NOT COMPLETED|Overall Study||9
1658337|NCT00695565|4049569|P1|NOT COMPLETED|Overall Study||13
1658338|NCT00695565|4049568|P2|COMPLETED|Overall Study||81
1658339|NCT00695565|4049569|P1|COMPLETED|Overall Study||77
1658340|NCT00695565|4049568|P2|STARTED|Overall Study||90
1658341|NCT00695565|4049569|P1|STARTED|Overall Study||90
1658342|NCT00695500|4049603|P2|NOT COMPLETED|Overall Study||5
1658343|NCT00695500|4049604|P1|NOT COMPLETED|Overall Study||3
1658344|NCT00695500|4049603|P2|COMPLETED|Overall Study||17
1658345|NCT00695500|4049604|P1|COMPLETED|Overall Study||21
1658346|NCT00695500|4049603|P2|STARTED|Overall Study||22
1658347|NCT00695500|4049604|P1|STARTED|Overall Study||24
1658348|NCT00695435|4049614|P3|NOT COMPLETED|Overall Study||0
1658349|NCT00695435|4049615|P2|NOT COMPLETED|Overall Study||0
1658350|NCT00695435|4049616|P1|NOT COMPLETED|Overall Study||0
1658351|NCT00695435|4049614|P3|COMPLETED|Overall Study||7
1658352|NCT00695435|4049615|P2|COMPLETED|Overall Study||7
1658353|NCT00695435|4049616|P1|COMPLETED|Overall Study||7
1658354|NCT00695435|4049614|P3|STARTED|Overall Study||7
1658355|NCT00695435|4049615|P2|STARTED|Overall Study||7
1658356|NCT00695435|4049616|P1|STARTED|Overall Study||7
1658357|NCT00695409|4049627|P1|NOT COMPLETED|Overall Study||0
1658358|NCT00695409|4049627|P1|COMPLETED|Overall Study||122
1658359|NCT00695409|4049627|P1|STARTED|Overall Study||122
1658360|NCT00695396|4049642|P3|NOT COMPLETED|Overall Study||8
1658361|NCT00695396|4049643|P2|NOT COMPLETED|Overall Study||8
1658362|NCT00695396|4049644|P1|NOT COMPLETED|Overall Study||7
1658363|NCT00695396|4049642|P3|COMPLETED|Overall Study||1
1658364|NCT00695396|4049643|P2|COMPLETED|Overall Study||0
1658365|NCT00695396|4049644|P1|COMPLETED|Overall Study||1
1658366|NCT00695396|4049642|P3|STARTED|Overall Study||9
1658367|NCT00695396|4049643|P2|STARTED|Overall Study||8
1658368|NCT00695396|4049644|P1|STARTED|Overall Study||8
1658369|NCT00695318|4049660|P2|NOT COMPLETED|Overall Study||1
1658370|NCT00695318|4049661|P1|NOT COMPLETED|Overall Study||5
1658371|NCT00695318|4049660|P2|COMPLETED|Overall Study||6
1658372|NCT00695318|4049661|P1|COMPLETED|Overall Study||5
1658373|NCT00695318|4049660|P2|STARTED|Overall Study||7
1658374|NCT00695318|4049661|P1|STARTED|Overall Study||10
1658375|NCT00695292|4049672|P1|NOT COMPLETED|Overall Study||0
1658376|NCT00695292|4049672|P1|COMPLETED|Overall Study||37
1658377|NCT00695292|4049672|P1|STARTED|Overall Study||37
1658378|NCT00695188|4049679|P2|NOT COMPLETED|Overall Study||0
1658379|NCT00695188|4049680|P1|NOT COMPLETED|Overall Study||0
1658380|NCT00695188|4049679|P2|COMPLETED|Overall Study||9
1658381|NCT00695188|4049680|P1|COMPLETED|Overall Study||10
1658382|NCT00695188|4049679|P2|STARTED|Overall Study||9
1658383|NCT00695188|4049680|P1|STARTED|Overall Study||10
1658384|NCT00695136|4049686|P1|NOT COMPLETED|Overall Study||2
1658385|NCT00695136|4049686|P1|COMPLETED|Overall Study||5
1658386|NCT00695136|4049686|P1|STARTED|Overall Study|7|7
1658387|NCT00695097|4049692|P2|NOT COMPLETED|Overall Study||0
1658388|NCT00695097|4049693|P1|NOT COMPLETED|Overall Study||1
1658389|NCT00695097|4049692|P2|COMPLETED|Overall Study||5
1658390|NCT00695097|4049693|P1|COMPLETED|Overall Study||9
1658391|NCT00695097|4049692|P2|STARTED|Overall Study||5
1658392|NCT00695097|4049693|P1|STARTED|Overall Study||10
1658393|NCT00695019|4049702|P3|NOT COMPLETED|Overall Study||10
1658394|NCT00695019|4049703|P2|NOT COMPLETED|Overall Study||14
1658395|NCT00695019|4049704|P1|NOT COMPLETED|Overall Study||13
1658396|NCT00695019|4049702|P3|COMPLETED|Overall Study||47
1658397|NCT00695019|4049703|P2|COMPLETED|Overall Study||39
1658398|NCT00695019|4049704|P1|COMPLETED|Overall Study||46
1658399|NCT00695019|4049702|P3|STARTED|Overall Study||57
1658400|NCT00695019|4049703|P2|STARTED|Overall Study||53
1658401|NCT00695019|4049704|P1|STARTED|Overall Study||59
1658402|NCT00694603|4049733|P1|NOT COMPLETED|Overall Study||0
1658403|NCT00694603|4049733|P1|COMPLETED|Overall Study||18
1658404|NCT00694603|4049733|P1|STARTED|Overall Study||18
1658405|NCT00694564|4049738|P1|NOT COMPLETED|Overall Study||2
1658406|NCT00694564|4049738|P1|COMPLETED|Overall Study||6
1658407|NCT00694564|4049738|P1|STARTED|Overall Study||8
1658408|NCT00694551|4049745|P3|NOT COMPLETED|Overall Study||1
1658409|NCT00694551|4049746|P2|NOT COMPLETED|Overall Study||0
1658410|NCT00694551|4049747|P1|NOT COMPLETED|Overall Study||1
1658411|NCT00694551|4049745|P3|COMPLETED|Overall Study||8
1658412|NCT00694551|4049746|P2|COMPLETED|Overall Study||10
1658413|NCT00694551|4049747|P1|COMPLETED|Overall Study||9
1658414|NCT00694551|4049745|P3|STARTED|Overall Study||9
1658415|NCT00694551|4049746|P2|STARTED|Overall Study||10
1658416|NCT00694551|4049747|P1|STARTED|Overall Study||10
1658417|NCT00694473|4049761|P1|NOT COMPLETED|Overall Study||7
1658418|NCT00694473|4049761|P1|COMPLETED|Overall Study|Dec 2010|69
1658419|NCT00694473|4049761|P1|STARTED|Overall Study|Aug 2008|76
1658420|NCT00694369|4049776|P5|NOT COMPLETED|Overall Study||6
1658421|NCT00694369|4049777|P4|NOT COMPLETED|Overall Study||3
1658422|NCT00694369|4049778|P3|NOT COMPLETED|Overall Study||2
1658423|NCT00694369|4049779|P2|NOT COMPLETED|Overall Study||3
1658424|NCT00694369|4049780|P1|NOT COMPLETED|Overall Study||1
1658425|NCT00694369|4049776|P5|COMPLETED|Overall Study||56
1658426|NCT00694369|4049777|P4|COMPLETED|Overall Study||189
1658427|NCT00694369|4049778|P3|COMPLETED|Overall Study||95
1658428|NCT00694369|4049779|P2|COMPLETED|Overall Study||188
1658429|NCT00694369|4049780|P1|COMPLETED|Overall Study||45
1658430|NCT00694369|4049776|P5|STARTED|Overall Study||62
1658431|NCT00694369|4049777|P4|STARTED|Overall Study||192
1658432|NCT00694369|4049778|P3|STARTED|Overall Study||97
1658433|NCT00694369|4049779|P2|STARTED|Overall Study||191
1658434|NCT00694369|4049780|P1|STARTED|Overall Study||46
1658435|NCT00694356|4049800|P3|NOT COMPLETED|Overall Study||6
1658436|NCT00694356|4049801|P2|NOT COMPLETED|Overall Study||6
1658437|NCT00694356|4049802|P1|NOT COMPLETED|Overall Study||3
1658438|NCT00694356|4049800|P3|COMPLETED|Overall Study||0
1658439|NCT00694356|4049801|P2|COMPLETED|Overall Study||0
1658440|NCT00694356|4049802|P1|COMPLETED|Overall Study||0
1658441|NCT00694356|4049800|P3|STARTED|Overall Study||6
1658442|NCT00694356|4049801|P2|STARTED|Overall Study||6
1658443|NCT00694356|4049802|P1|STARTED|Overall Study||3
1658444|NCT00694304|4049837|P1|NOT COMPLETED|Overall Study||207
1658445|NCT00694304|4049837|P1|COMPLETED|Overall Study||328
1658446|NCT00694304|4049837|P1|STARTED|Overall Study||535
1658447|NCT00694161|4049850|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
1658448|NCT00694161|4049850|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
1658449|NCT00694161|4049850|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
1658450|NCT00694161|4049850|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
1658451|NCT00694161|4049850|P1|COMPLETED|Part 1 (up to Week 6)||35
1658452|NCT00694161|4049850|P1|STARTED|Part 1 (up to Week 6)||35
1658453|NCT00694122|4049889|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
1658454|NCT00694122|4049890|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
1658455|NCT00694122|4049889|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
1658456|NCT00694122|4049890|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
1658457|NCT00694122|4049889|P2|STARTED|Second Intervention (3-4 Weeks)||5
1658458|NCT00694122|4049890|P1|STARTED|Second Intervention (3-4 Weeks)||10
1658459|NCT00694122|4049889|P2|NOT COMPLETED|Washout (1 Day)||0
1658460|NCT00694122|4049890|P1|NOT COMPLETED|Washout (1 Day)||0
1658461|NCT00694122|4049889|P2|COMPLETED|Washout (1 Day)||5
1658462|NCT00694122|4049890|P1|COMPLETED|Washout (1 Day)||10
1658463|NCT00694122|4049889|P2|STARTED|Washout (1 Day)||5
1658464|NCT00694122|4049890|P1|STARTED|Washout (1 Day)||10
1658465|NCT00694122|4049889|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
1658466|NCT00694122|4049890|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
1658467|NCT00694122|4049889|P2|COMPLETED|First Intervention (3-4 Weeks)||5
1658468|NCT00694122|4049890|P1|COMPLETED|First Intervention (3-4 Weeks)||10
1658469|NCT00694122|4049889|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
1658470|NCT00694122|4049890|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
1658471|NCT00694109|4049906|P1|NOT COMPLETED|Overall Study||117
1658472|NCT00694109|4049906|P1|COMPLETED|Overall Study||25
1658473|NCT00694109|4049906|P1|Completed Consented Length of Treatment|Overall Study||60
1658474|NCT00694109|4049906|P1|Consented 2 Years Additional Treatment|Overall Study||42
1658475|NCT00694109|4049906|P1|Treated|Overall Study||141
1658476|NCT00694109|4049906|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
1658477|NCT00694096|4049930|P1|NOT COMPLETED|Overall Study||5
1658478|NCT00694096|4049930|P1|COMPLETED|Overall Study||20
1658479|NCT00694096|4049930|P1|STARTED|Overall Study||25
1658480|NCT00694070|4049936|P1|NOT COMPLETED|Overall Study||0
1658481|NCT00694070|4049936|P1|COMPLETED|Overall Study||51
1658482|NCT00694070|4049936|P1|STARTED|Overall Study||51
1658483|NCT00694018|4049944|P2|NOT COMPLETED|Overall Study||9
1658484|NCT00694018|4049945|P1|NOT COMPLETED|Overall Study||13
1658485|NCT00694018|4049944|P2|COMPLETED|Overall Study||102
1658486|NCT00694018|4049945|P1|COMPLETED|Overall Study||105
1658487|NCT00694018|4049944|P2|6 Months|Overall Study||101
1658488|NCT00694018|4049945|P1|6 Months|Overall Study||106
1658489|NCT00694018|4049944|P2|STARTED|Overall Study||111
1658490|NCT00694018|4049945|P1|STARTED|Overall Study||118
1658491|NCT00693992|4049953|P2|NOT COMPLETED|Overall Study||0
1658492|NCT00693992|4049954|P1|NOT COMPLETED|Overall Study||0
1658493|NCT00693992|4049953|P2|COMPLETED|Overall Study||104
1658494|NCT00693992|4049954|P1|COMPLETED|Overall Study||106
1658495|NCT00693992|4049953|P2|STARTED|Overall Study||104
1658496|NCT00693992|4049954|P1|STARTED|Overall Study||106
1658497|NCT00693784|4049970|P1|NOT COMPLETED|Overall Study||4
1658498|NCT00693784|4049970|P1|COMPLETED|Overall Study||11
1658499|NCT00693784|4049970|P1|104-week Extended Follow-up|Overall Study||11
1658500|NCT00693784|4049970|P1|52-week Extended Follow-up|Overall Study||13
1658501|NCT00693784|4049970|P1|26-Week Primary Endpoint|Overall Study||15
1658502|NCT00693784|4049970|P1|STARTED|Overall Study||15
1658503|NCT00693719|4049976|P1|NOT COMPLETED|Overall Study||0
1658504|NCT00693719|4049976|P1|COMPLETED|Overall Study||31
1658505|NCT00693719|4049976|P1|STARTED|Overall Study||31
1658506|NCT00693706|4049983|P2|NOT COMPLETED|Overall Study||1
1658507|NCT00693706|4049984|P1|NOT COMPLETED|Overall Study||0
1658508|NCT00693706|4049983|P2|COMPLETED|Overall Study||98
1658509|NCT00693706|4049984|P1|COMPLETED|Overall Study||101
1658510|NCT00693706|4049983|P2|STARTED|Overall Study||99
1658511|NCT00693706|4049984|P1|STARTED|Overall Study||101
1658512|NCT00693693|4050011|P3|NOT COMPLETED|Overall Study||2
1658513|NCT00693693|4050012|P2|NOT COMPLETED|Overall Study||1
1658514|NCT00693693|4050013|P1|NOT COMPLETED|Overall Study||1
1658515|NCT00693693|4050011|P3|COMPLETED|Overall Study||7
1658516|NCT00693693|4050012|P2|COMPLETED|Overall Study||8
1658517|NCT00693693|4050013|P1|COMPLETED|Overall Study||6
1658518|NCT00693693|4050011|P3|STARTED|Overall Study||9
1658519|NCT00693693|4050012|P2|STARTED|Overall Study||9
1658520|NCT00693693|4050013|P1|STARTED|Overall Study||7
1658521|NCT00693654|4050023|P2|NOT COMPLETED|Overall Study||0
1658522|NCT00693654|4050024|P1|NOT COMPLETED|Overall Study||0
1658523|NCT00693654|4050023|P2|COMPLETED|Overall Study||14
1658524|NCT00693654|4050024|P1|COMPLETED|Overall Study||14
1658525|NCT00693654|4050023|P2|STARTED|Overall Study||14
1658526|NCT00693654|4050024|P1|STARTED|Overall Study||14
1658527|NCT00693628|4050034|P2|NOT COMPLETED|Overall Study||0
1658528|NCT00693628|4050035|P1|NOT COMPLETED|Overall Study||0
1658529|NCT00693628|4050034|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
1658530|NCT00693628|4050035|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
1658531|NCT00693628|4050034|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
1658532|NCT00693628|4050035|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
1658533|NCT00693498|4050043|P2|NOT COMPLETED|Overall Study||0
1658534|NCT00693498|4050044|P1|NOT COMPLETED|Overall Study||0
1658535|NCT00693498|4050043|P2|COMPLETED|Overall Study||81
1658536|NCT00693498|4050044|P1|COMPLETED|Overall Study||81
1658537|NCT00693498|4050043|P2|STARTED|Overall Study||81
1658538|NCT00693498|4050044|P1|STARTED|Overall Study||81
1658539|NCT00693485|4050055|P3|NOT COMPLETED|Overall Study||0
1658540|NCT00693485|4050056|P2|NOT COMPLETED|Overall Study||2
1658541|NCT00693485|4050057|P1|NOT COMPLETED|Overall Study||0
1658542|NCT00693485|4050055|P3|COMPLETED|Overall Study||24
1658543|NCT00693485|4050056|P2|COMPLETED|Overall Study||19
1658544|NCT00693485|4050057|P1|COMPLETED|Overall Study||25
1658545|NCT00693485|4050055|P3|STARTED|Overall Study||24
1658546|NCT00693485|4050056|P2|STARTED|Overall Study||21
1658547|NCT00693485|4050057|P1|STARTED|Overall Study||25
1658548|NCT00693472|4050072|P4|NOT COMPLETED|Part 2||2
1658549|NCT00693472|4050073|P3|NOT COMPLETED|Part 2||2
1658550|NCT00693472|4050074|P2|NOT COMPLETED|Part 2||0
1658551|NCT00693472|4050075|P1|NOT COMPLETED|Part 2||0
1658552|NCT00693472|4050072|P4|COMPLETED|Part 2||4
1658553|NCT00693472|4050073|P3|COMPLETED|Part 2||6
1658554|NCT00693472|4050074|P2|COMPLETED|Part 2||0
1658555|NCT00693472|4050075|P1|COMPLETED|Part 2||0
1658556|NCT00693472|4050072|P4|STARTED|Part 2||6
1658557|NCT00693472|4050073|P3|STARTED|Part 2||8
1658558|NCT00693472|4050074|P2|STARTED|Part 2||0
1658559|NCT00693472|4050075|P1|STARTED|Part 2||0
1658560|NCT00693472|4050072|P4|NOT COMPLETED|Part 1||0
1658561|NCT00693472|4050073|P3|NOT COMPLETED|Part 1||0
1658562|NCT00693472|4050074|P2|NOT COMPLETED|Part 1||4
1658563|NCT00693472|4050075|P1|NOT COMPLETED|Part 1||6
1658564|NCT00693472|4050072|P4|COMPLETED|Part 1||0
1658565|NCT00693472|4050073|P3|COMPLETED|Part 1||0
1658566|NCT00693472|4050074|P2|COMPLETED|Part 1||9
1658567|NCT00693472|4050075|P1|COMPLETED|Part 1||13
1658568|NCT00693472|4050072|P4|STARTED|Part 1||0
1658569|NCT00693472|4050073|P3|STARTED|Part 1||0
1658570|NCT00693472|4050074|P2|STARTED|Part 1||13
1658571|NCT00693472|4050075|P1|STARTED|Part 1||19
1658572|NCT00693420|4050095|P2|NOT COMPLETED|Overall Study||15
1658573|NCT00693420|4050096|P1|NOT COMPLETED|Overall Study||6
1658574|NCT00693420|4050095|P2|COMPLETED|Overall Study||126
1658575|NCT00693420|4050096|P1|COMPLETED|Overall Study||131
1658576|NCT00693420|4050095|P2|STARTED|Overall Study||141
1658577|NCT00693420|4050096|P1|STARTED|Overall Study||137
1658578|NCT00693303|4050120|P1|NOT COMPLETED|Overall Study||0
1658579|NCT00693303|4050120|P1|COMPLETED|Overall Study||21
1658580|NCT00693303|4050120|P1|STARTED|Overall Study||21
1658581|NCT00693238|4050126|P2|NOT COMPLETED|Overall Study||0
1658582|NCT00693238|4050127|P1|NOT COMPLETED|Overall Study||0
1658583|NCT00693238|4050126|P2|COMPLETED|Overall Study||106
1658584|NCT00693238|4050127|P1|COMPLETED|Overall Study||122
1658585|NCT00693238|4050126|P2|STARTED|Overall Study||106
1658586|NCT00693238|4050127|P1|STARTED|Overall Study||122
1658587|NCT00693225|4050135|P2|NOT COMPLETED|Overall Study||5
1658588|NCT00693225|4050136|P1|NOT COMPLETED|Overall Study||2
1658589|NCT00693225|4050135|P2|COMPLETED|Overall Study||43
1658590|NCT00693225|4050136|P1|COMPLETED|Overall Study||41
1658591|NCT00693225|4050135|P2|STARTED|Overall Study||48
1658592|NCT00693225|4050136|P1|STARTED|Overall Study||43
1658593|NCT00693160|4050148|P2|NOT COMPLETED|Overall Study||0
1658594|NCT00693160|4050149|P1|NOT COMPLETED|Overall Study||0
1658595|NCT00693160|4050148|P2|COMPLETED|Overall Study||16
1658596|NCT00693160|4050149|P1|COMPLETED|Overall Study||14
1658597|NCT00693160|4050148|P2|STARTED|Overall Study||16
1658598|NCT00693160|4050149|P1|STARTED|Overall Study||14
1658599|NCT00693017|4050159|P2|NOT COMPLETED|Overall Study||2
1658600|NCT00693017|4050160|P1|NOT COMPLETED|Overall Study||2
1658601|NCT00693017|4050159|P2|COMPLETED|Overall Study||0
1658602|NCT00693017|4050160|P1|COMPLETED|Overall Study||0
1658603|NCT00693017|4050159|P2|STARTED|Overall Study||2
1658604|NCT00693017|4050160|P1|STARTED|Overall Study||2
1658605|NCT00692913|4050170|P2|NOT COMPLETED|Overall Study||30
1658606|NCT00692913|4050171|P1|NOT COMPLETED|Overall Study||29
1658607|NCT00692913|4050170|P2|COMPLETED|Overall Study||228
1658608|NCT00692913|4050171|P1|COMPLETED|Overall Study||228
1658609|NCT00692913|4050170|P2|STARTED|Overall Study||258
1658610|NCT00692913|4050171|P1|STARTED|Overall Study||257
1658611|NCT00692770|4050193|P2|NOT COMPLETED|Overall Study||558
1658612|NCT00692770|4050194|P1|NOT COMPLETED|Overall Study||556
1658613|NCT00692770|4050193|P2|COMPLETED|Overall Study||0
1658614|NCT00692770|4050194|P1|COMPLETED|Overall Study||0
1658615|NCT00692770|4050193|P2|Participants Received Treatment|Overall Study||554
1658616|NCT00692770|4050194|P1|Participants Received Treatment|Overall Study||553
1658617|NCT00692770|4050193|P2|STARTED|Overall Study||558
1658618|NCT00692770|4050194|P1|STARTED|Overall Study||556
1658619|NCT00692692|4050218|P2|NOT COMPLETED|Overall Study||0
1658620|NCT00692692|4050219|P1|NOT COMPLETED|Overall Study||0
1658621|NCT00692692|4050218|P2|COMPLETED|Overall Study||16
1658622|NCT00692692|4050219|P1|COMPLETED|Overall Study||20
1658623|NCT00692692|4050218|P2|STARTED|Overall Study||16
1658624|NCT00692692|4050219|P1|STARTED|Overall Study||20
1658625|NCT00692419|4050229|P2|NOT COMPLETED|Overall Study||18
1658626|NCT00692419|4050230|P1|NOT COMPLETED|Overall Study||16
1658627|NCT00692419|4050229|P2|COMPLETED|Overall Study||102
1658628|NCT00692419|4050230|P1|COMPLETED|Overall Study||84
1658629|NCT00692419|4050229|P2|STARTED|Overall Study||120
1658630|NCT00692419|4050230|P1|STARTED|Overall Study||100
1658631|NCT00692406|4050240|P1|NOT COMPLETED|Overall Study||57
1658632|NCT00692406|4050240|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
1658633|NCT00692406|4050240|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
1658634|NCT00692341|4050254|P3|NOT COMPLETED|Overall Study||0
1658635|NCT00692341|4050255|P2|NOT COMPLETED|Overall Study||0
1658636|NCT00692341|4050256|P1|NOT COMPLETED|Overall Study||0
1658637|NCT00692341|4050254|P3|COMPLETED|Overall Study||8
1658638|NCT00692341|4050255|P2|COMPLETED|Overall Study||8
1658639|NCT00692341|4050256|P1|COMPLETED|Overall Study||8
1658640|NCT00692341|4050254|P3|STARTED|Overall Study||8
1658641|NCT00692341|4050255|P2|STARTED|Overall Study||8
1658642|NCT00692341|4050256|P1|STARTED|Overall Study||8
1658643|NCT00692237|4050302|P2|NOT COMPLETED|Overall Study||4
1658644|NCT00692237|4050303|P1|NOT COMPLETED|Overall Study||1
1658645|NCT00692237|4050302|P2|COMPLETED|Overall Study||25
1658646|NCT00692237|4050303|P1|COMPLETED|Overall Study||29
1658647|NCT00692237|4050302|P2|STARTED|Overall Study||29
1658648|NCT00692237|4050303|P1|STARTED|Overall Study||30
1658649|NCT00692211|4050313|P2|NOT COMPLETED|Overall Study||0
1658650|NCT00692211|4050314|P1|NOT COMPLETED|Overall Study||0
1658651|NCT00692211|4050313|P2|COMPLETED|Overall Study||202
1658652|NCT00692211|4050314|P1|COMPLETED|Overall Study||202
1658653|NCT00692211|4050313|P2|STARTED|Overall Study||202
1658654|NCT00692211|4050314|P1|STARTED|Overall Study||202
1658655|NCT00692198|4050322|P2|NOT COMPLETED|Overall Study||0
1658656|NCT00692198|4050323|P1|NOT COMPLETED|Overall Study||0
1658657|NCT00692198|4050322|P2|COMPLETED|Overall Study||370
1658658|NCT00692198|4050323|P1|COMPLETED|Overall Study||368
1658659|NCT00692198|4050322|P2|STARTED|Overall Study||370
1658660|NCT00692198|4050323|P1|STARTED|Overall Study||368
1658661|NCT00692185|4050358|P2|NOT COMPLETED|Overall Study||3
1658662|NCT00692185|4050359|P1|NOT COMPLETED|Overall Study||3
1658663|NCT00692185|4050358|P2|COMPLETED|Overall Study||9
1658664|NCT00692185|4050359|P1|COMPLETED|Overall Study||8
1658665|NCT00692185|4050358|P2|STARTED|Overall Study||12
1658666|NCT00692185|4050359|P1|STARTED|Overall Study||11
1658667|NCT00692003|4050367|P2|NOT COMPLETED|Overall Study||1
1658668|NCT00692003|4050368|P1|NOT COMPLETED|Overall Study||5
1658669|NCT00692003|4050367|P2|COMPLETED|Overall Study||0
1658670|NCT00692003|4050368|P1|COMPLETED|Overall Study||0
1658671|NCT00692003|4050367|P2|STARTED|Overall Study||1
1658672|NCT00692003|4050368|P1|STARTED|Overall Study||5
1658673|NCT00691938|4050383|P7|NOT COMPLETED|Overall Study||0
1658674|NCT00691938|4050384|P6|NOT COMPLETED|Overall Study||0
1658675|NCT00691938|4050385|P5|NOT COMPLETED|Overall Study||0
1658676|NCT00691938|4050386|P4|NOT COMPLETED|Overall Study||0
1658677|NCT00691938|4050387|P3|NOT COMPLETED|Overall Study||0
1658678|NCT00691938|4050388|P2|NOT COMPLETED|Overall Study||0
1658679|NCT00691938|4050389|P1|NOT COMPLETED|Overall Study||1
1658680|NCT00691938|4050383|P7|COMPLETED|Overall Study||14
1658681|NCT00691938|4050384|P6|COMPLETED|Overall Study||6
1658682|NCT00691938|4050385|P5|COMPLETED|Overall Study||10
1658683|NCT00691938|4050386|P4|COMPLETED|Overall Study||8
1658684|NCT00691938|4050387|P3|COMPLETED|Overall Study||6
1658685|NCT00691938|4050388|P2|COMPLETED|Overall Study||3
1658686|NCT00691938|4050389|P1|COMPLETED|Overall Study||4
1658687|NCT00691938|4050383|P7|STARTED|Overall Study||14
1658688|NCT00691938|4050384|P6|STARTED|Overall Study||6
1658689|NCT00691938|4050385|P5|STARTED|Overall Study||10
1658690|NCT00691938|4050386|P4|STARTED|Overall Study||8
1658691|NCT00691938|4050387|P3|STARTED|Overall Study||6
1658692|NCT00691938|4050388|P2|STARTED|Overall Study||3
1658693|NCT00691938|4050389|P1|STARTED|Overall Study||5
1658694|NCT00691808|4050413|P3|NOT COMPLETED|Overall Study||0
1658695|NCT00691808|4050414|P2|NOT COMPLETED|Overall Study||1
1658696|NCT00691808|4050415|P1|NOT COMPLETED|Overall Study||0
1658697|NCT00691808|4050413|P3|COMPLETED|Overall Study||32
1658698|NCT00691808|4050414|P2|COMPLETED|Overall Study||35
1658699|NCT00691808|4050415|P1|COMPLETED|Overall Study||35
1658700|NCT00691808|4050413|P3|STARTED|Overall Study||32
1658701|NCT00691808|4050414|P2|STARTED|Overall Study||36
1658702|NCT00691808|4050415|P1|STARTED|Overall Study||35
1658703|NCT00691704|4050456|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
1658704|NCT00691704|4050456|P1|COMPLETED|Two Years of Maintenance Therapy||3
1658705|NCT00691704|4050456|P1|STARTED|Two Years of Maintenance Therapy||16
1658706|NCT00691704|4050456|P1|NOT COMPLETED|Induction Therapy||2
1658707|NCT00691704|4050456|P1|COMPLETED|Induction Therapy||16
1658708|NCT00691704|4050456|P1|STARTED|Induction Therapy||18
1658709|NCT00691665|4050466|P2|NOT COMPLETED|Overall Study||0
1658710|NCT00691665|4050467|P1|NOT COMPLETED|Overall Study||0
1658711|NCT00691665|4050466|P2|COMPLETED|Overall Study||65
1658712|NCT00691665|4050467|P1|COMPLETED|Overall Study||65
1658713|NCT00691665|4050466|P2|STARTED|Overall Study||65
1658714|NCT00691665|4050467|P1|STARTED|Overall Study||65
1658715|NCT00691652|4050479|P1|NOT COMPLETED|Overall Study||1
1658716|NCT00691652|4050479|P1|COMPLETED|Overall Study||1
1658717|NCT00691652|4050479|P1|STARTED|Overall Study||2
1658718|NCT00691483|4050485|P2|NOT COMPLETED|Overall Study||25
1658719|NCT00691483|4050486|P1|NOT COMPLETED|Overall Study||68
1658720|NCT00691483|4050485|P2|COMPLETED|Overall Study||141
1658721|NCT00691483|4050486|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
1658722|NCT00691483|4050485|P2|Received Treatment|Overall Study||165
1658723|NCT00691483|4050486|P1|Received Treatment|Overall Study||486
1658724|NCT00691483|4050485|P2|STARTED|Overall Study||166
1658725|NCT00691483|4050486|P1|STARTED|Overall Study||493
1658726|NCT00691327|4050504|P2|NOT COMPLETED|Overall Study||2508
1658727|NCT00691327|4050505|P1|NOT COMPLETED|Overall Study||2841
1658728|NCT00691327|4050504|P2|COMPLETED|Overall Study||36766
1658729|NCT00691327|4050505|P1|COMPLETED|Overall Study||42214
1658730|NCT00691327|4050504|P2|STARTED|Overall Study||39274
1658731|NCT00691327|4050505|P1|STARTED|Overall Study||45055
1658732|NCT00691301|4050513|P1|NOT COMPLETED|Overall Study||54
1658733|NCT00691301|4050513|P1|COMPLETED|Overall Study||1
1658734|NCT00691301|4050513|P1|STARTED|Overall Study||55
1658735|NCT00691210|4050533|P8|NOT COMPLETED|Overall Study||0
1658736|NCT00691210|4050534|P7|NOT COMPLETED|Overall Study||0
1658737|NCT00691210|4050535|P6|NOT COMPLETED|Overall Study||1
1658738|NCT00691210|4050536|P5|NOT COMPLETED|Overall Study||0
1658739|NCT00691210|4050537|P4|NOT COMPLETED|Overall Study||3
1658740|NCT00691210|4050538|P3|NOT COMPLETED|Overall Study||0
1658741|NCT00691210|4050539|P2|NOT COMPLETED|Overall Study||0
1658742|NCT00691210|4050540|P1|NOT COMPLETED|Overall Study||0
1658743|NCT00691210|4050533|P8|COMPLETED|Overall Study||0
1658744|NCT00691210|4050534|P7|COMPLETED|Overall Study||6
1658745|NCT00691210|4050535|P6|COMPLETED|Overall Study||6
1658746|NCT00691210|4050536|P5|COMPLETED|Overall Study||5
1658747|NCT00691210|4050537|P4|COMPLETED|Overall Study||6
1658748|NCT00691210|4050538|P3|COMPLETED|Overall Study||3
1658749|NCT00691210|4050539|P2|COMPLETED|Overall Study||5
1658750|NCT00691210|4050540|P1|COMPLETED|Overall Study||3
1658751|NCT00691210|4050533|P8|STARTED|Overall Study||0
1658752|NCT00691210|4050534|P7|STARTED|Overall Study||6
1658753|NCT00691210|4050535|P6|STARTED|Overall Study||7
1658754|NCT00691210|4050536|P5|STARTED|Overall Study||5
1658755|NCT00691210|4050537|P4|STARTED|Overall Study||9
1658756|NCT00691210|4050538|P3|STARTED|Overall Study||3
1658757|NCT00691210|4050539|P2|STARTED|Overall Study||5
1658758|NCT00691210|4050540|P1|STARTED|Overall Study||3
1658759|NCT00691197|4050560|P2|NOT COMPLETED|Overall Study||5
1658760|NCT00691197|4050561|P1|NOT COMPLETED|Overall Study||11
1658761|NCT00691197|4050560|P2|COMPLETED|Overall Study||75
1658762|NCT00691197|4050561|P1|COMPLETED|Overall Study||155
1658763|NCT00691197|4050560|P2|STARTED|Overall Study||80
1658764|NCT00691197|4050561|P1|STARTED|Overall Study||166
1658765|NCT00691132|4050575|P2|NOT COMPLETED|Overall Study||13
1658766|NCT00691132|4050576|P1|NOT COMPLETED|Overall Study||12
1658767|NCT00691132|4050575|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
1658768|NCT00691132|4050576|P1|COMPLETED|Overall Study||41
1658769|NCT00691132|4050575|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
1658770|NCT00691132|4050576|P1|STARTED|Overall Study||53
1658771|NCT00691093|4050595|P1|NOT COMPLETED|Overall Study||7
1658772|NCT00691093|4050595|P1|COMPLETED|Overall Study||816
1658773|NCT00691093|4050595|P1|STARTED|Overall Study||823
1658774|NCT00691054|4050629|P1|NOT COMPLETED|Overall Study||1
1658775|NCT00691054|4050629|P1|COMPLETED|Overall Study||19
1658776|NCT00691054|4050629|P1|STARTED|Overall Study||20
1658777|NCT00691028|4050641|P4|NOT COMPLETED|Double-blind Period||0
1658778|NCT00691028|4050642|P3|NOT COMPLETED|Double-blind Period||9
1658779|NCT00691028|4050643|P2|NOT COMPLETED|Double-blind Period||13
1658780|NCT00691028|4050644|P1|NOT COMPLETED|Double-blind Period||13
1658781|NCT00691028|4050641|P4|COMPLETED|Double-blind Period||0
1658782|NCT00691028|4050642|P3|COMPLETED|Double-blind Period||95
1658783|NCT00691028|4050643|P2|COMPLETED|Double-blind Period||91
1658784|NCT00691028|4050644|P1|COMPLETED|Double-blind Period||86
1658785|NCT00691028|4050641|P4|STARTED|Double-blind Period||0
1658786|NCT00691028|4050642|P3|STARTED|Double-blind Period||104
1658787|NCT00691028|4050643|P2|STARTED|Double-blind Period||104
1658788|NCT00691028|4050644|P1|STARTED|Double-blind Period||99
1658789|NCT00691028|4050641|P4|NOT COMPLETED|Open-label Period||20
1658790|NCT00691028|4050642|P3|NOT COMPLETED|Open-label Period||0
1658791|NCT00691028|4050643|P2|NOT COMPLETED|Open-label Period||0
1658792|NCT00691028|4050644|P1|NOT COMPLETED|Open-label Period||0
1658793|NCT00691028|4050641|P4|COMPLETED|Open-label Period||307
1658794|NCT00691028|4050642|P3|COMPLETED|Open-label Period||0
1658795|NCT00691028|4050643|P2|COMPLETED|Open-label Period||0
1658796|NCT00691028|4050644|P1|COMPLETED|Open-label Period||0
1658797|NCT00691028|4050641|P4|STARTED|Open-label Period||327
1658798|NCT00691028|4050642|P3|STARTED|Open-label Period||0
1658799|NCT00691028|4050643|P2|STARTED|Open-label Period||0
1658800|NCT00691028|4050644|P1|STARTED|Open-label Period||0
1658801|NCT00691015|4050677|P1|NOT COMPLETED|Overall Study||1
1658802|NCT00691015|4050677|P1|COMPLETED|Overall Study||47
1658803|NCT00691015|4050677|P1|STARTED|Overall Study||48
1658804|NCT00690924|4050688|P1|NOT COMPLETED|Overall Study||0
1658805|NCT00690924|4050688|P1|COMPLETED|Overall Study||16
1658806|NCT00690924|4050688|P1|STARTED|Overall Study||16
1658807|NCT00690898|4050692|P1|NOT COMPLETED|TREATMENT||26
1658808|NCT00690898|4050692|P1|COMPLETED|TREATMENT||64
1658809|NCT00690898|4050692|P1|STARTED|TREATMENT|Total number of patients treated.|90
1658810|NCT00690898|4050692|P1|NOT COMPLETED|SCREENING||18
1658811|NCT00690898|4050692|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
1658812|NCT00690898|4050692|P1|STARTED|SCREENING|Total of patients screened for the study.|108
1658813|NCT00690833|4050706|P1|NOT COMPLETED|Overall Study||2
1658814|NCT00690833|4050706|P1|COMPLETED|Overall Study||39
1658815|NCT00690833|4050706|P1|STARTED|Overall Study||41
1658816|NCT00690820|4050712|P2|NOT COMPLETED|Period 2||0
1658817|NCT00690820|4050713|P1|NOT COMPLETED|Period 2||0
1658818|NCT00690820|4050712|P2|COMPLETED|Period 2||8
1658819|NCT00690820|4050713|P1|COMPLETED|Period 2||8
1658820|NCT00690820|4050712|P2|STARTED|Period 2||8
1658821|NCT00690820|4050713|P1|STARTED|Period 2||8
1658822|NCT00690820|4050712|P2|NOT COMPLETED|Period 1||1
1658823|NCT00690820|4050713|P1|NOT COMPLETED|Period 1||0
1658824|NCT00690820|4050712|P2|COMPLETED|Period 1||8
1658825|NCT00690820|4050713|P1|COMPLETED|Period 1||8
1658826|NCT00690820|4050712|P2|STARTED|Period 1||9
1658827|NCT00690820|4050713|P1|STARTED|Period 1||8
1658828|NCT00690794|4050735|P2|NOT COMPLETED|Overall Study||35
1658829|NCT00690794|4050736|P1|NOT COMPLETED|Overall Study||21
1658830|NCT00690794|4050735|P2|COMPLETED|Overall Study||328
1658831|NCT00690794|4050736|P1|COMPLETED|Overall Study||342
1658832|NCT00690794|4050735|P2|STARTED|Overall Study||363
1658833|NCT00690794|4050736|P1|STARTED|Overall Study||363
1658834|NCT00690755|4050751|P7|NOT COMPLETED|Overall Study||0
1658835|NCT00690755|4050752|P6|NOT COMPLETED|Overall Study||4
1658836|NCT00690755|4050753|P5|NOT COMPLETED|Overall Study||0
1658837|NCT00690755|4050754|P4|NOT COMPLETED|Overall Study||5
1658838|NCT00690755|4050755|P3|NOT COMPLETED|Overall Study||46
1658839|NCT00690755|4050756|P2|NOT COMPLETED|Overall Study||0
1658840|NCT00690755|4050757|P1|NOT COMPLETED|Overall Study||2
1658841|NCT00690755|4050751|P7|COMPLETED|Overall Study||0
1658842|NCT00690755|4050752|P6|COMPLETED|Overall Study||6
1658843|NCT00690755|4050753|P5|COMPLETED|Overall Study||0
1658844|NCT00690755|4050754|P4|COMPLETED|Overall Study||15
1658845|NCT00690755|4050755|P3|COMPLETED|Overall Study||51
1658846|NCT00690755|4050756|P2|COMPLETED|Overall Study||0
1658847|NCT00690755|4050757|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
1658848|NCT00690755|4050751|P7|STARTED|Overall Study||0
1658849|NCT00690755|4050752|P6|STARTED|Overall Study||10
1658850|NCT00690755|4050753|P5|STARTED|Overall Study||0
1658851|NCT00690755|4050754|P4|STARTED|Overall Study||20
1658852|NCT00690755|4050755|P3|STARTED|Overall Study||97
1658853|NCT00690755|4050756|P2|STARTED|Overall Study||0
1658854|NCT00690755|4050757|P1|STARTED|Overall Study||30
1658855|NCT00690612|4050773|P1|NOT COMPLETED|Overall Study||3
1658856|NCT00690612|4050773|P1|COMPLETED|Overall Study||32
1658857|NCT00690612|4050773|P1|STARTED|Overall Study||35
1658858|NCT00690573|4050778|P1|NOT COMPLETED|Overall Study||9
1658859|NCT00690573|4050778|P1|COMPLETED|Overall Study||16
1658860|NCT00690573|4050778|P1|STARTED|Overall Study||25
1658861|NCT00690495|4050788|P2|NOT COMPLETED|Overall Study||0
1658862|NCT00690495|4050789|P1|NOT COMPLETED|Overall Study||0
1658863|NCT00690495|4050788|P2|COMPLETED|Overall Study||50
1658864|NCT00690495|4050789|P1|COMPLETED|Overall Study||50
1658865|NCT00690495|4050788|P2|Primary Endpoint|Overall Study||50
1658866|NCT00690495|4050789|P1|Primary Endpoint|Overall Study||50
1658867|NCT00690495|4050788|P2|STARTED|Overall Study||50
1658868|NCT00690495|4050789|P1|STARTED|Overall Study||50
1658869|NCT00690482|4050797|P2|NOT COMPLETED|Overall Study||3
1658870|NCT00690482|4050798|P1|NOT COMPLETED|Overall Study||4
1658871|NCT00690482|4050797|P2|COMPLETED|Overall Study||54
1658872|NCT00690482|4050798|P1|COMPLETED|Overall Study||57
1658873|NCT00690482|4050797|P2|STARTED|Overall Study||57
1658874|NCT00690482|4050798|P1|STARTED|Overall Study||61
1658875|NCT00690443|4050832|P2|NOT COMPLETED|Overall Study||2
1658876|NCT00690443|4050833|P1|NOT COMPLETED|Overall Study||1
1658877|NCT00690443|4050832|P2|COMPLETED|Overall Study||19
1658878|NCT00690443|4050833|P1|COMPLETED|Overall Study||22
1658879|NCT00690443|4050832|P2|STARTED|Overall Study||21
1658880|NCT00690443|4050833|P1|STARTED|Overall Study||23
1658881|NCT00690430|4050843|P3|NOT COMPLETED|Extension Phase||13
1658882|NCT00690430|4050844|P2|NOT COMPLETED|Extension Phase||5
1658883|NCT00690430|4050845|P1|NOT COMPLETED|Extension Phase||18
1658884|NCT00690430|4050843|P3|COMPLETED|Extension Phase||2
1658885|NCT00690430|4050844|P2|COMPLETED|Extension Phase||1
1658886|NCT00690430|4050845|P1|COMPLETED|Extension Phase||2
1658887|NCT00690430|4050843|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
1658888|NCT00690430|4050844|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
1658889|NCT00690430|4050845|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
1658890|NCT00690430|4050843|P3|NOT COMPLETED|Core Phase||0
1658891|NCT00690430|4050844|P2|NOT COMPLETED|Core Phase||23
1658892|NCT00690430|4050845|P1|NOT COMPLETED|Core Phase||18
1658893|NCT00690430|4050843|P3|COMPLETED|Core Phase||0
1658894|NCT00690430|4050844|P2|COMPLETED|Core Phase||34
1658895|NCT00690430|4050845|P1|COMPLETED|Core Phase||35
1658896|NCT00690430|4050843|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
1658897|NCT00690430|4050844|P2|STARTED|Core Phase||57
1658898|NCT00690430|4050845|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
1658899|NCT00690378|4050874|P2|NOT COMPLETED|Overall Study||14
1658900|NCT00690378|4050875|P1|NOT COMPLETED|Overall Study||20
1658901|NCT00690378|4050874|P2|COMPLETED|Overall Study|Up to LFU visit|54
1658902|NCT00690378|4050875|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
1658903|NCT00690378|4050874|P2|Treated|Overall Study||67
1658904|NCT00690378|4050875|P1|Treated|Overall Study||68
1658905|NCT00690378|4050874|P2|STARTED|Overall Study|Randomized|68
1658906|NCT00690378|4050875|P1|STARTED|Overall Study|Randomized|69
1658907|NCT00690339|4050923|P4|NOT COMPLETED|Overall Study||25
1658908|NCT00690339|4050924|P3|NOT COMPLETED|Overall Study||57
1658909|NCT00690339|4050925|P2|NOT COMPLETED|Overall Study||81
1658910|NCT00690339|4050926|P1|NOT COMPLETED|Overall Study||117
1658911|NCT00690339|4050923|P4|COMPLETED|Overall Study||43
1658912|NCT00690339|4050924|P3|COMPLETED|Overall Study||99
1658913|NCT00690339|4050925|P2|COMPLETED|Overall Study||144
1658914|NCT00690339|4050926|P1|COMPLETED|Overall Study||375
1658915|NCT00690339|4050923|P4|STARTED|Overall Study||68
1658916|NCT00690339|4050924|P3|STARTED|Overall Study||156
1658917|NCT00690339|4050925|P2|STARTED|Overall Study||225
1658918|NCT00690339|4050926|P1|STARTED|Overall Study||492
1658919|NCT00690235|4050942|P2|NOT COMPLETED|Overall Study||4
1658920|NCT00690235|4050943|P1|NOT COMPLETED|Overall Study||5
1658921|NCT00690235|4050942|P2|COMPLETED|Overall Study||12
1658922|NCT00690235|4050943|P1|COMPLETED|Overall Study||12
1658923|NCT00690235|4050942|P2|STARTED|Overall Study||16
1658924|NCT00690235|4050943|P1|STARTED|Overall Study||17
1658925|NCT00690040|4050951|P2|NOT COMPLETED|Overall Study||0
1658926|NCT00690040|4050952|P1|NOT COMPLETED|Overall Study||0
1658927|NCT00690040|4050951|P2|COMPLETED|Overall Study||148
1658928|NCT00690040|4050952|P1|COMPLETED|Overall Study||145
1658929|NCT00690040|4050951|P2|STARTED|Overall Study||148
1658930|NCT00690040|4050952|P1|STARTED|Overall Study||145
1658931|NCT00689936|4050961|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
1658932|NCT00689936|4050962|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
1658933|NCT00689936|4050963|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
1658934|NCT00689936|4050961|P3|COMPLETED|Long-Term Follow Up Phase||315
1658935|NCT00689936|4050962|P2|COMPLETED|Long-Term Follow Up Phase||275
1658936|NCT00689936|4050963|P1|COMPLETED|Long-Term Follow Up Phase||255
1658937|NCT00689936|4050961|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
1658938|NCT00689936|4050962|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
1658939|NCT00689936|4050963|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
1658940|NCT00689936|4050961|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
1658941|NCT00689936|4050962|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
1658942|NCT00689936|4050963|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
1658943|NCT00689936|4050961|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
1658944|NCT00689936|4050962|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
1658945|NCT00689936|4050963|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
1658946|NCT00689936|4050961|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
1658947|NCT00689936|4050962|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
1658948|NCT00689936|4050963|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
1658949|NCT00689936|4050961|P3|NOT COMPLETED|Active Treatment Phase||547
1658950|NCT00689936|4050962|P2|NOT COMPLETED|Active Treatment Phase||541
1658951|NCT00689936|4050963|P1|NOT COMPLETED|Active Treatment Phase||535
1658952|NCT00689936|4050961|P3|COMPLETED|Active Treatment Phase||0
1658953|NCT00689936|4050962|P2|COMPLETED|Active Treatment Phase||0
1658954|NCT00689936|4050963|P1|COMPLETED|Active Treatment Phase||0
1658955|NCT00689936|4050961|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
1658956|NCT00689936|4050962|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
1658957|NCT00689936|4050963|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
1658958|NCT00689936|4050961|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
1658959|NCT00689936|4050962|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
1658960|NCT00689936|4050963|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
1658961|NCT00689936|4050961|P3|STARTED|Active Treatment Phase||547
1658962|NCT00689936|4050962|P2|STARTED|Active Treatment Phase||541
1658963|NCT00689936|4050963|P1|STARTED|Active Treatment Phase||535
1658964|NCT00689884|4051103|P1|NOT COMPLETED|Overall Study||0
1658965|NCT00689884|4051103|P1|COMPLETED|Overall Study||7
1658966|NCT00689884|4051103|P1|STARTED|Overall Study||7
1658967|NCT00689871|4051112|P4|NOT COMPLETED|Overall Study||7
1658968|NCT00689871|4051113|P3|NOT COMPLETED|Overall Study||73
1658969|NCT00689871|4051114|P2|NOT COMPLETED|Overall Study||52
1658970|NCT00689871|4051115|P1|NOT COMPLETED|Overall Study||175
1658971|NCT00689871|4051112|P4|COMPLETED|Overall Study|4 Patients discontinued|8
1658972|NCT00689871|4051113|P3|COMPLETED|Overall Study|28 Patients discontinued|74
1658973|NCT00689871|4051114|P2|COMPLETED|Overall Study|35 Patients discontinued|46
1658974|NCT00689871|4051115|P1|COMPLETED|Overall Study|35 Patients discontinued|280
1658975|NCT00689871|4051112|P4|STARTED|Overall Study|25 Implants|15
1658976|NCT00689871|4051113|P3|STARTED|Overall Study|288 Implants|147
1658977|NCT00689871|4051114|P2|STARTED|Overall Study|127 Implants|98
1658978|NCT00689871|4051115|P1|STARTED|Overall Study|908 Implants|455
1658979|NCT00689819|4051131|P2|NOT COMPLETED|Overall Study||15
1658980|NCT00689819|4051132|P1|NOT COMPLETED|Overall Study||20
1658981|NCT00689819|4051131|P2|COMPLETED|Overall Study||43
1658982|NCT00689819|4051132|P1|COMPLETED|Overall Study||45
1658983|NCT00689819|4051131|P2|STARTED|Overall Study||58
1658984|NCT00689819|4051132|P1|STARTED|Overall Study||65
1658985|NCT00689793|4051142|P2|NOT COMPLETED|Overall Study||5
1658986|NCT00689793|4051143|P1|NOT COMPLETED|Overall Study||4
1658987|NCT00689793|4051142|P2|COMPLETED|Overall Study||71
1658988|NCT00689793|4051143|P1|COMPLETED|Overall Study||74
1658989|NCT00689793|4051142|P2|STARTED|Overall Study||76
1658990|NCT00689793|4051143|P1|STARTED|Overall Study||78
1658991|NCT00689728|4051162|P3|NOT COMPLETED|Optional Follow-Up||6
1658992|NCT00689728|4051163|P2|NOT COMPLETED|Optional Follow-Up||6
1658993|NCT00689728|4051164|P1|NOT COMPLETED|Optional Follow-Up||3
1658994|NCT00689728|4051162|P3|COMPLETED|Optional Follow-Up||4
1658995|NCT00689728|4051163|P2|COMPLETED|Optional Follow-Up||5
1658996|NCT00689728|4051164|P1|COMPLETED|Optional Follow-Up||6
1658997|NCT00689728|4051162|P3|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
1658998|NCT00689728|4051163|P2|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
1658999|NCT00689728|4051164|P1|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
1659000|NCT00689728|4051162|P3|NOT COMPLETED|Rescue||1
1659001|NCT00689728|4051163|P2|NOT COMPLETED|Rescue||2
1659002|NCT00689728|4051164|P1|NOT COMPLETED|Rescue||1
1659003|NCT00689728|4051162|P3|COMPLETED|Rescue||29
1659004|NCT00689728|4051163|P2|COMPLETED|Rescue||24
1659005|NCT00689728|4051164|P1|COMPLETED|Rescue||30
1659006|NCT00689728|4051162|P3|STARTED|Rescue||30
1659007|NCT00689728|4051163|P2|STARTED|Rescue||26
1659008|NCT00689728|4051164|P1|STARTED|Rescue||31
1659009|NCT00689728|4051162|P3|NOT COMPLETED|Double-Blind Treatment||5
1659010|NCT00689728|4051163|P2|NOT COMPLETED|Double-Blind Treatment||4
1659011|NCT00689728|4051164|P1|NOT COMPLETED|Double-Blind Treatment||4
1659012|NCT00689728|4051162|P3|COMPLETED|Double-Blind Treatment||30
1659013|NCT00689728|4051163|P2|COMPLETED|Double-Blind Treatment||26
1659014|NCT00689728|4051164|P1|COMPLETED|Double-Blind Treatment||31
1659015|NCT00689728|4051162|P3|STARTED|Double-Blind Treatment||35
1659016|NCT00689728|4051163|P2|STARTED|Double-Blind Treatment||30
1659017|NCT00689728|4051164|P1|STARTED|Double-Blind Treatment||35
1659018|NCT00689611|4051247|P2|NOT COMPLETED|Overall Study||46
1659019|NCT00689611|4051248|P1|NOT COMPLETED|Overall Study||41
1659020|NCT00689611|4051247|P2|COMPLETED|Overall Study||146
1659021|NCT00689611|4051248|P1|COMPLETED|Overall Study||159
1659022|NCT00689611|4051247|P2|STARTED|Overall Study||192
1659023|NCT00689611|4051248|P1|STARTED|Overall Study||200
1659024|NCT00689481|4051258|P2|NOT COMPLETED|Overall Study||14
1659025|NCT00689481|4051259|P1|NOT COMPLETED|Overall Study||24
1659026|NCT00689481|4051258|P2|COMPLETED|Overall Study||95
1659027|NCT00689481|4051259|P1|COMPLETED|Overall Study||190
1659028|NCT00689481|4051258|P2|STARTED|Overall Study||109
1659029|NCT00689481|4051259|P1|STARTED|Overall Study||214
1659030|NCT00689390|4051277|P2|NOT COMPLETED|Overall Study||10
1659031|NCT00689390|4051278|P1|NOT COMPLETED|Overall Study||426
1659032|NCT00689390|4051277|P2|COMPLETED|Overall Study||37
1659033|NCT00689390|4051278|P1|COMPLETED|Overall Study||1481
1659034|NCT00689390|4051277|P2|STARTED|Overall Study||47
1659035|NCT00689390|4051278|P1|STARTED|Overall Study||1907
1659036|NCT00689351|4051296|P2|NOT COMPLETED|Toddler Dose||0
1659037|NCT00689351|4051297|P1|NOT COMPLETED|Toddler Dose||0
1659038|NCT00689351|4051296|P2|COMPLETED|Toddler Dose||88
1659039|NCT00689351|4051297|P1|COMPLETED|Toddler Dose||84
1659040|NCT00689351|4051296|P2|STARTED|Toddler Dose||88
1659041|NCT00689351|4051297|P1|STARTED|Toddler Dose||84
1659042|NCT00689351|4051296|P2|NOT COMPLETED|After Infant Series||0
1659043|NCT00689351|4051297|P1|NOT COMPLETED|After Infant Series||1
1659044|NCT00689351|4051296|P2|COMPLETED|After Infant Series||88
1659045|NCT00689351|4051297|P1|COMPLETED|After Infant Series||84
1659046|NCT00689351|4051296|P2|STARTED|After Infant Series||88
1659047|NCT00689351|4051297|P1|STARTED|After Infant Series||85
1659048|NCT00689351|4051296|P2|NOT COMPLETED|Infant Series of Dosing||1
1659049|NCT00689351|4051297|P1|NOT COMPLETED|Infant Series of Dosing||6
1659050|NCT00689351|4051296|P2|COMPLETED|Infant Series of Dosing||88
1659051|NCT00689351|4051297|P1|COMPLETED|Infant Series of Dosing||85
1659052|NCT00689351|4051296|P2|Vaccinated Dose 3|Infant Series of Dosing||88
1659053|NCT00689351|4051297|P1|Vaccinated Dose 3|Infant Series of Dosing||85
1659054|NCT00689351|4051296|P2|Vaccinated Dose 2|Infant Series of Dosing||88
1659055|NCT00689351|4051297|P1|Vaccinated Dose 2|Infant Series of Dosing||86
1659056|NCT00689351|4051296|P2|Vaccinated Dose 1|Infant Series of Dosing||89
1659057|NCT00689351|4051297|P1|Vaccinated Dose 1|Infant Series of Dosing||88
1659058|NCT00689351|4051296|P2|STARTED|Infant Series of Dosing||89
1659059|NCT00689351|4051297|P1|STARTED|Infant Series of Dosing||91
1659060|NCT00689338|4051329|P1|NOT COMPLETED|Overall Study||143
1659061|NCT00689338|4051329|P1|COMPLETED|Overall Study||73
1659062|NCT00689338|4051329|P1|STARTED|Overall Study||216
1659063|NCT00689299|4051342|P3|NOT COMPLETED|Overall Study||5
1659064|NCT00689299|4051343|P2|NOT COMPLETED|Overall Study||3
1659065|NCT00689299|4051344|P1|NOT COMPLETED|Overall Study||7
1659066|NCT00689299|4051342|P3|COMPLETED|Overall Study||49
1659067|NCT00689299|4051343|P2|COMPLETED|Overall Study||54
1659068|NCT00689299|4051344|P1|COMPLETED|Overall Study||51
1659069|NCT00689299|4051342|P3|STARTED|Overall Study||54
1659070|NCT00689299|4051343|P2|STARTED|Overall Study||57
1659071|NCT00689299|4051344|P1|STARTED|Overall Study||58
1659072|NCT00689260|4051354|P2|NOT COMPLETED|Overall Study||0
1659073|NCT00689260|4051355|P1|NOT COMPLETED|Overall Study||2
1659074|NCT00689260|4051354|P2|COMPLETED|Overall Study||21
1659075|NCT00689260|4051355|P1|COMPLETED|Overall Study||19
1659076|NCT00689260|4051354|P2|STARTED|Overall Study||21
1659077|NCT00689260|4051355|P1|STARTED|Overall Study||21
1659078|NCT00689221|4051373|P2|NOT COMPLETED|Overall Study||36
1659079|NCT00689221|4051374|P1|NOT COMPLETED|Overall Study||39
1659080|NCT00689221|4051373|P2|COMPLETED|Overall Study||237
1659081|NCT00689221|4051374|P1|COMPLETED|Overall Study||233
1659082|NCT00689221|4051373|P2|STARTED|Overall Study||273
1659083|NCT00689221|4051374|P1|STARTED|Overall Study||272
1659084|NCT00689117|4051403|P4|NOT COMPLETED|Overall Study||31
1659085|NCT00689117|4051404|P3|NOT COMPLETED|Overall Study||59
1659086|NCT00689117|4051405|P2|NOT COMPLETED|Overall Study||51
1659087|NCT00689117|4051406|P1|NOT COMPLETED|Overall Study||62
1659088|NCT00689117|4051403|P4|COMPLETED|Overall Study||211
1659089|NCT00689117|4051404|P3|COMPLETED|Overall Study||405
1659090|NCT00689117|4051405|P2|COMPLETED|Overall Study||416
1659091|NCT00689117|4051406|P1|COMPLETED|Overall Study||414
1659092|NCT00689117|4051403|P4|STARTED|Overall Study||242
1659093|NCT00689117|4051404|P3|STARTED|Overall Study||464
1659094|NCT00689117|4051405|P2|STARTED|Overall Study||467
1659095|NCT00689117|4051406|P1|STARTED|Overall Study||476
1659096|NCT00689104|4051436|P4|NOT COMPLETED|Overall Study||50
1659097|NCT00689104|4051437|P3|NOT COMPLETED|Overall Study||45
1659098|NCT00689104|4051438|P2|NOT COMPLETED|Overall Study||57
1659099|NCT00689104|4051439|P1|NOT COMPLETED|Overall Study||44
1659100|NCT00689104|4051436|P4|COMPLETED|Overall Study||445
1659101|NCT00689104|4051437|P3|COMPLETED|Overall Study||453
1659102|NCT00689104|4051438|P2|COMPLETED|Overall Study||440
1659103|NCT00689104|4051439|P1|COMPLETED|Overall Study||453
1659104|NCT00689104|4051436|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
1659105|NCT00689104|4051437|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
1659106|NCT00689104|4051438|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
1659107|NCT00689104|4051439|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
1659108|NCT00689104|4051436|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
1659109|NCT00689104|4051437|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
1659110|NCT00689104|4051438|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
1659111|NCT00689104|4051439|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
1659112|NCT00689104|4051436|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
1659113|NCT00689104|4051437|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
1659114|NCT00689104|4051438|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
1659115|NCT00689104|4051439|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
1659116|NCT00689104|4051436|P4|STARTED|Overall Study||495
1659117|NCT00689104|4051437|P3|STARTED|Overall Study||498
1659118|NCT00689104|4051438|P2|STARTED|Overall Study||497
1659119|NCT00689104|4051439|P1|STARTED|Overall Study||497
1659120|NCT00689091|4051571|P2|NOT COMPLETED|Overall Study||1394
1659121|NCT00689091|4051572|P1|NOT COMPLETED|Overall Study||1371
1659122|NCT00689091|4051571|P2|COMPLETED|Overall Study||9376
1659123|NCT00689091|4051572|P1|COMPLETED|Overall Study||9460
1659124|NCT00689091|4051571|P2|STARTED|Overall Study||10770
1659125|NCT00689091|4051572|P1|STARTED|Overall Study||10831
1659126|NCT00689078|4051594|P4|NOT COMPLETED|Overall Study||1
1659127|NCT00689078|4051595|P3|NOT COMPLETED|Overall Study||1
1659128|NCT00689078|4051596|P2|NOT COMPLETED|Overall Study||2
1659129|NCT00689078|4051597|P1|NOT COMPLETED|Overall Study||0
1659130|NCT00689078|4051594|P4|COMPLETED|Overall Study||8
1659131|NCT00689078|4051595|P3|COMPLETED|Overall Study||8
1659132|NCT00689078|4051596|P2|COMPLETED|Overall Study||7
1659133|NCT00689078|4051597|P1|COMPLETED|Overall Study||9
1659134|NCT00689078|4051594|P4|STARTED|Overall Study||9
1659135|NCT00689078|4051595|P3|STARTED|Overall Study||9
1659136|NCT00689078|4051596|P2|STARTED|Overall Study||9
1659137|NCT00689078|4051597|P1|STARTED|Overall Study||9
1659138|NCT00689052|4051645|P2|NOT COMPLETED|Overall Study||30
1659139|NCT00689052|4051646|P1|NOT COMPLETED|Overall Study||31
1659140|NCT00689052|4051645|P2|COMPLETED|Overall Study||0
1659141|NCT00689052|4051646|P1|COMPLETED|Overall Study||0
1659142|NCT00689052|4051645|P2|STARTED|Overall Study||30
1659143|NCT00689052|4051646|P1|STARTED|Overall Study||31
1659144|NCT00689026|4051678|P2|NOT COMPLETED|Overall Study||6
1659145|NCT00689026|4051679|P1|NOT COMPLETED|Overall Study||13
1659146|NCT00689026|4051678|P2|COMPLETED|Overall Study||24
1659147|NCT00689026|4051679|P1|COMPLETED|Overall Study||17
1659148|NCT00689026|4051678|P2|STARTED|Overall Study||30
1659149|NCT00689026|4051679|P1|STARTED|Overall Study||30
1659150|NCT00688870|4051687|P2|NOT COMPLETED|Toddler Dose||0
1659151|NCT00688870|4051688|P1|NOT COMPLETED|Toddler Dose||0
1659152|NCT00688870|4051687|P2|COMPLETED|Toddler Dose||84
1659153|NCT00688870|4051688|P1|COMPLETED|Toddler Dose||80
1659154|NCT00688870|4051687|P2|STARTED|Toddler Dose||84
1659155|NCT00688870|4051688|P1|STARTED|Toddler Dose||80
1659156|NCT00688870|4051687|P2|NOT COMPLETED|After Infant Series||0
1659157|NCT00688870|4051688|P1|NOT COMPLETED|After Infant Series||0
1659158|NCT00688870|4051687|P2|COMPLETED|After Infant Series||84
1659159|NCT00688870|4051688|P1|COMPLETED|After Infant Series||80
1659160|NCT00688870|4051687|P2|STARTED|After Infant Series||84
1659161|NCT00688870|4051688|P1|STARTED|After Infant Series||80
1659162|NCT00688870|4051687|P2|NOT COMPLETED|Infant Series||0
1659163|NCT00688870|4051688|P1|NOT COMPLETED|Infant Series||4
1659164|NCT00688870|4051687|P2|COMPLETED|Infant Series||84
1659165|NCT00688870|4051688|P1|COMPLETED|Infant Series||80
1659166|NCT00688870|4051687|P2|Vaccinated Dose 3|Infant Series||84
1659167|NCT00688870|4051688|P1|Vaccinated Dose 3|Infant Series||80
1659168|NCT00688870|4051687|P2|Vaccinated Dose 2|Infant Series||84
1659169|NCT00688870|4051688|P1|Vaccinated Dose 2|Infant Series||80
1659170|NCT00688870|4051687|P2|Vaccinated Dose 1|Infant Series||84
1659171|NCT00688870|4051688|P1|Vaccinated Dose 1|Infant Series||83
1659172|NCT00688870|4051687|P2|STARTED|Infant Series||84
1659173|NCT00688870|4051688|P1|STARTED|Infant Series||84
1659174|NCT00688844|4051720|P1|NOT COMPLETED|Overall Study||10
1659175|NCT00688844|4051720|P1|COMPLETED|Overall Study||48
1659176|NCT00688844|4051720|P1|STARTED|Overall Study||58
1659177|NCT00688753|4051730|P1|NOT COMPLETED|Overall Study||92
1659178|NCT00688753|4051730|P1|COMPLETED|Overall Study||0
1659179|NCT00688753|4051730|P1|STARTED|Overall Study||92
1659180|NCT00688740|4051741|P2|NOT COMPLETED|Overall Study||35
1659181|NCT00688740|4051742|P1|NOT COMPLETED|Overall Study||66
1659182|NCT00688740|4051741|P2|COMPLETED|Overall Study||711
1659183|NCT00688740|4051742|P1|COMPLETED|Overall Study||679
1659184|NCT00688740|4051741|P2|STARTED|Overall Study||746
1659185|NCT00688740|4051742|P1|STARTED|Overall Study||745
1659186|NCT00688701|4051755|P4|NOT COMPLETED|Overall Study||11
1659187|NCT00688701|4051756|P3|NOT COMPLETED|Overall Study||10
1659188|NCT00688701|4051757|P2|NOT COMPLETED|Overall Study||5
1659189|NCT00688701|4051758|P1|NOT COMPLETED|Overall Study||4
1659190|NCT00688701|4051755|P4|COMPLETED|Overall Study||108
1659191|NCT00688701|4051756|P3|COMPLETED|Overall Study||110
1659192|NCT00688701|4051757|P2|COMPLETED|Overall Study||56
1659193|NCT00688701|4051758|P1|COMPLETED|Overall Study||57
1659194|NCT00688701|4051755|P4|Subgroup for Standardized Meal Test|Overall Study||65
1659195|NCT00688701|4051756|P3|Subgroup for Standardized Meal Test|Overall Study||60
1659196|NCT00688701|4051757|P2|Subgroup for Standardized Meal Test|Overall Study||35
1659197|NCT00688701|4051758|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
1659198|NCT00688701|4051755|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
1659199|NCT00688701|4051756|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
1659200|NCT00688701|4051757|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
1659201|NCT00688701|4051758|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
1659202|NCT00688701|4051755|P4|Treated/Safety Population|Overall Study||119
1659203|NCT00688701|4051756|P3|Treated/Safety Population|Overall Study||120
1659204|NCT00688701|4051757|P2|Treated/Safety Population|Overall Study||61
1659205|NCT00688701|4051758|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
1659206|NCT00688701|4051755|P4|STARTED|Overall Study||119
1659207|NCT00688701|4051756|P3|STARTED|Overall Study||120
1659208|NCT00688701|4051757|P2|STARTED|Overall Study||61
1659209|NCT00688701|4051758|P1|STARTED|Overall Study|Randomized|61
1659210|NCT00688688|4051799|P3|NOT COMPLETED|Overall Study||192
1659211|NCT00688688|4051800|P2|NOT COMPLETED|Overall Study||179
1659212|NCT00688688|4051801|P1|NOT COMPLETED|Overall Study||186
1659213|NCT00688688|4051799|P3|COMPLETED|Overall Study||621
1659214|NCT00688688|4051800|P2|COMPLETED|Overall Study||645
1659215|NCT00688688|4051801|P1|COMPLETED|Overall Study||629
1659216|NCT00688688|4051799|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
1659217|NCT00688688|4051800|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
1659218|NCT00688688|4051801|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
1659219|NCT00688688|4051799|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
1659220|NCT00688688|4051800|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
1659221|NCT00688688|4051801|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
1659222|NCT00688688|4051799|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
1659223|NCT00688688|4051800|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
1659224|NCT00688688|4051801|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
1659225|NCT00688688|4051799|P3|STARTED|Overall Study||813
1659226|NCT00688688|4051800|P2|STARTED|Overall Study||824
1659227|NCT00688688|4051801|P1|STARTED|Overall Study||815
1659228|NCT00688662|4051892|P2|NOT COMPLETED|Overall Study||18
1659229|NCT00688662|4051893|P1|NOT COMPLETED|Overall Study||23
1659230|NCT00688662|4051892|P2|COMPLETED|Overall Study||55
1659231|NCT00688662|4051893|P1|COMPLETED|Overall Study||118
1659232|NCT00688662|4051892|P2|STARTED|Overall Study||73
1659233|NCT00688662|4051893|P1|STARTED|Overall Study||141
1659234|NCT00688636|4051903|P2|NOT COMPLETED|Overall Study||1
1659235|NCT00688636|4051904|P1|NOT COMPLETED|Overall Study||2
1659236|NCT00688636|4051903|P2|COMPLETED|Overall Study||12
1659237|NCT00688636|4051904|P1|COMPLETED|Overall Study||9
1659238|NCT00688636|4051903|P2|STARTED|Overall Study||13
1659239|NCT00688636|4051904|P1|STARTED|Overall Study||11
1659240|NCT00688597|4051921|P3|NOT COMPLETED|Overall Study||0
1659241|NCT00688597|4051922|P2|NOT COMPLETED|Overall Study||0
1659242|NCT00688597|4051923|P1|NOT COMPLETED|Overall Study||3
1659243|NCT00688597|4051921|P3|COMPLETED|Overall Study||0
1659244|NCT00688597|4051922|P2|COMPLETED|Overall Study||0
1659245|NCT00688597|4051923|P1|COMPLETED|Overall Study||0
1659246|NCT00688597|4051921|P3|Received at Least 1 Dose of Study Drug|Overall Study||0
1659247|NCT00688597|4051922|P2|Received at Least 1 Dose of Study Drug|Overall Study||0
1659248|NCT00688597|4051923|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1659249|NCT00688597|4051921|P3|STARTED|Overall Study||0
1659250|NCT00688597|4051922|P2|STARTED|Overall Study||0
1659251|NCT00688597|4051923|P1|STARTED|Overall Study||3
1659252|NCT00688545|4051936|P2|NOT COMPLETED|Overall Study||15
1659253|NCT00688545|4051937|P1|NOT COMPLETED|Overall Study||5
1659254|NCT00688545|4051936|P2|COMPLETED|Overall Study||204
1659255|NCT00688545|4051937|P1|COMPLETED|Overall Study||50
1659256|NCT00688545|4051936|P2|Switched Treatment at Least Once|Overall Study||13
1659257|NCT00688545|4051937|P1|Switched Treatment at Least Once|Overall Study||6
1659258|NCT00688545|4051936|P2|STARTED|Overall Study||219
1659259|NCT00688545|4051937|P1|STARTED|Overall Study||55
1659260|NCT00688519|4051947|P2|NOT COMPLETED|Overall Study||15
1659261|NCT00688519|4051948|P1|NOT COMPLETED|Overall Study||19
1659262|NCT00688519|4051947|P2|COMPLETED|Overall Study||98
1659263|NCT00688519|4051948|P1|COMPLETED|Overall Study||204
1659264|NCT00688519|4051947|P2|STARTED|Overall Study||113
1659265|NCT00688519|4051948|P1|STARTED|Overall Study||223
1659266|NCT00688467|4051966|P2|NOT COMPLETED|Treatment Period 2||2
1659267|NCT00688467|4051967|P1|NOT COMPLETED|Treatment Period 2||0
1659268|NCT00688467|4051966|P2|COMPLETED|Treatment Period 2||6
1659269|NCT00688467|4051967|P1|COMPLETED|Treatment Period 2||7
1659270|NCT00688467|4051966|P2|STARTED|Treatment Period 2||8
1659271|NCT00688467|4051967|P1|STARTED|Treatment Period 2||7
1659272|NCT00688467|4051966|P2|NOT COMPLETED|Treatment Period 1||2
1659273|NCT00688467|4051967|P1|NOT COMPLETED|Treatment Period 1||2
1659274|NCT00688467|4051966|P2|COMPLETED|Treatment Period 1||8
1659275|NCT00688467|4051967|P1|COMPLETED|Treatment Period 1||7
1659276|NCT00688467|4051966|P2|STARTED|Treatment Period 1||10
1659277|NCT00688467|4051967|P1|STARTED|Treatment Period 1||9
1659278|NCT00688324|4051997|P1|NOT COMPLETED|Overall Study||8
1659279|NCT00688324|4051997|P1|COMPLETED|Overall Study||28
1659280|NCT00688324|4051997|P1|STARTED|Overall Study||36
1659281|NCT00688259|4052042|P2|NOT COMPLETED|Overall Study||8
1659282|NCT00688259|4052043|P1|NOT COMPLETED|Overall Study||7
1659283|NCT00688259|4052042|P2|COMPLETED|Overall Study||36
1659284|NCT00688259|4052043|P1|COMPLETED|Overall Study||37
1659285|NCT00688259|4052042|P2|End to Active Treatment,|Overall Study||37
1659286|NCT00688259|4052043|P1|End to Active Treatment,|Overall Study||37
1659287|NCT00688259|4052042|P2|STARTED|Overall Study||44
1659288|NCT00688259|4052043|P1|STARTED|Overall Study||44
1659289|NCT00688155|4052063|P4|NOT COMPLETED|Overall Study||1
1659290|NCT00688155|4052064|P3|NOT COMPLETED|Overall Study||1
1659291|NCT00688155|4052065|P2|NOT COMPLETED|Overall Study||2
1659292|NCT00688155|4052066|P1|NOT COMPLETED|Overall Study||2
1659293|NCT00688155|4052063|P4|COMPLETED|Overall Study||17
1659294|NCT00688155|4052064|P3|COMPLETED|Overall Study||18
1659295|NCT00688155|4052065|P2|COMPLETED|Overall Study||16
1659296|NCT00688155|4052066|P1|COMPLETED|Overall Study||16
1659297|NCT00688155|4052063|P4|STARTED|Overall Study||18
1659298|NCT00688155|4052064|P3|STARTED|Overall Study||19
1659299|NCT00688155|4052065|P2|STARTED|Overall Study||18
1659300|NCT00688155|4052066|P1|STARTED|Overall Study||18
1659301|NCT00688103|4052086|P2|NOT COMPLETED|Overall Study||13
1659302|NCT00688103|4052087|P1|NOT COMPLETED|Overall Study||30
1659303|NCT00688103|4052086|P2|COMPLETED|Overall Study||64
1659304|NCT00688103|4052087|P1|COMPLETED|Overall Study||44
1659305|NCT00688103|4052086|P2|Actually Treated|Overall Study||76
1659306|NCT00688103|4052087|P1|Actually Treated|Overall Study||71
1659307|NCT00688103|4052086|P2|STARTED|Overall Study||77
1659308|NCT00688103|4052087|P1|STARTED|Overall Study||74
1659309|NCT00688064|4052099|P2|NOT COMPLETED|Overall Study||26
1659310|NCT00688064|4052100|P1|NOT COMPLETED|Overall Study||21
1659311|NCT00688064|4052099|P2|COMPLETED|Overall Study||201
1659312|NCT00688064|4052100|P1|COMPLETED|Overall Study||211
1659313|NCT00688064|4052099|P2|STARTED|Overall Study||227
1659314|NCT00688064|4052100|P1|STARTED|Overall Study||232
1659315|NCT00687973|4052116|P2|NOT COMPLETED|Overall Study||38
1659316|NCT00687973|4052117|P1|NOT COMPLETED|Overall Study||24
1659317|NCT00687973|4052116|P2|COMPLETED|Overall Study||162
1659318|NCT00687973|4052117|P1|COMPLETED|Overall Study||169
1659319|NCT00687973|4052116|P2|STARTED|Overall Study||200
1659320|NCT00687973|4052117|P1|STARTED|Overall Study||193
1659321|NCT00687908|4052146|P2|NOT COMPLETED|Overall Study||42
1659322|NCT00687908|4052147|P1|NOT COMPLETED|Overall Study||18
1659323|NCT00687908|4052146|P2|COMPLETED|Overall Study||78
1659324|NCT00687908|4052147|P1|COMPLETED|Overall Study||105
1659325|NCT00687908|4052146|P2|STARTED|Overall Study||120
1659326|NCT00687908|4052147|P1|STARTED|Overall Study||123
1659327|NCT00687856|4052161|P1|NOT COMPLETED|Overall Study||0
1659328|NCT00687856|4052161|P1|COMPLETED|Overall Study||211
1659329|NCT00687856|4052161|P1|STARTED|Overall Study||211
1659330|NCT00687830|4052167|P2|NOT COMPLETED|Overall Study||0
1659331|NCT00687830|4052168|P1|NOT COMPLETED|Overall Study||0
1659332|NCT00687830|4052167|P2|COMPLETED|Overall Study||68
1659333|NCT00687830|4052168|P1|COMPLETED|Overall Study||68
1659334|NCT00687830|4052167|P2|STARTED|Overall Study||68
1659335|NCT00687830|4052168|P1|STARTED|Overall Study||68
1659336|NCT00687804|4052179|P3|NOT COMPLETED|Open-Label Extension Study||11
1659337|NCT00687804|4052180|P2|NOT COMPLETED|Open-Label Extension Study||11
1659338|NCT00687804|4052181|P1|NOT COMPLETED|Open-Label Extension Study||10
1659339|NCT00687804|4052179|P3|COMPLETED|Open-Label Extension Study||63
1659340|NCT00687804|4052180|P2|COMPLETED|Open-Label Extension Study||72
1659341|NCT00687804|4052181|P1|COMPLETED|Open-Label Extension Study||73
1659342|NCT00687804|4052179|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
1659343|NCT00687804|4052180|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
1659344|NCT00687804|4052181|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
1659345|NCT00687804|4052179|P3|STARTED|Open-Label Extension Study||74
1659346|NCT00687804|4052180|P2|STARTED|Open-Label Extension Study||83
1659347|NCT00687804|4052181|P1|STARTED|Open-Label Extension Study||83
1659348|NCT00687804|4052179|P3|NOT COMPLETED|Core Study||13
1659349|NCT00687804|4052180|P2|NOT COMPLETED|Core Study||15
1659350|NCT00687804|4052181|P1|NOT COMPLETED|Core Study||14
1659351|NCT00687804|4052179|P3|COMPLETED|Core Study||98
1659352|NCT00687804|4052180|P2|COMPLETED|Core Study||103
1659353|NCT00687804|4052181|P1|COMPLETED|Core Study||102
1659354|NCT00687804|4052179|P3|STARTED|Core Study||111
1659355|NCT00687804|4052180|P2|STARTED|Core Study||118
1659356|NCT00687804|4052181|P1|STARTED|Core Study||116
1659357|NCT00687713|4052226|P2|NOT COMPLETED|Overall Study||40
1659358|NCT00687713|4052227|P1|NOT COMPLETED|Overall Study||32
1659359|NCT00687713|4052226|P2|COMPLETED|Overall Study||64
1659360|NCT00687713|4052227|P1|COMPLETED|Overall Study||68
1659361|NCT00687713|4052226|P2|STARTED|Overall Study||104
1659362|NCT00687713|4052227|P1|STARTED|Overall Study||100
1659363|NCT00687674|4052235|P1|NOT COMPLETED|Overall Study||2
1659364|NCT00687674|4052235|P1|COMPLETED|Overall Study||11
1659365|NCT00687674|4052235|P1|STARTED|Overall Study||13
1659366|NCT00687609|4052242|P1|NOT COMPLETED|Overall Study||3
1659367|NCT00687609|4052242|P1|COMPLETED|Overall Study||4
1659368|NCT00687609|4052242|P1|STARTED|Overall Study||7
1659369|NCT00687544|4052256|P1|NOT COMPLETED|Overall Study||11
1659370|NCT00687544|4052256|P1|COMPLETED|Overall Study||0
1659371|NCT00687544|4052256|P1|STARTED|Overall Study||11
1659372|NCT00687531|4052265|P1|NOT COMPLETED|Overall Study||135
1659373|NCT00687531|4052265|P1|COMPLETED|Overall Study||250
1659374|NCT00687531|4052265|P1|RECEIVED TREATMENT|Overall Study||281
1659375|NCT00687531|4052265|P1|STARTED|Overall Study|Completed screening procedures|385
1659376|NCT00687453|4052281|P2|NOT COMPLETED|Overall Study||6
1659377|NCT00687453|4052282|P1|NOT COMPLETED|Overall Study||3
1659378|NCT00687453|4052281|P2|COMPLETED|Overall Study||7
1659379|NCT00687453|4052282|P1|COMPLETED|Overall Study||8
1659380|NCT00687453|4052281|P2|STARTED|Overall Study||13
1659381|NCT00687453|4052282|P1|STARTED|Overall Study||11
1659382|NCT00687440|4052288|P1|NOT COMPLETED|Overall Study||12
1659383|NCT00687440|4052288|P1|COMPLETED|Overall Study||15
1659384|NCT00687440|4052288|P1|STARTED|Overall Study|Number of screened participants|27
1659385|NCT00687401|4052292|P1|NOT COMPLETED|Overall Study||30
1659386|NCT00687401|4052292|P1|COMPLETED|Overall Study||129
1659387|NCT00687401|4052292|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
1659388|NCT00687362|4052297|P1|NOT COMPLETED|Overall Study||3
1659389|NCT00687362|4052297|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
1659390|NCT00687362|4052297|P1|STARTED|Overall Study||22
1659391|NCT00687323|4052301|P1|NOT COMPLETED|Overall Study||180
1659392|NCT00687323|4052301|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
1659393|NCT00687323|4052301|P1|Received Treatment|Overall Study||47
1659394|NCT00687323|4052301|P1|STARTED|Overall Study|Number of screened participants|195
1659395|NCT00687297|4052317|P2|NOT COMPLETED|Maintenance||1
1659396|NCT00687297|4052318|P1|NOT COMPLETED|Maintenance||3
1659397|NCT00687297|4052317|P2|COMPLETED|Maintenance||25
1659398|NCT00687297|4052318|P1|COMPLETED|Maintenance||29
1659399|NCT00687297|4052317|P2|STARTED|Maintenance||26
1659400|NCT00687297|4052318|P1|STARTED|Maintenance||32
1659401|NCT00687297|4052317|P2|NOT COMPLETED|Induction||55
1659402|NCT00687297|4052318|P1|NOT COMPLETED|Induction||45
1659403|NCT00687297|4052317|P2|COMPLETED|Induction||26
1659404|NCT00687297|4052318|P1|COMPLETED|Induction||32
1659405|NCT00687297|4052317|P2|STARTED|Induction||81
1659406|NCT00687297|4052318|P1|STARTED|Induction||77
1659407|NCT00687297|4052317|P2|NOT COMPLETED|Randomization||1
1659408|NCT00687297|4052318|P1|NOT COMPLETED|Randomization||3
1659409|NCT00687297|4052317|P2|COMPLETED|Randomization||81
1659410|NCT00687297|4052318|P1|COMPLETED|Randomization||77
1659411|NCT00687297|4052317|P2|STARTED|Randomization||82
1659412|NCT00687297|4052318|P1|STARTED|Randomization||80
1659413|NCT00687271|4052332|P4|NOT COMPLETED|Overall Study||0
1659414|NCT00687271|4052333|P3|NOT COMPLETED|Overall Study||5
1659415|NCT00687271|4052334|P2|NOT COMPLETED|Overall Study||6
1659416|NCT00687271|4052335|P1|NOT COMPLETED|Overall Study||3
1659417|NCT00687271|4052332|P4|COMPLETED|Overall Study||48
1659418|NCT00687271|4052333|P3|COMPLETED|Overall Study||91
1659419|NCT00687271|4052334|P2|COMPLETED|Overall Study||90
1659420|NCT00687271|4052335|P1|COMPLETED|Overall Study||91
1659421|NCT00687271|4052332|P4|Treated|Overall Study||48
1659422|NCT00687271|4052333|P3|Treated|Overall Study||96
1659423|NCT00687271|4052334|P2|Treated|Overall Study||95
1659424|NCT00687271|4052335|P1|Treated|Overall Study||94
1659425|NCT00687271|4052332|P4|STARTED|Overall Study||48
1659426|NCT00687271|4052333|P3|STARTED|Overall Study||96
1659427|NCT00687271|4052334|P2|STARTED|Overall Study||96
1659428|NCT00687271|4052335|P1|STARTED|Overall Study||94
1659429|NCT00687219|4052373|P1|NOT COMPLETED|Overall Study||51
1659430|NCT00687219|4052373|P1|COMPLETED|Overall Study||51
1659431|NCT00687219|4052373|P1|STARTED|Overall Study||102
1659432|NCT00687193|4052385|P6|NOT COMPLETED|Overall Study||4
1659433|NCT00687193|4052386|P5|NOT COMPLETED|Overall Study||2
1659434|NCT00687193|4052387|P4|NOT COMPLETED|Overall Study||4
1659435|NCT00687193|4052388|P3|NOT COMPLETED|Overall Study||2
1659436|NCT00687193|4052389|P2|NOT COMPLETED|Overall Study||4
1659437|NCT00687193|4052390|P1|NOT COMPLETED|Overall Study||2
1659438|NCT00687193|4052385|P6|COMPLETED|Overall Study||48
1659439|NCT00687193|4052386|P5|COMPLETED|Overall Study||52
1659440|NCT00687193|4052387|P4|COMPLETED|Overall Study||49
1659441|NCT00687193|4052388|P3|COMPLETED|Overall Study||50
1659442|NCT00687193|4052389|P2|COMPLETED|Overall Study||49
1659443|NCT00687193|4052390|P1|COMPLETED|Overall Study||51
1659444|NCT00687193|4052385|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
1659445|NCT00687193|4052386|P5|STARTED|Overall Study||54
1659446|NCT00687193|4052387|P4|STARTED|Overall Study||53
1659447|NCT00687193|4052388|P3|STARTED|Overall Study||52
1659448|NCT00687193|4052389|P2|STARTED|Overall Study||53
1659449|NCT00687193|4052390|P1|STARTED|Overall Study||53
1659450|NCT00687167|4052554|P2|NOT COMPLETED|Second Intervention||0
1659451|NCT00687167|4052555|P1|NOT COMPLETED|Second Intervention||0
1659452|NCT00687167|4052554|P2|COMPLETED|Second Intervention||17
1659453|NCT00687167|4052555|P1|COMPLETED|Second Intervention||17
1659454|NCT00687167|4052554|P2|STARTED|Second Intervention||17
1659455|NCT00687167|4052555|P1|STARTED|Second Intervention||17
1659456|NCT00687167|4052554|P2|NOT COMPLETED|Washout Period of 28 Days||0
1659457|NCT00687167|4052555|P1|NOT COMPLETED|Washout Period of 28 Days||0
1659458|NCT00687167|4052554|P2|COMPLETED|Washout Period of 28 Days||17
1659459|NCT00687167|4052555|P1|COMPLETED|Washout Period of 28 Days||17
1659460|NCT00687167|4052554|P2|STARTED|Washout Period of 28 Days||17
1659461|NCT00687167|4052555|P1|STARTED|Washout Period of 28 Days||17
1659462|NCT00687167|4052554|P2|NOT COMPLETED|First Intervention||0
1659463|NCT00687167|4052555|P1|NOT COMPLETED|First Intervention||0
1659464|NCT00687167|4052554|P2|COMPLETED|First Intervention||17
1659465|NCT00687167|4052555|P1|COMPLETED|First Intervention||17
1659466|NCT00687167|4052554|P2|STARTED|First Intervention||17
1659467|NCT00687167|4052555|P1|STARTED|First Intervention||17
1659468|NCT00687102|4052565|P2|NOT COMPLETED|Overall Study||0
1659469|NCT00687102|4052566|P1|NOT COMPLETED|Overall Study||0
1659470|NCT00687102|4052565|P2|COMPLETED|Overall Study||765
1659471|NCT00687102|4052566|P1|COMPLETED|Overall Study||733
1659472|NCT00687102|4052565|P2|STARTED|Overall Study||765
1659473|NCT00687102|4052566|P1|STARTED|Overall Study||733
1659474|NCT00687076|4052588|P2|NOT COMPLETED|Overall Study||30
1659475|NCT00687076|4052589|P1|NOT COMPLETED|Overall Study||32
1659476|NCT00687076|4052588|P2|COMPLETED|Overall Study||21
1659477|NCT00687076|4052589|P1|COMPLETED|Overall Study||19
1659478|NCT00687076|4052588|P2|STARTED|Overall Study||51
1659479|NCT00687076|4052589|P1|STARTED|Overall Study||51
1659480|NCT00686998|4052600|P3|NOT COMPLETED|Overall Study||4
1659481|NCT00686998|4052601|P2|NOT COMPLETED|Overall Study||8
1659482|NCT00686998|4052602|P1|NOT COMPLETED|Overall Study||13
1659483|NCT00686998|4052600|P3|COMPLETED|Overall Study||18
1659484|NCT00686998|4052601|P2|COMPLETED|Overall Study||33
1659485|NCT00686998|4052602|P1|COMPLETED|Overall Study||30
1659486|NCT00686998|4052600|P3|Completed Scheduled Treatment|Overall Study||18
1659487|NCT00686998|4052601|P2|Completed Scheduled Treatment|Overall Study||33
1659488|NCT00686998|4052602|P1|Completed Scheduled Treatment|Overall Study||30
1659489|NCT00686998|4052600|P3|Eligible for Efficacy Analysis|Overall Study||21
1659490|NCT00686998|4052601|P2|Eligible for Efficacy Analysis|Overall Study||39
1659491|NCT00686998|4052602|P1|Eligible for Efficacy Analysis|Overall Study||42
1659492|NCT00686998|4052600|P3|Received Treatment|Overall Study||22
1659493|NCT00686998|4052601|P2|Received Treatment|Overall Study||41
1659494|NCT00686998|4052602|P1|Received Treatment|Overall Study||43
1659495|NCT00686998|4052600|P3|Randomized|Overall Study||22
1659496|NCT00686998|4052601|P2|Randomized|Overall Study||41
1659497|NCT00686998|4052602|P1|Randomized|Overall Study||43
1659498|NCT00686998|4052600|P3|STARTED|Overall Study|Randomized & received study medication|22
1659499|NCT00686998|4052601|P2|STARTED|Overall Study|Randomized & received study medication|41
1659500|NCT00686998|4052602|P1|STARTED|Overall Study|Randomized & received study medication|43
1659501|NCT00686972|4052610|P1|NOT COMPLETED|Overall Study||51
1659502|NCT00686972|4052610|P1|COMPLETED|Overall Study||0
1659503|NCT00686972|4052610|P1|STARTED|Overall Study||51
1659504|NCT00686959|4052616|P2|NOT COMPLETED|Overall Study||117
1659505|NCT00686959|4052617|P1|NOT COMPLETED|Overall Study||124
1659506|NCT00686959|4052616|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
1659507|NCT00686959|4052617|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
1659508|NCT00686959|4052616|P2|Entered Consolidation Phase|Overall Study||202
1659509|NCT00686959|4052617|P1|Entered Consolidation Phase|Overall Study||229
1659510|NCT00686959|4052616|P2|Received at Least One Dose of Study Drug|Overall Study||272
1659511|NCT00686959|4052617|P1|Received at Least One Dose of Study Drug|Overall Study||283
1659512|NCT00686959|4052616|P2|STARTED|Overall Study||297
1659513|NCT00686959|4052617|P1|STARTED|Overall Study||301
1659514|NCT00686894|4052635|P1|NOT COMPLETED|Overall Study||6
1659515|NCT00686894|4052635|P1|COMPLETED|Overall Study||1
1659516|NCT00686894|4052635|P1|STARTED|Overall Study||7
1659517|NCT00686881|4052641|P2|NOT COMPLETED|Overall Study||81
1659518|NCT00686881|4052642|P1|NOT COMPLETED|Overall Study||82
1659519|NCT00686881|4052641|P2|COMPLETED|Overall Study||53
1659520|NCT00686881|4052642|P1|COMPLETED|Overall Study||45
1659521|NCT00686881|4052641|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
1659522|NCT00686881|4052642|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
1659523|NCT00686855|4052654|P2|NOT COMPLETED|Overall Study||1
1659524|NCT00686855|4052655|P1|NOT COMPLETED|Overall Study||1
1659525|NCT00686855|4052654|P2|COMPLETED|Overall Study||17
1659526|NCT00686855|4052655|P1|COMPLETED|Overall Study||27
1659527|NCT00686855|4052654|P2|STARTED|Overall Study||18
1659528|NCT00686855|4052655|P1|STARTED|Overall Study||28
1659529|NCT00686842|4052661|P1|NOT COMPLETED|Overall Study||0
1659530|NCT00686842|4052661|P1|COMPLETED|Overall Study||17
1659531|NCT00686842|4052661|P1|STARTED|Overall Study||17
1659532|NCT00686803|4052668|P3|NOT COMPLETED|Overall Study||0
1659533|NCT00686803|4052669|P2|NOT COMPLETED|Overall Study||0
1659534|NCT00686803|4052670|P1|NOT COMPLETED|Overall Study||0
1659535|NCT00686803|4052668|P3|COMPLETED|Overall Study||3
1659536|NCT00686803|4052669|P2|COMPLETED|Overall Study||12
1659537|NCT00686803|4052670|P1|COMPLETED|Overall Study||6
1659538|NCT00686803|4052668|P3|STARTED|Overall Study||3
1659539|NCT00686803|4052669|P2|STARTED|Overall Study||12
1659540|NCT00686803|4052670|P1|STARTED|Overall Study||6
1659541|NCT00686790|4052681|P1|NOT COMPLETED|Overall Study||16
1659542|NCT00686790|4052681|P1|COMPLETED|Overall Study||32
1659543|NCT00686790|4052681|P1|STARTED|Overall Study||48
1659544|NCT00686777|4052689|P1|NOT COMPLETED|Overall Study||10
1659545|NCT00686777|4052689|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
1659546|NCT00686777|4052689|P1|Completed 24 Weeks of Follow-up|Overall Study||70
1659547|NCT00686777|4052689|P1|Included in Follow-up (All Treated)|Overall Study||75
1659548|NCT00686777|4052689|P1|Completed 48 Weeks of Treatment|Overall Study||65
1659549|NCT00686777|4052689|P1|Completed 24 Weeks of Treatment|Overall Study||69
1659550|NCT00686777|4052689|P1|STARTED|Overall Study||75
1659551|NCT00686725|4052697|P2|NOT COMPLETED|Overall Study||42
1659552|NCT00686725|4052698|P1|NOT COMPLETED|Overall Study||46
1659553|NCT00686725|4052697|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
1659554|NCT00686725|4052698|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
1659555|NCT00686725|4052697|P2|STARTED|Overall Study||52
1659556|NCT00686725|4052698|P1|STARTED|Overall Study||47
1659557|NCT00686712|4052723|P3|NOT COMPLETED|Overall Study||13
1659558|NCT00686712|4052724|P2|NOT COMPLETED|Overall Study||11
1659559|NCT00686712|4052725|P1|NOT COMPLETED|Overall Study||10
1659560|NCT00686712|4052723|P3|COMPLETED|Overall Study||17
1659561|NCT00686712|4052724|P2|COMPLETED|Overall Study||14
1659562|NCT00686712|4052725|P1|COMPLETED|Overall Study||20
1659563|NCT00686712|4052723|P3|STARTED|Overall Study||30
1659564|NCT00686712|4052724|P2|STARTED|Overall Study||25
1659565|NCT00686712|4052725|P1|STARTED|Overall Study||30
1659566|NCT00686699|4052753|P2|NOT COMPLETED|Treatment Period 2||0
1659567|NCT00686699|4052754|P1|NOT COMPLETED|Treatment Period 2||0
1659568|NCT00686699|4052753|P2|COMPLETED|Treatment Period 2||5
1659569|NCT00686699|4052754|P1|COMPLETED|Treatment Period 2||4
1659570|NCT00686699|4052753|P2|STARTED|Treatment Period 2||5
1659571|NCT00686699|4052754|P1|STARTED|Treatment Period 2||4
1659572|NCT00686699|4052753|P2|NOT COMPLETED|Treatment Period 1||2
1659573|NCT00686699|4052754|P1|NOT COMPLETED|Treatment Period 1||0
1659574|NCT00686699|4052753|P2|COMPLETED|Treatment Period 1||5
1659575|NCT00686699|4052754|P1|COMPLETED|Treatment Period 1||4
1659576|NCT00686699|4052753|P2|STARTED|Treatment Period 1||7
1659577|NCT00686699|4052754|P1|STARTED|Treatment Period 1||4
1659578|NCT00686686|4052778|P1|NOT COMPLETED|Overall Study||6
1659579|NCT00686686|4052778|P1|COMPLETED|Overall Study||17
1659580|NCT00686686|4052778|P1|STARTED|Overall Study||23
1659581|NCT00686647|4052786|P1|NOT COMPLETED|Overall Study||2
1659582|NCT00686647|4052786|P1|COMPLETED|Overall Study||91
1659583|NCT00686647|4052786|P1|STARTED|Overall Study||93
1659584|NCT00686634|4052792|P1|NOT COMPLETED|Overall Study||6
1659585|NCT00686634|4052792|P1|COMPLETED|Overall Study||102
1659586|NCT00686634|4052792|P1|STARTED|Overall Study||108
1659587|NCT00686595|4052799|P1|NOT COMPLETED|Overall Study||7
1659588|NCT00686595|4052799|P1|COMPLETED|Overall Study||31
1659589|NCT00686595|4052799|P1|STARTED|Overall Study||38
1659590|NCT00686543|4052828|P4|NOT COMPLETED|Overall Study||3
1659591|NCT00686543|4052829|P3|NOT COMPLETED|Overall Study||5
1659592|NCT00686543|4052830|P2|NOT COMPLETED|Overall Study||1
1659593|NCT00686543|4052831|P1|NOT COMPLETED|Overall Study||14
1659594|NCT00686543|4052828|P4|COMPLETED|Overall Study||17
1659595|NCT00686543|4052829|P3|COMPLETED|Overall Study||15
1659596|NCT00686543|4052830|P2|COMPLETED|Overall Study||20
1659597|NCT00686543|4052831|P1|COMPLETED|Overall Study||0
1659598|NCT00686543|4052828|P4|STARTED|Overall Study||20
1659599|NCT00686543|4052829|P3|STARTED|Overall Study||20
1659600|NCT00686543|4052830|P2|STARTED|Overall Study||21
1659601|NCT00686543|4052831|P1|STARTED|Overall Study||14
1659602|NCT00686517|4052852|P3|NOT COMPLETED|Follow-up||10
1659603|NCT00686517|4052853|P2|NOT COMPLETED|Follow-up||10
1659604|NCT00686517|4052854|P1|NOT COMPLETED|Follow-up||8
1659605|NCT00686517|4052852|P3|COMPLETED|Follow-up||29
1659606|NCT00686517|4052853|P2|COMPLETED|Follow-up||28
1659607|NCT00686517|4052854|P1|COMPLETED|Follow-up||29
1659608|NCT00686517|4052852|P3|STARTED|Follow-up||39
1659609|NCT00686517|4052853|P2|STARTED|Follow-up||38
1659610|NCT00686517|4052854|P1|STARTED|Follow-up||37
1659611|NCT00686517|4052852|P3|NOT COMPLETED|Treatment||1
1659612|NCT00686517|4052853|P2|NOT COMPLETED|Treatment||3
1659613|NCT00686517|4052854|P1|NOT COMPLETED|Treatment||6
1659614|NCT00686517|4052852|P3|COMPLETED|Treatment||42
1659615|NCT00686517|4052853|P2|COMPLETED|Treatment||40
1659616|NCT00686517|4052854|P1|COMPLETED|Treatment||38
1659617|NCT00686517|4052852|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
1659618|NCT00686517|4052853|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
1659619|NCT00686517|4052854|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
1659620|NCT00686517|4052852|P3|STARTED|Treatment||43
1659621|NCT00686517|4052853|P2|STARTED|Treatment||43
1659622|NCT00686517|4052854|P1|STARTED|Treatment||44
1659623|NCT00686374|4052877|P1|NOT COMPLETED|Overall Study||61
1659624|NCT00686374|4052877|P1|COMPLETED|Overall Study||39
1659625|NCT00686374|4052877|P1|STARTED|Overall Study||100
1659626|NCT00686335|4052888|P1|NOT COMPLETED|Treatment Period||0
1659627|NCT00686335|4052888|P1|COMPLETED|Treatment Period||7
1659628|NCT00686335|4052888|P1|STARTED|Treatment Period||7
1659629|NCT00686335|4052888|P1|NOT COMPLETED|Run-in Period||5
1659630|NCT00686335|4052888|P1|COMPLETED|Run-in Period||7
1659631|NCT00686335|4052888|P1|STARTED|Run-in Period||12
1659632|NCT00686257|4052896|P2|NOT COMPLETED|Overall Study||0
1659633|NCT00686257|4052897|P1|NOT COMPLETED|Overall Study||0
1659634|NCT00686257|4052896|P2|COMPLETED|Overall Study||31
1659635|NCT00686257|4052897|P1|COMPLETED|Overall Study||29
1659636|NCT00686257|4052896|P2|STARTED|Overall Study||31
1659637|NCT00686257|4052897|P1|STARTED|Overall Study||29
1659638|NCT00686231|4052920|P3|NOT COMPLETED|Overall Study||0
1659639|NCT00686231|4052921|P2|NOT COMPLETED|Overall Study||0
1659640|NCT00686231|4052922|P1|NOT COMPLETED|Overall Study||0
1659641|NCT00686231|4052920|P3|COMPLETED|Overall Study||20
1659642|NCT00686231|4052921|P2|COMPLETED|Overall Study||20
1659643|NCT00686231|4052922|P1|COMPLETED|Overall Study||20
1659644|NCT00686231|4052920|P3|STARTED|Overall Study||20
1659645|NCT00686231|4052921|P2|STARTED|Overall Study||20
1659646|NCT00686231|4052922|P1|STARTED|Overall Study||20
1659647|NCT00686205|4052932|P2|NOT COMPLETED|Overall Study||981
1659648|NCT00686205|4052933|P1|NOT COMPLETED|Overall Study||6007
1659649|NCT00686205|4052932|P2|COMPLETED|Overall Study||1524
1659650|NCT00686205|4052933|P1|COMPLETED|Overall Study||15599
1659651|NCT00686205|4052932|P2|STARTED|Overall Study||2505
1659652|NCT00686205|4052933|P1|STARTED|Overall Study||21606
1659653|NCT00686166|4052939|P1|NOT COMPLETED|Overall Study||20
1659654|NCT00686166|4052939|P1|COMPLETED|Overall Study||63
1659655|NCT00686166|4052939|P1|Eligible and Began Protocol Therapy|Overall Study||74
1659656|NCT00686166|4052939|P1|Eligible|Overall Study||78
1659657|NCT00686166|4052939|P1|STARTED|Overall Study||83
1659658|NCT00686127|4052951|P2|NOT COMPLETED|Overall Study||6
1659659|NCT00686127|4052952|P1|NOT COMPLETED|Overall Study||14
1659660|NCT00686127|4052951|P2|COMPLETED|Overall Study||1
1659661|NCT00686127|4052952|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
1659662|NCT00686127|4052951|P2|STARTED|Overall Study||7
1659663|NCT00686127|4052952|P1|STARTED|Overall Study||14
1659664|NCT00686075|4052968|P10|NOT COMPLETED|Overall Study||10
1659665|NCT00686075|4052969|P9|NOT COMPLETED|Overall Study||6
1659666|NCT00686075|4052970|P8|NOT COMPLETED|Overall Study||2
1659667|NCT00686075|4052971|P7|NOT COMPLETED|Overall Study||0
1659668|NCT00686075|4052972|P6|NOT COMPLETED|Overall Study||3
1659669|NCT00686075|4052973|P5|NOT COMPLETED|Overall Study||4
1659670|NCT00686075|4052974|P4|NOT COMPLETED|Overall Study||9
1659671|NCT00686075|4052975|P3|NOT COMPLETED|Overall Study||6
1659672|NCT00686075|4052976|P2|NOT COMPLETED|Overall Study||10
1659673|NCT00686075|4052977|P1|NOT COMPLETED|Overall Study||8
1659674|NCT00686075|4052968|P10|COMPLETED|Overall Study||69
1659675|NCT00686075|4052969|P9|COMPLETED|Overall Study||75
1659676|NCT00686075|4052970|P8|COMPLETED|Overall Study||76
1659677|NCT00686075|4052971|P7|COMPLETED|Overall Study||82
1659678|NCT00686075|4052972|P6|COMPLETED|Overall Study||37
1659679|NCT00686075|4052973|P5|COMPLETED|Overall Study||36
1659680|NCT00686075|4052974|P4|COMPLETED|Overall Study||71
1659681|NCT00686075|4052975|P3|COMPLETED|Overall Study||74
1659682|NCT00686075|4052976|P2|COMPLETED|Overall Study||71
1659683|NCT00686075|4052977|P1|COMPLETED|Overall Study||71
1659684|NCT00686075|4052968|P10|Treated|Overall Study||78
1659685|NCT00686075|4052969|P9|Treated|Overall Study||80
1659686|NCT00686075|4052970|P8|Treated|Overall Study||77
1659687|NCT00686075|4052971|P7|Treated|Overall Study||82
1659688|NCT00686075|4052972|P6|Treated|Overall Study||40
1659689|NCT00686075|4052973|P5|Treated|Overall Study||40
1659690|NCT00686075|4052974|P4|Treated|Overall Study||80
1659691|NCT00686075|4052975|P3|Treated|Overall Study||80
1659692|NCT00686075|4052976|P2|Treated|Overall Study||79
1659693|NCT00686075|4052977|P1|Treated|Overall Study||78
1659694|NCT00686075|4052968|P10|STARTED|Overall Study||79
1659695|NCT00686075|4052969|P9|STARTED|Overall Study||81
1659696|NCT00686075|4052970|P8|STARTED|Overall Study||78
1659697|NCT00686075|4052971|P7|STARTED|Overall Study||82
1659698|NCT00686075|4052972|P6|STARTED|Overall Study||40
1659699|NCT00686075|4052973|P5|STARTED|Overall Study||40
1659700|NCT00686075|4052974|P4|STARTED|Overall Study||80
1659701|NCT00686075|4052975|P3|STARTED|Overall Study||80
1659702|NCT00686075|4052976|P2|STARTED|Overall Study||81
1659703|NCT00686075|4052977|P1|STARTED|Overall Study||79
1659704|NCT00686036|4053171|P2|NOT COMPLETED|Overall Study||6
1659705|NCT00686036|4053172|P1|NOT COMPLETED|Overall Study||9
1659706|NCT00686036|4053171|P2|COMPLETED|Overall Study||2
1659707|NCT00686036|4053172|P1|COMPLETED|Overall Study||0
1659708|NCT00686036|4053171|P2|STARTED|Overall Study||8
1659709|NCT00686036|4053172|P1|STARTED|Overall Study||9
1659710|NCT00685945|4053184|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
1659711|NCT00685945|4053184|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
1659712|NCT00685945|4053184|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
1659713|NCT00685945|4053184|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
1659714|NCT00685945|4053184|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
1659715|NCT00685945|4053184|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
1659716|NCT00685945|4053184|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
1659717|NCT00685945|4053184|P1|COMPLETED|L-NMMA + Bradykinin||23
1659718|NCT00685945|4053184|P1|STARTED|L-NMMA + Bradykinin||24
1659719|NCT00685945|4053184|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
1659720|NCT00685945|4053184|P1|COMPLETED|Control (Bradykinin Infusion)||24
1659721|NCT00685945|4053184|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
1659722|NCT00685932|4053201|P2|NOT COMPLETED|Overall Study||20
1659723|NCT00685932|4053202|P1|NOT COMPLETED|Overall Study||21
1659724|NCT00685932|4053201|P2|COMPLETED|Overall Study||58
1659725|NCT00685932|4053202|P1|COMPLETED|Overall Study||55
1659726|NCT00685932|4053201|P2|STARTED|Overall Study||78
1659727|NCT00685932|4053202|P1|STARTED|Overall Study||76
1659728|NCT00685880|4053212|P2|NOT COMPLETED|Overall Study||0
1659729|NCT00685880|4053213|P1|NOT COMPLETED|Overall Study||0
1659730|NCT00685880|4053212|P2|COMPLETED|Overall Study||2
1659731|NCT00685880|4053213|P1|COMPLETED|Overall Study||0
1659732|NCT00685880|4053212|P2|STARTED|Overall Study||2
1659733|NCT00685880|4053213|P1|STARTED|Overall Study||0
1659734|NCT00685802|4053219|P2|NOT COMPLETED|Second Intervention||0
1659735|NCT00685802|4053220|P1|NOT COMPLETED|Second Intervention||0
1659736|NCT00685802|4053219|P2|COMPLETED|Second Intervention||15
1659737|NCT00685802|4053220|P1|COMPLETED|Second Intervention||14
1659738|NCT00685802|4053219|P2|STARTED|Second Intervention||15
1659739|NCT00685802|4053220|P1|STARTED|Second Intervention||14
1659740|NCT00685802|4053219|P2|NOT COMPLETED|Washout Period of 7 Days||1
1659741|NCT00685802|4053220|P1|NOT COMPLETED|Washout Period of 7 Days||2
1659742|NCT00685802|4053219|P2|COMPLETED|Washout Period of 7 Days||15
1659743|NCT00685802|4053220|P1|COMPLETED|Washout Period of 7 Days||14
1659744|NCT00685802|4053219|P2|STARTED|Washout Period of 7 Days||16
1659745|NCT00685802|4053220|P1|STARTED|Washout Period of 7 Days||16
1659746|NCT00685802|4053219|P2|NOT COMPLETED|First Intervention||0
1659747|NCT00685802|4053220|P1|NOT COMPLETED|First Intervention||0
1659748|NCT00685802|4053219|P2|COMPLETED|First Intervention||16
1659749|NCT00685802|4053220|P1|COMPLETED|First Intervention||16
1659750|NCT00685802|4053219|P2|STARTED|First Intervention||16
1659751|NCT00685802|4053220|P1|STARTED|First Intervention||16
1659752|NCT00685763|4053230|P1|NOT COMPLETED|Overall Study||2
1659753|NCT00685763|4053230|P1|COMPLETED|Overall Study||11
1659754|NCT00685763|4053230|P1|STARTED|Overall Study||13
1659755|NCT00685698|4053234|P1|NOT COMPLETED|Overall Study||13
1659756|NCT00685698|4053234|P1|COMPLETED|Overall Study||25
1659757|NCT00685698|4053234|P1|STARTED|Overall Study||38
1659758|NCT00685685|4053269|P2|NOT COMPLETED|Second Intervention||0
1659759|NCT00685685|4053270|P1|NOT COMPLETED|Second Intervention||0
1659760|NCT00685685|4053269|P2|COMPLETED|Second Intervention||26
1659761|NCT00685685|4053270|P1|COMPLETED|Second Intervention||25
1659762|NCT00685685|4053269|P2|STARTED|Second Intervention||26
1659763|NCT00685685|4053270|P1|STARTED|Second Intervention||25
1659764|NCT00685685|4053269|P2|NOT COMPLETED|Washout Period of 7 Days||1
1659765|NCT00685685|4053270|P1|NOT COMPLETED|Washout Period of 7 Days||2
1659766|NCT00685685|4053269|P2|COMPLETED|Washout Period of 7 Days||26
1659767|NCT00685685|4053270|P1|COMPLETED|Washout Period of 7 Days||25
1659768|NCT00685685|4053269|P2|STARTED|Washout Period of 7 Days||27
1659769|NCT00685685|4053270|P1|STARTED|Washout Period of 7 Days||27
1659770|NCT00685685|4053269|P2|NOT COMPLETED|First Intervention||0
1659771|NCT00685685|4053270|P1|NOT COMPLETED|First Intervention||0
1659772|NCT00685685|4053269|P2|COMPLETED|First Intervention||27
1659773|NCT00685685|4053270|P1|COMPLETED|First Intervention||27
1659774|NCT00685685|4053269|P2|STARTED|First Intervention||27
1659775|NCT00685685|4053270|P1|STARTED|First Intervention||27
1659776|NCT00685659|4053283|P3|NOT COMPLETED|Overall Study||15
1659777|NCT00685659|4053284|P2|NOT COMPLETED|Overall Study||25
1659778|NCT00685659|4053285|P1|NOT COMPLETED|Overall Study||31
1659779|NCT00685659|4053283|P3|COMPLETED|Overall Study||92
1659780|NCT00685659|4053284|P2|COMPLETED|Overall Study||81
1659781|NCT00685659|4053285|P1|COMPLETED|Overall Study||77
1659782|NCT00685659|4053283|P3|STARTED|Overall Study||107
1659783|NCT00685659|4053284|P2|STARTED|Overall Study||106
1659784|NCT00685659|4053285|P1|STARTED|Overall Study||108
1659785|NCT00685516|4053383|P3|NOT COMPLETED|Overall Study||7
1659786|NCT00685516|4053384|P2|NOT COMPLETED|Overall Study||5
1659787|NCT00685516|4053385|P1|NOT COMPLETED|Overall Study||8
1659788|NCT00685516|4053383|P3|COMPLETED|Overall Study||26
1659789|NCT00685516|4053384|P2|COMPLETED|Overall Study||33
1659790|NCT00685516|4053385|P1|COMPLETED|Overall Study||34
1659791|NCT00685516|4053383|P3|STARTED|Overall Study||33
1659792|NCT00685516|4053384|P2|STARTED|Overall Study||38
1659793|NCT00685516|4053385|P1|STARTED|Overall Study||42
1659794|NCT00685477|4053402|P6|NOT COMPLETED|Overall Study||0
1659795|NCT00685477|4053403|P5|NOT COMPLETED|Overall Study||0
1659796|NCT00685477|4053404|P4|NOT COMPLETED|Overall Study||0
1659797|NCT00685477|4053405|P3|NOT COMPLETED|Overall Study||0
1659798|NCT00685477|4053406|P2|NOT COMPLETED|Overall Study||0
1659799|NCT00685477|4053407|P1|NOT COMPLETED|Overall Study||0
1659800|NCT00685477|4053402|P6|COMPLETED|Overall Study||10
1659801|NCT00685477|4053403|P5|COMPLETED|Overall Study||10
1659802|NCT00685477|4053404|P4|COMPLETED|Overall Study||10
1659803|NCT00685477|4053405|P3|COMPLETED|Overall Study||10
1659804|NCT00685477|4053406|P2|COMPLETED|Overall Study||10
1659805|NCT00685477|4053407|P1|COMPLETED|Overall Study||10
1659806|NCT00685477|4053402|P6|STARTED|Overall Study||10
1659807|NCT00685477|4053403|P5|STARTED|Overall Study||10
1659808|NCT00685477|4053404|P4|STARTED|Overall Study||10
1659809|NCT00685477|4053405|P3|STARTED|Overall Study||10
1659810|NCT00685477|4053406|P2|STARTED|Overall Study||10
1659811|NCT00685477|4053407|P1|STARTED|Overall Study||10
1659812|NCT00685399|4053423|P8|NOT COMPLETED|Extension||0
1659813|NCT00685399|4053424|P7|NOT COMPLETED|Extension||0
1659814|NCT00685399|4053425|P6|NOT COMPLETED|Extension||0
1659815|NCT00685399|4053426|P5|NOT COMPLETED|Extension||0
1659816|NCT00685399|4053427|P4|NOT COMPLETED|Extension||7
1659817|NCT00685399|4053428|P3|NOT COMPLETED|Extension||0
1659818|NCT00685399|4053429|P2|NOT COMPLETED|Extension||0
1659819|NCT00685399|4053430|P1|NOT COMPLETED|Extension||0
1659820|NCT00685399|4053423|P8|COMPLETED|Extension||0
1659821|NCT00685399|4053424|P7|COMPLETED|Extension||0
1659822|NCT00685399|4053425|P6|COMPLETED|Extension||0
1659823|NCT00685399|4053426|P5|COMPLETED|Extension||0
1659824|NCT00685399|4053427|P4|COMPLETED|Extension||21
1659825|NCT00685399|4053428|P3|COMPLETED|Extension||0
1659826|NCT00685399|4053429|P2|COMPLETED|Extension||0
1659827|NCT00685399|4053430|P1|COMPLETED|Extension||0
1659828|NCT00685399|4053423|P8|STARTED|Extension||0
1659829|NCT00685399|4053424|P7|STARTED|Extension||0
1659830|NCT00685399|4053425|P6|STARTED|Extension||0
1659831|NCT00685399|4053426|P5|STARTED|Extension||0
1659832|NCT00685399|4053427|P4|STARTED|Extension||28
1659833|NCT00685399|4053428|P3|STARTED|Extension||0
1659834|NCT00685399|4053429|P2|STARTED|Extension||0
1659835|NCT00685399|4053430|P1|STARTED|Extension||0
1659836|NCT00685399|4053423|P8|NOT COMPLETED|Treatment Period 2||2
1659837|NCT00685399|4053424|P7|NOT COMPLETED|Treatment Period 2||0
1659838|NCT00685399|4053425|P6|NOT COMPLETED|Treatment Period 2||2
1659839|NCT00685399|4053426|P5|NOT COMPLETED|Treatment Period 2||0
1659840|NCT00685399|4053427|P4|NOT COMPLETED|Treatment Period 2||0
1659841|NCT00685399|4053428|P3|NOT COMPLETED|Treatment Period 2||3
1659842|NCT00685399|4053429|P2|NOT COMPLETED|Treatment Period 2||12
1659843|NCT00685399|4053430|P1|NOT COMPLETED|Treatment Period 2||0
1659844|NCT00685399|4053423|P8|COMPLETED|Treatment Period 2||10
1659845|NCT00685399|4053424|P7|COMPLETED|Treatment Period 2||13
1659846|NCT00685399|4053425|P6|COMPLETED|Treatment Period 2||10
1659847|NCT00685399|4053426|P5|COMPLETED|Treatment Period 2||4
1659848|NCT00685399|4053427|P4|COMPLETED|Treatment Period 2|in extension period only|0
1659849|NCT00685399|4053428|P3|COMPLETED|Treatment Period 2||2
1659850|NCT00685399|4053429|P2|COMPLETED|Treatment Period 2||2
1659851|NCT00685399|4053430|P1|COMPLETED|Treatment Period 2||0
1659852|NCT00685399|4053423|P8|STARTED|Treatment Period 2||12
1659853|NCT00685399|4053424|P7|STARTED|Treatment Period 2||13
1659854|NCT00685399|4053425|P6|STARTED|Treatment Period 2||12
1659855|NCT00685399|4053426|P5|STARTED|Treatment Period 2||4
1659856|NCT00685399|4053427|P4|STARTED|Treatment Period 2|in extension period only|0
1659857|NCT00685399|4053428|P3|STARTED|Treatment Period 2||5
1659858|NCT00685399|4053429|P2|STARTED|Treatment Period 2||14
1659859|NCT00685399|4053430|P1|STARTED|Treatment Period 2||0
1659860|NCT00685399|4053423|P8|NOT COMPLETED|Treatment Period 1||0
1659861|NCT00685399|4053424|P7|NOT COMPLETED|Treatment Period 1||0
1659862|NCT00685399|4053425|P6|NOT COMPLETED|Treatment Period 1||0
1659863|NCT00685399|4053426|P5|NOT COMPLETED|Treatment Period 1||0
1659864|NCT00685399|4053427|P4|NOT COMPLETED|Treatment Period 1||0
1659865|NCT00685399|4053428|P3|NOT COMPLETED|Treatment Period 1||0
1659866|NCT00685399|4053429|P2|NOT COMPLETED|Treatment Period 1||0
1659867|NCT00685399|4053430|P1|NOT COMPLETED|Treatment Period 1||6
1659868|NCT00685399|4053423|P8|COMPLETED|Treatment Period 1||0
1659869|NCT00685399|4053424|P7|COMPLETED|Treatment Period 1||0
1659870|NCT00685399|4053425|P6|COMPLETED|Treatment Period 1||0
1659871|NCT00685399|4053426|P5|COMPLETED|Treatment Period 1||0
1659872|NCT00685399|4053427|P4|COMPLETED|Treatment Period 1||0
1659873|NCT00685399|4053428|P3|COMPLETED|Treatment Period 1||0
1659874|NCT00685399|4053429|P2|COMPLETED|Treatment Period 1||0
1659875|NCT00685399|4053430|P1|COMPLETED|Treatment Period 1||10
1659876|NCT00685399|4053423|P8|STARTED|Treatment Period 1||0
1659877|NCT00685399|4053424|P7|STARTED|Treatment Period 1||0
1659878|NCT00685399|4053425|P6|STARTED|Treatment Period 1||0
1659879|NCT00685399|4053426|P5|STARTED|Treatment Period 1||0
1659880|NCT00685399|4053427|P4|STARTED|Treatment Period 1||0
1659881|NCT00685399|4053428|P3|STARTED|Treatment Period 1||0
1659882|NCT00685399|4053429|P2|STARTED|Treatment Period 1||0
1659883|NCT00685399|4053430|P1|STARTED|Treatment Period 1||16
1659884|NCT00685373|4053463|P1|NOT COMPLETED|Overall Study||15
1659885|NCT00685373|4053463|P1|COMPLETED|Overall Study||151
1659886|NCT00685373|4053463|P1|STARTED|Overall Study||166
1659887|NCT00685334|4053472|P2|NOT COMPLETED|Overall Study||7
1659888|NCT00685334|4053473|P1|NOT COMPLETED|Overall Study||10
1659889|NCT00685334|4053472|P2|COMPLETED|Overall Study||3
1659890|NCT00685334|4053473|P1|COMPLETED|Overall Study||2
1659891|NCT00685334|4053472|P2|STARTED|Overall Study||10
1659892|NCT00685334|4053473|P1|STARTED|Overall Study||12
1659893|NCT00685295|4053483|P2|NOT COMPLETED|Overall Study||0
1659894|NCT00685295|4053484|P1|NOT COMPLETED|Overall Study||0
1659895|NCT00685295|4053483|P2|COMPLETED|Overall Study||30
1659896|NCT00685295|4053484|P1|COMPLETED|Overall Study||30
1659897|NCT00685295|4053483|P2|STARTED|Overall Study||30
1659898|NCT00685295|4053484|P1|STARTED|Overall Study||30
1659899|NCT00685178|4053498|P4|NOT COMPLETED|Overall Study||14
1659900|NCT00685178|4053499|P3|NOT COMPLETED|Overall Study||12
1659901|NCT00685178|4053500|P2|NOT COMPLETED|Overall Study||19
1659902|NCT00685178|4053501|P1|NOT COMPLETED|Overall Study||13
1659903|NCT00685178|4053498|P4|COMPLETED|Overall Study||33
1659904|NCT00685178|4053499|P3|COMPLETED|Overall Study||27
1659905|NCT00685178|4053500|P2|COMPLETED|Overall Study||26
1659906|NCT00685178|4053501|P1|COMPLETED|Overall Study||27
1659907|NCT00685178|4053498|P4|STARTED|Overall Study||47
1659908|NCT00685178|4053499|P3|STARTED|Overall Study||39
1659909|NCT00685178|4053500|P2|STARTED|Overall Study||45
1659910|NCT00685178|4053501|P1|STARTED|Overall Study||40
1659911|NCT00685165|4053515|P2|NOT COMPLETED|Second Intervention||0
1659912|NCT00685165|4053516|P1|NOT COMPLETED|Second Intervention||0
1659913|NCT00685165|4053515|P2|COMPLETED|Second Intervention||11
1659914|NCT00685165|4053516|P1|COMPLETED|Second Intervention||10
1659915|NCT00685165|4053515|P2|STARTED|Second Intervention||11
1659916|NCT00685165|4053516|P1|STARTED|Second Intervention||10
1659917|NCT00685165|4053515|P2|NOT COMPLETED|Washout Period of 14 Days||0
1659918|NCT00685165|4053516|P1|NOT COMPLETED|Washout Period of 14 Days||1
1659919|NCT00685165|4053515|P2|COMPLETED|Washout Period of 14 Days||11
1659920|NCT00685165|4053516|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
1659921|NCT00685165|4053515|P2|STARTED|Washout Period of 14 Days||11
1659922|NCT00685165|4053516|P1|STARTED|Washout Period of 14 Days||11
1659923|NCT00685165|4053515|P2|NOT COMPLETED|First Intervention||0
1659924|NCT00685165|4053516|P1|NOT COMPLETED|First Intervention||0
1659925|NCT00685165|4053515|P2|COMPLETED|First Intervention||11
1659926|NCT00685165|4053516|P1|COMPLETED|First Intervention||11
1659927|NCT00685165|4053515|P2|STARTED|First Intervention||11
1659928|NCT00685165|4053516|P1|STARTED|First Intervention||11
1659929|NCT00685139|4053526|P2|NOT COMPLETED|Second Intervention||0
1659930|NCT00685139|4053527|P1|NOT COMPLETED|Second Intervention||0
1659931|NCT00685139|4053526|P2|COMPLETED|Second Intervention||17
1659932|NCT00685139|4053527|P1|COMPLETED|Second Intervention||17
1659933|NCT00685139|4053526|P2|STARTED|Second Intervention||17
1659934|NCT00685139|4053527|P1|STARTED|Second Intervention||17
1659935|NCT00685139|4053526|P2|NOT COMPLETED|Washout Period of 28 Days||0
1659936|NCT00685139|4053527|P1|NOT COMPLETED|Washout Period of 28 Days||0
1659937|NCT00685139|4053526|P2|COMPLETED|Washout Period of 28 Days||17
1659938|NCT00685139|4053527|P1|COMPLETED|Washout Period of 28 Days||17
1659939|NCT00685139|4053526|P2|STARTED|Washout Period of 28 Days||17
1659940|NCT00685139|4053527|P1|STARTED|Washout Period of 28 Days||17
1659941|NCT00685139|4053526|P2|NOT COMPLETED|First Intervention||0
1659942|NCT00685139|4053527|P1|NOT COMPLETED|First Intervention||0
1659943|NCT00685139|4053526|P2|COMPLETED|First Intervention||17
1659944|NCT00685139|4053527|P1|COMPLETED|First Intervention||17
1659945|NCT00685139|4053526|P2|STARTED|First Intervention||17
1659946|NCT00685139|4053527|P1|STARTED|First Intervention||17
1659947|NCT00685035|4053535|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
1659948|NCT00685035|4053536|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
1659949|NCT00685035|4053535|P2|COMPLETED|Period 3: 2nd Intervention||8
1659950|NCT00685035|4053536|P1|COMPLETED|Period 3: 2nd Intervention||8
1659951|NCT00685035|4053535|P2|STARTED|Period 3: 2nd Intervention||8
1659952|NCT00685035|4053536|P1|STARTED|Period 3: 2nd Intervention||8
1659953|NCT00685035|4053535|P2|NOT COMPLETED|Period 2: 2-day Washout||0
1659954|NCT00685035|4053536|P1|NOT COMPLETED|Period 2: 2-day Washout||0
1659955|NCT00685035|4053535|P2|COMPLETED|Period 2: 2-day Washout||8
1659956|NCT00685035|4053536|P1|COMPLETED|Period 2: 2-day Washout||8
1659957|NCT00685035|4053535|P2|STARTED|Period 2: 2-day Washout||8
1659958|NCT00685035|4053536|P1|STARTED|Period 2: 2-day Washout||8
1659959|NCT00685035|4053535|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
1659960|NCT00685035|4053536|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
1659961|NCT00685035|4053535|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
1659962|NCT00685035|4053536|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
1659963|NCT00685035|4053535|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
1659964|NCT00685035|4053536|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
1659965|NCT00684996|4053560|P1|NOT COMPLETED|Overall Study||5
1659966|NCT00684996|4053560|P1|COMPLETED|Overall Study||0
1659967|NCT00684996|4053560|P1|Eligible|Overall Study||5
1659968|NCT00684996|4053560|P1|STARTED|Overall Study||5
1659969|NCT00684983|4053575|P2|NOT COMPLETED|Overall Study||0
1659970|NCT00684983|4053576|P1|NOT COMPLETED|Overall Study||0
1659971|NCT00684983|4053575|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
1659972|NCT00684983|4053576|P1|COMPLETED|Overall Study||19
1659973|NCT00684983|4053575|P2|STARTED|Overall Study||45
1659974|NCT00684983|4053576|P1|STARTED|Overall Study||19
1659975|NCT00684814|4053592|P2|NOT COMPLETED|Second Intervention||0
1659976|NCT00684814|4053593|P1|NOT COMPLETED|Second Intervention||1
1659977|NCT00684814|4053592|P2|COMPLETED|Second Intervention||15
1659978|NCT00684814|4053593|P1|COMPLETED|Second Intervention||16
1659979|NCT00684814|4053592|P2|STARTED|Second Intervention||15
1659980|NCT00684814|4053593|P1|STARTED|Second Intervention||17
1659981|NCT00684814|4053592|P2|NOT COMPLETED|Washout Period of 7 Days||4
1659982|NCT00684814|4053593|P1|NOT COMPLETED|Washout Period of 7 Days||2
1659983|NCT00684814|4053592|P2|COMPLETED|Washout Period of 7 Days||15
1659984|NCT00684814|4053593|P1|COMPLETED|Washout Period of 7 Days||17
1659985|NCT00684814|4053592|P2|STARTED|Washout Period of 7 Days||19
1659986|NCT00684814|4053593|P1|STARTED|Washout Period of 7 Days||19
1659987|NCT00684814|4053592|P2|NOT COMPLETED|First Intervention||0
1659988|NCT00684814|4053593|P1|NOT COMPLETED|First Intervention||0
1659989|NCT00684814|4053592|P2|COMPLETED|First Intervention||19
1659990|NCT00684814|4053593|P1|COMPLETED|First Intervention||19
1659991|NCT00684814|4053592|P2|STARTED|First Intervention||19
1659992|NCT00684814|4053593|P1|STARTED|First Intervention||19
1659993|NCT00684788|4053605|P2|NOT COMPLETED|Overall Study||0
1659994|NCT00684788|4053606|P1|NOT COMPLETED|Overall Study||0
1659995|NCT00684788|4053605|P2|COMPLETED|Overall Study||18
1659996|NCT00684788|4053606|P1|COMPLETED|Overall Study||17
1659997|NCT00684788|4053605|P2|STARTED|Overall Study||18
1659998|NCT00684788|4053606|P1|STARTED|Overall Study||17
1659999|NCT00684775|4053626|P2|NOT COMPLETED|Overall Study||0
1660000|NCT00684775|4053627|P1|NOT COMPLETED|Overall Study||0
1660001|NCT00684775|4053626|P2|COMPLETED|Overall Study||19
1660002|NCT00684775|4053627|P1|COMPLETED|Overall Study||19
1660003|NCT00684775|4053626|P2|STARTED|Overall Study||19
1660004|NCT00684775|4053627|P1|STARTED|Overall Study||19
1660005|NCT00684762|4053645|P2|NOT COMPLETED|Second Intervention||0
1660006|NCT00684762|4053646|P1|NOT COMPLETED|Second Intervention||0
1660007|NCT00684762|4053645|P2|COMPLETED|Second Intervention||14
1660008|NCT00684762|4053646|P1|COMPLETED|Second Intervention||14
1660009|NCT00684762|4053645|P2|STARTED|Second Intervention||14
1660010|NCT00684762|4053646|P1|STARTED|Second Intervention||14
1660011|NCT00684762|4053645|P2|NOT COMPLETED|Washout Period of 7 Days||2
1660012|NCT00684762|4053646|P1|NOT COMPLETED|Washout Period of 7 Days||2
1660013|NCT00684762|4053645|P2|COMPLETED|Washout Period of 7 Days||14
1660014|NCT00684762|4053646|P1|COMPLETED|Washout Period of 7 Days||14
1660015|NCT00684762|4053645|P2|STARTED|Washout Period of 7 Days||16
1660016|NCT00684762|4053646|P1|STARTED|Washout Period of 7 Days||16
1660017|NCT00684762|4053645|P2|NOT COMPLETED|First Intervention||0
1660018|NCT00684762|4053646|P1|NOT COMPLETED|First Intervention||0
1660019|NCT00684762|4053645|P2|COMPLETED|First Intervention||16
1660020|NCT00684762|4053646|P1|COMPLETED|First Intervention||16
1660021|NCT00684762|4053645|P2|STARTED|First Intervention||16
1660022|NCT00684762|4053646|P1|STARTED|First Intervention||16
1660023|NCT00684749|4053656|P1|NOT COMPLETED|Overall Study||0
1660024|NCT00684749|4053656|P1|COMPLETED|Overall Study||142
1660025|NCT00684749|4053656|P1|STARTED|Overall Study||142
1660026|NCT00684723|4053660|P2|NOT COMPLETED|Second Intervention||0
1660027|NCT00684723|4053661|P1|NOT COMPLETED|Second Intervention||0
1660028|NCT00684723|4053660|P2|COMPLETED|Second Intervention||27
1660029|NCT00684723|4053661|P1|COMPLETED|Second Intervention||27
1660030|NCT00684723|4053660|P2|STARTED|Second Intervention||27
1660031|NCT00684723|4053661|P1|STARTED|Second Intervention||27
1660032|NCT00684723|4053660|P2|NOT COMPLETED|Washout Period of 7 Days||0
1660033|NCT00684723|4053661|P1|NOT COMPLETED|Washout Period of 7 Days||0
1660034|NCT00684723|4053660|P2|COMPLETED|Washout Period of 7 Days||27
1660035|NCT00684723|4053661|P1|COMPLETED|Washout Period of 7 Days||27
1660036|NCT00684723|4053660|P2|STARTED|Washout Period of 7 Days||27
1660037|NCT00684723|4053661|P1|STARTED|Washout Period of 7 Days||27
1660038|NCT00684723|4053660|P2|NOT COMPLETED|First Intervention||0
1660039|NCT00684723|4053661|P1|NOT COMPLETED|First Intervention||0
1660040|NCT00684723|4053660|P2|COMPLETED|First Intervention||27
1660041|NCT00684723|4053661|P1|COMPLETED|First Intervention||27
1660042|NCT00684723|4053660|P2|STARTED|First Intervention||27
1660043|NCT00684723|4053661|P1|STARTED|First Intervention||27
1660044|NCT00684671|4053674|P3|NOT COMPLETED|Overall Study||0
1660045|NCT00684671|4053675|P2|NOT COMPLETED|Overall Study||0
1660046|NCT00684671|4053676|P1|NOT COMPLETED|Overall Study||3
1660047|NCT00684671|4053674|P3|COMPLETED|Overall Study||164
1660048|NCT00684671|4053675|P2|COMPLETED|Overall Study||170
1660049|NCT00684671|4053676|P1|COMPLETED|Overall Study||169
1660050|NCT00684671|4053674|P3|STARTED|Overall Study||164
1660051|NCT00684671|4053675|P2|STARTED|Overall Study||170
1660052|NCT00684671|4053676|P1|STARTED|Overall Study||172
1660053|NCT00684645|4053705|P1|NOT COMPLETED|Overall Study||114
1660054|NCT00684645|4053705|P1|COMPLETED|Overall Study||72
1660055|NCT00684645|4053705|P1|STARTED|Overall Study||186
1660056|NCT00684593|4053725|P2|NOT COMPLETED|Overall Study||2
1660057|NCT00684593|4053726|P1|NOT COMPLETED|Overall Study||0
1660058|NCT00684593|4053725|P2|COMPLETED|Overall Study||8
1660059|NCT00684593|4053726|P1|COMPLETED|Overall Study||21
1660060|NCT00684593|4053725|P2|STARTED|Overall Study||10
1660061|NCT00684593|4053726|P1|STARTED|Overall Study||21
1660062|NCT00684567|4053738|P1|NOT COMPLETED|Monotherapy Period||14
1660063|NCT00684567|4053738|P1|COMPLETED|Monotherapy Period||9
1660064|NCT00684567|4053738|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
1660065|NCT00684567|4053738|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
1660066|NCT00684567|4053738|P1|COMPLETED|Concomitant Radiotherapy Period||28
1660067|NCT00684567|4053738|P1|STARTED|Concomitant Radiotherapy Period||30
1660068|NCT00684554|4053748|P2|NOT COMPLETED|Overall Study||0
1660069|NCT00684554|4053749|P1|NOT COMPLETED|Overall Study||0
1660070|NCT00684554|4053748|P2|COMPLETED|Overall Study||10
1660071|NCT00684554|4053749|P1|COMPLETED|Overall Study||10
1660072|NCT00684554|4053748|P2|STARTED|Overall Study||10
1660073|NCT00684554|4053749|P1|STARTED|Overall Study||10
1660074|NCT00684541|4053759|P2|NOT COMPLETED|Overall Study||3
1660075|NCT00684541|4053760|P1|NOT COMPLETED|Overall Study||3
1660076|NCT00684541|4053759|P2|COMPLETED|Overall Study||23
1660077|NCT00684541|4053760|P1|COMPLETED|Overall Study||20
1660078|NCT00684541|4053759|P2|STARTED|Overall Study||26
1660079|NCT00684541|4053760|P1|STARTED|Overall Study||23
1660080|NCT00684515|4053771|P3|NOT COMPLETED|Overall Study||1
1660081|NCT00684515|4053772|P2|NOT COMPLETED|Overall Study||3
1660082|NCT00684515|4053773|P1|NOT COMPLETED|Overall Study||4
1660083|NCT00684515|4053771|P3|COMPLETED|Overall Study||27
1660084|NCT00684515|4053772|P2|COMPLETED|Overall Study||26
1660085|NCT00684515|4053773|P1|COMPLETED|Overall Study||29
1660086|NCT00684515|4053771|P3|STARTED|Overall Study||28
1660087|NCT00684515|4053772|P2|STARTED|Overall Study||29
1660088|NCT00684515|4053773|P1|STARTED|Overall Study||33
1660089|NCT00684424|4053796|P1|NOT COMPLETED|Overall Study||5
1660090|NCT00684424|4053796|P1|COMPLETED|Overall Study||194
1660091|NCT00684424|4053796|P1|STARTED|Overall Study||199
1660092|NCT00684411|4053811|P1|NOT COMPLETED|Overall Study||12
1660093|NCT00684411|4053811|P1|COMPLETED|Overall Study||0
1660094|NCT00684411|4053811|P1|Disease Evaluable|Overall Study||11
1660095|NCT00684411|4053811|P1|STARTED|Overall Study||12
1660096|NCT00684320|4053819|P2|NOT COMPLETED|Overall Study||0
1660097|NCT00684320|4053820|P1|NOT COMPLETED|Overall Study||4
1660098|NCT00684320|4053819|P2|COMPLETED|Overall Study||22
1660099|NCT00684320|4053820|P1|COMPLETED|Overall Study||22
1660100|NCT00684320|4053819|P2|STARTED|Overall Study||22
1660101|NCT00684320|4053820|P1|STARTED|Overall Study||26
1660102|NCT00684307|4053833|P5|NOT COMPLETED|Overall Study||25
1660103|NCT00684307|4053834|P4|NOT COMPLETED|Overall Study||32
1660104|NCT00684307|4053835|P3|NOT COMPLETED|Overall Study||28
1660105|NCT00684307|4053836|P2|NOT COMPLETED|Overall Study||22
1660106|NCT00684307|4053837|P1|NOT COMPLETED|Overall Study||24
1660107|NCT00684307|4053833|P5|COMPLETED|Overall Study||293
1660108|NCT00684307|4053834|P4|COMPLETED|Overall Study||128
1660109|NCT00684307|4053835|P3|COMPLETED|Overall Study||128
1660110|NCT00684307|4053836|P2|COMPLETED|Overall Study||129
1660111|NCT00684307|4053837|P1|COMPLETED|Overall Study||140
1660112|NCT00684307|4053833|P5|On Treatment Period Completed|Overall Study||293
1660113|NCT00684307|4053834|P4|On Treatment Period Completed|Overall Study||128
1660114|NCT00684307|4053835|P3|On Treatment Period Completed|Overall Study||128
1660115|NCT00684307|4053836|P2|On Treatment Period Completed|Overall Study||129
1660116|NCT00684307|4053837|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
1660117|NCT00684307|4053833|P5|On Treatment Period Started|Overall Study||318
1660118|NCT00684307|4053834|P4|On Treatment Period Started|Overall Study||160
1660119|NCT00684307|4053835|P3|On Treatment Period Started|Overall Study||156
1660120|NCT00684307|4053836|P2|On Treatment Period Started|Overall Study||151
1660121|NCT00684307|4053837|P1|On Treatment Period Started|Overall Study||164
1660122|NCT00684307|4053833|P5|STARTED|Overall Study||318
1660123|NCT00684307|4053834|P4|STARTED|Overall Study||160
1660124|NCT00684307|4053835|P3|STARTED|Overall Study||156
1660125|NCT00684307|4053836|P2|STARTED|Overall Study||151
1660126|NCT00684307|4053837|P1|STARTED|Overall Study|Patients who received treatment|164
1660127|NCT00684255|4053904|P1|NOT COMPLETED|Overall Study||0
1660128|NCT00684255|4053904|P1|COMPLETED|Overall Study||1
1660129|NCT00684255|4053904|P1|STARTED|Overall Study||1
1660130|NCT00684242|4053909|P1|NOT COMPLETED|Overall Study||0
1660131|NCT00684242|4053909|P1|COMPLETED|Overall Study||3
1660132|NCT00684242|4053909|P1|STARTED|Overall Study||3
1660133|NCT00684203|4053919|P6|NOT COMPLETED|Overall Study||0
1660134|NCT00684203|4053920|P5|NOT COMPLETED|Overall Study||0
1660135|NCT00684203|4053921|P4|NOT COMPLETED|Overall Study||0
1660136|NCT00684203|4053922|P3|NOT COMPLETED|Overall Study||9
1660137|NCT00684203|4053923|P2|NOT COMPLETED|Overall Study||8
1660138|NCT00684203|4053924|P1|NOT COMPLETED|Overall Study||9
1660139|NCT00684203|4053919|P6|COMPLETED|Overall Study||2
1660140|NCT00684203|4053920|P5|COMPLETED|Overall Study||17
1660141|NCT00684203|4053921|P4|COMPLETED|Overall Study||6
1660142|NCT00684203|4053922|P3|COMPLETED|Overall Study||12
1660143|NCT00684203|4053923|P2|COMPLETED|Overall Study||23
1660144|NCT00684203|4053924|P1|COMPLETED|Overall Study||31
1660145|NCT00684203|4053919|P6|STARTED|Overall Study||2
1660146|NCT00684203|4053920|P5|STARTED|Overall Study||17
1660147|NCT00684203|4053921|P4|STARTED|Overall Study||6
1660148|NCT00684203|4053922|P3|STARTED|Overall Study||21
1660149|NCT00684203|4053923|P2|STARTED|Overall Study||31
1660150|NCT00684203|4053924|P1|STARTED|Overall Study||40
1660151|NCT00684177|4053985|P2|NOT COMPLETED|Overall Study||23
1660152|NCT00684177|4053986|P1|NOT COMPLETED|Overall Study||21
1660153|NCT00684177|4053985|P2|COMPLETED|Overall Study||141
1660154|NCT00684177|4053986|P1|COMPLETED|Overall Study||322
1660155|NCT00684177|4053985|P2|STARTED|Overall Study||164
1660156|NCT00684177|4053986|P1|STARTED|Overall Study||343
1660157|NCT00684138|4054004|P2|NOT COMPLETED|Overall Study||8
1660158|NCT00684138|4054005|P1|NOT COMPLETED|Overall Study||3
1660159|NCT00684138|4054004|P2|COMPLETED|Overall Study||131
1660160|NCT00684138|4054005|P1|COMPLETED|Overall Study||138
1660161|NCT00684138|4054004|P2|STARTED|Overall Study||139
1660162|NCT00684138|4054005|P1|STARTED|Overall Study||141
1660163|NCT00684073|4054021|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
1660164|NCT00684073|4054021|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
1660165|NCT00684073|4054021|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
1660166|NCT00684073|4054021|P1|NOT COMPLETED|Selection||7
1660167|NCT00684073|4054021|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
1660168|NCT00684073|4054021|P1|STARTED|Selection||60
1660169|NCT00684060|4054031|P2|NOT COMPLETED|Overall Study||3
1660170|NCT00684060|4054032|P1|NOT COMPLETED|Overall Study||3
1660171|NCT00684060|4054031|P2|COMPLETED|Overall Study||26
1660172|NCT00684060|4054032|P1|COMPLETED|Overall Study||55
1660173|NCT00684060|4054031|P2|STARTED|Overall Study||29
1660174|NCT00684060|4054032|P1|STARTED|Overall Study||58
1660175|NCT00684047|4054055|P3|NOT COMPLETED|Overall Study||5
1660176|NCT00684047|4054056|P2|NOT COMPLETED|Overall Study||16
1660177|NCT00684047|4054057|P1|NOT COMPLETED|Overall Study||13
1660178|NCT00684047|4054055|P3|COMPLETED|Overall Study||52
1660179|NCT00684047|4054056|P2|COMPLETED|Overall Study||94
1660180|NCT00684047|4054057|P1|COMPLETED|Overall Study||59
1660181|NCT00684047|4054055|P3|STARTED|Overall Study||57
1660182|NCT00684047|4054056|P2|STARTED|Overall Study||110
1660183|NCT00684047|4054057|P1|STARTED|Overall Study||72
1660184|NCT00684021|4054071|P4|NOT COMPLETED|Overall Study||2
1660185|NCT00684021|4054072|P3|NOT COMPLETED|Overall Study||2
1660186|NCT00684021|4054073|P2|NOT COMPLETED|Overall Study||2
1660187|NCT00684021|4054074|P1|NOT COMPLETED|Overall Study||2
1660188|NCT00684021|4054071|P4|COMPLETED|Overall Study||15
1660189|NCT00684021|4054072|P3|COMPLETED|Overall Study||34
1660190|NCT00684021|4054073|P2|COMPLETED|Overall Study||22
1660191|NCT00684021|4054074|P1|COMPLETED|Overall Study||41
1660192|NCT00684021|4054071|P4|STARTED|Overall Study||17
1660193|NCT00684021|4054072|P3|STARTED|Overall Study||36
1660194|NCT00684021|4054073|P2|STARTED|Overall Study||24
1660195|NCT00684021|4054074|P1|STARTED|Overall Study||43
1660196|NCT00683930|4054115|P3|NOT COMPLETED|Overall Study||9
1660197|NCT00683930|4054116|P2|NOT COMPLETED|Overall Study||3
1660198|NCT00683930|4054117|P1|NOT COMPLETED|Overall Study||7
1660199|NCT00683930|4054115|P3|COMPLETED|Overall Study||28
1660200|NCT00683930|4054116|P2|COMPLETED|Overall Study||18
1660201|NCT00683930|4054117|P1|COMPLETED|Overall Study||29
1660202|NCT00683930|4054115|P3|STARTED|Overall Study||37
1660203|NCT00683930|4054116|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
1660204|NCT00683930|4054117|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
1660205|NCT00683917|4054135|P1|NOT COMPLETED|Overall Study||10
1660206|NCT00683917|4054135|P1|COMPLETED|Overall Study||0
1660207|NCT00683917|4054135|P1|STARTED|Overall Study||10
1660208|NCT00683904|4054145|P2|NOT COMPLETED|Dose Level 2||2
1660209|NCT00683904|4054146|P1|NOT COMPLETED|Dose Level 2||0
1660210|NCT00683904|4054145|P2|COMPLETED|Dose Level 2||4
1660211|NCT00683904|4054146|P1|COMPLETED|Dose Level 2||0
1660212|NCT00683904|4054145|P2|STARTED|Dose Level 2||6
1660213|NCT00683904|4054146|P1|STARTED|Dose Level 2||0
1660214|NCT00683904|4054145|P2|NOT COMPLETED|Dose Level 1||0
1660215|NCT00683904|4054146|P1|NOT COMPLETED|Dose Level 1||3
1660216|NCT00683904|4054145|P2|COMPLETED|Dose Level 1||0
1660217|NCT00683904|4054146|P1|COMPLETED|Dose Level 1||3
1660218|NCT00683904|4054145|P2|STARTED|Dose Level 1||0
1660219|NCT00683904|4054146|P1|STARTED|Dose Level 1||6
1660220|NCT00683878|4054182|P3|NOT COMPLETED|Overall Study||14
1660221|NCT00683878|4054183|P2|NOT COMPLETED|Overall Study||16
1660222|NCT00683878|4054184|P1|NOT COMPLETED|Overall Study||23
1660223|NCT00683878|4054182|P3|COMPLETED|Overall Study||126
1660224|NCT00683878|4054183|P2|COMPLETED|Overall Study||125
1660225|NCT00683878|4054184|P1|COMPLETED|Overall Study||116
1660226|NCT00683878|4054182|P3|STARTED|Overall Study||140
1660227|NCT00683878|4054183|P2|STARTED|Overall Study||141
1660228|NCT00683878|4054184|P1|STARTED|Overall Study||139
1660229|NCT00683852|4054212|P3|NOT COMPLETED|30-Day Phase 2 Period||9
1660230|NCT00683852|4054213|P2|NOT COMPLETED|30-Day Phase 2 Period||5
1660231|NCT00683852|4054214|P1|NOT COMPLETED|30-Day Phase 2 Period||6
1660232|NCT00683852|4054212|P3|COMPLETED|30-Day Phase 2 Period||75
1660233|NCT00683852|4054213|P2|COMPLETED|30-Day Phase 2 Period||78
1660234|NCT00683852|4054214|P1|COMPLETED|30-Day Phase 2 Period||48
1660235|NCT00683852|4054212|P3|STARTED|30-Day Phase 2 Period||84
1660236|NCT00683852|4054213|P2|STARTED|30-Day Phase 2 Period||83
1660237|NCT00683852|4054214|P1|STARTED|30-Day Phase 2 Period||54
1660238|NCT00683852|4054212|P3|NOT COMPLETED|30-Day Phase 1 Period||1
1660239|NCT00683852|4054213|P2|NOT COMPLETED|30-Day Phase 1 Period||1
1660240|NCT00683852|4054214|P1|NOT COMPLETED|30-Day Phase 1 Period||2
1660241|NCT00683852|4054212|P3|COMPLETED|30-Day Phase 1 Period||84
1660242|NCT00683852|4054213|P2|COMPLETED|30-Day Phase 1 Period||83
1660243|NCT00683852|4054214|P1|COMPLETED|30-Day Phase 1 Period||54
1660244|NCT00683852|4054212|P3|STARTED|30-Day Phase 1 Period||85
1660245|NCT00683852|4054213|P2|STARTED|30-Day Phase 1 Period||84
1660246|NCT00683852|4054214|P1|STARTED|30-Day Phase 1 Period||56
1660247|NCT00683826|4054248|P1|NOT COMPLETED|Overall Study||1
1660248|NCT00683826|4054248|P1|COMPLETED|Overall Study||7
1660249|NCT00683826|4054248|P1|4g Leucine|Overall Study||7
1660250|NCT00683826|4054248|P1|8g Leucine|Overall Study||8
1660251|NCT00683826|4054248|P1|0g Leucine|Overall Study||8
1660252|NCT00683826|4054248|P1|STARTED|Overall Study||8
1660253|NCT00683800|4054258|P2|NOT COMPLETED|Overall Study||366
1660254|NCT00683800|4054259|P1|NOT COMPLETED|Overall Study||432
1660255|NCT00683800|4054258|P2|COMPLETED|Overall Study||719
1660256|NCT00683800|4054259|P1|COMPLETED|Overall Study||669
1660257|NCT00683800|4054258|P2|Treated|Overall Study||1052
1660258|NCT00683800|4054259|P1|Treated|Overall Study||1066
1660259|NCT00683800|4054258|P2|STARTED|Overall Study||1085
1660260|NCT00683800|4054259|P1|STARTED|Overall Study||1101
1660261|NCT00683787|4054326|P3|NOT COMPLETED|Overall Study||2
1660262|NCT00683787|4054327|P2|NOT COMPLETED|Overall Study||3
1660263|NCT00683787|4054328|P1|NOT COMPLETED|Overall Study||3
1660264|NCT00683787|4054326|P3|COMPLETED|Overall Study||0
1660265|NCT00683787|4054327|P2|COMPLETED|Overall Study||0
1660266|NCT00683787|4054328|P1|COMPLETED|Overall Study||0
1660267|NCT00683787|4054326|P3|STARTED|Overall Study||2
1660268|NCT00683787|4054327|P2|STARTED|Overall Study||3
1660269|NCT00683787|4054328|P1|STARTED|Overall Study||3
1660270|NCT00683774|4054347|P2|NOT COMPLETED|Overall Study||1
1660271|NCT00683774|4054348|P1|NOT COMPLETED|Overall Study||3
1660272|NCT00683774|4054347|P2|COMPLETED|Overall Study||9
1660273|NCT00683774|4054348|P1|COMPLETED|Overall Study||8
1660274|NCT00683774|4054347|P2|STARTED|Overall Study||10
1660275|NCT00683774|4054348|P1|STARTED|Overall Study||11
1660276|NCT00683696|4054358|P2|NOT COMPLETED|Overall Study||405
1660277|NCT00683696|4054359|P1|NOT COMPLETED|Overall Study||404
1660278|NCT00683696|4054358|P2|COMPLETED|Overall Study||0
1660279|NCT00683696|4054359|P1|COMPLETED|Overall Study||0
1660280|NCT00683696|4054358|P2|STARTED|Overall Study||405
1660281|NCT00683696|4054359|P1|STARTED|Overall Study||404
1660282|NCT00683657|4054378|P2|NOT COMPLETED|Overall Study||1
1660283|NCT00683657|4054379|P1|NOT COMPLETED|Overall Study||1
1660284|NCT00683657|4054378|P2|COMPLETED|Overall Study||46
1660285|NCT00683657|4054379|P1|COMPLETED|Overall Study||45
1660286|NCT00683657|4054378|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
1660287|NCT00683657|4054379|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
1660288|NCT00683657|4054378|P2|STARTED|Overall Study||47
1660289|NCT00683657|4054379|P1|STARTED|Overall Study||46
1660290|NCT00683644|4054395|P2|NOT COMPLETED|Overall Study||14
1660291|NCT00683644|4054396|P1|NOT COMPLETED|Overall Study||13
1660292|NCT00683644|4054395|P2|COMPLETED|Overall Study||44
1660293|NCT00683644|4054396|P1|COMPLETED|Overall Study||45
1660294|NCT00683644|4054395|P2|STARTED|Overall Study||58
1660295|NCT00683644|4054396|P1|STARTED|Overall Study||58
1660296|NCT00683618|4054409|P3|NOT COMPLETED|Extension Treatment Period||0
1660297|NCT00683618|4054410|P2|NOT COMPLETED|Extension Treatment Period||0
1660298|NCT00683618|4054411|P1|NOT COMPLETED|Extension Treatment Period||3
1660299|NCT00683618|4054409|P3|COMPLETED|Extension Treatment Period||0
1660300|NCT00683618|4054410|P2|COMPLETED|Extension Treatment Period||23
1660301|NCT00683618|4054411|P1|COMPLETED|Extension Treatment Period||33
1660302|NCT00683618|4054409|P3|STARTED|Extension Treatment Period||0
1660303|NCT00683618|4054410|P2|STARTED|Extension Treatment Period||23
1660304|NCT00683618|4054411|P1|STARTED|Extension Treatment Period||36
1660305|NCT00683618|4054409|P3|NOT COMPLETED|Randomised Treatment Period||6
1660306|NCT00683618|4054410|P2|NOT COMPLETED|Randomised Treatment Period||2
1660307|NCT00683618|4054411|P1|NOT COMPLETED|Randomised Treatment Period||6
1660308|NCT00683618|4054409|P3|COMPLETED|Randomised Treatment Period||140
1660309|NCT00683618|4054410|P2|COMPLETED|Randomised Treatment Period||143
1660310|NCT00683618|4054411|P1|COMPLETED|Randomised Treatment Period||139
1660311|NCT00683618|4054409|P3|STARTED|Randomised Treatment Period||146
1660312|NCT00683618|4054410|P2|STARTED|Randomised Treatment Period||145
1660313|NCT00683618|4054411|P1|STARTED|Randomised Treatment Period||145
1660314|NCT00683592|4054461|P2|NOT COMPLETED|Overall Study||46
1660315|NCT00683592|4054462|P1|NOT COMPLETED|Overall Study||47
1660316|NCT00683592|4054461|P2|COMPLETED|Overall Study||195
1660317|NCT00683592|4054462|P1|COMPLETED|Overall Study||193
1660318|NCT00683592|4054461|P2|Safety Population|Overall Study||233
1660319|NCT00683592|4054462|P1|Safety Population|Overall Study||235
1660320|NCT00683592|4054461|P2|Intent to Treat Population|Overall Study||232
1660321|NCT00683592|4054462|P1|Intent to Treat Population|Overall Study||231
1660322|NCT00683592|4054461|P2|STARTED|Overall Study||241
1660323|NCT00683592|4054462|P1|STARTED|Overall Study||240
1660324|NCT00683475|4054480|P2|NOT COMPLETED|Overall Study||3
1660325|NCT00683475|4054481|P1|NOT COMPLETED|Overall Study||4
1660326|NCT00683475|4054480|P2|COMPLETED|Overall Study||66
1660327|NCT00683475|4054481|P1|COMPLETED|Overall Study||65
1660328|NCT00683475|4054480|P2|Received Any Quantity of Study Drug|Overall Study||66
1660329|NCT00683475|4054481|P1|Received Any Quantity of Study Drug|Overall Study||66
1660330|NCT00683475|4054480|P2|STARTED|Overall Study||69
1660331|NCT00683475|4054481|P1|STARTED|Overall Study||69
1660332|NCT00683449|4054516|P5|NOT COMPLETED|Overall Study||0
1660333|NCT00683449|4054517|P4|NOT COMPLETED|Overall Study||0
1660334|NCT00683449|4054518|P3|NOT COMPLETED|Overall Study||0
1660335|NCT00683449|4054519|P2|NOT COMPLETED|Overall Study||1
1660336|NCT00683449|4054520|P1|NOT COMPLETED|Overall Study||0
1660337|NCT00683449|4054516|P5|COMPLETED|Overall Study||2
1660338|NCT00683449|4054517|P4|COMPLETED|Overall Study||6
1660339|NCT00683449|4054518|P3|COMPLETED|Overall Study||3
1660340|NCT00683449|4054519|P2|COMPLETED|Overall Study||12
1660341|NCT00683449|4054520|P1|COMPLETED|Overall Study||5
1660342|NCT00683449|4054516|P5|STARTED|Overall Study||2
1660343|NCT00683449|4054517|P4|STARTED|Overall Study||6
1660344|NCT00683449|4054518|P3|STARTED|Overall Study||3
1660345|NCT00683449|4054519|P2|STARTED|Overall Study||13
1660346|NCT00683449|4054520|P1|STARTED|Overall Study||5
1660347|NCT00683410|4054542|P1|NOT COMPLETED|Overall Study||0
1660348|NCT00683410|4054542|P1|COMPLETED|Overall Study||3366
1660349|NCT00683410|4054542|P1|Vaccinated Dose 4|Overall Study||175
1660350|NCT00683410|4054542|P1|Vaccinated Dose 3|Overall Study||817
1660351|NCT00683410|4054542|P1|Vaccinated Dose 2|Overall Study||1623
1660352|NCT00683410|4054542|P1|Vaccinated Dose 1|Overall Study||3240
1660353|NCT00683410|4054542|P1|STARTED|Overall Study||3366
1660354|NCT00683384|4054546|P1|NOT COMPLETED|Overall Study||2
1660355|NCT00683384|4054546|P1|COMPLETED|Overall Study||91
1660356|NCT00683384|4054546|P1|STARTED|Overall Study||93
1660357|NCT00683332|4054550|P1|NOT COMPLETED|Overall Study||0
1660358|NCT00683332|4054550|P1|COMPLETED|Overall Study||621
1660359|NCT00683332|4054550|P1|STARTED|Overall Study||621
1660360|NCT00683293|4054556|P2|NOT COMPLETED|Overall Study||3
1660361|NCT00683293|4054557|P1|NOT COMPLETED|Overall Study||2
1660362|NCT00683293|4054556|P2|COMPLETED|Overall Study||47
1660363|NCT00683293|4054557|P1|COMPLETED|Overall Study||48
1660364|NCT00683293|4054556|P2|STARTED|Overall Study||50
1660365|NCT00683293|4054557|P1|STARTED|Overall Study||50
1660366|NCT00683163|4054567|P2|NOT COMPLETED|Overall Study||0
1660367|NCT00683163|4054568|P1|NOT COMPLETED|Overall Study||0
1660368|NCT00683163|4054567|P2|COMPLETED|Overall Study||22
1660369|NCT00683163|4054568|P1|COMPLETED|Overall Study||22
1660370|NCT00683163|4054567|P2|STARTED|Overall Study||22
1660371|NCT00683163|4054568|P1|STARTED|Overall Study||22
1660372|NCT00683085|4054576|P1|NOT COMPLETED|Overall Study||0
1660373|NCT00683085|4054576|P1|COMPLETED|Overall Study||2
1660374|NCT00683085|4054576|P1|STARTED|Overall Study||2
1660375|NCT00683046|4054581|P1|NOT COMPLETED|Overall Study||0
1660376|NCT00683046|4054581|P1|COMPLETED|Overall Study||204
1660377|NCT00683046|4054581|P1|STARTED|Overall Study||204
1660378|NCT00683020|4054588|P2|NOT COMPLETED|Overall Study||55
1660379|NCT00683020|4054589|P1|NOT COMPLETED|Overall Study||55
1660380|NCT00683020|4054588|P2|COMPLETED|Overall Study||125
1660381|NCT00683020|4054589|P1|COMPLETED|Overall Study||127
1660382|NCT00683020|4054588|P2|STARTED|Overall Study||180
1660383|NCT00683020|4054589|P1|STARTED|Overall Study||182
1660384|NCT00682929|4054620|P3|NOT COMPLETED|Overall Study||2
1660385|NCT00682929|4054621|P2|NOT COMPLETED|Overall Study||5
1660386|NCT00682929|4054622|P1|NOT COMPLETED|Overall Study||6
1660387|NCT00682929|4054620|P3|COMPLETED|Overall Study||12
1660388|NCT00682929|4054621|P2|COMPLETED|Overall Study||9
1660389|NCT00682929|4054622|P1|COMPLETED|Overall Study||7
1660390|NCT00682929|4054620|P3|STARTED|Overall Study||14
1660391|NCT00682929|4054621|P2|STARTED|Overall Study||14
1660392|NCT00682929|4054622|P1|STARTED|Overall Study||13
1660393|NCT00682890|4054791|P2|NOT COMPLETED|Overall Study||2
1660394|NCT00682890|4054792|P1|NOT COMPLETED|Overall Study||2
1660395|NCT00682890|4054791|P2|COMPLETED|Overall Study||9
1660396|NCT00682890|4054792|P1|COMPLETED|Overall Study||10
1660397|NCT00682890|4054791|P2|STARTED|Overall Study||11
1660398|NCT00682890|4054792|P1|STARTED|Overall Study||12
1660399|NCT00682851|4054802|P2|NOT COMPLETED|Overall Study||0
1660400|NCT00682851|4054803|P1|NOT COMPLETED|Overall Study||0
1660401|NCT00682851|4054802|P2|COMPLETED|Overall Study||268
1660402|NCT00682851|4054803|P1|COMPLETED|Overall Study||251
1660403|NCT00682851|4054802|P2|STARTED|Overall Study||268
1660404|NCT00682851|4054803|P1|STARTED|Overall Study||251
1660405|NCT00682838|4054819|P4|NOT COMPLETED|Overall Study||0
1660406|NCT00682838|4054820|P3|NOT COMPLETED|Overall Study||0
1660407|NCT00682838|4054821|P2|NOT COMPLETED|Overall Study||0
1660408|NCT00682838|4054822|P1|NOT COMPLETED|Overall Study||0
1660409|NCT00682838|4054819|P4|COMPLETED|Overall Study||73
1660410|NCT00682838|4054820|P3|COMPLETED|Overall Study||75
1660411|NCT00682838|4054821|P2|COMPLETED|Overall Study||67
1660412|NCT00682838|4054822|P1|COMPLETED|Overall Study||65
1660413|NCT00682838|4054819|P4|STARTED|Overall Study||73
1660414|NCT00682838|4054820|P3|STARTED|Overall Study||75
1660415|NCT00682838|4054821|P2|STARTED|Overall Study||67
1660416|NCT00682838|4054822|P1|STARTED|Overall Study||65
1660417|NCT00682786|4054834|P2|NOT COMPLETED|Overall Study||3
1660418|NCT00682786|4054835|P1|NOT COMPLETED|Overall Study||2
1660419|NCT00682786|4054834|P2|COMPLETED|Overall Study||34
1660420|NCT00682786|4054835|P1|COMPLETED|Overall Study||96
1660421|NCT00682786|4054834|P2|STARTED|Overall Study||37
1660422|NCT00682786|4054835|P1|STARTED|Overall Study||98
1660423|NCT00682734|4054872|P3|NOT COMPLETED|48 Hour Follow-up||11
1660424|NCT00682734|4054873|P2|NOT COMPLETED|48 Hour Follow-up||6
1660425|NCT00682734|4054874|P1|NOT COMPLETED|48 Hour Follow-up||6
1660426|NCT00682734|4054872|P3|COMPLETED|48 Hour Follow-up||106
1660427|NCT00682734|4054873|P2|COMPLETED|48 Hour Follow-up||111
1660428|NCT00682734|4054874|P1|COMPLETED|48 Hour Follow-up||107
1660429|NCT00682734|4054872|P3|STARTED|48 Hour Follow-up||117
1660430|NCT00682734|4054873|P2|STARTED|48 Hour Follow-up||117
1660431|NCT00682734|4054874|P1|STARTED|48 Hour Follow-up||113
1660432|NCT00682734|4054872|P3|NOT COMPLETED|Emergency Department Portion||1
1660433|NCT00682734|4054873|P2|NOT COMPLETED|Emergency Department Portion||1
1660434|NCT00682734|4054874|P1|NOT COMPLETED|Emergency Department Portion||0
1660435|NCT00682734|4054872|P3|COMPLETED|Emergency Department Portion||117
1660436|NCT00682734|4054873|P2|COMPLETED|Emergency Department Portion||117
1660437|NCT00682734|4054874|P1|COMPLETED|Emergency Department Portion||113
1660438|NCT00682734|4054872|P3|STARTED|Emergency Department Portion||118
1660439|NCT00682734|4054873|P2|STARTED|Emergency Department Portion||118
1660440|NCT00682734|4054874|P1|STARTED|Emergency Department Portion||113
1660441|NCT00682643|4054884|P2|NOT COMPLETED|Overall Study||169
1660442|NCT00682643|4054885|P1|NOT COMPLETED|Overall Study||78
1660443|NCT00682643|4054884|P2|COMPLETED|Overall Study||199
1660444|NCT00682643|4054885|P1|COMPLETED|Overall Study||104
1660445|NCT00682643|4054884|P2|STARTED|Overall Study||368
1660446|NCT00682643|4054885|P1|STARTED|Overall Study||182
1660447|NCT00682565|4054920|P3|NOT COMPLETED|Overall Study||0
1660448|NCT00682565|4054921|P2|NOT COMPLETED|Overall Study||3
1660449|NCT00682565|4054922|P1|NOT COMPLETED|Overall Study||1
1660450|NCT00682565|4054920|P3|COMPLETED|Overall Study||29
1660451|NCT00682565|4054921|P2|COMPLETED|Overall Study||32
1660452|NCT00682565|4054922|P1|COMPLETED|Overall Study||30
1660453|NCT00682565|4054920|P3|STARTED|Overall Study||29
1660454|NCT00682565|4054921|P2|STARTED|Overall Study||35
1660455|NCT00682565|4054922|P1|STARTED|Overall Study||31
1660456|NCT00682539|4054946|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
1660457|NCT00682539|4054947|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
1660458|NCT00682539|4054948|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
1660459|NCT00682539|4054946|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
1660460|NCT00682539|4054947|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
1660461|NCT00682539|4054948|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
1660462|NCT00682539|4054946|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
1660463|NCT00682539|4054947|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
1660464|NCT00682539|4054948|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
1660465|NCT00682539|4054946|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
1660466|NCT00682539|4054947|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
1660467|NCT00682539|4054948|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
1660468|NCT00682539|4054946|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
1660469|NCT00682539|4054947|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
1660470|NCT00682539|4054948|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
1660471|NCT00682539|4054946|P3|STARTED|Bevacizumab vs Triamcinolone||0
1660472|NCT00682539|4054947|P2|STARTED|Bevacizumab vs Triamcinolone||16
1660473|NCT00682539|4054948|P1|STARTED|Bevacizumab vs Triamcinolone||18
1660474|NCT00682461|4054961|P2|NOT COMPLETED|Overall Study||31
1660475|NCT00682461|4054962|P1|NOT COMPLETED|Overall Study||25
1660476|NCT00682461|4054961|P2|COMPLETED|Overall Study||69
1660477|NCT00682461|4054962|P1|COMPLETED|Overall Study||75
1660478|NCT00682461|4054961|P2|STARTED|Overall Study||100
1660479|NCT00682461|4054962|P1|STARTED|Overall Study||100
1660480|NCT00682435|4054976|P1|NOT COMPLETED|Overall Study||7
1660481|NCT00682435|4054976|P1|COMPLETED|Overall Study||223
1660482|NCT00682435|4054976|P1|Sufficient Data to Carry Out Analysis|Overall Study||223
1660483|NCT00682435|4054976|P1|Ensured Enrolled Only Once|Overall Study||228
1660484|NCT00682435|4054976|P1|STARTED|Overall Study||230
1660485|NCT00682357|4054986|P3|NOT COMPLETED|Overall Study||0
1660486|NCT00682357|4054987|P2|NOT COMPLETED|Overall Study||0
1660487|NCT00682357|4054988|P1|NOT COMPLETED|Overall Study||0
1660488|NCT00682357|4054986|P3|COMPLETED|Overall Study||5
1660489|NCT00682357|4054987|P2|COMPLETED|Overall Study||10
1660490|NCT00682357|4054988|P1|COMPLETED|Overall Study||10
1660491|NCT00682357|4054986|P3|STARTED|Overall Study||5
1660492|NCT00682357|4054987|P2|STARTED|Overall Study||10
1660493|NCT00682357|4054988|P1|STARTED|Overall Study||10
1660494|NCT00681889|4055005|P1|NOT COMPLETED|Overall Study||0
1660495|NCT00681889|4055005|P1|COMPLETED|Overall Study||9
1660496|NCT00681889|4055005|P1|STARTED|Overall Study||9
1660497|NCT00681863|4055009|P1|NOT COMPLETED|Overall Study||23
1660498|NCT00681863|4055009|P1|COMPLETED|Overall Study||22
1660499|NCT00681863|4055009|P1|STARTED|Overall Study||45
1660500|NCT00681824|4055057|P3|NOT COMPLETED|Overall Study||1
1660501|NCT00681824|4055058|P2|NOT COMPLETED|Overall Study||1
1660502|NCT00681824|4055059|P1|NOT COMPLETED|Overall Study||1
1660503|NCT00681824|4055057|P3|COMPLETED|Overall Study||33
1660504|NCT00681824|4055058|P2|COMPLETED|Overall Study||12
1660505|NCT00681824|4055059|P1|COMPLETED|Overall Study||27
1660506|NCT00681824|4055057|P3|STARTED|Overall Study||34
1660507|NCT00681824|4055058|P2|STARTED|Overall Study||13
1660508|NCT00681824|4055059|P1|STARTED|Overall Study||28
1660509|NCT00681811|4055077|P2|NOT COMPLETED|Overall Study||4
1660510|NCT00681811|4055078|P1|NOT COMPLETED|Overall Study||3
1660511|NCT00681811|4055077|P2|COMPLETED|Overall Study||1
1660512|NCT00681811|4055078|P1|COMPLETED|Overall Study||3
1660513|NCT00681811|4055077|P2|STARTED|Overall Study||5
1660514|NCT00681811|4055078|P1|STARTED|Overall Study||6
1660515|NCT00681668|4055106|P1|NOT COMPLETED|Overall Study||2
1660516|NCT00681668|4055106|P1|COMPLETED|Overall Study||3
1660517|NCT00681668|4055106|P1|STARTED|Overall Study||5
1660518|NCT00681629|4055115|P2|NOT COMPLETED|Overall Study||2
1660519|NCT00681629|4055116|P1|NOT COMPLETED|Overall Study||5
1660520|NCT00681629|4055115|P2|COMPLETED|Overall Study||0
1660521|NCT00681629|4055116|P1|COMPLETED|Overall Study||0
1660522|NCT00681629|4055115|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
1660523|NCT00681629|4055116|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
1660524|NCT00681590|4055162|P2|NOT COMPLETED|Overall Study||12
1660525|NCT00681590|4055163|P1|NOT COMPLETED|Overall Study||2
1660526|NCT00681590|4055162|P2|COMPLETED|Overall Study||59
1660527|NCT00681590|4055163|P1|COMPLETED|Overall Study||32
1660528|NCT00681590|4055162|P2|STARTED|Overall Study||71
1660529|NCT00681590|4055163|P1|STARTED|Overall Study||34
1660530|NCT00681564|4055173|P2|NOT COMPLETED|Overall Study||8
1660531|NCT00681564|4055174|P1|NOT COMPLETED|Overall Study||6
1660532|NCT00681564|4055173|P2|COMPLETED|Overall Study||47
1660533|NCT00681564|4055174|P1|COMPLETED|Overall Study||41
1660534|NCT00681564|4055173|P2|STARTED|Overall Study||55
1660535|NCT00681564|4055174|P1|STARTED|Overall Study||47
1660536|NCT00681538|4055204|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
1660537|NCT00681538|4055205|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
1660538|NCT00681538|4055204|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
1660539|NCT00681538|4055205|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
1660540|NCT00681538|4055204|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
1660541|NCT00681538|4055205|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
1660542|NCT00681538|4055204|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
1660543|NCT00681538|4055205|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
1660544|NCT00681538|4055204|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
1660545|NCT00681538|4055205|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
1660546|NCT00681538|4055204|P2|STARTED|Phase A- 4 Weeks Single Blind||0
1660547|NCT00681538|4055205|P1|STARTED|Phase A- 4 Weeks Single Blind||572
1660548|NCT00681473|4055235|P1|NOT COMPLETED|Overall Study||0
1660549|NCT00681473|4055235|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
1660550|NCT00681473|4055235|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
1660551|NCT00681291|4055243|P2|NOT COMPLETED|Overall Study||27
1660552|NCT00681291|4055244|P1|NOT COMPLETED|Overall Study||13
1660553|NCT00681291|4055243|P2|COMPLETED|Overall Study||57
1660554|NCT00681291|4055244|P1|COMPLETED|Overall Study||75
1660555|NCT00681291|4055243|P2|STARTED|Overall Study||84
1660556|NCT00681291|4055244|P1|STARTED|Overall Study||88
1660557|NCT00681265|4055256|P1|NOT COMPLETED|Overall Study||0
1660558|NCT00681265|4055256|P1|COMPLETED|Overall Study||16
1660559|NCT00681265|4055256|P1|STARTED|Overall Study||16
1660560|NCT00681187|4055266|P2|NOT COMPLETED|Overall Study||2
1660561|NCT00681187|4055267|P1|NOT COMPLETED|Overall Study||1
1660562|NCT00681187|4055266|P2|COMPLETED|Overall Study||13
1660563|NCT00681187|4055267|P1|COMPLETED|Overall Study||10
1660564|NCT00681187|4055266|P2|STARTED|Overall Study||15
1660565|NCT00681187|4055267|P1|STARTED|Overall Study||11
1660566|NCT00681109|4055302|P3|NOT COMPLETED|Overall Study||0
1660567|NCT00681109|4055303|P2|NOT COMPLETED|Overall Study||6
1660568|NCT00681109|4055304|P1|NOT COMPLETED|Overall Study||2
1660569|NCT00681109|4055302|P3|COMPLETED|Overall Study||15
1660570|NCT00681109|4055303|P2|COMPLETED|Overall Study||24
1660571|NCT00681109|4055304|P1|COMPLETED|Overall Study||28
1660572|NCT00681109|4055302|P3|STARTED|Overall Study||15
1660573|NCT00681109|4055303|P2|STARTED|Overall Study||30
1660574|NCT00681109|4055304|P1|STARTED|Overall Study||30
1660575|NCT00681044|4055321|P1|NOT COMPLETED|Overall Study||0
1660576|NCT00681044|4055321|P1|COMPLETED|Overall Study||4
1660577|NCT00681044|4055321|P1|STARTED|Overall Study||4
1660578|NCT00681031|4055329|P1|NOT COMPLETED|Overall Study||0
1660579|NCT00681031|4055329|P1|COMPLETED|Overall Study||96
1660580|NCT00681031|4055329|P1|STARTED|Overall Study||96
1660581|NCT00680992|4055336|P3|NOT COMPLETED|Overall Study||12
1660582|NCT00680992|4055337|P2|NOT COMPLETED|Overall Study||252
1660583|NCT00680992|4055338|P1|NOT COMPLETED|Overall Study||268
1660584|NCT00680992|4055336|P3|COMPLETED|Overall Study||0
1660585|NCT00680992|4055337|P2|COMPLETED|Overall Study||0
1660586|NCT00680992|4055338|P1|COMPLETED|Overall Study||0
1660587|NCT00680992|4055336|P3|Efficacy Analysis Set|Overall Study||11
1660588|NCT00680992|4055337|P2|Efficacy Analysis Set|Overall Study||242
1660589|NCT00680992|4055338|P1|Efficacy Analysis Set|Overall Study||260
1660590|NCT00680992|4055336|P3|Safety Analysis Set|Overall Study||12
1660591|NCT00680992|4055337|P2|Safety Analysis Set|Overall Study||249
1660592|NCT00680992|4055338|P1|Safety Analysis Set|Overall Study||265
1660593|NCT00680992|4055336|P3|STARTED|Overall Study||12
1660594|NCT00680992|4055337|P2|STARTED|Overall Study||252
1660595|NCT00680992|4055338|P1|STARTED|Overall Study||268
1660596|NCT00680953|4055354|P3|NOT COMPLETED|Overall Study||47
1660597|NCT00680953|4055355|P2|NOT COMPLETED|Overall Study||95
1660598|NCT00680953|4055356|P1|NOT COMPLETED|Overall Study||86
1660599|NCT00680953|4055354|P3|COMPLETED|Overall Study||204
1660600|NCT00680953|4055355|P2|COMPLETED|Overall Study||416
1660601|NCT00680953|4055356|P1|COMPLETED|Overall Study||414
1660602|NCT00680953|4055354|P3|STARTED|Overall Study||251
1660603|NCT00680953|4055355|P2|STARTED|Overall Study||511
1660604|NCT00680953|4055356|P1|STARTED|Overall Study||500
1660605|NCT00680914|4055372|P2|NOT COMPLETED|Overall Study||4
1660606|NCT00680914|4055373|P1|NOT COMPLETED|Overall Study||10
1660607|NCT00680914|4055372|P2|COMPLETED|Overall Study||125
1660608|NCT00680914|4055373|P1|COMPLETED|Overall Study||364
1660609|NCT00680914|4055372|P2|STARTED|Overall Study||129
1660610|NCT00680914|4055373|P1|STARTED|Overall Study||374
1660611|NCT00680901|4055407|P2|NOT COMPLETED|Overall Study||76
1660612|NCT00680901|4055408|P1|NOT COMPLETED|Overall Study||73
1660613|NCT00680901|4055407|P2|COMPLETED|Overall Study||197
1660614|NCT00680901|4055408|P1|COMPLETED|Overall Study||199
1660615|NCT00680901|4055407|P2|Ongoing: In Follow Up|Overall Study||41
1660616|NCT00680901|4055408|P1|Ongoing: In Follow Up|Overall Study||45
1660617|NCT00680901|4055407|P2|Ongoing: On Study Treatment|Overall Study||13
1660618|NCT00680901|4055408|P1|Ongoing: On Study Treatment|Overall Study||16
1660619|NCT00680901|4055407|P2|STARTED|Overall Study||273
1660620|NCT00680901|4055408|P1|STARTED|Overall Study||272
1660621|NCT00680862|4055440|P1|NOT COMPLETED|Overall Study||0
1660622|NCT00680862|4055440|P1|COMPLETED|Overall Study||25
1660623|NCT00680862|4055440|P1|STARTED|Overall Study||25
1660624|NCT00680836|4055446|P2|NOT COMPLETED|Overall Study||2
1660625|NCT00680836|4055447|P1|NOT COMPLETED|Overall Study||8
1660626|NCT00680836|4055446|P2|COMPLETED|Overall Study||25
1660627|NCT00680836|4055447|P1|COMPLETED|Overall Study||19
1660628|NCT00680836|4055446|P2|STARTED|Overall Study||27
1660629|NCT00680836|4055447|P1|STARTED|Overall Study||27
1660630|NCT00680823|4055466|P3|NOT COMPLETED|Overall Study||0
1660631|NCT00680823|4055467|P2|NOT COMPLETED|Overall Study||0
1660632|NCT00680823|4055468|P1|NOT COMPLETED|Overall Study||0
1660633|NCT00680823|4055466|P3|COMPLETED|Overall Study||50
1660634|NCT00680823|4055467|P2|COMPLETED|Overall Study||50
1660635|NCT00680823|4055468|P1|COMPLETED|Overall Study||50
1660636|NCT00680823|4055466|P3|STARTED|Overall Study||50
1660637|NCT00680823|4055467|P2|STARTED|Overall Study||50
1660638|NCT00680823|4055468|P1|STARTED|Overall Study||50
1660639|NCT00680797|4055486|P4|NOT COMPLETED|Overall Study||0
1660640|NCT00680797|4055487|P3|NOT COMPLETED|Overall Study||0
1660641|NCT00680797|4055488|P2|NOT COMPLETED|Overall Study||0
1660642|NCT00680797|4055489|P1|NOT COMPLETED|Overall Study||0
1660643|NCT00680797|4055486|P4|COMPLETED|Overall Study||8
1660644|NCT00680797|4055487|P3|COMPLETED|Overall Study||8
1660645|NCT00680797|4055488|P2|COMPLETED|Overall Study||8
1660646|NCT00680797|4055489|P1|COMPLETED|Overall Study||9
1660647|NCT00680797|4055486|P4|STARTED|Overall Study||8
1660648|NCT00680797|4055487|P3|STARTED|Overall Study||8
1660649|NCT00680797|4055488|P2|STARTED|Overall Study||8
1660650|NCT00680797|4055489|P1|STARTED|Overall Study||9
1660651|NCT00680771|4055501|P2|NOT COMPLETED|Overall Study||2
1660652|NCT00680771|4055502|P1|NOT COMPLETED|Overall Study||6
1660653|NCT00680771|4055501|P2|COMPLETED|Overall Study||11
1660654|NCT00680771|4055502|P1|COMPLETED|Overall Study||9
1660655|NCT00680771|4055501|P2|STARTED|Overall Study||13
1660656|NCT00680771|4055502|P1|STARTED|Overall Study||15
1660657|NCT00680745|4055512|P4|NOT COMPLETED|Overall Study||13
1660658|NCT00680745|4055513|P3|NOT COMPLETED|Overall Study||10
1660659|NCT00680745|4055514|P2|NOT COMPLETED|Overall Study||13
1660660|NCT00680745|4055515|P1|NOT COMPLETED|Overall Study||14
1660661|NCT00680745|4055512|P4|COMPLETED|Overall Study||133
1660662|NCT00680745|4055513|P3|COMPLETED|Overall Study||141
1660663|NCT00680745|4055514|P2|COMPLETED|Overall Study||132
1660664|NCT00680745|4055515|P1|COMPLETED|Overall Study||140
1660665|NCT00680745|4055512|P4|STARTED|Overall Study|Safety Analysis Set|146
1660666|NCT00680745|4055513|P3|STARTED|Overall Study|Safety Analysis Set|151
1660667|NCT00680745|4055514|P2|STARTED|Overall Study|Safety Analysis Set|145
1660668|NCT00680745|4055515|P1|STARTED|Overall Study|Safety Analysis Set|154
1660669|NCT00680706|4055547|P2|NOT COMPLETED|Overall Study||5
1660670|NCT00680706|4055548|P1|NOT COMPLETED|Overall Study||7
1660671|NCT00680706|4055547|P2|COMPLETED|Overall Study||55
1660672|NCT00680706|4055548|P1|COMPLETED|Overall Study||63
1660673|NCT00680706|4055547|P2|STARTED|Overall Study||60
1660674|NCT00680706|4055548|P1|STARTED|Overall Study||70
1660675|NCT00680628|4055558|P2|NOT COMPLETED|Overall Study||0
1660676|NCT00680628|4055559|P1|NOT COMPLETED|Overall Study||0
1660677|NCT00680628|4055558|P2|COMPLETED|Overall Study||40
1660678|NCT00680628|4055559|P1|COMPLETED|Overall Study||43
1660679|NCT00680628|4055558|P2|STARTED|Overall Study||40
1660680|NCT00680628|4055559|P1|STARTED|Overall Study||43
1660681|NCT00680524|4055569|P1|NOT COMPLETED|Overall Study||3
1660682|NCT00680524|4055569|P1|COMPLETED|Overall Study||17
1660683|NCT00680524|4055569|P1|STARTED|Overall Study||20
1660684|NCT00680459|4055575|P2|NOT COMPLETED|Overall Study||0
1660685|NCT00680459|4055576|P1|NOT COMPLETED|Overall Study||0
1660686|NCT00680459|4055575|P2|COMPLETED|Overall Study||6
1660687|NCT00680459|4055576|P1|COMPLETED|Overall Study||7
1660688|NCT00680459|4055575|P2|STARTED|Overall Study||6
1660689|NCT00680459|4055576|P1|STARTED|Overall Study||7
1660690|NCT00680407|4055589|P3|NOT COMPLETED|Overall Study||3
1660691|NCT00680407|4055590|P2|NOT COMPLETED|Overall Study||5
1660692|NCT00680407|4055591|P1|NOT COMPLETED|Overall Study||8
1660693|NCT00680407|4055589|P3|COMPLETED|Overall Study||22
1660694|NCT00680407|4055590|P2|COMPLETED|Overall Study||22
1660695|NCT00680407|4055591|P1|COMPLETED|Overall Study||18
1660696|NCT00680407|4055589|P3|STARTED|Overall Study||25
1660697|NCT00680407|4055590|P2|STARTED|Overall Study||27
1660698|NCT00680407|4055591|P1|STARTED|Overall Study||26
1660699|NCT00680368|4055605|P1|NOT COMPLETED|Overall Study||15
1660700|NCT00680368|4055605|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
1660701|NCT00680368|4055605|P1|STARTED|Overall Study||112
1660702|NCT00680316|4055613|P2|NOT COMPLETED|Overall Study||0
1660703|NCT00680316|4055614|P1|NOT COMPLETED|Overall Study||0
1660704|NCT00680316|4055613|P2|COMPLETED|Overall Study||2
1660705|NCT00680316|4055614|P1|COMPLETED|Overall Study||1
1660706|NCT00680316|4055613|P2|STARTED|Overall Study||2
1660707|NCT00680316|4055614|P1|STARTED|Overall Study||1
1660708|NCT00680225|4055626|P1|NOT COMPLETED|Overall Study||2
1660709|NCT00680225|4055626|P1|COMPLETED|Overall Study||8
1660710|NCT00680225|4055626|P1|STARTED|Overall Study||10
1660711|NCT00680186|4055633|P2|NOT COMPLETED|Overall Study||116
1660712|NCT00680186|4055634|P1|NOT COMPLETED|Overall Study||125
1660713|NCT00680186|4055633|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
1660714|NCT00680186|4055634|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
1660715|NCT00680186|4055633|P2|STARTED|Overall Study|Started treatment.|1288
1660716|NCT00680186|4055634|P1|STARTED|Overall Study|Started treatment.|1280
1660717|NCT00680121|4055660|P2|NOT COMPLETED|Overall Study||23
1660718|NCT00680121|4055661|P1|NOT COMPLETED|Overall Study||27
1660719|NCT00680121|4055660|P2|COMPLETED|Overall Study||37
1660720|NCT00680121|4055661|P1|COMPLETED|Overall Study||33
1660721|NCT00680121|4055660|P2|STARTED|Overall Study||60
1660722|NCT00680121|4055661|P1|STARTED|Overall Study||60
1660723|NCT00680056|4055675|P2|NOT COMPLETED|Second Intervention||1
1660724|NCT00680056|4055676|P1|NOT COMPLETED|Second Intervention||3
1660725|NCT00680056|4055675|P2|COMPLETED|Second Intervention||14
1660726|NCT00680056|4055676|P1|COMPLETED|Second Intervention||12
1660727|NCT00680056|4055675|P2|STARTED|Second Intervention||15
1660728|NCT00680056|4055676|P1|STARTED|Second Intervention||15
1660729|NCT00680056|4055675|P2|NOT COMPLETED|Washout Period of One Week||0
1660730|NCT00680056|4055676|P1|NOT COMPLETED|Washout Period of One Week||0
1660731|NCT00680056|4055675|P2|COMPLETED|Washout Period of One Week||15
1660732|NCT00680056|4055676|P1|COMPLETED|Washout Period of One Week||15
1660733|NCT00680056|4055675|P2|STARTED|Washout Period of One Week||15
1660734|NCT00680056|4055676|P1|STARTED|Washout Period of One Week||15
1660735|NCT00680056|4055675|P2|NOT COMPLETED|First Intervention||2
1660736|NCT00680056|4055676|P1|NOT COMPLETED|First Intervention||1
1660737|NCT00680056|4055675|P2|COMPLETED|First Intervention||15
1660738|NCT00680056|4055676|P1|COMPLETED|First Intervention||15
1660739|NCT00680056|4055675|P2|STARTED|First Intervention||17
1660740|NCT00680056|4055676|P1|STARTED|First Intervention||16
1660741|NCT00680043|4055687|P3|NOT COMPLETED|Overall Study||4
1660742|NCT00680043|4055688|P2|NOT COMPLETED|Overall Study||1
1660743|NCT00680043|4055689|P1|NOT COMPLETED|Overall Study||2
1660744|NCT00680043|4055687|P3|COMPLETED|Overall Study||34
1660745|NCT00680043|4055688|P2|COMPLETED|Overall Study||36
1660746|NCT00680043|4055689|P1|COMPLETED|Overall Study||37
1660747|NCT00680043|4055687|P3|STARTED|Overall Study||38
1660748|NCT00680043|4055688|P2|STARTED|Overall Study||37
1660749|NCT00680043|4055689|P1|STARTED|Overall Study||39
1660750|NCT00680017|4055705|P2|NOT COMPLETED|Overall Study||12
1660751|NCT00680017|4055706|P1|NOT COMPLETED|Overall Study||17
1660752|NCT00680017|4055705|P2|COMPLETED|Overall Study||128
1660753|NCT00680017|4055706|P1|COMPLETED|Overall Study||123
1660754|NCT00680017|4055705|P2|STARTED|Overall Study||140
1660755|NCT00680017|4055706|P1|STARTED|Overall Study||140
1660756|NCT00679952|4055716|P2|NOT COMPLETED|Overall Study||0
1660757|NCT00679952|4055717|P1|NOT COMPLETED|Overall Study||0
1660758|NCT00679952|4055716|P2|COMPLETED|Overall Study||82
1660759|NCT00679952|4055717|P1|COMPLETED|Overall Study||86
1660760|NCT00679952|4055716|P2|STARTED|Overall Study||82
1660761|NCT00679952|4055717|P1|STARTED|Overall Study||86
1660762|NCT00679939|4055725|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
1660763|NCT00679939|4055726|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
1660764|NCT00679939|4055725|P2|COMPLETED|24-Week Open-Label (OL) Period||80
1660765|NCT00679939|4055726|P1|COMPLETED|24-Week Open-Label (OL) Period||69
1660766|NCT00679939|4055725|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
1660767|NCT00679939|4055726|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
1660768|NCT00679939|4055725|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
1660769|NCT00679939|4055726|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
1660770|NCT00679939|4055725|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
1660771|NCT00679939|4055726|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
1660772|NCT00679939|4055725|P2|STARTED|52-Week Double-Blind (DB) Period||112
1660773|NCT00679939|4055726|P1|STARTED|52-Week Double-Blind (DB) Period||114
1660774|NCT00679913|4055877|P2|NOT COMPLETED|Overall Study||13
1660775|NCT00679913|4055878|P1|NOT COMPLETED|Overall Study||18
1660776|NCT00679913|4055877|P2|COMPLETED|Overall Study||86
1660777|NCT00679913|4055878|P1|COMPLETED|Overall Study||83
1660778|NCT00679913|4055877|P2|STARTED|Overall Study||99
1660779|NCT00679913|4055878|P1|STARTED|Overall Study||101
1660780|NCT00679783|4055893|P7|NOT COMPLETED|Overall Study||1
1660781|NCT00679783|4055894|P6|NOT COMPLETED|Overall Study||0
1660782|NCT00679783|4055895|P5|NOT COMPLETED|Overall Study||1
1660783|NCT00679783|4055896|P4|NOT COMPLETED|Overall Study||20
1660784|NCT00679783|4055897|P3|NOT COMPLETED|Overall Study||1
1660785|NCT00679783|4055898|P2|NOT COMPLETED|Overall Study||3
1660786|NCT00679783|4055899|P1|NOT COMPLETED|Overall Study||2
1660787|NCT00679783|4055893|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
1660788|NCT00679783|4055894|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
1660789|NCT00679783|4055895|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
1660790|NCT00679783|4055896|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
1660791|NCT00679783|4055897|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
1660792|NCT00679783|4055898|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
1660793|NCT00679783|4055899|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
1660794|NCT00679783|4055893|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
1660795|NCT00679783|4055894|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
1660796|NCT00679783|4055895|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
1660797|NCT00679783|4055896|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
1660798|NCT00679783|4055897|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
1660799|NCT00679783|4055898|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
1660800|NCT00679783|4055899|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
1660801|NCT00679627|4055952|P2|NOT COMPLETED|Overall Study||685
1660802|NCT00679627|4055953|P1|NOT COMPLETED|Overall Study||699
1660803|NCT00679627|4055952|P2|COMPLETED|Overall Study||339
1660804|NCT00679627|4055953|P1|COMPLETED|Overall Study||322
1660805|NCT00679627|4055952|P2|STARTED|Overall Study||1024
1660806|NCT00679627|4055953|P1|STARTED|Overall Study||1021
1660807|NCT00679432|4055979|P4|NOT COMPLETED|Overall Study||32
1660808|NCT00679432|4055980|P3|NOT COMPLETED|Overall Study||53
1660809|NCT00679432|4055981|P2|NOT COMPLETED|Overall Study||38
1660810|NCT00679432|4055982|P1|NOT COMPLETED|Overall Study||37
1660811|NCT00679432|4055979|P4|COMPLETED|Overall Study||95
1660812|NCT00679432|4055980|P3|COMPLETED|Overall Study||76
1660813|NCT00679432|4055981|P2|COMPLETED|Overall Study||89
1660814|NCT00679432|4055982|P1|COMPLETED|Overall Study||89
1660815|NCT00679432|4055979|P4|STARTED|Overall Study||127
1660816|NCT00679432|4055980|P3|STARTED|Overall Study||129
1660817|NCT00679432|4055981|P2|STARTED|Overall Study||127
1660818|NCT00679432|4055982|P1|STARTED|Overall Study||126
1660819|NCT00679380|4056004|P4|NOT COMPLETED|Overall Study||28
1660820|NCT00679380|4056005|P3|NOT COMPLETED|Overall Study||35
1660821|NCT00679380|4056006|P2|NOT COMPLETED|Overall Study||33
1660822|NCT00679380|4056007|P1|NOT COMPLETED|Overall Study||42
1660823|NCT00679380|4056004|P4|COMPLETED|Overall Study||61
1660824|NCT00679380|4056005|P3|COMPLETED|Overall Study||68
1660825|NCT00679380|4056006|P2|COMPLETED|Overall Study||76
1660826|NCT00679380|4056007|P1|COMPLETED|Overall Study||67
1660827|NCT00679380|4056004|P4|STARTED|Overall Study||89
1660828|NCT00679380|4056005|P3|STARTED|Overall Study||103
1660829|NCT00679380|4056006|P2|STARTED|Overall Study||109
1660830|NCT00679380|4056007|P1|STARTED|Overall Study||109
1660831|NCT00679367|4056025|P1|NOT COMPLETED|Overall Study||12
1660832|NCT00679367|4056025|P1|COMPLETED|Overall Study||4
1660833|NCT00679367|4056025|P1|STARTED|Overall Study||16
1660834|NCT00679354|4056031|P1|NOT COMPLETED|Overall Study||30
1660835|NCT00679354|4056031|P1|COMPLETED|Overall Study||0
1660836|NCT00679354|4056031|P1|STARTED|Overall Study||30
1660837|NCT00679341|4056049|P2|NOT COMPLETED|Overall Study||51
1660838|NCT00679341|4056050|P1|NOT COMPLETED|Overall Study||53
1660839|NCT00679341|4056049|P2|COMPLETED|Overall Study||19
1660840|NCT00679341|4056050|P1|COMPLETED|Overall Study||14
1660841|NCT00679341|4056049|P2|STARTED|Overall Study||70
1660842|NCT00679341|4056050|P1|STARTED|Overall Study||67
1660843|NCT00679302|4056070|P2|NOT COMPLETED|Overall Study||4
1660844|NCT00679302|4056071|P1|NOT COMPLETED|Overall Study||8
1660845|NCT00679302|4056070|P2|COMPLETED|Overall Study||73
1660846|NCT00679302|4056071|P1|COMPLETED|Overall Study||76
1660847|NCT00679302|4056070|P2|STARTED|Overall Study||77
1660848|NCT00679302|4056071|P1|STARTED|Overall Study||84
1660849|NCT00679289|4056082|P3|NOT COMPLETED|Overall Study||23
1660850|NCT00679289|4056083|P2|NOT COMPLETED|Overall Study||6
1660851|NCT00679289|4056084|P1|NOT COMPLETED|Overall Study||5
1660852|NCT00679289|4056082|P3|COMPLETED|Overall Study||1
1660853|NCT00679289|4056083|P2|COMPLETED|Overall Study||0
1660854|NCT00679289|4056084|P1|COMPLETED|Overall Study||1
1660855|NCT00679289|4056082|P3|STARTED|Overall Study||24
1660856|NCT00679289|4056083|P2|STARTED|Overall Study||6
1660857|NCT00679289|4056084|P1|STARTED|Overall Study||6
1660858|NCT00679263|4056106|P3|NOT COMPLETED|Visit 2/Dose 1||0
1660859|NCT00679263|4056107|P2|NOT COMPLETED|Visit 2/Dose 1||1
1660860|NCT00679263|4056108|P1|NOT COMPLETED|Visit 2/Dose 1||2
1660861|NCT00679263|4056106|P3|COMPLETED|Visit 2/Dose 1||11
1660862|NCT00679263|4056107|P2|COMPLETED|Visit 2/Dose 1||5
1660863|NCT00679263|4056108|P1|COMPLETED|Visit 2/Dose 1||9
1660864|NCT00679263|4056106|P3|STARTED|Visit 2/Dose 1||11
1660865|NCT00679263|4056107|P2|STARTED|Visit 2/Dose 1||6
1660866|NCT00679263|4056108|P1|STARTED|Visit 2/Dose 1||11
1660867|NCT00679263|4056106|P3|NOT COMPLETED|Visit 3/Dose 2||0
1660868|NCT00679263|4056107|P2|NOT COMPLETED|Visit 3/Dose 2||5
1660869|NCT00679263|4056108|P1|NOT COMPLETED|Visit 3/Dose 2||1
1660870|NCT00679263|4056106|P3|COMPLETED|Visit 3/Dose 2||11
1660871|NCT00679263|4056107|P2|COMPLETED|Visit 3/Dose 2||6
1660872|NCT00679263|4056108|P1|COMPLETED|Visit 3/Dose 2||9
1660873|NCT00679263|4056106|P3|STARTED|Visit 3/Dose 2||11
1660874|NCT00679263|4056107|P2|STARTED|Visit 3/Dose 2||11
1660875|NCT00679263|4056108|P1|STARTED|Visit 3/Dose 2||10
1660876|NCT00679211|4056119|P1|NOT COMPLETED|Overall Study||110
1660877|NCT00679211|4056119|P1|COMPLETED|Overall Study||0
1660878|NCT00679211|4056119|P1|STARTED|Overall Study||110
1660879|NCT00679172|4056136|P5|NOT COMPLETED|Overall Study||0
1660880|NCT00679172|4056137|P4|NOT COMPLETED|Overall Study||1
1660881|NCT00679172|4056138|P3|NOT COMPLETED|Overall Study||1
1660882|NCT00679172|4056139|P2|NOT COMPLETED|Overall Study||1
1660883|NCT00679172|4056140|P1|NOT COMPLETED|Overall Study||1
1660884|NCT00679172|4056136|P5|COMPLETED|Overall Study||37
1660885|NCT00679172|4056137|P4|COMPLETED|Overall Study||38
1660886|NCT00679172|4056138|P3|COMPLETED|Overall Study||35
1660887|NCT00679172|4056139|P2|COMPLETED|Overall Study||37
1660888|NCT00679172|4056140|P1|COMPLETED|Overall Study||36
1660889|NCT00679172|4056136|P5|STARTED|Overall Study||37
1660890|NCT00679172|4056137|P4|STARTED|Overall Study||39
1660891|NCT00679172|4056138|P3|STARTED|Overall Study||36
1660892|NCT00679172|4056139|P2|STARTED|Overall Study||38
1660893|NCT00679172|4056140|P1|STARTED|Overall Study||37
1660894|NCT00679081|4056203|P1|NOT COMPLETED|Overall Study||1
1660895|NCT00679081|4056203|P1|COMPLETED|Overall Study||14
1660896|NCT00679081|4056203|P1|STARTED|Overall Study|Study design was within-subject control.|15
1660897|NCT00679055|4056213|P2|NOT COMPLETED|Overall Study||5
1660898|NCT00679055|4056214|P1|NOT COMPLETED|Overall Study||2
1660899|NCT00679055|4056213|P2|COMPLETED|Overall Study||1
1660900|NCT00679055|4056214|P1|COMPLETED|Overall Study||6
1660901|NCT00679055|4056213|P2|STARTED|Overall Study||6
1660902|NCT00679055|4056214|P1|STARTED|Overall Study||8
1660903|NCT00679029|4056224|P1|NOT COMPLETED|Overall Study||5
1660904|NCT00679029|4056224|P1|COMPLETED|Overall Study||10
1660905|NCT00679029|4056224|P1|STARTED|Overall Study||15
1660906|NCT00678899|4056231|P1|NOT COMPLETED|Overall Study||1
1660907|NCT00678899|4056231|P1|COMPLETED|Overall Study||49
1660908|NCT00678899|4056231|P1|STARTED|Overall Study||50
1660909|NCT00678886|4056240|P4|NOT COMPLETED|Overall Study||9
1660910|NCT00678886|4056241|P3|NOT COMPLETED|Overall Study||9
1660911|NCT00678886|4056242|P2|NOT COMPLETED|Overall Study||0
1660912|NCT00678886|4056243|P1|NOT COMPLETED|Overall Study||0
1660913|NCT00678886|4056240|P4|COMPLETED|Overall Study||153
1660914|NCT00678886|4056241|P3|COMPLETED|Overall Study||72
1660915|NCT00678886|4056242|P2|COMPLETED|Overall Study||19
1660916|NCT00678886|4056243|P1|COMPLETED|Overall Study||10
1660917|NCT00678886|4056240|P4|STARTED|Overall Study||162
1660918|NCT00678886|4056241|P3|STARTED|Overall Study||81
1660919|NCT00678886|4056242|P2|STARTED|Overall Study||19
1660920|NCT00678886|4056243|P1|STARTED|Overall Study||10
1660921|NCT00678834|4056290|P3|NOT COMPLETED|Overall Study||9
1660922|NCT00678834|4056291|P2|NOT COMPLETED|Overall Study||0
1660923|NCT00678834|4056292|P1|NOT COMPLETED|Overall Study||16
1660924|NCT00678834|4056290|P3|COMPLETED|Overall Study||16
1660925|NCT00678834|4056291|P2|COMPLETED|Overall Study||15
1660926|NCT00678834|4056292|P1|COMPLETED|Overall Study||24
1660927|NCT00678834|4056290|P3|STARTED|Overall Study||25
1660928|NCT00678834|4056291|P2|STARTED|Overall Study||15
1660929|NCT00678834|4056292|P1|STARTED|Overall Study||40
1660930|NCT00678795|4056312|P2|NOT COMPLETED|Overall Study||6
1660931|NCT00678795|4056313|P1|NOT COMPLETED|Overall Study||11
1660932|NCT00678795|4056312|P2|COMPLETED|Overall Study||62
1660933|NCT00678795|4056313|P1|COMPLETED|Overall Study||56
1660934|NCT00678795|4056312|P2|STARTED|Overall Study||68
1660935|NCT00678795|4056313|P1|STARTED|Overall Study||67
1660936|NCT00678691|4056335|P2|NOT COMPLETED|Overall Study||4
1660937|NCT00678691|4056336|P1|NOT COMPLETED|Overall Study||6
1660938|NCT00678691|4056335|P2|COMPLETED|Overall Study||24
1660939|NCT00678691|4056336|P1|COMPLETED|Overall Study||21
1660940|NCT00678691|4056335|P2|STARTED|Overall Study||28
1660941|NCT00678691|4056336|P1|STARTED|Overall Study||27
1660942|NCT00678652|4056346|P4|NOT COMPLETED|Overall Study||0
1660943|NCT00678652|4056347|P3|NOT COMPLETED|Overall Study||1
1660944|NCT00678652|4056348|P2|NOT COMPLETED|Overall Study||0
1660945|NCT00678652|4056349|P1|NOT COMPLETED|Overall Study||3
1660946|NCT00678652|4056346|P4|COMPLETED|Overall Study||9
1660947|NCT00678652|4056347|P3|COMPLETED|Overall Study||8
1660948|NCT00678652|4056348|P2|COMPLETED|Overall Study||9
1660949|NCT00678652|4056349|P1|COMPLETED|Overall Study||6
1660950|NCT00678652|4056346|P4|STARTED|Overall Study||9
1660951|NCT00678652|4056347|P3|STARTED|Overall Study||9
1660952|NCT00678652|4056348|P2|STARTED|Overall Study||9
1660953|NCT00678652|4056349|P1|STARTED|Overall Study||9
1660954|NCT00678639|4056373|P2|NOT COMPLETED|Overall Study||0
1660955|NCT00678639|4056374|P1|NOT COMPLETED|Overall Study||2
1660956|NCT00678639|4056373|P2|COMPLETED|Overall Study||57
1660957|NCT00678639|4056374|P1|COMPLETED|Overall Study||51
1660958|NCT00678639|4056373|P2|Hospital Discharge|Overall Study||57
1660959|NCT00678639|4056374|P1|Hospital Discharge|Overall Study||53
1660960|NCT00678639|4056373|P2|STARTED|Overall Study||57
1660961|NCT00678639|4056374|P1|STARTED|Overall Study||53
1660962|NCT00678587|4056389|P2|NOT COMPLETED|Overall Study||18
1660963|NCT00678587|4056390|P1|NOT COMPLETED|Overall Study||20
1660964|NCT00678587|4056389|P2|COMPLETED|Overall Study||127
1660965|NCT00678587|4056390|P1|COMPLETED|Overall Study||127
1660966|NCT00678587|4056389|P2|STARTED|Overall Study||145
1660967|NCT00678587|4056390|P1|STARTED|Overall Study||147
1660968|NCT00678574|4056424|P2|NOT COMPLETED|Overall Study||0
1660969|NCT00678574|4056425|P1|NOT COMPLETED|Overall Study||0
1660970|NCT00678574|4056424|P2|COMPLETED|Overall Study||27
1660971|NCT00678574|4056425|P1|COMPLETED|Overall Study||18
1660972|NCT00678574|4056424|P2|STARTED|Overall Study||27
1660973|NCT00678574|4056425|P1|STARTED|Overall Study||18
1660974|NCT00678535|4056433|P2|NOT COMPLETED|Overall Study||98
1660975|NCT00678535|4056434|P1|NOT COMPLETED|Overall Study||93
1660976|NCT00678535|4056433|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
1660977|NCT00678535|4056434|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
1660978|NCT00678535|4056433|P2|STARTED|Overall Study|ITT population|449
1660979|NCT00678535|4056434|P1|STARTED|Overall Study|ITT population|455
1660980|NCT00678470|4056450|P1|NOT COMPLETED|Overall Study||3
1660981|NCT00678470|4056450|P1|COMPLETED|Overall Study||15
1660982|NCT00678470|4056450|P1|STARTED|Overall Study||18
1660983|NCT00678444|4056456|P2|NOT COMPLETED|Overall Study||0
1660984|NCT00678444|4056457|P1|NOT COMPLETED|Overall Study||0
1660985|NCT00678444|4056456|P2|COMPLETED|Overall Study||99
1660986|NCT00678444|4056457|P1|COMPLETED|Overall Study||100
1660987|NCT00678444|4056456|P2|STARTED|Overall Study||99
1660988|NCT00678444|4056457|P1|STARTED|Overall Study||100
1660989|NCT00678418|4056467|P2|NOT COMPLETED|Part B (Open Label)||0
1660990|NCT00678418|4056468|P1|NOT COMPLETED|Part B (Open Label)||43
1660991|NCT00678418|4056467|P2|COMPLETED|Part B (Open Label)||0
1660992|NCT00678418|4056468|P1|COMPLETED|Part B (Open Label)||71
1660993|NCT00678418|4056467|P2|STARTED|Part B (Open Label)||0
1660994|NCT00678418|4056468|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
1660995|NCT00678418|4056467|P2|NOT COMPLETED|Part A (Double Blind)||77
1660996|NCT00678418|4056468|P1|NOT COMPLETED|Part A (Double Blind)||59
1660997|NCT00678418|4056467|P2|COMPLETED|Part A (Double Blind)||47
1660998|NCT00678418|4056468|P1|COMPLETED|Part A (Double Blind)||67
1660999|NCT00678418|4056467|P2|STARTED|Part A (Double Blind)||124
1661000|NCT00678418|4056468|P1|STARTED|Part A (Double Blind)||126
1661001|NCT00678392|4056484|P2|NOT COMPLETED|Overall Study||362
1661002|NCT00678392|4056485|P1|NOT COMPLETED|Overall Study||361
1661003|NCT00678392|4056484|P2|COMPLETED|Overall Study||0
1661004|NCT00678392|4056485|P1|COMPLETED|Overall Study||0
1661005|NCT00678392|4056484|P2|Treated|Overall Study||355
1661006|NCT00678392|4056485|P1|Treated|Overall Study||359
1661007|NCT00678392|4056484|P2|STARTED|Overall Study||362
1661008|NCT00678392|4056485|P1|STARTED|Overall Study||361
1661009|NCT00678379|4056520|P3|NOT COMPLETED|Overall Study||4
1661010|NCT00678379|4056521|P2|NOT COMPLETED|Overall Study||3
1661011|NCT00678379|4056522|P1|NOT COMPLETED|Overall Study||6
1661012|NCT00678379|4056520|P3|COMPLETED|Overall Study||36
1661013|NCT00678379|4056521|P2|COMPLETED|Overall Study||37
1661014|NCT00678379|4056522|P1|COMPLETED|Overall Study||34
1661015|NCT00678379|4056520|P3|STARTED|Overall Study||40
1661016|NCT00678379|4056521|P2|STARTED|Overall Study||40
1661017|NCT00678379|4056522|P1|STARTED|Overall Study||40
1661018|NCT00678301|4056550|P2|NOT COMPLETED|Overall Study||2
1661019|NCT00678301|4056551|P1|NOT COMPLETED|Overall Study||8
1661020|NCT00678301|4056550|P2|COMPLETED|Overall Study||116
1661021|NCT00678301|4056551|P1|COMPLETED|Overall Study||231
1661022|NCT00678301|4056550|P2|STARTED|Overall Study||118
1661023|NCT00678301|4056551|P1|STARTED|Overall Study||239
1661024|NCT00678288|4056609|P2|NOT COMPLETED|Overall Study||6
1661025|NCT00678288|4056610|P1|NOT COMPLETED|Overall Study||10
1661026|NCT00678288|4056609|P2|COMPLETED|Overall Study||0
1661027|NCT00678288|4056610|P1|COMPLETED|Overall Study||0
1661028|NCT00678288|4056609|P2|STARTED|Overall Study||6
1661029|NCT00678288|4056610|P1|STARTED|Overall Study||10
1661030|NCT00678249|4056627|P3|NOT COMPLETED|Overall Study||0
1661031|NCT00678249|4056628|P2|NOT COMPLETED|Overall Study||0
1661032|NCT00678249|4056629|P1|NOT COMPLETED|Overall Study||0
1661033|NCT00678249|4056627|P3|COMPLETED|Overall Study||37
1661034|NCT00678249|4056628|P2|COMPLETED|Overall Study||93
1661035|NCT00678249|4056629|P1|COMPLETED|Overall Study||97
1661036|NCT00678249|4056627|P3|STARTED|Overall Study||37
1661037|NCT00678249|4056628|P2|STARTED|Overall Study||93
1661038|NCT00678249|4056629|P1|STARTED|Overall Study||97
1661039|NCT00678210|4056665|P4|NOT COMPLETED|Overall Study||20
1661040|NCT00678210|4056666|P3|NOT COMPLETED|Overall Study||6
1661041|NCT00678210|4056667|P2|NOT COMPLETED|Overall Study||11
1661042|NCT00678210|4056668|P1|NOT COMPLETED|Overall Study||11
1661043|NCT00678210|4056665|P4|COMPLETED|Overall Study||30
1661044|NCT00678210|4056666|P3|COMPLETED|Overall Study||43
1661045|NCT00678210|4056667|P2|COMPLETED|Overall Study||38
1661046|NCT00678210|4056668|P1|COMPLETED|Overall Study||38
1661047|NCT00678210|4056665|P4|STARTED|Overall Study||50
1661048|NCT00678210|4056666|P3|STARTED|Overall Study||49
1661049|NCT00678210|4056667|P2|STARTED|Overall Study||49
1661050|NCT00678210|4056668|P1|STARTED|Overall Study||49
1661051|NCT00678080|4056704|P2|NOT COMPLETED|Overall Study||1
1661052|NCT00678080|4056705|P1|NOT COMPLETED|Overall Study||3
1661053|NCT00678080|4056704|P2|COMPLETED|Overall Study||13
1661054|NCT00678080|4056705|P1|COMPLETED|Overall Study||8
1661055|NCT00678080|4056704|P2|STARTED|Overall Study||14
1661056|NCT00678080|4056705|P1|STARTED|Overall Study||11
1661057|NCT00678041|4056731|P2|NOT COMPLETED|Overall Study||5
1661058|NCT00678041|4056732|P1|NOT COMPLETED|Overall Study||5
1661059|NCT00678041|4056731|P2|COMPLETED|Overall Study||0
1661060|NCT00678041|4056732|P1|COMPLETED|Overall Study||0
1661061|NCT00678041|4056731|P2|STARTED|Overall Study||5
1661062|NCT00678041|4056732|P1|STARTED|Overall Study||5
1661063|NCT00678015|4056744|P1|NOT COMPLETED|Overall Study||0
1661064|NCT00678015|4056744|P1|COMPLETED|Overall Study||12
1661065|NCT00678015|4056744|P1|STARTED|Overall Study||12
1661066|NCT00677924|4056753|P2|NOT COMPLETED|Overall Study||0
1661067|NCT00677924|4056754|P1|NOT COMPLETED|Overall Study||0
1661068|NCT00677924|4056753|P2|COMPLETED|Overall Study||6
1661069|NCT00677924|4056754|P1|COMPLETED|Overall Study||3
1661070|NCT00677924|4056753|P2|STARTED|Overall Study||6
1661071|NCT00677924|4056754|P1|STARTED|Overall Study||3
1661072|NCT00677898|4056764|P2|NOT COMPLETED|Overall Study||18
1661073|NCT00677898|4056765|P1|NOT COMPLETED|Overall Study||20
1661074|NCT00677898|4056764|P2|COMPLETED|Overall Study||102
1661075|NCT00677898|4056765|P1|COMPLETED|Overall Study||99
1661076|NCT00677898|4056764|P2|STARTED|Overall Study||120
1661077|NCT00677898|4056765|P1|STARTED|Overall Study||119
1661078|NCT00677833|4056785|P4|NOT COMPLETED|Overall Study||3
1661079|NCT00677833|4056786|P3|NOT COMPLETED|Overall Study||2
1661080|NCT00677833|4056787|P2|NOT COMPLETED|Overall Study||0
1661081|NCT00677833|4056788|P1|NOT COMPLETED|Overall Study||4
1661082|NCT00677833|4056785|P4|COMPLETED|Overall Study||128
1661083|NCT00677833|4056786|P3|COMPLETED|Overall Study||122
1661084|NCT00677833|4056787|P2|COMPLETED|Overall Study||51
1661085|NCT00677833|4056788|P1|COMPLETED|Overall Study||51
1661086|NCT00677833|4056785|P4|STARTED|Overall Study||131
1661087|NCT00677833|4056786|P3|STARTED|Overall Study||124
1661088|NCT00677833|4056787|P2|STARTED|Overall Study||51
1661089|NCT00677833|4056788|P1|STARTED|Overall Study||55
1661090|NCT00677820|4056838|P2|NOT COMPLETED|Overall Study||0
1661091|NCT00677820|4056839|P1|NOT COMPLETED|Overall Study||1
1661092|NCT00677820|4056838|P2|COMPLETED|Overall Study||60
1661093|NCT00677820|4056839|P1|COMPLETED|Overall Study||239
1661094|NCT00677820|4056838|P2|STARTED|Overall Study||60
1661095|NCT00677820|4056839|P1|STARTED|Overall Study||240
1661096|NCT00677807|4056860|P3|NOT COMPLETED|Overall Study||20
1661097|NCT00677807|4056861|P2|NOT COMPLETED|Overall Study||11
1661098|NCT00677807|4056862|P1|NOT COMPLETED|Overall Study||18
1661099|NCT00677807|4056860|P3|COMPLETED|Overall Study||105
1661100|NCT00677807|4056861|P2|COMPLETED|Overall Study||135
1661101|NCT00677807|4056862|P1|COMPLETED|Overall Study||126
1661102|NCT00677807|4056860|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
1661103|NCT00677807|4056861|P2|Safety/ITT: Received Study Drug|Overall Study||146
1661104|NCT00677807|4056862|P1|Safety/ITT: Received Study Drug|Overall Study||144
1661105|NCT00677807|4056860|P3|STARTED|Overall Study||125
1661106|NCT00677807|4056861|P2|STARTED|Overall Study||146
1661107|NCT00677807|4056862|P1|STARTED|Overall Study||144
1661108|NCT00677690|4056893|P2|NOT COMPLETED|Overall Study||0
1661109|NCT00677690|4056894|P1|NOT COMPLETED|Overall Study||0
1661110|NCT00677690|4056893|P2|COMPLETED|Overall Study||41
1661111|NCT00677690|4056894|P1|COMPLETED|Overall Study||42
1661112|NCT00677690|4056893|P2|STARTED|Overall Study||41
1661113|NCT00677690|4056894|P1|STARTED|Overall Study||42
1661114|NCT00677534|4056908|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
1661115|NCT00677534|4056908|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
1661116|NCT00677534|4056908|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
1661117|NCT00677534|4056908|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
1661118|NCT00677534|4056908|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
1661119|NCT00677534|4056908|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
1661120|NCT00677534|4056908|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
1661121|NCT00677534|4056908|P1|COMPLETED|Washout (Weeks 1-4)||7
1661122|NCT00677534|4056908|P1|STARTED|Washout (Weeks 1-4)||10
1661123|NCT00677365|4056916|P4|NOT COMPLETED|Overall Study||3
1661124|NCT00677365|4056917|P3|NOT COMPLETED|Overall Study||2
1661125|NCT00677365|4056918|P2|NOT COMPLETED|Overall Study||1
1661126|NCT00677365|4056919|P1|NOT COMPLETED|Overall Study||2
1661127|NCT00677365|4056916|P4|COMPLETED|Overall Study||36
1661128|NCT00677365|4056917|P3|COMPLETED|Overall Study||35
1661129|NCT00677365|4056918|P2|COMPLETED|Overall Study||37
1661130|NCT00677365|4056919|P1|COMPLETED|Overall Study||35
1661131|NCT00677365|4056916|P4|STARTED|Overall Study||39
1661132|NCT00677365|4056917|P3|STARTED|Overall Study||37
1661133|NCT00677365|4056918|P2|STARTED|Overall Study||38
1661134|NCT00677365|4056919|P1|STARTED|Overall Study||37
1661135|NCT00677352|4056951|P2|NOT COMPLETED|Tapering Phase||10
1661136|NCT00677352|4056952|P1|NOT COMPLETED|Tapering Phase||6
1661137|NCT00677352|4056951|P2|COMPLETED|Tapering Phase||112
1661138|NCT00677352|4056952|P1|COMPLETED|Tapering Phase||126
1661139|NCT00677352|4056951|P2|STARTED|Tapering Phase||122
1661140|NCT00677352|4056952|P1|STARTED|Tapering Phase||132
1661141|NCT00677352|4056951|P2|NOT COMPLETED|Treatment Phase||42
1661142|NCT00677352|4056952|P1|NOT COMPLETED|Treatment Phase||25
1661143|NCT00677352|4056951|P2|COMPLETED|Treatment Phase||122
1661144|NCT00677352|4056952|P1|COMPLETED|Treatment Phase||132
1661145|NCT00677352|4056951|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
1661146|NCT00677352|4056952|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
1661147|NCT00677235|4056972|P2|NOT COMPLETED|Overall Study||38
1661148|NCT00677235|4056973|P1|NOT COMPLETED|Overall Study||41
1661149|NCT00677235|4056972|P2|COMPLETED|Overall Study||94
1661150|NCT00677235|4056973|P1|COMPLETED|Overall Study||97
1661151|NCT00677235|4056972|P2|STARTED|Overall Study||132
1661152|NCT00677235|4056973|P1|STARTED|Overall Study||138
1661153|NCT00677092|4057013|P1|NOT COMPLETED|Overall Study||6
1661154|NCT00677092|4057013|P1|COMPLETED|Overall Study||6
1661155|NCT00677092|4057013|P1|Received Study Treatment|Overall Study||11
1661156|NCT00677092|4057013|P1|STARTED|Overall Study||12
1661157|NCT00677040|4057022|P1|NOT COMPLETED|Overall Study||0
1661158|NCT00677040|4057022|P1|COMPLETED|Overall Study||20
1661159|NCT00677040|4057022|P1|STARTED|Overall Study||20
1661160|NCT00677014|4057030|P3|NOT COMPLETED|Overall Study||49
1661161|NCT00677014|4057031|P2|NOT COMPLETED|Overall Study||41
1661162|NCT00677014|4057032|P1|NOT COMPLETED|Overall Study||44
1661163|NCT00677014|4057030|P3|COMPLETED|Overall Study||283
1661164|NCT00677014|4057031|P2|COMPLETED|Overall Study||282
1661165|NCT00677014|4057032|P1|COMPLETED|Overall Study||281
1661166|NCT00677014|4057030|P3|STARTED|Overall Study||332
1661167|NCT00677014|4057031|P2|STARTED|Overall Study||323
1661168|NCT00677014|4057032|P1|STARTED|Overall Study||325
1661169|NCT00676897|4057042|P2|NOT COMPLETED|Overall Study||0
1661170|NCT00676897|4057043|P1|NOT COMPLETED|Overall Study||0
1661171|NCT00676897|4057042|P2|COMPLETED|Overall Study||10
1661172|NCT00676897|4057043|P1|COMPLETED|Overall Study||8
1661173|NCT00676897|4057042|P2|STARTED|Overall Study||10
1661174|NCT00676897|4057043|P1|STARTED|Overall Study||8
1661175|NCT00676806|4057053|P2|NOT COMPLETED|Overall Study||0
1661176|NCT00676806|4057054|P1|NOT COMPLETED|Overall Study||0
1661177|NCT00676806|4057053|P2|COMPLETED|Overall Study||3
1661178|NCT00676806|4057054|P1|COMPLETED|Overall Study||3
1661179|NCT00676806|4057053|P2|STARTED|Overall Study||3
1661180|NCT00676806|4057054|P1|STARTED|Overall Study||3
1661181|NCT00676793|4057070|P1|NOT COMPLETED|Overall Study||13
1661182|NCT00676793|4057070|P1|COMPLETED|Overall Study||19
1661183|NCT00676793|4057070|P1|STARTED|Overall Study||32
1661184|NCT00676780|4057075|P1|NOT COMPLETED|Overall Study||7
1661185|NCT00676780|4057075|P1|COMPLETED|Overall Study||26
1661186|NCT00676780|4057075|P1|STARTED|Overall Study||33
1661187|NCT00676715|4057085|P4|NOT COMPLETED|Overall Study||40
1661188|NCT00676715|4057086|P3|NOT COMPLETED|Overall Study||41
1661189|NCT00676715|4057087|P2|NOT COMPLETED|Overall Study||47
1661190|NCT00676715|4057088|P1|NOT COMPLETED|Overall Study||40
1661191|NCT00676715|4057085|P4|COMPLETED|Overall Study||14
1661192|NCT00676715|4057086|P3|COMPLETED|Overall Study||14
1661193|NCT00676715|4057087|P2|COMPLETED|Overall Study||8
1661194|NCT00676715|4057088|P1|COMPLETED|Overall Study||14
1661195|NCT00676715|4057085|P4|STARTED|Overall Study||54
1661196|NCT00676715|4057086|P3|STARTED|Overall Study||55
1661197|NCT00676715|4057087|P2|STARTED|Overall Study||55
1661198|NCT00676715|4057088|P1|STARTED|Overall Study||54
1661199|NCT00676689|4057118|P1|NOT COMPLETED|Overall Study||61
1661200|NCT00676689|4057118|P1|COMPLETED|Overall Study||20
1661201|NCT00676689|4057118|P1|1 Year Follow-up|Overall Study||64
1661202|NCT00676689|4057118|P1|30 Day Follow-up|Overall Study||78
1661203|NCT00676689|4057118|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
1661204|NCT00676689|4057118|P1|STARTED|Overall Study||81
1661205|NCT00676676|4057124|P1|NOT COMPLETED|Overall Study||0
1661206|NCT00676676|4057124|P1|COMPLETED|Overall Study||9
1661207|NCT00676676|4057124|P1|STARTED|Overall Study||9
1661208|NCT00676650|4057130|P2|NOT COMPLETED|Overall Study||289
1661209|NCT00676650|4057131|P1|NOT COMPLETED|Overall Study||584
1661210|NCT00676650|4057130|P2|COMPLETED|Overall Study||0
1661211|NCT00676650|4057131|P1|COMPLETED|Overall Study||0
1661212|NCT00676650|4057130|P2|Treated|Overall Study||285
1661213|NCT00676650|4057131|P1|Treated|Overall Study||581
1661214|NCT00676650|4057130|P2|STARTED|Overall Study||289
1661215|NCT00676650|4057131|P1|STARTED|Overall Study||584
1661216|NCT00676585|4057151|P2|NOT COMPLETED|Overall Study||0
1661217|NCT00676585|4057152|P1|NOT COMPLETED|Overall Study||0
1661218|NCT00676585|4057151|P2|COMPLETED|Overall Study||25
1661219|NCT00676585|4057152|P1|COMPLETED|Overall Study||25
1661220|NCT00676585|4057151|P2|STARTED|Overall Study||25
1661221|NCT00676585|4057152|P1|STARTED|Overall Study||25
1661222|NCT00676520|4057162|P1|NOT COMPLETED|Overall Study||731
1661223|NCT00676520|4057162|P1|COMPLETED|Overall Study||7309
1661224|NCT00676520|4057162|P1|STARTED|Overall Study||8040
1661225|NCT00676494|4057219|P1|NOT COMPLETED|Overall Study||14
1661226|NCT00676494|4057219|P1|COMPLETED|Overall Study||158
1661227|NCT00676494|4057219|P1|STARTED|Overall Study||172
1661228|NCT00676455|4057225|P1|NOT COMPLETED|Overall Study||0
1661229|NCT00676455|4057225|P1|COMPLETED|Overall Study||14
1661230|NCT00676455|4057225|P1|STARTED|Overall Study||14
1661231|NCT00676403|4057236|P6|NOT COMPLETED|Overall Study||5
1661232|NCT00676403|4057237|P5|NOT COMPLETED|Overall Study||1
1661233|NCT00676403|4057238|P4|NOT COMPLETED|Overall Study||5
1661234|NCT00676403|4057239|P3|NOT COMPLETED|Overall Study||1
1661235|NCT00676403|4057240|P2|NOT COMPLETED|Overall Study||2
1661236|NCT00676403|4057241|P1|NOT COMPLETED|Overall Study||2
1661237|NCT00676403|4057236|P6|COMPLETED|Overall Study||18
1661238|NCT00676403|4057237|P5|COMPLETED|Overall Study||23
1661239|NCT00676403|4057238|P4|COMPLETED|Overall Study||17
1661240|NCT00676403|4057239|P3|COMPLETED|Overall Study||22
1661241|NCT00676403|4057240|P2|COMPLETED|Overall Study||20
1661242|NCT00676403|4057241|P1|COMPLETED|Overall Study||21
1661243|NCT00676403|4057236|P6|STARTED|Overall Study||23
1661244|NCT00676403|4057237|P5|STARTED|Overall Study||24
1661245|NCT00676403|4057238|P4|STARTED|Overall Study||22
1661246|NCT00676403|4057239|P3|STARTED|Overall Study||23
1661247|NCT00676403|4057240|P2|STARTED|Overall Study||22
1661248|NCT00676403|4057241|P1|STARTED|Overall Study||23
1661249|NCT00676364|4057371|P2|NOT COMPLETED|Overall Study||0
1661250|NCT00676364|4057372|P1|NOT COMPLETED|Overall Study||0
1661251|NCT00676364|4057371|P2|COMPLETED|Overall Study||57
1661252|NCT00676364|4057372|P1|COMPLETED|Overall Study||57
1661253|NCT00676364|4057371|P2|STARTED|Overall Study||57
1661254|NCT00676364|4057372|P1|STARTED|Overall Study||57
1661255|NCT00676338|4057384|P4|NOT COMPLETED|Overall Study||23
1661256|NCT00676338|4057385|P3|NOT COMPLETED|Overall Study||30
1661257|NCT00676338|4057386|P2|NOT COMPLETED|Overall Study||33
1661258|NCT00676338|4057387|P1|NOT COMPLETED|Overall Study||38
1661259|NCT00676338|4057384|P4|COMPLETED|Overall Study||140
1661260|NCT00676338|4057385|P3|COMPLETED|Overall Study||133
1661261|NCT00676338|4057386|P2|COMPLETED|Overall Study||213
1661262|NCT00676338|4057387|P1|COMPLETED|Overall Study||210
1661263|NCT00676338|4057384|P4|STARTED|Overall Study||163
1661264|NCT00676338|4057385|P3|STARTED|Overall Study||163
1661265|NCT00676338|4057386|P2|STARTED|Overall Study||246
1661266|NCT00676338|4057387|P1|STARTED|Overall Study||248
1661267|NCT00676208|4057439|P2|NOT COMPLETED|Overall Study||6
1661268|NCT00676208|4057440|P1|NOT COMPLETED|Overall Study||2
1661269|NCT00676208|4057439|P2|COMPLETED|Overall Study||13
1661270|NCT00676208|4057440|P1|COMPLETED|Overall Study||12
1661271|NCT00676208|4057439|P2|STARTED|Overall Study||19
1661272|NCT00676208|4057440|P1|STARTED|Overall Study||14
1661273|NCT00676195|4057448|P1|NOT COMPLETED|Overall Study||3
1661274|NCT00676195|4057448|P1|COMPLETED|Overall Study||21
1661275|NCT00676195|4057448|P1|STARTED|Overall Study||24
1661276|NCT00676182|4057458|P1|NOT COMPLETED|Overall Study||0
1661277|NCT00676182|4057458|P1|COMPLETED|Overall Study||75
1661278|NCT00676182|4057458|P1|STARTED|Overall Study||75
1661279|NCT00676143|4057473|P2|NOT COMPLETED|Overall Study||260
1661280|NCT00676143|4057474|P1|NOT COMPLETED|Overall Study||156
1661281|NCT00676143|4057473|P2|COMPLETED|Overall Study||398
1661282|NCT00676143|4057474|P1|COMPLETED|Overall Study||285
1661283|NCT00676143|4057473|P2|Treated|Overall Study||654
1661284|NCT00676143|4057474|P1|Treated|Overall Study||439
1661285|NCT00676143|4057473|P2|STARTED|Overall Study||658
1661286|NCT00676143|4057474|P1|STARTED|Overall Study||441
1661287|NCT00676130|4057514|P2|NOT COMPLETED|Overall Study||4
1661288|NCT00676130|4057515|P1|NOT COMPLETED|Overall Study||3
1661289|NCT00676130|4057514|P2|COMPLETED|Overall Study||73
1661290|NCT00676130|4057515|P1|COMPLETED|Overall Study||73
1661291|NCT00676130|4057514|P2|STARTED|Overall Study||77
1661292|NCT00676130|4057515|P1|STARTED|Overall Study||76
1661293|NCT00676091|4057525|P2|NOT COMPLETED|Toddler Dose||0
1661294|NCT00676091|4057526|P1|NOT COMPLETED|Toddler Dose||3
1661295|NCT00676091|4057525|P2|COMPLETED|Toddler Dose||156
1661296|NCT00676091|4057526|P1|COMPLETED|Toddler Dose||153
1661297|NCT00676091|4057525|P2|STARTED|Toddler Dose||156
1661298|NCT00676091|4057526|P1|STARTED|Toddler Dose||156
1661299|NCT00676091|4057525|P2|NOT COMPLETED|After Infant Series||3
1661300|NCT00676091|4057526|P1|NOT COMPLETED|After Infant Series||1
1661301|NCT00676091|4057525|P2|COMPLETED|After Infant Series||156
1661302|NCT00676091|4057526|P1|COMPLETED|After Infant Series||156
1661303|NCT00676091|4057525|P2|STARTED|After Infant Series||159
1661304|NCT00676091|4057526|P1|STARTED|After Infant Series||157
1661305|NCT00676091|4057525|P2|NOT COMPLETED|Infant Series||18
1661306|NCT00676091|4057526|P1|NOT COMPLETED|Infant Series||20
1661307|NCT00676091|4057525|P2|COMPLETED|Infant Series||159
1661308|NCT00676091|4057526|P1|COMPLETED|Infant Series||157
1661309|NCT00676091|4057525|P2|Vaccinated Dose 3|Infant Series||161
1661310|NCT00676091|4057526|P1|Vaccinated Dose 3|Infant Series||158
1661311|NCT00676091|4057525|P2|Vaccinated Dose 2|Infant Series||162
1661312|NCT00676091|4057526|P1|Vaccinated Dose 2|Infant Series||159
1661313|NCT00676091|4057525|P2|Vaccinated Dose 1|Infant Series||162
1661314|NCT00676091|4057526|P1|Vaccinated Dose 1|Infant Series||163
1661315|NCT00676091|4057525|P2|STARTED|Infant Series||177
1661316|NCT00676091|4057526|P1|STARTED|Infant Series||177
1661317|NCT00676065|4057561|P3|NOT COMPLETED|Overall Study||0
1661318|NCT00676065|4057562|P2|NOT COMPLETED|Overall Study||0
1661319|NCT00676065|4057563|P1|NOT COMPLETED|Overall Study||0
1661320|NCT00676065|4057561|P3|COMPLETED|Overall Study||26341
1661321|NCT00676065|4057562|P2|COMPLETED|Overall Study||15428
1661322|NCT00676065|4057563|P1|COMPLETED|Overall Study||16534
1661323|NCT00676065|4057561|P3|STARTED|Overall Study||26341
1661324|NCT00676065|4057562|P2|STARTED|Overall Study||15428
1661325|NCT00676065|4057563|P1|STARTED|Overall Study||16534
1661326|NCT00676052|4057583|P6|NOT COMPLETED|Overall Study||6
1661327|NCT00676052|4057584|P5|NOT COMPLETED|Overall Study||6
1661328|NCT00676052|4057585|P4|NOT COMPLETED|Overall Study||5
1661329|NCT00676052|4057586|P3|NOT COMPLETED|Overall Study||6
1661330|NCT00676052|4057587|P2|NOT COMPLETED|Overall Study||7
1661331|NCT00676052|4057588|P1|NOT COMPLETED|Overall Study||9
1661332|NCT00676052|4057583|P6|COMPLETED|Overall Study||91
1661333|NCT00676052|4057584|P5|COMPLETED|Overall Study||89
1661334|NCT00676052|4057585|P4|COMPLETED|Overall Study||92
1661335|NCT00676052|4057586|P3|COMPLETED|Overall Study||90
1661336|NCT00676052|4057587|P2|COMPLETED|Overall Study||88
1661337|NCT00676052|4057588|P1|COMPLETED|Overall Study||87
1661338|NCT00676052|4057583|P6|STARTED|Overall Study||97
1661339|NCT00676052|4057584|P5|STARTED|Overall Study||95
1661340|NCT00676052|4057585|P4|STARTED|Overall Study||97
1661341|NCT00676052|4057586|P3|STARTED|Overall Study||96
1661342|NCT00676052|4057587|P2|STARTED|Overall Study||95
1661343|NCT00676052|4057588|P1|STARTED|Overall Study||96
1661344|NCT00676026|4057620|P1|NOT COMPLETED|Overall Study||0
1661345|NCT00676026|4057620|P1|COMPLETED|Overall Study||8
1661346|NCT00676026|4057620|P1|STARTED|Overall Study||8
1661347|NCT00675987|4057626|P2|NOT COMPLETED|Overall Study||0
1661348|NCT00675987|4057627|P1|NOT COMPLETED|Overall Study||0
1661349|NCT00675987|4057626|P2|COMPLETED|Overall Study||27
1661350|NCT00675987|4057627|P1|COMPLETED|Overall Study||26
1661351|NCT00675987|4057626|P2|STARTED|Overall Study||27
1661352|NCT00675987|4057627|P1|STARTED|Overall Study||26
1661353|NCT00675948|4057651|P2|NOT COMPLETED|Overall Study||3
1661354|NCT00675948|4057652|P1|NOT COMPLETED|Overall Study||39
1661355|NCT00675948|4057651|P2|COMPLETED|Overall Study||1
1661356|NCT00675948|4057652|P1|COMPLETED|Overall Study||0
1661357|NCT00675948|4057651|P2|STARTED|Overall Study||4
1661358|NCT00675948|4057652|P1|STARTED|Overall Study||39
1661359|NCT00675922|4057662|P1|NOT COMPLETED|Overall Study||0
1661360|NCT00675922|4057662|P1|COMPLETED|Overall Study||98
1661361|NCT00675922|4057662|P1|STARTED|Overall Study||98
1661362|NCT00675909|4057670|P3|NOT COMPLETED|Overall Study||0
1661363|NCT00675909|4057671|P2|NOT COMPLETED|Overall Study||0
1661364|NCT00675909|4057672|P1|NOT COMPLETED|Overall Study||0
1661365|NCT00675909|4057670|P3|COMPLETED|Overall Study||60
1661366|NCT00675909|4057671|P2|COMPLETED|Overall Study||60
1661367|NCT00675909|4057672|P1|COMPLETED|Overall Study||60
1661368|NCT00675909|4057670|P3|STARTED|Overall Study||60
1661369|NCT00675909|4057671|P2|STARTED|Overall Study||60
1661370|NCT00675909|4057672|P1|STARTED|Overall Study||60
1661371|NCT00675792|4057694|P2|NOT COMPLETED|Overall Study||0
1661372|NCT00675792|4057695|P1|NOT COMPLETED|Overall Study||0
1661373|NCT00675792|4057694|P2|COMPLETED|Overall Study||49
1661374|NCT00675792|4057695|P1|COMPLETED|Overall Study||51
1661375|NCT00675792|4057694|P2|STARTED|Overall Study||49
1661376|NCT00675792|4057695|P1|STARTED|Overall Study||51
1661377|NCT00675766|4057715|P4|NOT COMPLETED|Overall Study||26
1661378|NCT00675766|4057716|P3|NOT COMPLETED|Overall Study||21
1661379|NCT00675766|4057717|P2|NOT COMPLETED|Overall Study||5
1661380|NCT00675766|4057718|P1|NOT COMPLETED|Overall Study||6
1661381|NCT00675766|4057715|P4|COMPLETED|Overall Study||11
1661382|NCT00675766|4057716|P3|COMPLETED|Overall Study||29
1661383|NCT00675766|4057717|P2|COMPLETED|Overall Study||25
1661384|NCT00675766|4057718|P1|COMPLETED|Overall Study||100
1661385|NCT00675766|4057715|P4|Year 3|Overall Study||11
1661386|NCT00675766|4057716|P3|Year 3|Overall Study||29
1661387|NCT00675766|4057717|P2|Year 3|Overall Study||25
1661388|NCT00675766|4057718|P1|Year 3|Overall Study||100
1661389|NCT00675766|4057715|P4|Year 2|Overall Study||20
1661390|NCT00675766|4057716|P3|Year 2|Overall Study||34
1661391|NCT00675766|4057717|P2|Year 2|Overall Study||28
1661392|NCT00675766|4057718|P1|Year 2|Overall Study||105
1661393|NCT00675766|4057715|P4|STARTED|Overall Study||37
1661394|NCT00675766|4057716|P3|STARTED|Overall Study||50
1661395|NCT00675766|4057717|P2|STARTED|Overall Study||30
1661396|NCT00675766|4057718|P1|STARTED|Overall Study||106
1661397|NCT00675597|4057728|P1|NOT COMPLETED|Overall Study||3
1661398|NCT00675597|4057728|P1|COMPLETED|Overall Study||23
1661399|NCT00675597|4057728|P1|STARTED|Overall Study||26
1661400|NCT00675584|4057734|P2|NOT COMPLETED|Overall Study||26
1661401|NCT00675584|4057735|P1|NOT COMPLETED|Overall Study||39
1661402|NCT00675584|4057734|P2|COMPLETED|Overall Study||113
1661403|NCT00675584|4057735|P1|COMPLETED|Overall Study||100
1661404|NCT00675584|4057734|P2|STARTED|Overall Study||139
1661405|NCT00675584|4057735|P1|STARTED|Overall Study||139
1661406|NCT00675558|4057764|P3|NOT COMPLETED|Second Operation||0
1661407|NCT00675558|4057765|P2|NOT COMPLETED|Second Operation||0
1661408|NCT00675558|4057766|P1|NOT COMPLETED|Second Operation||0
1661409|NCT00675558|4057764|P3|COMPLETED|Second Operation||10
1661410|NCT00675558|4057765|P2|COMPLETED|Second Operation||0
1661411|NCT00675558|4057766|P1|COMPLETED|Second Operation||0
1661412|NCT00675558|4057764|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
1661413|NCT00675558|4057765|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
1661414|NCT00675558|4057766|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
1661415|NCT00675558|4057764|P3|NOT COMPLETED|Surgery||0
1661416|NCT00675558|4057765|P2|NOT COMPLETED|Surgery||0
1661417|NCT00675558|4057766|P1|NOT COMPLETED|Surgery||0
1661418|NCT00675558|4057764|P3|COMPLETED|Surgery||30
1661419|NCT00675558|4057765|P2|COMPLETED|Surgery||10
1661420|NCT00675558|4057766|P1|COMPLETED|Surgery||10
1661421|NCT00675558|4057764|P3|STARTED|Surgery||30
1661422|NCT00675558|4057765|P2|STARTED|Surgery||10
1661423|NCT00675558|4057766|P1|STARTED|Surgery||10
1661424|NCT00675506|4057782|P2|NOT COMPLETED|Overall Study||12
1661425|NCT00675506|4057783|P1|NOT COMPLETED|Overall Study||12
1661426|NCT00675506|4057782|P2|COMPLETED|Overall Study||17
1661427|NCT00675506|4057783|P1|COMPLETED|Overall Study||19
1661428|NCT00675506|4057782|P2|Received Intervention|Overall Study||29
1661429|NCT00675506|4057783|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
1661430|NCT00675506|4057782|P2|STARTED|Overall Study||29
1661431|NCT00675506|4057783|P1|STARTED|Overall Study||31
1661432|NCT00675441|4057799|P1|NOT COMPLETED|Overall Study||3
1661433|NCT00675441|4057799|P1|COMPLETED|Overall Study||2
1661434|NCT00675441|4057799|P1|STARTED|Overall Study||5
1661435|NCT00675428|4057805|P2|NOT COMPLETED|Overall Study||3
1661436|NCT00675428|4057806|P1|NOT COMPLETED|Overall Study||3
1661437|NCT00675428|4057805|P2|COMPLETED|Overall Study||0
1661438|NCT00675428|4057806|P1|COMPLETED|Overall Study||0
1661439|NCT00675428|4057805|P2|STARTED|Overall Study||3
1661440|NCT00675428|4057806|P1|STARTED|Overall Study||3
1661441|NCT00675415|4057826|P2|NOT COMPLETED|Overall Study||8
1661442|NCT00675415|4057827|P1|NOT COMPLETED|Overall Study||8
1661443|NCT00675415|4057826|P2|COMPLETED|Overall Study||123
1661444|NCT00675415|4057827|P1|COMPLETED|Overall Study||124
1661445|NCT00675415|4057826|P2|STARTED|Overall Study||131
1661446|NCT00675415|4057827|P1|STARTED|Overall Study||132
1661447|NCT00675259|4057839|P1|NOT COMPLETED|Overall Study||14
1661448|NCT00675259|4057839|P1|COMPLETED|Overall Study||19
1661449|NCT00675259|4057839|P1|STARTED|Overall Study||33
1661450|NCT00675103|4057848|P1|NOT COMPLETED|Overall Study||3
1661451|NCT00675103|4057848|P1|COMPLETED|Overall Study||4
1661452|NCT00675103|4057848|P1|STARTED|Overall Study||7
1661453|NCT00674986|4057855|P2|NOT COMPLETED|Overall Study||81
1661454|NCT00674986|4057856|P1|NOT COMPLETED|Overall Study||43
1661455|NCT00674986|4057855|P2|COMPLETED|Overall Study||188
1661456|NCT00674986|4057856|P1|COMPLETED|Overall Study||187
1661457|NCT00674986|4057855|P2|Intent to Treat Population|Overall Study||256
1661458|NCT00674986|4057856|P1|Intent to Treat Population|Overall Study||227
1661459|NCT00674986|4057855|P2|STARTED|Overall Study||269
1661460|NCT00674986|4057856|P1|STARTED|Overall Study||230
1661461|NCT00674973|4057877|P2|NOT COMPLETED|Overall Study||102
1661462|NCT00674973|4057878|P1|NOT COMPLETED|Overall Study||100
1661463|NCT00674973|4057877|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
1661464|NCT00674973|4057878|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
1661465|NCT00674973|4057877|P2|Switch to Open-Label Erlotinib|Overall Study||0
1661466|NCT00674973|4057878|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
1661467|NCT00674973|4057877|P2|STARTED|Overall Study||104
1661468|NCT00674973|4057878|P1|STARTED|Overall Study||103
1661469|NCT00674817|4057892|P1|NOT COMPLETED|Period 6||0
1661470|NCT00674817|4057892|P1|COMPLETED|Period 6||38
1661471|NCT00674817|4057892|P1|STARTED|Period 6||38
1661472|NCT00674817|4057892|P1|NOT COMPLETED|Period 5||0
1661473|NCT00674817|4057892|P1|COMPLETED|Period 5||38
1661474|NCT00674817|4057892|P1|STARTED|Period 5||38
1661475|NCT00674817|4057892|P1|NOT COMPLETED|Period 4||1
1661476|NCT00674817|4057892|P1|COMPLETED|Period 4||38
1661477|NCT00674817|4057892|P1|STARTED|Period 4||39
1661478|NCT00674817|4057892|P1|NOT COMPLETED|Period 3||2
1661479|NCT00674817|4057892|P1|COMPLETED|Period 3||39
1661480|NCT00674817|4057892|P1|STARTED|Period 3||41
1661481|NCT00674817|4057892|P1|NOT COMPLETED|Period 2||0
1661482|NCT00674817|4057892|P1|COMPLETED|Period 2||41
1661483|NCT00674817|4057892|P1|STARTED|Period 2||41
1661484|NCT00674817|4057892|P1|NOT COMPLETED|Period 1||3
1661485|NCT00674817|4057892|P1|COMPLETED|Period 1||41
1661486|NCT00674817|4057892|P1|STARTED|Period 1||44
1661487|NCT00674765|4058040|P2|NOT COMPLETED|Overall Study||29
1661488|NCT00674765|4058041|P1|NOT COMPLETED|Overall Study||36
1661489|NCT00674765|4058040|P2|COMPLETED|Overall Study||46
1661490|NCT00674765|4058041|P1|COMPLETED|Overall Study||45
1661491|NCT00674765|4058040|P2|STARTED|Overall Study||75
1661492|NCT00674765|4058041|P1|STARTED|Overall Study||81
1661493|NCT00674739|4058050|P3|NOT COMPLETED|Overall Study||32
1661494|NCT00674739|4058051|P2|NOT COMPLETED|Overall Study||59
1661495|NCT00674739|4058052|P1|NOT COMPLETED|Overall Study||57
1661496|NCT00674739|4058050|P3|COMPLETED|Overall Study||65
1661497|NCT00674739|4058051|P2|COMPLETED|Overall Study||136
1661498|NCT00674739|4058052|P1|COMPLETED|Overall Study||121
1661499|NCT00674739|4058050|P3|STARTED|Overall Study||97
1661500|NCT00674739|4058051|P2|STARTED|Overall Study||195
1661501|NCT00674739|4058052|P1|STARTED|Overall Study||178
1661502|NCT00674700|4058069|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
1661503|NCT00674700|4058070|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
1661504|NCT00674700|4058071|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
1661505|NCT00674700|4058069|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
1661506|NCT00674700|4058070|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
1661507|NCT00674700|4058071|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
1661508|NCT00674700|4058069|P3|STARTED|Year 2 Follow-up Without Treatment||153
1661509|NCT00674700|4058070|P2|STARTED|Year 2 Follow-up Without Treatment||135
1661510|NCT00674700|4058071|P1|STARTED|Year 2 Follow-up Without Treatment||139
1661511|NCT00674700|4058069|P3|NOT COMPLETED|Year 1||17
1661512|NCT00674700|4058070|P2|NOT COMPLETED|Year 1||34
1661513|NCT00674700|4058071|P1|NOT COMPLETED|Year 1||31
1661514|NCT00674700|4058069|P3|COMPLETED|Year 1||153
1661515|NCT00674700|4058070|P2|COMPLETED|Year 1||135
1661516|NCT00674700|4058071|P1|COMPLETED|Year 1||139
1661517|NCT00674700|4058069|P3|STARTED|Year 1||170
1661518|NCT00674700|4058070|P2|STARTED|Year 1||169
1661519|NCT00674700|4058071|P1|STARTED|Year 1||170
1661520|NCT00674661|4058084|P2|NOT COMPLETED|Overall Study||15
1661521|NCT00674661|4058085|P1|NOT COMPLETED|Overall Study||11
1661522|NCT00674661|4058084|P2|COMPLETED|Overall Study||48
1661523|NCT00674661|4058085|P1|COMPLETED|Overall Study||56
1661524|NCT00674661|4058084|P2|STARTED|Overall Study||63
1661525|NCT00674661|4058085|P1|STARTED|Overall Study||67
1661526|NCT00674622|4058094|P3|NOT COMPLETED|Overall Study||0
1661527|NCT00674622|4058095|P2|NOT COMPLETED|Overall Study||4
1661528|NCT00674622|4058096|P1|NOT COMPLETED|Overall Study||1
1661529|NCT00674622|4058094|P3|COMPLETED|Overall Study||22
1661530|NCT00674622|4058095|P2|COMPLETED|Overall Study||18
1661531|NCT00674622|4058096|P1|COMPLETED|Overall Study||21
1661532|NCT00674622|4058094|P3|STARTED|Overall Study||22
1661533|NCT00674622|4058095|P2|STARTED|Overall Study||22
1661534|NCT00674622|4058096|P1|STARTED|Overall Study||22
1661535|NCT00674609|4058119|P3|NOT COMPLETED|Overall Study||8
1661536|NCT00674609|4058120|P2|NOT COMPLETED|Overall Study||13
1661537|NCT00674609|4058121|P1|NOT COMPLETED|Overall Study||12
1661538|NCT00674609|4058119|P3|COMPLETED|Overall Study||51
1661539|NCT00674609|4058120|P2|COMPLETED|Overall Study||45
1661540|NCT00674609|4058121|P1|COMPLETED|Overall Study||48
1661541|NCT00674609|4058119|P3|STARTED|Overall Study||59
1661542|NCT00674609|4058120|P2|STARTED|Overall Study||58
1661543|NCT00674609|4058121|P1|STARTED|Overall Study||60
1661544|NCT00674583|4058155|P2|NOT COMPLETED|Overall Study||0
1661545|NCT00674583|4058156|P1|NOT COMPLETED|Overall Study||0
1661546|NCT00674583|4058155|P2|COMPLETED|Overall Study||103
1661547|NCT00674583|4058156|P1|COMPLETED|Overall Study||311
1661548|NCT00674583|4058155|P2|STARTED|Overall Study||103
1661549|NCT00674583|4058156|P1|STARTED|Overall Study||311
1661550|NCT00674492|4058180|P1|NOT COMPLETED|Overall Study||0
1661551|NCT00674492|4058180|P1|COMPLETED|Overall Study||21
1661552|NCT00674492|4058180|P1|STARTED|Overall Study||21
1661553|NCT00674466|4058187|P3|NOT COMPLETED|Overall Study||9
1661554|NCT00674466|4058188|P2|NOT COMPLETED|Overall Study||8
1661555|NCT00674466|4058189|P1|NOT COMPLETED|Overall Study||7
1661556|NCT00674466|4058187|P3|COMPLETED|Overall Study||21
1661557|NCT00674466|4058188|P2|COMPLETED|Overall Study||22
1661558|NCT00674466|4058189|P1|COMPLETED|Overall Study||23
1661559|NCT00674466|4058187|P3|STARTED|Overall Study||30
1661560|NCT00674466|4058188|P2|STARTED|Overall Study||30
1661561|NCT00674466|4058189|P1|STARTED|Overall Study||30
1661562|NCT00674362|4058205|P2|NOT COMPLETED|Open Label||0
1661563|NCT00674362|4058206|P1|NOT COMPLETED|Open Label||2
1661564|NCT00674362|4058205|P2|COMPLETED|Open Label||7
1661565|NCT00674362|4058206|P1|COMPLETED|Open Label||18
1661566|NCT00674362|4058205|P2|STARTED|Open Label||7
1661567|NCT00674362|4058206|P1|STARTED|Open Label||20
1661568|NCT00674362|4058205|P2|NOT COMPLETED|Double Blind||18
1661569|NCT00674362|4058206|P1|NOT COMPLETED|Double Blind||12
1661570|NCT00674362|4058205|P2|COMPLETED|Double Blind||80
1661571|NCT00674362|4058206|P1|COMPLETED|Double Blind||84
1661572|NCT00674362|4058205|P2|STARTED|Double Blind||98
1661573|NCT00674362|4058206|P1|STARTED|Double Blind||96
1661574|NCT00674323|4058274|P3|NOT COMPLETED|Overall Study||0
1661575|NCT00674323|4058275|P2|NOT COMPLETED|Overall Study||1
1661576|NCT00674323|4058276|P1|NOT COMPLETED|Overall Study||1
1661577|NCT00674323|4058274|P3|COMPLETED|Overall Study||21
1661578|NCT00674323|4058275|P2|COMPLETED|Overall Study||20
1661579|NCT00674323|4058276|P1|COMPLETED|Overall Study||18
1661580|NCT00674323|4058274|P3|STARTED|Overall Study||21
1661581|NCT00674323|4058275|P2|STARTED|Overall Study||21
1661582|NCT00674323|4058276|P1|STARTED|Overall Study||19
1661583|NCT00674297|4058293|P4|NOT COMPLETED|Overall Study||3
1661584|NCT00674297|4058294|P3|NOT COMPLETED|Overall Study||4
1661585|NCT00674297|4058295|P2|NOT COMPLETED|Overall Study||0
1661586|NCT00674297|4058296|P1|NOT COMPLETED|Overall Study||10
1661587|NCT00674297|4058293|P4|COMPLETED|Overall Study||4
1661588|NCT00674297|4058294|P3|COMPLETED|Overall Study||5
1661589|NCT00674297|4058295|P2|COMPLETED|Overall Study||7
1661590|NCT00674297|4058296|P1|COMPLETED|Overall Study||8
1661591|NCT00674297|4058293|P4|STARTED|Overall Study||7
1661592|NCT00674297|4058294|P3|STARTED|Overall Study||9
1661593|NCT00674297|4058295|P2|STARTED|Overall Study||7
1661594|NCT00674297|4058296|P1|STARTED|Overall Study||18
1661595|NCT00674206|4058311|P1|NOT COMPLETED|Overall Study||0
1661596|NCT00674206|4058311|P1|COMPLETED|Overall Study||6
1661597|NCT00674206|4058311|P1|STARTED|Overall Study||6
1661598|NCT00674154|4058318|P2|NOT COMPLETED|Overall Study||3
1661599|NCT00674154|4058319|P1|NOT COMPLETED|Overall Study||3
1661600|NCT00674154|4058318|P2|COMPLETED|Overall Study||20
1661601|NCT00674154|4058319|P1|COMPLETED|Overall Study||20
1661602|NCT00674154|4058318|P2|STARTED|Overall Study||23
1661603|NCT00674154|4058319|P1|STARTED|Overall Study||23
1661604|NCT00674128|4058327|P2|NOT COMPLETED|Overall Study||23
1661605|NCT00674128|4058328|P1|NOT COMPLETED|Overall Study||25
1661606|NCT00674128|4058327|P2|COMPLETED|Overall Study||21
1661607|NCT00674128|4058328|P1|COMPLETED|Overall Study||25
1661608|NCT00674128|4058327|P2|STARTED|Overall Study||44
1661609|NCT00674128|4058328|P1|STARTED|Overall Study||50
1661610|NCT00674115|4058334|P4|NOT COMPLETED|Third Intervention||0
1661611|NCT00674115|4058335|P3|NOT COMPLETED|Third Intervention||0
1661612|NCT00674115|4058336|P2|NOT COMPLETED|Third Intervention||0
1661613|NCT00674115|4058337|P1|NOT COMPLETED|Third Intervention||0
1661614|NCT00674115|4058334|P4|COMPLETED|Third Intervention||0
1661615|NCT00674115|4058335|P3|COMPLETED|Third Intervention||0
1661616|NCT00674115|4058336|P2|COMPLETED|Third Intervention||16
1661617|NCT00674115|4058337|P1|COMPLETED|Third Intervention||14
1661618|NCT00674115|4058334|P4|STARTED|Third Intervention||0
1661619|NCT00674115|4058335|P3|STARTED|Third Intervention||0
1661620|NCT00674115|4058336|P2|STARTED|Third Intervention||16
1661621|NCT00674115|4058337|P1|STARTED|Third Intervention||14
1661622|NCT00674115|4058334|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1661623|NCT00674115|4058335|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1661624|NCT00674115|4058336|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1661625|NCT00674115|4058337|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1661626|NCT00674115|4058334|P4|COMPLETED|Washout Period of 2 Weeks||0
1661627|NCT00674115|4058335|P3|COMPLETED|Washout Period of 2 Weeks||0
1661628|NCT00674115|4058336|P2|COMPLETED|Washout Period of 2 Weeks||16
1661629|NCT00674115|4058337|P1|COMPLETED|Washout Period of 2 Weeks||14
1661630|NCT00674115|4058334|P4|STARTED|Washout Period of 2 Weeks||0
1661631|NCT00674115|4058335|P3|STARTED|Washout Period of 2 Weeks||0
1661632|NCT00674115|4058336|P2|STARTED|Washout Period of 2 Weeks||16
1661633|NCT00674115|4058337|P1|STARTED|Washout Period of 2 Weeks||14
1661634|NCT00674115|4058334|P4|NOT COMPLETED|Second Intervention||0
1661635|NCT00674115|4058335|P3|NOT COMPLETED|Second Intervention||0
1661636|NCT00674115|4058336|P2|NOT COMPLETED|Second Intervention||0
1661637|NCT00674115|4058337|P1|NOT COMPLETED|Second Intervention||0
1661638|NCT00674115|4058334|P4|COMPLETED|Second Intervention||16
1661639|NCT00674115|4058335|P3|COMPLETED|Second Intervention||14
1661640|NCT00674115|4058336|P2|COMPLETED|Second Intervention||16
1661641|NCT00674115|4058337|P1|COMPLETED|Second Intervention||14
1661642|NCT00674115|4058334|P4|STARTED|Second Intervention||16
1661643|NCT00674115|4058335|P3|STARTED|Second Intervention||14
1661644|NCT00674115|4058336|P2|STARTED|Second Intervention||16
1661645|NCT00674115|4058337|P1|STARTED|Second Intervention||14
1661646|NCT00674115|4058334|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1661647|NCT00674115|4058335|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1661648|NCT00674115|4058336|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1661649|NCT00674115|4058337|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1661650|NCT00674115|4058334|P4|COMPLETED|Washout Period of 2 Weeks||16
1661651|NCT00674115|4058335|P3|COMPLETED|Washout Period of 2 Weeks||14
1661652|NCT00674115|4058336|P2|COMPLETED|Washout Period of 2 Weeks||16
1661653|NCT00674115|4058337|P1|COMPLETED|Washout Period of 2 Weeks||14
1661654|NCT00674115|4058334|P4|STARTED|Washout Period of 2 Weeks||16
1661655|NCT00674115|4058335|P3|STARTED|Washout Period of 2 Weeks||14
1661656|NCT00674115|4058336|P2|STARTED|Washout Period of 2 Weeks||16
1661657|NCT00674115|4058337|P1|STARTED|Washout Period of 2 Weeks||14
1661658|NCT00674115|4058334|P4|NOT COMPLETED|First Intervention||0
1661659|NCT00674115|4058335|P3|NOT COMPLETED|First Intervention||0
1661660|NCT00674115|4058336|P2|NOT COMPLETED|First Intervention||0
1661661|NCT00674115|4058337|P1|NOT COMPLETED|First Intervention||0
1661662|NCT00674115|4058334|P4|COMPLETED|First Intervention||16
1661663|NCT00674115|4058335|P3|COMPLETED|First Intervention||14
1661664|NCT00674115|4058336|P2|COMPLETED|First Intervention||16
1661665|NCT00674115|4058337|P1|COMPLETED|First Intervention||14
1661666|NCT00674115|4058334|P4|STARTED|First Intervention||16
1661667|NCT00674115|4058335|P3|STARTED|First Intervention||14
1661668|NCT00674115|4058336|P2|STARTED|First Intervention||16
1661669|NCT00674115|4058337|P1|STARTED|First Intervention||14
1661670|NCT00673959|4058346|P2|NOT COMPLETED|Overall Study||0
1661671|NCT00673959|4058347|P1|NOT COMPLETED|Overall Study||0
1661672|NCT00673959|4058346|P2|COMPLETED|Overall Study||10
1661673|NCT00673959|4058347|P1|COMPLETED|Overall Study||10
1661674|NCT00673959|4058346|P2|STARTED|Overall Study||10
1661675|NCT00673959|4058347|P1|STARTED|Overall Study||10
1661676|NCT00673933|4058353|P1|NOT COMPLETED|Overall Study||3
1661677|NCT00673933|4058353|P1|COMPLETED|Overall Study||17
1661678|NCT00673933|4058353|P1|STARTED|Overall Study||20
1661679|NCT00673881|4058369|P1|NOT COMPLETED|Overall Study||1
1661680|NCT00673881|4058369|P1|COMPLETED|Overall Study||24
1661681|NCT00673881|4058369|P1|STARTED|Overall Study||25
1661682|NCT00673855|4058376|P2|NOT COMPLETED|Second Intervention||0
1661683|NCT00673855|4058377|P1|NOT COMPLETED|Second Intervention||0
1661684|NCT00673855|4058376|P2|COMPLETED|Second Intervention||10
1661685|NCT00673855|4058377|P1|COMPLETED|Second Intervention||10
1661686|NCT00673855|4058376|P2|STARTED|Second Intervention||10
1661687|NCT00673855|4058377|P1|STARTED|Second Intervention||10
1661688|NCT00673855|4058376|P2|NOT COMPLETED|First Intervention||0
1661689|NCT00673855|4058377|P1|NOT COMPLETED|First Intervention||0
1661690|NCT00673855|4058376|P2|COMPLETED|First Intervention||10
1661691|NCT00673855|4058377|P1|COMPLETED|First Intervention||10
1661692|NCT00673855|4058376|P2|STARTED|First Intervention||10
1661693|NCT00673855|4058377|P1|STARTED|First Intervention||10
1661694|NCT00673816|4058383|P1|NOT COMPLETED|Overall Study||2
1661695|NCT00673816|4058383|P1|COMPLETED|Overall Study||0
1661696|NCT00673816|4058383|P1|STARTED|Overall Study||2
1661697|NCT00673764|4058390|P2|NOT COMPLETED|Overall Study||0
1661698|NCT00673764|4058391|P1|NOT COMPLETED|Overall Study||0
1661699|NCT00673764|4058390|P2|COMPLETED|Overall Study||24
1661700|NCT00673764|4058391|P1|COMPLETED|Overall Study||24
1661701|NCT00673764|4058390|P2|STARTED|Overall Study||24
1661702|NCT00673764|4058391|P1|STARTED|Overall Study||24
1661703|NCT00673738|4058399|P1|NOT COMPLETED|Overall Study||0
1661704|NCT00673738|4058399|P1|COMPLETED|Overall Study||27
1661705|NCT00673738|4058399|P1|STARTED|Overall Study||27
1661706|NCT00673712|4058407|P2|NOT COMPLETED|Overall Study||0
1661707|NCT00673712|4058408|P1|NOT COMPLETED|Overall Study||0
1661708|NCT00673712|4058407|P2|COMPLETED|Overall Study||326
1661709|NCT00673712|4058408|P1|COMPLETED|Overall Study||321
1661710|NCT00673712|4058407|P2|STARTED|Overall Study||326
1661711|NCT00673712|4058408|P1|STARTED|Overall Study||321
1661712|NCT00673673|4058418|P1|NOT COMPLETED|Overall Study||36
1661713|NCT00673673|4058418|P1|COMPLETED|Overall Study||3
1661714|NCT00673673|4058418|P1|STARTED|Overall Study||39
1661715|NCT00673660|4058424|P1|NOT COMPLETED|Overall Study||107
1661716|NCT00673660|4058424|P1|COMPLETED|Overall Study||268
1661717|NCT00673660|4058424|P1|STARTED|Overall Study||375
1661718|NCT00673595|4058437|P2|NOT COMPLETED|Overall Study||0
1661719|NCT00673595|4058438|P1|NOT COMPLETED|Overall Study||0
1661720|NCT00673595|4058437|P2|COMPLETED|Overall Study||11
1661721|NCT00673595|4058438|P1|COMPLETED|Overall Study||8
1661722|NCT00673595|4058437|P2|STARTED|Overall Study||11
1661723|NCT00673595|4058438|P1|STARTED|Overall Study||8
1661724|NCT00673465|4058446|P12|NOT COMPLETED|Part 2 (India)||0
1661725|NCT00673465|4058447|P11|NOT COMPLETED|Part 2 (India)||0
1661726|NCT00673465|4058448|P10|NOT COMPLETED|Part 2 (India)||0
1661727|NCT00673465|4058449|P9|NOT COMPLETED|Part 2 (India)||0
1661728|NCT00673465|4058450|P8|NOT COMPLETED|Part 2 (India)||0
1661729|NCT00673465|4058451|P7|NOT COMPLETED|Part 2 (India)||0
1661730|NCT00673465|4058452|P6|NOT COMPLETED|Part 2 (India)||0
1661731|NCT00673465|4058453|P5|NOT COMPLETED|Part 2 (India)||0
1661732|NCT00673465|4058454|P4|NOT COMPLETED|Part 2 (India)||0
1661733|NCT00673465|4058455|P3|NOT COMPLETED|Part 2 (India)||0
1661734|NCT00673465|4058456|P2|NOT COMPLETED|Part 2 (India)||0
1661735|NCT00673465|4058457|P1|NOT COMPLETED|Part 2 (India)||0
1661736|NCT00673465|4058446|P12|COMPLETED|Part 2 (India)||0
1661737|NCT00673465|4058447|P11|COMPLETED|Part 2 (India)||0
1661738|NCT00673465|4058448|P10|COMPLETED|Part 2 (India)||0
1661739|NCT00673465|4058449|P9|COMPLETED|Part 2 (India)||0
1661740|NCT00673465|4058450|P8|COMPLETED|Part 2 (India)||0
1661741|NCT00673465|4058451|P7|COMPLETED|Part 2 (India)||0
1661742|NCT00673465|4058452|P6|COMPLETED|Part 2 (India)||0
1661743|NCT00673465|4058453|P5|COMPLETED|Part 2 (India)||0
1661744|NCT00673465|4058454|P4|COMPLETED|Part 2 (India)||0
1661745|NCT00673465|4058455|P3|COMPLETED|Part 2 (India)||0
1661746|NCT00673465|4058456|P2|COMPLETED|Part 2 (India)||0
1661747|NCT00673465|4058457|P1|COMPLETED|Part 2 (India)||0
1661748|NCT00673465|4058446|P12|STARTED|Part 2 (India)||0
1661749|NCT00673465|4058447|P11|STARTED|Part 2 (India)||0
1661750|NCT00673465|4058448|P10|STARTED|Part 2 (India)||0
1661751|NCT00673465|4058449|P9|STARTED|Part 2 (India)||0
1661752|NCT00673465|4058450|P8|STARTED|Part 2 (India)||0
1661753|NCT00673465|4058451|P7|STARTED|Part 2 (India)||0
1661754|NCT00673465|4058452|P6|STARTED|Part 2 (India)||0
1661755|NCT00673465|4058453|P5|STARTED|Part 2 (India)||0
1661756|NCT00673465|4058454|P4|STARTED|Part 2 (India)||0
1661757|NCT00673465|4058455|P3|STARTED|Part 2 (India)||0
1661758|NCT00673465|4058456|P2|STARTED|Part 2 (India)||0
1661759|NCT00673465|4058457|P1|STARTED|Part 2 (India)||0
1661760|NCT00673465|4058446|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661761|NCT00673465|4058447|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661762|NCT00673465|4058448|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661763|NCT00673465|4058449|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661764|NCT00673465|4058450|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661765|NCT00673465|4058451|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661766|NCT00673465|4058452|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661767|NCT00673465|4058453|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661768|NCT00673465|4058454|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661769|NCT00673465|4058455|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661770|NCT00673465|4058456|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661771|NCT00673465|4058457|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
1661772|NCT00673465|4058446|P12|COMPLETED|Part 1/Period 3 (United States)||0
1661773|NCT00673465|4058447|P11|COMPLETED|Part 1/Period 3 (United States)||0
1661774|NCT00673465|4058448|P10|COMPLETED|Part 1/Period 3 (United States)||0
1661775|NCT00673465|4058449|P9|COMPLETED|Part 1/Period 3 (United States)||0
1661776|NCT00673465|4058450|P8|COMPLETED|Part 1/Period 3 (United States)||0
1661777|NCT00673465|4058451|P7|COMPLETED|Part 1/Period 3 (United States)||0
1661778|NCT00673465|4058452|P6|COMPLETED|Part 1/Period 3 (United States)||1
1661779|NCT00673465|4058453|P5|COMPLETED|Part 1/Period 3 (United States)||1
1661780|NCT00673465|4058454|P4|COMPLETED|Part 1/Period 3 (United States)||3
1661781|NCT00673465|4058455|P3|COMPLETED|Part 1/Period 3 (United States)||3
1661782|NCT00673465|4058456|P2|COMPLETED|Part 1/Period 3 (United States)||3
1661783|NCT00673465|4058457|P1|COMPLETED|Part 1/Period 3 (United States)||3
1661784|NCT00673465|4058446|P12|STARTED|Part 1/Period 3 (United States)||0
1661785|NCT00673465|4058447|P11|STARTED|Part 1/Period 3 (United States)||0
1661786|NCT00673465|4058448|P10|STARTED|Part 1/Period 3 (United States)||0
1661787|NCT00673465|4058449|P9|STARTED|Part 1/Period 3 (United States)||0
1661788|NCT00673465|4058450|P8|STARTED|Part 1/Period 3 (United States)||0
1661789|NCT00673465|4058451|P7|STARTED|Part 1/Period 3 (United States)||0
1661790|NCT00673465|4058452|P6|STARTED|Part 1/Period 3 (United States)||1
1661791|NCT00673465|4058453|P5|STARTED|Part 1/Period 3 (United States)||1
1661792|NCT00673465|4058454|P4|STARTED|Part 1/Period 3 (United States)||3
1661793|NCT00673465|4058455|P3|STARTED|Part 1/Period 3 (United States)||3
1661794|NCT00673465|4058456|P2|STARTED|Part 1/Period 3 (United States)||3
1661795|NCT00673465|4058457|P1|STARTED|Part 1/Period 3 (United States)||3
1661796|NCT00673465|4058446|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661797|NCT00673465|4058447|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661798|NCT00673465|4058448|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661799|NCT00673465|4058449|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661800|NCT00673465|4058450|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661801|NCT00673465|4058451|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661802|NCT00673465|4058452|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661803|NCT00673465|4058453|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
1661804|NCT00673465|4058454|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661805|NCT00673465|4058455|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661806|NCT00673465|4058456|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661807|NCT00673465|4058457|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
1661808|NCT00673465|4058446|P12|COMPLETED|Part 1/Period 2 (United States)||0
1661809|NCT00673465|4058447|P11|COMPLETED|Part 1/Period 2 (United States)||0
1661810|NCT00673465|4058448|P10|COMPLETED|Part 1/Period 2 (United States)||0
1661811|NCT00673465|4058449|P9|COMPLETED|Part 1/Period 2 (United States)||0
1661812|NCT00673465|4058450|P8|COMPLETED|Part 1/Period 2 (United States)||0
1661813|NCT00673465|4058451|P7|COMPLETED|Part 1/Period 2 (United States)||0
1661814|NCT00673465|4058452|P6|COMPLETED|Part 1/Period 2 (United States)||1
1661815|NCT00673465|4058453|P5|COMPLETED|Part 1/Period 2 (United States)||1
1661816|NCT00673465|4058454|P4|COMPLETED|Part 1/Period 2 (United States)||3
1661817|NCT00673465|4058455|P3|COMPLETED|Part 1/Period 2 (United States)||3
1661818|NCT00673465|4058456|P2|COMPLETED|Part 1/Period 2 (United States)||3
1661819|NCT00673465|4058457|P1|COMPLETED|Part 1/Period 2 (United States)||3
1661820|NCT00673465|4058446|P12|STARTED|Part 1/Period 2 (United States)||0
1661821|NCT00673465|4058447|P11|STARTED|Part 1/Period 2 (United States)||0
1661822|NCT00673465|4058448|P10|STARTED|Part 1/Period 2 (United States)||0
1661823|NCT00673465|4058449|P9|STARTED|Part 1/Period 2 (United States)||0
1661824|NCT00673465|4058450|P8|STARTED|Part 1/Period 2 (United States)||0
1661825|NCT00673465|4058451|P7|STARTED|Part 1/Period 2 (United States)||0
1661826|NCT00673465|4058452|P6|STARTED|Part 1/Period 2 (United States)||1
1661827|NCT00673465|4058453|P5|STARTED|Part 1/Period 2 (United States)||2
1661828|NCT00673465|4058454|P4|STARTED|Part 1/Period 2 (United States)||3
1661829|NCT00673465|4058455|P3|STARTED|Part 1/Period 2 (United States)||3
1661830|NCT00673465|4058456|P2|STARTED|Part 1/Period 2 (United States)||3
1661831|NCT00673465|4058457|P1|STARTED|Part 1/Period 2 (United States)||3
1661832|NCT00673465|4058446|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661833|NCT00673465|4058447|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661834|NCT00673465|4058448|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661835|NCT00673465|4058449|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661836|NCT00673465|4058450|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661837|NCT00673465|4058451|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661838|NCT00673465|4058452|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
1661839|NCT00673465|4058453|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
1661840|NCT00673465|4058454|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661841|NCT00673465|4058455|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661842|NCT00673465|4058456|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661843|NCT00673465|4058457|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
1661844|NCT00673465|4058446|P12|COMPLETED|Part 1/Period 1 (United States)||0
1661845|NCT00673465|4058447|P11|COMPLETED|Part 1/Period 1 (United States)||0
1661846|NCT00673465|4058448|P10|COMPLETED|Part 1/Period 1 (United States)||0
1661847|NCT00673465|4058449|P9|COMPLETED|Part 1/Period 1 (United States)||0
1661848|NCT00673465|4058450|P8|COMPLETED|Part 1/Period 1 (United States)||0
1661849|NCT00673465|4058451|P7|COMPLETED|Part 1/Period 1 (United States)||0
1661850|NCT00673465|4058452|P6|COMPLETED|Part 1/Period 1 (United States)||1
1661851|NCT00673465|4058453|P5|COMPLETED|Part 1/Period 1 (United States)||2
1661852|NCT00673465|4058454|P4|COMPLETED|Part 1/Period 1 (United States)||3
1661853|NCT00673465|4058455|P3|COMPLETED|Part 1/Period 1 (United States)||3
1661854|NCT00673465|4058456|P2|COMPLETED|Part 1/Period 1 (United States)||3
1661855|NCT00673465|4058457|P1|COMPLETED|Part 1/Period 1 (United States)||3
1661856|NCT00673465|4058446|P12|STARTED|Part 1/Period 1 (United States)||0
1661857|NCT00673465|4058447|P11|STARTED|Part 1/Period 1 (United States)||0
1661858|NCT00673465|4058448|P10|STARTED|Part 1/Period 1 (United States)||0
1661859|NCT00673465|4058449|P9|STARTED|Part 1/Period 1 (United States)||0
1661860|NCT00673465|4058450|P8|STARTED|Part 1/Period 1 (United States)||0
1661861|NCT00673465|4058451|P7|STARTED|Part 1/Period 1 (United States)||0
1661862|NCT00673465|4058452|P6|STARTED|Part 1/Period 1 (United States)||2
1661863|NCT00673465|4058453|P5|STARTED|Part 1/Period 1 (United States)||3
1661864|NCT00673465|4058454|P4|STARTED|Part 1/Period 1 (United States)||3
1661865|NCT00673465|4058455|P3|STARTED|Part 1/Period 1 (United States)||3
1661866|NCT00673465|4058456|P2|STARTED|Part 1/Period 1 (United States)||3
1661867|NCT00673465|4058457|P1|STARTED|Part 1/Period 1 (United States)||3
1661868|NCT00673452|4058506|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
1661869|NCT00673452|4058507|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
1661870|NCT00673452|4058506|P2|COMPLETED|Continuation Double-Blind Phase||153
1661871|NCT00673452|4058507|P1|COMPLETED|Continuation Double-Blind Phase||151
1661872|NCT00673452|4058506|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
1661873|NCT00673452|4058507|P1|STARTED|Continuation Double-Blind Phase||176
1661874|NCT00673452|4058506|P2|NOT COMPLETED|Acute Double-Blind Phase||80
1661875|NCT00673452|4058507|P1|NOT COMPLETED|Acute Double-Blind Phase||87
1661876|NCT00673452|4058506|P2|COMPLETED|Acute Double-Blind Phase||187
1661877|NCT00673452|4058507|P1|COMPLETED|Acute Double-Blind Phase||176
1661878|NCT00673452|4058506|P2|STARTED|Acute Double-Blind Phase||267
1661879|NCT00673452|4058507|P1|STARTED|Acute Double-Blind Phase||263
1661880|NCT00673439|4058541|P1|NOT COMPLETED|Overall Study||0
1661881|NCT00673439|4058541|P1|COMPLETED|Overall Study||3
1661882|NCT00673439|4058541|P1|STARTED|Overall Study||3
1661883|NCT00673400|4058545|P1|NOT COMPLETED|Overall Study||0
1661884|NCT00673400|4058545|P1|COMPLETED|Overall Study||52
1661885|NCT00673400|4058545|P1|STARTED|Overall Study||52
1661886|NCT00673387|4058570|P8|NOT COMPLETED|Overall Study||35
1661887|NCT00673387|4058571|P7|NOT COMPLETED|Overall Study||30
1661888|NCT00673387|4058572|P6|NOT COMPLETED|Overall Study||34
1661889|NCT00673387|4058573|P5|NOT COMPLETED|Overall Study||30
1661890|NCT00673387|4058574|P4|NOT COMPLETED|Overall Study||26
1661891|NCT00673387|4058575|P3|NOT COMPLETED|Overall Study||31
1661892|NCT00673387|4058576|P2|NOT COMPLETED|Overall Study||23
1661893|NCT00673387|4058577|P1|NOT COMPLETED|Overall Study||29
1661894|NCT00673387|4058570|P8|COMPLETED|Overall Study||40
1661895|NCT00673387|4058571|P7|COMPLETED|Overall Study||48
1661896|NCT00673387|4058572|P6|COMPLETED|Overall Study||44
1661897|NCT00673387|4058573|P5|COMPLETED|Overall Study||48
1661898|NCT00673387|4058574|P4|COMPLETED|Overall Study||49
1661899|NCT00673387|4058575|P3|COMPLETED|Overall Study||41
1661900|NCT00673387|4058576|P2|COMPLETED|Overall Study||54
1661901|NCT00673387|4058577|P1|COMPLETED|Overall Study||46
1661902|NCT00673387|4058570|P8|STARTED|Overall Study||75
1661903|NCT00673387|4058571|P7|STARTED|Overall Study||78
1661904|NCT00673387|4058572|P6|STARTED|Overall Study||78
1661905|NCT00673387|4058573|P5|STARTED|Overall Study||78
1661906|NCT00673387|4058574|P4|STARTED|Overall Study||75
1661907|NCT00673387|4058575|P3|STARTED|Overall Study||72
1661908|NCT00673387|4058576|P2|STARTED|Overall Study||77
1661909|NCT00673387|4058577|P1|STARTED|Overall Study||75
1661910|NCT00673361|4058793|P1|NOT COMPLETED|Overall Study||2
1661911|NCT00673361|4058793|P1|COMPLETED|Overall Study||7
1661912|NCT00673361|4058793|P1|STARTED|Overall Study||9
1661913|NCT00673257|4058797|P1|NOT COMPLETED|Overall Study||5
1661914|NCT00673257|4058797|P1|COMPLETED|Overall Study||102
1661915|NCT00673257|4058797|P1|STARTED|Overall Study||107
1661916|NCT00673231|4058806|P4|NOT COMPLETED|Overall Study||18
1661917|NCT00673231|4058807|P3|NOT COMPLETED|Overall Study||26
1661918|NCT00673231|4058808|P2|NOT COMPLETED|Overall Study||22
1661919|NCT00673231|4058809|P1|NOT COMPLETED|Overall Study||29
1661920|NCT00673231|4058806|P4|COMPLETED|Overall Study||178
1661921|NCT00673231|4058807|P3|COMPLETED|Overall Study||186
1661922|NCT00673231|4058808|P2|COMPLETED|Overall Study||180
1661923|NCT00673231|4058809|P1|COMPLETED|Overall Study||168
1661924|NCT00673231|4058806|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
1661925|NCT00673231|4058807|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
1661926|NCT00673231|4058808|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
1661927|NCT00673231|4058809|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
1661928|NCT00673179|4058841|P2|NOT COMPLETED|Overall Study||0
1661929|NCT00673179|4058842|P1|NOT COMPLETED|Overall Study||3
1661930|NCT00673179|4058841|P2|COMPLETED|Overall Study||0
1661931|NCT00673179|4058842|P1|COMPLETED|Overall Study||4
1661932|NCT00673179|4058841|P2|STARTED|Overall Study||0
1661933|NCT00673179|4058842|P1|STARTED|Overall Study||7
1661934|NCT00673153|4058848|P1|NOT COMPLETED|Overall Study||1
1661935|NCT00673153|4058848|P1|COMPLETED|Overall Study||30
1661936|NCT00673153|4058848|P1|STARTED|Overall Study||31
1661937|NCT00673127|4058856|P1|NOT COMPLETED|Overall Study||0
1661938|NCT00673127|4058856|P1|COMPLETED|Overall Study||57
1661939|NCT00673127|4058856|P1|STARTED|Overall Study||57
1661940|NCT00673114|4058861|P1|NOT COMPLETED|Overall Study||0
1661941|NCT00673114|4058861|P1|COMPLETED|Overall Study||3
1661942|NCT00673114|4058861|P1|STARTED|Overall Study||3
1661943|NCT00673075|4058874|P2|NOT COMPLETED|Overall Study||7
1661944|NCT00673075|4058875|P1|NOT COMPLETED|Overall Study||9
1661945|NCT00673075|4058874|P2|COMPLETED|Overall Study||11
1661946|NCT00673075|4058875|P1|COMPLETED|Overall Study||12
1661947|NCT00673075|4058874|P2|STARTED|Overall Study||18
1661948|NCT00673075|4058875|P1|STARTED|Overall Study||21
1661949|NCT00673049|4058891|P4|NOT COMPLETED|After Progression on Erlotinib||83
1661950|NCT00673049|4058892|P3|NOT COMPLETED|After Progression on Erlotinib||0
1661951|NCT00673049|4058893|P2|NOT COMPLETED|After Progression on Erlotinib||0
1661952|NCT00673049|4058894|P1|NOT COMPLETED|After Progression on Erlotinib||0
1661953|NCT00673049|4058891|P4|COMPLETED|After Progression on Erlotinib||0
1661954|NCT00673049|4058892|P3|COMPLETED|After Progression on Erlotinib||0
1661955|NCT00673049|4058893|P2|COMPLETED|After Progression on Erlotinib||0
1661956|NCT00673049|4058894|P1|COMPLETED|After Progression on Erlotinib||0
1661957|NCT00673049|4058891|P4|STARTED|After Progression on Erlotinib||83
1661958|NCT00673049|4058892|P3|STARTED|After Progression on Erlotinib||0
1661959|NCT00673049|4058893|P2|STARTED|After Progression on Erlotinib||0
1661960|NCT00673049|4058894|P1|STARTED|After Progression on Erlotinib||0
1661961|NCT00673049|4058891|P4|NOT COMPLETED|Before Progression on Erlotinib||0
1661962|NCT00673049|4058892|P3|NOT COMPLETED|Before Progression on Erlotinib||1
1661963|NCT00673049|4058893|P2|NOT COMPLETED|Before Progression on Erlotinib||290
1661964|NCT00673049|4058894|P1|NOT COMPLETED|Before Progression on Erlotinib||292
1661965|NCT00673049|4058891|P4|COMPLETED|Before Progression on Erlotinib||0
1661966|NCT00673049|4058892|P3|COMPLETED|Before Progression on Erlotinib||0
1661967|NCT00673049|4058893|P2|COMPLETED|Before Progression on Erlotinib||0
1661968|NCT00673049|4058894|P1|COMPLETED|Before Progression on Erlotinib||0
1661969|NCT00673049|4058891|P4|Treated|Before Progression on Erlotinib||0
1661970|NCT00673049|4058892|P3|Treated|Before Progression on Erlotinib||1
1661971|NCT00673049|4058893|P2|Treated|Before Progression on Erlotinib||289
1661972|NCT00673049|4058894|P1|Treated|Before Progression on Erlotinib||289
1661973|NCT00673049|4058891|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
1661974|NCT00673049|4058892|P3|STARTED|Before Progression on Erlotinib||1
1661975|NCT00673049|4058893|P2|STARTED|Before Progression on Erlotinib||290
1661976|NCT00673049|4058894|P1|STARTED|Before Progression on Erlotinib||292
1661977|NCT00672984|4058918|P3|NOT COMPLETED|Third Intervention||1
1661978|NCT00672984|4058919|P2|NOT COMPLETED|Third Intervention||0
1661979|NCT00672984|4058920|P1|NOT COMPLETED|Third Intervention||1
1661980|NCT00672984|4058918|P3|COMPLETED|Third Intervention||23
1661981|NCT00672984|4058919|P2|COMPLETED|Third Intervention||17
1661982|NCT00672984|4058920|P1|COMPLETED|Third Intervention||21
1661983|NCT00672984|4058918|P3|STARTED|Third Intervention||24
1661984|NCT00672984|4058919|P2|STARTED|Third Intervention||17
1661985|NCT00672984|4058920|P1|STARTED|Third Intervention||22
1661986|NCT00672984|4058918|P3|NOT COMPLETED|Second Intervention||1
1661987|NCT00672984|4058919|P2|NOT COMPLETED|Second Intervention||6
1661988|NCT00672984|4058920|P1|NOT COMPLETED|Second Intervention||0
1661989|NCT00672984|4058918|P3|COMPLETED|Second Intervention||24
1661990|NCT00672984|4058919|P2|COMPLETED|Second Intervention||17
1661991|NCT00672984|4058920|P1|COMPLETED|Second Intervention||22
1661992|NCT00672984|4058918|P3|STARTED|Second Intervention||25
1661993|NCT00672984|4058919|P2|STARTED|Second Intervention||23
1661994|NCT00672984|4058920|P1|STARTED|Second Intervention||22
1661995|NCT00672984|4058918|P3|NOT COMPLETED|First Intervention||2
1661996|NCT00672984|4058919|P2|NOT COMPLETED|First Intervention||2
1661997|NCT00672984|4058920|P1|NOT COMPLETED|First Intervention||9
1661998|NCT00672984|4058918|P3|COMPLETED|First Intervention||25
1661999|NCT00672984|4058919|P2|COMPLETED|First Intervention||23
1662000|NCT00672984|4058920|P1|COMPLETED|First Intervention||22
1662001|NCT00672984|4058918|P3|STARTED|First Intervention||27
1662002|NCT00672984|4058919|P2|STARTED|First Intervention||25
1662003|NCT00672984|4058920|P1|STARTED|First Intervention||31
1662004|NCT00672958|4058971|P2|NOT COMPLETED|Overall Study||56
1662005|NCT00672958|4058972|P1|NOT COMPLETED|Overall Study||64
1662006|NCT00672958|4058971|P2|COMPLETED|Overall Study||244
1662007|NCT00672958|4058972|P1|COMPLETED|Overall Study||236
1662008|NCT00672958|4058971|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
1662009|NCT00672958|4058972|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
1662010|NCT00672958|4058971|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
1662011|NCT00672958|4058972|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
1662012|NCT00672958|4058971|P2|STARTED|Overall Study||300
1662013|NCT00672958|4058972|P1|STARTED|Overall Study||300
1662014|NCT00672932|4059004|P2|NOT COMPLETED|Overall Study||0
1662015|NCT00672932|4059005|P1|NOT COMPLETED|Overall Study||0
1662016|NCT00672932|4059004|P2|COMPLETED|Overall Study||9
1662017|NCT00672932|4059005|P1|COMPLETED|Overall Study||9
1662018|NCT00672932|4059004|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
1662019|NCT00672932|4059005|P1|Rolled Over to Raltegravir|Overall Study||0
1662020|NCT00672932|4059004|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
1662021|NCT00672932|4059005|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
1662022|NCT00672932|4059004|P2|Completed Initial 12-week Assignment|Overall Study||9
1662023|NCT00672932|4059005|P1|Completed Initial 12-week Assignment|Overall Study||9
1662024|NCT00672932|4059004|P2|STARTED|Overall Study||9
1662025|NCT00672932|4059005|P1|STARTED|Overall Study||9
1662026|NCT00672854|4059015|P2|NOT COMPLETED|Overall Study||0
1662027|NCT00672854|4059016|P1|NOT COMPLETED|Overall Study||0
1662028|NCT00672854|4059015|P2|COMPLETED|Overall Study||51
1662029|NCT00672854|4059016|P1|COMPLETED|Overall Study||49
1662030|NCT00672854|4059015|P2|STARTED|Overall Study||51
1662031|NCT00672854|4059016|P1|STARTED|Overall Study||49
1662032|NCT00672841|4059038|P2|NOT COMPLETED|Overall Study||15
1662033|NCT00672841|4059039|P1|NOT COMPLETED|Overall Study||1
1662034|NCT00672841|4059038|P2|COMPLETED|Overall Study||32
1662035|NCT00672841|4059039|P1|COMPLETED|Overall Study||16
1662036|NCT00672841|4059038|P2|STARTED|Overall Study||47
1662037|NCT00672841|4059039|P1|STARTED|Overall Study||17
1662038|NCT00672737|4059051|P1|NOT COMPLETED|Overall Study||8
1662039|NCT00672737|4059051|P1|COMPLETED|Overall Study||48
1662040|NCT00672737|4059051|P1|STARTED|Overall Study||56
1662041|NCT00672646|4059061|P3|NOT COMPLETED|Overall Study||3
1662042|NCT00672646|4059062|P2|NOT COMPLETED|Overall Study||1
1662043|NCT00672646|4059063|P1|NOT COMPLETED|Overall Study||0
1662044|NCT00672646|4059061|P3|COMPLETED|Overall Study||37
1662045|NCT00672646|4059062|P2|COMPLETED|Overall Study||22
1662046|NCT00672646|4059063|P1|COMPLETED|Overall Study||40
1662047|NCT00672646|4059061|P3|STARTED|Overall Study||40
1662048|NCT00672646|4059062|P2|STARTED|Overall Study||23
1662049|NCT00672646|4059063|P1|STARTED|Overall Study||40
1662050|NCT00672633|4059088|P2|NOT COMPLETED|Overall Study||1
1662051|NCT00672633|4059089|P1|NOT COMPLETED|Overall Study||0
1662052|NCT00672633|4059088|P2|COMPLETED|Overall Study||12
1662053|NCT00672633|4059089|P1|COMPLETED|Overall Study||12
1662054|NCT00672633|4059088|P2|STARTED|Overall Study||13
1662055|NCT00672633|4059089|P1|STARTED|Overall Study||12
1662056|NCT00672620|4059103|P4|NOT COMPLETED|Overall Study||42
1662057|NCT00672620|4059104|P3|NOT COMPLETED|Overall Study||31
1662058|NCT00672620|4059105|P2|NOT COMPLETED|Overall Study||54
1662059|NCT00672620|4059106|P1|NOT COMPLETED|Overall Study||33
1662060|NCT00672620|4059103|P4|COMPLETED|Overall Study||110
1662061|NCT00672620|4059104|P3|COMPLETED|Overall Study||122
1662062|NCT00672620|4059105|P2|COMPLETED|Overall Study||99
1662063|NCT00672620|4059106|P1|COMPLETED|Overall Study||120
1662064|NCT00672620|4059103|P4|Treated|Overall Study||150
1662065|NCT00672620|4059104|P3|Treated|Overall Study||153
1662066|NCT00672620|4059105|P2|Treated|Overall Study||149
1662067|NCT00672620|4059106|P1|Treated|Overall Study||151
1662068|NCT00672620|4059103|P4|STARTED|Overall Study||152
1662069|NCT00672620|4059104|P3|STARTED|Overall Study||153
1662070|NCT00672620|4059105|P2|STARTED|Overall Study||153
1662071|NCT00672620|4059106|P1|STARTED|Overall Study||153
1662072|NCT00672594|4059160|P1|NOT COMPLETED|Overall Study||3
1662073|NCT00672594|4059160|P1|COMPLETED|Overall Study||27
1662074|NCT00672594|4059160|P1|STARTED|Overall Study||30
1662075|NCT00672555|4059171|P1|NOT COMPLETED|Overall Study||6
1662076|NCT00672555|4059171|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
1662077|NCT00672555|4059171|P1|STARTED|Overall Study||70
1662078|NCT00672490|4059182|P2|NOT COMPLETED|Overall Study||32
1662079|NCT00672490|4059183|P1|NOT COMPLETED|Overall Study||24
1662080|NCT00672490|4059182|P2|COMPLETED|Overall Study||157
1662081|NCT00672490|4059183|P1|COMPLETED|Overall Study||163
1662082|NCT00672490|4059182|P2|STARTED|Overall Study||189
1662083|NCT00672490|4059183|P1|STARTED|Overall Study||187
1662084|NCT00672477|4059207|P2|NOT COMPLETED|Overall Study||26
1662085|NCT00672477|4059208|P1|NOT COMPLETED|Overall Study||27
1662086|NCT00672477|4059207|P2|COMPLETED|Overall Study||88
1662087|NCT00672477|4059208|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
1662088|NCT00672477|4059207|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
1662089|NCT00672477|4059208|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
1662090|NCT00672451|4059218|P2|NOT COMPLETED|Overall Study||0
1662091|NCT00672451|4059219|P1|NOT COMPLETED|Overall Study||0
1662092|NCT00672451|4059218|P2|COMPLETED|Overall Study||2
1662093|NCT00672451|4059219|P1|COMPLETED|Overall Study||1
1662094|NCT00672451|4059218|P2|STARTED|Overall Study||2
1662095|NCT00672451|4059219|P1|STARTED|Overall Study||1
1662096|NCT00672438|4059229|P2|NOT COMPLETED|Infusion 2||0
1662097|NCT00672438|4059230|P1|NOT COMPLETED|Infusion 2||0
1662098|NCT00672438|4059229|P2|COMPLETED|Infusion 2||118
1662099|NCT00672438|4059230|P1|COMPLETED|Infusion 2||119
1662100|NCT00672438|4059229|P2|STARTED|Infusion 2||118
1662101|NCT00672438|4059230|P1|STARTED|Infusion 2||119
1662102|NCT00672438|4059229|P2|NOT COMPLETED|Washout||0
1662103|NCT00672438|4059230|P1|NOT COMPLETED|Washout||0
1662104|NCT00672438|4059229|P2|COMPLETED|Washout||118
1662105|NCT00672438|4059230|P1|COMPLETED|Washout||119
1662106|NCT00672438|4059229|P2|STARTED|Washout||118
1662107|NCT00672438|4059230|P1|STARTED|Washout||119
1662108|NCT00672438|4059229|P2|NOT COMPLETED|Infusion 1||0
1662109|NCT00672438|4059230|P1|NOT COMPLETED|Infusion 1||0
1662110|NCT00672438|4059229|P2|COMPLETED|Infusion 1||118
1662111|NCT00672438|4059230|P1|COMPLETED|Infusion 1||119
1662112|NCT00672438|4059229|P2|STARTED|Infusion 1||118
1662113|NCT00672438|4059230|P1|STARTED|Infusion 1||119
1662114|NCT00672256|4059261|P1|NOT COMPLETED|Overall Study||44
1662115|NCT00672256|4059261|P1|COMPLETED|Overall Study||18
1662116|NCT00672256|4059261|P1|STARTED|Overall Study|January 2007|62
1662117|NCT00672243|4059268|P1|NOT COMPLETED|Overall Study||0
1662118|NCT00672243|4059268|P1|COMPLETED|Overall Study||32
1662119|NCT00672243|4059268|P1|STARTED|Overall Study||32
1662120|NCT00672204|4059276|P1|NOT COMPLETED|Overall Study||20
1662121|NCT00672204|4059276|P1|COMPLETED|Overall Study||3
1662122|NCT00672204|4059276|P1|STARTED|Overall Study||23
1662123|NCT00672178|4059280|P1|NOT COMPLETED|Overall Study||0
1662124|NCT00672178|4059280|P1|COMPLETED|Overall Study||1
1662125|NCT00672178|4059280|P1|STARTED|Overall Study||1
1662126|NCT00672139|4059286|P2|NOT COMPLETED|Overall Study||45
1662127|NCT00672139|4059287|P1|NOT COMPLETED|Overall Study||30
1662128|NCT00672139|4059286|P2|COMPLETED|Overall Study||47
1662129|NCT00672139|4059287|P1|COMPLETED|Overall Study||27
1662130|NCT00672139|4059286|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
1662131|NCT00672139|4059287|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
1662132|NCT00672100|4059296|P3|NOT COMPLETED|Overall Study||0
1662133|NCT00672100|4059297|P2|NOT COMPLETED|Overall Study||0
1662134|NCT00672100|4059298|P1|NOT COMPLETED|Overall Study||0
1662135|NCT00672100|4059296|P3|COMPLETED|Overall Study||12
1662136|NCT00672100|4059297|P2|COMPLETED|Overall Study||12
1662137|NCT00672100|4059298|P1|COMPLETED|Overall Study||12
1662138|NCT00672100|4059296|P3|PACU (Within 8 Hours)|Overall Study||12
1662139|NCT00672100|4059297|P2|PACU (Within 8 Hours)|Overall Study||12
1662140|NCT00672100|4059298|P1|PACU (Within 8 Hours)|Overall Study||12
1662141|NCT00672100|4059296|P3|STARTED|Overall Study||12
1662142|NCT00672100|4059297|P2|STARTED|Overall Study||12
1662143|NCT00672100|4059298|P1|STARTED|Overall Study||12
1662144|NCT00671970|4059315|P2|NOT COMPLETED|Overall Study||0
1662145|NCT00671970|4059316|P1|NOT COMPLETED|Overall Study||0
1662146|NCT00671970|4059315|P2|COMPLETED|Overall Study||25
1662147|NCT00671970|4059316|P1|COMPLETED|Overall Study||32
1662148|NCT00671970|4059315|P2|STARTED|Overall Study||25
1662149|NCT00671970|4059316|P1|STARTED|Overall Study||32
1662150|NCT00671931|4059344|P5|NOT COMPLETED|Overall Study||1
1662151|NCT00671931|4059345|P4|NOT COMPLETED|Overall Study||2
1662152|NCT00671931|4059346|P3|NOT COMPLETED|Overall Study||0
1662153|NCT00671931|4059347|P2|NOT COMPLETED|Overall Study||0
1662154|NCT00671931|4059348|P1|NOT COMPLETED|Overall Study||1
1662155|NCT00671931|4059344|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
1662156|NCT00671931|4059345|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
1662157|NCT00671931|4059346|P3|COMPLETED|Overall Study|all completed|9
1662158|NCT00671931|4059347|P2|COMPLETED|Overall Study|All completed|8
1662159|NCT00671931|4059348|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
1662160|NCT00671931|4059344|P5|STARTED|Overall Study||8
1662161|NCT00671931|4059345|P4|STARTED|Overall Study||10
1662162|NCT00671931|4059346|P3|STARTED|Overall Study||9
1662163|NCT00671931|4059347|P2|STARTED|Overall Study||8
1662164|NCT00671931|4059348|P1|STARTED|Overall Study||9
1662165|NCT00671918|4059360|P1|NOT COMPLETED|Overall Study||17
1662166|NCT00671918|4059360|P1|COMPLETED|Overall Study||169
1662167|NCT00671918|4059360|P1|STARTED|Overall Study||186
1662168|NCT00671879|4059368|P3|NOT COMPLETED|Overall Study||6
1662169|NCT00671879|4059369|P2|NOT COMPLETED|Overall Study||4
1662170|NCT00671879|4059370|P1|NOT COMPLETED|Overall Study||0
1662171|NCT00671879|4059368|P3|COMPLETED|Overall Study||274
1662172|NCT00671879|4059369|P2|COMPLETED|Overall Study||275
1662173|NCT00671879|4059370|P1|COMPLETED|Overall Study||281
1662174|NCT00671879|4059368|P3|STARTED|Overall Study||280
1662175|NCT00671879|4059369|P2|STARTED|Overall Study||279
1662176|NCT00671879|4059370|P1|STARTED|Overall Study||281
1662177|NCT00671853|4059383|P2|NOT COMPLETED|Overall Study||27
1662178|NCT00671853|4059384|P1|NOT COMPLETED|Overall Study||20
1662179|NCT00671853|4059383|P2|COMPLETED|Overall Study||18
1662180|NCT00671853|4059384|P1|COMPLETED|Overall Study||26
1662181|NCT00671853|4059383|P2|STARTED|Overall Study||45
1662182|NCT00671853|4059384|P1|STARTED|Overall Study||46
1662183|NCT00671788|4059400|P1|NOT COMPLETED|Overall Study||14
1662184|NCT00671788|4059400|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
1662185|NCT00671788|4059400|P1|STARTED|Overall Study||35
1662186|NCT00671749|4059407|P1|NOT COMPLETED|Overall Study||8
1662187|NCT00671749|4059407|P1|COMPLETED|Overall Study||92
1662188|NCT00671749|4059407|P1|STARTED|Overall Study||100
1662189|NCT00671723|4059420|P3|NOT COMPLETED|Overall Study||0
1662190|NCT00671723|4059421|P2|NOT COMPLETED|Overall Study||0
1662191|NCT00671723|4059422|P1|NOT COMPLETED|Overall Study||0
1662192|NCT00671723|4059420|P3|COMPLETED|Overall Study||11
1662193|NCT00671723|4059421|P2|COMPLETED|Overall Study||11
1662194|NCT00671723|4059422|P1|COMPLETED|Overall Study||11
1662195|NCT00671723|4059420|P3|STARTED|Overall Study||11
1662196|NCT00671723|4059421|P2|STARTED|Overall Study||11
1662197|NCT00671723|4059422|P1|STARTED|Overall Study||11
1662198|NCT00671671|4059435|P2|NOT COMPLETED|Overall Study||0
1662199|NCT00671671|4059436|P1|NOT COMPLETED|Overall Study||0
1662200|NCT00671671|4059435|P2|COMPLETED|Overall Study||10
1662201|NCT00671671|4059436|P1|COMPLETED|Overall Study||10
1662202|NCT00671671|4059435|P2|STARTED|Overall Study||10
1662203|NCT00671671|4059436|P1|STARTED|Overall Study||10
1662204|NCT00671606|4059462|P1|NOT COMPLETED|Overall Study||0
1662205|NCT00671606|4059462|P1|COMPLETED|Overall Study||5
1662206|NCT00671606|4059462|P1|STARTED|Overall Study||5
1662207|NCT00671554|4059466|P1|NOT COMPLETED|Overall Study||3
1662208|NCT00671554|4059466|P1|COMPLETED|Overall Study||0
1662209|NCT00671554|4059466|P1|STARTED|Overall Study||3
1662210|NCT00671528|4059474|P3|NOT COMPLETED|Overall Study||0
1662211|NCT00671528|4059475|P2|NOT COMPLETED|Overall Study||0
1662212|NCT00671528|4059476|P1|NOT COMPLETED|Overall Study||0
1662213|NCT00671528|4059474|P3|COMPLETED|Overall Study||1
1662214|NCT00671528|4059475|P2|COMPLETED|Overall Study||1
1662215|NCT00671528|4059476|P1|COMPLETED|Overall Study||1
1662216|NCT00671528|4059474|P3|STARTED|Overall Study||1
1662217|NCT00671528|4059475|P2|STARTED|Overall Study||1
1662218|NCT00671528|4059476|P1|STARTED|Overall Study||1
1662219|NCT00671515|4059487|P1|NOT COMPLETED|Phase 2||4
1662220|NCT00671515|4059487|P1|COMPLETED|Phase 2||9
1662221|NCT00671515|4059487|P1|STARTED|Phase 2||13
1662222|NCT00671515|4059487|P1|NOT COMPLETED|Phase 1||3
1662223|NCT00671515|4059487|P1|COMPLETED|Phase 1||20
1662224|NCT00671515|4059487|P1|STARTED|Phase 1||23
1662225|NCT00671502|4059495|P3|NOT COMPLETED|Overall Study||27
1662226|NCT00671502|4059496|P2|NOT COMPLETED|Overall Study||39
1662227|NCT00671502|4059497|P1|NOT COMPLETED|Overall Study||39
1662228|NCT00671502|4059495|P3|COMPLETED|Overall Study||252
1662229|NCT00671502|4059496|P2|COMPLETED|Overall Study||241
1662230|NCT00671502|4059497|P1|COMPLETED|Overall Study||242
1662231|NCT00671502|4059495|P3|STARTED|Overall Study||279
1662232|NCT00671502|4059496|P2|STARTED|Overall Study||280
1662233|NCT00671502|4059497|P1|STARTED|Overall Study||281
1662234|NCT00671437|4059505|P1|NOT COMPLETED|Overall Study||15
1662235|NCT00671437|4059505|P1|COMPLETED|Overall Study||27
1662236|NCT00671437|4059505|P1|STARTED|Overall Study||42
1662237|NCT00671177|4059526|P2|NOT COMPLETED|Overall Study||1
1662238|NCT00671177|4059527|P1|NOT COMPLETED|Overall Study||2
1662239|NCT00671177|4059526|P2|COMPLETED|Overall Study||114
1662240|NCT00671177|4059527|P1|COMPLETED|Overall Study||112
1662241|NCT00671177|4059526|P2|STARTED|Overall Study||115
1662242|NCT00671177|4059527|P1|STARTED|Overall Study||114
1662243|NCT00671060|4059539|P2|NOT COMPLETED|Overall Study||1
1662244|NCT00671060|4059540|P1|NOT COMPLETED|Overall Study||1
1662245|NCT00671060|4059539|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
1662246|NCT00671060|4059540|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
1662247|NCT00671060|4059539|P2|STARTED|Overall Study||76
1662248|NCT00671060|4059540|P1|STARTED|Overall Study||77
1662249|NCT00671034|4059549|P3|NOT COMPLETED|Overall Study||24
1662250|NCT00671034|4059550|P2|NOT COMPLETED|Overall Study||20
1662251|NCT00671034|4059551|P1|NOT COMPLETED|Overall Study||39
1662252|NCT00671034|4059549|P3|COMPLETED|Overall Study||31
1662253|NCT00671034|4059550|P2|COMPLETED|Overall Study||22
1662254|NCT00671034|4059551|P1|COMPLETED|Overall Study||30
1662255|NCT00671034|4059549|P3|STARTED|Overall Study||55
1662256|NCT00671034|4059550|P2|STARTED|Overall Study||42
1662257|NCT00671034|4059551|P1|STARTED|Overall Study||69
1662258|NCT00670982|4059588|P2|NOT COMPLETED|Overall Study||0
1662259|NCT00670982|4059589|P1|NOT COMPLETED|Overall Study||0
1662260|NCT00670982|4059588|P2|COMPLETED|Overall Study||7
1662261|NCT00670982|4059589|P1|COMPLETED|Overall Study||22
1662262|NCT00670982|4059588|P2|STARTED|Overall Study||7
1662263|NCT00670982|4059589|P1|STARTED|Overall Study||22
1662264|NCT00670956|4059598|P1|NOT COMPLETED|Overall Study||0
1662265|NCT00670956|4059598|P1|COMPLETED|Overall Study||1
1662266|NCT00670956|4059598|P1|STARTED|Overall Study||1
1662267|NCT00670930|4059606|P2|NOT COMPLETED|Overall Study||1
1662268|NCT00670930|4059607|P1|NOT COMPLETED|Overall Study||1
1662269|NCT00670930|4059606|P2|COMPLETED|Overall Study||12
1662270|NCT00670930|4059607|P1|COMPLETED|Overall Study||22
1662271|NCT00670930|4059606|P2|Intent to Treat (ITT) Population|Overall Study||12
1662272|NCT00670930|4059607|P1|Intent to Treat (ITT) Population|Overall Study||23
1662273|NCT00670930|4059606|P2|STARTED|Overall Study||13
1662274|NCT00670930|4059607|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
1662275|NCT00670800|4059623|P2|NOT COMPLETED|Overall Study||2
1662276|NCT00670800|4059624|P1|NOT COMPLETED|Overall Study||0
1662277|NCT00670800|4059623|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
1662278|NCT00670800|4059624|P1|COMPLETED|Overall Study||7
1662279|NCT00670800|4059623|P2|STARTED|Overall Study||7
1662280|NCT00670800|4059624|P1|STARTED|Overall Study||7
1662281|NCT00670774|4059640|P1|NOT COMPLETED|Overall Study||0
1662282|NCT00670774|4059640|P1|COMPLETED|Overall Study||26
1662283|NCT00670774|4059640|P1|STARTED|Overall Study||26
1662284|NCT00670748|4059655|P4|NOT COMPLETED|Overall Study||1
1662285|NCT00670748|4059656|P3|NOT COMPLETED|Overall Study||2
1662286|NCT00670748|4059657|P2|NOT COMPLETED|Overall Study||2
1662287|NCT00670748|4059658|P1|NOT COMPLETED|Overall Study||3
1662288|NCT00670748|4059655|P4|COMPLETED|Overall Study||4
1662289|NCT00670748|4059656|P3|COMPLETED|Overall Study||5
1662290|NCT00670748|4059657|P2|COMPLETED|Overall Study||14
1662291|NCT00670748|4059658|P1|COMPLETED|Overall Study||14
1662292|NCT00670748|4059655|P4|STARTED|Overall Study||5
1662293|NCT00670748|4059656|P3|STARTED|Overall Study||7
1662294|NCT00670748|4059657|P2|STARTED|Overall Study||16
1662295|NCT00670748|4059658|P1|STARTED|Overall Study||17
1662296|NCT00670709|4059678|P2|NOT COMPLETED|Overall Study||0
1662297|NCT00670709|4059679|P1|NOT COMPLETED|Overall Study||0
1662298|NCT00670709|4059678|P2|COMPLETED|Overall Study||15
1662299|NCT00670709|4059679|P1|COMPLETED|Overall Study||27
1662300|NCT00670709|4059678|P2|STARTED|Overall Study||15
1662301|NCT00670709|4059679|P1|STARTED|Overall Study||27
1662302|NCT00670631|4059687|P1|NOT COMPLETED|Overall Study||0
1662303|NCT00670631|4059687|P1|COMPLETED|Overall Study||0
1662304|NCT00670631|4059687|P1|STARTED|Overall Study||0
1662305|NCT00670540|4059693|P1|NOT COMPLETED|Overall Study||3325
1662306|NCT00670540|4059693|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
1662307|NCT00670540|4059693|P1|STARTED|Overall Study||8256
1662308|NCT00670462|4059705|P2|NOT COMPLETED|Overall Study||31
1662309|NCT00670462|4059706|P1|NOT COMPLETED|Overall Study||30
1662310|NCT00670462|4059705|P2|COMPLETED|Overall Study||76
1662311|NCT00670462|4059706|P1|COMPLETED|Overall Study||76
1662312|NCT00670462|4059705|P2|STARTED|Overall Study||107
1662313|NCT00670462|4059706|P1|STARTED|Overall Study||106
1662314|NCT00670449|4059738|P4|NOT COMPLETED|Overall Study||8
1662315|NCT00670449|4059739|P3|NOT COMPLETED|Overall Study||9
1662316|NCT00670449|4059740|P2|NOT COMPLETED|Overall Study||10
1662317|NCT00670449|4059741|P1|NOT COMPLETED|Overall Study||9
1662318|NCT00670449|4059738|P4|COMPLETED|Overall Study||15
1662319|NCT00670449|4059739|P3|COMPLETED|Overall Study||18
1662320|NCT00670449|4059740|P2|COMPLETED|Overall Study||36
1662321|NCT00670449|4059741|P1|COMPLETED|Overall Study||38
1662322|NCT00670449|4059738|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
1662323|NCT00670449|4059739|P3|Switched to 0.5mg (Open Label)|Overall Study||23
1662408|NCT00670007|4059856|P1|NOT COMPLETED|Overall Study||9
1662409|NCT00670007|4059856|P1|COMPLETED|Overall Study||131
1662324|NCT00670449|4059740|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
1662325|NCT00670449|4059741|P1|Switched to 0.5mg (Open Label)|Overall Study||45
1662326|NCT00670449|4059738|P4|STARTED|Overall Study||23
1662327|NCT00670449|4059739|P3|STARTED|Overall Study||27
1662328|NCT00670449|4059740|P2|STARTED|Overall Study||46
1662329|NCT00670449|4059741|P1|STARTED|Overall Study||47
1662330|NCT00670306|4059765|P1|NOT COMPLETED|Overall Study||55
1662331|NCT00670306|4059765|P1|COMPLETED|Overall Study||473
1662332|NCT00670306|4059765|P1|STARTED|Overall Study||528
1662333|NCT00670267|4059769|P1|NOT COMPLETED|Overall Study||1
1662334|NCT00670267|4059769|P1|COMPLETED|Overall Study||9
1662335|NCT00670267|4059769|P1|STARTED|Overall Study||10
1662336|NCT00670241|4059780|P3|NOT COMPLETED|Overall Study||27
1662337|NCT00670241|4059781|P2|NOT COMPLETED|Overall Study||21
1662338|NCT00670241|4059782|P1|NOT COMPLETED|Overall Study||12
1662339|NCT00670241|4059780|P3|COMPLETED|Overall Study||64
1662340|NCT00670241|4059781|P2|COMPLETED|Overall Study||163
1662341|NCT00670241|4059782|P1|COMPLETED|Overall Study||171
1662342|NCT00670241|4059780|P3|STARTED|Overall Study||91
1662343|NCT00670241|4059781|P2|STARTED|Overall Study||184
1662344|NCT00670241|4059782|P1|STARTED|Overall Study||183
1662345|NCT00670228|4059804|P2|NOT COMPLETED|Overall Study||3
1662346|NCT00670228|4059805|P1|NOT COMPLETED|Overall Study||5
1662347|NCT00670228|4059804|P2|COMPLETED|Overall Study||12
1662348|NCT00670228|4059805|P1|COMPLETED|Overall Study||13
1662349|NCT00670228|4059804|P2|STARTED|Overall Study||15
1662350|NCT00670228|4059805|P1|STARTED|Overall Study||18
1662351|NCT00670202|4059819|P2|NOT COMPLETED|Overall Study||0
1662352|NCT00670202|4059820|P1|NOT COMPLETED|Overall Study||0
1662353|NCT00670202|4059819|P2|COMPLETED|Overall Study||0
1662354|NCT00670202|4059820|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
1662355|NCT00670202|4059819|P2|STARTED|Overall Study||0
1662356|NCT00670202|4059820|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
1662357|NCT00670111|4059829|P3|NOT COMPLETED|Six Months to Twelve Months||0
1662358|NCT00670111|4059830|P2|NOT COMPLETED|Six Months to Twelve Months||0
1662359|NCT00670111|4059831|P1|NOT COMPLETED|Six Months to Twelve Months||0
1662360|NCT00670111|4059829|P3|COMPLETED|Six Months to Twelve Months||0
1662361|NCT00670111|4059830|P2|COMPLETED|Six Months to Twelve Months||8
1662362|NCT00670111|4059831|P1|COMPLETED|Six Months to Twelve Months||4
1662363|NCT00670111|4059829|P3|STARTED|Six Months to Twelve Months||0
1662364|NCT00670111|4059830|P2|STARTED|Six Months to Twelve Months||8
1662365|NCT00670111|4059831|P1|STARTED|Six Months to Twelve Months||4
1662366|NCT00670111|4059829|P3|NOT COMPLETED|One Month to Six Months||0
1662367|NCT00670111|4059830|P2|NOT COMPLETED|One Month to Six Months||0
1662368|NCT00670111|4059831|P1|NOT COMPLETED|One Month to Six Months||0
1662369|NCT00670111|4059829|P3|COMPLETED|One Month to Six Months||0
1662370|NCT00670111|4059830|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
1662371|NCT00670111|4059831|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
1662372|NCT00670111|4059829|P3|STARTED|One Month to Six Months||0
1662373|NCT00670111|4059830|P2|STARTED|One Month to Six Months||8
1662374|NCT00670111|4059831|P1|STARTED|One Month to Six Months||4
1662375|NCT00670111|4059829|P3|NOT COMPLETED|One Month Period B||0
1662376|NCT00670111|4059830|P2|NOT COMPLETED|One Month Period B||0
1662377|NCT00670111|4059831|P1|NOT COMPLETED|One Month Period B||0
1662378|NCT00670111|4059829|P3|COMPLETED|One Month Period B||0
1662379|NCT00670111|4059830|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
1662380|NCT00670111|4059831|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
1662381|NCT00670111|4059829|P3|STARTED|One Month Period B||0
1662382|NCT00670111|4059830|P2|STARTED|One Month Period B||8
1662383|NCT00670111|4059831|P1|STARTED|One Month Period B||4
1662384|NCT00670111|4059829|P3|NOT COMPLETED|One Month Period A||0
1662385|NCT00670111|4059830|P2|NOT COMPLETED|One Month Period A||0
1662386|NCT00670111|4059831|P1|NOT COMPLETED|One Month Period A||0
1662387|NCT00670111|4059829|P3|COMPLETED|One Month Period A||0
1662388|NCT00670111|4059830|P2|COMPLETED|One Month Period A||8
1662389|NCT00670111|4059831|P1|COMPLETED|One Month Period A||4
1662390|NCT00670111|4059829|P3|STARTED|One Month Period A||0
1662391|NCT00670111|4059830|P2|STARTED|One Month Period A||8
1662392|NCT00670111|4059831|P1|STARTED|One Month Period A||4
1662393|NCT00670111|4059829|P3|NOT COMPLETED|Enrollment to One Month||19
1662394|NCT00670111|4059830|P2|NOT COMPLETED|Enrollment to One Month||0
1662395|NCT00670111|4059831|P1|NOT COMPLETED|Enrollment to One Month||1
1662396|NCT00670111|4059829|P3|COMPLETED|Enrollment to One Month||0
1662397|NCT00670111|4059830|P2|COMPLETED|Enrollment to One Month||8
1662398|NCT00670111|4059831|P1|COMPLETED|Enrollment to One Month||4
1662399|NCT00670111|4059829|P3|STARTED|Enrollment to One Month||19
1662400|NCT00670111|4059830|P2|STARTED|Enrollment to One Month||8
1662401|NCT00670111|4059831|P1|STARTED|Enrollment to One Month||5
1662402|NCT00670046|4059841|P2|NOT COMPLETED|Overall Study||2
1662403|NCT00670046|4059842|P1|NOT COMPLETED|Overall Study||1
1662404|NCT00670046|4059841|P2|COMPLETED|Overall Study||6
1662405|NCT00670046|4059842|P1|COMPLETED|Overall Study||6
1662406|NCT00670046|4059841|P2|STARTED|Overall Study||8
1662407|NCT00670046|4059842|P1|STARTED|Overall Study||7
1662410|NCT00670007|4059856|P1|STARTED|Overall Study||140
1662411|NCT00669955|4059883|P2|NOT COMPLETED|Overall Study||27
1662412|NCT00669955|4059884|P1|NOT COMPLETED|Overall Study||14
1662413|NCT00669955|4059883|P2|COMPLETED|Overall Study||195
1662414|NCT00669955|4059884|P1|COMPLETED|Overall Study||204
1662415|NCT00669955|4059883|P2|STARTED|Overall Study||222
1662416|NCT00669955|4059884|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
1662417|NCT00669942|4059914|P12|NOT COMPLETED|Healthy Volunteers||0
1662418|NCT00669942|4059915|P11|NOT COMPLETED|Healthy Volunteers||1
1662419|NCT00669942|4059916|P10|NOT COMPLETED|Healthy Volunteers||0
1662420|NCT00669942|4059917|P9|NOT COMPLETED|Healthy Volunteers||0
1662421|NCT00669942|4059918|P8|NOT COMPLETED|Healthy Volunteers||0
1662422|NCT00669942|4059919|P7|NOT COMPLETED|Healthy Volunteers||0
1662423|NCT00669942|4059920|P6|NOT COMPLETED|Healthy Volunteers||0
1662424|NCT00669942|4059921|P5|NOT COMPLETED|Healthy Volunteers||0
1662425|NCT00669942|4059922|P4|NOT COMPLETED|Healthy Volunteers||0
1662426|NCT00669942|4059923|P3|NOT COMPLETED|Healthy Volunteers||0
1662427|NCT00669942|4059924|P2|NOT COMPLETED|Healthy Volunteers||0
1662428|NCT00669942|4059925|P1|NOT COMPLETED|Healthy Volunteers||0
1662429|NCT00669942|4059914|P12|COMPLETED|Healthy Volunteers||2
1662430|NCT00669942|4059915|P11|COMPLETED|Healthy Volunteers||2
1662431|NCT00669942|4059916|P10|COMPLETED|Healthy Volunteers||3
1662432|NCT00669942|4059917|P9|COMPLETED|Healthy Volunteers||0
1662433|NCT00669942|4059918|P8|COMPLETED|Healthy Volunteers||0
1662434|NCT00669942|4059919|P7|COMPLETED|Healthy Volunteers||0
1662435|NCT00669942|4059920|P6|COMPLETED|Healthy Volunteers||0
1662436|NCT00669942|4059921|P5|COMPLETED|Healthy Volunteers||0
1662437|NCT00669942|4059922|P4|COMPLETED|Healthy Volunteers||0
1662438|NCT00669942|4059923|P3|COMPLETED|Healthy Volunteers||0
1662439|NCT00669942|4059924|P2|COMPLETED|Healthy Volunteers||0
1662440|NCT00669942|4059925|P1|COMPLETED|Healthy Volunteers||0
1662441|NCT00669942|4059914|P12|STARTED|Healthy Volunteers||2
1662442|NCT00669942|4059915|P11|STARTED|Healthy Volunteers||3
1662443|NCT00669942|4059916|P10|STARTED|Healthy Volunteers||3
1662444|NCT00669942|4059917|P9|STARTED|Healthy Volunteers||0
1662445|NCT00669942|4059918|P8|STARTED|Healthy Volunteers||0
1662446|NCT00669942|4059919|P7|STARTED|Healthy Volunteers||0
1662447|NCT00669942|4059920|P6|STARTED|Healthy Volunteers||0
1662448|NCT00669942|4059921|P5|STARTED|Healthy Volunteers||0
1662449|NCT00669942|4059922|P4|STARTED|Healthy Volunteers||0
1662450|NCT00669942|4059923|P3|STARTED|Healthy Volunteers||0
1662451|NCT00669942|4059924|P2|STARTED|Healthy Volunteers||0
1662452|NCT00669942|4059925|P1|STARTED|Healthy Volunteers||0
1662453|NCT00669942|4059914|P12|NOT COMPLETED|Parts 2 and 3||0
1662454|NCT00669942|4059915|P11|NOT COMPLETED|Parts 2 and 3||0
1662455|NCT00669942|4059916|P10|NOT COMPLETED|Parts 2 and 3||0
1662456|NCT00669942|4059917|P9|NOT COMPLETED|Parts 2 and 3||3
1662457|NCT00669942|4059918|P8|NOT COMPLETED|Parts 2 and 3||2
1662458|NCT00669942|4059919|P7|NOT COMPLETED|Parts 2 and 3||0
1662459|NCT00669942|4059920|P6|NOT COMPLETED|Parts 2 and 3||2
1662460|NCT00669942|4059921|P5|NOT COMPLETED|Parts 2 and 3||0
1662461|NCT00669942|4059922|P4|NOT COMPLETED|Parts 2 and 3||0
1662462|NCT00669942|4059923|P3|NOT COMPLETED|Parts 2 and 3||0
1662463|NCT00669942|4059924|P2|NOT COMPLETED|Parts 2 and 3||0
1662464|NCT00669942|4059925|P1|NOT COMPLETED|Parts 2 and 3||0
1662465|NCT00669942|4059914|P12|COMPLETED|Parts 2 and 3||0
1662466|NCT00669942|4059915|P11|COMPLETED|Parts 2 and 3||0
1662467|NCT00669942|4059916|P10|COMPLETED|Parts 2 and 3||0
1662468|NCT00669942|4059917|P9|COMPLETED|Parts 2 and 3||23
1662469|NCT00669942|4059918|P8|COMPLETED|Parts 2 and 3||24
1662470|NCT00669942|4059919|P7|COMPLETED|Parts 2 and 3||6
1662471|NCT00669942|4059920|P6|COMPLETED|Parts 2 and 3||4
1662472|NCT00669942|4059921|P5|COMPLETED|Parts 2 and 3||0
1662473|NCT00669942|4059922|P4|COMPLETED|Parts 2 and 3||0
1662474|NCT00669942|4059923|P3|COMPLETED|Parts 2 and 3||0
1662475|NCT00669942|4059924|P2|COMPLETED|Parts 2 and 3||0
1662476|NCT00669942|4059925|P1|COMPLETED|Parts 2 and 3||0
1662477|NCT00669942|4059914|P12|STARTED|Parts 2 and 3||0
1662478|NCT00669942|4059915|P11|STARTED|Parts 2 and 3||0
1662479|NCT00669942|4059916|P10|STARTED|Parts 2 and 3||0
1662480|NCT00669942|4059917|P9|STARTED|Parts 2 and 3||26
1662481|NCT00669942|4059918|P8|STARTED|Parts 2 and 3||26
1662482|NCT00669942|4059919|P7|STARTED|Parts 2 and 3||6
1662483|NCT00669942|4059920|P6|STARTED|Parts 2 and 3||6
1662484|NCT00669942|4059921|P5|STARTED|Parts 2 and 3||0
1662485|NCT00669942|4059922|P4|STARTED|Parts 2 and 3||0
1662486|NCT00669942|4059923|P3|STARTED|Parts 2 and 3||0
1662487|NCT00669942|4059924|P2|STARTED|Parts 2 and 3||0
1662488|NCT00669942|4059925|P1|STARTED|Parts 2 and 3||0
1662489|NCT00669942|4059914|P12|NOT COMPLETED|Part 1||0
1662490|NCT00669942|4059915|P11|NOT COMPLETED|Part 1||0
1662491|NCT00669942|4059916|P10|NOT COMPLETED|Part 1||0
1662492|NCT00669942|4059917|P9|NOT COMPLETED|Part 1||0
1662493|NCT00669942|4059918|P8|NOT COMPLETED|Part 1||0
1662494|NCT00669942|4059919|P7|NOT COMPLETED|Part 1||0
1662495|NCT00669942|4059920|P6|NOT COMPLETED|Part 1||0
1662496|NCT00669942|4059921|P5|NOT COMPLETED|Part 1||0
1662497|NCT00669942|4059922|P4|NOT COMPLETED|Part 1||0
1662498|NCT00669942|4059923|P3|NOT COMPLETED|Part 1||0
1662499|NCT00669942|4059924|P2|NOT COMPLETED|Part 1||0
1662500|NCT00669942|4059925|P1|NOT COMPLETED|Part 1||0
1662501|NCT00669942|4059914|P12|COMPLETED|Part 1||0
1662502|NCT00669942|4059915|P11|COMPLETED|Part 1||0
1662503|NCT00669942|4059916|P10|COMPLETED|Part 1||0
1662504|NCT00669942|4059917|P9|COMPLETED|Part 1||0
1662505|NCT00669942|4059918|P8|COMPLETED|Part 1||0
1662506|NCT00669942|4059919|P7|COMPLETED|Part 1||0
1662507|NCT00669942|4059920|P6|COMPLETED|Part 1||0
1662508|NCT00669942|4059921|P5|COMPLETED|Part 1||8
1662509|NCT00669942|4059922|P4|COMPLETED|Part 1||6
1662510|NCT00669942|4059923|P3|COMPLETED|Part 1||6
1662511|NCT00669942|4059924|P2|COMPLETED|Part 1||6
1662512|NCT00669942|4059925|P1|COMPLETED|Part 1||6
1662513|NCT00669942|4059914|P12|STARTED|Part 1||0
1662514|NCT00669942|4059915|P11|STARTED|Part 1||0
1662515|NCT00669942|4059916|P10|STARTED|Part 1||0
1662516|NCT00669942|4059917|P9|STARTED|Part 1||0
1662517|NCT00669942|4059918|P8|STARTED|Part 1||0
1662518|NCT00669942|4059919|P7|STARTED|Part 1||0
1662519|NCT00669942|4059920|P6|STARTED|Part 1||0
1662520|NCT00669942|4059921|P5|STARTED|Part 1||8
1662521|NCT00669942|4059922|P4|STARTED|Part 1||6
1662522|NCT00669942|4059923|P3|STARTED|Part 1||6
1662523|NCT00669942|4059924|P2|STARTED|Part 1||6
1662524|NCT00669942|4059925|P1|STARTED|Part 1||6
1662525|NCT00669916|4059989|P2|NOT COMPLETED|Overall Study||0
1662526|NCT00669916|4059990|P1|NOT COMPLETED|Overall Study||0
1662527|NCT00669916|4059989|P2|COMPLETED|Overall Study||18
1662528|NCT00669916|4059990|P1|COMPLETED|Overall Study||18
1662529|NCT00669916|4059989|P2|STARTED|Overall Study||18
1662530|NCT00669916|4059990|P1|STARTED|Overall Study||18
1662531|NCT00669903|4060008|P4|NOT COMPLETED|Overall Study||4
1662532|NCT00669903|4060009|P3|NOT COMPLETED|Overall Study||5
1662533|NCT00669903|4060010|P2|NOT COMPLETED|Overall Study||5
1662534|NCT00669903|4060011|P1|NOT COMPLETED|Overall Study||1
1662535|NCT00669903|4060008|P4|COMPLETED|Overall Study||18
1662536|NCT00669903|4060009|P3|COMPLETED|Overall Study||13
1662537|NCT00669903|4060010|P2|COMPLETED|Overall Study||32
1662538|NCT00669903|4060011|P1|COMPLETED|Overall Study||22
1662539|NCT00669903|4060008|P4|Completed Treatment Period|Overall Study||19
1662540|NCT00669903|4060009|P3|Completed Treatment Period|Overall Study||13
1662541|NCT00669903|4060010|P2|Completed Treatment Period|Overall Study||33
1662542|NCT00669903|4060011|P1|Completed Treatment Period|Overall Study||23
1662543|NCT00669903|4060008|P4|STARTED|Overall Study||22
1662544|NCT00669903|4060009|P3|STARTED|Overall Study||18
1662545|NCT00669903|4060010|P2|STARTED|Overall Study||37
1662546|NCT00669903|4060011|P1|STARTED|Overall Study||23
1662547|NCT00669877|4060041|P1|NOT COMPLETED|Overall Study||4
1662548|NCT00669877|4060041|P1|COMPLETED|Overall Study||52
1662549|NCT00669877|4060041|P1|STARTED|Overall Study||56
1662550|NCT00669864|4060046|P1|NOT COMPLETED|Overall Study||9
1662551|NCT00669864|4060046|P1|COMPLETED|Overall Study||284
1662552|NCT00669864|4060046|P1|STARTED|Overall Study||293
1662553|NCT00669682|4060055|P1|NOT COMPLETED|Overall Study||0
1662554|NCT00669682|4060055|P1|COMPLETED|Overall Study||9
1662555|NCT00669682|4060055|P1|STARTED|Overall Study||9
1662556|NCT00669669|4060060|P1|NOT COMPLETED|Overall Study||1
1662557|NCT00669669|4060060|P1|COMPLETED|Overall Study||11
1662558|NCT00669669|4060060|P1|STARTED|Overall Study||12
1662559|NCT00669617|4060065|P5|NOT COMPLETED|Period 5||0
1662560|NCT00669617|4060066|P4|NOT COMPLETED|Period 5||0
1662561|NCT00669617|4060067|P3|NOT COMPLETED|Period 5||0
1662562|NCT00669617|4060068|P2|NOT COMPLETED|Period 5||0
1662563|NCT00669617|4060069|P1|NOT COMPLETED|Period 5||0
1662564|NCT00669617|4060065|P5|COMPLETED|Period 5||17
1662565|NCT00669617|4060066|P4|COMPLETED|Period 5||18
1662566|NCT00669617|4060067|P3|COMPLETED|Period 5||17
1662567|NCT00669617|4060068|P2|COMPLETED|Period 5||17
1662568|NCT00669617|4060069|P1|COMPLETED|Period 5||17
1662569|NCT00669617|4060065|P5|STARTED|Period 5||17
1662570|NCT00669617|4060066|P4|STARTED|Period 5||18
1662571|NCT00669617|4060067|P3|STARTED|Period 5||17
1662572|NCT00669617|4060068|P2|STARTED|Period 5||17
1662573|NCT00669617|4060069|P1|STARTED|Period 5||17
1662574|NCT00669617|4060065|P5|NOT COMPLETED|Period 4||0
1662575|NCT00669617|4060066|P4|NOT COMPLETED|Period 4||0
1662576|NCT00669617|4060067|P3|NOT COMPLETED|Period 4||0
1662577|NCT00669617|4060068|P2|NOT COMPLETED|Period 4||0
1662578|NCT00669617|4060069|P1|NOT COMPLETED|Period 4||0
1662579|NCT00669617|4060065|P5|COMPLETED|Period 4||17
1662580|NCT00669617|4060066|P4|COMPLETED|Period 4||18
1662581|NCT00669617|4060067|P3|COMPLETED|Period 4||17
1662582|NCT00669617|4060068|P2|COMPLETED|Period 4||17
1662583|NCT00669617|4060069|P1|COMPLETED|Period 4||17
1662584|NCT00669617|4060065|P5|STARTED|Period 4||17
1662585|NCT00669617|4060066|P4|STARTED|Period 4||18
1662586|NCT00669617|4060067|P3|STARTED|Period 4||17
1662587|NCT00669617|4060068|P2|STARTED|Period 4||17
1662588|NCT00669617|4060069|P1|STARTED|Period 4||17
1662589|NCT00669617|4060065|P5|NOT COMPLETED|Period 3||0
1662590|NCT00669617|4060066|P4|NOT COMPLETED|Period 3||0
1662591|NCT00669617|4060067|P3|NOT COMPLETED|Period 3||0
1662592|NCT00669617|4060068|P2|NOT COMPLETED|Period 3||0
1662593|NCT00669617|4060069|P1|NOT COMPLETED|Period 3||1
1662594|NCT00669617|4060065|P5|COMPLETED|Period 3||17
1662595|NCT00669617|4060066|P4|COMPLETED|Period 3||18
1662596|NCT00669617|4060067|P3|COMPLETED|Period 3||17
1662597|NCT00669617|4060068|P2|COMPLETED|Period 3||17
1662598|NCT00669617|4060069|P1|COMPLETED|Period 3||17
1662599|NCT00669617|4060065|P5|STARTED|Period 3||17
1662600|NCT00669617|4060066|P4|STARTED|Period 3||18
1662601|NCT00669617|4060067|P3|STARTED|Period 3||17
1662602|NCT00669617|4060068|P2|STARTED|Period 3||17
1662603|NCT00669617|4060069|P1|STARTED|Period 3||18
1662604|NCT00669617|4060065|P5|NOT COMPLETED|Period 2||0
1662605|NCT00669617|4060066|P4|NOT COMPLETED|Period 2||0
1662606|NCT00669617|4060067|P3|NOT COMPLETED|Period 2||0
1662607|NCT00669617|4060068|P2|NOT COMPLETED|Period 2||0
1662608|NCT00669617|4060069|P1|NOT COMPLETED|Period 2||0
1662609|NCT00669617|4060065|P5|COMPLETED|Period 2||17
1662610|NCT00669617|4060066|P4|COMPLETED|Period 2||18
1662611|NCT00669617|4060067|P3|COMPLETED|Period 2||17
1662612|NCT00669617|4060068|P2|COMPLETED|Period 2||17
1662613|NCT00669617|4060069|P1|COMPLETED|Period 2||18
1662614|NCT00669617|4060065|P5|STARTED|Period 2||17
1662615|NCT00669617|4060066|P4|STARTED|Period 2||18
1662616|NCT00669617|4060067|P3|STARTED|Period 2||17
1662617|NCT00669617|4060068|P2|STARTED|Period 2||17
1662618|NCT00669617|4060069|P1|STARTED|Period 2||18
1662619|NCT00669617|4060065|P5|NOT COMPLETED|Period 1||1
1662620|NCT00669617|4060066|P4|NOT COMPLETED|Period 1||0
1662621|NCT00669617|4060067|P3|NOT COMPLETED|Period 1||1
1662622|NCT00669617|4060068|P2|NOT COMPLETED|Period 1||0
1662623|NCT00669617|4060069|P1|NOT COMPLETED|Period 1||0
1662624|NCT00669617|4060065|P5|COMPLETED|Period 1||17
1662625|NCT00669617|4060066|P4|COMPLETED|Period 1||18
1662626|NCT00669617|4060067|P3|COMPLETED|Period 1||17
1662627|NCT00669617|4060068|P2|COMPLETED|Period 1||17
1662628|NCT00669617|4060069|P1|COMPLETED|Period 1||18
1662629|NCT00669617|4060065|P5|STARTED|Period 1||18
1662630|NCT00669617|4060066|P4|STARTED|Period 1||18
1662631|NCT00669617|4060067|P3|STARTED|Period 1||18
1662632|NCT00669617|4060068|P2|STARTED|Period 1||17
1662633|NCT00669617|4060069|P1|STARTED|Period 1||18
1662634|NCT00669578|4060083|P2|NOT COMPLETED|Overall Study||0
1662635|NCT00669578|4060084|P1|NOT COMPLETED|Overall Study||0
1662636|NCT00669578|4060083|P2|COMPLETED|Overall Study||65
1662637|NCT00669578|4060084|P1|COMPLETED|Overall Study||12
1662638|NCT00669578|4060083|P2|STARTED|Overall Study||65
1662639|NCT00669578|4060084|P1|STARTED|Overall Study||12
1662640|NCT00669552|4060097|P1|NOT COMPLETED|Overall Study||0
1662641|NCT00669552|4060097|P1|COMPLETED|Overall Study||11
1662642|NCT00669552|4060097|P1|STARTED|Overall Study||11
1662643|NCT00669539|4060103|P2|NOT COMPLETED|Overall Study||9
1662644|NCT00669539|4060104|P1|NOT COMPLETED|Overall Study||8
1662645|NCT00669539|4060103|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
1662646|NCT00669539|4060104|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
1662647|NCT00669539|4060103|P2|STARTED|Overall Study||52
1662648|NCT00669539|4060104|P1|STARTED|Overall Study||94
1662649|NCT00669461|4060110|P1|NOT COMPLETED|Overall Study||0
1662650|NCT00669461|4060110|P1|COMPLETED|Overall Study||1
1662651|NCT00669461|4060110|P1|STARTED|Overall Study||1
1662652|NCT00669396|4060117|P2|NOT COMPLETED|Overall Study||12
1662653|NCT00669396|4060118|P1|NOT COMPLETED|Overall Study||10
1662654|NCT00669396|4060117|P2|COMPLETED|Overall Study||22
1662655|NCT00669396|4060118|P1|COMPLETED|Overall Study||13
1662656|NCT00669396|4060117|P2|STARTED|Overall Study||34
1662657|NCT00669396|4060118|P1|STARTED|Overall Study||23
1662658|NCT00669331|4060132|P2|NOT COMPLETED|Blinded Treatment Period||39
1662659|NCT00669331|4060133|P1|NOT COMPLETED|Blinded Treatment Period||42
1662660|NCT00669331|4060132|P2|COMPLETED|Blinded Treatment Period||189
1662661|NCT00669331|4060133|P1|COMPLETED|Blinded Treatment Period||191
1662662|NCT00669331|4060132|P2|STARTED|Blinded Treatment Period||228
1662663|NCT00669331|4060133|P1|STARTED|Blinded Treatment Period||233
1662664|NCT00669331|4060132|P2|NOT COMPLETED|Randomisation to First Dose||13
1662665|NCT00669331|4060133|P1|NOT COMPLETED|Randomisation to First Dose||11
1662666|NCT00669331|4060132|P2|COMPLETED|Randomisation to First Dose||228
1662667|NCT00669331|4060133|P1|COMPLETED|Randomisation to First Dose||233
1662668|NCT00669331|4060132|P2|STARTED|Randomisation to First Dose||241
1662669|NCT00669331|4060133|P1|STARTED|Randomisation to First Dose||244
1662670|NCT00669318|4060175|P1|NOT COMPLETED|Overall Study||2
1662671|NCT00669318|4060175|P1|COMPLETED|Overall Study||39
1662672|NCT00669318|4060175|P1|STARTED|Overall Study||41
1662673|NCT00669279|4060185|P2|NOT COMPLETED|Overall Study||0
1662674|NCT00669279|4060186|P1|NOT COMPLETED|Overall Study||0
1662675|NCT00669279|4060185|P2|COMPLETED|Overall Study||19
1662676|NCT00669279|4060186|P1|COMPLETED|Overall Study||22
1662677|NCT00669279|4060185|P2|STARTED|Overall Study||19
1662678|NCT00669279|4060186|P1|STARTED|Overall Study||22
1662679|NCT00669240|4060192|P1|NOT COMPLETED|Overall Study||165
1662680|NCT00669240|4060192|P1|COMPLETED|Overall Study||402
1662681|NCT00669240|4060192|P1|Received Treatment|Overall Study||551
1662682|NCT00669240|4060192|P1|Assigned to Treatment|Overall Study||566
1662683|NCT00669240|4060192|P1|STARTED|Overall Study||567
1662684|NCT00669214|4060208|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
1662685|NCT00669214|4060209|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
1662686|NCT00669214|4060208|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
1662687|NCT00669214|4060209|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
1662688|NCT00669214|4060208|P2|STARTED|Open-Label Treatment Period (Week 24)||55
1662689|NCT00669214|4060209|P1|STARTED|Open-Label Treatment Period (Week 24)||22
1662690|NCT00669214|4060208|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
1662691|NCT00669214|4060209|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
1662692|NCT00669214|4060208|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
1662693|NCT00669214|4060209|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
1662694|NCT00669214|4060208|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
1662695|NCT00669214|4060209|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
1662696|NCT00669110|4060243|P2|NOT COMPLETED|Overall Study||13
1662697|NCT00669110|4060244|P1|NOT COMPLETED|Overall Study||8
1662698|NCT00669110|4060243|P2|COMPLETED|Overall Study||7
1662699|NCT00669110|4060244|P1|COMPLETED|Overall Study||12
1662700|NCT00669110|4060243|P2|STARTED|Overall Study||20
1662701|NCT00669110|4060244|P1|STARTED|Overall Study||20
1662702|NCT00669071|4060280|P1|NOT COMPLETED|Overall Study||4
1662703|NCT00669071|4060280|P1|COMPLETED|Overall Study||52
1662704|NCT00669071|4060280|P1|STARTED|Overall Study||56
1662705|NCT00669032|4060301|P2|NOT COMPLETED|Overall Study||59
1662706|NCT00669032|4060302|P1|NOT COMPLETED|Overall Study||44
1662707|NCT00669032|4060301|P2|COMPLETED|Overall Study||94
1662708|NCT00669032|4060302|P1|COMPLETED|Overall Study||109
1662709|NCT00669032|4060301|P2|STARTED|Overall Study||153
1662710|NCT00669032|4060302|P1|STARTED|Overall Study||153
1662711|NCT00669019|4060330|P1|NOT COMPLETED|Overall Study||0
1662712|NCT00669019|4060330|P1|COMPLETED|Overall Study||23
1662713|NCT00669019|4060330|P1|STARTED|Overall Study||23
1662714|NCT00668902|4060338|P3|NOT COMPLETED|Overall Study||0
1662715|NCT00668902|4060339|P2|NOT COMPLETED|Overall Study||0
1662716|NCT00668902|4060340|P1|NOT COMPLETED|Overall Study||0
1662717|NCT00668902|4060338|P3|COMPLETED|Overall Study||5
1662718|NCT00668902|4060339|P2|COMPLETED|Overall Study||10
1662719|NCT00668902|4060340|P1|COMPLETED|Overall Study||10
1662720|NCT00668902|4060338|P3|STARTED|Overall Study||5
1662721|NCT00668902|4060339|P2|STARTED|Overall Study||10
1662722|NCT00668902|4060340|P1|STARTED|Overall Study||10
1662723|NCT00668863|4060348|P1|NOT COMPLETED|Overall Study||71
1662724|NCT00668863|4060348|P1|COMPLETED|Overall Study||0
1662725|NCT00668863|4060348|P1|STARTED|Overall Study||71
1662726|NCT00668811|4060367|P1|NOT COMPLETED|Overall Study||0
1662727|NCT00668811|4060367|P1|COMPLETED|Overall Study||23
1662728|NCT00668811|4060367|P1|STARTED|Overall Study||23
1662729|NCT00668785|4060372|P1|NOT COMPLETED|Overall Study||0
1662730|NCT00668785|4060372|P1|COMPLETED|Overall Study||6
1662731|NCT00668785|4060372|P1|STARTED|Overall Study||6
1662732|NCT00668746|4060380|P2|NOT COMPLETED|Overall Study||1
1662733|NCT00668746|4060381|P1|NOT COMPLETED|Overall Study||2
1662734|NCT00668746|4060380|P2|COMPLETED|Overall Study||11
1662735|NCT00668746|4060381|P1|COMPLETED|Overall Study||21
1662736|NCT00668746|4060380|P2|STARTED|Overall Study||12
1662737|NCT00668746|4060381|P1|STARTED|Overall Study||23
1662738|NCT00668733|4060401|P2|NOT COMPLETED|Overall Study||7
1662739|NCT00668733|4060402|P1|NOT COMPLETED|Overall Study||2
1662740|NCT00668733|4060401|P2|COMPLETED|Overall Study||83
1662741|NCT00668733|4060402|P1|COMPLETED|Overall Study||87
1662742|NCT00668733|4060401|P2|STARTED|Overall Study||90
1662743|NCT00668733|4060402|P1|STARTED|Overall Study||89
1662744|NCT00668564|4060408|P1|NOT COMPLETED|Overall Study||0
1662745|NCT00668564|4060408|P1|COMPLETED|Overall Study||18
1662746|NCT00668564|4060408|P1|STARTED|Overall Study||18
1662747|NCT00668525|4060416|P3|NOT COMPLETED|Overall Study||53
1662748|NCT00668525|4060417|P2|NOT COMPLETED|Overall Study||93
1662749|NCT00668525|4060418|P1|NOT COMPLETED|Overall Study||77
1662750|NCT00668525|4060416|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
1662751|NCT00668525|4060417|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
1662752|NCT00668525|4060418|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
1662753|NCT00668525|4060416|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
1662754|NCT00668525|4060417|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
1662755|NCT00668525|4060418|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
1662756|NCT00668434|4060431|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
1662757|NCT00668434|4060432|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
1662758|NCT00668434|4060431|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
1662759|NCT00668434|4060432|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
1662760|NCT00668434|4060431|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
1662761|NCT00668434|4060432|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
1662762|NCT00668434|4060431|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
1662763|NCT00668434|4060432|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
1662764|NCT00668434|4060431|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
1662765|NCT00668434|4060432|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
1662766|NCT00668434|4060431|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
1662767|NCT00668434|4060432|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
1662768|NCT00668395|4060447|P3|NOT COMPLETED|Overall Study||1
1662769|NCT00668395|4060448|P2|NOT COMPLETED|Overall Study||6
1662770|NCT00668395|4060449|P1|NOT COMPLETED|Overall Study||6
1662771|NCT00668395|4060447|P3|COMPLETED|Overall Study||5
1662772|NCT00668395|4060448|P2|COMPLETED|Overall Study||16
1662773|NCT00668395|4060449|P1|COMPLETED|Overall Study||39
1662774|NCT00668395|4060447|P3|STARTED|Overall Study||6
1662775|NCT00668395|4060448|P2|STARTED|Overall Study||22
1662776|NCT00668395|4060449|P1|STARTED|Overall Study||45
1662777|NCT00668382|4060457|P1|NOT COMPLETED|Overall Study||0
1662778|NCT00668382|4060457|P1|COMPLETED|Overall Study||11
1662779|NCT00668382|4060457|P1|STARTED|Overall Study|beginning of trial|11
1662780|NCT00668317|4060461|P1|NOT COMPLETED|Overall Study||2
1662781|NCT00668317|4060461|P1|COMPLETED|Overall Study||3
1662782|NCT00668317|4060461|P1|STARTED|Overall Study||5
1662783|NCT00668265|4060467|P2|NOT COMPLETED|Overall Study||5
1662784|NCT00668265|4060468|P1|NOT COMPLETED|Overall Study||9
1662785|NCT00668265|4060467|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
1662786|NCT00668265|4060468|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
1662787|NCT00668265|4060467|P2|STARTED|Overall Study||5
1662788|NCT00668265|4060468|P1|STARTED|Overall Study||9
1662789|NCT00668200|4060476|P1|NOT COMPLETED|Overall Study||3
1662790|NCT00668200|4060476|P1|COMPLETED|Overall Study||77
1662791|NCT00668200|4060476|P1|Intent to Treat (ITT)|Overall Study||80
1662792|NCT00668200|4060476|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
1662793|NCT00668200|4060476|P1|STARTED|Overall Study||80
1662794|NCT00668148|4060482|P1|NOT COMPLETED|Overall Study||10
1662795|NCT00668148|4060482|P1|COMPLETED|Overall Study||103
1662796|NCT00668148|4060482|P1|Received at Least 1 Dose of Study Drug|Overall Study||111
1662797|NCT00668148|4060482|P1|STARTED|Overall Study||113
1662798|NCT00667992|4060521|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
1662799|NCT00667992|4060522|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
1662800|NCT00667992|4060521|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
1662801|NCT00667992|4060522|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
1662802|NCT00667992|4060521|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
1662803|NCT00667992|4060522|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
1662804|NCT00667992|4060521|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
1662805|NCT00667992|4060522|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
1662806|NCT00667992|4060521|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
1662807|NCT00667992|4060522|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
1662808|NCT00667992|4060521|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
1662809|NCT00667992|4060522|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
1662810|NCT00667992|4060521|P2|NOT COMPLETED|Wash-out||5
1662811|NCT00667992|4060522|P1|NOT COMPLETED|Wash-out||7
1662812|NCT00667992|4060521|P2|COMPLETED|Wash-out||36
1662813|NCT00667992|4060522|P1|COMPLETED|Wash-out||34
1662814|NCT00667992|4060521|P2|STARTED|Wash-out||41
1662815|NCT00667992|4060522|P1|STARTED|Wash-out||41
1662816|NCT00667992|4060521|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
1662817|NCT00667992|4060522|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
1662818|NCT00667992|4060521|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
1662819|NCT00667992|4060522|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
1662820|NCT00667992|4060521|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
1662821|NCT00667992|4060522|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
1662822|NCT00667992|4060521|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
1662823|NCT00667992|4060522|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
1662824|NCT00667992|4060521|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
1662825|NCT00667992|4060522|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
1662826|NCT00667992|4060521|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
1662827|NCT00667992|4060522|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
1662828|NCT00667875|4060579|P3|NOT COMPLETED|Overall Study||13
1662829|NCT00667875|4060580|P2|NOT COMPLETED|Overall Study||11
1662830|NCT00667875|4060581|P1|NOT COMPLETED|Overall Study||10
1662831|NCT00667875|4060579|P3|COMPLETED|Overall Study||8
1662832|NCT00667875|4060580|P2|COMPLETED|Overall Study||10
1662833|NCT00667875|4060581|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
1662834|NCT00667875|4060579|P3|Subjects Included in Analysisd|Overall Study||19
1662835|NCT00667875|4060580|P2|Subjects Included in Analysisd|Overall Study||21
1662836|NCT00667875|4060581|P1|Subjects Included in Analysisd|Overall Study||20
1662837|NCT00667875|4060579|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
1662838|NCT00667875|4060580|P2|STARTED|Overall Study||21
1662839|NCT00667875|4060581|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
1662840|NCT00667849|4060600|P2|NOT COMPLETED|Overall Study||121
1662841|NCT00667849|4060601|P1|NOT COMPLETED|Overall Study||108
1662842|NCT00667849|4060600|P2|COMPLETED|Overall Study||130
1662843|NCT00667849|4060601|P1|COMPLETED|Overall Study||142
1662844|NCT00667849|4060600|P2|STARTED|Overall Study||251
1662845|NCT00667849|4060601|P1|STARTED|Overall Study||250
1662846|NCT00667810|4060615|P4|NOT COMPLETED|Overall Study||2
1662847|NCT00667810|4060616|P3|NOT COMPLETED|Overall Study||222
1662848|NCT00667810|4060617|P2|NOT COMPLETED|Overall Study||170
1662849|NCT00667810|4060618|P1|NOT COMPLETED|Overall Study||167
1662850|NCT00667810|4060615|P4|COMPLETED|Overall Study||9
1662851|NCT00667810|4060616|P3|COMPLETED|Overall Study||124
1662852|NCT00667810|4060617|P2|COMPLETED|Overall Study||94
1662853|NCT00667810|4060618|P1|COMPLETED|Overall Study||102
1662854|NCT00667810|4060615|P4|Treated|Overall Study||11
1662855|NCT00667810|4060616|P3|Treated|Overall Study||344
1662856|NCT00667810|4060617|P2|Treated|Overall Study||263
1662857|NCT00667810|4060618|P1|Treated|Overall Study||267
1662858|NCT00667810|4060615|P4|STARTED|Overall Study||11
1662859|NCT00667810|4060616|P3|STARTED|Overall Study||346
1662860|NCT00667810|4060617|P2|STARTED|Overall Study||264
1662861|NCT00667810|4060618|P1|STARTED|Overall Study||269
1662862|NCT00667745|4060677|P2|NOT COMPLETED|Overall Study||21
1662863|NCT00667745|4060678|P1|NOT COMPLETED|Overall Study||25
1662864|NCT00667745|4060677|P2|COMPLETED|Overall Study||121
1662865|NCT00667745|4060678|P1|COMPLETED|Overall Study||116
1662866|NCT00667745|4060677|P2|STARTED|Overall Study||142
1662867|NCT00667745|4060678|P1|STARTED|Overall Study||141
1662868|NCT00667732|4060694|P3|NOT COMPLETED|Extension (26 Weeks)||0
1662869|NCT00667732|4060695|P2|NOT COMPLETED|Extension (26 Weeks)||0
1662870|NCT00667732|4060696|P1|NOT COMPLETED|Extension (26 Weeks)||0
1662871|NCT00667732|4060694|P3|COMPLETED|Extension (26 Weeks)||17
1662872|NCT00667732|4060695|P2|COMPLETED|Extension (26 Weeks)||14
1662873|NCT00667732|4060696|P1|COMPLETED|Extension (26 Weeks)||0
1662874|NCT00667732|4060694|P3|STARTED|Extension (26 Weeks)||17
1662875|NCT00667732|4060695|P2|STARTED|Extension (26 Weeks)||14
1662876|NCT00667732|4060696|P1|STARTED|Extension (26 Weeks)||0
1662877|NCT00667732|4060694|P3|NOT COMPLETED|Randomization (24 Weeks)||0
1662878|NCT00667732|4060695|P2|NOT COMPLETED|Randomization (24 Weeks)||1
1662879|NCT00667732|4060696|P1|NOT COMPLETED|Randomization (24 Weeks)||0
1662880|NCT00667732|4060694|P3|COMPLETED|Randomization (24 Weeks)||17
1662881|NCT00667732|4060695|P2|COMPLETED|Randomization (24 Weeks)||16
1662882|NCT00667732|4060696|P1|COMPLETED|Randomization (24 Weeks)||0
1662883|NCT00667732|4060694|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
1662884|NCT00667732|4060695|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
1662885|NCT00667732|4060696|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
1662886|NCT00667732|4060694|P3|STARTED|Randomization (24 Weeks)||17
1662887|NCT00667732|4060695|P2|STARTED|Randomization (24 Weeks)||17
1662888|NCT00667732|4060696|P1|STARTED|Randomization (24 Weeks)||0
1662889|NCT00667732|4060694|P3|NOT COMPLETED|Run -In (8 Weeks)||0
1662890|NCT00667732|4060695|P2|NOT COMPLETED|Run -In (8 Weeks)||0
1662891|NCT00667732|4060696|P1|NOT COMPLETED|Run -In (8 Weeks)||7
1662892|NCT00667732|4060694|P3|COMPLETED|Run -In (8 Weeks)||0
1662893|NCT00667732|4060695|P2|COMPLETED|Run -In (8 Weeks)||0
1662894|NCT00667732|4060696|P1|COMPLETED|Run -In (8 Weeks)||34
1662895|NCT00667732|4060694|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
1662896|NCT00667732|4060695|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
1662897|NCT00667732|4060696|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
1662898|NCT00667732|4060694|P3|STARTED|Run -In (8 Weeks)||0
1662899|NCT00667732|4060695|P2|STARTED|Run -In (8 Weeks)||0
1662900|NCT00667732|4060696|P1|STARTED|Run -In (8 Weeks)||41
1662901|NCT00667693|4060709|P2|NOT COMPLETED|Overall Study||2
1662902|NCT00667693|4060710|P1|NOT COMPLETED|Overall Study||0
1662903|NCT00667693|4060709|P2|COMPLETED|Overall Study||50
1662904|NCT00667693|4060710|P1|COMPLETED|Overall Study||49
1662905|NCT00667693|4060709|P2|STARTED|Overall Study||52
1662906|NCT00667693|4060710|P1|STARTED|Overall Study||49
1662907|NCT00667615|4060724|P1|NOT COMPLETED|Overall Study||0
1662908|NCT00667615|4060724|P1|COMPLETED|Overall Study||30
1662909|NCT00667615|4060724|P1|STARTED|Overall Study||30
1662910|NCT00667602|4060732|P3|NOT COMPLETED|Overall Study||18
1662911|NCT00667602|4060733|P2|NOT COMPLETED|Overall Study||15
1662912|NCT00667602|4060734|P1|NOT COMPLETED|Overall Study||8
1662913|NCT00667602|4060732|P3|COMPLETED|Overall Study||197
1662914|NCT00667602|4060733|P2|COMPLETED|Overall Study||213
1662915|NCT00667602|4060734|P1|COMPLETED|Overall Study||211
1662916|NCT00667602|4060732|P3|STARTED|Overall Study||215
1662917|NCT00667602|4060733|P2|STARTED|Overall Study||228
1662918|NCT00667602|4060734|P1|STARTED|Overall Study||219
1662919|NCT00667589|4060784|P4|NOT COMPLETED|Overall Study||1
1662920|NCT00667589|4060785|P3|NOT COMPLETED|Overall Study||3
1662921|NCT00667589|4060786|P2|NOT COMPLETED|Overall Study||0
1662922|NCT00667589|4060787|P1|NOT COMPLETED|Overall Study||1
1662923|NCT00667589|4060784|P4|COMPLETED|Overall Study||1
1662924|NCT00667589|4060785|P3|COMPLETED|Overall Study||0
1662925|NCT00667589|4060786|P2|COMPLETED|Overall Study||0
1662926|NCT00667589|4060787|P1|COMPLETED|Overall Study||0
1662927|NCT00667589|4060784|P4|STARTED|Overall Study||2
1662928|NCT00667589|4060785|P3|STARTED|Overall Study||3
1662929|NCT00667589|4060786|P2|STARTED|Overall Study||0
1662930|NCT00667589|4060787|P1|STARTED|Overall Study||1
1662931|NCT00667576|4060802|P5|NOT COMPLETED|Overall Study||1
1662932|NCT00667576|4060803|P4|NOT COMPLETED|Overall Study||4
1662933|NCT00667576|4060804|P3|NOT COMPLETED|Overall Study||2
1662934|NCT00667576|4060805|P2|NOT COMPLETED|Overall Study||1
1662935|NCT00667576|4060806|P1|NOT COMPLETED|Overall Study||2
1662936|NCT00667576|4060802|P5|COMPLETED|Overall Study||29
1662937|NCT00667576|4060803|P4|COMPLETED|Overall Study||27
1662938|NCT00667576|4060804|P3|COMPLETED|Overall Study||29
1662939|NCT00667576|4060805|P2|COMPLETED|Overall Study||30
1662940|NCT00667576|4060806|P1|COMPLETED|Overall Study||28
1662941|NCT00667576|4060802|P5|STARTED|Overall Study||30
1662942|NCT00667576|4060803|P4|STARTED|Overall Study||31
1662943|NCT00667576|4060804|P3|STARTED|Overall Study||31
1662944|NCT00667576|4060805|P2|STARTED|Overall Study||31
1662945|NCT00667576|4060806|P1|STARTED|Overall Study||30
1662946|NCT00667563|4060853|P1|NOT COMPLETED|Overall Study||24
1662947|NCT00667563|4060853|P1|COMPLETED|Overall Study||126
1662948|NCT00667563|4060853|P1|STARTED|Overall Study||150
1662949|NCT00667511|4060863|P1|NOT COMPLETED|Intervention 2: Home NHD||4
1662950|NCT00667511|4060863|P1|COMPLETED|Intervention 2: Home NHD||39
1662951|NCT00667511|4060863|P1|STARTED|Intervention 2: Home NHD||43
1662952|NCT00667511|4060863|P1|NOT COMPLETED|Training/Transition Period||8
1662953|NCT00667511|4060863|P1|COMPLETED|Training/Transition Period||43
1662954|NCT00667511|4060863|P1|STARTED|Training/Transition Period||51
1662955|NCT00667511|4060863|P1|NOT COMPLETED|Intervention 1: Home DHD||7
1662956|NCT00667511|4060863|P1|COMPLETED|Intervention 1: Home DHD||51
1662957|NCT00667511|4060863|P1|STARTED|Intervention 1: Home DHD||58
1662958|NCT00667459|4060873|P2|NOT COMPLETED|Overall Study||45
1662959|NCT00667459|4060874|P1|NOT COMPLETED|Overall Study||8
1662960|NCT00667459|4060873|P2|COMPLETED|Overall Study||220
1662961|NCT00667459|4060874|P1|COMPLETED|Overall Study||272
1662962|NCT00667459|4060873|P2|STARTED|Overall Study||265
1662963|NCT00667459|4060874|P1|STARTED|Overall Study||280
1662964|NCT00667446|4060916|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
1662965|NCT00667446|4060917|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
1662966|NCT00667446|4060916|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
1662967|NCT00667446|4060917|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
1662968|NCT00667446|4060916|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
1662969|NCT00667446|4060917|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
1662970|NCT00667446|4060916|P2|NOT COMPLETED|Treatment Period (36 Months)||25
1662971|NCT00667446|4060917|P1|NOT COMPLETED|Treatment Period (36 Months)||23
1662972|NCT00667446|4060916|P2|COMPLETED|Treatment Period (36 Months)||13
1662973|NCT00667446|4060917|P1|COMPLETED|Treatment Period (36 Months)||11
1662974|NCT00667446|4060916|P2|STARTED|Treatment Period (36 Months)||38
1662975|NCT00667446|4060917|P1|STARTED|Treatment Period (36 Months)||34
1662976|NCT00667420|4060939|P1|NOT COMPLETED|Overall Study||10
1662977|NCT00667420|4060939|P1|COMPLETED|Overall Study||7
1662978|NCT00667420|4060939|P1|Completion of Surgery/Re-staging|Overall Study||11
1662979|NCT00667420|4060939|P1|Completion of Pre-operative EOX-P|Overall Study||15
1662980|NCT00667420|4060939|P1|STARTED|Overall Study||17
1662981|NCT00667394|4060949|P2|NOT COMPLETED|Overall Study||0
1662982|NCT00667394|4060950|P1|NOT COMPLETED|Overall Study||4
1662983|NCT00667394|4060949|P2|COMPLETED|Overall Study||1
1662984|NCT00667394|4060950|P1|COMPLETED|Overall Study||37
1662985|NCT00667394|4060949|P2|STARTED|Overall Study||1
1662986|NCT00667394|4060950|P1|STARTED|Overall Study||41
1662987|NCT00667381|4060960|P2|NOT COMPLETED|Overall Study||0
1662988|NCT00667381|4060961|P1|NOT COMPLETED|Overall Study||0
1662989|NCT00667381|4060960|P2|COMPLETED|Overall Study||503
1662990|NCT00667381|4060961|P1|COMPLETED|Overall Study||501
1662991|NCT00667381|4060960|P2|STARTED|Overall Study||503
1662992|NCT00667381|4060961|P1|STARTED|Overall Study||501
1662993|NCT00667368|4060977|P2|NOT COMPLETED|Overall Study||172
1662994|NCT00667368|4060978|P1|NOT COMPLETED|Overall Study||200
1662995|NCT00667368|4060977|P2|COMPLETED|Overall Study||511
1662996|NCT00667368|4060978|P1|COMPLETED|Overall Study||482
1662997|NCT00667368|4060977|P2|STARTED|Overall Study||683
1662998|NCT00667368|4060978|P1|STARTED|Overall Study||682
1662999|NCT00667355|4060986|P1|NOT COMPLETED|Overall Study||11
1663000|NCT00667355|4060986|P1|COMPLETED|Overall Study||30
1663001|NCT00667355|4060986|P1|STARTED|Overall Study||41
1663002|NCT00667342|4061011|P3|NOT COMPLETED|Overall Study||9
1663003|NCT00667342|4061012|P2|NOT COMPLETED|Overall Study||0
1663004|NCT00667342|4061013|P1|NOT COMPLETED|Overall Study||14
1663005|NCT00667342|4061011|P3|COMPLETED|Overall Study||3
1663006|NCT00667342|4061012|P2|COMPLETED|Overall Study||0
1663007|NCT00667342|4061013|P1|COMPLETED|Overall Study||17
1663008|NCT00667342|4061011|P3|STARTED|Overall Study||12
1663009|NCT00667342|4061012|P2|STARTED|Overall Study||0
1663010|NCT00667342|4061013|P1|STARTED|Overall Study||31
1663011|NCT00667277|4061051|P1|NOT COMPLETED|Overall Study||2
1663012|NCT00667277|4061051|P1|COMPLETED|Overall Study||11
1663013|NCT00667277|4061051|P1|STARTED|Overall Study||13
1663014|NCT00667251|4061058|P2|NOT COMPLETED|Overall Study||95
1663015|NCT00667251|4061059|P1|NOT COMPLETED|Overall Study||70
1663016|NCT00667251|4061058|P2|COMPLETED|Overall Study||231
1663017|NCT00667251|4061059|P1|COMPLETED|Overall Study||256
1663018|NCT00667251|4061058|P2|Not Started|Overall Study||1
1663019|NCT00667251|4061059|P1|Not Started|Overall Study||4
1663020|NCT00667251|4061058|P2|Monotherapy|Overall Study||232
1663021|NCT00667251|4061059|P1|Monotherapy|Overall Study||225
1663022|NCT00667251|4061058|P2|Combination Rx|Overall Study||325
1663023|NCT00667251|4061059|P1|Combination Rx|Overall Study||322
1663024|NCT00667251|4061058|P2|STARTED|Overall Study||326
1663025|NCT00667251|4061059|P1|STARTED|Overall Study||326
1663026|NCT00667225|4061085|P2|NOT COMPLETED|Overall Study||1
1663027|NCT00667225|4061086|P1|NOT COMPLETED|Overall Study||1
1663028|NCT00667225|4061085|P2|COMPLETED|Overall Study||12
1663029|NCT00667225|4061086|P1|COMPLETED|Overall Study||15
1663030|NCT00667225|4061085|P2|STARTED|Overall Study||13
1663031|NCT00667225|4061086|P1|STARTED|Overall Study||16
1663032|NCT00667186|4061096|P2|NOT COMPLETED|Overall Study||0
1663033|NCT00667186|4061097|P1|NOT COMPLETED|Overall Study||0
1663034|NCT00667186|4061096|P2|COMPLETED|Overall Study||4880
1663035|NCT00667186|4061097|P1|COMPLETED|Overall Study||4692
1663036|NCT00667186|4061096|P2|STARTED|Overall Study||4880
1663037|NCT00667186|4061097|P1|STARTED|Overall Study||4692
1663038|NCT00667095|4061107|P2|NOT COMPLETED|Overall Study||1
1663039|NCT00667095|4061108|P1|NOT COMPLETED|Overall Study||0
1663040|NCT00667095|4061107|P2|COMPLETED|Overall Study||9
1663041|NCT00667095|4061108|P1|COMPLETED|Overall Study||11
1663042|NCT00667095|4061107|P2|STARTED|Overall Study||10
1663043|NCT00667095|4061108|P1|STARTED|Overall Study||11
1663044|NCT00667017|4061124|P1|NOT COMPLETED|Overall Study||1
1663045|NCT00667017|4061124|P1|COMPLETED|Overall Study||0
1663046|NCT00667017|4061124|P1|STARTED|Overall Study||1
1663047|NCT00666978|4061130|P2|NOT COMPLETED|Overall Study||83
1663048|NCT00666978|4061131|P1|NOT COMPLETED|Overall Study||78
1663049|NCT00666978|4061130|P2|COMPLETED|Overall Study||187
1663050|NCT00666978|4061131|P1|COMPLETED|Overall Study||192
1663051|NCT00666978|4061130|P2|STARTED|Overall Study||270
1663052|NCT00666978|4061131|P1|STARTED|Overall Study||270
1663053|NCT00666965|4061144|P4|NOT COMPLETED|Overall Study||15
1663054|NCT00666965|4061145|P3|NOT COMPLETED|Overall Study||2
1663055|NCT00666965|4061146|P2|NOT COMPLETED|Overall Study||4
1663056|NCT00666965|4061147|P1|NOT COMPLETED|Overall Study||3
1663057|NCT00666965|4061144|P4|COMPLETED|Overall Study||42
1663058|NCT00666965|4061145|P3|COMPLETED|Overall Study||56
1663059|NCT00666965|4061146|P2|COMPLETED|Overall Study||53
1663060|NCT00666965|4061147|P1|COMPLETED|Overall Study||55
1663061|NCT00666965|4061144|P4|STARTED|Overall Study||57
1663062|NCT00666965|4061145|P3|STARTED|Overall Study||58
1663063|NCT00666965|4061146|P2|STARTED|Overall Study||57
1663064|NCT00666965|4061147|P1|STARTED|Overall Study||58
1663065|NCT00666926|4061177|P16|NOT COMPLETED|Overall Study||8
1663066|NCT00666926|4061178|P15|NOT COMPLETED|Overall Study||7
1663067|NCT00666926|4061179|P14|NOT COMPLETED|Overall Study||4
1663068|NCT00666926|4061180|P13|NOT COMPLETED|Overall Study||3
1663069|NCT00666926|4061181|P12|NOT COMPLETED|Overall Study||33
1663070|NCT00666926|4061182|P11|NOT COMPLETED|Overall Study||6
1663071|NCT00666926|4061183|P10|NOT COMPLETED|Overall Study||10
1663072|NCT00666926|4061184|P9|NOT COMPLETED|Overall Study||3
1663073|NCT00666926|4061185|P8|NOT COMPLETED|Overall Study||1
1663074|NCT00666926|4061186|P7|NOT COMPLETED|Overall Study||4
1663075|NCT00666926|4061187|P6|NOT COMPLETED|Overall Study||4
1663076|NCT00666926|4061188|P5|NOT COMPLETED|Overall Study||3
1663077|NCT00666926|4061189|P4|NOT COMPLETED|Overall Study||4
1663078|NCT00666926|4061190|P3|NOT COMPLETED|Overall Study||3
1663079|NCT00666926|4061191|P2|NOT COMPLETED|Overall Study||4
1663080|NCT00666926|4061192|P1|NOT COMPLETED|Overall Study||2
1663081|NCT00666926|4061177|P16|COMPLETED|Overall Study||0
1663082|NCT00666926|4061178|P15|COMPLETED|Overall Study||0
1663083|NCT00666926|4061179|P14|COMPLETED|Overall Study||0
1663084|NCT00666926|4061180|P13|COMPLETED|Overall Study||0
1663085|NCT00666926|4061181|P12|COMPLETED|Overall Study||0
1663086|NCT00666926|4061182|P11|COMPLETED|Overall Study||0
1663087|NCT00666926|4061183|P10|COMPLETED|Overall Study||0
1663088|NCT00666926|4061184|P9|COMPLETED|Overall Study||0
1663089|NCT00666926|4061185|P8|COMPLETED|Overall Study||0
1663090|NCT00666926|4061186|P7|COMPLETED|Overall Study||0
1663091|NCT00666926|4061187|P6|COMPLETED|Overall Study||0
1663092|NCT00666926|4061188|P5|COMPLETED|Overall Study||0
1663093|NCT00666926|4061189|P4|COMPLETED|Overall Study||0
1663094|NCT00666926|4061190|P3|COMPLETED|Overall Study||0
1663095|NCT00666926|4061191|P2|COMPLETED|Overall Study||0
1663096|NCT00666926|4061192|P1|COMPLETED|Overall Study||0
1663097|NCT00666926|4061177|P16|STARTED|Overall Study||8
1663098|NCT00666926|4061178|P15|STARTED|Overall Study||7
1663099|NCT00666926|4061179|P14|STARTED|Overall Study||4
1663100|NCT00666926|4061180|P13|STARTED|Overall Study||3
1663101|NCT00666926|4061181|P12|STARTED|Overall Study||33
1663102|NCT00666926|4061182|P11|STARTED|Overall Study||6
1663103|NCT00666926|4061183|P10|STARTED|Overall Study||10
1663104|NCT00666926|4061184|P9|STARTED|Overall Study||3
1663105|NCT00666926|4061185|P8|STARTED|Overall Study||1
1663106|NCT00666926|4061186|P7|STARTED|Overall Study||4
1663107|NCT00666926|4061187|P6|STARTED|Overall Study||4
1663108|NCT00666926|4061188|P5|STARTED|Overall Study||3
1663109|NCT00666926|4061189|P4|STARTED|Overall Study||4
1663110|NCT00666926|4061190|P3|STARTED|Overall Study||3
1663111|NCT00666926|4061191|P2|STARTED|Overall Study||4
1663112|NCT00666926|4061192|P1|STARTED|Overall Study||2
1663113|NCT00666848|4061486|P3|NOT COMPLETED|Overall Study||0
1663114|NCT00666848|4061487|P2|NOT COMPLETED|Overall Study||0
1663115|NCT00666848|4061488|P1|NOT COMPLETED|Overall Study||0
1663116|NCT00666848|4061486|P3|COMPLETED|Overall Study|finished Aim 3|7
1663117|NCT00666848|4061487|P2|COMPLETED|Overall Study|finished Aim 1|9
1663118|NCT00666848|4061488|P1|COMPLETED|Overall Study|finished Aim 2|8
1663119|NCT00666848|4061486|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
1663120|NCT00666848|4061487|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
1663121|NCT00666848|4061488|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
1663122|NCT00666835|4061501|P2|NOT COMPLETED|Overall Study||22
1663123|NCT00666835|4061502|P1|NOT COMPLETED|Overall Study||53
1663124|NCT00666835|4061501|P2|COMPLETED|Overall Study||142
1663125|NCT00666835|4061502|P1|COMPLETED|Overall Study||261
1663126|NCT00666835|4061501|P2|STARTED|Overall Study||164
1663127|NCT00666835|4061502|P1|STARTED|Overall Study||314
1663128|NCT00666757|4061512|P2|NOT COMPLETED|Overall Study||97
1663129|NCT00666757|4061513|P1|NOT COMPLETED|Overall Study||100
1663130|NCT00666757|4061512|P2|COMPLETED|Overall Study||281
1663131|NCT00666757|4061513|P1|COMPLETED|Overall Study||272
1663132|NCT00666757|4061512|P2|STARTED|Overall Study||378
1663133|NCT00666757|4061513|P1|STARTED|Overall Study||372
1663134|NCT00666718|4061572|P2|NOT COMPLETED|Overall Study||18
1663135|NCT00666718|4061573|P1|NOT COMPLETED|Overall Study||12
1663136|NCT00666718|4061572|P2|COMPLETED|Overall Study||169
1663137|NCT00666718|4061573|P1|COMPLETED|Overall Study||175
1663138|NCT00666718|4061572|P2|STARTED|Overall Study||187
1663139|NCT00666718|4061573|P1|STARTED|Overall Study||187
1663140|NCT00666705|4061599|P1|NOT COMPLETED|Overall Study||1
1663141|NCT00666705|4061599|P1|COMPLETED|Overall Study||17
1663142|NCT00666705|4061599|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
1663143|NCT00666705|4061599|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
1663144|NCT00666705|4061599|P1|Washout (Days 4 - 5)|Overall Study||18
1663145|NCT00666705|4061599|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
1663146|NCT00666705|4061599|P1|STARTED|Overall Study||18
1663147|NCT00666679|4061618|P2|NOT COMPLETED|Second Intervention||1
1663148|NCT00666679|4061619|P1|NOT COMPLETED|Second Intervention||1
1663149|NCT00666679|4061618|P2|COMPLETED|Second Intervention||64
1663150|NCT00666679|4061619|P1|COMPLETED|Second Intervention||61
1663151|NCT00666679|4061618|P2|STARTED|Second Intervention||65
1663152|NCT00666679|4061619|P1|STARTED|Second Intervention||62
1663153|NCT00666679|4061618|P2|NOT COMPLETED|Washout Period of 1 Week||2
1663154|NCT00666679|4061619|P1|NOT COMPLETED|Washout Period of 1 Week||0
1663155|NCT00666679|4061618|P2|COMPLETED|Washout Period of 1 Week||65
1663156|NCT00666679|4061619|P1|COMPLETED|Washout Period of 1 Week||62
1663157|NCT00666679|4061618|P2|STARTED|Washout Period of 1 Week||67
1663158|NCT00666679|4061619|P1|STARTED|Washout Period of 1 Week||62
1663159|NCT00666679|4061618|P2|NOT COMPLETED|First Intervention||1
1663160|NCT00666679|4061619|P1|NOT COMPLETED|First Intervention||4
1663161|NCT00666679|4061618|P2|COMPLETED|First Intervention||67
1663162|NCT00666679|4061619|P1|COMPLETED|First Intervention||62
1663163|NCT00666679|4061618|P2|STARTED|First Intervention||68
1663164|NCT00666679|4061619|P1|STARTED|First Intervention||66
1663165|NCT00666666|4061639|P1|NOT COMPLETED|Overall Study||0
1663166|NCT00666666|4061639|P1|COMPLETED|Overall Study||55
1663167|NCT00666666|4061639|P1|STARTED|Overall Study||55
1663168|NCT00666588|4061649|P4|NOT COMPLETED|Overall Study||2
1663169|NCT00666588|4061650|P3|NOT COMPLETED|Overall Study||0
1663170|NCT00666588|4061651|P2|NOT COMPLETED|Overall Study||0
1663171|NCT00666588|4061652|P1|NOT COMPLETED|Overall Study||4
1663172|NCT00666588|4061649|P4|COMPLETED|Overall Study||20
1663173|NCT00666588|4061650|P3|COMPLETED|Overall Study||6
1663174|NCT00666588|4061651|P2|COMPLETED|Overall Study||6
1663175|NCT00666588|4061652|P1|COMPLETED|Overall Study||14
1663176|NCT00666588|4061649|P4|STARTED|Overall Study||22
1663177|NCT00666588|4061650|P3|STARTED|Overall Study||6
1663178|NCT00666588|4061651|P2|STARTED|Overall Study||6
1663179|NCT00666588|4061652|P1|STARTED|Overall Study||18
1663180|NCT00666562|4061685|P3|NOT COMPLETED|Overall Study||0
1663181|NCT00666562|4061686|P2|NOT COMPLETED|Overall Study||2
1663182|NCT00666562|4061687|P1|NOT COMPLETED|Overall Study||0
1663183|NCT00666562|4061685|P3|COMPLETED|Overall Study||10
1663184|NCT00666562|4061686|P2|COMPLETED|Overall Study||8
1663185|NCT00666562|4061687|P1|COMPLETED|Overall Study||11
1663186|NCT00666562|4061685|P3|STARTED|Overall Study||10
1663187|NCT00666562|4061686|P2|STARTED|Overall Study||10
1663188|NCT00666562|4061687|P1|STARTED|Overall Study||11
1663189|NCT00666536|4061734|P2|NOT COMPLETED|Overall Study||37
1663190|NCT00666536|4061735|P1|NOT COMPLETED|Overall Study||33
1663191|NCT00666536|4061734|P2|COMPLETED|Overall Study||322
1663192|NCT00666536|4061735|P1|COMPLETED|Overall Study||336
1663193|NCT00666536|4061734|P2|STARTED|Overall Study||359
1663194|NCT00666536|4061735|P1|STARTED|Overall Study||369
1663195|NCT00666458|4061753|P2|NOT COMPLETED|Overall Study||24
1663196|NCT00666458|4061754|P1|NOT COMPLETED|Overall Study||38
1663197|NCT00666458|4061753|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
1663198|NCT00666458|4061754|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
1663199|NCT00666458|4061753|P2|STARTED|Overall Study|Randomized and treated|398
1663200|NCT00666458|4061754|P1|STARTED|Overall Study|Randomized and treated|403
1663201|NCT00666406|4061766|P2|NOT COMPLETED|Second PK Infusion||0
1663202|NCT00666406|4061767|P1|NOT COMPLETED|Second PK Infusion||0
1663203|NCT00666406|4061766|P2|COMPLETED|Second PK Infusion||3
1663204|NCT00666406|4061767|P1|COMPLETED|Second PK Infusion||6
1663205|NCT00666406|4061766|P2|STARTED|Second PK Infusion||3
1663206|NCT00666406|4061767|P1|STARTED|Second PK Infusion||6
1663207|NCT00666406|4061766|P2|NOT COMPLETED|First PK Infusion||0
1663208|NCT00666406|4061767|P1|NOT COMPLETED|First PK Infusion||0
1663209|NCT00666406|4061766|P2|COMPLETED|First PK Infusion||3
1663210|NCT00666406|4061767|P1|COMPLETED|First PK Infusion||6
1663211|NCT00666406|4061766|P2|STARTED|First PK Infusion||3
1663212|NCT00666406|4061767|P1|STARTED|First PK Infusion||6
1663213|NCT00666328|4061842|P1|NOT COMPLETED|Overall Study||5
1663214|NCT00666328|4061842|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
1663215|NCT00666328|4061842|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
1663216|NCT00666328|4061842|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
1663217|NCT00666276|4061855|P1|NOT COMPLETED|Overall Study||34
1663218|NCT00666276|4061855|P1|COMPLETED|Overall Study||970
1663219|NCT00666276|4061855|P1|STARTED|Overall Study||1004
1663220|NCT00666263|4061879|P2|NOT COMPLETED|End of Study Visit||0
1663221|NCT00666263|4061880|P1|NOT COMPLETED|End of Study Visit||0
1663222|NCT00666263|4061879|P2|COMPLETED|End of Study Visit||22
1663223|NCT00666263|4061880|P1|COMPLETED|End of Study Visit||22
1663224|NCT00666263|4061879|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
1663225|NCT00666263|4061880|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
1663226|NCT00666263|4061879|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
1663227|NCT00666263|4061880|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
1663228|NCT00666263|4061879|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
1663229|NCT00666263|4061880|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
1663230|NCT00666263|4061879|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
1663231|NCT00666263|4061880|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
1663232|NCT00666263|4061879|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
1663233|NCT00666263|4061880|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
1663234|NCT00666263|4061879|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
1663235|NCT00666263|4061880|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
1663236|NCT00666263|4061879|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
1663237|NCT00666263|4061880|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
1663238|NCT00666263|4061879|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
1663239|NCT00666263|4061880|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
1663240|NCT00666263|4061879|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
1663241|NCT00666263|4061880|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
1663242|NCT00666263|4061879|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
1663243|NCT00666263|4061880|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
1663244|NCT00666263|4061879|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
1663245|NCT00666263|4061880|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
1663246|NCT00666263|4061879|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
1663247|NCT00666263|4061880|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
1663248|NCT00666263|4061879|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
1663249|NCT00666263|4061880|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
1663250|NCT00666263|4061879|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
1663251|NCT00666263|4061880|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
1663252|NCT00666263|4061879|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
1663253|NCT00666263|4061880|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
1663254|NCT00666263|4061879|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
1663255|NCT00666263|4061880|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
1663256|NCT00666224|4062024|P2|NOT COMPLETED|Open-Label||85
1663257|NCT00666224|4062025|P1|NOT COMPLETED|Open-Label||35
1663258|NCT00666224|4062024|P2|COMPLETED|Open-Label||126
1663259|NCT00666224|4062025|P1|COMPLETED|Open-Label||163
1663260|NCT00666224|4062024|P2|STARTED|Open-Label||211
1663261|NCT00666224|4062025|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
1663262|NCT00666224|4062024|P2|NOT COMPLETED|Double-Blind||27
1663263|NCT00666224|4062025|P1|NOT COMPLETED|Double-Blind||45
1663264|NCT00666224|4062024|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
1663265|NCT00666224|4062025|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
1663266|NCT00666224|4062024|P2|STARTED|Double-Blind||238
1663267|NCT00666224|4062025|P1|STARTED|Double-Blind||243
1663268|NCT00666211|4062044|P2|NOT COMPLETED|Overall Study||38
1663269|NCT00666211|4062045|P1|NOT COMPLETED|Overall Study||20
1663270|NCT00666211|4062044|P2|COMPLETED|Overall Study||18
1663271|NCT00666211|4062045|P1|COMPLETED|Overall Study||22
1663272|NCT00666211|4062044|P2|STARTED|Overall Study||56
1663273|NCT00666211|4062045|P1|STARTED|Overall Study||42
1663274|NCT00666198|4062063|P1|NOT COMPLETED|Overall Study||33
1663275|NCT00666198|4062063|P1|COMPLETED|Overall Study||3304
1663276|NCT00666198|4062063|P1|STARTED|Overall Study||3337
1663277|NCT00666029|4062078|P2|NOT COMPLETED|Overall Study||0
1663278|NCT00666029|4062079|P1|NOT COMPLETED|Overall Study||1
1663279|NCT00666029|4062078|P2|COMPLETED|Overall Study||20
1663280|NCT00666029|4062079|P1|COMPLETED|Overall Study||19
1663281|NCT00666029|4062078|P2|STARTED|Overall Study||20
1663282|NCT00666029|4062079|P1|STARTED|Overall Study||20
1663283|NCT00665925|4062091|P4|NOT COMPLETED|Overall Study||21
1663284|NCT00665925|4062092|P3|NOT COMPLETED|Overall Study||26
1663285|NCT00665925|4062093|P2|NOT COMPLETED|Overall Study||17
1663286|NCT00665925|4062094|P1|NOT COMPLETED|Overall Study||15
1663287|NCT00665925|4062091|P4|COMPLETED|Overall Study|Participants completed the study|131
1663288|NCT00665925|4062092|P3|COMPLETED|Overall Study|Participants completed the study|126
1663289|NCT00665925|4062093|P2|COMPLETED|Overall Study|Participants completed the study|59
1663290|NCT00665925|4062094|P1|COMPLETED|Overall Study|Participants completed the study|62
1663291|NCT00665925|4062091|P4|STARTED|Overall Study|Participants randomized|152
1663292|NCT00665925|4062092|P3|STARTED|Overall Study|Participants randomized|152
1663293|NCT00665925|4062093|P2|STARTED|Overall Study|Participants randomized|76
1663294|NCT00665925|4062094|P1|STARTED|Overall Study|Participants randomized|77
1663295|NCT00665847|4062505|P1|NOT COMPLETED|Overall Study||25
1663296|NCT00665847|4062505|P1|COMPLETED|Overall Study||76
1663297|NCT00665847|4062505|P1|STARTED|Overall Study||101
1663298|NCT00665704|4062517|P1|NOT COMPLETED|Overall Study||0
1663299|NCT00665704|4062517|P1|COMPLETED|Overall Study||9
1663300|NCT00665704|4062517|P1|STARTED|Overall Study||9
1663301|NCT00665652|4062522|P1|NOT COMPLETED|Overall Study||6
1663302|NCT00665652|4062522|P1|COMPLETED|Overall Study||2
1663303|NCT00665652|4062522|P1|STARTED|Overall Study||8
1663304|NCT00665626|4062528|P2|NOT COMPLETED|Overall Study||22
1663305|NCT00665626|4062529|P1|NOT COMPLETED|Overall Study||10
1663306|NCT00665626|4062528|P2|COMPLETED|Overall Study|Participants completed the study|124
1663307|NCT00665626|4062529|P1|COMPLETED|Overall Study|Participants completed the study|63
1663308|NCT00665626|4062528|P2|STARTED|Overall Study|Participants randomized|146
1663309|NCT00665626|4062529|P1|STARTED|Overall Study|Participants randomized|73
1663310|NCT00665470|4062597|P2|NOT COMPLETED|Overall Study||0
1663311|NCT00665470|4062598|P1|NOT COMPLETED|Overall Study||0
1663312|NCT00665470|4062597|P2|COMPLETED|Overall Study||0
1663313|NCT00665470|4062598|P1|COMPLETED|Overall Study||10
1663314|NCT00665470|4062597|P2|STARTED|Overall Study||0
1663315|NCT00665470|4062598|P1|STARTED|Overall Study||10
1663316|NCT00665457|4062606|P1|NOT COMPLETED|Overall Study||0
1663317|NCT00665457|4062606|P1|COMPLETED|Overall Study||3
1663318|NCT00665457|4062606|P1|STARTED|Overall Study||3
1663319|NCT00665444|4062611|P1|NOT COMPLETED|Overall Study||2
1663320|NCT00665444|4062611|P1|COMPLETED|Overall Study||1
1663321|NCT00665444|4062611|P1|STARTED|Overall Study||3
1663322|NCT00665431|4062623|P3|NOT COMPLETED|Overall Study||24
1663323|NCT00665431|4062624|P2|NOT COMPLETED|Overall Study||57
1663324|NCT00665431|4062625|P1|NOT COMPLETED|Overall Study||40
1663325|NCT00665431|4062623|P3|COMPLETED|Overall Study||98
1663326|NCT00665431|4062624|P2|COMPLETED|Overall Study||188
1663327|NCT00665431|4062625|P1|COMPLETED|Overall Study||203
1663328|NCT00665431|4062623|P3|STARTED|Overall Study|Safety population|122
1663329|NCT00665431|4062624|P2|STARTED|Overall Study|Safety population|245
1663330|NCT00665431|4062625|P1|STARTED|Overall Study|Safety population|243
1663331|NCT00665366|4062668|P2|NOT COMPLETED|Overall Study||59
1663332|NCT00665366|4062669|P1|NOT COMPLETED|Overall Study||58
1663333|NCT00665366|4062668|P2|COMPLETED|Overall Study||122
1663334|NCT00665366|4062669|P1|COMPLETED|Overall Study||131
1663335|NCT00665366|4062668|P2|STARTED|Overall Study|Participants randomized|181
1663336|NCT00665366|4062669|P1|STARTED|Overall Study|Participants randomized|189
1663337|NCT00665353|4062697|P1|NOT COMPLETED|Study Step 2||14
1663338|NCT00665353|4062697|P1|COMPLETED|Study Step 2||2
1663339|NCT00665353|4062697|P1|STARTED|Study Step 2||16
1663340|NCT00665353|4062697|P1|NOT COMPLETED|Study Step 1||3
1663341|NCT00665353|4062697|P1|COMPLETED|Study Step 1||16
1663342|NCT00665353|4062697|P1|STARTED|Study Step 1||19
1663343|NCT00665132|4062707|P1|NOT COMPLETED|Overall Study||0
1663344|NCT00665132|4062707|P1|COMPLETED|Overall Study||10
1663345|NCT00665132|4062707|P1|STARTED|Overall Study||10
1663346|NCT00665002|4062714|P1|NOT COMPLETED|Overall Study||12
1663347|NCT00665002|4062714|P1|COMPLETED|Overall Study||4
1663348|NCT00665002|4062714|P1|STARTED|Overall Study||16
1663349|NCT00664755|4062721|P2|NOT COMPLETED|Overall Study||0
1663350|NCT00664755|4062722|P1|NOT COMPLETED|Overall Study||0
1663351|NCT00664755|4062721|P2|COMPLETED|Overall Study||73
1663352|NCT00664755|4062722|P1|COMPLETED|Overall Study||67
1663353|NCT00664755|4062721|P2|STARTED|Overall Study||73
1663354|NCT00664755|4062722|P1|STARTED|Overall Study||67
1663355|NCT00664742|4062728|P1|NOT COMPLETED|Overall Study||126
1663356|NCT00664742|4062728|P1|COMPLETED|Overall Study||481
1663357|NCT00664742|4062728|P1|STARTED|Overall Study||607
1663358|NCT00664560|4062736|P3|NOT COMPLETED|Overall Study||19
1663359|NCT00664560|4062737|P2|NOT COMPLETED|Overall Study||35
1663360|NCT00664560|4062738|P1|NOT COMPLETED|Overall Study||39
1663361|NCT00664560|4062736|P3|COMPLETED|Overall Study||105
1663362|NCT00664560|4062737|P2|COMPLETED|Overall Study||208
1663363|NCT00664560|4062738|P1|COMPLETED|Overall Study||208
1663364|NCT00664560|4062736|P3|STARTED|Overall Study|Safety Population|124
1663365|NCT00664560|4062737|P2|STARTED|Overall Study|Safety Population|243
1663366|NCT00664560|4062738|P1|STARTED|Overall Study|Safety Population|247
1663367|NCT00664534|4062781|P2|NOT COMPLETED|Overall Study||33
1663368|NCT00664534|4062782|P1|NOT COMPLETED|Overall Study||41
1663369|NCT00664534|4062781|P2|COMPLETED|Overall Study||138
1663370|NCT00664534|4062782|P1|COMPLETED|Overall Study||132
1663371|NCT00664534|4062781|P2|STARTED|Overall Study||171
1663372|NCT00664534|4062782|P1|STARTED|Overall Study||173
1663373|NCT00664521|4062810|P2|NOT COMPLETED|Overall Study||1
1663374|NCT00664521|4062811|P1|NOT COMPLETED|Overall Study||6
1663375|NCT00664521|4062810|P2|COMPLETED|Overall Study||8
1663376|NCT00664521|4062811|P1|COMPLETED|Overall Study||12
1663377|NCT00664521|4062810|P2|STARTED|Overall Study||9
1663378|NCT00664521|4062811|P1|STARTED|Overall Study||18
1663379|NCT00664430|4062831|P1|NOT COMPLETED|Overall Study||13
1663380|NCT00664430|4062831|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
1663381|NCT00664430|4062831|P1|STARTED|Overall Study||13
1663382|NCT00664326|4062837|P1|NOT COMPLETED|Overall Study||24
1663383|NCT00664326|4062837|P1|COMPLETED|Overall Study||25
1663384|NCT00664326|4062837|P1|STARTED|Overall Study||49
1663385|NCT00664209|4062856|P1|NOT COMPLETED|Study Treatment Period||6
1663386|NCT00664209|4062856|P1|COMPLETED|Study Treatment Period||0
1663387|NCT00664209|4062856|P1|STARTED|Study Treatment Period||6
1663388|NCT00664209|4062856|P1|NOT COMPLETED|Motor Fluctuations Screen||7
1663389|NCT00664209|4062856|P1|COMPLETED|Motor Fluctuations Screen||6
1663390|NCT00664209|4062856|P1|STARTED|Motor Fluctuations Screen||13
1663391|NCT00664105|4062864|P1|NOT COMPLETED|Overall Study||24
1663392|NCT00664105|4062864|P1|COMPLETED|Overall Study||39
1663393|NCT00664105|4062864|P1|STARTED|Overall Study||63
1663394|NCT00664066|4062871|P1|NOT COMPLETED|Overall Study||3
1663395|NCT00664066|4062871|P1|COMPLETED|Overall Study||0
1663396|NCT00664066|4062871|P1|STARTED|Overall Study||3
1663397|NCT00663962|4062877|P2|NOT COMPLETED|Overall Study||0
1663398|NCT00663962|4062878|P1|NOT COMPLETED|Overall Study||1
1663399|NCT00663962|4062877|P2|COMPLETED|Overall Study||8
1663494|NCT00663169|4063186|P1|COMPLETED|Overall Study||3
1663400|NCT00663962|4062878|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
1663401|NCT00663962|4062877|P2|STARTED|Overall Study||8
1663402|NCT00663962|4062878|P1|STARTED|Overall Study||7
1663403|NCT00663923|4062884|P1|NOT COMPLETED|Overall Study||2
1663404|NCT00663923|4062884|P1|COMPLETED|Overall Study||48
1663405|NCT00663923|4062884|P1|STARTED|Overall Study||50
1663406|NCT00663858|4062901|P3|NOT COMPLETED|Overall Study||20
1663407|NCT00663858|4062902|P2|NOT COMPLETED|Overall Study||10
1663408|NCT00663858|4062903|P1|NOT COMPLETED|Overall Study||34
1663409|NCT00663858|4062901|P3|COMPLETED|Overall Study||82
1663410|NCT00663858|4062902|P2|COMPLETED|Overall Study||96
1663411|NCT00663858|4062903|P1|COMPLETED|Overall Study||178
1663412|NCT00663858|4062901|P3|STARTED|Overall Study||102
1663413|NCT00663858|4062902|P2|STARTED|Overall Study||106
1663414|NCT00663858|4062903|P1|STARTED|Overall Study||212
1663415|NCT00663819|4062913|P2|NOT COMPLETED|Overall Study||0
1663416|NCT00663819|4062914|P1|NOT COMPLETED|Overall Study||0
1663417|NCT00663819|4062913|P2|COMPLETED|Overall Study||135
1663418|NCT00663819|4062914|P1|COMPLETED|Overall Study||123
1663419|NCT00663819|4062913|P2|STARTED|Overall Study||135
1663420|NCT00663819|4062914|P1|STARTED|Overall Study||123
1663421|NCT00663793|4062928|P2|NOT COMPLETED|Overall Study||0
1663422|NCT00663793|4062929|P1|NOT COMPLETED|Overall Study||0
1663423|NCT00663793|4062928|P2|COMPLETED|Overall Study||8
1663424|NCT00663793|4062929|P1|COMPLETED|Overall Study||8
1663425|NCT00663793|4062928|P2|STARTED|Overall Study||8
1663426|NCT00663793|4062929|P1|STARTED|Overall Study||8
1663427|NCT00663702|4062941|P2|NOT COMPLETED|Overall Study||10
1663428|NCT00663702|4062942|P1|NOT COMPLETED|Overall Study||18
1663429|NCT00663702|4062941|P2|COMPLETED|Overall Study||61
1663430|NCT00663702|4062942|P1|COMPLETED|Overall Study||34
1663431|NCT00663702|4062941|P2|STARTED|Overall Study||71
1663432|NCT00663702|4062942|P1|STARTED|Overall Study||52
1663433|NCT00663403|4062965|P1|NOT COMPLETED|Overall Study||0
1663434|NCT00663403|4062965|P1|COMPLETED|Overall Study||8
1663435|NCT00663403|4062965|P1|STARTED|Overall Study||8
1663436|NCT00663260|4062978|P3|NOT COMPLETED|Overall Study||16
1663437|NCT00663260|4062979|P2|NOT COMPLETED|Overall Study||11
1663438|NCT00663260|4062980|P1|NOT COMPLETED|Overall Study||21
1663439|NCT00663260|4062978|P3|COMPLETED|Overall Study||69
1663440|NCT00663260|4062979|P2|COMPLETED|Overall Study||72
1663441|NCT00663260|4062980|P1|COMPLETED|Overall Study||63
1663442|NCT00663260|4062978|P3|STARTED|Overall Study||85
1663443|NCT00663260|4062979|P2|STARTED|Overall Study||83
1663444|NCT00663260|4062980|P1|STARTED|Overall Study||84
1663445|NCT00663234|4062994|P1|NOT COMPLETED|Overall Study||1
1663446|NCT00663234|4062994|P1|COMPLETED|Overall Study||27
1663447|NCT00663234|4062994|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
1663448|NCT00663234|4062994|P1|STARTED|Overall Study||28
1663449|NCT00663208|4063027|P7|NOT COMPLETED|Follow-up Period||1
1663450|NCT00663208|4063028|P6|NOT COMPLETED|Follow-up Period||0
1663451|NCT00663208|4063029|P5|NOT COMPLETED|Follow-up Period||0
1663452|NCT00663208|4063030|P4|NOT COMPLETED|Follow-up Period||2
1663453|NCT00663208|4063031|P3|NOT COMPLETED|Follow-up Period||3
1663454|NCT00663208|4063032|P2|NOT COMPLETED|Follow-up Period||0
1663455|NCT00663208|4063033|P1|NOT COMPLETED|Follow-up Period||3
1663456|NCT00663208|4063027|P7|COMPLETED|Follow-up Period||5
1663457|NCT00663208|4063028|P6|COMPLETED|Follow-up Period||4
1663458|NCT00663208|4063029|P5|COMPLETED|Follow-up Period||4
1663459|NCT00663208|4063030|P4|COMPLETED|Follow-up Period||2
1663460|NCT00663208|4063031|P3|COMPLETED|Follow-up Period||1
1663461|NCT00663208|4063032|P2|COMPLETED|Follow-up Period||3
1663462|NCT00663208|4063033|P1|COMPLETED|Follow-up Period||1
1663463|NCT00663208|4063027|P7|STARTED|Follow-up Period||6
1663464|NCT00663208|4063028|P6|STARTED|Follow-up Period||4
1663465|NCT00663208|4063029|P5|STARTED|Follow-up Period||4
1663466|NCT00663208|4063030|P4|STARTED|Follow-up Period||4
1663467|NCT00663208|4063031|P3|STARTED|Follow-up Period||4
1663468|NCT00663208|4063032|P2|STARTED|Follow-up Period||3
1663469|NCT00663208|4063033|P1|STARTED|Follow-up Period||4
1663470|NCT00663208|4063027|P7|NOT COMPLETED|Treatment Period||0
1663471|NCT00663208|4063028|P6|NOT COMPLETED|Treatment Period||0
1663472|NCT00663208|4063029|P5|NOT COMPLETED|Treatment Period||0
1663473|NCT00663208|4063030|P4|NOT COMPLETED|Treatment Period||0
1663474|NCT00663208|4063031|P3|NOT COMPLETED|Treatment Period||0
1663475|NCT00663208|4063032|P2|NOT COMPLETED|Treatment Period||1
1663476|NCT00663208|4063033|P1|NOT COMPLETED|Treatment Period||0
1663477|NCT00663208|4063027|P7|COMPLETED|Treatment Period||6
1663478|NCT00663208|4063028|P6|COMPLETED|Treatment Period||4
1663479|NCT00663208|4063029|P5|COMPLETED|Treatment Period||4
1663480|NCT00663208|4063030|P4|COMPLETED|Treatment Period||4
1663481|NCT00663208|4063031|P3|COMPLETED|Treatment Period||4
1663482|NCT00663208|4063032|P2|COMPLETED|Treatment Period||3
1663483|NCT00663208|4063033|P1|COMPLETED|Treatment Period||4
1663484|NCT00663208|4063027|P7|STARTED|Treatment Period||6
1663485|NCT00663208|4063028|P6|STARTED|Treatment Period||4
1663486|NCT00663208|4063029|P5|STARTED|Treatment Period||4
1663487|NCT00663208|4063030|P4|STARTED|Treatment Period||4
1663488|NCT00663208|4063031|P3|STARTED|Treatment Period||4
1663489|NCT00663208|4063032|P2|STARTED|Treatment Period||4
1663490|NCT00663208|4063033|P1|STARTED|Treatment Period||4
1663491|NCT00663169|4063185|P2|NOT COMPLETED|Overall Study||0
1663492|NCT00663169|4063186|P1|NOT COMPLETED|Overall Study||0
1663493|NCT00663169|4063185|P2|COMPLETED|Overall Study||3
1663495|NCT00663169|4063185|P2|STARTED|Overall Study||3
1663496|NCT00663169|4063186|P1|STARTED|Overall Study||3
1663497|NCT00663117|4063211|P2|NOT COMPLETED|Overall Study||0
1663498|NCT00663117|4063212|P1|NOT COMPLETED|Overall Study||1
1663499|NCT00663117|4063211|P2|COMPLETED|Overall Study||20
1663500|NCT00663117|4063212|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
1663501|NCT00663117|4063211|P2|STARTED|Overall Study||20
1663502|NCT00663117|4063212|P1|STARTED|Overall Study||20
1663503|NCT00663052|4063226|P2|NOT COMPLETED|Overall Study||10
1663504|NCT00663052|4063227|P1|NOT COMPLETED|Overall Study||12
1663505|NCT00663052|4063226|P2|COMPLETED|Overall Study||127
1663506|NCT00663052|4063227|P1|COMPLETED|Overall Study||124
1663507|NCT00663052|4063226|P2|STARTED|Overall Study||137
1663508|NCT00663052|4063227|P1|STARTED|Overall Study||136
1663509|NCT00663039|4063307|P2|NOT COMPLETED|Overall Study||4
1663510|NCT00663039|4063308|P1|NOT COMPLETED|Overall Study||4
1663511|NCT00663039|4063307|P2|COMPLETED|Overall Study||9
1663512|NCT00663039|4063308|P1|COMPLETED|Overall Study||10
1663513|NCT00663039|4063307|P2|STARTED|Overall Study||13
1663514|NCT00663039|4063308|P1|STARTED|Overall Study||14
1663515|NCT00663026|4063333|P3|NOT COMPLETED|Overall Study||4
1663516|NCT00663026|4063334|P2|NOT COMPLETED|Overall Study||6
1663517|NCT00663026|4063335|P1|NOT COMPLETED|Overall Study||2
1663518|NCT00663026|4063333|P3|COMPLETED|Overall Study||27
1663519|NCT00663026|4063334|P2|COMPLETED|Overall Study||23
1663520|NCT00663026|4063335|P1|COMPLETED|Overall Study||17
1663521|NCT00663026|4063333|P3|STARTED|Overall Study||31
1663522|NCT00663026|4063334|P2|STARTED|Overall Study||29
1663523|NCT00663026|4063335|P1|STARTED|Overall Study||19
1663524|NCT00662909|4063358|P3|NOT COMPLETED|Overall Study||53
1663525|NCT00662909|4063359|P2|NOT COMPLETED|Overall Study||59
1663526|NCT00662909|4063360|P1|NOT COMPLETED|Overall Study||69
1663527|NCT00662909|4063358|P3|COMPLETED|Overall Study||380
1663528|NCT00662909|4063359|P2|COMPLETED|Overall Study||383
1663529|NCT00662909|4063360|P1|COMPLETED|Overall Study||385
1663530|NCT00662909|4063358|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
1663531|NCT00662909|4063359|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
1663532|NCT00662909|4063360|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
1663533|NCT00662909|4063358|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
1663534|NCT00662909|4063359|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
1663535|NCT00662909|4063360|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
1663536|NCT00662909|4063358|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
1663537|NCT00662909|4063359|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
1663538|NCT00662909|4063360|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
1663539|NCT00662909|4063358|P3|STARTED|Overall Study||433
1663540|NCT00662909|4063359|P2|STARTED|Overall Study||442
1663541|NCT00662909|4063360|P1|STARTED|Overall Study||454
1663542|NCT00662857|4063458|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
1663543|NCT00662857|4063459|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
1663544|NCT00662857|4063458|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
1663545|NCT00662857|4063459|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
1663546|NCT00662857|4063458|P2|STARTED|Lispro Dosing Period (1 Day)||14
1663547|NCT00662857|4063459|P1|STARTED|Lispro Dosing Period (1 Day)||12
1663548|NCT00662857|4063458|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
1663549|NCT00662857|4063459|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
1663550|NCT00662857|4063458|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
1663551|NCT00662857|4063459|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
1663552|NCT00662857|4063458|P2|STARTED|Washout 2 (3 - 14 Days)||14
1663553|NCT00662857|4063459|P1|STARTED|Washout 2 (3 - 14 Days)||13
1663554|NCT00662857|4063458|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
1663555|NCT00662857|4063459|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
1663556|NCT00662857|4063458|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
1663557|NCT00662857|4063459|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
1663558|NCT00662857|4063458|P2|STARTED|TI Dosing Period 2 (1 Day)||14
1663559|NCT00662857|4063459|P1|STARTED|TI Dosing Period 2 (1 Day)||13
1663560|NCT00662857|4063458|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
1663561|NCT00662857|4063459|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
1663562|NCT00662857|4063458|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
1663563|NCT00662857|4063459|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
1663564|NCT00662857|4063458|P2|STARTED|Washout 1 (3 - 14 Days)||16
1663565|NCT00662857|4063459|P1|STARTED|Washout 1 (3 - 14 Days)||13
1663566|NCT00662857|4063458|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
1663567|NCT00662857|4063459|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
1663568|NCT00662857|4063458|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
1663569|NCT00662857|4063459|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
1663570|NCT00662857|4063458|P2|STARTED|TI Dosing Period 1 (1 Day)||16
1663571|NCT00662857|4063459|P1|STARTED|TI Dosing Period 1 (1 Day)||13
1663572|NCT00662831|4063474|P2|NOT COMPLETED|Overall Study||59
1663573|NCT00662831|4063475|P1|NOT COMPLETED|Overall Study||106
1663574|NCT00662831|4063474|P2|COMPLETED|Overall Study||33
1663575|NCT00662831|4063475|P1|COMPLETED|Overall Study||78
1663576|NCT00662831|4063474|P2|STARTED|Overall Study||92
1663577|NCT00662831|4063475|P1|STARTED|Overall Study||184
1663578|NCT00662818|4063515|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
1663579|NCT00662818|4063516|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
1663580|NCT00662818|4063515|P2|COMPLETED|Period 2 (6 Weeks)||41
1663581|NCT00662818|4063516|P1|COMPLETED|Period 2 (6 Weeks)||38
1663582|NCT00662818|4063515|P2|STARTED|Period 2 (6 Weeks)||53
1663583|NCT00662818|4063516|P1|STARTED|Period 2 (6 Weeks)||51
1663584|NCT00662818|4063515|P2|NOT COMPLETED|Wash-Out (14 Days)||5
1663585|NCT00662818|4063516|P1|NOT COMPLETED|Wash-Out (14 Days)||5
1663586|NCT00662818|4063515|P2|COMPLETED|Wash-Out (14 Days)||53
1663587|NCT00662818|4063516|P1|COMPLETED|Wash-Out (14 Days)||51
1663588|NCT00662818|4063515|P2|STARTED|Wash-Out (14 Days)||58
1663589|NCT00662818|4063516|P1|STARTED|Wash-Out (14 Days)||56
1663590|NCT00662818|4063515|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
1663591|NCT00662818|4063516|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
1663592|NCT00662818|4063515|P2|COMPLETED|Period 1 (6 Weeks)||58
1663593|NCT00662818|4063516|P1|COMPLETED|Period 1 (6 Weeks)||56
1663594|NCT00662818|4063515|P2|Treated|Period 1 (6 Weeks)||58
1663595|NCT00662818|4063516|P1|Treated|Period 1 (6 Weeks)||56
1663596|NCT00662818|4063515|P2|STARTED|Period 1 (6 Weeks)||81
1663597|NCT00662818|4063516|P1|STARTED|Period 1 (6 Weeks)||84
1663598|NCT00662675|4063540|P2|NOT COMPLETED|Overall Study||0
1663599|NCT00662675|4063541|P1|NOT COMPLETED|Overall Study||0
1663600|NCT00662675|4063540|P2|COMPLETED|Overall Study||20
1663601|NCT00662675|4063541|P1|COMPLETED|Overall Study||20
1663602|NCT00662675|4063540|P2|STARTED|Overall Study||20
1663603|NCT00662675|4063541|P1|STARTED|Overall Study||20
1663604|NCT00662649|4063555|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
1663605|NCT00662649|4063556|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
1663606|NCT00662649|4063557|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
1663607|NCT00662649|4063558|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
1663608|NCT00662649|4063559|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
1663609|NCT00662649|4063555|P5|COMPLETED|Extension Study (Month 24 to 60)||126
1663610|NCT00662649|4063556|P4|COMPLETED|Extension Study (Month 24 to 60)||112
1663611|NCT00662649|4063557|P3|COMPLETED|Extension Study (Month 24 to 60)||0
1663612|NCT00662649|4063558|P2|COMPLETED|Extension Study (Month 24 to 60)||290
1663613|NCT00662649|4063559|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
1663614|NCT00662649|4063555|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
1663615|NCT00662649|4063556|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
1663616|NCT00662649|4063557|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
1663617|NCT00662649|4063558|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
1663618|NCT00662649|4063559|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
1663619|NCT00662649|4063555|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
1663620|NCT00662649|4063556|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
1663621|NCT00662649|4063557|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
1663622|NCT00662649|4063558|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
1663623|NCT00662649|4063559|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
1663624|NCT00662649|4063555|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
1663625|NCT00662649|4063556|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
1663626|NCT00662649|4063557|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
1663627|NCT00662649|4063558|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
1663628|NCT00662649|4063559|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
1663629|NCT00662649|4063555|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
1663630|NCT00662649|4063556|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
1663631|NCT00662649|4063557|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
1663632|NCT00662649|4063558|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
1663633|NCT00662649|4063559|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
1663634|NCT00662649|4063555|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
1663635|NCT00662649|4063556|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
1663636|NCT00662649|4063557|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
1663637|NCT00662649|4063558|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
1663638|NCT00662649|4063559|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
1663639|NCT00662649|4063555|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
1663640|NCT00662649|4063556|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
1663641|NCT00662649|4063557|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
1663642|NCT00662649|4063558|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
1663643|NCT00662649|4063559|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
1663644|NCT00662649|4063555|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
1663645|NCT00662649|4063556|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
1663646|NCT00662649|4063557|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
1663647|NCT00662649|4063558|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
1663648|NCT00662649|4063559|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
1663649|NCT00662649|4063555|P5|STARTED|Extension Study (Month 24 to 60)||155
1663650|NCT00662649|4063556|P4|STARTED|Extension Study (Month 24 to 60)||145
1663651|NCT00662649|4063557|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
1663652|NCT00662649|4063558|P2|STARTED|Extension Study (Month 24 to 60)||331
1663653|NCT00662649|4063559|P1|STARTED|Extension Study (Month 24 to 60)||289
1663654|NCT00662649|4063555|P5|NOT COMPLETED|Core Study (24 Months)||0
1663655|NCT00662649|4063556|P4|NOT COMPLETED|Core Study (24 Months)||0
1663656|NCT00662649|4063557|P3|NOT COMPLETED|Core Study (24 Months)||86
1663657|NCT00662649|4063558|P2|NOT COMPLETED|Core Study (24 Months)||56
1663658|NCT00662649|4063559|P1|NOT COMPLETED|Core Study (24 Months)||97
1663659|NCT00662649|4063555|P5|COMPLETED|Core Study (24 Months)||0
1663660|NCT00662649|4063556|P4|COMPLETED|Core Study (24 Months)||0
1663661|NCT00662649|4063557|P3|COMPLETED|Core Study (24 Months)||332
1663662|NCT00662649|4063558|P2|COMPLETED|Core Study (24 Months)||369
1663663|NCT00662649|4063559|P1|COMPLETED|Core Study (24 Months)||332
1663664|NCT00662649|4063555|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
1663665|NCT00662649|4063556|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
1663666|NCT00662649|4063557|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
1663667|NCT00662649|4063558|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
1663668|NCT00662649|4063559|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
1663669|NCT00662649|4063555|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
1663670|NCT00662649|4063556|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
1663671|NCT00662649|4063557|P3|STARTED|Core Study (24 Months)||418
1663672|NCT00662649|4063558|P2|STARTED|Core Study (24 Months)||425
1663673|NCT00662649|4063559|P1|STARTED|Core Study (24 Months)||429
1663674|NCT00662558|4063599|P2|NOT COMPLETED|Overall Study||110
1663675|NCT00662558|4063600|P1|NOT COMPLETED|Overall Study||56
1663676|NCT00662558|4063599|P2|COMPLETED|Overall Study||294
1663677|NCT00662558|4063600|P1|COMPLETED|Overall Study||342
1663678|NCT00662558|4063599|P2|Received Treatment|Overall Study||396
1663679|NCT00662558|4063600|P1|Received Treatment|Overall Study||396
1663680|NCT00662558|4063599|P2|STARTED|Overall Study||404
1663681|NCT00662558|4063600|P1|STARTED|Overall Study||398
1663682|NCT00662545|4063634|P2|NOT COMPLETED|Overall Study||0
1663683|NCT00662545|4063635|P1|NOT COMPLETED|Overall Study||0
1663684|NCT00662545|4063634|P2|COMPLETED|Overall Study||5
1663685|NCT00662545|4063635|P1|COMPLETED|Overall Study||5
1663686|NCT00662545|4063634|P2|STARTED|Overall Study||5
1663687|NCT00662545|4063635|P1|STARTED|Overall Study||5
1663688|NCT00662532|4063651|P2|NOT COMPLETED|Overall Study||2
1663689|NCT00662532|4063652|P1|NOT COMPLETED|Overall Study||0
1663690|NCT00662532|4063651|P2|COMPLETED|Overall Study||20
1663691|NCT00662532|4063652|P1|COMPLETED|Overall Study||22
1663692|NCT00662532|4063651|P2|STARTED|Overall Study||22
1663693|NCT00662532|4063652|P1|STARTED|Overall Study||22
1663694|NCT00662389|4063662|P1|NOT COMPLETED|Overall Study||0
1663695|NCT00662389|4063662|P1|COMPLETED|Overall Study||4
1663696|NCT00662389|4063662|P1|STARTED|Overall Study||4
1663697|NCT00662363|4063667|P2|NOT COMPLETED|Overall Study||10
1663698|NCT00662363|4063668|P1|NOT COMPLETED|Overall Study||11
1663699|NCT00662363|4063667|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
1663700|NCT00662363|4063668|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
1663701|NCT00662363|4063667|P2|STARTED|Overall Study||32
1663702|NCT00662363|4063668|P1|STARTED|Overall Study||32
1663703|NCT00662311|4063679|P3|NOT COMPLETED|Overall Study||0
1663704|NCT00662311|4063680|P2|NOT COMPLETED|Overall Study||0
1663705|NCT00662311|4063681|P1|NOT COMPLETED|Overall Study||1
1663706|NCT00662311|4063679|P3|COMPLETED|Overall Study||0
1663707|NCT00662311|4063680|P2|COMPLETED|Overall Study||0
1663708|NCT00662311|4063681|P1|COMPLETED|Overall Study||4
1663709|NCT00662311|4063679|P3|STARTED|Overall Study||0
1663710|NCT00662311|4063680|P2|STARTED|Overall Study||0
1663711|NCT00662311|4063681|P1|STARTED|Overall Study||5
1663712|NCT00662207|4063704|P1|NOT COMPLETED|Overall Study||0
1663713|NCT00662207|4063704|P1|COMPLETED|Overall Study||3
1663714|NCT00662207|4063704|P1|STARTED|Overall Study||3
1663715|NCT00662155|4063715|P4|NOT COMPLETED|Overall Study||4
1663716|NCT00662155|4063716|P3|NOT COMPLETED|Overall Study||7
1663717|NCT00662155|4063717|P2|NOT COMPLETED|Overall Study||5
1663718|NCT00662155|4063718|P1|NOT COMPLETED|Overall Study||3
1663719|NCT00662155|4063715|P4|COMPLETED|Overall Study||14
1663720|NCT00662155|4063716|P3|COMPLETED|Overall Study||13
1663721|NCT00662155|4063717|P2|COMPLETED|Overall Study||15
1663722|NCT00662155|4063718|P1|COMPLETED|Overall Study||13
1663723|NCT00662155|4063715|P4|STARTED|Overall Study||18
1663724|NCT00662155|4063716|P3|STARTED|Overall Study||20
1663725|NCT00662155|4063717|P2|STARTED|Overall Study||20
1663726|NCT00662155|4063718|P1|STARTED|Overall Study||16
1663727|NCT00662129|4063732|P1|NOT COMPLETED|Overall Study||3
1663728|NCT00662129|4063732|P1|COMPLETED|Overall Study||47
1663729|NCT00662129|4063732|P1|STARTED|Overall Study||50
1663730|NCT00662038|4063742|P1|NOT COMPLETED|Overall Study||631
1663731|NCT00662038|4063742|P1|COMPLETED|Overall Study||427
1663732|NCT00662038|4063742|P1|STARTED|Overall Study||1058
1663733|NCT00662025|4063746|P1|NOT COMPLETED|Overall Study||63
1663734|NCT00662025|4063746|P1|COMPLETED|Overall Study||0
1663735|NCT00662025|4063746|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
1663736|NCT00662012|4063766|P1|NOT COMPLETED|Overall Study||87
1663737|NCT00662012|4063766|P1|COMPLETED|Overall Study||327
1663738|NCT00662012|4063766|P1|STARTED|Overall Study||414
1663739|NCT00661999|4063774|P3|NOT COMPLETED|Overall Study||57
1663740|NCT00661999|4063775|P2|NOT COMPLETED|Overall Study||50
1663741|NCT00661999|4063776|P1|NOT COMPLETED|Overall Study||59
1663742|NCT00661999|4063774|P3|COMPLETED|Overall Study||106
1663743|NCT00661999|4063775|P2|COMPLETED|Overall Study||113
1663744|NCT00661999|4063776|P1|COMPLETED|Overall Study||105
1663745|NCT00661999|4063774|P3|STARTED|Overall Study||163
1663746|NCT00661999|4063775|P2|STARTED|Overall Study||163
1663747|NCT00661999|4063776|P1|STARTED|Overall Study||164
1663748|NCT00661960|4063832|P3|NOT COMPLETED|Overall Study||1
1663749|NCT00661960|4063833|P2|NOT COMPLETED|Overall Study||3
1663750|NCT00661960|4063834|P1|NOT COMPLETED|Overall Study||0
1663751|NCT00661960|4063832|P3|COMPLETED|Overall Study||9
1663752|NCT00661960|4063833|P2|COMPLETED|Overall Study||7
1663753|NCT00661960|4063834|P1|COMPLETED|Overall Study||5
1663754|NCT00661960|4063832|P3|STARTED|Overall Study||10
1663755|NCT00661960|4063833|P2|STARTED|Overall Study||10
1663756|NCT00661960|4063834|P1|STARTED|Overall Study||5
1663757|NCT00661895|4063844|P2|NOT COMPLETED|Overall Study||0
1663758|NCT00661895|4063845|P1|NOT COMPLETED|Overall Study||0
1663759|NCT00661895|4063844|P2|COMPLETED|Overall Study||50
1663760|NCT00661895|4063845|P1|COMPLETED|Overall Study||49
1663761|NCT00661895|4063844|P2|STARTED|Overall Study||50
1663762|NCT00661895|4063845|P1|STARTED|Overall Study||49
1663763|NCT00661830|4063853|P2|NOT COMPLETED|Overall Study||42
1663764|NCT00661830|4063854|P1|NOT COMPLETED|Overall Study||40
1663765|NCT00661830|4063853|P2|COMPLETED|Overall Study||6
1663766|NCT00661830|4063854|P1|COMPLETED|Overall Study||9
1663767|NCT00661830|4063853|P2|STARTED|Overall Study||48
1663768|NCT00661830|4063854|P1|STARTED|Overall Study||49
1663769|NCT00661778|4063866|P1|NOT COMPLETED|Overall Study||50
1663770|NCT00661778|4063866|P1|COMPLETED|Overall Study||0
1663771|NCT00661778|4063866|P1|STARTED|Overall Study||50
1663772|NCT00661726|4063873|P1|NOT COMPLETED|Overall Study||1
1663773|NCT00661726|4063873|P1|COMPLETED|Overall Study||5
1663774|NCT00661726|4063873|P1|STARTED|Overall Study||6
1663775|NCT00661713|4063896|P8|NOT COMPLETED|Overall Study||11
1663776|NCT00661713|4063897|P7|NOT COMPLETED|Overall Study||64
1663777|NCT00661713|4063898|P6|NOT COMPLETED|Overall Study||37
1663778|NCT00661713|4063899|P5|NOT COMPLETED|Overall Study||20
1663779|NCT00661713|4063900|P4|NOT COMPLETED|Overall Study||28
1663780|NCT00661713|4063901|P3|NOT COMPLETED|Overall Study||17
1663781|NCT00661713|4063902|P2|NOT COMPLETED|Overall Study||39
1663782|NCT00661713|4063903|P1|NOT COMPLETED|Overall Study||16
1663783|NCT00661713|4063896|P8|COMPLETED|Overall Study||117
1663784|NCT00661713|4063897|P7|COMPLETED|Overall Study||309
1663785|NCT00661713|4063898|P6|COMPLETED|Overall Study||216
1663786|NCT00661713|4063899|P5|COMPLETED|Overall Study||107
1663787|NCT00661713|4063900|P4|COMPLETED|Overall Study||219
1663788|NCT00661713|4063901|P3|COMPLETED|Overall Study||111
1663789|NCT00661713|4063902|P2|COMPLETED|Overall Study||208
1663790|NCT00661713|4063903|P1|COMPLETED|Overall Study||112
1663791|NCT00661713|4063896|P8|STARTED|Overall Study||128
1663792|NCT00661713|4063897|P7|STARTED|Overall Study||373
1663793|NCT00661713|4063898|P6|STARTED|Overall Study||253
1663794|NCT00661713|4063899|P5|STARTED|Overall Study||127
1663795|NCT00661713|4063900|P4|STARTED|Overall Study||247
1663796|NCT00661713|4063901|P3|STARTED|Overall Study||128
1663797|NCT00661713|4063902|P2|STARTED|Overall Study||247
1663798|NCT00661713|4063903|P1|STARTED|Overall Study||128
1663799|NCT00661687|4063993|P1|NOT COMPLETED|Overall Study||15
1663800|NCT00661687|4063993|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
1663801|NCT00661687|4063993|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
1663802|NCT00661674|4064003|P6|NOT COMPLETED|Overall Study||0
1663803|NCT00661674|4064004|P5|NOT COMPLETED|Overall Study||0
1663804|NCT00661674|4064005|P4|NOT COMPLETED|Overall Study||0
1663805|NCT00661674|4064006|P3|NOT COMPLETED|Overall Study||0
1663806|NCT00661674|4064007|P2|NOT COMPLETED|Overall Study||0
1663807|NCT00661674|4064008|P1|NOT COMPLETED|Overall Study||0
1663808|NCT00661674|4064003|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
1663809|NCT00661674|4064004|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
1663810|NCT00661674|4064005|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
1663811|NCT00661674|4064006|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
1663812|NCT00661674|4064007|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
1663813|NCT00661674|4064008|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
1663814|NCT00661674|4064003|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
1663815|NCT00661674|4064004|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
1663816|NCT00661674|4064005|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
1663817|NCT00661674|4064006|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
1663818|NCT00661674|4064007|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
1663819|NCT00661674|4064008|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
1663820|NCT00661661|4064021|P2|NOT COMPLETED|Overall Study||39
1663821|NCT00661661|4064022|P1|NOT COMPLETED|Overall Study||140
1663822|NCT00661661|4064021|P2|COMPLETED|Overall Study||66
1663823|NCT00661661|4064022|P1|COMPLETED|Overall Study||242
1663824|NCT00661661|4064021|P2|STARTED|Overall Study||105
1663825|NCT00661661|4064022|P1|STARTED|Overall Study||382
1663826|NCT00661622|4064098|P2|NOT COMPLETED|Overall Study||0
1663827|NCT00661622|4064099|P1|NOT COMPLETED|Overall Study||1
1663828|NCT00661622|4064098|P2|COMPLETED|Overall Study||27
1663829|NCT00661622|4064099|P1|COMPLETED|Overall Study||25
1663830|NCT00661622|4064098|P2|STARTED|Overall Study||27
1663831|NCT00661622|4064099|P1|STARTED|Overall Study||26
1663832|NCT00661609|4064113|P1|NOT COMPLETED|Overall Study||41
1663833|NCT00661609|4064113|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1663834|NCT00661609|4064113|P1|STARTED|Overall Study|All dosed patients|41
1663835|NCT00661583|4064123|P3|NOT COMPLETED|Overall Study||0
1663836|NCT00661583|4064124|P2|NOT COMPLETED|Overall Study||0
1663837|NCT00661583|4064125|P1|NOT COMPLETED|Overall Study||0
1663838|NCT00661583|4064123|P3|COMPLETED|Overall Study||10
1663839|NCT00661583|4064124|P2|COMPLETED|Overall Study||10
1663840|NCT00661583|4064125|P1|COMPLETED|Overall Study||10
1663841|NCT00661583|4064123|P3|STARTED|Overall Study||10
1663842|NCT00661583|4064124|P2|STARTED|Overall Study||10
1663843|NCT00661583|4064125|P1|STARTED|Overall Study||10
1663844|NCT00661570|4064142|P1|NOT COMPLETED|Overall Study||0
1663845|NCT00661570|4064142|P1|COMPLETED|Overall Study||26
1663846|NCT00661570|4064142|P1|STARTED|Overall Study||26
1663847|NCT00661557|4064151|P2|NOT COMPLETED|Overall Study||0
1663848|NCT00661557|4064152|P1|NOT COMPLETED|Overall Study||9
1663849|NCT00661557|4064151|P2|COMPLETED|Overall Study||79
1663850|NCT00661557|4064152|P1|COMPLETED|Overall Study||183
1663851|NCT00661557|4064151|P2|STARTED|Overall Study||79
1663852|NCT00661557|4064152|P1|STARTED|Overall Study||192
1663853|NCT00661544|4064176|P1|NOT COMPLETED|Overall Study||0
1663854|NCT00661544|4064176|P1|COMPLETED|Overall Study||48
1663855|NCT00661544|4064176|P1|STARTED|Overall Study||48
1663856|NCT00661531|4064180|P1|NOT COMPLETED|Overall Study||3
1663857|NCT00661531|4064180|P1|COMPLETED|Overall Study||8
1663858|NCT00661531|4064180|P1|STARTED|Overall Study||11
1663859|NCT00661505|4064185|P1|NOT COMPLETED|Overall Study||30
1663860|NCT00661505|4064185|P1|COMPLETED|Overall Study||102
1663861|NCT00661505|4064185|P1|STARTED|Overall Study||132
1663862|NCT00661492|4064213|P2|NOT COMPLETED|Overall Study||29
1663863|NCT00661492|4064214|P1|NOT COMPLETED|Overall Study||68
1663864|NCT00661492|4064213|P2|COMPLETED|Overall Study||11
1663865|NCT00661492|4064214|P1|COMPLETED|Overall Study||7
1663866|NCT00661492|4064213|P2|STARTED|Overall Study||40
1663867|NCT00661492|4064214|P1|STARTED|Overall Study||75
1663868|NCT00661479|4064238|P4|NOT COMPLETED|Overall Study||0
1663869|NCT00661479|4064239|P3|NOT COMPLETED|Overall Study||0
1663870|NCT00661479|4064240|P2|NOT COMPLETED|Overall Study||0
1663871|NCT00661479|4064241|P1|NOT COMPLETED|Overall Study||0
1663872|NCT00661479|4064238|P4|COMPLETED|Overall Study||3
1663873|NCT00661479|4064239|P3|COMPLETED|Overall Study||3
1663874|NCT00661479|4064240|P2|COMPLETED|Overall Study||3
1663875|NCT00661479|4064241|P1|COMPLETED|Overall Study||12
1663876|NCT00661479|4064238|P4|STARTED|Overall Study||3
1663877|NCT00661479|4064239|P3|STARTED|Overall Study||3
1663878|NCT00661479|4064240|P2|STARTED|Overall Study||3
1663879|NCT00661479|4064241|P1|STARTED|Overall Study||12
1663880|NCT00661453|4064254|P1|NOT COMPLETED|Overall Study||13
1663881|NCT00661453|4064254|P1|COMPLETED|Overall Study||25
1663882|NCT00661453|4064254|P1|STARTED|Overall Study||38
1663883|NCT00661427|4064260|P2|NOT COMPLETED|Overall Study||7
1663884|NCT00661427|4064261|P1|NOT COMPLETED|Overall Study||5
1663885|NCT00661427|4064260|P2|COMPLETED|Overall Study||19
1663886|NCT00661427|4064261|P1|COMPLETED|Overall Study||30
1663887|NCT00661427|4064260|P2|STARTED|Overall Study||26
1663888|NCT00661427|4064261|P1|STARTED|Overall Study||35
1663889|NCT00661388|4064269|P1|NOT COMPLETED|Overall Study||24
1663890|NCT00661388|4064269|P1|COMPLETED|Overall Study||51
1663891|NCT00661388|4064269|P1|STARTED|Overall Study||75
1663892|NCT00661362|4064292|P2|NOT COMPLETED|Overall Study||40
1663893|NCT00661362|4064293|P1|NOT COMPLETED|Overall Study||29
1663894|NCT00661362|4064292|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
1663895|NCT00661362|4064293|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
1663896|NCT00661362|4064292|P2|STARTED|Overall Study|Randomized and treated|287
1663897|NCT00661362|4064293|P1|STARTED|Overall Study|Randomized and treated|283
1663898|NCT00661271|4064311|P2|NOT COMPLETED|Overall Study||25
1663899|NCT00661271|4064312|P1|NOT COMPLETED|Overall Study||28
1663900|NCT00661271|4064311|P2|COMPLETED|Overall Study||20
1663901|NCT00661271|4064312|P1|COMPLETED|Overall Study||20
1663902|NCT00661271|4064311|P2|STARTED|Overall Study||45
1663903|NCT00661271|4064312|P1|STARTED|Overall Study||48
1663904|NCT00661258|4064322|P2|NOT COMPLETED|Overall Study||1
1663905|NCT00661258|4064323|P1|NOT COMPLETED|Overall Study||3
1663906|NCT00661258|4064322|P2|COMPLETED|Overall Study||33
1663907|NCT00661258|4064323|P1|COMPLETED|Overall Study||31
1663908|NCT00661258|4064322|P2|STARTED|Overall Study||34
1663909|NCT00661258|4064323|P1|STARTED|Overall Study||34
1663910|NCT00661193|4064333|P2|NOT COMPLETED|Overall Study||26
1663911|NCT00661193|4064334|P1|NOT COMPLETED|Overall Study||33
1663912|NCT00661193|4064333|P2|COMPLETED|Overall Study||0
1663913|NCT00661193|4064334|P1|COMPLETED|Overall Study||0
1663914|NCT00661193|4064333|P2|STARTED|Overall Study||26
1663915|NCT00661193|4064334|P1|STARTED|Overall Study||33
1663916|NCT00661141|4064345|P6|NOT COMPLETED|Overall Study||0
1663917|NCT00661141|4064346|P5|NOT COMPLETED|Overall Study||0
1663918|NCT00661141|4064347|P4|NOT COMPLETED|Overall Study||0
1663919|NCT00661141|4064348|P3|NOT COMPLETED|Overall Study||0
1663920|NCT00661141|4064349|P2|NOT COMPLETED|Overall Study||0
1663921|NCT00661141|4064350|P1|NOT COMPLETED|Overall Study||0
1663922|NCT00661141|4064345|P6|COMPLETED|Overall Study||4
1663923|NCT00661141|4064346|P5|COMPLETED|Overall Study||4
1663924|NCT00661141|4064347|P4|COMPLETED|Overall Study||4
1663925|NCT00661141|4064348|P3|COMPLETED|Overall Study||4
1663926|NCT00661141|4064349|P2|COMPLETED|Overall Study||8
1663927|NCT00661141|4064350|P1|COMPLETED|Overall Study||8
1663928|NCT00661141|4064345|P6|Administered 30 Minutes After Ethanol|Overall Study||0
1663929|NCT00661141|4064346|P5|Administered 30 Minutes After Ethanol|Overall Study||0
1663930|NCT00661141|4064347|P4|Administered 30 Minutes After Ethanol|Overall Study||2
1663931|NCT00661141|4064348|P3|Administered 30 Minutes After Ethanol|Overall Study||2
1663932|NCT00661141|4064349|P2|Administered 30 Minutes After Ethanol|Overall Study||2
1663933|NCT00661141|4064350|P1|Administered 30 Minutes After Ethanol|Overall Study||2
1663934|NCT00661141|4064345|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
1663935|NCT00661141|4064346|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
1663936|NCT00661141|4064347|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
1663937|NCT00661141|4064348|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
1663938|NCT00661141|4064349|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
1663939|NCT00661141|4064350|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
1663940|NCT00661141|4064345|P6|STARTED|Overall Study||4
1663941|NCT00661141|4064346|P5|STARTED|Overall Study||4
1663942|NCT00661141|4064347|P4|STARTED|Overall Study||4
1663943|NCT00661141|4064348|P3|STARTED|Overall Study||4
1663944|NCT00661141|4064349|P2|STARTED|Overall Study||8
1663945|NCT00661141|4064350|P1|STARTED|Overall Study||8
1663946|NCT00661089|4064559|P2|NOT COMPLETED|Overall Study||2
1663947|NCT00661089|4064560|P1|NOT COMPLETED|Overall Study||0
1663948|NCT00661089|4064559|P2|COMPLETED|Overall Study||9
1663949|NCT00661089|4064560|P1|COMPLETED|Overall Study||10
1663950|NCT00661089|4064559|P2|STARTED|Overall Study||11
1663951|NCT00661089|4064560|P1|STARTED|Overall Study||10
1663952|NCT00661037|4064570|P2|NOT COMPLETED|Overall Study||257
1663953|NCT00661037|4064571|P1|NOT COMPLETED|Overall Study||154
1663954|NCT00661037|4064570|P2|COMPLETED|Overall Study||1027
1663955|NCT00661037|4064571|P1|COMPLETED|Overall Study||682
1663956|NCT00661037|4064570|P2|Deaths|Overall Study||188
1663957|NCT00661037|4064571|P1|Deaths|Overall Study||108
1663958|NCT00661037|4064570|P2|Witdrawn|Overall Study||68
1663959|NCT00661037|4064571|P1|Witdrawn|Overall Study||47
1663960|NCT00661037|4064570|P2|STARTED|Overall Study||1284
1663961|NCT00661037|4064571|P1|STARTED|Overall Study||836
1663962|NCT00660985|4064583|P2|NOT COMPLETED|Overall Study||0
1663963|NCT00660985|4064584|P1|NOT COMPLETED|Overall Study||1
1663964|NCT00660985|4064583|P2|COMPLETED|Overall Study||25
1663965|NCT00660985|4064584|P1|COMPLETED|Overall Study||25
1663966|NCT00660985|4064583|P2|STARTED|Overall Study||25
1663967|NCT00660985|4064584|P1|STARTED|Overall Study||26
1663968|NCT00660907|4064608|P2|NOT COMPLETED|Overall Study||94
1663969|NCT00660907|4064609|P1|NOT COMPLETED|Overall Study||84
1663970|NCT00660907|4064608|P2|COMPLETED|Overall Study||314
1663971|NCT00660907|4064609|P1|COMPLETED|Overall Study||322
1663972|NCT00660907|4064608|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
1663973|NCT00660907|4064609|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
1663974|NCT00660829|4064623|P2|NOT COMPLETED|Overall Study||19
1663975|NCT00660829|4064624|P1|NOT COMPLETED|Overall Study||18
1663976|NCT00660829|4064623|P2|COMPLETED|Overall Study||249
1663977|NCT00660829|4064624|P1|COMPLETED|Overall Study||250
1663978|NCT00660829|4064623|P2|STARTED|Overall Study|2 subjects were randomized in error|268
1663979|NCT00660829|4064624|P1|STARTED|Overall Study|2 subjects were randomized in error|268
1663980|NCT00660816|4064642|P2|NOT COMPLETED|Overall Study||19
1663981|NCT00660816|4064643|P1|NOT COMPLETED|Overall Study||20
1663982|NCT00660816|4064642|P2|COMPLETED|Overall Study||3
1663983|NCT00660816|4064643|P1|COMPLETED|Overall Study||4
1663984|NCT00660816|4064642|P2|STARTED|Overall Study||22
1663985|NCT00660816|4064643|P1|STARTED|Overall Study||24
1663986|NCT00660699|4064655|P1|NOT COMPLETED|Overall Study||2
1663987|NCT00660699|4064655|P1|COMPLETED|Overall Study||48
1663988|NCT00660699|4064655|P1|STARTED|Overall Study||50
1663989|NCT00660660|4064671|P2|NOT COMPLETED|Overall Study||9
1663990|NCT00660660|4064672|P1|NOT COMPLETED|Overall Study||5
1663991|NCT00660660|4064671|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
1663992|NCT00660660|4064672|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
1663993|NCT00660660|4064671|P2|Met Criteria for MITT Population|Overall Study||125
1663994|NCT00660660|4064672|P1|Met Criteria for MITT Population|Overall Study||137
1663995|NCT00660660|4064671|P2|STARTED|Overall Study|Randomized|133
1663996|NCT00660660|4064672|P1|STARTED|Overall Study|Randomized|143
1663997|NCT00660595|4064772|P2|NOT COMPLETED|Overall Study||9
1663998|NCT00660595|4064773|P1|NOT COMPLETED|Overall Study||18
1663999|NCT00660595|4064772|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
1664000|NCT00660595|4064773|P1|COMPLETED|Overall Study||1
1664001|NCT00660595|4064772|P2|STARTED|Overall Study||10
1664002|NCT00660595|4064773|P1|STARTED|Overall Study||19
1664003|NCT00660543|4064785|P1|NOT COMPLETED|Overall Study||0
1664004|NCT00660543|4064785|P1|COMPLETED|Overall Study||14
1664005|NCT00660543|4064785|P1|STARTED|Overall Study||14
1664006|NCT00660517|4064798|P4|NOT COMPLETED|Overall Study||7
1664007|NCT00660517|4064799|P3|NOT COMPLETED|Overall Study||7
1664008|NCT00660517|4064800|P2|NOT COMPLETED|Overall Study||8
1664009|NCT00660517|4064801|P1|NOT COMPLETED|Overall Study||8
1664010|NCT00660517|4064798|P4|COMPLETED|Overall Study||144
1664011|NCT00660517|4064799|P3|COMPLETED|Overall Study||144
1664012|NCT00660517|4064800|P2|COMPLETED|Overall Study||144
1664013|NCT00660517|4064801|P1|COMPLETED|Overall Study||145
1664014|NCT00660517|4064798|P4|STARTED|Overall Study||151
1664015|NCT00660517|4064799|P3|STARTED|Overall Study||151
1664016|NCT00660517|4064800|P2|STARTED|Overall Study||152
1664017|NCT00660517|4064801|P1|STARTED|Overall Study||153
1664018|NCT00660504|4064821|P2|NOT COMPLETED|Overall Study||1
1664019|NCT00660504|4064822|P1|NOT COMPLETED|Overall Study||0
1664020|NCT00660504|4064821|P2|COMPLETED|Overall Study||150
1664021|NCT00660504|4064822|P1|COMPLETED|Overall Study||149
1664022|NCT00660504|4064821|P2|STARTED|Overall Study||151
1664023|NCT00660504|4064822|P1|STARTED|Overall Study||149
1664024|NCT00660400|4064834|P1|NOT COMPLETED|Overall Study||4
1664025|NCT00660400|4064834|P1|COMPLETED|Overall Study||21
1664026|NCT00660400|4064834|P1|STARTED|Overall Study||25
1664027|NCT00660387|4064843|P2|NOT COMPLETED|Overall Study||3
1664028|NCT00660387|4064844|P1|NOT COMPLETED|Overall Study||2
1664029|NCT00660387|4064843|P2|COMPLETED|Overall Study||31
1664030|NCT00660387|4064844|P1|COMPLETED|Overall Study||35
1664031|NCT00660387|4064843|P2|STARTED|Overall Study||34
1664032|NCT00660387|4064844|P1|STARTED|Overall Study||37
1664033|NCT00660348|4064898|P2|NOT COMPLETED|Overall Study||0
1664034|NCT00660348|4064899|P1|NOT COMPLETED|Overall Study||1
1664035|NCT00660348|4064898|P2|COMPLETED|Overall Study||0
1664036|NCT00660348|4064899|P1|COMPLETED|Overall Study||0
1664037|NCT00660348|4064898|P2|STARTED|Overall Study||0
1664038|NCT00660348|4064899|P1|STARTED|Overall Study||1
1664039|NCT00660309|4064907|P2|NOT COMPLETED|Overall Study||3
1664040|NCT00660309|4064908|P1|NOT COMPLETED|Overall Study||2
1664041|NCT00660309|4064907|P2|COMPLETED|Overall Study||19
1664042|NCT00660309|4064908|P1|COMPLETED|Overall Study||21
1664043|NCT00660309|4064907|P2|Pharmacodynamic Analysis Set|Overall Study||20
1664044|NCT00660309|4064908|P1|Pharmacodynamic Analysis Set|Overall Study||22
1664045|NCT00660309|4064907|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
1664046|NCT00660309|4064908|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
1664047|NCT00660309|4064907|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
1664048|NCT00660309|4064908|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
1664049|NCT00660192|4064949|P2|NOT COMPLETED|Overall Study||3
1664050|NCT00660192|4064950|P1|NOT COMPLETED|Overall Study||2
1664051|NCT00660192|4064949|P2|COMPLETED|Overall Study||10
1664052|NCT00660192|4064950|P1|COMPLETED|Overall Study||10
1664053|NCT00660192|4064949|P2|STARTED|Overall Study||13
1664054|NCT00660192|4064950|P1|STARTED|Overall Study||12
1664055|NCT00660179|4064961|P3|NOT COMPLETED|Overall Study||41
1664056|NCT00660179|4064962|P2|NOT COMPLETED|Overall Study||58
1664057|NCT00660179|4064963|P1|NOT COMPLETED|Overall Study||56
1664058|NCT00660179|4064961|P3|COMPLETED|Overall Study||201
1664059|NCT00660179|4064962|P2|COMPLETED|Overall Study||192
1664060|NCT00660179|4064963|P1|COMPLETED|Overall Study||194
1664061|NCT00660179|4064961|P3|STARTED|Overall Study||242
1664062|NCT00660179|4064962|P2|STARTED|Overall Study||250
1664063|NCT00660179|4064963|P1|STARTED|Overall Study||250
1664064|NCT00660075|4064997|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
1664065|NCT00660075|4064998|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
1664066|NCT00660075|4064997|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
1664067|NCT00660075|4064998|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
1664068|NCT00660075|4064997|P2|STARTED|Second Intervention (Week 11 to Week 16||18
1664069|NCT00660075|4064998|P1|STARTED|Second Intervention (Week 11 to Week 16||18
1664070|NCT00660075|4064997|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
1664071|NCT00660075|4064998|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
1664072|NCT00660075|4064997|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
1664073|NCT00660075|4064998|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
1664074|NCT00660075|4064997|P2|STARTED|Washout Period (Week 7 to Week 10)||18
1664075|NCT00660075|4064998|P1|STARTED|Washout Period (Week 7 to Week 10)||18
1664076|NCT00660075|4064997|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
1664077|NCT00660075|4064998|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
1664078|NCT00660075|4064997|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
1664079|NCT00660075|4064998|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
1664080|NCT00660075|4064997|P2|STARTED|First Intervention (Week 1 to Week 6)||18
1664081|NCT00660075|4064998|P1|STARTED|First Intervention (Week 1 to Week 6)||18
1664082|NCT00660049|4065004|P1|NOT COMPLETED|Overall Study||6
1664083|NCT00660049|4065004|P1|COMPLETED|Overall Study||6
1664084|NCT00660049|4065004|P1|STARTED|Overall Study||12
1664085|NCT00660023|4065008|P1|NOT COMPLETED|Overall Study||29
1664086|NCT00660023|4065008|P1|COMPLETED|Overall Study||95
1664087|NCT00660023|4065008|P1|Treated|Overall Study||114
1664088|NCT00660023|4065008|P1|STARTED|Overall Study||124
1664089|NCT00660010|4065019|P1|NOT COMPLETED|Overall Study||9
1664090|NCT00660010|4065019|P1|COMPLETED|Overall Study||46
1664091|NCT00660010|4065019|P1|STARTED|Overall Study||55
1664092|NCT00659984|4065033|P1|NOT COMPLETED|Overall Study||1
1664093|NCT00659984|4065033|P1|COMPLETED|Overall Study||14
1664094|NCT00659984|4065033|P1|STARTED|Overall Study||15
1664095|NCT00659945|4065046|P2|NOT COMPLETED|Overall Study||0
1664096|NCT00659945|4065047|P1|NOT COMPLETED|Overall Study||0
1664097|NCT00659945|4065046|P2|COMPLETED|Overall Study||75
1664098|NCT00659945|4065047|P1|COMPLETED|Overall Study||75
1664099|NCT00659945|4065046|P2|STARTED|Overall Study||75
1664100|NCT00659945|4065047|P1|STARTED|Overall Study||75
1664101|NCT00659880|4065053|P1|NOT COMPLETED|Overall Study||5
1664102|NCT00659880|4065053|P1|COMPLETED|Overall Study|60 months|4
1664103|NCT00659880|4065053|P1|24 Months|Overall Study||6
1664104|NCT00659880|4065053|P1|12 Months|Overall Study||7
1664105|NCT00659880|4065053|P1|6 Months|Overall Study||9
1664106|NCT00659880|4065053|P1|6 Weeks|Overall Study||9
1664107|NCT00659880|4065053|P1|STARTED|Overall Study||9
1664108|NCT00659815|4065060|P2|NOT COMPLETED|Overall Study||4
1664109|NCT00659815|4065061|P1|NOT COMPLETED|Overall Study||4
1664110|NCT00659815|4065060|P2|COMPLETED|Overall Study||147
1664111|NCT00659815|4065061|P1|COMPLETED|Overall Study||153
1664112|NCT00659815|4065060|P2|STARTED|Overall Study||151
1664113|NCT00659815|4065061|P1|STARTED|Overall Study||157
1664114|NCT00659789|4065073|P2|NOT COMPLETED|Overall Study||7
1664115|NCT00659789|4065074|P1|NOT COMPLETED|Overall Study||7
1664116|NCT00659789|4065073|P2|COMPLETED|Overall Study||36
1664117|NCT00659789|4065074|P1|COMPLETED|Overall Study||86
1664118|NCT00659789|4065073|P2|STARTED|Overall Study||43
1664119|NCT00659789|4065074|P1|STARTED|Overall Study||93
1664120|NCT00659737|4065092|P2|NOT COMPLETED|Overall Study||0
1664121|NCT00659737|4065093|P1|NOT COMPLETED|Overall Study||0
1664122|NCT00659737|4065092|P2|COMPLETED|Overall Study||58
1664123|NCT00659737|4065093|P1|COMPLETED|Overall Study||57
1664124|NCT00659737|4065092|P2|STARTED|Overall Study||58
1664125|NCT00659737|4065093|P1|STARTED|Overall Study||57
1664126|NCT00659724|4065099|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
1664127|NCT00659724|4065099|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
1664128|NCT00659724|4065099|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
1664129|NCT00659724|4065099|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
1664130|NCT00659724|4065099|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
1664131|NCT00659724|4065099|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
1664132|NCT00659633|4065117|P1|NOT COMPLETED|Overall Study||0
1664133|NCT00659633|4065117|P1|COMPLETED|Overall Study||10
1664134|NCT00659633|4065117|P1|STARTED|Overall Study||10
1664135|NCT00659607|4065121|P1|NOT COMPLETED|Overall Study||316
1664136|NCT00659607|4065121|P1|COMPLETED|Overall Study||3616
1664137|NCT00659607|4065121|P1|STARTED|Overall Study||3932
1664138|NCT00659581|4065139|P1|NOT COMPLETED|Overall Study||8582
1664139|NCT00659581|4065139|P1|COMPLETED|Overall Study||12412
1664140|NCT00659581|4065139|P1|STARTED|Overall Study||20994
1664141|NCT00659529|4065151|P1|NOT COMPLETED|Overall Study||16
1664142|NCT00659529|4065151|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
1664143|NCT00659529|4065151|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
1664144|NCT00659529|4065151|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
1664145|NCT00659490|4065158|P3|NOT COMPLETED|Overall Study||1
1664146|NCT00659490|4065159|P2|NOT COMPLETED|Overall Study||0
1664147|NCT00659490|4065160|P1|NOT COMPLETED|Overall Study||2
1664148|NCT00659490|4065158|P3|COMPLETED|Overall Study||30
1664149|NCT00659490|4065159|P2|COMPLETED|Overall Study||59
1664150|NCT00659490|4065160|P1|COMPLETED|Overall Study||59
1664151|NCT00659490|4065158|P3|STARTED|Overall Study||31
1664152|NCT00659490|4065159|P2|STARTED|Overall Study||59
1664153|NCT00659490|4065160|P1|STARTED|Overall Study||61
1664154|NCT00659438|4065233|P2|NOT COMPLETED|Overall Study||8
1664155|NCT00659438|4065234|P1|NOT COMPLETED|Overall Study||14
1664156|NCT00659438|4065233|P2|COMPLETED|Overall Study||40
1664157|NCT00659438|4065234|P1|COMPLETED|Overall Study||33
1664158|NCT00659438|4065233|P2|Safety Analysis Set|Overall Study||47
1664159|NCT00659438|4065234|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
1664160|NCT00659438|4065233|P2|Secondary Analysis Set|Overall Study||48
1664161|NCT00659438|4065234|P1|Secondary Analysis Set|Overall Study||47
1664162|NCT00659438|4065233|P2|Assessable Set : Primary Analysis|Overall Study||45
1664163|NCT00659438|4065234|P1|Assessable Set : Primary Analysis|Overall Study||44
1664164|NCT00659438|4065233|P2|STARTED|Overall Study||48
1664165|NCT00659438|4065234|P1|STARTED|Overall Study||47
1664166|NCT00659425|4065266|P10|NOT COMPLETED|Overall Study||13
1664167|NCT00659425|4065267|P9|NOT COMPLETED|Overall Study||6
1664168|NCT00659425|4065268|P8|NOT COMPLETED|Overall Study||11
1664169|NCT00659425|4065269|P7|NOT COMPLETED|Overall Study||8
1664170|NCT00659425|4065270|P6|NOT COMPLETED|Overall Study||4
1664171|NCT00659425|4065271|P5|NOT COMPLETED|Overall Study||4
1664172|NCT00659425|4065272|P4|NOT COMPLETED|Overall Study||4
1664173|NCT00659425|4065273|P3|NOT COMPLETED|Overall Study||1
1664174|NCT00659425|4065274|P2|NOT COMPLETED|Overall Study||1
1664175|NCT00659425|4065275|P1|NOT COMPLETED|Overall Study||1
1664176|NCT00659425|4065266|P10|COMPLETED|Overall Study||1
1664177|NCT00659425|4065267|P9|COMPLETED|Overall Study||0
1664178|NCT00659425|4065268|P8|COMPLETED|Overall Study||0
1664179|NCT00659425|4065269|P7|COMPLETED|Overall Study||0
1664180|NCT00659425|4065270|P6|COMPLETED|Overall Study||1
1664181|NCT00659425|4065271|P5|COMPLETED|Overall Study||0
1664182|NCT00659425|4065272|P4|COMPLETED|Overall Study||0
1664183|NCT00659425|4065273|P3|COMPLETED|Overall Study||0
1664184|NCT00659425|4065274|P2|COMPLETED|Overall Study||0
1664185|NCT00659425|4065275|P1|COMPLETED|Overall Study||0
1664186|NCT00659425|4065266|P10|STARTED|Overall Study||14
1664187|NCT00659425|4065267|P9|STARTED|Overall Study||6
1664188|NCT00659425|4065268|P8|STARTED|Overall Study||11
1664189|NCT00659425|4065269|P7|STARTED|Overall Study||8
1664190|NCT00659425|4065270|P6|STARTED|Overall Study||5
1664191|NCT00659425|4065271|P5|STARTED|Overall Study||4
1664192|NCT00659425|4065272|P4|STARTED|Overall Study||4
1664193|NCT00659425|4065273|P3|STARTED|Overall Study||1
1664194|NCT00659425|4065274|P2|STARTED|Overall Study||1
1664195|NCT00659425|4065275|P1|STARTED|Overall Study||1
1664196|NCT00659373|4065506|P2|NOT COMPLETED|Overall Study||7
1664197|NCT00659373|4065507|P1|NOT COMPLETED|Overall Study||5
1664198|NCT00659373|4065506|P2|COMPLETED|Overall Study||54
1664199|NCT00659373|4065507|P1|COMPLETED|Overall Study||20
1664200|NCT00659373|4065506|P2|STARTED|Overall Study||61
1664201|NCT00659373|4065507|P1|STARTED|Overall Study||25
1664202|NCT00659360|4065513|P1|NOT COMPLETED|Overall Study||0
1664203|NCT00659360|4065513|P1|COMPLETED|Overall Study||17
1664204|NCT00659360|4065513|P1|STARTED|Overall Study||17
1664205|NCT00659334|4065529|P7|NOT COMPLETED|Overall Study||1
1664206|NCT00659334|4065530|P6|NOT COMPLETED|Overall Study||0
1664207|NCT00659334|4065531|P5|NOT COMPLETED|Overall Study||0
1664208|NCT00659334|4065532|P4|NOT COMPLETED|Overall Study||0
1664209|NCT00659334|4065533|P3|NOT COMPLETED|Overall Study||0
1664210|NCT00659334|4065534|P2|NOT COMPLETED|Overall Study||5
1664211|NCT00659334|4065535|P1|NOT COMPLETED|Overall Study||8
1664212|NCT00659334|4065529|P7|COMPLETED|Overall Study|1 screen failure|20
1664213|NCT00659334|4065530|P6|COMPLETED|Overall Study||0
1664214|NCT00659334|4065531|P5|COMPLETED|Overall Study||1
1664215|NCT00659334|4065532|P4|COMPLETED|Overall Study||2
1664216|NCT00659334|4065533|P3|COMPLETED|Overall Study||5
1664217|NCT00659334|4065534|P2|COMPLETED|Overall Study|5 Screen failures|36
1664218|NCT00659334|4065535|P1|COMPLETED|Overall Study|8 Screen failures|38
1664219|NCT00659334|4065529|P7|STARTED|Overall Study||21
1664220|NCT00659334|4065530|P6|STARTED|Overall Study||0
1664221|NCT00659334|4065531|P5|STARTED|Overall Study||1
1664222|NCT00659334|4065532|P4|STARTED|Overall Study||2
1664223|NCT00659334|4065533|P3|STARTED|Overall Study||5
1664224|NCT00659334|4065534|P2|STARTED|Overall Study||41
1664225|NCT00659334|4065535|P1|STARTED|Overall Study||46
1664226|NCT00659295|4065553|P2|NOT COMPLETED|Overall Study||5603
1664227|NCT00659295|4065554|P1|NOT COMPLETED|Overall Study||2708
1664228|NCT00659295|4065553|P2|COMPLETED|Overall Study||32038
1664229|NCT00659295|4065554|P1|COMPLETED|Overall Study||10821
1664230|NCT00659295|4065553|P2|STARTED|Overall Study||37641
1664231|NCT00659295|4065554|P1|STARTED|Overall Study||13529
1664232|NCT00659269|4065562|P2|NOT COMPLETED|Overall Study||1
1664233|NCT00659269|4065563|P1|NOT COMPLETED|Overall Study||1
1664234|NCT00659269|4065562|P2|COMPLETED|Overall Study||161
1664235|NCT00659269|4065563|P1|COMPLETED|Overall Study||156
1664236|NCT00659269|4065562|P2|Group 3 (Taxanes)|Overall Study||97
1664237|NCT00659269|4065563|P1|Group 3 (Taxanes)|Overall Study||92
1664238|NCT00659269|4065562|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
1664239|NCT00659269|4065563|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
1664240|NCT00659269|4065562|P2|Group 1 (Heavy Metals)|Overall Study||52
1664241|NCT00659269|4065563|P1|Group 1 (Heavy Metals)|Overall Study||52
1664242|NCT00659269|4065562|P2|STARTED|Overall Study||162
1664243|NCT00659269|4065563|P1|STARTED|Overall Study||157
1664244|NCT00659230|4065593|P2|NOT COMPLETED|Overall Study||12
1664245|NCT00659230|4065594|P1|NOT COMPLETED|Overall Study||9
1664246|NCT00659230|4065593|P2|COMPLETED|Overall Study||37
1664247|NCT00659230|4065594|P1|COMPLETED|Overall Study||42
1664248|NCT00659230|4065593|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
1664249|NCT00659230|4065594|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
1664250|NCT00659165|4065608|P2|NOT COMPLETED|Overall Study||0
1664251|NCT00659165|4065609|P1|NOT COMPLETED|Overall Study||0
1664252|NCT00659165|4065608|P2|COMPLETED|Overall Study||5
1664253|NCT00659165|4065609|P1|COMPLETED|Overall Study||5
1664254|NCT00659165|4065608|P2|STARTED|Overall Study||5
1664255|NCT00659165|4065609|P1|STARTED|Overall Study||5
1664256|NCT00659061|4065617|P2|NOT COMPLETED|Overall Study||15
1664257|NCT00659061|4065618|P1|NOT COMPLETED|Overall Study||21
1664258|NCT00659061|4065617|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
1664259|NCT00659061|4065618|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
1664260|NCT00659061|4065617|P2|STARTED|Overall Study||302
1664261|NCT00659061|4065618|P1|STARTED|Overall Study||308
1664262|NCT00658996|4065636|P2|NOT COMPLETED|Second Intervention||1
1664263|NCT00658996|4065637|P1|NOT COMPLETED|Second Intervention||1
1664264|NCT00658996|4065636|P2|COMPLETED|Second Intervention||104
1664265|NCT00658996|4065637|P1|COMPLETED|Second Intervention||105
1664266|NCT00658996|4065636|P2|STARTED|Second Intervention||105
1664267|NCT00658996|4065637|P1|STARTED|Second Intervention||106
1664268|NCT00658996|4065636|P2|NOT COMPLETED|Crossover Period||1
1664269|NCT00658996|4065637|P1|NOT COMPLETED|Crossover Period||2
1664270|NCT00658996|4065636|P2|COMPLETED|Crossover Period||105
1664271|NCT00658996|4065637|P1|COMPLETED|Crossover Period||106
1664272|NCT00658996|4065636|P2|STARTED|Crossover Period||106
1664273|NCT00658996|4065637|P1|STARTED|Crossover Period||108
1664274|NCT00658996|4065636|P2|NOT COMPLETED|First Intervention||1
1664275|NCT00658996|4065637|P1|NOT COMPLETED|First Intervention||1
1664276|NCT00658996|4065636|P2|COMPLETED|First Intervention||106
1664277|NCT00658996|4065637|P1|COMPLETED|First Intervention||108
1664278|NCT00658996|4065636|P2|STARTED|First Intervention||107
1664279|NCT00658996|4065637|P1|STARTED|First Intervention||109
1664280|NCT00658814|4065649|P2|NOT COMPLETED|Maintenance Therapy||1
1664281|NCT00658814|4065650|P1|NOT COMPLETED|Maintenance Therapy||3
1664282|NCT00658814|4065649|P2|COMPLETED|Maintenance Therapy||7
1664283|NCT00658814|4065650|P1|COMPLETED|Maintenance Therapy||17
1664284|NCT00658814|4065649|P2|Eligible|Maintenance Therapy||8
1664285|NCT00658814|4065650|P1|Eligible|Maintenance Therapy||19
1664286|NCT00658814|4065649|P2|STARTED|Maintenance Therapy||8
1664287|NCT00658814|4065650|P1|STARTED|Maintenance Therapy||20
1664288|NCT00658814|4065649|P2|NOT COMPLETED|Consolidation Therapy||3
1664289|NCT00658814|4065650|P1|NOT COMPLETED|Consolidation Therapy||2
1664290|NCT00658814|4065649|P2|COMPLETED|Consolidation Therapy||10
1664291|NCT00658814|4065650|P1|COMPLETED|Consolidation Therapy||22
1664292|NCT00658814|4065649|P2|Eligible|Consolidation Therapy||11
1664293|NCT00658814|4065650|P1|Eligible|Consolidation Therapy||22
1664294|NCT00658814|4065649|P2|STARTED|Consolidation Therapy||13
1664295|NCT00658814|4065650|P1|STARTED|Consolidation Therapy||24
1664296|NCT00658814|4065649|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
1664297|NCT00658814|4065650|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
1664298|NCT00658814|4065649|P2|COMPLETED|Remission Induction Chemotherapy||41
1664299|NCT00658814|4065650|P1|COMPLETED|Remission Induction Chemotherapy||75
1664300|NCT00658814|4065649|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
1664301|NCT00658814|4065650|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
1664302|NCT00658814|4065649|P2|Eligible|Remission Induction Chemotherapy||57
1664303|NCT00658814|4065650|P1|Eligible|Remission Induction Chemotherapy||82
1664304|NCT00658814|4065649|P2|STARTED|Remission Induction Chemotherapy||59
1664305|NCT00658814|4065650|P1|STARTED|Remission Induction Chemotherapy||83
1664306|NCT00658788|4065664|P1|NOT COMPLETED|Overall Study||74
1664307|NCT00658788|4065664|P1|COMPLETED|Overall Study||231
1664308|NCT00658788|4065664|P1|STARTED|Overall Study||305
1664309|NCT00658775|4065719|P2|NOT COMPLETED|Overall Study||43
1664310|NCT00658775|4065720|P1|NOT COMPLETED|Overall Study||42
1664311|NCT00658775|4065719|P2|COMPLETED|Overall Study||485
1664312|NCT00658775|4065720|P1|COMPLETED|Overall Study||495
1664313|NCT00658775|4065719|P2|STARTED|Overall Study|Treated|528
1664314|NCT00658775|4065720|P1|STARTED|Overall Study|Treated|537
1664315|NCT00658736|4065732|P2|NOT COMPLETED|Overall Study||2
1664316|NCT00658736|4065733|P1|NOT COMPLETED|Overall Study||6
1664317|NCT00658736|4065732|P2|COMPLETED|Overall Study||19
1664318|NCT00658736|4065733|P1|COMPLETED|Overall Study||13
1664319|NCT00658736|4065732|P2|STARTED|Overall Study||21
1664320|NCT00658736|4065733|P1|STARTED|Overall Study||19
1664321|NCT00658723|4065743|P3|NOT COMPLETED|Overall Study||7
1664322|NCT00658723|4065744|P2|NOT COMPLETED|Overall Study||4
1664323|NCT00658723|4065745|P1|NOT COMPLETED|Overall Study||4
1664324|NCT00658723|4065743|P3|COMPLETED|Overall Study||44
1664325|NCT00658723|4065744|P2|COMPLETED|Overall Study||26
1664326|NCT00658723|4065745|P1|COMPLETED|Overall Study||56
1664327|NCT00658723|4065743|P3|STARTED|Overall Study||51
1664328|NCT00658723|4065744|P2|STARTED|Overall Study||30
1664329|NCT00658723|4065745|P1|STARTED|Overall Study||60
1664330|NCT00658697|4065772|P1|NOT COMPLETED|Overall Study||0
1664331|NCT00658697|4065772|P1|COMPLETED|Overall Study||41
1664332|NCT00658697|4065772|P1|STARTED|Overall Study||41
1664333|NCT00658684|4065783|P4|NOT COMPLETED|Overall Study||1
1664334|NCT00658684|4065784|P3|NOT COMPLETED|Overall Study||3
1664335|NCT00658684|4065785|P2|NOT COMPLETED|Overall Study||15
1664336|NCT00658684|4065786|P1|NOT COMPLETED|Overall Study||19
1664337|NCT00658684|4065783|P4|COMPLETED|Overall Study||27
1664338|NCT00658684|4065784|P3|COMPLETED|Overall Study||22
1664339|NCT00658684|4065785|P2|COMPLETED|Overall Study||84
1664340|NCT00658684|4065786|P1|COMPLETED|Overall Study||133
1664341|NCT00658684|4065783|P4|STARTED|Overall Study||28
1664342|NCT00658684|4065784|P3|STARTED|Overall Study||25
1664343|NCT00658684|4065785|P2|STARTED|Overall Study||99
1664344|NCT00658684|4065786|P1|STARTED|Overall Study||152
1664345|NCT00658658|4065841|P5|NOT COMPLETED|Overall Study||5
1664346|NCT00658658|4065842|P4|NOT COMPLETED|Overall Study||2
1664347|NCT00658658|4065843|P3|NOT COMPLETED|Overall Study||0
1664348|NCT00658658|4065844|P2|NOT COMPLETED|Overall Study||2
1664349|NCT00658658|4065845|P1|NOT COMPLETED|Overall Study||5
1664350|NCT00658658|4065841|P5|COMPLETED|Overall Study||3
1664351|NCT00658658|4065842|P4|COMPLETED|Overall Study||4
1664352|NCT00658658|4065843|P3|COMPLETED|Overall Study||4
1664353|NCT00658658|4065844|P2|COMPLETED|Overall Study||5
1664354|NCT00658658|4065845|P1|COMPLETED|Overall Study||1
1664355|NCT00658658|4065841|P5|STARTED|Overall Study||8
1664356|NCT00658658|4065842|P4|STARTED|Overall Study||6
1664357|NCT00658658|4065843|P3|STARTED|Overall Study||4
1664358|NCT00658658|4065844|P2|STARTED|Overall Study||7
1664359|NCT00658658|4065845|P1|STARTED|Overall Study||6
1664360|NCT00658632|4065904|P2|NOT COMPLETED|Overall Study||65
1664361|NCT00658632|4065905|P1|NOT COMPLETED|Overall Study||64
1664362|NCT00658632|4065904|P2|COMPLETED|Overall Study||633
1664363|NCT00658632|4065905|P1|COMPLETED|Overall Study||618
1664364|NCT00658632|4065904|P2|STARTED|Overall Study|Treated|698
1664365|NCT00658632|4065905|P1|STARTED|Overall Study|Treated|682
1664366|NCT00658619|4065920|P5|NOT COMPLETED|Overall Study||2
1664367|NCT00658619|4065921|P4|NOT COMPLETED|Overall Study||12
1664368|NCT00658619|4065922|P3|NOT COMPLETED|Overall Study||10
1664369|NCT00658619|4065923|P2|NOT COMPLETED|Overall Study||1
1664370|NCT00658619|4065924|P1|NOT COMPLETED|Overall Study||0
1664371|NCT00658619|4065920|P5|COMPLETED|Overall Study||21
1664372|NCT00658619|4065921|P4|COMPLETED|Overall Study||37
1664373|NCT00658619|4065922|P3|COMPLETED|Overall Study||31
1664374|NCT00658619|4065923|P2|COMPLETED|Overall Study||2
1664375|NCT00658619|4065924|P1|COMPLETED|Overall Study||3
1664376|NCT00658619|4065920|P5|STARTED|Overall Study||23
1664377|NCT00658619|4065921|P4|STARTED|Overall Study||49
1664378|NCT00658619|4065922|P3|STARTED|Overall Study||41
1664379|NCT00658619|4065923|P2|STARTED|Overall Study||3
1664380|NCT00658619|4065924|P1|STARTED|Overall Study||3
1664381|NCT00658606|4065946|P2|NOT COMPLETED|Overall Study||23
1664382|NCT00658606|4065947|P1|NOT COMPLETED|Overall Study||16
1664383|NCT00658606|4065946|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
1664384|NCT00658606|4065947|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
1664385|NCT00658606|4065946|P2|Completed Treatment|Overall Study||44
1664386|NCT00658606|4065947|P1|Completed Treatment|Overall Study||42
1664387|NCT00658606|4065946|P2|STARTED|Overall Study||49
1664388|NCT00658606|4065947|P1|STARTED|Overall Study||49
1664389|NCT00658567|4065976|P3|NOT COMPLETED|Overall Study||6
1664390|NCT00658567|4065977|P2|NOT COMPLETED|Overall Study||4
1664391|NCT00658567|4065978|P1|NOT COMPLETED|Overall Study||8
1664392|NCT00658567|4065976|P3|COMPLETED|Overall Study||35
1664393|NCT00658567|4065977|P2|COMPLETED|Overall Study||38
1664394|NCT00658567|4065978|P1|COMPLETED|Overall Study||32
1664395|NCT00658567|4065976|P3|STARTED|Overall Study||41
1664396|NCT00658567|4065977|P2|STARTED|Overall Study||42
1664397|NCT00658567|4065978|P1|STARTED|Overall Study||40
1664398|NCT00658541|4065989|P2|NOT COMPLETED|Second Intervention||0
1664399|NCT00658541|4065990|P1|NOT COMPLETED|Second Intervention||0
1664400|NCT00658541|4065989|P2|COMPLETED|Second Intervention||17
1664401|NCT00658541|4065990|P1|COMPLETED|Second Intervention||18
1664402|NCT00658541|4065989|P2|STARTED|Second Intervention||17
1664403|NCT00658541|4065990|P1|STARTED|Second Intervention||18
1664404|NCT00658541|4065989|P2|NOT COMPLETED|Washout Period of 7 Days||2
1664405|NCT00658541|4065990|P1|NOT COMPLETED|Washout Period of 7 Days||1
1664406|NCT00658541|4065989|P2|COMPLETED|Washout Period of 7 Days||17
1664407|NCT00658541|4065990|P1|COMPLETED|Washout Period of 7 Days||18
1664408|NCT00658541|4065989|P2|STARTED|Washout Period of 7 Days||19
1664409|NCT00658541|4065990|P1|STARTED|Washout Period of 7 Days||19
1664410|NCT00658541|4065989|P2|NOT COMPLETED|First Intervention||0
1664411|NCT00658541|4065990|P1|NOT COMPLETED|First Intervention||0
1664412|NCT00658541|4065989|P2|COMPLETED|First Intervention||19
1664413|NCT00658541|4065990|P1|COMPLETED|First Intervention||19
1664414|NCT00658541|4065989|P2|STARTED|First Intervention||19
1664415|NCT00658541|4065990|P1|STARTED|First Intervention||19
1664416|NCT00658528|4066002|P2|NOT COMPLETED|Overall Study||45
1664417|NCT00658528|4066003|P1|NOT COMPLETED|Overall Study||40
1664418|NCT00658528|4066002|P2|COMPLETED|Overall Study||479
1664419|NCT00658528|4066003|P1|COMPLETED|Overall Study||491
1664420|NCT00658528|4066002|P2|STARTED|Overall Study|Treated|524
1664421|NCT00658528|4066003|P1|STARTED|Overall Study|Treated|531
1664422|NCT00658411|4066013|P1|NOT COMPLETED|Overall Study||0
1664423|NCT00658411|4066013|P1|COMPLETED|Overall Study||5
1664424|NCT00658411|4066013|P1|STARTED|Overall Study||5
1664425|NCT00658385|4066021|P1|NOT COMPLETED|Overall Study||0
1664426|NCT00658385|4066021|P1|COMPLETED|Overall Study||5
1664427|NCT00658385|4066021|P1|STARTED|Overall Study||5
1664428|NCT00658359|4066028|P3|NOT COMPLETED|Overall Study||46
1664429|NCT00658359|4066029|P2|NOT COMPLETED|Overall Study||45
1664430|NCT00658359|4066030|P1|NOT COMPLETED|Overall Study||28
1664431|NCT00658359|4066028|P3|COMPLETED|Overall Study||8
1664432|NCT00658359|4066029|P2|COMPLETED|Overall Study||15
1664433|NCT00658359|4066030|P1|COMPLETED|Overall Study||36
1664434|NCT00658359|4066028|P3|STARTED|Overall Study||54
1664435|NCT00658359|4066029|P2|STARTED|Overall Study||60
1664436|NCT00658359|4066030|P1|STARTED|Overall Study||64
1664437|NCT00658333|4066118|P2|NOT COMPLETED|Overall Study||1
1664438|NCT00658333|4066119|P1|NOT COMPLETED|Overall Study||2
1664439|NCT00658333|4066118|P2|COMPLETED|Overall Study||14
1664440|NCT00658333|4066119|P1|COMPLETED|Overall Study||13
1664441|NCT00658333|4066118|P2|STARTED|Overall Study||15
1664442|NCT00658333|4066119|P1|STARTED|Overall Study||15
1664443|NCT00658320|4066129|P2|NOT COMPLETED|Extension Study: After Month 24||0
1664444|NCT00658320|4066130|P1|NOT COMPLETED|Extension Study: After Month 24||2
1664445|NCT00658320|4066129|P2|COMPLETED|Extension Study: After Month 24||0
1664446|NCT00658320|4066130|P1|COMPLETED|Extension Study: After Month 24||42
1664447|NCT00658320|4066129|P2|STARTED|Extension Study: After Month 24||0
1664448|NCT00658320|4066130|P1|STARTED|Extension Study: After Month 24||44
1664449|NCT00658320|4066129|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
1664450|NCT00658320|4066130|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
1664451|NCT00658320|4066129|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
1664452|NCT00658320|4066130|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
1664453|NCT00658320|4066129|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
1664454|NCT00658320|4066130|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
1664455|NCT00658320|4066129|P2|STARTED|Extension Study: Month 12 to Month 24||57
1664456|NCT00658320|4066130|P1|STARTED|Extension Study: Month 12 to Month 24||53
1664457|NCT00658320|4066129|P2|NOT COMPLETED|Core Study: 12 Months||3
1664458|NCT00658320|4066130|P1|NOT COMPLETED|Core Study: 12 Months||5
1664459|NCT00658320|4066129|P2|COMPLETED|Core Study: 12 Months||58
1664460|NCT00658320|4066130|P1|COMPLETED|Core Study: 12 Months||56
1664461|NCT00658320|4066129|P2|STARTED|Core Study: 12 Months||61
1664462|NCT00658320|4066130|P1|STARTED|Core Study: 12 Months||61
1664463|NCT00658138|4066153|P1|NOT COMPLETED|Overall Study||21
1664464|NCT00658138|4066153|P1|COMPLETED|Overall Study||40
1664465|NCT00658138|4066153|P1|STARTED|Overall Study||61
1664466|NCT00658112|4066158|P1|NOT COMPLETED|Overall Study||9
1664467|NCT00658112|4066158|P1|COMPLETED|Overall Study||11
1664468|NCT00658112|4066158|P1|STARTED|Overall Study||20
1664469|NCT00657709|4066167|P5|NOT COMPLETED|Overall Study||33
1664470|NCT00657709|4066168|P4|NOT COMPLETED|Overall Study||14
1664471|NCT00657709|4066169|P3|NOT COMPLETED|Overall Study||28
1664472|NCT00657709|4066170|P2|NOT COMPLETED|Overall Study||33
1664473|NCT00657709|4066171|P1|NOT COMPLETED|Overall Study||23
1664474|NCT00657709|4066167|P5|COMPLETED|Overall Study||457
1664475|NCT00657709|4066168|P4|COMPLETED|Overall Study||645
1664476|NCT00657709|4066169|P3|COMPLETED|Overall Study||792
1664477|NCT00657709|4066170|P2|COMPLETED|Overall Study||795
1664478|NCT00657709|4066171|P1|COMPLETED|Overall Study||810
1664479|NCT00657709|4066167|P5|STARTED|Overall Study||490
1664480|NCT00657709|4066168|P4|STARTED|Overall Study||659
1664481|NCT00657709|4066169|P3|STARTED|Overall Study||820
1664482|NCT00657709|4066170|P2|STARTED|Overall Study||828
1664483|NCT00657709|4066171|P1|STARTED|Overall Study||833
1664484|NCT00657657|4066212|P1|NOT COMPLETED|Overall Study||0
1664485|NCT00657657|4066212|P1|COMPLETED|Overall Study||29
1664486|NCT00657657|4066212|P1|STARTED|Overall Study||29
1664487|NCT00657618|4066220|P1|NOT COMPLETED|Overall Study||43
1664488|NCT00657618|4066220|P1|COMPLETED|Overall Study||34
1664489|NCT00657618|4066220|P1|STARTED|Overall Study||77
1664490|NCT00657553|4066227|P2|NOT COMPLETED|Overall Study||5
1664491|NCT00657553|4066228|P1|NOT COMPLETED|Overall Study||5
1664492|NCT00657553|4066227|P2|COMPLETED|Overall Study||0
1664493|NCT00657553|4066228|P1|COMPLETED|Overall Study||0
1664494|NCT00657553|4066227|P2|STARTED|Overall Study||5
1664495|NCT00657553|4066228|P1|STARTED|Overall Study||5
1664496|NCT00657540|4066236|P2|NOT COMPLETED|Overall Study||4
1664497|NCT00657540|4066237|P1|NOT COMPLETED|Overall Study||1
1664498|NCT00657540|4066236|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
1664499|NCT00657540|4066237|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
1664500|NCT00657540|4066236|P2|STARTED|Overall Study||31
1664501|NCT00657540|4066237|P1|STARTED|Overall Study||29
1664502|NCT00657371|4066251|P1|NOT COMPLETED|Overall Study||39
1664503|NCT00657371|4066251|P1|COMPLETED|Overall Study||249
1664504|NCT00657371|4066251|P1|STARTED|Overall Study||288
1664505|NCT00657358|4066256|P1|NOT COMPLETED|Overall Study||6
1664506|NCT00657358|4066256|P1|COMPLETED|Overall Study||16
1664507|NCT00657358|4066256|P1|STARTED|Overall Study||22
1664508|NCT00657280|4066264|P1|NOT COMPLETED|Overall Study||0
1664509|NCT00657280|4066264|P1|COMPLETED|Overall Study||16
1664510|NCT00657280|4066264|P1|STARTED|Overall Study||16
1664511|NCT00657267|4066268|P1|NOT COMPLETED|Overall Study||54
1664512|NCT00657267|4066268|P1|COMPLETED|Overall Study||4
1664513|NCT00657267|4066268|P1|STARTED|Overall Study||58
1664514|NCT00657150|4066278|P2|NOT COMPLETED|Treatment||97
1664515|NCT00657150|4066279|P1|NOT COMPLETED|Treatment||107
1664516|NCT00657150|4066278|P2|COMPLETED|Treatment||906
1664517|NCT00657150|4066279|P1|COMPLETED|Treatment||903
1664518|NCT00657150|4066278|P2|STARTED|Treatment||1003
1664519|NCT00657150|4066279|P1|STARTED|Treatment||1010
1664520|NCT00657150|4066278|P2|NOT COMPLETED|Overall Study||93
1664521|NCT00657150|4066279|P1|NOT COMPLETED|Overall Study||115
1664522|NCT00657150|4066278|P2|COMPLETED|Overall Study||910
1664523|NCT00657150|4066279|P1|COMPLETED|Overall Study||895
1664524|NCT00657150|4066278|P2|STARTED|Overall Study||1003
1664525|NCT00657150|4066279|P1|STARTED|Overall Study||1010
1664526|NCT00657046|4066310|P3|NOT COMPLETED|Overall Study||2
1664527|NCT00657046|4066311|P2|NOT COMPLETED|Overall Study||3
1664528|NCT00657046|4066312|P1|NOT COMPLETED|Overall Study||4
1664529|NCT00657046|4066310|P3|COMPLETED|Overall Study||21
1664530|NCT00657046|4066311|P2|COMPLETED|Overall Study||29
1664531|NCT00657046|4066312|P1|COMPLETED|Overall Study||26
1664532|NCT00657046|4066310|P3|Had Visits up to Visit 18|Overall Study||23
1664533|NCT00657046|4066311|P2|Had Visits up to Visit 18|Overall Study||30
1664534|NCT00657046|4066312|P1|Had Visits up to Visit 18|Overall Study||28
1664535|NCT00657046|4066310|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
1664536|NCT00657046|4066311|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
1664537|NCT00657046|4066312|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
1664538|NCT00657046|4066310|P3|STARTED|Overall Study||23
1664539|NCT00657046|4066311|P2|STARTED|Overall Study||32
1664540|NCT00657046|4066312|P1|STARTED|Overall Study||30
1664541|NCT00657020|4066344|P2|NOT COMPLETED|PERIOD 2||0
1664542|NCT00657020|4066345|P1|NOT COMPLETED|PERIOD 2||0
1664543|NCT00657020|4066344|P2|COMPLETED|PERIOD 2||11
1664544|NCT00657020|4066345|P1|COMPLETED|PERIOD 2||11
1664545|NCT00657020|4066344|P2|STARTED|PERIOD 2||11
1664546|NCT00657020|4066345|P1|STARTED|PERIOD 2||11
1664547|NCT00657020|4066344|P2|NOT COMPLETED|PERIOD 1||1
1664548|NCT00657020|4066345|P1|NOT COMPLETED|PERIOD 1||0
1664549|NCT00657020|4066344|P2|COMPLETED|PERIOD 1||11
1664550|NCT00657020|4066345|P1|COMPLETED|PERIOD 1||11
1664551|NCT00657020|4066344|P2|STARTED|PERIOD 1||12
1664552|NCT00657020|4066345|P1|STARTED|PERIOD 1||11
1664553|NCT00656968|4066375|P2|NOT COMPLETED|Overall Study||0
1664554|NCT00656968|4066376|P1|NOT COMPLETED|Overall Study||0
1664555|NCT00656968|4066375|P2|COMPLETED|Overall Study||117
1664556|NCT00656968|4066376|P1|COMPLETED|Overall Study||115
1664557|NCT00656968|4066375|P2|STARTED|Overall Study||117
1664558|NCT00656968|4066376|P1|STARTED|Overall Study||115
1664559|NCT00656916|4066386|P2|NOT COMPLETED|Overall Study||0
1664560|NCT00656916|4066387|P1|NOT COMPLETED|Overall Study||0
1664561|NCT00656916|4066386|P2|COMPLETED|Overall Study||0
1664562|NCT00656916|4066387|P1|COMPLETED|Overall Study||1
1664563|NCT00656916|4066386|P2|STARTED|Overall Study||0
1664564|NCT00656916|4066387|P1|STARTED|Overall Study||1
1664565|NCT00656851|4066395|P2|NOT COMPLETED|Overall Study||4
1664566|NCT00656851|4066396|P1|NOT COMPLETED|Overall Study||0
1664567|NCT00656851|4066395|P2|COMPLETED|Overall Study||8
1664568|NCT00656851|4066396|P1|COMPLETED|Overall Study||12
1664569|NCT00656851|4066395|P2|STARTED|Overall Study||12
1664570|NCT00656851|4066396|P1|STARTED|Overall Study||12
1664571|NCT00656799|4066418|P1|NOT COMPLETED|Overall Study||2
1664572|NCT00656799|4066418|P1|COMPLETED|Overall Study||4
1664573|NCT00656799|4066418|P1|STARTED|Overall Study||6
1664574|NCT00656669|4066440|P1|NOT COMPLETED|AC (Cycles 6-9)||2
1664575|NCT00656669|4066440|P1|COMPLETED|AC (Cycles 6-9)||15
1664576|NCT00656669|4066440|P1|STARTED|AC (Cycles 6-9)||17
1664577|NCT00656669|4066440|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
1664578|NCT00656669|4066440|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
1664579|NCT00656669|4066440|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
1664580|NCT00656669|4066440|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
1664581|NCT00656669|4066440|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
1664582|NCT00656669|4066440|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
1664583|NCT00656656|4066449|P1|NOT COMPLETED|Overall Study||0
1664584|NCT00656656|4066449|P1|COMPLETED|Overall Study||23
1664585|NCT00656656|4066449|P1|STARTED|Overall Study||23
1664586|NCT00656630|4066457|P3|NOT COMPLETED|Overall Study||2
1664587|NCT00656630|4066458|P2|NOT COMPLETED|Overall Study||2
1664588|NCT00656630|4066459|P1|NOT COMPLETED|Overall Study||2
1664589|NCT00656630|4066457|P3|COMPLETED|Overall Study||17
1664590|NCT00656630|4066458|P2|COMPLETED|Overall Study||25
1664591|NCT00656630|4066459|P1|COMPLETED|Overall Study||20
1664592|NCT00656630|4066457|P3|STARTED|Overall Study||19
1664593|NCT00656630|4066458|P2|STARTED|Overall Study||27
1664594|NCT00656630|4066459|P1|STARTED|Overall Study||22
1664595|NCT00656617|4066479|P1|NOT COMPLETED|Overall Study||7
1664596|NCT00656617|4066479|P1|COMPLETED|Overall Study||99
1664597|NCT00656617|4066479|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
1664598|NCT00656617|4066479|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
1664599|NCT00656617|4066479|P1|STARTED|Overall Study||106
1664600|NCT00656513|4066488|P3|NOT COMPLETED|Overall Study||22
1664601|NCT00656513|4066489|P2|NOT COMPLETED|Overall Study||30
1664602|NCT00656513|4066490|P1|NOT COMPLETED|Overall Study||4
1664603|NCT00656513|4066488|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
1664604|NCT00656513|4066489|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
1664605|NCT00656513|4066490|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
1664606|NCT00656513|4066488|P3|STARTED|Overall Study||75
1664607|NCT00656513|4066489|P2|STARTED|Overall Study||73
1664608|NCT00656513|4066490|P1|STARTED|Overall Study||48
1664609|NCT00656487|4066512|P3|NOT COMPLETED|Overall Study||0
1664610|NCT00656487|4066513|P2|NOT COMPLETED|Overall Study||4
1664611|NCT00656487|4066514|P1|NOT COMPLETED|Overall Study||2
1664612|NCT00656487|4066512|P3|COMPLETED|Overall Study||20
1664613|NCT00656487|4066513|P2|COMPLETED|Overall Study||19
1664614|NCT00656487|4066514|P1|COMPLETED|Overall Study||21
1664615|NCT00656487|4066512|P3|STARTED|Overall Study||20
1664616|NCT00656487|4066513|P2|STARTED|Overall Study||23
1664617|NCT00656487|4066514|P1|STARTED|Overall Study||23
1664618|NCT00656474|4066537|P1|NOT COMPLETED|Overall Study||1
1664619|NCT00656474|4066537|P1|COMPLETED|Overall Study||11
1664620|NCT00656474|4066537|P1|STARTED|Overall Study||12
1664621|NCT00656448|4066546|P2|NOT COMPLETED|Overall Study||0
1664622|NCT00656448|4066547|P1|NOT COMPLETED|Overall Study||0
1664623|NCT00656448|4066546|P2|COMPLETED|Overall Study||25
1664624|NCT00656448|4066547|P1|COMPLETED|Overall Study||25
1664625|NCT00656448|4066546|P2|STARTED|Overall Study||25
1664626|NCT00656448|4066547|P1|STARTED|Overall Study||25
1664627|NCT00656370|4066555|P1|NOT COMPLETED|Overall Study||10
1664628|NCT00656370|4066555|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
1664629|NCT00656370|4066555|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
1664630|NCT00656305|4066571|P2|NOT COMPLETED|Overall Study||7
1664631|NCT00656305|4066572|P1|NOT COMPLETED|Overall Study||22
1664632|NCT00656305|4066571|P2|COMPLETED|Overall Study||21
1664633|NCT00656305|4066572|P1|COMPLETED|Overall Study||65
1664634|NCT00656305|4066571|P2|STARTED|Overall Study||28
1664635|NCT00656305|4066572|P1|STARTED|Overall Study||87
1664636|NCT00656292|4066584|P2|NOT COMPLETED|Overall Study||5
1664637|NCT00656292|4066585|P1|NOT COMPLETED|Overall Study||3
1664638|NCT00656292|4066584|P2|COMPLETED|Overall Study||24
1664639|NCT00656292|4066585|P1|COMPLETED|Overall Study||29
1664640|NCT00656292|4066584|P2|STARTED|Overall Study||29
1664641|NCT00656292|4066585|P1|STARTED|Overall Study||32
1664642|NCT00656201|4066603|P2|NOT COMPLETED|Overall Study||32
1664643|NCT00656201|4066604|P1|NOT COMPLETED|Overall Study||29
1664644|NCT00656201|4066603|P2|COMPLETED|Overall Study||201
1664645|NCT00656201|4066604|P1|COMPLETED|Overall Study||206
1664646|NCT00656201|4066603|P2|STARTED|Overall Study||233
1664647|NCT00656201|4066604|P1|STARTED|Overall Study||235
1664648|NCT00656175|4066612|P2|NOT COMPLETED|Overall Study||1
1664649|NCT00656175|4066613|P1|NOT COMPLETED|Overall Study||1
1664650|NCT00656175|4066612|P2|COMPLETED|Overall Study||20
1664651|NCT00656175|4066613|P1|COMPLETED|Overall Study||17
1664652|NCT00656175|4066612|P2|STARTED|Overall Study||21
1664653|NCT00656175|4066613|P1|STARTED|Overall Study||18
1664654|NCT00656136|4066621|P2|NOT COMPLETED|Overall Study||390
1664655|NCT00656136|4066622|P1|NOT COMPLETED|Overall Study||195
1664656|NCT00656136|4066621|P2|COMPLETED|Overall Study||0
1664657|NCT00656136|4066622|P1|COMPLETED|Overall Study||0
1664658|NCT00656136|4066621|P2|STARTED|Overall Study|Randomised patients.|390
1664659|NCT00656136|4066622|P1|STARTED|Overall Study|Randomised patients.|195
1664660|NCT00656084|4066632|P1|NOT COMPLETED|Overall Study||7
1664661|NCT00656084|4066632|P1|COMPLETED|Overall Study||9
1664662|NCT00656084|4066632|P1|STARTED|Overall Study||16
1664663|NCT00656058|4066639|P1|NOT COMPLETED|Overall Study||6
1664664|NCT00656058|4066639|P1|COMPLETED|Overall Study||19
1664665|NCT00656058|4066639|P1|STARTED|Overall Study||25
1664666|NCT00656019|4066652|P4|NOT COMPLETED|Overall Study||0
1664667|NCT00656019|4066653|P3|NOT COMPLETED|Overall Study||0
1664668|NCT00656019|4066654|P2|NOT COMPLETED|Overall Study||1
1664669|NCT00656019|4066655|P1|NOT COMPLETED|Overall Study||14
1664670|NCT00656019|4066652|P4|COMPLETED|Overall Study||4
1664671|NCT00656019|4066653|P3|COMPLETED|Overall Study||11
1664672|NCT00656019|4066654|P2|COMPLETED|Overall Study||18
1664673|NCT00656019|4066655|P1|COMPLETED|Overall Study||15
1664674|NCT00656019|4066652|P4|STARTED|Overall Study||4
1664675|NCT00656019|4066653|P3|STARTED|Overall Study||11
1664676|NCT00656019|4066654|P2|STARTED|Overall Study||19
1664677|NCT00656019|4066655|P1|STARTED|Overall Study||29
1664678|NCT00655889|4066665|P1|NOT COMPLETED|Overall Study||2
1664679|NCT00655889|4066665|P1|COMPLETED|Overall Study||11
1664680|NCT00655889|4066665|P1|STARTED|Overall Study||13
1664681|NCT00655876|4066672|P2|NOT COMPLETED|Overall Study||7
1664682|NCT00655876|4066673|P1|NOT COMPLETED|Overall Study||9
1664683|NCT00655876|4066672|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
1664684|NCT00655876|4066673|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
1664685|NCT00655876|4066672|P2|STARTED|Overall Study||176
1664686|NCT00655876|4066673|P1|STARTED|Overall Study||168
1664687|NCT00655863|4066692|P3|NOT COMPLETED|Overall Study||1
1664688|NCT00655863|4066693|P2|NOT COMPLETED|Overall Study||0
1664689|NCT00655863|4066694|P1|NOT COMPLETED|Overall Study||0
1664690|NCT00655863|4066692|P3|COMPLETED|Overall Study||21
1664691|NCT00655863|4066693|P2|COMPLETED|Overall Study||25
1664692|NCT00655863|4066694|P1|COMPLETED|Overall Study||24
1664693|NCT00655863|4066692|P3|STARTED|Overall Study||22
1664694|NCT00655863|4066693|P2|STARTED|Overall Study||25
1664695|NCT00655863|4066694|P1|STARTED|Overall Study||24
1664696|NCT00655850|4066753|P1|NOT COMPLETED|Overall Study||3
1664697|NCT00655850|4066753|P1|COMPLETED|Overall Study||36
1664698|NCT00655850|4066753|P1|STARTED|Overall Study||39
1664699|NCT00655824|4066760|P1|NOT COMPLETED|Overall Study||84
1664700|NCT00655824|4066760|P1|COMPLETED|Overall Study||8
1664701|NCT00655824|4066760|P1|STARTED|Overall Study||92
1664702|NCT00655811|4066794|P1|NOT COMPLETED|Overall Study||0
1664703|NCT00655811|4066794|P1|COMPLETED|Overall Study||40
1664704|NCT00655811|4066794|P1|STARTED|Overall Study||40
1664705|NCT00655746|4066808|P1|NOT COMPLETED|Overall Study||1
1664706|NCT00655746|4066808|P1|COMPLETED|Overall Study||13
1664707|NCT00655746|4066808|P1|STARTED|Overall Study||14
1664708|NCT00655733|4066827|P2|NOT COMPLETED|Overall Study||8
1664709|NCT00655733|4066828|P1|NOT COMPLETED|Overall Study||7
1664710|NCT00655733|4066827|P2|COMPLETED|Overall Study||42
1664711|NCT00655733|4066828|P1|COMPLETED|Overall Study||44
1664712|NCT00655733|4066827|P2|STARTED|Overall Study||50
1664713|NCT00655733|4066828|P1|STARTED|Overall Study||51
1664714|NCT00655668|4066834|P1|NOT COMPLETED|Overall Study||54
1664715|NCT00655668|4066834|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
1664716|NCT00655668|4066834|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
1664717|NCT00655642|4066846|P4|NOT COMPLETED|Overall Study||2
1664718|NCT00655642|4066847|P3|NOT COMPLETED|Overall Study||2
1664719|NCT00655642|4066848|P2|NOT COMPLETED|Overall Study||3
1664720|NCT00655642|4066849|P1|NOT COMPLETED|Overall Study||1
1664721|NCT00655642|4066846|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
1664722|NCT00655642|4066847|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
1664723|NCT00655642|4066848|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
1664724|NCT00655642|4066849|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
1664725|NCT00655642|4066846|P4|STARTED|Overall Study||41
1664726|NCT00655642|4066847|P3|STARTED|Overall Study||45
1664727|NCT00655642|4066848|P2|STARTED|Overall Study||43
1664728|NCT00655642|4066849|P1|STARTED|Overall Study||42
1664729|NCT00655629|4066861|P2|NOT COMPLETED|Overall Study||23
1664730|NCT00655629|4066862|P1|NOT COMPLETED|Overall Study||21
1664731|NCT00655629|4066861|P2|COMPLETED|Overall Study||144
1664732|NCT00655629|4066862|P1|COMPLETED|Overall Study||151
1664733|NCT00655629|4066861|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
1664734|NCT00655629|4066862|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
1664735|NCT00655629|4066861|P2|STARTED|Overall Study||167
1664736|NCT00655629|4066862|P1|STARTED|Overall Study||172
1664737|NCT00655564|4066898|P1|NOT COMPLETED|Overall Study||3
1664738|NCT00655564|4066898|P1|COMPLETED|Overall Study||12
1664739|NCT00655564|4066898|P1|STARTED|Overall Study||15
1664740|NCT00655551|4066906|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
1664741|NCT00655551|4066907|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
1664742|NCT00655551|4066908|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
1664743|NCT00655551|4066906|P3|COMPLETED|Period 4 (up to 7 Days)||0
1664744|NCT00655551|4066907|P2|COMPLETED|Period 4 (up to 7 Days)||23
1664745|NCT00655551|4066908|P1|COMPLETED|Period 4 (up to 7 Days)||0
1664746|NCT00655551|4066906|P3|STARTED|Period 4 (up to 7 Days)||0
1664747|NCT00655551|4066907|P2|STARTED|Period 4 (up to 7 Days)||25
1664748|NCT00655551|4066908|P1|STARTED|Period 4 (up to 7 Days)||0
1664749|NCT00655551|4066906|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
1664750|NCT00655551|4066907|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
1664751|NCT00655551|4066908|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
1664752|NCT00655551|4066906|P3|COMPLETED|Period 3 (up to 7 Days)||21
1664753|NCT00655551|4066907|P2|COMPLETED|Period 3 (up to 7 Days)||0
1664754|NCT00655551|4066908|P1|COMPLETED|Period 3 (up to 7 Days)||0
1664755|NCT00655551|4066906|P3|STARTED|Period 3 (up to 7 Days)||25
1664756|NCT00655551|4066907|P2|STARTED|Period 3 (up to 7 Days)||0
1664757|NCT00655551|4066908|P1|STARTED|Period 3 (up to 7 Days)||0
1664758|NCT00655551|4066906|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
1664759|NCT00655551|4066907|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
1664760|NCT00655551|4066908|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
1664761|NCT00655551|4066906|P3|COMPLETED|Period 2 (up to 7 Days)||0
1664762|NCT00655551|4066907|P2|COMPLETED|Period 2 (up to 7 Days)||24
1664763|NCT00655551|4066908|P1|COMPLETED|Period 2 (up to 7 Days)||0
1664764|NCT00655551|4066906|P3|STARTED|Period 2 (up to 7 Days)||0
1664765|NCT00655551|4066907|P2|STARTED|Period 2 (up to 7 Days)||25
1664766|NCT00655551|4066908|P1|STARTED|Period 2 (up to 7 Days)||0
1664767|NCT00655551|4066906|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
1664768|NCT00655551|4066907|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
1664769|NCT00655551|4066908|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
1664770|NCT00655551|4066906|P3|COMPLETED|Period 1 (up to 7 Days)||0
1664771|NCT00655551|4066907|P2|COMPLETED|Period 1 (up to 7 Days)||0
1664772|NCT00655551|4066908|P1|COMPLETED|Period 1 (up to 7 Days)||25
1664773|NCT00655551|4066906|P3|STARTED|Period 1 (up to 7 Days)||0
1664774|NCT00655551|4066907|P2|STARTED|Period 1 (up to 7 Days)||0
1664775|NCT00655551|4066908|P1|STARTED|Period 1 (up to 7 Days)||25
1664776|NCT00655551|4066906|P3|NOT COMPLETED|All Periods Combined||4
1664777|NCT00655551|4066907|P2|NOT COMPLETED|All Periods Combined||3
1664778|NCT00655551|4066908|P1|NOT COMPLETED|All Periods Combined||0
1664779|NCT00655551|4066906|P3|COMPLETED|All Periods Combined||21
1664780|NCT00655551|4066907|P2|COMPLETED|All Periods Combined||47
1664781|NCT00655551|4066908|P1|COMPLETED|All Periods Combined||25
1664782|NCT00655551|4066906|P3|STARTED|All Periods Combined||25
1664783|NCT00655551|4066907|P2|STARTED|All Periods Combined||50
1664784|NCT00655551|4066908|P1|STARTED|All Periods Combined||25
1664785|NCT00655486|4066922|P1|NOT COMPLETED|Overall Study||28
1664786|NCT00655486|4066922|P1|COMPLETED|Overall Study||69
1664787|NCT00655486|4066922|P1|STARTED|Overall Study||97
1664788|NCT00655356|4066929|P2|NOT COMPLETED|Overall Study||10
1664789|NCT00655356|4066930|P1|NOT COMPLETED|Overall Study||17
1664790|NCT00655356|4066929|P2|COMPLETED|Overall Study||98
1664791|NCT00655356|4066930|P1|COMPLETED|Overall Study||93
1664792|NCT00655356|4066929|P2|STARTED|Overall Study||108
1664793|NCT00655356|4066930|P1|STARTED|Overall Study||110
1664794|NCT00655083|4066944|P2|NOT COMPLETED|Overall Study||0
1664795|NCT00655083|4066945|P1|NOT COMPLETED|Overall Study||0
1664796|NCT00655083|4066944|P2|COMPLETED|Overall Study||8
1664797|NCT00655083|4066945|P1|COMPLETED|Overall Study||12
1664798|NCT00655083|4066944|P2|STARTED|Overall Study||8
1664799|NCT00655083|4066945|P1|STARTED|Overall Study||12
1664800|NCT00654992|4066959|P2|NOT COMPLETED|Overall Study||0
1664801|NCT00654992|4066960|P1|NOT COMPLETED|Overall Study||0
1664802|NCT00654992|4066959|P2|COMPLETED|Overall Study||35
1664803|NCT00654992|4066960|P1|COMPLETED|Overall Study||36
1664804|NCT00654992|4066959|P2|STARTED|Overall Study||35
1664805|NCT00654992|4066960|P1|STARTED|Overall Study||36
1664806|NCT00654953|4066969|P3|NOT COMPLETED|Overall Study||22
1664807|NCT00654953|4066970|P2|NOT COMPLETED|Overall Study||28
1664808|NCT00654953|4066971|P1|NOT COMPLETED|Overall Study||30
1664809|NCT00654953|4066969|P3|COMPLETED|Overall Study||8
1664810|NCT00654953|4066970|P2|COMPLETED|Overall Study||8
1664811|NCT00654953|4066971|P1|COMPLETED|Overall Study||6
1664812|NCT00654953|4066969|P3|STARTED|Overall Study||30
1664813|NCT00654953|4066970|P2|STARTED|Overall Study||36
1664814|NCT00654953|4066971|P1|STARTED|Overall Study||36
1664815|NCT00654940|4066981|P2|NOT COMPLETED|Period 2||0
1664816|NCT00654940|4066982|P1|NOT COMPLETED|Period 2||0
1664817|NCT00654940|4066981|P2|COMPLETED|Period 2||11
1664818|NCT00654940|4066982|P1|COMPLETED|Period 2||12
1664819|NCT00654940|4066981|P2|STARTED|Period 2||11
1664820|NCT00654940|4066982|P1|STARTED|Period 2||12
1664821|NCT00654940|4066981|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1664822|NCT00654940|4066982|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1664823|NCT00654940|4066981|P2|COMPLETED|Washout Period of 2 Weeks||11
1664824|NCT00654940|4066982|P1|COMPLETED|Washout Period of 2 Weeks||12
1664825|NCT00654940|4066981|P2|STARTED|Washout Period of 2 Weeks||11
1664826|NCT00654940|4066982|P1|STARTED|Washout Period of 2 Weeks||12
1664827|NCT00654940|4066981|P2|NOT COMPLETED|Period 1||1
1664828|NCT00654940|4066982|P1|NOT COMPLETED|Period 1||1
1664829|NCT00654940|4066981|P2|COMPLETED|Period 1||11
1664830|NCT00654940|4066982|P1|COMPLETED|Period 1||12
1664831|NCT00654940|4066981|P2|Received Study Treatment|Period 1||12
1664832|NCT00654940|4066982|P1|Received Study Treatment|Period 1||12
1664833|NCT00654940|4066981|P2|STARTED|Period 1|Assigned to study treatment.|12
1664834|NCT00654940|4066982|P1|STARTED|Period 1|Assigned to study treatment.|13
1664835|NCT00654927|4066994|P1|NOT COMPLETED|Overall Study||107
1664836|NCT00654927|4066994|P1|COMPLETED|Overall Study||70
1664837|NCT00654927|4066994|P1|STARTED|Overall Study||177
1664838|NCT00654901|4067006|P4|NOT COMPLETED|Overall Study||0
1664839|NCT00654901|4067007|P3|NOT COMPLETED|Overall Study||2
1664840|NCT00654901|4067008|P2|NOT COMPLETED|Overall Study||0
1664841|NCT00654901|4067009|P1|NOT COMPLETED|Overall Study||4
1664842|NCT00654901|4067006|P4|COMPLETED|Overall Study||113
1664843|NCT00654901|4067007|P3|COMPLETED|Overall Study||250
1664844|NCT00654901|4067008|P2|COMPLETED|Overall Study||262
1664845|NCT00654901|4067009|P1|COMPLETED|Overall Study||250
1664846|NCT00654901|4067006|P4|STARTED|Overall Study||113
1664847|NCT00654901|4067007|P3|STARTED|Overall Study||252
1664848|NCT00654901|4067008|P2|STARTED|Overall Study||262
1664849|NCT00654901|4067009|P1|STARTED|Overall Study||254
1664850|NCT00654875|4067029|P2|NOT COMPLETED|Overall Study||17
1664851|NCT00654875|4067030|P1|NOT COMPLETED|Overall Study||17
1664852|NCT00654875|4067029|P2|COMPLETED|Overall Study||147
1664853|NCT00654875|4067030|P1|COMPLETED|Overall Study||147
1664854|NCT00654875|4067029|P2|STARTED|Overall Study||164
1664855|NCT00654875|4067030|P1|STARTED|Overall Study||164
1664856|NCT00654836|4067048|P1|NOT COMPLETED|Overall Study||0
1664857|NCT00654836|4067048|P1|COMPLETED|Overall Study||32
1664858|NCT00654836|4067048|P1|STARTED|Overall Study||32
1664859|NCT00654784|4067056|P2|NOT COMPLETED|Overall Study||0
1664860|NCT00654784|4067057|P1|NOT COMPLETED|Overall Study||0
1664861|NCT00654784|4067056|P2|COMPLETED|Overall Study||8
1664862|NCT00654784|4067057|P1|COMPLETED|Overall Study||13
1664863|NCT00654784|4067056|P2|STARTED|Overall Study||8
1664864|NCT00654784|4067057|P1|STARTED|Overall Study||13
1664865|NCT00654745|4067063|P1|NOT COMPLETED|Overall Study||43
1664866|NCT00654745|4067063|P1|COMPLETED|Overall Study||164
1664867|NCT00654745|4067063|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
1664868|NCT00654654|4067101|P1|NOT COMPLETED|Overall Study||7
1664869|NCT00654654|4067101|P1|COMPLETED|Overall Study||43
1664870|NCT00654654|4067101|P1|STARTED|Overall Study||50
1664871|NCT00654641|4067108|P2|NOT COMPLETED|Overall Study||3
1664872|NCT00654641|4067109|P1|NOT COMPLETED|Overall Study||2
1664873|NCT00654641|4067108|P2|COMPLETED|Overall Study||23
1664874|NCT00654641|4067109|P1|COMPLETED|Overall Study||26
1664875|NCT00654641|4067108|P2|STARTED|Overall Study||26
1664876|NCT00654641|4067109|P1|STARTED|Overall Study||28
1664877|NCT00654628|4067115|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
1664878|NCT00654628|4067115|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
1664879|NCT00654628|4067115|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
1664880|NCT00654628|4067115|P1|NOT COMPLETED|6-week Active Treatment Period||21
1664881|NCT00654628|4067115|P1|COMPLETED|6-week Active Treatment Period||152
1664882|NCT00654628|4067115|P1|STARTED|6-week Active Treatment Period||173
1664883|NCT00654615|4067132|P2|NOT COMPLETED|Overall Study||7
1664884|NCT00654615|4067133|P1|NOT COMPLETED|Overall Study||8
1664885|NCT00654615|4067132|P2|COMPLETED|Overall Study||23
1664886|NCT00654615|4067133|P1|COMPLETED|Overall Study||22
1664887|NCT00654615|4067132|P2|STARTED|Overall Study||30
1664888|NCT00654615|4067133|P1|STARTED|Overall Study||30
1664889|NCT00654511|4067145|P4|NOT COMPLETED|Overall Study||0
1664890|NCT00654511|4067146|P3|NOT COMPLETED|Overall Study||0
1664891|NCT00654511|4067147|P2|NOT COMPLETED|Overall Study||0
1664892|NCT00654511|4067148|P1|NOT COMPLETED|Overall Study||0
1664893|NCT00654511|4067145|P4|COMPLETED|Overall Study||25
1664894|NCT00654511|4067146|P3|COMPLETED|Overall Study||25
1664895|NCT00654511|4067147|P2|COMPLETED|Overall Study||25
1664896|NCT00654511|4067148|P1|COMPLETED|Overall Study||26
1664897|NCT00654511|4067145|P4|STARTED|Overall Study||25
1664898|NCT00654511|4067146|P3|STARTED|Overall Study||25
1664899|NCT00654511|4067147|P2|STARTED|Overall Study||25
1664900|NCT00654511|4067148|P1|STARTED|Overall Study||26
1664901|NCT00654498|4067164|P2|NOT COMPLETED|Overall Study||12
1664902|NCT00654498|4067165|P1|NOT COMPLETED|Overall Study||14
1664903|NCT00654498|4067164|P2|COMPLETED|Overall Study||91
1664904|NCT00654498|4067165|P1|COMPLETED|Overall Study||189
1664905|NCT00654498|4067164|P2|STARTED|Overall Study||103
1664906|NCT00654498|4067165|P1|STARTED|Overall Study||203
1664907|NCT00654420|4067197|P4|NOT COMPLETED|Phase II||38
1664908|NCT00654420|4067198|P3|NOT COMPLETED|Phase II||37
1664909|NCT00654420|4067199|P2|NOT COMPLETED|Phase II||0
1664910|NCT00654420|4067200|P1|NOT COMPLETED|Phase II||0
1664911|NCT00654420|4067197|P4|COMPLETED|Phase II||0
1664912|NCT00654420|4067198|P3|COMPLETED|Phase II||0
1664913|NCT00654420|4067199|P2|COMPLETED|Phase II||0
1664914|NCT00654420|4067200|P1|COMPLETED|Phase II||0
1664915|NCT00654420|4067197|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
1664916|NCT00654420|4067198|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
1664917|NCT00654420|4067199|P2|STARTED|Phase II||0
1664918|NCT00654420|4067200|P1|STARTED|Phase II||0
1664919|NCT00654420|4067197|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
1664920|NCT00654420|4067198|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
1664921|NCT00654420|4067199|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
1664922|NCT00654420|4067200|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
1664923|NCT00654420|4067197|P4|COMPLETED|Phase I (Dose Escalation)||0
1664924|NCT00654420|4067198|P3|COMPLETED|Phase I (Dose Escalation)||0
1664925|NCT00654420|4067199|P2|COMPLETED|Phase I (Dose Escalation)||0
1664926|NCT00654420|4067200|P1|COMPLETED|Phase I (Dose Escalation)||0
1664927|NCT00654420|4067197|P4|STARTED|Phase I (Dose Escalation)||0
1664928|NCT00654420|4067198|P3|STARTED|Phase I (Dose Escalation)||0
1664929|NCT00654420|4067199|P2|STARTED|Phase I (Dose Escalation)||16
1664930|NCT00654420|4067200|P1|STARTED|Phase I (Dose Escalation)||4
1664931|NCT00654381|4067226|P6|NOT COMPLETED|Extension Stage||3
1664932|NCT00654381|4067227|P5|NOT COMPLETED|Extension Stage||3
1664933|NCT00654381|4067228|P4|NOT COMPLETED|Extension Stage||9
1664934|NCT00654381|4067229|P3|NOT COMPLETED|Extension Stage||11
1664935|NCT00654381|4067230|P2|NOT COMPLETED|Extension Stage||2
1664936|NCT00654381|4067231|P1|NOT COMPLETED|Extension Stage||1
1664937|NCT00654381|4067226|P6|COMPLETED|Extension Stage||73
1664938|NCT00654381|4067227|P5|COMPLETED|Extension Stage||68
1664939|NCT00654381|4067228|P4|COMPLETED|Extension Stage||142
1664940|NCT00654381|4067229|P3|COMPLETED|Extension Stage||142
1664941|NCT00654381|4067230|P2|COMPLETED|Extension Stage||36
1664942|NCT00654381|4067231|P1|COMPLETED|Extension Stage||33
1664943|NCT00654381|4067226|P6|STARTED|Extension Stage||76
1664944|NCT00654381|4067227|P5|STARTED|Extension Stage||71
1664945|NCT00654381|4067228|P4|STARTED|Extension Stage||151
1664946|NCT00654381|4067229|P3|STARTED|Extension Stage||153
1664947|NCT00654381|4067230|P2|STARTED|Extension Stage||38
1664948|NCT00654381|4067231|P1|STARTED|Extension Stage||34
1664949|NCT00654381|4067226|P6|NOT COMPLETED|2nd Stage||3
1664950|NCT00654381|4067227|P5|NOT COMPLETED|2nd Stage||8
1664951|NCT00654381|4067228|P4|NOT COMPLETED|2nd Stage||4
1664952|NCT00654381|4067229|P3|NOT COMPLETED|2nd Stage||3
1664953|NCT00654381|4067230|P2|NOT COMPLETED|2nd Stage||0
1664954|NCT00654381|4067231|P1|NOT COMPLETED|2nd Stage||2
1664955|NCT00654381|4067226|P6|COMPLETED|2nd Stage||76
1664956|NCT00654381|4067227|P5|COMPLETED|2nd Stage||71
1664957|NCT00654381|4067228|P4|COMPLETED|2nd Stage||151
1664958|NCT00654381|4067229|P3|COMPLETED|2nd Stage||153
1664959|NCT00654381|4067230|P2|COMPLETED|2nd Stage||38
1664960|NCT00654381|4067231|P1|COMPLETED|2nd Stage||34
1664961|NCT00654381|4067226|P6|STARTED|2nd Stage||79
1664962|NCT00654381|4067227|P5|STARTED|2nd Stage||79
1664963|NCT00654381|4067228|P4|STARTED|2nd Stage||155
1664964|NCT00654381|4067229|P3|STARTED|2nd Stage||156
1664965|NCT00654381|4067230|P2|STARTED|2nd Stage||38
1664966|NCT00654381|4067231|P1|STARTED|2nd Stage||36
1664967|NCT00654381|4067226|P6|NOT COMPLETED|1st Stage||2
1664968|NCT00654381|4067227|P5|NOT COMPLETED|1st Stage||2
1664969|NCT00654381|4067228|P4|NOT COMPLETED|1st Stage||5
1664970|NCT00654381|4067229|P3|NOT COMPLETED|1st Stage||3
1664971|NCT00654381|4067230|P2|NOT COMPLETED|1st Stage||3
1664972|NCT00654381|4067231|P1|NOT COMPLETED|1st Stage||3
1664973|NCT00654381|4067226|P6|COMPLETED|1st Stage||79
1664974|NCT00654381|4067227|P5|COMPLETED|1st Stage||79
1664975|NCT00654381|4067228|P4|COMPLETED|1st Stage||155
1664976|NCT00654381|4067229|P3|COMPLETED|1st Stage||156
1664977|NCT00654381|4067230|P2|COMPLETED|1st Stage||38
1664978|NCT00654381|4067231|P1|COMPLETED|1st Stage||36
1664979|NCT00654381|4067226|P6|STARTED|1st Stage||81
1664980|NCT00654381|4067227|P5|STARTED|1st Stage||81
1664981|NCT00654381|4067228|P4|STARTED|1st Stage||160
1664982|NCT00654381|4067229|P3|STARTED|1st Stage||159
1664983|NCT00654381|4067230|P2|STARTED|1st Stage||41
1664984|NCT00654381|4067231|P1|STARTED|1st Stage||39
1664985|NCT00654368|4067268|P3|NOT COMPLETED|Overall Study||32
1664986|NCT00654368|4067269|P2|NOT COMPLETED|Overall Study||48
1664987|NCT00654368|4067270|P1|NOT COMPLETED|Overall Study||53
1664988|NCT00654368|4067268|P3|COMPLETED|Overall Study||75
1664989|NCT00654368|4067269|P2|COMPLETED|Overall Study||50
1664990|NCT00654368|4067270|P1|COMPLETED|Overall Study||0
1664991|NCT00654368|4067268|P3|STARTED|Overall Study||107
1664992|NCT00654368|4067269|P2|STARTED|Overall Study||98
1664993|NCT00654368|4067270|P1|STARTED|Overall Study||53
1664994|NCT00654355|4067303|P2|NOT COMPLETED|Overall Study||2
1664995|NCT00654355|4067304|P1|NOT COMPLETED|Overall Study||2
1664996|NCT00654355|4067303|P2|COMPLETED|Overall Study||13
1664997|NCT00654355|4067304|P1|COMPLETED|Overall Study||13
1664998|NCT00654355|4067303|P2|STARTED|Overall Study||15
1664999|NCT00654355|4067304|P1|STARTED|Overall Study||15
1665000|NCT00654329|4067318|P4|NOT COMPLETED|Overall Study||0
1665001|NCT00654329|4067319|P3|NOT COMPLETED|Overall Study||0
1665002|NCT00654329|4067320|P2|NOT COMPLETED|Overall Study||0
1665003|NCT00654329|4067321|P1|NOT COMPLETED|Overall Study||0
1665004|NCT00654329|4067318|P4|COMPLETED|Overall Study||27
1665005|NCT00654329|4067319|P3|COMPLETED|Overall Study||23
1665006|NCT00654329|4067320|P2|COMPLETED|Overall Study||28
1665007|NCT00654329|4067321|P1|COMPLETED|Overall Study||23
1665008|NCT00654329|4067318|P4|STARTED|Overall Study||27
1665009|NCT00654329|4067319|P3|STARTED|Overall Study||23
1665010|NCT00654329|4067320|P2|STARTED|Overall Study||28
1665011|NCT00654329|4067321|P1|STARTED|Overall Study||23
1665012|NCT00654186|4067335|P1|NOT COMPLETED|Overall Study||5
1665013|NCT00654186|4067335|P1|COMPLETED|Overall Study||27
1665014|NCT00654186|4067335|P1|STARTED|Overall Study||32
1665015|NCT00654147|4067343|P2|NOT COMPLETED|Overall Study||4
1665016|NCT00654147|4067344|P1|NOT COMPLETED|Overall Study||2
1665017|NCT00654147|4067343|P2|COMPLETED|Overall Study||19
1665018|NCT00654147|4067344|P1|COMPLETED|Overall Study||19
1665019|NCT00654147|4067343|P2|STARTED|Overall Study||23
1665020|NCT00654147|4067344|P1|STARTED|Overall Study||21
1665021|NCT00654095|4067360|P1|NOT COMPLETED|Overall Study||32
1665022|NCT00654095|4067360|P1|COMPLETED|Overall Study||114
1665023|NCT00654095|4067360|P1|STARTED|Overall Study||146
1665024|NCT00654069|4067367|P3|NOT COMPLETED|Overall Study||18
1665025|NCT00654069|4067368|P2|NOT COMPLETED|Overall Study||11
1665026|NCT00654069|4067369|P1|NOT COMPLETED|Overall Study||17
1665027|NCT00654069|4067367|P3|COMPLETED|Overall Study||116
1665028|NCT00654069|4067368|P2|COMPLETED|Overall Study||124
1665029|NCT00654069|4067369|P1|COMPLETED|Overall Study||119
1665030|NCT00654069|4067367|P3|STARTED|Overall Study||134
1665031|NCT00654069|4067368|P2|STARTED|Overall Study||135
1665032|NCT00654069|4067369|P1|STARTED|Overall Study||136
1665033|NCT00654030|4067377|P1|NOT COMPLETED|Overall Study||1
1665034|NCT00654030|4067377|P1|COMPLETED|Overall Study||11
1665035|NCT00654030|4067377|P1|STARTED|Overall Study||12
1665036|NCT00654004|4067383|P2|NOT COMPLETED|Overall Study||0
1665037|NCT00654004|4067384|P1|NOT COMPLETED|Overall Study||1
1665038|NCT00654004|4067383|P2|COMPLETED|Overall Study||12
1665039|NCT00654004|4067384|P1|COMPLETED|Overall Study||13
1665040|NCT00654004|4067383|P2|STARTED|Overall Study||12
1665041|NCT00654004|4067384|P1|STARTED|Overall Study||14
1665042|NCT00653939|4067400|P2|NOT COMPLETED|Overall Study||15
1665043|NCT00653939|4067401|P1|NOT COMPLETED|Overall Study||12
1665044|NCT00653939|4067400|P2|COMPLETED|Overall Study||17
1665045|NCT00653939|4067401|P1|COMPLETED|Overall Study||19
1665046|NCT00653939|4067400|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
1665047|NCT00653939|4067401|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
1665048|NCT00653861|4067417|P1|NOT COMPLETED|Overall Study||0
1665049|NCT00653861|4067417|P1|COMPLETED|Overall Study||72
1665050|NCT00653861|4067417|P1|STARTED|Overall Study||72
1665051|NCT00653523|4067426|P1|NOT COMPLETED|Overall Study||19
1665052|NCT00653523|4067426|P1|COMPLETED|Overall Study||132
1665053|NCT00653523|4067426|P1|STARTED|Overall Study||151
1665054|NCT00653328|4067430|P1|NOT COMPLETED|Overall Study||15
1665055|NCT00653328|4067430|P1|COMPLETED|Overall Study||0
1665056|NCT00653328|4067430|P1|STARTED|Overall Study||15
1665057|NCT00653263|4067437|P1|NOT COMPLETED|Overall Study||2
1665058|NCT00653263|4067437|P1|COMPLETED|Overall Study||6
1665059|NCT00653263|4067437|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
1665060|NCT00653224|4067445|P2|NOT COMPLETED|Overall Study||7
1665061|NCT00653224|4067446|P1|NOT COMPLETED|Overall Study||7
1665062|NCT00653224|4067445|P2|COMPLETED|Overall Study||280
1665063|NCT00653224|4067446|P1|COMPLETED|Overall Study||286
1665064|NCT00653224|4067445|P2|STARTED|Overall Study||287
1665065|NCT00653224|4067446|P1|STARTED|Overall Study||293
1665066|NCT00653159|4067632|P2|NOT COMPLETED|Overall Study||3
1665067|NCT00653159|4067633|P1|NOT COMPLETED|Overall Study||5
1665068|NCT00653159|4067632|P2|COMPLETED|Overall Study||9
1665069|NCT00653159|4067633|P1|COMPLETED|Overall Study||6
1665070|NCT00653159|4067632|P2|STARTED|Overall Study||12
1665071|NCT00653159|4067633|P1|STARTED|Overall Study||11
1665072|NCT00653133|4067649|P2|NOT COMPLETED|Overall Study||0
1665073|NCT00653133|4067650|P1|NOT COMPLETED|Overall Study||0
1665074|NCT00653133|4067649|P2|COMPLETED|Overall Study||497
1665075|NCT00653133|4067650|P1|COMPLETED|Overall Study||1324
1665076|NCT00653133|4067649|P2|STARTED|Overall Study||497
1665077|NCT00653133|4067650|P1|STARTED|Overall Study||1324
1665078|NCT00653068|4067660|P1|NOT COMPLETED|Overall Study||50
1665079|NCT00653068|4067660|P1|COMPLETED|Overall Study||20
1665080|NCT00653068|4067660|P1|STARTED|Overall Study||70
1665081|NCT00652951|4067674|P3|NOT COMPLETED|Booster Phase||0
1665082|NCT00652951|4067675|P2|NOT COMPLETED|Booster Phase||1
1665083|NCT00652951|4067676|P1|NOT COMPLETED|Booster Phase||1
1665084|NCT00652951|4067674|P3|COMPLETED|Booster Phase||258
1665085|NCT00652951|4067675|P2|COMPLETED|Booster Phase||258
1665086|NCT00652951|4067676|P1|COMPLETED|Booster Phase||256
1665087|NCT00652951|4067674|P3|STARTED|Booster Phase||258
1665088|NCT00652951|4067675|P2|STARTED|Booster Phase||259
1665089|NCT00652951|4067676|P1|STARTED|Booster Phase||257
1665090|NCT00652951|4067674|P3|NOT COMPLETED|Primary Phase||0
1665091|NCT00652951|4067675|P2|NOT COMPLETED|Primary Phase||0
1665092|NCT00652951|4067676|P1|NOT COMPLETED|Primary Phase||0
1665093|NCT00652951|4067674|P3|COMPLETED|Primary Phase||260
1665094|NCT00652951|4067675|P2|COMPLETED|Primary Phase||260
1665095|NCT00652951|4067676|P1|COMPLETED|Primary Phase||260
1665096|NCT00652951|4067674|P3|STARTED|Primary Phase||260
1665097|NCT00652951|4067675|P2|STARTED|Primary Phase||260
1665098|NCT00652951|4067676|P1|STARTED|Primary Phase||260
1665099|NCT00652938|4067813|P3|NOT COMPLETED|Overall Study||5
1665100|NCT00652938|4067814|P2|NOT COMPLETED|Overall Study||7
1665101|NCT00652938|4067815|P1|NOT COMPLETED|Overall Study||1
1665102|NCT00652938|4067813|P3|COMPLETED|Overall Study||242
1665103|NCT00652938|4067814|P2|COMPLETED|Overall Study||240
1665104|NCT00652938|4067815|P1|COMPLETED|Overall Study||246
1665105|NCT00652938|4067813|P3|STARTED|Overall Study||247
1665106|NCT00652938|4067814|P2|STARTED|Overall Study||247
1665107|NCT00652938|4067815|P1|STARTED|Overall Study||247
1665108|NCT00652899|4067880|P1|NOT COMPLETED|Overall Study||2
1665109|NCT00652899|4067880|P1|COMPLETED|Overall Study||12
1665110|NCT00652899|4067880|P1|STARTED|Overall Study||14
1665111|NCT00652834|4067890|P1|NOT COMPLETED|Overall Study||5
1665112|NCT00652834|4067890|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
1665113|NCT00652834|4067890|P1|STARTED|Overall Study||23
1665114|NCT00652743|4067897|P3|NOT COMPLETED|Months 42-48||0
1665115|NCT00652743|4067898|P2|NOT COMPLETED|Months 42-48||0
1665116|NCT00652743|4067899|P1|NOT COMPLETED|Months 42-48||0
1665117|NCT00652743|4067897|P3|COMPLETED|Months 42-48||367
1665118|NCT00652743|4067898|P2|COMPLETED|Months 42-48||170
1665119|NCT00652743|4067899|P1|COMPLETED|Months 42-48||196
1665120|NCT00652743|4067897|P3|STARTED|Months 42-48||367
1665121|NCT00652743|4067898|P2|STARTED|Months 42-48||170
1665122|NCT00652743|4067899|P1|STARTED|Months 42-48||196
1665123|NCT00652743|4067897|P3|NOT COMPLETED|Months 36-42||9
1665124|NCT00652743|4067898|P2|NOT COMPLETED|Months 36-42||5
1665125|NCT00652743|4067899|P1|NOT COMPLETED|Months 36-42||6
1665126|NCT00652743|4067897|P3|COMPLETED|Months 36-42||381
1665127|NCT00652743|4067898|P2|COMPLETED|Months 36-42||180
1665128|NCT00652743|4067899|P1|COMPLETED|Months 36-42||210
1665129|NCT00652743|4067897|P3|STARTED|Months 36-42||390
1665130|NCT00652743|4067898|P2|STARTED|Months 36-42||185
1665131|NCT00652743|4067899|P1|STARTED|Months 36-42||216
1665132|NCT00652743|4067897|P3|NOT COMPLETED|Months 24-30||11
1665133|NCT00652743|4067898|P2|NOT COMPLETED|Months 24-30||1
1665134|NCT00652743|4067899|P1|NOT COMPLETED|Months 24-30||5
1665135|NCT00652743|4067897|P3|COMPLETED|Months 24-30||422
1665136|NCT00652743|4067898|P2|COMPLETED|Months 24-30||185
1665137|NCT00652743|4067899|P1|COMPLETED|Months 24-30||207
1665138|NCT00652743|4067897|P3|STARTED|Months 24-30||433
1665139|NCT00652743|4067898|P2|STARTED|Months 24-30||186
1665140|NCT00652743|4067899|P1|STARTED|Months 24-30||212
1665141|NCT00652743|4067897|P3|NOT COMPLETED|Months 12-18||7
1665142|NCT00652743|4067898|P2|NOT COMPLETED|Months 12-18||2
1665143|NCT00652743|4067899|P1|NOT COMPLETED|Months 12-18||1
1665144|NCT00652743|4067897|P3|COMPLETED|Months 12-18||430
1665145|NCT00652743|4067898|P2|COMPLETED|Months 12-18||186
1665146|NCT00652743|4067899|P1|COMPLETED|Months 12-18||218
1665147|NCT00652743|4067897|P3|STARTED|Months 12-18||437
1665148|NCT00652743|4067898|P2|STARTED|Months 12-18||188
1665149|NCT00652743|4067899|P1|STARTED|Months 12-18||219
1665150|NCT00652626|4067981|P7|NOT COMPLETED|Extension Phase||3
1665151|NCT00652626|4067982|P6|NOT COMPLETED|Extension Phase||12
1665152|NCT00652626|4067983|P5|NOT COMPLETED|Extension Phase||0
1665153|NCT00652626|4067984|P4|NOT COMPLETED|Extension Phase||0
1665154|NCT00652626|4067985|P3|NOT COMPLETED|Extension Phase||0
1665155|NCT00652626|4067986|P2|NOT COMPLETED|Extension Phase||0
1665156|NCT00652626|4067987|P1|NOT COMPLETED|Extension Phase||0
1665157|NCT00652626|4067981|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
1665158|NCT00652626|4067982|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
1665159|NCT00652626|4067983|P5|COMPLETED|Extension Phase||0
1665160|NCT00652626|4067984|P4|COMPLETED|Extension Phase||0
1665161|NCT00652626|4067985|P3|COMPLETED|Extension Phase||0
1665162|NCT00652626|4067986|P2|COMPLETED|Extension Phase||0
1665163|NCT00652626|4067987|P1|COMPLETED|Extension Phase||0
1665164|NCT00652626|4067981|P7|STARTED|Extension Phase||4
1665165|NCT00652626|4067982|P6|STARTED|Extension Phase||14
1665166|NCT00652626|4067983|P5|STARTED|Extension Phase||0
1665167|NCT00652626|4067984|P4|STARTED|Extension Phase||0
1665168|NCT00652626|4067985|P3|STARTED|Extension Phase||0
1665169|NCT00652626|4067986|P2|STARTED|Extension Phase||0
1665170|NCT00652626|4067987|P1|STARTED|Extension Phase||0
1665171|NCT00652626|4067981|P7|NOT COMPLETED|Initial Treatment Phase||0
1665172|NCT00652626|4067982|P6|NOT COMPLETED|Initial Treatment Phase||0
1665173|NCT00652626|4067983|P5|NOT COMPLETED|Initial Treatment Phase||3
1665174|NCT00652626|4067984|P4|NOT COMPLETED|Initial Treatment Phase||1
1665175|NCT00652626|4067985|P3|NOT COMPLETED|Initial Treatment Phase||1
1665176|NCT00652626|4067986|P2|NOT COMPLETED|Initial Treatment Phase||0
1665177|NCT00652626|4067987|P1|NOT COMPLETED|Initial Treatment Phase||0
1665178|NCT00652626|4067981|P7|COMPLETED|Initial Treatment Phase||0
1665179|NCT00652626|4067982|P6|COMPLETED|Initial Treatment Phase||0
1665180|NCT00652626|4067983|P5|COMPLETED|Initial Treatment Phase||5
1665181|NCT00652626|4067984|P4|COMPLETED|Initial Treatment Phase||5
1665182|NCT00652626|4067985|P3|COMPLETED|Initial Treatment Phase||6
1665183|NCT00652626|4067986|P2|COMPLETED|Initial Treatment Phase||5
1665184|NCT00652626|4067987|P1|COMPLETED|Initial Treatment Phase||5
1665185|NCT00652626|4067981|P7|Received Study Drug|Initial Treatment Phase||0
1665186|NCT00652626|4067982|P6|Received Study Drug|Initial Treatment Phase||0
1665187|NCT00652626|4067983|P5|Received Study Drug|Initial Treatment Phase||6
1665188|NCT00652626|4067984|P4|Received Study Drug|Initial Treatment Phase||5
1665189|NCT00652626|4067985|P3|Received Study Drug|Initial Treatment Phase||6
1665190|NCT00652626|4067986|P2|Received Study Drug|Initial Treatment Phase||5
1665191|NCT00652626|4067987|P1|Received Study Drug|Initial Treatment Phase||5
1665192|NCT00652626|4067981|P7|STARTED|Initial Treatment Phase||0
1665193|NCT00652626|4067982|P6|STARTED|Initial Treatment Phase||0
1665194|NCT00652626|4067983|P5|STARTED|Initial Treatment Phase||8
1665195|NCT00652626|4067984|P4|STARTED|Initial Treatment Phase||6
1665196|NCT00652626|4067985|P3|STARTED|Initial Treatment Phase||7
1665197|NCT00652626|4067986|P2|STARTED|Initial Treatment Phase||5
1665198|NCT00652626|4067987|P1|STARTED|Initial Treatment Phase||5
1665199|NCT00652366|4068056|P5|NOT COMPLETED|Overall Study||36
1665200|NCT00652366|4068057|P4|NOT COMPLETED|Overall Study||179
1665201|NCT00652366|4068058|P3|NOT COMPLETED|Overall Study||71
1665202|NCT00652366|4068059|P2|NOT COMPLETED|Overall Study||75
1665203|NCT00652366|4068060|P1|NOT COMPLETED|Overall Study||106
1665204|NCT00652366|4068056|P5|COMPLETED|Overall Study||0
1665205|NCT00652366|4068057|P4|COMPLETED|Overall Study||0
1665206|NCT00652366|4068058|P3|COMPLETED|Overall Study||0
1665207|NCT00652366|4068059|P2|COMPLETED|Overall Study||0
1665208|NCT00652366|4068060|P1|COMPLETED|Overall Study||0
1665209|NCT00652366|4068056|P5|STARTED|Overall Study||36
1665210|NCT00652366|4068057|P4|STARTED|Overall Study||179
1665211|NCT00652366|4068058|P3|STARTED|Overall Study||71
1665212|NCT00652366|4068059|P2|STARTED|Overall Study||75
1665213|NCT00652366|4068060|P1|STARTED|Overall Study||106
1665214|NCT00652340|4068095|P2|NOT COMPLETED|Overall Study||3
1665215|NCT00652340|4068096|P1|NOT COMPLETED|Overall Study||4
1665216|NCT00652340|4068095|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
1665217|NCT00652340|4068096|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
1665218|NCT00652340|4068095|P2|STARTED|Overall Study||42
1665219|NCT00652340|4068096|P1|STARTED|Overall Study||78
1665220|NCT00652327|4068106|P2|NOT COMPLETED|Overall Study||5
1665221|NCT00652327|4068107|P1|NOT COMPLETED|Overall Study||0
1665222|NCT00652327|4068106|P2|COMPLETED|Overall Study||36
1665223|NCT00652327|4068107|P1|COMPLETED|Overall Study||42
1665224|NCT00652327|4068106|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
1665225|NCT00652327|4068107|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
1665226|NCT00652314|4068115|P2|NOT COMPLETED|Overall Study||9
1665227|NCT00652314|4068116|P1|NOT COMPLETED|Overall Study||9
1665228|NCT00652314|4068115|P2|COMPLETED|Overall Study||26
1665229|NCT00652314|4068116|P1|COMPLETED|Overall Study||53
1665230|NCT00652314|4068115|P2|STARTED|Overall Study||35
1665231|NCT00652314|4068116|P1|STARTED|Overall Study||62
1665232|NCT00652145|4068132|P2|NOT COMPLETED|Overall Study||0
1665233|NCT00652145|4068133|P1|NOT COMPLETED|Overall Study||0
1665234|NCT00652145|4068132|P2|COMPLETED|Overall Study||26
1665235|NCT00652145|4068133|P1|COMPLETED|Overall Study||26
1665236|NCT00652145|4068132|P2|STARTED|Overall Study||26
1665237|NCT00652145|4068133|P1|STARTED|Overall Study||26
1665238|NCT00652093|4068149|P6|NOT COMPLETED|Overall Study||0
1665239|NCT00652093|4068150|P5|NOT COMPLETED|Overall Study||2
1665240|NCT00652093|4068151|P4|NOT COMPLETED|Overall Study||0
1665241|NCT00652093|4068152|P3|NOT COMPLETED|Overall Study||1
1665242|NCT00652093|4068153|P2|NOT COMPLETED|Overall Study||0
1665243|NCT00652093|4068154|P1|NOT COMPLETED|Overall Study||0
1665244|NCT00652093|4068149|P6|COMPLETED|Overall Study||4
1665245|NCT00652093|4068150|P5|COMPLETED|Overall Study||2
1665246|NCT00652093|4068151|P4|COMPLETED|Overall Study||4
1665247|NCT00652093|4068152|P3|COMPLETED|Overall Study||3
1665248|NCT00652093|4068153|P2|COMPLETED|Overall Study||4
1665249|NCT00652093|4068154|P1|COMPLETED|Overall Study||4
1665250|NCT00652093|4068149|P6|STARTED|Overall Study||4
1665251|NCT00652093|4068150|P5|STARTED|Overall Study||4
1665252|NCT00652093|4068151|P4|STARTED|Overall Study||4
1665253|NCT00652093|4068152|P3|STARTED|Overall Study||4
1665254|NCT00652093|4068153|P2|STARTED|Overall Study||4
1665255|NCT00652093|4068154|P1|STARTED|Overall Study||4
1665256|NCT00652028|4068238|P4|NOT COMPLETED|Overall Study||0
1665257|NCT00652028|4068239|P3|NOT COMPLETED|Overall Study||1
1665258|NCT00652028|4068240|P2|NOT COMPLETED|Overall Study||1
1665259|NCT00652028|4068241|P1|NOT COMPLETED|Overall Study||1
1665260|NCT00652028|4068238|P4|COMPLETED|Overall Study||14
1665261|NCT00652028|4068239|P3|COMPLETED|Overall Study||14
1665262|NCT00652028|4068240|P2|COMPLETED|Overall Study||13
1665263|NCT00652028|4068241|P1|COMPLETED|Overall Study||15
1665264|NCT00652028|4068238|P4|STARTED|Overall Study||14
1665265|NCT00652028|4068239|P3|STARTED|Overall Study||15
1665266|NCT00652028|4068240|P2|STARTED|Overall Study||14
1665267|NCT00652028|4068241|P1|STARTED|Overall Study||16
1665268|NCT00651924|4068285|P2|NOT COMPLETED|Overall Study||7
1665269|NCT00651924|4068286|P1|NOT COMPLETED|Overall Study||0
1665270|NCT00651924|4068285|P2|COMPLETED|Overall Study||2
1665271|NCT00651924|4068286|P1|COMPLETED|Overall Study||18
1665272|NCT00651924|4068285|P2|STARTED|Overall Study||9
1665273|NCT00651924|4068286|P1|STARTED|Overall Study||18
1665274|NCT00651820|4068292|P1|NOT COMPLETED|Overall Study||2
1665275|NCT00651820|4068292|P1|COMPLETED|Overall Study||26
1665276|NCT00651820|4068292|P1|STARTED|Overall Study||28
1665277|NCT00651794|4068302|P3|NOT COMPLETED|Overall Study||21
1665278|NCT00651794|4068303|P2|NOT COMPLETED|Overall Study||22
1665279|NCT00651794|4068304|P1|NOT COMPLETED|Overall Study||21
1665280|NCT00651794|4068302|P3|COMPLETED|Overall Study||10
1665281|NCT00651794|4068303|P2|COMPLETED|Overall Study||9
1665282|NCT00651794|4068304|P1|COMPLETED|Overall Study||15
1665283|NCT00651794|4068302|P3|STARTED|Overall Study||31
1665284|NCT00651794|4068303|P2|STARTED|Overall Study||31
1665285|NCT00651794|4068304|P1|STARTED|Overall Study||36
1665286|NCT00651755|4068324|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
1665287|NCT00651755|4068325|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
1665288|NCT00651755|4068324|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
1665289|NCT00651755|4068325|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
1665290|NCT00651755|4068324|P2|STARTED|Cycle 2 (Second 21 Days)||9
1665291|NCT00651755|4068325|P1|STARTED|Cycle 2 (Second 21 Days)||10
1665292|NCT00651755|4068324|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
1665293|NCT00651755|4068325|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
1665294|NCT00651755|4068324|P2|COMPLETED|Cycle 1 (First 21 Days)||9
1665295|NCT00651755|4068325|P1|COMPLETED|Cycle 1 (First 21 Days)||10
1665296|NCT00651755|4068324|P2|STARTED|Cycle 1 (First 21 Days)||9
1665297|NCT00651755|4068325|P1|STARTED|Cycle 1 (First 21 Days)||11
1665298|NCT00651625|4068343|P2|NOT COMPLETED|Overall Study||0
1665299|NCT00651625|4068344|P1|NOT COMPLETED|Overall Study||0
1665300|NCT00651625|4068343|P2|COMPLETED|Overall Study||218
1665301|NCT00651625|4068344|P1|COMPLETED|Overall Study||219
1665302|NCT00651625|4068343|P2|STARTED|Overall Study||218
1665303|NCT00651625|4068344|P1|STARTED|Overall Study||219
1665304|NCT00651482|4068356|P1|NOT COMPLETED|Overall Study||0
1665305|NCT00651482|4068356|P1|COMPLETED|Overall Study||10
1665306|NCT00651482|4068356|P1|STARTED|Overall Study||10
1665307|NCT00651313|4068370|P2|NOT COMPLETED|Overall Study||6
1665308|NCT00651313|4068371|P1|NOT COMPLETED|Overall Study||6
1665309|NCT00651313|4068370|P2|COMPLETED|Overall Study||37
1665310|NCT00651313|4068371|P1|COMPLETED|Overall Study||35
1665311|NCT00651313|4068370|P2|STARTED|Overall Study||43
1665312|NCT00651313|4068371|P1|STARTED|Overall Study||41
1665313|NCT00651261|4068379|P2|NOT COMPLETED|Overall Study||306
1665314|NCT00651261|4068380|P1|NOT COMPLETED|Overall Study||291
1665315|NCT00651261|4068379|P2|COMPLETED|Overall Study||51
1665316|NCT00651261|4068380|P1|COMPLETED|Overall Study||69
1665317|NCT00651261|4068379|P2|STARTED|Overall Study||357
1665318|NCT00651261|4068380|P1|STARTED|Overall Study||360
1665319|NCT00651183|4068396|P2|NOT COMPLETED|Overall Study||10
1665320|NCT00651183|4068397|P1|NOT COMPLETED|Overall Study||20
1665321|NCT00651183|4068396|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
1665322|NCT00651183|4068397|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
1665323|NCT00651183|4068396|P2|STARTED|Overall Study||97
1665324|NCT00651183|4068397|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
1665325|NCT00651157|4068409|P1|NOT COMPLETED|Overall Study||2
1665326|NCT00651157|4068409|P1|COMPLETED|Overall Study||21
1665327|NCT00651157|4068409|P1|STARTED|Overall Study||23
1665328|NCT00651118|4068419|P4|NOT COMPLETED|Overall Study||7
1665329|NCT00651118|4068420|P3|NOT COMPLETED|Overall Study||11
1665330|NCT00651118|4068421|P2|NOT COMPLETED|Overall Study||7
1665331|NCT00651118|4068422|P1|NOT COMPLETED|Overall Study||9
1665332|NCT00651118|4068419|P4|COMPLETED|Overall Study||203
1665333|NCT00651118|4068420|P3|COMPLETED|Overall Study||197
1665334|NCT00651118|4068421|P2|COMPLETED|Overall Study||200
1665335|NCT00651118|4068422|P1|COMPLETED|Overall Study||198
1665336|NCT00651118|4068419|P4|STARTED|Overall Study||210
1665337|NCT00651118|4068420|P3|STARTED|Overall Study||208
1665338|NCT00651118|4068421|P2|STARTED|Overall Study||207
1665339|NCT00651118|4068422|P1|STARTED|Overall Study||207
1665340|NCT00651040|4068442|P2|NOT COMPLETED|Overall Study||1
1665341|NCT00651040|4068443|P1|NOT COMPLETED|Overall Study||3
1665342|NCT00651040|4068442|P2|COMPLETED|Overall Study||14
1665343|NCT00651040|4068443|P1|COMPLETED|Overall Study||13
1665344|NCT00651040|4068442|P2|STARTED|Overall Study||15
1665345|NCT00651040|4068443|P1|STARTED|Overall Study||16
1665346|NCT00650858|4068452|P3|NOT COMPLETED|Overall Study||0
1665347|NCT00650858|4068453|P2|NOT COMPLETED|Overall Study||0
1665348|NCT00650858|4068454|P1|NOT COMPLETED|Overall Study||0
1665349|NCT00650858|4068452|P3|COMPLETED|Overall Study||36
1665350|NCT00650858|4068453|P2|COMPLETED|Overall Study||8
1665351|NCT00650858|4068454|P1|COMPLETED|Overall Study||8
1665352|NCT00650858|4068452|P3|STARTED|Overall Study||36
1665353|NCT00650858|4068453|P2|STARTED|Overall Study||8
1665354|NCT00650858|4068454|P1|STARTED|Overall Study||8
1665355|NCT00650845|4068485|P2|NOT COMPLETED|Overall Study||13
1665356|NCT00650845|4068486|P1|NOT COMPLETED|Overall Study||5
1665357|NCT00650845|4068485|P2|COMPLETED|Overall Study||44
1665358|NCT00650845|4068486|P1|COMPLETED|Overall Study||70
1665359|NCT00650845|4068485|P2|STARTED|Overall Study||57
1665360|NCT00650845|4068486|P1|STARTED|Overall Study||75
1665361|NCT00650806|4068506|P4|NOT COMPLETED|Overall Study||26
1665362|NCT00650806|4068507|P3|NOT COMPLETED|Overall Study||29
1665363|NCT00650806|4068508|P2|NOT COMPLETED|Overall Study||21
1665364|NCT00650806|4068509|P1|NOT COMPLETED|Overall Study||18
1665365|NCT00650806|4068506|P4|COMPLETED|Overall Study||70
1665366|NCT00650806|4068507|P3|COMPLETED|Overall Study||64
1665367|NCT00650806|4068508|P2|COMPLETED|Overall Study||77
1665368|NCT00650806|4068509|P1|COMPLETED|Overall Study||71
1665369|NCT00650806|4068506|P4|STARTED|Overall Study||96
1665370|NCT00650806|4068507|P3|STARTED|Overall Study||93
1665371|NCT00650806|4068508|P2|STARTED|Overall Study||98
1665372|NCT00650806|4068509|P1|STARTED|Overall Study||89
1665373|NCT00650767|4068551|P4|NOT COMPLETED|Overall Study||11
1665374|NCT00650767|4068552|P3|NOT COMPLETED|Overall Study||14
1665375|NCT00650767|4068553|P2|NOT COMPLETED|Overall Study||9
1665376|NCT00650767|4068554|P1|NOT COMPLETED|Overall Study||5
1665377|NCT00650767|4068551|P4|COMPLETED|Overall Study||39
1665378|NCT00650767|4068552|P3|COMPLETED|Overall Study||36
1665379|NCT00650767|4068553|P2|COMPLETED|Overall Study||41
1665380|NCT00650767|4068554|P1|COMPLETED|Overall Study||46
1665381|NCT00650767|4068551|P4|STARTED|Overall Study||50
1665382|NCT00650767|4068552|P3|STARTED|Overall Study||50
1665383|NCT00650767|4068553|P2|STARTED|Overall Study||50
1665384|NCT00650767|4068554|P1|STARTED|Overall Study||51
1665385|NCT00650585|4069058|P2|NOT COMPLETED|Overall Study||1477
1665386|NCT00650585|4069059|P1|NOT COMPLETED|Overall Study||1797
1665387|NCT00650585|4069058|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
1665388|NCT00650585|4069059|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
1665389|NCT00650585|4069058|P2|STARTED|Overall Study||3990
1665390|NCT00650585|4069059|P1|STARTED|Overall Study||4348
1665391|NCT00650546|4069079|P1|NOT COMPLETED|Overall Study||0
1665392|NCT00650546|4069079|P1|COMPLETED|Overall Study||8
1665393|NCT00650546|4069079|P1|STARTED|Overall Study||8
1665394|NCT00650260|4069086|P2|NOT COMPLETED|Overall Study||0
1665395|NCT00650260|4069087|P1|NOT COMPLETED|Overall Study||0
1665396|NCT00650260|4069086|P2|COMPLETED|Overall Study||21
1665397|NCT00650260|4069087|P1|COMPLETED|Overall Study||21
1665398|NCT00650260|4069086|P2|STARTED|Overall Study||21
1665399|NCT00650260|4069087|P1|STARTED|Overall Study||21
1665400|NCT00650104|4069103|P1|NOT COMPLETED|Overall Study||41
1665401|NCT00650104|4069103|P1|COMPLETED|Overall Study||42
1665402|NCT00650104|4069103|P1|STARTED|Overall Study||83
1665403|NCT00650091|4069118|P3|NOT COMPLETED|Amended Study Design||0
1665404|NCT00650091|4069119|P2|NOT COMPLETED|Amended Study Design||20
1665405|NCT00650091|4069120|P1|NOT COMPLETED|Amended Study Design||23
1665406|NCT00650091|4069118|P3|COMPLETED|Amended Study Design||0
1665407|NCT00650091|4069119|P2|COMPLETED|Amended Study Design||111
1665408|NCT00650091|4069120|P1|COMPLETED|Amended Study Design||110
1665409|NCT00650091|4069118|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
1665410|NCT00650091|4069119|P2|STARTED|Amended Study Design||131
1665411|NCT00650091|4069120|P1|STARTED|Amended Study Design||133
1665412|NCT00650091|4069118|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
1665413|NCT00650091|4069119|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
1665414|NCT00650091|4069120|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
1665415|NCT00650091|4069118|P3|COMPLETED|Initial Study Design - Interim Analysis||77
1665416|NCT00650091|4069119|P2|COMPLETED|Initial Study Design - Interim Analysis||78
1665417|NCT00650091|4069120|P1|COMPLETED|Initial Study Design - Interim Analysis||81
1665418|NCT00650091|4069118|P3|STARTED|Initial Study Design - Interim Analysis||77
1665419|NCT00650091|4069119|P2|STARTED|Initial Study Design - Interim Analysis||78
1665420|NCT00650091|4069120|P1|STARTED|Initial Study Design - Interim Analysis||81
1665421|NCT00650078|4069140|P2|NOT COMPLETED|Overall Study||13
1665422|NCT00650078|4069141|P1|NOT COMPLETED|Overall Study||14
1665423|NCT00650078|4069140|P2|COMPLETED|Overall Study||106
1665424|NCT00650078|4069141|P1|COMPLETED|Overall Study||217
1665425|NCT00650078|4069140|P2|STARTED|Overall Study||119
1665426|NCT00650078|4069141|P1|STARTED|Overall Study||231
1665427|NCT00649961|4069149|P1|NOT COMPLETED|Overall Study||0
1665428|NCT00649961|4069149|P1|COMPLETED|Overall Study||18
1665429|NCT00649961|4069149|P1|STARTED|Overall Study||18
1665430|NCT00649792|4069153|P1|NOT COMPLETED|Overall Study||68
1665431|NCT00649792|4069153|P1|COMPLETED|Overall Study||146
1665432|NCT00649792|4069153|P1|STARTED|Overall Study||214
1665433|NCT00649428|4069163|P2|NOT COMPLETED|Overall Study||15
1665434|NCT00649428|4069164|P1|NOT COMPLETED|Overall Study||20
1665435|NCT00649428|4069163|P2|COMPLETED|Overall Study||88
1665436|NCT00649428|4069164|P1|COMPLETED|Overall Study||80
1665437|NCT00649428|4069163|P2|STARTED|Overall Study||103
1665438|NCT00649428|4069164|P1|STARTED|Overall Study||100
1665439|NCT00649389|4069180|P4|NOT COMPLETED|Overall Study||111
1665440|NCT00649389|4069181|P3|NOT COMPLETED|Overall Study||88
1665441|NCT00649389|4069182|P2|NOT COMPLETED|Overall Study||106
1665442|NCT00649389|4069183|P1|NOT COMPLETED|Overall Study||71
1665443|NCT00649389|4069180|P4|COMPLETED|Overall Study||516
1665444|NCT00649389|4069181|P3|COMPLETED|Overall Study||512
1665445|NCT00649389|4069182|P2|COMPLETED|Overall Study||531
1665446|NCT00649389|4069183|P1|COMPLETED|Overall Study||557
1665447|NCT00649389|4069180|P4|STARTED|Overall Study||627
1665448|NCT00649389|4069181|P3|STARTED|Overall Study||600
1665449|NCT00649389|4069182|P2|STARTED|Overall Study||637
1665450|NCT00649389|4069183|P1|STARTED|Overall Study||628
1665451|NCT00649220|4069205|P1|NOT COMPLETED|Overall Study||3
1665452|NCT00649220|4069205|P1|COMPLETED|Overall Study||16
1665453|NCT00649220|4069205|P1|STARTED|Overall Study||19
1665454|NCT00648908|4069216|P1|NOT COMPLETED|Overall Study||115
1665455|NCT00648908|4069216|P1|COMPLETED|Overall Study||154
1665456|NCT00648908|4069216|P1|STARTED|Overall Study||269
1665457|NCT00648895|4069226|P2|NOT COMPLETED|Overall Study||1
1665458|NCT00648895|4069227|P1|NOT COMPLETED|Overall Study||0
1665459|NCT00648895|4069226|P2|COMPLETED|Overall Study||5
1665460|NCT00648895|4069227|P1|COMPLETED|Overall Study||6
1665461|NCT00648895|4069226|P2|STARTED|Overall Study||6
1665462|NCT00648895|4069227|P1|STARTED|Overall Study||6
1665463|NCT00648167|4069233|P1|NOT COMPLETED|Overall Study||7
1665464|NCT00648167|4069233|P1|COMPLETED|Overall Study||48
1665465|NCT00648167|4069233|P1|Start Dose 6 g/Day|Overall Study||21
1665466|NCT00648167|4069233|P1|Start Dose 4.5 g/Day|Overall Study||34
1665467|NCT00648167|4069233|P1|STARTED|Overall Study||55
1665468|NCT00648115|4069240|P3|NOT COMPLETED|Overall Study||0
1665469|NCT00648115|4069241|P2|NOT COMPLETED|Overall Study||0
1665470|NCT00648115|4069242|P1|NOT COMPLETED|Overall Study||0
1665471|NCT00648115|4069240|P3|COMPLETED|Overall Study||27
1665472|NCT00648115|4069241|P2|COMPLETED|Overall Study||42
1665473|NCT00648115|4069242|P1|COMPLETED|Overall Study||42
1665474|NCT00648115|4069240|P3|STARTED|Overall Study||27
1665475|NCT00648115|4069241|P2|STARTED|Overall Study||42
1665476|NCT00648115|4069242|P1|STARTED|Overall Study||42
1665477|NCT00648037|4069253|P1|NOT COMPLETED|Overall Study||16
1665478|NCT00648037|4069253|P1|COMPLETED|Overall Study||10
1665479|NCT00648037|4069253|P1|STARTED|Overall Study||26
1665480|NCT00647998|4069259|P2|NOT COMPLETED|Overall Study||0
1665481|NCT00647998|4069260|P1|NOT COMPLETED|Overall Study||0
1665482|NCT00647998|4069259|P2|COMPLETED|Overall Study||9
1665483|NCT00647998|4069260|P1|COMPLETED|Overall Study||9
1665484|NCT00647998|4069259|P2|STARTED|Overall Study||9
1665485|NCT00647998|4069260|P1|STARTED|Overall Study||9
1665486|NCT00647699|4069272|P2|NOT COMPLETED|Overall Study||12
1665487|NCT00647699|4069273|P1|NOT COMPLETED|Overall Study||8
1665488|NCT00647699|4069272|P2|COMPLETED|Overall Study||62
1665489|NCT00647699|4069273|P1|COMPLETED|Overall Study||65
1665490|NCT00647699|4069272|P2|STARTED|Overall Study||74
1665491|NCT00647699|4069273|P1|STARTED|Overall Study||73
1665492|NCT00647556|4069281|P2|NOT COMPLETED|Overall Study||2
1665493|NCT00647556|4069282|P1|NOT COMPLETED|Overall Study||3
1665494|NCT00647556|4069281|P2|COMPLETED|Overall Study||13
1665495|NCT00647556|4069282|P1|COMPLETED|Overall Study||12
1665496|NCT00647556|4069281|P2|STARTED|Overall Study||15
1665497|NCT00647556|4069282|P1|STARTED|Overall Study||15
1665498|NCT00647400|4069298|P2|NOT COMPLETED|Overall Study||13
1665499|NCT00647400|4069299|P1|NOT COMPLETED|Overall Study||22
1665500|NCT00647400|4069298|P2|COMPLETED|Overall Study||45
1665501|NCT00647400|4069299|P1|COMPLETED|Overall Study||67
1665502|NCT00647400|4069298|P2|STARTED|Overall Study||58
1665503|NCT00647400|4069299|P1|STARTED|Overall Study||89
1665504|NCT00647270|4069312|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
1665505|NCT00647270|4069313|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
1665506|NCT00647270|4069314|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
1665507|NCT00647270|4069312|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
1665508|NCT00647270|4069313|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
1665509|NCT00647270|4069314|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
1665510|NCT00647270|4069312|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
1665511|NCT00647270|4069313|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
1665512|NCT00647270|4069314|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
1665513|NCT00647270|4069312|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
1665514|NCT00647270|4069313|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
1665515|NCT00647270|4069314|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
1665516|NCT00647270|4069312|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
1665517|NCT00647270|4069313|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
1665518|NCT00647270|4069314|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
1665519|NCT00647270|4069312|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
1665520|NCT00647270|4069313|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
1665521|NCT00647270|4069314|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
1665522|NCT00646958|4069340|P3|NOT COMPLETED|Overall Study||9
1665523|NCT00646958|4069341|P2|NOT COMPLETED|Overall Study||9
1665524|NCT00646958|4069342|P1|NOT COMPLETED|Overall Study||11
1665525|NCT00646958|4069340|P3|COMPLETED|Overall Study||40
1665526|NCT00646958|4069341|P2|COMPLETED|Overall Study||41
1665527|NCT00646958|4069342|P1|COMPLETED|Overall Study||40
1665528|NCT00646958|4069340|P3|STARTED|Overall Study|No. Participants Randomized|49
1665529|NCT00646958|4069341|P2|STARTED|Overall Study|No. Participants Randomized|50
1665530|NCT00646958|4069342|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
1665531|NCT00646776|4069355|P2|NOT COMPLETED|Overall Study||13
1665532|NCT00646776|4069356|P1|NOT COMPLETED|Overall Study||1
1665533|NCT00646776|4069355|P2|COMPLETED|Overall Study||5
1665534|NCT00646776|4069356|P1|COMPLETED|Overall Study||14
1665535|NCT00646776|4069355|P2|STARTED|Overall Study|Treated on Day 1|18
1665536|NCT00646776|4069356|P1|STARTED|Overall Study|Treated on Day 1|15
1665537|NCT00646763|4069405|P2|NOT COMPLETED|Overall Study||0
1665538|NCT00646763|4069406|P1|NOT COMPLETED|Overall Study||0
1665539|NCT00646763|4069405|P2|COMPLETED|Overall Study||17
1665540|NCT00646763|4069406|P1|COMPLETED|Overall Study||18
1665541|NCT00646763|4069405|P2|STARTED|Overall Study||17
1665542|NCT00646763|4069406|P1|STARTED|Overall Study||18
1665543|NCT00646646|4069420|P4|NOT COMPLETED|Overall Study||0
1665544|NCT00646646|4069421|P3|NOT COMPLETED|Overall Study||0
1665545|NCT00646646|4069422|P2|NOT COMPLETED|Overall Study||0
1665546|NCT00646646|4069423|P1|NOT COMPLETED|Overall Study||0
1665547|NCT00646646|4069420|P4|COMPLETED|Overall Study||20
1665548|NCT00646646|4069421|P3|COMPLETED|Overall Study||15
1665549|NCT00646646|4069422|P2|COMPLETED|Overall Study||15
1665550|NCT00646646|4069423|P1|COMPLETED|Overall Study||15
1665551|NCT00646646|4069420|P4|STARTED|Overall Study||20
1665552|NCT00646646|4069421|P3|STARTED|Overall Study||15
1665553|NCT00646646|4069422|P2|STARTED|Overall Study||15
1665554|NCT00646646|4069423|P1|STARTED|Overall Study||15
1665555|NCT00646581|4069435|P2|NOT COMPLETED|Overall Study||0
1665556|NCT00646581|4069436|P1|NOT COMPLETED|Overall Study||0
1665557|NCT00646581|4069435|P2|COMPLETED|Overall Study||15
1665558|NCT00646581|4069436|P1|COMPLETED|Overall Study||15
1665559|NCT00646581|4069435|P2|STARTED|Overall Study||15
1665560|NCT00646581|4069436|P1|STARTED|Overall Study||15
1665561|NCT00646399|4069454|P2|NOT COMPLETED|Overall Study||74
1665562|NCT00646399|4069455|P1|NOT COMPLETED|Overall Study||83
1665563|NCT00646399|4069454|P2|COMPLETED|Overall Study||713
1665564|NCT00646399|4069455|P1|COMPLETED|Overall Study||709
1665565|NCT00646399|4069454|P2|STARTED|Overall Study||787
1665566|NCT00646399|4069455|P1|STARTED|Overall Study||792
1665567|NCT00646282|4069463|P2|NOT COMPLETED|Overall Study||4
1665568|NCT00646282|4069464|P1|NOT COMPLETED|Overall Study||4
1665569|NCT00646282|4069463|P2|COMPLETED|Overall Study||0
1665570|NCT00646282|4069464|P1|COMPLETED|Overall Study||0
1665571|NCT00646282|4069463|P2|STARTED|Overall Study||4
1665572|NCT00646282|4069464|P1|STARTED|Overall Study||4
1665573|NCT00646048|4069470|P1|NOT COMPLETED|Overall Study||16
1665574|NCT00646048|4069470|P1|COMPLETED|Overall Study||27
1665575|NCT00646048|4069470|P1|STARTED|Overall Study||43
1665576|NCT00645970|4069478|P2|NOT COMPLETED|Overall Study||186
1665577|NCT00645970|4069479|P1|NOT COMPLETED|Overall Study||109
1665578|NCT00645970|4069478|P2|COMPLETED|Overall Study||32
1665579|NCT00645970|4069479|P1|COMPLETED|Overall Study||32
1665580|NCT00645970|4069478|P2|1 Year|Overall Study||42
1665581|NCT00645970|4069479|P1|1 Year|Overall Study||37
1665582|NCT00645970|4069478|P2|6 Months|Overall Study||97
1665583|NCT00645970|4069479|P1|6 Months|Overall Study||58
1665584|NCT00645970|4069478|P2|STARTED|Overall Study||218
1665585|NCT00645970|4069479|P1|STARTED|Overall Study||141
1665586|NCT00645944|4069487|P2|NOT COMPLETED|Received Medication||3
1665587|NCT00645944|4069488|P1|NOT COMPLETED|Received Medication||6
1665588|NCT00645944|4069487|P2|COMPLETED|Received Medication||14
1665589|NCT00645944|4069488|P1|COMPLETED|Received Medication||13
1665590|NCT00645944|4069487|P2|STARTED|Received Medication||17
1665591|NCT00645944|4069488|P1|STARTED|Received Medication||19
1665592|NCT00645944|4069487|P2|NOT COMPLETED|Randomized||2
1665593|NCT00645944|4069488|P1|NOT COMPLETED|Randomized||1
1665594|NCT00645944|4069487|P2|COMPLETED|Randomized||17
1665595|NCT00645944|4069488|P1|COMPLETED|Randomized||19
1665596|NCT00645944|4069487|P2|STARTED|Randomized||19
1665597|NCT00645944|4069488|P1|STARTED|Randomized||20
1665598|NCT00645853|4069496|P2|NOT COMPLETED|Overall Study||57
1665599|NCT00645853|4069497|P1|NOT COMPLETED|Overall Study||92
1665600|NCT00645853|4069496|P2|COMPLETED|Overall Study||178
1665601|NCT00645853|4069497|P1|COMPLETED|Overall Study||196
1665602|NCT00645853|4069496|P2|AZ Study Closure in Hungary|Overall Study||40
1665603|NCT00645853|4069497|P1|AZ Study Closure in Hungary|Overall Study||60
1665604|NCT00645853|4069496|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
1665605|NCT00645853|4069497|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
1665606|NCT00645853|4069496|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
1665607|NCT00645853|4069497|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
1665608|NCT00645853|4069496|P2|STARTED|Overall Study||235
1665609|NCT00645853|4069497|P1|STARTED|Overall Study||288
1665610|NCT00645827|4069517|P2|NOT COMPLETED|Overall Study||0
1665611|NCT00645827|4069518|P1|NOT COMPLETED|Overall Study||0
1665612|NCT00645827|4069517|P2|COMPLETED|Overall Study||17
1665613|NCT00645827|4069518|P1|COMPLETED|Overall Study||14
1665614|NCT00645827|4069517|P2|STARTED|Overall Study||17
1665615|NCT00645827|4069518|P1|STARTED|Overall Study||14
1665616|NCT00645788|4069528|P4|NOT COMPLETED|Overall Study||14
1665617|NCT00645788|4069529|P3|NOT COMPLETED|Overall Study||18
1665618|NCT00645788|4069530|P2|NOT COMPLETED|Overall Study||27
1665619|NCT00645788|4069531|P1|NOT COMPLETED|Overall Study||20
1665620|NCT00645788|4069528|P4|COMPLETED|Overall Study||21
1665621|NCT00645788|4069529|P3|COMPLETED|Overall Study||47
1665622|NCT00645788|4069530|P2|COMPLETED|Overall Study||67
1665623|NCT00645788|4069531|P1|COMPLETED|Overall Study||74
1665624|NCT00645788|4069528|P4|Participants Receive Treatment|Overall Study||35
1665625|NCT00645788|4069529|P3|Participants Receive Treatment|Overall Study||65
1665626|NCT00645788|4069530|P2|Participants Receive Treatment|Overall Study||93
1665627|NCT00645788|4069531|P1|Participants Receive Treatment|Overall Study||93
1665628|NCT00645788|4069528|P4|STARTED|Overall Study||35
1665629|NCT00645788|4069529|P3|STARTED|Overall Study||65
1665630|NCT00645788|4069530|P2|STARTED|Overall Study||94
1665631|NCT00645788|4069531|P1|STARTED|Overall Study||94
1665632|NCT00645762|4069581|P1|NOT COMPLETED|Overall Study||4
1665633|NCT00645762|4069581|P1|COMPLETED|Overall Study||67
1665634|NCT00645762|4069581|P1|STARTED|Overall Study||71
1665635|NCT00645671|4069589|P2|NOT COMPLETED|Overall Study||6
1665636|NCT00645671|4069590|P1|NOT COMPLETED|Overall Study||1
1665637|NCT00645671|4069589|P2|COMPLETED|Overall Study||193
1665638|NCT00645671|4069590|P1|COMPLETED|Overall Study||200
1665639|NCT00645671|4069589|P2|STARTED|Overall Study||199
1665640|NCT00645671|4069590|P1|STARTED|Overall Study||201
1665641|NCT00645593|4069604|P2|NOT COMPLETED|Overall Study||0
1665642|NCT00645593|4069605|P1|NOT COMPLETED|Overall Study||1
1665643|NCT00645593|4069604|P2|COMPLETED|Overall Study||60
1665644|NCT00645593|4069605|P1|COMPLETED|Overall Study||28
1665645|NCT00645593|4069604|P2|STARTED|Overall Study||60
1665646|NCT00645593|4069605|P1|STARTED|Overall Study||29
1665647|NCT00645567|4069617|P1|NOT COMPLETED|Overall Study||1
1665648|NCT00645567|4069617|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
1665649|NCT00645567|4069617|P1|STARTED|Overall Study||5
1665650|NCT00645528|4069625|P1|NOT COMPLETED|Overall Study||7
1665651|NCT00645528|4069625|P1|COMPLETED|Overall Study||32
1665652|NCT00645528|4069625|P1|STARTED|Overall Study||39
1665653|NCT00645411|4069638|P4|NOT COMPLETED|Overall Study||103
1665654|NCT00645411|4069639|P3|NOT COMPLETED|Overall Study||151
1665655|NCT00645411|4069640|P2|NOT COMPLETED|Overall Study||6
1665656|NCT00645411|4069641|P1|NOT COMPLETED|Overall Study||13
1665657|NCT00645411|4069638|P4|COMPLETED|Overall Study||919
1665658|NCT00645411|4069639|P3|COMPLETED|Overall Study||1457
1665659|NCT00645411|4069640|P2|COMPLETED|Overall Study||312
1665660|NCT00645411|4069641|P1|COMPLETED|Overall Study||643
1665661|NCT00645411|4069638|P4|STARTED|Overall Study||1022
1665662|NCT00645411|4069639|P3|STARTED|Overall Study||1608
1665663|NCT00645411|4069640|P2|STARTED|Overall Study||318
1665664|NCT00645411|4069641|P1|STARTED|Overall Study||656
1665665|NCT00645359|4069673|P1|NOT COMPLETED|Overall Study||0
1665666|NCT00645359|4069673|P1|COMPLETED|Overall Study||9
1665667|NCT00645359|4069673|P1|STARTED|Overall Study||9
1665668|NCT00645333|4069678|P1|NOT COMPLETED|Overall Study||0
1665669|NCT00645333|4069678|P1|COMPLETED|Overall Study||30
1665670|NCT00645333|4069678|P1|STARTED|Overall Study||30
1665671|NCT00645164|4069683|P1|NOT COMPLETED|Overall Study||7
1665672|NCT00645164|4069683|P1|COMPLETED|Overall Study||52
1665673|NCT00645164|4069683|P1|STARTED|Overall Study||59
1665674|NCT00645099|4069689|P2|NOT COMPLETED|Overall Study||42
1665675|NCT00645099|4069690|P1|NOT COMPLETED|Overall Study||71
1665676|NCT00645099|4069689|P2|COMPLETED|Overall Study||178
1665677|NCT00645099|4069690|P1|COMPLETED|Overall Study||168
1665678|NCT00645099|4069689|P2|STARTED|Overall Study||220
1665679|NCT00645099|4069690|P1|STARTED|Overall Study||239
1665680|NCT00645047|4069734|P2|NOT COMPLETED|Overall Study||39
1665681|NCT00645047|4069735|P1|NOT COMPLETED|Overall Study||43
1665682|NCT00645047|4069734|P2|COMPLETED|Overall Study||65
1665683|NCT00645047|4069735|P1|COMPLETED|Overall Study|6 month follow up|60
1665684|NCT00645047|4069734|P2|Post|Overall Study||80
1665685|NCT00645047|4069735|P1|Post|Overall Study||74
1665686|NCT00645047|4069734|P2|STARTED|Overall Study||104
1665687|NCT00645047|4069735|P1|STARTED|Overall Study||103
1665688|NCT00644995|4069759|P2|NOT COMPLETED|Overall Study||4
1665689|NCT00644995|4069760|P1|NOT COMPLETED|Overall Study||2
1665690|NCT00644995|4069759|P2|COMPLETED|Overall Study||23
1665691|NCT00644995|4069760|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
1665692|NCT00644995|4069759|P2|Completed 4 Month Assessment|Overall Study||24
1665693|NCT00644995|4069760|P1|Completed 4 Month Assessment|Overall Study||23
1665694|NCT00644995|4069759|P2|STARTED|Overall Study||27
1665695|NCT00644995|4069760|P1|STARTED|Overall Study||25
1665696|NCT00644969|4069780|P2|NOT COMPLETED|Post Treatment Phase||3
1665697|NCT00644969|4069781|P1|NOT COMPLETED|Post Treatment Phase||10
1665698|NCT00644969|4069780|P2|COMPLETED|Post Treatment Phase||37
1665699|NCT00644969|4069781|P1|COMPLETED|Post Treatment Phase||61
1665700|NCT00644969|4069780|P2|STARTED|Post Treatment Phase||40
1665701|NCT00644969|4069781|P1|STARTED|Post Treatment Phase||71
1665702|NCT00644969|4069780|P2|NOT COMPLETED|Treatment Phase||3
1665703|NCT00644969|4069781|P1|NOT COMPLETED|Treatment Phase||14
1665704|NCT00644969|4069780|P2|COMPLETED|Treatment Phase||40
1665705|NCT00644969|4069781|P1|COMPLETED|Treatment Phase||71
1665706|NCT00644969|4069780|P2|STARTED|Treatment Phase||43
1665707|NCT00644969|4069781|P1|STARTED|Treatment Phase||85
1665708|NCT00644917|4069827|P1|NOT COMPLETED|Overall Study||2
1665709|NCT00644917|4069827|P1|COMPLETED|Overall Study||36
1665710|NCT00644917|4069827|P1|STARTED|Overall Study||38
1665711|NCT00644787|4069835|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
1665712|NCT00644787|4069836|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
1665713|NCT00644787|4069837|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
1665714|NCT00644787|4069835|P3|COMPLETED|Period 2: Double Blind Phase||55
1665715|NCT00644787|4069836|P2|COMPLETED|Period 2: Double Blind Phase||49
1665716|NCT00644787|4069837|P1|COMPLETED|Period 2: Double Blind Phase||0
1665717|NCT00644787|4069835|P3|STARTED|Period 2: Double Blind Phase||62
1665718|NCT00644787|4069836|P2|STARTED|Period 2: Double Blind Phase||58
1665719|NCT00644787|4069837|P1|STARTED|Period 2: Double Blind Phase||0
1665720|NCT00644787|4069835|P3|NOT COMPLETED|Period 1: Titration Phase||0
1665721|NCT00644787|4069836|P2|NOT COMPLETED|Period 1: Titration Phase||0
1665722|NCT00644787|4069837|P1|NOT COMPLETED|Period 1: Titration Phase||27
1665723|NCT00644787|4069835|P3|COMPLETED|Period 1: Titration Phase||0
1665724|NCT00644787|4069836|P2|COMPLETED|Period 1: Titration Phase||0
1665725|NCT00644787|4069837|P1|COMPLETED|Period 1: Titration Phase||129
1665726|NCT00644787|4069835|P3|STARTED|Period 1: Titration Phase||0
1665727|NCT00644787|4069836|P2|STARTED|Period 1: Titration Phase||0
1665728|NCT00644787|4069837|P1|STARTED|Period 1: Titration Phase||156
1665729|NCT00644657|4069865|P1|NOT COMPLETED|Overall Study||0
1665730|NCT00644657|4069865|P1|COMPLETED|Overall Study||27
1665731|NCT00644657|4069865|P1|STARTED|Overall Study||27
1665732|NCT00644592|4069872|P2|NOT COMPLETED|Overall Study||0
1665733|NCT00644592|4069873|P1|NOT COMPLETED|Overall Study||0
1665734|NCT00644592|4069872|P2|COMPLETED|Overall Study||6
1665735|NCT00644592|4069873|P1|COMPLETED|Overall Study||5
1665736|NCT00644592|4069872|P2|STARTED|Overall Study||6
1665737|NCT00644592|4069873|P1|STARTED|Overall Study||5
1665738|NCT00644358|4069879|P1|NOT COMPLETED|Overall Study||362
1665739|NCT00644358|4069879|P1|COMPLETED|Overall Study||254
1665740|NCT00644358|4069879|P1|STARTED|Overall Study||616
1665741|NCT00644332|4069886|P1|NOT COMPLETED|Overall Study||21
1665742|NCT00644332|4069886|P1|COMPLETED|Overall Study||150
1665743|NCT00644332|4069886|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
1665744|NCT00644280|4069901|P2|NOT COMPLETED|Overall Study||0
1665745|NCT00644280|4069902|P1|NOT COMPLETED|Overall Study||0
1665746|NCT00644280|4069901|P2|COMPLETED|Overall Study||5
1665747|NCT00644280|4069902|P1|COMPLETED|Overall Study||6
1665748|NCT00644280|4069901|P2|STARTED|Overall Study||5
1665749|NCT00644280|4069902|P1|STARTED|Overall Study||6
1665750|NCT00644228|4069912|P2|NOT COMPLETED|Maintenance||135
1665751|NCT00644228|4069913|P1|NOT COMPLETED|Maintenance||143
1665752|NCT00644228|4069912|P2|COMPLETED|Maintenance||0
1665753|NCT00644228|4069913|P1|COMPLETED|Maintenance||0
1665754|NCT00644228|4069912|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
1665755|NCT00644228|4069913|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
1665756|NCT00644228|4069912|P2|NOT COMPLETED|Induction Therapy||105
1665757|NCT00644228|4069913|P1|NOT COMPLETED|Induction Therapy||83
1665758|NCT00644228|4069912|P2|COMPLETED|Induction Therapy||137
1665759|NCT00644228|4069913|P1|COMPLETED|Induction Therapy||146
1665760|NCT00644228|4069912|P2|STARTED|Induction Therapy||242
1665761|NCT00644228|4069913|P1|STARTED|Induction Therapy||229
1665762|NCT00644228|4069912|P2|NOT COMPLETED|Randomization & Eligibility||22
1665763|NCT00644228|4069913|P1|NOT COMPLETED|Randomization & Eligibility||32
1665764|NCT00644228|4069912|P2|COMPLETED|Randomization & Eligibility||242
1665765|NCT00644228|4069913|P1|COMPLETED|Randomization & Eligibility||229
1665766|NCT00644228|4069912|P2|Eligible and Analyzable|Randomization & Eligibility||242
1665767|NCT00644228|4069913|P1|Eligible and Analyzable|Randomization & Eligibility||229
1665768|NCT00644228|4069912|P2|STARTED|Randomization & Eligibility||264
1665769|NCT00644228|4069913|P1|STARTED|Randomization & Eligibility||261
1665770|NCT00644189|4069923|P4|NOT COMPLETED|Phase II||0
1665771|NCT00644189|4069924|P3|NOT COMPLETED|Phase II||0
1665772|NCT00644189|4069925|P2|NOT COMPLETED|Phase II||0
1665773|NCT00644189|4069926|P1|NOT COMPLETED|Phase II||0
1665774|NCT00644189|4069923|P4|COMPLETED|Phase II||50
1665775|NCT00644189|4069924|P3|COMPLETED|Phase II||0
1665776|NCT00644189|4069925|P2|COMPLETED|Phase II||0
1665777|NCT00644189|4069926|P1|COMPLETED|Phase II||0
1665778|NCT00644189|4069923|P4|Completed All 6 Cycles of Treatment|Phase II||19
1665779|NCT00644189|4069924|P3|Completed All 6 Cycles of Treatment|Phase II||0
1665780|NCT00644189|4069925|P2|Completed All 6 Cycles of Treatment|Phase II||0
1665781|NCT00644189|4069926|P1|Completed All 6 Cycles of Treatment|Phase II||0
1665782|NCT00644189|4069923|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
1665783|NCT00644189|4069924|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
1665784|NCT00644189|4069925|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
1665785|NCT00644189|4069926|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
1665786|NCT00644189|4069923|P4|NOT COMPLETED|Phase I||0
1665787|NCT00644189|4069924|P3|NOT COMPLETED|Phase I||0
1665788|NCT00644189|4069925|P2|NOT COMPLETED|Phase I||0
1665789|NCT00644189|4069926|P1|NOT COMPLETED|Phase I||0
1665790|NCT00644189|4069923|P4|COMPLETED|Phase I||18
1665791|NCT00644189|4069924|P3|COMPLETED|Phase I||6
1665792|NCT00644189|4069925|P2|COMPLETED|Phase I||3
1665793|NCT00644189|4069926|P1|COMPLETED|Phase I||3
1665794|NCT00644189|4069923|P4|STARTED|Phase I||18
1665795|NCT00644189|4069924|P3|STARTED|Phase I||6
1665796|NCT00644189|4069925|P2|STARTED|Phase I||3
1665797|NCT00644189|4069926|P1|STARTED|Phase I||3
1665798|NCT00644059|4069942|P3|NOT COMPLETED|Overall Study||65
1665799|NCT00644059|4069943|P2|NOT COMPLETED|Overall Study||123
1665800|NCT00644059|4069944|P1|NOT COMPLETED|Overall Study||124
1665801|NCT00644059|4069942|P3|COMPLETED|Overall Study||969
1665802|NCT00644059|4069943|P2|COMPLETED|Overall Study||1726
1665803|NCT00644059|4069944|P1|COMPLETED|Overall Study||1895
1665804|NCT00644059|4069942|P3|STARTED|Overall Study||1034
1665805|NCT00644059|4069943|P2|STARTED|Overall Study||1849
1665806|NCT00644059|4069944|P1|STARTED|Overall Study||2019
1665807|NCT00643916|4070034|P6|NOT COMPLETED|Overall Study||1
1665808|NCT00643916|4070035|P5|NOT COMPLETED|Overall Study||2
1665809|NCT00643916|4070036|P4|NOT COMPLETED|Overall Study||2
1665810|NCT00643916|4070037|P3|NOT COMPLETED|Overall Study||6
1665811|NCT00643916|4070038|P2|NOT COMPLETED|Overall Study||6
1665812|NCT00643916|4070039|P1|NOT COMPLETED|Overall Study||4
1665813|NCT00643916|4070034|P6|COMPLETED|Overall Study||66
1665814|NCT00643916|4070035|P5|COMPLETED|Overall Study||57
1665815|NCT00643916|4070036|P4|COMPLETED|Overall Study||60
1665816|NCT00643916|4070037|P3|COMPLETED|Overall Study||62
1665817|NCT00643916|4070038|P2|COMPLETED|Overall Study||61
1665818|NCT00643916|4070039|P1|COMPLETED|Overall Study||51
1665819|NCT00643916|4070034|P6|STARTED|Overall Study||67
1665820|NCT00643916|4070035|P5|STARTED|Overall Study||59
1665821|NCT00643916|4070036|P4|STARTED|Overall Study||62
1665822|NCT00643916|4070037|P3|STARTED|Overall Study||68
1665823|NCT00643916|4070038|P2|STARTED|Overall Study||67
1665824|NCT00643916|4070039|P1|STARTED|Overall Study||55
1665825|NCT00643851|4070062|P3|NOT COMPLETED|Overall Study||30
1665826|NCT00643851|4070063|P2|NOT COMPLETED|Overall Study||33
1665827|NCT00643851|4070064|P1|NOT COMPLETED|Overall Study||17
1665828|NCT00643851|4070062|P3|COMPLETED|Overall Study||171
1665829|NCT00643851|4070063|P2|COMPLETED|Overall Study||170
1665830|NCT00643851|4070064|P1|COMPLETED|Overall Study||177
1665831|NCT00643851|4070062|P3|STARTED|Overall Study||201
1665832|NCT00643851|4070063|P2|STARTED|Overall Study||203
1665833|NCT00643851|4070064|P1|STARTED|Overall Study||194
1665834|NCT00643760|4070092|P5|NOT COMPLETED|Overall Study||19
1665835|NCT00643760|4070093|P4|NOT COMPLETED|Overall Study||38
1665836|NCT00643760|4070094|P3|NOT COMPLETED|Overall Study||19
1665837|NCT00643760|4070095|P2|NOT COMPLETED|Overall Study||15
1665838|NCT00643760|4070096|P1|NOT COMPLETED|Overall Study||30
1665839|NCT00643760|4070092|P5|COMPLETED|Overall Study||47
1665840|NCT00643760|4070093|P4|COMPLETED|Overall Study||79
1665841|NCT00643760|4070094|P3|COMPLETED|Overall Study||37
1665842|NCT00643760|4070095|P2|COMPLETED|Overall Study||47
1665843|NCT00643760|4070096|P1|COMPLETED|Overall Study||90
1665844|NCT00643760|4070092|P5|ITT Population|Overall Study||66
1665845|NCT00643760|4070093|P4|ITT Population|Overall Study||116
1665846|NCT00643760|4070094|P3|ITT Population|Overall Study||56
1665847|NCT00643760|4070095|P2|ITT Population|Overall Study||62
1665848|NCT00643760|4070096|P1|ITT Population|Overall Study||120
1665849|NCT00643760|4070092|P5|Safety Population/Treated With Drug|Overall Study||66
1665850|NCT00643760|4070093|P4|Safety Population/Treated With Drug|Overall Study||116
1665851|NCT00643760|4070094|P3|Safety Population/Treated With Drug|Overall Study||56
1665852|NCT00643760|4070095|P2|Safety Population/Treated With Drug|Overall Study||62
1665853|NCT00643760|4070096|P1|Safety Population/Treated With Drug|Overall Study||120
1665854|NCT00643760|4070092|P5|STARTED|Overall Study||66
1665855|NCT00643760|4070093|P4|STARTED|Overall Study||117
1665856|NCT00643760|4070094|P3|STARTED|Overall Study||56
1665857|NCT00643760|4070095|P2|STARTED|Overall Study||62
1665858|NCT00643760|4070096|P1|STARTED|Overall Study||120
1665859|NCT00643682|4070200|P2|NOT COMPLETED|Overall Study||509
1665860|NCT00643682|4070201|P1|NOT COMPLETED|Overall Study||522
1665861|NCT00643682|4070200|P2|COMPLETED|Overall Study||492
1665862|NCT00643682|4070201|P1|COMPLETED|Overall Study||477
1665863|NCT00643682|4070200|P2|STARTED|Overall Study||1001
1665864|NCT00643682|4070201|P1|STARTED|Overall Study||999
1665865|NCT00643604|4070213|P1|NOT COMPLETED|Overall Study||1
1665866|NCT00643604|4070213|P1|COMPLETED|Overall Study||6
1665867|NCT00643604|4070213|P1|STARTED|Overall Study||7
1665868|NCT00643578|4070230|P2|NOT COMPLETED|Overall Study||0
1665869|NCT00643578|4070231|P1|NOT COMPLETED|Overall Study||2
1665870|NCT00643578|4070230|P2|COMPLETED|Overall Study||6
1665871|NCT00643578|4070231|P1|COMPLETED|Overall Study||4
1665872|NCT00643578|4070230|P2|STARTED|Overall Study||6
1665873|NCT00643578|4070231|P1|STARTED|Overall Study||6
1665874|NCT00643565|4070241|P2|NOT COMPLETED|Overall Study||74
1665875|NCT00643565|4070242|P1|NOT COMPLETED|Overall Study||80
1665876|NCT00643565|4070241|P2|COMPLETED|Overall Study||0
1665877|NCT00643565|4070242|P1|COMPLETED|Overall Study||0
1665878|NCT00643565|4070241|P2|STARTED|Overall Study||74
1665879|NCT00643565|4070242|P1|STARTED|Overall Study||80
1665880|NCT00643487|4070264|P1|NOT COMPLETED|Overall Study||3
1665881|NCT00643487|4070264|P1|COMPLETED|Overall Study||5
1665882|NCT00643487|4070264|P1|STARTED|Overall Study||8
1665883|NCT00643448|4070271|P3|NOT COMPLETED|Overall Study||6
1665884|NCT00643448|4070272|P2|NOT COMPLETED|Overall Study||5
1665885|NCT00643448|4070273|P1|NOT COMPLETED|Overall Study||4
1665886|NCT00643448|4070271|P3|COMPLETED|Overall Study||16
1665887|NCT00643448|4070272|P2|COMPLETED|Overall Study||17
1665888|NCT00643448|4070273|P1|COMPLETED|Overall Study||17
1665889|NCT00643448|4070271|P3|STARTED|Overall Study||22
1665890|NCT00643448|4070272|P2|STARTED|Overall Study||22
1665891|NCT00643448|4070273|P1|STARTED|Overall Study||21
1665892|NCT00643201|4070290|P2|NOT COMPLETED|Completed Study Follow Up||79
1665893|NCT00643201|4070291|P1|NOT COMPLETED|Completed Study Follow Up||70
1665894|NCT00643201|4070290|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
1665895|NCT00643201|4070291|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
1665896|NCT00643201|4070290|P2|STARTED|Completed Study Follow Up||2639
1665897|NCT00643201|4070291|P1|STARTED|Completed Study Follow Up||2617
1665898|NCT00643201|4070290|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
1665899|NCT00643201|4070291|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
1665900|NCT00643201|4070290|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
1665901|NCT00643201|4070291|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
1665902|NCT00643201|4070290|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
1665903|NCT00643201|4070291|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
1665904|NCT00643123|4070339|P2|NOT COMPLETED|Overall Study||1
1665905|NCT00643123|4070340|P1|NOT COMPLETED|Overall Study||5
1665906|NCT00643123|4070339|P2|COMPLETED|Overall Study||11
1665907|NCT00643123|4070340|P1|COMPLETED|Overall Study||10
1665908|NCT00643123|4070339|P2|STARTED|Overall Study||12
1665909|NCT00643123|4070340|P1|STARTED|Overall Study||15
1665910|NCT00643097|4070349|P3|NOT COMPLETED|Overall Study||0
1665911|NCT00643097|4070350|P2|NOT COMPLETED|Overall Study||0
1665912|NCT00643097|4070351|P1|NOT COMPLETED|Overall Study||0
1665913|NCT00643097|4070349|P3|COMPLETED|Overall Study||10
1665914|NCT00643097|4070350|P2|COMPLETED|Overall Study||12
1665915|NCT00643097|4070351|P1|COMPLETED|Overall Study||18
1665916|NCT00643097|4070349|P3|STARTED|Overall Study||10
1665917|NCT00643097|4070350|P2|STARTED|Overall Study||12
1665918|NCT00643097|4070351|P1|STARTED|Overall Study||18
1665919|NCT00643006|4070370|P2|NOT COMPLETED|Overall Study||4
1665920|NCT00643006|4070371|P1|NOT COMPLETED|Overall Study||5
1665921|NCT00643006|4070370|P2|COMPLETED|Overall Study||29
1665922|NCT00643006|4070371|P1|COMPLETED|Overall Study||29
1665923|NCT00643006|4070370|P2|STARTED|Overall Study||33
1665924|NCT00643006|4070371|P1|STARTED|Overall Study||34
1665925|NCT00642993|4070381|P2|NOT COMPLETED|Overall Study||16
1665926|NCT00642993|4070382|P1|NOT COMPLETED|Overall Study||106
1665927|NCT00642993|4070381|P2|COMPLETED|Overall Study||118
1665928|NCT00642993|4070382|P1|COMPLETED|Overall Study||161
1665929|NCT00642993|4070381|P2|STARTED|Overall Study||134
1665930|NCT00642993|4070382|P1|STARTED|Overall Study||267
1665931|NCT00642902|4070400|P4|NOT COMPLETED|Overall Study||40
1665932|NCT00642902|4070401|P3|NOT COMPLETED|Overall Study||43
1665933|NCT00642902|4070402|P2|NOT COMPLETED|Overall Study||42
1665934|NCT00642902|4070403|P1|NOT COMPLETED|Overall Study||40
1665935|NCT00642902|4070400|P4|COMPLETED|Overall Study||25
1665936|NCT00642902|4070401|P3|COMPLETED|Overall Study||21
1665937|NCT00642902|4070402|P2|COMPLETED|Overall Study||21
1665938|NCT00642902|4070403|P1|COMPLETED|Overall Study||23
1665939|NCT00642902|4070400|P4|Treated|Overall Study||65
1665940|NCT00642902|4070401|P3|Treated|Overall Study||63
1665941|NCT00642902|4070402|P2|Treated|Overall Study||63
1665942|NCT00642902|4070403|P1|Treated|Overall Study||63
1665943|NCT00642902|4070400|P4|STARTED|Overall Study||65
1665944|NCT00642902|4070401|P3|STARTED|Overall Study||64
1665945|NCT00642902|4070402|P2|STARTED|Overall Study||63
1665946|NCT00642902|4070403|P1|STARTED|Overall Study||63
1665947|NCT00642850|4070425|P1|NOT COMPLETED|Overall Study||33
1665948|NCT00642850|4070425|P1|COMPLETED|Overall Study||155
1665949|NCT00642850|4070425|P1|STARTED|Overall Study||188
1665950|NCT00642811|4070441|P6|NOT COMPLETED|Overall Study||1
1665951|NCT00642811|4070442|P5|NOT COMPLETED|Overall Study||1
1665952|NCT00642811|4070443|P4|NOT COMPLETED|Overall Study||1
1665953|NCT00642811|4070444|P3|NOT COMPLETED|Overall Study||0
1665954|NCT00642811|4070445|P2|NOT COMPLETED|Overall Study||4
1665955|NCT00642811|4070446|P1|NOT COMPLETED|Overall Study||3
1665956|NCT00642811|4070441|P6|COMPLETED|Overall Study||13
1665957|NCT00642811|4070442|P5|COMPLETED|Overall Study||13
1665958|NCT00642811|4070443|P4|COMPLETED|Overall Study||15
1665959|NCT00642811|4070444|P3|COMPLETED|Overall Study||13
1665960|NCT00642811|4070445|P2|COMPLETED|Overall Study||17
1665961|NCT00642811|4070446|P1|COMPLETED|Overall Study||17
1665962|NCT00642811|4070441|P6|STARTED|Overall Study||14
1665963|NCT00642811|4070442|P5|STARTED|Overall Study||14
1665964|NCT00642811|4070443|P4|STARTED|Overall Study||16
1665965|NCT00642811|4070444|P3|STARTED|Overall Study||13
1665966|NCT00642811|4070445|P2|STARTED|Overall Study||21
1665967|NCT00642811|4070446|P1|STARTED|Overall Study||20
1665968|NCT00642772|4070468|P1|NOT COMPLETED|Overall Study||10
1665969|NCT00642772|4070468|P1|COMPLETED|Overall Study||14
1665970|NCT00642772|4070468|P1|STARTED|Overall Study||24
1665971|NCT00642759|4070472|P1|NOT COMPLETED|Overall Study||1
1665972|NCT00642759|4070472|P1|COMPLETED|Overall Study||35
1665973|NCT00642759|4070472|P1|STARTED|Overall Study||36
1665974|NCT00642746|4070481|P2|NOT COMPLETED|Overall Study||0
1665975|NCT00642746|4070482|P1|NOT COMPLETED|Overall Study||1
1665976|NCT00642746|4070481|P2|COMPLETED|Overall Study||1
1665977|NCT00642746|4070482|P1|COMPLETED|Overall Study||9
1665978|NCT00642746|4070481|P2|STARTED|Overall Study||1
1665979|NCT00642746|4070482|P1|STARTED|Overall Study||10
1665980|NCT00642707|4070496|P4|NOT COMPLETED|Overall Study||2
1665981|NCT00642707|4070497|P3|NOT COMPLETED|Overall Study||0
1665982|NCT00642707|4070498|P2|NOT COMPLETED|Overall Study||0
1665983|NCT00642707|4070499|P1|NOT COMPLETED|Overall Study||1
1665984|NCT00642707|4070496|P4|COMPLETED|Overall Study||8
1665985|NCT00642707|4070497|P3|COMPLETED|Overall Study||12
1665986|NCT00642707|4070498|P2|COMPLETED|Overall Study||11
1665987|NCT00642707|4070499|P1|COMPLETED|Overall Study||10
1665988|NCT00642707|4070496|P4|STARTED|Overall Study||10
1665989|NCT00642707|4070497|P3|STARTED|Overall Study||12
1665990|NCT00642707|4070498|P2|STARTED|Overall Study||11
1665991|NCT00642707|4070499|P1|STARTED|Overall Study||11
1665992|NCT00642694|4070511|P2|NOT COMPLETED|Overall Study||4
1665993|NCT00642694|4070512|P1|NOT COMPLETED|Overall Study||6
1665994|NCT00642694|4070511|P2|COMPLETED|Overall Study||11
1665995|NCT00642694|4070512|P1|COMPLETED|Overall Study||8
1665996|NCT00642694|4070511|P2|STARTED|Overall Study||15
1665997|NCT00642694|4070512|P1|STARTED|Overall Study||14
1665998|NCT00642668|4070520|P1|NOT COMPLETED|Overall Study||14
1665999|NCT00642668|4070520|P1|COMPLETED|Overall Study||21
1666000|NCT00642668|4070520|P1|STARTED|Overall Study||35
1666001|NCT00642642|4070528|P1|NOT COMPLETED|Treatment & Follow Up||17
1666002|NCT00642642|4070528|P1|COMPLETED|Treatment & Follow Up||92
1666003|NCT00642642|4070528|P1|STARTED|Treatment & Follow Up||109
1666004|NCT00642642|4070528|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
1666005|NCT00642642|4070528|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
1666006|NCT00642642|4070528|P1|STARTED|Biopsy & Product Manufacture||122
1666007|NCT00642616|4070545|P4|NOT COMPLETED|Overall Study||7
1666008|NCT00642616|4070546|P3|NOT COMPLETED|Overall Study||9
1666009|NCT00642616|4070547|P2|NOT COMPLETED|Overall Study||7
1666010|NCT00642616|4070548|P1|NOT COMPLETED|Overall Study||9
1666011|NCT00642616|4070545|P4|COMPLETED|Overall Study||1
1666012|NCT00642616|4070546|P3|COMPLETED|Overall Study||0
1666013|NCT00642616|4070547|P2|COMPLETED|Overall Study||1
1666014|NCT00642616|4070548|P1|COMPLETED|Overall Study||0
1666015|NCT00642616|4070545|P4|STARTED|Overall Study||8
1666016|NCT00642616|4070546|P3|STARTED|Overall Study||9
1666017|NCT00642616|4070547|P2|STARTED|Overall Study||8
1666018|NCT00642616|4070548|P1|STARTED|Overall Study||9
1666019|NCT00642603|4070572|P2|NOT COMPLETED|Overall Study||18
1666020|NCT00642603|4070573|P1|NOT COMPLETED|Overall Study||21
1666021|NCT00642603|4070572|P2|COMPLETED|Overall Study||2
1666022|NCT00642603|4070573|P1|COMPLETED|Overall Study||0
1666023|NCT00642603|4070572|P2|Safety Population|Overall Study||20
1666024|NCT00642603|4070573|P1|Safety Population|Overall Study||19
1666025|NCT00642603|4070572|P2|STARTED|Overall Study||20
1666026|NCT00642603|4070573|P1|STARTED|Overall Study||21
1666027|NCT00642473|4070581|P2|NOT COMPLETED|Overall Study||11
1666028|NCT00642473|4070582|P1|NOT COMPLETED|Overall Study||4
1666029|NCT00642473|4070581|P2|COMPLETED|Overall Study||5
1666030|NCT00642473|4070582|P1|COMPLETED|Overall Study||14
1666031|NCT00642473|4070581|P2|STARTED|Overall Study||16
1666032|NCT00642473|4070582|P1|STARTED|Overall Study||18
1666033|NCT00642460|4070596|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
1666034|NCT00642460|4070597|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
1666035|NCT00642460|4070598|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1666036|NCT00642460|4070599|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1666037|NCT00642460|4070600|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1666038|NCT00642460|4070601|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1666039|NCT00642460|4070596|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
1666040|NCT00642460|4070597|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
1666041|NCT00642460|4070598|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
1666042|NCT00642460|4070599|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
1666043|NCT00642460|4070600|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
1666044|NCT00642460|4070601|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
1666045|NCT00642460|4070596|P6|STARTED|Part III: Open-Label Up to Week 260||59
1666046|NCT00642460|4070597|P5|STARTED|Part III: Open-Label Up to Week 260||53
1666047|NCT00642460|4070598|P4|STARTED|Part III: Open-Label Up to Week 260||0
1666048|NCT00642460|4070599|P3|STARTED|Part III: Open-Label Up to Week 260||0
1666049|NCT00642460|4070600|P2|STARTED|Part III: Open-Label Up to Week 260||0
1666050|NCT00642460|4070601|P1|STARTED|Part III: Open-Label Up to Week 260||0
1666051|NCT00642460|4070596|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
1666052|NCT00642460|4070597|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
1666053|NCT00642460|4070598|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
1666054|NCT00642460|4070599|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
1666055|NCT00642460|4070600|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
1666056|NCT00642460|4070601|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
1666057|NCT00642460|4070596|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
1666058|NCT00642460|4070597|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
1666059|NCT00642460|4070598|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
1666060|NCT00642460|4070599|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
1666061|NCT00642460|4070600|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
1666062|NCT00642460|4070601|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
1666063|NCT00642460|4070596|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
1666064|NCT00642460|4070597|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
1666065|NCT00642460|4070598|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
1666066|NCT00642460|4070599|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
1666067|NCT00642460|4070600|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
1666068|NCT00642460|4070601|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
1666069|NCT00642460|4070596|P6|STARTED|Part II: Open-Label Up to Week 92||0
1666070|NCT00642460|4070597|P5|STARTED|Part II: Open-Label Up to Week 92||0
1666071|NCT00642460|4070598|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
1666072|NCT00642460|4070599|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
1666073|NCT00642460|4070600|P2|STARTED|Part II: Open-Label Up to Week 92||40
1666074|NCT00642460|4070601|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
1666075|NCT00642460|4070596|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
1666076|NCT00642460|4070597|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
1666077|NCT00642460|4070598|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
1666078|NCT00642460|4070599|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
1666079|NCT00642460|4070600|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
1666080|NCT00642460|4070601|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
1666081|NCT00642460|4070596|P6|COMPLETED|Part I: 12 Week Double-Blind||0
1666082|NCT00642460|4070597|P5|COMPLETED|Part I: 12 Week Double-Blind||0
1666083|NCT00642460|4070598|P4|COMPLETED|Part I: 12 Week Double-Blind||0
1666084|NCT00642460|4070599|P3|COMPLETED|Part I: 12 Week Double-Blind||36
1666085|NCT00642460|4070600|P2|COMPLETED|Part I: 12 Week Double-Blind||37
1666086|NCT00642460|4070601|P1|COMPLETED|Part I: 12 Week Double-Blind||36
1666087|NCT00642460|4070596|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
1666088|NCT00642460|4070597|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
1666089|NCT00642460|4070598|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
1666090|NCT00642460|4070599|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
1666091|NCT00642460|4070600|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
1666092|NCT00642460|4070601|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
1666093|NCT00642460|4070596|P6|STARTED|Part I: 12 Week Double-Blind||0
1666094|NCT00642460|4070597|P5|STARTED|Part I: 12 Week Double-Blind||0
1666095|NCT00642460|4070598|P4|STARTED|Part I: 12 Week Double-Blind||0
1666096|NCT00642460|4070599|P3|STARTED|Part I: 12 Week Double-Blind||37
1666097|NCT00642460|4070600|P2|STARTED|Part I: 12 Week Double-Blind||38
1666098|NCT00642460|4070601|P1|STARTED|Part I: 12 Week Double-Blind||37
1666099|NCT00642382|4070667|P2|NOT COMPLETED|Overall Study||0
1666100|NCT00642382|4070668|P1|NOT COMPLETED|Overall Study||0
1666101|NCT00642382|4070667|P2|COMPLETED|Overall Study||0
1666102|NCT00642382|4070668|P1|COMPLETED|Overall Study||0
1666103|NCT00642382|4070667|P2|STARTED|Overall Study||0
1666104|NCT00642382|4070668|P1|STARTED|Overall Study||0
1666105|NCT00642369|4070676|P2|NOT COMPLETED|Overall Study||6
1666106|NCT00642369|4070677|P1|NOT COMPLETED|Overall Study||5
1666107|NCT00642369|4070676|P2|COMPLETED|Overall Study||24
1666108|NCT00642369|4070677|P1|COMPLETED|Overall Study||25
1666109|NCT00642369|4070676|P2|STARTED|Overall Study||30
1666110|NCT00642369|4070677|P1|STARTED|Overall Study||30
1666111|NCT00642356|4070687|P2|NOT COMPLETED|Overall Study||3
1666112|NCT00642356|4070688|P1|NOT COMPLETED|Overall Study||2
1666113|NCT00642356|4070687|P2|COMPLETED|Overall Study||4
1666114|NCT00642356|4070688|P1|COMPLETED|Overall Study||5
1666115|NCT00642356|4070687|P2|STARTED|Overall Study||7
1666116|NCT00642356|4070688|P1|STARTED|Overall Study||7
1666117|NCT00642304|4070696|P1|NOT COMPLETED|Overall Study||6
1666118|NCT00642304|4070696|P1|COMPLETED|Overall Study||14
1666119|NCT00642304|4070696|P1|STARTED|Overall Study||20
1666120|NCT00642278|4070712|P7|NOT COMPLETED|Overall Study||5
1666121|NCT00642278|4070713|P6|NOT COMPLETED|Overall Study||7
1666122|NCT00642278|4070714|P5|NOT COMPLETED|Overall Study||8
1666123|NCT00642278|4070715|P4|NOT COMPLETED|Overall Study||9
1666124|NCT00642278|4070716|P3|NOT COMPLETED|Overall Study||5
1666125|NCT00642278|4070717|P2|NOT COMPLETED|Overall Study||5
1666126|NCT00642278|4070718|P1|NOT COMPLETED|Overall Study||10
1666127|NCT00642278|4070712|P7|COMPLETED|Overall Study||60
1666128|NCT00642278|4070713|P6|COMPLETED|Overall Study||57
1666129|NCT00642278|4070714|P5|COMPLETED|Overall Study||56
1666130|NCT00642278|4070715|P4|COMPLETED|Overall Study||56
1666131|NCT00642278|4070716|P3|COMPLETED|Overall Study||59
1666132|NCT00642278|4070717|P2|COMPLETED|Overall Study||59
1666133|NCT00642278|4070718|P1|COMPLETED|Overall Study||55
1666134|NCT00642278|4070712|P7|STARTED|Overall Study||65
1666135|NCT00642278|4070713|P6|STARTED|Overall Study||64
1666136|NCT00642278|4070714|P5|STARTED|Overall Study||64
1666137|NCT00642278|4070715|P4|STARTED|Overall Study||65
1666138|NCT00642278|4070716|P3|STARTED|Overall Study||64
1666139|NCT00642278|4070717|P2|STARTED|Overall Study||64
1666140|NCT00642278|4070718|P1|STARTED|Overall Study||65
1666141|NCT00642174|4070771|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
1666142|NCT00642174|4070772|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
1666143|NCT00642174|4070771|P2|COMPLETED|Period 2 - Crossover Drug||16
1666144|NCT00642174|4070772|P1|COMPLETED|Period 2 - Crossover Drug||18
1666145|NCT00642174|4070771|P2|STARTED|Period 2 - Crossover Drug||16
1666146|NCT00642174|4070772|P1|STARTED|Period 2 - Crossover Drug||18
1666147|NCT00642174|4070771|P2|NOT COMPLETED|Period 1 - Initial Drug||1
1666148|NCT00642174|4070772|P1|NOT COMPLETED|Period 1 - Initial Drug||0
1666149|NCT00642174|4070771|P2|COMPLETED|Period 1 - Initial Drug||16
1666150|NCT00642174|4070772|P1|COMPLETED|Period 1 - Initial Drug||18
1666151|NCT00642174|4070771|P2|STARTED|Period 1 - Initial Drug||17
1666152|NCT00642174|4070772|P1|STARTED|Period 1 - Initial Drug||18
1666153|NCT00641862|4070788|P2|NOT COMPLETED|Overall Study||38
1666154|NCT00641862|4070789|P1|NOT COMPLETED|Overall Study||44
1666155|NCT00641862|4070788|P2|COMPLETED|Overall Study||145
1666156|NCT00641862|4070789|P1|COMPLETED|Overall Study||139
1666157|NCT00641862|4070788|P2|STARTED|Overall Study||183
1666158|NCT00641862|4070789|P1|STARTED|Overall Study||183
1666159|NCT00641797|4070797|P2|NOT COMPLETED|Overall Study||0
1666160|NCT00641797|4070798|P1|NOT COMPLETED|Overall Study||0
1666161|NCT00641797|4070797|P2|COMPLETED|Overall Study||15
1666162|NCT00641797|4070798|P1|COMPLETED|Overall Study||11
1666163|NCT00641797|4070797|P2|STARTED|Overall Study||15
1666164|NCT00641797|4070798|P1|STARTED|Overall Study||11
1666165|NCT00641745|4070806|P2|NOT COMPLETED|Overall Study||113
1666166|NCT00641745|4070807|P1|NOT COMPLETED|Overall Study||280
1666167|NCT00641745|4070806|P2|COMPLETED|Overall Study||89
1666168|NCT00641745|4070807|P1|COMPLETED|Overall Study||147
1666169|NCT00641745|4070806|P2|STARTED|Overall Study||202
1666170|NCT00641745|4070807|P1|STARTED|Overall Study||427
1666171|NCT00641719|4070815|P2|NOT COMPLETED|Overall Study||37
1666172|NCT00641719|4070816|P1|NOT COMPLETED|Overall Study||30
1666173|NCT00641719|4070815|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
1666174|NCT00641719|4070816|P1|COMPLETED|Overall Study||99
1666175|NCT00641719|4070815|P2|STARTED|Overall Study||129
1666176|NCT00641719|4070816|P1|STARTED|Overall Study||129
1666177|NCT00641706|4070840|P2|NOT COMPLETED|Overall Study||3
1666178|NCT00641706|4070841|P1|NOT COMPLETED|Overall Study||9
1666179|NCT00641706|4070840|P2|COMPLETED|Overall Study||4
1666180|NCT00641706|4070841|P1|COMPLETED|Overall Study||28
1666181|NCT00641706|4070840|P2|STARTED|Overall Study||7
1666182|NCT00641706|4070841|P1|STARTED|Overall Study||37
1666183|NCT00641667|4070853|P1|NOT COMPLETED|Overall Study||6
1666184|NCT00641667|4070853|P1|COMPLETED|Overall Study||60
1666185|NCT00641667|4070853|P1|STARTED|Overall Study||66
1666186|NCT00641641|4070863|P1|NOT COMPLETED|Overall Study||0
1666187|NCT00641641|4070863|P1|COMPLETED|Overall Study||16
1666188|NCT00641641|4070863|P1|STARTED|Overall Study||16
1666189|NCT00641563|4070867|P2|NOT COMPLETED|Infusion 2||0
1666190|NCT00641563|4070868|P1|NOT COMPLETED|Infusion 2||0
1666191|NCT00641563|4070867|P2|COMPLETED|Infusion 2||5
1666192|NCT00641563|4070868|P1|COMPLETED|Infusion 2||5
1666193|NCT00641563|4070867|P2|STARTED|Infusion 2||5
1666194|NCT00641563|4070868|P1|STARTED|Infusion 2||5
1666195|NCT00641563|4070867|P2|NOT COMPLETED|Infusion 1||0
1666196|NCT00641563|4070868|P1|NOT COMPLETED|Infusion 1||0
1666197|NCT00641563|4070867|P2|COMPLETED|Infusion 1||5
1666198|NCT00641563|4070868|P1|COMPLETED|Infusion 1||5
1666199|NCT00641563|4070867|P2|STARTED|Infusion 1||5
1666200|NCT00641563|4070868|P1|STARTED|Infusion 1||5
1666201|NCT00641537|4070881|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
1666202|NCT00641537|4070882|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
1666203|NCT00641537|4070883|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
1666204|NCT00641537|4070884|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
1666205|NCT00641537|4070885|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
1666206|NCT00641537|4070886|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
1666207|NCT00641537|4070887|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
1666208|NCT00641537|4070888|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
1666209|NCT00641537|4070881|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
1666210|NCT00641537|4070882|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
1666211|NCT00641537|4070883|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
1666212|NCT00641537|4070884|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
1666213|NCT00641537|4070885|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
1666214|NCT00641537|4070886|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
1666215|NCT00641537|4070887|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
1666216|NCT00641537|4070888|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
1666217|NCT00641537|4070881|P8|STARTED|24-Week Supplemental Follow-up Period||11
1666218|NCT00641537|4070882|P7|STARTED|24-Week Supplemental Follow-up Period||9
1666219|NCT00641537|4070883|P6|STARTED|24-Week Supplemental Follow-up Period||15
1666220|NCT00641537|4070884|P5|STARTED|24-Week Supplemental Follow-up Period||198
1666221|NCT00641537|4070885|P4|STARTED|24-Week Supplemental Follow-up Period||151
1666222|NCT00641537|4070886|P3|STARTED|24-Week Supplemental Follow-up Period||143
1666223|NCT00641537|4070887|P2|STARTED|24-Week Supplemental Follow-up Period||69
1666224|NCT00641537|4070888|P1|STARTED|24-Week Supplemental Follow-up Period||75
1666225|NCT00641537|4070881|P8|NOT COMPLETED|96-week Period||6
1666226|NCT00641537|4070882|P7|NOT COMPLETED|96-week Period||5
1666227|NCT00641537|4070883|P6|NOT COMPLETED|96-week Period||7
1666228|NCT00641537|4070884|P5|NOT COMPLETED|96-week Period||18
1666229|NCT00641537|4070885|P4|NOT COMPLETED|96-week Period||12
1666230|NCT00641537|4070886|P3|NOT COMPLETED|96-week Period||20
1666231|NCT00641537|4070887|P2|NOT COMPLETED|96-week Period||10
1666232|NCT00641537|4070888|P1|NOT COMPLETED|96-week Period||9
1666233|NCT00641537|4070881|P8|COMPLETED|96-week Period||16
1666234|NCT00641537|4070882|P7|COMPLETED|96-week Period||12
1666235|NCT00641537|4070883|P6|COMPLETED|96-week Period||15
1666236|NCT00641537|4070884|P5|COMPLETED|96-week Period||226
1666237|NCT00641537|4070885|P4|COMPLETED|96-week Period||174
1666238|NCT00641537|4070886|P3|COMPLETED|96-week Period||166
1666239|NCT00641537|4070887|P2|COMPLETED|96-week Period||82
1666240|NCT00641537|4070888|P1|COMPLETED|96-week Period||89
1666241|NCT00641537|4070881|P8|STARTED|96-week Period||22
1666242|NCT00641537|4070882|P7|STARTED|96-week Period||17
1666243|NCT00641537|4070883|P6|STARTED|96-week Period||22
1666244|NCT00641537|4070884|P5|STARTED|96-week Period||244
1666245|NCT00641537|4070885|P4|STARTED|96-week Period||186
1666246|NCT00641537|4070886|P3|STARTED|96-week Period||186
1666247|NCT00641537|4070887|P2|STARTED|96-week Period||92
1666248|NCT00641537|4070888|P1|STARTED|96-week Period||98
1666249|NCT00641147|4070943|P2|NOT COMPLETED|Completed 16 Months.||0
1666250|NCT00641147|4070944|P1|NOT COMPLETED|Completed 16 Months.||2
1666251|NCT00641147|4070943|P2|COMPLETED|Completed 16 Months.||19
1666252|NCT00641147|4070944|P1|COMPLETED|Completed 16 Months.||13
1666253|NCT00641147|4070943|P2|STARTED|Completed 16 Months.||19
1666254|NCT00641147|4070944|P1|STARTED|Completed 16 Months.||15
1666255|NCT00641147|4070943|P2|NOT COMPLETED|Completed 12 Months.||2
1666256|NCT00641147|4070944|P1|NOT COMPLETED|Completed 12 Months.||1
1666257|NCT00641147|4070943|P2|COMPLETED|Completed 12 Months.||19
1666258|NCT00641147|4070944|P1|COMPLETED|Completed 12 Months.||15
1666259|NCT00641147|4070943|P2|STARTED|Completed 12 Months.||21
1666260|NCT00641147|4070944|P1|STARTED|Completed 12 Months.||16
1666261|NCT00641147|4070943|P2|NOT COMPLETED|Completed 8 Months.||2
1666262|NCT00641147|4070944|P1|NOT COMPLETED|Completed 8 Months.||3
1666263|NCT00641147|4070943|P2|COMPLETED|Completed 8 Months.||21
1666264|NCT00641147|4070944|P1|COMPLETED|Completed 8 Months.||16
1666265|NCT00641147|4070943|P2|STARTED|Completed 8 Months.||23
1666266|NCT00641147|4070944|P1|STARTED|Completed 8 Months.||19
1666267|NCT00641147|4070943|P2|NOT COMPLETED|Completed 4 Months.||0
1666268|NCT00641147|4070944|P1|NOT COMPLETED|Completed 4 Months.||2
1666269|NCT00641147|4070943|P2|COMPLETED|Completed 4 Months.||23
1666270|NCT00641147|4070944|P1|COMPLETED|Completed 4 Months.||19
1666271|NCT00641147|4070943|P2|STARTED|Completed 4 Months.||23
1666272|NCT00641147|4070944|P1|STARTED|Completed 4 Months.||21
1666273|NCT00641056|4070988|P2|NOT COMPLETED|Overall Study||25
1666274|NCT00641056|4070989|P1|NOT COMPLETED|Overall Study||29
1666275|NCT00641056|4070988|P2|COMPLETED|Overall Study||209
1666276|NCT00641056|4070989|P1|COMPLETED|Overall Study||204
1666277|NCT00641056|4070988|P2|Intent to Treat (ITT)|Overall Study||223
1666278|NCT00641056|4070989|P1|Intent to Treat (ITT)|Overall Study||233
1666279|NCT00641056|4070988|P2|STARTED|Overall Study||234
1666280|NCT00641056|4070989|P1|STARTED|Overall Study||233
1666281|NCT00641043|4071017|P2|NOT COMPLETED|Overall Study||15
1666282|NCT00641043|4071018|P1|NOT COMPLETED|Overall Study||19
1666283|NCT00641043|4071017|P2|COMPLETED|Overall Study|number who completed treatment|244
1666284|NCT00641043|4071018|P1|COMPLETED|Overall Study|number who completed treatment|111
1666285|NCT00641043|4071017|P2|STARTED|Overall Study|number who started treatment|259
1666286|NCT00641043|4071018|P1|STARTED|Overall Study|number who started treatment|130
1666287|NCT00640978|4071048|P1|NOT COMPLETED|Overall Study||0
1666288|NCT00640978|4071048|P1|COMPLETED|Overall Study||15
1666289|NCT00640978|4071048|P1|STARTED|Overall Study||15
1666290|NCT00640926|4071055|P3|NOT COMPLETED|Overall Study||8
1666291|NCT00640926|4071056|P2|NOT COMPLETED|Overall Study||6
1666292|NCT00640926|4071057|P1|NOT COMPLETED|Overall Study||8
1666293|NCT00640926|4071055|P3|COMPLETED|Overall Study||45
1666294|NCT00640926|4071056|P2|COMPLETED|Overall Study||46
1666295|NCT00640926|4071057|P1|COMPLETED|Overall Study||45
1666296|NCT00640926|4071055|P3|STARTED|Overall Study||53
1666297|NCT00640926|4071056|P2|STARTED|Overall Study||52
1666298|NCT00640926|4071057|P1|STARTED|Overall Study||53
1666299|NCT00640835|4071070|P2|NOT COMPLETED|Overall Study||57
1666300|NCT00640835|4071071|P1|NOT COMPLETED|Overall Study||76
1666301|NCT00640835|4071070|P2|COMPLETED|Overall Study||131
1666302|NCT00640835|4071071|P1|COMPLETED|Overall Study||118
1666303|NCT00640835|4071070|P2|STARTED|Overall Study||188
1666304|NCT00640835|4071071|P1|STARTED|Overall Study||194
1666305|NCT00640822|4071082|P3|NOT COMPLETED|Overall Study||25
1666306|NCT00640822|4071083|P2|NOT COMPLETED|Overall Study||59
1666307|NCT00640822|4071084|P1|NOT COMPLETED|Overall Study||43
1666308|NCT00640822|4071082|P3|COMPLETED|Overall Study||77
1666309|NCT00640822|4071083|P2|COMPLETED|Overall Study||258
1666310|NCT00640822|4071084|P1|COMPLETED|Overall Study||279
1666311|NCT00640822|4071082|P3|STARTED|Overall Study||102
1666312|NCT00640822|4071083|P2|STARTED|Overall Study||317
1666313|NCT00640822|4071084|P1|STARTED|Overall Study||322
1666314|NCT00640653|4071097|P5|NOT COMPLETED|Overall Study||5
1666315|NCT00640653|4071098|P4|NOT COMPLETED|Overall Study||2
1666316|NCT00640653|4071099|P3|NOT COMPLETED|Overall Study||0
1666317|NCT00640653|4071100|P2|NOT COMPLETED|Overall Study||3
1666318|NCT00640653|4071101|P1|NOT COMPLETED|Overall Study||3
1666319|NCT00640653|4071097|P5|COMPLETED|Overall Study||129
1666320|NCT00640653|4071098|P4|COMPLETED|Overall Study||132
1666321|NCT00640653|4071099|P3|COMPLETED|Overall Study||129
1666322|NCT00640653|4071100|P2|COMPLETED|Overall Study||131
1666323|NCT00640653|4071101|P1|COMPLETED|Overall Study||128
1666324|NCT00640653|4071097|P5|Followed-up at 24 mo|Overall Study||112
1666325|NCT00640653|4071098|P4|Followed-up at 24 mo|Overall Study||112
1666326|NCT00640653|4071099|P3|Followed-up at 24 mo|Overall Study||105
1666327|NCT00640653|4071100|P2|Followed-up at 24 mo|Overall Study||116
1666328|NCT00640653|4071101|P1|Followed-up at 24 mo|Overall Study||114
1666329|NCT00640653|4071097|P5|Followed-up at 18 mo|Overall Study||117
1666330|NCT00640653|4071098|P4|Followed-up at 18 mo|Overall Study||117
1666331|NCT00640653|4071099|P3|Followed-up at 18 mo|Overall Study||113
1666332|NCT00640653|4071100|P2|Followed-up at 18 mo|Overall Study||112
1666333|NCT00640653|4071101|P1|Followed-up at 18 mo|Overall Study||118
1666334|NCT00640653|4071097|P5|Followed-up at 12 mo|Overall Study||116
1666335|NCT00640653|4071098|P4|Followed-up at 12 mo|Overall Study||122
1666336|NCT00640653|4071099|P3|Followed-up at 12 mo|Overall Study||115
1666337|NCT00640653|4071100|P2|Followed-up at 12 mo|Overall Study||121
1666338|NCT00640653|4071101|P1|Followed-up at 12 mo|Overall Study||124
1666339|NCT00640653|4071097|P5|Followed-up at 6 mo|Overall Study||125
1666340|NCT00640653|4071098|P4|Followed-up at 6 mo|Overall Study||130
1666341|NCT00640653|4071099|P3|Followed-up at 6 mo|Overall Study||124
1666342|NCT00640653|4071100|P2|Followed-up at 6 mo|Overall Study||130
1666343|NCT00640653|4071101|P1|Followed-up at 6 mo|Overall Study||127
1666344|NCT00640653|4071097|P5|Followed-up at 3 mo|Overall Study||126
1666345|NCT00640653|4071098|P4|Followed-up at 3 mo|Overall Study||129
1666346|NCT00640653|4071099|P3|Followed-up at 3 mo|Overall Study||125
1666347|NCT00640653|4071100|P2|Followed-up at 3 mo|Overall Study||127
1666348|NCT00640653|4071101|P1|Followed-up at 3 mo|Overall Study||126
1666349|NCT00640653|4071097|P5|STARTED|Overall Study||134
1666350|NCT00640653|4071098|P4|STARTED|Overall Study||134
1666351|NCT00640653|4071099|P3|STARTED|Overall Study||129
1666352|NCT00640653|4071100|P2|STARTED|Overall Study||134
1666353|NCT00640653|4071101|P1|STARTED|Overall Study||131
1666354|NCT00640614|4071135|P2|NOT COMPLETED|Overall Study||0
1666355|NCT00640614|4071136|P1|NOT COMPLETED|Overall Study||1
1666356|NCT00640614|4071135|P2|COMPLETED|Overall Study||110
1666357|NCT00640614|4071136|P1|COMPLETED|Overall Study||124
1666358|NCT00640614|4071135|P2|STARTED|Overall Study||110
1666359|NCT00640614|4071136|P1|STARTED|Overall Study||125
1666360|NCT00640601|4071178|P1|NOT COMPLETED|Overall Study||112
1666361|NCT00640601|4071178|P1|COMPLETED|Overall Study||183
1666362|NCT00640601|4071178|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
1666363|NCT00640562|4071194|P2|NOT COMPLETED|Overall Study||26
1666364|NCT00640562|4071195|P1|NOT COMPLETED|Overall Study||18
1666365|NCT00640562|4071194|P2|COMPLETED|Overall Study||81
1666366|NCT00640562|4071195|P1|COMPLETED|Overall Study||91
1666367|NCT00640562|4071194|P2|STARTED|Overall Study||107
1666368|NCT00640562|4071195|P1|STARTED|Overall Study||109
1666369|NCT00640510|4071223|P2|NOT COMPLETED|Overall Study||2
1666370|NCT00640510|4071224|P1|NOT COMPLETED|Overall Study||1
1666371|NCT00640510|4071223|P2|COMPLETED|Overall Study||15
1666372|NCT00640510|4071224|P1|COMPLETED|Overall Study||16
1666373|NCT00640510|4071223|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
1666374|NCT00640510|4071224|P1|STARTED|Overall Study||17
1666375|NCT00640393|4071236|P3|NOT COMPLETED|Part 2||3
1666376|NCT00640393|4071237|P2|NOT COMPLETED|Part 2||10
1666377|NCT00640393|4071238|P1|NOT COMPLETED|Part 2||0
1666378|NCT00640393|4071236|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
1666379|NCT00640393|4071237|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
1666380|NCT00640393|4071238|P1|COMPLETED|Part 2||0
1666381|NCT00640393|4071236|P3|STARTED|Part 2||38
1666382|NCT00640393|4071237|P2|STARTED|Part 2||37
1666383|NCT00640393|4071238|P1|STARTED|Part 2||0
1666384|NCT00640393|4071236|P3|NOT COMPLETED|Randomization||0
1666385|NCT00640393|4071237|P2|NOT COMPLETED|Randomization||0
1666386|NCT00640393|4071238|P1|NOT COMPLETED|Randomization||19
1666387|NCT00640393|4071236|P3|COMPLETED|Randomization||0
1666388|NCT00640393|4071237|P2|COMPLETED|Randomization||0
1666389|NCT00640393|4071238|P1|COMPLETED|Randomization||75
1666390|NCT00640393|4071236|P3|STARTED|Randomization||0
1666391|NCT00640393|4071237|P2|STARTED|Randomization||0
1666392|NCT00640393|4071238|P1|STARTED|Randomization||94
1666393|NCT00640393|4071236|P3|NOT COMPLETED|Part 1||0
1666394|NCT00640393|4071237|P2|NOT COMPLETED|Part 1||0
1666395|NCT00640393|4071238|P1|NOT COMPLETED|Part 1||5
1666396|NCT00640393|4071236|P3|COMPLETED|Part 1||0
1666397|NCT00640393|4071237|P2|COMPLETED|Part 1||0
1666398|NCT00640393|4071238|P1|COMPLETED|Part 1||94
1666399|NCT00640393|4071236|P3|STARTED|Part 1||0
1666400|NCT00640393|4071237|P2|STARTED|Part 1||0
1666401|NCT00640393|4071238|P1|STARTED|Part 1||99
1666402|NCT00640341|4071303|P3|NOT COMPLETED|Overall Study||7
1666403|NCT00640341|4071304|P2|NOT COMPLETED|Overall Study||5
1666404|NCT00640341|4071305|P1|NOT COMPLETED|Overall Study||21
1666405|NCT00640341|4071303|P3|COMPLETED|Overall Study||163
1666406|NCT00640341|4071304|P2|COMPLETED|Overall Study||165
1666407|NCT00640341|4071305|P1|COMPLETED|Overall Study||149
1666408|NCT00640341|4071303|P3|Eligible Participants at Baseline|Overall Study||168
1666409|NCT00640341|4071304|P2|Eligible Participants at Baseline|Overall Study||167
1666410|NCT00640341|4071305|P1|Eligible Participants at Baseline|Overall Study||165
1666411|NCT00640341|4071303|P3|STARTED|Overall Study||170
1666412|NCT00640341|4071304|P2|STARTED|Overall Study||170
1666413|NCT00640341|4071305|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
1666414|NCT00640328|4071325|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
1666415|NCT00640328|4071326|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
1666416|NCT00640328|4071327|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
1666417|NCT00640328|4071328|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
1666418|NCT00640328|4071329|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
1666419|NCT00640328|4071330|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
1666420|NCT00640328|4071325|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
1666421|NCT00640328|4071326|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
1666422|NCT00640328|4071327|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
1666423|NCT00640328|4071328|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
1666424|NCT00640328|4071329|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
1666425|NCT00640328|4071330|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
1666426|NCT00640328|4071325|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
1666427|NCT00640328|4071326|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
1666428|NCT00640328|4071327|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
1666429|NCT00640328|4071328|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
1666430|NCT00640328|4071329|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
1666431|NCT00640328|4071330|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
1666432|NCT00640328|4071325|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1666433|NCT00640328|4071326|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
1666434|NCT00640328|4071327|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1666435|NCT00640328|4071328|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1666436|NCT00640328|4071329|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1666437|NCT00640328|4071330|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1666438|NCT00640328|4071325|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
1666439|NCT00640328|4071326|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
1666440|NCT00640328|4071327|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
1666441|NCT00640328|4071328|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
1666442|NCT00640328|4071329|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
1666443|NCT00640328|4071330|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
1666444|NCT00640328|4071325|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
1666445|NCT00640328|4071326|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
1666446|NCT00640328|4071327|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
1666447|NCT00640328|4071328|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
1666448|NCT00640328|4071329|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
1666449|NCT00640328|4071330|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
1666450|NCT00640328|4071325|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1666451|NCT00640328|4071326|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1666452|NCT00640328|4071327|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1666453|NCT00640328|4071328|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1666454|NCT00640328|4071329|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
1666455|NCT00640328|4071330|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1666456|NCT00640328|4071325|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
1666457|NCT00640328|4071326|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
1666458|NCT00640328|4071327|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
1666459|NCT00640328|4071328|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
1666460|NCT00640328|4071329|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
1666461|NCT00640328|4071330|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
1666462|NCT00640328|4071325|P6|STARTED|First Treatment Period (Weeks 0-24)||4
1666463|NCT00640328|4071326|P5|STARTED|First Treatment Period (Weeks 0-24)||4
1666464|NCT00640328|4071327|P4|STARTED|First Treatment Period (Weeks 0-24)||4
1666465|NCT00640328|4071328|P3|STARTED|First Treatment Period (Weeks 0-24)||7
1666466|NCT00640328|4071329|P2|STARTED|First Treatment Period (Weeks 0-24)||11
1666467|NCT00640328|4071330|P1|STARTED|First Treatment Period (Weeks 0-24)||8
1666468|NCT00640315|4071496|P2|NOT COMPLETED|Overall Study||1
1666469|NCT00640315|4071497|P1|NOT COMPLETED|Overall Study||0
1666470|NCT00640315|4071496|P2|COMPLETED|Overall Study||12
1666471|NCT00640315|4071497|P1|COMPLETED|Overall Study||10
1666472|NCT00640315|4071496|P2|Participants Received Treatment|Overall Study||13
1666473|NCT00640315|4071497|P1|Participants Received Treatment|Overall Study||10
1666474|NCT00640315|4071496|P2|STARTED|Overall Study||13
1666475|NCT00640315|4071497|P1|STARTED|Overall Study||10
1666476|NCT00640289|4071623|P1|NOT COMPLETED|Overall Study||13
1666477|NCT00640289|4071623|P1|COMPLETED|Overall Study||59
1666478|NCT00640289|4071623|P1|STARTED|Overall Study||72
1666479|NCT00640250|4071628|P1|NOT COMPLETED|Overall Study||0
1666480|NCT00640250|4071628|P1|COMPLETED|Overall Study||48
1666481|NCT00640250|4071628|P1|STARTED|Overall Study||48
1666482|NCT00640224|4071735|P4|NOT COMPLETED|Overall Study||0
1666483|NCT00640224|4071736|P3|NOT COMPLETED|Overall Study||0
1666484|NCT00640224|4071737|P2|NOT COMPLETED|Overall Study||3
1666485|NCT00640224|4071738|P1|NOT COMPLETED|Overall Study||6
1666486|NCT00640224|4071735|P4|COMPLETED|Overall Study||0
1666487|NCT00640224|4071736|P3|COMPLETED|Overall Study||0
1666488|NCT00640224|4071737|P2|COMPLETED|Overall Study||20
1666489|NCT00640224|4071738|P1|COMPLETED|Overall Study||17
1666490|NCT00640224|4071735|P4|STARTED|Overall Study||0
1666491|NCT00640224|4071736|P3|STARTED|Overall Study||0
1666492|NCT00640224|4071737|P2|STARTED|Overall Study||23
1666493|NCT00640224|4071738|P1|STARTED|Overall Study||23
1666494|NCT00640042|4071836|P1|NOT COMPLETED|Treatment||926
1666495|NCT00640042|4071836|P1|COMPLETED|Treatment||561
1666496|NCT00640042|4071836|P1|STARTED|Treatment||1487
1666497|NCT00640042|4071836|P1|NOT COMPLETED|Enrollment||83
1666498|NCT00640042|4071836|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
1666499|NCT00640042|4071836|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
1666500|NCT00640016|4071852|P4|NOT COMPLETED|Overall Study||3
1666501|NCT00640016|4071853|P3|NOT COMPLETED|Overall Study||3
1666502|NCT00640016|4071854|P2|NOT COMPLETED|Overall Study||2
1666503|NCT00640016|4071855|P1|NOT COMPLETED|Overall Study||2
1666504|NCT00640016|4071852|P4|COMPLETED|Overall Study||1
1666505|NCT00640016|4071853|P3|COMPLETED|Overall Study||1
1666506|NCT00640016|4071854|P2|COMPLETED|Overall Study||1
1666507|NCT00640016|4071855|P1|COMPLETED|Overall Study||1
1666508|NCT00640016|4071852|P4|Treated|Overall Study||4
1666509|NCT00640016|4071853|P3|Treated|Overall Study||4
1666510|NCT00640016|4071854|P2|Treated|Overall Study||2
1666511|NCT00640016|4071855|P1|Treated|Overall Study||3
1666512|NCT00640016|4071852|P4|STARTED|Overall Study||4
1666513|NCT00640016|4071853|P3|STARTED|Overall Study||4
1666514|NCT00640016|4071854|P2|STARTED|Overall Study||3
1666515|NCT00640016|4071855|P1|STARTED|Overall Study||3
1666516|NCT00639860|4071899|P1|NOT COMPLETED|Overall Study||0
1666517|NCT00639860|4071899|P1|COMPLETED|Overall Study||10
1666518|NCT00639860|4071899|P1|STARTED|Overall Study||10
1666519|NCT00639769|4071907|P1|NOT COMPLETED|Overall Study||40
1666520|NCT00639769|4071907|P1|COMPLETED|Overall Study||0
1666521|NCT00639769|4071907|P1|STARTED|Overall Study||40
1666522|NCT00639717|4071912|P1|NOT COMPLETED|Overall Study||0
1666523|NCT00639717|4071912|P1|COMPLETED|Overall Study||48
1666524|NCT00639717|4071912|P1|STARTED|Overall Study||48
1666525|NCT00639678|4071924|P4|NOT COMPLETED|Overall Study||0
1666526|NCT00639678|4071925|P3|NOT COMPLETED|Overall Study||11
1666527|NCT00639678|4071926|P2|NOT COMPLETED|Overall Study||1
1666528|NCT00639678|4071927|P1|NOT COMPLETED|Overall Study||4
1666529|NCT00639678|4071924|P4|COMPLETED|Overall Study||23
1666530|NCT00639678|4071925|P3|COMPLETED|Overall Study||206
1666531|NCT00639678|4071926|P2|COMPLETED|Overall Study||5
1666532|NCT00639678|4071927|P1|COMPLETED|Overall Study||70
1666533|NCT00639678|4071924|P4|STARTED|Overall Study||23
1666534|NCT00639678|4071925|P3|STARTED|Overall Study||217
1666535|NCT00639678|4071926|P2|STARTED|Overall Study||6
1666536|NCT00639678|4071927|P1|STARTED|Overall Study||74
1666537|NCT00639626|4071987|P1|NOT COMPLETED|Overall Study||0
1666538|NCT00639626|4071987|P1|COMPLETED|Overall Study||0
1666539|NCT00639626|4071987|P1|STARTED|Overall Study||0
1666540|NCT00639509|4071992|P1|NOT COMPLETED|Overall Study||1
1666541|NCT00639509|4071992|P1|COMPLETED|Overall Study||23
1666542|NCT00639509|4071992|P1|STARTED|Overall Study||24
1666543|NCT00639457|4072000|P2|NOT COMPLETED|Overall Study||3
1666544|NCT00639457|4072001|P1|NOT COMPLETED|Overall Study||2
1666545|NCT00639457|4072000|P2|COMPLETED|Overall Study||19
1666546|NCT00639457|4072001|P1|COMPLETED|Overall Study||20
1666547|NCT00639457|4072000|P2|STARTED|Overall Study||22
1666548|NCT00639457|4072001|P1|STARTED|Overall Study||22
1666549|NCT00639418|4072039|P4|NOT COMPLETED|Overall Study||0
1666550|NCT00639418|4072040|P3|NOT COMPLETED|Overall Study||0
1666551|NCT00639418|4072041|P2|NOT COMPLETED|Overall Study||0
1666552|NCT00639418|4072042|P1|NOT COMPLETED|Overall Study||0
1666553|NCT00639418|4072039|P4|COMPLETED|Overall Study||46930
1666554|NCT00639418|4072040|P3|COMPLETED|Overall Study||36496
1666555|NCT00639418|4072041|P2|COMPLETED|Overall Study||35967
1666556|NCT00639418|4072042|P1|COMPLETED|Overall Study||28101
1666557|NCT00639418|4072039|P4|STARTED|Overall Study||46930
1666558|NCT00639418|4072040|P3|STARTED|Overall Study||36496
1666559|NCT00639418|4072041|P2|STARTED|Overall Study||35967
1666560|NCT00639418|4072042|P1|STARTED|Overall Study||28101
1666561|NCT00639379|4072060|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
1666562|NCT00639379|4072061|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
1666563|NCT00639379|4072060|P2|COMPLETED|Period 2 - 2 Weeks||45
1666564|NCT00639379|4072061|P1|COMPLETED|Period 2 - 2 Weeks||39
1666565|NCT00639379|4072060|P2|STARTED|Period 2 - 2 Weeks||45
1666566|NCT00639379|4072061|P1|STARTED|Period 2 - 2 Weeks||39
1666567|NCT00639379|4072060|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
1666568|NCT00639379|4072061|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
1666569|NCT00639379|4072060|P2|COMPLETED|Period 1 - 2 Weeks||45
1666570|NCT00639379|4072061|P1|COMPLETED|Period 1 - 2 Weeks||39
1666571|NCT00639379|4072060|P2|STARTED|Period 1 - 2 Weeks||45
1666572|NCT00639379|4072061|P1|STARTED|Period 1 - 2 Weeks||44
1666573|NCT00639223|4072077|P2|NOT COMPLETED|Overall Study||2
1666574|NCT00639223|4072078|P1|NOT COMPLETED|Overall Study||0
1666575|NCT00639223|4072077|P2|COMPLETED|Overall Study||19
1666576|NCT00639223|4072078|P1|COMPLETED|Overall Study||22
1666577|NCT00639223|4072077|P2|STARTED|Overall Study||21
1666578|NCT00639223|4072078|P1|STARTED|Overall Study||22
1666579|NCT00639158|4072088|P2|NOT COMPLETED|Overall Study||30
1666580|NCT00639158|4072089|P1|NOT COMPLETED|Overall Study||26
1666581|NCT00639158|4072088|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
1666582|NCT00639158|4072089|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
1666583|NCT00639158|4072088|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
1666584|NCT00639158|4072089|P1|STARTED|Overall Study|All randomized subjects were treated.|272
1666585|NCT00639093|4072111|P2|NOT COMPLETED|Overall Study||0
1666586|NCT00639093|4072112|P1|NOT COMPLETED|Overall Study||0
1666587|NCT00639093|4072111|P2|COMPLETED|Overall Study|46|46
1666588|NCT00639093|4072112|P1|COMPLETED|Overall Study|45|45
1666589|NCT00639093|4072111|P2|STARTED|Overall Study|46|46
1666590|NCT00639093|4072112|P1|STARTED|Overall Study|45|45
1666591|NCT00639002|4072118|P1|NOT COMPLETED|Overall Study||13
1666592|NCT00639002|4072118|P1|COMPLETED|Overall Study||0
1666593|NCT00639002|4072118|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
1666594|NCT00639002|4072118|P1|Received Ruxolitinib|Overall Study||13
1666595|NCT00639002|4072118|P1|STARTED|Overall Study||13
1666596|NCT00638989|4072127|P3|NOT COMPLETED|Overall Study||1
1666597|NCT00638989|4072128|P2|NOT COMPLETED|Overall Study||0
1666598|NCT00638989|4072129|P1|NOT COMPLETED|Overall Study||0
1666599|NCT00638989|4072127|P3|COMPLETED|Overall Study||9
1666600|NCT00638989|4072128|P2|COMPLETED|Overall Study||10
1666601|NCT00638989|4072129|P1|COMPLETED|Overall Study||10
1666602|NCT00638989|4072127|P3|STARTED|Overall Study||10
1666603|NCT00638989|4072128|P2|STARTED|Overall Study||10
1666604|NCT00638989|4072129|P1|STARTED|Overall Study||10
1666605|NCT00638963|4072169|P2|NOT COMPLETED|Overall Study||0
1666606|NCT00638963|4072170|P1|NOT COMPLETED|Overall Study||1
1666607|NCT00638963|4072169|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
1666608|NCT00638963|4072170|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
1666609|NCT00638963|4072169|P2|STARTED|Overall Study|Received randomized treatment assignment|3
1666610|NCT00638963|4072170|P1|STARTED|Overall Study|Received randomized treatment assignment|3
1666611|NCT00638937|4072189|P1|NOT COMPLETED|Overall Study||0
1666612|NCT00638937|4072189|P1|COMPLETED|Overall Study||37
1666613|NCT00638937|4072189|P1|STARTED|Overall Study||37
1666614|NCT00638924|4072200|P1|NOT COMPLETED|Overall Study||0
1666615|NCT00638924|4072200|P1|COMPLETED|Overall Study||40
1666616|NCT00638924|4072200|P1|2 Months|Overall Study||40
1666617|NCT00638924|4072200|P1|STARTED|Overall Study||40
1666618|NCT00638885|4072205|P1|NOT COMPLETED|Overall Study||0
1666619|NCT00638885|4072205|P1|COMPLETED|Overall Study||142
1666620|NCT00638885|4072205|P1|STARTED|Overall Study||142
1666621|NCT00638846|4072211|P2|NOT COMPLETED|Overall Study||6
1666622|NCT00638846|4072212|P1|NOT COMPLETED|Overall Study||4
1666623|NCT00638846|4072211|P2|COMPLETED|Overall Study||133
1666624|NCT00638846|4072212|P1|COMPLETED|Overall Study||133
1666625|NCT00638846|4072211|P2|STARTED|Overall Study||139
1666626|NCT00638846|4072212|P1|STARTED|Overall Study||137
1666627|NCT00638820|4072228|P1|NOT COMPLETED|Overall Study||0
1666628|NCT00638820|4072228|P1|COMPLETED|Overall Study||3
1666629|NCT00638820|4072228|P1|STARTED|Overall Study||3
1666630|NCT00638716|4072238|P3|NOT COMPLETED|Overall Study||12
1666631|NCT00638716|4072239|P2|NOT COMPLETED|Overall Study||15
1666632|NCT00638716|4072240|P1|NOT COMPLETED|Overall Study||7
1666633|NCT00638716|4072238|P3|COMPLETED|Overall Study||46
1666634|NCT00638716|4072239|P2|COMPLETED|Overall Study||37
1666635|NCT00638716|4072240|P1|COMPLETED|Overall Study||43
1666636|NCT00638716|4072238|P3|STARTED|Overall Study||58
1666637|NCT00638716|4072239|P2|STARTED|Overall Study||52
1666638|NCT00638716|4072240|P1|STARTED|Overall Study||50
1666639|NCT00638690|4072256|P2|NOT COMPLETED|Overall Study||342
1666640|NCT00638690|4072257|P1|NOT COMPLETED|Overall Study||681
1666641|NCT00638690|4072256|P2|COMPLETED|Overall Study||56
1666642|NCT00638690|4072257|P1|COMPLETED|Overall Study||116
1666643|NCT00638690|4072256|P2|STARTED|Overall Study||398
1666644|NCT00638690|4072257|P1|STARTED|Overall Study||797
1666645|NCT00638651|4072270|P1|NOT COMPLETED|Overall Study||0
1666646|NCT00638651|4072270|P1|COMPLETED|Overall Study||3
1666647|NCT00638651|4072270|P1|STARTED|Overall Study||3
1666648|NCT00638508|4072277|P2|NOT COMPLETED|Overall Study||2
1666649|NCT00638508|4072278|P1|NOT COMPLETED|Overall Study||5
1666650|NCT00638508|4072277|P2|COMPLETED|Overall Study||30
1666651|NCT00638508|4072278|P1|COMPLETED|Overall Study||30
1666652|NCT00638508|4072277|P2|STARTED|Overall Study||32
1666653|NCT00638508|4072278|P1|STARTED|Overall Study||35
1666654|NCT00638443|4072322|P2|NOT COMPLETED|Second Intervention||0
1666655|NCT00638443|4072323|P1|NOT COMPLETED|Second Intervention||0
1666656|NCT00638443|4072322|P2|COMPLETED|Second Intervention||14
1666657|NCT00638443|4072323|P1|COMPLETED|Second Intervention||12
1666658|NCT00638443|4072322|P2|STARTED|Second Intervention||14
1666659|NCT00638443|4072323|P1|STARTED|Second Intervention||12
1666660|NCT00638443|4072322|P2|NOT COMPLETED|Washout||0
1666661|NCT00638443|4072323|P1|NOT COMPLETED|Washout||0
1666662|NCT00638443|4072322|P2|COMPLETED|Washout||14
1666663|NCT00638443|4072323|P1|COMPLETED|Washout||12
1666664|NCT00638443|4072322|P2|STARTED|Washout||14
1666665|NCT00638443|4072323|P1|STARTED|Washout||12
1666666|NCT00638443|4072322|P2|NOT COMPLETED|First Intervention||1
1666667|NCT00638443|4072323|P1|NOT COMPLETED|First Intervention||2
1666668|NCT00638443|4072322|P2|COMPLETED|First Intervention||14
1666669|NCT00638443|4072323|P1|COMPLETED|First Intervention||12
1666670|NCT00638443|4072322|P2|STARTED|First Intervention||15
1666671|NCT00638443|4072323|P1|STARTED|First Intervention||14
1666672|NCT00638404|4072353|P2|NOT COMPLETED|Overall Study||0
1666673|NCT00638404|4072354|P1|NOT COMPLETED|Overall Study||8
1666674|NCT00638404|4072353|P2|COMPLETED|Overall Study||100
1666675|NCT00638404|4072354|P1|COMPLETED|Overall Study||192
1666676|NCT00638404|4072353|P2|STARTED|Overall Study||100
1666677|NCT00638404|4072354|P1|STARTED|Overall Study||200
1666678|NCT00638378|4072366|P1|NOT COMPLETED|Overall Study||22
1666679|NCT00638378|4072366|P1|COMPLETED|Overall Study||0
1666680|NCT00638378|4072366|P1|STARTED|Overall Study||22
1666681|NCT00638365|4072376|P3|NOT COMPLETED|Overall Study||0
1666682|NCT00638365|4072377|P2|NOT COMPLETED|Overall Study||0
1666683|NCT00638365|4072378|P1|NOT COMPLETED|Overall Study||0
1666684|NCT00638365|4072376|P3|COMPLETED|Overall Study||8
1666685|NCT00638365|4072377|P2|COMPLETED|Overall Study||10
1666686|NCT00638365|4072378|P1|COMPLETED|Overall Study||9
1666687|NCT00638365|4072376|P3|STARTED|Overall Study||8
1666688|NCT00638365|4072377|P2|STARTED|Overall Study||10
1666689|NCT00638365|4072378|P1|STARTED|Overall Study||9
1666690|NCT00638274|4072388|P2|NOT COMPLETED|Overall Study||5
1666691|NCT00638274|4072389|P1|NOT COMPLETED|Overall Study||6
1666692|NCT00638274|4072388|P2|COMPLETED|Overall Study||172
1666693|NCT00638274|4072389|P1|COMPLETED|Overall Study||173
1666694|NCT00638274|4072388|P2|STARTED|Overall Study||177
1666695|NCT00638274|4072389|P1|STARTED|Overall Study||179
1666696|NCT00638235|4072406|P9|NOT COMPLETED|Overall Study||18
1666697|NCT00638235|4072407|P8|NOT COMPLETED|Overall Study||1
1666698|NCT00638235|4072408|P7|NOT COMPLETED|Overall Study||0
1666699|NCT00638235|4072409|P6|NOT COMPLETED|Overall Study||26
1666700|NCT00638235|4072410|P5|NOT COMPLETED|Overall Study||13
1666701|NCT00638235|4072411|P4|NOT COMPLETED|Overall Study||10
1666702|NCT00638235|4072412|P3|NOT COMPLETED|Overall Study||18
1666703|NCT00638235|4072413|P2|NOT COMPLETED|Overall Study||3
1666704|NCT00638235|4072414|P1|NOT COMPLETED|Overall Study||31
1666705|NCT00638235|4072406|P9|COMPLETED|Overall Study||124
1666706|NCT00638235|4072407|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
1666707|NCT00638235|4072408|P7|COMPLETED|Overall Study||23
1666708|NCT00638235|4072409|P6|COMPLETED|Overall Study||113
1666709|NCT00638235|4072410|P5|COMPLETED|Overall Study||42
1666710|NCT00638235|4072411|P4|COMPLETED|Overall Study||46
1666711|NCT00638235|4072412|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
1666712|NCT00638235|4072413|P2|COMPLETED|Overall Study||23
1666713|NCT00638235|4072414|P1|COMPLETED|Overall Study||110
1666714|NCT00638235|4072406|P9|STARTED|Overall Study||142
1666715|NCT00638235|4072407|P8|STARTED|Overall Study||35
1666716|NCT00638235|4072408|P7|STARTED|Overall Study||23
1666717|NCT00638235|4072409|P6|STARTED|Overall Study||139
1666718|NCT00638235|4072410|P5|STARTED|Overall Study||55
1666719|NCT00638235|4072411|P4|STARTED|Overall Study||56
1666720|NCT00638235|4072412|P3|STARTED|Overall Study||81
1666721|NCT00638235|4072413|P2|STARTED|Overall Study||26
1666722|NCT00638235|4072414|P1|STARTED|Overall Study||141
1666723|NCT00638222|4072815|P3|NOT COMPLETED|Overall Study||0
1666724|NCT00638222|4072816|P2|NOT COMPLETED|Overall Study||0
1666725|NCT00638222|4072817|P1|NOT COMPLETED|Overall Study||0
1666726|NCT00638222|4072815|P3|COMPLETED|Overall Study||6
1666727|NCT00638222|4072816|P2|COMPLETED|Overall Study||0
1666728|NCT00638222|4072817|P1|COMPLETED|Overall Study||0
1666729|NCT00638222|4072815|P3|STARTED|Overall Study||6
1666730|NCT00638222|4072816|P2|STARTED|Overall Study||0
1666731|NCT00638222|4072817|P1|STARTED|Overall Study||0
1666732|NCT00638183|4072824|P1|NOT COMPLETED|Overall Study||119
1666733|NCT00638183|4072824|P1|COMPLETED|Overall Study||266
1666734|NCT00638183|4072824|P1|STARTED|Overall Study||385
1666735|NCT00638157|4072833|P2|NOT COMPLETED|Overall Study||4
1666736|NCT00638157|4072834|P1|NOT COMPLETED|Overall Study||7
1666737|NCT00638157|4072833|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
1666738|NCT00638157|4072834|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
1666739|NCT00638157|4072833|P2|Treated|Overall Study||12
1666740|NCT00638157|4072834|P1|Treated|Overall Study||10
1666741|NCT00638157|4072833|P2|STARTED|Overall Study||12
1666742|NCT00638157|4072834|P1|STARTED|Overall Study||12
1666743|NCT00638027|4072844|P2|NOT COMPLETED|Overall Study||2
1666744|NCT00638027|4072845|P1|NOT COMPLETED|Overall Study||0
1666745|NCT00638027|4072844|P2|COMPLETED|Overall Study|all 10 included in analyses|8
1666746|NCT00638027|4072845|P1|COMPLETED|Overall Study||11
1666747|NCT00638027|4072844|P2|STARTED|Overall Study||10
1666748|NCT00638027|4072845|P1|STARTED|Overall Study||11
1666749|NCT00638014|4072857|P2|NOT COMPLETED|Overall Study||0
1666750|NCT00638014|4072858|P1|NOT COMPLETED|Overall Study||0
1666751|NCT00638014|4072857|P2|COMPLETED|Overall Study||28
1666752|NCT00638014|4072858|P1|COMPLETED|Overall Study||23
1666753|NCT00638014|4072857|P2|STARTED|Overall Study||28
1666754|NCT00638014|4072858|P1|STARTED|Overall Study||23
1666755|NCT00637923|4072868|P2|NOT COMPLETED|Overall Study||19
1666756|NCT00637923|4072869|P1|NOT COMPLETED|Overall Study||30
1666757|NCT00637923|4072868|P2|COMPLETED|Overall Study||18
1666758|NCT00637923|4072869|P1|COMPLETED|Overall Study||45
1666759|NCT00637923|4072868|P2|STARTED|Overall Study||37
1666760|NCT00637923|4072869|P1|STARTED|Overall Study||75
1666761|NCT00637806|4072892|P4|NOT COMPLETED|Extension Phase||1
1666762|NCT00637806|4072893|P3|NOT COMPLETED|Extension Phase||0
1666763|NCT00637806|4072894|P2|NOT COMPLETED|Extension Phase||0
1666764|NCT00637806|4072895|P1|NOT COMPLETED|Extension Phase||0
1666765|NCT00637806|4072892|P4|COMPLETED|Extension Phase||0
1666766|NCT00637806|4072893|P3|COMPLETED|Extension Phase||0
1666767|NCT00637806|4072894|P2|COMPLETED|Extension Phase||0
1666768|NCT00637806|4072895|P1|COMPLETED|Extension Phase||0
1666769|NCT00637806|4072892|P4|STARTED|Extension Phase||1
1666770|NCT00637806|4072893|P3|STARTED|Extension Phase||0
1666771|NCT00637806|4072894|P2|STARTED|Extension Phase||0
1666772|NCT00637806|4072895|P1|STARTED|Extension Phase||0
1666773|NCT00637806|4072892|P4|NOT COMPLETED|Double-blind Phase||0
1666774|NCT00637806|4072893|P3|NOT COMPLETED|Double-blind Phase||1
1666775|NCT00637806|4072894|P2|NOT COMPLETED|Double-blind Phase||0
1666776|NCT00637806|4072895|P1|NOT COMPLETED|Double-blind Phase||2
1666777|NCT00637806|4072892|P4|COMPLETED|Double-blind Phase||0
1666778|NCT00637806|4072893|P3|COMPLETED|Double-blind Phase||1
1666779|NCT00637806|4072894|P2|COMPLETED|Double-blind Phase||0
1666780|NCT00637806|4072895|P1|COMPLETED|Double-blind Phase||0
1666781|NCT00637806|4072892|P4|STARTED|Double-blind Phase||0
1666782|NCT00637806|4072893|P3|STARTED|Double-blind Phase||2
1666783|NCT00637806|4072894|P2|STARTED|Double-blind Phase||0
1666784|NCT00637806|4072895|P1|STARTED|Double-blind Phase||2
1666785|NCT00637780|4072913|P1|NOT COMPLETED|Overall Study||0
1666786|NCT00637780|4072913|P1|COMPLETED|Overall Study||2
1666787|NCT00637780|4072913|P1|STARTED|Overall Study||2
1666788|NCT00637728|4072930|P3|NOT COMPLETED|Extension Phase||0
1666789|NCT00637728|4072931|P2|NOT COMPLETED|Extension Phase||0
1666790|NCT00637728|4072932|P1|NOT COMPLETED|Extension Phase||0
1666791|NCT00637728|4072930|P3|COMPLETED|Extension Phase||0
1666792|NCT00637728|4072931|P2|COMPLETED|Extension Phase||0
1666793|NCT00637728|4072932|P1|COMPLETED|Extension Phase||0
1666794|NCT00637728|4072930|P3|STARTED|Extension Phase||0
1666795|NCT00637728|4072931|P2|STARTED|Extension Phase||0
1666796|NCT00637728|4072932|P1|STARTED|Extension Phase||0
1666797|NCT00637728|4072930|P3|NOT COMPLETED|Double-blind Phase||0
1666798|NCT00637728|4072931|P2|NOT COMPLETED|Double-blind Phase||1
1666799|NCT00637728|4072932|P1|NOT COMPLETED|Double-blind Phase||4
1666800|NCT00637728|4072930|P3|COMPLETED|Double-blind Phase||0
1666801|NCT00637728|4072931|P2|COMPLETED|Double-blind Phase||0
1666802|NCT00637728|4072932|P1|COMPLETED|Double-blind Phase||0
1666803|NCT00637728|4072930|P3|STARTED|Double-blind Phase||0
1666804|NCT00637728|4072931|P2|STARTED|Double-blind Phase||1
1666805|NCT00637728|4072932|P1|STARTED|Double-blind Phase||4
1666806|NCT00637572|4072947|P2|NOT COMPLETED|Overall Study||7
1666807|NCT00637572|4072948|P1|NOT COMPLETED|Overall Study||3
1666808|NCT00637572|4072947|P2|COMPLETED|Overall Study||24
1666809|NCT00637572|4072948|P1|COMPLETED|Overall Study||29
1666810|NCT00637572|4072947|P2|STARTED|Overall Study||31
1666811|NCT00637572|4072948|P1|STARTED|Overall Study||32
1666812|NCT00637494|4072976|P2|NOT COMPLETED|Overall Study||43
1666813|NCT00637494|4072977|P1|NOT COMPLETED|Overall Study||32
1666814|NCT00637494|4072976|P2|COMPLETED|Overall Study||108
1666815|NCT00637494|4072977|P1|COMPLETED|Overall Study||109
1666816|NCT00637494|4072976|P2|STARTED|Overall Study||151
1666817|NCT00637494|4072977|P1|STARTED|Overall Study||141
1666818|NCT00637416|4072987|P2|NOT COMPLETED|Overall Study||2
1666819|NCT00637416|4072988|P1|NOT COMPLETED|Overall Study||1
1666820|NCT00637416|4072987|P2|COMPLETED|Overall Study||3
1666821|NCT00637416|4072988|P1|COMPLETED|Overall Study||3
1666822|NCT00637416|4072987|P2|STARTED|Overall Study||5
1666823|NCT00637416|4072988|P1|STARTED|Overall Study||4
1666824|NCT00637377|4072998|P4|NOT COMPLETED|Overall Study||29
1666825|NCT00637377|4072999|P3|NOT COMPLETED|Overall Study||37
1666826|NCT00637377|4073000|P2|NOT COMPLETED|Overall Study||32
1666827|NCT00637377|4073001|P1|NOT COMPLETED|Overall Study||27
1666828|NCT00637377|4072998|P4|COMPLETED|Overall Study||284
1666829|NCT00637377|4072999|P3|COMPLETED|Overall Study||274
1666830|NCT00637377|4073000|P2|COMPLETED|Overall Study||281
1666831|NCT00637377|4073001|P1|COMPLETED|Overall Study||276
1666832|NCT00637377|4072998|P4|Participants Treated (FAS)|Overall Study||306
1666833|NCT00637377|4072999|P3|Participants Treated (FAS)|Overall Study||296
1666834|NCT00637377|4073000|P2|Participants Treated (FAS)|Overall Study||309
1666835|NCT00637377|4073001|P1|Participants Treated (FAS)|Overall Study||291
1666836|NCT00637377|4072998|P4|Participants Received Treatment|Overall Study|safety population|307
1666837|NCT00637377|4072999|P3|Participants Received Treatment|Overall Study|safety population|297
1666838|NCT00637377|4073000|P2|Participants Received Treatment|Overall Study|safety population|309
1666839|NCT00637377|4073001|P1|Participants Received Treatment|Overall Study|safety population|291
1666840|NCT00637377|4072998|P4|STARTED|Overall Study||313
1666841|NCT00637377|4072999|P3|STARTED|Overall Study||311
1666842|NCT00637377|4073000|P2|STARTED|Overall Study||313
1666843|NCT00637377|4073001|P1|STARTED|Overall Study||303
1666844|NCT00637312|4073029|P2|NOT COMPLETED|Overall Study||17
1666845|NCT00637312|4073030|P1|NOT COMPLETED|Overall Study||42
1666846|NCT00637312|4073029|P2|COMPLETED|Overall Study||19
1666847|NCT00637312|4073030|P1|COMPLETED|Overall Study||30
1666848|NCT00637312|4073029|P2|STARTED|Overall Study||36
1666849|NCT00637312|4073030|P1|STARTED|Overall Study||72
1666850|NCT00637299|4073038|P2|NOT COMPLETED|Overall Study||0
1666851|NCT00637299|4073039|P1|NOT COMPLETED|Overall Study||0
1666852|NCT00637299|4073038|P2|COMPLETED|Overall Study||10
1666853|NCT00637299|4073039|P1|COMPLETED|Overall Study||10
1666854|NCT00637299|4073038|P2|STARTED|Overall Study||10
1666855|NCT00637299|4073039|P1|STARTED|Overall Study||10
1666856|NCT00637273|4073050|P3|NOT COMPLETED|Overall Study||41
1666857|NCT00637273|4073051|P2|NOT COMPLETED|Overall Study||28
1666858|NCT00637273|4073052|P1|NOT COMPLETED|Overall Study||43
1666859|NCT00637273|4073050|P3|COMPLETED|Overall Study||131
1666860|NCT00637273|4073051|P2|COMPLETED|Overall Study||144
1666861|NCT00637273|4073052|P1|COMPLETED|Overall Study||127
1666862|NCT00637273|4073050|P3|Intent to Treat (ITT)|Overall Study||165
1666863|NCT00637273|4073051|P2|Intent to Treat (ITT)|Overall Study||166
1666864|NCT00637273|4073052|P1|Intent to Treat (ITT)|Overall Study||160
1666865|NCT00637273|4073050|P3|STARTED|Overall Study||172
1666866|NCT00637273|4073051|P2|STARTED|Overall Study||172
1666867|NCT00637273|4073052|P1|STARTED|Overall Study||170
1666868|NCT00637247|4073095|P2|NOT COMPLETED|Overall Study||0
1666869|NCT00637247|4073096|P1|NOT COMPLETED|Overall Study||0
1666870|NCT00637247|4073095|P2|COMPLETED|Overall Study||70
1666871|NCT00637247|4073096|P1|COMPLETED|Overall Study||72
1666872|NCT00637247|4073095|P2|STARTED|Overall Study||70
1666873|NCT00637247|4073096|P1|STARTED|Overall Study||72
1666874|NCT00637195|4073108|P2|NOT COMPLETED|Overall Study||1
1666875|NCT00637195|4073109|P1|NOT COMPLETED|Overall Study||3
1666876|NCT00637195|4073108|P2|COMPLETED|Overall Study||75
1666877|NCT00637195|4073109|P1|COMPLETED|Overall Study||73
1666878|NCT00637195|4073108|P2|STARTED|Overall Study||76
1666879|NCT00637195|4073109|P1|STARTED|Overall Study||76
1666880|NCT00637156|4073145|P2|NOT COMPLETED|Overall Study||24
1666881|NCT00637156|4073146|P1|NOT COMPLETED|Overall Study||10
1666882|NCT00637156|4073145|P2|COMPLETED|Overall Study||164
1666883|NCT00637156|4073146|P1|COMPLETED|Overall Study||199
1666884|NCT00637156|4073145|P2|STARTED|Overall Study||188
1666885|NCT00637156|4073146|P1|STARTED|Overall Study||209
1666886|NCT00637000|4073188|P2|NOT COMPLETED|Overall Study||3
1666887|NCT00637000|4073189|P1|NOT COMPLETED|Overall Study||4
1666888|NCT00637000|4073188|P2|COMPLETED|Overall Study||15
1666889|NCT00637000|4073189|P1|COMPLETED|Overall Study||16
1666890|NCT00637000|4073188|P2|Evaluable|Overall Study||16
1666891|NCT00637000|4073189|P1|Evaluable|Overall Study||18
1666892|NCT00637000|4073188|P2|STARTED|Overall Study|Randomized and treated|18
1666893|NCT00637000|4073189|P1|STARTED|Overall Study|Randomized and treated|20
1666894|NCT00636987|4073229|P1|NOT COMPLETED|Overall Study||189
1666895|NCT00636987|4073229|P1|COMPLETED|Overall Study||108
1666896|NCT00636987|4073229|P1|STARTED|Overall Study||297
1666897|NCT00636961|4073239|P2|NOT COMPLETED|Period 2||0
1666898|NCT00636961|4073240|P1|NOT COMPLETED|Period 2||1
1666899|NCT00636961|4073239|P2|COMPLETED|Period 2||12
1666900|NCT00636961|4073240|P1|COMPLETED|Period 2||12
1666901|NCT00636961|4073239|P2|STARTED|Period 2||12
1666902|NCT00636961|4073240|P1|STARTED|Period 2||13
1666903|NCT00636961|4073239|P2|NOT COMPLETED|Period 1||1
1666904|NCT00636961|4073240|P1|NOT COMPLETED|Period 1||1
1666905|NCT00636961|4073239|P2|COMPLETED|Period 1||12
1666906|NCT00636961|4073240|P1|COMPLETED|Period 1||13
1666907|NCT00636961|4073239|P2|STARTED|Period 1||13
1666908|NCT00636961|4073240|P1|STARTED|Period 1||14
1666909|NCT00636818|4073254|P1|NOT COMPLETED|Overall Study||11
1666910|NCT00636818|4073254|P1|COMPLETED|Overall Study||34
1666911|NCT00636818|4073254|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
1666912|NCT00636818|4073254|P1|STARTED|Overall Study||45
1666913|NCT00636805|4073269|P1|NOT COMPLETED|Overall Study||0
1666914|NCT00636805|4073269|P1|COMPLETED|Overall Study||63
1666915|NCT00636805|4073269|P1|STARTED|Overall Study||63
1666916|NCT00636792|4073279|P1|NOT COMPLETED|Overall Study||33
1666917|NCT00636792|4073279|P1|COMPLETED|Overall Study||40
1666918|NCT00636792|4073279|P1|STARTED|Overall Study||73
1666919|NCT00636701|4073286|P2|NOT COMPLETED|Overall Study||0
1666920|NCT00636701|4073287|P1|NOT COMPLETED|Overall Study||0
1666921|NCT00636701|4073286|P2|COMPLETED|Overall Study||2
1666922|NCT00636701|4073287|P1|COMPLETED|Overall Study||2
1666923|NCT00636701|4073286|P2|STARTED|Overall Study||2
1666924|NCT00636701|4073287|P1|STARTED|Overall Study||2
1666925|NCT00636675|4073295|P2|NOT COMPLETED|Overall Study||41
1666926|NCT00636675|4073296|P1|NOT COMPLETED|Overall Study||140
1666927|NCT00636675|4073295|P2|COMPLETED|Overall Study||734
1666928|NCT00636675|4073296|P1|COMPLETED|Overall Study||811
1666929|NCT00636675|4073295|P2|STARTED|Overall Study||775
1666930|NCT00636675|4073296|P1|STARTED|Overall Study||951
1666931|NCT00636649|4073308|P2|NOT COMPLETED|Overall Study||0
1666932|NCT00636649|4073309|P1|NOT COMPLETED|Overall Study||0
1666933|NCT00636649|4073308|P2|COMPLETED|Overall Study||20
1666934|NCT00636649|4073309|P1|COMPLETED|Overall Study||20
1666935|NCT00636649|4073308|P2|STARTED|Overall Study||20
1666936|NCT00636649|4073309|P1|STARTED|Overall Study||20
1666937|NCT00636636|4073339|P2|NOT COMPLETED|Overall Study||39
1666938|NCT00636636|4073340|P1|NOT COMPLETED|Overall Study||36
1666939|NCT00636636|4073339|P2|COMPLETED|Overall Study||192
1666940|NCT00636636|4073340|P1|COMPLETED|Overall Study||185
1666941|NCT00636636|4073339|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
1666942|NCT00636636|4073340|P1|379|Overall Study||186
1666943|NCT00636636|4073339|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
1666944|NCT00636636|4073340|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
1666945|NCT00636636|4073339|P2|STARTED|Overall Study||231
1666946|NCT00636636|4073340|P1|STARTED|Overall Study||221
1666947|NCT00636610|4073356|P2|NOT COMPLETED|Overall Study||83
1666948|NCT00636610|4073357|P1|NOT COMPLETED|Overall Study||92
1666949|NCT00636610|4073356|P2|COMPLETED|Overall Study||18
1666950|NCT00636610|4073357|P1|COMPLETED|Overall Study||6
1666951|NCT00636610|4073356|P2|STARTED|Overall Study||101
1666952|NCT00636610|4073357|P1|STARTED|Overall Study||98
1666953|NCT00636441|4073374|P7|NOT COMPLETED|Overall Study||18
1666954|NCT00636441|4073375|P6|NOT COMPLETED|Overall Study||1
1666955|NCT00636441|4073376|P5|NOT COMPLETED|Overall Study||0
1666956|NCT00636441|4073377|P4|NOT COMPLETED|Overall Study||0
1666957|NCT00636441|4073378|P3|NOT COMPLETED|Overall Study||1
1666958|NCT00636441|4073379|P2|NOT COMPLETED|Overall Study||1
1666959|NCT00636441|4073380|P1|NOT COMPLETED|Overall Study||0
1666960|NCT00636441|4073374|P7|COMPLETED|Overall Study||0
1666961|NCT00636441|4073375|P6|COMPLETED|Overall Study||6
1666962|NCT00636441|4073376|P5|COMPLETED|Overall Study||6
1666963|NCT00636441|4073377|P4|COMPLETED|Overall Study||6
1666964|NCT00636441|4073378|P3|COMPLETED|Overall Study||5
1666965|NCT00636441|4073379|P2|COMPLETED|Overall Study||6
1666966|NCT00636441|4073380|P1|COMPLETED|Overall Study||6
1666967|NCT00636441|4073374|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
1666968|NCT00636441|4073375|P6|Assigned Treatment|Overall Study||7
1666969|NCT00636441|4073376|P5|Assigned Treatment|Overall Study||6
1666970|NCT00636441|4073377|P4|Assigned Treatment|Overall Study||6
1666971|NCT00636441|4073378|P3|Assigned Treatment|Overall Study||6
1666972|NCT00636441|4073379|P2|Assigned Treatment|Overall Study||7
1666973|NCT00636441|4073380|P1|Assigned Treatment|Overall Study||6
1666974|NCT00636441|4073374|P7|STARTED|Overall Study||18
1666975|NCT00636441|4073375|P6|STARTED|Overall Study||7
1666976|NCT00636441|4073376|P5|STARTED|Overall Study||6
1666977|NCT00636441|4073377|P4|STARTED|Overall Study||6
1666978|NCT00636441|4073378|P3|STARTED|Overall Study||6
1666979|NCT00636441|4073379|P2|STARTED|Overall Study||7
1666980|NCT00636441|4073380|P1|STARTED|Overall Study||6
1666981|NCT00636389|4073409|P2|NOT COMPLETED|Period 2 - 1 Week||0
1666982|NCT00636389|4073410|P1|NOT COMPLETED|Period 2 - 1 Week||0
1666983|NCT00636389|4073409|P2|COMPLETED|Period 2 - 1 Week||5
1666984|NCT00636389|4073410|P1|COMPLETED|Period 2 - 1 Week||7
1666985|NCT00636389|4073409|P2|STARTED|Period 2 - 1 Week||5
1666986|NCT00636389|4073410|P1|STARTED|Period 2 - 1 Week||7
1666987|NCT00636389|4073409|P2|NOT COMPLETED|Period 1 - 1 Week||0
1666988|NCT00636389|4073410|P1|NOT COMPLETED|Period 1 - 1 Week||0
1666989|NCT00636389|4073409|P2|COMPLETED|Period 1 - 1 Week||5
1666990|NCT00636389|4073410|P1|COMPLETED|Period 1 - 1 Week||7
1666991|NCT00636389|4073409|P2|STARTED|Period 1 - 1 Week||5
1666992|NCT00636389|4073410|P1|STARTED|Period 1 - 1 Week||7
1666993|NCT00636363|4073423|P3|NOT COMPLETED|Overall Study||18
1666994|NCT00636363|4073424|P2|NOT COMPLETED|Overall Study||20
1666995|NCT00636363|4073425|P1|NOT COMPLETED|Overall Study||13
1666996|NCT00636363|4073423|P3|COMPLETED|Overall Study||163
1666997|NCT00636363|4073424|P2|COMPLETED|Overall Study||156
1666998|NCT00636363|4073425|P1|COMPLETED|Overall Study||165
1666999|NCT00636363|4073423|P3|STARTED|Overall Study||181
1667000|NCT00636363|4073424|P2|STARTED|Overall Study||176
1667001|NCT00636363|4073425|P1|STARTED|Overall Study||178
1667002|NCT00636220|4073439|P1|NOT COMPLETED|Overall Study||0
1667003|NCT00636220|4073439|P1|COMPLETED|Overall Study||101
1667004|NCT00636220|4073439|P1|STARTED|Overall Study||101
1667005|NCT00636207|4073446|P7|NOT COMPLETED|Overall Study||0
1667006|NCT00636207|4073447|P6|NOT COMPLETED|Overall Study||0
1667007|NCT00636207|4073448|P5|NOT COMPLETED|Overall Study||1
1667008|NCT00636207|4073449|P4|NOT COMPLETED|Overall Study||0
1667009|NCT00636207|4073450|P3|NOT COMPLETED|Overall Study||0
1667010|NCT00636207|4073451|P2|NOT COMPLETED|Overall Study||1
1667011|NCT00636207|4073452|P1|NOT COMPLETED|Overall Study||1
1667012|NCT00636207|4073446|P7|COMPLETED|Overall Study||3
1667013|NCT00636207|4073447|P6|COMPLETED|Overall Study||1
1667014|NCT00636207|4073448|P5|COMPLETED|Overall Study||8
1667015|NCT00636207|4073449|P4|COMPLETED|Overall Study||6
1667016|NCT00636207|4073450|P3|COMPLETED|Overall Study||18
1667017|NCT00636207|4073451|P2|COMPLETED|Overall Study||7
1667018|NCT00636207|4073452|P1|COMPLETED|Overall Study||0
1667019|NCT00636207|4073446|P7|STARTED|Overall Study||3
1667020|NCT00636207|4073447|P6|STARTED|Overall Study||1
1667021|NCT00636207|4073448|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
1667022|NCT00636207|4073449|P4|STARTED|Overall Study||6
1667023|NCT00636207|4073450|P3|STARTED|Overall Study||18
1667024|NCT00636207|4073451|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
1667025|NCT00636207|4073452|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
1667026|NCT00636194|4073516|P2|NOT COMPLETED|Overall Study||0
1667027|NCT00636194|4073517|P1|NOT COMPLETED|Overall Study||3
1667028|NCT00636194|4073516|P2|COMPLETED|Overall Study||175
1667029|NCT00636194|4073517|P1|COMPLETED|Overall Study||172
1667030|NCT00636194|4073516|P2|STARTED|Overall Study||175
1667031|NCT00636194|4073517|P1|STARTED|Overall Study||175
1667032|NCT00636168|4073529|P2|NOT COMPLETED|Treated With Study Drug||411
1667033|NCT00636168|4073530|P1|NOT COMPLETED|Treated With Study Drug||447
1667034|NCT00636168|4073529|P2|COMPLETED|Treated With Study Drug||63
1667035|NCT00636168|4073530|P1|COMPLETED|Treated With Study Drug||24
1667036|NCT00636168|4073529|P2|STARTED|Treated With Study Drug||474
1667037|NCT00636168|4073530|P1|STARTED|Treated With Study Drug||471
1667038|NCT00636168|4073529|P2|NOT COMPLETED|Randomized to Study Drug||2
1667039|NCT00636168|4073530|P1|NOT COMPLETED|Randomized to Study Drug||4
1667040|NCT00636168|4073529|P2|COMPLETED|Randomized to Study Drug||474
1667041|NCT00636168|4073530|P1|COMPLETED|Randomized to Study Drug||471
1667042|NCT00636168|4073529|P2|STARTED|Randomized to Study Drug||476
1667043|NCT00636168|4073530|P1|STARTED|Randomized to Study Drug||475
1667044|NCT00636155|4073550|P1|NOT COMPLETED|Overall Study||18
1667045|NCT00636155|4073550|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
1667046|NCT00636155|4073550|P1|STARTED|Overall Study||20
1667047|NCT00636077|4073556|P4|NOT COMPLETED|Week 4||0
1667048|NCT00636077|4073557|P3|NOT COMPLETED|Week 4||0
1667049|NCT00636077|4073558|P2|NOT COMPLETED|Week 4||0
1667050|NCT00636077|4073559|P1|NOT COMPLETED|Week 4||0
1667051|NCT00636077|4073556|P4|COMPLETED|Week 4||3
1667052|NCT00636077|4073557|P3|COMPLETED|Week 4||3
1667053|NCT00636077|4073558|P2|COMPLETED|Week 4||3
1667054|NCT00636077|4073559|P1|COMPLETED|Week 4||3
1667055|NCT00636077|4073556|P4|STARTED|Week 4||3
1667056|NCT00636077|4073557|P3|STARTED|Week 4||3
1667057|NCT00636077|4073558|P2|STARTED|Week 4||3
1667058|NCT00636077|4073559|P1|STARTED|Week 4||3
1667059|NCT00636077|4073556|P4|NOT COMPLETED|Week 3||0
1667060|NCT00636077|4073557|P3|NOT COMPLETED|Week 3||0
1667061|NCT00636077|4073558|P2|NOT COMPLETED|Week 3||0
1667062|NCT00636077|4073559|P1|NOT COMPLETED|Week 3||0
1667063|NCT00636077|4073556|P4|COMPLETED|Week 3||3
1667064|NCT00636077|4073557|P3|COMPLETED|Week 3||3
1667065|NCT00636077|4073558|P2|COMPLETED|Week 3||3
1667066|NCT00636077|4073559|P1|COMPLETED|Week 3||3
1667067|NCT00636077|4073556|P4|STARTED|Week 3||3
1667068|NCT00636077|4073557|P3|STARTED|Week 3||3
1667069|NCT00636077|4073558|P2|STARTED|Week 3||3
1667070|NCT00636077|4073559|P1|STARTED|Week 3||3
1667071|NCT00636077|4073556|P4|NOT COMPLETED|Week 2||0
1667072|NCT00636077|4073557|P3|NOT COMPLETED|Week 2||0
1667073|NCT00636077|4073558|P2|NOT COMPLETED|Week 2||0
1667074|NCT00636077|4073559|P1|NOT COMPLETED|Week 2||0
1667075|NCT00636077|4073556|P4|COMPLETED|Week 2||3
1667076|NCT00636077|4073557|P3|COMPLETED|Week 2||3
1667077|NCT00636077|4073558|P2|COMPLETED|Week 2||3
1667078|NCT00636077|4073559|P1|COMPLETED|Week 2||3
1667079|NCT00636077|4073556|P4|STARTED|Week 2||3
1667080|NCT00636077|4073557|P3|STARTED|Week 2||3
1667081|NCT00636077|4073558|P2|STARTED|Week 2||3
1667082|NCT00636077|4073559|P1|STARTED|Week 2||3
1667083|NCT00636077|4073556|P4|NOT COMPLETED|Week 1||0
1667084|NCT00636077|4073557|P3|NOT COMPLETED|Week 1||0
1667085|NCT00636077|4073558|P2|NOT COMPLETED|Week 1||0
1667086|NCT00636077|4073559|P1|NOT COMPLETED|Week 1||0
1667087|NCT00636077|4073556|P4|COMPLETED|Week 1||3
1667088|NCT00636077|4073557|P3|COMPLETED|Week 1||3
1667089|NCT00636077|4073558|P2|COMPLETED|Week 1||3
1667090|NCT00636077|4073559|P1|COMPLETED|Week 1||3
1667091|NCT00636077|4073556|P4|STARTED|Week 1||3
1667092|NCT00636077|4073557|P3|STARTED|Week 1||3
1667093|NCT00636077|4073558|P2|STARTED|Week 1||3
1667094|NCT00636077|4073559|P1|STARTED|Week 1||3
1667095|NCT00635999|4073592|P3|NOT COMPLETED|Overall Study||1
1667096|NCT00635999|4073593|P2|NOT COMPLETED|Overall Study||2
1667097|NCT00635999|4073594|P1|NOT COMPLETED|Overall Study||4
1667098|NCT00635999|4073592|P3|COMPLETED|Overall Study||23
1667099|NCT00635999|4073593|P2|COMPLETED|Overall Study||23
1667100|NCT00635999|4073594|P1|COMPLETED|Overall Study||23
1667101|NCT00635999|4073592|P3|STARTED|Overall Study||24
1667102|NCT00635999|4073593|P2|STARTED|Overall Study||25
1667103|NCT00635999|4073594|P1|STARTED|Overall Study||27
1667104|NCT00635882|4073611|P6|NOT COMPLETED|Overall Study||0
1667105|NCT00635882|4073612|P5|NOT COMPLETED|Overall Study||0
1667106|NCT00635882|4073613|P4|NOT COMPLETED|Overall Study||0
1667107|NCT00635882|4073614|P3|NOT COMPLETED|Overall Study||0
1667108|NCT00635882|4073615|P2|NOT COMPLETED|Overall Study||0
1667109|NCT00635882|4073616|P1|NOT COMPLETED|Overall Study||1
1667110|NCT00635882|4073611|P6|COMPLETED|Overall Study||13
1667111|NCT00635882|4073612|P5|COMPLETED|Overall Study||16
1667112|NCT00635882|4073613|P4|COMPLETED|Overall Study||15
1667113|NCT00635882|4073614|P3|COMPLETED|Overall Study||12
1667114|NCT00635882|4073615|P2|COMPLETED|Overall Study||17
1667115|NCT00635882|4073616|P1|COMPLETED|Overall Study||19
1667116|NCT00635882|4073611|P6|STARTED|Overall Study||13
1667117|NCT00635882|4073612|P5|STARTED|Overall Study||16
1667118|NCT00635882|4073613|P4|STARTED|Overall Study||15
1667119|NCT00635882|4073614|P3|STARTED|Overall Study||12
1667120|NCT00635882|4073615|P2|STARTED|Overall Study||17
1667121|NCT00635882|4073616|P1|STARTED|Overall Study||20
1667122|NCT00635830|4073680|P2|NOT COMPLETED|Overall Study||0
1667123|NCT00635830|4073681|P1|NOT COMPLETED|Overall Study||0
1667124|NCT00635830|4073680|P2|COMPLETED|Overall Study||20
1667125|NCT00635830|4073681|P1|COMPLETED|Overall Study||20
1667126|NCT00635830|4073680|P2|STARTED|Overall Study||20
1667127|NCT00635830|4073681|P1|STARTED|Overall Study||20
1667128|NCT00635817|4073691|P4|NOT COMPLETED|Overall Study||0
1667129|NCT00635817|4073692|P3|NOT COMPLETED|Overall Study||2
1667130|NCT00635817|4073693|P2|NOT COMPLETED|Overall Study||2
1667131|NCT00635817|4073694|P1|NOT COMPLETED|Overall Study||6
1667132|NCT00635817|4073691|P4|COMPLETED|Overall Study||21
1667133|NCT00635817|4073692|P3|COMPLETED|Overall Study||19
1667134|NCT00635817|4073693|P2|COMPLETED|Overall Study||19
1667135|NCT00635817|4073694|P1|COMPLETED|Overall Study||15
1667136|NCT00635817|4073691|P4|STARTED|Overall Study||21
1667137|NCT00635817|4073692|P3|STARTED|Overall Study||21
1667138|NCT00635817|4073693|P2|STARTED|Overall Study||21
1667139|NCT00635817|4073694|P1|STARTED|Overall Study||21
1667140|NCT00635804|4073746|P8|NOT COMPLETED|Overall Study||0
1667141|NCT00635804|4073747|P7|NOT COMPLETED|Overall Study||0
1667142|NCT00635804|4073748|P6|NOT COMPLETED|Overall Study||1
1667143|NCT00635804|4073749|P5|NOT COMPLETED|Overall Study||0
1667144|NCT00635804|4073750|P4|NOT COMPLETED|Overall Study||0
1667145|NCT00635804|4073751|P3|NOT COMPLETED|Overall Study||0
1667146|NCT00635804|4073752|P2|NOT COMPLETED|Overall Study||0
1667147|NCT00635804|4073753|P1|NOT COMPLETED|Overall Study||1
1667148|NCT00635804|4073746|P8|COMPLETED|Overall Study||14
1667149|NCT00635804|4073747|P7|COMPLETED|Overall Study||3
1667150|NCT00635804|4073748|P6|COMPLETED|Overall Study||11
1667151|NCT00635804|4073749|P5|COMPLETED|Overall Study||6
1667152|NCT00635804|4073750|P4|COMPLETED|Overall Study||6
1667153|NCT00635804|4073751|P3|COMPLETED|Overall Study||6
1667154|NCT00635804|4073752|P2|COMPLETED|Overall Study||6
1667155|NCT00635804|4073753|P1|COMPLETED|Overall Study||6
1667156|NCT00635804|4073746|P8|STARTED|Overall Study||14
1667157|NCT00635804|4073747|P7|STARTED|Overall Study||3
1667158|NCT00635804|4073748|P6|STARTED|Overall Study||12
1667159|NCT00635804|4073749|P5|STARTED|Overall Study||6
1667160|NCT00635804|4073750|P4|STARTED|Overall Study||6
1667161|NCT00635804|4073751|P3|STARTED|Overall Study||6
1667162|NCT00635804|4073752|P2|STARTED|Overall Study||6
1667163|NCT00635804|4073753|P1|STARTED|Overall Study||7
1667164|NCT00635778|4073857|P7|NOT COMPLETED|Overall Study||6
1667165|NCT00635778|4073858|P6|NOT COMPLETED|Overall Study||21
1667166|NCT00635778|4073859|P5|NOT COMPLETED|Overall Study||8
1667167|NCT00635778|4073860|P4|NOT COMPLETED|Overall Study||8
1667168|NCT00635778|4073861|P3|NOT COMPLETED|Overall Study||3
1667169|NCT00635778|4073862|P2|NOT COMPLETED|Overall Study||3
1667170|NCT00635778|4073863|P1|NOT COMPLETED|Overall Study||1
1667171|NCT00635778|4073857|P7|COMPLETED|Overall Study||0
1667172|NCT00635778|4073858|P6|COMPLETED|Overall Study||0
1667173|NCT00635778|4073859|P5|COMPLETED|Overall Study||0
1667174|NCT00635778|4073860|P4|COMPLETED|Overall Study||0
1667175|NCT00635778|4073861|P3|COMPLETED|Overall Study||0
1667176|NCT00635778|4073862|P2|COMPLETED|Overall Study||0
1667177|NCT00635778|4073863|P1|COMPLETED|Overall Study||0
1667178|NCT00635778|4073857|P7|STARTED|Overall Study||6
1667179|NCT00635778|4073858|P6|STARTED|Overall Study||21
1667180|NCT00635778|4073859|P5|STARTED|Overall Study||8
1667181|NCT00635778|4073860|P4|STARTED|Overall Study||8
1667182|NCT00635778|4073861|P3|STARTED|Overall Study||3
1667183|NCT00635778|4073862|P2|STARTED|Overall Study||3
1667184|NCT00635778|4073863|P1|STARTED|Overall Study||1
1667185|NCT00635700|4073916|P2|NOT COMPLETED|Overall Study||14
1667186|NCT00635700|4073917|P1|NOT COMPLETED|Overall Study||15
1667187|NCT00635700|4073916|P2|COMPLETED|Overall Study||13
1667188|NCT00635700|4073917|P1|COMPLETED|Overall Study||9
1667189|NCT00635700|4073916|P2|STARTED|Overall Study||27
1667190|NCT00635700|4073917|P1|STARTED|Overall Study||24
1667191|NCT00635661|4073923|P1|NOT COMPLETED|Overall Study||4
1667192|NCT00635661|4073923|P1|COMPLETED|Overall Study||30
1667193|NCT00635661|4073923|P1|STARTED|Overall Study||34
1667194|NCT00635648|4073927|P1|NOT COMPLETED|Overall Study||37
1667195|NCT00635648|4073927|P1|COMPLETED|Overall Study||26
1667196|NCT00635648|4073927|P1|STARTED|Overall Study||63
1667197|NCT00635609|4073936|P2|NOT COMPLETED|Overall Study||3
1667198|NCT00635609|4073937|P1|NOT COMPLETED|Overall Study||7
1667199|NCT00635609|4073936|P2|COMPLETED|Overall Study||42
1667200|NCT00635609|4073937|P1|COMPLETED|Overall Study||41
1667201|NCT00635609|4073936|P2|STARTED|Overall Study||45
1667202|NCT00635609|4073937|P1|STARTED|Overall Study||48
1667203|NCT00635570|4073949|P2|NOT COMPLETED|Overall Study||11
1667204|NCT00635570|4073950|P1|NOT COMPLETED|Overall Study||15
1667205|NCT00635570|4073949|P2|COMPLETED|Overall Study||126
1667206|NCT00635570|4073950|P1|COMPLETED|Overall Study||121
1667207|NCT00635570|4073949|P2|STARTED|Overall Study||137
1667208|NCT00635570|4073950|P1|STARTED|Overall Study||136
1667209|NCT00635492|4073964|P2|NOT COMPLETED|Overall Study||282
1667210|NCT00635492|4073965|P1|NOT COMPLETED|Overall Study||279
1667211|NCT00635492|4073964|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
1667212|NCT00635492|4073965|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
1667213|NCT00635492|4073964|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
1667214|NCT00635492|4073965|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
1667215|NCT00635479|4074011|P2|NOT COMPLETED|Overall Study||18
1667216|NCT00635479|4074012|P1|NOT COMPLETED|Overall Study||6
1667217|NCT00635479|4074011|P2|COMPLETED|Overall Study||42
1667218|NCT00635479|4074012|P1|COMPLETED|Overall Study||49
1667219|NCT00635479|4074011|P2|STARTED|Overall Study||60
1667220|NCT00635479|4074012|P1|STARTED|Overall Study||55
1667221|NCT00635427|4074023|P5|NOT COMPLETED|Overall Study||8
1667222|NCT00635427|4074024|P4|NOT COMPLETED|Overall Study||9
1667223|NCT00635427|4074025|P3|NOT COMPLETED|Overall Study||11
1667224|NCT00635427|4074026|P2|NOT COMPLETED|Overall Study||6
1667225|NCT00635427|4074027|P1|NOT COMPLETED|Overall Study||12
1667226|NCT00635427|4074023|P5|COMPLETED|Overall Study||30
1667227|NCT00635427|4074024|P4|COMPLETED|Overall Study||7
1667228|NCT00635427|4074025|P3|COMPLETED|Overall Study||5
1667229|NCT00635427|4074026|P2|COMPLETED|Overall Study||6
1667230|NCT00635427|4074027|P1|COMPLETED|Overall Study||1
1667231|NCT00635427|4074023|P5|STARTED|Overall Study||38
1667232|NCT00635427|4074024|P4|STARTED|Overall Study||16
1667233|NCT00635427|4074025|P3|STARTED|Overall Study||16
1667234|NCT00635427|4074026|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
1667235|NCT00635427|4074027|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
1667236|NCT00635362|4074049|P2|NOT COMPLETED|Overall Study||8
1667237|NCT00635362|4074050|P1|NOT COMPLETED|Overall Study||13
1667238|NCT00635362|4074049|P2|COMPLETED|Overall Study||12
1667239|NCT00635362|4074050|P1|COMPLETED|Overall Study||9
1667240|NCT00635362|4074049|P2|STARTED|Overall Study||20
1667241|NCT00635362|4074050|P1|STARTED|Overall Study||22
1667242|NCT00635349|4074066|P2|NOT COMPLETED|Overall Study||48
1667243|NCT00635349|4074067|P1|NOT COMPLETED|Overall Study||44
1667244|NCT00635349|4074066|P2|COMPLETED|Overall Study||19
1667245|NCT00635349|4074067|P1|COMPLETED|Overall Study||29
1667246|NCT00635349|4074066|P2|STARTED|Overall Study||67
1667247|NCT00635349|4074067|P1|STARTED|Overall Study||73
1667248|NCT00635232|4074090|P5|NOT COMPLETED|Overall Study||8
1667249|NCT00635232|4074091|P4|NOT COMPLETED|Overall Study||10
1667250|NCT00635232|4074092|P3|NOT COMPLETED|Overall Study||3
1667251|NCT00635232|4074093|P2|NOT COMPLETED|Overall Study||20
1667252|NCT00635232|4074094|P1|NOT COMPLETED|Overall Study||14
1667253|NCT00635232|4074090|P5|COMPLETED|Overall Study||20
1667254|NCT00635232|4074091|P4|COMPLETED|Overall Study||48
1667255|NCT00635232|4074092|P3|COMPLETED|Overall Study||55
1667256|NCT00635232|4074093|P2|COMPLETED|Overall Study||39
1667257|NCT00635232|4074094|P1|COMPLETED|Overall Study||44
1667258|NCT00635232|4074090|P5|STARTED|Overall Study||28
1667259|NCT00635232|4074091|P4|STARTED|Overall Study||58
1667260|NCT00635232|4074092|P3|STARTED|Overall Study||58
1667261|NCT00635232|4074093|P2|STARTED|Overall Study||59
1667262|NCT00635232|4074094|P1|STARTED|Overall Study||58
1667263|NCT00635219|4074121|P5|NOT COMPLETED|Overall Study||42
1667264|NCT00635219|4074122|P4|NOT COMPLETED|Overall Study||34
1667265|NCT00635219|4074123|P3|NOT COMPLETED|Overall Study||35
1667266|NCT00635219|4074124|P2|NOT COMPLETED|Overall Study||25
1667267|NCT00635219|4074125|P1|NOT COMPLETED|Overall Study||25
1667268|NCT00635219|4074121|P5|COMPLETED|Overall Study||113
1667269|NCT00635219|4074122|P4|COMPLETED|Overall Study||117
1667270|NCT00635219|4074123|P3|COMPLETED|Overall Study||122
1667271|NCT00635219|4074124|P2|COMPLETED|Overall Study||130
1667272|NCT00635219|4074125|P1|COMPLETED|Overall Study||123
1667273|NCT00635219|4074121|P5|STARTED|Overall Study||155
1667274|NCT00635219|4074122|P4|STARTED|Overall Study||151
1667275|NCT00635219|4074123|P3|STARTED|Overall Study||157
1667276|NCT00635219|4074124|P2|STARTED|Overall Study||155
1667277|NCT00635219|4074125|P1|STARTED|Overall Study||148
1667278|NCT00635167|4074182|P1|NOT COMPLETED|Overall Study||0
1667279|NCT00635167|4074182|P1|COMPLETED|Overall Study||1
1667280|NCT00635167|4074182|P1|STARTED|Overall Study||1
1667281|NCT00635154|4074188|P1|NOT COMPLETED|Overall Study||33
1667282|NCT00635154|4074188|P1|COMPLETED|Overall Study||21
1667283|NCT00635154|4074188|P1|STARTED|Overall Study||54
1667284|NCT00635128|4074200|P2|NOT COMPLETED|Overall Study||0
1667285|NCT00635128|4074201|P1|NOT COMPLETED|Overall Study||0
1667286|NCT00635128|4074200|P2|COMPLETED|Overall Study||64
1667287|NCT00635128|4074201|P1|COMPLETED|Overall Study||351
1667288|NCT00635128|4074200|P2|STARTED|Overall Study||64
1667289|NCT00635128|4074201|P1|STARTED|Overall Study||351
1667290|NCT00635102|4074231|P2|NOT COMPLETED|Overall Study||8
1667291|NCT00635102|4074232|P1|NOT COMPLETED|Overall Study||7
1667292|NCT00635102|4074231|P2|COMPLETED|Overall Study||22
1667293|NCT00635102|4074232|P1|COMPLETED|Overall Study||20
1667294|NCT00635102|4074231|P2|STARTED|Overall Study||30
1667295|NCT00635102|4074232|P1|STARTED|Overall Study||27
1667296|NCT00635089|4074326|P1|NOT COMPLETED|Overall Study||78
1667297|NCT00635089|4074326|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
1667298|NCT00635089|4074326|P1|Completed >/= 16 Weeks of Study|Overall Study||181
1667299|NCT00635089|4074326|P1|STARTED|Overall Study||190
1667300|NCT00635050|4074353|P1|NOT COMPLETED|Overall Study||1
1667301|NCT00635050|4074353|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
1667302|NCT00635050|4074353|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
1667303|NCT00635024|4074360|P1|NOT COMPLETED|Overall Study||1
1667304|NCT00635024|4074360|P1|COMPLETED|Overall Study||0
1667305|NCT00635024|4074360|P1|STARTED|Overall Study||1
1667306|NCT00634933|4074371|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
1667307|NCT00634933|4074372|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
1667308|NCT00634933|4074373|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
1667309|NCT00634933|4074374|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
1667310|NCT00634933|4074375|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
1667311|NCT00634933|4074371|P5|COMPLETED|Part B: Week 24 to Week 52||22
1667312|NCT00634933|4074372|P4|COMPLETED|Part B: Week 24 to Week 52||25
1667313|NCT00634933|4074373|P3|COMPLETED|Part B: Week 24 to Week 52||33
1667314|NCT00634933|4074374|P2|COMPLETED|Part B: Week 24 to Week 52||42
1667315|NCT00634933|4074375|P1|COMPLETED|Part B: Week 24 to Week 52||0
1667316|NCT00634933|4074371|P5|STARTED|Part B: Week 24 to Week 52||32
1667317|NCT00634933|4074372|P4|STARTED|Part B: Week 24 to Week 52||31
1667318|NCT00634933|4074373|P3|STARTED|Part B: Week 24 to Week 52||55
1667319|NCT00634933|4074374|P2|STARTED|Part B: Week 24 to Week 52||56
1667320|NCT00634933|4074375|P1|STARTED|Part B: Week 24 to Week 52||0
1667321|NCT00634933|4074371|P5|NOT COMPLETED|Between Part A and Part B||0
1667322|NCT00634933|4074372|P4|NOT COMPLETED|Between Part A and Part B||0
1667323|NCT00634933|4074373|P3|NOT COMPLETED|Between Part A and Part B||0
1667324|NCT00634933|4074374|P2|NOT COMPLETED|Between Part A and Part B||1
1667325|NCT00634933|4074375|P1|NOT COMPLETED|Between Part A and Part B||0
1667326|NCT00634933|4074371|P5|COMPLETED|Between Part A and Part B||32
1667327|NCT00634933|4074372|P4|COMPLETED|Between Part A and Part B||31
1667328|NCT00634933|4074373|P3|COMPLETED|Between Part A and Part B||55
1667329|NCT00634933|4074374|P2|COMPLETED|Between Part A and Part B||56
1667330|NCT00634933|4074375|P1|COMPLETED|Between Part A and Part B||0
1667331|NCT00634933|4074371|P5|STARTED|Between Part A and Part B||32
1667332|NCT00634933|4074372|P4|STARTED|Between Part A and Part B||31
1667333|NCT00634933|4074373|P3|STARTED|Between Part A and Part B||55
1667334|NCT00634933|4074374|P2|STARTED|Between Part A and Part B||57
1667335|NCT00634933|4074375|P1|STARTED|Between Part A and Part B||0
1667336|NCT00634933|4074371|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
1667337|NCT00634933|4074372|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
1667338|NCT00634933|4074373|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
1667339|NCT00634933|4074374|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
1667340|NCT00634933|4074375|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
1667341|NCT00634933|4074371|P5|COMPLETED|Part A: Baseline to Week 24||0
1667342|NCT00634933|4074372|P4|COMPLETED|Part A: Baseline to Week 24||0
1667343|NCT00634933|4074373|P3|COMPLETED|Part A: Baseline to Week 24||55
1667344|NCT00634933|4074374|P2|COMPLETED|Part A: Baseline to Week 24||57
1667345|NCT00634933|4074375|P1|COMPLETED|Part A: Baseline to Week 24||63
1667346|NCT00634933|4074371|P5|STARTED|Part A: Baseline to Week 24||0
1667347|NCT00634933|4074372|P4|STARTED|Part A: Baseline to Week 24||0
1667348|NCT00634933|4074373|P3|STARTED|Part A: Baseline to Week 24||73
1667349|NCT00634933|4074374|P2|STARTED|Part A: Baseline to Week 24||75
1667350|NCT00634933|4074375|P1|STARTED|Part A: Baseline to Week 24||74
1667351|NCT00634920|4074444|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
1667352|NCT00634920|4074445|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
1667353|NCT00634920|4074446|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
1667354|NCT00634920|4074444|P3|COMPLETED|Period 2 - Post-Randomization||0
1667355|NCT00634920|4074445|P2|COMPLETED|Period 2 - Post-Randomization||68
1667356|NCT00634920|4074446|P1|COMPLETED|Period 2 - Post-Randomization||43
1667357|NCT00634920|4074444|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
1667358|NCT00634920|4074445|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
1667359|NCT00634920|4074446|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
1667360|NCT00634920|4074444|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
1667361|NCT00634920|4074445|P2|STARTED|Period 2 - Post-Randomization||100
1667362|NCT00634920|4074446|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
1667363|NCT00634920|4074444|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
1667364|NCT00634920|4074445|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
1667365|NCT00634920|4074446|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
1667366|NCT00634920|4074444|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
1667367|NCT00634920|4074445|P2|COMPLETED|Period 1 - Pre-Randomization||0
1667368|NCT00634920|4074446|P1|COMPLETED|Period 1 - Pre-Randomization||0
1667369|NCT00634920|4074444|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
1667370|NCT00634920|4074445|P2|STARTED|Period 1 - Pre-Randomization||0
1667371|NCT00634920|4074446|P1|STARTED|Period 1 - Pre-Randomization||0
1667372|NCT00634907|4074490|P2|NOT COMPLETED|Overall Study||17
1667373|NCT00634907|4074491|P1|NOT COMPLETED|Overall Study||17
1667374|NCT00634907|4074490|P2|COMPLETED|Overall Study||115
1667375|NCT00634907|4074491|P1|COMPLETED|Overall Study||114
1667376|NCT00634907|4074490|P2|STARTED|Overall Study||132
1667377|NCT00634907|4074491|P1|STARTED|Overall Study||131
1667378|NCT00634842|4074515|P2|NOT COMPLETED|Overall Study||18
1667379|NCT00634842|4074516|P1|NOT COMPLETED|Overall Study||15
1667380|NCT00634842|4074515|P2|COMPLETED|Overall Study||104
1667381|NCT00634842|4074516|P1|COMPLETED|Overall Study||107
1667382|NCT00634842|4074515|P2|STARTED|Overall Study||122
1667383|NCT00634842|4074516|P1|STARTED|Overall Study||122
1667384|NCT00634751|4074532|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
1667385|NCT00634751|4074533|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
1667386|NCT00634751|4074534|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
1667387|NCT00634751|4074535|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
1667388|NCT00634751|4074532|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
1667389|NCT00634751|4074533|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
1667390|NCT00634751|4074534|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
1667391|NCT00634751|4074535|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
1667392|NCT00634751|4074532|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
1667393|NCT00634751|4074533|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
1667394|NCT00634751|4074534|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
1667395|NCT00634751|4074535|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
1667396|NCT00634751|4074532|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1667397|NCT00634751|4074533|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1667398|NCT00634751|4074534|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
1667399|NCT00634751|4074535|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1667400|NCT00634751|4074532|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1667401|NCT00634751|4074533|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1667402|NCT00634751|4074534|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
1667403|NCT00634751|4074535|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1667404|NCT00634751|4074532|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
1667405|NCT00634751|4074533|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
1667406|NCT00634751|4074534|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
1667407|NCT00634751|4074535|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
1667408|NCT00634751|4074532|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1667409|NCT00634751|4074533|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1667410|NCT00634751|4074534|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1667411|NCT00634751|4074535|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
1667412|NCT00634751|4074532|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1667413|NCT00634751|4074533|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1667414|NCT00634751|4074534|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1667415|NCT00634751|4074535|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
1667416|NCT00634751|4074532|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
1667417|NCT00634751|4074533|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
1667418|NCT00634751|4074534|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
1667419|NCT00634751|4074535|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
1667420|NCT00634647|4074553|P1|NOT COMPLETED|Overall Study||7
1667421|NCT00634647|4074553|P1|COMPLETED|Overall Study||17
1667422|NCT00634647|4074553|P1|STARTED|Overall Study||24
1667423|NCT00634621|4074559|P1|NOT COMPLETED|Overall Study||0
1667424|NCT00634621|4074559|P1|COMPLETED|Overall Study||283
1667425|NCT00634621|4074559|P1|STARTED|Overall Study||283
1667426|NCT00634582|4074567|P1|NOT COMPLETED|Overall Study||0
1667427|NCT00634582|4074567|P1|COMPLETED|Overall Study||2
1667428|NCT00634582|4074567|P1|STARTED|Overall Study||2
1667429|NCT00634569|4074573|P2|NOT COMPLETED|Overall Study||5
1667430|NCT00634569|4074574|P1|NOT COMPLETED|Overall Study||0
1667431|NCT00634569|4074573|P2|COMPLETED|Overall Study||5
1667432|NCT00634569|4074574|P1|COMPLETED|Overall Study||14
1667433|NCT00634569|4074573|P2|STARTED|Overall Study||10
1667434|NCT00634569|4074574|P1|STARTED|Overall Study||14
1667435|NCT00634543|4074588|P2|NOT COMPLETED|Overall Study||21
1667436|NCT00634543|4074589|P1|NOT COMPLETED|Overall Study||19
1667437|NCT00634543|4074588|P2|COMPLETED|Overall Study||63
1667438|NCT00634543|4074589|P1|COMPLETED|Overall Study||59
1667439|NCT00634543|4074588|P2|Treated|Overall Study||80
1667440|NCT00634543|4074589|P1|Treated|Overall Study||76
1667441|NCT00634543|4074588|P2|STARTED|Overall Study||84
1667442|NCT00634543|4074589|P1|STARTED|Overall Study||78
1667443|NCT00634504|4074607|P2|NOT COMPLETED|Overall Study||0
1667444|NCT00634504|4074608|P1|NOT COMPLETED|Overall Study||1
1667445|NCT00634504|4074607|P2|COMPLETED|Overall Study||9
1667446|NCT00634504|4074608|P1|COMPLETED|Overall Study||10
1667447|NCT00634504|4074607|P2|STARTED|Overall Study||9
1667448|NCT00634504|4074608|P1|STARTED|Overall Study||11
1667449|NCT00634322|4074617|P3|NOT COMPLETED|Overall Study||0
1667450|NCT00634322|4074618|P2|NOT COMPLETED|Overall Study||0
1667451|NCT00634322|4074619|P1|NOT COMPLETED|Overall Study||0
1667452|NCT00634322|4074617|P3|COMPLETED|Overall Study||5
1667453|NCT00634322|4074618|P2|COMPLETED|Overall Study||1
1667454|NCT00634322|4074619|P1|COMPLETED|Overall Study||1
1667455|NCT00634322|4074617|P3|STARTED|Overall Study||5
1667456|NCT00634322|4074618|P2|STARTED|Overall Study||1
1667457|NCT00634322|4074619|P1|STARTED|Overall Study||1
1667458|NCT00634270|4074629|P2|NOT COMPLETED|Overall Study||1
1667459|NCT00634270|4074630|P1|NOT COMPLETED|Overall Study||3
1667460|NCT00634270|4074629|P2|COMPLETED|Overall Study||12
1667461|NCT00634270|4074630|P1|COMPLETED|Overall Study||46
1667462|NCT00634270|4074629|P2|STARTED|Overall Study||13
1667463|NCT00634270|4074630|P1|STARTED|Overall Study|February 12, 2008|49
1667464|NCT00634244|4074659|P3|NOT COMPLETED|Overall Study||0
1667465|NCT00634244|4074660|P2|NOT COMPLETED|Overall Study||13
1667466|NCT00634244|4074661|P1|NOT COMPLETED|Overall Study||1
1667467|NCT00634244|4074659|P3|COMPLETED|Overall Study||20
1667468|NCT00634244|4074660|P2|COMPLETED|Overall Study||24
1667469|NCT00634244|4074661|P1|COMPLETED|Overall Study||34
1667470|NCT00634244|4074659|P3|Eligible and Treated|Overall Study||20
1667471|NCT00634244|4074660|P2|Eligible and Treated|Overall Study||36
1667472|NCT00634244|4074661|P1|Eligible and Treated|Overall Study||35
1667473|NCT00634244|4074659|P3|STARTED|Overall Study||20
1667474|NCT00634244|4074660|P2|STARTED|Overall Study||37
1667475|NCT00634244|4074661|P1|STARTED|Overall Study||35
1667476|NCT00634179|4074672|P1|NOT COMPLETED|Phase II: Maintenance||1
1667477|NCT00634179|4074672|P1|COMPLETED|Phase II: Maintenance||29
1667478|NCT00634179|4074672|P1|STARTED|Phase II: Maintenance||30
1667479|NCT00634179|4074672|P1|NOT COMPLETED|Phase I: Induction||0
1667480|NCT00634179|4074672|P1|COMPLETED|Phase I: Induction||19
1667481|NCT00634179|4074672|P1|STARTED|Phase I: Induction||19
1667482|NCT00634166|4074681|P2|NOT COMPLETED|Overall Study||60
1667483|NCT00634166|4074682|P1|NOT COMPLETED|Overall Study||60
1667484|NCT00634166|4074681|P2|COMPLETED|Overall Study||78
1667485|NCT00634166|4074682|P1|COMPLETED|Overall Study||22
1667486|NCT00634166|4074681|P2|STARTED|Overall Study||138
1667487|NCT00634166|4074682|P1|STARTED|Overall Study||82
1667488|NCT00634114|4074691|P3|NOT COMPLETED|Overall Study||39
1667489|NCT00634114|4074692|P2|NOT COMPLETED|Overall Study||35
1667490|NCT00634114|4074693|P1|NOT COMPLETED|Overall Study||28
1667491|NCT00634114|4074691|P3|COMPLETED|Overall Study|Completed|148
1667492|NCT00634114|4074692|P2|COMPLETED|Overall Study|Completed|154
1667493|NCT00634114|4074693|P1|COMPLETED|Overall Study|Completed|160
1667494|NCT00634114|4074691|P3|STARTED|Overall Study|Randomised|187
1667495|NCT00634114|4074692|P2|STARTED|Overall Study|Randomised|189
1667496|NCT00634114|4074693|P1|STARTED|Overall Study|Randomised|188
1667497|NCT00634088|4074711|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
1667498|NCT00634088|4074712|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
1667499|NCT00634088|4074713|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
1667500|NCT00634088|4074714|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
1667501|NCT00634088|4074711|P4|COMPLETED|Time Period 4: Triplet Combination||0
1667502|NCT00634088|4074712|P3|COMPLETED|Time Period 4: Triplet Combination||0
1667503|NCT00634088|4074713|P2|COMPLETED|Time Period 4: Triplet Combination||0
1667504|NCT00634088|4074714|P1|COMPLETED|Time Period 4: Triplet Combination||0
1667505|NCT00634088|4074711|P4|STARTED|Time Period 4: Triplet Combination||0
1667506|NCT00634088|4074712|P3|STARTED|Time Period 4: Triplet Combination||0
1667507|NCT00634088|4074713|P2|STARTED|Time Period 4: Triplet Combination||0
1667508|NCT00634088|4074714|P1|STARTED|Time Period 4: Triplet Combination||0
1667509|NCT00634088|4074711|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
1667510|NCT00634088|4074712|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
1667511|NCT00634088|4074713|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
1667512|NCT00634088|4074714|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
1667513|NCT00634088|4074711|P4|COMPLETED|Time Period 3: Dose Level 3||0
1667514|NCT00634088|4074712|P3|COMPLETED|Time Period 3: Dose Level 3||0
1667515|NCT00634088|4074713|P2|COMPLETED|Time Period 3: Dose Level 3||0
1667516|NCT00634088|4074714|P1|COMPLETED|Time Period 3: Dose Level 3||0
1667517|NCT00634088|4074711|P4|STARTED|Time Period 3: Dose Level 3||0
1667518|NCT00634088|4074712|P3|STARTED|Time Period 3: Dose Level 3||1
1667519|NCT00634088|4074713|P2|STARTED|Time Period 3: Dose Level 3||0
1667520|NCT00634088|4074714|P1|STARTED|Time Period 3: Dose Level 3||0
1667521|NCT00634088|4074711|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
1667522|NCT00634088|4074712|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
1667523|NCT00634088|4074713|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
1667524|NCT00634088|4074714|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
1667525|NCT00634088|4074711|P4|COMPLETED|Time Period 2: Dose Level 2||0
1667526|NCT00634088|4074712|P3|COMPLETED|Time Period 2: Dose Level 2||0
1667527|NCT00634088|4074713|P2|COMPLETED|Time Period 2: Dose Level 2||0
1667528|NCT00634088|4074714|P1|COMPLETED|Time Period 2: Dose Level 2||0
1667529|NCT00634088|4074711|P4|STARTED|Time Period 2: Dose Level 2||0
1667530|NCT00634088|4074712|P3|STARTED|Time Period 2: Dose Level 2||0
1667531|NCT00634088|4074713|P2|STARTED|Time Period 2: Dose Level 2||3
1667532|NCT00634088|4074714|P1|STARTED|Time Period 2: Dose Level 2||0
1667533|NCT00634088|4074711|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
1667534|NCT00634088|4074712|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
1667535|NCT00634088|4074713|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
1667536|NCT00634088|4074714|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
1667537|NCT00634088|4074711|P4|COMPLETED|Time Period 1: Dose Level 1||0
1667538|NCT00634088|4074712|P3|COMPLETED|Time Period 1: Dose Level 1||0
1667539|NCT00634088|4074713|P2|COMPLETED|Time Period 1: Dose Level 1||0
1667540|NCT00634088|4074714|P1|COMPLETED|Time Period 1: Dose Level 1||0
1667541|NCT00634088|4074711|P4|STARTED|Time Period 1: Dose Level 1||0
1667542|NCT00634088|4074712|P3|STARTED|Time Period 1: Dose Level 1||0
1667543|NCT00634088|4074713|P2|STARTED|Time Period 1: Dose Level 1||0
1667544|NCT00634088|4074714|P1|STARTED|Time Period 1: Dose Level 1||6
1667545|NCT00634049|4074765|P1|NOT COMPLETED|Overall Study||3
1667546|NCT00634049|4074765|P1|COMPLETED|Overall Study||146
1667547|NCT00634049|4074765|P1|STARTED|Overall Study||149
1667548|NCT00634036|4074844|P2|NOT COMPLETED|Overall Study||2
1667549|NCT00634036|4074845|P1|NOT COMPLETED|Overall Study||2
1667550|NCT00634036|4074844|P2|COMPLETED|Overall Study||9
1667551|NCT00634036|4074845|P1|COMPLETED|Overall Study||10
1667552|NCT00634036|4074844|P2|STARTED|Overall Study||11
1667553|NCT00634036|4074845|P1|STARTED|Overall Study||12
1667554|NCT00634010|4074859|P2|NOT COMPLETED|Overall Study||14
1667555|NCT00634010|4074860|P1|NOT COMPLETED|Overall Study||10
1667556|NCT00634010|4074859|P2|COMPLETED|Overall Study||4
1667557|NCT00634010|4074860|P1|COMPLETED|Overall Study||8
1667558|NCT00634010|4074859|P2|STARTED|Overall Study||18
1667559|NCT00634010|4074860|P1|STARTED|Overall Study||18
1667560|NCT00633984|4074868|P2|NOT COMPLETED|Overall Study||13
1667561|NCT00633984|4074869|P1|NOT COMPLETED|Overall Study||9
1667562|NCT00633984|4074868|P2|COMPLETED|Overall Study||69
1667563|NCT00633984|4074869|P1|COMPLETED|Overall Study||78
1667564|NCT00633984|4074868|P2|STARTED|Overall Study||82
1667565|NCT00633984|4074869|P1|STARTED|Overall Study||87
1667566|NCT00633932|4074880|P3|NOT COMPLETED|Overall Study||11
1667567|NCT00633932|4074881|P2|NOT COMPLETED|Overall Study||14
1667568|NCT00633932|4074882|P1|NOT COMPLETED|Overall Study||12
1667569|NCT00633932|4074880|P3|COMPLETED|Overall Study||180
1667570|NCT00633932|4074881|P2|COMPLETED|Overall Study||176
1667571|NCT00633932|4074882|P1|COMPLETED|Overall Study||179
1667572|NCT00633932|4074880|P3|STARTED|Overall Study|Randomised|191
1667573|NCT00633932|4074881|P2|STARTED|Overall Study|Randomised|190
1667574|NCT00633932|4074882|P1|STARTED|Overall Study|Randomised|191
1667575|NCT00633919|4074895|P2|NOT COMPLETED|Overall Study||22
1667576|NCT00633919|4074896|P1|NOT COMPLETED|Overall Study||27
1667577|NCT00633919|4074895|P2|COMPLETED|Overall Study||39
1667578|NCT00633919|4074896|P1|COMPLETED|Overall Study||36
1667579|NCT00633919|4074895|P2|STARTED|Overall Study||61
1667580|NCT00633919|4074896|P1|STARTED|Overall Study||63
1667581|NCT00633893|4074913|P3|NOT COMPLETED|Overall Study||188
1667582|NCT00633893|4074914|P2|NOT COMPLETED|Overall Study||129
1667583|NCT00633893|4074915|P1|NOT COMPLETED|Overall Study||114
1667584|NCT00633893|4074913|P3|COMPLETED|Overall Study||641
1667585|NCT00633893|4074914|P2|COMPLETED|Overall Study||684
1667586|NCT00633893|4074915|P1|COMPLETED|Overall Study||726
1667587|NCT00633893|4074913|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
1667588|NCT00633893|4074914|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
1667589|NCT00633893|4074915|P1|STARTED|Overall Study||840
1667590|NCT00633880|4074989|P3|NOT COMPLETED|Randomized Double Blind||0
1667591|NCT00633880|4074990|P2|NOT COMPLETED|Randomized Double Blind||0
1667592|NCT00633880|4074991|P1|NOT COMPLETED|Randomized Double Blind||0
1667593|NCT00633880|4074989|P3|COMPLETED|Randomized Double Blind||51
1667594|NCT00633880|4074990|P2|COMPLETED|Randomized Double Blind||50
1667595|NCT00633880|4074991|P1|COMPLETED|Randomized Double Blind||0
1667596|NCT00633880|4074989|P3|STARTED|Randomized Double Blind||51
1667597|NCT00633880|4074990|P2|STARTED|Randomized Double Blind||50
1667598|NCT00633880|4074991|P1|STARTED|Randomized Double Blind||0
1667599|NCT00633880|4074989|P3|NOT COMPLETED|Open Label Titration||0
1667600|NCT00633880|4074990|P2|NOT COMPLETED|Open Label Titration||0
1667601|NCT00633880|4074991|P1|NOT COMPLETED|Open Label Titration||80
1667602|NCT00633880|4074989|P3|COMPLETED|Open Label Titration||0
1667603|NCT00633880|4074990|P2|COMPLETED|Open Label Titration||0
1667604|NCT00633880|4074991|P1|COMPLETED|Open Label Titration||101
1667605|NCT00633880|4074989|P3|STARTED|Open Label Titration||0
1667606|NCT00633880|4074990|P2|STARTED|Open Label Titration||0
1667607|NCT00633880|4074991|P1|STARTED|Open Label Titration||181
1667608|NCT00633867|4075020|P2|NOT COMPLETED|Overall Study||0
1667609|NCT00633867|4075021|P1|NOT COMPLETED|Overall Study||0
1667610|NCT00633867|4075020|P2|COMPLETED|Overall Study||60
1667611|NCT00633867|4075021|P1|COMPLETED|Overall Study||60
1667612|NCT00633867|4075020|P2|STARTED|Overall Study||60
1667613|NCT00633867|4075021|P1|STARTED|Overall Study||60
1667614|NCT00633750|4075027|P1|NOT COMPLETED|Overall Study||5
1667615|NCT00633750|4075027|P1|COMPLETED|Overall Study||42
1667616|NCT00633750|4075027|P1|STARTED|Overall Study||47
1667617|NCT00633594|4075036|P3|NOT COMPLETED|Overall Study||10
1667618|NCT00633594|4075037|P2|NOT COMPLETED|Overall Study||5
1667619|NCT00633594|4075038|P1|NOT COMPLETED|Overall Study||0
1667620|NCT00633594|4075036|P3|COMPLETED|Overall Study||16
1667621|NCT00633594|4075037|P2|COMPLETED|Overall Study||3
1667622|NCT00633594|4075038|P1|COMPLETED|Overall Study||5
1667623|NCT00633594|4075036|P3|STARTED|Overall Study||26
1667624|NCT00633594|4075037|P2|STARTED|Overall Study||8
1667625|NCT00633594|4075038|P1|STARTED|Overall Study||5
1667626|NCT00633477|4075067|P2|NOT COMPLETED|Overall Study||0
1667627|NCT00633477|4075068|P1|NOT COMPLETED|Overall Study||2
1667718|NCT00633009|4075282|P1|NOT COMPLETED|Overall Study||4
1667628|NCT00633477|4075067|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
1667629|NCT00633477|4075068|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
1667630|NCT00633477|4075067|P2|Completed Study Through Day 28|Overall Study||8
1667631|NCT00633477|4075068|P1|Completed Study Through Day 28|Overall Study||4
1667632|NCT00633477|4075067|P2|Prematurely Discontinued Study Drug|Overall Study||0
1667633|NCT00633477|4075068|P1|Prematurely Discontinued Study Drug|Overall Study||1
1667634|NCT00633477|4075067|P2|Randomized But Not Treated|Overall Study||0
1667635|NCT00633477|4075068|P1|Randomized But Not Treated|Overall Study||1
1667636|NCT00633477|4075067|P2|STARTED|Overall Study||11
1667637|NCT00633477|4075068|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
1667638|NCT00633464|4075084|P2|NOT COMPLETED|Overall Study||2
1667639|NCT00633464|4075085|P1|NOT COMPLETED|Overall Study||0
1667640|NCT00633464|4075084|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
1667641|NCT00633464|4075085|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
1667642|NCT00633464|4075084|P2|Treated|Overall Study||37
1667643|NCT00633464|4075085|P1|Treated|Overall Study||40
1667644|NCT00633464|4075084|P2|STARTED|Overall Study||39
1667645|NCT00633464|4075085|P1|STARTED|Overall Study||40
1667646|NCT00633399|4075107|P2|NOT COMPLETED|Overall Study||15
1667647|NCT00633399|4075108|P1|NOT COMPLETED|Overall Study||22
1667648|NCT00633399|4075107|P2|COMPLETED|Overall Study||53
1667649|NCT00633399|4075108|P1|COMPLETED|Overall Study||49
1667650|NCT00633399|4075107|P2|STARTED|Overall Study||68
1667651|NCT00633399|4075108|P1|STARTED|Overall Study||71
1667652|NCT00633360|4075120|P2|NOT COMPLETED|Overall Study||3
1667653|NCT00633360|4075121|P1|NOT COMPLETED|Overall Study||4
1667654|NCT00633360|4075120|P2|COMPLETED|Overall Study||13
1667655|NCT00633360|4075121|P1|COMPLETED|Overall Study||12
1667656|NCT00633360|4075120|P2|STARTED|Overall Study||16
1667657|NCT00633360|4075121|P1|STARTED|Overall Study||16
1667658|NCT00633256|4075131|P2|NOT COMPLETED|Overall Study||3
1667659|NCT00633256|4075132|P1|NOT COMPLETED|Overall Study||4
1667660|NCT00633256|4075131|P2|COMPLETED|Overall Study||10
1667661|NCT00633256|4075132|P1|COMPLETED|Overall Study||8
1667662|NCT00633256|4075131|P2|STARTED|Overall Study||13
1667663|NCT00633256|4075132|P1|STARTED|Overall Study||12
1667664|NCT00633243|4075144|P2|NOT COMPLETED|Overall Study||7
1667665|NCT00633243|4075145|P1|NOT COMPLETED|Overall Study||1
1667666|NCT00633243|4075144|P2|COMPLETED|Overall Study||2
1667667|NCT00633243|4075145|P1|COMPLETED|Overall Study||11
1667668|NCT00633243|4075144|P2|STARTED|Overall Study||9
1667669|NCT00633243|4075145|P1|STARTED|Overall Study||12
1667670|NCT00633217|4075153|P2|NOT COMPLETED|Overall Study||23
1667671|NCT00633217|4075154|P1|NOT COMPLETED|Overall Study||15
1667672|NCT00633217|4075153|P2|COMPLETED|Overall Study||103
1667673|NCT00633217|4075154|P1|COMPLETED|Overall Study||106
1667674|NCT00633217|4075153|P2|STARTED|Overall Study||126
1667675|NCT00633217|4075154|P1|STARTED|Overall Study||121
1667676|NCT00633152|4075166|P2|NOT COMPLETED|Overall Study||6
1667677|NCT00633152|4075167|P1|NOT COMPLETED|Overall Study||14
1667678|NCT00633152|4075166|P2|COMPLETED|Overall Study||41
1667679|NCT00633152|4075167|P1|COMPLETED|Overall Study||89
1667680|NCT00633152|4075166|P2|Clinically Evaluable Population|Overall Study||39
1667681|NCT00633152|4075167|P1|Clinically Evaluable Population|Overall Study||86
1667682|NCT00633152|4075166|P2|MITT and Safety Population|Overall Study||45
1667683|NCT00633152|4075167|P1|MITT and Safety Population|Overall Study||98
1667684|NCT00633152|4075166|P2|STARTED|Overall Study||47
1667685|NCT00633152|4075167|P1|STARTED|Overall Study||103
1667686|NCT00633139|4075178|P3|NOT COMPLETED|Overall Study||1
1667687|NCT00633139|4075179|P2|NOT COMPLETED|Overall Study||1
1667688|NCT00633139|4075180|P1|NOT COMPLETED|Overall Study||0
1667689|NCT00633139|4075178|P3|COMPLETED|Overall Study||3
1667690|NCT00633139|4075179|P2|COMPLETED|Overall Study||4
1667691|NCT00633139|4075180|P1|COMPLETED|Overall Study||4
1667692|NCT00633139|4075178|P3|STARTED|Overall Study||4
1667693|NCT00633139|4075179|P2|STARTED|Overall Study||5
1667694|NCT00633139|4075180|P1|STARTED|Overall Study||4
1667695|NCT00633126|4075194|P1|NOT COMPLETED|Overall Study||1
1667696|NCT00633126|4075194|P1|COMPLETED|Overall Study||8
1667697|NCT00633126|4075194|P1|STARTED|Overall Study||9
1667698|NCT00633087|4075199|P1|NOT COMPLETED|Overall Study||0
1667699|NCT00633087|4075199|P1|COMPLETED|Overall Study||12
1667700|NCT00633087|4075199|P1|STARTED|Overall Study||12
1667701|NCT00633074|4075208|P2|NOT COMPLETED|Overall Study||0
1667702|NCT00633074|4075209|P1|NOT COMPLETED|Overall Study||1
1667703|NCT00633074|4075208|P2|COMPLETED|Overall Study||360
1667704|NCT00633074|4075209|P1|COMPLETED|Overall Study||359
1667705|NCT00633074|4075208|P2|STARTED|Overall Study||360
1667706|NCT00633074|4075209|P1|STARTED|Overall Study||360
1667707|NCT00633022|4075240|P3|NOT COMPLETED|Overall Study||5
1667708|NCT00633022|4075241|P2|NOT COMPLETED|Overall Study||1
1667709|NCT00633022|4075242|P1|NOT COMPLETED|Overall Study||1
1667710|NCT00633022|4075240|P3|COMPLETED|Overall Study||27
1667711|NCT00633022|4075241|P2|COMPLETED|Overall Study||32
1667712|NCT00633022|4075242|P1|COMPLETED|Overall Study||33
1667713|NCT00633022|4075240|P3|STARTED|Overall Study||32
1667714|NCT00633022|4075241|P2|STARTED|Overall Study||33
1667715|NCT00633022|4075242|P1|STARTED|Overall Study||34
1667716|NCT00633009|4075280|P3|NOT COMPLETED|Overall Study||1
1667717|NCT00633009|4075281|P2|NOT COMPLETED|Overall Study||4
1667719|NCT00633009|4075280|P3|COMPLETED|Overall Study||10
1667720|NCT00633009|4075281|P2|COMPLETED|Overall Study||23
1667721|NCT00633009|4075282|P1|COMPLETED|Overall Study||8
1667722|NCT00633009|4075280|P3|STARTED|Overall Study||11
1667723|NCT00633009|4075281|P2|STARTED|Overall Study||27
1667724|NCT00633009|4075282|P1|STARTED|Overall Study||12
1667725|NCT00632970|4075295|P2|NOT COMPLETED|Overall Study||0
1667726|NCT00632970|4075296|P1|NOT COMPLETED|Overall Study||0
1667727|NCT00632970|4075295|P2|COMPLETED|Overall Study||3
1667728|NCT00632970|4075296|P1|COMPLETED|Overall Study||3
1667729|NCT00632970|4075295|P2|STARTED|Overall Study||3
1667730|NCT00632970|4075296|P1|STARTED|Overall Study||3
1667731|NCT00632931|4075304|P3|NOT COMPLETED|Part 2||24
1667732|NCT00632931|4075305|P2|NOT COMPLETED|Part 2||0
1667733|NCT00632931|4075306|P1|NOT COMPLETED|Part 2||0
1667734|NCT00632931|4075304|P3|COMPLETED|Part 2||0
1667735|NCT00632931|4075305|P2|COMPLETED|Part 2||0
1667736|NCT00632931|4075306|P1|COMPLETED|Part 2||0
1667737|NCT00632931|4075304|P3|STARTED|Part 2||24
1667738|NCT00632931|4075305|P2|STARTED|Part 2||0
1667739|NCT00632931|4075306|P1|STARTED|Part 2||0
1667740|NCT00632931|4075304|P3|NOT COMPLETED|Post-Part 1 Washout||0
1667741|NCT00632931|4075305|P2|NOT COMPLETED|Post-Part 1 Washout||0
1667742|NCT00632931|4075306|P1|NOT COMPLETED|Post-Part 1 Washout||0
1667743|NCT00632931|4075304|P3|COMPLETED|Post-Part 1 Washout||0
1667744|NCT00632931|4075305|P2|COMPLETED|Post-Part 1 Washout||12
1667745|NCT00632931|4075306|P1|COMPLETED|Post-Part 1 Washout||12
1667746|NCT00632931|4075304|P3|STARTED|Post-Part 1 Washout||0
1667747|NCT00632931|4075305|P2|STARTED|Post-Part 1 Washout||12
1667748|NCT00632931|4075306|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
1667749|NCT00632931|4075304|P3|NOT COMPLETED|Part 1, Period 2||0
1667750|NCT00632931|4075305|P2|NOT COMPLETED|Part 1, Period 2||0
1667751|NCT00632931|4075306|P1|NOT COMPLETED|Part 1, Period 2||0
1667752|NCT00632931|4075304|P3|COMPLETED|Part 1, Period 2||0
1667753|NCT00632931|4075305|P2|COMPLETED|Part 1, Period 2||12
1667754|NCT00632931|4075306|P1|COMPLETED|Part 1, Period 2||11
1667755|NCT00632931|4075304|P3|STARTED|Part 1, Period 2||0
1667756|NCT00632931|4075305|P2|STARTED|Part 1, Period 2||12
1667757|NCT00632931|4075306|P1|STARTED|Part 1, Period 2||11
1667758|NCT00632931|4075304|P3|NOT COMPLETED|Part 1, Washout||0
1667759|NCT00632931|4075305|P2|NOT COMPLETED|Part 1, Washout||0
1667760|NCT00632931|4075306|P1|NOT COMPLETED|Part 1, Washout||0
1667761|NCT00632931|4075304|P3|COMPLETED|Part 1, Washout||0
1667762|NCT00632931|4075305|P2|COMPLETED|Part 1, Washout||12
1667763|NCT00632931|4075306|P1|COMPLETED|Part 1, Washout||11
1667764|NCT00632931|4075304|P3|STARTED|Part 1, Washout||0
1667765|NCT00632931|4075305|P2|STARTED|Part 1, Washout||12
1667766|NCT00632931|4075306|P1|STARTED|Part 1, Washout||11
1667767|NCT00632931|4075304|P3|NOT COMPLETED|Part 1, Period 1||0
1667768|NCT00632931|4075305|P2|NOT COMPLETED|Part 1, Period 1||0
1667769|NCT00632931|4075306|P1|NOT COMPLETED|Part 1, Period 1||2
1667770|NCT00632931|4075304|P3|COMPLETED|Part 1, Period 1||0
1667771|NCT00632931|4075305|P2|COMPLETED|Part 1, Period 1||12
1667772|NCT00632931|4075306|P1|COMPLETED|Part 1, Period 1||11
1667773|NCT00632931|4075304|P3|STARTED|Part 1, Period 1||0
1667774|NCT00632931|4075305|P2|STARTED|Part 1, Period 1||12
1667775|NCT00632931|4075306|P1|STARTED|Part 1, Period 1||13
1667776|NCT00632814|4075328|P3|NOT COMPLETED|Overall Study||0
1667777|NCT00632814|4075329|P2|NOT COMPLETED|Overall Study||0
1667778|NCT00632814|4075330|P1|NOT COMPLETED|Overall Study||0
1667779|NCT00632814|4075328|P3|COMPLETED|Overall Study||8
1667780|NCT00632814|4075329|P2|COMPLETED|Overall Study||13
1667781|NCT00632814|4075330|P1|COMPLETED|Overall Study||11
1667782|NCT00632814|4075328|P3|STARTED|Overall Study||8
1667783|NCT00632814|4075329|P2|STARTED|Overall Study||13
1667784|NCT00632814|4075330|P1|STARTED|Overall Study||11
1667785|NCT00632749|4075376|P14|NOT COMPLETED|Overall Study||6
1667786|NCT00632749|4075377|P13|NOT COMPLETED|Overall Study||3
1667787|NCT00632749|4075378|P12|NOT COMPLETED|Overall Study||4
1667788|NCT00632749|4075379|P11|NOT COMPLETED|Overall Study||7
1667789|NCT00632749|4075380|P10|NOT COMPLETED|Overall Study||3
1667790|NCT00632749|4075381|P9|NOT COMPLETED|Overall Study||5
1667791|NCT00632749|4075382|P8|NOT COMPLETED|Overall Study||4
1667792|NCT00632749|4075383|P7|NOT COMPLETED|Overall Study||5
1667793|NCT00632749|4075384|P6|NOT COMPLETED|Overall Study||8
1667794|NCT00632749|4075385|P5|NOT COMPLETED|Overall Study||7
1667795|NCT00632749|4075386|P4|NOT COMPLETED|Overall Study||4
1667796|NCT00632749|4075387|P3|NOT COMPLETED|Overall Study||3
1667797|NCT00632749|4075388|P2|NOT COMPLETED|Overall Study||5
1667798|NCT00632749|4075389|P1|NOT COMPLETED|Overall Study||4
1667799|NCT00632749|4075376|P14|COMPLETED|Overall Study||0
1667800|NCT00632749|4075377|P13|COMPLETED|Overall Study||0
1667801|NCT00632749|4075378|P12|COMPLETED|Overall Study||0
1667802|NCT00632749|4075379|P11|COMPLETED|Overall Study||0
1667803|NCT00632749|4075380|P10|COMPLETED|Overall Study||0
1667804|NCT00632749|4075381|P9|COMPLETED|Overall Study||0
1667805|NCT00632749|4075382|P8|COMPLETED|Overall Study||0
1667806|NCT00632749|4075383|P7|COMPLETED|Overall Study||0
1667807|NCT00632749|4075384|P6|COMPLETED|Overall Study||0
1667808|NCT00632749|4075385|P5|COMPLETED|Overall Study||0
1667809|NCT00632749|4075386|P4|COMPLETED|Overall Study||0
1667810|NCT00632749|4075387|P3|COMPLETED|Overall Study||0
1667811|NCT00632749|4075388|P2|COMPLETED|Overall Study||0
1667812|NCT00632749|4075389|P1|COMPLETED|Overall Study||0
1667813|NCT00632749|4075376|P14|Not Treated|Overall Study||0
1667814|NCT00632749|4075377|P13|Not Treated|Overall Study||0
1667815|NCT00632749|4075378|P12|Not Treated|Overall Study||0
1667816|NCT00632749|4075379|P11|Not Treated|Overall Study||0
1667817|NCT00632749|4075380|P10|Not Treated|Overall Study||0
1667818|NCT00632749|4075381|P9|Not Treated|Overall Study||0
1667819|NCT00632749|4075382|P8|Not Treated|Overall Study||0
1667820|NCT00632749|4075383|P7|Not Treated|Overall Study||1
1667821|NCT00632749|4075384|P6|Not Treated|Overall Study||1
1667822|NCT00632749|4075385|P5|Not Treated|Overall Study||0
1667823|NCT00632749|4075386|P4|Not Treated|Overall Study||0
1667824|NCT00632749|4075387|P3|Not Treated|Overall Study||0
1667825|NCT00632749|4075388|P2|Not Treated|Overall Study||2
1667826|NCT00632749|4075389|P1|Not Treated|Overall Study||0
1667827|NCT00632749|4075376|P14|Treated|Overall Study||6
1667828|NCT00632749|4075377|P13|Treated|Overall Study||3
1667829|NCT00632749|4075378|P12|Treated|Overall Study||4
1667830|NCT00632749|4075379|P11|Treated|Overall Study||7
1667831|NCT00632749|4075380|P10|Treated|Overall Study||3
1667832|NCT00632749|4075381|P9|Treated|Overall Study||5
1667833|NCT00632749|4075382|P8|Treated|Overall Study||4
1667834|NCT00632749|4075383|P7|Treated|Overall Study||4
1667835|NCT00632749|4075384|P6|Treated|Overall Study||7
1667836|NCT00632749|4075385|P5|Treated|Overall Study||7
1667837|NCT00632749|4075386|P4|Treated|Overall Study||4
1667838|NCT00632749|4075387|P3|Treated|Overall Study||3
1667839|NCT00632749|4075388|P2|Treated|Overall Study||3
1667840|NCT00632749|4075389|P1|Treated|Overall Study||4
1667841|NCT00632749|4075376|P14|STARTED|Overall Study||6
1667842|NCT00632749|4075377|P13|STARTED|Overall Study||3
1667843|NCT00632749|4075378|P12|STARTED|Overall Study||4
1667844|NCT00632749|4075379|P11|STARTED|Overall Study||7
1667845|NCT00632749|4075380|P10|STARTED|Overall Study||3
1667846|NCT00632749|4075381|P9|STARTED|Overall Study||5
1667847|NCT00632749|4075382|P8|STARTED|Overall Study||4
1667848|NCT00632749|4075383|P7|STARTED|Overall Study||5
1667849|NCT00632749|4075384|P6|STARTED|Overall Study||8
1667850|NCT00632749|4075385|P5|STARTED|Overall Study||7
1667851|NCT00632749|4075386|P4|STARTED|Overall Study||4
1667852|NCT00632749|4075387|P3|STARTED|Overall Study||3
1667853|NCT00632749|4075388|P2|STARTED|Overall Study||5
1667854|NCT00632749|4075389|P1|STARTED|Overall Study||4
1667855|NCT00632736|4075683|P1|NOT COMPLETED|Overall Study||268
1667856|NCT00632736|4075683|P1|COMPLETED|Overall Study||151
1667857|NCT00632736|4075683|P1|STARTED|Overall Study||419
1667858|NCT00632632|4075690|P2|NOT COMPLETED|Overall Study||3
1667859|NCT00632632|4075691|P1|NOT COMPLETED|Overall Study||0
1667860|NCT00632632|4075690|P2|COMPLETED|Overall Study||9
1667861|NCT00632632|4075691|P1|COMPLETED|Overall Study||13
1667862|NCT00632632|4075690|P2|STARTED|Overall Study||12
1667863|NCT00632632|4075691|P1|STARTED|Overall Study||13
1667864|NCT00632619|4075703|P2|NOT COMPLETED|Overall Study||4
1667865|NCT00632619|4075704|P1|NOT COMPLETED|Overall Study||8
1667866|NCT00632619|4075703|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
1667867|NCT00632619|4075704|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
1667868|NCT00632619|4075703|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
1667869|NCT00632619|4075704|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
1667870|NCT00632541|4075718|P1|NOT COMPLETED|Overall Study||7
1667871|NCT00632541|4075718|P1|COMPLETED|Overall Study||11
1667872|NCT00632541|4075718|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
1667873|NCT00632502|4075727|P2|NOT COMPLETED|Overall Study||1
1667874|NCT00632502|4075728|P1|NOT COMPLETED|Overall Study||3
1667875|NCT00632502|4075727|P2|COMPLETED|Overall Study||11
1667876|NCT00632502|4075728|P1|COMPLETED|Overall Study||22
1667877|NCT00632502|4075727|P2|Completed Treatment|Overall Study||9
1667878|NCT00632502|4075728|P1|Completed Treatment|Overall Study||19
1667879|NCT00632502|4075727|P2|Treated|Overall Study||12
1667880|NCT00632502|4075728|P1|Treated|Overall Study||22
1667881|NCT00632502|4075727|P2|STARTED|Overall Study||12
1667882|NCT00632502|4075728|P1|STARTED|Overall Study||25
1667883|NCT00632489|4075756|P3|NOT COMPLETED|Overall Study||0
1667884|NCT00632489|4075757|P2|NOT COMPLETED|Overall Study||5
1667885|NCT00632489|4075758|P1|NOT COMPLETED|Overall Study||15
1667886|NCT00632489|4075756|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
1667887|NCT00632489|4075757|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
1667888|NCT00632489|4075758|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
1667889|NCT00632489|4075756|P3|STARTED|Overall Study||0
1667890|NCT00632489|4075757|P2|STARTED|Overall Study||5
1667891|NCT00632489|4075758|P1|STARTED|Overall Study||15
1667892|NCT00632463|4075772|P3|NOT COMPLETED|Overall Study||0
1667893|NCT00632463|4075773|P2|NOT COMPLETED|Overall Study||1
1667894|NCT00632463|4075774|P1|NOT COMPLETED|Overall Study||0
1667895|NCT00632463|4075772|P3|COMPLETED|Overall Study||7
1667896|NCT00632463|4075773|P2|COMPLETED|Overall Study||6
1667897|NCT00632463|4075774|P1|COMPLETED|Overall Study||7
1667898|NCT00632463|4075772|P3|STARTED|Overall Study||7
1667899|NCT00632463|4075773|P2|STARTED|Overall Study||7
1667900|NCT00632463|4075774|P1|STARTED|Overall Study||7
1667901|NCT00632424|4075791|P1|NOT COMPLETED|Overall Study||18
1667902|NCT00632424|4075791|P1|COMPLETED|Overall Study||0
1667903|NCT00632424|4075791|P1|STARTED|Overall Study||18
1667904|NCT00632411|4075815|P2|NOT COMPLETED|Overall Study||176
1667905|NCT00632411|4075816|P1|NOT COMPLETED|Overall Study||160
1667906|NCT00632411|4075815|P2|COMPLETED|Overall Study||473
1667907|NCT00632411|4075816|P1|COMPLETED|Overall Study||489
1667908|NCT00632411|4075815|P2|STARTED|Overall Study||649
1667909|NCT00632411|4075816|P1|STARTED|Overall Study||649
1667910|NCT00632281|4075822|P1|NOT COMPLETED|Overall Study||0
1667911|NCT00632281|4075822|P1|COMPLETED|Overall Study||38
1667912|NCT00632281|4075822|P1|STARTED|Overall Study||38
1667913|NCT00632229|4075829|P2|NOT COMPLETED|Overall Study||6
1667914|NCT00632229|4075830|P1|NOT COMPLETED|Overall Study||6
1667915|NCT00632229|4075829|P2|COMPLETED|Overall Study||11
1667916|NCT00632229|4075830|P1|COMPLETED|Overall Study||11
1667917|NCT00632229|4075829|P2|STARTED|Overall Study||17
1667918|NCT00632229|4075830|P1|STARTED|Overall Study||17
1667919|NCT00632203|4075840|P2|NOT COMPLETED|Overall Study||0
1667920|NCT00632203|4075841|P1|NOT COMPLETED|Overall Study||1
1667921|NCT00632203|4075840|P2|COMPLETED|Overall Study||27
1667922|NCT00632203|4075841|P1|COMPLETED|Overall Study||25
1667923|NCT00632203|4075840|P2|STARTED|Overall Study||27
1667924|NCT00632203|4075841|P1|STARTED|Overall Study||26
1667925|NCT00632125|4075859|P1|NOT COMPLETED|Overall Study||302
1667926|NCT00632125|4075859|P1|COMPLETED|Overall Study||1393
1667927|NCT00632125|4075859|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
1667928|NCT00632099|4075865|P2|NOT COMPLETED|Overall Study||3
1667929|NCT00632099|4075866|P1|NOT COMPLETED|Overall Study||3
1667930|NCT00632099|4075865|P2|COMPLETED|Overall Study||8
1667931|NCT00632099|4075866|P1|COMPLETED|Overall Study||7
1667932|NCT00632099|4075865|P2|STARTED|Overall Study||11
1667933|NCT00632099|4075866|P1|STARTED|Overall Study||10
1667934|NCT00632021|4075874|P2|NOT COMPLETED|Overall Study||7
1667935|NCT00632021|4075875|P1|NOT COMPLETED|Overall Study||4
1667936|NCT00632021|4075874|P2|COMPLETED|Overall Study||423
1667937|NCT00632021|4075875|P1|COMPLETED|Overall Study||428
1667938|NCT00632021|4075874|P2|STARTED|Overall Study||430
1667939|NCT00632021|4075875|P1|STARTED|Overall Study||432
1667940|NCT00631969|4075885|P2|NOT COMPLETED|Overall Study||21
1667941|NCT00631969|4075886|P1|NOT COMPLETED|Overall Study||15
1667942|NCT00631969|4075885|P2|COMPLETED|Overall Study||155
1667943|NCT00631969|4075886|P1|COMPLETED|Overall Study||171
1667944|NCT00631969|4075885|P2|Received Treatment|Overall Study|safety population|174
1667945|NCT00631969|4075886|P1|Received Treatment|Overall Study|safety population|184
1667946|NCT00631969|4075885|P2|STARTED|Overall Study||176
1667947|NCT00631969|4075886|P1|STARTED|Overall Study||186
1667948|NCT00631917|4075932|P2|NOT COMPLETED|Overall Study||108
1667949|NCT00631917|4075933|P1|NOT COMPLETED|Overall Study||88
1667950|NCT00631917|4075932|P2|COMPLETED|Overall Study||291
1667951|NCT00631917|4075933|P1|COMPLETED|Overall Study||287
1667952|NCT00631917|4075932|P2|STARTED|Overall Study||399
1667953|NCT00631917|4075933|P1|STARTED|Overall Study||375
1667954|NCT00631748|4075949|P2|NOT COMPLETED|Overall Study||22
1667955|NCT00631748|4075950|P1|NOT COMPLETED|Overall Study||18
1667956|NCT00631748|4075949|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
1667957|NCT00631748|4075950|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
1667958|NCT00631748|4075949|P2|STARTED|Overall Study||31
1667959|NCT00631748|4075950|P1|STARTED|Overall Study||29
1667960|NCT00631696|4075960|P2|NOT COMPLETED|Overall Study||40
1667961|NCT00631696|4075961|P1|NOT COMPLETED|Overall Study||37
1667962|NCT00631696|4075960|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
1667963|NCT00631696|4075961|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
1667964|NCT00631696|4075960|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
1667965|NCT00631696|4075961|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
1667966|NCT00631696|4075960|P2|Received Study Treatment (Tx)|Overall Study||109
1667967|NCT00631696|4075961|P1|Received Study Treatment (Tx)|Overall Study||111
1667968|NCT00631696|4075960|P2|STARTED|Overall Study||110
1667969|NCT00631696|4075961|P1|STARTED|Overall Study||112
1667970|NCT00631670|4075987|P2|NOT COMPLETED|Overall Study||0
1667971|NCT00631670|4075988|P1|NOT COMPLETED|Overall Study||0
1667972|NCT00631670|4075987|P2|COMPLETED|Overall Study||0
1667973|NCT00631670|4075988|P1|COMPLETED|Overall Study||21
1667974|NCT00631670|4075987|P2|STARTED|Overall Study||0
1667975|NCT00631670|4075988|P1|STARTED|Overall Study||21
1667976|NCT00631657|4076004|P3|NOT COMPLETED|7-Day Discontinuation Period||1
1667977|NCT00631657|4076005|P2|NOT COMPLETED|7-Day Discontinuation Period||1
1667978|NCT00631657|4076006|P1|NOT COMPLETED|7-Day Discontinuation Period||2
1667979|NCT00631657|4076004|P3|COMPLETED|7-Day Discontinuation Period||65
1667980|NCT00631657|4076005|P2|COMPLETED|7-Day Discontinuation Period||136
1667981|NCT00631657|4076006|P1|COMPLETED|7-Day Discontinuation Period||65
1667982|NCT00631657|4076004|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
1667983|NCT00631657|4076005|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
1667984|NCT00631657|4076006|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
1667985|NCT00631657|4076004|P3|STARTED|7-Day Discontinuation Period||66
1667986|NCT00631657|4076005|P2|STARTED|7-Day Discontinuation Period||137
1668078|NCT00631137|4076210|P1|NOT COMPLETED|Overall Study||1
1667987|NCT00631657|4076006|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
1667988|NCT00631657|4076004|P3|NOT COMPLETED|6-Month Treatment Period||50
1667989|NCT00631657|4076005|P2|NOT COMPLETED|6-Month Treatment Period||0
1667990|NCT00631657|4076006|P1|NOT COMPLETED|6-Month Treatment Period||141
1667991|NCT00631657|4076004|P3|COMPLETED|6-Month Treatment Period||66
1667992|NCT00631657|4076005|P2|COMPLETED|6-Month Treatment Period||0
1667993|NCT00631657|4076006|P1|COMPLETED|6-Month Treatment Period||203
1667994|NCT00631657|4076004|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
1667995|NCT00631657|4076005|P2|Treated|6-Month Treatment Period||0
1667996|NCT00631657|4076006|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
1667997|NCT00631657|4076004|P3|STARTED|6-Month Treatment Period||116
1667998|NCT00631657|4076005|P2|STARTED|6-Month Treatment Period||0
1667999|NCT00631657|4076006|P1|STARTED|6-Month Treatment Period||344
1668000|NCT00631566|4076036|P3|NOT COMPLETED|Overall Study||0
1668001|NCT00631566|4076037|P2|NOT COMPLETED|Overall Study||4
1668002|NCT00631566|4076038|P1|NOT COMPLETED|Overall Study||2
1668003|NCT00631566|4076036|P3|COMPLETED|Overall Study||501
1668004|NCT00631566|4076037|P2|COMPLETED|Overall Study||24
1668005|NCT00631566|4076038|P1|COMPLETED|Overall Study||19
1668006|NCT00631566|4076036|P3|STARTED|Overall Study||501
1668007|NCT00631566|4076037|P2|STARTED|Overall Study||28
1668008|NCT00631566|4076038|P1|STARTED|Overall Study||21
1668009|NCT00631540|4076055|P1|NOT COMPLETED|Overall Study||14
1668010|NCT00631540|4076055|P1|COMPLETED|Overall Study||86
1668011|NCT00631540|4076055|P1|STARTED|Overall Study||100
1668012|NCT00631488|4076067|P3|NOT COMPLETED|Overall Study||2
1668013|NCT00631488|4076068|P2|NOT COMPLETED|Overall Study||2
1668014|NCT00631488|4076069|P1|NOT COMPLETED|Overall Study||4
1668015|NCT00631488|4076067|P3|COMPLETED|Overall Study||47
1668016|NCT00631488|4076068|P2|COMPLETED|Overall Study||47
1668017|NCT00631488|4076069|P1|COMPLETED|Overall Study||44
1668018|NCT00631488|4076067|P3|Completed Post-Treatment Period|Overall Study||47
1668019|NCT00631488|4076068|P2|Completed Post-Treatment Period|Overall Study||47
1668020|NCT00631488|4076069|P1|Completed Post-Treatment Period|Overall Study||44
1668021|NCT00631488|4076067|P3|STARTED|Overall Study||49
1668022|NCT00631488|4076068|P2|STARTED|Overall Study||49
1668023|NCT00631488|4076069|P1|STARTED|Overall Study||48
1668024|NCT00631475|4076089|P1|NOT COMPLETED|Overall Study||45
1668025|NCT00631475|4076089|P1|COMPLETED|Overall Study||83
1668026|NCT00631475|4076089|P1|STARTED|Overall Study||128
1668027|NCT00631449|4076099|P2|NOT COMPLETED|Overall Study||0
1668028|NCT00631449|4076100|P1|NOT COMPLETED|Overall Study||0
1668029|NCT00631449|4076099|P2|COMPLETED|Overall Study||15
1668030|NCT00631449|4076100|P1|COMPLETED|Overall Study||15
1668031|NCT00631449|4076099|P2|STARTED|Overall Study||15
1668032|NCT00631449|4076100|P1|STARTED|Overall Study||15
1668033|NCT00631410|4076108|P2|NOT COMPLETED|Overall Study||6
1668034|NCT00631410|4076109|P1|NOT COMPLETED|Overall Study||6
1668035|NCT00631410|4076108|P2|COMPLETED|Overall Study||0
1668036|NCT00631410|4076109|P1|COMPLETED|Overall Study||0
1668037|NCT00631410|4076108|P2|STARTED|Overall Study||6
1668038|NCT00631410|4076109|P1|STARTED|Overall Study||6
1668039|NCT00631371|4076128|P2|NOT COMPLETED|Overall Study||391
1668040|NCT00631371|4076129|P1|NOT COMPLETED|Overall Study||400
1668041|NCT00631371|4076128|P2|COMPLETED|Overall Study||0
1668042|NCT00631371|4076129|P1|COMPLETED|Overall Study||0
1668043|NCT00631371|4076128|P2|Treated|Overall Study||391
1668044|NCT00631371|4076129|P1|Treated|Overall Study||393
1668045|NCT00631371|4076128|P2|STARTED|Overall Study||391
1668046|NCT00631371|4076129|P1|STARTED|Overall Study||400
1668047|NCT00631358|4076143|P2|NOT COMPLETED|Overall Study||2
1668048|NCT00631358|4076144|P1|NOT COMPLETED|Overall Study||6
1668049|NCT00631358|4076143|P2|COMPLETED|Overall Study||45
1668050|NCT00631358|4076144|P1|COMPLETED|Overall Study||44
1668051|NCT00631358|4076143|P2|STARTED|Overall Study||47
1668052|NCT00631358|4076144|P1|STARTED|Overall Study||50
1668053|NCT00631189|4076162|P4|NOT COMPLETED|Treatment Phase||7
1668054|NCT00631189|4076163|P3|NOT COMPLETED|Treatment Phase||11
1668055|NCT00631189|4076164|P2|NOT COMPLETED|Treatment Phase||7
1668056|NCT00631189|4076165|P1|NOT COMPLETED|Treatment Phase||0
1668057|NCT00631189|4076162|P4|COMPLETED|Treatment Phase||103
1668058|NCT00631189|4076163|P3|COMPLETED|Treatment Phase||92
1668059|NCT00631189|4076164|P2|COMPLETED|Treatment Phase||97
1668060|NCT00631189|4076165|P1|COMPLETED|Treatment Phase||0
1668061|NCT00631189|4076162|P4|STARTED|Treatment Phase||110
1668062|NCT00631189|4076163|P3|STARTED|Treatment Phase||103
1668063|NCT00631189|4076164|P2|STARTED|Treatment Phase||104
1668064|NCT00631189|4076165|P1|STARTED|Treatment Phase||0
1668065|NCT00631189|4076162|P4|NOT COMPLETED|Initial Phase||0
1668066|NCT00631189|4076163|P3|NOT COMPLETED|Initial Phase||0
1668067|NCT00631189|4076164|P2|NOT COMPLETED|Initial Phase||0
1668068|NCT00631189|4076165|P1|NOT COMPLETED|Initial Phase||351
1668069|NCT00631189|4076162|P4|COMPLETED|Initial Phase||0
1668070|NCT00631189|4076163|P3|COMPLETED|Initial Phase||0
1668071|NCT00631189|4076164|P2|COMPLETED|Initial Phase||0
1668072|NCT00631189|4076165|P1|COMPLETED|Initial Phase||317
1668073|NCT00631189|4076162|P4|STARTED|Initial Phase||0
1668074|NCT00631189|4076163|P3|STARTED|Initial Phase||0
1668075|NCT00631189|4076164|P2|STARTED|Initial Phase||0
1668076|NCT00631189|4076165|P1|STARTED|Initial Phase||668
1668077|NCT00631137|4076209|P2|NOT COMPLETED|Overall Study||0
1668079|NCT00631137|4076209|P2|COMPLETED|Overall Study||0
1668080|NCT00631137|4076210|P1|COMPLETED|Overall Study||0
1668081|NCT00631137|4076209|P2|STARTED|Overall Study||0
1668082|NCT00631137|4076210|P1|STARTED|Overall Study||1
1668083|NCT00631020|4076228|P1|NOT COMPLETED|Overall Study||8
1668084|NCT00631020|4076228|P1|COMPLETED|Overall Study||26
1668085|NCT00631020|4076228|P1|STARTED|Overall Study||34
1668086|NCT00631007|4076243|P6|NOT COMPLETED|Overall Study||15
1668087|NCT00631007|4076244|P5|NOT COMPLETED|Overall Study||12
1668088|NCT00631007|4076245|P4|NOT COMPLETED|Overall Study||9
1668089|NCT00631007|4076246|P3|NOT COMPLETED|Overall Study||10
1668090|NCT00631007|4076247|P2|NOT COMPLETED|Overall Study||11
1668091|NCT00631007|4076248|P1|NOT COMPLETED|Overall Study||11
1668092|NCT00631007|4076243|P6|COMPLETED|Overall Study||46
1668093|NCT00631007|4076244|P5|COMPLETED|Overall Study||48
1668094|NCT00631007|4076245|P4|COMPLETED|Overall Study||53
1668095|NCT00631007|4076246|P3|COMPLETED|Overall Study||53
1668096|NCT00631007|4076247|P2|COMPLETED|Overall Study||50
1668097|NCT00631007|4076248|P1|COMPLETED|Overall Study||49
1668098|NCT00631007|4076243|P6|STARTED|Overall Study||61
1668099|NCT00631007|4076244|P5|STARTED|Overall Study||60
1668100|NCT00631007|4076245|P4|STARTED|Overall Study||62
1668101|NCT00631007|4076246|P3|STARTED|Overall Study||63
1668102|NCT00631007|4076247|P2|STARTED|Overall Study||61
1668103|NCT00631007|4076248|P1|STARTED|Overall Study||60
1668104|NCT00630994|4076268|P1|NOT COMPLETED|Overall Study||4
1668105|NCT00630994|4076268|P1|COMPLETED|Overall Study||0
1668106|NCT00630994|4076268|P1|STARTED|Overall Study||4
1668107|NCT00630955|4076279|P3|NOT COMPLETED|Overall Study||12
1668108|NCT00630955|4076280|P2|NOT COMPLETED|Overall Study||6
1668109|NCT00630955|4076281|P1|NOT COMPLETED|Overall Study||3
1668110|NCT00630955|4076279|P3|COMPLETED|Overall Study||28
1668111|NCT00630955|4076280|P2|COMPLETED|Overall Study||31
1668112|NCT00630955|4076281|P1|COMPLETED|Overall Study||31
1668113|NCT00630955|4076279|P3|STARTED|Overall Study||40
1668114|NCT00630955|4076280|P2|STARTED|Overall Study||37
1668115|NCT00630955|4076281|P1|STARTED|Overall Study||34
1668116|NCT00630916|4076298|P1|NOT COMPLETED|Overall Study||210
1668117|NCT00630916|4076298|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
1668118|NCT00630916|4076298|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
1668119|NCT00630916|4076298|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
1668120|NCT00630877|4076308|P3|NOT COMPLETED|Overall Study||10
1668121|NCT00630877|4076309|P2|NOT COMPLETED|Overall Study||15
1668122|NCT00630877|4076310|P1|NOT COMPLETED|Overall Study||19
1668123|NCT00630877|4076308|P3|COMPLETED|Overall Study||80
1668124|NCT00630877|4076309|P2|COMPLETED|Overall Study||75
1668125|NCT00630877|4076310|P1|COMPLETED|Overall Study||72
1668126|NCT00630877|4076308|P3|STARTED|Overall Study||90
1668127|NCT00630877|4076309|P2|STARTED|Overall Study||90
1668128|NCT00630877|4076310|P1|STARTED|Overall Study|For all arms, started means treated.|91
1668129|NCT00630864|4076328|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
1668130|NCT00630864|4076328|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
1668131|NCT00630864|4076328|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
1668132|NCT00630864|4076328|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
1668133|NCT00630864|4076328|P1|COMPLETED|Part 1 (up to Week 6)||20
1668134|NCT00630864|4076328|P1|STARTED|Part 1 (up to Week 6)||21
1668135|NCT00630838|4076367|P2|NOT COMPLETED|Overall Study||2
1668136|NCT00630838|4076368|P1|NOT COMPLETED|Overall Study||0
1668137|NCT00630838|4076367|P2|COMPLETED|Overall Study||28
1668138|NCT00630838|4076368|P1|COMPLETED|Overall Study||32
1668139|NCT00630838|4076367|P2|STARTED|Overall Study||30
1668140|NCT00630838|4076368|P1|STARTED|Overall Study||32
1668141|NCT00630825|4076380|P4|NOT COMPLETED|Overall Study||6
1668142|NCT00630825|4076381|P3|NOT COMPLETED|Overall Study||8
1668143|NCT00630825|4076382|P2|NOT COMPLETED|Overall Study||7
1668144|NCT00630825|4076383|P1|NOT COMPLETED|Overall Study||9
1668145|NCT00630825|4076380|P4|COMPLETED|Overall Study||60
1668146|NCT00630825|4076381|P3|COMPLETED|Overall Study||58
1668147|NCT00630825|4076382|P2|COMPLETED|Overall Study||58
1668148|NCT00630825|4076383|P1|COMPLETED|Overall Study||56
1668149|NCT00630825|4076380|P4|Received at Least One Dose of Study Drug|Overall Study||66
1668150|NCT00630825|4076381|P3|Received at Least One Dose of Study Drug|Overall Study||66
1668151|NCT00630825|4076382|P2|Received at Least One Dose of Study Drug|Overall Study||65
1668152|NCT00630825|4076383|P1|Received at Least One Dose of Study Drug|Overall Study||65
1668153|NCT00630825|4076380|P4|STARTED|Overall Study||66
1668154|NCT00630825|4076381|P3|STARTED|Overall Study||66
1668155|NCT00630825|4076382|P2|STARTED|Overall Study||65
1668156|NCT00630825|4076383|P1|STARTED|Overall Study||65
1668157|NCT00630786|4076455|P3|NOT COMPLETED|Overall Study||2
1668158|NCT00630786|4076456|P2|NOT COMPLETED|Overall Study||2
1668159|NCT00630786|4076457|P1|NOT COMPLETED|Overall Study||1
1668160|NCT00630786|4076455|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
1668161|NCT00630786|4076456|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
1668162|NCT00630786|4076457|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
1668163|NCT00630786|4076455|P3|Received Study Medication|Overall Study||8
1668164|NCT00630786|4076456|P2|Received Study Medication|Overall Study||25
1668165|NCT00630786|4076457|P1|Received Study Medication|Overall Study||19
1668166|NCT00630786|4076455|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
1668167|NCT00630786|4076456|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
1668168|NCT00630786|4076457|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
1668169|NCT00630747|4076476|P1|NOT COMPLETED|Overall Study||9
1668170|NCT00630747|4076476|P1|COMPLETED|Overall Study||85
1668171|NCT00630747|4076476|P1|Participants Treated in Phase I of Study|Overall Study||94
1668172|NCT00630747|4076476|P1|STARTED|Overall Study||94
1668173|NCT00630734|4076488|P3|NOT COMPLETED|Overall Study||1
1668174|NCT00630734|4076489|P2|NOT COMPLETED|Overall Study||1
1668175|NCT00630734|4076490|P1|NOT COMPLETED|Overall Study||2
1668176|NCT00630734|4076488|P3|COMPLETED|Overall Study||7
1668177|NCT00630734|4076489|P2|COMPLETED|Overall Study||12
1668178|NCT00630734|4076490|P1|COMPLETED|Overall Study||9
1668179|NCT00630734|4076488|P3|STARTED|Overall Study||8
1668180|NCT00630734|4076489|P2|STARTED|Overall Study||13
1668181|NCT00630734|4076490|P1|STARTED|Overall Study||11
1668182|NCT00630539|4076529|P4|NOT COMPLETED|Overall Study||3
1668183|NCT00630539|4076530|P3|NOT COMPLETED|Overall Study||1
1668184|NCT00630539|4076531|P2|NOT COMPLETED|Overall Study||4
1668185|NCT00630539|4076532|P1|NOT COMPLETED|Overall Study||1
1668186|NCT00630539|4076529|P4|COMPLETED|Overall Study||27
1668187|NCT00630539|4076530|P3|COMPLETED|Overall Study||28
1668188|NCT00630539|4076531|P2|COMPLETED|Overall Study||29
1668189|NCT00630539|4076532|P1|COMPLETED|Overall Study||33
1668190|NCT00630539|4076529|P4|STARTED|Overall Study||30
1668191|NCT00630539|4076530|P3|STARTED|Overall Study||29
1668192|NCT00630539|4076531|P2|STARTED|Overall Study||33
1668193|NCT00630539|4076532|P1|STARTED|Overall Study||34
1668194|NCT00630487|4076588|P2|NOT COMPLETED|Overall Study||0
1668195|NCT00630487|4076589|P1|NOT COMPLETED|Overall Study||0
1668196|NCT00630487|4076588|P2|COMPLETED|Overall Study||0
1668197|NCT00630487|4076589|P1|COMPLETED|Overall Study||0
1668198|NCT00630487|4076588|P2|STARTED|Overall Study||0
1668199|NCT00630487|4076589|P1|STARTED|Overall Study||0
1668200|NCT00630409|4076623|P1|NOT COMPLETED|Overall Study||1
1668201|NCT00630409|4076623|P1|COMPLETED|Overall Study||4
1668202|NCT00630409|4076623|P1|STARTED|Overall Study||5
1668203|NCT00630396|4076628|P1|NOT COMPLETED|Overall Study||7
1668204|NCT00630396|4076628|P1|COMPLETED|Overall Study||53
1668205|NCT00630396|4076628|P1|STARTED|Overall Study||60
1668206|NCT00630344|4076634|P1|NOT COMPLETED|Overall Study||36
1668207|NCT00630344|4076634|P1|COMPLETED|Overall Study||0
1668208|NCT00630344|4076634|P1|STARTED|Overall Study||36
1668209|NCT00630331|4076646|P3|NOT COMPLETED|Overall Study||188
1668210|NCT00630331|4076647|P2|NOT COMPLETED|Overall Study||166
1668211|NCT00630331|4076648|P1|NOT COMPLETED|Overall Study||206
1668212|NCT00630331|4076646|P3|COMPLETED|Overall Study||3712
1668213|NCT00630331|4076647|P2|COMPLETED|Overall Study||3510
1668214|NCT00630331|4076648|P1|COMPLETED|Overall Study||3622
1668215|NCT00630331|4076646|P3|STARTED|Overall Study||3900
1668216|NCT00630331|4076647|P2|STARTED|Overall Study||3676
1668217|NCT00630331|4076648|P1|STARTED|Overall Study||3828
1668218|NCT00630305|4076689|P1|NOT COMPLETED|Overall Study||2
1668219|NCT00630305|4076689|P1|COMPLETED|Overall Study||35
1668220|NCT00630305|4076689|P1|STARTED|Overall Study||37
1668221|NCT00630292|4076711|P1|NOT COMPLETED|Overall Study||1
1668222|NCT00630292|4076711|P1|COMPLETED|Overall Study||5
1668223|NCT00630292|4076711|P1|STARTED|Overall Study||6
1668224|NCT00630058|4076717|P2|NOT COMPLETED|Overall Study||4
1668225|NCT00630058|4076718|P1|NOT COMPLETED|Overall Study||4
1668226|NCT00630058|4076717|P2|COMPLETED|Overall Study||6
1668227|NCT00630058|4076718|P1|COMPLETED|Overall Study||6
1668228|NCT00630058|4076717|P2|STARTED|Overall Study||10
1668229|NCT00630058|4076718|P1|STARTED|Overall Study||10
1668230|NCT00629850|4076736|P2|NOT COMPLETED|Overall Study||0
1668231|NCT00629850|4076737|P1|NOT COMPLETED|Overall Study||0
1668232|NCT00629850|4076736|P2|COMPLETED|Overall Study||0
1668233|NCT00629850|4076737|P1|COMPLETED|Overall Study||1
1668234|NCT00629850|4076736|P2|STARTED|Overall Study||0
1668235|NCT00629850|4076737|P1|STARTED|Overall Study||1
1668236|NCT00629772|4076749|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
1668237|NCT00629772|4076750|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
1668238|NCT00629772|4076749|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
1668239|NCT00629772|4076750|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
1668240|NCT00629772|4076749|P2|STARTED|Second Intervention Week 14 - Week 26||12
1668241|NCT00629772|4076750|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
1668242|NCT00629772|4076749|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
1668243|NCT00629772|4076750|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
1668244|NCT00629772|4076749|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
1668245|NCT00629772|4076750|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
1668246|NCT00629772|4076749|P2|STARTED|First Intervention - Day 0 - Week 14||12
1668247|NCT00629772|4076750|P1|STARTED|First Intervention - Day 0 - Week 14||12
1668248|NCT00629707|4076770|P2|NOT COMPLETED|Overall Study||2
1668249|NCT00629707|4076771|P1|NOT COMPLETED|Overall Study||0
1668250|NCT00629707|4076770|P2|COMPLETED|Overall Study||8
1668251|NCT00629707|4076771|P1|COMPLETED|Overall Study||10
1668252|NCT00629707|4076770|P2|STARTED|Overall Study||10
1668253|NCT00629707|4076771|P1|STARTED|Overall Study||10
1668254|NCT00629525|4076777|P1|NOT COMPLETED|Overall Study||3
1668255|NCT00629525|4076777|P1|COMPLETED|Overall Study||32
1668256|NCT00629525|4076777|P1|STARTED|Overall Study||35
1668257|NCT00629499|4076785|P1|NOT COMPLETED|Overall Study||0
1668258|NCT00629499|4076785|P1|COMPLETED|Overall Study||63
1668259|NCT00629499|4076785|P1|STARTED|Overall Study||63
1668260|NCT00629265|4076791|P2|NOT COMPLETED|Overall Study||20
1668261|NCT00629265|4076792|P1|NOT COMPLETED|Overall Study||32
1668262|NCT00629265|4076791|P2|COMPLETED|Overall Study||34
1668263|NCT00629265|4076792|P1|COMPLETED|Overall Study||84
1668264|NCT00629265|4076791|P2|STARTED|Overall Study||54
1668265|NCT00629265|4076792|P1|STARTED|Overall Study||116
1668266|NCT00629239|4076802|P2|NOT COMPLETED|Overall Study||4
1668267|NCT00629239|4076803|P1|NOT COMPLETED|Overall Study||8
1668268|NCT00629239|4076802|P2|COMPLETED|Overall Study||28
1668269|NCT00629239|4076803|P1|COMPLETED|Overall Study||26
1668270|NCT00629239|4076802|P2|STARTED|Overall Study||32
1668271|NCT00629239|4076803|P1|STARTED|Overall Study||34
1668272|NCT00629122|4076837|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
1668273|NCT00629122|4076838|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
1668274|NCT00629122|4076837|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
1668275|NCT00629122|4076838|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
1668276|NCT00629122|4076837|P2|STARTED|Third Period: Day 6-8 (Oral)||3
1668277|NCT00629122|4076838|P1|STARTED|Third Period: Day 6-8 (Oral)||2
1668278|NCT00629122|4076837|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
1668279|NCT00629122|4076838|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
1668280|NCT00629122|4076837|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
1668281|NCT00629122|4076838|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
1668282|NCT00629122|4076837|P2|STARTED|Second Period: Day 3-5 (Washout)||3
1668283|NCT00629122|4076838|P1|STARTED|Second Period: Day 3-5 (Washout)||2
1668284|NCT00629122|4076837|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
1668285|NCT00629122|4076838|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
1668286|NCT00629122|4076837|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
1668287|NCT00629122|4076838|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
1668288|NCT00629122|4076837|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
1668289|NCT00629122|4076838|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
1668290|NCT00629018|4076856|P2|NOT COMPLETED|Overall Study||0
1668291|NCT00629018|4076857|P1|NOT COMPLETED|Overall Study||0
1668292|NCT00629018|4076856|P2|COMPLETED|Overall Study||55
1668293|NCT00629018|4076857|P1|COMPLETED|Overall Study||55
1668294|NCT00629018|4076856|P2|STARTED|Overall Study||55
1668295|NCT00629018|4076857|P1|STARTED|Overall Study||55
1668296|NCT00628927|4076867|P2|NOT COMPLETED|Overall Study||0
1668297|NCT00628927|4076868|P1|NOT COMPLETED|Overall Study||8
1668298|NCT00628927|4076867|P2|COMPLETED|Overall Study||30
1668299|NCT00628927|4076868|P1|COMPLETED|Overall Study||175
1668300|NCT00628927|4076867|P2|STARTED|Overall Study||30
1668301|NCT00628927|4076868|P1|STARTED|Overall Study||183
1668302|NCT00628901|4076881|P2|NOT COMPLETED|Overall Study||1
1668303|NCT00628901|4076882|P1|NOT COMPLETED|Overall Study||3
1668304|NCT00628901|4076881|P2|COMPLETED|Overall Study||29
1668305|NCT00628901|4076882|P1|COMPLETED|Overall Study||27
1668306|NCT00628901|4076881|P2|STARTED|Overall Study||30
1668307|NCT00628901|4076882|P1|STARTED|Overall Study||30
1668308|NCT00628862|4076913|P3|NOT COMPLETED|Overall Study||22
1668309|NCT00628862|4076914|P2|NOT COMPLETED|Overall Study||17
1668310|NCT00628862|4076915|P1|NOT COMPLETED|Overall Study||11
1668311|NCT00628862|4076913|P3|COMPLETED|Overall Study|randomised patients|186
1668312|NCT00628862|4076914|P2|COMPLETED|Overall Study|randomised patients|182
1668313|NCT00628862|4076915|P1|COMPLETED|Overall Study|randomised patients|195
1668314|NCT00628862|4076913|P3|STARTED|Overall Study|randomised patients|208
1668315|NCT00628862|4076914|P2|STARTED|Overall Study|randomised patients|199
1668316|NCT00628862|4076915|P1|STARTED|Overall Study|randomised patients|206
1668317|NCT00628758|4076961|P2|NOT COMPLETED|Overall Study||42
1668318|NCT00628758|4076962|P1|NOT COMPLETED|Overall Study||44
1668319|NCT00628758|4076961|P2|COMPLETED|Overall Study||179
1668320|NCT00628758|4076962|P1|COMPLETED|Overall Study||165
1668321|NCT00628758|4076961|P2|STARTED|Overall Study||221
1668322|NCT00628758|4076962|P1|STARTED|Overall Study||209
1668323|NCT00628628|4076976|P2|NOT COMPLETED|Overall Study||0
1668324|NCT00628628|4076977|P1|NOT COMPLETED|Overall Study||0
1668325|NCT00628628|4076976|P2|COMPLETED|Overall Study||40
1668326|NCT00628628|4076977|P1|COMPLETED|Overall Study||40
1668327|NCT00628628|4076976|P2|STARTED|Overall Study||40
1668328|NCT00628628|4076977|P1|STARTED|Overall Study||40
1668329|NCT00628589|4076986|P3|NOT COMPLETED|Overall Study||3
1668330|NCT00628589|4076987|P2|NOT COMPLETED|Overall Study||2
1668331|NCT00628589|4076988|P1|NOT COMPLETED|Overall Study||1
1668332|NCT00628589|4076986|P3|COMPLETED|Overall Study||110
1668333|NCT00628589|4076987|P2|COMPLETED|Overall Study||114
1668334|NCT00628589|4076988|P1|COMPLETED|Overall Study||114
1668335|NCT00628589|4076986|P3|STARTED|Overall Study||113
1668336|NCT00628589|4076987|P2|STARTED|Overall Study||116
1668337|NCT00628589|4076988|P1|STARTED|Overall Study||115
1668338|NCT00628498|4077002|P1|NOT COMPLETED|Overall Study||52
1668339|NCT00628498|4077002|P1|COMPLETED|Overall Study||1154
1668340|NCT00628498|4077002|P1|STARTED|Overall Study||1206
1668341|NCT00628446|4077006|P1|NOT COMPLETED|Overall Study||7
1668342|NCT00628446|4077006|P1|COMPLETED|Overall Study||38
1668343|NCT00628446|4077006|P1|STARTED|Overall Study||45
1668344|NCT00628407|4077011|P1|NOT COMPLETED|Overall Study||0
1668345|NCT00628407|4077011|P1|COMPLETED|Overall Study||13
1668346|NCT00628407|4077011|P1|STARTED|Overall Study||13
1668347|NCT00628355|4077017|P2|NOT COMPLETED|Overall Study||1
1668348|NCT00628355|4077018|P1|NOT COMPLETED|Overall Study||1
1668349|NCT00628355|4077017|P2|COMPLETED|Overall Study||14
1668350|NCT00628355|4077018|P1|COMPLETED|Overall Study||14
1668351|NCT00628355|4077017|P2|STARTED|Overall Study||15
1668352|NCT00628355|4077018|P1|STARTED|Overall Study||15
1668353|NCT00628251|4077029|P3|NOT COMPLETED|Cross-over/ Continuation of Olaparib||17
1668354|NCT00628251|4077030|P2|NOT COMPLETED|Cross-over/ Continuation of Olaparib||26
1668355|NCT00628251|4077031|P1|NOT COMPLETED|Cross-over/ Continuation of Olaparib||27
1668356|NCT00628251|4077029|P3|COMPLETED|Cross-over/ Continuation of Olaparib|Patients ongoing crossover treatment|8
1668357|NCT00628251|4077030|P2|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|6
1668358|NCT00628251|4077031|P1|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|5
1668359|NCT00628251|4077029|P3|STARTED|Cross-over/ Continuation of Olaparib|Patients who crossed over from Liposomal doxorubicin to Olaparib 400 mg bd|25
1668360|NCT00628251|4077030|P2|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
1668361|NCT00628251|4077031|P1|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
1668362|NCT00628251|4077029|P3|NOT COMPLETED|Randomised Part||8
1668363|NCT00628251|4077030|P2|NOT COMPLETED|Randomised Part||0
1668364|NCT00628251|4077031|P1|NOT COMPLETED|Randomised Part||0
1668365|NCT00628251|4077029|P3|COMPLETED|Randomised Part|Patients who received olaparib (crossed over). 1 of 33 did not receive Liposomal Doxorubicin.|25
1668366|NCT00628251|4077030|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
1668367|NCT00628251|4077031|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
1668368|NCT00628251|4077029|P3|STARTED|Randomised Part|Patients randomised|33
1668369|NCT00628251|4077030|P2|STARTED|Randomised Part|Patients randomised|32
1668370|NCT00628251|4077031|P1|STARTED|Randomised Part|Patients randomised|32
1668371|NCT00628212|4077074|P4|NOT COMPLETED|Overall Study||5
1668372|NCT00628212|4077075|P3|NOT COMPLETED|Overall Study||3
1668373|NCT00628212|4077076|P2|NOT COMPLETED|Overall Study||1
1668374|NCT00628212|4077077|P1|NOT COMPLETED|Overall Study||3
1668375|NCT00628212|4077074|P4|COMPLETED|Overall Study||76
1668376|NCT00628212|4077075|P3|COMPLETED|Overall Study||76
1668377|NCT00628212|4077076|P2|COMPLETED|Overall Study||83
1668378|NCT00628212|4077077|P1|COMPLETED|Overall Study||77
1668379|NCT00628212|4077074|P4|STARTED|Overall Study||81
1668380|NCT00628212|4077075|P3|STARTED|Overall Study||79
1668381|NCT00628212|4077076|P2|STARTED|Overall Study||84
1668382|NCT00628212|4077077|P1|STARTED|Overall Study||80
1668383|NCT00628147|4077101|P2|NOT COMPLETED|Overall Study||1
1668384|NCT00628147|4077102|P1|NOT COMPLETED|Overall Study||7
1668385|NCT00628147|4077101|P2|COMPLETED|Overall Study||141
1668386|NCT00628147|4077102|P1|COMPLETED|Overall Study||135
1668387|NCT00628147|4077101|P2|STARTED|Overall Study||142
1668388|NCT00628147|4077102|P1|STARTED|Overall Study||142
1668389|NCT00628134|4077114|P2|NOT COMPLETED|Overall Study||0
1668390|NCT00628134|4077115|P1|NOT COMPLETED|Overall Study||0
1668391|NCT00628134|4077114|P2|COMPLETED|Overall Study||4
1668392|NCT00628134|4077115|P1|COMPLETED|Overall Study||4
1668393|NCT00628134|4077114|P2|STARTED|Overall Study||4
1668394|NCT00628134|4077115|P1|STARTED|Overall Study||4
1668395|NCT00628108|4077125|P2|NOT COMPLETED|Overall Study||3
1668396|NCT00628108|4077126|P1|NOT COMPLETED|Overall Study||1
1668397|NCT00628108|4077125|P2|COMPLETED|Overall Study||43
1668398|NCT00628108|4077126|P1|COMPLETED|Overall Study||22
1668399|NCT00628108|4077125|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
1668400|NCT00628108|4077126|P1|Safety Population|Overall Study||24
1668401|NCT00628108|4077125|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
1668402|NCT00628108|4077126|P1|STARTED|Overall Study||23
1668403|NCT00628030|4077158|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
1668404|NCT00628030|4077159|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
1668405|NCT00628030|4077158|P2|COMPLETED|Post to 6 Month Follow-up||33
1668406|NCT00628030|4077159|P1|COMPLETED|Post to 6 Month Follow-up||27
1668407|NCT00628030|4077158|P2|STARTED|Post to 6 Month Follow-up||63
1668408|NCT00628030|4077159|P1|STARTED|Post to 6 Month Follow-up||59
1668409|NCT00628030|4077158|P2|NOT COMPLETED|Baseline to Post-Assessment||29
1668410|NCT00628030|4077159|P1|NOT COMPLETED|Baseline to Post-Assessment||33
1668411|NCT00628030|4077158|P2|COMPLETED|Baseline to Post-Assessment||63
1668412|NCT00628030|4077159|P1|COMPLETED|Baseline to Post-Assessment||59
1668413|NCT00628030|4077158|P2|STARTED|Baseline to Post-Assessment||92
1668414|NCT00628030|4077159|P1|STARTED|Baseline to Post-Assessment||92
1668415|NCT00627978|4077175|P2|NOT COMPLETED|Overall Study||0
1668416|NCT00627978|4077176|P1|NOT COMPLETED|Overall Study||0
1668417|NCT00627978|4077175|P2|COMPLETED|Overall Study||5
1668418|NCT00627978|4077176|P1|COMPLETED|Overall Study||10
1668419|NCT00627978|4077175|P2|STARTED|Overall Study||5
1668420|NCT00627978|4077176|P1|STARTED|Overall Study||10
1668421|NCT00627926|4077185|P3|NOT COMPLETED|Overall Study||95
1668422|NCT00627926|4077186|P2|NOT COMPLETED|Overall Study||104
1668423|NCT00627926|4077187|P1|NOT COMPLETED|Overall Study||159
1668424|NCT00627926|4077185|P3|COMPLETED|Overall Study||268
1668425|NCT00627926|4077186|P2|COMPLETED|Overall Study||260
1668426|NCT00627926|4077187|P1|COMPLETED|Overall Study||202
1668427|NCT00627926|4077185|P3|STARTED|Overall Study||363
1668428|NCT00627926|4077186|P2|STARTED|Overall Study||364
1668429|NCT00627926|4077187|P1|STARTED|Overall Study||361
1668430|NCT00627861|4077231|P1|NOT COMPLETED|Overall Study||0
1668431|NCT00627861|4077231|P1|COMPLETED|Overall Study||1
1668432|NCT00627861|4077231|P1|STARTED|Overall Study||1
1668433|NCT00627705|4077239|P2|NOT COMPLETED|Overall Study||6
1668434|NCT00627705|4077240|P1|NOT COMPLETED|Overall Study||2
1668435|NCT00627705|4077239|P2|COMPLETED|Overall Study||12
1668436|NCT00627705|4077240|P1|COMPLETED|Overall Study||13
1668437|NCT00627705|4077239|P2|STARTED|Overall Study||18
1668438|NCT00627705|4077240|P1|STARTED|Overall Study||15
1668439|NCT00627679|4077260|P4|NOT COMPLETED|Overall Study||0
1668440|NCT00627679|4077261|P3|NOT COMPLETED|Overall Study||0
1668441|NCT00627679|4077262|P2|NOT COMPLETED|Overall Study||0
1668442|NCT00627679|4077263|P1|NOT COMPLETED|Overall Study||0
1668443|NCT00627679|4077260|P4|COMPLETED|Overall Study||4
1668444|NCT00627679|4077261|P3|COMPLETED|Overall Study||4
1668445|NCT00627679|4077262|P2|COMPLETED|Overall Study||4
1668446|NCT00627679|4077263|P1|COMPLETED|Overall Study||4
1668447|NCT00627679|4077260|P4|STARTED|Overall Study||4
1668448|NCT00627679|4077261|P3|STARTED|Overall Study||4
1668449|NCT00627679|4077262|P2|STARTED|Overall Study||4
1668450|NCT00627679|4077263|P1|STARTED|Overall Study||4
1668451|NCT00627523|4077291|P2|NOT COMPLETED|Overall Study||2
1668452|NCT00627523|4077292|P1|NOT COMPLETED|Overall Study||2
1668453|NCT00627523|4077291|P2|COMPLETED|Overall Study||20
1668454|NCT00627523|4077292|P1|COMPLETED|Overall Study||19
1668455|NCT00627523|4077291|P2|STARTED|Overall Study||22
1668456|NCT00627523|4077292|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
1668457|NCT00627497|4077320|P4|NOT COMPLETED|Overall Study||0
1668458|NCT00627497|4077321|P3|NOT COMPLETED|Overall Study||0
1668459|NCT00627497|4077322|P2|NOT COMPLETED|Overall Study||1
1668460|NCT00627497|4077323|P1|NOT COMPLETED|Overall Study||1
1668461|NCT00627497|4077320|P4|COMPLETED|Overall Study||2
1668462|NCT00627497|4077321|P3|COMPLETED|Overall Study||4
1668463|NCT00627497|4077322|P2|COMPLETED|Overall Study||11
1668464|NCT00627497|4077323|P1|COMPLETED|Overall Study||13
1668465|NCT00627497|4077320|P4|STARTED|Overall Study||2
1668466|NCT00627497|4077321|P3|STARTED|Overall Study||4
1668467|NCT00627497|4077322|P2|STARTED|Overall Study||12
1668468|NCT00627497|4077323|P1|STARTED|Overall Study||14
1668469|NCT00627458|4077384|P3|NOT COMPLETED|Overall Study||6
1668470|NCT00627458|4077385|P2|NOT COMPLETED|Overall Study||7
1668471|NCT00627458|4077386|P1|NOT COMPLETED|Overall Study||4
1668472|NCT00627458|4077384|P3|COMPLETED|Overall Study||133
1668473|NCT00627458|4077385|P2|COMPLETED|Overall Study||130
1668474|NCT00627458|4077386|P1|COMPLETED|Overall Study||123
1668475|NCT00627458|4077384|P3|STARTED|Overall Study||139
1668476|NCT00627458|4077385|P2|STARTED|Overall Study||137
1668477|NCT00627458|4077386|P1|STARTED|Overall Study||127
1668478|NCT00627445|4077461|P2|NOT COMPLETED|Overall Study||12
1668479|NCT00627445|4077462|P1|NOT COMPLETED|Overall Study||9
1668480|NCT00627445|4077461|P2|COMPLETED|Overall Study||210
1668481|NCT00627445|4077462|P1|COMPLETED|Overall Study||210
1668482|NCT00627445|4077461|P2|Exposed to Study Drug|Overall Study||222
1668483|NCT00627445|4077462|P1|Exposed to Study Drug|Overall Study||219
1668484|NCT00627445|4077461|P2|STARTED|Overall Study||222
1668485|NCT00627445|4077462|P1|STARTED|Overall Study||219
1668486|NCT00627406|4077486|P4|NOT COMPLETED|Overall Study||0
1668487|NCT00627406|4077487|P3|NOT COMPLETED|Overall Study||0
1668488|NCT00627406|4077488|P2|NOT COMPLETED|Overall Study||0
1668489|NCT00627406|4077489|P1|NOT COMPLETED|Overall Study||0
1668490|NCT00627406|4077486|P4|COMPLETED|Overall Study||141
1668491|NCT00627406|4077487|P3|COMPLETED|Overall Study||125
1668492|NCT00627406|4077488|P2|COMPLETED|Overall Study||58
1668493|NCT00627406|4077489|P1|COMPLETED|Overall Study||60
1668494|NCT00627406|4077486|P4|STARTED|Overall Study||141
1668495|NCT00627406|4077487|P3|STARTED|Overall Study||125
1668496|NCT00627406|4077488|P2|STARTED|Overall Study||58
1668497|NCT00627406|4077489|P1|STARTED|Overall Study||60
1668498|NCT00627393|4077505|P2|NOT COMPLETED|Per-Protocol Analysis||13
1668499|NCT00627393|4077506|P1|NOT COMPLETED|Per-Protocol Analysis||10
1668500|NCT00627393|4077505|P2|COMPLETED|Per-Protocol Analysis||35
1668501|NCT00627393|4077506|P1|COMPLETED|Per-Protocol Analysis||39
1668502|NCT00627393|4077505|P2|STARTED|Per-Protocol Analysis||48
1668503|NCT00627393|4077506|P1|STARTED|Per-Protocol Analysis||49
1668504|NCT00627393|4077505|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
1668505|NCT00627393|4077506|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
1668506|NCT00627393|4077505|P2|COMPLETED|Intention-To-Treat Analysis||48
1668507|NCT00627393|4077506|P1|COMPLETED|Intention-To-Treat Analysis||49
1668508|NCT00627393|4077505|P2|STARTED|Intention-To-Treat Analysis||56
1668509|NCT00627393|4077506|P1|STARTED|Intention-To-Treat Analysis||58
1668510|NCT00627367|4077527|P2|NOT COMPLETED|Overall Study||0
1668511|NCT00627367|4077528|P1|NOT COMPLETED|Overall Study||0
1668512|NCT00627367|4077527|P2|COMPLETED|Overall Study||112
1668513|NCT00627367|4077528|P1|COMPLETED|Overall Study||112
1668514|NCT00627367|4077527|P2|STARTED|Overall Study||112
1668515|NCT00627367|4077528|P1|STARTED|Overall Study||112
1668516|NCT00627094|4077542|P2|NOT COMPLETED|Overall Study||15
1668517|NCT00627094|4077543|P1|NOT COMPLETED|Overall Study||12
1668518|NCT00627094|4077542|P2|COMPLETED|Overall Study||45
1668519|NCT00627094|4077543|P1|COMPLETED|Overall Study||48
1668520|NCT00627094|4077542|P2|STARTED|Overall Study||60
1668521|NCT00627094|4077543|P1|STARTED|Overall Study||60
1668522|NCT00627042|4077555|P1|NOT COMPLETED|Overall Study||2
1668523|NCT00627042|4077555|P1|COMPLETED|Overall Study||40
1668524|NCT00627042|4077555|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
1668525|NCT00627042|4077555|P1|STARTED|Overall Study||42
1668526|NCT00627016|4077567|P2|NOT COMPLETED|Overall Study||6
1668527|NCT00627016|4077568|P1|NOT COMPLETED|Overall Study||6
1668528|NCT00627016|4077567|P2|COMPLETED|Overall Study||146
1668529|NCT00627016|4077568|P1|COMPLETED|Overall Study||147
1668530|NCT00627016|4077567|P2|STARTED|Overall Study||152
1668531|NCT00627016|4077568|P1|STARTED|Overall Study||153
1668532|NCT00626925|4077580|P2|NOT COMPLETED|Overall Study||9
1668533|NCT00626925|4077581|P1|NOT COMPLETED|Overall Study||12
1668534|NCT00626925|4077580|P2|COMPLETED|Overall Study||62
1668535|NCT00626925|4077581|P1|COMPLETED|Overall Study||55
1668536|NCT00626925|4077580|P2|STARTED|Overall Study||71
1668537|NCT00626925|4077581|P1|STARTED|Overall Study||67
1668538|NCT00626821|4077613|P1|NOT COMPLETED|Overall Study||221
1668539|NCT00626821|4077613|P1|COMPLETED|Overall Study||2796
1668540|NCT00626821|4077613|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
1668541|NCT00626821|4077613|P1|STARTED|Overall Study||3017
1668542|NCT00626808|4077621|P4|NOT COMPLETED|Overall Study||0
1668543|NCT00626808|4077622|P3|NOT COMPLETED|Overall Study||0
1668544|NCT00626808|4077623|P2|NOT COMPLETED|Overall Study||0
1668545|NCT00626808|4077624|P1|NOT COMPLETED|Overall Study||0
1668546|NCT00626808|4077621|P4|COMPLETED|Overall Study||2906
1668547|NCT00626808|4077622|P3|COMPLETED|Overall Study||30011
1668548|NCT00626808|4077623|P2|COMPLETED|Overall Study||34316
1668549|NCT00626808|4077624|P1|COMPLETED|Overall Study||254464
1668550|NCT00626808|4077621|P4|STARTED|Overall Study||2906
1668551|NCT00626808|4077622|P3|STARTED|Overall Study||30011
1668552|NCT00626808|4077623|P2|STARTED|Overall Study||34316
1668553|NCT00626808|4077624|P1|STARTED|Overall Study||254464
1668554|NCT00626795|4077693|P3|NOT COMPLETED|Blinded Treatment||9
1668555|NCT00626795|4077694|P2|NOT COMPLETED|Blinded Treatment||5
1668556|NCT00626795|4077695|P1|NOT COMPLETED|Blinded Treatment||10
1668557|NCT00626795|4077693|P3|COMPLETED|Blinded Treatment||196
1668558|NCT00626795|4077694|P2|COMPLETED|Blinded Treatment||200
1668559|NCT00626795|4077695|P1|COMPLETED|Blinded Treatment||194
1668560|NCT00626795|4077693|P3|STARTED|Blinded Treatment||205
1668561|NCT00626795|4077694|P2|STARTED|Blinded Treatment||205
1668562|NCT00626795|4077695|P1|STARTED|Blinded Treatment||204
1668563|NCT00626795|4077693|P3|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
1668564|NCT00626795|4077694|P2|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
1668565|NCT00626795|4077695|P1|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
1668566|NCT00626795|4077693|P3|COMPLETED|Open-label TD1414 Cream TID Treatment||0
1668567|NCT00626795|4077694|P2|COMPLETED|Open-label TD1414 Cream TID Treatment||64
1668568|NCT00626795|4077695|P1|COMPLETED|Open-label TD1414 Cream TID Treatment||0
1668569|NCT00626795|4077693|P3|STARTED|Open-label TD1414 Cream TID Treatment||0
1668570|NCT00626795|4077694|P2|STARTED|Open-label TD1414 Cream TID Treatment||65
1668571|NCT00626795|4077695|P1|STARTED|Open-label TD1414 Cream TID Treatment||0
1668572|NCT00626782|4077724|P2|NOT COMPLETED|Overall Study||0
1668573|NCT00626782|4077725|P1|NOT COMPLETED|Overall Study||0
1668574|NCT00626782|4077724|P2|COMPLETED|Overall Study||12
1668575|NCT00626782|4077725|P1|COMPLETED|Overall Study||12
1668576|NCT00626782|4077724|P2|STARTED|Overall Study||12
1668577|NCT00626782|4077725|P1|STARTED|Overall Study||12
1668578|NCT00626743|4077735|P2|NOT COMPLETED|Treatment Period 2||0
1668579|NCT00626743|4077736|P1|NOT COMPLETED|Treatment Period 2||0
1668580|NCT00626743|4077735|P2|COMPLETED|Treatment Period 2||6
1668581|NCT00626743|4077736|P1|COMPLETED|Treatment Period 2||6
1668582|NCT00626743|4077735|P2|STARTED|Treatment Period 2||6
1668583|NCT00626743|4077736|P1|STARTED|Treatment Period 2||6
1668584|NCT00626743|4077735|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
1668585|NCT00626743|4077736|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
1668586|NCT00626743|4077735|P2|COMPLETED|Wash-out Period of 6 Days||6
1668587|NCT00626743|4077736|P1|COMPLETED|Wash-out Period of 6 Days||6
1668588|NCT00626743|4077735|P2|STARTED|Wash-out Period of 6 Days||6
1668589|NCT00626743|4077736|P1|STARTED|Wash-out Period of 6 Days||6
1668590|NCT00626743|4077735|P2|NOT COMPLETED|Treatment Period 1||1
1668591|NCT00626743|4077736|P1|NOT COMPLETED|Treatment Period 1||0
1668592|NCT00626743|4077735|P2|COMPLETED|Treatment Period 1||6
1668593|NCT00626743|4077736|P1|COMPLETED|Treatment Period 1||6
1668594|NCT00626743|4077735|P2|STARTED|Treatment Period 1||7
1668595|NCT00626743|4077736|P1|STARTED|Treatment Period 1||6
1668596|NCT00626639|4077746|P2|NOT COMPLETED|Overall Study||2
1668597|NCT00626639|4077747|P1|NOT COMPLETED|Overall Study||2
1668598|NCT00626639|4077746|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
1668599|NCT00626639|4077747|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
1668600|NCT00626639|4077746|P2|STARTED|Overall Study||3
1668601|NCT00626639|4077747|P1|STARTED|Overall Study||2
1668602|NCT00626626|4077767|P2|NOT COMPLETED|Overall Study||0
1668603|NCT00626626|4077768|P1|NOT COMPLETED|Overall Study||0
1668604|NCT00626626|4077767|P2|COMPLETED|Overall Study||3
1668605|NCT00626626|4077768|P1|COMPLETED|Overall Study||5
1668606|NCT00626626|4077767|P2|STARTED|Overall Study||3
1668607|NCT00626626|4077768|P1|STARTED|Overall Study||5
1668608|NCT00626574|4077780|P2|NOT COMPLETED|Overall Study||0
1668609|NCT00626574|4077781|P1|NOT COMPLETED|Overall Study||0
1668610|NCT00626574|4077780|P2|COMPLETED|Overall Study||1
1668611|NCT00626574|4077781|P1|COMPLETED|Overall Study||2
1668612|NCT00626574|4077780|P2|STARTED|Overall Study||1
1668613|NCT00626574|4077781|P1|STARTED|Overall Study||2
1668614|NCT00626561|4077793|P1|NOT COMPLETED|Overall Study||4
1668615|NCT00626561|4077793|P1|COMPLETED|Overall Study||0
1668616|NCT00626561|4077793|P1|STARTED|Overall Study||4
1668617|NCT00626548|4077799|P2|NOT COMPLETED|Overall Study||716
1668618|NCT00626548|4077800|P1|NOT COMPLETED|Overall Study||705
1668619|NCT00626548|4077799|P2|COMPLETED|Overall Study||0
1668620|NCT00626548|4077800|P1|COMPLETED|Overall Study||0
1668621|NCT00626548|4077799|P2|Patients Received Treatment|Overall Study||712
1668622|NCT00626548|4077800|P1|Patients Received Treatment|Overall Study||703
1668623|NCT00626548|4077799|P2|STARTED|Overall Study||716
1668624|NCT00626548|4077800|P1|STARTED|Overall Study||705
1668625|NCT00626522|4077814|P6|NOT COMPLETED|Overall Study||2
1668626|NCT00626522|4077815|P5|NOT COMPLETED|Overall Study||7
1668627|NCT00626522|4077816|P4|NOT COMPLETED|Overall Study||2
1668628|NCT00626522|4077817|P3|NOT COMPLETED|Overall Study||8
1668629|NCT00626522|4077818|P2|NOT COMPLETED|Overall Study||7
1668630|NCT00626522|4077819|P1|NOT COMPLETED|Overall Study||6
1668631|NCT00626522|4077814|P6|COMPLETED|Overall Study||57
1668632|NCT00626522|4077815|P5|COMPLETED|Overall Study||58
1668633|NCT00626522|4077816|P4|COMPLETED|Overall Study||74
1668634|NCT00626522|4077817|P3|COMPLETED|Overall Study||117
1668635|NCT00626522|4077818|P2|COMPLETED|Overall Study||113
1668636|NCT00626522|4077819|P1|COMPLETED|Overall Study||115
1668637|NCT00626522|4077814|P6|STARTED|Overall Study||59
1668638|NCT00626522|4077815|P5|STARTED|Overall Study||65
1668639|NCT00626522|4077816|P4|STARTED|Overall Study||76
1668640|NCT00626522|4077817|P3|STARTED|Overall Study||125
1668641|NCT00626522|4077818|P2|STARTED|Overall Study||120
1668642|NCT00626522|4077819|P1|STARTED|Overall Study||121
1668643|NCT00626444|4077857|P1|NOT COMPLETED|Overall Study||0
1668644|NCT00626444|4077857|P1|COMPLETED|Overall Study||2
1668645|NCT00626444|4077857|P1|STARTED|Overall Study||2
1668646|NCT00626431|4077864|P2|NOT COMPLETED|Overall Study||45
1668647|NCT00626431|4077865|P1|NOT COMPLETED|Overall Study||17
1668648|NCT00626431|4077864|P2|COMPLETED|Overall Study||114
1668649|NCT00626431|4077865|P1|COMPLETED|Overall Study||134
1668650|NCT00626431|4077864|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
1668651|NCT00626431|4077865|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
1668652|NCT00626405|4077882|P2|NOT COMPLETED|Overall Study||1
1668653|NCT00626405|4077883|P1|NOT COMPLETED|Overall Study||1
1668654|NCT00626405|4077882|P2|COMPLETED|Overall Study||51
1668655|NCT00626405|4077883|P1|COMPLETED|Overall Study||42
1668656|NCT00626405|4077882|P2|STARTED|Overall Study||52
1668657|NCT00626405|4077883|P1|STARTED|Overall Study||43
1668658|NCT00626392|4077899|P6|NOT COMPLETED|Coadministration Period||6
1668659|NCT00626392|4077900|P5|NOT COMPLETED|Coadministration Period||5
1668660|NCT00626392|4077901|P4|NOT COMPLETED|Coadministration Period||7
1668661|NCT00626392|4077902|P3|NOT COMPLETED|Coadministration Period||10
1668662|NCT00626392|4077903|P2|NOT COMPLETED|Coadministration Period||5
1668663|NCT00626392|4077904|P1|NOT COMPLETED|Coadministration Period||4
1668664|NCT00626392|4077899|P6|COMPLETED|Coadministration Period||38
1668665|NCT00626392|4077900|P5|COMPLETED|Coadministration Period||36
1668666|NCT00626392|4077901|P4|COMPLETED|Coadministration Period||36
1668667|NCT00626392|4077902|P3|COMPLETED|Coadministration Period||31
1668668|NCT00626392|4077903|P2|COMPLETED|Coadministration Period||38
1668669|NCT00626392|4077904|P1|COMPLETED|Coadministration Period||40
1668670|NCT00626392|4077899|P6|STARTED|Coadministration Period||44
1668671|NCT00626392|4077900|P5|STARTED|Coadministration Period||41
1668672|NCT00626392|4077901|P4|STARTED|Coadministration Period||43
1668673|NCT00626392|4077902|P3|STARTED|Coadministration Period||41
1668674|NCT00626392|4077903|P2|STARTED|Coadministration Period||43
1668675|NCT00626392|4077904|P1|STARTED|Coadministration Period||44
1668676|NCT00626392|4077899|P6|NOT COMPLETED|Run-in Period||1
1668677|NCT00626392|4077900|P5|NOT COMPLETED|Run-in Period||4
1668678|NCT00626392|4077901|P4|NOT COMPLETED|Run-in Period||1
1668679|NCT00626392|4077902|P3|NOT COMPLETED|Run-in Period||3
1668680|NCT00626392|4077903|P2|NOT COMPLETED|Run-in Period||1
1668681|NCT00626392|4077904|P1|NOT COMPLETED|Run-in Period||1
1668682|NCT00626392|4077899|P6|COMPLETED|Run-in Period||44
1668683|NCT00626392|4077900|P5|COMPLETED|Run-in Period||41
1668684|NCT00626392|4077901|P4|COMPLETED|Run-in Period||43
1668685|NCT00626392|4077902|P3|COMPLETED|Run-in Period||41
1668686|NCT00626392|4077903|P2|COMPLETED|Run-in Period||43
1668687|NCT00626392|4077904|P1|COMPLETED|Run-in Period||44
1668688|NCT00626392|4077899|P6|STARTED|Run-in Period||45
1668689|NCT00626392|4077900|P5|STARTED|Run-in Period||45
1668690|NCT00626392|4077901|P4|STARTED|Run-in Period||44
1668691|NCT00626392|4077902|P3|STARTED|Run-in Period||44
1668692|NCT00626392|4077903|P2|STARTED|Run-in Period||44
1668693|NCT00626392|4077904|P1|STARTED|Run-in Period||45
1668694|NCT00626340|4077916|P1|NOT COMPLETED|Overall Study||0
1668695|NCT00626340|4077916|P1|COMPLETED|Overall Study||18
1668696|NCT00626340|4077916|P1|STARTED|Overall Study||18
1668697|NCT00626327|4077923|P3|NOT COMPLETED|Overall Study||88
1668698|NCT00626327|4077924|P2|NOT COMPLETED|Overall Study||59
1668699|NCT00626327|4077925|P1|NOT COMPLETED|Overall Study||78
1668700|NCT00626327|4077923|P3|COMPLETED|Overall Study||422
1668701|NCT00626327|4077924|P2|COMPLETED|Overall Study||557
1668702|NCT00626327|4077925|P1|COMPLETED|Overall Study||426
1668703|NCT00626327|4077923|P3|STARTED|Overall Study||510
1668704|NCT00626327|4077924|P2|STARTED|Overall Study||616
1668705|NCT00626327|4077925|P1|STARTED|Overall Study||504
1668706|NCT00626275|4077951|P8|NOT COMPLETED|Part B||1
1668707|NCT00626275|4077952|P7|NOT COMPLETED|Part B||1
1668708|NCT00626275|4077953|P6|NOT COMPLETED|Part B||0
1668709|NCT00626275|4077954|P5|NOT COMPLETED|Part B||0
1668710|NCT00626275|4077955|P4|NOT COMPLETED|Part B||0
1668711|NCT00626275|4077956|P3|NOT COMPLETED|Part B||0
1668712|NCT00626275|4077957|P2|NOT COMPLETED|Part B||0
1668713|NCT00626275|4077958|P1|NOT COMPLETED|Part B||0
1668714|NCT00626275|4077951|P8|COMPLETED|Part B||23
1668715|NCT00626275|4077952|P7|COMPLETED|Part B||19
1668716|NCT00626275|4077953|P6|COMPLETED|Part B||0
1668717|NCT00626275|4077954|P5|COMPLETED|Part B||0
1668718|NCT00626275|4077955|P4|COMPLETED|Part B||0
1668719|NCT00626275|4077956|P3|COMPLETED|Part B||0
1668720|NCT00626275|4077957|P2|COMPLETED|Part B||0
1668721|NCT00626275|4077958|P1|COMPLETED|Part B||0
1668722|NCT00626275|4077951|P8|STARTED|Part B||24
1668723|NCT00626275|4077952|P7|STARTED|Part B||20
1668724|NCT00626275|4077953|P6|STARTED|Part B||0
1668725|NCT00626275|4077954|P5|STARTED|Part B||0
1668726|NCT00626275|4077955|P4|STARTED|Part B||0
1668727|NCT00626275|4077956|P3|STARTED|Part B||0
1668728|NCT00626275|4077957|P2|STARTED|Part B||0
1668729|NCT00626275|4077958|P1|STARTED|Part B||0
1668730|NCT00626275|4077951|P8|NOT COMPLETED|Re-randomization Period for Part B||0
1668731|NCT00626275|4077952|P7|NOT COMPLETED|Re-randomization Period for Part B||0
1668732|NCT00626275|4077953|P6|NOT COMPLETED|Re-randomization Period for Part B||0
1668733|NCT00626275|4077954|P5|NOT COMPLETED|Re-randomization Period for Part B||0
1668734|NCT00626275|4077955|P4|NOT COMPLETED|Re-randomization Period for Part B||0
1668735|NCT00626275|4077956|P3|NOT COMPLETED|Re-randomization Period for Part B||0
1668736|NCT00626275|4077957|P2|NOT COMPLETED|Re-randomization Period for Part B||0
1668737|NCT00626275|4077958|P1|NOT COMPLETED|Re-randomization Period for Part B||0
1668738|NCT00626275|4077951|P8|COMPLETED|Re-randomization Period for Part B||24
1668739|NCT00626275|4077952|P7|COMPLETED|Re-randomization Period for Part B||20
1668740|NCT00626275|4077953|P6|COMPLETED|Re-randomization Period for Part B||0
1668741|NCT00626275|4077954|P5|COMPLETED|Re-randomization Period for Part B||0
1668742|NCT00626275|4077955|P4|COMPLETED|Re-randomization Period for Part B||0
1668743|NCT00626275|4077956|P3|COMPLETED|Re-randomization Period for Part B||0
1668744|NCT00626275|4077957|P2|COMPLETED|Re-randomization Period for Part B||0
1668745|NCT00626275|4077958|P1|COMPLETED|Re-randomization Period for Part B||0
1668746|NCT00626275|4077951|P8|STARTED|Re-randomization Period for Part B||24
1668747|NCT00626275|4077952|P7|STARTED|Re-randomization Period for Part B||20
1668748|NCT00626275|4077953|P6|STARTED|Re-randomization Period for Part B||0
1668749|NCT00626275|4077954|P5|STARTED|Re-randomization Period for Part B||0
1668750|NCT00626275|4077955|P4|STARTED|Re-randomization Period for Part B||0
1668751|NCT00626275|4077956|P3|STARTED|Re-randomization Period for Part B||0
1668752|NCT00626275|4077957|P2|STARTED|Re-randomization Period for Part B||0
1668753|NCT00626275|4077958|P1|STARTED|Re-randomization Period for Part B||0
1668754|NCT00626275|4077951|P8|NOT COMPLETED|Part A - Treatment Period 3||0
1668755|NCT00626275|4077952|P7|NOT COMPLETED|Part A - Treatment Period 3||0
1668756|NCT00626275|4077953|P6|NOT COMPLETED|Part A - Treatment Period 3||0
1668757|NCT00626275|4077954|P5|NOT COMPLETED|Part A - Treatment Period 3||0
1668758|NCT00626275|4077955|P4|NOT COMPLETED|Part A - Treatment Period 3||0
1668759|NCT00626275|4077956|P3|NOT COMPLETED|Part A - Treatment Period 3||0
1668760|NCT00626275|4077957|P2|NOT COMPLETED|Part A - Treatment Period 3||0
1668761|NCT00626275|4077958|P1|NOT COMPLETED|Part A - Treatment Period 3||0
1668762|NCT00626275|4077951|P8|COMPLETED|Part A - Treatment Period 3||0
1668763|NCT00626275|4077952|P7|COMPLETED|Part A - Treatment Period 3||0
1668764|NCT00626275|4077953|P6|COMPLETED|Part A - Treatment Period 3||8
1668765|NCT00626275|4077954|P5|COMPLETED|Part A - Treatment Period 3||9
1668766|NCT00626275|4077955|P4|COMPLETED|Part A - Treatment Period 3||8
1668767|NCT00626275|4077956|P3|COMPLETED|Part A - Treatment Period 3||6
1668768|NCT00626275|4077957|P2|COMPLETED|Part A - Treatment Period 3||7
1668769|NCT00626275|4077958|P1|COMPLETED|Part A - Treatment Period 3||6
1668770|NCT00626275|4077951|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
1668771|NCT00626275|4077952|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
1668772|NCT00626275|4077953|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
1668773|NCT00626275|4077954|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
1668774|NCT00626275|4077955|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
1668775|NCT00626275|4077956|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
1668776|NCT00626275|4077957|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
1668777|NCT00626275|4077958|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
1668778|NCT00626275|4077951|P8|STARTED|Part A - Treatment Period 3||0
1668779|NCT00626275|4077952|P7|STARTED|Part A - Treatment Period 3||0
1668780|NCT00626275|4077953|P6|STARTED|Part A - Treatment Period 3||8
1668781|NCT00626275|4077954|P5|STARTED|Part A - Treatment Period 3||9
1668782|NCT00626275|4077955|P4|STARTED|Part A - Treatment Period 3||8
1668783|NCT00626275|4077956|P3|STARTED|Part A - Treatment Period 3||6
1668784|NCT00626275|4077957|P2|STARTED|Part A - Treatment Period 3||7
1668785|NCT00626275|4077958|P1|STARTED|Part A - Treatment Period 3||6
1668786|NCT00626275|4077951|P8|NOT COMPLETED|Part A - Washout Period 2||0
1668787|NCT00626275|4077952|P7|NOT COMPLETED|Part A - Washout Period 2||0
1668788|NCT00626275|4077953|P6|NOT COMPLETED|Part A - Washout Period 2||0
1668789|NCT00626275|4077954|P5|NOT COMPLETED|Part A - Washout Period 2||0
1668790|NCT00626275|4077955|P4|NOT COMPLETED|Part A - Washout Period 2||0
1668791|NCT00626275|4077956|P3|NOT COMPLETED|Part A - Washout Period 2||0
1668792|NCT00626275|4077957|P2|NOT COMPLETED|Part A - Washout Period 2||0
1668793|NCT00626275|4077958|P1|NOT COMPLETED|Part A - Washout Period 2||0
1668794|NCT00626275|4077951|P8|COMPLETED|Part A - Washout Period 2||0
1668795|NCT00626275|4077952|P7|COMPLETED|Part A - Washout Period 2||0
1668796|NCT00626275|4077953|P6|COMPLETED|Part A - Washout Period 2||8
1668797|NCT00626275|4077954|P5|COMPLETED|Part A - Washout Period 2||9
1668798|NCT00626275|4077955|P4|COMPLETED|Part A - Washout Period 2||8
1668799|NCT00626275|4077956|P3|COMPLETED|Part A - Washout Period 2||6
1668800|NCT00626275|4077957|P2|COMPLETED|Part A - Washout Period 2||7
1668801|NCT00626275|4077958|P1|COMPLETED|Part A - Washout Period 2||6
1668802|NCT00626275|4077951|P8|STARTED|Part A - Washout Period 2||0
1668803|NCT00626275|4077952|P7|STARTED|Part A - Washout Period 2||0
1668804|NCT00626275|4077953|P6|STARTED|Part A - Washout Period 2||8
1668805|NCT00626275|4077954|P5|STARTED|Part A - Washout Period 2||9
1668806|NCT00626275|4077955|P4|STARTED|Part A - Washout Period 2||8
1668807|NCT00626275|4077956|P3|STARTED|Part A - Washout Period 2||6
1668808|NCT00626275|4077957|P2|STARTED|Part A - Washout Period 2||7
1668809|NCT00626275|4077958|P1|STARTED|Part A - Washout Period 2||6
1668810|NCT00626275|4077951|P8|NOT COMPLETED|Part A - Treatment Period 2||0
1668811|NCT00626275|4077952|P7|NOT COMPLETED|Part A - Treatment Period 2||0
1668812|NCT00626275|4077953|P6|NOT COMPLETED|Part A - Treatment Period 2||0
1668813|NCT00626275|4077954|P5|NOT COMPLETED|Part A - Treatment Period 2||0
1668814|NCT00626275|4077955|P4|NOT COMPLETED|Part A - Treatment Period 2||0
1668815|NCT00626275|4077956|P3|NOT COMPLETED|Part A - Treatment Period 2||0
1668816|NCT00626275|4077957|P2|NOT COMPLETED|Part A - Treatment Period 2||0
1668817|NCT00626275|4077958|P1|NOT COMPLETED|Part A - Treatment Period 2||0
1668818|NCT00626275|4077951|P8|COMPLETED|Part A - Treatment Period 2||0
1668819|NCT00626275|4077952|P7|COMPLETED|Part A - Treatment Period 2||0
1668820|NCT00626275|4077953|P6|COMPLETED|Part A - Treatment Period 2||8
1668821|NCT00626275|4077954|P5|COMPLETED|Part A - Treatment Period 2||9
1668822|NCT00626275|4077955|P4|COMPLETED|Part A - Treatment Period 2||8
1668823|NCT00626275|4077956|P3|COMPLETED|Part A - Treatment Period 2||6
1668824|NCT00626275|4077957|P2|COMPLETED|Part A - Treatment Period 2||7
1668825|NCT00626275|4077958|P1|COMPLETED|Part A - Treatment Period 2||6
1668826|NCT00626275|4077951|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
1668827|NCT00626275|4077952|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
1668828|NCT00626275|4077953|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
1668829|NCT00626275|4077954|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
1668830|NCT00626275|4077955|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
1668831|NCT00626275|4077956|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
1668832|NCT00626275|4077957|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
1668833|NCT00626275|4077958|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
1668834|NCT00626275|4077951|P8|STARTED|Part A - Treatment Period 2||0
1668835|NCT00626275|4077952|P7|STARTED|Part A - Treatment Period 2||0
1668836|NCT00626275|4077953|P6|STARTED|Part A - Treatment Period 2||8
1668837|NCT00626275|4077954|P5|STARTED|Part A - Treatment Period 2||9
1668838|NCT00626275|4077955|P4|STARTED|Part A - Treatment Period 2||8
1668839|NCT00626275|4077956|P3|STARTED|Part A - Treatment Period 2||6
1668840|NCT00626275|4077957|P2|STARTED|Part A - Treatment Period 2||7
1668841|NCT00626275|4077958|P1|STARTED|Part A - Treatment Period 2||6
1668842|NCT00626275|4077951|P8|NOT COMPLETED|Part A - Washout Period 1||0
1668843|NCT00626275|4077952|P7|NOT COMPLETED|Part A - Washout Period 1||0
1668844|NCT00626275|4077953|P6|NOT COMPLETED|Part A - Washout Period 1||0
1668845|NCT00626275|4077954|P5|NOT COMPLETED|Part A - Washout Period 1||0
1668846|NCT00626275|4077955|P4|NOT COMPLETED|Part A - Washout Period 1||0
1668847|NCT00626275|4077956|P3|NOT COMPLETED|Part A - Washout Period 1||0
1668848|NCT00626275|4077957|P2|NOT COMPLETED|Part A - Washout Period 1||0
1668849|NCT00626275|4077958|P1|NOT COMPLETED|Part A - Washout Period 1||0
1668850|NCT00626275|4077951|P8|COMPLETED|Part A - Washout Period 1||0
1668851|NCT00626275|4077952|P7|COMPLETED|Part A - Washout Period 1||0
1668852|NCT00626275|4077953|P6|COMPLETED|Part A - Washout Period 1||8
1668853|NCT00626275|4077954|P5|COMPLETED|Part A - Washout Period 1||9
1668854|NCT00626275|4077955|P4|COMPLETED|Part A - Washout Period 1||8
1668855|NCT00626275|4077956|P3|COMPLETED|Part A - Washout Period 1||6
1668856|NCT00626275|4077957|P2|COMPLETED|Part A - Washout Period 1||7
1668857|NCT00626275|4077958|P1|COMPLETED|Part A - Washout Period 1||6
1668858|NCT00626275|4077951|P8|STARTED|Part A - Washout Period 1||0
1668859|NCT00626275|4077952|P7|STARTED|Part A - Washout Period 1||0
1668860|NCT00626275|4077953|P6|STARTED|Part A - Washout Period 1||8
1668861|NCT00626275|4077954|P5|STARTED|Part A - Washout Period 1||9
1668862|NCT00626275|4077955|P4|STARTED|Part A - Washout Period 1||8
1668863|NCT00626275|4077956|P3|STARTED|Part A - Washout Period 1||6
1668864|NCT00626275|4077957|P2|STARTED|Part A - Washout Period 1||7
1668865|NCT00626275|4077958|P1|STARTED|Part A - Washout Period 1||6
1668866|NCT00626275|4077951|P8|NOT COMPLETED|Part A - Treatment Period 1||0
1668867|NCT00626275|4077952|P7|NOT COMPLETED|Part A - Treatment Period 1||0
1668868|NCT00626275|4077953|P6|NOT COMPLETED|Part A - Treatment Period 1||0
1668869|NCT00626275|4077954|P5|NOT COMPLETED|Part A - Treatment Period 1||0
1668870|NCT00626275|4077955|P4|NOT COMPLETED|Part A - Treatment Period 1||0
1668871|NCT00626275|4077956|P3|NOT COMPLETED|Part A - Treatment Period 1||1
1668872|NCT00626275|4077957|P2|NOT COMPLETED|Part A - Treatment Period 1||0
1668873|NCT00626275|4077958|P1|NOT COMPLETED|Part A - Treatment Period 1||1
1668874|NCT00626275|4077951|P8|COMPLETED|Part A - Treatment Period 1||0
1668875|NCT00626275|4077952|P7|COMPLETED|Part A - Treatment Period 1||0
1668876|NCT00626275|4077953|P6|COMPLETED|Part A - Treatment Period 1||8
1668877|NCT00626275|4077954|P5|COMPLETED|Part A - Treatment Period 1||9
1668878|NCT00626275|4077955|P4|COMPLETED|Part A - Treatment Period 1||8
1668879|NCT00626275|4077956|P3|COMPLETED|Part A - Treatment Period 1||6
1668880|NCT00626275|4077957|P2|COMPLETED|Part A - Treatment Period 1||7
1668881|NCT00626275|4077958|P1|COMPLETED|Part A - Treatment Period 1||6
1668882|NCT00626275|4077951|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
1668883|NCT00626275|4077952|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
1668884|NCT00626275|4077953|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
1668885|NCT00626275|4077954|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
1668886|NCT00626275|4077955|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
1668887|NCT00626275|4077956|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
1668888|NCT00626275|4077957|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
1668889|NCT00626275|4077958|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
1668890|NCT00626275|4077951|P8|STARTED|Part A - Treatment Period 1||0
1668891|NCT00626275|4077952|P7|STARTED|Part A - Treatment Period 1||0
1668892|NCT00626275|4077953|P6|STARTED|Part A - Treatment Period 1||8
1668893|NCT00626275|4077954|P5|STARTED|Part A - Treatment Period 1||9
1668894|NCT00626275|4077955|P4|STARTED|Part A - Treatment Period 1||8
1668895|NCT00626275|4077956|P3|STARTED|Part A - Treatment Period 1||7
1668896|NCT00626275|4077957|P2|STARTED|Part A - Treatment Period 1||7
1668897|NCT00626275|4077958|P1|STARTED|Part A - Treatment Period 1||7
1668898|NCT00626210|4077998|P1|NOT COMPLETED|Overall Study||0
1668899|NCT00626210|4077998|P1|COMPLETED|Overall Study||2
1668900|NCT00626210|4077998|P1|STARTED|Overall Study||2
1668901|NCT00626093|4078002|P1|NOT COMPLETED|Overall Study||23
1668902|NCT00626093|4078002|P1|COMPLETED|Overall Study||54
1668903|NCT00626093|4078002|P1|STARTED|Overall Study||77
1668904|NCT00626028|4078009|P2|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
1668905|NCT00626028|4078010|P1|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
1668906|NCT00626028|4078009|P2|COMPLETED|Treatment 3 10 Minute Dose NO or O2||59
1668907|NCT00626028|4078010|P1|COMPLETED|Treatment 3 10 Minute Dose NO or O2||62
1668908|NCT00626028|4078009|P2|STARTED|Treatment 3 10 Minute Dose NO or O2||59
1668909|NCT00626028|4078010|P1|STARTED|Treatment 3 10 Minute Dose NO or O2||62
1668910|NCT00626028|4078009|P2|NOT COMPLETED|Washout Period of 10 Minutes||0
1668911|NCT00626028|4078010|P1|NOT COMPLETED|Washout Period of 10 Minutes||0
1668912|NCT00626028|4078009|P2|COMPLETED|Washout Period of 10 Minutes||59
1668913|NCT00626028|4078010|P1|COMPLETED|Washout Period of 10 Minutes||62
1668914|NCT00626028|4078009|P2|STARTED|Washout Period of 10 Minutes||59
1668915|NCT00626028|4078010|P1|STARTED|Washout Period of 10 Minutes||62
1668916|NCT00626028|4078009|P2|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
1668917|NCT00626028|4078010|P1|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
1668918|NCT00626028|4078009|P2|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||59
1668919|NCT00626028|4078010|P1|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||62
1668920|NCT00626028|4078009|P2|STARTED|Treatment 2 10 Minute Dose NO Plus O2||59
1668921|NCT00626028|4078010|P1|STARTED|Treatment 2 10 Minute Dose NO Plus O2||62
1668922|NCT00626028|4078009|P2|NOT COMPLETED|Treatment 1 NO First, O2 Last||9
1668923|NCT00626028|4078010|P1|NOT COMPLETED|Treatment 1 NO First, O2 Last||6
1668924|NCT00626028|4078009|P2|COMPLETED|Treatment 1 NO First, O2 Last||59
1668925|NCT00626028|4078010|P1|COMPLETED|Treatment 1 NO First, O2 Last||62
1668926|NCT00626028|4078009|P2|STARTED|Treatment 1 NO First, O2 Last||68
1668927|NCT00626028|4078010|P1|STARTED|Treatment 1 NO First, O2 Last||68
1668928|NCT00625989|4078020|P2|NOT COMPLETED|Overall Study||0
1668929|NCT00625989|4078021|P1|NOT COMPLETED|Overall Study||0
1668930|NCT00625989|4078020|P2|COMPLETED|Overall Study||6
1668931|NCT00625989|4078021|P1|COMPLETED|Overall Study||6
1668932|NCT00625989|4078020|P2|STARTED|Overall Study||6
1668933|NCT00625989|4078021|P1|STARTED|Overall Study||6
1668934|NCT00625872|4078030|P2|NOT COMPLETED|Overall Study||6
1668935|NCT00625872|4078031|P1|NOT COMPLETED|Overall Study||4
1668936|NCT00625872|4078030|P2|COMPLETED|Overall Study||5
1668937|NCT00625872|4078031|P1|COMPLETED|Overall Study||8
1668938|NCT00625872|4078030|P2|Treated|Overall Study||10
1668939|NCT00625872|4078031|P1|Treated|Overall Study||12
1668940|NCT00625872|4078030|P2|STARTED|Overall Study||11
1668941|NCT00625872|4078031|P1|STARTED|Overall Study||12
1668942|NCT00625820|4078141|P1|NOT COMPLETED|Overall Study||1
1668943|NCT00625820|4078141|P1|COMPLETED|Overall Study||16
1668944|NCT00625820|4078141|P1|STARTED|Overall Study||17
1668945|NCT00625807|4078149|P2|NOT COMPLETED|Overall Study||8
1668946|NCT00625807|4078150|P1|NOT COMPLETED|Overall Study||2
1668947|NCT00625807|4078149|P2|COMPLETED|Overall Study||20
1668948|NCT00625807|4078150|P1|COMPLETED|Overall Study||20
1668949|NCT00625807|4078149|P2|STARTED|Overall Study||28
1668950|NCT00625807|4078150|P1|STARTED|Overall Study||22
1668951|NCT00625742|4078166|P1|NOT COMPLETED|Overall Study||12
1668952|NCT00625742|4078166|P1|COMPLETED|Overall Study||3
1668953|NCT00625742|4078166|P1|STARTED|Overall Study||15
1668954|NCT00625729|4078171|P1|NOT COMPLETED|Overall Study||0
1668955|NCT00625729|4078171|P1|COMPLETED|Overall Study||6
1668956|NCT00625729|4078171|P1|STARTED|Overall Study||6
1668957|NCT00625586|4078180|P1|NOT COMPLETED|Overall Study||1
1668958|NCT00625586|4078180|P1|COMPLETED|Overall Study||1
1668959|NCT00625586|4078180|P1|STARTED|Overall Study||2
1668960|NCT00625443|4078193|P3|NOT COMPLETED|Overall Study||5
1668961|NCT00625443|4078194|P2|NOT COMPLETED|Overall Study||11
1668962|NCT00625443|4078195|P1|NOT COMPLETED|Overall Study||2
1668963|NCT00625443|4078193|P3|COMPLETED|Overall Study||10
1668964|NCT00625443|4078194|P2|COMPLETED|Overall Study||15
1668965|NCT00625443|4078195|P1|COMPLETED|Overall Study||10
1668966|NCT00625443|4078193|P3|STARTED|Overall Study||15
1668967|NCT00625443|4078194|P2|STARTED|Overall Study||26
1668968|NCT00625443|4078195|P1|STARTED|Overall Study||12
1668969|NCT00625404|4078225|P2|NOT COMPLETED|Overall Study||173
1668970|NCT00625404|4078226|P1|NOT COMPLETED|Overall Study||207
1668971|NCT00625404|4078225|P2|COMPLETED|Overall Study||885
1668972|NCT00625404|4078226|P1|COMPLETED|Overall Study||855
1668973|NCT00625404|4078225|P2|STARTED|Overall Study||1058
1668974|NCT00625404|4078226|P1|STARTED|Overall Study||1062
1668975|NCT00625391|4078258|P4|NOT COMPLETED|Overall Study||1
1668976|NCT00625391|4078259|P3|NOT COMPLETED|Overall Study||5
1668977|NCT00625391|4078260|P2|NOT COMPLETED|Overall Study||8
1668978|NCT00625391|4078261|P1|NOT COMPLETED|Overall Study||7
1668979|NCT00625391|4078258|P4|COMPLETED|Overall Study||37
1668980|NCT00625391|4078259|P3|COMPLETED|Overall Study||37
1668981|NCT00625391|4078260|P2|COMPLETED|Overall Study||39
1668982|NCT00625391|4078261|P1|COMPLETED|Overall Study||37
1668983|NCT00625391|4078258|P4|STARTED|Overall Study||38
1668984|NCT00625391|4078259|P3|STARTED|Overall Study||42
1668985|NCT00625391|4078260|P2|STARTED|Overall Study||47
1668986|NCT00625391|4078261|P1|STARTED|Overall Study||44
1668987|NCT00625365|4078275|P1|NOT COMPLETED|Overall Study||7
1668988|NCT00625365|4078275|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
1668989|NCT00625365|4078275|P1|STARTED|Overall Study||1060
1668990|NCT00625183|4078281|P1|NOT COMPLETED|Overall Study||1
1668991|NCT00625183|4078281|P1|COMPLETED|Overall Study||4
1668992|NCT00625183|4078281|P1|STARTED|Overall Study||5
1668993|NCT00625131|4078292|P3|NOT COMPLETED|Overall Study||5
1668994|NCT00625131|4078293|P2|NOT COMPLETED|Overall Study||2
1668995|NCT00625131|4078294|P1|NOT COMPLETED|Overall Study||4
1668996|NCT00625131|4078292|P3|COMPLETED|Overall Study||0
1668997|NCT00625131|4078293|P2|COMPLETED|Overall Study||42
1668998|NCT00625131|4078294|P1|COMPLETED|Overall Study||34
1668999|NCT00625131|4078292|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
1669000|NCT00625131|4078293|P2|STARTED|Overall Study||44
1669001|NCT00625131|4078294|P1|STARTED|Overall Study||38
1669002|NCT00624923|4078306|P2|NOT COMPLETED|Overall Study||23
1669003|NCT00624923|4078307|P1|NOT COMPLETED|Overall Study||38
1669004|NCT00624923|4078306|P2|COMPLETED|Overall Study||101
1669005|NCT00624923|4078307|P1|COMPLETED|Overall Study||89
1669006|NCT00624923|4078306|P2|STARTED|Overall Study||124
1669007|NCT00624923|4078307|P1|STARTED|Overall Study||127
1669008|NCT00624832|4078317|P4|NOT COMPLETED|Overall Study||1
1669009|NCT00624832|4078318|P3|NOT COMPLETED|Overall Study||0
1669010|NCT00624832|4078319|P2|NOT COMPLETED|Overall Study||1
1669011|NCT00624832|4078320|P1|NOT COMPLETED|Overall Study||2
1669012|NCT00624832|4078317|P4|COMPLETED|Overall Study||15
1669013|NCT00624832|4078318|P3|COMPLETED|Overall Study||10
1669014|NCT00624832|4078319|P2|COMPLETED|Overall Study||15
1669015|NCT00624832|4078320|P1|COMPLETED|Overall Study||16
1669016|NCT00624832|4078317|P4|STARTED|Overall Study||16
1669017|NCT00624832|4078318|P3|STARTED|Overall Study||10
1669018|NCT00624832|4078319|P2|STARTED|Overall Study||16
1669019|NCT00624832|4078320|P1|STARTED|Overall Study||18
1669020|NCT00624806|4078334|P2|NOT COMPLETED|Overall Study||0
1669021|NCT00624806|4078335|P1|NOT COMPLETED|Overall Study||0
1669022|NCT00624806|4078334|P2|COMPLETED|Overall Study||8
1669023|NCT00624806|4078335|P1|COMPLETED|Overall Study||10
1669024|NCT00624806|4078334|P2|STARTED|Overall Study||8
1669025|NCT00624806|4078335|P1|STARTED|Overall Study||10
1669026|NCT00624780|4078351|P6|NOT COMPLETED|Follow-up (Week 26)||0
1669027|NCT00624780|4078352|P5|NOT COMPLETED|Follow-up (Week 26)||2
1669028|NCT00624780|4078353|P4|NOT COMPLETED|Follow-up (Week 26)||0
1669029|NCT00624780|4078354|P3|NOT COMPLETED|Follow-up (Week 26)||2
1669030|NCT00624780|4078355|P2|NOT COMPLETED|Follow-up (Week 26)||1
1669031|NCT00624780|4078356|P1|NOT COMPLETED|Follow-up (Week 26)||2
1669032|NCT00624780|4078351|P6|COMPLETED|Follow-up (Week 26)||29
1669033|NCT00624780|4078352|P5|COMPLETED|Follow-up (Week 26)||93
1669034|NCT00624780|4078353|P4|COMPLETED|Follow-up (Week 26)||26
1669035|NCT00624780|4078354|P3|COMPLETED|Follow-up (Week 26)||89
1669036|NCT00624780|4078355|P2|COMPLETED|Follow-up (Week 26)||27
1669037|NCT00624780|4078356|P1|COMPLETED|Follow-up (Week 26)||102
1669038|NCT00624780|4078351|P6|STARTED|Follow-up (Week 26)||29
1669039|NCT00624780|4078352|P5|STARTED|Follow-up (Week 26)||95
1669040|NCT00624780|4078353|P4|STARTED|Follow-up (Week 26)||26
1669041|NCT00624780|4078354|P3|STARTED|Follow-up (Week 26)||91
1669042|NCT00624780|4078355|P2|STARTED|Follow-up (Week 26)||28
1669043|NCT00624780|4078356|P1|STARTED|Follow-up (Week 26)||104
1669044|NCT00624780|4078351|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
1669045|NCT00624780|4078352|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
1669046|NCT00624780|4078353|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
1669047|NCT00624780|4078354|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
1669048|NCT00624780|4078355|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
1669049|NCT00624780|4078356|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
1669050|NCT00624780|4078351|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
1669051|NCT00624780|4078352|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
1669052|NCT00624780|4078353|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
1669053|NCT00624780|4078354|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
1669054|NCT00624780|4078355|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
1669055|NCT00624780|4078356|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
1669056|NCT00624780|4078351|P6|STARTED|Treatment Discontinuation (Week 25)||30
1669057|NCT00624780|4078352|P5|STARTED|Treatment Discontinuation (Week 25)||95
1669058|NCT00624780|4078353|P4|STARTED|Treatment Discontinuation (Week 25)||27
1669059|NCT00624780|4078354|P3|STARTED|Treatment Discontinuation (Week 25)||94
1669060|NCT00624780|4078355|P2|STARTED|Treatment Discontinuation (Week 25)||28
1669061|NCT00624780|4078356|P1|STARTED|Treatment Discontinuation (Week 25)||106
1669062|NCT00624780|4078351|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
1669063|NCT00624780|4078352|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
1669064|NCT00624780|4078353|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
1669065|NCT00624780|4078354|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
1669066|NCT00624780|4078355|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
1669067|NCT00624780|4078356|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
1669068|NCT00624780|4078351|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
1669069|NCT00624780|4078352|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
1669070|NCT00624780|4078353|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
1669071|NCT00624780|4078354|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
1669072|NCT00624780|4078355|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
1669073|NCT00624780|4078356|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
1669074|NCT00624780|4078351|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
1669075|NCT00624780|4078352|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
1669076|NCT00624780|4078353|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
1669077|NCT00624780|4078354|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
1669078|NCT00624780|4078355|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
1669079|NCT00624780|4078356|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
1669080|NCT00624780|4078351|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
1669081|NCT00624780|4078352|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
1669082|NCT00624780|4078353|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
1669083|NCT00624780|4078354|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
1669084|NCT00624780|4078355|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
1669085|NCT00624780|4078356|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
1669086|NCT00624780|4078351|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
1669087|NCT00624780|4078352|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
1669088|NCT00624780|4078353|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
1669089|NCT00624780|4078354|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
1669090|NCT00624780|4078355|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
1669091|NCT00624780|4078356|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
1669092|NCT00624780|4078351|P6|STARTED|Treatment Optimization (Up to Week 12)||50
1669093|NCT00624780|4078352|P5|STARTED|Treatment Optimization (Up to Week 12)||153
1669094|NCT00624780|4078353|P4|STARTED|Treatment Optimization (Up to Week 12)||52
1669095|NCT00624780|4078354|P3|STARTED|Treatment Optimization (Up to Week 12)||154
1669096|NCT00624780|4078355|P2|STARTED|Treatment Optimization (Up to Week 12)||52
1669097|NCT00624780|4078356|P1|STARTED|Treatment Optimization (Up to Week 12)||154
1669098|NCT00624585|4078538|P1|NOT COMPLETED|Overall Study||12
1669099|NCT00624585|4078538|P1|COMPLETED|Overall Study||6
1669100|NCT00624585|4078538|P1|STARTED|Overall Study||18
1669101|NCT00624559|4078549|P4|NOT COMPLETED|Overall Study||0
1669102|NCT00624559|4078550|P3|NOT COMPLETED|Overall Study||0
1669103|NCT00624559|4078551|P2|NOT COMPLETED|Overall Study||0
1669104|NCT00624559|4078552|P1|NOT COMPLETED|Overall Study||0
1669105|NCT00624559|4078549|P4|COMPLETED|Overall Study||3
1669106|NCT00624559|4078550|P3|COMPLETED|Overall Study||3
1669107|NCT00624559|4078551|P2|COMPLETED|Overall Study||3
1669108|NCT00624559|4078552|P1|COMPLETED|Overall Study||3
1669109|NCT00624559|4078549|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
1669110|NCT00624559|4078550|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
1669111|NCT00624559|4078551|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
1669112|NCT00624559|4078552|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
1669113|NCT00624520|4078568|P2|NOT COMPLETED|Overall Study||8
1669114|NCT00624520|4078569|P1|NOT COMPLETED|Overall Study||12
1669115|NCT00624520|4078568|P2|COMPLETED|Overall Study||39
1669116|NCT00624520|4078569|P1|COMPLETED|Overall Study||44
1669117|NCT00624520|4078568|P2|STARTED|Overall Study||47
1669118|NCT00624520|4078569|P1|STARTED|Overall Study||56
1669119|NCT00624468|4078596|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
1669120|NCT00624468|4078597|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
1669121|NCT00624468|4078598|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
1669122|NCT00624468|4078599|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
1669123|NCT00624468|4078596|P4|COMPLETED|Safety Follow-up (SFU) Period||11
1669124|NCT00624468|4078597|P3|COMPLETED|Safety Follow-up (SFU) Period||11
1669125|NCT00624468|4078598|P2|COMPLETED|Safety Follow-up (SFU) Period||0
1669126|NCT00624468|4078599|P1|COMPLETED|Safety Follow-up (SFU) Period||0
1669127|NCT00624468|4078596|P4|STARTED|Safety Follow-up (SFU) Period||14
1669128|NCT00624468|4078597|P3|STARTED|Safety Follow-up (SFU) Period||13
1669129|NCT00624468|4078598|P2|STARTED|Safety Follow-up (SFU) Period||0
1669130|NCT00624468|4078599|P1|STARTED|Safety Follow-up (SFU) Period||0
1669131|NCT00624468|4078596|P4|NOT COMPLETED|Double-blind Period||0
1669132|NCT00624468|4078597|P3|NOT COMPLETED|Double-blind Period||0
1669133|NCT00624468|4078598|P2|NOT COMPLETED|Double-blind Period||13
1669134|NCT00624468|4078599|P1|NOT COMPLETED|Double-blind Period||14
1669135|NCT00624468|4078596|P4|COMPLETED|Double-blind Period||0
1669136|NCT00624468|4078597|P3|COMPLETED|Double-blind Period||0
1669137|NCT00624468|4078598|P2|COMPLETED|Double-blind Period||4
1669138|NCT00624468|4078599|P1|COMPLETED|Double-blind Period||3
1669139|NCT00624468|4078596|P4|STARTED|Double-blind Period||0
1669140|NCT00624468|4078597|P3|STARTED|Double-blind Period||0
1669141|NCT00624468|4078598|P2|STARTED|Double-blind Period||17
1669142|NCT00624468|4078599|P1|STARTED|Double-blind Period||17
1669143|NCT00624442|4078630|P5|NOT COMPLETED|Overall Study||2
1669144|NCT00624442|4078631|P4|NOT COMPLETED|Overall Study||0
1669145|NCT00624442|4078632|P3|NOT COMPLETED|Overall Study||2
1669146|NCT00624442|4078633|P2|NOT COMPLETED|Overall Study||1
1669147|NCT00624442|4078634|P1|NOT COMPLETED|Overall Study||0
1669148|NCT00624442|4078630|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
1669149|NCT00624442|4078631|P4|COMPLETED|Overall Study||8
1669150|NCT00624442|4078632|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
1669151|NCT00624442|4078633|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
1669152|NCT00624442|4078634|P1|COMPLETED|Overall Study||8
1669153|NCT00624442|4078630|P5|STARTED|Overall Study||10
1669154|NCT00624442|4078631|P4|STARTED|Overall Study||8
1669155|NCT00624442|4078632|P3|STARTED|Overall Study||10
1669156|NCT00624442|4078633|P2|STARTED|Overall Study||9
1669157|NCT00624442|4078634|P1|STARTED|Overall Study||8
1669158|NCT00624416|4078660|P1|NOT COMPLETED|Overall Study||0
1669159|NCT00624416|4078660|P1|COMPLETED|Overall Study||10
1669160|NCT00624416|4078660|P1|STARTED|Overall Study||10
1669161|NCT00624377|4078666|P1|NOT COMPLETED|Overall Study||644
1669162|NCT00624377|4078666|P1|COMPLETED|Overall Study||1387
1669163|NCT00624377|4078666|P1|STARTED|Overall Study||2031
1669164|NCT00624338|4078680|P3|NOT COMPLETED|Overall Study||46
1669165|NCT00624338|4078681|P2|NOT COMPLETED|Overall Study||83
1669166|NCT00624338|4078682|P1|NOT COMPLETED|Overall Study||47
1669167|NCT00624338|4078680|P3|COMPLETED|Overall Study||111
1669168|NCT00624338|4078681|P2|COMPLETED|Overall Study||62
1669169|NCT00624338|4078682|P1|COMPLETED|Overall Study||112
1669170|NCT00624338|4078680|P3|Treated|Overall Study||154
1669171|NCT00624338|4078681|P2|Treated|Overall Study||144
1669172|NCT00624338|4078682|P1|Treated|Overall Study||157
1669173|NCT00624338|4078680|P3|STARTED|Overall Study||157
1669174|NCT00624338|4078681|P2|STARTED|Overall Study||145
1669175|NCT00624338|4078682|P1|STARTED|Overall Study||159
1669176|NCT00624286|4078704|P2|NOT COMPLETED|Overall Study||27
1669177|NCT00624286|4078705|P1|NOT COMPLETED|Overall Study||25
1669178|NCT00624286|4078704|P2|COMPLETED|Overall Study||178
1669179|NCT00624286|4078705|P1|COMPLETED|Overall Study||186
1669180|NCT00624286|4078704|P2|STARTED|Overall Study||205
1669181|NCT00624286|4078705|P1|STARTED|Overall Study||211
1669182|NCT00624234|4078719|P6|NOT COMPLETED|Overall Study||0
1669183|NCT00624234|4078720|P5|NOT COMPLETED|Overall Study||0
1669184|NCT00624234|4078721|P4|NOT COMPLETED|Overall Study||0
1669185|NCT00624234|4078722|P3|NOT COMPLETED|Overall Study||0
1669186|NCT00624234|4078723|P2|NOT COMPLETED|Overall Study||0
1669187|NCT00624234|4078724|P1|NOT COMPLETED|Overall Study||0
1669188|NCT00624234|4078719|P6|COMPLETED|Overall Study||14
1669189|NCT00624234|4078720|P5|COMPLETED|Overall Study||18
1669190|NCT00624234|4078721|P4|COMPLETED|Overall Study||14
1669191|NCT00624234|4078722|P3|COMPLETED|Overall Study||26
1669192|NCT00624234|4078723|P2|COMPLETED|Overall Study||9
1669193|NCT00624234|4078724|P1|COMPLETED|Overall Study||8
1669194|NCT00624234|4078719|P6|STARTED|Overall Study||14
1669195|NCT00624234|4078720|P5|STARTED|Overall Study||18
1669196|NCT00624234|4078721|P4|STARTED|Overall Study||14
1669197|NCT00624234|4078722|P3|STARTED|Overall Study||26
1669198|NCT00624234|4078723|P2|STARTED|Overall Study||9
1669199|NCT00624234|4078724|P1|STARTED|Overall Study||8
1669200|NCT00624221|4078740|P2|NOT COMPLETED|Overall Study||0
1669201|NCT00624221|4078741|P1|NOT COMPLETED|Overall Study||0
1669202|NCT00624221|4078740|P2|COMPLETED|Overall Study||20
1669203|NCT00624221|4078741|P1|COMPLETED|Overall Study||20
1669204|NCT00624221|4078740|P2|STARTED|Overall Study||20
1669205|NCT00624221|4078741|P1|STARTED|Overall Study||20
1669206|NCT00624195|4078749|P2|NOT COMPLETED|Overall Study||7
1669207|NCT00624195|4078750|P1|NOT COMPLETED|Overall Study||3
1669208|NCT00624195|4078749|P2|COMPLETED|Overall Study||23
1669209|NCT00624195|4078750|P1|COMPLETED|Overall Study||26
1669210|NCT00624195|4078749|P2|STARTED|Overall Study||30
1669211|NCT00624195|4078750|P1|STARTED|Overall Study||29
1669212|NCT00624065|4078758|P2|NOT COMPLETED|Overall Study||24
1669213|NCT00624065|4078759|P1|NOT COMPLETED|Overall Study||19
1669214|NCT00624065|4078758|P2|COMPLETED|Overall Study||192
1669215|NCT00624065|4078759|P1|COMPLETED|Overall Study||197
1669216|NCT00624065|4078758|P2|STARTED|Overall Study||216
1669217|NCT00624065|4078759|P1|STARTED|Overall Study||216
1669218|NCT00624052|4078771|P4|NOT COMPLETED|Overall Study||4
1669219|NCT00624052|4078772|P3|NOT COMPLETED|Overall Study||3
1669220|NCT00624052|4078773|P2|NOT COMPLETED|Overall Study||14
1669221|NCT00624052|4078774|P1|NOT COMPLETED|Overall Study||15
1669222|NCT00624052|4078771|P4|COMPLETED|Overall Study||88
1669223|NCT00624052|4078772|P3|COMPLETED|Overall Study||88
1669224|NCT00624052|4078773|P2|COMPLETED|Overall Study||422
1669225|NCT00624052|4078774|P1|COMPLETED|Overall Study||204
1669226|NCT00624052|4078771|P4|STARTED|Overall Study||92
1669227|NCT00624052|4078772|P3|STARTED|Overall Study||91
1669228|NCT00624052|4078773|P2|STARTED|Overall Study||436
1669229|NCT00624052|4078774|P1|STARTED|Overall Study||219
1669230|NCT00624013|4078825|P2|NOT COMPLETED|Overall Study||6
1669231|NCT00624013|4078826|P1|NOT COMPLETED|Overall Study||8
1669232|NCT00624013|4078825|P2|COMPLETED|Overall Study||39
1669233|NCT00624013|4078826|P1|COMPLETED|Overall Study||36
1669234|NCT00624013|4078825|P2|STARTED|Overall Study||45
1669235|NCT00624013|4078826|P1|STARTED|Overall Study||44
1669236|NCT00623974|4078838|P4|NOT COMPLETED|Overall Study||0
1669237|NCT00623974|4078839|P3|NOT COMPLETED|Overall Study||0
1669238|NCT00623974|4078840|P2|NOT COMPLETED|Overall Study||0
1669239|NCT00623974|4078841|P1|NOT COMPLETED|Overall Study||0
1669240|NCT00623974|4078838|P4|COMPLETED|Overall Study||0
1669241|NCT00623974|4078839|P3|COMPLETED|Overall Study||0
1669242|NCT00623974|4078840|P2|COMPLETED|Overall Study||0
1669243|NCT00623974|4078841|P1|COMPLETED|Overall Study||0
1669244|NCT00623974|4078838|P4|STARTED|Overall Study||0
1669245|NCT00623974|4078839|P3|STARTED|Overall Study||0
1669246|NCT00623974|4078840|P2|STARTED|Overall Study||0
1669247|NCT00623974|4078841|P1|STARTED|Overall Study||0
1669248|NCT00623935|4078851|P1|NOT COMPLETED|Overall Study||2
1669249|NCT00623935|4078851|P1|COMPLETED|Overall Study||54
1669250|NCT00623935|4078851|P1|STARTED|Overall Study||56
1669251|NCT00623831|4078858|P2|NOT COMPLETED|Overall Study||1
1669252|NCT00623831|4078859|P1|NOT COMPLETED|Overall Study||1
1669253|NCT00623831|4078858|P2|COMPLETED|Overall Study||3
1669254|NCT00623831|4078859|P1|COMPLETED|Overall Study||12
1669255|NCT00623831|4078858|P2|STARTED|Overall Study||4
1669256|NCT00623831|4078859|P1|STARTED|Overall Study||13
1669257|NCT00623805|4078871|P2|NOT COMPLETED|Overall Study||22
1669258|NCT00623805|4078872|P1|NOT COMPLETED|Overall Study||20
1669259|NCT00623805|4078871|P2|COMPLETED|Overall Study||39
1669260|NCT00623805|4078872|P1|COMPLETED|Overall Study||42
1669261|NCT00623805|4078871|P2|STARTED|Overall Study||61
1669262|NCT00623805|4078872|P1|STARTED|Overall Study||62
1669263|NCT00623779|4078889|P3|NOT COMPLETED|Overall Study||1
1669264|NCT00623779|4078890|P2|NOT COMPLETED|Overall Study||3
1669265|NCT00623779|4078891|P1|NOT COMPLETED|Overall Study||3
1669266|NCT00623779|4078889|P3|COMPLETED|Overall Study||44
1669267|NCT00623779|4078890|P2|COMPLETED|Overall Study||39
1669268|NCT00623779|4078891|P1|COMPLETED|Overall Study||38
1669269|NCT00623779|4078889|P3|STARTED|Overall Study||45
1669270|NCT00623779|4078890|P2|STARTED|Overall Study||42
1669271|NCT00623779|4078891|P1|STARTED|Overall Study||41
1669272|NCT00623766|4078940|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
1669273|NCT00623766|4078941|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
1669274|NCT00623766|4078940|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
1669275|NCT00623766|4078941|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
1669276|NCT00623766|4078940|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
1669277|NCT00623766|4078941|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
1669278|NCT00623766|4078940|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
1669279|NCT00623766|4078941|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
1669280|NCT00623766|4078940|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
1669281|NCT00623766|4078941|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
1669282|NCT00623766|4078940|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
1669283|NCT00623766|4078941|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
1669284|NCT00623727|4078965|P2|NOT COMPLETED|Open Label Extension Period||0
1669285|NCT00623727|4078966|P1|NOT COMPLETED|Open Label Extension Period||0
1669286|NCT00623727|4078965|P2|COMPLETED|Open Label Extension Period||0
1669287|NCT00623727|4078966|P1|COMPLETED|Open Label Extension Period||20
1669288|NCT00623727|4078965|P2|STARTED|Open Label Extension Period||0
1669289|NCT00623727|4078966|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
1669290|NCT00623727|4078965|P2|NOT COMPLETED|Open Label Follow-up||8
1669291|NCT00623727|4078966|P1|NOT COMPLETED|Open Label Follow-up||0
1669292|NCT00623727|4078965|P2|COMPLETED|Open Label Follow-up||18
1669293|NCT00623727|4078966|P1|COMPLETED|Open Label Follow-up||0
1669294|NCT00623727|4078965|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
1669295|NCT00623727|4078966|P1|STARTED|Open Label Follow-up||0
1669296|NCT00623727|4078965|P2|NOT COMPLETED|Double Blind (DB)||32
1669297|NCT00623727|4078966|P1|NOT COMPLETED|Double Blind (DB)||36
1669298|NCT00623727|4078965|P2|COMPLETED|Double Blind (DB)||41
1669299|NCT00623727|4078966|P1|COMPLETED|Double Blind (DB)||34
1669300|NCT00623727|4078965|P2|Participants Received Treatment|Double Blind (DB)||72
1669301|NCT00623727|4078966|P1|Participants Received Treatment|Double Blind (DB)||67
1669302|NCT00623727|4078965|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
1669303|NCT00623727|4078966|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
1669304|NCT00623714|4078986|P2|NOT COMPLETED|Period 2||0
1669305|NCT00623714|4078987|P1|NOT COMPLETED|Period 2||0
1669306|NCT00623714|4078986|P2|COMPLETED|Period 2||7
1669307|NCT00623714|4078987|P1|COMPLETED|Period 2||6
1669308|NCT00623714|4078986|P2|STARTED|Period 2||7
1669309|NCT00623714|4078987|P1|STARTED|Period 2||6
1669310|NCT00623714|4078986|P2|NOT COMPLETED|Period 1||0
1669311|NCT00623714|4078987|P1|NOT COMPLETED|Period 1||0
1669312|NCT00623714|4078986|P2|COMPLETED|Period 1||7
1669313|NCT00623714|4078987|P1|COMPLETED|Period 1||6
1669314|NCT00623714|4078986|P2|STARTED|Period 1||7
1669315|NCT00623714|4078987|P1|STARTED|Period 1||6
1669316|NCT00623636|4078997|P2|NOT COMPLETED|Open Label||412
1669317|NCT00623636|4078998|P1|NOT COMPLETED|Open Label||0
1669318|NCT00623636|4078997|P2|COMPLETED|Open Label||263
1669319|NCT00623636|4078998|P1|COMPLETED|Open Label||0
1669320|NCT00623636|4078997|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
1669321|NCT00623636|4078998|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
1669322|NCT00623636|4078997|P2|NOT COMPLETED|Double Blind||28
1669323|NCT00623636|4078998|P1|NOT COMPLETED|Double Blind||33
1669324|NCT00623636|4078997|P2|COMPLETED|Double Blind||422
1669325|NCT00623636|4078998|P1|COMPLETED|Double Blind||419
1669326|NCT00623636|4078997|P2|STARTED|Double Blind||450
1669327|NCT00623636|4078998|P1|STARTED|Double Blind||452
1669328|NCT00623597|4079021|P2|NOT COMPLETED|Overall Study||0
1669329|NCT00623597|4079022|P1|NOT COMPLETED|Overall Study||1
1669330|NCT00623597|4079021|P2|COMPLETED|Overall Study||13
1669331|NCT00623597|4079022|P1|COMPLETED|Overall Study||4
1669332|NCT00623597|4079021|P2|STARTED|Overall Study||13
1669333|NCT00623597|4079022|P1|STARTED|Overall Study||5
1669334|NCT00623545|4079085|P1|NOT COMPLETED|Overall Study||10
1669335|NCT00623545|4079085|P1|COMPLETED|Overall Study||18
1669336|NCT00623545|4079085|P1|STARTED|Overall Study||28
1669337|NCT00623506|4079092|P2|NOT COMPLETED|Overall Study||4
1669338|NCT00623506|4079093|P1|NOT COMPLETED|Overall Study||4
1669339|NCT00623506|4079092|P2|COMPLETED|Overall Study||11
1669340|NCT00623506|4079093|P1|COMPLETED|Overall Study||11
1669341|NCT00623506|4079092|P2|Week 4|Overall Study||11
1669342|NCT00623506|4079093|P1|Week 4|Overall Study||11
1669343|NCT00623506|4079092|P2|STARTED|Overall Study||15
1669344|NCT00623506|4079093|P1|STARTED|Overall Study||15
1669345|NCT00623480|4079105|P2|NOT COMPLETED|Overall Study||7
1669346|NCT00623480|4079106|P1|NOT COMPLETED|Overall Study||7
1669347|NCT00623480|4079105|P2|COMPLETED|Overall Study||35
1669348|NCT00623480|4079106|P1|COMPLETED|Overall Study||35
1669349|NCT00623480|4079105|P2|STARTED|Overall Study||42
1669350|NCT00623480|4079106|P1|STARTED|Overall Study||42
1669351|NCT00623467|4079118|P1|NOT COMPLETED|Overall Study||7
1669352|NCT00623467|4079118|P1|COMPLETED|Overall Study||336
1669353|NCT00623467|4079118|P1|STARTED|Overall Study||343
1669354|NCT00623441|4079182|P1|NOT COMPLETED|Overall Study||0
1669355|NCT00623441|4079182|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
1669356|NCT00623441|4079182|P1|STARTED|Overall Study||8314
1669357|NCT00623428|4079188|P2|NOT COMPLETED|Follow-up Period||15
1669358|NCT00623428|4079189|P1|NOT COMPLETED|Follow-up Period||29
1669359|NCT00623428|4079188|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
1669360|NCT00623428|4079189|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
1669361|NCT00623428|4079188|P2|STARTED|Follow-up Period||93
1669362|NCT00623428|4079189|P1|STARTED|Follow-up Period||95
1669363|NCT00623428|4079188|P2|NOT COMPLETED|Treatment Period||27
1669364|NCT00623428|4079189|P1|NOT COMPLETED|Treatment Period||0
1669365|NCT00623428|4079188|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
1669366|NCT00623428|4079189|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
1669367|NCT00623428|4079188|P2|STARTED|Treatment Period||93
1669368|NCT00623428|4079189|P1|STARTED|Treatment Period||95
1669369|NCT00623233|4079207|P1|NOT COMPLETED|Overall Study||24
1669370|NCT00623233|4079207|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
1669371|NCT00623233|4079207|P1|STARTED|Overall Study||52
1669372|NCT00623194|4079214|P1|NOT COMPLETED|Overall Study||5
1669373|NCT00623194|4079214|P1|COMPLETED|Overall Study||141
1669374|NCT00623194|4079214|P1|STARTED|Overall Study||146
1669375|NCT00623181|4079236|P2|NOT COMPLETED|Overall Study||0
1669376|NCT00623181|4079237|P1|NOT COMPLETED|Overall Study||0
1669377|NCT00623181|4079236|P2|COMPLETED|Overall Study||54
1669378|NCT00623181|4079237|P1|COMPLETED|Overall Study||56
1669379|NCT00623181|4079236|P2|STARTED|Overall Study||54
1669380|NCT00623181|4079237|P1|STARTED|Overall Study||56
1669381|NCT00623103|4079251|P2|NOT COMPLETED|Overall Study||113
1669382|NCT00623103|4079252|P1|NOT COMPLETED|Overall Study||111
1669383|NCT00623103|4079251|P2|COMPLETED|Overall Study||175
1669384|NCT00623103|4079252|P1|COMPLETED|Overall Study||184
1669385|NCT00623103|4079251|P2|Safety Set: Received Study Drug|Overall Study||288
1669386|NCT00623103|4079252|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
1669387|NCT00623103|4079251|P2|STARTED|Overall Study||288
1669388|NCT00623103|4079252|P1|STARTED|Overall Study||295
1669389|NCT00623012|4079272|P1|NOT COMPLETED|Overall Study||0
1669390|NCT00623012|4079272|P1|COMPLETED|Overall Study||2
1669391|NCT00623012|4079272|P1|STARTED|Overall Study||2
1669392|NCT00622908|4079280|P2|NOT COMPLETED|Overall Study||10
1669393|NCT00622908|4079281|P1|NOT COMPLETED|Overall Study||3
1669394|NCT00622908|4079280|P2|COMPLETED|Overall Study||122
1669395|NCT00622908|4079281|P1|COMPLETED|Overall Study||134
1669396|NCT00622908|4079280|P2|STARTED|Overall Study|Intent to treat population|132
1669397|NCT00622908|4079281|P1|STARTED|Overall Study|Intent to treat population|137
1669398|NCT00622895|4079293|P1|NOT COMPLETED|Overall Study||0
1669399|NCT00622895|4079293|P1|COMPLETED|Overall Study||3
1669400|NCT00622895|4079293|P1|STARTED|Overall Study||3
1669401|NCT00622869|4079311|P3|NOT COMPLETED|Overall Study||39
1669402|NCT00622869|4079312|P2|NOT COMPLETED|Overall Study||57
1669403|NCT00622869|4079313|P1|NOT COMPLETED|Overall Study||43
1669404|NCT00622869|4079311|P3|COMPLETED|Overall Study||204
1669405|NCT00622869|4079312|P2|COMPLETED|Overall Study||174
1669406|NCT00622869|4079313|P1|COMPLETED|Overall Study||202
1669407|NCT00622869|4079311|P3|STARTED|Overall Study||243
1669408|NCT00622869|4079312|P2|STARTED|Overall Study||231
1669409|NCT00622869|4079313|P1|STARTED|Overall Study||245
1669410|NCT00622739|4079332|P2|NOT COMPLETED|Overall Study||6
1669411|NCT00622739|4079333|P1|NOT COMPLETED|Overall Study||2
1669412|NCT00622739|4079332|P2|COMPLETED|Overall Study||9
1669413|NCT00622739|4079333|P1|COMPLETED|Overall Study||11
1669414|NCT00622739|4079332|P2|STARTED|Overall Study||15
1669415|NCT00622739|4079333|P1|STARTED|Overall Study||13
1669416|NCT00622726|4079341|P2|NOT COMPLETED|August, 2010 to April, 2013||5
1669417|NCT00622726|4079342|P1|NOT COMPLETED|August, 2010 to April, 2013||1
1669418|NCT00622726|4079341|P2|COMPLETED|August, 2010 to April, 2013||68
1669419|NCT00622726|4079342|P1|COMPLETED|August, 2010 to April, 2013||69
1669420|NCT00622726|4079341|P2|STARTED|August, 2010 to April, 2013||73
1669421|NCT00622726|4079342|P1|STARTED|August, 2010 to April, 2013||70
1669422|NCT00622726|4079341|P2|NOT COMPLETED|March, 2008 to August, 2010||2
1669423|NCT00622726|4079342|P1|NOT COMPLETED|March, 2008 to August, 2010||5
1669424|NCT00622726|4079341|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
1669425|NCT00622726|4079342|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
1669426|NCT00622726|4079341|P2|STARTED|March, 2008 to August, 2010||75
1669427|NCT00622726|4079342|P1|STARTED|March, 2008 to August, 2010||75
1669428|NCT00622713|4079352|P1|NOT COMPLETED|Overall Study||59
1669429|NCT00622713|4079352|P1|COMPLETED|Overall Study||169
1669430|NCT00622713|4079352|P1|Intent to Treat (ITT) Population|Overall Study||218
1669431|NCT00622713|4079352|P1|Exposed to Study Drug|Overall Study||226
1669432|NCT00622713|4079352|P1|STARTED|Overall Study||228
1669433|NCT00622700|4079363|P7|NOT COMPLETED|Extension Treatment Period||30
1669434|NCT00622700|4079364|P6|NOT COMPLETED|Extension Treatment Period||17
1669435|NCT00622700|4079365|P5|NOT COMPLETED|Extension Treatment Period||39
1669436|NCT00622700|4079366|P4|NOT COMPLETED|Extension Treatment Period||21
1669437|NCT00622700|4079367|P3|NOT COMPLETED|Extension Treatment Period||0
1669438|NCT00622700|4079368|P2|NOT COMPLETED|Extension Treatment Period||0
1669439|NCT00622700|4079369|P1|NOT COMPLETED|Extension Treatment Period||0
1669440|NCT00622700|4079363|P7|COMPLETED|Extension Treatment Period||120
1669441|NCT00622700|4079364|P6|COMPLETED|Extension Treatment Period||50
1669442|NCT00622700|4079365|P5|COMPLETED|Extension Treatment Period||103
1669443|NCT00622700|4079366|P4|COMPLETED|Extension Treatment Period||43
1669444|NCT00622700|4079367|P3|COMPLETED|Extension Treatment Period||0
1669445|NCT00622700|4079368|P2|COMPLETED|Extension Treatment Period||0
1669446|NCT00622700|4079369|P1|COMPLETED|Extension Treatment Period||0
1669447|NCT00622700|4079363|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
1669448|NCT00622700|4079364|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
1669449|NCT00622700|4079365|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
1669450|NCT00622700|4079366|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
1669451|NCT00622700|4079367|P3|STARTED|Extension Treatment Period||0
1669452|NCT00622700|4079368|P2|STARTED|Extension Treatment Period||0
1669453|NCT00622700|4079369|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
1669454|NCT00622700|4079363|P7|NOT COMPLETED|Core Treatment Period||0
1669455|NCT00622700|4079364|P6|NOT COMPLETED|Core Treatment Period||0
1669456|NCT00622700|4079365|P5|NOT COMPLETED|Core Treatment Period||0
1669457|NCT00622700|4079366|P4|NOT COMPLETED|Core Treatment Period||0
1669458|NCT00622700|4079367|P3|NOT COMPLETED|Core Treatment Period||53
1669459|NCT00622700|4079368|P2|NOT COMPLETED|Core Treatment Period||55
1669460|NCT00622700|4079369|P1|NOT COMPLETED|Core Treatment Period||56
1669461|NCT00622700|4079363|P7|COMPLETED|Core Treatment Period||0
1669462|NCT00622700|4079364|P6|COMPLETED|Core Treatment Period||0
1669463|NCT00622700|4079365|P5|COMPLETED|Core Treatment Period||0
1669464|NCT00622700|4079366|P4|COMPLETED|Core Treatment Period||0
1669465|NCT00622700|4079367|P3|COMPLETED|Core Treatment Period||163
1669466|NCT00622700|4079368|P2|COMPLETED|Core Treatment Period||150
1669467|NCT00622700|4079369|P1|COMPLETED|Core Treatment Period||141
1669468|NCT00622700|4079363|P7|Treated|Core Treatment Period||0
1669469|NCT00622700|4079364|P6|Treated|Core Treatment Period||0
1669470|NCT00622700|4079365|P5|Treated|Core Treatment Period||0
1669471|NCT00622700|4079366|P4|Treated|Core Treatment Period||0
1669472|NCT00622700|4079367|P3|Treated|Core Treatment Period||214
1669473|NCT00622700|4079368|P2|Treated|Core Treatment Period||203
1669474|NCT00622700|4079369|P1|Treated|Core Treatment Period||197
1669475|NCT00622700|4079363|P7|STARTED|Core Treatment Period||0
1669476|NCT00622700|4079364|P6|STARTED|Core Treatment Period||0
1669477|NCT00622700|4079365|P5|STARTED|Core Treatment Period||0
1669478|NCT00622700|4079366|P4|STARTED|Core Treatment Period||0
1669479|NCT00622700|4079367|P3|STARTED|Core Treatment Period||216
1669480|NCT00622700|4079368|P2|STARTED|Core Treatment Period||205
1669481|NCT00622700|4079369|P1|STARTED|Core Treatment Period||197
1669482|NCT00622635|4079428|P6|NOT COMPLETED|Treatment Period 3||0
1669483|NCT00622635|4079429|P5|NOT COMPLETED|Treatment Period 3||0
1669484|NCT00622635|4079430|P4|NOT COMPLETED|Treatment Period 3||3
1669485|NCT00622635|4079431|P3|NOT COMPLETED|Treatment Period 3||0
1669486|NCT00622635|4079432|P2|NOT COMPLETED|Treatment Period 3||0
1669487|NCT00622635|4079433|P1|NOT COMPLETED|Treatment Period 3||0
1669488|NCT00622635|4079428|P6|COMPLETED|Treatment Period 3||10
1669489|NCT00622635|4079429|P5|COMPLETED|Treatment Period 3||9
1669490|NCT00622635|4079430|P4|COMPLETED|Treatment Period 3||10
1669491|NCT00622635|4079431|P3|COMPLETED|Treatment Period 3||10
1669492|NCT00622635|4079432|P2|COMPLETED|Treatment Period 3||10
1669493|NCT00622635|4079433|P1|COMPLETED|Treatment Period 3||12
1669494|NCT00622635|4079428|P6|STARTED|Treatment Period 3||10
1669495|NCT00622635|4079429|P5|STARTED|Treatment Period 3||9
1669496|NCT00622635|4079430|P4|STARTED|Treatment Period 3||13
1669497|NCT00622635|4079431|P3|STARTED|Treatment Period 3||10
1669498|NCT00622635|4079432|P2|STARTED|Treatment Period 3||10
1669499|NCT00622635|4079433|P1|STARTED|Treatment Period 3||12
1669500|NCT00622635|4079428|P6|NOT COMPLETED|Treatment Period 2||0
1669501|NCT00622635|4079429|P5|NOT COMPLETED|Treatment Period 2||0
1669502|NCT00622635|4079430|P4|NOT COMPLETED|Treatment Period 2||0
1669503|NCT00622635|4079431|P3|NOT COMPLETED|Treatment Period 2||0
1669504|NCT00622635|4079432|P2|NOT COMPLETED|Treatment Period 2||0
1669505|NCT00622635|4079433|P1|NOT COMPLETED|Treatment Period 2||1
1669506|NCT00622635|4079428|P6|COMPLETED|Treatment Period 2||10
1669507|NCT00622635|4079429|P5|COMPLETED|Treatment Period 2||9
1669508|NCT00622635|4079430|P4|COMPLETED|Treatment Period 2||13
1669509|NCT00622635|4079431|P3|COMPLETED|Treatment Period 2||10
1669510|NCT00622635|4079432|P2|COMPLETED|Treatment Period 2||10
1669511|NCT00622635|4079433|P1|COMPLETED|Treatment Period 2||12
1669512|NCT00622635|4079428|P6|STARTED|Treatment Period 2||10
1669513|NCT00622635|4079429|P5|STARTED|Treatment Period 2||9
1669514|NCT00622635|4079430|P4|STARTED|Treatment Period 2||13
1669515|NCT00622635|4079431|P3|STARTED|Treatment Period 2||10
1669516|NCT00622635|4079432|P2|STARTED|Treatment Period 2||10
1669517|NCT00622635|4079433|P1|STARTED|Treatment Period 2||13
1669518|NCT00622635|4079428|P6|NOT COMPLETED|Treatment Period 1||0
1669519|NCT00622635|4079429|P5|NOT COMPLETED|Treatment Period 1||1
1669520|NCT00622635|4079430|P4|NOT COMPLETED|Treatment Period 1||0
1669521|NCT00622635|4079431|P3|NOT COMPLETED|Treatment Period 1||1
1669522|NCT00622635|4079432|P2|NOT COMPLETED|Treatment Period 1||1
1669523|NCT00622635|4079433|P1|NOT COMPLETED|Treatment Period 1||0
1669524|NCT00622635|4079428|P6|COMPLETED|Treatment Period 1||10
1669525|NCT00622635|4079429|P5|COMPLETED|Treatment Period 1||9
1669526|NCT00622635|4079430|P4|COMPLETED|Treatment Period 1||13
1669527|NCT00622635|4079431|P3|COMPLETED|Treatment Period 1||10
1669528|NCT00622635|4079432|P2|COMPLETED|Treatment Period 1||10
1669529|NCT00622635|4079433|P1|COMPLETED|Treatment Period 1||13
1669530|NCT00622635|4079428|P6|STARTED|Treatment Period 1||10
1669531|NCT00622635|4079429|P5|STARTED|Treatment Period 1||10
1669532|NCT00622635|4079430|P4|STARTED|Treatment Period 1||13
1669533|NCT00622635|4079431|P3|STARTED|Treatment Period 1||11
1669534|NCT00622635|4079432|P2|STARTED|Treatment Period 1||11
1669535|NCT00622635|4079433|P1|STARTED|Treatment Period 1||13
1669536|NCT00622544|4079498|P1|NOT COMPLETED|Overall Study||9
1669537|NCT00622544|4079498|P1|COMPLETED|Overall Study|35|35
1669538|NCT00622544|4079498|P1|STARTED|Overall Study||44
1669539|NCT00622518|4079505|P2|NOT COMPLETED|Overall Study||0
1669540|NCT00622518|4079506|P1|NOT COMPLETED|Overall Study||0
1669541|NCT00622518|4079505|P2|COMPLETED|Overall Study||60
1669542|NCT00622518|4079506|P1|COMPLETED|Overall Study||59
1669543|NCT00622518|4079505|P2|STARTED|Overall Study||60
1669544|NCT00622518|4079506|P1|STARTED|Overall Study||59
1669545|NCT00622440|4079516|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
1669546|NCT00622440|4079517|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
1669547|NCT00622440|4079516|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
1669548|NCT00622440|4079517|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
1669549|NCT00622440|4079516|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
1669550|NCT00622440|4079517|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
1669551|NCT00622440|4079516|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
1669552|NCT00622440|4079517|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
1669553|NCT00622440|4079516|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
1669554|NCT00622440|4079517|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
1669555|NCT00622440|4079516|P2|STARTED|Week 12 - Week 48 (Treatment)||34
1669556|NCT00622440|4079517|P1|STARTED|Week 12 - Week 48 (Treatment)||31
1669557|NCT00622440|4079516|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
1669558|NCT00622440|4079517|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
1669559|NCT00622440|4079516|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
1669560|NCT00622440|4079517|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
1669561|NCT00622440|4079516|P2|STARTED|Baseline - Week 12 (Treatment)||35
1669562|NCT00622440|4079517|P1|STARTED|Baseline - Week 12 (Treatment)||35
1669563|NCT00622427|4079531|P2|NOT COMPLETED|Overall Study||0
1669564|NCT00622427|4079532|P1|NOT COMPLETED|Overall Study||0
1669565|NCT00622427|4079531|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
1669566|NCT00622427|4079532|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
1669567|NCT00622427|4079531|P2|STARTED|Overall Study||16
1669568|NCT00622427|4079532|P1|STARTED|Overall Study||16
1669569|NCT00622401|4079543|P3|NOT COMPLETED|Overall Study||0
1669570|NCT00622401|4079544|P2|NOT COMPLETED|Overall Study||2
1669571|NCT00622401|4079545|P1|NOT COMPLETED|Overall Study||3
1669572|NCT00622401|4079543|P3|COMPLETED|Overall Study||0
1669573|NCT00622401|4079544|P2|COMPLETED|Overall Study||0
1669574|NCT00622401|4079545|P1|COMPLETED|Overall Study||3
1669575|NCT00622401|4079543|P3|STARTED|Overall Study|Never Opened|0
1669576|NCT00622401|4079544|P2|STARTED|Overall Study||2
1669577|NCT00622401|4079545|P1|STARTED|Overall Study||6
1669578|NCT00622388|4079552|P1|NOT COMPLETED|Overall Study||72
1669579|NCT00622388|4079552|P1|COMPLETED|Overall Study||9
1669580|NCT00622388|4079552|P1|STARTED|Overall Study||81
1669581|NCT00622336|4079570|P1|NOT COMPLETED|Extension Phase||21
1669582|NCT00622336|4079570|P1|COMPLETED|Extension Phase||0
1669583|NCT00622336|4079570|P1|STARTED|Extension Phase||21
1669584|NCT00622336|4079570|P1|NOT COMPLETED|Treatment Phase||309
1669585|NCT00622336|4079570|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
1669586|NCT00622336|4079570|P1|Safety Population|Treatment Phase||330
1669587|NCT00622336|4079570|P1|STARTED|Treatment Phase||330
1669588|NCT00622284|4079581|P2|NOT COMPLETED|Overall Study||171
1669589|NCT00622284|4079582|P1|NOT COMPLETED|Overall Study||189
1669590|NCT00622284|4079581|P2|COMPLETED|Overall Study|Number who completed treatment.|604
1669591|NCT00622284|4079582|P1|COMPLETED|Overall Study|Number who completed treatment.|587
1669592|NCT00622284|4079581|P2|STARTED|Overall Study|Number who started treatment.|775
1669593|NCT00622284|4079582|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
1669594|NCT00622167|4079644|P1|NOT COMPLETED|Overall Study||20
1669595|NCT00622167|4079644|P1|COMPLETED|Overall Study||4
1669596|NCT00622167|4079644|P1|STARTED|Overall Study||24
1669597|NCT00621985|4079648|P1|NOT COMPLETED|Dexamethasone Admission||1
1669598|NCT00621985|4079648|P1|COMPLETED|Dexamethasone Admission||4
1669599|NCT00621985|4079648|P1|STARTED|Dexamethasone Admission||5
1669600|NCT00621985|4079648|P1|NOT COMPLETED|Hydrocortisone Admission||0
1669601|NCT00621985|4079648|P1|COMPLETED|Hydrocortisone Admission||5
1669602|NCT00621985|4079648|P1|STARTED|Hydrocortisone Admission||5
1669603|NCT00621959|4079656|P2|NOT COMPLETED|Overall Study||9
1669604|NCT00621959|4079657|P1|NOT COMPLETED|Overall Study||7
1669605|NCT00621959|4079656|P2|COMPLETED|Overall Study||292
1669606|NCT00621959|4079657|P1|COMPLETED|Overall Study||288
1669607|NCT00621959|4079656|P2|STARTED|Overall Study||301
1669608|NCT00621959|4079657|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
1669609|NCT00621946|4079667|P2|NOT COMPLETED|Overall Study||1
1669610|NCT00621946|4079668|P1|NOT COMPLETED|Overall Study||0
1669611|NCT00621946|4079667|P2|COMPLETED|Overall Study||12
1669612|NCT00621946|4079668|P1|COMPLETED|Overall Study||13
1669613|NCT00621946|4079667|P2|STARTED|Overall Study||13
1669614|NCT00621946|4079668|P1|STARTED|Overall Study||13
1669615|NCT00621933|4079684|P1|NOT COMPLETED|Overall Study||0
1669616|NCT00621933|4079684|P1|COMPLETED|Overall Study||399
1669617|NCT00621933|4079684|P1|STARTED|Overall Study||399
1669618|NCT00621855|4079696|P5|NOT COMPLETED|Overall Study||55
1669619|NCT00621855|4079697|P4|NOT COMPLETED|Overall Study||67
1669620|NCT00621855|4079698|P3|NOT COMPLETED|Overall Study||81
1669621|NCT00621855|4079699|P2|NOT COMPLETED|Overall Study||61
1669622|NCT00621855|4079700|P1|NOT COMPLETED|Overall Study||76
1669623|NCT00621855|4079696|P5|COMPLETED|Overall Study|Completed means completed treatment|318
1669624|NCT00621855|4079697|P4|COMPLETED|Overall Study|Completed means completed treatment|284
1669625|NCT00621855|4079698|P3|COMPLETED|Overall Study|Completed means completed treatment|330
1669626|NCT00621855|4079699|P2|COMPLETED|Overall Study|Completed means completed treatment|310
1669627|NCT00621855|4079700|P1|COMPLETED|Overall Study|Completed means completed treatment|296
1669628|NCT00621855|4079696|P5|STARTED|Overall Study|Started means randomised to treatment|373
1669629|NCT00621855|4079697|P4|STARTED|Overall Study|Started means randomised to treatment|351
1669630|NCT00621855|4079698|P3|STARTED|Overall Study|Started means randomised to treatment|411
1669631|NCT00621855|4079699|P2|STARTED|Overall Study|Started means randomised to treatment|371
1669632|NCT00621855|4079700|P1|STARTED|Overall Study|Started means randomised to treatment|372
1669633|NCT00621842|4079742|P1|NOT COMPLETED|Overall Study||19
1669634|NCT00621842|4079742|P1|COMPLETED|Overall Study||38
1669635|NCT00621842|4079742|P1|STARTED|Overall Study||57
1669636|NCT00621777|4079759|P2|NOT COMPLETED|Randomized Phase||19
1669637|NCT00621777|4079760|P1|NOT COMPLETED|Randomized Phase||7
1669638|NCT00621777|4079759|P2|COMPLETED|Randomized Phase||28
1669639|NCT00621777|4079760|P1|COMPLETED|Randomized Phase||33
1669640|NCT00621777|4079759|P2|STARTED|Randomized Phase||47
1669641|NCT00621777|4079760|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
1669642|NCT00621777|4079759|P2|NOT COMPLETED|Open Phase||0
1669643|NCT00621777|4079760|P1|NOT COMPLETED|Open Phase||116
1669644|NCT00621777|4079759|P2|COMPLETED|Open Phase||0
1669645|NCT00621777|4079760|P1|COMPLETED|Open Phase||87
1669646|NCT00621777|4079759|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
1669647|NCT00621777|4079760|P1|STARTED|Open Phase||203
1669648|NCT00621764|4079775|P4|NOT COMPLETED|Overall Study||1
1669649|NCT00621764|4079776|P3|NOT COMPLETED|Overall Study||0
1669650|NCT00621764|4079777|P2|NOT COMPLETED|Overall Study||0
1669651|NCT00621764|4079778|P1|NOT COMPLETED|Overall Study||0
1669652|NCT00621764|4079775|P4|COMPLETED|Overall Study||98
1669653|NCT00621764|4079776|P3|COMPLETED|Overall Study||101
1669654|NCT00621764|4079777|P2|COMPLETED|Overall Study||50
1669655|NCT00621764|4079778|P1|COMPLETED|Overall Study||50
1669656|NCT00621764|4079775|P4|STARTED|Overall Study||99
1669657|NCT00621764|4079776|P3|STARTED|Overall Study||101
1669658|NCT00621764|4079777|P2|STARTED|Overall Study||50
1669659|NCT00621764|4079778|P1|STARTED|Overall Study||50
1669660|NCT00621686|4079810|P2|NOT COMPLETED|Overall Study||0
1669661|NCT00621686|4079811|P1|NOT COMPLETED|Overall Study||0
1669662|NCT00621686|4079810|P2|COMPLETED|Overall Study||35
1669663|NCT00621686|4079811|P1|COMPLETED|Overall Study||19
1669664|NCT00621686|4079810|P2|STARTED|Overall Study||35
1669665|NCT00621686|4079811|P1|STARTED|Overall Study||19
1669666|NCT00621621|4079824|P2|NOT COMPLETED|Overall Study||0
1669667|NCT00621621|4079825|P1|NOT COMPLETED|Overall Study||30
1669668|NCT00621621|4079824|P2|COMPLETED|Overall Study||705
1669669|NCT00621621|4079825|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
1669670|NCT00621621|4079824|P2|STARTED|Overall Study||705
1669671|NCT00621621|4079825|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
1669672|NCT00621582|4079833|P1|NOT COMPLETED|Overall Study||106
1669673|NCT00621582|4079833|P1|COMPLETED|Overall Study||4812
1669674|NCT00621582|4079833|P1|STARTED|Overall Study||4918
1669675|NCT00621543|4079840|P1|NOT COMPLETED|Overall Study||23
1669676|NCT00621543|4079840|P1|COMPLETED|Overall Study||97
1669677|NCT00621543|4079840|P1|STARTED|Overall Study||120
1669678|NCT00621530|4079847|P2|NOT COMPLETED|Overall Study||3
1669679|NCT00621530|4079848|P1|NOT COMPLETED|Overall Study||2
1669680|NCT00621530|4079847|P2|COMPLETED|Overall Study||29
1669681|NCT00621530|4079848|P1|COMPLETED|Overall Study||28
1669682|NCT00621530|4079847|P2|STARTED|Overall Study||32
1669683|NCT00621530|4079848|P1|STARTED|Overall Study||30
1669684|NCT00621517|4079864|P2|NOT COMPLETED|Overall Study||7
1669685|NCT00621517|4079865|P1|NOT COMPLETED|Overall Study||7
1669686|NCT00621517|4079864|P2|COMPLETED|Overall Study||24
1669687|NCT00621517|4079865|P1|COMPLETED|Overall Study||22
1669688|NCT00621517|4079864|P2|STARTED|Overall Study||31
1669689|NCT00621517|4079865|P1|STARTED|Overall Study||29
1669690|NCT00621504|4079873|P2|NOT COMPLETED|Overall Study||25
1669691|NCT00621504|4079874|P1|NOT COMPLETED|Overall Study||26
1669692|NCT00621504|4079873|P2|COMPLETED|Overall Study||282
1669693|NCT00621504|4079874|P1|COMPLETED|Overall Study||273
1669694|NCT00621504|4079873|P2|STARTED|Overall Study||307
1669695|NCT00621504|4079874|P1|STARTED|Overall Study||299
1669696|NCT00621348|4079883|P3|NOT COMPLETED|Overall Study||0
1669697|NCT00621348|4079884|P2|NOT COMPLETED|Overall Study||0
1669698|NCT00621348|4079885|P1|NOT COMPLETED|Overall Study||0
1669699|NCT00621348|4079883|P3|COMPLETED|Overall Study||56
1669700|NCT00621348|4079884|P2|COMPLETED|Overall Study||53
1669701|NCT00621348|4079885|P1|COMPLETED|Overall Study||58
1669702|NCT00621348|4079883|P3|STARTED|Overall Study||56
1669703|NCT00621348|4079884|P2|STARTED|Overall Study||53
1669704|NCT00621348|4079885|P1|STARTED|Overall Study||58
1669705|NCT00621322|4079908|P6|NOT COMPLETED|Overall Study||4
1669706|NCT00621322|4079909|P5|NOT COMPLETED|Overall Study||1
1669707|NCT00621322|4079910|P4|NOT COMPLETED|Overall Study||3
1669708|NCT00621322|4079911|P3|NOT COMPLETED|Overall Study||2
1669709|NCT00621322|4079912|P2|NOT COMPLETED|Overall Study||0
1669710|NCT00621322|4079913|P1|NOT COMPLETED|Overall Study||1
1669711|NCT00621322|4079908|P6|COMPLETED|Overall Study||36
1669712|NCT00621322|4079909|P5|COMPLETED|Overall Study||39
1669713|NCT00621322|4079910|P4|COMPLETED|Overall Study||37
1669714|NCT00621322|4079911|P3|COMPLETED|Overall Study||38
1669715|NCT00621322|4079912|P2|COMPLETED|Overall Study||10
1669716|NCT00621322|4079913|P1|COMPLETED|Overall Study||9
1669717|NCT00621322|4079908|P6|STARTED|Overall Study||40
1669718|NCT00621322|4079909|P5|STARTED|Overall Study||40
1669719|NCT00621322|4079910|P4|STARTED|Overall Study||40
1669720|NCT00621322|4079911|P3|STARTED|Overall Study||40
1669721|NCT00621322|4079912|P2|STARTED|Overall Study||10
1669722|NCT00621322|4079913|P1|STARTED|Overall Study||10
1669723|NCT00621296|4079993|P1|NOT COMPLETED|Overall Study||14
1669724|NCT00621296|4079993|P1|COMPLETED|Overall Study||1
1669725|NCT00621296|4079993|P1|STARTED|Overall Study||15
1669726|NCT00621257|4080002|P5|NOT COMPLETED|Overall Study||9
1669727|NCT00621257|4080003|P4|NOT COMPLETED|Overall Study||6
1669728|NCT00621257|4080004|P3|NOT COMPLETED|Overall Study||3
1669729|NCT00621257|4080005|P2|NOT COMPLETED|Overall Study||3
1669730|NCT00621257|4080006|P1|NOT COMPLETED|Overall Study||4
1669731|NCT00621257|4080002|P5|COMPLETED|Overall Study||22
1669732|NCT00621257|4080003|P4|COMPLETED|Overall Study||26
1669733|NCT00621257|4080004|P3|COMPLETED|Overall Study||20
1669734|NCT00621257|4080005|P2|COMPLETED|Overall Study||21
1669735|NCT00621257|4080006|P1|COMPLETED|Overall Study||20
1669736|NCT00621257|4080002|P5|STARTED|Overall Study||31
1669737|NCT00621257|4080003|P4|STARTED|Overall Study||32
1669738|NCT00621257|4080004|P3|STARTED|Overall Study||23
1669739|NCT00621257|4080005|P2|STARTED|Overall Study||24
1669740|NCT00621257|4080006|P1|STARTED|Overall Study||24
1669741|NCT00621244|4080022|P4|NOT COMPLETED|Overall Study||23
1669742|NCT00621244|4080023|P3|NOT COMPLETED|Overall Study||33
1669743|NCT00621244|4080024|P2|NOT COMPLETED|Overall Study||34
1669744|NCT00621244|4080025|P1|NOT COMPLETED|Overall Study||86
1669745|NCT00621244|4080022|P4|COMPLETED|Overall Study||0
1669746|NCT00621244|4080023|P3|COMPLETED|Overall Study||0
1669747|NCT00621244|4080024|P2|COMPLETED|Overall Study||0
1669748|NCT00621244|4080025|P1|COMPLETED|Overall Study||0
1669749|NCT00621244|4080022|P4|STARTED|Overall Study||23
1669750|NCT00621244|4080023|P3|STARTED|Overall Study||33
1669751|NCT00621244|4080024|P2|STARTED|Overall Study||34
1669752|NCT00621244|4080025|P1|STARTED|Overall Study||86
1669753|NCT00621192|4080129|P4|NOT COMPLETED|Overall Study||3
1669754|NCT00621192|4080130|P3|NOT COMPLETED|Overall Study||5
1669755|NCT00621192|4080131|P2|NOT COMPLETED|Overall Study||9
1669756|NCT00621192|4080132|P1|NOT COMPLETED|Overall Study||4
1669757|NCT00621192|4080129|P4|COMPLETED|Overall Study||24
1669758|NCT00621192|4080130|P3|COMPLETED|Overall Study||26
1669759|NCT00621192|4080131|P2|COMPLETED|Overall Study||94
1669760|NCT00621192|4080132|P1|COMPLETED|Overall Study||35
1669761|NCT00621192|4080129|P4|Efficacy Population|Overall Study||27
1669762|NCT00621192|4080130|P3|Efficacy Population|Overall Study||28
1669763|NCT00621192|4080131|P2|Efficacy Population|Overall Study||101
1669764|NCT00621192|4080132|P1|Efficacy Population|Overall Study||39
1669765|NCT00621192|4080129|P4|Safety Population|Overall Study||27
1669766|NCT00621192|4080130|P3|Safety Population|Overall Study||31
1669767|NCT00621192|4080131|P2|Safety Population|Overall Study||103
1669768|NCT00621192|4080132|P1|Safety Population|Overall Study||39
1669769|NCT00621192|4080129|P4|STARTED|Overall Study||27
1669770|NCT00621192|4080130|P3|STARTED|Overall Study||31
1669771|NCT00621192|4080131|P2|STARTED|Overall Study||103
1669772|NCT00621192|4080132|P1|STARTED|Overall Study||39
1669773|NCT00621153|4080156|P2|NOT COMPLETED|Overall Study||15
1669774|NCT00621153|4080157|P1|NOT COMPLETED|Overall Study||20
1669775|NCT00621153|4080156|P2|COMPLETED|Overall Study|completed|101
1669776|NCT00621153|4080157|P1|COMPLETED|Overall Study|completed|97
1669777|NCT00621153|4080156|P2|Discontinued|Overall Study||15
1669778|NCT00621153|4080157|P1|Discontinued|Overall Study||20
1669779|NCT00621153|4080156|P2|STARTED|Overall Study|randomised|116
1669780|NCT00621153|4080157|P1|STARTED|Overall Study|randomised|117
1669781|NCT00621140|4080165|P2|NOT COMPLETED|Overall Study||18
1669782|NCT00621140|4080166|P1|NOT COMPLETED|Overall Study||15
1669783|NCT00621140|4080165|P2|COMPLETED|Overall Study|number who completed treatment|318
1669784|NCT00621140|4080166|P1|COMPLETED|Overall Study|number who completed treatment|152
1669785|NCT00621140|4080165|P2|STARTED|Overall Study|number who started treatment|336
1669786|NCT00621140|4080166|P1|STARTED|Overall Study|number who started treatment|167
1669787|NCT00621049|4080200|P2|NOT COMPLETED|Maintenance Treatment||0
1669788|NCT00621049|4080201|P1|NOT COMPLETED|Maintenance Treatment||15
1669789|NCT00621049|4080200|P2|COMPLETED|Maintenance Treatment||0
1669790|NCT00621049|4080201|P1|COMPLETED|Maintenance Treatment||34
1669791|NCT00621049|4080200|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
1669792|NCT00621049|4080201|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
1669793|NCT00621049|4080200|P2|NOT COMPLETED|Adjuvant Treatment||10
1669794|NCT00621049|4080201|P1|NOT COMPLETED|Adjuvant Treatment||3
1669795|NCT00621049|4080200|P2|COMPLETED|Adjuvant Treatment||47
1669796|NCT00621049|4080201|P1|COMPLETED|Adjuvant Treatment||52
1669797|NCT00621049|4080200|P2|STARTED|Adjuvant Treatment||57
1669798|NCT00621049|4080201|P1|STARTED|Adjuvant Treatment||55
1669799|NCT00621023|4080213|P1|NOT COMPLETED|Overall Study||6
1669800|NCT00621023|4080213|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
1669801|NCT00621023|4080213|P1|STARTED|Overall Study||6
1669802|NCT00620945|4080219|P1|NOT COMPLETED|Overall Study||0
1669803|NCT00620945|4080219|P1|COMPLETED|Overall Study||87
1669804|NCT00620945|4080219|P1|STARTED|Overall Study|Total number in the study|87
1669805|NCT00620854|4080230|P6|NOT COMPLETED|Period 3||0
1669806|NCT00620854|4080231|P5|NOT COMPLETED|Period 3||0
1669807|NCT00620854|4080232|P4|NOT COMPLETED|Period 3||0
1669808|NCT00620854|4080233|P3|NOT COMPLETED|Period 3||0
1669809|NCT00620854|4080234|P2|NOT COMPLETED|Period 3||0
1669810|NCT00620854|4080235|P1|NOT COMPLETED|Period 3||0
1669811|NCT00620854|4080230|P6|COMPLETED|Period 3||4
1669812|NCT00620854|4080231|P5|COMPLETED|Period 3||4
1669813|NCT00620854|4080232|P4|COMPLETED|Period 3||3
1669814|NCT00620854|4080233|P3|COMPLETED|Period 3||3
1669815|NCT00620854|4080234|P2|COMPLETED|Period 3||4
1669816|NCT00620854|4080235|P1|COMPLETED|Period 3||4
1669817|NCT00620854|4080230|P6|STARTED|Period 3||4
1669818|NCT00620854|4080231|P5|STARTED|Period 3||4
1669819|NCT00620854|4080232|P4|STARTED|Period 3||3
1669820|NCT00620854|4080233|P3|STARTED|Period 3||3
1669821|NCT00620854|4080234|P2|STARTED|Period 3||4
1669822|NCT00620854|4080235|P1|STARTED|Period 3||4
1669823|NCT00620854|4080230|P6|NOT COMPLETED|Washout 2||0
1669824|NCT00620854|4080231|P5|NOT COMPLETED|Washout 2||0
1669825|NCT00620854|4080232|P4|NOT COMPLETED|Washout 2||0
1669826|NCT00620854|4080233|P3|NOT COMPLETED|Washout 2||0
1669827|NCT00620854|4080234|P2|NOT COMPLETED|Washout 2||0
1669828|NCT00620854|4080235|P1|NOT COMPLETED|Washout 2||0
1669829|NCT00620854|4080230|P6|COMPLETED|Washout 2||4
1669830|NCT00620854|4080231|P5|COMPLETED|Washout 2||4
1669831|NCT00620854|4080232|P4|COMPLETED|Washout 2||3
1669832|NCT00620854|4080233|P3|COMPLETED|Washout 2||3
1669833|NCT00620854|4080234|P2|COMPLETED|Washout 2||4
1669834|NCT00620854|4080235|P1|COMPLETED|Washout 2||4
1669835|NCT00620854|4080230|P6|STARTED|Washout 2||4
1669836|NCT00620854|4080231|P5|STARTED|Washout 2||4
1669837|NCT00620854|4080232|P4|STARTED|Washout 2||3
1669838|NCT00620854|4080233|P3|STARTED|Washout 2||3
1669839|NCT00620854|4080234|P2|STARTED|Washout 2||4
1669840|NCT00620854|4080235|P1|STARTED|Washout 2||4
1669841|NCT00620854|4080230|P6|NOT COMPLETED|Period 2||0
1669842|NCT00620854|4080231|P5|NOT COMPLETED|Period 2||0
1669843|NCT00620854|4080232|P4|NOT COMPLETED|Period 2||0
1669844|NCT00620854|4080233|P3|NOT COMPLETED|Period 2||0
1669845|NCT00620854|4080234|P2|NOT COMPLETED|Period 2||0
1669846|NCT00620854|4080235|P1|NOT COMPLETED|Period 2||0
1669847|NCT00620854|4080230|P6|COMPLETED|Period 2||4
1669848|NCT00620854|4080231|P5|COMPLETED|Period 2||4
1669849|NCT00620854|4080232|P4|COMPLETED|Period 2||3
1669850|NCT00620854|4080233|P3|COMPLETED|Period 2||3
1669851|NCT00620854|4080234|P2|COMPLETED|Period 2||4
1669852|NCT00620854|4080235|P1|COMPLETED|Period 2||4
1669853|NCT00620854|4080230|P6|STARTED|Period 2||4
1669854|NCT00620854|4080231|P5|STARTED|Period 2||4
1669855|NCT00620854|4080232|P4|STARTED|Period 2||3
1669856|NCT00620854|4080233|P3|STARTED|Period 2||3
1669857|NCT00620854|4080234|P2|STARTED|Period 2||4
1669858|NCT00620854|4080235|P1|STARTED|Period 2||4
1669859|NCT00620854|4080230|P6|NOT COMPLETED|Washout 1||0
1669860|NCT00620854|4080231|P5|NOT COMPLETED|Washout 1||0
1669861|NCT00620854|4080232|P4|NOT COMPLETED|Washout 1||1
1669862|NCT00620854|4080233|P3|NOT COMPLETED|Washout 1||1
1669863|NCT00620854|4080234|P2|NOT COMPLETED|Washout 1||0
1669864|NCT00620854|4080235|P1|NOT COMPLETED|Washout 1||0
1669865|NCT00620854|4080230|P6|COMPLETED|Washout 1||4
1669866|NCT00620854|4080231|P5|COMPLETED|Washout 1||4
1669867|NCT00620854|4080232|P4|COMPLETED|Washout 1||3
1669868|NCT00620854|4080233|P3|COMPLETED|Washout 1||3
1669869|NCT00620854|4080234|P2|COMPLETED|Washout 1||4
1669870|NCT00620854|4080235|P1|COMPLETED|Washout 1||4
1669871|NCT00620854|4080230|P6|STARTED|Washout 1||4
1669872|NCT00620854|4080231|P5|STARTED|Washout 1||4
1669873|NCT00620854|4080232|P4|STARTED|Washout 1||4
1669874|NCT00620854|4080233|P3|STARTED|Washout 1||4
1669875|NCT00620854|4080234|P2|STARTED|Washout 1||4
1669876|NCT00620854|4080235|P1|STARTED|Washout 1||4
1669877|NCT00620854|4080230|P6|NOT COMPLETED|Period 1||0
1669878|NCT00620854|4080231|P5|NOT COMPLETED|Period 1||0
1669879|NCT00620854|4080232|P4|NOT COMPLETED|Period 1||0
1669880|NCT00620854|4080233|P3|NOT COMPLETED|Period 1||0
1669881|NCT00620854|4080234|P2|NOT COMPLETED|Period 1||0
1669882|NCT00620854|4080235|P1|NOT COMPLETED|Period 1||0
1669883|NCT00620854|4080230|P6|COMPLETED|Period 1||4
1669884|NCT00620854|4080231|P5|COMPLETED|Period 1||4
1669885|NCT00620854|4080232|P4|COMPLETED|Period 1||4
1669886|NCT00620854|4080233|P3|COMPLETED|Period 1||4
1669887|NCT00620854|4080234|P2|COMPLETED|Period 1||4
1669888|NCT00620854|4080235|P1|COMPLETED|Period 1||4
1669889|NCT00620854|4080230|P6|STARTED|Period 1||4
1669890|NCT00620854|4080231|P5|STARTED|Period 1||4
1669891|NCT00620854|4080232|P4|STARTED|Period 1||4
1669892|NCT00620854|4080233|P3|STARTED|Period 1||4
1669893|NCT00620854|4080234|P2|STARTED|Period 1||4
1669894|NCT00620854|4080235|P1|STARTED|Period 1||4
1669895|NCT00620828|4080248|P2|NOT COMPLETED|Overall Study||0
1669896|NCT00620828|4080249|P1|NOT COMPLETED|Overall Study||0
1669897|NCT00620828|4080248|P2|COMPLETED|Overall Study||35
1669898|NCT00620828|4080249|P1|COMPLETED|Overall Study||32
1669899|NCT00620828|4080248|P2|Number of Subjects Enrolled = 67|Overall Study||35
1669900|NCT00620828|4080249|P1|Number of Subjects Enrolled = 67|Overall Study||32
1669901|NCT00620828|4080248|P2|STARTED|Overall Study||35
1669902|NCT00620828|4080249|P1|STARTED|Overall Study||32
1669903|NCT00620815|4080266|P3|NOT COMPLETED|Overall Study||7
1669904|NCT00620815|4080267|P2|NOT COMPLETED|Overall Study||11
1669905|NCT00620815|4080268|P1|NOT COMPLETED|Overall Study||4
1669906|NCT00620815|4080266|P3|COMPLETED|Overall Study||192
1669907|NCT00620815|4080267|P2|COMPLETED|Overall Study||192
1669908|NCT00620815|4080268|P1|COMPLETED|Overall Study||195
1669909|NCT00620815|4080266|P3|STARTED|Overall Study||199
1669910|NCT00620815|4080267|P2|STARTED|Overall Study||203
1669911|NCT00620815|4080268|P1|STARTED|Overall Study||199
1669912|NCT00620776|4080308|P2|NOT COMPLETED|Overall Study||16
1669913|NCT00620776|4080309|P1|NOT COMPLETED|Overall Study||12
1669914|NCT00620776|4080308|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
1669915|NCT00620776|4080309|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
1669916|NCT00620776|4080308|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
1669917|NCT00620776|4080309|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
1669918|NCT00620776|4080308|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
1669919|NCT00620776|4080309|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
1669920|NCT00620763|4080337|P2|NOT COMPLETED|Period: Second Intervention||0
1669921|NCT00620763|4080338|P1|NOT COMPLETED|Period: Second Intervention||1
1669922|NCT00620763|4080337|P2|COMPLETED|Period: Second Intervention||7
1669923|NCT00620763|4080338|P1|COMPLETED|Period: Second Intervention||9
1669924|NCT00620763|4080337|P2|STARTED|Period: Second Intervention||7
1669925|NCT00620763|4080338|P1|STARTED|Period: Second Intervention||10
1669926|NCT00620763|4080337|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
1669927|NCT00620763|4080338|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
1669928|NCT00620763|4080337|P2|COMPLETED|Period: Washout Period of 1 Week||7
1669929|NCT00620763|4080338|P1|COMPLETED|Period: Washout Period of 1 Week||10
1669930|NCT00620763|4080337|P2|STARTED|Period: Washout Period of 1 Week||7
1669931|NCT00620763|4080338|P1|STARTED|Period: Washout Period of 1 Week||10
1669932|NCT00620763|4080337|P2|NOT COMPLETED|Period: First Intervention||5
1669933|NCT00620763|4080338|P1|NOT COMPLETED|Period: First Intervention||0
1669934|NCT00620763|4080337|P2|COMPLETED|Period: First Intervention||7
1669935|NCT00620763|4080338|P1|COMPLETED|Period: First Intervention||10
1669936|NCT00620763|4080337|P2|STARTED|Period: First Intervention||12
1669937|NCT00620763|4080338|P1|STARTED|Period: First Intervention||10
1669938|NCT00620750|4080344|P1|NOT COMPLETED|Overall Study||25
1669939|NCT00620750|4080344|P1|COMPLETED|Overall Study||40
1669940|NCT00620750|4080344|P1|STARTED|Overall Study||65
1669941|NCT00620711|4080348|P1|NOT COMPLETED|Overall Study||0
1669942|NCT00620711|4080348|P1|COMPLETED|Overall Study||4
1669943|NCT00620711|4080348|P1|STARTED|Overall Study||4
1669944|NCT00620698|4080353|P1|NOT COMPLETED|Overall Study||29
1669945|NCT00620698|4080353|P1|COMPLETED|Overall Study||60
1669946|NCT00620698|4080353|P1|STARTED|Overall Study||89
1669947|NCT00620659|4080359|P6|NOT COMPLETED|Treatment Period 3||0
1669948|NCT00620659|4080360|P5|NOT COMPLETED|Treatment Period 3||0
1669949|NCT00620659|4080361|P4|NOT COMPLETED|Treatment Period 3||1
1669950|NCT00620659|4080362|P3|NOT COMPLETED|Treatment Period 3||0
1669951|NCT00620659|4080363|P2|NOT COMPLETED|Treatment Period 3||2
1669952|NCT00620659|4080364|P1|NOT COMPLETED|Treatment Period 3||0
1669953|NCT00620659|4080359|P6|COMPLETED|Treatment Period 3||20
1669954|NCT00620659|4080360|P5|COMPLETED|Treatment Period 3||15
1669955|NCT00620659|4080361|P4|COMPLETED|Treatment Period 3||17
1669956|NCT00620659|4080362|P3|COMPLETED|Treatment Period 3||19
1669957|NCT00620659|4080363|P2|COMPLETED|Treatment Period 3||16
1669958|NCT00620659|4080364|P1|COMPLETED|Treatment Period 3||16
1669959|NCT00620659|4080359|P6|STARTED|Treatment Period 3||20
1669960|NCT00620659|4080360|P5|STARTED|Treatment Period 3||15
1669961|NCT00620659|4080361|P4|STARTED|Treatment Period 3||18
1669962|NCT00620659|4080362|P3|STARTED|Treatment Period 3||19
1669963|NCT00620659|4080363|P2|STARTED|Treatment Period 3||18
1669964|NCT00620659|4080364|P1|STARTED|Treatment Period 3||16
1669965|NCT00620659|4080359|P6|NOT COMPLETED|Placebo Washout Period 2||0
1669966|NCT00620659|4080360|P5|NOT COMPLETED|Placebo Washout Period 2||0
1669967|NCT00620659|4080361|P4|NOT COMPLETED|Placebo Washout Period 2||0
1669968|NCT00620659|4080362|P3|NOT COMPLETED|Placebo Washout Period 2||0
1669969|NCT00620659|4080363|P2|NOT COMPLETED|Placebo Washout Period 2||0
1669970|NCT00620659|4080364|P1|NOT COMPLETED|Placebo Washout Period 2||2
1669971|NCT00620659|4080359|P6|COMPLETED|Placebo Washout Period 2||20
1669972|NCT00620659|4080360|P5|COMPLETED|Placebo Washout Period 2||15
1669973|NCT00620659|4080361|P4|COMPLETED|Placebo Washout Period 2||18
1669974|NCT00620659|4080362|P3|COMPLETED|Placebo Washout Period 2||19
1669975|NCT00620659|4080363|P2|COMPLETED|Placebo Washout Period 2||18
1669976|NCT00620659|4080364|P1|COMPLETED|Placebo Washout Period 2||16
1669977|NCT00620659|4080359|P6|STARTED|Placebo Washout Period 2||20
1669978|NCT00620659|4080360|P5|STARTED|Placebo Washout Period 2||15
1669979|NCT00620659|4080361|P4|STARTED|Placebo Washout Period 2||18
1669980|NCT00620659|4080362|P3|STARTED|Placebo Washout Period 2||19
1669981|NCT00620659|4080363|P2|STARTED|Placebo Washout Period 2||18
1669982|NCT00620659|4080364|P1|STARTED|Placebo Washout Period 2||18
1669983|NCT00620659|4080359|P6|NOT COMPLETED|Treatment Period 2||0
1669984|NCT00620659|4080360|P5|NOT COMPLETED|Treatment Period 2||5
1669985|NCT00620659|4080361|P4|NOT COMPLETED|Treatment Period 2||0
1669986|NCT00620659|4080362|P3|NOT COMPLETED|Treatment Period 2||1
1669987|NCT00620659|4080363|P2|NOT COMPLETED|Treatment Period 2||3
1669988|NCT00620659|4080364|P1|NOT COMPLETED|Treatment Period 2||0
1669989|NCT00620659|4080359|P6|COMPLETED|Treatment Period 2||20
1669990|NCT00620659|4080360|P5|COMPLETED|Treatment Period 2||15
1669991|NCT00620659|4080361|P4|COMPLETED|Treatment Period 2||18
1669992|NCT00620659|4080362|P3|COMPLETED|Treatment Period 2||19
1669993|NCT00620659|4080363|P2|COMPLETED|Treatment Period 2||18
1669994|NCT00620659|4080364|P1|COMPLETED|Treatment Period 2||18
1669995|NCT00620659|4080359|P6|STARTED|Treatment Period 2||20
1669996|NCT00620659|4080360|P5|STARTED|Treatment Period 2||20
1669997|NCT00620659|4080361|P4|STARTED|Treatment Period 2||18
1669998|NCT00620659|4080362|P3|STARTED|Treatment Period 2||20
1669999|NCT00620659|4080363|P2|STARTED|Treatment Period 2||21
1670000|NCT00620659|4080364|P1|STARTED|Treatment Period 2||18
1670001|NCT00620659|4080359|P6|NOT COMPLETED|Placebo Washout Period 1||0
1670002|NCT00620659|4080360|P5|NOT COMPLETED|Placebo Washout Period 1||0
1670003|NCT00620659|4080361|P4|NOT COMPLETED|Placebo Washout Period 1||1
1670004|NCT00620659|4080362|P3|NOT COMPLETED|Placebo Washout Period 1||0
1670005|NCT00620659|4080363|P2|NOT COMPLETED|Placebo Washout Period 1||0
1670006|NCT00620659|4080364|P1|NOT COMPLETED|Placebo Washout Period 1||0
1670007|NCT00620659|4080359|P6|COMPLETED|Placebo Washout Period 1||20
1670008|NCT00620659|4080360|P5|COMPLETED|Placebo Washout Period 1||20
1670009|NCT00620659|4080361|P4|COMPLETED|Placebo Washout Period 1||18
1670010|NCT00620659|4080362|P3|COMPLETED|Placebo Washout Period 1||20
1670011|NCT00620659|4080363|P2|COMPLETED|Placebo Washout Period 1||21
1670012|NCT00620659|4080364|P1|COMPLETED|Placebo Washout Period 1||18
1670013|NCT00620659|4080359|P6|STARTED|Placebo Washout Period 1||20
1670014|NCT00620659|4080360|P5|STARTED|Placebo Washout Period 1||20
1670015|NCT00620659|4080361|P4|STARTED|Placebo Washout Period 1||19
1670016|NCT00620659|4080362|P3|STARTED|Placebo Washout Period 1||20
1670017|NCT00620659|4080363|P2|STARTED|Placebo Washout Period 1||21
1670018|NCT00620659|4080364|P1|STARTED|Placebo Washout Period 1||18
1670019|NCT00620659|4080359|P6|NOT COMPLETED|Treatment Period 1||0
1670020|NCT00620659|4080360|P5|NOT COMPLETED|Treatment Period 1||1
1670021|NCT00620659|4080361|P4|NOT COMPLETED|Treatment Period 1||3
1670022|NCT00620659|4080362|P3|NOT COMPLETED|Treatment Period 1||1
1670023|NCT00620659|4080363|P2|NOT COMPLETED|Treatment Period 1||0
1670024|NCT00620659|4080364|P1|NOT COMPLETED|Treatment Period 1||3
1670025|NCT00620659|4080359|P6|COMPLETED|Treatment Period 1||20
1670026|NCT00620659|4080360|P5|COMPLETED|Treatment Period 1||20
1670027|NCT00620659|4080361|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
1670028|NCT00620659|4080362|P3|COMPLETED|Treatment Period 1||20
1670029|NCT00620659|4080363|P2|COMPLETED|Treatment Period 1||21
1670030|NCT00620659|4080364|P1|COMPLETED|Treatment Period 1||18
1670031|NCT00620659|4080359|P6|STARTED|Treatment Period 1||20
1670032|NCT00620659|4080360|P5|STARTED|Treatment Period 1||21
1670033|NCT00620659|4080361|P4|STARTED|Treatment Period 1||21
1670034|NCT00620659|4080362|P3|STARTED|Treatment Period 1||21
1670035|NCT00620659|4080363|P2|STARTED|Treatment Period 1||21
1670036|NCT00620659|4080364|P1|STARTED|Treatment Period 1||21
1670037|NCT00620555|4080382|P1|NOT COMPLETED|Overall Study||21
1670038|NCT00620555|4080382|P1|COMPLETED|Overall Study||44
1670039|NCT00620555|4080382|P1|STARTED|Overall Study||65
1670040|NCT00620542|4080391|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
1670041|NCT00620542|4080392|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
1670042|NCT00620542|4080393|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
1670043|NCT00620542|4080394|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
1670044|NCT00620542|4080391|P4|COMPLETED|Part B (2 Year Core Study)||547
1670045|NCT00620542|4080392|P3|COMPLETED|Part B (2 Year Core Study)||546
1670046|NCT00620542|4080393|P2|COMPLETED|Part B (2 Year Core Study)||0
1670047|NCT00620542|4080394|P1|COMPLETED|Part B (2 Year Core Study)||0
1670048|NCT00620542|4080391|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
1670049|NCT00620542|4080392|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
1670050|NCT00620542|4080393|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
1670051|NCT00620542|4080394|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
1670052|NCT00620542|4080391|P4|Received Treatment|Part B (2 Year Core Study)||689
1670053|NCT00620542|4080392|P3|Received Treatment|Part B (2 Year Core Study)||691
1670054|NCT00620542|4080393|P2|Received Treatment|Part B (2 Year Core Study)||0
1670055|NCT00620542|4080394|P1|Received Treatment|Part B (2 Year Core Study)||0
1670056|NCT00620542|4080391|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
1670057|NCT00620542|4080392|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
1670058|NCT00620542|4080393|P2|STARTED|Part B (2 Year Core Study)||0
1670059|NCT00620542|4080394|P1|STARTED|Part B (2 Year Core Study)||0
1670060|NCT00620542|4080391|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
1670061|NCT00620542|4080392|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
1670062|NCT00620542|4080393|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
1670063|NCT00620542|4080394|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
1670064|NCT00620542|4080391|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
1670065|NCT00620542|4080392|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
1670066|NCT00620542|4080393|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
1670067|NCT00620542|4080394|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
1670068|NCT00620542|4080391|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
1670069|NCT00620542|4080392|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
1670070|NCT00620542|4080393|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
1670071|NCT00620542|4080394|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
1670072|NCT00620542|4080391|P4|STARTED|Part A (Run-in - 2 Weeks)||0
1670073|NCT00620542|4080392|P3|STARTED|Part A (Run-in - 2 Weeks)||0
1670074|NCT00620542|4080393|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
1670075|NCT00620542|4080394|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
1670076|NCT00620464|4080434|P2|NOT COMPLETED|Overall Study||24
1670077|NCT00620464|4080435|P1|NOT COMPLETED|Overall Study||20
1670078|NCT00620464|4080434|P2|COMPLETED|Overall Study||32
1670079|NCT00620464|4080435|P1|COMPLETED|Overall Study||32
1670080|NCT00620464|4080434|P2|STARTED|Overall Study||56
1670081|NCT00620464|4080435|P1|STARTED|Overall Study||52
1670082|NCT00620425|4080443|P1|NOT COMPLETED|Overall Study||0
1670083|NCT00620425|4080443|P1|COMPLETED|Overall Study||18
1670084|NCT00620425|4080443|P1|STARTED|Overall Study||18
1670085|NCT00620373|4080454|P1|NOT COMPLETED|Overall Study||33
1670086|NCT00620373|4080454|P1|COMPLETED|Overall Study||936
1670087|NCT00620373|4080454|P1|STARTED|Overall Study||969
1670088|NCT00620282|4080473|P3|NOT COMPLETED|Overall Study||1
1670089|NCT00620282|4080474|P2|NOT COMPLETED|Overall Study||2
1670090|NCT00620282|4080475|P1|NOT COMPLETED|Overall Study||0
1670091|NCT00620282|4080473|P3|COMPLETED|Overall Study||16
1670092|NCT00620282|4080474|P2|COMPLETED|Overall Study||14
1670093|NCT00620282|4080475|P1|COMPLETED|Overall Study||16
1670094|NCT00620282|4080473|P3|STARTED|Overall Study||17
1670095|NCT00620282|4080474|P2|STARTED|Overall Study||16
1670096|NCT00620282|4080475|P1|STARTED|Overall Study||16
1670097|NCT00620126|4080524|P2|NOT COMPLETED|Overall Study||5
1670098|NCT00620126|4080525|P1|NOT COMPLETED|Overall Study||11
1670099|NCT00620126|4080524|P2|COMPLETED|Overall Study||17
1670100|NCT00620126|4080525|P1|COMPLETED|Overall Study||14
1670101|NCT00620126|4080524|P2|STARTED|Overall Study||22
1670102|NCT00620126|4080525|P1|STARTED|Overall Study||25
1670103|NCT00620113|4080539|P4|NOT COMPLETED|Overall Study||10
1670104|NCT00620113|4080540|P3|NOT COMPLETED|Overall Study||5
1670105|NCT00620113|4080541|P2|NOT COMPLETED|Overall Study||7
1670106|NCT00620113|4080542|P1|NOT COMPLETED|Overall Study||13
1670107|NCT00620113|4080539|P4|COMPLETED|Overall Study||59
1670108|NCT00620113|4080540|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
1670109|NCT00620113|4080541|P2|COMPLETED|Overall Study||67
1670110|NCT00620113|4080542|P1|COMPLETED|Overall Study||60
1670111|NCT00620113|4080539|P4|Efficacy/Safety Population|Overall Study||69
1670112|NCT00620113|4080540|P3|Efficacy/Safety Population|Overall Study||70
1670113|NCT00620113|4080541|P2|Efficacy/Safety Population|Overall Study||74
1670114|NCT00620113|4080542|P1|Efficacy/Safety Population|Overall Study||73
1670115|NCT00620113|4080539|P4|STARTED|Overall Study||69
1670116|NCT00620113|4080540|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
1670117|NCT00620113|4080541|P2|STARTED|Overall Study||74
1670118|NCT00620113|4080542|P1|STARTED|Overall Study||73
1670119|NCT00620074|4080592|P1|NOT COMPLETED|Overall Study||1
1670120|NCT00620074|4080592|P1|COMPLETED|Overall Study||5
1670121|NCT00620074|4080592|P1|STARTED|Overall Study||6
1670122|NCT00620035|4080600|P1|NOT COMPLETED|Overall Study||145
1670123|NCT00620035|4080600|P1|COMPLETED|Overall Study||156
1670124|NCT00620035|4080600|P1|STARTED|Overall Study||301
1670125|NCT00620022|4080610|P2|NOT COMPLETED|Treatment Period 2||2
1670126|NCT00620022|4080611|P1|NOT COMPLETED|Treatment Period 2||2
1670127|NCT00620022|4080610|P2|COMPLETED|Treatment Period 2||35
1670128|NCT00620022|4080611|P1|COMPLETED|Treatment Period 2||39
1670129|NCT00620022|4080610|P2|STARTED|Treatment Period 2||37
1670130|NCT00620022|4080611|P1|STARTED|Treatment Period 2||41
1670131|NCT00620022|4080610|P2|NOT COMPLETED|Treatment Period 1||6
1670132|NCT00620022|4080611|P1|NOT COMPLETED|Treatment Period 1||5
1670133|NCT00620022|4080610|P2|COMPLETED|Treatment Period 1||37
1670134|NCT00620022|4080611|P1|COMPLETED|Treatment Period 1||41
1670135|NCT00620022|4080610|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
1670136|NCT00620022|4080611|P1|STARTED|Treatment Period 1||46
1670137|NCT00619983|4080623|P4|NOT COMPLETED|Gabapentin Alone||0
1670138|NCT00619983|4080624|P3|NOT COMPLETED|Gabapentin Alone||0
1670139|NCT00619983|4080625|P2|NOT COMPLETED|Gabapentin Alone||0
1670140|NCT00619983|4080626|P1|NOT COMPLETED|Gabapentin Alone||0
1670141|NCT00619983|4080623|P4|COMPLETED|Gabapentin Alone||3
1670142|NCT00619983|4080624|P3|COMPLETED|Gabapentin Alone||4
1670143|NCT00619983|4080625|P2|COMPLETED|Gabapentin Alone||4
1670144|NCT00619983|4080626|P1|COMPLETED|Gabapentin Alone||3
1670145|NCT00619983|4080623|P4|STARTED|Gabapentin Alone||3
1670146|NCT00619983|4080624|P3|STARTED|Gabapentin Alone||4
1670147|NCT00619983|4080625|P2|STARTED|Gabapentin Alone||4
1670148|NCT00619983|4080626|P1|STARTED|Gabapentin Alone||3
1670149|NCT00619983|4080623|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
1670150|NCT00619983|4080624|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
1670151|NCT00619983|4080625|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
1670152|NCT00619983|4080626|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
1670153|NCT00619983|4080623|P4|COMPLETED|Test Drug Plus Gabapentin||3
1670154|NCT00619983|4080624|P3|COMPLETED|Test Drug Plus Gabapentin||4
1670155|NCT00619983|4080625|P2|COMPLETED|Test Drug Plus Gabapentin||4
1670156|NCT00619983|4080626|P1|COMPLETED|Test Drug Plus Gabapentin||3
1670157|NCT00619983|4080623|P4|STARTED|Test Drug Plus Gabapentin||3
1670158|NCT00619983|4080624|P3|STARTED|Test Drug Plus Gabapentin||4
1670159|NCT00619983|4080625|P2|STARTED|Test Drug Plus Gabapentin||4
1670160|NCT00619983|4080626|P1|STARTED|Test Drug Plus Gabapentin||3
1670161|NCT00619983|4080623|P4|NOT COMPLETED|Test Drug Alone||3
1670162|NCT00619983|4080624|P3|NOT COMPLETED|Test Drug Alone||2
1670163|NCT00619983|4080625|P2|NOT COMPLETED|Test Drug Alone||1
1670164|NCT00619983|4080626|P1|NOT COMPLETED|Test Drug Alone||2
1670165|NCT00619983|4080623|P4|COMPLETED|Test Drug Alone||3
1670166|NCT00619983|4080624|P3|COMPLETED|Test Drug Alone||4
1670167|NCT00619983|4080625|P2|COMPLETED|Test Drug Alone||4
1670168|NCT00619983|4080626|P1|COMPLETED|Test Drug Alone||3
1670169|NCT00619983|4080623|P4|STARTED|Test Drug Alone||6
1670170|NCT00619983|4080624|P3|STARTED|Test Drug Alone||6
1670171|NCT00619983|4080625|P2|STARTED|Test Drug Alone||5
1670172|NCT00619983|4080626|P1|STARTED|Test Drug Alone||5
1670173|NCT00619970|4080639|P3|NOT COMPLETED|Overall Study||2
1670174|NCT00619970|4080640|P2|NOT COMPLETED|Overall Study||3
1670175|NCT00619970|4080641|P1|NOT COMPLETED|Overall Study||0
1670176|NCT00619970|4080639|P3|COMPLETED|Overall Study||24
1670177|NCT00619970|4080640|P2|COMPLETED|Overall Study||46
1670178|NCT00619970|4080641|P1|COMPLETED|Overall Study||40
1670179|NCT00619970|4080639|P3|STARTED|Overall Study||26
1670180|NCT00619970|4080640|P2|STARTED|Overall Study||49
1670181|NCT00619970|4080641|P1|STARTED|Overall Study||40
1670182|NCT00619957|4080653|P2|NOT COMPLETED|Month 48 Open-Label||17
1670183|NCT00619957|4080654|P1|NOT COMPLETED|Month 48 Open-Label||12
1670184|NCT00619957|4080653|P2|COMPLETED|Month 48 Open-Label||134
1670185|NCT00619957|4080654|P1|COMPLETED|Month 48 Open-Label||55
1670186|NCT00619957|4080653|P2|STARTED|Month 48 Open-Label||151
1670187|NCT00619957|4080654|P1|STARTED|Month 48 Open-Label||67
1670188|NCT00619957|4080653|P2|NOT COMPLETED|Month 24 Double-Blind||17
1670189|NCT00619957|4080654|P1|NOT COMPLETED|Month 24 Double-Blind||18
1670190|NCT00619957|4080653|P2|COMPLETED|Month 24 Double-Blind||175
1670191|NCT00619957|4080654|P1|COMPLETED|Month 24 Double-Blind||75
1670192|NCT00619957|4080653|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
1670193|NCT00619957|4080654|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
1670194|NCT00619957|4080653|P2|STARTED|Month 24 Double-Blind||192
1670195|NCT00619957|4080654|P1|STARTED|Month 24 Double-Blind||93
1670196|NCT00619918|4080736|P2|NOT COMPLETED|Overall Study||22
1670197|NCT00619918|4080737|P1|NOT COMPLETED|Overall Study||20
1670198|NCT00619918|4080736|P2|COMPLETED|Overall Study||195
1670199|NCT00619918|4080737|P1|COMPLETED|Overall Study||210
1670200|NCT00619918|4080736|P2|STARTED|Overall Study||217
1670201|NCT00619918|4080737|P1|STARTED|Overall Study||230
1670202|NCT00619892|4080747|P2|NOT COMPLETED|Overall Study||2
1670203|NCT00619892|4080748|P1|NOT COMPLETED|Overall Study||3
1670204|NCT00619892|4080747|P2|COMPLETED|Overall Study||11
1670205|NCT00619892|4080748|P1|COMPLETED|Overall Study||10
1670206|NCT00619892|4080747|P2|STARTED|Overall Study||13
1670207|NCT00619892|4080748|P1|STARTED|Overall Study||13
1670208|NCT00619866|4080759|P5|NOT COMPLETED|Weeks 13 - 24||2
1670209|NCT00619866|4080760|P4|NOT COMPLETED|Weeks 13 - 24||4
1670210|NCT00619866|4080761|P3|NOT COMPLETED|Weeks 13 - 24||5
1670211|NCT00619866|4080762|P2|NOT COMPLETED|Weeks 13 - 24||7
1670212|NCT00619866|4080763|P1|NOT COMPLETED|Weeks 13 - 24||0
1670213|NCT00619866|4080759|P5|COMPLETED|Weeks 13 - 24||18
1670214|NCT00619866|4080760|P4|COMPLETED|Weeks 13 - 24||14
1670215|NCT00619866|4080761|P3|COMPLETED|Weeks 13 - 24||37
1670216|NCT00619866|4080762|P2|COMPLETED|Weeks 13 - 24||38
1670217|NCT00619866|4080763|P1|COMPLETED|Weeks 13 - 24||0
1670218|NCT00619866|4080759|P5|STARTED|Weeks 13 - 24||20
1670219|NCT00619866|4080760|P4|STARTED|Weeks 13 - 24||18
1670220|NCT00619866|4080761|P3|STARTED|Weeks 13 - 24||42
1670221|NCT00619866|4080762|P2|STARTED|Weeks 13 - 24||45
1670222|NCT00619866|4080763|P1|STARTED|Weeks 13 - 24||0
1670223|NCT00619866|4080759|P5|NOT COMPLETED|Weeks 1 - 12||0
1670224|NCT00619866|4080760|P4|NOT COMPLETED|Weeks 1 - 12||0
1670225|NCT00619866|4080761|P3|NOT COMPLETED|Weeks 1 - 12||10
1670226|NCT00619866|4080762|P2|NOT COMPLETED|Weeks 1 - 12||6
1670227|NCT00619866|4080763|P1|NOT COMPLETED|Weeks 1 - 12||14
1670228|NCT00619866|4080759|P5|COMPLETED|Weeks 1 - 12||0
1670229|NCT00619866|4080760|P4|COMPLETED|Weeks 1 - 12||0
1670230|NCT00619866|4080761|P3|COMPLETED|Weeks 1 - 12||42
1670231|NCT00619866|4080762|P2|COMPLETED|Weeks 1 - 12||45
1670232|NCT00619866|4080763|P1|COMPLETED|Weeks 1 - 12||38
1670233|NCT00619866|4080759|P5|STARTED|Weeks 1 - 12||0
1670234|NCT00619866|4080760|P4|STARTED|Weeks 1 - 12||0
1670235|NCT00619866|4080761|P3|STARTED|Weeks 1 - 12||52
1670236|NCT00619866|4080762|P2|STARTED|Weeks 1 - 12||51
1670237|NCT00619866|4080763|P1|STARTED|Weeks 1 - 12||52
1670238|NCT00619827|4080850|P2|NOT COMPLETED|Overall Study||4
1670239|NCT00619827|4080851|P1|NOT COMPLETED|Overall Study||3
1670240|NCT00619827|4080850|P2|COMPLETED|Overall Study||40
1670241|NCT00619827|4080851|P1|COMPLETED|Overall Study||42
1670242|NCT00619827|4080850|P2|STARTED|Overall Study||44
1670243|NCT00619827|4080851|P1|STARTED|Overall Study||45
1670244|NCT00619801|4080859|P2|NOT COMPLETED|Overall Study||3
1670245|NCT00619801|4080860|P1|NOT COMPLETED|Overall Study||1
1670246|NCT00619801|4080859|P2|COMPLETED|Overall Study||111
1670247|NCT00619801|4080860|P1|COMPLETED|Overall Study||58
1670248|NCT00619801|4080859|P2|Safety Population|Overall Study||114
1670249|NCT00619801|4080860|P1|Safety Population|Overall Study||59
1670250|NCT00619801|4080859|P2|STARTED|Overall Study||114
1670251|NCT00619801|4080860|P1|STARTED|Overall Study||59
1670252|NCT00619762|4080890|P1|NOT COMPLETED|Overall Study||3
1670253|NCT00619762|4080890|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
1670254|NCT00619762|4080890|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
1670255|NCT00619723|4080897|P2|NOT COMPLETED|Overall Study||6
1670256|NCT00619723|4080898|P1|NOT COMPLETED|Overall Study||2
1670257|NCT00619723|4080897|P2|COMPLETED|Overall Study||61
1670258|NCT00619723|4080898|P1|COMPLETED|Overall Study||61
1670259|NCT00619723|4080897|P2|STARTED|Overall Study||67
1670260|NCT00619723|4080898|P1|STARTED|Overall Study||63
1670261|NCT00619684|4080908|P1|NOT COMPLETED|Overall Study||0
1670262|NCT00619684|4080908|P1|COMPLETED|Overall Study||18
1670263|NCT00619684|4080908|P1|STARTED|Overall Study||18
1670264|NCT00619645|4080917|P1|NOT COMPLETED|Overall Study||1
1670265|NCT00619645|4080917|P1|COMPLETED|Overall Study||7
1670266|NCT00619645|4080917|P1|STARTED|Overall Study||8
1670267|NCT00619619|4080931|P8|NOT COMPLETED|Overall Study||3
1670268|NCT00619619|4080932|P7|NOT COMPLETED|Overall Study||1
1670269|NCT00619619|4080933|P6|NOT COMPLETED|Overall Study||0
1670270|NCT00619619|4080934|P5|NOT COMPLETED|Overall Study||2
1670271|NCT00619619|4080935|P4|NOT COMPLETED|Overall Study||1
1670272|NCT00619619|4080936|P3|NOT COMPLETED|Overall Study||1
1670273|NCT00619619|4080937|P2|NOT COMPLETED|Overall Study||0
1670274|NCT00619619|4080938|P1|NOT COMPLETED|Overall Study||0
1670275|NCT00619619|4080931|P8|COMPLETED|Overall Study||5
1670276|NCT00619619|4080932|P7|COMPLETED|Overall Study||7
1670277|NCT00619619|4080933|P6|COMPLETED|Overall Study||7
1670278|NCT00619619|4080934|P5|COMPLETED|Overall Study||5
1670279|NCT00619619|4080935|P4|COMPLETED|Overall Study||6
1670280|NCT00619619|4080936|P3|COMPLETED|Overall Study||8
1670281|NCT00619619|4080937|P2|COMPLETED|Overall Study||7
1670374|NCT00619190|4081247|P1|STARTED|Overall Study||21
1670282|NCT00619619|4080938|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
1670283|NCT00619619|4080931|P8|Entered the Extension Study|Overall Study||7
1670284|NCT00619619|4080932|P7|Entered the Extension Study|Overall Study||6
1670285|NCT00619619|4080933|P6|Entered the Extension Study|Overall Study||6
1670286|NCT00619619|4080934|P5|Entered the Extension Study|Overall Study||7
1670287|NCT00619619|4080935|P4|Entered the Extension Study|Overall Study||3
1670288|NCT00619619|4080936|P3|Entered the Extension Study|Overall Study||8
1670289|NCT00619619|4080937|P2|Entered the Extension Study|Overall Study||5
1670290|NCT00619619|4080938|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
1670291|NCT00619619|4080931|P8|STARTED|Overall Study||8
1670292|NCT00619619|4080932|P7|STARTED|Overall Study||8
1670293|NCT00619619|4080933|P6|STARTED|Overall Study||7
1670294|NCT00619619|4080934|P5|STARTED|Overall Study||7
1670295|NCT00619619|4080935|P4|STARTED|Overall Study||7
1670296|NCT00619619|4080936|P3|STARTED|Overall Study||9
1670297|NCT00619619|4080937|P2|STARTED|Overall Study||7
1670298|NCT00619619|4080938|P1|STARTED|Overall Study||6
1670299|NCT00619502|4081025|P2|NOT COMPLETED|Overall Study||10
1670300|NCT00619502|4081026|P1|NOT COMPLETED|Overall Study||8
1670301|NCT00619502|4081025|P2|COMPLETED|Overall Study||114
1670302|NCT00619502|4081026|P1|COMPLETED|Overall Study||122
1670303|NCT00619502|4081025|P2|STARTED|Overall Study||124
1670304|NCT00619502|4081026|P1|STARTED|Overall Study||130
1670305|NCT00619489|4081038|P2|NOT COMPLETED|Overall Study||34
1670306|NCT00619489|4081039|P1|NOT COMPLETED|Overall Study||23
1670307|NCT00619489|4081038|P2|COMPLETED|Overall Study||1
1670308|NCT00619489|4081039|P1|COMPLETED|Overall Study||14
1670309|NCT00619489|4081038|P2|STARTED|Overall Study||35
1670310|NCT00619489|4081039|P1|STARTED|Overall Study||37
1670311|NCT00619476|4081061|P4|NOT COMPLETED|Overall Study||34
1670312|NCT00619476|4081062|P3|NOT COMPLETED|Overall Study||24
1670313|NCT00619476|4081063|P2|NOT COMPLETED|Overall Study||22
1670314|NCT00619476|4081064|P1|NOT COMPLETED|Overall Study||31
1670315|NCT00619476|4081061|P4|COMPLETED|Overall Study||56
1670316|NCT00619476|4081062|P3|COMPLETED|Overall Study||60
1670317|NCT00619476|4081063|P2|COMPLETED|Overall Study||85
1670318|NCT00619476|4081064|P1|COMPLETED|Overall Study||64
1670319|NCT00619476|4081061|P4|Safety Population|Overall Study||87
1670320|NCT00619476|4081062|P3|Safety Population|Overall Study||82
1670321|NCT00619476|4081063|P2|Safety Population|Overall Study||107
1670322|NCT00619476|4081064|P1|Safety Population|Overall Study||95
1670323|NCT00619476|4081061|P4|Intent-to-Treat Population|Overall Study||87
1670324|NCT00619476|4081062|P3|Intent-to-Treat Population|Overall Study||82
1670325|NCT00619476|4081063|P2|Intent-to-Treat Population|Overall Study||107
1670326|NCT00619476|4081064|P1|Intent-to-Treat Population|Overall Study||95
1670327|NCT00619476|4081061|P4|STARTED|Overall Study||90
1670328|NCT00619476|4081062|P3|STARTED|Overall Study||84
1670329|NCT00619476|4081063|P2|STARTED|Overall Study||107
1670330|NCT00619476|4081064|P1|STARTED|Overall Study||95
1670331|NCT00619385|4081149|P3|NOT COMPLETED|Overall Study||4
1670332|NCT00619385|4081150|P2|NOT COMPLETED|Overall Study||2
1670333|NCT00619385|4081151|P1|NOT COMPLETED|Overall Study||1
1670334|NCT00619385|4081149|P3|COMPLETED|Overall Study||6
1670335|NCT00619385|4081150|P2|COMPLETED|Overall Study||6
1670336|NCT00619385|4081151|P1|COMPLETED|Overall Study||6
1670337|NCT00619385|4081149|P3|STARTED|Overall Study||10
1670338|NCT00619385|4081150|P2|STARTED|Overall Study||8
1670339|NCT00619385|4081151|P1|STARTED|Overall Study||7
1670340|NCT00619359|4081166|P2|NOT COMPLETED|Overall Study||81
1670341|NCT00619359|4081167|P1|NOT COMPLETED|Overall Study||67
1670342|NCT00619359|4081166|P2|COMPLETED|Overall Study||1094
1670343|NCT00619359|4081167|P1|COMPLETED|Overall Study||1080
1670344|NCT00619359|4081166|P2|STARTED|Overall Study||1175
1670345|NCT00619359|4081167|P1|STARTED|Overall Study||1147
1670346|NCT00619307|4081179|P2|NOT COMPLETED|Overall Study||4
1670347|NCT00619307|4081180|P1|NOT COMPLETED|Overall Study||4
1670348|NCT00619307|4081179|P2|COMPLETED|Overall Study||53
1670349|NCT00619307|4081180|P1|COMPLETED|Overall Study||56
1670350|NCT00619307|4081179|P2|STARTED|Overall Study||57
1670351|NCT00619307|4081180|P1|STARTED|Overall Study||60
1670352|NCT00619255|4081196|P2|NOT COMPLETED|Overall Study||0
1670353|NCT00619255|4081197|P1|NOT COMPLETED|Overall Study||2
1670354|NCT00619255|4081196|P2|COMPLETED|Overall Study||61
1670355|NCT00619255|4081197|P1|COMPLETED|Overall Study||57
1670356|NCT00619255|4081196|P2|STARTED|Overall Study||61
1670357|NCT00619255|4081197|P1|STARTED|Overall Study||59
1670358|NCT00619242|4081211|P1|NOT COMPLETED|Overall Study||0
1670359|NCT00619242|4081211|P1|COMPLETED|Overall Study||3
1670360|NCT00619242|4081211|P1|STARTED|Overall Study||3
1670361|NCT00619229|4081217|P2|NOT COMPLETED|Overall Study||2
1670362|NCT00619229|4081218|P1|NOT COMPLETED|Overall Study||4
1670363|NCT00619229|4081217|P2|COMPLETED|Overall Study||16
1670364|NCT00619229|4081218|P1|COMPLETED|Overall Study||14
1670365|NCT00619229|4081217|P2|Full Analysis Set (FAS)|Overall Study||17
1670366|NCT00619229|4081218|P1|Full Analysis Set (FAS)|Overall Study||16
1670367|NCT00619229|4081217|P2|STARTED|Overall Study||18
1670368|NCT00619229|4081218|P1|STARTED|Overall Study||18
1670369|NCT00619190|4081246|P2|NOT COMPLETED|Overall Study||0
1670370|NCT00619190|4081247|P1|NOT COMPLETED|Overall Study||1
1670371|NCT00619190|4081246|P2|COMPLETED|Overall Study||9
1670372|NCT00619190|4081247|P1|COMPLETED|Overall Study||20
1670373|NCT00619190|4081246|P2|STARTED|Overall Study||9
1670375|NCT00619177|4081257|P1|NOT COMPLETED|Overall Study||508
1670376|NCT00619177|4081257|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
1670377|NCT00619177|4081257|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
1670378|NCT00619151|4081267|P2|NOT COMPLETED|Overall Study||0
1670379|NCT00619151|4081268|P1|NOT COMPLETED|Overall Study||1
1670380|NCT00619151|4081267|P2|COMPLETED|Overall Study||0
1670381|NCT00619151|4081268|P1|COMPLETED|Overall Study||1
1670382|NCT00619151|4081267|P2|STARTED|Overall Study||0
1670383|NCT00619151|4081268|P1|STARTED|Overall Study||2
1670384|NCT00619112|4081278|P2|NOT COMPLETED|Overall Study||2
1670385|NCT00619112|4081279|P1|NOT COMPLETED|Overall Study||1
1670386|NCT00619112|4081278|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
1670387|NCT00619112|4081279|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
1670388|NCT00619112|4081278|P2|STARTED|Overall Study||20
1670389|NCT00619112|4081279|P1|STARTED|Overall Study||40
1670390|NCT00619099|4081300|P2|NOT COMPLETED|Overall Study||19
1670391|NCT00619099|4081301|P1|NOT COMPLETED|Overall Study||33
1670392|NCT00619099|4081300|P2|COMPLETED|Overall Study||4
1670393|NCT00619099|4081301|P1|COMPLETED|Overall Study||11
1670394|NCT00619099|4081300|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
1670395|NCT00619099|4081301|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
1670396|NCT00619099|4081300|P2|STARTED|Overall Study|All randomized subjects|23
1670397|NCT00619099|4081301|P1|STARTED|Overall Study|All randomized subjects|44
1670398|NCT00619073|4081307|P2|NOT COMPLETED|Second Intervention - 60 Days||0
1670399|NCT00619073|4081308|P1|NOT COMPLETED|Second Intervention - 60 Days||0
1670400|NCT00619073|4081307|P2|COMPLETED|Second Intervention - 60 Days||8
1670401|NCT00619073|4081308|P1|COMPLETED|Second Intervention - 60 Days||8
1670402|NCT00619073|4081307|P2|STARTED|Second Intervention - 60 Days||8
1670403|NCT00619073|4081308|P1|STARTED|Second Intervention - 60 Days||8
1670404|NCT00619073|4081307|P2|NOT COMPLETED|Washout Period (30 Days)||0
1670405|NCT00619073|4081308|P1|NOT COMPLETED|Washout Period (30 Days)||0
1670406|NCT00619073|4081307|P2|COMPLETED|Washout Period (30 Days)||8
1670407|NCT00619073|4081308|P1|COMPLETED|Washout Period (30 Days)||8
1670408|NCT00619073|4081307|P2|STARTED|Washout Period (30 Days)||8
1670409|NCT00619073|4081308|P1|STARTED|Washout Period (30 Days)||8
1670410|NCT00619073|4081307|P2|NOT COMPLETED|First Intervention - 60 Days||0
1670411|NCT00619073|4081308|P1|NOT COMPLETED|First Intervention - 60 Days||0
1670412|NCT00619073|4081307|P2|COMPLETED|First Intervention - 60 Days||8
1670413|NCT00619073|4081308|P1|COMPLETED|First Intervention - 60 Days||8
1670414|NCT00619073|4081307|P2|STARTED|First Intervention - 60 Days||8
1670415|NCT00619073|4081308|P1|STARTED|First Intervention - 60 Days||8
1670416|NCT00619060|4081314|P2|NOT COMPLETED|Overall Study||0
1670417|NCT00619060|4081315|P1|NOT COMPLETED|Overall Study||0
1670418|NCT00619060|4081314|P2|COMPLETED|Overall Study||12
1670419|NCT00619060|4081315|P1|COMPLETED|Overall Study||10
1670420|NCT00619060|4081314|P2|STARTED|Overall Study||12
1670421|NCT00619060|4081315|P1|STARTED|Overall Study||10
1670422|NCT00618995|4081323|P4|NOT COMPLETED|Period 4||0
1670423|NCT00618995|4081324|P3|NOT COMPLETED|Period 4||0
1670424|NCT00618995|4081325|P2|NOT COMPLETED|Period 4||0
1670425|NCT00618995|4081326|P1|NOT COMPLETED|Period 4||1
1670426|NCT00618995|4081323|P4|COMPLETED|Period 4||6
1670427|NCT00618995|4081324|P3|COMPLETED|Period 4||4
1670428|NCT00618995|4081325|P2|COMPLETED|Period 4||6
1670429|NCT00618995|4081326|P1|COMPLETED|Period 4||5
1670430|NCT00618995|4081323|P4|STARTED|Period 4||6
1670431|NCT00618995|4081324|P3|STARTED|Period 4||4
1670432|NCT00618995|4081325|P2|STARTED|Period 4||6
1670433|NCT00618995|4081326|P1|STARTED|Period 4||6
1670434|NCT00618995|4081323|P4|NOT COMPLETED|Period 3||0
1670435|NCT00618995|4081324|P3|NOT COMPLETED|Period 3||0
1670436|NCT00618995|4081325|P2|NOT COMPLETED|Period 3||0
1670437|NCT00618995|4081326|P1|NOT COMPLETED|Period 3||0
1670438|NCT00618995|4081323|P4|COMPLETED|Period 3||6
1670439|NCT00618995|4081324|P3|COMPLETED|Period 3||4
1670440|NCT00618995|4081325|P2|COMPLETED|Period 3||6
1670441|NCT00618995|4081326|P1|COMPLETED|Period 3||6
1670442|NCT00618995|4081323|P4|STARTED|Period 3||6
1670443|NCT00618995|4081324|P3|STARTED|Period 3||4
1670444|NCT00618995|4081325|P2|STARTED|Period 3||6
1670445|NCT00618995|4081326|P1|STARTED|Period 3||6
1670446|NCT00618995|4081323|P4|NOT COMPLETED|Period 2||0
1670447|NCT00618995|4081324|P3|NOT COMPLETED|Period 2||1
1670448|NCT00618995|4081325|P2|NOT COMPLETED|Period 2||0
1670449|NCT00618995|4081326|P1|NOT COMPLETED|Period 2||0
1670450|NCT00618995|4081323|P4|COMPLETED|Period 2||6
1670451|NCT00618995|4081324|P3|COMPLETED|Period 2||4
1670452|NCT00618995|4081325|P2|COMPLETED|Period 2||6
1670453|NCT00618995|4081326|P1|COMPLETED|Period 2||6
1670454|NCT00618995|4081323|P4|STARTED|Period 2||6
1670455|NCT00618995|4081324|P3|STARTED|Period 2||5
1670456|NCT00618995|4081325|P2|STARTED|Period 2||6
1670457|NCT00618995|4081326|P1|STARTED|Period 2||6
1670458|NCT00618995|4081323|P4|NOT COMPLETED|Period 1||0
1670459|NCT00618995|4081324|P3|NOT COMPLETED|Period 1||2
1670460|NCT00618995|4081325|P2|NOT COMPLETED|Period 1||1
1670461|NCT00618995|4081326|P1|NOT COMPLETED|Period 1||0
1670462|NCT00618995|4081323|P4|COMPLETED|Period 1||6
1670463|NCT00618995|4081324|P3|COMPLETED|Period 1||5
1670464|NCT00618995|4081325|P2|COMPLETED|Period 1||6
1670465|NCT00618995|4081326|P1|COMPLETED|Period 1||6
1670466|NCT00618995|4081323|P4|STARTED|Period 1||6
1670467|NCT00618995|4081324|P3|STARTED|Period 1||7
1670468|NCT00618995|4081325|P2|STARTED|Period 1||7
1670469|NCT00618995|4081326|P1|STARTED|Period 1||6
1670470|NCT00618982|4081340|P1|NOT COMPLETED|Overall Study||50
1670471|NCT00618982|4081340|P1|COMPLETED|Overall Study||33
1670472|NCT00618982|4081340|P1|STARTED|Overall Study||83
1670473|NCT00618956|4081363|P2|NOT COMPLETED|Overall Study||50
1670474|NCT00618956|4081364|P1|NOT COMPLETED|Overall Study||25
1670475|NCT00618956|4081363|P2|COMPLETED|Overall Study||160
1670476|NCT00618956|4081364|P1|COMPLETED|Overall Study||86
1670477|NCT00618956|4081363|P2|STARTED|Overall Study||210
1670478|NCT00618956|4081364|P1|STARTED|Overall Study||111
1670479|NCT00618839|4081380|P1|NOT COMPLETED|Overall Study||0
1670480|NCT00618839|4081380|P1|COMPLETED|Overall Study||15
1670481|NCT00618839|4081380|P1|STARTED|Overall Study||15
1670482|NCT00618826|4081389|P1|NOT COMPLETED|Overall Study||1
1670483|NCT00618826|4081389|P1|COMPLETED|Overall Study||13
1670484|NCT00618826|4081389|P1|STARTED|Overall Study||14
1670485|NCT00618813|4081394|P1|NOT COMPLETED|Overall Study||4
1670486|NCT00618813|4081394|P1|COMPLETED|Overall Study||31
1670487|NCT00618813|4081394|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
1670488|NCT00618813|4081394|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
1670489|NCT00618813|4081394|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
1670490|NCT00618813|4081394|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
1670491|NCT00618813|4081394|P1|STARTED|Overall Study||35
1670492|NCT00618787|4081404|P2|NOT COMPLETED|Overall Study||2
1670493|NCT00618787|4081405|P1|NOT COMPLETED|Overall Study||3
1670494|NCT00618787|4081404|P2|COMPLETED|Overall Study||21
1670495|NCT00618787|4081405|P1|COMPLETED|Overall Study||19
1670496|NCT00618787|4081404|P2|STARTED|Overall Study||23
1670497|NCT00618787|4081405|P1|STARTED|Overall Study||22
1670498|NCT00618774|4081413|P2|NOT COMPLETED|Overall Study||3
1670499|NCT00618774|4081414|P1|NOT COMPLETED|Overall Study||6
1670500|NCT00618774|4081413|P2|COMPLETED|Overall Study||45
1670501|NCT00618774|4081414|P1|COMPLETED|Overall Study||205
1670502|NCT00618774|4081413|P2|STARTED|Overall Study||48
1670503|NCT00618774|4081414|P1|STARTED|Overall Study||211
1670504|NCT00618748|4081447|P3|NOT COMPLETED|Overall Study||14
1670505|NCT00618748|4081448|P2|NOT COMPLETED|Overall Study||5
1670506|NCT00618748|4081449|P1|NOT COMPLETED|Overall Study||11
1670507|NCT00618748|4081447|P3|COMPLETED|Overall Study||6
1670508|NCT00618748|4081448|P2|COMPLETED|Overall Study||20
1670509|NCT00618748|4081449|P1|COMPLETED|Overall Study||45
1670510|NCT00618748|4081447|P3|STARTED|Overall Study||20
1670511|NCT00618748|4081448|P2|STARTED|Overall Study||25
1670512|NCT00618748|4081449|P1|STARTED|Overall Study||56
1670513|NCT00618722|4081494|P4|NOT COMPLETED|Overall Study||4
1670514|NCT00618722|4081495|P3|NOT COMPLETED|Overall Study||3
1670515|NCT00618722|4081496|P2|NOT COMPLETED|Overall Study||2
1670516|NCT00618722|4081497|P1|NOT COMPLETED|Overall Study||3
1670517|NCT00618722|4081494|P4|COMPLETED|Overall Study||18
1670518|NCT00618722|4081495|P3|COMPLETED|Overall Study||19
1670519|NCT00618722|4081496|P2|COMPLETED|Overall Study||18
1670520|NCT00618722|4081497|P1|COMPLETED|Overall Study||18
1670521|NCT00618722|4081494|P4|Received Treatment|Overall Study||22
1670522|NCT00618722|4081495|P3|Received Treatment|Overall Study||22
1670523|NCT00618722|4081496|P2|Received Treatment|Overall Study||20
1670524|NCT00618722|4081497|P1|Received Treatment|Overall Study||20
1670525|NCT00618722|4081494|P4|STARTED|Overall Study||22
1670526|NCT00618722|4081495|P3|STARTED|Overall Study||22
1670527|NCT00618722|4081496|P2|STARTED|Overall Study||20
1670528|NCT00618722|4081497|P1|STARTED|Overall Study||21
1670529|NCT00618618|4081535|P4|NOT COMPLETED|Overall Study||1
1670530|NCT00618618|4081536|P3|NOT COMPLETED|Overall Study||3
1670531|NCT00618618|4081537|P2|NOT COMPLETED|Overall Study||3
1670532|NCT00618618|4081538|P1|NOT COMPLETED|Overall Study||4
1670533|NCT00618618|4081535|P4|COMPLETED|Overall Study||13
1670534|NCT00618618|4081536|P3|COMPLETED|Overall Study||18
1670535|NCT00618618|4081537|P2|COMPLETED|Overall Study||11
1670536|NCT00618618|4081538|P1|COMPLETED|Overall Study||20
1670537|NCT00618618|4081535|P4|Received Treatment|Overall Study||14
1670538|NCT00618618|4081536|P3|Received Treatment|Overall Study||20
1670539|NCT00618618|4081537|P2|Received Treatment|Overall Study||13
1670540|NCT00618618|4081538|P1|Received Treatment|Overall Study||24
1670541|NCT00618618|4081535|P4|STARTED|Overall Study||14
1670542|NCT00618618|4081536|P3|STARTED|Overall Study||21
1670543|NCT00618618|4081537|P2|STARTED|Overall Study||14
1670544|NCT00618618|4081538|P1|STARTED|Overall Study||24
1670545|NCT00618540|4081584|P1|NOT COMPLETED|Overall Study||0
1670546|NCT00618540|4081584|P1|COMPLETED|Overall Study||1
1670547|NCT00618540|4081584|P1|STARTED|Overall Study||1
1670548|NCT00618514|4081597|P3|NOT COMPLETED|Overall Study||4
1670549|NCT00618514|4081598|P2|NOT COMPLETED|Overall Study||12
1670550|NCT00618514|4081599|P1|NOT COMPLETED|Overall Study||11
1670551|NCT00618514|4081597|P3|COMPLETED|Overall Study||12
1670552|NCT00618514|4081598|P2|COMPLETED|Overall Study||26
1670553|NCT00618514|4081599|P1|COMPLETED|Overall Study||25
1670554|NCT00618514|4081597|P3|STARTED|Overall Study||16
1670555|NCT00618514|4081598|P2|STARTED|Overall Study||38
1670556|NCT00618514|4081599|P1|STARTED|Overall Study||36
1670557|NCT00618449|4081619|P2|NOT COMPLETED|Overall Study||110
1670558|NCT00618449|4081620|P1|NOT COMPLETED|Overall Study||98
1670559|NCT00618449|4081619|P2|COMPLETED|Overall Study||558
1670560|NCT00618449|4081620|P1|COMPLETED|Overall Study||581
1670561|NCT00618449|4081619|P2|1-year, Post-treatment|Overall Study||558
1670562|NCT00618449|4081620|P1|1-year, Post-treatment|Overall Study||581
1670563|NCT00618449|4081619|P2|1-month, Post-treatment|Overall Study||656
1670564|NCT00618449|4081620|P1|1-month, Post-treatment|Overall Study||666
1670565|NCT00618449|4081619|P2|STARTED|Overall Study||668
1670566|NCT00618449|4081620|P1|STARTED|Overall Study||679
1670567|NCT00618436|4081628|P2|NOT COMPLETED|Overall Study||0
1670568|NCT00618436|4081629|P1|NOT COMPLETED|Overall Study||0
1670569|NCT00618436|4081628|P2|COMPLETED|Overall Study||18
1670570|NCT00618436|4081629|P1|COMPLETED|Overall Study||34
1670571|NCT00618436|4081628|P2|STARTED|Overall Study||18
1670572|NCT00618436|4081629|P1|STARTED|Overall Study||34
1670573|NCT00618410|4081639|P2|NOT COMPLETED|Second Intervention||0
1670574|NCT00618410|4081640|P1|NOT COMPLETED|Second Intervention||0
1670575|NCT00618410|4081639|P2|COMPLETED|Second Intervention||5
1670576|NCT00618410|4081640|P1|COMPLETED|Second Intervention||7
1670577|NCT00618410|4081639|P2|STARTED|Second Intervention||5
1670578|NCT00618410|4081640|P1|STARTED|Second Intervention||7
1670579|NCT00618410|4081639|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
1670580|NCT00618410|4081640|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
1670581|NCT00618410|4081639|P2|COMPLETED|Washout Period (2 Weeks)||5
1670582|NCT00618410|4081640|P1|COMPLETED|Washout Period (2 Weeks)||7
1670583|NCT00618410|4081639|P2|STARTED|Washout Period (2 Weeks)||6
1670584|NCT00618410|4081640|P1|STARTED|Washout Period (2 Weeks)||7
1670585|NCT00618410|4081639|P2|NOT COMPLETED|First Intervention||0
1670586|NCT00618410|4081640|P1|NOT COMPLETED|First Intervention||0
1670587|NCT00618410|4081639|P2|COMPLETED|First Intervention||6
1670588|NCT00618410|4081640|P1|COMPLETED|First Intervention||7
1670589|NCT00618410|4081639|P2|STARTED|First Intervention||6
1670590|NCT00618410|4081640|P1|STARTED|First Intervention||7
1670591|NCT00618371|4081656|P1|NOT COMPLETED|Overall Study||2
1670592|NCT00618371|4081656|P1|COMPLETED|Overall Study||10
1670593|NCT00618371|4081656|P1|STARTED|Overall Study||12
1670594|NCT00618332|4081663|P2|NOT COMPLETED|Overall Study||0
1670595|NCT00618332|4081664|P1|NOT COMPLETED|Overall Study||0
1670596|NCT00618332|4081663|P2|COMPLETED|Overall Study||20
1670597|NCT00618332|4081664|P1|COMPLETED|Overall Study||20
1670598|NCT00618332|4081663|P2|STARTED|Overall Study||20
1670599|NCT00618332|4081664|P1|STARTED|Overall Study||20
1670600|NCT00618072|4081689|P3|NOT COMPLETED|Overall Study||4
1670601|NCT00618072|4081690|P2|NOT COMPLETED|Overall Study||1
1670602|NCT00618072|4081691|P1|NOT COMPLETED|Overall Study||2
1670603|NCT00618072|4081689|P3|COMPLETED|Overall Study||11
1670604|NCT00618072|4081690|P2|COMPLETED|Overall Study||14
1670605|NCT00618072|4081691|P1|COMPLETED|Overall Study||14
1670606|NCT00618072|4081689|P3|STARTED|Overall Study||15
1670607|NCT00618072|4081690|P2|STARTED|Overall Study||15
1670608|NCT00618072|4081691|P1|STARTED|Overall Study||16
1670609|NCT00617981|4081725|P2|NOT COMPLETED|Overall Study||102
1670610|NCT00617981|4081726|P1|NOT COMPLETED|Overall Study||110
1670611|NCT00617981|4081725|P2|COMPLETED|Overall Study||245
1670612|NCT00617981|4081726|P1|COMPLETED|Overall Study||244
1670613|NCT00617981|4081725|P2|STARTED|Overall Study||347
1670614|NCT00617981|4081726|P1|STARTED|Overall Study||354
1670615|NCT00617942|4081734|P2|NOT COMPLETED|Overall Study||4
1670616|NCT00617942|4081735|P1|NOT COMPLETED|Overall Study||8
1670617|NCT00617942|4081734|P2|COMPLETED|Overall Study||19
1670618|NCT00617942|4081735|P1|COMPLETED|Overall Study||29
1670619|NCT00617942|4081734|P2|STARTED|Overall Study||23
1670620|NCT00617942|4081735|P1|STARTED|Overall Study||37
1670621|NCT00617929|4081747|P1|NOT COMPLETED|Overall Study||1
1670622|NCT00617929|4081747|P1|COMPLETED|Overall Study||11
1670623|NCT00617929|4081747|P1|STARTED|Overall Study||12
1670624|NCT00617903|4081759|P2|NOT COMPLETED|Overall Study||7
1670625|NCT00617903|4081760|P1|NOT COMPLETED|Overall Study||3
1670626|NCT00617903|4081759|P2|COMPLETED|Overall Study||35
1670627|NCT00617903|4081760|P1|COMPLETED|Overall Study||38
1670628|NCT00617903|4081759|P2|STARTED|Overall Study||42
1670629|NCT00617903|4081760|P1|STARTED|Overall Study||41
1670630|NCT00617890|4081806|P4|NOT COMPLETED|Overall Study||115
1670631|NCT00617890|4081807|P3|NOT COMPLETED|Overall Study||35
1670632|NCT00617890|4081808|P2|NOT COMPLETED|Overall Study||28
1670633|NCT00617890|4081809|P1|NOT COMPLETED|Overall Study||31
1670634|NCT00617890|4081806|P4|COMPLETED|Overall Study||1
1670635|NCT00617890|4081807|P3|COMPLETED|Overall Study||0
1670636|NCT00617890|4081808|P2|COMPLETED|Overall Study||5
1670637|NCT00617890|4081809|P1|COMPLETED|Overall Study||4
1670638|NCT00617890|4081806|P4|Received Treatment|Overall Study||115
1670639|NCT00617890|4081807|P3|Received Treatment|Overall Study||34
1670640|NCT00617890|4081808|P2|Received Treatment|Overall Study||33
1670641|NCT00617890|4081809|P1|Received Treatment|Overall Study||34
1670642|NCT00617890|4081806|P4|STARTED|Overall Study||116
1670643|NCT00617890|4081807|P3|STARTED|Overall Study||35
1670644|NCT00617890|4081808|P2|STARTED|Overall Study||33
1670645|NCT00617890|4081809|P1|STARTED|Overall Study||35
1670646|NCT00617851|4081845|P4|NOT COMPLETED|Overall Study||25
1670647|NCT00617851|4081846|P3|NOT COMPLETED|Overall Study||45
1670648|NCT00617851|4081847|P2|NOT COMPLETED|Overall Study||40
1670649|NCT00617851|4081848|P1|NOT COMPLETED|Overall Study||47
1670650|NCT00617851|4081845|P4|COMPLETED|Overall Study||192
1670651|NCT00617851|4081846|P3|COMPLETED|Overall Study||384
1670652|NCT00617851|4081847|P2|COMPLETED|Overall Study||391
1670653|NCT00617851|4081848|P1|COMPLETED|Overall Study||383
1670654|NCT00617851|4081845|P4|STARTED|Overall Study||217
1670655|NCT00617851|4081846|P3|STARTED|Overall Study||429
1670656|NCT00617851|4081847|P2|STARTED|Overall Study||431
1670657|NCT00617851|4081848|P1|STARTED|Overall Study||430
1670658|NCT00617773|4081886|P1|NOT COMPLETED|Overall Study||24
1670659|NCT00617773|4081886|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
1670660|NCT00617773|4081886|P1|STARTED|Overall Study||31
1670661|NCT00617734|4081903|P2|NOT COMPLETED|Overall Study||6
1670662|NCT00617734|4081904|P1|NOT COMPLETED|Overall Study||8
1670663|NCT00617734|4081903|P2|COMPLETED|Overall Study||42
1670664|NCT00617734|4081904|P1|COMPLETED|Overall Study||41
1670665|NCT00617734|4081903|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
1670666|NCT00617734|4081904|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
1670667|NCT00617734|4081903|P2|STARTED|Overall Study||48
1670668|NCT00617734|4081904|P1|STARTED|Overall Study||49
1670669|NCT00617708|4081925|P3|NOT COMPLETED|Overall Study||64
1670670|NCT00617708|4081926|P2|NOT COMPLETED|Overall Study||60
1670671|NCT00617708|4081927|P1|NOT COMPLETED|Overall Study||10
1670672|NCT00617708|4081925|P3|COMPLETED|Overall Study||0
1670673|NCT00617708|4081926|P2|COMPLETED|Overall Study||0
1670674|NCT00617708|4081927|P1|COMPLETED|Overall Study||0
1670675|NCT00617708|4081925|P3|Eligible and Began Protocol Therapy|Overall Study||59
1670676|NCT00617708|4081926|P2|Eligible and Began Protocol Therapy|Overall Study||57
1670677|NCT00617708|4081927|P1|Eligible and Began Protocol Therapy|Overall Study||9
1670678|NCT00617708|4081925|P3|STARTED|Overall Study||64
1670679|NCT00617708|4081926|P2|STARTED|Overall Study||60
1670680|NCT00617708|4081927|P1|STARTED|Overall Study||10
1670681|NCT00617669|4081944|P2|NOT COMPLETED|Overall Study||451
1670682|NCT00617669|4081945|P1|NOT COMPLETED|Overall Study||430
1670683|NCT00617669|4081944|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
1670684|NCT00617669|4081945|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
1670685|NCT00617669|4081944|P2|Patients Who Received IP|Overall Study||525
1670686|NCT00617669|4081945|P1|Patients Who Received IP|Overall Study||522
1670687|NCT00617669|4081944|P2|STARTED|Overall Study||528
1670688|NCT00617669|4081945|P1|STARTED|Overall Study||524
1670689|NCT00617604|4081967|P2|NOT COMPLETED|Overall Study||20
1670690|NCT00617604|4081968|P1|NOT COMPLETED|Overall Study||18
1670691|NCT00617604|4081967|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
1670692|NCT00617604|4081968|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
1670693|NCT00617604|4081967|P2|Completed 12 Weeks of Treatment|Overall Study||83
1670694|NCT00617604|4081968|P1|Completed 12 Weeks of Treatment|Overall Study||89
1670695|NCT00617604|4081967|P2|Received Treatment|Overall Study||105
1670696|NCT00617604|4081968|P1|Received Treatment|Overall Study||107
1670697|NCT00617604|4081967|P2|STARTED|Overall Study||108
1670698|NCT00617604|4081968|P1|STARTED|Overall Study||110
1670699|NCT00617591|4082012|P1|NOT COMPLETED|Overall Study||10
1670700|NCT00617591|4082012|P1|COMPLETED|Overall Study||47
1670701|NCT00617591|4082012|P1|STARTED|Overall Study||57
1670702|NCT00617539|4082020|P1|NOT COMPLETED|Overall Study||0
1670703|NCT00617539|4082020|P1|COMPLETED|Overall Study||30
1670704|NCT00617539|4082020|P1|STARTED|Overall Study||30
1670705|NCT00617461|4082028|P2|NOT COMPLETED|6-Day Down-Titration Period||2
1670706|NCT00617461|4082029|P1|NOT COMPLETED|6-Day Down-Titration Period||2
1670707|NCT00617461|4082028|P2|COMPLETED|6-Day Down-Titration Period||35
1670708|NCT00617461|4082029|P1|COMPLETED|6-Day Down-Titration Period||39
1670709|NCT00617461|4082028|P2|STARTED|6-Day Down-Titration Period||37
1670710|NCT00617461|4082029|P1|STARTED|6-Day Down-Titration Period||41
1670711|NCT00617461|4082028|P2|NOT COMPLETED|Second Treatment Intervention Period||4
1670712|NCT00617461|4082029|P1|NOT COMPLETED|Second Treatment Intervention Period||0
1670713|NCT00617461|4082028|P2|COMPLETED|Second Treatment Intervention Period||37
1670714|NCT00617461|4082029|P1|COMPLETED|Second Treatment Intervention Period||41
1670715|NCT00617461|4082028|P2|STARTED|Second Treatment Intervention Period||41
1670716|NCT00617461|4082029|P1|STARTED|Second Treatment Intervention Period||41
1670717|NCT00617461|4082028|P2|NOT COMPLETED|4-Day Crossover Period||0
1670718|NCT00617461|4082029|P1|NOT COMPLETED|4-Day Crossover Period||1
1670719|NCT00617461|4082028|P2|COMPLETED|4-Day Crossover Period||40
1670720|NCT00617461|4082029|P1|COMPLETED|4-Day Crossover Period||41
1670721|NCT00617461|4082028|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
1670722|NCT00617461|4082029|P1|STARTED|4-Day Crossover Period||42
1670723|NCT00617461|4082028|P2|NOT COMPLETED|First Treatment Intervention Period||3
1670724|NCT00617461|4082029|P1|NOT COMPLETED|First Treatment Intervention Period||10
1670725|NCT00617461|4082028|P2|COMPLETED|First Treatment Intervention Period||41
1670726|NCT00617461|4082029|P1|COMPLETED|First Treatment Intervention Period||42
1670727|NCT00617461|4082028|P2|STARTED|First Treatment Intervention Period||44
1670728|NCT00617461|4082029|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
1670729|NCT00617409|4082085|P3|NOT COMPLETED|Overall Study||27
1670730|NCT00617409|4082086|P2|NOT COMPLETED|Overall Study||18
1670731|NCT00617409|4082087|P1|NOT COMPLETED|Overall Study||16
1670732|NCT00617409|4082085|P3|COMPLETED|Overall Study||4
1670733|NCT00617409|4082086|P2|COMPLETED|Overall Study||2
1670734|NCT00617409|4082087|P1|COMPLETED|Overall Study||2
1670735|NCT00617409|4082085|P3|STARTED|Overall Study||31
1670736|NCT00617409|4082086|P2|STARTED|Overall Study||20
1670737|NCT00617409|4082087|P1|STARTED|Overall Study||18
1670738|NCT00617396|4082098|P1|NOT COMPLETED|Overall Study||0
1670739|NCT00617396|4082098|P1|COMPLETED|Overall Study||25
1670740|NCT00617396|4082098|P1|STARTED|Overall Study||25
1670741|NCT00617357|4082102|P1|NOT COMPLETED|Overall Study||16
1670742|NCT00617357|4082102|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
1670743|NCT00617357|4082102|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
1670744|NCT00617305|4082115|P3|NOT COMPLETED|Overall Study||1
1670745|NCT00617305|4082116|P2|NOT COMPLETED|Overall Study||0
1670746|NCT00617305|4082117|P1|NOT COMPLETED|Overall Study||8
1670747|NCT00617305|4082115|P3|COMPLETED|Overall Study||0
1670748|NCT00617305|4082116|P2|COMPLETED|Overall Study||4
1670749|NCT00617305|4082117|P1|COMPLETED|Overall Study||25
1670750|NCT00617305|4082115|P3|Completed 24-week Primary Analysis|Overall Study||0
1670751|NCT00617305|4082116|P2|Completed 24-week Primary Analysis|Overall Study||4
1670752|NCT00617305|4082117|P1|Completed 24-week Primary Analysis|Overall Study||31
1670753|NCT00617305|4082115|P3|STARTED|Overall Study||1
1670754|NCT00617305|4082116|P2|STARTED|Overall Study||4
1670755|NCT00617305|4082117|P1|STARTED|Overall Study||33
1670756|NCT00617279|4082173|P2|NOT COMPLETED|Overall Study||17
1670757|NCT00617279|4082174|P1|NOT COMPLETED|Overall Study||14
1670758|NCT00617279|4082173|P2|COMPLETED|Overall Study||0
1670759|NCT00617279|4082174|P1|COMPLETED|Overall Study||0
1670760|NCT00617279|4082173|P2|STARTED|Overall Study||17
1670761|NCT00617279|4082174|P1|STARTED|Overall Study||14
1670762|NCT00617240|4082230|P2|NOT COMPLETED|Overall Study||0
1670763|NCT00617240|4082231|P1|NOT COMPLETED|Overall Study||1
1670764|NCT00617240|4082230|P2|COMPLETED|Overall Study||4
1670765|NCT00617240|4082231|P1|COMPLETED|Overall Study||4
1670766|NCT00617240|4082230|P2|STARTED|Overall Study||4
1670767|NCT00617240|4082231|P1|STARTED|Overall Study||5
1670768|NCT00617201|4082251|P2|NOT COMPLETED|Overall Study||13
1670769|NCT00617201|4082252|P1|NOT COMPLETED|Overall Study||9
1670770|NCT00617201|4082251|P2|COMPLETED|Overall Study||12
1670771|NCT00617201|4082252|P1|COMPLETED|Overall Study||16
1670772|NCT00617201|4082251|P2|STARTED|Overall Study||25
1670773|NCT00617201|4082252|P1|STARTED|Overall Study||25
1670774|NCT00617188|4082260|P1|NOT COMPLETED|Overall Study||0
1670775|NCT00617188|4082260|P1|COMPLETED|Overall Study||26
1670776|NCT00617188|4082260|P1|STARTED|Overall Study||26
1670777|NCT00617175|4082271|P2|NOT COMPLETED|Overall Study||0
1670778|NCT00617175|4082272|P1|NOT COMPLETED|Overall Study||0
1670779|NCT00617175|4082271|P2|COMPLETED|Overall Study||948
1670780|NCT00617175|4082272|P1|COMPLETED|Overall Study||954
1670781|NCT00617175|4082271|P2|STARTED|Overall Study||948
1670782|NCT00617175|4082272|P1|STARTED|Overall Study||954
1670783|NCT00617123|4082280|P2|NOT COMPLETED|Study Treatment Period||16
1670784|NCT00617123|4082281|P1|NOT COMPLETED|Study Treatment Period||17
1670785|NCT00617123|4082280|P2|COMPLETED|Study Treatment Period||79
1670786|NCT00617123|4082281|P1|COMPLETED|Study Treatment Period||81
1670787|NCT00617123|4082280|P2|Treated|Study Treatment Period||95
1670788|NCT00617123|4082281|P1|Treated|Study Treatment Period|1 participant was not treated|97
1670789|NCT00617123|4082280|P2|STARTED|Study Treatment Period||95
1670790|NCT00617123|4082281|P1|STARTED|Study Treatment Period||98
1670791|NCT00617123|4082280|P2|NOT COMPLETED|Referral Screening Period||26
1670792|NCT00617123|4082281|P1|NOT COMPLETED|Referral Screening Period||39
1670793|NCT00617123|4082280|P2|COMPLETED|Referral Screening Period||95
1670794|NCT00617123|4082281|P1|COMPLETED|Referral Screening Period||98
1670795|NCT00617123|4082280|P2|STARTED|Referral Screening Period||121
1670796|NCT00617123|4082281|P1|STARTED|Referral Screening Period||137
1670797|NCT00617097|4082297|P2|NOT COMPLETED|Overall Study||0
1670798|NCT00617097|4082298|P1|NOT COMPLETED|Overall Study||0
1670799|NCT00617097|4082297|P2|COMPLETED|Overall Study||25
1670800|NCT00617097|4082298|P1|COMPLETED|Overall Study||25
1670801|NCT00617097|4082297|P2|STARTED|Overall Study||25
1670802|NCT00617097|4082298|P1|STARTED|Overall Study||25
1670803|NCT00617084|4082312|P2|NOT COMPLETED|Overall Study||26
1670804|NCT00617084|4082313|P1|NOT COMPLETED|Overall Study||21
1670805|NCT00617084|4082312|P2|COMPLETED|Overall Study||1126
1670806|NCT00617084|4082313|P1|COMPLETED|Overall Study||1119
1670807|NCT00617084|4082312|P2|STARTED|Overall Study||1152
1670808|NCT00617084|4082313|P1|STARTED|Overall Study||1140
1670809|NCT00617058|4082324|P3|NOT COMPLETED|Overall Study||0
1670810|NCT00617058|4082325|P2|NOT COMPLETED|Overall Study||0
1670811|NCT00617058|4082326|P1|NOT COMPLETED|Overall Study||0
1670812|NCT00617058|4082324|P3|COMPLETED|Overall Study||0
1670813|NCT00617058|4082325|P2|COMPLETED|Overall Study||0
1670814|NCT00617058|4082326|P1|COMPLETED|Overall Study||1
1670815|NCT00617058|4082324|P3|STARTED|Overall Study||0
1670816|NCT00617058|4082325|P2|STARTED|Overall Study||0
1670817|NCT00617058|4082326|P1|STARTED|Overall Study||1
1670818|NCT00616967|4082366|P3|NOT COMPLETED|Overall Study||1
1670819|NCT00616967|4082367|P2|NOT COMPLETED|Overall Study||0
1670820|NCT00616967|4082368|P1|NOT COMPLETED|Overall Study||0
1670821|NCT00616967|4082366|P3|COMPLETED|Overall Study||30
1670822|NCT00616967|4082367|P2|COMPLETED|Overall Study||31
1670823|NCT00616967|4082368|P1|COMPLETED|Overall Study||6
1670824|NCT00616967|4082366|P3|STARTED|Overall Study||31
1670825|NCT00616967|4082367|P2|STARTED|Overall Study||31
1670826|NCT00616967|4082368|P1|STARTED|Overall Study||6
1670827|NCT00616941|4082380|P3|NOT COMPLETED|Overall Study||6
1670828|NCT00616941|4082381|P2|NOT COMPLETED|Overall Study||5
1670829|NCT00616941|4082382|P1|NOT COMPLETED|Overall Study||1
1670830|NCT00616941|4082380|P3|COMPLETED|Overall Study||5
1670831|NCT00616941|4082381|P2|COMPLETED|Overall Study||8
1670832|NCT00616941|4082382|P1|COMPLETED|Overall Study||3
1670833|NCT00616941|4082380|P3|STARTED|Overall Study||11
1670834|NCT00616941|4082381|P2|STARTED|Overall Study||13
1670835|NCT00616941|4082382|P1|STARTED|Overall Study||4
1670836|NCT00616928|4082409|P4|NOT COMPLETED|Overall Study||7
1670837|NCT00616928|4082410|P3|NOT COMPLETED|Overall Study||17
1670838|NCT00616928|4082411|P2|NOT COMPLETED|Overall Study||18
1670839|NCT00616928|4082412|P1|NOT COMPLETED|Overall Study||62
1670840|NCT00616928|4082409|P4|COMPLETED|Overall Study||364
1670841|NCT00616928|4082410|P3|COMPLETED|Overall Study||1101
1670842|NCT00616928|4082411|P2|COMPLETED|Overall Study||750
1670843|NCT00616928|4082412|P1|COMPLETED|Overall Study||2242
1670844|NCT00616928|4082409|P4|STARTED|Overall Study||371
1670845|NCT00616928|4082410|P3|STARTED|Overall Study||1118
1670846|NCT00616928|4082411|P2|STARTED|Overall Study||768
1670847|NCT00616928|4082412|P1|STARTED|Overall Study||2304
1670848|NCT00616902|4082476|P2|NOT COMPLETED|Overall Study||6
1670849|NCT00616902|4082477|P1|NOT COMPLETED|Overall Study||6
1670850|NCT00616902|4082476|P2|COMPLETED|Overall Study||0
1670851|NCT00616902|4082477|P1|COMPLETED|Overall Study||0
1670852|NCT00616902|4082476|P2|STARTED|Overall Study||6
1670853|NCT00616902|4082477|P1|STARTED|Overall Study||6
1670854|NCT00616772|4082503|P2|NOT COMPLETED|Overall Study||102
1670855|NCT00616772|4082504|P1|NOT COMPLETED|Overall Study||115
1670856|NCT00616772|4082503|P2|COMPLETED|Overall Study||240
1670857|NCT00616772|4082504|P1|COMPLETED|Overall Study||225
1670858|NCT00616772|4082503|P2|Treated|Overall Study||339
1670859|NCT00616772|4082504|P1|Treated|Overall Study||337
1670860|NCT00616772|4082503|P2|STARTED|Overall Study||342
1670861|NCT00616772|4082504|P1|STARTED|Overall Study||340
1670862|NCT00616759|4082520|P2|NOT COMPLETED|Overall Study||2
1670863|NCT00616759|4082521|P1|NOT COMPLETED|Overall Study||3
1670864|NCT00616759|4082520|P2|COMPLETED|Overall Study||8
1670865|NCT00616759|4082521|P1|COMPLETED|Overall Study||7
1670866|NCT00616759|4082520|P2|STARTED|Overall Study||10
1670867|NCT00616759|4082521|P1|STARTED|Overall Study||10
1670868|NCT00616655|4082530|P3|NOT COMPLETED|Overall Study||48
1670869|NCT00616655|4082531|P2|NOT COMPLETED|Overall Study||41
1670870|NCT00616655|4082532|P1|NOT COMPLETED|Overall Study||35
1670871|NCT00616655|4082530|P3|COMPLETED|Overall Study||103
1670872|NCT00616655|4082531|P2|COMPLETED|Overall Study||112
1670873|NCT00616655|4082532|P1|COMPLETED|Overall Study||117
1670874|NCT00616655|4082530|P3|STARTED|Overall Study||151
1670875|NCT00616655|4082531|P2|STARTED|Overall Study||153
1670876|NCT00616655|4082532|P1|STARTED|Overall Study||152
1670877|NCT00616642|4082572|P2|NOT COMPLETED|Overall Study||1
1670878|NCT00616642|4082573|P1|NOT COMPLETED|Overall Study||0
1670879|NCT00616642|4082572|P2|COMPLETED|Overall Study||0
1670880|NCT00616642|4082573|P1|COMPLETED|Overall Study||0
1670881|NCT00616642|4082572|P2|STARTED|Overall Study||1
1670882|NCT00616642|4082573|P1|STARTED|Overall Study||0
1670883|NCT00616629|4082584|P5|NOT COMPLETED|Overall Study||0
1670884|NCT00616629|4082585|P4|NOT COMPLETED|Overall Study||0
1670885|NCT00616629|4082586|P3|NOT COMPLETED|Overall Study||1
1670886|NCT00616629|4082587|P2|NOT COMPLETED|Overall Study||2
1670887|NCT00616629|4082588|P1|NOT COMPLETED|Overall Study||2
1670888|NCT00616629|4082584|P5|COMPLETED|Overall Study||12
1670889|NCT00616629|4082585|P4|COMPLETED|Overall Study||2
1670890|NCT00616629|4082586|P3|COMPLETED|Overall Study||13
1670891|NCT00616629|4082587|P2|COMPLETED|Overall Study||12
1670892|NCT00616629|4082588|P1|COMPLETED|Overall Study||11
1670893|NCT00616629|4082584|P5|STARTED|Overall Study||12
1670894|NCT00616629|4082585|P4|STARTED|Overall Study||2
1670895|NCT00616629|4082586|P3|STARTED|Overall Study|One patient never received study drug|14
1670896|NCT00616629|4082587|P2|STARTED|Overall Study|Two patients never received study drug|14
1670897|NCT00616629|4082588|P1|STARTED|Overall Study|Two patients never received study drug|13
1670898|NCT00616603|4082633|P3|NOT COMPLETED|Overall Study||2
1670899|NCT00616603|4082634|P2|NOT COMPLETED|Overall Study||0
1670900|NCT00616603|4082635|P1|NOT COMPLETED|Overall Study||2
1670901|NCT00616603|4082633|P3|COMPLETED|Overall Study||13
1670902|NCT00616603|4082634|P2|COMPLETED|Overall Study||14
1670903|NCT00616603|4082635|P1|COMPLETED|Overall Study||12
1670904|NCT00616603|4082633|P3|STARTED|Overall Study||15
1670905|NCT00616603|4082634|P2|STARTED|Overall Study||14
1670906|NCT00616603|4082635|P1|STARTED|Overall Study||14
1670907|NCT00616577|4082646|P3|NOT COMPLETED|Overall Study||0
1670908|NCT00616577|4082647|P2|NOT COMPLETED|Overall Study||0
1670909|NCT00616577|4082648|P1|NOT COMPLETED|Overall Study||0
1670910|NCT00616577|4082646|P3|COMPLETED|Overall Study||7
1670911|NCT00616577|4082647|P2|COMPLETED|Overall Study||9
1670912|NCT00616577|4082648|P1|COMPLETED|Overall Study||6
1670913|NCT00616577|4082646|P3|STARTED|Overall Study||7
1670914|NCT00616577|4082647|P2|STARTED|Overall Study||9
1670915|NCT00616577|4082648|P1|STARTED|Overall Study||6
1670916|NCT00616434|4082658|P2|NOT COMPLETED|Overall Study||8
1670917|NCT00616434|4082659|P1|NOT COMPLETED|Overall Study||6
1670918|NCT00616434|4082658|P2|COMPLETED|Overall Study||53
1670919|NCT00616434|4082659|P1|COMPLETED|Overall Study||56
1670920|NCT00616434|4082658|P2|STARTED|Overall Study||61
1670921|NCT00616434|4082659|P1|STARTED|Overall Study||62
1670922|NCT00616421|4082672|P3|NOT COMPLETED|Overall Study||41
1670923|NCT00616421|4082673|P2|NOT COMPLETED|Overall Study||38
1670924|NCT00616421|4082674|P1|NOT COMPLETED|Overall Study||26
1670925|NCT00616421|4082672|P3|COMPLETED|Overall Study||1229
1670926|NCT00616421|4082673|P2|COMPLETED|Overall Study||1240
1670927|NCT00616421|4082674|P1|COMPLETED|Overall Study||333
1670928|NCT00616421|4082672|P3|STARTED|Overall Study||1270
1670929|NCT00616421|4082673|P2|STARTED|Overall Study||1278
1670930|NCT00616421|4082674|P1|STARTED|Overall Study||359
1670931|NCT00616343|4082711|P1|NOT COMPLETED|Overall Study||0
1670932|NCT00616343|4082711|P1|COMPLETED|Overall Study||9
1670933|NCT00616343|4082711|P1|STARTED|Overall Study||9
1670934|NCT00616239|4082715|P1|NOT COMPLETED|Overall Study||2
1670935|NCT00616239|4082715|P1|COMPLETED|Overall Study||18
1670936|NCT00616239|4082715|P1|STARTED|Overall Study||20
1670937|NCT00616200|4082719|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
1670938|NCT00616200|4082719|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
1670939|NCT00616200|4082719|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
1670940|NCT00616200|4082719|P1|NOT COMPLETED|Two Week Standard Diet||1
1670941|NCT00616200|4082719|P1|COMPLETED|Two Week Standard Diet||16
1670942|NCT00616200|4082719|P1|STARTED|Two Week Standard Diet||17
1670943|NCT00616122|4082725|P1|NOT COMPLETED|Overall Study||7
1670944|NCT00616122|4082725|P1|COMPLETED|Overall Study||25
1670945|NCT00616122|4082725|P1|STARTED|Overall Study||32
1670946|NCT00616109|4082732|P1|NOT COMPLETED|Overall Study||0
1670947|NCT00616109|4082732|P1|COMPLETED|Overall Study||16
1670948|NCT00616109|4082732|P1|STARTED|Overall Study||16
1670949|NCT00616018|4082739|P1|NOT COMPLETED|Overall Study||3
1670950|NCT00616018|4082739|P1|COMPLETED|Overall Study||24
1670951|NCT00616018|4082739|P1|STARTED|Overall Study||27
1670952|NCT00615992|4082744|P1|NOT COMPLETED|Overall Study||67
1670953|NCT00615992|4082744|P1|COMPLETED|Overall Study||687
1670954|NCT00615992|4082744|P1|STARTED|Overall Study||754
1670955|NCT00615927|4082755|P2|NOT COMPLETED|Overall Study||0
1670956|NCT00615927|4082756|P1|NOT COMPLETED|Overall Study||0
1670957|NCT00615927|4082755|P2|COMPLETED|Overall Study||32
1670958|NCT00615927|4082756|P1|COMPLETED|Overall Study||32
1670959|NCT00615927|4082755|P2|STARTED|Overall Study||32
1670960|NCT00615927|4082756|P1|STARTED|Overall Study||32
1670961|NCT00615914|4082770|P1|NOT COMPLETED|Overall Study||637
1670962|NCT00615914|4082770|P1|COMPLETED|Overall Study||1008
1670963|NCT00615914|4082770|P1|STARTED|Overall Study|The number of patients enrolled|1645
1670964|NCT00615901|4082777|P1|NOT COMPLETED|Overall Study||9
1670965|NCT00615901|4082777|P1|COMPLETED|Overall Study||29
1670966|NCT00615901|4082777|P1|STARTED|Overall Study||38
1670967|NCT00615836|4082785|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
1670968|NCT00615836|4082786|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
1670969|NCT00615836|4082787|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
1670970|NCT00615836|4082788|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
1670971|NCT00615836|4082789|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
1670972|NCT00615836|4082785|P5|COMPLETED|Extension Study (FE992026 CS31)||0
1670973|NCT00615836|4082786|P4|COMPLETED|Extension Study (FE992026 CS31)||53
1670974|NCT00615836|4082787|P3|COMPLETED|Extension Study (FE992026 CS31)||59
1670975|NCT00615836|4082788|P2|COMPLETED|Extension Study (FE992026 CS31)||58
1670976|NCT00615836|4082789|P1|COMPLETED|Extension Study (FE992026 CS31)||0
1670977|NCT00615836|4082785|P5|STARTED|Extension Study (FE992026 CS31)||0
1670978|NCT00615836|4082786|P4|STARTED|Extension Study (FE992026 CS31)||137
1670979|NCT00615836|4082787|P3|STARTED|Extension Study (FE992026 CS31)||132
1670980|NCT00615836|4082788|P2|STARTED|Extension Study (FE992026 CS31)||144
1670981|NCT00615836|4082789|P1|STARTED|Extension Study (FE992026 CS31)||141
1670982|NCT00615836|4082785|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
1670983|NCT00615836|4082786|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
1670984|NCT00615836|4082787|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
1670985|NCT00615836|4082788|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
1670986|NCT00615836|4082789|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
1670987|NCT00615836|4082785|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
1670988|NCT00615836|4082786|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
1670989|NCT00615836|4082787|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
1670990|NCT00615836|4082788|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
1670991|NCT00615836|4082789|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
1670992|NCT00615836|4082785|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
1670993|NCT00615836|4082786|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
1670994|NCT00615836|4082787|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
1670995|NCT00615836|4082788|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
1670996|NCT00615836|4082789|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
1670997|NCT00615836|4082785|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
1670998|NCT00615836|4082786|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
1670999|NCT00615836|4082787|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
1671000|NCT00615836|4082788|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
1671001|NCT00615836|4082789|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
1671002|NCT00615719|4082849|P1|NOT COMPLETED|Overall Study||5
1671003|NCT00615719|4082849|P1|COMPLETED|Overall Study||30
1671004|NCT00615719|4082849|P1|STARTED|Overall Study||35
1671005|NCT00615589|4082853|P1|NOT COMPLETED|Overall Study||0
1671006|NCT00615589|4082853|P1|COMPLETED|Overall Study||22
1671007|NCT00615589|4082853|P1|STARTED|Overall Study||22
1671008|NCT00615550|4082863|P2|NOT COMPLETED|Overall Study||1
1671009|NCT00615550|4082864|P1|NOT COMPLETED|Overall Study||6
1671010|NCT00615550|4082863|P2|COMPLETED|Overall Study||235
1671011|NCT00615550|4082864|P1|COMPLETED|Overall Study||223
1671012|NCT00615550|4082863|P2|STARTED|Overall Study||236
1671013|NCT00615550|4082864|P1|STARTED|Overall Study||229
1671014|NCT00615472|4082880|P2|NOT COMPLETED|Overall Study||0
1671015|NCT00615472|4082881|P1|NOT COMPLETED|Overall Study||0
1671016|NCT00615472|4082880|P2|COMPLETED|Overall Study||28
1671017|NCT00615472|4082881|P1|COMPLETED|Overall Study||30
1671018|NCT00615472|4082880|P2|STARTED|Overall Study||28
1671019|NCT00615472|4082881|P1|STARTED|Overall Study||30
1671020|NCT00615459|4082887|P4|NOT COMPLETED|Period III||0
1671021|NCT00615459|4082888|P3|NOT COMPLETED|Period III||1
1671022|NCT00615459|4082889|P2|NOT COMPLETED|Period III||3
1671023|NCT00615459|4082890|P1|NOT COMPLETED|Period III||0
1671024|NCT00615459|4082887|P4|COMPLETED|Period III||41
1671025|NCT00615459|4082888|P3|COMPLETED|Period III||39
1671026|NCT00615459|4082889|P2|COMPLETED|Period III||37
1671027|NCT00615459|4082890|P1|COMPLETED|Period III||36
1671028|NCT00615459|4082887|P4|STARTED|Period III||41
1671029|NCT00615459|4082888|P3|STARTED|Period III||40
1671030|NCT00615459|4082889|P2|STARTED|Period III||40
1671031|NCT00615459|4082890|P1|STARTED|Period III||36
1671032|NCT00615459|4082887|P4|NOT COMPLETED|Period II||1
1671033|NCT00615459|4082888|P3|NOT COMPLETED|Period II||0
1671034|NCT00615459|4082889|P2|NOT COMPLETED|Period II||0
1671035|NCT00615459|4082890|P1|NOT COMPLETED|Period II||1
1671036|NCT00615459|4082887|P4|COMPLETED|Period II||41
1671037|NCT00615459|4082888|P3|COMPLETED|Period II||40
1671038|NCT00615459|4082889|P2|COMPLETED|Period II||40
1671039|NCT00615459|4082890|P1|COMPLETED|Period II||36
1671040|NCT00615459|4082887|P4|STARTED|Period II||42
1671041|NCT00615459|4082888|P3|STARTED|Period II||40
1671042|NCT00615459|4082889|P2|STARTED|Period II||40
1671043|NCT00615459|4082890|P1|STARTED|Period II||37
1671044|NCT00615459|4082887|P4|NOT COMPLETED|Period I||1
1671045|NCT00615459|4082888|P3|NOT COMPLETED|Period I||2
1671046|NCT00615459|4082889|P2|NOT COMPLETED|Period I||1
1671047|NCT00615459|4082890|P1|NOT COMPLETED|Period I||4
1671048|NCT00615459|4082887|P4|COMPLETED|Period I||42
1671049|NCT00615459|4082888|P3|COMPLETED|Period I||40
1671050|NCT00615459|4082889|P2|COMPLETED|Period I||40
1671051|NCT00615459|4082890|P1|COMPLETED|Period I||37
1671052|NCT00615459|4082887|P4|STARTED|Period I||43
1671053|NCT00615459|4082888|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
1671054|NCT00615459|4082889|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
1671055|NCT00615459|4082890|P1|STARTED|Period I||41
1671056|NCT00615433|4082908|P4|NOT COMPLETED|Overall Study||45
1671057|NCT00615433|4082909|P3|NOT COMPLETED|Overall Study||39
1671058|NCT00615433|4082910|P2|NOT COMPLETED|Overall Study||53
1671059|NCT00615433|4082911|P1|NOT COMPLETED|Overall Study||43
1671060|NCT00615433|4082908|P4|COMPLETED|Overall Study||71
1671061|NCT00615433|4082909|P3|COMPLETED|Overall Study||84
1671062|NCT00615433|4082910|P2|COMPLETED|Overall Study||66
1671063|NCT00615433|4082911|P1|COMPLETED|Overall Study||77
1671064|NCT00615433|4082908|P4|STARTED|Overall Study||116
1671065|NCT00615433|4082909|P3|STARTED|Overall Study||123
1671066|NCT00615433|4082910|P2|STARTED|Overall Study||119
1671067|NCT00615433|4082911|P1|STARTED|Overall Study||120
1671068|NCT00615290|4082925|P1|NOT COMPLETED|Overall Study||8
1671069|NCT00615290|4082925|P1|COMPLETED|Overall Study||34
1671070|NCT00615290|4082925|P1|STARTED|Overall Study||42
1671071|NCT00615264|4082939|P2|NOT COMPLETED|Overall Study||52
1671072|NCT00615264|4082940|P1|NOT COMPLETED|Overall Study||50
1671073|NCT00615264|4082939|P2|COMPLETED|Overall Study||180
1671074|NCT00615264|4082940|P1|COMPLETED|Overall Study||175
1671075|NCT00615264|4082939|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
1671076|NCT00615264|4082940|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
1671077|NCT00615264|4082939|P2|Received at Least One Dose (ITT)|Overall Study||231
1671078|NCT00615264|4082940|P1|Received at Least One Dose (ITT)|Overall Study||225
1671079|NCT00615264|4082939|P2|STARTED|Overall Study||232
1671080|NCT00615264|4082940|P1|STARTED|Overall Study||225
1671081|NCT00615199|4082952|P4|NOT COMPLETED|Overall Study||2
1671082|NCT00615199|4082953|P3|NOT COMPLETED|Overall Study||1
1671083|NCT00615199|4082954|P2|NOT COMPLETED|Overall Study||2
1671084|NCT00615199|4082955|P1|NOT COMPLETED|Overall Study||8
1671085|NCT00615199|4082952|P4|COMPLETED|Overall Study||33
1671086|NCT00615199|4082953|P3|COMPLETED|Overall Study||33
1671087|NCT00615199|4082954|P2|COMPLETED|Overall Study||34
1671088|NCT00615199|4082955|P1|COMPLETED|Overall Study||26
1671089|NCT00615199|4082952|P4|STARTED|Overall Study||35
1671090|NCT00615199|4082953|P3|STARTED|Overall Study||34
1671091|NCT00615199|4082954|P2|STARTED|Overall Study||36
1671092|NCT00615199|4082955|P1|STARTED|Overall Study||34
1671093|NCT00615108|4082989|P1|NOT COMPLETED|Overall Study||507
1671094|NCT00615108|4082989|P1|COMPLETED|Overall Study||2641
1671095|NCT00615108|4082989|P1|STARTED|Overall Study||3148
1671096|NCT00615069|4083004|P1|NOT COMPLETED|Overall Study||16
1671097|NCT00615069|4083004|P1|COMPLETED|Overall Study||19
1671098|NCT00615069|4083004|P1|STARTED|Overall Study||35
1671099|NCT00615056|4083013|P4|NOT COMPLETED|Overall Study||35
1671100|NCT00615056|4083014|P3|NOT COMPLETED|Overall Study||36
1671101|NCT00615056|4083015|P2|NOT COMPLETED|Overall Study||51
1671102|NCT00615056|4083016|P1|NOT COMPLETED|Overall Study||49
1671103|NCT00615056|4083013|P4|COMPLETED|Overall Study||0
1671104|NCT00615056|4083014|P3|COMPLETED|Overall Study||0
1671105|NCT00615056|4083015|P2|COMPLETED|Overall Study||0
1671106|NCT00615056|4083016|P1|COMPLETED|Overall Study||0
1671107|NCT00615056|4083013|P4|Treated|Overall Study||35
1671108|NCT00615056|4083014|P3|Treated|Overall Study||36
1671109|NCT00615056|4083015|P2|Treated|Overall Study||51
1671110|NCT00615056|4083016|P1|Treated|Overall Study||46
1671111|NCT00615056|4083013|P4|STARTED|Overall Study||35
1671112|NCT00615056|4083014|P3|STARTED|Overall Study||36
1671113|NCT00615056|4083015|P2|STARTED|Overall Study||51
1671114|NCT00615056|4083016|P1|STARTED|Overall Study||49
1671115|NCT00615030|4083046|P12|NOT COMPLETED|Period III||0
1671116|NCT00615030|4083047|P11|NOT COMPLETED|Period III||0
1671117|NCT00615030|4083048|P10|NOT COMPLETED|Period III||0
1671118|NCT00615030|4083049|P9|NOT COMPLETED|Period III||0
1671119|NCT00615030|4083050|P8|NOT COMPLETED|Period III||0
1671120|NCT00615030|4083051|P7|NOT COMPLETED|Period III||0
1671121|NCT00615030|4083052|P6|NOT COMPLETED|Period III||0
1671122|NCT00615030|4083053|P5|NOT COMPLETED|Period III||0
1671123|NCT00615030|4083054|P4|NOT COMPLETED|Period III||1
1671124|NCT00615030|4083055|P3|NOT COMPLETED|Period III||0
1671125|NCT00615030|4083056|P2|NOT COMPLETED|Period III||0
1671126|NCT00615030|4083057|P1|NOT COMPLETED|Period III||1
1671127|NCT00615030|4083046|P12|COMPLETED|Period III||6
1671128|NCT00615030|4083047|P11|COMPLETED|Period III||7
1671129|NCT00615030|4083048|P10|COMPLETED|Period III||8
1671130|NCT00615030|4083049|P9|COMPLETED|Period III||7
1671131|NCT00615030|4083050|P8|COMPLETED|Period III||7
1671132|NCT00615030|4083051|P7|COMPLETED|Period III||6
1671133|NCT00615030|4083052|P6|COMPLETED|Period III||5
1671134|NCT00615030|4083053|P5|COMPLETED|Period III||8
1671135|NCT00615030|4083054|P4|COMPLETED|Period III||6
1671136|NCT00615030|4083055|P3|COMPLETED|Period III||8
1671137|NCT00615030|4083056|P2|COMPLETED|Period III||8
1671138|NCT00615030|4083057|P1|COMPLETED|Period III||7
1671139|NCT00615030|4083046|P12|STARTED|Period III||6
1671140|NCT00615030|4083047|P11|STARTED|Period III||7
1671141|NCT00615030|4083048|P10|STARTED|Period III||8
1671142|NCT00615030|4083049|P9|STARTED|Period III||7
1671143|NCT00615030|4083050|P8|STARTED|Period III||7
1671144|NCT00615030|4083051|P7|STARTED|Period III||6
1671145|NCT00615030|4083052|P6|STARTED|Period III||5
1671146|NCT00615030|4083053|P5|STARTED|Period III||8
1671147|NCT00615030|4083054|P4|STARTED|Period III||7
1671148|NCT00615030|4083055|P3|STARTED|Period III||8
1671149|NCT00615030|4083056|P2|STARTED|Period III||8
1671150|NCT00615030|4083057|P1|STARTED|Period III||8
1671151|NCT00615030|4083046|P12|NOT COMPLETED|Period II||0
1671152|NCT00615030|4083047|P11|NOT COMPLETED|Period II||0
1671153|NCT00615030|4083048|P10|NOT COMPLETED|Period II||0
1671154|NCT00615030|4083049|P9|NOT COMPLETED|Period II||1
1671155|NCT00615030|4083050|P8|NOT COMPLETED|Period II||0
1671156|NCT00615030|4083051|P7|NOT COMPLETED|Period II||1
1671157|NCT00615030|4083052|P6|NOT COMPLETED|Period II||0
1671158|NCT00615030|4083053|P5|NOT COMPLETED|Period II||0
1671159|NCT00615030|4083054|P4|NOT COMPLETED|Period II||1
1671160|NCT00615030|4083055|P3|NOT COMPLETED|Period II||1
1671161|NCT00615030|4083056|P2|NOT COMPLETED|Period II||0
1671162|NCT00615030|4083057|P1|NOT COMPLETED|Period II||0
1671163|NCT00615030|4083046|P12|COMPLETED|Period II||6
1671164|NCT00615030|4083047|P11|COMPLETED|Period II||7
1671165|NCT00615030|4083048|P10|COMPLETED|Period II||8
1671166|NCT00615030|4083049|P9|COMPLETED|Period II||7
1671167|NCT00615030|4083050|P8|COMPLETED|Period II||7
1671168|NCT00615030|4083051|P7|COMPLETED|Period II||6
1671169|NCT00615030|4083052|P6|COMPLETED|Period II||5
1671170|NCT00615030|4083053|P5|COMPLETED|Period II||8
1671171|NCT00615030|4083054|P4|COMPLETED|Period II||7
1671172|NCT00615030|4083055|P3|COMPLETED|Period II||8
1671173|NCT00615030|4083056|P2|COMPLETED|Period II||8
1671174|NCT00615030|4083057|P1|COMPLETED|Period II||8
1671175|NCT00615030|4083046|P12|STARTED|Period II||6
1671176|NCT00615030|4083047|P11|STARTED|Period II||7
1671177|NCT00615030|4083048|P10|STARTED|Period II||8
1671178|NCT00615030|4083049|P9|STARTED|Period II||8
1671179|NCT00615030|4083050|P8|STARTED|Period II||7
1671180|NCT00615030|4083051|P7|STARTED|Period II||7
1671181|NCT00615030|4083052|P6|STARTED|Period II||5
1671182|NCT00615030|4083053|P5|STARTED|Period II||8
1671183|NCT00615030|4083054|P4|STARTED|Period II||8
1671184|NCT00615030|4083055|P3|STARTED|Period II||9
1671185|NCT00615030|4083056|P2|STARTED|Period II||8
1671186|NCT00615030|4083057|P1|STARTED|Period II||8
1671187|NCT00615030|4083046|P12|NOT COMPLETED|Period I||1
1671188|NCT00615030|4083047|P11|NOT COMPLETED|Period I||1
1671189|NCT00615030|4083048|P10|NOT COMPLETED|Period I||0
1671190|NCT00615030|4083049|P9|NOT COMPLETED|Period I||1
1671191|NCT00615030|4083050|P8|NOT COMPLETED|Period I||0
1671192|NCT00615030|4083051|P7|NOT COMPLETED|Period I||0
1671193|NCT00615030|4083052|P6|NOT COMPLETED|Period I||1
1671194|NCT00615030|4083053|P5|NOT COMPLETED|Period I||1
1671195|NCT00615030|4083054|P4|NOT COMPLETED|Period I||0
1671196|NCT00615030|4083055|P3|NOT COMPLETED|Period I||0
1671197|NCT00615030|4083056|P2|NOT COMPLETED|Period I||0
1671198|NCT00615030|4083057|P1|NOT COMPLETED|Period I||1
1671199|NCT00615030|4083046|P12|COMPLETED|Period I||6
1671200|NCT00615030|4083047|P11|COMPLETED|Period I||7
1671201|NCT00615030|4083048|P10|COMPLETED|Period I||8
1671202|NCT00615030|4083049|P9|COMPLETED|Period I||8
1671203|NCT00615030|4083050|P8|COMPLETED|Period I||7
1671204|NCT00615030|4083051|P7|COMPLETED|Period I||7
1671205|NCT00615030|4083052|P6|COMPLETED|Period I||5
1671206|NCT00615030|4083053|P5|COMPLETED|Period I||8
1671207|NCT00615030|4083054|P4|COMPLETED|Period I||8
1671208|NCT00615030|4083055|P3|COMPLETED|Period I||9
1671209|NCT00615030|4083056|P2|COMPLETED|Period I||8
1671210|NCT00615030|4083057|P1|COMPLETED|Period I||8
1671211|NCT00615030|4083046|P12|STARTED|Period I||7
1671212|NCT00615030|4083047|P11|STARTED|Period I||8
1671213|NCT00615030|4083048|P10|STARTED|Period I||8
1671214|NCT00615030|4083049|P9|STARTED|Period I||9
1671215|NCT00615030|4083050|P8|STARTED|Period I||7
1671216|NCT00615030|4083051|P7|STARTED|Period I||7
1671217|NCT00615030|4083052|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
1671218|NCT00615030|4083053|P5|STARTED|Period I||9
1671219|NCT00615030|4083054|P4|STARTED|Period I||8
1671220|NCT00615030|4083055|P3|STARTED|Period I||9
1671221|NCT00615030|4083056|P2|STARTED|Period I||8
1671222|NCT00615030|4083057|P1|STARTED|Period I||9
1671223|NCT00615017|4083077|P6|NOT COMPLETED|Overall Study||3
1671224|NCT00615017|4083078|P5|NOT COMPLETED|Overall Study||1
1671225|NCT00615017|4083079|P4|NOT COMPLETED|Overall Study||1
1671226|NCT00615017|4083080|P3|NOT COMPLETED|Overall Study||5
1671227|NCT00615017|4083081|P2|NOT COMPLETED|Overall Study||1
1671228|NCT00615017|4083082|P1|NOT COMPLETED|Overall Study||0
1671229|NCT00615017|4083077|P6|COMPLETED|Overall Study|Patient completed the study drug|20
1671230|NCT00615017|4083078|P5|COMPLETED|Overall Study|Patient completed the study drug|7
1671231|NCT00615017|4083079|P4|COMPLETED|Overall Study|Patient completed the study drug|9
1671232|NCT00615017|4083080|P3|COMPLETED|Overall Study|Patient completed the study drug|7
1671233|NCT00615017|4083081|P2|COMPLETED|Overall Study|Patient completed the study drug|8
1671234|NCT00615017|4083082|P1|COMPLETED|Overall Study|Patient completed the study drug|8
1671235|NCT00615017|4083077|P6|STARTED|Overall Study|Patients received treatment|23
1671236|NCT00615017|4083078|P5|STARTED|Overall Study|Patients received treatment|8
1671237|NCT00615017|4083079|P4|STARTED|Overall Study|Patients received treatment|10
1671238|NCT00615017|4083080|P3|STARTED|Overall Study|Patients received treatment|12
1671239|NCT00615017|4083081|P2|STARTED|Overall Study|Patients received treatment|9
1671240|NCT00615017|4083082|P1|STARTED|Overall Study|Patients received treatment|8
1671241|NCT00614991|4083240|P6|NOT COMPLETED|Overall Study||0
1671242|NCT00614991|4083241|P5|NOT COMPLETED|Overall Study||1
1671243|NCT00614991|4083242|P4|NOT COMPLETED|Overall Study||0
1671244|NCT00614991|4083243|P3|NOT COMPLETED|Overall Study||0
1671245|NCT00614991|4083244|P2|NOT COMPLETED|Overall Study||3
1671246|NCT00614991|4083245|P1|NOT COMPLETED|Overall Study||3
1671247|NCT00614991|4083240|P6|COMPLETED|Overall Study||6
1671248|NCT00614991|4083241|P5|COMPLETED|Overall Study||6
1671249|NCT00614991|4083242|P4|COMPLETED|Overall Study||7
1671250|NCT00614991|4083243|P3|COMPLETED|Overall Study||7
1671251|NCT00614991|4083244|P2|COMPLETED|Overall Study||6
1671252|NCT00614991|4083245|P1|COMPLETED|Overall Study||5
1671253|NCT00614991|4083240|P6|STARTED|Overall Study||6
1671254|NCT00614991|4083241|P5|STARTED|Overall Study||7
1671255|NCT00614991|4083242|P4|STARTED|Overall Study||7
1671256|NCT00614991|4083243|P3|STARTED|Overall Study||7
1671257|NCT00614991|4083244|P2|STARTED|Overall Study||9
1671258|NCT00614991|4083245|P1|STARTED|Overall Study||8
1671259|NCT00614939|4083279|P2|NOT COMPLETED|Overall Study||43
1671260|NCT00614939|4083280|P1|NOT COMPLETED|Overall Study||35
1671261|NCT00614939|4083279|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
1671262|NCT00614939|4083280|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
1671263|NCT00614939|4083279|P2|STARTED|Overall Study|Randomized and treated|85
1671264|NCT00614939|4083280|P1|STARTED|Overall Study|Randomized and treated|85
1671265|NCT00614926|4083314|P2|NOT COMPLETED|Overall Study||0
1671266|NCT00614926|4083315|P1|NOT COMPLETED|Overall Study||4
1671267|NCT00614926|4083314|P2|COMPLETED|Overall Study||7
1671268|NCT00614926|4083315|P1|COMPLETED|Overall Study||21
1671269|NCT00614926|4083314|P2|STARTED|Overall Study||7
1671270|NCT00614926|4083315|P1|STARTED|Overall Study||25
1671271|NCT00614913|4083323|P1|NOT COMPLETED|Overall Study||0
1671272|NCT00614913|4083323|P1|COMPLETED|Overall Study||76
1671273|NCT00614913|4083323|P1|STARTED|Overall Study||76
1671274|NCT00614874|4083328|P1|NOT COMPLETED|Overall Study||2
1671275|NCT00614874|4083328|P1|COMPLETED|Overall Study||14
1671276|NCT00614874|4083328|P1|STARTED|Overall Study||16
1671277|NCT00614744|4083337|P2|NOT COMPLETED|Overall Study||6
1671278|NCT00614744|4083338|P1|NOT COMPLETED|Overall Study||5
1671279|NCT00614744|4083337|P2|COMPLETED|Overall Study||79
1671280|NCT00614744|4083338|P1|COMPLETED|Overall Study||78
1671281|NCT00614744|4083337|P2|STARTED|Overall Study||85
1671282|NCT00614744|4083338|P1|STARTED|Overall Study||83
1671283|NCT00614614|4083364|P5|NOT COMPLETED|Booster Vaccination Phase||13
1671284|NCT00614614|4083365|P4|NOT COMPLETED|Booster Vaccination Phase||19
1671285|NCT00614614|4083366|P3|NOT COMPLETED|Booster Vaccination Phase||27
1671286|NCT00614614|4083367|P2|NOT COMPLETED|Booster Vaccination Phase||6
1671287|NCT00614614|4083368|P1|NOT COMPLETED|Booster Vaccination Phase||0
1671288|NCT00614614|4083364|P5|COMPLETED|Booster Vaccination Phase||396
1671289|NCT00614614|4083365|P4|COMPLETED|Booster Vaccination Phase||210
1671290|NCT00614614|4083366|P3|COMPLETED|Booster Vaccination Phase||405
1671291|NCT00614614|4083367|P2|COMPLETED|Booster Vaccination Phase||227
1671292|NCT00614614|4083368|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
1671293|NCT00614614|4083364|P5|STARTED|Booster Vaccination Phase||409
1671294|NCT00614614|4083365|P4|STARTED|Booster Vaccination Phase||229
1671295|NCT00614614|4083366|P3|STARTED|Booster Vaccination Phase||432
1671296|NCT00614614|4083367|P2|STARTED|Booster Vaccination Phase||233
1671297|NCT00614614|4083368|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
1671298|NCT00614614|4083364|P5|NOT COMPLETED|Primary Vaccination Phase||0
1671299|NCT00614614|4083365|P4|NOT COMPLETED|Primary Vaccination Phase||0
1671300|NCT00614614|4083366|P3|NOT COMPLETED|Primary Vaccination Phase||0
1671301|NCT00614614|4083367|P2|NOT COMPLETED|Primary Vaccination Phase||17
1671302|NCT00614614|4083368|P1|NOT COMPLETED|Primary Vaccination Phase||90
1671303|NCT00614614|4083364|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1671304|NCT00614614|4083365|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1671305|NCT00614614|4083366|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1671306|NCT00614614|4083367|P2|COMPLETED|Primary Vaccination Phase||265
1671307|NCT00614614|4083368|P1|COMPLETED|Primary Vaccination Phase||1182
1671308|NCT00614614|4083364|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1671309|NCT00614614|4083365|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1671310|NCT00614614|4083366|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1671311|NCT00614614|4083367|P2|STARTED|Primary Vaccination Phase||282
1671312|NCT00614614|4083368|P1|STARTED|Primary Vaccination Phase||1272
1671313|NCT00614575|4083491|P1|NOT COMPLETED|Overall Study||228
1671314|NCT00614575|4083491|P1|COMPLETED|Overall Study||861
1671315|NCT00614575|4083491|P1|STARTED|Overall Study|The number of patients enrolled.|1089
1671316|NCT00614523|4083502|P2|NOT COMPLETED|Overall Study||131
1671317|NCT00614523|4083503|P1|NOT COMPLETED|Overall Study||63
1671318|NCT00614523|4083502|P2|COMPLETED|Overall Study||36
1671319|NCT00614523|4083503|P1|COMPLETED|Overall Study||20
1671320|NCT00614523|4083502|P2|STARTED|Overall Study||167
1671321|NCT00614523|4083503|P1|STARTED|Overall Study||83
1671322|NCT00614484|4083527|P1|NOT COMPLETED|Overall Study||0
1671323|NCT00614484|4083527|P1|COMPLETED|Overall Study||28
1671324|NCT00614484|4083527|P1|STARTED|Overall Study||28
1671325|NCT00614458|4083532|P1|NOT COMPLETED|Overall Study||0
1671326|NCT00614458|4083532|P1|COMPLETED|Overall Study||6
1671327|NCT00614458|4083532|P1|STARTED|Overall Study||6
1671328|NCT00614445|4083538|P2|NOT COMPLETED|Overall Study||49
1671329|NCT00614445|4083539|P1|NOT COMPLETED|Overall Study||28
1671330|NCT00614445|4083538|P2|COMPLETED|Overall Study||91
1671331|NCT00614445|4083539|P1|COMPLETED|Overall Study||112
1671332|NCT00614445|4083538|P2|STARTED|Overall Study||140
1671333|NCT00614445|4083539|P1|STARTED|Overall Study||140
1671334|NCT00614432|4083547|P2|NOT COMPLETED|Overall Study||0
1671335|NCT00614432|4083548|P1|NOT COMPLETED|Overall Study||0
1671336|NCT00614432|4083547|P2|COMPLETED|Overall Study||6
1671337|NCT00614432|4083548|P1|COMPLETED|Overall Study||4
1671338|NCT00614432|4083547|P2|STARTED|Overall Study||6
1671339|NCT00614432|4083548|P1|STARTED|Overall Study||4
1671340|NCT00614406|4083556|P2|NOT COMPLETED|Overall Study||0
1671341|NCT00614406|4083557|P1|NOT COMPLETED|Overall Study||0
1671342|NCT00614406|4083556|P2|COMPLETED|Overall Study||4
1671343|NCT00614406|4083557|P1|COMPLETED|Overall Study||7
1671344|NCT00614406|4083556|P2|STARTED|Overall Study||4
1671345|NCT00614406|4083557|P1|STARTED|Overall Study||7
1671346|NCT00614393|4083568|P5|NOT COMPLETED|Overall Study||180
1671347|NCT00614393|4083569|P4|NOT COMPLETED|Overall Study||180
1671348|NCT00614393|4083570|P3|NOT COMPLETED|Overall Study||10
1671349|NCT00614393|4083571|P2|NOT COMPLETED|Overall Study||8
1671350|NCT00614393|4083572|P1|NOT COMPLETED|Overall Study||180
1671351|NCT00614393|4083568|P5|COMPLETED|Overall Study||0
1671352|NCT00614393|4083569|P4|COMPLETED|Overall Study||0
1671353|NCT00614393|4083570|P3|COMPLETED|Overall Study||0
1671354|NCT00614393|4083571|P2|COMPLETED|Overall Study||0
1671355|NCT00614393|4083572|P1|COMPLETED|Overall Study||0
1671356|NCT00614393|4083568|P5|Treated|Overall Study||178
1671357|NCT00614393|4083569|P4|Treated|Overall Study||180
1671358|NCT00614393|4083570|P3|Treated|Overall Study||10
1671359|NCT00614393|4083571|P2|Treated|Overall Study||8
1671360|NCT00614393|4083572|P1|Treated|Overall Study||180
1671361|NCT00614393|4083568|P5|STARTED|Overall Study||180
1671362|NCT00614393|4083569|P4|STARTED|Overall Study||180
1671363|NCT00614393|4083570|P3|STARTED|Overall Study||10
1671364|NCT00614393|4083571|P2|STARTED|Overall Study||8
1671365|NCT00614393|4083572|P1|STARTED|Overall Study||180
1671366|NCT00614380|4083618|P4|NOT COMPLETED|Overall Study||2
1671367|NCT00614380|4083619|P3|NOT COMPLETED|Overall Study||1
1671368|NCT00614380|4083620|P2|NOT COMPLETED|Overall Study||8
1671369|NCT00614380|4083621|P1|NOT COMPLETED|Overall Study||35
1671370|NCT00614380|4083618|P4|COMPLETED|Overall Study||179
1671371|NCT00614380|4083619|P3|COMPLETED|Overall Study||24
1671372|NCT00614380|4083620|P2|COMPLETED|Overall Study||198
1671373|NCT00614380|4083621|P1|COMPLETED|Overall Study||529
1671374|NCT00614380|4083618|P4|STARTED|Overall Study||181
1671375|NCT00614380|4083619|P3|STARTED|Overall Study||25
1671376|NCT00614380|4083620|P2|STARTED|Overall Study||206
1671377|NCT00614380|4083621|P1|STARTED|Overall Study||564
1671378|NCT00614315|4083670|P1|NOT COMPLETED|Overall Study||0
1671379|NCT00614315|4083670|P1|COMPLETED|Overall Study||30
1671380|NCT00614315|4083670|P1|STARTED|Overall Study||30
1671381|NCT00614198|4083677|P2|NOT COMPLETED|Stage 2||12
1671382|NCT00614198|4083678|P1|NOT COMPLETED|Stage 2||8
1671383|NCT00614198|4083677|P2|COMPLETED|Stage 2||17
1671384|NCT00614198|4083678|P1|COMPLETED|Stage 2||18
1671385|NCT00614198|4083677|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
1671386|NCT00614198|4083678|P1|STARTED|Stage 2||26
1671387|NCT00614198|4083677|P2|NOT COMPLETED|Stage 1||5
1671388|NCT00614198|4083678|P1|NOT COMPLETED|Stage 1||12
1671389|NCT00614198|4083677|P2|COMPLETED|Stage 1||29
1671390|NCT00614198|4083678|P1|COMPLETED|Stage 1||26
1671391|NCT00614198|4083677|P2|STARTED|Stage 1||34
1671392|NCT00614198|4083678|P1|STARTED|Stage 1||38
1671393|NCT00614120|4083688|P4|NOT COMPLETED|Overall Study||16
1671394|NCT00614120|4083689|P3|NOT COMPLETED|Overall Study||59
1671395|NCT00614120|4083690|P2|NOT COMPLETED|Overall Study||46
1671396|NCT00614120|4083691|P1|NOT COMPLETED|Overall Study||29
1671397|NCT00614120|4083688|P4|COMPLETED|Overall Study||215
1671398|NCT00614120|4083689|P3|COMPLETED|Overall Study||175
1671399|NCT00614120|4083690|P2|COMPLETED|Overall Study||187
1671400|NCT00614120|4083691|P1|COMPLETED|Overall Study||202
1671401|NCT00614120|4083688|P4|Exposed to Study Drug|Overall Study||231
1671402|NCT00614120|4083689|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
1671403|NCT00614120|4083690|P2|Exposed to Study Drug|Overall Study||233
1671404|NCT00614120|4083691|P1|Exposed to Study Drug|Overall Study||231
1671405|NCT00614120|4083688|P4|STARTED|Overall Study|Randomised|231
1671406|NCT00614120|4083689|P3|STARTED|Overall Study|Randomised|234
1671407|NCT00614120|4083690|P2|STARTED|Overall Study|Randomised|233
1671408|NCT00614120|4083691|P1|STARTED|Overall Study|Randomised|231
1671409|NCT00614055|4083732|P3|NOT COMPLETED|Overall Study||5
1671410|NCT00614055|4083733|P2|NOT COMPLETED|Overall Study||6
1671411|NCT00614055|4083734|P1|NOT COMPLETED|Overall Study||4
1671412|NCT00614055|4083732|P3|COMPLETED|Overall Study||55
1671413|NCT00614055|4083733|P2|COMPLETED|Overall Study||53
1671414|NCT00614055|4083734|P1|COMPLETED|Overall Study||55
1671415|NCT00614055|4083732|P3|Exposed|Overall Study||60
1671416|NCT00614055|4083733|P2|Exposed|Overall Study||59
1671417|NCT00614055|4083734|P1|Exposed|Overall Study||59
1671418|NCT00614055|4083732|P3|STARTED|Overall Study||60
1671419|NCT00614055|4083733|P2|STARTED|Overall Study||59
1671420|NCT00614055|4083734|P1|STARTED|Overall Study||59
1671421|NCT00613951|4083781|P3|NOT COMPLETED|Overall Study||5
1671422|NCT00613951|4083782|P2|NOT COMPLETED|Overall Study||5
1671423|NCT00613951|4083783|P1|NOT COMPLETED|Overall Study||7
1671424|NCT00613951|4083781|P3|COMPLETED|Overall Study||57
1671425|NCT00613951|4083782|P2|COMPLETED|Overall Study||54
1671426|NCT00613951|4083783|P1|COMPLETED|Overall Study||54
1671427|NCT00613951|4083781|P3|Exposed|Overall Study||62
1671428|NCT00613951|4083782|P2|Exposed|Overall Study||59
1671429|NCT00613951|4083783|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
1671430|NCT00613951|4083781|P3|STARTED|Overall Study||62
1671431|NCT00613951|4083782|P2|STARTED|Overall Study||59
1671432|NCT00613951|4083783|P1|STARTED|Overall Study||61
1671433|NCT00613938|4083828|P4|NOT COMPLETED|Overall Study||26
1671434|NCT00613938|4083829|P3|NOT COMPLETED|Overall Study||23
1671435|NCT00613938|4083830|P2|NOT COMPLETED|Overall Study||28
1671436|NCT00613938|4083831|P1|NOT COMPLETED|Overall Study||20
1671437|NCT00613938|4083828|P4|COMPLETED|Overall Study||253
1671438|NCT00613938|4083829|P3|COMPLETED|Overall Study||255
1671439|NCT00613938|4083830|P2|COMPLETED|Overall Study||247
1671440|NCT00613938|4083831|P1|COMPLETED|Overall Study||49
1671441|NCT00613938|4083828|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
1671442|NCT00613938|4083829|P3|STARTED|Overall Study||278
1671443|NCT00613938|4083830|P2|STARTED|Overall Study||275
1671444|NCT00613938|4083831|P1|STARTED|Overall Study||69
1671445|NCT00613925|4083863|P2|NOT COMPLETED|Overall Study||1
1671446|NCT00613925|4083864|P1|NOT COMPLETED|Overall Study||0
1671447|NCT00613925|4083863|P2|COMPLETED|Overall Study||32
1671448|NCT00613925|4083864|P1|COMPLETED|Overall Study||37
1671449|NCT00613925|4083863|P2|STARTED|Overall Study||33
1671450|NCT00613925|4083864|P1|STARTED|Overall Study||37
1671451|NCT00613821|4083874|P2|NOT COMPLETED|Overall Study||1
1671452|NCT00613821|4083875|P1|NOT COMPLETED|Overall Study||2
1671453|NCT00613821|4083874|P2|COMPLETED|Overall Study||39
1671454|NCT00613821|4083875|P1|COMPLETED|Overall Study||38
1671455|NCT00613821|4083874|P2|STARTED|Overall Study||40
1671456|NCT00613821|4083875|P1|STARTED|Overall Study||40
1671457|NCT00613730|4083881|P1|NOT COMPLETED|Overall Study||3
1671458|NCT00613730|4083881|P1|COMPLETED|Overall Study||0
1671459|NCT00613730|4083881|P1|STARTED|Overall Study||3
1671460|NCT00613626|4083890|P3|NOT COMPLETED|Overall Study||0
1671461|NCT00613626|4083891|P2|NOT COMPLETED|Overall Study||1
1671462|NCT00613626|4083892|P1|NOT COMPLETED|Overall Study||0
1671463|NCT00613626|4083890|P3|COMPLETED|Overall Study||7
1671464|NCT00613626|4083891|P2|COMPLETED|Overall Study||33
1671465|NCT00613626|4083892|P1|COMPLETED|Overall Study||33
1671466|NCT00613626|4083890|P3|1st Dose ZD6474|Overall Study||7
1671467|NCT00613626|4083891|P2|1st Dose ZD6474|Overall Study||34
1671468|NCT00613626|4083892|P1|1st Dose ZD6474|Overall Study||33
1671469|NCT00613626|4083890|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
1671470|NCT00613626|4083891|P2|STARTED|Overall Study||34
1671471|NCT00613626|4083892|P1|STARTED|Overall Study||33
1671472|NCT00613574|4083908|P1|NOT COMPLETED|Overall Study||6
1671473|NCT00613574|4083908|P1|COMPLETED|Overall Study||401
1671474|NCT00613574|4083908|P1|STARTED|Overall Study||407
1671475|NCT00613509|4083920|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
1671476|NCT00613509|4083921|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
1671477|NCT00613509|4083920|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
1671478|NCT00613509|4083921|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
1671479|NCT00613509|4083920|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
1671480|NCT00613509|4083921|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
1671481|NCT00613509|4083920|P2|NOT COMPLETED|Cycle 1||8
1671482|NCT00613509|4083921|P1|NOT COMPLETED|Cycle 1||5
1671483|NCT00613509|4083920|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
1671484|NCT00613509|4083921|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
1671485|NCT00613509|4083920|P2|STARTED|Cycle 1||12
1671486|NCT00613509|4083921|P1|STARTED|Cycle 1||11
1671487|NCT00613405|4083945|P2|NOT COMPLETED|Overall Study||0
1671488|NCT00613405|4083946|P1|NOT COMPLETED|Overall Study||0
1671489|NCT00613405|4083945|P2|COMPLETED|Overall Study||42
1671490|NCT00613405|4083946|P1|COMPLETED|Overall Study||45
1671491|NCT00613405|4083945|P2|STARTED|Overall Study||42
1671492|NCT00613405|4083946|P1|STARTED|Overall Study||45
1671493|NCT00613379|4083955|P3|NOT COMPLETED|Overall Study||0
1671494|NCT00613379|4083956|P2|NOT COMPLETED|Overall Study||0
1671495|NCT00613379|4083957|P1|NOT COMPLETED|Overall Study||0
1671496|NCT00613379|4083955|P3|COMPLETED|Overall Study||11
1671497|NCT00613379|4083956|P2|COMPLETED|Overall Study||10
1671498|NCT00613379|4083957|P1|COMPLETED|Overall Study||10
1671499|NCT00613379|4083955|P3|STARTED|Overall Study||11
1671500|NCT00613379|4083956|P2|STARTED|Overall Study||10
1671501|NCT00613379|4083957|P1|STARTED|Overall Study||10
1671502|NCT00613366|4083967|P2|NOT COMPLETED|Overall Study||2
1671503|NCT00613366|4083968|P1|NOT COMPLETED|Overall Study||3
1671504|NCT00613366|4083967|P2|COMPLETED|Overall Study||18
1671505|NCT00613366|4083968|P1|COMPLETED|Overall Study||17
1671506|NCT00613366|4083967|P2|STARTED|Overall Study||20
1671507|NCT00613366|4083968|P1|STARTED|Overall Study||20
1671508|NCT00613327|4083976|P1|NOT COMPLETED|Overall Study||101
1671509|NCT00613327|4083976|P1|COMPLETED|Overall Study||244
1671510|NCT00613327|4083976|P1|STARTED|Overall Study||345
1671511|NCT00613314|4083995|P1|NOT COMPLETED|Overall Study||155
1671512|NCT00613314|4083995|P1|COMPLETED|Overall Study||15113
1671513|NCT00613314|4083995|P1|STARTED|Overall Study||15268
1671514|NCT00613301|4084003|P1|NOT COMPLETED|Overall Study||228
1671515|NCT00613301|4084003|P1|COMPLETED|Overall Study||188
1671516|NCT00613301|4084003|P1|STARTED|Overall Study||416
1671517|NCT00613106|4084012|P2|NOT COMPLETED|Overall Study||9
1671518|NCT00613106|4084013|P1|NOT COMPLETED|Overall Study||20
1671519|NCT00613106|4084012|P2|COMPLETED|Overall Study||38
1671520|NCT00613106|4084013|P1|COMPLETED|Overall Study||112
1671521|NCT00613106|4084012|P2|STARTED|Overall Study||47
1671522|NCT00613106|4084013|P1|STARTED|Overall Study||132
1671523|NCT00613080|4084019|P1|NOT COMPLETED|Overall Study||11
1671524|NCT00613080|4084019|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
1671525|NCT00613080|4084019|P1|STARTED|Overall Study||79
1671526|NCT00613028|4084033|P2|NOT COMPLETED|Overall Study||1
1671527|NCT00613028|4084034|P1|NOT COMPLETED|Overall Study||0
1671528|NCT00613028|4084033|P2|COMPLETED|Overall Study||12
1671529|NCT00613028|4084034|P1|COMPLETED|Overall Study||10
1671530|NCT00613028|4084033|P2|STARTED|Overall Study||13
1671531|NCT00613028|4084034|P1|STARTED|Overall Study||10
1671532|NCT00613015|4084054|P6|NOT COMPLETED|Overall Study||3
1671533|NCT00613015|4084055|P5|NOT COMPLETED|Overall Study||2
1671534|NCT00613015|4084056|P4|NOT COMPLETED|Overall Study||3
1671535|NCT00613015|4084057|P3|NOT COMPLETED|Overall Study||3
1671536|NCT00613015|4084058|P2|NOT COMPLETED|Overall Study||1
1671537|NCT00613015|4084059|P1|NOT COMPLETED|Overall Study||0
1671538|NCT00613015|4084054|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
1671539|NCT00613015|4084055|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
1671540|NCT00613015|4084056|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
1671541|NCT00613015|4084057|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
1671542|NCT00613015|4084058|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
1671543|NCT00613015|4084059|P1|COMPLETED|Overall Study||13
1671544|NCT00613015|4084054|P6|STARTED|Overall Study||19
1671545|NCT00613015|4084055|P5|STARTED|Overall Study||15
1671546|NCT00613015|4084056|P4|STARTED|Overall Study||24
1671547|NCT00613015|4084057|P3|STARTED|Overall Study||26
1671548|NCT00613015|4084058|P2|STARTED|Overall Study||12
1671549|NCT00613015|4084059|P1|STARTED|Overall Study||13
1671550|NCT00612924|4084081|P2|NOT COMPLETED|Overall Study||9
1671551|NCT00612924|4084082|P1|NOT COMPLETED|Overall Study||7
1671552|NCT00612924|4084081|P2|COMPLETED|Overall Study||85
1671553|NCT00612924|4084082|P1|COMPLETED|Overall Study||94
1671554|NCT00612924|4084081|P2|STARTED|Overall Study||94
1671555|NCT00612924|4084082|P1|STARTED|Overall Study||101
1671556|NCT00612807|4084095|P2|NOT COMPLETED|Overall Study||0
1671557|NCT00612807|4084096|P1|NOT COMPLETED|Overall Study||2
1671558|NCT00612807|4084095|P2|COMPLETED|Overall Study||28
1671559|NCT00612807|4084096|P1|COMPLETED|Overall Study||12
1671560|NCT00612807|4084095|P2|STARTED|Overall Study||28
1671561|NCT00612807|4084096|P1|STARTED|Overall Study||14
1671562|NCT00612768|4084104|P1|NOT COMPLETED|Overall Study||0
1671563|NCT00612768|4084104|P1|COMPLETED|Overall Study||50
1671564|NCT00612768|4084104|P1|STARTED|Overall Study||50
1671565|NCT00612690|4084131|P2|NOT COMPLETED|Overall Study||118
1671566|NCT00612690|4084132|P1|NOT COMPLETED|Overall Study||115
1671567|NCT00612690|4084131|P2|COMPLETED|Overall Study||89
1671568|NCT00612690|4084132|P1|COMPLETED|Overall Study||160
1671569|NCT00612690|4084131|P2|STARTED|Overall Study||207
1671570|NCT00612690|4084132|P1|STARTED|Overall Study||275
1671571|NCT00612677|4084140|P1|NOT COMPLETED|Overall Study||1
1671572|NCT00612677|4084140|P1|COMPLETED|Overall Study||0
1671573|NCT00612677|4084140|P1|STARTED|Overall Study||1
1671574|NCT00612573|4084150|P4|NOT COMPLETED|Overall Study||13
1671575|NCT00612573|4084151|P3|NOT COMPLETED|Overall Study||9
1671576|NCT00612573|4084152|P2|NOT COMPLETED|Overall Study||14
1671577|NCT00612573|4084153|P1|NOT COMPLETED|Overall Study||12
1671578|NCT00612573|4084150|P4|COMPLETED|Overall Study||54
1671579|NCT00612573|4084151|P3|COMPLETED|Overall Study||52
1671580|NCT00612573|4084152|P2|COMPLETED|Overall Study||51
1671581|NCT00612573|4084153|P1|COMPLETED|Overall Study||52
1671582|NCT00612573|4084150|P4|STARTED|Overall Study||67
1671583|NCT00612573|4084151|P3|STARTED|Overall Study||61
1671584|NCT00612573|4084152|P2|STARTED|Overall Study||65
1671585|NCT00612573|4084153|P1|STARTED|Overall Study||64
1671586|NCT00612560|4084179|P4|NOT COMPLETED|Overall Study||0
1671587|NCT00612560|4084180|P3|NOT COMPLETED|Overall Study||0
1671588|NCT00612560|4084181|P2|NOT COMPLETED|Overall Study||0
1671589|NCT00612560|4084182|P1|NOT COMPLETED|Overall Study||0
1671590|NCT00612560|4084179|P4|COMPLETED|Overall Study||6
1671591|NCT00612560|4084180|P3|COMPLETED|Overall Study||8
1671592|NCT00612560|4084181|P2|COMPLETED|Overall Study||7
1671593|NCT00612560|4084182|P1|COMPLETED|Overall Study||7
1671594|NCT00612560|4084179|P4|STARTED|Overall Study||6
1671595|NCT00612560|4084180|P3|STARTED|Overall Study||8
1671596|NCT00612560|4084181|P2|STARTED|Overall Study||7
1671597|NCT00612560|4084182|P1|STARTED|Overall Study||7
1671598|NCT00612534|4084208|P4|NOT COMPLETED|Overall Study||17
1671599|NCT00612534|4084209|P3|NOT COMPLETED|Overall Study||7
1671600|NCT00612534|4084210|P2|NOT COMPLETED|Overall Study||17
1671601|NCT00612534|4084211|P1|NOT COMPLETED|Overall Study||13
1671602|NCT00612534|4084208|P4|COMPLETED|Overall Study||7
1671603|NCT00612534|4084209|P3|COMPLETED|Overall Study||13
1671604|NCT00612534|4084210|P2|COMPLETED|Overall Study||9
1671605|NCT00612534|4084211|P1|COMPLETED|Overall Study||11
1671606|NCT00612534|4084208|P4|STARTED|Overall Study||24
1671607|NCT00612534|4084209|P3|STARTED|Overall Study||20
1671608|NCT00612534|4084210|P2|STARTED|Overall Study||26
1671609|NCT00612534|4084211|P1|STARTED|Overall Study||24
1671610|NCT00612508|4084223|P2|NOT COMPLETED|Overall Study||4
1671611|NCT00612508|4084224|P1|NOT COMPLETED|Overall Study||3
1671612|NCT00612508|4084223|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
1671613|NCT00612508|4084224|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
1671614|NCT00612508|4084223|P2|STARTED|Overall Study||7
1671615|NCT00612508|4084224|P1|STARTED|Overall Study||7
1671616|NCT00612456|4084235|P3|NOT COMPLETED|Overall Study||0
1671617|NCT00612456|4084236|P2|NOT COMPLETED|Overall Study||2
1671618|NCT00612456|4084237|P1|NOT COMPLETED|Overall Study||2
1671619|NCT00612456|4084235|P3|COMPLETED|Overall Study||16
1671620|NCT00612456|4084236|P2|COMPLETED|Overall Study||25
1671621|NCT00612456|4084237|P1|COMPLETED|Overall Study||25
1671622|NCT00612456|4084235|P3|STARTED|Overall Study||16
1671623|NCT00612456|4084236|P2|STARTED|Overall Study||27
1671624|NCT00612456|4084237|P1|STARTED|Overall Study||27
1671625|NCT00612430|4084283|P2|NOT COMPLETED|Overall Study||0
1671626|NCT00612430|4084284|P1|NOT COMPLETED|Overall Study||0
1671627|NCT00612430|4084283|P2|COMPLETED|Overall Study||27
1671628|NCT00612430|4084284|P1|COMPLETED|Overall Study||32
1671629|NCT00612430|4084283|P2|STARTED|Overall Study||27
1671630|NCT00612430|4084284|P1|STARTED|Overall Study||32
1671631|NCT00612352|4084300|P2|NOT COMPLETED|Overall Study||6
1671632|NCT00612352|4084301|P1|NOT COMPLETED|Overall Study||9
1671633|NCT00612352|4084300|P2|COMPLETED|Overall Study||109
1671634|NCT00612352|4084301|P1|COMPLETED|Overall Study||56
1671635|NCT00612352|4084300|P2|Placebo|Overall Study||4
1671636|NCT00612352|4084301|P1|Placebo|Overall Study||4
1671637|NCT00612352|4084300|P2|40%mg|Overall Study||0
1671638|NCT00612352|4084301|P1|40%mg|Overall Study||1
1671639|NCT00612352|4084300|P2|100%mg|Overall Study||1
1671640|NCT00612352|4084301|P1|100%mg|Overall Study||2
1671641|NCT00612352|4084300|P2|Placebo & 100%mg|Overall Study||0
1671642|NCT00612352|4084301|P1|Placebo & 100%mg|Overall Study||1
1671643|NCT00612352|4084300|P2|40%mg & 100%mg|Overall Study||1
1671644|NCT00612352|4084301|P1|40%mg & 100%mg|Overall Study||1
1671645|NCT00612352|4084300|P2|STARTED|Overall Study||115
1671646|NCT00612352|4084301|P1|STARTED|Overall Study||65
1671647|NCT00612339|4084415|P1|NOT COMPLETED|Overall Study||0
1671648|NCT00612339|4084415|P1|COMPLETED|Overall Study||41
1671649|NCT00612339|4084415|P1|STARTED|Overall Study||41
1671650|NCT00612313|4084421|P2|NOT COMPLETED|Overall Study||13
1671651|NCT00612313|4084422|P1|NOT COMPLETED|Overall Study||17
1671652|NCT00612313|4084421|P2|COMPLETED|Overall Study||62
1671653|NCT00612313|4084422|P1|COMPLETED|Overall Study||52
1671654|NCT00612313|4084421|P2|STARTED|Overall Study||75
1671655|NCT00612313|4084422|P1|STARTED|Overall Study||69
1671656|NCT00612235|4084442|P4|NOT COMPLETED|Overall Study||0
1671657|NCT00612235|4084443|P3|NOT COMPLETED|Overall Study||0
1671658|NCT00612235|4084444|P2|NOT COMPLETED|Overall Study||0
1671659|NCT00612235|4084445|P1|NOT COMPLETED|Overall Study||0
1671660|NCT00612235|4084442|P4|COMPLETED|Overall Study||20
1671661|NCT00612235|4084443|P3|COMPLETED|Overall Study||20
1671662|NCT00612235|4084444|P2|COMPLETED|Overall Study||20
1671663|NCT00612235|4084445|P1|COMPLETED|Overall Study||20
1671664|NCT00612235|4084442|P4|STARTED|Overall Study||20
1671665|NCT00612235|4084443|P3|STARTED|Overall Study||20
1671666|NCT00612235|4084444|P2|STARTED|Overall Study||20
1671667|NCT00612235|4084445|P1|STARTED|Overall Study||20
1671668|NCT00612222|4084456|P1|NOT COMPLETED|Overall Study||0
1671669|NCT00612222|4084456|P1|COMPLETED|Overall Study||4
1671670|NCT00612222|4084456|P1|STARTED|Overall Study||4
1671671|NCT00612105|4084464|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
1671672|NCT00612105|4084465|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
1671673|NCT00612105|4084464|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
1671674|NCT00612105|4084465|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
1671675|NCT00612105|4084464|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
1671676|NCT00612105|4084465|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
1671677|NCT00612105|4084464|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
1671678|NCT00612105|4084465|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
1671679|NCT00612105|4084464|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
1671680|NCT00612105|4084465|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
1671681|NCT00612105|4084464|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
1671682|NCT00612105|4084465|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
1671683|NCT00612105|4084464|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
1671684|NCT00612105|4084465|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
1671685|NCT00612105|4084464|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
1671686|NCT00612105|4084465|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
1671687|NCT00612105|4084464|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
1671688|NCT00612105|4084465|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
1671689|NCT00612066|4084515|P1|NOT COMPLETED|Overall Study||1
1671690|NCT00612066|4084515|P1|COMPLETED|Overall Study||1
1671691|NCT00612066|4084515|P1|STARTED|Overall Study||2
1671692|NCT00612040|4084522|P3|NOT COMPLETED|Overall Study||7
1671693|NCT00612040|4084523|P2|NOT COMPLETED|Overall Study||7
1671694|NCT00612040|4084524|P1|NOT COMPLETED|Overall Study||5
1671695|NCT00612040|4084522|P3|COMPLETED|Overall Study||52
1671696|NCT00612040|4084523|P2|COMPLETED|Overall Study||52
1671697|NCT00612040|4084524|P1|COMPLETED|Overall Study||55
1671698|NCT00612040|4084522|P3|Exposed|Overall Study||59
1671699|NCT00612040|4084523|P2|Exposed|Overall Study||59
1671700|NCT00612040|4084524|P1|Exposed|Overall Study||60
1671701|NCT00612040|4084522|P3|STARTED|Overall Study||59
1671702|NCT00612040|4084523|P2|STARTED|Overall Study||59
1671703|NCT00612040|4084524|P1|STARTED|Overall Study||60
1671704|NCT00611897|4084568|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
1671705|NCT00611897|4084569|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
1671706|NCT00611897|4084568|P2|COMPLETED|Day 2: Crossover Treatment||8
1671707|NCT00611897|4084569|P1|COMPLETED|Day 2: Crossover Treatment||8
1671708|NCT00611897|4084568|P2|STARTED|Day 2: Crossover Treatment||8
1671709|NCT00611897|4084569|P1|STARTED|Day 2: Crossover Treatment||8
1671710|NCT00611897|4084568|P2|NOT COMPLETED|Day 1: Initial Treatment||0
1671711|NCT00611897|4084569|P1|NOT COMPLETED|Day 1: Initial Treatment||0
1671712|NCT00611897|4084568|P2|COMPLETED|Day 1: Initial Treatment||8
1671713|NCT00611897|4084569|P1|COMPLETED|Day 1: Initial Treatment||8
1671714|NCT00611897|4084568|P2|STARTED|Day 1: Initial Treatment||8
1671715|NCT00611897|4084569|P1|STARTED|Day 1: Initial Treatment||8
1671716|NCT00611884|4084597|P4|NOT COMPLETED|Overall Study||6
1671717|NCT00611884|4084598|P3|NOT COMPLETED|Overall Study||4
1671718|NCT00611884|4084599|P2|NOT COMPLETED|Overall Study||9
1671719|NCT00611884|4084600|P1|NOT COMPLETED|Overall Study||9
1671720|NCT00611884|4084597|P4|COMPLETED|Overall Study||56
1671721|NCT00611884|4084598|P3|COMPLETED|Overall Study||58
1671722|NCT00611884|4084599|P2|COMPLETED|Overall Study||51
1671723|NCT00611884|4084600|P1|COMPLETED|Overall Study||52
1671724|NCT00611884|4084597|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
1671725|NCT00611884|4084598|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
1671726|NCT00611884|4084599|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
1671727|NCT00611884|4084600|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
1671728|NCT00611884|4084597|P4|STARTED|Overall Study||62
1671729|NCT00611884|4084598|P3|STARTED|Overall Study||62
1671730|NCT00611884|4084599|P2|STARTED|Overall Study||60
1671731|NCT00611884|4084600|P1|STARTED|Overall Study||61
1671732|NCT00611858|4084654|P1|NOT COMPLETED|Overall Study||4
1671733|NCT00611858|4084654|P1|COMPLETED|Overall Study||9
1671734|NCT00611858|4084654|P1|STARTED|Overall Study||13
1671735|NCT00611806|4084666|P2|NOT COMPLETED|Overall Study||3
1671736|NCT00611806|4084667|P1|NOT COMPLETED|Overall Study||16
1671737|NCT00611806|4084666|P2|COMPLETED|Overall Study||43
1671738|NCT00611806|4084667|P1|COMPLETED|Overall Study||78
1671739|NCT00611806|4084666|P2|STARTED|Overall Study||46
1671740|NCT00611806|4084667|P1|STARTED|Overall Study||94
1671741|NCT00611767|4084681|P2|NOT COMPLETED|Overall Study||2
1671742|NCT00611767|4084682|P1|NOT COMPLETED|Overall Study||9
1671743|NCT00611767|4084681|P2|COMPLETED|Overall Study||22
1671744|NCT00611767|4084682|P1|COMPLETED|Overall Study||40
1671745|NCT00611767|4084681|P2|Placebo Test Day|Overall Study||1
1671746|NCT00611767|4084682|P1|Placebo Test Day|Overall Study||6
1671747|NCT00611767|4084681|P2|Thiopental Test Day|Overall Study||1
1671748|NCT00611767|4084682|P1|Thiopental Test Day|Overall Study||3
1671749|NCT00611767|4084681|P2|STARTED|Overall Study||24
1671750|NCT00611767|4084682|P1|STARTED|Overall Study||49
1671751|NCT00611715|4084844|P2|NOT COMPLETED|Overall Study||6
1671752|NCT00611715|4084845|P1|NOT COMPLETED|Overall Study||41
1671753|NCT00611715|4084844|P2|COMPLETED|Overall Study||0
1671754|NCT00611715|4084845|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
1671755|NCT00611715|4084844|P2|STARTED|Overall Study||6
1671756|NCT00611715|4084845|P1|STARTED|Overall Study||42
1671757|NCT00611624|4084857|P1|NOT COMPLETED|Overall Study||0
1671758|NCT00611624|4084857|P1|COMPLETED|Overall Study||28
1671759|NCT00611624|4084857|P1|STARTED|Overall Study||28
1671760|NCT00611559|4084865|P3|NOT COMPLETED|Overall Study||1
1671761|NCT00611559|4084866|P2|NOT COMPLETED|Overall Study||1
1671762|NCT00611559|4084867|P1|NOT COMPLETED|Overall Study||1
1671763|NCT00611559|4084865|P3|COMPLETED|Overall Study||56
1671764|NCT00611559|4084866|P2|COMPLETED|Overall Study||114
1671765|NCT00611559|4084867|P1|COMPLETED|Overall Study||110
1671766|NCT00611559|4084865|P3|STARTED|Overall Study||57
1671767|NCT00611559|4084866|P2|STARTED|Overall Study||115
1671768|NCT00611559|4084867|P1|STARTED|Overall Study||111
1671769|NCT00611533|4084926|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
1671770|NCT00611533|4084927|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1671771|NCT00611533|4084926|P2|COMPLETED|Second Intervention (6 Weeks)||4
1671772|NCT00611533|4084927|P1|COMPLETED|Second Intervention (6 Weeks)||8
1671773|NCT00611533|4084926|P2|STARTED|Second Intervention (6 Weeks)||6
1671774|NCT00611533|4084927|P1|STARTED|Second Intervention (6 Weeks)||8
1671775|NCT00611533|4084926|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
1671776|NCT00611533|4084927|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
1671777|NCT00611533|4084926|P2|COMPLETED|First Intervention (6 Weeks)||6
1671778|NCT00611533|4084927|P1|COMPLETED|First Intervention (6 Weeks)||8
1671779|NCT00611533|4084926|P2|STARTED|First Intervention (6 Weeks)||8
1671780|NCT00611533|4084927|P1|STARTED|First Intervention (6 Weeks)||8
1671781|NCT00611468|4084946|P4|NOT COMPLETED|Overall Study||0
1671782|NCT00611468|4084947|P3|NOT COMPLETED|Overall Study||0
1671783|NCT00611468|4084948|P2|NOT COMPLETED|Overall Study||1
1671784|NCT00611468|4084949|P1|NOT COMPLETED|Overall Study||0
1671785|NCT00611468|4084946|P4|COMPLETED|Overall Study||13
1671786|NCT00611468|4084947|P3|COMPLETED|Overall Study||6
1671787|NCT00611468|4084948|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
1671788|NCT00611468|4084949|P1|COMPLETED|Overall Study||3
1671789|NCT00611468|4084946|P4|STARTED|Overall Study||13
1671790|NCT00611468|4084947|P3|STARTED|Overall Study||6
1671791|NCT00611468|4084948|P2|STARTED|Overall Study||7
1671792|NCT00611468|4084949|P1|STARTED|Overall Study||3
1671793|NCT00611455|4084961|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
1671794|NCT00611455|4084962|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1671795|NCT00611455|4084963|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1671796|NCT00611455|4084961|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
1671797|NCT00611455|4084962|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1671798|NCT00611455|4084963|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1671799|NCT00611455|4084961|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
1671800|NCT00611455|4084962|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
1671801|NCT00611455|4084963|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
1671802|NCT00611455|4084961|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1671803|NCT00611455|4084962|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
1671804|NCT00611455|4084963|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1671805|NCT00611455|4084961|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
1671806|NCT00611455|4084962|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
1671807|NCT00611455|4084963|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
1671808|NCT00611455|4084961|P3|STARTED|OL Treatment Period (120 Weeks)||0
1671809|NCT00611455|4084962|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
1671810|NCT00611455|4084963|P1|STARTED|OL Treatment Period (120 Weeks)||0
1671811|NCT00611455|4084961|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
1671812|NCT00611455|4084962|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
1671813|NCT00611455|4084963|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
1671814|NCT00611455|4084961|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
1671815|NCT00611455|4084962|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
1671816|NCT00611455|4084963|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
1671817|NCT00611455|4084961|P3|STARTED|DB Treatment Period (24 Weeks)||0
1671818|NCT00611455|4084962|P2|STARTED|DB Treatment Period (24 Weeks)||131
1671819|NCT00611455|4084963|P1|STARTED|DB Treatment Period (24 Weeks)||134
1671820|NCT00611442|4085091|P2|NOT COMPLETED|Overall Study||2
1671821|NCT00611442|4085092|P1|NOT COMPLETED|Overall Study||1
1671822|NCT00611442|4085091|P2|COMPLETED|Overall Study||94
1671823|NCT00611442|4085092|P1|COMPLETED|Overall Study||94
1671824|NCT00611442|4085091|P2|STARTED|Overall Study||96
1671825|NCT00611442|4085092|P1|STARTED|Overall Study||95
1671826|NCT00611403|4085106|P2|NOT COMPLETED|Post Treatment Extension Phase||1
1671827|NCT00611403|4085107|P1|NOT COMPLETED|Post Treatment Extension Phase||4
1671828|NCT00611403|4085106|P2|COMPLETED|Post Treatment Extension Phase||24
1671829|NCT00611403|4085107|P1|COMPLETED|Post Treatment Extension Phase||22
1671830|NCT00611403|4085106|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
1671831|NCT00611403|4085107|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
1671832|NCT00611403|4085106|P2|NOT COMPLETED|Treatment Phase||11
1671833|NCT00611403|4085107|P1|NOT COMPLETED|Treatment Phase||6
1671834|NCT00611403|4085106|P2|COMPLETED|Treatment Phase||58
1671835|NCT00611403|4085107|P1|COMPLETED|Treatment Phase||62
1671836|NCT00611403|4085106|P2|STARTED|Treatment Phase||69
1671837|NCT00611403|4085107|P1|STARTED|Treatment Phase||68
1671838|NCT00611351|4085117|P1|NOT COMPLETED|Overall Study||2
1671839|NCT00611351|4085117|P1|COMPLETED|Overall Study||3
1671840|NCT00611351|4085117|P1|STARTED|Overall Study||5
1671841|NCT00611325|4085126|P2|NOT COMPLETED|Overall Study||0
1671842|NCT00611325|4085127|P1|NOT COMPLETED|Overall Study||0
1671843|NCT00611325|4085126|P2|COMPLETED|Overall Study||28
1671844|NCT00611325|4085127|P1|COMPLETED|Overall Study||28
1671845|NCT00611325|4085126|P2|STARTED|Overall Study||28
1671846|NCT00611325|4085127|P1|STARTED|Overall Study||28
1671847|NCT00611247|4085143|P2|NOT COMPLETED|Overall Study||21
1671848|NCT00611247|4085144|P1|NOT COMPLETED|Overall Study||2
1671849|NCT00611247|4085143|P2|COMPLETED|Overall Study||10
1671850|NCT00611247|4085144|P1|COMPLETED|Overall Study||3
1671851|NCT00611247|4085143|P2|STARTED|Overall Study||31
1671852|NCT00611247|4085144|P1|STARTED|Overall Study||5
1671853|NCT00611130|4085156|P2|NOT COMPLETED|Overall Study||47
1671854|NCT00611130|4085157|P1|NOT COMPLETED|Overall Study||49
1671855|NCT00611130|4085156|P2|COMPLETED|Overall Study||47
1671856|NCT00611130|4085157|P1|COMPLETED|Overall Study||43
1671857|NCT00611130|4085156|P2|Completed 12 Week Treatment Phase|Overall Study||64
1671858|NCT00611130|4085157|P1|Completed 12 Week Treatment Phase|Overall Study||61
1671859|NCT00611130|4085156|P2|STARTED|Overall Study||94
1671860|NCT00611130|4085157|P1|STARTED|Overall Study||92
1671861|NCT00611026|4085167|P3|NOT COMPLETED|Double-blind Treatment Period||98
1671862|NCT00611026|4085168|P2|NOT COMPLETED|Double-blind Treatment Period||88
1671863|NCT00611026|4085169|P1|NOT COMPLETED|Double-blind Treatment Period||47
1671864|NCT00611026|4085167|P3|COMPLETED|Double-blind Treatment Period||862
1671865|NCT00611026|4085168|P2|COMPLETED|Double-blind Treatment Period||885
1671866|NCT00611026|4085169|P1|COMPLETED|Double-blind Treatment Period||431
1671867|NCT00611026|4085167|P3|STARTED|Double-blind Treatment Period||960
1671868|NCT00611026|4085168|P2|STARTED|Double-blind Treatment Period||973
1671869|NCT00611026|4085169|P1|STARTED|Double-blind Treatment Period||478
1671870|NCT00611026|4085167|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
1671871|NCT00611026|4085168|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
1671872|NCT00611026|4085169|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
1671873|NCT00611026|4085167|P3|COMPLETED|Randomized to Double-blind Treatment||960
1671874|NCT00611026|4085168|P2|COMPLETED|Randomized to Double-blind Treatment||973
1671875|NCT00611026|4085169|P1|COMPLETED|Randomized to Double-blind Treatment||478
1671876|NCT00611026|4085167|P3|STARTED|Randomized to Double-blind Treatment||963
1671877|NCT00611026|4085168|P2|STARTED|Randomized to Double-blind Treatment||974
1671878|NCT00611026|4085169|P1|STARTED|Randomized to Double-blind Treatment||480
1671879|NCT00610987|4085235|P2|NOT COMPLETED|Overall Study||0
1671880|NCT00610987|4085236|P1|NOT COMPLETED|Overall Study||0
1671881|NCT00610987|4085235|P2|COMPLETED|Overall Study||71
1671882|NCT00610987|4085236|P1|COMPLETED|Overall Study||75
1671883|NCT00610987|4085235|P2|STARTED|Overall Study||71
1671884|NCT00610987|4085236|P1|STARTED|Overall Study||75
1671885|NCT00610883|4085242|P1|NOT COMPLETED|Overall Study||0
1671886|NCT00610883|4085242|P1|COMPLETED|Overall Study||17
1671887|NCT00610883|4085242|P1|STARTED|Overall Study||17
1671888|NCT00610857|4085246|P1|NOT COMPLETED|Overall Study||2
1671889|NCT00610857|4085246|P1|COMPLETED|Overall Study||35
1671890|NCT00610857|4085246|P1|STARTED|Overall Study||37
1671891|NCT00610740|4085253|P1|NOT COMPLETED|Overall Study||0
1671892|NCT00610740|4085253|P1|COMPLETED|Overall Study||18
1671893|NCT00610740|4085253|P1|STARTED|Overall Study||18
1671894|NCT00610727|4085265|P6|NOT COMPLETED|Overall Study||0
1671895|NCT00610727|4085266|P5|NOT COMPLETED|Overall Study||0
1671896|NCT00610727|4085267|P4|NOT COMPLETED|Overall Study||0
1671897|NCT00610727|4085268|P3|NOT COMPLETED|Overall Study||0
1671898|NCT00610727|4085269|P2|NOT COMPLETED|Overall Study||0
1671899|NCT00610727|4085270|P1|NOT COMPLETED|Overall Study||0
1671900|NCT00610727|4085265|P6|COMPLETED|Overall Study||8
1671901|NCT00610727|4085266|P5|COMPLETED|Overall Study||8
1671902|NCT00610727|4085267|P4|COMPLETED|Overall Study||8
1671903|NCT00610727|4085268|P3|COMPLETED|Overall Study||8
1671904|NCT00610727|4085269|P2|COMPLETED|Overall Study||8
1671905|NCT00610727|4085270|P1|COMPLETED|Overall Study||14
1671906|NCT00610727|4085265|P6|STARTED|Overall Study||8
1671907|NCT00610727|4085266|P5|STARTED|Overall Study||8
1671908|NCT00610727|4085267|P4|STARTED|Overall Study||8
1671909|NCT00610727|4085268|P3|STARTED|Overall Study||8
1671910|NCT00610727|4085269|P2|STARTED|Overall Study||8
1671911|NCT00610727|4085270|P1|STARTED|Overall Study||14
1671912|NCT00610714|4085290|P2|NOT COMPLETED|Overall Study||24
1671913|NCT00610714|4085291|P1|NOT COMPLETED|Overall Study||26
1671914|NCT00610714|4085290|P2|COMPLETED|Overall Study||82
1671915|NCT00610714|4085291|P1|COMPLETED|Overall Study||79
1671916|NCT00610714|4085290|P2|STARTED|Overall Study||106
1671917|NCT00610714|4085291|P1|STARTED|Overall Study||105
1671918|NCT00610701|4085303|P2|NOT COMPLETED|Overall Study||11
1671919|NCT00610701|4085304|P1|NOT COMPLETED|Overall Study||10
1671920|NCT00610701|4085303|P2|COMPLETED|Overall Study||9
1671921|NCT00610701|4085304|P1|COMPLETED|Overall Study||5
1671922|NCT00610701|4085303|P2|STARTED|Overall Study||20
1671923|NCT00610701|4085304|P1|STARTED|Overall Study||15
1671924|NCT00610688|4085313|P3|NOT COMPLETED|Overall Study||8
1671925|NCT00610688|4085314|P2|NOT COMPLETED|Overall Study||13
1671926|NCT00610688|4085315|P1|NOT COMPLETED|Overall Study||9
1671927|NCT00610688|4085313|P3|COMPLETED|Overall Study||55
1671928|NCT00610688|4085314|P2|COMPLETED|Overall Study||52
1671929|NCT00610688|4085315|P1|COMPLETED|Overall Study||55
1671930|NCT00610688|4085313|P3|STARTED|Overall Study||63
1671931|NCT00610688|4085314|P2|STARTED|Overall Study||65
1671932|NCT00610688|4085315|P1|STARTED|Overall Study||64
1671933|NCT00610675|4085329|P1|NOT COMPLETED|Overall Study||220
1671934|NCT00610675|4085329|P1|COMPLETED|Overall Study||126
1671935|NCT00610675|4085329|P1|Treated|Overall Study||342
1671936|NCT00610675|4085329|P1|STARTED|Overall Study||346
1671937|NCT00610649|4085351|P11|NOT COMPLETED|Overall Study||1
1671938|NCT00610649|4085352|P10|NOT COMPLETED|Overall Study||1
1671939|NCT00610649|4085353|P9|NOT COMPLETED|Overall Study||0
1671940|NCT00610649|4085354|P8|NOT COMPLETED|Overall Study||0
1671941|NCT00610649|4085355|P7|NOT COMPLETED|Overall Study||0
1671942|NCT00610649|4085356|P6|NOT COMPLETED|Overall Study||0
1671943|NCT00610649|4085357|P5|NOT COMPLETED|Overall Study||0
1671944|NCT00610649|4085358|P4|NOT COMPLETED|Overall Study||0
1671945|NCT00610649|4085359|P3|NOT COMPLETED|Overall Study||0
1671946|NCT00610649|4085360|P2|NOT COMPLETED|Overall Study||1
1671947|NCT00610649|4085361|P1|NOT COMPLETED|Overall Study||1
1671948|NCT00610649|4085351|P11|COMPLETED|Overall Study||9
1671949|NCT00610649|4085352|P10|COMPLETED|Overall Study||9
1671950|NCT00610649|4085353|P9|COMPLETED|Overall Study||10
1671951|NCT00610649|4085354|P8|COMPLETED|Overall Study||2
1671952|NCT00610649|4085355|P7|COMPLETED|Overall Study||4
1671953|NCT00610649|4085356|P6|COMPLETED|Overall Study||2
1671954|NCT00610649|4085357|P5|COMPLETED|Overall Study||4
1671955|NCT00610649|4085358|P4|COMPLETED|Overall Study||2
1671956|NCT00610649|4085359|P3|COMPLETED|Overall Study||4
1671957|NCT00610649|4085360|P2|COMPLETED|Overall Study||1
1671958|NCT00610649|4085361|P1|COMPLETED|Overall Study||3
1671959|NCT00610649|4085351|P11|STARTED|Overall Study||10
1671960|NCT00610649|4085352|P10|STARTED|Overall Study||10
1671961|NCT00610649|4085353|P9|STARTED|Overall Study||10
1671962|NCT00610649|4085354|P8|STARTED|Overall Study||2
1671963|NCT00610649|4085355|P7|STARTED|Overall Study||4
1671964|NCT00610649|4085356|P6|STARTED|Overall Study||2
1671965|NCT00610649|4085357|P5|STARTED|Overall Study||4
1671966|NCT00610649|4085358|P4|STARTED|Overall Study||2
1671967|NCT00610649|4085359|P3|STARTED|Overall Study||4
1671968|NCT00610649|4085360|P2|STARTED|Overall Study||2
1671969|NCT00610649|4085361|P1|STARTED|Overall Study||4
1671970|NCT00610532|4085415|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
1671971|NCT00610532|4085415|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
1671972|NCT00610532|4085415|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
1671973|NCT00610532|4085415|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
1671974|NCT00610532|4085415|P1|COMPLETED|Intravenous Phenytoin Alone||8
1671975|NCT00610532|4085415|P1|STARTED|Intravenous Phenytoin Alone||8
1671976|NCT00610441|4085425|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
1671977|NCT00610441|4085426|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
1671978|NCT00610441|4085427|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
1671979|NCT00610441|4085428|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
1671980|NCT00610441|4085425|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
1671981|NCT00610441|4085426|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
1671982|NCT00610441|4085427|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
1671983|NCT00610441|4085428|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
1671984|NCT00610441|4085425|P4|STARTED|Treatment Period 2 - 3 Weeks||16
1671985|NCT00610441|4085426|P3|STARTED|Treatment Period 2 - 3 Weeks||9
1671986|NCT00610441|4085427|P2|STARTED|Treatment Period 2 - 3 Weeks||13
1671987|NCT00610441|4085428|P1|STARTED|Treatment Period 2 - 3 Weeks||12
1671988|NCT00610441|4085425|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
1671989|NCT00610441|4085426|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
1671990|NCT00610441|4085427|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
1671991|NCT00610441|4085428|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
1671992|NCT00610441|4085425|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
1671993|NCT00610441|4085426|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
1671994|NCT00610441|4085427|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
1671995|NCT00610441|4085428|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
1671996|NCT00610441|4085425|P4|STARTED|Placebo Washout Period - 2 Weeks||16
1671997|NCT00610441|4085426|P3|STARTED|Placebo Washout Period - 2 Weeks||11
1671998|NCT00610441|4085427|P2|STARTED|Placebo Washout Period - 2 Weeks||14
1671999|NCT00610441|4085428|P1|STARTED|Placebo Washout Period - 2 Weeks||12
1672000|NCT00610441|4085425|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
1672001|NCT00610441|4085426|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
1672002|NCT00610441|4085427|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
1672003|NCT00610441|4085428|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
1672004|NCT00610441|4085425|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
1672005|NCT00610441|4085426|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
1672006|NCT00610441|4085427|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
1672007|NCT00610441|4085428|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
1672008|NCT00610441|4085425|P4|STARTED|Treatment Period 1 - 3 Weeks||18
1672009|NCT00610441|4085426|P3|STARTED|Treatment Period 1 - 3 Weeks||18
1672010|NCT00610441|4085427|P2|STARTED|Treatment Period 1 - 3 Weeks||16
1672011|NCT00610441|4085428|P1|STARTED|Treatment Period 1 - 3 Weeks||15
1672012|NCT00610428|4085522|P3|NOT COMPLETED|Overall Study||2
1672013|NCT00610428|4085523|P2|NOT COMPLETED|Overall Study||1
1672014|NCT00610428|4085524|P1|NOT COMPLETED|Overall Study||0
1672015|NCT00610428|4085522|P3|COMPLETED|Overall Study||25
1672016|NCT00610428|4085523|P2|COMPLETED|Overall Study||23
1672017|NCT00610428|4085524|P1|COMPLETED|Overall Study||24
1672018|NCT00610428|4085522|P3|STARTED|Overall Study||27
1672019|NCT00610428|4085523|P2|STARTED|Overall Study||24
1672020|NCT00610428|4085524|P1|STARTED|Overall Study||24
1672021|NCT00610363|4085537|P2|NOT COMPLETED|Overall Study||3
1672022|NCT00610363|4085538|P1|NOT COMPLETED|Overall Study||11
1672023|NCT00610363|4085537|P2|COMPLETED|Overall Study||38
1672024|NCT00610363|4085538|P1|COMPLETED|Overall Study||31
1672025|NCT00610363|4085537|P2|STARTED|Overall Study||41
1672026|NCT00610363|4085538|P1|STARTED|Overall Study||42
1672027|NCT00610311|4085556|P1|NOT COMPLETED|Overall Study||0
1672028|NCT00610311|4085556|P1|COMPLETED|Overall Study||3
1672029|NCT00610311|4085556|P1|STARTED|Overall Study||3
1672030|NCT00610207|4085563|P1|NOT COMPLETED|Overall Study||3
1672031|NCT00610207|4085563|P1|COMPLETED|Overall Study||18
1672032|NCT00610207|4085563|P1|STARTED|Overall Study||21
1672033|NCT00610168|4085570|P2|NOT COMPLETED|Overall Study||0
1672034|NCT00610168|4085571|P1|NOT COMPLETED|Overall Study||2
1672035|NCT00610168|4085570|P2|COMPLETED|Overall Study||7
1672036|NCT00610168|4085571|P1|COMPLETED|Overall Study||73
1672037|NCT00610168|4085570|P2|STARTED|Overall Study||7
1672038|NCT00610168|4085571|P1|STARTED|Overall Study||75
1672039|NCT00610155|4085590|P6|NOT COMPLETED|Period 3||0
1672040|NCT00610155|4085591|P5|NOT COMPLETED|Period 3||0
1672041|NCT00610155|4085592|P4|NOT COMPLETED|Period 3||0
1672042|NCT00610155|4085593|P3|NOT COMPLETED|Period 3||0
1672043|NCT00610155|4085594|P2|NOT COMPLETED|Period 3||0
1672044|NCT00610155|4085595|P1|NOT COMPLETED|Period 3||1
1672045|NCT00610155|4085590|P6|COMPLETED|Period 3||1
1672046|NCT00610155|4085591|P5|COMPLETED|Period 3||3
1672047|NCT00610155|4085592|P4|COMPLETED|Period 3||3
1672048|NCT00610155|4085593|P3|COMPLETED|Period 3||3
1672049|NCT00610155|4085594|P2|COMPLETED|Period 3||3
1672050|NCT00610155|4085595|P1|COMPLETED|Period 3||3
1672051|NCT00610155|4085590|P6|STARTED|Period 3||1
1672052|NCT00610155|4085591|P5|STARTED|Period 3||3
1672053|NCT00610155|4085592|P4|STARTED|Period 3||3
1672054|NCT00610155|4085593|P3|STARTED|Period 3||3
1672055|NCT00610155|4085594|P2|STARTED|Period 3||3
1672056|NCT00610155|4085595|P1|STARTED|Period 3||4
1672057|NCT00610155|4085590|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1672058|NCT00610155|4085591|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1672059|NCT00610155|4085592|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1672060|NCT00610155|4085593|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1672061|NCT00610155|4085594|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1672062|NCT00610155|4085595|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1672063|NCT00610155|4085590|P6|COMPLETED|Washout Period 2 (7 Days)||1
1672064|NCT00610155|4085591|P5|COMPLETED|Washout Period 2 (7 Days)||3
1672065|NCT00610155|4085592|P4|COMPLETED|Washout Period 2 (7 Days)||3
1672066|NCT00610155|4085593|P3|COMPLETED|Washout Period 2 (7 Days)||3
1672067|NCT00610155|4085594|P2|COMPLETED|Washout Period 2 (7 Days)||3
1672068|NCT00610155|4085595|P1|COMPLETED|Washout Period 2 (7 Days)||4
1672069|NCT00610155|4085590|P6|STARTED|Washout Period 2 (7 Days)||1
1672070|NCT00610155|4085591|P5|STARTED|Washout Period 2 (7 Days)||3
1672071|NCT00610155|4085592|P4|STARTED|Washout Period 2 (7 Days)||3
1672072|NCT00610155|4085593|P3|STARTED|Washout Period 2 (7 Days)||3
1672073|NCT00610155|4085594|P2|STARTED|Washout Period 2 (7 Days)||3
1672074|NCT00610155|4085595|P1|STARTED|Washout Period 2 (7 Days)||4
1672075|NCT00610155|4085590|P6|NOT COMPLETED|Period 2||0
1672076|NCT00610155|4085591|P5|NOT COMPLETED|Period 2||0
1672077|NCT00610155|4085592|P4|NOT COMPLETED|Period 2||0
1672078|NCT00610155|4085593|P3|NOT COMPLETED|Period 2||0
1672079|NCT00610155|4085594|P2|NOT COMPLETED|Period 2||0
1672080|NCT00610155|4085595|P1|NOT COMPLETED|Period 2||0
1672081|NCT00610155|4085590|P6|COMPLETED|Period 2||1
1672082|NCT00610155|4085591|P5|COMPLETED|Period 2||3
1672083|NCT00610155|4085592|P4|COMPLETED|Period 2||3
1672084|NCT00610155|4085593|P3|COMPLETED|Period 2||3
1672085|NCT00610155|4085594|P2|COMPLETED|Period 2||3
1672086|NCT00610155|4085595|P1|COMPLETED|Period 2||4
1672087|NCT00610155|4085590|P6|STARTED|Period 2||1
1672088|NCT00610155|4085591|P5|STARTED|Period 2||3
1672089|NCT00610155|4085592|P4|STARTED|Period 2||3
1672090|NCT00610155|4085593|P3|STARTED|Period 2||3
1672091|NCT00610155|4085594|P2|STARTED|Period 2||3
1672092|NCT00610155|4085595|P1|STARTED|Period 2||4
1672093|NCT00610155|4085590|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1672094|NCT00610155|4085591|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1672095|NCT00610155|4085592|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1672096|NCT00610155|4085593|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1672097|NCT00610155|4085594|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1672098|NCT00610155|4085595|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1672099|NCT00610155|4085590|P6|COMPLETED|Washout Period 1 (7 Days)||1
1672100|NCT00610155|4085591|P5|COMPLETED|Washout Period 1 (7 Days)||3
1672101|NCT00610155|4085592|P4|COMPLETED|Washout Period 1 (7 Days)||3
1672102|NCT00610155|4085593|P3|COMPLETED|Washout Period 1 (7 Days)||3
1672103|NCT00610155|4085594|P2|COMPLETED|Washout Period 1 (7 Days)||3
1672104|NCT00610155|4085595|P1|COMPLETED|Washout Period 1 (7 Days)||4
1672105|NCT00610155|4085590|P6|STARTED|Washout Period 1 (7 Days)||1
1672106|NCT00610155|4085591|P5|STARTED|Washout Period 1 (7 Days)||3
1672107|NCT00610155|4085592|P4|STARTED|Washout Period 1 (7 Days)||3
1672108|NCT00610155|4085593|P3|STARTED|Washout Period 1 (7 Days)||3
1672109|NCT00610155|4085594|P2|STARTED|Washout Period 1 (7 Days)||3
1672110|NCT00610155|4085595|P1|STARTED|Washout Period 1 (7 Days)||4
1672111|NCT00610155|4085590|P6|NOT COMPLETED|Period 1||0
1672112|NCT00610155|4085591|P5|NOT COMPLETED|Period 1||0
1672113|NCT00610155|4085592|P4|NOT COMPLETED|Period 1||0
1672114|NCT00610155|4085593|P3|NOT COMPLETED|Period 1||1
1672115|NCT00610155|4085594|P2|NOT COMPLETED|Period 1||0
1672116|NCT00610155|4085595|P1|NOT COMPLETED|Period 1||0
1672117|NCT00610155|4085590|P6|COMPLETED|Period 1||1
1672118|NCT00610155|4085591|P5|COMPLETED|Period 1||3
1672119|NCT00610155|4085592|P4|COMPLETED|Period 1||3
1672120|NCT00610155|4085593|P3|COMPLETED|Period 1||3
1672121|NCT00610155|4085594|P2|COMPLETED|Period 1||3
1672122|NCT00610155|4085595|P1|COMPLETED|Period 1||4
1672123|NCT00610155|4085590|P6|STARTED|Period 1||1
1672124|NCT00610155|4085591|P5|STARTED|Period 1||3
1672125|NCT00610155|4085592|P4|STARTED|Period 1||3
1672126|NCT00610155|4085593|P3|STARTED|Period 1||4
1672127|NCT00610155|4085594|P2|STARTED|Period 1||3
1672128|NCT00610155|4085595|P1|STARTED|Period 1||4
1672129|NCT00610129|4085642|P1|NOT COMPLETED|Overall Study||3
1672130|NCT00610129|4085642|P1|COMPLETED|Overall Study||25
1672131|NCT00610129|4085642|P1|STARTED|Overall Study||28
1672132|NCT00609986|4085648|P2|NOT COMPLETED|Overall Study||3
1672133|NCT00609986|4085649|P1|NOT COMPLETED|Overall Study||8
1672134|NCT00609986|4085648|P2|COMPLETED|Overall Study||49
1672135|NCT00609986|4085649|P1|COMPLETED|Overall Study||44
1672136|NCT00609986|4085648|P2|Received Transplant|Overall Study||49
1672137|NCT00609986|4085649|P1|Received Transplant|Overall Study||44
1672138|NCT00609986|4085648|P2|STARTED|Overall Study||52
1672139|NCT00609986|4085649|P1|STARTED|Overall Study||52
1672140|NCT00609973|4085663|P2|NOT COMPLETED|Overall Study||6
1672141|NCT00609973|4085664|P1|NOT COMPLETED|Overall Study||8
1672142|NCT00609973|4085663|P2|COMPLETED|Overall Study||10
1672143|NCT00609973|4085664|P1|COMPLETED|Overall Study||9
1672144|NCT00609973|4085663|P2|STARTED|Overall Study||16
1672145|NCT00609973|4085664|P1|STARTED|Overall Study||17
1672146|NCT00609947|4085672|P1|NOT COMPLETED|Overall Study||1
1672147|NCT00609947|4085672|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
1672148|NCT00609947|4085672|P1|STARTED|Overall Study||241
1672149|NCT00609869|4085677|P1|NOT COMPLETED|Overall Study||11
1672150|NCT00609869|4085677|P1|COMPLETED|Overall Study||18
1672151|NCT00609869|4085677|P1|STARTED|Overall Study||29
1672152|NCT00609804|4085685|P2|NOT COMPLETED|Overall Study||28
1672153|NCT00609804|4085686|P1|NOT COMPLETED|Overall Study||25
1672154|NCT00609804|4085685|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
1672155|NCT00609804|4085686|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
1672156|NCT00609804|4085685|P2|STARTED|Overall Study||28
1672157|NCT00609804|4085686|P1|STARTED|Overall Study||25
1672158|NCT00609765|4085696|P1|NOT COMPLETED|Overall Study||1
1672159|NCT00609765|4085696|P1|COMPLETED|Overall Study||0
1672160|NCT00609765|4085696|P1|STARTED|Overall Study||1
1672161|NCT00609739|4085701|P1|NOT COMPLETED|Overall Study||0
1672162|NCT00609739|4085701|P1|COMPLETED|Overall Study||1
1672163|NCT00609739|4085701|P1|STARTED|Overall Study||1
1672164|NCT00609674|4085710|P2|NOT COMPLETED|Overall Study||7
1672165|NCT00609674|4085711|P1|NOT COMPLETED|Overall Study||7
1672166|NCT00609674|4085710|P2|COMPLETED|Overall Study||153
1672167|NCT00609674|4085711|P1|COMPLETED|Overall Study||148
1672168|NCT00609674|4085710|P2|STARTED|Overall Study||160
1672169|NCT00609674|4085711|P1|STARTED|Overall Study||155
1672170|NCT00609622|4085747|P2|NOT COMPLETED|Overall Study||95
1672171|NCT00609622|4085748|P1|NOT COMPLETED|Overall Study||96
1672172|NCT00609622|4085747|P2|COMPLETED|Overall Study||0
1672173|NCT00609622|4085748|P1|COMPLETED|Overall Study||0
1672174|NCT00609622|4085747|P2|STARTED|Overall Study||95
1672175|NCT00609622|4085748|P1|STARTED|Overall Study||96
1672176|NCT00609609|4085770|P2|NOT COMPLETED|Overall Study||2
1672177|NCT00609609|4085771|P1|NOT COMPLETED|Overall Study||6
1672178|NCT00609609|4085770|P2|COMPLETED|Overall Study||49
1672179|NCT00609609|4085771|P1|COMPLETED|Overall Study||24
1672180|NCT00609609|4085770|P2|STARTED|Overall Study||51
1672181|NCT00609609|4085771|P1|STARTED|Overall Study||30
1672182|NCT00609518|4085783|P2|NOT COMPLETED|Overall Study||40
1672183|NCT00609518|4085784|P1|NOT COMPLETED|Overall Study||43
1672184|NCT00609518|4085783|P2|COMPLETED|Overall Study||17
1672185|NCT00609518|4085784|P1|COMPLETED|Overall Study||11
1672186|NCT00609518|4085783|P2|Completed 6 Treatment Cycles|Overall Study||22
1672187|NCT00609518|4085784|P1|Completed 6 Treatment Cycles|Overall Study||19
1672188|NCT00609518|4085783|P2|STARTED|Overall Study||57
1672189|NCT00609518|4085784|P1|STARTED|Overall Study||54
1672190|NCT00609492|4085799|P3|NOT COMPLETED|Overall Study||7
1672191|NCT00609492|4085800|P2|NOT COMPLETED|Overall Study||3
1672192|NCT00609492|4085801|P1|NOT COMPLETED|Overall Study||1
1672193|NCT00609492|4085799|P3|COMPLETED|Overall Study||122
1672194|NCT00609492|4085800|P2|COMPLETED|Overall Study||69
1672195|NCT00609492|4085801|P1|COMPLETED|Overall Study||43
1672196|NCT00609492|4085799|P3|STARTED|Overall Study||129
1672197|NCT00609492|4085800|P2|STARTED|Overall Study||72
1672198|NCT00609492|4085801|P1|STARTED|Overall Study||44
1672199|NCT00609466|4085886|P3|NOT COMPLETED|Overall Study||4
1672200|NCT00609466|4085887|P2|NOT COMPLETED|Overall Study||6
1672201|NCT00609466|4085888|P1|NOT COMPLETED|Overall Study||2
1672202|NCT00609466|4085886|P3|COMPLETED|Overall Study||95
1672203|NCT00609466|4085887|P2|COMPLETED|Overall Study||90
1672204|NCT00609466|4085888|P1|COMPLETED|Overall Study||94
1672205|NCT00609466|4085886|P3|STARTED|Overall Study||99
1672206|NCT00609466|4085887|P2|STARTED|Overall Study||96
1672207|NCT00609466|4085888|P1|STARTED|Overall Study||96
1672208|NCT00609362|4085916|P2|NOT COMPLETED|Overall Study||1
1672209|NCT00609362|4085917|P1|NOT COMPLETED|Overall Study||3
1672210|NCT00609362|4085916|P2|COMPLETED|Overall Study||27
1672211|NCT00609362|4085917|P1|COMPLETED|Overall Study||26
1672212|NCT00609362|4085916|P2|STARTED|Overall Study||28
1672213|NCT00609362|4085917|P1|STARTED|Overall Study||29
1672214|NCT00609336|4085927|P1|NOT COMPLETED|Overall Study||13
1672215|NCT00609336|4085927|P1|COMPLETED|Overall Study||22
1672216|NCT00609336|4085927|P1|Surgery|Overall Study||22
1672217|NCT00609336|4085927|P1|STARTED|Overall Study||35
1672218|NCT00609271|4085941|P2|NOT COMPLETED|Overall Study||13
1672219|NCT00609271|4085942|P1|NOT COMPLETED|Overall Study||16
1672220|NCT00609271|4085941|P2|COMPLETED|Overall Study||60
1672221|NCT00609271|4085942|P1|COMPLETED|Overall Study||59
1672222|NCT00609271|4085941|P2|STARTED|Overall Study||73
1672223|NCT00609271|4085942|P1|STARTED|Overall Study||75
1672224|NCT00609245|4085978|P1|NOT COMPLETED|Overall Study||1
1672225|NCT00609245|4085978|P1|COMPLETED|Overall Study||12
1672226|NCT00609245|4085978|P1|STARTED|Overall Study||13
1672227|NCT00609167|4085986|P2|NOT COMPLETED|Overall Study||7
1672228|NCT00609167|4085987|P1|NOT COMPLETED|Overall Study||8
1672229|NCT00609167|4085986|P2|COMPLETED|Overall Study||23
1672230|NCT00609167|4085987|P1|COMPLETED|Overall Study||25
1672231|NCT00609167|4085986|P2|STARTED|Overall Study||30
1672232|NCT00609167|4085987|P1|STARTED|Overall Study||33
1672233|NCT00609128|4086009|P1|NOT COMPLETED|Overall Study||0
1672234|NCT00609128|4086009|P1|COMPLETED|Overall Study||21
1672235|NCT00609128|4086009|P1|STARTED|Overall Study||21
1672236|NCT00608985|4086018|P4|NOT COMPLETED|Overall Study||9
1672237|NCT00608985|4086019|P3|NOT COMPLETED|Overall Study||6
1672238|NCT00608985|4086020|P2|NOT COMPLETED|Overall Study||13
1672239|NCT00608985|4086021|P1|NOT COMPLETED|Overall Study||16
1672240|NCT00608985|4086018|P4|COMPLETED|Overall Study|Completed follow-up|159
1672241|NCT00608985|4086019|P3|COMPLETED|Overall Study|Completed follow-up|170
1672242|NCT00608985|4086020|P2|COMPLETED|Overall Study|Completed follow-up|173
1672243|NCT00608985|4086021|P1|COMPLETED|Overall Study|Completed follow-up|161
1672244|NCT00608985|4086018|P4|Completed Double-blind Treatment|Overall Study||161
1672245|NCT00608985|4086019|P3|Completed Double-blind Treatment|Overall Study||171
1672246|NCT00608985|4086020|P2|Completed Double-blind Treatment|Overall Study||174
1672247|NCT00608985|4086021|P1|Completed Double-blind Treatment|Overall Study||163
1672248|NCT00608985|4086018|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
1672249|NCT00608985|4086019|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
1672250|NCT00608985|4086020|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
1672251|NCT00608985|4086021|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
1672252|NCT00608959|4086053|P1|NOT COMPLETED|Part 2||0
1672253|NCT00608959|4086053|P1|COMPLETED|Part 2||25
1672254|NCT00608959|4086053|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
1672255|NCT00608959|4086053|P1|NOT COMPLETED|Part 1||1
1672256|NCT00608959|4086053|P1|COMPLETED|Part 1||24
1672257|NCT00608959|4086053|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
1672258|NCT00608907|4086066|P3|NOT COMPLETED|Overall Study||1
1672259|NCT00608907|4086067|P2|NOT COMPLETED|Overall Study||0
1672260|NCT00608907|4086068|P1|NOT COMPLETED|Overall Study||12
1672261|NCT00608907|4086066|P3|COMPLETED|Overall Study||17
1672262|NCT00608907|4086067|P2|COMPLETED|Overall Study||13
1672263|NCT00608907|4086068|P1|COMPLETED|Overall Study||18
1672264|NCT00608907|4086066|P3|STARTED|Overall Study||18
1672265|NCT00608907|4086067|P2|STARTED|Overall Study||13
1672266|NCT00608907|4086068|P1|STARTED|Overall Study||30
1672267|NCT00608881|4086078|P2|NOT COMPLETED|Overall Study||66
1672268|NCT00608881|4086079|P1|NOT COMPLETED|Overall Study||79
1672269|NCT00608881|4086078|P2|COMPLETED|Overall Study||240
1672270|NCT00608881|4086079|P1|COMPLETED|Overall Study||224
1672271|NCT00608881|4086078|P2|STARTED|Overall Study||306
1672272|NCT00608881|4086079|P1|STARTED|Overall Study||303
1672273|NCT00608868|4086113|P1|NOT COMPLETED|Overall Study||15
1672274|NCT00608868|4086113|P1|COMPLETED|Overall Study||141
1672275|NCT00608868|4086113|P1|Per Protocol (PP) Population|Overall Study||121
1672276|NCT00608868|4086113|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
1672277|NCT00608868|4086113|P1|Treatment Completed|Overall Study||141
1672278|NCT00608868|4086113|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
1672279|NCT00608868|4086113|P1|Enrolled|Overall Study||156
1672280|NCT00608868|4086113|P1|STARTED|Overall Study||156
1672281|NCT00608842|4086124|P4|NOT COMPLETED|Overall Study||1
1672282|NCT00608842|4086125|P3|NOT COMPLETED|Overall Study||2
1672283|NCT00608842|4086126|P2|NOT COMPLETED|Overall Study||1
1672284|NCT00608842|4086127|P1|NOT COMPLETED|Overall Study||1
1672285|NCT00608842|4086124|P4|COMPLETED|Overall Study||16
1672286|NCT00608842|4086125|P3|COMPLETED|Overall Study||13
1672287|NCT00608842|4086126|P2|COMPLETED|Overall Study||14
1672288|NCT00608842|4086127|P1|COMPLETED|Overall Study||14
1672289|NCT00608842|4086124|P4|STARTED|Overall Study||17
1672290|NCT00608842|4086125|P3|STARTED|Overall Study||15
1672291|NCT00608842|4086126|P2|STARTED|Overall Study||15
1672292|NCT00608842|4086127|P1|STARTED|Overall Study||15
1672293|NCT00608829|4086161|P1|NOT COMPLETED|Overall Study||15
1672294|NCT00608829|4086161|P1|COMPLETED|Overall Study||8
1672295|NCT00608829|4086161|P1|STARTED|Overall Study||23
1672296|NCT00608777|4086165|P1|NOT COMPLETED|Overall Study||0
1672297|NCT00608777|4086165|P1|COMPLETED|Overall Study||6
1672298|NCT00608777|4086165|P1|STARTED|Overall Study||6
1672299|NCT00608634|4086172|P3|NOT COMPLETED|Overall Study||1
1672300|NCT00608634|4086173|P2|NOT COMPLETED|Overall Study||1
1672301|NCT00608634|4086174|P1|NOT COMPLETED|Overall Study||2
1672302|NCT00608634|4086172|P3|COMPLETED|Overall Study||27
1672303|NCT00608634|4086173|P2|COMPLETED|Overall Study||26
1672304|NCT00608634|4086174|P1|COMPLETED|Overall Study||26
1672305|NCT00608634|4086172|P3|STARTED|Overall Study||28
1672306|NCT00608634|4086173|P2|STARTED|Overall Study||27
1672307|NCT00608634|4086174|P1|STARTED|Overall Study||28
1672308|NCT00608582|4086187|P2|NOT COMPLETED|Overall Study||4
1672309|NCT00608582|4086188|P1|NOT COMPLETED|Overall Study||4
1672310|NCT00608582|4086187|P2|COMPLETED|Overall Study||7
1672311|NCT00608582|4086188|P1|COMPLETED|Overall Study||10
1672312|NCT00608582|4086187|P2|STARTED|Overall Study||11
1672313|NCT00608582|4086188|P1|STARTED|Overall Study||14
1672314|NCT00608569|4086198|P2|NOT COMPLETED|Overall Study||9
1672315|NCT00608569|4086199|P1|NOT COMPLETED|Overall Study||10
1672316|NCT00608569|4086198|P2|COMPLETED|Overall Study||119
1672317|NCT00608569|4086199|P1|COMPLETED|Overall Study||119
1672318|NCT00608569|4086198|P2|STARTED|Overall Study||128
1672319|NCT00608569|4086199|P1|STARTED|Overall Study||129
1672320|NCT00608543|4086219|P1|NOT COMPLETED|Overall Study||4
1672321|NCT00608543|4086219|P1|COMPLETED|Overall Study||13
1672322|NCT00608543|4086219|P1|STARTED|Overall Study||17
1672323|NCT00608530|4086232|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
1672324|NCT00608530|4086233|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
1672325|NCT00608530|4086234|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
1672326|NCT00608530|4086235|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
1672327|NCT00608530|4086232|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
1672328|NCT00608530|4086233|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
1672329|NCT00608530|4086234|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
1672330|NCT00608530|4086235|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
1672331|NCT00608530|4086232|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
1672332|NCT00608530|4086233|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
1672333|NCT00608530|4086234|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
1672334|NCT00608530|4086235|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
1672335|NCT00608530|4086232|P4|STARTED|Study 2 Nurse-delivered Treatments||34
1672336|NCT00608530|4086233|P3|STARTED|Study 2 Nurse-delivered Treatments||33
1672337|NCT00608530|4086234|P2|STARTED|Study 2 Nurse-delivered Treatments||0
1672338|NCT00608530|4086235|P1|STARTED|Study 2 Nurse-delivered Treatments||0
1672339|NCT00608530|4086232|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
1672340|NCT00608530|4086233|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
1672341|NCT00608530|4086234|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
1672342|NCT00608530|4086235|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
1672343|NCT00608530|4086232|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
1672344|NCT00608530|4086233|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
1672345|NCT00608530|4086234|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
1672346|NCT00608530|4086235|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
1672347|NCT00608530|4086232|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
1672348|NCT00608530|4086233|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
1672349|NCT00608530|4086234|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
1672350|NCT00608530|4086235|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
1672351|NCT00608530|4086232|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
1672352|NCT00608530|4086233|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
1672353|NCT00608530|4086234|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
1672354|NCT00608530|4086235|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
1672355|NCT00608517|4086256|P3|NOT COMPLETED|Overall Study||0
1672356|NCT00608517|4086257|P2|NOT COMPLETED|Overall Study||0
1672357|NCT00608517|4086258|P1|NOT COMPLETED|Overall Study||1
1672358|NCT00608517|4086256|P3|COMPLETED|Overall Study||1
1672359|NCT00608517|4086257|P2|COMPLETED|Overall Study||3
1672360|NCT00608517|4086258|P1|COMPLETED|Overall Study||1
1672361|NCT00608517|4086256|P3|STARTED|Overall Study||1
1672362|NCT00608517|4086257|P2|STARTED|Overall Study||3
1672363|NCT00608517|4086258|P1|STARTED|Overall Study||2
1672364|NCT00608491|4086286|P2|NOT COMPLETED|Overall Study||22
1672365|NCT00608491|4086287|P1|NOT COMPLETED|Overall Study||21
1672366|NCT00608491|4086286|P2|COMPLETED|Overall Study||72
1672367|NCT00608491|4086287|P1|COMPLETED|Overall Study||73
1672368|NCT00608491|4086286|P2|STARTED|Overall Study||94
1672369|NCT00608491|4086287|P1|STARTED|Overall Study||94
1672370|NCT00608465|4086431|P1|NOT COMPLETED|Overall Study||0
1672371|NCT00608465|4086431|P1|COMPLETED|Overall Study||4
1672372|NCT00608465|4086431|P1|STARTED|Overall Study||4
1672373|NCT00608426|4086438|P2|NOT COMPLETED|Overall Study||905
1672374|NCT00608426|4086439|P1|NOT COMPLETED|Overall Study||836
1672375|NCT00608426|4086438|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
1672376|NCT00608426|4086439|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
1672377|NCT00608426|4086438|P2|STARTED|Overall Study||2519
1672378|NCT00608426|4086439|P1|STARTED|Overall Study||2604
1672379|NCT00608322|4086451|P2|NOT COMPLETED|Overall Study||1
1672380|NCT00608322|4086452|P1|NOT COMPLETED|Overall Study||2
1672381|NCT00608322|4086451|P2|COMPLETED|Overall Study||22
1672382|NCT00608322|4086452|P1|COMPLETED|Overall Study||24
1672383|NCT00608322|4086451|P2|STARTED|Overall Study||23
1672384|NCT00608322|4086452|P1|STARTED|Overall Study||26
1672385|NCT00608244|4086458|P1|NOT COMPLETED|Overall Study||2
1672386|NCT00608244|4086458|P1|COMPLETED|Overall Study||57
1672387|NCT00608244|4086458|P1|STARTED|Overall Study||59
1672388|NCT00608205|4086469|P2|NOT COMPLETED|Overall Study||3
1672389|NCT00608205|4086470|P1|NOT COMPLETED|Overall Study||3
1672390|NCT00608205|4086469|P2|COMPLETED|Overall Study||31
1672391|NCT00608205|4086470|P1|COMPLETED|Overall Study||32
1672392|NCT00608205|4086469|P2|STARTED|Overall Study||34
1672393|NCT00608205|4086470|P1|STARTED|Overall Study||35
1672394|NCT00608140|4086560|P2|NOT COMPLETED|Overall Study||1
1672395|NCT00608140|4086561|P1|NOT COMPLETED|Overall Study||1
1672396|NCT00608140|4086560|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
1672397|NCT00608140|4086561|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
1672398|NCT00608140|4086560|P2|STARTED|Overall Study||1
1672399|NCT00608140|4086561|P1|STARTED|Overall Study||1
1672400|NCT00608023|4086587|P3|NOT COMPLETED|Overall Study||14
1672401|NCT00608023|4086588|P2|NOT COMPLETED|Overall Study||22
1672402|NCT00608023|4086589|P1|NOT COMPLETED|Overall Study||12
1672403|NCT00608023|4086587|P3|COMPLETED|Overall Study||72
1672404|NCT00608023|4086588|P2|COMPLETED|Overall Study||63
1672405|NCT00608023|4086589|P1|COMPLETED|Overall Study||80
1672406|NCT00608023|4086587|P3|STARTED|Overall Study||86
1672407|NCT00608023|4086588|P2|STARTED|Overall Study||85
1672408|NCT00608023|4086589|P1|STARTED|Overall Study||92
1672409|NCT00607997|4086613|P4|NOT COMPLETED|Overall Study||16
1672410|NCT00607997|4086614|P3|NOT COMPLETED|Overall Study||24
1672411|NCT00607997|4086615|P2|NOT COMPLETED|Overall Study||27
1672412|NCT00607997|4086616|P1|NOT COMPLETED|Overall Study||27
1672413|NCT00607997|4086613|P4|COMPLETED|Overall Study||4
1672414|NCT00607997|4086614|P3|COMPLETED|Overall Study||5
1672415|NCT00607997|4086615|P2|COMPLETED|Overall Study||8
1672416|NCT00607997|4086616|P1|COMPLETED|Overall Study||2
1672417|NCT00607997|4086613|P4|STARTED|Overall Study||20
1672418|NCT00607997|4086614|P3|STARTED|Overall Study||29
1672419|NCT00607997|4086615|P2|STARTED|Overall Study||35
1672420|NCT00607997|4086616|P1|STARTED|Overall Study||29
1672421|NCT00607919|4086674|P2|NOT COMPLETED|Open-Label Phase||12
1672422|NCT00607919|4086675|P1|NOT COMPLETED|Open-Label Phase||10
1672423|NCT00607919|4086674|P2|COMPLETED|Open-Label Phase||59
1672424|NCT00607919|4086675|P1|COMPLETED|Open-Label Phase||74
1672425|NCT00607919|4086674|P2|STARTED|Open-Label Phase||71
1672426|NCT00607919|4086675|P1|STARTED|Open-Label Phase||84
1672427|NCT00607919|4086674|P2|NOT COMPLETED|Acute Phase||16
1672428|NCT00607919|4086675|P1|NOT COMPLETED|Acute Phase||34
1672429|NCT00607919|4086674|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
1672430|NCT00607919|4086675|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
1672431|NCT00607919|4086674|P2|STARTED|Acute Phase||89
1672432|NCT00607919|4086675|P1|STARTED|Acute Phase||120
1672433|NCT00607893|4086733|P2|NOT COMPLETED|Overall Study||4
1672434|NCT00607893|4086734|P1|NOT COMPLETED|Overall Study||6
1672435|NCT00607893|4086733|P2|COMPLETED|Overall Study||72
1672436|NCT00607893|4086734|P1|COMPLETED|Overall Study||71
1672437|NCT00607893|4086733|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
1672438|NCT00607893|4086734|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
1672439|NCT00607893|4086733|P2|Completed 8 Week Visit|Overall Study||72
1672440|NCT00607893|4086734|P1|Completed 8 Week Visit|Overall Study||71
1672441|NCT00607893|4086733|P2|Completed Baseline Visit|Overall Study||75
1672442|NCT00607893|4086734|P1|Completed Baseline Visit|Overall Study||74
1672443|NCT00607893|4086733|P2|STARTED|Overall Study||76
1672444|NCT00607893|4086734|P1|STARTED|Overall Study||77
1672445|NCT00607880|4086762|P2|NOT COMPLETED|Overall Study||0
1672446|NCT00607880|4086763|P1|NOT COMPLETED|Overall Study||1
1672447|NCT00607880|4086762|P2|COMPLETED|Overall Study||50
1672448|NCT00607880|4086763|P1|COMPLETED|Overall Study||49
1672449|NCT00607880|4086762|P2|STARTED|Overall Study||50
1672450|NCT00607880|4086763|P1|STARTED|Overall Study||50
1672451|NCT00607867|4086777|P2|NOT COMPLETED|Overall Study||0
1672452|NCT00607867|4086778|P1|NOT COMPLETED|Overall Study||0
1672453|NCT00607867|4086777|P2|COMPLETED|Overall Study||7
1672454|NCT00607867|4086778|P1|COMPLETED|Overall Study||7
1672455|NCT00607867|4086777|P2|STARTED|Overall Study||7
1672456|NCT00607867|4086778|P1|STARTED|Overall Study||7
1672457|NCT00607815|4086796|P2|NOT COMPLETED|Overall Study||11
1672458|NCT00607815|4086797|P1|NOT COMPLETED|Overall Study||23
1672459|NCT00607815|4086796|P2|COMPLETED|Overall Study||25
1672460|NCT00607815|4086797|P1|COMPLETED|Overall Study||20
1672461|NCT00607815|4086796|P2|STARTED|Overall Study||36
1672462|NCT00607815|4086797|P1|STARTED|Overall Study||43
1672463|NCT00607789|4086813|P2|NOT COMPLETED|Overall Study||6
1672464|NCT00607789|4086814|P1|NOT COMPLETED|Overall Study||7
1672465|NCT00607789|4086813|P2|COMPLETED|Overall Study||14
1672466|NCT00607789|4086814|P1|COMPLETED|Overall Study||13
1672467|NCT00607789|4086813|P2|STARTED|Overall Study||20
1672468|NCT00607789|4086814|P1|STARTED|Overall Study|20 participants were randomized in each group|20
1672469|NCT00607724|4086829|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
1672470|NCT00607724|4086830|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
1672471|NCT00607724|4086831|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
1672472|NCT00607724|4086832|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
1672473|NCT00607724|4086833|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
1672474|NCT00607724|4086834|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
1672475|NCT00607724|4086835|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
1672476|NCT00607724|4086829|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
1672477|NCT00607724|4086830|P6|COMPLETED|Stage 2: Expanded Cohort||0
1672478|NCT00607724|4086831|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
1672479|NCT00607724|4086832|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
1672480|NCT00607724|4086833|P3|COMPLETED|Stage 2: Expanded Cohort||0
1672481|NCT00607724|4086834|P2|COMPLETED|Stage 2: Expanded Cohort||0
1672482|NCT00607724|4086835|P1|COMPLETED|Stage 2: Expanded Cohort||0
1672483|NCT00607724|4086829|P7|STARTED|Stage 2: Expanded Cohort||16
1672484|NCT00607724|4086830|P6|STARTED|Stage 2: Expanded Cohort||12
1672485|NCT00607724|4086831|P5|STARTED|Stage 2: Expanded Cohort||14
1672486|NCT00607724|4086832|P4|STARTED|Stage 2: Expanded Cohort||6
1672487|NCT00607724|4086833|P3|STARTED|Stage 2: Expanded Cohort||0
1672488|NCT00607724|4086834|P2|STARTED|Stage 2: Expanded Cohort||0
1672489|NCT00607724|4086835|P1|STARTED|Stage 2: Expanded Cohort||0
1672490|NCT00607724|4086829|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
1672491|NCT00607724|4086830|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
1672492|NCT00607724|4086831|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
1672493|NCT00607724|4086832|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
1672494|NCT00607724|4086833|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
1672495|NCT00607724|4086834|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
1672496|NCT00607724|4086835|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
1672497|NCT00607724|4086829|P7|COMPLETED|Stage 1: Dose Escalation||0
1672498|NCT00607724|4086830|P6|COMPLETED|Stage 1: Dose Escalation||0
1672499|NCT00607724|4086831|P5|COMPLETED|Stage 1: Dose Escalation||0
1672500|NCT00607724|4086832|P4|COMPLETED|Stage 1: Dose Escalation||0
1672501|NCT00607724|4086833|P3|COMPLETED|Stage 1: Dose Escalation||0
1672502|NCT00607724|4086834|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
1672503|NCT00607724|4086835|P1|COMPLETED|Stage 1: Dose Escalation||0
1672504|NCT00607724|4086829|P7|STARTED|Stage 1: Dose Escalation||0
1672505|NCT00607724|4086830|P6|STARTED|Stage 1: Dose Escalation||0
1672506|NCT00607724|4086831|P5|STARTED|Stage 1: Dose Escalation||0
1672507|NCT00607724|4086832|P4|STARTED|Stage 1: Dose Escalation||0
1672508|NCT00607724|4086833|P3|STARTED|Stage 1: Dose Escalation||4
1672509|NCT00607724|4086834|P2|STARTED|Stage 1: Dose Escalation||9
1672510|NCT00607724|4086835|P1|STARTED|Stage 1: Dose Escalation||7
1672511|NCT00607672|4086914|P3|NOT COMPLETED|Overall Study||5
1672512|NCT00607672|4086915|P2|NOT COMPLETED|Overall Study||3
1672513|NCT00607672|4086916|P1|NOT COMPLETED|Overall Study||4
1672514|NCT00607672|4086914|P3|COMPLETED|Overall Study||22
1672515|NCT00607672|4086915|P2|COMPLETED|Overall Study||24
1672516|NCT00607672|4086916|P1|COMPLETED|Overall Study||28
1672517|NCT00607672|4086914|P3|STARTED|Overall Study||27
1672518|NCT00607672|4086915|P2|STARTED|Overall Study||27
1672519|NCT00607672|4086916|P1|STARTED|Overall Study||32
1672520|NCT00607620|4086962|P2|NOT COMPLETED|Overall Study||0
1672521|NCT00607620|4086963|P1|NOT COMPLETED|Overall Study||0
1672522|NCT00607620|4086962|P2|COMPLETED|Overall Study||469
1672523|NCT00607620|4086963|P1|COMPLETED|Overall Study||409
1672524|NCT00607620|4086962|P2|STARTED|Overall Study||469
1672525|NCT00607620|4086963|P1|STARTED|Overall Study||409
1672526|NCT00607594|4086977|P1|NOT COMPLETED|Overall Study||0
1672527|NCT00607594|4086977|P1|COMPLETED|Overall Study||21
1672528|NCT00607594|4086977|P1|STARTED|Overall Study||21
1672529|NCT00607477|4086991|P2|NOT COMPLETED|Overall Study||0
1672530|NCT00607477|4086992|P1|NOT COMPLETED|Overall Study||0
1672531|NCT00607477|4086991|P2|COMPLETED|Overall Study||2
1672532|NCT00607477|4086992|P1|COMPLETED|Overall Study||0
1672533|NCT00607477|4086991|P2|STARTED|Overall Study||2
1672534|NCT00607477|4086992|P1|STARTED|Overall Study||0
1672535|NCT00607386|4086998|P1|NOT COMPLETED|Overall Study||1
1672536|NCT00607386|4086998|P1|COMPLETED|Overall Study||27
1672537|NCT00607386|4086998|P1|STARTED|Overall Study||28
1672538|NCT00607373|4087013|P2|NOT COMPLETED|Follow-up Period||5
1672539|NCT00607373|4087014|P1|NOT COMPLETED|Follow-up Period||1
1672540|NCT00607373|4087013|P2|COMPLETED|Follow-up Period||6
1672541|NCT00607373|4087014|P1|COMPLETED|Follow-up Period||0
1672542|NCT00607373|4087013|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
1672543|NCT00607373|4087014|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
1672544|NCT00607373|4087013|P2|NOT COMPLETED|Treatment Period||6
1672545|NCT00607373|4087014|P1|NOT COMPLETED|Treatment Period||0
1672546|NCT00607373|4087013|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
1672547|NCT00607373|4087014|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
1672548|NCT00607373|4087013|P2|STARTED|Treatment Period||34
1672549|NCT00607373|4087014|P1|STARTED|Treatment Period||17
1672550|NCT00607321|4087058|P1|NOT COMPLETED|Overall Study||0
1672551|NCT00607321|4087058|P1|COMPLETED|Overall Study||60
1672552|NCT00607321|4087058|P1|STARTED|Overall Study||60
1672553|NCT00607269|4087068|P2|NOT COMPLETED|Overall Study||0
1672554|NCT00607269|4087069|P1|NOT COMPLETED|Overall Study||0
1672555|NCT00607269|4087068|P2|COMPLETED|Overall Study||64
1672556|NCT00607269|4087069|P1|COMPLETED|Overall Study||67
1672557|NCT00607269|4087068|P2|STARTED|Overall Study||64
1672558|NCT00607269|4087069|P1|STARTED|Overall Study||67
1672559|NCT00607243|4087083|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
1672560|NCT00607243|4087084|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
1672561|NCT00607243|4087083|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
1672562|NCT00607243|4087084|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
1672563|NCT00607243|4087083|P2|STARTED|Telephone Safety Assessment Period||41
1672564|NCT00607243|4087084|P1|STARTED|Telephone Safety Assessment Period||82
1672565|NCT00607243|4087083|P2|NOT COMPLETED|Initial Post-vaccination Period||0
1672566|NCT00607243|4087084|P1|NOT COMPLETED|Initial Post-vaccination Period||0
1672567|NCT00607243|4087083|P2|COMPLETED|Initial Post-vaccination Period||41
1672568|NCT00607243|4087084|P1|COMPLETED|Initial Post-vaccination Period||82
1672569|NCT00607243|4087083|P2|STARTED|Initial Post-vaccination Period||41
1672570|NCT00607243|4087084|P1|STARTED|Initial Post-vaccination Period||82
1672571|NCT00607126|4087092|P2|NOT COMPLETED|Overall Study||0
1672572|NCT00607126|4087093|P1|NOT COMPLETED|Overall Study||0
1672573|NCT00607126|4087092|P2|COMPLETED|Overall Study||19
1672574|NCT00607126|4087093|P1|COMPLETED|Overall Study||17
1672575|NCT00607126|4087092|P2|STARTED|Overall Study||19
1672576|NCT00607126|4087093|P1|STARTED|Overall Study||17
1672577|NCT00607113|4087107|P2|NOT COMPLETED|Overall Study||0
1672578|NCT00607113|4087108|P1|NOT COMPLETED|Overall Study||0
1672579|NCT00607113|4087107|P2|COMPLETED|Overall Study||20
1672580|NCT00607113|4087108|P1|COMPLETED|Overall Study||19
1672581|NCT00607113|4087107|P2|STARTED|Overall Study||20
1672582|NCT00607113|4087108|P1|STARTED|Overall Study||19
1672583|NCT00607087|4087116|P3|NOT COMPLETED|Period 3||0
1672584|NCT00607087|4087117|P2|NOT COMPLETED|Period 3||2
1672585|NCT00607087|4087118|P1|NOT COMPLETED|Period 3||2
1672586|NCT00607087|4087116|P3|COMPLETED|Period 3||84
1672587|NCT00607087|4087117|P2|COMPLETED|Period 3||84
1672588|NCT00607087|4087118|P1|COMPLETED|Period 3||84
1672589|NCT00607087|4087116|P3|STARTED|Period 3||84
1672590|NCT00607087|4087117|P2|STARTED|Period 3||86
1672591|NCT00607087|4087118|P1|STARTED|Period 3||86
1672592|NCT00607087|4087116|P3|NOT COMPLETED|Period 2||5
1672593|NCT00607087|4087117|P2|NOT COMPLETED|Period 2||3
1672594|NCT00607087|4087118|P1|NOT COMPLETED|Period 2||1
1672595|NCT00607087|4087116|P3|COMPLETED|Period 2||84
1672596|NCT00607087|4087117|P2|COMPLETED|Period 2||86
1672597|NCT00607087|4087118|P1|COMPLETED|Period 2||86
1672598|NCT00607087|4087116|P3|STARTED|Period 2||89
1672599|NCT00607087|4087117|P2|STARTED|Period 2||89
1672600|NCT00607087|4087118|P1|STARTED|Period 2||87
1672601|NCT00607087|4087116|P3|NOT COMPLETED|Period 1||5
1672602|NCT00607087|4087117|P2|NOT COMPLETED|Period 1||6
1672603|NCT00607087|4087118|P1|NOT COMPLETED|Period 1||12
1672604|NCT00607087|4087116|P3|COMPLETED|Period 1||89
1672605|NCT00607087|4087117|P2|COMPLETED|Period 1||89
1672606|NCT00607087|4087118|P1|COMPLETED|Period 1||87
1672607|NCT00607087|4087116|P3|STARTED|Period 1||94
1672608|NCT00607087|4087117|P2|STARTED|Period 1||95
1672609|NCT00607087|4087118|P1|STARTED|Period 1||99
1672610|NCT00607087|4087116|P3|NOT COMPLETED|Overall Study||10
1672611|NCT00607087|4087117|P2|NOT COMPLETED|Overall Study||11
1672612|NCT00607087|4087118|P1|NOT COMPLETED|Overall Study||15
1672613|NCT00607087|4087116|P3|COMPLETED|Overall Study||84
1672614|NCT00607087|4087117|P2|COMPLETED|Overall Study||84
1672615|NCT00607087|4087118|P1|COMPLETED|Overall Study||84
1672616|NCT00607087|4087116|P3|STARTED|Overall Study||94
1672617|NCT00607087|4087117|P2|STARTED|Overall Study||95
1672618|NCT00607087|4087118|P1|STARTED|Overall Study||99
1672619|NCT00607048|4087176|P6|NOT COMPLETED|Overall Study||5
1672620|NCT00607048|4087177|P5|NOT COMPLETED|Overall Study||6
1672621|NCT00607048|4087178|P4|NOT COMPLETED|Overall Study||3
1672622|NCT00607048|4087179|P3|NOT COMPLETED|Overall Study||4
1672623|NCT00607048|4087180|P2|NOT COMPLETED|Overall Study||4
1672624|NCT00607048|4087181|P1|NOT COMPLETED|Overall Study||3
1672625|NCT00607048|4087176|P6|COMPLETED|Overall Study||2
1672626|NCT00607048|4087177|P5|COMPLETED|Overall Study||0
1672627|NCT00607048|4087178|P4|COMPLETED|Overall Study||0
1672628|NCT00607048|4087179|P3|COMPLETED|Overall Study||3
1672629|NCT00607048|4087180|P2|COMPLETED|Overall Study||2
1672630|NCT00607048|4087181|P1|COMPLETED|Overall Study||0
1672631|NCT00607048|4087176|P6|STARTED|Overall Study||7
1672632|NCT00607048|4087177|P5|STARTED|Overall Study||6
1672633|NCT00607048|4087178|P4|STARTED|Overall Study||3
1672634|NCT00607048|4087179|P3|STARTED|Overall Study||7
1672635|NCT00607048|4087180|P2|STARTED|Overall Study||6
1672636|NCT00607048|4087181|P1|STARTED|Overall Study||3
1672637|NCT00607022|4087266|P3|NOT COMPLETED|Overall Study||0
1672638|NCT00607022|4087267|P2|NOT COMPLETED|Overall Study||0
1672639|NCT00607022|4087268|P1|NOT COMPLETED|Overall Study||1
1672640|NCT00607022|4087266|P3|COMPLETED|Overall Study||19
1672641|NCT00607022|4087267|P2|COMPLETED|Overall Study||15
1672642|NCT00607022|4087268|P1|COMPLETED|Overall Study||6
1672643|NCT00607022|4087266|P3|STARTED|Overall Study||19
1672644|NCT00607022|4087267|P2|STARTED|Overall Study||15
1672645|NCT00607022|4087268|P1|STARTED|Overall Study||7
1672646|NCT00606944|4087278|P2|NOT COMPLETED|Overall Study||0
1672647|NCT00606944|4087279|P1|NOT COMPLETED|Overall Study||0
1672648|NCT00606944|4087278|P2|COMPLETED|Overall Study||100
1672649|NCT00606944|4087279|P1|COMPLETED|Overall Study||98
1672650|NCT00606944|4087278|P2|STARTED|Overall Study||100
1672651|NCT00606944|4087279|P1|STARTED|Overall Study||98
1672652|NCT00606931|4087285|P1|NOT COMPLETED|Overall Study||3
1672653|NCT00606931|4087285|P1|COMPLETED|Overall Study||19
1672654|NCT00606931|4087285|P1|STARTED|Overall Study||22
1672655|NCT00606905|4087293|P2|NOT COMPLETED|Overall Study||15
1672656|NCT00606905|4087294|P1|NOT COMPLETED|Overall Study||15
1672657|NCT00606905|4087293|P2|COMPLETED|Overall Study||24
1672658|NCT00606905|4087294|P1|COMPLETED|Overall Study||23
1672659|NCT00606905|4087293|P2|Pregnancy|Overall Study||33
1672660|NCT00606905|4087294|P1|Pregnancy|Overall Study||29
1672661|NCT00606905|4087293|P2|STARTED|Overall Study||39
1672662|NCT00606905|4087294|P1|STARTED|Overall Study||38
1672663|NCT00606892|4087300|P2|NOT COMPLETED|Second Intervention||0
1672664|NCT00606892|4087301|P1|NOT COMPLETED|Second Intervention||0
1672665|NCT00606892|4087300|P2|COMPLETED|Second Intervention||4
1672666|NCT00606892|4087301|P1|COMPLETED|Second Intervention||8
1672667|NCT00606892|4087300|P2|STARTED|Second Intervention||4
1672668|NCT00606892|4087301|P1|STARTED|Second Intervention||8
1672669|NCT00606892|4087300|P2|NOT COMPLETED|Washout Period||0
1672670|NCT00606892|4087301|P1|NOT COMPLETED|Washout Period||0
1672671|NCT00606892|4087300|P2|COMPLETED|Washout Period||4
1672672|NCT00606892|4087301|P1|COMPLETED|Washout Period||8
1672673|NCT00606892|4087300|P2|STARTED|Washout Period||4
1672674|NCT00606892|4087301|P1|STARTED|Washout Period||8
1672675|NCT00606892|4087300|P2|NOT COMPLETED|First Intervention||4
1672676|NCT00606892|4087301|P1|NOT COMPLETED|First Intervention||1
1672677|NCT00606892|4087300|P2|COMPLETED|First Intervention||4
1672678|NCT00606892|4087301|P1|COMPLETED|First Intervention||8
1672679|NCT00606892|4087300|P2|STARTED|First Intervention||8
1672680|NCT00606892|4087301|P1|STARTED|First Intervention||9
1672681|NCT00606892|4087300|P2|NOT COMPLETED|Adaptation||0
1672682|NCT00606892|4087301|P1|NOT COMPLETED|Adaptation||0
1672683|NCT00606892|4087300|P2|COMPLETED|Adaptation||8
1672684|NCT00606892|4087301|P1|COMPLETED|Adaptation||9
1672685|NCT00606892|4087300|P2|STARTED|Adaptation||8
1672686|NCT00606892|4087301|P1|STARTED|Adaptation||9
1672687|NCT00606801|4087335|P2|NOT COMPLETED|Intervention||3
1672688|NCT00606801|4087336|P1|NOT COMPLETED|Intervention||3
1672689|NCT00606801|4087335|P2|COMPLETED|Intervention||14
1672690|NCT00606801|4087336|P1|COMPLETED|Intervention||14
1672691|NCT00606801|4087335|P2|STARTED|Intervention||17
1672692|NCT00606801|4087336|P1|STARTED|Intervention||17
1672693|NCT00606801|4087335|P2|NOT COMPLETED|Adaptation||0
1672694|NCT00606801|4087336|P1|NOT COMPLETED|Adaptation||0
1672695|NCT00606801|4087335|P2|COMPLETED|Adaptation||17
1672696|NCT00606801|4087336|P1|COMPLETED|Adaptation||17
1672697|NCT00606801|4087335|P2|STARTED|Adaptation||17
1672698|NCT00606801|4087336|P1|STARTED|Adaptation||17
1672699|NCT00606684|4087364|P7|NOT COMPLETED|Double-Blind Treatment Period||8
1672700|NCT00606684|4087365|P6|NOT COMPLETED|Double-Blind Treatment Period||9
1672701|NCT00606684|4087366|P5|NOT COMPLETED|Double-Blind Treatment Period||9
1672702|NCT00606684|4087367|P4|NOT COMPLETED|Double-Blind Treatment Period||10
1672703|NCT00606684|4087368|P3|NOT COMPLETED|Double-Blind Treatment Period||11
1672704|NCT00606684|4087369|P2|NOT COMPLETED|Double-Blind Treatment Period||16
1672705|NCT00606684|4087370|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1672706|NCT00606684|4087364|P7|COMPLETED|Double-Blind Treatment Period||91
1672707|NCT00606684|4087365|P6|COMPLETED|Double-Blind Treatment Period||92
1672708|NCT00606684|4087366|P5|COMPLETED|Double-Blind Treatment Period||92
1672709|NCT00606684|4087367|P4|COMPLETED|Double-Blind Treatment Period||91
1672710|NCT00606684|4087368|P3|COMPLETED|Double-Blind Treatment Period||88
1672711|NCT00606684|4087369|P2|COMPLETED|Double-Blind Treatment Period||85
1672712|NCT00606684|4087370|P1|COMPLETED|Double-Blind Treatment Period||0
1672713|NCT00606684|4087364|P7|STARTED|Double-Blind Treatment Period||99
1672714|NCT00606684|4087365|P6|STARTED|Double-Blind Treatment Period||101
1672715|NCT00606684|4087366|P5|STARTED|Double-Blind Treatment Period||101
1672716|NCT00606684|4087367|P4|STARTED|Double-Blind Treatment Period||101
1672717|NCT00606684|4087368|P3|STARTED|Double-Blind Treatment Period||99
1672718|NCT00606684|4087369|P2|STARTED|Double-Blind Treatment Period||101
1672719|NCT00606684|4087370|P1|STARTED|Double-Blind Treatment Period||0
1672720|NCT00606684|4087364|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1672721|NCT00606684|4087365|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1672722|NCT00606684|4087366|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1672723|NCT00606684|4087367|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1672724|NCT00606684|4087368|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1672725|NCT00606684|4087369|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1672726|NCT00606684|4087370|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
1672727|NCT00606684|4087364|P7|COMPLETED|2-week Single-Blind Run-in Period||0
1672728|NCT00606684|4087365|P6|COMPLETED|2-week Single-Blind Run-in Period||0
1672729|NCT00606684|4087366|P5|COMPLETED|2-week Single-Blind Run-in Period||0
1672730|NCT00606684|4087367|P4|COMPLETED|2-week Single-Blind Run-in Period||0
1672731|NCT00606684|4087368|P3|COMPLETED|2-week Single-Blind Run-in Period||0
1672732|NCT00606684|4087369|P2|COMPLETED|2-week Single-Blind Run-in Period||0
1672733|NCT00606684|4087370|P1|COMPLETED|2-week Single-Blind Run-in Period||605
1672734|NCT00606684|4087364|P7|STARTED|2-week Single-Blind Run-in Period||0
1672735|NCT00606684|4087365|P6|STARTED|2-week Single-Blind Run-in Period||0
1672736|NCT00606684|4087366|P5|STARTED|2-week Single-Blind Run-in Period||0
1672737|NCT00606684|4087367|P4|STARTED|2-week Single-Blind Run-in Period||0
1672738|NCT00606684|4087368|P3|STARTED|2-week Single-Blind Run-in Period||0
1672739|NCT00606684|4087369|P2|STARTED|2-week Single-Blind Run-in Period||0
1672740|NCT00606684|4087370|P1|STARTED|2-week Single-Blind Run-in Period||851
1672741|NCT00606632|4087402|P1|NOT COMPLETED|Overall Study||22
1672742|NCT00606632|4087402|P1|COMPLETED|Overall Study||204
1672743|NCT00606632|4087402|P1|STARTED|Overall Study||226
1672744|NCT00606593|4087415|P10|NOT COMPLETED|Overall Study||0
1672745|NCT00606593|4087416|P9|NOT COMPLETED|Overall Study||1
1672746|NCT00606593|4087417|P8|NOT COMPLETED|Overall Study||2
1672747|NCT00606593|4087418|P7|NOT COMPLETED|Overall Study||1
1672748|NCT00606593|4087419|P6|NOT COMPLETED|Overall Study||0
1672749|NCT00606593|4087420|P5|NOT COMPLETED|Overall Study||1
1672750|NCT00606593|4087421|P4|NOT COMPLETED|Overall Study||1
1672751|NCT00606593|4087422|P3|NOT COMPLETED|Overall Study||2
1672752|NCT00606593|4087423|P2|NOT COMPLETED|Overall Study||0
1672753|NCT00606593|4087424|P1|NOT COMPLETED|Overall Study||1
1672754|NCT00606593|4087415|P10|COMPLETED|Overall Study||11
1672755|NCT00606593|4087416|P9|COMPLETED|Overall Study||11
1672756|NCT00606593|4087417|P8|COMPLETED|Overall Study||9
1672757|NCT00606593|4087418|P7|COMPLETED|Overall Study||10
1672758|NCT00606593|4087419|P6|COMPLETED|Overall Study||11
1672759|NCT00606593|4087420|P5|COMPLETED|Overall Study||11
1672760|NCT00606593|4087421|P4|COMPLETED|Overall Study||10
1672761|NCT00606593|4087422|P3|COMPLETED|Overall Study||9
1672762|NCT00606593|4087423|P2|COMPLETED|Overall Study||11
1672763|NCT00606593|4087424|P1|COMPLETED|Overall Study||10
1672764|NCT00606593|4087415|P10|5th Double-blind Treatment|Overall Study||11
1672765|NCT00606593|4087416|P9|5th Double-blind Treatment|Overall Study||11
1672766|NCT00606593|4087417|P8|5th Double-blind Treatment|Overall Study||9
1672767|NCT00606593|4087418|P7|5th Double-blind Treatment|Overall Study||10
1672768|NCT00606593|4087419|P6|5th Double-blind Treatment|Overall Study||11
1672769|NCT00606593|4087420|P5|5th Double-blind Treatment|Overall Study||11
1672770|NCT00606593|4087421|P4|5th Double-blind Treatment|Overall Study||10
1672771|NCT00606593|4087422|P3|5th Double-blind Treatment|Overall Study||9
1672772|NCT00606593|4087423|P2|5th Double-blind Treatment|Overall Study||11
1672773|NCT00606593|4087424|P1|5th Double-blind Treatment|Overall Study||10
1672774|NCT00606593|4087415|P10|4th Double-blind Treatment|Overall Study||11
1672775|NCT00606593|4087416|P9|4th Double-blind Treatment|Overall Study||11
1672776|NCT00606593|4087417|P8|4th Double-blind Treatment|Overall Study||9
1672777|NCT00606593|4087418|P7|4th Double-blind Treatment|Overall Study||10
1672778|NCT00606593|4087419|P6|4th Double-blind Treatment|Overall Study||11
1672779|NCT00606593|4087420|P5|4th Double-blind Treatment|Overall Study||11
1672780|NCT00606593|4087421|P4|4th Double-blind Treatment|Overall Study||10
1672781|NCT00606593|4087422|P3|4th Double-blind Treatment|Overall Study||10
1672782|NCT00606593|4087423|P2|4th Double-blind Treatment|Overall Study||11
1672783|NCT00606593|4087424|P1|4th Double-blind Treatment|Overall Study||10
1672784|NCT00606593|4087415|P10|3rd Double-blind Treatment|Overall Study||11
1672785|NCT00606593|4087416|P9|3rd Double-blind Treatment|Overall Study||12
1672786|NCT00606593|4087417|P8|3rd Double-blind Treatment|Overall Study||9
1672787|NCT00606593|4087418|P7|3rd Double-blind Treatment|Overall Study||10
1672788|NCT00606593|4087419|P6|3rd Double-blind Treatment|Overall Study||11
1672789|NCT00606593|4087420|P5|3rd Double-blind Treatment|Overall Study||11
1672790|NCT00606593|4087421|P4|3rd Double-blind Treatment|Overall Study||10
1672791|NCT00606593|4087422|P3|3rd Double-blind Treatment|Overall Study||10
1672792|NCT00606593|4087423|P2|3rd Double-blind Treatment|Overall Study||11
1672793|NCT00606593|4087424|P1|3rd Double-blind Treatment|Overall Study||11
1672794|NCT00606593|4087415|P10|2nd Double-blind Treatment|Overall Study||11
1672795|NCT00606593|4087416|P9|2nd Double-blind Treatment|Overall Study||12
1672796|NCT00606593|4087417|P8|2nd Double-blind Treatment|Overall Study||9
1672797|NCT00606593|4087418|P7|2nd Double-blind Treatment|Overall Study||10
1672798|NCT00606593|4087419|P6|2nd Double-blind Treatment|Overall Study||11
1672799|NCT00606593|4087420|P5|2nd Double-blind Treatment|Overall Study||12
1672800|NCT00606593|4087421|P4|2nd Double-blind Treatment|Overall Study||10
1672801|NCT00606593|4087422|P3|2nd Double-blind Treatment|Overall Study||11
1672802|NCT00606593|4087423|P2|2nd Double-blind Treatment|Overall Study||11
1672803|NCT00606593|4087424|P1|2nd Double-blind Treatment|Overall Study||11
1672804|NCT00606593|4087415|P10|1st Double-blind Treatment|Overall Study||11
1672805|NCT00606593|4087416|P9|1st Double-blind Treatment|Overall Study||12
1672806|NCT00606593|4087417|P8|1st Double-blind Treatment|Overall Study||11
1672807|NCT00606593|4087418|P7|1st Double-blind Treatment|Overall Study||11
1672808|NCT00606593|4087419|P6|1st Double-blind Treatment|Overall Study||11
1672809|NCT00606593|4087420|P5|1st Double-blind Treatment|Overall Study||12
1672810|NCT00606593|4087421|P4|1st Double-blind Treatment|Overall Study||11
1672811|NCT00606593|4087422|P3|1st Double-blind Treatment|Overall Study||11
1672812|NCT00606593|4087423|P2|1st Double-blind Treatment|Overall Study||11
1672813|NCT00606593|4087424|P1|1st Double-blind Treatment|Overall Study||11
1672814|NCT00606593|4087415|P10|STARTED|Overall Study|Randomized participants|11
1672815|NCT00606593|4087416|P9|STARTED|Overall Study|Randomized participants|12
1672816|NCT00606593|4087417|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
1672817|NCT00606593|4087418|P7|STARTED|Overall Study|Randomized participants|11
1672818|NCT00606593|4087419|P6|STARTED|Overall Study|Randomized participants|11
1672819|NCT00606593|4087420|P5|STARTED|Overall Study|Randomized participants|12
1672820|NCT00606593|4087421|P4|STARTED|Overall Study|Randomized participants|11
1672821|NCT00606593|4087422|P3|STARTED|Overall Study|Randomized participants|11
1672822|NCT00606593|4087423|P2|STARTED|Overall Study|Randomized participants|11
1672823|NCT00606593|4087424|P1|STARTED|Overall Study|Randomized participants|11
1672824|NCT00606580|4087445|P3|NOT COMPLETED|Overall Study||22
1672825|NCT00606580|4087446|P2|NOT COMPLETED|Overall Study||3
1672826|NCT00606580|4087447|P1|NOT COMPLETED|Overall Study||2
1672827|NCT00606580|4087445|P3|COMPLETED|Overall Study||103
1672828|NCT00606580|4087446|P2|COMPLETED|Overall Study||122
1672829|NCT00606580|4087447|P1|COMPLETED|Overall Study||123
1672830|NCT00606580|4087445|P3|STARTED|Overall Study||125
1672831|NCT00606580|4087446|P2|STARTED|Overall Study||125
1672832|NCT00606580|4087447|P1|STARTED|Overall Study||125
1672833|NCT00606554|4087490|P2|NOT COMPLETED|Overall Study||0
1672834|NCT00606554|4087491|P1|NOT COMPLETED|Overall Study||0
1672835|NCT00606554|4087490|P2|COMPLETED|Overall Study||18
1672836|NCT00606554|4087491|P1|COMPLETED|Overall Study||15
1672837|NCT00606554|4087490|P2|STARTED|Overall Study||18
1672838|NCT00606554|4087491|P1|STARTED|Overall Study||15
1672839|NCT00606502|4087513|P2|NOT COMPLETED|Treatment||3
1672840|NCT00606502|4087514|P1|NOT COMPLETED|Treatment||0
1672841|NCT00606502|4087513|P2|COMPLETED|Treatment||98
1672842|NCT00606502|4087514|P1|COMPLETED|Treatment||97
1672843|NCT00606502|4087513|P2|STARTED|Treatment||101
1672844|NCT00606502|4087514|P1|STARTED|Treatment||97
1672845|NCT00606502|4087513|P2|NOT COMPLETED|Randomization||0
1672846|NCT00606502|4087514|P1|NOT COMPLETED|Randomization||3
1672847|NCT00606502|4087513|P2|COMPLETED|Randomization||101
1672848|NCT00606502|4087514|P1|COMPLETED|Randomization||97
1672849|NCT00606502|4087513|P2|STARTED|Randomization||101
1672850|NCT00606502|4087514|P1|STARTED|Randomization||100
1672851|NCT00606489|4087528|P2|NOT COMPLETED|Overall Study||0
1672852|NCT00606489|4087529|P1|NOT COMPLETED|Overall Study||0
1672853|NCT00606489|4087528|P2|COMPLETED|Overall Study||40
1672854|NCT00606489|4087529|P1|COMPLETED|Overall Study||21
1672855|NCT00606489|4087528|P2|STARTED|Overall Study||40
1672856|NCT00606489|4087529|P1|STARTED|Overall Study||21
1672857|NCT00606320|4087535|P1|NOT COMPLETED|Overall Study||37
1672858|NCT00606320|4087535|P1|COMPLETED|Overall Study||22
1672859|NCT00606320|4087535|P1|STARTED|Overall Study||59
1672860|NCT00606281|4087542|P2|NOT COMPLETED|Overall Study||66
1672861|NCT00606281|4087543|P1|NOT COMPLETED|Overall Study||56
1672862|NCT00606281|4087542|P2|COMPLETED|Overall Study||64
1672863|NCT00606281|4087543|P1|COMPLETED|Overall Study||72
1672864|NCT00606281|4087542|P2|STARTED|Overall Study||130
1672865|NCT00606281|4087543|P1|STARTED|Overall Study||128
1672866|NCT00606229|4087551|P1|NOT COMPLETED|Overall Study||22
1672867|NCT00606229|4087551|P1|COMPLETED|Overall Study||19
1672868|NCT00606229|4087551|P1|STARTED|Overall Study||41
1672869|NCT00606177|4087558|P2|NOT COMPLETED|Overall Study||25
1672870|NCT00606177|4087559|P1|NOT COMPLETED|Overall Study||27
1672871|NCT00606177|4087558|P2|COMPLETED|Overall Study||19
1672872|NCT00606177|4087559|P1|COMPLETED|Overall Study||28
1672873|NCT00606177|4087558|P2|STARTED|Overall Study||44
1672874|NCT00606177|4087559|P1|STARTED|Overall Study||55
1672875|NCT00606138|4087569|P2|NOT COMPLETED|Overall Study||0
1672876|NCT00606138|4087570|P1|NOT COMPLETED|Overall Study||0
1672877|NCT00606138|4087569|P2|COMPLETED|Overall Study||2
1672878|NCT00606138|4087570|P1|COMPLETED|Overall Study||6
1672879|NCT00606138|4087569|P2|STARTED|Overall Study||2
1672880|NCT00606138|4087570|P1|STARTED|Overall Study||6
1672881|NCT00606086|4087586|P2|NOT COMPLETED|Overall Study||15
1672882|NCT00606086|4087587|P1|NOT COMPLETED|Overall Study||12
1672883|NCT00606086|4087586|P2|COMPLETED|Overall Study||53
1672884|NCT00606086|4087587|P1|COMPLETED|Overall Study||60
1672885|NCT00606086|4087586|P2|STARTED|Overall Study||68
1672886|NCT00606086|4087587|P1|STARTED|Overall Study||72
1672887|NCT00606034|4087593|P1|NOT COMPLETED|Overall Study||1
1672888|NCT00606034|4087593|P1|COMPLETED|Overall Study||20
1672889|NCT00606034|4087593|P1|STARTED|Overall Study||21
1672890|NCT00606021|4087601|P3|NOT COMPLETED|Maintenance Phase||17
1672891|NCT00606021|4087602|P2|NOT COMPLETED|Maintenance Phase||23
1672892|NCT00606021|4087603|P1|NOT COMPLETED|Maintenance Phase||0
1672893|NCT00606021|4087601|P3|COMPLETED|Maintenance Phase||10
1672894|NCT00606021|4087602|P2|COMPLETED|Maintenance Phase||5
1672895|NCT00606021|4087603|P1|COMPLETED|Maintenance Phase||0
1672896|NCT00606021|4087601|P3|STARTED|Maintenance Phase||27
1672897|NCT00606021|4087602|P2|STARTED|Maintenance Phase||28
1672898|NCT00606021|4087603|P1|STARTED|Maintenance Phase||0
1672899|NCT00606021|4087601|P3|NOT COMPLETED|Induction Phase||0
1672900|NCT00606021|4087602|P2|NOT COMPLETED|Induction Phase||0
1672901|NCT00606021|4087603|P1|NOT COMPLETED|Induction Phase||87
1672902|NCT00606021|4087601|P3|COMPLETED|Induction Phase||0
1672903|NCT00606021|4087602|P2|COMPLETED|Induction Phase||0
1672904|NCT00606021|4087603|P1|COMPLETED|Induction Phase||19
1672905|NCT00606021|4087601|P3|STARTED|Induction Phase||0
1672906|NCT00606021|4087602|P2|STARTED|Induction Phase||0
1672907|NCT00606021|4087603|P1|STARTED|Induction Phase||106
1672908|NCT00606008|4087621|P1|NOT COMPLETED|Overall Study||5
1672909|NCT00606008|4087621|P1|COMPLETED|Overall Study||25
1672910|NCT00606008|4087621|P1|STARTED|Overall Study||30
1672911|NCT00605917|4087635|P1|NOT COMPLETED|Overall Study||79
1672912|NCT00605917|4087635|P1|COMPLETED|Overall Study||908
1672913|NCT00605917|4087635|P1|STARTED|Overall Study||987
1672914|NCT00605904|4087676|P2|NOT COMPLETED|Infusion Sessions||3
1672915|NCT00605904|4087677|P1|NOT COMPLETED|Infusion Sessions||1
1672916|NCT00605904|4087676|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
1672917|NCT00605904|4087677|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
1672918|NCT00605904|4087676|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
1672919|NCT00605904|4087677|P1|Yohimbine Infusion|Infusion Sessions||12
1672920|NCT00605904|4087676|P2|mCPP Infusion|Infusion Sessions||13
1672921|NCT00605904|4087677|P1|mCPP Infusion|Infusion Sessions||12
1672922|NCT00605904|4087676|P2|Saline Infusion|Infusion Sessions||14
1672923|NCT00605904|4087677|P1|Saline Infusion|Infusion Sessions||13
1672924|NCT00605904|4087676|P2|STARTED|Infusion Sessions||16
1672925|NCT00605904|4087677|P1|STARTED|Infusion Sessions||13
1672926|NCT00605904|4087676|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
1672927|NCT00605904|4087677|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
1672928|NCT00605904|4087676|P2|COMPLETED|Baseline Data Collection and Dosing||16
1672929|NCT00605904|4087677|P1|COMPLETED|Baseline Data Collection and Dosing||13
1672930|NCT00605904|4087676|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
1672931|NCT00605904|4087677|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
1672932|NCT00605865|4087687|P1|NOT COMPLETED|Overall Study||115
1672933|NCT00605865|4087687|P1|COMPLETED|Overall Study||2157
1672934|NCT00605865|4087687|P1|STARTED|Overall Study||2272
1672935|NCT00605839|4087729|P3|NOT COMPLETED|Overall Study||0
1672936|NCT00605839|4087730|P2|NOT COMPLETED|Overall Study||0
1672937|NCT00605839|4087731|P1|NOT COMPLETED|Overall Study||1
1672938|NCT00605839|4087729|P3|COMPLETED|Overall Study||28
1672939|NCT00605839|4087730|P2|COMPLETED|Overall Study||37
1672940|NCT00605839|4087731|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
1672941|NCT00605839|4087729|P3|STARTED|Overall Study||28
1672942|NCT00605839|4087730|P2|STARTED|Overall Study||37
1672943|NCT00605839|4087731|P1|STARTED|Overall Study||40
1672944|NCT00605813|4087739|P1|NOT COMPLETED|Overall Study||25
1672945|NCT00605813|4087739|P1|COMPLETED|Overall Study||517
1672946|NCT00605813|4087739|P1|STARTED|Overall Study||542
1672947|NCT00605722|4087752|P1|NOT COMPLETED|Overall Study||51
1672948|NCT00605722|4087752|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
1672949|NCT00605722|4087752|P1|STARTED|Overall Study||51
1672950|NCT00605696|4087764|P2|NOT COMPLETED|Overall Study||0
1672951|NCT00605696|4087765|P1|NOT COMPLETED|Overall Study||0
1672952|NCT00605696|4087764|P2|COMPLETED|Overall Study||11
1672953|NCT00605696|4087765|P1|COMPLETED|Overall Study||7
1672954|NCT00605696|4087764|P2|STARTED|Overall Study||11
1672955|NCT00605696|4087765|P1|STARTED|Overall Study||7
1672956|NCT00605657|4087773|P1|NOT COMPLETED|Overall Study||2
1672957|NCT00605657|4087773|P1|COMPLETED|Overall Study||3
1672958|NCT00605657|4087773|P1|STARTED|Overall Study||5
1672959|NCT00605540|4087778|P1|NOT COMPLETED|Overall Study||38
1672960|NCT00605540|4087778|P1|COMPLETED|Overall Study||95
1672961|NCT00605540|4087778|P1|STARTED|Overall Study||133
1672962|NCT00605475|4087796|P10|NOT COMPLETED|Overall Study||2
1672963|NCT00605475|4087797|P9|NOT COMPLETED|Overall Study||2
1672964|NCT00605475|4087798|P8|NOT COMPLETED|Overall Study||0
1672965|NCT00605475|4087799|P7|NOT COMPLETED|Overall Study||1
1672966|NCT00605475|4087800|P6|NOT COMPLETED|Overall Study||2
1672967|NCT00605475|4087801|P5|NOT COMPLETED|Overall Study||1
1672968|NCT00605475|4087802|P4|NOT COMPLETED|Overall Study||0
1672969|NCT00605475|4087803|P3|NOT COMPLETED|Overall Study||0
1672970|NCT00605475|4087804|P2|NOT COMPLETED|Overall Study||0
1672971|NCT00605475|4087805|P1|NOT COMPLETED|Overall Study||0
1672972|NCT00605475|4087796|P10|COMPLETED|Overall Study||8
1672973|NCT00605475|4087797|P9|COMPLETED|Overall Study||18
1672974|NCT00605475|4087798|P8|COMPLETED|Overall Study||24
1672975|NCT00605475|4087799|P7|COMPLETED|Overall Study||22
1672976|NCT00605475|4087800|P6|COMPLETED|Overall Study||22
1672977|NCT00605475|4087801|P5|COMPLETED|Overall Study||24
1672978|NCT00605475|4087802|P4|COMPLETED|Overall Study||45
1672979|NCT00605475|4087803|P3|COMPLETED|Overall Study||45
1672980|NCT00605475|4087804|P2|COMPLETED|Overall Study||5
1672981|NCT00605475|4087805|P1|COMPLETED|Overall Study||10
1672982|NCT00605475|4087796|P10|STARTED|Overall Study||10
1672983|NCT00605475|4087797|P9|STARTED|Overall Study||20
1672984|NCT00605475|4087798|P8|STARTED|Overall Study||24
1672985|NCT00605475|4087799|P7|STARTED|Overall Study||23
1672986|NCT00605475|4087800|P6|STARTED|Overall Study||24
1672987|NCT00605475|4087801|P5|STARTED|Overall Study||25
1672988|NCT00605475|4087802|P4|STARTED|Overall Study||45
1672989|NCT00605475|4087803|P3|STARTED|Overall Study||45
1672990|NCT00605475|4087804|P2|STARTED|Overall Study||5
1672991|NCT00605475|4087805|P1|STARTED|Overall Study||10
1672992|NCT00605423|4087929|P2|NOT COMPLETED|Overall Study||0
1672993|NCT00605423|4087930|P1|NOT COMPLETED|Overall Study||0
1672994|NCT00605423|4087929|P2|COMPLETED|Overall Study||2
1672995|NCT00605423|4087930|P1|COMPLETED|Overall Study||4
1672996|NCT00605423|4087929|P2|STARTED|Overall Study||2
1672997|NCT00605423|4087930|P1|STARTED|Overall Study||4
1672998|NCT00605384|4087942|P2|NOT COMPLETED|Overall Study||1
1672999|NCT00605384|4087943|P1|NOT COMPLETED|Overall Study||1
1673000|NCT00605384|4087942|P2|COMPLETED|Overall Study|study terminated early|0
1673001|NCT00605384|4087943|P1|COMPLETED|Overall Study|study terminated early|0
1673002|NCT00605384|4087942|P2|STARTED|Overall Study||1
1673003|NCT00605384|4087943|P1|STARTED|Overall Study||1
1673004|NCT00605358|4087973|P2|NOT COMPLETED|Overall Study||0
1673005|NCT00605358|4087974|P1|NOT COMPLETED|Overall Study||0
1673006|NCT00605358|4087973|P2|COMPLETED|Overall Study||80
1673007|NCT00605358|4087974|P1|COMPLETED|Overall Study||81
1673008|NCT00605358|4087973|P2|STARTED|Overall Study||80
1673009|NCT00605358|4087974|P1|STARTED|Overall Study||81
1673010|NCT00605345|4087982|P2|NOT COMPLETED|Overall Study||3
1673011|NCT00605345|4087983|P1|NOT COMPLETED|Overall Study||1
1673012|NCT00605345|4087982|P2|COMPLETED|Overall Study||22
1673013|NCT00605345|4087983|P1|COMPLETED|Overall Study||45
1673014|NCT00605345|4087982|P2|STARTED|Overall Study||25
1673015|NCT00605345|4087983|P1|STARTED|Overall Study||46
1673016|NCT00605319|4087999|P1|NOT COMPLETED|Overall Study||6
1673017|NCT00605319|4087999|P1|COMPLETED|Overall Study||11
1673018|NCT00605319|4087999|P1|STARTED|Overall Study||17
1673019|NCT00605306|4088011|P2|NOT COMPLETED|Overall Study||1
1673020|NCT00605306|4088012|P1|NOT COMPLETED|Overall Study||0
1673021|NCT00605306|4088011|P2|COMPLETED|Overall Study||13
1673022|NCT00605306|4088012|P1|COMPLETED|Overall Study||14
1673023|NCT00605306|4088011|P2|STARTED|Overall Study||14
1673024|NCT00605306|4088012|P1|STARTED|Overall Study||14
1673025|NCT00605293|4088026|P2|NOT COMPLETED|Overall Study||5
1673026|NCT00605293|4088027|P1|NOT COMPLETED|Overall Study||17
1673027|NCT00605293|4088026|P2|COMPLETED|Overall Study||31
1673028|NCT00605293|4088027|P1|COMPLETED|Overall Study||48
1673029|NCT00605293|4088026|P2|STARTED|Overall Study||36
1673030|NCT00605293|4088027|P1|STARTED|Overall Study||65
1673031|NCT00605280|4088047|P4|NOT COMPLETED|Year 3 Extension||9
1673032|NCT00605280|4088048|P3|NOT COMPLETED|Year 3 Extension||0
1673033|NCT00605280|4088049|P2|NOT COMPLETED|Year 3 Extension||0
1673034|NCT00605280|4088050|P1|NOT COMPLETED|Year 3 Extension||8
1673035|NCT00605280|4088047|P4|COMPLETED|Year 3 Extension||45
1673036|NCT00605280|4088048|P3|COMPLETED|Year 3 Extension||0
1673037|NCT00605280|4088049|P2|COMPLETED|Year 3 Extension||0
1673038|NCT00605280|4088050|P1|COMPLETED|Year 3 Extension||38
1673039|NCT00605280|4088047|P4|Received 0.3 mg Treatment|Year 3 Extension||54
1673040|NCT00605280|4088048|P3|Received 0.3 mg Treatment|Year 3 Extension||0
1673041|NCT00605280|4088049|P2|Received 0.3 mg Treatment|Year 3 Extension||0
1673042|NCT00605280|4088050|P1|Received 0.3 mg Treatment|Year 3 Extension||46
1673043|NCT00605280|4088047|P4|STARTED|Year 3 Extension||54
1673044|NCT00605280|4088048|P3|STARTED|Year 3 Extension||0
1673045|NCT00605280|4088049|P2|STARTED|Year 3 Extension||0
1673046|NCT00605280|4088050|P1|STARTED|Year 3 Extension||46
1673047|NCT00605280|4088047|P4|NOT COMPLETED|Year 2||22
1673048|NCT00605280|4088048|P3|NOT COMPLETED|Year 2||6
1673049|NCT00605280|4088049|P2|NOT COMPLETED|Year 2||6
1673050|NCT00605280|4088050|P1|NOT COMPLETED|Year 2||24
1673051|NCT00605280|4088047|P4|COMPLETED|Year 2||102
1673052|NCT00605280|4088048|P3|COMPLETED|Year 2||0
1673053|NCT00605280|4088049|P2|COMPLETED|Year 2||5
1673054|NCT00605280|4088050|P1|COMPLETED|Year 2||102
1673055|NCT00605280|4088047|P4|Received 0.3 mg Treatment|Year 2||0
1673056|NCT00605280|4088048|P3|Received 0.3 mg Treatment|Year 2||2
1673057|NCT00605280|4088049|P2|Received 0.3 mg Treatment|Year 2||3
1673058|NCT00605280|4088050|P1|Received 0.3 mg Treatment|Year 2||126
1673059|NCT00605280|4088047|P4|STARTED|Year 2||124
1673060|NCT00605280|4088048|P3|STARTED|Year 2||6
1673061|NCT00605280|4088049|P2|STARTED|Year 2||11
1673062|NCT00605280|4088050|P1|STARTED|Year 2||126
1673063|NCT00605280|4088047|P4|NOT COMPLETED|Year 1||19
1673064|NCT00605280|4088048|P3|NOT COMPLETED|Year 1||1
1673065|NCT00605280|4088049|P2|NOT COMPLETED|Year 1||11
1673066|NCT00605280|4088050|P1|NOT COMPLETED|Year 1||19
1673067|NCT00605280|4088047|P4|COMPLETED|Year 1||124
1673068|NCT00605280|4088048|P3|COMPLETED|Year 1||6
1673069|NCT00605280|4088049|P2|COMPLETED|Year 1||11
1673070|NCT00605280|4088050|P1|COMPLETED|Year 1||126
1673071|NCT00605280|4088047|P4|Received 0.3 mg Treatment|Year 1||0
1673072|NCT00605280|4088048|P3|Received 0.3 mg Treatment|Year 1||3
1673073|NCT00605280|4088049|P2|Received 0.3 mg Treatment|Year 1||13
1673074|NCT00605280|4088050|P1|Received 0.3 mg Treatment|Year 1||144
1673075|NCT00605280|4088047|P4|STARTED|Year 1||143
1673076|NCT00605280|4088048|P3|STARTED|Year 1||7
1673077|NCT00605280|4088049|P2|STARTED|Year 1||22
1673078|NCT00605280|4088050|P1|STARTED|Year 1||145
1673079|NCT00605267|4088084|P2|NOT COMPLETED|Overall Study||9
1673080|NCT00605267|4088085|P1|NOT COMPLETED|Overall Study||3
1673081|NCT00605267|4088084|P2|COMPLETED|Overall Study|Breast surgery performed|90
1673082|NCT00605267|4088085|P1|COMPLETED|Overall Study|Breast surgery performed|95
1673083|NCT00605267|4088084|P2|STARTED|Overall Study||99
1673084|NCT00605267|4088085|P1|STARTED|Overall Study||98
1673085|NCT00605202|4088123|P2|NOT COMPLETED|Second Intervention||0
1673086|NCT00605202|4088124|P1|NOT COMPLETED|Second Intervention||0
1673087|NCT00605202|4088123|P2|COMPLETED|Second Intervention||5
1673088|NCT00605202|4088124|P1|COMPLETED|Second Intervention||5
1673089|NCT00605202|4088123|P2|STARTED|Second Intervention||5
1673090|NCT00605202|4088124|P1|STARTED|Second Intervention||5
1673091|NCT00605202|4088123|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
1673092|NCT00605202|4088124|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
1673093|NCT00605202|4088123|P2|COMPLETED|Washout Period of 3 Weeks||5
1673094|NCT00605202|4088124|P1|COMPLETED|Washout Period of 3 Weeks||5
1673095|NCT00605202|4088123|P2|STARTED|Washout Period of 3 Weeks||5
1673096|NCT00605202|4088124|P1|STARTED|Washout Period of 3 Weeks||5
1673097|NCT00605202|4088123|P2|NOT COMPLETED|First Intervention||0
1673098|NCT00605202|4088124|P1|NOT COMPLETED|First Intervention||0
1673099|NCT00605202|4088123|P2|COMPLETED|First Intervention||5
1673100|NCT00605202|4088124|P1|COMPLETED|First Intervention||5
1673101|NCT00605202|4088123|P2|STARTED|First Intervention||5
1673102|NCT00605202|4088124|P1|STARTED|First Intervention||5
1673103|NCT00605189|4088133|P3|NOT COMPLETED|Overall Study||0
1673104|NCT00605189|4088134|P2|NOT COMPLETED|Overall Study||2
1673105|NCT00605189|4088135|P1|NOT COMPLETED|Overall Study||3
1673106|NCT00605189|4088133|P3|COMPLETED|Overall Study||9
1673107|NCT00605189|4088134|P2|COMPLETED|Overall Study||19
1673108|NCT00605189|4088135|P1|COMPLETED|Overall Study||17
1673109|NCT00605189|4088133|P3|STARTED|Overall Study||9
1673110|NCT00605189|4088134|P2|STARTED|Overall Study||21
1673111|NCT00605189|4088135|P1|STARTED|Overall Study||20
1673112|NCT00605176|4088146|P3|NOT COMPLETED|Overall Study||9
1673113|NCT00605176|4088147|P2|NOT COMPLETED|Overall Study||6
1673114|NCT00605176|4088148|P1|NOT COMPLETED|Overall Study||11
1673115|NCT00605176|4088146|P3|COMPLETED|Overall Study||150
1673116|NCT00605176|4088147|P2|COMPLETED|Overall Study||154
1673117|NCT00605176|4088148|P1|COMPLETED|Overall Study||149
1673118|NCT00605176|4088146|P3|STARTED|Overall Study||159
1673119|NCT00605176|4088147|P2|STARTED|Overall Study||160
1673120|NCT00605176|4088148|P1|STARTED|Overall Study||160
1673121|NCT00605150|4088165|P1|NOT COMPLETED|Overall Study||1
1673122|NCT00605150|4088165|P1|COMPLETED|Overall Study||10
1673123|NCT00605150|4088165|P1|STARTED|Overall Study|11 started|11
1673124|NCT00605085|4088171|P2|NOT COMPLETED|Overall Study||25
1673125|NCT00605085|4088172|P1|NOT COMPLETED|Overall Study||50
1673126|NCT00605085|4088171|P2|COMPLETED|Overall Study||638
1673127|NCT00605085|4088172|P1|COMPLETED|Overall Study||1962
1673128|NCT00605085|4088171|P2|STARTED|Overall Study||663
1673129|NCT00605085|4088172|P1|STARTED|Overall Study||2012
1673130|NCT00605072|4088181|P3|NOT COMPLETED|Overall Study||4
1673131|NCT00605072|4088182|P2|NOT COMPLETED|Overall Study||11
1673132|NCT00605072|4088183|P1|NOT COMPLETED|Overall Study||7
1673133|NCT00605072|4088181|P3|COMPLETED|Overall Study||11
1673134|NCT00605072|4088182|P2|COMPLETED|Overall Study||9
1673135|NCT00605072|4088183|P1|COMPLETED|Overall Study||11
1673136|NCT00605072|4088181|P3|STARTED|Overall Study||15
1673137|NCT00605072|4088182|P2|STARTED|Overall Study||20
1673138|NCT00605072|4088183|P1|STARTED|Overall Study||18
1673139|NCT00605033|4088205|P2|NOT COMPLETED|Overall Study||8
1673140|NCT00605033|4088206|P1|NOT COMPLETED|Overall Study||7
1673141|NCT00605033|4088205|P2|COMPLETED|Overall Study||90
1673142|NCT00605033|4088206|P1|COMPLETED|Overall Study||136
1673143|NCT00605033|4088205|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
1673144|NCT00605033|4088206|P1|STARTED|Overall Study||143
1673145|NCT00604968|4088212|P1|NOT COMPLETED|Overall Study||0
1673146|NCT00604968|4088212|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
1673147|NCT00604968|4088212|P1|STARTED|Overall Study||25
1673148|NCT00604825|4088229|P4|NOT COMPLETED|Overall Study||11
1673149|NCT00604825|4088230|P3|NOT COMPLETED|Overall Study||16
1673150|NCT00604825|4088231|P2|NOT COMPLETED|Overall Study||15
1673151|NCT00604825|4088232|P1|NOT COMPLETED|Overall Study||9
1673152|NCT00604825|4088229|P4|COMPLETED|Overall Study||79
1673153|NCT00604825|4088230|P3|COMPLETED|Overall Study||73
1673154|NCT00604825|4088231|P2|COMPLETED|Overall Study||72
1673155|NCT00604825|4088232|P1|COMPLETED|Overall Study||81
1673156|NCT00604825|4088229|P4|STARTED|Overall Study||90
1673157|NCT00604825|4088230|P3|STARTED|Overall Study||89
1673158|NCT00604825|4088231|P2|STARTED|Overall Study||87
1673159|NCT00604825|4088232|P1|STARTED|Overall Study||90
1673160|NCT00604812|4088433|P6|NOT COMPLETED|Overall Study||0
1673161|NCT00604812|4088434|P5|NOT COMPLETED|Overall Study||0
1673162|NCT00604812|4088435|P4|NOT COMPLETED|Overall Study||0
1673163|NCT00604812|4088436|P3|NOT COMPLETED|Overall Study||0
1673164|NCT00604812|4088437|P2|NOT COMPLETED|Overall Study||0
1673165|NCT00604812|4088438|P1|NOT COMPLETED|Overall Study||0
1673166|NCT00604812|4088433|P6|COMPLETED|Overall Study||1
1673167|NCT00604812|4088434|P5|COMPLETED|Overall Study||5
1673168|NCT00604812|4088435|P4|COMPLETED|Overall Study||3
1673169|NCT00604812|4088436|P3|COMPLETED|Overall Study||10
1673170|NCT00604812|4088437|P2|COMPLETED|Overall Study||3
1673171|NCT00604812|4088438|P1|COMPLETED|Overall Study||9
1673172|NCT00604812|4088433|P6|STARTED|Overall Study||1
1673173|NCT00604812|4088434|P5|STARTED|Overall Study||5
1673174|NCT00604812|4088435|P4|STARTED|Overall Study||3
1673175|NCT00604812|4088436|P3|STARTED|Overall Study||10
1673176|NCT00604812|4088437|P2|STARTED|Overall Study||3
1673177|NCT00604812|4088438|P1|STARTED|Overall Study||9
1673178|NCT00604786|4088460|P2|NOT COMPLETED|Overall Study||0
1673179|NCT00604786|4088461|P1|NOT COMPLETED|Overall Study||2
1673180|NCT00604786|4088460|P2|COMPLETED|Overall Study||4
1673181|NCT00604786|4088461|P1|COMPLETED|Overall Study||12
1673182|NCT00604786|4088460|P2|STARTED|Overall Study||4
1673183|NCT00604786|4088461|P1|STARTED|Overall Study||14
1673184|NCT00604721|4088467|P1|NOT COMPLETED|Overall Study||2
1673185|NCT00604721|4088467|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
1673186|NCT00604721|4088467|P1|STARTED|Overall Study||19
1673187|NCT00604708|4088475|P2|NOT COMPLETED|Overall Study||40
1673188|NCT00604708|4088476|P1|NOT COMPLETED|Overall Study||31
1673189|NCT00604708|4088475|P2|COMPLETED|Overall Study||397
1673190|NCT00604708|4088476|P1|COMPLETED|Overall Study||399
1673191|NCT00604708|4088475|P2|STARTED|Overall Study||437
1673192|NCT00604708|4088476|P1|STARTED|Overall Study||430
1673193|NCT00604695|4088486|P2|NOT COMPLETED|Overall Study||4
1673194|NCT00604695|4088487|P1|NOT COMPLETED|Overall Study||0
1673195|NCT00604695|4088486|P2|COMPLETED|Overall Study||16
1673196|NCT00604695|4088487|P1|COMPLETED|Overall Study||20
1673197|NCT00604695|4088486|P2|STARTED|Overall Study||20
1673198|NCT00604695|4088487|P1|STARTED|Overall Study||20
1673199|NCT00604669|4088509|P1|NOT COMPLETED|Overall Study||7
1673200|NCT00604669|4088509|P1|COMPLETED|Overall Study||163
1673201|NCT00604669|4088509|P1|STARTED|Overall Study||170
1673202|NCT00604565|4088515|P2|NOT COMPLETED|Overall Study||3
1673203|NCT00604565|4088516|P1|NOT COMPLETED|Overall Study||0
1673204|NCT00604565|4088515|P2|COMPLETED|Overall Study||4
1673205|NCT00604565|4088516|P1|COMPLETED|Overall Study||4
1673206|NCT00604565|4088515|P2|STARTED|Overall Study||7
1673207|NCT00604565|4088516|P1|STARTED|Overall Study||4
1673208|NCT00604552|4088526|P2|NOT COMPLETED|Overall Study||0
1673209|NCT00604552|4088527|P1|NOT COMPLETED|Overall Study||0
1673210|NCT00604552|4088526|P2|COMPLETED|Overall Study||160
1673211|NCT00604552|4088527|P1|COMPLETED|Overall Study||189
1673212|NCT00604552|4088526|P2|STARTED|Overall Study||160
1673213|NCT00604552|4088527|P1|STARTED|Overall Study||189
1673214|NCT00604500|4088535|P1|NOT COMPLETED|Overall Study||11
1673215|NCT00604500|4088535|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
1673216|NCT00604500|4088535|P1|STARTED|Overall Study||272
1673217|NCT00604461|4088542|P1|NOT COMPLETED|Overall Study||1
1673218|NCT00604461|4088542|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
1673219|NCT00604461|4088542|P1|STARTED|Overall Study||13
1673220|NCT00604383|4088549|P2|NOT COMPLETED|Overall Study||84
1673221|NCT00604383|4088550|P1|NOT COMPLETED|Overall Study||87
1673222|NCT00604383|4088549|P2|COMPLETED|Overall Study||256
1673223|NCT00604383|4088550|P1|COMPLETED|Overall Study||258
1673224|NCT00604383|4088549|P2|Received Extended Treatment|Overall Study||141
1673225|NCT00604383|4088550|P1|Received Extended Treatment|Overall Study||136
1673226|NCT00604383|4088549|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
1673227|NCT00604383|4088550|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
1673228|NCT00604383|4088549|P2|STARTED|Overall Study||340
1673229|NCT00604383|4088550|P1|STARTED|Overall Study||345
1673230|NCT00604279|4088566|P2|NOT COMPLETED|Overall Study||38
1673231|NCT00604279|4088567|P1|NOT COMPLETED|Overall Study||64
1673232|NCT00604279|4088566|P2|COMPLETED|Overall Study||185
1673233|NCT00604279|4088567|P1|COMPLETED|Overall Study||165
1673234|NCT00604279|4088566|P2|STARTED|Overall Study||223
1673235|NCT00604279|4088567|P1|STARTED|Overall Study||229
1673236|NCT00604214|4088583|P2|NOT COMPLETED|Day 91 to Day 180||32
1673237|NCT00604214|4088584|P1|NOT COMPLETED|Day 91 to Day 180||26
1673238|NCT00604214|4088583|P2|COMPLETED|Day 91 to Day 180||521
1673239|NCT00604214|4088584|P1|COMPLETED|Day 91 to Day 180||529
1673240|NCT00604214|4088583|P2|STARTED|Day 91 to Day 180||553
1673241|NCT00604214|4088584|P1|STARTED|Day 91 to Day 180||555
1673242|NCT00604214|4088583|P2|NOT COMPLETED|Day 29 to Day 90||79
1673243|NCT00604214|4088584|P1|NOT COMPLETED|Day 29 to Day 90||68
1673244|NCT00604214|4088583|P2|COMPLETED|Day 29 to Day 90||553
1673245|NCT00604214|4088584|P1|COMPLETED|Day 29 to Day 90||555
1673246|NCT00604214|4088583|P2|STARTED|Day 29 to Day 90||632
1673247|NCT00604214|4088584|P1|STARTED|Day 29 to Day 90||623
1673248|NCT00604214|4088583|P2|NOT COMPLETED|Baseline to Day 28||213
1673249|NCT00604214|4088584|P1|NOT COMPLETED|Baseline to Day 28||228
1673250|NCT00604214|4088583|P2|COMPLETED|Baseline to Day 28||632
1673251|NCT00604214|4088584|P1|COMPLETED|Baseline to Day 28||623
1673252|NCT00604214|4088583|P2|Received Study Drug|Baseline to Day 28||833
1673253|NCT00604214|4088584|P1|Received Study Drug|Baseline to Day 28||833
1673254|NCT00604214|4088583|P2|STARTED|Baseline to Day 28||845
1673255|NCT00604214|4088584|P1|STARTED|Baseline to Day 28||851
1673256|NCT00604188|4088616|P2|NOT COMPLETED|Overall Study||25
1673257|NCT00604188|4088617|P1|NOT COMPLETED|Overall Study||27
1673258|NCT00604188|4088616|P2|COMPLETED|Overall Study||70
1673259|NCT00604188|4088617|P1|COMPLETED|Overall Study||66
1673260|NCT00604188|4088616|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
1673261|NCT00604188|4088617|P1|STARTED|Overall Study||93
1673262|NCT00604175|4088640|P3|NOT COMPLETED|Week 29 Through Week 72||4
1673263|NCT00604175|4088641|P2|NOT COMPLETED|Week 29 Through Week 72||7
1673264|NCT00604175|4088642|P1|NOT COMPLETED|Week 29 Through Week 72||12
1673265|NCT00604175|4088640|P3|COMPLETED|Week 29 Through Week 72||89
1673266|NCT00604175|4088641|P2|COMPLETED|Week 29 Through Week 72||85
1673267|NCT00604175|4088642|P1|COMPLETED|Week 29 Through Week 72||108
1673268|NCT00604175|4088640|P3|STARTED|Week 29 Through Week 72||93
1673269|NCT00604175|4088641|P2|STARTED|Week 29 Through Week 72||92
1673270|NCT00604175|4088642|P1|STARTED|Week 29 Through Week 72||120
1673271|NCT00604175|4088640|P3|NOT COMPLETED|Entry Through Week 28||1
1673272|NCT00604175|4088641|P2|NOT COMPLETED|Entry Through Week 28||3
1673273|NCT00604175|4088642|P1|NOT COMPLETED|Entry Through Week 28||10
1673274|NCT00604175|4088640|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
1673275|NCT00604175|4088641|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
1673276|NCT00604175|4088642|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
1673277|NCT00604175|4088640|P3|STARTED|Entry Through Week 28||94
1673278|NCT00604175|4088641|P2|STARTED|Entry Through Week 28||95
1673279|NCT00604175|4088642|P1|STARTED|Entry Through Week 28||130
1673280|NCT00604162|4088695|P1|NOT COMPLETED|Overall Study||4
1673281|NCT00604162|4088695|P1|COMPLETED|Overall Study||328
1673282|NCT00604162|4088695|P1|STARTED|Overall Study||332
1673283|NCT00604045|4088708|P2|NOT COMPLETED|Overall Study||1
1673284|NCT00604045|4088709|P1|NOT COMPLETED|Overall Study||1
1673285|NCT00604045|4088708|P2|COMPLETED|Overall Study||9
1673286|NCT00604045|4088709|P1|COMPLETED|Overall Study||14
1673287|NCT00604045|4088708|P2|STARTED|Overall Study||10
1673288|NCT00604045|4088709|P1|STARTED|Overall Study||15
1673289|NCT00604019|4088717|P2|NOT COMPLETED|Overall Study||0
1673290|NCT00604019|4088718|P1|NOT COMPLETED|Overall Study||0
1673291|NCT00604019|4088717|P2|COMPLETED|Overall Study||118
1673292|NCT00604019|4088718|P1|COMPLETED|Overall Study||134
1673293|NCT00604019|4088717|P2|STARTED|Overall Study||118
1673294|NCT00604019|4088718|P1|STARTED|Overall Study||134
1673295|NCT00603993|4088724|P1|NOT COMPLETED|Overall Study||20
1673296|NCT00603993|4088724|P1|COMPLETED|Overall Study||68
1673297|NCT00603993|4088724|P1|STARTED|Overall Study||88
1673298|NCT00603915|4088737|P1|NOT COMPLETED|Overall Study||1
1673299|NCT00603915|4088737|P1|COMPLETED|Overall Study||19
1673300|NCT00603915|4088737|P1|STARTED|Overall Study||20
1673301|NCT00603902|4088745|P3|NOT COMPLETED|Overall Study||769
1673302|NCT00603902|4088746|P2|NOT COMPLETED|Overall Study||686
1673303|NCT00603902|4088747|P1|NOT COMPLETED|Overall Study||329
1673304|NCT00603902|4088745|P3|COMPLETED|Overall Study||834
1673305|NCT00603902|4088746|P2|COMPLETED|Overall Study||917
1673306|NCT00603902|4088747|P1|COMPLETED|Overall Study||473
1673307|NCT00603902|4088745|P3|STARTED|Overall Study||1603
1673308|NCT00603902|4088746|P2|STARTED|Overall Study||1603
1673309|NCT00603902|4088747|P1|STARTED|Overall Study||802
1673310|NCT00603889|4088758|P1|NOT COMPLETED|Overall Study||0
1673311|NCT00603889|4088758|P1|COMPLETED|Overall Study||12
1673312|NCT00603889|4088758|P1|STARTED|Overall Study||12
1673313|NCT00603837|4088767|P2|NOT COMPLETED|Overall Study||0
1673314|NCT00603837|4088768|P1|NOT COMPLETED|Overall Study||3
1673315|NCT00603837|4088767|P2|COMPLETED|Overall Study||19
1673316|NCT00603837|4088768|P1|COMPLETED|Overall Study||17
1673317|NCT00603837|4088767|P2|STARTED|Overall Study||19
1673318|NCT00603837|4088768|P1|STARTED|Overall Study||20
1673319|NCT00603798|4088777|P3|NOT COMPLETED|Overall Study||10
1673320|NCT00603798|4088778|P2|NOT COMPLETED|Overall Study||7
1673321|NCT00603798|4088779|P1|NOT COMPLETED|Overall Study||10
1673322|NCT00603798|4088777|P3|COMPLETED|Overall Study||154
1673323|NCT00603798|4088778|P2|COMPLETED|Overall Study||157
1673324|NCT00603798|4088779|P1|COMPLETED|Overall Study||152
1673325|NCT00603798|4088777|P3|STARTED|Overall Study||164
1673326|NCT00603798|4088778|P2|STARTED|Overall Study||164
1673327|NCT00603798|4088779|P1|STARTED|Overall Study||162
1673328|NCT00603746|4088802|P6|NOT COMPLETED|Overall Study||13
1673329|NCT00603746|4088803|P5|NOT COMPLETED|Overall Study||17
1673330|NCT00603746|4088804|P4|NOT COMPLETED|Overall Study||13
1673331|NCT00603746|4088805|P3|NOT COMPLETED|Overall Study||8
1673332|NCT00603746|4088806|P2|NOT COMPLETED|Overall Study||18
1673333|NCT00603746|4088807|P1|NOT COMPLETED|Overall Study||38
1673334|NCT00603746|4088802|P6|COMPLETED|Overall Study||97
1673335|NCT00603746|4088803|P5|COMPLETED|Overall Study||85
1673336|NCT00603746|4088804|P4|COMPLETED|Overall Study||94
1673337|NCT00603746|4088805|P3|COMPLETED|Overall Study||93
1673338|NCT00603746|4088806|P2|COMPLETED|Overall Study||81
1673339|NCT00603746|4088807|P1|COMPLETED|Overall Study||65
1673340|NCT00603746|4088802|P6|STARTED|Overall Study||110
1673341|NCT00603746|4088803|P5|STARTED|Overall Study||102
1673342|NCT00603746|4088804|P4|STARTED|Overall Study||107
1673343|NCT00603746|4088805|P3|STARTED|Overall Study||101
1673344|NCT00603746|4088806|P2|STARTED|Overall Study||99
1673345|NCT00603746|4088807|P1|STARTED|Overall Study||103
1673346|NCT00603733|4088955|P2|NOT COMPLETED|Maintenance Phase ITT||16
1673347|NCT00603733|4088956|P1|NOT COMPLETED|Maintenance Phase ITT||10
1673348|NCT00603733|4088955|P2|COMPLETED|Maintenance Phase ITT||66
1673349|NCT00603733|4088956|P1|COMPLETED|Maintenance Phase ITT||61
1673350|NCT00603733|4088955|P2|STARTED|Maintenance Phase ITT||82
1673351|NCT00603733|4088956|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
1673352|NCT00603733|4088955|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
1673353|NCT00603733|4088956|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
1673354|NCT00603733|4088955|P2|COMPLETED|Run-In Phase - 4 Weeks||36
1673355|NCT00603733|4088956|P1|COMPLETED|Run-In Phase - 4 Weeks||35
1673356|NCT00603733|4088955|P2|STARTED|Run-In Phase - 4 Weeks||49
1673357|NCT00603733|4088956|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
1673358|NCT00603733|4088955|P2|NOT COMPLETED|Active Phase ITT||17
1673359|NCT00603733|4088956|P1|NOT COMPLETED|Active Phase ITT||11
1673360|NCT00603733|4088955|P2|COMPLETED|Active Phase ITT||78
1673361|NCT00603733|4088956|P1|COMPLETED|Active Phase ITT||84
1673362|NCT00603733|4088955|P2|STARTED|Active Phase ITT||95
1673363|NCT00603733|4088956|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
1673364|NCT00603720|4088971|P5|NOT COMPLETED|Overall Study||0
1673365|NCT00603720|4088972|P4|NOT COMPLETED|Overall Study||0
1673366|NCT00603720|4088973|P3|NOT COMPLETED|Overall Study||0
1673367|NCT00603720|4088974|P2|NOT COMPLETED|Overall Study||0
1673368|NCT00603720|4088975|P1|NOT COMPLETED|Overall Study||0
1673369|NCT00603720|4088971|P5|COMPLETED|Overall Study||12
1673370|NCT00603720|4088972|P4|COMPLETED|Overall Study||10
1673371|NCT00603720|4088973|P3|COMPLETED|Overall Study||12
1673372|NCT00603720|4088974|P2|COMPLETED|Overall Study||10
1673373|NCT00603720|4088975|P1|COMPLETED|Overall Study||10
1673374|NCT00603720|4088971|P5|STARTED|Overall Study||12
1673375|NCT00603720|4088972|P4|STARTED|Overall Study||10
1673376|NCT00603720|4088973|P3|STARTED|Overall Study||12
1673377|NCT00603720|4088974|P2|STARTED|Overall Study||10
1673378|NCT00603720|4088975|P1|STARTED|Overall Study||10
1673379|NCT00603642|4088989|P2|NOT COMPLETED|Overall Study||0
1673380|NCT00603642|4088990|P1|NOT COMPLETED|Overall Study||0
1673381|NCT00603642|4088989|P2|COMPLETED|Overall Study||22
1673382|NCT00603642|4088990|P1|COMPLETED|Overall Study||12
1673383|NCT00603642|4088989|P2|STARTED|Overall Study||22
1673384|NCT00603642|4088990|P1|STARTED|Overall Study||12
1673385|NCT00603590|4089006|P2|NOT COMPLETED|Overall Study||51
1673386|NCT00603590|4089007|P1|NOT COMPLETED|Overall Study||76
1673387|NCT00603590|4089006|P2|COMPLETED|Overall Study||183
1673388|NCT00603590|4089007|P1|COMPLETED|Overall Study||165
1673389|NCT00603590|4089006|P2|Eight Months|Overall Study||194
1673390|NCT00603590|4089007|P1|Eight Months|Overall Study||178
1673391|NCT00603590|4089006|P2|Four Months|Overall Study||200
1673392|NCT00603590|4089007|P1|Four Months|Overall Study||187
1673393|NCT00603590|4089006|P2|One Month|Overall Study||212
1673394|NCT00603590|4089007|P1|One Month|Overall Study||204
1673395|NCT00603590|4089006|P2|STARTED|Overall Study||234
1673396|NCT00603590|4089007|P1|STARTED|Overall Study||241
1673397|NCT00603564|4089019|P2|NOT COMPLETED|Overall Study||0
1673398|NCT00603564|4089020|P1|NOT COMPLETED|Overall Study||0
1673399|NCT00603564|4089019|P2|COMPLETED|Overall Study|February 2008|27
1673400|NCT00603564|4089020|P1|COMPLETED|Overall Study|February 2008|20
1673401|NCT00603564|4089019|P2|STARTED|Overall Study|January 2006|27
1673402|NCT00603564|4089020|P1|STARTED|Overall Study|January 2006|20
1673403|NCT00603538|4089031|P3|NOT COMPLETED|Overall Study||2
1673404|NCT00603538|4089032|P2|NOT COMPLETED|Overall Study||4
1673405|NCT00603538|4089033|P1|NOT COMPLETED|Overall Study||3
1673406|NCT00603538|4089031|P3|COMPLETED|Overall Study||4
1673407|NCT00603538|4089032|P2|COMPLETED|Overall Study||3
1673408|NCT00603538|4089033|P1|COMPLETED|Overall Study||3
1673409|NCT00603538|4089031|P3|STARTED|Overall Study||6
1673410|NCT00603538|4089032|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
1673411|NCT00603538|4089033|P1|STARTED|Overall Study||6
1673412|NCT00603525|4089073|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
1673413|NCT00603525|4089074|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1673414|NCT00603525|4089075|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1673415|NCT00603525|4089073|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
1673416|NCT00603525|4089074|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1673417|NCT00603525|4089075|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1673418|NCT00603525|4089073|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
1673419|NCT00603525|4089074|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
1673420|NCT00603525|4089075|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
1673421|NCT00603525|4089073|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
1673422|NCT00603525|4089074|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
1673423|NCT00603525|4089075|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
1673424|NCT00603525|4089073|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1673425|NCT00603525|4089074|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
1673426|NCT00603525|4089075|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1673427|NCT00603525|4089073|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
1673428|NCT00603525|4089074|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
1673429|NCT00603525|4089075|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
1673430|NCT00603525|4089073|P3|STARTED|OL Treatment Period (120 Weeks)||0
1673431|NCT00603525|4089074|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
1673432|NCT00603525|4089075|P1|STARTED|OL Treatment Period (120 Weeks)||0
1673433|NCT00603525|4089073|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
1673434|NCT00603525|4089074|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
1673435|NCT00603525|4089075|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
1673436|NCT00603525|4089073|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
1673437|NCT00603525|4089074|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
1673438|NCT00603525|4089075|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
1673439|NCT00603525|4089073|P3|STARTED|DB Treatment Period (24 Weeks)||0
1673440|NCT00603525|4089074|P2|STARTED|DB Treatment Period (24 Weeks)||85
1673441|NCT00603525|4089075|P1|STARTED|DB Treatment Period (24 Weeks)||84
1673442|NCT00603512|4089207|P5|NOT COMPLETED|Overall Study||5
1673443|NCT00603512|4089208|P4|NOT COMPLETED|Overall Study||7
1673444|NCT00603512|4089209|P3|NOT COMPLETED|Overall Study||5
1673445|NCT00603512|4089210|P2|NOT COMPLETED|Overall Study||5
1673446|NCT00603512|4089211|P1|NOT COMPLETED|Overall Study||2
1673447|NCT00603512|4089207|P5|COMPLETED|Overall Study||23
1673448|NCT00603512|4089208|P4|COMPLETED|Overall Study||21
1673449|NCT00603512|4089209|P3|COMPLETED|Overall Study||23
1673450|NCT00603512|4089210|P2|COMPLETED|Overall Study||23
1673451|NCT00603512|4089211|P1|COMPLETED|Overall Study||26
1673452|NCT00603512|4089207|P5|Treated|Overall Study||28
1673453|NCT00603512|4089208|P4|Treated|Overall Study||26
1673454|NCT00603512|4089209|P3|Treated|Overall Study||27
1673455|NCT00603512|4089210|P2|Treated|Overall Study||27
1673456|NCT00603512|4089211|P1|Treated|Overall Study||28
1673457|NCT00603512|4089207|P5|STARTED|Overall Study||28
1673458|NCT00603512|4089208|P4|STARTED|Overall Study||28
1673459|NCT00603512|4089209|P3|STARTED|Overall Study||28
1673460|NCT00603512|4089210|P2|STARTED|Overall Study||28
1673461|NCT00603512|4089211|P1|STARTED|Overall Study||28
1673462|NCT00603473|4089353|P1|NOT COMPLETED|Overall Study||9
1673463|NCT00603473|4089353|P1|COMPLETED|Overall Study||80
1673464|NCT00603473|4089353|P1|STARTED|Overall Study||89
1673465|NCT00603447|4089366|P7|NOT COMPLETED|Overall Study||24
1673466|NCT00603447|4089367|P6|NOT COMPLETED|Overall Study||2
1673467|NCT00603447|4089368|P5|NOT COMPLETED|Overall Study||5
1673468|NCT00603447|4089369|P4|NOT COMPLETED|Overall Study||2
1673469|NCT00603447|4089370|P3|NOT COMPLETED|Overall Study||2
1673470|NCT00603447|4089371|P2|NOT COMPLETED|Overall Study||3
1673471|NCT00603447|4089372|P1|NOT COMPLETED|Overall Study||0
1673472|NCT00603447|4089366|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
1673473|NCT00603447|4089367|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
1673474|NCT00603447|4089368|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
1673475|NCT00603447|4089369|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
1673476|NCT00603447|4089370|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
1673477|NCT00603447|4089371|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
1673478|NCT00603447|4089372|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
1673479|NCT00603447|4089366|P7|STARTED|Overall Study||44
1673480|NCT00603447|4089367|P6|STARTED|Overall Study||8
1673481|NCT00603447|4089368|P5|STARTED|Overall Study||6
1673482|NCT00603447|4089369|P4|STARTED|Overall Study||6
1673483|NCT00603447|4089370|P3|STARTED|Overall Study||8
1673484|NCT00603447|4089371|P2|STARTED|Overall Study||6
1673485|NCT00603447|4089372|P1|STARTED|Overall Study||6
1673486|NCT00603408|4089394|P1|NOT COMPLETED|Overall Study||0
1673487|NCT00603408|4089394|P1|COMPLETED|Overall Study||5
1673488|NCT00603408|4089394|P1|STARTED|Overall Study||5
1673489|NCT00603382|4089411|P6|NOT COMPLETED|Overall Study||18
1673490|NCT00603382|4089412|P5|NOT COMPLETED|Overall Study||9
1673491|NCT00603382|4089413|P4|NOT COMPLETED|Overall Study||12
1673492|NCT00603382|4089414|P3|NOT COMPLETED|Overall Study||9
1673493|NCT00603382|4089415|P2|NOT COMPLETED|Overall Study||14
1673494|NCT00603382|4089416|P1|NOT COMPLETED|Overall Study||18
1673495|NCT00603382|4089411|P6|COMPLETED|Overall Study||84
1673496|NCT00603382|4089412|P5|COMPLETED|Overall Study||86
1673497|NCT00603382|4089413|P4|COMPLETED|Overall Study||98
1673498|NCT00603382|4089414|P3|COMPLETED|Overall Study||91
1673499|NCT00603382|4089415|P2|COMPLETED|Overall Study||83
1673500|NCT00603382|4089416|P1|COMPLETED|Overall Study||76
1673501|NCT00603382|4089411|P6|STARTED|Overall Study||102
1673502|NCT00603382|4089412|P5|STARTED|Overall Study||95
1673503|NCT00603382|4089413|P4|STARTED|Overall Study||110
1673504|NCT00603382|4089414|P3|STARTED|Overall Study||100
1673505|NCT00603382|4089415|P2|STARTED|Overall Study||97
1673506|NCT00603382|4089416|P1|STARTED|Overall Study||94
1673507|NCT00603304|4089564|P2|NOT COMPLETED|Overall Study||31
1673508|NCT00603304|4089565|P1|NOT COMPLETED|Overall Study||32
1673509|NCT00603304|4089564|P2|COMPLETED|Overall Study||155
1673510|NCT00603304|4089565|P1|COMPLETED|Overall Study||151
1673511|NCT00603304|4089564|P2|STARTED|Overall Study||186
1673512|NCT00603304|4089565|P1|STARTED|Overall Study||183
1673513|NCT00603291|4089602|P3|NOT COMPLETED|Overall Study||96
1673514|NCT00603291|4089603|P2|NOT COMPLETED|Overall Study||87
1673515|NCT00603291|4089604|P1|NOT COMPLETED|Overall Study||20
1673516|NCT00603291|4089602|P3|COMPLETED|Overall Study||157
1673517|NCT00603291|4089603|P2|COMPLETED|Overall Study||169
1673518|NCT00603291|4089604|P1|COMPLETED|Overall Study||75
1673519|NCT00603291|4089602|P3|STARTED|Overall Study||253
1673520|NCT00603291|4089603|P2|STARTED|Overall Study||256
1673521|NCT00603291|4089604|P1|STARTED|Overall Study||95
1673522|NCT00603278|4089621|P6|NOT COMPLETED|Overall Study||19
1673523|NCT00603278|4089622|P5|NOT COMPLETED|Overall Study||13
1673524|NCT00603278|4089623|P4|NOT COMPLETED|Overall Study||11
1673525|NCT00603278|4089624|P3|NOT COMPLETED|Overall Study||14
1673526|NCT00603278|4089625|P2|NOT COMPLETED|Overall Study||17
1673527|NCT00603278|4089626|P1|NOT COMPLETED|Overall Study||41
1673528|NCT00603278|4089621|P6|COMPLETED|Overall Study||81
1673529|NCT00603278|4089622|P5|COMPLETED|Overall Study||86
1673530|NCT00603278|4089623|P4|COMPLETED|Overall Study||92
1673531|NCT00603278|4089624|P3|COMPLETED|Overall Study||87
1673532|NCT00603278|4089625|P2|COMPLETED|Overall Study||88
1673533|NCT00603278|4089626|P1|COMPLETED|Overall Study||66
1673534|NCT00603278|4089621|P6|STARTED|Overall Study||100
1673535|NCT00603278|4089622|P5|STARTED|Overall Study||99
1673536|NCT00603278|4089623|P4|STARTED|Overall Study||103
1673537|NCT00603278|4089624|P3|STARTED|Overall Study||101
1673538|NCT00603278|4089625|P2|STARTED|Overall Study||105
1673539|NCT00603278|4089626|P1|STARTED|Overall Study||107
1673540|NCT00603265|4089775|P3|NOT COMPLETED|Overall Study||5
1673541|NCT00603265|4089776|P2|NOT COMPLETED|Overall Study||16
1673542|NCT00603265|4089777|P1|NOT COMPLETED|Overall Study||7
1673543|NCT00603265|4089775|P3|COMPLETED|Overall Study||67
1673544|NCT00603265|4089776|P2|COMPLETED|Overall Study||62
1673545|NCT00603265|4089777|P1|COMPLETED|Overall Study||69
1673546|NCT00603265|4089775|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
1673547|NCT00603265|4089776|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
1673548|NCT00603265|4089777|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
1673549|NCT00603265|4089775|P3|STARTED|Overall Study||72
1673550|NCT00603265|4089776|P2|STARTED|Overall Study||78
1673551|NCT00603265|4089777|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
1673552|NCT00603239|4089805|P2|NOT COMPLETED|Overall Study||4
1673553|NCT00603239|4089806|P1|NOT COMPLETED|Overall Study||15
1673554|NCT00603239|4089805|P2|COMPLETED|Overall Study||50
1673555|NCT00603239|4089806|P1|COMPLETED|Overall Study||96
1673556|NCT00603239|4089805|P2|STARTED|Overall Study||54
1673557|NCT00603239|4089806|P1|STARTED|Overall Study||111
1673558|NCT00603187|4089832|P1|NOT COMPLETED|Overall Study||0
1673559|NCT00603187|4089832|P1|COMPLETED|Overall Study||4
1673560|NCT00603187|4089832|P1|STARTED|Overall Study||4
1673561|NCT00603044|4089840|P2|NOT COMPLETED|Overall Study||0
1673562|NCT00603044|4089841|P1|NOT COMPLETED|Overall Study||0
1673563|NCT00603044|4089840|P2|COMPLETED|Overall Study||13
1673564|NCT00603044|4089841|P1|COMPLETED|Overall Study||11
1673565|NCT00603044|4089840|P2|STARTED|Overall Study||13
1673566|NCT00603044|4089841|P1|STARTED|Overall Study||11
1673567|NCT00603018|4089857|P1|NOT COMPLETED|Overall Study||0
1673568|NCT00603018|4089857|P1|COMPLETED|Overall Study||23
1673569|NCT00603018|4089857|P1|STARTED|Overall Study||23
1673570|NCT00602979|4089867|P5|NOT COMPLETED|Overall Study||3
1673571|NCT00602979|4089868|P4|NOT COMPLETED|Overall Study||3
1673572|NCT00602979|4089869|P3|NOT COMPLETED|Overall Study||3
1673573|NCT00602979|4089870|P2|NOT COMPLETED|Overall Study||3
1673574|NCT00602979|4089871|P1|NOT COMPLETED|Overall Study||3
1673575|NCT00602979|4089867|P5|COMPLETED|Overall Study||45
1673576|NCT00602979|4089868|P4|COMPLETED|Overall Study||45
1673577|NCT00602979|4089869|P3|COMPLETED|Overall Study||45
1673578|NCT00602979|4089870|P2|COMPLETED|Overall Study||45
1673579|NCT00602979|4089871|P1|COMPLETED|Overall Study||45
1673580|NCT00602979|4089867|P5|STARTED|Overall Study||48
1673581|NCT00602979|4089868|P4|STARTED|Overall Study||48
1673582|NCT00602979|4089869|P3|STARTED|Overall Study||48
1673583|NCT00602979|4089870|P2|STARTED|Overall Study||48
1673584|NCT00602979|4089871|P1|STARTED|Overall Study||48
1673585|NCT00602953|4089888|P5|NOT COMPLETED|Overall Study||0
1673586|NCT00602953|4089889|P4|NOT COMPLETED|Overall Study||0
1673587|NCT00602953|4089890|P3|NOT COMPLETED|Overall Study||0
1673588|NCT00602953|4089891|P2|NOT COMPLETED|Overall Study||0
1673589|NCT00602953|4089892|P1|NOT COMPLETED|Overall Study||0
1673590|NCT00602953|4089888|P5|COMPLETED|Overall Study||0
1673591|NCT00602953|4089889|P4|COMPLETED|Overall Study||13
1673592|NCT00602953|4089890|P3|COMPLETED|Overall Study||47
1673593|NCT00602953|4089891|P2|COMPLETED|Overall Study||26
1673594|NCT00602953|4089892|P1|COMPLETED|Overall Study||15
1673595|NCT00602953|4089888|P5|STARTED|Overall Study||0
1673596|NCT00602953|4089889|P4|STARTED|Overall Study||13
1673597|NCT00602953|4089890|P3|STARTED|Overall Study||47
1673598|NCT00602953|4089891|P2|STARTED|Overall Study||26
1673599|NCT00602953|4089892|P1|STARTED|Overall Study||15
1673600|NCT00602927|4089921|P2|NOT COMPLETED|Period 3: 13 Days||3
1673601|NCT00602927|4089922|P1|NOT COMPLETED|Period 3: 13 Days||2
1673602|NCT00602927|4089921|P2|COMPLETED|Period 3: 13 Days||9
1673603|NCT00602927|4089922|P1|COMPLETED|Period 3: 13 Days||13
1673604|NCT00602927|4089921|P2|STARTED|Period 3: 13 Days||12
1673605|NCT00602927|4089922|P1|STARTED|Period 3: 13 Days||15
1673606|NCT00602927|4089921|P2|NOT COMPLETED|Period 2: 14 Days||2
1673607|NCT00602927|4089922|P1|NOT COMPLETED|Period 2: 14 Days||0
1673608|NCT00602927|4089921|P2|COMPLETED|Period 2: 14 Days||12
1673609|NCT00602927|4089922|P1|COMPLETED|Period 2: 14 Days||15
1673610|NCT00602927|4089921|P2|STARTED|Period 2: 14 Days||14
1673611|NCT00602927|4089922|P1|STARTED|Period 2: 14 Days||15
1673612|NCT00602927|4089921|P2|NOT COMPLETED|Period 1: 13 Days||5
1673613|NCT00602927|4089922|P1|NOT COMPLETED|Period 1: 13 Days||4
1673614|NCT00602927|4089921|P2|COMPLETED|Period 1: 13 Days||14
1673615|NCT00602927|4089922|P1|COMPLETED|Period 1: 13 Days||15
1673616|NCT00602927|4089921|P2|STARTED|Period 1: 13 Days||19
1673617|NCT00602927|4089922|P1|STARTED|Period 1: 13 Days||19
1673618|NCT00602836|4089930|P1|NOT COMPLETED|Overall Study||5
1673619|NCT00602836|4089930|P1|COMPLETED|Overall Study||39
1673620|NCT00602836|4089930|P1|STARTED|Overall Study||44
1673621|NCT00602797|4089934|P1|NOT COMPLETED|Overall Study||1
1673622|NCT00602797|4089934|P1|COMPLETED|Overall Study||19
1673623|NCT00602797|4089934|P1|STARTED|Overall Study||20
1673624|NCT00602771|4089942|P2|NOT COMPLETED|Overall Study||0
1673625|NCT00602771|4089943|P1|NOT COMPLETED|Overall Study||1
1673626|NCT00602771|4089942|P2|COMPLETED|Overall Study||21
1673627|NCT00602771|4089943|P1|COMPLETED|Overall Study||62
1673628|NCT00602771|4089942|P2|STARTED|Overall Study||21
1673629|NCT00602771|4089943|P1|STARTED|Overall Study||63
1673630|NCT00602641|4089951|P2|NOT COMPLETED|Overall Study||152
1673631|NCT00602641|4089952|P1|NOT COMPLETED|Overall Study||154
1673632|NCT00602641|4089951|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
1673633|NCT00602641|4089952|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
1673634|NCT00602641|4089951|P2|Started Protocol Therapy|Overall Study||150
1673635|NCT00602641|4089952|P1|Started Protocol Therapy|Overall Study||148
1673636|NCT00602641|4089951|P2|STARTED|Overall Study||152
1673637|NCT00602641|4089952|P1|STARTED|Overall Study||154
1673638|NCT00602537|4089966|P2|NOT COMPLETED|Follow Up Study Comparison||3
1673639|NCT00602537|4089967|P1|NOT COMPLETED|Follow Up Study Comparison||11
1673640|NCT00602537|4089966|P2|COMPLETED|Follow Up Study Comparison||14
1673641|NCT00602537|4089967|P1|COMPLETED|Follow Up Study Comparison||31
1673642|NCT00602537|4089966|P2|STARTED|Follow Up Study Comparison||17
1673643|NCT00602537|4089967|P1|STARTED|Follow Up Study Comparison||42
1673644|NCT00602537|4089966|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
1673645|NCT00602537|4089967|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
1673646|NCT00602537|4089966|P2|COMPLETED|12 Week Double Blind Comparison||17
1673647|NCT00602537|4089967|P1|COMPLETED|12 Week Double Blind Comparison||42
1673648|NCT00602537|4089966|P2|Responded|12 Week Double Blind Comparison||22
1673649|NCT00602537|4089967|P1|Responded|12 Week Double Blind Comparison||44
1673650|NCT00602537|4089966|P2|STARTED|12 Week Double Blind Comparison||64
1673651|NCT00602537|4089967|P1|STARTED|12 Week Double Blind Comparison||65
1673652|NCT00602472|4089977|P2|NOT COMPLETED|Overall Study||58
1673653|NCT00602472|4089978|P1|NOT COMPLETED|Overall Study||21
1673654|NCT00602472|4089977|P2|COMPLETED|Overall Study|number who completed treatment|734
1673655|NCT00602472|4089978|P1|COMPLETED|Overall Study|number who completed treatment|242
1673656|NCT00602472|4089977|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
1673657|NCT00602472|4089978|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
1673658|NCT00602459|4090012|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1673659|NCT00602459|4090013|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1673660|NCT00602459|4090014|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1673661|NCT00602459|4090015|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1673662|NCT00602459|4090012|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
1673663|NCT00602459|4090013|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
1673664|NCT00602459|4090014|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
1673665|NCT00602459|4090015|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
1673666|NCT00602459|4090012|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
1673667|NCT00602459|4090013|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
1673668|NCT00602459|4090014|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
1673669|NCT00602459|4090015|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
1673670|NCT00602459|4090012|P4|NOT COMPLETED|Initial Registration/Randomization||0
1673671|NCT00602459|4090013|P3|NOT COMPLETED|Initial Registration/Randomization||3
1673672|NCT00602459|4090014|P2|NOT COMPLETED|Initial Registration/Randomization||10
1673673|NCT00602459|4090015|P1|NOT COMPLETED|Initial Registration/Randomization||5
1673674|NCT00602459|4090012|P4|COMPLETED|Initial Registration/Randomization||0
1673675|NCT00602459|4090013|P3|COMPLETED|Initial Registration/Randomization||137
1673676|NCT00602459|4090014|P2|COMPLETED|Initial Registration/Randomization||130
1673677|NCT00602459|4090015|P1|COMPLETED|Initial Registration/Randomization||133
1673678|NCT00602459|4090012|P4|STARTED|Initial Registration/Randomization||0
1673679|NCT00602459|4090013|P3|STARTED|Initial Registration/Randomization||140
1673680|NCT00602459|4090014|P2|STARTED|Initial Registration/Randomization||140
1673681|NCT00602459|4090015|P1|STARTED|Initial Registration/Randomization||138
1673682|NCT00602446|4090036|P1|NOT COMPLETED|Overall Study||0
1673683|NCT00602446|4090036|P1|COMPLETED|Overall Study||3
1673684|NCT00602446|4090036|P1|STARTED|Overall Study||3
1673685|NCT00602420|4090043|P2|NOT COMPLETED|Overall Study||24
1673686|NCT00602420|4090044|P1|NOT COMPLETED|Overall Study||25
1673687|NCT00602420|4090043|P2|COMPLETED|Overall Study||229
1673688|NCT00602420|4090044|P1|COMPLETED|Overall Study||232
1673689|NCT00602420|4090043|P2|STARTED|Overall Study||253
1673690|NCT00602420|4090044|P1|STARTED|Overall Study||257
1673691|NCT00602355|4090053|P3|NOT COMPLETED|Overall Study||10
1673692|NCT00602355|4090054|P2|NOT COMPLETED|Overall Study||18
1673693|NCT00602355|4090055|P1|NOT COMPLETED|Overall Study||9
1673694|NCT00602355|4090053|P3|COMPLETED|Overall Study||43
1673695|NCT00602355|4090054|P2|COMPLETED|Overall Study||38
1673696|NCT00602355|4090055|P1|COMPLETED|Overall Study||44
1673697|NCT00602355|4090053|P3|STARTED|Overall Study||53
1673698|NCT00602355|4090054|P2|STARTED|Overall Study||56
1673699|NCT00602355|4090055|P1|STARTED|Overall Study||53
1673700|NCT00602290|4090078|P3|NOT COMPLETED|Overall Study||1
1673701|NCT00602290|4090079|P2|NOT COMPLETED|Overall Study||2
1673702|NCT00602290|4090080|P1|NOT COMPLETED|Overall Study||2
1673703|NCT00602290|4090078|P3|COMPLETED|Overall Study||46
1673704|NCT00602290|4090079|P2|COMPLETED|Overall Study||46
1673705|NCT00602290|4090080|P1|COMPLETED|Overall Study||46
1673706|NCT00602290|4090078|P3|STARTED|Overall Study||47
1673707|NCT00602290|4090079|P2|STARTED|Overall Study||48
1673708|NCT00602290|4090080|P1|STARTED|Overall Study||48
1673709|NCT00602225|4090091|P1|NOT COMPLETED|Overall Study||0
1673710|NCT00602225|4090091|P1|COMPLETED|Overall Study||50
1673711|NCT00602225|4090091|P1|STARTED|Overall Study||50
1673712|NCT00602043|4090104|P1|NOT COMPLETED|Overall Study||5
1673713|NCT00602043|4090104|P1|COMPLETED|Overall Study||15
1673714|NCT00602043|4090104|P1|STARTED|Overall Study||20
1673715|NCT00601965|4090118|P4|NOT COMPLETED|Overall Study||1
1673716|NCT00601965|4090119|P3|NOT COMPLETED|Overall Study||0
1673717|NCT00601965|4090120|P2|NOT COMPLETED|Overall Study||2
1673718|NCT00601965|4090121|P1|NOT COMPLETED|Overall Study||0
1673719|NCT00601965|4090118|P4|COMPLETED|Overall Study||17
1673720|NCT00601965|4090119|P3|COMPLETED|Overall Study||19
1673721|NCT00601965|4090120|P2|COMPLETED|Overall Study||16
1673722|NCT00601965|4090121|P1|COMPLETED|Overall Study||18
1673723|NCT00601965|4090118|P4|STARTED|Overall Study||18
1673724|NCT00601965|4090119|P3|STARTED|Overall Study||19
1673725|NCT00601965|4090120|P2|STARTED|Overall Study||18
1673726|NCT00601965|4090121|P1|STARTED|Overall Study||18
1673727|NCT00601952|4090137|P2|NOT COMPLETED|Overall Study||0
1673728|NCT00601952|4090138|P1|NOT COMPLETED|Overall Study||2
1673729|NCT00601952|4090137|P2|COMPLETED|Overall Study||17
1673730|NCT00601952|4090138|P1|COMPLETED|Overall Study||12
1673731|NCT00601952|4090137|P2|STARTED|Overall Study||17
1673732|NCT00601952|4090138|P1|STARTED|Overall Study||14
1673733|NCT00601926|4090144|P1|NOT COMPLETED|Overall Study||0
1673734|NCT00601926|4090144|P1|COMPLETED|Overall Study||5
1673735|NCT00601926|4090144|P1|STARTED|Overall Study||5
1673736|NCT00601900|4090152|P2|NOT COMPLETED|Overall Study||3
1673737|NCT00601900|4090153|P1|NOT COMPLETED|Overall Study||0
1673738|NCT00601900|4090152|P2|COMPLETED|Overall Study||196
1673739|NCT00601900|4090153|P1|COMPLETED|Overall Study||195
1673740|NCT00601900|4090152|P2|STARTED|Overall Study||199
1673741|NCT00601900|4090153|P1|STARTED|Overall Study||195
1673742|NCT00601835|4090169|P2|NOT COMPLETED|Overall Study||14
1673743|NCT00601835|4090170|P1|NOT COMPLETED|Overall Study||60
1673744|NCT00601835|4090169|P2|COMPLETED|Overall Study||686
1673745|NCT00601835|4090170|P1|COMPLETED|Overall Study||2890
1673746|NCT00601835|4090169|P2|STARTED|Overall Study||700
1673747|NCT00601835|4090170|P1|STARTED|Overall Study||2950
1673748|NCT00601796|4090180|P1|NOT COMPLETED|Overall Study||0
1673749|NCT00601796|4090180|P1|COMPLETED|Overall Study||24
1673750|NCT00601796|4090180|P1|STARTED|Overall Study||24
1673751|NCT00601731|4090199|P4|NOT COMPLETED|Overall Study||1
1673752|NCT00601731|4090200|P3|NOT COMPLETED|Overall Study||15
1673753|NCT00601731|4090201|P2|NOT COMPLETED|Overall Study||0
1673754|NCT00601731|4090202|P1|NOT COMPLETED|Overall Study||23
1673755|NCT00601731|4090199|P4|COMPLETED|Overall Study||29
1673756|NCT00601731|4090200|P3|COMPLETED|Overall Study||151
1673757|NCT00601731|4090201|P2|COMPLETED|Overall Study||43
1673758|NCT00601731|4090202|P1|COMPLETED|Overall Study||120
1673759|NCT00601731|4090199|P4|STARTED|Overall Study||30
1673760|NCT00601731|4090200|P3|STARTED|Overall Study||166
1673761|NCT00601731|4090201|P2|STARTED|Overall Study||43
1673762|NCT00601731|4090202|P1|STARTED|Overall Study||143
1673763|NCT00601718|4090252|P1|NOT COMPLETED|Overall Study||0
1673764|NCT00601718|4090252|P1|COMPLETED|Overall Study||29
1673765|NCT00601718|4090252|P1|STARTED|Overall Study||29
1673766|NCT00601640|4090262|P3|NOT COMPLETED|Overall Study||10
1673767|NCT00601640|4090263|P2|NOT COMPLETED|Overall Study||5
1673768|NCT00601640|4090264|P1|NOT COMPLETED|Overall Study||5
1673769|NCT00601640|4090262|P3|COMPLETED|Overall Study||42
1673770|NCT00601640|4090263|P2|COMPLETED|Overall Study||47
1673771|NCT00601640|4090264|P1|COMPLETED|Overall Study||47
1673772|NCT00601640|4090262|P3|STARTED|Overall Study||52
1673773|NCT00601640|4090263|P2|STARTED|Overall Study||52
1673774|NCT00601640|4090264|P1|STARTED|Overall Study||52
1673775|NCT00601627|4090278|P1|NOT COMPLETED|Overall Study||0
1673776|NCT00601627|4090278|P1|COMPLETED|Overall Study||51
1673777|NCT00601627|4090278|P1|STARTED|Overall Study||51
1673778|NCT00601523|4090289|P2|NOT COMPLETED|Overall Study||26
1673779|NCT00601523|4090290|P1|NOT COMPLETED|Overall Study||77
1673780|NCT00601523|4090289|P2|COMPLETED|Overall Study||117
1673781|NCT00601523|4090290|P1|COMPLETED|Overall Study||291
1673782|NCT00601523|4090289|P2|STARTED|Overall Study||143
1673783|NCT00601523|4090290|P1|STARTED|Overall Study||368
1673784|NCT00601458|4090325|P3|NOT COMPLETED|Overall Study||2
1673785|NCT00601458|4090326|P2|NOT COMPLETED|Overall Study||5
1673786|NCT00601458|4090327|P1|NOT COMPLETED|Overall Study||4
1673787|NCT00601458|4090325|P3|COMPLETED|Overall Study||28
1673788|NCT00601458|4090326|P2|COMPLETED|Overall Study||29
1673789|NCT00601458|4090327|P1|COMPLETED|Overall Study||32
1673790|NCT00601458|4090325|P3|STARTED|Overall Study||30
1673791|NCT00601458|4090326|P2|STARTED|Overall Study||34
1673792|NCT00601458|4090327|P1|STARTED|Overall Study||36
1673793|NCT00601419|4090338|P1|NOT COMPLETED|Overall Study||4
1673794|NCT00601419|4090338|P1|COMPLETED|Overall Study||226
1673795|NCT00601419|4090338|P1|STARTED|Overall Study||230
1673796|NCT00601367|4090362|P1|NOT COMPLETED|Overall Study||187
1673797|NCT00601367|4090362|P1|COMPLETED|Overall Study||293
1673798|NCT00601367|4090362|P1|STARTED|Overall Study||480
1673799|NCT00601354|4090368|P2|NOT COMPLETED|Overall Study||5
1673800|NCT00601354|4090369|P1|NOT COMPLETED|Overall Study||4
1673801|NCT00601354|4090368|P2|COMPLETED|Overall Study||4
1673802|NCT00601354|4090369|P1|COMPLETED|Overall Study||4
1673803|NCT00601354|4090368|P2|STARTED|Overall Study||9
1673804|NCT00601354|4090369|P1|STARTED|Overall Study||8
1673805|NCT00601250|4090381|P2|NOT COMPLETED|Overall Study||39
1673806|NCT00601250|4090382|P1|NOT COMPLETED|Overall Study||14
1673807|NCT00601250|4090381|P2|COMPLETED|Overall Study|number who completed treatment|484
1673808|NCT00601250|4090382|P1|COMPLETED|Overall Study|number who completed treatment|163
1673809|NCT00601250|4090381|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
1673810|NCT00601250|4090382|P1|STARTED|Overall Study|number who started treatment|177
1673811|NCT00601172|4090418|P2|NOT COMPLETED|Overall Study||127
1673812|NCT00601172|4090419|P1|NOT COMPLETED|Overall Study||141
1673813|NCT00601172|4090418|P2|COMPLETED|Overall Study||228
1673814|NCT00601172|4090419|P1|COMPLETED|Overall Study||214
1673815|NCT00601172|4090418|P2|STARTED|Overall Study||355
1673816|NCT00601172|4090419|P1|STARTED|Overall Study||355
1673817|NCT00601146|4090468|P1|NOT COMPLETED|Overall Study||161
1673818|NCT00601146|4090468|P1|COMPLETED|Overall Study||39
1673819|NCT00601146|4090468|P1|STARTED|Overall Study||200
1673820|NCT00601107|4090476|P4|NOT COMPLETED|Overall Study||12
1673821|NCT00601107|4090477|P3|NOT COMPLETED|Overall Study||12
1673822|NCT00601107|4090478|P2|NOT COMPLETED|Overall Study||9
1673823|NCT00601107|4090479|P1|NOT COMPLETED|Overall Study||13
1673824|NCT00601107|4090476|P4|COMPLETED|Overall Study||13
1673825|NCT00601107|4090477|P3|COMPLETED|Overall Study||16
1673826|NCT00601107|4090478|P2|COMPLETED|Overall Study||22
1673827|NCT00601107|4090479|P1|COMPLETED|Overall Study||14
1673828|NCT00601107|4090476|P4|Treated|Overall Study||25
1673829|NCT00601107|4090477|P3|Treated|Overall Study||28
1673830|NCT00601107|4090478|P2|Treated|Overall Study||31
1673831|NCT00601107|4090479|P1|Treated|Overall Study||27
1673832|NCT00601107|4090476|P4|STARTED|Overall Study||25
1673833|NCT00601107|4090477|P3|STARTED|Overall Study||28
1673834|NCT00601107|4090478|P2|STARTED|Overall Study||31
1673835|NCT00601107|4090479|P1|STARTED|Overall Study|Randomized.|27
1673836|NCT00600938|4090499|P4|NOT COMPLETED|Extension Study||1
1673837|NCT00600938|4090500|P3|NOT COMPLETED|Extension Study||9
1673838|NCT00600938|4090501|P2|NOT COMPLETED|Extension Study||5
1673839|NCT00600938|4090502|P1|NOT COMPLETED|Extension Study||9
1673840|NCT00600938|4090499|P4|COMPLETED|Extension Study||0
1673841|NCT00600938|4090500|P3|COMPLETED|Extension Study||33
1673842|NCT00600938|4090501|P2|COMPLETED|Extension Study||24
1673843|NCT00600938|4090502|P1|COMPLETED|Extension Study||65
1673844|NCT00600938|4090499|P4|Extension Safety Set|Extension Study||1
1673845|NCT00600938|4090500|P3|Extension Safety Set|Extension Study||42
1673846|NCT00600938|4090501|P2|Extension Safety Set|Extension Study||29
1673847|NCT00600938|4090502|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
1673848|NCT00600938|4090499|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
1673849|NCT00600938|4090500|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
1673850|NCT00600938|4090501|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
1673851|NCT00600938|4090502|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
1673852|NCT00600938|4090499|P4|NOT COMPLETED|Core Study||0
1673853|NCT00600938|4090500|P3|NOT COMPLETED|Core Study||0
1673854|NCT00600938|4090501|P2|NOT COMPLETED|Core Study||21
1673855|NCT00600938|4090502|P1|NOT COMPLETED|Core Study||16
1673856|NCT00600938|4090499|P4|COMPLETED|Core Study||0
1673857|NCT00600938|4090500|P3|COMPLETED|Core Study||0
1673858|NCT00600938|4090501|P2|COMPLETED|Core Study||78
1673859|NCT00600938|4090502|P1|COMPLETED|Core Study||82
1673860|NCT00600938|4090499|P4|Per Protocol Set (PPS)|Core Study||0
1673861|NCT00600938|4090500|P3|Per Protocol Set (PPS)|Core Study||0
1673862|NCT00600938|4090501|P2|Per Protocol Set (PPS)|Core Study||81
1673863|NCT00600938|4090502|P1|Per Protocol Set (PPS)|Core Study||91
1673864|NCT00600938|4090499|P4|Core Safety Set|Core Study||0
1673865|NCT00600938|4090500|P3|Core Safety Set|Core Study||0
1673866|NCT00600938|4090501|P2|Core Safety Set|Core Study||91
1673867|NCT00600938|4090502|P1|Core Safety Set|Core Study||96
1673868|NCT00600938|4090499|P4|STARTED|Core Study||0
1673869|NCT00600938|4090500|P3|STARTED|Core Study||0
1673870|NCT00600938|4090501|P2|STARTED|Core Study||99
1673871|NCT00600938|4090502|P1|STARTED|Core Study||98
1673872|NCT00600886|4090566|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
1673873|NCT00600886|4090567|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
1673874|NCT00600886|4090566|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
1673875|NCT00600886|4090567|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
1673876|NCT00600886|4090566|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
1673877|NCT00600886|4090567|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
1673878|NCT00600886|4090566|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
1673879|NCT00600886|4090567|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
1673880|NCT00600886|4090566|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
1673881|NCT00600886|4090567|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
1673882|NCT00600886|4090566|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
1673883|NCT00600886|4090567|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
1673884|NCT00600886|4090566|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
1673885|NCT00600886|4090567|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
1673886|NCT00600886|4090566|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
1673887|NCT00600886|4090567|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
1673888|NCT00600886|4090566|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
1673889|NCT00600886|4090567|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
1673890|NCT00600886|4090566|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
1673891|NCT00600886|4090567|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
1673892|NCT00600886|4090566|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
1673893|NCT00600886|4090567|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
1673894|NCT00600886|4090566|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
1673895|NCT00600886|4090567|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
1673896|NCT00600886|4090566|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
1673897|NCT00600886|4090567|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
1673898|NCT00600886|4090566|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
1673899|NCT00600886|4090567|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
1673900|NCT00600886|4090566|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
1673901|NCT00600886|4090567|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
1673902|NCT00600886|4090566|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
1673903|NCT00600886|4090567|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
1673904|NCT00600886|4090566|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
1673905|NCT00600886|4090567|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
1673906|NCT00600886|4090566|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
1673907|NCT00600886|4090567|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
1673908|NCT00600886|4090566|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
1673909|NCT00600886|4090567|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
1673910|NCT00600886|4090566|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
1673911|NCT00600886|4090567|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
1673912|NCT00600821|4090631|P2|NOT COMPLETED|Overall Study||60
1673913|NCT00600821|4090632|P1|NOT COMPLETED|Overall Study||58
1673914|NCT00600821|4090631|P2|COMPLETED|Overall Study||0
1673915|NCT00600821|4090632|P1|COMPLETED|Overall Study||0
1673916|NCT00600821|4090631|P2|Treated|Overall Study||59
1673917|NCT00600821|4090632|P1|Treated|Overall Study||58
1673918|NCT00600821|4090631|P2|STARTED|Overall Study||60
1673919|NCT00600821|4090632|P1|STARTED|Overall Study||58
1673920|NCT00600756|4090660|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
1673921|NCT00600756|4090661|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
1673922|NCT00600756|4090660|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
1673923|NCT00600756|4090661|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
1673924|NCT00600756|4090660|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
1673925|NCT00600756|4090661|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
1673926|NCT00600756|4090660|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
1673927|NCT00600756|4090661|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
1673928|NCT00600756|4090660|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
1673929|NCT00600756|4090661|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
1673930|NCT00600756|4090660|P2|STARTED|Overall Study Analysis After 12 Months||403
1673931|NCT00600756|4090661|P1|STARTED|Overall Study Analysis After 12 Months||395
1673932|NCT00600756|4090660|P2|NOT COMPLETED|Analysis After 6 Months||120
1673933|NCT00600756|4090661|P1|NOT COMPLETED|Analysis After 6 Months||131
1673934|NCT00600756|4090660|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
1673935|NCT00600756|4090661|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
1673936|NCT00600756|4090660|P2|STARTED|Analysis After 6 Months||403
1673937|NCT00600756|4090661|P1|STARTED|Analysis After 6 Months||395
1673938|NCT00600743|4090731|P4|NOT COMPLETED|Overall Study||0
1673939|NCT00600743|4090732|P3|NOT COMPLETED|Overall Study||0
1673940|NCT00600743|4090733|P2|NOT COMPLETED|Overall Study||0
1673941|NCT00600743|4090734|P1|NOT COMPLETED|Overall Study||0
1673942|NCT00600743|4090731|P4|COMPLETED|Overall Study||7
1673943|NCT00600743|4090732|P3|COMPLETED|Overall Study||8
1673944|NCT00600743|4090733|P2|COMPLETED|Overall Study||4
1673945|NCT00600743|4090734|P1|COMPLETED|Overall Study||4
1673946|NCT00600743|4090731|P4|STARTED|Overall Study||7
1673947|NCT00600743|4090732|P3|STARTED|Overall Study||8
1673948|NCT00600743|4090733|P2|STARTED|Overall Study||4
1673949|NCT00600743|4090734|P1|STARTED|Overall Study||4
1673950|NCT00600704|4090763|P2|NOT COMPLETED|Overall Study||0
1673951|NCT00600704|4090764|P1|NOT COMPLETED|Overall Study||0
1673952|NCT00600704|4090763|P2|COMPLETED|Overall Study||92
1673953|NCT00600704|4090764|P1|COMPLETED|Overall Study||100
1673954|NCT00600704|4090763|P2|STARTED|Overall Study||92
1673955|NCT00600704|4090764|P1|STARTED|Overall Study||100
1673956|NCT00600613|4090770|P1|NOT COMPLETED|Overall Study||1
1673957|NCT00600613|4090770|P1|COMPLETED|Overall Study||5
1673958|NCT00600613|4090770|P1|STARTED|Overall Study||6
1673959|NCT00600353|4090776|P2|NOT COMPLETED|Overall Study||1
1673960|NCT00600353|4090777|P1|NOT COMPLETED|Overall Study||1
1673961|NCT00600353|4090776|P2|COMPLETED|Overall Study||9
1673962|NCT00600353|4090777|P1|COMPLETED|Overall Study||9
1673963|NCT00600353|4090776|P2|STARTED|Overall Study||10
1673964|NCT00600353|4090777|P1|STARTED|Overall Study||10
1673965|NCT00600171|4090795|P6|NOT COMPLETED|Overall Study||5
1673966|NCT00600171|4090796|P5|NOT COMPLETED|Overall Study||8
1673967|NCT00600171|4090797|P4|NOT COMPLETED|Overall Study||12
1673968|NCT00600171|4090798|P3|NOT COMPLETED|Overall Study||10
1673969|NCT00600171|4090799|P2|NOT COMPLETED|Overall Study||17
1673970|NCT00600171|4090800|P1|NOT COMPLETED|Overall Study||16
1673971|NCT00600171|4090795|P6|COMPLETED|Overall Study||97
1673972|NCT00600171|4090796|P5|COMPLETED|Overall Study||93
1673973|NCT00600171|4090797|P4|COMPLETED|Overall Study||88
1673974|NCT00600171|4090798|P3|COMPLETED|Overall Study||91
1673975|NCT00600171|4090799|P2|COMPLETED|Overall Study||84
1673976|NCT00600171|4090800|P1|COMPLETED|Overall Study||86
1673977|NCT00600171|4090795|P6|STARTED|Overall Study||102
1673978|NCT00600171|4090796|P5|STARTED|Overall Study||101
1673979|NCT00600171|4090797|P4|STARTED|Overall Study||100
1673980|NCT00600171|4090798|P3|STARTED|Overall Study||101
1673981|NCT00600171|4090799|P2|STARTED|Overall Study||101
1673982|NCT00600171|4090800|P1|STARTED|Overall Study||102
1673983|NCT00600119|4090874|P6|NOT COMPLETED|Follow-up Period||1
1673984|NCT00600119|4090875|P5|NOT COMPLETED|Follow-up Period||0
1673985|NCT00600119|4090876|P4|NOT COMPLETED|Follow-up Period||0
1673986|NCT00600119|4090877|P3|NOT COMPLETED|Follow-up Period||0
1673987|NCT00600119|4090878|P2|NOT COMPLETED|Follow-up Period||0
1673988|NCT00600119|4090879|P1|NOT COMPLETED|Follow-up Period||1
1673989|NCT00600119|4090874|P6|COMPLETED|Follow-up Period||20
1673990|NCT00600119|4090875|P5|COMPLETED|Follow-up Period||31
1673991|NCT00600119|4090876|P4|COMPLETED|Follow-up Period||28
1673992|NCT00600119|4090877|P3|COMPLETED|Follow-up Period||27
1673993|NCT00600119|4090878|P2|COMPLETED|Follow-up Period||28
1673994|NCT00600119|4090879|P1|COMPLETED|Follow-up Period||26
1673995|NCT00600119|4090874|P6|STARTED|Follow-up Period||21
1673996|NCT00600119|4090875|P5|STARTED|Follow-up Period||31
1673997|NCT00600119|4090876|P4|STARTED|Follow-up Period||28
1673998|NCT00600119|4090877|P3|STARTED|Follow-up Period||27
1673999|NCT00600119|4090878|P2|STARTED|Follow-up Period||28
1674000|NCT00600119|4090879|P1|STARTED|Follow-up Period||27
1674001|NCT00600119|4090874|P6|NOT COMPLETED|Double-blind Treatment Period||14
1674002|NCT00600119|4090875|P5|NOT COMPLETED|Double-blind Treatment Period||6
1674003|NCT00600119|4090876|P4|NOT COMPLETED|Double-blind Treatment Period||2
1674004|NCT00600119|4090877|P3|NOT COMPLETED|Double-blind Treatment Period||0
1674005|NCT00600119|4090878|P2|NOT COMPLETED|Double-blind Treatment Period||5
1674006|NCT00600119|4090879|P1|NOT COMPLETED|Double-blind Treatment Period||5
1674007|NCT00600119|4090874|P6|COMPLETED|Double-blind Treatment Period||21
1674008|NCT00600119|4090875|P5|COMPLETED|Double-blind Treatment Period||31
1674009|NCT00600119|4090876|P4|COMPLETED|Double-blind Treatment Period||28
1674010|NCT00600119|4090877|P3|COMPLETED|Double-blind Treatment Period||27
1674011|NCT00600119|4090878|P2|COMPLETED|Double-blind Treatment Period||28
1674012|NCT00600119|4090879|P1|COMPLETED|Double-blind Treatment Period||27
1674013|NCT00600119|4090874|P6|STARTED|Double-blind Treatment Period||35
1674014|NCT00600119|4090875|P5|STARTED|Double-blind Treatment Period||37
1674015|NCT00600119|4090876|P4|STARTED|Double-blind Treatment Period||30
1674016|NCT00600119|4090877|P3|STARTED|Double-blind Treatment Period||27
1674017|NCT00600119|4090878|P2|STARTED|Double-blind Treatment Period||33
1674018|NCT00600119|4090879|P1|STARTED|Double-blind Treatment Period||32
1674019|NCT00600119|4090874|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
1674020|NCT00600119|4090875|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
1674021|NCT00600119|4090876|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
1674022|NCT00600119|4090877|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
1674023|NCT00600119|4090878|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
1674024|NCT00600119|4090879|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
1674025|NCT00600119|4090874|P6|COMPLETED|Single-blind Placebo run-in Period||35
1674026|NCT00600119|4090875|P5|COMPLETED|Single-blind Placebo run-in Period||37
1674027|NCT00600119|4090876|P4|COMPLETED|Single-blind Placebo run-in Period||30
1674028|NCT00600119|4090877|P3|COMPLETED|Single-blind Placebo run-in Period||27
1674029|NCT00600119|4090878|P2|COMPLETED|Single-blind Placebo run-in Period||33
1674030|NCT00600119|4090879|P1|COMPLETED|Single-blind Placebo run-in Period||32
1674031|NCT00600119|4090874|P6|STARTED|Single-blind Placebo run-in Period||37
1674032|NCT00600119|4090875|P5|STARTED|Single-blind Placebo run-in Period||39
1674033|NCT00600119|4090876|P4|STARTED|Single-blind Placebo run-in Period||31
1674034|NCT00600119|4090877|P3|STARTED|Single-blind Placebo run-in Period||29
1674035|NCT00600119|4090878|P2|STARTED|Single-blind Placebo run-in Period||35
1674036|NCT00600119|4090879|P1|STARTED|Single-blind Placebo run-in Period||36
1674037|NCT00600106|4090913|P2|NOT COMPLETED|Overall Study||1
1674038|NCT00600106|4090914|P1|NOT COMPLETED|Overall Study||1
1674039|NCT00600106|4090913|P2|COMPLETED|Overall Study||18
1674040|NCT00600106|4090914|P1|COMPLETED|Overall Study||17
1674041|NCT00600106|4090913|P2|STARTED|Overall Study||19
1674042|NCT00600106|4090914|P1|STARTED|Overall Study||18
1674043|NCT00600080|4090946|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
1674044|NCT00600080|4090947|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
1674045|NCT00600080|4090946|P2|COMPLETED|Period 2: One-week to Two-weeks||32
1674046|NCT00600080|4090947|P1|COMPLETED|Period 2: One-week to Two-weeks||28
1674047|NCT00600080|4090946|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
1674048|NCT00600080|4090947|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
1674049|NCT00600080|4090946|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
1674050|NCT00600080|4090947|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
1674051|NCT00600080|4090946|P2|COMPLETED|Period 1: Baseline to One-week||32
1674052|NCT00600080|4090947|P1|COMPLETED|Period 1: Baseline to One-week||28
1674053|NCT00600080|4090946|P2|STARTED|Period 1: Baseline to One-week||32
1674054|NCT00600080|4090947|P1|STARTED|Period 1: Baseline to One-week||28
1674055|NCT00600067|4090961|P2|NOT COMPLETED|Overall Study||7
1674056|NCT00600067|4090962|P1|NOT COMPLETED|Overall Study||3
1674057|NCT00600067|4090961|P2|COMPLETED|Overall Study||68
1674058|NCT00600067|4090962|P1|COMPLETED|Overall Study||52
1674059|NCT00600067|4090961|P2|STARTED|Overall Study||75
1674060|NCT00600067|4090962|P1|STARTED|Overall Study||55
1674061|NCT00600028|4090972|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
1674062|NCT00600028|4090973|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
1674063|NCT00600028|4090972|P2|COMPLETED|Second Intervention (12 Weeks)||8
1674064|NCT00600028|4090973|P1|COMPLETED|Second Intervention (12 Weeks)||12
1674065|NCT00600028|4090972|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
1674066|NCT00600028|4090973|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
1674067|NCT00600028|4090972|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
1674068|NCT00600028|4090973|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
1674069|NCT00600028|4090972|P2|COMPLETED|First Intervention (12 Weeks)||10
1674070|NCT00600028|4090973|P1|COMPLETED|First Intervention (12 Weeks)||12
1674071|NCT00600028|4090972|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
1674072|NCT00600028|4090973|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
1674073|NCT00600015|4090987|P2|NOT COMPLETED|Overall Study||35
1674074|NCT00600015|4090988|P1|NOT COMPLETED|Overall Study||60
1674075|NCT00600015|4090987|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
1674076|NCT00600015|4090988|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
1674077|NCT00600015|4090987|P2|STARTED|Overall Study||55
1674078|NCT00600015|4090988|P1|STARTED|Overall Study||111
1674079|NCT00599924|4091003|P7|NOT COMPLETED|Overall Study||5
1674080|NCT00599924|4091004|P6|NOT COMPLETED|Overall Study||4
1674081|NCT00599924|4091005|P5|NOT COMPLETED|Overall Study||6
1674082|NCT00599924|4091006|P4|NOT COMPLETED|Overall Study||8
1674083|NCT00599924|4091007|P3|NOT COMPLETED|Overall Study||2
1674084|NCT00599924|4091008|P2|NOT COMPLETED|Overall Study||5
1674085|NCT00599924|4091009|P1|NOT COMPLETED|Overall Study||3
1674086|NCT00599924|4091003|P7|COMPLETED|Overall Study||3
1674087|NCT00599924|4091004|P6|COMPLETED|Overall Study||2
1674088|NCT00599924|4091005|P5|COMPLETED|Overall Study||3
1674089|NCT00599924|4091006|P4|COMPLETED|Overall Study||4
1674090|NCT00599924|4091007|P3|COMPLETED|Overall Study||3
1674091|NCT00599924|4091008|P2|COMPLETED|Overall Study||4
1674092|NCT00599924|4091009|P1|COMPLETED|Overall Study||1
1674093|NCT00599924|4091003|P7|STARTED|Overall Study||8
1674094|NCT00599924|4091004|P6|STARTED|Overall Study||6
1674095|NCT00599924|4091005|P5|STARTED|Overall Study||9
1674096|NCT00599924|4091006|P4|STARTED|Overall Study||12
1674097|NCT00599924|4091007|P3|STARTED|Overall Study||5
1674098|NCT00599924|4091008|P2|STARTED|Overall Study||9
1674099|NCT00599924|4091009|P1|STARTED|Overall Study||4
1674100|NCT00599872|4091096|P2|NOT COMPLETED|Overall Study||33
1674101|NCT00599872|4091097|P1|NOT COMPLETED|Overall Study||49
1674102|NCT00599872|4091096|P2|COMPLETED|Overall Study||181
1674103|NCT00599872|4091097|P1|COMPLETED|Overall Study||167
1674104|NCT00599872|4091096|P2|STARTED|Overall Study||214
1674105|NCT00599872|4091097|P1|STARTED|Overall Study||216
1674106|NCT00599755|4091113|P1|NOT COMPLETED|Overall Study||19
1674107|NCT00599755|4091113|P1|COMPLETED|Overall Study||49
1674108|NCT00599755|4091113|P1|STARTED|Overall Study||68
1674109|NCT00599521|4091124|P2|NOT COMPLETED|Overall Study||69
1674110|NCT00599521|4091125|P1|NOT COMPLETED|Overall Study||60
1674111|NCT00599521|4091124|P2|COMPLETED|Overall Study||462
1674112|NCT00599521|4091125|P1|COMPLETED|Overall Study||475
1674113|NCT00599521|4091124|P2|STARTED|Overall Study||531
1674114|NCT00599521|4091125|P1|STARTED|Overall Study||535
1674115|NCT00599339|4091139|P1|NOT COMPLETED|Overall Study||664
1674116|NCT00599339|4091139|P1|COMPLETED|Overall Study||1531
1674117|NCT00599339|4091139|P1|Safety Set|Overall Study||2179
1674118|NCT00599339|4091139|P1|STARTED|Overall Study||2195
1674119|NCT00599326|4091241|P1|NOT COMPLETED|Overall Study||2
1674120|NCT00599326|4091241|P1|COMPLETED|Overall Study||8
1674121|NCT00599326|4091241|P1|STARTED|Overall Study||10
1674122|NCT00599313|4091246|P1|NOT COMPLETED|Overall Study||36
1674123|NCT00599313|4091246|P1|COMPLETED|Overall Study||0
1674124|NCT00599313|4091246|P1|STARTED|Overall Study||36
1674125|NCT00599248|4091257|P4|NOT COMPLETED|Overall Study||0
1674126|NCT00599248|4091258|P3|NOT COMPLETED|Overall Study||0
1674127|NCT00599248|4091259|P2|NOT COMPLETED|Overall Study||0
1674128|NCT00599248|4091260|P1|NOT COMPLETED|Overall Study||0
1674129|NCT00599248|4091257|P4|COMPLETED|Overall Study||3
1674130|NCT00599248|4091258|P3|COMPLETED|Overall Study||3
1674131|NCT00599248|4091259|P2|COMPLETED|Overall Study||3
1674132|NCT00599248|4091260|P1|COMPLETED|Overall Study||3
1674133|NCT00599248|4091257|P4|STARTED|Overall Study||3
1674134|NCT00599248|4091258|P3|STARTED|Overall Study||3
1674135|NCT00599248|4091259|P2|STARTED|Overall Study||3
1674136|NCT00599248|4091260|P1|STARTED|Overall Study||3
1674137|NCT00599196|4091288|P1|NOT COMPLETED|Overall Study||381
1674138|NCT00599196|4091288|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
1674139|NCT00599196|4091288|P1|STARTED|Overall Study||381
1674140|NCT00599131|4091294|P1|NOT COMPLETED|Overall Study||0
1674141|NCT00599131|4091294|P1|COMPLETED|Overall Study||4
1674142|NCT00599131|4091294|P1|STARTED|Overall Study||4
1674143|NCT00599053|4091304|P2|NOT COMPLETED|Overall Study||0
1674144|NCT00599053|4091305|P1|NOT COMPLETED|Overall Study||0
1674145|NCT00599053|4091304|P2|COMPLETED|Overall Study||2
1674146|NCT00599053|4091305|P1|COMPLETED|Overall Study||5
1674147|NCT00599053|4091304|P2|STARTED|Overall Study||2
1674148|NCT00599053|4091305|P1|STARTED|Overall Study||5
1674149|NCT00599027|4091319|P2|NOT COMPLETED|Overall Study||3
1674150|NCT00599027|4091320|P1|NOT COMPLETED|Overall Study||1
1674151|NCT00599027|4091319|P2|COMPLETED|Overall Study||22
1674152|NCT00599027|4091320|P1|COMPLETED|Overall Study||25
1674153|NCT00599027|4091319|P2|STARTED|Overall Study||25
1674154|NCT00599027|4091320|P1|STARTED|Overall Study||26
1674155|NCT00599014|4091326|P1|NOT COMPLETED|Overall Study||0
1674156|NCT00599014|4091326|P1|COMPLETED|Overall Study||335
1674157|NCT00599014|4091326|P1|STARTED|Overall Study||335
1674158|NCT00598871|4091333|P2|NOT COMPLETED|Overall Study||1
1674159|NCT00598871|4091334|P1|NOT COMPLETED|Overall Study||0
1674160|NCT00598871|4091333|P2|COMPLETED|Overall Study||8
1674161|NCT00598871|4091334|P1|COMPLETED|Overall Study||3
1674162|NCT00598871|4091333|P2|STARTED|Overall Study||9
1674163|NCT00598871|4091334|P1|STARTED|Overall Study||3
1674164|NCT00598832|4091344|P2|NOT COMPLETED|Overall Study||82
1674165|NCT00598832|4091345|P1|NOT COMPLETED|Overall Study||62
1674166|NCT00598832|4091344|P2|COMPLETED|Overall Study||460
1674167|NCT00598832|4091345|P1|COMPLETED|Overall Study||471
1674168|NCT00598832|4091344|P2|STARTED|Overall Study||542
1674169|NCT00598832|4091345|P1|STARTED|Overall Study||533
1674170|NCT00598819|4091359|P1|NOT COMPLETED|Overall Study||0
1674171|NCT00598819|4091359|P1|COMPLETED|Overall Study||14
1674172|NCT00598819|4091359|P1|STARTED|Overall Study||14
1674173|NCT00598806|4091369|P2|NOT COMPLETED|Overall Study||64
1674174|NCT00598806|4091370|P1|NOT COMPLETED|Overall Study||73
1674175|NCT00598806|4091369|P2|COMPLETED|Overall Study||346
1674176|NCT00598806|4091370|P1|COMPLETED|Overall Study||329
1674177|NCT00598806|4091369|P2|STARTED|Overall Study||410
1674178|NCT00598806|4091370|P1|STARTED|Overall Study||402
1674179|NCT00598702|4091398|P8|NOT COMPLETED|Overall Study||0
1674180|NCT00598702|4091399|P7|NOT COMPLETED|Overall Study||1
1674181|NCT00598702|4091400|P6|NOT COMPLETED|Overall Study||12
1674182|NCT00598702|4091401|P5|NOT COMPLETED|Overall Study||3
1674183|NCT00598702|4091402|P4|NOT COMPLETED|Overall Study||8
1674184|NCT00598702|4091403|P3|NOT COMPLETED|Overall Study||2
1674185|NCT00598702|4091404|P2|NOT COMPLETED|Overall Study||2
1674186|NCT00598702|4091405|P1|NOT COMPLETED|Overall Study||0
1674187|NCT00598702|4091398|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
1674188|NCT00598702|4091399|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
1674189|NCT00598702|4091400|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
1674190|NCT00598702|4091401|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
1674191|NCT00598702|4091402|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
1674192|NCT00598702|4091403|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
1674193|NCT00598702|4091404|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
1674194|NCT00598702|4091405|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
1674195|NCT00598702|4091398|P8|STARTED|Overall Study||4
1674196|NCT00598702|4091399|P7|STARTED|Overall Study||1
1674197|NCT00598702|4091400|P6|STARTED|Overall Study||42
1674198|NCT00598702|4091401|P5|STARTED|Overall Study||9
1674199|NCT00598702|4091402|P4|STARTED|Overall Study||33
1674200|NCT00598702|4091403|P3|STARTED|Overall Study||7
1674201|NCT00598702|4091404|P2|STARTED|Overall Study||3
1674202|NCT00598702|4091405|P1|STARTED|Overall Study||1
1674203|NCT00598689|4091449|P2|NOT COMPLETED|Overall Study||0
1674204|NCT00598689|4091450|P1|NOT COMPLETED|Overall Study||0
1674205|NCT00598689|4091449|P2|COMPLETED|Overall Study||40
1674206|NCT00598689|4091450|P1|COMPLETED|Overall Study||40
1674207|NCT00598689|4091449|P2|STARTED|Overall Study||40
1674208|NCT00598689|4091450|P1|STARTED|Overall Study||40
1674209|NCT00598650|4091460|P1|NOT COMPLETED|Overall Study||27
1674210|NCT00598650|4091460|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
1674211|NCT00598650|4091460|P1|STARTED|Overall Study||108
1674212|NCT00598585|4091469|P2|NOT COMPLETED|Overall Study||0
1674213|NCT00598585|4091470|P1|NOT COMPLETED|Overall Study||1
1674214|NCT00598585|4091469|P2|COMPLETED|Overall Study||6
1674215|NCT00598585|4091470|P1|COMPLETED|Overall Study||5
1674216|NCT00598585|4091469|P2|STARTED|Overall Study||6
1674217|NCT00598585|4091470|P1|STARTED|Overall Study||6
1674218|NCT00598559|4091479|P3|NOT COMPLETED|Overall Study||3
1674219|NCT00598559|4091480|P2|NOT COMPLETED|Overall Study||28
1674220|NCT00598559|4091481|P1|NOT COMPLETED|Overall Study||27
1674221|NCT00598559|4091479|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
1674222|NCT00598559|4091480|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
1674223|NCT00598559|4091481|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
1674224|NCT00598559|4091479|P3|STARTED|Overall Study||30
1674225|NCT00598559|4091480|P2|STARTED|Overall Study||91
1674226|NCT00598559|4091481|P1|STARTED|Overall Study||92
1674227|NCT00598507|4091498|P1|NOT COMPLETED|Overall Study||0
1674228|NCT00598507|4091498|P1|COMPLETED|Overall Study||35
1674229|NCT00598507|4091498|P1|STARTED|Overall Study||35
1674230|NCT00598442|4091508|P3|NOT COMPLETED|Overall Study||24
1674231|NCT00598442|4091509|P2|NOT COMPLETED|Overall Study||39
1674232|NCT00598442|4091510|P1|NOT COMPLETED|Overall Study||43
1674233|NCT00598442|4091508|P3|COMPLETED|Overall Study||139
1674234|NCT00598442|4091509|P2|COMPLETED|Overall Study||124
1674235|NCT00598442|4091510|P1|COMPLETED|Overall Study||124
1674236|NCT00598442|4091508|P3|STARTED|Overall Study||163
1674237|NCT00598442|4091509|P2|STARTED|Overall Study||163
1674238|NCT00598442|4091510|P1|STARTED|Overall Study||167
1674239|NCT00598273|4091527|P3|NOT COMPLETED|Overall Study||39
1674240|NCT00598273|4091528|P2|NOT COMPLETED|Overall Study||38
1674241|NCT00598273|4091529|P1|NOT COMPLETED|Overall Study||41
1674242|NCT00598273|4091527|P3|COMPLETED|Overall Study||125
1674243|NCT00598273|4091528|P2|COMPLETED|Overall Study||127
1674244|NCT00598273|4091529|P1|COMPLETED|Overall Study||120
1674245|NCT00598273|4091527|P3|STARTED|Overall Study||164
1674246|NCT00598273|4091528|P2|STARTED|Overall Study||165
1674247|NCT00598273|4091529|P1|STARTED|Overall Study||161
1674248|NCT00598078|4091543|P2|NOT COMPLETED|Period 3 (Day 3)||0
1674249|NCT00598078|4091544|P1|NOT COMPLETED|Period 3 (Day 3)||0
1674250|NCT00598078|4091543|P2|COMPLETED|Period 3 (Day 3)||10
1674251|NCT00598078|4091544|P1|COMPLETED|Period 3 (Day 3)||9
1674252|NCT00598078|4091543|P2|STARTED|Period 3 (Day 3)||10
1674253|NCT00598078|4091544|P1|STARTED|Period 3 (Day 3)||9
1674254|NCT00598078|4091543|P2|NOT COMPLETED|Period 2 (Day 2)||0
1674255|NCT00598078|4091544|P1|NOT COMPLETED|Period 2 (Day 2)||1
1674256|NCT00598078|4091543|P2|COMPLETED|Period 2 (Day 2)||10
1674257|NCT00598078|4091544|P1|COMPLETED|Period 2 (Day 2)||9
1674258|NCT00598078|4091543|P2|STARTED|Period 2 (Day 2)||10
1674259|NCT00598078|4091544|P1|STARTED|Period 2 (Day 2)||10
1674260|NCT00598078|4091543|P2|NOT COMPLETED|Period 1 (Day 1)||0
1674261|NCT00598078|4091544|P1|NOT COMPLETED|Period 1 (Day 1)||0
1674262|NCT00598078|4091543|P2|COMPLETED|Period 1 (Day 1)||10
1674263|NCT00598078|4091544|P1|COMPLETED|Period 1 (Day 1)||10
1674264|NCT00598078|4091543|P2|STARTED|Period 1 (Day 1)||10
1674265|NCT00598078|4091544|P1|STARTED|Period 1 (Day 1)||10
1674266|NCT00597909|4091555|P3|NOT COMPLETED|Overall Study||0
1674267|NCT00597909|4091556|P2|NOT COMPLETED|Overall Study||0
1674268|NCT00597909|4091557|P1|NOT COMPLETED|Overall Study||0
1674269|NCT00597909|4091555|P3|COMPLETED|Overall Study||0
1674270|NCT00597909|4091556|P2|COMPLETED|Overall Study||0
1674271|NCT00597909|4091557|P1|COMPLETED|Overall Study||0
1674272|NCT00597909|4091555|P3|STARTED|Overall Study||0
1674273|NCT00597909|4091556|P2|STARTED|Overall Study||0
1674274|NCT00597909|4091557|P1|STARTED|Overall Study||0
1674275|NCT00597896|4091567|P2|NOT COMPLETED|Overall Study||2
1674276|NCT00597896|4091568|P1|NOT COMPLETED|Overall Study||3
1674277|NCT00597896|4091567|P2|COMPLETED|Overall Study||24
1674278|NCT00597896|4091568|P1|COMPLETED|Overall Study||21
1674279|NCT00597896|4091567|P2|STARTED|Overall Study||26
1674280|NCT00597896|4091568|P1|STARTED|Overall Study||24
1674281|NCT00597766|4091597|P3|NOT COMPLETED|Follow-up 3, Week 12||0
1674282|NCT00597766|4091598|P2|NOT COMPLETED|Follow-up 3, Week 12||0
1674283|NCT00597766|4091599|P1|NOT COMPLETED|Follow-up 3, Week 12||0
1674284|NCT00597766|4091597|P3|COMPLETED|Follow-up 3, Week 12||9
1674285|NCT00597766|4091598|P2|COMPLETED|Follow-up 3, Week 12||9
1674286|NCT00597766|4091599|P1|COMPLETED|Follow-up 3, Week 12||8
1674287|NCT00597766|4091597|P3|STARTED|Follow-up 3, Week 12||9
1674288|NCT00597766|4091598|P2|STARTED|Follow-up 3, Week 12||9
1674289|NCT00597766|4091599|P1|STARTED|Follow-up 3, Week 12||8
1674290|NCT00597766|4091597|P3|NOT COMPLETED|Follow-up 2, Week 8||1
1674291|NCT00597766|4091598|P2|NOT COMPLETED|Follow-up 2, Week 8||0
1674292|NCT00597766|4091599|P1|NOT COMPLETED|Follow-up 2, Week 8||0
1674293|NCT00597766|4091597|P3|COMPLETED|Follow-up 2, Week 8||9
1674294|NCT00597766|4091598|P2|COMPLETED|Follow-up 2, Week 8||9
1674295|NCT00597766|4091599|P1|COMPLETED|Follow-up 2, Week 8||8
1674296|NCT00597766|4091597|P3|STARTED|Follow-up 2, Week 8||10
1674297|NCT00597766|4091598|P2|STARTED|Follow-up 2, Week 8||9
1674298|NCT00597766|4091599|P1|STARTED|Follow-up 2, Week 8||8
1674299|NCT00597766|4091597|P3|NOT COMPLETED|Follow-up 1, Week 4||0
1674300|NCT00597766|4091598|P2|NOT COMPLETED|Follow-up 1, Week 4||0
1674301|NCT00597766|4091599|P1|NOT COMPLETED|Follow-up 1, Week 4||1
1674302|NCT00597766|4091597|P3|COMPLETED|Follow-up 1, Week 4||10
1674303|NCT00597766|4091598|P2|COMPLETED|Follow-up 1, Week 4||9
1674304|NCT00597766|4091599|P1|COMPLETED|Follow-up 1, Week 4||8
1674305|NCT00597766|4091597|P3|STARTED|Follow-up 1, Week 4||10
1674306|NCT00597766|4091598|P2|STARTED|Follow-up 1, Week 4||9
1674307|NCT00597766|4091599|P1|STARTED|Follow-up 1, Week 4||9
1674308|NCT00597766|4091597|P3|NOT COMPLETED|Enrolled||0
1674309|NCT00597766|4091598|P2|NOT COMPLETED|Enrolled||0
1674310|NCT00597766|4091599|P1|NOT COMPLETED|Enrolled||0
1674311|NCT00597766|4091597|P3|COMPLETED|Enrolled||10
1674312|NCT00597766|4091598|P2|COMPLETED|Enrolled||9
1674313|NCT00597766|4091599|P1|COMPLETED|Enrolled||9
1674314|NCT00597766|4091597|P3|STARTED|Enrolled||10
1674315|NCT00597766|4091598|P2|STARTED|Enrolled||9
1674316|NCT00597766|4091599|P1|STARTED|Enrolled||9
1674317|NCT00597753|4091618|P2|NOT COMPLETED|Overall Study||69
1674318|NCT00597753|4091619|P1|NOT COMPLETED|Overall Study||166
1674319|NCT00597753|4091618|P2|COMPLETED|Overall Study||202
1674320|NCT00597753|4091619|P1|COMPLETED|Overall Study||366
1674321|NCT00597753|4091618|P2|STARTED|Overall Study||271
1674322|NCT00597753|4091619|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
1674323|NCT00597727|4091633|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
1674324|NCT00597727|4091634|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
1674325|NCT00597727|4091635|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
1674326|NCT00597727|4091636|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
1674327|NCT00597727|4091637|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
1674328|NCT00597727|4091633|P5|COMPLETED|Open-label Extended Maintenance Phase||1
1674329|NCT00597727|4091634|P4|COMPLETED|Open-label Extended Maintenance Phase||14
1674330|NCT00597727|4091635|P3|COMPLETED|Open-label Extended Maintenance Phase||23
1674331|NCT00597727|4091636|P2|COMPLETED|Open-label Extended Maintenance Phase||0
1674332|NCT00597727|4091637|P1|COMPLETED|Open-label Extended Maintenance Phase||0
1674333|NCT00597727|4091633|P5|STARTED|Open-label Extended Maintenance Phase||3
1674334|NCT00597727|4091634|P4|STARTED|Open-label Extended Maintenance Phase||17
1674335|NCT00597727|4091635|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
1674336|NCT00597727|4091636|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
1674337|NCT00597727|4091637|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
1674338|NCT00597727|4091633|P5|NOT COMPLETED|12 Month Blinded Phase||1
1674339|NCT00597727|4091634|P4|NOT COMPLETED|12 Month Blinded Phase||10
1674340|NCT00597727|4091635|P3|NOT COMPLETED|12 Month Blinded Phase||0
1674341|NCT00597727|4091636|P2|NOT COMPLETED|12 Month Blinded Phase||0
1674342|NCT00597727|4091637|P1|NOT COMPLETED|12 Month Blinded Phase||0
1674343|NCT00597727|4091633|P5|COMPLETED|12 Month Blinded Phase||3
1674344|NCT00597727|4091634|P4|COMPLETED|12 Month Blinded Phase||17
1674345|NCT00597727|4091635|P3|COMPLETED|12 Month Blinded Phase||0
1674346|NCT00597727|4091636|P2|COMPLETED|12 Month Blinded Phase||15
1674347|NCT00597727|4091637|P1|COMPLETED|12 Month Blinded Phase||14
1674348|NCT00597727|4091633|P5|STARTED|12 Month Blinded Phase||4
1674349|NCT00597727|4091634|P4|STARTED|12 Month Blinded Phase||27
1674350|NCT00597727|4091635|P3|STARTED|12 Month Blinded Phase||0
1674351|NCT00597727|4091636|P2|STARTED|12 Month Blinded Phase||15
1674352|NCT00597727|4091637|P1|STARTED|12 Month Blinded Phase||14
1674353|NCT00597714|4091653|P3|NOT COMPLETED|Overall Study||10
1674354|NCT00597714|4091654|P2|NOT COMPLETED|Overall Study||46
1674355|NCT00597714|4091655|P1|NOT COMPLETED|Overall Study||56
1674356|NCT00597714|4091653|P3|COMPLETED|Overall Study||84
1674357|NCT00597714|4091654|P2|COMPLETED|Overall Study||11
1674358|NCT00597714|4091655|P1|COMPLETED|Overall Study||24
1674359|NCT00597714|4091653|P3|STARTED|Overall Study||94
1674360|NCT00597714|4091654|P2|STARTED|Overall Study||57
1674361|NCT00597714|4091655|P1|STARTED|Overall Study||80
1674362|NCT00597701|4091667|P2|NOT COMPLETED|Overall Study||8
1674363|NCT00597701|4091668|P1|NOT COMPLETED|Overall Study||7
1674364|NCT00597701|4091667|P2|COMPLETED|Overall Study||13
1674365|NCT00597701|4091668|P1|COMPLETED|Overall Study||18
1674366|NCT00597701|4091667|P2|STARTED|Overall Study||21
1674367|NCT00597701|4091668|P1|STARTED|Overall Study||25
1674368|NCT00597675|4091676|P2|NOT COMPLETED|Open Label Phase||0
1674369|NCT00597675|4091677|P1|NOT COMPLETED|Open Label Phase||0
1674370|NCT00597675|4091676|P2|COMPLETED|Open Label Phase||5
1674371|NCT00597675|4091677|P1|COMPLETED|Open Label Phase||2
1674372|NCT00597675|4091676|P2|STARTED|Open Label Phase||5
1674373|NCT00597675|4091677|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
1674374|NCT00597675|4091676|P2|NOT COMPLETED|Blinded Phase||1
1674375|NCT00597675|4091677|P1|NOT COMPLETED|Blinded Phase||2
1674376|NCT00597675|4091676|P2|COMPLETED|Blinded Phase||5
1674377|NCT00597675|4091677|P1|COMPLETED|Blinded Phase||2
1674378|NCT00597675|4091676|P2|STARTED|Blinded Phase||6
1674379|NCT00597675|4091677|P1|STARTED|Blinded Phase||4
1674380|NCT00597584|4091690|P2|NOT COMPLETED|Overall Study||63
1674381|NCT00597584|4091691|P1|NOT COMPLETED|Overall Study||128
1674382|NCT00597584|4091690|P2|COMPLETED|Overall Study||211
1674383|NCT00597584|4091691|P1|COMPLETED|Overall Study||421
1674384|NCT00597584|4091690|P2|STARTED|Overall Study||274
1674385|NCT00597584|4091691|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
1674386|NCT00597558|4091701|P1|NOT COMPLETED|Overall Study||4
1674387|NCT00597558|4091701|P1|COMPLETED|Overall Study||9
1674388|NCT00597558|4091701|P1|STARTED|Overall Study||13
1674389|NCT00597545|4091709|P2|NOT COMPLETED|Overall Study||0
1674390|NCT00597545|4091710|P1|NOT COMPLETED|Overall Study||0
1674391|NCT00597545|4091709|P2|COMPLETED|Overall Study||6
1674392|NCT00597545|4091710|P1|COMPLETED|Overall Study||4
1674393|NCT00597545|4091709|P2|STARTED|Overall Study||6
1674394|NCT00597545|4091710|P1|STARTED|Overall Study||4
1674395|NCT00597519|4091716|P1|NOT COMPLETED|Overall Study||1
1674396|NCT00597519|4091716|P1|COMPLETED|Overall Study||27
1674397|NCT00597519|4091716|P1|STARTED|Overall Study||28
1674398|NCT00597506|4091720|P1|NOT COMPLETED|Overall Study||1
1674399|NCT00597506|4091720|P1|COMPLETED|Overall Study||49
1674400|NCT00597506|4091720|P1|STARTED|Overall Study||50
1674401|NCT00597493|4091725|P1|NOT COMPLETED|Overall Study||0
1674402|NCT00597493|4091725|P1|COMPLETED|Overall Study||32
1674403|NCT00597493|4091725|P1|STARTED|Overall Study||32
1674404|NCT00597428|4091744|P2|NOT COMPLETED|Overall Study||71
1674405|NCT00597428|4091745|P1|NOT COMPLETED|Overall Study||61
1674406|NCT00597428|4091744|P2|COMPLETED|Overall Study||152
1674407|NCT00597428|4091745|P1|COMPLETED|Overall Study||153
1674408|NCT00597428|4091744|P2|STARTED|Overall Study||223
1674409|NCT00597428|4091745|P1|STARTED|Overall Study||214
1674410|NCT00597402|4091761|P1|NOT COMPLETED|Overall Study||0
1674411|NCT00597402|4091761|P1|COMPLETED|Overall Study||125
1674412|NCT00597402|4091761|P1|STARTED|Overall Study||125
1674413|NCT00597376|4091770|P2|NOT COMPLETED|Overall Study||4
1674414|NCT00597376|4091771|P1|NOT COMPLETED|Overall Study||8
1674415|NCT00597376|4091770|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
1674416|NCT00597376|4091771|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
1674417|NCT00597376|4091770|P2|STARTED|Overall Study||53
1674418|NCT00597376|4091771|P1|STARTED|Overall Study||51
1674419|NCT00597272|4091788|P7|NOT COMPLETED|Overall Study||0
1674420|NCT00597272|4091789|P6|NOT COMPLETED|Overall Study||0
1674421|NCT00597272|4091790|P5|NOT COMPLETED|Overall Study||0
1674422|NCT00597272|4091791|P4|NOT COMPLETED|Overall Study||0
1674423|NCT00597272|4091792|P3|NOT COMPLETED|Overall Study||0
1674424|NCT00597272|4091793|P2|NOT COMPLETED|Overall Study||0
1674425|NCT00597272|4091794|P1|NOT COMPLETED|Overall Study||0
1674426|NCT00597272|4091788|P7|COMPLETED|Overall Study||10
1674427|NCT00597272|4091789|P6|COMPLETED|Overall Study||10
1674428|NCT00597272|4091790|P5|COMPLETED|Overall Study||1
1674429|NCT00597272|4091791|P4|COMPLETED|Overall Study||1
1674430|NCT00597272|4091792|P3|COMPLETED|Overall Study||10
1674431|NCT00597272|4091793|P2|COMPLETED|Overall Study||1
1674432|NCT00597272|4091794|P1|COMPLETED|Overall Study||1
1674433|NCT00597272|4091788|P7|STARTED|Overall Study||10
1674434|NCT00597272|4091789|P6|STARTED|Overall Study||10
1674435|NCT00597272|4091790|P5|STARTED|Overall Study||1
1674436|NCT00597272|4091791|P4|STARTED|Overall Study||1
1674437|NCT00597272|4091792|P3|STARTED|Overall Study||10
1674438|NCT00597272|4091793|P2|STARTED|Overall Study||1
1674439|NCT00597272|4091794|P1|STARTED|Overall Study||1
1674440|NCT00597207|4091812|P2|NOT COMPLETED|Overall Study||7
1674441|NCT00597207|4091813|P1|NOT COMPLETED|Overall Study||5
1674442|NCT00597207|4091812|P2|COMPLETED|Overall Study||2125
1674443|NCT00597207|4091813|P1|COMPLETED|Overall Study||2094
1674444|NCT00597207|4091812|P2|STARTED|Overall Study||2132
1674445|NCT00597207|4091813|P1|STARTED|Overall Study||2099
1674446|NCT00597116|4091821|P2|NOT COMPLETED|Overall Study||11
1674447|NCT00597116|4091822|P1|NOT COMPLETED|Overall Study||14
1674448|NCT00597116|4091821|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
1674449|NCT00597116|4091822|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
1674450|NCT00597116|4091821|P2|STARTED|Overall Study||11
1674451|NCT00597116|4091822|P1|STARTED|Overall Study||14
1674452|NCT00597038|4091836|P2|NOT COMPLETED|Overall Study||4
1674453|NCT00597038|4091837|P1|NOT COMPLETED|Overall Study||2
1674454|NCT00597038|4091836|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
1674455|NCT00597038|4091837|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
1674456|NCT00597038|4091836|P2|STARTED|Overall Study||34
1674457|NCT00597038|4091837|P1|STARTED|Overall Study||16
1674458|NCT00597012|4091848|P2|NOT COMPLETED|Overall Study||8
1674459|NCT00597012|4091849|P1|NOT COMPLETED|Overall Study||13
1674460|NCT00597012|4091848|P2|COMPLETED|Overall Study||169
1674461|NCT00597012|4091849|P1|COMPLETED|Overall Study||161
1674462|NCT00597012|4091848|P2|STARTED|Overall Study||177
1674463|NCT00597012|4091849|P1|STARTED|Overall Study||174
1674464|NCT00596960|4091861|P2|NOT COMPLETED|Overall Study||9
1674465|NCT00596960|4091862|P1|NOT COMPLETED|Overall Study||11
1674466|NCT00596960|4091861|P2|COMPLETED|Overall Study||60
1674467|NCT00596960|4091862|P1|COMPLETED|Overall Study||59
1674468|NCT00596960|4091861|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
1674469|NCT00596960|4091862|P1|STARTED|Overall Study||70
1674470|NCT00596947|4091874|P2|NOT COMPLETED|Overall Study||3
1674471|NCT00596947|4091875|P1|NOT COMPLETED|Overall Study||6
1674472|NCT00596947|4091874|P2|COMPLETED|Overall Study||6
1674473|NCT00596947|4091875|P1|COMPLETED|Overall Study||3
1674474|NCT00596947|4091874|P2|STARTED|Overall Study||9
1674475|NCT00596947|4091875|P1|STARTED|Overall Study||9
1674476|NCT00596934|4091915|P1|NOT COMPLETED|Overall Study||2
1674477|NCT00596934|4091915|P1|COMPLETED|Overall Study||7
1674478|NCT00596934|4091915|P1|STARTED|Overall Study||9
1674479|NCT00596830|4091928|P2|NOT COMPLETED|Overall Study||339
1674480|NCT00596830|4091929|P1|NOT COMPLETED|Overall Study||342
1674481|NCT00596830|4091928|P2|COMPLETED|Overall Study||0
1674482|NCT00596830|4091929|P1|COMPLETED|Overall Study||0
1674483|NCT00596830|4091928|P2|Treated|Overall Study||332
1674484|NCT00596830|4091929|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
1674485|NCT00596830|4091928|P2|STARTED|Overall Study||339
1674486|NCT00596830|4091929|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
1674487|NCT00596817|4091955|P2|NOT COMPLETED|Double-blind Period||79
1674488|NCT00596817|4091956|P1|NOT COMPLETED|Double-blind Period||88
1674489|NCT00596817|4091955|P2|COMPLETED|Double-blind Period||125
1674490|NCT00596817|4091956|P1|COMPLETED|Double-blind Period||104
1674491|NCT00596817|4091955|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
1674492|NCT00596817|4091956|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
1674493|NCT00596817|4091955|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
1674494|NCT00596817|4091956|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
1674495|NCT00596817|4091955|P2|COMPLETED|Open-label Period to Double-blind Period||400
1674496|NCT00596817|4091956|P1|COMPLETED|Open-label Period to Double-blind Period||0
1674497|NCT00596817|4091955|P2|STARTED|Open-label Period to Double-blind Period||492
1674498|NCT00596817|4091956|P1|STARTED|Open-label Period to Double-blind Period||0
1674499|NCT00596817|4091955|P2|NOT COMPLETED|Open-label Period||147
1674500|NCT00596817|4091956|P1|NOT COMPLETED|Open-label Period||0
1674501|NCT00596817|4091955|P2|COMPLETED|Open-label Period||492
1674502|NCT00596817|4091956|P1|COMPLETED|Open-label Period||0
1674503|NCT00596817|4091955|P2|STARTED|Open-label Period||639
1674504|NCT00596817|4091956|P1|STARTED|Open-label Period||0
1674505|NCT00596752|4091981|P2|NOT COMPLETED|Overall Study||143
1674506|NCT00596752|4091982|P1|NOT COMPLETED|Overall Study||126
1674507|NCT00596752|4091981|P2|COMPLETED|Overall Study||282
1674508|NCT00596752|4091982|P1|COMPLETED|Overall Study||289
1674509|NCT00596752|4091981|P2|Randomized and Treated|Overall Study||424
1674510|NCT00596752|4091982|P1|Randomized and Treated|Overall Study||415
1674511|NCT00596752|4091981|P2|STARTED|Overall Study||425
1674512|NCT00596752|4091982|P1|STARTED|Overall Study||415
1674513|NCT00596687|4092012|P2|NOT COMPLETED|Overall Study||9
1674514|NCT00596687|4092013|P1|NOT COMPLETED|Overall Study||14
1674515|NCT00596687|4092012|P2|COMPLETED|Overall Study||107
1674516|NCT00596687|4092013|P1|COMPLETED|Overall Study||104
1674517|NCT00596687|4092012|P2|STARTED|Overall Study||116
1674518|NCT00596687|4092013|P1|STARTED|Overall Study||118
1674519|NCT00596635|4092024|P3|NOT COMPLETED|Overall Study||8
1674520|NCT00596635|4092025|P2|NOT COMPLETED|Overall Study||13
1674521|NCT00596635|4092026|P1|NOT COMPLETED|Overall Study||7
1674522|NCT00596635|4092024|P3|COMPLETED|Overall Study||11
1674523|NCT00596635|4092025|P2|COMPLETED|Overall Study||7
1674524|NCT00596635|4092026|P1|COMPLETED|Overall Study||10
1674525|NCT00596635|4092024|P3|STARTED|Overall Study||19
1674526|NCT00596635|4092025|P2|STARTED|Overall Study||20
1674527|NCT00596635|4092026|P1|STARTED|Overall Study||17
1674528|NCT00596622|4092043|P1|NOT COMPLETED|Overall Study||13
1674529|NCT00596622|4092043|P1|COMPLETED|Overall Study||33
1674530|NCT00596622|4092043|P1|STARTED|Overall Study||46
1674531|NCT00596466|4092052|P1|NOT COMPLETED|Overall Study||17
1674532|NCT00596466|4092052|P1|COMPLETED|Overall Study||58
1674533|NCT00596466|4092052|P1|Enrolled, Treated|Overall Study||73
1674534|NCT00596466|4092052|P1|STARTED|Overall Study||75
1674535|NCT00596453|4092060|P2|NOT COMPLETED|Overall Study||3
1674536|NCT00596453|4092061|P1|NOT COMPLETED|Overall Study||1
1674537|NCT00596453|4092060|P2|COMPLETED|Overall Study||12
1674538|NCT00596453|4092061|P1|COMPLETED|Overall Study||12
1674539|NCT00596453|4092060|P2|STARTED|Overall Study||15
1674540|NCT00596453|4092061|P1|STARTED|Overall Study||13
1674541|NCT00596440|4092069|P2|NOT COMPLETED|Overall Study||80
1674542|NCT00596440|4092070|P1|NOT COMPLETED|Overall Study||65
1674543|NCT00596440|4092069|P2|COMPLETED|Overall Study||41
1674544|NCT00596440|4092070|P1|COMPLETED|Overall Study||48
1674545|NCT00596440|4092069|P2|Showed to First Treatment Session|Overall Study||52
1674546|NCT00596440|4092070|P1|Showed to First Treatment Session|Overall Study||61
1674547|NCT00596440|4092069|P2|Showed to Eligibility Visit|Overall Study||72
1674548|NCT00596440|4092070|P1|Showed to Eligibility Visit|Overall Study||85
1674549|NCT00596440|4092069|P2|STARTED|Overall Study||121
1674550|NCT00596440|4092070|P1|STARTED|Overall Study||113
1674551|NCT00596427|4092082|P2|NOT COMPLETED|Overall Study||2
1674552|NCT00596427|4092083|P1|NOT COMPLETED|Overall Study||4
1674553|NCT00596427|4092082|P2|COMPLETED|Overall Study||28
1674554|NCT00596427|4092083|P1|COMPLETED|Overall Study||26
1674555|NCT00596427|4092082|P2|STARTED|Overall Study||30
1674556|NCT00596427|4092083|P1|STARTED|Overall Study||30
1674557|NCT00596362|4092111|P1|NOT COMPLETED|Overall Study||1
1674558|NCT00596362|4092111|P1|COMPLETED|Overall Study||0
1674559|NCT00596362|4092111|P1|STARTED|Overall Study||1
1674560|NCT00596271|4092118|P3|NOT COMPLETED|Overall Study||1
1674561|NCT00596271|4092119|P2|NOT COMPLETED|Overall Study||6
1674562|NCT00596271|4092120|P1|NOT COMPLETED|Overall Study||5
1674563|NCT00596271|4092118|P3|COMPLETED|Overall Study||61
1674564|NCT00596271|4092119|P2|COMPLETED|Overall Study||59
1674565|NCT00596271|4092120|P1|COMPLETED|Overall Study||60
1674566|NCT00596271|4092118|P3|STARTED|Overall Study||62
1674567|NCT00596271|4092119|P2|STARTED|Overall Study||65
1674568|NCT00596271|4092120|P1|STARTED|Overall Study||65
1674569|NCT00596167|4092129|P1|NOT COMPLETED|Overall Study||0
1674570|NCT00596167|4092129|P1|COMPLETED|Overall Study||6
1674571|NCT00596167|4092129|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
1674572|NCT00596102|4092136|P3|NOT COMPLETED|Up to Month 60||637
1674573|NCT00596102|4092137|P2|NOT COMPLETED|Up to Month 60||338
1674574|NCT00596102|4092138|P1|NOT COMPLETED|Up to Month 60||2181
1674575|NCT00596102|4092136|P3|COMPLETED|Up to Month 60||0
1674576|NCT00596102|4092137|P2|COMPLETED|Up to Month 60||0
1674577|NCT00596102|4092138|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
1674578|NCT00596102|4092136|P3|STARTED|Up to Month 60||637
1674579|NCT00596102|4092137|P2|STARTED|Up to Month 60||338
1674580|NCT00596102|4092138|P1|STARTED|Up to Month 60||2283
1674581|NCT00596102|4092136|P3|NOT COMPLETED|Up to Month 6||0
1674582|NCT00596102|4092137|P2|NOT COMPLETED|Up to Month 6||0
1674583|NCT00596102|4092138|P1|NOT COMPLETED|Up to Month 6||0
1674584|NCT00596102|4092136|P3|COMPLETED|Up to Month 6||637
1674585|NCT00596102|4092137|P2|COMPLETED|Up to Month 6||338
1674586|NCT00596102|4092138|P1|COMPLETED|Up to Month 6||2283
1674587|NCT00596102|4092136|P3|STARTED|Up to Month 6||637
1674588|NCT00596102|4092137|P2|STARTED|Up to Month 6||338
1674589|NCT00596102|4092138|P1|STARTED|Up to Month 6||2283
1674590|NCT00596011|4092147|P2|NOT COMPLETED|Overall Study||10
1674591|NCT00596011|4092148|P1|NOT COMPLETED|Overall Study||13
1674592|NCT00596011|4092147|P2|COMPLETED|Overall Study||38
1674593|NCT00596011|4092148|P1|COMPLETED|Overall Study||36
1674594|NCT00596011|4092147|P2|STARTED|Overall Study||48
1674595|NCT00596011|4092148|P1|STARTED|Overall Study||49
1674596|NCT00595959|4092164|P1|NOT COMPLETED|Overall Study||2
1674597|NCT00595959|4092164|P1|COMPLETED|Overall Study||63
1674598|NCT00595959|4092164|P1|STARTED|Overall Study||65
1674599|NCT00595946|4092181|P2|NOT COMPLETED|Overall Study||69
1674600|NCT00595946|4092182|P1|NOT COMPLETED|Overall Study||64
1674601|NCT00595946|4092181|P2|COMPLETED|Overall Study||152
1674602|NCT00595946|4092182|P1|COMPLETED|Overall Study||154
1674603|NCT00595946|4092181|P2|STARTED|Overall Study||221
1674604|NCT00595946|4092182|P1|STARTED|Overall Study||218
1674605|NCT00595920|4092198|P1|NOT COMPLETED|Overall Study||116
1674606|NCT00595920|4092198|P1|COMPLETED|Overall Study||0
1674607|NCT00595920|4092198|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
1674608|NCT00595920|4092198|P1|STARTED|Overall Study||116
1674609|NCT00595881|4092202|P1|NOT COMPLETED|Overall Study||0
1674610|NCT00595881|4092202|P1|COMPLETED|Overall Study||420
1674611|NCT00595881|4092202|P1|STARTED|Overall Study||420
1674612|NCT00595868|4092209|P2|NOT COMPLETED|Overall Study||50
1674613|NCT00595868|4092210|P1|NOT COMPLETED|Overall Study||45
1674614|NCT00595868|4092209|P2|COMPLETED|Overall Study||61
1674615|NCT00595868|4092210|P1|COMPLETED|Overall Study||62
1674616|NCT00595868|4092209|P2|STARTED|Overall Study||111
1674617|NCT00595868|4092210|P1|STARTED|Overall Study||107
1674618|NCT00595790|4092221|P3|NOT COMPLETED|Overall Study||3
1674619|NCT00595790|4092222|P2|NOT COMPLETED|Overall Study||1
1674620|NCT00595790|4092223|P1|NOT COMPLETED|Overall Study||2
1674621|NCT00595790|4092221|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
1674622|NCT00595790|4092222|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
1674623|NCT00595790|4092223|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
1674624|NCT00595790|4092221|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
1674625|NCT00595790|4092222|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
1674626|NCT00595790|4092223|P1|STARTED|Overall Study||125
1674627|NCT00595764|4092233|P2|NOT COMPLETED|Overall Study||43
1674628|NCT00595764|4092234|P1|NOT COMPLETED|Overall Study||39
1674629|NCT00595764|4092233|P2|COMPLETED|Overall Study||27
1674630|NCT00595764|4092234|P1|COMPLETED|Overall Study||32
1674631|NCT00595764|4092233|P2|STARTED|Overall Study||70
1674632|NCT00595764|4092234|P1|STARTED|Overall Study||71
1674633|NCT00595582|4092248|P1|NOT COMPLETED|Overall Study||10
1674634|NCT00595582|4092248|P1|COMPLETED|Overall Study||0
1674635|NCT00595582|4092248|P1|STARTED|Overall Study||10
1674636|NCT00595556|4092254|P2|NOT COMPLETED|Overall Study||1
1674637|NCT00595556|4092255|P1|NOT COMPLETED|Overall Study||3
1674638|NCT00595556|4092254|P2|COMPLETED|Overall Study||19
1674639|NCT00595556|4092255|P1|COMPLETED|Overall Study||17
1674640|NCT00595556|4092254|P2|STARTED|Overall Study||20
1674641|NCT00595556|4092255|P1|STARTED|Overall Study||20
1674642|NCT00595530|4092269|P1|NOT COMPLETED|Overall Study||0
1674643|NCT00595530|4092269|P1|COMPLETED|Overall Study||3
1674644|NCT00595530|4092269|P1|STARTED|Overall Study||3
1674645|NCT00595517|4092273|P1|NOT COMPLETED|Overall Study||19
1674646|NCT00595517|4092273|P1|COMPLETED|Overall Study||111
1674647|NCT00595517|4092273|P1|STARTED|Overall Study||130
1674648|NCT00595504|4092282|P2|NOT COMPLETED|Overall Study||3
1674649|NCT00595504|4092283|P1|NOT COMPLETED|Overall Study||2
1674650|NCT00595504|4092282|P2|COMPLETED|Overall Study||6
1674651|NCT00595504|4092283|P1|COMPLETED|Overall Study||14
1674652|NCT00595504|4092282|P2|STARTED|Overall Study||9
1674653|NCT00595504|4092283|P1|STARTED|Overall Study||16
1674654|NCT00595478|4092295|P2|NOT COMPLETED|36-week Follow-up Period||8
1674655|NCT00595478|4092296|P1|NOT COMPLETED|36-week Follow-up Period||9
1674656|NCT00595478|4092295|P2|COMPLETED|36-week Follow-up Period||30
1674657|NCT00595478|4092296|P1|COMPLETED|36-week Follow-up Period||28
1674658|NCT00595478|4092295|P2|STARTED|36-week Follow-up Period||38
1674659|NCT00595478|4092296|P1|STARTED|36-week Follow-up Period||37
1674660|NCT00595478|4092295|P2|NOT COMPLETED|Treatment||0
1674661|NCT00595478|4092296|P1|NOT COMPLETED|Treatment||0
1674662|NCT00595478|4092295|P2|COMPLETED|Treatment||38
1674663|NCT00595478|4092296|P1|COMPLETED|Treatment||37
1674664|NCT00595478|4092295|P2|STARTED|Treatment||38
1674665|NCT00595478|4092296|P1|STARTED|Treatment||37
1674666|NCT00595465|4092307|P3|NOT COMPLETED|Overall Study||7
1674667|NCT00595465|4092308|P2|NOT COMPLETED|Overall Study||4
1674668|NCT00595465|4092309|P1|NOT COMPLETED|Overall Study||6
1674669|NCT00595465|4092307|P3|COMPLETED|Overall Study||121
1674670|NCT00595465|4092308|P2|COMPLETED|Overall Study||125
1674671|NCT00595465|4092309|P1|COMPLETED|Overall Study||124
1674672|NCT00595465|4092307|P3|STARTED|Overall Study||128
1674673|NCT00595465|4092308|P2|STARTED|Overall Study||129
1674674|NCT00595465|4092309|P1|STARTED|Overall Study||130
1674675|NCT00595413|4092321|P4|NOT COMPLETED|Overall Study||4
1674676|NCT00595413|4092322|P3|NOT COMPLETED|Overall Study||8
1674677|NCT00595413|4092323|P2|NOT COMPLETED|Overall Study||5
1674678|NCT00595413|4092324|P1|NOT COMPLETED|Overall Study||7
1674679|NCT00595413|4092321|P4|COMPLETED|Overall Study||75
1674680|NCT00595413|4092322|P3|COMPLETED|Overall Study||70
1674681|NCT00595413|4092323|P2|COMPLETED|Overall Study||73
1674682|NCT00595413|4092324|P1|COMPLETED|Overall Study||69
1674683|NCT00595413|4092321|P4|STARTED|Overall Study||79
1674684|NCT00595413|4092322|P3|STARTED|Overall Study||78
1674685|NCT00595413|4092323|P2|STARTED|Overall Study||78
1674686|NCT00595413|4092324|P1|STARTED|Overall Study||76
1674687|NCT00595361|4092352|P2|NOT COMPLETED|Overall Study||0
1674688|NCT00595361|4092353|P1|NOT COMPLETED|Overall Study||0
1674689|NCT00595361|4092352|P2|COMPLETED|Overall Study||18
1674690|NCT00595361|4092353|P1|COMPLETED|Overall Study||12
1674691|NCT00595361|4092352|P2|STARTED|Overall Study||18
1674692|NCT00595361|4092353|P1|STARTED|Overall Study||12
1674693|NCT00595335|4092365|P2|NOT COMPLETED|Six Months to Twelve Months||1
1674694|NCT00595335|4092366|P1|NOT COMPLETED|Six Months to Twelve Months||1
1674695|NCT00595335|4092365|P2|COMPLETED|Six Months to Twelve Months||9
1674696|NCT00595335|4092366|P1|COMPLETED|Six Months to Twelve Months||10
1674697|NCT00595335|4092365|P2|STARTED|Six Months to Twelve Months||10
1674698|NCT00595335|4092366|P1|STARTED|Six Months to Twelve Months||11
1674699|NCT00595335|4092365|P2|NOT COMPLETED|Baseline to Six Months||2
1674700|NCT00595335|4092366|P1|NOT COMPLETED|Baseline to Six Months||2
1674701|NCT00595335|4092365|P2|COMPLETED|Baseline to Six Months||10
1674702|NCT00595335|4092366|P1|COMPLETED|Baseline to Six Months||11
1674703|NCT00595335|4092365|P2|STARTED|Baseline to Six Months||12
1674704|NCT00595335|4092366|P1|STARTED|Baseline to Six Months||13
1674705|NCT00595309|4092386|P1|NOT COMPLETED|Overall Study||4
1674706|NCT00595309|4092386|P1|COMPLETED|Overall Study||194
1674707|NCT00595309|4092386|P1|STARTED|Overall Study||198
1674708|NCT00595270|4092393|P3|NOT COMPLETED|Overall Study||8
1674709|NCT00595270|4092394|P2|NOT COMPLETED|Overall Study||10
1674710|NCT00595270|4092395|P1|NOT COMPLETED|Overall Study||6
1674711|NCT00595270|4092393|P3|COMPLETED|Overall Study||108
1674712|NCT00595270|4092394|P2|COMPLETED|Overall Study||107
1674713|NCT00595270|4092395|P1|COMPLETED|Overall Study||110
1674714|NCT00595270|4092393|P3|STARTED|Overall Study||116
1674715|NCT00595270|4092394|P2|STARTED|Overall Study||117
1674716|NCT00595270|4092395|P1|STARTED|Overall Study||116
1674717|NCT00595153|4092406|P3|NOT COMPLETED|Overall Study||25
1674718|NCT00595153|4092407|P2|NOT COMPLETED|Overall Study||16
1674719|NCT00595153|4092408|P1|NOT COMPLETED|Overall Study||4
1674720|NCT00595153|4092406|P3|COMPLETED|Overall Study||36
1674721|NCT00595153|4092407|P2|COMPLETED|Overall Study||26
1674722|NCT00595153|4092408|P1|COMPLETED|Overall Study||20
1674723|NCT00595153|4092406|P3|STARTED|Overall Study||61
1674724|NCT00595153|4092407|P2|STARTED|Overall Study||42
1674725|NCT00595153|4092408|P1|STARTED|Overall Study||24
1674726|NCT00595127|4092416|P1|NOT COMPLETED|Overall Study||10
1674727|NCT00595127|4092416|P1|COMPLETED|Overall Study||11
1674728|NCT00595127|4092416|P1|STARTED|Overall Study||21
1674729|NCT00595114|4092422|P2|NOT COMPLETED|Overall Study||0
1674730|NCT00595114|4092423|P1|NOT COMPLETED|Overall Study||0
1674731|NCT00595114|4092422|P2|COMPLETED|Overall Study||19
1674732|NCT00595114|4092423|P1|COMPLETED|Overall Study||24
1674733|NCT00595114|4092422|P2|STARTED|Overall Study||19
1674734|NCT00595114|4092423|P1|STARTED|Overall Study||24
1674735|NCT00595088|4092429|P1|NOT COMPLETED|Overall Study||40
1674736|NCT00595088|4092429|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
1674737|NCT00595088|4092429|P1|STARTED|Overall Study||47
1674738|NCT00595075|4092438|P2|NOT COMPLETED|Overall Study||0
1674739|NCT00595075|4092439|P1|NOT COMPLETED|Overall Study||1
1674740|NCT00595075|4092438|P2|COMPLETED|Overall Study||5
1674741|NCT00595075|4092439|P1|COMPLETED|Overall Study||5
1674742|NCT00595075|4092438|P2|STARTED|Overall Study||5
1674743|NCT00595075|4092439|P1|STARTED|Overall Study||6
1674744|NCT00594958|4092460|P3|NOT COMPLETED|Overall Study||10
1674745|NCT00594958|4092461|P2|NOT COMPLETED|Overall Study||3
1674746|NCT00594958|4092462|P1|NOT COMPLETED|Overall Study||14
1674747|NCT00594958|4092460|P3|COMPLETED|Overall Study||202
1674748|NCT00594958|4092461|P2|COMPLETED|Overall Study||210
1674749|NCT00594958|4092462|P1|COMPLETED|Overall Study||200
1674750|NCT00594958|4092460|P3|Randomized and at Least 1 Vaccination|Overall Study||211
1674751|NCT00594958|4092461|P2|Randomized and at Least 1 Vaccination|Overall Study||213
1674752|NCT00594958|4092462|P1|Randomized and at Least 1 Vaccination|Overall Study||212
1674753|NCT00594958|4092460|P3|STARTED|Overall Study||212
1674754|NCT00594958|4092461|P2|STARTED|Overall Study||213
1674755|NCT00594958|4092462|P1|STARTED|Overall Study||214
1674756|NCT00594945|4092473|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
1674757|NCT00594945|4092474|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
1674758|NCT00594945|4092475|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
1674759|NCT00594945|4092473|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
1674760|NCT00594945|4092474|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
1674761|NCT00594945|4092475|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
1674762|NCT00594945|4092473|P3|STARTED|Cohort 2 / Treatment Period 2||2
1674763|NCT00594945|4092474|P2|STARTED|Cohort 2 / Treatment Period 2||3
1674764|NCT00594945|4092475|P1|STARTED|Cohort 2 / Treatment Period 2||0
1674765|NCT00594945|4092473|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
1674766|NCT00594945|4092474|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
1674767|NCT00594945|4092475|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
1674768|NCT00594945|4092473|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
1674769|NCT00594945|4092474|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
1674770|NCT00594945|4092475|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
1674771|NCT00594945|4092473|P3|STARTED|Cohort 1 / Treatment Period 1||2
1674772|NCT00594945|4092474|P2|STARTED|Cohort 1 / Treatment Period 1||0
1674773|NCT00594945|4092475|P1|STARTED|Cohort 1 / Treatment Period 1||4
1674774|NCT00594906|4092483|P2|NOT COMPLETED|Overall Study||2
1674775|NCT00594906|4092484|P1|NOT COMPLETED|Overall Study||1
1674776|NCT00594906|4092483|P2|COMPLETED|Overall Study||1
1674777|NCT00594906|4092484|P1|COMPLETED|Overall Study||6
1674778|NCT00594906|4092483|P2|STARTED|Overall Study||3
1674779|NCT00594906|4092484|P1|STARTED|Overall Study||7
1674780|NCT00594880|4092492|P2|NOT COMPLETED|Overall Study||1
1674781|NCT00594880|4092493|P1|NOT COMPLETED|Overall Study||2
1674782|NCT00594880|4092492|P2|COMPLETED|Overall Study||10
1674783|NCT00594880|4092493|P1|COMPLETED|Overall Study||10
1674784|NCT00594880|4092492|P2|STARTED|Overall Study||11
1674785|NCT00594880|4092493|P1|STARTED|Overall Study||12
1674786|NCT00594854|4092505|P2|NOT COMPLETED|Overall Study||10
1674787|NCT00594854|4092506|P1|NOT COMPLETED|Overall Study||7
1674788|NCT00594854|4092505|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
1674789|NCT00594854|4092506|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
1674790|NCT00594854|4092505|P2|STARTED|Overall Study||11
1674791|NCT00594854|4092506|P1|STARTED|Overall Study||9
1674792|NCT00594815|4092516|P1|NOT COMPLETED|Overall Study||9
1674793|NCT00594815|4092516|P1|COMPLETED|Overall Study||43
1674794|NCT00594815|4092516|P1|STARTED|Overall Study||52
1674795|NCT00594685|4092521|P1|NOT COMPLETED|Overall Study||0
1674796|NCT00594685|4092521|P1|COMPLETED|Overall Study||10
1674797|NCT00594685|4092521|P1|STARTED|Overall Study||10
1674798|NCT00594659|4092541|P3|NOT COMPLETED|Overall Study||7
1674799|NCT00594659|4092542|P2|NOT COMPLETED|Overall Study||9
1674800|NCT00594659|4092543|P1|NOT COMPLETED|Overall Study||13
1674801|NCT00594659|4092541|P3|COMPLETED|Overall Study||9
1674802|NCT00594659|4092542|P2|COMPLETED|Overall Study||21
1674803|NCT00594659|4092543|P1|COMPLETED|Overall Study||16
1674804|NCT00594659|4092541|P3|STARTED|Overall Study||16
1674805|NCT00594659|4092542|P2|STARTED|Overall Study||30
1674806|NCT00594659|4092543|P1|STARTED|Overall Study||29
1674807|NCT00594646|4092554|P1|NOT COMPLETED|Overall Study||16
1674808|NCT00594646|4092554|P1|COMPLETED|Overall Study||84
1674809|NCT00594646|4092554|P1|STARTED|Overall Study||100
1674810|NCT00594568|4092562|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
1674811|NCT00594568|4092563|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
1674812|NCT00594568|4092564|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
1674813|NCT00594568|4092562|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
1674814|NCT00594568|4092563|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
1674815|NCT00594568|4092564|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
1674816|NCT00594568|4092562|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
1674817|NCT00594568|4092563|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
1674896|NCT00594308|4092821|P1|STARTED|Overall Study||10
1674818|NCT00594568|4092564|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
1674819|NCT00594568|4092562|P3|NOT COMPLETED|Delayed Start||66
1674820|NCT00594568|4092563|P2|NOT COMPLETED|Delayed Start||77
1674821|NCT00594568|4092564|P1|NOT COMPLETED|Delayed Start||98
1674822|NCT00594568|4092562|P3|COMPLETED|Delayed Start||55
1674823|NCT00594568|4092563|P2|COMPLETED|Delayed Start||76
1674824|NCT00594568|4092564|P1|COMPLETED|Delayed Start||91
1674825|NCT00594568|4092562|P3|STARTED|Delayed Start||121
1674826|NCT00594568|4092563|P2|STARTED|Delayed Start||153
1674827|NCT00594568|4092564|P1|STARTED|Delayed Start||189
1674828|NCT00594568|4092562|P3|NOT COMPLETED|Initial Treatment||408
1674829|NCT00594568|4092563|P2|NOT COMPLETED|Initial Treatment||354
1674830|NCT00594568|4092564|P1|NOT COMPLETED|Initial Treatment||312
1674831|NCT00594568|4092562|P3|COMPLETED|Initial Treatment||121
1674832|NCT00594568|4092563|P2|COMPLETED|Initial Treatment||153
1674833|NCT00594568|4092564|P1|COMPLETED|Initial Treatment||189
1674834|NCT00594568|4092562|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
1674835|NCT00594568|4092563|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
1674836|NCT00594568|4092564|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
1674837|NCT00594568|4092562|P3|STARTED|Initial Treatment||529
1674838|NCT00594568|4092563|P2|STARTED|Initial Treatment||507
1674839|NCT00594568|4092564|P1|STARTED|Initial Treatment||501
1674840|NCT00594516|4092652|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
1674841|NCT00594516|4092653|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
1674842|NCT00594516|4092654|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
1674843|NCT00594516|4092652|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
1674844|NCT00594516|4092653|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
1674845|NCT00594516|4092654|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
1674846|NCT00594516|4092652|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
1674847|NCT00594516|4092653|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
1674848|NCT00594516|4092654|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
1674849|NCT00594516|4092652|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
1674850|NCT00594516|4092653|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
1674851|NCT00594516|4092654|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
1674852|NCT00594516|4092652|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
1674853|NCT00594516|4092653|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
1674854|NCT00594516|4092654|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
1674855|NCT00594516|4092652|P3|STARTED|Open Label (OL): Tapentadol IR||0
1674856|NCT00594516|4092653|P2|STARTED|Open Label (OL): Tapentadol IR||0
1674857|NCT00594516|4092654|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
1674858|NCT00594464|4092662|P1|NOT COMPLETED|Overall Study||3
1674859|NCT00594464|4092662|P1|COMPLETED|Overall Study||11
1674860|NCT00594464|4092662|P1|STARTED|Overall Study||14
1674861|NCT00594425|4092677|P3|NOT COMPLETED|Overall Study||10
1674862|NCT00594425|4092678|P2|NOT COMPLETED|Overall Study||14
1674863|NCT00594425|4092679|P1|NOT COMPLETED|Overall Study||7
1674864|NCT00594425|4092677|P3|COMPLETED|Overall Study||42
1674865|NCT00594425|4092678|P2|COMPLETED|Overall Study||34
1674866|NCT00594425|4092679|P1|COMPLETED|Overall Study||43
1674867|NCT00594425|4092677|P3|STARTED|Overall Study||52
1674868|NCT00594425|4092678|P2|STARTED|Overall Study||48
1674869|NCT00594425|4092679|P1|STARTED|Overall Study||50
1674870|NCT00594399|4092791|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
1674871|NCT00594399|4092792|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
1674872|NCT00594399|4092793|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
1674873|NCT00594399|4092791|P3|COMPLETED|Rerandomization Arm 1 Only||82
1674874|NCT00594399|4092792|P2|COMPLETED|Rerandomization Arm 1 Only||114
1674875|NCT00594399|4092793|P1|COMPLETED|Rerandomization Arm 1 Only||79
1674876|NCT00594399|4092791|P3|Rerandomization|Rerandomization Arm 1 Only||82
1674877|NCT00594399|4092792|P2|Rerandomization|Rerandomization Arm 1 Only||114
1674878|NCT00594399|4092793|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
1674879|NCT00594399|4092791|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
1674880|NCT00594399|4092792|P2|STARTED|Rerandomization Arm 1 Only||118
1674881|NCT00594399|4092793|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
1674882|NCT00594399|4092791|P3|NOT COMPLETED|Initial 3 Month Counseling||0
1674883|NCT00594399|4092792|P2|NOT COMPLETED|Initial 3 Month Counseling||4
1674884|NCT00594399|4092793|P1|NOT COMPLETED|Initial 3 Month Counseling||17
1674885|NCT00594399|4092791|P3|COMPLETED|Initial 3 Month Counseling||0
1674886|NCT00594399|4092792|P2|COMPLETED|Initial 3 Month Counseling||118
1674887|NCT00594399|4092793|P1|COMPLETED|Initial 3 Month Counseling||163
1674888|NCT00594399|4092791|P3|STARTED|Initial 3 Month Counseling||0
1674889|NCT00594399|4092792|P2|STARTED|Initial 3 Month Counseling||122
1674890|NCT00594399|4092793|P1|STARTED|Initial 3 Month Counseling||180
1674891|NCT00594386|4092815|P1|NOT COMPLETED|Overall Study||258
1674892|NCT00594386|4092815|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
1674893|NCT00594386|4092815|P1|STARTED|Overall Study||258
1674894|NCT00594308|4092821|P1|NOT COMPLETED|Overall Study||0
1674895|NCT00594308|4092821|P1|COMPLETED|Overall Study||10
1674897|NCT00594256|4092829|P1|NOT COMPLETED|Overall Study||0
1674898|NCT00594256|4092829|P1|COMPLETED|Overall Study||8
1674899|NCT00594256|4092829|P1|STARTED|Overall Study||8
1674900|NCT00594230|4092839|P2|NOT COMPLETED|Overall Study||9
1674901|NCT00594230|4092840|P1|NOT COMPLETED|Overall Study||15
1674902|NCT00594230|4092839|P2|COMPLETED|Overall Study||1
1674903|NCT00594230|4092840|P1|COMPLETED|Overall Study||1
1674904|NCT00594230|4092839|P2|STARTED|Overall Study||10
1674905|NCT00594230|4092840|P1|STARTED|Overall Study||16
1674906|NCT00594204|4092848|P2|NOT COMPLETED|Overall Study||45
1674907|NCT00594204|4092849|P1|NOT COMPLETED|Overall Study||58
1674908|NCT00594204|4092848|P2|COMPLETED|Overall Study||154
1674909|NCT00594204|4092849|P1|COMPLETED|Overall Study||336
1674910|NCT00594204|4092848|P2|Received Treatment|Overall Study||198
1674911|NCT00594204|4092849|P1|Received Treatment|Overall Study||390
1674912|NCT00594204|4092848|P2|STARTED|Overall Study||199
1674913|NCT00594204|4092849|P1|STARTED|Overall Study||394
1674914|NCT00594178|4092859|P1|NOT COMPLETED|Overall Study||5
1674915|NCT00594178|4092859|P1|COMPLETED|Overall Study||12
1674916|NCT00594178|4092859|P1|STARTED|Overall Study||17
1674917|NCT00594165|4092864|P1|NOT COMPLETED|Overall Study||217
1674918|NCT00594165|4092864|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
1674919|NCT00594165|4092864|P1|STARTED|Overall Study||217
1674920|NCT00594100|4092870|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
1674921|NCT00594100|4092870|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
1674922|NCT00594100|4092870|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
1674923|NCT00594100|4092870|P1|NOT COMPLETED|Procedure||9
1674924|NCT00594100|4092870|P1|COMPLETED|Procedure||236
1674925|NCT00594100|4092870|P1|STARTED|Procedure||245
1674926|NCT00594061|4092879|P1|NOT COMPLETED|Overall Study||0
1674927|NCT00594061|4092879|P1|COMPLETED|Overall Study||9
1674928|NCT00594061|4092879|P1|STARTED|Overall Study||9
1674929|NCT00594035|4092886|P2|NOT COMPLETED|Overall Study||3
1674930|NCT00594035|4092887|P1|NOT COMPLETED|Overall Study||2
1674931|NCT00594035|4092886|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
1674932|NCT00594035|4092887|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
1674933|NCT00594035|4092886|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
1674934|NCT00594035|4092887|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
1674935|NCT00594022|4092895|P2|NOT COMPLETED|Overall Study||0
1674936|NCT00594022|4092896|P1|NOT COMPLETED|Overall Study||0
1674937|NCT00594022|4092895|P2|COMPLETED|Overall Study||173
1674938|NCT00594022|4092896|P1|COMPLETED|Overall Study||176
1674939|NCT00594022|4092895|P2|STARTED|Overall Study||173
1674940|NCT00594022|4092896|P1|STARTED|Overall Study||176
1674941|NCT00593957|4092913|P3|NOT COMPLETED|Overall Study||2
1674942|NCT00593957|4092914|P2|NOT COMPLETED|Overall Study||1
1674943|NCT00593957|4092915|P1|NOT COMPLETED|Overall Study||0
1674944|NCT00593957|4092913|P3|COMPLETED|Overall Study||10
1674945|NCT00593957|4092914|P2|COMPLETED|Overall Study||12
1674946|NCT00593957|4092915|P1|COMPLETED|Overall Study||13
1674947|NCT00593957|4092913|P3|STARTED|Overall Study||12
1674948|NCT00593957|4092914|P2|STARTED|Overall Study||13
1674949|NCT00593957|4092915|P1|STARTED|Overall Study||13
1674950|NCT00593918|4092939|P2|NOT COMPLETED|Overall Study||24
1674951|NCT00593918|4092940|P1|NOT COMPLETED|Overall Study||5
1674952|NCT00593918|4092939|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
1674953|NCT00593918|4092940|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
1674954|NCT00593918|4092939|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
1674955|NCT00593918|4092940|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
1674956|NCT00593866|4092948|P1|NOT COMPLETED|Overall Study||0
1674957|NCT00593866|4092948|P1|COMPLETED|Overall Study||50
1674958|NCT00593866|4092948|P1|STARTED|Overall Study||50
1674959|NCT00593840|4092953|P1|NOT COMPLETED|Overall Study||1
1674960|NCT00593840|4092953|P1|COMPLETED|Overall Study||72
1674961|NCT00593840|4092953|P1|STARTED|Overall Study||73
1674962|NCT00593827|4092965|P2|NOT COMPLETED|Overall Study||2
1674963|NCT00593827|4092966|P1|NOT COMPLETED|Overall Study||0
1674964|NCT00593827|4092965|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
1674965|NCT00593827|4092966|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
1674966|NCT00593827|4092965|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
1674967|NCT00593827|4092966|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
1674968|NCT00593827|4092965|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
1674969|NCT00593827|4092966|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
1674970|NCT00593827|4092965|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
1674971|NCT00593827|4092966|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
1674972|NCT00593814|4092990|P2|NOT COMPLETED|Overall Study||0
1674973|NCT00593814|4092991|P1|NOT COMPLETED|Overall Study||24
1674974|NCT00593814|4092990|P2|COMPLETED|Overall Study||120
1674975|NCT00593814|4092991|P1|COMPLETED|Overall Study||115
1674976|NCT00593814|4092990|P2|STARTED|Overall Study||120
1674977|NCT00593814|4092991|P1|STARTED|Overall Study||139
1674978|NCT00593736|4093003|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
1674979|NCT00593736|4093004|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
1674980|NCT00593736|4093005|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
1674981|NCT00593736|4093006|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
1674982|NCT00593736|4093003|P4|COMPLETED|Treatment Period and Placebo Run-out||28
1674983|NCT00593736|4093004|P3|COMPLETED|Treatment Period and Placebo Run-out||30
1674984|NCT00593736|4093005|P2|COMPLETED|Treatment Period and Placebo Run-out||31
1674985|NCT00593736|4093006|P1|COMPLETED|Treatment Period and Placebo Run-out||29
1674986|NCT00593736|4093003|P4|STARTED|Treatment Period and Placebo Run-out||32
1674987|NCT00593736|4093004|P3|STARTED|Treatment Period and Placebo Run-out||35
1674988|NCT00593736|4093005|P2|STARTED|Treatment Period and Placebo Run-out||33
1674989|NCT00593736|4093006|P1|STARTED|Treatment Period and Placebo Run-out||32
1674990|NCT00593736|4093003|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
1674991|NCT00593736|4093004|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
1674992|NCT00593736|4093005|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
1674993|NCT00593736|4093006|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
1674994|NCT00593736|4093003|P4|COMPLETED|Screening Period and Placebo Run-in||132
1674995|NCT00593736|4093004|P3|COMPLETED|Screening Period and Placebo Run-in||0
1674996|NCT00593736|4093005|P2|COMPLETED|Screening Period and Placebo Run-in||0
1674997|NCT00593736|4093006|P1|COMPLETED|Screening Period and Placebo Run-in||0
1674998|NCT00593736|4093003|P4|STARTED|Screening Period and Placebo Run-in||549
1674999|NCT00593736|4093004|P3|STARTED|Screening Period and Placebo Run-in||0
1675000|NCT00593736|4093005|P2|STARTED|Screening Period and Placebo Run-in||0
1675001|NCT00593736|4093006|P1|STARTED|Screening Period and Placebo Run-in||0
1675002|NCT00593684|4093254|P2|NOT COMPLETED|Overall Study||1
1675003|NCT00593684|4093255|P1|NOT COMPLETED|Overall Study||2
1675004|NCT00593684|4093254|P2|COMPLETED|Overall Study||24
1675005|NCT00593684|4093255|P1|COMPLETED|Overall Study||23
1675006|NCT00593684|4093254|P2|STARTED|Overall Study||25
1675007|NCT00593684|4093255|P1|STARTED|Overall Study||25
1675008|NCT00593645|4093267|P1|NOT COMPLETED|Overall Study||0
1675009|NCT00593645|4093267|P1|COMPLETED|Overall Study||7
1675010|NCT00593645|4093267|P1|STARTED|Overall Study||7
1675011|NCT00593606|4093281|P1|NOT COMPLETED|Overall Study||27
1675012|NCT00593606|4093281|P1|COMPLETED|Overall Study||97
1675013|NCT00593606|4093281|P1|Treatment Period Completed|Overall Study||99
1675014|NCT00593606|4093281|P1|Full Analysis Set|Overall Study||114
1675015|NCT00593606|4093281|P1|Start of Treatment - Safety Set|Overall Study||116
1675016|NCT00593606|4093281|P1|STARTED|Overall Study||124
1675017|NCT00593554|4093379|P2|NOT COMPLETED|Overall Study||5
1675018|NCT00593554|4093380|P1|NOT COMPLETED|Overall Study||3
1675019|NCT00593554|4093379|P2|COMPLETED|Overall Study||0
1675020|NCT00593554|4093380|P1|COMPLETED|Overall Study||0
1675021|NCT00593554|4093379|P2|STARTED|Overall Study||5
1675022|NCT00593554|4093380|P1|STARTED|Overall Study||3
1675023|NCT00593450|4093402|P4|NOT COMPLETED|Overall Study||29
1675024|NCT00593450|4093403|P3|NOT COMPLETED|Overall Study||13
1675025|NCT00593450|4093404|P2|NOT COMPLETED|Overall Study||21
1675026|NCT00593450|4093405|P1|NOT COMPLETED|Overall Study||17
1675027|NCT00593450|4093402|P4|COMPLETED|Overall Study||271
1675028|NCT00593450|4093403|P3|COMPLETED|Overall Study||285
1675029|NCT00593450|4093404|P2|COMPLETED|Overall Study||265
1675030|NCT00593450|4093405|P1|COMPLETED|Overall Study||284
1675031|NCT00593450|4093402|P4|STARTED|Overall Study||300
1675032|NCT00593450|4093403|P3|STARTED|Overall Study||298
1675033|NCT00593450|4093404|P2|STARTED|Overall Study||286
1675034|NCT00593450|4093405|P1|STARTED|Overall Study||301
1675035|NCT00593385|4093475|P1|NOT COMPLETED|Overall Study||40
1675036|NCT00593385|4093475|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
1675037|NCT00593385|4093475|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
1675038|NCT00593385|4093475|P1|STARTED|Overall Study||165
1675039|NCT00593372|4093512|P2|NOT COMPLETED|Overall Study||0
1675040|NCT00593372|4093513|P1|NOT COMPLETED|Overall Study||0
1675041|NCT00593372|4093512|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
1675042|NCT00593372|4093513|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
1675043|NCT00593372|4093512|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
1675044|NCT00593372|4093513|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
1675045|NCT00593346|4093519|P1|NOT COMPLETED|Overall Study||0
1675046|NCT00593346|4093519|P1|COMPLETED|Overall Study||151
1675047|NCT00593346|4093519|P1|STARTED|Overall Study||151
1675048|NCT00593333|4093536|P2|NOT COMPLETED|Overall Study||11
1675049|NCT00593333|4093537|P1|NOT COMPLETED|Overall Study||10
1675050|NCT00593333|4093536|P2|COMPLETED|Overall Study||45
1675051|NCT00593333|4093537|P1|COMPLETED|Overall Study||44
1675052|NCT00593333|4093536|P2|STARTED|Overall Study||56
1675053|NCT00593333|4093537|P1|STARTED|Overall Study||54
1675054|NCT00593320|4093545|P2|NOT COMPLETED|Overall Study||0
1675055|NCT00593320|4093546|P1|NOT COMPLETED|Overall Study||0
1675056|NCT00593320|4093545|P2|COMPLETED|Overall Study||1
1675057|NCT00593320|4093546|P1|COMPLETED|Overall Study||1
1675058|NCT00593320|4093545|P2|STARTED|Overall Study||1
1675059|NCT00593320|4093546|P1|STARTED|Overall Study||1
1675060|NCT00593112|4093560|P2|NOT COMPLETED|Overall Study||0
1675061|NCT00593112|4093561|P1|NOT COMPLETED|Overall Study||10
1675062|NCT00593112|4093560|P2|COMPLETED|Overall Study||12
1675063|NCT00593112|4093561|P1|COMPLETED|Overall Study||17
1675064|NCT00593112|4093560|P2|STARTED|Overall Study||12
1675065|NCT00593112|4093561|P1|STARTED|Overall Study||27
1675066|NCT00592943|4093573|P2|NOT COMPLETED|Overall Study||0
1675067|NCT00592943|4093574|P1|NOT COMPLETED|Overall Study||0
1675068|NCT00592943|4093573|P2|COMPLETED|Overall Study||6
1675069|NCT00592943|4093574|P1|COMPLETED|Overall Study||6
1675070|NCT00592943|4093573|P2|STARTED|Overall Study||6
1675071|NCT00592943|4093574|P1|STARTED|Overall Study||6
1675072|NCT00592904|4093588|P4|NOT COMPLETED|Overall Study||11
1675073|NCT00592904|4093589|P3|NOT COMPLETED|Overall Study||17
1675074|NCT00592904|4093590|P2|NOT COMPLETED|Overall Study||55
1675075|NCT00592904|4093591|P1|NOT COMPLETED|Overall Study||25
1675076|NCT00592904|4093588|P4|COMPLETED|Overall Study||19
1675077|NCT00592904|4093589|P3|COMPLETED|Overall Study||10
1675078|NCT00592904|4093590|P2|COMPLETED|Overall Study||93
1675079|NCT00592904|4093591|P1|COMPLETED|Overall Study||32
1675080|NCT00592904|4093588|P4|STARTED|Overall Study||30
1675081|NCT00592904|4093589|P3|STARTED|Overall Study||27
1675082|NCT00592904|4093590|P2|STARTED|Overall Study||148
1675083|NCT00592904|4093591|P1|STARTED|Overall Study||57
1675084|NCT00592852|4093617|P1|NOT COMPLETED|Overall Study||6
1675085|NCT00592852|4093617|P1|COMPLETED|Overall Study||7
1675086|NCT00592852|4093617|P1|STARTED|Overall Study||13
1675087|NCT00592839|4093625|P3|NOT COMPLETED|Overall Study||6
1675088|NCT00592839|4093626|P2|NOT COMPLETED|Overall Study||4
1675089|NCT00592839|4093627|P1|NOT COMPLETED|Overall Study||2
1675090|NCT00592839|4093625|P3|COMPLETED|Overall Study||46
1675091|NCT00592839|4093626|P2|COMPLETED|Overall Study||48
1675092|NCT00592839|4093627|P1|COMPLETED|Overall Study||51
1675093|NCT00592839|4093625|P3|STARTED|Overall Study||52
1675094|NCT00592839|4093626|P2|STARTED|Overall Study||52
1675095|NCT00592839|4093627|P1|STARTED|Overall Study||53
1675096|NCT00592774|4093655|P5|NOT COMPLETED|Overall Study||14
1675097|NCT00592774|4093656|P4|NOT COMPLETED|Overall Study||14
1675098|NCT00592774|4093657|P3|NOT COMPLETED|Overall Study||4
1675099|NCT00592774|4093658|P2|NOT COMPLETED|Overall Study||32
1675100|NCT00592774|4093659|P1|NOT COMPLETED|Overall Study||11
1675101|NCT00592774|4093655|P5|COMPLETED|Overall Study||9
1675102|NCT00592774|4093656|P4|COMPLETED|Overall Study||8
1675103|NCT00592774|4093657|P3|COMPLETED|Overall Study||18
1675104|NCT00592774|4093658|P2|COMPLETED|Overall Study||21
1675105|NCT00592774|4093659|P1|COMPLETED|Overall Study||15
1675106|NCT00592774|4093655|P5|STARTED|Overall Study||23
1675107|NCT00592774|4093656|P4|STARTED|Overall Study||22
1675108|NCT00592774|4093657|P3|STARTED|Overall Study||22
1675109|NCT00592774|4093658|P2|STARTED|Overall Study||53
1675110|NCT00592774|4093659|P1|STARTED|Overall Study||26
1675111|NCT00592761|4093716|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
1675112|NCT00592761|4093717|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
1675113|NCT00592761|4093716|P2|COMPLETED|Second Intervention (2 Weeks)||9
1675114|NCT00592761|4093717|P1|COMPLETED|Second Intervention (2 Weeks)||9
1675115|NCT00592761|4093716|P2|STARTED|Second Intervention (2 Weeks)||9
1675116|NCT00592761|4093717|P1|STARTED|Second Intervention (2 Weeks)||9
1675117|NCT00592761|4093716|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
1675118|NCT00592761|4093717|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
1675119|NCT00592761|4093716|P2|COMPLETED|First Intervention (2 Weeks)||9
1675120|NCT00592761|4093717|P1|COMPLETED|First Intervention (2 Weeks)||9
1675121|NCT00592761|4093716|P2|STARTED|First Intervention (2 Weeks)||9
1675122|NCT00592761|4093717|P1|STARTED|First Intervention (2 Weeks)||9
1675123|NCT00592683|4093731|P2|NOT COMPLETED|Overall Study||4
1675124|NCT00592683|4093732|P1|NOT COMPLETED|Overall Study||4
1675125|NCT00592683|4093731|P2|COMPLETED|Overall Study||6
1675126|NCT00592683|4093732|P1|COMPLETED|Overall Study||6
1675127|NCT00592683|4093731|P2|STARTED|Overall Study||10
1675128|NCT00592683|4093732|P1|STARTED|Overall Study||10
1675129|NCT00592631|4093742|P2|NOT COMPLETED|Overall Study||2
1675130|NCT00592631|4093743|P1|NOT COMPLETED|Overall Study||0
1675131|NCT00592631|4093742|P2|COMPLETED|Overall Study||9
1675132|NCT00592631|4093743|P1|COMPLETED|Overall Study||16
1675133|NCT00592631|4093742|P2|STARTED|Overall Study||11
1675134|NCT00592631|4093743|P1|STARTED|Overall Study||16
1675135|NCT00592488|4093751|P2|NOT COMPLETED|Overall Study||0
1675136|NCT00592488|4093752|P1|NOT COMPLETED|Overall Study||0
1675137|NCT00592488|4093751|P2|COMPLETED|Overall Study||7
1675138|NCT00592488|4093752|P1|COMPLETED|Overall Study||6
1675139|NCT00592488|4093751|P2|STARTED|Overall Study||7
1675140|NCT00592488|4093752|P1|STARTED|Overall Study||6
1675141|NCT00592475|4093765|P3|NOT COMPLETED|Overall Study||0
1675142|NCT00592475|4093766|P2|NOT COMPLETED|Overall Study||0
1675143|NCT00592475|4093767|P1|NOT COMPLETED|Overall Study||0
1675144|NCT00592475|4093765|P3|COMPLETED|Overall Study||5
1675145|NCT00592475|4093766|P2|COMPLETED|Overall Study||9
1675146|NCT00592475|4093767|P1|COMPLETED|Overall Study||6
1675147|NCT00592475|4093765|P3|STARTED|Overall Study||5
1675148|NCT00592475|4093766|P2|STARTED|Overall Study||9
1675149|NCT00592475|4093767|P1|STARTED|Overall Study||6
1675150|NCT00592384|4093792|P2|NOT COMPLETED|Overall Study||6
1675151|NCT00592384|4093793|P1|NOT COMPLETED|Overall Study||5
1675152|NCT00592384|4093792|P2|COMPLETED|Overall Study||63
1675153|NCT00592384|4093793|P1|COMPLETED|Overall Study||59
1675154|NCT00592384|4093792|P2|STARTED|Overall Study||69
1675155|NCT00592384|4093793|P1|STARTED|Overall Study||64
1675156|NCT00592358|4093801|P1|NOT COMPLETED|Overall Study||6
1675157|NCT00592358|4093801|P1|COMPLETED|Overall Study||11
1675158|NCT00592358|4093801|P1|STARTED|Overall Study||17
1675159|NCT00592319|4093808|P2|NOT COMPLETED|Overall Study||3
1675160|NCT00592319|4093809|P1|NOT COMPLETED|Overall Study||0
1675161|NCT00592319|4093808|P2|COMPLETED|Overall Study||5
1675162|NCT00592319|4093809|P1|COMPLETED|Overall Study||2
1675163|NCT00592319|4093808|P2|STARTED|Overall Study||8
1675164|NCT00592319|4093809|P1|STARTED|Overall Study||2
1675165|NCT00592176|4093817|P1|NOT COMPLETED|Overall Study||0
1675166|NCT00592176|4093817|P1|COMPLETED|Overall Study||5
1675167|NCT00592176|4093817|P1|STARTED|Overall Study||5
1675168|NCT00592124|4093828|P6|NOT COMPLETED|Overall Study||3
1675169|NCT00592124|4093829|P5|NOT COMPLETED|Overall Study||3
1675170|NCT00592124|4093830|P4|NOT COMPLETED|Overall Study||3
1675171|NCT00592124|4093831|P3|NOT COMPLETED|Overall Study||6
1675172|NCT00592124|4093832|P2|NOT COMPLETED|Overall Study||5
1675173|NCT00592124|4093833|P1|NOT COMPLETED|Overall Study||4
1675174|NCT00592124|4093828|P6|COMPLETED|Overall Study||24
1675175|NCT00592124|4093829|P5|COMPLETED|Overall Study||24
1675176|NCT00592124|4093830|P4|COMPLETED|Overall Study||24
1675177|NCT00592124|4093831|P3|COMPLETED|Overall Study||24
1675178|NCT00592124|4093832|P2|COMPLETED|Overall Study||24
1675179|NCT00592124|4093833|P1|COMPLETED|Overall Study||24
1675180|NCT00592124|4093828|P6|STARTED|Overall Study||27
1675181|NCT00592124|4093829|P5|STARTED|Overall Study||27
1675182|NCT00592124|4093830|P4|STARTED|Overall Study||27
1675183|NCT00592124|4093831|P3|STARTED|Overall Study||30
1675184|NCT00592124|4093832|P2|STARTED|Overall Study||29
1675185|NCT00592124|4093833|P1|STARTED|Overall Study||28
1675186|NCT00592072|4093884|P2|NOT COMPLETED|Second Sequence||0
1675187|NCT00592072|4093885|P1|NOT COMPLETED|Second Sequence||0
1675188|NCT00592072|4093884|P2|COMPLETED|Second Sequence||5
1675189|NCT00592072|4093885|P1|COMPLETED|Second Sequence||5
1675190|NCT00592072|4093884|P2|STARTED|Second Sequence||5
1675191|NCT00592072|4093885|P1|STARTED|Second Sequence||5
1675192|NCT00592072|4093884|P2|NOT COMPLETED|Wash Out Period||1
1675193|NCT00592072|4093885|P1|NOT COMPLETED|Wash Out Period||1
1675194|NCT00592072|4093884|P2|COMPLETED|Wash Out Period||5
1675195|NCT00592072|4093885|P1|COMPLETED|Wash Out Period||5
1675196|NCT00592072|4093884|P2|STARTED|Wash Out Period||6
1675197|NCT00592072|4093885|P1|STARTED|Wash Out Period||6
1675198|NCT00592072|4093884|P2|NOT COMPLETED|First Sequence||0
1675199|NCT00592072|4093885|P1|NOT COMPLETED|First Sequence||0
1675200|NCT00592072|4093884|P2|COMPLETED|First Sequence||6
1675201|NCT00592072|4093885|P1|COMPLETED|First Sequence||6
1675202|NCT00592072|4093884|P2|STARTED|First Sequence||6
1675203|NCT00592072|4093885|P1|STARTED|First Sequence||6
1675204|NCT00592007|4093907|P1|NOT COMPLETED|Overall Study||2
1675205|NCT00592007|4093907|P1|COMPLETED|Overall Study||5
1675206|NCT00592007|4093907|P1|STARTED|Overall Study||7
1675207|NCT00591942|4093912|P2|NOT COMPLETED|Overall Study||0
1675208|NCT00591942|4093913|P1|NOT COMPLETED|Overall Study||0
1675209|NCT00591942|4093912|P2|COMPLETED|Overall Study||36
1675210|NCT00591942|4093913|P1|COMPLETED|Overall Study||36
1675211|NCT00591942|4093912|P2|STARTED|Overall Study||36
1675212|NCT00591942|4093913|P1|STARTED|Overall Study||36
1675213|NCT00591864|4093919|P1|NOT COMPLETED|Overall Study||5
1675214|NCT00591864|4093919|P1|COMPLETED|Overall Study||84
1675215|NCT00591864|4093919|P1|STARTED|Overall Study||89
1675216|NCT00591851|4093925|P1|NOT COMPLETED|Overall Study||6
1675217|NCT00591851|4093925|P1|COMPLETED|Overall Study||64
1675218|NCT00591851|4093925|P1|STARTED|Overall Study||70
1675219|NCT00591825|4093933|P4|NOT COMPLETED|Overall Study||0
1675220|NCT00591825|4093934|P3|NOT COMPLETED|Overall Study||0
1675221|NCT00591825|4093935|P2|NOT COMPLETED|Overall Study||0
1675222|NCT00591825|4093936|P1|NOT COMPLETED|Overall Study||0
1675223|NCT00591825|4093933|P4|COMPLETED|Overall Study||14
1675224|NCT00591825|4093934|P3|COMPLETED|Overall Study||13
1675225|NCT00591825|4093935|P2|COMPLETED|Overall Study||13
1675226|NCT00591825|4093936|P1|COMPLETED|Overall Study||14
1675227|NCT00591825|4093933|P4|STARTED|Overall Study||14
1675228|NCT00591825|4093934|P3|STARTED|Overall Study||13
1675229|NCT00591825|4093935|P2|STARTED|Overall Study||13
1675230|NCT00591825|4093936|P1|STARTED|Overall Study||14
1675231|NCT00591773|4093965|P3|NOT COMPLETED|Overall Study||16
1675232|NCT00591773|4093966|P2|NOT COMPLETED|Overall Study||24
1675233|NCT00591773|4093967|P1|NOT COMPLETED|Overall Study||16
1675234|NCT00591773|4093965|P3|COMPLETED|Overall Study||168
1675235|NCT00591773|4093966|P2|COMPLETED|Overall Study||158
1675236|NCT00591773|4093967|P1|COMPLETED|Overall Study||169
1675237|NCT00591773|4093965|P3|STARTED|Overall Study||184
1675238|NCT00591773|4093966|P2|STARTED|Overall Study||182
1675239|NCT00591773|4093967|P1|STARTED|Overall Study||185
1675240|NCT00591760|4094019|P2|NOT COMPLETED|Overall Study||0
1675241|NCT00591760|4094020|P1|NOT COMPLETED|Overall Study||0
1675242|NCT00591760|4094019|P2|COMPLETED|Overall Study||28
1675243|NCT00591760|4094020|P1|COMPLETED|Overall Study||28
1675244|NCT00591760|4094019|P2|STARTED|Overall Study||28
1675245|NCT00591760|4094020|P1|STARTED|Overall Study||28
1675246|NCT00591734|4094026|P1|NOT COMPLETED|Overall Study||53
1675247|NCT00591734|4094026|P1|COMPLETED|Overall Study||4
1675248|NCT00591734|4094026|P1|STARTED|Overall Study||57
1675249|NCT00591721|4094032|P2|NOT COMPLETED|Overall Study||22
1675250|NCT00591721|4094033|P1|NOT COMPLETED|Overall Study||21
1675251|NCT00591721|4094032|P2|COMPLETED|Overall Study||70
1675252|NCT00591721|4094033|P1|COMPLETED|Overall Study||68
1675253|NCT00591721|4094032|P2|STARTED|Overall Study||92
1675254|NCT00591721|4094033|P1|STARTED|Overall Study||89
1675255|NCT00591591|4094041|P2|NOT COMPLETED|Overall Study||39
1675256|NCT00591591|4094042|P1|NOT COMPLETED|Overall Study||11
1675257|NCT00591591|4094041|P2|COMPLETED|Overall Study||94
1675258|NCT00591591|4094042|P1|COMPLETED|Overall Study||165
1675259|NCT00591591|4094041|P2|STARTED|Overall Study||133
1675260|NCT00591591|4094042|P1|STARTED|Overall Study||176
1675261|NCT00591578|4094059|P3|NOT COMPLETED|Open-Label Extension Phase||0
1675262|NCT00591578|4094060|P2|NOT COMPLETED|Open-Label Extension Phase||10
1675263|NCT00591578|4094061|P1|NOT COMPLETED|Open-Label Extension Phase||6
1675264|NCT00591578|4094059|P3|COMPLETED|Open-Label Extension Phase||0
1675265|NCT00591578|4094060|P2|COMPLETED|Open-Label Extension Phase||105
1675266|NCT00591578|4094061|P1|COMPLETED|Open-Label Extension Phase||49
1675267|NCT00591578|4094059|P3|STARTED|Open-Label Extension Phase||0
1675268|NCT00591578|4094060|P2|STARTED|Open-Label Extension Phase||115
1675269|NCT00591578|4094061|P1|STARTED|Open-Label Extension Phase||55
1675270|NCT00591578|4094059|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
1675271|NCT00591578|4094060|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
1675272|NCT00591578|4094061|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
1675273|NCT00591578|4094059|P3|COMPLETED|Double-Blind Treatment Phase||244
1675274|NCT00591578|4094060|P2|COMPLETED|Double-Blind Treatment Phase||249
1675275|NCT00591578|4094061|P1|COMPLETED|Double-Blind Treatment Phase||249
1675276|NCT00591578|4094059|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
1675277|NCT00591578|4094060|P2|STARTED|Double-Blind Treatment Phase||329
1675278|NCT00591578|4094061|P1|STARTED|Double-Blind Treatment Phase||327
1675279|NCT00591565|4094112|P1|NOT COMPLETED|Overall Study||5
1675280|NCT00591565|4094112|P1|COMPLETED|Overall Study||8
1675281|NCT00591565|4094112|P1|STARTED|Overall Study||13
1675282|NCT00591370|4094116|P1|NOT COMPLETED|Overall Study||2
1675283|NCT00591370|4094116|P1|COMPLETED|Overall Study||49
1675284|NCT00591370|4094116|P1|STARTED|Overall Study||51
1675285|NCT00591344|4094124|P2|NOT COMPLETED|Overall Study||8
1675286|NCT00591344|4094125|P1|NOT COMPLETED|Overall Study||5
1675287|NCT00591344|4094124|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
1675288|NCT00591344|4094125|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
1675289|NCT00591344|4094124|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
1675290|NCT00591344|4094125|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
1675291|NCT00591344|4094124|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
1675292|NCT00591344|4094125|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
1675293|NCT00591305|4094137|P2|NOT COMPLETED|Overall Study||0
1675294|NCT00591305|4094138|P1|NOT COMPLETED|Overall Study||0
1675295|NCT00591305|4094137|P2|COMPLETED|Overall Study||0
1675296|NCT00591305|4094138|P1|COMPLETED|Overall Study||1
1675297|NCT00591305|4094137|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
1675298|NCT00591305|4094138|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
1675299|NCT00591305|4094137|P2|STARTED|Overall Study||0
1675300|NCT00591305|4094138|P1|STARTED|Overall Study||1
1675301|NCT00591266|4094151|P3|NOT COMPLETED|Overall Study||14
1675302|NCT00591266|4094152|P2|NOT COMPLETED|Overall Study||11
1675303|NCT00591266|4094153|P1|NOT COMPLETED|Overall Study||9
1675304|NCT00591266|4094151|P3|COMPLETED|Overall Study||175
1675305|NCT00591266|4094152|P2|COMPLETED|Overall Study||177
1675306|NCT00591266|4094153|P1|COMPLETED|Overall Study||180
1675307|NCT00591266|4094151|P3|STARTED|Overall Study|Randomized only|189
1675308|NCT00591266|4094152|P2|STARTED|Overall Study|Randomized only|188
1675309|NCT00591266|4094153|P1|STARTED|Overall Study|Randomized only|189
1675310|NCT00591253|4094206|P3|NOT COMPLETED|Overall Study||15
1675311|NCT00591253|4094207|P2|NOT COMPLETED|Overall Study||21
1675312|NCT00591253|4094208|P1|NOT COMPLETED|Overall Study||14
1675313|NCT00591253|4094206|P3|COMPLETED|Overall Study||123
1675314|NCT00591253|4094207|P2|COMPLETED|Overall Study||116
1675315|NCT00591253|4094208|P1|COMPLETED|Overall Study||126
1675316|NCT00591253|4094206|P3|STARTED|Overall Study|Randomized or Treated|138
1675317|NCT00591253|4094207|P2|STARTED|Overall Study|Randomized or Treated|137
1675318|NCT00591253|4094208|P1|STARTED|Overall Study|Randomized or Treated|140
1675319|NCT00591240|4094260|P2|NOT COMPLETED|Overall Study||0
1675320|NCT00591240|4094261|P1|NOT COMPLETED|Overall Study||0
1675321|NCT00591240|4094260|P2|COMPLETED|Overall Study||222
1675322|NCT00591240|4094261|P1|COMPLETED|Overall Study||116
1675323|NCT00591240|4094260|P2|STARTED|Overall Study||222
1675324|NCT00591240|4094261|P1|STARTED|Overall Study||116
1675325|NCT00591227|4094269|P2|NOT COMPLETED|Overall Study||0
1675326|NCT00591227|4094270|P1|NOT COMPLETED|Overall Study||0
1675327|NCT00591227|4094269|P2|COMPLETED|Overall Study||87
1675328|NCT00591227|4094270|P1|COMPLETED|Overall Study||89
1675329|NCT00591227|4094269|P2|STARTED|Overall Study||87
1675330|NCT00591227|4094270|P1|STARTED|Overall Study||89
1675331|NCT00591214|4094276|P1|NOT COMPLETED|Overall Study||8
1675332|NCT00591214|4094276|P1|COMPLETED|Overall Study||2
1675333|NCT00591214|4094276|P1|STARTED|Overall Study||10
1675334|NCT00591149|4094285|P1|NOT COMPLETED|Overall Study||5
1675335|NCT00591149|4094285|P1|COMPLETED|Overall Study||11
1675336|NCT00591149|4094285|P1|STARTED|Overall Study||16
1675337|NCT00591019|4094289|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
1675338|NCT00591019|4094290|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
1675339|NCT00591019|4094289|P2|COMPLETED|Intevention 2 (14 Days)||3
1675340|NCT00591019|4094290|P1|COMPLETED|Intevention 2 (14 Days)||2
1675341|NCT00591019|4094289|P2|STARTED|Intevention 2 (14 Days)||3
1675342|NCT00591019|4094290|P1|STARTED|Intevention 2 (14 Days)||2
1675343|NCT00591019|4094289|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
1675344|NCT00591019|4094290|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
1675345|NCT00591019|4094289|P2|COMPLETED|Intervention 1 (14 Days)||3
1675346|NCT00591019|4094290|P1|COMPLETED|Intervention 1 (14 Days)||2
1675347|NCT00591019|4094289|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
1675348|NCT00591019|4094290|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
1675349|NCT00591019|4094289|P2|NOT COMPLETED|Baseline (1 Day)||0
1675350|NCT00591019|4094290|P1|NOT COMPLETED|Baseline (1 Day)||0
1675351|NCT00591019|4094289|P2|COMPLETED|Baseline (1 Day)||4
1675352|NCT00591019|4094290|P1|COMPLETED|Baseline (1 Day)||3
1675353|NCT00591019|4094289|P2|STARTED|Baseline (1 Day)||4
1675354|NCT00591019|4094290|P1|STARTED|Baseline (1 Day)||3
1675355|NCT00591006|4094301|P24|NOT COMPLETED|Overall Study||1
1675356|NCT00591006|4094302|P23|NOT COMPLETED|Overall Study||1
1675357|NCT00591006|4094303|P22|NOT COMPLETED|Overall Study||0
1675358|NCT00591006|4094304|P21|NOT COMPLETED|Overall Study||0
1675359|NCT00591006|4094305|P20|NOT COMPLETED|Overall Study||0
1675360|NCT00591006|4094306|P19|NOT COMPLETED|Overall Study||0
1675361|NCT00591006|4094307|P18|NOT COMPLETED|Overall Study||0
1675362|NCT00591006|4094308|P17|NOT COMPLETED|Overall Study||0
1675363|NCT00591006|4094309|P16|NOT COMPLETED|Overall Study||1
1675364|NCT00591006|4094310|P15|NOT COMPLETED|Overall Study||0
1675365|NCT00591006|4094311|P14|NOT COMPLETED|Overall Study||0
1675366|NCT00591006|4094312|P13|NOT COMPLETED|Overall Study||0
1675367|NCT00591006|4094313|P12|NOT COMPLETED|Overall Study||0
1675368|NCT00591006|4094314|P11|NOT COMPLETED|Overall Study||0
1675369|NCT00591006|4094315|P10|NOT COMPLETED|Overall Study||0
1675370|NCT00591006|4094316|P9|NOT COMPLETED|Overall Study||0
1675371|NCT00591006|4094317|P8|NOT COMPLETED|Overall Study||0
1675372|NCT00591006|4094318|P7|NOT COMPLETED|Overall Study||0
1675373|NCT00591006|4094319|P6|NOT COMPLETED|Overall Study||0
1675374|NCT00591006|4094320|P5|NOT COMPLETED|Overall Study||0
1675375|NCT00591006|4094321|P4|NOT COMPLETED|Overall Study||0
1675376|NCT00591006|4094322|P3|NOT COMPLETED|Overall Study||0
1675377|NCT00591006|4094323|P2|NOT COMPLETED|Overall Study||0
1675378|NCT00591006|4094324|P1|NOT COMPLETED|Overall Study||0
1675379|NCT00591006|4094301|P24|COMPLETED|Overall Study||0
1675380|NCT00591006|4094302|P23|COMPLETED|Overall Study||0
1675381|NCT00591006|4094303|P22|COMPLETED|Overall Study||1
1675382|NCT00591006|4094304|P21|COMPLETED|Overall Study||0
1675383|NCT00591006|4094305|P20|COMPLETED|Overall Study||1
1675384|NCT00591006|4094306|P19|COMPLETED|Overall Study||0
1675385|NCT00591006|4094307|P18|COMPLETED|Overall Study||1
1675386|NCT00591006|4094308|P17|COMPLETED|Overall Study||0
1675387|NCT00591006|4094309|P16|COMPLETED|Overall Study||0
1675388|NCT00591006|4094310|P15|COMPLETED|Overall Study||0
1675389|NCT00591006|4094311|P14|COMPLETED|Overall Study||2
1675390|NCT00591006|4094312|P13|COMPLETED|Overall Study||1
1675391|NCT00591006|4094313|P12|COMPLETED|Overall Study||1
1675392|NCT00591006|4094314|P11|COMPLETED|Overall Study||0
1675393|NCT00591006|4094315|P10|COMPLETED|Overall Study||1
1675394|NCT00591006|4094316|P9|COMPLETED|Overall Study||1
1675395|NCT00591006|4094317|P8|COMPLETED|Overall Study||0
1675396|NCT00591006|4094318|P7|COMPLETED|Overall Study||1
1675397|NCT00591006|4094319|P6|COMPLETED|Overall Study||0
1675398|NCT00591006|4094320|P5|COMPLETED|Overall Study||1
1675399|NCT00591006|4094321|P4|COMPLETED|Overall Study||1
1675400|NCT00591006|4094322|P3|COMPLETED|Overall Study||1
1675401|NCT00591006|4094323|P2|COMPLETED|Overall Study||0
1675402|NCT00591006|4094324|P1|COMPLETED|Overall Study||1
1675403|NCT00591006|4094301|P24|Treatment #4|Overall Study||0
1675404|NCT00591006|4094302|P23|Treatment #4|Overall Study||0
1675405|NCT00591006|4094303|P22|Treatment #4|Overall Study||1
1675406|NCT00591006|4094304|P21|Treatment #4|Overall Study||0
1675407|NCT00591006|4094305|P20|Treatment #4|Overall Study||1
1675408|NCT00591006|4094306|P19|Treatment #4|Overall Study||0
1675409|NCT00591006|4094307|P18|Treatment #4|Overall Study||1
1675410|NCT00591006|4094308|P17|Treatment #4|Overall Study||0
1675411|NCT00591006|4094309|P16|Treatment #4|Overall Study||0
1675412|NCT00591006|4094310|P15|Treatment #4|Overall Study||0
1675413|NCT00591006|4094311|P14|Treatment #4|Overall Study||2
1675414|NCT00591006|4094312|P13|Treatment #4|Overall Study||1
1675415|NCT00591006|4094313|P12|Treatment #4|Overall Study||1
1675416|NCT00591006|4094314|P11|Treatment #4|Overall Study||0
1675417|NCT00591006|4094315|P10|Treatment #4|Overall Study||1
1675418|NCT00591006|4094316|P9|Treatment #4|Overall Study||1
1675419|NCT00591006|4094317|P8|Treatment #4|Overall Study||0
1675420|NCT00591006|4094318|P7|Treatment #4|Overall Study||1
1675421|NCT00591006|4094319|P6|Treatment #4|Overall Study||0
1675422|NCT00591006|4094320|P5|Treatment #4|Overall Study||1
1675423|NCT00591006|4094321|P4|Treatment #4|Overall Study||1
1675424|NCT00591006|4094322|P3|Treatment #4|Overall Study||1
1675425|NCT00591006|4094323|P2|Treatment #4|Overall Study||0
1675426|NCT00591006|4094324|P1|Treatment #4|Overall Study||1
1675427|NCT00591006|4094301|P24|Treatment #3|Overall Study||1
1675428|NCT00591006|4094302|P23|Treatment #3|Overall Study||1
1675429|NCT00591006|4094303|P22|Treatment #3|Overall Study||1
1675430|NCT00591006|4094304|P21|Treatment #3|Overall Study||0
1675431|NCT00591006|4094305|P20|Treatment #3|Overall Study||1
1675432|NCT00591006|4094306|P19|Treatment #3|Overall Study||0
1675433|NCT00591006|4094307|P18|Treatment #3|Overall Study||1
1675434|NCT00591006|4094308|P17|Treatment #3|Overall Study||0
1675435|NCT00591006|4094309|P16|Treatment #3|Overall Study||0
1675436|NCT00591006|4094310|P15|Treatment #3|Overall Study||0
1675437|NCT00591006|4094311|P14|Treatment #3|Overall Study||2
1675438|NCT00591006|4094312|P13|Treatment #3|Overall Study||1
1675439|NCT00591006|4094313|P12|Treatment #3|Overall Study||1
1675440|NCT00591006|4094314|P11|Treatment #3|Overall Study||0
1675441|NCT00591006|4094315|P10|Treatment #3|Overall Study||1
1675442|NCT00591006|4094316|P9|Treatment #3|Overall Study||1
1675443|NCT00591006|4094317|P8|Treatment #3|Overall Study||0
1675444|NCT00591006|4094318|P7|Treatment #3|Overall Study||1
1675445|NCT00591006|4094319|P6|Treatment #3|Overall Study||0
1675446|NCT00591006|4094320|P5|Treatment #3|Overall Study||1
1675447|NCT00591006|4094321|P4|Treatment #3|Overall Study||1
1675448|NCT00591006|4094322|P3|Treatment #3|Overall Study||1
1675449|NCT00591006|4094323|P2|Treatment #3|Overall Study||0
1675450|NCT00591006|4094324|P1|Treatment #3|Overall Study||1
1675451|NCT00591006|4094301|P24|Treatment #2|Overall Study||1
1675452|NCT00591006|4094302|P23|Treatment #2|Overall Study||1
1675453|NCT00591006|4094303|P22|Treatment #2|Overall Study||1
1675454|NCT00591006|4094304|P21|Treatment #2|Overall Study||0
1675455|NCT00591006|4094305|P20|Treatment #2|Overall Study||1
1675456|NCT00591006|4094306|P19|Treatment #2|Overall Study||0
1675457|NCT00591006|4094307|P18|Treatment #2|Overall Study||1
1675458|NCT00591006|4094308|P17|Treatment #2|Overall Study||0
1675459|NCT00591006|4094309|P16|Treatment #2|Overall Study||0
1675460|NCT00591006|4094310|P15|Treatment #2|Overall Study||0
1675461|NCT00591006|4094311|P14|Treatment #2|Overall Study||2
1675462|NCT00591006|4094312|P13|Treatment #2|Overall Study||1
1675463|NCT00591006|4094313|P12|Treatment #2|Overall Study||1
1675464|NCT00591006|4094314|P11|Treatment #2|Overall Study||0
1675465|NCT00591006|4094315|P10|Treatment #2|Overall Study||1
1675466|NCT00591006|4094316|P9|Treatment #2|Overall Study||1
1675467|NCT00591006|4094317|P8|Treatment #2|Overall Study||0
1675468|NCT00591006|4094318|P7|Treatment #2|Overall Study||1
1675469|NCT00591006|4094319|P6|Treatment #2|Overall Study||0
1675470|NCT00591006|4094320|P5|Treatment #2|Overall Study||1
1675471|NCT00591006|4094321|P4|Treatment #2|Overall Study||1
1675472|NCT00591006|4094322|P3|Treatment #2|Overall Study||1
1675473|NCT00591006|4094323|P2|Treatment #2|Overall Study||0
1675474|NCT00591006|4094324|P1|Treatment #2|Overall Study||1
1675475|NCT00591006|4094301|P24|STARTED|Overall Study||1
1675476|NCT00591006|4094302|P23|STARTED|Overall Study||1
1675477|NCT00591006|4094303|P22|STARTED|Overall Study||1
1675478|NCT00591006|4094304|P21|STARTED|Overall Study||0
1675479|NCT00591006|4094305|P20|STARTED|Overall Study||1
1675480|NCT00591006|4094306|P19|STARTED|Overall Study||0
1675481|NCT00591006|4094307|P18|STARTED|Overall Study||1
1675482|NCT00591006|4094308|P17|STARTED|Overall Study||0
1675483|NCT00591006|4094309|P16|STARTED|Overall Study||1
1675484|NCT00591006|4094310|P15|STARTED|Overall Study||0
1675485|NCT00591006|4094311|P14|STARTED|Overall Study||2
1675486|NCT00591006|4094312|P13|STARTED|Overall Study||1
1675487|NCT00591006|4094313|P12|STARTED|Overall Study||1
1675488|NCT00591006|4094314|P11|STARTED|Overall Study||0
1675489|NCT00591006|4094315|P10|STARTED|Overall Study||1
1675490|NCT00591006|4094316|P9|STARTED|Overall Study||1
1675491|NCT00591006|4094317|P8|STARTED|Overall Study||0
1675492|NCT00591006|4094318|P7|STARTED|Overall Study||1
1675493|NCT00591006|4094319|P6|STARTED|Overall Study||0
1675494|NCT00591006|4094320|P5|STARTED|Overall Study||1
1675495|NCT00591006|4094321|P4|STARTED|Overall Study||1
1675496|NCT00591006|4094322|P3|STARTED|Overall Study||1
1675497|NCT00591006|4094323|P2|STARTED|Overall Study||0
1675498|NCT00591006|4094324|P1|STARTED|Overall Study||1
1675499|NCT00590980|4094342|P1|NOT COMPLETED|Overall Study||10
1675500|NCT00590980|4094342|P1|COMPLETED|Overall Study||72
1675501|NCT00590980|4094342|P1|STARTED|Overall Study||82
1675502|NCT00590967|4094348|P2|NOT COMPLETED|Overall Study||5
1675503|NCT00590967|4094349|P1|NOT COMPLETED|Overall Study||3
1675504|NCT00590967|4094348|P2|COMPLETED|Overall Study||20
1675505|NCT00590967|4094349|P1|COMPLETED|Overall Study||41
1675506|NCT00590967|4094348|P2|STARTED|Overall Study||25
1675507|NCT00590967|4094349|P1|STARTED|Overall Study||44
1675508|NCT00590902|4094361|P1|NOT COMPLETED|Overall Study||1
1675509|NCT00590902|4094361|P1|COMPLETED|Overall Study||80
1675510|NCT00590902|4094361|P1|STARTED|Overall Study||81
1675511|NCT00590889|4094367|P2|NOT COMPLETED|Overall Study||299
1675512|NCT00590889|4094368|P1|NOT COMPLETED|Overall Study||286
1675513|NCT00590889|4094367|P2|COMPLETED|Overall Study||104
1675514|NCT00590889|4094368|P1|COMPLETED|Overall Study||118
1675515|NCT00590889|4094367|P2|STARTED|Overall Study||403
1675516|NCT00590889|4094368|P1|STARTED|Overall Study||404
1675517|NCT00590863|4094377|P3|NOT COMPLETED|Overall Study||78
1675518|NCT00590863|4094378|P2|NOT COMPLETED|Overall Study||82
1675519|NCT00590863|4094379|P1|NOT COMPLETED|Overall Study||84
1675520|NCT00590863|4094377|P3|COMPLETED|Overall Study||146
1675521|NCT00590863|4094378|P2|COMPLETED|Overall Study||138
1675522|NCT00590863|4094379|P1|COMPLETED|Overall Study||137
1675523|NCT00590863|4094377|P3|STARTED|Overall Study||224
1675524|NCT00590863|4094378|P2|STARTED|Overall Study||220
1675525|NCT00590863|4094379|P1|STARTED|Overall Study||221
1675526|NCT00590772|4094390|P1|NOT COMPLETED|Overall Study||0
1675527|NCT00590772|4094390|P1|COMPLETED|Overall Study||31
1675528|NCT00590772|4094390|P1|STARTED|Overall Study||31
1675529|NCT00590759|4094396|P1|NOT COMPLETED|Overall Study||80
1675530|NCT00590759|4094396|P1|COMPLETED|Overall Study||70
1675531|NCT00590759|4094396|P1|STARTED|Overall Study||150
1675532|NCT00590720|4094403|P2|NOT COMPLETED|Overall Study||1
1675533|NCT00590720|4094404|P1|NOT COMPLETED|Overall Study||1
1675534|NCT00590720|4094403|P2|COMPLETED|Overall Study||6
1675535|NCT00590720|4094404|P1|COMPLETED|Overall Study||3
1675536|NCT00590720|4094403|P2|STARTED|Overall Study||7
1675537|NCT00590720|4094404|P1|STARTED|Overall Study||4
1675538|NCT00590707|4094448|P2|NOT COMPLETED|Overall Study||0
1675539|NCT00590707|4094449|P1|NOT COMPLETED|Overall Study||0
1675540|NCT00590707|4094448|P2|COMPLETED|Overall Study||100
1675541|NCT00590707|4094449|P1|COMPLETED|Overall Study||100
1675542|NCT00590707|4094448|P2|STARTED|Overall Study||100
1675543|NCT00590707|4094449|P1|STARTED|Overall Study||100
1675544|NCT00590590|4094466|P3|NOT COMPLETED|Overall Study||6
1675545|NCT00590590|4094467|P2|NOT COMPLETED|Overall Study||6
1675546|NCT00590590|4094468|P1|NOT COMPLETED|Overall Study||7
1675547|NCT00590590|4094466|P3|COMPLETED|Overall Study||21
1675548|NCT00590590|4094467|P2|COMPLETED|Overall Study||33
1675549|NCT00590590|4094468|P1|COMPLETED|Overall Study||32
1675550|NCT00590590|4094466|P3|STARTED|Overall Study||27
1675551|NCT00590590|4094467|P2|STARTED|Overall Study||39
1675552|NCT00590590|4094468|P1|STARTED|Overall Study||39
1675553|NCT00590577|4094495|P4|NOT COMPLETED|Overall Study||93
1675554|NCT00590577|4094496|P3|NOT COMPLETED|Overall Study||73
1675555|NCT00590577|4094497|P2|NOT COMPLETED|Overall Study||76
1675556|NCT00590577|4094498|P1|NOT COMPLETED|Overall Study||77
1675557|NCT00590577|4094495|P4|COMPLETED|Overall Study||71
1675558|NCT00590577|4094496|P3|COMPLETED|Overall Study||90
1675559|NCT00590577|4094497|P2|COMPLETED|Overall Study||89
1675560|NCT00590577|4094498|P1|COMPLETED|Overall Study||83
1675561|NCT00590577|4094495|P4|STARTED|Overall Study||164
1675562|NCT00590577|4094496|P3|STARTED|Overall Study||163
1675563|NCT00590577|4094497|P2|STARTED|Overall Study||165
1675564|NCT00590577|4094498|P1|STARTED|Overall Study||160
1675565|NCT00590564|4094516|P1|NOT COMPLETED|Overall Study||18
1675566|NCT00590564|4094516|P1|COMPLETED|Overall Study||24
1675567|NCT00590564|4094516|P1|STARTED|Overall Study||42
1675568|NCT00590538|4094520|P1|NOT COMPLETED|Overall Study||2
1675569|NCT00590538|4094520|P1|COMPLETED|Overall Study||7
1675570|NCT00590538|4094520|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
1675571|NCT00590460|4094528|P1|NOT COMPLETED|Overall Study||0
1675572|NCT00590460|4094528|P1|COMPLETED|Overall Study||5
1675573|NCT00590460|4094528|P1|STARTED|Overall Study||5
1675574|NCT00590369|4094543|P2|NOT COMPLETED|Overall Study||0
1675575|NCT00590369|4094544|P1|NOT COMPLETED|Overall Study||0
1675576|NCT00590369|4094543|P2|COMPLETED|Overall Study||5
1675577|NCT00590369|4094544|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
1675578|NCT00590369|4094543|P2|STARTED|Overall Study||5
1675579|NCT00590369|4094544|P1|STARTED|Overall Study||6
1675580|NCT00590317|4094562|P2|NOT COMPLETED|Overall Study||5
1675581|NCT00590317|4094563|P1|NOT COMPLETED|Overall Study||1
1675582|NCT00590317|4094562|P2|COMPLETED|Overall Study||27
1675583|NCT00590317|4094563|P1|COMPLETED|Overall Study||31
1675584|NCT00590317|4094562|P2|STARTED|Overall Study||32
1675585|NCT00590317|4094563|P1|STARTED|Overall Study||32
1675586|NCT00590226|4094575|P2|NOT COMPLETED|Overall Study||0
1675587|NCT00590226|4094576|P1|NOT COMPLETED|Overall Study||0
1675588|NCT00590226|4094575|P2|COMPLETED|Overall Study||63
1675589|NCT00590226|4094576|P1|COMPLETED|Overall Study||67
1675590|NCT00590226|4094575|P2|STARTED|Overall Study||63
1675591|NCT00590226|4094576|P1|STARTED|Overall Study||67
1675592|NCT00590161|4094586|P2|NOT COMPLETED|Overall Study||3
1675593|NCT00590161|4094587|P1|NOT COMPLETED|Overall Study||3
1675594|NCT00590161|4094586|P2|COMPLETED|Overall Study||26
1675595|NCT00590161|4094587|P1|COMPLETED|Overall Study||23
1675596|NCT00590161|4094586|P2|STARTED|Overall Study||29
1675597|NCT00590161|4094587|P1|STARTED|Overall Study||26
1675598|NCT00590135|4094593|P1|NOT COMPLETED|Overall Study||59
1675599|NCT00590135|4094593|P1|COMPLETED|Overall Study||0
1675600|NCT00590135|4094593|P1|STARTED|Overall Study||59
1675601|NCT00590044|4094603|P2|NOT COMPLETED|Overall Study||2
1675602|NCT00590044|4094604|P1|NOT COMPLETED|Overall Study||4
1675603|NCT00590044|4094603|P2|COMPLETED|Overall Study||34
1675604|NCT00590044|4094604|P1|COMPLETED|Overall Study||34
1675605|NCT00590044|4094603|P2|STARTED|Overall Study||36
1675606|NCT00590044|4094604|P1|STARTED|Overall Study||38
1675607|NCT00590031|4094616|P1|NOT COMPLETED|Overall Study||6
1675608|NCT00590031|4094616|P1|COMPLETED|Overall Study||55
1675609|NCT00590031|4094616|P1|STARTED|Overall Study||61
1675610|NCT00590018|4094623|P2|NOT COMPLETED|Overall Study||0
1675611|NCT00590018|4094624|P1|NOT COMPLETED|Overall Study||0
1675612|NCT00590018|4094623|P2|COMPLETED|Overall Study||9
1675613|NCT00590018|4094624|P1|COMPLETED|Overall Study||9
1675614|NCT00590018|4094623|P2|STARTED|Overall Study||9
1675615|NCT00590018|4094624|P1|STARTED|Overall Study||9
1675616|NCT00590005|4094632|P2|NOT COMPLETED|Overall Study||0
1675617|NCT00590005|4094633|P1|NOT COMPLETED|Overall Study||0
1675618|NCT00590005|4094632|P2|COMPLETED|Overall Study||119
1675619|NCT00590005|4094633|P1|COMPLETED|Overall Study||106
1675620|NCT00590005|4094632|P2|STARTED|Overall Study||119
1675621|NCT00590005|4094633|P1|STARTED|Overall Study||106
1675622|NCT00589979|4094643|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
1675623|NCT00589979|4094644|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
1675624|NCT00589979|4094645|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
1675625|NCT00589979|4094643|P3|COMPLETED|Double-Blind Treatment Period 3||38
1675626|NCT00589979|4094644|P2|COMPLETED|Double-Blind Treatment Period 3||46
1675627|NCT00589979|4094645|P1|COMPLETED|Double-Blind Treatment Period 3||0
1675628|NCT00589979|4094643|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
1675629|NCT00589979|4094644|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
1675630|NCT00589979|4094645|P1|STARTED|Double-Blind Treatment Period 3||0
1675631|NCT00589979|4094643|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
1675632|NCT00589979|4094644|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
1675633|NCT00589979|4094645|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
1675634|NCT00589979|4094643|P3|COMPLETED|Double-Blind Treatment Period 2||39
1675635|NCT00589979|4094644|P2|COMPLETED|Double-Blind Treatment Period 2||47
1675636|NCT00589979|4094645|P1|COMPLETED|Double-Blind Treatment Period 2||0
1675637|NCT00589979|4094643|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
1675638|NCT00589979|4094644|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
1675639|NCT00589979|4094645|P1|STARTED|Double-Blind Treatment Period 2||0
1675640|NCT00589979|4094643|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
1675641|NCT00589979|4094644|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
1675642|NCT00589979|4094645|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
1675643|NCT00589979|4094643|P3|COMPLETED|Double-Blind Treatment Period 1||41
1675644|NCT00589979|4094644|P2|COMPLETED|Double-Blind Treatment Period 1||48
1675645|NCT00589979|4094645|P1|COMPLETED|Double-Blind Treatment Period 1||0
1675646|NCT00589979|4094643|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
1675647|NCT00589979|4094644|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
1675648|NCT00589979|4094645|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
1675649|NCT00589979|4094643|P3|NOT COMPLETED|Run-In Period||0
1675650|NCT00589979|4094644|P2|NOT COMPLETED|Run-In Period||0
1675651|NCT00589979|4094645|P1|NOT COMPLETED|Run-In Period||76
1675652|NCT00589979|4094643|P3|COMPLETED|Run-In Period||0
1675653|NCT00589979|4094644|P2|COMPLETED|Run-In Period||0
1675654|NCT00589979|4094645|P1|COMPLETED|Run-In Period||93
1675655|NCT00589979|4094643|P3|STARTED|Run-In Period||0
1675656|NCT00589979|4094644|P2|STARTED|Run-In Period||0
1675657|NCT00589979|4094645|P1|STARTED|Run-In Period||169
1675658|NCT00589914|4094684|P2|NOT COMPLETED|Overall Study||137
1675659|NCT00589914|4094685|P1|NOT COMPLETED|Overall Study||150
1675660|NCT00589914|4094684|P2|COMPLETED|Overall Study||471
1675661|NCT00589914|4094685|P1|COMPLETED|Overall Study||456
1675662|NCT00589914|4094684|P2|STARTED|Overall Study||608
1675663|NCT00589914|4094685|P1|STARTED|Overall Study||606
1675664|NCT00589888|4094695|P5|NOT COMPLETED|64-gram Oral Fat Load||0
1675665|NCT00589888|4094696|P4|NOT COMPLETED|64-gram Oral Fat Load||0
1675666|NCT00589888|4094697|P3|NOT COMPLETED|64-gram Oral Fat Load||0
1675667|NCT00589888|4094698|P2|NOT COMPLETED|64-gram Oral Fat Load||0
1675668|NCT00589888|4094699|P1|NOT COMPLETED|64-gram Oral Fat Load||0
1675669|NCT00589888|4094695|P5|COMPLETED|64-gram Oral Fat Load||13
1675670|NCT00589888|4094696|P4|COMPLETED|64-gram Oral Fat Load||0
1675671|NCT00589888|4094697|P3|COMPLETED|64-gram Oral Fat Load||0
1675672|NCT00589888|4094698|P2|COMPLETED|64-gram Oral Fat Load||0
1675673|NCT00589888|4094699|P1|COMPLETED|64-gram Oral Fat Load||0
1675674|NCT00589888|4094695|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
1675675|NCT00589888|4094696|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
1675676|NCT00589888|4094697|P3|STARTED|64-gram Oral Fat Load||0
1675677|NCT00589888|4094698|P2|STARTED|64-gram Oral Fat Load||0
1675678|NCT00589888|4094699|P1|STARTED|64-gram Oral Fat Load||0
1675679|NCT00589888|4094695|P5|NOT COMPLETED|32-gram Oral Fat Load||0
1675680|NCT00589888|4094696|P4|NOT COMPLETED|32-gram Oral Fat Load||0
1675681|NCT00589888|4094697|P3|NOT COMPLETED|32-gram Oral Fat Load||0
1675682|NCT00589888|4094698|P2|NOT COMPLETED|32-gram Oral Fat Load||0
1675683|NCT00589888|4094699|P1|NOT COMPLETED|32-gram Oral Fat Load||0
1675684|NCT00589888|4094695|P5|COMPLETED|32-gram Oral Fat Load||0
1675685|NCT00589888|4094696|P4|COMPLETED|32-gram Oral Fat Load||13
1675686|NCT00589888|4094697|P3|COMPLETED|32-gram Oral Fat Load||0
1675687|NCT00589888|4094698|P2|COMPLETED|32-gram Oral Fat Load||0
1675688|NCT00589888|4094699|P1|COMPLETED|32-gram Oral Fat Load||0
1675689|NCT00589888|4094695|P5|STARTED|32-gram Oral Fat Load||0
1675690|NCT00589888|4094696|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
1675691|NCT00589888|4094697|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
1675692|NCT00589888|4094698|P2|STARTED|32-gram Oral Fat Load||0
1675693|NCT00589888|4094699|P1|STARTED|32-gram Oral Fat Load||0
1675694|NCT00589888|4094695|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1675695|NCT00589888|4094696|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1675696|NCT00589888|4094697|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1675697|NCT00589888|4094698|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1675698|NCT00589888|4094699|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1675699|NCT00589888|4094695|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1675700|NCT00589888|4094696|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1675701|NCT00589888|4094697|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
1675702|NCT00589888|4094698|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1675703|NCT00589888|4094699|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1675704|NCT00589888|4094695|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
1675705|NCT00589888|4094696|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
1675706|NCT00589888|4094697|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
1675707|NCT00589888|4094698|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
1675708|NCT00589888|4094699|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
1675709|NCT00589888|4094695|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1675710|NCT00589888|4094696|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1675711|NCT00589888|4094697|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1675712|NCT00589888|4094698|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1675713|NCT00589888|4094699|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1675714|NCT00589888|4094695|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
1675715|NCT00589888|4094696|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
1675716|NCT00589888|4094697|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
1675717|NCT00589888|4094698|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
1675718|NCT00589888|4094699|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
1675719|NCT00589888|4094695|P5|STARTED|Intralipid 20% @ 20cc/hr||0
1675720|NCT00589888|4094696|P4|STARTED|Intralipid 20% @ 20cc/hr||0
1675721|NCT00589888|4094697|P3|STARTED|Intralipid 20% @ 20cc/hr||0
1675722|NCT00589888|4094698|P2|STARTED|Intralipid 20% @ 20cc/hr||13
1675723|NCT00589888|4094699|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
1675724|NCT00589888|4094695|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1675725|NCT00589888|4094696|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1675726|NCT00589888|4094697|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1675727|NCT00589888|4094698|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1675728|NCT00589888|4094699|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1675729|NCT00589888|4094695|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
1675730|NCT00589888|4094696|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
1675731|NCT00589888|4094697|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
1675732|NCT00589888|4094698|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
1675733|NCT00589888|4094699|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
1675734|NCT00589888|4094695|P5|STARTED|Normal Saline @ 40cc/Hour||0
1675735|NCT00589888|4094696|P4|STARTED|Normal Saline @ 40cc/Hour||0
1675736|NCT00589888|4094697|P3|STARTED|Normal Saline @ 40cc/Hour||0
1675737|NCT00589888|4094698|P2|STARTED|Normal Saline @ 40cc/Hour||0
1675738|NCT00589888|4094699|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
1675739|NCT00589849|4094731|P1|NOT COMPLETED|Overall Study||0
1675740|NCT00589849|4094731|P1|COMPLETED|Overall Study||32
1675741|NCT00589849|4094731|P1|STARTED|Overall Study||32
1675742|NCT00589836|4094735|P1|NOT COMPLETED|Overall Study||0
1675743|NCT00589836|4094735|P1|COMPLETED|Overall Study||20
1675744|NCT00589836|4094735|P1|STARTED|Overall Study||20
1675745|NCT00589797|4094741|P2|NOT COMPLETED|Overall Study||23
1675746|NCT00589797|4094742|P1|NOT COMPLETED|Overall Study||73
1675747|NCT00589797|4094741|P2|COMPLETED|Overall Study||89
1675748|NCT00589797|4094742|P1|COMPLETED|Overall Study||191
1675749|NCT00589797|4094741|P2|24 Months|Overall Study||89
1675750|NCT00589797|4094742|P1|24 Months|Overall Study||191
1675751|NCT00589797|4094741|P2|Baseline|Overall Study||106
1675752|NCT00589797|4094742|P1|Baseline|Overall Study||218
1675753|NCT00589797|4094741|P2|STARTED|Overall Study||112
1675754|NCT00589797|4094742|P1|STARTED|Overall Study||264
1675755|NCT00589784|4094766|P2|NOT COMPLETED|Overall Study||10
1675756|NCT00589784|4094767|P1|NOT COMPLETED|Overall Study||1
1675757|NCT00589784|4094766|P2|COMPLETED|Overall Study||4
1675758|NCT00589784|4094767|P1|COMPLETED|Overall Study||35
1675759|NCT00589784|4094766|P2|STARTED|Overall Study||14
1675760|NCT00589784|4094767|P1|STARTED|Overall Study||36
1675761|NCT00589693|4094774|P2|NOT COMPLETED|Overall Study||29
1675762|NCT00589693|4094775|P1|NOT COMPLETED|Overall Study||44
1675763|NCT00589693|4094774|P2|COMPLETED|Overall Study||83
1675764|NCT00589693|4094775|P1|COMPLETED|Overall Study||71
1675765|NCT00589693|4094774|P2|STARTED|Overall Study||112
1675766|NCT00589693|4094775|P1|STARTED|Overall Study||115
1675767|NCT00589667|4094789|P1|NOT COMPLETED|Overall Study||3
1675768|NCT00589667|4094789|P1|COMPLETED|Overall Study||23
1675769|NCT00589667|4094789|P1|STARTED|Overall Study||26
1675770|NCT00589628|4094796|P2|NOT COMPLETED|Overall Study||1
1675771|NCT00589628|4094797|P1|NOT COMPLETED|Overall Study||0
1675772|NCT00589628|4094796|P2|COMPLETED|Overall Study||5
1675773|NCT00589628|4094797|P1|COMPLETED|Overall Study||7
1675774|NCT00589628|4094796|P2|STARTED|Overall Study||6
1675775|NCT00589628|4094797|P1|STARTED|Overall Study||7
1675776|NCT00589602|4094803|P1|NOT COMPLETED|Overall Study||1
1675777|NCT00589602|4094803|P1|COMPLETED|Overall Study||12
1675778|NCT00589602|4094803|P1|STARTED|Overall Study||13
1675779|NCT00589563|4094811|P1|NOT COMPLETED|Overall Study||0
1675780|NCT00589563|4094811|P1|COMPLETED|Overall Study||32
1675781|NCT00589563|4094811|P1|STARTED|Overall Study||32
1675782|NCT00589550|4094828|P1|NOT COMPLETED|Overall Study||1
1675783|NCT00589550|4094828|P1|COMPLETED|Overall Study||0
1675784|NCT00589550|4094828|P1|Withdrew From Study|Overall Study||1
1675785|NCT00589550|4094828|P1|STARTED|Overall Study||1
1675786|NCT00589472|4094838|P1|NOT COMPLETED|Overall Study||1
1675787|NCT00589472|4094838|P1|COMPLETED|Overall Study||18
1675788|NCT00589472|4094838|P1|STARTED|Overall Study||19
1675789|NCT00589303|4094850|P2|NOT COMPLETED|Overall Study||1
1675790|NCT00589303|4094851|P1|NOT COMPLETED|Overall Study||2
1675791|NCT00589303|4094850|P2|COMPLETED|Overall Study||12
1675792|NCT00589303|4094851|P1|COMPLETED|Overall Study||12
1675793|NCT00589303|4094850|P2|STARTED|Overall Study||13
1675794|NCT00589303|4094851|P1|STARTED|Overall Study||14
1675795|NCT00589290|4094857|P1|NOT COMPLETED|Overall Study||1
1675796|NCT00589290|4094857|P1|COMPLETED|Overall Study||40
1675797|NCT00589290|4094857|P1|STARTED|Overall Study||41
1675798|NCT00589277|4094867|P2|NOT COMPLETED|Overall Study||286
1675799|NCT00589277|4094868|P1|NOT COMPLETED|Overall Study||460
1675800|NCT00589277|4094867|P2|COMPLETED|Overall Study||524
1675801|NCT00589277|4094868|P1|COMPLETED|Overall Study||762
1675802|NCT00589277|4094867|P2|Completed 3 Month Follow Up|Overall Study||524
1675803|NCT00589277|4094868|P1|Completed 3 Month Follow Up|Overall Study||762
1675804|NCT00589277|4094867|P2|Completed 2 Week Follow Up|Overall Study||424
1675805|NCT00589277|4094868|P1|Completed 2 Week Follow Up|Overall Study||603
1675806|NCT00589277|4094867|P2|STARTED|Overall Study||810
1675807|NCT00589277|4094868|P1|STARTED|Overall Study||1222
1675808|NCT00589121|4094880|P2|NOT COMPLETED|Overall Study||7
1675809|NCT00589121|4094881|P1|NOT COMPLETED|Overall Study||2
1675810|NCT00589121|4094880|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
1675811|NCT00589121|4094881|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
1675812|NCT00589121|4094880|P2|STARTED|Overall Study||86
1675813|NCT00589121|4094881|P1|STARTED|Overall Study||12
1675814|NCT00589108|4094901|P3|NOT COMPLETED|Overall Study||5
1675815|NCT00589108|4094902|P2|NOT COMPLETED|Overall Study||4
1675816|NCT00589108|4094903|P1|NOT COMPLETED|Overall Study||4
1675817|NCT00589108|4094901|P3|COMPLETED|Overall Study||75
1675818|NCT00589108|4094902|P2|COMPLETED|Overall Study||76
1675819|NCT00589108|4094903|P1|COMPLETED|Overall Study||76
1675820|NCT00589108|4094901|P3|STARTED|Overall Study||80
1675821|NCT00589108|4094902|P2|STARTED|Overall Study||80
1675822|NCT00589108|4094903|P1|STARTED|Overall Study||80
1675823|NCT00588965|4094923|P1|NOT COMPLETED|Overall Study||0
1675824|NCT00588965|4094923|P1|COMPLETED|Overall Study||35
1675825|NCT00588965|4094923|P1|STARTED|Overall Study||35
1675826|NCT00588952|4094933|P2|NOT COMPLETED|Overall Study||7
1675827|NCT00588952|4094934|P1|NOT COMPLETED|Overall Study||3
1675828|NCT00588952|4094933|P2|COMPLETED|Overall Study||63
1675829|NCT00588952|4094934|P1|COMPLETED|Overall Study||26
1675830|NCT00588952|4094933|P2|STARTED|Overall Study||70
1675831|NCT00588952|4094934|P1|STARTED|Overall Study||29
1675832|NCT00588900|4094954|P1|NOT COMPLETED|Overall Study||0
1675833|NCT00588900|4094954|P1|COMPLETED|Overall Study||5
1675834|NCT00588900|4094954|P1|STARTED|Overall Study||5
1675835|NCT00588861|4094962|P2|NOT COMPLETED|10 Years||114
1675836|NCT00588861|4094963|P1|NOT COMPLETED|10 Years||107
1675837|NCT00588861|4094962|P2|COMPLETED|10 Years||0
1675838|NCT00588861|4094963|P1|COMPLETED|10 Years||0
1675839|NCT00588861|4094962|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
1675840|NCT00588861|4094963|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
1675841|NCT00588861|4094962|P2|NOT COMPLETED|8 Years||114
1675842|NCT00588861|4094963|P1|NOT COMPLETED|8 Years||105
1675843|NCT00588861|4094962|P2|COMPLETED|8 Years||0
1675844|NCT00588861|4094963|P1|COMPLETED|8 Years||2
1675845|NCT00588861|4094962|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
1675846|NCT00588861|4094963|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
1675847|NCT00588861|4094962|P2|NOT COMPLETED|6 Years||109
1675848|NCT00588861|4094963|P1|NOT COMPLETED|6 Years||104
1675849|NCT00588861|4094962|P2|COMPLETED|6 Years||5
1675850|NCT00588861|4094963|P1|COMPLETED|6 Years||3
1675851|NCT00588861|4094962|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
1675852|NCT00588861|4094963|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
1675853|NCT00588861|4094962|P2|NOT COMPLETED|4 Years||103
1675854|NCT00588861|4094963|P1|NOT COMPLETED|4 Years||91
1675855|NCT00588861|4094962|P2|COMPLETED|4 Years||11
1675856|NCT00588861|4094963|P1|COMPLETED|4 Years||16
1675857|NCT00588861|4094962|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
1675858|NCT00588861|4094963|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
1675859|NCT00588861|4094962|P2|NOT COMPLETED|2 Years||87
1675860|NCT00588861|4094963|P1|NOT COMPLETED|2 Years||92
1675861|NCT00588861|4094962|P2|COMPLETED|2 Years||27
1675862|NCT00588861|4094963|P1|COMPLETED|2 Years||15
1675863|NCT00588861|4094962|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
1675864|NCT00588861|4094963|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
1675865|NCT00588861|4094962|P2|NOT COMPLETED|1 Year||82
1675866|NCT00588861|4094963|P1|NOT COMPLETED|1 Year||89
1675867|NCT00588861|4094962|P2|COMPLETED|1 Year||32
1675868|NCT00588861|4094963|P1|COMPLETED|1 Year||18
1675869|NCT00588861|4094962|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
1675870|NCT00588861|4094963|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
1675871|NCT00588861|4094962|P2|NOT COMPLETED|6 Months||73
1675872|NCT00588861|4094963|P1|NOT COMPLETED|6 Months||98
1675873|NCT00588861|4094962|P2|COMPLETED|6 Months||41
1675874|NCT00588861|4094963|P1|COMPLETED|6 Months||9
1675875|NCT00588861|4094962|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
1675876|NCT00588861|4094963|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
1675877|NCT00588861|4094962|P2|NOT COMPLETED|Pre-Operative||86
1675878|NCT00588861|4094963|P1|NOT COMPLETED|Pre-Operative||95
1675879|NCT00588861|4094962|P2|COMPLETED|Pre-Operative||114
1675880|NCT00588861|4094963|P1|COMPLETED|Pre-Operative||107
1675881|NCT00588861|4094962|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
1675882|NCT00588861|4094963|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
1675883|NCT00588848|4094973|P2|NOT COMPLETED|Overall Study||0
1675884|NCT00588848|4094974|P1|NOT COMPLETED|Overall Study||0
1675885|NCT00588848|4094973|P2|COMPLETED|Overall Study||8
1675886|NCT00588848|4094974|P1|COMPLETED|Overall Study||3
1675887|NCT00588848|4094973|P2|STARTED|Overall Study||8
1675888|NCT00588848|4094974|P1|STARTED|Overall Study||3
1675889|NCT00588822|4094984|P1|NOT COMPLETED|Overall Study||8
1675890|NCT00588822|4094984|P1|COMPLETED|Overall Study||13
1675891|NCT00588822|4094984|P1|STARTED|Overall Study||21
1675892|NCT00588809|4094993|P1|NOT COMPLETED|Overall Study||0
1675893|NCT00588809|4094993|P1|COMPLETED|Overall Study||47
1675894|NCT00588809|4094993|P1|STARTED|Overall Study||47
1675895|NCT00588731|4095004|P2|NOT COMPLETED|Overall Study||2
1675896|NCT00588731|4095005|P1|NOT COMPLETED|Overall Study||3
1675897|NCT00588731|4095004|P2|COMPLETED|Overall Study||18
1675898|NCT00588731|4095005|P1|COMPLETED|Overall Study||18
1675899|NCT00588731|4095004|P2|STARTED|Overall Study||20
1675900|NCT00588731|4095005|P1|STARTED|Overall Study||21
1675901|NCT00588692|4095015|P2|NOT COMPLETED|Overall Study||3
1675902|NCT00588692|4095016|P1|NOT COMPLETED|Overall Study||7
1675903|NCT00588692|4095015|P2|COMPLETED|Overall Study||27
1675904|NCT00588692|4095016|P1|COMPLETED|Overall Study||23
1675905|NCT00588692|4095015|P2|STARTED|Overall Study||30
1675906|NCT00588692|4095016|P1|STARTED|Overall Study||30
1675907|NCT00588666|4095052|P1|NOT COMPLETED|Overall Study||4
1675908|NCT00588666|4095052|P1|COMPLETED|Overall Study||47
1675909|NCT00588666|4095052|P1|STARTED|Overall Study||51
1675910|NCT00588640|4095057|P1|NOT COMPLETED|Overall Study||2
1675911|NCT00588640|4095057|P1|COMPLETED|Overall Study||8
1675912|NCT00588640|4095057|P1|STARTED|Overall Study||10
1675913|NCT00588536|4095061|P1|NOT COMPLETED|Overall Study||0
1675914|NCT00588536|4095061|P1|COMPLETED|Overall Study||5
1675915|NCT00588536|4095061|P1|STARTED|Overall Study||5
1675916|NCT00588471|4095067|P2|NOT COMPLETED|Overall Study||0
1675917|NCT00588471|4095068|P1|NOT COMPLETED|Overall Study||0
1675918|NCT00588471|4095067|P2|COMPLETED|Overall Study||29
1675919|NCT00588471|4095068|P1|COMPLETED|Overall Study||28
1675920|NCT00588471|4095067|P2|STARTED|Overall Study||29
1675921|NCT00588471|4095068|P1|STARTED|Overall Study||28
1675922|NCT00588445|4095076|P1|NOT COMPLETED|Overall Study||15
1675923|NCT00588445|4095076|P1|COMPLETED|Overall Study||50
1675924|NCT00588445|4095076|P1|STARTED|Overall Study||65
1675925|NCT00588406|4095084|P2|NOT COMPLETED|Overall Study||0
1675926|NCT00588406|4095085|P1|NOT COMPLETED|Overall Study||0
1675927|NCT00588406|4095084|P2|COMPLETED|Overall Study||49
1675928|NCT00588406|4095085|P1|COMPLETED|Overall Study||46
1675929|NCT00588406|4095084|P2|STARTED|Overall Study||49
1675930|NCT00588406|4095085|P1|STARTED|Overall Study||46
1675931|NCT00588380|4095093|P1|NOT COMPLETED|Overall Study||0
1675932|NCT00588380|4095093|P1|COMPLETED|Overall Study||88
1675933|NCT00588380|4095093|P1|STARTED|Overall Study||88
1675934|NCT00588354|4095100|P2|NOT COMPLETED|Baseline to 4 Weeks||1
1675935|NCT00588354|4095101|P1|NOT COMPLETED|Baseline to 4 Weeks||0
1675936|NCT00588354|4095100|P2|COMPLETED|Baseline to 4 Weeks||14
1675937|NCT00588354|4095101|P1|COMPLETED|Baseline to 4 Weeks||9
1675938|NCT00588354|4095100|P2|STARTED|Baseline to 4 Weeks||15
1675939|NCT00588354|4095101|P1|STARTED|Baseline to 4 Weeks||9
1675940|NCT00588354|4095100|P2|NOT COMPLETED|Baseline to 2 Weeks||0
1675941|NCT00588354|4095101|P1|NOT COMPLETED|Baseline to 2 Weeks||2
1675942|NCT00588354|4095100|P2|COMPLETED|Baseline to 2 Weeks||15
1675943|NCT00588354|4095101|P1|COMPLETED|Baseline to 2 Weeks||9
1675944|NCT00588354|4095100|P2|STARTED|Baseline to 2 Weeks||15
1675945|NCT00588354|4095101|P1|STARTED|Baseline to 2 Weeks||11
1675946|NCT00588341|4095121|P1|NOT COMPLETED|Overall Study||5
1675947|NCT00588341|4095121|P1|COMPLETED|Overall Study||19
1675948|NCT00588341|4095121|P1|STARTED|Overall Study||24
1675949|NCT00588237|4095125|P1|NOT COMPLETED|Overall Study||4
1675950|NCT00588237|4095125|P1|COMPLETED|Overall Study||38
1675951|NCT00588237|4095125|P1|STARTED|Overall Study||42
1675952|NCT00588159|4095131|P2|NOT COMPLETED|Overall Study||11
1675953|NCT00588159|4095132|P1|NOT COMPLETED|Overall Study||15
1675954|NCT00588159|4095131|P2|COMPLETED|Overall Study||63
1675955|NCT00588159|4095132|P1|COMPLETED|Overall Study||57
1675956|NCT00588159|4095131|P2|STARTED|Overall Study||74
1675957|NCT00588159|4095132|P1|STARTED|Overall Study||72
1675958|NCT00588146|4095148|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
1675959|NCT00588146|4095149|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
1675960|NCT00588146|4095148|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
1675961|NCT00588146|4095149|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
1675962|NCT00588146|4095148|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
1675963|NCT00588146|4095149|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
1675964|NCT00588146|4095148|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
1675965|NCT00588146|4095149|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
1675966|NCT00588146|4095148|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
1675967|NCT00588146|4095149|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
1675968|NCT00588146|4095148|P2|STARTED|First Intervention (Baseline to 6 mo)||5
1675969|NCT00588146|4095149|P1|STARTED|First Intervention (Baseline to 6 mo)||5
1675970|NCT00588094|4095155|P1|NOT COMPLETED|Overall Study||5
1675971|NCT00588094|4095155|P1|COMPLETED|Overall Study||15
1675972|NCT00588094|4095155|P1|STARTED|Overall Study||20
1675973|NCT00587990|4095162|P3|NOT COMPLETED|Overall Study||0
1675974|NCT00587990|4095163|P2|NOT COMPLETED|Overall Study||0
1675975|NCT00587990|4095164|P1|NOT COMPLETED|Overall Study||0
1675976|NCT00587990|4095162|P3|COMPLETED|Overall Study||3
1675977|NCT00587990|4095163|P2|COMPLETED|Overall Study||4
1675978|NCT00587990|4095164|P1|COMPLETED|Overall Study||2
1675979|NCT00587990|4095162|P3|STARTED|Overall Study||3
1675980|NCT00587990|4095163|P2|STARTED|Overall Study||4
1675981|NCT00587990|4095164|P1|STARTED|Overall Study||2
1675982|NCT00587964|4095178|P1|NOT COMPLETED|Overall Study||12
1675983|NCT00587964|4095178|P1|COMPLETED|Overall Study||39
1675984|NCT00587964|4095178|P1|STARTED|Overall Study||51
1675985|NCT00587860|4095184|P2|NOT COMPLETED|Overall Study||5
1675986|NCT00587860|4095185|P1|NOT COMPLETED|Overall Study||5
1675987|NCT00587860|4095184|P2|COMPLETED|Overall Study||30
1675988|NCT00587860|4095185|P1|COMPLETED|Overall Study||30
1675989|NCT00587860|4095184|P2|STARTED|Overall Study||35
1675990|NCT00587860|4095185|P1|STARTED|Overall Study||35
1675991|NCT00587847|4095205|P1|NOT COMPLETED|Overall Study||7
1675992|NCT00587847|4095205|P1|COMPLETED|Overall Study||5
1675993|NCT00587847|4095205|P1|STARTED|Overall Study||12
1675994|NCT00587834|4095210|P1|NOT COMPLETED|Overall Study||0
1675995|NCT00587834|4095210|P1|COMPLETED|Overall Study||96
1675996|NCT00587834|4095210|P1|STARTED|Overall Study||96
1675997|NCT00587795|4095228|P2|NOT COMPLETED|Overall Study||0
1675998|NCT00587795|4095229|P1|NOT COMPLETED|Overall Study||1
1675999|NCT00587795|4095228|P2|COMPLETED|Overall Study||0
1676000|NCT00587795|4095229|P1|COMPLETED|Overall Study||0
1676001|NCT00587795|4095228|P2|STARTED|Overall Study||0
1676002|NCT00587795|4095229|P1|STARTED|Overall Study||1
1676003|NCT00587769|4095235|P1|NOT COMPLETED|Overall Study||0
1676004|NCT00587769|4095235|P1|COMPLETED|Overall Study||38
1676005|NCT00587769|4095235|P1|STARTED|Overall Study||38
1676006|NCT00587678|4095243|P3|NOT COMPLETED|Overall Study||8
1676007|NCT00587678|4095244|P2|NOT COMPLETED|Overall Study||4
1676008|NCT00587678|4095245|P1|NOT COMPLETED|Overall Study||6
1676009|NCT00587678|4095243|P3|COMPLETED|Overall Study||33
1676010|NCT00587678|4095244|P2|COMPLETED|Overall Study||18
1676011|NCT00587678|4095245|P1|COMPLETED|Overall Study||16
1676012|NCT00587678|4095243|P3|STARTED|Overall Study||41
1676013|NCT00587678|4095244|P2|STARTED|Overall Study||22
1676014|NCT00587678|4095245|P1|STARTED|Overall Study||22
1676015|NCT00587639|4095283|P1|NOT COMPLETED|Overall Study||1
1676016|NCT00587639|4095283|P1|COMPLETED|Overall Study||7
1676017|NCT00587639|4095283|P1|STARTED|Overall Study||8
1676018|NCT00587587|4095290|P2|NOT COMPLETED|Overall Study||1
1676019|NCT00587587|4095291|P1|NOT COMPLETED|Overall Study||6
1676020|NCT00587587|4095290|P2|COMPLETED|Overall Study||12
1676021|NCT00587587|4095291|P1|COMPLETED|Overall Study||11
1676022|NCT00587587|4095290|P2|STARTED|Overall Study||13
1676023|NCT00587587|4095291|P1|STARTED|Overall Study||17
1676024|NCT00587483|4095314|P3|NOT COMPLETED|Overall Study||0
1676025|NCT00587483|4095315|P2|NOT COMPLETED|Overall Study||0
1676026|NCT00587483|4095316|P1|NOT COMPLETED|Overall Study||0
1676027|NCT00587483|4095314|P3|COMPLETED|Overall Study||112
1676028|NCT00587483|4095315|P2|COMPLETED|Overall Study||115
1676029|NCT00587483|4095316|P1|COMPLETED|Overall Study||115
1676030|NCT00587483|4095314|P3|STARTED|Overall Study||112
1676031|NCT00587483|4095315|P2|STARTED|Overall Study||115
1676032|NCT00587483|4095316|P1|STARTED|Overall Study||115
1676033|NCT00587457|4095345|P3|NOT COMPLETED|Overall Study||5
1676034|NCT00587457|4095346|P2|NOT COMPLETED|Overall Study||3
1676035|NCT00587457|4095347|P1|NOT COMPLETED|Overall Study||3
1676036|NCT00587457|4095345|P3|COMPLETED|Overall Study||0
1676037|NCT00587457|4095346|P2|COMPLETED|Overall Study||0
1676038|NCT00587457|4095347|P1|COMPLETED|Overall Study||0
1676039|NCT00587457|4095345|P3|STARTED|Overall Study||5
1676040|NCT00587457|4095346|P2|STARTED|Overall Study||3
1676041|NCT00587457|4095347|P1|STARTED|Overall Study||3
1676042|NCT00587431|4095384|P2|NOT COMPLETED|Overall Study||1
1676043|NCT00587431|4095385|P1|NOT COMPLETED|Overall Study||1
1676044|NCT00587431|4095384|P2|COMPLETED|Overall Study||38
1676045|NCT00587431|4095385|P1|COMPLETED|Overall Study||62
1676046|NCT00587431|4095384|P2|STARTED|Overall Study||39
1676047|NCT00587431|4095385|P1|STARTED|Overall Study||63
1676048|NCT00587288|4095396|P2|NOT COMPLETED|Overall Study||9
1676049|NCT00587288|4095397|P1|NOT COMPLETED|Overall Study||3
1676050|NCT00587288|4095396|P2|COMPLETED|Overall Study||44
1676051|NCT00587288|4095397|P1|COMPLETED|Overall Study||50
1676052|NCT00587288|4095396|P2|STARTED|Overall Study||53
1676053|NCT00587288|4095397|P1|STARTED|Overall Study||53
1676054|NCT00587223|4095415|P1|NOT COMPLETED|Overall Study||1
1676055|NCT00587223|4095415|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
1676056|NCT00587223|4095415|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
1676057|NCT00587171|4095432|P2|NOT COMPLETED|Overall Study||1
1676058|NCT00587171|4095433|P1|NOT COMPLETED|Overall Study||1
1676059|NCT00587171|4095432|P2|COMPLETED|Overall Study||9
1676060|NCT00587171|4095433|P1|COMPLETED|Overall Study||8
1676061|NCT00587171|4095432|P2|STARTED|Overall Study||10
1676062|NCT00587171|4095433|P1|STARTED|Overall Study||9
1676063|NCT00587158|4095463|P2|NOT COMPLETED|Overall Study||8
1676064|NCT00587158|4095464|P1|NOT COMPLETED|Overall Study||5
1676065|NCT00587158|4095463|P2|COMPLETED|Overall Study||43
1676066|NCT00587158|4095464|P1|COMPLETED|Overall Study||44
1676067|NCT00587158|4095463|P2|Continued in Study|Overall Study||46
1676068|NCT00587158|4095464|P1|Continued in Study|Overall Study||45
1676069|NCT00587158|4095463|P2|STARTED|Overall Study||51
1676070|NCT00587158|4095464|P1|STARTED|Overall Study||49
1676071|NCT00587132|4095498|P4|NOT COMPLETED|Overall Study||0
1676072|NCT00587132|4095499|P3|NOT COMPLETED|Overall Study||0
1676073|NCT00587132|4095500|P2|NOT COMPLETED|Overall Study||0
1676074|NCT00587132|4095501|P1|NOT COMPLETED|Overall Study||0
1676075|NCT00587132|4095498|P4|COMPLETED|Overall Study||0
1676076|NCT00587132|4095499|P3|COMPLETED|Overall Study||0
1676077|NCT00587132|4095500|P2|COMPLETED|Overall Study||0
1676078|NCT00587132|4095501|P1|COMPLETED|Overall Study||4
1676079|NCT00587132|4095498|P4|STARTED|Overall Study||0
1676080|NCT00587132|4095499|P3|STARTED|Overall Study||0
1676081|NCT00587132|4095500|P2|STARTED|Overall Study||0
1676082|NCT00587132|4095501|P1|STARTED|Overall Study||4
1676083|NCT00587067|4095511|P1|NOT COMPLETED|Overall Study||0
1676084|NCT00587067|4095511|P1|COMPLETED|Overall Study||34
1676085|NCT00587067|4095511|P1|STARTED|Overall Study||34
1676086|NCT00587054|4095517|P1|NOT COMPLETED|Overall Study||9
1676087|NCT00587054|4095517|P1|COMPLETED|Overall Study||120
1676088|NCT00587054|4095517|P1|STARTED|Overall Study||129
1676089|NCT00587041|4095524|P3|NOT COMPLETED|Overall Study||0
1676090|NCT00587041|4095525|P2|NOT COMPLETED|Overall Study||0
1676091|NCT00587041|4095526|P1|NOT COMPLETED|Overall Study||0
1676092|NCT00587041|4095524|P3|COMPLETED|Overall Study||14
1676093|NCT00587041|4095525|P2|COMPLETED|Overall Study||14
1676094|NCT00587041|4095526|P1|COMPLETED|Overall Study||12
1676095|NCT00587041|4095524|P3|STARTED|Overall Study||14
1676096|NCT00587041|4095525|P2|STARTED|Overall Study||14
1676097|NCT00587041|4095526|P1|STARTED|Overall Study||12
1676098|NCT00586898|4095537|P1|NOT COMPLETED|Overall Study||7
1676099|NCT00586898|4095537|P1|COMPLETED|Overall Study||29
1676100|NCT00586898|4095537|P1|STARTED|Overall Study||36
1676101|NCT00586846|4095541|P1|NOT COMPLETED|Overall Study||6
1676102|NCT00586846|4095541|P1|COMPLETED|Overall Study||34
1676103|NCT00586846|4095541|P1|STARTED|Overall Study||40
1676104|NCT00586820|4095547|P2|NOT COMPLETED|Overall Study||0
1676105|NCT00586820|4095548|P1|NOT COMPLETED|Overall Study||1
1676106|NCT00586820|4095547|P2|COMPLETED|Overall Study||11
1676107|NCT00586820|4095548|P1|COMPLETED|Overall Study||11
1676108|NCT00586820|4095547|P2|STARTED|Overall Study||11
1676109|NCT00586820|4095548|P1|STARTED|Overall Study||12
1676110|NCT00586729|4095558|P2|NOT COMPLETED|Overall Study||1
1676111|NCT00586729|4095559|P1|NOT COMPLETED|Overall Study||3
1676112|NCT00586729|4095558|P2|COMPLETED|Overall Study||8
1676113|NCT00586729|4095559|P1|COMPLETED|Overall Study||11
1676114|NCT00586729|4095558|P2|STARTED|Overall Study||9
1676115|NCT00586729|4095559|P1|STARTED|Overall Study||14
1676116|NCT00586716|4095571|P2|NOT COMPLETED|Overall Study||0
1676117|NCT00586716|4095572|P1|NOT COMPLETED|Overall Study||0
1676118|NCT00586716|4095571|P2|COMPLETED|Overall Study||8
1676119|NCT00586716|4095572|P1|COMPLETED|Overall Study||14
1676120|NCT00586716|4095571|P2|STARTED|Overall Study||8
1676121|NCT00586716|4095572|P1|STARTED|Overall Study||14
1676122|NCT00586703|4095579|P1|NOT COMPLETED|Overall Study||12
1676123|NCT00586703|4095579|P1|COMPLETED|Overall Study||4
1676124|NCT00586703|4095579|P1|STARTED|Overall Study||16
1676125|NCT00586690|4095586|P2|NOT COMPLETED|Overall Study||0
1676126|NCT00586690|4095587|P1|NOT COMPLETED|Overall Study||16
1676127|NCT00586690|4095586|P2|COMPLETED|Overall Study||22
1676128|NCT00586690|4095587|P1|COMPLETED|Overall Study||5
1676129|NCT00586690|4095586|P2|STARTED|Overall Study||22
1676130|NCT00586690|4095587|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
1676131|NCT00586664|4095597|P3|NOT COMPLETED|Overall Study||1
1676132|NCT00586664|4095598|P2|NOT COMPLETED|Overall Study||7
1676133|NCT00586664|4095599|P1|NOT COMPLETED|Overall Study||5
1676134|NCT00586664|4095597|P3|COMPLETED|Overall Study||43
1676135|NCT00586664|4095598|P2|COMPLETED|Overall Study||36
1676136|NCT00586664|4095599|P1|COMPLETED|Overall Study||38
1676137|NCT00586664|4095597|P3|STARTED|Overall Study||44
1676138|NCT00586664|4095598|P2|STARTED|Overall Study||43
1676139|NCT00586664|4095599|P1|STARTED|Overall Study||43
1676140|NCT00586625|4095645|P2|NOT COMPLETED|Overall Study||17
1676141|NCT00586625|4095646|P1|NOT COMPLETED|Overall Study||43
1676142|NCT00586625|4095645|P2|COMPLETED|Overall Study||269
1676143|NCT00586625|4095646|P1|COMPLETED|Overall Study||532
1676144|NCT00586625|4095645|P2|STARTED|Overall Study||286
1676145|NCT00586625|4095646|P1|STARTED|Overall Study||575
1676146|NCT00586612|4095654|P2|NOT COMPLETED|Booster Phase||1
1676147|NCT00586612|4095655|P1|NOT COMPLETED|Booster Phase||3
1676148|NCT00586612|4095654|P2|COMPLETED|Booster Phase||143
1676149|NCT00586612|4095655|P1|COMPLETED|Booster Phase||151
1676150|NCT00586612|4095654|P2|STARTED|Booster Phase||144
1676151|NCT00586612|4095655|P1|STARTED|Booster Phase||154
1676152|NCT00586612|4095654|P2|NOT COMPLETED|Primary Phase||3
1676153|NCT00586612|4095655|P1|NOT COMPLETED|Primary Phase||1
1676154|NCT00586612|4095654|P2|COMPLETED|Primary Phase||147
1676155|NCT00586612|4095655|P1|COMPLETED|Primary Phase||162
1676156|NCT00586612|4095654|P2|STARTED|Primary Phase||150
1676157|NCT00586612|4095655|P1|STARTED|Primary Phase||163
1676158|NCT00586573|4095721|P1|NOT COMPLETED|Overall Study||6
1676159|NCT00586573|4095721|P1|COMPLETED|Overall Study||28
1676160|NCT00586573|4095721|P1|STARTED|Overall Study||34
1676161|NCT00586521|4095725|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
1676162|NCT00586521|4095725|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
1676163|NCT00586521|4095725|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
1676164|NCT00586521|4095725|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
1676165|NCT00586521|4095725|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
1676166|NCT00586521|4095725|P1|STARTED|On Demand Treatment (Months 1-6)||20
1676167|NCT00586495|4095732|P1|NOT COMPLETED|Follow-up||92
1676168|NCT00586495|4095732|P1|COMPLETED|Follow-up||0
1676169|NCT00586495|4095732|P1|STARTED|Follow-up||92
1676170|NCT00586495|4095732|P1|NOT COMPLETED|Treatment Period||95
1676171|NCT00586495|4095732|P1|COMPLETED|Treatment Period||0
1676172|NCT00586495|4095732|P1|STARTED|Treatment Period||95
1676173|NCT00586482|4095744|P2|NOT COMPLETED|Overall Study||0
1676174|NCT00586482|4095745|P1|NOT COMPLETED|Overall Study||0
1676175|NCT00586482|4095744|P2|COMPLETED|Overall Study||24
1676176|NCT00586482|4095745|P1|COMPLETED|Overall Study||22
1676177|NCT00586482|4095744|P2|STARTED|Overall Study||24
1676178|NCT00586482|4095745|P1|STARTED|Overall Study||22
1676179|NCT00586469|4095761|P2|NOT COMPLETED|Overall Study||1
1676180|NCT00586469|4095762|P1|NOT COMPLETED|Overall Study||0
1676181|NCT00586469|4095761|P2|COMPLETED|Overall Study||499
1676182|NCT00586469|4095762|P1|COMPLETED|Overall Study||500
1676183|NCT00586469|4095761|P2|STARTED|Overall Study||500
1676184|NCT00586469|4095762|P1|STARTED|Overall Study||500
1676185|NCT00586339|4095789|P3|NOT COMPLETED|Overall Study||6
1676186|NCT00586339|4095790|P2|NOT COMPLETED|Overall Study||7
1676187|NCT00586339|4095791|P1|NOT COMPLETED|Overall Study||7
1676188|NCT00586339|4095789|P3|COMPLETED|Overall Study||24
1676189|NCT00586339|4095790|P2|COMPLETED|Overall Study||52
1676190|NCT00586339|4095791|P1|COMPLETED|Overall Study||54
1676191|NCT00586339|4095789|P3|STARTED|Overall Study||30
1676192|NCT00586339|4095790|P2|STARTED|Overall Study||59
1676193|NCT00586339|4095791|P1|STARTED|Overall Study||61
1676194|NCT00586326|4095889|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
1676195|NCT00586326|4095889|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
1676196|NCT00586326|4095889|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
1676197|NCT00586326|4095889|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
1676198|NCT00586326|4095889|P1|COMPLETED|Device Placed toTreatment-ITT||100
1676199|NCT00586326|4095889|P1|STARTED|Device Placed toTreatment-ITT||118
1676200|NCT00586326|4095889|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
1676201|NCT00586326|4095889|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
1676202|NCT00586326|4095889|P1|STARTED|Enrollment to Device Placement-Enrolled||133
1676203|NCT00586313|4095900|P1|NOT COMPLETED|Overall Study||2
1676204|NCT00586313|4095900|P1|COMPLETED|Overall Study||19
1676205|NCT00586313|4095900|P1|STARTED|Overall Study||21
1676206|NCT00586261|4095907|P2|NOT COMPLETED|Overall Study||0
1676207|NCT00586261|4095908|P1|NOT COMPLETED|Overall Study||0
1676208|NCT00586261|4095907|P2|COMPLETED|Overall Study||19
1676209|NCT00586261|4095908|P1|COMPLETED|Overall Study||17
1676210|NCT00586261|4095907|P2|STARTED|Overall Study||19
1676211|NCT00586261|4095908|P1|STARTED|Overall Study||17
1676212|NCT00586196|4095916|P2|NOT COMPLETED|Overall Study||0
1676213|NCT00586196|4095917|P1|NOT COMPLETED|Overall Study||0
1676214|NCT00586196|4095916|P2|COMPLETED|Overall Study||9
1676215|NCT00586196|4095917|P1|COMPLETED|Overall Study||7
1676216|NCT00586196|4095916|P2|STARTED|Overall Study||9
1676217|NCT00586196|4095917|P1|STARTED|Overall Study||7
1676218|NCT00586170|4095927|P2|NOT COMPLETED|Overall Study||0
1676219|NCT00586170|4095928|P1|NOT COMPLETED|Overall Study||0
1676220|NCT00586170|4095927|P2|COMPLETED|Overall Study||3
1676221|NCT00586170|4095928|P1|COMPLETED|Overall Study||5
1676222|NCT00586170|4095927|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
1676223|NCT00586170|4095928|P1|STARTED|Overall Study||5
1676224|NCT00586157|4095936|P2|NOT COMPLETED|Second Intervention||1
1676225|NCT00586157|4095937|P1|NOT COMPLETED|Second Intervention||2
1676226|NCT00586157|4095936|P2|COMPLETED|Second Intervention||14
1676227|NCT00586157|4095937|P1|COMPLETED|Second Intervention||12
1676228|NCT00586157|4095936|P2|STARTED|Second Intervention||15
1676229|NCT00586157|4095937|P1|STARTED|Second Intervention||14
1676230|NCT00586157|4095936|P2|NOT COMPLETED|First Intervention||0
1676231|NCT00586157|4095937|P1|NOT COMPLETED|First Intervention||1
1676232|NCT00586157|4095936|P2|COMPLETED|First Intervention||15
1676233|NCT00586157|4095937|P1|COMPLETED|First Intervention||14
1676234|NCT00586157|4095936|P2|STARTED|First Intervention||15
1676235|NCT00586157|4095937|P1|STARTED|First Intervention||15
1676236|NCT00586105|4095947|P1|NOT COMPLETED|Overall Study||39
1676237|NCT00586105|4095947|P1|COMPLETED|Overall Study||0
1676238|NCT00586105|4095947|P1|STARTED|Overall Study||39
1676239|NCT00586066|4095962|P2|NOT COMPLETED|Overall Study||10
1676240|NCT00586066|4095963|P1|NOT COMPLETED|Overall Study||18
1676241|NCT00586066|4095962|P2|COMPLETED|Overall Study||14
1676242|NCT00586066|4095963|P1|COMPLETED|Overall Study||30
1676243|NCT00586066|4095962|P2|STARTED|Overall Study||24
1676244|NCT00586066|4095963|P1|STARTED|Overall Study||48
1676245|NCT00586001|4095975|P2|NOT COMPLETED|Overall Study||1
1676246|NCT00586001|4095976|P1|NOT COMPLETED|Overall Study||4
1676247|NCT00586001|4095975|P2|COMPLETED|Overall Study||10
1676248|NCT00586001|4095976|P1|COMPLETED|Overall Study||22
1676249|NCT00586001|4095975|P2|STARTED|Overall Study||11
1676250|NCT00586001|4095976|P1|STARTED|Overall Study||26
1676251|NCT00585975|4096020|P2|NOT COMPLETED|Overall Study||13
1676252|NCT00585975|4096021|P1|NOT COMPLETED|Overall Study||15
1676253|NCT00585975|4096020|P2|COMPLETED|Overall Study||278
1676254|NCT00585975|4096021|P1|COMPLETED|Overall Study||262
1676255|NCT00585975|4096020|P2|STARTED|Overall Study||291
1676256|NCT00585975|4096021|P1|STARTED|Overall Study||277
1676257|NCT00585923|4096031|P2|NOT COMPLETED|Overall Study||33
1676258|NCT00585923|4096032|P1|NOT COMPLETED|Overall Study||31
1676259|NCT00585923|4096031|P2|COMPLETED|Overall Study||26
1676260|NCT00585923|4096032|P1|COMPLETED|Overall Study||25
1676261|NCT00585923|4096031|P2|STARTED|Overall Study||59
1676262|NCT00585923|4096032|P1|STARTED|Overall Study||56
1676263|NCT00585910|4096046|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
1676264|NCT00585910|4096046|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
1676265|NCT00585910|4096046|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
1676266|NCT00585910|4096046|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
1676267|NCT00585910|4096046|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
1676268|NCT00585910|4096046|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
1676269|NCT00585715|4096054|P2|NOT COMPLETED|Overall Study||0
1676270|NCT00585715|4096055|P1|NOT COMPLETED|Overall Study||3
1676271|NCT00585715|4096054|P2|COMPLETED|Overall Study||11
1676272|NCT00585715|4096055|P1|COMPLETED|Overall Study||8
1676273|NCT00585715|4096054|P2|STARTED|Overall Study||11
1676274|NCT00585715|4096055|P1|STARTED|Overall Study||11
1676275|NCT00585689|4096063|P1|NOT COMPLETED|Overall Study||7
1676276|NCT00585689|4096063|P1|COMPLETED|Overall Study||22
1676277|NCT00585689|4096063|P1|STARTED|Overall Study||29
1676278|NCT00585650|4096069|P2|NOT COMPLETED|Overall Study||0
1676279|NCT00585650|4096070|P1|NOT COMPLETED|Overall Study||0
1676280|NCT00585650|4096069|P2|COMPLETED|Overall Study||12
1676281|NCT00585650|4096070|P1|COMPLETED|Overall Study||8
1676282|NCT00585650|4096069|P2|STARTED|Overall Study||12
1676283|NCT00585650|4096070|P1|STARTED|Overall Study||8
1676284|NCT00585637|4096080|P4|NOT COMPLETED|6-month Time Point||6
1676285|NCT00585637|4096081|P3|NOT COMPLETED|6-month Time Point||11
1676286|NCT00585637|4096082|P2|NOT COMPLETED|6-month Time Point||13
1676287|NCT00585637|4096083|P1|NOT COMPLETED|6-month Time Point||6
1676288|NCT00585637|4096080|P4|COMPLETED|6-month Time Point||77
1676289|NCT00585637|4096081|P3|COMPLETED|6-month Time Point||72
1676290|NCT00585637|4096082|P2|COMPLETED|6-month Time Point||68
1676291|NCT00585637|4096083|P1|COMPLETED|6-month Time Point||75
1676292|NCT00585637|4096080|P4|STARTED|6-month Time Point||83
1676293|NCT00585637|4096081|P3|STARTED|6-month Time Point||83
1676294|NCT00585637|4096082|P2|STARTED|6-month Time Point||81
1676295|NCT00585637|4096083|P1|STARTED|6-month Time Point||81
1676296|NCT00585637|4096080|P4|NOT COMPLETED|3-month Time Point||5
1676297|NCT00585637|4096081|P3|NOT COMPLETED|3-month Time Point||7
1676298|NCT00585637|4096082|P2|NOT COMPLETED|3-month Time Point||14
1676299|NCT00585637|4096083|P1|NOT COMPLETED|3-month Time Point||10
1676300|NCT00585637|4096080|P4|COMPLETED|3-month Time Point||78
1676301|NCT00585637|4096081|P3|COMPLETED|3-month Time Point||76
1676302|NCT00585637|4096082|P2|COMPLETED|3-month Time Point||67
1676303|NCT00585637|4096083|P1|COMPLETED|3-month Time Point||71
1676304|NCT00585637|4096080|P4|STARTED|3-month Time Point||83
1676305|NCT00585637|4096081|P3|STARTED|3-month Time Point||83
1676306|NCT00585637|4096082|P2|STARTED|3-month Time Point||81
1676307|NCT00585637|4096083|P1|STARTED|3-month Time Point||81
1676308|NCT00585637|4096080|P4|NOT COMPLETED|Baseline||0
1676309|NCT00585637|4096081|P3|NOT COMPLETED|Baseline||0
1676310|NCT00585637|4096082|P2|NOT COMPLETED|Baseline||0
1676311|NCT00585637|4096083|P1|NOT COMPLETED|Baseline||0
1676312|NCT00585637|4096080|P4|COMPLETED|Baseline||83
1676313|NCT00585637|4096081|P3|COMPLETED|Baseline||83
1676314|NCT00585637|4096082|P2|COMPLETED|Baseline||81
1676315|NCT00585637|4096083|P1|COMPLETED|Baseline||81
1676316|NCT00585637|4096080|P4|STARTED|Baseline||83
1676317|NCT00585637|4096081|P3|STARTED|Baseline||83
1676318|NCT00585637|4096082|P2|STARTED|Baseline||81
1676319|NCT00585637|4096083|P1|STARTED|Baseline||81
1676320|NCT00585585|4096109|P1|NOT COMPLETED|Overall Study||1
1676321|NCT00585585|4096109|P1|COMPLETED|Overall Study||0
1676322|NCT00585585|4096109|P1|Patients Receiving Drug|Overall Study||1
1676323|NCT00585585|4096109|P1|STARTED|Overall Study||1
1676324|NCT00585546|4096113|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
1676325|NCT00585546|4096113|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
1676326|NCT00585546|4096113|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
1676327|NCT00585546|4096113|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
1676328|NCT00585546|4096113|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
1676329|NCT00585546|4096113|P1|STARTED|LVAD Implantation Required for 4 Months||18
1676330|NCT00585533|4096127|P1|NOT COMPLETED|Overall Study||9
1676331|NCT00585533|4096127|P1|COMPLETED|Overall Study||31
1676332|NCT00585533|4096127|P1|STARTED|Overall Study||40
1676333|NCT00585494|4096132|P1|NOT COMPLETED|Overall Study||56
1676334|NCT00585494|4096132|P1|COMPLETED|Overall Study||244
1676335|NCT00585494|4096132|P1|STARTED|Overall Study||300
1676336|NCT00585468|4096136|P2|NOT COMPLETED|Second Intervention||0
1676337|NCT00585468|4096137|P1|NOT COMPLETED|Second Intervention||0
1676338|NCT00585468|4096136|P2|COMPLETED|Second Intervention||10
1676339|NCT00585468|4096137|P1|COMPLETED|Second Intervention||9
1676340|NCT00585468|4096136|P2|STARTED|Second Intervention||10
1676341|NCT00585468|4096137|P1|STARTED|Second Intervention||9
1676342|NCT00585468|4096136|P2|NOT COMPLETED|First Intervention||1
1676343|NCT00585468|4096137|P1|NOT COMPLETED|First Intervention||1
1676344|NCT00585468|4096136|P2|COMPLETED|First Intervention||10
1676345|NCT00585468|4096137|P1|COMPLETED|First Intervention||9
1676346|NCT00585468|4096136|P2|STARTED|First Intervention||11
1676347|NCT00585468|4096137|P1|STARTED|First Intervention||10
1676348|NCT00585377|4096157|P1|NOT COMPLETED|Overall Study||0
1676349|NCT00585377|4096157|P1|COMPLETED|Overall Study||50
1676350|NCT00585377|4096157|P1|STARTED|Overall Study||50
1676351|NCT00585351|4096169|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
1676352|NCT00585351|4096170|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
1676353|NCT00585351|4096171|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
1676354|NCT00585351|4096172|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
1676355|NCT00585351|4096173|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
1676356|NCT00585351|4096174|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
1676357|NCT00585351|4096175|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
1676358|NCT00585351|4096176|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
1676359|NCT00585351|4096169|P8|COMPLETED|Enrollment Period (Intervention)||2
1676360|NCT00585351|4096170|P7|COMPLETED|Enrollment Period (Intervention)||5
1676361|NCT00585351|4096171|P6|COMPLETED|Enrollment Period (Intervention)||5
1676362|NCT00585351|4096172|P5|COMPLETED|Enrollment Period (Intervention)||3
1676363|NCT00585351|4096173|P4|COMPLETED|Enrollment Period (Intervention)||15
1676364|NCT00585351|4096174|P3|COMPLETED|Enrollment Period (Intervention)||15
1676365|NCT00585351|4096175|P2|COMPLETED|Enrollment Period (Intervention)||0
1676366|NCT00585351|4096176|P1|COMPLETED|Enrollment Period (Intervention)||0
1676367|NCT00585351|4096169|P8|STARTED|Enrollment Period (Intervention)||3
1676368|NCT00585351|4096170|P7|STARTED|Enrollment Period (Intervention)||7
1676369|NCT00585351|4096171|P6|STARTED|Enrollment Period (Intervention)||7
1676370|NCT00585351|4096172|P5|STARTED|Enrollment Period (Intervention)||5
1676371|NCT00585351|4096173|P4|STARTED|Enrollment Period (Intervention)||15
1676372|NCT00585351|4096174|P3|STARTED|Enrollment Period (Intervention)||15
1676373|NCT00585351|4096175|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
1676374|NCT00585351|4096176|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
1676375|NCT00585351|4096169|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
1676376|NCT00585351|4096170|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
1676377|NCT00585351|4096171|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
1676378|NCT00585351|4096172|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
1676379|NCT00585351|4096173|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
1676380|NCT00585351|4096174|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
1676381|NCT00585351|4096175|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
1676382|NCT00585351|4096176|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
1676383|NCT00585351|4096169|P8|COMPLETED|Notification Period (Informed Consent)||0
1676384|NCT00585351|4096170|P7|COMPLETED|Notification Period (Informed Consent)||0
1676385|NCT00585351|4096171|P6|COMPLETED|Notification Period (Informed Consent)||0
1676386|NCT00585351|4096172|P5|COMPLETED|Notification Period (Informed Consent)||0
1676387|NCT00585351|4096173|P4|COMPLETED|Notification Period (Informed Consent)||0
1676388|NCT00585351|4096174|P3|COMPLETED|Notification Period (Informed Consent)||0
1676389|NCT00585351|4096175|P2|COMPLETED|Notification Period (Informed Consent)||25
1676390|NCT00585351|4096176|P1|COMPLETED|Notification Period (Informed Consent)||27
1676391|NCT00585351|4096169|P8|STARTED|Notification Period (Informed Consent)||0
1676392|NCT00585351|4096170|P7|STARTED|Notification Period (Informed Consent)||0
1676393|NCT00585351|4096171|P6|STARTED|Notification Period (Informed Consent)||0
1676394|NCT00585351|4096172|P5|STARTED|Notification Period (Informed Consent)||0
1676395|NCT00585351|4096173|P4|STARTED|Notification Period (Informed Consent)||0
1676396|NCT00585351|4096174|P3|STARTED|Notification Period (Informed Consent)||0
1676397|NCT00585351|4096175|P2|STARTED|Notification Period (Informed Consent)||50
1676398|NCT00585351|4096176|P1|STARTED|Notification Period (Informed Consent)||50
1676399|NCT00585325|4096192|P2|NOT COMPLETED|Overall Study||1
1676400|NCT00585325|4096193|P1|NOT COMPLETED|Overall Study||1
1676401|NCT00585325|4096192|P2|COMPLETED|Overall Study||12
1676402|NCT00585325|4096193|P1|COMPLETED|Overall Study||9
1676403|NCT00585325|4096192|P2|STARTED|Overall Study||13
1676404|NCT00585325|4096193|P1|STARTED|Overall Study||10
1676405|NCT00585312|4096201|P2|NOT COMPLETED|Overall Study||44
1676406|NCT00585312|4096202|P1|NOT COMPLETED|Overall Study||51
1676407|NCT00585312|4096201|P2|COMPLETED|Overall Study||7
1676408|NCT00585312|4096202|P1|COMPLETED|Overall Study||4
1676409|NCT00585312|4096201|P2|Treated|Overall Study||48
1676410|NCT00585312|4096202|P1|Treated|Overall Study||53
1676411|NCT00585312|4096201|P2|STARTED|Overall Study|STARTED=Randomized|51
1676412|NCT00585312|4096202|P1|STARTED|Overall Study|STARTED=Randomized|55
1676413|NCT00585286|4096214|P1|NOT COMPLETED|Overall Study||1
1676414|NCT00585286|4096214|P1|COMPLETED|Overall Study||14
1676415|NCT00585286|4096214|P1|STARTED|Overall Study||15
1676416|NCT00585247|4096223|P2|NOT COMPLETED|Overall Study||0
1676417|NCT00585247|4096224|P1|NOT COMPLETED|Overall Study||0
1676418|NCT00585247|4096223|P2|COMPLETED|Overall Study||13
1676419|NCT00585247|4096224|P1|COMPLETED|Overall Study||14
1676420|NCT00585247|4096223|P2|STARTED|Overall Study||13
1676421|NCT00585247|4096224|P1|STARTED|Overall Study||14
1676422|NCT00585221|4096230|P1|NOT COMPLETED|Overall Study||8
1676423|NCT00585221|4096230|P1|COMPLETED|Overall Study||0
1676424|NCT00585221|4096230|P1|STARTED|Overall Study||8
1676425|NCT00585182|4096235|P1|NOT COMPLETED|Overall Study||0
1676426|NCT00585182|4096235|P1|COMPLETED|Overall Study||28
1676427|NCT00585182|4096235|P1|STARTED|Overall Study||28
1676428|NCT00585169|4096240|P1|NOT COMPLETED|Overall Study||1
1676429|NCT00585169|4096240|P1|COMPLETED|Overall Study||28
1676430|NCT00585169|4096240|P1|STARTED|Overall Study||29
1676431|NCT00585104|4096246|P1|NOT COMPLETED|Overall Study||4
1676432|NCT00585104|4096246|P1|COMPLETED|Overall Study||6
1676433|NCT00585104|4096246|P1|STARTED|Overall Study||10
1676434|NCT00585078|4096250|P1|NOT COMPLETED|Overall Study||40
1676435|NCT00585078|4096250|P1|COMPLETED|Overall Study||0
1676436|NCT00585078|4096250|P1|Response Evaluable|Overall Study||24
1676437|NCT00585078|4096250|P1|Toxicity Evaluable|Overall Study||36
1676438|NCT00585078|4096250|P1|Treated|Overall Study||37
1676439|NCT00585078|4096250|P1|STARTED|Overall Study||40
1676440|NCT00585052|4096257|P1|NOT COMPLETED|Overall Study||1
1676441|NCT00585052|4096257|P1|COMPLETED|Overall Study||10
1676442|NCT00585052|4096257|P1|STARTED|Overall Study||11
1676443|NCT00585039|4096264|P2|NOT COMPLETED|Overall Study||0
1676444|NCT00585039|4096265|P1|NOT COMPLETED|Overall Study||2
1676445|NCT00585039|4096264|P2|COMPLETED|Overall Study||44
1676446|NCT00585039|4096265|P1|COMPLETED|Overall Study||55
1676447|NCT00585039|4096264|P2|STARTED|Overall Study||44
1676448|NCT00585039|4096265|P1|STARTED|Overall Study||57
1676449|NCT00585013|4096275|P2|NOT COMPLETED|Overall Study||0
1676450|NCT00585013|4096276|P1|NOT COMPLETED|Overall Study||0
1676451|NCT00585013|4096275|P2|COMPLETED|Overall Study||8
1676452|NCT00585013|4096276|P1|COMPLETED|Overall Study||8
1676453|NCT00585013|4096275|P2|STARTED|Overall Study||8
1676454|NCT00585013|4096276|P1|STARTED|Overall Study||8
1676455|NCT00584987|4096294|P4|NOT COMPLETED|Overall Study||1
1676456|NCT00584987|4096295|P3|NOT COMPLETED|Overall Study||1
1676457|NCT00584987|4096296|P2|NOT COMPLETED|Overall Study||1
1676458|NCT00584987|4096297|P1|NOT COMPLETED|Overall Study||1
1676459|NCT00584987|4096294|P4|COMPLETED|Overall Study||15
1676460|NCT00584987|4096295|P3|COMPLETED|Overall Study||16
1676461|NCT00584987|4096296|P2|COMPLETED|Overall Study||15
1676462|NCT00584987|4096297|P1|COMPLETED|Overall Study||14
1676463|NCT00584987|4096294|P4|STARTED|Overall Study||16
1676464|NCT00584987|4096295|P3|STARTED|Overall Study||17
1676465|NCT00584987|4096296|P2|STARTED|Overall Study||16
1676466|NCT00584987|4096297|P1|STARTED|Overall Study||15
1676467|NCT00584948|4096329|P2|NOT COMPLETED|Overall Study||11
1676468|NCT00584948|4096330|P1|NOT COMPLETED|Overall Study||13
1676469|NCT00584948|4096329|P2|COMPLETED|Overall Study||36
1676470|NCT00584948|4096330|P1|COMPLETED|Overall Study||34
1676471|NCT00584948|4096329|P2|STARTED|Overall Study||47
1676472|NCT00584948|4096330|P1|STARTED|Overall Study||47
1676473|NCT00584935|4096338|P1|NOT COMPLETED|Overall Study||0
1676474|NCT00584935|4096338|P1|COMPLETED|Overall Study||3
1676475|NCT00584935|4096338|P1|STARTED|Overall Study||3
1676476|NCT00584909|4096345|P1|NOT COMPLETED|Overall Study||4
1676477|NCT00584909|4096345|P1|COMPLETED|Overall Study||9
1676478|NCT00584909|4096345|P1|STARTED|Overall Study||13
1676479|NCT00584857|4096350|P1|NOT COMPLETED|Overall Study||0
1676480|NCT00584857|4096350|P1|COMPLETED|Overall Study||30
1676481|NCT00584857|4096350|P1|STARTED|Overall Study||30
1676482|NCT00584844|4096355|P1|NOT COMPLETED|Overall Study||79
1676483|NCT00584844|4096355|P1|COMPLETED|Overall Study||405
1676484|NCT00584844|4096355|P1|STARTED|Overall Study||484
1676485|NCT00584831|4096365|P19|NOT COMPLETED|Intervention 4||0
1676486|NCT00584831|4096366|P18|NOT COMPLETED|Intervention 4||0
1676487|NCT00584831|4096367|P17|NOT COMPLETED|Intervention 4||0
1676488|NCT00584831|4096368|P16|NOT COMPLETED|Intervention 4||0
1676489|NCT00584831|4096369|P15|NOT COMPLETED|Intervention 4||0
1676490|NCT00584831|4096370|P14|NOT COMPLETED|Intervention 4||0
1676491|NCT00584831|4096371|P13|NOT COMPLETED|Intervention 4||0
1676492|NCT00584831|4096372|P12|NOT COMPLETED|Intervention 4||0
1676493|NCT00584831|4096373|P11|NOT COMPLETED|Intervention 4||0
1676494|NCT00584831|4096374|P10|NOT COMPLETED|Intervention 4||0
1676495|NCT00584831|4096375|P9|NOT COMPLETED|Intervention 4||0
1676496|NCT00584831|4096376|P8|NOT COMPLETED|Intervention 4||0
1676497|NCT00584831|4096377|P7|NOT COMPLETED|Intervention 4||0
1676498|NCT00584831|4096378|P6|NOT COMPLETED|Intervention 4||0
1676499|NCT00584831|4096379|P5|NOT COMPLETED|Intervention 4||0
1676500|NCT00584831|4096380|P4|NOT COMPLETED|Intervention 4||0
1676501|NCT00584831|4096381|P3|NOT COMPLETED|Intervention 4||0
1676502|NCT00584831|4096382|P2|NOT COMPLETED|Intervention 4||0
1676503|NCT00584831|4096383|P1|NOT COMPLETED|Intervention 4||0
1676504|NCT00584831|4096365|P19|COMPLETED|Intervention 4||1
1676505|NCT00584831|4096366|P18|COMPLETED|Intervention 4||1
1676506|NCT00584831|4096367|P17|COMPLETED|Intervention 4||4
1676507|NCT00584831|4096368|P16|COMPLETED|Intervention 4||1
1676508|NCT00584831|4096369|P15|COMPLETED|Intervention 4||2
1676509|NCT00584831|4096370|P14|COMPLETED|Intervention 4||1
1676510|NCT00584831|4096371|P13|COMPLETED|Intervention 4||2
1676511|NCT00584831|4096372|P12|COMPLETED|Intervention 4||1
1676512|NCT00584831|4096373|P11|COMPLETED|Intervention 4||2
1676513|NCT00584831|4096374|P10|COMPLETED|Intervention 4||2
1676514|NCT00584831|4096375|P9|COMPLETED|Intervention 4||3
1676515|NCT00584831|4096376|P8|COMPLETED|Intervention 4||2
1676516|NCT00584831|4096377|P7|COMPLETED|Intervention 4||6
1676517|NCT00584831|4096378|P6|COMPLETED|Intervention 4||1
1676518|NCT00584831|4096379|P5|COMPLETED|Intervention 4||2
1676519|NCT00584831|4096380|P4|COMPLETED|Intervention 4||1
1676520|NCT00584831|4096381|P3|COMPLETED|Intervention 4||2
1676521|NCT00584831|4096382|P2|COMPLETED|Intervention 4||3
1676522|NCT00584831|4096383|P1|COMPLETED|Intervention 4||1
1676523|NCT00584831|4096365|P19|STARTED|Intervention 4||1
1676524|NCT00584831|4096366|P18|STARTED|Intervention 4||1
1676525|NCT00584831|4096367|P17|STARTED|Intervention 4||4
1676526|NCT00584831|4096368|P16|STARTED|Intervention 4||1
1676527|NCT00584831|4096369|P15|STARTED|Intervention 4||2
1676528|NCT00584831|4096370|P14|STARTED|Intervention 4||1
1676529|NCT00584831|4096371|P13|STARTED|Intervention 4||2
1676530|NCT00584831|4096372|P12|STARTED|Intervention 4||1
1676531|NCT00584831|4096373|P11|STARTED|Intervention 4||2
1676532|NCT00584831|4096374|P10|STARTED|Intervention 4||2
1676533|NCT00584831|4096375|P9|STARTED|Intervention 4||3
1676534|NCT00584831|4096376|P8|STARTED|Intervention 4||2
1676535|NCT00584831|4096377|P7|STARTED|Intervention 4||6
1676536|NCT00584831|4096378|P6|STARTED|Intervention 4||1
1676537|NCT00584831|4096379|P5|STARTED|Intervention 4||2
1676538|NCT00584831|4096380|P4|STARTED|Intervention 4||1
1676539|NCT00584831|4096381|P3|STARTED|Intervention 4||2
1676540|NCT00584831|4096382|P2|STARTED|Intervention 4||3
1676541|NCT00584831|4096383|P1|STARTED|Intervention 4||1
1676542|NCT00584831|4096365|P19|NOT COMPLETED|Intervention 3||0
1676543|NCT00584831|4096366|P18|NOT COMPLETED|Intervention 3||0
1676544|NCT00584831|4096367|P17|NOT COMPLETED|Intervention 3||0
1676545|NCT00584831|4096368|P16|NOT COMPLETED|Intervention 3||0
1676546|NCT00584831|4096369|P15|NOT COMPLETED|Intervention 3||0
1676547|NCT00584831|4096370|P14|NOT COMPLETED|Intervention 3||0
1676548|NCT00584831|4096371|P13|NOT COMPLETED|Intervention 3||0
1676549|NCT00584831|4096372|P12|NOT COMPLETED|Intervention 3||0
1676550|NCT00584831|4096373|P11|NOT COMPLETED|Intervention 3||0
1676551|NCT00584831|4096374|P10|NOT COMPLETED|Intervention 3||0
1676552|NCT00584831|4096375|P9|NOT COMPLETED|Intervention 3||0
1676553|NCT00584831|4096376|P8|NOT COMPLETED|Intervention 3||0
1676554|NCT00584831|4096377|P7|NOT COMPLETED|Intervention 3||0
1676555|NCT00584831|4096378|P6|NOT COMPLETED|Intervention 3||0
1676556|NCT00584831|4096379|P5|NOT COMPLETED|Intervention 3||0
1676557|NCT00584831|4096380|P4|NOT COMPLETED|Intervention 3||0
1676558|NCT00584831|4096381|P3|NOT COMPLETED|Intervention 3||0
1676559|NCT00584831|4096382|P2|NOT COMPLETED|Intervention 3||0
1676560|NCT00584831|4096383|P1|NOT COMPLETED|Intervention 3||0
1676561|NCT00584831|4096365|P19|COMPLETED|Intervention 3||1
1676562|NCT00584831|4096366|P18|COMPLETED|Intervention 3||1
1676563|NCT00584831|4096367|P17|COMPLETED|Intervention 3||4
1676564|NCT00584831|4096368|P16|COMPLETED|Intervention 3||1
1676565|NCT00584831|4096369|P15|COMPLETED|Intervention 3||3
1676566|NCT00584831|4096370|P14|COMPLETED|Intervention 3||1
1676567|NCT00584831|4096371|P13|COMPLETED|Intervention 3||2
1676568|NCT00584831|4096372|P12|COMPLETED|Intervention 3||1
1676569|NCT00584831|4096373|P11|COMPLETED|Intervention 3||2
1676570|NCT00584831|4096374|P10|COMPLETED|Intervention 3||2
1676571|NCT00584831|4096375|P9|COMPLETED|Intervention 3||4
1676572|NCT00584831|4096376|P8|COMPLETED|Intervention 3||2
1676573|NCT00584831|4096377|P7|COMPLETED|Intervention 3||6
1676574|NCT00584831|4096378|P6|COMPLETED|Intervention 3||1
1676575|NCT00584831|4096379|P5|COMPLETED|Intervention 3||2
1676576|NCT00584831|4096380|P4|COMPLETED|Intervention 3||1
1676577|NCT00584831|4096381|P3|COMPLETED|Intervention 3||2
1676578|NCT00584831|4096382|P2|COMPLETED|Intervention 3||3
1676579|NCT00584831|4096383|P1|COMPLETED|Intervention 3||1
1676580|NCT00584831|4096365|P19|STARTED|Intervention 3||1
1676581|NCT00584831|4096366|P18|STARTED|Intervention 3||1
1676582|NCT00584831|4096367|P17|STARTED|Intervention 3||4
1676583|NCT00584831|4096368|P16|STARTED|Intervention 3||1
1676584|NCT00584831|4096369|P15|STARTED|Intervention 3||3
1676585|NCT00584831|4096370|P14|STARTED|Intervention 3||1
1676586|NCT00584831|4096371|P13|STARTED|Intervention 3||2
1676587|NCT00584831|4096372|P12|STARTED|Intervention 3||1
1676588|NCT00584831|4096373|P11|STARTED|Intervention 3||2
1676589|NCT00584831|4096374|P10|STARTED|Intervention 3||2
1676590|NCT00584831|4096375|P9|STARTED|Intervention 3||4
1676591|NCT00584831|4096376|P8|STARTED|Intervention 3||2
1676592|NCT00584831|4096377|P7|STARTED|Intervention 3||6
1676593|NCT00584831|4096378|P6|STARTED|Intervention 3||1
1676594|NCT00584831|4096379|P5|STARTED|Intervention 3||2
1676595|NCT00584831|4096380|P4|STARTED|Intervention 3||1
1676596|NCT00584831|4096381|P3|STARTED|Intervention 3||2
1676597|NCT00584831|4096382|P2|STARTED|Intervention 3||3
1676598|NCT00584831|4096383|P1|STARTED|Intervention 3||1
1676599|NCT00584831|4096365|P19|NOT COMPLETED|Intervention 2||0
1676600|NCT00584831|4096366|P18|NOT COMPLETED|Intervention 2||0
1676601|NCT00584831|4096367|P17|NOT COMPLETED|Intervention 2||0
1676602|NCT00584831|4096368|P16|NOT COMPLETED|Intervention 2||0
1676603|NCT00584831|4096369|P15|NOT COMPLETED|Intervention 2||0
1676604|NCT00584831|4096370|P14|NOT COMPLETED|Intervention 2||0
1676605|NCT00584831|4096371|P13|NOT COMPLETED|Intervention 2||0
1676606|NCT00584831|4096372|P12|NOT COMPLETED|Intervention 2||0
1676607|NCT00584831|4096373|P11|NOT COMPLETED|Intervention 2||0
1676608|NCT00584831|4096374|P10|NOT COMPLETED|Intervention 2||0
1676609|NCT00584831|4096375|P9|NOT COMPLETED|Intervention 2||0
1676610|NCT00584831|4096376|P8|NOT COMPLETED|Intervention 2||0
1676611|NCT00584831|4096377|P7|NOT COMPLETED|Intervention 2||0
1676612|NCT00584831|4096378|P6|NOT COMPLETED|Intervention 2||0
1676613|NCT00584831|4096379|P5|NOT COMPLETED|Intervention 2||0
1676614|NCT00584831|4096380|P4|NOT COMPLETED|Intervention 2||0
1676615|NCT00584831|4096381|P3|NOT COMPLETED|Intervention 2||0
1676616|NCT00584831|4096382|P2|NOT COMPLETED|Intervention 2||0
1676617|NCT00584831|4096383|P1|NOT COMPLETED|Intervention 2||0
1676618|NCT00584831|4096365|P19|COMPLETED|Intervention 2||1
1676619|NCT00584831|4096366|P18|COMPLETED|Intervention 2||1
1676620|NCT00584831|4096367|P17|COMPLETED|Intervention 2||4
1676621|NCT00584831|4096368|P16|COMPLETED|Intervention 2||1
1676622|NCT00584831|4096369|P15|COMPLETED|Intervention 2||3
1676623|NCT00584831|4096370|P14|COMPLETED|Intervention 2||1
1676624|NCT00584831|4096371|P13|COMPLETED|Intervention 2||2
1676625|NCT00584831|4096372|P12|COMPLETED|Intervention 2||1
1676626|NCT00584831|4096373|P11|COMPLETED|Intervention 2||2
1676627|NCT00584831|4096374|P10|COMPLETED|Intervention 2||2
1676628|NCT00584831|4096375|P9|COMPLETED|Intervention 2||4
1676629|NCT00584831|4096376|P8|COMPLETED|Intervention 2||2
1676630|NCT00584831|4096377|P7|COMPLETED|Intervention 2||6
1676631|NCT00584831|4096378|P6|COMPLETED|Intervention 2||1
1676632|NCT00584831|4096379|P5|COMPLETED|Intervention 2||2
1676633|NCT00584831|4096380|P4|COMPLETED|Intervention 2||1
1676634|NCT00584831|4096381|P3|COMPLETED|Intervention 2||2
1676635|NCT00584831|4096382|P2|COMPLETED|Intervention 2||3
1676636|NCT00584831|4096383|P1|COMPLETED|Intervention 2||1
1676637|NCT00584831|4096365|P19|STARTED|Intervention 2||1
1676638|NCT00584831|4096366|P18|STARTED|Intervention 2||1
1676639|NCT00584831|4096367|P17|STARTED|Intervention 2||4
1676640|NCT00584831|4096368|P16|STARTED|Intervention 2||1
1676641|NCT00584831|4096369|P15|STARTED|Intervention 2||3
1676642|NCT00584831|4096370|P14|STARTED|Intervention 2||1
1676643|NCT00584831|4096371|P13|STARTED|Intervention 2||2
1676644|NCT00584831|4096372|P12|STARTED|Intervention 2||1
1676645|NCT00584831|4096373|P11|STARTED|Intervention 2||2
1676646|NCT00584831|4096374|P10|STARTED|Intervention 2||2
1676647|NCT00584831|4096375|P9|STARTED|Intervention 2||4
1676648|NCT00584831|4096376|P8|STARTED|Intervention 2||2
1676649|NCT00584831|4096377|P7|STARTED|Intervention 2||6
1676650|NCT00584831|4096378|P6|STARTED|Intervention 2||1
1676651|NCT00584831|4096379|P5|STARTED|Intervention 2||2
1676652|NCT00584831|4096380|P4|STARTED|Intervention 2||1
1676653|NCT00584831|4096381|P3|STARTED|Intervention 2||2
1676654|NCT00584831|4096382|P2|STARTED|Intervention 2||3
1676655|NCT00584831|4096383|P1|STARTED|Intervention 2||1
1676656|NCT00584831|4096365|P19|NOT COMPLETED|Intervention 1||0
1676657|NCT00584831|4096366|P18|NOT COMPLETED|Intervention 1||0
1676658|NCT00584831|4096367|P17|NOT COMPLETED|Intervention 1||0
1676659|NCT00584831|4096368|P16|NOT COMPLETED|Intervention 1||0
1676660|NCT00584831|4096369|P15|NOT COMPLETED|Intervention 1||0
1676661|NCT00584831|4096370|P14|NOT COMPLETED|Intervention 1||0
1676662|NCT00584831|4096371|P13|NOT COMPLETED|Intervention 1||0
1676663|NCT00584831|4096372|P12|NOT COMPLETED|Intervention 1||0
1676664|NCT00584831|4096373|P11|NOT COMPLETED|Intervention 1||0
1676665|NCT00584831|4096374|P10|NOT COMPLETED|Intervention 1||0
1676666|NCT00584831|4096375|P9|NOT COMPLETED|Intervention 1||0
1676667|NCT00584831|4096376|P8|NOT COMPLETED|Intervention 1||0
1676668|NCT00584831|4096377|P7|NOT COMPLETED|Intervention 1||0
1676669|NCT00584831|4096378|P6|NOT COMPLETED|Intervention 1||0
1676670|NCT00584831|4096379|P5|NOT COMPLETED|Intervention 1||0
1676671|NCT00584831|4096380|P4|NOT COMPLETED|Intervention 1||0
1676672|NCT00584831|4096381|P3|NOT COMPLETED|Intervention 1||0
1676673|NCT00584831|4096382|P2|NOT COMPLETED|Intervention 1||0
1676674|NCT00584831|4096383|P1|NOT COMPLETED|Intervention 1||0
1676675|NCT00584831|4096365|P19|COMPLETED|Intervention 1||1
1676676|NCT00584831|4096366|P18|COMPLETED|Intervention 1||1
1676677|NCT00584831|4096367|P17|COMPLETED|Intervention 1||4
1676678|NCT00584831|4096368|P16|COMPLETED|Intervention 1||1
1676679|NCT00584831|4096369|P15|COMPLETED|Intervention 1||3
1676680|NCT00584831|4096370|P14|COMPLETED|Intervention 1||1
1676681|NCT00584831|4096371|P13|COMPLETED|Intervention 1||2
1676682|NCT00584831|4096372|P12|COMPLETED|Intervention 1||1
1676683|NCT00584831|4096373|P11|COMPLETED|Intervention 1||2
1676684|NCT00584831|4096374|P10|COMPLETED|Intervention 1||2
1676685|NCT00584831|4096375|P9|COMPLETED|Intervention 1||4
1676686|NCT00584831|4096376|P8|COMPLETED|Intervention 1||2
1676687|NCT00584831|4096377|P7|COMPLETED|Intervention 1||6
1676688|NCT00584831|4096378|P6|COMPLETED|Intervention 1||1
1676689|NCT00584831|4096379|P5|COMPLETED|Intervention 1||2
1676690|NCT00584831|4096380|P4|COMPLETED|Intervention 1||1
1676691|NCT00584831|4096381|P3|COMPLETED|Intervention 1||2
1676692|NCT00584831|4096382|P2|COMPLETED|Intervention 1||3
1676693|NCT00584831|4096383|P1|COMPLETED|Intervention 1||1
1676694|NCT00584831|4096365|P19|STARTED|Intervention 1||1
1676695|NCT00584831|4096366|P18|STARTED|Intervention 1||1
1676696|NCT00584831|4096367|P17|STARTED|Intervention 1||4
1676697|NCT00584831|4096368|P16|STARTED|Intervention 1||1
1676698|NCT00584831|4096369|P15|STARTED|Intervention 1||3
1676699|NCT00584831|4096370|P14|STARTED|Intervention 1||1
1676700|NCT00584831|4096371|P13|STARTED|Intervention 1||2
1676701|NCT00584831|4096372|P12|STARTED|Intervention 1||1
1676702|NCT00584831|4096373|P11|STARTED|Intervention 1||2
1676703|NCT00584831|4096374|P10|STARTED|Intervention 1||2
1676704|NCT00584831|4096375|P9|STARTED|Intervention 1||4
1676705|NCT00584831|4096376|P8|STARTED|Intervention 1||2
1676706|NCT00584831|4096377|P7|STARTED|Intervention 1||6
1676707|NCT00584831|4096378|P6|STARTED|Intervention 1||1
1676708|NCT00584831|4096379|P5|STARTED|Intervention 1||2
1676709|NCT00584831|4096380|P4|STARTED|Intervention 1||1
1676710|NCT00584831|4096381|P3|STARTED|Intervention 1||2
1676711|NCT00584831|4096382|P2|STARTED|Intervention 1||3
1676712|NCT00584831|4096383|P1|STARTED|Intervention 1||1
1676713|NCT00584740|4096407|P2|NOT COMPLETED|Overall Study||6
1676714|NCT00584740|4096408|P1|NOT COMPLETED|Overall Study||12
1676715|NCT00584740|4096407|P2|COMPLETED|Overall Study||14
1676716|NCT00584740|4096408|P1|COMPLETED|Overall Study||27
1676717|NCT00584740|4096407|P2|STARTED|Overall Study||20
1676718|NCT00584740|4096408|P1|STARTED|Overall Study||39
1676719|NCT00584727|4096426|P6|NOT COMPLETED|Third Intervention||2
1676720|NCT00584727|4096427|P5|NOT COMPLETED|Third Intervention||4
1676721|NCT00584727|4096428|P4|NOT COMPLETED|Third Intervention||0
1676722|NCT00584727|4096429|P3|NOT COMPLETED|Third Intervention||1
1676723|NCT00584727|4096430|P2|NOT COMPLETED|Third Intervention||0
1676724|NCT00584727|4096431|P1|NOT COMPLETED|Third Intervention||0
1676725|NCT00584727|4096426|P6|COMPLETED|Third Intervention||14
1676726|NCT00584727|4096427|P5|COMPLETED|Third Intervention||12
1676727|NCT00584727|4096428|P4|COMPLETED|Third Intervention||14
1676728|NCT00584727|4096429|P3|COMPLETED|Third Intervention||14
1676729|NCT00584727|4096430|P2|COMPLETED|Third Intervention||17
1676730|NCT00584727|4096431|P1|COMPLETED|Third Intervention||17
1676731|NCT00584727|4096426|P6|STARTED|Third Intervention||16
1676732|NCT00584727|4096427|P5|STARTED|Third Intervention||16
1676733|NCT00584727|4096428|P4|STARTED|Third Intervention||14
1676734|NCT00584727|4096429|P3|STARTED|Third Intervention||15
1676735|NCT00584727|4096430|P2|STARTED|Third Intervention||17
1676736|NCT00584727|4096431|P1|STARTED|Third Intervention||17
1676737|NCT00584727|4096426|P6|NOT COMPLETED|Second Intervention||0
1676738|NCT00584727|4096427|P5|NOT COMPLETED|Second Intervention||0
1676739|NCT00584727|4096428|P4|NOT COMPLETED|Second Intervention||0
1676740|NCT00584727|4096429|P3|NOT COMPLETED|Second Intervention||0
1676741|NCT00584727|4096430|P2|NOT COMPLETED|Second Intervention||0
1676742|NCT00584727|4096431|P1|NOT COMPLETED|Second Intervention||0
1676743|NCT00584727|4096426|P6|COMPLETED|Second Intervention||16
1676744|NCT00584727|4096427|P5|COMPLETED|Second Intervention||16
1676745|NCT00584727|4096428|P4|COMPLETED|Second Intervention||14
1676746|NCT00584727|4096429|P3|COMPLETED|Second Intervention||15
1676747|NCT00584727|4096430|P2|COMPLETED|Second Intervention||17
1676748|NCT00584727|4096431|P1|COMPLETED|Second Intervention||17
1676749|NCT00584727|4096426|P6|STARTED|Second Intervention||16
1676750|NCT00584727|4096427|P5|STARTED|Second Intervention||16
1676751|NCT00584727|4096428|P4|STARTED|Second Intervention||14
1676752|NCT00584727|4096429|P3|STARTED|Second Intervention||15
1676753|NCT00584727|4096430|P2|STARTED|Second Intervention||17
1676754|NCT00584727|4096431|P1|STARTED|Second Intervention||17
1676755|NCT00584727|4096426|P6|NOT COMPLETED|First Intervention||0
1676756|NCT00584727|4096427|P5|NOT COMPLETED|First Intervention||0
1676757|NCT00584727|4096428|P4|NOT COMPLETED|First Intervention||0
1676758|NCT00584727|4096429|P3|NOT COMPLETED|First Intervention||1
1676759|NCT00584727|4096430|P2|NOT COMPLETED|First Intervention||0
1676760|NCT00584727|4096431|P1|NOT COMPLETED|First Intervention||0
1676761|NCT00584727|4096426|P6|COMPLETED|First Intervention||16
1676762|NCT00584727|4096427|P5|COMPLETED|First Intervention||16
1676763|NCT00584727|4096428|P4|COMPLETED|First Intervention||14
1676764|NCT00584727|4096429|P3|COMPLETED|First Intervention||15
1676765|NCT00584727|4096430|P2|COMPLETED|First Intervention||17
1676766|NCT00584727|4096431|P1|COMPLETED|First Intervention||17
1676767|NCT00584727|4096426|P6|STARTED|First Intervention||16
1676768|NCT00584727|4096427|P5|STARTED|First Intervention||16
1676769|NCT00584727|4096428|P4|STARTED|First Intervention||14
1676770|NCT00584727|4096429|P3|STARTED|First Intervention||16
1676771|NCT00584727|4096430|P2|STARTED|First Intervention||17
1676772|NCT00584727|4096431|P1|STARTED|First Intervention||17
1676773|NCT00584701|4096455|P1|NOT COMPLETED|Follow-up||12
1676774|NCT00584701|4096455|P1|COMPLETED|Follow-up||34
1676775|NCT00584701|4096455|P1|STARTED|Follow-up||46
1676776|NCT00584701|4096455|P1|NOT COMPLETED|Active Risperidone||3
1676777|NCT00584701|4096455|P1|COMPLETED|Active Risperidone||46
1676778|NCT00584701|4096455|P1|STARTED|Active Risperidone||49
1676779|NCT00584558|4096460|P1|NOT COMPLETED|Overall Study||0
1676780|NCT00584558|4096460|P1|COMPLETED|Overall Study||2420
1676781|NCT00584558|4096460|P1|STARTED|Overall Study||2420
1676782|NCT00584480|4096465|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
1676783|NCT00584480|4096465|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
1676784|NCT00584480|4096465|P1|STARTED|Second 8 Weeks (40 Treatments)||10
1676785|NCT00584480|4096465|P1|NOT COMPLETED|4-Week Break From Treatment||0
1676786|NCT00584480|4096465|P1|COMPLETED|4-Week Break From Treatment||10
1676787|NCT00584480|4096465|P1|STARTED|4-Week Break From Treatment||10
1676788|NCT00584480|4096465|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
1676789|NCT00584480|4096465|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
1676790|NCT00584480|4096465|P1|STARTED|First 8 Weeks (40 Treatments)||10
1676791|NCT00584454|4096469|P1|NOT COMPLETED|Overall Study||4
1676792|NCT00584454|4096469|P1|COMPLETED|Overall Study||6
1676793|NCT00584454|4096469|P1|STARTED|Overall Study||10
1676794|NCT00584415|4096473|P1|NOT COMPLETED|Overall Study||7
1676795|NCT00584415|4096473|P1|COMPLETED|Overall Study||112
1676796|NCT00584415|4096473|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
1676797|NCT00584402|4096478|P1|NOT COMPLETED|Overall Study||0
1676798|NCT00584402|4096478|P1|COMPLETED|Overall Study||8
1676799|NCT00584402|4096478|P1|STARTED|Overall Study||8
1676800|NCT00584285|4096483|P1|NOT COMPLETED|Overall Study||0
1676801|NCT00584285|4096483|P1|COMPLETED|Overall Study||18
1676802|NCT00584285|4096483|P1|STARTED|Overall Study||18
1676803|NCT00584220|4096487|P2|NOT COMPLETED|Second Period||0
1676804|NCT00584220|4096488|P1|NOT COMPLETED|Second Period||0
1676805|NCT00584220|4096487|P2|COMPLETED|Second Period||39
1676806|NCT00584220|4096488|P1|COMPLETED|Second Period||48
1676807|NCT00584220|4096487|P2|STARTED|Second Period||39
1676808|NCT00584220|4096488|P1|STARTED|Second Period||48
1676809|NCT00584220|4096487|P2|NOT COMPLETED|First Period||0
1676810|NCT00584220|4096488|P1|NOT COMPLETED|First Period||0
1676811|NCT00584220|4096487|P2|COMPLETED|First Period||39
1676812|NCT00584220|4096488|P1|COMPLETED|First Period||48
1676813|NCT00584220|4096487|P2|STARTED|First Period||39
1676814|NCT00584220|4096488|P1|STARTED|First Period||48
1676815|NCT00584194|4096496|P1|NOT COMPLETED|Overall Study||135
1676816|NCT00584194|4096496|P1|COMPLETED|Overall Study||143
1676817|NCT00584194|4096496|P1|STARTED|Overall Study||278
1676818|NCT00584077|4096504|P1|NOT COMPLETED|Overall Study||0
1676819|NCT00584077|4096504|P1|COMPLETED|Overall Study||15
1676820|NCT00584077|4096504|P1|STARTED|Overall Study||15
1676821|NCT00584012|4096509|P1|NOT COMPLETED|Overall Study||1
1676822|NCT00584012|4096509|P1|COMPLETED|Overall Study||8
1676823|NCT00584012|4096509|P1|STARTED|Overall Study||9
1676824|NCT00583947|4096515|P2|NOT COMPLETED|Open Label Period||0
1676825|NCT00583947|4096516|P1|NOT COMPLETED|Open Label Period||0
1676826|NCT00583947|4096515|P2|COMPLETED|Open Label Period||24
1676827|NCT00583947|4096516|P1|COMPLETED|Open Label Period||22
1676828|NCT00583947|4096515|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
1676829|NCT00583947|4096516|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
1676830|NCT00583947|4096515|P2|NOT COMPLETED|Washout||0
1676831|NCT00583947|4096516|P1|NOT COMPLETED|Washout||0
1676832|NCT00583947|4096515|P2|COMPLETED|Washout||24
1676833|NCT00583947|4096516|P1|COMPLETED|Washout||22
1676834|NCT00583947|4096515|P2|STARTED|Washout||24
1676835|NCT00583947|4096516|P1|STARTED|Washout||22
1676836|NCT00583947|4096515|P2|NOT COMPLETED|Cross-over Period||2
1676837|NCT00583947|4096516|P1|NOT COMPLETED|Cross-over Period||5
1676838|NCT00583947|4096515|P2|COMPLETED|Cross-over Period||24
1676839|NCT00583947|4096516|P1|COMPLETED|Cross-over Period||22
1676840|NCT00583947|4096515|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
1676841|NCT00583947|4096516|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
1676842|NCT00583908|4096566|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676843|NCT00583908|4096567|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676844|NCT00583908|4096568|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676845|NCT00583908|4096569|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676846|NCT00583908|4096570|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676847|NCT00583908|4096571|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676848|NCT00583908|4096572|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676849|NCT00583908|4096573|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676850|NCT00583908|4096574|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676851|NCT00583908|4096575|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676852|NCT00583908|4096576|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676853|NCT00583908|4096577|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
1676854|NCT00583908|4096566|P12|COMPLETED|Period 4 - Fourth Intervention||1
1676855|NCT00583908|4096567|P11|COMPLETED|Period 4 - Fourth Intervention||1
1676856|NCT00583908|4096568|P10|COMPLETED|Period 4 - Fourth Intervention||1
1676857|NCT00583908|4096569|P9|COMPLETED|Period 4 - Fourth Intervention||1
1676858|NCT00583908|4096570|P8|COMPLETED|Period 4 - Fourth Intervention||1
1676859|NCT00583908|4096571|P7|COMPLETED|Period 4 - Fourth Intervention||1
1676860|NCT00583908|4096572|P6|COMPLETED|Period 4 - Fourth Intervention||1
1676861|NCT00583908|4096573|P5|COMPLETED|Period 4 - Fourth Intervention||2
1676862|NCT00583908|4096574|P4|COMPLETED|Period 4 - Fourth Intervention||1
1676863|NCT00583908|4096575|P3|COMPLETED|Period 4 - Fourth Intervention||1
1676864|NCT00583908|4096576|P2|COMPLETED|Period 4 - Fourth Intervention||2
1676865|NCT00583908|4096577|P1|COMPLETED|Period 4 - Fourth Intervention||1
1676866|NCT00583908|4096566|P12|STARTED|Period 4 - Fourth Intervention||1
1676867|NCT00583908|4096567|P11|STARTED|Period 4 - Fourth Intervention||1
1676868|NCT00583908|4096568|P10|STARTED|Period 4 - Fourth Intervention||1
1676869|NCT00583908|4096569|P9|STARTED|Period 4 - Fourth Intervention||1
1676870|NCT00583908|4096570|P8|STARTED|Period 4 - Fourth Intervention||1
1676871|NCT00583908|4096571|P7|STARTED|Period 4 - Fourth Intervention||1
1676872|NCT00583908|4096572|P6|STARTED|Period 4 - Fourth Intervention||1
1676873|NCT00583908|4096573|P5|STARTED|Period 4 - Fourth Intervention||2
1676874|NCT00583908|4096574|P4|STARTED|Period 4 - Fourth Intervention||1
1676875|NCT00583908|4096575|P3|STARTED|Period 4 - Fourth Intervention||1
1676876|NCT00583908|4096576|P2|STARTED|Period 4 - Fourth Intervention||2
1676877|NCT00583908|4096577|P1|STARTED|Period 4 - Fourth Intervention||1
1676878|NCT00583908|4096566|P12|NOT COMPLETED|Period 3 - Third Intervention||0
1676879|NCT00583908|4096567|P11|NOT COMPLETED|Period 3 - Third Intervention||0
1676880|NCT00583908|4096568|P10|NOT COMPLETED|Period 3 - Third Intervention||0
1676881|NCT00583908|4096569|P9|NOT COMPLETED|Period 3 - Third Intervention||0
1676882|NCT00583908|4096570|P8|NOT COMPLETED|Period 3 - Third Intervention||0
1676883|NCT00583908|4096571|P7|NOT COMPLETED|Period 3 - Third Intervention||0
1676884|NCT00583908|4096572|P6|NOT COMPLETED|Period 3 - Third Intervention||0
1676885|NCT00583908|4096573|P5|NOT COMPLETED|Period 3 - Third Intervention||0
1676886|NCT00583908|4096574|P4|NOT COMPLETED|Period 3 - Third Intervention||0
1676887|NCT00583908|4096575|P3|NOT COMPLETED|Period 3 - Third Intervention||0
1676888|NCT00583908|4096576|P2|NOT COMPLETED|Period 3 - Third Intervention||0
1676889|NCT00583908|4096577|P1|NOT COMPLETED|Period 3 - Third Intervention||0
1676890|NCT00583908|4096566|P12|COMPLETED|Period 3 - Third Intervention||1
1676891|NCT00583908|4096567|P11|COMPLETED|Period 3 - Third Intervention||1
1676892|NCT00583908|4096568|P10|COMPLETED|Period 3 - Third Intervention||1
1676893|NCT00583908|4096569|P9|COMPLETED|Period 3 - Third Intervention||1
1676894|NCT00583908|4096570|P8|COMPLETED|Period 3 - Third Intervention||1
1676895|NCT00583908|4096571|P7|COMPLETED|Period 3 - Third Intervention||1
1676896|NCT00583908|4096572|P6|COMPLETED|Period 3 - Third Intervention||1
1676897|NCT00583908|4096573|P5|COMPLETED|Period 3 - Third Intervention||2
1676898|NCT00583908|4096574|P4|COMPLETED|Period 3 - Third Intervention||1
1676899|NCT00583908|4096575|P3|COMPLETED|Period 3 - Third Intervention||1
1676900|NCT00583908|4096576|P2|COMPLETED|Period 3 - Third Intervention||2
1676901|NCT00583908|4096577|P1|COMPLETED|Period 3 - Third Intervention||1
1676902|NCT00583908|4096566|P12|STARTED|Period 3 - Third Intervention||1
1676903|NCT00583908|4096567|P11|STARTED|Period 3 - Third Intervention||1
1676904|NCT00583908|4096568|P10|STARTED|Period 3 - Third Intervention||1
1676905|NCT00583908|4096569|P9|STARTED|Period 3 - Third Intervention||1
1676906|NCT00583908|4096570|P8|STARTED|Period 3 - Third Intervention||1
1676907|NCT00583908|4096571|P7|STARTED|Period 3 - Third Intervention||1
1676908|NCT00583908|4096572|P6|STARTED|Period 3 - Third Intervention||1
1676909|NCT00583908|4096573|P5|STARTED|Period 3 - Third Intervention||2
1676910|NCT00583908|4096574|P4|STARTED|Period 3 - Third Intervention||1
1676911|NCT00583908|4096575|P3|STARTED|Period 3 - Third Intervention||1
1676912|NCT00583908|4096576|P2|STARTED|Period 3 - Third Intervention||2
1676913|NCT00583908|4096577|P1|STARTED|Period 3 - Third Intervention||1
1676914|NCT00583908|4096566|P12|NOT COMPLETED|Period 2 - Second Intervention||0
1676915|NCT00583908|4096567|P11|NOT COMPLETED|Period 2 - Second Intervention||0
1676916|NCT00583908|4096568|P10|NOT COMPLETED|Period 2 - Second Intervention||0
1676917|NCT00583908|4096569|P9|NOT COMPLETED|Period 2 - Second Intervention||0
1676918|NCT00583908|4096570|P8|NOT COMPLETED|Period 2 - Second Intervention||0
1676919|NCT00583908|4096571|P7|NOT COMPLETED|Period 2 - Second Intervention||0
1676920|NCT00583908|4096572|P6|NOT COMPLETED|Period 2 - Second Intervention||0
1676921|NCT00583908|4096573|P5|NOT COMPLETED|Period 2 - Second Intervention||0
1676922|NCT00583908|4096574|P4|NOT COMPLETED|Period 2 - Second Intervention||0
1676923|NCT00583908|4096575|P3|NOT COMPLETED|Period 2 - Second Intervention||0
1676924|NCT00583908|4096576|P2|NOT COMPLETED|Period 2 - Second Intervention||0
1676925|NCT00583908|4096577|P1|NOT COMPLETED|Period 2 - Second Intervention||0
1676926|NCT00583908|4096566|P12|COMPLETED|Period 2 - Second Intervention||1
1676927|NCT00583908|4096567|P11|COMPLETED|Period 2 - Second Intervention||1
1676928|NCT00583908|4096568|P10|COMPLETED|Period 2 - Second Intervention||1
1676929|NCT00583908|4096569|P9|COMPLETED|Period 2 - Second Intervention||1
1676930|NCT00583908|4096570|P8|COMPLETED|Period 2 - Second Intervention||1
1676931|NCT00583908|4096571|P7|COMPLETED|Period 2 - Second Intervention||1
1676932|NCT00583908|4096572|P6|COMPLETED|Period 2 - Second Intervention||1
1676933|NCT00583908|4096573|P5|COMPLETED|Period 2 - Second Intervention||2
1676934|NCT00583908|4096574|P4|COMPLETED|Period 2 - Second Intervention||1
1676935|NCT00583908|4096575|P3|COMPLETED|Period 2 - Second Intervention||1
1676936|NCT00583908|4096576|P2|COMPLETED|Period 2 - Second Intervention||2
1676937|NCT00583908|4096577|P1|COMPLETED|Period 2 - Second Intervention||1
1676938|NCT00583908|4096566|P12|STARTED|Period 2 - Second Intervention||1
1676939|NCT00583908|4096567|P11|STARTED|Period 2 - Second Intervention||1
1676940|NCT00583908|4096568|P10|STARTED|Period 2 - Second Intervention||1
1676941|NCT00583908|4096569|P9|STARTED|Period 2 - Second Intervention||1
1676942|NCT00583908|4096570|P8|STARTED|Period 2 - Second Intervention||1
1676943|NCT00583908|4096571|P7|STARTED|Period 2 - Second Intervention||1
1676944|NCT00583908|4096572|P6|STARTED|Period 2 - Second Intervention||1
1676945|NCT00583908|4096573|P5|STARTED|Period 2 - Second Intervention||2
1676946|NCT00583908|4096574|P4|STARTED|Period 2 - Second Intervention||1
1676947|NCT00583908|4096575|P3|STARTED|Period 2 - Second Intervention||1
1676948|NCT00583908|4096576|P2|STARTED|Period 2 - Second Intervention||2
1676949|NCT00583908|4096577|P1|STARTED|Period 2 - Second Intervention||1
1676950|NCT00583908|4096566|P12|NOT COMPLETED|Period 1 - First Intervention||0
1676951|NCT00583908|4096567|P11|NOT COMPLETED|Period 1 - First Intervention||0
1676952|NCT00583908|4096568|P10|NOT COMPLETED|Period 1 - First Intervention||0
1676953|NCT00583908|4096569|P9|NOT COMPLETED|Period 1 - First Intervention||0
1676954|NCT00583908|4096570|P8|NOT COMPLETED|Period 1 - First Intervention||0
1676955|NCT00583908|4096571|P7|NOT COMPLETED|Period 1 - First Intervention||0
1676956|NCT00583908|4096572|P6|NOT COMPLETED|Period 1 - First Intervention||0
1676957|NCT00583908|4096573|P5|NOT COMPLETED|Period 1 - First Intervention||0
1676958|NCT00583908|4096574|P4|NOT COMPLETED|Period 1 - First Intervention||0
1676959|NCT00583908|4096575|P3|NOT COMPLETED|Period 1 - First Intervention||0
1676960|NCT00583908|4096576|P2|NOT COMPLETED|Period 1 - First Intervention||0
1676961|NCT00583908|4096577|P1|NOT COMPLETED|Period 1 - First Intervention||0
1676962|NCT00583908|4096566|P12|COMPLETED|Period 1 - First Intervention||1
1676963|NCT00583908|4096567|P11|COMPLETED|Period 1 - First Intervention||1
1676964|NCT00583908|4096568|P10|COMPLETED|Period 1 - First Intervention||1
1676965|NCT00583908|4096569|P9|COMPLETED|Period 1 - First Intervention||1
1676966|NCT00583908|4096570|P8|COMPLETED|Period 1 - First Intervention||1
1676967|NCT00583908|4096571|P7|COMPLETED|Period 1 - First Intervention||1
1676968|NCT00583908|4096572|P6|COMPLETED|Period 1 - First Intervention||1
1676969|NCT00583908|4096573|P5|COMPLETED|Period 1 - First Intervention||2
1676970|NCT00583908|4096574|P4|COMPLETED|Period 1 - First Intervention||1
1676971|NCT00583908|4096575|P3|COMPLETED|Period 1 - First Intervention||1
1676972|NCT00583908|4096576|P2|COMPLETED|Period 1 - First Intervention||2
1676973|NCT00583908|4096577|P1|COMPLETED|Period 1 - First Intervention||1
1676974|NCT00583908|4096566|P12|STARTED|Period 1 - First Intervention||1
1676975|NCT00583908|4096567|P11|STARTED|Period 1 - First Intervention||1
1676976|NCT00583908|4096568|P10|STARTED|Period 1 - First Intervention||1
1676977|NCT00583908|4096569|P9|STARTED|Period 1 - First Intervention||1
1676978|NCT00583908|4096570|P8|STARTED|Period 1 - First Intervention||1
1676979|NCT00583908|4096571|P7|STARTED|Period 1 - First Intervention||1
1676980|NCT00583908|4096572|P6|STARTED|Period 1 - First Intervention||1
1676981|NCT00583908|4096573|P5|STARTED|Period 1 - First Intervention||2
1676982|NCT00583908|4096574|P4|STARTED|Period 1 - First Intervention||1
1676983|NCT00583908|4096575|P3|STARTED|Period 1 - First Intervention||1
1676984|NCT00583908|4096576|P2|STARTED|Period 1 - First Intervention||2
1676985|NCT00583908|4096577|P1|STARTED|Period 1 - First Intervention||1
1676986|NCT00583804|4096631|P1|NOT COMPLETED|Overall Study||0
1676987|NCT00583804|4096631|P1|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
1676988|NCT00583804|4096631|P1|STARTED|Overall Study||10
1676989|NCT00583713|4096640|P3|NOT COMPLETED|Overall Study||0
1676990|NCT00583713|4096641|P2|NOT COMPLETED|Overall Study||0
1676991|NCT00583713|4096642|P1|NOT COMPLETED|Overall Study||0
1676992|NCT00583713|4096640|P3|COMPLETED|Overall Study||6
1676993|NCT00583713|4096641|P2|COMPLETED|Overall Study||6
1676994|NCT00583713|4096642|P1|COMPLETED|Overall Study||6
1676995|NCT00583713|4096640|P3|STARTED|Overall Study||6
1676996|NCT00583713|4096641|P2|STARTED|Overall Study||6
1676997|NCT00583713|4096642|P1|STARTED|Overall Study||6
1676998|NCT00583700|4096667|P2|NOT COMPLETED|Overall Study||4
1676999|NCT00583700|4096668|P1|NOT COMPLETED|Overall Study||3
1677000|NCT00583700|4096667|P2|COMPLETED|Overall Study||23
1677001|NCT00583700|4096668|P1|COMPLETED|Overall Study||24
1677002|NCT00583700|4096667|P2|STARTED|Overall Study||27
1677003|NCT00583700|4096668|P1|STARTED|Overall Study||27
1677004|NCT00583661|4096676|P1|NOT COMPLETED|Overall Study||0
1677005|NCT00583661|4096676|P1|COMPLETED|Overall Study||48
1677006|NCT00583661|4096676|P1|STARTED|Overall Study||48
1677007|NCT00583622|4096683|P1|NOT COMPLETED|Overall Study||0
1677008|NCT00583622|4096683|P1|COMPLETED|Overall Study||12
1677009|NCT00583622|4096683|P1|STARTED|Overall Study||12
1677010|NCT00583596|4096688|P1|NOT COMPLETED|Overall Study||284
1677011|NCT00583596|4096688|P1|COMPLETED|Overall Study||152
1677012|NCT00583596|4096688|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
1677013|NCT00583557|4096693|P1|NOT COMPLETED|Overall Study||70
1677014|NCT00583557|4096693|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
1677015|NCT00583557|4096693|P1|Received at Least 1 Dose Belimumab|Overall Study||153
1677016|NCT00583557|4096693|P1|STARTED|Overall Study||155
1677017|NCT00583492|4096699|P2|NOT COMPLETED|Overall Study||0
1677018|NCT00583492|4096700|P1|NOT COMPLETED|Overall Study||0
1677019|NCT00583492|4096699|P2|COMPLETED|Overall Study||23
1677020|NCT00583492|4096700|P1|COMPLETED|Overall Study||21
1677021|NCT00583492|4096699|P2|STARTED|Overall Study||23
1677022|NCT00583492|4096700|P1|STARTED|Overall Study||21
1677023|NCT00583466|4096716|P1|NOT COMPLETED|Overall Study||0
1677024|NCT00583466|4096716|P1|COMPLETED|Overall Study||18
1677025|NCT00583466|4096716|P1|STARTED|Overall Study||18
1677026|NCT00583453|4096724|P2|NOT COMPLETED|Overall Study||2
1677027|NCT00583453|4096725|P1|NOT COMPLETED|Overall Study||0
1677028|NCT00583453|4096724|P2|COMPLETED|Overall Study||6
1677029|NCT00583453|4096725|P1|COMPLETED|Overall Study||9
1677030|NCT00583453|4096724|P2|STARTED|Overall Study||8
1677031|NCT00583453|4096725|P1|STARTED|Overall Study||9
1677032|NCT00583375|4096741|P2|NOT COMPLETED|Overall Study||0
1677033|NCT00583375|4096742|P1|NOT COMPLETED|Overall Study||0
1677034|NCT00583375|4096741|P2|COMPLETED|Overall Study||272
1677035|NCT00583375|4096742|P1|COMPLETED|Overall Study||142
1677036|NCT00583375|4096741|P2|STARTED|Overall Study||272
1677037|NCT00583375|4096742|P1|STARTED|Overall Study||142
1677038|NCT00583362|4096758|P1|NOT COMPLETED|Overall Study||202
1677039|NCT00583362|4096758|P1|COMPLETED|Overall Study||96
1677040|NCT00583362|4096758|P1|STARTED|Overall Study||298
1677041|NCT00583219|4096782|P1|NOT COMPLETED|Phase 2||1
1677042|NCT00583219|4096782|P1|COMPLETED|Phase 2||21
1677043|NCT00583219|4096782|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
1677044|NCT00583219|4096782|P1|NOT COMPLETED|Phase 1||0
1677045|NCT00583219|4096782|P1|COMPLETED|Phase 1||9
1677046|NCT00583219|4096782|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
1677047|NCT00583115|4096799|P1|NOT COMPLETED|Overall Study||1
1677048|NCT00583115|4096799|P1|COMPLETED|Overall Study||0
1677049|NCT00583115|4096799|P1|STARTED|Overall Study||1
1677050|NCT00583102|4096804|P1|NOT COMPLETED|Overall Study||3
1677051|NCT00583102|4096804|P1|COMPLETED|Overall Study||20
1677052|NCT00583102|4096804|P1|STARTED|Overall Study||23
1677053|NCT00582972|4096808|P1|NOT COMPLETED|Overall Study||2
1677054|NCT00582972|4096808|P1|COMPLETED|Overall Study||21
1677055|NCT00582972|4096808|P1|STARTED|Overall Study||23
1677056|NCT00582946|4096813|P1|NOT COMPLETED|Overall Study||0
1677057|NCT00582946|4096813|P1|COMPLETED|Overall Study||16
1677058|NCT00582946|4096813|P1|STARTED|Overall Study||16
1677059|NCT00582933|4096817|P1|NOT COMPLETED|Overall Study||3
1677060|NCT00582933|4096817|P1|COMPLETED|Overall Study||92
1677061|NCT00582933|4096817|P1|STARTED|Overall Study||95
1677062|NCT00582907|4096821|P4|NOT COMPLETED|4th Course||0
1677063|NCT00582907|4096822|P3|NOT COMPLETED|4th Course||0
1677064|NCT00582907|4096823|P2|NOT COMPLETED|4th Course||0
1677065|NCT00582907|4096824|P1|NOT COMPLETED|4th Course||0
1677066|NCT00582907|4096821|P4|COMPLETED|4th Course||3
1677067|NCT00582907|4096822|P3|COMPLETED|4th Course||3
1677068|NCT00582907|4096823|P2|COMPLETED|4th Course||3
1677069|NCT00582907|4096824|P1|COMPLETED|4th Course||2
1677070|NCT00582907|4096821|P4|STARTED|4th Course||3
1677071|NCT00582907|4096822|P3|STARTED|4th Course||3
1677072|NCT00582907|4096823|P2|STARTED|4th Course||3
1677073|NCT00582907|4096824|P1|STARTED|4th Course||2
1677074|NCT00582907|4096821|P4|NOT COMPLETED|3rd Course||0
1677075|NCT00582907|4096822|P3|NOT COMPLETED|3rd Course||0
1677076|NCT00582907|4096823|P2|NOT COMPLETED|3rd Course||0
1677077|NCT00582907|4096824|P1|NOT COMPLETED|3rd Course||0
1677078|NCT00582907|4096821|P4|COMPLETED|3rd Course||3
1677079|NCT00582907|4096822|P3|COMPLETED|3rd Course||3
1677080|NCT00582907|4096823|P2|COMPLETED|3rd Course||3
1677081|NCT00582907|4096824|P1|COMPLETED|3rd Course||2
1677082|NCT00582907|4096821|P4|STARTED|3rd Course||3
1677083|NCT00582907|4096822|P3|STARTED|3rd Course||3
1677084|NCT00582907|4096823|P2|STARTED|3rd Course||3
1677085|NCT00582907|4096824|P1|STARTED|3rd Course||2
1677086|NCT00582907|4096821|P4|NOT COMPLETED|2nd Course||0
1677087|NCT00582907|4096822|P3|NOT COMPLETED|2nd Course||0
1677088|NCT00582907|4096823|P2|NOT COMPLETED|2nd Course||0
1677089|NCT00582907|4096824|P1|NOT COMPLETED|2nd Course||1
1677090|NCT00582907|4096821|P4|COMPLETED|2nd Course||3
1677091|NCT00582907|4096822|P3|COMPLETED|2nd Course||3
1677092|NCT00582907|4096823|P2|COMPLETED|2nd Course||3
1677093|NCT00582907|4096824|P1|COMPLETED|2nd Course||2
1677094|NCT00582907|4096821|P4|STARTED|2nd Course||3
1677095|NCT00582907|4096822|P3|STARTED|2nd Course||3
1677096|NCT00582907|4096823|P2|STARTED|2nd Course||3
1677097|NCT00582907|4096824|P1|STARTED|2nd Course||3
1677098|NCT00582907|4096821|P4|NOT COMPLETED|1st Course||1
1677099|NCT00582907|4096822|P3|NOT COMPLETED|1st Course||0
1677100|NCT00582907|4096823|P2|NOT COMPLETED|1st Course||0
1677101|NCT00582907|4096824|P1|NOT COMPLETED|1st Course||1
1677102|NCT00582907|4096821|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
1677103|NCT00582907|4096822|P3|COMPLETED|1st Course||3
1677104|NCT00582907|4096823|P2|COMPLETED|1st Course||3
1677105|NCT00582907|4096824|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
1677106|NCT00582907|4096821|P4|STARTED|1st Course||4
1677107|NCT00582907|4096822|P3|STARTED|1st Course||3
1677108|NCT00582907|4096823|P2|STARTED|1st Course||3
1677109|NCT00582907|4096824|P1|STARTED|1st Course||4
1677110|NCT00582894|4096856|P1|NOT COMPLETED|Overall Study||0
1677111|NCT00582894|4096856|P1|COMPLETED|Overall Study||17
1677112|NCT00582894|4096856|P1|Day 100 Post Transplant|Overall Study||17
1677113|NCT00582894|4096856|P1|STARTED|Overall Study||17
1677114|NCT00582816|4096863|P1|NOT COMPLETED|Overall Study||3
1677115|NCT00582816|4096863|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
1677116|NCT00582816|4096863|P1|STARTED|Overall Study||9
1677117|NCT00582790|4096873|P1|NOT COMPLETED|Overall Study||1
1677118|NCT00582790|4096873|P1|COMPLETED|Overall Study||11
1677119|NCT00582790|4096873|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
1677120|NCT00582738|4096882|P2|NOT COMPLETED|Overall Study||18
1677121|NCT00582738|4096883|P1|NOT COMPLETED|Overall Study||9
1677122|NCT00582738|4096882|P2|COMPLETED|Overall Study||4
1677123|NCT00582738|4096883|P1|COMPLETED|Overall Study||12
1677124|NCT00582738|4096882|P2|STARTED|Overall Study||22
1677125|NCT00582738|4096883|P1|STARTED|Overall Study||21
1677126|NCT00582712|4096907|P1|NOT COMPLETED|Overall Study||4
1677127|NCT00582712|4096907|P1|COMPLETED|Overall Study||1
1677128|NCT00582712|4096907|P1|STARTED|Overall Study||5
1677129|NCT00582660|4096913|P2|NOT COMPLETED|Overall Study||0
1677130|NCT00582660|4096914|P1|NOT COMPLETED|Overall Study||0
1677131|NCT00582660|4096913|P2|COMPLETED|Overall Study||20
1677132|NCT00582660|4096914|P1|COMPLETED|Overall Study||20
1677133|NCT00582660|4096913|P2|STARTED|Overall Study||20
1677134|NCT00582660|4096914|P1|STARTED|Overall Study||20
1677135|NCT00582608|4096922|P1|NOT COMPLETED|Overall Study||12
1677136|NCT00582608|4096922|P1|COMPLETED|Overall Study||0
1677137|NCT00582608|4096922|P1|STARTED|Overall Study||12
1677138|NCT00582556|4096929|P3|NOT COMPLETED|Overall Study||2
1677139|NCT00582556|4096930|P2|NOT COMPLETED|Overall Study||1
1677140|NCT00582556|4096931|P1|NOT COMPLETED|Overall Study||0
1677141|NCT00582556|4096929|P3|COMPLETED|Overall Study||12
1677142|NCT00582556|4096930|P2|COMPLETED|Overall Study||14
1677143|NCT00582556|4096931|P1|COMPLETED|Overall Study||14
1677144|NCT00582556|4096929|P3|STARTED|Overall Study||14
1677145|NCT00582556|4096930|P2|STARTED|Overall Study||15
1677146|NCT00582556|4096931|P1|STARTED|Overall Study||14
1677147|NCT00582517|4096950|P2|NOT COMPLETED|Overall Study||0
1677148|NCT00582517|4096951|P1|NOT COMPLETED|Overall Study||0
1677149|NCT00582517|4096950|P2|COMPLETED|Overall Study||55
1677150|NCT00582517|4096951|P1|COMPLETED|Overall Study||45
1677151|NCT00582517|4096950|P2|STARTED|Overall Study||55
1677152|NCT00582517|4096951|P1|STARTED|Overall Study||45
1677153|NCT00582491|4096959|P2|NOT COMPLETED|Overall Study||0
1677154|NCT00582491|4096960|P1|NOT COMPLETED|Overall Study||1
1677155|NCT00582491|4096959|P2|COMPLETED|Overall Study||10
1677156|NCT00582491|4096960|P1|COMPLETED|Overall Study||10
1677157|NCT00582491|4096959|P2|STARTED|Overall Study||10
1677158|NCT00582491|4096960|P1|STARTED|Overall Study||11
1677159|NCT00582426|4096984|P2|NOT COMPLETED|Overall Study||13
1677160|NCT00582426|4096985|P1|NOT COMPLETED|Overall Study||20
1677161|NCT00582426|4096984|P2|COMPLETED|Overall Study||58
1677162|NCT00582426|4096985|P1|COMPLETED|Overall Study||48
1677163|NCT00582426|4096984|P2|STARTED|Overall Study||71
1677164|NCT00582426|4096985|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
1677165|NCT00582400|4097011|P1|NOT COMPLETED|Overall Study||3
1677166|NCT00582400|4097011|P1|COMPLETED|Overall Study||6
1677167|NCT00582400|4097011|P1|STARTED|Overall Study||9
1677168|NCT00582361|4097020|P2|NOT COMPLETED|Overall Study||0
1677169|NCT00582361|4097021|P1|NOT COMPLETED|Overall Study||0
1677170|NCT00582361|4097020|P2|COMPLETED|Overall Study||38
1677171|NCT00582361|4097021|P1|COMPLETED|Overall Study||25
1677172|NCT00582361|4097020|P2|STARTED|Overall Study||38
1677173|NCT00582361|4097021|P1|STARTED|Overall Study||25
1677174|NCT00582309|4097032|P3|NOT COMPLETED|Overall Study||2
1677175|NCT00582309|4097033|P2|NOT COMPLETED|Overall Study||0
1677176|NCT00582309|4097034|P1|NOT COMPLETED|Overall Study||0
1677177|NCT00582309|4097032|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
1677178|NCT00582309|4097033|P2|COMPLETED|Overall Study||49
1677179|NCT00582309|4097034|P1|COMPLETED|Overall Study||56
1677180|NCT00582309|4097032|P3|STARTED|Overall Study||46
1677181|NCT00582309|4097033|P2|STARTED|Overall Study||49
1677182|NCT00582309|4097034|P1|STARTED|Overall Study||56
1677183|NCT00582205|4097042|P1|NOT COMPLETED|Overall Study||10
1677184|NCT00582205|4097042|P1|COMPLETED|Overall Study||11
1677185|NCT00582205|4097042|P1|STARTED|Overall Study||21
1677186|NCT00582166|4097047|P1|NOT COMPLETED|Overall Study||2
1677187|NCT00582166|4097047|P1|COMPLETED|Overall Study||16
1677188|NCT00582166|4097047|P1|STARTED|Overall Study||18
1677189|NCT00582114|4097057|P2|NOT COMPLETED|Overall Study||54
1677190|NCT00582114|4097058|P1|NOT COMPLETED|Overall Study||42
1677191|NCT00582114|4097057|P2|COMPLETED|Overall Study||46
1677192|NCT00582114|4097058|P1|COMPLETED|Overall Study||58
1677193|NCT00582114|4097057|P2|STARTED|Overall Study||100
1677194|NCT00582114|4097058|P1|STARTED|Overall Study||100
1677195|NCT00582075|4097066|P1|NOT COMPLETED|Overall Study||0
1677196|NCT00582075|4097066|P1|COMPLETED|Overall Study||25
1677197|NCT00582075|4097066|P1|STARTED|Overall Study||25
1677198|NCT00582036|4097073|P2|NOT COMPLETED|Overall Study||1
1677199|NCT00582036|4097074|P1|NOT COMPLETED|Overall Study||0
1677200|NCT00582036|4097073|P2|COMPLETED|Overall Study|One patient withdrew consent|5
1677201|NCT00582036|4097074|P1|COMPLETED|Overall Study||5
1677202|NCT00582036|4097073|P2|STARTED|Overall Study||6
1677203|NCT00582036|4097074|P1|STARTED|Overall Study||5
1677204|NCT00582010|4097082|P2|NOT COMPLETED|Overall Study||1
1677205|NCT00582010|4097083|P1|NOT COMPLETED|Overall Study||0
1677206|NCT00582010|4097082|P2|COMPLETED|Overall Study||39
1677207|NCT00582010|4097083|P1|COMPLETED|Overall Study||40
1677208|NCT00582010|4097082|P2|STARTED|Overall Study||40
1677209|NCT00582010|4097083|P1|STARTED|Overall Study||40
1677210|NCT00581971|4097105|P1|NOT COMPLETED|Overall Study||0
1677211|NCT00581971|4097105|P1|COMPLETED|Overall Study||30
1677212|NCT00581971|4097105|P1|STARTED|Overall Study||30
1677213|NCT00581945|4097112|P2|NOT COMPLETED|Overall Study||10
1677214|NCT00581945|4097113|P1|NOT COMPLETED|Overall Study||9
1677215|NCT00581945|4097112|P2|COMPLETED|Overall Study||63
1677216|NCT00581945|4097113|P1|COMPLETED|Overall Study||65
1677217|NCT00581945|4097112|P2|STARTED|Overall Study||73
1677218|NCT00581945|4097113|P1|STARTED|Overall Study||74
1677219|NCT00581919|4097129|P1|NOT COMPLETED|Overall Study||24
1677220|NCT00581919|4097129|P1|COMPLETED|Overall Study||8
1677221|NCT00581919|4097129|P1|STARTED|Overall Study||32
1677222|NCT00581867|4097135|P2|NOT COMPLETED|Second Intervention||0
1677223|NCT00581867|4097136|P1|NOT COMPLETED|Second Intervention||0
1677224|NCT00581867|4097135|P2|COMPLETED|Second Intervention||14
1677225|NCT00581867|4097136|P1|COMPLETED|Second Intervention||15
1677226|NCT00581867|4097135|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
1677227|NCT00581867|4097136|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
1677228|NCT00581867|4097135|P2|NOT COMPLETED|First Intervention||0
1677229|NCT00581867|4097136|P1|NOT COMPLETED|First Intervention||0
1677230|NCT00581867|4097135|P2|COMPLETED|First Intervention||15
1677231|NCT00581867|4097136|P1|COMPLETED|First Intervention||16
1677232|NCT00581867|4097135|P2|STARTED|First Intervention||15
1677233|NCT00581867|4097136|P1|STARTED|First Intervention||16
1677234|NCT00581854|4097144|P1|NOT COMPLETED|Overall Study||0
1677235|NCT00581854|4097144|P1|COMPLETED|Overall Study||22
1677236|NCT00581854|4097144|P1|STARTED|Overall Study||22
1677237|NCT00581828|4097148|P1|NOT COMPLETED|Overall Study||1
1677238|NCT00581828|4097148|P1|COMPLETED|Overall Study||18
1677239|NCT00581828|4097148|P1|STARTED|Overall Study||19
1677240|NCT00581776|4097152|P1|NOT COMPLETED|Overall Study||3
1677241|NCT00581776|4097152|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
1677242|NCT00581776|4097152|P1|STARTED|Overall Study||30
1677243|NCT00581581|4097161|P2|NOT COMPLETED|Overall Study||0
1677244|NCT00581581|4097162|P1|NOT COMPLETED|Overall Study||0
1677245|NCT00581581|4097161|P2|COMPLETED|Overall Study||30
1677246|NCT00581581|4097162|P1|COMPLETED|Overall Study||32
1677247|NCT00581581|4097161|P2|STARTED|Overall Study||30
1677248|NCT00581581|4097162|P1|STARTED|Overall Study||32
1677249|NCT00581555|4097170|P2|NOT COMPLETED|Overall Study||20
1677250|NCT00581555|4097171|P1|NOT COMPLETED|Overall Study||43
1677251|NCT00581555|4097170|P2|COMPLETED|Overall Study||38
1677252|NCT00581555|4097171|P1|COMPLETED|Overall Study||19
1677253|NCT00581555|4097170|P2|STARTED|Overall Study||58
1677254|NCT00581555|4097171|P1|STARTED|Overall Study||62
1677255|NCT00581542|4097195|P2|NOT COMPLETED|Overall Study||23
1677256|NCT00581542|4097196|P1|NOT COMPLETED|Overall Study||11
1677257|NCT00581542|4097195|P2|COMPLETED|Overall Study||39
1677258|NCT00581542|4097196|P1|COMPLETED|Overall Study||51
1677259|NCT00581542|4097195|P2|STARTED|Overall Study||62
1677260|NCT00581542|4097196|P1|STARTED|Overall Study||62
1677261|NCT00581529|4097204|P1|NOT COMPLETED|Overall Study||0
1677262|NCT00581529|4097204|P1|COMPLETED|Overall Study||34
1677263|NCT00581529|4097204|P1|STARTED|Overall Study||34
1677264|NCT00581399|4097213|P2|NOT COMPLETED|Overall Study||0
1677265|NCT00581399|4097214|P1|NOT COMPLETED|Overall Study||0
1677266|NCT00581399|4097213|P2|COMPLETED|Overall Study||48
1677267|NCT00581399|4097214|P1|COMPLETED|Overall Study||46
1677268|NCT00581399|4097213|P2|STARTED|Overall Study||48
1677269|NCT00581399|4097214|P1|STARTED|Overall Study||46
1677270|NCT00581386|4097225|P3|NOT COMPLETED|Overall Study||0
1677271|NCT00581386|4097226|P2|NOT COMPLETED|Overall Study||0
1677272|NCT00581386|4097227|P1|NOT COMPLETED|Overall Study||0
1677273|NCT00581386|4097225|P3|COMPLETED|Overall Study|04/15/2009|72
1677274|NCT00581386|4097226|P2|COMPLETED|Overall Study|04/15/2009|73
1677275|NCT00581386|4097227|P1|COMPLETED|Overall Study|04/15/2009|73
1677276|NCT00581386|4097225|P3|STARTED|Overall Study|05/30/2007|72
1677277|NCT00581386|4097226|P2|STARTED|Overall Study|05/30/2007|73
1677278|NCT00581386|4097227|P1|STARTED|Overall Study|05/30/2007|73
1677279|NCT00581360|4097250|P1|NOT COMPLETED|Overall Study||1
1677280|NCT00581360|4097250|P1|COMPLETED|Overall Study||9
1677281|NCT00581360|4097250|P1|STARTED|Overall Study||10
1677282|NCT00581347|4097260|P2|NOT COMPLETED|Overall Study||0
1677283|NCT00581347|4097261|P1|NOT COMPLETED|Overall Study||0
1677284|NCT00581347|4097260|P2|COMPLETED|Overall Study||3707
1677285|NCT00581347|4097261|P1|COMPLETED|Overall Study||3839
1677286|NCT00581347|4097260|P2|STARTED|Overall Study||3707
1677287|NCT00581347|4097261|P1|STARTED|Overall Study||3839
1677288|NCT00581308|4097269|P1|NOT COMPLETED|60 Months||3
1677289|NCT00581308|4097269|P1|COMPLETED|60 Months||158
1677290|NCT00581308|4097269|P1|STARTED|60 Months||161
1677291|NCT00581308|4097269|P1|NOT COMPLETED|48 Months||9
1677292|NCT00581308|4097269|P1|COMPLETED|48 Months||161
1677293|NCT00581308|4097269|P1|STARTED|48 Months||170
1677294|NCT00581308|4097269|P1|NOT COMPLETED|36 Months||6
1677295|NCT00581308|4097269|P1|COMPLETED|36 Months||170
1677296|NCT00581308|4097269|P1|STARTED|36 Months||176
1677297|NCT00581308|4097269|P1|NOT COMPLETED|24 Months||6
1677298|NCT00581308|4097269|P1|COMPLETED|24 Months||176
1677299|NCT00581308|4097269|P1|STARTED|24 Months||182
1677300|NCT00581308|4097269|P1|NOT COMPLETED|Month 12||20
1677301|NCT00581308|4097269|P1|COMPLETED|Month 12||182
1677302|NCT00581308|4097269|P1|STARTED|Month 12||202
1677303|NCT00581308|4097269|P1|NOT COMPLETED|Month 6||3
1677304|NCT00581308|4097269|P1|COMPLETED|Month 6||202
1677305|NCT00581308|4097269|P1|STARTED|Month 6||205
1677306|NCT00581308|4097269|P1|NOT COMPLETED|Month 1||8
1677307|NCT00581308|4097269|P1|COMPLETED|Month 1||205
1677308|NCT00581308|4097269|P1|STARTED|Month 1||213
1677309|NCT00581308|4097269|P1|NOT COMPLETED|Pre Discharge||2
1677310|NCT00581308|4097269|P1|COMPLETED|Pre Discharge||213
1677311|NCT00581308|4097269|P1|STARTED|Pre Discharge||215
1677312|NCT00581256|4097278|P2|NOT COMPLETED|Overall Study||0
1677313|NCT00581256|4097279|P1|NOT COMPLETED|Overall Study||0
1677314|NCT00581256|4097278|P2|COMPLETED|Overall Study||26
1677315|NCT00581256|4097279|P1|COMPLETED|Overall Study||28
1677316|NCT00581256|4097278|P2|STARTED|Overall Study||26
1677317|NCT00581256|4097279|P1|STARTED|Overall Study||28
1677318|NCT00581230|4097291|P1|NOT COMPLETED|Overall Study||0
1677319|NCT00581230|4097291|P1|COMPLETED|Overall Study||51
1677320|NCT00581230|4097291|P1|Laryngoscopy With RAMP|Overall Study||51
1677321|NCT00581230|4097291|P1|Laryngoscopy Without RAMP|Overall Study||51
1677322|NCT00581230|4097291|P1|STARTED|Overall Study||51
1677323|NCT00581113|4097300|P2|NOT COMPLETED|Overall Study||1
1677324|NCT00581113|4097301|P1|NOT COMPLETED|Overall Study||0
1677325|NCT00581113|4097300|P2|COMPLETED|Overall Study||3
1677326|NCT00581113|4097301|P1|COMPLETED|Overall Study||4
1677327|NCT00581113|4097300|P2|STARTED|Overall Study||4
1677328|NCT00581113|4097301|P1|STARTED|Overall Study||4
1677329|NCT00581100|4097311|P2|NOT COMPLETED|Overall Study||5
1677330|NCT00581100|4097312|P1|NOT COMPLETED|Overall Study||7
1677331|NCT00581100|4097311|P2|COMPLETED|Overall Study||29
1677332|NCT00581100|4097312|P1|COMPLETED|Overall Study||31
1677333|NCT00581100|4097311|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
1677334|NCT00581100|4097312|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
1677335|NCT00581100|4097311|P2|STARTED|Overall Study||34
1677336|NCT00581100|4097312|P1|STARTED|Overall Study||38
1677337|NCT00581061|4097348|P1|NOT COMPLETED|Overall Study||0
1677338|NCT00581061|4097348|P1|COMPLETED|Overall Study||13
1677339|NCT00581061|4097348|P1|STARTED|Overall Study||13
1677340|NCT00581048|4097354|P1|NOT COMPLETED|Overall Study||0
1677341|NCT00581048|4097354|P1|COMPLETED|Overall Study||33
1677342|NCT00581048|4097354|P1|STARTED|Overall Study||33
1677343|NCT00580983|4097365|P1|NOT COMPLETED|Overall Study||7
1677344|NCT00580983|4097365|P1|COMPLETED|Overall Study||73
1677345|NCT00580983|4097365|P1|STARTED|Overall Study||80
1677346|NCT00580970|4097372|P1|NOT COMPLETED|Treatment (Lovastatin)||19
1677347|NCT00580970|4097372|P1|COMPLETED|Treatment (Lovastatin)||53
1677348|NCT00580970|4097372|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
1677349|NCT00580970|4097372|P1|STARTED|Treatment (Lovastatin)||72
1677350|NCT00580970|4097372|P1|NOT COMPLETED|Pre-treatment||1
1677351|NCT00580970|4097372|P1|COMPLETED|Pre-treatment||72
1677352|NCT00580970|4097372|P1|STARTED|Pre-treatment||73
1677353|NCT00580957|4097378|P2|NOT COMPLETED|Overall Study||7
1677354|NCT00580957|4097379|P1|NOT COMPLETED|Overall Study||7
1677355|NCT00580957|4097378|P2|COMPLETED|Overall Study||21
1677356|NCT00580957|4097379|P1|COMPLETED|Overall Study||21
1677357|NCT00580957|4097378|P2|STARTED|Overall Study||28
1677358|NCT00580957|4097379|P1|STARTED|Overall Study||28
1677359|NCT00580866|4097387|P2|NOT COMPLETED|Overall Study||2
1677360|NCT00580866|4097388|P1|NOT COMPLETED|Overall Study||2
1677361|NCT00580866|4097387|P2|COMPLETED|Overall Study||5
1677362|NCT00580866|4097388|P1|COMPLETED|Overall Study||8
1677363|NCT00580866|4097387|P2|STARTED|Overall Study||7
1677364|NCT00580866|4097388|P1|STARTED|Overall Study||10
1677365|NCT00580853|4097399|P3|NOT COMPLETED|Overall Study||0
1677366|NCT00580853|4097400|P2|NOT COMPLETED|Overall Study||0
1677367|NCT00580853|4097401|P1|NOT COMPLETED|Overall Study||0
1677368|NCT00580853|4097399|P3|COMPLETED|Overall Study||21
1677369|NCT00580853|4097400|P2|COMPLETED|Overall Study||21
1677370|NCT00580853|4097401|P1|COMPLETED|Overall Study||20
1677371|NCT00580853|4097399|P3|STARTED|Overall Study||21
1677372|NCT00580853|4097400|P2|STARTED|Overall Study||21
1677373|NCT00580853|4097401|P1|STARTED|Overall Study||20
1677374|NCT00580840|4097412|P4|NOT COMPLETED|Double-Blind||15
1677375|NCT00580840|4097413|P3|NOT COMPLETED|Double-Blind||9
1677376|NCT00580840|4097414|P2|NOT COMPLETED|Double-Blind||7
1677377|NCT00580840|4097415|P1|NOT COMPLETED|Double-Blind||0
1677378|NCT00580840|4097412|P4|COMPLETED|Double-Blind||54
1677379|NCT00580840|4097413|P3|COMPLETED|Double-Blind||61
1677380|NCT00580840|4097414|P2|COMPLETED|Double-Blind||63
1677381|NCT00580840|4097415|P1|COMPLETED|Double-Blind||0
1677382|NCT00580840|4097412|P4|STARTED|Double-Blind||69
1677383|NCT00580840|4097413|P3|STARTED|Double-Blind||70
1677384|NCT00580840|4097414|P2|STARTED|Double-Blind||70
1677385|NCT00580840|4097415|P1|STARTED|Double-Blind||0
1677386|NCT00580840|4097412|P4|NOT COMPLETED|Run-in||0
1677387|NCT00580840|4097413|P3|NOT COMPLETED|Run-in||0
1677388|NCT00580840|4097414|P2|NOT COMPLETED|Run-in||0
1677389|NCT00580840|4097415|P1|NOT COMPLETED|Run-in||124
1677390|NCT00580840|4097412|P4|COMPLETED|Run-in||0
1677391|NCT00580840|4097413|P3|COMPLETED|Run-in||0
1677392|NCT00580840|4097414|P2|COMPLETED|Run-in||0
1677393|NCT00580840|4097415|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
1677394|NCT00580840|4097412|P4|STARTED|Run-in||0
1677395|NCT00580840|4097413|P3|STARTED|Run-in||0
1677396|NCT00580840|4097414|P2|STARTED|Run-in||0
1677397|NCT00580840|4097415|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
1677398|NCT00580801|4097523|P3|NOT COMPLETED|Overall Study||3
1677399|NCT00580801|4097524|P2|NOT COMPLETED|Overall Study||1
1677400|NCT00580801|4097525|P1|NOT COMPLETED|Overall Study||6
1677401|NCT00580801|4097523|P3|COMPLETED|Overall Study||5
1677402|NCT00580801|4097524|P2|COMPLETED|Overall Study||7
1677403|NCT00580801|4097525|P1|COMPLETED|Overall Study||2
1677404|NCT00580801|4097523|P3|STARTED|Overall Study||8
1677405|NCT00580801|4097524|P2|STARTED|Overall Study||8
1677406|NCT00580801|4097525|P1|STARTED|Overall Study||8
1677407|NCT00580788|4097564|P4|NOT COMPLETED|Overall Study||1
1677408|NCT00580788|4097565|P3|NOT COMPLETED|Overall Study||0
1677409|NCT00580788|4097566|P2|NOT COMPLETED|Overall Study||0
1677410|NCT00580788|4097567|P1|NOT COMPLETED|Overall Study||0
1677411|NCT00580788|4097564|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
1677412|NCT00580788|4097565|P3|COMPLETED|Overall Study||3
1677413|NCT00580788|4097566|P2|COMPLETED|Overall Study||6
1677414|NCT00580788|4097567|P1|COMPLETED|Overall Study||3
1677415|NCT00580788|4097564|P4|STARTED|Overall Study||2
1677416|NCT00580788|4097565|P3|STARTED|Overall Study||3
1677417|NCT00580788|4097566|P2|STARTED|Overall Study||6
1677418|NCT00580788|4097567|P1|STARTED|Overall Study||3
1677419|NCT00580723|4097625|P1|NOT COMPLETED|Overall Study||8
1677420|NCT00580723|4097625|P1|COMPLETED|Overall Study||16
1677421|NCT00580723|4097625|P1|STARTED|Overall Study||24
1677422|NCT00580671|4097634|P3|NOT COMPLETED|Overall Study||17
1677423|NCT00580671|4097635|P2|NOT COMPLETED|Overall Study||16
1677424|NCT00580671|4097636|P1|NOT COMPLETED|Overall Study||16
1677425|NCT00580671|4097634|P3|COMPLETED|Overall Study||34
1677426|NCT00580671|4097635|P2|COMPLETED|Overall Study||35
1677427|NCT00580671|4097636|P1|COMPLETED|Overall Study||35
1677428|NCT00580671|4097634|P3|STARTED|Overall Study||51
1677429|NCT00580671|4097635|P2|STARTED|Overall Study||51
1677430|NCT00580671|4097636|P1|STARTED|Overall Study||51
1677431|NCT00580645|4097653|P3|NOT COMPLETED|Overall Study||0
1677432|NCT00580645|4097654|P2|NOT COMPLETED|Overall Study||0
1677433|NCT00580645|4097655|P1|NOT COMPLETED|Overall Study||0
1677434|NCT00580645|4097653|P3|COMPLETED|Overall Study||20
1677435|NCT00580645|4097654|P2|COMPLETED|Overall Study||20
1677436|NCT00580645|4097655|P1|COMPLETED|Overall Study||20
1677437|NCT00580645|4097653|P3|STARTED|Overall Study||20
1677438|NCT00580645|4097654|P2|STARTED|Overall Study||20
1677439|NCT00580645|4097655|P1|STARTED|Overall Study||20
1677440|NCT00580606|4097668|P2|NOT COMPLETED|Open Label (OL)||12
1677441|NCT00580606|4097669|P1|NOT COMPLETED|Open Label (OL)||9
1677442|NCT00580606|4097668|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
1677443|NCT00580606|4097669|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
1677444|NCT00580606|4097668|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
1677445|NCT00580606|4097669|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
1677446|NCT00580606|4097668|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
1677447|NCT00580606|4097669|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
1677448|NCT00580606|4097668|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
1677449|NCT00580606|4097669|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
1677450|NCT00580606|4097668|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
1677451|NCT00580606|4097669|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
1677452|NCT00580606|4097668|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
1677453|NCT00580606|4097669|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
1677454|NCT00580606|4097668|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
1677455|NCT00580606|4097669|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
1677456|NCT00580606|4097668|P2|NOT COMPLETED|Double Blind (DB)||0
1677457|NCT00580606|4097669|P1|NOT COMPLETED|Double Blind (DB)||0
1677458|NCT00580606|4097668|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
1677459|NCT00580606|4097669|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
1677460|NCT00580606|4097668|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
1677461|NCT00580606|4097669|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
1677462|NCT00580606|4097668|P2|STARTED|Double Blind (DB)||20
1677463|NCT00580606|4097669|P1|STARTED|Double Blind (DB)||20
1677464|NCT00580502|4097687|P1|NOT COMPLETED|Overall Study||0
1677465|NCT00580502|4097687|P1|COMPLETED|Overall Study||50
1677466|NCT00580502|4097687|P1|STARTED|Overall Study||50
1677467|NCT00580398|4097696|P2|NOT COMPLETED|Overall Study||0
1677468|NCT00580398|4097697|P1|NOT COMPLETED|Overall Study||0
1677469|NCT00580398|4097696|P2|COMPLETED|Overall Study||32
1677470|NCT00580398|4097697|P1|COMPLETED|Overall Study||17
1677471|NCT00580398|4097696|P2|STARTED|Overall Study||32
1677472|NCT00580398|4097697|P1|STARTED|Overall Study||17
1677473|NCT00580372|4097705|P1|NOT COMPLETED|Overall Study||0
1677474|NCT00580372|4097705|P1|COMPLETED|Overall Study||231
1677475|NCT00580372|4097705|P1|STARTED|Overall Study||231
1677476|NCT00580333|4097709|P1|NOT COMPLETED|Overall Study||0
1677477|NCT00580333|4097709|P1|COMPLETED|Overall Study||51
1677478|NCT00580333|4097709|P1|STARTED|Overall Study||51
1677479|NCT00580294|4097716|P1|NOT COMPLETED|Overall Study||0
1677480|NCT00580294|4097716|P1|COMPLETED|Overall Study||12
1677481|NCT00580294|4097716|P1|STARTED|Overall Study||12
1677482|NCT00580229|4097720|P1|NOT COMPLETED|Overall Study||0
1677483|NCT00580229|4097720|P1|COMPLETED|Overall Study||50
1677484|NCT00580229|4097720|P1|STARTED|Overall Study||50
1677485|NCT00580151|4097728|P2|NOT COMPLETED|Overall Study||0
1677486|NCT00580151|4097729|P1|NOT COMPLETED|Overall Study||0
1677487|NCT00580151|4097728|P2|COMPLETED|Overall Study||0
1677488|NCT00580151|4097729|P1|COMPLETED|Overall Study||9
1677489|NCT00580151|4097728|P2|STARTED|Overall Study||0
1677490|NCT00580151|4097729|P1|STARTED|Overall Study||9
1677491|NCT00580138|4097737|P1|NOT COMPLETED|Overall Study||0
1677492|NCT00580138|4097737|P1|COMPLETED|Overall Study||30
1677493|NCT00580138|4097737|P1|STARTED|Overall Study||30
1677494|NCT00580073|4097741|P1|NOT COMPLETED|Overall Study||0
1677495|NCT00580073|4097741|P1|COMPLETED|Overall Study||6
1677496|NCT00580073|4097741|P1|STARTED|Overall Study||6
1677497|NCT00580047|4097750|P3|NOT COMPLETED|Overall Study||2
1677498|NCT00580047|4097751|P2|NOT COMPLETED|Overall Study||2
1677499|NCT00580047|4097752|P1|NOT COMPLETED|Overall Study||3
1677500|NCT00580047|4097750|P3|COMPLETED|Overall Study||10
1677501|NCT00580047|4097751|P2|COMPLETED|Overall Study||21
1677502|NCT00580047|4097752|P1|COMPLETED|Overall Study||21
1677503|NCT00580047|4097750|P3|STARTED|Overall Study||12
1677504|NCT00580047|4097751|P2|STARTED|Overall Study||23
1677505|NCT00580047|4097752|P1|STARTED|Overall Study||24
1677506|NCT00580034|4097763|P2|NOT COMPLETED|Overall Study||0
1677507|NCT00580034|4097764|P1|NOT COMPLETED|Overall Study||10
1677508|NCT00580034|4097763|P2|COMPLETED|Overall Study||88
1677509|NCT00580034|4097764|P1|COMPLETED|Overall Study||78
1677510|NCT00580034|4097763|P2|STARTED|Overall Study||88
1677511|NCT00580034|4097764|P1|STARTED|Overall Study||88
1677512|NCT00579982|4097770|P1|NOT COMPLETED|Overall Study||8
1677513|NCT00579982|4097770|P1|COMPLETED|Overall Study||89
1677514|NCT00579982|4097770|P1|STARTED|Overall Study||97
1677515|NCT00579826|4097791|P2|NOT COMPLETED|Overall Study||3
1677516|NCT00579826|4097792|P1|NOT COMPLETED|Overall Study||5
1677517|NCT00579826|4097791|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
1677518|NCT00579826|4097792|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
1677519|NCT00579826|4097791|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
1677520|NCT00579826|4097792|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
1677521|NCT00579826|4097791|P2|STARTED|Overall Study||26
1677522|NCT00579826|4097792|P1|STARTED|Overall Study||29
1677523|NCT00579813|4097804|P2|NOT COMPLETED|Overall Study||0
1677524|NCT00579813|4097805|P1|NOT COMPLETED|Overall Study||0
1677525|NCT00579813|4097804|P2|COMPLETED|Overall Study||10
1677526|NCT00579813|4097805|P1|COMPLETED|Overall Study||60
1677527|NCT00579813|4097804|P2|STARTED|Overall Study||10
1677528|NCT00579813|4097805|P1|STARTED|Overall Study||60
1677529|NCT00579670|4097826|P5|NOT COMPLETED|Overall Study||0
1677530|NCT00579670|4097827|P4|NOT COMPLETED|Overall Study||22
1677531|NCT00579670|4097828|P3|NOT COMPLETED|Overall Study||4
1677532|NCT00579670|4097829|P2|NOT COMPLETED|Overall Study||1
1677533|NCT00579670|4097830|P1|NOT COMPLETED|Overall Study||2
1677534|NCT00579670|4097826|P5|COMPLETED|Overall Study||5
1677535|NCT00579670|4097827|P4|COMPLETED|Overall Study||263
1677536|NCT00579670|4097828|P3|COMPLETED|Overall Study||84
1677537|NCT00579670|4097829|P2|COMPLETED|Overall Study||56
1677538|NCT00579670|4097830|P1|COMPLETED|Overall Study||13
1677539|NCT00579670|4097826|P5|Population: Within SmPC (Completed)|Overall Study||0
1677540|NCT00579670|4097827|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
1677541|NCT00579670|4097828|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
1677542|NCT00579670|4097829|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
1677543|NCT00579670|4097830|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
1677544|NCT00579670|4097826|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
1677545|NCT00579670|4097827|P4|Population: Within SmPC (Started)|Overall Study||159
1677546|NCT00579670|4097828|P3|Population: Within SmPC (Started)|Overall Study||83
1677547|NCT00579670|4097829|P2|Population: Within SmPC (Started)|Overall Study||56
1677548|NCT00579670|4097830|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
1677549|NCT00579670|4097826|P5|STARTED|Overall Study||5
1677550|NCT00579670|4097827|P4|STARTED|Overall Study||285
1677551|NCT00579670|4097828|P3|STARTED|Overall Study||88
1677552|NCT00579670|4097829|P2|STARTED|Overall Study||57
1677553|NCT00579670|4097830|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
1677554|NCT00579501|4098042|P1|NOT COMPLETED|Overall Study||29
1677555|NCT00579501|4098042|P1|COMPLETED|Overall Study||0
1677556|NCT00579501|4098042|P1|STARTED|Overall Study||29
1677557|NCT00579436|4098049|P2|NOT COMPLETED|Overall Study||0
1677558|NCT00579436|4098050|P1|NOT COMPLETED|Overall Study||0
1677559|NCT00579436|4098049|P2|COMPLETED|Overall Study||14
1677560|NCT00579436|4098050|P1|COMPLETED|Overall Study||19
1677561|NCT00579436|4098049|P2|STARTED|Overall Study||14
1677562|NCT00579436|4098050|P1|STARTED|Overall Study||19
1677563|NCT00579345|4098070|P8|NOT COMPLETED|Overall Study||2
1677564|NCT00579345|4098071|P7|NOT COMPLETED|Overall Study||0
1677565|NCT00579345|4098072|P6|NOT COMPLETED|Overall Study||0
1677566|NCT00579345|4098073|P5|NOT COMPLETED|Overall Study||0
1677567|NCT00579345|4098074|P4|NOT COMPLETED|Overall Study||1
1677568|NCT00579345|4098075|P3|NOT COMPLETED|Overall Study||2
1677569|NCT00579345|4098076|P2|NOT COMPLETED|Overall Study||1
1677570|NCT00579345|4098077|P1|NOT COMPLETED|Overall Study||5
1677571|NCT00579345|4098070|P8|COMPLETED|Overall Study||42
1677572|NCT00579345|4098071|P7|COMPLETED|Overall Study||57
1677573|NCT00579345|4098072|P6|COMPLETED|Overall Study||78
1677574|NCT00579345|4098073|P5|COMPLETED|Overall Study||90
1677575|NCT00579345|4098074|P4|COMPLETED|Overall Study||143
1677576|NCT00579345|4098075|P3|COMPLETED|Overall Study||389
1677577|NCT00579345|4098076|P2|COMPLETED|Overall Study||168
1677578|NCT00579345|4098077|P1|COMPLETED|Overall Study||544
1677579|NCT00579345|4098070|P8|STARTED|Overall Study||44
1677580|NCT00579345|4098071|P7|STARTED|Overall Study||57
1677581|NCT00579345|4098072|P6|STARTED|Overall Study||78
1677582|NCT00579345|4098073|P5|STARTED|Overall Study||90
1677583|NCT00579345|4098074|P4|STARTED|Overall Study||144
1677584|NCT00579345|4098075|P3|STARTED|Overall Study||391
1677585|NCT00579345|4098076|P2|STARTED|Overall Study||169
1677586|NCT00579345|4098077|P1|STARTED|Overall Study||549
1677587|NCT00579254|4098109|P1|NOT COMPLETED|Overall Study||112
1677588|NCT00579254|4098109|P1|COMPLETED|Overall Study||0
1677589|NCT00579254|4098109|P1|STARTED|Overall Study||112
1677590|NCT00579137|4098113|P1|NOT COMPLETED|Overall Study||0
1677591|NCT00579137|4098113|P1|COMPLETED|Overall Study||3
1677592|NCT00579137|4098113|P1|STARTED|Overall Study||3
1677593|NCT00579111|4098122|P2|NOT COMPLETED|Overall Study||1
1677594|NCT00579111|4098123|P1|NOT COMPLETED|Overall Study||2
1677595|NCT00579111|4098122|P2|COMPLETED|Overall Study||0
1677596|NCT00579111|4098123|P1|COMPLETED|Overall Study||1
1677597|NCT00579111|4098122|P2|STARTED|Overall Study||1
1677598|NCT00579111|4098123|P1|STARTED|Overall Study||3
1677599|NCT00579098|4098133|P2|NOT COMPLETED|Overall Study||8
1677600|NCT00579098|4098134|P1|NOT COMPLETED|Overall Study||9
1677601|NCT00579098|4098133|P2|COMPLETED|Overall Study||55
1677602|NCT00579098|4098134|P1|COMPLETED|Overall Study||53
1677603|NCT00579098|4098133|P2|STARTED|Overall Study||63
1677604|NCT00579098|4098134|P1|STARTED|Overall Study||62
1677605|NCT00579059|4098150|P2|NOT COMPLETED|Overall Study||10
1677606|NCT00579059|4098151|P1|NOT COMPLETED|Overall Study||21
1677607|NCT00579059|4098150|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
1677608|NCT00579059|4098151|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
1677609|NCT00579059|4098150|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1677610|NCT00579059|4098151|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1677611|NCT00579059|4098150|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1677612|NCT00579059|4098151|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1677613|NCT00579059|4098150|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
1677614|NCT00579059|4098151|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
1677615|NCT00579059|4098150|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
1677616|NCT00579059|4098151|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
1677617|NCT00579059|4098150|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
1677618|NCT00579059|4098151|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
1677619|NCT00579059|4098150|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
1677620|NCT00579059|4098151|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
1677621|NCT00578968|4098162|P3|NOT COMPLETED|Intervention||0
1677622|NCT00578968|4098163|P2|NOT COMPLETED|Intervention||0
1677623|NCT00578968|4098164|P1|NOT COMPLETED|Intervention||0
1677624|NCT00578968|4098162|P3|COMPLETED|Intervention||0
1677625|NCT00578968|4098163|P2|COMPLETED|Intervention||12
1677626|NCT00578968|4098164|P1|COMPLETED|Intervention||12
1677627|NCT00578968|4098162|P3|STARTED|Intervention||0
1677628|NCT00578968|4098163|P2|STARTED|Intervention||12
1677629|NCT00578968|4098164|P1|STARTED|Intervention||12
1677630|NCT00578968|4098162|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
1677631|NCT00578968|4098163|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
1677632|NCT00578968|4098164|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
1677633|NCT00578968|4098162|P3|COMPLETED|Baseline (Prior to Intervention)||12
1677634|NCT00578968|4098163|P2|COMPLETED|Baseline (Prior to Intervention)||12
1677635|NCT00578968|4098164|P1|COMPLETED|Baseline (Prior to Intervention)||12
1677636|NCT00578968|4098162|P3|STARTED|Baseline (Prior to Intervention)||12
1677637|NCT00578968|4098163|P2|STARTED|Baseline (Prior to Intervention)||12
1677638|NCT00578968|4098164|P1|STARTED|Baseline (Prior to Intervention)||12
1677639|NCT00578942|4098225|P1|NOT COMPLETED|Overall Study||1
1677640|NCT00578942|4098225|P1|COMPLETED|Overall Study||47
1677641|NCT00578942|4098225|P1|STARTED|Overall Study||48
1677642|NCT00578929|4098235|P4|NOT COMPLETED|Randomized Period||14
1677643|NCT00578929|4098236|P3|NOT COMPLETED|Randomized Period||8
1677644|NCT00578929|4098237|P2|NOT COMPLETED|Randomized Period||14
1677645|NCT00578929|4098238|P1|NOT COMPLETED|Randomized Period||17
1677646|NCT00578929|4098235|P4|COMPLETED|Randomized Period||283
1677647|NCT00578929|4098236|P3|COMPLETED|Randomized Period||288
1677648|NCT00578929|4098237|P2|COMPLETED|Randomized Period||283
1677649|NCT00578929|4098238|P1|COMPLETED|Randomized Period||281
1677650|NCT00578929|4098235|P4|STARTED|Randomized Period||297
1677651|NCT00578929|4098236|P3|STARTED|Randomized Period||296
1677652|NCT00578929|4098237|P2|STARTED|Randomized Period||297
1677653|NCT00578929|4098238|P1|STARTED|Randomized Period||298
1677654|NCT00578929|4098235|P4|NOT COMPLETED|Vehicle Run-In Period||0
1677655|NCT00578929|4098236|P3|NOT COMPLETED|Vehicle Run-In Period||0
1677656|NCT00578929|4098237|P2|NOT COMPLETED|Vehicle Run-In Period||0
1677657|NCT00578929|4098238|P1|NOT COMPLETED|Vehicle Run-In Period||0
1677658|NCT00578929|4098235|P4|COMPLETED|Vehicle Run-In Period||0
1677659|NCT00578929|4098236|P3|COMPLETED|Vehicle Run-In Period||0
1677660|NCT00578929|4098237|P2|COMPLETED|Vehicle Run-In Period||2388
1677661|NCT00578929|4098238|P1|COMPLETED|Vehicle Run-In Period||0
1677662|NCT00578929|4098235|P4|STARTED|Vehicle Run-In Period||0
1677663|NCT00578929|4098236|P3|STARTED|Vehicle Run-In Period||0
1677664|NCT00578929|4098237|P2|STARTED|Vehicle Run-In Period||2388
1677665|NCT00578929|4098238|P1|STARTED|Vehicle Run-In Period||0
1677666|NCT00578903|4098253|P1|NOT COMPLETED|Overall Study||0
1677667|NCT00578903|4098253|P1|COMPLETED|Overall Study||22
1677668|NCT00578903|4098253|P1|STARTED|Overall Study||22
1677669|NCT00578877|4098264|P2|NOT COMPLETED|Overall Study||128
1677670|NCT00578877|4098265|P1|NOT COMPLETED|Overall Study||81
1677671|NCT00578877|4098264|P2|COMPLETED|Overall Study||172
1677672|NCT00578877|4098265|P1|COMPLETED|Overall Study||69
1677673|NCT00578877|4098264|P2|STARTED|Overall Study||300
1677674|NCT00578877|4098265|P1|STARTED|Overall Study||150
1677675|NCT00578864|4098273|P2|NOT COMPLETED|Overall Study||0
1677676|NCT00578864|4098274|P1|NOT COMPLETED|Overall Study||1
1677677|NCT00578864|4098273|P2|COMPLETED|Overall Study||6
1677678|NCT00578864|4098274|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
1677679|NCT00578864|4098273|P2|STARTED|Overall Study||6
1677680|NCT00578864|4098274|P1|STARTED|Overall Study||7
1677681|NCT00578812|4098290|P2|NOT COMPLETED|Overall Study||7
1677682|NCT00578812|4098291|P1|NOT COMPLETED|Overall Study||6
1677683|NCT00578812|4098290|P2|COMPLETED|Overall Study||185
1677684|NCT00578812|4098291|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
1677685|NCT00578812|4098290|P2|STARTED|Overall Study||192
1677686|NCT00578812|4098291|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
1677687|NCT00578786|4098330|P3|NOT COMPLETED|Overall Study||30
1677688|NCT00578786|4098331|P2|NOT COMPLETED|Overall Study||66
1677689|NCT00578786|4098332|P1|NOT COMPLETED|Overall Study||39
1677690|NCT00578786|4098330|P3|COMPLETED|Overall Study||67
1677691|NCT00578786|4098331|P2|COMPLETED|Overall Study||124
1677692|NCT00578786|4098332|P1|COMPLETED|Overall Study||57
1677693|NCT00578786|4098330|P3|STARTED|Overall Study||97
1677694|NCT00578786|4098331|P2|STARTED|Overall Study||190
1677695|NCT00578786|4098332|P1|STARTED|Overall Study||96
1677696|NCT00578734|4098413|P2|NOT COMPLETED|Overall Study||0
1677697|NCT00578734|4098414|P1|NOT COMPLETED|Overall Study||0
1677698|NCT00578734|4098413|P2|COMPLETED|Overall Study||81
1677699|NCT00578734|4098414|P1|COMPLETED|Overall Study||84
1677700|NCT00578734|4098413|P2|STARTED|Overall Study||81
1677701|NCT00578734|4098414|P1|STARTED|Overall Study||84
1677702|NCT00578669|4098424|P2|NOT COMPLETED|Overall Study||0
1677703|NCT00578669|4098425|P1|NOT COMPLETED|Overall Study||0
1677704|NCT00578669|4098424|P2|COMPLETED|Overall Study||99
1677705|NCT00578669|4098425|P1|COMPLETED|Overall Study||107
1677706|NCT00578669|4098424|P2|STARTED|Overall Study||99
1677707|NCT00578669|4098425|P1|STARTED|Overall Study||107
1677708|NCT00578643|4098433|P1|NOT COMPLETED|Overall Study||2
1677709|NCT00578643|4098433|P1|COMPLETED|Overall Study||13
1677710|NCT00578643|4098433|P1|STARTED|Overall Study||15
1677711|NCT00578617|4098442|P2|NOT COMPLETED|Overall Study||0
1677712|NCT00578617|4098443|P1|NOT COMPLETED|Overall Study||0
1677713|NCT00578617|4098442|P2|COMPLETED|Overall Study||29
1677714|NCT00578617|4098443|P1|COMPLETED|Overall Study||31
1677715|NCT00578617|4098442|P2|STARTED|Overall Study||29
1677716|NCT00578617|4098443|P1|STARTED|Overall Study||31
1677717|NCT00578565|4098449|P1|NOT COMPLETED|Overall Study||3
1677718|NCT00578565|4098449|P1|COMPLETED|Overall Study||7
1677719|NCT00578565|4098449|P1|STARTED|Overall Study||10
1677720|NCT00578552|4098461|P3|NOT COMPLETED|Overall Study||15
1677721|NCT00578552|4098462|P2|NOT COMPLETED|Overall Study||14
1677722|NCT00578552|4098463|P1|NOT COMPLETED|Overall Study||15
1677723|NCT00578552|4098461|P3|COMPLETED|Overall Study||11
1677724|NCT00578552|4098462|P2|COMPLETED|Overall Study||13
1677725|NCT00578552|4098463|P1|COMPLETED|Overall Study||12
1677726|NCT00578552|4098461|P3|STARTED|Overall Study||26
1677727|NCT00578552|4098462|P2|STARTED|Overall Study||27
1677728|NCT00578552|4098463|P1|STARTED|Overall Study||27
1677729|NCT00578539|4098471|P1|NOT COMPLETED|Overall Study||0
1677730|NCT00578539|4098471|P1|COMPLETED|Overall Study||24
1677731|NCT00578539|4098471|P1|STARTED|Overall Study||24
1677732|NCT00578461|4098475|P1|NOT COMPLETED|Overall Study||0
1677733|NCT00578461|4098475|P1|COMPLETED|Overall Study||26
1677734|NCT00578461|4098475|P1|STARTED|Overall Study||26
1677735|NCT00578448|4098479|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
1677736|NCT00578448|4098479|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
1677737|NCT00578448|4098479|P1|STARTED|1 Year Long Term Extension (LTE)||9
1677738|NCT00578448|4098479|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
1677739|NCT00578448|4098479|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
1677740|NCT00578448|4098479|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
1677741|NCT00578383|4098497|P4|NOT COMPLETED|Overall Study||6
1677742|NCT00578383|4098498|P3|NOT COMPLETED|Overall Study||6
1677743|NCT00578383|4098499|P2|NOT COMPLETED|Overall Study||16
1677744|NCT00578383|4098500|P1|NOT COMPLETED|Overall Study||16
1677745|NCT00578383|4098497|P4|COMPLETED|Overall Study||9
1677746|NCT00578383|4098498|P3|COMPLETED|Overall Study||13
1677747|NCT00578383|4098499|P2|COMPLETED|Overall Study||20
1677748|NCT00578383|4098500|P1|COMPLETED|Overall Study||21
1677749|NCT00578383|4098497|P4|STARTED|Overall Study||15
1677750|NCT00578383|4098498|P3|STARTED|Overall Study||19
1677751|NCT00578383|4098499|P2|STARTED|Overall Study||36
1677752|NCT00578383|4098500|P1|STARTED|Overall Study||37
1677753|NCT00578331|4098532|P2|NOT COMPLETED|Overall Study||125
1677754|NCT00578331|4098533|P1|NOT COMPLETED|Overall Study||116
1677755|NCT00578331|4098532|P2|COMPLETED|Overall Study||320
1677756|NCT00578331|4098533|P1|COMPLETED|Overall Study||329
1677757|NCT00578331|4098532|P2|STARTED|Overall Study||445
1677758|NCT00578331|4098533|P1|STARTED|Overall Study||445
1677759|NCT00578318|4098543|P2|NOT COMPLETED|Overall Study||0
1677760|NCT00578318|4098544|P1|NOT COMPLETED|Overall Study||3
1677761|NCT00578318|4098543|P2|COMPLETED|Overall Study||8
1677762|NCT00578318|4098544|P1|COMPLETED|Overall Study||5
1677763|NCT00578318|4098543|P2|STARTED|Overall Study||8
1677764|NCT00578318|4098544|P1|STARTED|Overall Study||8
1677765|NCT00578305|4098553|P3|NOT COMPLETED|Safety Follow-up Phase||46
1677766|NCT00578305|4098554|P2|NOT COMPLETED|Safety Follow-up Phase||45
1677767|NCT00578305|4098555|P1|NOT COMPLETED|Safety Follow-up Phase||46
1677768|NCT00578305|4098553|P3|COMPLETED|Safety Follow-up Phase||8
1677769|NCT00578305|4098554|P2|COMPLETED|Safety Follow-up Phase||9
1677770|NCT00578305|4098555|P1|COMPLETED|Safety Follow-up Phase||11
1677771|NCT00578305|4098553|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
1677772|NCT00578305|4098554|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
1677773|NCT00578305|4098555|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
1677774|NCT00578305|4098553|P3|NOT COMPLETED|Extension Phase||3
1677775|NCT00578305|4098554|P2|NOT COMPLETED|Extension Phase||1
1677776|NCT00578305|4098555|P1|NOT COMPLETED|Extension Phase||4
1677777|NCT00578305|4098553|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
1677778|NCT00578305|4098554|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
1677779|NCT00578305|4098555|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
1677780|NCT00578305|4098553|P3|STARTED|Extension Phase||43
1677781|NCT00578305|4098554|P2|STARTED|Extension Phase||50
1677782|NCT00578305|4098555|P1|STARTED|Extension Phase||53
1677783|NCT00578305|4098553|P3|NOT COMPLETED|Double-blind Treatment Phase||14
1677784|NCT00578305|4098554|P2|NOT COMPLETED|Double-blind Treatment Phase||4
1677785|NCT00578305|4098555|P1|NOT COMPLETED|Double-blind Treatment Phase||3
1677786|NCT00578305|4098553|P3|COMPLETED|Double-blind Treatment Phase||49
1677787|NCT00578305|4098554|P2|COMPLETED|Double-blind Treatment Phase||56
1677788|NCT00578305|4098555|P1|COMPLETED|Double-blind Treatment Phase||59
1677789|NCT00578305|4098553|P3|Treated|Double-blind Treatment Phase||63
1677790|NCT00578305|4098554|P2|Treated|Double-blind Treatment Phase||60
1677791|NCT00578305|4098555|P1|Treated|Double-blind Treatment Phase||62
1677792|NCT00578305|4098553|P3|STARTED|Double-blind Treatment Phase||63
1677793|NCT00578305|4098554|P2|STARTED|Double-blind Treatment Phase||60
1677794|NCT00578305|4098555|P1|STARTED|Double-blind Treatment Phase||62
1677795|NCT00578279|4098616|P2|NOT COMPLETED|Overall Study||0
1677796|NCT00578279|4098617|P1|NOT COMPLETED|Overall Study||0
1677797|NCT00578279|4098616|P2|COMPLETED|Overall Study||10
1677798|NCT00578279|4098617|P1|COMPLETED|Overall Study||10
1677799|NCT00578279|4098616|P2|STARTED|Overall Study||10
1677800|NCT00578279|4098617|P1|STARTED|Overall Study||10
1677801|NCT00578227|4098626|P3|NOT COMPLETED|Overall Study||4
1677802|NCT00578227|4098627|P2|NOT COMPLETED|Overall Study||2
1677803|NCT00578227|4098628|P1|NOT COMPLETED|Overall Study||5
1677804|NCT00578227|4098626|P3|COMPLETED|Overall Study||267
1677805|NCT00578227|4098627|P2|COMPLETED|Overall Study||268
1677806|NCT00578227|4098628|P1|COMPLETED|Overall Study||267
1677807|NCT00578227|4098626|P3|STARTED|Overall Study||271
1677808|NCT00578227|4098627|P2|STARTED|Overall Study||270
1677809|NCT00578227|4098628|P1|STARTED|Overall Study||272
1677810|NCT00578214|4098701|P3|NOT COMPLETED|Overall Study||0
1677811|NCT00578214|4098702|P2|NOT COMPLETED|Overall Study||0
1677812|NCT00578214|4098703|P1|NOT COMPLETED|Overall Study||0
1677813|NCT00578214|4098701|P3|COMPLETED|Overall Study||31
1677814|NCT00578214|4098702|P2|COMPLETED|Overall Study||22
1677815|NCT00578214|4098703|P1|COMPLETED|Overall Study||22
1677816|NCT00578214|4098701|P3|STARTED|Overall Study||31
1677817|NCT00578214|4098702|P2|STARTED|Overall Study||22
1677818|NCT00578214|4098703|P1|STARTED|Overall Study||22
1677819|NCT00578175|4098753|P3|NOT COMPLETED|Overall Study||24
1677820|NCT00578175|4098754|P2|NOT COMPLETED|Overall Study||43
1677821|NCT00578175|4098755|P1|NOT COMPLETED|Overall Study||70
1677822|NCT00578175|4098753|P3|COMPLETED|Overall Study||365
1677823|NCT00578175|4098754|P2|COMPLETED|Overall Study||646
1677824|NCT00578175|4098755|P1|COMPLETED|Overall Study||635
1677825|NCT00578175|4098753|P3|STARTED|Overall Study||389
1677826|NCT00578175|4098754|P2|STARTED|Overall Study||689
1677827|NCT00578175|4098755|P1|STARTED|Overall Study||705
1677828|NCT00578136|4098834|P2|NOT COMPLETED|Overall Study||1
1677829|NCT00578136|4098835|P1|NOT COMPLETED|Overall Study||1
1677830|NCT00578136|4098834|P2|COMPLETED|Overall Study||26
1677831|NCT00578136|4098835|P1|COMPLETED|Overall Study||26
1677832|NCT00578136|4098834|P2|STARTED|Overall Study||27
1677833|NCT00578136|4098835|P1|STARTED|Overall Study||27
1677834|NCT00578071|4098843|P1|NOT COMPLETED|Overall Study||0
1677835|NCT00578071|4098843|P1|COMPLETED|Overall Study||29
1677836|NCT00578071|4098843|P1|STARTED|Overall Study||29
1677837|NCT00577889|4098853|P3|NOT COMPLETED|Overall Study||0
1677838|NCT00577889|4098854|P2|NOT COMPLETED|Overall Study||0
1677839|NCT00577889|4098855|P1|NOT COMPLETED|Overall Study||1
1677840|NCT00577889|4098853|P3|COMPLETED|Overall Study||6
1677841|NCT00577889|4098854|P2|COMPLETED|Overall Study||6
1677842|NCT00577889|4098855|P1|COMPLETED|Overall Study||8
1677843|NCT00577889|4098853|P3|STARTED|Overall Study||6
1677844|NCT00577889|4098854|P2|STARTED|Overall Study||6
1677845|NCT00577889|4098855|P1|STARTED|Overall Study||9
1677846|NCT00577863|4098874|P2|NOT COMPLETED|Overall Study||14
1677847|NCT00577863|4098875|P1|NOT COMPLETED|Overall Study||10
1677848|NCT00577863|4098874|P2|COMPLETED|Overall Study||94
1677849|NCT00577863|4098875|P1|COMPLETED|Overall Study||82
1677850|NCT00577863|4098874|P2|Received at Least One Injection|Overall Study||107
1677851|NCT00577863|4098875|P1|Received at Least One Injection|Overall Study||92
1677852|NCT00577863|4098874|P2|STARTED|Overall Study||108
1677853|NCT00577863|4098875|P1|STARTED|Overall Study||92
1677854|NCT00577824|4098917|P3|NOT COMPLETED|Overall Study||2
1677855|NCT00577824|4098918|P2|NOT COMPLETED|Overall Study||20
1677856|NCT00577824|4098919|P1|NOT COMPLETED|Overall Study||7
1677857|NCT00577824|4098917|P3|COMPLETED|Overall Study||34
1677858|NCT00577824|4098918|P2|COMPLETED|Overall Study||53
1677859|NCT00577824|4098919|P1|COMPLETED|Overall Study||65
1677860|NCT00577824|4098917|P3|Full Analysis Set|Overall Study||35
1677861|NCT00577824|4098918|P2|Full Analysis Set|Overall Study||72
1677862|NCT00577824|4098919|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
1677863|NCT00577824|4098917|P3|STARTED|Overall Study||36
1677864|NCT00577824|4098918|P2|STARTED|Overall Study||73
1677865|NCT00577824|4098919|P1|STARTED|Overall Study|Started=Randomized|72
1677866|NCT00577772|4098977|P2|NOT COMPLETED|Overall Study||1
1677867|NCT00577772|4098978|P1|NOT COMPLETED|Overall Study||0
1677868|NCT00577772|4098977|P2|COMPLETED|Overall Study||6
1677869|NCT00577772|4098978|P1|COMPLETED|Overall Study||10
1677870|NCT00577772|4098977|P2|STARTED|Overall Study||7
1677871|NCT00577772|4098978|P1|STARTED|Overall Study||10
1677872|NCT00577720|4098988|P4|NOT COMPLETED|Overall Study||7
1677873|NCT00577720|4098989|P3|NOT COMPLETED|Overall Study||1
1677874|NCT00577720|4098990|P2|NOT COMPLETED|Overall Study||1
1677875|NCT00577720|4098991|P1|NOT COMPLETED|Overall Study||4
1677876|NCT00577720|4098988|P4|COMPLETED|Overall Study||65
1677877|NCT00577720|4098989|P3|COMPLETED|Overall Study||35
1677878|NCT00577720|4098990|P2|COMPLETED|Overall Study||35
1677879|NCT00577720|4098991|P1|COMPLETED|Overall Study||33
1677880|NCT00577720|4098988|P4|ITT (Intent to Treat) Population|Overall Study||65
1677881|NCT00577720|4098989|P3|ITT (Intent to Treat) Population|Overall Study||35
1677882|NCT00577720|4098990|P2|ITT (Intent to Treat) Population|Overall Study||35
1677883|NCT00577720|4098991|P1|ITT (Intent to Treat) Population|Overall Study||34
1677884|NCT00577720|4098988|P4|STARTED|Overall Study||72
1677885|NCT00577720|4098989|P3|STARTED|Overall Study||36
1677886|NCT00577720|4098990|P2|STARTED|Overall Study||36
1677887|NCT00577720|4098991|P1|STARTED|Overall Study||37
1677888|NCT00577707|4099009|P1|NOT COMPLETED|Overall Study||3
1677889|NCT00577707|4099009|P1|COMPLETED|Overall Study||6
1677890|NCT00577707|4099009|P1|STARTED|Overall Study||9
1677891|NCT00577655|4099017|P2|NOT COMPLETED|Overall Study||4
1677892|NCT00577655|4099018|P1|NOT COMPLETED|Overall Study||1
1677893|NCT00577655|4099017|P2|COMPLETED|Overall Study||47
1677894|NCT00577655|4099018|P1|COMPLETED|Overall Study||51
1677895|NCT00577655|4099017|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
1677896|NCT00577655|4099018|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
1677897|NCT00577642|4099056|P1|NOT COMPLETED|Overall Study||1
1677898|NCT00577642|4099056|P1|COMPLETED|Overall Study||28
1677899|NCT00577642|4099056|P1|STARTED|Overall Study||29
1677900|NCT00577629|4099060|P1|NOT COMPLETED|Long Term Follow-Up||25
1677901|NCT00577629|4099060|P1|COMPLETED|Long Term Follow-Up||13
1677902|NCT00577629|4099060|P1|STARTED|Long Term Follow-Up||38
1677903|NCT00577629|4099060|P1|NOT COMPLETED|Treatment Period||1
1677904|NCT00577629|4099060|P1|COMPLETED|Treatment Period||38
1677905|NCT00577629|4099060|P1|STARTED|Treatment Period||39
1677906|NCT00577590|4099071|P3|NOT COMPLETED|Overall Study||0
1677907|NCT00577590|4099072|P2|NOT COMPLETED|Overall Study||0
1677908|NCT00577590|4099073|P1|NOT COMPLETED|Overall Study||0
1677909|NCT00577590|4099071|P3|COMPLETED|Overall Study||23
1677910|NCT00577590|4099072|P2|COMPLETED|Overall Study||27
1677911|NCT00577590|4099073|P1|COMPLETED|Overall Study||28
1677912|NCT00577590|4099071|P3|STARTED|Overall Study||23
1677913|NCT00577590|4099072|P2|STARTED|Overall Study||27
1677914|NCT00577590|4099073|P1|STARTED|Overall Study||28
1677915|NCT00577512|4099081|P1|NOT COMPLETED|Overall Study||4
1677916|NCT00577512|4099081|P1|COMPLETED|Overall Study||0
1677917|NCT00577512|4099081|P1|STARTED|Overall Study||4
1677918|NCT00577473|4099087|P2|NOT COMPLETED|Overall Study||24
1677919|NCT00577473|4099088|P1|NOT COMPLETED|Overall Study||21
1677920|NCT00577473|4099087|P2|COMPLETED|Overall Study||123
1677921|NCT00577473|4099088|P1|COMPLETED|Overall Study||133
1677922|NCT00577473|4099087|P2|ITT Population|Overall Study||136
1677923|NCT00577473|4099088|P1|ITT Population|Overall Study||150
1677924|NCT00577473|4099087|P2|STARTED|Overall Study||147
1677925|NCT00577473|4099088|P1|STARTED|Overall Study||154
1677926|NCT00577460|4099119|P3|NOT COMPLETED|Overall Study||27
1677927|NCT00577460|4099120|P2|NOT COMPLETED|Overall Study||19
1677928|NCT00577460|4099121|P1|NOT COMPLETED|Overall Study||16
1677929|NCT00577460|4099119|P3|COMPLETED|Overall Study||112
1677930|NCT00577460|4099120|P2|COMPLETED|Overall Study||104
1677931|NCT00577460|4099121|P1|COMPLETED|Overall Study||113
1677932|NCT00577460|4099119|P3|STARTED|Overall Study||139
1677933|NCT00577460|4099120|P2|STARTED|Overall Study||123
1677934|NCT00577460|4099121|P1|STARTED|Overall Study||129
1677935|NCT00577408|4099230|P2|NOT COMPLETED|Overall Study||23
1677936|NCT00577408|4099231|P1|NOT COMPLETED|Overall Study||12
1677937|NCT00577408|4099230|P2|COMPLETED|Overall Study||9
1677938|NCT00577408|4099231|P1|COMPLETED|Overall Study||16
1677939|NCT00577408|4099230|P2|STARTED|Overall Study||32
1677940|NCT00577408|4099231|P1|STARTED|Overall Study||28
1677941|NCT00577395|4099239|P2|NOT COMPLETED|Overall Study||6
1677942|NCT00577395|4099240|P1|NOT COMPLETED|Overall Study||7
1677943|NCT00577395|4099239|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
1677944|NCT00577395|4099240|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
1677945|NCT00577395|4099239|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
1677946|NCT00577395|4099240|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
1677947|NCT00577382|4099250|P2|NOT COMPLETED|Overall Study||31
1677948|NCT00577382|4099251|P1|NOT COMPLETED|Overall Study||21
1677949|NCT00577382|4099250|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1677950|NCT00577382|4099251|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1677951|NCT00577382|4099250|P2|STARTED|Overall Study||31
1677952|NCT00577382|4099251|P1|STARTED|Overall Study||21
1677953|NCT00577356|4099263|P1|NOT COMPLETED|Overall Study||0
1677954|NCT00577356|4099263|P1|COMPLETED|Overall Study||6
1677955|NCT00577356|4099263|P1|STARTED|Overall Study||6
1677956|NCT00577135|4099271|P4|NOT COMPLETED|Overall Study||0
1677957|NCT00577135|4099272|P3|NOT COMPLETED|Overall Study||0
1677958|NCT00577135|4099273|P2|NOT COMPLETED|Overall Study||0
1677959|NCT00577135|4099274|P1|NOT COMPLETED|Overall Study||0
1677960|NCT00577135|4099271|P4|COMPLETED|Overall Study||75
1677961|NCT00577135|4099272|P3|COMPLETED|Overall Study||77
1677962|NCT00577135|4099273|P2|COMPLETED|Overall Study||82
1677963|NCT00577135|4099274|P1|COMPLETED|Overall Study||74
1677964|NCT00577135|4099271|P4|STARTED|Overall Study||75
1677965|NCT00577135|4099272|P3|STARTED|Overall Study||77
1677966|NCT00577135|4099273|P2|STARTED|Overall Study||82
1677967|NCT00577135|4099274|P1|STARTED|Overall Study||74
1677968|NCT00577122|4099394|P2|NOT COMPLETED|Overall Study||16
1677969|NCT00577122|4099395|P1|NOT COMPLETED|Overall Study||14
1677970|NCT00577122|4099394|P2|COMPLETED|Overall Study||0
1677971|NCT00577122|4099395|P1|COMPLETED|Overall Study||0
1677972|NCT00577122|4099394|P2|STARTED|Overall Study||16
1677973|NCT00577122|4099395|P1|STARTED|Overall Study||14
1677974|NCT00577096|4099409|P2|NOT COMPLETED|Long Term Participation||0
1677975|NCT00577096|4099410|P1|NOT COMPLETED|Long Term Participation||0
1677976|NCT00577096|4099409|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
1677977|NCT00577096|4099410|P1|COMPLETED|Long Term Participation||34
1677978|NCT00577096|4099409|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
1677979|NCT00577096|4099410|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
1677980|NCT00577096|4099409|P2|NOT COMPLETED|Short Term Participation||8
1677981|NCT00577096|4099410|P1|NOT COMPLETED|Short Term Participation||7
1677982|NCT00577096|4099409|P2|COMPLETED|Short Term Participation||58
1677983|NCT00577096|4099410|P1|COMPLETED|Short Term Participation||62
1677984|NCT00577096|4099409|P2|STARTED|Short Term Participation||66
1677985|NCT00577096|4099410|P1|STARTED|Short Term Participation||69
1677986|NCT00577083|4099436|P2|NOT COMPLETED|Second Intervention (14days)||0
1677987|NCT00577083|4099437|P1|NOT COMPLETED|Second Intervention (14days)||0
1677988|NCT00577083|4099436|P2|COMPLETED|Second Intervention (14days)||52
1677989|NCT00577083|4099437|P1|COMPLETED|Second Intervention (14days)||48
1677990|NCT00577083|4099436|P2|STARTED|Second Intervention (14days)||52
1677991|NCT00577083|4099437|P1|STARTED|Second Intervention (14days)||48
1677992|NCT00577083|4099436|P2|NOT COMPLETED|Washout (14 Days)||0
1677993|NCT00577083|4099437|P1|NOT COMPLETED|Washout (14 Days)||0
1677994|NCT00577083|4099436|P2|COMPLETED|Washout (14 Days)||52
1677995|NCT00577083|4099437|P1|COMPLETED|Washout (14 Days)||48
1677996|NCT00577083|4099436|P2|STARTED|Washout (14 Days)||52
1677997|NCT00577083|4099437|P1|STARTED|Washout (14 Days)||48
1677998|NCT00577083|4099436|P2|NOT COMPLETED|First Intervention (14 Days)||0
1677999|NCT00577083|4099437|P1|NOT COMPLETED|First Intervention (14 Days)||0
1678000|NCT00577083|4099436|P2|COMPLETED|First Intervention (14 Days)||52
1678001|NCT00577083|4099437|P1|COMPLETED|First Intervention (14 Days)||48
1678002|NCT00577083|4099436|P2|STARTED|First Intervention (14 Days)||52
1678003|NCT00577083|4099437|P1|STARTED|First Intervention (14 Days)||48
1678004|NCT00577031|4099449|P1|NOT COMPLETED|Overall Study||205
1678005|NCT00577031|4099449|P1|COMPLETED|Overall Study||0
1678006|NCT00577031|4099449|P1|STARTED|Overall Study||205
1678007|NCT00577005|4099470|P2|NOT COMPLETED|Overall Study||3
1678008|NCT00577005|4099471|P1|NOT COMPLETED|Overall Study||5
1678009|NCT00577005|4099470|P2|COMPLETED|Overall Study||9
1678010|NCT00577005|4099471|P1|COMPLETED|Overall Study||11
1678011|NCT00577005|4099470|P2|STARTED|Overall Study||12
1678012|NCT00577005|4099471|P1|STARTED|Overall Study||16
1678013|NCT00576927|4099485|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
1678014|NCT00576927|4099485|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
1678015|NCT00576927|4099485|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
1678016|NCT00576927|4099485|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
1678017|NCT00576927|4099485|P1|COMPLETED|Sleep Hygiene With Study Drug||22
1678018|NCT00576927|4099485|P1|STARTED|Sleep Hygiene With Study Drug||22
1678019|NCT00576927|4099485|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
1678020|NCT00576927|4099485|P1|COMPLETED|Sleep Hygiene With the Placebo||22
1678021|NCT00576927|4099485|P1|STARTED|Sleep Hygiene With the Placebo||23
1678022|NCT00576927|4099485|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
1678023|NCT00576927|4099485|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
1678024|NCT00576927|4099485|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
1678025|NCT00576927|4099485|P1|NOT COMPLETED|Baseline||13
1678026|NCT00576927|4099485|P1|COMPLETED|Baseline||30
1678027|NCT00576927|4099485|P1|STARTED|Baseline||43
1678028|NCT00576927|4099485|P1|NOT COMPLETED|Clinical Assessment||36
1678029|NCT00576927|4099485|P1|COMPLETED|Clinical Assessment||43
1678030|NCT00576927|4099485|P1|STARTED|Clinical Assessment||79
1678031|NCT00576901|4099497|P1|NOT COMPLETED|Overall Study||3
1678032|NCT00576901|4099497|P1|COMPLETED|Overall Study||20
1678033|NCT00576901|4099497|P1|STARTED|Overall Study||23
1678034|NCT00576823|4099508|P3|NOT COMPLETED|40-week Safety Extension Phase||0
1678035|NCT00576823|4099509|P2|NOT COMPLETED|40-week Safety Extension Phase||0
1678036|NCT00576823|4099510|P1|NOT COMPLETED|40-week Safety Extension Phase||1
1678037|NCT00576823|4099508|P3|COMPLETED|40-week Safety Extension Phase||6
1678038|NCT00576823|4099509|P2|COMPLETED|40-week Safety Extension Phase||6
1678039|NCT00576823|4099510|P1|COMPLETED|40-week Safety Extension Phase||10
1678040|NCT00576823|4099508|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
1678041|NCT00576823|4099509|P2|STARTED|40-week Safety Extension Phase||6
1678042|NCT00576823|4099510|P1|STARTED|40-week Safety Extension Phase||11
1678043|NCT00576823|4099508|P3|NOT COMPLETED|12-week Efficacy Phase||0
1678044|NCT00576823|4099509|P2|NOT COMPLETED|12-week Efficacy Phase||0
1678045|NCT00576823|4099510|P1|NOT COMPLETED|12-week Efficacy Phase||1
1678046|NCT00576823|4099508|P3|COMPLETED|12-week Efficacy Phase||7
1678047|NCT00576823|4099509|P2|COMPLETED|12-week Efficacy Phase||6
1678048|NCT00576823|4099510|P1|COMPLETED|12-week Efficacy Phase||11
1678049|NCT00576823|4099508|P3|STARTED|12-week Efficacy Phase||7
1678050|NCT00576823|4099509|P2|STARTED|12-week Efficacy Phase||6
1678051|NCT00576823|4099510|P1|STARTED|12-week Efficacy Phase||12
1678052|NCT00576758|4099526|P2|NOT COMPLETED|Follow-up Period||17
1678053|NCT00576758|4099527|P1|NOT COMPLETED|Follow-up Period||27
1678054|NCT00576758|4099526|P2|COMPLETED|Follow-up Period||34
1678055|NCT00576758|4099527|P1|COMPLETED|Follow-up Period||28
1678056|NCT00576758|4099526|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
1678057|NCT00576758|4099527|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
1678058|NCT00576758|4099526|P2|NOT COMPLETED|Extension Treatment Period||43
1678059|NCT00576758|4099527|P1|NOT COMPLETED|Extension Treatment Period||42
1678060|NCT00576758|4099526|P2|COMPLETED|Extension Treatment Period||30
1678061|NCT00576758|4099527|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
1678062|NCT00576758|4099526|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
1678063|NCT00576758|4099527|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
1678064|NCT00576758|4099526|P2|NOT COMPLETED|Induction Treatment Period||5
1678065|NCT00576758|4099527|P1|NOT COMPLETED|Induction Treatment Period||8
1678066|NCT00576758|4099526|P2|COMPLETED|Induction Treatment Period||83
1678067|NCT00576758|4099527|P1|COMPLETED|Induction Treatment Period||79
1678068|NCT00576758|4099526|P2|Received Treatment|Induction Treatment Period||87
1678069|NCT00576758|4099527|P1|Received Treatment|Induction Treatment Period||86
1678070|NCT00576758|4099526|P2|STARTED|Induction Treatment Period||88
1678071|NCT00576758|4099527|P1|STARTED|Induction Treatment Period||87
1678072|NCT00576732|4099573|P6|NOT COMPLETED|OPEN LABEL||8
1678073|NCT00576732|4099574|P5|NOT COMPLETED|OPEN LABEL||4
1678074|NCT00576732|4099575|P4|NOT COMPLETED|OPEN LABEL||11
1678075|NCT00576732|4099576|P3|NOT COMPLETED|OPEN LABEL||0
1678076|NCT00576732|4099577|P2|NOT COMPLETED|OPEN LABEL||0
1678077|NCT00576732|4099578|P1|NOT COMPLETED|OPEN LABEL||0
1678078|NCT00576732|4099573|P6|COMPLETED|OPEN LABEL||17
1678079|NCT00576732|4099574|P5|COMPLETED|OPEN LABEL||20
1678080|NCT00576732|4099575|P4|COMPLETED|OPEN LABEL||19
1678081|NCT00576732|4099576|P3|COMPLETED|OPEN LABEL||0
1678082|NCT00576732|4099577|P2|COMPLETED|OPEN LABEL||0
1678083|NCT00576732|4099578|P1|COMPLETED|OPEN LABEL||0
1678084|NCT00576732|4099573|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
1678085|NCT00576732|4099574|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
1678086|NCT00576732|4099575|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
1678087|NCT00576732|4099576|P3|STARTED|OPEN LABEL||0
1678088|NCT00576732|4099577|P2|STARTED|OPEN LABEL||0
1678089|NCT00576732|4099578|P1|STARTED|OPEN LABEL||0
1678090|NCT00576732|4099573|P6|NOT COMPLETED|DOUBLE BLIND||0
1678091|NCT00576732|4099574|P5|NOT COMPLETED|DOUBLE BLIND||0
1678092|NCT00576732|4099575|P4|NOT COMPLETED|DOUBLE BLIND||0
1678093|NCT00576732|4099576|P3|NOT COMPLETED|DOUBLE BLIND||6
1678094|NCT00576732|4099577|P2|NOT COMPLETED|DOUBLE BLIND||5
1678095|NCT00576732|4099578|P1|NOT COMPLETED|DOUBLE BLIND||8
1678096|NCT00576732|4099573|P6|COMPLETED|DOUBLE BLIND||0
1678097|NCT00576732|4099574|P5|COMPLETED|DOUBLE BLIND||0
1678098|NCT00576732|4099575|P4|COMPLETED|DOUBLE BLIND||0
1678099|NCT00576732|4099576|P3|COMPLETED|DOUBLE BLIND||25
1678100|NCT00576732|4099577|P2|COMPLETED|DOUBLE BLIND||25
1678101|NCT00576732|4099578|P1|COMPLETED|DOUBLE BLIND||27
1678102|NCT00576732|4099573|P6|STARTED|DOUBLE BLIND||0
1678103|NCT00576732|4099574|P5|STARTED|DOUBLE BLIND||0
1678104|NCT00576732|4099575|P4|STARTED|DOUBLE BLIND||0
1678105|NCT00576732|4099576|P3|STARTED|DOUBLE BLIND||31
1678106|NCT00576732|4099577|P2|STARTED|DOUBLE BLIND||30
1678107|NCT00576732|4099578|P1|STARTED|DOUBLE BLIND||35
1678108|NCT00576693|4099610|P2|NOT COMPLETED|Overall Study||24
1678109|NCT00576693|4099611|P1|NOT COMPLETED|Overall Study||10
1678110|NCT00576693|4099610|P2|COMPLETED|Overall Study||203
1678111|NCT00576693|4099611|P1|COMPLETED|Overall Study||214
1678112|NCT00576693|4099610|P2|STARTED|Overall Study||227
1678113|NCT00576693|4099611|P1|STARTED|Overall Study||224
1678114|NCT00576628|4099617|P1|NOT COMPLETED|Overall Study||43
1678115|NCT00576628|4099617|P1|COMPLETED|Overall Study||82
1678116|NCT00576628|4099617|P1|STARTED|Overall Study||125
1678117|NCT00576576|4099637|P1|NOT COMPLETED|Overall Study||7
1678118|NCT00576576|4099637|P1|COMPLETED|Overall Study||20
1678119|NCT00576576|4099637|P1|STARTED|Overall Study||27
1678120|NCT00576524|4099645|P2|NOT COMPLETED|Overall Study||0
1678121|NCT00576524|4099646|P1|NOT COMPLETED|Overall Study||0
1678122|NCT00576524|4099645|P2|COMPLETED|Overall Study||0
1678123|NCT00576524|4099646|P1|COMPLETED|Overall Study||2
1678124|NCT00576524|4099645|P2|STARTED|Overall Study||0
1678125|NCT00576524|4099646|P1|STARTED|Overall Study||2
1678126|NCT00576472|4099671|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
1678127|NCT00576472|4099672|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
1678128|NCT00576472|4099673|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
1678129|NCT00576472|4099674|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
1678130|NCT00576472|4099675|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
1678131|NCT00576472|4099676|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
1678132|NCT00576472|4099677|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
1678133|NCT00576472|4099678|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
1678134|NCT00576472|4099679|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
1678135|NCT00576472|4099680|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
1678136|NCT00576472|4099681|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
1678137|NCT00576472|4099682|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
1678138|NCT00576472|4099683|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
1678139|NCT00576472|4099684|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
1678140|NCT00576472|4099685|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
1678141|NCT00576472|4099671|P15|COMPLETED|MPH Home Maintenance Phase||68
1678142|NCT00576472|4099672|P14|COMPLETED|MPH Home Maintenance Phase||0
1678143|NCT00576472|4099673|P13|COMPLETED|MPH Home Maintenance Phase||0
1678144|NCT00576472|4099674|P12|COMPLETED|MPH Home Maintenance Phase||0
1678145|NCT00576472|4099675|P11|COMPLETED|MPH Home Maintenance Phase||0
1678146|NCT00576472|4099676|P10|COMPLETED|MPH Home Maintenance Phase||0
1678147|NCT00576472|4099677|P9|COMPLETED|MPH Home Maintenance Phase||0
1678148|NCT00576472|4099678|P8|COMPLETED|MPH Home Maintenance Phase||0
1678149|NCT00576472|4099679|P7|COMPLETED|MPH Home Maintenance Phase||0
1678150|NCT00576472|4099680|P6|COMPLETED|MPH Home Maintenance Phase||0
1678151|NCT00576472|4099681|P5|COMPLETED|MPH Home Maintenance Phase||0
1678152|NCT00576472|4099682|P4|COMPLETED|MPH Home Maintenance Phase||0
1678153|NCT00576472|4099683|P3|COMPLETED|MPH Home Maintenance Phase||0
1678154|NCT00576472|4099684|P2|COMPLETED|MPH Home Maintenance Phase||0
1678155|NCT00576472|4099685|P1|COMPLETED|MPH Home Maintenance Phase||0
1678156|NCT00576472|4099671|P15|STARTED|MPH Home Maintenance Phase||91
1678157|NCT00576472|4099672|P14|STARTED|MPH Home Maintenance Phase||27
1678158|NCT00576472|4099673|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678159|NCT00576472|4099674|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678160|NCT00576472|4099675|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678161|NCT00576472|4099676|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678162|NCT00576472|4099677|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678163|NCT00576472|4099678|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678164|NCT00576472|4099679|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678165|NCT00576472|4099680|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678166|NCT00576472|4099681|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678167|NCT00576472|4099682|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678168|NCT00576472|4099683|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678169|NCT00576472|4099684|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678170|NCT00576472|4099685|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1678171|NCT00576472|4099671|P15|NOT COMPLETED|MPH Cross Over Phase||0
1678172|NCT00576472|4099672|P14|NOT COMPLETED|MPH Cross Over Phase||0
1678173|NCT00576472|4099673|P13|NOT COMPLETED|MPH Cross Over Phase||0
1678174|NCT00576472|4099674|P12|NOT COMPLETED|MPH Cross Over Phase||1
1678175|NCT00576472|4099675|P11|NOT COMPLETED|MPH Cross Over Phase||1
1678176|NCT00576472|4099676|P10|NOT COMPLETED|MPH Cross Over Phase||0
1678177|NCT00576472|4099677|P9|NOT COMPLETED|MPH Cross Over Phase||2
1678178|NCT00576472|4099678|P8|NOT COMPLETED|MPH Cross Over Phase||0
1678179|NCT00576472|4099679|P7|NOT COMPLETED|MPH Cross Over Phase||12
1678180|NCT00576472|4099680|P6|NOT COMPLETED|MPH Cross Over Phase||0
1678181|NCT00576472|4099681|P5|NOT COMPLETED|MPH Cross Over Phase||0
1678182|NCT00576472|4099682|P4|NOT COMPLETED|MPH Cross Over Phase||0
1678183|NCT00576472|4099683|P3|NOT COMPLETED|MPH Cross Over Phase||0
1678184|NCT00576472|4099684|P2|NOT COMPLETED|MPH Cross Over Phase||0
1678185|NCT00576472|4099685|P1|NOT COMPLETED|MPH Cross Over Phase||0
1678186|NCT00576472|4099671|P15|COMPLETED|MPH Cross Over Phase||0
1678187|NCT00576472|4099672|P14|COMPLETED|MPH Cross Over Phase||0
1678188|NCT00576472|4099673|P13|COMPLETED|MPH Cross Over Phase||21
1678189|NCT00576472|4099674|P12|COMPLETED|MPH Cross Over Phase||17
1678190|NCT00576472|4099675|P11|COMPLETED|MPH Cross Over Phase||22
1678191|NCT00576472|4099676|P10|COMPLETED|MPH Cross Over Phase||22
1678192|NCT00576472|4099677|P9|COMPLETED|MPH Cross Over Phase||16
1678193|NCT00576472|4099678|P8|COMPLETED|MPH Cross Over Phase||20
1678194|NCT00576472|4099679|P7|COMPLETED|MPH Cross Over Phase||0
1678195|NCT00576472|4099680|P6|COMPLETED|MPH Cross Over Phase||0
1678196|NCT00576472|4099681|P5|COMPLETED|MPH Cross Over Phase||0
1678197|NCT00576472|4099682|P4|COMPLETED|MPH Cross Over Phase||0
1678198|NCT00576472|4099683|P3|COMPLETED|MPH Cross Over Phase||0
1678199|NCT00576472|4099684|P2|COMPLETED|MPH Cross Over Phase||0
1678200|NCT00576472|4099685|P1|COMPLETED|MPH Cross Over Phase||0
1678201|NCT00576472|4099671|P15|STARTED|MPH Cross Over Phase||0
1678202|NCT00576472|4099672|P14|STARTED|MPH Cross Over Phase||0
1678203|NCT00576472|4099673|P13|STARTED|MPH Cross Over Phase||21
1678204|NCT00576472|4099674|P12|STARTED|MPH Cross Over Phase||18
1678205|NCT00576472|4099675|P11|STARTED|MPH Cross Over Phase||23
1678206|NCT00576472|4099676|P10|STARTED|MPH Cross Over Phase||22
1678207|NCT00576472|4099677|P9|STARTED|MPH Cross Over Phase||18
1678208|NCT00576472|4099678|P8|STARTED|MPH Cross Over Phase||20
1678209|NCT00576472|4099679|P7|STARTED|MPH Cross Over Phase||12
1678210|NCT00576472|4099680|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1678211|NCT00576472|4099681|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1678212|NCT00576472|4099682|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1678213|NCT00576472|4099683|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1678214|NCT00576472|4099684|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1678215|NCT00576472|4099685|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1678216|NCT00576472|4099671|P15|NOT COMPLETED|MPH In-Lab Phase||0
1678217|NCT00576472|4099672|P14|NOT COMPLETED|MPH In-Lab Phase||0
1678218|NCT00576472|4099673|P13|NOT COMPLETED|MPH In-Lab Phase||0
1678219|NCT00576472|4099674|P12|NOT COMPLETED|MPH In-Lab Phase||0
1678220|NCT00576472|4099675|P11|NOT COMPLETED|MPH In-Lab Phase||0
1678221|NCT00576472|4099676|P10|NOT COMPLETED|MPH In-Lab Phase||0
1678222|NCT00576472|4099677|P9|NOT COMPLETED|MPH In-Lab Phase||0
1678223|NCT00576472|4099678|P8|NOT COMPLETED|MPH In-Lab Phase||0
1678224|NCT00576472|4099679|P7|NOT COMPLETED|MPH In-Lab Phase||0
1678225|NCT00576472|4099680|P6|NOT COMPLETED|MPH In-Lab Phase||0
1678226|NCT00576472|4099681|P5|NOT COMPLETED|MPH In-Lab Phase||0
1678227|NCT00576472|4099682|P4|NOT COMPLETED|MPH In-Lab Phase||335
1678228|NCT00576472|4099683|P3|NOT COMPLETED|MPH In-Lab Phase||0
1678229|NCT00576472|4099684|P2|NOT COMPLETED|MPH In-Lab Phase||0
1678230|NCT00576472|4099685|P1|NOT COMPLETED|MPH In-Lab Phase||0
1678231|NCT00576472|4099671|P15|COMPLETED|MPH In-Lab Phase||0
1678232|NCT00576472|4099672|P14|COMPLETED|MPH In-Lab Phase||0
1678233|NCT00576472|4099673|P13|COMPLETED|MPH In-Lab Phase||0
1678234|NCT00576472|4099674|P12|COMPLETED|MPH In-Lab Phase||0
1678235|NCT00576472|4099675|P11|COMPLETED|MPH In-Lab Phase||0
1678236|NCT00576472|4099676|P10|COMPLETED|MPH In-Lab Phase||0
1678237|NCT00576472|4099677|P9|COMPLETED|MPH In-Lab Phase||0
1678238|NCT00576472|4099678|P8|COMPLETED|MPH In-Lab Phase||0
1678239|NCT00576472|4099679|P7|COMPLETED|MPH In-Lab Phase||0
1678240|NCT00576472|4099680|P6|COMPLETED|MPH In-Lab Phase||67
1678241|NCT00576472|4099681|P5|COMPLETED|MPH In-Lab Phase||67
1678242|NCT00576472|4099682|P4|COMPLETED|MPH In-Lab Phase||0
1678243|NCT00576472|4099683|P3|COMPLETED|MPH In-Lab Phase||0
1678244|NCT00576472|4099684|P2|COMPLETED|MPH In-Lab Phase||0
1678245|NCT00576472|4099685|P1|COMPLETED|MPH In-Lab Phase||0
1678246|NCT00576472|4099671|P15|STARTED|MPH In-Lab Phase||0
1678247|NCT00576472|4099672|P14|STARTED|MPH In-Lab Phase||0
1678248|NCT00576472|4099673|P13|STARTED|MPH In-Lab Phase||0
1678249|NCT00576472|4099674|P12|STARTED|MPH In-Lab Phase||0
1678250|NCT00576472|4099675|P11|STARTED|MPH In-Lab Phase||0
1678251|NCT00576472|4099676|P10|STARTED|MPH In-Lab Phase||0
1678252|NCT00576472|4099677|P9|STARTED|MPH In-Lab Phase||0
1678253|NCT00576472|4099678|P8|STARTED|MPH In-Lab Phase||0
1678254|NCT00576472|4099679|P7|STARTED|MPH In-Lab Phase||0
1678255|NCT00576472|4099680|P6|STARTED|MPH In-Lab Phase||67
1678256|NCT00576472|4099681|P5|STARTED|MPH In-Lab Phase||67
1678257|NCT00576472|4099682|P4|STARTED|MPH In-Lab Phase||335
1678258|NCT00576472|4099683|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
1678259|NCT00576472|4099684|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
1678260|NCT00576472|4099685|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
1678261|NCT00576472|4099671|P15|NOT COMPLETED|Initial Screening||0
1678262|NCT00576472|4099672|P14|NOT COMPLETED|Initial Screening||0
1678263|NCT00576472|4099673|P13|NOT COMPLETED|Initial Screening||0
1678264|NCT00576472|4099674|P12|NOT COMPLETED|Initial Screening||0
1678265|NCT00576472|4099675|P11|NOT COMPLETED|Initial Screening||0
1678266|NCT00576472|4099676|P10|NOT COMPLETED|Initial Screening||0
1678267|NCT00576472|4099677|P9|NOT COMPLETED|Initial Screening||0
1678268|NCT00576472|4099678|P8|NOT COMPLETED|Initial Screening||0
1678269|NCT00576472|4099679|P7|NOT COMPLETED|Initial Screening||0
1678270|NCT00576472|4099680|P6|NOT COMPLETED|Initial Screening||0
1678271|NCT00576472|4099681|P5|NOT COMPLETED|Initial Screening||0
1678272|NCT00576472|4099682|P4|NOT COMPLETED|Initial Screening||0
1678273|NCT00576472|4099683|P3|NOT COMPLETED|Initial Screening||0
1678274|NCT00576472|4099684|P2|NOT COMPLETED|Initial Screening||0
1678275|NCT00576472|4099685|P1|NOT COMPLETED|Initial Screening||0
1678276|NCT00576472|4099671|P15|COMPLETED|Initial Screening||0
1678277|NCT00576472|4099672|P14|COMPLETED|Initial Screening||0
1678278|NCT00576472|4099673|P13|COMPLETED|Initial Screening||0
1678279|NCT00576472|4099674|P12|COMPLETED|Initial Screening||0
1678280|NCT00576472|4099675|P11|COMPLETED|Initial Screening||0
1678281|NCT00576472|4099676|P10|COMPLETED|Initial Screening||0
1678282|NCT00576472|4099677|P9|COMPLETED|Initial Screening||0
1678283|NCT00576472|4099678|P8|COMPLETED|Initial Screening||0
1678284|NCT00576472|4099679|P7|COMPLETED|Initial Screening||0
1678285|NCT00576472|4099680|P6|COMPLETED|Initial Screening||0
1678286|NCT00576472|4099681|P5|COMPLETED|Initial Screening||0
1678287|NCT00576472|4099682|P4|COMPLETED|Initial Screening||0
1678288|NCT00576472|4099683|P3|COMPLETED|Initial Screening||199
1678289|NCT00576472|4099684|P2|COMPLETED|Initial Screening||40
1678290|NCT00576472|4099685|P1|COMPLETED|Initial Screening||230
1678291|NCT00576472|4099671|P15|STARTED|Initial Screening||0
1678292|NCT00576472|4099672|P14|STARTED|Initial Screening||0
1678293|NCT00576472|4099673|P13|STARTED|Initial Screening||0
1678294|NCT00576472|4099674|P12|STARTED|Initial Screening||0
1678295|NCT00576472|4099675|P11|STARTED|Initial Screening||0
1678296|NCT00576472|4099676|P10|STARTED|Initial Screening||0
1678297|NCT00576472|4099677|P9|STARTED|Initial Screening||0
1678298|NCT00576472|4099678|P8|STARTED|Initial Screening||0
1678299|NCT00576472|4099679|P7|STARTED|Initial Screening||0
1678300|NCT00576472|4099680|P6|STARTED|Initial Screening||0
1678301|NCT00576472|4099681|P5|STARTED|Initial Screening||0
1678302|NCT00576472|4099682|P4|STARTED|Initial Screening||0
1678303|NCT00576472|4099683|P3|STARTED|Initial Screening||199
1678304|NCT00576472|4099684|P2|STARTED|Initial Screening||40
1678305|NCT00576472|4099685|P1|STARTED|Initial Screening||230
1678306|NCT00576420|4099778|P3|NOT COMPLETED|Overall Study||1
1678307|NCT00576420|4099779|P2|NOT COMPLETED|Overall Study||0
1678308|NCT00576420|4099780|P1|NOT COMPLETED|Overall Study||0
1678309|NCT00576420|4099778|P3|COMPLETED|Overall Study||22
1678310|NCT00576420|4099779|P2|COMPLETED|Overall Study||24
1678311|NCT00576420|4099780|P1|COMPLETED|Overall Study||26
1678312|NCT00576420|4099778|P3|STARTED|Overall Study||23
1678313|NCT00576420|4099779|P2|STARTED|Overall Study||24
1678314|NCT00576420|4099780|P1|STARTED|Overall Study||26
1678315|NCT00576381|4099945|P1|NOT COMPLETED|Overall Study||7
1678316|NCT00576381|4099945|P1|COMPLETED|Overall Study||23
1678317|NCT00576381|4099945|P1|STARTED|Overall Study||30
1678318|NCT00576316|4099949|P1|NOT COMPLETED|Overall Study||20
1678319|NCT00576316|4099949|P1|COMPLETED|Overall Study|Number of patients who completed study|181
1678320|NCT00576316|4099949|P1|STARTED|Overall Study|Number of patients recruited|201
1678321|NCT00576303|4099954|P1|NOT COMPLETED|Long Term Safety Period||16
1678322|NCT00576303|4099954|P1|COMPLETED|Long Term Safety Period||162
1678323|NCT00576303|4099954|P1|STARTED|Long Term Safety Period||178
1678324|NCT00576303|4099954|P1|NOT COMPLETED|Efficacy Evaluation Period||5
1678325|NCT00576303|4099954|P1|COMPLETED|Efficacy Evaluation Period||178
1678326|NCT00576303|4099954|P1|STARTED|Efficacy Evaluation Period||183
1678327|NCT00576303|4099954|P1|NOT COMPLETED|Dose Titration Period||17
1678328|NCT00576303|4099954|P1|COMPLETED|Dose Titration Period||183
1678329|NCT00576303|4099954|P1|STARTED|Dose Titration Period||200
1678330|NCT00576251|4099965|P2|NOT COMPLETED|Overall Study||1
1678331|NCT00576251|4099966|P1|NOT COMPLETED|Overall Study||1
1678332|NCT00576251|4099965|P2|COMPLETED|Overall Study||111
1678333|NCT00576251|4099966|P1|COMPLETED|Overall Study||108
1678334|NCT00576251|4099965|P2|STARTED|Overall Study||112
1678335|NCT00576251|4099966|P1|STARTED|Overall Study||109
1678336|NCT00576199|4099972|P1|NOT COMPLETED|Overall Study||30
1678337|NCT00576199|4099972|P1|COMPLETED|Overall Study||0
1678338|NCT00576199|4099972|P1|STARTED|Overall Study||30
1678339|NCT00576147|4099981|P1|NOT COMPLETED|Overall Study||0
1678340|NCT00576147|4099981|P1|COMPLETED|Overall Study||431
1678341|NCT00576147|4099981|P1|STARTED|Overall Study||431
1678342|NCT00576056|4099985|P1|NOT COMPLETED|Overall Study||14
1678343|NCT00576056|4099985|P1|COMPLETED|Overall Study||5
1678344|NCT00576056|4099985|P1|STARTED|Overall Study||19
1678345|NCT00575965|4099990|P1|NOT COMPLETED|Overall Study||0
1678346|NCT00575965|4099990|P1|COMPLETED|Overall Study||18
1678347|NCT00575965|4099990|P1|STARTED|Overall Study||18
1678348|NCT00575887|4099995|P1|NOT COMPLETED|Overall Study||0
1678349|NCT00575887|4099995|P1|COMPLETED|Overall Study||25
1678350|NCT00575887|4099995|P1|STARTED|Overall Study||25
1678351|NCT00575666|4100001|P2|NOT COMPLETED|Overall Study||3
1678352|NCT00575666|4100002|P1|NOT COMPLETED|Overall Study||4
1678353|NCT00575666|4100001|P2|COMPLETED|Overall Study||21
1678354|NCT00575666|4100002|P1|COMPLETED|Overall Study||17
1678355|NCT00575666|4100001|P2|STARTED|Overall Study||24
1678356|NCT00575666|4100002|P1|STARTED|Overall Study||21
1678357|NCT00575588|4100042|P2|NOT COMPLETED|Overall Study||283
1678358|NCT00575588|4100043|P1|NOT COMPLETED|Overall Study||263
1678359|NCT00575588|4100042|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
1678360|NCT00575588|4100043|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
1678361|NCT00575588|4100042|P2|STARTED|Overall Study|Randomized and treated|430
1678362|NCT00575588|4100043|P1|STARTED|Overall Study|Randomized and treated|428
1678363|NCT00575510|4100066|P3|NOT COMPLETED|Overall Study||17
1678364|NCT00575510|4100067|P2|NOT COMPLETED|Overall Study||13
1678365|NCT00575510|4100068|P1|NOT COMPLETED|Overall Study||12
1678366|NCT00575510|4100066|P3|COMPLETED|Overall Study||96
1678367|NCT00575510|4100067|P2|COMPLETED|Overall Study||101
1678368|NCT00575510|4100068|P1|COMPLETED|Overall Study||102
1678369|NCT00575510|4100066|P3|STARTED|Overall Study||113
1678370|NCT00575510|4100067|P2|STARTED|Overall Study||114
1678371|NCT00575510|4100068|P1|STARTED|Overall Study||114
1678372|NCT00575380|4100081|P2|NOT COMPLETED|Overall Study||3
1678373|NCT00575380|4100082|P1|NOT COMPLETED|Overall Study||1
1678374|NCT00575380|4100081|P2|COMPLETED|Overall Study||55
1678375|NCT00575380|4100082|P1|COMPLETED|Overall Study||57
1678376|NCT00575380|4100081|P2|STARTED|Overall Study||58
1678377|NCT00575380|4100082|P1|STARTED|Overall Study||58
1678378|NCT00575367|4100092|P2|NOT COMPLETED|Overall Study||0
1678379|NCT00575367|4100093|P1|NOT COMPLETED|Overall Study||0
1678380|NCT00575367|4100092|P2|COMPLETED|Overall Study||18
1678381|NCT00575367|4100093|P1|COMPLETED|Overall Study||19
1678382|NCT00575367|4100092|P2|STARTED|Overall Study||18
1678383|NCT00575367|4100093|P1|STARTED|Overall Study||19
1678384|NCT00575185|4100101|P2|NOT COMPLETED|Overall Study||0
1678385|NCT00575185|4100102|P1|NOT COMPLETED|Overall Study||0
1678386|NCT00575185|4100101|P2|COMPLETED|Overall Study||11
1678387|NCT00575185|4100102|P1|COMPLETED|Overall Study||12
1678388|NCT00575185|4100101|P2|STARTED|Overall Study||11
1678389|NCT00575185|4100102|P1|STARTED|Overall Study||12
1678390|NCT00575159|4100110|P1|NOT COMPLETED|Overall Study||0
1678391|NCT00575159|4100110|P1|COMPLETED|Overall Study||10
1678392|NCT00575159|4100110|P1|STARTED|Overall Study||10
1678393|NCT00575146|4100218|P1|NOT COMPLETED|Overall Study||3
1678394|NCT00575146|4100218|P1|COMPLETED|Overall Study||17
1678395|NCT00575146|4100218|P1|STARTED|Overall Study||20
1678396|NCT00575094|4100224|P1|NOT COMPLETED|Overall Study||3
1678397|NCT00575094|4100224|P1|COMPLETED|Overall Study||6
1678398|NCT00575094|4100224|P1|STARTED|Overall Study||9
1678399|NCT00575042|4100228|P1|NOT COMPLETED|Overall Study||3
1678400|NCT00575042|4100228|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
1678401|NCT00575042|4100228|P1|STARTED|Overall Study||20
1678402|NCT00575029|4100233|P1|NOT COMPLETED|Overall Study||0
1678403|NCT00575029|4100233|P1|COMPLETED|Overall Study||7
1678404|NCT00575029|4100233|P1|STARTED|Overall Study||7
1678405|NCT00575016|4100242|P4|NOT COMPLETED|Treatment Cycle 2||0
1678406|NCT00575016|4100243|P3|NOT COMPLETED|Treatment Cycle 2||0
1678407|NCT00575016|4100244|P2|NOT COMPLETED|Treatment Cycle 2||0
1678408|NCT00575016|4100245|P1|NOT COMPLETED|Treatment Cycle 2||1
1678409|NCT00575016|4100242|P4|COMPLETED|Treatment Cycle 2||0
1678410|NCT00575016|4100243|P3|COMPLETED|Treatment Cycle 2||0
1678411|NCT00575016|4100244|P2|COMPLETED|Treatment Cycle 2||0
1678412|NCT00575016|4100245|P1|COMPLETED|Treatment Cycle 2||30
1678413|NCT00575016|4100242|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
1678414|NCT00575016|4100243|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
1678415|NCT00575016|4100244|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
1678416|NCT00575016|4100245|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
1678417|NCT00575016|4100242|P4|NOT COMPLETED|Treatment Cycle 1||5
1678418|NCT00575016|4100243|P3|NOT COMPLETED|Treatment Cycle 1||4
1678419|NCT00575016|4100244|P2|NOT COMPLETED|Treatment Cycle 1||5
1678420|NCT00575016|4100245|P1|NOT COMPLETED|Treatment Cycle 1||9
1678421|NCT00575016|4100242|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
1678422|NCT00575016|4100243|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
1678423|NCT00575016|4100244|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
1678424|NCT00575016|4100245|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
1678425|NCT00575016|4100242|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
1678426|NCT00575016|4100243|P3|STARTED|Treatment Cycle 1||19
1678427|NCT00575016|4100244|P2|STARTED|Treatment Cycle 1||21
1678428|NCT00575016|4100245|P1|STARTED|Treatment Cycle 1||17
1678429|NCT00574990|4100266|P3|NOT COMPLETED|Overall Study||0
1678430|NCT00574990|4100267|P2|NOT COMPLETED|Overall Study||0
1678431|NCT00574990|4100268|P1|NOT COMPLETED|Overall Study||0
1678432|NCT00574990|4100266|P3|COMPLETED|Overall Study||8
1678433|NCT00574990|4100267|P2|COMPLETED|Overall Study||19
1678434|NCT00574990|4100268|P1|COMPLETED|Overall Study||12
1678435|NCT00574990|4100266|P3|STARTED|Overall Study||8
1678436|NCT00574990|4100267|P2|STARTED|Overall Study||19
1678437|NCT00574990|4100268|P1|STARTED|Overall Study||12
1678438|NCT00574951|4100279|P1|NOT COMPLETED|Overall Study||1
1678439|NCT00574951|4100279|P1|COMPLETED|Overall Study||22
1678440|NCT00574951|4100279|P1|STARTED|Overall Study||23
1678441|NCT00574912|4100287|P1|NOT COMPLETED|Overall Study||8
1678442|NCT00574912|4100287|P1|COMPLETED|Overall Study||12
1678443|NCT00574912|4100287|P1|Completed 2.0|Overall Study||12
1678444|NCT00574912|4100287|P1|Completed 1.5|Overall Study||12
1678445|NCT00574912|4100287|P1|Completed 1.0|Overall Study||12
1678446|NCT00574912|4100287|P1|Completed 0.5|Overall Study||12
1678447|NCT00574912|4100287|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
1678448|NCT00574912|4100287|P1|STARTED|Overall Study||20
1678449|NCT00574873|4100301|P2|NOT COMPLETED|Overall Study||251
1678450|NCT00574873|4100302|P1|NOT COMPLETED|Overall Study||238
1678451|NCT00574873|4100301|P2|COMPLETED|Overall Study||1
1678452|NCT00574873|4100302|P1|COMPLETED|Overall Study||12
1678453|NCT00574873|4100301|P2|Treated|Overall Study||251
1678454|NCT00574873|4100302|P1|Treated|Overall Study||248
1678455|NCT00574873|4100301|P2|STARTED|Overall Study||252
1678456|NCT00574873|4100302|P1|STARTED|Overall Study||250
1678457|NCT00574847|4100320|P2|NOT COMPLETED|Overall Study||7
1678458|NCT00574847|4100321|P1|NOT COMPLETED|Overall Study||8
1678459|NCT00574847|4100320|P2|COMPLETED|Overall Study||56
1678460|NCT00574847|4100321|P1|COMPLETED|Overall Study||56
1678461|NCT00574847|4100320|P2|STARTED|Overall Study||63
1678462|NCT00574847|4100321|P1|STARTED|Overall Study||64
1678463|NCT00574834|4100356|P3|NOT COMPLETED|Overall Study||0
1678464|NCT00574834|4100357|P2|NOT COMPLETED|Overall Study||0
1678465|NCT00574834|4100358|P1|NOT COMPLETED|Overall Study||0
1678466|NCT00574834|4100356|P3|COMPLETED|Overall Study||4
1678467|NCT00574834|4100357|P2|COMPLETED|Overall Study||4
1678468|NCT00574834|4100358|P1|COMPLETED|Overall Study||9
1678469|NCT00574834|4100356|P3|STARTED|Overall Study||4
1678470|NCT00574834|4100357|P2|STARTED|Overall Study||4
1678471|NCT00574834|4100358|P1|STARTED|Overall Study||9
1678472|NCT00574795|4100366|P1|NOT COMPLETED|Toddler Dose||1
1678473|NCT00574795|4100366|P1|COMPLETED|Toddler Dose||184
1678474|NCT00574795|4100366|P1|STARTED|Toddler Dose||185
1678475|NCT00574795|4100366|P1|NOT COMPLETED|After Infant Series||3
1678476|NCT00574795|4100366|P1|COMPLETED|After Infant Series||185
1678477|NCT00574795|4100366|P1|STARTED|After Infant Series||188
1678478|NCT00574795|4100366|P1|NOT COMPLETED|Infant Series||5
1678479|NCT00574795|4100366|P1|COMPLETED|Infant Series||188
1678480|NCT00574795|4100366|P1|Vaccinated Dose 3|Infant Series||190
1678481|NCT00574795|4100366|P1|Vaccinated Dose 2|Infant Series||190
1678482|NCT00574795|4100366|P1|Vaccinated Dose 1|Infant Series||193
1678483|NCT00574795|4100366|P1|STARTED|Infant Series||193
1678484|NCT00574704|4100387|P4|NOT COMPLETED|Overall Study||0
1678485|NCT00574704|4100388|P3|NOT COMPLETED|Overall Study||1
1678486|NCT00574704|4100389|P2|NOT COMPLETED|Overall Study||0
1678487|NCT00574704|4100390|P1|NOT COMPLETED|Overall Study||0
1678488|NCT00574704|4100387|P4|COMPLETED|Overall Study||10
1678489|NCT00574704|4100388|P3|COMPLETED|Overall Study||9
1678490|NCT00574704|4100389|P2|COMPLETED|Overall Study||10
1678491|NCT00574704|4100390|P1|COMPLETED|Overall Study||10
1678492|NCT00574704|4100387|P4|STARTED|Overall Study||10
1678493|NCT00574704|4100388|P3|STARTED|Overall Study||10
1678494|NCT00574704|4100389|P2|STARTED|Overall Study||10
1678495|NCT00574704|4100390|P1|STARTED|Overall Study||10
1678496|NCT00574548|4100402|P2|NOT COMPLETED|Overall Study||16
1678497|NCT00574548|4100403|P1|NOT COMPLETED|Overall Study||61
1678498|NCT00574548|4100402|P2|COMPLETED|Overall Study||222
1678499|NCT00574548|4100403|P1|COMPLETED|Overall Study||421
1678500|NCT00574548|4100402|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
1678501|NCT00574548|4100403|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
1678502|NCT00574548|4100402|P2|Received Vax 2|Overall Study||223
1678503|NCT00574548|4100403|P1|Received Vax 2|Overall Study||427
1678504|NCT00574548|4100402|P2|Withdrawn Before Vax 2|Overall Study||11
1678505|NCT00574548|4100403|P1|Withdrawn Before Vax 2|Overall Study||41
1678506|NCT00574548|4100402|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
1678507|NCT00574548|4100403|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
1678508|NCT00574548|4100402|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
1678509|NCT00574548|4100403|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
1678510|NCT00574548|4100402|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
1678511|NCT00574548|4100403|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
1678512|NCT00574548|4100402|P2|STARTED|Overall Study||238
1678513|NCT00574548|4100403|P1|STARTED|Overall Study||482
1678514|NCT00574405|4100449|P2|NOT COMPLETED|Overall Study||2
1678515|NCT00574405|4100450|P1|NOT COMPLETED|Overall Study||3
1678516|NCT00574405|4100449|P2|COMPLETED|Overall Study||10
1678517|NCT00574405|4100450|P1|COMPLETED|Overall Study||9
1678518|NCT00574405|4100449|P2|STARTED|Overall Study||12
1678519|NCT00574405|4100450|P1|STARTED|Overall Study||12
1678520|NCT00574340|4100456|P2|NOT COMPLETED|Study 2 (2 Days)||0
1678521|NCT00574340|4100457|P1|NOT COMPLETED|Study 2 (2 Days)||0
1678522|NCT00574340|4100456|P2|COMPLETED|Study 2 (2 Days)||6
1678523|NCT00574340|4100457|P1|COMPLETED|Study 2 (2 Days)||6
1678524|NCT00574340|4100456|P2|STARTED|Study 2 (2 Days)||6
1678525|NCT00574340|4100457|P1|STARTED|Study 2 (2 Days)||6
1678526|NCT00574340|4100456|P2|NOT COMPLETED|Study 1 (2 Days)||0
1678527|NCT00574340|4100457|P1|NOT COMPLETED|Study 1 (2 Days)||0
1678528|NCT00574340|4100456|P2|COMPLETED|Study 1 (2 Days)||10
1678529|NCT00574340|4100457|P1|COMPLETED|Study 1 (2 Days)||10
1678530|NCT00574340|4100456|P2|STARTED|Study 1 (2 Days)||10
1678531|NCT00574340|4100457|P1|STARTED|Study 1 (2 Days)||10
1678532|NCT00574288|4100470|P7|NOT COMPLETED|Overall Study||28
1678533|NCT00574288|4100471|P6|NOT COMPLETED|Overall Study||26
1678534|NCT00574288|4100472|P5|NOT COMPLETED|Overall Study||2
1678535|NCT00574288|4100473|P4|NOT COMPLETED|Overall Study||2
1678536|NCT00574288|4100474|P3|NOT COMPLETED|Overall Study||3
1678537|NCT00574288|4100475|P2|NOT COMPLETED|Overall Study||3
1678538|NCT00574288|4100476|P1|NOT COMPLETED|Overall Study||20
1678539|NCT00574288|4100470|P7|COMPLETED|Overall Study||14
1678540|NCT00574288|4100471|P6|COMPLETED|Overall Study||4
1678541|NCT00574288|4100472|P5|COMPLETED|Overall Study||1
1678542|NCT00574288|4100473|P4|COMPLETED|Overall Study||1
1678543|NCT00574288|4100474|P3|COMPLETED|Overall Study||0
1678544|NCT00574288|4100475|P2|COMPLETED|Overall Study||0
1678545|NCT00574288|4100476|P1|COMPLETED|Overall Study||0
1678546|NCT00574288|4100470|P7|STARTED|Overall Study||42
1678547|NCT00574288|4100471|P6|STARTED|Overall Study||30
1678548|NCT00574288|4100472|P5|STARTED|Overall Study||3
1678549|NCT00574288|4100473|P4|STARTED|Overall Study||3
1678550|NCT00574288|4100474|P3|STARTED|Overall Study||3
1678551|NCT00574288|4100475|P2|STARTED|Overall Study||3
1678552|NCT00574288|4100476|P1|STARTED|Overall Study||20
1678553|NCT00574275|4100514|P2|NOT COMPLETED|Overall Study||271
1678554|NCT00574275|4100515|P1|NOT COMPLETED|Overall Study||275
1678555|NCT00574275|4100514|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
1678556|NCT00574275|4100515|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
1678557|NCT00574275|4100514|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
1678558|NCT00574275|4100515|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
1678559|NCT00574275|4100514|P2|TREATED|Overall Study||268
1678560|NCT00574275|4100515|P1|TREATED|Overall Study||273
1678561|NCT00574275|4100514|P2|STARTED|Overall Study||271
1678562|NCT00574275|4100515|P1|STARTED|Overall Study||275
1678563|NCT00574249|4100533|P2|NOT COMPLETED|Overall Study||28
1678564|NCT00574249|4100534|P1|NOT COMPLETED|Overall Study||26
1678565|NCT00574249|4100533|P2|COMPLETED|Overall Study||338
1678566|NCT00574249|4100534|P1|COMPLETED|Overall Study||338
1678567|NCT00574249|4100533|P2|STARTED|Overall Study||366
1678568|NCT00574249|4100534|P1|STARTED|Overall Study||364
1678569|NCT00574236|4100574|P1|NOT COMPLETED|Overall Study||0
1678570|NCT00574236|4100574|P1|COMPLETED|Overall Study||4
1678571|NCT00574236|4100574|P1|STARTED|Overall Study||4
1678572|NCT00574171|4100579|P1|NOT COMPLETED|Overall Study||0
1678573|NCT00574171|4100579|P1|COMPLETED|Overall Study||29
1678574|NCT00574171|4100579|P1|STARTED|Overall Study||29
1678575|NCT00574145|4100585|P2|NOT COMPLETED|Overall Study||1
1678576|NCT00574145|4100586|P1|NOT COMPLETED|Overall Study||2
1678577|NCT00574145|4100585|P2|COMPLETED|Overall Study||21
1678578|NCT00574145|4100586|P1|COMPLETED|Overall Study||20
1678579|NCT00574145|4100585|P2|STARTED|Overall Study||22
1678580|NCT00574145|4100586|P1|STARTED|Overall Study||22
1678581|NCT00574080|4100598|P2|NOT COMPLETED|Overall Study||10
1678582|NCT00574080|4100599|P1|NOT COMPLETED|Overall Study||10
1678583|NCT00574080|4100598|P2|COMPLETED|Overall Study||0
1678584|NCT00574080|4100599|P1|COMPLETED|Overall Study||0
1678585|NCT00574080|4100598|P2|STARTED|Overall Study||10
1678586|NCT00574080|4100599|P1|STARTED|Overall Study||10
1678587|NCT00574067|4100609|P4|NOT COMPLETED|Overall Study||0
1678588|NCT00574067|4100610|P3|NOT COMPLETED|Overall Study||0
1678589|NCT00574067|4100611|P2|NOT COMPLETED|Overall Study||1
1678590|NCT00574067|4100612|P1|NOT COMPLETED|Overall Study||1
1678591|NCT00574067|4100609|P4|COMPLETED|Overall Study||53
1678592|NCT00574067|4100610|P3|COMPLETED|Overall Study||54
1678593|NCT00574067|4100611|P2|COMPLETED|Overall Study||52
1678594|NCT00574067|4100612|P1|COMPLETED|Overall Study||52
1678595|NCT00574067|4100609|P4|STARTED|Overall Study||53
1678596|NCT00574067|4100610|P3|STARTED|Overall Study||54
1678597|NCT00574067|4100611|P2|STARTED|Overall Study||53
1678598|NCT00574067|4100612|P1|STARTED|Overall Study||53
1678599|NCT00573989|4100646|P4|NOT COMPLETED|Erlotinib 125mg- Phase II||0
1678600|NCT00573989|4100647|P3|NOT COMPLETED|Erlotinib 125mg- Phase II||0
1678601|NCT00573989|4100648|P2|NOT COMPLETED|Erlotinib 125mg- Phase II||0
1678602|NCT00573989|4100649|P1|NOT COMPLETED|Erlotinib 125mg- Phase II||0
1678603|NCT00573989|4100646|P4|COMPLETED|Erlotinib 125mg- Phase II||12
1678604|NCT00573989|4100647|P3|COMPLETED|Erlotinib 125mg- Phase II||0
1678605|NCT00573989|4100648|P2|COMPLETED|Erlotinib 125mg- Phase II||0
1678606|NCT00573989|4100649|P1|COMPLETED|Erlotinib 125mg- Phase II||0
1678607|NCT00573989|4100646|P4|STARTED|Erlotinib 125mg- Phase II||12
1678608|NCT00573989|4100647|P3|STARTED|Erlotinib 125mg- Phase II||0
1678609|NCT00573989|4100648|P2|STARTED|Erlotinib 125mg- Phase II||0
1678610|NCT00573989|4100649|P1|STARTED|Erlotinib 125mg- Phase II||0
1678611|NCT00573989|4100646|P4|NOT COMPLETED|Erlotinib Phase I||0
1678612|NCT00573989|4100647|P3|NOT COMPLETED|Erlotinib Phase I||0
1678613|NCT00573989|4100648|P2|NOT COMPLETED|Erlotinib Phase I||0
1678614|NCT00573989|4100649|P1|NOT COMPLETED|Erlotinib Phase I||0
1678615|NCT00573989|4100646|P4|COMPLETED|Erlotinib Phase I||0
1678616|NCT00573989|4100647|P3|COMPLETED|Erlotinib Phase I||5
1678617|NCT00573989|4100648|P2|COMPLETED|Erlotinib Phase I||6
1678618|NCT00573989|4100649|P1|COMPLETED|Erlotinib Phase I||4
1678619|NCT00573989|4100646|P4|STARTED|Erlotinib Phase I||0
1678620|NCT00573989|4100647|P3|STARTED|Erlotinib Phase I||5
1678621|NCT00573989|4100648|P2|STARTED|Erlotinib Phase I||6
1678622|NCT00573989|4100649|P1|STARTED|Erlotinib Phase I||4
1678623|NCT00573937|4100668|P2|NOT COMPLETED|Overall Study||1
1678624|NCT00573937|4100669|P1|NOT COMPLETED|Overall Study||0
1678625|NCT00573937|4100668|P2|COMPLETED|Overall Study||0
1678626|NCT00573937|4100669|P1|COMPLETED|Overall Study||0
1678627|NCT00573937|4100668|P2|STARTED|Overall Study||1
1678628|NCT00573937|4100669|P1|STARTED|Overall Study||0
1678629|NCT00573872|4100677|P1|NOT COMPLETED|Overall Study||11
1678630|NCT00573872|4100677|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
1678631|NCT00573872|4100677|P1|STARTED|Overall Study|# of patients that signed consent|43
1678632|NCT00573859|4100683|P1|NOT COMPLETED|Smoking Versus Abstinence||12
1678633|NCT00573859|4100683|P1|COMPLETED|Smoking Versus Abstinence||15
1678634|NCT00573859|4100683|P1|STARTED|Smoking Versus Abstinence||27
1678635|NCT00573859|4100683|P1|NOT COMPLETED|Medication Versus Placebo||12
1678636|NCT00573859|4100683|P1|COMPLETED|Medication Versus Placebo||15
1678637|NCT00573859|4100683|P1|STARTED|Medication Versus Placebo||27
1678638|NCT00573833|4100689|P1|NOT COMPLETED|Overall Study||2
1678639|NCT00573833|4100689|P1|COMPLETED|Overall Study||21
1678640|NCT00573833|4100689|P1|STARTED|Overall Study||23
1678641|NCT00573794|4100696|P1|NOT COMPLETED|Overall Study||330
1678642|NCT00573794|4100696|P1|COMPLETED|Overall Study||255
1678643|NCT00573794|4100696|P1|STARTED|Overall Study||585
1678644|NCT00573768|4100727|P3|NOT COMPLETED|Overall Study||4
1678645|NCT00573768|4100728|P2|NOT COMPLETED|Overall Study||2
1678646|NCT00573768|4100729|P1|NOT COMPLETED|Overall Study||2
1678647|NCT00573768|4100727|P3|COMPLETED|Overall Study||87
1678648|NCT00573768|4100728|P2|COMPLETED|Overall Study||89
1678649|NCT00573768|4100729|P1|COMPLETED|Overall Study||87
1678650|NCT00573768|4100727|P3|STARTED|Overall Study||91
1678651|NCT00573768|4100728|P2|STARTED|Overall Study||91
1678652|NCT00573768|4100729|P1|STARTED|Overall Study||89
1678653|NCT00573755|4100739|P2|NOT COMPLETED|Overall Study||0
1678654|NCT00573755|4100740|P1|NOT COMPLETED|Overall Study||1
1678655|NCT00573755|4100739|P2|COMPLETED|Overall Study||2
1678656|NCT00573755|4100740|P1|COMPLETED|Overall Study||1
1678657|NCT00573755|4100739|P2|STARTED|Overall Study||2
1678658|NCT00573755|4100740|P1|STARTED|Overall Study||2
1678659|NCT00573534|4100756|P1|NOT COMPLETED|Overall Study||3
1678660|NCT00573534|4100756|P1|COMPLETED|Overall Study||5
1678661|NCT00573534|4100756|P1|STARTED|Overall Study||8
1678662|NCT00573508|4100763|P2|NOT COMPLETED|Overall Study||41
1678663|NCT00573508|4100764|P1|NOT COMPLETED|Overall Study||64
1678664|NCT00573508|4100763|P2|COMPLETED|Overall Study||345
1678665|NCT00573508|4100764|P1|COMPLETED|Overall Study||318
1678666|NCT00573508|4100763|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
1678667|NCT00573508|4100764|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
1678668|NCT00573508|4100763|P2|STARTED|Overall Study||386
1678669|NCT00573508|4100764|P1|STARTED|Overall Study||382
1678670|NCT00573469|4100797|P3|NOT COMPLETED|Overall Study||4
1678671|NCT00573469|4100798|P2|NOT COMPLETED|Overall Study||4
1678672|NCT00573469|4100799|P1|NOT COMPLETED|Overall Study||6
1678673|NCT00573469|4100797|P3|COMPLETED|Overall Study||22
1678674|NCT00573469|4100798|P2|COMPLETED|Overall Study||21
1678675|NCT00573469|4100799|P1|COMPLETED|Overall Study||20
1678676|NCT00573469|4100797|P3|STARTED|Overall Study||26
1678677|NCT00573469|4100798|P2|STARTED|Overall Study||25
1678678|NCT00573469|4100799|P1|STARTED|Overall Study||26
1678679|NCT00573443|4100822|P3|NOT COMPLETED|Open-Label Extension Phase||0
1678680|NCT00573443|4100823|P2|NOT COMPLETED|Open-Label Extension Phase||0
1678681|NCT00573443|4100824|P1|NOT COMPLETED|Open-Label Extension Phase||18
1678682|NCT00573443|4100822|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1678683|NCT00573443|4100823|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1678684|NCT00573443|4100824|P1|COMPLETED|Open-Label Extension Phase||235
1678685|NCT00573443|4100822|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1678686|NCT00573443|4100823|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1678687|NCT00573443|4100824|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
1678688|NCT00573443|4100822|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1678689|NCT00573443|4100823|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1678690|NCT00573443|4100824|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
1678691|NCT00573443|4100822|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1678692|NCT00573443|4100823|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1678693|NCT00573443|4100824|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
1678694|NCT00573443|4100822|P3|NOT COMPLETED|Double-Blind Phase||15
1678695|NCT00573443|4100823|P2|NOT COMPLETED|Double-Blind Phase||19
1678696|NCT00573443|4100824|P1|NOT COMPLETED|Double-Blind Phase||9
1678697|NCT00573443|4100822|P3|COMPLETED|Double-Blind Phase||94
1678698|NCT00573443|4100823|P2|COMPLETED|Double-Blind Phase||88
1678699|NCT00573443|4100824|P1|COMPLETED|Double-Blind Phase||101
1678700|NCT00573443|4100822|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
1678701|NCT00573443|4100823|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
1678702|NCT00573443|4100824|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
1678703|NCT00573443|4100822|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
1678704|NCT00573443|4100823|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
1678705|NCT00573443|4100824|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
1678706|NCT00573443|4100822|P3|STARTED|Double-Blind Phase||109
1678707|NCT00573443|4100823|P2|STARTED|Double-Blind Phase||107
1678708|NCT00573443|4100824|P1|STARTED|Double-Blind Phase||110
1678709|NCT00573430|4100854|P3|NOT COMPLETED|Overall Study||10
1678710|NCT00573430|4100855|P2|NOT COMPLETED|Overall Study||5
1678711|NCT00573430|4100856|P1|NOT COMPLETED|Overall Study||1
1678712|NCT00573430|4100854|P3|COMPLETED|Overall Study||33
1678713|NCT00573430|4100855|P2|COMPLETED|Overall Study||40
1678714|NCT00573430|4100856|P1|COMPLETED|Overall Study||39
1678715|NCT00573430|4100854|P3|STARTED|Overall Study|randomized|43
1678716|NCT00573430|4100855|P2|STARTED|Overall Study|randomized|45
1678717|NCT00573430|4100856|P1|STARTED|Overall Study|randomized|40
1678718|NCT00573391|4100878|P2|NOT COMPLETED|Overall Study||2
1678719|NCT00573391|4100879|P1|NOT COMPLETED|Overall Study||3
1678720|NCT00573391|4100878|P2|COMPLETED|Overall Study||0
1678721|NCT00573391|4100879|P1|COMPLETED|Overall Study||0
1678722|NCT00573391|4100878|P2|STARTED|Overall Study||2
1678723|NCT00573391|4100879|P1|STARTED|Overall Study||3
1678724|NCT00573313|4100889|P4|NOT COMPLETED|Overall Study||0
1678725|NCT00573313|4100890|P3|NOT COMPLETED|Overall Study||6
1678726|NCT00573313|4100891|P2|NOT COMPLETED|Overall Study||0
1678727|NCT00573313|4100892|P1|NOT COMPLETED|Overall Study||5
1678728|NCT00573313|4100889|P4|COMPLETED|Overall Study||26
1678729|NCT00573313|4100890|P3|COMPLETED|Overall Study||13
1678730|NCT00573313|4100891|P2|COMPLETED|Overall Study||28
1678731|NCT00573313|4100892|P1|COMPLETED|Overall Study||13
1678732|NCT00573313|4100889|P4|STARTED|Overall Study||26
1678733|NCT00573313|4100890|P3|STARTED|Overall Study|Nineteen recruited to start.|19
1678734|NCT00573313|4100891|P2|STARTED|Overall Study||28
1678735|NCT00573313|4100892|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
1678736|NCT00573287|4100902|P2|NOT COMPLETED|Overall Study||3
1678737|NCT00573287|4100903|P1|NOT COMPLETED|Overall Study||4
1678738|NCT00573287|4100902|P2|COMPLETED|Overall Study||4
1678739|NCT00573287|4100903|P1|COMPLETED|Overall Study||3
1678740|NCT00573287|4100902|P2|STARTED|Overall Study||7
1678741|NCT00573287|4100903|P1|STARTED|Overall Study||7
1678742|NCT00573261|4100913|P2|NOT COMPLETED|Overall Study||5
1678743|NCT00573261|4100914|P1|NOT COMPLETED|Overall Study||6
1678744|NCT00573261|4100913|P2|COMPLETED|Overall Study||15
1678745|NCT00573261|4100914|P1|COMPLETED|Overall Study||14
1678746|NCT00573261|4100913|P2|STARTED|Overall Study||20
1678747|NCT00573261|4100914|P1|STARTED|Overall Study||20
1678748|NCT00573248|4100942|P2|NOT COMPLETED|Overall Study||11
1678749|NCT00573248|4100943|P1|NOT COMPLETED|Overall Study||15
1678750|NCT00573248|4100942|P2|COMPLETED|Overall Study||27
1678751|NCT00573248|4100943|P1|COMPLETED|Overall Study||25
1678752|NCT00573248|4100942|P2|Nicotine Patches and Placebo Patches|Overall Study||27
1678753|NCT00573248|4100943|P1|Nicotine Patches and Placebo Patches|Overall Study||25
1678754|NCT00573248|4100942|P2|STARTED|Overall Study||38
1678755|NCT00573248|4100943|P1|STARTED|Overall Study||40
1678756|NCT00573183|4100957|P2|NOT COMPLETED|Overall Study||63
1678757|NCT00573183|4100958|P1|NOT COMPLETED|Overall Study||72
1678758|NCT00573183|4100957|P2|COMPLETED|Overall Study||174
1678759|NCT00573183|4100958|P1|COMPLETED|Overall Study||162
1678760|NCT00573183|4100957|P2|STARTED|Overall Study||237
1678761|NCT00573183|4100958|P1|STARTED|Overall Study||234
1678762|NCT00573170|4100966|P6|NOT COMPLETED|Third Treatment Period||2
1678763|NCT00573170|4100967|P5|NOT COMPLETED|Third Treatment Period||0
1678764|NCT00573170|4100968|P4|NOT COMPLETED|Third Treatment Period||0
1678765|NCT00573170|4100969|P3|NOT COMPLETED|Third Treatment Period||0
1678766|NCT00573170|4100970|P2|NOT COMPLETED|Third Treatment Period||0
1678767|NCT00573170|4100971|P1|NOT COMPLETED|Third Treatment Period||1
1678768|NCT00573170|4100966|P6|COMPLETED|Third Treatment Period||51
1678769|NCT00573170|4100967|P5|COMPLETED|Third Treatment Period||51
1678770|NCT00573170|4100968|P4|COMPLETED|Third Treatment Period||56
1678771|NCT00573170|4100969|P3|COMPLETED|Third Treatment Period||55
1678772|NCT00573170|4100970|P2|COMPLETED|Third Treatment Period||54
1678773|NCT00573170|4100971|P1|COMPLETED|Third Treatment Period||50
1678774|NCT00573170|4100966|P6|STARTED|Third Treatment Period||53
1678775|NCT00573170|4100967|P5|STARTED|Third Treatment Period||51
1678776|NCT00573170|4100968|P4|STARTED|Third Treatment Period||56
1678777|NCT00573170|4100969|P3|STARTED|Third Treatment Period||55
1678778|NCT00573170|4100970|P2|STARTED|Third Treatment Period||54
1678779|NCT00573170|4100971|P1|STARTED|Third Treatment Period||51
1678780|NCT00573170|4100966|P6|NOT COMPLETED|Second Washout Period||2
1678781|NCT00573170|4100967|P5|NOT COMPLETED|Second Washout Period||8
1678782|NCT00573170|4100968|P4|NOT COMPLETED|Second Washout Period||5
1678783|NCT00573170|4100969|P3|NOT COMPLETED|Second Washout Period||4
1678784|NCT00573170|4100970|P2|NOT COMPLETED|Second Washout Period||4
1678785|NCT00573170|4100971|P1|NOT COMPLETED|Second Washout Period||5
1678786|NCT00573170|4100966|P6|COMPLETED|Second Washout Period||53
1678787|NCT00573170|4100967|P5|COMPLETED|Second Washout Period||51
1678788|NCT00573170|4100968|P4|COMPLETED|Second Washout Period||56
1678789|NCT00573170|4100969|P3|COMPLETED|Second Washout Period||55
1678790|NCT00573170|4100970|P2|COMPLETED|Second Washout Period||54
1678791|NCT00573170|4100971|P1|COMPLETED|Second Washout Period||51
1678792|NCT00573170|4100966|P6|STARTED|Second Washout Period||55
1678793|NCT00573170|4100967|P5|STARTED|Second Washout Period||59
1678794|NCT00573170|4100968|P4|STARTED|Second Washout Period||61
1678795|NCT00573170|4100969|P3|STARTED|Second Washout Period||59
1678796|NCT00573170|4100970|P2|STARTED|Second Washout Period||58
1678797|NCT00573170|4100971|P1|STARTED|Second Washout Period||56
1678798|NCT00573170|4100966|P6|NOT COMPLETED|Second Treatment Period||0
1678799|NCT00573170|4100967|P5|NOT COMPLETED|Second Treatment Period||0
1678800|NCT00573170|4100968|P4|NOT COMPLETED|Second Treatment Period||0
1678801|NCT00573170|4100969|P3|NOT COMPLETED|Second Treatment Period||0
1678802|NCT00573170|4100970|P2|NOT COMPLETED|Second Treatment Period||0
1678803|NCT00573170|4100971|P1|NOT COMPLETED|Second Treatment Period||0
1678804|NCT00573170|4100966|P6|COMPLETED|Second Treatment Period||55
1678805|NCT00573170|4100967|P5|COMPLETED|Second Treatment Period||59
1678806|NCT00573170|4100968|P4|COMPLETED|Second Treatment Period||61
1678807|NCT00573170|4100969|P3|COMPLETED|Second Treatment Period||59
1678808|NCT00573170|4100970|P2|COMPLETED|Second Treatment Period||58
1678809|NCT00573170|4100971|P1|COMPLETED|Second Treatment Period||56
1678810|NCT00573170|4100966|P6|STARTED|Second Treatment Period||55
1678811|NCT00573170|4100967|P5|STARTED|Second Treatment Period||59
1678812|NCT00573170|4100968|P4|STARTED|Second Treatment Period||61
1678813|NCT00573170|4100969|P3|STARTED|Second Treatment Period||59
1678814|NCT00573170|4100970|P2|STARTED|Second Treatment Period||58
1678815|NCT00573170|4100971|P1|STARTED|Second Treatment Period||56
1678816|NCT00573170|4100966|P6|NOT COMPLETED|First Washout Period||7
1678817|NCT00573170|4100967|P5|NOT COMPLETED|First Washout Period||3
1678818|NCT00573170|4100968|P4|NOT COMPLETED|First Washout Period||5
1678819|NCT00573170|4100969|P3|NOT COMPLETED|First Washout Period||1
1678820|NCT00573170|4100970|P2|NOT COMPLETED|First Washout Period||2
1678821|NCT00573170|4100971|P1|NOT COMPLETED|First Washout Period||8
1678822|NCT00573170|4100966|P6|COMPLETED|First Washout Period||55
1678823|NCT00573170|4100967|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
1678824|NCT00573170|4100968|P4|COMPLETED|First Washout Period||61
1678825|NCT00573170|4100969|P3|COMPLETED|First Washout Period||59
1678826|NCT00573170|4100970|P2|COMPLETED|First Washout Period||58
1678827|NCT00573170|4100971|P1|COMPLETED|First Washout Period||56
1678828|NCT00573170|4100966|P6|STARTED|First Washout Period||62
1678829|NCT00573170|4100967|P5|STARTED|First Washout Period||62
1678830|NCT00573170|4100968|P4|STARTED|First Washout Period||66
1678831|NCT00573170|4100969|P3|STARTED|First Washout Period||60
1678832|NCT00573170|4100970|P2|STARTED|First Washout Period||60
1678833|NCT00573170|4100971|P1|STARTED|First Washout Period||64
1678834|NCT00573170|4100966|P6|NOT COMPLETED|First Treatment Period||0
1678835|NCT00573170|4100967|P5|NOT COMPLETED|First Treatment Period||1
1678836|NCT00573170|4100968|P4|NOT COMPLETED|First Treatment Period||0
1678837|NCT00573170|4100969|P3|NOT COMPLETED|First Treatment Period||0
1678838|NCT00573170|4100970|P2|NOT COMPLETED|First Treatment Period||0
1678839|NCT00573170|4100971|P1|NOT COMPLETED|First Treatment Period||0
1678840|NCT00573170|4100966|P6|COMPLETED|First Treatment Period||62
1678841|NCT00573170|4100967|P5|COMPLETED|First Treatment Period||62
1678842|NCT00573170|4100968|P4|COMPLETED|First Treatment Period||66
1678843|NCT00573170|4100969|P3|COMPLETED|First Treatment Period||60
1678844|NCT00573170|4100970|P2|COMPLETED|First Treatment Period||60
1678845|NCT00573170|4100971|P1|COMPLETED|First Treatment Period||64
1678846|NCT00573170|4100966|P6|STARTED|First Treatment Period||62
1678847|NCT00573170|4100967|P5|STARTED|First Treatment Period||63
1678848|NCT00573170|4100968|P4|STARTED|First Treatment Period||66
1678849|NCT00573170|4100969|P3|STARTED|First Treatment Period||60
1678850|NCT00573170|4100970|P2|STARTED|First Treatment Period||60
1678851|NCT00573170|4100971|P1|STARTED|First Treatment Period||64
1678852|NCT00573157|4101047|P2|NOT COMPLETED|Overall Study||2
1678853|NCT00573157|4101048|P1|NOT COMPLETED|Overall Study||4
1678854|NCT00573157|4101047|P2|COMPLETED|Overall Study||0
1678855|NCT00573157|4101048|P1|COMPLETED|Overall Study||0
1678856|NCT00573157|4101047|P2|STARTED|Overall Study||2
1678857|NCT00573157|4101048|P1|STARTED|Overall Study||4
1678858|NCT00573144|4101060|P2|NOT COMPLETED|Overall Study||3
1678859|NCT00573144|4101061|P1|NOT COMPLETED|Overall Study||2
1678860|NCT00573144|4101060|P2|COMPLETED|Overall Study||25
1678861|NCT00573144|4101061|P1|COMPLETED|Overall Study||28
1678862|NCT00573144|4101060|P2|STARTED|Overall Study||28
1678863|NCT00573144|4101061|P1|STARTED|Overall Study||30
1678864|NCT00573131|4101073|P2|NOT COMPLETED|Overall Study||8
1678865|NCT00573131|4101074|P1|NOT COMPLETED|Overall Study||10
1678866|NCT00573131|4101073|P2|COMPLETED|Overall Study||57
1678867|NCT00573131|4101074|P1|COMPLETED|Overall Study||62
1678868|NCT00573131|4101073|P2|STARTED|Overall Study||65
1678869|NCT00573131|4101074|P1|STARTED|Overall Study||72
1678870|NCT00573066|4101080|P1|NOT COMPLETED|Overall Study||20
1678871|NCT00573066|4101080|P1|COMPLETED|Overall Study||36
1678872|NCT00573066|4101080|P1|STARTED|Overall Study||56
1678873|NCT00572936|4101084|P6|NOT COMPLETED|Third Intervention||0
1678874|NCT00572936|4101085|P5|NOT COMPLETED|Third Intervention||0
1678875|NCT00572936|4101086|P4|NOT COMPLETED|Third Intervention||0
1678876|NCT00572936|4101087|P3|NOT COMPLETED|Third Intervention||0
1678877|NCT00572936|4101088|P2|NOT COMPLETED|Third Intervention||0
1678878|NCT00572936|4101089|P1|NOT COMPLETED|Third Intervention||0
1678879|NCT00572936|4101084|P6|COMPLETED|Third Intervention||5
1678880|NCT00572936|4101085|P5|COMPLETED|Third Intervention||3
1678881|NCT00572936|4101086|P4|COMPLETED|Third Intervention||5
1678882|NCT00572936|4101087|P3|COMPLETED|Third Intervention||4
1678883|NCT00572936|4101088|P2|COMPLETED|Third Intervention||3
1678884|NCT00572936|4101089|P1|COMPLETED|Third Intervention||4
1678885|NCT00572936|4101084|P6|STARTED|Third Intervention||5
1678886|NCT00572936|4101085|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
1678887|NCT00572936|4101086|P4|STARTED|Third Intervention||5
1678888|NCT00572936|4101087|P3|STARTED|Third Intervention||4
1678889|NCT00572936|4101088|P2|STARTED|Third Intervention||3
1678890|NCT00572936|4101089|P1|STARTED|Third Intervention||4
1678891|NCT00572936|4101084|P6|NOT COMPLETED|Second Intervention||0
1678892|NCT00572936|4101085|P5|NOT COMPLETED|Second Intervention||0
1678893|NCT00572936|4101086|P4|NOT COMPLETED|Second Intervention||0
1678894|NCT00572936|4101087|P3|NOT COMPLETED|Second Intervention||0
1678895|NCT00572936|4101088|P2|NOT COMPLETED|Second Intervention||0
1678896|NCT00572936|4101089|P1|NOT COMPLETED|Second Intervention||0
1678897|NCT00572936|4101084|P6|COMPLETED|Second Intervention||5
1678898|NCT00572936|4101085|P5|COMPLETED|Second Intervention||4
1678899|NCT00572936|4101086|P4|COMPLETED|Second Intervention||5
1678900|NCT00572936|4101087|P3|COMPLETED|Second Intervention||4
1678901|NCT00572936|4101088|P2|COMPLETED|Second Intervention||3
1678902|NCT00572936|4101089|P1|COMPLETED|Second Intervention||4
1678903|NCT00572936|4101084|P6|STARTED|Second Intervention||5
1678904|NCT00572936|4101085|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
1678905|NCT00572936|4101086|P4|STARTED|Second Intervention||5
1678906|NCT00572936|4101087|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
1678907|NCT00572936|4101088|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
1678908|NCT00572936|4101089|P1|STARTED|Second Intervention||4
1678909|NCT00572936|4101084|P6|NOT COMPLETED|First Intervention||0
1678910|NCT00572936|4101085|P5|NOT COMPLETED|First Intervention||0
1678911|NCT00572936|4101086|P4|NOT COMPLETED|First Intervention||0
1678912|NCT00572936|4101087|P3|NOT COMPLETED|First Intervention||0
1678913|NCT00572936|4101088|P2|NOT COMPLETED|First Intervention||0
1678914|NCT00572936|4101089|P1|NOT COMPLETED|First Intervention||0
1678915|NCT00572936|4101084|P6|COMPLETED|First Intervention||5
1678916|NCT00572936|4101085|P5|COMPLETED|First Intervention||5
1678917|NCT00572936|4101086|P4|COMPLETED|First Intervention||5
1678918|NCT00572936|4101087|P3|COMPLETED|First Intervention||5
1678919|NCT00572936|4101088|P2|COMPLETED|First Intervention||4
1678920|NCT00572936|4101089|P1|COMPLETED|First Intervention||4
1678921|NCT00572936|4101084|P6|STARTED|First Intervention||5
1678922|NCT00572936|4101085|P5|STARTED|First Intervention||5
1678923|NCT00572936|4101086|P4|STARTED|First Intervention||5
1678924|NCT00572936|4101087|P3|STARTED|First Intervention||5
1678925|NCT00572936|4101088|P2|STARTED|First Intervention||4
1678926|NCT00572936|4101089|P1|STARTED|First Intervention||4
1678927|NCT00572910|4101124|P11|NOT COMPLETED|Overall Study||3
1678928|NCT00572910|4101125|P10|NOT COMPLETED|Overall Study||6
1678929|NCT00572910|4101126|P9|NOT COMPLETED|Overall Study||3
1678930|NCT00572910|4101127|P8|NOT COMPLETED|Overall Study||4
1678931|NCT00572910|4101128|P7|NOT COMPLETED|Overall Study||4
1678932|NCT00572910|4101129|P6|NOT COMPLETED|Overall Study||3
1678933|NCT00572910|4101130|P5|NOT COMPLETED|Overall Study||2
1678934|NCT00572910|4101131|P4|NOT COMPLETED|Overall Study||4
1678935|NCT00572910|4101132|P3|NOT COMPLETED|Overall Study||2
1678936|NCT00572910|4101133|P2|NOT COMPLETED|Overall Study||3
1678937|NCT00572910|4101134|P1|NOT COMPLETED|Overall Study||4
1678938|NCT00572910|4101124|P11|COMPLETED|Overall Study||15
1678939|NCT00572910|4101125|P10|COMPLETED|Overall Study||13
1678940|NCT00572910|4101126|P9|COMPLETED|Overall Study||16
1678941|NCT00572910|4101127|P8|COMPLETED|Overall Study||15
1678942|NCT00572910|4101128|P7|COMPLETED|Overall Study||15
1678943|NCT00572910|4101129|P6|COMPLETED|Overall Study||16
1678944|NCT00572910|4101130|P5|COMPLETED|Overall Study||17
1678945|NCT00572910|4101131|P4|COMPLETED|Overall Study||14
1678946|NCT00572910|4101132|P3|COMPLETED|Overall Study||17
1678947|NCT00572910|4101133|P2|COMPLETED|Overall Study||15
1678948|NCT00572910|4101134|P1|COMPLETED|Overall Study||15
1678949|NCT00572910|4101124|P11|STARTED|Overall Study||18
1678950|NCT00572910|4101125|P10|STARTED|Overall Study||19
1678951|NCT00572910|4101126|P9|STARTED|Overall Study||19
1678952|NCT00572910|4101127|P8|STARTED|Overall Study||19
1678953|NCT00572910|4101128|P7|STARTED|Overall Study||19
1678954|NCT00572910|4101129|P6|STARTED|Overall Study||19
1678955|NCT00572910|4101130|P5|STARTED|Overall Study||19
1678956|NCT00572910|4101131|P4|STARTED|Overall Study||18
1678957|NCT00572910|4101132|P3|STARTED|Overall Study||19
1678958|NCT00572910|4101133|P2|STARTED|Overall Study||18
1678959|NCT00572910|4101134|P1|STARTED|Overall Study||19
1678960|NCT00572897|4101182|P2|NOT COMPLETED|Overall Study||0
1678961|NCT00572897|4101183|P1|NOT COMPLETED|Overall Study||0
1678962|NCT00572897|4101182|P2|COMPLETED|Overall Study||34
1678963|NCT00572897|4101183|P1|COMPLETED|Overall Study||32
1678964|NCT00572897|4101182|P2|STARTED|Overall Study||34
1678965|NCT00572897|4101183|P1|STARTED|Overall Study||32
1678966|NCT00572832|4101201|P2|NOT COMPLETED|Overall Study||12
1678967|NCT00572832|4101202|P1|NOT COMPLETED|Overall Study||0
1678968|NCT00572832|4101201|P2|COMPLETED|Overall Study||88
1678969|NCT00572832|4101202|P1|COMPLETED|Overall Study||100
1678970|NCT00572832|4101201|P2|STARTED|Overall Study||100
1678971|NCT00572832|4101202|P1|STARTED|Overall Study||100
1678972|NCT00572728|4101208|P1|NOT COMPLETED|Overall Study||39
1678973|NCT00572728|4101208|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
1678974|NCT00572728|4101208|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
1678975|NCT00572728|4101208|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
1678976|NCT00572728|4101208|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
1678977|NCT00572728|4101208|P1|Pathology Complete|Overall Study||51
1678978|NCT00572728|4101208|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
1678979|NCT00572728|4101208|P1|Second Chemotherapy Initiated|Overall Study||59
1678980|NCT00572728|4101208|P1|Completed FLT2 Scan|Overall Study||60
1678981|NCT00572728|4101208|P1|First Therapy Initiated|Overall Study||65
1678982|NCT00572728|4101208|P1|Completed FLT1 Scan|Overall Study||67
1678983|NCT00572728|4101208|P1|On Study|Overall Study||71
1678984|NCT00572728|4101208|P1|Did Not Withdraw|Overall Study||72
1678985|NCT00572728|4101208|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
1678986|NCT00572728|4101208|P1|Eligible|Overall Study||87
1678987|NCT00572728|4101208|P1|STARTED|Overall Study|Registered|90
1678988|NCT00572624|4101222|P2|NOT COMPLETED|Overall Study||4
1678989|NCT00572624|4101223|P1|NOT COMPLETED|Overall Study||17
1678990|NCT00572624|4101222|P2|COMPLETED|Overall Study||10
1678991|NCT00572624|4101223|P1|COMPLETED|Overall Study||20
1678992|NCT00572624|4101222|P2|STARTED|Overall Study||14
1678993|NCT00572624|4101223|P1|STARTED|Overall Study||37
1678994|NCT00572572|4101251|P2|NOT COMPLETED|Overall Study||6
1678995|NCT00572572|4101252|P1|NOT COMPLETED|Overall Study||3
1678996|NCT00572572|4101251|P2|COMPLETED|Overall Study||28
1678997|NCT00572572|4101252|P1|COMPLETED|Overall Study||32
1678998|NCT00572572|4101251|P2|STARTED|Overall Study||34
1678999|NCT00572572|4101252|P1|STARTED|Overall Study||35
1679000|NCT00572533|4101270|P2|NOT COMPLETED|Overall Study||3
1679001|NCT00572533|4101271|P1|NOT COMPLETED|Overall Study||7
1679002|NCT00572533|4101270|P2|COMPLETED|Overall Study||28
1679003|NCT00572533|4101271|P1|COMPLETED|Overall Study||24
1679004|NCT00572533|4101270|P2|STARTED|Overall Study||31
1679005|NCT00572533|4101271|P1|STARTED|Overall Study||31
1679006|NCT00572468|4101293|P2|NOT COMPLETED|Overall Study||4
1679007|NCT00572468|4101294|P1|NOT COMPLETED|Overall Study||2
1679008|NCT00572468|4101293|P2|COMPLETED|Overall Study||16
1679009|NCT00572468|4101294|P1|COMPLETED|Overall Study||20
1679010|NCT00572468|4101293|P2|STARTED|Overall Study||20
1679011|NCT00572468|4101294|P1|STARTED|Overall Study||22
1679012|NCT00572260|4101302|P1|NOT COMPLETED|Overall Study||0
1679013|NCT00572260|4101302|P1|COMPLETED|Overall Study||11
1679014|NCT00572260|4101302|P1|STARTED|Overall Study||11
1679015|NCT00572156|4101310|P4|NOT COMPLETED|Overall Study||25
1679016|NCT00572156|4101311|P3|NOT COMPLETED|Overall Study||27
1679017|NCT00572156|4101312|P2|NOT COMPLETED|Overall Study||26
1679018|NCT00572156|4101313|P1|NOT COMPLETED|Overall Study||26
1679019|NCT00572156|4101310|P4|COMPLETED|Overall Study||1
1679020|NCT00572156|4101311|P3|COMPLETED|Overall Study||0
1679021|NCT00572156|4101312|P2|COMPLETED|Overall Study||1
1679022|NCT00572156|4101313|P1|COMPLETED|Overall Study||0
1679023|NCT00572156|4101310|P4|STARTED|Overall Study||26
1679024|NCT00572156|4101311|P3|STARTED|Overall Study||27
1679025|NCT00572156|4101312|P2|STARTED|Overall Study||27
1679026|NCT00572156|4101313|P1|STARTED|Overall Study||26
1679027|NCT00572117|4101373|P2|NOT COMPLETED|Overall Study||2
1679028|NCT00572117|4101374|P1|NOT COMPLETED|Overall Study||2
1679029|NCT00572117|4101373|P2|COMPLETED|Overall Study||5
1679030|NCT00572117|4101374|P1|COMPLETED|Overall Study||3
1679031|NCT00572117|4101373|P2|STARTED|Overall Study||7
1679032|NCT00572117|4101374|P1|STARTED|Overall Study||5
1679033|NCT00572039|4101384|P2|NOT COMPLETED|Overall Study||10
1679034|NCT00572039|4101385|P1|NOT COMPLETED|Overall Study||16
1679035|NCT00572039|4101384|P2|COMPLETED|Overall Study||110
1679036|NCT00572039|4101385|P1|COMPLETED|Overall Study||105
1679037|NCT00572039|4101384|P2|STARTED|Overall Study||120
1679038|NCT00572039|4101385|P1|STARTED|Overall Study||121
1679039|NCT00571987|4101397|P1|NOT COMPLETED|Overall Study||7
1679040|NCT00571987|4101397|P1|COMPLETED|Overall Study||100
1679041|NCT00571987|4101397|P1|STARTED|Overall Study||107
1679042|NCT00571974|4101404|P2|NOT COMPLETED|Phase II||4
1679043|NCT00571974|4101405|P1|NOT COMPLETED|Phase II||0
1679044|NCT00571974|4101404|P2|COMPLETED|Phase II||17
1679045|NCT00571974|4101405|P1|COMPLETED|Phase II||0
1679046|NCT00571974|4101404|P2|STARTED|Phase II|3 participants are from phase I|21
1679047|NCT00571974|4101405|P1|STARTED|Phase II||0
1679048|NCT00571974|4101404|P2|NOT COMPLETED|Phase I||0
1679049|NCT00571974|4101405|P1|NOT COMPLETED|Phase I||0
1679050|NCT00571974|4101404|P2|COMPLETED|Phase I||0
1679051|NCT00571974|4101405|P1|COMPLETED|Phase I||9
1679052|NCT00571974|4101404|P2|STARTED|Phase I||0
1679053|NCT00571974|4101405|P1|STARTED|Phase I||9
1679054|NCT00571961|4101411|P1|NOT COMPLETED|Overall Study||0
1679055|NCT00571961|4101411|P1|COMPLETED|Overall Study||12
1679056|NCT00571961|4101411|P1|STARTED|Overall Study||12
1679057|NCT00571948|4101417|P2|NOT COMPLETED|Overall Study||14
1679058|NCT00571948|4101418|P1|NOT COMPLETED|Overall Study||11
1679059|NCT00571948|4101417|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
1679060|NCT00571948|4101418|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
1679061|NCT00571948|4101417|P2|STARTED|Overall Study||66
1679062|NCT00571948|4101418|P1|STARTED|Overall Study||66
1679063|NCT00571922|4101426|P2|NOT COMPLETED|Overall Study||36
1679064|NCT00571922|4101427|P1|NOT COMPLETED|Overall Study||36
1679065|NCT00571922|4101426|P2|COMPLETED|Overall Study||0
1679066|NCT00571922|4101427|P1|COMPLETED|Overall Study||0
1679067|NCT00571922|4101426|P2|STARTED|Overall Study||36
1679068|NCT00571922|4101427|P1|STARTED|Overall Study||36
1679069|NCT00571701|4101437|P2|NOT COMPLETED|Second Intervention 12 Months||1
1679070|NCT00571701|4101438|P1|NOT COMPLETED|Second Intervention 12 Months||3
1679071|NCT00571701|4101437|P2|COMPLETED|Second Intervention 12 Months||20
1679072|NCT00571701|4101438|P1|COMPLETED|Second Intervention 12 Months||13
1679073|NCT00571701|4101437|P2|STARTED|Second Intervention 12 Months||21
1679074|NCT00571701|4101438|P1|STARTED|Second Intervention 12 Months||16
1679075|NCT00571701|4101437|P2|NOT COMPLETED|First Intervention 12 Months||1
1679076|NCT00571701|4101438|P1|NOT COMPLETED|First Intervention 12 Months||3
1679077|NCT00571701|4101437|P2|COMPLETED|First Intervention 12 Months||21
1679078|NCT00571701|4101438|P1|COMPLETED|First Intervention 12 Months||16
1679079|NCT00571701|4101437|P2|STARTED|First Intervention 12 Months||22
1679080|NCT00571701|4101438|P1|STARTED|First Intervention 12 Months||19
1679081|NCT00571688|4101464|P2|NOT COMPLETED|Overall Study||6
1679082|NCT00571688|4101465|P1|NOT COMPLETED|Overall Study||5
1679083|NCT00571688|4101464|P2|COMPLETED|Overall Study||19
1679084|NCT00571688|4101465|P1|COMPLETED|Overall Study||20
1679085|NCT00571688|4101464|P2|STARTED|Overall Study||25
1679086|NCT00571688|4101465|P1|STARTED|Overall Study||25
1679087|NCT00571662|4101471|P1|NOT COMPLETED|Overall Study||8
1679088|NCT00571662|4101471|P1|COMPLETED|Overall Study||68
1679089|NCT00571662|4101471|P1|STARTED|Overall Study||76
1679090|NCT00571649|4101482|P2|NOT COMPLETED|Follow-up Period||528
1679091|NCT00571649|4101483|P1|NOT COMPLETED|Follow-up Period||545
1679092|NCT00571649|4101482|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
1679093|NCT00571649|4101483|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
1679094|NCT00571649|4101482|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
1679095|NCT00571649|4101483|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
1679096|NCT00571649|4101482|P2|NOT COMPLETED|Treatment Period||1004
1679097|NCT00571649|4101483|P1|NOT COMPLETED|Treatment Period||1092
1679098|NCT00571649|4101482|P2|COMPLETED|Treatment Period||3047
1679099|NCT00571649|4101483|P1|COMPLETED|Treatment Period||2958
1679100|NCT00571649|4101482|P2|Day 35|Treatment Period||3115
1679101|NCT00571649|4101483|P1|Day 35|Treatment Period||3033
1679102|NCT00571649|4101482|P2|Day 10|Treatment Period||3499
1679103|NCT00571649|4101483|P1|Day 10|Treatment Period||3454
1679104|NCT00571649|4101482|P2|Participants Received Treatment|Treatment Period||4001
1679105|NCT00571649|4101483|P1|Participants Received Treatment|Treatment Period||3997
1679106|NCT00571649|4101482|P2|STARTED|Treatment Period||4051
1679107|NCT00571649|4101483|P1|STARTED|Treatment Period||4050
1679108|NCT00571493|4101515|P7|NOT COMPLETED|Overall Study||0
1679109|NCT00571493|4101516|P6|NOT COMPLETED|Overall Study||0
1679110|NCT00571493|4101517|P5|NOT COMPLETED|Overall Study||0
1679111|NCT00571493|4101518|P4|NOT COMPLETED|Overall Study||0
1679112|NCT00571493|4101519|P3|NOT COMPLETED|Overall Study||0
1679113|NCT00571493|4101520|P2|NOT COMPLETED|Overall Study||0
1679114|NCT00571493|4101521|P1|NOT COMPLETED|Overall Study||0
1679115|NCT00571493|4101515|P7|COMPLETED|Overall Study||6
1679116|NCT00571493|4101516|P6|COMPLETED|Overall Study||12
1679117|NCT00571493|4101517|P5|COMPLETED|Overall Study||11
1679118|NCT00571493|4101518|P4|COMPLETED|Overall Study||3
1679119|NCT00571493|4101519|P3|COMPLETED|Overall Study||3
1679120|NCT00571493|4101520|P2|COMPLETED|Overall Study||4
1679121|NCT00571493|4101521|P1|COMPLETED|Overall Study||3
1679122|NCT00571493|4101515|P7|STARTED|Overall Study||6
1679123|NCT00571493|4101516|P6|STARTED|Overall Study||12
1679124|NCT00571493|4101517|P5|STARTED|Overall Study||11
1679125|NCT00571493|4101518|P4|STARTED|Overall Study||3
1679126|NCT00571493|4101519|P3|STARTED|Overall Study||3
1679127|NCT00571493|4101520|P2|STARTED|Overall Study||4
1679128|NCT00571493|4101521|P1|STARTED|Overall Study||3
1679129|NCT00571428|4101531|P2|NOT COMPLETED|Overall Study||0
1679130|NCT00571428|4101532|P1|NOT COMPLETED|Overall Study||0
1679131|NCT00571428|4101531|P2|COMPLETED|Overall Study||18
1679132|NCT00571428|4101532|P1|COMPLETED|Overall Study||15
1679133|NCT00571428|4101531|P2|STARTED|Overall Study||18
1679134|NCT00571428|4101532|P1|STARTED|Overall Study||15
1679135|NCT00571324|4101564|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
1679136|NCT00571324|4101565|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
1679137|NCT00571324|4101564|P2|COMPLETED|Intervention 2 (7 Hours)||4
1679138|NCT00571324|4101565|P1|COMPLETED|Intervention 2 (7 Hours)||5
1679139|NCT00571324|4101564|P2|STARTED|Intervention 2 (7 Hours)||4
1679140|NCT00571324|4101565|P1|STARTED|Intervention 2 (7 Hours)||5
1679141|NCT00571324|4101564|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
1679142|NCT00571324|4101565|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
1679143|NCT00571324|4101564|P2|COMPLETED|Intervention 1 (7 Hours)||4
1679144|NCT00571324|4101565|P1|COMPLETED|Intervention 1 (7 Hours)||5
1679145|NCT00571324|4101564|P2|STARTED|Intervention 1 (7 Hours)||4
1679146|NCT00571324|4101565|P1|STARTED|Intervention 1 (7 Hours)||5
1679147|NCT00571194|4101577|P1|NOT COMPLETED|Overall Study||0
1679148|NCT00571194|4101577|P1|COMPLETED|Overall Study||7
1679149|NCT00571194|4101577|P1|STARTED|Overall Study||7
1679150|NCT00571103|4101581|P1|NOT COMPLETED|Overall Study||2
1679151|NCT00571103|4101581|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
1679152|NCT00571103|4101581|P1|STARTED|Overall Study||28
1679153|NCT00571064|4101586|P1|NOT COMPLETED|Overall Study||21
1679154|NCT00571064|4101586|P1|COMPLETED|Overall Study||76
1679155|NCT00571064|4101586|P1|STARTED|Overall Study||97
1679156|NCT00571038|4101601|P2|NOT COMPLETED|Overall Study||14
1679157|NCT00571038|4101602|P1|NOT COMPLETED|Overall Study||11
1679158|NCT00571038|4101601|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
1679159|NCT00571038|4101602|P1|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
1679160|NCT00571038|4101601|P2|18 Month Survey Only|Overall Study||163
1679161|NCT00571038|4101602|P1|18 Month Survey Only|Overall Study||199
1679162|NCT00571038|4101601|P2|6 Month Follow up|Overall Study||176
1679163|NCT00571038|4101602|P1|6 Month Follow up|Overall Study||208
1679164|NCT00571038|4101601|P2|STARTED|Overall Study||185
1679165|NCT00571038|4101602|P1|STARTED|Overall Study||219
1679166|NCT00570960|4101650|P2|NOT COMPLETED|Overall Study||0
1679167|NCT00570960|4101651|P1|NOT COMPLETED|Overall Study||0
1679168|NCT00570960|4101650|P2|COMPLETED|Overall Study||4
1679169|NCT00570960|4101651|P1|COMPLETED|Overall Study||4
1679170|NCT00570960|4101650|P2|STARTED|Overall Study||4
1679171|NCT00570960|4101651|P1|STARTED|Overall Study||4
1679172|NCT00570921|4101657|P1|NOT COMPLETED|Overall Study||2
1679173|NCT00570921|4101657|P1|COMPLETED|Overall Study||31
1679174|NCT00570921|4101657|P1|STARTED|Overall Study||33
1679175|NCT00570908|4101663|P1|NOT COMPLETED|Overall Study||7
1679176|NCT00570908|4101663|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
1679177|NCT00570908|4101663|P1|STARTED|Overall Study||12
1679178|NCT00570778|4101667|P4|NOT COMPLETED|Overall Study||4
1679179|NCT00570778|4101668|P3|NOT COMPLETED|Overall Study||7
1679180|NCT00570778|4101669|P2|NOT COMPLETED|Overall Study||4
1679181|NCT00570778|4101670|P1|NOT COMPLETED|Overall Study||4
1679182|NCT00570778|4101667|P4|COMPLETED|Overall Study||34
1679183|NCT00570778|4101668|P3|COMPLETED|Overall Study||30
1679184|NCT00570778|4101669|P2|COMPLETED|Overall Study||34
1679185|NCT00570778|4101670|P1|COMPLETED|Overall Study||37
1679186|NCT00570778|4101667|P4|Modified Intent-to-treat Population|Overall Study||37
1679187|NCT00570778|4101668|P3|Modified Intent-to-treat Population|Overall Study||35
1679188|NCT00570778|4101669|P2|Modified Intent-to-treat Population|Overall Study||37
1679189|NCT00570778|4101670|P1|Modified Intent-to-treat Population|Overall Study||40
1679190|NCT00570778|4101667|P4|Safety Population: Received Study Drug|Overall Study||38
1679191|NCT00570778|4101668|P3|Safety Population: Received Study Drug|Overall Study||36
1679192|NCT00570778|4101669|P2|Safety Population: Received Study Drug|Overall Study||38
1679193|NCT00570778|4101670|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
1679194|NCT00570778|4101667|P4|STARTED|Overall Study||38
1679195|NCT00570778|4101668|P3|STARTED|Overall Study||37
1679196|NCT00570778|4101669|P2|STARTED|Overall Study||38
1679197|NCT00570778|4101670|P1|STARTED|Overall Study||41
1679198|NCT00570765|4101691|P3|NOT COMPLETED|Overall Study||0
1679199|NCT00570765|4101692|P2|NOT COMPLETED|Overall Study||7
1679200|NCT00570765|4101693|P1|NOT COMPLETED|Overall Study||4
1679201|NCT00570765|4101691|P3|COMPLETED|Overall Study||23
1679202|NCT00570765|4101692|P2|COMPLETED|Overall Study||9
1679203|NCT00570765|4101693|P1|COMPLETED|Overall Study||16
1679204|NCT00570765|4101691|P3|STARTED|Overall Study||23
1679205|NCT00570765|4101692|P2|STARTED|Overall Study||16
1679206|NCT00570765|4101693|P1|STARTED|Overall Study||20
1679207|NCT00570739|4101711|P4|NOT COMPLETED|Overall Study||12
1679208|NCT00570739|4101712|P3|NOT COMPLETED|Overall Study||16
1679209|NCT00570739|4101713|P2|NOT COMPLETED|Overall Study||21
1679210|NCT00570739|4101714|P1|NOT COMPLETED|Overall Study||21
1679211|NCT00570739|4101711|P4|COMPLETED|Overall Study||96
1679212|NCT00570739|4101712|P3|COMPLETED|Overall Study||92
1679213|NCT00570739|4101713|P2|COMPLETED|Overall Study||124
1679214|NCT00570739|4101714|P1|COMPLETED|Overall Study||120
1679215|NCT00570739|4101711|P4|STARTED|Overall Study||108
1679216|NCT00570739|4101712|P3|STARTED|Overall Study||108
1679217|NCT00570739|4101713|P2|STARTED|Overall Study||145
1679218|NCT00570739|4101714|P1|STARTED|Overall Study||141
1679219|NCT00570713|4101866|P2|NOT COMPLETED|Overall Study||77
1679220|NCT00570713|4101867|P1|NOT COMPLETED|Overall Study||78
1679221|NCT00570713|4101866|P2|COMPLETED|Overall Study||0
1679222|NCT00570713|4101867|P1|COMPLETED|Overall Study||0
1679223|NCT00570713|4101866|P2|STARTED|Overall Study||77
1679224|NCT00570713|4101867|P1|STARTED|Overall Study||78
1679225|NCT00570700|4101877|P1|NOT COMPLETED|Overall Study||11
1679226|NCT00570700|4101877|P1|COMPLETED|Overall Study||27
1679227|NCT00570700|4101877|P1|STARTED|Overall Study||38
1679228|NCT00570687|4101885|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679229|NCT00570687|4101886|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679230|NCT00570687|4101887|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679231|NCT00570687|4101888|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679232|NCT00570687|4101889|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679233|NCT00570687|4101890|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679234|NCT00570687|4101891|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679235|NCT00570687|4101892|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679236|NCT00570687|4101893|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679237|NCT00570687|4101894|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679238|NCT00570687|4101885|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679239|NCT00570687|4101886|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679240|NCT00570687|4101887|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679241|NCT00570687|4101888|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679242|NCT00570687|4101889|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679243|NCT00570687|4101890|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1679244|NCT00570687|4101891|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
1679245|NCT00570687|4101892|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
1679246|NCT00570687|4101893|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
1679247|NCT00570687|4101894|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
1679248|NCT00570687|4101885|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1679249|NCT00570687|4101886|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1679250|NCT00570687|4101887|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1679251|NCT00570687|4101888|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1679252|NCT00570687|4101889|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1679253|NCT00570687|4101890|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1679254|NCT00570687|4101891|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
1679255|NCT00570687|4101892|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
1679256|NCT00570687|4101893|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
1679257|NCT00570687|4101894|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
1679258|NCT00570687|4101885|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679259|NCT00570687|4101886|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679260|NCT00570687|4101887|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679261|NCT00570687|4101888|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679262|NCT00570687|4101889|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679263|NCT00570687|4101890|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679264|NCT00570687|4101891|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679265|NCT00570687|4101892|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679266|NCT00570687|4101893|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679267|NCT00570687|4101894|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679268|NCT00570687|4101885|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679269|NCT00570687|4101886|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679270|NCT00570687|4101887|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679271|NCT00570687|4101888|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679272|NCT00570687|4101889|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679273|NCT00570687|4101890|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1679274|NCT00570687|4101891|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
1679275|NCT00570687|4101892|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
1679276|NCT00570687|4101893|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
1679277|NCT00570687|4101894|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
1679278|NCT00570687|4101885|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1679279|NCT00570687|4101886|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1679280|NCT00570687|4101887|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1679281|NCT00570687|4101888|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1679282|NCT00570687|4101889|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1679283|NCT00570687|4101890|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1679284|NCT00570687|4101891|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
1679285|NCT00570687|4101892|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
1679286|NCT00570687|4101893|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
1679287|NCT00570687|4101894|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
1679288|NCT00570687|4101885|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679289|NCT00570687|4101886|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679290|NCT00570687|4101887|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679291|NCT00570687|4101888|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679292|NCT00570687|4101889|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679293|NCT00570687|4101890|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679294|NCT00570687|4101891|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679295|NCT00570687|4101892|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679296|NCT00570687|4101893|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679297|NCT00570687|4101894|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679298|NCT00570687|4101885|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679299|NCT00570687|4101886|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679300|NCT00570687|4101887|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679301|NCT00570687|4101888|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679302|NCT00570687|4101889|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679303|NCT00570687|4101890|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1679304|NCT00570687|4101891|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
1679305|NCT00570687|4101892|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
1679306|NCT00570687|4101893|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
1679307|NCT00570687|4101894|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
1679308|NCT00570687|4101885|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1679309|NCT00570687|4101886|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1679310|NCT00570687|4101887|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1679311|NCT00570687|4101888|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1679312|NCT00570687|4101889|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1679313|NCT00570687|4101890|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1679314|NCT00570687|4101891|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
1679315|NCT00570687|4101892|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
1679316|NCT00570687|4101893|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
1679317|NCT00570687|4101894|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
1679318|NCT00570687|4101885|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679319|NCT00570687|4101886|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679320|NCT00570687|4101887|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679321|NCT00570687|4101888|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679322|NCT00570687|4101889|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679323|NCT00570687|4101890|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679324|NCT00570687|4101891|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679325|NCT00570687|4101892|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679326|NCT00570687|4101893|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679327|NCT00570687|4101894|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679328|NCT00570687|4101885|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679329|NCT00570687|4101886|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679330|NCT00570687|4101887|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679331|NCT00570687|4101888|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679332|NCT00570687|4101889|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679333|NCT00570687|4101890|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1679334|NCT00570687|4101891|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
1679335|NCT00570687|4101892|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
1679336|NCT00570687|4101893|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
1679337|NCT00570687|4101894|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
1679338|NCT00570687|4101885|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1679339|NCT00570687|4101886|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1679340|NCT00570687|4101887|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1679341|NCT00570687|4101888|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1679342|NCT00570687|4101889|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1679343|NCT00570687|4101890|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1679344|NCT00570687|4101891|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
1679345|NCT00570687|4101892|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
1679346|NCT00570687|4101893|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
1679347|NCT00570687|4101894|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
1679348|NCT00570687|4101885|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679349|NCT00570687|4101886|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679350|NCT00570687|4101887|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679351|NCT00570687|4101888|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679352|NCT00570687|4101889|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679353|NCT00570687|4101890|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679354|NCT00570687|4101891|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679355|NCT00570687|4101892|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679356|NCT00570687|4101893|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679357|NCT00570687|4101894|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679358|NCT00570687|4101885|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679359|NCT00570687|4101886|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679360|NCT00570687|4101887|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679361|NCT00570687|4101888|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679362|NCT00570687|4101889|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679363|NCT00570687|4101890|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679364|NCT00570687|4101891|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
1679365|NCT00570687|4101892|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
1679366|NCT00570687|4101893|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
1679367|NCT00570687|4101894|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
1679368|NCT00570687|4101885|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679369|NCT00570687|4101886|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679370|NCT00570687|4101887|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679371|NCT00570687|4101888|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679372|NCT00570687|4101889|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679373|NCT00570687|4101890|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1679374|NCT00570687|4101891|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
1679375|NCT00570687|4101892|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
1679376|NCT00570687|4101893|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
1679377|NCT00570687|4101894|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
1679378|NCT00570687|4101885|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679379|NCT00570687|4101886|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679380|NCT00570687|4101887|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679381|NCT00570687|4101888|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679382|NCT00570687|4101889|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679383|NCT00570687|4101890|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679384|NCT00570687|4101891|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679385|NCT00570687|4101892|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679386|NCT00570687|4101893|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679387|NCT00570687|4101894|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679388|NCT00570687|4101885|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679389|NCT00570687|4101886|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679390|NCT00570687|4101887|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679391|NCT00570687|4101888|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679392|NCT00570687|4101889|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679393|NCT00570687|4101890|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1679394|NCT00570687|4101891|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
1679395|NCT00570687|4101892|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
1679396|NCT00570687|4101893|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
1679397|NCT00570687|4101894|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
1679398|NCT00570687|4101885|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1679399|NCT00570687|4101886|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1679400|NCT00570687|4101887|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1679401|NCT00570687|4101888|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1679402|NCT00570687|4101889|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1679403|NCT00570687|4101890|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1679404|NCT00570687|4101891|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
1679405|NCT00570687|4101892|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
1679406|NCT00570687|4101893|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
1679407|NCT00570687|4101894|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
1679408|NCT00570687|4101885|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679409|NCT00570687|4101886|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679410|NCT00570687|4101887|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679411|NCT00570687|4101888|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679412|NCT00570687|4101889|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679413|NCT00570687|4101890|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679414|NCT00570687|4101891|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679415|NCT00570687|4101892|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679416|NCT00570687|4101893|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679417|NCT00570687|4101894|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679418|NCT00570687|4101885|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679419|NCT00570687|4101886|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679420|NCT00570687|4101887|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679421|NCT00570687|4101888|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679422|NCT00570687|4101889|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679423|NCT00570687|4101890|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679424|NCT00570687|4101891|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
1679425|NCT00570687|4101892|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
1679426|NCT00570687|4101893|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
1679427|NCT00570687|4101894|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
1679428|NCT00570687|4101885|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679429|NCT00570687|4101886|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679430|NCT00570687|4101887|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679431|NCT00570687|4101888|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679432|NCT00570687|4101889|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679433|NCT00570687|4101890|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1679434|NCT00570687|4101891|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
1679435|NCT00570687|4101892|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
1679436|NCT00570687|4101893|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
1679437|NCT00570687|4101894|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
1679438|NCT00570687|4101885|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679439|NCT00570687|4101886|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679440|NCT00570687|4101887|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679441|NCT00570687|4101888|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
1679442|NCT00570687|4101889|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679443|NCT00570687|4101890|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679444|NCT00570687|4101891|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679445|NCT00570687|4101892|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679446|NCT00570687|4101893|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679447|NCT00570687|4101894|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679448|NCT00570687|4101885|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679449|NCT00570687|4101886|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679450|NCT00570687|4101887|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679451|NCT00570687|4101888|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679452|NCT00570687|4101889|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679453|NCT00570687|4101890|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679454|NCT00570687|4101891|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679455|NCT00570687|4101892|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679456|NCT00570687|4101893|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679457|NCT00570687|4101894|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1679458|NCT00570687|4101885|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1679459|NCT00570687|4101886|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1679460|NCT00570687|4101887|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1679461|NCT00570687|4101888|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
1679462|NCT00570687|4101889|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1679463|NCT00570687|4101890|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1679464|NCT00570687|4101891|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1679465|NCT00570687|4101892|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1679466|NCT00570687|4101893|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1679467|NCT00570687|4101894|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1679468|NCT00570687|4101885|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679469|NCT00570687|4101886|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679470|NCT00570687|4101887|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679471|NCT00570687|4101888|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679472|NCT00570687|4101889|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679473|NCT00570687|4101890|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679474|NCT00570687|4101891|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679475|NCT00570687|4101892|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679476|NCT00570687|4101893|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679477|NCT00570687|4101894|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679478|NCT00570687|4101885|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679479|NCT00570687|4101886|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679480|NCT00570687|4101887|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679481|NCT00570687|4101888|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
1679482|NCT00570687|4101889|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679483|NCT00570687|4101890|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679484|NCT00570687|4101891|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679485|NCT00570687|4101892|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679486|NCT00570687|4101893|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679487|NCT00570687|4101894|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1679488|NCT00570687|4101885|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1679489|NCT00570687|4101886|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1679490|NCT00570687|4101887|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1679491|NCT00570687|4101888|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
1679492|NCT00570687|4101889|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1679493|NCT00570687|4101890|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1679494|NCT00570687|4101891|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1679495|NCT00570687|4101892|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1679496|NCT00570687|4101893|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1679497|NCT00570687|4101894|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1679498|NCT00570687|4101885|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679499|NCT00570687|4101886|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
1679500|NCT00570687|4101887|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679501|NCT00570687|4101888|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679502|NCT00570687|4101889|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679503|NCT00570687|4101890|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679504|NCT00570687|4101891|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679505|NCT00570687|4101892|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679506|NCT00570687|4101893|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679507|NCT00570687|4101894|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679508|NCT00570687|4101885|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679509|NCT00570687|4101886|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679510|NCT00570687|4101887|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679511|NCT00570687|4101888|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
1679512|NCT00570687|4101889|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679513|NCT00570687|4101890|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679514|NCT00570687|4101891|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679515|NCT00570687|4101892|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679516|NCT00570687|4101893|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679517|NCT00570687|4101894|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1679518|NCT00570687|4101885|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1679519|NCT00570687|4101886|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
1679520|NCT00570687|4101887|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1679521|NCT00570687|4101888|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
1679522|NCT00570687|4101889|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1679523|NCT00570687|4101890|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1679524|NCT00570687|4101891|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1679525|NCT00570687|4101892|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1679526|NCT00570687|4101893|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1679527|NCT00570687|4101894|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1679528|NCT00570687|4101885|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679529|NCT00570687|4101886|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679530|NCT00570687|4101887|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679531|NCT00570687|4101888|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679532|NCT00570687|4101889|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679533|NCT00570687|4101890|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679534|NCT00570687|4101891|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679535|NCT00570687|4101892|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679536|NCT00570687|4101893|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679537|NCT00570687|4101894|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679538|NCT00570687|4101885|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679539|NCT00570687|4101886|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
1679540|NCT00570687|4101887|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679541|NCT00570687|4101888|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
1679542|NCT00570687|4101889|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679543|NCT00570687|4101890|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679544|NCT00570687|4101891|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679545|NCT00570687|4101892|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679546|NCT00570687|4101893|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679547|NCT00570687|4101894|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1679548|NCT00570687|4101885|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1679549|NCT00570687|4101886|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
1679550|NCT00570687|4101887|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1679551|NCT00570687|4101888|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
1679552|NCT00570687|4101889|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1679553|NCT00570687|4101890|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1679554|NCT00570687|4101891|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1679555|NCT00570687|4101892|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1679556|NCT00570687|4101893|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1679557|NCT00570687|4101894|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1679558|NCT00570687|4101885|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1679559|NCT00570687|4101886|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
1679560|NCT00570687|4101887|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1679561|NCT00570687|4101888|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
1679562|NCT00570687|4101889|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1679563|NCT00570687|4101890|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1679564|NCT00570687|4101891|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679565|NCT00570687|4101892|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679566|NCT00570687|4101893|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679567|NCT00570687|4101894|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679568|NCT00570687|4101885|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679569|NCT00570687|4101886|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
1679570|NCT00570687|4101887|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679571|NCT00570687|4101888|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
1679572|NCT00570687|4101889|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679573|NCT00570687|4101890|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679574|NCT00570687|4101891|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679575|NCT00570687|4101892|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679576|NCT00570687|4101893|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679577|NCT00570687|4101894|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1679578|NCT00570687|4101885|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1679579|NCT00570687|4101886|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1679580|NCT00570687|4101887|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1679581|NCT00570687|4101888|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1679582|NCT00570687|4101889|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1679583|NCT00570687|4101890|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1679584|NCT00570687|4101891|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1679585|NCT00570687|4101892|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1679586|NCT00570687|4101893|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1679587|NCT00570687|4101894|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1679588|NCT00570687|4101885|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679589|NCT00570687|4101886|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679590|NCT00570687|4101887|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679591|NCT00570687|4101888|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679592|NCT00570687|4101889|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679593|NCT00570687|4101890|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679594|NCT00570687|4101891|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679595|NCT00570687|4101892|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679596|NCT00570687|4101893|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679597|NCT00570687|4101894|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679598|NCT00570687|4101885|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679599|NCT00570687|4101886|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679600|NCT00570687|4101887|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679601|NCT00570687|4101888|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679602|NCT00570687|4101889|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679603|NCT00570687|4101890|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679604|NCT00570687|4101891|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679605|NCT00570687|4101892|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679606|NCT00570687|4101893|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679607|NCT00570687|4101894|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679608|NCT00570687|4101885|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679609|NCT00570687|4101886|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679610|NCT00570687|4101887|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679611|NCT00570687|4101888|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679612|NCT00570687|4101889|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679613|NCT00570687|4101890|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1679614|NCT00570687|4101891|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679615|NCT00570687|4101892|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679616|NCT00570687|4101893|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679617|NCT00570687|4101894|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1679618|NCT00570687|4101885|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679619|NCT00570687|4101886|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679620|NCT00570687|4101887|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679621|NCT00570687|4101888|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679622|NCT00570687|4101889|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679623|NCT00570687|4101890|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679624|NCT00570687|4101891|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679625|NCT00570687|4101892|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679626|NCT00570687|4101893|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679627|NCT00570687|4101894|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679628|NCT00570687|4101885|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1679879|NCT00569803|4102180|P5|STARTED|Overall Study||5
1679629|NCT00570687|4101886|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1679630|NCT00570687|4101887|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1679631|NCT00570687|4101888|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1679632|NCT00570687|4101889|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1679633|NCT00570687|4101890|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1679634|NCT00570687|4101891|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679635|NCT00570687|4101892|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679636|NCT00570687|4101893|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679637|NCT00570687|4101894|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1679638|NCT00570687|4101885|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1679639|NCT00570687|4101886|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1679640|NCT00570687|4101887|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1679641|NCT00570687|4101888|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1679642|NCT00570687|4101889|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1679643|NCT00570687|4101890|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1679644|NCT00570687|4101891|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1679645|NCT00570687|4101892|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1679646|NCT00570687|4101893|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1679647|NCT00570687|4101894|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1679648|NCT00570687|4101885|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679649|NCT00570687|4101886|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679650|NCT00570687|4101887|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679651|NCT00570687|4101888|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679652|NCT00570687|4101889|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679653|NCT00570687|4101890|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679654|NCT00570687|4101891|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679655|NCT00570687|4101892|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679656|NCT00570687|4101893|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679657|NCT00570687|4101894|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679658|NCT00570687|4101885|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679659|NCT00570687|4101886|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679660|NCT00570687|4101887|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679661|NCT00570687|4101888|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679662|NCT00570687|4101889|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679663|NCT00570687|4101890|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679664|NCT00570687|4101891|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679665|NCT00570687|4101892|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679666|NCT00570687|4101893|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679667|NCT00570687|4101894|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679668|NCT00570687|4101885|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679669|NCT00570687|4101886|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679670|NCT00570687|4101887|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679671|NCT00570687|4101888|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679672|NCT00570687|4101889|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679673|NCT00570687|4101890|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1679674|NCT00570687|4101891|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679675|NCT00570687|4101892|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679676|NCT00570687|4101893|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679677|NCT00570687|4101894|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1679678|NCT00570687|4101885|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679679|NCT00570687|4101886|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679680|NCT00570687|4101887|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679681|NCT00570687|4101888|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679682|NCT00570687|4101889|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679683|NCT00570687|4101890|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679684|NCT00570687|4101891|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679685|NCT00570687|4101892|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679686|NCT00570687|4101893|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679687|NCT00570687|4101894|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679688|NCT00570687|4101885|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1679689|NCT00570687|4101886|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1679690|NCT00570687|4101887|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1679691|NCT00570687|4101888|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1679692|NCT00570687|4101889|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1679693|NCT00570687|4101890|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1679694|NCT00570687|4101891|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679695|NCT00570687|4101892|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679696|NCT00570687|4101893|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679697|NCT00570687|4101894|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1679698|NCT00570687|4101885|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1679699|NCT00570687|4101886|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1679700|NCT00570687|4101887|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1679701|NCT00570687|4101888|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1679702|NCT00570687|4101889|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1679703|NCT00570687|4101890|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1679704|NCT00570687|4101891|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1679705|NCT00570687|4101892|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1679706|NCT00570687|4101893|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1679707|NCT00570687|4101894|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1679708|NCT00570687|4101885|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679709|NCT00570687|4101886|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679710|NCT00570687|4101887|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679711|NCT00570687|4101888|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679712|NCT00570687|4101889|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679713|NCT00570687|4101890|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679714|NCT00570687|4101891|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679715|NCT00570687|4101892|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679716|NCT00570687|4101893|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679717|NCT00570687|4101894|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679718|NCT00570687|4101885|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679719|NCT00570687|4101886|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679720|NCT00570687|4101887|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679721|NCT00570687|4101888|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679722|NCT00570687|4101889|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679723|NCT00570687|4101890|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679724|NCT00570687|4101891|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679725|NCT00570687|4101892|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679726|NCT00570687|4101893|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679727|NCT00570687|4101894|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679728|NCT00570687|4101885|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679729|NCT00570687|4101886|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679730|NCT00570687|4101887|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679731|NCT00570687|4101888|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679732|NCT00570687|4101889|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679733|NCT00570687|4101890|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1679734|NCT00570687|4101891|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679735|NCT00570687|4101892|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679736|NCT00570687|4101893|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679737|NCT00570687|4101894|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1679738|NCT00570674|4101920|P7|NOT COMPLETED|Overall Study||0
1679739|NCT00570674|4101921|P6|NOT COMPLETED|Overall Study||0
1679740|NCT00570674|4101922|P5|NOT COMPLETED|Overall Study||0
1679741|NCT00570674|4101923|P4|NOT COMPLETED|Overall Study||0
1679742|NCT00570674|4101924|P3|NOT COMPLETED|Overall Study||1
1679743|NCT00570674|4101925|P2|NOT COMPLETED|Overall Study||0
1679744|NCT00570674|4101926|P1|NOT COMPLETED|Overall Study||0
1679745|NCT00570674|4101920|P7|COMPLETED|Overall Study||0
1679746|NCT00570674|4101921|P6|COMPLETED|Overall Study||10
1679747|NCT00570674|4101922|P5|COMPLETED|Overall Study||3
1679748|NCT00570674|4101923|P4|COMPLETED|Overall Study||3
1679749|NCT00570674|4101924|P3|COMPLETED|Overall Study||3
1679750|NCT00570674|4101925|P2|COMPLETED|Overall Study||3
1679751|NCT00570674|4101926|P1|COMPLETED|Overall Study||6
1679752|NCT00570674|4101920|P7|PEG Evaluable|Overall Study||0
1679753|NCT00570674|4101921|P6|PEG Evaluable|Overall Study||10
1679754|NCT00570674|4101922|P5|PEG Evaluable|Overall Study||2
1679755|NCT00570674|4101923|P4|PEG Evaluable|Overall Study||3
1679756|NCT00570674|4101924|P3|PEG Evaluable|Overall Study||3
1679757|NCT00570674|4101925|P2|PEG Evaluable|Overall Study||3
1679758|NCT00570674|4101926|P1|PEG Evaluable|Overall Study||6
1679759|NCT00570674|4101920|P7|Treated|Overall Study||0
1679760|NCT00570674|4101921|P6|Treated|Overall Study||10
1679761|NCT00570674|4101922|P5|Treated|Overall Study||3
1679762|NCT00570674|4101923|P4|Treated|Overall Study||3
1679763|NCT00570674|4101924|P3|Treated|Overall Study||3
1679764|NCT00570674|4101925|P2|Treated|Overall Study||3
1679765|NCT00570674|4101926|P1|Treated|Overall Study||6
1679766|NCT00570674|4101920|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
1679767|NCT00570674|4101921|P6|STARTED|Overall Study||10
1679768|NCT00570674|4101922|P5|STARTED|Overall Study||3
1679769|NCT00570674|4101923|P4|STARTED|Overall Study||3
1679770|NCT00570674|4101924|P3|STARTED|Overall Study||4
1679771|NCT00570674|4101925|P2|STARTED|Overall Study||3
1679772|NCT00570674|4101926|P1|STARTED|Overall Study||6
1679773|NCT00570531|4101943|P1|NOT COMPLETED|Overall Study||0
1679774|NCT00570531|4101943|P1|COMPLETED|Overall Study||6
1679775|NCT00570531|4101943|P1|STARTED|Overall Study||6
1679776|NCT00570505|4101949|P1|NOT COMPLETED|Overall Study||41
1679777|NCT00570505|4101949|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
1679778|NCT00570505|4101949|P1|STARTED|Overall Study||149
1679779|NCT00570492|4101962|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
1679780|NCT00570492|4101963|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
1679781|NCT00570492|4101964|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
1679782|NCT00570492|4101962|P3|COMPLETED|52-week Double-blind Treatment Period||186
1679783|NCT00570492|4101963|P2|COMPLETED|52-week Double-blind Treatment Period||187
1679784|NCT00570492|4101964|P1|COMPLETED|52-week Double-blind Treatment Period||0
1679785|NCT00570492|4101962|P3|STARTED|52-week Double-blind Treatment Period||237
1679786|NCT00570492|4101963|P2|STARTED|52-week Double-blind Treatment Period||237
1679787|NCT00570492|4101964|P1|STARTED|52-week Double-blind Treatment Period||0
1679788|NCT00570492|4101962|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
1679789|NCT00570492|4101963|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
1679790|NCT00570492|4101964|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
1679791|NCT00570492|4101962|P3|COMPLETED|16-week Single-blind Baseline Period||0
1679792|NCT00570492|4101963|P2|COMPLETED|16-week Single-blind Baseline Period||0
1679793|NCT00570492|4101964|P1|COMPLETED|16-week Single-blind Baseline Period||474
1679794|NCT00570492|4101962|P3|STARTED|16-week Single-blind Baseline Period||0
1679795|NCT00570492|4101963|P2|STARTED|16-week Single-blind Baseline Period||0
1679796|NCT00570492|4101964|P1|STARTED|16-week Single-blind Baseline Period||910
1679797|NCT00570401|4102002|P1|NOT COMPLETED|Overall Study||2
1679798|NCT00570401|4102002|P1|COMPLETED|Overall Study||19
1679799|NCT00570401|4102002|P1|STARTED|Overall Study||21
1679800|NCT00570362|4102008|P2|NOT COMPLETED|Overall Study||0
1679801|NCT00570362|4102009|P1|NOT COMPLETED|Overall Study||0
1679802|NCT00570362|4102008|P2|COMPLETED|Overall Study||30
1679803|NCT00570362|4102009|P1|COMPLETED|Overall Study||19
1679804|NCT00570362|4102008|P2|STARTED|Overall Study||30
1679805|NCT00570362|4102009|P1|STARTED|Overall Study||19
1679806|NCT00570349|4102018|P3|NOT COMPLETED|Overall Study||0
1679807|NCT00570349|4102019|P2|NOT COMPLETED|Overall Study||0
1679808|NCT00570349|4102020|P1|NOT COMPLETED|Overall Study||0
1679809|NCT00570349|4102018|P3|COMPLETED|Overall Study||6
1679810|NCT00570349|4102019|P2|COMPLETED|Overall Study||6
1679811|NCT00570349|4102020|P1|COMPLETED|Overall Study||6
1679812|NCT00570349|4102018|P3|STARTED|Overall Study||6
1679813|NCT00570349|4102019|P2|STARTED|Overall Study||6
1679814|NCT00570349|4102020|P1|STARTED|Overall Study||6
1679815|NCT00570310|4102036|P2|NOT COMPLETED|Overall Study||6
1679816|NCT00570310|4102037|P1|NOT COMPLETED|Overall Study||2
1679817|NCT00570310|4102036|P2|COMPLETED|Overall Study||45
1679818|NCT00570310|4102037|P1|COMPLETED|Overall Study||51
1679819|NCT00570310|4102036|P2|STARTED|Overall Study||51
1679820|NCT00570310|4102037|P1|STARTED|Overall Study||53
1679821|NCT00570232|4102045|P1|NOT COMPLETED|Overall Study||23
1679822|NCT00570232|4102045|P1|COMPLETED|Overall Study||8
1679823|NCT00570232|4102045|P1|STARTED|Overall Study||31
1679824|NCT00570141|4102051|P1|NOT COMPLETED|Overall Study||3
1679825|NCT00570141|4102051|P1|COMPLETED|Overall Study||10
1679826|NCT00570141|4102051|P1|STARTED|Overall Study||13
1679827|NCT00570089|4102056|P2|NOT COMPLETED|Perod 2||0
1679828|NCT00570089|4102057|P1|NOT COMPLETED|Perod 2||0
1679829|NCT00570089|4102056|P2|COMPLETED|Perod 2||10
1679830|NCT00570089|4102057|P1|COMPLETED|Perod 2||10
1679831|NCT00570089|4102056|P2|STARTED|Perod 2||10
1679832|NCT00570089|4102057|P1|STARTED|Perod 2||10
1679833|NCT00570089|4102056|P2|NOT COMPLETED|Period 1||0
1679834|NCT00570089|4102057|P1|NOT COMPLETED|Period 1||0
1679835|NCT00570089|4102056|P2|COMPLETED|Period 1||10
1679836|NCT00570089|4102057|P1|COMPLETED|Period 1||10
1679837|NCT00570089|4102056|P2|STARTED|Period 1||10
1679838|NCT00570089|4102057|P1|STARTED|Period 1||10
1679839|NCT00570063|4102067|P2|NOT COMPLETED|Overall Study||8
1679840|NCT00570063|4102068|P1|NOT COMPLETED|Overall Study||15
1679841|NCT00570063|4102067|P2|COMPLETED|Overall Study||3
1679842|NCT00570063|4102068|P1|COMPLETED|Overall Study||9
1679843|NCT00570063|4102067|P2|STARTED|Overall Study||11
1679844|NCT00570063|4102068|P1|STARTED|Overall Study||24
1679845|NCT00570037|4102134|P2|NOT COMPLETED|Overall Study||69
1679846|NCT00570037|4102135|P1|NOT COMPLETED|Overall Study||44
1679847|NCT00570037|4102134|P2|COMPLETED|Overall Study||237
1679848|NCT00570037|4102135|P1|COMPLETED|Overall Study||194
1679849|NCT00570037|4102134|P2|STARTED|Overall Study||306
1679850|NCT00570037|4102135|P1|STARTED|Overall Study||238
1679851|NCT00569946|4102145|P1|NOT COMPLETED|Overall Study||59
1679852|NCT00569946|4102145|P1|COMPLETED|Overall Study||5
1679853|NCT00569946|4102145|P1|STARTED|Overall Study||64
1679854|NCT00569868|4102161|P1|NOT COMPLETED|Overall Study||0
1679855|NCT00569868|4102161|P1|COMPLETED|Overall Study||11
1679856|NCT00569868|4102161|P1|STARTED|Overall Study||11
1679857|NCT00569855|4102165|P1|NOT COMPLETED|Overall Study||0
1679858|NCT00569855|4102165|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
1679859|NCT00569855|4102165|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
1679860|NCT00569803|4102177|P8|NOT COMPLETED|Overall Study||1
1679861|NCT00569803|4102178|P7|NOT COMPLETED|Overall Study||0
1679862|NCT00569803|4102179|P6|NOT COMPLETED|Overall Study||0
1679863|NCT00569803|4102180|P5|NOT COMPLETED|Overall Study||0
1679864|NCT00569803|4102181|P4|NOT COMPLETED|Overall Study||1
1679865|NCT00569803|4102182|P3|NOT COMPLETED|Overall Study||0
1679866|NCT00569803|4102183|P2|NOT COMPLETED|Overall Study||0
1679867|NCT00569803|4102184|P1|NOT COMPLETED|Overall Study||1
1679868|NCT00569803|4102177|P8|COMPLETED|Overall Study||5
1679869|NCT00569803|4102178|P7|COMPLETED|Overall Study||10
1679870|NCT00569803|4102179|P6|COMPLETED|Overall Study||5
1679871|NCT00569803|4102180|P5|COMPLETED|Overall Study||5
1679872|NCT00569803|4102181|P4|COMPLETED|Overall Study||5
1679873|NCT00569803|4102182|P3|COMPLETED|Overall Study||5
1679874|NCT00569803|4102183|P2|COMPLETED|Overall Study||5
1679875|NCT00569803|4102184|P1|COMPLETED|Overall Study||4
1679876|NCT00569803|4102177|P8|STARTED|Overall Study||6
1679877|NCT00569803|4102178|P7|STARTED|Overall Study||10
1679878|NCT00569803|4102179|P6|STARTED|Overall Study||5
1679880|NCT00569803|4102181|P4|STARTED|Overall Study||6
1679881|NCT00569803|4102182|P3|STARTED|Overall Study||5
1679882|NCT00569803|4102183|P2|STARTED|Overall Study||5
1679883|NCT00569803|4102184|P1|STARTED|Overall Study||5
1679884|NCT00569777|4102311|P2|NOT COMPLETED|Overall Study||3
1679885|NCT00569777|4102312|P1|NOT COMPLETED|Overall Study||10
1679886|NCT00569777|4102311|P2|COMPLETED|Overall Study||101
1679887|NCT00569777|4102312|P1|COMPLETED|Overall Study||196
1679888|NCT00569777|4102311|P2|STARTED|Overall Study||104
1679889|NCT00569777|4102312|P1|STARTED|Overall Study||206
1679890|NCT00569673|4102354|P1|NOT COMPLETED|Overall Study||0
1679891|NCT00569673|4102354|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
1679892|NCT00569673|4102354|P1|STARTED|Overall Study|Total number participants enrolled on study|71
1679893|NCT00569660|4102359|P1|NOT COMPLETED|Overall Study||0
1679894|NCT00569660|4102359|P1|COMPLETED|Overall Study||34
1679895|NCT00569660|4102359|P1|STARTED|Overall Study||34
1679896|NCT00569582|4102363|P1|NOT COMPLETED|Overall Study||16
1679897|NCT00569582|4102363|P1|COMPLETED|Overall Study||34
1679898|NCT00569582|4102363|P1|STARTED|Overall Study||50
1679899|NCT00569530|4102370|P2|NOT COMPLETED|Overall Study||0
1679900|NCT00569530|4102371|P1|NOT COMPLETED|Overall Study||0
1679901|NCT00569530|4102370|P2|COMPLETED|Overall Study||42
1679902|NCT00569530|4102371|P1|COMPLETED|Overall Study||43
1679903|NCT00569530|4102370|P2|STARTED|Overall Study||42
1679904|NCT00569530|4102371|P1|STARTED|Overall Study||43
1679905|NCT00569374|4102379|P1|NOT COMPLETED|Overall Study||4
1679906|NCT00569374|4102379|P1|COMPLETED|Overall Study||4
1679907|NCT00569374|4102379|P1|STARTED|Overall Study||8
1679908|NCT00569309|4102389|P1|NOT COMPLETED|Overall Study||0
1679909|NCT00569309|4102389|P1|COMPLETED|Overall Study||30
1679910|NCT00569309|4102389|P1|STARTED|Overall Study||30
1679911|NCT00569270|4102398|P2|NOT COMPLETED|Period: Second Intervention||0
1679912|NCT00569270|4102399|P1|NOT COMPLETED|Period: Second Intervention||0
1679913|NCT00569270|4102398|P2|COMPLETED|Period: Second Intervention||14
1679914|NCT00569270|4102399|P1|COMPLETED|Period: Second Intervention||15
1679915|NCT00569270|4102398|P2|29 Days|Period: Second Intervention||14
1679916|NCT00569270|4102399|P1|29 Days|Period: Second Intervention||15
1679917|NCT00569270|4102398|P2|STARTED|Period: Second Intervention||14
1679918|NCT00569270|4102399|P1|STARTED|Period: Second Intervention||15
1679919|NCT00569270|4102398|P2|NOT COMPLETED|Period: First Intervention||1
1679920|NCT00569270|4102399|P1|NOT COMPLETED|Period: First Intervention||0
1679921|NCT00569270|4102398|P2|COMPLETED|Period: First Intervention||14
1679922|NCT00569270|4102399|P1|COMPLETED|Period: First Intervention||15
1679923|NCT00569270|4102398|P2|STARTED|Period: First Intervention||15
1679924|NCT00569270|4102399|P1|STARTED|Period: First Intervention|randomized cross over study|15
1679925|NCT00569231|4102434|P1|NOT COMPLETED|Overall Study||7
1679926|NCT00569231|4102434|P1|COMPLETED|Overall Study||11
1679927|NCT00569231|4102434|P1|STARTED|Overall Study||18
1679928|NCT00569192|4102444|P3|NOT COMPLETED|Overall Study||25
1679929|NCT00569192|4102445|P2|NOT COMPLETED|Overall Study||20
1679930|NCT00569192|4102446|P1|NOT COMPLETED|Overall Study||23
1679931|NCT00569192|4102444|P3|COMPLETED|Overall Study||99
1679932|NCT00569192|4102445|P2|COMPLETED|Overall Study||105
1679933|NCT00569192|4102446|P1|COMPLETED|Overall Study||88
1679934|NCT00569192|4102444|P3|STARTED|Overall Study||124
1679935|NCT00569192|4102445|P2|STARTED|Overall Study||125
1679936|NCT00569192|4102446|P1|STARTED|Overall Study||111
1679937|NCT00569166|4102472|P3|NOT COMPLETED|Overall Study||4
1679938|NCT00569166|4102473|P2|NOT COMPLETED|Overall Study||6
1679939|NCT00569166|4102474|P1|NOT COMPLETED|Overall Study||9
1679940|NCT00569166|4102472|P3|COMPLETED|Overall Study||27
1679941|NCT00569166|4102473|P2|COMPLETED|Overall Study||25
1679942|NCT00569166|4102474|P1|COMPLETED|Overall Study||21
1679943|NCT00569166|4102472|P3|STARTED|Overall Study||31
1679944|NCT00569166|4102473|P2|STARTED|Overall Study||31
1679945|NCT00569166|4102474|P1|STARTED|Overall Study||30
1679946|NCT00569127|4102508|P2|NOT COMPLETED|Overall Study||213
1679947|NCT00569127|4102509|P1|NOT COMPLETED|Overall Study||214
1679948|NCT00569127|4102508|P2|COMPLETED|Overall Study||0
1679949|NCT00569127|4102509|P1|COMPLETED|Overall Study||0
1679950|NCT00569127|4102508|P2|Eligible|Overall Study||202
1679951|NCT00569127|4102509|P1|Eligible|Overall Study||200
1679952|NCT00569127|4102508|P2|STARTED|Overall Study||213
1679953|NCT00569127|4102509|P1|STARTED|Overall Study||214
1679954|NCT00569010|4102529|P4|NOT COMPLETED|Overall Study||0
1679955|NCT00569010|4102530|P3|NOT COMPLETED|Overall Study||0
1679956|NCT00569010|4102531|P2|NOT COMPLETED|Overall Study||0
1679957|NCT00569010|4102532|P1|NOT COMPLETED|Overall Study||0
1679958|NCT00569010|4102529|P4|COMPLETED|Overall Study||11
1679959|NCT00569010|4102530|P3|COMPLETED|Overall Study||11
1679960|NCT00569010|4102531|P2|COMPLETED|Overall Study||6
1679961|NCT00569010|4102532|P1|COMPLETED|Overall Study||6
1679962|NCT00569010|4102529|P4|STARTED|Overall Study||11
1679963|NCT00569010|4102530|P3|STARTED|Overall Study||11
1679964|NCT00569010|4102531|P2|STARTED|Overall Study||6
1679965|NCT00569010|4102532|P1|STARTED|Overall Study||6
1679966|NCT00568958|4102544|P2|NOT COMPLETED|Follow-Up||7
1679967|NCT00568958|4102545|P1|NOT COMPLETED|Follow-Up||9
1679968|NCT00568958|4102544|P2|COMPLETED|Follow-Up||60
1679969|NCT00568958|4102545|P1|COMPLETED|Follow-Up||52
1679970|NCT00568958|4102544|P2|STARTED|Follow-Up||67
1679971|NCT00568958|4102545|P1|STARTED|Follow-Up||61
1679972|NCT00568958|4102544|P2|NOT COMPLETED|Allocation||3
1679973|NCT00568958|4102545|P1|NOT COMPLETED|Allocation||9
1679974|NCT00568958|4102544|P2|COMPLETED|Allocation||67
1679975|NCT00568958|4102545|P1|COMPLETED|Allocation||61
1679976|NCT00568958|4102544|P2|STARTED|Allocation||70
1679977|NCT00568958|4102545|P1|STARTED|Allocation||70
1679978|NCT00568854|4102565|P2|NOT COMPLETED|Overall Study||0
1679979|NCT00568854|4102566|P1|NOT COMPLETED|Overall Study||0
1679980|NCT00568854|4102565|P2|COMPLETED|Overall Study||4
1679981|NCT00568854|4102566|P1|COMPLETED|Overall Study||6
1679982|NCT00568854|4102565|P2|STARTED|Overall Study||4
1679983|NCT00568854|4102566|P1|STARTED|Overall Study||6
1679984|NCT00568776|4102578|P4|NOT COMPLETED|Overall Study||72
1679985|NCT00568776|4102579|P3|NOT COMPLETED|Overall Study||74
1679986|NCT00568776|4102580|P2|NOT COMPLETED|Overall Study||36
1679987|NCT00568776|4102581|P1|NOT COMPLETED|Overall Study||30
1679988|NCT00568776|4102578|P4|COMPLETED|Overall Study||19
1679989|NCT00568776|4102579|P3|COMPLETED|Overall Study||15
1679990|NCT00568776|4102580|P2|COMPLETED|Overall Study||52
1679991|NCT00568776|4102581|P1|COMPLETED|Overall Study||53
1679992|NCT00568776|4102578|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
1679993|NCT00568776|4102579|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
1679994|NCT00568776|4102580|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
1679995|NCT00568776|4102581|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
1679996|NCT00568685|4102618|P3|NOT COMPLETED|Overall Study||5
1679997|NCT00568685|4102619|P2|NOT COMPLETED|Overall Study||5
1679998|NCT00568685|4102620|P1|NOT COMPLETED|Overall Study||10
1679999|NCT00568685|4102618|P3|COMPLETED|Overall Study||46
1680000|NCT00568685|4102619|P2|COMPLETED|Overall Study||46
1680001|NCT00568685|4102620|P1|COMPLETED|Overall Study||41
1680002|NCT00568685|4102618|P3|STARTED|Overall Study||51
1680003|NCT00568685|4102619|P2|STARTED|Overall Study||51
1680004|NCT00568685|4102620|P1|STARTED|Overall Study||51
1680005|NCT00568555|4102654|P2|NOT COMPLETED|Overall Study||1
1680006|NCT00568555|4102655|P1|NOT COMPLETED|Overall Study||1
1680007|NCT00568555|4102654|P2|COMPLETED|Overall Study||14
1680008|NCT00568555|4102655|P1|COMPLETED|Overall Study||15
1680009|NCT00568555|4102654|P2|STARTED|Overall Study||15
1680010|NCT00568555|4102655|P1|STARTED|Overall Study||16
1680011|NCT00568451|4102673|P4|NOT COMPLETED|Overall Study||7
1680012|NCT00568451|4102674|P3|NOT COMPLETED|Overall Study||2
1680013|NCT00568451|4102675|P2|NOT COMPLETED|Overall Study||0
1680014|NCT00568451|4102676|P1|NOT COMPLETED|Overall Study||0
1680015|NCT00568451|4102673|P4|COMPLETED|Overall Study||2
1680016|NCT00568451|4102674|P3|COMPLETED|Overall Study||0
1680017|NCT00568451|4102675|P2|COMPLETED|Overall Study||0
1680018|NCT00568451|4102676|P1|COMPLETED|Overall Study||0
1680019|NCT00568451|4102673|P4|STARTED|Overall Study||9
1680020|NCT00568451|4102674|P3|STARTED|Overall Study||2
1680021|NCT00568451|4102675|P2|STARTED|Overall Study||0
1680022|NCT00568451|4102676|P1|STARTED|Overall Study||0
1680023|NCT00568399|4102692|P1|NOT COMPLETED|Overall Study||15
1680024|NCT00568399|4102692|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
1680025|NCT00568399|4102692|P1|STARTED|Overall Study||37
1680026|NCT00568386|4102698|P2|NOT COMPLETED|Overall Study||0
1680027|NCT00568386|4102699|P1|NOT COMPLETED|Overall Study||0
1680028|NCT00568386|4102698|P2|COMPLETED|Overall Study||20
1680029|NCT00568386|4102699|P1|COMPLETED|Overall Study||20
1680030|NCT00568386|4102698|P2|STARTED|Overall Study||20
1680031|NCT00568386|4102699|P1|STARTED|Overall Study||20
1680032|NCT00568334|4102707|P2|NOT COMPLETED|Overall Study||1
1680033|NCT00568334|4102708|P1|NOT COMPLETED|Overall Study||1
1680034|NCT00568334|4102707|P2|COMPLETED|Overall Study||121
1680035|NCT00568334|4102708|P1|COMPLETED|Overall Study||121
1680036|NCT00568334|4102707|P2|STARTED|Overall Study||122
1680037|NCT00568334|4102708|P1|STARTED|Overall Study||122
1680038|NCT00568178|4102734|P6|NOT COMPLETED|Open Label Extension||80
1680039|NCT00568178|4102735|P5|NOT COMPLETED|Open Label Extension||79
1680040|NCT00568178|4102736|P4|NOT COMPLETED|Open Label Extension||0
1680041|NCT00568178|4102737|P3|NOT COMPLETED|Open Label Extension||0
1680042|NCT00568178|4102738|P2|NOT COMPLETED|Open Label Extension||0
1680043|NCT00568178|4102739|P1|NOT COMPLETED|Open Label Extension||0
1680044|NCT00568178|4102734|P6|COMPLETED|Open Label Extension||54
1680045|NCT00568178|4102735|P5|COMPLETED|Open Label Extension||55
1680046|NCT00568178|4102736|P4|COMPLETED|Open Label Extension||0
1680047|NCT00568178|4102737|P3|COMPLETED|Open Label Extension||0
1680048|NCT00568178|4102738|P2|COMPLETED|Open Label Extension||0
1680049|NCT00568178|4102739|P1|COMPLETED|Open Label Extension||0
1680050|NCT00568178|4102734|P6|STARTED|Open Label Extension||134
1680051|NCT00568178|4102735|P5|STARTED|Open Label Extension||134
1680052|NCT00568178|4102736|P4|STARTED|Open Label Extension||0
1680053|NCT00568178|4102737|P3|STARTED|Open Label Extension||0
1680054|NCT00568178|4102738|P2|STARTED|Open Label Extension||0
1680055|NCT00568178|4102739|P1|STARTED|Open Label Extension||0
1680056|NCT00568178|4102734|P6|NOT COMPLETED|Double Blind Base Study||0
1680057|NCT00568178|4102735|P5|NOT COMPLETED|Double Blind Base Study||0
1680058|NCT00568178|4102736|P4|NOT COMPLETED|Double Blind Base Study||5
1680059|NCT00568178|4102737|P3|NOT COMPLETED|Double Blind Base Study||1
1680060|NCT00568178|4102738|P2|NOT COMPLETED|Double Blind Base Study||6
1680061|NCT00568178|4102739|P1|NOT COMPLETED|Double Blind Base Study||6
1680062|NCT00568178|4102734|P6|COMPLETED|Double Blind Base Study||0
1680063|NCT00568178|4102735|P5|COMPLETED|Double Blind Base Study||0
1680064|NCT00568178|4102736|P4|COMPLETED|Double Blind Base Study||25
1680065|NCT00568178|4102737|P3|COMPLETED|Double Blind Base Study||29
1680066|NCT00568178|4102738|P2|COMPLETED|Double Blind Base Study||118
1680067|NCT00568178|4102739|P1|COMPLETED|Double Blind Base Study||116
1680068|NCT00568178|4102734|P6|STARTED|Double Blind Base Study||0
1680069|NCT00568178|4102735|P5|STARTED|Double Blind Base Study||0
1680070|NCT00568178|4102736|P4|STARTED|Double Blind Base Study||30
1680071|NCT00568178|4102737|P3|STARTED|Double Blind Base Study||30
1680072|NCT00568178|4102738|P2|STARTED|Double Blind Base Study||124
1680073|NCT00568178|4102739|P1|STARTED|Double Blind Base Study||122
1680074|NCT00568087|4102757|P2|NOT COMPLETED|Overall Study||7
1680075|NCT00568087|4102758|P1|NOT COMPLETED|Overall Study||7
1680076|NCT00568087|4102757|P2|COMPLETED|Overall Study||17
1680077|NCT00568087|4102758|P1|COMPLETED|Overall Study||15
1680078|NCT00568087|4102757|P2|Received Intervention|Overall Study||23
1680079|NCT00568087|4102758|P1|Received Intervention|Overall Study||21
1680080|NCT00568087|4102757|P2|STARTED|Overall Study||24
1680081|NCT00568087|4102758|P1|STARTED|Overall Study||22
1680082|NCT00568061|4102770|P2|NOT COMPLETED|Overall Study||2
1680083|NCT00568061|4102771|P1|NOT COMPLETED|Overall Study||5
1680084|NCT00568061|4102770|P2|COMPLETED|Overall Study||14
1680085|NCT00568061|4102771|P1|COMPLETED|Overall Study||8
1680086|NCT00568061|4102770|P2|STARTED|Overall Study||16
1680087|NCT00568061|4102771|P1|STARTED|Overall Study||13
1680088|NCT00568022|4102780|P3|NOT COMPLETED|Overall Study||0
1680089|NCT00568022|4102781|P2|NOT COMPLETED|Overall Study||0
1680090|NCT00568022|4102782|P1|NOT COMPLETED|Overall Study||0
1680091|NCT00568022|4102780|P3|COMPLETED|Overall Study||3
1680092|NCT00568022|4102781|P2|COMPLETED|Overall Study||3
1680093|NCT00568022|4102782|P1|COMPLETED|Overall Study||3
1680094|NCT00568022|4102780|P3|STARTED|Overall Study||3
1680095|NCT00568022|4102781|P2|STARTED|Overall Study||3
1680096|NCT00568022|4102782|P1|STARTED|Overall Study||3
1680097|NCT00567996|4102815|P3|NOT COMPLETED|Overall Study||70
1680098|NCT00567996|4102816|P2|NOT COMPLETED|Overall Study||50
1680099|NCT00567996|4102817|P1|NOT COMPLETED|Overall Study||44
1680100|NCT00567996|4102815|P3|COMPLETED|Overall Study||265
1680101|NCT00567996|4102816|P2|COMPLETED|Overall Study||284
1680102|NCT00567996|4102817|P1|COMPLETED|Overall Study||289
1680103|NCT00567996|4102815|P3|Intent-to-treat: Received Study Drug|Overall Study||335
1680104|NCT00567996|4102816|P2|Intent-to-treat: Received Study Drug|Overall Study||333
1680105|NCT00567996|4102817|P1|Intent-to-treat: Received Study Drug|Overall Study||330
1680106|NCT00567996|4102815|P3|STARTED|Overall Study||335
1680107|NCT00567996|4102816|P2|STARTED|Overall Study||334
1680108|NCT00567996|4102817|P1|STARTED|Overall Study|Randomized participants|333
1680109|NCT00567892|4102833|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
1680110|NCT00567892|4102834|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
1680111|NCT00567892|4102835|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
1680112|NCT00567892|4102836|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
1680113|NCT00567892|4102833|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
1680114|NCT00567892|4102834|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
1680115|NCT00567892|4102835|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
1680116|NCT00567892|4102836|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
1680117|NCT00567892|4102833|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
1680118|NCT00567892|4102834|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
1680119|NCT00567892|4102835|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
1680120|NCT00567892|4102836|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
1680121|NCT00567892|4102833|P4|NOT COMPLETED|Washout (2 Weeks)||0
1680122|NCT00567892|4102834|P3|NOT COMPLETED|Washout (2 Weeks)||0
1680123|NCT00567892|4102835|P2|NOT COMPLETED|Washout (2 Weeks)||0
1680124|NCT00567892|4102836|P1|NOT COMPLETED|Washout (2 Weeks)||0
1680125|NCT00567892|4102833|P4|COMPLETED|Washout (2 Weeks)||6
1680126|NCT00567892|4102834|P3|COMPLETED|Washout (2 Weeks)||9
1680127|NCT00567892|4102835|P2|COMPLETED|Washout (2 Weeks)||7
1680128|NCT00567892|4102836|P1|COMPLETED|Washout (2 Weeks)||7
1680129|NCT00567892|4102833|P4|STARTED|Washout (2 Weeks)||6
1680130|NCT00567892|4102834|P3|STARTED|Washout (2 Weeks)||9
1680131|NCT00567892|4102835|P2|STARTED|Washout (2 Weeks)||7
1680132|NCT00567892|4102836|P1|STARTED|Washout (2 Weeks)||7
1680133|NCT00567892|4102833|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
1680134|NCT00567892|4102834|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
1680135|NCT00567892|4102835|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
1680136|NCT00567892|4102836|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
1680137|NCT00567892|4102833|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
1680138|NCT00567892|4102834|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
1680139|NCT00567892|4102835|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
1680140|NCT00567892|4102836|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
1680141|NCT00567892|4102833|P4|STARTED|First Treatment (2 or 4 Weeks)||10
1680142|NCT00567892|4102834|P3|STARTED|First Treatment (2 or 4 Weeks)||10
1680143|NCT00567892|4102835|P2|STARTED|First Treatment (2 or 4 Weeks)||7
1680144|NCT00567892|4102836|P1|STARTED|First Treatment (2 or 4 Weeks)||7
1680145|NCT00567879|4102854|P6|NOT COMPLETED|Overall Study||3
1680146|NCT00567879|4102855|P5|NOT COMPLETED|Overall Study||12
1680147|NCT00567879|4102856|P4|NOT COMPLETED|Overall Study||6
1680148|NCT00567879|4102857|P3|NOT COMPLETED|Overall Study||21
1680149|NCT00567879|4102858|P2|NOT COMPLETED|Overall Study||7
1680150|NCT00567879|4102859|P1|NOT COMPLETED|Overall Study||7
1680151|NCT00567879|4102854|P6|COMPLETED|Overall Study||0
1680152|NCT00567879|4102855|P5|COMPLETED|Overall Study||0
1680153|NCT00567879|4102856|P4|COMPLETED|Overall Study||0
1680154|NCT00567879|4102857|P3|COMPLETED|Overall Study||0
1680155|NCT00567879|4102858|P2|COMPLETED|Overall Study||0
1680156|NCT00567879|4102859|P1|COMPLETED|Overall Study||0
1680157|NCT00567879|4102854|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
1680158|NCT00567879|4102855|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
1680159|NCT00567879|4102856|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
1680160|NCT00567879|4102857|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
1680161|NCT00567879|4102858|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
1680162|NCT00567879|4102859|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
1680163|NCT00567879|4102854|P6|STARTED|Overall Study||3
1680164|NCT00567879|4102855|P5|STARTED|Overall Study||12
1680165|NCT00567879|4102856|P4|STARTED|Overall Study||6
1680166|NCT00567879|4102857|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
1680167|NCT00567879|4102858|P2|STARTED|Overall Study||7
1680168|NCT00567879|4102859|P1|STARTED|Overall Study||7
1680169|NCT00567840|4102885|P5|NOT COMPLETED|Overall Study||0
1680170|NCT00567840|4102886|P4|NOT COMPLETED|Overall Study||1
1680171|NCT00567840|4102887|P3|NOT COMPLETED|Overall Study||1
1680172|NCT00567840|4102888|P2|NOT COMPLETED|Overall Study||0
1680173|NCT00567840|4102889|P1|NOT COMPLETED|Overall Study||2
1680174|NCT00567840|4102885|P5|COMPLETED|Overall Study||8
1680175|NCT00567840|4102886|P4|COMPLETED|Overall Study||14
1680176|NCT00567840|4102887|P3|COMPLETED|Overall Study||15
1680177|NCT00567840|4102888|P2|COMPLETED|Overall Study||15
1680178|NCT00567840|4102889|P1|COMPLETED|Overall Study||13
1680179|NCT00567840|4102885|P5|STARTED|Overall Study||8
1680180|NCT00567840|4102886|P4|STARTED|Overall Study||15
1680181|NCT00567840|4102887|P3|STARTED|Overall Study||16
1680182|NCT00567840|4102888|P2|STARTED|Overall Study||15
1680183|NCT00567840|4102889|P1|STARTED|Overall Study||15
1680184|NCT00567593|4102926|P1|NOT COMPLETED|Overall Study||2
1680185|NCT00567593|4102926|P1|COMPLETED|Overall Study||10
1680186|NCT00567593|4102926|P1|STARTED|Overall Study||12
1680187|NCT00567567|4102933|P3|NOT COMPLETED|Overall Study||278
1680188|NCT00567567|4102934|P2|NOT COMPLETED|Overall Study||134
1680189|NCT00567567|4102935|P1|NOT COMPLETED|Overall Study||152
1680190|NCT00567567|4102933|P3|COMPLETED|Overall Study||1
1680191|NCT00567567|4102934|P2|COMPLETED|Overall Study||42
1680192|NCT00567567|4102935|P1|COMPLETED|Overall Study||58
1680193|NCT00567567|4102933|P3|STARTED|Overall Study||279
1680194|NCT00567567|4102934|P2|STARTED|Overall Study||176
1680195|NCT00567567|4102935|P1|STARTED|Overall Study||210
1680196|NCT00567541|4102961|P2|NOT COMPLETED|Overall Study||1
1680197|NCT00567541|4102962|P1|NOT COMPLETED|Overall Study||0
1680198|NCT00567541|4102961|P2|COMPLETED|Overall Study||8
1680199|NCT00567541|4102962|P1|COMPLETED|Overall Study||7
1680200|NCT00567541|4102961|P2|STARTED|Overall Study||9
1680201|NCT00567541|4102962|P1|STARTED|Overall Study||7
1680202|NCT00567502|4102972|P4|NOT COMPLETED|Overall Study||87
1680203|NCT00567502|4102973|P3|NOT COMPLETED|Overall Study||908
1680204|NCT00567502|4102974|P2|NOT COMPLETED|Overall Study||33
1680205|NCT00567502|4102975|P1|NOT COMPLETED|Overall Study||241
1680206|NCT00567502|4102972|P4|COMPLETED|Overall Study||23
1680207|NCT00567502|4102973|P3|COMPLETED|Overall Study||1758
1680208|NCT00567502|4102974|P2|COMPLETED|Overall Study||108
1680209|NCT00567502|4102975|P1|COMPLETED|Overall Study||563
1680210|NCT00567502|4102972|P4|Initiated Treatment|Overall Study||38
1680211|NCT00567502|4102973|P3|Initiated Treatment|Overall Study||2666
1680212|NCT00567502|4102974|P2|Initiated Treatment|Overall Study||141
1680213|NCT00567502|4102975|P1|Initiated Treatment|Overall Study||804
1680214|NCT00567502|4102972|P4|STARTED|Overall Study||110
1680215|NCT00567502|4102973|P3|STARTED|Overall Study||2666
1680216|NCT00567502|4102974|P2|STARTED|Overall Study||141
1680217|NCT00567502|4102975|P1|STARTED|Overall Study||804
1680218|NCT00567476|4103012|P2|NOT COMPLETED|Overall Study||4
1680219|NCT00567476|4103013|P1|NOT COMPLETED|Overall Study||8
1680220|NCT00567476|4103012|P2|COMPLETED|Overall Study||34
1680221|NCT00567476|4103013|P1|COMPLETED|Overall Study||70
1680222|NCT00567476|4103012|P2|STARTED|Overall Study||38
1680223|NCT00567476|4103013|P1|STARTED|Overall Study||78
1680224|NCT00567359|4103037|P1|NOT COMPLETED|Overall Study||1
1680225|NCT00567359|4103037|P1|COMPLETED|Overall Study||99
1680226|NCT00567359|4103037|P1|STARTED|Overall Study||100
1680227|NCT00567320|4103046|P2|NOT COMPLETED|Overall Study||0
1680228|NCT00567320|4103047|P1|NOT COMPLETED|Overall Study||0
1680229|NCT00567320|4103046|P2|COMPLETED|Overall Study||18
1680230|NCT00567320|4103047|P1|COMPLETED|Overall Study||13
1680231|NCT00567320|4103046|P2|STARTED|Overall Study||18
1680232|NCT00567320|4103047|P1|STARTED|Overall Study||13
1680233|NCT00567307|4103055|P2|NOT COMPLETED|Overall Study||1
1680234|NCT00567307|4103056|P1|NOT COMPLETED|Overall Study||12
1680235|NCT00567307|4103055|P2|COMPLETED|Overall Study||104
1680236|NCT00567307|4103056|P1|COMPLETED|Overall Study||99
1680237|NCT00567307|4103055|P2|STARTED|Overall Study||105
1680238|NCT00567307|4103056|P1|STARTED|Overall Study||111
1680239|NCT00567268|4103062|P1|NOT COMPLETED|Overall Study||50
1680240|NCT00567268|4103062|P1|COMPLETED|Overall Study||1144
1680241|NCT00567268|4103062|P1|STARTED|Overall Study||1194
1680242|NCT00567255|4103113|P2|NOT COMPLETED|Overall Study||228
1680243|NCT00567255|4103114|P1|NOT COMPLETED|Overall Study||463
1680244|NCT00567255|4103113|P2|COMPLETED|Overall Study||267
1680245|NCT00567255|4103114|P1|COMPLETED|Overall Study||538
1680246|NCT00567255|4103113|P2|STARTED|Overall Study||495
1680247|NCT00567255|4103114|P1|STARTED|Overall Study||1001
1680248|NCT00567242|4103160|P2|NOT COMPLETED|Overall Study||0
1680249|NCT00567242|4103161|P1|NOT COMPLETED|Overall Study||0
1680250|NCT00567242|4103160|P2|COMPLETED|Overall Study||7
1680251|NCT00567242|4103161|P1|COMPLETED|Overall Study||7
1680252|NCT00567242|4103160|P2|STARTED|Overall Study||7
1680253|NCT00567242|4103161|P1|STARTED|Overall Study||7
1680254|NCT00567229|4103171|P1|NOT COMPLETED|Overall Study||0
1680255|NCT00567229|4103171|P1|COMPLETED|Overall Study||3
1680256|NCT00567229|4103171|P1|STARTED|Overall Study||3
1680257|NCT00567190|4103177|P2|NOT COMPLETED|Overall Study||264
1680258|NCT00567190|4103178|P1|NOT COMPLETED|Overall Study||210
1680259|NCT00567190|4103177|P2|COMPLETED|Overall Study|On 11 February 2014, 37 were alive and on study treatment; 105 were alive and in survival follow-up|142
1680260|NCT00567190|4103178|P1|COMPLETED|Overall Study|On 11 February 2014, 67 were alive and on study treatment; 125 were alive and in survival follow-up|192
1680261|NCT00567190|4103177|P2|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|406
1680262|NCT00567190|4103178|P1|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|402
1680263|NCT00567164|4103198|P3|NOT COMPLETED|Overall Study||72
1680264|NCT00567164|4103199|P2|NOT COMPLETED|Overall Study||73
1680265|NCT00567164|4103200|P1|NOT COMPLETED|Overall Study||546
1680266|NCT00567164|4103198|P3|COMPLETED|Overall Study||160
1680267|NCT00567164|4103199|P2|COMPLETED|Overall Study||161
1680268|NCT00567164|4103200|P1|COMPLETED|Overall Study||875
1680269|NCT00567164|4103198|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
1680270|NCT00567164|4103199|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
1680271|NCT00567164|4103200|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
1680272|NCT00567164|4103198|P3|STARTED|Overall Study||232
1680273|NCT00567164|4103199|P2|STARTED|Overall Study||234
1680274|NCT00567164|4103200|P1|STARTED|Overall Study||1421
1680275|NCT00567112|4103272|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1680276|NCT00567112|4103273|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1680277|NCT00567112|4103274|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1680278|NCT00567112|4103272|P3|COMPLETED|Treatment Period 4 (3 Days)||3
1680279|NCT00567112|4103273|P2|COMPLETED|Treatment Period 4 (3 Days)||7
1680280|NCT00567112|4103274|P1|COMPLETED|Treatment Period 4 (3 Days)||4
1680281|NCT00567112|4103272|P3|STARTED|Treatment Period 4 (3 Days)||3
1680282|NCT00567112|4103273|P2|STARTED|Treatment Period 4 (3 Days)||7
1680283|NCT00567112|4103274|P1|STARTED|Treatment Period 4 (3 Days)||4
1680284|NCT00567112|4103272|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
1680285|NCT00567112|4103273|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
1680286|NCT00567112|4103274|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
1680287|NCT00567112|4103272|P3|COMPLETED|Washout Period 3 (3 Days)||3
1680288|NCT00567112|4103273|P2|COMPLETED|Washout Period 3 (3 Days)||7
1680289|NCT00567112|4103274|P1|COMPLETED|Washout Period 3 (3 Days)||4
1680290|NCT00567112|4103272|P3|STARTED|Washout Period 3 (3 Days)||3
1680291|NCT00567112|4103273|P2|STARTED|Washout Period 3 (3 Days)||7
1680292|NCT00567112|4103274|P1|STARTED|Washout Period 3 (3 Days)||7
1680293|NCT00567112|4103272|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1680294|NCT00567112|4103273|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1680295|NCT00567112|4103274|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1680296|NCT00567112|4103272|P3|COMPLETED|Treatment Period 3 (3 Days)||3
1680297|NCT00567112|4103273|P2|COMPLETED|Treatment Period 3 (3 Days)||7
1680298|NCT00567112|4103274|P1|COMPLETED|Treatment Period 3 (3 Days)||7
1680299|NCT00567112|4103272|P3|STARTED|Treatment Period 3 (3 Days)||3
1680300|NCT00567112|4103273|P2|STARTED|Treatment Period 3 (3 Days)||7
1680301|NCT00567112|4103274|P1|STARTED|Treatment Period 3 (3 Days)||7
1680302|NCT00567112|4103272|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
1680303|NCT00567112|4103273|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
1680304|NCT00567112|4103274|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
1680305|NCT00567112|4103272|P3|COMPLETED|Washout Period 2 (3 Days)||3
1680306|NCT00567112|4103273|P2|COMPLETED|Washout Period 2 (3 Days)||7
1680307|NCT00567112|4103274|P1|COMPLETED|Washout Period 2 (3 Days)||7
1680308|NCT00567112|4103272|P3|STARTED|Washout Period 2 (3 Days)||3
1680309|NCT00567112|4103273|P2|STARTED|Washout Period 2 (3 Days)||7
1680310|NCT00567112|4103274|P1|STARTED|Washout Period 2 (3 Days)||7
1680311|NCT00567112|4103272|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1680312|NCT00567112|4103273|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
1680313|NCT00567112|4103274|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1680314|NCT00567112|4103272|P3|COMPLETED|Treatment Period 2 (3 Days)||3
1680315|NCT00567112|4103273|P2|COMPLETED|Treatment Period 2 (3 Days)||7
1680316|NCT00567112|4103274|P1|COMPLETED|Treatment Period 2 (3 Days)||7
1680317|NCT00567112|4103272|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
1680318|NCT00567112|4103273|P2|STARTED|Treatment Period 2 (3 Days)||8
1680319|NCT00567112|4103274|P1|STARTED|Treatment Period 2 (3 Days)||7
1680320|NCT00567112|4103272|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
1680321|NCT00567112|4103273|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
1680322|NCT00567112|4103274|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
1680323|NCT00567112|4103272|P3|COMPLETED|Washout Period 1 (3 Days)||0
1680324|NCT00567112|4103273|P2|COMPLETED|Washout Period 1 (3 Days)||8
1680325|NCT00567112|4103274|P1|COMPLETED|Washout Period 1 (3 Days)||7
1680326|NCT00567112|4103272|P3|STARTED|Washout Period 1 (3 Days)||0
1680327|NCT00567112|4103273|P2|STARTED|Washout Period 1 (3 Days)||8
1680328|NCT00567112|4103274|P1|STARTED|Washout Period 1 (3 Days)||7
1680329|NCT00567112|4103272|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1680330|NCT00567112|4103273|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1680331|NCT00567112|4103274|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1680332|NCT00567112|4103272|P3|COMPLETED|Treatment Period 1 (3 Days)||0
1680333|NCT00567112|4103273|P2|COMPLETED|Treatment Period 1 (3 Days)||8
1680334|NCT00567112|4103274|P1|COMPLETED|Treatment Period 1 (3 Days)||7
1680335|NCT00567112|4103272|P3|STARTED|Treatment Period 1 (3 Days)||0
1680336|NCT00567112|4103273|P2|STARTED|Treatment Period 1 (3 Days)||8
1680337|NCT00567112|4103274|P1|STARTED|Treatment Period 1 (3 Days)||7
1680338|NCT00567008|4103298|P2|NOT COMPLETED|Overall Study||1
1680339|NCT00567008|4103299|P1|NOT COMPLETED|Overall Study||1
1680340|NCT00567008|4103298|P2|COMPLETED|Overall Study||18
1680341|NCT00567008|4103299|P1|COMPLETED|Overall Study||17
1680342|NCT00567008|4103298|P2|STARTED|Overall Study||19
1680343|NCT00567008|4103299|P1|STARTED|Overall Study||18
1680344|NCT00566995|4103305|P1|NOT COMPLETED|Overall Study||7
1680345|NCT00566995|4103305|P1|COMPLETED|Overall Study||30
1680346|NCT00566995|4103305|P1|STARTED|Overall Study||37
1680347|NCT00566982|4103320|P2|NOT COMPLETED|Overall Study||69
1680348|NCT00566982|4103321|P1|NOT COMPLETED|Overall Study||8
1680349|NCT00566982|4103320|P2|COMPLETED|Overall Study||294
1680350|NCT00566982|4103321|P1|COMPLETED|Overall Study||55
1680351|NCT00566982|4103320|P2|STARTED|Overall Study||363
1680352|NCT00566982|4103321|P1|STARTED|Overall Study||63
1680353|NCT00566969|4103346|P3|NOT COMPLETED|Overall Study||12
1680354|NCT00566969|4103347|P2|NOT COMPLETED|Overall Study||9
1680355|NCT00566969|4103348|P1|NOT COMPLETED|Overall Study||15
1680356|NCT00566969|4103346|P3|COMPLETED|Overall Study||23
1680357|NCT00566969|4103347|P2|COMPLETED|Overall Study||28
1680358|NCT00566969|4103348|P1|COMPLETED|Overall Study||19
1680359|NCT00566969|4103346|P3|STARTED|Overall Study||35
1680360|NCT00566969|4103347|P2|STARTED|Overall Study||37
1680361|NCT00566969|4103348|P1|STARTED|Overall Study||34
1680362|NCT00566943|4103358|P2|NOT COMPLETED|Overall Study||0
1680363|NCT00566943|4103359|P1|NOT COMPLETED|Overall Study||0
1680364|NCT00566943|4103358|P2|COMPLETED|Overall Study||49
1680365|NCT00566943|4103359|P1|COMPLETED|Overall Study||52
1680366|NCT00566943|4103358|P2|STARTED|Overall Study||49
1680367|NCT00566943|4103359|P1|STARTED|Overall Study||52
1680368|NCT00566930|4103374|P3|NOT COMPLETED|Overall Study||1
1680369|NCT00566930|4103375|P2|NOT COMPLETED|Overall Study||4
1680370|NCT00566930|4103376|P1|NOT COMPLETED|Overall Study||2
1680371|NCT00566930|4103374|P3|COMPLETED|Overall Study||32
1680372|NCT00566930|4103375|P2|COMPLETED|Overall Study||32
1680373|NCT00566930|4103376|P1|COMPLETED|Overall Study||27
1680374|NCT00566930|4103374|P3|STARTED|Overall Study||33
1680375|NCT00566930|4103375|P2|STARTED|Overall Study||36
1680376|NCT00566930|4103376|P1|STARTED|Overall Study||29
1680377|NCT00566852|4103386|P2|NOT COMPLETED|Overall Study||198
1680378|NCT00566852|4103387|P1|NOT COMPLETED|Overall Study||207
1680379|NCT00566852|4103386|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
1680380|NCT00566852|4103387|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
1680381|NCT00566852|4103386|P2|STARTED|Overall Study||276
1680382|NCT00566852|4103387|P1|STARTED|Overall Study||278
1680383|NCT00566813|4103405|P2|NOT COMPLETED|Overall Study||0
1680384|NCT00566813|4103406|P1|NOT COMPLETED|Overall Study||0
1680385|NCT00566813|4103405|P2|COMPLETED|Overall Study||6
1680386|NCT00566813|4103406|P1|COMPLETED|Overall Study||4
1680387|NCT00566813|4103405|P2|STARTED|Overall Study||6
1680388|NCT00566813|4103406|P1|STARTED|Overall Study||4
1680389|NCT00566735|4103418|P2|NOT COMPLETED|Overall Study||7
1680390|NCT00566735|4103419|P1|NOT COMPLETED|Overall Study||2
1680391|NCT00566735|4103418|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
1680392|NCT00566735|4103419|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
1680393|NCT00566735|4103418|P2|Withdrew Before Baseline Measures|Overall Study||7
1680394|NCT00566735|4103419|P1|Withdrew Before Baseline Measures|Overall Study||2
1680395|NCT00566735|4103418|P2|STARTED|Overall Study||19
1680396|NCT00566735|4103419|P1|STARTED|Overall Study||20
1680397|NCT00566722|4103432|P3|NOT COMPLETED|Overall Study||9
1680398|NCT00566722|4103433|P2|NOT COMPLETED|Overall Study||5
1680399|NCT00566722|4103434|P1|NOT COMPLETED|Overall Study||2
1680400|NCT00566722|4103432|P3|COMPLETED|Overall Study||73
1680401|NCT00566722|4103433|P2|COMPLETED|Overall Study||24
1680402|NCT00566722|4103434|P1|COMPLETED|Overall Study||39
1680403|NCT00566722|4103432|P3|STARTED|Overall Study||82
1680404|NCT00566722|4103433|P2|STARTED|Overall Study||29
1680405|NCT00566722|4103434|P1|STARTED|Overall Study||41
1680406|NCT00566709|4103480|P2|NOT COMPLETED|Overall Study||0
1680407|NCT00566709|4103481|P1|NOT COMPLETED|Overall Study||5
1680408|NCT00566709|4103480|P2|COMPLETED|Overall Study||51
1680409|NCT00566709|4103481|P1|COMPLETED|Overall Study||46
1680410|NCT00566709|4103480|P2|STARTED|Overall Study||51
1680411|NCT00566709|4103481|P1|STARTED|Overall Study||51
1680412|NCT00566696|4103497|P1|NOT COMPLETED|Overall Study||42
1680413|NCT00566696|4103497|P1|COMPLETED|Overall Study||31
1680414|NCT00566696|4103497|P1|STARTED|Overall Study||73
1680415|NCT00566631|4103505|P1|NOT COMPLETED|Part 2: Extension Phase||82
1680416|NCT00566631|4103505|P1|COMPLETED|Part 2: Extension Phase||57
1680417|NCT00566631|4103505|P1|STARTED|Part 2: Extension Phase||139
1680418|NCT00566631|4103505|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
1680419|NCT00566631|4103505|P1|COMPLETED|Between Treatment and Extension Phase||139
1680420|NCT00566631|4103505|P1|STARTED|Between Treatment and Extension Phase||234
1680421|NCT00566631|4103505|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
1680422|NCT00566631|4103505|P1|COMPLETED|Part 1: Core Treatment Phase||234
1680423|NCT00566631|4103505|P1|STARTED|Part 1: Core Treatment Phase||294
1680424|NCT00566579|4103522|P2|NOT COMPLETED|Overall Study||0
1680425|NCT00566579|4103523|P1|NOT COMPLETED|Overall Study||0
1680426|NCT00566579|4103522|P2|COMPLETED|Overall Study||31
1680427|NCT00566579|4103523|P1|COMPLETED|Overall Study||29
1680428|NCT00566579|4103522|P2|STARTED|Overall Study||31
1680429|NCT00566579|4103523|P1|STARTED|Overall Study||29
1680430|NCT00566527|4103532|P3|NOT COMPLETED|Overall Study||78
1680431|NCT00566527|4103533|P2|NOT COMPLETED|Overall Study||66
1680432|NCT00566527|4103534|P1|NOT COMPLETED|Overall Study||17
1680433|NCT00566527|4103532|P3|COMPLETED|Overall Study||461
1680434|NCT00566527|4103533|P2|COMPLETED|Overall Study||474
1680435|NCT00566527|4103534|P1|COMPLETED|Overall Study||524
1680436|NCT00566527|4103532|P3|Received ProQuad® Dose 2|Overall Study||462
1680437|NCT00566527|4103533|P2|Received ProQuad® Dose 2|Overall Study||478
1680438|NCT00566527|4103534|P1|Received ProQuad® Dose 2|Overall Study||525
1680439|NCT00566527|4103532|P3|Received ProQuad® Dose 1|Overall Study||470
1680440|NCT00566527|4103533|P2|Received ProQuad® Dose 1|Overall Study||484
1680441|NCT00566527|4103534|P1|Received ProQuad® Dose 1|Overall Study||529
1680442|NCT00566527|4103532|P3|STARTED|Overall Study|Number randomized.|539
1680443|NCT00566527|4103533|P2|STARTED|Overall Study|Number randomized.|540
1680444|NCT00566527|4103534|P1|STARTED|Overall Study|Number randomized.|541
1680445|NCT00566501|4103575|P2|NOT COMPLETED|Overall Study||126
1680446|NCT00566501|4103576|P1|NOT COMPLETED|Overall Study||156
1680447|NCT00566501|4103575|P2|COMPLETED|Overall Study||210
1680448|NCT00566501|4103576|P1|COMPLETED|Overall Study||423
1680449|NCT00566501|4103575|P2|Not Determined|Overall Study||0
1680450|NCT00566501|4103576|P1|Not Determined|Overall Study||1
1680451|NCT00566501|4103575|P2|Other ( Not Specified)|Overall Study||21
1680452|NCT00566501|4103576|P1|Other ( Not Specified)|Overall Study||24
1680453|NCT00566501|4103575|P2|Medication Non-compliance|Overall Study||0
1680454|NCT00566501|4103576|P1|Medication Non-compliance|Overall Study||5
1680455|NCT00566501|4103575|P2|Protocol Violation|Overall Study||2
1680456|NCT00566501|4103576|P1|Protocol Violation|Overall Study||2
1680457|NCT00566501|4103575|P2|Request of Investigator or Sponsor|Overall Study||7
1680458|NCT00566501|4103576|P1|Request of Investigator or Sponsor|Overall Study||6
1680459|NCT00566501|4103575|P2|Withdraw of Consent by Subject|Overall Study||30
1680460|NCT00566501|4103576|P1|Withdraw of Consent by Subject|Overall Study||33
1680461|NCT00566501|4103575|P2|Lack of Efficacy|Overall Study||3
1680462|NCT00566501|4103576|P1|Lack of Efficacy|Overall Study||8
1680463|NCT00566501|4103575|P2|Adverse Event|Overall Study||59
1680464|NCT00566501|4103576|P1|Adverse Event|Overall Study||68
1680465|NCT00566501|4103575|P2|Discontinued|Overall Study||122
1680466|NCT00566501|4103576|P1|Discontinued|Overall Study||146
1680467|NCT00566501|4103575|P2|Safety Population|Overall Study||332
1680468|NCT00566501|4103576|P1|Safety Population|Overall Study||570
1680469|NCT00566501|4103575|P2|STARTED|Overall Study||336
1680470|NCT00566501|4103576|P1|STARTED|Overall Study||579
1680471|NCT00566462|4103584|P2|NOT COMPLETED|Overall Study||0
1680472|NCT00566462|4103585|P1|NOT COMPLETED|Overall Study||0
1680473|NCT00566462|4103584|P2|COMPLETED|Overall Study||0
1680474|NCT00566462|4103585|P1|COMPLETED|Overall Study||1
1680475|NCT00566462|4103584|P2|STARTED|Overall Study||0
1680476|NCT00566462|4103585|P1|STARTED|Overall Study||1
1680477|NCT00566254|4103595|P2|NOT COMPLETED|Overall Study||14
1680478|NCT00566254|4103596|P1|NOT COMPLETED|Overall Study||10
1680479|NCT00566254|4103595|P2|COMPLETED|Overall Study||93
1680480|NCT00566254|4103596|P1|COMPLETED|Overall Study||90
1680481|NCT00566254|4103595|P2|STARTED|Overall Study||107
1680482|NCT00566254|4103596|P1|STARTED|Overall Study||100
1680483|NCT00566228|4103610|P2|NOT COMPLETED|Overall Study||5
1680484|NCT00566228|4103611|P1|NOT COMPLETED|Overall Study||6
1680485|NCT00566228|4103610|P2|COMPLETED|Overall Study||55
1680486|NCT00566228|4103611|P1|COMPLETED|Overall Study||56
1680487|NCT00566228|4103610|P2|STARTED|Overall Study||60
1680488|NCT00566228|4103611|P1|STARTED|Overall Study||62
1680489|NCT00566150|4103629|P2|NOT COMPLETED|Overall Study||5
1680490|NCT00566150|4103630|P1|NOT COMPLETED|Overall Study||9
1680491|NCT00566150|4103629|P2|COMPLETED|Overall Study||11
1680492|NCT00566150|4103630|P1|COMPLETED|Overall Study||10
1680493|NCT00566150|4103629|P2|STARTED|Overall Study||16
1680494|NCT00566150|4103630|P1|STARTED|Overall Study||19
1680495|NCT00566111|4103644|P2|NOT COMPLETED|Overall Study||2
1680496|NCT00566111|4103645|P1|NOT COMPLETED|Overall Study||0
1680497|NCT00566111|4103644|P2|COMPLETED|Overall Study||1
1680498|NCT00566111|4103645|P1|COMPLETED|Overall Study||2
1680499|NCT00566111|4103644|P2|STARTED|Overall Study||3
1680500|NCT00566111|4103645|P1|STARTED|Overall Study||2
1680501|NCT00566098|4103659|P1|NOT COMPLETED|Administration of ASCT+MILs||18
1680502|NCT00566098|4103659|P1|COMPLETED|Administration of ASCT+MILs||4
1680503|NCT00566098|4103659|P1|STARTED|Administration of ASCT+MILs||22
1680504|NCT00566098|4103659|P1|NOT COMPLETED|Generation of MILs Product||1
1680505|NCT00566098|4103659|P1|COMPLETED|Generation of MILs Product||22
1680506|NCT00566098|4103659|P1|STARTED|Generation of MILs Product||23
1680507|NCT00566098|4103659|P1|NOT COMPLETED|Collection of MILs||2
1680508|NCT00566098|4103659|P1|COMPLETED|Collection of MILs||23
1680509|NCT00566098|4103659|P1|STARTED|Collection of MILs||25
1680510|NCT00566020|4103669|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
1680511|NCT00566020|4103670|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
1680512|NCT00566020|4103669|P2|COMPLETED|46-week Long-term Administration Phase||68
1680513|NCT00566020|4103670|P1|COMPLETED|46-week Long-term Administration Phase||0
1680514|NCT00566020|4103669|P2|STARTED|46-week Long-term Administration Phase||85
1680515|NCT00566020|4103670|P1|STARTED|46-week Long-term Administration Phase||0
1680516|NCT00566020|4103669|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
1680517|NCT00566020|4103670|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
1680518|NCT00566020|4103669|P2|COMPLETED|6-week Dosage Adjustment Phase||0
1680519|NCT00566020|4103670|P1|COMPLETED|6-week Dosage Adjustment Phase||85
1680520|NCT00566020|4103669|P2|STARTED|6-week Dosage Adjustment Phase||0
1680521|NCT00566020|4103670|P1|STARTED|6-week Dosage Adjustment Phase||92
1680522|NCT00565916|4103697|P2|NOT COMPLETED|Overall Study||0
1680523|NCT00565916|4103698|P1|NOT COMPLETED|Overall Study||0
1680524|NCT00565916|4103697|P2|COMPLETED|Overall Study||11
1680525|NCT00565916|4103698|P1|COMPLETED|Overall Study||11
1680526|NCT00565916|4103697|P2|STARTED|Overall Study||11
1680527|NCT00565916|4103698|P1|STARTED|Overall Study||11
1680528|NCT00565864|4103707|P3|NOT COMPLETED|Overall Study||11
1680529|NCT00565864|4103708|P2|NOT COMPLETED|Overall Study||12
1680530|NCT00565864|4103709|P1|NOT COMPLETED|Overall Study||12
1680531|NCT00565864|4103707|P3|COMPLETED|Overall Study||45
1680532|NCT00565864|4103708|P2|COMPLETED|Overall Study||47
1680533|NCT00565864|4103709|P1|COMPLETED|Overall Study||46
1680534|NCT00565864|4103707|P3|STARTED|Overall Study||56
1680535|NCT00565864|4103708|P2|STARTED|Overall Study||59
1680536|NCT00565864|4103709|P1|STARTED|Overall Study||58
1680537|NCT00565812|4103759|P3|NOT COMPLETED|Overall Study||130
1680538|NCT00565812|4103760|P2|NOT COMPLETED|Overall Study||135
1680539|NCT00565812|4103761|P1|NOT COMPLETED|Overall Study||144
1680540|NCT00565812|4103759|P3|COMPLETED|Overall Study||356
1680541|NCT00565812|4103760|P2|COMPLETED|Overall Study||351
1680542|NCT00565812|4103761|P1|COMPLETED|Overall Study||341
1680543|NCT00565812|4103759|P3|STARTED|Overall Study||486
1680544|NCT00565812|4103760|P2|STARTED|Overall Study||486
1680545|NCT00565812|4103761|P1|STARTED|Overall Study||485
1680546|NCT00565747|4103900|P2|NOT COMPLETED|Overall Study||73
1680547|NCT00565747|4103901|P1|NOT COMPLETED|Overall Study||67
1680548|NCT00565747|4103900|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
1680549|NCT00565747|4103901|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
1680550|NCT00565747|4103900|P2|STARTED|Overall Study||678
1680551|NCT00565747|4103901|P1|STARTED|Overall Study||654
1680552|NCT00565721|4103911|P1|NOT COMPLETED|Overall Study||17
1680553|NCT00565721|4103911|P1|COMPLETED|Overall Study||16
1680554|NCT00565721|4103911|P1|STARTED|Overall Study||33
1680555|NCT00565669|4103932|P2|NOT COMPLETED|Overall Study||0
1680556|NCT00565669|4103933|P1|NOT COMPLETED|Overall Study||0
1680557|NCT00565669|4103932|P2|COMPLETED|Overall Study||9
1680558|NCT00565669|4103933|P1|COMPLETED|Overall Study||11
1680559|NCT00565669|4103932|P2|STARTED|Overall Study||9
1680560|NCT00565669|4103933|P1|STARTED|Overall Study||11
1680561|NCT00565643|4103941|P2|NOT COMPLETED|Overall Study||0
1680562|NCT00565643|4103942|P1|NOT COMPLETED|Overall Study||0
1680563|NCT00565643|4103941|P2|COMPLETED|Overall Study||373
1680564|NCT00565643|4103942|P1|COMPLETED|Overall Study||380
1680565|NCT00565643|4103941|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
1680566|NCT00565643|4103942|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
1680567|NCT00565643|4103941|P2|Safety Data|Overall Study||373
1680568|NCT00565643|4103942|P1|Safety Data|Overall Study||380
1680569|NCT00565643|4103941|P2|STARTED|Overall Study||373
1680570|NCT00565643|4103942|P1|STARTED|Overall Study||380
1680571|NCT00565617|4103960|P1|NOT COMPLETED|Overall Study||1
1680572|NCT00565617|4103960|P1|COMPLETED|Overall Study||5
1680573|NCT00565617|4103960|P1|STARTED|Overall Study||6
1680574|NCT00565604|4103964|P1|NOT COMPLETED|Overall Study||4
1680575|NCT00565604|4103964|P1|COMPLETED|Overall Study||39
1680576|NCT00565604|4103964|P1|6 Month|Overall Study||39
1680577|NCT00565604|4103964|P1|6 Week|Overall Study||39
1680578|NCT00565604|4103964|P1|2 Week|Overall Study||41
1680579|NCT00565604|4103964|P1|7 Day|Overall Study||41
1680580|NCT00565604|4103964|P1|STARTED|Overall Study||43
1680581|NCT00565461|4103975|P4|NOT COMPLETED|Overall Study||3
1680582|NCT00565461|4103976|P3|NOT COMPLETED|Overall Study||1
1680583|NCT00565461|4103977|P2|NOT COMPLETED|Overall Study||1
1680584|NCT00565461|4103978|P1|NOT COMPLETED|Overall Study||0
1680585|NCT00565461|4103975|P4|COMPLETED|Overall Study||37
1680586|NCT00565461|4103976|P3|COMPLETED|Overall Study||39
1680587|NCT00565461|4103977|P2|COMPLETED|Overall Study||39
1680588|NCT00565461|4103978|P1|COMPLETED|Overall Study||40
1680589|NCT00565461|4103975|P4|STARTED|Overall Study||40
1680590|NCT00565461|4103976|P3|STARTED|Overall Study||40
1680591|NCT00565461|4103977|P2|STARTED|Overall Study||40
1680592|NCT00565461|4103978|P1|STARTED|Overall Study||40
1680593|NCT00565448|4103992|P2|NOT COMPLETED|Overall Study||2
1680594|NCT00565448|4103993|P1|NOT COMPLETED|Overall Study||3
1680595|NCT00565448|4103992|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
1680596|NCT00565448|4103993|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
1680597|NCT00565448|4103992|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
1680598|NCT00565448|4103993|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
1680599|NCT00565409|4104004|P4|NOT COMPLETED|Period 2 Double-Blind||59
1680600|NCT00565409|4104005|P3|NOT COMPLETED|Period 2 Double-Blind||27
1680601|NCT00565409|4104006|P2|NOT COMPLETED|Period 2 Double-Blind||21
1680602|NCT00565409|4104007|P1|NOT COMPLETED|Period 2 Double-Blind||0
1680603|NCT00565409|4104004|P4|COMPLETED|Period 2 Double-Blind||141
1680604|NCT00565409|4104005|P3|COMPLETED|Period 2 Double-Blind||175
1680605|NCT00565409|4104006|P2|COMPLETED|Period 2 Double-Blind||181
1680606|NCT00565409|4104007|P1|COMPLETED|Period 2 Double-Blind||0
1680607|NCT00565409|4104004|P4|STARTED|Period 2 Double-Blind||200
1680608|NCT00565409|4104005|P3|STARTED|Period 2 Double-Blind||202
1680609|NCT00565409|4104006|P2|STARTED|Period 2 Double-Blind||202
1680610|NCT00565409|4104007|P1|STARTED|Period 2 Double-Blind||0
1680611|NCT00565409|4104004|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
1680612|NCT00565409|4104005|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
1680613|NCT00565409|4104006|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
1680614|NCT00565409|4104007|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
1680615|NCT00565409|4104004|P4|COMPLETED|After Period 1, Prior to Period 2||0
1680616|NCT00565409|4104005|P3|COMPLETED|After Period 1, Prior to Period 2||0
1680617|NCT00565409|4104006|P2|COMPLETED|After Period 1, Prior to Period 2||0
1680618|NCT00565409|4104007|P1|COMPLETED|After Period 1, Prior to Period 2||604
1680619|NCT00565409|4104004|P4|STARTED|After Period 1, Prior to Period 2||0
1680620|NCT00565409|4104005|P3|STARTED|After Period 1, Prior to Period 2||0
1680621|NCT00565409|4104006|P2|STARTED|After Period 1, Prior to Period 2||0
1680622|NCT00565409|4104007|P1|STARTED|After Period 1, Prior to Period 2||756
1680623|NCT00565409|4104004|P4|NOT COMPLETED|Period 1 Open Label||0
1680624|NCT00565409|4104005|P3|NOT COMPLETED|Period 1 Open Label||0
1680625|NCT00565409|4104006|P2|NOT COMPLETED|Period 1 Open Label||0
1680626|NCT00565409|4104007|P1|NOT COMPLETED|Period 1 Open Label||78
1680627|NCT00565409|4104004|P4|COMPLETED|Period 1 Open Label||0
1680628|NCT00565409|4104005|P3|COMPLETED|Period 1 Open Label||0
1680629|NCT00565409|4104006|P2|COMPLETED|Period 1 Open Label||0
1680630|NCT00565409|4104007|P1|COMPLETED|Period 1 Open Label||756
1680631|NCT00565409|4104004|P4|STARTED|Period 1 Open Label||0
1680632|NCT00565409|4104005|P3|STARTED|Period 1 Open Label||0
1680633|NCT00565409|4104006|P2|STARTED|Period 1 Open Label||0
1680634|NCT00565409|4104007|P1|STARTED|Period 1 Open Label||834
1680635|NCT00565370|4104109|P1|NOT COMPLETED|Overall Study||0
1680636|NCT00565370|4104109|P1|COMPLETED|Overall Study||21
1680637|NCT00565370|4104109|P1|STARTED|Overall Study||21
1680638|NCT00565266|4104117|P1|NOT COMPLETED|Overall Study||36
1680639|NCT00565266|4104117|P1|COMPLETED|Overall Study||174
1680640|NCT00565266|4104117|P1|STARTED|Overall Study||210
1680641|NCT00565136|4104143|P1|NOT COMPLETED|Overall Study||3
1680642|NCT00565136|4104143|P1|COMPLETED|Overall Study||26
1680643|NCT00565136|4104143|P1|STARTED|Overall Study||29
1680644|NCT00565110|4104163|P2|NOT COMPLETED|Overall Study||131
1680645|NCT00565110|4104164|P1|NOT COMPLETED|Overall Study||131
1680646|NCT00565110|4104163|P2|COMPLETED|Overall Study||111
1680647|NCT00565110|4104164|P1|COMPLETED|Overall Study||99
1680648|NCT00565110|4104163|P2|12-Month|Overall Study||144
1680649|NCT00565110|4104164|P1|12-Month|Overall Study||114
1680650|NCT00565110|4104163|P2|STARTED|Overall Study||242
1680651|NCT00565110|4104164|P1|STARTED|Overall Study||230
1680652|NCT00565084|4104172|P3|NOT COMPLETED|Third Treatment Period||0
1680653|NCT00565084|4104173|P2|NOT COMPLETED|Third Treatment Period||0
1680654|NCT00565084|4104174|P1|NOT COMPLETED|Third Treatment Period||0
1680655|NCT00565084|4104172|P3|COMPLETED|Third Treatment Period||11
1680656|NCT00565084|4104173|P2|COMPLETED|Third Treatment Period||11
1680657|NCT00565084|4104174|P1|COMPLETED|Third Treatment Period||11
1680658|NCT00565084|4104172|P3|STARTED|Third Treatment Period||11
1680659|NCT00565084|4104173|P2|STARTED|Third Treatment Period||11
1680660|NCT00565084|4104174|P1|STARTED|Third Treatment Period||11
1680661|NCT00565084|4104172|P3|NOT COMPLETED|Second Treatment Period||0
1680662|NCT00565084|4104173|P2|NOT COMPLETED|Second Treatment Period||0
1680663|NCT00565084|4104174|P1|NOT COMPLETED|Second Treatment Period||0
1680664|NCT00565084|4104172|P3|COMPLETED|Second Treatment Period||11
1680665|NCT00565084|4104173|P2|COMPLETED|Second Treatment Period||11
1680666|NCT00565084|4104174|P1|COMPLETED|Second Treatment Period||11
1680667|NCT00565084|4104172|P3|STARTED|Second Treatment Period||11
1680668|NCT00565084|4104173|P2|STARTED|Second Treatment Period||11
1680669|NCT00565084|4104174|P1|STARTED|Second Treatment Period||11
1680670|NCT00565084|4104172|P3|NOT COMPLETED|First Treatment Period||0
1680671|NCT00565084|4104173|P2|NOT COMPLETED|First Treatment Period||0
1680672|NCT00565084|4104174|P1|NOT COMPLETED|First Treatment Period||0
1680673|NCT00565084|4104172|P3|COMPLETED|First Treatment Period||11
1680674|NCT00565084|4104173|P2|COMPLETED|First Treatment Period||11
1680675|NCT00565084|4104174|P1|COMPLETED|First Treatment Period||11
1680676|NCT00565084|4104172|P3|STARTED|First Treatment Period||11
1680677|NCT00565084|4104173|P2|STARTED|First Treatment Period||11
1680678|NCT00565084|4104174|P1|STARTED|First Treatment Period||11
1680679|NCT00565058|4104184|P2|NOT COMPLETED|Overall Study||0
1680680|NCT00565058|4104185|P1|NOT COMPLETED|Overall Study||1
1680681|NCT00565058|4104184|P2|COMPLETED|Overall Study||15
1680682|NCT00565058|4104185|P1|COMPLETED|Overall Study||9
1680683|NCT00565058|4104184|P2|STARTED|Overall Study||15
1680684|NCT00565058|4104185|P1|STARTED|Overall Study||10
1680685|NCT00565045|4104195|P2|NOT COMPLETED|Overall Study||3
1680686|NCT00565045|4104196|P1|NOT COMPLETED|Overall Study||1
1680687|NCT00565045|4104195|P2|COMPLETED|Overall Study||8
1680688|NCT00565045|4104196|P1|COMPLETED|Overall Study||9
1680689|NCT00565045|4104195|P2|STARTED|Overall Study||11
1680690|NCT00565045|4104196|P1|STARTED|Overall Study||10
1680691|NCT00564954|4104212|P2|NOT COMPLETED|Period 2- 1 Week||0
1680692|NCT00564954|4104213|P1|NOT COMPLETED|Period 2- 1 Week||0
1680693|NCT00564954|4104212|P2|COMPLETED|Period 2- 1 Week||42
1680694|NCT00564954|4104213|P1|COMPLETED|Period 2- 1 Week||44
1680695|NCT00564954|4104212|P2|STARTED|Period 2- 1 Week||42
1680696|NCT00564954|4104213|P1|STARTED|Period 2- 1 Week||44
1680697|NCT00564954|4104212|P2|NOT COMPLETED|Period 1- 1 Week||0
1680698|NCT00564954|4104213|P1|NOT COMPLETED|Period 1- 1 Week||0
1680699|NCT00564954|4104212|P2|COMPLETED|Period 1- 1 Week||42
1680700|NCT00564954|4104213|P1|COMPLETED|Period 1- 1 Week||44
1680701|NCT00564954|4104212|P2|STARTED|Period 1- 1 Week||42
1680702|NCT00564954|4104213|P1|STARTED|Period 1- 1 Week||44
1680703|NCT00564902|4104232|P3|NOT COMPLETED|Overall Study||4
1680704|NCT00564902|4104233|P2|NOT COMPLETED|Overall Study||4
1680705|NCT00564902|4104234|P1|NOT COMPLETED|Overall Study||1
1680706|NCT00564902|4104232|P3|COMPLETED|Overall Study||21
1680707|NCT00564902|4104233|P2|COMPLETED|Overall Study||21
1680708|NCT00564902|4104234|P1|COMPLETED|Overall Study||9
1680709|NCT00564902|4104232|P3|12 Months|Overall Study||21
1680710|NCT00564902|4104233|P2|12 Months|Overall Study||21
1680711|NCT00564902|4104234|P1|12 Months|Overall Study||9
1680712|NCT00564902|4104232|P3|8 Months|Overall Study||21
1680713|NCT00564902|4104233|P2|8 Months|Overall Study||22
1680714|NCT00564902|4104234|P1|8 Months|Overall Study||9
1680715|NCT00564902|4104232|P3|4 Months|Overall Study||23
1680716|NCT00564902|4104233|P2|4 Months|Overall Study||24
1680717|NCT00564902|4104234|P1|4 Months|Overall Study||9
1680718|NCT00564902|4104232|P3|STARTED|Overall Study||25
1680719|NCT00564902|4104233|P2|STARTED|Overall Study||25
1680720|NCT00564902|4104234|P1|STARTED|Overall Study||10
1680721|NCT00564889|4104266|P1|NOT COMPLETED|Overall Study||29
1680722|NCT00564889|4104266|P1|COMPLETED|Overall Study||6
1680723|NCT00564889|4104266|P1|STARTED|Overall Study||35
1680724|NCT00564876|4104274|P1|NOT COMPLETED|Overall Study||0
1680725|NCT00564876|4104274|P1|COMPLETED|Overall Study||2
1680726|NCT00564876|4104274|P1|STARTED|Overall Study||2
1680727|NCT00564850|4104281|P1|NOT COMPLETED|Overall Study||2
1680728|NCT00564850|4104281|P1|COMPLETED|Overall Study||35
1680729|NCT00564850|4104281|P1|STARTED|Overall Study||37
1680730|NCT00564733|4104299|P1|NOT COMPLETED|Overall Study||9
1680731|NCT00564733|4104299|P1|COMPLETED|Overall Study||46
1680732|NCT00564733|4104299|P1|STARTED|Overall Study||55
1680733|NCT00564681|4104307|P4|NOT COMPLETED|Overall Study||2
1680734|NCT00564681|4104308|P3|NOT COMPLETED|Overall Study||3
1680735|NCT00564681|4104309|P2|NOT COMPLETED|Overall Study||3
1680736|NCT00564681|4104310|P1|NOT COMPLETED|Overall Study||11
1680737|NCT00564681|4104307|P4|COMPLETED|Overall Study||19
1680738|NCT00564681|4104308|P3|COMPLETED|Overall Study||40
1680739|NCT00564681|4104309|P2|COMPLETED|Overall Study||58
1680740|NCT00564681|4104310|P1|COMPLETED|Overall Study||106
1680741|NCT00564681|4104307|P4|STARTED|Overall Study||21
1680742|NCT00564681|4104308|P3|STARTED|Overall Study||43
1680743|NCT00564681|4104309|P2|STARTED|Overall Study||61
1680744|NCT00564681|4104310|P1|STARTED|Overall Study||117
1680745|NCT00564629|4104333|P2|NOT COMPLETED|Overall Study||9
1680746|NCT00564629|4104334|P1|NOT COMPLETED|Overall Study||15
1680747|NCT00564629|4104333|P2|COMPLETED|Overall Study||45
1680748|NCT00564629|4104334|P1|COMPLETED|Overall Study||36
1680749|NCT00564629|4104333|P2|STARTED|Overall Study||54
1680750|NCT00564629|4104334|P1|STARTED|Overall Study||51
1680751|NCT00564486|4104359|P4|NOT COMPLETED|Overall Study||7
1680752|NCT00564486|4104360|P3|NOT COMPLETED|Overall Study||3
1680753|NCT00564486|4104361|P2|NOT COMPLETED|Overall Study||1
1680754|NCT00564486|4104362|P1|NOT COMPLETED|Overall Study||7
1680755|NCT00564486|4104359|P4|COMPLETED|Overall Study||60
1680756|NCT00564486|4104360|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
1680757|NCT00564486|4104361|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
1680758|NCT00564486|4104362|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
1680759|NCT00564486|4104359|P4|STARTED|Overall Study||67
1680760|NCT00564486|4104360|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
1680761|NCT00564486|4104361|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
1680762|NCT00564486|4104362|P1|STARTED|Overall Study||43
1680763|NCT00564447|4104386|P8|NOT COMPLETED|Overall Study||0
1680764|NCT00564447|4104387|P7|NOT COMPLETED|Overall Study||0
1680765|NCT00564447|4104388|P6|NOT COMPLETED|Overall Study||0
1680766|NCT00564447|4104389|P5|NOT COMPLETED|Overall Study||0
1680767|NCT00564447|4104390|P4|NOT COMPLETED|Overall Study||0
1680768|NCT00564447|4104391|P3|NOT COMPLETED|Overall Study||0
1680769|NCT00564447|4104392|P2|NOT COMPLETED|Overall Study||0
1680770|NCT00564447|4104393|P1|NOT COMPLETED|Overall Study||0
1680771|NCT00564447|4104386|P8|COMPLETED|Overall Study||6
1680772|NCT00564447|4104387|P7|COMPLETED|Overall Study||6
1680773|NCT00564447|4104388|P6|COMPLETED|Overall Study||6
1680774|NCT00564447|4104389|P5|COMPLETED|Overall Study||6
1680775|NCT00564447|4104390|P4|COMPLETED|Overall Study||6
1680776|NCT00564447|4104391|P3|COMPLETED|Overall Study||6
1680777|NCT00564447|4104392|P2|COMPLETED|Overall Study||6
1680778|NCT00564447|4104393|P1|COMPLETED|Overall Study||6
1680779|NCT00564447|4104386|P8|STARTED|Overall Study||6
1680780|NCT00564447|4104387|P7|STARTED|Overall Study||6
1680781|NCT00564447|4104388|P6|STARTED|Overall Study||6
1680782|NCT00564447|4104389|P5|STARTED|Overall Study||6
1680783|NCT00564447|4104390|P4|STARTED|Overall Study||6
1680784|NCT00564447|4104391|P3|STARTED|Overall Study||6
1680785|NCT00564447|4104392|P2|STARTED|Overall Study||6
1680786|NCT00564447|4104393|P1|STARTED|Overall Study||6
1680787|NCT00564395|4104411|P2|NOT COMPLETED|Second Intervention (10 Days)||0
1680788|NCT00564395|4104412|P1|NOT COMPLETED|Second Intervention (10 Days)||0
1680789|NCT00564395|4104411|P2|COMPLETED|Second Intervention (10 Days)||7
1680790|NCT00564395|4104412|P1|COMPLETED|Second Intervention (10 Days)||7
1680791|NCT00564395|4104411|P2|STARTED|Second Intervention (10 Days)||7
1680792|NCT00564395|4104412|P1|STARTED|Second Intervention (10 Days)||7
1680793|NCT00564395|4104411|P2|NOT COMPLETED|First Intervention (10 Days)||2
1680794|NCT00564395|4104412|P1|NOT COMPLETED|First Intervention (10 Days)||2
1680795|NCT00564395|4104411|P2|COMPLETED|First Intervention (10 Days)||7
1680796|NCT00564395|4104412|P1|COMPLETED|First Intervention (10 Days)||7
1680797|NCT00564395|4104411|P2|Received Intervention|First Intervention (10 Days)||7
1680798|NCT00564395|4104412|P1|Received Intervention|First Intervention (10 Days)||7
1680799|NCT00564395|4104411|P2|STARTED|First Intervention (10 Days)||9
1680800|NCT00564395|4104412|P1|STARTED|First Intervention (10 Days)||9
1680801|NCT00564278|4104420|P2|NOT COMPLETED|Overall Study||42
1680802|NCT00564278|4104421|P1|NOT COMPLETED|Overall Study||47
1680803|NCT00564278|4104420|P2|COMPLETED|Overall Study||56
1680804|NCT00564278|4104421|P1|COMPLETED|Overall Study||50
1680805|NCT00564278|4104420|P2|STARTED|Overall Study||98
1680806|NCT00564278|4104421|P1|STARTED|Overall Study||97
1680807|NCT00564265|4104437|P1|NOT COMPLETED|Overall Study||0
1680808|NCT00564265|4104437|P1|COMPLETED|Overall Study||24
1680809|NCT00564265|4104437|P1|STARTED|Overall Study||24
1680810|NCT00564070|4104443|P2|NOT COMPLETED|Overall Study||7
1680811|NCT00564070|4104444|P1|NOT COMPLETED|Overall Study||12
1680812|NCT00564070|4104443|P2|COMPLETED|Overall Study||38
1680813|NCT00564070|4104444|P1|COMPLETED|Overall Study||30
1680814|NCT00564070|4104443|P2|STARTED|Overall Study||45
1680815|NCT00564070|4104444|P1|STARTED|Overall Study||42
1680816|NCT00563797|4104470|P2|NOT COMPLETED|Overall Study||2
1680817|NCT00563797|4104471|P1|NOT COMPLETED|Overall Study||7
1680818|NCT00563797|4104470|P2|COMPLETED|Overall Study||8
1680819|NCT00563797|4104471|P1|COMPLETED|Overall Study||4
1680820|NCT00563797|4104470|P2|Follow-Up|Overall Study||10
1680821|NCT00563797|4104471|P1|Follow-Up|Overall Study||11
1680822|NCT00563797|4104470|P2|Received Allocated Intervention|Overall Study||10
1680823|NCT00563797|4104471|P1|Received Allocated Intervention|Overall Study||11
1680824|NCT00563797|4104470|P2|STARTED|Overall Study||10
1680825|NCT00563797|4104471|P1|STARTED|Overall Study||11
1680826|NCT00563706|4104492|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1680827|NCT00563706|4104493|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1680828|NCT00563706|4104494|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1680829|NCT00563706|4104495|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1680830|NCT00563706|4104496|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1680831|NCT00563706|4104497|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1680832|NCT00563706|4104498|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1680833|NCT00563706|4104499|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1680834|NCT00563706|4104500|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1680835|NCT00563706|4104492|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
1680836|NCT00563706|4104493|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
1680837|NCT00563706|4104494|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
1680838|NCT00563706|4104495|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
1680839|NCT00563706|4104496|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
1680840|NCT00563706|4104497|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
1680841|NCT00563706|4104498|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
1680842|NCT00563706|4104499|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
1680843|NCT00563706|4104500|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
1680844|NCT00563706|4104492|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
1680845|NCT00563706|4104493|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
1680846|NCT00563706|4104494|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
1680847|NCT00563706|4104495|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
1680848|NCT00563706|4104496|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
1680849|NCT00563706|4104497|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
1680850|NCT00563706|4104498|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
1680851|NCT00563706|4104499|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
1680852|NCT00563706|4104500|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
1680853|NCT00563706|4104492|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
1680854|NCT00563706|4104493|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
1680855|NCT00563706|4104494|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
1680856|NCT00563706|4104495|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1680857|NCT00563706|4104496|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1680858|NCT00563706|4104497|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
1680859|NCT00563706|4104498|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1680860|NCT00563706|4104499|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1680861|NCT00563706|4104500|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
1680862|NCT00563706|4104492|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
1680863|NCT00563706|4104493|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
1680864|NCT00563706|4104494|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
1680865|NCT00563706|4104495|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
1680866|NCT00563706|4104496|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
1680867|NCT00563706|4104497|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
1680868|NCT00563706|4104498|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
1680869|NCT00563706|4104499|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
1680870|NCT00563706|4104500|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
1680871|NCT00563706|4104492|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
1680872|NCT00563706|4104493|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
1680873|NCT00563706|4104494|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
1680874|NCT00563706|4104495|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
1680875|NCT00563706|4104496|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
1680876|NCT00563706|4104497|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
1680877|NCT00563706|4104498|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
1680878|NCT00563706|4104499|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
1680879|NCT00563706|4104500|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
1680880|NCT00563576|4104603|P2|NOT COMPLETED|Overall Study||14
1680881|NCT00563576|4104604|P1|NOT COMPLETED|Overall Study||14
1680882|NCT00563576|4104603|P2|COMPLETED|Overall Study||22
1680883|NCT00563576|4104604|P1|COMPLETED|Overall Study||21
1680884|NCT00563576|4104603|P2|STARTED|Overall Study||36
1680885|NCT00563576|4104604|P1|STARTED|Overall Study||35
1680886|NCT00563381|4104616|P2|NOT COMPLETED|Overall Study||648
1680887|NCT00563381|4104617|P1|NOT COMPLETED|Overall Study||585
1680888|NCT00563381|4104616|P2|COMPLETED|Overall Study|Completed treatment|3021
1680889|NCT00563381|4104617|P1|COMPLETED|Overall Study|Completed treatment|3122
1680890|NCT00563381|4104616|P2|STARTED|Overall Study|Started treatment|3669
1680891|NCT00563381|4104617|P1|STARTED|Overall Study|Started treatment|3707
1680892|NCT00563368|4104690|P7|NOT COMPLETED|Overall Study||33
1680893|NCT00563368|4104691|P6|NOT COMPLETED|Overall Study||30
1680894|NCT00563368|4104692|P5|NOT COMPLETED|Overall Study||28
1680895|NCT00563368|4104693|P4|NOT COMPLETED|Overall Study||29
1680896|NCT00563368|4104694|P3|NOT COMPLETED|Overall Study||30
1680897|NCT00563368|4104695|P2|NOT COMPLETED|Overall Study||30
1680898|NCT00563368|4104696|P1|NOT COMPLETED|Overall Study||35
1680899|NCT00563368|4104690|P7|COMPLETED|Overall Study||75
1680900|NCT00563368|4104691|P6|COMPLETED|Overall Study||77
1680901|NCT00563368|4104692|P5|COMPLETED|Overall Study||80
1680902|NCT00563368|4104693|P4|COMPLETED|Overall Study||78
1680903|NCT00563368|4104694|P3|COMPLETED|Overall Study||78
1680904|NCT00563368|4104695|P2|COMPLETED|Overall Study||79
1680905|NCT00563368|4104696|P1|COMPLETED|Overall Study||74
1680906|NCT00563368|4104690|P7|STARTED|Overall Study||108
1680907|NCT00563368|4104691|P6|STARTED|Overall Study||107
1680908|NCT00563368|4104692|P5|STARTED|Overall Study||108
1680909|NCT00563368|4104693|P4|STARTED|Overall Study||107
1680910|NCT00563368|4104694|P3|STARTED|Overall Study||108
1680911|NCT00563368|4104695|P2|STARTED|Overall Study||109
1680912|NCT00563368|4104696|P1|STARTED|Overall Study||109
1680913|NCT00563316|4104719|P1|NOT COMPLETED|Overall Study||12
1680914|NCT00563316|4104719|P1|COMPLETED|Overall Study||16
1680915|NCT00563316|4104719|P1|Received Investigational Product|Overall Study||27
1680916|NCT00563316|4104719|P1|STARTED|Overall Study||28
1680917|NCT00563290|4104732|P2|NOT COMPLETED|Overall Study||0
1680918|NCT00563290|4104733|P1|NOT COMPLETED|Overall Study||0
1680919|NCT00563290|4104732|P2|COMPLETED|Overall Study||4
1680920|NCT00563290|4104733|P1|COMPLETED|Overall Study||3
1680921|NCT00563290|4104732|P2|STARTED|Overall Study||4
1680922|NCT00563290|4104733|P1|STARTED|Overall Study||3
1680923|NCT00563186|4104744|P2|NOT COMPLETED|Overall Study||75
1680924|NCT00563186|4104745|P1|NOT COMPLETED|Overall Study||98
1680925|NCT00563186|4104744|P2|COMPLETED|Overall Study||604
1680926|NCT00563186|4104745|P1|COMPLETED|Overall Study||910
1680927|NCT00563186|4104744|P2|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
1680928|NCT00563186|4104745|P1|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
1680929|NCT00562965|4104756|P2|NOT COMPLETED|Overall Study||6
1680930|NCT00562965|4104757|P1|NOT COMPLETED|Overall Study||3
1680931|NCT00562965|4104756|P2|COMPLETED|Overall Study||8
1680932|NCT00562965|4104757|P1|COMPLETED|Overall Study||12
1680933|NCT00562965|4104756|P2|Treated|Overall Study||13
1680934|NCT00562965|4104757|P1|Treated|Overall Study||15
1680935|NCT00562965|4104756|P2|STARTED|Overall Study||14
1680936|NCT00562965|4104757|P1|STARTED|Overall Study||15
1680937|NCT00562861|4104778|P2|NOT COMPLETED|Overall Study||11
1680938|NCT00562861|4104779|P1|NOT COMPLETED|Overall Study||20
1680939|NCT00562861|4104778|P2|COMPLETED|Overall Study||48
1680940|NCT00562861|4104779|P1|COMPLETED|Overall Study||40
1680941|NCT00562861|4104778|P2|STARTED|Overall Study||59
1680942|NCT00562861|4104779|P1|STARTED|Overall Study||60
1680943|NCT00562627|4104788|P3|NOT COMPLETED|Overall Study||1
1680944|NCT00562627|4104789|P2|NOT COMPLETED|Overall Study||1
1680945|NCT00562627|4104790|P1|NOT COMPLETED|Overall Study||1
1680946|NCT00562627|4104788|P3|COMPLETED|Overall Study||33
1680947|NCT00562627|4104789|P2|COMPLETED|Overall Study||33
1680948|NCT00562627|4104790|P1|COMPLETED|Overall Study||33
1680949|NCT00562627|4104788|P3|STARTED|Overall Study||34
1680950|NCT00562627|4104789|P2|STARTED|Overall Study||34
1680951|NCT00562627|4104790|P1|STARTED|Overall Study||34
1680952|NCT00562588|4104806|P2|NOT COMPLETED|Overall Study||99
1680953|NCT00562588|4104807|P1|NOT COMPLETED|Overall Study||92
1680954|NCT00562588|4104806|P2|COMPLETED|Overall Study||184
1680955|NCT00562588|4104807|P1|COMPLETED|Overall Study||168
1680956|NCT00562588|4104806|P2|STARTED|Overall Study||283
1680957|NCT00562588|4104807|P1|STARTED|Overall Study||260
1680958|NCT00562484|4104837|P2|NOT COMPLETED|Overall Study||104
1680959|NCT00562484|4104838|P1|NOT COMPLETED|Overall Study||206
1680960|NCT00562484|4104837|P2|COMPLETED|Overall Study||4907
1680961|NCT00562484|4104838|P1|COMPLETED|Overall Study||9827
1680962|NCT00562484|4104837|P2|STARTED|Overall Study||5011
1680963|NCT00562484|4104838|P1|STARTED|Overall Study||10033
1680964|NCT00562354|4104870|P2|NOT COMPLETED|Overall Study||2
1680965|NCT00562354|4104871|P1|NOT COMPLETED|Overall Study||0
1680966|NCT00562354|4104870|P2|COMPLETED|Overall Study||135
1680967|NCT00562354|4104871|P1|COMPLETED|Overall Study||134
1680968|NCT00562354|4104870|P2|Evaluable Immunogenicity Population|Overall Study||134
1680969|NCT00562354|4104871|P1|Evaluable Immunogenicity Population|Overall Study||134
1680970|NCT00562354|4104870|P2|Received Study Treatment|Overall Study||136
1680971|NCT00562354|4104871|P1|Received Study Treatment|Overall Study||134
1680972|NCT00562354|4104870|P2|STARTED|Overall Study||137
1680973|NCT00562354|4104871|P1|STARTED|Overall Study||134
1680974|NCT00562328|4104912|P1|NOT COMPLETED|Overall Study||0
1680975|NCT00562328|4104912|P1|COMPLETED|Overall Study||33
1680976|NCT00562328|4104912|P1|STARTED|Overall Study||33
1680977|NCT00562315|4104916|P1|NOT COMPLETED|Overall Study||0
1680978|NCT00562315|4104916|P1|COMPLETED|Overall Study||93
1680979|NCT00562315|4104916|P1|STARTED|Overall Study||93
1680980|NCT00562302|4104933|P2|NOT COMPLETED|Overall Study||32
1680981|NCT00562302|4104934|P1|NOT COMPLETED|Overall Study||20
1680982|NCT00562302|4104933|P2|COMPLETED|Overall Study||137
1680983|NCT00562302|4104934|P1|COMPLETED|Overall Study||150
1680984|NCT00562302|4104933|P2|STARTED|Overall Study||169
1680985|NCT00562302|4104934|P1|STARTED|Overall Study||170
1680986|NCT00562159|4104956|P2|NOT COMPLETED|Overall Study||33
1680987|NCT00562159|4104957|P1|NOT COMPLETED|Overall Study||38
1680988|NCT00562159|4104956|P2|COMPLETED|Overall Study||192
1680989|NCT00562159|4104957|P1|COMPLETED|Overall Study||175
1680990|NCT00562159|4104956|P2|STARTED|Overall Study||225
1680991|NCT00562159|4104957|P1|STARTED|Overall Study||213
1680992|NCT00562120|4104969|P4|NOT COMPLETED|Fourth Intervention Period||0
1680993|NCT00562120|4104970|P3|NOT COMPLETED|Fourth Intervention Period||0
1680994|NCT00562120|4104971|P2|NOT COMPLETED|Fourth Intervention Period||0
1680995|NCT00562120|4104972|P1|NOT COMPLETED|Fourth Intervention Period||0
1680996|NCT00562120|4104969|P4|COMPLETED|Fourth Intervention Period||5
1680997|NCT00562120|4104970|P3|COMPLETED|Fourth Intervention Period||5
1680998|NCT00562120|4104971|P2|COMPLETED|Fourth Intervention Period||5
1680999|NCT00562120|4104972|P1|COMPLETED|Fourth Intervention Period||4
1681000|NCT00562120|4104969|P4|STARTED|Fourth Intervention Period||5
1681001|NCT00562120|4104970|P3|STARTED|Fourth Intervention Period||5
1681002|NCT00562120|4104971|P2|STARTED|Fourth Intervention Period||5
1681003|NCT00562120|4104972|P1|STARTED|Fourth Intervention Period||4
1681004|NCT00562120|4104969|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1681005|NCT00562120|4104970|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1681006|NCT00562120|4104971|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1681007|NCT00562120|4104972|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1681008|NCT00562120|4104969|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
1681009|NCT00562120|4104970|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
1681010|NCT00562120|4104971|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
1681011|NCT00562120|4104972|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
1681012|NCT00562120|4104969|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
1681013|NCT00562120|4104970|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
1681014|NCT00562120|4104971|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
1681015|NCT00562120|4104972|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
1681016|NCT00562120|4104969|P4|NOT COMPLETED|Third Intervention Period||0
1681017|NCT00562120|4104970|P3|NOT COMPLETED|Third Intervention Period||0
1681018|NCT00562120|4104971|P2|NOT COMPLETED|Third Intervention Period||0
1681019|NCT00562120|4104972|P1|NOT COMPLETED|Third Intervention Period||0
1681020|NCT00562120|4104969|P4|COMPLETED|Third Intervention Period||5
1681021|NCT00562120|4104970|P3|COMPLETED|Third Intervention Period||5
1681022|NCT00562120|4104971|P2|COMPLETED|Third Intervention Period||5
1681023|NCT00562120|4104972|P1|COMPLETED|Third Intervention Period||4
1681024|NCT00562120|4104969|P4|STARTED|Third Intervention Period||5
1681025|NCT00562120|4104970|P3|STARTED|Third Intervention Period||5
1681026|NCT00562120|4104971|P2|STARTED|Third Intervention Period||5
1681027|NCT00562120|4104972|P1|STARTED|Third Intervention Period||4
1681028|NCT00562120|4104969|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1681029|NCT00562120|4104970|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1681030|NCT00562120|4104971|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1681031|NCT00562120|4104972|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1681032|NCT00562120|4104969|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
1681033|NCT00562120|4104970|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
1681034|NCT00562120|4104971|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
1681035|NCT00562120|4104972|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
1681036|NCT00562120|4104969|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
1681037|NCT00562120|4104970|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
1681038|NCT00562120|4104971|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
1681039|NCT00562120|4104972|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
1681040|NCT00562120|4104969|P4|NOT COMPLETED|Second Intervention Period||0
1681041|NCT00562120|4104970|P3|NOT COMPLETED|Second Intervention Period||0
1681042|NCT00562120|4104971|P2|NOT COMPLETED|Second Intervention Period||0
1681043|NCT00562120|4104972|P1|NOT COMPLETED|Second Intervention Period||0
1681044|NCT00562120|4104969|P4|COMPLETED|Second Intervention Period||5
1681045|NCT00562120|4104970|P3|COMPLETED|Second Intervention Period||5
1681046|NCT00562120|4104971|P2|COMPLETED|Second Intervention Period||5
1681047|NCT00562120|4104972|P1|COMPLETED|Second Intervention Period||4
1681048|NCT00562120|4104969|P4|STARTED|Second Intervention Period||5
1681049|NCT00562120|4104970|P3|STARTED|Second Intervention Period||5
1681050|NCT00562120|4104971|P2|STARTED|Second Intervention Period||5
1681051|NCT00562120|4104972|P1|STARTED|Second Intervention Period||4
1681052|NCT00562120|4104969|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1681053|NCT00562120|4104970|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1681054|NCT00562120|4104971|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1681055|NCT00562120|4104972|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1681056|NCT00562120|4104969|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
1681057|NCT00562120|4104970|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
1681058|NCT00562120|4104971|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
1681059|NCT00562120|4104972|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
1681060|NCT00562120|4104969|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
1681061|NCT00562120|4104970|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
1681062|NCT00562120|4104971|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
1681063|NCT00562120|4104972|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
1681064|NCT00562120|4104969|P4|NOT COMPLETED|First Intervention Period||0
1681065|NCT00562120|4104970|P3|NOT COMPLETED|First Intervention Period||0
1681066|NCT00562120|4104971|P2|NOT COMPLETED|First Intervention Period||0
1681067|NCT00562120|4104972|P1|NOT COMPLETED|First Intervention Period||2
1681068|NCT00562120|4104969|P4|COMPLETED|First Intervention Period||5
1681069|NCT00562120|4104970|P3|COMPLETED|First Intervention Period||5
1681070|NCT00562120|4104971|P2|COMPLETED|First Intervention Period||5
1681071|NCT00562120|4104972|P1|COMPLETED|First Intervention Period||4
1681072|NCT00562120|4104969|P4|Treated|First Intervention Period||5
1681073|NCT00562120|4104970|P3|Treated|First Intervention Period||5
1681074|NCT00562120|4104971|P2|Treated|First Intervention Period||5
1681075|NCT00562120|4104972|P1|Treated|First Intervention Period||5
1681076|NCT00562120|4104969|P4|STARTED|First Intervention Period||5
1681077|NCT00562120|4104970|P3|STARTED|First Intervention Period||5
1681078|NCT00562120|4104971|P2|STARTED|First Intervention Period||5
1681079|NCT00562120|4104972|P1|STARTED|First Intervention Period||6
1681080|NCT00562094|4105004|P1|NOT COMPLETED|Overall Study||62
1681081|NCT00562094|4105004|P1|COMPLETED|Overall Study||8554
1681082|NCT00562094|4105004|P1|STARTED|Overall Study||8616
1681083|NCT00561977|4105019|P3|NOT COMPLETED|Overall Study||2
1681084|NCT00561977|4105020|P2|NOT COMPLETED|Overall Study||3
1681085|NCT00561977|4105021|P1|NOT COMPLETED|Overall Study||0
1681086|NCT00561977|4105019|P3|COMPLETED|Overall Study||10
1681087|NCT00561977|4105020|P2|COMPLETED|Overall Study||9
1681088|NCT00561977|4105021|P1|COMPLETED|Overall Study||12
1681089|NCT00561977|4105019|P3|STARTED|Overall Study||12
1681090|NCT00561977|4105020|P2|STARTED|Overall Study||12
1681091|NCT00561977|4105021|P1|STARTED|Overall Study||12
1681092|NCT00561951|4105047|P3|NOT COMPLETED|Overall Study||32
1681093|NCT00561951|4105048|P2|NOT COMPLETED|Overall Study||34
1681094|NCT00561951|4105049|P1|NOT COMPLETED|Overall Study||33
1681095|NCT00561951|4105047|P3|COMPLETED|Overall Study||281
1681096|NCT00561951|4105048|P2|COMPLETED|Overall Study||286
1681097|NCT00561951|4105049|P1|COMPLETED|Overall Study||285
1681098|NCT00561951|4105047|P3|STARTED|Overall Study||313
1681099|NCT00561951|4105048|P2|STARTED|Overall Study||320
1681100|NCT00561951|4105049|P1|STARTED|Overall Study||318
1681101|NCT00561925|4105105|P5|NOT COMPLETED|Open-Label Extension Period||50
1681102|NCT00561925|4105106|P4|NOT COMPLETED|Open-Label Extension Period||43
1681103|NCT00561925|4105107|P3|NOT COMPLETED|Open-Label Extension Period||0
1681104|NCT00561925|4105108|P2|NOT COMPLETED|Open-Label Extension Period||0
1681105|NCT00561925|4105109|P1|NOT COMPLETED|Open-Label Extension Period||0
1681106|NCT00561925|4105105|P5|COMPLETED|Open-Label Extension Period||328
1681107|NCT00561925|4105106|P4|COMPLETED|Open-Label Extension Period||315
1681108|NCT00561925|4105107|P3|COMPLETED|Open-Label Extension Period||0
1681109|NCT00561925|4105108|P2|COMPLETED|Open-Label Extension Period||1
1681110|NCT00561925|4105109|P1|COMPLETED|Open-Label Extension Period||0
1681111|NCT00561925|4105105|P5|STARTED|Open-Label Extension Period||378
1681112|NCT00561925|4105106|P4|STARTED|Open-Label Extension Period||358
1681113|NCT00561925|4105107|P3|STARTED|Open-Label Extension Period||0
1681114|NCT00561925|4105108|P2|STARTED|Open-Label Extension Period||1
1681115|NCT00561925|4105109|P1|STARTED|Open-Label Extension Period||0
1681116|NCT00561925|4105105|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
1681117|NCT00561925|4105106|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
1681118|NCT00561925|4105107|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
1681119|NCT00561925|4105108|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
1681120|NCT00561925|4105109|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
1681121|NCT00561925|4105105|P5|COMPLETED|144-week Double-blind, Double-dummy||0
1681122|NCT00561925|4105106|P4|COMPLETED|144-week Double-blind, Double-dummy||0
1681123|NCT00561925|4105107|P3|COMPLETED|144-week Double-blind, Double-dummy||378
1681124|NCT00561925|4105108|P2|COMPLETED|144-week Double-blind, Double-dummy||358
1681125|NCT00561925|4105109|P1|COMPLETED|144-week Double-blind, Double-dummy||0
1681126|NCT00561925|4105105|P5|STARTED|144-week Double-blind, Double-dummy||0
1681127|NCT00561925|4105106|P4|STARTED|144-week Double-blind, Double-dummy||0
1681128|NCT00561925|4105107|P3|STARTED|144-week Double-blind, Double-dummy||505
1681129|NCT00561925|4105108|P2|STARTED|144-week Double-blind, Double-dummy||508
1681130|NCT00561925|4105109|P1|STARTED|144-week Double-blind, Double-dummy||0
1681131|NCT00561925|4105105|P5|NOT COMPLETED|14 Day Lead-In Period||0
1681132|NCT00561925|4105106|P4|NOT COMPLETED|14 Day Lead-In Period||0
1681133|NCT00561925|4105107|P3|NOT COMPLETED|14 Day Lead-In Period||0
1681134|NCT00561925|4105108|P2|NOT COMPLETED|14 Day Lead-In Period||0
1681135|NCT00561925|4105109|P1|NOT COMPLETED|14 Day Lead-In Period||55
1681136|NCT00561925|4105105|P5|COMPLETED|14 Day Lead-In Period||0
1681137|NCT00561925|4105106|P4|COMPLETED|14 Day Lead-In Period||0
1681138|NCT00561925|4105107|P3|COMPLETED|14 Day Lead-In Period||0
1681139|NCT00561925|4105108|P2|COMPLETED|14 Day Lead-In Period||0
1681140|NCT00561925|4105109|P1|COMPLETED|14 Day Lead-In Period||1013
1681141|NCT00561925|4105105|P5|STARTED|14 Day Lead-In Period||0
1681142|NCT00561925|4105106|P4|STARTED|14 Day Lead-In Period||0
1681143|NCT00561925|4105107|P3|STARTED|14 Day Lead-In Period||0
1681144|NCT00561925|4105108|P2|STARTED|14 Day Lead-In Period||0
1681145|NCT00561925|4105109|P1|STARTED|14 Day Lead-In Period||1068
1681146|NCT00561912|4105158|P1|NOT COMPLETED|Overall Study||1
1681147|NCT00561912|4105158|P1|COMPLETED|Overall Study||1
1681148|NCT00561912|4105158|P1|STARTED|Overall Study||2
1681149|NCT00561834|4105162|P1|NOT COMPLETED|Overall Study||0
1681150|NCT00561834|4105162|P1|COMPLETED|Overall Study||2
1681151|NCT00561834|4105162|P1|STARTED|Overall Study||2
1681152|NCT00561821|4105170|P4|NOT COMPLETED|Overall Study||3
1681153|NCT00561821|4105171|P3|NOT COMPLETED|Overall Study||2
1681154|NCT00561821|4105172|P2|NOT COMPLETED|Overall Study||6
1681155|NCT00561821|4105173|P1|NOT COMPLETED|Overall Study||5
1681156|NCT00561821|4105170|P4|COMPLETED|Overall Study||133
1681157|NCT00561821|4105171|P3|COMPLETED|Overall Study||132
1681158|NCT00561821|4105172|P2|COMPLETED|Overall Study||130
1681159|NCT00561821|4105173|P1|COMPLETED|Overall Study||127
1681160|NCT00561821|4105170|P4|Treated|Overall Study||136
1681161|NCT00561821|4105171|P3|Treated|Overall Study||133
1681162|NCT00561821|4105172|P2|Treated|Overall Study||136
1681163|NCT00561821|4105173|P1|Treated|Overall Study||132
1681164|NCT00561821|4105170|P4|STARTED|Overall Study||136
1681165|NCT00561821|4105171|P3|STARTED|Overall Study||134
1681166|NCT00561821|4105172|P2|STARTED|Overall Study||136
1681167|NCT00561821|4105173|P1|STARTED|Overall Study||132
1681168|NCT00561795|4105249|P4|NOT COMPLETED|Overall Study||0
1681169|NCT00561795|4105250|P3|NOT COMPLETED|Overall Study||0
1681170|NCT00561795|4105251|P2|NOT COMPLETED|Overall Study||6
1681171|NCT00561795|4105252|P1|NOT COMPLETED|Overall Study||4
1681172|NCT00561795|4105249|P4|COMPLETED|Overall Study||0
1681173|NCT00561795|4105250|P3|COMPLETED|Overall Study||0
1681174|NCT00561795|4105251|P2|COMPLETED|Overall Study||0
1681175|NCT00561795|4105252|P1|COMPLETED|Overall Study||2
1681176|NCT00561795|4105249|P4|STARTED|Overall Study||0
1681177|NCT00561795|4105250|P3|STARTED|Overall Study||0
1681178|NCT00561795|4105251|P2|STARTED|Overall Study||6
1681179|NCT00561795|4105252|P1|STARTED|Overall Study||6
1681180|NCT00561730|4105272|P1|NOT COMPLETED|Overall Study||9
1681181|NCT00561730|4105272|P1|COMPLETED|Overall Study||1986
1681182|NCT00561730|4105272|P1|STARTED|Overall Study||1995
1681183|NCT00561678|4105288|P2|NOT COMPLETED|Overall Study||6
1681184|NCT00561678|4105289|P1|NOT COMPLETED|Overall Study||8
1681185|NCT00561678|4105288|P2|COMPLETED|Overall Study||201
1681186|NCT00561678|4105289|P1|COMPLETED|Overall Study||189
1681187|NCT00561678|4105288|P2|STARTED|Overall Study||207
1681188|NCT00561678|4105289|P1|STARTED|Overall Study||197
1681189|NCT00561652|4105307|P2|NOT COMPLETED|Overall Study||1
1681190|NCT00561652|4105308|P1|NOT COMPLETED|Overall Study||0
1681191|NCT00561652|4105307|P2|COMPLETED|Overall Study||19
1681192|NCT00561652|4105308|P1|COMPLETED|Overall Study||10
1681193|NCT00561652|4105307|P2|STARTED|Overall Study||20
1681194|NCT00561652|4105308|P1|STARTED|Overall Study||10
1681195|NCT00561600|4105328|P2|NOT COMPLETED|Overall Study||16
1681196|NCT00561600|4105329|P1|NOT COMPLETED|Overall Study||18
1681197|NCT00561600|4105328|P2|COMPLETED|Overall Study||119
1681198|NCT00561600|4105329|P1|COMPLETED|Overall Study||112
1681199|NCT00561600|4105328|P2|STARTED|Overall Study||135
1681200|NCT00561600|4105329|P1|STARTED|Overall Study||130
1681201|NCT00561574|4105391|P2|NOT COMPLETED|Overall Study||58
1681202|NCT00561574|4105392|P1|NOT COMPLETED|Overall Study||48
1681203|NCT00561574|4105391|P2|COMPLETED|Overall Study||73
1681204|NCT00561574|4105392|P1|COMPLETED|Overall Study||80
1681205|NCT00561574|4105391|P2|STARTED|Overall Study||131
1681206|NCT00561574|4105392|P1|STARTED|Overall Study||128
1681207|NCT00561470|4105418|P2|NOT COMPLETED|Overall Study||612
1681208|NCT00561470|4105419|P1|NOT COMPLETED|Overall Study||614
1681209|NCT00561470|4105418|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
1681210|NCT00561470|4105419|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
1681211|NCT00561470|4105418|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
1681298|NCT00561080|4105663|P2|COMPLETED|12-month Post Last Dose Follow-up||220
1681212|NCT00561470|4105419|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
1681213|NCT00561470|4105418|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
1681214|NCT00561470|4105419|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
1681215|NCT00561470|4105418|P2|TREATED|Overall Study||607
1681216|NCT00561470|4105419|P1|TREATED|Overall Study||609
1681217|NCT00561470|4105418|P2|STARTED|Overall Study||612
1681218|NCT00561470|4105419|P1|STARTED|Overall Study||614
1681219|NCT00561457|4105433|P1|NOT COMPLETED|Overall Study||24
1681220|NCT00561457|4105433|P1|COMPLETED|Overall Study||110
1681221|NCT00561457|4105433|P1|STARTED|Overall Study||134
1681222|NCT00561431|4105439|P2|NOT COMPLETED|Overall Study||0
1681223|NCT00561431|4105440|P1|NOT COMPLETED|Overall Study||0
1681224|NCT00561431|4105439|P2|COMPLETED|Overall Study||100
1681225|NCT00561431|4105440|P1|COMPLETED|Overall Study||100
1681226|NCT00561431|4105439|P2|STARTED|Overall Study||100
1681227|NCT00561431|4105440|P1|STARTED|Overall Study||100
1681228|NCT00561418|4105448|P1|NOT COMPLETED|Overall Study||0
1681229|NCT00561418|4105448|P1|COMPLETED|Overall Study||23
1681230|NCT00561418|4105448|P1|STARTED|Overall Study||23
1681231|NCT00561392|4105455|P1|NOT COMPLETED|Overall Study||53
1681232|NCT00561392|4105455|P1|COMPLETED|Overall Study||155
1681233|NCT00561392|4105455|P1|STARTED|Overall Study||208
1681234|NCT00561353|4105477|P10|NOT COMPLETED|Overall Study||2
1681235|NCT00561353|4105478|P9|NOT COMPLETED|Overall Study||7
1681236|NCT00561353|4105479|P8|NOT COMPLETED|Overall Study||4
1681237|NCT00561353|4105480|P7|NOT COMPLETED|Overall Study||6
1681238|NCT00561353|4105481|P6|NOT COMPLETED|Overall Study||6
1681239|NCT00561353|4105482|P5|NOT COMPLETED|Overall Study||1
1681240|NCT00561353|4105483|P4|NOT COMPLETED|Overall Study||6
1681241|NCT00561353|4105484|P3|NOT COMPLETED|Overall Study||3
1681242|NCT00561353|4105485|P2|NOT COMPLETED|Overall Study||3
1681243|NCT00561353|4105486|P1|NOT COMPLETED|Overall Study||5
1681244|NCT00561353|4105477|P10|COMPLETED|Overall Study||3
1681245|NCT00561353|4105478|P9|COMPLETED|Overall Study||2
1681246|NCT00561353|4105479|P8|COMPLETED|Overall Study||6
1681247|NCT00561353|4105480|P7|COMPLETED|Overall Study||3
1681248|NCT00561353|4105481|P6|COMPLETED|Overall Study||3
1681249|NCT00561353|4105482|P5|COMPLETED|Overall Study||5
1681250|NCT00561353|4105483|P4|COMPLETED|Overall Study||12
1681251|NCT00561353|4105484|P3|COMPLETED|Overall Study||10
1681252|NCT00561353|4105485|P2|COMPLETED|Overall Study||16
1681253|NCT00561353|4105486|P1|COMPLETED|Overall Study||13
1681254|NCT00561353|4105477|P10|STARTED|Overall Study||5
1681255|NCT00561353|4105478|P9|STARTED|Overall Study||9
1681256|NCT00561353|4105479|P8|STARTED|Overall Study||10
1681257|NCT00561353|4105480|P7|STARTED|Overall Study||9
1681258|NCT00561353|4105481|P6|STARTED|Overall Study||9
1681259|NCT00561353|4105482|P5|STARTED|Overall Study||6
1681260|NCT00561353|4105483|P4|STARTED|Overall Study||18
1681261|NCT00561353|4105484|P3|STARTED|Overall Study||13
1681262|NCT00561353|4105485|P2|STARTED|Overall Study||19
1681263|NCT00561353|4105486|P1|STARTED|Overall Study||18
1681264|NCT00561340|4105641|P2|NOT COMPLETED|Overall Study||0
1681265|NCT00561340|4105642|P1|NOT COMPLETED|Overall Study||6
1681266|NCT00561340|4105641|P2|COMPLETED|Overall Study||16
1681267|NCT00561340|4105642|P1|COMPLETED|Overall Study||7
1681268|NCT00561340|4105641|P2|STARTED|Overall Study||16
1681269|NCT00561340|4105642|P1|STARTED|Overall Study||13
1681270|NCT00561145|4105652|P2|NOT COMPLETED|Overall Study||0
1681271|NCT00561145|4105653|P1|NOT COMPLETED|Overall Study||0
1681272|NCT00561145|4105652|P2|COMPLETED|Overall Study||17
1681273|NCT00561145|4105653|P1|COMPLETED|Overall Study||15
1681274|NCT00561145|4105652|P2|STARTED|Overall Study||17
1681275|NCT00561145|4105653|P1|STARTED|Overall Study||15
1681276|NCT00561080|4105662|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
1681277|NCT00561080|4105663|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
1681278|NCT00561080|4105664|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
1681279|NCT00561080|4105662|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
1681280|NCT00561080|4105663|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
1681281|NCT00561080|4105664|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
1681282|NCT00561080|4105662|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1681283|NCT00561080|4105663|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1681284|NCT00561080|4105664|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1681285|NCT00561080|4105662|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
1681286|NCT00561080|4105663|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
1681287|NCT00561080|4105664|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
1681288|NCT00561080|4105662|P3|COMPLETED|24-month Post Last Dose Follow-up||0
1681289|NCT00561080|4105663|P2|COMPLETED|24-month Post Last Dose Follow-up||0
1681290|NCT00561080|4105664|P1|COMPLETED|24-month Post Last Dose Follow-up||0
1681291|NCT00561080|4105662|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1681292|NCT00561080|4105663|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1681293|NCT00561080|4105664|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
1681294|NCT00561080|4105662|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
1681295|NCT00561080|4105663|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
1681296|NCT00561080|4105664|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
1681297|NCT00561080|4105662|P3|COMPLETED|12-month Post Last Dose Follow-up||215
1681299|NCT00561080|4105664|P1|COMPLETED|12-month Post Last Dose Follow-up||243
1681300|NCT00561080|4105662|P3|STARTED|12-month Post Last Dose Follow-up||225
1681301|NCT00561080|4105663|P2|STARTED|12-month Post Last Dose Follow-up||229
1681302|NCT00561080|4105664|P1|STARTED|12-month Post Last Dose Follow-up||250
1681303|NCT00561080|4105662|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
1681304|NCT00561080|4105663|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
1681305|NCT00561080|4105664|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
1681306|NCT00561080|4105662|P3|COMPLETED|Vaccination Period (up to Month 4)||225
1681307|NCT00561080|4105663|P2|COMPLETED|Vaccination Period (up to Month 4)||229
1681308|NCT00561080|4105664|P1|COMPLETED|Vaccination Period (up to Month 4)||250
1681309|NCT00561080|4105662|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
1681310|NCT00561080|4105663|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
1681311|NCT00561080|4105664|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
1681312|NCT00561080|4105662|P3|STARTED|Vaccination Period (up to Month 4)||251
1681313|NCT00561080|4105663|P2|STARTED|Vaccination Period (up to Month 4)||255
1681314|NCT00561080|4105664|P1|STARTED|Vaccination Period (up to Month 4)||253
1681315|NCT00561015|4105741|P6|NOT COMPLETED|Overall Study||3
1681316|NCT00561015|4105742|P5|NOT COMPLETED|Overall Study||1
1681317|NCT00561015|4105743|P4|NOT COMPLETED|Overall Study||1
1681318|NCT00561015|4105744|P3|NOT COMPLETED|Overall Study||0
1681319|NCT00561015|4105745|P2|NOT COMPLETED|Overall Study||0
1681320|NCT00561015|4105746|P1|NOT COMPLETED|Overall Study||4
1681321|NCT00561015|4105741|P6|COMPLETED|Overall Study||6
1681322|NCT00561015|4105742|P5|COMPLETED|Overall Study||8
1681323|NCT00561015|4105743|P4|COMPLETED|Overall Study||7
1681324|NCT00561015|4105744|P3|COMPLETED|Overall Study||9
1681325|NCT00561015|4105745|P2|COMPLETED|Overall Study||5
1681326|NCT00561015|4105746|P1|COMPLETED|Overall Study||5
1681327|NCT00561015|4105741|P6|STARTED|Overall Study||9
1681328|NCT00561015|4105742|P5|STARTED|Overall Study||9
1681329|NCT00561015|4105743|P4|STARTED|Overall Study||8
1681330|NCT00561015|4105744|P3|STARTED|Overall Study||9
1681331|NCT00561015|4105745|P2|STARTED|Overall Study||5
1681332|NCT00561015|4105746|P1|STARTED|Overall Study||9
1681333|NCT00561002|4105822|P2|NOT COMPLETED|Overall Study||0
1681334|NCT00561002|4105823|P1|NOT COMPLETED|Overall Study||0
1681335|NCT00561002|4105822|P2|COMPLETED|Overall Study||9
1681336|NCT00561002|4105823|P1|COMPLETED|Overall Study||23
1681337|NCT00561002|4105822|P2|STARTED|Overall Study||9
1681338|NCT00561002|4105823|P1|STARTED|Overall Study||23
1681339|NCT00560950|4105837|P2|NOT COMPLETED|Overall Study||0
1681340|NCT00560950|4105838|P1|NOT COMPLETED|Overall Study||1
1681341|NCT00560950|4105837|P2|COMPLETED|Overall Study||71
1681342|NCT00560950|4105838|P1|COMPLETED|Overall Study||71
1681343|NCT00560950|4105837|P2|STARTED|Overall Study||71
1681344|NCT00560950|4105838|P1|STARTED|Overall Study||72
1681345|NCT00560937|4105876|P2|NOT COMPLETED|Overall Study||2
1681346|NCT00560937|4105877|P1|NOT COMPLETED|Overall Study||1
1681347|NCT00560937|4105876|P2|COMPLETED|Overall Study||9
1681348|NCT00560937|4105877|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
1681349|NCT00560937|4105876|P2|STARTED|Overall Study||11
1681350|NCT00560937|4105877|P1|STARTED|Overall Study||10
1681351|NCT00560885|4105893|P1|NOT COMPLETED|Overall Study||8
1681352|NCT00560885|4105893|P1|COMPLETED|Overall Study||47
1681353|NCT00560885|4105893|P1|2 Year Follow-up|Overall Study||47
1681354|NCT00560885|4105893|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
1681355|NCT00560885|4105893|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
1681356|NCT00560885|4105893|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
1681357|NCT00560885|4105893|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
1681358|NCT00560885|4105893|P1|STARTED|Overall Study||55
1681359|NCT00560859|4105902|P2|NOT COMPLETED|Overall Study||24
1681360|NCT00560859|4105903|P1|NOT COMPLETED|Overall Study||32
1681361|NCT00560859|4105902|P2|COMPLETED|Overall Study||203
1681362|NCT00560859|4105903|P1|COMPLETED|Overall Study||194
1681363|NCT00560859|4105902|P2|STARTED|Overall Study||227
1681364|NCT00560859|4105903|P1|STARTED|Overall Study||226
1681365|NCT00560833|4105918|P5|NOT COMPLETED|Overall Study||42
1681366|NCT00560833|4105919|P4|NOT COMPLETED|Overall Study||31
1681367|NCT00560833|4105920|P3|NOT COMPLETED|Overall Study||39
1681368|NCT00560833|4105921|P2|NOT COMPLETED|Overall Study||26
1681369|NCT00560833|4105922|P1|NOT COMPLETED|Overall Study||44
1681370|NCT00560833|4105918|P5|COMPLETED|Overall Study||114
1681371|NCT00560833|4105919|P4|COMPLETED|Overall Study||124
1681372|NCT00560833|4105920|P3|COMPLETED|Overall Study||121
1681373|NCT00560833|4105921|P2|COMPLETED|Overall Study||129
1681374|NCT00560833|4105922|P1|COMPLETED|Overall Study||273
1681375|NCT00560833|4105918|P5|Treated|Overall Study|One participant was randomized but not treated|155
1681376|NCT00560833|4105919|P4|Treated|Overall Study||155
1681377|NCT00560833|4105920|P3|Treated|Overall Study||160
1681378|NCT00560833|4105921|P2|Treated|Overall Study|One participant was randomized but not treated|154
1681379|NCT00560833|4105922|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
1681380|NCT00560833|4105918|P5|STARTED|Overall Study||156
1681381|NCT00560833|4105919|P4|STARTED|Overall Study||155
1681382|NCT00560833|4105920|P3|STARTED|Overall Study||160
1681383|NCT00560833|4105921|P2|STARTED|Overall Study||155
1681384|NCT00560833|4105922|P1|STARTED|Overall Study||317
1681385|NCT00560794|4105954|P1|NOT COMPLETED|Overall Study||11
1681386|NCT00560794|4105954|P1|COMPLETED|Overall Study||10
1681387|NCT00560794|4105954|P1|Completed 1 Treatment Cycle|Overall Study||20
1681388|NCT00560794|4105954|P1|STARTED|Overall Study||21
1681389|NCT00560755|4105971|P1|NOT COMPLETED|Overall Study||60
1681390|NCT00560755|4105971|P1|COMPLETED|Overall Study||3328
1681391|NCT00560755|4105971|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
1681392|NCT00560755|4105971|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
1681393|NCT00560703|4105992|P2|NOT COMPLETED|Overall Study||6
1681394|NCT00560703|4105993|P1|NOT COMPLETED|Overall Study||0
1681395|NCT00560703|4105992|P2|COMPLETED|Overall Study||18
1681396|NCT00560703|4105993|P1|COMPLETED|Overall Study||46
1681397|NCT00560703|4105992|P2|STARTED|Overall Study||24
1681398|NCT00560703|4105993|P1|STARTED|Overall Study||46
1681399|NCT00560612|4106003|P2|NOT COMPLETED|Overall Study||0
1681400|NCT00560612|4106004|P1|NOT COMPLETED|Overall Study||0
1681401|NCT00560612|4106003|P2|COMPLETED|Overall Study||7
1681402|NCT00560612|4106004|P1|COMPLETED|Overall Study||5
1681403|NCT00560612|4106003|P2|STARTED|Overall Study||7
1681404|NCT00560612|4106004|P1|STARTED|Overall Study||5
1681405|NCT00560573|4106010|P6|NOT COMPLETED|Overall Study||13
1681406|NCT00560573|4106011|P5|NOT COMPLETED|Overall Study||7
1681407|NCT00560573|4106012|P4|NOT COMPLETED|Overall Study||10
1681408|NCT00560573|4106013|P3|NOT COMPLETED|Overall Study||6
1681409|NCT00560573|4106014|P2|NOT COMPLETED|Overall Study||3
1681410|NCT00560573|4106015|P1|NOT COMPLETED|Overall Study||6
1681411|NCT00560573|4106010|P6|COMPLETED|Overall Study||0
1681412|NCT00560573|4106011|P5|COMPLETED|Overall Study||1
1681413|NCT00560573|4106012|P4|COMPLETED|Overall Study||0
1681414|NCT00560573|4106013|P3|COMPLETED|Overall Study||0
1681415|NCT00560573|4106014|P2|COMPLETED|Overall Study||0
1681416|NCT00560573|4106015|P1|COMPLETED|Overall Study||0
1681417|NCT00560573|4106010|P6|Treated|Overall Study||13
1681418|NCT00560573|4106011|P5|Treated|Overall Study||7
1681419|NCT00560573|4106012|P4|Treated|Overall Study||10
1681420|NCT00560573|4106013|P3|Treated|Overall Study||6
1681421|NCT00560573|4106014|P2|Treated|Overall Study||3
1681422|NCT00560573|4106015|P1|Treated|Overall Study||6
1681423|NCT00560573|4106010|P6|STARTED|Overall Study||13
1681424|NCT00560573|4106011|P5|STARTED|Overall Study||8
1681425|NCT00560573|4106012|P4|STARTED|Overall Study||10
1681426|NCT00560573|4106013|P3|STARTED|Overall Study||6
1681427|NCT00560573|4106014|P2|STARTED|Overall Study||3
1681428|NCT00560573|4106015|P1|STARTED|Overall Study||6
1681429|NCT00560560|4106069|P2|NOT COMPLETED|Overall Study||83
1681430|NCT00560560|4106070|P1|NOT COMPLETED|Overall Study||85
1681431|NCT00560560|4106069|P2|COMPLETED|Overall Study||0
1681432|NCT00560560|4106070|P1|COMPLETED|Overall Study||0
1681433|NCT00560560|4106069|P2|STARTED|Overall Study||83
1681434|NCT00560560|4106070|P1|STARTED|Overall Study||85
1681435|NCT00560508|4106092|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
1681436|NCT00560508|4106093|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
1681437|NCT00560508|4106092|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
1681438|NCT00560508|4106093|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
1681439|NCT00560508|4106092|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
1681440|NCT00560508|4106093|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
1681441|NCT00560508|4106092|P2|NOT COMPLETED|12 Week Double-blind Period||3
1681442|NCT00560508|4106093|P1|NOT COMPLETED|12 Week Double-blind Period||5
1681443|NCT00560508|4106092|P2|COMPLETED|12 Week Double-blind Period||53
1681444|NCT00560508|4106093|P1|COMPLETED|12 Week Double-blind Period||51
1681445|NCT00560508|4106092|P2|STARTED|12 Week Double-blind Period||56
1681446|NCT00560508|4106093|P1|STARTED|12 Week Double-blind Period||56
1681447|NCT00560417|4106152|P2|NOT COMPLETED|Overall Study||17
1681448|NCT00560417|4106153|P1|NOT COMPLETED|Overall Study||17
1681449|NCT00560417|4106152|P2|COMPLETED|Overall Study||151
1681450|NCT00560417|4106153|P1|COMPLETED|Overall Study||154
1681451|NCT00560417|4106152|P2|Intention to Treat (ITT) Population|Overall Study||167
1681452|NCT00560417|4106153|P1|Intention to Treat (ITT) Population|Overall Study||170
1681453|NCT00560417|4106152|P2|STARTED|Overall Study||168
1681454|NCT00560417|4106153|P1|STARTED|Overall Study||171
1681455|NCT00560404|4106181|P2|NOT COMPLETED|Overall Study||21
1681456|NCT00560404|4106182|P1|NOT COMPLETED|Overall Study||36
1681457|NCT00560404|4106181|P2|COMPLETED|Overall Study||100
1681458|NCT00560404|4106182|P1|COMPLETED|Overall Study||76
1681459|NCT00560404|4106181|P2|STARTED|Overall Study||121
1681460|NCT00560404|4106182|P1|STARTED|Overall Study||112
1681461|NCT00560391|4106229|P5|NOT COMPLETED|Overall Study||2
1681462|NCT00560391|4106230|P4|NOT COMPLETED|Overall Study||1
1681463|NCT00560391|4106231|P3|NOT COMPLETED|Overall Study||0
1681464|NCT00560391|4106232|P2|NOT COMPLETED|Overall Study||0
1681465|NCT00560391|4106233|P1|NOT COMPLETED|Overall Study||0
1681466|NCT00560391|4106229|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
1681467|NCT00560391|4106230|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
1681468|NCT00560391|4106231|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
1681469|NCT00560391|4106232|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
1681470|NCT00560391|4106233|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
1681471|NCT00560391|4106229|P5|STARTED|Overall Study|Participants who received treatment|17
1681472|NCT00560391|4106230|P4|STARTED|Overall Study|Participants who received treatment|6
1681473|NCT00560391|4106231|P3|STARTED|Overall Study|Participants who received treatment|3
1681474|NCT00560391|4106232|P2|STARTED|Overall Study|Participants who received treatment|3
1681475|NCT00560391|4106233|P1|STARTED|Overall Study|Participants who received treatment|6
1681476|NCT00560352|4106289|P3|NOT COMPLETED|Overall Study||4
1681477|NCT00560352|4106290|P2|NOT COMPLETED|Overall Study||3
1681478|NCT00560352|4106291|P1|NOT COMPLETED|Overall Study||7
1681479|NCT00560352|4106289|P3|COMPLETED|Overall Study||0
1681480|NCT00560352|4106290|P2|COMPLETED|Overall Study||0
1681481|NCT00560352|4106291|P1|COMPLETED|Overall Study||0
1681482|NCT00560352|4106289|P3|STARTED|Overall Study||4
1681483|NCT00560352|4106290|P2|STARTED|Overall Study||3
1681484|NCT00560352|4106291|P1|STARTED|Overall Study||7
1681485|NCT00560313|4106308|P1|NOT COMPLETED|Overall Study||6
1681486|NCT00560313|4106308|P1|COMPLETED|Overall Study||48
1681487|NCT00560313|4106308|P1|STARTED|Overall Study||54
1681488|NCT00560235|4106335|P3|NOT COMPLETED|Phase 2||97
1681489|NCT00560235|4106336|P2|NOT COMPLETED|Phase 2||0
1681490|NCT00560235|4106337|P1|NOT COMPLETED|Phase 2||0
1681491|NCT00560235|4106335|P3|COMPLETED|Phase 2||10
1681492|NCT00560235|4106336|P2|COMPLETED|Phase 2||0
1681493|NCT00560235|4106337|P1|COMPLETED|Phase 2||0
1681494|NCT00560235|4106335|P3|STARTED|Phase 2||107
1681495|NCT00560235|4106336|P2|STARTED|Phase 2||0
1681496|NCT00560235|4106337|P1|STARTED|Phase 2||0
1681497|NCT00560235|4106335|P3|NOT COMPLETED|Phase 1B||0
1681498|NCT00560235|4106336|P2|NOT COMPLETED|Phase 1B||19
1681499|NCT00560235|4106337|P1|NOT COMPLETED|Phase 1B||0
1681500|NCT00560235|4106335|P3|COMPLETED|Phase 1B||0
1681501|NCT00560235|4106336|P2|COMPLETED|Phase 1B||2
1681502|NCT00560235|4106337|P1|COMPLETED|Phase 1B||0
1681503|NCT00560235|4106335|P3|STARTED|Phase 1B||0
1681504|NCT00560235|4106336|P2|STARTED|Phase 1B||21
1681505|NCT00560235|4106337|P1|STARTED|Phase 1B||0
1681506|NCT00560235|4106335|P3|NOT COMPLETED|Phase 1||0
1681507|NCT00560235|4106336|P2|NOT COMPLETED|Phase 1||0
1681508|NCT00560235|4106337|P1|NOT COMPLETED|Phase 1||8
1681509|NCT00560235|4106335|P3|COMPLETED|Phase 1||0
1681510|NCT00560235|4106336|P2|COMPLETED|Phase 1||0
1681511|NCT00560235|4106337|P1|COMPLETED|Phase 1||2
1681512|NCT00560235|4106335|P3|STARTED|Phase 1||0
1681513|NCT00560235|4106336|P2|STARTED|Phase 1||0
1681514|NCT00560235|4106337|P1|STARTED|Phase 1||10
1681515|NCT00560105|4106368|P2|NOT COMPLETED|Overall Study||2
1681516|NCT00560105|4106369|P1|NOT COMPLETED|Overall Study||1
1681517|NCT00560105|4106368|P2|COMPLETED|Overall Study||18
1681518|NCT00560105|4106369|P1|COMPLETED|Overall Study||19
1681519|NCT00560105|4106368|P2|STARTED|Overall Study||20
1681520|NCT00560105|4106369|P1|STARTED|Overall Study||20
1681521|NCT00560066|4106383|P2|NOT COMPLETED|Overall Study||22
1681522|NCT00560066|4106384|P1|NOT COMPLETED|Overall Study||6
1681523|NCT00560066|4106383|P2|COMPLETED|Overall Study||980
1681524|NCT00560066|4106384|P1|COMPLETED|Overall Study||390
1681525|NCT00560066|4106383|P2|STARTED|Overall Study||1002
1681526|NCT00560066|4106384|P1|STARTED|Overall Study||396
1681527|NCT00559988|4106416|P2|NOT COMPLETED|Overall Study||352
1681528|NCT00559988|4106417|P1|NOT COMPLETED|Overall Study||351
1681529|NCT00559988|4106416|P2|COMPLETED|Overall Study||1009
1681530|NCT00559988|4106417|P1|COMPLETED|Overall Study||1006
1681531|NCT00559988|4106416|P2|STARTED|Overall Study||1361
1681532|NCT00559988|4106417|P1|STARTED|Overall Study||1357
1681533|NCT00559962|4106447|P8|NOT COMPLETED|Overall Study||4
1681534|NCT00559962|4106448|P7|NOT COMPLETED|Overall Study||5
1681535|NCT00559962|4106449|P6|NOT COMPLETED|Overall Study||5
1681536|NCT00559962|4106450|P5|NOT COMPLETED|Overall Study||14
1681537|NCT00559962|4106451|P4|NOT COMPLETED|Overall Study||5
1681538|NCT00559962|4106452|P3|NOT COMPLETED|Overall Study||10
1681539|NCT00559962|4106453|P2|NOT COMPLETED|Overall Study||9
1681540|NCT00559962|4106454|P1|NOT COMPLETED|Overall Study||2
1681541|NCT00559962|4106447|P8|COMPLETED|Overall Study||25
1681542|NCT00559962|4106448|P7|COMPLETED|Overall Study||28
1681543|NCT00559962|4106449|P6|COMPLETED|Overall Study||23
1681544|NCT00559962|4106450|P5|COMPLETED|Overall Study||21
1681545|NCT00559962|4106451|P4|COMPLETED|Overall Study||29
1681546|NCT00559962|4106452|P3|COMPLETED|Overall Study||24
1681547|NCT00559962|4106453|P2|COMPLETED|Overall Study||25
1681548|NCT00559962|4106454|P1|COMPLETED|Overall Study||31
1681549|NCT00559962|4106447|P8|STARTED|Overall Study||29
1681550|NCT00559962|4106448|P7|STARTED|Overall Study||33
1681551|NCT00559962|4106449|P6|STARTED|Overall Study||28
1681552|NCT00559962|4106450|P5|STARTED|Overall Study||35
1681553|NCT00559962|4106451|P4|STARTED|Overall Study||34
1681554|NCT00559962|4106452|P3|STARTED|Overall Study||34
1681555|NCT00559962|4106453|P2|STARTED|Overall Study||34
1681556|NCT00559962|4106454|P1|STARTED|Overall Study||33
1681557|NCT00559949|4106474|P1|NOT COMPLETED|Overall Study||7
1681558|NCT00559949|4106474|P1|COMPLETED|Overall Study||32
1681559|NCT00559949|4106474|P1|STARTED|Overall Study||39
1681560|NCT00559936|4106481|P1|NOT COMPLETED|Overall Study||4
1681561|NCT00559936|4106481|P1|COMPLETED|Overall Study||20
1681562|NCT00559936|4106481|P1|STARTED|Overall Study||24
1681563|NCT00559897|4106486|P1|NOT COMPLETED|Overall Study||0
1681564|NCT00559897|4106486|P1|COMPLETED|Overall Study||6
1681565|NCT00559897|4106486|P1|STARTED|Overall Study||6
1681566|NCT00559845|4106490|P1|NOT COMPLETED|Overall Study||7
1681567|NCT00559845|4106490|P1|COMPLETED|Overall Study||49
1681568|NCT00559845|4106490|P1|STARTED|Overall Study||56
1681569|NCT00559754|4106499|P1|NOT COMPLETED|Overall Study||11
1681570|NCT00559754|4106499|P1|COMPLETED|Overall Study||61
1681571|NCT00559754|4106499|P1|STARTED|Overall Study||72
1681572|NCT00559637|4106523|P1|NOT COMPLETED|Overall Study||54
1681573|NCT00559637|4106523|P1|COMPLETED|Overall Study||130
1681574|NCT00559637|4106523|P1|STARTED|Overall Study||184
1681575|NCT00559585|4106536|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
1681576|NCT00559585|4106537|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
1681577|NCT00559585|4106536|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
1681578|NCT00559585|4106537|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
1681579|NCT00559585|4106536|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
1681580|NCT00559585|4106537|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
1681581|NCT00559585|4106536|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
1681582|NCT00559585|4106537|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
1681583|NCT00559585|4106536|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
1681584|NCT00559585|4106537|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
1681585|NCT00559585|4106536|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
1681586|NCT00559585|4106537|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
1681587|NCT00559585|4106536|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
1681588|NCT00559585|4106537|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
1681589|NCT00559585|4106536|P2|COMPLETED|Double Blind ST Period Main Study||676
1681590|NCT00559585|4106537|P1|COMPLETED|Double Blind ST Period Main Study||693
1681591|NCT00559585|4106536|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
1681592|NCT00559585|4106537|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
1681593|NCT00559507|4106597|P1|NOT COMPLETED|Overall Study||3
1681594|NCT00559507|4106597|P1|COMPLETED|Overall Study||9
1681595|NCT00559507|4106597|P1|STARTED|Overall Study||12
1681596|NCT00559377|4106603|P1|NOT COMPLETED|Overall Study||9
1681597|NCT00559377|4106603|P1|COMPLETED|Overall Study||7
1681598|NCT00559377|4106603|P1|STARTED|Overall Study||16
1681599|NCT00559364|4106613|P2|NOT COMPLETED|Overall Study||0
1681600|NCT00559364|4106614|P1|NOT COMPLETED|Overall Study||1
1681601|NCT00559364|4106613|P2|COMPLETED|Overall Study||20
1681602|NCT00559364|4106614|P1|COMPLETED|Overall Study||29
1681603|NCT00559364|4106613|P2|STARTED|Overall Study||20
1681604|NCT00559364|4106614|P1|STARTED|Overall Study||30
1681605|NCT00559273|4106626|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
1681606|NCT00559273|4106627|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
1681607|NCT00559273|4106626|P2|COMPLETED|Evaluation Period (8 Weeks)||137
1681608|NCT00559273|4106627|P1|COMPLETED|Evaluation Period (8 Weeks)||141
1681609|NCT00559273|4106626|P2|STARTED|Evaluation Period (8 Weeks)||142
1681610|NCT00559273|4106627|P1|STARTED|Evaluation Period (8 Weeks)||144
1681611|NCT00559273|4106626|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
1681612|NCT00559273|4106627|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
1681613|NCT00559273|4106626|P2|COMPLETED|Correction Period (20 Weeks)||142
1681614|NCT00559273|4106627|P1|COMPLETED|Correction Period (20 Weeks)||144
1681615|NCT00559273|4106626|P2|Treated|Correction Period (20 Weeks)||154
1681616|NCT00559273|4106627|P1|Treated|Correction Period (20 Weeks)||151
1681617|NCT00559273|4106626|P2|STARTED|Correction Period (20 Weeks)||154
1681618|NCT00559273|4106627|P1|STARTED|Correction Period (20 Weeks)||153
1681619|NCT00559104|4106649|P2|NOT COMPLETED|Overall Study||0
1681620|NCT00559104|4106650|P1|NOT COMPLETED|Overall Study||9
1681621|NCT00559104|4106649|P2|COMPLETED|Overall Study||5
1681622|NCT00559104|4106650|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
1681623|NCT00559104|4106649|P2|STARTED|Overall Study||5
1681624|NCT00559104|4106650|P1|STARTED|Overall Study||55
1681625|NCT00559013|4106660|P1|NOT COMPLETED|Overall Study||0
1681626|NCT00559013|4106660|P1|COMPLETED|Overall Study||38
1681627|NCT00559013|4106660|P1|STARTED|Overall Study||38
1681628|NCT00558896|4106671|P7|NOT COMPLETED|Overall Study||24
1681629|NCT00558896|4106672|P6|NOT COMPLETED|Overall Study||52
1681630|NCT00558896|4106673|P5|NOT COMPLETED|Overall Study||23
1681631|NCT00558896|4106674|P4|NOT COMPLETED|Overall Study||12
1681632|NCT00558896|4106675|P3|NOT COMPLETED|Overall Study||5
1681633|NCT00558896|4106676|P2|NOT COMPLETED|Overall Study||7
1681634|NCT00558896|4106677|P1|NOT COMPLETED|Overall Study||21
1681635|NCT00558896|4106671|P7|COMPLETED|Overall Study||9
1681636|NCT00558896|4106672|P6|COMPLETED|Overall Study||68
1681637|NCT00558896|4106673|P5|COMPLETED|Overall Study||37
1681638|NCT00558896|4106674|P4|COMPLETED|Overall Study||23
1681639|NCT00558896|4106675|P3|COMPLETED|Overall Study||30
1681640|NCT00558896|4106676|P2|COMPLETED|Overall Study||27
1681641|NCT00558896|4106677|P1|COMPLETED|Overall Study||39
1681642|NCT00558896|4106671|P7|STARTED|Overall Study||33
1681643|NCT00558896|4106672|P6|STARTED|Overall Study||120
1681644|NCT00558896|4106673|P5|STARTED|Overall Study||60
1681645|NCT00558896|4106674|P4|STARTED|Overall Study||35
1681646|NCT00558896|4106675|P3|STARTED|Overall Study||35
1681647|NCT00558896|4106676|P2|STARTED|Overall Study||34
1681648|NCT00558896|4106677|P1|STARTED|Overall Study||60
1681649|NCT00558870|4106709|P2|NOT COMPLETED|Overall Study||0
1681650|NCT00558870|4106710|P1|NOT COMPLETED|Overall Study||0
1681651|NCT00558870|4106709|P2|COMPLETED|Overall Study||2
1681652|NCT00558870|4106710|P1|COMPLETED|Overall Study||2
1681653|NCT00558870|4106709|P2|STARTED|Overall Study||2
1681654|NCT00558870|4106710|P1|STARTED|Overall Study||2
1681655|NCT00558831|4106718|P1|NOT COMPLETED|Overall Study||1
1681656|NCT00558831|4106718|P1|COMPLETED|Overall Study||10
1681657|NCT00558831|4106718|P1|STARTED|Overall Study||11
1681658|NCT00558792|4106727|P3|NOT COMPLETED|Overall Study||0
1681659|NCT00558792|4106728|P2|NOT COMPLETED|Overall Study||0
1681660|NCT00558792|4106729|P1|NOT COMPLETED|Overall Study||0
1681661|NCT00558792|4106727|P3|COMPLETED|Overall Study||60
1681662|NCT00558792|4106728|P2|COMPLETED|Overall Study||63
1681663|NCT00558792|4106729|P1|COMPLETED|Overall Study||68
1681664|NCT00558792|4106727|P3|STARTED|Overall Study||60
1681665|NCT00558792|4106728|P2|STARTED|Overall Study||63
1681666|NCT00558792|4106729|P1|STARTED|Overall Study||68
1681667|NCT00558753|4106775|P2|NOT COMPLETED|Overall Study||7
1681668|NCT00558753|4106776|P1|NOT COMPLETED|Overall Study||5
1681669|NCT00558753|4106775|P2|COMPLETED|Overall Study||113
1681670|NCT00558753|4106776|P1|COMPLETED|Overall Study||115
1681671|NCT00558753|4106775|P2|STARTED|Overall Study||120
1681672|NCT00558753|4106776|P1|STARTED|Overall Study||120
1681673|NCT00558701|4106788|P2|NOT COMPLETED|Overall Study||4
1681674|NCT00558701|4106789|P1|NOT COMPLETED|Overall Study||1
1681675|NCT00558701|4106788|P2|COMPLETED|Overall Study||11
1681676|NCT00558701|4106789|P1|COMPLETED|Overall Study||14
1681677|NCT00558701|4106788|P2|STARTED|Overall Study||15
1681678|NCT00558701|4106789|P1|STARTED|Overall Study||15
1681679|NCT00558636|4106797|P2|NOT COMPLETED|Follow-up||7
1681680|NCT00558636|4106798|P1|NOT COMPLETED|Follow-up||12
1681681|NCT00558636|4106797|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
1681682|NCT00558636|4106798|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
1681683|NCT00558636|4106797|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
1681684|NCT00558636|4106798|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
1681685|NCT00558636|4106797|P2|NOT COMPLETED|Treatment||44
1681686|NCT00558636|4106798|P1|NOT COMPLETED|Treatment||47
1681687|NCT00558636|4106797|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
1681688|NCT00558636|4106798|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
1681689|NCT00558636|4106797|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
1681690|NCT00558636|4106798|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
1681691|NCT00558636|4106797|P2|STARTED|Treatment||44
1681692|NCT00558636|4106798|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
1681693|NCT00558571|4106820|P4|NOT COMPLETED|Overall Study||0
1681694|NCT00558571|4106821|P3|NOT COMPLETED|Overall Study||0
1681695|NCT00558571|4106822|P2|NOT COMPLETED|Overall Study||0
1681696|NCT00558571|4106823|P1|NOT COMPLETED|Overall Study||0
1681697|NCT00558571|4106820|P4|COMPLETED|Overall Study||30
1681698|NCT00558571|4106821|P3|COMPLETED|Overall Study||16
1681699|NCT00558571|4106822|P2|COMPLETED|Overall Study||16
1681700|NCT00558571|4106823|P1|COMPLETED|Overall Study||16
1681701|NCT00558571|4106820|P4|STARTED|Overall Study||30
1681702|NCT00558571|4106821|P3|STARTED|Overall Study||16
1681703|NCT00558571|4106822|P2|STARTED|Overall Study||16
1681704|NCT00558571|4106823|P1|STARTED|Overall Study||16
1681705|NCT00558558|4106898|P1|NOT COMPLETED|Overall Study||6
1681706|NCT00558558|4106898|P1|COMPLETED|Overall Study||0
1681707|NCT00558558|4106898|P1|STARTED|Overall Study||6
1681708|NCT00558467|4106904|P2|NOT COMPLETED|Overall Study||4
1681709|NCT00558467|4106905|P1|NOT COMPLETED|Overall Study||1
1681710|NCT00558467|4106904|P2|COMPLETED|Overall Study||39
1681711|NCT00558467|4106905|P1|COMPLETED|Overall Study||19
1681712|NCT00558467|4106904|P2|STARTED|Overall Study||43
1681713|NCT00558467|4106905|P1|STARTED|Overall Study||20
1681714|NCT00558428|4106965|P4|NOT COMPLETED|Overall Study||11
1681715|NCT00558428|4106966|P3|NOT COMPLETED|Overall Study||4
1681716|NCT00558428|4106967|P2|NOT COMPLETED|Overall Study||24
1681717|NCT00558428|4106968|P1|NOT COMPLETED|Overall Study||12
1681718|NCT00558428|4106965|P4|COMPLETED|Overall Study||266
1681719|NCT00558428|4106966|P3|COMPLETED|Overall Study||273
1681720|NCT00558428|4106967|P2|COMPLETED|Overall Study||252
1681721|NCT00558428|4106968|P1|COMPLETED|Overall Study||255
1681722|NCT00558428|4106965|P4|STARTED|Overall Study||277
1681723|NCT00558428|4106966|P3|STARTED|Overall Study||277
1681724|NCT00558428|4106967|P2|STARTED|Overall Study||276
1681725|NCT00558428|4106968|P1|STARTED|Overall Study||267
1681726|NCT00558363|4107008|P2|NOT COMPLETED|Overall Study||36
1681727|NCT00558363|4107009|P1|NOT COMPLETED|Overall Study||71
1681728|NCT00558363|4107008|P2|COMPLETED|Overall Study||111
1681729|NCT00558363|4107009|P1|COMPLETED|Overall Study||76
1681730|NCT00558363|4107008|P2|STARTED|Overall Study||147
1681731|NCT00558363|4107009|P1|STARTED|Overall Study||147
1681732|NCT00558285|4107064|P5|NOT COMPLETED|Overall Study||4
1681733|NCT00558285|4107065|P4|NOT COMPLETED|Overall Study||4
1681734|NCT00558285|4107066|P3|NOT COMPLETED|Overall Study||5
1681735|NCT00558285|4107067|P2|NOT COMPLETED|Overall Study||3
1681736|NCT00558285|4107068|P1|NOT COMPLETED|Overall Study||6
1681737|NCT00558285|4107064|P5|COMPLETED|Overall Study||49
1681738|NCT00558285|4107065|P4|COMPLETED|Overall Study||48
1681739|NCT00558285|4107066|P3|COMPLETED|Overall Study||46
1681740|NCT00558285|4107067|P2|COMPLETED|Overall Study||48
1681741|NCT00558285|4107068|P1|COMPLETED|Overall Study||44
1681742|NCT00558285|4107064|P5|Safety: Received Study Drug|Overall Study||53
1681743|NCT00558285|4107065|P4|Safety: Received Study Drug|Overall Study||51
1681744|NCT00558285|4107066|P3|Safety: Received Study Drug|Overall Study||51
1681745|NCT00558285|4107067|P2|Safety: Received Study Drug|Overall Study||51
1681746|NCT00558285|4107068|P1|Safety: Received Study Drug|Overall Study||49
1681747|NCT00558285|4107064|P5|STARTED|Overall Study||53
1681748|NCT00558285|4107065|P4|STARTED|Overall Study||52
1681749|NCT00558285|4107066|P3|STARTED|Overall Study||51
1681750|NCT00558285|4107067|P2|STARTED|Overall Study||51
1681751|NCT00558285|4107068|P1|STARTED|Overall Study||50
1681752|NCT00558272|4107112|P2|NOT COMPLETED|Overall Study||2
1681753|NCT00558272|4107113|P1|NOT COMPLETED|Overall Study||13
1681754|NCT00558272|4107112|P2|COMPLETED|Overall Study|4-week treatment period|68
1681755|NCT00558272|4107113|P1|COMPLETED|Overall Study|4-week treatment period|56
1681756|NCT00558272|4107112|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
1681757|NCT00558272|4107113|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
1681758|NCT00558272|4107112|P2|STARTED|Overall Study|Randomised|70
1681759|NCT00558272|4107113|P1|STARTED|Overall Study|Randomised|69
1681760|NCT00558259|4107153|P2|NOT COMPLETED|Overall Study||99
1681761|NCT00558259|4107154|P1|NOT COMPLETED|Overall Study||71
1681762|NCT00558259|4107153|P2|COMPLETED|Overall Study|Completed treatment.|563
1681763|NCT00558259|4107154|P1|COMPLETED|Overall Study|Completed treatment.|610
1681764|NCT00558259|4107153|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
1681765|NCT00558259|4107154|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
1681766|NCT00558246|4107174|P1|NOT COMPLETED|Overall Study||0
1681767|NCT00558246|4107174|P1|COMPLETED|Overall Study||79
1681768|NCT00558246|4107174|P1|STARTED|Overall Study||79
1681769|NCT00558103|4107194|P6|NOT COMPLETED|Monotherapy Extension Phase||9
1681770|NCT00558103|4107195|P5|NOT COMPLETED|Monotherapy Extension Phase||0
1681771|NCT00558103|4107196|P4|NOT COMPLETED|Monotherapy Extension Phase||0
1681772|NCT00558103|4107197|P3|NOT COMPLETED|Monotherapy Extension Phase||0
1681773|NCT00558103|4107198|P2|NOT COMPLETED|Monotherapy Extension Phase||0
1681774|NCT00558103|4107199|P1|NOT COMPLETED|Monotherapy Extension Phase||0
1681775|NCT00558103|4107194|P6|COMPLETED|Monotherapy Extension Phase||0
1681776|NCT00558103|4107195|P5|COMPLETED|Monotherapy Extension Phase||0
1681777|NCT00558103|4107196|P4|COMPLETED|Monotherapy Extension Phase||0
1681778|NCT00558103|4107197|P3|COMPLETED|Monotherapy Extension Phase||0
1681779|NCT00558103|4107198|P2|COMPLETED|Monotherapy Extension Phase||0
1681780|NCT00558103|4107199|P1|COMPLETED|Monotherapy Extension Phase||0
1681781|NCT00558103|4107194|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
1681782|NCT00558103|4107195|P5|STARTED|Monotherapy Extension Phase||0
1681783|NCT00558103|4107196|P4|STARTED|Monotherapy Extension Phase||0
1681784|NCT00558103|4107197|P3|STARTED|Monotherapy Extension Phase||0
1681785|NCT00558103|4107198|P2|STARTED|Monotherapy Extension Phase||0
1681786|NCT00558103|4107199|P1|STARTED|Monotherapy Extension Phase||0
1681787|NCT00558103|4107194|P6|NOT COMPLETED|Randomized Treatment Phase||0
1681788|NCT00558103|4107195|P5|NOT COMPLETED|Randomized Treatment Phase||5
1681789|NCT00558103|4107196|P4|NOT COMPLETED|Randomized Treatment Phase||2
1681790|NCT00558103|4107197|P3|NOT COMPLETED|Randomized Treatment Phase||3
1681791|NCT00558103|4107198|P2|NOT COMPLETED|Randomized Treatment Phase||4
1681792|NCT00558103|4107199|P1|NOT COMPLETED|Randomized Treatment Phase||5
1681793|NCT00558103|4107194|P6|COMPLETED|Randomized Treatment Phase||0
1681794|NCT00558103|4107195|P5|COMPLETED|Randomized Treatment Phase||33
1681795|NCT00558103|4107196|P4|COMPLETED|Randomized Treatment Phase||11
1681796|NCT00558103|4107197|P3|COMPLETED|Randomized Treatment Phase||33
1681797|NCT00558103|4107198|P2|COMPLETED|Randomized Treatment Phase||34
1681798|NCT00558103|4107199|P1|COMPLETED|Randomized Treatment Phase||33
1681799|NCT00558103|4107194|P6|STARTED|Randomized Treatment Phase||0
1681800|NCT00558103|4107195|P5|STARTED|Randomized Treatment Phase||38
1681801|NCT00558103|4107196|P4|STARTED|Randomized Treatment Phase||13
1681802|NCT00558103|4107197|P3|STARTED|Randomized Treatment Phase||36
1681803|NCT00558103|4107198|P2|STARTED|Randomized Treatment Phase||38
1681804|NCT00558103|4107199|P1|STARTED|Randomized Treatment Phase||38
1681805|NCT00558064|4107229|P2|NOT COMPLETED|Overall Study||5
1681806|NCT00558064|4107230|P1|NOT COMPLETED|Overall Study||5
1681807|NCT00558064|4107229|P2|COMPLETED|Overall Study||257
1681808|NCT00558064|4107230|P1|COMPLETED|Overall Study||264
1681809|NCT00558064|4107229|P2|STARTED|Overall Study||262
1681810|NCT00558064|4107230|P1|STARTED|Overall Study||269
1681811|NCT00558025|4107252|P2|NOT COMPLETED|Overall Study||3
1681812|NCT00558025|4107253|P1|NOT COMPLETED|Overall Study||4
1681813|NCT00558025|4107252|P2|COMPLETED|Overall Study||49
1681814|NCT00558025|4107253|P1|COMPLETED|Overall Study||100
1681815|NCT00558025|4107252|P2|STARTED|Overall Study||52
1681816|NCT00558025|4107253|P1|STARTED|Overall Study||104
1681817|NCT00558012|4107277|P2|NOT COMPLETED|Overall Study||18
1681818|NCT00558012|4107278|P1|NOT COMPLETED|Overall Study||25
1681819|NCT00558012|4107277|P2|COMPLETED|Overall Study||74
1681820|NCT00558012|4107278|P1|COMPLETED|Overall Study||64
1681821|NCT00558012|4107277|P2|STARTED|Overall Study||92
1681822|NCT00558012|4107278|P1|STARTED|Overall Study||89
1681823|NCT00557947|4107284|P1|NOT COMPLETED|Overall Study||0
1681824|NCT00557947|4107284|P1|COMPLETED|Overall Study||83
1681825|NCT00557947|4107284|P1|STARTED|Overall Study||83
1681826|NCT00557856|4107300|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
1681827|NCT00557856|4107301|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
1681828|NCT00557856|4107302|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
1681829|NCT00557856|4107303|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
1681830|NCT00557856|4107304|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
1681831|NCT00557856|4107305|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
1681832|NCT00557856|4107306|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
1681833|NCT00557856|4107307|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
1681834|NCT00557856|4107308|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
1681835|NCT00557856|4107300|P9|COMPLETED|Part 2: Exploratory Phase||0
1681836|NCT00557856|4107301|P8|COMPLETED|Part 2: Exploratory Phase||0
1681837|NCT00557856|4107302|P7|COMPLETED|Part 2: Exploratory Phase||0
1681838|NCT00557856|4107303|P6|COMPLETED|Part 2: Exploratory Phase||0
1681839|NCT00557856|4107304|P5|COMPLETED|Part 2: Exploratory Phase||0
1681840|NCT00557856|4107305|P4|COMPLETED|Part 2: Exploratory Phase||0
1681841|NCT00557856|4107306|P3|COMPLETED|Part 2: Exploratory Phase||0
1681842|NCT00557856|4107307|P2|COMPLETED|Part 2: Exploratory Phase||0
1681843|NCT00557856|4107308|P1|COMPLETED|Part 2: Exploratory Phase||0
1681844|NCT00557856|4107300|P9|STARTED|Part 2: Exploratory Phase||24
1681845|NCT00557856|4107301|P8|STARTED|Part 2: Exploratory Phase||0
1681846|NCT00557856|4107302|P7|STARTED|Part 2: Exploratory Phase||0
1681847|NCT00557856|4107303|P6|STARTED|Part 2: Exploratory Phase||0
1681848|NCT00557856|4107304|P5|STARTED|Part 2: Exploratory Phase||0
1681849|NCT00557856|4107305|P4|STARTED|Part 2: Exploratory Phase||0
1681850|NCT00557856|4107306|P3|STARTED|Part 2: Exploratory Phase||0
1681851|NCT00557856|4107307|P2|STARTED|Part 2: Exploratory Phase||0
1681852|NCT00557856|4107308|P1|STARTED|Part 2: Exploratory Phase||0
1681853|NCT00557856|4107300|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
1681854|NCT00557856|4107301|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
1681855|NCT00557856|4107302|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
1681856|NCT00557856|4107303|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
1681857|NCT00557856|4107304|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
1681858|NCT00557856|4107305|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
1681859|NCT00557856|4107306|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
1681860|NCT00557856|4107307|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
1681861|NCT00557856|4107308|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
1681862|NCT00557856|4107300|P9|COMPLETED|Part 1: Dose Escalation Phase||0
1681863|NCT00557856|4107301|P8|COMPLETED|Part 1: Dose Escalation Phase||0
1681864|NCT00557856|4107302|P7|COMPLETED|Part 1: Dose Escalation Phase||0
1681865|NCT00557856|4107303|P6|COMPLETED|Part 1: Dose Escalation Phase||0
1681866|NCT00557856|4107304|P5|COMPLETED|Part 1: Dose Escalation Phase||0
1681867|NCT00557856|4107305|P4|COMPLETED|Part 1: Dose Escalation Phase||0
1681868|NCT00557856|4107306|P3|COMPLETED|Part 1: Dose Escalation Phase||0
1681869|NCT00557856|4107307|P2|COMPLETED|Part 1: Dose Escalation Phase||0
1681870|NCT00557856|4107308|P1|COMPLETED|Part 1: Dose Escalation Phase||0
1681871|NCT00557856|4107300|P9|Treated|Part 1: Dose Escalation Phase||0
1681872|NCT00557856|4107301|P8|Treated|Part 1: Dose Escalation Phase||6
1681873|NCT00557856|4107302|P7|Treated|Part 1: Dose Escalation Phase||7
1681874|NCT00557856|4107303|P6|Treated|Part 1: Dose Escalation Phase||8
1681875|NCT00557856|4107304|P5|Treated|Part 1: Dose Escalation Phase||4
1681876|NCT00557856|4107305|P4|Treated|Part 1: Dose Escalation Phase||3
1681877|NCT00557856|4107306|P3|Treated|Part 1: Dose Escalation Phase||6
1681878|NCT00557856|4107307|P2|Treated|Part 1: Dose Escalation Phase||5
1681879|NCT00557856|4107308|P1|Treated|Part 1: Dose Escalation Phase||5
1681880|NCT00557856|4107300|P9|STARTED|Part 1: Dose Escalation Phase||0
1681881|NCT00557856|4107301|P8|STARTED|Part 1: Dose Escalation Phase||6
1681882|NCT00557856|4107302|P7|STARTED|Part 1: Dose Escalation Phase||7
1681883|NCT00557856|4107303|P6|STARTED|Part 1: Dose Escalation Phase||8
1681884|NCT00557856|4107304|P5|STARTED|Part 1: Dose Escalation Phase||4
1681885|NCT00557856|4107305|P4|STARTED|Part 1: Dose Escalation Phase||3
1681886|NCT00557856|4107306|P3|STARTED|Part 1: Dose Escalation Phase||6
1681887|NCT00557856|4107307|P2|STARTED|Part 1: Dose Escalation Phase||5
1681888|NCT00557856|4107308|P1|STARTED|Part 1: Dose Escalation Phase||7
1681889|NCT00557830|4107507|P3|NOT COMPLETED|Treatment Phase||0
1681890|NCT00557830|4107508|P2|NOT COMPLETED|Treatment Phase||0
1681891|NCT00557830|4107509|P1|NOT COMPLETED|Treatment Phase||0
1681892|NCT00557830|4107507|P3|COMPLETED|Treatment Phase||2
1681893|NCT00557830|4107508|P2|COMPLETED|Treatment Phase||4
1681894|NCT00557830|4107509|P1|COMPLETED|Treatment Phase||0
1681895|NCT00557830|4107507|P3|STARTED|Treatment Phase||2
1681896|NCT00557830|4107508|P2|STARTED|Treatment Phase||4
1681897|NCT00557830|4107509|P1|STARTED|Treatment Phase||0
1681898|NCT00557830|4107507|P3|NOT COMPLETED|Screening Treatment Phase||0
1681899|NCT00557830|4107508|P2|NOT COMPLETED|Screening Treatment Phase||0
1681900|NCT00557830|4107509|P1|NOT COMPLETED|Screening Treatment Phase||6
1681901|NCT00557830|4107507|P3|COMPLETED|Screening Treatment Phase||0
1681902|NCT00557830|4107508|P2|COMPLETED|Screening Treatment Phase||0
1681903|NCT00557830|4107509|P1|COMPLETED|Screening Treatment Phase||6
1681904|NCT00557830|4107507|P3|STARTED|Screening Treatment Phase||0
1681905|NCT00557830|4107508|P2|STARTED|Screening Treatment Phase||0
1681906|NCT00557830|4107509|P1|STARTED|Screening Treatment Phase||12
1681907|NCT00557622|4107531|P2|NOT COMPLETED|12-Week Treatment Phase||1
1681908|NCT00557622|4107532|P1|NOT COMPLETED|12-Week Treatment Phase||0
1681909|NCT00557622|4107531|P2|COMPLETED|12-Week Treatment Phase||1
1681910|NCT00557622|4107532|P1|COMPLETED|12-Week Treatment Phase||1
1681911|NCT00557622|4107531|P2|STARTED|12-Week Treatment Phase||2
1681912|NCT00557622|4107532|P1|STARTED|12-Week Treatment Phase||1
1681913|NCT00557622|4107531|P2|NOT COMPLETED|4-Week Run-in Phase||0
1681914|NCT00557622|4107532|P1|NOT COMPLETED|4-Week Run-in Phase||2
1681915|NCT00557622|4107531|P2|COMPLETED|4-Week Run-in Phase||0
1681916|NCT00557622|4107532|P1|COMPLETED|4-Week Run-in Phase||3
1681917|NCT00557622|4107531|P2|STARTED|4-Week Run-in Phase||0
1681918|NCT00557622|4107532|P1|STARTED|4-Week Run-in Phase||5
1681919|NCT00557505|4107561|P9|NOT COMPLETED|Overall Study||17
1681920|NCT00557505|4107562|P8|NOT COMPLETED|Overall Study||5
1681921|NCT00557505|4107563|P7|NOT COMPLETED|Overall Study||3
1681922|NCT00557505|4107564|P6|NOT COMPLETED|Overall Study||3
1681923|NCT00557505|4107565|P5|NOT COMPLETED|Overall Study||2
1681924|NCT00557505|4107566|P4|NOT COMPLETED|Overall Study||3
1681925|NCT00557505|4107567|P3|NOT COMPLETED|Overall Study||4
1681926|NCT00557505|4107568|P2|NOT COMPLETED|Overall Study||3
1681927|NCT00557505|4107569|P1|NOT COMPLETED|Overall Study||3
1681928|NCT00557505|4107561|P9|COMPLETED|Overall Study||0
1681929|NCT00557505|4107562|P8|COMPLETED|Overall Study||0
1681930|NCT00557505|4107563|P7|COMPLETED|Overall Study||0
1681931|NCT00557505|4107564|P6|COMPLETED|Overall Study||0
1681932|NCT00557505|4107565|P5|COMPLETED|Overall Study||0
1681933|NCT00557505|4107566|P4|COMPLETED|Overall Study||0
1681934|NCT00557505|4107567|P3|COMPLETED|Overall Study||0
1681935|NCT00557505|4107568|P2|COMPLETED|Overall Study||0
1681936|NCT00557505|4107569|P1|COMPLETED|Overall Study||0
1681937|NCT00557505|4107561|P9|STARTED|Overall Study||17
1681938|NCT00557505|4107562|P8|STARTED|Overall Study||5
1681939|NCT00557505|4107563|P7|STARTED|Overall Study||3
1681940|NCT00557505|4107564|P6|STARTED|Overall Study||3
1681941|NCT00557505|4107565|P5|STARTED|Overall Study||2
1681942|NCT00557505|4107566|P4|STARTED|Overall Study||3
1681943|NCT00557505|4107567|P3|STARTED|Overall Study||4
1681944|NCT00557505|4107568|P2|STARTED|Overall Study||3
1681945|NCT00557505|4107569|P1|STARTED|Overall Study||3
1681946|NCT00557492|4107733|P1|NOT COMPLETED|Overall Study||1
1681947|NCT00557492|4107733|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
1681948|NCT00557492|4107733|P1|STARTED|Overall Study||59
1681949|NCT00557466|4107751|P6|NOT COMPLETED|Overall Study||6
1681950|NCT00557466|4107752|P5|NOT COMPLETED|Overall Study||3
1681951|NCT00557466|4107753|P4|NOT COMPLETED|Overall Study||4
1681952|NCT00557466|4107754|P3|NOT COMPLETED|Overall Study||6
1681953|NCT00557466|4107755|P2|NOT COMPLETED|Overall Study||5
1681954|NCT00557466|4107756|P1|NOT COMPLETED|Overall Study||4
1681955|NCT00557466|4107751|P6|COMPLETED|Overall Study||85
1681956|NCT00557466|4107752|P5|COMPLETED|Overall Study||87
1681957|NCT00557466|4107753|P4|COMPLETED|Overall Study||92
1681958|NCT00557466|4107754|P3|COMPLETED|Overall Study||95
1681959|NCT00557466|4107755|P2|COMPLETED|Overall Study||87
1681960|NCT00557466|4107756|P1|COMPLETED|Overall Study||94
1681961|NCT00557466|4107751|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
1681962|NCT00557466|4107752|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
1681963|NCT00557466|4107753|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
1681964|NCT00557466|4107754|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
1681965|NCT00557466|4107755|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
1681966|NCT00557466|4107756|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
1681967|NCT00557466|4107751|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
1681968|NCT00557466|4107752|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
1681969|NCT00557466|4107753|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
1681970|NCT00557466|4107754|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
1681971|NCT00557466|4107755|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
1681972|NCT00557466|4107756|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
1681973|NCT00557466|4107751|P6|STARTED|Overall Study||91
1681974|NCT00557466|4107752|P5|STARTED|Overall Study||90
1681975|NCT00557466|4107753|P4|STARTED|Overall Study||96
1681976|NCT00557466|4107754|P3|STARTED|Overall Study||101
1681977|NCT00557466|4107755|P2|STARTED|Overall Study||92
1681978|NCT00557466|4107756|P1|STARTED|Overall Study||98
1681979|NCT00557440|4107809|P3|NOT COMPLETED|Treatment Period 3||0
1681980|NCT00557440|4107810|P2|NOT COMPLETED|Treatment Period 3||0
1681981|NCT00557440|4107811|P1|NOT COMPLETED|Treatment Period 3||0
1681982|NCT00557440|4107809|P3|COMPLETED|Treatment Period 3||12
1681983|NCT00557440|4107810|P2|COMPLETED|Treatment Period 3||12
1681984|NCT00557440|4107811|P1|COMPLETED|Treatment Period 3||12
1681985|NCT00557440|4107809|P3|STARTED|Treatment Period 3||12
1681986|NCT00557440|4107810|P2|STARTED|Treatment Period 3||12
1681987|NCT00557440|4107811|P1|STARTED|Treatment Period 3||12
1681988|NCT00557440|4107809|P3|NOT COMPLETED|Treatment Period 2||0
1681989|NCT00557440|4107810|P2|NOT COMPLETED|Treatment Period 2||0
1681990|NCT00557440|4107811|P1|NOT COMPLETED|Treatment Period 2||0
1681991|NCT00557440|4107809|P3|COMPLETED|Treatment Period 2||12
1681992|NCT00557440|4107810|P2|COMPLETED|Treatment Period 2||12
1681993|NCT00557440|4107811|P1|COMPLETED|Treatment Period 2||12
1681994|NCT00557440|4107809|P3|STARTED|Treatment Period 2||12
1681995|NCT00557440|4107810|P2|STARTED|Treatment Period 2||12
1681996|NCT00557440|4107811|P1|STARTED|Treatment Period 2||12
1681997|NCT00557440|4107809|P3|NOT COMPLETED|Treatment Period 1||1
1681998|NCT00557440|4107810|P2|NOT COMPLETED|Treatment Period 1||0
1681999|NCT00557440|4107811|P1|NOT COMPLETED|Treatment Period 1||0
1682000|NCT00557440|4107809|P3|COMPLETED|Treatment Period 1||12
1682001|NCT00557440|4107810|P2|COMPLETED|Treatment Period 1||12
1682002|NCT00557440|4107811|P1|COMPLETED|Treatment Period 1||12
1682003|NCT00557440|4107809|P3|STARTED|Treatment Period 1||13
1682004|NCT00557440|4107810|P2|STARTED|Treatment Period 1||12
1682005|NCT00557440|4107811|P1|STARTED|Treatment Period 1||12
1682006|NCT00557362|4107835|P4|NOT COMPLETED|Overall Study||3
1682007|NCT00557362|4107836|P3|NOT COMPLETED|Overall Study||4
1682008|NCT00557362|4107837|P2|NOT COMPLETED|Overall Study||2
1682009|NCT00557362|4107838|P1|NOT COMPLETED|Overall Study||2
1682010|NCT00557362|4107835|P4|COMPLETED|Overall Study||27
1682011|NCT00557362|4107836|P3|COMPLETED|Overall Study||26
1682012|NCT00557362|4107837|P2|COMPLETED|Overall Study||28
1682013|NCT00557362|4107838|P1|COMPLETED|Overall Study||28
1682014|NCT00557362|4107835|P4|STARTED|Overall Study||30
1682015|NCT00557362|4107836|P3|STARTED|Overall Study||30
1682016|NCT00557362|4107837|P2|STARTED|Overall Study||30
1682017|NCT00557362|4107838|P1|STARTED|Overall Study||30
1682018|NCT00557349|4107856|P2|NOT COMPLETED|Overall Study||5
1682019|NCT00557349|4107857|P1|NOT COMPLETED|Overall Study||5
1682020|NCT00557349|4107856|P2|COMPLETED|Overall Study||13
1682021|NCT00557349|4107857|P1|COMPLETED|Overall Study||17
1682022|NCT00557349|4107856|P2|STARTED|Overall Study||18
1682023|NCT00557349|4107857|P1|STARTED|Overall Study|omeprazole/bicarb|22
1682024|NCT00557323|4107865|P1|NOT COMPLETED|Overall Study||7
1682025|NCT00557323|4107865|P1|COMPLETED|Overall Study||27
1682026|NCT00557323|4107865|P1|STARTED|Overall Study||34
1682027|NCT00557310|4107870|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
1682028|NCT00557310|4107870|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
1682029|NCT00557310|4107870|P1|STARTED|Extension Phase (18 - 24 Months)||30
1682030|NCT00557310|4107870|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
1682031|NCT00557310|4107870|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
1682032|NCT00557310|4107870|P1|STARTED|Main Study (0 - 18 Months)||35
1682033|NCT00557284|4107892|P2|NOT COMPLETED|Overall Study||0
1682034|NCT00557284|4107893|P1|NOT COMPLETED|Overall Study||0
1682035|NCT00557284|4107892|P2|COMPLETED|Overall Study||11
1682036|NCT00557284|4107893|P1|COMPLETED|Overall Study||9
1682037|NCT00557284|4107892|P2|STARTED|Overall Study||11
1682038|NCT00557284|4107893|P1|STARTED|Overall Study||9
1682039|NCT00557245|4107916|P3|NOT COMPLETED|Overall Study||12
1682040|NCT00557245|4107917|P2|NOT COMPLETED|Overall Study||12
1682041|NCT00557245|4107918|P1|NOT COMPLETED|Overall Study||12
1682042|NCT00557245|4107916|P3|COMPLETED|Overall Study||1574
1682043|NCT00557245|4107917|P2|COMPLETED|Overall Study||1571
1682044|NCT00557245|4107918|P1|COMPLETED|Overall Study||1577
1682045|NCT00557245|4107916|P3|STARTED|Overall Study||1586
1682046|NCT00557245|4107917|P2|STARTED|Overall Study||1583
1682047|NCT00557245|4107918|P1|STARTED|Overall Study||1589
1682048|NCT00557193|4107956|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
1682049|NCT00557193|4107957|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
1682050|NCT00557193|4107958|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
1682051|NCT00557193|4107959|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
1682052|NCT00557193|4107960|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
1682053|NCT00557193|4107961|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
1682054|NCT00557193|4107956|P6|COMPLETED|Post Induction Therapy by Tx Assignment||19
1682055|NCT00557193|4107957|P5|COMPLETED|Post Induction Therapy by Tx Assignment||4
1682056|NCT00557193|4107958|P4|COMPLETED|Post Induction Therapy by Tx Assignment||4
1682057|NCT00557193|4107959|P3|COMPLETED|Post Induction Therapy by Tx Assignment||22
1682058|NCT00557193|4107960|P2|COMPLETED|Post Induction Therapy by Tx Assignment||50
1682059|NCT00557193|4107961|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
1682060|NCT00557193|4107956|P6|STARTED|Post Induction Therapy by Tx Assignment||56
1682061|NCT00557193|4107957|P5|STARTED|Post Induction Therapy by Tx Assignment||11
1682062|NCT00557193|4107958|P4|STARTED|Post Induction Therapy by Tx Assignment||11
1682063|NCT00557193|4107959|P3|STARTED|Post Induction Therapy by Tx Assignment||54
1682064|NCT00557193|4107960|P2|STARTED|Post Induction Therapy by Tx Assignment||60
1682065|NCT00557193|4107961|P1|STARTED|Post Induction Therapy by Tx Assignment||0
1682066|NCT00557193|4107956|P6|NOT COMPLETED|Induction||0
1682067|NCT00557193|4107957|P5|NOT COMPLETED|Induction||0
1682068|NCT00557193|4107958|P4|NOT COMPLETED|Induction||0
1682069|NCT00557193|4107959|P3|NOT COMPLETED|Induction||0
1682070|NCT00557193|4107960|P2|NOT COMPLETED|Induction||0
1682071|NCT00557193|4107961|P1|NOT COMPLETED|Induction||26
1682072|NCT00557193|4107956|P6|COMPLETED|Induction||0
1682073|NCT00557193|4107957|P5|COMPLETED|Induction||0
1682074|NCT00557193|4107958|P4|COMPLETED|Induction||0
1682075|NCT00557193|4107959|P3|COMPLETED|Induction||0
1682076|NCT00557193|4107960|P2|COMPLETED|Induction||0
1682077|NCT00557193|4107961|P1|COMPLETED|Induction||192
1682078|NCT00557193|4107956|P6|STARTED|Induction||0
1682079|NCT00557193|4107957|P5|STARTED|Induction||0
1682080|NCT00557193|4107958|P4|STARTED|Induction||0
1682081|NCT00557193|4107959|P3|STARTED|Induction||0
1682082|NCT00557193|4107960|P2|STARTED|Induction||0
1682083|NCT00557193|4107961|P1|STARTED|Induction||218
1682084|NCT00557076|4107986|P2|NOT COMPLETED|Overall Study||1
1682085|NCT00557076|4107987|P1|NOT COMPLETED|Overall Study||0
1682086|NCT00557076|4107986|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
1682087|NCT00557076|4107987|P1|COMPLETED|Overall Study||8
1682088|NCT00557076|4107986|P2|STARTED|Overall Study||8
1682089|NCT00557076|4107987|P1|STARTED|Overall Study||8
1682090|NCT00556998|4107995|P1|NOT COMPLETED|Voriconazole Oral||2
1682091|NCT00556998|4107995|P1|COMPLETED|Voriconazole Oral||20
1682092|NCT00556998|4107995|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
1682093|NCT00556998|4107995|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
1682094|NCT00556998|4107995|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
1682095|NCT00556998|4107995|P1|Treated|Voriconazole Intravenous (IV)||26
1682096|NCT00556998|4107995|P1|STARTED|Voriconazole Intravenous (IV)||26
1682097|NCT00556972|4108015|P1|NOT COMPLETED|Overall Study||0
1682098|NCT00556972|4108015|P1|COMPLETED|Overall Study||4
1682099|NCT00556972|4108015|P1|STARTED|Overall Study||4
1682100|NCT00556946|4108022|P1|NOT COMPLETED|Overall Study||1
1682101|NCT00556946|4108022|P1|COMPLETED|Overall Study||16
1682102|NCT00556946|4108022|P1|STARTED|Overall Study||17
1682103|NCT00556933|4108030|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
1682104|NCT00556933|4108031|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
1682105|NCT00556933|4108032|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
1682106|NCT00556933|4108033|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
1682107|NCT00556933|4108030|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
1682108|NCT00556933|4108031|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
1682109|NCT00556933|4108032|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
1682110|NCT00556933|4108033|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
1682111|NCT00556933|4108030|P4|STARTED|CNI Withdrawal vs. Minimization||43
1682112|NCT00556933|4108031|P3|STARTED|CNI Withdrawal vs. Minimization||39
1682113|NCT00556933|4108032|P2|STARTED|CNI Withdrawal vs. Minimization||37
1682114|NCT00556933|4108033|P1|STARTED|CNI Withdrawal vs. Minimization||43
1682115|NCT00556933|4108030|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
1682116|NCT00556933|4108031|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
1682117|NCT00556933|4108032|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
1682118|NCT00556933|4108033|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
1682119|NCT00556933|4108030|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
1682120|NCT00556933|4108031|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
1682121|NCT00556933|4108032|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
1682122|NCT00556933|4108033|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
1682123|NCT00556933|4108030|P4|STARTED|Single vs. Divided-dose rATG Induction||45
1682124|NCT00556933|4108031|P3|STARTED|Single vs. Divided-dose rATG Induction||45
1682125|NCT00556933|4108032|P2|STARTED|Single vs. Divided-dose rATG Induction||45
1682126|NCT00556933|4108033|P1|STARTED|Single vs. Divided-dose rATG Induction||45
1682127|NCT00556894|4108090|P3|NOT COMPLETED|Overall Study||19
1682128|NCT00556894|4108091|P2|NOT COMPLETED|Overall Study||19
1682129|NCT00556894|4108092|P1|NOT COMPLETED|Overall Study||16
1682130|NCT00556894|4108090|P3|COMPLETED|Overall Study||65
1682131|NCT00556894|4108091|P2|COMPLETED|Overall Study||68
1682132|NCT00556894|4108092|P1|COMPLETED|Overall Study||66
1682133|NCT00556894|4108090|P3|STARTED|Overall Study||84
1682134|NCT00556894|4108091|P2|STARTED|Overall Study||87
1682135|NCT00556894|4108092|P1|STARTED|Overall Study||82
1682136|NCT00556712|4108102|P2|NOT COMPLETED|Overall Study||438
1682137|NCT00556712|4108103|P1|NOT COMPLETED|Overall Study||451
1682138|NCT00556712|4108102|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
1682139|NCT00556712|4108103|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
1682140|NCT00556712|4108102|P2|STARTED|Overall Study||438
1682141|NCT00556712|4108103|P1|STARTED|Overall Study||451
1682142|NCT00556673|4108181|P2|NOT COMPLETED|Overall Study||2
1682143|NCT00556673|4108182|P1|NOT COMPLETED|Overall Study||3
1682144|NCT00556673|4108181|P2|COMPLETED|Overall Study||13
1682145|NCT00556673|4108182|P1|COMPLETED|Overall Study||13
1682146|NCT00556673|4108181|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
1682147|NCT00556673|4108182|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
1682148|NCT00556673|4108181|P2|STARTED|Overall Study||15
1682149|NCT00556673|4108182|P1|STARTED|Overall Study||16
1682150|NCT00556543|4108218|P1|NOT COMPLETED|Overall Study||0
1682151|NCT00556543|4108218|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
1682152|NCT00556543|4108218|P1|STARTED|Overall Study||10
1682153|NCT00556504|4108236|P2|NOT COMPLETED|Overall Study||9
1682154|NCT00556504|4108237|P1|NOT COMPLETED|Overall Study||8
1682155|NCT00556504|4108236|P2|COMPLETED|Overall Study||33
1682156|NCT00556504|4108237|P1|COMPLETED|Overall Study||34
1682157|NCT00556504|4108236|P2|Safety Population|Overall Study||42
1682158|NCT00556504|4108237|P1|Safety Population|Overall Study||41
1682159|NCT00556504|4108236|P2|Intend-to Treat Population|Overall Study||42
1682160|NCT00556504|4108237|P1|Intend-to Treat Population|Overall Study||42
1682161|NCT00556504|4108236|P2|STARTED|Overall Study||42
1682162|NCT00556504|4108237|P1|STARTED|Overall Study||42
1682163|NCT00556491|4108257|P2|NOT COMPLETED|Overall Study||1
1682164|NCT00556491|4108258|P1|NOT COMPLETED|Overall Study||1
1682165|NCT00556491|4108257|P2|COMPLETED|Overall Study||19
1682166|NCT00556491|4108258|P1|COMPLETED|Overall Study||19
1682167|NCT00556491|4108257|P2|STARTED|Overall Study||20
1682168|NCT00556491|4108258|P1|STARTED|Overall Study|January 2008|20
1682169|NCT00556478|4108276|P2|NOT COMPLETED|Open-Label Phase||10
1682170|NCT00556478|4108277|P1|NOT COMPLETED|Open-Label Phase||14
1682171|NCT00556478|4108276|P2|COMPLETED|Open-Label Phase||67
1682172|NCT00556478|4108277|P1|COMPLETED|Open-Label Phase||132
1682173|NCT00556478|4108276|P2|Treated in Open-label|Open-Label Phase||71
1682174|NCT00556478|4108277|P1|Treated in Open-label|Open-Label Phase||142
1682175|NCT00556478|4108276|P2|STARTED|Open-Label Phase||77
1682176|NCT00556478|4108277|P1|STARTED|Open-Label Phase||146
1682177|NCT00556478|4108276|P2|NOT COMPLETED|Double-blind Phase||8
1682178|NCT00556478|4108277|P1|NOT COMPLETED|Double-blind Phase||21
1682179|NCT00556478|4108276|P2|COMPLETED|Double-blind Phase||77
1682180|NCT00556478|4108277|P1|COMPLETED|Double-blind Phase||150
1682181|NCT00556478|4108276|P2|ITT|Double-blind Phase||82
1682182|NCT00556478|4108277|P1|ITT|Double-blind Phase||167
1682183|NCT00556478|4108276|P2|STARTED|Double-blind Phase||85
1682184|NCT00556478|4108277|P1|STARTED|Double-blind Phase||171
1682185|NCT00556452|4108305|P3|NOT COMPLETED|Overall Study||0
1682186|NCT00556452|4108306|P2|NOT COMPLETED|Overall Study||0
1682187|NCT00556452|4108307|P1|NOT COMPLETED|Overall Study||0
1682188|NCT00556452|4108305|P3|COMPLETED|Overall Study||19
1682189|NCT00556452|4108306|P2|COMPLETED|Overall Study||21
1682190|NCT00556452|4108307|P1|COMPLETED|Overall Study||6
1682191|NCT00556452|4108305|P3|STARTED|Overall Study||19
1682192|NCT00556452|4108306|P2|STARTED|Overall Study||21
1682193|NCT00556452|4108307|P1|STARTED|Overall Study||6
1682194|NCT00556439|4108318|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
1682195|NCT00556439|4108319|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
1682196|NCT00556439|4108320|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
1682197|NCT00556439|4108321|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
1682198|NCT00556439|4108318|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
1682199|NCT00556439|4108319|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
1682200|NCT00556439|4108320|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
1682201|NCT00556439|4108321|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
1682202|NCT00556439|4108318|P4|STARTED|After Week 12 (Randomized Study Period)||15
1682203|NCT00556439|4108319|P3|STARTED|After Week 12 (Randomized Study Period)||11
1682204|NCT00556439|4108320|P2|STARTED|After Week 12 (Randomized Study Period)||21
1682205|NCT00556439|4108321|P1|STARTED|After Week 12 (Randomized Study Period)||20
1682206|NCT00556439|4108318|P4|NOT COMPLETED|Study Entry to Week 12||0
1682207|NCT00556439|4108319|P3|NOT COMPLETED|Study Entry to Week 12||8
1682208|NCT00556439|4108320|P2|NOT COMPLETED|Study Entry to Week 12||0
1682209|NCT00556439|4108321|P1|NOT COMPLETED|Study Entry to Week 12||8
1682210|NCT00556439|4108318|P4|COMPLETED|Study Entry to Week 12||0
1682211|NCT00556439|4108319|P3|COMPLETED|Study Entry to Week 12||26
1682212|NCT00556439|4108320|P2|COMPLETED|Study Entry to Week 12||0
1682213|NCT00556439|4108321|P1|COMPLETED|Study Entry to Week 12||41
1682214|NCT00556439|4108318|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
1682215|NCT00556439|4108319|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
1682216|NCT00556439|4108320|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
1682217|NCT00556439|4108321|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
1682218|NCT00556426|4108331|P1|NOT COMPLETED|Overall Study||9
1682219|NCT00556426|4108331|P1|COMPLETED|Overall Study||91
1682220|NCT00556426|4108331|P1|STARTED|Overall Study||100
1682221|NCT00556400|4108341|P2|NOT COMPLETED|Overall Study||0
1682222|NCT00556400|4108342|P1|NOT COMPLETED|Overall Study||0
1682223|NCT00556400|4108341|P2|COMPLETED|Overall Study||0
1682224|NCT00556400|4108342|P1|COMPLETED|Overall Study||1
1682225|NCT00556400|4108341|P2|STARTED|Overall Study||0
1682226|NCT00556400|4108342|P1|STARTED|Overall Study||1
1682227|NCT00556374|4108353|P2|NOT COMPLETED|Overall Study||220
1682228|NCT00556374|4108354|P1|NOT COMPLETED|Overall Study||247
1682229|NCT00556374|4108353|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
1682230|NCT00556374|4108354|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
1682231|NCT00556374|4108353|P2|Received Study Drug|Overall Study||1700
1682232|NCT00556374|4108354|P1|Received Study Drug|Overall Study||1699
1682233|NCT00556374|4108353|P2|STARTED|Overall Study||1711
1682234|NCT00556374|4108354|P1|STARTED|Overall Study||1709
1682235|NCT00556322|4108372|P2|NOT COMPLETED|Overall Study||203
1682236|NCT00556322|4108373|P1|NOT COMPLETED|Overall Study||221
1682237|NCT00556322|4108372|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
1682238|NCT00556322|4108373|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
1682239|NCT00556322|4108372|P2|STARTED|Overall Study||203
1682240|NCT00556322|4108373|P1|STARTED|Overall Study||221
1682241|NCT00556166|4108421|P1|NOT COMPLETED|Overall Study||1
1682242|NCT00556166|4108421|P1|COMPLETED|Overall Study||3
1682243|NCT00556166|4108421|P1|STARTED|Overall Study||4
1682244|NCT00556140|4108426|P1|NOT COMPLETED|Overall Study||3
1682245|NCT00556140|4108426|P1|COMPLETED|Overall Study||13
1682246|NCT00556140|4108426|P1|STARTED|Overall Study||16
1682247|NCT00556075|4108434|P3|NOT COMPLETED|Overall Study||8
1682248|NCT00556075|4108435|P2|NOT COMPLETED|Overall Study||9
1682249|NCT00556075|4108436|P1|NOT COMPLETED|Overall Study||13
1682250|NCT00556075|4108434|P3|COMPLETED|Overall Study||15
1682251|NCT00556075|4108435|P2|COMPLETED|Overall Study||13
1682252|NCT00556075|4108436|P1|COMPLETED|Overall Study||9
1682253|NCT00556075|4108434|P3|STARTED|Overall Study||23
1682254|NCT00556075|4108435|P2|STARTED|Overall Study||22
1682255|NCT00556075|4108436|P1|STARTED|Overall Study||22
1682256|NCT00556049|4108459|P1|NOT COMPLETED|Overall Study||0
1682257|NCT00556049|4108459|P1|COMPLETED|Overall Study||72
1682258|NCT00556049|4108459|P1|STARTED|Overall Study||72
1682259|NCT00555997|4108466|P4|NOT COMPLETED|Phase 2 SPCD||3
1682260|NCT00555997|4108467|P3|NOT COMPLETED|Phase 2 SPCD||7
1682261|NCT00555997|4108468|P2|NOT COMPLETED|Phase 2 SPCD||0
1682262|NCT00555997|4108469|P1|NOT COMPLETED|Phase 2 SPCD||0
1682263|NCT00555997|4108466|P4|COMPLETED|Phase 2 SPCD||22
1682264|NCT00555997|4108467|P3|COMPLETED|Phase 2 SPCD||31
1682265|NCT00555997|4108468|P2|COMPLETED|Phase 2 SPCD||0
1682266|NCT00555997|4108469|P1|COMPLETED|Phase 2 SPCD||0
1682267|NCT00555997|4108466|P4|STARTED|Phase 2 SPCD||25
1682268|NCT00555997|4108467|P3|STARTED|Phase 2 SPCD||38
1682269|NCT00555997|4108468|P2|STARTED|Phase 2 SPCD||0
1682270|NCT00555997|4108469|P1|STARTED|Phase 2 SPCD||0
1682271|NCT00555997|4108466|P4|NOT COMPLETED|Phase 1 SPCD||0
1682272|NCT00555997|4108467|P3|NOT COMPLETED|Phase 1 SPCD||0
1682273|NCT00555997|4108468|P2|NOT COMPLETED|Phase 1 SPCD||15
1682274|NCT00555997|4108469|P1|NOT COMPLETED|Phase 1 SPCD||12
1682275|NCT00555997|4108466|P4|COMPLETED|Phase 1 SPCD||0
1682276|NCT00555997|4108467|P3|COMPLETED|Phase 1 SPCD||0
1682277|NCT00555997|4108468|P2|COMPLETED|Phase 1 SPCD||76
1682278|NCT00555997|4108469|P1|COMPLETED|Phase 1 SPCD||17
1682279|NCT00555997|4108466|P4|STARTED|Phase 1 SPCD||0
1682280|NCT00555997|4108467|P3|STARTED|Phase 1 SPCD||0
1682281|NCT00555997|4108468|P2|STARTED|Phase 1 SPCD||91
1682282|NCT00555997|4108469|P1|STARTED|Phase 1 SPCD||29
1682283|NCT00555906|4108488|P5|NOT COMPLETED|Phase 2||32
1682284|NCT00555906|4108489|P4|NOT COMPLETED|Phase 2||0
1682285|NCT00555906|4108490|P3|NOT COMPLETED|Phase 2||0
1682286|NCT00555906|4108491|P2|NOT COMPLETED|Phase 2||0
1682287|NCT00555906|4108492|P1|NOT COMPLETED|Phase 2||0
1682288|NCT00555906|4108488|P5|COMPLETED|Phase 2||0
1682289|NCT00555906|4108489|P4|COMPLETED|Phase 2||0
1682290|NCT00555906|4108490|P3|COMPLETED|Phase 2||0
1682291|NCT00555906|4108491|P2|COMPLETED|Phase 2||0
1682292|NCT00555906|4108492|P1|COMPLETED|Phase 2||0
1682293|NCT00555906|4108488|P5|Treated|Phase 2||30
1682294|NCT00555906|4108489|P4|Treated|Phase 2||0
1682295|NCT00555906|4108490|P3|Treated|Phase 2||0
1682296|NCT00555906|4108491|P2|Treated|Phase 2||0
1682297|NCT00555906|4108492|P1|Treated|Phase 2||0
1682298|NCT00555906|4108488|P5|STARTED|Phase 2||32
1682299|NCT00555906|4108489|P4|STARTED|Phase 2||0
1682300|NCT00555906|4108490|P3|STARTED|Phase 2||0
1682301|NCT00555906|4108491|P2|STARTED|Phase 2||0
1682302|NCT00555906|4108492|P1|STARTED|Phase 2||0
1682303|NCT00555906|4108488|P5|NOT COMPLETED|Phase 1||0
1682304|NCT00555906|4108489|P4|NOT COMPLETED|Phase 1||5
1682305|NCT00555906|4108490|P3|NOT COMPLETED|Phase 1||7
1682306|NCT00555906|4108491|P2|NOT COMPLETED|Phase 1||6
1682307|NCT00555906|4108492|P1|NOT COMPLETED|Phase 1||3
1682308|NCT00555906|4108488|P5|COMPLETED|Phase 1||0
1682309|NCT00555906|4108489|P4|COMPLETED|Phase 1||0
1682310|NCT00555906|4108490|P3|COMPLETED|Phase 1||0
1682311|NCT00555906|4108491|P2|COMPLETED|Phase 1||0
1682312|NCT00555906|4108492|P1|COMPLETED|Phase 1||0
1682313|NCT00555906|4108488|P5|STARTED|Phase 1||0
1682314|NCT00555906|4108489|P4|STARTED|Phase 1||5
1682315|NCT00555906|4108490|P3|STARTED|Phase 1||7
1682316|NCT00555906|4108491|P2|STARTED|Phase 1||6
1682317|NCT00555906|4108492|P1|STARTED|Phase 1||3
1682318|NCT00555893|4108524|P2|NOT COMPLETED|Overall Study||0
1682319|NCT00555893|4108525|P1|NOT COMPLETED|Overall Study||0
1682320|NCT00555893|4108524|P2|COMPLETED|Overall Study||63
1682321|NCT00555893|4108525|P1|COMPLETED|Overall Study||130
1682322|NCT00555893|4108524|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
1682323|NCT00555893|4108525|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
1682324|NCT00555893|4108524|P2|STARTED|Overall Study||63
1682325|NCT00555893|4108525|P1|STARTED|Overall Study||130
1682326|NCT00555880|4108541|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1682327|NCT00555880|4108542|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1682328|NCT00555880|4108541|P2|COMPLETED|Treatment Period 2 (1 Day)||11
1682329|NCT00555880|4108542|P1|COMPLETED|Treatment Period 2 (1 Day)||13
1682330|NCT00555880|4108541|P2|STARTED|Treatment Period 2 (1 Day)||11
1682331|NCT00555880|4108542|P1|STARTED|Treatment Period 2 (1 Day)||13
1682332|NCT00555880|4108541|P2|NOT COMPLETED|Washout (1 Day)||0
1682333|NCT00555880|4108542|P1|NOT COMPLETED|Washout (1 Day)||0
1682334|NCT00555880|4108541|P2|COMPLETED|Washout (1 Day)||11
1682335|NCT00555880|4108542|P1|COMPLETED|Washout (1 Day)||13
1682336|NCT00555880|4108541|P2|STARTED|Washout (1 Day)||11
1682337|NCT00555880|4108542|P1|STARTED|Washout (1 Day)||13
1682338|NCT00555880|4108541|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1682339|NCT00555880|4108542|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1682340|NCT00555880|4108541|P2|COMPLETED|Treatment Period 1 (1 Day)||11
1682341|NCT00555880|4108542|P1|COMPLETED|Treatment Period 1 (1 Day)||13
1682342|NCT00555880|4108541|P2|STARTED|Treatment Period 1 (1 Day)||11
1682343|NCT00555880|4108542|P1|STARTED|Treatment Period 1 (1 Day)||13
1682344|NCT00555750|4108581|P2|NOT COMPLETED|Overall Study||0
1682345|NCT00555750|4108582|P1|NOT COMPLETED|Overall Study||0
1682346|NCT00555750|4108581|P2|COMPLETED|Overall Study||10
1682347|NCT00555750|4108582|P1|COMPLETED|Overall Study||10
1682348|NCT00555750|4108581|P2|STARTED|Overall Study||10
1682349|NCT00555750|4108582|P1|STARTED|Overall Study||10
1682350|NCT00555672|4108614|P2|NOT COMPLETED|Overall Study||10
1682351|NCT00555672|4108615|P1|NOT COMPLETED|Overall Study||24
1682352|NCT00555672|4108614|P2|COMPLETED|Overall Study||0
1682353|NCT00555672|4108615|P1|COMPLETED|Overall Study||0
1682354|NCT00555672|4108614|P2|STARTED|Overall Study||10
1682355|NCT00555672|4108615|P1|STARTED|Overall Study||24
1682356|NCT00555620|4108640|P6|NOT COMPLETED|Overall Study||22
1682357|NCT00555620|4108641|P5|NOT COMPLETED|Overall Study||3
1682358|NCT00555620|4108642|P4|NOT COMPLETED|Overall Study||23
1682359|NCT00555620|4108643|P3|NOT COMPLETED|Overall Study||15
1682360|NCT00555620|4108644|P2|NOT COMPLETED|Overall Study||7
1682361|NCT00555620|4108645|P1|NOT COMPLETED|Overall Study||6
1682362|NCT00555620|4108640|P6|COMPLETED|Overall Study||0
1682363|NCT00555620|4108641|P5|COMPLETED|Overall Study||0
1682364|NCT00555620|4108642|P4|COMPLETED|Overall Study||0
1682365|NCT00555620|4108643|P3|COMPLETED|Overall Study||0
1682366|NCT00555620|4108644|P2|COMPLETED|Overall Study||0
1682367|NCT00555620|4108645|P1|COMPLETED|Overall Study||0
1682368|NCT00555620|4108640|P6|STARTED|Overall Study||22
1682369|NCT00555620|4108641|P5|STARTED|Overall Study||3
1682370|NCT00555620|4108642|P4|STARTED|Overall Study||23
1682371|NCT00555620|4108643|P3|STARTED|Overall Study||15
1682372|NCT00555620|4108644|P2|STARTED|Overall Study||7
1682373|NCT00555620|4108645|P1|STARTED|Overall Study||6
1682374|NCT00555581|4108757|P1|NOT COMPLETED|Overall Study||6
1682375|NCT00555581|4108757|P1|COMPLETED|Overall Study||24
1682376|NCT00555581|4108757|P1|STARTED|Overall Study||30
1682377|NCT00555568|4108769|P3|NOT COMPLETED|Overall Study||16
1682378|NCT00555568|4108770|P2|NOT COMPLETED|Overall Study||16
1682379|NCT00555568|4108771|P1|NOT COMPLETED|Overall Study||26
1682380|NCT00555568|4108769|P3|COMPLETED|Overall Study||84
1682381|NCT00555568|4108770|P2|COMPLETED|Overall Study||82
1682382|NCT00555568|4108771|P1|COMPLETED|Overall Study||74
1682383|NCT00555568|4108769|P3|STARTED|Overall Study||100
1682384|NCT00555568|4108770|P2|STARTED|Overall Study||98
1682385|NCT00555568|4108771|P1|STARTED|Overall Study||100
1682386|NCT00555477|4108793|P2|NOT COMPLETED|Overall Study||13
1682387|NCT00555477|4108794|P1|NOT COMPLETED|Overall Study||2
1682388|NCT00555477|4108793|P2|COMPLETED|Overall Study||32
1682389|NCT00555477|4108794|P1|COMPLETED|Overall Study||12
1682390|NCT00555477|4108793|P2|STARTED|Overall Study||45
1682391|NCT00555477|4108794|P1|STARTED|Overall Study||14
1682392|NCT00555464|4108801|P2|NOT COMPLETED|Overall Study||3
1682393|NCT00555464|4108802|P1|NOT COMPLETED|Overall Study||0
1682394|NCT00555464|4108801|P2|COMPLETED|Overall Study||1
1682395|NCT00555464|4108802|P1|COMPLETED|Overall Study||4
1682396|NCT00555464|4108801|P2|STARTED|Overall Study||4
1682397|NCT00555464|4108802|P1|STARTED|Overall Study||4
1682398|NCT00555438|4108810|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
1682399|NCT00555438|4108810|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
1682400|NCT00555438|4108810|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
1682401|NCT00555438|4108810|P1|NOT COMPLETED|10 Days Post-operative||4
1682402|NCT00555438|4108810|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
1682403|NCT00555438|4108810|P1|STARTED|10 Days Post-operative||442
1682404|NCT00555425|4108820|P2|NOT COMPLETED|Overall Study||19
1682405|NCT00555425|4108821|P1|NOT COMPLETED|Overall Study||51
1682406|NCT00555425|4108820|P2|COMPLETED|Overall Study||37
1682407|NCT00555425|4108821|P1|COMPLETED|Overall Study||6
1682408|NCT00555425|4108820|P2|STARTED|Overall Study||56
1682409|NCT00555425|4108821|P1|STARTED|Overall Study||57
1682410|NCT00555360|4108841|P2|NOT COMPLETED|Overall Study||36
1682411|NCT00555360|4108842|P1|NOT COMPLETED|Overall Study||27
1682412|NCT00555360|4108841|P2|COMPLETED|Overall Study||153
1682413|NCT00555360|4108842|P1|COMPLETED|Overall Study||156
1682414|NCT00555360|4108841|P2|STARTED|Overall Study||189
1682415|NCT00555360|4108842|P1|STARTED|Overall Study||183
1682416|NCT00555321|4108857|P5|NOT COMPLETED|Long-term Extension Phase||26
1682417|NCT00555321|4108858|P4|NOT COMPLETED|Long-term Extension Phase||38
1682418|NCT00555321|4108859|P3|NOT COMPLETED|Long-term Extension Phase||24
1682419|NCT00555321|4108860|P2|NOT COMPLETED|Long-term Extension Phase||27
1682420|NCT00555321|4108861|P1|NOT COMPLETED|Long-term Extension Phase||30
1682421|NCT00555321|4108857|P5|COMPLETED|Long-term Extension Phase||0
1682422|NCT00555321|4108858|P4|COMPLETED|Long-term Extension Phase||0
1682423|NCT00555321|4108859|P3|COMPLETED|Long-term Extension Phase||0
1682424|NCT00555321|4108860|P2|COMPLETED|Long-term Extension Phase||0
1682425|NCT00555321|4108861|P1|COMPLETED|Long-term Extension Phase||0
1682426|NCT00555321|4108857|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
1682427|NCT00555321|4108858|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
1682428|NCT00555321|4108859|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
1682429|NCT00555321|4108860|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
1682430|NCT00555321|4108861|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
1682431|NCT00555321|4108857|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
1682432|NCT00555321|4108858|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
1682433|NCT00555321|4108859|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
1682434|NCT00555321|4108860|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
1682435|NCT00555321|4108861|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
1682436|NCT00555321|4108857|P5|COMPLETED|Treatment Phase up to 12-months||32
1682437|NCT00555321|4108858|P4|COMPLETED|Treatment Phase up to 12-months||46
1682438|NCT00555321|4108859|P3|COMPLETED|Treatment Phase up to 12-months||26
1682439|NCT00555321|4108860|P2|COMPLETED|Treatment Phase up to 12-months||29
1682440|NCT00555321|4108861|P1|COMPLETED|Treatment Phase up to 12-months||31
1682441|NCT00555321|4108857|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
1682442|NCT00555321|4108858|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
1682443|NCT00555321|4108859|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
1682444|NCT00555321|4108860|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
1682445|NCT00555321|4108861|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
1682446|NCT00555321|4108857|P5|STARTED|Treatment Phase up to 12-months||54
1682447|NCT00555321|4108858|P4|STARTED|Treatment Phase up to 12-months||53
1682448|NCT00555321|4108859|P3|STARTED|Treatment Phase up to 12-months||50
1682449|NCT00555321|4108860|P2|STARTED|Treatment Phase up to 12-months||51
1682450|NCT00555321|4108861|P1|STARTED|Treatment Phase up to 12-months||52
1682451|NCT00555217|4109165|P2|NOT COMPLETED|Overall Study||68
1682452|NCT00555217|4109166|P1|NOT COMPLETED|Overall Study||75
1682453|NCT00555217|4109165|P2|COMPLETED|Overall Study||656
1682454|NCT00555217|4109166|P1|COMPLETED|Overall Study||649
1682455|NCT00555217|4109165|P2|STARTED|Overall Study||724
1682456|NCT00555217|4109166|P1|STARTED|Overall Study||724
1682457|NCT00555152|4109178|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1682458|NCT00555152|4109179|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1682459|NCT00555152|4109180|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1682460|NCT00555152|4109181|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1682461|NCT00555152|4109178|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
1682462|NCT00555152|4109179|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1682463|NCT00555152|4109180|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
1682464|NCT00555152|4109181|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1682465|NCT00555152|4109178|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
1682466|NCT00555152|4109179|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1682467|NCT00555152|4109180|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
1682468|NCT00555152|4109181|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
1682469|NCT00555152|4109178|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1682470|NCT00555152|4109179|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1682471|NCT00555152|4109180|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1682472|NCT00555152|4109181|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1682473|NCT00555152|4109178|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
1682474|NCT00555152|4109179|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1682475|NCT00555152|4109180|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1682476|NCT00555152|4109181|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
1682477|NCT00555152|4109178|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
1682478|NCT00555152|4109179|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
1682479|NCT00555152|4109180|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
1682480|NCT00555152|4109181|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
1682481|NCT00555061|4109203|P1|NOT COMPLETED|Overall Study||9
1682482|NCT00555061|4109203|P1|COMPLETED|Overall Study||78
1682483|NCT00555061|4109203|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
1682484|NCT00555048|4109210|P1|NOT COMPLETED|Overall Study||0
1682485|NCT00555048|4109210|P1|COMPLETED|Overall Study||1
1682486|NCT00555048|4109210|P1|STARTED|Overall Study||1
1682487|NCT00555009|4109222|P2|NOT COMPLETED|Overall Study||6
1682488|NCT00555009|4109223|P1|NOT COMPLETED|Overall Study||2
1682489|NCT00555009|4109222|P2|COMPLETED|Overall Study||0
1682490|NCT00555009|4109223|P1|COMPLETED|Overall Study||2
1682491|NCT00555009|4109222|P2|STARTED|Overall Study||6
1682492|NCT00555009|4109223|P1|STARTED|Overall Study||4
1682493|NCT00554996|4109245|P1|NOT COMPLETED|Overall Study||0
1682494|NCT00554996|4109245|P1|COMPLETED|Overall Study||10
1682495|NCT00554996|4109245|P1|STARTED|Overall Study||10
1682496|NCT00554970|4109253|P4|NOT COMPLETED|Period 2||0
1682497|NCT00554970|4109254|P3|NOT COMPLETED|Period 2||1
1682498|NCT00554970|4109255|P2|NOT COMPLETED|Period 2||0
1682499|NCT00554970|4109256|P1|NOT COMPLETED|Period 2||0
1682500|NCT00554970|4109253|P4|COMPLETED|Period 2||8
1682501|NCT00554970|4109254|P3|COMPLETED|Period 2||7
1682502|NCT00554970|4109255|P2|COMPLETED|Period 2||8
1682503|NCT00554970|4109256|P1|COMPLETED|Period 2||7
1682504|NCT00554970|4109253|P4|STARTED|Period 2||8
1682505|NCT00554970|4109254|P3|STARTED|Period 2||8
1682506|NCT00554970|4109255|P2|STARTED|Period 2||8
1682507|NCT00554970|4109256|P1|STARTED|Period 2||7
1682508|NCT00554970|4109253|P4|NOT COMPLETED|Period 1||0
1682509|NCT00554970|4109254|P3|NOT COMPLETED|Period 1||0
1682510|NCT00554970|4109255|P2|NOT COMPLETED|Period 1||0
1682511|NCT00554970|4109256|P1|NOT COMPLETED|Period 1||1
1682512|NCT00554970|4109253|P4|COMPLETED|Period 1||8
1682513|NCT00554970|4109254|P3|COMPLETED|Period 1||8
1682514|NCT00554970|4109255|P2|COMPLETED|Period 1||8
1682515|NCT00554970|4109256|P1|COMPLETED|Period 1||7
1682516|NCT00554970|4109253|P4|STARTED|Period 1||8
1682517|NCT00554970|4109254|P3|STARTED|Period 1||8
1682518|NCT00554970|4109255|P2|STARTED|Period 1||8
1682519|NCT00554970|4109256|P1|STARTED|Period 1||8
1682520|NCT00554853|4109288|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
1682521|NCT00554853|4109289|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
1682522|NCT00554853|4109288|P2|COMPLETED|Crossover Arm (3 Months)||55
1682523|NCT00554853|4109289|P1|COMPLETED|Crossover Arm (3 Months)||53
1682524|NCT00554853|4109288|P2|STARTED|Crossover Arm (3 Months)||57
1682525|NCT00554853|4109289|P1|STARTED|Crossover Arm (3 Months)||56
1682526|NCT00554853|4109288|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
1682527|NCT00554853|4109289|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
1682528|NCT00554853|4109288|P2|COMPLETED|Washout Period (2 Weeks)||57
1682529|NCT00554853|4109289|P1|COMPLETED|Washout Period (2 Weeks)||56
1682530|NCT00554853|4109288|P2|STARTED|Washout Period (2 Weeks)||64
1682531|NCT00554853|4109289|P1|STARTED|Washout Period (2 Weeks)||56
1682532|NCT00554853|4109288|P2|NOT COMPLETED|First Arm of Study||7
1682533|NCT00554853|4109289|P1|NOT COMPLETED|First Arm of Study||16
1682534|NCT00554853|4109288|P2|COMPLETED|First Arm of Study||64
1682535|NCT00554853|4109289|P1|COMPLETED|First Arm of Study||56
1682536|NCT00554853|4109288|P2|STARTED|First Arm of Study||71
1682537|NCT00554853|4109289|P1|STARTED|First Arm of Study||72
1682538|NCT00554840|4109303|P2|NOT COMPLETED|Overall Study||1
1682539|NCT00554840|4109304|P1|NOT COMPLETED|Overall Study||0
1682540|NCT00554840|4109303|P2|COMPLETED|Overall Study||4
1682541|NCT00554840|4109304|P1|COMPLETED|Overall Study||4
1682542|NCT00554840|4109303|P2|STARTED|Overall Study||5
1682543|NCT00554840|4109304|P1|STARTED|Overall Study||4
1682544|NCT00554801|4109322|P2|NOT COMPLETED|Overall Study||0
1682545|NCT00554801|4109323|P1|NOT COMPLETED|Overall Study||19
1682546|NCT00554801|4109322|P2|COMPLETED|Overall Study||29
1682547|NCT00554801|4109323|P1|COMPLETED|Overall Study||36
1682548|NCT00554801|4109322|P2|STARTED|Overall Study||29
1682549|NCT00554801|4109323|P1|STARTED|Overall Study||55
1682550|NCT00554749|4109331|P1|NOT COMPLETED|Overall Study||0
1682551|NCT00554749|4109331|P1|COMPLETED|Overall Study||7
1682552|NCT00554749|4109331|P1|STARTED|Overall Study||7
1682553|NCT00554671|4109338|P2|NOT COMPLETED|Overall Study||16
1682554|NCT00554671|4109339|P1|NOT COMPLETED|Overall Study||20
1682555|NCT00554671|4109338|P2|COMPLETED|Overall Study||117
1682556|NCT00554671|4109339|P1|COMPLETED|Overall Study||97
1682557|NCT00554671|4109338|P2|STARTED|Overall Study||133
1682558|NCT00554671|4109339|P1|STARTED|Overall Study||117
1682559|NCT00554619|4109351|P1|NOT COMPLETED|Overall Study||3
1682560|NCT00554619|4109351|P1|COMPLETED|Overall Study||18
1682561|NCT00554619|4109351|P1|STARTED|Overall Study||21
1682562|NCT00554515|4109363|P1|NOT COMPLETED|Overall Study||118
1682563|NCT00554515|4109363|P1|COMPLETED|Overall Study||5
1682564|NCT00554515|4109363|P1|Treated|Overall Study||120
1682565|NCT00554515|4109363|P1|STARTED|Overall Study||123
1682566|NCT00554463|4109392|P1|NOT COMPLETED|Overall Study||0
1682567|NCT00554463|4109392|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|5
1682568|NCT00554463|4109392|P1|STARTED|Overall Study||5
1682569|NCT00554372|4109398|P2|NOT COMPLETED|Overall Study||0
1682570|NCT00554372|4109399|P1|NOT COMPLETED|Overall Study||0
1682571|NCT00554372|4109398|P2|COMPLETED|Overall Study||16
1682572|NCT00554372|4109399|P1|COMPLETED|Overall Study||14
1682573|NCT00554372|4109398|P2|STARTED|Overall Study||16
1682574|NCT00554372|4109399|P1|STARTED|Overall Study||14
1682575|NCT00554294|4109413|P2|NOT COMPLETED|Overall Study||80
1682576|NCT00554294|4109414|P1|NOT COMPLETED|Overall Study||160
1682577|NCT00554294|4109413|P2|COMPLETED|Overall Study||1641
1682578|NCT00554294|4109414|P1|COMPLETED|Overall Study||1309
1682579|NCT00554294|4109413|P2|STARTED|Overall Study||1721
1682580|NCT00554294|4109414|P1|STARTED|Overall Study||1469
1682581|NCT00554229|4109420|P2|NOT COMPLETED|Overall Study||225
1682582|NCT00554229|4109421|P1|NOT COMPLETED|Overall Study||226
1682583|NCT00554229|4109420|P2|COMPLETED|Overall Study||70
1682584|NCT00554229|4109421|P1|COMPLETED|Overall Study||73
1682585|NCT00554229|4109420|P2|Patients Who Received Treatment|Overall Study||295
1682586|NCT00554229|4109421|P1|Patients Who Received Treatment|Overall Study||298
1682587|NCT00554229|4109420|P2|STARTED|Overall Study||295
1682588|NCT00554229|4109421|P1|STARTED|Overall Study||299
1682589|NCT00554216|4109446|P3|NOT COMPLETED|Overall Study||172
1682590|NCT00554216|4109447|P2|NOT COMPLETED|Overall Study||94
1682591|NCT00554216|4109448|P1|NOT COMPLETED|Overall Study||242
1682592|NCT00554216|4109446|P3|COMPLETED|Overall Study||340
1682593|NCT00554216|4109447|P2|COMPLETED|Overall Study||147
1682594|NCT00554216|4109448|P1|COMPLETED|Overall Study||272
1682595|NCT00554216|4109446|P3|STARTED|Overall Study||512
1682596|NCT00554216|4109447|P2|STARTED|Overall Study||241
1682597|NCT00554216|4109448|P1|STARTED|Overall Study||514
1682598|NCT00554190|4109459|P1|NOT COMPLETED|Overall Study||10
1682599|NCT00554190|4109459|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
1682600|NCT00554190|4109459|P1|STARTED|Overall Study|29 subjects treated.|29
1682601|NCT00554099|4109468|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
1682602|NCT00554099|4109469|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
1682603|NCT00554099|4109470|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
1682604|NCT00554099|4109468|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
1682605|NCT00554099|4109469|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
1682606|NCT00554099|4109470|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
1682607|NCT00554099|4109468|P3|STARTED|Non-Treatment Phase (9 Months)||27
1682608|NCT00554099|4109469|P2|STARTED|Non-Treatment Phase (9 Months)||32
1682609|NCT00554099|4109470|P1|STARTED|Non-Treatment Phase (9 Months)||29
1682610|NCT00554099|4109468|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
1682611|NCT00554099|4109469|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
1682612|NCT00554099|4109470|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
1682613|NCT00554099|4109468|P3|COMPLETED|Treatment Period (12 Weeks)||27
1682614|NCT00554099|4109469|P2|COMPLETED|Treatment Period (12 Weeks)||32
1682615|NCT00554099|4109470|P1|COMPLETED|Treatment Period (12 Weeks)||29
1682616|NCT00554099|4109468|P3|STARTED|Treatment Period (12 Weeks)||36
1682617|NCT00554099|4109469|P2|STARTED|Treatment Period (12 Weeks)||40
1682618|NCT00554099|4109470|P1|STARTED|Treatment Period (12 Weeks)||41
1682619|NCT00553969|4109503|P4|NOT COMPLETED|Overall Study||1
1682620|NCT00553969|4109504|P3|NOT COMPLETED|Overall Study||1
1682621|NCT00553969|4109505|P2|NOT COMPLETED|Overall Study||0
1682622|NCT00553969|4109506|P1|NOT COMPLETED|Overall Study||8
1682623|NCT00553969|4109503|P4|COMPLETED|Overall Study||23
1682624|NCT00553969|4109504|P3|COMPLETED|Overall Study||21
1682625|NCT00553969|4109505|P2|COMPLETED|Overall Study||24
1682626|NCT00553969|4109506|P1|COMPLETED|Overall Study||23
1682627|NCT00553969|4109503|P4|STARTED|Overall Study||24
1682628|NCT00553969|4109504|P3|STARTED|Overall Study||22
1682629|NCT00553969|4109505|P2|STARTED|Overall Study||24
1682630|NCT00553969|4109506|P1|STARTED|Overall Study||31
1682631|NCT00553839|4109516|P1|NOT COMPLETED|Overall Study||0
1682632|NCT00553839|4109516|P1|COMPLETED|Overall Study||21
1682633|NCT00553839|4109516|P1|STARTED|Overall Study||21
1682634|NCT00553787|4109525|P3|NOT COMPLETED|Overall Study||262
1682635|NCT00553787|4109526|P2|NOT COMPLETED|Overall Study||124
1682636|NCT00553787|4109527|P1|NOT COMPLETED|Overall Study||378
1682637|NCT00553787|4109525|P3|COMPLETED|Overall Study||733
1682638|NCT00553787|4109526|P2|COMPLETED|Overall Study||374
1682639|NCT00553787|4109527|P1|COMPLETED|Overall Study||616
1682640|NCT00553787|4109525|P3|STARTED|Overall Study||995
1682641|NCT00553787|4109526|P2|STARTED|Overall Study||498
1682642|NCT00553787|4109527|P1|STARTED|Overall Study||994
1682643|NCT00553735|4109538|P1|NOT COMPLETED|Overall Study||7
1682644|NCT00553735|4109538|P1|COMPLETED|Overall Study||1
1682645|NCT00553735|4109538|P1|STARTED|Overall Study||8
1682646|NCT00553696|4109559|P4|NOT COMPLETED|Overall Study||1
1682647|NCT00553696|4109560|P3|NOT COMPLETED|Overall Study||6
1682648|NCT00553696|4109561|P2|NOT COMPLETED|Overall Study||16
1682649|NCT00553696|4109562|P1|NOT COMPLETED|Overall Study||4
1682650|NCT00553696|4109559|P4|COMPLETED|Overall Study||0
1682651|NCT00553696|4109560|P3|COMPLETED|Overall Study||0
1682652|NCT00553696|4109561|P2|COMPLETED|Overall Study||0
1682653|NCT00553696|4109562|P1|COMPLETED|Overall Study||0
1682654|NCT00553696|4109559|P4|STARTED|Overall Study||1
1682655|NCT00553696|4109560|P3|STARTED|Overall Study||6
1682656|NCT00553696|4109561|P2|STARTED|Overall Study||16
1682657|NCT00553696|4109562|P1|STARTED|Overall Study||4
1682658|NCT00553644|4109600|P1|NOT COMPLETED|Overall Study||28
1682659|NCT00553644|4109600|P1|COMPLETED|Overall Study||25
1682660|NCT00553644|4109600|P1|STARTED|Overall Study||53
1682661|NCT00553631|4109609|P2|NOT COMPLETED|Overall Study||1
1682662|NCT00553631|4109610|P1|NOT COMPLETED|Overall Study||1
1682663|NCT00553631|4109609|P2|COMPLETED|Overall Study||16
1682664|NCT00553631|4109610|P1|COMPLETED|Overall Study||16
1682665|NCT00553631|4109609|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
1682666|NCT00553631|4109610|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
1682667|NCT00553605|4109632|P2|NOT COMPLETED|Overall Study||3
1682668|NCT00553605|4109633|P1|NOT COMPLETED|Overall Study||4
1682669|NCT00553605|4109632|P2|COMPLETED|Overall Study||161
1682670|NCT00553605|4109633|P1|COMPLETED|Overall Study||172
1682671|NCT00553605|4109632|P2|Treated|Overall Study||164
1682672|NCT00553605|4109633|P1|Treated|Overall Study||174
1682673|NCT00553605|4109632|P2|STARTED|Overall Study||164
1682674|NCT00553605|4109633|P1|STARTED|Overall Study||176
1682675|NCT00553514|4109662|P5|NOT COMPLETED|Overall Study||7
1682676|NCT00553514|4109663|P4|NOT COMPLETED|Overall Study||7
1682677|NCT00553514|4109664|P3|NOT COMPLETED|Overall Study||6
1682678|NCT00553514|4109665|P2|NOT COMPLETED|Overall Study||8
1682679|NCT00553514|4109666|P1|NOT COMPLETED|Overall Study||8
1682680|NCT00553514|4109662|P5|COMPLETED|Overall Study||8
1682681|NCT00553514|4109663|P4|COMPLETED|Overall Study||6
1682682|NCT00553514|4109664|P3|COMPLETED|Overall Study||9
1682683|NCT00553514|4109665|P2|COMPLETED|Overall Study||6
1682684|NCT00553514|4109666|P1|COMPLETED|Overall Study||6
1682685|NCT00553514|4109662|P5|STARTED|Overall Study||15
1682686|NCT00553514|4109663|P4|STARTED|Overall Study||13
1682687|NCT00553514|4109664|P3|STARTED|Overall Study||15
1682688|NCT00553514|4109665|P2|STARTED|Overall Study||14
1682689|NCT00553514|4109666|P1|STARTED|Overall Study||14
1682690|NCT00553501|4109703|P1|NOT COMPLETED|Overall Study||4
1682691|NCT00553501|4109703|P1|COMPLETED|Overall Study||55
1682692|NCT00553501|4109703|P1|STARTED|Overall Study||59
1682693|NCT00553475|4109712|P3|NOT COMPLETED|Overall Study||13
1682694|NCT00553475|4109713|P2|NOT COMPLETED|Overall Study||20
1682695|NCT00553475|4109714|P1|NOT COMPLETED|Overall Study||16
1682696|NCT00553475|4109712|P3|COMPLETED|Overall Study||32
1682697|NCT00553475|4109713|P2|COMPLETED|Overall Study||114
1682698|NCT00553475|4109714|P1|COMPLETED|Overall Study||119
1682699|NCT00553475|4109712|P3|STARTED|Overall Study||45
1682700|NCT00553475|4109713|P2|STARTED|Overall Study||134
1682701|NCT00553475|4109714|P1|STARTED|Overall Study||135
1682702|NCT00553462|4109836|P1|NOT COMPLETED|Overall Study||14
1682703|NCT00553462|4109836|P1|COMPLETED|Overall Study||61
1682704|NCT00553462|4109836|P1|STARTED|Overall Study||75
1682705|NCT00553436|4109842|P1|NOT COMPLETED|Overall Study||1
1682706|NCT00553436|4109842|P1|COMPLETED|Overall Study|09 April 2009|6
1682707|NCT00553436|4109842|P1|STARTED|Overall Study|20 August 2007|7
1682708|NCT00553358|4109851|P3|NOT COMPLETED|Overall Study||60
1682709|NCT00553358|4109852|P2|NOT COMPLETED|Overall Study||12
1682710|NCT00553358|4109853|P1|NOT COMPLETED|Overall Study||53
1682711|NCT00553358|4109851|P3|COMPLETED|Overall Study||92
1682712|NCT00553358|4109852|P2|COMPLETED|Overall Study||137
1682713|NCT00553358|4109853|P1|COMPLETED|Overall Study||101
1682714|NCT00553358|4109851|P3|STARTED|Overall Study||152
1682715|NCT00553358|4109852|P2|STARTED|Overall Study||149
1682716|NCT00553358|4109853|P1|STARTED|Overall Study||154
1682717|NCT00553332|4109879|P1|NOT COMPLETED|Overall Study||1
1682718|NCT00553332|4109879|P1|COMPLETED|Overall Study|evaluable for response|28
1682719|NCT00553332|4109879|P1|STARTED|Overall Study||29
1682720|NCT00553319|4109891|P3|NOT COMPLETED|Overall Study||9
1682721|NCT00553319|4109892|P2|NOT COMPLETED|Overall Study||10
1682722|NCT00553319|4109893|P1|NOT COMPLETED|Overall Study||14
1682723|NCT00553319|4109891|P3|COMPLETED|Overall Study||34
1682724|NCT00553319|4109892|P2|COMPLETED|Overall Study||30
1682725|NCT00553319|4109893|P1|COMPLETED|Overall Study||29
1682726|NCT00553319|4109891|P3|STARTED|Overall Study||43
1682727|NCT00553319|4109892|P2|STARTED|Overall Study||40
1682728|NCT00553319|4109893|P1|STARTED|Overall Study||43
1682729|NCT00553280|4109904|P1|NOT COMPLETED|Overall Study||26
1682730|NCT00553280|4109904|P1|COMPLETED|Overall Study||97
1682731|NCT00553280|4109904|P1|STARTED|Overall Study||123
1682732|NCT00553267|4109916|P3|NOT COMPLETED|Overall Study||10
1682733|NCT00553267|4109917|P2|NOT COMPLETED|Overall Study||18
1682734|NCT00553267|4109918|P1|NOT COMPLETED|Overall Study||14
1682735|NCT00553267|4109916|P3|COMPLETED|Overall Study||307
1682736|NCT00553267|4109917|P2|COMPLETED|Overall Study||297
1682737|NCT00553267|4109918|P1|COMPLETED|Overall Study||301
1682738|NCT00553267|4109916|P3|STARTED|Overall Study||317
1682739|NCT00553267|4109917|P2|STARTED|Overall Study||315
1682740|NCT00553267|4109918|P1|STARTED|Overall Study||315
1682741|NCT00553202|4109953|P1|NOT COMPLETED|Overall Study||68
1682742|NCT00553202|4109953|P1|COMPLETED|Overall Study||90
1682743|NCT00553202|4109953|P1|STARTED|Overall Study||158
1682744|NCT00553150|4109963|P4|NOT COMPLETED|Overall Study||4
1682745|NCT00553150|4109964|P3|NOT COMPLETED|Overall Study||0
1682746|NCT00553150|4109965|P2|NOT COMPLETED|Overall Study||0
1682747|NCT00553150|4109966|P1|NOT COMPLETED|Overall Study||0
1682748|NCT00553150|4109963|P4|COMPLETED|Overall Study||100
1682749|NCT00553150|4109964|P3|COMPLETED|Overall Study||6
1682750|NCT00553150|4109965|P2|COMPLETED|Overall Study||6
1682751|NCT00553150|4109966|P1|COMPLETED|Overall Study||6
1682752|NCT00553150|4109963|P4|STARTED|Overall Study||104
1682753|NCT00553150|4109964|P3|STARTED|Overall Study||6
1682754|NCT00553150|4109965|P2|STARTED|Overall Study||6
1682755|NCT00553150|4109966|P1|STARTED|Overall Study||6
1682756|NCT00553098|4109978|P1|NOT COMPLETED|Overall Study||1
1682757|NCT00553098|4109978|P1|COMPLETED|Overall Study||28
1682758|NCT00553098|4109978|P1|STARTED|Overall Study||29
1682759|NCT00552812|4109992|P1|NOT COMPLETED|Overall Study||20
1682760|NCT00552812|4109992|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
1682761|NCT00552812|4109992|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
1682762|NCT00552786|4110000|P2|NOT COMPLETED|Second Intervention||0
1682763|NCT00552786|4110001|P1|NOT COMPLETED|Second Intervention||0
1682764|NCT00552786|4110000|P2|COMPLETED|Second Intervention||28
1682765|NCT00552786|4110001|P1|COMPLETED|Second Intervention||25
1682766|NCT00552786|4110000|P2|STARTED|Second Intervention||28
1682767|NCT00552786|4110001|P1|STARTED|Second Intervention||25
1682768|NCT00552786|4110000|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1682769|NCT00552786|4110001|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1682770|NCT00552786|4110000|P2|COMPLETED|Washout Period of 2 Weeks||28
1682771|NCT00552786|4110001|P1|COMPLETED|Washout Period of 2 Weeks||25
1682772|NCT00552786|4110000|P2|STARTED|Washout Period of 2 Weeks||28
1682773|NCT00552786|4110001|P1|STARTED|Washout Period of 2 Weeks||25
1682774|NCT00552786|4110000|P2|NOT COMPLETED|First Intervention||0
1682775|NCT00552786|4110001|P1|NOT COMPLETED|First Intervention||0
1682776|NCT00552786|4110000|P2|COMPLETED|First Intervention||28
1682777|NCT00552786|4110001|P1|COMPLETED|First Intervention||25
1682778|NCT00552786|4110000|P2|Medication and Hearing Evaluation|First Intervention||28
1682779|NCT00552786|4110001|P1|Medication and Hearing Evaluation|First Intervention||25
1682780|NCT00552786|4110000|P2|STARTED|First Intervention||28
1682781|NCT00552786|4110001|P1|STARTED|First Intervention||25
1682782|NCT00552760|4110011|P2|NOT COMPLETED|Overall Study||33
1682783|NCT00552760|4110012|P1|NOT COMPLETED|Overall Study||26
1682784|NCT00552760|4110011|P2|COMPLETED|Overall Study||8
1682785|NCT00552760|4110012|P1|COMPLETED|Overall Study||16
1682786|NCT00552760|4110011|P2|STARTED|Overall Study||41
1682787|NCT00552760|4110012|P1|STARTED|Overall Study||42
1682788|NCT00552695|4110028|P2|NOT COMPLETED|Overall Study||0
1682789|NCT00552695|4110029|P1|NOT COMPLETED|Overall Study||0
1682790|NCT00552695|4110028|P2|COMPLETED|Overall Study|September 2007|23
1682791|NCT00552695|4110029|P1|COMPLETED|Overall Study|September 2007|22
1682792|NCT00552695|4110028|P2|STARTED|Overall Study|August 2007|23
1682793|NCT00552695|4110029|P1|STARTED|Overall Study|August 2007|22
1682794|NCT00552669|4110039|P2|NOT COMPLETED|Overall Study||7
1682795|NCT00552669|4110040|P1|NOT COMPLETED|Overall Study||3
1682796|NCT00552669|4110039|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
1682797|NCT00552669|4110040|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
1682798|NCT00552669|4110039|P2|STARTED|Overall Study|patients|100
1682799|NCT00552669|4110040|P1|STARTED|Overall Study|patients|100
1682800|NCT00552578|4110052|P2|NOT COMPLETED|Overall Study||1
1682801|NCT00552578|4110053|P1|NOT COMPLETED|Overall Study||1
1682802|NCT00552578|4110052|P2|COMPLETED|Overall Study||5
1682803|NCT00552578|4110053|P1|COMPLETED|Overall Study||5
1682804|NCT00552578|4110052|P2|STARTED|Overall Study||6
1682805|NCT00552578|4110053|P1|STARTED|Overall Study||6
1682806|NCT00552513|4110065|P2|NOT COMPLETED|Overall Study||1
1682807|NCT00552513|4110066|P1|NOT COMPLETED|Overall Study||5
1682808|NCT00552513|4110065|P2|COMPLETED|Overall Study||1437
1682809|NCT00552513|4110066|P1|COMPLETED|Overall Study||1588
1682810|NCT00552513|4110065|P2|STARTED|Overall Study||1438
1682811|NCT00552513|4110066|P1|STARTED|Overall Study||1593
1682812|NCT00552448|4110078|P2|NOT COMPLETED|Overall Study||0
1682813|NCT00552448|4110079|P1|NOT COMPLETED|Overall Study||1
1682814|NCT00552448|4110078|P2|COMPLETED|Overall Study||16
1682815|NCT00552448|4110079|P1|COMPLETED|Overall Study||19
1682816|NCT00552448|4110078|P2|STARTED|Overall Study||16
1682817|NCT00552448|4110079|P1|STARTED|Overall Study||20
1682818|NCT00552422|4110091|P1|NOT COMPLETED|Overall Study||0
1682819|NCT00552422|4110091|P1|COMPLETED|Overall Study||6
1682820|NCT00552422|4110091|P1|STARTED|Overall Study||6
1682821|NCT00552409|4110097|P2|NOT COMPLETED|Overall Study||2
1682822|NCT00552409|4110098|P1|NOT COMPLETED|Overall Study||1
1682823|NCT00552409|4110097|P2|COMPLETED|Overall Study||9
1682824|NCT00552409|4110098|P1|COMPLETED|Overall Study||10
1682825|NCT00552409|4110097|P2|STARTED|Overall Study||11
1682826|NCT00552409|4110098|P1|STARTED|Overall Study||11
1682827|NCT00552396|4110111|P7|NOT COMPLETED|Overall Study||9
1682828|NCT00552396|4110112|P6|NOT COMPLETED|Overall Study||3
1682829|NCT00552396|4110113|P5|NOT COMPLETED|Overall Study||3
1682830|NCT00552396|4110114|P4|NOT COMPLETED|Overall Study||6
1682831|NCT00552396|4110115|P3|NOT COMPLETED|Overall Study||3
1682832|NCT00552396|4110116|P2|NOT COMPLETED|Overall Study||3
1682833|NCT00552396|4110117|P1|NOT COMPLETED|Overall Study||3
1682834|NCT00552396|4110111|P7|COMPLETED|Overall Study||1
1682835|NCT00552396|4110112|P6|COMPLETED|Overall Study||0
1682836|NCT00552396|4110113|P5|COMPLETED|Overall Study||0
1682837|NCT00552396|4110114|P4|COMPLETED|Overall Study||0
1682838|NCT00552396|4110115|P3|COMPLETED|Overall Study||0
1682839|NCT00552396|4110116|P2|COMPLETED|Overall Study||0
1682840|NCT00552396|4110117|P1|COMPLETED|Overall Study||1
1682841|NCT00552396|4110111|P7|STARTED|Overall Study||10
1682842|NCT00552396|4110112|P6|STARTED|Overall Study||3
1682843|NCT00552396|4110113|P5|STARTED|Overall Study||3
1682844|NCT00552396|4110114|P4|STARTED|Overall Study||6
1682845|NCT00552396|4110115|P3|STARTED|Overall Study||3
1682846|NCT00552396|4110116|P2|STARTED|Overall Study||3
1682847|NCT00552396|4110117|P1|STARTED|Overall Study||4
1682848|NCT00552344|4110154|P1|NOT COMPLETED|Overall Study||315
1682849|NCT00552344|4110154|P1|COMPLETED|Overall Study||87
1682850|NCT00552344|4110154|P1|STARTED|Overall Study||402
1682851|NCT00552305|4110163|P1|NOT COMPLETED|Overall Study||250
1682852|NCT00552305|4110163|P1|COMPLETED|Overall Study||120
1682853|NCT00552305|4110163|P1|STARTED|Overall Study||370
1682854|NCT00552279|4110173|P2|NOT COMPLETED|Overall Study||3
1682855|NCT00552279|4110174|P1|NOT COMPLETED|Overall Study||14
1682856|NCT00552279|4110173|P2|COMPLETED|Overall Study||398
1682857|NCT00552279|4110174|P1|COMPLETED|Overall Study||389
1682858|NCT00552279|4110173|P2|STARTED|Overall Study||401
1682859|NCT00552279|4110174|P1|STARTED|Overall Study||403
1682860|NCT00552240|4110200|P2|NOT COMPLETED|Overall Study||18
1682861|NCT00552240|4110201|P1|NOT COMPLETED|Overall Study||24
1682862|NCT00552240|4110200|P2|COMPLETED|Overall Study||59
1682863|NCT00552240|4110201|P1|COMPLETED|Overall Study||51
1682864|NCT00552240|4110200|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
1682865|NCT00552240|4110201|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
1682866|NCT00552188|4110303|P2|NOT COMPLETED|Overall Study||5
1682867|NCT00552188|4110304|P1|NOT COMPLETED|Overall Study||2
1682868|NCT00552188|4110303|P2|COMPLETED|Overall Study||21
1682869|NCT00552188|4110304|P1|COMPLETED|Overall Study||24
1682870|NCT00552188|4110303|P2|STARTED|Overall Study||26
1682871|NCT00552188|4110304|P1|STARTED|Overall Study||26
1682872|NCT00552175|4110315|P3|NOT COMPLETED|Overall Study||14
1682873|NCT00552175|4110316|P2|NOT COMPLETED|Overall Study||13
1682874|NCT00552175|4110317|P1|NOT COMPLETED|Overall Study||17
1682875|NCT00552175|4110315|P3|COMPLETED|Overall Study||72
1682876|NCT00552175|4110316|P2|COMPLETED|Overall Study||73
1682877|NCT00552175|4110317|P1|COMPLETED|Overall Study||150
1682878|NCT00552175|4110315|P3|Full Analysis Set Population|Overall Study||86
1682879|NCT00552175|4110316|P2|Full Analysis Set Population|Overall Study||85
1682880|NCT00552175|4110317|P1|Full Analysis Set Population|Overall Study||167
1682881|NCT00552175|4110315|P3|STARTED|Overall Study||86
1682882|NCT00552175|4110316|P2|STARTED|Overall Study||86
1682883|NCT00552175|4110317|P1|STARTED|Overall Study||167
1682884|NCT00552110|4110357|P5|NOT COMPLETED|Overall Study||9
1682885|NCT00552110|4110358|P4|NOT COMPLETED|Overall Study||8
1682886|NCT00552110|4110359|P3|NOT COMPLETED|Overall Study||2
1682887|NCT00552110|4110360|P2|NOT COMPLETED|Overall Study||5
1682888|NCT00552110|4110361|P1|NOT COMPLETED|Overall Study||4
1682889|NCT00552110|4110357|P5|COMPLETED|Overall Study||133
1682890|NCT00552110|4110358|P4|COMPLETED|Overall Study||133
1682891|NCT00552110|4110359|P3|COMPLETED|Overall Study||137
1682892|NCT00552110|4110360|P2|COMPLETED|Overall Study||134
1682893|NCT00552110|4110361|P1|COMPLETED|Overall Study||142
1682894|NCT00552110|4110357|P5|STARTED|Overall Study||142
1682895|NCT00552110|4110358|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
1682896|NCT00552110|4110359|P3|STARTED|Overall Study||139
1682897|NCT00552110|4110360|P2|STARTED|Overall Study||139
1682898|NCT00552110|4110361|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
1682899|NCT00552084|4110380|P2|NOT COMPLETED|Overall Study||9
1682900|NCT00552084|4110381|P1|NOT COMPLETED|Overall Study||8
1682901|NCT00552084|4110380|P2|COMPLETED|Overall Study||55
1682902|NCT00552084|4110381|P1|COMPLETED|Overall Study||118
1682903|NCT00552084|4110380|P2|STARTED|Overall Study||64
1682904|NCT00552084|4110381|P1|STARTED|Overall Study||126
1682905|NCT00552071|4110389|P2|NOT COMPLETED|Overall Study||2
1682906|NCT00552071|4110390|P1|NOT COMPLETED|Overall Study||4
1682907|NCT00552071|4110389|P2|COMPLETED|Overall Study||9
1682908|NCT00552071|4110390|P1|COMPLETED|Overall Study||6
1682909|NCT00552071|4110389|P2|STARTED|Overall Study||11
1682910|NCT00552071|4110390|P1|STARTED|Overall Study||10
1682911|NCT00552058|4110400|P2|NOT COMPLETED|Overall Study||24
1682912|NCT00552058|4110401|P1|NOT COMPLETED|Overall Study||16
1682913|NCT00552058|4110400|P2|COMPLETED|Overall Study||192
1682914|NCT00552058|4110401|P1|COMPLETED|Overall Study||207
1682915|NCT00552058|4110400|P2|STARTED|Overall Study||216
1682916|NCT00552058|4110401|P1|STARTED|Overall Study||223
1682917|NCT00552032|4110441|P2|NOT COMPLETED|Overall Study||19
1682918|NCT00552032|4110442|P1|NOT COMPLETED|Overall Study||17
1682919|NCT00552032|4110441|P2|COMPLETED|Overall Study||47
1682920|NCT00552032|4110442|P1|COMPLETED|Overall Study||49
1682921|NCT00552032|4110441|P2|STARTED|Overall Study||66
1682922|NCT00552032|4110442|P1|STARTED|Overall Study||66
1682923|NCT00551759|4110486|P1|NOT COMPLETED|Overall Study||13
1682924|NCT00551759|4110486|P1|COMPLETED|Overall Study||9
1682925|NCT00551759|4110486|P1|Received Adjuvant Therapy|Overall Study||12
1682926|NCT00551759|4110486|P1|Underwent Surgery|Overall Study||17
1682927|NCT00551759|4110486|P1|Eligible and Began Treatment|Overall Study||21
1682928|NCT00551759|4110486|P1|STARTED|Overall Study||22
1682929|NCT00551746|4110492|P2|NOT COMPLETED|Overall Study||8
1682930|NCT00551746|4110493|P1|NOT COMPLETED|Overall Study||11
1682931|NCT00551746|4110492|P2|COMPLETED|Overall Study||26
1682932|NCT00551746|4110493|P1|COMPLETED|Overall Study||25
1682933|NCT00551746|4110492|P2|STARTED|Overall Study||34
1682934|NCT00551746|4110493|P1|STARTED|Overall Study||36
1682935|NCT00551707|4110504|P5|NOT COMPLETED|Overall Study||1
1682936|NCT00551707|4110505|P4|NOT COMPLETED|Overall Study||4
1682937|NCT00551707|4110506|P3|NOT COMPLETED|Overall Study||3
1682938|NCT00551707|4110507|P2|NOT COMPLETED|Overall Study||6
1682939|NCT00551707|4110508|P1|NOT COMPLETED|Overall Study||0
1682940|NCT00551707|4110504|P5|COMPLETED|Overall Study||3
1682941|NCT00551707|4110505|P4|COMPLETED|Overall Study||4
1682942|NCT00551707|4110506|P3|COMPLETED|Overall Study||10
1682943|NCT00551707|4110507|P2|COMPLETED|Overall Study||16
1682944|NCT00551707|4110508|P1|COMPLETED|Overall Study||4
1682945|NCT00551707|4110504|P5|STARTED|Overall Study||4
1682946|NCT00551707|4110505|P4|STARTED|Overall Study||8
1682947|NCT00551707|4110506|P3|STARTED|Overall Study||13
1682948|NCT00551707|4110507|P2|STARTED|Overall Study||22
1682949|NCT00551707|4110508|P1|STARTED|Overall Study||4
1682950|NCT00551642|4110527|P2|NOT COMPLETED|Overall Study||63
1682951|NCT00551642|4110528|P1|NOT COMPLETED|Overall Study||61
1682952|NCT00551642|4110527|P2|COMPLETED|Overall Study||338
1682953|NCT00551642|4110528|P1|COMPLETED|Overall Study||338
1682954|NCT00551642|4110527|P2|STARTED|Overall Study||401
1682955|NCT00551642|4110528|P1|STARTED|Overall Study||399
1682956|NCT00551525|4110534|P1|NOT COMPLETED|Overall Study||5
1682957|NCT00551525|4110534|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
1682958|NCT00551525|4110534|P1|STARTED|Overall Study||67
1682959|NCT00551460|4110543|P1|NOT COMPLETED|Overall Study||18
1682960|NCT00551460|4110543|P1|COMPLETED|Overall Study||60
1682961|NCT00551460|4110543|P1|STARTED|Overall Study||78
1682962|NCT00551421|4110549|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
1682963|NCT00551421|4110549|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
1682964|NCT00551421|4110549|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
1682965|NCT00551421|4110549|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
1682966|NCT00551421|4110549|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
1682967|NCT00551421|4110549|P1|STARTED|Original Protocol, Dose Level 1||3
1682968|NCT00551369|4110556|P1|NOT COMPLETED|Overall Study||7
1682969|NCT00551369|4110556|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
1682970|NCT00551369|4110556|P1|STARTED|Overall Study||33
1682971|NCT00551291|4110564|P1|NOT COMPLETED|Overall Study||1
1682972|NCT00551291|4110564|P1|COMPLETED|Overall Study||9
1682973|NCT00551291|4110564|P1|STARTED|Overall Study||10
1682974|NCT00551213|4110572|P2|NOT COMPLETED|Overall Study||17
1682975|NCT00551213|4110573|P1|NOT COMPLETED|Overall Study||50
1682976|NCT00551213|4110572|P2|COMPLETED|Overall Study||0
1682977|NCT00551213|4110573|P1|COMPLETED|Overall Study||0
1682978|NCT00551213|4110572|P2|Treated|Overall Study||15
1682979|NCT00551213|4110573|P1|Treated|Overall Study||49
1682980|NCT00551213|4110572|P2|STARTED|Overall Study||17
1682981|NCT00551213|4110573|P1|STARTED|Overall Study||50
1682982|NCT00551200|4110589|P1|NOT COMPLETED|Overall Study||4
1682983|NCT00551200|4110589|P1|COMPLETED|Overall Study||10
1682984|NCT00551200|4110589|P1|STARTED|Overall Study||14
1682985|NCT00551174|4110604|P2|NOT COMPLETED|Overall Study||6
1682986|NCT00551174|4110605|P1|NOT COMPLETED|Overall Study||19
1682987|NCT00551174|4110604|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
1682988|NCT00551174|4110605|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
1682989|NCT00551174|4110604|P2|STARTED|Overall Study||400
1682990|NCT00551174|4110605|P1|STARTED|Overall Study||381
1682991|NCT00551161|4110617|P1|NOT COMPLETED|Overall Study||1
1682992|NCT00551161|4110617|P1|COMPLETED|Overall Study||11
1682993|NCT00551161|4110617|P1|STARTED|Overall Study||12
1682994|NCT00551135|4110625|P4|NOT COMPLETED|Overall Study||5
1682995|NCT00551135|4110626|P3|NOT COMPLETED|Overall Study||5
1682996|NCT00551135|4110627|P2|NOT COMPLETED|Overall Study||2
1682997|NCT00551135|4110628|P1|NOT COMPLETED|Overall Study||5
1682998|NCT00551135|4110625|P4|COMPLETED|Overall Study||103
1682999|NCT00551135|4110626|P3|COMPLETED|Overall Study||98
1683000|NCT00551135|4110627|P2|COMPLETED|Overall Study||104
1683001|NCT00551135|4110628|P1|COMPLETED|Overall Study||103
1683002|NCT00551135|4110625|P4|STARTED|Overall Study||108
1683003|NCT00551135|4110626|P3|STARTED|Overall Study||103
1683004|NCT00551135|4110627|P2|STARTED|Overall Study||106
1683005|NCT00551135|4110628|P1|STARTED|Overall Study||108
1683006|NCT00551070|4110742|P1|NOT COMPLETED|Overall Study||0
1683007|NCT00551070|4110742|P1|COMPLETED|Overall Study||52
1683008|NCT00551070|4110742|P1|STARTED|Overall Study||52
1683009|NCT00551031|4110757|P5|NOT COMPLETED|Overall Study||1
1683010|NCT00551031|4110758|P4|NOT COMPLETED|Overall Study||3
1683011|NCT00551031|4110759|P3|NOT COMPLETED|Overall Study||2
1683012|NCT00551031|4110760|P2|NOT COMPLETED|Overall Study||11
1683013|NCT00551031|4110761|P1|NOT COMPLETED|Overall Study||2
1683014|NCT00551031|4110757|P5|COMPLETED|Overall Study||185
1683015|NCT00551031|4110758|P4|COMPLETED|Overall Study||317
1683016|NCT00551031|4110759|P3|COMPLETED|Overall Study||317
1683017|NCT00551031|4110760|P2|COMPLETED|Overall Study||625
1683018|NCT00551031|4110761|P1|COMPLETED|Overall Study||635
1683019|NCT00551031|4110757|P5|STARTED|Overall Study||186
1683020|NCT00551031|4110758|P4|STARTED|Overall Study||320
1683021|NCT00551031|4110759|P3|STARTED|Overall Study||319
1683022|NCT00551031|4110760|P2|STARTED|Overall Study||636
1683023|NCT00551031|4110761|P1|STARTED|Overall Study||637
1683024|NCT00550953|4110790|P2|NOT COMPLETED|Overall Study||6
1683025|NCT00550953|4110791|P1|NOT COMPLETED|Overall Study||6
1683026|NCT00550953|4110790|P2|COMPLETED|Overall Study||152
1683027|NCT00550953|4110791|P1|COMPLETED|Overall Study||150
1683028|NCT00550953|4110790|P2|STARTED|Overall Study||158
1683029|NCT00550953|4110791|P1|STARTED|Overall Study||156
1683030|NCT00550862|4110815|P4|NOT COMPLETED|Overall Study||1
1683031|NCT00550862|4110816|P3|NOT COMPLETED|Overall Study||16
1683032|NCT00550862|4110817|P2|NOT COMPLETED|Overall Study||6
1683033|NCT00550862|4110818|P1|NOT COMPLETED|Overall Study||6
1683034|NCT00550862|4110815|P4|COMPLETED|Overall Study||37
1683035|NCT00550862|4110816|P3|COMPLETED|Overall Study||25
1683036|NCT00550862|4110817|P2|COMPLETED|Overall Study||42
1683037|NCT00550862|4110818|P1|COMPLETED|Overall Study||32
1683038|NCT00550862|4110815|P4|STARTED|Overall Study||38
1683039|NCT00550862|4110816|P3|STARTED|Overall Study||41
1683040|NCT00550862|4110817|P2|STARTED|Overall Study||48
1683041|NCT00550862|4110818|P1|STARTED|Overall Study||38
1683042|NCT00550836|4110838|P2|NOT COMPLETED|Overall Study||9
1683043|NCT00550836|4110839|P1|NOT COMPLETED|Overall Study||3
1683044|NCT00550836|4110838|P2|COMPLETED|Overall Study||46
1683045|NCT00550836|4110839|P1|COMPLETED|Overall Study||46
1683046|NCT00550836|4110838|P2|STARTED|Overall Study||55
1683047|NCT00550836|4110839|P1|STARTED|Overall Study||49
1683048|NCT00550771|4110855|P2|NOT COMPLETED|Overall Study||10
1683049|NCT00550771|4110856|P1|NOT COMPLETED|Overall Study||17
1683050|NCT00550771|4110855|P2|COMPLETED|Overall Study||50
1683051|NCT00550771|4110856|P1|COMPLETED|Overall Study||104
1683052|NCT00550771|4110855|P2|STARTED|Overall Study||60
1683053|NCT00550771|4110856|P1|STARTED|Overall Study||121
1683054|NCT00550745|4110870|P2|NOT COMPLETED|Overall Study||60
1683055|NCT00550745|4110871|P1|NOT COMPLETED|Overall Study||87
1683056|NCT00550745|4110870|P2|COMPLETED|Overall Study||5939
1683057|NCT00550745|4110871|P1|COMPLETED|Overall Study||5913
1683058|NCT00550745|4110870|P2|STARTED|Overall Study||5999
1683059|NCT00550745|4110871|P1|STARTED|Overall Study||6000
1683060|NCT00550732|4110879|P1|NOT COMPLETED|Overall Study||11
1683061|NCT00550732|4110879|P1|COMPLETED|Overall Study||29
1683062|NCT00550732|4110879|P1|STARTED|Overall Study||40
1683063|NCT00550680|4110890|P1|NOT COMPLETED|Overall Study||56
1683064|NCT00550680|4110890|P1|COMPLETED|Overall Study||152
1683065|NCT00550680|4110890|P1|STARTED|Overall Study||208
1683066|NCT00550654|4110899|P1|NOT COMPLETED|Overall Study||0
1683067|NCT00550654|4110899|P1|COMPLETED|Overall Study||1
1683068|NCT00550654|4110899|P1|STARTED|Overall Study||1
1683069|NCT00550589|4110909|P1|NOT COMPLETED|Overall Study||0
1683070|NCT00550589|4110909|P1|COMPLETED|Overall Study||33
1683071|NCT00550589|4110909|P1|STARTED|Overall Study||33
1683072|NCT00550550|4110922|P2|NOT COMPLETED|Overall Study||29
1683073|NCT00550550|4110923|P1|NOT COMPLETED|Overall Study||34
1683074|NCT00550550|4110922|P2|COMPLETED|Overall Study||140
1683075|NCT00550550|4110923|P1|COMPLETED|Overall Study||142
1683076|NCT00550550|4110922|P2|Number Treated|Overall Study||169
1683077|NCT00550550|4110923|P1|Number Treated|Overall Study||175
1683078|NCT00550550|4110922|P2|STARTED|Overall Study||169
1683079|NCT00550550|4110923|P1|STARTED|Overall Study||176
1683080|NCT00550537|4110935|P1|NOT COMPLETED|Overall Study||104
1683081|NCT00550537|4110935|P1|COMPLETED|Overall Study||12
1683082|NCT00550537|4110935|P1|STARTED|Overall Study||116
1683083|NCT00550459|4110952|P2|NOT COMPLETED|Overall Study||3
1683084|NCT00550459|4110953|P1|NOT COMPLETED|Overall Study||1
1683085|NCT00550459|4110952|P2|COMPLETED|Overall Study||26
1683086|NCT00550459|4110953|P1|COMPLETED|Overall Study||27
1683087|NCT00550459|4110952|P2|STARTED|Overall Study||29
1683088|NCT00550459|4110953|P1|STARTED|Overall Study||28
1683089|NCT00550446|4111022|P11|NOT COMPLETED|Post Week 12||1
1683090|NCT00550446|4111023|P10|NOT COMPLETED|Post Week 12||7
1683091|NCT00550446|4111024|P9|NOT COMPLETED|Post Week 12||2
1683092|NCT00550446|4111025|P8|NOT COMPLETED|Post Week 12||1
1683093|NCT00550446|4111026|P7|NOT COMPLETED|Post Week 12||2
1683094|NCT00550446|4111027|P6|NOT COMPLETED|Post Week 12||1
1683095|NCT00550446|4111028|P5|NOT COMPLETED|Post Week 12||2
1683096|NCT00550446|4111029|P4|NOT COMPLETED|Post Week 12||3
1683097|NCT00550446|4111030|P3|NOT COMPLETED|Post Week 12||3
1683098|NCT00550446|4111031|P2|NOT COMPLETED|Post Week 12||2
1683099|NCT00550446|4111032|P1|NOT COMPLETED|Post Week 12||3
1683100|NCT00550446|4111022|P11|COMPLETED|Post Week 12||24
1683101|NCT00550446|4111023|P10|COMPLETED|Post Week 12||37
1683102|NCT00550446|4111024|P9|COMPLETED|Post Week 12||15
1683103|NCT00550446|4111025|P8|COMPLETED|Post Week 12||16
1683104|NCT00550446|4111026|P7|COMPLETED|Post Week 12||19
1683105|NCT00550446|4111027|P6|COMPLETED|Post Week 12||0
1683106|NCT00550446|4111028|P5|COMPLETED|Post Week 12||52
1683107|NCT00550446|4111029|P4|COMPLETED|Post Week 12||55
1683108|NCT00550446|4111030|P3|COMPLETED|Post Week 12||43
1683109|NCT00550446|4111031|P2|COMPLETED|Post Week 12||28
1683110|NCT00550446|4111032|P1|COMPLETED|Post Week 12||24
1683111|NCT00550446|4111022|P11|STARTED|Post Week 12||25
1683112|NCT00550446|4111023|P10|STARTED|Post Week 12||44
1683113|NCT00550446|4111024|P9|STARTED|Post Week 12||17
1683114|NCT00550446|4111025|P8|STARTED|Post Week 12||17
1683115|NCT00550446|4111026|P7|STARTED|Post Week 12||21
1683116|NCT00550446|4111027|P6|STARTED|Post Week 12||1
1683117|NCT00550446|4111028|P5|STARTED|Post Week 12||54
1683118|NCT00550446|4111029|P4|STARTED|Post Week 12||58
1683119|NCT00550446|4111030|P3|STARTED|Post Week 12||46
1683120|NCT00550446|4111031|P2|STARTED|Post Week 12||30
1683121|NCT00550446|4111032|P1|STARTED|Post Week 12||27
1683122|NCT00550446|4111022|P11|NOT COMPLETED|Up To Week 12||0
1683123|NCT00550446|4111023|P10|NOT COMPLETED|Up To Week 12||0
1683124|NCT00550446|4111024|P9|NOT COMPLETED|Up To Week 12||0
1683125|NCT00550446|4111025|P8|NOT COMPLETED|Up To Week 12||0
1683126|NCT00550446|4111026|P7|NOT COMPLETED|Up To Week 12||13
1683127|NCT00550446|4111027|P6|NOT COMPLETED|Up To Week 12||8
1683128|NCT00550446|4111028|P5|NOT COMPLETED|Up To Week 12||3
1683129|NCT00550446|4111029|P4|NOT COMPLETED|Up To Week 12||3
1683130|NCT00550446|4111030|P3|NOT COMPLETED|Up To Week 12||4
1683131|NCT00550446|4111031|P2|NOT COMPLETED|Up To Week 12||5
1683132|NCT00550446|4111032|P1|NOT COMPLETED|Up To Week 12||10
1683133|NCT00550446|4111022|P11|COMPLETED|Up To Week 12||0
1683134|NCT00550446|4111023|P10|COMPLETED|Up To Week 12||0
1683135|NCT00550446|4111024|P9|COMPLETED|Up To Week 12||0
1683136|NCT00550446|4111025|P8|COMPLETED|Up To Week 12||0
1683137|NCT00550446|4111026|P7|COMPLETED|Up To Week 12||46
1683138|NCT00550446|4111027|P6|COMPLETED|Up To Week 12||45
1683139|NCT00550446|4111028|P5|COMPLETED|Up To Week 12||54
1683140|NCT00550446|4111029|P4|COMPLETED|Up To Week 12||58
1683141|NCT00550446|4111030|P3|COMPLETED|Up To Week 12||46
1683142|NCT00550446|4111031|P2|COMPLETED|Up To Week 12||47
1683143|NCT00550446|4111032|P1|COMPLETED|Up To Week 12||44
1683144|NCT00550446|4111022|P11|Treated|Up To Week 12||0
1683145|NCT00550446|4111023|P10|Treated|Up To Week 12||0
1683146|NCT00550446|4111024|P9|Treated|Up To Week 12||0
1683147|NCT00550446|4111025|P8|Treated|Up To Week 12||0
1683148|NCT00550446|4111026|P7|Treated|Up To Week 12||59
1683149|NCT00550446|4111027|P6|Treated|Up To Week 12||53
1683150|NCT00550446|4111028|P5|Treated|Up To Week 12||57
1683151|NCT00550446|4111029|P4|Treated|Up To Week 12||61
1683152|NCT00550446|4111030|P3|Treated|Up To Week 12||49
1683153|NCT00550446|4111031|P2|Treated|Up To Week 12||51
1683154|NCT00550446|4111032|P1|Treated|Up To Week 12||54
1683155|NCT00550446|4111022|P11|STARTED|Up To Week 12||0
1683156|NCT00550446|4111023|P10|STARTED|Up To Week 12||0
1683157|NCT00550446|4111024|P9|STARTED|Up To Week 12||0
1683158|NCT00550446|4111025|P8|STARTED|Up To Week 12||0
1683159|NCT00550446|4111026|P7|STARTED|Up To Week 12||59
1683160|NCT00550446|4111027|P6|STARTED|Up To Week 12||53
1683161|NCT00550446|4111028|P5|STARTED|Up To Week 12||57
1683162|NCT00550446|4111029|P4|STARTED|Up To Week 12||61
1683163|NCT00550446|4111030|P3|STARTED|Up To Week 12||50
1683164|NCT00550446|4111031|P2|STARTED|Up To Week 12||52
1683165|NCT00550446|4111032|P1|STARTED|Up To Week 12||54
1683166|NCT00550420|4111464|P1|NOT COMPLETED|Overall Study||305
1683167|NCT00550420|4111464|P1|COMPLETED|Overall Study||26
1683168|NCT00550420|4111464|P1|STARTED|Overall Study||331
1683169|NCT00550407|4111487|P3|NOT COMPLETED|26-Week Randomized Phase||24
1683170|NCT00550407|4111488|P2|NOT COMPLETED|26-Week Randomized Phase||43
1683171|NCT00550407|4111489|P1|NOT COMPLETED|26-Week Randomized Phase||0
1683172|NCT00550407|4111487|P3|COMPLETED|26-Week Randomized Phase||21
1683173|NCT00550407|4111488|P2|COMPLETED|26-Week Randomized Phase||15
1683174|NCT00550407|4111489|P1|COMPLETED|26-Week Randomized Phase||0
1683175|NCT00550407|4111487|P3|STARTED|26-Week Randomized Phase||45
1683176|NCT00550407|4111488|P2|STARTED|26-Week Randomized Phase||58
1683177|NCT00550407|4111489|P1|STARTED|26-Week Randomized Phase||0
1683178|NCT00550407|4111487|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1683179|NCT00550407|4111488|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1683180|NCT00550407|4111489|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
1683181|NCT00550407|4111487|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1683182|NCT00550407|4111488|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1683183|NCT00550407|4111489|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
1683184|NCT00550407|4111487|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
1683185|NCT00550407|4111488|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
1683186|NCT00550407|4111489|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
1683187|NCT00550394|4111524|P2|NOT COMPLETED|Overall Study||13
1683188|NCT00550394|4111525|P1|NOT COMPLETED|Overall Study||12
1683189|NCT00550394|4111524|P2|COMPLETED|Overall Study||5
1683190|NCT00550394|4111525|P1|COMPLETED|Overall Study||9
1683191|NCT00550394|4111524|P2|STARTED|Overall Study||18
1683192|NCT00550394|4111525|P1|STARTED|Overall Study||21
1683193|NCT00550368|4111539|P2|NOT COMPLETED|Overall Study||0
1683194|NCT00550368|4111540|P1|NOT COMPLETED|Overall Study||0
1683195|NCT00550368|4111539|P2|COMPLETED|Overall Study||19
1683196|NCT00550368|4111540|P1|COMPLETED|Overall Study||26
1683197|NCT00550368|4111539|P2|STARTED|Overall Study||19
1683198|NCT00550368|4111540|P1|STARTED|Overall Study||26
1683199|NCT00550290|4111550|P2|NOT COMPLETED|Overall Study||0
1683200|NCT00550290|4111551|P1|NOT COMPLETED|Overall Study||0
1683201|NCT00550290|4111550|P2|COMPLETED|Overall Study||8
1683202|NCT00550290|4111551|P1|COMPLETED|Overall Study||10
1683203|NCT00550290|4111550|P2|STARTED|Overall Study||8
1683204|NCT00550290|4111551|P1|STARTED|Overall Study||10
1683205|NCT00550277|4111557|P1|NOT COMPLETED|Overall Study||9
1683206|NCT00550277|4111557|P1|COMPLETED|Overall Study||11
1683207|NCT00550277|4111557|P1|STARTED|Overall Study||20
1683208|NCT00550173|4111564|P3|NOT COMPLETED|Overall Study||73
1683209|NCT00550173|4111565|P2|NOT COMPLETED|Overall Study||63
1683210|NCT00550173|4111566|P1|NOT COMPLETED|Overall Study||72
1683211|NCT00550173|4111564|P3|COMPLETED|Overall Study||11
1683212|NCT00550173|4111565|P2|COMPLETED|Overall Study||19
1683213|NCT00550173|4111566|P1|COMPLETED|Overall Study||9
1683214|NCT00550173|4111564|P3|Not Discontinued at 18 Months|Overall Study||11
1683215|NCT00550173|4111565|P2|Not Discontinued at 18 Months|Overall Study||19
1683216|NCT00550173|4111566|P1|Not Discontinued at 18 Months|Overall Study||9
1683217|NCT00550173|4111564|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
1683218|NCT00550173|4111565|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
1683219|NCT00550173|4111566|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
1683220|NCT00550173|4111564|P3|STARTED|Overall Study||84
1683221|NCT00550173|4111565|P2|STARTED|Overall Study||82
1683222|NCT00550173|4111566|P1|STARTED|Overall Study||81
1683223|NCT00550147|4111595|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
1683224|NCT00550147|4111595|P1|COMPLETED|Quetiapine Addition Treatment Period||18
1683225|NCT00550147|4111595|P1|STARTED|Quetiapine Addition Treatment Period||24
1683226|NCT00550147|4111595|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
1683227|NCT00550147|4111595|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
1683228|NCT00550147|4111595|P1|STARTED|OROS Methylphenidate Monotherapy||30
1683229|NCT00550043|4111618|P5|NOT COMPLETED|Overall Study||1
1683230|NCT00550043|4111619|P4|NOT COMPLETED|Overall Study||2
1683231|NCT00550043|4111620|P3|NOT COMPLETED|Overall Study||1
1683232|NCT00550043|4111621|P2|NOT COMPLETED|Overall Study||3
1683233|NCT00550043|4111622|P1|NOT COMPLETED|Overall Study||0
1683234|NCT00550043|4111618|P5|COMPLETED|Overall Study||9
1683235|NCT00550043|4111619|P4|COMPLETED|Overall Study||8
1683236|NCT00550043|4111620|P3|COMPLETED|Overall Study||8
1683237|NCT00550043|4111621|P2|COMPLETED|Overall Study||9
1683238|NCT00550043|4111622|P1|COMPLETED|Overall Study||9
1683239|NCT00550043|4111618|P5|STARTED|Overall Study||10
1683240|NCT00550043|4111619|P4|STARTED|Overall Study||10
1683241|NCT00550043|4111620|P3|STARTED|Overall Study||9
1683242|NCT00550043|4111621|P2|STARTED|Overall Study||12
1683243|NCT00550043|4111622|P1|STARTED|Overall Study||9
1683244|NCT00549939|4111677|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
1683245|NCT00549939|4111678|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
1683246|NCT00549939|4111679|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
1683247|NCT00549939|4111677|P3|COMPLETED|40-week Open Label Treatment Period||78
1683248|NCT00549939|4111678|P2|COMPLETED|40-week Open Label Treatment Period||75
1683249|NCT00549939|4111679|P1|COMPLETED|40-week Open Label Treatment Period||0
1683250|NCT00549939|4111677|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
1683251|NCT00549939|4111678|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
1683332|NCT00549718|4111918|P2|NOT COMPLETED|Overall Study||37
1683252|NCT00549939|4111679|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
1683253|NCT00549939|4111677|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
1683254|NCT00549939|4111678|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
1683255|NCT00549939|4111679|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
1683256|NCT00549939|4111677|P3|COMPLETED|12-week Double Blind Treatment Period||56
1683257|NCT00549939|4111678|P2|COMPLETED|12-week Double Blind Treatment Period||55
1683258|NCT00549939|4111679|P1|COMPLETED|12-week Double Blind Treatment Period||56
1683259|NCT00549939|4111677|P3|STARTED|12-week Double Blind Treatment Period||58
1683260|NCT00549939|4111678|P2|STARTED|12-week Double Blind Treatment Period||57
1683261|NCT00549939|4111679|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
1683262|NCT00549900|4111706|P1|NOT COMPLETED|Overall Study||1
1683263|NCT00549900|4111706|P1|COMPLETED|Overall Study||29
1683264|NCT00549900|4111706|P1|STARTED|Overall Study||30
1683265|NCT00549822|4111715|P1|NOT COMPLETED|Overall Study||0
1683266|NCT00549822|4111715|P1|COMPLETED|Overall Study||3
1683267|NCT00549822|4111715|P1|STARTED|Overall Study||3
1683268|NCT00549783|4111723|P2|NOT COMPLETED|Overall Study||13
1683269|NCT00549783|4111724|P1|NOT COMPLETED|Overall Study||8
1683270|NCT00549783|4111723|P2|COMPLETED|Overall Study||122
1683271|NCT00549783|4111724|P1|COMPLETED|Overall Study||131
1683272|NCT00549783|4111723|P2|STARTED|Overall Study||135
1683273|NCT00549783|4111724|P1|STARTED|Overall Study||139
1683274|NCT00549770|4111762|P8|NOT COMPLETED|Overall Study||25
1683275|NCT00549770|4111763|P7|NOT COMPLETED|Overall Study||14
1683276|NCT00549770|4111764|P6|NOT COMPLETED|Overall Study||13
1683277|NCT00549770|4111765|P5|NOT COMPLETED|Overall Study||17
1683278|NCT00549770|4111766|P4|NOT COMPLETED|Overall Study||16
1683279|NCT00549770|4111767|P3|NOT COMPLETED|Overall Study||10
1683280|NCT00549770|4111768|P2|NOT COMPLETED|Overall Study||11
1683281|NCT00549770|4111769|P1|NOT COMPLETED|Overall Study||7
1683282|NCT00549770|4111762|P8|COMPLETED|Overall Study||148
1683283|NCT00549770|4111763|P7|COMPLETED|Overall Study||151
1683284|NCT00549770|4111764|P6|COMPLETED|Overall Study||151
1683285|NCT00549770|4111765|P5|COMPLETED|Overall Study||149
1683286|NCT00549770|4111766|P4|COMPLETED|Overall Study||147
1683287|NCT00549770|4111767|P3|COMPLETED|Overall Study||162
1683288|NCT00549770|4111768|P2|COMPLETED|Overall Study||158
1683289|NCT00549770|4111769|P1|COMPLETED|Overall Study||149
1683290|NCT00549770|4111762|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
1683291|NCT00549770|4111763|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
1683292|NCT00549770|4111764|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
1683293|NCT00549770|4111765|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
1683294|NCT00549770|4111766|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
1683295|NCT00549770|4111767|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
1683296|NCT00549770|4111768|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
1683297|NCT00549770|4111769|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
1683298|NCT00549770|4111762|P8|Intent-to-treat Population|Overall Study||172
1683299|NCT00549770|4111763|P7|Intent-to-treat Population|Overall Study||164
1683300|NCT00549770|4111764|P6|Intent-to-treat Population|Overall Study||163
1683301|NCT00549770|4111765|P5|Intent-to-treat Population|Overall Study||163
1683302|NCT00549770|4111766|P4|Intent-to-treat Population|Overall Study||163
1683303|NCT00549770|4111767|P3|Intent-to-treat Population|Overall Study||170
1683304|NCT00549770|4111768|P2|Intent-to-treat Population|Overall Study||168
1683305|NCT00549770|4111769|P1|Intent-to-treat Population|Overall Study||154
1683306|NCT00549770|4111762|P8|STARTED|Overall Study||173
1683307|NCT00549770|4111763|P7|STARTED|Overall Study||165
1683308|NCT00549770|4111764|P6|STARTED|Overall Study||164
1683309|NCT00549770|4111765|P5|STARTED|Overall Study||166
1683310|NCT00549770|4111766|P4|STARTED|Overall Study||163
1683311|NCT00549770|4111767|P3|STARTED|Overall Study||172
1683312|NCT00549770|4111768|P2|STARTED|Overall Study||169
1683313|NCT00549770|4111769|P1|STARTED|Overall Study||156
1683314|NCT00549757|4111853|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
1683315|NCT00549757|4111854|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
1683316|NCT00549757|4111853|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
1683317|NCT00549757|4111854|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
1683318|NCT00549757|4111853|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
1683319|NCT00549757|4111854|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
1683320|NCT00549757|4111853|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
1683321|NCT00549757|4111854|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
1683322|NCT00549757|4111853|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
1683323|NCT00549757|4111854|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
1683324|NCT00549757|4111853|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
1683325|NCT00549757|4111854|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
1683326|NCT00549757|4111853|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
1683327|NCT00549757|4111854|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
1683328|NCT00549757|4111853|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
1683329|NCT00549757|4111854|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
1683330|NCT00549718|4111916|P4|NOT COMPLETED|Overall Study||55
1683331|NCT00549718|4111917|P3|NOT COMPLETED|Overall Study||39
1683333|NCT00549718|4111919|P1|NOT COMPLETED|Overall Study||41
1683334|NCT00549718|4111916|P4|COMPLETED|Overall Study||73
1683335|NCT00549718|4111917|P3|COMPLETED|Overall Study||85
1683336|NCT00549718|4111918|P2|COMPLETED|Overall Study||86
1683337|NCT00549718|4111919|P1|COMPLETED|Overall Study||84
1683338|NCT00549718|4111916|P4|STARTED|Overall Study||128
1683339|NCT00549718|4111917|P3|STARTED|Overall Study||124
1683340|NCT00549718|4111918|P2|STARTED|Overall Study||123
1683341|NCT00549718|4111919|P1|STARTED|Overall Study||125
1683342|NCT00549640|4111935|P2|NOT COMPLETED|Overall Study||16
1683343|NCT00549640|4111936|P1|NOT COMPLETED|Overall Study||18
1683344|NCT00549640|4111935|P2|COMPLETED|Overall Study||24
1683345|NCT00549640|4111936|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
1683346|NCT00549640|4111935|P2|STARTED|Overall Study||40
1683347|NCT00549640|4111936|P1|STARTED|Overall Study||40
1683348|NCT00549601|4111949|P3|NOT COMPLETED|Received Study Drug||4
1683349|NCT00549601|4111950|P2|NOT COMPLETED|Received Study Drug||11
1683350|NCT00549601|4111951|P1|NOT COMPLETED|Received Study Drug||7
1683351|NCT00549601|4111949|P3|COMPLETED|Received Study Drug||45
1683352|NCT00549601|4111950|P2|COMPLETED|Received Study Drug||36
1683353|NCT00549601|4111951|P1|COMPLETED|Received Study Drug||36
1683354|NCT00549601|4111949|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
1683355|NCT00549601|4111950|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
1683356|NCT00549601|4111951|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
1683357|NCT00549601|4111949|P3|NOT COMPLETED|Randomized||2
1683358|NCT00549601|4111950|P2|NOT COMPLETED|Randomized||1
1683359|NCT00549601|4111951|P1|NOT COMPLETED|Randomized||0
1683360|NCT00549601|4111949|P3|COMPLETED|Randomized||49
1683361|NCT00549601|4111950|P2|COMPLETED|Randomized||47
1683362|NCT00549601|4111951|P1|COMPLETED|Randomized||43
1683363|NCT00549601|4111949|P3|STARTED|Randomized||51
1683364|NCT00549601|4111950|P2|STARTED|Randomized||48
1683365|NCT00549601|4111951|P1|STARTED|Randomized||43
1683366|NCT00549562|4111973|P1|NOT COMPLETED|Overall Study||2
1683367|NCT00549562|4111973|P1|COMPLETED|Overall Study||23
1683368|NCT00549562|4111973|P1|STARTED|Overall Study||25
1683369|NCT00549549|4111985|P4|NOT COMPLETED|Overall Study||25
1683370|NCT00549549|4111986|P3|NOT COMPLETED|Overall Study||17
1683371|NCT00549549|4111987|P2|NOT COMPLETED|Overall Study||22
1683372|NCT00549549|4111988|P1|NOT COMPLETED|Overall Study||24
1683373|NCT00549549|4111985|P4|COMPLETED|Overall Study||78
1683374|NCT00549549|4111986|P3|COMPLETED|Overall Study||82
1683375|NCT00549549|4111987|P2|COMPLETED|Overall Study||77
1683376|NCT00549549|4111988|P1|COMPLETED|Overall Study||77
1683377|NCT00549549|4111985|P4|Treated|Overall Study||102
1683378|NCT00549549|4111986|P3|Treated|Overall Study||98
1683379|NCT00549549|4111987|P2|Treated|Overall Study||99
1683380|NCT00549549|4111988|P1|Treated|Overall Study||101
1683381|NCT00549549|4111985|P4|STARTED|Overall Study||103
1683382|NCT00549549|4111986|P3|STARTED|Overall Study||99
1683383|NCT00549549|4111987|P2|STARTED|Overall Study||99
1683384|NCT00549549|4111988|P1|STARTED|Overall Study||101
1683385|NCT00549445|4112056|P2|NOT COMPLETED|Overall Study||17
1683386|NCT00549445|4112057|P1|NOT COMPLETED|Overall Study||15
1683387|NCT00549445|4112056|P2|COMPLETED|Overall Study||13
1683388|NCT00549445|4112057|P1|COMPLETED|Overall Study||8
1683389|NCT00549445|4112056|P2|STARTED|Overall Study||30
1683390|NCT00549445|4112057|P1|STARTED|Overall Study||23
1683391|NCT00549393|4112065|P2|NOT COMPLETED|Period 3 (6 Months)||0
1683392|NCT00549393|4112066|P1|NOT COMPLETED|Period 3 (6 Months)||0
1683393|NCT00549393|4112065|P2|COMPLETED|Period 3 (6 Months)||1326
1683394|NCT00549393|4112066|P1|COMPLETED|Period 3 (6 Months)||1103
1683395|NCT00549393|4112065|P2|Per Protocol|Period 3 (6 Months)||1326
1683396|NCT00549393|4112066|P1|Per Protocol|Period 3 (6 Months)||667
1683397|NCT00549393|4112065|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
1683398|NCT00549393|4112066|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
1683399|NCT00549393|4112065|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
1683400|NCT00549393|4112066|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
1683401|NCT00549393|4112065|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
1683402|NCT00549393|4112066|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
1683403|NCT00549393|4112065|P2|STARTED|Period 2 Washout (2 Weeks)||0
1683404|NCT00549393|4112066|P1|STARTED|Period 2 Washout (2 Weeks)||0
1683405|NCT00549393|4112065|P2|NOT COMPLETED|Period 1 (6 Months)||0
1683406|NCT00549393|4112066|P1|NOT COMPLETED|Period 1 (6 Months)||0
1683407|NCT00549393|4112065|P2|COMPLETED|Period 1 (6 Months)||1199
1683408|NCT00549393|4112066|P1|COMPLETED|Period 1 (6 Months)||1319
1683409|NCT00549393|4112065|P2|Per Protocol|Period 1 (6 Months)||1199
1683410|NCT00549393|4112066|P1|Per Protocol|Period 1 (6 Months)||880
1683411|NCT00549393|4112065|P2|STARTED|Period 1 (6 Months)|ITT|1199
1683412|NCT00549393|4112066|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
1683413|NCT00549328|4112076|P1|NOT COMPLETED|Overall Study||14
1683414|NCT00549328|4112076|P1|COMPLETED|Overall Study||0
1683415|NCT00549328|4112076|P1|STARTED|Overall Study||14
1683416|NCT00549302|4112087|P3|NOT COMPLETED|Open-Label||69
1683417|NCT00549302|4112088|P2|NOT COMPLETED|Open-Label||0
1683418|NCT00549302|4112089|P1|NOT COMPLETED|Open-Label||0
1683419|NCT00549302|4112087|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
1683420|NCT00549302|4112088|P2|COMPLETED|Open-Label||0
1683421|NCT00549302|4112089|P1|COMPLETED|Open-Label||0
1683422|NCT00549302|4112087|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
1683423|NCT00549302|4112088|P2|STARTED|Open-Label||0
1683424|NCT00549302|4112089|P1|STARTED|Open-Label||0
1683425|NCT00549302|4112087|P3|NOT COMPLETED|Double-Blind||0
1683426|NCT00549302|4112088|P2|NOT COMPLETED|Double-Blind||53
1683427|NCT00549302|4112089|P1|NOT COMPLETED|Double-Blind||11
1683428|NCT00549302|4112087|P3|COMPLETED|Double-Blind||0
1683429|NCT00549302|4112088|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
1683430|NCT00549302|4112089|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
1683431|NCT00549302|4112087|P3|Received at Least One Dose of Study Drug|Double-Blind||0
1683432|NCT00549302|4112088|P2|Received at Least One Dose of Study Drug|Double-Blind||294
1683433|NCT00549302|4112089|P1|Received at Least One Dose of Study Drug|Double-Blind||63
1683434|NCT00549302|4112087|P3|STARTED|Double-Blind||0
1683435|NCT00549302|4112088|P2|STARTED|Double-Blind||294
1683436|NCT00549302|4112089|P1|STARTED|Double-Blind||63
1683437|NCT00549198|4112101|P2|NOT COMPLETED|Overall Study||63
1683438|NCT00549198|4112102|P1|NOT COMPLETED|Overall Study||80
1683439|NCT00549198|4112101|P2|COMPLETED|Overall Study||134
1683440|NCT00549198|4112102|P1|COMPLETED|Overall Study||115
1683441|NCT00549198|4112101|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
1683442|NCT00549198|4112102|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
1683443|NCT00549172|4112224|P2|NOT COMPLETED|Overall Study||0
1683444|NCT00549172|4112225|P1|NOT COMPLETED|Overall Study||0
1683445|NCT00549172|4112224|P2|COMPLETED|Overall Study||76
1683446|NCT00549172|4112225|P1|COMPLETED|Overall Study||70
1683447|NCT00549172|4112224|P2|STARTED|Overall Study||76
1683448|NCT00549172|4112225|P1|STARTED|Overall Study||70
1683449|NCT00549055|4112239|P1|NOT COMPLETED|Overall Study||35
1683450|NCT00549055|4112239|P1|COMPLETED|Overall Study||3
1683451|NCT00549055|4112239|P1|STARTED|Overall Study||38
1683452|NCT00548886|4112249|P1|NOT COMPLETED|Overall Study||0
1683453|NCT00548886|4112249|P1|COMPLETED|Overall Study||7
1683454|NCT00548886|4112249|P1|STARTED|Overall Study||7
1683455|NCT00548860|4112256|P2|NOT COMPLETED|Overall Study||175
1683456|NCT00548860|4112257|P1|NOT COMPLETED|Overall Study||136
1683457|NCT00548860|4112256|P2|COMPLETED|Overall Study||847
1683458|NCT00548860|4112257|P1|COMPLETED|Overall Study||860
1683459|NCT00548860|4112256|P2|STARTED|Overall Study||1022
1683460|NCT00548860|4112257|P1|STARTED|Overall Study||996
1683461|NCT00548847|4112263|P1|NOT COMPLETED|Overall Study||7
1683462|NCT00548847|4112263|P1|COMPLETED|Overall Study||8
1683463|NCT00548847|4112263|P1|STARTED|Overall Study||15
1683464|NCT00548808|4112270|P2|NOT COMPLETED|Overall Study||26
1683465|NCT00548808|4112271|P1|NOT COMPLETED|Overall Study||42
1683466|NCT00548808|4112270|P2|COMPLETED|Overall Study||186
1683467|NCT00548808|4112271|P1|COMPLETED|Overall Study||172
1683468|NCT00548808|4112270|P2|Per-Protocol Set|Overall Study||184
1683469|NCT00548808|4112271|P1|Per-Protocol Set|Overall Study||177
1683470|NCT00548808|4112270|P2|Full Analysis Set|Overall Study||212
1683471|NCT00548808|4112271|P1|Full Analysis Set|Overall Study||211
1683472|NCT00548808|4112270|P2|STARTED|Overall Study||212
1683473|NCT00548808|4112271|P1|STARTED|Overall Study||214
1683474|NCT00548717|4112295|P2|NOT COMPLETED|Overall Study||2
1683475|NCT00548717|4112296|P1|NOT COMPLETED|Overall Study||9
1683476|NCT00548717|4112295|P2|COMPLETED|Overall Study||0
1683477|NCT00548717|4112296|P1|COMPLETED|Overall Study||4
1683478|NCT00548717|4112295|P2|STARTED|Overall Study||2
1683479|NCT00548717|4112296|P1|STARTED|Overall Study||13
1683480|NCT00548691|4112315|P2|NOT COMPLETED|Overall Study||9
1683481|NCT00548691|4112316|P1|NOT COMPLETED|Overall Study||7
1683482|NCT00548691|4112315|P2|COMPLETED|Overall Study||250
1683483|NCT00548691|4112316|P1|COMPLETED|Overall Study||251
1683484|NCT00548691|4112315|P2|STARTED|Overall Study||259
1683485|NCT00548691|4112316|P1|STARTED|Overall Study||258
1683486|NCT00548548|4112324|P2|NOT COMPLETED|Overall Study||366
1683487|NCT00548548|4112325|P1|NOT COMPLETED|Overall Study||362
1683488|NCT00548548|4112324|P2|COMPLETED|Overall Study||21
1683489|NCT00548548|4112325|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
1683490|NCT00548548|4112324|P2|Safety Population|Overall Study||381
1683491|NCT00548548|4112325|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
1683492|NCT00548548|4112324|P2|Treated|Overall Study||384
1683493|NCT00548548|4112325|P1|Treated|Overall Study||383
1683494|NCT00548548|4112324|P2|STARTED|Overall Study||387
1683495|NCT00548548|4112325|P1|STARTED|Overall Study||387
1683496|NCT00548470|4112345|P1|NOT COMPLETED|Overall Study||2
1683497|NCT00548470|4112345|P1|COMPLETED|Overall Study||12
1683498|NCT00548470|4112345|P1|STARTED|Overall Study||14
1683499|NCT00548431|4112353|P1|NOT COMPLETED|Overall Study||0
1683500|NCT00548431|4112353|P1|COMPLETED|Overall Study||38
1683501|NCT00548431|4112353|P1|STARTED|Overall Study||38
1683502|NCT00548418|4112357|P1|NOT COMPLETED|Overall Study||0
1683503|NCT00548418|4112357|P1|COMPLETED|Overall Study||27
1683504|NCT00548418|4112357|P1|STARTED|Overall Study||27
1683505|NCT00548405|4112368|P3|NOT COMPLETED|Overall Study||9
1683506|NCT00548405|4112369|P2|NOT COMPLETED|Overall Study||20
1683507|NCT00548405|4112370|P1|NOT COMPLETED|Overall Study||56
1683508|NCT00548405|4112368|P3|COMPLETED|Overall Study||164
1683509|NCT00548405|4112369|P2|COMPLETED|Overall Study||416
1683510|NCT00548405|4112370|P1|COMPLETED|Overall Study||175
1683511|NCT00548405|4112368|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
1683512|NCT00548405|4112369|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
1683513|NCT00548405|4112370|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
1683514|NCT00548405|4112368|P3|STARTED|Overall Study|Randomized.|173
1683515|NCT00548405|4112369|P2|STARTED|Overall Study|Randomized.|436
1683516|NCT00548405|4112370|P1|STARTED|Overall Study|Randomized.|231
1683517|NCT00548340|4112391|P3|NOT COMPLETED|Overall Study||9
1683518|NCT00548340|4112392|P2|NOT COMPLETED|Overall Study||11
1683519|NCT00548340|4112393|P1|NOT COMPLETED|Overall Study||8
1683520|NCT00548340|4112391|P3|COMPLETED|Overall Study||95
1683521|NCT00548340|4112392|P2|COMPLETED|Overall Study||98
1683522|NCT00548340|4112393|P1|COMPLETED|Overall Study||101
1683523|NCT00548340|4112391|P3|STARTED|Overall Study||104
1683524|NCT00548340|4112392|P2|STARTED|Overall Study||109
1683525|NCT00548340|4112393|P1|STARTED|Overall Study||109
1683526|NCT00548327|4112412|P2|NOT COMPLETED|Overall Study||1
1683527|NCT00548327|4112413|P1|NOT COMPLETED|Overall Study||0
1683528|NCT00548327|4112412|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
1683529|NCT00548327|4112413|P1|COMPLETED|Overall Study||6
1683530|NCT00548327|4112412|P2|STARTED|Overall Study||5
1683531|NCT00548327|4112413|P1|STARTED|Overall Study||6
1683532|NCT00548262|4112431|P1|NOT COMPLETED|Overall Study||32
1683533|NCT00548262|4112431|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
1683534|NCT00548262|4112431|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
1683535|NCT00548249|4112461|P5|NOT COMPLETED|Overall Study||21
1683536|NCT00548249|4112462|P4|NOT COMPLETED|Overall Study||13
1683537|NCT00548249|4112463|P3|NOT COMPLETED|Overall Study||20
1683538|NCT00548249|4112464|P2|NOT COMPLETED|Overall Study||13
1683539|NCT00548249|4112465|P1|NOT COMPLETED|Overall Study||16
1683540|NCT00548249|4112461|P5|COMPLETED|Overall Study||7
1683541|NCT00548249|4112462|P4|COMPLETED|Overall Study||9
1683542|NCT00548249|4112463|P3|COMPLETED|Overall Study||9
1683543|NCT00548249|4112464|P2|COMPLETED|Overall Study||13
1683544|NCT00548249|4112465|P1|COMPLETED|Overall Study||10
1683545|NCT00548249|4112461|P5|STARTED|Overall Study||28
1683546|NCT00548249|4112462|P4|STARTED|Overall Study||22
1683547|NCT00548249|4112463|P3|STARTED|Overall Study||29
1683548|NCT00548249|4112464|P2|STARTED|Overall Study||26
1683549|NCT00548249|4112465|P1|STARTED|Overall Study||26
1683550|NCT00548197|4112504|P2|NOT COMPLETED|Overall Study||0
1683551|NCT00548197|4112505|P1|NOT COMPLETED|Overall Study||0
1683552|NCT00548197|4112504|P2|COMPLETED|Overall Study||22
1683553|NCT00548197|4112505|P1|COMPLETED|Overall Study||18
1683554|NCT00548197|4112504|P2|STARTED|Overall Study||22
1683555|NCT00548197|4112505|P1|STARTED|Overall Study||18
1683556|NCT00548184|4112513|P1|NOT COMPLETED|Overall Study||5
1683557|NCT00548184|4112513|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
1683558|NCT00548184|4112513|P1|STARTED|Overall Study||65
1683559|NCT00548145|4112519|P2|NOT COMPLETED|Overall Study||4
1683560|NCT00548145|4112520|P1|NOT COMPLETED|Overall Study||1
1683561|NCT00548145|4112519|P2|COMPLETED|Overall Study||16
1683562|NCT00548145|4112520|P1|COMPLETED|Overall Study||17
1683563|NCT00548145|4112519|P2|STARTED|Overall Study||20
1683564|NCT00548145|4112520|P1|STARTED|Overall Study||18
1683565|NCT00548132|4112528|P2|NOT COMPLETED|Overall Study||0
1683566|NCT00548132|4112529|P1|NOT COMPLETED|Overall Study||0
1683567|NCT00548132|4112528|P2|COMPLETED|Overall Study||554
1683568|NCT00548132|4112529|P1|COMPLETED|Overall Study||534
1683569|NCT00548132|4112528|P2|Consented to Study|Overall Study||554
1683570|NCT00548132|4112529|P1|Consented to Study|Overall Study||534
1683571|NCT00548132|4112528|P2|STARTED|Overall Study||554
1683572|NCT00548132|4112529|P1|STARTED|Overall Study||534
1683573|NCT00548041|4112537|P1|NOT COMPLETED|Overall Study||0
1683574|NCT00548041|4112537|P1|COMPLETED|Overall Study||100
1683575|NCT00548041|4112537|P1|STARTED|Overall Study||100
1683576|NCT00547911|4112545|P6|NOT COMPLETED|Overall Study||0
1683577|NCT00547911|4112546|P5|NOT COMPLETED|Overall Study||0
1683578|NCT00547911|4112547|P4|NOT COMPLETED|Overall Study||1
1683579|NCT00547911|4112548|P3|NOT COMPLETED|Overall Study||0
1683580|NCT00547911|4112549|P2|NOT COMPLETED|Overall Study||0
1683581|NCT00547911|4112550|P1|NOT COMPLETED|Overall Study||0
1683582|NCT00547911|4112545|P6|COMPLETED|Overall Study||3
1683583|NCT00547911|4112546|P5|COMPLETED|Overall Study||3
1683584|NCT00547911|4112547|P4|COMPLETED|Overall Study||1
1683585|NCT00547911|4112548|P3|COMPLETED|Overall Study||2
1683586|NCT00547911|4112549|P2|COMPLETED|Overall Study||2
1683587|NCT00547911|4112550|P1|COMPLETED|Overall Study||2
1683588|NCT00547911|4112545|P6|STARTED|Overall Study||3
1683589|NCT00547911|4112546|P5|STARTED|Overall Study||3
1683590|NCT00547911|4112547|P4|STARTED|Overall Study||2
1683591|NCT00547911|4112548|P3|STARTED|Overall Study||2
1683592|NCT00547911|4112549|P2|STARTED|Overall Study||2
1683593|NCT00547911|4112550|P1|STARTED|Overall Study||2
1683594|NCT00547703|4112581|P2|NOT COMPLETED|Overall Study||0
1683595|NCT00547703|4112582|P1|NOT COMPLETED|Overall Study||1
1683596|NCT00547703|4112581|P2|COMPLETED|Overall Study||1
1683597|NCT00547703|4112582|P1|COMPLETED|Overall Study||3
1683598|NCT00547703|4112581|P2|STARTED|Overall Study||1
1683599|NCT00547703|4112582|P1|STARTED|Overall Study||4
1683600|NCT00547638|4112590|P2|NOT COMPLETED|Overall Study||14
1683601|NCT00547638|4112591|P1|NOT COMPLETED|Overall Study||24
1683602|NCT00547638|4112590|P2|COMPLETED|Overall Study||59
1683603|NCT00547638|4112591|P1|COMPLETED|Overall Study||119
1683604|NCT00547638|4112590|P2|STARTED|Overall Study||73
1683605|NCT00547638|4112591|P1|STARTED|Overall Study||143
1683606|NCT00547534|4112607|P1|NOT COMPLETED|Overall Study||11
1683607|NCT00547534|4112607|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
1683608|NCT00547534|4112607|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
1683609|NCT00547521|4112615|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
1683610|NCT00547521|4112616|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
1683611|NCT00547521|4112615|P2|COMPLETED|Long Term Extension (LTE) Study||59
1683612|NCT00547521|4112616|P1|COMPLETED|Long Term Extension (LTE) Study||0
1683613|NCT00547521|4112615|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
1683614|NCT00547521|4112616|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
1683615|NCT00547521|4112615|P2|NOT COMPLETED|Short Term Study (4 Months)||4
1683616|NCT00547521|4112616|P1|NOT COMPLETED|Short Term Study (4 Months)||1
1683617|NCT00547521|4112615|P2|COMPLETED|Short Term Study (4 Months)||45
1683618|NCT00547521|4112616|P1|COMPLETED|Short Term Study (4 Months)||50
1683619|NCT00547521|4112615|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
1683620|NCT00547521|4112616|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
1683621|NCT00547456|4112686|P1|NOT COMPLETED|Overall Study||0
1683622|NCT00547456|4112686|P1|COMPLETED|Overall Study||20
1683623|NCT00547456|4112686|P1|STARTED|Overall Study||20
1683624|NCT00547378|4112693|P3|NOT COMPLETED|All Implanted Cohort||70
1683625|NCT00547378|4112694|P2|NOT COMPLETED|All Implanted Cohort||18
1683626|NCT00547378|4112695|P1|NOT COMPLETED|All Implanted Cohort||15
1683627|NCT00547378|4112693|P3|COMPLETED|All Implanted Cohort||111
1683628|NCT00547378|4112694|P2|COMPLETED|All Implanted Cohort||22
1683629|NCT00547378|4112695|P1|COMPLETED|All Implanted Cohort||36
1683630|NCT00547378|4112693|P3|Month 60|All Implanted Cohort||114
1683631|NCT00547378|4112694|P2|Month 60|All Implanted Cohort||23
1683632|NCT00547378|4112695|P1|Month 60|All Implanted Cohort||36
1683633|NCT00547378|4112693|P3|Month 48|All Implanted Cohort||136
1683634|NCT00547378|4112694|P2|Month 48|All Implanted Cohort||27
1683635|NCT00547378|4112695|P1|Month 48|All Implanted Cohort||38
1683636|NCT00547378|4112693|P3|Month 36|All Implanted Cohort||146
1683637|NCT00547378|4112694|P2|Month 36|All Implanted Cohort||29
1683638|NCT00547378|4112695|P1|Month 36|All Implanted Cohort||42
1683639|NCT00547378|4112693|P3|Month 24|All Implanted Cohort||161
1683640|NCT00547378|4112694|P2|Month 24|All Implanted Cohort||30
1683641|NCT00547378|4112695|P1|Month 24|All Implanted Cohort||42
1683642|NCT00547378|4112693|P3|Month 12|All Implanted Cohort||175
1683643|NCT00547378|4112694|P2|Month 12|All Implanted Cohort||32
1683644|NCT00547378|4112695|P1|Month 12|All Implanted Cohort||48
1683645|NCT00547378|4112693|P3|Month 6|All Implanted Cohort||178
1683646|NCT00547378|4112694|P2|Month 6|All Implanted Cohort||36
1683647|NCT00547378|4112695|P1|Month 6|All Implanted Cohort||50
1683648|NCT00547378|4112693|P3|Month 3|All Implanted Cohort||178
1683649|NCT00547378|4112694|P2|Month 3|All Implanted Cohort||39
1683650|NCT00547378|4112695|P1|Month 3|All Implanted Cohort||51
1683651|NCT00547378|4112693|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
1683652|NCT00547378|4112694|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
1683653|NCT00547378|4112695|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
1683654|NCT00547378|4112693|P3|NOT COMPLETED|Randomized Cohort||0
1683655|NCT00547378|4112694|P2|NOT COMPLETED|Randomized Cohort||6
1683656|NCT00547378|4112695|P1|NOT COMPLETED|Randomized Cohort||11
1683657|NCT00547378|4112693|P3|COMPLETED|Randomized Cohort||0
1683658|NCT00547378|4112694|P2|COMPLETED|Randomized Cohort||71
1683659|NCT00547378|4112695|P1|COMPLETED|Randomized Cohort||59
1683660|NCT00547378|4112693|P3|Month 6|Randomized Cohort||0
1683661|NCT00547378|4112694|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
1683662|NCT00547378|4112695|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
1683663|NCT00547378|4112693|P3|Month 3|Randomized Cohort||0
1683664|NCT00547378|4112694|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
1683665|NCT00547378|4112695|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
1683666|NCT00547378|4112693|P3|STARTED|Randomized Cohort||0
1683667|NCT00547378|4112694|P2|STARTED|Randomized Cohort||77
1683668|NCT00547378|4112695|P1|STARTED|Randomized Cohort||70
1683669|NCT00547365|4112705|P1|NOT COMPLETED|Overall Study||8
1683670|NCT00547365|4112705|P1|COMPLETED|Overall Study||2
1683671|NCT00547365|4112705|P1|STARTED|Overall Study||10
1683672|NCT00547157|4112712|P2|NOT COMPLETED|Overall Study||23
1683673|NCT00547157|4112713|P1|NOT COMPLETED|Overall Study||49
1683674|NCT00547157|4112712|P2|COMPLETED|Overall Study||39
1683675|NCT00547157|4112713|P1|COMPLETED|Overall Study||41
1683676|NCT00547157|4112712|P2|STARTED|Overall Study||62
1683677|NCT00547157|4112713|P1|STARTED|Overall Study||90
1683678|NCT00547118|4112731|P2|NOT COMPLETED|Overall Study||9
1683679|NCT00547118|4112732|P1|NOT COMPLETED|Overall Study||8
1683680|NCT00547118|4112731|P2|COMPLETED|Overall Study||0
1683681|NCT00547118|4112732|P1|COMPLETED|Overall Study||0
1683682|NCT00547118|4112731|P2|STARTED|Overall Study||9
1683683|NCT00547118|4112732|P1|STARTED|Overall Study||8
1683684|NCT00547105|4112764|P1|NOT COMPLETED|Overall Study||0
1683685|NCT00547105|4112764|P1|COMPLETED|Overall Study||24
1683686|NCT00547105|4112764|P1|STARTED|Overall Study||24
1683687|NCT00546910|4112776|P2|NOT COMPLETED|Overall Study||11
1683688|NCT00546910|4112777|P1|NOT COMPLETED|Overall Study||9
1683689|NCT00546910|4112776|P2|COMPLETED|Overall Study||51
1683690|NCT00546910|4112777|P1|COMPLETED|Overall Study||54
1683691|NCT00546910|4112776|P2|STARTED|Overall Study||62
1683692|NCT00546910|4112777|P1|STARTED|Overall Study||63
1683693|NCT00546897|4112797|P2|NOT COMPLETED|Overall Study||0
1683694|NCT00546897|4112798|P1|NOT COMPLETED|Overall Study||0
1683695|NCT00546897|4112797|P2|COMPLETED|Overall Study||33
1683696|NCT00546897|4112798|P1|COMPLETED|Overall Study||15
1683697|NCT00546897|4112797|P2|STARTED|Overall Study||33
1683698|NCT00546897|4112798|P1|STARTED|Overall Study||15
1683699|NCT00546884|4112836|P2|NOT COMPLETED|Overall Study||0
1683700|NCT00546884|4112837|P1|NOT COMPLETED|Overall Study||0
1683701|NCT00546884|4112836|P2|COMPLETED|Overall Study||117
1683702|NCT00546884|4112837|P1|COMPLETED|Overall Study||145
1683703|NCT00546884|4112836|P2|STARTED|Overall Study||117
1683704|NCT00546884|4112837|P1|STARTED|Overall Study||145
1683705|NCT00546871|4112843|P2|NOT COMPLETED|Study Extension Period||1
1683706|NCT00546871|4112844|P1|NOT COMPLETED|Study Extension Period||1
1683707|NCT00546871|4112843|P2|COMPLETED|Study Extension Period||25
1683708|NCT00546871|4112844|P1|COMPLETED|Study Extension Period||9
1683709|NCT00546871|4112843|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
1683710|NCT00546871|4112844|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
1683711|NCT00546871|4112843|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
1683712|NCT00546871|4112844|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
1683713|NCT00546871|4112843|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
1683714|NCT00546871|4112844|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
1683715|NCT00546871|4112843|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
1683716|NCT00546871|4112844|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
1683717|NCT00546871|4112843|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
1683718|NCT00546871|4112844|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
1683719|NCT00546871|4112843|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
1683720|NCT00546871|4112844|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
1683721|NCT00546871|4112843|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
1683722|NCT00546871|4112844|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
1683723|NCT00546871|4112843|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
1683724|NCT00546871|4112844|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
1683725|NCT00546871|4112843|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
1683726|NCT00546871|4112844|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
1683727|NCT00546871|4112843|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
1683728|NCT00546871|4112844|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
1683729|NCT00546871|4112843|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
1683730|NCT00546871|4112844|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
1683731|NCT00546871|4112843|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
1683732|NCT00546871|4112844|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
1683733|NCT00546871|4112843|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
1683734|NCT00546871|4112844|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
1683735|NCT00546819|4112949|P2|NOT COMPLETED|Overall Study||6
1683736|NCT00546819|4112950|P1|NOT COMPLETED|Overall Study||8
1683737|NCT00546819|4112949|P2|COMPLETED|Overall Study||96
1683738|NCT00546819|4112950|P1|COMPLETED|Overall Study||199
1683739|NCT00546819|4112949|P2|VACCINATED|Overall Study||100
1683740|NCT00546819|4112950|P1|VACCINATED|Overall Study||206
1683741|NCT00546819|4112949|P2|STARTED|Overall Study||102
1683742|NCT00546819|4112950|P1|STARTED|Overall Study||207
1683743|NCT00546754|4112962|P2|NOT COMPLETED|Overall Study||49
1683744|NCT00546754|4112963|P1|NOT COMPLETED|Overall Study||50
1683745|NCT00546754|4112962|P2|COMPLETED|Overall Study||334
1683746|NCT00546754|4112963|P1|COMPLETED|Overall Study||375
1683747|NCT00546754|4112962|P2|Week 12|Overall Study||334
1683748|NCT00546754|4112963|P1|Week 12|Overall Study||375
1683749|NCT00546754|4112962|P2|Week 6|Overall Study||347
1683750|NCT00546754|4112963|P1|Week 6|Overall Study||396
1683751|NCT00546754|4112962|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
1683752|NCT00546754|4112963|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
1683753|NCT00546754|4112962|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
1683754|NCT00546754|4112963|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
1683755|NCT00546728|4112995|P2|NOT COMPLETED|Overall Study||0
1683756|NCT00546728|4112996|P1|NOT COMPLETED|Overall Study||0
1683757|NCT00546728|4112995|P2|COMPLETED|Overall Study||25
1683758|NCT00546728|4112996|P1|COMPLETED|Overall Study||25
1683759|NCT00546728|4112995|P2|STARTED|Overall Study||25
1683760|NCT00546728|4112996|P1|STARTED|Overall Study||25
1683761|NCT00546715|4113006|P4|NOT COMPLETED|Overall Study||0
1683762|NCT00546715|4113007|P3|NOT COMPLETED|Overall Study||0
1683763|NCT00546715|4113008|P2|NOT COMPLETED|Overall Study||1
1683764|NCT00546715|4113009|P1|NOT COMPLETED|Overall Study||0
1683765|NCT00546715|4113006|P4|COMPLETED|Overall Study||2
1683766|NCT00546715|4113007|P3|COMPLETED|Overall Study||5
1683767|NCT00546715|4113008|P2|COMPLETED|Overall Study||4
1683768|NCT00546715|4113009|P1|COMPLETED|Overall Study||6
1683769|NCT00546715|4113006|P4|STARTED|Overall Study||2
1683770|NCT00546715|4113007|P3|STARTED|Overall Study||5
1683771|NCT00546715|4113008|P2|STARTED|Overall Study||5
1683772|NCT00546715|4113009|P1|STARTED|Overall Study||6
1683773|NCT00546637|4113064|P2|NOT COMPLETED|Overall Study||49
1683774|NCT00546637|4113065|P1|NOT COMPLETED|Overall Study||73
1683775|NCT00546637|4113064|P2|COMPLETED|Overall Study||424
1683776|NCT00546637|4113065|P1|COMPLETED|Overall Study||401
1683777|NCT00546637|4113064|P2|Received Treatment|Overall Study||472
1683778|NCT00546637|4113065|P1|Received Treatment|Overall Study||471
1683779|NCT00546637|4113064|P2|STARTED|Overall Study||473
1683780|NCT00546637|4113065|P1|STARTED|Overall Study||474
1683781|NCT00546572|4113139|P2|NOT COMPLETED|Vax 2 / Year 1||2
1683782|NCT00546572|4113140|P1|NOT COMPLETED|Vax 2 / Year 1||4
1683783|NCT00546572|4113139|P2|COMPLETED|Vax 2 / Year 1||402
1683784|NCT00546572|4113140|P1|COMPLETED|Vax 2 / Year 1||387
1683785|NCT00546572|4113139|P2|Received Vax 2|Vax 2 / Year 1||404
1683786|NCT00546572|4113140|P1|Received Vax 2|Vax 2 / Year 1||391
1683787|NCT00546572|4113139|P2|STARTED|Vax 2 / Year 1||404
1683788|NCT00546572|4113140|P1|STARTED|Vax 2 / Year 1||391
1683789|NCT00546572|4113139|P2|NOT COMPLETED|Vax 1 / Year 0||70
1683790|NCT00546572|4113140|P1|NOT COMPLETED|Vax 1 / Year 0||73
1683791|NCT00546572|4113139|P2|COMPLETED|Vax 1 / Year 0||404
1683792|NCT00546572|4113140|P1|COMPLETED|Vax 1 / Year 0||391
1683793|NCT00546572|4113139|P2|Received Vax 1|Vax 1 / Year 0||473
1683794|NCT00546572|4113140|P1|Received Vax 1|Vax 1 / Year 0||463
1683795|NCT00546572|4113139|P2|STARTED|Vax 1 / Year 0||474
1683796|NCT00546572|4113140|P1|STARTED|Vax 1 / Year 0||464
1683797|NCT00546481|4113184|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
1683798|NCT00546481|4113185|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
1683799|NCT00546481|4113186|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
1683800|NCT00546481|4113184|P3|COMPLETED|Maintenance Phase (CERA)||50
1683801|NCT00546481|4113185|P2|COMPLETED|Maintenance Phase (CERA)||0
1683802|NCT00546481|4113186|P1|COMPLETED|Maintenance Phase (CERA)||0
1683803|NCT00546481|4113184|P3|STARTED|Maintenance Phase (CERA)||54
1683804|NCT00546481|4113185|P2|STARTED|Maintenance Phase (CERA)||0
1683805|NCT00546481|4113186|P1|STARTED|Maintenance Phase (CERA)||0
1683806|NCT00546481|4113184|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
1683807|NCT00546481|4113185|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
1683808|NCT00546481|4113186|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
1683809|NCT00546481|4113184|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
1683810|NCT00546481|4113185|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
1683811|NCT00546481|4113186|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
1683812|NCT00546481|4113184|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
1683813|NCT00546481|4113185|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
1683814|NCT00546481|4113186|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
1683815|NCT00546429|4113209|P1|NOT COMPLETED|Overall Study||30
1683816|NCT00546429|4113209|P1|COMPLETED|Overall Study||32
1683817|NCT00546429|4113209|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
1683818|NCT00546377|4113213|P1|NOT COMPLETED|Overall Study||7
1683819|NCT00546377|4113213|P1|COMPLETED|Overall Study||43
1683820|NCT00546377|4113213|P1|STARTED|Overall Study||50
1683821|NCT00546364|4113221|P3|NOT COMPLETED|Overall Study||17
1683822|NCT00546364|4113222|P2|NOT COMPLETED|Overall Study||18
1683823|NCT00546364|4113223|P1|NOT COMPLETED|Overall Study||17
1683824|NCT00546364|4113221|P3|COMPLETED|Overall Study|Still on treatment|3
1683825|NCT00546364|4113222|P2|COMPLETED|Overall Study|Still on treatment|4
1683826|NCT00546364|4113223|P1|COMPLETED|Overall Study|Still on treatment|3
1683827|NCT00546364|4113221|P3|Never Treated|Overall Study||0
1683828|NCT00546364|4113222|P2|Never Treated|Overall Study||0
1683829|NCT00546364|4113223|P1|Never Treated|Overall Study||0
1683830|NCT00546364|4113221|P3|STARTED|Overall Study||20
1683831|NCT00546364|4113222|P2|STARTED|Overall Study||22
1683832|NCT00546364|4113223|P1|STARTED|Overall Study||20
1683833|NCT00546351|4113258|P1|NOT COMPLETED|Overall Study||236
1683834|NCT00546351|4113258|P1|COMPLETED|Overall Study||385
1683835|NCT00546351|4113258|P1|STARTED|Overall Study||621
1683836|NCT00546273|4113291|P5|NOT COMPLETED|IV||0
1683837|NCT00546273|4113292|P4|NOT COMPLETED|IV||0
1683838|NCT00546273|4113293|P3|NOT COMPLETED|IV||0
1683839|NCT00546273|4113294|P2|NOT COMPLETED|IV||0
1683840|NCT00546273|4113295|P1|NOT COMPLETED|IV||0
1683841|NCT00546273|4113291|P5|COMPLETED|IV||2
1683842|NCT00546273|4113292|P4|COMPLETED|IV||4
1683843|NCT00546273|4113293|P3|COMPLETED|IV||0
1683844|NCT00546273|4113294|P2|COMPLETED|IV||0
1683845|NCT00546273|4113295|P1|COMPLETED|IV||0
1683846|NCT00546273|4113291|P5|STARTED|IV||2
1683847|NCT00546273|4113292|P4|STARTED|IV||4
1683848|NCT00546273|4113293|P3|STARTED|IV||0
1683849|NCT00546273|4113294|P2|STARTED|IV||0
1683850|NCT00546273|4113295|P1|STARTED|IV||0
1683851|NCT00546273|4113291|P5|NOT COMPLETED|III||0
1683852|NCT00546273|4113292|P4|NOT COMPLETED|III||0
1683853|NCT00546273|4113293|P3|NOT COMPLETED|III||0
1683854|NCT00546273|4113294|P2|NOT COMPLETED|III||0
1683855|NCT00546273|4113295|P1|NOT COMPLETED|III||0
1683856|NCT00546273|4113291|P5|COMPLETED|III||2
1683857|NCT00546273|4113292|P4|COMPLETED|III||0
1683858|NCT00546273|4113293|P3|COMPLETED|III||4
1683859|NCT00546273|4113294|P2|COMPLETED|III||0
1683860|NCT00546273|4113295|P1|COMPLETED|III||0
1683861|NCT00546273|4113291|P5|STARTED|III||2
1683862|NCT00546273|4113292|P4|STARTED|III||0
1683863|NCT00546273|4113293|P3|STARTED|III||4
1683864|NCT00546273|4113294|P2|STARTED|III||0
1683865|NCT00546273|4113295|P1|STARTED|III||0
1683866|NCT00546273|4113291|P5|NOT COMPLETED|II||0
1683867|NCT00546273|4113292|P4|NOT COMPLETED|II||0
1683868|NCT00546273|4113293|P3|NOT COMPLETED|II||0
1683869|NCT00546273|4113294|P2|NOT COMPLETED|II||0
1683870|NCT00546273|4113295|P1|NOT COMPLETED|II||0
1683871|NCT00546273|4113291|P5|COMPLETED|II||2
1683872|NCT00546273|4113292|P4|COMPLETED|II||0
1683873|NCT00546273|4113293|P3|COMPLETED|II||0
1683874|NCT00546273|4113294|P2|COMPLETED|II||4
1683875|NCT00546273|4113295|P1|COMPLETED|II||0
1683876|NCT00546273|4113291|P5|STARTED|II||2
1683877|NCT00546273|4113292|P4|STARTED|II||0
1683878|NCT00546273|4113293|P3|STARTED|II||0
1683879|NCT00546273|4113294|P2|STARTED|II||4
1683880|NCT00546273|4113295|P1|STARTED|II||0
1683881|NCT00546273|4113291|P5|NOT COMPLETED|I||0
1683882|NCT00546273|4113292|P4|NOT COMPLETED|I||0
1683883|NCT00546273|4113293|P3|NOT COMPLETED|I||0
1683884|NCT00546273|4113294|P2|NOT COMPLETED|I||0
1683885|NCT00546273|4113295|P1|NOT COMPLETED|I||0
1683886|NCT00546273|4113291|P5|COMPLETED|I||2
1683887|NCT00546273|4113292|P4|COMPLETED|I||0
1683888|NCT00546273|4113293|P3|COMPLETED|I||0
1683889|NCT00546273|4113294|P2|COMPLETED|I||0
1683890|NCT00546273|4113295|P1|COMPLETED|I||4
1683891|NCT00546273|4113291|P5|STARTED|I||2
1683892|NCT00546273|4113292|P4|STARTED|I||0
1683893|NCT00546273|4113293|P3|STARTED|I||0
1683894|NCT00546273|4113294|P2|STARTED|I||0
1683895|NCT00546273|4113295|P1|STARTED|I||4
1683896|NCT00546260|4113304|P2|NOT COMPLETED|Overall Study||2
1683897|NCT00546260|4113305|P1|NOT COMPLETED|Overall Study||8
1683898|NCT00546260|4113304|P2|COMPLETED|Overall Study||32
1683899|NCT00546260|4113305|P1|COMPLETED|Overall Study||28
1683900|NCT00546260|4113304|P2|STARTED|Overall Study||34
1683901|NCT00546260|4113305|P1|STARTED|Overall Study||36
1683902|NCT00546156|4113317|P2|NOT COMPLETED|Overall Study||1
1683903|NCT00546156|4113318|P1|NOT COMPLETED|Overall Study||14
1683904|NCT00546156|4113317|P2|COMPLETED|Overall Study||19
1683905|NCT00546156|4113318|P1|COMPLETED|Overall Study||70
1683906|NCT00546156|4113317|P2|STARTED|Overall Study||20
1683907|NCT00546156|4113318|P1|STARTED|Overall Study||84
1683908|NCT00546117|4113327|P2|NOT COMPLETED|Overall Study||0
1683909|NCT00546117|4113328|P1|NOT COMPLETED|Overall Study||4
1683910|NCT00546117|4113327|P2|COMPLETED|Overall Study||7
1683911|NCT00546117|4113328|P1|COMPLETED|Overall Study||5
1683912|NCT00546117|4113327|P2|STARTED|Overall Study||7
1683913|NCT00546117|4113328|P1|STARTED|Overall Study||9
1683914|NCT00546104|4113342|P1|NOT COMPLETED|Overall Study||0
1683915|NCT00546104|4113342|P1|COMPLETED|Overall Study||31
1683916|NCT00546104|4113342|P1|STARTED|Overall Study||31
1683917|NCT00546078|4113353|P2|NOT COMPLETED|Overall Study||7
1683918|NCT00546078|4113354|P1|NOT COMPLETED|Overall Study||4
1683919|NCT00546078|4113353|P2|COMPLETED|Overall Study||43
1683920|NCT00546078|4113354|P1|COMPLETED|Overall Study||61
1683921|NCT00546078|4113353|P2|Month 18|Overall Study||45
1683922|NCT00546078|4113354|P1|Month 18|Overall Study||61
1683923|NCT00546078|4113353|P2|STARTED|Overall Study||50
1683924|NCT00546078|4113354|P1|STARTED|Overall Study||65
1683925|NCT00546052|4113392|P1|NOT COMPLETED|Overall Study||227
1683926|NCT00546052|4113392|P1|COMPLETED|Overall Study||1511
1683927|NCT00546052|4113392|P1|Week 52|Overall Study||1511
1683928|NCT00546052|4113392|P1|Week 32|Overall Study||1583
1683929|NCT00546052|4113392|P1|Week 12|Overall Study||1650
1683930|NCT00546052|4113392|P1|Week 8|Overall Study||1680
1683931|NCT00546052|4113392|P1|Week 4|Overall Study||1714
1683932|NCT00546052|4113392|P1|STARTED|Overall Study||1738
1683933|NCT00546000|4113410|P1|NOT COMPLETED|Overall Study||4
1683934|NCT00546000|4113410|P1|COMPLETED|Overall Study||52
1683935|NCT00546000|4113410|P1|STARTED|Overall Study||56
1683936|NCT00545974|4113417|P2|NOT COMPLETED|Overall Study||3
1683937|NCT00545974|4113418|P1|NOT COMPLETED|Overall Study||2
1683938|NCT00545974|4113417|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
1683939|NCT00545974|4113418|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
1683940|NCT00545974|4113417|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
1683941|NCT00545974|4113418|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
1683942|NCT00545948|4113429|P3|NOT COMPLETED|Overall Study||7
1683943|NCT00545948|4113430|P2|NOT COMPLETED|Overall Study||1
1683944|NCT00545948|4113431|P1|NOT COMPLETED|Overall Study||1
1683945|NCT00545948|4113429|P3|COMPLETED|Overall Study||0
1683946|NCT00545948|4113430|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
1683947|NCT00545948|4113431|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
1683948|NCT00545948|4113429|P3|Assigned Treatment|Overall Study||0
1683949|NCT00545948|4113430|P2|Assigned Treatment|Overall Study||15
1683950|NCT00545948|4113431|P1|Assigned Treatment|Overall Study||9
1683951|NCT00545948|4113429|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
1683952|NCT00545948|4113430|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
1683953|NCT00545948|4113431|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
1683954|NCT00545844|4113441|P1|NOT COMPLETED|Overall Study||12
1683955|NCT00545844|4113441|P1|COMPLETED|Overall Study||301
1683956|NCT00545844|4113441|P1|STARTED|Overall Study||313
1683957|NCT00545792|4113455|P1|NOT COMPLETED|Overall Study||1
1683958|NCT00545792|4113455|P1|COMPLETED|Overall Study||20
1683959|NCT00545792|4113455|P1|STARTED|Overall Study||21
1683960|NCT00545779|4113460|P1|NOT COMPLETED|Overall Study||44
1683961|NCT00545779|4113460|P1|COMPLETED|Overall Study||633
1683962|NCT00545779|4113460|P1|STARTED|Overall Study||677
1683963|NCT00545766|4113473|P1|NOT COMPLETED|Overall Study||5
1683964|NCT00545766|4113473|P1|COMPLETED|Overall Study||36
1683965|NCT00545766|4113473|P1|STARTED|Overall Study||41
1683966|NCT00545753|4113480|P3|NOT COMPLETED|Overall Study||26
1683967|NCT00545753|4113481|P2|NOT COMPLETED|Overall Study||5
1683968|NCT00545753|4113482|P1|NOT COMPLETED|Overall Study||16
1683969|NCT00545753|4113480|P3|COMPLETED|Overall Study||230
1683970|NCT00545753|4113481|P2|COMPLETED|Overall Study||54
1683971|NCT00545753|4113482|P1|COMPLETED|Overall Study||227
1683972|NCT00545753|4113480|P3|STARTED|Overall Study||256
1683973|NCT00545753|4113481|P2|STARTED|Overall Study||59
1683974|NCT00545753|4113482|P1|STARTED|Overall Study||243
1683975|NCT00545740|4113495|P4|NOT COMPLETED|Overall Study||71
1683976|NCT00545740|4113496|P3|NOT COMPLETED|Overall Study||96
1683977|NCT00545740|4113497|P2|NOT COMPLETED|Overall Study||83
1683978|NCT00545740|4113498|P1|NOT COMPLETED|Overall Study||75
1683979|NCT00545740|4113495|P4|COMPLETED|Overall Study||78
1683980|NCT00545740|4113496|P3|COMPLETED|Overall Study||55
1683981|NCT00545740|4113497|P2|COMPLETED|Overall Study||62
1683982|NCT00545740|4113498|P1|COMPLETED|Overall Study||70
1683983|NCT00545740|4113495|P4|STARTED|Overall Study||149
1683984|NCT00545740|4113496|P3|STARTED|Overall Study||151
1683985|NCT00545740|4113497|P2|STARTED|Overall Study||145
1683986|NCT00545740|4113498|P1|STARTED|Overall Study||145
1683987|NCT00545688|4113536|P4|NOT COMPLETED|Follow-Up Period||27
1683988|NCT00545688|4113537|P3|NOT COMPLETED|Follow-Up Period||20
1683989|NCT00545688|4113538|P2|NOT COMPLETED|Follow-Up Period||19
1683990|NCT00545688|4113539|P1|NOT COMPLETED|Follow-Up Period||21
1683991|NCT00545688|4113536|P4|COMPLETED|Follow-Up Period||60
1683992|NCT00545688|4113537|P3|COMPLETED|Follow-Up Period||78
1683993|NCT00545688|4113538|P2|COMPLETED|Follow-Up Period||83
1683994|NCT00545688|4113539|P1|COMPLETED|Follow-Up Period||77
1683995|NCT00545688|4113536|P4|STARTED|Follow-Up Period||87
1683996|NCT00545688|4113537|P3|STARTED|Follow-Up Period||98
1683997|NCT00545688|4113538|P2|STARTED|Follow-Up Period||102
1683998|NCT00545688|4113539|P1|STARTED|Follow-Up Period||98
1683999|NCT00545688|4113536|P4|NOT COMPLETED|Adjuvant Treatment Period||14
1684000|NCT00545688|4113537|P3|NOT COMPLETED|Adjuvant Treatment Period||4
1684001|NCT00545688|4113538|P2|NOT COMPLETED|Adjuvant Treatment Period||8
1684002|NCT00545688|4113539|P1|NOT COMPLETED|Adjuvant Treatment Period||5
1684003|NCT00545688|4113536|P4|COMPLETED|Adjuvant Treatment Period||74
1684004|NCT00545688|4113537|P3|COMPLETED|Adjuvant Treatment Period||90
1684005|NCT00545688|4113538|P2|COMPLETED|Adjuvant Treatment Period||94
1684006|NCT00545688|4113539|P1|COMPLETED|Adjuvant Treatment Period||98
1684007|NCT00545688|4113536|P4|STARTED|Adjuvant Treatment Period||88
1684008|NCT00545688|4113537|P3|STARTED|Adjuvant Treatment Period||94
1684009|NCT00545688|4113538|P2|STARTED|Adjuvant Treatment Period||102
1684010|NCT00545688|4113539|P1|STARTED|Adjuvant Treatment Period||103
1684011|NCT00545688|4113536|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
1684012|NCT00545688|4113537|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
1684013|NCT00545688|4113538|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
1684014|NCT00545688|4113539|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
1684015|NCT00545688|4113536|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
1684016|NCT00545688|4113537|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
1684017|NCT00545688|4113538|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
1684018|NCT00545688|4113539|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
1684019|NCT00545688|4113536|P4|STARTED|Neo-Adjuvant Treatment Period||94
1684020|NCT00545688|4113537|P3|STARTED|Neo-Adjuvant Treatment Period||108
1684021|NCT00545688|4113538|P2|STARTED|Neo-Adjuvant Treatment Period||107
1684022|NCT00545688|4113539|P1|STARTED|Neo-Adjuvant Treatment Period||107
1684023|NCT00545662|4113611|P2|NOT COMPLETED|Overall Study||79
1684024|NCT00545662|4113612|P1|NOT COMPLETED|Overall Study||85
1684025|NCT00545662|4113611|P2|COMPLETED|Overall Study||528
1684026|NCT00545662|4113612|P1|COMPLETED|Overall Study||521
1684027|NCT00545662|4113611|P2|STARTED|Overall Study||607
1684028|NCT00545662|4113612|P1|STARTED|Overall Study||606
1684029|NCT00545623|4113622|P4|NOT COMPLETED|Overall Study||11
1684030|NCT00545623|4113623|P3|NOT COMPLETED|Overall Study||13
1684031|NCT00545623|4113624|P2|NOT COMPLETED|Overall Study||10
1684032|NCT00545623|4113625|P1|NOT COMPLETED|Overall Study||7
1684033|NCT00545623|4113622|P4|COMPLETED|Overall Study||23
1684034|NCT00545623|4113623|P3|COMPLETED|Overall Study||20
1684035|NCT00545623|4113624|P2|COMPLETED|Overall Study||21
1684036|NCT00545623|4113625|P1|COMPLETED|Overall Study||25
1684037|NCT00545623|4113622|P4|STARTED|Overall Study||34
1684038|NCT00545623|4113623|P3|STARTED|Overall Study||33
1684039|NCT00545623|4113624|P2|STARTED|Overall Study||31
1684040|NCT00545623|4113625|P1|STARTED|Overall Study||32
1684041|NCT00545584|4113638|P3|NOT COMPLETED|Overall Study||56
1684042|NCT00545584|4113639|P2|NOT COMPLETED|Overall Study||80
1684043|NCT00545584|4113640|P1|NOT COMPLETED|Overall Study||79
1684044|NCT00545584|4113638|P3|COMPLETED|Overall Study||250
1684045|NCT00545584|4113639|P2|COMPLETED|Overall Study||334
1684046|NCT00545584|4113640|P1|COMPLETED|Overall Study||333
1684047|NCT00545584|4113638|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
1684048|NCT00545584|4113639|P2|STARTED|Overall Study||414
1684049|NCT00545584|4113640|P1|STARTED|Overall Study||412
1684050|NCT00545571|4113651|P1|NOT COMPLETED|Overall Study||67
1684051|NCT00545571|4113651|P1|COMPLETED|Overall Study||53
1684052|NCT00545571|4113651|P1|STARTED|Overall Study||120
1684053|NCT00545532|4113666|P2|NOT COMPLETED|Overall Study||10
1684054|NCT00545532|4113667|P1|NOT COMPLETED|Overall Study||6
1684055|NCT00545532|4113666|P2|COMPLETED|Overall Study||100
1684056|NCT00545532|4113667|P1|COMPLETED|Overall Study||99
1684057|NCT00545532|4113666|P2|STARTED|Overall Study||110
1684058|NCT00545532|4113667|P1|STARTED|Overall Study||105
1684059|NCT00545506|4113749|P2|NOT COMPLETED|Overall Study||0
1684060|NCT00545506|4113750|P1|NOT COMPLETED|Overall Study||0
1684061|NCT00545506|4113749|P2|COMPLETED|Overall Study||3
1684062|NCT00545506|4113750|P1|COMPLETED|Overall Study||3
1684063|NCT00545506|4113749|P2|STARTED|Overall Study||3
1684064|NCT00545506|4113750|P1|STARTED|Overall Study||3
1684065|NCT00545441|4113758|P2|NOT COMPLETED|Overall Study||16
1684066|NCT00545441|4113759|P1|NOT COMPLETED|Overall Study||18
1684067|NCT00545441|4113758|P2|COMPLETED|Overall Study||26
1684068|NCT00545441|4113759|P1|COMPLETED|Overall Study||26
1684069|NCT00545441|4113758|P2|STARTED|Overall Study||42
1684070|NCT00545441|4113759|P1|STARTED|Overall Study||44
1684071|NCT00545402|4113767|P2|NOT COMPLETED|Overall Study||29
1684072|NCT00545402|4113768|P1|NOT COMPLETED|Overall Study||34
1684073|NCT00545402|4113767|P2|COMPLETED|Overall Study||61
1684074|NCT00545402|4113768|P1|COMPLETED|Overall Study||56
1684075|NCT00545402|4113767|P2|STARTED|Overall Study||90
1684076|NCT00545402|4113768|P1|STARTED|Overall Study||90
1684077|NCT00545363|4113786|P2|NOT COMPLETED|Overall Study||15
1684078|NCT00545363|4113787|P1|NOT COMPLETED|Overall Study||19
1684079|NCT00545363|4113786|P2|COMPLETED|Overall Study||343
1684080|NCT00545363|4113787|P1|COMPLETED|Overall Study||339
1684081|NCT00545363|4113786|P2|Treated|Overall Study||357
1684082|NCT00545363|4113787|P1|Treated|Overall Study||354
1684083|NCT00545363|4113786|P2|STARTED|Overall Study||358
1684084|NCT00545363|4113787|P1|STARTED|Overall Study||358
1684085|NCT00545298|4113802|P3|NOT COMPLETED|Overall Study||1
1684086|NCT00545298|4113803|P2|NOT COMPLETED|Overall Study||0
1684087|NCT00545298|4113804|P1|NOT COMPLETED|Overall Study||2
1684088|NCT00545298|4113802|P3|COMPLETED|Overall Study||0
1684089|NCT00545298|4113803|P2|COMPLETED|Overall Study||1
1684090|NCT00545298|4113804|P1|COMPLETED|Overall Study||0
1684091|NCT00545298|4113802|P3|STARTED|Overall Study||1
1684092|NCT00545298|4113803|P2|STARTED|Overall Study||1
1684093|NCT00545298|4113804|P1|STARTED|Overall Study||2
1684094|NCT00545272|4113821|P6|NOT COMPLETED|Overall Study||3
1684095|NCT00545272|4113822|P5|NOT COMPLETED|Overall Study||2
1684096|NCT00545272|4113823|P4|NOT COMPLETED|Overall Study||1
1684097|NCT00545272|4113824|P3|NOT COMPLETED|Overall Study||1
1684098|NCT00545272|4113825|P2|NOT COMPLETED|Overall Study||1
1684099|NCT00545272|4113826|P1|NOT COMPLETED|Overall Study||0
1684100|NCT00545272|4113821|P6|COMPLETED|Overall Study||59
1684101|NCT00545272|4113822|P5|COMPLETED|Overall Study||62
1684102|NCT00545272|4113823|P4|COMPLETED|Overall Study||71
1684103|NCT00545272|4113824|P3|COMPLETED|Overall Study||64
1684104|NCT00545272|4113825|P2|COMPLETED|Overall Study||67
1684105|NCT00545272|4113826|P1|COMPLETED|Overall Study||61
1684106|NCT00545272|4113821|P6|STARTED|Overall Study||62
1684107|NCT00545272|4113822|P5|STARTED|Overall Study||64
1684108|NCT00545272|4113823|P4|STARTED|Overall Study||72
1684109|NCT00545272|4113824|P3|STARTED|Overall Study||65
1684110|NCT00545272|4113825|P2|STARTED|Overall Study||68
1684111|NCT00545272|4113826|P1|STARTED|Overall Study||61
1684112|NCT00545233|4113878|P2|NOT COMPLETED|Overall Study||35
1684113|NCT00545233|4113879|P1|NOT COMPLETED|Overall Study||46
1684114|NCT00545233|4113878|P2|COMPLETED|Overall Study||41
1684115|NCT00545233|4113879|P1|COMPLETED|Overall Study||33
1684116|NCT00545233|4113878|P2|Intent-to-Treat (ITT)|Overall Study||73
1684117|NCT00545233|4113879|P1|Intent-to-Treat (ITT)|Overall Study||77
1684118|NCT00545233|4113878|P2|Safety Set|Overall Study||75
1684119|NCT00545233|4113879|P1|Safety Set|Overall Study||77
1684120|NCT00545233|4113878|P2|STARTED|Overall Study||76
1684121|NCT00545233|4113879|P1|STARTED|Overall Study||79
1684122|NCT00545181|4113928|P2|NOT COMPLETED|Overall Study||0
1684123|NCT00545181|4113929|P1|NOT COMPLETED|Overall Study||0
1684124|NCT00545181|4113928|P2|COMPLETED|Overall Study||25
1684125|NCT00545181|4113929|P1|COMPLETED|Overall Study||29
1684126|NCT00545181|4113928|P2|STARTED|Overall Study||25
1684127|NCT00545181|4113929|P1|STARTED|Overall Study||29
1684128|NCT00545168|4113938|P3|NOT COMPLETED|Overall Study||21
1684129|NCT00545168|4113939|P2|NOT COMPLETED|Overall Study||5
1684130|NCT00545168|4113940|P1|NOT COMPLETED|Overall Study||16
1684131|NCT00545168|4113938|P3|COMPLETED|Overall Study||193
1684132|NCT00545168|4113939|P2|COMPLETED|Overall Study||58
1684133|NCT00545168|4113940|P1|COMPLETED|Overall Study||187
1684134|NCT00545168|4113938|P3|STARTED|Overall Study||214
1684135|NCT00545168|4113939|P2|STARTED|Overall Study||63
1684136|NCT00545168|4113940|P1|STARTED|Overall Study||203
1684137|NCT00545155|4113949|P1|NOT COMPLETED|Overall Study||0
1684138|NCT00545155|4113949|P1|COMPLETED|Overall Study||187
1684139|NCT00545155|4113949|P1|STARTED|Overall Study||187
1684140|NCT00545103|4113966|P4|NOT COMPLETED|Overall Study||70
1684141|NCT00545103|4113967|P3|NOT COMPLETED|Overall Study||76
1684142|NCT00545103|4113968|P2|NOT COMPLETED|Overall Study||78
1684143|NCT00545103|4113969|P1|NOT COMPLETED|Overall Study||75
1684144|NCT00545103|4113966|P4|COMPLETED|Overall Study||76
1684145|NCT00545103|4113967|P3|COMPLETED|Overall Study||74
1684146|NCT00545103|4113968|P2|COMPLETED|Overall Study||70
1684147|NCT00545103|4113969|P1|COMPLETED|Overall Study||73
1684148|NCT00545103|4113966|P4|STARTED|Overall Study||146
1684149|NCT00545103|4113967|P3|STARTED|Overall Study||150
1684150|NCT00545103|4113968|P2|STARTED|Overall Study||148
1684151|NCT00545103|4113969|P1|STARTED|Overall Study||148
1684152|NCT00545064|4114003|P1|NOT COMPLETED|Overall Study||8
1684153|NCT00545064|4114003|P1|COMPLETED|Overall Study||170
1684154|NCT00545064|4114003|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
1684155|NCT00545064|4114003|P1|Visit 2 (Week 4)|Overall Study||169
1684156|NCT00545064|4114003|P1|Visit 1 (Baseline)|Overall Study||178
1684157|NCT00545064|4114003|P1|STARTED|Overall Study||178
1684158|NCT00545051|4114014|P2|NOT COMPLETED|Overall Study||7
1684159|NCT00545051|4114015|P1|NOT COMPLETED|Overall Study||9
1684160|NCT00545051|4114014|P2|COMPLETED|Overall Study||65
1684161|NCT00545051|4114015|P1|COMPLETED|Overall Study||59
1684162|NCT00545051|4114014|P2|STARTED|Overall Study||72
1684163|NCT00545051|4114015|P1|STARTED|Overall Study||68
1684164|NCT00545025|4114031|P2|NOT COMPLETED|Overall Study||0
1684165|NCT00545025|4114032|P1|NOT COMPLETED|Overall Study||0
1684166|NCT00545025|4114031|P2|COMPLETED|Overall Study||83
1684167|NCT00545025|4114032|P1|COMPLETED|Overall Study||160
1684168|NCT00545025|4114031|P2|STARTED|Overall Study||83
1684169|NCT00545025|4114032|P1|STARTED|Overall Study||160
1684170|NCT00544908|4114052|P1|NOT COMPLETED|Overall Study||0
1684171|NCT00544908|4114052|P1|COMPLETED|Overall Study||7
1684172|NCT00544908|4114052|P1|STARTED|Overall Study||7
1684173|NCT00544882|4114059|P3|NOT COMPLETED|Cycle 3: Follow-up||0
1684174|NCT00544882|4114060|P2|NOT COMPLETED|Cycle 3: Follow-up||2
1684175|NCT00544882|4114061|P1|NOT COMPLETED|Cycle 3: Follow-up||0
1684176|NCT00544882|4114059|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
1684177|NCT00544882|4114060|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
1684178|NCT00544882|4114061|P1|COMPLETED|Cycle 3: Follow-up||0
1684179|NCT00544882|4114059|P3|STARTED|Cycle 3: Follow-up||28
1684180|NCT00544882|4114060|P2|STARTED|Cycle 3: Follow-up||28
1684181|NCT00544882|4114061|P1|STARTED|Cycle 3: Follow-up||0
1684182|NCT00544882|4114059|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
1684183|NCT00544882|4114060|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
1684184|NCT00544882|4114061|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
1684185|NCT00544882|4114059|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
1684186|NCT00544882|4114060|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
1684187|NCT00544882|4114061|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
1684188|NCT00544882|4114059|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
1684189|NCT00544882|4114060|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
1684190|NCT00544882|4114061|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
1684191|NCT00544882|4114059|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
1684192|NCT00544882|4114060|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
1684193|NCT00544882|4114061|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
1684194|NCT00544882|4114059|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
1684195|NCT00544882|4114060|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
1684196|NCT00544882|4114061|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
1684197|NCT00544882|4114059|P3|COMPLETED|Cycle 1: Run-in Cycle||0
1684198|NCT00544882|4114060|P2|COMPLETED|Cycle 1: Run-in Cycle||0
1684199|NCT00544882|4114061|P1|COMPLETED|Cycle 1: Run-in Cycle||58
1684200|NCT00544882|4114059|P3|STARTED|Cycle 1: Run-in Cycle||0
1684201|NCT00544882|4114060|P2|STARTED|Cycle 1: Run-in Cycle||0
1684202|NCT00544882|4114061|P1|STARTED|Cycle 1: Run-in Cycle||61
1684203|NCT00544869|4114086|P3|NOT COMPLETED|Overall Study||0
1684204|NCT00544869|4114087|P2|NOT COMPLETED|Overall Study||2
1684205|NCT00544869|4114088|P1|NOT COMPLETED|Overall Study||12
1684206|NCT00544869|4114086|P3|COMPLETED|Overall Study||2
1684207|NCT00544869|4114087|P2|COMPLETED|Overall Study||12
1684208|NCT00544869|4114088|P1|COMPLETED|Overall Study||24
1684209|NCT00544869|4114086|P3|STARTED|Overall Study||2
1684210|NCT00544869|4114087|P2|STARTED|Overall Study||14
1684211|NCT00544869|4114088|P1|STARTED|Overall Study||36
1684212|NCT00544817|4114096|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
1684213|NCT00544817|4114096|P1|COMPLETED|Follow-up Systemic Therapy||9
1684214|NCT00544817|4114096|P1|STARTED|Follow-up Systemic Therapy||28
1684215|NCT00544817|4114096|P1|NOT COMPLETED|No Treatment Interval||12
1684216|NCT00544817|4114096|P1|COMPLETED|No Treatment Interval||28
1684217|NCT00544817|4114096|P1|STARTED|No Treatment Interval||40
1684218|NCT00544817|4114096|P1|NOT COMPLETED|Combined Modality||7
1684219|NCT00544817|4114096|P1|COMPLETED|Combined Modality||40
1684220|NCT00544817|4114096|P1|STARTED|Combined Modality||47
1684221|NCT00544778|4114102|P1|NOT COMPLETED|Overall Study||0
1684222|NCT00544778|4114102|P1|COMPLETED|Overall Study||7
1684223|NCT00544778|4114102|P1|STARTED|Overall Study||7
1684224|NCT00544713|4114108|P2|NOT COMPLETED|Overall Study||5
1684225|NCT00544713|4114109|P1|NOT COMPLETED|Overall Study||3
1684226|NCT00544713|4114108|P2|COMPLETED|Overall Study||109
1684227|NCT00544713|4114109|P1|COMPLETED|Overall Study||111
1684228|NCT00544713|4114108|P2|STARTED|Overall Study||114
1684229|NCT00544713|4114109|P1|STARTED|Overall Study||114
1684230|NCT00544674|4114139|P1|NOT COMPLETED|Overall Study||1
1684231|NCT00544674|4114139|P1|COMPLETED|Overall Study||4
1684232|NCT00544674|4114139|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
1684233|NCT00544648|4114145|P2|NOT COMPLETED|Overall Study||1
1684234|NCT00544648|4114146|P1|NOT COMPLETED|Overall Study||3
1684235|NCT00544648|4114145|P2|COMPLETED|Overall Study||1
1684236|NCT00544648|4114146|P1|COMPLETED|Overall Study||8
1684237|NCT00544648|4114145|P2|STARTED|Overall Study||2
1684238|NCT00544648|4114146|P1|STARTED|Overall Study||11
1684239|NCT00544557|4114160|P1|NOT COMPLETED|Overall Study||434
1684240|NCT00544557|4114160|P1|COMPLETED|Overall Study||1251
1684241|NCT00544557|4114160|P1|STARTED|Overall Study||1685
1684242|NCT00544544|4114191|P1|NOT COMPLETED|Overall Study||3
1684243|NCT00544544|4114191|P1|COMPLETED|Overall Study||11
1684244|NCT00544544|4114191|P1|STARTED|Overall Study||14
1684245|NCT00544440|4114198|P1|NOT COMPLETED|Overall Study||57
1684246|NCT00544440|4114198|P1|COMPLETED|Overall Study||0
1684247|NCT00544440|4114198|P1|STARTED|Overall Study||57
1684248|NCT00544167|4114205|P1|NOT COMPLETED|Overall Study||29
1684249|NCT00544167|4114205|P1|COMPLETED|Overall Study||16
1684250|NCT00544167|4114205|P1|STARTED|Overall Study||45
1684251|NCT00543985|4114209|P1|NOT COMPLETED|Overall Study||4
1684252|NCT00543985|4114209|P1|COMPLETED|Overall Study||32
1684253|NCT00543985|4114209|P1|STARTED|Overall Study||36
1684254|NCT00543855|4114220|P4|NOT COMPLETED|Overall Study||4
1684255|NCT00543855|4114221|P3|NOT COMPLETED|Overall Study||6
1684256|NCT00543855|4114222|P2|NOT COMPLETED|Overall Study||2
1684257|NCT00543855|4114223|P1|NOT COMPLETED|Overall Study||4
1684258|NCT00543855|4114220|P4|COMPLETED|Overall Study||30
1684259|NCT00543855|4114221|P3|COMPLETED|Overall Study||31
1684260|NCT00543855|4114222|P2|COMPLETED|Overall Study||31
1684261|NCT00543855|4114223|P1|COMPLETED|Overall Study||31
1684262|NCT00543855|4114220|P4|STARTED|Overall Study||34
1684263|NCT00543855|4114221|P3|STARTED|Overall Study||37
1684264|NCT00543855|4114222|P2|STARTED|Overall Study||33
1684265|NCT00543855|4114223|P1|STARTED|Overall Study||35
1684266|NCT00543803|4114245|P1|NOT COMPLETED|Overall Study||142
1684267|NCT00543803|4114245|P1|COMPLETED|Overall Study||192
1684268|NCT00543803|4114245|P1|STARTED|Overall Study||334
1684269|NCT00543764|4114264|P2|NOT COMPLETED|Overall Study||0
1684270|NCT00543764|4114265|P1|NOT COMPLETED|Overall Study||0
1684271|NCT00543764|4114264|P2|COMPLETED|Overall Study||50
1684272|NCT00543764|4114265|P1|COMPLETED|Overall Study||100
1684273|NCT00543764|4114264|P2|STARTED|Overall Study||50
1684274|NCT00543764|4114265|P1|STARTED|Overall Study||100
1684275|NCT00543725|4114273|P2|NOT COMPLETED|Overall Study||74
1684276|NCT00543725|4114274|P1|NOT COMPLETED|Overall Study||68
1684277|NCT00543725|4114273|P2|COMPLETED|Overall Study||264
1684278|NCT00543725|4114274|P1|COMPLETED|Overall Study||272
1684279|NCT00543725|4114273|P2|STARTED|Overall Study||338
1684280|NCT00543725|4114274|P1|STARTED|Overall Study||340
1684281|NCT00543569|4114300|P4|NOT COMPLETED|Overall Study||9
1684282|NCT00543569|4114301|P3|NOT COMPLETED|Overall Study||20
1684283|NCT00543569|4114302|P2|NOT COMPLETED|Overall Study||8
1684284|NCT00543569|4114303|P1|NOT COMPLETED|Overall Study||12
1684285|NCT00543569|4114300|P4|COMPLETED|Overall Study||72
1684286|NCT00543569|4114301|P3|COMPLETED|Overall Study||60
1684287|NCT00543569|4114302|P2|COMPLETED|Overall Study||72
1684288|NCT00543569|4114303|P1|COMPLETED|Overall Study||70
1684289|NCT00543569|4114300|P4|Received Treatment|Overall Study||78
1684290|NCT00543569|4114301|P3|Received Treatment|Overall Study||75
1684291|NCT00543569|4114302|P2|Received Treatment|Overall Study||77
1684292|NCT00543569|4114303|P1|Received Treatment|Overall Study||79
1684293|NCT00543569|4114300|P4|STARTED|Overall Study||81
1684294|NCT00543569|4114301|P3|STARTED|Overall Study||80
1684295|NCT00543569|4114302|P2|STARTED|Overall Study||80
1684296|NCT00543569|4114303|P1|STARTED|Overall Study||82
1684297|NCT00543543|4114409|P4|NOT COMPLETED|Extension Study||226
1684298|NCT00543543|4114410|P3|NOT COMPLETED|Extension Study||0
1684299|NCT00543543|4114411|P2|NOT COMPLETED|Extension Study||0
1684300|NCT00543543|4114412|P1|NOT COMPLETED|Extension Study||0
1684301|NCT00543543|4114409|P4|COMPLETED|Extension Study||2824
1684302|NCT00543543|4114410|P3|COMPLETED|Extension Study||0
1684303|NCT00543543|4114411|P2|COMPLETED|Extension Study||150
1684304|NCT00543543|4114412|P1|COMPLETED|Extension Study||0
1684305|NCT00543543|4114409|P4|STARTED|Extension Study|Cohort 2|3050
1684306|NCT00543543|4114410|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
1684307|NCT00543543|4114411|P2|STARTED|Extension Study|Cohort 1|150
1684308|NCT00543543|4114412|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
1684309|NCT00543543|4114409|P4|NOT COMPLETED|Base Study||1222
1684310|NCT00543543|4114410|P3|NOT COMPLETED|Base Study||14
1684311|NCT00543543|4114411|P2|NOT COMPLETED|Base Study||1252
1684312|NCT00543543|4114412|P1|NOT COMPLETED|Base Study||20
1684313|NCT00543543|4114409|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
1684314|NCT00543543|4114410|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
1684315|NCT00543543|4114411|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
1684316|NCT00543543|4114412|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
1684317|NCT00543543|4114409|P4|Completed 3 Vaccinations|Base Study||6934
1684318|NCT00543543|4114410|P3|Completed 3 Vaccinations|Base Study||297
1684319|NCT00543543|4114411|P2|Completed 3 Vaccinations|Base Study||6928
1684320|NCT00543543|4114412|P1|Completed 3 Vaccinations|Base Study||300
1684321|NCT00543543|4114409|P4|STARTED|Base Study||7109
1684322|NCT00543543|4114410|P3|STARTED|Base Study||310
1684323|NCT00543543|4114411|P2|STARTED|Base Study||7106
1684324|NCT00543543|4114412|P1|STARTED|Base Study||315
1684325|NCT00543400|4114457|P4|NOT COMPLETED|Overall Study||5
1684326|NCT00543400|4114458|P3|NOT COMPLETED|Overall Study||4
1684327|NCT00543400|4114459|P2|NOT COMPLETED|Overall Study||1
1684328|NCT00543400|4114460|P1|NOT COMPLETED|Overall Study||5
1684329|NCT00543400|4114457|P4|COMPLETED|Overall Study||151
1684330|NCT00543400|4114458|P3|COMPLETED|Overall Study||148
1684331|NCT00543400|4114459|P2|COMPLETED|Overall Study||43
1684332|NCT00543400|4114460|P1|COMPLETED|Overall Study||146
1684333|NCT00543400|4114457|P4|STARTED|Overall Study||156
1684334|NCT00543400|4114458|P3|STARTED|Overall Study||152
1684335|NCT00543400|4114459|P2|STARTED|Overall Study||44
1684336|NCT00543400|4114460|P1|STARTED|Overall Study||151
1684337|NCT00543387|4114479|P11|NOT COMPLETED|Crossover Participants||3
1684338|NCT00543387|4114480|P10|NOT COMPLETED|Crossover Participants||1
1684339|NCT00543387|4114481|P9|NOT COMPLETED|Crossover Participants||0
1684340|NCT00543387|4114482|P8|NOT COMPLETED|Crossover Participants||0
1684341|NCT00543387|4114483|P7|NOT COMPLETED|Crossover Participants||0
1684342|NCT00543387|4114484|P6|NOT COMPLETED|Crossover Participants||0
1684343|NCT00543387|4114485|P5|NOT COMPLETED|Crossover Participants||0
1684344|NCT00543387|4114486|P4|NOT COMPLETED|Crossover Participants||0
1684345|NCT00543387|4114487|P3|NOT COMPLETED|Crossover Participants||0
1684346|NCT00543387|4114488|P2|NOT COMPLETED|Crossover Participants||0
1684347|NCT00543387|4114489|P1|NOT COMPLETED|Crossover Participants||0
1684348|NCT00543387|4114479|P11|COMPLETED|Crossover Participants||0
1684349|NCT00543387|4114480|P10|COMPLETED|Crossover Participants||0
1684350|NCT00543387|4114481|P9|COMPLETED|Crossover Participants||0
1684351|NCT00543387|4114482|P8|COMPLETED|Crossover Participants||0
1684352|NCT00543387|4114483|P7|COMPLETED|Crossover Participants||0
1684353|NCT00543387|4114484|P6|COMPLETED|Crossover Participants||0
1684354|NCT00543387|4114485|P5|COMPLETED|Crossover Participants||0
1684355|NCT00543387|4114486|P4|COMPLETED|Crossover Participants||0
1684356|NCT00543387|4114487|P3|COMPLETED|Crossover Participants||0
1684357|NCT00543387|4114488|P2|COMPLETED|Crossover Participants||0
1684358|NCT00543387|4114489|P1|COMPLETED|Crossover Participants||0
1684359|NCT00543387|4114479|P11|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
1684360|NCT00543387|4114480|P10|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
1684361|NCT00543387|4114481|P9|STARTED|Crossover Participants||0
1684362|NCT00543387|4114482|P8|STARTED|Crossover Participants||0
1684363|NCT00543387|4114483|P7|STARTED|Crossover Participants||0
1684364|NCT00543387|4114484|P6|STARTED|Crossover Participants||0
1684365|NCT00543387|4114485|P5|STARTED|Crossover Participants||0
1684366|NCT00543387|4114486|P4|STARTED|Crossover Participants||0
1684367|NCT00543387|4114487|P3|STARTED|Crossover Participants||0
1684368|NCT00543387|4114488|P2|STARTED|Crossover Participants||0
1684369|NCT00543387|4114489|P1|STARTED|Crossover Participants||0
1684370|NCT00543387|4114479|P11|NOT COMPLETED|Panel 1 + Panel 2||0
1684371|NCT00543387|4114480|P10|NOT COMPLETED|Panel 1 + Panel 2||0
1684372|NCT00543387|4114481|P9|NOT COMPLETED|Panel 1 + Panel 2||5
1684373|NCT00543387|4114482|P8|NOT COMPLETED|Panel 1 + Panel 2||6
1684374|NCT00543387|4114483|P7|NOT COMPLETED|Panel 1 + Panel 2||6
1684375|NCT00543387|4114484|P6|NOT COMPLETED|Panel 1 + Panel 2||3
1684376|NCT00543387|4114485|P5|NOT COMPLETED|Panel 1 + Panel 2||3
1684377|NCT00543387|4114486|P4|NOT COMPLETED|Panel 1 + Panel 2||3
1684378|NCT00543387|4114487|P3|NOT COMPLETED|Panel 1 + Panel 2||3
1684379|NCT00543387|4114488|P2|NOT COMPLETED|Panel 1 + Panel 2||3
1684380|NCT00543387|4114489|P1|NOT COMPLETED|Panel 1 + Panel 2||3
1684381|NCT00543387|4114479|P11|COMPLETED|Panel 1 + Panel 2||0
1684382|NCT00543387|4114480|P10|COMPLETED|Panel 1 + Panel 2||0
1684383|NCT00543387|4114481|P9|COMPLETED|Panel 1 + Panel 2||0
1684384|NCT00543387|4114482|P8|COMPLETED|Panel 1 + Panel 2||0
1684385|NCT00543387|4114483|P7|COMPLETED|Panel 1 + Panel 2||0
1684386|NCT00543387|4114484|P6|COMPLETED|Panel 1 + Panel 2||0
1684387|NCT00543387|4114485|P5|COMPLETED|Panel 1 + Panel 2||0
1684388|NCT00543387|4114486|P4|COMPLETED|Panel 1 + Panel 2||0
1684389|NCT00543387|4114487|P3|COMPLETED|Panel 1 + Panel 2||0
1684390|NCT00543387|4114488|P2|COMPLETED|Panel 1 + Panel 2||0
1684391|NCT00543387|4114489|P1|COMPLETED|Panel 1 + Panel 2||0
1684392|NCT00543387|4114479|P11|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1684393|NCT00543387|4114480|P10|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1684394|NCT00543387|4114481|P9|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1684395|NCT00543387|4114482|P8|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1684396|NCT00543387|4114483|P7|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1684397|NCT00543387|4114484|P6|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
1684398|NCT00543387|4114485|P5|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
1684399|NCT00543387|4114486|P4|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1684400|NCT00543387|4114487|P3|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1684401|NCT00543387|4114488|P2|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
1684402|NCT00543387|4114489|P1|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
1684403|NCT00543387|4114479|P11|STARTED|Panel 1 + Panel 2||0
1684404|NCT00543387|4114480|P10|STARTED|Panel 1 + Panel 2||0
1684405|NCT00543387|4114481|P9|STARTED|Panel 1 + Panel 2||5
1684406|NCT00543387|4114482|P8|STARTED|Panel 1 + Panel 2||6
1684407|NCT00543387|4114483|P7|STARTED|Panel 1 + Panel 2||6
1684408|NCT00543387|4114484|P6|STARTED|Panel 1 + Panel 2||3
1684409|NCT00543387|4114485|P5|STARTED|Panel 1 + Panel 2||3
1684410|NCT00543387|4114486|P4|STARTED|Panel 1 + Panel 2||3
1684411|NCT00543387|4114487|P3|STARTED|Panel 1 + Panel 2||3
1684412|NCT00543387|4114488|P2|STARTED|Panel 1 + Panel 2||3
1684413|NCT00543387|4114489|P1|STARTED|Panel 1 + Panel 2||3
1684414|NCT00543309|4114527|P3|NOT COMPLETED|Overall Study||0
1684415|NCT00543309|4114528|P2|NOT COMPLETED|Overall Study||1
1684416|NCT00543309|4114529|P1|NOT COMPLETED|Overall Study||0
1684417|NCT00543309|4114527|P3|COMPLETED|Overall Study||35
1684418|NCT00543309|4114528|P2|COMPLETED|Overall Study||35
1684419|NCT00543309|4114529|P1|COMPLETED|Overall Study||35
1684420|NCT00543309|4114527|P3|STARTED|Overall Study||35
1684421|NCT00543309|4114528|P2|STARTED|Overall Study||36
1684422|NCT00543309|4114529|P1|STARTED|Overall Study||35
1684423|NCT00543296|4114579|P1|NOT COMPLETED|Overall Study||7
1684424|NCT00543296|4114579|P1|COMPLETED|Overall Study||14
1684425|NCT00543296|4114579|P1|STARTED|Overall Study||21
1684426|NCT00543140|4114586|P1|NOT COMPLETED|Overall Study||72
1684427|NCT00543140|4114586|P1|COMPLETED|Overall Study||231
1684428|NCT00543140|4114586|P1|STARTED|Overall Study||303
1684429|NCT00543101|4114596|P2|NOT COMPLETED|Overall Study||0
1684430|NCT00543101|4114597|P1|NOT COMPLETED|Overall Study||0
1684431|NCT00543101|4114596|P2|COMPLETED|Overall Study||12
1684432|NCT00543101|4114597|P1|COMPLETED|Overall Study||12
1684433|NCT00543101|4114596|P2|STARTED|Overall Study||12
1684434|NCT00543101|4114597|P1|STARTED|Overall Study||12
1684435|NCT00542997|4114609|P1|NOT COMPLETED|Efficacy Period||3
1684436|NCT00542997|4114609|P1|COMPLETED|Efficacy Period||43
1684437|NCT00542997|4114609|P1|STARTED|Efficacy Period||46
1684438|NCT00542997|4114609|P1|NOT COMPLETED|Wash in / Wash Out Period||5
1684439|NCT00542997|4114609|P1|COMPLETED|Wash in / Wash Out Period||46
1684440|NCT00542997|4114609|P1|STARTED|Wash in / Wash Out Period||51
1684441|NCT00542971|4114624|P1|NOT COMPLETED|Overall Study||0
1684442|NCT00542971|4114624|P1|COMPLETED|Overall Study||75
1684443|NCT00542971|4114624|P1|STARTED|Overall Study||75
1684444|NCT00542880|4114631|P2|NOT COMPLETED|Period 3||2
1684445|NCT00542880|4114632|P1|NOT COMPLETED|Period 3||0
1684446|NCT00542880|4114631|P2|COMPLETED|Period 3||201
1684447|NCT00542880|4114632|P1|COMPLETED|Period 3||204
1684448|NCT00542880|4114631|P2|STARTED|Period 3||203
1684449|NCT00542880|4114632|P1|STARTED|Period 3||204
1684450|NCT00542880|4114631|P2|NOT COMPLETED|Period 2||10
1684451|NCT00542880|4114632|P1|NOT COMPLETED|Period 2||7
1684452|NCT00542880|4114631|P2|COMPLETED|Period 2||203
1684453|NCT00542880|4114632|P1|COMPLETED|Period 2||204
1684454|NCT00542880|4114631|P2|STARTED|Period 2||213
1684455|NCT00542880|4114632|P1|STARTED|Period 2||211
1684456|NCT00542880|4114631|P2|NOT COMPLETED|Period 1||12
1684457|NCT00542880|4114632|P1|NOT COMPLETED|Period 1||6
1684458|NCT00542880|4114631|P2|COMPLETED|Period 1||213
1684459|NCT00542880|4114632|P1|COMPLETED|Period 1||211
1684460|NCT00542880|4114631|P2|STARTED|Period 1||225
1684461|NCT00542880|4114632|P1|STARTED|Period 1|This was a cross-over study|217
1684462|NCT00542828|4114668|P1|NOT COMPLETED|Overall Study||13
1684463|NCT00542828|4114668|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
1684464|NCT00542828|4114668|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
1684465|NCT00542815|4114686|P3|NOT COMPLETED|Overall Study||32
1684466|NCT00542815|4114687|P2|NOT COMPLETED|Overall Study||32
1684467|NCT00542815|4114688|P1|NOT COMPLETED|Overall Study||106
1684468|NCT00542815|4114686|P3|COMPLETED|Overall Study||92
1684469|NCT00542815|4114687|P2|COMPLETED|Overall Study||44
1684470|NCT00542815|4114688|P1|COMPLETED|Overall Study||326
1684471|NCT00542815|4114686|P3|STARTED|Overall Study||124
1684472|NCT00542815|4114687|P2|STARTED|Overall Study||76
1684473|NCT00542815|4114688|P1|STARTED|Overall Study||432
1684474|NCT00542789|4114701|P2|NOT COMPLETED|Overall Study||78
1684475|NCT00542789|4114702|P1|NOT COMPLETED|Overall Study||41
1684476|NCT00542789|4114701|P2|COMPLETED|Overall Study||90
1684477|NCT00542789|4114702|P1|COMPLETED|Overall Study||134
1684478|NCT00542789|4114701|P2|STARTED|Overall Study|Randomised|168
1684479|NCT00542789|4114702|P1|STARTED|Overall Study|Randomised|175
1684480|NCT00542750|4114712|P1|NOT COMPLETED|Overall Study||0
1684481|NCT00542750|4114712|P1|COMPLETED|Overall Study||24
1684482|NCT00542750|4114712|P1|STARTED|Overall Study||24
1684483|NCT00542620|4114718|P2|NOT COMPLETED|Overall Study||0
1684484|NCT00542620|4114719|P1|NOT COMPLETED|Overall Study||0
1684485|NCT00542620|4114718|P2|COMPLETED|Overall Study||12
1684486|NCT00542620|4114719|P1|COMPLETED|Overall Study||13
1684487|NCT00542620|4114718|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
1684488|NCT00542620|4114719|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
1684489|NCT00542620|4114718|P2|STARTED|Overall Study||12
1684490|NCT00542620|4114719|P1|STARTED|Overall Study||13
1684491|NCT00542542|4114785|P2|NOT COMPLETED|Overall Study||0
1684492|NCT00542542|4114786|P1|NOT COMPLETED|Overall Study||0
1684493|NCT00542542|4114785|P2|COMPLETED|Overall Study||44
1684494|NCT00542542|4114786|P1|COMPLETED|Overall Study||44
1684495|NCT00542542|4114785|P2|STARTED|Overall Study||44
1684496|NCT00542542|4114786|P1|STARTED|Overall Study||44
1684497|NCT00542490|4114792|P1|NOT COMPLETED|Overall Study||2
1684498|NCT00542490|4114792|P1|COMPLETED|Overall Study||21
1684499|NCT00542490|4114792|P1|STARTED|Overall Study||23
1684500|NCT00542425|4114802|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
1684501|NCT00542425|4114803|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
1684502|NCT00542425|4114804|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
1684503|NCT00542425|4114805|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
1684504|NCT00542425|4114806|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
1684505|NCT00542425|4114802|P5|COMPLETED|Extended 24 Weeks of Treatment||13
1684506|NCT00542425|4114803|P4|COMPLETED|Extended 24 Weeks of Treatment||6
1684507|NCT00542425|4114804|P3|COMPLETED|Extended 24 Weeks of Treatment||8
1684508|NCT00542425|4114805|P2|COMPLETED|Extended 24 Weeks of Treatment||11
1684509|NCT00542425|4114806|P1|COMPLETED|Extended 24 Weeks of Treatment||10
1684510|NCT00542425|4114802|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
1684511|NCT00542425|4114803|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
1684512|NCT00542425|4114804|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
1684513|NCT00542425|4114805|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
1684514|NCT00542425|4114806|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
1684515|NCT00542425|4114802|P5|NOT COMPLETED|Initial 24 Weeks||6
1684516|NCT00542425|4114803|P4|NOT COMPLETED|Initial 24 Weeks||11
1684517|NCT00542425|4114804|P3|NOT COMPLETED|Initial 24 Weeks||7
1684518|NCT00542425|4114805|P2|NOT COMPLETED|Initial 24 Weeks||10
1684519|NCT00542425|4114806|P1|NOT COMPLETED|Initial 24 Weeks||4
1684520|NCT00542425|4114802|P5|COMPLETED|Initial 24 Weeks||39
1684521|NCT00542425|4114803|P4|COMPLETED|Initial 24 Weeks||34
1684522|NCT00542425|4114804|P3|COMPLETED|Initial 24 Weeks||36
1684523|NCT00542425|4114805|P2|COMPLETED|Initial 24 Weeks||33
1684524|NCT00542425|4114806|P1|COMPLETED|Initial 24 Weeks||42
1684525|NCT00542425|4114802|P5|STARTED|Initial 24 Weeks||45
1684526|NCT00542425|4114803|P4|STARTED|Initial 24 Weeks||45
1684527|NCT00542425|4114804|P3|STARTED|Initial 24 Weeks||43
1684528|NCT00542425|4114805|P2|STARTED|Initial 24 Weeks||43
1684529|NCT00542425|4114806|P1|STARTED|Initial 24 Weeks||46
1684530|NCT00542386|4114844|P6|NOT COMPLETED|Overall Study||50
1684531|NCT00542386|4114845|P5|NOT COMPLETED|Overall Study||40
1684532|NCT00542386|4114846|P4|NOT COMPLETED|Overall Study||38
1684533|NCT00542386|4114847|P3|NOT COMPLETED|Overall Study||33
1684534|NCT00542386|4114848|P2|NOT COMPLETED|Overall Study||28
1684535|NCT00542386|4114849|P1|NOT COMPLETED|Overall Study||43
1684536|NCT00542386|4114844|P6|COMPLETED|Overall Study||82
1684537|NCT00542386|4114845|P5|COMPLETED|Overall Study||62
1684538|NCT00542386|4114846|P4|COMPLETED|Overall Study||65
1684539|NCT00542386|4114847|P3|COMPLETED|Overall Study||66
1684540|NCT00542386|4114848|P2|COMPLETED|Overall Study||74
1684541|NCT00542386|4114849|P1|COMPLETED|Overall Study||61
1684542|NCT00542386|4114844|P6|STARTED|Overall Study||132
1684543|NCT00542386|4114845|P5|STARTED|Overall Study||102
1684544|NCT00542386|4114846|P4|STARTED|Overall Study||103
1684545|NCT00542386|4114847|P3|STARTED|Overall Study||99
1684546|NCT00542386|4114848|P2|STARTED|Overall Study||102
1684547|NCT00542386|4114849|P1|STARTED|Overall Study||104
1684548|NCT00542321|4114871|P2|NOT COMPLETED|Overall Study||1
1684549|NCT00542321|4114872|P1|NOT COMPLETED|Overall Study||0
1684550|NCT00542321|4114871|P2|COMPLETED|Overall Study||7
1684551|NCT00542321|4114872|P1|COMPLETED|Overall Study||8
1684552|NCT00542321|4114871|P2|STARTED|Overall Study||8
1684553|NCT00542321|4114872|P1|STARTED|Overall Study||8
1684554|NCT00542308|4114886|P1|NOT COMPLETED|Overall Study||0
1684555|NCT00542308|4114886|P1|COMPLETED|Overall Study||90
1684556|NCT00542308|4114886|P1|STARTED|Overall Study||90
1684557|NCT00542269|4114894|P3|NOT COMPLETED|Overall Study||6
1684558|NCT00542269|4114895|P2|NOT COMPLETED|Overall Study||6
1684559|NCT00542269|4114896|P1|NOT COMPLETED|Overall Study||13
1684560|NCT00542269|4114894|P3|COMPLETED|Overall Study||51
1684561|NCT00542269|4114895|P2|COMPLETED|Overall Study||54
1684562|NCT00542269|4114896|P1|COMPLETED|Overall Study||48
1684563|NCT00542269|4114894|P3|STARTED|Overall Study||57
1684564|NCT00542269|4114895|P2|STARTED|Overall Study||60
1684565|NCT00542269|4114896|P1|STARTED|Overall Study||61
1684566|NCT00542178|4114931|P8|NOT COMPLETED|Overall Study||85
1684567|NCT00542178|4114932|P7|NOT COMPLETED|Overall Study||87
1684568|NCT00542178|4114933|P6|NOT COMPLETED|Overall Study||89
1684569|NCT00542178|4114934|P5|NOT COMPLETED|Overall Study||64
1684570|NCT00542178|4114935|P4|NOT COMPLETED|Overall Study||62
1684571|NCT00542178|4114936|P3|NOT COMPLETED|Overall Study||74
1684572|NCT00542178|4114937|P2|NOT COMPLETED|Overall Study||80
1684573|NCT00542178|4114938|P1|NOT COMPLETED|Overall Study||75
1684574|NCT00542178|4114931|P8|COMPLETED|Overall Study||381
1684575|NCT00542178|4114932|P7|COMPLETED|Overall Study||406
1684576|NCT00542178|4114933|P6|COMPLETED|Overall Study||406
1684577|NCT00542178|4114934|P5|COMPLETED|Overall Study||400
1684578|NCT00542178|4114935|P4|COMPLETED|Overall Study||308
1684579|NCT00542178|4114936|P3|COMPLETED|Overall Study||308
1684580|NCT00542178|4114937|P2|COMPLETED|Overall Study||332
1684581|NCT00542178|4114938|P1|COMPLETED|Overall Study||315
1684582|NCT00542178|4114931|P8|STARTED|Overall Study||466
1684583|NCT00542178|4114932|P7|STARTED|Overall Study||493
1684584|NCT00542178|4114933|P6|STARTED|Overall Study||495
1684585|NCT00542178|4114934|P5|STARTED|Overall Study||464
1684586|NCT00542178|4114935|P4|STARTED|Overall Study||370
1684587|NCT00542178|4114936|P3|STARTED|Overall Study||382
1684588|NCT00542178|4114937|P2|STARTED|Overall Study||412
1684589|NCT00542178|4114938|P1|STARTED|Overall Study||390
1684590|NCT00541970|4114974|P4|NOT COMPLETED|Month 60||72
1684591|NCT00541970|4114975|P3|NOT COMPLETED|Month 60||82
1684592|NCT00541970|4114976|P2|NOT COMPLETED|Month 60||77
1684593|NCT00541970|4114977|P1|NOT COMPLETED|Month 60||78
1684594|NCT00541970|4114974|P4|COMPLETED|Month 60||167
1684595|NCT00541970|4114975|P3|COMPLETED|Month 60||158
1684596|NCT00541970|4114976|P2|COMPLETED|Month 60||164
1684597|NCT00541970|4114977|P1|COMPLETED|Month 60||162
1684598|NCT00541970|4114974|P4|STARTED|Month 60||239
1684599|NCT00541970|4114975|P3|STARTED|Month 60||240
1684600|NCT00541970|4114976|P2|STARTED|Month 60||241
1684601|NCT00541970|4114977|P1|STARTED|Month 60||240
1684602|NCT00541970|4114974|P4|NOT COMPLETED|Month 48||75
1684603|NCT00541970|4114975|P3|NOT COMPLETED|Month 48||73
1684604|NCT00541970|4114976|P2|NOT COMPLETED|Month 48||73
1684605|NCT00541970|4114977|P1|NOT COMPLETED|Month 48||71
1684606|NCT00541970|4114974|P4|COMPLETED|Month 48||164
1684607|NCT00541970|4114975|P3|COMPLETED|Month 48||167
1684608|NCT00541970|4114976|P2|COMPLETED|Month 48||168
1684609|NCT00541970|4114977|P1|COMPLETED|Month 48||169
1684610|NCT00541970|4114974|P4|STARTED|Month 48||239
1684611|NCT00541970|4114975|P3|STARTED|Month 48||240
1684612|NCT00541970|4114976|P2|STARTED|Month 48||241
1684613|NCT00541970|4114977|P1|STARTED|Month 48||240
1684614|NCT00541970|4114974|P4|NOT COMPLETED|Month 36||60
1684615|NCT00541970|4114975|P3|NOT COMPLETED|Month 36||66
1684616|NCT00541970|4114976|P2|NOT COMPLETED|Month 36||66
1684617|NCT00541970|4114977|P1|NOT COMPLETED|Month 36||61
1684618|NCT00541970|4114974|P4|COMPLETED|Month 36||179
1684619|NCT00541970|4114975|P3|COMPLETED|Month 36||174
1684620|NCT00541970|4114976|P2|COMPLETED|Month 36||175
1684621|NCT00541970|4114977|P1|COMPLETED|Month 36||179
1684622|NCT00541970|4114974|P4|STARTED|Month 36||239
1684623|NCT00541970|4114975|P3|STARTED|Month 36||240
1684624|NCT00541970|4114976|P2|STARTED|Month 36||241
1684625|NCT00541970|4114977|P1|STARTED|Month 36||240
1684626|NCT00541970|4114974|P4|NOT COMPLETED|Month 24||22
1684627|NCT00541970|4114975|P3|NOT COMPLETED|Month 24||32
1684628|NCT00541970|4114976|P2|NOT COMPLETED|Month 24||32
1684629|NCT00541970|4114977|P1|NOT COMPLETED|Month 24||29
1684630|NCT00541970|4114974|P4|COMPLETED|Month 24||217
1684631|NCT00541970|4114975|P3|COMPLETED|Month 24||208
1684632|NCT00541970|4114976|P2|COMPLETED|Month 24||209
1684633|NCT00541970|4114977|P1|COMPLETED|Month 24||211
1684634|NCT00541970|4114974|P4|STARTED|Month 24||239
1684635|NCT00541970|4114975|P3|STARTED|Month 24||240
1684636|NCT00541970|4114976|P2|STARTED|Month 24||241
1684637|NCT00541970|4114977|P1|STARTED|Month 24||240
1684638|NCT00541970|4114974|P4|NOT COMPLETED|Month 18||17
1684639|NCT00541970|4114975|P3|NOT COMPLETED|Month 18||25
1684640|NCT00541970|4114976|P2|NOT COMPLETED|Month 18||24
1684641|NCT00541970|4114977|P1|NOT COMPLETED|Month 18||14
1684642|NCT00541970|4114974|P4|COMPLETED|Month 18||222
1684643|NCT00541970|4114975|P3|COMPLETED|Month 18||215
1684644|NCT00541970|4114976|P2|COMPLETED|Month 18||217
1684645|NCT00541970|4114977|P1|COMPLETED|Month 18||226
1684646|NCT00541970|4114974|P4|STARTED|Month 18||239
1684647|NCT00541970|4114975|P3|STARTED|Month 18||240
1684648|NCT00541970|4114976|P2|STARTED|Month 18||241
1684649|NCT00541970|4114977|P1|STARTED|Month 18||240
1684650|NCT00541970|4114974|P4|NOT COMPLETED|Month 12||16
1684651|NCT00541970|4114975|P3|NOT COMPLETED|Month 12||21
1684652|NCT00541970|4114976|P2|NOT COMPLETED|Month 12||22
1684653|NCT00541970|4114977|P1|NOT COMPLETED|Month 12||12
1684654|NCT00541970|4114974|P4|COMPLETED|Month 12||223
1684655|NCT00541970|4114975|P3|COMPLETED|Month 12||219
1684656|NCT00541970|4114976|P2|COMPLETED|Month 12||219
1684657|NCT00541970|4114977|P1|COMPLETED|Month 12||228
1684658|NCT00541970|4114974|P4|STARTED|Month 12||239
1684659|NCT00541970|4114975|P3|STARTED|Month 12||240
1684660|NCT00541970|4114976|P2|STARTED|Month 12||241
1684661|NCT00541970|4114977|P1|STARTED|Month 12||240
1684662|NCT00541970|4114974|P4|NOT COMPLETED|Month 7||5
1684663|NCT00541970|4114975|P3|NOT COMPLETED|Month 7||11
1684664|NCT00541970|4114976|P2|NOT COMPLETED|Month 7||13
1684665|NCT00541970|4114977|P1|NOT COMPLETED|Month 7||9
1684666|NCT00541970|4114974|P4|COMPLETED|Month 7||234
1684667|NCT00541970|4114975|P3|COMPLETED|Month 7||229
1684668|NCT00541970|4114976|P2|COMPLETED|Month 7||228
1684669|NCT00541970|4114977|P1|COMPLETED|Month 7||231
1684670|NCT00541970|4114974|P4|STARTED|Month 7||239
1684671|NCT00541970|4114975|P3|STARTED|Month 7||240
1684672|NCT00541970|4114976|P2|STARTED|Month 7||241
1684673|NCT00541970|4114977|P1|STARTED|Month 7||240
1684674|NCT00541931|4115128|P2|NOT COMPLETED|Overall Study||4
1684675|NCT00541931|4115129|P1|NOT COMPLETED|Overall Study||5
1684676|NCT00541931|4115128|P2|COMPLETED|Overall Study||11
1684677|NCT00541931|4115129|P1|COMPLETED|Overall Study||17
1684678|NCT00541931|4115128|P2|STARTED|Overall Study||15
1684679|NCT00541931|4115129|P1|STARTED|Overall Study||22
1684680|NCT00541866|4115142|P5|NOT COMPLETED|Overall Study||15
1684681|NCT00541866|4115143|P4|NOT COMPLETED|Overall Study||16
1684682|NCT00541866|4115144|P3|NOT COMPLETED|Overall Study||15
1684683|NCT00541866|4115145|P2|NOT COMPLETED|Overall Study||18
1684684|NCT00541866|4115146|P1|NOT COMPLETED|Overall Study||34
1684685|NCT00541866|4115142|P5|COMPLETED|Overall Study||3
1684686|NCT00541866|4115143|P4|COMPLETED|Overall Study||0
1684687|NCT00541866|4115144|P3|COMPLETED|Overall Study||2
1684688|NCT00541866|4115145|P2|COMPLETED|Overall Study||0
1684689|NCT00541866|4115146|P1|COMPLETED|Overall Study||7
1684690|NCT00541866|4115142|P5|STARTED|Overall Study||18
1684691|NCT00541866|4115143|P4|STARTED|Overall Study||16
1684692|NCT00541866|4115144|P3|STARTED|Overall Study||17
1684693|NCT00541866|4115145|P2|STARTED|Overall Study||18
1684694|NCT00541866|4115146|P1|STARTED|Overall Study|41 started, but only 39 treated|41
1684695|NCT00541775|4115187|P3|NOT COMPLETED|Overall Study||8
1684696|NCT00541775|4115188|P2|NOT COMPLETED|Overall Study||2
1684697|NCT00541775|4115189|P1|NOT COMPLETED|Overall Study||9
1684698|NCT00541775|4115187|P3|COMPLETED|Overall Study||84
1684699|NCT00541775|4115188|P2|COMPLETED|Overall Study||85
1684700|NCT00541775|4115189|P1|COMPLETED|Overall Study||85
1684701|NCT00541775|4115187|P3|STARTED|Overall Study||92
1684702|NCT00541775|4115188|P2|STARTED|Overall Study||87
1684703|NCT00541775|4115189|P1|STARTED|Overall Study||94
1684704|NCT00541671|4115205|P2|NOT COMPLETED|Overall Study||0
1684705|NCT00541671|4115206|P1|NOT COMPLETED|Overall Study||0
1684706|NCT00541671|4115205|P2|COMPLETED|Overall Study||12
1684707|NCT00541671|4115206|P1|COMPLETED|Overall Study||13
1684708|NCT00541671|4115205|P2|STARTED|Overall Study||12
1684709|NCT00541671|4115206|P1|STARTED|Overall Study||13
1684710|NCT00541658|4115215|P3|NOT COMPLETED|Overall Study||68
1684711|NCT00541658|4115216|P2|NOT COMPLETED|Overall Study||73
1684712|NCT00541658|4115217|P1|NOT COMPLETED|Overall Study||60
1684713|NCT00541658|4115215|P3|COMPLETED|Overall Study||240
1684714|NCT00541658|4115216|P2|COMPLETED|Overall Study||234
1684715|NCT00541658|4115217|P1|COMPLETED|Overall Study||248
1684716|NCT00541658|4115215|P3|ITT Population|Overall Study||308
1684717|NCT00541658|4115216|P2|ITT Population|Overall Study||307
1684718|NCT00541658|4115217|P1|ITT Population|Overall Study||307
1684719|NCT00541658|4115215|P3|STARTED|Overall Study||308
1684720|NCT00541658|4115216|P2|STARTED|Overall Study||307
1684721|NCT00541658|4115217|P1|STARTED|Overall Study||308
1684722|NCT00541593|4115374|P1|NOT COMPLETED|Overall Study||0
1684723|NCT00541593|4115374|P1|COMPLETED|Overall Study||5
1684724|NCT00541593|4115374|P1|STARTED|Overall Study||5
1684725|NCT00541450|4115380|P2|NOT COMPLETED|Phase B||31
1684726|NCT00541450|4115381|P1|NOT COMPLETED|Phase B||37
1684727|NCT00541450|4115380|P2|COMPLETED|Phase B||200
1684728|NCT00541450|4115381|P1|COMPLETED|Phase B||187
1684729|NCT00541450|4115380|P2|STARTED|Phase B||231
1684730|NCT00541450|4115381|P1|STARTED|Phase B||224
1684731|NCT00541450|4115380|P2|NOT COMPLETED|Phase A||17
1684732|NCT00541450|4115381|P1|NOT COMPLETED|Phase A||20
1684733|NCT00541450|4115380|P2|COMPLETED|Phase A||231
1684734|NCT00541450|4115381|P1|COMPLETED|Phase A||224
1684735|NCT00541450|4115380|P2|STARTED|Phase A||248
1684736|NCT00541450|4115381|P1|STARTED|Phase A||244
1684737|NCT00541346|4115399|P1|NOT COMPLETED|Follow-up||1
1684738|NCT00541346|4115399|P1|COMPLETED|Follow-up||15
1684739|NCT00541346|4115399|P1|STARTED|Follow-up||16
1684740|NCT00541346|4115399|P1|NOT COMPLETED|Baseline||0
1684741|NCT00541346|4115399|P1|COMPLETED|Baseline||16
1684742|NCT00541346|4115399|P1|STARTED|Baseline||16
1684743|NCT00541307|4115413|P1|NOT COMPLETED|Overall Study||24
1684744|NCT00541307|4115413|P1|COMPLETED|Overall Study||95
1684745|NCT00541307|4115413|P1|STARTED|Overall Study||119
1684746|NCT00541242|4115423|P2|NOT COMPLETED|Treatment Period 2||7
1684747|NCT00541242|4115424|P1|NOT COMPLETED|Treatment Period 2||9
1684748|NCT00541242|4115423|P2|COMPLETED|Treatment Period 2||266
1684749|NCT00541242|4115424|P1|COMPLETED|Treatment Period 2||261
1684750|NCT00541242|4115423|P2|STARTED|Treatment Period 2||273
1684751|NCT00541242|4115424|P1|STARTED|Treatment Period 2||270
1684752|NCT00541242|4115423|P2|NOT COMPLETED|Treatment Period 1||0
1684753|NCT00541242|4115424|P1|NOT COMPLETED|Treatment Period 1||0
1684754|NCT00541242|4115423|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
1684755|NCT00541242|4115424|P1|COMPLETED|Treatment Period 1||0
1684756|NCT00541242|4115423|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
1684757|NCT00541242|4115424|P1|STARTED|Treatment Period 1||0
1684758|NCT00541229|4115438|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
1684759|NCT00541229|4115439|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
1684760|NCT00541229|4115440|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
1684761|NCT00541229|4115441|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
1684762|NCT00541229|4115442|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
1684763|NCT00541229|4115443|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
1684764|NCT00541229|4115438|P6|COMPLETED|Treatment Period III (Week 11)||4
1684765|NCT00541229|4115439|P5|COMPLETED|Treatment Period III (Week 11)||6
1684766|NCT00541229|4115440|P4|COMPLETED|Treatment Period III (Week 11)||8
1684767|NCT00541229|4115441|P3|COMPLETED|Treatment Period III (Week 11)||9
1684768|NCT00541229|4115442|P2|COMPLETED|Treatment Period III (Week 11)||8
1684769|NCT00541229|4115443|P1|COMPLETED|Treatment Period III (Week 11)||7
1684770|NCT00541229|4115438|P6|STARTED|Treatment Period III (Week 11)||5
1684771|NCT00541229|4115439|P5|STARTED|Treatment Period III (Week 11)||7
1684772|NCT00541229|4115440|P4|STARTED|Treatment Period III (Week 11)||8
1684773|NCT00541229|4115441|P3|STARTED|Treatment Period III (Week 11)||10
1684774|NCT00541229|4115442|P2|STARTED|Treatment Period III (Week 11)||8
1684775|NCT00541229|4115443|P1|STARTED|Treatment Period III (Week 11)||7
1684776|NCT00541229|4115438|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
1684777|NCT00541229|4115439|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
1684778|NCT00541229|4115440|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
1684779|NCT00541229|4115441|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
1684780|NCT00541229|4115442|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
1684781|NCT00541229|4115443|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
1684782|NCT00541229|4115438|P6|COMPLETED|Washout Period II (Week 7-10)||5
1684783|NCT00541229|4115439|P5|COMPLETED|Washout Period II (Week 7-10)||7
1684784|NCT00541229|4115440|P4|COMPLETED|Washout Period II (Week 7-10)||8
1684785|NCT00541229|4115441|P3|COMPLETED|Washout Period II (Week 7-10)||10
1684786|NCT00541229|4115442|P2|COMPLETED|Washout Period II (Week 7-10)||8
1684787|NCT00541229|4115443|P1|COMPLETED|Washout Period II (Week 7-10)||7
1684788|NCT00541229|4115438|P6|STARTED|Washout Period II (Week 7-10)||8
1684789|NCT00541229|4115439|P5|STARTED|Washout Period II (Week 7-10)||11
1684790|NCT00541229|4115440|P4|STARTED|Washout Period II (Week 7-10)||12
1684791|NCT00541229|4115441|P3|STARTED|Washout Period II (Week 7-10)||12
1684792|NCT00541229|4115442|P2|STARTED|Washout Period II (Week 7-10)||12
1684793|NCT00541229|4115443|P1|STARTED|Washout Period II (Week 7-10)||11
1684794|NCT00541229|4115438|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
1684795|NCT00541229|4115439|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
1684796|NCT00541229|4115440|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
1684797|NCT00541229|4115441|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
1684798|NCT00541229|4115442|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
1684799|NCT00541229|4115443|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
1684800|NCT00541229|4115438|P6|COMPLETED|Treatment Period II (Week 6)||8
1684801|NCT00541229|4115439|P5|COMPLETED|Treatment Period II (Week 6)||11
1684802|NCT00541229|4115440|P4|COMPLETED|Treatment Period II (Week 6)||12
1684803|NCT00541229|4115441|P3|COMPLETED|Treatment Period II (Week 6)||12
1684804|NCT00541229|4115442|P2|COMPLETED|Treatment Period II (Week 6)||12
1684805|NCT00541229|4115443|P1|COMPLETED|Treatment Period II (Week 6)||11
1684806|NCT00541229|4115438|P6|STARTED|Treatment Period II (Week 6)||11
1684807|NCT00541229|4115439|P5|STARTED|Treatment Period II (Week 6)||13
1684808|NCT00541229|4115440|P4|STARTED|Treatment Period II (Week 6)||13
1684809|NCT00541229|4115441|P3|STARTED|Treatment Period II (Week 6)||13
1684810|NCT00541229|4115442|P2|STARTED|Treatment Period II (Week 6)||13
1684811|NCT00541229|4115443|P1|STARTED|Treatment Period II (Week 6)||13
1684812|NCT00541229|4115438|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
1684813|NCT00541229|4115439|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
1684814|NCT00541229|4115440|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
1684815|NCT00541229|4115441|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
1684816|NCT00541229|4115442|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
1684817|NCT00541229|4115443|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
1684818|NCT00541229|4115438|P6|COMPLETED|Washout Period I (Week 2-5)||11
1684819|NCT00541229|4115439|P5|COMPLETED|Washout Period I (Week 2-5)||13
1684820|NCT00541229|4115440|P4|COMPLETED|Washout Period I (Week 2-5)||13
1684821|NCT00541229|4115441|P3|COMPLETED|Washout Period I (Week 2-5)||13
1684822|NCT00541229|4115442|P2|COMPLETED|Washout Period I (Week 2-5)||13
1684823|NCT00541229|4115443|P1|COMPLETED|Washout Period I (Week 2-5)||13
1684824|NCT00541229|4115438|P6|STARTED|Washout Period I (Week 2-5)||16
1684825|NCT00541229|4115439|P5|STARTED|Washout Period I (Week 2-5)||14
1684826|NCT00541229|4115440|P4|STARTED|Washout Period I (Week 2-5)||17
1684827|NCT00541229|4115441|P3|STARTED|Washout Period I (Week 2-5)||17
1684828|NCT00541229|4115442|P2|STARTED|Washout Period I (Week 2-5)||15
1684829|NCT00541229|4115443|P1|STARTED|Washout Period I (Week 2-5)||17
1684830|NCT00541229|4115438|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
1684831|NCT00541229|4115439|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
1684832|NCT00541229|4115440|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
1684833|NCT00541229|4115441|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
1684834|NCT00541229|4115442|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
1684835|NCT00541229|4115443|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
1684836|NCT00541229|4115438|P6|COMPLETED|Treatment Period I (Week 1)||16
1684837|NCT00541229|4115439|P5|COMPLETED|Treatment Period I (Week 1)||14
1684838|NCT00541229|4115440|P4|COMPLETED|Treatment Period I (Week 1)||17
1684839|NCT00541229|4115441|P3|COMPLETED|Treatment Period I (Week 1)||17
1684840|NCT00541229|4115442|P2|COMPLETED|Treatment Period I (Week 1)||15
1684841|NCT00541229|4115443|P1|COMPLETED|Treatment Period I (Week 1)||17
1684842|NCT00541229|4115438|P6|STARTED|Treatment Period I (Week 1)||18
1684843|NCT00541229|4115439|P5|STARTED|Treatment Period I (Week 1)||14
1684844|NCT00541229|4115440|P4|STARTED|Treatment Period I (Week 1)||18
1684845|NCT00541229|4115441|P3|STARTED|Treatment Period I (Week 1)||20
1684846|NCT00541229|4115442|P2|STARTED|Treatment Period I (Week 1)||16
1684847|NCT00541229|4115443|P1|STARTED|Treatment Period I (Week 1)||17
1684848|NCT00541190|4115453|P2|NOT COMPLETED|Overall Study||0
1684849|NCT00541190|4115454|P1|NOT COMPLETED|Overall Study||0
1684850|NCT00541190|4115453|P2|COMPLETED|Overall Study||11
1684851|NCT00541190|4115454|P1|COMPLETED|Overall Study||10
1684852|NCT00541190|4115453|P2|STARTED|Overall Study||11
1684853|NCT00541190|4115454|P1|STARTED|Overall Study||10
1684854|NCT00541099|4115462|P1|NOT COMPLETED|Overall Study||3
1684855|NCT00541099|4115462|P1|COMPLETED|Overall Study||8
1684856|NCT00541099|4115462|P1|STARTED|Overall Study||11
1684857|NCT00541034|4115468|P1|NOT COMPLETED|Overall Study||3
1684858|NCT00541034|4115468|P1|COMPLETED|Overall Study||46
1684859|NCT00541034|4115468|P1|STARTED|Overall Study||49
1684860|NCT00540969|4115474|P2|NOT COMPLETED|Overall Study||0
1684861|NCT00540969|4115475|P1|NOT COMPLETED|Overall Study||0
1684862|NCT00540969|4115474|P2|COMPLETED|Overall Study||1
1684863|NCT00540969|4115475|P1|COMPLETED|Overall Study||2
1684864|NCT00540969|4115474|P2|STARTED|Overall Study||1
1684865|NCT00540969|4115475|P1|STARTED|Overall Study||2
1684866|NCT00540722|4115485|P1|NOT COMPLETED|Overall Study||0
1684867|NCT00540722|4115485|P1|COMPLETED|Overall Study||56
1684868|NCT00540722|4115485|P1|STARTED|Overall Study||56
1684869|NCT00540644|4115495|P2|NOT COMPLETED|Overall Study||9
1684870|NCT00540644|4115496|P1|NOT COMPLETED|Overall Study||9
1684871|NCT00540644|4115495|P2|COMPLETED|Overall Study||13
1684872|NCT00540644|4115496|P1|COMPLETED|Overall Study||39
1684873|NCT00540644|4115495|P2|STARTED|Overall Study||22
1684874|NCT00540644|4115496|P1|STARTED|Overall Study||48
1684875|NCT00540592|4115516|P10|NOT COMPLETED|Overall Study||2
1684876|NCT00540592|4115517|P9|NOT COMPLETED|Overall Study||1
1684877|NCT00540592|4115518|P8|NOT COMPLETED|Overall Study||1
1684878|NCT00540592|4115519|P7|NOT COMPLETED|Overall Study||0
1684879|NCT00540592|4115520|P6|NOT COMPLETED|Overall Study||0
1684880|NCT00540592|4115521|P5|NOT COMPLETED|Overall Study||1
1684881|NCT00540592|4115522|P4|NOT COMPLETED|Overall Study||1
1684882|NCT00540592|4115523|P3|NOT COMPLETED|Overall Study||1
1684883|NCT00540592|4115524|P2|NOT COMPLETED|Overall Study||1
1684884|NCT00540592|4115525|P1|NOT COMPLETED|Overall Study||2
1684885|NCT00540592|4115516|P10|COMPLETED|Overall Study||201
1684886|NCT00540592|4115517|P9|COMPLETED|Overall Study||199
1684887|NCT00540592|4115518|P8|COMPLETED|Overall Study||198
1684888|NCT00540592|4115519|P7|COMPLETED|Overall Study||198
1684889|NCT00540592|4115520|P6|COMPLETED|Overall Study||198
1684890|NCT00540592|4115521|P5|COMPLETED|Overall Study||198
1684891|NCT00540592|4115522|P4|COMPLETED|Overall Study||201
1684892|NCT00540592|4115523|P3|COMPLETED|Overall Study||201
1684893|NCT00540592|4115524|P2|COMPLETED|Overall Study||201
1684894|NCT00540592|4115525|P1|COMPLETED|Overall Study||202
1684895|NCT00540592|4115516|P10|Completed at Day 180|Overall Study||189
1684896|NCT00540592|4115517|P9|Completed at Day 180|Overall Study||198
1684897|NCT00540592|4115518|P8|Completed at Day 180|Overall Study||193
1684898|NCT00540592|4115519|P7|Completed at Day 180|Overall Study||196
1684899|NCT00540592|4115520|P6|Completed at Day 180|Overall Study||198
1684900|NCT00540592|4115521|P5|Completed at Day 180|Overall Study||195
1684901|NCT00540592|4115522|P4|Completed at Day 180|Overall Study||197
1684902|NCT00540592|4115523|P3|Completed at Day 180|Overall Study||197
1684903|NCT00540592|4115524|P2|Completed at Day 180|Overall Study||201
1684904|NCT00540592|4115525|P1|Completed at Day 180|Overall Study||200
1684905|NCT00540592|4115516|P10|STARTED|Overall Study||203
1684906|NCT00540592|4115517|P9|STARTED|Overall Study||200
1684907|NCT00540592|4115518|P8|STARTED|Overall Study||199
1684908|NCT00540592|4115519|P7|STARTED|Overall Study||198
1684909|NCT00540592|4115520|P6|STARTED|Overall Study||198
1684910|NCT00540592|4115521|P5|STARTED|Overall Study||199
1684911|NCT00540592|4115522|P4|STARTED|Overall Study||202
1684912|NCT00540592|4115523|P3|STARTED|Overall Study||202
1684913|NCT00540592|4115524|P2|STARTED|Overall Study||202
1684914|NCT00540592|4115525|P1|STARTED|Overall Study||204
1684915|NCT00540579|4115757|P1|NOT COMPLETED|Overall Study||0
1684916|NCT00540579|4115757|P1|COMPLETED|Overall Study||23
1684917|NCT00540579|4115757|P1|STARTED|Overall Study||23
1684918|NCT00540514|4115764|P2|NOT COMPLETED|Overall Study||266
1684919|NCT00540514|4115765|P1|NOT COMPLETED|Overall Study||246
1684920|NCT00540514|4115764|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
1684921|NCT00540514|4115765|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
1684922|NCT00540514|4115764|P2|Biomarker Population|Overall Study||36
1684923|NCT00540514|4115765|P1|Biomarker Population|Overall Study||35
1684924|NCT00540514|4115764|P2|Treated|Overall Study||524
1684925|NCT00540514|4115765|P1|Treated|Overall Study||514
1684926|NCT00540514|4115764|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
1684927|NCT00540514|4115765|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
1684928|NCT00540449|4115797|P2|NOT COMPLETED|Overall Study||78
1684929|NCT00540449|4115798|P1|NOT COMPLETED|Overall Study||84
1684930|NCT00540449|4115797|P2|COMPLETED|Overall Study||266
1684931|NCT00540449|4115798|P1|COMPLETED|Overall Study||262
1684932|NCT00540449|4115797|P2|STARTED|Overall Study||344
1684933|NCT00540449|4115798|P1|STARTED|Overall Study||346
1684934|NCT00540436|4115820|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
1684935|NCT00540436|4115820|P1|COMPLETED|Second 12-Week Treatment Period||21
1684936|NCT00540436|4115820|P1|STARTED|Second 12-Week Treatment Period||22
1684937|NCT00540436|4115820|P1|NOT COMPLETED|First 12-Week Treatment Period||3
1684938|NCT00540436|4115820|P1|COMPLETED|First 12-Week Treatment Period||22
1684939|NCT00540436|4115820|P1|STARTED|First 12-Week Treatment Period||25
1684940|NCT00540423|4115835|P3|NOT COMPLETED|Open-Label Treatment Period||2
1684941|NCT00540423|4115836|P2|NOT COMPLETED|Open-Label Treatment Period||0
1684942|NCT00540423|4115837|P1|NOT COMPLETED|Open-Label Treatment Period||0
1684943|NCT00540423|4115835|P3|COMPLETED|Open-Label Treatment Period||20
1684944|NCT00540423|4115836|P2|COMPLETED|Open-Label Treatment Period||0
1684945|NCT00540423|4115837|P1|COMPLETED|Open-Label Treatment Period||0
1684946|NCT00540423|4115835|P3|STARTED|Open-Label Treatment Period||22
1684947|NCT00540423|4115836|P2|STARTED|Open-Label Treatment Period||0
1684948|NCT00540423|4115837|P1|STARTED|Open-Label Treatment Period||0
1684949|NCT00540423|4115835|P3|NOT COMPLETED|Double-Blind Treatment Period||0
1684950|NCT00540423|4115836|P2|NOT COMPLETED|Double-Blind Treatment Period||1
1684951|NCT00540423|4115837|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1684952|NCT00540423|4115835|P3|COMPLETED|Double-Blind Treatment Period||0
1684953|NCT00540423|4115836|P2|COMPLETED|Double-Blind Treatment Period||14
1684954|NCT00540423|4115837|P1|COMPLETED|Double-Blind Treatment Period||8
1684955|NCT00540423|4115835|P3|STARTED|Double-Blind Treatment Period||0
1684956|NCT00540423|4115836|P2|STARTED|Double-Blind Treatment Period||15
1684957|NCT00540423|4115837|P1|STARTED|Double-Blind Treatment Period||8
1684958|NCT00540293|4115887|P1|NOT COMPLETED|Overall Study||35
1684959|NCT00540293|4115887|P1|COMPLETED|Overall Study||390
1684960|NCT00540293|4115887|P1|STARTED|Overall Study||425
1684961|NCT00540228|4115935|P5|NOT COMPLETED|Overall Study||0
1684962|NCT00540228|4115936|P4|NOT COMPLETED|Overall Study||0
1684963|NCT00540228|4115937|P3|NOT COMPLETED|Overall Study||0
1684964|NCT00540228|4115938|P2|NOT COMPLETED|Overall Study||1
1684965|NCT00540228|4115939|P1|NOT COMPLETED|Overall Study||3
1684966|NCT00540228|4115935|P5|COMPLETED|Overall Study||202
1684967|NCT00540228|4115936|P4|COMPLETED|Overall Study||202
1684968|NCT00540228|4115937|P3|COMPLETED|Overall Study||204
1684969|NCT00540228|4115938|P2|COMPLETED|Overall Study||197
1684970|NCT00540228|4115939|P1|COMPLETED|Overall Study||197
1684971|NCT00540228|4115935|P5|STARTED|Overall Study||202
1684972|NCT00540228|4115936|P4|STARTED|Overall Study||202
1684973|NCT00540228|4115937|P3|STARTED|Overall Study||204
1684974|NCT00540228|4115938|P2|STARTED|Overall Study||198
1684975|NCT00540228|4115939|P1|STARTED|Overall Study||200
1684976|NCT00540124|4116009|P3|NOT COMPLETED|Overall Study||1
1684977|NCT00540124|4116010|P2|NOT COMPLETED|Overall Study||3
1684978|NCT00540124|4116011|P1|NOT COMPLETED|Overall Study||4
1684979|NCT00540124|4116009|P3|COMPLETED|Overall Study||48
1684980|NCT00540124|4116010|P2|COMPLETED|Overall Study||48
1684981|NCT00540124|4116011|P1|COMPLETED|Overall Study||47
1684982|NCT00540124|4116009|P3|STARTED|Overall Study||49
1684983|NCT00540124|4116010|P2|STARTED|Overall Study||51
1684984|NCT00540124|4116011|P1|STARTED|Overall Study||51
1684985|NCT00540046|4116057|P2|NOT COMPLETED|Overall Study||23
1684986|NCT00540046|4116058|P1|NOT COMPLETED|Overall Study||33
1684987|NCT00540046|4116057|P2|COMPLETED|Overall Study||88
1684988|NCT00540046|4116058|P1|COMPLETED|Overall Study||71
1684989|NCT00540046|4116057|P2|STARTED|Overall Study||111
1684990|NCT00540046|4116058|P1|STARTED|Overall Study||104
1684991|NCT00540007|4116068|P2|NOT COMPLETED|Overall Study||0
1684992|NCT00540007|4116069|P1|NOT COMPLETED|Overall Study||0
1684993|NCT00540007|4116068|P2|COMPLETED|Overall Study||42
1684994|NCT00540007|4116069|P1|COMPLETED|Overall Study||38
1684995|NCT00540007|4116068|P2|STARTED|Overall Study||42
1684996|NCT00540007|4116069|P1|STARTED|Overall Study||38
1684997|NCT00539994|4116094|P3|NOT COMPLETED|Overall Study||2
1684998|NCT00539994|4116095|P2|NOT COMPLETED|Overall Study||1
1684999|NCT00539994|4116096|P1|NOT COMPLETED|Overall Study||3
1685000|NCT00539994|4116094|P3|COMPLETED|Overall Study||13
1685001|NCT00539994|4116095|P2|COMPLETED|Overall Study||18
1685002|NCT00539994|4116096|P1|COMPLETED|Overall Study||20
1685003|NCT00539994|4116094|P3|STARTED|Overall Study||15
1685004|NCT00539994|4116095|P2|STARTED|Overall Study||19
1685005|NCT00539994|4116096|P1|STARTED|Overall Study||23
1685006|NCT00539942|4116135|P2|NOT COMPLETED|Overall Study||0
1685007|NCT00539942|4116136|P1|NOT COMPLETED|Overall Study||0
1685008|NCT00539942|4116135|P2|COMPLETED|Overall Study||3
1685009|NCT00539942|4116136|P1|COMPLETED|Overall Study||4
1685010|NCT00539942|4116135|P2|STARTED|Overall Study||3
1685011|NCT00539942|4116136|P1|STARTED|Overall Study||4
1685012|NCT00539864|4116146|P2|NOT COMPLETED|Overall Study||2
1685013|NCT00539864|4116147|P1|NOT COMPLETED|Overall Study||1
1685014|NCT00539864|4116146|P2|COMPLETED|Overall Study||300
1685015|NCT00539864|4116147|P1|COMPLETED|Overall Study||299
1685016|NCT00539864|4116146|P2|STARTED|Overall Study||302
1685017|NCT00539864|4116147|P1|STARTED|Overall Study||300
1685018|NCT00539734|4116159|P1|NOT COMPLETED|Overall Study||1
1685019|NCT00539734|4116159|P1|COMPLETED|Overall Study||25
1685020|NCT00539734|4116159|P1|STARTED|Overall Study||26
1685021|NCT00539695|4116164|P1|NOT COMPLETED|Overall Study||13
1685022|NCT00539695|4116164|P1|COMPLETED|Overall Study||12
1685023|NCT00539695|4116164|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
1685024|NCT00539695|4116164|P1|STARTED|Overall Study||25
1685025|NCT00539617|4116170|P1|NOT COMPLETED|Treatment Period||0
1685026|NCT00539617|4116170|P1|COMPLETED|Treatment Period||3
1685027|NCT00539617|4116170|P1|STARTED|Treatment Period||3
1685028|NCT00539617|4116170|P1|NOT COMPLETED|Run-In Period||1
1685029|NCT00539617|4116170|P1|COMPLETED|Run-In Period||3
1685030|NCT00539617|4116170|P1|STARTED|Run-In Period||4
1685031|NCT00539617|4116170|P1|NOT COMPLETED|Pre-screening Period||3
1685032|NCT00539617|4116170|P1|COMPLETED|Pre-screening Period||4
1685033|NCT00539617|4116170|P1|STARTED|Pre-screening Period||7
1685034|NCT00539591|4116178|P3|NOT COMPLETED|Overall Study||3
1685035|NCT00539591|4116179|P2|NOT COMPLETED|Overall Study||2
1685036|NCT00539591|4116180|P1|NOT COMPLETED|Overall Study||5
1685037|NCT00539591|4116178|P3|COMPLETED|Overall Study||1
1685038|NCT00539591|4116179|P2|COMPLETED|Overall Study||0
1685039|NCT00539591|4116180|P1|COMPLETED|Overall Study||18
1685040|NCT00539591|4116178|P3|STARTED|Overall Study||4
1685041|NCT00539591|4116179|P2|STARTED|Overall Study||2
1685042|NCT00539591|4116180|P1|STARTED|Overall Study||23
1685043|NCT00539539|4116290|P2|NOT COMPLETED|Overall Study||0
1685044|NCT00539539|4116291|P1|NOT COMPLETED|Overall Study||0
1685045|NCT00539539|4116290|P2|COMPLETED|Overall Study||771
1685046|NCT00539539|4116291|P1|COMPLETED|Overall Study||815
1685047|NCT00539539|4116290|P2|STARTED|Overall Study||771
1685048|NCT00539539|4116291|P1|STARTED|Overall Study||815
1685049|NCT00539526|4116314|P3|NOT COMPLETED|Overall Study||2
1685050|NCT00539526|4116315|P2|NOT COMPLETED|Overall Study||2
1685051|NCT00539526|4116316|P1|NOT COMPLETED|Overall Study||3
1685052|NCT00539526|4116314|P3|COMPLETED|Overall Study||36
1685053|NCT00539526|4116315|P2|COMPLETED|Overall Study||31
1685054|NCT00539526|4116316|P1|COMPLETED|Overall Study||32
1685055|NCT00539526|4116314|P3|STARTED|Overall Study||38
1685056|NCT00539526|4116315|P2|STARTED|Overall Study||33
1685057|NCT00539526|4116316|P1|STARTED|Overall Study||35
1685058|NCT00539513|4116332|P2|NOT COMPLETED|Overall Study||2
1685059|NCT00539513|4116333|P1|NOT COMPLETED|Overall Study||2
1685060|NCT00539513|4116332|P2|COMPLETED|Overall Study||3
1685061|NCT00539513|4116333|P1|COMPLETED|Overall Study||3
1685062|NCT00539513|4116332|P2|Received Allocated Intervention|Overall Study||4
1685063|NCT00539513|4116333|P1|Received Allocated Intervention|Overall Study||3
1685064|NCT00539513|4116332|P2|STARTED|Overall Study||5
1685065|NCT00539513|4116333|P1|STARTED|Overall Study||5
1685066|NCT00539305|4116347|P2|NOT COMPLETED|Overall Study||2
1685067|NCT00539305|4116348|P1|NOT COMPLETED|Overall Study||1
1685068|NCT00539305|4116347|P2|COMPLETED|Overall Study||10
1685069|NCT00539305|4116348|P1|COMPLETED|Overall Study||9
1685070|NCT00539305|4116347|P2|STARTED|Overall Study||12
1685071|NCT00539305|4116348|P1|STARTED|Overall Study||10
1685072|NCT00539279|4116362|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
1685073|NCT00539279|4116363|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
1685074|NCT00539279|4116362|P2|COMPLETED|6-Month Follow-Up Assessment||22
1685075|NCT00539279|4116363|P1|COMPLETED|6-Month Follow-Up Assessment||17
1685076|NCT00539279|4116362|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
1685077|NCT00539279|4116363|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
1685078|NCT00539279|4116362|P2|NOT COMPLETED|Post-Treatment Assessment||9
1685079|NCT00539279|4116363|P1|NOT COMPLETED|Post-Treatment Assessment||12
1685080|NCT00539279|4116362|P2|COMPLETED|Post-Treatment Assessment||29
1685081|NCT00539279|4116363|P1|COMPLETED|Post-Treatment Assessment||18
1685082|NCT00539279|4116362|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
1685083|NCT00539279|4116363|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
1685084|NCT00539279|4116362|P2|NOT COMPLETED|Treatment||8
1685085|NCT00539279|4116363|P1|NOT COMPLETED|Treatment||11
1685086|NCT00539279|4116362|P2|COMPLETED|Treatment||38
1685087|NCT00539279|4116363|P1|COMPLETED|Treatment||30
1685088|NCT00539279|4116362|P2|STARTED|Treatment||46
1685089|NCT00539279|4116363|P1|STARTED|Treatment||41
1685090|NCT00539253|4116381|P1|NOT COMPLETED|Overall Study||26
1685091|NCT00539253|4116381|P1|COMPLETED|Overall Study||19
1685092|NCT00539253|4116381|P1|STARTED|Overall Study||45
1685093|NCT00539240|4116389|P3|NOT COMPLETED|Overall Study||15
1685094|NCT00539240|4116390|P2|NOT COMPLETED|Overall Study||7
1685095|NCT00539240|4116391|P1|NOT COMPLETED|Overall Study||6
1685096|NCT00539240|4116389|P3|COMPLETED|Overall Study||39
1685097|NCT00539240|4116390|P2|COMPLETED|Overall Study||48
1685098|NCT00539240|4116391|P1|COMPLETED|Overall Study||53
1685099|NCT00539240|4116389|P3|STARTED|Overall Study||54
1685100|NCT00539240|4116390|P2|STARTED|Overall Study||55
1685101|NCT00539240|4116391|P1|STARTED|Overall Study||59
1685102|NCT00539188|4116410|P2|NOT COMPLETED|Overall Study||1
1685103|NCT00539188|4116411|P1|NOT COMPLETED|Overall Study||3
1685104|NCT00539188|4116410|P2|COMPLETED|Overall Study||1
1685105|NCT00539188|4116411|P1|COMPLETED|Overall Study||1
1685106|NCT00539188|4116410|P2|Received Allocated Intervention|Overall Study||2
1685107|NCT00539188|4116411|P1|Received Allocated Intervention|Overall Study||3
1685108|NCT00539188|4116410|P2|STARTED|Overall Study||2
1685109|NCT00539188|4116411|P1|STARTED|Overall Study||4
1685110|NCT00539110|4116425|P2|NOT COMPLETED|Overall Study||0
1685111|NCT00539110|4116426|P1|NOT COMPLETED|Overall Study||0
1685112|NCT00539110|4116425|P2|COMPLETED|Overall Study||5
1685113|NCT00539110|4116426|P1|COMPLETED|Overall Study||5
1685114|NCT00539110|4116425|P2|STARTED|Overall Study||5
1685115|NCT00539110|4116426|P1|STARTED|Overall Study||5
1685116|NCT00539032|4116434|P2|NOT COMPLETED|Overall Study||1
1685117|NCT00539032|4116435|P1|NOT COMPLETED|Overall Study||2
1685118|NCT00539032|4116434|P2|COMPLETED|Overall Study||84
1685119|NCT00539032|4116435|P1|COMPLETED|Overall Study||151
1685120|NCT00539032|4116434|P2|STARTED|Overall Study||85
1685121|NCT00539032|4116435|P1|STARTED|Overall Study||153
1685122|NCT00539006|4116449|P4|NOT COMPLETED|Post-Study||0
1685123|NCT00539006|4116450|P3|NOT COMPLETED|Post-Study||0
1685124|NCT00539006|4116451|P2|NOT COMPLETED|Post-Study||0
1685125|NCT00539006|4116452|P1|NOT COMPLETED|Post-Study||0
1685126|NCT00539006|4116449|P4|COMPLETED|Post-Study||81
1685127|NCT00539006|4116450|P3|COMPLETED|Post-Study||77
1685128|NCT00539006|4116451|P2|COMPLETED|Post-Study||83
1685129|NCT00539006|4116452|P1|COMPLETED|Post-Study||75
1685130|NCT00539006|4116449|P4|STARTED|Post-Study||81
1685131|NCT00539006|4116450|P3|STARTED|Post-Study||77
1685132|NCT00539006|4116451|P2|STARTED|Post-Study||83
1685133|NCT00539006|4116452|P1|STARTED|Post-Study||75
1685134|NCT00539006|4116449|P4|NOT COMPLETED|Treatment Period 2||0
1685135|NCT00539006|4116450|P3|NOT COMPLETED|Treatment Period 2||0
1685136|NCT00539006|4116451|P2|NOT COMPLETED|Treatment Period 2||1
1685137|NCT00539006|4116452|P1|NOT COMPLETED|Treatment Period 2||1
1685138|NCT00539006|4116449|P4|COMPLETED|Treatment Period 2||81
1685139|NCT00539006|4116450|P3|COMPLETED|Treatment Period 2||77
1685140|NCT00539006|4116451|P2|COMPLETED|Treatment Period 2||83
1685141|NCT00539006|4116452|P1|COMPLETED|Treatment Period 2||75
1685142|NCT00539006|4116449|P4|STARTED|Treatment Period 2||81
1685143|NCT00539006|4116450|P3|STARTED|Treatment Period 2||77
1685144|NCT00539006|4116451|P2|STARTED|Treatment Period 2||84
1685145|NCT00539006|4116452|P1|STARTED|Treatment Period 2||76
1685146|NCT00539006|4116449|P4|NOT COMPLETED|Washout||9
1685147|NCT00539006|4116450|P3|NOT COMPLETED|Washout||16
1685148|NCT00539006|4116451|P2|NOT COMPLETED|Washout||10
1685149|NCT00539006|4116452|P1|NOT COMPLETED|Washout||20
1685150|NCT00539006|4116449|P4|COMPLETED|Washout||81
1685151|NCT00539006|4116450|P3|COMPLETED|Washout||77
1685152|NCT00539006|4116451|P2|COMPLETED|Washout||84
1685153|NCT00539006|4116452|P1|COMPLETED|Washout||76
1685154|NCT00539006|4116449|P4|STARTED|Washout||90
1685155|NCT00539006|4116450|P3|STARTED|Washout||93
1685156|NCT00539006|4116451|P2|STARTED|Washout||94
1685157|NCT00539006|4116452|P1|STARTED|Washout||96
1685158|NCT00539006|4116449|P4|NOT COMPLETED|Treatment Period 1||1
1685159|NCT00539006|4116450|P3|NOT COMPLETED|Treatment Period 1||2
1685160|NCT00539006|4116451|P2|NOT COMPLETED|Treatment Period 1||0
1685161|NCT00539006|4116452|P1|NOT COMPLETED|Treatment Period 1||0
1685162|NCT00539006|4116449|P4|COMPLETED|Treatment Period 1||90
1685163|NCT00539006|4116450|P3|COMPLETED|Treatment Period 1||93
1685164|NCT00539006|4116451|P2|COMPLETED|Treatment Period 1||94
1685165|NCT00539006|4116452|P1|COMPLETED|Treatment Period 1||96
1685166|NCT00539006|4116449|P4|STARTED|Treatment Period 1||91
1685167|NCT00539006|4116450|P3|STARTED|Treatment Period 1||95
1685168|NCT00539006|4116451|P2|STARTED|Treatment Period 1||94
1685169|NCT00539006|4116452|P1|STARTED|Treatment Period 1||96
1685170|NCT00539006|4116449|P4|NOT COMPLETED|Pre-treatment||0
1685171|NCT00539006|4116450|P3|NOT COMPLETED|Pre-treatment||0
1685172|NCT00539006|4116451|P2|NOT COMPLETED|Pre-treatment||1
1685173|NCT00539006|4116452|P1|NOT COMPLETED|Pre-treatment||0
1685174|NCT00539006|4116449|P4|COMPLETED|Pre-treatment||91
1685175|NCT00539006|4116450|P3|COMPLETED|Pre-treatment||95
1685176|NCT00539006|4116451|P2|COMPLETED|Pre-treatment||94
1685177|NCT00539006|4116452|P1|COMPLETED|Pre-treatment||96
1685178|NCT00539006|4116449|P4|STARTED|Pre-treatment||91
1685179|NCT00539006|4116450|P3|STARTED|Pre-treatment||95
1685180|NCT00539006|4116451|P2|STARTED|Pre-treatment||95
1685181|NCT00539006|4116452|P1|STARTED|Pre-treatment||96
1685182|NCT00538980|4116482|P1|NOT COMPLETED|Overall Study||10
1685183|NCT00538980|4116482|P1|COMPLETED|Overall Study||0
1685184|NCT00538980|4116482|P1|STARTED|Overall Study||10
1685185|NCT00538915|4116490|P1|NOT COMPLETED|Overall Study||11
1685186|NCT00538915|4116490|P1|COMPLETED|Overall Study||52
1685187|NCT00538915|4116490|P1|STARTED|Overall Study||63
1685188|NCT00538902|4116497|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
1685189|NCT00538902|4116498|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
1685190|NCT00538902|4116499|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
1685191|NCT00538902|4116497|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
1685192|NCT00538902|4116498|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
1685193|NCT00538902|4116499|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
1685194|NCT00538902|4116497|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
1685195|NCT00538902|4116498|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
1685196|NCT00538902|4116499|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
1685197|NCT00538902|4116497|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
1685198|NCT00538902|4116498|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
1685199|NCT00538902|4116499|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
1685200|NCT00538902|4116497|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
1685201|NCT00538902|4116498|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
1685202|NCT00538902|4116499|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
1685203|NCT00538902|4116497|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
1685204|NCT00538902|4116498|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
1685205|NCT00538902|4116499|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
1685206|NCT00538863|4116534|P1|NOT COMPLETED|Open-label Maintenance||106
1685207|NCT00538863|4116534|P1|COMPLETED|Open-label Maintenance||163
1685208|NCT00538863|4116534|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
1685209|NCT00538863|4116534|P1|NOT COMPLETED|Open-label Titration||45
1685210|NCT00538863|4116534|P1|COMPLETED|Open-label Titration||184
1685211|NCT00538863|4116534|P1|STARTED|Open-label Titration||229
1685212|NCT00538850|4116540|P3|NOT COMPLETED|Placebo - Double-blind||3
1685213|NCT00538850|4116541|P2|NOT COMPLETED|Placebo - Double-blind||0
1685214|NCT00538850|4116542|P1|NOT COMPLETED|Placebo - Double-blind||0
1685215|NCT00538850|4116540|P3|COMPLETED|Placebo - Double-blind||95
1685216|NCT00538850|4116541|P2|COMPLETED|Placebo - Double-blind||0
1685217|NCT00538850|4116542|P1|COMPLETED|Placebo - Double-blind||0
1685218|NCT00538850|4116540|P3|STARTED|Placebo - Double-blind||98
1685219|NCT00538850|4116541|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1685220|NCT00538850|4116542|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1685221|NCT00538850|4116540|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1685222|NCT00538850|4116541|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
1685223|NCT00538850|4116542|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1685224|NCT00538850|4116540|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1685225|NCT00538850|4116541|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
1685226|NCT00538850|4116542|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1685227|NCT00538850|4116540|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1685228|NCT00538850|4116541|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
1685229|NCT00538850|4116542|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1685230|NCT00538850|4116540|P3|NOT COMPLETED|Titration Period||0
1685231|NCT00538850|4116541|P2|NOT COMPLETED|Titration Period||0
1685232|NCT00538850|4116542|P1|NOT COMPLETED|Titration Period||32
1685233|NCT00538850|4116540|P3|COMPLETED|Titration Period||0
1685234|NCT00538850|4116541|P2|COMPLETED|Titration Period||0
1685235|NCT00538850|4116542|P1|COMPLETED|Titration Period||98
1685236|NCT00538850|4116540|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
1685237|NCT00538850|4116541|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
1685238|NCT00538850|4116542|P1|STARTED|Titration Period||130
1685239|NCT00538824|4116554|P1|NOT COMPLETED|Overall Study||0
1685240|NCT00538824|4116554|P1|COMPLETED|Overall Study||5
1685241|NCT00538824|4116554|P1|Progression of Disease|Overall Study||2
1685242|NCT00538824|4116554|P1|STARTED|Overall Study||5
1685243|NCT00538785|4116560|P2|NOT COMPLETED|Overall Study||17
1685244|NCT00538785|4116561|P1|NOT COMPLETED|Overall Study||19
1685245|NCT00538785|4116560|P2|COMPLETED|Overall Study||595
1685246|NCT00538785|4116561|P1|COMPLETED|Overall Study||604
1685247|NCT00538785|4116560|P2|STARTED|Overall Study||612
1685248|NCT00538785|4116561|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
1685249|NCT00538733|4116582|P1|NOT COMPLETED|Overall Study||12
1685250|NCT00538733|4116582|P1|COMPLETED|Overall Study||14
1685251|NCT00538733|4116582|P1|Removed to Pursue Alternative Theray|Overall Study||2
1685252|NCT00538733|4116582|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
1685253|NCT00538733|4116582|P1|Removed Due to Progression of Disease|Overall Study||1
1685254|NCT00538733|4116582|P1|STARTED|Overall Study||26
1685255|NCT00538642|4116591|P2|NOT COMPLETED|Overall Study||5
1685256|NCT00538642|4116592|P1|NOT COMPLETED|Overall Study||1
1685257|NCT00538642|4116591|P2|COMPLETED|Overall Study||9
1685258|NCT00538642|4116592|P1|COMPLETED|Overall Study||9
1685259|NCT00538642|4116591|P2|STARTED|Overall Study||14
1685260|NCT00538642|4116592|P1|STARTED|Overall Study||10
1685261|NCT00538629|4116632|P1|NOT COMPLETED|Overall Study||22
1685262|NCT00538629|4116632|P1|COMPLETED|Overall Study||449
1685263|NCT00538629|4116632|P1|STARTED|Overall Study||471
1685264|NCT00538616|4116679|P2|NOT COMPLETED|Overall Study||0
1685265|NCT00538616|4116680|P1|NOT COMPLETED|Overall Study||0
1685266|NCT00538616|4116679|P2|COMPLETED|Overall Study||3
1685267|NCT00538616|4116680|P1|COMPLETED|Overall Study||5
1685268|NCT00538616|4116679|P2|STARTED|Overall Study||3
1685269|NCT00538616|4116680|P1|STARTED|Overall Study||5
1685270|NCT00538590|4116688|P2|NOT COMPLETED|Overall Study||0
1685271|NCT00538590|4116689|P1|NOT COMPLETED|Overall Study||1
1685272|NCT00538590|4116688|P2|COMPLETED|Overall Study||10
1685273|NCT00538590|4116689|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
1685274|NCT00538590|4116688|P2|STARTED|Overall Study||10
1685275|NCT00538590|4116689|P1|STARTED|Overall Study||10
1685276|NCT00538512|4116706|P3|NOT COMPLETED|Overall Study||13
1685277|NCT00538512|4116707|P2|NOT COMPLETED|Overall Study||30
1685278|NCT00538512|4116708|P1|NOT COMPLETED|Overall Study||27
1685279|NCT00538512|4116706|P3|COMPLETED|Overall Study||312
1685280|NCT00538512|4116707|P2|COMPLETED|Overall Study||783
1685281|NCT00538512|4116708|P1|COMPLETED|Overall Study||787
1685282|NCT00538512|4116706|P3|STARTED|Overall Study||325
1685283|NCT00538512|4116707|P2|STARTED|Overall Study||813
1685284|NCT00538512|4116708|P1|STARTED|Overall Study||814
1685285|NCT00538473|4116727|P2|NOT COMPLETED|Overall Study||0
1685286|NCT00538473|4116728|P1|NOT COMPLETED|Overall Study||1
1685287|NCT00538473|4116727|P2|COMPLETED|Overall Study||35
1685288|NCT00538473|4116728|P1|COMPLETED|Overall Study||32
1685289|NCT00538473|4116727|P2|STARTED|Overall Study||35
1685290|NCT00538473|4116728|P1|STARTED|Overall Study||33
1685291|NCT00538434|4116764|P4|NOT COMPLETED|Overall Study||6
1685292|NCT00538434|4116765|P3|NOT COMPLETED|Overall Study||7
1685293|NCT00538434|4116766|P2|NOT COMPLETED|Overall Study||11
1685294|NCT00538434|4116767|P1|NOT COMPLETED|Overall Study||9
1685295|NCT00538434|4116764|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
1685296|NCT00538434|4116765|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
1685297|NCT00538434|4116766|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
1685298|NCT00538434|4116767|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
1685299|NCT00538434|4116764|P4|Intent-to-treat (ITT) Population|Overall Study||57
1685300|NCT00538434|4116765|P3|Intent-to-treat (ITT) Population|Overall Study||57
1685301|NCT00538434|4116766|P2|Intent-to-treat (ITT) Population|Overall Study||57
1685302|NCT00538434|4116767|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
1685303|NCT00538434|4116764|P4|STARTED|Overall Study||57
1685304|NCT00538434|4116765|P3|STARTED|Overall Study||57
1685305|NCT00538434|4116766|P2|STARTED|Overall Study||57
1685306|NCT00538434|4116767|P1|STARTED|Overall Study||56
1685307|NCT00538304|4116791|P2|NOT COMPLETED|Overall Study||5
1685308|NCT00538304|4116792|P1|NOT COMPLETED|Overall Study||7
1685309|NCT00538304|4116791|P2|COMPLETED|Overall Study||66
1685310|NCT00538304|4116792|P1|COMPLETED|Overall Study||144
1685311|NCT00538304|4116791|P2|STARTED|Overall Study||71
1685312|NCT00538304|4116792|P1|STARTED|Overall Study||151
1685313|NCT00538291|4116808|P1|NOT COMPLETED|Overall Study||3
1685314|NCT00538291|4116808|P1|COMPLETED|Overall Study||10
1685315|NCT00538291|4116808|P1|STARTED|Overall Study||13
1685316|NCT00538213|4116815|P3|NOT COMPLETED|Overall Study||0
1685317|NCT00538213|4116816|P2|NOT COMPLETED|Overall Study||0
1685318|NCT00538213|4116817|P1|NOT COMPLETED|Overall Study||0
1685319|NCT00538213|4116815|P3|COMPLETED|Overall Study||38
1685320|NCT00538213|4116816|P2|COMPLETED|Overall Study||40
1685321|NCT00538213|4116817|P1|COMPLETED|Overall Study||55
1685322|NCT00538213|4116815|P3|STARTED|Overall Study||38
1685323|NCT00538213|4116816|P2|STARTED|Overall Study||40
1685324|NCT00538213|4116817|P1|STARTED|Overall Study||55
1685325|NCT00537979|4116866|P2|NOT COMPLETED|Overall Study||20
1685326|NCT00537979|4116867|P1|NOT COMPLETED|Overall Study||6
1685327|NCT00537979|4116866|P2|COMPLETED|Overall Study||89
1685328|NCT00537979|4116867|P1|COMPLETED|Overall Study||32
1685329|NCT00537979|4116866|P2|STARTED|Overall Study||109
1685330|NCT00537979|4116867|P1|STARTED|Overall Study||38
1685331|NCT00537940|4116883|P2|NOT COMPLETED|Overall Study||179
1685332|NCT00537940|4116884|P1|NOT COMPLETED|Overall Study||183
1685333|NCT00537940|4116883|P2|COMPLETED|Overall Study||62
1685334|NCT00537940|4116884|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
1685335|NCT00537940|4116883|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
1685336|NCT00537940|4116884|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
1685337|NCT00537940|4116883|P2|Completed Maintenance Phase|Overall Study||172
1685338|NCT00537940|4116884|P1|Completed Maintenance Phase|Overall Study||187
1685339|NCT00537940|4116883|P2|Completed Titration Phase|Overall Study||210
1685340|NCT00537940|4116884|P1|Completed Titration Phase|Overall Study||213
1685341|NCT00537940|4116883|P2|STARTED|Overall Study||241
1685342|NCT00537940|4116884|P1|STARTED|Overall Study||241
1685343|NCT00537823|4116908|P2|NOT COMPLETED|Overall Study||0
1685344|NCT00537823|4116909|P1|NOT COMPLETED|Overall Study||2
1685345|NCT00537823|4116908|P2|COMPLETED|Overall Study||2
1685346|NCT00537823|4116909|P1|COMPLETED|Overall Study||5
1685347|NCT00537823|4116908|P2|STARTED|Overall Study||2
1685348|NCT00537823|4116909|P1|STARTED|Overall Study||7
1685349|NCT00537810|4116935|P4|NOT COMPLETED|Overall Study||4
1685350|NCT00537810|4116936|P3|NOT COMPLETED|Overall Study||4
1685351|NCT00537810|4116937|P2|NOT COMPLETED|Overall Study||13
1685352|NCT00537810|4116938|P1|NOT COMPLETED|Overall Study||6
1685353|NCT00537810|4116935|P4|COMPLETED|Overall Study||22
1685354|NCT00537810|4116936|P3|COMPLETED|Overall Study||21
1685355|NCT00537810|4116937|P2|COMPLETED|Overall Study||14
1685356|NCT00537810|4116938|P1|COMPLETED|Overall Study||20
1685357|NCT00537810|4116935|P4|STARTED|Overall Study||26
1685358|NCT00537810|4116936|P3|STARTED|Overall Study||25
1685359|NCT00537810|4116937|P2|STARTED|Overall Study||27
1685360|NCT00537810|4116938|P1|STARTED|Overall Study||26
1685361|NCT00537771|4116954|P2|NOT COMPLETED|Overall Study||61
1685362|NCT00537771|4116955|P1|NOT COMPLETED|Overall Study||29
1685363|NCT00537771|4116954|P2|COMPLETED|Overall Study||114
1685364|NCT00537771|4116955|P1|COMPLETED|Overall Study||149
1685365|NCT00537771|4116954|P2|STARTED|Overall Study||175
1685366|NCT00537771|4116955|P1|STARTED|Overall Study||178
1685367|NCT00537745|4116965|P1|NOT COMPLETED|Overall Study||5
1685368|NCT00537745|4116965|P1|COMPLETED|Overall Study||9
1685369|NCT00537745|4116965|P1|Began Intervention|Overall Study||11
1685370|NCT00537745|4116965|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
1685371|NCT00537680|4116973|P3|NOT COMPLETED|Overall Study||0
1685372|NCT00537680|4116974|P2|NOT COMPLETED|Overall Study||2
1685373|NCT00537680|4116975|P1|NOT COMPLETED|Overall Study||0
1685374|NCT00537680|4116973|P3|COMPLETED|Overall Study||24
1685375|NCT00537680|4116974|P2|COMPLETED|Overall Study||22
1685376|NCT00537680|4116975|P1|COMPLETED|Overall Study||22
1685377|NCT00537680|4116973|P3|STARTED|Overall Study||24
1685378|NCT00537680|4116974|P2|STARTED|Overall Study||24
1685379|NCT00537680|4116975|P1|STARTED|Overall Study||22
1685380|NCT00537511|4116983|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
1685381|NCT00537511|4116983|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
1685382|NCT00537511|4116983|P1|STARTED|Maintenance Phase (Monotherapy)||8
1685383|NCT00537511|4116983|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
1685384|NCT00537511|4116983|P1|COMPLETED|Recovery Period (Monotherapy)||3
1685385|NCT00537511|4116983|P1|STARTED|Recovery Period (Monotherapy)||11
1685386|NCT00537511|4116983|P1|NOT COMPLETED|Extension Period (Combination)||6
1685387|NCT00537511|4116983|P1|COMPLETED|Extension Period (Combination)||11
1685388|NCT00537511|4116983|P1|STARTED|Extension Period (Combination)||17
1685389|NCT00537511|4116983|P1|NOT COMPLETED|Treatment Period (Combination)||5
1685390|NCT00537511|4116983|P1|COMPLETED|Treatment Period (Combination)||17
1685391|NCT00537511|4116983|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
1685392|NCT00537511|4116983|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
1685393|NCT00537511|4116983|P1|STARTED|Treatment Period (Combination)||22
1685394|NCT00537485|4117010|P2|NOT COMPLETED|Overall Study||10
1685395|NCT00537485|4117011|P1|NOT COMPLETED|Overall Study||15
1685396|NCT00537485|4117010|P2|COMPLETED|Overall Study||80
1685397|NCT00537485|4117011|P1|COMPLETED|Overall Study||75
1685398|NCT00537485|4117010|P2|STARTED|Overall Study||90
1685399|NCT00537485|4117011|P1|STARTED|Overall Study||90
1685400|NCT00537407|4117040|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
1685401|NCT00537407|4117041|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
1685402|NCT00537407|4117042|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
1685403|NCT00537407|4117043|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
1685404|NCT00537407|4117044|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
1685405|NCT00537407|4117040|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
1685406|NCT00537407|4117041|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
1685407|NCT00537407|4117042|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
1685408|NCT00537407|4117043|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
1685409|NCT00537407|4117044|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
1685410|NCT00537407|4117040|P5|STARTED|Part 2 Weeks 5-48 or 72||10
1685411|NCT00537407|4117041|P4|STARTED|Part 2 Weeks 5-48 or 72||10
1685412|NCT00537407|4117042|P3|STARTED|Part 2 Weeks 5-48 or 72||11
1685413|NCT00537407|4117043|P2|STARTED|Part 2 Weeks 5-48 or 72||9
1685414|NCT00537407|4117044|P1|STARTED|Part 2 Weeks 5-48 or 72||10
1685415|NCT00537407|4117040|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
1685416|NCT00537407|4117041|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
1685417|NCT00537407|4117042|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
1685418|NCT00537407|4117043|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
1685419|NCT00537407|4117044|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
1685420|NCT00537407|4117040|P5|COMPLETED|Part 1 Weeks 1-4||10
1685421|NCT00537407|4117041|P4|COMPLETED|Part 1 Weeks 1-4||10
1685422|NCT00537407|4117042|P3|COMPLETED|Part 1 Weeks 1-4||11
1685423|NCT00537407|4117043|P2|COMPLETED|Part 1 Weeks 1-4||9
1685424|NCT00537407|4117044|P1|COMPLETED|Part 1 Weeks 1-4||10
1685425|NCT00537407|4117040|P5|STARTED|Part 1 Weeks 1-4||10
1685426|NCT00537407|4117041|P4|STARTED|Part 1 Weeks 1-4||10
1685427|NCT00537407|4117042|P3|STARTED|Part 1 Weeks 1-4||11
1685428|NCT00537407|4117043|P2|STARTED|Part 1 Weeks 1-4||9
1685429|NCT00537407|4117044|P1|STARTED|Part 1 Weeks 1-4||10
1685430|NCT00537394|4117084|P3|NOT COMPLETED|2nd Year of Follow-up||6
1685431|NCT00537394|4117085|P2|NOT COMPLETED|2nd Year of Follow-up||9
1685432|NCT00537394|4117086|P1|NOT COMPLETED|2nd Year of Follow-up||11
1685433|NCT00537394|4117084|P3|COMPLETED|2nd Year of Follow-up||44
1685434|NCT00537394|4117085|P2|COMPLETED|2nd Year of Follow-up||159
1685435|NCT00537394|4117086|P1|COMPLETED|2nd Year of Follow-up||158
1685436|NCT00537394|4117084|P3|STARTED|2nd Year of Follow-up||50
1685437|NCT00537394|4117085|P2|STARTED|2nd Year of Follow-up||168
1685438|NCT00537394|4117086|P1|STARTED|2nd Year of Follow-up||169
1685439|NCT00537394|4117084|P3|NOT COMPLETED|First Year of Follow-up||3
1685440|NCT00537394|4117085|P2|NOT COMPLETED|First Year of Follow-up||11
1685441|NCT00537394|4117086|P1|NOT COMPLETED|First Year of Follow-up||12
1685442|NCT00537394|4117084|P3|COMPLETED|First Year of Follow-up||50
1685443|NCT00537394|4117085|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
1685444|NCT00537394|4117086|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
1685445|NCT00537394|4117084|P3|STARTED|First Year of Follow-up||53
1685446|NCT00537394|4117085|P2|STARTED|First Year of Follow-up||179
1685447|NCT00537394|4117086|P1|STARTED|First Year of Follow-up||181
1685448|NCT00537381|4117122|P2|NOT COMPLETED|Overall Study||62
1685449|NCT00537381|4117123|P1|NOT COMPLETED|Overall Study||56
1685450|NCT00537381|4117122|P2|COMPLETED|Overall Study||4
1685451|NCT00537381|4117123|P1|COMPLETED|Overall Study||9
1685452|NCT00537381|4117122|P2|STARTED|Overall Study||66
1685453|NCT00537381|4117123|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
1685454|NCT00537329|4117143|P1|NOT COMPLETED|Overall Study||26
1685455|NCT00537329|4117143|P1|COMPLETED|Overall Study||17
1685456|NCT00537329|4117143|P1|STARTED|Overall Study||43
1685457|NCT00537316|4117163|P7|NOT COMPLETED|Part 2||2
1685458|NCT00537316|4117164|P6|NOT COMPLETED|Part 2||4
1685459|NCT00537316|4117165|P5|NOT COMPLETED|Part 2||1
1685460|NCT00537316|4117166|P4|NOT COMPLETED|Part 2||3
1685461|NCT00537316|4117167|P3|NOT COMPLETED|Part 2||32
1685462|NCT00537316|4117168|P2|NOT COMPLETED|Part 2||9
1685463|NCT00537316|4117169|P1|NOT COMPLETED|Part 2||26
1685464|NCT00537316|4117163|P7|COMPLETED|Part 2||0
1685465|NCT00537316|4117164|P6|COMPLETED|Part 2||0
1685466|NCT00537316|4117165|P5|COMPLETED|Part 2||1
1685467|NCT00537316|4117166|P4|COMPLETED|Part 2||2
1685468|NCT00537316|4117167|P3|COMPLETED|Part 2||16
1685469|NCT00537316|4117168|P2|COMPLETED|Part 2||1
1685470|NCT00537316|4117169|P1|COMPLETED|Part 2||11
1685471|NCT00537316|4117163|P7|STARTED|Part 2||2
1685472|NCT00537316|4117164|P6|STARTED|Part 2||4
1685473|NCT00537316|4117165|P5|STARTED|Part 2||2
1685474|NCT00537316|4117166|P4|STARTED|Part 2||5
1685475|NCT00537316|4117167|P3|STARTED|Part 2||48
1685476|NCT00537316|4117168|P2|STARTED|Part 2||10
1685477|NCT00537316|4117169|P1|STARTED|Part 2||37
1685478|NCT00537316|4117163|P7|NOT COMPLETED|Part 1||0
1685479|NCT00537316|4117164|P6|NOT COMPLETED|Part 1||0
1685480|NCT00537316|4117165|P5|NOT COMPLETED|Part 1||0
1685481|NCT00537316|4117166|P4|NOT COMPLETED|Part 1||0
1685482|NCT00537316|4117167|P3|NOT COMPLETED|Part 1||17
1685483|NCT00537316|4117168|P2|NOT COMPLETED|Part 1||27
1685484|NCT00537316|4117169|P1|NOT COMPLETED|Part 1||14
1685485|NCT00537316|4117163|P7|COMPLETED|Part 1||0
1685486|NCT00537316|4117164|P6|COMPLETED|Part 1||0
1685487|NCT00537316|4117165|P5|COMPLETED|Part 1||0
1685488|NCT00537316|4117166|P4|COMPLETED|Part 1||0
1685489|NCT00537316|4117167|P3|COMPLETED|Part 1||63
1685490|NCT00537316|4117168|P2|COMPLETED|Part 1||53
1685491|NCT00537316|4117169|P1|COMPLETED|Part 1||65
1685492|NCT00537316|4117163|P7|STARTED|Part 1||0
1685493|NCT00537316|4117164|P6|STARTED|Part 1||0
1685494|NCT00537316|4117165|P5|STARTED|Part 1||0
1685495|NCT00537316|4117166|P4|STARTED|Part 1||0
1685496|NCT00537316|4117167|P3|STARTED|Part 1||80
1685497|NCT00537316|4117168|P2|STARTED|Part 1||80
1685498|NCT00537316|4117169|P1|STARTED|Part 1||79
1685499|NCT00537303|4117196|P2|NOT COMPLETED|Overall Study||25
1685500|NCT00537303|4117197|P1|NOT COMPLETED|Overall Study||26
1685501|NCT00537303|4117196|P2|COMPLETED|Overall Study||125
1685502|NCT00537303|4117197|P1|COMPLETED|Overall Study||120
1685503|NCT00537303|4117196|P2|STARTED|Overall Study||150
1685504|NCT00537303|4117197|P1|STARTED|Overall Study||146
1685505|NCT00537290|4117213|P1|NOT COMPLETED|Overall Study||0
1685506|NCT00537290|4117213|P1|COMPLETED|Overall Study||19
1685507|NCT00537290|4117213|P1|STARTED|Overall Study||19
1685508|NCT00537277|4117218|P1|NOT COMPLETED|Overall Study||49
1685509|NCT00537277|4117218|P1|COMPLETED|Overall Study||112
1685510|NCT00537277|4117218|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
1685511|NCT00537277|4117218|P1|STARTED|Overall Study||161
1685512|NCT00537238|4117229|P2|NOT COMPLETED|Overall Study||173
1685513|NCT00537238|4117230|P1|NOT COMPLETED|Overall Study||174
1685514|NCT00537238|4117229|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
1685515|NCT00537238|4117230|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
1685516|NCT00537238|4117229|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
1685517|NCT00537238|4117230|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
1685518|NCT00537238|4117229|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
1685519|NCT00537238|4117230|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
1685520|NCT00537238|4117229|P2|Completed Titration Phase|Overall Study||236
1685521|NCT00537238|4117230|P1|Completed Titration Phase|Overall Study||226
1685522|NCT00537238|4117229|P2|STARTED|Overall Study||255
1685523|NCT00537238|4117230|P1|STARTED|Overall Study||254
1685524|NCT00537199|4117250|P1|NOT COMPLETED|Overall Study||1
1685525|NCT00537199|4117250|P1|COMPLETED|Overall Study||0
1685526|NCT00537199|4117250|P1|STARTED|Overall Study||1
1685527|NCT00537095|4117256|P2|NOT COMPLETED|Overall Study||57
1685528|NCT00537095|4117257|P1|NOT COMPLETED|Overall Study||51
1685529|NCT00537095|4117256|P2|COMPLETED|Overall Study||16
1685530|NCT00537095|4117257|P1|COMPLETED|Overall Study||21
1685531|NCT00537095|4117256|P2|STARTED|Overall Study||73
1685532|NCT00537095|4117257|P1|STARTED|Overall Study||72
1685533|NCT00537082|4117272|P3|NOT COMPLETED|Overall Study||6
1685534|NCT00537082|4117273|P2|NOT COMPLETED|Overall Study||9
1685535|NCT00537082|4117274|P1|NOT COMPLETED|Overall Study||9
1685536|NCT00537082|4117272|P3|COMPLETED|Overall Study||51
1685537|NCT00537082|4117273|P2|COMPLETED|Overall Study||48
1685538|NCT00537082|4117274|P1|COMPLETED|Overall Study||48
1685539|NCT00537082|4117272|P3|STARTED|Overall Study||57
1685540|NCT00537082|4117273|P2|STARTED|Overall Study||57
1685541|NCT00537082|4117274|P1|STARTED|Overall Study||57
1685542|NCT00537056|4117291|P1|NOT COMPLETED|12-month Follow-up||0
1685543|NCT00537056|4117291|P1|COMPLETED|12-month Follow-up||17
1685544|NCT00537056|4117291|P1|STARTED|12-month Follow-up||17
1685545|NCT00537056|4117291|P1|NOT COMPLETED|Interim PET/CT||5
1685546|NCT00537056|4117291|P1|COMPLETED|Interim PET/CT||12
1685547|NCT00537056|4117291|P1|STARTED|Interim PET/CT||17
1685548|NCT00537056|4117291|P1|NOT COMPLETED|Baseline PET/CT||0
1685549|NCT00537056|4117291|P1|COMPLETED|Baseline PET/CT||17
1685550|NCT00537056|4117291|P1|STARTED|Baseline PET/CT||17
1685551|NCT00537030|4117303|P1|NOT COMPLETED|Overall Study||16
1685552|NCT00537030|4117303|P1|COMPLETED|Overall Study||43
1685553|NCT00537030|4117303|P1|STARTED|Overall Study||59
1685554|NCT00537017|4117307|P1|NOT COMPLETED|Follow-up Phase||9
1685555|NCT00537017|4117307|P1|COMPLETED|Follow-up Phase||126
1685556|NCT00537017|4117307|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
1685557|NCT00537017|4117307|P1|NOT COMPLETED|Treatment Phase||34
1685558|NCT00537017|4117307|P1|COMPLETED|Treatment Phase||106
1685559|NCT00537017|4117307|P1|STARTED|Treatment Phase||140
1685560|NCT00536991|4117318|P1|NOT COMPLETED|Overall Study||13
1685561|NCT00536991|4117318|P1|COMPLETED|Overall Study||38
1685562|NCT00536991|4117318|P1|STARTED|Overall Study||51
1685563|NCT00536978|4117325|P1|NOT COMPLETED|Overall Study||22
1685564|NCT00536978|4117325|P1|COMPLETED|Overall Study||0
1685565|NCT00536978|4117325|P1|STARTED|Overall Study||22
1685566|NCT00536913|4117331|P2|NOT COMPLETED|Overall Study||0
1685567|NCT00536913|4117332|P1|NOT COMPLETED|Overall Study||0
1685568|NCT00536913|4117331|P2|COMPLETED|Overall Study||52
1685569|NCT00536913|4117332|P1|COMPLETED|Overall Study||55
1685570|NCT00536913|4117331|P2|STARTED|Overall Study||52
1685571|NCT00536913|4117332|P1|STARTED|Overall Study||55
1685572|NCT00536874|4117354|P1|NOT COMPLETED|Overall Study||4
1685573|NCT00536874|4117354|P1|COMPLETED|Overall Study||35
1685574|NCT00536874|4117354|P1|STARTED|Overall Study||39
1685575|NCT00536809|4117364|P1|NOT COMPLETED|Phase II||2
1685576|NCT00536809|4117364|P1|COMPLETED|Phase II||0
1685577|NCT00536809|4117364|P1|STARTED|Phase II||2
1685578|NCT00536809|4117364|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
1685579|NCT00536809|4117364|P1|COMPLETED|Phase I (Dose-finding Phase)||10
1685580|NCT00536809|4117364|P1|STARTED|Phase I (Dose-finding Phase)||10
1685581|NCT00536744|4117387|P2|NOT COMPLETED|Overall Study||28
1685582|NCT00536744|4117388|P1|NOT COMPLETED|Overall Study||29
1685583|NCT00536744|4117387|P2|COMPLETED|Overall Study||71
1685584|NCT00536744|4117388|P1|COMPLETED|Overall Study||78
1685585|NCT00536744|4117387|P2|STARTED|Overall Study||99
1685586|NCT00536744|4117388|P1|STARTED|Overall Study||107
1685587|NCT00536731|4117397|P3|NOT COMPLETED|Overall Study||5
1685588|NCT00536731|4117398|P2|NOT COMPLETED|Overall Study||5
1685589|NCT00536731|4117399|P1|NOT COMPLETED|Overall Study||4
1685590|NCT00536731|4117397|P3|COMPLETED|Overall Study||238
1685591|NCT00536731|4117398|P2|COMPLETED|Overall Study||241
1685592|NCT00536731|4117399|P1|COMPLETED|Overall Study||249
1685593|NCT00536731|4117397|P3|STARTED|Overall Study||243
1685594|NCT00536731|4117398|P2|STARTED|Overall Study||246
1685595|NCT00536731|4117399|P1|STARTED|Overall Study||253
1685596|NCT00536575|4117443|P1|NOT COMPLETED|Overall Study||2
1685597|NCT00536575|4117443|P1|COMPLETED|Overall Study||11
1685598|NCT00536575|4117443|P1|STARTED|Overall Study||13
1685599|NCT00536510|4117449|P2|NOT COMPLETED|Overall Study||29
1685600|NCT00536510|4117450|P1|NOT COMPLETED|Overall Study||82
1685601|NCT00536510|4117449|P2|COMPLETED|Overall Study||295
1685602|NCT00536510|4117450|P1|COMPLETED|Overall Study||240
1685603|NCT00536510|4117449|P2|STARTED|Overall Study||324
1685604|NCT00536510|4117450|P1|STARTED|Overall Study||322
1685605|NCT00536484|4117460|P2|NOT COMPLETED|Overall Study||56
1685606|NCT00536484|4117461|P1|NOT COMPLETED|Overall Study||60
1685607|NCT00536484|4117460|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
1685608|NCT00536484|4117461|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
1685609|NCT00536484|4117460|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
1685610|NCT00536484|4117461|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
1685611|NCT00536471|4117495|P4|NOT COMPLETED|Overall Study||74
1685612|NCT00536471|4117496|P3|NOT COMPLETED|Overall Study||139
1685613|NCT00536471|4117497|P2|NOT COMPLETED|Overall Study||84
1685614|NCT00536471|4117498|P1|NOT COMPLETED|Overall Study||156
1685615|NCT00536471|4117495|P4|COMPLETED|Overall Study||57
1685616|NCT00536471|4117496|P3|COMPLETED|Overall Study||122
1685617|NCT00536471|4117497|P2|COMPLETED|Overall Study||43
1685618|NCT00536471|4117498|P1|COMPLETED|Overall Study||101
1685619|NCT00536471|4117495|P4|STARTED|Overall Study||131
1685620|NCT00536471|4117496|P3|STARTED|Overall Study||261
1685621|NCT00536471|4117497|P2|STARTED|Overall Study||127
1685622|NCT00536471|4117498|P1|STARTED|Overall Study||257
1685623|NCT00536380|4117743|P3|NOT COMPLETED|Overall Study||10
1685624|NCT00536380|4117744|P2|NOT COMPLETED|Overall Study||9
1685625|NCT00536380|4117745|P1|NOT COMPLETED|Overall Study||12
1685626|NCT00536380|4117743|P3|COMPLETED|Overall Study||94
1685627|NCT00536380|4117744|P2|COMPLETED|Overall Study||95
1685628|NCT00536380|4117745|P1|COMPLETED|Overall Study||94
1685629|NCT00536380|4117743|P3|STARTED|Overall Study||104
1685630|NCT00536380|4117744|P2|STARTED|Overall Study||104
1685631|NCT00536380|4117745|P1|STARTED|Overall Study||106
1685632|NCT00536341|4117755|P2|NOT COMPLETED|Overall Study||11
1685633|NCT00536341|4117756|P1|NOT COMPLETED|Overall Study||5
1685634|NCT00536341|4117755|P2|COMPLETED|Overall Study||43
1685635|NCT00536341|4117756|P1|COMPLETED|Overall Study||5
1685636|NCT00536341|4117755|P2|STARTED|Overall Study||54
1685637|NCT00536341|4117756|P1|STARTED|Overall Study||10
1685638|NCT00536263|4117769|P3|NOT COMPLETED|Overall Study||21
1685639|NCT00536263|4117770|P2|NOT COMPLETED|Overall Study||14
1685640|NCT00536263|4117771|P1|NOT COMPLETED|Overall Study||11
1685641|NCT00536263|4117769|P3|COMPLETED|Overall Study||204
1685642|NCT00536263|4117770|P2|COMPLETED|Overall Study||207
1685643|NCT00536263|4117771|P1|COMPLETED|Overall Study||214
1685644|NCT00536263|4117769|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
1685645|NCT00536263|4117770|P2|STARTED|Overall Study||221
1685646|NCT00536263|4117771|P1|STARTED|Overall Study||225
1685647|NCT00536198|4117811|P2|NOT COMPLETED|Overall Study||39
1685648|NCT00536198|4117812|P1|NOT COMPLETED|Overall Study||37
1685649|NCT00536198|4117811|P2|COMPLETED|Overall Study||88
1685650|NCT00536198|4117812|P1|COMPLETED|Overall Study||88
1685651|NCT00536198|4117811|P2|Cycle 6|Overall Study||88
1685652|NCT00536198|4117812|P1|Cycle 6|Overall Study||88
1685653|NCT00536198|4117811|P2|Cycle 5|Overall Study||85
1685654|NCT00536198|4117812|P1|Cycle 5|Overall Study||88
1685655|NCT00536198|4117811|P2|Cycle 4|Overall Study||98
1685656|NCT00536198|4117812|P1|Cycle 4|Overall Study||95
1685657|NCT00536198|4117811|P2|Cycle 3|Overall Study||101
1685658|NCT00536198|4117812|P1|Cycle 3|Overall Study||100
1685659|NCT00536198|4117811|P2|Cycle 2|Overall Study||112
1685660|NCT00536198|4117812|P1|Cycle 2|Overall Study||104
1685661|NCT00536198|4117811|P2|Cycle 1|Overall Study||123
1685662|NCT00536198|4117812|P1|Cycle 1|Overall Study||110
1685663|NCT00536198|4117811|P2|STARTED|Overall Study||127
1685664|NCT00536198|4117812|P1|STARTED|Overall Study||125
1685665|NCT00536172|4117842|P2|NOT COMPLETED|Overall Study||9
1685666|NCT00536172|4117843|P1|NOT COMPLETED|Overall Study||14
1685667|NCT00536172|4117842|P2|COMPLETED|Overall Study||65
1685668|NCT00536172|4117843|P1|COMPLETED|Overall Study||60
1685669|NCT00536172|4117842|P2|STARTED|Overall Study||74
1685670|NCT00536172|4117843|P1|STARTED|Overall Study||74
1685671|NCT00536120|4117851|P2|NOT COMPLETED|Overall Study||3
1685672|NCT00536120|4117852|P1|NOT COMPLETED|Overall Study||6
1685673|NCT00536120|4117851|P2|COMPLETED|Overall Study||27
1685674|NCT00536120|4117852|P1|COMPLETED|Overall Study||24
1685675|NCT00536120|4117851|P2|STARTED|Overall Study||30
1685676|NCT00536120|4117852|P1|STARTED|Overall Study||30
1685677|NCT00536107|4117866|P2|NOT COMPLETED|Overall Study||6
1685678|NCT00536107|4117867|P1|NOT COMPLETED|Overall Study||8
1685679|NCT00536107|4117866|P2|COMPLETED|Overall Study||0
1685680|NCT00536107|4117867|P1|COMPLETED|Overall Study||0
1685681|NCT00536107|4117866|P2|STARTED|Overall Study||6
1685682|NCT00536107|4117867|P1|STARTED|Overall Study||8
1685683|NCT00535938|4117877|P2|NOT COMPLETED|Overall Study||462
1685684|NCT00535938|4117878|P1|NOT COMPLETED|Overall Study||391
1685685|NCT00535938|4117877|P2|COMPLETED|Overall Study||404
1685686|NCT00535938|4117878|P1|COMPLETED|Overall Study||115
1685687|NCT00535938|4117877|P2|STARTED|Overall Study||866
1685688|NCT00535938|4117878|P1|STARTED|Overall Study||506
1685689|NCT00535873|4117914|P1|NOT COMPLETED|Overall Study||0
1685690|NCT00535873|4117914|P1|COMPLETED|Overall Study||60
1685691|NCT00535873|4117914|P1|STARTED|Overall Study||60
1685692|NCT00535847|4117921|P3|NOT COMPLETED|Overall Study||2
1685693|NCT00535847|4117922|P2|NOT COMPLETED|Overall Study||14
1685694|NCT00535847|4117923|P1|NOT COMPLETED|Overall Study||22
1685695|NCT00535847|4117921|P3|COMPLETED|Overall Study||0
1685696|NCT00535847|4117922|P2|COMPLETED|Overall Study||20
1685697|NCT00535847|4117923|P1|COMPLETED|Overall Study||59
1685698|NCT00535847|4117921|P3|STARTED|Overall Study||2
1685699|NCT00535847|4117922|P2|STARTED|Overall Study||34
1685700|NCT00535847|4117923|P1|STARTED|Overall Study||81
1685701|NCT00535821|4117949|P2|NOT COMPLETED|Overall Study||0
1685702|NCT00535821|4117950|P1|NOT COMPLETED|Overall Study||0
1685703|NCT00535821|4117949|P2|COMPLETED|Overall Study||3
1685704|NCT00535821|4117950|P1|COMPLETED|Overall Study||2
1685705|NCT00535821|4117949|P2|STARTED|Overall Study||3
1685706|NCT00535821|4117950|P1|STARTED|Overall Study||2
1685707|NCT00535782|4117958|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
1685708|NCT00535782|4117959|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
1685709|NCT00535782|4117960|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
1685710|NCT00535782|4117958|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
1685711|NCT00535782|4117959|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
1685712|NCT00535782|4117960|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
1685713|NCT00535782|4117958|P3|STARTED|Part 2: 80-Week Open-label Period||124
1685714|NCT00535782|4117959|P2|STARTED|Part 2: 80-Week Open-label Period||0
1685715|NCT00535782|4117960|P1|STARTED|Part 2: 80-Week Open-label Period||0
1685716|NCT00535782|4117958|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
1685717|NCT00535782|4117959|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
1685718|NCT00535782|4117960|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
1685719|NCT00535782|4117958|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
1685720|NCT00535782|4117959|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
1685721|NCT00535782|4117960|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
1685722|NCT00535782|4117958|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
1685723|NCT00535782|4117959|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
1685724|NCT00535782|4117960|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
1685725|NCT00535782|4117958|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
1685726|NCT00535782|4117959|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
1685727|NCT00535782|4117960|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
1685728|NCT00535782|4117958|P3|STARTED|Part 1: 24-Week Double-blind Period||0
1685729|NCT00535782|4117959|P2|STARTED|Part 1: 24-Week Double-blind Period||63
1685730|NCT00535782|4117960|P1|STARTED|Part 1: 24-Week Double-blind Period||69
1685731|NCT00535769|4117977|P2|NOT COMPLETED|Overall Study||0
1685732|NCT00535769|4117978|P1|NOT COMPLETED|Overall Study||0
1685733|NCT00535769|4117977|P2|COMPLETED|Overall Study||35
1685734|NCT00535769|4117978|P1|COMPLETED|Overall Study||35
1685735|NCT00535769|4117977|P2|STARTED|Overall Study||35
1685736|NCT00535769|4117978|P1|STARTED|Overall Study||35
1685737|NCT00535730|4117989|P2|NOT COMPLETED|Overall Study||7
1685738|NCT00535730|4117990|P1|NOT COMPLETED|Overall Study||2
1685739|NCT00535730|4117989|P2|COMPLETED|Overall Study||230
1685740|NCT00535730|4117990|P1|COMPLETED|Overall Study||234
1685741|NCT00535730|4117989|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
1685742|NCT00535730|4117990|P1|STARTED|Overall Study||236
1685743|NCT00535652|4118007|P1|NOT COMPLETED|Overall Study||3
1685744|NCT00535652|4118007|P1|COMPLETED|Overall Study||20
1685745|NCT00535652|4118007|P1|STARTED|Overall Study||23
1685746|NCT00535626|4118011|P1|NOT COMPLETED|Overall Study||105
1685747|NCT00535626|4118011|P1|COMPLETED|Overall Study||85
1685748|NCT00535626|4118011|P1|STARTED|Overall Study||190
1685749|NCT00535587|4118025|P4|NOT COMPLETED|Overall Study||13
1685750|NCT00535587|4118026|P3|NOT COMPLETED|Overall Study||8
1685751|NCT00535587|4118027|P2|NOT COMPLETED|Overall Study||11
1685752|NCT00535587|4118028|P1|NOT COMPLETED|Overall Study||10
1685753|NCT00535587|4118025|P4|COMPLETED|Overall Study||41
1685754|NCT00535587|4118026|P3|COMPLETED|Overall Study||39
1685755|NCT00535587|4118027|P2|COMPLETED|Overall Study||42
1685756|NCT00535587|4118028|P1|COMPLETED|Overall Study||43
1685757|NCT00535587|4118025|P4|STARTED|Overall Study||54
1685758|NCT00535587|4118026|P3|STARTED|Overall Study||47
1685759|NCT00535587|4118027|P2|STARTED|Overall Study||53
1685760|NCT00535587|4118028|P1|STARTED|Overall Study||53
1685761|NCT00535496|4118038|P4|NOT COMPLETED|Overall Study||0
1685762|NCT00535496|4118039|P3|NOT COMPLETED|Overall Study||0
1685763|NCT00535496|4118040|P2|NOT COMPLETED|Overall Study||2
1685764|NCT00535496|4118041|P1|NOT COMPLETED|Overall Study||0
1685765|NCT00535496|4118038|P4|COMPLETED|Overall Study||31
1685766|NCT00535496|4118039|P3|COMPLETED|Overall Study||30
1685767|NCT00535496|4118040|P2|COMPLETED|Overall Study||13
1685768|NCT00535496|4118041|P1|COMPLETED|Overall Study||15
1685769|NCT00535496|4118038|P4|All-Subjects-Treated (AST) Group|Overall Study||31
1685770|NCT00535496|4118039|P3|All-Subjects-Treated (AST) Group|Overall Study||30
1685771|NCT00535496|4118040|P2|All-Subjects-Treated (AST) Group|Overall Study||14
1685772|NCT00535496|4118041|P1|All-Subjects-Treated (AST) Group|Overall Study||15
1685773|NCT00535496|4118038|P4|STARTED|Overall Study||31
1685774|NCT00535496|4118039|P3|STARTED|Overall Study||30
1685775|NCT00535496|4118040|P2|STARTED|Overall Study||15
1685776|NCT00535496|4118041|P1|STARTED|Overall Study||15
1685777|NCT00535405|4118061|P5|NOT COMPLETED|Overall Study||16
1685778|NCT00535405|4118062|P4|NOT COMPLETED|Overall Study||22
1685779|NCT00535405|4118063|P3|NOT COMPLETED|Overall Study||18
1685780|NCT00535405|4118064|P2|NOT COMPLETED|Overall Study||26
1685781|NCT00535405|4118065|P1|NOT COMPLETED|Overall Study||17
1685782|NCT00535405|4118061|P5|COMPLETED|Overall Study||241
1685783|NCT00535405|4118062|P4|COMPLETED|Overall Study||235
1685784|NCT00535405|4118063|P3|COMPLETED|Overall Study||241
1685785|NCT00535405|4118064|P2|COMPLETED|Overall Study||233
1685786|NCT00535405|4118065|P1|COMPLETED|Overall Study||240
1685787|NCT00535405|4118061|P5|STARTED|Overall Study||257
1685788|NCT00535405|4118062|P4|STARTED|Overall Study||257
1685789|NCT00535405|4118063|P3|STARTED|Overall Study||259
1685790|NCT00535405|4118064|P2|STARTED|Overall Study||259
1685791|NCT00535405|4118065|P1|STARTED|Overall Study||257
1685792|NCT00535392|4118102|P1|NOT COMPLETED|Overall Study||0
1685793|NCT00535392|4118102|P1|COMPLETED|Overall Study||33
1685794|NCT00535392|4118102|P1|STARTED|Overall Study||33
1685795|NCT00535301|4118110|P2|NOT COMPLETED|Overall Study||5
1685796|NCT00535301|4118111|P1|NOT COMPLETED|Overall Study||5
1685797|NCT00535301|4118110|P2|COMPLETED|Overall Study||33
1685798|NCT00535301|4118111|P1|COMPLETED|Overall Study||33
1685799|NCT00535301|4118110|P2|STARTED|Overall Study||38
1685800|NCT00535301|4118111|P1|STARTED|Overall Study||38
1685801|NCT00535288|4118126|P5|NOT COMPLETED|Overall Study||42
1685802|NCT00535288|4118127|P4|NOT COMPLETED|Overall Study||29
1685803|NCT00535288|4118128|P3|NOT COMPLETED|Overall Study||33
1685804|NCT00535288|4118129|P2|NOT COMPLETED|Overall Study||32
1685805|NCT00535288|4118130|P1|NOT COMPLETED|Overall Study||54
1685806|NCT00535288|4118126|P5|COMPLETED|Overall Study||116
1685807|NCT00535288|4118127|P4|COMPLETED|Overall Study||122
1685808|NCT00535288|4118128|P3|COMPLETED|Overall Study||127
1685809|NCT00535288|4118129|P2|COMPLETED|Overall Study||130
1685810|NCT00535288|4118130|P1|COMPLETED|Overall Study||260
1685811|NCT00535288|4118126|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
1685812|NCT00535288|4118127|P4|STARTED|Overall Study||151
1685813|NCT00535288|4118128|P3|STARTED|Overall Study||160
1685814|NCT00535288|4118129|P2|STARTED|Overall Study||162
1685815|NCT00535288|4118130|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
1685816|NCT00535262|4118207|P1|NOT COMPLETED|Overall Study||3
1685817|NCT00535262|4118207|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
1685818|NCT00535262|4118207|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
1685819|NCT00535223|4118213|P2|NOT COMPLETED|Overall Study||1
1685820|NCT00535223|4118214|P1|NOT COMPLETED|Overall Study||4
1685821|NCT00535223|4118213|P2|COMPLETED|Overall Study||39
1685822|NCT00535223|4118214|P1|COMPLETED|Overall Study||37
1685823|NCT00535223|4118213|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
1685824|NCT00535223|4118214|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
1685825|NCT00535145|4118222|P1|NOT COMPLETED|Phase II||15
1685826|NCT00535145|4118222|P1|COMPLETED|Phase II||69
1685827|NCT00535145|4118222|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
1685828|NCT00535145|4118222|P1|NOT COMPLETED|Phase I||29
1685829|NCT00535145|4118222|P1|COMPLETED|Phase I||85
1685830|NCT00535145|4118222|P1|STARTED|Phase I||114
1685831|NCT00535132|4118234|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
1685832|NCT00535132|4118235|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
1685833|NCT00535132|4118234|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
1685834|NCT00535132|4118235|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
1685835|NCT00535132|4118234|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
1685836|NCT00535132|4118235|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
1685837|NCT00535132|4118234|P2|NOT COMPLETED|Safety Analysis Set||2
1685838|NCT00535132|4118235|P1|NOT COMPLETED|Safety Analysis Set||2
1685839|NCT00535132|4118234|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
1685840|NCT00535132|4118235|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
1685841|NCT00535132|4118234|P2|STARTED|Safety Analysis Set||101
1685842|NCT00535132|4118235|P1|STARTED|Safety Analysis Set||100
1685843|NCT00535132|4118234|P2|NOT COMPLETED|Randomized Population||0
1685844|NCT00535132|4118235|P1|NOT COMPLETED|Randomized Population||0
1685845|NCT00535132|4118234|P2|COMPLETED|Randomized Population||101
1685846|NCT00535132|4118235|P1|COMPLETED|Randomized Population||100
1685847|NCT00535132|4118234|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
1685848|NCT00535132|4118235|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
1685849|NCT00535002|4118293|P8|NOT COMPLETED|Overall Study||0
1685850|NCT00535002|4118294|P7|NOT COMPLETED|Overall Study||0
1685851|NCT00535002|4118295|P6|NOT COMPLETED|Overall Study||0
1685852|NCT00535002|4118296|P5|NOT COMPLETED|Overall Study||0
1685853|NCT00535002|4118297|P4|NOT COMPLETED|Overall Study||0
1685854|NCT00535002|4118298|P3|NOT COMPLETED|Overall Study||0
1685855|NCT00535002|4118299|P2|NOT COMPLETED|Overall Study||0
1685856|NCT00535002|4118300|P1|NOT COMPLETED|Overall Study||0
1685857|NCT00535002|4118293|P8|COMPLETED|Overall Study||16
1685858|NCT00535002|4118294|P7|COMPLETED|Overall Study||12
1685859|NCT00535002|4118295|P6|COMPLETED|Overall Study||17
1685860|NCT00535002|4118296|P5|COMPLETED|Overall Study||9
1685861|NCT00535002|4118297|P4|COMPLETED|Overall Study||14
1685862|NCT00535002|4118298|P3|COMPLETED|Overall Study||13
1685863|NCT00535002|4118299|P2|COMPLETED|Overall Study||12
1685864|NCT00535002|4118300|P1|COMPLETED|Overall Study||19
1685865|NCT00535002|4118293|P8|STARTED|Overall Study||16
1685866|NCT00535002|4118294|P7|STARTED|Overall Study||12
1685867|NCT00535002|4118295|P6|STARTED|Overall Study||17
1685868|NCT00535002|4118296|P5|STARTED|Overall Study||9
1685869|NCT00535002|4118297|P4|STARTED|Overall Study||14
1685870|NCT00535002|4118298|P3|STARTED|Overall Study||13
1685871|NCT00535002|4118299|P2|STARTED|Overall Study||12
1685872|NCT00535002|4118300|P1|STARTED|Overall Study||19
1685873|NCT00534976|4118316|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
1685874|NCT00534976|4118317|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
1685875|NCT00534976|4118316|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
1685876|NCT00534976|4118317|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
1685877|NCT00534976|4118316|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
1685878|NCT00534976|4118317|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
1685879|NCT00534976|4118316|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
1685880|NCT00534976|4118317|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
1685881|NCT00534976|4118316|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
1685882|NCT00534976|4118317|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
1685883|NCT00534976|4118316|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
1685884|NCT00534976|4118317|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
1685885|NCT00534976|4118316|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
1685886|NCT00534976|4118317|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
1685887|NCT00534976|4118316|P2|COMPLETED|Period 1: Placebo Run-in||33
1685888|NCT00534976|4118317|P1|COMPLETED|Period 1: Placebo Run-in||33
1685889|NCT00534976|4118316|P2|STARTED|Period 1: Placebo Run-in||33
1685890|NCT00534976|4118317|P1|STARTED|Period 1: Placebo Run-in||33
1685891|NCT00534937|4118339|P2|NOT COMPLETED|Overall Study||12
1685892|NCT00534937|4118340|P1|NOT COMPLETED|Overall Study||8
1685893|NCT00534937|4118339|P2|COMPLETED|Overall Study||35
1685894|NCT00534937|4118340|P1|COMPLETED|Overall Study||34
1685895|NCT00534937|4118339|P2|STARTED|Overall Study||47
1685896|NCT00534937|4118340|P1|STARTED|Overall Study||42
1685897|NCT00534833|4118354|P2|NOT COMPLETED|Overall Study||0
1685898|NCT00534833|4118355|P1|NOT COMPLETED|Overall Study||0
1685899|NCT00534833|4118354|P2|COMPLETED|Overall Study||180
1685900|NCT00534833|4118355|P1|COMPLETED|Overall Study||182
1685901|NCT00534833|4118354|P2|STARTED|Overall Study||180
1685902|NCT00534833|4118355|P1|STARTED|Overall Study||182
1685903|NCT00534794|4118367|P2|NOT COMPLETED|Overall Study||0
1685904|NCT00534794|4118368|P1|NOT COMPLETED|Overall Study||0
1685905|NCT00534794|4118367|P2|COMPLETED|Overall Study||39
1685906|NCT00534794|4118368|P1|COMPLETED|Overall Study||40
1685907|NCT00534794|4118367|P2|STARTED|Overall Study||39
1685908|NCT00534794|4118368|P1|STARTED|Overall Study||40
1685909|NCT00534638|4118378|P2|NOT COMPLETED|Overall Study||11791
1685910|NCT00534638|4118379|P1|NOT COMPLETED|Overall Study||6491
1685911|NCT00534638|4118378|P2|COMPLETED|Overall Study||5547
1685912|NCT00534638|4118379|P1|COMPLETED|Overall Study||8346
1685913|NCT00534638|4118378|P2|STARTED|Overall Study||17338
1685914|NCT00534638|4118379|P1|STARTED|Overall Study||14837
1685915|NCT00534599|4118414|P2|NOT COMPLETED|Overall Study||32
1685916|NCT00534599|4118415|P1|NOT COMPLETED|Overall Study||57
1685917|NCT00534599|4118414|P2|COMPLETED|Overall Study||168
1685918|NCT00534599|4118415|P1|COMPLETED|Overall Study||152
1685919|NCT00534599|4118414|P2|STARTED|Overall Study|Randomized|200
1685920|NCT00534599|4118415|P1|STARTED|Overall Study|Randomized|209
1685921|NCT00534495|4118451|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
1685922|NCT00534495|4118452|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1685923|NCT00534495|4118453|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1685924|NCT00534495|4118451|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
1685925|NCT00534495|4118452|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1685926|NCT00534495|4118453|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1685927|NCT00534495|4118451|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
1685928|NCT00534495|4118452|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
1685929|NCT00534495|4118453|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
1685930|NCT00534495|4118451|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
1685931|NCT00534495|4118452|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
1685932|NCT00534495|4118453|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
1685933|NCT00534495|4118451|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
1685934|NCT00534495|4118452|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
1685935|NCT00534495|4118453|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
1685936|NCT00534495|4118451|P3|STARTED|All Active Treatment Phase Week 4-24||0
1685937|NCT00534495|4118452|P2|STARTED|All Active Treatment Phase Week 4-24||34
1685938|NCT00534495|4118453|P1|STARTED|All Active Treatment Phase Week 4-24||36
1685939|NCT00534495|4118451|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
1685940|NCT00534495|4118452|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
1685941|NCT00534495|4118453|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
1685942|NCT00534495|4118451|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
1685943|NCT00534495|4118452|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
1685944|NCT00534495|4118453|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
1685945|NCT00534495|4118451|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
1685946|NCT00534495|4118452|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
1685947|NCT00534495|4118453|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
1685948|NCT00534417|4118476|P1|NOT COMPLETED|Overall Study||0
1685949|NCT00534417|4118476|P1|COMPLETED|Overall Study||41
1685950|NCT00534417|4118476|P1|STARTED|Overall Study||41
1685951|NCT00534404|4118491|P3|NOT COMPLETED|Overall Study||242
1685952|NCT00534404|4118492|P2|NOT COMPLETED|Overall Study||143
1685953|NCT00534404|4118493|P1|NOT COMPLETED|Overall Study||180
1685954|NCT00534404|4118491|P3|COMPLETED|Overall Study||586
1685955|NCT00534404|4118492|P2|COMPLETED|Overall Study||687
1685956|NCT00534404|4118493|P1|COMPLETED|Overall Study||647
1685957|NCT00534404|4118491|P3|3-month Follow up Completed|Overall Study||593
1685958|NCT00534404|4118492|P2|3-month Follow up Completed|Overall Study||731
1685959|NCT00534404|4118493|P1|3-month Follow up Completed|Overall Study||682
1685960|NCT00534404|4118491|P3|1-month Follow up Completed|Overall Study||626
1685961|NCT00534404|4118492|P2|1-month Follow up Completed|Overall Study||781
1685962|NCT00534404|4118493|P1|1-month Follow up Completed|Overall Study||742
1685963|NCT00534404|4118491|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
1685964|NCT00534404|4118492|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
1685965|NCT00534404|4118493|P1|Completed at Least 1 Counseling Call|Overall Study||813
1685966|NCT00534404|4118491|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
1685967|NCT00534404|4118492|P2|Completed Second NRT Order|Overall Study||789
1685968|NCT00534404|4118493|P1|Completed Second NRT Order|Overall Study||640
1685969|NCT00534404|4118491|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
1685970|NCT00534404|4118492|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
1685971|NCT00534404|4118493|P1|Completed First NRT Order|Overall Study||765
1685972|NCT00534404|4118491|P3|Completed at Least 1 Online Session|Overall Study||658
1685973|NCT00534404|4118492|P2|Completed at Least 1 Online Session|Overall Study||813
1685974|NCT00534404|4118493|P1|Completed at Least 1 Online Session|Overall Study||781
1685975|NCT00534404|4118491|P3|STARTED|Overall Study||828
1685976|NCT00534404|4118492|P2|STARTED|Overall Study||830
1685977|NCT00534404|4118493|P1|STARTED|Overall Study||827
1685978|NCT00534365|4118509|P2|NOT COMPLETED|Overall Study||7
1685979|NCT00534365|4118510|P1|NOT COMPLETED|Overall Study||0
1685980|NCT00534365|4118509|P2|COMPLETED|Overall Study||129
1685981|NCT00534365|4118510|P1|COMPLETED|Overall Study||127
1685982|NCT00534365|4118509|P2|Included in Intent to Treat Analysis|Overall Study||136
1685983|NCT00534365|4118510|P1|Included in Intent to Treat Analysis|Overall Study||127
1685984|NCT00534365|4118509|P2|Follow up at 12 Months or More|Overall Study||128
1685985|NCT00534365|4118510|P1|Follow up at 12 Months or More|Overall Study||119
1685986|NCT00534365|4118509|P2|Any Follow up|Overall Study||135
1685987|NCT00534365|4118510|P1|Any Follow up|Overall Study||126
1685988|NCT00534365|4118509|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
1685989|NCT00534365|4118510|P1|Received Procedure|Overall Study||127
1685990|NCT00534365|4118509|P2|STARTED|Overall Study||136
1685991|NCT00534365|4118510|P1|STARTED|Overall Study||127
1685992|NCT00534352|4118524|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
1685993|NCT00534352|4118524|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
1685994|NCT00534352|4118524|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
1685995|NCT00534352|4118524|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
1685996|NCT00534352|4118524|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
1685997|NCT00534352|4118524|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
1685998|NCT00534352|4118524|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
1685999|NCT00534352|4118524|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
1686000|NCT00534352|4118524|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
1686001|NCT00534352|4118524|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
1686002|NCT00534352|4118524|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
1686003|NCT00534352|4118524|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
1686004|NCT00534313|4118568|P4|NOT COMPLETED|Long-term Period||33
1686005|NCT00534313|4118569|P3|NOT COMPLETED|Long-term Period||43
1686006|NCT00534313|4118570|P2|NOT COMPLETED|Long-term Period||34
1686007|NCT00534313|4118571|P1|NOT COMPLETED|Long-term Period||37
1686008|NCT00534313|4118568|P4|COMPLETED|Long-term Period||0
1686009|NCT00534313|4118569|P3|COMPLETED|Long-term Period||0
1686010|NCT00534313|4118570|P2|COMPLETED|Long-term Period||0
1686011|NCT00534313|4118571|P1|COMPLETED|Long-term Period||0
1686012|NCT00534313|4118568|P4|STARTED|Long-term Period||33
1686013|NCT00534313|4118569|P3|STARTED|Long-term Period||43
1686014|NCT00534313|4118570|P2|STARTED|Long-term Period||34
1686015|NCT00534313|4118571|P1|STARTED|Long-term Period||37
1686016|NCT00534313|4118568|P4|NOT COMPLETED|Short-term Period||9
1686017|NCT00534313|4118569|P3|NOT COMPLETED|Short-term Period||2
1686018|NCT00534313|4118570|P2|NOT COMPLETED|Short-term Period||6
1686019|NCT00534313|4118571|P1|NOT COMPLETED|Short-term Period||6
1686020|NCT00534313|4118568|P4|COMPLETED|Short-term Period|Completed the short-term study|33
1686021|NCT00534313|4118569|P3|COMPLETED|Short-term Period|Completed the short-term study|43
1686022|NCT00534313|4118570|P2|COMPLETED|Short-term Period|Completed the short-term study|34
1686023|NCT00534313|4118571|P1|COMPLETED|Short-term Period|Completed the short-term study|37
1686024|NCT00534313|4118568|P4|STARTED|Short-term Period||42
1686025|NCT00534313|4118569|P3|STARTED|Short-term Period||45
1686026|NCT00534313|4118570|P2|STARTED|Short-term Period||40
1686027|NCT00534313|4118571|P1|STARTED|Short-term Period||43
1686028|NCT00534248|4118666|P2|NOT COMPLETED|Overall Study||673
1686029|NCT00534248|4118667|P1|NOT COMPLETED|Overall Study||661
1686030|NCT00534248|4118666|P2|COMPLETED|Overall Study||10555
1686031|NCT00534248|4118667|P1|COMPLETED|Overall Study||10550
1686032|NCT00534248|4118666|P2|VACCINATED|Overall Study||11210
1686033|NCT00534248|4118667|P1|VACCINATED|Overall Study||11186
1686034|NCT00534248|4118666|P2|STARTED|Overall Study||11228
1686035|NCT00534248|4118667|P1|STARTED|Overall Study||11211
1686036|NCT00534209|4118677|P1|NOT COMPLETED|Overall Study||0
1686037|NCT00534209|4118677|P1|COMPLETED|Overall Study||1
1686038|NCT00534209|4118677|P1|STARTED|Overall Study||1
1686039|NCT00534105|4118697|P2|NOT COMPLETED|Overall Study||39
1686040|NCT00534105|4118698|P1|NOT COMPLETED|Overall Study||23
1686041|NCT00534105|4118697|P2|COMPLETED|Overall Study||20
1686042|NCT00534105|4118698|P1|COMPLETED|Overall Study||24
1686043|NCT00534105|4118697|P2|STARTED|Overall Study||59
1686044|NCT00534105|4118698|P1|STARTED|Overall Study||47
1686045|NCT00534092|4118712|P2|NOT COMPLETED|Overall Study||0
1686046|NCT00534092|4118713|P1|NOT COMPLETED|Overall Study||2
1686047|NCT00534092|4118712|P2|COMPLETED|Overall Study||14
1686048|NCT00534092|4118713|P1|COMPLETED|Overall Study||53
1686049|NCT00534092|4118712|P2|STARTED|Overall Study||14
1686050|NCT00534092|4118713|P1|STARTED|Overall Study||55
1686051|NCT00534001|4118738|P2|NOT COMPLETED|Overall Study||4
1686052|NCT00534001|4118739|P1|NOT COMPLETED|Overall Study||5
1686053|NCT00534001|4118738|P2|COMPLETED|Overall Study||43
1686054|NCT00534001|4118739|P1|COMPLETED|Overall Study||43
1686055|NCT00534001|4118738|P2|STARTED|Overall Study||47
1686056|NCT00534001|4118739|P1|STARTED|Overall Study||48
1686057|NCT00533949|4118751|P4|NOT COMPLETED|Overall Study||10
1686058|NCT00533949|4118752|P3|NOT COMPLETED|Overall Study||10
1686059|NCT00533949|4118753|P2|NOT COMPLETED|Overall Study||14
1686060|NCT00533949|4118754|P1|NOT COMPLETED|Overall Study||15
1686061|NCT00533949|4118751|P4|COMPLETED|Overall Study||100
1686062|NCT00533949|4118752|P3|COMPLETED|Overall Study||137
1686063|NCT00533949|4118753|P2|COMPLETED|Overall Study||107
1686064|NCT00533949|4118754|P1|COMPLETED|Overall Study||151
1686065|NCT00533949|4118751|P4|STARTED|Overall Study||110
1686066|NCT00533949|4118752|P3|STARTED|Overall Study||147
1686067|NCT00533949|4118753|P2|STARTED|Overall Study||121
1686068|NCT00533949|4118754|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
1686069|NCT00533897|4118785|P8|NOT COMPLETED|Long Term Extension (LTE)||25
1686070|NCT00533897|4118786|P7|NOT COMPLETED|Long Term Extension (LTE)||13
1686071|NCT00533897|4118787|P6|NOT COMPLETED|Long Term Extension (LTE)||0
1686072|NCT00533897|4118788|P5|NOT COMPLETED|Long Term Extension (LTE)||0
1686073|NCT00533897|4118789|P4|NOT COMPLETED|Long Term Extension (LTE)||0
1686074|NCT00533897|4118790|P3|NOT COMPLETED|Long Term Extension (LTE)||0
1686075|NCT00533897|4118791|P2|NOT COMPLETED|Long Term Extension (LTE)||0
1686076|NCT00533897|4118792|P1|NOT COMPLETED|Long Term Extension (LTE)||0
1686077|NCT00533897|4118785|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
1686078|NCT00533897|4118786|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
1686079|NCT00533897|4118787|P6|COMPLETED|Long Term Extension (LTE)||0
1686080|NCT00533897|4118788|P5|COMPLETED|Long Term Extension (LTE)||0
1686081|NCT00533897|4118789|P4|COMPLETED|Long Term Extension (LTE)||0
1686082|NCT00533897|4118790|P3|COMPLETED|Long Term Extension (LTE)||0
1686083|NCT00533897|4118791|P2|COMPLETED|Long Term Extension (LTE)||0
1686084|NCT00533897|4118792|P1|COMPLETED|Long Term Extension (LTE)||0
1686085|NCT00533897|4118785|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
1686086|NCT00533897|4118786|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
1686087|NCT00533897|4118787|P6|STARTED|Long Term Extension (LTE)||0
1686088|NCT00533897|4118788|P5|STARTED|Long Term Extension (LTE)||0
1686089|NCT00533897|4118789|P4|STARTED|Long Term Extension (LTE)||0
1686090|NCT00533897|4118790|P3|STARTED|Long Term Extension (LTE)||0
1686091|NCT00533897|4118791|P2|STARTED|Long Term Extension (LTE)||0
1686092|NCT00533897|4118792|P1|STARTED|Long Term Extension (LTE)||0
1686093|NCT00533897|4118785|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
1686094|NCT00533897|4118786|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
1686095|NCT00533897|4118787|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
1686096|NCT00533897|4118788|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
1686097|NCT00533897|4118789|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
1686098|NCT00533897|4118790|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
1686099|NCT00533897|4118791|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
1686100|NCT00533897|4118792|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
1686101|NCT00533897|4118785|P8|COMPLETED|Re-introduction (RI) Period 3||0
1686102|NCT00533897|4118786|P7|COMPLETED|Re-introduction (RI) Period 3||0
1686103|NCT00533897|4118787|P6|COMPLETED|Re-introduction (RI) Period 3||42
1686104|NCT00533897|4118788|P5|COMPLETED|Re-introduction (RI) Period 3||35
1686105|NCT00533897|4118789|P4|COMPLETED|Re-introduction (RI) Period 3||40
1686106|NCT00533897|4118790|P3|COMPLETED|Re-introduction (RI) Period 3||0
1686107|NCT00533897|4118791|P2|COMPLETED|Re-introduction (RI) Period 3||0
1686108|NCT00533897|4118792|P1|COMPLETED|Re-introduction (RI) Period 3||0
1686109|NCT00533897|4118785|P8|STARTED|Re-introduction (RI) Period 3||0
1686110|NCT00533897|4118786|P7|STARTED|Re-introduction (RI) Period 3||0
1686111|NCT00533897|4118787|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
1686112|NCT00533897|4118788|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
1686113|NCT00533897|4118789|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
1686114|NCT00533897|4118790|P3|STARTED|Re-introduction (RI) Period 3||0
1686115|NCT00533897|4118791|P2|STARTED|Re-introduction (RI) Period 3||0
1686116|NCT00533897|4118792|P1|STARTED|Re-introduction (RI) Period 3||0
1686117|NCT00533897|4118785|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686118|NCT00533897|4118786|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686119|NCT00533897|4118787|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686120|NCT00533897|4118788|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686121|NCT00533897|4118789|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686122|NCT00533897|4118790|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
1686123|NCT00533897|4118791|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
1686124|NCT00533897|4118792|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686125|NCT00533897|4118785|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686126|NCT00533897|4118786|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686127|NCT00533897|4118787|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686128|NCT00533897|4118788|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686129|NCT00533897|4118789|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686130|NCT00533897|4118790|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
1686131|NCT00533897|4118791|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
1686132|NCT00533897|4118792|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1686133|NCT00533897|4118785|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1686134|NCT00533897|4118786|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1686135|NCT00533897|4118787|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1686136|NCT00533897|4118788|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1686137|NCT00533897|4118789|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1686138|NCT00533897|4118790|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
1686139|NCT00533897|4118791|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
1686140|NCT00533897|4118792|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1686141|NCT00533897|4118785|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
1686142|NCT00533897|4118786|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
1686143|NCT00533897|4118787|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
1686144|NCT00533897|4118788|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
1686145|NCT00533897|4118789|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
1686146|NCT00533897|4118790|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
1686147|NCT00533897|4118791|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
1686148|NCT00533897|4118792|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
1686149|NCT00533897|4118785|P8|COMPLETED|Lead-in (LI) Period 1||0
1686150|NCT00533897|4118786|P7|COMPLETED|Lead-in (LI) Period 1||0
1686151|NCT00533897|4118787|P6|COMPLETED|Lead-in (LI) Period 1||0
1686152|NCT00533897|4118788|P5|COMPLETED|Lead-in (LI) Period 1||0
1686153|NCT00533897|4118789|P4|COMPLETED|Lead-in (LI) Period 1||0
1686154|NCT00533897|4118790|P3|COMPLETED|Lead-in (LI) Period 1||0
1686155|NCT00533897|4118791|P2|COMPLETED|Lead-in (LI) Period 1||0
1686156|NCT00533897|4118792|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
1686157|NCT00533897|4118785|P8|STARTED|Lead-in (LI) Period 1||0
1686158|NCT00533897|4118786|P7|STARTED|Lead-in (LI) Period 1||0
1686159|NCT00533897|4118787|P6|STARTED|Lead-in (LI) Period 1||0
1686160|NCT00533897|4118788|P5|STARTED|Lead-in (LI) Period 1||0
1686161|NCT00533897|4118789|P4|STARTED|Lead-in (LI) Period 1||0
1686162|NCT00533897|4118790|P3|STARTED|Lead-in (LI) Period 1||0
1686163|NCT00533897|4118791|P2|STARTED|Lead-in (LI) Period 1||0
1686164|NCT00533897|4118792|P1|STARTED|Lead-in (LI) Period 1||167
1686165|NCT00533702|4118932|P2|NOT COMPLETED|Overall Study||2
1686166|NCT00533702|4118933|P1|NOT COMPLETED|Overall Study||5
1686167|NCT00533702|4118932|P2|COMPLETED|Overall Study||50
1686168|NCT00533702|4118933|P1|COMPLETED|Overall Study||49
1686169|NCT00533702|4118932|P2|Received Any Quantity of Study Drug|Overall Study||50
1686170|NCT00533702|4118933|P1|Received Any Quantity of Study Drug|Overall Study||52
1686171|NCT00533702|4118932|P2|STARTED|Overall Study||52
1686172|NCT00533702|4118933|P1|STARTED|Overall Study||54
1686173|NCT00533546|4118957|P1|NOT COMPLETED|Overall Study||0
1686174|NCT00533546|4118957|P1|COMPLETED|Overall Study||12
1686175|NCT00533546|4118957|P1|STARTED|Overall Study||12
1686176|NCT00533507|4118964|P1|NOT COMPLETED|Overall Study||1
1686177|NCT00533507|4118964|P1|COMPLETED|Overall Study||229
1686178|NCT00533507|4118964|P1|STARTED|Overall Study||230
1686179|NCT00533442|4118985|P2|NOT COMPLETED|Follow-up||10
1686180|NCT00533442|4118986|P1|NOT COMPLETED|Follow-up||9
1686181|NCT00533442|4118985|P2|COMPLETED|Follow-up||74
1686182|NCT00533442|4118986|P1|COMPLETED|Follow-up||77
1686183|NCT00533442|4118985|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
1686184|NCT00533442|4118986|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
1686185|NCT00533442|4118985|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
1686186|NCT00533442|4118986|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
1686187|NCT00533442|4118985|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
1686188|NCT00533442|4118986|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
1686189|NCT00533442|4118985|P2|STARTED|Allocation and Intent to Treat Analysis||84
1686190|NCT00533442|4118986|P1|STARTED|Allocation and Intent to Treat Analysis||86
1686191|NCT00533351|4118998|P2|NOT COMPLETED|Period 3||0
1686192|NCT00533351|4118999|P1|NOT COMPLETED|Period 3||0
1686193|NCT00533351|4118998|P2|COMPLETED|Period 3||0
1686194|NCT00533351|4118999|P1|COMPLETED|Period 3||3
1686195|NCT00533351|4118998|P2|STARTED|Period 3|No patients continued to Period 3|0
1686196|NCT00533351|4118999|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
1686197|NCT00533351|4118998|P2|NOT COMPLETED|Period 2||0
1686198|NCT00533351|4118999|P1|NOT COMPLETED|Period 2||0
1686199|NCT00533351|4118998|P2|COMPLETED|Period 2||1
1686200|NCT00533351|4118999|P1|COMPLETED|Period 2||5
1686201|NCT00533351|4118998|P2|STARTED|Period 2||1
1686202|NCT00533351|4118999|P1|STARTED|Period 2||5
1686203|NCT00533351|4118998|P2|NOT COMPLETED|Period 1||1
1686204|NCT00533351|4118999|P1|NOT COMPLETED|Period 1||2
1686205|NCT00533351|4118998|P2|COMPLETED|Period 1||1
1686206|NCT00533351|4118999|P1|COMPLETED|Period 1||5
1686207|NCT00533351|4118998|P2|STARTED|Period 1||2
1686208|NCT00533351|4118999|P1|STARTED|Period 1||7
1686209|NCT00533273|4119009|P2|NOT COMPLETED|Open-label||0
1686210|NCT00533273|4119010|P1|NOT COMPLETED|Open-label||6
1686211|NCT00533273|4119009|P2|COMPLETED|Open-label||0
1686212|NCT00533273|4119010|P1|COMPLETED|Open-label||58
1686213|NCT00533273|4119009|P2|STARTED|Open-label|no placebo - this phase was open label|0
1686214|NCT00533273|4119010|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
1686215|NCT00533273|4119009|P2|NOT COMPLETED|Double-blind||2
1686216|NCT00533273|4119010|P1|NOT COMPLETED|Double-blind||0
1686217|NCT00533273|4119009|P2|COMPLETED|Double-blind||19
1686218|NCT00533273|4119010|P1|COMPLETED|Double-blind||45
1686219|NCT00533273|4119009|P2|STARTED|Double-blind||21
1686220|NCT00533273|4119010|P1|STARTED|Double-blind||45
1686221|NCT00533117|4119045|P4|NOT COMPLETED|Overall Study||5
1686222|NCT00533117|4119046|P3|NOT COMPLETED|Overall Study||6
1686223|NCT00533117|4119047|P2|NOT COMPLETED|Overall Study||5
1686224|NCT00533117|4119048|P1|NOT COMPLETED|Overall Study||4
1686225|NCT00533117|4119045|P4|COMPLETED|Overall Study||13
1686226|NCT00533117|4119046|P3|COMPLETED|Overall Study||14
1686227|NCT00533117|4119047|P2|COMPLETED|Overall Study||14
1686228|NCT00533117|4119048|P1|COMPLETED|Overall Study||14
1686229|NCT00533117|4119045|P4|STARTED|Overall Study||18
1686230|NCT00533117|4119046|P3|STARTED|Overall Study||20
1686231|NCT00533117|4119047|P2|STARTED|Overall Study||19
1686232|NCT00533117|4119048|P1|STARTED|Overall Study||18
1686233|NCT00532948|4119059|P3|NOT COMPLETED|Overall Study||4
1686234|NCT00532948|4119060|P2|NOT COMPLETED|Overall Study||5
1686235|NCT00532948|4119061|P1|NOT COMPLETED|Overall Study||4
1686236|NCT00532948|4119059|P3|COMPLETED|Overall Study||2
1686237|NCT00532948|4119060|P2|COMPLETED|Overall Study||9
1686238|NCT00532948|4119061|P1|COMPLETED|Overall Study||0
1686239|NCT00532948|4119059|P3|STARTED|Overall Study||6
1686240|NCT00532948|4119060|P2|STARTED|Overall Study||14
1686241|NCT00532948|4119061|P1|STARTED|Overall Study||4
1686242|NCT00532935|4119093|P2|NOT COMPLETED|Overall Study||52
1686243|NCT00532935|4119094|P1|NOT COMPLETED|Overall Study||51
1686244|NCT00532935|4119093|P2|COMPLETED|Overall Study||204
1686245|NCT00532935|4119094|P1|COMPLETED|Overall Study||210
1686246|NCT00532935|4119093|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
1686247|NCT00532935|4119094|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
1686248|NCT00532883|4119112|P4|NOT COMPLETED|Overall Study||5
1686249|NCT00532883|4119113|P3|NOT COMPLETED|Overall Study||4
1686250|NCT00532883|4119114|P2|NOT COMPLETED|Overall Study||7
1686251|NCT00532883|4119115|P1|NOT COMPLETED|Overall Study||6
1686252|NCT00532883|4119112|P4|COMPLETED|Overall Study|Study terminated early.|6
1686253|NCT00532883|4119113|P3|COMPLETED|Overall Study|Study terminated early.|6
1686254|NCT00532883|4119114|P2|COMPLETED|Overall Study|Study terminated early.|5
1686255|NCT00532883|4119115|P1|COMPLETED|Overall Study|Study terminated early.|5
1686256|NCT00532883|4119112|P4|STARTED|Overall Study||11
1686257|NCT00532883|4119113|P3|STARTED|Overall Study||10
1686258|NCT00532883|4119114|P2|STARTED|Overall Study||12
1686259|NCT00532883|4119115|P1|STARTED|Overall Study||11
1686260|NCT00532779|4119128|P3|NOT COMPLETED|Overall Study||291
1686261|NCT00532779|4119129|P2|NOT COMPLETED|Overall Study||287
1686262|NCT00532779|4119130|P1|NOT COMPLETED|Overall Study||294
1686263|NCT00532779|4119128|P3|COMPLETED|Overall Study||290
1686264|NCT00532779|4119129|P2|COMPLETED|Overall Study||296
1686265|NCT00532779|4119130|P1|COMPLETED|Overall Study||284
1686266|NCT00532779|4119128|P3|STARTED|Overall Study||581
1686267|NCT00532779|4119129|P2|STARTED|Overall Study||583
1686268|NCT00532779|4119130|P1|STARTED|Overall Study||578
1686269|NCT00532493|4119191|P2|NOT COMPLETED|Overall Study||29
1686270|NCT00532493|4119192|P1|NOT COMPLETED|Overall Study||30
1686271|NCT00532493|4119191|P2|COMPLETED|Overall Study||123
1686272|NCT00532493|4119192|P1|COMPLETED|Overall Study||122
1686273|NCT00532493|4119191|P2|STARTED|Overall Study||152
1686274|NCT00532493|4119192|P1|STARTED|Overall Study||152
1686275|NCT00532480|4119222|P1|NOT COMPLETED|Overall Study||3
1686276|NCT00532480|4119222|P1|COMPLETED|Overall Study||7
1686277|NCT00532480|4119222|P1|STARTED|Overall Study||10
1686278|NCT00532441|4119226|P2|NOT COMPLETED|Overall Study||0
1686279|NCT00532441|4119227|P1|NOT COMPLETED|Overall Study||1
1686280|NCT00532441|4119226|P2|COMPLETED|Overall Study||11
1686281|NCT00532441|4119227|P1|COMPLETED|Overall Study||13
1686282|NCT00532441|4119226|P2|STARTED|Overall Study||11
1686283|NCT00532441|4119227|P1|STARTED|Overall Study||14
1686284|NCT00532298|4119242|P6|NOT COMPLETED|Overall Study||2
1686285|NCT00532298|4119243|P5|NOT COMPLETED|Overall Study||1
1686286|NCT00532298|4119244|P4|NOT COMPLETED|Overall Study||0
1686287|NCT00532298|4119245|P3|NOT COMPLETED|Overall Study||1
1686288|NCT00532298|4119246|P2|NOT COMPLETED|Overall Study||1
1686289|NCT00532298|4119247|P1|NOT COMPLETED|Overall Study||2
1686290|NCT00532298|4119242|P6|COMPLETED|Overall Study||261
1686291|NCT00532298|4119243|P5|COMPLETED|Overall Study||267
1686292|NCT00532298|4119244|P4|COMPLETED|Overall Study||264
1686293|NCT00532298|4119245|P3|COMPLETED|Overall Study||263
1686294|NCT00532298|4119246|P2|COMPLETED|Overall Study||265
1686295|NCT00532298|4119247|P1|COMPLETED|Overall Study||267
1686296|NCT00532298|4119242|P6|STARTED|Overall Study||263
1686297|NCT00532298|4119243|P5|STARTED|Overall Study||268
1686298|NCT00532298|4119244|P4|STARTED|Overall Study||264
1686299|NCT00532298|4119245|P3|STARTED|Overall Study||264
1686300|NCT00532298|4119246|P2|STARTED|Overall Study||266
1686301|NCT00532298|4119247|P1|STARTED|Overall Study||269
1686302|NCT00532259|4119327|P1|NOT COMPLETED|Overall Study||32
1686303|NCT00532259|4119327|P1|COMPLETED|Overall Study||40
1686304|NCT00532259|4119327|P1|STARTED|Overall Study||72
1686305|NCT00532155|4119334|P2|NOT COMPLETED|Overall Study||456
1686306|NCT00532155|4119335|P1|NOT COMPLETED|Overall Study||457
1686307|NCT00532155|4119334|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
1686308|NCT00532155|4119335|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
1686309|NCT00532155|4119334|P2|SAFETY POPULATION|Overall Study||450
1686310|NCT00532155|4119335|P1|SAFETY POPULATION|Overall Study||455
1686311|NCT00532155|4119334|P2|STARTED|Overall Study||456
1686312|NCT00532155|4119335|P1|STARTED|Overall Study||457
1686313|NCT00532129|4119349|P1|NOT COMPLETED|Follow-up Period||65
1686314|NCT00532129|4119349|P1|COMPLETED|Follow-up Period||33
1686315|NCT00532129|4119349|P1|STARTED|Follow-up Period||98
1686316|NCT00532129|4119349|P1|NOT COMPLETED|Treatment Period||49
1686317|NCT00532129|4119349|P1|COMPLETED|Treatment Period||51
1686318|NCT00532129|4119349|P1|STARTED|Treatment Period||100
1686319|NCT00531960|4119369|P2|NOT COMPLETED|Overall Study||63
1686320|NCT00531960|4119370|P1|NOT COMPLETED|Overall Study||61
1686321|NCT00531960|4119369|P2|COMPLETED|Overall Study||0
1686322|NCT00531960|4119370|P1|COMPLETED|Overall Study||0
1686323|NCT00531960|4119369|P2|STARTED|Overall Study||63
1686324|NCT00531960|4119370|P1|STARTED|Overall Study||61
1686325|NCT00531947|4119388|P2|NOT COMPLETED|Overall Study||51
1686326|NCT00531947|4119389|P1|NOT COMPLETED|Overall Study||42
1686327|NCT00531947|4119388|P2|COMPLETED|Overall Study||101
1686328|NCT00531947|4119389|P1|COMPLETED|Overall Study||114
1686329|NCT00531947|4119388|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
1686330|NCT00531947|4119389|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
1686331|NCT00531934|4119433|P2|NOT COMPLETED|Overall Study||63
1686332|NCT00531934|4119434|P1|NOT COMPLETED|Overall Study||66
1686333|NCT00531934|4119433|P2|COMPLETED|Overall Study||11
1686334|NCT00531934|4119434|P1|COMPLETED|Overall Study||7
1686335|NCT00531934|4119433|P2|STARTED|Overall Study||74
1686336|NCT00531934|4119434|P1|STARTED|Overall Study||73
1686337|NCT00531882|4119505|P3|NOT COMPLETED|Overall Study||0
1686338|NCT00531882|4119506|P2|NOT COMPLETED|Overall Study||0
1686339|NCT00531882|4119507|P1|NOT COMPLETED|Overall Study||0
1686340|NCT00531882|4119505|P3|COMPLETED|Overall Study||5
1686341|NCT00531882|4119506|P2|COMPLETED|Overall Study||10
1686342|NCT00531882|4119507|P1|COMPLETED|Overall Study||10
1686343|NCT00531882|4119505|P3|STARTED|Overall Study||5
1686344|NCT00531882|4119506|P2|STARTED|Overall Study||10
1686345|NCT00531882|4119507|P1|STARTED|Overall Study||10
1686346|NCT00531843|4119517|P2|NOT COMPLETED|Overall Study||0
1686347|NCT00531843|4119518|P1|NOT COMPLETED|Overall Study||0
1686348|NCT00531843|4119517|P2|COMPLETED|Overall Study||6
1686349|NCT00531843|4119518|P1|COMPLETED|Overall Study||81
1686350|NCT00531843|4119517|P2|STARTED|Overall Study||6
1686351|NCT00531843|4119518|P1|STARTED|Overall Study||81
1686352|NCT00531817|4119530|P2|NOT COMPLETED|Entered Extended Treatment Period||57
1686353|NCT00531817|4119531|P1|NOT COMPLETED|Entered Extended Treatment Period||137
1686354|NCT00531817|4119530|P2|COMPLETED|Entered Extended Treatment Period||113
1686355|NCT00531817|4119531|P1|COMPLETED|Entered Extended Treatment Period||206
1686356|NCT00531817|4119530|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
1686357|NCT00531817|4119531|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
1686358|NCT00531817|4119530|P2|NOT COMPLETED|Randomized||34
1686359|NCT00531817|4119531|P1|NOT COMPLETED|Randomized||59
1686360|NCT00531817|4119530|P2|COMPLETED|Randomized||173
1686361|NCT00531817|4119531|P1|COMPLETED|Randomized||353
1686362|NCT00531817|4119530|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
1686363|NCT00531817|4119531|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
1686364|NCT00531817|4119530|P2|STARTED|Randomized||207
1686365|NCT00531817|4119531|P1|STARTED|Randomized||412
1686366|NCT00531752|4119562|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
1686367|NCT00531752|4119563|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
1686368|NCT00531752|4119564|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
1686369|NCT00531752|4119565|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
1686370|NCT00531752|4119562|P4|COMPLETED|Second Double-blind Intervention Period||11
1686371|NCT00531752|4119563|P3|COMPLETED|Second Double-blind Intervention Period||9
1686372|NCT00531752|4119564|P2|COMPLETED|Second Double-blind Intervention Period||11
1686373|NCT00531752|4119565|P1|COMPLETED|Second Double-blind Intervention Period||9
1686374|NCT00531752|4119562|P4|STARTED|Second Double-blind Intervention Period||13
1686375|NCT00531752|4119563|P3|STARTED|Second Double-blind Intervention Period||9
1686376|NCT00531752|4119564|P2|STARTED|Second Double-blind Intervention Period||13
1686377|NCT00531752|4119565|P1|STARTED|Second Double-blind Intervention Period||11
1686378|NCT00531752|4119562|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1686379|NCT00531752|4119563|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1686380|NCT00531752|4119564|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1686381|NCT00531752|4119565|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1686382|NCT00531752|4119562|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
1686383|NCT00531752|4119563|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
1686384|NCT00531752|4119564|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
1686385|NCT00531752|4119565|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
1686386|NCT00531752|4119562|P4|STARTED|Wash-out Period (at Least 7 Days)||13
1686387|NCT00531752|4119563|P3|STARTED|Wash-out Period (at Least 7 Days)||9
1686388|NCT00531752|4119564|P2|STARTED|Wash-out Period (at Least 7 Days)||13
1686389|NCT00531752|4119565|P1|STARTED|Wash-out Period (at Least 7 Days)||11
1686390|NCT00531752|4119562|P4|NOT COMPLETED|First Double-blind Intervention Period||3
1686391|NCT00531752|4119563|P3|NOT COMPLETED|First Double-blind Intervention Period||7
1686392|NCT00531752|4119564|P2|NOT COMPLETED|First Double-blind Intervention Period||4
1686393|NCT00531752|4119565|P1|NOT COMPLETED|First Double-blind Intervention Period||6
1686394|NCT00531752|4119562|P4|COMPLETED|First Double-blind Intervention Period||13
1686395|NCT00531752|4119563|P3|COMPLETED|First Double-blind Intervention Period||9
1686396|NCT00531752|4119564|P2|COMPLETED|First Double-blind Intervention Period||13
1686397|NCT00531752|4119565|P1|COMPLETED|First Double-blind Intervention Period||11
1686398|NCT00531752|4119562|P4|Treated|First Double-blind Intervention Period||16
1686399|NCT00531752|4119563|P3|Treated|First Double-blind Intervention Period||16
1686400|NCT00531752|4119564|P2|Treated|First Double-blind Intervention Period||17
1686401|NCT00531752|4119565|P1|Treated|First Double-blind Intervention Period||16
1686402|NCT00531752|4119562|P4|STARTED|First Double-blind Intervention Period||16
1686403|NCT00531752|4119563|P3|STARTED|First Double-blind Intervention Period||16
1686404|NCT00531752|4119564|P2|STARTED|First Double-blind Intervention Period||17
1686405|NCT00531752|4119565|P1|STARTED|First Double-blind Intervention Period||17
1686406|NCT00531661|4119644|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
1686407|NCT00531661|4119645|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
1686408|NCT00531661|4119644|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
1686409|NCT00531661|4119645|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
1686410|NCT00531661|4119644|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
1686411|NCT00531661|4119645|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
1686412|NCT00531661|4119644|P2|NOT COMPLETED|6 Months||26
1686413|NCT00531661|4119645|P1|NOT COMPLETED|6 Months||26
1686414|NCT00531661|4119644|P2|COMPLETED|6 Months||254
1686415|NCT00531661|4119645|P1|COMPLETED|6 Months||244
1686416|NCT00531661|4119644|P2|STARTED|6 Months||280
1686417|NCT00531661|4119645|P1|STARTED|6 Months||270
1686418|NCT00531518|4119667|P2|NOT COMPLETED|Overall Study||71
1686419|NCT00531518|4119668|P1|NOT COMPLETED|Overall Study||32
1686420|NCT00531518|4119667|P2|COMPLETED|Overall Study||134
1686421|NCT00531518|4119668|P1|COMPLETED|Overall Study||55
1686422|NCT00531518|4119667|P2|STARTED|Overall Study||205
1686423|NCT00531518|4119668|P1|STARTED|Overall Study||87
1686424|NCT00531479|4119676|P2|NOT COMPLETED|Overall Study||83
1686425|NCT00531479|4119677|P1|NOT COMPLETED|Overall Study||76
1686426|NCT00531479|4119676|P2|COMPLETED|Overall Study||146
1686427|NCT00531479|4119677|P1|COMPLETED|Overall Study||154
1686428|NCT00531479|4119676|P2|Treated|Overall Study||226
1686429|NCT00531479|4119677|P1|Treated|Overall Study||228
1686430|NCT00531479|4119676|P2|STARTED|Overall Study||229
1686431|NCT00531479|4119677|P1|STARTED|Overall Study||230
1686432|NCT00531453|4119697|P2|NOT COMPLETED|Overall Study||0
1686433|NCT00531453|4119698|P1|NOT COMPLETED|Overall Study||0
1686434|NCT00531453|4119697|P2|COMPLETED|Overall Study|10 April 2009|49
1686435|NCT00531453|4119698|P1|COMPLETED|Overall Study|10 April 2009|49
1686436|NCT00531453|4119697|P2|STARTED|Overall Study|02 October 2007|49
1686437|NCT00531453|4119698|P1|STARTED|Overall Study|02 October 2007|49
1686438|NCT00531427|4119708|P2|NOT COMPLETED|Overall Study||94
1686439|NCT00531427|4119709|P1|NOT COMPLETED|Overall Study||73
1686440|NCT00531427|4119708|P2|COMPLETED|Overall Study||191
1686441|NCT00531427|4119709|P1|COMPLETED|Overall Study||209
1686442|NCT00531427|4119708|P2|STARTED|Overall Study||285
1686443|NCT00531427|4119709|P1|STARTED|Overall Study||282
1686444|NCT00531284|4119737|P17|NOT COMPLETED|Overall Study||8
1686445|NCT00531284|4119738|P16|NOT COMPLETED|Overall Study||12
1686446|NCT00531284|4119739|P15|NOT COMPLETED|Overall Study||4
1686447|NCT00531284|4119740|P14|NOT COMPLETED|Overall Study||3
1686448|NCT00531284|4119741|P13|NOT COMPLETED|Overall Study||2
1686449|NCT00531284|4119742|P12|NOT COMPLETED|Overall Study||24
1686450|NCT00531284|4119743|P11|NOT COMPLETED|Overall Study||3
1686451|NCT00531284|4119744|P10|NOT COMPLETED|Overall Study||4
1686452|NCT00531284|4119745|P9|NOT COMPLETED|Overall Study||11
1686453|NCT00531284|4119746|P8|NOT COMPLETED|Overall Study||10
1686454|NCT00531284|4119747|P7|NOT COMPLETED|Overall Study||6
1686455|NCT00531284|4119748|P6|NOT COMPLETED|Overall Study||7
1686456|NCT00531284|4119749|P5|NOT COMPLETED|Overall Study||6
1686457|NCT00531284|4119750|P4|NOT COMPLETED|Overall Study||63
1686458|NCT00531284|4119751|P3|NOT COMPLETED|Overall Study||6
1686459|NCT00531284|4119752|P2|NOT COMPLETED|Overall Study||4
1686460|NCT00531284|4119753|P1|NOT COMPLETED|Overall Study||3
1686461|NCT00531284|4119737|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686462|NCT00531284|4119738|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
1686463|NCT00531284|4119739|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
1686464|NCT00531284|4119740|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686465|NCT00531284|4119741|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686466|NCT00531284|4119742|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686467|NCT00531284|4119743|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686468|NCT00531284|4119744|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686469|NCT00531284|4119745|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686470|NCT00531284|4119746|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686471|NCT00531284|4119747|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686472|NCT00531284|4119748|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686473|NCT00531284|4119749|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1686474|NCT00531284|4119750|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
1686475|NCT00531284|4119751|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
1686476|NCT00531284|4119752|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
1686477|NCT00531284|4119753|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
1686478|NCT00531284|4119737|P17|STARTED|Overall Study||8
1686479|NCT00531284|4119738|P16|STARTED|Overall Study||14
1686480|NCT00531284|4119739|P15|STARTED|Overall Study||7
1686481|NCT00531284|4119740|P14|STARTED|Overall Study||3
1686482|NCT00531284|4119741|P13|STARTED|Overall Study||2
1686483|NCT00531284|4119742|P12|STARTED|Overall Study||24
1686484|NCT00531284|4119743|P11|STARTED|Overall Study||3
1686485|NCT00531284|4119744|P10|STARTED|Overall Study||4
1686486|NCT00531284|4119745|P9|STARTED|Overall Study||11
1686487|NCT00531284|4119746|P8|STARTED|Overall Study||10
1686488|NCT00531284|4119747|P7|STARTED|Overall Study||6
1686489|NCT00531284|4119748|P6|STARTED|Overall Study||7
1686490|NCT00531284|4119749|P5|STARTED|Overall Study||6
1686491|NCT00531284|4119750|P4|STARTED|Overall Study||65
1686492|NCT00531284|4119751|P3|STARTED|Overall Study||7
1686493|NCT00531284|4119752|P2|STARTED|Overall Study||4
1686494|NCT00531284|4119753|P1|STARTED|Overall Study||3
1686495|NCT00531206|4119903|P1|NOT COMPLETED|Overall Study||20
1686496|NCT00531206|4119903|P1|COMPLETED|Overall Study||45
1686497|NCT00531206|4119903|P1|STARTED|Overall Study||65
1686498|NCT00531050|4119933|P6|NOT COMPLETED|Part 2: Period 3||1
1686499|NCT00531050|4119934|P5|NOT COMPLETED|Part 2: Period 3||0
1686500|NCT00531050|4119935|P4|NOT COMPLETED|Part 2: Period 3||0
1686501|NCT00531050|4119936|P3|NOT COMPLETED|Part 2: Period 3||0
1686502|NCT00531050|4119937|P2|NOT COMPLETED|Part 2: Period 3||0
1686503|NCT00531050|4119938|P1|NOT COMPLETED|Part 2: Period 3||1
1686504|NCT00531050|4119933|P6|COMPLETED|Part 2: Period 3||3
1686505|NCT00531050|4119934|P5|COMPLETED|Part 2: Period 3||4
1686506|NCT00531050|4119935|P4|COMPLETED|Part 2: Period 3||4
1686507|NCT00531050|4119936|P3|COMPLETED|Part 2: Period 3||4
1686508|NCT00531050|4119937|P2|COMPLETED|Part 2: Period 3||4
1686509|NCT00531050|4119938|P1|COMPLETED|Part 2: Period 3||2
1686510|NCT00531050|4119933|P6|STARTED|Part 2: Period 3||4
1686511|NCT00531050|4119934|P5|STARTED|Part 2: Period 3||4
1686512|NCT00531050|4119935|P4|STARTED|Part 2: Period 3||4
1686513|NCT00531050|4119936|P3|STARTED|Part 2: Period 3||4
1686514|NCT00531050|4119937|P2|STARTED|Part 2: Period 3||4
1686515|NCT00531050|4119938|P1|STARTED|Part 2: Period 3||3
1686516|NCT00531050|4119933|P6|NOT COMPLETED|Part 2: Period 2||0
1686517|NCT00531050|4119934|P5|NOT COMPLETED|Part 2: Period 2||0
1686518|NCT00531050|4119935|P4|NOT COMPLETED|Part 2: Period 2||0
1686519|NCT00531050|4119936|P3|NOT COMPLETED|Part 2: Period 2||0
1686520|NCT00531050|4119937|P2|NOT COMPLETED|Part 2: Period 2||0
1686521|NCT00531050|4119938|P1|NOT COMPLETED|Part 2: Period 2||0
1686522|NCT00531050|4119933|P6|COMPLETED|Part 2: Period 2||4
1686523|NCT00531050|4119934|P5|COMPLETED|Part 2: Period 2||4
1686524|NCT00531050|4119935|P4|COMPLETED|Part 2: Period 2||4
1686525|NCT00531050|4119936|P3|COMPLETED|Part 2: Period 2||4
1686526|NCT00531050|4119937|P2|COMPLETED|Part 2: Period 2||4
1686527|NCT00531050|4119938|P1|COMPLETED|Part 2: Period 2||3
1686528|NCT00531050|4119933|P6|STARTED|Part 2: Period 2||4
1686529|NCT00531050|4119934|P5|STARTED|Part 2: Period 2||4
1686530|NCT00531050|4119935|P4|STARTED|Part 2: Period 2||4
1686531|NCT00531050|4119936|P3|STARTED|Part 2: Period 2||4
1686532|NCT00531050|4119937|P2|STARTED|Part 2: Period 2||4
1686533|NCT00531050|4119938|P1|STARTED|Part 2: Period 2||3
1686534|NCT00531050|4119933|P6|NOT COMPLETED|Part 2: Period 1||1
1686535|NCT00531050|4119934|P5|NOT COMPLETED|Part 2: Period 1||0
1686536|NCT00531050|4119935|P4|NOT COMPLETED|Part 2: Period 1||0
1686537|NCT00531050|4119936|P3|NOT COMPLETED|Part 2: Period 1||0
1686538|NCT00531050|4119937|P2|NOT COMPLETED|Part 2: Period 1||0
1686539|NCT00531050|4119938|P1|NOT COMPLETED|Part 2: Period 1||0
1686540|NCT00531050|4119933|P6|COMPLETED|Part 2: Period 1||4
1686541|NCT00531050|4119934|P5|COMPLETED|Part 2: Period 1||4
1686542|NCT00531050|4119935|P4|COMPLETED|Part 2: Period 1||4
1686543|NCT00531050|4119936|P3|COMPLETED|Part 2: Period 1||4
1686544|NCT00531050|4119937|P2|COMPLETED|Part 2: Period 1||4
1686545|NCT00531050|4119938|P1|COMPLETED|Part 2: Period 1||3
1686546|NCT00531050|4119933|P6|STARTED|Part 2: Period 1||5
1686547|NCT00531050|4119934|P5|STARTED|Part 2: Period 1||4
1686548|NCT00531050|4119935|P4|STARTED|Part 2: Period 1||4
1686549|NCT00531050|4119936|P3|STARTED|Part 2: Period 1||4
1686550|NCT00531050|4119937|P2|STARTED|Part 2: Period 1||4
1686551|NCT00531050|4119938|P1|STARTED|Part 2: Period 1||3
1686552|NCT00531050|4119933|P6|NOT COMPLETED|Part 1: Period 3||0
1686553|NCT00531050|4119934|P5|NOT COMPLETED|Part 1: Period 3||0
1686554|NCT00531050|4119935|P4|NOT COMPLETED|Part 1: Period 3||0
1686555|NCT00531050|4119936|P3|NOT COMPLETED|Part 1: Period 3||0
1686556|NCT00531050|4119937|P2|NOT COMPLETED|Part 1: Period 3||0
1686557|NCT00531050|4119938|P1|NOT COMPLETED|Part 1: Period 3||1
1686558|NCT00531050|4119933|P6|COMPLETED|Part 1: Period 3||5
1686559|NCT00531050|4119934|P5|COMPLETED|Part 1: Period 3||4
1686560|NCT00531050|4119935|P4|COMPLETED|Part 1: Period 3||4
1686561|NCT00531050|4119936|P3|COMPLETED|Part 1: Period 3||4
1686562|NCT00531050|4119937|P2|COMPLETED|Part 1: Period 3||4
1686563|NCT00531050|4119938|P1|COMPLETED|Part 1: Period 3||3
1686564|NCT00531050|4119933|P6|STARTED|Part 1: Period 3||5
1686565|NCT00531050|4119934|P5|STARTED|Part 1: Period 3||4
1686566|NCT00531050|4119935|P4|STARTED|Part 1: Period 3||4
1686567|NCT00531050|4119936|P3|STARTED|Part 1: Period 3||4
1686568|NCT00531050|4119937|P2|STARTED|Part 1: Period 3||4
1686569|NCT00531050|4119938|P1|STARTED|Part 1: Period 3||4
1686570|NCT00531050|4119933|P6|NOT COMPLETED|Part 1: Period 2||0
1686571|NCT00531050|4119934|P5|NOT COMPLETED|Part 1: Period 2||0
1686572|NCT00531050|4119935|P4|NOT COMPLETED|Part 1: Period 2||0
1686573|NCT00531050|4119936|P3|NOT COMPLETED|Part 1: Period 2||0
1686574|NCT00531050|4119937|P2|NOT COMPLETED|Part 1: Period 2||0
1686575|NCT00531050|4119938|P1|NOT COMPLETED|Part 1: Period 2||0
1686576|NCT00531050|4119933|P6|COMPLETED|Part 1: Period 2||5
1686577|NCT00531050|4119934|P5|COMPLETED|Part 1: Period 2||4
1686578|NCT00531050|4119935|P4|COMPLETED|Part 1: Period 2||4
1686579|NCT00531050|4119936|P3|COMPLETED|Part 1: Period 2||4
1686580|NCT00531050|4119937|P2|COMPLETED|Part 1: Period 2||4
1686581|NCT00531050|4119938|P1|COMPLETED|Part 1: Period 2||4
1686582|NCT00531050|4119933|P6|STARTED|Part 1: Period 2||5
1686583|NCT00531050|4119934|P5|STARTED|Part 1: Period 2||4
1686584|NCT00531050|4119935|P4|STARTED|Part 1: Period 2||4
1686585|NCT00531050|4119936|P3|STARTED|Part 1: Period 2||4
1686586|NCT00531050|4119937|P2|STARTED|Part 1: Period 2||4
1686587|NCT00531050|4119938|P1|STARTED|Part 1: Period 2||4
1686588|NCT00531050|4119933|P6|NOT COMPLETED|Part 1: Period 1||0
1686589|NCT00531050|4119934|P5|NOT COMPLETED|Part 1: Period 1||0
1686590|NCT00531050|4119935|P4|NOT COMPLETED|Part 1: Period 1||1
1686591|NCT00531050|4119936|P3|NOT COMPLETED|Part 1: Period 1||0
1686592|NCT00531050|4119937|P2|NOT COMPLETED|Part 1: Period 1||1
1686593|NCT00531050|4119938|P1|NOT COMPLETED|Part 1: Period 1||0
1686594|NCT00531050|4119933|P6|COMPLETED|Part 1: Period 1||5
1686595|NCT00531050|4119934|P5|COMPLETED|Part 1: Period 1||4
1686596|NCT00531050|4119935|P4|COMPLETED|Part 1: Period 1||4
1686597|NCT00531050|4119936|P3|COMPLETED|Part 1: Period 1||4
1686598|NCT00531050|4119937|P2|COMPLETED|Part 1: Period 1||4
1686599|NCT00531050|4119938|P1|COMPLETED|Part 1: Period 1||4
1686600|NCT00531050|4119933|P6|STARTED|Part 1: Period 1||5
1686601|NCT00531050|4119934|P5|STARTED|Part 1: Period 1||4
1686602|NCT00531050|4119935|P4|STARTED|Part 1: Period 1||5
1686603|NCT00531050|4119936|P3|STARTED|Part 1: Period 1||4
1686604|NCT00531050|4119937|P2|STARTED|Part 1: Period 1||5
1686605|NCT00531050|4119938|P1|STARTED|Part 1: Period 1||4
1686606|NCT00531011|4119967|P2|NOT COMPLETED|Overall Study||7
1686607|NCT00531011|4119968|P1|NOT COMPLETED|Overall Study||4
1686608|NCT00531011|4119967|P2|COMPLETED|Overall Study||90
1686609|NCT00531011|4119968|P1|COMPLETED|Overall Study||99
1686610|NCT00531011|4119967|P2|STARTED|Overall Study||97
1686611|NCT00531011|4119968|P1|STARTED|Overall Study||103
1686612|NCT00530946|4120014|P4|NOT COMPLETED|Overall Study||2
1686613|NCT00530946|4120015|P3|NOT COMPLETED|Overall Study||1
1686614|NCT00530946|4120016|P2|NOT COMPLETED|Overall Study||2
1686615|NCT00530946|4120017|P1|NOT COMPLETED|Overall Study||2
1686616|NCT00530946|4120014|P4|COMPLETED|Overall Study||38
1686617|NCT00530946|4120015|P3|COMPLETED|Overall Study||40
1686618|NCT00530946|4120016|P2|COMPLETED|Overall Study||39
1686619|NCT00530946|4120017|P1|COMPLETED|Overall Study||41
1686620|NCT00530946|4120014|P4|STARTED|Overall Study||40
1686621|NCT00530946|4120015|P3|STARTED|Overall Study||41
1686622|NCT00530946|4120016|P2|STARTED|Overall Study||41
1686623|NCT00530946|4120017|P1|STARTED|Overall Study||43
1686624|NCT00530920|4120070|P3|NOT COMPLETED|Overall Study||4
1686625|NCT00530920|4120071|P2|NOT COMPLETED|Overall Study||2
1686626|NCT00530920|4120072|P1|NOT COMPLETED|Overall Study||0
1686627|NCT00530920|4120070|P3|COMPLETED|Overall Study||24
1686628|NCT00530920|4120071|P2|COMPLETED|Overall Study||25
1686629|NCT00530920|4120072|P1|COMPLETED|Overall Study||30
1686630|NCT00530920|4120070|P3|STARTED|Overall Study||28
1686631|NCT00530920|4120071|P2|STARTED|Overall Study||27
1686632|NCT00530920|4120072|P1|STARTED|Overall Study||30
1686633|NCT00530894|4120132|P4|NOT COMPLETED|Overall Study||94
1686634|NCT00530894|4120133|P3|NOT COMPLETED|Overall Study||55
1686635|NCT00530894|4120134|P2|NOT COMPLETED|Overall Study||115
1686636|NCT00530894|4120135|P1|NOT COMPLETED|Overall Study||88
1686637|NCT00530894|4120132|P4|COMPLETED|Overall Study||85
1686638|NCT00530894|4120133|P3|COMPLETED|Overall Study||124
1686639|NCT00530894|4120134|P2|COMPLETED|Overall Study||236
1686640|NCT00530894|4120135|P1|COMPLETED|Overall Study||260
1686641|NCT00530894|4120132|P4|STARTED|Overall Study||179
1686642|NCT00530894|4120133|P3|STARTED|Overall Study||179
1686643|NCT00530894|4120134|P2|STARTED|Overall Study||351
1686644|NCT00530894|4120135|P1|STARTED|Overall Study||348
1686645|NCT00530855|4120163|P1|NOT COMPLETED|Overall Study||112
1686646|NCT00530855|4120163|P1|COMPLETED|Overall Study||210
1686647|NCT00530855|4120163|P1|STARTED|Overall Study||322
1686648|NCT00530842|4120172|P2|NOT COMPLETED|Period 2||9
1686649|NCT00530842|4120173|P1|NOT COMPLETED|Period 2||8
1686650|NCT00530842|4120172|P2|COMPLETED|Period 2||151
1686651|NCT00530842|4120173|P1|COMPLETED|Period 2||149
1686652|NCT00530842|4120172|P2|STARTED|Period 2||160
1686653|NCT00530842|4120173|P1|STARTED|Period 2||157
1686654|NCT00530842|4120172|P2|NOT COMPLETED|Period 1||11
1686655|NCT00530842|4120173|P1|NOT COMPLETED|Period 1||14
1686656|NCT00530842|4120172|P2|COMPLETED|Period 1||161
1686657|NCT00530842|4120173|P1|COMPLETED|Period 1||158
1686658|NCT00530842|4120172|P2|STARTED|Period 1||172
1686659|NCT00530842|4120173|P1|STARTED|Period 1||172
1686660|NCT00530842|4120172|P2|NOT COMPLETED|Overall Study||21
1686661|NCT00530842|4120173|P1|NOT COMPLETED|Overall Study||23
1686662|NCT00530842|4120172|P2|COMPLETED|Overall Study||151
1686663|NCT00530842|4120173|P1|COMPLETED|Overall Study||149
1686664|NCT00530842|4120172|P2|STARTED|Overall Study||172
1686665|NCT00530842|4120173|P1|STARTED|Overall Study||172
1686666|NCT00530816|4120300|P3|NOT COMPLETED|Overall Study||41
1686667|NCT00530816|4120301|P2|NOT COMPLETED|Overall Study||42
1686668|NCT00530816|4120302|P1|NOT COMPLETED|Overall Study||26
1686669|NCT00530816|4120300|P3|COMPLETED|Overall Study||29
1686670|NCT00530816|4120301|P2|COMPLETED|Overall Study||17
1686671|NCT00530816|4120302|P1|COMPLETED|Overall Study||9
1686672|NCT00530816|4120300|P3|STARTED|Overall Study||70
1686673|NCT00530816|4120301|P2|STARTED|Overall Study||59
1686674|NCT00530816|4120302|P1|STARTED|Overall Study||35
1686675|NCT00530803|4120330|P2|NOT COMPLETED|Overall Study||0
1686676|NCT00530803|4120331|P1|NOT COMPLETED|Overall Study||0
1686677|NCT00530803|4120330|P2|COMPLETED|Overall Study||50
1686678|NCT00530803|4120331|P1|COMPLETED|Overall Study||50
1686679|NCT00530803|4120330|P2|STARTED|Overall Study||50
1686680|NCT00530803|4120331|P1|STARTED|Overall Study||50
1686681|NCT00530790|4120345|P1|NOT COMPLETED|Overall Study||5
1686682|NCT00530790|4120345|P1|COMPLETED|Overall Study||30
1686683|NCT00530790|4120345|P1|STARTED|Overall Study||35
1686684|NCT00530777|4120367|P2|NOT COMPLETED|Overall Study||5
1686685|NCT00530777|4120368|P1|NOT COMPLETED|Overall Study||7
1686686|NCT00530777|4120367|P2|COMPLETED|Overall Study||69
1686687|NCT00530777|4120368|P1|COMPLETED|Overall Study||67
1686688|NCT00530777|4120367|P2|STARTED|Overall Study||74
1686689|NCT00530777|4120368|P1|STARTED|Overall Study||74
1686690|NCT00530764|4120380|P4|NOT COMPLETED|Overall Study||25
1686691|NCT00530764|4120381|P3|NOT COMPLETED|Overall Study||20
1686692|NCT00530764|4120382|P2|NOT COMPLETED|Overall Study||21
1686693|NCT00530764|4120383|P1|NOT COMPLETED|Overall Study||31
1686694|NCT00530764|4120380|P4|COMPLETED|Overall Study||66
1686695|NCT00530764|4120381|P3|COMPLETED|Overall Study||71
1686696|NCT00530764|4120382|P2|COMPLETED|Overall Study||67
1686697|NCT00530764|4120383|P1|COMPLETED|Overall Study||59
1686698|NCT00530764|4120380|P4|STARTED|Overall Study||91
1686699|NCT00530764|4120381|P3|STARTED|Overall Study||91
1686700|NCT00530764|4120382|P2|STARTED|Overall Study||88
1686701|NCT00530764|4120383|P1|STARTED|Overall Study||90
1686702|NCT00530712|4120425|P1|NOT COMPLETED|12 Month Follow-up Visit||24
1686703|NCT00530712|4120425|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
1686704|NCT00530712|4120425|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
1686705|NCT00530712|4120425|P1|NOT COMPLETED|6 Month Follow-up Visit||12
1686706|NCT00530712|4120425|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
1686707|NCT00530712|4120425|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
1686708|NCT00530712|4120425|P1|NOT COMPLETED|30 Day Follow-up Visit||7
1686709|NCT00530712|4120425|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
1686710|NCT00530712|4120425|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
1686711|NCT00530712|4120425|P1|NOT COMPLETED|Enrollment||0
1686712|NCT00530712|4120425|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
1686713|NCT00530712|4120425|P1|STARTED|Enrollment|Total Enrolled Subjects|287
1686714|NCT00530634|4120440|P1|NOT COMPLETED|Overall Study||0
1686715|NCT00530634|4120440|P1|COMPLETED|Overall Study||3
1686716|NCT00530634|4120440|P1|STARTED|Overall Study||3
1686717|NCT00530504|4120444|P1|NOT COMPLETED|Overall Study||152
1686718|NCT00530504|4120444|P1|COMPLETED|Overall Study||1348
1686719|NCT00530504|4120444|P1|STARTED|Overall Study||1500
1686720|NCT00530439|4120450|P2|NOT COMPLETED|Overall Study||26
1686721|NCT00530439|4120451|P1|NOT COMPLETED|Overall Study||30
1686722|NCT00530439|4120450|P2|COMPLETED|Overall Study||154
1686723|NCT00530439|4120451|P1|COMPLETED|Overall Study||150
1686724|NCT00530439|4120450|P2|STARTED|Overall Study||180
1686725|NCT00530439|4120451|P1|STARTED|Overall Study||180
1686726|NCT00530348|4120459|P2|NOT COMPLETED|Overall Study||19
1686727|NCT00530348|4120460|P1|NOT COMPLETED|Overall Study||22
1686728|NCT00530348|4120459|P2|COMPLETED|Overall Study||367
1686729|NCT00530348|4120460|P1|COMPLETED|Overall Study||173
1686730|NCT00530348|4120459|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
1686731|NCT00530348|4120460|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
1686732|NCT00530348|4120459|P2|STARTED|Overall Study|Randomized.|386
1686733|NCT00530348|4120460|P1|STARTED|Overall Study|Randomized.|195
1686734|NCT00530335|4120476|P1|NOT COMPLETED|Overall Study||6
1686735|NCT00530335|4120476|P1|COMPLETED|Overall Study||39
1686736|NCT00530335|4120476|P1|STARTED|Overall Study||45
1686737|NCT00530270|4120493|P2|NOT COMPLETED|Overall Study||0
1686738|NCT00530270|4120494|P1|NOT COMPLETED|Overall Study||1
1686739|NCT00530270|4120493|P2|COMPLETED|Overall Study||6
1686740|NCT00530270|4120494|P1|COMPLETED|Overall Study||5
1686741|NCT00530270|4120493|P2|STARTED|Overall Study||6
1686742|NCT00530270|4120494|P1|STARTED|Overall Study||6
1686743|NCT00530257|4120508|P1|NOT COMPLETED|Overall Study||1
1686744|NCT00530257|4120508|P1|COMPLETED|Overall Study||30
1686745|NCT00530257|4120508|P1|STARTED|Overall Study||31
1686746|NCT00530218|4120536|P1|NOT COMPLETED|Overall Study||25
1686747|NCT00530218|4120536|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
1686748|NCT00530218|4120536|P1|STARTED|Overall Study||61
1686749|NCT00530088|4120543|P1|NOT COMPLETED|Overall Study||10
1686750|NCT00530088|4120543|P1|COMPLETED|Overall Study||20
1686751|NCT00530088|4120543|P1|STARTED|Overall Study||30
1686752|NCT00530075|4120548|P1|NOT COMPLETED|Overall Study||7
1686753|NCT00530075|4120548|P1|COMPLETED|Overall Study||38
1686754|NCT00530075|4120548|P1|STARTED|Overall Study||45
1686755|NCT00530023|4120561|P2|NOT COMPLETED|Overall Study||1
1686756|NCT00530023|4120562|P1|NOT COMPLETED|Overall Study||0
1686757|NCT00530023|4120561|P2|COMPLETED|Overall Study||14
1686758|NCT00530023|4120562|P1|COMPLETED|Overall Study||14
1686759|NCT00530023|4120561|P2|STARTED|Overall Study||15
1686760|NCT00530023|4120562|P1|STARTED|Overall Study||14
1686761|NCT00529802|4120576|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
1686762|NCT00529802|4120576|P1|COMPLETED|Evaluable for Secondary Endpoint||48
1686763|NCT00529802|4120576|P1|STARTED|Evaluable for Secondary Endpoint||50
1686764|NCT00529802|4120576|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
1686765|NCT00529802|4120576|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
1686766|NCT00529802|4120576|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
1686767|NCT00529789|4120582|P1|NOT COMPLETED|Study Period IV||6
1686768|NCT00529789|4120582|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
1686769|NCT00529789|4120582|P1|STARTED|Study Period IV||48
1686770|NCT00529789|4120582|P1|NOT COMPLETED|Study Period II/III||24
1686771|NCT00529789|4120582|P1|COMPLETED|Study Period II/III||48
1686772|NCT00529789|4120582|P1|STARTED|Study Period II/III||72
1686773|NCT00529763|4120607|P3|NOT COMPLETED|Overall Study||7
1686774|NCT00529763|4120608|P2|NOT COMPLETED|Overall Study||33
1686775|NCT00529763|4120609|P1|NOT COMPLETED|Overall Study||10
1686776|NCT00529763|4120607|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
1686777|NCT00529763|4120608|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
1686778|NCT00529763|4120609|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
1686779|NCT00529763|4120607|P3|STARTED|Overall Study||59
1686780|NCT00529763|4120608|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
1686781|NCT00529763|4120609|P1|STARTED|Overall Study||25
1686782|NCT00529659|4120647|P2|NOT COMPLETED|Overall Study||23
1686783|NCT00529659|4120648|P1|NOT COMPLETED|Overall Study||11
1686784|NCT00529659|4120647|P2|COMPLETED|Overall Study||66
1686785|NCT00529659|4120648|P1|COMPLETED|Overall Study||70
1686786|NCT00529659|4120647|P2|STARTED|Overall Study||89
1686787|NCT00529659|4120648|P1|STARTED|Overall Study||81
1686788|NCT00529633|4120666|P2|NOT COMPLETED|Overall Study||1
1686789|NCT00529633|4120667|P1|NOT COMPLETED|Overall Study||1
1686790|NCT00529633|4120666|P2|COMPLETED|Overall Study||1
1686791|NCT00529633|4120667|P1|COMPLETED|Overall Study||1
1686792|NCT00529633|4120666|P2|STARTED|Overall Study||2
1686793|NCT00529633|4120667|P1|STARTED|Overall Study||2
1686794|NCT00529568|4120679|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
1686795|NCT00529568|4120680|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
1686796|NCT00529568|4120681|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
1686797|NCT00529568|4120679|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
1686798|NCT00529568|4120680|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
1686799|NCT00529568|4120681|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
1686800|NCT00529568|4120679|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
1686801|NCT00529568|4120680|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
1686802|NCT00529568|4120681|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
1686803|NCT00529568|4120679|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1686804|NCT00529568|4120680|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1686805|NCT00529568|4120681|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
1686806|NCT00529568|4120679|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1686807|NCT00529568|4120680|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1686808|NCT00529568|4120681|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
1686809|NCT00529568|4120679|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
1686810|NCT00529568|4120680|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
1686811|NCT00529568|4120681|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
1686812|NCT00529555|4120732|P3|NOT COMPLETED|Overall Study||26
1686813|NCT00529555|4120733|P2|NOT COMPLETED|Overall Study||30
1686814|NCT00529555|4120734|P1|NOT COMPLETED|Overall Study||29
1686815|NCT00529555|4120732|P3|COMPLETED|Overall Study||174
1686816|NCT00529555|4120733|P2|COMPLETED|Overall Study||172
1686817|NCT00529555|4120734|P1|COMPLETED|Overall Study||171
1686818|NCT00529555|4120732|P3|STARTED|Overall Study||200
1686819|NCT00529555|4120733|P2|STARTED|Overall Study||202
1686820|NCT00529555|4120734|P1|STARTED|Overall Study||200
1686821|NCT00529542|4120744|P2|NOT COMPLETED|Overall Study||1
1686822|NCT00529542|4120745|P1|NOT COMPLETED|Overall Study||1
1686823|NCT00529542|4120744|P2|COMPLETED|Overall Study||10
1686824|NCT00529542|4120745|P1|COMPLETED|Overall Study||8
1686825|NCT00529542|4120744|P2|STARTED|Overall Study||11
1686826|NCT00529542|4120745|P1|STARTED|Overall Study||9
1686827|NCT00529529|4120788|P3|NOT COMPLETED|Overall Study||31
1686828|NCT00529529|4120789|P2|NOT COMPLETED|Overall Study||43
1686829|NCT00529529|4120790|P1|NOT COMPLETED|Overall Study||43
1686830|NCT00529529|4120788|P3|COMPLETED|Overall Study||238
1686831|NCT00529529|4120789|P2|COMPLETED|Overall Study||225
1686832|NCT00529529|4120790|P1|COMPLETED|Overall Study||225
1686833|NCT00529529|4120788|P3|STARTED|Overall Study||269
1686834|NCT00529529|4120789|P2|STARTED|Overall Study||268
1686835|NCT00529529|4120790|P1|STARTED|Overall Study||268
1686836|NCT00529516|4120849|P3|NOT COMPLETED|Overall Study||1
1686837|NCT00529516|4120850|P2|NOT COMPLETED|Overall Study||2
1686838|NCT00529516|4120851|P1|NOT COMPLETED|Overall Study||3
1686839|NCT00529516|4120849|P3|COMPLETED|Overall Study||288
1686840|NCT00529516|4120850|P2|COMPLETED|Overall Study||486
1686841|NCT00529516|4120851|P1|COMPLETED|Overall Study||472
1686842|NCT00529516|4120849|P3|STARTED|Overall Study||289
1686843|NCT00529516|4120850|P2|STARTED|Overall Study||488
1686844|NCT00529516|4120851|P1|STARTED|Overall Study||475
1686845|NCT00529464|4120922|P3|NOT COMPLETED|Overall Study||0
1686846|NCT00529464|4120923|P2|NOT COMPLETED|Overall Study||0
1686847|NCT00529464|4120924|P1|NOT COMPLETED|Overall Study||0
1686848|NCT00529464|4120922|P3|COMPLETED|Overall Study||0
1686849|NCT00529464|4120923|P2|COMPLETED|Overall Study||0
1686850|NCT00529464|4120924|P1|COMPLETED|Overall Study||0
1686851|NCT00529464|4120922|P3|STARTED|Overall Study||0
1686852|NCT00529464|4120923|P2|STARTED|Overall Study||0
1686853|NCT00529464|4120924|P1|STARTED|Overall Study||0
1686854|NCT00529451|4120936|P4|NOT COMPLETED|Overall Study||31
1686855|NCT00529451|4120937|P3|NOT COMPLETED|Overall Study||40
1686856|NCT00529451|4120938|P2|NOT COMPLETED|Overall Study||48
1686857|NCT00529451|4120939|P1|NOT COMPLETED|Overall Study||37
1686858|NCT00529451|4120936|P4|COMPLETED|Overall Study||299
1686859|NCT00529451|4120937|P3|COMPLETED|Overall Study||292
1686860|NCT00529451|4120938|P2|COMPLETED|Overall Study||275
1686861|NCT00529451|4120939|P1|COMPLETED|Overall Study||294
1686862|NCT00529451|4120936|P4|STARTED|Overall Study||330
1686863|NCT00529451|4120937|P3|STARTED|Overall Study||332
1686864|NCT00529451|4120938|P2|STARTED|Overall Study||323
1686865|NCT00529451|4120939|P1|STARTED|Overall Study||331
1686866|NCT00529399|4120966|P3|NOT COMPLETED|Overall Study||2
1686867|NCT00529399|4120967|P2|NOT COMPLETED|Overall Study||1
1686868|NCT00529399|4120968|P1|NOT COMPLETED|Overall Study||2
1686869|NCT00529399|4120966|P3|COMPLETED|Overall Study||46
1686870|NCT00529399|4120967|P2|COMPLETED|Overall Study||48
1686871|NCT00529399|4120968|P1|COMPLETED|Overall Study||46
1686872|NCT00529399|4120966|P3|STARTED|Overall Study||48
1686873|NCT00529399|4120967|P2|STARTED|Overall Study||49
1686874|NCT00529399|4120968|P1|STARTED|Overall Study||48
1686875|NCT00529308|4120978|P2|NOT COMPLETED|Overall Study||1
1686876|NCT00529308|4120979|P1|NOT COMPLETED|Overall Study||1
1686877|NCT00529308|4120978|P2|COMPLETED|Overall Study||10
1686878|NCT00529308|4120979|P1|COMPLETED|Overall Study||8
1686879|NCT00529308|4120978|P2|STARTED|Overall Study||11
1686880|NCT00529308|4120979|P1|STARTED|Overall Study||9
1686881|NCT00529282|4120995|P2|NOT COMPLETED|Overall Study||0
1686882|NCT00529282|4120996|P1|NOT COMPLETED|Overall Study||0
1686883|NCT00529282|4120995|P2|COMPLETED|Overall Study||2
1686884|NCT00529282|4120996|P1|COMPLETED|Overall Study||0
1686885|NCT00529282|4120995|P2|STARTED|Overall Study||2
1686886|NCT00529282|4120996|P1|STARTED|Overall Study||0
1686887|NCT00529243|4121008|P1|NOT COMPLETED|Overall Study||3
1686888|NCT00529243|4121008|P1|COMPLETED|Overall Study||49
1686889|NCT00529243|4121008|P1|STARTED|Overall Study||52
1686890|NCT00529217|4121013|P1|NOT COMPLETED|Overall Study||4
1686891|NCT00529217|4121013|P1|COMPLETED|Overall Study||8
1686892|NCT00529217|4121013|P1|STARTED|Overall Study||12
1686893|NCT00529204|4121018|P1|NOT COMPLETED|Overall Study||0
1686894|NCT00529204|4121018|P1|COMPLETED|Overall Study||1
1686895|NCT00529204|4121018|P1|STARTED|Overall Study||1
1686896|NCT00529191|4121026|P2|NOT COMPLETED|Overall Study||0
1686897|NCT00529191|4121027|P1|NOT COMPLETED|Overall Study||3
1686898|NCT00529191|4121026|P2|COMPLETED|Overall Study||13
1686899|NCT00529191|4121027|P1|COMPLETED|Overall Study||24
1686900|NCT00529191|4121026|P2|STARTED|Overall Study||13
1686901|NCT00529191|4121027|P1|STARTED|Overall Study||27
1686902|NCT00529152|4121049|P1|NOT COMPLETED|Overall Study||5
1686903|NCT00529152|4121049|P1|COMPLETED|Overall Study||95
1686904|NCT00529152|4121049|P1|STARTED|Overall Study||100
1686905|NCT00529126|4121057|P4|NOT COMPLETED|Overall Study||0
1686906|NCT00529126|4121058|P3|NOT COMPLETED|Overall Study||0
1686907|NCT00529126|4121059|P2|NOT COMPLETED|Overall Study||0
1686908|NCT00529126|4121060|P1|NOT COMPLETED|Overall Study||0
1686909|NCT00529126|4121057|P4|COMPLETED|Overall Study||26
1686910|NCT00529126|4121058|P3|COMPLETED|Overall Study||24
1686911|NCT00529126|4121059|P2|COMPLETED|Overall Study||25
1686912|NCT00529126|4121060|P1|COMPLETED|Overall Study||25
1686913|NCT00529126|4121057|P4|STARTED|Overall Study||26
1686914|NCT00529126|4121058|P3|STARTED|Overall Study||24
1686915|NCT00529126|4121059|P2|STARTED|Overall Study||25
1686916|NCT00529126|4121060|P1|STARTED|Overall Study||25
1686917|NCT00529100|4121073|P2|NOT COMPLETED|Overall Study||9
1686918|NCT00529100|4121074|P1|NOT COMPLETED|Overall Study||0
1686919|NCT00529100|4121073|P2|COMPLETED|Overall Study||24
1686920|NCT00529100|4121074|P1|COMPLETED|Overall Study||16
1686921|NCT00529100|4121073|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
1686922|NCT00529100|4121074|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
1686923|NCT00529100|4121073|P2|STARTED|Overall Study||33
1686924|NCT00529100|4121074|P1|STARTED|Overall Study||16
1686925|NCT00529087|4121091|P3|NOT COMPLETED|Overall Study||16
1686926|NCT00529087|4121092|P2|NOT COMPLETED|Overall Study||28
1686927|NCT00529087|4121093|P1|NOT COMPLETED|Overall Study||28
1686928|NCT00529087|4121091|P3|COMPLETED|Overall Study||146
1686929|NCT00529087|4121092|P2|COMPLETED|Overall Study||120
1686930|NCT00529087|4121093|P1|COMPLETED|Overall Study||122
1686931|NCT00529087|4121091|P3|STARTED|Overall Study||162
1686932|NCT00529087|4121092|P2|STARTED|Overall Study||148
1686933|NCT00529087|4121093|P1|STARTED|Overall Study||150
1686934|NCT00529035|4121157|P1|NOT COMPLETED|Overall Study||1
1686935|NCT00529035|4121157|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
1686936|NCT00529035|4121157|P1|STARTED|Overall Study|29 enrolled|29
1686937|NCT00528957|4121170|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
1686938|NCT00528957|4121171|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
1686939|NCT00528957|4121170|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
1686940|NCT00528957|4121171|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
1686941|NCT00528957|4121170|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
1686942|NCT00528957|4121171|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
1686943|NCT00528957|4121170|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
1686944|NCT00528957|4121171|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
1686945|NCT00528957|4121170|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
1686946|NCT00528957|4121171|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
1686947|NCT00528957|4121170|P2|STARTED|Third Extension (Week 240 to Week 336)||37
1686948|NCT00528957|4121171|P1|STARTED|Third Extension (Week 240 to Week 336)||27
1686949|NCT00528957|4121170|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
1686950|NCT00528957|4121171|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
1686951|NCT00528957|4121170|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
1686952|NCT00528957|4121171|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
1686953|NCT00528957|4121170|P2|STARTED|Second Extension (Week 144 to Week 240)||40
1686954|NCT00528957|4121171|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
1686955|NCT00528957|4121170|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
1686956|NCT00528957|4121171|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
1686957|NCT00528957|4121170|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
1686958|NCT00528957|4121171|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
1687040|NCT00528567|4121486|P1|STARTED|Overall Study||1301
1686959|NCT00528957|4121170|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
1686960|NCT00528957|4121171|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
1686961|NCT00528957|4121170|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
1686962|NCT00528957|4121171|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
1686963|NCT00528957|4121170|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
1686964|NCT00528957|4121171|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
1686965|NCT00528957|4121170|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
1686966|NCT00528957|4121171|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
1686967|NCT00528931|4121312|P1|NOT COMPLETED|Overall Study||1
1686968|NCT00528931|4121312|P1|COMPLETED|Overall Study||15
1686969|NCT00528931|4121312|P1|STARTED|Overall Study||16
1686970|NCT00528879|4121324|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
1686971|NCT00528879|4121325|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
1686972|NCT00528879|4121326|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
1686973|NCT00528879|4121327|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
1686974|NCT00528879|4121324|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
1686975|NCT00528879|4121325|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
1686976|NCT00528879|4121326|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
1686977|NCT00528879|4121327|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
1686978|NCT00528879|4121324|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
1686979|NCT00528879|4121325|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
1686980|NCT00528879|4121326|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
1686981|NCT00528879|4121327|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
1686982|NCT00528879|4121324|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
1686983|NCT00528879|4121325|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
1686984|NCT00528879|4121326|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
1686985|NCT00528879|4121327|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
1686986|NCT00528879|4121324|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
1686987|NCT00528879|4121325|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
1686988|NCT00528879|4121326|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
1686989|NCT00528879|4121327|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
1686990|NCT00528879|4121324|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
1686991|NCT00528879|4121325|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
1686992|NCT00528879|4121326|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
1686993|NCT00528879|4121327|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
1686994|NCT00528879|4121324|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
1686995|NCT00528879|4121325|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
1686996|NCT00528879|4121326|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
1686997|NCT00528879|4121327|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
1686998|NCT00528866|4121393|P1|NOT COMPLETED|Overall Study||6
1686999|NCT00528866|4121393|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
1687000|NCT00528866|4121393|P1|STARTED|Overall Study||80
1687001|NCT00528840|4121405|P1|NOT COMPLETED|Overall Study||33
1687002|NCT00528840|4121405|P1|COMPLETED|Overall Study||168
1687003|NCT00528840|4121405|P1|STARTED|Overall Study||201
1687004|NCT00528801|4121419|P2|NOT COMPLETED|Overall Study||11
1687005|NCT00528801|4121420|P1|NOT COMPLETED|Overall Study||27
1687006|NCT00528801|4121419|P2|COMPLETED|Overall Study||41
1687007|NCT00528801|4121420|P1|COMPLETED|Overall Study||133
1687008|NCT00528801|4121419|P2|STARTED|Overall Study||52
1687009|NCT00528801|4121420|P1|STARTED|Overall Study||160
1687010|NCT00528788|4121430|P1|NOT COMPLETED|Overall Study||4
1687011|NCT00528788|4121430|P1|COMPLETED|Overall Study||20
1687012|NCT00528788|4121430|P1|STARTED|Overall Study||24
1687013|NCT00528775|4121434|P1|NOT COMPLETED|Overall Study||1
1687014|NCT00528775|4121434|P1|COMPLETED|Overall Study||5
1687015|NCT00528775|4121434|P1|STARTED|Overall Study||6
1687016|NCT00528645|4121442|P1|NOT COMPLETED|Overall Study||3
1687017|NCT00528645|4121442|P1|COMPLETED|Overall Study||20
1687018|NCT00528645|4121442|P1|STARTED|Overall Study||23
1687019|NCT00528606|4121451|P2|NOT COMPLETED|Overall Study||4
1687020|NCT00528606|4121452|P1|NOT COMPLETED|Overall Study||13
1687021|NCT00528606|4121451|P2|COMPLETED|Overall Study||100
1687022|NCT00528606|4121452|P1|COMPLETED|Overall Study||191
1687023|NCT00528606|4121451|P2|STARTED|Overall Study||104
1687024|NCT00528606|4121452|P1|STARTED|Overall Study||204
1687025|NCT00528580|4121476|P2|NOT COMPLETED|Overall Study||0
1687026|NCT00528580|4121477|P1|NOT COMPLETED|Overall Study||0
1687027|NCT00528580|4121476|P2|COMPLETED|Overall Study||34
1687028|NCT00528580|4121477|P1|COMPLETED|Overall Study||34
1687029|NCT00528580|4121476|P2|STARTED|Overall Study||34
1687030|NCT00528580|4121477|P1|STARTED|Overall Study||34
1687031|NCT00528567|4121485|P2|NOT COMPLETED|Overall Study||308
1687032|NCT00528567|4121486|P1|NOT COMPLETED|Overall Study||431
1687033|NCT00528567|4121485|P2|COMPLETED|Overall Study||982
1687034|NCT00528567|4121486|P1|COMPLETED|Overall Study||870
1687035|NCT00528567|4121485|P2|Safety Population|Overall Study||1271
1687036|NCT00528567|4121486|P1|Safety Population|Overall Study||1288
1687037|NCT00528567|4121485|P2|Intention to Treat|Overall Study||1290
1687038|NCT00528567|4121486|P1|Intention to Treat|Overall Study||1301
1687039|NCT00528567|4121485|P2|STARTED|Overall Study||1290
1687041|NCT00528541|4121526|P2|NOT COMPLETED|Overall Study||1
1687042|NCT00528541|4121527|P1|NOT COMPLETED|Overall Study||2
1687043|NCT00528541|4121526|P2|COMPLETED|Overall Study||69
1687044|NCT00528541|4121527|P1|COMPLETED|Overall Study||73
1687045|NCT00528541|4121526|P2|STARTED|Overall Study||70
1687046|NCT00528541|4121527|P1|STARTED|Overall Study||75
1687047|NCT00528528|4121553|P4|NOT COMPLETED|Overall Study||3
1687048|NCT00528528|4121554|P3|NOT COMPLETED|Overall Study||3
1687049|NCT00528528|4121555|P2|NOT COMPLETED|Overall Study||3
1687050|NCT00528528|4121556|P1|NOT COMPLETED|Overall Study||3
1687051|NCT00528528|4121553|P4|COMPLETED|Overall Study||36
1687052|NCT00528528|4121554|P3|COMPLETED|Overall Study||37
1687053|NCT00528528|4121555|P2|COMPLETED|Overall Study||39
1687054|NCT00528528|4121556|P1|COMPLETED|Overall Study||37
1687055|NCT00528528|4121553|P4|Ongoing at Time of Cut-off|Overall Study||0
1687056|NCT00528528|4121554|P3|Ongoing at Time of Cut-off|Overall Study||1
1687057|NCT00528528|4121555|P2|Ongoing at Time of Cut-off|Overall Study||0
1687058|NCT00528528|4121556|P1|Ongoing at Time of Cut-off|Overall Study||0
1687059|NCT00528528|4121553|P4|STARTED|Overall Study||39
1687060|NCT00528528|4121554|P3|STARTED|Overall Study||40
1687061|NCT00528528|4121555|P2|STARTED|Overall Study||42
1687062|NCT00528528|4121556|P1|STARTED|Overall Study||40
1687063|NCT00528450|4121590|P1|NOT COMPLETED|Overall Study||0
1687064|NCT00528450|4121590|P1|COMPLETED|Overall Study||1
1687065|NCT00528450|4121590|P1|STARTED|Overall Study||1
1687066|NCT00528424|4121594|P1|NOT COMPLETED|Overall Study||29
1687067|NCT00528424|4121594|P1|COMPLETED|Overall Study||257
1687068|NCT00528424|4121594|P1|STARTED|Overall Study||286
1687069|NCT00528411|4121609|P3|NOT COMPLETED|Overall Study||1
1687070|NCT00528411|4121610|P2|NOT COMPLETED|Overall Study||3
1687071|NCT00528411|4121611|P1|NOT COMPLETED|Overall Study||5
1687072|NCT00528411|4121609|P3|COMPLETED|Overall Study||11
1687073|NCT00528411|4121610|P2|COMPLETED|Overall Study||51
1687074|NCT00528411|4121611|P1|COMPLETED|Overall Study||52
1687075|NCT00528411|4121609|P3|STARTED|Overall Study||12
1687076|NCT00528411|4121610|P2|STARTED|Overall Study||54
1687077|NCT00528411|4121611|P1|STARTED|Overall Study||57
1687078|NCT00528398|4121734|P1|NOT COMPLETED|Overall Study||0
1687079|NCT00528398|4121734|P1|COMPLETED|Overall Study||111
1687080|NCT00528398|4121734|P1|STARTED|Overall Study||111
1687081|NCT00528372|4121748|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
1687082|NCT00528372|4121749|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
1687083|NCT00528372|4121750|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
1687084|NCT00528372|4121751|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
1687085|NCT00528372|4121752|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
1687086|NCT00528372|4121753|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
1687087|NCT00528372|4121754|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
1687088|NCT00528372|4121755|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
1687089|NCT00528372|4121756|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
1687090|NCT00528372|4121748|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
1687091|NCT00528372|4121749|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
1687092|NCT00528372|4121750|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
1687093|NCT00528372|4121751|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
1687094|NCT00528372|4121752|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
1687095|NCT00528372|4121753|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
1687096|NCT00528372|4121754|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
1687097|NCT00528372|4121755|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
1687098|NCT00528372|4121756|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
1687099|NCT00528372|4121748|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
1687100|NCT00528372|4121749|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
1687101|NCT00528372|4121750|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
1687102|NCT00528372|4121751|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
1687103|NCT00528372|4121752|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
1687104|NCT00528372|4121753|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
1687105|NCT00528372|4121754|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
1687106|NCT00528372|4121755|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
1687107|NCT00528372|4121756|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
1687108|NCT00528372|4121748|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
1687109|NCT00528372|4121749|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
1687110|NCT00528372|4121750|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
1687111|NCT00528372|4121751|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
1687112|NCT00528372|4121752|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
1687113|NCT00528372|4121753|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
1687114|NCT00528372|4121754|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
1687115|NCT00528372|4121755|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
1687116|NCT00528372|4121756|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
1687117|NCT00528372|4121748|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
1687118|NCT00528372|4121749|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
1687119|NCT00528372|4121750|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
1687120|NCT00528372|4121751|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
1687121|NCT00528372|4121752|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
1687122|NCT00528372|4121753|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
1687123|NCT00528372|4121754|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
1687124|NCT00528372|4121755|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
1687125|NCT00528372|4121756|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
1687126|NCT00528372|4121748|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
1687127|NCT00528372|4121749|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
1687128|NCT00528372|4121750|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
1687129|NCT00528372|4121751|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
1687130|NCT00528372|4121752|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
1687131|NCT00528372|4121753|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
1687132|NCT00528372|4121754|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
1687133|NCT00528372|4121755|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
1687134|NCT00528372|4121756|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
1687135|NCT00528268|4121870|P2|NOT COMPLETED|Overall Study||1
1687136|NCT00528268|4121871|P1|NOT COMPLETED|Overall Study||1
1687137|NCT00528268|4121870|P2|COMPLETED|Overall Study||7
1687138|NCT00528268|4121871|P1|COMPLETED|Overall Study||5
1687139|NCT00528268|4121870|P2|STARTED|Overall Study||8
1687140|NCT00528268|4121871|P1|STARTED|Overall Study||6
1687141|NCT00528190|4121879|P2|NOT COMPLETED|Overall Study||1
1687142|NCT00528190|4121880|P1|NOT COMPLETED|Overall Study||0
1687143|NCT00528190|4121879|P2|COMPLETED|Overall Study||16
1687144|NCT00528190|4121880|P1|COMPLETED|Overall Study||18
1687145|NCT00528190|4121879|P2|STARTED|Overall Study||17
1687146|NCT00528190|4121880|P1|STARTED|Overall Study||18
1687147|NCT00528112|4121888|P2|NOT COMPLETED|Extension Phase||157
1687148|NCT00528112|4121889|P1|NOT COMPLETED|Extension Phase||0
1687149|NCT00528112|4121888|P2|COMPLETED|Extension Phase||550
1687150|NCT00528112|4121889|P1|COMPLETED|Extension Phase||0
1687151|NCT00528112|4121888|P2|STARTED|Extension Phase||707
1687152|NCT00528112|4121889|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
1687153|NCT00528112|4121888|P2|NOT COMPLETED|Treatment up to 3 Years||583
1687154|NCT00528112|4121889|P1|NOT COMPLETED|Treatment up to 3 Years||613
1687155|NCT00528112|4121888|P2|COMPLETED|Treatment up to 3 Years||870
1687156|NCT00528112|4121889|P1|COMPLETED|Treatment up to 3 Years||819
1687157|NCT00528112|4121888|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
1687158|NCT00528112|4121889|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
1687159|NCT00528112|4121888|P2|STARTED|Treatment up to 3 Years||1453
1687160|NCT00528112|4121889|P1|STARTED|Treatment up to 3 Years||1432
1687161|NCT00528021|4121947|P4|NOT COMPLETED|Overall Study||9
1687162|NCT00528021|4121948|P3|NOT COMPLETED|Overall Study||7
1687163|NCT00528021|4121949|P2|NOT COMPLETED|Overall Study||13
1687164|NCT00528021|4121950|P1|NOT COMPLETED|Overall Study||17
1687165|NCT00528021|4121947|P4|COMPLETED|Overall Study||47
1687166|NCT00528021|4121948|P3|COMPLETED|Overall Study||49
1687167|NCT00528021|4121949|P2|COMPLETED|Overall Study||46
1687168|NCT00528021|4121950|P1|COMPLETED|Overall Study||42
1687169|NCT00528021|4121947|P4|STARTED|Overall Study||56
1687170|NCT00528021|4121948|P3|STARTED|Overall Study||56
1687171|NCT00528021|4121949|P2|STARTED|Overall Study||59
1687172|NCT00528021|4121950|P1|STARTED|Overall Study||59
1687173|NCT00527982|4121962|P2|NOT COMPLETED|Overall Study||0
1687174|NCT00527982|4121963|P1|NOT COMPLETED|Overall Study||1
1687175|NCT00527982|4121962|P2|COMPLETED|Overall Study||0
1687176|NCT00527982|4121963|P1|COMPLETED|Overall Study||0
1687177|NCT00527982|4121962|P2|STARTED|Overall Study||0
1687178|NCT00527982|4121963|P1|STARTED|Overall Study||1
1687179|NCT00527943|4121971|P2|NOT COMPLETED|Overall Study||146
1687180|NCT00527943|4121972|P1|NOT COMPLETED|Overall Study||160
1687181|NCT00527943|4121971|P2|COMPLETED|Overall Study||6327
1687182|NCT00527943|4121972|P1|COMPLETED|Overall Study||6311
1687183|NCT00527943|4121971|P2|Received Treatment|Overall Study||6446
1687184|NCT00527943|4121972|P1|Received Treatment|Overall Study||6441
1687185|NCT00527943|4121971|P2|STARTED|Overall Study||6473
1687186|NCT00527943|4121972|P1|STARTED|Overall Study||6471
1687187|NCT00527904|4122004|P1|NOT COMPLETED|Overall Study||96
1687188|NCT00527904|4122004|P1|COMPLETED|Overall Study||143
1687189|NCT00527904|4122004|P1|STARTED|Overall Study||239
1687190|NCT00527878|4122008|P2|NOT COMPLETED|Intervention 2||0
1687191|NCT00527878|4122009|P1|NOT COMPLETED|Intervention 2||0
1687192|NCT00527878|4122008|P2|COMPLETED|Intervention 2||4
1687193|NCT00527878|4122009|P1|COMPLETED|Intervention 2||5
1687194|NCT00527878|4122008|P2|STARTED|Intervention 2||4
1687195|NCT00527878|4122009|P1|STARTED|Intervention 2||5
1687196|NCT00527878|4122008|P2|NOT COMPLETED|Intervention 1||3
1687197|NCT00527878|4122009|P1|NOT COMPLETED|Intervention 1||2
1687198|NCT00527878|4122008|P2|COMPLETED|Intervention 1||4
1687199|NCT00527878|4122009|P1|COMPLETED|Intervention 1||5
1687200|NCT00527878|4122008|P2|STARTED|Intervention 1||7
1687201|NCT00527878|4122009|P1|STARTED|Intervention 1||7
1687202|NCT00527826|4122023|P2|NOT COMPLETED|Overall Study||26
1687203|NCT00527826|4122024|P1|NOT COMPLETED|Overall Study||21
1687204|NCT00527826|4122023|P2|COMPLETED|Overall Study||80
1687205|NCT00527826|4122024|P1|COMPLETED|Overall Study||87
1687206|NCT00527826|4122023|P2|STARTED|Overall Study||106
1687207|NCT00527826|4122024|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
1687208|NCT00527787|4122073|P2|NOT COMPLETED|Overall Study||63
1687209|NCT00527787|4122074|P1|NOT COMPLETED|Overall Study||38
1687210|NCT00527787|4122073|P2|COMPLETED|Overall Study||153
1687211|NCT00527787|4122074|P1|COMPLETED|Overall Study||180
1687212|NCT00527787|4122073|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
1687213|NCT00527787|4122074|P1|STARTED|Overall Study||218
1687214|NCT00527748|4122096|P1|NOT COMPLETED|Overall Study||3
1687215|NCT00527748|4122096|P1|COMPLETED|Overall Study||23
1687216|NCT00527748|4122096|P1|STARTED|Overall Study||26
1687217|NCT00527735|4122103|P3|NOT COMPLETED|Overall Study||107
1687218|NCT00527735|4122104|P2|NOT COMPLETED|Overall Study||107
1687219|NCT00527735|4122105|P1|NOT COMPLETED|Overall Study||108
1687220|NCT00527735|4122103|P3|COMPLETED|Overall Study|Still on treatment|2
1687221|NCT00527735|4122104|P2|COMPLETED|Overall Study|Still on treatment|2
1687222|NCT00527735|4122105|P1|COMPLETED|Overall Study|Still on treatment|5
1687223|NCT00527735|4122103|P3|STARTED|Overall Study|Treated|109
1687224|NCT00527735|4122104|P2|STARTED|Overall Study|Treated|109
1687225|NCT00527735|4122105|P1|STARTED|Overall Study|Treated|113
1687226|NCT00527722|4122179|P2|NOT COMPLETED|Overall Study||0
1687227|NCT00527722|4122180|P1|NOT COMPLETED|Overall Study||0
1687228|NCT00527722|4122179|P2|COMPLETED|Overall Study||25
1687229|NCT00527722|4122180|P1|COMPLETED|Overall Study||22
1687230|NCT00527722|4122179|P2|STARTED|Overall Study||25
1687231|NCT00527722|4122180|P1|STARTED|Overall Study||22
1687232|NCT00527644|4122186|P1|NOT COMPLETED|Overall Study||0
1687233|NCT00527644|4122186|P1|COMPLETED|Overall Study||14
1687234|NCT00527644|4122186|P1|STARTED|Overall Study||14
1687235|NCT00527618|4122191|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
1687236|NCT00527618|4122192|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
1687237|NCT00527618|4122191|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
1687238|NCT00527618|4122192|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
1687239|NCT00527618|4122191|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
1687240|NCT00527618|4122192|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
1687241|NCT00527618|4122191|P2|NOT COMPLETED|Week 13-14 (Washout)||0
1687242|NCT00527618|4122192|P1|NOT COMPLETED|Week 13-14 (Washout)||1
1687243|NCT00527618|4122191|P2|COMPLETED|Week 13-14 (Washout)||16
1687244|NCT00527618|4122192|P1|COMPLETED|Week 13-14 (Washout)||12
1687245|NCT00527618|4122191|P2|STARTED|Week 13-14 (Washout)||16
1687246|NCT00527618|4122192|P1|STARTED|Week 13-14 (Washout)||13
1687247|NCT00527618|4122191|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
1687248|NCT00527618|4122192|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
1687249|NCT00527618|4122191|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
1687250|NCT00527618|4122192|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
1687251|NCT00527618|4122191|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
1687252|NCT00527618|4122192|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
1687253|NCT00527605|4122207|P2|NOT COMPLETED|Overall Study||11
1687254|NCT00527605|4122208|P1|NOT COMPLETED|Overall Study||13
1687255|NCT00527605|4122207|P2|COMPLETED|Overall Study||116
1687256|NCT00527605|4122208|P1|COMPLETED|Overall Study||113
1687257|NCT00527605|4122207|P2|STARTED|Overall Study||127
1687258|NCT00527605|4122208|P1|STARTED|Overall Study||126
1687259|NCT00527592|4122244|P1|NOT COMPLETED|Overall Study||0
1687260|NCT00527592|4122244|P1|COMPLETED|Overall Study||54
1687261|NCT00527592|4122244|P1|STARTED|Overall Study||54
1687262|NCT00527566|4122250|P1|NOT COMPLETED|Overall Study||0
1687263|NCT00527566|4122250|P1|COMPLETED|Overall Study||10
1687264|NCT00527566|4122250|P1|STARTED|Overall Study||10
1687265|NCT00527514|4122259|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
1687266|NCT00527514|4122259|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
1687267|NCT00527514|4122259|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
1687268|NCT00527514|4122259|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
1687269|NCT00527514|4122259|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
1687270|NCT00527514|4122259|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
1687271|NCT00527514|4122259|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
1687272|NCT00527514|4122259|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
1687273|NCT00527514|4122259|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
1687274|NCT00527514|4122259|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
1687275|NCT00527514|4122259|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
1687276|NCT00527514|4122259|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
1687277|NCT00527488|4122275|P4|NOT COMPLETED|Overall Study||0
1687278|NCT00527488|4122276|P3|NOT COMPLETED|Overall Study||1
1687279|NCT00527488|4122277|P2|NOT COMPLETED|Overall Study||1
1687280|NCT00527488|4122278|P1|NOT COMPLETED|Overall Study||0
1687281|NCT00527488|4122275|P4|COMPLETED|Overall Study||13
1687282|NCT00527488|4122276|P3|COMPLETED|Overall Study||12
1687283|NCT00527488|4122277|P2|COMPLETED|Overall Study||12
1687284|NCT00527488|4122278|P1|COMPLETED|Overall Study||13
1687285|NCT00527488|4122275|P4|STARTED|Overall Study||13
1687286|NCT00527488|4122276|P3|STARTED|Overall Study||13
1687287|NCT00527488|4122277|P2|STARTED|Overall Study||13
1687288|NCT00527488|4122278|P1|STARTED|Overall Study||13
1687289|NCT00527475|4122354|P2|NOT COMPLETED|Overall Study||1
1687290|NCT00527475|4122355|P1|NOT COMPLETED|Overall Study||3
1687291|NCT00527475|4122354|P2|COMPLETED|Overall Study||29
1687292|NCT00527475|4122355|P1|COMPLETED|Overall Study||27
1687293|NCT00527475|4122354|P2|STARTED|Overall Study||30
1687294|NCT00527475|4122355|P1|STARTED|Overall Study||30
1687295|NCT00527423|4122361|P1|NOT COMPLETED|Overall Study||37
1687296|NCT00527423|4122361|P1|COMPLETED|Overall Study||120
1687297|NCT00527423|4122361|P1|STARTED|Overall Study||157
1687298|NCT00527397|4122367|P1|NOT COMPLETED|Overall Study||24
1687299|NCT00527397|4122367|P1|COMPLETED|Overall Study||0
1687300|NCT00527397|4122367|P1|STARTED|Overall Study||24
1687301|NCT00527332|4122393|P2|NOT COMPLETED|Overall Study||9
1687302|NCT00527332|4122394|P1|NOT COMPLETED|Overall Study||9
1687303|NCT00527332|4122393|P2|COMPLETED|Overall Study||80
1687304|NCT00527332|4122394|P1|COMPLETED|Overall Study||82
1687305|NCT00527332|4122393|P2|STARTED|Overall Study||89
1687306|NCT00527332|4122394|P1|STARTED|Overall Study||91
1687307|NCT00527319|4122403|P3|NOT COMPLETED|Overall Study||6
1687308|NCT00527319|4122404|P2|NOT COMPLETED|Overall Study||4
1687309|NCT00527319|4122405|P1|NOT COMPLETED|Overall Study||6
1687310|NCT00527319|4122403|P3|COMPLETED|Overall Study||7
1687311|NCT00527319|4122404|P2|COMPLETED|Overall Study||8
1687312|NCT00527319|4122405|P1|COMPLETED|Overall Study||6
1687313|NCT00527319|4122403|P3|STARTED|Overall Study||13
1687314|NCT00527319|4122404|P2|STARTED|Overall Study||12
1687315|NCT00527319|4122405|P1|STARTED|Overall Study||12
1687316|NCT00527124|4122418|P2|NOT COMPLETED|Overall Study||0
1687317|NCT00527124|4122419|P1|NOT COMPLETED|Overall Study||0
1687318|NCT00527124|4122418|P2|COMPLETED|Overall Study||28
1687319|NCT00527124|4122419|P1|COMPLETED|Overall Study||29
1687320|NCT00527124|4122418|P2|STARTED|Overall Study||28
1687321|NCT00527124|4122419|P1|STARTED|Overall Study||29
1687322|NCT00527111|4122435|P2|NOT COMPLETED|Overall Study||22
1687323|NCT00527111|4122436|P1|NOT COMPLETED|Overall Study||20
1687324|NCT00527111|4122435|P2|COMPLETED|Overall Study||47
1687325|NCT00527111|4122436|P1|COMPLETED|Overall Study||50
1687326|NCT00527111|4122435|P2|STARTED|Overall Study||69
1687327|NCT00527111|4122436|P1|STARTED|Overall Study||70
1687328|NCT00527098|4122452|P2|NOT COMPLETED|Overall Study||0
1687329|NCT00527098|4122453|P1|NOT COMPLETED|Overall Study||0
1687330|NCT00527098|4122452|P2|COMPLETED|Overall Study||83
1687331|NCT00527098|4122453|P1|COMPLETED|Overall Study||36
1687332|NCT00527098|4122452|P2|STARTED|Overall Study||83
1687333|NCT00527098|4122453|P1|STARTED|Overall Study||36
1687334|NCT00527072|4122458|P1|NOT COMPLETED|Overall Study||36
1687335|NCT00527072|4122458|P1|COMPLETED|Overall Study||179
1687336|NCT00527072|4122458|P1|STARTED|Overall Study||215
1687337|NCT00526994|4122467|P3|NOT COMPLETED|Overall Study||107
1687338|NCT00526994|4122468|P2|NOT COMPLETED|Overall Study||121
1687339|NCT00526994|4122469|P1|NOT COMPLETED|Overall Study||108
1687340|NCT00526994|4122467|P3|COMPLETED|Overall Study||791
1687341|NCT00526994|4122468|P2|COMPLETED|Overall Study||772
1687342|NCT00526994|4122469|P1|COMPLETED|Overall Study||801
1687343|NCT00526994|4122467|P3|STARTED|Overall Study||898
1687344|NCT00526994|4122468|P2|STARTED|Overall Study||893
1687345|NCT00526994|4122469|P1|STARTED|Overall Study||909
1687346|NCT00526890|4122486|P1|NOT COMPLETED|Overall Study||2
1687347|NCT00526890|4122486|P1|COMPLETED|Overall Study||14
1687348|NCT00526890|4122486|P1|STARTED|Overall Study||16
1687349|NCT00526799|4122498|P2|NOT COMPLETED|Overall Study||1
1687350|NCT00526799|4122499|P1|NOT COMPLETED|Overall Study||1
1687351|NCT00526799|4122498|P2|COMPLETED|Overall Study||13
1687352|NCT00526799|4122499|P1|COMPLETED|Overall Study||15
1687353|NCT00526799|4122498|P2|STARTED|Overall Study||14
1687354|NCT00526799|4122499|P1|STARTED|Overall Study||16
1687355|NCT00526669|4122507|P2|NOT COMPLETED|Combined Treatment Phase||8
1687356|NCT00526669|4122508|P1|NOT COMPLETED|Combined Treatment Phase||0
1687357|NCT00526669|4122507|P2|COMPLETED|Combined Treatment Phase||59
1687358|NCT00526669|4122508|P1|COMPLETED|Combined Treatment Phase||0
1687359|NCT00526669|4122507|P2|STARTED|Combined Treatment Phase||67
1687360|NCT00526669|4122508|P1|STARTED|Combined Treatment Phase||0
1687361|NCT00526669|4122507|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
1687362|NCT00526669|4122508|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
1687363|NCT00526669|4122507|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
1687364|NCT00526669|4122508|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
1687365|NCT00526669|4122507|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
1687366|NCT00526669|4122508|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
1687367|NCT00526630|4122537|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
1687368|NCT00526630|4122538|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
1687369|NCT00526630|4122537|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
1687370|NCT00526630|4122538|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
1687371|NCT00526630|4122537|P2|STARTED|Second Intervention Period - 12 Weeks||8
1687372|NCT00526630|4122538|P1|STARTED|Second Intervention Period - 12 Weeks||12
1687373|NCT00526630|4122537|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
1687374|NCT00526630|4122538|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
1687375|NCT00526630|4122537|P2|COMPLETED|First Intervention Period - 12 Weeks||8
1687376|NCT00526630|4122538|P1|COMPLETED|First Intervention Period - 12 Weeks||12
1687377|NCT00526630|4122537|P2|STARTED|First Intervention Period - 12 Weeks||11
1687378|NCT00526630|4122538|P1|STARTED|First Intervention Period - 12 Weeks||12
1687379|NCT00526591|4122568|P2|NOT COMPLETED|Overall Study||0
1687380|NCT00526591|4122569|P1|NOT COMPLETED|Overall Study||0
1687381|NCT00526591|4122568|P2|COMPLETED|Overall Study||9
1687382|NCT00526591|4122569|P1|COMPLETED|Overall Study||8
1687383|NCT00526591|4122568|P2|STARTED|Overall Study||9
1687384|NCT00526591|4122569|P1|STARTED|Overall Study||8
1687385|NCT00526474|4122581|P2|NOT COMPLETED|Overall Study||272
1687386|NCT00526474|4122582|P1|NOT COMPLETED|Overall Study||292
1687387|NCT00526474|4122581|P2|COMPLETED|Overall Study||12953
1687388|NCT00526474|4122582|P1|COMPLETED|Overall Study||12932
1687389|NCT00526474|4122581|P2|Received Study Drug|Overall Study||13186
1687390|NCT00526474|4122582|P1|Received Study Drug|Overall Study||13166
1687391|NCT00526474|4122581|P2|STARTED|Overall Study||13225
1687392|NCT00526474|4122582|P1|STARTED|Overall Study||13224
1687393|NCT00526331|4122650|P1|NOT COMPLETED|Overall Study||55
1687394|NCT00526331|4122650|P1|COMPLETED|Overall Study||0
1687395|NCT00526331|4122650|P1|STARTED|Overall Study||55
1687396|NCT00526292|4122654|P1|NOT COMPLETED|Overall Study||0
1687397|NCT00526292|4122654|P1|COMPLETED|Overall Study||6
1687398|NCT00526292|4122654|P1|STARTED|Overall Study||6
1687399|NCT00526227|4122658|P1|NOT COMPLETED|Overall Study||2
1687400|NCT00526227|4122658|P1|COMPLETED|Overall Study||79
1687401|NCT00526227|4122658|P1|STARTED|Overall Study||81
1687402|NCT00526188|4122663|P1|NOT COMPLETED|Overall Study||0
1687403|NCT00526188|4122663|P1|COMPLETED|Overall Study||234
1687404|NCT00526188|4122663|P1|STARTED|Overall Study||234
1687405|NCT00526162|4122669|P1|NOT COMPLETED|Overall Study||3
1687406|NCT00526162|4122669|P1|COMPLETED|Overall Study||80
1687407|NCT00526162|4122669|P1|STARTED|Overall Study||83
1687408|NCT00526123|4122676|P2|NOT COMPLETED|Overall Study||246
1687409|NCT00526123|4122677|P1|NOT COMPLETED|Overall Study||264
1687410|NCT00526123|4122676|P2|COMPLETED|Overall Study||50
1687411|NCT00526123|4122677|P1|COMPLETED|Overall Study||39
1687412|NCT00526123|4122676|P2|STARTED|Overall Study|Intent-to-Treat population|296
1687413|NCT00526123|4122677|P1|STARTED|Overall Study|Intent-to-Treat population|303
1687414|NCT00526110|4122699|P2|NOT COMPLETED|Overall Study||41
1687415|NCT00526110|4122700|P1|NOT COMPLETED|Overall Study||2
1687416|NCT00526110|4122699|P2|COMPLETED|Overall Study||4
1687417|NCT00526110|4122700|P1|COMPLETED|Overall Study||51
1687418|NCT00526110|4122699|P2|STARTED|Overall Study||45
1687419|NCT00526110|4122700|P1|STARTED|Overall Study||53
1687420|NCT00526097|4122709|P2|NOT COMPLETED|Overall Study||56
1687421|NCT00526097|4122710|P1|NOT COMPLETED|Overall Study||15
1687422|NCT00526097|4122709|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
1687423|NCT00526097|4122710|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
1687424|NCT00526097|4122709|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
1687425|NCT00526097|4122710|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
1687426|NCT00526071|4122886|P1|NOT COMPLETED|Overall Study||6
1687427|NCT00526071|4122886|P1|COMPLETED|Overall Study||17
1687428|NCT00526071|4122886|P1|Non-amenable Population; Women|Overall Study||4
1687429|NCT00526071|4122886|P1|Non-amenable Population; Men|Overall Study||3
1687430|NCT00526071|4122886|P1|Amenable Population; Women|Overall Study||5
1687431|NCT00526071|4122886|P1|Amenable Population; Men|Overall Study||11
1687432|NCT00526071|4122886|P1|Pharmacodynamic (PD) Population|Overall Study||23
1687433|NCT00526071|4122886|P1|Safety Population|Overall Study||23
1687434|NCT00526071|4122886|P1|STARTED|Overall Study||23
1687435|NCT00526058|4122897|P2|NOT COMPLETED|Period: Second Intervention||0
1687436|NCT00526058|4122898|P1|NOT COMPLETED|Period: Second Intervention||0
1687437|NCT00526058|4122897|P2|COMPLETED|Period: Second Intervention||9
1687438|NCT00526058|4122898|P1|COMPLETED|Period: Second Intervention||9
1687439|NCT00526058|4122897|P2|STARTED|Period: Second Intervention||9
1687440|NCT00526058|4122898|P1|STARTED|Period: Second Intervention||9
1687441|NCT00526058|4122897|P2|NOT COMPLETED|Period: First Intervention||0
1687442|NCT00526058|4122898|P1|NOT COMPLETED|Period: First Intervention||0
1687443|NCT00526058|4122897|P2|COMPLETED|Period: First Intervention||9
1687444|NCT00526058|4122898|P1|COMPLETED|Period: First Intervention||9
1687445|NCT00526058|4122897|P2|STARTED|Period: First Intervention||9
1687446|NCT00526058|4122898|P1|STARTED|Period: First Intervention||9
1687447|NCT00525915|4122912|P2|NOT COMPLETED|Overall Study||9
1687448|NCT00525915|4122913|P1|NOT COMPLETED|Overall Study||8
1687449|NCT00525915|4122912|P2|COMPLETED|Overall Study||54
1687450|NCT00525915|4122913|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
1687451|NCT00525915|4122912|P2|STARTED|Overall Study||63
1687452|NCT00525915|4122913|P1|STARTED|Overall Study||63
1687453|NCT00525902|4122919|P1|NOT COMPLETED|Overall Study||1
1687454|NCT00525902|4122919|P1|COMPLETED|Overall Study||30
1687455|NCT00525902|4122919|P1|50 Weeks|Overall Study||12
1687456|NCT00525902|4122919|P1|10 Weeks|Overall Study||30
1687457|NCT00525902|4122919|P1|STARTED|Overall Study||31
1687458|NCT00525876|4122926|P2|NOT COMPLETED|Overall Study||0
1687459|NCT00525876|4122927|P1|NOT COMPLETED|Overall Study||0
1687460|NCT00525876|4122926|P2|COMPLETED|Overall Study||20
1687461|NCT00525876|4122927|P1|COMPLETED|Overall Study||16
1687462|NCT00525876|4122926|P2|STARTED|Overall Study||20
1687463|NCT00525876|4122927|P1|STARTED|Overall Study||16
1687464|NCT00525837|4122933|P1|NOT COMPLETED|Overall Study||4
1687465|NCT00525837|4122933|P1|COMPLETED|Overall Study||14
1687466|NCT00525837|4122933|P1|STARTED|Overall Study||18
1687467|NCT00525824|4122943|P4|NOT COMPLETED|Overall Study||15
1687468|NCT00525824|4122944|P3|NOT COMPLETED|Overall Study||19
1687469|NCT00525824|4122945|P2|NOT COMPLETED|Overall Study||28
1687470|NCT00525824|4122946|P1|NOT COMPLETED|Overall Study||19
1687471|NCT00525824|4122943|P4|COMPLETED|Overall Study||188
1687472|NCT00525824|4122944|P3|COMPLETED|Overall Study||183
1687473|NCT00525824|4122945|P2|COMPLETED|Overall Study||186
1687474|NCT00525824|4122946|P1|COMPLETED|Overall Study||195
1687475|NCT00525824|4122943|P4|STARTED|Overall Study|Randomized population|203
1687476|NCT00525824|4122944|P3|STARTED|Overall Study|Randomized population|202
1687477|NCT00525824|4122945|P2|STARTED|Overall Study|Randomized population|214
1687478|NCT00525824|4122946|P1|STARTED|Overall Study|Randomized population|214
1687479|NCT00525798|4123010|P2|NOT COMPLETED|Overall Study||599
1687480|NCT00525798|4123011|P1|NOT COMPLETED|Overall Study||756
1687481|NCT00525798|4123010|P2|COMPLETED|Overall Study||1732
1687482|NCT00525798|4123011|P1|COMPLETED|Overall Study||1578
1687483|NCT00525798|4123010|P2|STARTED|Overall Study||2331
1687484|NCT00525798|4123011|P1|STARTED|Overall Study||2334
1687485|NCT00525733|4123021|P2|NOT COMPLETED|Overall Study||3
1687486|NCT00525733|4123022|P1|NOT COMPLETED|Overall Study||3
1687487|NCT00525733|4123021|P2|COMPLETED|Overall Study||23
1687488|NCT00525733|4123022|P1|COMPLETED|Overall Study||11
1687489|NCT00525733|4123021|P2|STARTED|Overall Study||26
1687490|NCT00525733|4123022|P1|STARTED|Overall Study||14
1687491|NCT00525629|4123028|P2|NOT COMPLETED|Second Intervention||15
1687492|NCT00525629|4123029|P1|NOT COMPLETED|Second Intervention||15
1687493|NCT00525629|4123028|P2|COMPLETED|Second Intervention||0
1687494|NCT00525629|4123029|P1|COMPLETED|Second Intervention||0
1687495|NCT00525629|4123028|P2|STARTED|Second Intervention||15
1687496|NCT00525629|4123029|P1|STARTED|Second Intervention||15
1687497|NCT00525629|4123028|P2|NOT COMPLETED|Washout||0
1687498|NCT00525629|4123029|P1|NOT COMPLETED|Washout||0
1687499|NCT00525629|4123028|P2|COMPLETED|Washout||15
1687500|NCT00525629|4123029|P1|COMPLETED|Washout||15
1687501|NCT00525629|4123028|P2|STARTED|Washout||15
1687502|NCT00525629|4123029|P1|STARTED|Washout||15
1687503|NCT00525629|4123028|P2|NOT COMPLETED|First Intervention||5
1687504|NCT00525629|4123029|P1|NOT COMPLETED|First Intervention||5
1687505|NCT00525629|4123028|P2|COMPLETED|First Intervention||15
1687506|NCT00525629|4123029|P1|COMPLETED|First Intervention||15
1687507|NCT00525629|4123028|P2|STARTED|First Intervention||20
1687508|NCT00525629|4123029|P1|STARTED|First Intervention||20
1687509|NCT00525603|4123035|P1|NOT COMPLETED|Overall Study||0
1687510|NCT00525603|4123035|P1|COMPLETED|Overall Study||60
1687511|NCT00525603|4123035|P1|STARTED|Overall Study||60
1687512|NCT00525525|4123041|P2|NOT COMPLETED|Overall Study||0
1687513|NCT00525525|4123042|P1|NOT COMPLETED|Overall Study||0
1687514|NCT00525525|4123041|P2|COMPLETED|Overall Study||15
1687515|NCT00525525|4123042|P1|COMPLETED|Overall Study||59
1687516|NCT00525525|4123041|P2|STARTED|Overall Study||15
1687517|NCT00525525|4123042|P1|STARTED|Overall Study||59
1687518|NCT00525512|4123051|P4|NOT COMPLETED|Open-Label Phase||5
1687519|NCT00525512|4123052|P3|NOT COMPLETED|Open-Label Phase||6
1687520|NCT00525512|4123053|P2|NOT COMPLETED|Open-Label Phase||0
1687521|NCT00525512|4123054|P1|NOT COMPLETED|Open-Label Phase||0
1687522|NCT00525512|4123051|P4|COMPLETED|Open-Label Phase||189
1687523|NCT00525512|4123052|P3|COMPLETED|Open-Label Phase||158
1687524|NCT00525512|4123053|P2|COMPLETED|Open-Label Phase||0
1687525|NCT00525512|4123054|P1|COMPLETED|Open-Label Phase||0
1687526|NCT00525512|4123051|P4|STARTED|Open-Label Phase||194
1687527|NCT00525512|4123052|P3|STARTED|Open-Label Phase||164
1687528|NCT00525512|4123053|P2|STARTED|Open-Label Phase||0
1687529|NCT00525512|4123054|P1|STARTED|Open-Label Phase||0
1687530|NCT00525512|4123051|P4|NOT COMPLETED|Double-Blind Phase||0
1687531|NCT00525512|4123052|P3|NOT COMPLETED|Double-Blind Phase||0
1687532|NCT00525512|4123053|P2|NOT COMPLETED|Double-Blind Phase||66
1687533|NCT00525512|4123054|P1|NOT COMPLETED|Double-Blind Phase||96
1687534|NCT00525512|4123051|P4|COMPLETED|Double-Blind Phase||0
1687535|NCT00525512|4123052|P3|COMPLETED|Double-Blind Phase||0
1687536|NCT00525512|4123053|P2|COMPLETED|Double-Blind Phase||194
1687537|NCT00525512|4123054|P1|COMPLETED|Double-Blind Phase||163
1687538|NCT00525512|4123051|P4|STARTED|Double-Blind Phase||0
1687539|NCT00525512|4123052|P3|STARTED|Double-Blind Phase||0
1687540|NCT00525512|4123053|P2|STARTED|Double-Blind Phase||260
1687541|NCT00525512|4123054|P1|STARTED|Double-Blind Phase||259
1687542|NCT00525499|4123196|P4|NOT COMPLETED|Overall Study||7
1687543|NCT00525499|4123197|P3|NOT COMPLETED|Overall Study||7
1687544|NCT00525499|4123198|P2|NOT COMPLETED|Overall Study||7
1687545|NCT00525499|4123199|P1|NOT COMPLETED|Overall Study||7
1687546|NCT00525499|4123196|P4|COMPLETED|Overall Study||39
1687547|NCT00525499|4123197|P3|COMPLETED|Overall Study||40
1687548|NCT00525499|4123198|P2|COMPLETED|Overall Study||39
1687549|NCT00525499|4123199|P1|COMPLETED|Overall Study||40
1687550|NCT00525499|4123196|P4|STARTED|Overall Study||46
1687551|NCT00525499|4123197|P3|STARTED|Overall Study||47
1687552|NCT00525499|4123198|P2|STARTED|Overall Study||46
1687553|NCT00525499|4123199|P1|STARTED|Overall Study||47
1687554|NCT00525421|4123215|P2|NOT COMPLETED|Overall Study||0
1687555|NCT00525421|4123216|P1|NOT COMPLETED|Overall Study||0
1687556|NCT00525421|4123215|P2|COMPLETED|Overall Study||10
1687557|NCT00525421|4123216|P1|COMPLETED|Overall Study||10
1687558|NCT00525421|4123215|P2|STARTED|Overall Study||10
1687559|NCT00525421|4123216|P1|STARTED|Overall Study|Enrollment started october 2007|10
1687560|NCT00525265|4123226|P2|NOT COMPLETED|Overall Study||0
1687561|NCT00525265|4123227|P1|NOT COMPLETED|Overall Study||1
1687562|NCT00525265|4123226|P2|COMPLETED|Overall Study||10
1687563|NCT00525265|4123227|P1|COMPLETED|Overall Study||9
1687564|NCT00525265|4123226|P2|STARTED|Overall Study||10
1687565|NCT00525265|4123227|P1|STARTED|Overall Study||10
1687566|NCT00525174|4123235|P2|NOT COMPLETED|Overall Study||8
1687567|NCT00525174|4123236|P1|NOT COMPLETED|Overall Study||9
1687568|NCT00525174|4123235|P2|COMPLETED|Overall Study||81
1687569|NCT00525174|4123236|P1|COMPLETED|Overall Study||88
1687570|NCT00525174|4123235|P2|STARTED|Overall Study||89
1687571|NCT00525174|4123236|P1|STARTED|Overall Study||97
1687572|NCT00525161|4123284|P1|NOT COMPLETED|Overall Study||1
1687573|NCT00525161|4123284|P1|COMPLETED|Overall Study||10
1687574|NCT00525161|4123284|P1|STARTED|Overall Study||11
1687575|NCT00525148|4123294|P4|NOT COMPLETED|Overall Study||61
1687576|NCT00525148|4123295|P3|NOT COMPLETED|Overall Study||7
1687577|NCT00525148|4123296|P2|NOT COMPLETED|Overall Study||38
1687578|NCT00525148|4123297|P1|NOT COMPLETED|Overall Study||23
1687579|NCT00525148|4123294|P4|COMPLETED|Overall Study||0
1687580|NCT00525148|4123295|P3|COMPLETED|Overall Study||0
1687581|NCT00525148|4123296|P2|COMPLETED|Overall Study||0
1687582|NCT00525148|4123297|P1|COMPLETED|Overall Study||0
1687583|NCT00525148|4123294|P4|STARTED|Overall Study|entered and treated|61
1687584|NCT00525148|4123295|P3|STARTED|Overall Study|entered and treated|7
1687585|NCT00525148|4123296|P2|STARTED|Overall Study|entered and treated|38
1687586|NCT00525148|4123297|P1|STARTED|Overall Study|entered and treated|23
1687587|NCT00525135|4123315|P1|NOT COMPLETED|Overall Study||0
1687588|NCT00525135|4123315|P1|COMPLETED|Overall Study||5
1687589|NCT00525135|4123315|P1|STARTED|Overall Study||5
1687590|NCT00525031|4123325|P2|NOT COMPLETED|Overall Study||1
1687591|NCT00525031|4123326|P1|NOT COMPLETED|Overall Study||1
1687592|NCT00525031|4123325|P2|COMPLETED|Overall Study||24
1687593|NCT00525031|4123326|P1|COMPLETED|Overall Study||26
1687594|NCT00525031|4123325|P2|STARTED|Overall Study||25
1687595|NCT00525031|4123326|P1|STARTED|Overall Study||27
1687596|NCT00524940|4123333|P1|NOT COMPLETED|Overall Study||0
1687597|NCT00524940|4123333|P1|COMPLETED|Overall Study||124
1687598|NCT00524940|4123333|P1|STARTED|Overall Study||124
1687599|NCT00524771|4123340|P2|NOT COMPLETED|Overall Study||585
1687600|NCT00524771|4123341|P1|NOT COMPLETED|Overall Study||220
1687601|NCT00524771|4123340|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
1687602|NCT00524771|4123341|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
1687603|NCT00524771|4123340|P2|STARTED|Overall Study||17016
1687604|NCT00524771|4123341|P1|STARTED|Overall Study||17084
1687605|NCT00524745|4123355|P4|NOT COMPLETED|Overall Study||22
1687606|NCT00524745|4123356|P3|NOT COMPLETED|Overall Study||29
1687607|NCT00524745|4123357|P2|NOT COMPLETED|Overall Study||13
1687608|NCT00524745|4123358|P1|NOT COMPLETED|Overall Study||34
1687609|NCT00524745|4123355|P4|COMPLETED|Overall Study||205
1687610|NCT00524745|4123356|P3|COMPLETED|Overall Study||212
1687611|NCT00524745|4123357|P2|COMPLETED|Overall Study||193
1687612|NCT00524745|4123358|P1|COMPLETED|Overall Study||195
1687613|NCT00524745|4123355|P4|STARTED|Overall Study||227
1687614|NCT00524745|4123356|P3|STARTED|Overall Study||241
1687615|NCT00524745|4123357|P2|STARTED|Overall Study||206
1687616|NCT00524745|4123358|P1|STARTED|Overall Study||229
1687617|NCT00524680|4123384|P4|NOT COMPLETED|Overall Study||6
1687618|NCT00524680|4123385|P3|NOT COMPLETED|Overall Study||3
1687619|NCT00524680|4123386|P2|NOT COMPLETED|Overall Study||1
1687620|NCT00524680|4123387|P1|NOT COMPLETED|Overall Study||3
1687621|NCT00524680|4123384|P4|COMPLETED|Overall Study||34
1687622|NCT00524680|4123385|P3|COMPLETED|Overall Study||33
1687623|NCT00524680|4123386|P2|COMPLETED|Overall Study||34
1687624|NCT00524680|4123387|P1|COMPLETED|Overall Study||34
1687625|NCT00524680|4123384|P4|STARTED|Overall Study||40
1687626|NCT00524680|4123385|P3|STARTED|Overall Study||36
1687627|NCT00524680|4123386|P2|STARTED|Overall Study||35
1687628|NCT00524680|4123387|P1|STARTED|Overall Study||37
1687629|NCT00524589|4123409|P1|NOT COMPLETED|Overall Study||18
1687630|NCT00524589|4123409|P1|COMPLETED|Overall Study||0
1687631|NCT00524589|4123409|P1|STARTED|Overall Study||18
1687632|NCT00524576|4123416|P2|NOT COMPLETED|Overall Study||0
1687633|NCT00524576|4123417|P1|NOT COMPLETED|Overall Study||0
1687634|NCT00524576|4123416|P2|COMPLETED|Overall Study||47
1687635|NCT00524576|4123417|P1|COMPLETED|Overall Study||97
1687636|NCT00524576|4123416|P2|STARTED|Overall Study||47
1687637|NCT00524576|4123417|P1|STARTED|Overall Study||97
1687638|NCT00524537|4123435|P1|NOT COMPLETED|Overall Study||2574
1687639|NCT00524537|4123435|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
1687640|NCT00524537|4123435|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
1687641|NCT00524537|4123435|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
1687642|NCT00524537|4123435|P1|Discontinued|Overall Study|Discontinued from study|2811
1687643|NCT00524537|4123435|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
1687644|NCT00524511|4123451|P2|NOT COMPLETED|Overall Study||7
1687645|NCT00524511|4123452|P1|NOT COMPLETED|Overall Study||4
1687646|NCT00524511|4123451|P2|COMPLETED|Overall Study||61
1687647|NCT00524511|4123452|P1|COMPLETED|Overall Study||64
1687648|NCT00524511|4123451|P2|STARTED|Overall Study||68
1687649|NCT00524511|4123452|P1|STARTED|Overall Study||68
1687650|NCT00524485|4123460|P1|NOT COMPLETED|Overall Study||5
1687651|NCT00524485|4123460|P1|COMPLETED|Overall Study||7
1687652|NCT00524485|4123460|P1|STARTED|Overall Study||12
1687653|NCT00524472|4123472|P2|NOT COMPLETED|Overall Study||0
1687654|NCT00524472|4123473|P1|NOT COMPLETED|Overall Study||0
1687655|NCT00524472|4123472|P2|COMPLETED|Overall Study||730
1687656|NCT00524472|4123473|P1|COMPLETED|Overall Study||709
1687657|NCT00524472|4123472|P2|STARTED|Overall Study||730
1687658|NCT00524472|4123473|P1|STARTED|Overall Study||709
1687659|NCT00524459|4123489|P1|NOT COMPLETED|Overall Study||2
1687660|NCT00524459|4123489|P1|COMPLETED|Overall Study||4
1687661|NCT00524459|4123489|P1|STARTED|Overall Study||6
1687662|NCT00524420|4123499|P2|NOT COMPLETED|Overall Study||0
1687663|NCT00524420|4123500|P1|NOT COMPLETED|Overall Study||1
1687664|NCT00524420|4123499|P2|COMPLETED|Overall Study||11
1687665|NCT00524420|4123500|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
1687666|NCT00524420|4123499|P2|STARTED|Overall Study||11
1687667|NCT00524420|4123500|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
1687668|NCT00524394|4123512|P1|NOT COMPLETED|Overall Study||1
1687669|NCT00524394|4123512|P1|COMPLETED|Overall Study||1
1687670|NCT00524394|4123512|P1|STARTED|Overall Study||2
1687671|NCT00524368|4123518|P2|NOT COMPLETED|Overall Study||48
1687672|NCT00524368|4123519|P1|NOT COMPLETED|Overall Study||41
1687673|NCT00524368|4123518|P2|COMPLETED|Overall Study||248
1687674|NCT00524368|4123519|P1|COMPLETED|Overall Study||253
1687675|NCT00524368|4123518|P2|STARTED|Overall Study||296
1687676|NCT00524368|4123519|P1|STARTED|Overall Study||294
1687677|NCT00524342|4123547|P1|NOT COMPLETED|Overall Study||0
1687678|NCT00524342|4123547|P1|COMPLETED|Overall Study||7
1687679|NCT00524342|4123547|P1|STARTED|Overall Study||7
1687680|NCT00524316|4123553|P1|NOT COMPLETED|Overall Study||16
1687681|NCT00524316|4123553|P1|COMPLETED|Overall Study||0
1687682|NCT00524316|4123553|P1|STARTED|Overall Study||16
1687683|NCT00524303|4123565|P3|NOT COMPLETED|Overall Study||18
1687684|NCT00524303|4123566|P2|NOT COMPLETED|Overall Study||10
1687685|NCT00524303|4123567|P1|NOT COMPLETED|Overall Study||12
1687686|NCT00524303|4123565|P3|COMPLETED|Overall Study||15
1687687|NCT00524303|4123566|P2|COMPLETED|Overall Study||24
1687688|NCT00524303|4123567|P1|COMPLETED|Overall Study||21
1687689|NCT00524303|4123565|P3|STARTED|Overall Study||33
1687690|NCT00524303|4123566|P2|STARTED|Overall Study||34
1687691|NCT00524303|4123567|P1|STARTED|Overall Study||33
1687692|NCT00524264|4123597|P2|NOT COMPLETED|Overall Study||27
1687693|NCT00524264|4123598|P1|NOT COMPLETED|Overall Study||20
1687694|NCT00524264|4123597|P2|COMPLETED|Overall Study||57
1687695|NCT00524264|4123598|P1|COMPLETED|Overall Study||144
1687696|NCT00524264|4123597|P2|STARTED|Overall Study||84
1687697|NCT00524264|4123598|P1|STARTED|Overall Study||164
1687698|NCT00524225|4123610|P1|NOT COMPLETED|Overall Study||0
1687699|NCT00524225|4123610|P1|COMPLETED|Overall Study||3
1687700|NCT00524225|4123610|P1|STARTED|Overall Study||3
1687701|NCT00524173|4123619|P2|NOT COMPLETED|Overall Study||2
1687702|NCT00524173|4123620|P1|NOT COMPLETED|Overall Study||5
1687703|NCT00524173|4123619|P2|COMPLETED|Overall Study||13
1687704|NCT00524173|4123620|P1|COMPLETED|Overall Study||12
1687705|NCT00524173|4123619|P2|STARTED|Overall Study||15
1687706|NCT00524173|4123620|P1|STARTED|Overall Study||17
1687707|NCT00524134|4123632|P1|NOT COMPLETED|Overall Study||2
1687708|NCT00524134|4123632|P1|COMPLETED|Overall Study||4
1687709|NCT00524134|4123632|P1|STARTED|Overall Study||6
1687710|NCT00524121|4123639|P1|NOT COMPLETED|Overall Study||19
1687711|NCT00524121|4123639|P1|COMPLETED|Overall Study||3
1687712|NCT00524121|4123639|P1|STARTED|Overall Study||22
1687713|NCT00524043|4123659|P3|NOT COMPLETED|Overall Study||31
1687714|NCT00524043|4123660|P2|NOT COMPLETED|Overall Study||28
1687715|NCT00524043|4123661|P1|NOT COMPLETED|Overall Study||30
1687716|NCT00524043|4123659|P3|COMPLETED|Overall Study||35
1687717|NCT00524043|4123660|P2|COMPLETED|Overall Study||42
1687718|NCT00524043|4123661|P1|COMPLETED|Overall Study||34
1687719|NCT00524043|4123659|P3|STARTED|Overall Study||66
1687720|NCT00524043|4123660|P2|STARTED|Overall Study||70
1687721|NCT00524043|4123661|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
1687722|NCT00524030|4123683|P2|NOT COMPLETED|Overall Study||59
1687723|NCT00524030|4123684|P1|NOT COMPLETED|Overall Study||17
1687724|NCT00524030|4123683|P2|COMPLETED|Overall Study||70
1687725|NCT00524030|4123684|P1|COMPLETED|Overall Study||15
1687726|NCT00524030|4123683|P2|Completed Taper/Titration Phase|Overall Study||70
1687727|NCT00524030|4123684|P1|Completed Taper/Titration Phase|Overall Study||15
1687728|NCT00524030|4123683|P2|Completed Double-Blind Treatment Phase|Overall Study||70
1687729|NCT00524030|4123684|P1|Completed Double-Blind Treatment Phase|Overall Study||15
1687730|NCT00524030|4123683|P2|STARTED|Overall Study||129
1687731|NCT00524030|4123684|P1|STARTED|Overall Study||32
1687732|NCT00523991|4123702|P2|NOT COMPLETED|Overall Study||27
1687733|NCT00523991|4123703|P1|NOT COMPLETED|Overall Study||21
1687734|NCT00523991|4123702|P2|COMPLETED|Overall Study||211
1687735|NCT00523991|4123703|P1|COMPLETED|Overall Study||198
1687736|NCT00523991|4123702|P2|STARTED|Overall Study||238
1687737|NCT00523991|4123703|P1|STARTED|Overall Study||219
1687738|NCT00523978|4123983|P2|NOT COMPLETED|Overall Study||8
1687739|NCT00523978|4123984|P1|NOT COMPLETED|Overall Study||9
1687740|NCT00523978|4123983|P2|COMPLETED|Overall Study||79
1687741|NCT00523978|4123984|P1|COMPLETED|Overall Study||162
1687742|NCT00523978|4123983|P2|STARTED|Overall Study||87
1687743|NCT00523978|4123984|P1|STARTED|Overall Study||171
1687744|NCT00523939|4123998|P2|NOT COMPLETED|Overall Study||0
1687745|NCT00523939|4123999|P1|NOT COMPLETED|Overall Study||0
1687746|NCT00523939|4123998|P2|COMPLETED|Overall Study||2
1687747|NCT00523939|4123999|P1|COMPLETED|Overall Study||2
1687748|NCT00523939|4123998|P2|STARTED|Overall Study||2
1687749|NCT00523939|4123999|P1|STARTED|Overall Study||2
1687750|NCT00523848|4124006|P1|NOT COMPLETED|Overall Study||24
1687751|NCT00523848|4124006|P1|COMPLETED|Overall Study||22
1687752|NCT00523848|4124006|P1|Treated With Study Therapy|Overall Study||44
1687753|NCT00523848|4124006|P1|STARTED|Overall Study||46
1687754|NCT00523809|4124012|P1|NOT COMPLETED|Overall Study||0
1687755|NCT00523809|4124012|P1|COMPLETED|Overall Study||5
1687756|NCT00523809|4124012|P1|STARTED|Overall Study||5
1687757|NCT00523744|4124016|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
1687758|NCT00523744|4124016|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
1687759|NCT00523744|4124016|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
1687760|NCT00523744|4124016|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
1687761|NCT00523744|4124016|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
1687762|NCT00523744|4124016|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
1687763|NCT00523744|4124016|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
1687764|NCT00523744|4124016|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
1687765|NCT00523744|4124016|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
1687766|NCT00523718|4124035|P2|NOT COMPLETED|Overall Study||0
1687767|NCT00523718|4124036|P1|NOT COMPLETED|Overall Study||3
1687768|NCT00523718|4124035|P2|COMPLETED|Overall Study||18
1687769|NCT00523718|4124036|P1|COMPLETED|Overall Study||17
1687770|NCT00523718|4124035|P2|STARTED|Overall Study||18
1687771|NCT00523718|4124036|P1|STARTED|Overall Study||20
1687772|NCT00523705|4124050|P2|NOT COMPLETED|Overall Study||1
1687773|NCT00523705|4124051|P1|NOT COMPLETED|Overall Study||0
1687774|NCT00523705|4124050|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
1687775|NCT00523705|4124051|P1|COMPLETED|Overall Study||7
1687776|NCT00523705|4124050|P2|STARTED|Overall Study||4
1687777|NCT00523705|4124051|P1|STARTED|Overall Study||7
1687778|NCT00523640|4124063|P1|NOT COMPLETED|Overall Study||1
1687779|NCT00523640|4124063|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
1687780|NCT00523640|4124063|P1|STARTED|Overall Study||30
1687781|NCT00523614|4124071|P2|NOT COMPLETED|Overall Study||0
1687782|NCT00523614|4124072|P1|NOT COMPLETED|Overall Study||0
1687783|NCT00523614|4124071|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
1687784|NCT00523614|4124072|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
1687785|NCT00523614|4124071|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
1687786|NCT00523614|4124072|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
1687787|NCT00523549|4124080|P2|NOT COMPLETED|Overall Study||16
1687788|NCT00523549|4124081|P1|NOT COMPLETED|Overall Study||19
1687789|NCT00523549|4124080|P2|COMPLETED|Overall Study||99
1687790|NCT00523549|4124081|P1|COMPLETED|Overall Study||95
1687791|NCT00523549|4124080|P2|STARTED|Overall Study||115
1687792|NCT00523549|4124081|P1|STARTED|Overall Study||114
1687793|NCT00523419|4124099|P1|NOT COMPLETED|Overall Study||32
1687794|NCT00523419|4124099|P1|COMPLETED|Overall Study||0
1687795|NCT00523419|4124099|P1|STARTED|Overall Study||32
1687796|NCT00523367|4124109|P1|NOT COMPLETED|Overall Study||23
1687797|NCT00523367|4124109|P1|COMPLETED|Overall Study||2
1687798|NCT00523367|4124109|P1|STARTED|Overall Study||25
1687799|NCT00523341|4124115|P2|NOT COMPLETED|Overall Study||1000
1687800|NCT00523341|4124116|P1|NOT COMPLETED|Overall Study||924
1687801|NCT00523341|4124115|P2|COMPLETED|Overall Study||1343
1687802|NCT00523341|4124116|P1|COMPLETED|Overall Study||1283
1687803|NCT00523341|4124115|P2|Received Treatment|Overall Study||2343
1687804|NCT00523341|4124116|P1|Received Treatment|Overall Study||2206
1687805|NCT00523341|4124115|P2|STARTED|Overall Study||2343
1687806|NCT00523341|4124116|P1|STARTED|Overall Study||2207
1687807|NCT00523302|4124218|P2|NOT COMPLETED|Overall Study||0
1687808|NCT00523302|4124219|P1|NOT COMPLETED|Overall Study||0
1687809|NCT00523302|4124218|P2|COMPLETED|Overall Study||10
1687810|NCT00523302|4124219|P1|COMPLETED|Overall Study||10
1687811|NCT00523302|4124218|P2|STARTED|Overall Study||10
1687812|NCT00523302|4124219|P1|STARTED|Overall Study||10
1687813|NCT00523237|4124229|P1|NOT COMPLETED|Overall Study||0
1687814|NCT00523237|4124229|P1|COMPLETED|Overall Study||14
1687815|NCT00523237|4124229|P1|STARTED|Overall Study||14
1687816|NCT00522951|4124233|P2|NOT COMPLETED|Period 2||1
1687817|NCT00522951|4124234|P1|NOT COMPLETED|Period 2||2
1687818|NCT00522951|4124233|P2|COMPLETED|Period 2||75
1687819|NCT00522951|4124234|P1|COMPLETED|Period 2||84
1687820|NCT00522951|4124233|P2|Subjects Received Treatment|Period 2||75
1687821|NCT00522951|4124234|P1|Subjects Received Treatment|Period 2||84
1687822|NCT00522951|4124233|P2|STARTED|Period 2||76
1687823|NCT00522951|4124234|P1|STARTED|Period 2||86
1687824|NCT00522951|4124233|P2|NOT COMPLETED|Washout Period||2
1687825|NCT00522951|4124234|P1|NOT COMPLETED|Washout Period||0
1687826|NCT00522951|4124233|P2|COMPLETED|Washout Period||76
1687827|NCT00522951|4124234|P1|COMPLETED|Washout Period||86
1687828|NCT00522951|4124233|P2|STARTED|Washout Period||78
1687829|NCT00522951|4124234|P1|STARTED|Washout Period||86
1687830|NCT00522951|4124233|P2|NOT COMPLETED|Period 1||1
1687831|NCT00522951|4124234|P1|NOT COMPLETED|Period 1||0
1687832|NCT00522951|4124233|P2|COMPLETED|Period 1||78
1687833|NCT00522951|4124234|P1|COMPLETED|Period 1||86
1687834|NCT00522951|4124233|P2|Received Treatment|Period 1||78
1687835|NCT00522951|4124234|P1|Received Treatment|Period 1||86
1687836|NCT00522951|4124233|P2|STARTED|Period 1||79
1687837|NCT00522951|4124234|P1|STARTED|Period 1||86
1687838|NCT00522925|4124277|P3|NOT COMPLETED|Overall Study||2
1687839|NCT00522925|4124278|P2|NOT COMPLETED|Overall Study||1
1687840|NCT00522925|4124279|P1|NOT COMPLETED|Overall Study||8
1687841|NCT00522925|4124277|P3|COMPLETED|Overall Study||36
1687842|NCT00522925|4124278|P2|COMPLETED|Overall Study||38
1687843|NCT00522925|4124279|P1|COMPLETED|Overall Study||28
1687844|NCT00522925|4124277|P3|STARTED|Overall Study||38
1687845|NCT00522925|4124278|P2|STARTED|Overall Study||39
1687846|NCT00522925|4124279|P1|STARTED|Overall Study||36
1687847|NCT00522873|4124289|P2|NOT COMPLETED|Overall Study||44
1687848|NCT00522873|4124290|P1|NOT COMPLETED|Overall Study||96
1687849|NCT00522873|4124289|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
1687850|NCT00522873|4124290|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
1687851|NCT00522873|4124289|P2|Received Treatment|Overall Study||172
1687852|NCT00522873|4124290|P1|Received Treatment|Overall Study||489
1687853|NCT00522873|4124289|P2|STARTED|Overall Study||172
1687854|NCT00522873|4124290|P1|STARTED|Overall Study||490
1687855|NCT00522795|4124299|P1|NOT COMPLETED|Overall Study||0
1687856|NCT00522795|4124299|P1|COMPLETED|Overall Study||40
1687857|NCT00522795|4124299|P1|STARTED|Overall Study||40
1687858|NCT00522626|4124303|P1|NOT COMPLETED|Overall Study||7
1687859|NCT00522626|4124303|P1|COMPLETED|Overall Study||12
1687860|NCT00522626|4124303|P1|STARTED|Overall Study||19
1687861|NCT00522548|4124309|P2|NOT COMPLETED|Overall Study||4
1687862|NCT00522548|4124310|P1|NOT COMPLETED|Overall Study||2
1687863|NCT00522548|4124309|P2|COMPLETED|Overall Study||15
1687864|NCT00522548|4124310|P1|COMPLETED|Overall Study||16
1687865|NCT00522548|4124309|P2|Completed 2/2 PK Visits|Overall Study||5
1687866|NCT00522548|4124310|P1|Completed 2/2 PK Visits|Overall Study||7
1687867|NCT00522548|4124309|P2|Completed 1/2 PK Visits|Overall Study||1
1687868|NCT00522548|4124310|P1|Completed 1/2 PK Visits|Overall Study||1
1687869|NCT00522548|4124309|P2|Completed 0/2 PK Visits|Overall Study||4
1687870|NCT00522548|4124310|P1|Completed 0/2 PK Visits|Overall Study||3
1687871|NCT00522548|4124309|P2|Consented to Pharmacokinetic Study|Overall Study||10
1687872|NCT00522548|4124310|P1|Consented to Pharmacokinetic Study|Overall Study||11
1687873|NCT00522548|4124309|P2|STARTED|Overall Study||19
1687874|NCT00522548|4124310|P1|STARTED|Overall Study||18
1687875|NCT00522457|4124338|P1|NOT COMPLETED|Overall Study||18
1687876|NCT00522457|4124338|P1|COMPLETED|Overall Study||1
1687877|NCT00522457|4124338|P1|STARTED|Overall Study||19
1687878|NCT00522431|4124344|P1|NOT COMPLETED|Overall Study||11
1687879|NCT00522431|4124344|P1|COMPLETED|Overall Study||138
1687880|NCT00522431|4124344|P1|STARTED|Overall Study||149
1687881|NCT00522418|4124351|P2|NOT COMPLETED|Overall Study||58
1687882|NCT00522418|4124352|P1|NOT COMPLETED|Overall Study||57
1687883|NCT00522418|4124351|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
1687884|NCT00522418|4124352|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
1687885|NCT00522418|4124351|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
1687886|NCT00522418|4124352|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
1687887|NCT00522418|4124351|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
1687888|NCT00522418|4124352|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
1687889|NCT00522418|4124351|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
1687890|NCT00522418|4124352|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
1687891|NCT00522418|4124351|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
1687892|NCT00522418|4124352|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
1687893|NCT00522418|4124351|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
1687894|NCT00522418|4124352|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
1687895|NCT00522418|4124351|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
1687896|NCT00522418|4124352|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
1687897|NCT00522418|4124351|P2|STARTED|Overall Study||63
1687898|NCT00522418|4124352|P1|STARTED|Overall Study||59
1687899|NCT00522392|4124400|P2|NOT COMPLETED|Overall Study||13
1687900|NCT00522392|4124401|P1|NOT COMPLETED|Overall Study||8
1687901|NCT00522392|4124400|P2|COMPLETED|Overall Study||12
1687902|NCT00522392|4124401|P1|COMPLETED|Overall Study||15
1687903|NCT00522392|4124400|P2|Pts w/ QOL Assessments Complete|Overall Study||8
1687904|NCT00522392|4124401|P1|Pts w/ QOL Assessments Complete|Overall Study||12
1687905|NCT00522392|4124400|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
1687906|NCT00522392|4124401|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
1687907|NCT00522392|4124400|P2|STARTED|Overall Study||25
1687908|NCT00522392|4124401|P1|STARTED|Overall Study||23
1687909|NCT00522379|4124418|P5|NOT COMPLETED|Overall Study||27
1687910|NCT00522379|4124419|P4|NOT COMPLETED|Overall Study||14
1687911|NCT00522379|4124420|P3|NOT COMPLETED|Overall Study||22
1687912|NCT00522379|4124421|P2|NOT COMPLETED|Overall Study||23
1687913|NCT00522379|4124422|P1|NOT COMPLETED|Overall Study||22
1687914|NCT00522379|4124418|P5|COMPLETED|Overall Study||81
1687915|NCT00522379|4124419|P4|COMPLETED|Overall Study||80
1687916|NCT00522379|4124420|P3|COMPLETED|Overall Study||82
1687917|NCT00522379|4124421|P2|COMPLETED|Overall Study||84
1687918|NCT00522379|4124422|P1|COMPLETED|Overall Study||79
1687919|NCT00522379|4124418|P5|STARTED|Overall Study||108
1687920|NCT00522379|4124419|P4|STARTED|Overall Study||94
1687921|NCT00522379|4124420|P3|STARTED|Overall Study||104
1687922|NCT00522379|4124421|P2|STARTED|Overall Study||107
1687923|NCT00522379|4124422|P1|STARTED|Overall Study||101
1687924|NCT00522301|4124524|P1|NOT COMPLETED|Overall Study||6
1687925|NCT00522301|4124524|P1|COMPLETED|Overall Study||0
1687926|NCT00522301|4124524|P1|STARTED|Overall Study||6
1687927|NCT00522275|4124528|P1|NOT COMPLETED|Overall Study||170
1687928|NCT00522275|4124528|P1|COMPLETED|Overall Study||138
1687929|NCT00522275|4124528|P1|STARTED|Overall Study||308
1687930|NCT00522171|4124538|P2|NOT COMPLETED|Overall Study||0
1687931|NCT00522171|4124539|P1|NOT COMPLETED|Overall Study||0
1687932|NCT00522171|4124538|P2|COMPLETED|Overall Study||15
1687933|NCT00522171|4124539|P1|COMPLETED|Overall Study||15
1687934|NCT00522171|4124538|P2|STARTED|Overall Study||15
1687935|NCT00522171|4124539|P1|STARTED|Overall Study||15
1687936|NCT00522041|4124549|P2|NOT COMPLETED|Overall Study||12
1687937|NCT00522041|4124550|P1|NOT COMPLETED|Overall Study||17
1687938|NCT00522041|4124549|P2|COMPLETED|Overall Study||113
1687939|NCT00522041|4124550|P1|COMPLETED|Overall Study||106
1687940|NCT00522041|4124549|P2|Received Treatment|Overall Study||124
1687941|NCT00522041|4124550|P1|Received Treatment|Overall Study||123
1687942|NCT00522041|4124549|P2|STARTED|Overall Study||125
1687943|NCT00522041|4124550|P1|STARTED|Overall Study||123
1687944|NCT00521989|4124565|P5|NOT COMPLETED|Overall Study||23
1687945|NCT00521989|4124566|P4|NOT COMPLETED|Overall Study||12
1687946|NCT00521989|4124567|P3|NOT COMPLETED|Overall Study||16
1687947|NCT00521989|4124568|P2|NOT COMPLETED|Overall Study||17
1687948|NCT00521989|4124569|P1|NOT COMPLETED|Overall Study||20
1687949|NCT00521989|4124565|P5|COMPLETED|Overall Study||35
1687950|NCT00521989|4124566|P4|COMPLETED|Overall Study||42
1687951|NCT00521989|4124567|P3|COMPLETED|Overall Study||41
1687952|NCT00521989|4124568|P2|COMPLETED|Overall Study||37
1687953|NCT00521989|4124569|P1|COMPLETED|Overall Study||36
1687954|NCT00521989|4124565|P5|STARTED|Overall Study||58
1687955|NCT00521989|4124566|P4|STARTED|Overall Study||54
1687956|NCT00521989|4124567|P3|STARTED|Overall Study||57
1687957|NCT00521989|4124568|P2|STARTED|Overall Study||54
1687958|NCT00521989|4124569|P1|STARTED|Overall Study||56
1687959|NCT00521976|4124581|P1|NOT COMPLETED|Overall Study||0
1687960|NCT00521976|4124581|P1|COMPLETED|Overall Study||871
1687961|NCT00521976|4124581|P1|STARTED|Overall Study||871
1687962|NCT00521924|4124588|P2|NOT COMPLETED|Overall Study||4
1687963|NCT00521924|4124589|P1|NOT COMPLETED|Overall Study||4
1687964|NCT00521924|4124588|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
1687965|NCT00521924|4124589|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
1687966|NCT00521924|4124588|P2|STARTED|Overall Study|Subjects randomized|4
1687967|NCT00521924|4124589|P1|STARTED|Overall Study|Subjects randomized|4
1687968|NCT00521885|4124597|P2|NOT COMPLETED|Overall Study||0
1687969|NCT00521885|4124598|P1|NOT COMPLETED|Overall Study||0
1687970|NCT00521885|4124597|P2|COMPLETED|Overall Study||0
1687971|NCT00521885|4124598|P1|COMPLETED|Overall Study||0
1687972|NCT00521885|4124597|P2|STARTED|Overall Study||0
1687973|NCT00521885|4124598|P1|STARTED|Overall Study||0
1687974|NCT00521599|4124609|P3|NOT COMPLETED|Overall Study||36
1687975|NCT00521599|4124610|P2|NOT COMPLETED|Overall Study||29
1687976|NCT00521599|4124611|P1|NOT COMPLETED|Overall Study||25
1687977|NCT00521599|4124609|P3|COMPLETED|Overall Study||100
1687978|NCT00521599|4124610|P2|COMPLETED|Overall Study||239
1687979|NCT00521599|4124611|P1|COMPLETED|Overall Study||243
1687980|NCT00521599|4124609|P3|STARTED|Overall Study||136
1687981|NCT00521599|4124610|P2|STARTED|Overall Study||268
1687982|NCT00521599|4124611|P1|STARTED|Overall Study||268
1687983|NCT00521586|4124622|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
1687984|NCT00521586|4124623|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
1687985|NCT00521586|4124622|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
1687986|NCT00521586|4124623|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
1687987|NCT00521586|4124622|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
1687988|NCT00521586|4124623|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
1687989|NCT00521586|4124622|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
1687990|NCT00521586|4124623|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
1687991|NCT00521586|4124622|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
1687992|NCT00521586|4124623|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
1687993|NCT00521586|4124622|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
1687994|NCT00521586|4124623|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
1687995|NCT00521586|4124622|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
1687996|NCT00521586|4124623|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
1687997|NCT00521586|4124622|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
1687998|NCT00521586|4124623|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
1687999|NCT00521586|4124622|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
1688000|NCT00521586|4124623|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
1688001|NCT00521586|4124622|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
1688002|NCT00521586|4124623|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
1688003|NCT00521586|4124622|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
1688004|NCT00521586|4124623|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
1688005|NCT00521586|4124622|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
1688006|NCT00521586|4124623|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
1688007|NCT00521586|4124622|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
1688008|NCT00521586|4124623|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
1688009|NCT00521586|4124622|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
1688010|NCT00521586|4124623|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
1688011|NCT00521586|4124622|P2|STARTED|Initial Vaccination (Year 0)||562
1688012|NCT00521586|4124623|P1|STARTED|Initial Vaccination (Year 0)||554
1688013|NCT00521456|4124683|P2|NOT COMPLETED|Overall Study||28
1688014|NCT00521456|4124684|P1|NOT COMPLETED|Overall Study||13
1688015|NCT00521456|4124683|P2|COMPLETED|Overall Study||59
1688016|NCT00521456|4124684|P1|COMPLETED|Overall Study||163
1688017|NCT00521456|4124683|P2|STARTED|Overall Study||87
1688018|NCT00521456|4124684|P1|STARTED|Overall Study||176
1688019|NCT00521365|4124696|P1|NOT COMPLETED|Overall Study||20
1688020|NCT00521365|4124696|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
1688021|NCT00521365|4124696|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
1688022|NCT00521365|4124696|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
1688023|NCT00521365|4124696|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
1688024|NCT00521365|4124696|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
1688025|NCT00521352|4124715|P2|NOT COMPLETED|Overall Study||3
1688026|NCT00521352|4124716|P1|NOT COMPLETED|Overall Study||1
1688027|NCT00521352|4124715|P2|COMPLETED|Overall Study||10
1688028|NCT00521352|4124716|P1|COMPLETED|Overall Study||11
1688029|NCT00521352|4124715|P2|STARTED|Overall Study||13
1688030|NCT00521352|4124716|P1|STARTED|Overall Study||12
1688031|NCT00521339|4124726|P3|NOT COMPLETED|Observational Follow Up Phase||0
1688032|NCT00521339|4124727|P2|NOT COMPLETED|Observational Follow Up Phase||0
1688033|NCT00521339|4124728|P1|NOT COMPLETED|Observational Follow Up Phase||0
1688034|NCT00521339|4124726|P3|COMPLETED|Observational Follow Up Phase||4
1688035|NCT00521339|4124727|P2|COMPLETED|Observational Follow Up Phase||4
1688036|NCT00521339|4124728|P1|COMPLETED|Observational Follow Up Phase||14
1688037|NCT00521339|4124726|P3|STARTED|Observational Follow Up Phase||4
1688038|NCT00521339|4124727|P2|STARTED|Observational Follow Up Phase||4
1688039|NCT00521339|4124728|P1|STARTED|Observational Follow Up Phase||14
1688040|NCT00521339|4124726|P3|NOT COMPLETED|Treatment Extension Phase||3
1688041|NCT00521339|4124727|P2|NOT COMPLETED|Treatment Extension Phase||0
1688042|NCT00521339|4124728|P1|NOT COMPLETED|Treatment Extension Phase||0
1688043|NCT00521339|4124726|P3|COMPLETED|Treatment Extension Phase||4
1688044|NCT00521339|4124727|P2|COMPLETED|Treatment Extension Phase||4
1688045|NCT00521339|4124728|P1|COMPLETED|Treatment Extension Phase||0
1688046|NCT00521339|4124726|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
1688047|NCT00521339|4124727|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
1688048|NCT00521339|4124728|P1|STARTED|Treatment Extension Phase||0
1688049|NCT00521339|4124726|P3|NOT COMPLETED|Treatment Phase||0
1688050|NCT00521339|4124727|P2|NOT COMPLETED|Treatment Phase||0
1688051|NCT00521339|4124728|P1|NOT COMPLETED|Treatment Phase||12
1688052|NCT00521339|4124726|P3|COMPLETED|Treatment Phase||0
1688053|NCT00521339|4124727|P2|COMPLETED|Treatment Phase||0
1688054|NCT00521339|4124728|P1|COMPLETED|Treatment Phase||19
1688055|NCT00521339|4124726|P3|Received Apremilast|Treatment Phase||0
1688056|NCT00521339|4124727|P2|Received Apremilast|Treatment Phase||0
1688057|NCT00521339|4124728|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
1688058|NCT00521339|4124726|P3|STARTED|Treatment Phase||0
1688059|NCT00521339|4124727|P2|STARTED|Treatment Phase||0
1688060|NCT00521339|4124728|P1|STARTED|Treatment Phase||31
1688061|NCT00521144|4124796|P5|NOT COMPLETED|Overall Study||7
1688062|NCT00521144|4124797|P4|NOT COMPLETED|Overall Study||1
1688063|NCT00521144|4124798|P3|NOT COMPLETED|Overall Study||2
1688064|NCT00521144|4124799|P2|NOT COMPLETED|Overall Study||3
1688065|NCT00521144|4124800|P1|NOT COMPLETED|Overall Study||4
1688066|NCT00521144|4124796|P5|COMPLETED|Overall Study||0
1688067|NCT00521144|4124797|P4|COMPLETED|Overall Study||0
1688068|NCT00521144|4124798|P3|COMPLETED|Overall Study||1
1688069|NCT00521144|4124799|P2|COMPLETED|Overall Study||2
1688070|NCT00521144|4124800|P1|COMPLETED|Overall Study||2
1688071|NCT00521144|4124796|P5|STARTED|Overall Study||7
1688072|NCT00521144|4124797|P4|STARTED|Overall Study||1
1688073|NCT00521144|4124798|P3|STARTED|Overall Study||3
1688074|NCT00521144|4124799|P2|STARTED|Overall Study||5
1688075|NCT00521144|4124800|P1|STARTED|Overall Study||6
1688076|NCT00521079|4124814|P2|NOT COMPLETED|Overall Study||5
1688077|NCT00521079|4124815|P1|NOT COMPLETED|Overall Study||14
1688078|NCT00521079|4124814|P2|COMPLETED|Overall Study||97
1688079|NCT00521079|4124815|P1|COMPLETED|Overall Study||178
1688080|NCT00521079|4124814|P2|Surgical Roll-In|Overall Study||5
1688081|NCT00521079|4124815|P1|Surgical Roll-In|Overall Study||9
1688082|NCT00521079|4124814|P2|STARTED|Overall Study||102
1688083|NCT00521079|4124815|P1|STARTED|Overall Study||192
1688084|NCT00521053|4124825|P1|NOT COMPLETED|Observation Phase||68
1688085|NCT00521053|4124825|P1|COMPLETED|Observation Phase||12
1688086|NCT00521053|4124825|P1|STARTED|Observation Phase||80
1688087|NCT00521053|4124825|P1|NOT COMPLETED|Treatment Phase||0
1688088|NCT00521053|4124825|P1|COMPLETED|Treatment Phase||80
1688089|NCT00521053|4124825|P1|Received 4 Cycles of PV-10|Treatment Phase||3
1688090|NCT00521053|4124825|P1|Received 3 Cycles of PV-10|Treatment Phase||16
1688091|NCT00521053|4124825|P1|Received 2 Cycles of PV-10|Treatment Phase||26
1688092|NCT00521053|4124825|P1|Received 1 Cycle of PV-10|Treatment Phase||35
1688093|NCT00521053|4124825|P1|STARTED|Treatment Phase||80
1688094|NCT00521014|4124835|P1|NOT COMPLETED|Overall Study||1
1688095|NCT00521014|4124835|P1|COMPLETED|Overall Study||13
1688096|NCT00521014|4124835|P1|STARTED|Overall Study||14
1688097|NCT00521001|4124839|P1|NOT COMPLETED|Overall Study||1
1688098|NCT00521001|4124839|P1|COMPLETED|Overall Study||48
1688099|NCT00521001|4124839|P1|STARTED|Overall Study||49
1688100|NCT00520975|4124848|P2|NOT COMPLETED|Overall Study||48
1688101|NCT00520975|4124849|P1|NOT COMPLETED|Overall Study||48
1688102|NCT00520975|4124848|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
1688103|NCT00520975|4124849|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
1688104|NCT00520975|4124848|P2|Treated and Reported Adverse Events Data|Overall Study||45
1688105|NCT00520975|4124849|P1|Treated and Reported Adverse Events Data|Overall Study||47
1688106|NCT00520975|4124848|P2|STARTED|Overall Study||48
1688107|NCT00520975|4124849|P1|STARTED|Overall Study||48
1688108|NCT00520936|4124881|P8|NOT COMPLETED|Overall Study||1
1688109|NCT00520936|4124882|P7|NOT COMPLETED|Overall Study||4
1688110|NCT00520936|4124883|P6|NOT COMPLETED|Overall Study||0
1688111|NCT00520936|4124884|P5|NOT COMPLETED|Overall Study||1
1688112|NCT00520936|4124885|P4|NOT COMPLETED|Overall Study||0
1688113|NCT00520936|4124886|P3|NOT COMPLETED|Overall Study||2
1688114|NCT00520936|4124887|P2|NOT COMPLETED|Overall Study||4
1688115|NCT00520936|4124888|P1|NOT COMPLETED|Overall Study||0
1688116|NCT00520936|4124881|P8|COMPLETED|Overall Study||9
1688117|NCT00520936|4124882|P7|COMPLETED|Overall Study||7
1688118|NCT00520936|4124883|P6|COMPLETED|Overall Study||10
1688119|NCT00520936|4124884|P5|COMPLETED|Overall Study||5
1688120|NCT00520936|4124885|P4|COMPLETED|Overall Study||5
1688121|NCT00520936|4124886|P3|COMPLETED|Overall Study||7
1688122|NCT00520936|4124887|P2|COMPLETED|Overall Study||7
1688123|NCT00520936|4124888|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
1688124|NCT00520936|4124881|P8|STARTED|Overall Study||10
1688125|NCT00520936|4124882|P7|STARTED|Overall Study||11
1688126|NCT00520936|4124883|P6|STARTED|Overall Study||10
1688127|NCT00520936|4124884|P5|STARTED|Overall Study||6
1688128|NCT00520936|4124885|P4|STARTED|Overall Study||5
1688129|NCT00520936|4124886|P3|STARTED|Overall Study||9
1688130|NCT00520936|4124887|P2|STARTED|Overall Study||11
1688131|NCT00520936|4124888|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
1688132|NCT00520845|4124915|P1|NOT COMPLETED|Overall Study||22
1688133|NCT00520845|4124915|P1|COMPLETED|Overall Study||1
1688134|NCT00520845|4124915|P1|STARTED|Overall Study||23
1688135|NCT00520767|4124923|P1|NOT COMPLETED|Overall Study||2
1688136|NCT00520767|4124923|P1|COMPLETED|Overall Study||33
1688137|NCT00520767|4124923|P1|STARTED|Overall Study||35
1688138|NCT00520741|4124929|P2|NOT COMPLETED|Overall Study||125
1688139|NCT00520741|4124930|P1|NOT COMPLETED|Overall Study||37
1688140|NCT00520741|4124929|P2|COMPLETED|Overall Study||194
1688141|NCT00520741|4124930|P1|COMPLETED|Overall Study||69
1688142|NCT00520741|4124929|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
1688143|NCT00520741|4124930|P1|STARTED|Overall Study||106
1688144|NCT00520676|4124948|P2|NOT COMPLETED|Overall Study||103
1688145|NCT00520676|4124949|P1|NOT COMPLETED|Overall Study||101
1688146|NCT00520676|4124948|P2|COMPLETED|Overall Study||29
1688147|NCT00520676|4124949|P1|COMPLETED|Overall Study||27
1688148|NCT00520676|4124948|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
1688149|NCT00520676|4124949|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
1688150|NCT00520676|4124948|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
1688151|NCT00520676|4124949|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
1688152|NCT00520676|4124948|P2|STARTED|Overall Study||132
1688153|NCT00520676|4124949|P1|STARTED|Overall Study||128
1688154|NCT00520572|4124975|P6|NOT COMPLETED|Overall Study||2
1688155|NCT00520572|4124976|P5|NOT COMPLETED|Overall Study||12
1688156|NCT00520572|4124977|P4|NOT COMPLETED|Overall Study||14
1688157|NCT00520572|4124978|P3|NOT COMPLETED|Overall Study||15
1688158|NCT00520572|4124979|P2|NOT COMPLETED|Overall Study||14
1688159|NCT00520572|4124980|P1|NOT COMPLETED|Overall Study||12
1688160|NCT00520572|4124975|P6|COMPLETED|Overall Study|Participants completed the study.|62
1688161|NCT00520572|4124976|P5|COMPLETED|Overall Study|Participants completed the study.|53
1688162|NCT00520572|4124977|P4|COMPLETED|Overall Study|Participants completed the study.|50
1688163|NCT00520572|4124978|P3|COMPLETED|Overall Study|Participants completed the study.|49
1688164|NCT00520572|4124979|P2|COMPLETED|Overall Study|Participants completed the study.|50
1688165|NCT00520572|4124980|P1|COMPLETED|Overall Study|Participants completed the study.|52
1688166|NCT00520572|4124975|P6|STARTED|Overall Study|Participants randomised.|64
1688167|NCT00520572|4124976|P5|STARTED|Overall Study|Participants randomised.|65
1688168|NCT00520572|4124977|P4|STARTED|Overall Study|Participants randomised.|64
1688169|NCT00520572|4124978|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
1688170|NCT00520572|4124979|P2|STARTED|Overall Study|Participants randomised.|64
1688171|NCT00520572|4124980|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
1688172|NCT00520546|4125018|P1|NOT COMPLETED|Overall Study||6
1688173|NCT00520546|4125018|P1|COMPLETED|Overall Study||38
1688174|NCT00520546|4125018|P1|STARTED|Overall Study||44
1688175|NCT00520494|4125033|P1|NOT COMPLETED|Overall Study||1
1688176|NCT00520494|4125033|P1|COMPLETED|Overall Study||17
1688177|NCT00520494|4125033|P1|STARTED|Overall Study||18
1688178|NCT00520481|4125058|P2|NOT COMPLETED|Overall Study||1
1688179|NCT00520481|4125059|P1|NOT COMPLETED|Overall Study||7
1688180|NCT00520481|4125058|P2|COMPLETED|Overall Study||9
1688181|NCT00520481|4125059|P1|COMPLETED|Overall Study||24
1688182|NCT00520481|4125058|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
1688183|NCT00520481|4125059|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
1688184|NCT00520481|4125058|P2|STARTED|Overall Study||10
1688185|NCT00520481|4125059|P1|STARTED|Overall Study||31
1688186|NCT00520468|4125079|P1|NOT COMPLETED|Overall Study||0
1688187|NCT00520468|4125079|P1|COMPLETED|Overall Study||14
1688188|NCT00520468|4125079|P1|STARTED|Overall Study||14
1688189|NCT00520403|4125083|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
1688190|NCT00520403|4125083|P1|COMPLETED|Bevacizumab Monotherapy||0
1688191|NCT00520403|4125083|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
1688192|NCT00520403|4125083|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
1688193|NCT00520403|4125083|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
1688194|NCT00520403|4125083|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
1688195|NCT00520351|4125092|P2|NOT COMPLETED|Second Intervention||0
1688196|NCT00520351|4125093|P1|NOT COMPLETED|Second Intervention||0
1688197|NCT00520351|4125092|P2|COMPLETED|Second Intervention||14
1688198|NCT00520351|4125093|P1|COMPLETED|Second Intervention||14
1688199|NCT00520351|4125092|P2|STARTED|Second Intervention||14
1688200|NCT00520351|4125093|P1|STARTED|Second Intervention||14
1688201|NCT00520351|4125092|P2|NOT COMPLETED|First Intervention||1
1688202|NCT00520351|4125093|P1|NOT COMPLETED|First Intervention||1
1688203|NCT00520351|4125092|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
1688204|NCT00520351|4125093|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
1688205|NCT00520351|4125092|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
1688206|NCT00520351|4125093|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
1688207|NCT00520299|4125108|P3|NOT COMPLETED|Overall Study||6
1688208|NCT00520299|4125109|P2|NOT COMPLETED|Overall Study||3
1688209|NCT00520299|4125110|P1|NOT COMPLETED|Overall Study||0
1688210|NCT00520299|4125108|P3|COMPLETED|Overall Study||13
1688211|NCT00520299|4125109|P2|COMPLETED|Overall Study||3
1688212|NCT00520299|4125110|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
1688213|NCT00520299|4125108|P3|STARTED|Overall Study||19
1688214|NCT00520299|4125109|P2|STARTED|Overall Study||6
1688215|NCT00520299|4125110|P1|STARTED|Overall Study||6
1688216|NCT00520286|4125141|P2|NOT COMPLETED|Overall Study||32
1688217|NCT00520286|4125142|P1|NOT COMPLETED|Overall Study||66
1688218|NCT00520286|4125141|P2|COMPLETED|Overall Study||36
1688219|NCT00520286|4125142|P1|COMPLETED|Overall Study||76
1688220|NCT00520286|4125141|P2|STARTED|Overall Study||68
1688221|NCT00520286|4125142|P1|STARTED|Overall Study||142
1688222|NCT00520234|4125152|P2|NOT COMPLETED|Overall Study||2
1688223|NCT00520234|4125153|P1|NOT COMPLETED|Overall Study||1
1688224|NCT00520234|4125152|P2|COMPLETED|Overall Study||102
1688225|NCT00520234|4125153|P1|COMPLETED|Overall Study||117
1688226|NCT00520234|4125152|P2|STARTED|Overall Study||104
1688227|NCT00520234|4125153|P1|STARTED|Overall Study||118
1688228|NCT00520130|4125165|P2|NOT COMPLETED|Overall Study||1
1688229|NCT00520130|4125166|P1|NOT COMPLETED|Overall Study||5
1688230|NCT00520130|4125165|P2|COMPLETED|Overall Study||44
1688231|NCT00520130|4125166|P1|COMPLETED|Overall Study||39
1688232|NCT00520130|4125165|P2|STARTED|Overall Study||45
1688233|NCT00520130|4125166|P1|STARTED|Overall Study||44
1688234|NCT00520039|4125208|P2|NOT COMPLETED|Overall Study||5
1688235|NCT00520039|4125209|P1|NOT COMPLETED|Overall Study||7
1688236|NCT00520039|4125208|P2|COMPLETED|Overall Study||19
1688237|NCT00520039|4125209|P1|COMPLETED|Overall Study||21
1688238|NCT00520039|4125208|P2|STARTED|Overall Study||24
1688239|NCT00520039|4125209|P1|STARTED|Overall Study||28
1688240|NCT00520013|4125222|P3|NOT COMPLETED|Overall Study||11
1688241|NCT00520013|4125223|P2|NOT COMPLETED|Overall Study||15
1688242|NCT00520013|4125224|P1|NOT COMPLETED|Overall Study||12
1688243|NCT00520013|4125222|P3|COMPLETED|Overall Study||0
1688244|NCT00520013|4125223|P2|COMPLETED|Overall Study||10
1688245|NCT00520013|4125224|P1|COMPLETED|Overall Study||11
1688246|NCT00520013|4125222|P3|Treated|Overall Study||11
1688247|NCT00520013|4125223|P2|Treated|Overall Study||25
1688248|NCT00520013|4125224|P1|Treated|Overall Study||23
1688249|NCT00520013|4125222|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
1688250|NCT00520013|4125223|P2|STARTED|Overall Study||25
1688251|NCT00520013|4125224|P1|STARTED|Overall Study||23
1688252|NCT00519896|4125234|P1|NOT COMPLETED|Overall Study||2
1688253|NCT00519896|4125234|P1|COMPLETED|Overall Study||33
1688254|NCT00519896|4125234|P1|STARTED|Overall Study||35
1688255|NCT00519831|4125240|P1|NOT COMPLETED|Overall Study||3
1688256|NCT00519831|4125240|P1|COMPLETED|Overall Study||13
1688257|NCT00519831|4125240|P1|STARTED|Overall Study||16
1688258|NCT00519818|4125247|P1|NOT COMPLETED|Overall Study||0
1688259|NCT00519818|4125247|P1|COMPLETED|Overall Study||14
1688260|NCT00519818|4125247|P1|STARTED|Overall Study||14
1688261|NCT00519779|4125257|P2|NOT COMPLETED|Overall Study||1
1688262|NCT00519779|4125258|P1|NOT COMPLETED|Overall Study||0
1688263|NCT00519779|4125257|P2|COMPLETED|Overall Study||33
1688264|NCT00519779|4125258|P1|COMPLETED|Overall Study||34
1688265|NCT00519779|4125257|P2|STARTED|Overall Study||34
1688266|NCT00519779|4125258|P1|STARTED|Overall Study||34
1688267|NCT00519649|4125274|P1|NOT COMPLETED|Overall Study||1
1688268|NCT00519649|4125274|P1|COMPLETED|Overall Study||299
1688269|NCT00519649|4125274|P1|STARTED|Overall Study||300
1688270|NCT00519636|4125287|P4|NOT COMPLETED|Post Study Period||1
1688271|NCT00519636|4125288|P3|NOT COMPLETED|Post Study Period||0
1688272|NCT00519636|4125289|P2|NOT COMPLETED|Post Study Period||0
1688273|NCT00519636|4125290|P1|NOT COMPLETED|Post Study Period||0
1688274|NCT00519636|4125287|P4|COMPLETED|Post Study Period||85
1688275|NCT00519636|4125288|P3|COMPLETED|Post Study Period||74
1688276|NCT00519636|4125289|P2|COMPLETED|Post Study Period||71
1688277|NCT00519636|4125290|P1|COMPLETED|Post Study Period||69
1688278|NCT00519636|4125287|P4|STARTED|Post Study Period||86
1688279|NCT00519636|4125288|P3|STARTED|Post Study Period||74
1688280|NCT00519636|4125289|P2|STARTED|Post Study Period||71
1688281|NCT00519636|4125290|P1|STARTED|Post Study Period||69
1688282|NCT00519636|4125287|P4|NOT COMPLETED|Treatment Period 2||2
1688283|NCT00519636|4125288|P3|NOT COMPLETED|Treatment Period 2||1
1688284|NCT00519636|4125289|P2|NOT COMPLETED|Treatment Period 2||1
1688285|NCT00519636|4125290|P1|NOT COMPLETED|Treatment Period 2||0
1688286|NCT00519636|4125287|P4|COMPLETED|Treatment Period 2||86
1688287|NCT00519636|4125288|P3|COMPLETED|Treatment Period 2||74
1688288|NCT00519636|4125289|P2|COMPLETED|Treatment Period 2||71
1688289|NCT00519636|4125290|P1|COMPLETED|Treatment Period 2||69
1688290|NCT00519636|4125287|P4|STARTED|Treatment Period 2||88
1688291|NCT00519636|4125288|P3|STARTED|Treatment Period 2||75
1688292|NCT00519636|4125289|P2|STARTED|Treatment Period 2||72
1688293|NCT00519636|4125290|P1|STARTED|Treatment Period 2||69
1688294|NCT00519636|4125287|P4|NOT COMPLETED|Washout Period||5
1688295|NCT00519636|4125288|P3|NOT COMPLETED|Washout Period||14
1688296|NCT00519636|4125289|P2|NOT COMPLETED|Washout Period||14
1688297|NCT00519636|4125290|P1|NOT COMPLETED|Washout Period||20
1688298|NCT00519636|4125287|P4|COMPLETED|Washout Period||88
1688299|NCT00519636|4125288|P3|COMPLETED|Washout Period||75
1688300|NCT00519636|4125289|P2|COMPLETED|Washout Period||72
1688301|NCT00519636|4125290|P1|COMPLETED|Washout Period||69
1688302|NCT00519636|4125287|P4|STARTED|Washout Period||93
1688303|NCT00519636|4125288|P3|STARTED|Washout Period||89
1688304|NCT00519636|4125289|P2|STARTED|Washout Period||86
1688305|NCT00519636|4125290|P1|STARTED|Washout Period||89
1688306|NCT00519636|4125287|P4|NOT COMPLETED|Treatment Period 1||0
1688307|NCT00519636|4125288|P3|NOT COMPLETED|Treatment Period 1||1
1688308|NCT00519636|4125289|P2|NOT COMPLETED|Treatment Period 1||0
1688309|NCT00519636|4125290|P1|NOT COMPLETED|Treatment Period 1||2
1688310|NCT00519636|4125287|P4|COMPLETED|Treatment Period 1||93
1688311|NCT00519636|4125288|P3|COMPLETED|Treatment Period 1||89
1688312|NCT00519636|4125289|P2|COMPLETED|Treatment Period 1||86
1688313|NCT00519636|4125290|P1|COMPLETED|Treatment Period 1||89
1688314|NCT00519636|4125287|P4|STARTED|Treatment Period 1||93
1688315|NCT00519636|4125288|P3|STARTED|Treatment Period 1||90
1688316|NCT00519636|4125289|P2|STARTED|Treatment Period 1||86
1688317|NCT00519636|4125290|P1|STARTED|Treatment Period 1||91
1688318|NCT00519623|4125320|P1|NOT COMPLETED|Overall Study||1
1688319|NCT00519623|4125320|P1|COMPLETED|Overall Study||8
1688320|NCT00519623|4125320|P1|STARTED|Overall Study||9
1688321|NCT00519584|4125329|P4|NOT COMPLETED|Overall Study||0
1688322|NCT00519584|4125330|P3|NOT COMPLETED|Overall Study||0
1688323|NCT00519584|4125331|P2|NOT COMPLETED|Overall Study||0
1688324|NCT00519584|4125332|P1|NOT COMPLETED|Overall Study||0
1688325|NCT00519584|4125329|P4|COMPLETED|Overall Study||56
1688326|NCT00519584|4125330|P3|COMPLETED|Overall Study||54
1688327|NCT00519584|4125331|P2|COMPLETED|Overall Study||54
1688328|NCT00519584|4125332|P1|COMPLETED|Overall Study||54
1688329|NCT00519584|4125329|P4|STARTED|Overall Study||56
1688330|NCT00519584|4125330|P3|STARTED|Overall Study||54
1688331|NCT00519584|4125331|P2|STARTED|Overall Study||54
1688332|NCT00519584|4125332|P1|STARTED|Overall Study||54
1688333|NCT00519532|4125354|P1|NOT COMPLETED|Overall Study||18
1688334|NCT00519532|4125354|P1|COMPLETED|Overall Study||66
1688335|NCT00519532|4125354|P1|STARTED|Overall Study||84
1688336|NCT00519428|4125364|P3|NOT COMPLETED|Overall Study||25
1688337|NCT00519428|4125365|P2|NOT COMPLETED|Overall Study||15
1688338|NCT00519428|4125366|P1|NOT COMPLETED|Overall Study||21
1688339|NCT00519428|4125364|P3|COMPLETED|Overall Study||58
1688340|NCT00519428|4125365|P2|COMPLETED|Overall Study||69
1688341|NCT00519428|4125366|P1|COMPLETED|Overall Study||57
1688342|NCT00519428|4125364|P3|STARTED|Overall Study||83
1688343|NCT00519428|4125365|P2|STARTED|Overall Study||84
1688344|NCT00519428|4125366|P1|STARTED|Overall Study||78
1688345|NCT00519376|4125386|P16|NOT COMPLETED|Treatment Period 4||0
1688346|NCT00519376|4125387|P15|NOT COMPLETED|Treatment Period 4||0
1688347|NCT00519376|4125388|P14|NOT COMPLETED|Treatment Period 4||0
1688348|NCT00519376|4125389|P13|NOT COMPLETED|Treatment Period 4||0
1688349|NCT00519376|4125390|P12|NOT COMPLETED|Treatment Period 4||0
1688350|NCT00519376|4125391|P11|NOT COMPLETED|Treatment Period 4||0
1688351|NCT00519376|4125392|P10|NOT COMPLETED|Treatment Period 4||0
1688352|NCT00519376|4125393|P9|NOT COMPLETED|Treatment Period 4||0
1688353|NCT00519376|4125394|P8|NOT COMPLETED|Treatment Period 4||0
1688354|NCT00519376|4125395|P7|NOT COMPLETED|Treatment Period 4||0
1688355|NCT00519376|4125396|P6|NOT COMPLETED|Treatment Period 4||0
1688356|NCT00519376|4125397|P5|NOT COMPLETED|Treatment Period 4||0
1688357|NCT00519376|4125398|P4|NOT COMPLETED|Treatment Period 4||0
1688358|NCT00519376|4125399|P3|NOT COMPLETED|Treatment Period 4||1
1688359|NCT00519376|4125400|P2|NOT COMPLETED|Treatment Period 4||0
1688360|NCT00519376|4125401|P1|NOT COMPLETED|Treatment Period 4||0
1688361|NCT00519376|4125386|P16|COMPLETED|Treatment Period 4||1
1688362|NCT00519376|4125387|P15|COMPLETED|Treatment Period 4||1
1688363|NCT00519376|4125388|P14|COMPLETED|Treatment Period 4||1
1688364|NCT00519376|4125389|P13|COMPLETED|Treatment Period 4||0
1688365|NCT00519376|4125390|P12|COMPLETED|Treatment Period 4||1
1688366|NCT00519376|4125391|P11|COMPLETED|Treatment Period 4||1
1688367|NCT00519376|4125392|P10|COMPLETED|Treatment Period 4||1
1688368|NCT00519376|4125393|P9|COMPLETED|Treatment Period 4||1
1688369|NCT00519376|4125394|P8|COMPLETED|Treatment Period 4||1
1688370|NCT00519376|4125395|P7|COMPLETED|Treatment Period 4||1
1688371|NCT00519376|4125396|P6|COMPLETED|Treatment Period 4||1
1688372|NCT00519376|4125397|P5|COMPLETED|Treatment Period 4||1
1688373|NCT00519376|4125398|P4|COMPLETED|Treatment Period 4||2
1688374|NCT00519376|4125399|P3|COMPLETED|Treatment Period 4||1
1688375|NCT00519376|4125400|P2|COMPLETED|Treatment Period 4||2
1688376|NCT00519376|4125401|P1|COMPLETED|Treatment Period 4||2
1688377|NCT00519376|4125386|P16|STARTED|Treatment Period 4||1
1688378|NCT00519376|4125387|P15|STARTED|Treatment Period 4||1
1688379|NCT00519376|4125388|P14|STARTED|Treatment Period 4||1
1688380|NCT00519376|4125389|P13|STARTED|Treatment Period 4||0
1688381|NCT00519376|4125390|P12|STARTED|Treatment Period 4||1
1688382|NCT00519376|4125391|P11|STARTED|Treatment Period 4||1
1688383|NCT00519376|4125392|P10|STARTED|Treatment Period 4||1
1688384|NCT00519376|4125393|P9|STARTED|Treatment Period 4||1
1688385|NCT00519376|4125394|P8|STARTED|Treatment Period 4||1
1688386|NCT00519376|4125395|P7|STARTED|Treatment Period 4||1
1688387|NCT00519376|4125396|P6|STARTED|Treatment Period 4||1
1688388|NCT00519376|4125397|P5|STARTED|Treatment Period 4||1
1688389|NCT00519376|4125398|P4|STARTED|Treatment Period 4||2
1688390|NCT00519376|4125399|P3|STARTED|Treatment Period 4||2
1688391|NCT00519376|4125400|P2|STARTED|Treatment Period 4||2
1688392|NCT00519376|4125401|P1|STARTED|Treatment Period 4||2
1688393|NCT00519376|4125386|P16|NOT COMPLETED|Washout Period 3||0
1688394|NCT00519376|4125387|P15|NOT COMPLETED|Washout Period 3||0
1688395|NCT00519376|4125388|P14|NOT COMPLETED|Washout Period 3||0
1688396|NCT00519376|4125389|P13|NOT COMPLETED|Washout Period 3||0
1688397|NCT00519376|4125390|P12|NOT COMPLETED|Washout Period 3||0
1688398|NCT00519376|4125391|P11|NOT COMPLETED|Washout Period 3||0
1688399|NCT00519376|4125392|P10|NOT COMPLETED|Washout Period 3||0
1688400|NCT00519376|4125393|P9|NOT COMPLETED|Washout Period 3||0
1688401|NCT00519376|4125394|P8|NOT COMPLETED|Washout Period 3||0
1688402|NCT00519376|4125395|P7|NOT COMPLETED|Washout Period 3||0
1688403|NCT00519376|4125396|P6|NOT COMPLETED|Washout Period 3||0
1688404|NCT00519376|4125397|P5|NOT COMPLETED|Washout Period 3||0
1688405|NCT00519376|4125398|P4|NOT COMPLETED|Washout Period 3||0
1688406|NCT00519376|4125399|P3|NOT COMPLETED|Washout Period 3||0
1688407|NCT00519376|4125400|P2|NOT COMPLETED|Washout Period 3||0
1688408|NCT00519376|4125401|P1|NOT COMPLETED|Washout Period 3||0
1688409|NCT00519376|4125386|P16|COMPLETED|Washout Period 3||1
1688410|NCT00519376|4125387|P15|COMPLETED|Washout Period 3||1
1688411|NCT00519376|4125388|P14|COMPLETED|Washout Period 3||1
1688412|NCT00519376|4125389|P13|COMPLETED|Washout Period 3||0
1688413|NCT00519376|4125390|P12|COMPLETED|Washout Period 3||1
1688414|NCT00519376|4125391|P11|COMPLETED|Washout Period 3||1
1688415|NCT00519376|4125392|P10|COMPLETED|Washout Period 3||1
1688416|NCT00519376|4125393|P9|COMPLETED|Washout Period 3||1
1688417|NCT00519376|4125394|P8|COMPLETED|Washout Period 3||1
1688418|NCT00519376|4125395|P7|COMPLETED|Washout Period 3||1
1688419|NCT00519376|4125396|P6|COMPLETED|Washout Period 3||1
1688420|NCT00519376|4125397|P5|COMPLETED|Washout Period 3||1
1688421|NCT00519376|4125398|P4|COMPLETED|Washout Period 3||2
1688422|NCT00519376|4125399|P3|COMPLETED|Washout Period 3||2
1688423|NCT00519376|4125400|P2|COMPLETED|Washout Period 3||2
1688424|NCT00519376|4125401|P1|COMPLETED|Washout Period 3||2
1688425|NCT00519376|4125386|P16|STARTED|Washout Period 3||1
1688426|NCT00519376|4125387|P15|STARTED|Washout Period 3||1
1688427|NCT00519376|4125388|P14|STARTED|Washout Period 3||1
1688428|NCT00519376|4125389|P13|STARTED|Washout Period 3||0
1688429|NCT00519376|4125390|P12|STARTED|Washout Period 3||1
1688430|NCT00519376|4125391|P11|STARTED|Washout Period 3||1
1688431|NCT00519376|4125392|P10|STARTED|Washout Period 3||1
1688432|NCT00519376|4125393|P9|STARTED|Washout Period 3||1
1688433|NCT00519376|4125394|P8|STARTED|Washout Period 3||1
1688434|NCT00519376|4125395|P7|STARTED|Washout Period 3||1
1688435|NCT00519376|4125396|P6|STARTED|Washout Period 3||1
1688436|NCT00519376|4125397|P5|STARTED|Washout Period 3||1
1688437|NCT00519376|4125398|P4|STARTED|Washout Period 3||2
1688438|NCT00519376|4125399|P3|STARTED|Washout Period 3||2
1688439|NCT00519376|4125400|P2|STARTED|Washout Period 3||2
1688440|NCT00519376|4125401|P1|STARTED|Washout Period 3||2
1688441|NCT00519376|4125386|P16|NOT COMPLETED|Treatment Period 3||0
1688442|NCT00519376|4125387|P15|NOT COMPLETED|Treatment Period 3||0
1688443|NCT00519376|4125388|P14|NOT COMPLETED|Treatment Period 3||0
1688444|NCT00519376|4125389|P13|NOT COMPLETED|Treatment Period 3||0
1688445|NCT00519376|4125390|P12|NOT COMPLETED|Treatment Period 3||0
1688446|NCT00519376|4125391|P11|NOT COMPLETED|Treatment Period 3||0
1688447|NCT00519376|4125392|P10|NOT COMPLETED|Treatment Period 3||0
1688448|NCT00519376|4125393|P9|NOT COMPLETED|Treatment Period 3||0
1688449|NCT00519376|4125394|P8|NOT COMPLETED|Treatment Period 3||0
1688450|NCT00519376|4125395|P7|NOT COMPLETED|Treatment Period 3||0
1688451|NCT00519376|4125396|P6|NOT COMPLETED|Treatment Period 3||0
1688452|NCT00519376|4125397|P5|NOT COMPLETED|Treatment Period 3||0
1688453|NCT00519376|4125398|P4|NOT COMPLETED|Treatment Period 3||0
1688454|NCT00519376|4125399|P3|NOT COMPLETED|Treatment Period 3||0
1688455|NCT00519376|4125400|P2|NOT COMPLETED|Treatment Period 3||0
1688456|NCT00519376|4125401|P1|NOT COMPLETED|Treatment Period 3||0
1688457|NCT00519376|4125386|P16|COMPLETED|Treatment Period 3||1
1688458|NCT00519376|4125387|P15|COMPLETED|Treatment Period 3||1
1688459|NCT00519376|4125388|P14|COMPLETED|Treatment Period 3||1
1688460|NCT00519376|4125389|P13|COMPLETED|Treatment Period 3||0
1688461|NCT00519376|4125390|P12|COMPLETED|Treatment Period 3||1
1688462|NCT00519376|4125391|P11|COMPLETED|Treatment Period 3||1
1688463|NCT00519376|4125392|P10|COMPLETED|Treatment Period 3||1
1688464|NCT00519376|4125393|P9|COMPLETED|Treatment Period 3||1
1688465|NCT00519376|4125394|P8|COMPLETED|Treatment Period 3||1
1688466|NCT00519376|4125395|P7|COMPLETED|Treatment Period 3||1
1688467|NCT00519376|4125396|P6|COMPLETED|Treatment Period 3||1
1688468|NCT00519376|4125397|P5|COMPLETED|Treatment Period 3||1
1688469|NCT00519376|4125398|P4|COMPLETED|Treatment Period 3||2
1688470|NCT00519376|4125399|P3|COMPLETED|Treatment Period 3||2
1688471|NCT00519376|4125400|P2|COMPLETED|Treatment Period 3||2
1688472|NCT00519376|4125401|P1|COMPLETED|Treatment Period 3||2
1688473|NCT00519376|4125386|P16|STARTED|Treatment Period 3||1
1688474|NCT00519376|4125387|P15|STARTED|Treatment Period 3||1
1688475|NCT00519376|4125388|P14|STARTED|Treatment Period 3||1
1688476|NCT00519376|4125389|P13|STARTED|Treatment Period 3||0
1688477|NCT00519376|4125390|P12|STARTED|Treatment Period 3||1
1688478|NCT00519376|4125391|P11|STARTED|Treatment Period 3||1
1688479|NCT00519376|4125392|P10|STARTED|Treatment Period 3||1
1688480|NCT00519376|4125393|P9|STARTED|Treatment Period 3||1
1688481|NCT00519376|4125394|P8|STARTED|Treatment Period 3||1
1688482|NCT00519376|4125395|P7|STARTED|Treatment Period 3||1
1688483|NCT00519376|4125396|P6|STARTED|Treatment Period 3||1
1688484|NCT00519376|4125397|P5|STARTED|Treatment Period 3||1
1688485|NCT00519376|4125398|P4|STARTED|Treatment Period 3||2
1688486|NCT00519376|4125399|P3|STARTED|Treatment Period 3||2
1688487|NCT00519376|4125400|P2|STARTED|Treatment Period 3||2
1688488|NCT00519376|4125401|P1|STARTED|Treatment Period 3||2
1688489|NCT00519376|4125386|P16|NOT COMPLETED|Washout Period 2||0
1688490|NCT00519376|4125387|P15|NOT COMPLETED|Washout Period 2||0
1688491|NCT00519376|4125388|P14|NOT COMPLETED|Washout Period 2||0
1688492|NCT00519376|4125389|P13|NOT COMPLETED|Washout Period 2||0
1688493|NCT00519376|4125390|P12|NOT COMPLETED|Washout Period 2||0
1688494|NCT00519376|4125391|P11|NOT COMPLETED|Washout Period 2||0
1688495|NCT00519376|4125392|P10|NOT COMPLETED|Washout Period 2||0
1688496|NCT00519376|4125393|P9|NOT COMPLETED|Washout Period 2||0
1688497|NCT00519376|4125394|P8|NOT COMPLETED|Washout Period 2||0
1688498|NCT00519376|4125395|P7|NOT COMPLETED|Washout Period 2||0
1688499|NCT00519376|4125396|P6|NOT COMPLETED|Washout Period 2||0
1688500|NCT00519376|4125397|P5|NOT COMPLETED|Washout Period 2||0
1688501|NCT00519376|4125398|P4|NOT COMPLETED|Washout Period 2||0
1688502|NCT00519376|4125399|P3|NOT COMPLETED|Washout Period 2||0
1688503|NCT00519376|4125400|P2|NOT COMPLETED|Washout Period 2||0
1688504|NCT00519376|4125401|P1|NOT COMPLETED|Washout Period 2||0
1688505|NCT00519376|4125386|P16|COMPLETED|Washout Period 2||1
1688506|NCT00519376|4125387|P15|COMPLETED|Washout Period 2||1
1688507|NCT00519376|4125388|P14|COMPLETED|Washout Period 2||1
1688508|NCT00519376|4125389|P13|COMPLETED|Washout Period 2||0
1688509|NCT00519376|4125390|P12|COMPLETED|Washout Period 2||1
1688510|NCT00519376|4125391|P11|COMPLETED|Washout Period 2||1
1688511|NCT00519376|4125392|P10|COMPLETED|Washout Period 2||1
1688512|NCT00519376|4125393|P9|COMPLETED|Washout Period 2||1
1688513|NCT00519376|4125394|P8|COMPLETED|Washout Period 2||1
1688514|NCT00519376|4125395|P7|COMPLETED|Washout Period 2||1
1688515|NCT00519376|4125396|P6|COMPLETED|Washout Period 2||1
1688516|NCT00519376|4125397|P5|COMPLETED|Washout Period 2||1
1688517|NCT00519376|4125398|P4|COMPLETED|Washout Period 2||2
1688518|NCT00519376|4125399|P3|COMPLETED|Washout Period 2||2
1688519|NCT00519376|4125400|P2|COMPLETED|Washout Period 2||2
1688520|NCT00519376|4125401|P1|COMPLETED|Washout Period 2||2
1688521|NCT00519376|4125386|P16|STARTED|Washout Period 2||1
1688522|NCT00519376|4125387|P15|STARTED|Washout Period 2||1
1688523|NCT00519376|4125388|P14|STARTED|Washout Period 2||1
1688524|NCT00519376|4125389|P13|STARTED|Washout Period 2||0
1688525|NCT00519376|4125390|P12|STARTED|Washout Period 2||1
1688526|NCT00519376|4125391|P11|STARTED|Washout Period 2||1
1688527|NCT00519376|4125392|P10|STARTED|Washout Period 2||1
1688528|NCT00519376|4125393|P9|STARTED|Washout Period 2||1
1688529|NCT00519376|4125394|P8|STARTED|Washout Period 2||1
1688530|NCT00519376|4125395|P7|STARTED|Washout Period 2||1
1688531|NCT00519376|4125396|P6|STARTED|Washout Period 2||1
1688532|NCT00519376|4125397|P5|STARTED|Washout Period 2||1
1688533|NCT00519376|4125398|P4|STARTED|Washout Period 2||2
1688534|NCT00519376|4125399|P3|STARTED|Washout Period 2||2
1688535|NCT00519376|4125400|P2|STARTED|Washout Period 2||2
1688536|NCT00519376|4125401|P1|STARTED|Washout Period 2||2
1688537|NCT00519376|4125386|P16|NOT COMPLETED|Treatment Period 2||0
1688538|NCT00519376|4125387|P15|NOT COMPLETED|Treatment Period 2||0
1688539|NCT00519376|4125388|P14|NOT COMPLETED|Treatment Period 2||0
1688540|NCT00519376|4125389|P13|NOT COMPLETED|Treatment Period 2||1
1688541|NCT00519376|4125390|P12|NOT COMPLETED|Treatment Period 2||0
1688542|NCT00519376|4125391|P11|NOT COMPLETED|Treatment Period 2||0
1688543|NCT00519376|4125392|P10|NOT COMPLETED|Treatment Period 2||0
1688544|NCT00519376|4125393|P9|NOT COMPLETED|Treatment Period 2||0
1688545|NCT00519376|4125394|P8|NOT COMPLETED|Treatment Period 2||0
1688546|NCT00519376|4125395|P7|NOT COMPLETED|Treatment Period 2||0
1688547|NCT00519376|4125396|P6|NOT COMPLETED|Treatment Period 2||0
1688548|NCT00519376|4125397|P5|NOT COMPLETED|Treatment Period 2||0
1688549|NCT00519376|4125398|P4|NOT COMPLETED|Treatment Period 2||0
1688550|NCT00519376|4125399|P3|NOT COMPLETED|Treatment Period 2||0
1688551|NCT00519376|4125400|P2|NOT COMPLETED|Treatment Period 2||0
1688552|NCT00519376|4125401|P1|NOT COMPLETED|Treatment Period 2||0
1688553|NCT00519376|4125386|P16|COMPLETED|Treatment Period 2||1
1688554|NCT00519376|4125387|P15|COMPLETED|Treatment Period 2||1
1688555|NCT00519376|4125388|P14|COMPLETED|Treatment Period 2||1
1688556|NCT00519376|4125389|P13|COMPLETED|Treatment Period 2||0
1688557|NCT00519376|4125390|P12|COMPLETED|Treatment Period 2||1
1688558|NCT00519376|4125391|P11|COMPLETED|Treatment Period 2||1
1688559|NCT00519376|4125392|P10|COMPLETED|Treatment Period 2||1
1688560|NCT00519376|4125393|P9|COMPLETED|Treatment Period 2||1
1688561|NCT00519376|4125394|P8|COMPLETED|Treatment Period 2||1
1688562|NCT00519376|4125395|P7|COMPLETED|Treatment Period 2||1
1688563|NCT00519376|4125396|P6|COMPLETED|Treatment Period 2||1
1688564|NCT00519376|4125397|P5|COMPLETED|Treatment Period 2||1
1688565|NCT00519376|4125398|P4|COMPLETED|Treatment Period 2||2
1688566|NCT00519376|4125399|P3|COMPLETED|Treatment Period 2||2
1688567|NCT00519376|4125400|P2|COMPLETED|Treatment Period 2||2
1688568|NCT00519376|4125401|P1|COMPLETED|Treatment Period 2||2
1688569|NCT00519376|4125386|P16|STARTED|Treatment Period 2||1
1688570|NCT00519376|4125387|P15|STARTED|Treatment Period 2||1
1688571|NCT00519376|4125388|P14|STARTED|Treatment Period 2||1
1688572|NCT00519376|4125389|P13|STARTED|Treatment Period 2||1
1688573|NCT00519376|4125390|P12|STARTED|Treatment Period 2||1
1688574|NCT00519376|4125391|P11|STARTED|Treatment Period 2||1
1688575|NCT00519376|4125392|P10|STARTED|Treatment Period 2||1
1688576|NCT00519376|4125393|P9|STARTED|Treatment Period 2||1
1688577|NCT00519376|4125394|P8|STARTED|Treatment Period 2||1
1688578|NCT00519376|4125395|P7|STARTED|Treatment Period 2||1
1688579|NCT00519376|4125396|P6|STARTED|Treatment Period 2||1
1688580|NCT00519376|4125397|P5|STARTED|Treatment Period 2||1
1688581|NCT00519376|4125398|P4|STARTED|Treatment Period 2||2
1688582|NCT00519376|4125399|P3|STARTED|Treatment Period 2||2
1688583|NCT00519376|4125400|P2|STARTED|Treatment Period 2||2
1688584|NCT00519376|4125401|P1|STARTED|Treatment Period 2||2
1688585|NCT00519376|4125386|P16|NOT COMPLETED|Washout Period 1||0
1688586|NCT00519376|4125387|P15|NOT COMPLETED|Washout Period 1||0
1688587|NCT00519376|4125388|P14|NOT COMPLETED|Washout Period 1||0
1688588|NCT00519376|4125389|P13|NOT COMPLETED|Washout Period 1||0
1688589|NCT00519376|4125390|P12|NOT COMPLETED|Washout Period 1||0
1688590|NCT00519376|4125391|P11|NOT COMPLETED|Washout Period 1||0
1688591|NCT00519376|4125392|P10|NOT COMPLETED|Washout Period 1||0
1688592|NCT00519376|4125393|P9|NOT COMPLETED|Washout Period 1||0
1688593|NCT00519376|4125394|P8|NOT COMPLETED|Washout Period 1||0
1688594|NCT00519376|4125395|P7|NOT COMPLETED|Washout Period 1||0
1688595|NCT00519376|4125396|P6|NOT COMPLETED|Washout Period 1||0
1688596|NCT00519376|4125397|P5|NOT COMPLETED|Washout Period 1||0
1688597|NCT00519376|4125398|P4|NOT COMPLETED|Washout Period 1||0
1688598|NCT00519376|4125399|P3|NOT COMPLETED|Washout Period 1||0
1688599|NCT00519376|4125400|P2|NOT COMPLETED|Washout Period 1||0
1688600|NCT00519376|4125401|P1|NOT COMPLETED|Washout Period 1||0
1688601|NCT00519376|4125386|P16|COMPLETED|Washout Period 1||1
1688602|NCT00519376|4125387|P15|COMPLETED|Washout Period 1||1
1688603|NCT00519376|4125388|P14|COMPLETED|Washout Period 1||1
1688604|NCT00519376|4125389|P13|COMPLETED|Washout Period 1||1
1688605|NCT00519376|4125390|P12|COMPLETED|Washout Period 1||1
1688606|NCT00519376|4125391|P11|COMPLETED|Washout Period 1||1
1688607|NCT00519376|4125392|P10|COMPLETED|Washout Period 1||1
1688608|NCT00519376|4125393|P9|COMPLETED|Washout Period 1||1
1688609|NCT00519376|4125394|P8|COMPLETED|Washout Period 1||1
1688610|NCT00519376|4125395|P7|COMPLETED|Washout Period 1||1
1688611|NCT00519376|4125396|P6|COMPLETED|Washout Period 1||1
1688612|NCT00519376|4125397|P5|COMPLETED|Washout Period 1||1
1688613|NCT00519376|4125398|P4|COMPLETED|Washout Period 1||2
1688614|NCT00519376|4125399|P3|COMPLETED|Washout Period 1||2
1688615|NCT00519376|4125400|P2|COMPLETED|Washout Period 1||2
1688616|NCT00519376|4125401|P1|COMPLETED|Washout Period 1||2
1688617|NCT00519376|4125386|P16|STARTED|Washout Period 1||1
1688618|NCT00519376|4125387|P15|STARTED|Washout Period 1||1
1688619|NCT00519376|4125388|P14|STARTED|Washout Period 1||1
1688620|NCT00519376|4125389|P13|STARTED|Washout Period 1||1
1688621|NCT00519376|4125390|P12|STARTED|Washout Period 1||1
1688622|NCT00519376|4125391|P11|STARTED|Washout Period 1||1
1688623|NCT00519376|4125392|P10|STARTED|Washout Period 1||1
1688624|NCT00519376|4125393|P9|STARTED|Washout Period 1||1
1688625|NCT00519376|4125394|P8|STARTED|Washout Period 1||1
1688626|NCT00519376|4125395|P7|STARTED|Washout Period 1||1
1688627|NCT00519376|4125396|P6|STARTED|Washout Period 1||1
1688628|NCT00519376|4125397|P5|STARTED|Washout Period 1||1
1688629|NCT00519376|4125398|P4|STARTED|Washout Period 1||2
1688630|NCT00519376|4125399|P3|STARTED|Washout Period 1||2
1688631|NCT00519376|4125400|P2|STARTED|Washout Period 1||2
1688632|NCT00519376|4125401|P1|STARTED|Washout Period 1||2
1688633|NCT00519376|4125386|P16|NOT COMPLETED|Treatment Period 1||0
1688634|NCT00519376|4125387|P15|NOT COMPLETED|Treatment Period 1||0
1688635|NCT00519376|4125388|P14|NOT COMPLETED|Treatment Period 1||0
1688636|NCT00519376|4125389|P13|NOT COMPLETED|Treatment Period 1||0
1688637|NCT00519376|4125390|P12|NOT COMPLETED|Treatment Period 1||0
1688638|NCT00519376|4125391|P11|NOT COMPLETED|Treatment Period 1||0
1688639|NCT00519376|4125392|P10|NOT COMPLETED|Treatment Period 1||0
1688640|NCT00519376|4125393|P9|NOT COMPLETED|Treatment Period 1||0
1688641|NCT00519376|4125394|P8|NOT COMPLETED|Treatment Period 1||0
1688642|NCT00519376|4125395|P7|NOT COMPLETED|Treatment Period 1||0
1688643|NCT00519376|4125396|P6|NOT COMPLETED|Treatment Period 1||0
1688644|NCT00519376|4125397|P5|NOT COMPLETED|Treatment Period 1||0
1688645|NCT00519376|4125398|P4|NOT COMPLETED|Treatment Period 1||0
1688646|NCT00519376|4125399|P3|NOT COMPLETED|Treatment Period 1||0
1688647|NCT00519376|4125400|P2|NOT COMPLETED|Treatment Period 1||0
1688648|NCT00519376|4125401|P1|NOT COMPLETED|Treatment Period 1||0
1688649|NCT00519376|4125386|P16|COMPLETED|Treatment Period 1||1
1688650|NCT00519376|4125387|P15|COMPLETED|Treatment Period 1||1
1688651|NCT00519376|4125388|P14|COMPLETED|Treatment Period 1||1
1688652|NCT00519376|4125389|P13|COMPLETED|Treatment Period 1||1
1688653|NCT00519376|4125390|P12|COMPLETED|Treatment Period 1||1
1688654|NCT00519376|4125391|P11|COMPLETED|Treatment Period 1||1
1688655|NCT00519376|4125392|P10|COMPLETED|Treatment Period 1||1
1688656|NCT00519376|4125393|P9|COMPLETED|Treatment Period 1||1
1688657|NCT00519376|4125394|P8|COMPLETED|Treatment Period 1||1
1688658|NCT00519376|4125395|P7|COMPLETED|Treatment Period 1||1
1688659|NCT00519376|4125396|P6|COMPLETED|Treatment Period 1||1
1688660|NCT00519376|4125397|P5|COMPLETED|Treatment Period 1||1
1688661|NCT00519376|4125398|P4|COMPLETED|Treatment Period 1||2
1688662|NCT00519376|4125399|P3|COMPLETED|Treatment Period 1||2
1688663|NCT00519376|4125400|P2|COMPLETED|Treatment Period 1||2
1688664|NCT00519376|4125401|P1|COMPLETED|Treatment Period 1||2
1688665|NCT00519376|4125386|P16|STARTED|Treatment Period 1||1
1688666|NCT00519376|4125387|P15|STARTED|Treatment Period 1||1
1688667|NCT00519376|4125388|P14|STARTED|Treatment Period 1||1
1688668|NCT00519376|4125389|P13|STARTED|Treatment Period 1||1
1688669|NCT00519376|4125390|P12|STARTED|Treatment Period 1||1
1688670|NCT00519376|4125391|P11|STARTED|Treatment Period 1||1
1688671|NCT00519376|4125392|P10|STARTED|Treatment Period 1||1
1688672|NCT00519376|4125393|P9|STARTED|Treatment Period 1||1
1688673|NCT00519376|4125394|P8|STARTED|Treatment Period 1||1
1688674|NCT00519376|4125395|P7|STARTED|Treatment Period 1||1
1688675|NCT00519376|4125396|P6|STARTED|Treatment Period 1||1
1688676|NCT00519376|4125397|P5|STARTED|Treatment Period 1||1
1688677|NCT00519376|4125398|P4|STARTED|Treatment Period 1||2
1688678|NCT00519376|4125399|P3|STARTED|Treatment Period 1||2
1688679|NCT00519376|4125400|P2|STARTED|Treatment Period 1||2
1688680|NCT00519376|4125401|P1|STARTED|Treatment Period 1||2
1688681|NCT00519285|4125525|P2|NOT COMPLETED|Overall Study||612
1688682|NCT00519285|4125526|P1|NOT COMPLETED|Overall Study||612
1688683|NCT00519285|4125525|P2|COMPLETED|Overall Study||0
1688684|NCT00519285|4125526|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
1688685|NCT00519285|4125525|P2|Still Treated at Cut-off Date|Overall Study||2
1688686|NCT00519285|4125526|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
1688687|NCT00519285|4125525|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
1688688|NCT00519285|4125526|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
1688689|NCT00519285|4125525|P2|STARTED|Overall Study|Randomized|612
1688690|NCT00519285|4125526|P1|STARTED|Overall Study|Randomized|612
1688691|NCT00519194|4125552|P1|NOT COMPLETED|Overall Study||21
1688692|NCT00519194|4125552|P1|COMPLETED|Overall Study||91
1688693|NCT00519194|4125552|P1|STARTED|Overall Study||112
1688694|NCT00519090|4125558|P2|NOT COMPLETED|Overall Study||0
1688695|NCT00519090|4125559|P1|NOT COMPLETED|Overall Study||0
1688696|NCT00519090|4125558|P2|COMPLETED|Overall Study||4
1688697|NCT00519090|4125559|P1|COMPLETED|Overall Study||2
1688698|NCT00519090|4125558|P2|STARTED|Overall Study||4
1688699|NCT00519090|4125559|P1|STARTED|Overall Study||2
1688700|NCT00519077|4125567|P1|NOT COMPLETED|Overall Study||8
1688701|NCT00519077|4125567|P1|COMPLETED|Overall Study||36
1688702|NCT00519077|4125567|P1|STARTED|Overall Study||44
1688703|NCT00518986|4125574|P2|NOT COMPLETED|Overall Study||26
1688704|NCT00518986|4125575|P1|NOT COMPLETED|Overall Study||26
1688705|NCT00518986|4125574|P2|COMPLETED|Overall Study||98
1688706|NCT00518986|4125575|P1|COMPLETED|Overall Study||99
1688707|NCT00518986|4125574|P2|STARTED|Overall Study||124
1688708|NCT00518986|4125575|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
1688709|NCT00518882|4125701|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
1688710|NCT00518882|4125702|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
1688711|NCT00518882|4125701|P2|COMPLETED|Open-Label Extension, Week 26-78||138
1688712|NCT00518882|4125702|P1|COMPLETED|Open-Label Extension, Week 26-78||161
1688713|NCT00518882|4125701|P2|STARTED|Open-Label Extension, Week 26-78||187
1688714|NCT00518882|4125702|P1|STARTED|Open-Label Extension, Week 26-78||202
1688715|NCT00518882|4125701|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
1688716|NCT00518882|4125702|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
1688717|NCT00518882|4125701|P2|COMPLETED|Double-Blind, Week 0-26||187
1688718|NCT00518882|4125702|P1|COMPLETED|Double-Blind, Week 0-26||202
1688719|NCT00518882|4125701|P2|Randomised|Double-Blind, Week 0-26||231
1688720|NCT00518882|4125702|P1|Randomised|Double-Blind, Week 0-26||233
1688721|NCT00518882|4125701|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
1688722|NCT00518882|4125702|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
1688723|NCT00518713|4125820|P4|NOT COMPLETED|Overall Study||18
1688724|NCT00518713|4125821|P3|NOT COMPLETED|Overall Study||18
1688725|NCT00518713|4125822|P2|NOT COMPLETED|Overall Study||17
1688726|NCT00518713|4125823|P1|NOT COMPLETED|Overall Study||8
1688727|NCT00518713|4125820|P4|COMPLETED|Overall Study||41
1688728|NCT00518713|4125821|P3|COMPLETED|Overall Study||41
1688729|NCT00518713|4125822|P2|COMPLETED|Overall Study||45
1688730|NCT00518713|4125823|P1|COMPLETED|Overall Study||50
1688731|NCT00518713|4125820|P4|Modified Intent-to-Treat Population|Overall Study||57
1688732|NCT00518713|4125821|P3|Modified Intent-to-Treat Population|Overall Study||49
1688733|NCT00518713|4125822|P2|Modified Intent-to-Treat Population|Overall Study||58
1688734|NCT00518713|4125823|P1|Modified Intent-to-Treat Population|Overall Study||53
1688735|NCT00518713|4125820|P4|STARTED|Overall Study||59
1688736|NCT00518713|4125821|P3|STARTED|Overall Study||59
1688737|NCT00518713|4125822|P2|STARTED|Overall Study||62
1688738|NCT00518713|4125823|P1|STARTED|Overall Study||58
1688739|NCT00518687|4125883|P2|NOT COMPLETED|Overall Study||1420
1688740|NCT00518687|4125884|P1|NOT COMPLETED|Overall Study||1437
1688741|NCT00518687|4125883|P2|COMPLETED|Overall Study||2585
1688742|NCT00518687|4125884|P1|COMPLETED|Overall Study||2568
1688743|NCT00518687|4125883|P2|Vaccinated|Overall Study||3982
1688744|NCT00518687|4125884|P1|Vaccinated|Overall Study||3981
1688745|NCT00518687|4125883|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
1688746|NCT00518687|4125884|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
1688747|NCT00518622|4125904|P8|NOT COMPLETED|Overall Study||0
1688748|NCT00518622|4125905|P7|NOT COMPLETED|Overall Study||0
1688749|NCT00518622|4125906|P6|NOT COMPLETED|Overall Study||0
1688750|NCT00518622|4125907|P5|NOT COMPLETED|Overall Study||0
1688751|NCT00518622|4125908|P4|NOT COMPLETED|Overall Study||0
1688752|NCT00518622|4125909|P3|NOT COMPLETED|Overall Study||1
1688753|NCT00518622|4125910|P2|NOT COMPLETED|Overall Study||1
1688754|NCT00518622|4125911|P1|NOT COMPLETED|Overall Study||0
1688755|NCT00518622|4125904|P8|COMPLETED|Overall Study||5
1688756|NCT00518622|4125905|P7|COMPLETED|Overall Study||4
1688757|NCT00518622|4125906|P6|COMPLETED|Overall Study||5
1688758|NCT00518622|4125907|P5|COMPLETED|Overall Study||6
1688759|NCT00518622|4125908|P4|COMPLETED|Overall Study||5
1688760|NCT00518622|4125909|P3|COMPLETED|Overall Study||5
1688761|NCT00518622|4125910|P2|COMPLETED|Overall Study||5
1688762|NCT00518622|4125911|P1|COMPLETED|Overall Study||3
1688763|NCT00518622|4125904|P8|Discontinued Therapy|Overall Study||0
1688764|NCT00518622|4125905|P7|Discontinued Therapy|Overall Study||0
1688765|NCT00518622|4125906|P6|Discontinued Therapy|Overall Study||0
1688766|NCT00518622|4125907|P5|Discontinued Therapy|Overall Study||0
1688767|NCT00518622|4125908|P4|Discontinued Therapy|Overall Study||0
1688768|NCT00518622|4125909|P3|Discontinued Therapy|Overall Study||0
1688769|NCT00518622|4125910|P2|Discontinued Therapy|Overall Study||1
1688770|NCT00518622|4125911|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
1688771|NCT00518622|4125904|P8|Completed Therapy|Overall Study||5
1688772|NCT00518622|4125905|P7|Completed Therapy|Overall Study||4
1688773|NCT00518622|4125906|P6|Completed Therapy|Overall Study||5
1688774|NCT00518622|4125907|P5|Completed Therapy|Overall Study||6
1688775|NCT00518622|4125908|P4|Completed Therapy|Overall Study||5
1688776|NCT00518622|4125909|P3|Completed Therapy|Overall Study||6
1688777|NCT00518622|4125910|P2|Completed Therapy|Overall Study||5
1688778|NCT00518622|4125911|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
1688779|NCT00518622|4125904|P8|STARTED|Overall Study||5
1688780|NCT00518622|4125905|P7|STARTED|Overall Study||4
1688781|NCT00518622|4125906|P6|STARTED|Overall Study||5
1688782|NCT00518622|4125907|P5|STARTED|Overall Study||6
1688783|NCT00518622|4125908|P4|STARTED|Overall Study||5
1688784|NCT00518622|4125909|P3|STARTED|Overall Study||6
1688785|NCT00518622|4125910|P2|STARTED|Overall Study||6
1688786|NCT00518622|4125911|P1|STARTED|Overall Study||3
1688787|NCT00518531|4125939|P2|NOT COMPLETED|Treatment Period 2||20
1688788|NCT00518531|4125940|P1|NOT COMPLETED|Treatment Period 2||3
1688789|NCT00518531|4125939|P2|COMPLETED|Treatment Period 2||95
1688790|NCT00518531|4125940|P1|COMPLETED|Treatment Period 2||103
1688791|NCT00518531|4125939|P2|Received Treatment|Treatment Period 2||110
1688792|NCT00518531|4125940|P1|Received Treatment|Treatment Period 2||106
1688793|NCT00518531|4125939|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
1688794|NCT00518531|4125940|P1|STARTED|Treatment Period 2||106
1688795|NCT00518531|4125939|P2|NOT COMPLETED|Treatment Period 1||12
1688796|NCT00518531|4125940|P1|NOT COMPLETED|Treatment Period 1||18
1688797|NCT00518531|4125939|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
1688798|NCT00518531|4125940|P1|COMPLETED|Treatment Period 1||106
1688799|NCT00518531|4125939|P2|Received Treatment|Treatment Period 1||124
1688800|NCT00518531|4125940|P1|Received Treatment|Treatment Period 1||119
1688801|NCT00518531|4125939|P2|STARTED|Treatment Period 1||126
1688802|NCT00518531|4125940|P1|STARTED|Treatment Period 1||124
1688803|NCT00518349|4125976|P2|NOT COMPLETED|Overall Study||0
1688804|NCT00518349|4125977|P1|NOT COMPLETED|Overall Study||0
1688805|NCT00518349|4125976|P2|COMPLETED|Overall Study||60
1688806|NCT00518349|4125977|P1|COMPLETED|Overall Study||60
1688807|NCT00518349|4125976|P2|STARTED|Overall Study||60
1688808|NCT00518349|4125977|P1|STARTED|Overall Study||60
1688809|NCT00518336|4125985|P2|NOT COMPLETED|Year 9||1
1688810|NCT00518336|4125986|P1|NOT COMPLETED|Year 9||5
1688811|NCT00518336|4125985|P2|COMPLETED|Year 9||212
1688812|NCT00518336|4125986|P1|COMPLETED|Year 9||219
1688813|NCT00518336|4125985|P2|STARTED|Year 9||213
1688814|NCT00518336|4125986|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
1688815|NCT00518336|4125985|P2|NOT COMPLETED|Year 8||2
1688816|NCT00518336|4125986|P1|NOT COMPLETED|Year 8||1
1688817|NCT00518336|4125985|P2|COMPLETED|Year 8||211
1688818|NCT00518336|4125986|P1|COMPLETED|Year 8||222
1688819|NCT00518336|4125985|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
1688820|NCT00518336|4125986|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
1688821|NCT00518336|4125985|P2|NOT COMPLETED|Year 7||3
1688822|NCT00518336|4125986|P1|NOT COMPLETED|Year 7||2
1688823|NCT00518336|4125985|P2|COMPLETED|Year 7||208
1688824|NCT00518336|4125986|P1|COMPLETED|Year 7||220
1688825|NCT00518336|4125985|P2|STARTED|Year 7||211
1688826|NCT00518336|4125986|P1|STARTED|Year 7||222
1688827|NCT00518323|4126152|P4|NOT COMPLETED|Overall Study||25
1688828|NCT00518323|4126153|P3|NOT COMPLETED|Overall Study||11
1688829|NCT00518323|4126154|P2|NOT COMPLETED|Overall Study||8
1688830|NCT00518323|4126155|P1|NOT COMPLETED|Overall Study||19
1688831|NCT00518323|4126152|P4|COMPLETED|Overall Study||26
1688832|NCT00518323|4126153|P3|COMPLETED|Overall Study||37
1688833|NCT00518323|4126154|P2|COMPLETED|Overall Study||40
1688834|NCT00518323|4126155|P1|COMPLETED|Overall Study||35
1688835|NCT00518323|4126152|P4|STARTED|Overall Study||51
1688836|NCT00518323|4126153|P3|STARTED|Overall Study||48
1688837|NCT00518323|4126154|P2|STARTED|Overall Study||48
1688838|NCT00518323|4126155|P1|STARTED|Overall Study||54
1688839|NCT00518284|4126185|P4|NOT COMPLETED|Overall Study||2
1688840|NCT00518284|4126186|P3|NOT COMPLETED|Overall Study||1
1688841|NCT00518284|4126187|P2|NOT COMPLETED|Overall Study||3
1688842|NCT00518284|4126188|P1|NOT COMPLETED|Overall Study||0
1688843|NCT00518284|4126185|P4|COMPLETED|Overall Study||0
1688844|NCT00518284|4126186|P3|COMPLETED|Overall Study||0
1688845|NCT00518284|4126187|P2|COMPLETED|Overall Study||0
1688846|NCT00518284|4126188|P1|COMPLETED|Overall Study||0
1688847|NCT00518284|4126185|P4|STARTED|Overall Study||2
1688848|NCT00518284|4126186|P3|STARTED|Overall Study||1
1688849|NCT00518284|4126187|P2|STARTED|Overall Study||3
1688850|NCT00518284|4126188|P1|STARTED|Overall Study||0
1688851|NCT00518206|4126244|P2|NOT COMPLETED|Overall Study||6
1688852|NCT00518206|4126245|P1|NOT COMPLETED|Overall Study||11
1688853|NCT00518206|4126244|P2|COMPLETED|Overall Study||13
1688854|NCT00518206|4126245|P1|COMPLETED|Overall Study||16
1688855|NCT00518206|4126244|P2|STARTED|Overall Study||19
1688856|NCT00518206|4126245|P1|STARTED|Overall Study||27
1688857|NCT00518180|4126262|P3|NOT COMPLETED|Overall Study||82
1688858|NCT00518180|4126263|P2|NOT COMPLETED|Overall Study||69
1688859|NCT00518180|4126264|P1|NOT COMPLETED|Overall Study||65
1688860|NCT00518180|4126262|P3|COMPLETED|Overall Study||457
1688861|NCT00518180|4126263|P2|COMPLETED|Overall Study||472
1688862|NCT00518180|4126264|P1|COMPLETED|Overall Study||475
1688863|NCT00518180|4126262|P3|STARTED|Overall Study||539
1688864|NCT00518180|4126263|P2|STARTED|Overall Study||541
1688865|NCT00518180|4126264|P1|STARTED|Overall Study||540
1688866|NCT00518115|4126316|P10|NOT COMPLETED|Overall Study||15
1688867|NCT00518115|4126317|P9|NOT COMPLETED|Overall Study||5
1688868|NCT00518115|4126318|P8|NOT COMPLETED|Overall Study||15
1688869|NCT00518115|4126319|P7|NOT COMPLETED|Overall Study||8
1688870|NCT00518115|4126320|P6|NOT COMPLETED|Overall Study||15
1688871|NCT00518115|4126321|P5|NOT COMPLETED|Overall Study||10
1688872|NCT00518115|4126322|P4|NOT COMPLETED|Overall Study||11
1688873|NCT00518115|4126323|P3|NOT COMPLETED|Overall Study||17
1688874|NCT00518115|4126324|P2|NOT COMPLETED|Overall Study||6
1688875|NCT00518115|4126325|P1|NOT COMPLETED|Overall Study||12
1688876|NCT00518115|4126316|P10|COMPLETED|Overall Study||20
1688877|NCT00518115|4126317|P9|COMPLETED|Overall Study||30
1688878|NCT00518115|4126318|P8|COMPLETED|Overall Study||20
1688879|NCT00518115|4126319|P7|COMPLETED|Overall Study||25
1688880|NCT00518115|4126320|P6|COMPLETED|Overall Study||19
1688881|NCT00518115|4126321|P5|COMPLETED|Overall Study||21
1688882|NCT00518115|4126322|P4|COMPLETED|Overall Study||24
1688883|NCT00518115|4126323|P3|COMPLETED|Overall Study||19
1688884|NCT00518115|4126324|P2|COMPLETED|Overall Study||29
1688885|NCT00518115|4126325|P1|COMPLETED|Overall Study||40
1688886|NCT00518115|4126316|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
1688887|NCT00518115|4126317|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1688888|NCT00518115|4126318|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1688889|NCT00518115|4126319|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
1688890|NCT00518115|4126320|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
1688891|NCT00518115|4126321|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
1688892|NCT00518115|4126322|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1688893|NCT00518115|4126323|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1688894|NCT00518115|4126324|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1688895|NCT00518115|4126325|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
1688896|NCT00518115|4126316|P10|STARTED|Overall Study||35
1688897|NCT00518115|4126317|P9|STARTED|Overall Study||35
1688898|NCT00518115|4126318|P8|STARTED|Overall Study||35
1688899|NCT00518115|4126319|P7|STARTED|Overall Study||33
1688900|NCT00518115|4126320|P6|STARTED|Overall Study||34
1688901|NCT00518115|4126321|P5|STARTED|Overall Study||31
1688902|NCT00518115|4126322|P4|STARTED|Overall Study||35
1688903|NCT00518115|4126323|P3|STARTED|Overall Study||36
1688904|NCT00518115|4126324|P2|STARTED|Overall Study||35
1688905|NCT00518115|4126325|P1|STARTED|Overall Study||52
1688906|NCT00518089|4126483|P2|NOT COMPLETED|Overall Study||31
1688907|NCT00518089|4126484|P1|NOT COMPLETED|Overall Study||28
1688908|NCT00518089|4126483|P2|COMPLETED|Overall Study||398
1688909|NCT00518089|4126484|P1|COMPLETED|Overall Study||402
1688910|NCT00518089|4126483|P2|STARTED|Overall Study||429
1688911|NCT00518089|4126484|P1|STARTED|Overall Study||430
1688912|NCT00518011|4126500|P2|NOT COMPLETED|Overall Study||8
1688913|NCT00518011|4126501|P1|NOT COMPLETED|Overall Study||9
1688914|NCT00518011|4126500|P2|COMPLETED|Overall Study||0
1688915|NCT00518011|4126501|P1|COMPLETED|Overall Study||0
1688916|NCT00518011|4126500|P2|STARTED|Overall Study||8
1688917|NCT00518011|4126501|P1|STARTED|Overall Study||9
1688918|NCT00517933|4126523|P2|NOT COMPLETED|Period 2||13
1688919|NCT00517933|4126524|P1|NOT COMPLETED|Period 2||6
1688920|NCT00517933|4126523|P2|COMPLETED|Period 2||70
1688921|NCT00517933|4126524|P1|COMPLETED|Period 2||73
1688922|NCT00517933|4126523|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
1688923|NCT00517933|4126524|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
1688924|NCT00517933|4126523|P2|NOT COMPLETED|Period 1||6
1688925|NCT00517933|4126524|P1|NOT COMPLETED|Period 1||8
1688926|NCT00517933|4126523|P2|COMPLETED|Period 1||85
1688927|NCT00517933|4126524|P1|COMPLETED|Period 1||81
1688928|NCT00517933|4126523|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
1688929|NCT00517933|4126524|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
1688930|NCT00517881|4126588|P1|NOT COMPLETED|Overall Study||5
1688931|NCT00517881|4126588|P1|COMPLETED|Overall Study||24
1688932|NCT00517881|4126588|P1|STARTED|Overall Study||29
1688933|NCT00517829|4126600|P2|NOT COMPLETED|Overall Study||75
1688934|NCT00517829|4126601|P1|NOT COMPLETED|Overall Study||75
1688935|NCT00517829|4126600|P2|COMPLETED|Overall Study||0
1688936|NCT00517829|4126601|P1|COMPLETED|Overall Study||0
1688937|NCT00517829|4126600|P2|STARTED|Overall Study||75
1688938|NCT00517829|4126601|P1|STARTED|Overall Study||75
1688939|NCT00517751|4126615|P1|NOT COMPLETED|Overall Study||129
1688940|NCT00517751|4126615|P1|COMPLETED|Overall Study||33
1688941|NCT00517751|4126615|P1|STARTED|Overall Study||162
1688942|NCT00517699|4126638|P1|NOT COMPLETED|Overall Study||5
1688943|NCT00517699|4126638|P1|COMPLETED|Overall Study||0
1688944|NCT00517699|4126638|P1|STARTED|Overall Study||5
1688945|NCT00517634|4126646|P6|NOT COMPLETED|Third Treatment Period||0
1688946|NCT00517634|4126647|P5|NOT COMPLETED|Third Treatment Period||0
1688947|NCT00517634|4126648|P4|NOT COMPLETED|Third Treatment Period||0
1688948|NCT00517634|4126649|P3|NOT COMPLETED|Third Treatment Period||0
1688949|NCT00517634|4126650|P2|NOT COMPLETED|Third Treatment Period||0
1688950|NCT00517634|4126651|P1|NOT COMPLETED|Third Treatment Period||0
1688951|NCT00517634|4126646|P6|COMPLETED|Third Treatment Period||4
1688952|NCT00517634|4126647|P5|COMPLETED|Third Treatment Period||3
1688953|NCT00517634|4126648|P4|COMPLETED|Third Treatment Period||3
1688954|NCT00517634|4126649|P3|COMPLETED|Third Treatment Period||4
1688955|NCT00517634|4126650|P2|COMPLETED|Third Treatment Period||4
1688956|NCT00517634|4126651|P1|COMPLETED|Third Treatment Period||4
1688957|NCT00517634|4126646|P6|STARTED|Third Treatment Period||4
1688958|NCT00517634|4126647|P5|STARTED|Third Treatment Period||3
1688959|NCT00517634|4126648|P4|STARTED|Third Treatment Period||3
1688960|NCT00517634|4126649|P3|STARTED|Third Treatment Period||4
1688961|NCT00517634|4126650|P2|STARTED|Third Treatment Period||4
1688962|NCT00517634|4126651|P1|STARTED|Third Treatment Period||4
1688963|NCT00517634|4126646|P6|NOT COMPLETED|Second Treatment Period||0
1688964|NCT00517634|4126647|P5|NOT COMPLETED|Second Treatment Period||1
1688965|NCT00517634|4126648|P4|NOT COMPLETED|Second Treatment Period||0
1688966|NCT00517634|4126649|P3|NOT COMPLETED|Second Treatment Period||0
1688967|NCT00517634|4126650|P2|NOT COMPLETED|Second Treatment Period||0
1688968|NCT00517634|4126651|P1|NOT COMPLETED|Second Treatment Period||0
1688969|NCT00517634|4126646|P6|COMPLETED|Second Treatment Period||4
1688970|NCT00517634|4126647|P5|COMPLETED|Second Treatment Period||3
1688971|NCT00517634|4126648|P4|COMPLETED|Second Treatment Period||3
1688972|NCT00517634|4126649|P3|COMPLETED|Second Treatment Period||4
1688973|NCT00517634|4126650|P2|COMPLETED|Second Treatment Period||4
1688974|NCT00517634|4126651|P1|COMPLETED|Second Treatment Period||4
1688975|NCT00517634|4126646|P6|STARTED|Second Treatment Period||4
1688976|NCT00517634|4126647|P5|STARTED|Second Treatment Period||4
1688977|NCT00517634|4126648|P4|STARTED|Second Treatment Period||3
1688978|NCT00517634|4126649|P3|STARTED|Second Treatment Period||4
1688979|NCT00517634|4126650|P2|STARTED|Second Treatment Period||4
1688980|NCT00517634|4126651|P1|STARTED|Second Treatment Period||4
1688981|NCT00517634|4126646|P6|NOT COMPLETED|First Treatment Period||0
1688982|NCT00517634|4126647|P5|NOT COMPLETED|First Treatment Period||0
1688983|NCT00517634|4126648|P4|NOT COMPLETED|First Treatment Period||0
1688984|NCT00517634|4126649|P3|NOT COMPLETED|First Treatment Period||0
1688985|NCT00517634|4126650|P2|NOT COMPLETED|First Treatment Period||0
1688986|NCT00517634|4126651|P1|NOT COMPLETED|First Treatment Period||0
1688987|NCT00517634|4126646|P6|COMPLETED|First Treatment Period||4
1688988|NCT00517634|4126647|P5|COMPLETED|First Treatment Period||4
1688989|NCT00517634|4126648|P4|COMPLETED|First Treatment Period||3
1688990|NCT00517634|4126649|P3|COMPLETED|First Treatment Period||4
1688991|NCT00517634|4126650|P2|COMPLETED|First Treatment Period||4
1688992|NCT00517634|4126651|P1|COMPLETED|First Treatment Period||4
1688993|NCT00517634|4126646|P6|STARTED|First Treatment Period||4
1688994|NCT00517634|4126647|P5|STARTED|First Treatment Period||4
1688995|NCT00517634|4126648|P4|STARTED|First Treatment Period||3
1688996|NCT00517634|4126649|P3|STARTED|First Treatment Period||4
1688997|NCT00517634|4126650|P2|STARTED|First Treatment Period||4
1688998|NCT00517634|4126651|P1|STARTED|First Treatment Period||4
1688999|NCT00517595|4126662|P1|NOT COMPLETED|Overall Study||0
1689000|NCT00517595|4126662|P1|COMPLETED|Overall Study||48
1689001|NCT00517595|4126662|P1|STARTED|Overall Study||48
1689002|NCT00517556|4126673|P2|NOT COMPLETED|Overall Study||5
1689003|NCT00517556|4126674|P1|NOT COMPLETED|Overall Study||4
1689004|NCT00517556|4126673|P2|COMPLETED|Overall Study||14
1689005|NCT00517556|4126674|P1|COMPLETED|Overall Study||15
1689006|NCT00517556|4126673|P2|STARTED|Overall Study||19
1689007|NCT00517556|4126674|P1|STARTED|Overall Study||19
1689008|NCT00517530|4126687|P7|NOT COMPLETED|Overall Study||19
1689009|NCT00517530|4126688|P6|NOT COMPLETED|Overall Study||19
1689010|NCT00517530|4126689|P5|NOT COMPLETED|Overall Study||20
1689011|NCT00517530|4126690|P4|NOT COMPLETED|Overall Study||21
1689012|NCT00517530|4126691|P3|NOT COMPLETED|Overall Study||18
1689013|NCT00517530|4126692|P2|NOT COMPLETED|Overall Study||13
1689014|NCT00517530|4126693|P1|NOT COMPLETED|Overall Study||19
1689015|NCT00517530|4126687|P7|COMPLETED|Overall Study||1
1689016|NCT00517530|4126688|P6|COMPLETED|Overall Study||0
1689017|NCT00517530|4126689|P5|COMPLETED|Overall Study||1
1689018|NCT00517530|4126690|P4|COMPLETED|Overall Study||1
1689019|NCT00517530|4126691|P3|COMPLETED|Overall Study||0
1689020|NCT00517530|4126692|P2|COMPLETED|Overall Study||0
1689021|NCT00517530|4126693|P1|COMPLETED|Overall Study||2
1689022|NCT00517530|4126687|P7|Retreated Population|Overall Study||0
1689023|NCT00517530|4126688|P6|Retreated Population|Overall Study||2
1689024|NCT00517530|4126689|P5|Retreated Population|Overall Study||2
1689025|NCT00517530|4126690|P4|Retreated Population|Overall Study||4
1689026|NCT00517530|4126691|P3|Retreated Population|Overall Study||1
1689027|NCT00517530|4126692|P2|Retreated Population|Overall Study||2
1689028|NCT00517530|4126693|P1|Retreated Population|Overall Study||2
1689029|NCT00517530|4126687|P7|Completed Follow-up|Overall Study||1
1689030|NCT00517530|4126688|P6|Completed Follow-up|Overall Study||0
1689031|NCT00517530|4126689|P5|Completed Follow-up|Overall Study||0
1689032|NCT00517530|4126690|P4|Completed Follow-up|Overall Study||1
1689033|NCT00517530|4126691|P3|Completed Follow-up|Overall Study||0
1689034|NCT00517530|4126692|P2|Completed Follow-up|Overall Study||0
1689035|NCT00517530|4126693|P1|Completed Follow-up|Overall Study||2
1689036|NCT00517530|4126687|P7|Started Follow-up|Overall Study||19
1689037|NCT00517530|4126688|P6|Started Follow-up|Overall Study||16
1689038|NCT00517530|4126689|P5|Started Follow-up|Overall Study||17
1689039|NCT00517530|4126690|P4|Started Follow-up|Overall Study||21
1689040|NCT00517530|4126691|P3|Started Follow-up|Overall Study||17
1689041|NCT00517530|4126692|P2|Started Follow-up|Overall Study||13
1689042|NCT00517530|4126693|P1|Started Follow-up|Overall Study||20
1689043|NCT00517530|4126687|P7|Completed Treatment|Overall Study||13
1689044|NCT00517530|4126688|P6|Completed Treatment|Overall Study||9
1689045|NCT00517530|4126689|P5|Completed Treatment|Overall Study||9
1689046|NCT00517530|4126690|P4|Completed Treatment|Overall Study||18
1689047|NCT00517530|4126691|P3|Completed Treatment|Overall Study||13
1689048|NCT00517530|4126692|P2|Completed Treatment|Overall Study||13
1689049|NCT00517530|4126693|P1|Completed Treatment|Overall Study||11
1689050|NCT00517530|4126687|P7|STARTED|Overall Study||20
1689051|NCT00517530|4126688|P6|STARTED|Overall Study||19
1689052|NCT00517530|4126689|P5|STARTED|Overall Study||21
1689053|NCT00517530|4126690|P4|STARTED|Overall Study||22
1689054|NCT00517530|4126691|P3|STARTED|Overall Study||18
1689055|NCT00517530|4126692|P2|STARTED|Overall Study||13
1689056|NCT00517530|4126693|P1|STARTED|Overall Study||21
1689057|NCT00517413|4126753|P1|NOT COMPLETED|Overall Study||61
1689058|NCT00517413|4126753|P1|COMPLETED|Overall Study||102
1689059|NCT00517413|4126753|P1|STARTED|Overall Study||163
1689060|NCT00517361|4126774|P1|NOT COMPLETED|Overall Study||11
1689061|NCT00517361|4126774|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
1689062|NCT00517361|4126774|P1|STARTED|Overall Study||11
1689063|NCT00517296|4126783|P2|NOT COMPLETED|Overall Study||0
1689064|NCT00517296|4126784|P1|NOT COMPLETED|Overall Study||1
1689065|NCT00517296|4126783|P2|COMPLETED|Overall Study||11
1689066|NCT00517296|4126784|P1|COMPLETED|Overall Study||9
1689067|NCT00517296|4126783|P2|STARTED|Overall Study||11
1689068|NCT00517296|4126784|P1|STARTED|Overall Study||10
1689069|NCT00517192|4126796|P2|NOT COMPLETED|Overall Study||20
1689070|NCT00517192|4126797|P1|NOT COMPLETED|Overall Study||19
1689071|NCT00517192|4126796|P2|COMPLETED|Overall Study||0
1689072|NCT00517192|4126797|P1|COMPLETED|Overall Study||0
1689073|NCT00517192|4126796|P2|STARTED|Overall Study||20
1689074|NCT00517192|4126797|P1|STARTED|Overall Study||19
1689075|NCT00517075|4126849|P4|NOT COMPLETED|Overall Study||0
1689076|NCT00517075|4126850|P3|NOT COMPLETED|Overall Study||0
1689077|NCT00517075|4126851|P2|NOT COMPLETED|Overall Study||0
1689078|NCT00517075|4126852|P1|NOT COMPLETED|Overall Study||0
1689079|NCT00517075|4126849|P4|COMPLETED|Overall Study||0
1689080|NCT00517075|4126850|P3|COMPLETED|Overall Study||0
1689081|NCT00517075|4126851|P2|COMPLETED|Overall Study||0
1689082|NCT00517075|4126852|P1|COMPLETED|Overall Study||0
1689083|NCT00517075|4126849|P4|STARTED|Overall Study||0
1689084|NCT00517075|4126850|P3|STARTED|Overall Study||0
1689085|NCT00517075|4126851|P2|STARTED|Overall Study||0
1689086|NCT00517075|4126852|P1|STARTED|Overall Study||0
1689087|NCT00517010|4126890|P1|NOT COMPLETED|Overall Study||1
1689088|NCT00517010|4126890|P1|COMPLETED|Overall Study||5
1689089|NCT00517010|4126890|P1|STARTED|Overall Study||6
1689090|NCT00516919|4126895|P2|NOT COMPLETED|Overall Study||7
1689091|NCT00516919|4126896|P1|NOT COMPLETED|Overall Study||10
1689092|NCT00516919|4126895|P2|COMPLETED|Overall Study||32
1689093|NCT00516919|4126896|P1|COMPLETED|Overall Study||30
1689094|NCT00516919|4126895|P2|STARTED|Overall Study||39
1689095|NCT00516919|4126896|P1|STARTED|Overall Study||40
1689096|NCT00516906|4126904|P2|NOT COMPLETED|Overall Study||2
1689097|NCT00516906|4126905|P1|NOT COMPLETED|Overall Study||6
1689098|NCT00516906|4126904|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
1689099|NCT00516906|4126905|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
1689100|NCT00516906|4126904|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
1689101|NCT00516906|4126905|P1|STARTED|Overall Study||36
1689102|NCT00516893|4126915|P1|NOT COMPLETED|Overall Study||21
1689103|NCT00516893|4126915|P1|COMPLETED|Overall Study||92
1689104|NCT00516893|4126915|P1|Received Study Treatment|Overall Study||112
1689105|NCT00516893|4126915|P1|STARTED|Overall Study||113
1689106|NCT00516737|4126924|P2|NOT COMPLETED|Overall Study||8
1689107|NCT00516737|4126925|P1|NOT COMPLETED|Overall Study||11
1689108|NCT00516737|4126924|P2|COMPLETED|Overall Study||96
1689109|NCT00516737|4126925|P1|COMPLETED|Overall Study||92
1689110|NCT00516737|4126924|P2|STARTED|Overall Study||104
1689111|NCT00516737|4126925|P1|STARTED|Overall Study||103
1689112|NCT00516503|4126945|P2|NOT COMPLETED|Overall Study||0
1689113|NCT00516503|4126946|P1|NOT COMPLETED|Overall Study||0
1689114|NCT00516503|4126945|P2|COMPLETED|Overall Study||102
1689115|NCT00516503|4126946|P1|COMPLETED|Overall Study||101
1689116|NCT00516503|4126945|P2|STARTED|Overall Study||102
1689117|NCT00516503|4126946|P1|STARTED|Overall Study||101
1689118|NCT00516386|4126964|P1|NOT COMPLETED|Overall Study||6
1689119|NCT00516386|4126964|P1|COMPLETED|Overall Study||10
1689120|NCT00516386|4126964|P1|STARTED|Overall Study||16
1689121|NCT00516321|4126971|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
1689122|NCT00516321|4126972|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
1689123|NCT00516321|4126973|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
1689124|NCT00516321|4126971|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
1689125|NCT00516321|4126972|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
1689126|NCT00516321|4126973|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
1689127|NCT00516321|4126971|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
1689128|NCT00516321|4126972|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
1689129|NCT00516321|4126973|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
1689130|NCT00516321|4126971|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1689131|NCT00516321|4126972|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1689132|NCT00516321|4126973|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
1689133|NCT00516321|4126971|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1689134|NCT00516321|4126972|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1689135|NCT00516321|4126973|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
1689136|NCT00516321|4126971|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
1689137|NCT00516321|4126972|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
1689138|NCT00516321|4126973|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
1689139|NCT00516295|4127024|P3|NOT COMPLETED|Overall Study||0
1689140|NCT00516295|4127025|P2|NOT COMPLETED|Overall Study||0
1689141|NCT00516295|4127026|P1|NOT COMPLETED|Overall Study||3
1689142|NCT00516295|4127024|P3|COMPLETED|Overall Study||0
1689143|NCT00516295|4127025|P2|COMPLETED|Overall Study||0
1689144|NCT00516295|4127026|P1|COMPLETED|Overall Study||4
1689145|NCT00516295|4127024|P3|STARTED|Overall Study||0
1689146|NCT00516295|4127025|P2|STARTED|Overall Study||0
1689147|NCT00516295|4127026|P1|STARTED|Overall Study||7
1689148|NCT00516269|4127039|P2|NOT COMPLETED|Overall Study||3
1689149|NCT00516269|4127040|P1|NOT COMPLETED|Overall Study||2
1689150|NCT00516269|4127039|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
1689151|NCT00516269|4127040|P1|COMPLETED|Overall Study|2 patients had an early termination|17
1689152|NCT00516269|4127039|P2|STARTED|Overall Study||19
1689153|NCT00516269|4127040|P1|STARTED|Overall Study||19
1689154|NCT00516217|4127046|P1|NOT COMPLETED|Overall Study||0
1689155|NCT00516217|4127046|P1|COMPLETED|Overall Study||29
1689156|NCT00516217|4127046|P1|STARTED|Overall Study||29
1689157|NCT00516165|4127052|P1|NOT COMPLETED|Overall Study||0
1689158|NCT00516165|4127052|P1|COMPLETED|Overall Study||28
1689159|NCT00516165|4127052|P1|STARTED|Overall Study||28
1689160|NCT00516139|4127061|P1|NOT COMPLETED|Overall Study||38
1689161|NCT00516139|4127061|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
1689162|NCT00516139|4127061|P1|STARTED|Overall Study||122
1689163|NCT00516074|4127092|P2|NOT COMPLETED|Overall Study||3
1689164|NCT00516074|4127093|P1|NOT COMPLETED|Overall Study||6
1689165|NCT00516074|4127092|P2|COMPLETED|Overall Study||23
1689166|NCT00516074|4127093|P1|COMPLETED|Overall Study||22
1689167|NCT00516074|4127092|P2|STARTED|Overall Study||26
1689168|NCT00516074|4127093|P1|STARTED|Overall Study||28
1689169|NCT00516048|4127111|P3|NOT COMPLETED|Overall Study||1
1689170|NCT00516048|4127112|P2|NOT COMPLETED|Overall Study||2
1689171|NCT00516048|4127113|P1|NOT COMPLETED|Overall Study||0
1689172|NCT00516048|4127111|P3|COMPLETED|Overall Study||0
1689173|NCT00516048|4127112|P2|COMPLETED|Overall Study||40
1689174|NCT00516048|4127113|P1|COMPLETED|Overall Study||15
1689175|NCT00516048|4127111|P3|STARTED|Overall Study||1
1689176|NCT00516048|4127112|P2|STARTED|Overall Study||42
1689177|NCT00516048|4127113|P1|STARTED|Overall Study||15
1689178|NCT00515879|4127129|P2|NOT COMPLETED|Overall Study||20
1689179|NCT00515879|4127130|P1|NOT COMPLETED|Overall Study||25
1689180|NCT00515879|4127129|P2|COMPLETED|Overall Study||62
1689181|NCT00515879|4127130|P1|COMPLETED|Overall Study||62
1689182|NCT00515879|4127129|P2|STARTED|Overall Study||82
1689183|NCT00515879|4127130|P1|STARTED|Overall Study||87
1689184|NCT00515827|4127140|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
1689185|NCT00515827|4127141|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
1689186|NCT00515827|4127140|P2|COMPLETED|Second Intervention (12 Weeks)||25
1689187|NCT00515827|4127141|P1|COMPLETED|Second Intervention (12 Weeks)||25
1689188|NCT00515827|4127140|P2|STARTED|Second Intervention (12 Weeks)||25
1689189|NCT00515827|4127141|P1|STARTED|Second Intervention (12 Weeks)||26
1689190|NCT00515827|4127140|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
1689191|NCT00515827|4127141|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
1689192|NCT00515827|4127140|P2|COMPLETED|First Intervention (12 Weeks)||25
1689193|NCT00515827|4127141|P1|COMPLETED|First Intervention (12 Weeks)||26
1689194|NCT00515827|4127140|P2|STARTED|First Intervention (12 Weeks)||26
1689195|NCT00515827|4127141|P1|STARTED|First Intervention (12 Weeks)||27
1689196|NCT00515697|4127163|P1|NOT COMPLETED|Overall Study||0
1689197|NCT00515697|4127163|P1|COMPLETED|Overall Study||39
1689198|NCT00515697|4127163|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
1689199|NCT00515697|4127163|P1|STARTED|Overall Study||39
1689200|NCT00515671|4127176|P2|NOT COMPLETED|Overall Study||17
1689201|NCT00515671|4127177|P1|NOT COMPLETED|Overall Study||17
1689202|NCT00515671|4127176|P2|COMPLETED|Overall Study||41
1689203|NCT00515671|4127177|P1|COMPLETED|Overall Study||43
1689204|NCT00515671|4127176|P2|STARTED|Overall Study||58
1689205|NCT00515671|4127177|P1|STARTED|Overall Study||60
1689206|NCT00515619|4127185|P1|NOT COMPLETED|Overall Study||216
1689207|NCT00515619|4127185|P1|COMPLETED|Overall Study||160
1689208|NCT00515619|4127185|P1|Safety Set|Overall Study||376
1689209|NCT00515619|4127185|P1|STARTED|Overall Study||376
1689210|NCT00515541|4127197|P4|NOT COMPLETED|Overall Study||5
1689211|NCT00515541|4127198|P3|NOT COMPLETED|Overall Study||0
1689212|NCT00515541|4127199|P2|NOT COMPLETED|Overall Study||5
1689213|NCT00515541|4127200|P1|NOT COMPLETED|Overall Study||0
1689214|NCT00515541|4127197|P4|COMPLETED|Overall Study||6
1689215|NCT00515541|4127198|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
1689216|NCT00515541|4127199|P2|COMPLETED|Overall Study||7
1689217|NCT00515541|4127200|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
1689218|NCT00515541|4127197|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
1689219|NCT00515541|4127198|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
1689220|NCT00515541|4127199|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
1689221|NCT00515541|4127200|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
1689222|NCT00515541|4127197|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
1689223|NCT00515541|4127198|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
1689224|NCT00515541|4127199|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
1689225|NCT00515541|4127200|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
1689226|NCT00515541|4127197|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
1689227|NCT00515541|4127198|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
1689228|NCT00515541|4127199|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
1689229|NCT00515541|4127200|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
1689230|NCT00515541|4127197|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
1689231|NCT00515541|4127198|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
1689232|NCT00515541|4127199|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
1689233|NCT00515541|4127200|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
1689234|NCT00515541|4127197|P4|STARTED|Overall Study||11
1689235|NCT00515541|4127198|P3|STARTED|Overall Study||10
1689236|NCT00515541|4127199|P2|STARTED|Overall Study||12
1689237|NCT00515541|4127200|P1|STARTED|Overall Study||10
1689238|NCT00515502|4127222|P12|NOT COMPLETED|Treatment Period 4||0
1689239|NCT00515502|4127223|P11|NOT COMPLETED|Treatment Period 4||0
1689240|NCT00515502|4127224|P10|NOT COMPLETED|Treatment Period 4||0
1689241|NCT00515502|4127225|P9|NOT COMPLETED|Treatment Period 4||0
1689242|NCT00515502|4127226|P8|NOT COMPLETED|Treatment Period 4||0
1689243|NCT00515502|4127227|P7|NOT COMPLETED|Treatment Period 4||0
1689244|NCT00515502|4127228|P6|NOT COMPLETED|Treatment Period 4||0
1689245|NCT00515502|4127229|P5|NOT COMPLETED|Treatment Period 4||0
1689246|NCT00515502|4127230|P4|NOT COMPLETED|Treatment Period 4||0
1689247|NCT00515502|4127231|P3|NOT COMPLETED|Treatment Period 4||0
1689248|NCT00515502|4127232|P2|NOT COMPLETED|Treatment Period 4||0
1689249|NCT00515502|4127233|P1|NOT COMPLETED|Treatment Period 4||0
1689250|NCT00515502|4127222|P12|COMPLETED|Treatment Period 4||0
1689251|NCT00515502|4127223|P11|COMPLETED|Treatment Period 4||1
1689252|NCT00515502|4127224|P10|COMPLETED|Treatment Period 4||2
1689253|NCT00515502|4127225|P9|COMPLETED|Treatment Period 4||0
1689254|NCT00515502|4127226|P8|COMPLETED|Treatment Period 4||1
1689255|NCT00515502|4127227|P7|COMPLETED|Treatment Period 4||1
1689256|NCT00515502|4127228|P6|COMPLETED|Treatment Period 4||1
1689257|NCT00515502|4127229|P5|COMPLETED|Treatment Period 4||3
1689258|NCT00515502|4127230|P4|COMPLETED|Treatment Period 4||3
1689259|NCT00515502|4127231|P3|COMPLETED|Treatment Period 4||4
1689260|NCT00515502|4127232|P2|COMPLETED|Treatment Period 4||3
1689261|NCT00515502|4127233|P1|COMPLETED|Treatment Period 4||1
1689262|NCT00515502|4127222|P12|STARTED|Treatment Period 4||0
1689263|NCT00515502|4127223|P11|STARTED|Treatment Period 4||1
1689264|NCT00515502|4127224|P10|STARTED|Treatment Period 4||2
1689265|NCT00515502|4127225|P9|STARTED|Treatment Period 4||0
1689266|NCT00515502|4127226|P8|STARTED|Treatment Period 4||1
1689267|NCT00515502|4127227|P7|STARTED|Treatment Period 4||1
1689268|NCT00515502|4127228|P6|STARTED|Treatment Period 4||1
1689269|NCT00515502|4127229|P5|STARTED|Treatment Period 4||3
1689270|NCT00515502|4127230|P4|STARTED|Treatment Period 4||3
1689271|NCT00515502|4127231|P3|STARTED|Treatment Period 4||4
1689272|NCT00515502|4127232|P2|STARTED|Treatment Period 4||3
1689273|NCT00515502|4127233|P1|STARTED|Treatment Period 4||1
1689274|NCT00515502|4127222|P12|NOT COMPLETED|Washout Period 3||0
1689275|NCT00515502|4127223|P11|NOT COMPLETED|Washout Period 3||0
1689276|NCT00515502|4127224|P10|NOT COMPLETED|Washout Period 3||0
1689277|NCT00515502|4127225|P9|NOT COMPLETED|Washout Period 3||0
1689278|NCT00515502|4127226|P8|NOT COMPLETED|Washout Period 3||0
1689279|NCT00515502|4127227|P7|NOT COMPLETED|Washout Period 3||0
1689280|NCT00515502|4127228|P6|NOT COMPLETED|Washout Period 3||0
1689281|NCT00515502|4127229|P5|NOT COMPLETED|Washout Period 3||0
1689282|NCT00515502|4127230|P4|NOT COMPLETED|Washout Period 3||0
1689283|NCT00515502|4127231|P3|NOT COMPLETED|Washout Period 3||0
1689284|NCT00515502|4127232|P2|NOT COMPLETED|Washout Period 3||0
1689285|NCT00515502|4127233|P1|NOT COMPLETED|Washout Period 3||0
1689286|NCT00515502|4127222|P12|COMPLETED|Washout Period 3||0
1689287|NCT00515502|4127223|P11|COMPLETED|Washout Period 3||1
1689288|NCT00515502|4127224|P10|COMPLETED|Washout Period 3||2
1689289|NCT00515502|4127225|P9|COMPLETED|Washout Period 3||0
1689290|NCT00515502|4127226|P8|COMPLETED|Washout Period 3||1
1689291|NCT00515502|4127227|P7|COMPLETED|Washout Period 3||1
1689292|NCT00515502|4127228|P6|COMPLETED|Washout Period 3||1
1689293|NCT00515502|4127229|P5|COMPLETED|Washout Period 3||3
1689294|NCT00515502|4127230|P4|COMPLETED|Washout Period 3||3
1689295|NCT00515502|4127231|P3|COMPLETED|Washout Period 3||4
1689296|NCT00515502|4127232|P2|COMPLETED|Washout Period 3||3
1689297|NCT00515502|4127233|P1|COMPLETED|Washout Period 3||1
1689298|NCT00515502|4127222|P12|STARTED|Washout Period 3||0
1689299|NCT00515502|4127223|P11|STARTED|Washout Period 3||1
1689300|NCT00515502|4127224|P10|STARTED|Washout Period 3||2
1689301|NCT00515502|4127225|P9|STARTED|Washout Period 3||0
1689302|NCT00515502|4127226|P8|STARTED|Washout Period 3||1
1689303|NCT00515502|4127227|P7|STARTED|Washout Period 3||1
1689304|NCT00515502|4127228|P6|STARTED|Washout Period 3||1
1689305|NCT00515502|4127229|P5|STARTED|Washout Period 3||3
1689306|NCT00515502|4127230|P4|STARTED|Washout Period 3||3
1689307|NCT00515502|4127231|P3|STARTED|Washout Period 3||4
1689308|NCT00515502|4127232|P2|STARTED|Washout Period 3||3
1689309|NCT00515502|4127233|P1|STARTED|Washout Period 3||1
1689310|NCT00515502|4127222|P12|NOT COMPLETED|Treatment Period 3||0
1689311|NCT00515502|4127223|P11|NOT COMPLETED|Treatment Period 3||0
1689312|NCT00515502|4127224|P10|NOT COMPLETED|Treatment Period 3||0
1689313|NCT00515502|4127225|P9|NOT COMPLETED|Treatment Period 3||0
1689314|NCT00515502|4127226|P8|NOT COMPLETED|Treatment Period 3||0
1689315|NCT00515502|4127227|P7|NOT COMPLETED|Treatment Period 3||0
1689316|NCT00515502|4127228|P6|NOT COMPLETED|Treatment Period 3||0
1689317|NCT00515502|4127229|P5|NOT COMPLETED|Treatment Period 3||0
1689318|NCT00515502|4127230|P4|NOT COMPLETED|Treatment Period 3||0
1689319|NCT00515502|4127231|P3|NOT COMPLETED|Treatment Period 3||0
1689320|NCT00515502|4127232|P2|NOT COMPLETED|Treatment Period 3||0
1689321|NCT00515502|4127233|P1|NOT COMPLETED|Treatment Period 3||0
1689322|NCT00515502|4127222|P12|COMPLETED|Treatment Period 3||0
1689323|NCT00515502|4127223|P11|COMPLETED|Treatment Period 3||1
1689324|NCT00515502|4127224|P10|COMPLETED|Treatment Period 3||2
1689325|NCT00515502|4127225|P9|COMPLETED|Treatment Period 3||0
1689326|NCT00515502|4127226|P8|COMPLETED|Treatment Period 3||1
1689327|NCT00515502|4127227|P7|COMPLETED|Treatment Period 3||1
1689328|NCT00515502|4127228|P6|COMPLETED|Treatment Period 3||1
1689329|NCT00515502|4127229|P5|COMPLETED|Treatment Period 3||3
1689330|NCT00515502|4127230|P4|COMPLETED|Treatment Period 3||3
1689331|NCT00515502|4127231|P3|COMPLETED|Treatment Period 3||4
1689332|NCT00515502|4127232|P2|COMPLETED|Treatment Period 3||3
1689333|NCT00515502|4127233|P1|COMPLETED|Treatment Period 3||1
1689334|NCT00515502|4127222|P12|STARTED|Treatment Period 3||0
1689335|NCT00515502|4127223|P11|STARTED|Treatment Period 3||1
1689336|NCT00515502|4127224|P10|STARTED|Treatment Period 3||2
1689337|NCT00515502|4127225|P9|STARTED|Treatment Period 3||0
1689338|NCT00515502|4127226|P8|STARTED|Treatment Period 3||1
1689339|NCT00515502|4127227|P7|STARTED|Treatment Period 3||1
1689340|NCT00515502|4127228|P6|STARTED|Treatment Period 3||1
1689341|NCT00515502|4127229|P5|STARTED|Treatment Period 3||3
1689342|NCT00515502|4127230|P4|STARTED|Treatment Period 3||3
1689343|NCT00515502|4127231|P3|STARTED|Treatment Period 3||4
1689344|NCT00515502|4127232|P2|STARTED|Treatment Period 3||3
1689345|NCT00515502|4127233|P1|STARTED|Treatment Period 3||1
1689346|NCT00515502|4127222|P12|NOT COMPLETED|Washout Period 2||0
1689347|NCT00515502|4127223|P11|NOT COMPLETED|Washout Period 2||0
1689348|NCT00515502|4127224|P10|NOT COMPLETED|Washout Period 2||0
1689349|NCT00515502|4127225|P9|NOT COMPLETED|Washout Period 2||0
1689350|NCT00515502|4127226|P8|NOT COMPLETED|Washout Period 2||0
1689351|NCT00515502|4127227|P7|NOT COMPLETED|Washout Period 2||0
1689352|NCT00515502|4127228|P6|NOT COMPLETED|Washout Period 2||0
1689353|NCT00515502|4127229|P5|NOT COMPLETED|Washout Period 2||0
1689354|NCT00515502|4127230|P4|NOT COMPLETED|Washout Period 2||0
1689355|NCT00515502|4127231|P3|NOT COMPLETED|Washout Period 2||0
1689356|NCT00515502|4127232|P2|NOT COMPLETED|Washout Period 2||0
1689357|NCT00515502|4127233|P1|NOT COMPLETED|Washout Period 2||0
1689358|NCT00515502|4127222|P12|COMPLETED|Washout Period 2||0
1689359|NCT00515502|4127223|P11|COMPLETED|Washout Period 2||1
1689360|NCT00515502|4127224|P10|COMPLETED|Washout Period 2||2
1689361|NCT00515502|4127225|P9|COMPLETED|Washout Period 2||0
1689362|NCT00515502|4127226|P8|COMPLETED|Washout Period 2||1
1689363|NCT00515502|4127227|P7|COMPLETED|Washout Period 2||1
1689364|NCT00515502|4127228|P6|COMPLETED|Washout Period 2||1
1689365|NCT00515502|4127229|P5|COMPLETED|Washout Period 2||3
1689366|NCT00515502|4127230|P4|COMPLETED|Washout Period 2||3
1689367|NCT00515502|4127231|P3|COMPLETED|Washout Period 2||4
1689368|NCT00515502|4127232|P2|COMPLETED|Washout Period 2||3
1689369|NCT00515502|4127233|P1|COMPLETED|Washout Period 2||1
1689370|NCT00515502|4127222|P12|STARTED|Washout Period 2||0
1689371|NCT00515502|4127223|P11|STARTED|Washout Period 2||1
1689372|NCT00515502|4127224|P10|STARTED|Washout Period 2||2
1689373|NCT00515502|4127225|P9|STARTED|Washout Period 2||0
1689374|NCT00515502|4127226|P8|STARTED|Washout Period 2||1
1689375|NCT00515502|4127227|P7|STARTED|Washout Period 2||1
1689376|NCT00515502|4127228|P6|STARTED|Washout Period 2||1
1689377|NCT00515502|4127229|P5|STARTED|Washout Period 2||3
1689378|NCT00515502|4127230|P4|STARTED|Washout Period 2||3
1689379|NCT00515502|4127231|P3|STARTED|Washout Period 2||4
1689380|NCT00515502|4127232|P2|STARTED|Washout Period 2||3
1689381|NCT00515502|4127233|P1|STARTED|Washout Period 2||1
1689382|NCT00515502|4127222|P12|NOT COMPLETED|Treatment Period 2||0
1689383|NCT00515502|4127223|P11|NOT COMPLETED|Treatment Period 2||0
1689384|NCT00515502|4127224|P10|NOT COMPLETED|Treatment Period 2||0
1689385|NCT00515502|4127225|P9|NOT COMPLETED|Treatment Period 2||0
1689386|NCT00515502|4127226|P8|NOT COMPLETED|Treatment Period 2||0
1689387|NCT00515502|4127227|P7|NOT COMPLETED|Treatment Period 2||0
1689388|NCT00515502|4127228|P6|NOT COMPLETED|Treatment Period 2||0
1689389|NCT00515502|4127229|P5|NOT COMPLETED|Treatment Period 2||0
1689390|NCT00515502|4127230|P4|NOT COMPLETED|Treatment Period 2||0
1689391|NCT00515502|4127231|P3|NOT COMPLETED|Treatment Period 2||0
1689392|NCT00515502|4127232|P2|NOT COMPLETED|Treatment Period 2||1
1689393|NCT00515502|4127233|P1|NOT COMPLETED|Treatment Period 2||0
1689394|NCT00515502|4127222|P12|COMPLETED|Treatment Period 2||0
1689395|NCT00515502|4127223|P11|COMPLETED|Treatment Period 2||1
1689396|NCT00515502|4127224|P10|COMPLETED|Treatment Period 2||2
1689397|NCT00515502|4127225|P9|COMPLETED|Treatment Period 2||0
1689398|NCT00515502|4127226|P8|COMPLETED|Treatment Period 2||1
1689399|NCT00515502|4127227|P7|COMPLETED|Treatment Period 2||1
1689400|NCT00515502|4127228|P6|COMPLETED|Treatment Period 2||1
1689401|NCT00515502|4127229|P5|COMPLETED|Treatment Period 2||3
1689402|NCT00515502|4127230|P4|COMPLETED|Treatment Period 2||3
1689403|NCT00515502|4127231|P3|COMPLETED|Treatment Period 2||4
1689404|NCT00515502|4127232|P2|COMPLETED|Treatment Period 2||3
1689405|NCT00515502|4127233|P1|COMPLETED|Treatment Period 2||1
1689406|NCT00515502|4127222|P12|STARTED|Treatment Period 2||0
1689407|NCT00515502|4127223|P11|STARTED|Treatment Period 2||1
1689408|NCT00515502|4127224|P10|STARTED|Treatment Period 2||2
1689409|NCT00515502|4127225|P9|STARTED|Treatment Period 2||0
1689410|NCT00515502|4127226|P8|STARTED|Treatment Period 2||1
1689411|NCT00515502|4127227|P7|STARTED|Treatment Period 2||1
1689412|NCT00515502|4127228|P6|STARTED|Treatment Period 2||1
1689413|NCT00515502|4127229|P5|STARTED|Treatment Period 2||3
1689414|NCT00515502|4127230|P4|STARTED|Treatment Period 2||3
1689415|NCT00515502|4127231|P3|STARTED|Treatment Period 2||4
1689416|NCT00515502|4127232|P2|STARTED|Treatment Period 2||4
1689417|NCT00515502|4127233|P1|STARTED|Treatment Period 2||1
1689418|NCT00515502|4127222|P12|NOT COMPLETED|Washout Period 1||0
1689419|NCT00515502|4127223|P11|NOT COMPLETED|Washout Period 1||0
1689420|NCT00515502|4127224|P10|NOT COMPLETED|Washout Period 1||0
1689421|NCT00515502|4127225|P9|NOT COMPLETED|Washout Period 1||0
1689422|NCT00515502|4127226|P8|NOT COMPLETED|Washout Period 1||0
1689423|NCT00515502|4127227|P7|NOT COMPLETED|Washout Period 1||0
1689424|NCT00515502|4127228|P6|NOT COMPLETED|Washout Period 1||0
1689425|NCT00515502|4127229|P5|NOT COMPLETED|Washout Period 1||0
1689426|NCT00515502|4127230|P4|NOT COMPLETED|Washout Period 1||0
1689427|NCT00515502|4127231|P3|NOT COMPLETED|Washout Period 1||0
1689428|NCT00515502|4127232|P2|NOT COMPLETED|Washout Period 1||0
1689429|NCT00515502|4127233|P1|NOT COMPLETED|Washout Period 1||0
1689430|NCT00515502|4127222|P12|COMPLETED|Washout Period 1||0
1689431|NCT00515502|4127223|P11|COMPLETED|Washout Period 1||1
1689432|NCT00515502|4127224|P10|COMPLETED|Washout Period 1||2
1689433|NCT00515502|4127225|P9|COMPLETED|Washout Period 1||0
1689434|NCT00515502|4127226|P8|COMPLETED|Washout Period 1||1
1689435|NCT00515502|4127227|P7|COMPLETED|Washout Period 1||1
1689436|NCT00515502|4127228|P6|COMPLETED|Washout Period 1||1
1689437|NCT00515502|4127229|P5|COMPLETED|Washout Period 1||3
1689438|NCT00515502|4127230|P4|COMPLETED|Washout Period 1||3
1689439|NCT00515502|4127231|P3|COMPLETED|Washout Period 1||4
1689440|NCT00515502|4127232|P2|COMPLETED|Washout Period 1||4
1689441|NCT00515502|4127233|P1|COMPLETED|Washout Period 1||1
1689442|NCT00515502|4127222|P12|STARTED|Washout Period 1||0
1689443|NCT00515502|4127223|P11|STARTED|Washout Period 1||1
1689444|NCT00515502|4127224|P10|STARTED|Washout Period 1||2
1689445|NCT00515502|4127225|P9|STARTED|Washout Period 1||0
1689446|NCT00515502|4127226|P8|STARTED|Washout Period 1||1
1689447|NCT00515502|4127227|P7|STARTED|Washout Period 1||1
1689448|NCT00515502|4127228|P6|STARTED|Washout Period 1||1
1689449|NCT00515502|4127229|P5|STARTED|Washout Period 1||3
1689450|NCT00515502|4127230|P4|STARTED|Washout Period 1||3
1689451|NCT00515502|4127231|P3|STARTED|Washout Period 1||4
1689452|NCT00515502|4127232|P2|STARTED|Washout Period 1||4
1689453|NCT00515502|4127233|P1|STARTED|Washout Period 1||1
1689454|NCT00515502|4127222|P12|NOT COMPLETED|Treatment Period 1||1
1689455|NCT00515502|4127223|P11|NOT COMPLETED|Treatment Period 1||0
1689456|NCT00515502|4127224|P10|NOT COMPLETED|Treatment Period 1||0
1689457|NCT00515502|4127225|P9|NOT COMPLETED|Treatment Period 1||1
1689458|NCT00515502|4127226|P8|NOT COMPLETED|Treatment Period 1||0
1689459|NCT00515502|4127227|P7|NOT COMPLETED|Treatment Period 1||1
1689460|NCT00515502|4127228|P6|NOT COMPLETED|Treatment Period 1||0
1689461|NCT00515502|4127229|P5|NOT COMPLETED|Treatment Period 1||0
1689462|NCT00515502|4127230|P4|NOT COMPLETED|Treatment Period 1||0
1689463|NCT00515502|4127231|P3|NOT COMPLETED|Treatment Period 1||0
1689464|NCT00515502|4127232|P2|NOT COMPLETED|Treatment Period 1||0
1689465|NCT00515502|4127233|P1|NOT COMPLETED|Treatment Period 1||0
1689466|NCT00515502|4127222|P12|COMPLETED|Treatment Period 1||0
1689467|NCT00515502|4127223|P11|COMPLETED|Treatment Period 1||1
1689468|NCT00515502|4127224|P10|COMPLETED|Treatment Period 1||2
1689469|NCT00515502|4127225|P9|COMPLETED|Treatment Period 1||0
1689470|NCT00515502|4127226|P8|COMPLETED|Treatment Period 1||1
1689471|NCT00515502|4127227|P7|COMPLETED|Treatment Period 1||1
1689472|NCT00515502|4127228|P6|COMPLETED|Treatment Period 1||1
1689473|NCT00515502|4127229|P5|COMPLETED|Treatment Period 1||3
1689474|NCT00515502|4127230|P4|COMPLETED|Treatment Period 1||3
1689475|NCT00515502|4127231|P3|COMPLETED|Treatment Period 1||4
1689476|NCT00515502|4127232|P2|COMPLETED|Treatment Period 1||4
1689477|NCT00515502|4127233|P1|COMPLETED|Treatment Period 1||1
1689478|NCT00515502|4127222|P12|STARTED|Treatment Period 1||1
1689479|NCT00515502|4127223|P11|STARTED|Treatment Period 1||1
1689480|NCT00515502|4127224|P10|STARTED|Treatment Period 1||2
1689481|NCT00515502|4127225|P9|STARTED|Treatment Period 1||1
1689482|NCT00515502|4127226|P8|STARTED|Treatment Period 1||1
1689483|NCT00515502|4127227|P7|STARTED|Treatment Period 1||2
1689484|NCT00515502|4127228|P6|STARTED|Treatment Period 1||1
1689485|NCT00515502|4127229|P5|STARTED|Treatment Period 1||3
1689486|NCT00515502|4127230|P4|STARTED|Treatment Period 1||3
1689487|NCT00515502|4127231|P3|STARTED|Treatment Period 1||4
1689488|NCT00515502|4127232|P2|STARTED|Treatment Period 1||4
1689489|NCT00515502|4127233|P1|STARTED|Treatment Period 1||1
1689490|NCT00515463|4127393|P2|NOT COMPLETED|Overall Study||14
1689491|NCT00515463|4127394|P1|NOT COMPLETED|Overall Study||14
1689492|NCT00515463|4127393|P2|COMPLETED|Overall Study||142
1689493|NCT00515463|4127394|P1|COMPLETED|Overall Study||141
1689494|NCT00515463|4127393|P2|Received Study Medication|Overall Study||156
1689495|NCT00515463|4127394|P1|Received Study Medication|Overall Study||154
1689496|NCT00515463|4127393|P2|STARTED|Overall Study||156
1689497|NCT00515463|4127394|P1|STARTED|Overall Study||155
1689498|NCT00515437|4127548|P4|NOT COMPLETED|Overall Study||1
1689499|NCT00515437|4127549|P3|NOT COMPLETED|Overall Study||0
1689500|NCT00515437|4127550|P2|NOT COMPLETED|Overall Study||0
1689501|NCT00515437|4127551|P1|NOT COMPLETED|Overall Study||0
1689502|NCT00515437|4127548|P4|COMPLETED|Overall Study||14
1689503|NCT00515437|4127549|P3|COMPLETED|Overall Study||13
1689504|NCT00515437|4127550|P2|COMPLETED|Overall Study||12
1689505|NCT00515437|4127551|P1|COMPLETED|Overall Study||14
1689506|NCT00515437|4127548|P4|STARTED|Overall Study||15
1689507|NCT00515437|4127549|P3|STARTED|Overall Study||13
1689508|NCT00515437|4127550|P2|STARTED|Overall Study||12
1689509|NCT00515437|4127551|P1|STARTED|Overall Study||14
1689510|NCT00515294|4127577|P4|NOT COMPLETED|Overall Study||4
1689511|NCT00515294|4127578|P3|NOT COMPLETED|Overall Study||11
1689512|NCT00515294|4127579|P2|NOT COMPLETED|Overall Study||3
1689513|NCT00515294|4127580|P1|NOT COMPLETED|Overall Study||9
1689514|NCT00515294|4127577|P4|COMPLETED|Overall Study||35
1689515|NCT00515294|4127578|P3|COMPLETED|Overall Study||27
1689516|NCT00515294|4127579|P2|COMPLETED|Overall Study||36
1689517|NCT00515294|4127580|P1|COMPLETED|Overall Study||29
1689518|NCT00515294|4127577|P4|STARTED|Overall Study||39
1689519|NCT00515294|4127578|P3|STARTED|Overall Study||38
1689520|NCT00515294|4127579|P2|STARTED|Overall Study||39
1689521|NCT00515294|4127580|P1|STARTED|Overall Study||38
1689522|NCT00515216|4127594|P1|NOT COMPLETED|Overall Study||1
1689523|NCT00515216|4127594|P1|COMPLETED|Overall Study||25
1689524|NCT00515216|4127594|P1|STARTED|Overall Study||26
1689525|NCT00515203|4127618|P2|NOT COMPLETED|Overall Study||0
1689526|NCT00515203|4127619|P1|NOT COMPLETED|Overall Study||0
1689527|NCT00515203|4127618|P2|COMPLETED|Overall Study||5
1689528|NCT00515203|4127619|P1|COMPLETED|Overall Study||17
1689529|NCT00515203|4127618|P2|STARTED|Overall Study||5
1689530|NCT00515203|4127619|P1|STARTED|Overall Study||17
1689531|NCT00515177|4127637|P2|NOT COMPLETED|Overall Study||1
1689532|NCT00515177|4127638|P1|NOT COMPLETED|Overall Study||2
1689533|NCT00515177|4127637|P2|COMPLETED|Overall Study||9
1689534|NCT00515177|4127638|P1|COMPLETED|Overall Study||18
1689535|NCT00515177|4127637|P2|STARTED|Overall Study||10
1689536|NCT00515177|4127638|P1|STARTED|Overall Study||20
1689537|NCT00515112|4127656|P2|NOT COMPLETED|Overall Study||3
1689538|NCT00515112|4127657|P1|NOT COMPLETED|Overall Study||3
1689539|NCT00515112|4127656|P2|COMPLETED|Overall Study||0
1689540|NCT00515112|4127657|P1|COMPLETED|Overall Study||0
1689541|NCT00515112|4127656|P2|STARTED|Overall Study||3
1689542|NCT00515112|4127657|P1|STARTED|Overall Study||3
1689543|NCT00515099|4127667|P2|NOT COMPLETED|Overall Study||4
1689544|NCT00515099|4127668|P1|NOT COMPLETED|Overall Study||3
1689545|NCT00515099|4127667|P2|COMPLETED|Overall Study||16
1689546|NCT00515099|4127668|P1|COMPLETED|Overall Study||35
1689547|NCT00515099|4127667|P2|STARTED|Overall Study||20
1689548|NCT00515099|4127668|P1|STARTED|Overall Study||38
1689549|NCT00515086|4127690|P4|NOT COMPLETED|Overall Study||6
1689550|NCT00515086|4127691|P3|NOT COMPLETED|Overall Study||5
1689551|NCT00515086|4127692|P2|NOT COMPLETED|Overall Study||6
1689552|NCT00515086|4127693|P1|NOT COMPLETED|Overall Study||24
1689553|NCT00515086|4127690|P4|COMPLETED|Overall Study||0
1689554|NCT00515086|4127691|P3|COMPLETED|Overall Study||0
1689555|NCT00515086|4127692|P2|COMPLETED|Overall Study||0
1689556|NCT00515086|4127693|P1|COMPLETED|Overall Study||0
1689557|NCT00515086|4127690|P4|STARTED|Overall Study||6
1689558|NCT00515086|4127691|P3|STARTED|Overall Study||5
1689559|NCT00515086|4127692|P2|STARTED|Overall Study||6
1689560|NCT00515086|4127693|P1|STARTED|Overall Study||24
1689561|NCT00515073|4127720|P1|NOT COMPLETED|Overall Study||2
1689562|NCT00515073|4127720|P1|COMPLETED|Overall Study||28
1689563|NCT00515073|4127720|P1|STARTED|Overall Study||30
1689564|NCT00515034|4127728|P4|NOT COMPLETED|Overall Study||5
1689565|NCT00515034|4127729|P3|NOT COMPLETED|Overall Study||8
1689566|NCT00515034|4127730|P2|NOT COMPLETED|Overall Study||2
1689567|NCT00515034|4127731|P1|NOT COMPLETED|Overall Study||8
1689568|NCT00515034|4127728|P4|COMPLETED|Overall Study||15
1689569|NCT00515034|4127729|P3|COMPLETED|Overall Study||54
1689570|NCT00515034|4127730|P2|COMPLETED|Overall Study||13
1689571|NCT00515034|4127731|P1|COMPLETED|Overall Study||41
1689572|NCT00515034|4127728|P4|TREATED|Overall Study||19
1689573|NCT00515034|4127729|P3|TREATED|Overall Study||61
1689574|NCT00515034|4127730|P2|TREATED|Overall Study||15
1689575|NCT00515034|4127731|P1|TREATED|Overall Study||48
1689576|NCT00515034|4127728|P4|STARTED|Overall Study||20
1689577|NCT00515034|4127729|P3|STARTED|Overall Study||62
1689578|NCT00515034|4127730|P2|STARTED|Overall Study||15
1689579|NCT00515034|4127731|P1|STARTED|Overall Study||49
1689580|NCT00515008|4127751|P2|NOT COMPLETED|Overall Study||4
1689581|NCT00515008|4127752|P1|NOT COMPLETED|Overall Study||3
1689582|NCT00515008|4127751|P2|COMPLETED|Overall Study||29
1689583|NCT00515008|4127752|P1|COMPLETED|Overall Study||30
1689584|NCT00515008|4127751|P2|Completed 12 Week Evaluation|Overall Study||29
1689585|NCT00515008|4127752|P1|Completed 12 Week Evaluation|Overall Study||32
1689586|NCT00515008|4127751|P2|STARTED|Overall Study||33
1689587|NCT00515008|4127752|P1|STARTED|Overall Study||33
1689588|NCT00514943|4127776|P2|NOT COMPLETED|Stage 2||36
1689589|NCT00514943|4127777|P1|NOT COMPLETED|Stage 2||32
1689590|NCT00514943|4127776|P2|COMPLETED|Stage 2||0
1689591|NCT00514943|4127777|P1|COMPLETED|Stage 2||0
1689592|NCT00514943|4127776|P2|STARTED|Stage 2||36
1689593|NCT00514943|4127777|P1|STARTED|Stage 2||32
1689594|NCT00514943|4127776|P2|NOT COMPLETED|Stage 1||26
1689595|NCT00514943|4127777|P1|NOT COMPLETED|Stage 1||30
1689596|NCT00514943|4127776|P2|COMPLETED|Stage 1||36
1689597|NCT00514943|4127777|P1|COMPLETED|Stage 1||32
1689598|NCT00514943|4127776|P2|STARTED|Stage 1|2 randomized patients were not treated|62
1689599|NCT00514943|4127777|P1|STARTED|Stage 1|1 randomized patient was not treated|62
1689600|NCT00514917|4127835|P2|NOT COMPLETED|Overall Study||115
1689601|NCT00514917|4127836|P1|NOT COMPLETED|Overall Study||126
1689602|NCT00514917|4127835|P2|COMPLETED|Overall Study||91
1689603|NCT00514917|4127836|P1|COMPLETED|Overall Study||81
1689604|NCT00514917|4127835|P2|Testosterone-Specific Evaluable|Overall Study||124
1689605|NCT00514917|4127836|P1|Testosterone-Specific Evaluable|Overall Study||122
1689606|NCT00514917|4127835|P2|Completed Study Treatment|Overall Study||182
1689607|NCT00514917|4127836|P1|Completed Study Treatment|Overall Study||170
1689608|NCT00514917|4127835|P2|Treated|Overall Study||204
1689609|NCT00514917|4127836|P1|Treated|Overall Study||196
1689610|NCT00514917|4127835|P2|STARTED|Overall Study||206
1689611|NCT00514917|4127836|P1|STARTED|Overall Study||207
1689612|NCT00514904|4127864|P2|NOT COMPLETED|Overall Study||5
1689613|NCT00514904|4127865|P1|NOT COMPLETED|Overall Study||24
1689614|NCT00514904|4127864|P2|COMPLETED|Overall Study||371
1689615|NCT00514904|4127865|P1|COMPLETED|Overall Study||1101
1689616|NCT00514904|4127864|P2|STARTED|Overall Study||376
1689617|NCT00514904|4127865|P1|STARTED|Overall Study||1125
1689618|NCT00514852|4127901|P2|NOT COMPLETED|Overall Study||5
1689619|NCT00514852|4127902|P1|NOT COMPLETED|Overall Study||5
1689620|NCT00514852|4127901|P2|COMPLETED|Overall Study||154
1689621|NCT00514852|4127902|P1|COMPLETED|Overall Study||152
1689622|NCT00514852|4127901|P2|STARTED|Overall Study||159
1689623|NCT00514852|4127902|P1|STARTED|Overall Study||157
1689624|NCT00514813|4127930|P4|NOT COMPLETED|Overall Study||4
1689625|NCT00514813|4127931|P3|NOT COMPLETED|Overall Study||47
1689626|NCT00514813|4127932|P2|NOT COMPLETED|Overall Study||86
1689627|NCT00514813|4127933|P1|NOT COMPLETED|Overall Study||15
1689628|NCT00514813|4127930|P4|COMPLETED|Overall Study||0
1689629|NCT00514813|4127931|P3|COMPLETED|Overall Study||0
1689630|NCT00514813|4127932|P2|COMPLETED|Overall Study||0
1689631|NCT00514813|4127933|P1|COMPLETED|Overall Study||0
1689632|NCT00514813|4127930|P4|STARTED|Overall Study||4
1689633|NCT00514813|4127931|P3|STARTED|Overall Study||47
1689634|NCT00514813|4127932|P2|STARTED|Overall Study||86
1689635|NCT00514813|4127933|P1|STARTED|Overall Study||15
1689636|NCT00514735|4127953|P2|NOT COMPLETED|Overall Study||6
1689637|NCT00514735|4127954|P1|NOT COMPLETED|Overall Study||14
1689638|NCT00514735|4127953|P2|COMPLETED|Overall Study||66
1689639|NCT00514735|4127954|P1|COMPLETED|Overall Study||124
1689640|NCT00514735|4127953|P2|STARTED|Overall Study||72
1689641|NCT00514735|4127954|P1|STARTED|Overall Study||138
1689642|NCT00514709|4127974|P2|NOT COMPLETED|Overall Study||0
1689643|NCT00514709|4127975|P1|NOT COMPLETED|Overall Study||0
1689644|NCT00514709|4127974|P2|COMPLETED|Overall Study||613
1689645|NCT00514709|4127975|P1|COMPLETED|Overall Study||1230
1689646|NCT00514709|4127974|P2|STARTED|Overall Study||613
1689647|NCT00514709|4127975|P1|STARTED|Overall Study||1230
1689648|NCT00514683|4127990|P5|NOT COMPLETED|Overall Study||33
1689649|NCT00514683|4127991|P4|NOT COMPLETED|Overall Study||14
1689650|NCT00514683|4127992|P3|NOT COMPLETED|Overall Study||18
1689651|NCT00514683|4127993|P2|NOT COMPLETED|Overall Study||25
1689652|NCT00514683|4127994|P1|NOT COMPLETED|Overall Study||26
1689653|NCT00514683|4127990|P5|COMPLETED|Overall Study||53
1689654|NCT00514683|4127991|P4|COMPLETED|Overall Study||72
1689655|NCT00514683|4127992|P3|COMPLETED|Overall Study||68
1689656|NCT00514683|4127993|P2|COMPLETED|Overall Study||62
1689657|NCT00514683|4127994|P1|COMPLETED|Overall Study||61
1689658|NCT00514683|4127990|P5|STARTED|Overall Study|Randomised|86
1689659|NCT00514683|4127991|P4|STARTED|Overall Study|Randomised|86
1689660|NCT00514683|4127992|P3|STARTED|Overall Study|Randomised|86
1689661|NCT00514683|4127993|P2|STARTED|Overall Study|Randomised|87
1689662|NCT00514683|4127994|P1|STARTED|Overall Study|Randomised|87
1689663|NCT00514592|4128185|P1|NOT COMPLETED|Overall Study||0
1689664|NCT00514592|4128185|P1|COMPLETED|Overall Study||230
1689665|NCT00514592|4128185|P1|STARTED|Overall Study||230
1689666|NCT00514514|4128193|P3|NOT COMPLETED|Extension - 4 Years||21
1689667|NCT00514514|4128194|P2|NOT COMPLETED|Extension - 4 Years||22
1689668|NCT00514514|4128195|P1|NOT COMPLETED|Extension - 4 Years||37
1689669|NCT00514514|4128193|P3|COMPLETED|Extension - 4 Years||113
1689670|NCT00514514|4128194|P2|COMPLETED|Extension - 4 Years||117
1689671|NCT00514514|4128195|P1|COMPLETED|Extension - 4 Years||108
1689672|NCT00514514|4128193|P3|Non-randomized (Followed)|Extension - 4 Years||0
1689673|NCT00514514|4128194|P2|Non-randomized (Followed)|Extension - 4 Years||0
1689674|NCT00514514|4128195|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
1689675|NCT00514514|4128193|P3|STARTED|Extension - 4 Years||134
1689676|NCT00514514|4128194|P2|STARTED|Extension - 4 Years||139
1689677|NCT00514514|4128195|P1|STARTED|Extension - 4 Years||145
1689678|NCT00514514|4128193|P3|NOT COMPLETED|Randomized - 9 Month||38
1689679|NCT00514514|4128194|P2|NOT COMPLETED|Randomized - 9 Month||61
1689680|NCT00514514|4128195|P1|NOT COMPLETED|Randomized - 9 Month||39
1689681|NCT00514514|4128193|P3|COMPLETED|Randomized - 9 Month||124
1689682|NCT00514514|4128194|P2|COMPLETED|Randomized - 9 Month||110
1689683|NCT00514514|4128195|P1|COMPLETED|Randomized - 9 Month||127
1689684|NCT00514514|4128193|P3|Randomized - Received Treatment|Randomized - 9 Month||161
1689685|NCT00514514|4128194|P2|Randomized - Received Treatment|Randomized - 9 Month||171
1689686|NCT00514514|4128195|P1|Randomized - Received Treatment|Randomized - 9 Month||165
1689687|NCT00514514|4128193|P3|STARTED|Randomized - 9 Month||162
1689688|NCT00514514|4128194|P2|STARTED|Randomized - 9 Month||171
1689689|NCT00514514|4128195|P1|STARTED|Randomized - 9 Month||166
1689690|NCT00514514|4128193|P3|NOT COMPLETED|Pre-phase||0
1689691|NCT00514514|4128194|P2|NOT COMPLETED|Pre-phase||0
1689692|NCT00514514|4128195|P1|NOT COMPLETED|Pre-phase||303
1689693|NCT00514514|4128193|P3|COMPLETED|Pre-phase||0
1689694|NCT00514514|4128194|P2|COMPLETED|Pre-phase||0
1689695|NCT00514514|4128195|P1|COMPLETED|Pre-phase||499
1689696|NCT00514514|4128193|P3|STARTED|Pre-phase||0
1689697|NCT00514514|4128194|P2|STARTED|Pre-phase||0
1689698|NCT00514514|4128195|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
1689699|NCT00514501|4128239|P1|NOT COMPLETED|Overall Study||3
1689700|NCT00514501|4128239|P1|COMPLETED|Overall Study||507
1689701|NCT00514501|4128239|P1|STARTED|Overall Study||510
1689702|NCT00514449|4128247|P2|NOT COMPLETED|Overall Study||4
1689703|NCT00514449|4128248|P1|NOT COMPLETED|Overall Study||3
1689704|NCT00514449|4128247|P2|COMPLETED|Overall Study||8
1689705|NCT00514449|4128248|P1|COMPLETED|Overall Study||9
1689706|NCT00514449|4128247|P2|STARTED|Overall Study||12
1689707|NCT00514449|4128248|P1|STARTED|Overall Study||12
1689708|NCT00514215|4128258|P1|NOT COMPLETED|Overall Study||0
1689709|NCT00514215|4128258|P1|COMPLETED|Overall Study||8
1689710|NCT00514215|4128258|P1|STARTED|Overall Study||8
1689711|NCT00514137|4128262|P1|NOT COMPLETED|Overall Study||0
1689712|NCT00514137|4128262|P1|COMPLETED|Overall Study||13
1689713|NCT00514137|4128262|P1|STARTED|Overall Study||13
1689714|NCT00514020|4128269|P1|NOT COMPLETED|Overall Study||28
1689715|NCT00514020|4128269|P1|COMPLETED|Overall Study||5
1689716|NCT00514020|4128269|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
1689717|NCT00513799|4128277|P4|NOT COMPLETED|Four-Month Follow-Up||3
1689718|NCT00513799|4128278|P3|NOT COMPLETED|Four-Month Follow-Up||7
1689719|NCT00513799|4128279|P2|NOT COMPLETED|Four-Month Follow-Up||5
1689720|NCT00513799|4128280|P1|NOT COMPLETED|Four-Month Follow-Up||0
1689721|NCT00513799|4128277|P4|COMPLETED|Four-Month Follow-Up||51
1689722|NCT00513799|4128278|P3|COMPLETED|Four-Month Follow-Up||57
1689723|NCT00513799|4128279|P2|COMPLETED|Four-Month Follow-Up||57
1689724|NCT00513799|4128280|P1|COMPLETED|Four-Month Follow-Up||64
1689725|NCT00513799|4128277|P4|STARTED|Four-Month Follow-Up||54
1689726|NCT00513799|4128278|P3|STARTED|Four-Month Follow-Up||64
1689727|NCT00513799|4128279|P2|STARTED|Four-Month Follow-Up||62
1689728|NCT00513799|4128280|P1|STARTED|Four-Month Follow-Up||64
1689729|NCT00513799|4128277|P4|NOT COMPLETED|One-Month Follow-Up||21
1689730|NCT00513799|4128278|P3|NOT COMPLETED|One-Month Follow-Up||11
1689731|NCT00513799|4128279|P2|NOT COMPLETED|One-Month Follow-Up||13
1689732|NCT00513799|4128280|P1|NOT COMPLETED|One-Month Follow-Up||11
1689733|NCT00513799|4128277|P4|COMPLETED|One-Month Follow-Up||54
1689734|NCT00513799|4128278|P3|COMPLETED|One-Month Follow-Up||64
1689735|NCT00513799|4128279|P2|COMPLETED|One-Month Follow-Up||62
1689736|NCT00513799|4128280|P1|COMPLETED|One-Month Follow-Up||64
1689737|NCT00513799|4128277|P4|STARTED|One-Month Follow-Up||75
1689738|NCT00513799|4128278|P3|STARTED|One-Month Follow-Up||75
1689739|NCT00513799|4128279|P2|STARTED|One-Month Follow-Up||75
1689740|NCT00513799|4128280|P1|STARTED|One-Month Follow-Up||75
1689741|NCT00513708|4128301|P3|NOT COMPLETED|Overall Study||4
1689742|NCT00513708|4128302|P2|NOT COMPLETED|Overall Study||4
1689743|NCT00513708|4128303|P1|NOT COMPLETED|Overall Study||4
1689744|NCT00513708|4128301|P3|COMPLETED|Overall Study||46
1689745|NCT00513708|4128302|P2|COMPLETED|Overall Study||46
1689746|NCT00513708|4128303|P1|COMPLETED|Overall Study||46
1689747|NCT00513708|4128301|P3|STARTED|Overall Study||50
1689748|NCT00513708|4128302|P2|STARTED|Overall Study||50
1689749|NCT00513708|4128303|P1|STARTED|Overall Study||50
1689750|NCT00513695|4128317|P1|NOT COMPLETED|Overall Study||5
1689751|NCT00513695|4128317|P1|COMPLETED|Overall Study||63
1689752|NCT00513695|4128317|P1|STARTED|Overall Study||68
1689753|NCT00513682|4128326|P1|NOT COMPLETED|Treatment Phase||0
1689754|NCT00513682|4128326|P1|COMPLETED|Treatment Phase||7
1689755|NCT00513682|4128326|P1|STARTED|Treatment Phase||7
1689756|NCT00513682|4128326|P1|NOT COMPLETED|Washout Phase||2
1689757|NCT00513682|4128326|P1|COMPLETED|Washout Phase||7
1689758|NCT00513682|4128326|P1|STARTED|Washout Phase||9
1689759|NCT00513682|4128326|P1|NOT COMPLETED|Screening Phase||0
1689760|NCT00513682|4128326|P1|COMPLETED|Screening Phase||9
1689761|NCT00513682|4128326|P1|STARTED|Screening Phase||9
1689762|NCT00513617|4128338|P3|NOT COMPLETED|Overall Study||8
1689763|NCT00513617|4128339|P2|NOT COMPLETED|Overall Study||10
1689764|NCT00513617|4128340|P1|NOT COMPLETED|Overall Study||11
1689765|NCT00513617|4128338|P3|COMPLETED|Overall Study||30
1689766|NCT00513617|4128339|P2|COMPLETED|Overall Study||25
1689767|NCT00513617|4128340|P1|COMPLETED|Overall Study||25
1689768|NCT00513617|4128338|P3|STARTED|Overall Study||38
1689769|NCT00513617|4128339|P2|STARTED|Overall Study||35
1689770|NCT00513617|4128340|P1|STARTED|Overall Study||36
1689771|NCT00513604|4128356|P5|NOT COMPLETED|Overall Study||0
1689772|NCT00513604|4128357|P4|NOT COMPLETED|Overall Study||0
1689773|NCT00513604|4128358|P3|NOT COMPLETED|Overall Study||3
1689774|NCT00513604|4128359|P2|NOT COMPLETED|Overall Study||3
1689775|NCT00513604|4128360|P1|NOT COMPLETED|Overall Study||2
1689776|NCT00513604|4128356|P5|COMPLETED|Overall Study||35
1689777|NCT00513604|4128357|P4|COMPLETED|Overall Study||34
1689778|NCT00513604|4128358|P3|COMPLETED|Overall Study||21
1689779|NCT00513604|4128359|P2|COMPLETED|Overall Study||36
1689780|NCT00513604|4128360|P1|COMPLETED|Overall Study||24
1689781|NCT00513604|4128356|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
1689782|NCT00513604|4128357|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
1689783|NCT00513604|4128358|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
1689784|NCT00513604|4128359|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
1689785|NCT00513604|4128360|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
1689786|NCT00513526|4128377|P1|NOT COMPLETED|Overall Study||17
1689787|NCT00513526|4128377|P1|COMPLETED|Overall Study||92
1689788|NCT00513526|4128377|P1|STARTED|Overall Study||109
1689789|NCT00513500|4128394|P2|NOT COMPLETED|Overall Study||54
1689790|NCT00513500|4128395|P1|NOT COMPLETED|Overall Study||41
1689791|NCT00513500|4128394|P2|COMPLETED|Overall Study||2054
1689792|NCT00513500|4128395|P1|COMPLETED|Overall Study||976
1689793|NCT00513500|4128394|P2|STARTED|Overall Study||2108
1689794|NCT00513500|4128395|P1|STARTED|Overall Study||1017
1689795|NCT00513474|4128407|P2|NOT COMPLETED|Overall Study||9
1689796|NCT00513474|4128408|P1|NOT COMPLETED|Overall Study||7
1689797|NCT00513474|4128407|P2|COMPLETED|Overall Study||12
1689798|NCT00513474|4128408|P1|COMPLETED|Overall Study||18
1689799|NCT00513474|4128407|P2|Received Rasburicase Per Protocol|Overall Study||0
1689800|NCT00513474|4128408|P1|Received Rasburicase Per Protocol|Overall Study||24
1689801|NCT00513474|4128407|P2|STARTED|Overall Study||21
1689802|NCT00513474|4128408|P1|STARTED|Overall Study||25
1689803|NCT00513461|4128422|P2|NOT COMPLETED|Overall Study||10
1689804|NCT00513461|4128423|P1|NOT COMPLETED|Overall Study||13
1689805|NCT00513461|4128422|P2|COMPLETED|Overall Study||43
1689806|NCT00513461|4128423|P1|COMPLETED|Overall Study||44
1689807|NCT00513461|4128422|P2|STARTED|Overall Study||53
1689808|NCT00513461|4128423|P1|STARTED|Overall Study||57
1689809|NCT00513435|4128457|P1|NOT COMPLETED|Overall Study||0
1689810|NCT00513435|4128457|P1|COMPLETED|Overall Study||9
1689811|NCT00513435|4128457|P1|STARTED|Overall Study||9
1689812|NCT00513409|4128464|P2|NOT COMPLETED|Overall Study||6
1689813|NCT00513409|4128465|P1|NOT COMPLETED|Overall Study||2
1689814|NCT00513409|4128464|P2|COMPLETED|Overall Study||73
1689815|NCT00513409|4128465|P1|COMPLETED|Overall Study||82
1689816|NCT00513409|4128464|P2|STARTED|Overall Study||79
1689817|NCT00513409|4128465|P1|STARTED|Overall Study||84
1689818|NCT00513370|4128491|P1|NOT COMPLETED|Overall Study||24
1689819|NCT00513370|4128491|P1|COMPLETED|Overall Study||179
1689820|NCT00513370|4128491|P1|STARTED|Overall Study||203
1689821|NCT00513357|4128521|P2|NOT COMPLETED|Overall Study||10
1689822|NCT00513357|4128522|P1|NOT COMPLETED|Overall Study||15
1689823|NCT00513357|4128521|P2|COMPLETED|Overall Study||25
1689824|NCT00513357|4128522|P1|COMPLETED|Overall Study||23
1689825|NCT00513357|4128521|P2|STARTED|Overall Study||35
1689826|NCT00513357|4128522|P1|STARTED|Overall Study||38
1689827|NCT00513344|4128528|P1|NOT COMPLETED|3rd Intervention 1 Day||0
1689828|NCT00513344|4128528|P1|COMPLETED|3rd Intervention 1 Day||5
1689829|NCT00513344|4128528|P1|STARTED|3rd Intervention 1 Day||5
1689830|NCT00513344|4128528|P1|NOT COMPLETED|Washout Period 3 Days||0
1689831|NCT00513344|4128528|P1|COMPLETED|Washout Period 3 Days||5
1689832|NCT00513344|4128528|P1|STARTED|Washout Period 3 Days||5
1689833|NCT00513344|4128528|P1|NOT COMPLETED|2nd Intervention 1 Day||0
1689834|NCT00513344|4128528|P1|COMPLETED|2nd Intervention 1 Day||5
1689835|NCT00513344|4128528|P1|STARTED|2nd Intervention 1 Day||5
1689836|NCT00513344|4128528|P1|NOT COMPLETED|Washout Period 3 Days||0
1689837|NCT00513344|4128528|P1|COMPLETED|Washout Period 3 Days||5
1689838|NCT00513344|4128528|P1|STARTED|Washout Period 3 Days||5
1689839|NCT00513344|4128528|P1|NOT COMPLETED|1st Intervention 1 Day||0
1689840|NCT00513344|4128528|P1|COMPLETED|1st Intervention 1 Day||5
1689841|NCT00513344|4128528|P1|STARTED|1st Intervention 1 Day||5
1689842|NCT00513344|4128528|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
1689843|NCT00513344|4128528|P1|COMPLETED|Diet Restriction (3 Days)||5
1689844|NCT00513344|4128528|P1|STARTED|Diet Restriction (3 Days)||5
1689845|NCT00513305|4128541|P2|NOT COMPLETED|Overall Study||27
1689846|NCT00513305|4128542|P1|NOT COMPLETED|Overall Study||28
1689847|NCT00513305|4128541|P2|COMPLETED|Overall Study||7
1689848|NCT00513305|4128542|P1|COMPLETED|Overall Study||5
1689849|NCT00513305|4128541|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
1689850|NCT00513305|4128542|P1|STARTED|Overall Study||33
1689851|NCT00513292|4128560|P2|NOT COMPLETED|Overall Study||0
1689852|NCT00513292|4128561|P1|NOT COMPLETED|Overall Study||0
1689853|NCT00513292|4128560|P2|COMPLETED|Overall Study||142
1689854|NCT00513292|4128561|P1|COMPLETED|Overall Study||138
1689855|NCT00513292|4128560|P2|STARTED|Overall Study||142
1689856|NCT00513292|4128561|P1|STARTED|Overall Study||138
1689857|NCT00513240|4128579|P2|NOT COMPLETED|Overall Study||7
1689858|NCT00513240|4128580|P1|NOT COMPLETED|Overall Study||13
1689859|NCT00513240|4128579|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
1689860|NCT00513240|4128580|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
1689861|NCT00513240|4128579|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
1689862|NCT00513240|4128580|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
1689863|NCT00513240|4128579|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
1689864|NCT00513240|4128580|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
1689865|NCT00513071|4128587|P1|NOT COMPLETED|Overall Study||5
1689866|NCT00513071|4128587|P1|COMPLETED|Overall Study||23
1689867|NCT00513071|4128587|P1|STARTED|Overall Study||28
1689868|NCT00513019|4128599|P2|NOT COMPLETED|Overall Study||5
1689869|NCT00513019|4128600|P1|NOT COMPLETED|Overall Study||5
1689870|NCT00513019|4128599|P2|COMPLETED|Overall Study||13
1689871|NCT00513019|4128600|P1|COMPLETED|Overall Study||12
1689872|NCT00513019|4128599|P2|STARTED|Overall Study||18
1689873|NCT00513019|4128600|P1|STARTED|Overall Study||17
1689874|NCT00512902|4128606|P1|NOT COMPLETED|Overall Study||8
1689875|NCT00512902|4128606|P1|COMPLETED|Overall Study||12
1689876|NCT00512902|4128606|P1|STARTED|Overall Study||20
1689877|NCT00512876|4128614|P1|NOT COMPLETED|Overall Study||4
1689878|NCT00512876|4128614|P1|COMPLETED|Overall Study||20
1689879|NCT00512876|4128614|P1|STARTED|Overall Study||24
1689880|NCT00512798|4128621|P2|NOT COMPLETED|Overall Study||27
1689881|NCT00512798|4128622|P1|NOT COMPLETED|Overall Study||19
1689882|NCT00512798|4128621|P2|COMPLETED|Overall Study||1
1689883|NCT00512798|4128622|P1|COMPLETED|Overall Study||0
1689884|NCT00512798|4128621|P2|STARTED|Overall Study||28
1689885|NCT00512798|4128622|P1|STARTED|Overall Study||19
1689886|NCT00512707|4128633|P2|NOT COMPLETED|Overall Study||12
1689887|NCT00512707|4128634|P1|NOT COMPLETED|Overall Study||10
1689888|NCT00512707|4128633|P2|COMPLETED|Overall Study||58
1689889|NCT00512707|4128634|P1|COMPLETED|Overall Study||60
1689890|NCT00512707|4128633|P2|STARTED|Overall Study||70
1689891|NCT00512707|4128634|P1|STARTED|Overall Study||70
1689892|NCT00512278|4128666|P2|NOT COMPLETED|Overall Study||17
1689893|NCT00512278|4128667|P1|NOT COMPLETED|Overall Study||28
1689894|NCT00512278|4128666|P2|COMPLETED|Overall Study||56
1689895|NCT00512278|4128667|P1|COMPLETED|Overall Study||45
1689896|NCT00512278|4128666|P2|STARTED|Overall Study||73
1689897|NCT00512278|4128667|P1|STARTED|Overall Study||73
1689898|NCT00512252|4128684|P3|NOT COMPLETED|Overall Study||3
1689899|NCT00512252|4128685|P2|NOT COMPLETED|Overall Study||0
1689900|NCT00512252|4128686|P1|NOT COMPLETED|Overall Study||0
1689901|NCT00512252|4128684|P3|COMPLETED|Overall Study||43
1689902|NCT00512252|4128685|P2|COMPLETED|Overall Study||3
1689903|NCT00512252|4128686|P1|COMPLETED|Overall Study||3
1689904|NCT00512252|4128684|P3|STARTED|Overall Study||46
1689905|NCT00512252|4128685|P2|STARTED|Overall Study||3
1689906|NCT00512252|4128686|P1|STARTED|Overall Study||3
1689907|NCT00512148|4128714|P1|NOT COMPLETED|Long Term Follow Up Period||6
1689908|NCT00512148|4128714|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
1689909|NCT00512148|4128714|P1|STARTED|Long Term Follow Up Period||6
1689910|NCT00512148|4128714|P1|NOT COMPLETED|Primay Study Period||1
1689911|NCT00512148|4128714|P1|COMPLETED|Primay Study Period||6
1689912|NCT00512148|4128714|P1|STARTED|Primay Study Period||7
1689913|NCT00512096|4128720|P1|NOT COMPLETED|Overall Study||7
1689914|NCT00512096|4128720|P1|COMPLETED|Overall Study||23
1689915|NCT00512096|4128720|P1|STARTED|Overall Study||30
1689916|NCT00511992|4128724|P1|NOT COMPLETED|Overall Study||7
1689917|NCT00511992|4128724|P1|COMPLETED|Overall Study||13
1689918|NCT00511992|4128724|P1|STARTED|Overall Study||20
1689919|NCT00511914|4128731|P2|NOT COMPLETED|Overall Study||0
1689920|NCT00511914|4128732|P1|NOT COMPLETED|Overall Study||0
1689921|NCT00511914|4128731|P2|COMPLETED|Overall Study||67
1689922|NCT00511914|4128732|P1|COMPLETED|Overall Study||68
1689923|NCT00511914|4128731|P2|STARTED|Overall Study||67
1689924|NCT00511914|4128732|P1|STARTED|Overall Study||68
1689925|NCT00511901|4128748|P2|NOT COMPLETED|Overall Study||3
1689926|NCT00511901|4128749|P1|NOT COMPLETED|Overall Study||1
1689927|NCT00511901|4128748|P2|COMPLETED|Overall Study||8
1689928|NCT00511901|4128749|P1|COMPLETED|Overall Study||10
1689929|NCT00511901|4128748|P2|STARTED|Overall Study||11
1689930|NCT00511901|4128749|P1|STARTED|Overall Study||11
1689931|NCT00511875|4128771|P2|NOT COMPLETED|Overall Study||0
1689932|NCT00511875|4128772|P1|NOT COMPLETED|Overall Study||5
1689933|NCT00511875|4128771|P2|COMPLETED|Overall Study||15
1689934|NCT00511875|4128772|P1|COMPLETED|Overall Study||10
1689935|NCT00511875|4128771|P2|STARTED|Overall Study||15
1689936|NCT00511875|4128772|P1|STARTED|Overall Study||15
1689937|NCT00511862|4128797|P3|NOT COMPLETED|Overall Study||0
1689938|NCT00511862|4128798|P2|NOT COMPLETED|Overall Study||0
1689939|NCT00511862|4128799|P1|NOT COMPLETED|Overall Study||0
1689940|NCT00511862|4128797|P3|COMPLETED|Overall Study||47
1689941|NCT00511862|4128798|P2|COMPLETED|Overall Study||43
1689942|NCT00511862|4128799|P1|COMPLETED|Overall Study||61
1689943|NCT00511862|4128797|P3|STARTED|Overall Study||47
1689944|NCT00511862|4128798|P2|STARTED|Overall Study||43
1689945|NCT00511862|4128799|P1|STARTED|Overall Study||61
1689946|NCT00511836|4128812|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
1689947|NCT00511836|4128813|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
1689948|NCT00511836|4128812|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
1689949|NCT00511836|4128813|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
1689950|NCT00511836|4128812|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
1689951|NCT00511836|4128813|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
1689952|NCT00511836|4128812|P2|NOT COMPLETED|Double-blind Period||0
1689953|NCT00511836|4128813|P1|NOT COMPLETED|Double-blind Period||1
1689954|NCT00511836|4128812|P2|COMPLETED|Double-blind Period||15
1689955|NCT00511836|4128813|P1|COMPLETED|Double-blind Period||15
1689956|NCT00511836|4128812|P2|STARTED|Double-blind Period||15
1689957|NCT00511836|4128813|P1|STARTED|Double-blind Period||16
1689958|NCT00511810|4128830|P2|NOT COMPLETED|Overall Study||5
1689959|NCT00511810|4128831|P1|NOT COMPLETED|Overall Study||1
1689960|NCT00511810|4128830|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
1689961|NCT00511810|4128831|P1|COMPLETED|Overall Study||7
1689962|NCT00511810|4128830|P2|STARTED|Overall Study||12
1689963|NCT00511810|4128831|P1|STARTED|Overall Study||8
1689964|NCT00511797|4128841|P4|NOT COMPLETED|Overall Study||15
1689965|NCT00511797|4128842|P3|NOT COMPLETED|Overall Study||11
1689966|NCT00511797|4128843|P2|NOT COMPLETED|Overall Study||8
1689967|NCT00511797|4128844|P1|NOT COMPLETED|Overall Study||7
1689968|NCT00511797|4128841|P4|COMPLETED|Overall Study||47
1689969|NCT00511797|4128842|P3|COMPLETED|Overall Study||51
1689970|NCT00511797|4128843|P2|COMPLETED|Overall Study||55
1689971|NCT00511797|4128844|P1|COMPLETED|Overall Study||55
1689972|NCT00511797|4128841|P4|Subjects Received Treatment|Overall Study|FAS|58
1689973|NCT00511797|4128842|P3|Subjects Received Treatment|Overall Study|FAS|61
1689974|NCT00511797|4128843|P2|Subjects Received Treatment|Overall Study|FAS|62
1689975|NCT00511797|4128844|P1|Subjects Received Treatment|Overall Study|FAS|61
1689976|NCT00511797|4128841|P4|Subjects Dispensed Drugs|Overall Study||59
1689977|NCT00511797|4128842|P3|Subjects Dispensed Drugs|Overall Study||61
1689978|NCT00511797|4128843|P2|Subjects Dispensed Drugs|Overall Study||63
1689979|NCT00511797|4128844|P1|Subjects Dispensed Drugs|Overall Study||61
1689980|NCT00511797|4128841|P4|STARTED|Overall Study||62
1689981|NCT00511797|4128842|P3|STARTED|Overall Study||62
1689982|NCT00511797|4128843|P2|STARTED|Overall Study||63
1689983|NCT00511797|4128844|P1|STARTED|Overall Study||62
1689984|NCT00511706|4128948|P2|NOT COMPLETED|Overall Study||5
1689985|NCT00511706|4128949|P1|NOT COMPLETED|Overall Study||8
1689986|NCT00511706|4128948|P2|COMPLETED|Overall Study||115
1689987|NCT00511706|4128949|P1|COMPLETED|Overall Study||115
1689988|NCT00511706|4128948|P2|STARTED|Overall Study||120
1689989|NCT00511706|4128949|P1|STARTED|Overall Study||123
1689990|NCT00511667|4128963|P2|NOT COMPLETED|Overall Study||3
1689991|NCT00511667|4128964|P1|NOT COMPLETED|Overall Study||12
1689992|NCT00511667|4128963|P2|COMPLETED|Overall Study||15
1689993|NCT00511667|4128964|P1|COMPLETED|Overall Study||40
1689994|NCT00511667|4128963|P2|STARTED|Overall Study||18
1689995|NCT00511667|4128964|P1|STARTED|Overall Study||52
1689996|NCT00511472|4128999|P2|NOT COMPLETED|Overall Study||6
1689997|NCT00511472|4129000|P1|NOT COMPLETED|Overall Study||3
1689998|NCT00511472|4128999|P2|COMPLETED|Overall Study||17
1689999|NCT00511472|4129000|P1|COMPLETED|Overall Study||44
1690000|NCT00511472|4128999|P2|STARTED|Overall Study||23
1690001|NCT00511472|4129000|P1|STARTED|Overall Study||47
1690002|NCT00511433|4129019|P2|NOT COMPLETED|Overall Study||1
1690003|NCT00511433|4129020|P1|NOT COMPLETED|Overall Study||6
1690004|NCT00511433|4129019|P2|COMPLETED|Overall Study||15
1690005|NCT00511433|4129020|P1|COMPLETED|Overall Study||26
1690006|NCT00511433|4129019|P2|STARTED|Overall Study||16
1690007|NCT00511433|4129020|P1|STARTED|Overall Study||32
1690008|NCT00511355|4129060|P2|NOT COMPLETED|Overall Study||9
1690009|NCT00511355|4129061|P1|NOT COMPLETED|Overall Study||7
1690010|NCT00511355|4129060|P2|COMPLETED|Overall Study||52
1690011|NCT00511355|4129061|P1|COMPLETED|Overall Study||53
1690012|NCT00511355|4129060|P2|STARTED|Overall Study||61
1690013|NCT00511355|4129061|P1|STARTED|Overall Study||60
1690014|NCT00511342|4129161|P2|NOT COMPLETED|Overall Study||22
1690015|NCT00511342|4129162|P1|NOT COMPLETED|Overall Study||13
1690016|NCT00511342|4129161|P2|COMPLETED|Overall Study||32
1690017|NCT00511342|4129162|P1|COMPLETED|Overall Study||43
1690018|NCT00511342|4129161|P2|STARTED|Overall Study||54
1690019|NCT00511342|4129162|P1|STARTED|Overall Study||56
1690020|NCT00511329|4129186|P1|NOT COMPLETED|Overall Study||0
1690021|NCT00511329|4129186|P1|COMPLETED|Overall Study||0
1690022|NCT00511329|4129186|P1|STARTED|Overall Study||0
1690023|NCT00511238|4129193|P2|NOT COMPLETED|Overall Study||226
1690024|NCT00511238|4129194|P1|NOT COMPLETED|Overall Study||42
1690025|NCT00511238|4129193|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
1690026|NCT00511238|4129194|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
1690027|NCT00511238|4129193|P2|STARTED|Overall Study||266
1690028|NCT00511238|4129194|P1|STARTED|Overall Study||46
1690029|NCT00511199|4129213|P2|NOT COMPLETED|Overall Study||125
1690030|NCT00511199|4129214|P1|NOT COMPLETED|Overall Study||449
1690031|NCT00511199|4129213|P2|COMPLETED|Overall Study||410
1690032|NCT00511199|4129214|P1|COMPLETED|Overall Study||1142
1690033|NCT00511199|4129213|P2|STARTED|Overall Study||535
1690034|NCT00511199|4129214|P1|STARTED|Overall Study||1591
1690035|NCT00511173|4129238|P1|NOT COMPLETED|Overall Study||0
1690036|NCT00511173|4129238|P1|COMPLETED|Overall Study||102
1690037|NCT00511173|4129238|P1|STARTED|Overall Study||102
1690038|NCT00511147|4129243|P1|NOT COMPLETED|Overall Study||7
1690039|NCT00511147|4129243|P1|COMPLETED|Overall Study||57
1690040|NCT00511147|4129243|P1|STARTED|Overall Study||64
1690041|NCT00511134|4129252|P2|NOT COMPLETED|Overall Study||2
1690042|NCT00511134|4129253|P1|NOT COMPLETED|Overall Study||0
1690043|NCT00511134|4129252|P2|COMPLETED|Overall Study||1
1690044|NCT00511134|4129253|P1|COMPLETED|Overall Study||1
1690045|NCT00511134|4129252|P2|STARTED|Overall Study||3
1690046|NCT00511134|4129253|P1|STARTED|Overall Study||1
1690047|NCT00511108|4129265|P4|NOT COMPLETED|Overall Study||5
1690048|NCT00511108|4129266|P3|NOT COMPLETED|Overall Study||5
1690049|NCT00511108|4129267|P2|NOT COMPLETED|Overall Study||2
1690050|NCT00511108|4129268|P1|NOT COMPLETED|Overall Study||6
1690051|NCT00511108|4129265|P4|COMPLETED|Overall Study||48
1690052|NCT00511108|4129266|P3|COMPLETED|Overall Study||47
1690053|NCT00511108|4129267|P2|COMPLETED|Overall Study||52
1690054|NCT00511108|4129268|P1|COMPLETED|Overall Study||46
1690055|NCT00511108|4129265|P4|STARTED|Overall Study||53
1690056|NCT00511108|4129266|P3|STARTED|Overall Study||52
1690057|NCT00511108|4129267|P2|STARTED|Overall Study||54
1690058|NCT00511108|4129268|P1|STARTED|Overall Study||52
1690059|NCT00511095|4129286|P1|NOT COMPLETED|Overall Study||11
1690060|NCT00511095|4129286|P1|COMPLETED|Overall Study||196
1690061|NCT00511095|4129286|P1|STARTED|Overall Study||207
1690062|NCT00511004|4129299|P3|NOT COMPLETED|Overall Study||4
1690063|NCT00511004|4129300|P2|NOT COMPLETED|Overall Study||0
1690064|NCT00511004|4129301|P1|NOT COMPLETED|Overall Study||0
1690065|NCT00511004|4129299|P3|COMPLETED|Overall Study||10
1690066|NCT00511004|4129300|P2|COMPLETED|Overall Study||13
1690067|NCT00511004|4129301|P1|COMPLETED|Overall Study||13
1690068|NCT00511004|4129299|P3|STARTED|Overall Study||14
1690069|NCT00511004|4129300|P2|STARTED|Overall Study||13
1690070|NCT00511004|4129301|P1|STARTED|Overall Study||13
1690071|NCT00510952|4129320|P2|NOT COMPLETED|Overall Study||16
1690072|NCT00510952|4129321|P1|NOT COMPLETED|Overall Study||26
1690073|NCT00510952|4129320|P2|COMPLETED|Overall Study||220
1690074|NCT00510952|4129321|P1|COMPLETED|Overall Study||209
1690075|NCT00510952|4129320|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
1690076|NCT00510952|4129321|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
1690077|NCT00510952|4129320|P2|STARTED|Overall Study||236
1690078|NCT00510952|4129321|P1|STARTED|Overall Study||235
1690079|NCT00510887|4129347|P1|NOT COMPLETED|Overall Study||1
1690080|NCT00510887|4129347|P1|COMPLETED|Overall Study||11
1690081|NCT00510887|4129347|P1|STARTED|Overall Study||12
1690082|NCT00510874|4129363|P7|NOT COMPLETED|Overall Study||1
1690083|NCT00510874|4129364|P6|NOT COMPLETED|Overall Study||0
1690084|NCT00510874|4129365|P5|NOT COMPLETED|Overall Study||7
1690085|NCT00510874|4129366|P4|NOT COMPLETED|Overall Study||3
1690086|NCT00510874|4129367|P3|NOT COMPLETED|Overall Study||1
1690087|NCT00510874|4129368|P2|NOT COMPLETED|Overall Study||4
1690088|NCT00510874|4129369|P1|NOT COMPLETED|Overall Study||3
1690089|NCT00510874|4129363|P7|COMPLETED|Overall Study|Upto Day 182|49
1690090|NCT00510874|4129364|P6|COMPLETED|Overall Study|Upto Day 182|50
1690091|NCT00510874|4129365|P5|COMPLETED|Overall Study|Upto Day 182|141
1690092|NCT00510874|4129366|P4|COMPLETED|Overall Study|Upto Day 182|148
1690093|NCT00510874|4129367|P3|COMPLETED|Overall Study|Upto Day 182|150
1690094|NCT00510874|4129368|P2|COMPLETED|Overall Study|Upto Day 182|148
1690095|NCT00510874|4129369|P1|COMPLETED|Overall Study|Upto Day 182|75
1690096|NCT00510874|4129363|P7|STARTED|Overall Study||50
1690097|NCT00510874|4129364|P6|STARTED|Overall Study||50
1690098|NCT00510874|4129365|P5|STARTED|Overall Study||148
1690099|NCT00510874|4129366|P4|STARTED|Overall Study||151
1690100|NCT00510874|4129367|P3|STARTED|Overall Study||151
1690101|NCT00510874|4129368|P2|STARTED|Overall Study||152
1690102|NCT00510874|4129369|P1|STARTED|Overall Study||78
1690103|NCT00510835|4129472|P3|NOT COMPLETED|Overall Study||2
1690104|NCT00510835|4129473|P2|NOT COMPLETED|Overall Study||2
1690105|NCT00510835|4129474|P1|NOT COMPLETED|Overall Study||6
1690106|NCT00510835|4129472|P3|COMPLETED|Overall Study||456
1690107|NCT00510835|4129473|P2|COMPLETED|Overall Study||446
1690108|NCT00510835|4129474|P1|COMPLETED|Overall Study||439
1690109|NCT00510835|4129472|P3|STARTED|Overall Study||458
1690110|NCT00510835|4129473|P2|STARTED|Overall Study||448
1690111|NCT00510835|4129474|P1|STARTED|Overall Study||445
1690112|NCT00510809|4129485|P3|NOT COMPLETED|Overall Study||0
1690113|NCT00510809|4129486|P2|NOT COMPLETED|Overall Study||0
1690114|NCT00510809|4129487|P1|NOT COMPLETED|Overall Study||0
1690115|NCT00510809|4129485|P3|COMPLETED|Overall Study||18
1690116|NCT00510809|4129486|P2|COMPLETED|Overall Study||18
1690117|NCT00510809|4129487|P1|COMPLETED|Overall Study||18
1690118|NCT00510809|4129485|P3|STARTED|Overall Study||18
1690119|NCT00510809|4129486|P2|STARTED|Overall Study||18
1690120|NCT00510809|4129487|P1|STARTED|Overall Study||18
1690121|NCT00510783|4129500|P2|NOT COMPLETED|Overall Study||29
1690122|NCT00510783|4129501|P1|NOT COMPLETED|Overall Study||31
1690123|NCT00510783|4129500|P2|COMPLETED|Overall Study||47
1690124|NCT00510783|4129501|P1|COMPLETED|Overall Study||51
1690125|NCT00510783|4129500|P2|STARTED|Overall Study||76
1690126|NCT00510783|4129501|P1|STARTED|Overall Study||82
1690127|NCT00510744|4129507|P1|NOT COMPLETED|Overall Study||0
1690128|NCT00510744|4129507|P1|COMPLETED|Overall Study||5
1690129|NCT00510744|4129507|P1|STARTED|Overall Study||5
1690130|NCT00510692|4129513|P2|NOT COMPLETED|Overall Study||3
1690131|NCT00510692|4129514|P1|NOT COMPLETED|Overall Study||2
1690132|NCT00510692|4129513|P2|COMPLETED|Overall Study||26
1690133|NCT00510692|4129514|P1|COMPLETED|Overall Study||27
1690134|NCT00510692|4129513|P2|STARTED|Overall Study||29
1690135|NCT00510692|4129514|P1|STARTED|Overall Study||29
1690136|NCT00510653|4129528|P1|NOT COMPLETED|Overall Study||11
1690137|NCT00510653|4129528|P1|COMPLETED|Overall Study||13
1690138|NCT00510653|4129528|P1|STARTED|Overall Study||24
1690139|NCT00510510|4129535|P3|NOT COMPLETED|Overall Study||17
1690140|NCT00510510|4129536|P2|NOT COMPLETED|Overall Study||9
1690141|NCT00510510|4129537|P1|NOT COMPLETED|Overall Study||5
1690142|NCT00510510|4129535|P3|COMPLETED|Overall Study||74
1690143|NCT00510510|4129536|P2|COMPLETED|Overall Study||89
1690144|NCT00510510|4129537|P1|COMPLETED|Overall Study||87
1690145|NCT00510510|4129535|P3|STARTED|Overall Study||91
1690146|NCT00510510|4129536|P2|STARTED|Overall Study||98
1690147|NCT00510510|4129537|P1|STARTED|Overall Study||92
1690148|NCT00510497|4129548|P1|NOT COMPLETED|Overall Study||3
1690149|NCT00510497|4129548|P1|COMPLETED|Overall Study||8
1690150|NCT00510497|4129548|P1|STARTED|Overall Study||11
1690151|NCT00510484|4129555|P2|NOT COMPLETED|Period 2||0
1690152|NCT00510484|4129556|P1|NOT COMPLETED|Period 2||0
1690153|NCT00510484|4129555|P2|COMPLETED|Period 2||15
1690154|NCT00510484|4129556|P1|COMPLETED|Period 2||16
1690155|NCT00510484|4129555|P2|STARTED|Period 2||15
1690156|NCT00510484|4129556|P1|STARTED|Period 2||16
1690157|NCT00510484|4129555|P2|NOT COMPLETED|Wash-out Period||1
1690158|NCT00510484|4129556|P1|NOT COMPLETED|Wash-out Period||0
1690159|NCT00510484|4129555|P2|COMPLETED|Wash-out Period||15
1690160|NCT00510484|4129556|P1|COMPLETED|Wash-out Period||16
1690161|NCT00510484|4129555|P2|STARTED|Wash-out Period||16
1690162|NCT00510484|4129556|P1|STARTED|Wash-out Period||16
1690163|NCT00510484|4129555|P2|NOT COMPLETED|Period 1||0
1690164|NCT00510484|4129556|P1|NOT COMPLETED|Period 1||0
1690165|NCT00510484|4129555|P2|COMPLETED|Period 1||16
1690166|NCT00510484|4129556|P1|COMPLETED|Period 1||16
1690167|NCT00510484|4129555|P2|STARTED|Period 1||16
1690168|NCT00510484|4129556|P1|STARTED|Period 1||16
1690169|NCT00510458|4129576|P1|NOT COMPLETED|Overall Study||47
1690170|NCT00510458|4129576|P1|COMPLETED|Overall Study||27
1690171|NCT00510458|4129576|P1|STARTED|Overall Study||74
1690172|NCT00510289|4129589|P1|NOT COMPLETED|Overall Study||12
1690173|NCT00510289|4129589|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
1690174|NCT00510289|4129589|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
1690175|NCT00510289|4129589|P1|STARTED|Overall Study|All patients who consented|19
1690176|NCT00510276|4129599|P2|NOT COMPLETED|Extension Open-Label Phase||48
1690177|NCT00510276|4129600|P1|NOT COMPLETED|Extension Open-Label Phase||33
1690178|NCT00510276|4129599|P2|COMPLETED|Extension Open-Label Phase||81
1690179|NCT00510276|4129600|P1|COMPLETED|Extension Open-Label Phase||78
1690180|NCT00510276|4129599|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
1690181|NCT00510276|4129600|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
1690182|NCT00510276|4129599|P2|NOT COMPLETED|Acute Double-Blind Phase||95
1690183|NCT00510276|4129600|P1|NOT COMPLETED|Acute Double-Blind Phase||105
1690184|NCT00510276|4129599|P2|COMPLETED|Acute Double-Blind Phase||130
1690185|NCT00510276|4129600|P1|COMPLETED|Acute Double-Blind Phase||115
1690186|NCT00510276|4129599|P2|STARTED|Acute Double-Blind Phase||225
1690187|NCT00510276|4129600|P1|STARTED|Acute Double-Blind Phase||220
1690188|NCT00510224|4129685|P1|NOT COMPLETED|Overall Study||3
1690189|NCT00510224|4129685|P1|COMPLETED|Overall Study||10
1690190|NCT00510224|4129685|P1|STARTED|Overall Study||13
1690191|NCT00510146|4129694|P2|NOT COMPLETED|Open-Label Treatment||26
1690192|NCT00510146|4129695|P1|NOT COMPLETED|Open-Label Treatment||71
1690193|NCT00510146|4129694|P2|COMPLETED|Open-Label Treatment||96
1690194|NCT00510146|4129695|P1|COMPLETED|Open-Label Treatment||196
1690195|NCT00510146|4129694|P2|STARTED|Open-Label Treatment||122
1690196|NCT00510146|4129695|P1|STARTED|Open-Label Treatment||267
1690197|NCT00510146|4129694|P2|NOT COMPLETED|Double-Blind Treatment||49
1690198|NCT00510146|4129695|P1|NOT COMPLETED|Double-Blind Treatment||76
1690199|NCT00510146|4129694|P2|COMPLETED|Double-Blind Treatment||122
1690200|NCT00510146|4129695|P1|COMPLETED|Double-Blind Treatment||267
1690201|NCT00510146|4129694|P2|STARTED|Double-Blind Treatment||171
1690202|NCT00510146|4129695|P1|STARTED|Double-Blind Treatment||343
1690203|NCT00510068|4129784|P2|NOT COMPLETED|Open-label Period||0
1690204|NCT00510068|4129785|P1|NOT COMPLETED|Open-label Period||225
1690205|NCT00510068|4129784|P2|COMPLETED|Open-label Period||0
1690206|NCT00510068|4129785|P1|COMPLETED|Open-label Period||0
1690207|NCT00510068|4129784|P2|STARTED|Open-label Period||0
1690208|NCT00510068|4129785|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
1690209|NCT00510068|4129784|P2|NOT COMPLETED|Double-blind Period||203
1690210|NCT00510068|4129785|P1|NOT COMPLETED|Double-blind Period||207
1690211|NCT00510068|4129784|P2|COMPLETED|Double-blind Period||0
1690212|NCT00510068|4129785|P1|COMPLETED|Double-blind Period||0
1690213|NCT00510068|4129784|P2|Safety Population|Double-blind Period||203
1690214|NCT00510068|4129785|P1|Safety Population|Double-blind Period||204
1690215|NCT00510068|4129784|P2|STARTED|Double-blind Period||203
1690216|NCT00510068|4129785|P1|STARTED|Double-blind Period||207
1690217|NCT00509925|4129826|P2|NOT COMPLETED|Overall Study||1
1690218|NCT00509925|4129827|P1|NOT COMPLETED|Overall Study||0
1690219|NCT00509925|4129826|P2|COMPLETED|Overall Study||10
1690220|NCT00509925|4129827|P1|COMPLETED|Overall Study||12
1690221|NCT00509925|4129826|P2|STARTED|Overall Study||11
1690222|NCT00509925|4129827|P1|STARTED|Overall Study||12
1690223|NCT00509899|4129875|P8|NOT COMPLETED|Overall Study||1
1690224|NCT00509899|4129876|P7|NOT COMPLETED|Overall Study||1
1690225|NCT00509899|4129877|P6|NOT COMPLETED|Overall Study||10
1690226|NCT00509899|4129878|P5|NOT COMPLETED|Overall Study||5
1690227|NCT00509899|4129879|P4|NOT COMPLETED|Overall Study||4
1690228|NCT00509899|4129880|P3|NOT COMPLETED|Overall Study||20
1690229|NCT00509899|4129881|P2|NOT COMPLETED|Overall Study||9
1690230|NCT00509899|4129882|P1|NOT COMPLETED|Overall Study||16
1690231|NCT00509899|4129875|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
1690232|NCT00509899|4129876|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
1690233|NCT00509899|4129877|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
1690234|NCT00509899|4129878|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
1690235|NCT00509899|4129879|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
1690236|NCT00509899|4129880|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
1690237|NCT00509899|4129881|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
1690412|NCT00508742|4130273|P1|NOT COMPLETED|Period 2: After Infant Series||7
1690238|NCT00509899|4129882|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
1690239|NCT00509899|4129875|P8|STARTED|Overall Study||3
1690240|NCT00509899|4129876|P7|STARTED|Overall Study||6
1690241|NCT00509899|4129877|P6|STARTED|Overall Study||22
1690242|NCT00509899|4129878|P5|STARTED|Overall Study||6
1690243|NCT00509899|4129879|P4|STARTED|Overall Study||5
1690244|NCT00509899|4129880|P3|STARTED|Overall Study||47
1690245|NCT00509899|4129881|P2|STARTED|Overall Study||35
1690246|NCT00509899|4129882|P1|STARTED|Overall Study||30
1690247|NCT00509873|4129922|P2|NOT COMPLETED|Overall Study||15
1690248|NCT00509873|4129923|P1|NOT COMPLETED|Overall Study||11
1690249|NCT00509873|4129922|P2|COMPLETED|Overall Study||276
1690250|NCT00509873|4129923|P1|COMPLETED|Overall Study||276
1690251|NCT00509873|4129922|P2|STARTED|Overall Study||291
1690252|NCT00509873|4129923|P1|STARTED|Overall Study||287
1690253|NCT00509795|4129941|P4|NOT COMPLETED|Overall Study||27
1690254|NCT00509795|4129942|P3|NOT COMPLETED|Overall Study||27
1690255|NCT00509795|4129943|P2|NOT COMPLETED|Overall Study||11
1690256|NCT00509795|4129944|P1|NOT COMPLETED|Overall Study||22
1690257|NCT00509795|4129941|P4|COMPLETED|Overall Study||276
1690258|NCT00509795|4129942|P3|COMPLETED|Overall Study||277
1690259|NCT00509795|4129943|P2|COMPLETED|Overall Study||293
1690260|NCT00509795|4129944|P1|COMPLETED|Overall Study||284
1690261|NCT00509795|4129941|P4|Per Protocol Set (PPS) Population|Overall Study||265
1690262|NCT00509795|4129942|P3|Per Protocol Set (PPS) Population|Overall Study||270
1690263|NCT00509795|4129943|P2|Per Protocol Set (PPS) Population|Overall Study||285
1690264|NCT00509795|4129944|P1|Per Protocol Set (PPS) Population|Overall Study||269
1690265|NCT00509795|4129941|P4|Full Analysis Set (FAS) Population|Overall Study||301
1690266|NCT00509795|4129942|P3|Full Analysis Set (FAS) Population|Overall Study||301
1690267|NCT00509795|4129943|P2|Full Analysis Set (FAS) Population|Overall Study||304
1690268|NCT00509795|4129944|P1|Full Analysis Set (FAS) Population|Overall Study||304
1690269|NCT00509795|4129941|P4|Patients Received Treatment (SAF)|Overall Study||303
1690270|NCT00509795|4129942|P3|Patients Received Treatment (SAF)|Overall Study||304
1690271|NCT00509795|4129943|P2|Patients Received Treatment (SAF)|Overall Study||304
1690272|NCT00509795|4129944|P1|Patients Received Treatment (SAF)|Overall Study||304
1690273|NCT00509795|4129941|P4|STARTED|Overall Study||303
1690274|NCT00509795|4129942|P3|STARTED|Overall Study||304
1690275|NCT00509795|4129943|P2|STARTED|Overall Study||304
1690276|NCT00509795|4129944|P1|STARTED|Overall Study||306
1690277|NCT00509769|4129975|P1|NOT COMPLETED|Overall Study||91
1690278|NCT00509769|4129975|P1|COMPLETED|Overall Study||21
1690279|NCT00509769|4129975|P1|STARTED|Overall Study||112
1690280|NCT00509665|4129984|P1|NOT COMPLETED|Overall Study||0
1690281|NCT00509665|4129984|P1|COMPLETED|Overall Study||18
1690282|NCT00509665|4129984|P1|STARTED|Overall Study||18
1690283|NCT00509600|4129994|P1|NOT COMPLETED|Overall Study||1
1690284|NCT00509600|4129994|P1|COMPLETED|Overall Study||0
1690285|NCT00509600|4129994|P1|STARTED|Overall Study||1
1690286|NCT00509587|4129998|P1|NOT COMPLETED|Overall Study||0
1690287|NCT00509587|4129998|P1|COMPLETED|Overall Study||21
1690288|NCT00509587|4129998|P1|STARTED|Overall Study||21
1690289|NCT00509496|4130009|P2|NOT COMPLETED|Overall Study||0
1690290|NCT00509496|4130010|P1|NOT COMPLETED|Overall Study||0
1690291|NCT00509496|4130009|P2|COMPLETED|Overall Study||2
1690292|NCT00509496|4130010|P1|COMPLETED|Overall Study||19
1690293|NCT00509496|4130009|P2|STARTED|Overall Study||2
1690294|NCT00509496|4130010|P1|STARTED|Overall Study||19
1690295|NCT00509392|4130020|P3|NOT COMPLETED|Overall Study||0
1690296|NCT00509392|4130021|P2|NOT COMPLETED|Overall Study||0
1690297|NCT00509392|4130022|P1|NOT COMPLETED|Overall Study||0
1690298|NCT00509392|4130020|P3|COMPLETED|Overall Study||4
1690299|NCT00509392|4130021|P2|COMPLETED|Overall Study||33
1690300|NCT00509392|4130022|P1|COMPLETED|Overall Study||32
1690301|NCT00509392|4130020|P3|STARTED|Overall Study||4
1690302|NCT00509392|4130021|P2|STARTED|Overall Study||33
1690303|NCT00509392|4130022|P1|STARTED|Overall Study||32
1690304|NCT00509366|4130073|P5|NOT COMPLETED|Overall Study||0
1690305|NCT00509366|4130074|P4|NOT COMPLETED|Overall Study||0
1690306|NCT00509366|4130075|P3|NOT COMPLETED|Overall Study||1
1690307|NCT00509366|4130076|P2|NOT COMPLETED|Overall Study||1
1690308|NCT00509366|4130077|P1|NOT COMPLETED|Overall Study||1
1690309|NCT00509366|4130073|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
1690310|NCT00509366|4130074|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
1690311|NCT00509366|4130075|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
1690312|NCT00509366|4130076|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
1690313|NCT00509366|4130077|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
1690314|NCT00509366|4130073|P5|Assigned Treatment|Overall Study||0
1690315|NCT00509366|4130074|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
1690316|NCT00509366|4130075|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
1690317|NCT00509366|4130076|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
1690318|NCT00509366|4130077|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
1690319|NCT00509366|4130073|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
1690320|NCT00509366|4130074|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
1690321|NCT00509366|4130075|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
1690322|NCT00509366|4130076|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
1690323|NCT00509366|4130077|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
1690324|NCT00509288|4130090|P2|NOT COMPLETED|Overall Study||0
1690325|NCT00509288|4130091|P1|NOT COMPLETED|Overall Study||0
1690326|NCT00509288|4130090|P2|COMPLETED|Overall Study||3
1690327|NCT00509288|4130091|P1|COMPLETED|Overall Study||21
1690328|NCT00509288|4130090|P2|STARTED|Overall Study||3
1690329|NCT00509288|4130091|P1|STARTED|Overall Study||21
1690330|NCT00509262|4130101|P2|NOT COMPLETED|Overall Study||42
1690331|NCT00509262|4130102|P1|NOT COMPLETED|Overall Study||47
1690332|NCT00509262|4130101|P2|COMPLETED|Overall Study||170
1690333|NCT00509262|4130102|P1|COMPLETED|Overall Study||164
1690334|NCT00509262|4130101|P2|STARTED|Overall Study||212
1690335|NCT00509262|4130102|P1|STARTED|Overall Study||211
1690336|NCT00509249|4130114|P1|NOT COMPLETED|Overall Study||0
1690337|NCT00509249|4130114|P1|COMPLETED|Overall Study||18
1690338|NCT00509249|4130114|P1|STARTED|Overall Study||18
1690339|NCT00509236|4130120|P2|NOT COMPLETED|Overall Study||20
1690340|NCT00509236|4130121|P1|NOT COMPLETED|Overall Study||17
1690341|NCT00509236|4130120|P2|COMPLETED|Overall Study||45
1690342|NCT00509236|4130121|P1|COMPLETED|Overall Study||47
1690343|NCT00509236|4130120|P2|STARTED|Overall Study||65
1690344|NCT00509236|4130121|P1|STARTED|Overall Study||64
1690345|NCT00509223|4130136|P2|NOT COMPLETED|Overall Study||72
1690346|NCT00509223|4130137|P1|NOT COMPLETED|Overall Study||88
1690347|NCT00509223|4130136|P2|COMPLETED|Overall Study||137
1690348|NCT00509223|4130137|P1|COMPLETED|Overall Study||119
1690349|NCT00509223|4130136|P2|STARTED|Overall Study||209
1690350|NCT00509223|4130137|P1|STARTED|Overall Study||207
1690351|NCT00509197|4130145|P2|NOT COMPLETED|Overall Study||0
1690352|NCT00509197|4130146|P1|NOT COMPLETED|Overall Study||0
1690353|NCT00509197|4130145|P2|COMPLETED|Overall Study||6
1690354|NCT00509197|4130146|P1|COMPLETED|Overall Study||6
1690355|NCT00509197|4130145|P2|STARTED|Overall Study||6
1690356|NCT00509197|4130146|P1|STARTED|Overall Study||6
1690357|NCT00509106|4130160|P2|NOT COMPLETED|Overall Study||29
1690358|NCT00509106|4130161|P1|NOT COMPLETED|Overall Study||31
1690359|NCT00509106|4130160|P2|COMPLETED|Overall Study||278
1690360|NCT00509106|4130161|P1|COMPLETED|Overall Study||284
1690361|NCT00509106|4130160|P2|STARTED|Overall Study||307
1690362|NCT00509106|4130161|P1|STARTED|Overall Study||315
1690363|NCT00509067|4130169|P2|NOT COMPLETED|Overall Study||5
1690364|NCT00509067|4130170|P1|NOT COMPLETED|Overall Study||4
1690365|NCT00509067|4130169|P2|COMPLETED|Overall Study||19
1690366|NCT00509067|4130170|P1|COMPLETED|Overall Study||15
1690367|NCT00509067|4130169|P2|STARTED|Overall Study||24
1690368|NCT00509067|4130170|P1|STARTED|Overall Study||19
1690369|NCT00509041|4130180|P1|NOT COMPLETED|Overall Study||0
1690370|NCT00509041|4130180|P1|COMPLETED|Overall Study||43
1690371|NCT00509041|4130180|P1|STARTED|Overall Study||43
1690372|NCT00509028|4130189|P2|NOT COMPLETED|Overall Study||7
1690373|NCT00509028|4130190|P1|NOT COMPLETED|Overall Study||12
1690374|NCT00509028|4130189|P2|COMPLETED|Overall Study||113
1690375|NCT00509028|4130190|P1|COMPLETED|Overall Study||109
1690376|NCT00509028|4130189|P2|STARTED|Overall Study||120
1690377|NCT00509028|4130190|P1|STARTED|Overall Study||121
1690378|NCT00509002|4130222|P1|NOT COMPLETED|Overall Study||0
1690379|NCT00509002|4130222|P1|COMPLETED|Overall Study||37
1690380|NCT00509002|4130222|P1|STARTED|Overall Study||37
1690381|NCT00508924|4130230|P4|NOT COMPLETED|Overall Study||1
1690382|NCT00508924|4130231|P3|NOT COMPLETED|Overall Study||1
1690383|NCT00508924|4130232|P2|NOT COMPLETED|Overall Study||0
1690384|NCT00508924|4130233|P1|NOT COMPLETED|Overall Study||0
1690385|NCT00508924|4130230|P4|COMPLETED|Overall Study||33
1690386|NCT00508924|4130231|P3|COMPLETED|Overall Study||31
1690387|NCT00508924|4130232|P2|COMPLETED|Overall Study||38
1690388|NCT00508924|4130233|P1|COMPLETED|Overall Study||36
1690389|NCT00508924|4130230|P4|STARTED|Overall Study||34
1690390|NCT00508924|4130231|P3|STARTED|Overall Study||32
1690391|NCT00508924|4130232|P2|STARTED|Overall Study||38
1690392|NCT00508924|4130233|P1|STARTED|Overall Study||36
1690393|NCT00508872|4130247|P1|NOT COMPLETED|Overall Study||2
1690394|NCT00508872|4130247|P1|COMPLETED|Overall Study||0
1690395|NCT00508872|4130247|P1|STARTED|Overall Study||2
1690396|NCT00508820|4130253|P2|NOT COMPLETED|Overall Study||64
1690397|NCT00508820|4130254|P1|NOT COMPLETED|Overall Study||55
1690398|NCT00508820|4130253|P2|COMPLETED|Overall Study||175
1690399|NCT00508820|4130254|P1|COMPLETED|Overall Study||113
1690400|NCT00508820|4130253|P2|STARTED|Overall Study||239
1690401|NCT00508820|4130254|P1|STARTED|Overall Study||168
1690402|NCT00508755|4130264|P1|NOT COMPLETED|Overall Study||1
1690403|NCT00508755|4130264|P1|COMPLETED|Overall Study||5
1690404|NCT00508755|4130264|P1|STARTED|Overall Study||6
1690405|NCT00508742|4130272|P2|NOT COMPLETED|Period 3: Toddler Dose||15
1690406|NCT00508742|4130273|P1|NOT COMPLETED|Period 3: Toddler Dose||25
1690407|NCT00508742|4130272|P2|COMPLETED|Period 3: Toddler Dose||863
1690408|NCT00508742|4130273|P1|COMPLETED|Period 3: Toddler Dose||858
1690409|NCT00508742|4130272|P2|STARTED|Period 3: Toddler Dose||878
1690410|NCT00508742|4130273|P1|STARTED|Period 3: Toddler Dose||883
1690411|NCT00508742|4130272|P2|NOT COMPLETED|Period 2: After Infant Series||11
1690413|NCT00508742|4130272|P2|COMPLETED|Period 2: After Infant Series||878
1690414|NCT00508742|4130273|P1|COMPLETED|Period 2: After Infant Series||883
1690415|NCT00508742|4130272|P2|STARTED|Period 2: After Infant Series||889
1690416|NCT00508742|4130273|P1|STARTED|Period 2: After Infant Series||890
1690417|NCT00508742|4130272|P2|NOT COMPLETED|Period 1: Infant Series||45
1690418|NCT00508742|4130273|P1|NOT COMPLETED|Period 1: Infant Series||42
1690419|NCT00508742|4130272|P2|COMPLETED|Period 1: Infant Series||889
1690420|NCT00508742|4130273|P1|COMPLETED|Period 1: Infant Series||890
1690421|NCT00508742|4130272|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
1690422|NCT00508742|4130273|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
1690423|NCT00508742|4130272|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
1690424|NCT00508742|4130273|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
1690425|NCT00508742|4130272|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
1690426|NCT00508742|4130273|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
1690427|NCT00508742|4130272|P2|STARTED|Period 1: Infant Series||934
1690428|NCT00508742|4130273|P1|STARTED|Period 1: Infant Series||932
1690429|NCT00508716|4130289|P2|NOT COMPLETED|Overall Study||0
1690430|NCT00508716|4130290|P1|NOT COMPLETED|Overall Study||0
1690431|NCT00508716|4130289|P2|COMPLETED|Overall Study||63
1690432|NCT00508716|4130290|P1|COMPLETED|Overall Study||61
1690433|NCT00508716|4130289|P2|STARTED|Overall Study||63
1690434|NCT00508716|4130290|P1|STARTED|Overall Study||61
1690435|NCT00508651|4130298|P2|NOT COMPLETED|Overall Study||2
1690436|NCT00508651|4130299|P1|NOT COMPLETED|Overall Study||4
1690437|NCT00508651|4130298|P2|COMPLETED|Overall Study||8
1690438|NCT00508651|4130299|P1|COMPLETED|Overall Study||16
1690439|NCT00508651|4130298|P2|STARTED|Overall Study||10
1690440|NCT00508651|4130299|P1|STARTED|Overall Study||20
1690441|NCT00508521|4130373|P1|NOT COMPLETED|Overall Study||0
1690442|NCT00508521|4130373|P1|COMPLETED|Overall Study||4
1690443|NCT00508521|4130373|P1|STARTED|Overall Study||4
1690444|NCT00508482|4130380|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
1690445|NCT00508482|4130381|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
1690446|NCT00508482|4130382|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
1690447|NCT00508482|4130380|P3|COMPLETED|at the 12th Week of Follow-up||98
1690448|NCT00508482|4130381|P2|COMPLETED|at the 12th Week of Follow-up||96
1690449|NCT00508482|4130382|P1|COMPLETED|at the 12th Week of Follow-up||196
1690450|NCT00508482|4130380|P3|STARTED|at the 12th Week of Follow-up||98
1690451|NCT00508482|4130381|P2|STARTED|at the 12th Week of Follow-up||96
1690452|NCT00508482|4130382|P1|STARTED|at the 12th Week of Follow-up||196
1690453|NCT00508482|4130380|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
1690454|NCT00508482|4130381|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
1690455|NCT00508482|4130382|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
1690456|NCT00508482|4130380|P3|COMPLETED|at the 4th Week of Follow-up||98
1690457|NCT00508482|4130381|P2|COMPLETED|at the 4th Week of Follow-up||96
1690458|NCT00508482|4130382|P1|COMPLETED|at the 4th Week of Follow-up||196
1690459|NCT00508482|4130380|P3|STARTED|at the 4th Week of Follow-up||99
1690460|NCT00508482|4130381|P2|STARTED|at the 4th Week of Follow-up||102
1690461|NCT00508482|4130382|P1|STARTED|at the 4th Week of Follow-up||216
1690462|NCT00508482|4130380|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
1690463|NCT00508482|4130381|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
1690464|NCT00508482|4130382|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
1690465|NCT00508482|4130380|P3|COMPLETED|Over 4 Weeks of Treatment||99
1690466|NCT00508482|4130381|P2|COMPLETED|Over 4 Weeks of Treatment||102
1690467|NCT00508482|4130382|P1|COMPLETED|Over 4 Weeks of Treatment||216
1690468|NCT00508482|4130380|P3|STARTED|Over 4 Weeks of Treatment||119
1690469|NCT00508482|4130381|P2|STARTED|Over 4 Weeks of Treatment||119
1690470|NCT00508482|4130382|P1|STARTED|Over 4 Weeks of Treatment||237
1690471|NCT00508469|4130419|P2|NOT COMPLETED|Overall Study||10
1690472|NCT00508469|4130420|P1|NOT COMPLETED|Overall Study||17
1690473|NCT00508469|4130419|P2|COMPLETED|Overall Study||40
1690474|NCT00508469|4130420|P1|COMPLETED|Overall Study||35
1690475|NCT00508469|4130419|P2|STARTED|Overall Study||50
1690476|NCT00508469|4130420|P1|STARTED|Overall Study||52
1690477|NCT00508404|4130426|P1|NOT COMPLETED|Overall Study||42
1690478|NCT00508404|4130426|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
1690479|NCT00508404|4130426|P1|STARTED|Overall Study||154
1690480|NCT00508391|4130453|P2|NOT COMPLETED|Second Treatment||0
1690481|NCT00508391|4130454|P1|NOT COMPLETED|Second Treatment||2
1690482|NCT00508391|4130453|P2|COMPLETED|Second Treatment||59
1690483|NCT00508391|4130454|P1|COMPLETED|Second Treatment||52
1690484|NCT00508391|4130453|P2|STARTED|Second Treatment||59
1690485|NCT00508391|4130454|P1|STARTED|Second Treatment||54
1690486|NCT00508391|4130453|P2|NOT COMPLETED|First Treatment||3
1690487|NCT00508391|4130454|P1|NOT COMPLETED|First Treatment||6
1690488|NCT00508391|4130453|P2|COMPLETED|First Treatment||59
1690489|NCT00508391|4130454|P1|COMPLETED|First Treatment||54
1690490|NCT00508391|4130453|P2|STARTED|First Treatment||62
1690491|NCT00508391|4130454|P1|STARTED|First Treatment||60
1690492|NCT00508274|4130465|P1|NOT COMPLETED|Overall Study||2
1690493|NCT00508274|4130465|P1|COMPLETED|Overall Study||50
1690494|NCT00508274|4130465|P1|STARTED|Overall Study||52
1690495|NCT00508183|4130476|P2|NOT COMPLETED|Overall Study||8
1690496|NCT00508183|4130477|P1|NOT COMPLETED|Overall Study||9
1690497|NCT00508183|4130476|P2|COMPLETED|Overall Study||34
1690498|NCT00508183|4130477|P1|COMPLETED|Overall Study||39
1690499|NCT00508183|4130476|P2|STARTED|Overall Study||42
1690500|NCT00508183|4130477|P1|STARTED|Overall Study||48
1690501|NCT00508157|4130493|P2|NOT COMPLETED|Overall Study||3
1690502|NCT00508157|4130494|P1|NOT COMPLETED|Overall Study||2
1690503|NCT00508157|4130493|P2|COMPLETED|Overall Study||23
1690504|NCT00508157|4130494|P1|COMPLETED|Overall Study||24
1690505|NCT00508157|4130493|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
1690506|NCT00508157|4130494|P1|Safety Sample|Overall Study||26
1690507|NCT00508157|4130493|P2|Randomized Sample|Overall Study||26
1690508|NCT00508157|4130494|P1|Randomized Sample|Overall Study||26
1690509|NCT00508157|4130493|P2|STARTED|Overall Study||26
1690510|NCT00508157|4130494|P1|STARTED|Overall Study||26
1690511|NCT00508144|4130516|P1|NOT COMPLETED|Overall Study||11
1690512|NCT00508144|4130516|P1|COMPLETED|Overall Study||53
1690513|NCT00508144|4130516|P1|STARTED|Overall Study||64
1690514|NCT00508118|4130522|P2|NOT COMPLETED|Overall Study||0
1690515|NCT00508118|4130523|P1|NOT COMPLETED|Overall Study||0
1690516|NCT00508118|4130522|P2|COMPLETED|Overall Study||4
1690517|NCT00508118|4130523|P1|COMPLETED|Overall Study||3
1690518|NCT00508118|4130522|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
1690519|NCT00508118|4130523|P1|STARTED|Overall Study||3
1690520|NCT00508027|4130542|P1|NOT COMPLETED|Dose Level 3||0
1690521|NCT00508027|4130542|P1|COMPLETED|Dose Level 3||2
1690522|NCT00508027|4130542|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
1690523|NCT00508027|4130542|P1|NOT COMPLETED|Dose Level 2||4
1690524|NCT00508027|4130542|P1|COMPLETED|Dose Level 2||16
1690525|NCT00508027|4130542|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
1690526|NCT00508027|4130542|P1|NOT COMPLETED|Dose Level 1||8
1690527|NCT00508027|4130542|P1|COMPLETED|Dose Level 1||12
1690528|NCT00508027|4130542|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
1690529|NCT00508001|4130583|P3|NOT COMPLETED|Overall Study||7
1690530|NCT00508001|4130584|P2|NOT COMPLETED|Overall Study||12
1690531|NCT00508001|4130585|P1|NOT COMPLETED|Overall Study||19
1690532|NCT00508001|4130583|P3|COMPLETED|Overall Study||16
1690533|NCT00508001|4130584|P2|COMPLETED|Overall Study||13
1690534|NCT00508001|4130585|P1|COMPLETED|Overall Study||0
1690535|NCT00508001|4130583|P3|Secondary Treatment Phase|Overall Study||16
1690536|NCT00508001|4130584|P2|Secondary Treatment Phase|Overall Study||13
1690537|NCT00508001|4130585|P1|Secondary Treatment Phase|Overall Study||0
1690538|NCT00508001|4130583|P3|STARTED|Overall Study||23
1690539|NCT00508001|4130584|P2|STARTED|Overall Study||25
1690540|NCT00508001|4130585|P1|STARTED|Overall Study||19
1690541|NCT00507819|4130602|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1690542|NCT00507819|4130603|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1690543|NCT00507819|4130602|P2|COMPLETED|Second Intervention (6 Weeks)||14
1690544|NCT00507819|4130603|P1|COMPLETED|Second Intervention (6 Weeks)||13
1690545|NCT00507819|4130602|P2|STARTED|Second Intervention (6 Weeks)||14
1690546|NCT00507819|4130603|P1|STARTED|Second Intervention (6 Weeks)||13
1690547|NCT00507819|4130602|P2|NOT COMPLETED|Washout (6 Weeks)||0
1690548|NCT00507819|4130603|P1|NOT COMPLETED|Washout (6 Weeks)||1
1690549|NCT00507819|4130602|P2|COMPLETED|Washout (6 Weeks)||14
1690550|NCT00507819|4130603|P1|COMPLETED|Washout (6 Weeks)||13
1690551|NCT00507819|4130602|P2|STARTED|Washout (6 Weeks)||14
1690552|NCT00507819|4130603|P1|STARTED|Washout (6 Weeks)||14
1690553|NCT00507819|4130602|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
1690554|NCT00507819|4130603|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
1690555|NCT00507819|4130602|P2|COMPLETED|First Intervention (6 Weeks)||14
1690556|NCT00507819|4130603|P1|COMPLETED|First Intervention (6 Weeks)||14
1690557|NCT00507819|4130602|P2|STARTED|First Intervention (6 Weeks)||14
1690558|NCT00507819|4130603|P1|STARTED|First Intervention (6 Weeks)||14
1690559|NCT00507767|4130615|P1|NOT COMPLETED|Overall Study||0
1690560|NCT00507767|4130615|P1|COMPLETED|Overall Study||15
1690561|NCT00507767|4130615|P1|STARTED|Overall Study||15
1690562|NCT00507689|4130622|P2|NOT COMPLETED|Randomized Period||2
1690563|NCT00507689|4130623|P1|NOT COMPLETED|Randomized Period||1
1690564|NCT00507689|4130622|P2|COMPLETED|Randomized Period||16
1690565|NCT00507689|4130623|P1|COMPLETED|Randomized Period||18
1690566|NCT00507689|4130622|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
1690567|NCT00507689|4130623|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
1690568|NCT00507689|4130622|P2|NOT COMPLETED|Pre-Randomization Period||0
1690569|NCT00507689|4130623|P1|NOT COMPLETED|Pre-Randomization Period||3
1690570|NCT00507689|4130622|P2|COMPLETED|Pre-Randomization Period||0
1690571|NCT00507689|4130623|P1|COMPLETED|Pre-Randomization Period||37
1690572|NCT00507689|4130622|P2|STARTED|Pre-Randomization Period||0
1690573|NCT00507689|4130623|P1|STARTED|Pre-Randomization Period||40
1690574|NCT00507559|4130640|P1|NOT COMPLETED|Overall Study||71
1690575|NCT00507559|4130640|P1|COMPLETED|Overall Study||84
1690576|NCT00507559|4130640|P1|STARTED|Overall Study||155
1690577|NCT00507546|4130655|P2|NOT COMPLETED|Overall Study||1
1690578|NCT00507546|4130656|P1|NOT COMPLETED|Overall Study||2
1690579|NCT00507546|4130655|P2|COMPLETED|Overall Study||3
1690580|NCT00507546|4130656|P1|COMPLETED|Overall Study||2
1690581|NCT00507546|4130655|P2|STARTED|Overall Study||4
1690582|NCT00507546|4130656|P1|STARTED|Overall Study||4
1690583|NCT00507507|4130666|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
1690584|NCT00507507|4130667|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
1690585|NCT00507507|4130666|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
1690586|NCT00507507|4130667|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
1690587|NCT00507507|4130666|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
1690588|NCT00507507|4130667|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
1690589|NCT00507507|4130666|P2|NOT COMPLETED|Treatment Period||53
1690590|NCT00507507|4130667|P1|NOT COMPLETED|Treatment Period||52
1690591|NCT00507507|4130666|P2|COMPLETED|Treatment Period||9
1690592|NCT00507507|4130667|P1|COMPLETED|Treatment Period||12
1690593|NCT00507507|4130666|P2|Completed 192 Weeks of Treatment|Treatment Period||52
1690594|NCT00507507|4130667|P1|Completed 192 Weeks of Treatment|Treatment Period||52
1690595|NCT00507507|4130666|P2|STARTED|Treatment Period||62
1690596|NCT00507507|4130667|P1|STARTED|Treatment Period||64
1690597|NCT00507455|4130702|P3|NOT COMPLETED|Overall Study||12
1690598|NCT00507455|4130703|P2|NOT COMPLETED|Overall Study||6
1690599|NCT00507455|4130704|P1|NOT COMPLETED|Overall Study||12
1690600|NCT00507455|4130702|P3|COMPLETED|Overall Study||62
1690601|NCT00507455|4130703|P2|COMPLETED|Overall Study||68
1690602|NCT00507455|4130704|P1|COMPLETED|Overall Study||62
1690603|NCT00507455|4130702|P3|STARTED|Overall Study||74
1690604|NCT00507455|4130703|P2|STARTED|Overall Study||74
1690605|NCT00507455|4130704|P1|STARTED|Overall Study||74
1690606|NCT00507442|4130767|P4|NOT COMPLETED|Overall Study||5
1690607|NCT00507442|4130768|P3|NOT COMPLETED|Overall Study||15
1690608|NCT00507442|4130769|P2|NOT COMPLETED|Overall Study||27
1690609|NCT00507442|4130770|P1|NOT COMPLETED|Overall Study||16
1690610|NCT00507442|4130767|P4|COMPLETED|Overall Study||12
1690611|NCT00507442|4130768|P3|COMPLETED|Overall Study||18
1690612|NCT00507442|4130769|P2|COMPLETED|Overall Study||39
1690613|NCT00507442|4130770|P1|COMPLETED|Overall Study||26
1690614|NCT00507442|4130767|P4|STARTED|Overall Study||17
1690615|NCT00507442|4130768|P3|STARTED|Overall Study||33
1690616|NCT00507442|4130769|P2|STARTED|Overall Study||66
1690617|NCT00507442|4130770|P1|STARTED|Overall Study||42
1690618|NCT00507429|4130822|P2|NOT COMPLETED|Maintenance Phase||0
1690619|NCT00507429|4130823|P1|NOT COMPLETED|Maintenance Phase||14
1690620|NCT00507429|4130822|P2|COMPLETED|Maintenance Phase||0
1690621|NCT00507429|4130823|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
1690622|NCT00507429|4130822|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
1690623|NCT00507429|4130823|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
1690624|NCT00507429|4130822|P2|NOT COMPLETED|Treatment Phase||18
1690625|NCT00507429|4130823|P1|NOT COMPLETED|Treatment Phase||37
1690626|NCT00507429|4130822|P2|COMPLETED|Treatment Phase||7
1690627|NCT00507429|4130823|P1|COMPLETED|Treatment Phase||18
1690628|NCT00507429|4130822|P2|STARTED|Treatment Phase|Randomized|25
1690629|NCT00507429|4130823|P1|STARTED|Treatment Phase|Randomized|55
1690630|NCT00507416|4130834|P3|NOT COMPLETED|Overall Study||114
1690631|NCT00507416|4130835|P2|NOT COMPLETED|Overall Study||125
1690632|NCT00507416|4130836|P1|NOT COMPLETED|Overall Study||118
1690633|NCT00507416|4130834|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
1690634|NCT00507416|4130835|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
1690635|NCT00507416|4130836|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
1690636|NCT00507416|4130834|P3|Completed 8 Treatment Cycles|Overall Study||69
1690637|NCT00507416|4130835|P2|Completed 8 Treatment Cycles|Overall Study||60
1690638|NCT00507416|4130836|P1|Completed 8 Treatment Cycles|Overall Study||82
1690639|NCT00507416|4130834|P3|Treated (Safety Population)|Overall Study||163
1690640|NCT00507416|4130835|P2|Treated (Safety Population)|Overall Study||158
1690641|NCT00507416|4130836|P1|Treated (Safety Population)|Overall Study||165
1690642|NCT00507416|4130834|P3|STARTED|Overall Study||167
1690643|NCT00507416|4130835|P2|STARTED|Overall Study||167
1690644|NCT00507416|4130836|P1|STARTED|Overall Study||168
1690645|NCT00507208|4130867|P2|NOT COMPLETED|Overall Study||0
1690646|NCT00507208|4130868|P1|NOT COMPLETED|Overall Study||0
1690647|NCT00507208|4130867|P2|COMPLETED|Overall Study||26
1690648|NCT00507208|4130868|P1|COMPLETED|Overall Study||27
1690649|NCT00507208|4130867|P2|Received Dynasplint in Crossover|Overall Study||3
1690650|NCT00507208|4130868|P1|Received Dynasplint in Crossover|Overall Study||0
1690651|NCT00507208|4130867|P2|STARTED|Overall Study||26
1690652|NCT00507208|4130868|P1|STARTED|Overall Study||27
1690653|NCT00507130|4130878|P4|NOT COMPLETED|Overall Study||1
1690654|NCT00507130|4130879|P3|NOT COMPLETED|Overall Study||1
1690655|NCT00507130|4130880|P2|NOT COMPLETED|Overall Study||0
1690656|NCT00507130|4130881|P1|NOT COMPLETED|Overall Study||1
1690657|NCT00507130|4130878|P4|COMPLETED|Overall Study||8
1690658|NCT00507130|4130879|P3|COMPLETED|Overall Study||8
1690659|NCT00507130|4130880|P2|COMPLETED|Overall Study||9
1690660|NCT00507130|4130881|P1|COMPLETED|Overall Study||8
1690661|NCT00507130|4130878|P4|STARTED|Overall Study||9
1690662|NCT00507130|4130879|P3|STARTED|Overall Study||9
1690663|NCT00507130|4130880|P2|STARTED|Overall Study||9
1690664|NCT00507130|4130881|P1|STARTED|Overall Study||9
1690665|NCT00506948|4130923|P1|NOT COMPLETED|Overall Study||10
1690666|NCT00506948|4130923|P1|COMPLETED|Overall Study||0
1690667|NCT00506948|4130923|P1|STARTED|Overall Study||10
1690668|NCT00506922|4130932|P5|NOT COMPLETED|Overall Study||1
1690669|NCT00506922|4130933|P4|NOT COMPLETED|Overall Study||2
1690670|NCT00506922|4130934|P3|NOT COMPLETED|Overall Study||0
1690671|NCT00506922|4130935|P2|NOT COMPLETED|Overall Study||0
1690672|NCT00506922|4130936|P1|NOT COMPLETED|Overall Study||0
1690673|NCT00506922|4130932|P5|COMPLETED|Overall Study||10
1690674|NCT00506922|4130933|P4|COMPLETED|Overall Study||61
1690675|NCT00506922|4130934|P3|COMPLETED|Overall Study||29
1690676|NCT00506922|4130935|P2|COMPLETED|Overall Study||10
1690677|NCT00506922|4130936|P1|COMPLETED|Overall Study||37
1690678|NCT00506922|4130932|P5|STARTED|Overall Study||11
1690679|NCT00506922|4130933|P4|STARTED|Overall Study||63
1690680|NCT00506922|4130934|P3|STARTED|Overall Study||29
1690681|NCT00506922|4130935|P2|STARTED|Overall Study||10
1690682|NCT00506922|4130936|P1|STARTED|Overall Study||37
1690683|NCT00506883|4130947|P3|NOT COMPLETED|Overall Study||4
1690684|NCT00506883|4130948|P2|NOT COMPLETED|Overall Study||3
1690685|NCT00506883|4130949|P1|NOT COMPLETED|Overall Study||7
1690686|NCT00506883|4130947|P3|COMPLETED|Overall Study||55
1690687|NCT00506883|4130948|P2|COMPLETED|Overall Study||71
1690688|NCT00506883|4130949|P1|COMPLETED|Overall Study||45
1690689|NCT00506883|4130947|P3|STARTED|Overall Study||59
1690690|NCT00506883|4130948|P2|STARTED|Overall Study||74
1690691|NCT00506883|4130949|P1|STARTED|Overall Study||52
1690692|NCT00506857|4130957|P1|NOT COMPLETED|Overall Study||0
1690693|NCT00506857|4130957|P1|COMPLETED|Overall Study||80
1690694|NCT00506857|4130957|P1|STARTED|Overall Study||80
1690695|NCT00506831|4130962|P1|NOT COMPLETED|Overall Study||2
1690696|NCT00506831|4130962|P1|COMPLETED|Overall Study||7
1690697|NCT00506831|4130962|P1|STARTED|Overall Study||9
1690698|NCT00506714|4130975|P2|NOT COMPLETED|Overall Study||0
1690699|NCT00506714|4130976|P1|NOT COMPLETED|Overall Study||0
1690700|NCT00506714|4130975|P2|COMPLETED|Overall Study||13
1690701|NCT00506714|4130976|P1|COMPLETED|Overall Study||13
1690702|NCT00506714|4130975|P2|STARTED|Overall Study||13
1690703|NCT00506714|4130976|P1|STARTED|Overall Study||13
1690704|NCT00506675|4130986|P2|NOT COMPLETED|Overall Study||0
1690705|NCT00506675|4130987|P1|NOT COMPLETED|Overall Study||0
1690706|NCT00506675|4130986|P2|COMPLETED|Overall Study||28
1690707|NCT00506675|4130987|P1|COMPLETED|Overall Study||27
1690708|NCT00506675|4130986|P2|STARTED|Overall Study||28
1690709|NCT00506675|4130987|P1|STARTED|Overall Study||27
1690710|NCT00506662|4131001|P2|NOT COMPLETED|Overall Study||28
1690711|NCT00506662|4131002|P1|NOT COMPLETED|Overall Study||17
1690712|NCT00506662|4131001|P2|COMPLETED|Overall Study||20
1690713|NCT00506662|4131002|P1|COMPLETED|Overall Study||21
1690714|NCT00506662|4131001|P2|STARTED|Overall Study||48
1690715|NCT00506662|4131002|P1|STARTED|Overall Study||38
1690716|NCT00506597|4131032|P1|NOT COMPLETED|Overall Study||0
1690717|NCT00506597|4131032|P1|COMPLETED|Overall Study||33
1690718|NCT00506597|4131032|P1|STARTED|Overall Study||33
1690719|NCT00506493|4131036|P1|NOT COMPLETED|Overall Study||11
1690720|NCT00506493|4131036|P1|COMPLETED|Overall Study||64
1690721|NCT00506493|4131036|P1|STARTED|Overall Study||75
1690722|NCT00506454|4131045|P2|NOT COMPLETED|Overall Study||1
1690723|NCT00506454|4131046|P1|NOT COMPLETED|Overall Study||1
1690724|NCT00506454|4131045|P2|COMPLETED|Overall Study||10
1690725|NCT00506454|4131046|P1|COMPLETED|Overall Study||10
1690726|NCT00506454|4131045|P2|STARTED|Overall Study||11
1690727|NCT00506454|4131046|P1|STARTED|Overall Study||11
1690728|NCT00506441|4131052|P2|NOT COMPLETED|Period 2; Double-blind Period||5
1690729|NCT00506441|4131053|P1|NOT COMPLETED|Period 2; Double-blind Period||3
1690730|NCT00506441|4131052|P2|COMPLETED|Period 2; Double-blind Period||79
1690731|NCT00506441|4131053|P1|COMPLETED|Period 2; Double-blind Period||82
1690732|NCT00506441|4131052|P2|STARTED|Period 2; Double-blind Period||84
1690733|NCT00506441|4131053|P1|STARTED|Period 2; Double-blind Period||85
1690734|NCT00506441|4131052|P2|NOT COMPLETED|Period 1; Open-label Period||0
1690735|NCT00506441|4131053|P1|NOT COMPLETED|Period 1; Open-label Period||76
1690736|NCT00506441|4131052|P2|COMPLETED|Period 1; Open-label Period||0
1690737|NCT00506441|4131053|P1|COMPLETED|Period 1; Open-label Period||169
1690738|NCT00506441|4131052|P2|STARTED|Period 1; Open-label Period||0
1690739|NCT00506441|4131053|P1|STARTED|Period 1; Open-label Period||245
1690740|NCT00506415|4131061|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
1690741|NCT00506415|4131062|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1690742|NCT00506415|4131063|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1690743|NCT00506415|4131064|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1690744|NCT00506415|4131061|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
1690745|NCT00506415|4131062|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1690746|NCT00506415|4131063|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1690747|NCT00506415|4131064|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1690748|NCT00506415|4131061|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
1690749|NCT00506415|4131062|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
1690750|NCT00506415|4131063|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
1690751|NCT00506415|4131064|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
1690752|NCT00506415|4131061|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
1690753|NCT00506415|4131062|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
1690754|NCT00506415|4131063|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
1690755|NCT00506415|4131064|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
1690756|NCT00506415|4131061|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
1690757|NCT00506415|4131062|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
1690758|NCT00506415|4131063|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
1690759|NCT00506415|4131064|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
1690760|NCT00506415|4131061|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
1690761|NCT00506415|4131062|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
1690762|NCT00506415|4131063|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
1690763|NCT00506415|4131064|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
1690764|NCT00506415|4131061|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1690765|NCT00506415|4131062|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1690766|NCT00506415|4131063|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1690767|NCT00506415|4131064|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
1690768|NCT00506415|4131061|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1690769|NCT00506415|4131062|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1690770|NCT00506415|4131063|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1690771|NCT00506415|4131064|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
1690772|NCT00506415|4131061|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
1690773|NCT00506415|4131062|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
1690774|NCT00506415|4131063|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
1690775|NCT00506415|4131064|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
1690776|NCT00506415|4131061|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
1690777|NCT00506415|4131062|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
1690778|NCT00506415|4131063|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
1690779|NCT00506415|4131064|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
1690780|NCT00506389|4131089|P3|NOT COMPLETED|Follow-up Period||0
1690781|NCT00506389|4131090|P2|NOT COMPLETED|Follow-up Period||0
1690782|NCT00506389|4131091|P1|NOT COMPLETED|Follow-up Period||0
1690783|NCT00506389|4131089|P3|COMPLETED|Follow-up Period||136
1690784|NCT00506389|4131090|P2|COMPLETED|Follow-up Period||138
1690785|NCT00506389|4131091|P1|COMPLETED|Follow-up Period||139
1690786|NCT00506389|4131089|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
1690787|NCT00506389|4131090|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
1690788|NCT00506389|4131091|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
1690789|NCT00506389|4131089|P3|NOT COMPLETED|In-treatment Period||12
1690790|NCT00506389|4131090|P2|NOT COMPLETED|In-treatment Period||15
1690791|NCT00506389|4131091|P1|NOT COMPLETED|In-treatment Period||26
1690792|NCT00506389|4131089|P3|COMPLETED|In-treatment Period||125
1690793|NCT00506389|4131090|P2|COMPLETED|In-treatment Period||124
1690794|NCT00506389|4131091|P1|COMPLETED|In-treatment Period||117
1690795|NCT00506389|4131089|P3|All Participants Treated|In-treatment Period||136
1690796|NCT00506389|4131090|P2|All Participants Treated|In-treatment Period||138
1690797|NCT00506389|4131091|P1|All Participants Treated|In-treatment Period||139
1690798|NCT00506389|4131089|P3|STARTED|In-treatment Period||137
1690799|NCT00506389|4131090|P2|STARTED|In-treatment Period||139
1690800|NCT00506389|4131091|P1|STARTED|In-treatment Period||143
1690801|NCT00506350|4131117|P9|NOT COMPLETED|Overall Study||5
1690802|NCT00506350|4131118|P8|NOT COMPLETED|Overall Study||5
1690803|NCT00506350|4131119|P7|NOT COMPLETED|Overall Study||2
1690804|NCT00506350|4131120|P6|NOT COMPLETED|Overall Study||2
1690805|NCT00506350|4131121|P5|NOT COMPLETED|Overall Study||10
1690806|NCT00506350|4131122|P4|NOT COMPLETED|Overall Study||2
1690807|NCT00506350|4131123|P3|NOT COMPLETED|Overall Study||6
1690808|NCT00506350|4131124|P2|NOT COMPLETED|Overall Study||3
1690809|NCT00506350|4131125|P1|NOT COMPLETED|Overall Study||3
1690810|NCT00506350|4131117|P9|COMPLETED|Overall Study||30
1690811|NCT00506350|4131118|P8|COMPLETED|Overall Study||36
1690812|NCT00506350|4131119|P7|COMPLETED|Overall Study||33
1690813|NCT00506350|4131120|P6|COMPLETED|Overall Study||38
1690814|NCT00506350|4131121|P5|COMPLETED|Overall Study||40
1690815|NCT00506350|4131122|P4|COMPLETED|Overall Study||34
1690816|NCT00506350|4131123|P3|COMPLETED|Overall Study||31
1690817|NCT00506350|4131124|P2|COMPLETED|Overall Study||37
1690818|NCT00506350|4131125|P1|COMPLETED|Overall Study||33
1690819|NCT00506350|4131117|P9|STARTED|Overall Study||35
1690820|NCT00506350|4131118|P8|STARTED|Overall Study||41
1690821|NCT00506350|4131119|P7|STARTED|Overall Study||35
1690822|NCT00506350|4131120|P6|STARTED|Overall Study||40
1690823|NCT00506350|4131121|P5|STARTED|Overall Study||50
1690824|NCT00506350|4131122|P4|STARTED|Overall Study||36
1690825|NCT00506350|4131123|P3|STARTED|Overall Study||37
1690826|NCT00506350|4131124|P2|STARTED|Overall Study||40
1690827|NCT00506350|4131125|P1|STARTED|Overall Study||36
1690828|NCT00506285|4131272|P2|NOT COMPLETED|6-month Open Label Phase||12
1690829|NCT00506285|4131273|P1|NOT COMPLETED|6-month Open Label Phase||10
1690830|NCT00506285|4131272|P2|COMPLETED|6-month Open Label Phase||19
1690831|NCT00506285|4131273|P1|COMPLETED|6-month Open Label Phase||10
1690832|NCT00506285|4131272|P2|STARTED|6-month Open Label Phase||31
1690833|NCT00506285|4131273|P1|STARTED|6-month Open Label Phase||20
1690834|NCT00506285|4131272|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
1690835|NCT00506285|4131273|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
1690836|NCT00506285|4131272|P2|COMPLETED|Double Blind Cross-Over Phase||31
1690837|NCT00506285|4131273|P1|COMPLETED|Double Blind Cross-Over Phase||20
1690838|NCT00506285|4131272|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
1690839|NCT00506285|4131273|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
1690840|NCT00506285|4131272|P2|STARTED|Double Blind Cross-Over Phase||36
1690841|NCT00506285|4131273|P1|STARTED|Double Blind Cross-Over Phase||29
1690842|NCT00506285|4131272|P2|NOT COMPLETED|3 Week Screening Phase||10
1690843|NCT00506285|4131273|P1|NOT COMPLETED|3 Week Screening Phase||17
1690844|NCT00506285|4131272|P2|COMPLETED|3 Week Screening Phase||36
1690845|NCT00506285|4131273|P1|COMPLETED|3 Week Screening Phase||29
1690846|NCT00506285|4131272|P2|STARTED|3 Week Screening Phase||46
1690847|NCT00506285|4131273|P1|STARTED|3 Week Screening Phase||46
1690848|NCT00506155|4131281|P1|NOT COMPLETED|Overall Study||0
1690849|NCT00506155|4131281|P1|COMPLETED|Overall Study||60
1690850|NCT00506155|4131281|P1|STARTED|Overall Study||60
1690851|NCT00506077|4131288|P2|NOT COMPLETED|Treatment Period 2||1
1690852|NCT00506077|4131289|P1|NOT COMPLETED|Treatment Period 2||1
1690853|NCT00506077|4131288|P2|COMPLETED|Treatment Period 2||23
1690854|NCT00506077|4131289|P1|COMPLETED|Treatment Period 2||23
1690855|NCT00506077|4131288|P2|STARTED|Treatment Period 2||24
1690856|NCT00506077|4131289|P1|STARTED|Treatment Period 2||24
1690857|NCT00506077|4131288|P2|NOT COMPLETED|Washout||0
1690858|NCT00506077|4131289|P1|NOT COMPLETED|Washout||0
1690859|NCT00506077|4131288|P2|COMPLETED|Washout||24
1690860|NCT00506077|4131289|P1|COMPLETED|Washout||24
1690861|NCT00506077|4131288|P2|STARTED|Washout||24
1690862|NCT00506077|4131289|P1|STARTED|Washout||24
1690863|NCT00506077|4131288|P2|NOT COMPLETED|Treatment Period 1||3
1690864|NCT00506077|4131289|P1|NOT COMPLETED|Treatment Period 1||4
1690865|NCT00506077|4131288|P2|COMPLETED|Treatment Period 1||24
1690866|NCT00506077|4131289|P1|COMPLETED|Treatment Period 1||24
1690867|NCT00506077|4131288|P2|STARTED|Treatment Period 1||27
1690868|NCT00506077|4131289|P1|STARTED|Treatment Period 1||28
1690869|NCT00506064|4131311|P2|NOT COMPLETED|Overall Study||0
1690870|NCT00506064|4131312|P1|NOT COMPLETED|Overall Study||0
1690871|NCT00506064|4131311|P2|COMPLETED|Overall Study||0
1690872|NCT00506064|4131312|P1|COMPLETED|Overall Study||1
1690873|NCT00506064|4131311|P2|STARTED|Overall Study||0
1690874|NCT00506064|4131312|P1|STARTED|Overall Study||1
1690875|NCT00506025|4131321|P3|NOT COMPLETED|Overall Study||0
1690876|NCT00506025|4131322|P2|NOT COMPLETED|Overall Study||0
1690877|NCT00506025|4131323|P1|NOT COMPLETED|Overall Study||0
1690878|NCT00506025|4131321|P3|COMPLETED|Overall Study||8
1690879|NCT00506025|4131322|P2|COMPLETED|Overall Study||9
1690880|NCT00506025|4131323|P1|COMPLETED|Overall Study||10
1690881|NCT00506025|4131321|P3|STARTED|Overall Study||8
1690882|NCT00506025|4131322|P2|STARTED|Overall Study||9
1690883|NCT00506025|4131323|P1|STARTED|Overall Study||10
1690884|NCT00505934|4131331|P1|NOT COMPLETED|Overall Study||3
1690885|NCT00505934|4131331|P1|COMPLETED|Overall Study||16
1690886|NCT00505934|4131331|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
1690887|NCT00505921|4131337|P1|NOT COMPLETED|Overall Study||9
1690888|NCT00505921|4131337|P1|COMPLETED|Overall Study||18
1690889|NCT00505921|4131337|P1|STARTED|Overall Study||27
1690890|NCT00505895|4131343|P2|NOT COMPLETED|Overall Study||0
1690891|NCT00505895|4131344|P1|NOT COMPLETED|Overall Study||0
1690892|NCT00505895|4131343|P2|COMPLETED|Overall Study||23
1690893|NCT00505895|4131344|P1|COMPLETED|Overall Study||27
1690894|NCT00505895|4131343|P2|STARTED|Overall Study||23
1690895|NCT00505895|4131344|P1|STARTED|Overall Study||27
1690896|NCT00505778|4131354|P2|NOT COMPLETED|Overall Study||135
1690897|NCT00505778|4131355|P1|NOT COMPLETED|Overall Study||134
1690898|NCT00505778|4131354|P2|COMPLETED|Overall Study||378
1690899|NCT00505778|4131355|P1|COMPLETED|Overall Study||380
1690900|NCT00505778|4131354|P2|Intent to Treat (ITT) Population|Overall Study||511
1690901|NCT00505778|4131355|P1|Intent to Treat (ITT) Population|Overall Study||512
1690902|NCT00505778|4131354|P2|STARTED|Overall Study||513
1690903|NCT00505778|4131355|P1|STARTED|Overall Study||514
1690904|NCT00505765|4131374|P3|NOT COMPLETED|Overall Study||3
1690905|NCT00505765|4131375|P2|NOT COMPLETED|Overall Study||3
1690906|NCT00505765|4131376|P1|NOT COMPLETED|Overall Study||2
1690907|NCT00505765|4131374|P3|COMPLETED|Overall Study||19
1690908|NCT00505765|4131375|P2|COMPLETED|Overall Study||17
1690909|NCT00505765|4131376|P1|COMPLETED|Overall Study||19
1690910|NCT00505765|4131374|P3|Mid-Point Assessment|Overall Study||21
1690911|NCT00505765|4131375|P2|Mid-Point Assessment|Overall Study||19
1690912|NCT00505765|4131376|P1|Mid-Point Assessment|Overall Study||20
1690913|NCT00505765|4131374|P3|STARTED|Overall Study||22
1690914|NCT00505765|4131375|P2|STARTED|Overall Study||20
1690915|NCT00505765|4131376|P1|STARTED|Overall Study||21
1690916|NCT00505752|4131403|P4|NOT COMPLETED|Overall Study||6
1690917|NCT00505752|4131404|P3|NOT COMPLETED|Overall Study||8
1690918|NCT00505752|4131405|P2|NOT COMPLETED|Overall Study||9
1690919|NCT00505752|4131406|P1|NOT COMPLETED|Overall Study||6
1690920|NCT00505752|4131403|P4|COMPLETED|Overall Study||126
1690921|NCT00505752|4131404|P3|COMPLETED|Overall Study||120
1690922|NCT00505752|4131405|P2|COMPLETED|Overall Study||119
1690923|NCT00505752|4131406|P1|COMPLETED|Overall Study||126
1690924|NCT00505752|4131403|P4|STARTED|Overall Study||132
1690925|NCT00505752|4131404|P3|STARTED|Overall Study||128
1690926|NCT00505752|4131405|P2|STARTED|Overall Study||128
1690927|NCT00505752|4131406|P1|STARTED|Overall Study||132
1690928|NCT00505687|4131420|P1|NOT COMPLETED|Overall Study||95
1690929|NCT00505687|4131420|P1|COMPLETED|Overall Study||91
1690930|NCT00505687|4131420|P1|STARTED|Overall Study||186
1690931|NCT00505661|4131426|P1|NOT COMPLETED|Overall Study||4
1690932|NCT00505661|4131426|P1|COMPLETED|Overall Study||12
1690933|NCT00505661|4131426|P1|STARTED|Overall Study||16
1690934|NCT00505635|4131430|P1|NOT COMPLETED|Overall Study||0
1690935|NCT00505635|4131430|P1|COMPLETED|Overall Study||5
1690936|NCT00505635|4131430|P1|STARTED|Overall Study||5
1690937|NCT00505622|4131437|P3|NOT COMPLETED|Overall Study||96
1690938|NCT00505622|4131438|P2|NOT COMPLETED|Overall Study||108
1690939|NCT00505622|4131439|P1|NOT COMPLETED|Overall Study||121
1690940|NCT00505622|4131437|P3|COMPLETED|Overall Study||0
1690941|NCT00505622|4131438|P2|COMPLETED|Overall Study||0
1690942|NCT00505622|4131439|P1|COMPLETED|Overall Study||0
1690943|NCT00505622|4131437|P3|STARTED|Overall Study||96
1690944|NCT00505622|4131438|P2|STARTED|Overall Study||108
1690945|NCT00505622|4131439|P1|STARTED|Overall Study||121
1690946|NCT00505518|4131456|P1|NOT COMPLETED|Overall Study||0
1690947|NCT00505518|4131456|P1|COMPLETED|Overall Study||9
1690948|NCT00505518|4131456|P1|STARTED|Overall Study||9
1690949|NCT00505414|4131464|P5|NOT COMPLETED|Maintenance Phase||0
1690950|NCT00505414|4131465|P4|NOT COMPLETED|Maintenance Phase||0
1690951|NCT00505414|4131466|P3|NOT COMPLETED|Maintenance Phase||8
1690952|NCT00505414|4131467|P2|NOT COMPLETED|Maintenance Phase||5
1690953|NCT00505414|4131468|P1|NOT COMPLETED|Maintenance Phase||6
1690954|NCT00505414|4131464|P5|COMPLETED|Maintenance Phase||0
1690955|NCT00505414|4131465|P4|COMPLETED|Maintenance Phase||0
1690956|NCT00505414|4131466|P3|COMPLETED|Maintenance Phase||6
1690957|NCT00505414|4131467|P2|COMPLETED|Maintenance Phase||10
1690958|NCT00505414|4131468|P1|COMPLETED|Maintenance Phase||12
1690959|NCT00505414|4131464|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
1690960|NCT00505414|4131465|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
1690961|NCT00505414|4131466|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
1690962|NCT00505414|4131467|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
1690963|NCT00505414|4131468|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
1690964|NCT00505414|4131464|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
1690965|NCT00505414|4131465|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
1690966|NCT00505414|4131466|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
1690967|NCT00505414|4131467|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
1690968|NCT00505414|4131468|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
1690969|NCT00505414|4131464|P5|NOT COMPLETED|Titration Phase||12
1690970|NCT00505414|4131465|P4|NOT COMPLETED|Titration Phase||30
1690971|NCT00505414|4131466|P3|NOT COMPLETED|Titration Phase||0
1690972|NCT00505414|4131467|P2|NOT COMPLETED|Titration Phase||0
1690973|NCT00505414|4131468|P1|NOT COMPLETED|Titration Phase||0
1690974|NCT00505414|4131464|P5|COMPLETED|Titration Phase||19
1690975|NCT00505414|4131465|P4|COMPLETED|Titration Phase||32
1690976|NCT00505414|4131466|P3|COMPLETED|Titration Phase||0
1690977|NCT00505414|4131467|P2|COMPLETED|Titration Phase||0
1690978|NCT00505414|4131468|P1|COMPLETED|Titration Phase||0
1690979|NCT00505414|4131464|P5|STARTED|Titration Phase||31
1690980|NCT00505414|4131465|P4|STARTED|Titration Phase||62
1690981|NCT00505414|4131466|P3|STARTED|Titration Phase||0
1690982|NCT00505414|4131467|P2|STARTED|Titration Phase||0
1690983|NCT00505414|4131468|P1|STARTED|Titration Phase||0
1690984|NCT00505375|4131485|P2|NOT COMPLETED|Overall Study||5
1690985|NCT00505375|4131486|P1|NOT COMPLETED|Overall Study||4
1690986|NCT00505375|4131485|P2|COMPLETED|Overall Study||30
1690987|NCT00505375|4131486|P1|COMPLETED|Overall Study||73
1690988|NCT00505375|4131485|P2|STARTED|Overall Study||35
1690989|NCT00505375|4131486|P1|STARTED|Overall Study||77
1690990|NCT00505362|4131494|P2|NOT COMPLETED|Overall Study||0
1690991|NCT00505362|4131495|P1|NOT COMPLETED|Overall Study||0
1690992|NCT00505362|4131494|P2|COMPLETED|Overall Study||28
1690993|NCT00505362|4131495|P1|COMPLETED|Overall Study||35
1690994|NCT00505362|4131494|P2|STARTED|Overall Study||28
1690995|NCT00505362|4131495|P1|STARTED|Overall Study||35
1690996|NCT00505284|4131508|P5|NOT COMPLETED|Overall Study||33
1690997|NCT00505284|4131509|P4|NOT COMPLETED|Overall Study||19
1690998|NCT00505284|4131510|P3|NOT COMPLETED|Overall Study||12
1690999|NCT00505284|4131511|P2|NOT COMPLETED|Overall Study||16
1691000|NCT00505284|4131512|P1|NOT COMPLETED|Overall Study||10
1691001|NCT00505284|4131508|P5|COMPLETED|Overall Study||37
1691002|NCT00505284|4131509|P4|COMPLETED|Overall Study||49
1691003|NCT00505284|4131510|P3|COMPLETED|Overall Study||57
1691004|NCT00505284|4131511|P2|COMPLETED|Overall Study||56
1691005|NCT00505284|4131512|P1|COMPLETED|Overall Study||63
1691006|NCT00505284|4131508|P5|STARTED|Overall Study||70
1691007|NCT00505284|4131509|P4|STARTED|Overall Study||68
1691008|NCT00505284|4131510|P3|STARTED|Overall Study||69
1691009|NCT00505284|4131511|P2|STARTED|Overall Study||72
1691010|NCT00505284|4131512|P1|STARTED|Overall Study||73
1691011|NCT00505076|4131582|P3|NOT COMPLETED|Overall Study||5
1691012|NCT00505076|4131583|P2|NOT COMPLETED|Overall Study||2
1691013|NCT00505076|4131584|P1|NOT COMPLETED|Overall Study||3
1691014|NCT00505076|4131582|P3|COMPLETED|Overall Study||17
1691015|NCT00505076|4131583|P2|COMPLETED|Overall Study||17
1691016|NCT00505076|4131584|P1|COMPLETED|Overall Study||19
1691017|NCT00505076|4131582|P3|STARTED|Overall Study||22
1691018|NCT00505076|4131583|P2|STARTED|Overall Study||19
1691019|NCT00505076|4131584|P1|STARTED|Overall Study||22
1691020|NCT00504985|4131598|P1|NOT COMPLETED|Overall Study||0
1691021|NCT00504985|4131598|P1|COMPLETED|Overall Study||14
1691022|NCT00504985|4131598|P1|STARTED|Overall Study||14
1691023|NCT00504894|4131604|P2|NOT COMPLETED|Overall Study||0
1691024|NCT00504894|4131605|P1|NOT COMPLETED|Overall Study||0
1691025|NCT00504894|4131604|P2|COMPLETED|Overall Study||18
1691026|NCT00504894|4131605|P1|COMPLETED|Overall Study||17
1691027|NCT00504894|4131604|P2|STARTED|Overall Study||18
1691028|NCT00504894|4131605|P1|STARTED|Overall Study||17
1691029|NCT00504881|4131613|P2|NOT COMPLETED|Overall Study||36
1691030|NCT00504881|4131614|P1|NOT COMPLETED|Overall Study||10
1691031|NCT00504881|4131613|P2|COMPLETED|Overall Study||323
1691032|NCT00504881|4131614|P1|COMPLETED|Overall Study||111
1691033|NCT00504881|4131613|P2|STARTED|Overall Study||359
1691034|NCT00504881|4131614|P1|STARTED|Overall Study||121
1691035|NCT00504777|4131664|P1|NOT COMPLETED|Overall Study||1
1691036|NCT00504777|4131664|P1|COMPLETED|Overall Study||35
1691037|NCT00504777|4131664|P1|STARTED|Overall Study||36
1691038|NCT00504751|4131671|P1|NOT COMPLETED|Overall Study||0
1691039|NCT00504751|4131671|P1|COMPLETED|Overall Study||15
1691040|NCT00504751|4131671|P1|STARTED|Overall Study||15
1691041|NCT00504725|4131677|P2|NOT COMPLETED|Overall Study||0
1691042|NCT00504725|4131678|P1|NOT COMPLETED|Overall Study||1
1691043|NCT00504725|4131677|P2|COMPLETED|Overall Study||20
1691044|NCT00504725|4131678|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
1691045|NCT00504725|4131677|P2|STARTED|Overall Study||20
1691046|NCT00504725|4131678|P1|STARTED|Overall Study||21
1691047|NCT00504660|4131690|P2|NOT COMPLETED|Overall Study||0
1691048|NCT00504660|4131691|P1|NOT COMPLETED|Overall Study||0
1691049|NCT00504660|4131690|P2|COMPLETED|Overall Study||43
1691050|NCT00504660|4131691|P1|COMPLETED|Overall Study||31
1691051|NCT00504660|4131690|P2|STARTED|Overall Study||43
1691052|NCT00504660|4131691|P1|STARTED|Overall Study||31
1691053|NCT00504595|4131701|P4|NOT COMPLETED|Overall Study||0
1691054|NCT00504595|4131702|P3|NOT COMPLETED|Overall Study||2
1691055|NCT00504595|4131703|P2|NOT COMPLETED|Overall Study||0
1691056|NCT00504595|4131704|P1|NOT COMPLETED|Overall Study||1
1691057|NCT00504595|4131701|P4|COMPLETED|Overall Study||10
1691058|NCT00504595|4131702|P3|COMPLETED|Overall Study||8
1691059|NCT00504595|4131703|P2|COMPLETED|Overall Study||10
1691060|NCT00504595|4131704|P1|COMPLETED|Overall Study||49
1691061|NCT00504595|4131701|P4|STARTED|Overall Study||10
1691062|NCT00504595|4131702|P3|STARTED|Overall Study||10
1691063|NCT00504595|4131703|P2|STARTED|Overall Study||10
1691064|NCT00504595|4131704|P1|STARTED|Overall Study||50
1691065|NCT00504556|4131721|P5|NOT COMPLETED|Overall Study||25
1691066|NCT00504556|4131722|P4|NOT COMPLETED|Overall Study||128
1691067|NCT00504556|4131723|P3|NOT COMPLETED|Overall Study||31
1691068|NCT00504556|4131724|P2|NOT COMPLETED|Overall Study||38
1691069|NCT00504556|4131725|P1|NOT COMPLETED|Overall Study||35
1691070|NCT00504556|4131721|P5|COMPLETED|Overall Study||226
1691071|NCT00504556|4131722|P4|COMPLETED|Overall Study||52
1691072|NCT00504556|4131723|P3|COMPLETED|Overall Study||204
1691073|NCT00504556|4131724|P2|COMPLETED|Overall Study||207
1691074|NCT00504556|4131725|P1|COMPLETED|Overall Study||200
1691075|NCT00504556|4131721|P5|Pharmacodynamic Analysis Set|Overall Study||244
1691076|NCT00504556|4131722|P4|Pharmacodynamic Analysis Set|Overall Study||170
1691077|NCT00504556|4131723|P3|Pharmacodynamic Analysis Set|Overall Study||228
1691078|NCT00504556|4131724|P2|Pharmacodynamic Analysis Set|Overall Study||236
1691079|NCT00504556|4131725|P1|Pharmacodynamic Analysis Set|Overall Study||230
1691080|NCT00504556|4131721|P5|Per Protocol Analysis Set|Overall Study||250
1691081|NCT00504556|4131722|P4|Per Protocol Analysis Set|Overall Study||180
1691082|NCT00504556|4131723|P3|Per Protocol Analysis Set|Overall Study||234
1691083|NCT00504556|4131724|P2|Per Protocol Analysis Set|Overall Study||243
1691084|NCT00504556|4131725|P1|Per Protocol Analysis Set|Overall Study||235
1691085|NCT00504556|4131721|P5|Safety Analysis Set|Overall Study||250
1691086|NCT00504556|4131722|P4|Safety Analysis Set|Overall Study||180
1691087|NCT00504556|4131723|P3|Safety Analysis Set|Overall Study||234
1691088|NCT00504556|4131724|P2|Safety Analysis Set|Overall Study||244
1691089|NCT00504556|4131725|P1|Safety Analysis Set|Overall Study||235
1691090|NCT00504556|4131721|P5|STARTED|Overall Study||251
1691091|NCT00504556|4131722|P4|STARTED|Overall Study||180
1691092|NCT00504556|4131723|P3|STARTED|Overall Study||235
1691093|NCT00504556|4131724|P2|STARTED|Overall Study||245
1691094|NCT00504556|4131725|P1|STARTED|Overall Study||235
1691095|NCT00504504|4131785|P1|NOT COMPLETED|Overall Study||0
1691096|NCT00504504|4131785|P1|COMPLETED|Overall Study||82
1691097|NCT00504504|4131785|P1|STARTED|Overall Study||82
1691098|NCT00504426|4131793|P4|NOT COMPLETED|Overall Study||0
1691099|NCT00504426|4131794|P3|NOT COMPLETED|Overall Study||4
1691100|NCT00504426|4131795|P2|NOT COMPLETED|Overall Study||1
1691101|NCT00504426|4131796|P1|NOT COMPLETED|Overall Study||3
1691102|NCT00504426|4131793|P4|COMPLETED|Overall Study||24
1691103|NCT00504426|4131794|P3|COMPLETED|Overall Study||18
1691104|NCT00504426|4131795|P2|COMPLETED|Overall Study||22
1691105|NCT00504426|4131796|P1|COMPLETED|Overall Study||29
1691106|NCT00504426|4131793|P4|STARTED|Overall Study||24
1691107|NCT00504426|4131794|P3|STARTED|Overall Study||22
1691108|NCT00504426|4131795|P2|STARTED|Overall Study||23
1691109|NCT00504426|4131796|P1|STARTED|Overall Study||32
1691110|NCT00504309|4131816|P6|NOT COMPLETED|Overall Study||0
1691111|NCT00504309|4131817|P5|NOT COMPLETED|Overall Study||1
1691112|NCT00504309|4131818|P4|NOT COMPLETED|Overall Study||0
1691113|NCT00504309|4131819|P3|NOT COMPLETED|Overall Study||1
1691114|NCT00504309|4131820|P2|NOT COMPLETED|Overall Study||0
1691115|NCT00504309|4131821|P1|NOT COMPLETED|Overall Study||0
1691116|NCT00504309|4131816|P6|COMPLETED|Overall Study||3
1691117|NCT00504309|4131817|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
1691118|NCT00504309|4131818|P4|COMPLETED|Overall Study||3
1691119|NCT00504309|4131819|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
1691120|NCT00504309|4131820|P2|COMPLETED|Overall Study||5
1691121|NCT00504309|4131821|P1|COMPLETED|Overall Study||7
1691122|NCT00504309|4131816|P6|STARTED|Overall Study||3
1691123|NCT00504309|4131817|P5|STARTED|Overall Study||8
1691124|NCT00504309|4131818|P4|STARTED|Overall Study||3
1691125|NCT00504309|4131819|P3|STARTED|Overall Study||2
1691126|NCT00504309|4131820|P2|STARTED|Overall Study||5
1691127|NCT00504309|4131821|P1|STARTED|Overall Study||7
1691128|NCT00504257|4131859|P1|NOT COMPLETED|Overall Study||4
1691129|NCT00504257|4131859|P1|COMPLETED|Overall Study||41
1691130|NCT00504257|4131859|P1|STARTED|Overall Study||45
1691131|NCT00504231|4131871|P4|NOT COMPLETED|Overall Study||0
1691132|NCT00504231|4131872|P3|NOT COMPLETED|Overall Study||1
1691133|NCT00504231|4131873|P2|NOT COMPLETED|Overall Study||0
1691134|NCT00504231|4131874|P1|NOT COMPLETED|Overall Study||0
1691135|NCT00504231|4131871|P4|COMPLETED|Overall Study||65
1691136|NCT00504231|4131872|P3|COMPLETED|Overall Study||63
1691137|NCT00504231|4131873|P2|COMPLETED|Overall Study||64
1691138|NCT00504231|4131874|P1|COMPLETED|Overall Study||65
1691139|NCT00504231|4131871|P4|STARTED|Overall Study||65
1691140|NCT00504231|4131872|P3|STARTED|Overall Study||64
1691141|NCT00504231|4131873|P2|STARTED|Overall Study||64
1691142|NCT00504231|4131874|P1|STARTED|Overall Study||65
1691143|NCT00504166|4131894|P2|NOT COMPLETED|Overall Study||14
1691144|NCT00504166|4131895|P1|NOT COMPLETED|Overall Study||6
1691145|NCT00504166|4131894|P2|COMPLETED|Overall Study||13
1691146|NCT00504166|4131895|P1|COMPLETED|Overall Study||20
1691147|NCT00504166|4131894|P2|STARTED|Overall Study||27
1691148|NCT00504166|4131895|P1|STARTED|Overall Study||26
1691149|NCT00504153|4131901|P1|NOT COMPLETED|Overall Study||6
1691150|NCT00504153|4131901|P1|COMPLETED|Overall Study||13
1691151|NCT00504153|4131901|P1|STARTED|Overall Study||19
1691152|NCT00504075|4131909|P1|NOT COMPLETED|Overall Study||8
1691153|NCT00504075|4131909|P1|COMPLETED|Overall Study||27
1691154|NCT00504075|4131909|P1|STARTED|Overall Study||35
1691155|NCT00504023|4131915|P1|NOT COMPLETED|Overall Study||0
1691156|NCT00504023|4131915|P1|COMPLETED|Overall Study||8
1691157|NCT00504023|4131915|P1|STARTED|Overall Study||8
1691158|NCT00503997|4131919|P1|NOT COMPLETED|Overall Study||8
1691159|NCT00503997|4131919|P1|COMPLETED|Overall Study||34
1691160|NCT00503997|4131919|P1|STARTED|Overall Study||42
1691161|NCT00503984|4131925|P6|NOT COMPLETED|Overall Study||0
1691162|NCT00503984|4131926|P5|NOT COMPLETED|Overall Study||1
1691163|NCT00503984|4131927|P4|NOT COMPLETED|Overall Study||0
1691164|NCT00503984|4131928|P3|NOT COMPLETED|Overall Study||0
1691165|NCT00503984|4131929|P2|NOT COMPLETED|Overall Study||2
1691166|NCT00503984|4131930|P1|NOT COMPLETED|Overall Study||0
1691167|NCT00503984|4131925|P6|COMPLETED|Overall Study||1
1691168|NCT00503984|4131926|P5|COMPLETED|Overall Study||5
1691169|NCT00503984|4131927|P4|COMPLETED|Overall Study||6
1691170|NCT00503984|4131928|P3|COMPLETED|Overall Study||3
1691171|NCT00503984|4131929|P2|COMPLETED|Overall Study||1
1691172|NCT00503984|4131930|P1|COMPLETED|Overall Study||3
1691173|NCT00503984|4131925|P6|STARTED|Overall Study||1
1691174|NCT00503984|4131926|P5|STARTED|Overall Study||6
1691175|NCT00503984|4131927|P4|STARTED|Overall Study||6
1691176|NCT00503984|4131928|P3|STARTED|Overall Study||3
1691177|NCT00503984|4131929|P2|STARTED|Overall Study||3
1691178|NCT00503984|4131930|P1|STARTED|Overall Study||3
1691179|NCT00503906|4131956|P1|NOT COMPLETED|Overall Study||1
1691180|NCT00503906|4131956|P1|COMPLETED|Overall Study||29
1691181|NCT00503906|4131956|P1|STARTED|Overall Study||30
1691182|NCT00503880|4131965|P5|NOT COMPLETED|Overall Study||0
1691183|NCT00503880|4131966|P4|NOT COMPLETED|Overall Study||0
1691184|NCT00503880|4131967|P3|NOT COMPLETED|Overall Study||0
1691185|NCT00503880|4131968|P2|NOT COMPLETED|Overall Study||0
1691186|NCT00503880|4131969|P1|NOT COMPLETED|Overall Study||2
1691187|NCT00503880|4131965|P5|COMPLETED|Overall Study||0
1691188|NCT00503880|4131966|P4|COMPLETED|Overall Study||0
1691189|NCT00503880|4131967|P3|COMPLETED|Overall Study||0
1691190|NCT00503880|4131968|P2|COMPLETED|Overall Study||0
1691191|NCT00503880|4131969|P1|COMPLETED|Overall Study||0
1691192|NCT00503880|4131965|P5|STARTED|Overall Study||0
1691193|NCT00503880|4131966|P4|STARTED|Overall Study||0
1691194|NCT00503880|4131967|P3|STARTED|Overall Study||0
1691195|NCT00503880|4131968|P2|STARTED|Overall Study||0
1691196|NCT00503880|4131969|P1|STARTED|Overall Study||2
1691197|NCT00503841|4131978|P1|NOT COMPLETED|Overall Study||44
1691198|NCT00503841|4131978|P1|COMPLETED|Overall Study||0
1691199|NCT00503841|4131978|P1|STARTED|Overall Study||44
1691200|NCT00503776|4131986|P4|NOT COMPLETED|Overall Study||2
1691201|NCT00503776|4131987|P3|NOT COMPLETED|Overall Study||2
1691202|NCT00503776|4131988|P2|NOT COMPLETED|Overall Study||0
1691203|NCT00503776|4131989|P1|NOT COMPLETED|Overall Study||1
1691204|NCT00503776|4131986|P4|COMPLETED|Overall Study||8
1691205|NCT00503776|4131987|P3|COMPLETED|Overall Study||10
1691206|NCT00503776|4131988|P2|COMPLETED|Overall Study||12
1691207|NCT00503776|4131989|P1|COMPLETED|Overall Study||7
1691208|NCT00503776|4131986|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
1691209|NCT00503776|4131987|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
1691210|NCT00503776|4131988|P2|STARTED|Overall Study||12
1691211|NCT00503776|4131989|P1|STARTED|Overall Study||8
1691212|NCT00503750|4132015|P1|NOT COMPLETED|Overall Study||0
1691213|NCT00503750|4132015|P1|COMPLETED|Overall Study||27
1691214|NCT00503750|4132015|P1|STARTED|Overall Study||27
1691215|NCT00503698|4132022|P2|NOT COMPLETED|Overall Study||355
1691216|NCT00503698|4132023|P1|NOT COMPLETED|Overall Study||357
1691217|NCT00503698|4132022|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
1691218|NCT00503698|4132023|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
1691219|NCT00503698|4132022|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
1691220|NCT00503698|4132023|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
1691221|NCT00503698|4132022|P2|STARTED|Overall Study|Randomised|355
1691222|NCT00503698|4132023|P1|STARTED|Overall Study|Randomised|357
1691223|NCT00503685|4132040|P3|NOT COMPLETED|Overall Study||2
1691224|NCT00503685|4132041|P2|NOT COMPLETED|Overall Study||3
1691225|NCT00503685|4132042|P1|NOT COMPLETED|Overall Study||0
1691226|NCT00503685|4132040|P3|COMPLETED|Overall Study||18
1691227|NCT00503685|4132041|P2|COMPLETED|Overall Study||19
1691228|NCT00503685|4132042|P1|COMPLETED|Overall Study||23
1691229|NCT00503685|4132040|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
1691230|NCT00503685|4132041|P2|Received at Least 1 Dose of Study Drug|Overall Study||21
1691231|NCT00503685|4132042|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
1691232|NCT00503685|4132040|P3|STARTED|Overall Study||20
1691233|NCT00503685|4132041|P2|STARTED|Overall Study||22
1691234|NCT00503685|4132042|P1|STARTED|Overall Study||23
1691235|NCT00503425|4132084|P1|NOT COMPLETED|Overall Study||54
1691236|NCT00503425|4132084|P1|COMPLETED|Overall Study||161
1691237|NCT00503425|4132084|P1|STARTED|Overall Study||215
1691238|NCT00503399|4132094|P2|NOT COMPLETED|Overall Study||8
1691239|NCT00503399|4132095|P1|NOT COMPLETED|Overall Study||7
1691240|NCT00503399|4132094|P2|COMPLETED|Overall Study||39
1691241|NCT00503399|4132095|P1|COMPLETED|Overall Study||38
1691242|NCT00503399|4132094|P2|STARTED|Overall Study||47
1691243|NCT00503399|4132095|P1|STARTED|Overall Study||45
1691244|NCT00503308|4132119|P2|NOT COMPLETED|Overall Study||1
1691245|NCT00503308|4132120|P1|NOT COMPLETED|Overall Study||2
1691246|NCT00503308|4132119|P2|COMPLETED|Overall Study||134
1691247|NCT00503308|4132120|P1|COMPLETED|Overall Study||144
1691248|NCT00503308|4132119|P2|STARTED|Overall Study||135
1691249|NCT00503308|4132120|P1|STARTED|Overall Study||146
1691250|NCT00503139|4132126|P1|NOT COMPLETED|Overall Study||8
1691251|NCT00503139|4132126|P1|COMPLETED|Overall Study||676
1691252|NCT00503139|4132126|P1|STARTED|Overall Study||684
1691253|NCT00503113|4132140|P3|NOT COMPLETED|Overall Study||28
1691254|NCT00503113|4132141|P2|NOT COMPLETED|Overall Study||28
1691255|NCT00503113|4132142|P1|NOT COMPLETED|Overall Study||33
1691256|NCT00503113|4132140|P3|COMPLETED|Overall Study||241
1691257|NCT00503113|4132141|P2|COMPLETED|Overall Study||236
1691258|NCT00503113|4132142|P1|COMPLETED|Overall Study||235
1691259|NCT00503113|4132140|P3|Safety Population|Overall Study||267
1691260|NCT00503113|4132141|P2|Safety Population|Overall Study||263
1691261|NCT00503113|4132142|P1|Safety Population|Overall Study||263
1691262|NCT00503113|4132140|P3|Per Protocol Population (PP)|Overall Study||241
1691263|NCT00503113|4132141|P2|Per Protocol Population (PP)|Overall Study||243
1691264|NCT00503113|4132142|P1|Per Protocol Population (PP)|Overall Study||246
1691265|NCT00503113|4132140|P3|Intent to Treat Population (ITT)|Overall Study||268
1691266|NCT00503113|4132141|P2|Intent to Treat Population (ITT)|Overall Study||261
1691267|NCT00503113|4132142|P1|Intent to Treat Population (ITT)|Overall Study||262
1691268|NCT00503113|4132140|P3|STARTED|Overall Study||269
1691269|NCT00503113|4132141|P2|STARTED|Overall Study||264
1691270|NCT00503113|4132142|P1|STARTED|Overall Study||268
1691271|NCT00503009|4132174|P3|NOT COMPLETED|Overall Study||3
1691272|NCT00503009|4132175|P2|NOT COMPLETED|Overall Study||2
1691273|NCT00503009|4132176|P1|NOT COMPLETED|Overall Study||1
1691274|NCT00503009|4132174|P3|COMPLETED|Overall Study||3
1691275|NCT00503009|4132175|P2|COMPLETED|Overall Study||3
1691276|NCT00503009|4132176|P1|COMPLETED|Overall Study||4
1691277|NCT00503009|4132174|P3|STARTED|Overall Study||6
1691278|NCT00503009|4132175|P2|STARTED|Overall Study||5
1691279|NCT00503009|4132176|P1|STARTED|Overall Study||5
1691280|NCT00502996|4132193|P1|NOT COMPLETED|Overall Study||44
1691281|NCT00502996|4132193|P1|COMPLETED|Overall Study||188
1691282|NCT00502996|4132193|P1|STARTED|Overall Study||232
1691283|NCT00502944|4132219|P2|NOT COMPLETED|Overall Study||1766
1691284|NCT00502944|4132220|P1|NOT COMPLETED|Overall Study||1064
1691285|NCT00502944|4132219|P2|COMPLETED|Overall Study||643
1691286|NCT00502944|4132220|P1|COMPLETED|Overall Study||1382
1691287|NCT00502944|4132219|P2|STARTED|Overall Study||2409
1691288|NCT00502944|4132220|P1|STARTED|Overall Study||2446
1691289|NCT00502905|4132232|P1|NOT COMPLETED|Overall Study||0
1691290|NCT00502905|4132232|P1|COMPLETED|Overall Study||196
1691291|NCT00502905|4132232|P1|STARTED|Overall Study||196
1691292|NCT00502853|4132236|P1|NOT COMPLETED|Overall Study||0
1691293|NCT00502853|4132236|P1|COMPLETED|Overall Study||10
1691294|NCT00502853|4132236|P1|STARTED|Overall Study||10
1691295|NCT00502840|4132261|P1|NOT COMPLETED|Overall Study||100
1691296|NCT00502840|4132261|P1|COMPLETED|Overall Study||93
1691297|NCT00502840|4132261|P1|STARTED|Overall Study||193
1691298|NCT00502801|4132289|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
1691299|NCT00502801|4132289|P1|COMPLETED|End of Therapy to Test of Cure||121
1691300|NCT00502801|4132289|P1|STARTED|End of Therapy to Test of Cure||129
1691301|NCT00502801|4132289|P1|NOT COMPLETED|Treatment Period||54
1691302|NCT00502801|4132289|P1|COMPLETED|Treatment Period||129
1691303|NCT00502801|4132289|P1|STARTED|Treatment Period||183
1691304|NCT00502775|4132297|P3|NOT COMPLETED|Overall Study||13
1691305|NCT00502775|4132298|P2|NOT COMPLETED|Overall Study||15
1691306|NCT00502775|4132299|P1|NOT COMPLETED|Overall Study||10
1691307|NCT00502775|4132297|P3|COMPLETED|Overall Study||214
1691308|NCT00502775|4132298|P2|COMPLETED|Overall Study||209
1691309|NCT00502775|4132299|P1|COMPLETED|Overall Study||219
1691310|NCT00502775|4132297|P3|STARTED|Overall Study||227
1691311|NCT00502775|4132298|P2|STARTED|Overall Study||224
1691312|NCT00502775|4132299|P1|STARTED|Overall Study||229
1691313|NCT00502697|4132342|P2|NOT COMPLETED|Overall Study||12
1691314|NCT00502697|4132343|P1|NOT COMPLETED|Overall Study||13
1691315|NCT00502697|4132342|P2|COMPLETED|Overall Study||102
1691316|NCT00502697|4132343|P1|COMPLETED|Overall Study||109
1691317|NCT00502697|4132342|P2|STARTED|Overall Study||114
1691318|NCT00502697|4132343|P1|STARTED|Overall Study||122
1691319|NCT00502671|4132351|P1|NOT COMPLETED|Overall Study||77
1691320|NCT00502671|4132351|P1|COMPLETED|Overall Study||151
1691321|NCT00502671|4132351|P1|STARTED|Overall Study||228
1691322|NCT00502593|4132368|P12|NOT COMPLETED|Overall Study||0
1691323|NCT00502593|4132369|P11|NOT COMPLETED|Overall Study||2
1691324|NCT00502593|4132370|P10|NOT COMPLETED|Overall Study||0
1691325|NCT00502593|4132371|P9|NOT COMPLETED|Overall Study||6
1691326|NCT00502593|4132372|P8|NOT COMPLETED|Overall Study||0
1691327|NCT00502593|4132373|P7|NOT COMPLETED|Overall Study||5
1691328|NCT00502593|4132374|P6|NOT COMPLETED|Overall Study||0
1691329|NCT00502593|4132375|P5|NOT COMPLETED|Overall Study||4
1691330|NCT00502593|4132376|P4|NOT COMPLETED|Overall Study||4
1691331|NCT00502593|4132377|P3|NOT COMPLETED|Overall Study||10
1691332|NCT00502593|4132378|P2|NOT COMPLETED|Overall Study||2
1691333|NCT00502593|4132379|P1|NOT COMPLETED|Overall Study||3
1691334|NCT00502593|4132368|P12|COMPLETED|Overall Study||18
1691335|NCT00502593|4132369|P11|COMPLETED|Overall Study||47
1691336|NCT00502593|4132370|P10|COMPLETED|Overall Study||17
1691337|NCT00502593|4132371|P9|COMPLETED|Overall Study||43
1691338|NCT00502593|4132372|P8|COMPLETED|Overall Study||17
1691339|NCT00502593|4132373|P7|COMPLETED|Overall Study||44
1691340|NCT00502593|4132374|P6|COMPLETED|Overall Study||17
1691341|NCT00502593|4132375|P5|COMPLETED|Overall Study||47
1691342|NCT00502593|4132376|P4|COMPLETED|Overall Study||14
1691343|NCT00502593|4132377|P3|COMPLETED|Overall Study||41
1691344|NCT00502593|4132378|P2|COMPLETED|Overall Study||16
1691345|NCT00502593|4132379|P1|COMPLETED|Overall Study||48
1691346|NCT00502593|4132368|P12|STARTED|Overall Study||18
1691347|NCT00502593|4132369|P11|STARTED|Overall Study||49
1691348|NCT00502593|4132370|P10|STARTED|Overall Study||17
1691349|NCT00502593|4132371|P9|STARTED|Overall Study||49
1691350|NCT00502593|4132372|P8|STARTED|Overall Study||17
1691351|NCT00502593|4132373|P7|STARTED|Overall Study||49
1691352|NCT00502593|4132374|P6|STARTED|Overall Study||17
1691353|NCT00502593|4132375|P5|STARTED|Overall Study||51
1691354|NCT00502593|4132376|P4|STARTED|Overall Study||18
1691355|NCT00502593|4132377|P3|STARTED|Overall Study||51
1691356|NCT00502593|4132378|P2|STARTED|Overall Study||18
1691357|NCT00502593|4132379|P1|STARTED|Overall Study||51
1691358|NCT00502320|4132895|P2|NOT COMPLETED|Overall Study||7
1691359|NCT00502320|4132896|P1|NOT COMPLETED|Overall Study||6
1691360|NCT00502320|4132895|P2|COMPLETED|Overall Study||18
1691361|NCT00502320|4132896|P1|COMPLETED|Overall Study||19
1691362|NCT00502320|4132895|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
1691363|NCT00502320|4132896|P1|Screening Visit|Overall Study||25
1691364|NCT00502320|4132895|P2|STARTED|Overall Study||25
1691365|NCT00502320|4132896|P1|STARTED|Overall Study||25
1691366|NCT00502242|4132908|P2|NOT COMPLETED|Overall Study||56
1691367|NCT00502242|4132909|P1|NOT COMPLETED|Overall Study||51
1691368|NCT00502242|4132908|P2|COMPLETED|Overall Study||84
1691369|NCT00502242|4132909|P1|COMPLETED|Overall Study||104
1691370|NCT00502242|4132908|P2|STARTED|Overall Study||140
1691371|NCT00502242|4132909|P1|STARTED|Overall Study||155
1691372|NCT00502216|4132962|P2|NOT COMPLETED|Overall Study||0
1691373|NCT00502216|4132963|P1|NOT COMPLETED|Overall Study||0
1691374|NCT00502216|4132962|P2|COMPLETED|Overall Study||19
1691375|NCT00502216|4132963|P1|COMPLETED|Overall Study||21
1691376|NCT00502216|4132962|P2|STARTED|Overall Study||19
1691377|NCT00502216|4132963|P1|STARTED|Overall Study||21
1691378|NCT00502203|4132973|P1|NOT COMPLETED|Overall Study||1
1691379|NCT00502203|4132973|P1|COMPLETED|Overall Study||22
1691380|NCT00502203|4132973|P1|STARTED|Overall Study||23
1691381|NCT00501995|4132977|P1|NOT COMPLETED|Overall Study||1
1691382|NCT00501995|4132977|P1|COMPLETED|Overall Study||5
1691383|NCT00501995|4132977|P1|STARTED|Overall Study||6
1691384|NCT00501969|4132982|P1|NOT COMPLETED|Overall Study||206
1691385|NCT00501969|4132982|P1|COMPLETED|Overall Study||189
1691386|NCT00501969|4132982|P1|STARTED|Overall Study||395
1691387|NCT00501943|4132990|P2|NOT COMPLETED|Overall Study||3
1691388|NCT00501943|4132991|P1|NOT COMPLETED|Overall Study||2
1691389|NCT00501943|4132990|P2|COMPLETED|Overall Study||18
1691390|NCT00501943|4132991|P1|COMPLETED|Overall Study||20
1691391|NCT00501943|4132990|P2|STARTED|Overall Study||21
1691392|NCT00501943|4132991|P1|STARTED|Overall Study||22
1691393|NCT00501891|4133007|P1|NOT COMPLETED|Overall Study||0
1691394|NCT00501891|4133007|P1|COMPLETED|Overall Study||32
1691395|NCT00501891|4133007|P1|STARTED|Overall Study||32
1691396|NCT00501852|4133014|P1|NOT COMPLETED|Overall Study||5
1691397|NCT00501852|4133014|P1|COMPLETED|Overall Study||78
1691398|NCT00501852|4133014|P1|Tiotropium|Overall Study||55
1691399|NCT00501852|4133014|P1|Placebo|Overall Study||55
1691400|NCT00501852|4133014|P1|NVA237 100µg|Overall Study||54
1691401|NCT00501852|4133014|P1|NVA237 50µg|Overall Study||53
1691402|NCT00501852|4133014|P1|NVA237 25µg|Overall Study||51
1691403|NCT00501852|4133014|P1|NVA237 12.5µg|Overall Study||55
1691404|NCT00501852|4133014|P1|STARTED|Overall Study||83
1691405|NCT00501644|4133034|P1|NOT COMPLETED|Overall Study||5
1691406|NCT00501644|4133034|P1|COMPLETED|Overall Study||54
1691407|NCT00501644|4133034|P1|STARTED|Overall Study||59
1691408|NCT00501631|4133040|P2|NOT COMPLETED|Part B (Open-label Period)||51
1691409|NCT00501631|4133041|P1|NOT COMPLETED|Part B (Open-label Period)||53
1691410|NCT00501631|4133040|P2|COMPLETED|Part B (Open-label Period)||48
1691411|NCT00501631|4133041|P1|COMPLETED|Part B (Open-label Period)||37
1691412|NCT00501631|4133040|P2|STARTED|Part B (Open-label Period)||99
1691413|NCT00501631|4133041|P1|STARTED|Part B (Open-label Period)||90
1691414|NCT00501631|4133040|P2|NOT COMPLETED|Part A (Double-blind Period)||49
1691415|NCT00501631|4133041|P1|NOT COMPLETED|Part A (Double-blind Period)||62
1691416|NCT00501631|4133040|P2|COMPLETED|Part A (Double-blind Period)||99
1691417|NCT00501631|4133041|P1|COMPLETED|Part A (Double-blind Period)||90
1691418|NCT00501631|4133040|P2|STARTED|Part A (Double-blind Period)||148
1691419|NCT00501631|4133041|P1|STARTED|Part A (Double-blind Period)||152
1691420|NCT00501592|4133050|P3|NOT COMPLETED|Overall Study||3
1691421|NCT00501592|4133051|P2|NOT COMPLETED|Overall Study||5
1691422|NCT00501592|4133052|P1|NOT COMPLETED|Overall Study||0
1691423|NCT00501592|4133050|P3|COMPLETED|Overall Study||20
1691424|NCT00501592|4133051|P2|COMPLETED|Overall Study||16
1691425|NCT00501592|4133052|P1|COMPLETED|Overall Study||20
1691426|NCT00501592|4133050|P3|STARTED|Overall Study||23
1691427|NCT00501592|4133051|P2|STARTED|Overall Study||21
1691428|NCT00501592|4133052|P1|STARTED|Overall Study||20
1691429|NCT00501540|4133063|P1|NOT COMPLETED|Overall Study||5
1691430|NCT00501540|4133063|P1|COMPLETED|Overall Study||10
1691431|NCT00501540|4133063|P1|STARTED|Overall Study||15
1691432|NCT00501345|4133069|P1|NOT COMPLETED|Overall Study||0
1691433|NCT00501345|4133069|P1|COMPLETED|Overall Study||5
1691434|NCT00501345|4133069|P1|STARTED|Overall Study||5
1691435|NCT00501293|4133075|P2|NOT COMPLETED|Maintenance Period||28
1691436|NCT00501293|4133076|P1|NOT COMPLETED|Maintenance Period||46
1691437|NCT00501293|4133075|P2|COMPLETED|Maintenance Period||25
1691438|NCT00501293|4133076|P1|COMPLETED|Maintenance Period||63
1691439|NCT00501293|4133075|P2|STARTED|Maintenance Period||53
1691440|NCT00501293|4133076|P1|STARTED|Maintenance Period||109
1691441|NCT00501293|4133075|P2|NOT COMPLETED|Optimization Period||0
1691442|NCT00501293|4133076|P1|NOT COMPLETED|Optimization Period||1
1691443|NCT00501293|4133075|P2|COMPLETED|Optimization Period||53
1691444|NCT00501293|4133076|P1|COMPLETED|Optimization Period||109
1691445|NCT00501293|4133075|P2|STARTED|Optimization Period||53
1691446|NCT00501293|4133076|P1|STARTED|Optimization Period||110
1691447|NCT00501228|4133103|P1|NOT COMPLETED|Overall Study||1
1691448|NCT00501228|4133103|P1|COMPLETED|Overall Study||1
1691449|NCT00501228|4133103|P1|STARTED|Overall Study||2
1691450|NCT00501085|4133107|P1|NOT COMPLETED|Overall Study||432
1691451|NCT00501085|4133107|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
1691452|NCT00501085|4133107|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
1691453|NCT00501059|4133117|P2|NOT COMPLETED|Overall Study||1892
1691454|NCT00501059|4133118|P1|NOT COMPLETED|Overall Study||1868
1691455|NCT00501059|4133117|P2|COMPLETED|Overall Study||4384
1691456|NCT00501059|4133118|P1|COMPLETED|Overall Study||4402
1691457|NCT00501059|4133117|P2|STARTED|Overall Study||6276
1691458|NCT00501059|4133118|P1|STARTED|Overall Study||6270
1691459|NCT00501046|4133142|P2|NOT COMPLETED|Overall Study||294
1691460|NCT00501046|4133143|P1|NOT COMPLETED|Overall Study||270
1691461|NCT00501046|4133142|P2|COMPLETED|Overall Study||213
1691462|NCT00501046|4133143|P1|COMPLETED|Overall Study||238
1691463|NCT00501046|4133142|P2|STARTED|Overall Study||507
1691464|NCT00501046|4133143|P1|STARTED|Overall Study||508
1691465|NCT00501007|4133149|P2|NOT COMPLETED|Overall Study||25
1691466|NCT00501007|4133150|P1|NOT COMPLETED|Overall Study||29
1691467|NCT00501007|4133149|P2|COMPLETED|Overall Study||78
1691468|NCT00501007|4133150|P1|COMPLETED|Overall Study||71
1691469|NCT00501007|4133149|P2|STARTED|Overall Study||103
1691470|NCT00501007|4133150|P1|STARTED|Overall Study||100
1691471|NCT00500760|4133158|P2|NOT COMPLETED|Overall Study||24
1691472|NCT00500760|4133159|P1|NOT COMPLETED|Overall Study||43
1691473|NCT00500760|4133158|P2|COMPLETED|Overall Study||40
1691474|NCT00500760|4133159|P1|COMPLETED|Overall Study||46
1691475|NCT00500760|4133158|P2|Received Treatment|Overall Study||63
1691476|NCT00500760|4133159|P1|Received Treatment|Overall Study||87
1691477|NCT00500760|4133158|P2|STARTED|Overall Study||64
1691478|NCT00500760|4133159|P1|STARTED|Overall Study||89
1691479|NCT00500682|4133179|P2|NOT COMPLETED|Overall Study||287
1691480|NCT00500682|4133180|P1|NOT COMPLETED|Overall Study||306
1691481|NCT00500682|4133179|P2|COMPLETED|Overall Study||223
1691482|NCT00500682|4133180|P1|COMPLETED|Overall Study||204
1691483|NCT00500682|4133179|P2|STARTED|Overall Study||510
1691484|NCT00500682|4133180|P1|STARTED|Overall Study||510
1691485|NCT00500656|4133190|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
1691486|NCT00500656|4133191|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
1691487|NCT00500656|4133192|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
1691488|NCT00500656|4133193|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
1691489|NCT00500656|4133190|P4|COMPLETED|Open Label Extension (OLE) Phase||6
1691490|NCT00500656|4133191|P3|COMPLETED|Open Label Extension (OLE) Phase||1
1691491|NCT00500656|4133192|P2|COMPLETED|Open Label Extension (OLE) Phase||9
1691492|NCT00500656|4133193|P1|COMPLETED|Open Label Extension (OLE) Phase||16
1691493|NCT00500656|4133190|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
1691494|NCT00500656|4133191|P3|STARTED|Open Label Extension (OLE) Phase||2
1691495|NCT00500656|4133192|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
1691496|NCT00500656|4133193|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
1691497|NCT00500656|4133190|P4|NOT COMPLETED|Controlled Phase||8
1691498|NCT00500656|4133191|P3|NOT COMPLETED|Controlled Phase||1
1691499|NCT00500656|4133192|P2|NOT COMPLETED|Controlled Phase||10
1691500|NCT00500656|4133193|P1|NOT COMPLETED|Controlled Phase||10
1691501|NCT00500656|4133190|P4|COMPLETED|Controlled Phase||0
1691502|NCT00500656|4133191|P3|COMPLETED|Controlled Phase||2
1691503|NCT00500656|4133192|P2|COMPLETED|Controlled Phase||28
1691504|NCT00500656|4133193|P1|COMPLETED|Controlled Phase||26
1691505|NCT00500656|4133190|P4|STARTED|Controlled Phase||8
1691506|NCT00500656|4133191|P3|STARTED|Controlled Phase||3
1691507|NCT00500656|4133192|P2|STARTED|Controlled Phase||38
1691508|NCT00500656|4133193|P1|STARTED|Controlled Phase||36
1691509|NCT00500578|4133207|P2|NOT COMPLETED|Overall Study||0
1691510|NCT00500578|4133208|P1|NOT COMPLETED|Overall Study||0
1691511|NCT00500578|4133207|P2|COMPLETED|Overall Study|All completed|32
1691512|NCT00500578|4133208|P1|COMPLETED|Overall Study|All completed|18
1691513|NCT00500578|4133207|P2|STARTED|Overall Study||32
1691514|NCT00500578|4133208|P1|STARTED|Overall Study||18
1691515|NCT00500539|4133214|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
1691516|NCT00500539|4133214|P1|COMPLETED|Follow-up Period (16 Weeks)||136
1691517|NCT00500539|4133214|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
1691518|NCT00500539|4133214|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
1691519|NCT00500539|4133214|P1|COMPLETED|Treatment Period (24 Weeks)||140
1691520|NCT00500539|4133214|P1|STARTED|Treatment Period (24 Weeks)||155
1691521|NCT00500448|4133223|P2|NOT COMPLETED|Overall Study||0
1691522|NCT00500448|4133224|P1|NOT COMPLETED|Overall Study||0
1691523|NCT00500448|4133223|P2|COMPLETED|Overall Study||16
1691524|NCT00500448|4133224|P1|COMPLETED|Overall Study||14
1691525|NCT00500448|4133223|P2|STARTED|Overall Study||16
1691526|NCT00500448|4133224|P1|STARTED|Overall Study||14
1691527|NCT00500370|4133240|P2|NOT COMPLETED|Overall Study||34
1691528|NCT00500370|4133241|P1|NOT COMPLETED|Overall Study||33
1691529|NCT00500370|4133240|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
1691530|NCT00500370|4133241|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
1691531|NCT00500370|4133240|P2|Treatment Complete (Week 24)|Overall Study||54
1691532|NCT00500370|4133241|P1|Treatment Complete (Week 24)|Overall Study||48
1691533|NCT00500370|4133240|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
1691534|NCT00500370|4133241|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
1691535|NCT00500370|4133240|P2|STARTED|Overall Study||83
1691536|NCT00500370|4133241|P1|STARTED|Overall Study||80
1691537|NCT00500357|4133277|P1|NOT COMPLETED|Overall Study||1
1691538|NCT00500357|4133277|P1|COMPLETED|Overall Study||104
1691539|NCT00500357|4133277|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
1691540|NCT00500357|4133277|P1|Received 13vPnC (Vax 3)|Overall Study||105
1691541|NCT00500357|4133277|P1|STARTED|Overall Study||105
1691542|NCT00500331|4133303|P7|NOT COMPLETED|Overall Study||2
1691543|NCT00500331|4133304|P6|NOT COMPLETED|Overall Study||5
1691544|NCT00500331|4133305|P5|NOT COMPLETED|Overall Study||4
1691545|NCT00500331|4133306|P4|NOT COMPLETED|Overall Study||10
1691546|NCT00500331|4133307|P3|NOT COMPLETED|Overall Study||5
1691547|NCT00500331|4133308|P2|NOT COMPLETED|Overall Study||5
1691548|NCT00500331|4133309|P1|NOT COMPLETED|Overall Study||15
1691549|NCT00500331|4133303|P7|COMPLETED|Overall Study||46
1691550|NCT00500331|4133304|P6|COMPLETED|Overall Study||42
1691551|NCT00500331|4133305|P5|COMPLETED|Overall Study||44
1691552|NCT00500331|4133306|P4|COMPLETED|Overall Study||38
1691553|NCT00500331|4133307|P3|COMPLETED|Overall Study||43
1691554|NCT00500331|4133308|P2|COMPLETED|Overall Study||42
1691555|NCT00500331|4133309|P1|COMPLETED|Overall Study||33
1691556|NCT00500331|4133303|P7|STARTED|Overall Study||48
1691557|NCT00500331|4133304|P6|STARTED|Overall Study||47
1691558|NCT00500331|4133305|P5|STARTED|Overall Study||48
1691559|NCT00500331|4133306|P4|STARTED|Overall Study||48
1691560|NCT00500331|4133307|P3|STARTED|Overall Study||48
1691561|NCT00500331|4133308|P2|STARTED|Overall Study||47
1691562|NCT00500331|4133309|P1|STARTED|Overall Study||48
1691563|NCT00500318|4133446|P2|NOT COMPLETED|Overall Study||17
1691564|NCT00500318|4133447|P1|NOT COMPLETED|Overall Study||5
1691565|NCT00500318|4133446|P2|COMPLETED|Overall Study||78
1691566|NCT00500318|4133447|P1|COMPLETED|Overall Study||81
1691567|NCT00500318|4133446|P2|STARTED|Overall Study||95
1691568|NCT00500318|4133447|P1|STARTED|Overall Study||86
1691569|NCT00500292|4133464|P3|NOT COMPLETED|Overall Study||27
1691570|NCT00500292|4133465|P2|NOT COMPLETED|Overall Study||31
1691571|NCT00500292|4133466|P1|NOT COMPLETED|Overall Study||25
1691572|NCT00500292|4133464|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
1691573|NCT00500292|4133465|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
1691574|NCT00500292|4133466|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
1691575|NCT00500292|4133464|P3|STARTED|Overall Study|randomised patients|37
1691576|NCT00500292|4133465|P2|STARTED|Overall Study|randomised patients|35
1691577|NCT00500292|4133466|P1|STARTED|Overall Study|randomised patients|32
1691578|NCT00500240|4133476|P2|NOT COMPLETED|Overall Study||0
1691579|NCT00500240|4133477|P1|NOT COMPLETED|Overall Study||0
1691580|NCT00500240|4133476|P2|COMPLETED|Overall Study||26
1691581|NCT00500240|4133477|P1|COMPLETED|Overall Study||25
1691582|NCT00500240|4133476|P2|STARTED|Overall Study||26
1691583|NCT00500240|4133477|P1|STARTED|Overall Study||25
1691584|NCT00500149|4133487|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
1691585|NCT00500149|4133488|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
1691586|NCT00500149|4133487|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
1691587|NCT00500149|4133488|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
1691588|NCT00500149|4133487|P2|STARTED|Second Intervention (Cross-over Phase)||57
1691589|NCT00500149|4133488|P1|STARTED|Second Intervention (Cross-over Phase)||56
1691590|NCT00500149|4133487|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
1691591|NCT00500149|4133488|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
1691592|NCT00500149|4133487|P2|COMPLETED|First Intervention (Cross-over Phase)||57
1691593|NCT00500149|4133488|P1|COMPLETED|First Intervention (Cross-over Phase)||56
1691594|NCT00500149|4133487|P2|STARTED|First Intervention (Cross-over Phase)||59
1691595|NCT00500149|4133488|P1|STARTED|First Intervention (Cross-over Phase)||58
1691596|NCT00500149|4133487|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
1691597|NCT00500149|4133488|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
1691598|NCT00500149|4133487|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
1691599|NCT00500149|4133488|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
1691600|NCT00500149|4133487|P2|STARTED|Enrolled (Dose-optimization Phase)||0
1691601|NCT00500149|4133488|P1|STARTED|Enrolled (Dose-optimization Phase)||129
1691602|NCT00500110|4133496|P1|NOT COMPLETED|Overall Study||3
1691603|NCT00500110|4133496|P1|COMPLETED|Overall Study||36
1691604|NCT00500110|4133496|P1|STARTED|Overall Study||39
1691605|NCT00500071|4133500|P1|NOT COMPLETED|30-day Safety Follow-up||17
1691606|NCT00500071|4133500|P1|COMPLETED|30-day Safety Follow-up||278
1691607|NCT00500071|4133500|P1|STARTED|30-day Safety Follow-up||295
1691608|NCT00500071|4133500|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
1691609|NCT00500071|4133500|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
1691610|NCT00500071|4133500|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
1691611|NCT00500071|4133500|P1|NOT COMPLETED|Screening and Washout Phase||1
1691612|NCT00500071|4133500|P1|COMPLETED|Screening and Washout Phase||317
1691613|NCT00500071|4133500|P1|STARTED|Screening and Washout Phase||318
1691614|NCT00499915|4133511|P2|NOT COMPLETED|Overall Study||6
1691615|NCT00499915|4133512|P1|NOT COMPLETED|Overall Study||15
1691616|NCT00499915|4133511|P2|COMPLETED|Overall Study||76
1691617|NCT00499915|4133512|P1|COMPLETED|Overall Study||68
1691618|NCT00499915|4133511|P2|STARTED|Overall Study||82
1691619|NCT00499915|4133512|P1|STARTED|Overall Study||83
1691620|NCT00499889|4133518|P1|NOT COMPLETED|Overall Study||1
1691621|NCT00499889|4133518|P1|COMPLETED|Overall Study||41
1691622|NCT00499889|4133518|P1|STARTED|Overall Study||42
1691623|NCT00499863|4133526|P2|NOT COMPLETED|Overall Study||43
1691624|NCT00499863|4133527|P1|NOT COMPLETED|Overall Study||50
1691625|NCT00499863|4133526|P2|COMPLETED|Overall Study||29
1691626|NCT00499863|4133527|P1|COMPLETED|Overall Study||95
1691627|NCT00499863|4133526|P2|STARTED|Overall Study||72
1691628|NCT00499863|4133527|P1|STARTED|Overall Study||145
1691629|NCT00500266|4133555|P1|NOT COMPLETED|Overall Study||13
1691630|NCT00500266|4133555|P1|COMPLETED|Overall Study||1040
1691631|NCT00500266|4133555|P1|Treated|Overall Study||1049
1691632|NCT00500266|4133555|P1|STARTED|Overall Study||1053
1691633|NCT00499746|4133562|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
1691634|NCT00499746|4133562|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
1691635|NCT00499746|4133562|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
1691636|NCT00499746|4133562|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
1691637|NCT00499746|4133562|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
1691638|NCT00499746|4133562|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
1691639|NCT00499746|4133562|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
1691640|NCT00499746|4133562|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
1691641|NCT00499746|4133562|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
1691642|NCT00499694|4133631|P1|NOT COMPLETED|Overall Study||1
1691643|NCT00499694|4133631|P1|COMPLETED|Overall Study||30
1691644|NCT00499694|4133631|P1|STARTED|Overall Study||31
1691645|NCT00499681|4133640|P2|NOT COMPLETED|Overall Study||2
1691646|NCT00499681|4133641|P1|NOT COMPLETED|Overall Study||0
1691647|NCT00499681|4133640|P2|COMPLETED|Overall Study||0
1691648|NCT00499681|4133641|P1|COMPLETED|Overall Study||4
1691649|NCT00499681|4133640|P2|STARTED|Overall Study||2
1691650|NCT00499681|4133641|P1|STARTED|Overall Study||4
1691651|NCT00499655|4133649|P2|NOT COMPLETED|Overall Study||0
1691652|NCT00499655|4133650|P1|NOT COMPLETED|Overall Study||0
1691653|NCT00499655|4133649|P2|COMPLETED|Overall Study||54
1691654|NCT00499655|4133650|P1|COMPLETED|Overall Study||53
1691655|NCT00499655|4133649|P2|STARTED|Overall Study||54
1691656|NCT00499655|4133650|P1|STARTED|Overall Study||53
1691657|NCT00499616|4133668|P4|NOT COMPLETED|Overall Study||57
1691658|NCT00499616|4133669|P3|NOT COMPLETED|Overall Study||36
1691659|NCT00499616|4133670|P2|NOT COMPLETED|Overall Study||28
1691660|NCT00499616|4133671|P1|NOT COMPLETED|Overall Study||15
1691661|NCT00499616|4133668|P4|COMPLETED|Overall Study||0
1691662|NCT00499616|4133669|P3|COMPLETED|Overall Study||53
1691663|NCT00499616|4133670|P2|COMPLETED|Overall Study||114
1691664|NCT00499616|4133671|P1|COMPLETED|Overall Study||161
1691665|NCT00499616|4133668|P4|STARTED|Overall Study||57
1691666|NCT00499616|4133669|P3|STARTED|Overall Study||89
1691667|NCT00499616|4133670|P2|STARTED|Overall Study||142
1691668|NCT00499616|4133671|P1|STARTED|Overall Study||176
1691669|NCT00499603|4133708|P2|NOT COMPLETED|Overall Study||1
1691670|NCT00499603|4133709|P1|NOT COMPLETED|Overall Study||0
1691671|NCT00499603|4133708|P2|COMPLETED|Overall Study||22
1691672|NCT00499603|4133709|P1|COMPLETED|Overall Study||27
1691673|NCT00499603|4133708|P2|STARTED|Overall Study||23
1691674|NCT00499603|4133709|P1|STARTED|Overall Study||27
1691675|NCT00499590|4133722|P3|NOT COMPLETED|Overall Study||113
1691676|NCT00499590|4133723|P2|NOT COMPLETED|Overall Study||112
1691677|NCT00499590|4133724|P1|NOT COMPLETED|Overall Study||113
1691678|NCT00499590|4133722|P3|COMPLETED|Overall Study||0
1691679|NCT00499590|4133723|P2|COMPLETED|Overall Study||0
1691680|NCT00499590|4133724|P1|COMPLETED|Overall Study||0
1691681|NCT00499590|4133722|P3|STARTED|Overall Study||113
1691682|NCT00499590|4133723|P2|STARTED|Overall Study||112
1691683|NCT00499590|4133724|P1|STARTED|Overall Study||113
1691684|NCT00499486|4133735|P1|NOT COMPLETED|Overall Study||16
1691685|NCT00499486|4133735|P1|COMPLETED|Overall Study||31
1691686|NCT00499486|4133735|P1|STARTED|Overall Study||47
1691687|NCT00499473|4133743|P2|NOT COMPLETED|Overall Study||0
1691688|NCT00499473|4133744|P1|NOT COMPLETED|Overall Study||6
1691689|NCT00499473|4133743|P2|COMPLETED|Overall Study||4
1691690|NCT00499473|4133744|P1|COMPLETED|Overall Study|Patients evaluable|21
1691691|NCT00499473|4133743|P2|STARTED|Overall Study||4
1691692|NCT00499473|4133744|P1|STARTED|Overall Study||27
1691693|NCT00499460|4133762|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
1691694|NCT00499460|4133763|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
1691695|NCT00499460|4133762|P2|COMPLETED|Intervention 2 (30 Days)||6
1691696|NCT00499460|4133763|P1|COMPLETED|Intervention 2 (30 Days)||6
1691697|NCT00499460|4133762|P2|STARTED|Intervention 2 (30 Days)||7
1691698|NCT00499460|4133763|P1|STARTED|Intervention 2 (30 Days)||6
1691699|NCT00499460|4133762|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
1691700|NCT00499460|4133763|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
1691701|NCT00499460|4133762|P2|COMPLETED|Intervention 1 (30 Days)||7
1691702|NCT00499460|4133763|P1|COMPLETED|Intervention 1 (30 Days)||6
1691703|NCT00499460|4133762|P2|STARTED|Intervention 1 (30 Days)||7
1691704|NCT00499460|4133763|P1|STARTED|Intervention 1 (30 Days)||8
1691705|NCT00499447|4133779|P1|NOT COMPLETED|Overall Study||0
1691706|NCT00499447|4133779|P1|COMPLETED|Overall Study||13
1691707|NCT00499447|4133779|P1|STARTED|Overall Study||13
1691708|NCT00499408|4133783|P1|NOT COMPLETED|Overall Study||0
1691709|NCT00499408|4133783|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
1691710|NCT00499408|4133783|P1|STARTED|Overall Study||26
1691711|NCT00499369|4133796|P5|NOT COMPLETED|Overall Study||12
1691712|NCT00499369|4133797|P4|NOT COMPLETED|Overall Study||9
1691713|NCT00499369|4133798|P3|NOT COMPLETED|Overall Study||17
1691714|NCT00499369|4133799|P2|NOT COMPLETED|Overall Study||18
1691715|NCT00499369|4133800|P1|NOT COMPLETED|Overall Study||16
1691716|NCT00499369|4133796|P5|COMPLETED|Overall Study||0
1691717|NCT00499369|4133797|P4|COMPLETED|Overall Study||0
1691718|NCT00499369|4133798|P3|COMPLETED|Overall Study||0
1691719|NCT00499369|4133799|P2|COMPLETED|Overall Study||0
1691720|NCT00499369|4133800|P1|COMPLETED|Overall Study||0
1691721|NCT00499369|4133796|P5|Eligible|Overall Study||12
1691722|NCT00499369|4133797|P4|Eligible|Overall Study||8
1691723|NCT00499369|4133798|P3|Eligible|Overall Study||16
1691724|NCT00499369|4133799|P2|Eligible|Overall Study||16
1691725|NCT00499369|4133800|P1|Eligible|Overall Study||14
1691726|NCT00499369|4133796|P5|STARTED|Overall Study||12
1691727|NCT00499369|4133797|P4|STARTED|Overall Study||9
1691728|NCT00499369|4133798|P3|STARTED|Overall Study||17
1691729|NCT00499369|4133799|P2|STARTED|Overall Study||18
1691730|NCT00499369|4133800|P1|STARTED|Overall Study||16
1691731|NCT00499343|4133829|P2|NOT COMPLETED|Overall Study||0
1691732|NCT00499343|4133830|P1|NOT COMPLETED|Overall Study||0
1691733|NCT00499343|4133829|P2|COMPLETED|Overall Study||43
1691734|NCT00499343|4133830|P1|COMPLETED|Overall Study||41
1691735|NCT00499343|4133829|P2|STARTED|Overall Study||43
1691736|NCT00499343|4133830|P1|STARTED|Overall Study||41
1691737|NCT00499252|4133836|P1|NOT COMPLETED|Overall Study||12
1691738|NCT00499252|4133836|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
1691739|NCT00499252|4133836|P1|STARTED|Overall Study||51
1691740|NCT00499122|4133846|P1|NOT COMPLETED|Overall Study||2
1691741|NCT00499122|4133846|P1|COMPLETED|Overall Study||39
1691742|NCT00499122|4133846|P1|STARTED|Overall Study||41
1691743|NCT00499109|4133854|P2|NOT COMPLETED|Overall Study||7
1691744|NCT00499109|4133855|P1|NOT COMPLETED|Overall Study||18
1691745|NCT00499109|4133854|P2|COMPLETED|Overall Study||85
1691746|NCT00499109|4133855|P1|COMPLETED|Overall Study||165
1691747|NCT00499109|4133854|P2|STARTED|Overall Study||92
1691748|NCT00499109|4133855|P1|STARTED|Overall Study||183
1691749|NCT00499096|4133870|P2|NOT COMPLETED|Overall Study||20
1691750|NCT00499096|4133871|P1|NOT COMPLETED|Overall Study||23
1691751|NCT00499096|4133870|P2|COMPLETED|Overall Study||40
1691752|NCT00499096|4133871|P1|COMPLETED|Overall Study||35
1691753|NCT00499096|4133870|P2|STARTED|Overall Study||60
1691754|NCT00499096|4133871|P1|STARTED|Overall Study||58
1691755|NCT00499083|4133889|P1|NOT COMPLETED|Overall Study||3
1691756|NCT00499083|4133889|P1|COMPLETED|Overall Study||14
1691757|NCT00499083|4133889|P1|Participants at Moffitt Cancer Center|Overall Study||14
1691758|NCT00499083|4133889|P1|Participants at UNMC|Overall Study||3
1691759|NCT00499083|4133889|P1|STARTED|Overall Study||17
1691760|NCT00499031|4133896|P1|NOT COMPLETED|Overall Study||3
1691761|NCT00499031|4133896|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
1691762|NCT00499031|4133896|P1|STARTED|Overall Study|Total number participants enrolled on study|38
1691763|NCT00498940|4133903|P2|NOT COMPLETED|Overall Study||0
1691764|NCT00498940|4133904|P1|NOT COMPLETED|Overall Study||0
1691765|NCT00498940|4133903|P2|COMPLETED|Overall Study||31
1691766|NCT00498940|4133904|P1|COMPLETED|Overall Study||30
1691767|NCT00498940|4133903|P2|STARTED|Overall Study||31
1691768|NCT00498940|4133904|P1|STARTED|Overall Study||30
1691769|NCT00498927|4133912|P1|NOT COMPLETED|Overall Study||0
1691770|NCT00498927|4133912|P1|COMPLETED|Overall Study||47
1691771|NCT00498927|4133912|P1|STARTED|Overall Study||47
1691772|NCT00498797|4133919|P2|NOT COMPLETED|Overall Study||29
1691773|NCT00498797|4133920|P1|NOT COMPLETED|Overall Study||38
1691774|NCT00498797|4133919|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
1691775|NCT00498797|4133920|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
1691776|NCT00498797|4133919|P2|STARTED|Overall Study|randomised patients|43
1691777|NCT00498797|4133920|P1|STARTED|Overall Study|randomised patients|43
1691778|NCT00498706|4133930|P2|NOT COMPLETED|Overall Study||0
1691779|NCT00498706|4133931|P1|NOT COMPLETED|Overall Study||0
1691780|NCT00498706|4133930|P2|COMPLETED|Overall Study||162
1691781|NCT00498706|4133931|P1|COMPLETED|Overall Study||163
1691782|NCT00498706|4133930|P2|Post Treatment Week 18|Overall Study||162
1691783|NCT00498706|4133931|P1|Post Treatment Week 18|Overall Study||163
1691784|NCT00498706|4133930|P2|STARTED|Overall Study||162
1691785|NCT00498706|4133931|P1|STARTED|Overall Study||163
1691786|NCT00498628|4133945|P2|NOT COMPLETED|Overall Study||21
1691787|NCT00498628|4133946|P1|NOT COMPLETED|Overall Study||15
1691788|NCT00498628|4133945|P2|COMPLETED|Overall Study||92
1691789|NCT00498628|4133946|P1|COMPLETED|Overall Study||90
1691790|NCT00498628|4133945|P2|STARTED|Overall Study||113
1691791|NCT00498628|4133946|P1|STARTED|Overall Study||105
1691792|NCT00498615|4133952|P6|NOT COMPLETED|Placebo||0
1691793|NCT00498615|4133953|P5|NOT COMPLETED|Placebo||0
1691794|NCT00498615|4133954|P4|NOT COMPLETED|Placebo||0
1691795|NCT00498615|4133955|P3|NOT COMPLETED|Placebo||0
1691796|NCT00498615|4133956|P2|NOT COMPLETED|Placebo||0
1691797|NCT00498615|4133957|P1|NOT COMPLETED|Placebo||0
1691798|NCT00498615|4133952|P6|COMPLETED|Placebo||3
1691799|NCT00498615|4133953|P5|COMPLETED|Placebo||3
1691800|NCT00498615|4133954|P4|COMPLETED|Placebo||2
1691801|NCT00498615|4133955|P3|COMPLETED|Placebo||3
1691802|NCT00498615|4133956|P2|COMPLETED|Placebo||4
1691803|NCT00498615|4133957|P1|COMPLETED|Placebo||2
1691804|NCT00498615|4133952|P6|STARTED|Placebo||3
1691805|NCT00498615|4133953|P5|STARTED|Placebo||3
1691806|NCT00498615|4133954|P4|STARTED|Placebo||2
1691807|NCT00498615|4133955|P3|STARTED|Placebo||3
1691808|NCT00498615|4133956|P2|STARTED|Placebo||4
1691809|NCT00498615|4133957|P1|STARTED|Placebo||2
1691810|NCT00498615|4133952|P6|NOT COMPLETED|Fasudil 40mg||0
1691811|NCT00498615|4133953|P5|NOT COMPLETED|Fasudil 40mg||0
1691812|NCT00498615|4133954|P4|NOT COMPLETED|Fasudil 40mg||0
1691813|NCT00498615|4133955|P3|NOT COMPLETED|Fasudil 40mg||0
1691814|NCT00498615|4133956|P2|NOT COMPLETED|Fasudil 40mg||0
1691815|NCT00498615|4133957|P1|NOT COMPLETED|Fasudil 40mg||0
1691816|NCT00498615|4133952|P6|COMPLETED|Fasudil 40mg||3
1691817|NCT00498615|4133953|P5|COMPLETED|Fasudil 40mg||3
1691818|NCT00498615|4133954|P4|COMPLETED|Fasudil 40mg||2
1691819|NCT00498615|4133955|P3|COMPLETED|Fasudil 40mg||3
1691820|NCT00498615|4133956|P2|COMPLETED|Fasudil 40mg||4
1691821|NCT00498615|4133957|P1|COMPLETED|Fasudil 40mg||2
1691822|NCT00498615|4133952|P6|STARTED|Fasudil 40mg||3
1691823|NCT00498615|4133953|P5|STARTED|Fasudil 40mg||3
1691824|NCT00498615|4133954|P4|STARTED|Fasudil 40mg||2
1691825|NCT00498615|4133955|P3|STARTED|Fasudil 40mg||3
1691826|NCT00498615|4133956|P2|STARTED|Fasudil 40mg||4
1691827|NCT00498615|4133957|P1|STARTED|Fasudil 40mg||2
1691828|NCT00498615|4133952|P6|NOT COMPLETED|Fasudil 80mg||0
1691829|NCT00498615|4133953|P5|NOT COMPLETED|Fasudil 80mg||0
1691830|NCT00498615|4133954|P4|NOT COMPLETED|Fasudil 80mg||0
1691831|NCT00498615|4133955|P3|NOT COMPLETED|Fasudil 80mg||0
1691832|NCT00498615|4133956|P2|NOT COMPLETED|Fasudil 80mg||0
1691833|NCT00498615|4133957|P1|NOT COMPLETED|Fasudil 80mg||0
1691834|NCT00498615|4133952|P6|COMPLETED|Fasudil 80mg||3
1691835|NCT00498615|4133953|P5|COMPLETED|Fasudil 80mg||3
1691836|NCT00498615|4133954|P4|COMPLETED|Fasudil 80mg||2
1691837|NCT00498615|4133955|P3|COMPLETED|Fasudil 80mg||3
1691838|NCT00498615|4133956|P2|COMPLETED|Fasudil 80mg||4
1691839|NCT00498615|4133957|P1|COMPLETED|Fasudil 80mg||2
1691840|NCT00498615|4133952|P6|STARTED|Fasudil 80mg||3
1691841|NCT00498615|4133953|P5|STARTED|Fasudil 80mg||3
1691842|NCT00498615|4133954|P4|STARTED|Fasudil 80mg||2
1691843|NCT00498615|4133955|P3|STARTED|Fasudil 80mg||3
1691844|NCT00498615|4133956|P2|STARTED|Fasudil 80mg||4
1691845|NCT00498615|4133957|P1|STARTED|Fasudil 80mg||2
1691846|NCT00498602|4133978|P7|NOT COMPLETED|Overall Study||2
1691847|NCT00498602|4133979|P6|NOT COMPLETED|Overall Study||13
1691848|NCT00498602|4133980|P5|NOT COMPLETED|Overall Study||4
1691849|NCT00498602|4133981|P4|NOT COMPLETED|Overall Study||5
1691850|NCT00498602|4133982|P3|NOT COMPLETED|Overall Study||8
1691851|NCT00498602|4133983|P2|NOT COMPLETED|Overall Study||10
1691852|NCT00498602|4133984|P1|NOT COMPLETED|Overall Study||10
1691853|NCT00498602|4133978|P7|COMPLETED|Overall Study||15
1691854|NCT00498602|4133979|P6|COMPLETED|Overall Study||31
1691855|NCT00498602|4133980|P5|COMPLETED|Overall Study||8
1691856|NCT00498602|4133981|P4|COMPLETED|Overall Study||30
1691857|NCT00498602|4133982|P3|COMPLETED|Overall Study||32
1691858|NCT00498602|4133983|P2|COMPLETED|Overall Study||51
1691859|NCT00498602|4133984|P1|COMPLETED|Overall Study||26
1691860|NCT00498602|4133978|P7|Treated|Overall Study||17
1691861|NCT00498602|4133979|P6|Treated|Overall Study||44
1691862|NCT00498602|4133980|P5|Treated|Overall Study||12
1691863|NCT00498602|4133981|P4|Treated|Overall Study||35
1691864|NCT00498602|4133982|P3|Treated|Overall Study||40
1691865|NCT00498602|4133983|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
1691866|NCT00498602|4133984|P1|Treated|Overall Study||36
1691867|NCT00498602|4133978|P7|STARTED|Overall Study||17
1691868|NCT00498602|4133979|P6|STARTED|Overall Study||44
1691869|NCT00498602|4133980|P5|STARTED|Overall Study||12
1691870|NCT00498602|4133981|P4|STARTED|Overall Study||35
1691871|NCT00498602|4133982|P3|STARTED|Overall Study||40
1691872|NCT00498602|4133983|P2|STARTED|Overall Study||61
1691873|NCT00498602|4133984|P1|STARTED|Overall Study||36
1691874|NCT00498550|4134023|P2|NOT COMPLETED|Overall Study||1
1691875|NCT00498550|4134024|P1|NOT COMPLETED|Overall Study||0
1691876|NCT00498550|4134023|P2|COMPLETED|Overall Study||15
1691877|NCT00498550|4134024|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
1691878|NCT00498550|4134023|P2|STARTED|Overall Study||16
1691879|NCT00498550|4134024|P1|STARTED|Overall Study||15
1691880|NCT00498485|4134032|P2|NOT COMPLETED|Overall Study||5
1691881|NCT00498485|4134033|P1|NOT COMPLETED|Overall Study||1
1691882|NCT00498485|4134032|P2|COMPLETED|Overall Study||5
1691883|NCT00498485|4134033|P1|COMPLETED|Overall Study||6
1691884|NCT00498485|4134032|P2|STARTED|Overall Study||10
1691885|NCT00498485|4134033|P1|STARTED|Overall Study||7
1691886|NCT00498433|4134044|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
1691887|NCT00498433|4134045|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
1691888|NCT00498433|4134046|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
1691889|NCT00498433|4134044|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
1691890|NCT00498433|4134045|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
1691891|NCT00498433|4134046|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
1691892|NCT00498433|4134044|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
1691893|NCT00498433|4134045|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
1691894|NCT00498433|4134046|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
1691895|NCT00498433|4134044|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
1691896|NCT00498433|4134045|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
1691897|NCT00498433|4134046|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
1691898|NCT00498433|4134044|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
1691899|NCT00498433|4134045|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
1691900|NCT00498433|4134046|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
1691901|NCT00498433|4134044|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
1691902|NCT00498433|4134045|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
1691903|NCT00498433|4134046|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
1691904|NCT00498433|4134044|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1691905|NCT00498433|4134045|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1691906|NCT00498433|4134046|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1691907|NCT00498433|4134044|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
1691908|NCT00498433|4134045|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1691909|NCT00498433|4134046|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1691910|NCT00498433|4134044|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
1691911|NCT00498433|4134045|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1691912|NCT00498433|4134046|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
1691913|NCT00498433|4134044|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1691914|NCT00498433|4134045|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1691915|NCT00498433|4134046|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1691916|NCT00498433|4134044|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1691917|NCT00498433|4134045|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
1691918|NCT00498433|4134046|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1691919|NCT00498433|4134044|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1691920|NCT00498433|4134045|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
1691921|NCT00498433|4134046|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
1691922|NCT00498433|4134044|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1691923|NCT00498433|4134045|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1691924|NCT00498433|4134046|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1691925|NCT00498433|4134044|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1691926|NCT00498433|4134045|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1691927|NCT00498433|4134046|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
1691928|NCT00498433|4134044|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1691929|NCT00498433|4134045|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
1691930|NCT00498433|4134046|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
1691931|NCT00498368|4134091|P2|NOT COMPLETED|Overall Study||2
1691932|NCT00498368|4134092|P1|NOT COMPLETED|Overall Study||3
1691933|NCT00498368|4134091|P2|COMPLETED|Overall Study||15
1691934|NCT00498368|4134092|P1|COMPLETED|Overall Study||14
1691935|NCT00498368|4134091|P2|STARTED|Overall Study||17
1691936|NCT00498368|4134092|P1|STARTED|Overall Study||17
1691937|NCT00498355|4134104|P1|NOT COMPLETED|Overall Study||1
1691938|NCT00498355|4134104|P1|COMPLETED|Overall Study||6
1691939|NCT00498355|4134104|P1|STARTED|Overall Study||7
1691940|NCT00498186|4134112|P1|NOT COMPLETED|Overall Study||173
1691941|NCT00498186|4134112|P1|COMPLETED|Overall Study||122
1691942|NCT00498186|4134112|P1|STARTED|Overall Study||295
1691943|NCT00498173|4134119|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1691944|NCT00498173|4134120|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1691945|NCT00498173|4134121|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1691946|NCT00498173|4134119|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
1691947|NCT00498173|4134120|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1691948|NCT00498173|4134121|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1691949|NCT00498173|4134119|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
1691950|NCT00498173|4134120|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1691951|NCT00498173|4134121|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
1691952|NCT00498173|4134119|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
1691953|NCT00498173|4134120|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
1691954|NCT00498173|4134121|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
1691955|NCT00498173|4134119|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
1691956|NCT00498173|4134120|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
1691957|NCT00498173|4134121|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
1691958|NCT00498173|4134119|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
1691959|NCT00498173|4134120|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
1691960|NCT00498173|4134121|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
1691961|NCT00497874|4134151|P2|NOT COMPLETED|Overall Study||116
1691962|NCT00497874|4134152|P1|NOT COMPLETED|Overall Study||147
1691963|NCT00497874|4134151|P2|COMPLETED|Overall Study||343
1691964|NCT00497874|4134152|P1|COMPLETED|Overall Study||296
1691965|NCT00497874|4134151|P2|STARTED|Overall Study||459
1691966|NCT00497874|4134152|P1|STARTED|Overall Study||443
1691967|NCT00497796|4134170|P2|NOT COMPLETED|Overall Study||59
1691968|NCT00497796|4134171|P1|NOT COMPLETED|Overall Study||85
1691969|NCT00497796|4134170|P2|COMPLETED|Overall Study||101
1691970|NCT00497796|4134171|P1|COMPLETED|Overall Study||62
1691971|NCT00497796|4134170|P2|STARTED|Overall Study||160
1691972|NCT00497796|4134171|P1|STARTED|Overall Study||147
1691973|NCT00497770|4134203|P4|NOT COMPLETED|Overall Study||0
1691974|NCT00497770|4134204|P3|NOT COMPLETED|Overall Study||0
1691975|NCT00497770|4134205|P2|NOT COMPLETED|Overall Study||0
1691976|NCT00497770|4134206|P1|NOT COMPLETED|Overall Study||0
1691977|NCT00497770|4134203|P4|COMPLETED|Overall Study||28
1691978|NCT00497770|4134204|P3|COMPLETED|Overall Study||37
1691979|NCT00497770|4134205|P2|COMPLETED|Overall Study||65
1691980|NCT00497770|4134206|P1|COMPLETED|Overall Study||304
1691981|NCT00497770|4134203|P4|STARTED|Overall Study||28
1691982|NCT00497770|4134204|P3|STARTED|Overall Study||37
1691983|NCT00497770|4134205|P2|STARTED|Overall Study||65
1691984|NCT00497770|4134206|P1|STARTED|Overall Study||304
1691985|NCT00497198|4134258|P2|NOT COMPLETED|Overall Study||5
1691986|NCT00497198|4134259|P1|NOT COMPLETED|Overall Study||5
1691987|NCT00497198|4134258|P2|COMPLETED|Overall Study||86
1691988|NCT00497198|4134259|P1|COMPLETED|Overall Study||87
1691989|NCT00497198|4134258|P2|STARTED|Overall Study||91
1691990|NCT00497198|4134259|P1|STARTED|Overall Study||92
1691991|NCT00497146|4134275|P2|NOT COMPLETED|Long-term Follow-up Period||6
1691992|NCT00497146|4134276|P1|NOT COMPLETED|Long-term Follow-up Period||15
1691993|NCT00497146|4134275|P2|COMPLETED|Long-term Follow-up Period||66
1691994|NCT00497146|4134276|P1|COMPLETED|Long-term Follow-up Period||50
1691995|NCT00497146|4134275|P2|STARTED|Long-term Follow-up Period||72
1691996|NCT00497146|4134276|P1|STARTED|Long-term Follow-up Period||65
1691997|NCT00497146|4134275|P2|NOT COMPLETED|Treatment Period||21
1691998|NCT00497146|4134276|P1|NOT COMPLETED|Treatment Period||27
1691999|NCT00497146|4134275|P2|COMPLETED|Treatment Period||91
1692000|NCT00497146|4134276|P1|COMPLETED|Treatment Period||88
1692001|NCT00497146|4134275|P2|STARTED|Treatment Period||112
1692002|NCT00497146|4134276|P1|STARTED|Treatment Period||115
1692003|NCT00497081|4134318|P2|NOT COMPLETED|Overall Study||2
1692004|NCT00497081|4134319|P1|NOT COMPLETED|Overall Study||2
1692005|NCT00497081|4134318|P2|COMPLETED|Overall Study||28
1692006|NCT00497081|4134319|P1|COMPLETED|Overall Study||28
1692007|NCT00497081|4134318|P2|STARTED|Overall Study||30
1692008|NCT00497081|4134319|P1|STARTED|Overall Study||30
1692009|NCT00497055|4134331|P2|NOT COMPLETED|Overall Study||5
1692010|NCT00497055|4134332|P1|NOT COMPLETED|Overall Study||10
1692011|NCT00497055|4134331|P2|COMPLETED|Overall Study||40
1692012|NCT00497055|4134332|P1|COMPLETED|Overall Study||35
1692013|NCT00497055|4134331|P2|STARTED|Overall Study||45
1692014|NCT00497055|4134332|P1|STARTED|Overall Study||45
1692015|NCT00496964|4134344|P2|NOT COMPLETED|Overall Study||1
1692016|NCT00496964|4134345|P1|NOT COMPLETED|Overall Study||0
1692017|NCT00496964|4134344|P2|COMPLETED|Overall Study||3
1692018|NCT00496964|4134345|P1|COMPLETED|Overall Study||1
1692019|NCT00496964|4134344|P2|STARTED|Overall Study||4
1692020|NCT00496964|4134345|P1|STARTED|Overall Study||1
1692021|NCT00496873|4134363|P1|NOT COMPLETED|Overall Study||7
1692022|NCT00496873|4134363|P1|COMPLETED|Overall Study||78
1692023|NCT00496873|4134363|P1|STARTED|Overall Study||85
1692024|NCT00496860|4134372|P3|NOT COMPLETED|Overall Study||0
1692025|NCT00496860|4134373|P2|NOT COMPLETED|Overall Study||1
1692026|NCT00496860|4134374|P1|NOT COMPLETED|Overall Study||1
1692027|NCT00496860|4134372|P3|COMPLETED|Overall Study||6
1692028|NCT00496860|4134373|P2|COMPLETED|Overall Study||15
1692029|NCT00496860|4134374|P1|COMPLETED|Overall Study||3
1692030|NCT00496860|4134372|P3|STARTED|Overall Study||6
1692031|NCT00496860|4134373|P2|STARTED|Overall Study||16
1692032|NCT00496860|4134374|P1|STARTED|Overall Study||4
1692033|NCT00496834|4134396|P2|NOT COMPLETED|Overall Study||13
1692034|NCT00496834|4134397|P1|NOT COMPLETED|Overall Study||18
1692035|NCT00496834|4134396|P2|COMPLETED|Overall Study||87
1692036|NCT00496834|4134397|P1|COMPLETED|Overall Study||83
1692037|NCT00496834|4134396|P2|STARTED|Overall Study||100
1692038|NCT00496834|4134397|P1|STARTED|Overall Study||101
1692039|NCT00496808|4134409|P1|NOT COMPLETED|Overall Study||0
1692040|NCT00496808|4134409|P1|COMPLETED|Overall Study||69
1692041|NCT00496808|4134409|P1|STARTED|Overall Study||69
1692042|NCT00496782|4134416|P2|NOT COMPLETED|Overall Study||2
1692043|NCT00496782|4134417|P1|NOT COMPLETED|Overall Study||1
1692044|NCT00496782|4134416|P2|COMPLETED|Overall Study||5
1692045|NCT00496782|4134417|P1|COMPLETED|Overall Study||8
1692046|NCT00496782|4134416|P2|STARTED|Overall Study||7
1692047|NCT00496782|4134417|P1|STARTED|Overall Study||9
1692048|NCT00496769|4134451|P3|NOT COMPLETED|Open Label||1011
1692049|NCT00496769|4134452|P2|NOT COMPLETED|Open Label||0
1692050|NCT00496769|4134453|P1|NOT COMPLETED|Open Label||0
1692051|NCT00496769|4134451|P3|COMPLETED|Open Label||2264
1692052|NCT00496769|4134452|P2|COMPLETED|Open Label||0
1692053|NCT00496769|4134453|P1|COMPLETED|Open Label||0
1692054|NCT00496769|4134451|P3|STARTED|Open Label||3275
1692055|NCT00496769|4134452|P2|STARTED|Open Label||0
1692056|NCT00496769|4134453|P1|STARTED|Open Label||0
1692057|NCT00496769|4134451|P3|NOT COMPLETED|Double Blind||0
1692058|NCT00496769|4134452|P2|NOT COMPLETED|Double Blind||649
1692059|NCT00496769|4134453|P1|NOT COMPLETED|Double Blind||558
1692060|NCT00496769|4134451|P3|COMPLETED|Double Blind||0
1692061|NCT00496769|4134452|P2|COMPLETED|Double Blind||2142
1692062|NCT00496769|4134453|P1|COMPLETED|Double Blind||2249
1692063|NCT00496769|4134451|P3|Received Treatment|Double Blind||0
1692064|NCT00496769|4134452|P2|Received Treatment|Double Blind||2708
1692065|NCT00496769|4134453|P1|Received Treatment|Double Blind||2798
1692066|NCT00496769|4134451|P3|STARTED|Double Blind||0
1692067|NCT00496769|4134452|P2|STARTED|Double Blind|Randomized|2791
1692068|NCT00496769|4134453|P1|STARTED|Double Blind|Randomized|2807
1692069|NCT00496730|4134478|P2|NOT COMPLETED|Overall Study||5
1692070|NCT00496730|4134479|P1|NOT COMPLETED|Overall Study||6
1692071|NCT00496730|4134478|P2|COMPLETED|Overall Study||121
1692072|NCT00496730|4134479|P1|COMPLETED|Overall Study||124
1692073|NCT00496730|4134478|P2|STARTED|Overall Study||126
1692074|NCT00496730|4134479|P1|STARTED|Overall Study||130
1692075|NCT00496626|4134491|P2|NOT COMPLETED|Overall Study||6
1692076|NCT00496626|4134492|P1|NOT COMPLETED|Overall Study||6
1692077|NCT00496626|4134491|P2|COMPLETED|Overall Study||292
1692078|NCT00496626|4134492|P1|COMPLETED|Overall Study||296
1692079|NCT00496626|4134491|P2|STARTED|Overall Study||298
1692080|NCT00496626|4134492|P1|STARTED|Overall Study||302
1692081|NCT00496587|4134504|P1|NOT COMPLETED|Overall Study||31
1692082|NCT00496587|4134504|P1|COMPLETED|Overall Study||3
1692083|NCT00496587|4134504|P1|STARTED|Overall Study||34
1692084|NCT00496483|4134510|P1|NOT COMPLETED|Overall Study||12
1692085|NCT00496483|4134510|P1|COMPLETED|Overall Study||48
1692086|NCT00496483|4134510|P1|Dosed|Overall Study||51
1692087|NCT00496483|4134510|P1|STARTED|Overall Study||60
1692088|NCT00496470|4134527|P2|NOT COMPLETED|Overall Study||29
1692089|NCT00496470|4134528|P1|NOT COMPLETED|Overall Study||26
1692090|NCT00496470|4134527|P2|COMPLETED|Overall Study||302
1692091|NCT00496470|4134528|P1|COMPLETED|Overall Study||303
1692092|NCT00496470|4134527|P2|Received Study Medication|Overall Study||330
1692093|NCT00496470|4134528|P1|Received Study Medication|Overall Study||329
1692094|NCT00496470|4134527|P2|STARTED|Overall Study||331
1692095|NCT00496470|4134528|P1|STARTED|Overall Study||329
1692096|NCT00496379|4134606|P1|NOT COMPLETED|Overall Study||0
1692097|NCT00496379|4134606|P1|COMPLETED|Overall Study||15
1692098|NCT00496379|4134606|P1|STARTED|Overall Study||15
1692099|NCT00496366|4134614|P1|NOT COMPLETED|Overall Study||1
1692100|NCT00496366|4134614|P1|COMPLETED|Overall Study||10
1692101|NCT00496366|4134614|P1|STARTED|Overall Study||11
1692102|NCT00496340|4134619|P1|NOT COMPLETED|Overall Study||0
1692103|NCT00496340|4134619|P1|COMPLETED|Overall Study||42
1692104|NCT00496340|4134619|P1|STARTED|Overall Study||42
1692105|NCT00496262|4134632|P1|NOT COMPLETED|Overall Study||0
1692106|NCT00496262|4134632|P1|COMPLETED|Overall Study||15
1692107|NCT00496262|4134632|P1|STARTED|Overall Study||15
1692108|NCT00496197|4134645|P1|NOT COMPLETED|Overall Study||122
1692109|NCT00496197|4134645|P1|COMPLETED|Overall Study||160
1692110|NCT00496197|4134645|P1|STARTED|Overall Study||282
1692111|NCT00496080|4134672|P1|NOT COMPLETED|Overall Study||27
1692112|NCT00496080|4134672|P1|COMPLETED|Overall Study||60
1692113|NCT00496080|4134672|P1|STARTED|Overall Study||87
1692114|NCT00496054|4134682|P1|NOT COMPLETED|Overall Study||8
1692115|NCT00496054|4134682|P1|COMPLETED|Overall Study||102
1692116|NCT00496054|4134682|P1|STARTED|Overall Study||110
1692117|NCT00495820|4134711|P2|NOT COMPLETED|Overall Study||1
1692118|NCT00495820|4134712|P1|NOT COMPLETED|Overall Study||1
1692119|NCT00495820|4134711|P2|COMPLETED|Overall Study||29
1692120|NCT00495820|4134712|P1|COMPLETED|Overall Study||29
1692121|NCT00495820|4134711|P2|STARTED|Overall Study||30
1692122|NCT00495820|4134712|P1|STARTED|Overall Study||30
1692123|NCT00495794|4134724|P2|NOT COMPLETED|Overall Study||0
1692124|NCT00495794|4134725|P1|NOT COMPLETED|Overall Study||522
1692125|NCT00495794|4134724|P2|COMPLETED|Overall Study||2303
1692126|NCT00495794|4134725|P1|COMPLETED|Overall Study||1797
1692127|NCT00495794|4134724|P2|STARTED|Overall Study||2303
1692128|NCT00495794|4134725|P1|STARTED|Overall Study||2319
1692129|NCT00495755|4134735|P1|NOT COMPLETED|Overall Study||3
1692130|NCT00495755|4134735|P1|COMPLETED|Overall Study||10
1692131|NCT00495755|4134735|P1|STARTED|Overall Study||13
1692132|NCT00495677|4134747|P7|NOT COMPLETED|Stage 2 (25 Days)||0
1692133|NCT00495677|4134748|P6|NOT COMPLETED|Stage 2 (25 Days)||0
1692134|NCT00495677|4134749|P5|NOT COMPLETED|Stage 2 (25 Days)||0
1692135|NCT00495677|4134750|P4|NOT COMPLETED|Stage 2 (25 Days)||0
1692136|NCT00495677|4134751|P3|NOT COMPLETED|Stage 2 (25 Days)||0
1692137|NCT00495677|4134752|P2|NOT COMPLETED|Stage 2 (25 Days)||0
1692138|NCT00495677|4134753|P1|NOT COMPLETED|Stage 2 (25 Days)||0
1692139|NCT00495677|4134747|P7|COMPLETED|Stage 2 (25 Days)||7
1692140|NCT00495677|4134748|P6|COMPLETED|Stage 2 (25 Days)||8
1692141|NCT00495677|4134749|P5|COMPLETED|Stage 2 (25 Days)||8
1692142|NCT00495677|4134750|P4|COMPLETED|Stage 2 (25 Days)||0
1692143|NCT00495677|4134751|P3|COMPLETED|Stage 2 (25 Days)||0
1692144|NCT00495677|4134752|P2|COMPLETED|Stage 2 (25 Days)||0
1692145|NCT00495677|4134753|P1|COMPLETED|Stage 2 (25 Days)||0
1692146|NCT00495677|4134747|P7|STARTED|Stage 2 (25 Days)||7
1692147|NCT00495677|4134748|P6|STARTED|Stage 2 (25 Days)||8
1692148|NCT00495677|4134749|P5|STARTED|Stage 2 (25 Days)||8
1692149|NCT00495677|4134750|P4|STARTED|Stage 2 (25 Days)||0
1692150|NCT00495677|4134751|P3|STARTED|Stage 2 (25 Days)||0
1692151|NCT00495677|4134752|P2|STARTED|Stage 2 (25 Days)||0
1692152|NCT00495677|4134753|P1|STARTED|Stage 2 (25 Days)||0
1692153|NCT00495677|4134747|P7|NOT COMPLETED|Stage 1 (25 Days)||0
1692154|NCT00495677|4134748|P6|NOT COMPLETED|Stage 1 (25 Days)||0
1692155|NCT00495677|4134749|P5|NOT COMPLETED|Stage 1 (25 Days)||0
1692156|NCT00495677|4134750|P4|NOT COMPLETED|Stage 1 (25 Days)||0
1692157|NCT00495677|4134751|P3|NOT COMPLETED|Stage 1 (25 Days)||1
1692158|NCT00495677|4134752|P2|NOT COMPLETED|Stage 1 (25 Days)||0
1692159|NCT00495677|4134753|P1|NOT COMPLETED|Stage 1 (25 Days)||0
1692160|NCT00495677|4134747|P7|COMPLETED|Stage 1 (25 Days)||0
1692161|NCT00495677|4134748|P6|COMPLETED|Stage 1 (25 Days)||0
1692162|NCT00495677|4134749|P5|COMPLETED|Stage 1 (25 Days)||0
1692163|NCT00495677|4134750|P4|COMPLETED|Stage 1 (25 Days)||6
1692164|NCT00495677|4134751|P3|COMPLETED|Stage 1 (25 Days)||5
1692165|NCT00495677|4134752|P2|COMPLETED|Stage 1 (25 Days)||6
1692166|NCT00495677|4134753|P1|COMPLETED|Stage 1 (25 Days)||2
1692167|NCT00495677|4134747|P7|STARTED|Stage 1 (25 Days)||0
1692168|NCT00495677|4134748|P6|STARTED|Stage 1 (25 Days)||0
1692169|NCT00495677|4134749|P5|STARTED|Stage 1 (25 Days)||0
1692170|NCT00495677|4134750|P4|STARTED|Stage 1 (25 Days)||6
1692171|NCT00495677|4134751|P3|STARTED|Stage 1 (25 Days)||6
1692172|NCT00495677|4134752|P2|STARTED|Stage 1 (25 Days)||6
1692173|NCT00495677|4134753|P1|STARTED|Stage 1 (25 Days)||2
1692174|NCT00495625|4134808|P1|NOT COMPLETED|Overall Study||10
1692175|NCT00495625|4134808|P1|COMPLETED|Overall Study||23
1692176|NCT00495625|4134808|P1|STARTED|Overall Study||33
1692177|NCT00495612|4134819|P2|NOT COMPLETED|Overall Study||0
1692178|NCT00495612|4134820|P1|NOT COMPLETED|Overall Study||4
1692179|NCT00495612|4134819|P2|COMPLETED|Overall Study||33
1692180|NCT00495612|4134820|P1|COMPLETED|Overall Study||32
1692181|NCT00495612|4134819|P2|STARTED|Overall Study||33
1692182|NCT00495612|4134820|P1|STARTED|Overall Study||36
1692183|NCT00495586|4134838|P2|NOT COMPLETED|Overall Study||4
1692184|NCT00495586|4134839|P1|NOT COMPLETED|Overall Study||4
1692185|NCT00495586|4134838|P2|COMPLETED|Overall Study||158
1692186|NCT00495586|4134839|P1|COMPLETED|Overall Study||152
1692187|NCT00495586|4134838|P2|STARTED|Overall Study||162
1692188|NCT00495586|4134839|P1|STARTED|Overall Study||156
1692189|NCT00495521|4134849|P2|NOT COMPLETED|Overall Study||1
1692190|NCT00495521|4134850|P1|NOT COMPLETED|Overall Study||0
1692191|NCT00495521|4134849|P2|COMPLETED|Overall Study||0
1692192|NCT00495521|4134850|P1|COMPLETED|Overall Study||1
1692193|NCT00495521|4134849|P2|STARTED|Overall Study||1
1692194|NCT00495521|4134850|P1|STARTED|Overall Study||1
1692195|NCT00495495|4134880|P1|NOT COMPLETED|Overall Study||99
1692196|NCT00495495|4134880|P1|COMPLETED|Overall Study||295
1692197|NCT00495495|4134880|P1|STARTED|Overall Study||394
1692198|NCT00495469|4134900|P7|NOT COMPLETED|Overall Study||5
1692199|NCT00495469|4134901|P6|NOT COMPLETED|Overall Study||5
1692200|NCT00495469|4134902|P5|NOT COMPLETED|Overall Study||5
1692201|NCT00495469|4134903|P4|NOT COMPLETED|Overall Study||4
1692202|NCT00495469|4134904|P3|NOT COMPLETED|Overall Study||7
1692203|NCT00495469|4134905|P2|NOT COMPLETED|Overall Study||7
1692204|NCT00495469|4134906|P1|NOT COMPLETED|Overall Study||6
1692205|NCT00495469|4134900|P7|COMPLETED|Overall Study||30
1692206|NCT00495469|4134901|P6|COMPLETED|Overall Study||31
1692207|NCT00495469|4134902|P5|COMPLETED|Overall Study||31
1692208|NCT00495469|4134903|P4|COMPLETED|Overall Study||32
1692209|NCT00495469|4134904|P3|COMPLETED|Overall Study||27
1692210|NCT00495469|4134905|P2|COMPLETED|Overall Study||30
1692211|NCT00495469|4134906|P1|COMPLETED|Overall Study||30
1692212|NCT00495469|4134900|P7|STARTED|Overall Study||35
1692213|NCT00495469|4134901|P6|STARTED|Overall Study||36
1692214|NCT00495469|4134902|P5|STARTED|Overall Study||36
1692215|NCT00495469|4134903|P4|STARTED|Overall Study||36
1692216|NCT00495469|4134904|P3|STARTED|Overall Study||34
1692217|NCT00495469|4134905|P2|STARTED|Overall Study||37
1692218|NCT00495469|4134906|P1|STARTED|Overall Study||36
1692219|NCT00495391|4135050|P2|NOT COMPLETED|Overall Study||21
1692220|NCT00495391|4135051|P1|NOT COMPLETED|Overall Study||36
1692221|NCT00495391|4135050|P2|COMPLETED|Overall Study||1
1692222|NCT00495391|4135051|P1|COMPLETED|Overall Study||6
1692223|NCT00495391|4135050|P2|From Baseline to End of Follow up|Overall Study||1
1692224|NCT00495391|4135051|P1|From Baseline to End of Follow up|Overall Study||6
1692225|NCT00495391|4135050|P2|From Baseline to End of Treatment|Overall Study||1
1692226|NCT00495391|4135051|P1|From Baseline to End of Treatment|Overall Study||6
1692227|NCT00495391|4135050|P2|From Baseline to Week 16|Overall Study||11
1692228|NCT00495391|4135051|P1|From Baseline to Week 16|Overall Study||24
1692229|NCT00495391|4135050|P2|From Baseline to Week 8|Overall Study||20
1692230|NCT00495391|4135051|P1|From Baseline to Week 8|Overall Study||31
1692231|NCT00495391|4135050|P2|STARTED|Overall Study||22
1692232|NCT00495391|4135051|P1|STARTED|Overall Study||42
1692233|NCT00495222|4135071|P1|NOT COMPLETED|Overall Study||0
1692234|NCT00495222|4135071|P1|COMPLETED|Overall Study||9
1692235|NCT00495222|4135071|P1|STARTED|Overall Study||9
1692236|NCT00495157|4135077|P3|NOT COMPLETED|Overall Study||13
1692237|NCT00495157|4135078|P2|NOT COMPLETED|Overall Study||23
1692238|NCT00495157|4135079|P1|NOT COMPLETED|Overall Study||16
1692239|NCT00495157|4135077|P3|COMPLETED|Overall Study||101
1692240|NCT00495157|4135078|P2|COMPLETED|Overall Study||92
1692241|NCT00495157|4135079|P1|COMPLETED|Overall Study||97
1692242|NCT00495157|4135077|P3|STARTED|Overall Study||114
1692243|NCT00495157|4135078|P2|STARTED|Overall Study||115
1692244|NCT00495157|4135079|P1|STARTED|Overall Study||113
1692245|NCT00495131|4135089|P2|NOT COMPLETED|Overall Study||6
1692246|NCT00495131|4135090|P1|NOT COMPLETED|Overall Study||7
1692247|NCT00495131|4135089|P2|COMPLETED|Overall Study||148
1692248|NCT00495131|4135090|P1|COMPLETED|Overall Study||147
1692249|NCT00495131|4135089|P2|STARTED|Overall Study||154
1692250|NCT00495131|4135090|P1|STARTED|Overall Study||154
1692251|NCT00495079|4135100|P1|NOT COMPLETED|Overall Study||0
1692252|NCT00495079|4135100|P1|COMPLETED|Overall Study||65
1692253|NCT00495079|4135100|P1|STARTED|Overall Study||65
1692254|NCT00494975|4135109|P2|NOT COMPLETED|Overall Study||1
1692255|NCT00494975|4135110|P1|NOT COMPLETED|Overall Study||2
1692256|NCT00494975|4135109|P2|COMPLETED|Overall Study||10
1692257|NCT00494975|4135110|P1|COMPLETED|Overall Study||8
1692258|NCT00494975|4135109|P2|STARTED|Overall Study||11
1692259|NCT00494975|4135110|P1|STARTED|Overall Study||10
1692260|NCT00494871|4135118|P2|NOT COMPLETED|Follow-up (FU) Period||23
1692261|NCT00494871|4135119|P1|NOT COMPLETED|Follow-up (FU) Period||29
1692262|NCT00494871|4135118|P2|COMPLETED|Follow-up (FU) Period||616
1692263|NCT00494871|4135119|P1|COMPLETED|Follow-up (FU) Period||610
1692264|NCT00494871|4135118|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
1692265|NCT00494871|4135119|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
1692266|NCT00494871|4135118|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
1692267|NCT00494871|4135119|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
1692268|NCT00494871|4135118|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
1692269|NCT00494871|4135119|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
1692270|NCT00494871|4135118|P2|COMPLETED|Double-blind (DB) Treatment Period||468
1692271|NCT00494871|4135119|P1|COMPLETED|Double-blind (DB) Treatment Period||480
1692272|NCT00494871|4135118|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
1692273|NCT00494871|4135119|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
1692274|NCT00494871|4135118|P2|STARTED|Double-blind (DB) Treatment Period||640
1692275|NCT00494871|4135119|P1|STARTED|Double-blind (DB) Treatment Period||640
1692276|NCT00494806|4135151|P2|NOT COMPLETED|Overall Study||0
1692277|NCT00494806|4135152|P1|NOT COMPLETED|Overall Study||0
1692278|NCT00494806|4135151|P2|COMPLETED|Overall Study||32
1692279|NCT00494806|4135152|P1|COMPLETED|Overall Study||34
1692280|NCT00494806|4135151|P2|STARTED|Overall Study||32
1692281|NCT00494806|4135152|P1|STARTED|Overall Study||34
1692282|NCT00494780|4135160|P2|NOT COMPLETED|Overall Study||13
1692283|NCT00494780|4135161|P1|NOT COMPLETED|Overall Study||11
1692284|NCT00494780|4135160|P2|COMPLETED|Overall Study||17
1692285|NCT00494780|4135161|P1|COMPLETED|Overall Study||18
1692286|NCT00494780|4135160|P2|STARTED|Overall Study||30
1692287|NCT00494780|4135161|P1|STARTED|Overall Study||29
1692288|NCT00494676|4135199|P2|NOT COMPLETED|Second Intervention||1
1692289|NCT00494676|4135200|P1|NOT COMPLETED|Second Intervention||1
1692290|NCT00494676|4135199|P2|COMPLETED|Second Intervention||28
1692291|NCT00494676|4135200|P1|COMPLETED|Second Intervention||33
1692292|NCT00494676|4135199|P2|STARTED|Second Intervention||29
1692293|NCT00494676|4135200|P1|STARTED|Second Intervention||34
1692294|NCT00494676|4135199|P2|NOT COMPLETED|First Intervention||3
1692295|NCT00494676|4135200|P1|NOT COMPLETED|First Intervention||1
1692296|NCT00494676|4135199|P2|COMPLETED|First Intervention||29
1692297|NCT00494676|4135200|P1|COMPLETED|First Intervention||34
1692298|NCT00494676|4135199|P2|STARTED|First Intervention||32
1692299|NCT00494676|4135200|P1|STARTED|First Intervention||35
1692300|NCT00494676|4135199|P2|NOT COMPLETED|Allocation||4
1692301|NCT00494676|4135200|P1|NOT COMPLETED|Allocation||2
1692302|NCT00494676|4135199|P2|COMPLETED|Allocation||32
1692303|NCT00494676|4135200|P1|COMPLETED|Allocation||35
1692304|NCT00494676|4135199|P2|STARTED|Allocation||36
1692305|NCT00494676|4135200|P1|STARTED|Allocation||37
1692306|NCT00494585|4135207|P1|NOT COMPLETED|Overall Study||0
1692307|NCT00494585|4135207|P1|COMPLETED|Overall Study||22
1692308|NCT00494585|4135207|P1|STARTED|Overall Study||22
1692309|NCT00494507|4135215|P4|NOT COMPLETED|Open-Label Phase||5
1692310|NCT00494507|4135216|P3|NOT COMPLETED|Open-Label Phase||5
1692311|NCT00494507|4135217|P2|NOT COMPLETED|Open-Label Phase||1
1692312|NCT00494507|4135218|P1|NOT COMPLETED|Open-Label Phase||0
1692313|NCT00494507|4135215|P4|COMPLETED|Open-Label Phase||14
1692314|NCT00494507|4135216|P3|COMPLETED|Open-Label Phase||17
1692315|NCT00494507|4135217|P2|COMPLETED|Open-Label Phase||7
1692316|NCT00494507|4135218|P1|COMPLETED|Open-Label Phase||9
1692317|NCT00494507|4135215|P4|STARTED|Open-Label Phase||19
1692318|NCT00494507|4135216|P3|STARTED|Open-Label Phase||22
1692319|NCT00494507|4135217|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
1692320|NCT00494507|4135218|P1|STARTED|Open-Label Phase||9
1692321|NCT00494507|4135215|P4|NOT COMPLETED|Double-Blind Phase||1
1692322|NCT00494507|4135216|P3|NOT COMPLETED|Double-Blind Phase||2
1692323|NCT00494507|4135217|P2|NOT COMPLETED|Double-Blind Phase||0
1692324|NCT00494507|4135218|P1|NOT COMPLETED|Double-Blind Phase||3
1692325|NCT00494507|4135215|P4|COMPLETED|Double-Blind Phase||19
1692326|NCT00494507|4135216|P3|COMPLETED|Double-Blind Phase||22
1692327|NCT00494507|4135217|P2|COMPLETED|Double-Blind Phase||9
1692328|NCT00494507|4135218|P1|COMPLETED|Double-Blind Phase||9
1692329|NCT00494507|4135215|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
1692330|NCT00494507|4135216|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
1692331|NCT00494507|4135217|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
1692332|NCT00494507|4135218|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
1692333|NCT00494507|4135215|P4|STARTED|Double-Blind Phase||20
1692334|NCT00494507|4135216|P3|STARTED|Double-Blind Phase||24
1692335|NCT00494507|4135217|P2|STARTED|Double-Blind Phase||9
1692336|NCT00494507|4135218|P1|STARTED|Double-Blind Phase||12
1692337|NCT00494494|4135268|P2|NOT COMPLETED|Overall Study||0
1692338|NCT00494494|4135269|P1|NOT COMPLETED|Overall Study||0
1692339|NCT00494494|4135268|P2|COMPLETED|Overall Study||39
1692340|NCT00494494|4135269|P1|COMPLETED|Overall Study||40
1692341|NCT00494494|4135268|P2|STARTED|Overall Study||39
1692342|NCT00494494|4135269|P1|STARTED|Overall Study||40
1692343|NCT00494481|4135285|P2|NOT COMPLETED|Overall Study||24
1692344|NCT00494481|4135286|P1|NOT COMPLETED|Overall Study||29
1692345|NCT00494481|4135285|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
1692346|NCT00494481|4135286|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
1692347|NCT00494481|4135285|P2|STARTED|Overall Study|randomised patients|29
1692348|NCT00494481|4135286|P1|STARTED|Overall Study|randomised patients|35
1692349|NCT00494442|4135294|P2|NOT COMPLETED|Overall Study||16
1692350|NCT00494442|4135295|P1|NOT COMPLETED|Overall Study||17
1692351|NCT00494442|4135294|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
1692352|NCT00494442|4135295|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
1692353|NCT00494442|4135294|P2|STARTED|Overall Study|Patients received treatment|33
1692354|NCT00494442|4135295|P1|STARTED|Overall Study|Patients received treatment|24
1692355|NCT00494299|4135311|P2|NOT COMPLETED|Overall Study||229
1692356|NCT00494299|4135312|P1|NOT COMPLETED|Overall Study||229
1692357|NCT00494299|4135311|P2|COMPLETED|Overall Study||0
1692358|NCT00494299|4135312|P1|COMPLETED|Overall Study||0
1692359|NCT00494299|4135311|P2|Received Treatment|Overall Study||227
1692360|NCT00494299|4135312|P1|Received Treatment|Overall Study||229
1692361|NCT00494299|4135311|P2|STARTED|Overall Study||229
1692362|NCT00494299|4135312|P1|STARTED|Overall Study||229
1692363|NCT00494234|4135324|P2|NOT COMPLETED|Overall Study||10
1692364|NCT00494234|4135325|P1|NOT COMPLETED|Overall Study||15
1692365|NCT00494234|4135324|P2|COMPLETED|Overall Study||17
1692366|NCT00494234|4135325|P1|COMPLETED|Overall Study||12
1692367|NCT00494234|4135324|P2|STARTED|Overall Study||27
1692368|NCT00494234|4135325|P1|STARTED|Overall Study||27
1692369|NCT00494221|4135344|P3|NOT COMPLETED|Overall Study||14
1692370|NCT00494221|4135345|P2|NOT COMPLETED|Overall Study||11
1692371|NCT00494221|4135346|P1|NOT COMPLETED|Overall Study||16
1692372|NCT00494221|4135344|P3|COMPLETED|Overall Study||44
1692373|NCT00494221|4135345|P2|COMPLETED|Overall Study||45
1692374|NCT00494221|4135346|P1|COMPLETED|Overall Study||42
1692375|NCT00494221|4135344|P3|STARTED|Overall Study||58
1692376|NCT00494221|4135345|P2|STARTED|Overall Study||56
1692377|NCT00494221|4135346|P1|STARTED|Overall Study||58
1692378|NCT00494143|4135366|P6|NOT COMPLETED|Overall Study||0
1692379|NCT00494143|4135367|P5|NOT COMPLETED|Overall Study||0
1692380|NCT00494143|4135368|P4|NOT COMPLETED|Overall Study||0
1692381|NCT00494143|4135369|P3|NOT COMPLETED|Overall Study||0
1692382|NCT00494143|4135370|P2|NOT COMPLETED|Overall Study||0
1692383|NCT00494143|4135371|P1|NOT COMPLETED|Overall Study||0
1692384|NCT00494143|4135366|P6|COMPLETED|Overall Study||0
1692385|NCT00494143|4135367|P5|COMPLETED|Overall Study||1
1692386|NCT00494143|4135368|P4|COMPLETED|Overall Study||0
1692387|NCT00494143|4135369|P3|COMPLETED|Overall Study||3
1692388|NCT00494143|4135370|P2|COMPLETED|Overall Study||2
1692389|NCT00494143|4135371|P1|COMPLETED|Overall Study||1
1692390|NCT00494143|4135366|P6|STARTED|Overall Study||0
1692391|NCT00494143|4135367|P5|STARTED|Overall Study||1
1692392|NCT00494143|4135368|P4|STARTED|Overall Study||0
1692393|NCT00494143|4135369|P3|STARTED|Overall Study||3
1692394|NCT00494143|4135370|P2|STARTED|Overall Study||2
1692395|NCT00494143|4135371|P1|STARTED|Overall Study||1
1692396|NCT00494091|4135387|P2|NOT COMPLETED|Overall Study||76
1692397|NCT00494091|4135388|P1|NOT COMPLETED|Overall Study||6
1692398|NCT00494091|4135387|P2|COMPLETED|Overall Study||0
1692399|NCT00494091|4135388|P1|COMPLETED|Overall Study||0
1692400|NCT00494091|4135387|P2|STARTED|Overall Study||76
1692401|NCT00494091|4135388|P1|STARTED|Overall Study||6
1692402|NCT00494026|4135410|P1|NOT COMPLETED|Overall Study||4
1692403|NCT00494026|4135410|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
1692404|NCT00494026|4135410|P1|STARTED|Overall Study||4
1692405|NCT00494013|4135420|P2|NOT COMPLETED|Overall Study||36
1692406|NCT00494013|4135421|P1|NOT COMPLETED|Overall Study||30
1692407|NCT00494013|4135420|P2|COMPLETED|Overall Study||183
1692408|NCT00494013|4135421|P1|COMPLETED|Overall Study||193
1692409|NCT00494013|4135420|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
1692410|NCT00494013|4135421|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
1692411|NCT00494013|4135420|P2|STARTED|Overall Study||219
1692412|NCT00494013|4135421|P1|STARTED|Overall Study||223
1692413|NCT00493974|4135451|P2|NOT COMPLETED|Overall Study||14
1692414|NCT00493974|4135452|P1|NOT COMPLETED|Overall Study||13
1692415|NCT00493974|4135451|P2|COMPLETED|Overall Study||45
1692416|NCT00493974|4135452|P1|COMPLETED|Overall Study||47
1692417|NCT00493974|4135451|P2|STARTED|Overall Study||59
1692418|NCT00493974|4135452|P1|STARTED|Overall Study||60
1692419|NCT00493805|4135470|P2|NOT COMPLETED|Overall Study||0
1692420|NCT00493805|4135471|P1|NOT COMPLETED|Overall Study||0
1692421|NCT00493805|4135470|P2|COMPLETED|Overall Study||42
1692422|NCT00493805|4135471|P1|COMPLETED|Overall Study||17
1692423|NCT00493805|4135470|P2|STARTED|Overall Study||42
1692424|NCT00493805|4135471|P1|STARTED|Overall Study||17
1692425|NCT00493779|4135479|P1|NOT COMPLETED|Overall Study||1
1692426|NCT00493779|4135479|P1|COMPLETED|Overall Study|Completed follow-up phase|97
1692427|NCT00493779|4135479|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
1692428|NCT00493649|4135486|P1|NOT COMPLETED|Overall Study||82
1692429|NCT00493649|4135486|P1|COMPLETED|Overall Study||411
1692430|NCT00493649|4135486|P1|STARTED|Overall Study||493
1692431|NCT00493636|4135499|P2|NOT COMPLETED|Overall Study||2
1692432|NCT00493636|4135500|P1|NOT COMPLETED|Overall Study||2
1692433|NCT00493636|4135499|P2|COMPLETED|Overall Study||77
1692434|NCT00493636|4135500|P1|COMPLETED|Overall Study||79
1692435|NCT00493636|4135499|P2|STARTED|Overall Study||79
1692436|NCT00493636|4135500|P1|STARTED|Overall Study||81
1692437|NCT00493454|4135514|P1|NOT COMPLETED|Overall Study||1
1692438|NCT00493454|4135514|P1|COMPLETED|Overall Study||5
1692439|NCT00493454|4135514|P1|STARTED|Overall Study||6
1692440|NCT00493311|4135520|P2|NOT COMPLETED|Overall Study||2
1692441|NCT00493311|4135521|P1|NOT COMPLETED|Overall Study||2
1692442|NCT00493311|4135520|P2|COMPLETED|Overall Study||29
1692443|NCT00493311|4135521|P1|COMPLETED|Overall Study||27
1692444|NCT00493311|4135520|P2|STARTED|Overall Study||31
1692445|NCT00493311|4135521|P1|STARTED|Overall Study||29
1692446|NCT00493285|4135541|P6|NOT COMPLETED|Overall Study||0
1692447|NCT00493285|4135542|P5|NOT COMPLETED|Overall Study||1
1692448|NCT00493285|4135543|P4|NOT COMPLETED|Overall Study||0
1692449|NCT00493285|4135544|P3|NOT COMPLETED|Overall Study||0
1692450|NCT00493285|4135545|P2|NOT COMPLETED|Overall Study||0
1692451|NCT00493285|4135546|P1|NOT COMPLETED|Overall Study||0
1692452|NCT00493285|4135541|P6|COMPLETED|Overall Study||5
1692453|NCT00493285|4135542|P5|COMPLETED|Overall Study||9
1692454|NCT00493285|4135543|P4|COMPLETED|Overall Study||6
1692455|NCT00493285|4135544|P3|COMPLETED|Overall Study||9
1692456|NCT00493285|4135545|P2|COMPLETED|Overall Study||6
1692457|NCT00493285|4135546|P1|COMPLETED|Overall Study||13
1692458|NCT00493285|4135541|P6|STARTED|Overall Study||5
1692459|NCT00493285|4135542|P5|STARTED|Overall Study||10
1692460|NCT00493285|4135543|P4|STARTED|Overall Study||6
1692461|NCT00493285|4135544|P3|STARTED|Overall Study||9
1692462|NCT00493285|4135545|P2|STARTED|Overall Study||6
1692463|NCT00493285|4135546|P1|STARTED|Overall Study||13
1692464|NCT00493246|4135778|P8|NOT COMPLETED|Overall Study||0
1692465|NCT00493246|4135779|P7|NOT COMPLETED|Overall Study||1
1692466|NCT00493246|4135780|P6|NOT COMPLETED|Overall Study||1
1692467|NCT00493246|4135781|P5|NOT COMPLETED|Overall Study||1
1692468|NCT00493246|4135782|P4|NOT COMPLETED|Overall Study||0
1692469|NCT00493246|4135783|P3|NOT COMPLETED|Overall Study||0
1692470|NCT00493246|4135784|P2|NOT COMPLETED|Overall Study||0
1692471|NCT00493246|4135785|P1|NOT COMPLETED|Overall Study||0
1692472|NCT00493246|4135778|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
1692473|NCT00493246|4135779|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
1692474|NCT00493246|4135780|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
1692475|NCT00493246|4135781|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
1692476|NCT00493246|4135782|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
1692477|NCT00493246|4135783|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
1692478|NCT00493246|4135784|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
1692479|NCT00493246|4135785|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
1692480|NCT00493246|4135778|P8|STARTED|Overall Study|All subjects who were randomized.|10
1692481|NCT00493246|4135779|P7|STARTED|Overall Study|All subjects who were randomized.|12
1692482|NCT00493246|4135780|P6|STARTED|Overall Study|All subjects who were randomized.|16
1692483|NCT00493246|4135781|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
1692484|NCT00493246|4135782|P4|STARTED|Overall Study||13
1692485|NCT00493246|4135783|P3|STARTED|Overall Study||12
1692486|NCT00493246|4135784|P2|STARTED|Overall Study||1
1692487|NCT00493246|4135785|P1|STARTED|Overall Study||2
1692488|NCT00493220|4135849|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1692489|NCT00493220|4135850|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1692490|NCT00493220|4135851|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1692491|NCT00493220|4135852|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1692492|NCT00493220|4135853|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1692493|NCT00493220|4135854|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
1692494|NCT00493220|4135849|P6|COMPLETED|Final 7-Day Safety Follow-up||5
1692495|NCT00493220|4135850|P5|COMPLETED|Final 7-Day Safety Follow-up||5
1692496|NCT00493220|4135851|P4|COMPLETED|Final 7-Day Safety Follow-up||5
1692497|NCT00493220|4135852|P3|COMPLETED|Final 7-Day Safety Follow-up||5
1692498|NCT00493220|4135853|P2|COMPLETED|Final 7-Day Safety Follow-up||5
1692499|NCT00493220|4135854|P1|COMPLETED|Final 7-Day Safety Follow-up||4
1692500|NCT00493220|4135849|P6|STARTED|Final 7-Day Safety Follow-up||5
1692501|NCT00493220|4135850|P5|STARTED|Final 7-Day Safety Follow-up||5
1692502|NCT00493220|4135851|P4|STARTED|Final 7-Day Safety Follow-up||5
1692503|NCT00493220|4135852|P3|STARTED|Final 7-Day Safety Follow-up||5
1692504|NCT00493220|4135853|P2|STARTED|Final 7-Day Safety Follow-up||5
1692505|NCT00493220|4135854|P1|STARTED|Final 7-Day Safety Follow-up||4
1692506|NCT00493220|4135849|P6|NOT COMPLETED|Third Intervention||0
1692507|NCT00493220|4135850|P5|NOT COMPLETED|Third Intervention||0
1692508|NCT00493220|4135851|P4|NOT COMPLETED|Third Intervention||0
1692509|NCT00493220|4135852|P3|NOT COMPLETED|Third Intervention||0
1692510|NCT00493220|4135853|P2|NOT COMPLETED|Third Intervention||0
1692511|NCT00493220|4135854|P1|NOT COMPLETED|Third Intervention||1
1692512|NCT00493220|4135849|P6|COMPLETED|Third Intervention||5
1692513|NCT00493220|4135850|P5|COMPLETED|Third Intervention||5
1692514|NCT00493220|4135851|P4|COMPLETED|Third Intervention||5
1692515|NCT00493220|4135852|P3|COMPLETED|Third Intervention||5
1692516|NCT00493220|4135853|P2|COMPLETED|Third Intervention||5
1692517|NCT00493220|4135854|P1|COMPLETED|Third Intervention||4
1692518|NCT00493220|4135849|P6|STARTED|Third Intervention||5
1692519|NCT00493220|4135850|P5|STARTED|Third Intervention||5
1692520|NCT00493220|4135851|P4|STARTED|Third Intervention||5
1692521|NCT00493220|4135852|P3|STARTED|Third Intervention||5
1692522|NCT00493220|4135853|P2|STARTED|Third Intervention||5
1692523|NCT00493220|4135854|P1|STARTED|Third Intervention||5
1692524|NCT00493220|4135849|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1692525|NCT00493220|4135850|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1692526|NCT00493220|4135851|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1692527|NCT00493220|4135852|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1692528|NCT00493220|4135853|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1692529|NCT00493220|4135854|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
1692530|NCT00493220|4135849|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1692531|NCT00493220|4135850|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1692532|NCT00493220|4135851|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1692533|NCT00493220|4135852|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1692534|NCT00493220|4135853|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1692535|NCT00493220|4135854|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
1692536|NCT00493220|4135849|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
1692537|NCT00493220|4135850|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
1692538|NCT00493220|4135851|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
1692539|NCT00493220|4135852|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
1692540|NCT00493220|4135853|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
1692541|NCT00493220|4135854|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
1692542|NCT00493220|4135849|P6|NOT COMPLETED|Second Intervention||0
1692543|NCT00493220|4135850|P5|NOT COMPLETED|Second Intervention||0
1692544|NCT00493220|4135851|P4|NOT COMPLETED|Second Intervention||0
1692545|NCT00493220|4135852|P3|NOT COMPLETED|Second Intervention||0
1692546|NCT00493220|4135853|P2|NOT COMPLETED|Second Intervention||0
1692547|NCT00493220|4135854|P1|NOT COMPLETED|Second Intervention||0
1692548|NCT00493220|4135849|P6|COMPLETED|Second Intervention||5
1692549|NCT00493220|4135850|P5|COMPLETED|Second Intervention||5
1692550|NCT00493220|4135851|P4|COMPLETED|Second Intervention||5
1692551|NCT00493220|4135852|P3|COMPLETED|Second Intervention||5
1692552|NCT00493220|4135853|P2|COMPLETED|Second Intervention||5
1692553|NCT00493220|4135854|P1|COMPLETED|Second Intervention||5
1692554|NCT00493220|4135849|P6|STARTED|Second Intervention||5
1692555|NCT00493220|4135850|P5|STARTED|Second Intervention||5
1692556|NCT00493220|4135851|P4|STARTED|Second Intervention||5
1692557|NCT00493220|4135852|P3|STARTED|Second Intervention||5
1692558|NCT00493220|4135853|P2|STARTED|Second Intervention||5
1692559|NCT00493220|4135854|P1|STARTED|Second Intervention||5
1692560|NCT00493220|4135849|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1692561|NCT00493220|4135850|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1692562|NCT00493220|4135851|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1692563|NCT00493220|4135852|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1692564|NCT00493220|4135853|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1692565|NCT00493220|4135854|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
1692566|NCT00493220|4135849|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1692567|NCT00493220|4135850|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1692568|NCT00493220|4135851|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1692569|NCT00493220|4135852|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1692570|NCT00493220|4135853|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1692571|NCT00493220|4135854|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
1692572|NCT00493220|4135849|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
1692573|NCT00493220|4135850|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
1692574|NCT00493220|4135851|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
1692575|NCT00493220|4135852|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
1692576|NCT00493220|4135853|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
1692577|NCT00493220|4135854|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
1692578|NCT00493220|4135849|P6|NOT COMPLETED|First Intervention||0
1692579|NCT00493220|4135850|P5|NOT COMPLETED|First Intervention||0
1692580|NCT00493220|4135851|P4|NOT COMPLETED|First Intervention||0
1692581|NCT00493220|4135852|P3|NOT COMPLETED|First Intervention||0
1692582|NCT00493220|4135853|P2|NOT COMPLETED|First Intervention||0
1692583|NCT00493220|4135854|P1|NOT COMPLETED|First Intervention||0
1692584|NCT00493220|4135849|P6|COMPLETED|First Intervention||5
1692585|NCT00493220|4135850|P5|COMPLETED|First Intervention||5
1692586|NCT00493220|4135851|P4|COMPLETED|First Intervention||5
1692587|NCT00493220|4135852|P3|COMPLETED|First Intervention||5
1692588|NCT00493220|4135853|P2|COMPLETED|First Intervention||5
1692589|NCT00493220|4135854|P1|COMPLETED|First Intervention||5
1692590|NCT00493220|4135849|P6|STARTED|First Intervention||5
1692591|NCT00493220|4135850|P5|STARTED|First Intervention||5
1692592|NCT00493220|4135851|P4|STARTED|First Intervention||5
1692593|NCT00493220|4135852|P3|STARTED|First Intervention||5
1692594|NCT00493220|4135853|P2|STARTED|First Intervention||5
1692595|NCT00493220|4135854|P1|STARTED|First Intervention||5
1692596|NCT00493181|4135871|P1|NOT COMPLETED|Overall Study||0
1692597|NCT00493181|4135871|P1|COMPLETED|Overall Study||8
1692598|NCT00493181|4135871|P1|STARTED|Overall Study||8
1692599|NCT00493064|4135875|P1|NOT COMPLETED|Overall Study||11
1692600|NCT00493064|4135875|P1|COMPLETED|Overall Study||52
1692601|NCT00493064|4135875|P1|STARTED|Overall Study||63
1692602|NCT00493038|4135882|P2|NOT COMPLETED|Follow-up||0
1692603|NCT00493038|4135883|P1|NOT COMPLETED|Follow-up||1
1692604|NCT00493038|4135882|P2|COMPLETED|Follow-up||126
1692605|NCT00493038|4135883|P1|COMPLETED|Follow-up||122
1692606|NCT00493038|4135882|P2|STARTED|Follow-up||126
1692607|NCT00493038|4135883|P1|STARTED|Follow-up||123
1692608|NCT00493038|4135882|P2|NOT COMPLETED|Treatment||20
1692609|NCT00493038|4135883|P1|NOT COMPLETED|Treatment||24
1692610|NCT00493038|4135882|P2|COMPLETED|Treatment||126
1692611|NCT00493038|4135883|P1|COMPLETED|Treatment||123
1692612|NCT00493038|4135882|P2|Test-of-Cure Visit|Treatment||126
1692613|NCT00493038|4135883|P1|Test-of-Cure Visit|Treatment||123
1692614|NCT00493038|4135882|P2|Treated With Study Medication|Treatment||142
1692615|NCT00493038|4135883|P1|Treated With Study Medication|Treatment||145
1692616|NCT00493038|4135882|P2|Randomization|Treatment||146
1692617|NCT00493038|4135883|P1|Randomization|Treatment||147
1692618|NCT00493038|4135882|P2|STARTED|Treatment||146
1692619|NCT00493038|4135883|P1|STARTED|Treatment||147
1692620|NCT00493025|4135897|P1|NOT COMPLETED|Overall Study||19
1692621|NCT00493025|4135897|P1|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
1692622|NCT00493025|4135897|P1|STARTED|Overall Study||19
1692623|NCT00493012|4135908|P2|NOT COMPLETED|Overall Study||17
1692624|NCT00493012|4135909|P1|NOT COMPLETED|Overall Study||18
1692625|NCT00493012|4135908|P2|COMPLETED|Overall Study||83
1692626|NCT00493012|4135909|P1|COMPLETED|Overall Study||82
1692627|NCT00493012|4135908|P2|STARTED|Overall Study||100
1692628|NCT00493012|4135909|P1|STARTED|Overall Study||100
1692629|NCT00492973|4135937|P2|NOT COMPLETED|Overall Study||1
1692630|NCT00492973|4135938|P1|NOT COMPLETED|Overall Study||0
1692631|NCT00492973|4135937|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
1692632|NCT00492973|4135938|P1|COMPLETED|Overall Study||37
1692633|NCT00492973|4135937|P2|STARTED|Overall Study||39
1692634|NCT00492973|4135938|P1|STARTED|Overall Study||37
1692635|NCT00492921|4135952|P3|NOT COMPLETED|Overall Study||1
1692636|NCT00492921|4135953|P2|NOT COMPLETED|Overall Study||0
1692637|NCT00492921|4135954|P1|NOT COMPLETED|Overall Study||1
1692638|NCT00492921|4135952|P3|COMPLETED|Overall Study||2
1692639|NCT00492921|4135953|P2|COMPLETED|Overall Study||4
1692640|NCT00492921|4135954|P1|COMPLETED|Overall Study||4
1692641|NCT00492921|4135952|P3|STARTED|Overall Study||3
1692642|NCT00492921|4135953|P2|STARTED|Overall Study||4
1692643|NCT00492921|4135954|P1|STARTED|Overall Study||5
1692644|NCT00492856|4135965|P4|NOT COMPLETED|Post-consolidation||1
1692645|NCT00492856|4135966|P3|NOT COMPLETED|Post-consolidation||27
1692646|NCT00492856|4135967|P2|NOT COMPLETED|Post-consolidation||12
1692647|NCT00492856|4135968|P1|NOT COMPLETED|Post-consolidation||0
1692648|NCT00492856|4135965|P4|COMPLETED|Post-consolidation||0
1692649|NCT00492856|4135966|P3|COMPLETED|Post-consolidation||0
1692650|NCT00492856|4135967|P2|COMPLETED|Post-consolidation||29
1692651|NCT00492856|4135968|P1|COMPLETED|Post-consolidation||0
1692652|NCT00492856|4135965|P4|STARTED|Post-consolidation||1
1692653|NCT00492856|4135966|P3|STARTED|Post-consolidation||27
1692654|NCT00492856|4135967|P2|STARTED|Post-consolidation||41
1692655|NCT00492856|4135968|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
1692656|NCT00492856|4135965|P4|NOT COMPLETED|Consolidation||0
1692657|NCT00492856|4135966|P3|NOT COMPLETED|Consolidation||0
1692658|NCT00492856|4135967|P2|NOT COMPLETED|Consolidation||0
1692659|NCT00492856|4135968|P1|NOT COMPLETED|Consolidation||9
1692660|NCT00492856|4135965|P4|COMPLETED|Consolidation||0
1692661|NCT00492856|4135966|P3|COMPLETED|Consolidation||0
1692662|NCT00492856|4135967|P2|COMPLETED|Consolidation||0
1692663|NCT00492856|4135968|P1|COMPLETED|Consolidation||83
1692664|NCT00492856|4135965|P4|STARTED|Consolidation||0
1692665|NCT00492856|4135966|P3|STARTED|Consolidation||0
1692666|NCT00492856|4135967|P2|STARTED|Consolidation||0
1692667|NCT00492856|4135968|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
1692668|NCT00492856|4135965|P4|NOT COMPLETED|Induction||0
1692669|NCT00492856|4135966|P3|NOT COMPLETED|Induction||0
1692670|NCT00492856|4135967|P2|NOT COMPLETED|Induction||0
1692671|NCT00492856|4135968|P1|NOT COMPLETED|Induction||6
1692672|NCT00492856|4135965|P4|COMPLETED|Induction||0
1692673|NCT00492856|4135966|P3|COMPLETED|Induction||0
1692674|NCT00492856|4135967|P2|COMPLETED|Induction||0
1692675|NCT00492856|4135968|P1|COMPLETED|Induction||99
1692676|NCT00492856|4135965|P4|STARTED|Induction||0
1692677|NCT00492856|4135966|P3|STARTED|Induction||0
1692678|NCT00492856|4135967|P2|STARTED|Induction||0
1692679|NCT00492856|4135968|P1|STARTED|Induction||105
1692680|NCT00492752|4135982|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
1692681|NCT00492752|4135983|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
1692682|NCT00492752|4135984|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
1692683|NCT00492752|4135985|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
1692684|NCT00492752|4135982|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
1692685|NCT00492752|4135983|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
1692686|NCT00492752|4135984|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
1692687|NCT00492752|4135985|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
1692688|NCT00492752|4135982|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
1692689|NCT00492752|4135983|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
1692690|NCT00492752|4135984|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
1692691|NCT00492752|4135985|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
1692692|NCT00492752|4135982|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
1692693|NCT00492752|4135983|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
1692694|NCT00492752|4135984|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
1692695|NCT00492752|4135985|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
1692696|NCT00492752|4135982|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
1692697|NCT00492752|4135983|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
1692698|NCT00492752|4135984|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
1692699|NCT00492752|4135985|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
1692700|NCT00492752|4135982|P4|NOT COMPLETED|Double Blind Treatment||0
1692701|NCT00492752|4135983|P3|NOT COMPLETED|Double Blind Treatment||3
1692702|NCT00492752|4135984|P2|NOT COMPLETED|Double Blind Treatment||0
1692703|NCT00492752|4135985|P1|NOT COMPLETED|Double Blind Treatment||14
1692704|NCT00492752|4135982|P4|COMPLETED|Double Blind Treatment||6
1692705|NCT00492752|4135983|P3|COMPLETED|Double Blind Treatment||67
1692706|NCT00492752|4135984|P2|COMPLETED|Double Blind Treatment||16
1692707|NCT00492752|4135985|P1|COMPLETED|Double Blind Treatment||120
1692708|NCT00492752|4135982|P4|Received Treatment|Double Blind Treatment|Safety Population|6
1692709|NCT00492752|4135983|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
1692710|NCT00492752|4135984|P2|Received Treatment|Double Blind Treatment|Safety Population|16
1692711|NCT00492752|4135985|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
1692712|NCT00492752|4135982|P4|STARTED|Double Blind Treatment||6
1692713|NCT00492752|4135983|P3|STARTED|Double Blind Treatment||70
1692714|NCT00492752|4135984|P2|STARTED|Double Blind Treatment||16
1692715|NCT00492752|4135985|P1|STARTED|Double Blind Treatment||134
1692716|NCT00492726|4136020|P2|NOT COMPLETED|Overall Study||36
1692717|NCT00492726|4136021|P1|NOT COMPLETED|Overall Study||50
1692718|NCT00492726|4136020|P2|COMPLETED|Overall Study||358
1692719|NCT00492726|4136021|P1|COMPLETED|Overall Study||360
1692720|NCT00492726|4136020|P2|End of Study|Overall Study||358
1692721|NCT00492726|4136021|P1|End of Study|Overall Study||360
1692722|NCT00492726|4136020|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
1692723|NCT00492726|4136021|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
1692724|NCT00492726|4136020|P2|STARTED|Overall Study||394
1692725|NCT00492726|4136021|P1|STARTED|Overall Study||410
1692726|NCT00492648|4136047|P2|NOT COMPLETED|Month 42 (109674 Study)||0
1692727|NCT00492648|4136048|P1|NOT COMPLETED|Month 42 (109674 Study)||0
1692728|NCT00492648|4136047|P2|COMPLETED|Month 42 (109674 Study)||20
1692729|NCT00492648|4136048|P1|COMPLETED|Month 42 (109674 Study)||3
1692730|NCT00492648|4136047|P2|STARTED|Month 42 (109674 Study)||20
1692731|NCT00492648|4136048|P1|STARTED|Month 42 (109674 Study)||3
1692732|NCT00492648|4136047|P2|NOT COMPLETED|Month 30 (109671 Study)||1
1692733|NCT00492648|4136048|P1|NOT COMPLETED|Month 30 (109671 Study)||0
1692734|NCT00492648|4136047|P2|COMPLETED|Month 30 (109671 Study)||29
1692735|NCT00492648|4136048|P1|COMPLETED|Month 30 (109671 Study)||4
1692736|NCT00492648|4136047|P2|STARTED|Month 30 (109671 Study)||30
1692737|NCT00492648|4136048|P1|STARTED|Month 30 (109671 Study)||4
1692738|NCT00492622|4136074|P1|NOT COMPLETED|Overall Study||0
1692739|NCT00492622|4136074|P1|COMPLETED|Overall Study||12
1692740|NCT00492622|4136074|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
1692741|NCT00492583|4136086|P2|NOT COMPLETED|Overall Study||0
1692742|NCT00492583|4136087|P1|NOT COMPLETED|Overall Study||0
1692743|NCT00492583|4136086|P2|COMPLETED|Overall Study||87
1692744|NCT00492583|4136087|P1|COMPLETED|Overall Study||95
1692745|NCT00492583|4136086|P2|STARTED|Overall Study||87
1692746|NCT00492583|4136087|P1|STARTED|Overall Study||95
1692747|NCT00492557|4136095|P2|NOT COMPLETED|Overall Study||23
1692748|NCT00492557|4136096|P1|NOT COMPLETED|Overall Study||24
1692749|NCT00492557|4136095|P2|COMPLETED|Overall Study||557
1692750|NCT00492557|4136096|P1|COMPLETED|Overall Study||556
1692751|NCT00492557|4136095|P2|Vaccinated Dose 2|Overall Study||558
1692752|NCT00492557|4136096|P1|Vaccinated Dose 2|Overall Study||560
1692753|NCT00492557|4136095|P2|Vaccinated Dose 1|Overall Study||575
1692754|NCT00492557|4136096|P1|Vaccinated Dose 1|Overall Study||577
1692755|NCT00492557|4136095|P2|STARTED|Overall Study||580
1692756|NCT00492557|4136096|P1|STARTED|Overall Study||580
1692757|NCT00492544|4136112|P1|NOT COMPLETED|Overall Study||0
1692758|NCT00492544|4136112|P1|COMPLETED|Overall Study||100
1692759|NCT00492544|4136112|P1|STARTED|Overall Study||100
1692760|NCT00492531|4136126|P2|NOT COMPLETED|Overall Study||23
1692761|NCT00492531|4136127|P1|NOT COMPLETED|Overall Study||22
1692762|NCT00492531|4136126|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
1692763|NCT00492531|4136127|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
1692764|NCT00492531|4136126|P2|STARTED|Overall Study||37
1692765|NCT00492531|4136127|P1|STARTED|Overall Study||37
1692766|NCT00492401|4136139|P1|NOT COMPLETED|Overall Study||0
1692767|NCT00492401|4136139|P1|COMPLETED|Overall Study||55
1692768|NCT00492401|4136139|P1|STARTED|Overall Study||55
1692769|NCT00492349|4136150|P2|NOT COMPLETED|Overall Study||7
1692770|NCT00492349|4136151|P1|NOT COMPLETED|Overall Study||3
1692771|NCT00492349|4136150|P2|COMPLETED|Overall Study||27
1692772|NCT00492349|4136151|P1|COMPLETED|Overall Study||32
1692773|NCT00492349|4136150|P2|Week 8|Overall Study||27
1692774|NCT00492349|4136151|P1|Week 8|Overall Study||32
1692775|NCT00492349|4136150|P2|Week 2|Overall Study||33
1692776|NCT00492349|4136151|P1|Week 2|Overall Study||32
1692777|NCT00492349|4136150|P2|STARTED|Overall Study||34
1692778|NCT00492349|4136151|P1|STARTED|Overall Study||35
1692779|NCT00492336|4136173|P2|NOT COMPLETED|Overall Study||6
1692780|NCT00492336|4136174|P1|NOT COMPLETED|Overall Study||2
1692781|NCT00492336|4136173|P2|COMPLETED|Overall Study||23
1692782|NCT00492336|4136174|P1|COMPLETED|Overall Study||26
1692783|NCT00492336|4136173|P2|STARTED|Overall Study||29
1692784|NCT00492336|4136174|P1|STARTED|Overall Study||28
1692785|NCT00492297|4136200|P1|NOT COMPLETED|Survival Only Follow-up||59
1692786|NCT00492297|4136200|P1|COMPLETED|Survival Only Follow-up||0
1692787|NCT00492297|4136200|P1|STARTED|Survival Only Follow-up||59
1692788|NCT00492297|4136200|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
1692789|NCT00492297|4136200|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
1692790|NCT00492297|4136200|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
1692791|NCT00492297|4136200|P1|NOT COMPLETED|Treatment||5
1692792|NCT00492297|4136200|P1|COMPLETED|Treatment||78
1692793|NCT00492297|4136200|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
1692794|NCT00492297|4136200|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
1692795|NCT00492297|4136200|P1|STARTED|Treatment||83
1692796|NCT00492284|4136218|P4|NOT COMPLETED|Overall Study||10
1692797|NCT00492284|4136219|P3|NOT COMPLETED|Overall Study||6
1692798|NCT00492284|4136220|P2|NOT COMPLETED|Overall Study||4
1692799|NCT00492284|4136221|P1|NOT COMPLETED|Overall Study||1
1692800|NCT00492284|4136218|P4|COMPLETED|Overall Study||31
1692801|NCT00492284|4136219|P3|COMPLETED|Overall Study||37
1692802|NCT00492284|4136220|P2|COMPLETED|Overall Study||35
1692803|NCT00492284|4136221|P1|COMPLETED|Overall Study||38
1692804|NCT00492284|4136218|P4|STARTED|Overall Study||41
1692805|NCT00492284|4136219|P3|STARTED|Overall Study||43
1692806|NCT00492284|4136220|P2|STARTED|Overall Study||39
1692807|NCT00492284|4136221|P1|STARTED|Overall Study||39
1692808|NCT00492232|4136265|P2|NOT COMPLETED|Open-Label Treatment||0
1692809|NCT00492232|4136266|P1|NOT COMPLETED|Open-Label Treatment||1
1692810|NCT00492232|4136265|P2|COMPLETED|Open-Label Treatment||0
1692811|NCT00492232|4136266|P1|COMPLETED|Open-Label Treatment||88
1692812|NCT00492232|4136265|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
1692813|NCT00492232|4136266|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
1692814|NCT00492232|4136265|P2|NOT COMPLETED|Double-Blind Treatment||25
1692815|NCT00492232|4136266|P1|NOT COMPLETED|Double-Blind Treatment||18
1692816|NCT00492232|4136265|P2|COMPLETED|Double-Blind Treatment||45
1692817|NCT00492232|4136266|P1|COMPLETED|Double-Blind Treatment||47
1692818|NCT00492232|4136265|P2|STARTED|Double-Blind Treatment||70
1692819|NCT00492232|4136266|P1|STARTED|Double-Blind Treatment||65
1692820|NCT00492232|4136265|P2|NOT COMPLETED|Placebo Run-in||70
1692821|NCT00492232|4136266|P1|NOT COMPLETED|Placebo Run-in||0
1692822|NCT00492232|4136265|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
1692823|NCT00492232|4136266|P1|COMPLETED|Placebo Run-in||0
1692824|NCT00492232|4136265|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
1692825|NCT00492232|4136266|P1|STARTED|Placebo Run-in||0
1692826|NCT00492206|4136298|P1|NOT COMPLETED|Overall Study||0
1692827|NCT00492206|4136298|P1|COMPLETED|Overall Study||40
1692828|NCT00492206|4136298|P1|STARTED|Overall Study||40
1692829|NCT00492115|4136307|P2|NOT COMPLETED|Overall Study||4
1692830|NCT00492115|4136308|P1|NOT COMPLETED|Overall Study||3
1692831|NCT00492115|4136307|P2|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
1692832|NCT00492115|4136308|P1|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
1692833|NCT00492115|4136307|P2|STARTED|Overall Study||19
1692834|NCT00492115|4136308|P1|STARTED|Overall Study||19
1692835|NCT00492089|4136318|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1692836|NCT00492089|4136319|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1692837|NCT00492089|4136318|P2|COMPLETED|Second Intervention (6 Weeks)||6
1692838|NCT00492089|4136319|P1|COMPLETED|Second Intervention (6 Weeks)||5
1692839|NCT00492089|4136318|P2|STARTED|Second Intervention (6 Weeks)||6
1692840|NCT00492089|4136319|P1|STARTED|Second Intervention (6 Weeks)||5
1692841|NCT00492089|4136318|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
1692842|NCT00492089|4136319|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
1692843|NCT00492089|4136318|P2|COMPLETED|First Intervention (6 Weeks)||6
1692844|NCT00492089|4136319|P1|COMPLETED|First Intervention (6 Weeks)||5
1692845|NCT00492089|4136318|P2|STARTED|First Intervention (6 Weeks)||6
1692846|NCT00492089|4136319|P1|STARTED|First Intervention (6 Weeks)||5
1692847|NCT00492063|4136329|P4|NOT COMPLETED|Overall Study||10
1692848|NCT00492063|4136330|P3|NOT COMPLETED|Overall Study||11
1692849|NCT00492063|4136331|P2|NOT COMPLETED|Overall Study||14
1692850|NCT00492063|4136332|P1|NOT COMPLETED|Overall Study||10
1692851|NCT00492063|4136329|P4|COMPLETED|Overall Study||666
1692852|NCT00492063|4136330|P3|COMPLETED|Overall Study||667
1692853|NCT00492063|4136331|P2|COMPLETED|Overall Study||634
1692854|NCT00492063|4136332|P1|COMPLETED|Overall Study||642
1692855|NCT00492063|4136329|P4|STARTED|Overall Study||676
1692856|NCT00492063|4136330|P3|STARTED|Overall Study||678
1692857|NCT00492063|4136331|P2|STARTED|Overall Study||648
1692858|NCT00492063|4136332|P1|STARTED|Overall Study||652
1692859|NCT00492024|4136356|P2|NOT COMPLETED|Follow up||2
1692860|NCT00492024|4136357|P1|NOT COMPLETED|Follow up||1
1692861|NCT00492024|4136356|P2|COMPLETED|Follow up||99
1692862|NCT00492024|4136357|P1|COMPLETED|Follow up||221
1692863|NCT00492024|4136356|P2|STARTED|Follow up||101
1692864|NCT00492024|4136357|P1|STARTED|Follow up||222
1692865|NCT00492024|4136356|P2|NOT COMPLETED|Treatment||22
1692866|NCT00492024|4136357|P1|NOT COMPLETED|Treatment||29
1692867|NCT00492024|4136356|P2|COMPLETED|Treatment||101
1692868|NCT00492024|4136357|P1|COMPLETED|Treatment||222
1692869|NCT00492024|4136356|P2|STARTED|Treatment||123
1692870|NCT00492024|4136357|P1|STARTED|Treatment||251
1692871|NCT00491894|4136373|P1|NOT COMPLETED|Overall Study||34
1692872|NCT00491894|4136373|P1|COMPLETED|Overall Study||103
1692873|NCT00491894|4136373|P1|STARTED|Overall Study||137
1692874|NCT00491829|4136384|P3|NOT COMPLETED|Overall Study||75
1692875|NCT00491829|4136385|P2|NOT COMPLETED|Overall Study||114
1692876|NCT00491829|4136386|P1|NOT COMPLETED|Overall Study||95
1692877|NCT00491829|4136384|P3|COMPLETED|Overall Study||243
1692878|NCT00491829|4136385|P2|COMPLETED|Overall Study||202
1692879|NCT00491829|4136386|P1|COMPLETED|Overall Study||216
1692880|NCT00491829|4136384|P3|STARTED|Overall Study||318
1692881|NCT00491829|4136385|P2|STARTED|Overall Study||316
1692882|NCT00491829|4136386|P1|STARTED|Overall Study||311
1692883|NCT00491764|4136400|P6|NOT COMPLETED|Overall Study||9
1692884|NCT00491764|4136401|P5|NOT COMPLETED|Overall Study||3
1692885|NCT00491764|4136402|P4|NOT COMPLETED|Overall Study||8
1692886|NCT00491764|4136403|P3|NOT COMPLETED|Overall Study||8
1692887|NCT00491764|4136404|P2|NOT COMPLETED|Overall Study||7
1692888|NCT00491764|4136405|P1|NOT COMPLETED|Overall Study||5
1692889|NCT00491764|4136400|P6|COMPLETED|Overall Study||27
1692890|NCT00491764|4136401|P5|COMPLETED|Overall Study||33
1692891|NCT00491764|4136402|P4|COMPLETED|Overall Study||28
1692892|NCT00491764|4136403|P3|COMPLETED|Overall Study||28
1692893|NCT00491764|4136404|P2|COMPLETED|Overall Study||30
1692894|NCT00491764|4136405|P1|COMPLETED|Overall Study||32
1692895|NCT00491764|4136400|P6|STARTED|Overall Study||36
1692896|NCT00491764|4136401|P5|STARTED|Overall Study||36
1692897|NCT00491764|4136402|P4|STARTED|Overall Study||36
1692898|NCT00491764|4136403|P3|STARTED|Overall Study||36
1692899|NCT00491764|4136404|P2|STARTED|Overall Study||37
1692900|NCT00491764|4136405|P1|STARTED|Overall Study||37
1692901|NCT00491751|4136434|P3|NOT COMPLETED|Overall Study||0
1692902|NCT00491751|4136435|P2|NOT COMPLETED|Overall Study||0
1692903|NCT00491751|4136436|P1|NOT COMPLETED|Overall Study||0
1692904|NCT00491751|4136434|P3|COMPLETED|Overall Study||42
1692905|NCT00491751|4136435|P2|COMPLETED|Overall Study||44
1692906|NCT00491751|4136436|P1|COMPLETED|Overall Study||22
1692907|NCT00491751|4136434|P3|STARTED|Overall Study||42
1692908|NCT00491751|4136435|P2|STARTED|Overall Study||44
1692909|NCT00491751|4136436|P1|STARTED|Overall Study||22
1692910|NCT00491738|4136448|P2|NOT COMPLETED|Overall Study||0
1692911|NCT00491738|4136449|P1|NOT COMPLETED|Overall Study||0
1692912|NCT00491738|4136448|P2|COMPLETED|Overall Study||9
1692913|NCT00491738|4136449|P1|COMPLETED|Overall Study||7
1692914|NCT00491738|4136448|P2|STARTED|Overall Study||9
1692915|NCT00491738|4136449|P1|STARTED|Overall Study||7
1692916|NCT00491608|4136453|P1|NOT COMPLETED|Overall Study||3
1692917|NCT00491608|4136453|P1|COMPLETED|Overall Study||206
1692918|NCT00491608|4136453|P1|STARTED|Overall Study|Participants who received treatment|209
1692919|NCT00491556|4136464|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
1692920|NCT00491556|4136465|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
1692921|NCT00491556|4136464|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
1692922|NCT00491556|4136465|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
1692923|NCT00491556|4136464|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
1692924|NCT00491556|4136465|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
1692925|NCT00491556|4136464|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
1692926|NCT00491556|4136465|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
1692927|NCT00491556|4136464|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
1692928|NCT00491556|4136465|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
1692929|NCT00491556|4136464|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
1692930|NCT00491556|4136465|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
1692931|NCT00491556|4136464|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
1692932|NCT00491556|4136465|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
1692933|NCT00491530|4136524|P3|NOT COMPLETED|Overall Study||5
1692934|NCT00491530|4136525|P2|NOT COMPLETED|Overall Study||6
1692935|NCT00491530|4136526|P1|NOT COMPLETED|Overall Study||12
1692936|NCT00491530|4136524|P3|COMPLETED|Overall Study||81
1692937|NCT00491530|4136525|P2|COMPLETED|Overall Study||44
1692938|NCT00491530|4136526|P1|COMPLETED|Overall Study||162
1692939|NCT00491530|4136524|P3|STARTED|Overall Study||86
1692940|NCT00491530|4136525|P2|STARTED|Overall Study||50
1692941|NCT00491530|4136526|P1|STARTED|Overall Study||174
1692942|NCT00491504|4136556|P4|NOT COMPLETED|Overall Study||4
1692943|NCT00491504|4136557|P3|NOT COMPLETED|Overall Study||4
1692944|NCT00491504|4136558|P2|NOT COMPLETED|Overall Study||1
1692945|NCT00491504|4136559|P1|NOT COMPLETED|Overall Study||0
1692946|NCT00491504|4136556|P4|COMPLETED|Overall Study||73
1692947|NCT00491504|4136557|P3|COMPLETED|Overall Study||74
1692948|NCT00491504|4136558|P2|COMPLETED|Overall Study||77
1692949|NCT00491504|4136559|P1|COMPLETED|Overall Study||77
1692950|NCT00491504|4136556|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
1692951|NCT00491504|4136557|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
1692952|NCT00491504|4136558|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
1692953|NCT00491504|4136559|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
1692954|NCT00491400|4136569|P2|NOT COMPLETED|Overall Study||4
1692955|NCT00491400|4136570|P1|NOT COMPLETED|Overall Study||5
1692956|NCT00491400|4136569|P2|COMPLETED|Overall Study||9
1692957|NCT00491400|4136570|P1|COMPLETED|Overall Study||10
1692958|NCT00491400|4136569|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
1692959|NCT00491400|4136570|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
1692960|NCT00491400|4136569|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
1692961|NCT00491400|4136570|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
1692962|NCT00491400|4136569|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
1692963|NCT00491400|4136570|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
1692964|NCT00491400|4136569|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
1692965|NCT00491400|4136570|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
1692966|NCT00491400|4136569|P2|STARTED|Overall Study||13
1692967|NCT00491400|4136570|P1|STARTED|Overall Study||15
1692968|NCT00491387|4136578|P1|NOT COMPLETED|Overall Study||20
1692969|NCT00491387|4136578|P1|COMPLETED|Overall Study||4
1692970|NCT00491387|4136578|P1|Study Enrollment|Overall Study||24
1692971|NCT00491387|4136578|P1|STARTED|Overall Study||24
1692972|NCT00491374|4136584|P2|NOT COMPLETED|Overall Study||0
1692973|NCT00491374|4136585|P1|NOT COMPLETED|Overall Study||0
1692974|NCT00491374|4136584|P2|COMPLETED|Overall Study||0
1692975|NCT00491374|4136585|P1|COMPLETED|Overall Study||0
1692976|NCT00491374|4136584|P2|STARTED|Overall Study||0
1692977|NCT00491374|4136585|P1|STARTED|Overall Study||0
1692978|NCT00491322|4136593|P2|NOT COMPLETED|Overall Study||1
1692979|NCT00491322|4136594|P1|NOT COMPLETED|Overall Study||1
1692980|NCT00491322|4136593|P2|COMPLETED|Overall Study||50
1692981|NCT00491322|4136594|P1|COMPLETED|Overall Study||40
1692982|NCT00491322|4136593|P2|STARTED|Overall Study||51
1692983|NCT00491322|4136594|P1|STARTED|Overall Study||41
1692984|NCT00491244|4136602|P2|NOT COMPLETED|Overall Study||20
1692985|NCT00491244|4136603|P1|NOT COMPLETED|Overall Study||27
1692986|NCT00491244|4136602|P2|COMPLETED|Overall Study||168
1692987|NCT00491244|4136603|P1|COMPLETED|Overall Study||162
1692988|NCT00491244|4136602|P2|STARTED|Overall Study||188
1692989|NCT00491244|4136603|P1|STARTED|Overall Study||189
1692990|NCT00491179|4136613|P2|NOT COMPLETED|Overall Study||2
1692991|NCT00491179|4136614|P1|NOT COMPLETED|Overall Study||7
1692992|NCT00491179|4136613|P2|COMPLETED|Overall Study||8
1692993|NCT00491179|4136614|P1|COMPLETED|Overall Study||18
1692994|NCT00491179|4136613|P2|STARTED|Overall Study||10
1692995|NCT00491179|4136614|P1|STARTED|Overall Study||25
1692996|NCT00491075|4136622|P1|NOT COMPLETED|Overall Study||2
1692997|NCT00491075|4136622|P1|COMPLETED|Overall Study||14
1692998|NCT00491075|4136622|P1|STARTED|Overall Study||16
1692999|NCT00490971|4136628|P5|NOT COMPLETED|Maintenance||39
1693000|NCT00490971|4136629|P4|NOT COMPLETED|Maintenance||53
1693001|NCT00490971|4136630|P3|NOT COMPLETED|Maintenance||51
1693002|NCT00490971|4136631|P2|NOT COMPLETED|Maintenance||0
1693003|NCT00490971|4136632|P1|NOT COMPLETED|Maintenance||0
1693004|NCT00490971|4136628|P5|COMPLETED|Maintenance||44
1693005|NCT00490971|4136629|P4|COMPLETED|Maintenance||96
1693006|NCT00490971|4136630|P3|COMPLETED|Maintenance||96
1693007|NCT00490971|4136631|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
1693008|NCT00490971|4136632|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
1693009|NCT00490971|4136628|P5|STARTED|Maintenance||83
1693010|NCT00490971|4136629|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
1693011|NCT00490971|4136630|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
1693012|NCT00490971|4136631|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
1693013|NCT00490971|4136632|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
1693014|NCT00490971|4136628|P5|NOT COMPLETED|Acute/Continuation||0
1693015|NCT00490971|4136629|P4|NOT COMPLETED|Acute/Continuation||0
1693016|NCT00490971|4136630|P3|NOT COMPLETED|Acute/Continuation||0
1693017|NCT00490971|4136631|P2|NOT COMPLETED|Acute/Continuation||62
1693018|NCT00490971|4136632|P1|NOT COMPLETED|Acute/Continuation||306
1693019|NCT00490971|4136628|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1693020|NCT00490971|4136629|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1693021|NCT00490971|4136630|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1693022|NCT00490971|4136631|P2|COMPLETED|Acute/Continuation||86
1693023|NCT00490971|4136632|P1|COMPLETED|Acute/Continuation||308
1693024|NCT00490971|4136628|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1693025|NCT00490971|4136629|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1693026|NCT00490971|4136630|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
1693027|NCT00490971|4136631|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
1693028|NCT00490971|4136632|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
1693029|NCT00490945|4136679|P5|NOT COMPLETED|Overall Study||0
1693030|NCT00490945|4136680|P4|NOT COMPLETED|Overall Study||0
1693031|NCT00490945|4136681|P3|NOT COMPLETED|Overall Study||0
1693032|NCT00490945|4136682|P2|NOT COMPLETED|Overall Study||1
1693033|NCT00490945|4136683|P1|NOT COMPLETED|Overall Study||0
1693034|NCT00490945|4136679|P5|COMPLETED|Overall Study||7
1693035|NCT00490945|4136680|P4|COMPLETED|Overall Study||7
1693036|NCT00490945|4136681|P3|COMPLETED|Overall Study||8
1693037|NCT00490945|4136682|P2|COMPLETED|Overall Study||8
1693038|NCT00490945|4136683|P1|COMPLETED|Overall Study||8
1693039|NCT00490945|4136679|P5|STARTED|Overall Study||7
1693040|NCT00490945|4136680|P4|STARTED|Overall Study||7
1693041|NCT00490945|4136681|P3|STARTED|Overall Study||8
1693042|NCT00490945|4136682|P2|STARTED|Overall Study||9
1693043|NCT00490945|4136683|P1|STARTED|Overall Study||8
1693044|NCT00490919|4136719|P3|NOT COMPLETED|Double-blind Phase||84
1693045|NCT00490919|4136720|P2|NOT COMPLETED|Double-blind Phase||86
1693046|NCT00490919|4136721|P1|NOT COMPLETED|Double-blind Phase||0
1693047|NCT00490919|4136719|P3|COMPLETED|Double-blind Phase||199
1693048|NCT00490919|4136720|P2|COMPLETED|Double-blind Phase||170
1693049|NCT00490919|4136721|P1|COMPLETED|Double-blind Phase||0
1693050|NCT00490919|4136719|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
1693051|NCT00490919|4136720|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
1693052|NCT00490919|4136721|P1|STARTED|Double-blind Phase||0
1693053|NCT00490919|4136719|P3|NOT COMPLETED|Open-label Run-in Period||0
1693054|NCT00490919|4136720|P2|NOT COMPLETED|Open-label Run-in Period||0
1693055|NCT00490919|4136721|P1|NOT COMPLETED|Open-label Run-in Period||483
1693056|NCT00490919|4136719|P3|COMPLETED|Open-label Run-in Period||0
1693057|NCT00490919|4136720|P2|COMPLETED|Open-label Run-in Period||0
1693058|NCT00490919|4136721|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
1693059|NCT00490919|4136719|P3|STARTED|Open-label Run-in Period||0
1693060|NCT00490919|4136720|P2|STARTED|Open-label Run-in Period||0
1693061|NCT00490919|4136721|P1|STARTED|Open-label Run-in Period||1024
1693062|NCT00490841|4136732|P1|NOT COMPLETED|Overall Study||13
1693063|NCT00490841|4136732|P1|COMPLETED|Overall Study||189
1693064|NCT00490841|4136732|P1|STARTED|Overall Study||202
1693065|NCT00490815|4136754|P2|NOT COMPLETED|Overall Study||9
1693066|NCT00490815|4136755|P1|NOT COMPLETED|Overall Study||8
1693067|NCT00490815|4136754|P2|COMPLETED|Overall Study||8
1693068|NCT00490815|4136755|P1|COMPLETED|Overall Study||12
1693069|NCT00490815|4136754|P2|STARTED|Overall Study||17
1693070|NCT00490815|4136755|P1|STARTED|Overall Study||20
1693071|NCT00490802|4136765|P2|NOT COMPLETED|Overall Study||2
1693072|NCT00490802|4136766|P1|NOT COMPLETED|Overall Study||1
1693073|NCT00490802|4136765|P2|COMPLETED|Overall Study||7
1693074|NCT00490802|4136766|P1|COMPLETED|Overall Study||9
1693075|NCT00490802|4136765|P2|STARTED|Overall Study||9
1693076|NCT00490802|4136766|P1|STARTED|Overall Study||10
1693077|NCT00490724|4136783|P3|NOT COMPLETED|Period II||3
1693078|NCT00490724|4136784|P2|NOT COMPLETED|Period II||1
1693079|NCT00490724|4136785|P1|NOT COMPLETED|Period II||3
1693080|NCT00490724|4136783|P3|COMPLETED|Period II||16
1693081|NCT00490724|4136784|P2|COMPLETED|Period II||19
1693082|NCT00490724|4136785|P1|COMPLETED|Period II||18
1693083|NCT00490724|4136783|P3|STARTED|Period II||19
1693084|NCT00490724|4136784|P2|STARTED|Period II||20
1693085|NCT00490724|4136785|P1|STARTED|Period II||21
1693086|NCT00490724|4136783|P3|NOT COMPLETED|Period I||1
1693087|NCT00490724|4136784|P2|NOT COMPLETED|Period I||0
1693088|NCT00490724|4136785|P1|NOT COMPLETED|Period I||0
1693089|NCT00490724|4136783|P3|COMPLETED|Period I||19
1693090|NCT00490724|4136784|P2|COMPLETED|Period I||20
1693091|NCT00490724|4136785|P1|COMPLETED|Period I||21
1693092|NCT00490724|4136783|P3|STARTED|Period I||20
1693093|NCT00490724|4136784|P2|STARTED|Period I||20
1693094|NCT00490724|4136785|P1|STARTED|Period I||21
1693095|NCT00490698|4136850|P1|NOT COMPLETED|Overall Study||10
1693096|NCT00490698|4136850|P1|COMPLETED|Overall Study||1
1693097|NCT00490698|4136850|P1|STARTED|Overall Study||11
1693098|NCT00490646|4136856|P2|NOT COMPLETED|Overall Study||2
1693099|NCT00490646|4136857|P1|NOT COMPLETED|Overall Study||2
1693100|NCT00490646|4136856|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
1693101|NCT00490646|4136857|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
1693102|NCT00490646|4136856|P2|Treated|Overall Study||24
1693103|NCT00490646|4136857|P1|Treated|Overall Study||24
1693104|NCT00490646|4136856|P2|STARTED|Overall Study||25
1693105|NCT00490646|4136857|P1|STARTED|Overall Study||25
1693106|NCT00490568|4136877|P1|NOT COMPLETED|Overall Study||1364
1693107|NCT00490568|4136877|P1|COMPLETED|Overall Study||97
1693108|NCT00490568|4136877|P1|STARTED|Overall Study||1461
1693109|NCT00490555|4136901|P4|NOT COMPLETED|Overall Study||0
1693110|NCT00490555|4136902|P3|NOT COMPLETED|Overall Study||2
1693111|NCT00490555|4136903|P2|NOT COMPLETED|Overall Study||0
1693112|NCT00490555|4136904|P1|NOT COMPLETED|Overall Study||0
1693113|NCT00490555|4136901|P4|COMPLETED|Overall Study||7
1693114|NCT00490555|4136902|P3|COMPLETED|Overall Study||7
1693115|NCT00490555|4136903|P2|COMPLETED|Overall Study||8
1693116|NCT00490555|4136904|P1|COMPLETED|Overall Study||8
1693117|NCT00490555|4136901|P4|STARTED|Overall Study||7
1693118|NCT00490555|4136902|P3|STARTED|Overall Study||9
1693119|NCT00490555|4136903|P2|STARTED|Overall Study||8
1693120|NCT00490555|4136904|P1|STARTED|Overall Study||8
1693121|NCT00490542|4136932|P2|NOT COMPLETED|Overall Study||4
1693122|NCT00490542|4136933|P1|NOT COMPLETED|Overall Study||7
1693123|NCT00490542|4136932|P2|COMPLETED|Overall Study||31
1693124|NCT00490542|4136933|P1|COMPLETED|Overall Study||31
1693125|NCT00490542|4136932|P2|STARTED|Overall Study||35
1693126|NCT00490542|4136933|P1|STARTED|Overall Study||38
1693127|NCT00490490|4136939|P1|NOT COMPLETED|Completed Assessment for TTP||3
1693128|NCT00490490|4136939|P1|COMPLETED|Completed Assessment for TTP||5
1693129|NCT00490490|4136939|P1|STARTED|Completed Assessment for TTP||8
1693130|NCT00490490|4136939|P1|NOT COMPLETED|Completed Assessment for CR||0
1693131|NCT00490490|4136939|P1|COMPLETED|Completed Assessment for CR||8
1693132|NCT00490490|4136939|P1|STARTED|Completed Assessment for CR||8
1693133|NCT00490477|4136947|P2|NOT COMPLETED|Overall Study||0
1693134|NCT00490477|4136948|P1|NOT COMPLETED|Overall Study||0
1693135|NCT00490477|4136947|P2|COMPLETED|Overall Study||8
1693136|NCT00490477|4136948|P1|COMPLETED|Overall Study||8
1693137|NCT00490477|4136947|P2|STARTED|Overall Study||8
1693138|NCT00490477|4136948|P1|STARTED|Overall Study||8
1693139|NCT00490451|4136956|P2|NOT COMPLETED|Overall Study||38
1693140|NCT00490451|4136957|P1|NOT COMPLETED|Overall Study||63
1693141|NCT00490451|4136956|P2|COMPLETED|Overall Study||0
1693142|NCT00490451|4136957|P1|COMPLETED|Overall Study||0
1693143|NCT00490451|4136956|P2|STARTED|Overall Study||38
1693144|NCT00490451|4136957|P1|STARTED|Overall Study||63
1693145|NCT00490269|4136979|P2|NOT COMPLETED|Placebo Then Dronabinol||0
1693146|NCT00490269|4136980|P1|NOT COMPLETED|Placebo Then Dronabinol||0
1693147|NCT00490269|4136979|P2|COMPLETED|Placebo Then Dronabinol||6
1693148|NCT00490269|4136980|P1|COMPLETED|Placebo Then Dronabinol||6
1693149|NCT00490269|4136979|P2|STARTED|Placebo Then Dronabinol||6
1693150|NCT00490269|4136980|P1|STARTED|Placebo Then Dronabinol||6
1693151|NCT00490269|4136979|P2|NOT COMPLETED|Dronabinol Then Placebo||0
1693152|NCT00490269|4136980|P1|NOT COMPLETED|Dronabinol Then Placebo||0
1693153|NCT00490269|4136979|P2|COMPLETED|Dronabinol Then Placebo||6
1693154|NCT00490269|4136980|P1|COMPLETED|Dronabinol Then Placebo||6
1693155|NCT00490269|4136979|P2|STARTED|Dronabinol Then Placebo||6
1693156|NCT00490269|4136980|P1|STARTED|Dronabinol Then Placebo||6
1693157|NCT00490256|4136988|P2|NOT COMPLETED|Overall Study||0
1693158|NCT00490256|4136989|P1|NOT COMPLETED|Overall Study||0
1693159|NCT00490256|4136988|P2|COMPLETED|Overall Study||7
1693160|NCT00490256|4136989|P1|COMPLETED|Overall Study||7
1693161|NCT00490256|4136988|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
1693162|NCT00490256|4136989|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
1693163|NCT00490256|4136988|P2|STARTED|Overall Study||7
1693164|NCT00490256|4136989|P1|STARTED|Overall Study||7
1693165|NCT00490139|4136999|P4|NOT COMPLETED|Overall Study||307
1693166|NCT00490139|4137000|P3|NOT COMPLETED|Overall Study||434
1693167|NCT00490139|4137001|P2|NOT COMPLETED|Overall Study||275
1693168|NCT00490139|4137002|P1|NOT COMPLETED|Overall Study||308
1693169|NCT00490139|4136999|P4|COMPLETED|Overall Study||1790
1693170|NCT00490139|4137000|P3|COMPLETED|Overall Study||1666
1693171|NCT00490139|4137001|P2|COMPLETED|Overall Study||1816
1693172|NCT00490139|4137002|P1|COMPLETED|Overall Study||1785
1693173|NCT00490139|4136999|P4|STARTED|Overall Study||2097
1693174|NCT00490139|4137000|P3|STARTED|Overall Study||2100
1693175|NCT00490139|4137001|P2|STARTED|Overall Study||2091
1693176|NCT00490139|4137002|P1|STARTED|Overall Study||2093
1693177|NCT00490100|4137032|P1|NOT COMPLETED|Overall Study||3
1693178|NCT00490100|4137032|P1|COMPLETED|Overall Study||3
1693179|NCT00490100|4137032|P1|STARTED|Overall Study||6
1693180|NCT00490061|4137037|P1|NOT COMPLETED|Overall Study||1
1693181|NCT00490061|4137037|P1|COMPLETED|Overall Study||16
1693182|NCT00490061|4137037|P1|STARTED|Overall Study||17
1693183|NCT00490035|4137046|P4|NOT COMPLETED|Overall Study||6
1693184|NCT00490035|4137047|P3|NOT COMPLETED|Overall Study||12
1693185|NCT00490035|4137048|P2|NOT COMPLETED|Overall Study||6
1693186|NCT00490035|4137049|P1|NOT COMPLETED|Overall Study||8
1693187|NCT00490035|4137046|P4|COMPLETED|Overall Study||94
1693188|NCT00490035|4137047|P3|COMPLETED|Overall Study||88
1693189|NCT00490035|4137048|P2|COMPLETED|Overall Study||93
1693190|NCT00490035|4137049|P1|COMPLETED|Overall Study||92
1693191|NCT00490035|4137046|P4|STARTED|Overall Study||100
1693192|NCT00490035|4137047|P3|STARTED|Overall Study||100
1693193|NCT00490035|4137048|P2|STARTED|Overall Study||99
1693194|NCT00490035|4137049|P1|STARTED|Overall Study||100
1693195|NCT00490022|4137149|P2|NOT COMPLETED|Overall Study||3
1693196|NCT00490022|4137150|P1|NOT COMPLETED|Overall Study||1
1693197|NCT00490022|4137149|P2|COMPLETED|Overall Study||12
1693198|NCT00490022|4137150|P1|COMPLETED|Overall Study||15
1693199|NCT00490022|4137149|P2|STARTED|Overall Study||15
1693200|NCT00490022|4137150|P1|STARTED|Overall Study||16
1693201|NCT00490009|4137158|P1|NOT COMPLETED|Overall Study||0
1693202|NCT00490009|4137158|P1|COMPLETED|Overall Study||9
1693203|NCT00490009|4137158|P1|STARTED|Overall Study||9
1693204|NCT00489970|4137166|P2|NOT COMPLETED|Persistence Year 5||0
1693205|NCT00489970|4137167|P1|NOT COMPLETED|Persistence Year 5||0
1693206|NCT00489970|4137166|P2|COMPLETED|Persistence Year 5||401
1693207|NCT00489970|4137167|P1|COMPLETED|Persistence Year 5||856
1693208|NCT00489970|4137166|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
1693209|NCT00489970|4137167|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
1693210|NCT00489970|4137166|P2|NOT COMPLETED|Persistence Year 3||0
1693211|NCT00489970|4137167|P1|NOT COMPLETED|Persistence Year 3||0
1693212|NCT00489970|4137166|P2|COMPLETED|Persistence Year 3||486
1693213|NCT00489970|4137167|P1|COMPLETED|Persistence Year 3||1019
1693214|NCT00489970|4137166|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
1693215|NCT00489970|4137167|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
1693216|NCT00489970|4137166|P2|NOT COMPLETED|Persistence Year 1||0
1693217|NCT00489970|4137167|P1|NOT COMPLETED|Persistence Year 1||0
1693218|NCT00489970|4137166|P2|COMPLETED|Persistence Year 1||523
1693219|NCT00489970|4137167|P1|COMPLETED|Persistence Year 1||1069
1693220|NCT00489970|4137166|P2|STARTED|Persistence Year 1||523
1693221|NCT00489970|4137167|P1|STARTED|Persistence Year 1||1069
1693222|NCT00489918|4137196|P5|NOT COMPLETED|Overall Study||1
1693223|NCT00489918|4137197|P4|NOT COMPLETED|Overall Study||1
1693224|NCT00489918|4137198|P3|NOT COMPLETED|Overall Study||4
1693225|NCT00489918|4137199|P2|NOT COMPLETED|Overall Study||2
1693226|NCT00489918|4137200|P1|NOT COMPLETED|Overall Study||2
1693227|NCT00489918|4137196|P5|COMPLETED|Overall Study||32
1693228|NCT00489918|4137197|P4|COMPLETED|Overall Study||32
1693229|NCT00489918|4137198|P3|COMPLETED|Overall Study||28
1693230|NCT00489918|4137199|P2|COMPLETED|Overall Study||32
1693231|NCT00489918|4137200|P1|COMPLETED|Overall Study||31
1693232|NCT00489918|4137196|P5|STARTED|Overall Study||33
1693233|NCT00489918|4137197|P4|STARTED|Overall Study||33
1693234|NCT00489918|4137198|P3|STARTED|Overall Study||32
1693235|NCT00489918|4137199|P2|STARTED|Overall Study||34
1693236|NCT00489918|4137200|P1|STARTED|Overall Study||33
1693237|NCT00489866|4137234|P2|NOT COMPLETED|Overall Study||0
1693238|NCT00489866|4137235|P1|NOT COMPLETED|Overall Study||2
1693239|NCT00489866|4137234|P2|COMPLETED|Overall Study||7
1693240|NCT00489866|4137235|P1|COMPLETED|Overall Study||5
1693241|NCT00489866|4137234|P2|STARTED|Overall Study||7
1693242|NCT00489866|4137235|P1|STARTED|Overall Study||7
1693243|NCT00489853|4137249|P3|NOT COMPLETED|Follow-up Period||0
1693244|NCT00489853|4137250|P2|NOT COMPLETED|Follow-up Period||0
1693245|NCT00489853|4137251|P1|NOT COMPLETED|Follow-up Period||0
1693246|NCT00489853|4137249|P3|COMPLETED|Follow-up Period||33
1693247|NCT00489853|4137250|P2|COMPLETED|Follow-up Period||29
1693248|NCT00489853|4137251|P1|COMPLETED|Follow-up Period||29
1693249|NCT00489853|4137249|P3|STARTED|Follow-up Period||33
1693250|NCT00489853|4137250|P2|STARTED|Follow-up Period||29
1693251|NCT00489853|4137251|P1|STARTED|Follow-up Period||29
1693252|NCT00489853|4137249|P3|NOT COMPLETED|Treatment Period 3||0
1693253|NCT00489853|4137250|P2|NOT COMPLETED|Treatment Period 3||1
1693254|NCT00489853|4137251|P1|NOT COMPLETED|Treatment Period 3||0
1693255|NCT00489853|4137249|P3|COMPLETED|Treatment Period 3||33
1693256|NCT00489853|4137250|P2|COMPLETED|Treatment Period 3||29
1693257|NCT00489853|4137251|P1|COMPLETED|Treatment Period 3||29
1693258|NCT00489853|4137249|P3|STARTED|Treatment Period 3||33
1693259|NCT00489853|4137250|P2|STARTED|Treatment Period 3||30
1693260|NCT00489853|4137251|P1|STARTED|Treatment Period 3||29
1693261|NCT00489853|4137249|P3|NOT COMPLETED|Wash-out Period 2||2
1693262|NCT00489853|4137250|P2|NOT COMPLETED|Wash-out Period 2||3
1693263|NCT00489853|4137251|P1|NOT COMPLETED|Wash-out Period 2||4
1693264|NCT00489853|4137249|P3|COMPLETED|Wash-out Period 2||31
1693265|NCT00489853|4137250|P2|COMPLETED|Wash-out Period 2||32
1693266|NCT00489853|4137251|P1|COMPLETED|Wash-out Period 2||29
1693267|NCT00489853|4137249|P3|STARTED|Wash-out Period 2||33
1693268|NCT00489853|4137250|P2|STARTED|Wash-out Period 2||35
1693269|NCT00489853|4137251|P1|STARTED|Wash-out Period 2||33
1693270|NCT00489853|4137249|P3|NOT COMPLETED|Treatment Period 2||0
1693271|NCT00489853|4137250|P2|NOT COMPLETED|Treatment Period 2||0
1693272|NCT00489853|4137251|P1|NOT COMPLETED|Treatment Period 2||0
1693273|NCT00489853|4137249|P3|COMPLETED|Treatment Period 2||33
1693274|NCT00489853|4137250|P2|COMPLETED|Treatment Period 2||35
1693275|NCT00489853|4137251|P1|COMPLETED|Treatment Period 2||33
1693276|NCT00489853|4137249|P3|STARTED|Treatment Period 2||33
1693277|NCT00489853|4137250|P2|STARTED|Treatment Period 2||35
1693278|NCT00489853|4137251|P1|STARTED|Treatment Period 2||33
1693279|NCT00489853|4137249|P3|NOT COMPLETED|Wash-out Period 1||6
1693280|NCT00489853|4137250|P2|NOT COMPLETED|Wash-out Period 1||3
1693281|NCT00489853|4137251|P1|NOT COMPLETED|Wash-out Period 1||1
1693282|NCT00489853|4137249|P3|COMPLETED|Wash-out Period 1||32
1693283|NCT00489853|4137250|P2|COMPLETED|Wash-out Period 1||34
1693284|NCT00489853|4137251|P1|COMPLETED|Wash-out Period 1||35
1693285|NCT00489853|4137249|P3|STARTED|Wash-out Period 1||38
1693286|NCT00489853|4137250|P2|STARTED|Wash-out Period 1||37
1693287|NCT00489853|4137251|P1|STARTED|Wash-out Period 1||36
1693288|NCT00489853|4137249|P3|NOT COMPLETED|Treatment Period 1||0
1693289|NCT00489853|4137250|P2|NOT COMPLETED|Treatment Period 1||0
1693290|NCT00489853|4137251|P1|NOT COMPLETED|Treatment Period 1||0
1693291|NCT00489853|4137249|P3|COMPLETED|Treatment Period 1||38
1693292|NCT00489853|4137250|P2|COMPLETED|Treatment Period 1||37
1693293|NCT00489853|4137251|P1|COMPLETED|Treatment Period 1||36
1693294|NCT00489853|4137249|P3|STARTED|Treatment Period 1||38
1693295|NCT00489853|4137250|P2|STARTED|Treatment Period 1||37
1693296|NCT00489853|4137251|P1|STARTED|Treatment Period 1||36
1693297|NCT00489736|4137348|P2|NOT COMPLETED|Overall Study||69
1693298|NCT00489736|4137349|P1|NOT COMPLETED|Overall Study||96
1693299|NCT00489736|4137348|P2|COMPLETED|Overall Study|completed study drug period|186
1693300|NCT00489736|4137349|P1|COMPLETED|Overall Study|completed study drug period|153
1693301|NCT00489736|4137348|P2|STARTED|Overall Study|Randomized and treated patients|255
1693302|NCT00489736|4137349|P1|STARTED|Overall Study|Randomized and treated patients|249
1693303|NCT00489554|4137359|P1|NOT COMPLETED|Overall Study||4
1693304|NCT00489554|4137359|P1|COMPLETED|Overall Study||226
1693305|NCT00489554|4137359|P1|STARTED|Overall Study||230
1693306|NCT00489541|4137379|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
1693307|NCT00489541|4137380|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
1693308|NCT00489541|4137379|P2|COMPLETED|9-Month Angiographic Follow-up||108
1693309|NCT00489541|4137380|P1|COMPLETED|9-Month Angiographic Follow-up||197
1693310|NCT00489541|4137379|P2|STARTED|9-Month Angiographic Follow-up||125
1693311|NCT00489541|4137380|P1|STARTED|9-Month Angiographic Follow-up||224
1693312|NCT00489541|4137379|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
1693313|NCT00489541|4137380|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
1693314|NCT00489541|4137379|P2|COMPLETED|12-Month Clinical Follow-up||120
1693315|NCT00489541|4137380|P1|COMPLETED|12-Month Clinical Follow-up||215
1693316|NCT00489541|4137379|P2|STARTED|12-Month Clinical Follow-up||125
1693317|NCT00489541|4137380|P1|STARTED|12-Month Clinical Follow-up||224
1693318|NCT00489489|4137391|P3|NOT COMPLETED|Overall Study||3
1693319|NCT00489489|4137392|P2|NOT COMPLETED|Overall Study||5
1693320|NCT00489489|4137393|P1|NOT COMPLETED|Overall Study||3
1693321|NCT00489489|4137391|P3|COMPLETED|Overall Study|completed treatment period|37
1693322|NCT00489489|4137392|P2|COMPLETED|Overall Study|completed treatment period|32
1693323|NCT00489489|4137393|P1|COMPLETED|Overall Study|completed treatment period|38
1693324|NCT00489489|4137391|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
1693325|NCT00489489|4137392|P2|Treated|Overall Study||36
1693326|NCT00489489|4137393|P1|Treated|Overall Study||41
1693327|NCT00489489|4137391|P3|STARTED|Overall Study|randomized|40
1693328|NCT00489489|4137392|P2|STARTED|Overall Study|randomized|37
1693329|NCT00489489|4137393|P1|STARTED|Overall Study|randomized|41
1693330|NCT00489476|4137425|P4|NOT COMPLETED|Overall Study||0
1693331|NCT00489476|4137426|P3|NOT COMPLETED|Overall Study||0
1693332|NCT00489476|4137427|P2|NOT COMPLETED|Overall Study||1
1693333|NCT00489476|4137428|P1|NOT COMPLETED|Overall Study||0
1693334|NCT00489476|4137425|P4|COMPLETED|Overall Study||43
1693335|NCT00489476|4137426|P3|COMPLETED|Overall Study||43
1693336|NCT00489476|4137427|P2|COMPLETED|Overall Study||42
1693337|NCT00489476|4137428|P1|COMPLETED|Overall Study||39
1693338|NCT00489476|4137425|P4|STARTED|Overall Study||43
1693339|NCT00489476|4137426|P3|STARTED|Overall Study||43
1693340|NCT00489476|4137427|P2|STARTED|Overall Study||43
1693341|NCT00489476|4137428|P1|STARTED|Overall Study||39
1693342|NCT00489424|4137449|P3|NOT COMPLETED|Overall Study||5
1693343|NCT00489424|4137450|P2|NOT COMPLETED|Overall Study||5
1693344|NCT00489424|4137451|P1|NOT COMPLETED|Overall Study||4
1693345|NCT00489424|4137449|P3|COMPLETED|Overall Study||257
1693346|NCT00489424|4137450|P2|COMPLETED|Overall Study||259
1693347|NCT00489424|4137451|P1|COMPLETED|Overall Study||263
1693348|NCT00489424|4137449|P3|STARTED|Overall Study||262
1693349|NCT00489424|4137450|P2|STARTED|Overall Study||264
1693350|NCT00489424|4137451|P1|STARTED|Overall Study||267
1693351|NCT00489411|4137482|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
1693352|NCT00489411|4137483|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
1693353|NCT00489411|4137482|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
1693354|NCT00489411|4137483|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
1693355|NCT00489411|4137482|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
1693356|NCT00489411|4137483|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
1693357|NCT00489411|4137482|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
1693358|NCT00489411|4137483|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
1693359|NCT00489411|4137482|P2|COMPLETED|Washout Period (Weeks 6-7)||93
1693360|NCT00489411|4137483|P1|COMPLETED|Washout Period (Weeks 6-7)||85
1693361|NCT00489411|4137482|P2|STARTED|Washout Period (Weeks 6-7)||94
1693362|NCT00489411|4137483|P1|STARTED|Washout Period (Weeks 6-7)||87
1693363|NCT00489411|4137482|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
1693364|NCT00489411|4137483|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
1693365|NCT00489411|4137482|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
1693366|NCT00489411|4137483|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
1693367|NCT00489411|4137482|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
1693368|NCT00489411|4137483|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
1693369|NCT00489359|4137497|P2|NOT COMPLETED|Overall Study||29
1693370|NCT00489359|4137498|P1|NOT COMPLETED|Overall Study||7
1693371|NCT00489359|4137497|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
1693372|NCT00489359|4137498|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
1693373|NCT00489359|4137497|P2|STARTED|Overall Study||66
1693374|NCT00489359|4137498|P1|STARTED|Overall Study||20
1693375|NCT00489268|4137526|P5|NOT COMPLETED|Overall Study||20
1693376|NCT00489268|4137527|P4|NOT COMPLETED|Overall Study||0
1693377|NCT00489268|4137528|P3|NOT COMPLETED|Overall Study||1
1693378|NCT00489268|4137529|P2|NOT COMPLETED|Overall Study||0
1693379|NCT00489268|4137530|P1|NOT COMPLETED|Overall Study||0
1693380|NCT00489268|4137526|P5|COMPLETED|Overall Study||50
1693381|NCT00489268|4137527|P4|COMPLETED|Overall Study||11
1693382|NCT00489268|4137528|P3|COMPLETED|Overall Study||9
1693383|NCT00489268|4137529|P2|COMPLETED|Overall Study||10
1693384|NCT00489268|4137530|P1|COMPLETED|Overall Study||1
1693385|NCT00489268|4137526|P5|STARTED|Overall Study||70
1693386|NCT00489268|4137527|P4|STARTED|Overall Study||11
1693387|NCT00489268|4137528|P3|STARTED|Overall Study||10
1693388|NCT00489268|4137529|P2|STARTED|Overall Study||10
1693389|NCT00489268|4137530|P1|STARTED|Overall Study||1
1693390|NCT00489255|4137559|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
1693391|NCT00489255|4137560|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
1693392|NCT00489255|4137559|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
1693393|NCT00489255|4137560|P1|COMPLETED|Period 3: Days 57 to 84||24
1693394|NCT00489255|4137559|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
1693395|NCT00489255|4137560|P1|STARTED|Period 3: Days 57 to 84||28
1693396|NCT00489255|4137559|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
1693397|NCT00489255|4137560|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
1693398|NCT00489255|4137559|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
1693399|NCT00489255|4137560|P1|COMPLETED|Period 2: Days 29 to 56||61
1693400|NCT00489255|4137559|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
1693401|NCT00489255|4137560|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
1693402|NCT00489255|4137559|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
1693403|NCT00489255|4137560|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
1693404|NCT00489255|4137559|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
1693405|NCT00489255|4137560|P1|STARTED|Period 2: Days 29 to 56||64
1693406|NCT00489255|4137559|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
1693407|NCT00489255|4137560|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
1693408|NCT00489255|4137559|P2|COMPLETED|Period 1: Days 1 to 28||34
1693409|NCT00489255|4137560|P1|COMPLETED|Period 1: Days 1 to 28||107
1693410|NCT00489255|4137559|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
1693411|NCT00489255|4137560|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
1693670|NCT00487539|4138581|P1|STARTED|Overall Study||331
1693412|NCT00489255|4137559|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
1693413|NCT00489255|4137560|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
1693414|NCT00489255|4137559|P2|STARTED|Period 1: Days 1 to 28||46
1693415|NCT00489255|4137560|P1|STARTED|Period 1: Days 1 to 28||136
1693416|NCT00489255|4137559|P2|NOT COMPLETED|Screening and Initial Randomization||3
1693417|NCT00489255|4137560|P1|NOT COMPLETED|Screening and Initial Randomization||9
1693418|NCT00489255|4137559|P2|COMPLETED|Screening and Initial Randomization||46
1693419|NCT00489255|4137560|P1|COMPLETED|Screening and Initial Randomization||136
1693420|NCT00489255|4137559|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
1693421|NCT00489255|4137560|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
1693422|NCT00489216|4137608|P1|NOT COMPLETED|Overall Study||1
1693423|NCT00489216|4137608|P1|COMPLETED|Overall Study||1
1693424|NCT00489216|4137608|P1|STARTED|Overall Study||2
1693425|NCT00489086|4137617|P1|NOT COMPLETED|Overall Study||23
1693426|NCT00489086|4137617|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
1693427|NCT00489086|4137617|P1|STARTED|Overall Study||36
1693428|NCT00488865|4137621|P1|NOT COMPLETED|Overall Study||0
1693429|NCT00488865|4137621|P1|COMPLETED|Overall Study||100
1693430|NCT00488865|4137621|P1|STARTED|Overall Study||100
1693431|NCT00488826|4137630|P3|NOT COMPLETED|Overall Study||26
1693432|NCT00488826|4137631|P2|NOT COMPLETED|Overall Study||52
1693433|NCT00488826|4137632|P1|NOT COMPLETED|Overall Study||56
1693434|NCT00488826|4137630|P3|COMPLETED|Overall Study||178
1693435|NCT00488826|4137631|P2|COMPLETED|Overall Study||244
1693436|NCT00488826|4137632|P1|COMPLETED|Overall Study||244
1693437|NCT00488826|4137630|P3|STARTED|Overall Study||204
1693438|NCT00488826|4137631|P2|STARTED|Overall Study||296
1693439|NCT00488826|4137632|P1|STARTED|Overall Study||300
1693440|NCT00488774|4137647|P4|NOT COMPLETED|Overall Study||3
1693441|NCT00488774|4137648|P3|NOT COMPLETED|Overall Study||5
1693442|NCT00488774|4137649|P2|NOT COMPLETED|Overall Study||5
1693443|NCT00488774|4137650|P1|NOT COMPLETED|Overall Study||8
1693444|NCT00488774|4137647|P4|COMPLETED|Overall Study||74
1693445|NCT00488774|4137648|P3|COMPLETED|Overall Study||70
1693446|NCT00488774|4137649|P2|COMPLETED|Overall Study||57
1693447|NCT00488774|4137650|P1|COMPLETED|Overall Study||69
1693448|NCT00488774|4137647|P4|STARTED|Overall Study||77
1693449|NCT00488774|4137648|P3|STARTED|Overall Study||75
1693450|NCT00488774|4137649|P2|STARTED|Overall Study||62
1693451|NCT00488774|4137650|P1|STARTED|Overall Study||77
1693452|NCT00488683|4137667|P3|NOT COMPLETED|Overall Study||2
1693453|NCT00488683|4137668|P2|NOT COMPLETED|Overall Study||6
1693454|NCT00488683|4137669|P1|NOT COMPLETED|Overall Study||12
1693455|NCT00488683|4137667|P3|COMPLETED|Overall Study||52
1693456|NCT00488683|4137668|P2|COMPLETED|Overall Study||48
1693457|NCT00488683|4137669|P1|COMPLETED|Overall Study||96
1693458|NCT00488683|4137667|P3|STARTED|Overall Study||54
1693459|NCT00488683|4137668|P2|STARTED|Overall Study||54
1693460|NCT00488683|4137669|P1|STARTED|Overall Study||108
1693461|NCT00488644|4137728|P1|NOT COMPLETED|Overall Study||2
1693462|NCT00488644|4137728|P1|COMPLETED|Overall Study||10
1693463|NCT00488644|4137728|P1|STARTED|Overall Study||12
1693464|NCT00488631|4137738|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
1693465|NCT00488631|4137739|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
1693466|NCT00488631|4137740|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
1693467|NCT00488631|4137741|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
1693468|NCT00488631|4137742|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1693469|NCT00488631|4137743|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1693470|NCT00488631|4137744|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1693471|NCT00488631|4137745|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1693472|NCT00488631|4137746|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1693473|NCT00488631|4137747|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
1693474|NCT00488631|4137738|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
1693475|NCT00488631|4137739|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
1693476|NCT00488631|4137740|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
1693477|NCT00488631|4137741|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
1693478|NCT00488631|4137742|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
1693479|NCT00488631|4137743|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
1693480|NCT00488631|4137744|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
1693481|NCT00488631|4137745|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
1693482|NCT00488631|4137746|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
1693483|NCT00488631|4137747|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
1693484|NCT00488631|4137738|P10|STARTED|Open Label Study Extension (Week 54-228)||7
1693485|NCT00488631|4137739|P9|STARTED|Open Label Study Extension (Week 54-228)||470
1693486|NCT00488631|4137740|P8|STARTED|Open Label Study Extension (Week 54-228)||93
1693487|NCT00488631|4137741|P7|STARTED|Open Label Study Extension (Week 54-228)||96
1693488|NCT00488631|4137742|P6|STARTED|Open Label Study Extension (Week 54-228)||0
1693489|NCT00488631|4137743|P5|STARTED|Open Label Study Extension (Week 54-228)||0
1693490|NCT00488631|4137744|P4|STARTED|Open Label Study Extension (Week 54-228)||0
1693491|NCT00488631|4137745|P3|STARTED|Open Label Study Extension (Week 54-228)||0
1693492|NCT00488631|4137746|P2|STARTED|Open Label Study Extension (Week 54-228)||0
1693493|NCT00488631|4137747|P1|STARTED|Open Label Study Extension (Week 54-228)||0
1693494|NCT00488631|4137738|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
1693495|NCT00488631|4137739|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
1693496|NCT00488631|4137740|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
1693497|NCT00488631|4137741|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
1693498|NCT00488631|4137742|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
1693499|NCT00488631|4137743|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
1693500|NCT00488631|4137744|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
1693501|NCT00488631|4137745|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
1693502|NCT00488631|4137746|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
1693503|NCT00488631|4137747|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
1693504|NCT00488631|4137738|P10|COMPLETED|Double Blind Period (Week 0-54)||0
1693505|NCT00488631|4137739|P9|COMPLETED|Double Blind Period (Week 0-54)||0
1693506|NCT00488631|4137740|P8|COMPLETED|Double Blind Period (Week 0-54)||0
1693507|NCT00488631|4137741|P7|COMPLETED|Double Blind Period (Week 0-54)||0
1693508|NCT00488631|4137742|P6|COMPLETED|Double Blind Period (Week 0-54)||189
1693509|NCT00488631|4137743|P5|COMPLETED|Double Blind Period (Week 0-54)||127
1693510|NCT00488631|4137744|P4|COMPLETED|Double Blind Period (Week 0-54)||88
1693511|NCT00488631|4137745|P3|COMPLETED|Double Blind Period (Week 0-54)||109
1693512|NCT00488631|4137746|P2|COMPLETED|Double Blind Period (Week 0-54)||111
1693513|NCT00488631|4137747|P1|COMPLETED|Double Blind Period (Week 0-54)||113
1693514|NCT00488631|4137738|P10|STARTED|Double Blind Period (Week 0-54)||0
1693515|NCT00488631|4137739|P9|STARTED|Double Blind Period (Week 0-54)||0
1693516|NCT00488631|4137740|P8|STARTED|Double Blind Period (Week 0-54)||0
1693517|NCT00488631|4137741|P7|STARTED|Double Blind Period (Week 0-54)||0
1693518|NCT00488631|4137742|P6|STARTED|Double Blind Period (Week 0-54)||405
1693519|NCT00488631|4137743|P5|STARTED|Double Blind Period (Week 0-54)||230
1693520|NCT00488631|4137744|P4|STARTED|Double Blind Period (Week 0-54)||129
1693521|NCT00488631|4137745|P3|STARTED|Double Blind Period (Week 0-54)||154
1693522|NCT00488631|4137746|P2|STARTED|Double Blind Period (Week 0-54)||154
1693523|NCT00488631|4137747|P1|STARTED|Double Blind Period (Week 0-54)||156
1693524|NCT00488618|4137784|P2|NOT COMPLETED|Overall Study||43
1693525|NCT00488618|4137785|P1|NOT COMPLETED|Overall Study||47
1693526|NCT00488618|4137784|P2|COMPLETED|Overall Study||75
1693527|NCT00488618|4137785|P1|COMPLETED|Overall Study||73
1693528|NCT00488618|4137784|P2|Safety Population: Received Study Drug|Overall Study||118
1693529|NCT00488618|4137785|P1|Safety Population: Received Study Drug|Overall Study||118
1693530|NCT00488618|4137784|P2|STARTED|Overall Study||118
1693531|NCT00488618|4137785|P1|STARTED|Overall Study||120
1693532|NCT00488592|4137793|P1|NOT COMPLETED|Overall Study||3
1693533|NCT00488592|4137793|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
1693534|NCT00488592|4137793|P1|STARTED|Overall Study|10 subjects were accrued|10
1693535|NCT00488514|4137797|P1|NOT COMPLETED|Overall Study||293
1693536|NCT00488514|4137797|P1|COMPLETED|Overall Study||363
1693537|NCT00488514|4137797|P1|STARTED|Overall Study||656
1693538|NCT00488488|4137870|P1|NOT COMPLETED|Overall Study||268
1693539|NCT00488488|4137870|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
1693540|NCT00488488|4137870|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
1693541|NCT00488488|4137870|P1|STARTED|Overall Study||1028
1693542|NCT00488475|4137885|P1|NOT COMPLETED|Overall Study||1754
1693543|NCT00488475|4137885|P1|COMPLETED|Overall Study||3191
1693544|NCT00488475|4137885|P1|STARTED|Overall Study||4945
1693545|NCT00488345|4137914|P3|NOT COMPLETED|Overall Study||3
1693546|NCT00488345|4137915|P2|NOT COMPLETED|Overall Study||4
1693547|NCT00488345|4137916|P1|NOT COMPLETED|Overall Study||0
1693548|NCT00488345|4137914|P3|COMPLETED|Overall Study||17
1693549|NCT00488345|4137915|P2|COMPLETED|Overall Study||17
1693550|NCT00488345|4137916|P1|COMPLETED|Overall Study||17
1693551|NCT00488345|4137914|P3|STARTED|Overall Study||20
1693552|NCT00488345|4137915|P2|STARTED|Overall Study||21
1693553|NCT00488345|4137916|P1|STARTED|Overall Study||17
1693554|NCT00488319|4137942|P3|NOT COMPLETED|Overall Study||122
1693555|NCT00488319|4137943|P2|NOT COMPLETED|Overall Study||43
1693556|NCT00488319|4137944|P1|NOT COMPLETED|Overall Study||15
1693557|NCT00488319|4137942|P3|COMPLETED|Overall Study||121
1693558|NCT00488319|4137943|P2|COMPLETED|Overall Study||75
1693559|NCT00488319|4137944|P1|COMPLETED|Overall Study||24
1693560|NCT00488319|4137942|P3|STARTED|Overall Study||243
1693561|NCT00488319|4137943|P2|STARTED|Overall Study||118
1693562|NCT00488319|4137944|P1|STARTED|Overall Study||39
1693563|NCT00488293|4138031|P2|NOT COMPLETED|Overall Study||30
1693564|NCT00488293|4138032|P1|NOT COMPLETED|Overall Study||36
1693565|NCT00488293|4138031|P2|COMPLETED|Overall Study||166
1693566|NCT00488293|4138032|P1|COMPLETED|Overall Study||160
1693567|NCT00488293|4138031|P2|STARTED|Overall Study||196
1693568|NCT00488293|4138032|P1|STARTED|Overall Study||196
1693569|NCT00488059|4138056|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
1693570|NCT00488059|4138057|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1693571|NCT00488059|4138058|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1693572|NCT00488059|4138056|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
1693573|NCT00488059|4138057|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1693574|NCT00488059|4138058|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1693575|NCT00488059|4138056|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
1693576|NCT00488059|4138057|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1693577|NCT00488059|4138058|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
1693578|NCT00488059|4138056|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1693579|NCT00488059|4138057|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
1693580|NCT00488059|4138058|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1693581|NCT00488059|4138056|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1693582|NCT00488059|4138057|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
1693583|NCT00488059|4138058|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1693584|NCT00488059|4138056|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1693585|NCT00488059|4138057|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
1693586|NCT00488059|4138058|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
1693587|NCT00488059|4138056|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
1693588|NCT00488059|4138057|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
1693589|NCT00488059|4138058|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
1693590|NCT00488059|4138056|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
1693591|NCT00488059|4138057|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
1693592|NCT00488059|4138058|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
1693593|NCT00488059|4138056|P3|STARTED|Phase I: ENF 90mg SC BID||0
1693594|NCT00488059|4138057|P2|STARTED|Phase I: ENF 90mg SC BID||0
1693595|NCT00488059|4138058|P1|STARTED|Phase I: ENF 90mg SC BID||29
1693596|NCT00488033|4138077|P2|NOT COMPLETED|Overall Study||0
1693597|NCT00488033|4138078|P1|NOT COMPLETED|Overall Study||1
1693598|NCT00488033|4138077|P2|COMPLETED|Overall Study||452
1693599|NCT00488033|4138078|P1|COMPLETED|Overall Study||447
1693600|NCT00488033|4138077|P2|STARTED|Overall Study||452
1693601|NCT00488033|4138078|P1|STARTED|Overall Study||448
1693602|NCT00487981|4138094|P1|NOT COMPLETED|Overall Study||1
1693603|NCT00487981|4138094|P1|COMPLETED|Overall Study||0
1693604|NCT00487981|4138094|P1|STARTED|Overall Study||1
1693605|NCT00487942|4138102|P4|NOT COMPLETED|Overall Study||2
1693606|NCT00487942|4138103|P3|NOT COMPLETED|Overall Study||3
1693607|NCT00487942|4138104|P2|NOT COMPLETED|Overall Study||3
1693608|NCT00487942|4138105|P1|NOT COMPLETED|Overall Study||3
1693609|NCT00487942|4138102|P4|COMPLETED|Overall Study||13
1693610|NCT00487942|4138103|P3|COMPLETED|Overall Study||12
1693611|NCT00487942|4138104|P2|COMPLETED|Overall Study||12
1693612|NCT00487942|4138105|P1|COMPLETED|Overall Study||12
1693613|NCT00487942|4138102|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
1693614|NCT00487942|4138103|P3|STARTED|Overall Study||15
1693615|NCT00487942|4138104|P2|STARTED|Overall Study||15
1693616|NCT00487942|4138105|P1|STARTED|Overall Study||15
1693617|NCT00487825|4138489|P2|NOT COMPLETED|Overall Study||5
1693618|NCT00487825|4138490|P1|NOT COMPLETED|Overall Study||6
1693619|NCT00487825|4138489|P2|COMPLETED|Overall Study||21
1693620|NCT00487825|4138490|P1|COMPLETED|Overall Study||46
1693621|NCT00487825|4138489|P2|STARTED|Overall Study||26
1693622|NCT00487825|4138490|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
1693623|NCT00487747|4138502|P1|NOT COMPLETED|Overall Study||11
1693624|NCT00487747|4138502|P1|COMPLETED|Overall Study||7
1693625|NCT00487747|4138502|P1|STARTED|Overall Study||18
1693626|NCT00487721|4138513|P2|NOT COMPLETED|Overall Study||0
1693627|NCT00487721|4138514|P1|NOT COMPLETED|Overall Study||0
1693628|NCT00487721|4138513|P2|COMPLETED|Overall Study||6
1693629|NCT00487721|4138514|P1|COMPLETED|Overall Study||6
1693630|NCT00487721|4138513|P2|STARTED|Overall Study||6
1693631|NCT00487721|4138514|P1|STARTED|Overall Study||6
1693632|NCT00487695|4138519|P2|NOT COMPLETED|Second Procedure||3
1693633|NCT00487695|4138520|P1|NOT COMPLETED|Second Procedure||1
1693634|NCT00487695|4138519|P2|COMPLETED|Second Procedure||20
1693635|NCT00487695|4138520|P1|COMPLETED|Second Procedure||19
1693636|NCT00487695|4138519|P2|STARTED|Second Procedure||23
1693637|NCT00487695|4138520|P1|STARTED|Second Procedure||20
1693638|NCT00487695|4138519|P2|NOT COMPLETED|First Procedure||0
1693639|NCT00487695|4138520|P1|NOT COMPLETED|First Procedure||3
1693640|NCT00487695|4138519|P2|COMPLETED|First Procedure||23
1693641|NCT00487695|4138520|P1|COMPLETED|First Procedure||20
1693642|NCT00487695|4138519|P2|STARTED|First Procedure||23
1693643|NCT00487695|4138520|P1|STARTED|First Procedure||23
1693644|NCT00487669|4138536|P1|NOT COMPLETED|Overall Study||0
1693645|NCT00487669|4138536|P1|COMPLETED|Overall Study||12
1693646|NCT00487669|4138536|P1|STARTED|Overall Study||12
1693647|NCT00487578|4138548|P2|NOT COMPLETED|Overall Study||4
1693648|NCT00487578|4138549|P1|NOT COMPLETED|Overall Study||1
1693649|NCT00487578|4138548|P2|COMPLETED|Overall Study||5
1693650|NCT00487578|4138549|P1|COMPLETED|Overall Study||2
1693651|NCT00487578|4138548|P2|STARTED|Overall Study||9
1693652|NCT00487578|4138549|P1|STARTED|Overall Study||3
1693653|NCT00487565|4138565|P1|NOT COMPLETED|Overall Study||28
1693654|NCT00487565|4138565|P1|COMPLETED|Overall Study||182
1693655|NCT00487565|4138565|P1|STARTED|Overall Study||210
1693656|NCT00487552|4138569|P1|NOT COMPLETED|Overall Study||6
1693657|NCT00487552|4138569|P1|COMPLETED|Overall Study||12
1693658|NCT00487552|4138569|P1|STARTED|Overall Study||18
1693659|NCT00487539|4138578|P4|NOT COMPLETED|Overall Study||4
1693660|NCT00487539|4138579|P3|NOT COMPLETED|Overall Study||3
1693661|NCT00487539|4138580|P2|NOT COMPLETED|Overall Study||3
1693662|NCT00487539|4138581|P1|NOT COMPLETED|Overall Study||7
1693663|NCT00487539|4138578|P4|COMPLETED|Overall Study||327
1693664|NCT00487539|4138579|P3|COMPLETED|Overall Study||328
1693665|NCT00487539|4138580|P2|COMPLETED|Overall Study||69
1693666|NCT00487539|4138581|P1|COMPLETED|Overall Study||324
1693667|NCT00487539|4138578|P4|STARTED|Overall Study||331
1693668|NCT00487539|4138579|P3|STARTED|Overall Study||331
1693669|NCT00487539|4138580|P2|STARTED|Overall Study||72
1693671|NCT00487461|4138602|P3|NOT COMPLETED|Overall Study||4
1693672|NCT00487461|4138603|P2|NOT COMPLETED|Overall Study||2
1693673|NCT00487461|4138604|P1|NOT COMPLETED|Overall Study||0
1693674|NCT00487461|4138602|P3|COMPLETED|Overall Study||7
1693675|NCT00487461|4138603|P2|COMPLETED|Overall Study||10
1693676|NCT00487461|4138604|P1|COMPLETED|Overall Study||2
1693677|NCT00487461|4138602|P3|STARTED|Overall Study||11
1693678|NCT00487461|4138603|P2|STARTED|Overall Study||12
1693679|NCT00487461|4138604|P1|STARTED|Overall Study||2
1693680|NCT00487435|4138615|P1|NOT COMPLETED|Overall Study||485
1693681|NCT00487435|4138615|P1|COMPLETED|Overall Study||669
1693682|NCT00487435|4138615|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
1693683|NCT00487396|4138620|P1|NOT COMPLETED|Overall Study||3
1693684|NCT00487396|4138620|P1|COMPLETED|Overall Study||95
1693685|NCT00487396|4138620|P1|STARTED|Overall Study||98
1693686|NCT00487279|4138628|P2|NOT COMPLETED|Overall Study||2
1693687|NCT00487279|4138629|P1|NOT COMPLETED|Overall Study||1
1693688|NCT00487279|4138628|P2|COMPLETED|Overall Study||35
1693689|NCT00487279|4138629|P1|COMPLETED|Overall Study||43
1693690|NCT00487279|4138628|P2|STARTED|Overall Study||37
1693691|NCT00487279|4138629|P1|STARTED|Overall Study||44
1693692|NCT00487240|4138639|P2|NOT COMPLETED|Overall Study||26
1693693|NCT00487240|4138640|P1|NOT COMPLETED|Overall Study||31
1693694|NCT00487240|4138639|P2|COMPLETED|Overall Study||166
1693695|NCT00487240|4138640|P1|COMPLETED|Overall Study||164
1693696|NCT00487240|4138639|P2|Full Analysis Set (ITT Population)|Overall Study||189
1693697|NCT00487240|4138640|P1|Full Analysis Set (ITT Population)|Overall Study||192
1693698|NCT00487240|4138639|P2|STARTED|Overall Study||192
1693699|NCT00487240|4138640|P1|STARTED|Overall Study||195
1693700|NCT00487188|4138668|P3|NOT COMPLETED|Maintenance Phase||1
1693701|NCT00487188|4138669|P2|NOT COMPLETED|Maintenance Phase||0
1693702|NCT00487188|4138670|P1|NOT COMPLETED|Maintenance Phase||3
1693703|NCT00487188|4138668|P3|COMPLETED|Maintenance Phase||8
1693704|NCT00487188|4138669|P2|COMPLETED|Maintenance Phase||8
1693705|NCT00487188|4138670|P1|COMPLETED|Maintenance Phase||7
1693706|NCT00487188|4138668|P3|STARTED|Maintenance Phase||9
1693707|NCT00487188|4138669|P2|STARTED|Maintenance Phase||8
1693708|NCT00487188|4138670|P1|STARTED|Maintenance Phase||10
1693709|NCT00487188|4138668|P3|NOT COMPLETED|Induction Phase||0
1693710|NCT00487188|4138669|P2|NOT COMPLETED|Induction Phase||7
1693711|NCT00487188|4138670|P1|NOT COMPLETED|Induction Phase||9
1693712|NCT00487188|4138668|P3|COMPLETED|Induction Phase||0
1693713|NCT00487188|4138669|P2|COMPLETED|Induction Phase||9
1693714|NCT00487188|4138670|P1|COMPLETED|Induction Phase||22
1693715|NCT00487188|4138668|P3|Safety Population|Induction Phase||0
1693716|NCT00487188|4138669|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
1693717|NCT00487188|4138670|P1|Safety Population|Induction Phase||29
1693718|NCT00487188|4138668|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
1693719|NCT00487188|4138669|P2|STARTED|Induction Phase||16
1693720|NCT00487188|4138670|P1|STARTED|Induction Phase||31
1693721|NCT00487162|4138709|P2|NOT COMPLETED|Overall Study||5
1693722|NCT00487162|4138710|P1|NOT COMPLETED|Overall Study||2
1693723|NCT00487162|4138709|P2|COMPLETED|Overall Study||21
1693724|NCT00487162|4138710|P1|COMPLETED|Overall Study||28
1693725|NCT00487162|4138709|P2|STARTED|Overall Study||26
1693726|NCT00487162|4138710|P1|STARTED|Overall Study||30
1693727|NCT00487084|4138721|P3|NOT COMPLETED|Overall Study||5
1693728|NCT00487084|4138722|P2|NOT COMPLETED|Overall Study||3
1693729|NCT00487084|4138723|P1|NOT COMPLETED|Overall Study||4
1693730|NCT00487084|4138721|P3|COMPLETED|Overall Study||28
1693731|NCT00487084|4138722|P2|COMPLETED|Overall Study||30
1693732|NCT00487084|4138723|P1|COMPLETED|Overall Study||29
1693733|NCT00487084|4138721|P3|STARTED|Overall Study||33
1693734|NCT00487084|4138722|P2|STARTED|Overall Study||33
1693735|NCT00487084|4138723|P1|STARTED|Overall Study||33
1693736|NCT00486954|4138744|P5|NOT COMPLETED|Randomized Part||14
1693737|NCT00486954|4138745|P4|NOT COMPLETED|Randomized Part||20
1693738|NCT00486954|4138746|P3|NOT COMPLETED|Randomized Part||0
1693739|NCT00486954|4138747|P2|NOT COMPLETED|Randomized Part||0
1693740|NCT00486954|4138748|P1|NOT COMPLETED|Randomized Part||0
1693741|NCT00486954|4138744|P5|COMPLETED|Randomized Part||115
1693742|NCT00486954|4138745|P4|COMPLETED|Randomized Part||112
1693743|NCT00486954|4138746|P3|COMPLETED|Randomized Part||0
1693744|NCT00486954|4138747|P2|COMPLETED|Randomized Part||0
1693745|NCT00486954|4138748|P1|COMPLETED|Randomized Part||0
1693746|NCT00486954|4138744|P5|STARTED|Randomized Part||129
1693747|NCT00486954|4138745|P4|STARTED|Randomized Part||132
1693748|NCT00486954|4138746|P3|STARTED|Randomized Part||0
1693749|NCT00486954|4138747|P2|STARTED|Randomized Part||0
1693750|NCT00486954|4138748|P1|STARTED|Randomized Part||0
1693751|NCT00486954|4138744|P5|NOT COMPLETED|Pilot Part||0
1693752|NCT00486954|4138745|P4|NOT COMPLETED|Pilot Part||0
1693753|NCT00486954|4138746|P3|NOT COMPLETED|Pilot Part||6
1693754|NCT00486954|4138747|P2|NOT COMPLETED|Pilot Part||0
1693755|NCT00486954|4138748|P1|NOT COMPLETED|Pilot Part||6
1693756|NCT00486954|4138744|P5|COMPLETED|Pilot Part||0
1693757|NCT00486954|4138745|P4|COMPLETED|Pilot Part||0
1693758|NCT00486954|4138746|P3|COMPLETED|Pilot Part||0
1693759|NCT00486954|4138747|P2|COMPLETED|Pilot Part||0
1693760|NCT00486954|4138748|P1|COMPLETED|Pilot Part||0
1693761|NCT00486954|4138744|P5|STARTED|Pilot Part||0
1693762|NCT00486954|4138745|P4|STARTED|Pilot Part||0
1693763|NCT00486954|4138746|P3|STARTED|Pilot Part||6
1693764|NCT00486954|4138747|P2|STARTED|Pilot Part||0
1693765|NCT00486954|4138748|P1|STARTED|Pilot Part||6
1693766|NCT00486902|4138846|P2|NOT COMPLETED|Overall Study||5
1693767|NCT00486902|4138847|P1|NOT COMPLETED|Overall Study||9
1693768|NCT00486902|4138846|P2|COMPLETED|Overall Study||89
1693769|NCT00486902|4138847|P1|COMPLETED|Overall Study||85
1693770|NCT00486902|4138846|P2|STARTED|Overall Study||94
1693771|NCT00486902|4138847|P1|STARTED|Overall Study||94
1693772|NCT00486863|4138869|P2|NOT COMPLETED|Overall Study||3
1693773|NCT00486863|4138870|P1|NOT COMPLETED|Overall Study||1
1693774|NCT00486863|4138869|P2|COMPLETED|Overall Study||183
1693775|NCT00486863|4138870|P1|COMPLETED|Overall Study||183
1693776|NCT00486863|4138869|P2|STARTED|Overall Study||186
1693777|NCT00486863|4138870|P1|STARTED|Overall Study||184
1693778|NCT00486837|4138914|P2|NOT COMPLETED|Overall Study||7
1693779|NCT00486837|4138915|P1|NOT COMPLETED|Overall Study||9
1693780|NCT00486837|4138914|P2|COMPLETED|Overall Study||28
1693781|NCT00486837|4138915|P1|COMPLETED|Overall Study||28
1693782|NCT00486837|4138914|P2|STARTED|Overall Study||35
1693783|NCT00486837|4138915|P1|STARTED|Overall Study||37
1693784|NCT00486824|4138933|P2|NOT COMPLETED|Overall Study||2
1693785|NCT00486824|4138934|P1|NOT COMPLETED|Overall Study||2
1693786|NCT00486824|4138933|P2|COMPLETED|Overall Study||3
1693787|NCT00486824|4138934|P1|COMPLETED|Overall Study||3
1693788|NCT00486824|4138933|P2|STARTED|Overall Study||5
1693789|NCT00486824|4138934|P1|STARTED|Overall Study||5
1693790|NCT00486811|4138955|P3|NOT COMPLETED|Overall Study||214
1693791|NCT00486811|4138956|P2|NOT COMPLETED|Overall Study||141
1693792|NCT00486811|4138957|P1|NOT COMPLETED|Overall Study||122
1693793|NCT00486811|4138955|P3|COMPLETED|Overall Study||119
1693794|NCT00486811|4138956|P2|COMPLETED|Overall Study||179
1693795|NCT00486811|4138957|P1|COMPLETED|Overall Study||215
1693796|NCT00486811|4138955|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
1693797|NCT00486811|4138956|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
1693798|NCT00486811|4138957|P1|STARTED|Overall Study||337
1693799|NCT00486759|4139000|P2|NOT COMPLETED|Safety Follow-up||118
1693800|NCT00486759|4139001|P1|NOT COMPLETED|Safety Follow-up||139
1693801|NCT00486759|4139000|P2|COMPLETED|Safety Follow-up||142
1693802|NCT00486759|4139001|P1|COMPLETED|Safety Follow-up||64
1693803|NCT00486759|4139000|P2|STARTED|Safety Follow-up||260
1693804|NCT00486759|4139001|P1|STARTED|Safety Follow-up||203
1693805|NCT00486759|4139000|P2|NOT COMPLETED|Treatment||137
1693806|NCT00486759|4139001|P1|NOT COMPLETED|Treatment||187
1693807|NCT00486759|4139000|P2|COMPLETED|Treatment||260
1693808|NCT00486759|4139001|P1|COMPLETED|Treatment||203
1693809|NCT00486759|4139000|P2|STARTED|Treatment||397
1693810|NCT00486759|4139001|P1|STARTED|Treatment||390
1693811|NCT00486720|4139013|P2|NOT COMPLETED|Overall Study||12
1693812|NCT00486720|4139014|P1|NOT COMPLETED|Overall Study||10
1693813|NCT00486720|4139013|P2|COMPLETED|Overall Study||0
1693814|NCT00486720|4139014|P1|COMPLETED|Overall Study||0
1693815|NCT00486720|4139013|P2|STARTED|Overall Study||12
1693816|NCT00486720|4139014|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
1693817|NCT00486642|4139024|P2|NOT COMPLETED|Overall Study||0
1693818|NCT00486642|4139025|P1|NOT COMPLETED|Overall Study||0
1693819|NCT00486642|4139024|P2|COMPLETED|Overall Study||13
1693820|NCT00486642|4139025|P1|COMPLETED|Overall Study||10
1693821|NCT00486642|4139024|P2|STARTED|Overall Study||13
1693822|NCT00486642|4139025|P1|STARTED|Overall Study||10
1693823|NCT00486525|4139049|P2|NOT COMPLETED|Overall Study||13
1693824|NCT00486525|4139050|P1|NOT COMPLETED|Overall Study||6
1693825|NCT00486525|4139049|P2|COMPLETED|Overall Study||87
1693826|NCT00486525|4139050|P1|COMPLETED|Overall Study||94
1693827|NCT00486525|4139049|P2|STARTED|Overall Study||100
1693828|NCT00486525|4139050|P1|STARTED|Overall Study||100
1693829|NCT00486447|4139066|P1|NOT COMPLETED|Overall Study||0
1693830|NCT00486447|4139066|P1|COMPLETED|Overall Study||249
1693831|NCT00486447|4139066|P1|STARTED|Overall Study||249
1693832|NCT00486434|4139073|P2|NOT COMPLETED|Overall Study||134
1693833|NCT00486434|4139074|P1|NOT COMPLETED|Overall Study||194
1693834|NCT00486434|4139073|P2|COMPLETED|Overall Study||454
1693835|NCT00486434|4139074|P1|COMPLETED|Overall Study||394
1693836|NCT00486434|4139073|P2|STARTED|Overall Study||588
1693837|NCT00486434|4139074|P1|STARTED|Overall Study||588
1693838|NCT00486330|4139084|P1|NOT COMPLETED|Overall Study||2
1693839|NCT00486330|4139084|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
1693840|NCT00486330|4139084|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
1693841|NCT00486291|4139090|P2|NOT COMPLETED|Overall Study||29
1693842|NCT00486291|4139091|P1|NOT COMPLETED|Overall Study||16
1693843|NCT00486291|4139090|P2|COMPLETED|Overall Study||76
1693844|NCT00486291|4139091|P1|COMPLETED|Overall Study||89
1693845|NCT00486291|4139090|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
1693846|NCT00486291|4139091|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
1693847|NCT00486278|4139099|P1|NOT COMPLETED|Overall Study||9
1693848|NCT00486278|4139099|P1|COMPLETED|Overall Study||42
1693849|NCT00486278|4139099|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
1693850|NCT00486265|4139233|P1|NOT COMPLETED|Overall Study||9
1693851|NCT00486265|4139233|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
1693852|NCT00486265|4139233|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
1693853|NCT00486252|4139237|P1|NOT COMPLETED|Overall Study||58
1693854|NCT00486252|4139237|P1|COMPLETED|Overall Study||938
1693855|NCT00486252|4139237|P1|STARTED|Overall Study||996
1693856|NCT00486226|4139252|P1|NOT COMPLETED|Overall Study||13
1693857|NCT00486226|4139252|P1|COMPLETED|Overall Study||92
1693858|NCT00486226|4139252|P1|STARTED|Overall Study||105
1693859|NCT00486044|4139262|P2|NOT COMPLETED|Overall Study||3
1693860|NCT00486044|4139263|P1|NOT COMPLETED|Overall Study||2
1693861|NCT00486044|4139262|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
1693862|NCT00486044|4139263|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
1693863|NCT00486044|4139262|P2|STARTED|Overall Study|23 in MRI sub-study|49
1693864|NCT00486044|4139263|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
1693865|NCT00486031|4139275|P1|NOT COMPLETED|Overall Study||3
1693866|NCT00486031|4139275|P1|COMPLETED|Overall Study||440
1693867|NCT00486031|4139275|P1|STARTED|Overall Study||443
1693868|NCT00486018|4139282|P3|NOT COMPLETED|Overall Study||6
1693869|NCT00486018|4139283|P2|NOT COMPLETED|Overall Study||6
1693870|NCT00486018|4139284|P1|NOT COMPLETED|Overall Study||9
1693871|NCT00486018|4139282|P3|COMPLETED|Overall Study||125
1693872|NCT00486018|4139283|P2|COMPLETED|Overall Study||128
1693873|NCT00486018|4139284|P1|COMPLETED|Overall Study||123
1693874|NCT00486018|4139282|P3|Received Drug (Safety Population)|Overall Study||130
1693875|NCT00486018|4139283|P2|Received Drug (Safety Population)|Overall Study||134
1693876|NCT00486018|4139284|P1|Received Drug (Safety Population)|Overall Study||131
1693877|NCT00486018|4139282|P3|STARTED|Overall Study||131
1693878|NCT00486018|4139283|P2|STARTED|Overall Study||134
1693879|NCT00486018|4139284|P1|STARTED|Overall Study||132
1693880|NCT00485953|4139312|P2|NOT COMPLETED|Overall Study||7
1693881|NCT00485953|4139313|P1|NOT COMPLETED|Overall Study||7
1693882|NCT00485953|4139312|P2|COMPLETED|Overall Study||47
1693883|NCT00485953|4139313|P1|COMPLETED|Overall Study||48
1693884|NCT00485953|4139312|P2|STARTED|Overall Study||54
1693885|NCT00485953|4139313|P1|STARTED|Overall Study||55
1693886|NCT00485836|4139326|P3|NOT COMPLETED|Overall Study||11
1693887|NCT00485836|4139327|P2|NOT COMPLETED|Overall Study||3
1693888|NCT00485836|4139328|P1|NOT COMPLETED|Overall Study||15
1693889|NCT00485836|4139326|P3|COMPLETED|Overall Study||119
1693890|NCT00485836|4139327|P2|COMPLETED|Overall Study||129
1693891|NCT00485836|4139328|P1|COMPLETED|Overall Study||115
1693892|NCT00485836|4139326|P3|Received Study Drug (Safety Population)|Overall Study||129
1693893|NCT00485836|4139327|P2|Received Study Drug (Safety Population)|Overall Study||132
1693894|NCT00485836|4139328|P1|Received Study Drug (Safety Population)|Overall Study||129
1693895|NCT00485836|4139326|P3|STARTED|Overall Study||130
1693896|NCT00485836|4139327|P2|STARTED|Overall Study||132
1693897|NCT00485836|4139328|P1|STARTED|Overall Study||130
1693898|NCT00485758|4139356|P2|NOT COMPLETED|Overall Study||65
1693899|NCT00485758|4139357|P1|NOT COMPLETED|Overall Study||156
1693900|NCT00485758|4139356|P2|COMPLETED|Overall Study||277
1693901|NCT00485758|4139357|P1|COMPLETED|Overall Study||298
1693902|NCT00485758|4139356|P2|STARTED|Overall Study||342
1693903|NCT00485758|4139357|P1|STARTED|Overall Study||454
1693904|NCT00485732|4139369|P2|NOT COMPLETED|Overall Study||9
1693905|NCT00485732|4139370|P1|NOT COMPLETED|Overall Study||8
1693906|NCT00485732|4139369|P2|COMPLETED|Overall Study||67
1693907|NCT00485732|4139370|P1|COMPLETED|Overall Study||141
1693908|NCT00485732|4139369|P2|STARTED|Overall Study||76
1693909|NCT00485732|4139370|P1|STARTED|Overall Study||149
1693910|NCT00485693|4139392|P2|NOT COMPLETED|Overall Study||0
1693911|NCT00485693|4139393|P1|NOT COMPLETED|Overall Study||0
1693912|NCT00485693|4139392|P2|COMPLETED|Overall Study||104
1693913|NCT00485693|4139393|P1|COMPLETED|Overall Study||34
1693914|NCT00485693|4139392|P2|STARTED|Overall Study||104
1693915|NCT00485693|4139393|P1|STARTED|Overall Study||34
1693916|NCT00485485|4139402|P1|NOT COMPLETED|Overall Study||0
1693917|NCT00485485|4139402|P1|COMPLETED|Overall Study||7
1693918|NCT00485485|4139402|P1|STARTED|Overall Study||7
1693919|NCT00485472|4139408|P2|NOT COMPLETED|Overall Study||12
1693920|NCT00485472|4139409|P1|NOT COMPLETED|Overall Study||16
1693921|NCT00485472|4139408|P2|COMPLETED|Overall Study||64
1693922|NCT00485472|4139409|P1|COMPLETED|Overall Study||57
1693923|NCT00485472|4139408|P2|Entered Maintenance Phase|Overall Study||67
1693924|NCT00485472|4139409|P1|Entered Maintenance Phase|Overall Study||65
1693925|NCT00485472|4139408|P2|STARTED|Overall Study||76
1693926|NCT00485472|4139409|P1|STARTED|Overall Study||73
1693927|NCT00485433|4139435|P4|NOT COMPLETED|Overall Study||0
1693928|NCT00485433|4139436|P3|NOT COMPLETED|Overall Study||0
1693929|NCT00485433|4139437|P2|NOT COMPLETED|Overall Study||0
1693930|NCT00485433|4139438|P1|NOT COMPLETED|Overall Study||0
1693931|NCT00485433|4139435|P4|COMPLETED|Overall Study||25
1693932|NCT00485433|4139436|P3|COMPLETED|Overall Study||24
1693933|NCT00485433|4139437|P2|COMPLETED|Overall Study||25
1693934|NCT00485433|4139438|P1|COMPLETED|Overall Study||24
1693935|NCT00485433|4139435|P4|STARTED|Overall Study||25
1693936|NCT00485433|4139436|P3|STARTED|Overall Study||24
1693937|NCT00485433|4139437|P2|STARTED|Overall Study||25
1693938|NCT00485433|4139438|P1|STARTED|Overall Study||24
1693939|NCT00485303|4139446|P1|NOT COMPLETED|Overall Study||56
1693940|NCT00485303|4139446|P1|COMPLETED|Overall Study||2
1693941|NCT00485303|4139446|P1|STARTED|Overall Study||58
1693942|NCT00485264|4139464|P6|NOT COMPLETED|Overall Study||7
1693943|NCT00485264|4139465|P5|NOT COMPLETED|Overall Study||6
1693944|NCT00485264|4139466|P4|NOT COMPLETED|Overall Study||4
1693945|NCT00485264|4139467|P3|NOT COMPLETED|Overall Study||6
1693946|NCT00485264|4139468|P2|NOT COMPLETED|Overall Study||7
1693947|NCT00485264|4139469|P1|NOT COMPLETED|Overall Study||36
1693948|NCT00485264|4139464|P6|COMPLETED|Overall Study||5
1693949|NCT00485264|4139465|P5|COMPLETED|Overall Study||9
1693950|NCT00485264|4139466|P4|COMPLETED|Overall Study||17
1693951|NCT00485264|4139467|P3|COMPLETED|Overall Study||12
1693952|NCT00485264|4139468|P2|COMPLETED|Overall Study||9
1693953|NCT00485264|4139469|P1|COMPLETED|Overall Study||35
1693954|NCT00485264|4139464|P6|Completed Week 24|Overall Study||11
1693955|NCT00485264|4139465|P5|Completed Week 24|Overall Study||14
1693956|NCT00485264|4139466|P4|Completed Week 24|Overall Study||21
1693957|NCT00485264|4139467|P3|Completed Week 24|Overall Study||18
1693958|NCT00485264|4139468|P2|Completed Week 24|Overall Study||16
1693959|NCT00485264|4139469|P1|Completed Week 24|Overall Study||67
1693960|NCT00485264|4139464|P6|STARTED|Overall Study||12
1693961|NCT00485264|4139465|P5|STARTED|Overall Study||15
1693962|NCT00485264|4139466|P4|STARTED|Overall Study||21
1693963|NCT00485264|4139467|P3|STARTED|Overall Study||18
1693964|NCT00485264|4139468|P2|STARTED|Overall Study||16
1693965|NCT00485264|4139469|P1|STARTED|Overall Study||71
1693966|NCT00485173|4139557|P2|NOT COMPLETED|Overall Study||64
1693967|NCT00485173|4139558|P1|NOT COMPLETED|Overall Study||36
1693968|NCT00485173|4139557|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
1693969|NCT00485173|4139558|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
1693970|NCT00485173|4139557|P2|STARTED|Overall Study||486
1693971|NCT00485173|4139558|P1|STARTED|Overall Study||224
1693972|NCT00485134|4139606|P8|NOT COMPLETED|Overall Study||1
1693973|NCT00485134|4139607|P7|NOT COMPLETED|Overall Study||3
1693974|NCT00485134|4139608|P6|NOT COMPLETED|Overall Study||4
1693975|NCT00485134|4139609|P5|NOT COMPLETED|Overall Study||3
1693976|NCT00485134|4139610|P4|NOT COMPLETED|Overall Study||1
1693977|NCT00485134|4139611|P3|NOT COMPLETED|Overall Study||3
1693978|NCT00485134|4139612|P2|NOT COMPLETED|Overall Study||2
1693979|NCT00485134|4139613|P1|NOT COMPLETED|Overall Study||1
1693980|NCT00485134|4139606|P8|COMPLETED|Overall Study||20
1693981|NCT00485134|4139607|P7|COMPLETED|Overall Study||28
1693982|NCT00485134|4139608|P6|COMPLETED|Overall Study||3
1693983|NCT00485134|4139609|P5|COMPLETED|Overall Study||7
1693984|NCT00485134|4139610|P4|COMPLETED|Overall Study||7
1693985|NCT00485134|4139611|P3|COMPLETED|Overall Study||9
1693986|NCT00485134|4139612|P2|COMPLETED|Overall Study||10
1693987|NCT00485134|4139613|P1|COMPLETED|Overall Study||11
1693988|NCT00485134|4139606|P8|STARTED|Overall Study||21
1693989|NCT00485134|4139607|P7|STARTED|Overall Study||31
1693990|NCT00485134|4139608|P6|STARTED|Overall Study||7
1693991|NCT00485134|4139609|P5|STARTED|Overall Study||10
1693992|NCT00485134|4139610|P4|STARTED|Overall Study||8
1693993|NCT00485134|4139611|P3|STARTED|Overall Study||12
1693994|NCT00485134|4139612|P2|STARTED|Overall Study||12
1693995|NCT00485134|4139613|P1|STARTED|Overall Study||12
1693996|NCT00485069|4139635|P2|NOT COMPLETED|Overall Study||12
1693997|NCT00485069|4139636|P1|NOT COMPLETED|Overall Study||18
1693998|NCT00485069|4139635|P2|COMPLETED|Overall Study||46
1693999|NCT00485069|4139636|P1|COMPLETED|Overall Study||47
1694000|NCT00485069|4139635|P2|STARTED|Overall Study||58
1694001|NCT00485069|4139636|P1|STARTED|Overall Study||65
1694002|NCT00484939|4139681|P2|NOT COMPLETED|Overall Study||140
1694003|NCT00484939|4139682|P1|NOT COMPLETED|Overall Study||140
1694004|NCT00484939|4139681|P2|COMPLETED|Overall Study||0
1694005|NCT00484939|4139682|P1|COMPLETED|Overall Study||0
1694006|NCT00484939|4139681|P2|STARTED|Overall Study||140
1694007|NCT00484939|4139682|P1|STARTED|Overall Study||140
1694008|NCT00484874|4139702|P1|NOT COMPLETED|Overall Study||0
1694009|NCT00484874|4139702|P1|COMPLETED|Overall Study||12
1694010|NCT00484874|4139702|P1|STARTED|Overall Study||12
1694011|NCT00484679|4139709|P1|NOT COMPLETED|Overall Study||3
1694012|NCT00484679|4139709|P1|COMPLETED|Overall Study||15
1694013|NCT00484679|4139709|P1|STARTED|Overall Study||18
1694014|NCT00484419|4139716|P3|NOT COMPLETED|Overall Study||11
1694015|NCT00484419|4139717|P2|NOT COMPLETED|Overall Study||5
1694016|NCT00484419|4139718|P1|NOT COMPLETED|Overall Study||12
1694017|NCT00484419|4139716|P3|COMPLETED|Overall Study||45
1694018|NCT00484419|4139717|P2|COMPLETED|Overall Study||51
1694019|NCT00484419|4139718|P1|COMPLETED|Overall Study||45
1694020|NCT00484419|4139716|P3|STARTED|Overall Study||56
1694021|NCT00484419|4139717|P2|STARTED|Overall Study||56
1694022|NCT00484419|4139718|P1|STARTED|Overall Study||57
1694023|NCT00484393|4139776|P2|NOT COMPLETED|Overall Study||0
1694024|NCT00484393|4139777|P1|NOT COMPLETED|Overall Study||0
1694025|NCT00484393|4139776|P2|COMPLETED|Overall Study||3
1694026|NCT00484393|4139777|P1|COMPLETED|Overall Study||4
1694027|NCT00484393|4139776|P2|STARTED|Overall Study||3
1694028|NCT00484393|4139777|P1|STARTED|Overall Study||4
1694029|NCT00484354|4139785|P2|NOT COMPLETED|Overall Study||2
1694030|NCT00484354|4139786|P1|NOT COMPLETED|Overall Study||1
1694031|NCT00484354|4139785|P2|COMPLETED|Overall Study||57
1694032|NCT00484354|4139786|P1|COMPLETED|Overall Study||63
1694033|NCT00484354|4139785|P2|STARTED|Overall Study||59
1694034|NCT00484354|4139786|P1|STARTED|Overall Study||64
1694035|NCT00484315|4139802|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
1694036|NCT00484315|4139803|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
1694037|NCT00484315|4139802|P2|COMPLETED|9-Month Angiographic Follow-up||61
1694038|NCT00484315|4139803|P1|COMPLETED|9-Month Angiographic Follow-up||228
1694039|NCT00484315|4139802|P2|STARTED|9-Month Angiographic Follow-up||74
1694040|NCT00484315|4139803|P1|STARTED|9-Month Angiographic Follow-up||256
1694041|NCT00484315|4139802|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
1694042|NCT00484315|4139803|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
1694043|NCT00484315|4139802|P2|COMPLETED|12-Month Clinical Follow-up||311
1694044|NCT00484315|4139803|P1|COMPLETED|12-Month Clinical Follow-up||914
1694045|NCT00484315|4139802|P2|STARTED|12-Month Clinical Follow-up||320
1694046|NCT00484315|4139803|P1|STARTED|12-Month Clinical Follow-up||942
1694047|NCT00484289|4139814|P3|NOT COMPLETED|Post Marketing Phase||0
1694048|NCT00484289|4139815|P2|NOT COMPLETED|Post Marketing Phase||1
1694049|NCT00484289|4139816|P1|NOT COMPLETED|Post Marketing Phase||0
1694050|NCT00484289|4139814|P3|COMPLETED|Post Marketing Phase||10
1694051|NCT00484289|4139815|P2|COMPLETED|Post Marketing Phase||141
1694052|NCT00484289|4139816|P1|COMPLETED|Post Marketing Phase||10
1694053|NCT00484289|4139814|P3|STARTED|Post Marketing Phase||10
1694054|NCT00484289|4139815|P2|STARTED|Post Marketing Phase||142
1694055|NCT00484289|4139816|P1|STARTED|Post Marketing Phase||10
1694056|NCT00484289|4139814|P3|NOT COMPLETED|Long Term Phase||16
1694057|NCT00484289|4139815|P2|NOT COMPLETED|Long Term Phase||36
1694058|NCT00484289|4139816|P1|NOT COMPLETED|Long Term Phase||3
1694059|NCT00484289|4139814|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
1694060|NCT00484289|4139815|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
1694061|NCT00484289|4139816|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
1694062|NCT00484289|4139814|P3|STARTED|Long Term Phase||26
1694063|NCT00484289|4139815|P2|STARTED|Long Term Phase||178
1694064|NCT00484289|4139816|P1|STARTED|Long Term Phase||13
1694065|NCT00484185|4139888|P1|NOT COMPLETED|Overall Study||71
1694066|NCT00484185|4139888|P1|COMPLETED|Overall Study||112
1694067|NCT00484185|4139888|P1|Treated|Overall Study||178
1694068|NCT00484185|4139888|P1|STARTED|Overall Study||183
1694069|NCT00484159|4139910|P3|NOT COMPLETED|Overall Study||0
1694070|NCT00484159|4139911|P2|NOT COMPLETED|Overall Study||1
1694071|NCT00484159|4139912|P1|NOT COMPLETED|Overall Study||1
1694072|NCT00484159|4139910|P3|COMPLETED|Overall Study||51
1694073|NCT00484159|4139911|P2|COMPLETED|Overall Study||49
1694074|NCT00484159|4139912|P1|COMPLETED|Overall Study||49
1694075|NCT00484159|4139910|P3|STARTED|Overall Study||51
1694076|NCT00484159|4139911|P2|STARTED|Overall Study||50
1694077|NCT00484159|4139912|P1|STARTED|Overall Study||50
1694078|NCT00484094|4139923|P1|NOT COMPLETED|Overall Study||42
1694079|NCT00484094|4139923|P1|COMPLETED|Overall Study||167
1694080|NCT00484094|4139923|P1|STARTED|Overall Study||209
1694081|NCT00483938|4139939|P7|NOT COMPLETED|Overall Study||40
1694082|NCT00483938|4139940|P6|NOT COMPLETED|Overall Study||8
1694083|NCT00483938|4139941|P5|NOT COMPLETED|Overall Study||2
1694084|NCT00483938|4139942|P4|NOT COMPLETED|Overall Study||6
1694085|NCT00483938|4139943|P3|NOT COMPLETED|Overall Study||0
1694086|NCT00483938|4139944|P2|NOT COMPLETED|Overall Study||19
1694087|NCT00483938|4139945|P1|NOT COMPLETED|Overall Study||5
1694088|NCT00483938|4139939|P7|COMPLETED|Overall Study||0
1694089|NCT00483938|4139940|P6|COMPLETED|Overall Study||18
1694090|NCT00483938|4139941|P5|COMPLETED|Overall Study||23
1694091|NCT00483938|4139942|P4|COMPLETED|Overall Study||25
1694092|NCT00483938|4139943|P3|COMPLETED|Overall Study||30
1694093|NCT00483938|4139944|P2|COMPLETED|Overall Study||24
1694094|NCT00483938|4139945|P1|COMPLETED|Overall Study||36
1694095|NCT00483938|4139939|P7|STARTED|Overall Study||40
1694096|NCT00483938|4139940|P6|STARTED|Overall Study||26
1694097|NCT00483938|4139941|P5|STARTED|Overall Study||25
1694098|NCT00483938|4139942|P4|STARTED|Overall Study||31
1694099|NCT00483938|4139943|P3|STARTED|Overall Study||30
1694100|NCT00483938|4139944|P2|STARTED|Overall Study||43
1694101|NCT00483938|4139945|P1|STARTED|Overall Study||41
1694102|NCT00483756|4139969|P3|NOT COMPLETED|Overall Study||52
1694103|NCT00483756|4139970|P2|NOT COMPLETED|Overall Study||50
1694104|NCT00483756|4139971|P1|NOT COMPLETED|Overall Study||33
1694105|NCT00483756|4139969|P3|COMPLETED|Overall Study||59
1694106|NCT00483756|4139970|P2|COMPLETED|Overall Study||60
1694107|NCT00483756|4139971|P1|COMPLETED|Overall Study||77
1694108|NCT00483756|4139969|P3|Treated|Overall Study||107
1694109|NCT00483756|4139970|P2|Treated|Overall Study||106
1694110|NCT00483756|4139971|P1|Treated|Overall Study||109
1694111|NCT00483756|4139969|P3|STARTED|Overall Study||111
1694112|NCT00483756|4139970|P2|STARTED|Overall Study||110
1694113|NCT00483756|4139971|P1|STARTED|Overall Study||110
1694114|NCT00483717|4140035|P2|NOT COMPLETED|Overall Study||21
1694115|NCT00483717|4140036|P1|NOT COMPLETED|Overall Study||24
1694116|NCT00483717|4140035|P2|COMPLETED|Overall Study||65
1694117|NCT00483717|4140036|P1|COMPLETED|Overall Study||63
1694118|NCT00483717|4140035|P2|STARTED|Overall Study||86
1694119|NCT00483717|4140036|P1|STARTED|Overall Study||87
1694120|NCT00483704|4140059|P3|NOT COMPLETED|Treatment||156
1694121|NCT00483704|4140060|P2|NOT COMPLETED|Treatment||129
1694122|NCT00483704|4140061|P1|NOT COMPLETED|Treatment||129
1694123|NCT00483704|4140059|P3|COMPLETED|Treatment||399
1694124|NCT00483704|4140060|P2|COMPLETED|Treatment||420
1694125|NCT00483704|4140061|P1|COMPLETED|Treatment||444
1694126|NCT00483704|4140059|P3|STARTED|Treatment||555
1694127|NCT00483704|4140060|P2|STARTED|Treatment||549
1694128|NCT00483704|4140061|P1|STARTED|Treatment||573
1694129|NCT00483704|4140059|P3|NOT COMPLETED|Randomization||91
1694130|NCT00483704|4140060|P2|NOT COMPLETED|Randomization||96
1694131|NCT00483704|4140061|P1|NOT COMPLETED|Randomization||71
1694132|NCT00483704|4140059|P3|COMPLETED|Randomization||555
1694133|NCT00483704|4140060|P2|COMPLETED|Randomization||549
1694134|NCT00483704|4140061|P1|COMPLETED|Randomization||573
1694135|NCT00483704|4140059|P3|STARTED|Randomization||646
1694136|NCT00483704|4140060|P2|STARTED|Randomization||645
1694137|NCT00483704|4140061|P1|STARTED|Randomization||644
1694138|NCT00483652|4140107|P2|NOT COMPLETED|Post-study Follow-up||0
1694139|NCT00483652|4140108|P1|NOT COMPLETED|Post-study Follow-up||0
1694140|NCT00483652|4140107|P2|COMPLETED|Post-study Follow-up||114
1694141|NCT00483652|4140108|P1|COMPLETED|Post-study Follow-up||113
1694142|NCT00483652|4140107|P2|STARTED|Post-study Follow-up||114
1694143|NCT00483652|4140108|P1|STARTED|Post-study Follow-up||113
1694144|NCT00483652|4140107|P2|NOT COMPLETED|Double-blind Treatment Period||5
1694145|NCT00483652|4140108|P1|NOT COMPLETED|Double-blind Treatment Period||7
1694146|NCT00483652|4140107|P2|COMPLETED|Double-blind Treatment Period||114
1694147|NCT00483652|4140108|P1|COMPLETED|Double-blind Treatment Period||113
1694148|NCT00483652|4140107|P2|STARTED|Double-blind Treatment Period||119
1694149|NCT00483652|4140108|P1|STARTED|Double-blind Treatment Period||120
1694150|NCT00483574|4140118|P2|NOT COMPLETED|Overall Study||13
1694151|NCT00483574|4140119|P1|NOT COMPLETED|Overall Study||102
1694152|NCT00483574|4140118|P2|COMPLETED|Overall Study||308
1694153|NCT00483574|4140119|P1|COMPLETED|Overall Study||951
1694154|NCT00483574|4140118|P2|STARTED|Overall Study||321
1694155|NCT00483574|4140119|P1|STARTED|Overall Study||1053
1694156|NCT00483561|4140127|P1|NOT COMPLETED|Overall Study||11
1694157|NCT00483561|4140127|P1|COMPLETED|Overall Study||15
1694158|NCT00483561|4140127|P1|STARTED|Overall Study||26
1694159|NCT00483548|4140134|P2|NOT COMPLETED|Overall Study||46
1694160|NCT00483548|4140135|P1|NOT COMPLETED|Overall Study||60
1694161|NCT00483548|4140134|P2|COMPLETED|Overall Study||104
1694162|NCT00483548|4140135|P1|COMPLETED|Overall Study||88
1694163|NCT00483548|4140134|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
1694164|NCT00483548|4140135|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
1694165|NCT00483548|4140134|P2|STARTED|Overall Study||150
1694166|NCT00483548|4140135|P1|STARTED|Overall Study||148
1694167|NCT00483496|4140173|P1|NOT COMPLETED|Overall Study||1
1694168|NCT00483496|4140173|P1|COMPLETED|Overall Study||15
1694169|NCT00483496|4140173|P1|STARTED|Overall Study||16
1694170|NCT00483405|4140185|P1|NOT COMPLETED|Overall Study||28
1694171|NCT00483405|4140185|P1|COMPLETED|Overall Study||0
1694172|NCT00483405|4140185|P1|STARTED|Overall Study||28
1694173|NCT00483379|4140194|P2|NOT COMPLETED|Extension Period||0
1694174|NCT00483379|4140195|P1|NOT COMPLETED|Extension Period||0
1694175|NCT00483379|4140194|P2|COMPLETED|Extension Period||2
1694176|NCT00483379|4140195|P1|COMPLETED|Extension Period||1
1694177|NCT00483379|4140194|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
1694178|NCT00483379|4140195|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
1694179|NCT00483379|4140194|P2|NOT COMPLETED|Treatment Period||0
1694180|NCT00483379|4140195|P1|NOT COMPLETED|Treatment Period||2
1694181|NCT00483379|4140194|P2|COMPLETED|Treatment Period||7
1694182|NCT00483379|4140195|P1|COMPLETED|Treatment Period||4
1694183|NCT00483379|4140194|P2|STARTED|Treatment Period||7
1694184|NCT00483379|4140195|P1|STARTED|Treatment Period||6
1694185|NCT00483327|4140231|P1|NOT COMPLETED|Overall Study||10
1694186|NCT00483327|4140231|P1|COMPLETED|Overall Study||20
1694187|NCT00483327|4140231|P1|STARTED|Overall Study||30
1694188|NCT00483262|4140242|P2|NOT COMPLETED|Overall Study||0
1694189|NCT00483262|4140243|P1|NOT COMPLETED|Overall Study||0
1694190|NCT00483262|4140242|P2|COMPLETED|Overall Study||43
1694191|NCT00483262|4140243|P1|COMPLETED|Overall Study||20
1694192|NCT00483262|4140242|P2|STARTED|Overall Study||43
1694193|NCT00483262|4140243|P1|STARTED|Overall Study||20
1694194|NCT00483223|4140253|P1|NOT COMPLETED|Overall Study||0
1694195|NCT00483223|4140253|P1|COMPLETED|Overall Study||86
1694196|NCT00483223|4140253|P1|STARTED|Overall Study||86
1694197|NCT00483184|4140263|P3|NOT COMPLETED|Overall Study||3
1694198|NCT00483184|4140264|P2|NOT COMPLETED|Overall Study||4
1694199|NCT00483184|4140265|P1|NOT COMPLETED|Overall Study||5
1694200|NCT00483184|4140263|P3|COMPLETED|Overall Study||23
1694201|NCT00483184|4140264|P2|COMPLETED|Overall Study||27
1694202|NCT00483184|4140265|P1|COMPLETED|Overall Study||22
1694203|NCT00483184|4140263|P3|STARTED|Overall Study||26
1694204|NCT00483184|4140264|P2|STARTED|Overall Study||31
1694205|NCT00483184|4140265|P1|STARTED|Overall Study||27
1694206|NCT00483119|4140275|P2|NOT COMPLETED|Overall Study||1
1694207|NCT00483119|4140276|P1|NOT COMPLETED|Overall Study||1
1694208|NCT00483119|4140275|P2|COMPLETED|Overall Study||3
1694209|NCT00483119|4140276|P1|COMPLETED|Overall Study||4
1694210|NCT00483119|4140275|P2|STARTED|Overall Study||4
1694211|NCT00483119|4140276|P1|STARTED|Overall Study||5
1694212|NCT00483041|4140290|P2|NOT COMPLETED|Overall Study||1
1694213|NCT00483041|4140291|P1|NOT COMPLETED|Overall Study||0
1694214|NCT00483041|4140290|P2|COMPLETED|Overall Study||5
1694215|NCT00483041|4140291|P1|COMPLETED|Overall Study||5
1694216|NCT00483041|4140290|P2|STARTED|Overall Study||6
1694217|NCT00483041|4140291|P1|STARTED|Overall Study||5
1694218|NCT00483002|4140321|P1|NOT COMPLETED|Overall Study||2554
1694219|NCT00483002|4140321|P1|COMPLETED|Overall Study||1165
1694220|NCT00483002|4140321|P1|STARTED|Overall Study||3719
1694221|NCT00482911|4140329|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
1694222|NCT00482911|4140330|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
1694223|NCT00482911|4140329|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
1694224|NCT00482911|4140330|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
1694225|NCT00482911|4140329|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
1694226|NCT00482911|4140330|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
1694227|NCT00482911|4140329|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
1694228|NCT00482911|4140330|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
1694229|NCT00482911|4140329|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
1694230|NCT00482911|4140330|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
1694231|NCT00482911|4140329|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
1694232|NCT00482911|4140330|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
1694233|NCT00482911|4140329|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
1694234|NCT00482911|4140330|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
1694235|NCT00482911|4140329|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
1694236|NCT00482911|4140330|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
1694237|NCT00482911|4140329|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
1694238|NCT00482911|4140330|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
1694239|NCT00482729|4140346|P2|NOT COMPLETED|Overall Study||218
1694240|NCT00482729|4140347|P1|NOT COMPLETED|Overall Study||217
1694241|NCT00482729|4140346|P2|COMPLETED|Overall Study||406
1694242|NCT00482729|4140347|P1|COMPLETED|Overall Study||409
1694243|NCT00482729|4140346|P2|Completed Phase B|Overall Study||406
1694244|NCT00482729|4140347|P1|Completed Phase B|Overall Study||409
1694245|NCT00482729|4140346|P2|Completed Phase A|Overall Study||482
1694246|NCT00482729|4140347|P1|Completed Phase A|Overall Study||484
1694247|NCT00482729|4140346|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
1694248|NCT00482729|4140347|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
1694249|NCT00482703|4140363|P2|NOT COMPLETED|Overall Study||0
1694250|NCT00482703|4140364|P1|NOT COMPLETED|Overall Study||1
1694251|NCT00482703|4140363|P2|COMPLETED|Overall Study||12
1694252|NCT00482703|4140364|P1|COMPLETED|Overall Study||10
1694253|NCT00482703|4140363|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
1694254|NCT00482703|4140364|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
1694255|NCT00482677|4140411|P2|NOT COMPLETED|Overall Study||0
1694256|NCT00482677|4140412|P1|NOT COMPLETED|Overall Study||0
1694257|NCT00482677|4140411|P2|COMPLETED|Overall Study||281
1694258|NCT00482677|4140412|P1|COMPLETED|Overall Study||281
1694259|NCT00482677|4140411|P2|STARTED|Overall Study||281
1694260|NCT00482677|4140412|P1|STARTED|Overall Study||281
1694261|NCT00482625|4140422|P1|NOT COMPLETED|Overall Study||0
1694262|NCT00482625|4140422|P1|COMPLETED|Overall Study||6
1694263|NCT00482625|4140422|P1|STARTED|Overall Study||6
1694264|NCT00482612|4140435|P4|NOT COMPLETED|Follow-up Period||8
1694265|NCT00482612|4140436|P3|NOT COMPLETED|Follow-up Period||22
1694266|NCT00482612|4140437|P2|NOT COMPLETED|Follow-up Period||18
1694267|NCT00482612|4140438|P1|NOT COMPLETED|Follow-up Period||14
1694268|NCT00482612|4140435|P4|COMPLETED|Follow-up Period||127
1694269|NCT00482612|4140436|P3|COMPLETED|Follow-up Period||106
1694270|NCT00482612|4140437|P2|COMPLETED|Follow-up Period||107
1694271|NCT00482612|4140438|P1|COMPLETED|Follow-up Period||123
1694272|NCT00482612|4140435|P4|STARTED|Follow-up Period||135
1694273|NCT00482612|4140436|P3|STARTED|Follow-up Period||128
1694274|NCT00482612|4140437|P2|STARTED|Follow-up Period||125
1694275|NCT00482612|4140438|P1|STARTED|Follow-up Period||137
1694276|NCT00482612|4140435|P4|NOT COMPLETED|In-treatment Period||0
1694277|NCT00482612|4140436|P3|NOT COMPLETED|In-treatment Period||1
1694278|NCT00482612|4140437|P2|NOT COMPLETED|In-treatment Period||0
1694279|NCT00482612|4140438|P1|NOT COMPLETED|In-treatment Period||0
1694280|NCT00482612|4140435|P4|COMPLETED|In-treatment Period||135
1694281|NCT00482612|4140436|P3|COMPLETED|In-treatment Period||128
1694282|NCT00482612|4140437|P2|COMPLETED|In-treatment Period||125
1694283|NCT00482612|4140438|P1|COMPLETED|In-treatment Period||137
1694284|NCT00482612|4140435|P4|Treated|In-treatment Period||135
1694285|NCT00482612|4140436|P3|Treated|In-treatment Period||128
1694286|NCT00482612|4140437|P2|Treated|In-treatment Period||125
1694287|NCT00482612|4140438|P1|Treated|In-treatment Period||137
1694288|NCT00482612|4140435|P4|STARTED|In-treatment Period||135
1694289|NCT00482612|4140436|P3|STARTED|In-treatment Period||129
1694290|NCT00482612|4140437|P2|STARTED|In-treatment Period||125
1694291|NCT00482612|4140438|P1|STARTED|In-treatment Period||137
1694292|NCT00482547|4140466|P2|NOT COMPLETED|Overall Study||161
1694293|NCT00482547|4140467|P1|NOT COMPLETED|Overall Study||173
1694294|NCT00482547|4140466|P2|COMPLETED|Overall Study||428
1694295|NCT00482547|4140467|P1|COMPLETED|Overall Study||426
1694296|NCT00482547|4140466|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
1694297|NCT00482547|4140467|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
1694298|NCT00482547|4140466|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
1694299|NCT00482547|4140467|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
1694300|NCT00482547|4140466|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
1694301|NCT00482547|4140467|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
1694302|NCT00482391|4140487|P1|NOT COMPLETED|Overall Study||3
1694303|NCT00482391|4140487|P1|COMPLETED|Overall Study||92
1694304|NCT00482391|4140487|P1|STARTED|Overall Study||95
1694305|NCT00482274|4140492|P1|NOT COMPLETED|Overall Study||1
1694306|NCT00482274|4140492|P1|COMPLETED|Overall Study||2
1694307|NCT00482274|4140492|P1|STARTED|Overall Study||3
1694308|NCT00482170|4140502|P2|NOT COMPLETED|Overall Study||20
1694309|NCT00482170|4140503|P1|NOT COMPLETED|Overall Study||15
1694310|NCT00482170|4140502|P2|COMPLETED|Overall Study||194
1694311|NCT00482170|4140503|P1|COMPLETED|Overall Study||192
1694312|NCT00482170|4140502|P2|Treated|Overall Study||211
1694313|NCT00482170|4140503|P1|Treated|Overall Study||207
1694314|NCT00482170|4140502|P2|STARTED|Overall Study||214
1694315|NCT00482170|4140503|P1|STARTED|Overall Study||207
1694316|NCT00482053|4140621|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
1694317|NCT00482053|4140621|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
1694318|NCT00482053|4140621|P1|STARTED|Allogeneic Peripheral Stem Cells||2
1694319|NCT00482053|4140621|P1|NOT COMPLETED|Inter-treatment Period||1
1694320|NCT00482053|4140621|P1|COMPLETED|Inter-treatment Period||2
1694321|NCT00482053|4140621|P1|STARTED|Inter-treatment Period||3
1694322|NCT00482053|4140621|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
1694323|NCT00482053|4140621|P1|COMPLETED|Autologous Peripheral Stem Cells||3
1694324|NCT00482053|4140621|P1|STARTED|Autologous Peripheral Stem Cells||3
1694325|NCT00482014|4140635|P4|NOT COMPLETED|Overall Study||23
1694326|NCT00482014|4140636|P3|NOT COMPLETED|Overall Study||11
1694327|NCT00482014|4140637|P2|NOT COMPLETED|Overall Study||6
1694328|NCT00482014|4140638|P1|NOT COMPLETED|Overall Study||7
1694329|NCT00482014|4140635|P4|COMPLETED|Overall Study||29
1694330|NCT00482014|4140636|P3|COMPLETED|Overall Study||35
1694331|NCT00482014|4140637|P2|COMPLETED|Overall Study||7
1694332|NCT00482014|4140638|P1|COMPLETED|Overall Study||2
1694333|NCT00482014|4140635|P4|STARTED|Overall Study||52
1694334|NCT00482014|4140636|P3|STARTED|Overall Study||46
1694335|NCT00482014|4140637|P2|STARTED|Overall Study||13
1694336|NCT00482014|4140638|P1|STARTED|Overall Study||9
1694337|NCT00481988|4140662|P2|NOT COMPLETED|Overall Study||1
1694338|NCT00481988|4140663|P1|NOT COMPLETED|Overall Study||1
1694339|NCT00481988|4140662|P2|COMPLETED|Overall Study||8
1694340|NCT00481988|4140663|P1|COMPLETED|Overall Study||11
1694341|NCT00481988|4140662|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
1694342|NCT00481988|4140663|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
1694343|NCT00481988|4140662|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
1694344|NCT00481988|4140663|P1|STARTED|Overall Study||12
1694345|NCT00481871|4140676|P5|NOT COMPLETED|Overall Study||0
1694346|NCT00481871|4140677|P4|NOT COMPLETED|Overall Study||0
1694347|NCT00481871|4140678|P3|NOT COMPLETED|Overall Study||1
1694348|NCT00481871|4140679|P2|NOT COMPLETED|Overall Study||0
1694349|NCT00481871|4140680|P1|NOT COMPLETED|Overall Study||0
1694350|NCT00481871|4140676|P5|COMPLETED|Overall Study||34
1694351|NCT00481871|4140677|P4|COMPLETED|Overall Study||38
1694352|NCT00481871|4140678|P3|COMPLETED|Overall Study||17
1694353|NCT00481871|4140679|P2|COMPLETED|Overall Study||10
1694354|NCT00481871|4140680|P1|COMPLETED|Overall Study||7
1694355|NCT00481871|4140676|P5|STARTED|Overall Study||34
1694356|NCT00481871|4140677|P4|STARTED|Overall Study||38
1694357|NCT00481871|4140678|P3|STARTED|Overall Study||18
1694358|NCT00481871|4140679|P2|STARTED|Overall Study||10
1694359|NCT00481871|4140680|P1|STARTED|Overall Study||7
1694360|NCT00481845|4140696|P2|NOT COMPLETED|Overall Study||0
1694361|NCT00481845|4140697|P1|NOT COMPLETED|Overall Study||0
1694362|NCT00481845|4140696|P2|COMPLETED|Overall Study||0
1694363|NCT00481845|4140697|P1|COMPLETED|Overall Study||1
1694364|NCT00481845|4140696|P2|STARTED|Overall Study||0
1694365|NCT00481845|4140697|P1|STARTED|Overall Study||1
1694366|NCT00481832|4140705|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
1694367|NCT00481832|4140705|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
1694368|NCT00481832|4140705|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
1694369|NCT00481832|4140705|P1|NOT COMPLETED|Inter-transplant Period||27
1694370|NCT00481832|4140705|P1|COMPLETED|Inter-transplant Period||13
1694371|NCT00481832|4140705|P1|STARTED|Inter-transplant Period||40
1694372|NCT00481832|4140705|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
1694373|NCT00481832|4140705|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
1694374|NCT00481832|4140705|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
1694375|NCT00481832|4140705|P1|NOT COMPLETED|Enrollment||10
1694376|NCT00481832|4140705|P1|COMPLETED|Enrollment||40
1694377|NCT00481832|4140705|P1|STARTED|Enrollment||50
1694378|NCT00481767|4140720|P2|NOT COMPLETED|Overall Study||21
1694379|NCT00481767|4140721|P1|NOT COMPLETED|Overall Study||32
1694380|NCT00481767|4140720|P2|COMPLETED|Overall Study||205
1694381|NCT00481767|4140721|P1|COMPLETED|Overall Study||418
1694382|NCT00481767|4140720|P2|STARTED|Overall Study||226
1694383|NCT00481767|4140721|P1|STARTED|Overall Study||450
1694384|NCT00481676|4140755|P2|NOT COMPLETED|Overall Study||5
1694385|NCT00481676|4140756|P1|NOT COMPLETED|Overall Study||2
1694386|NCT00481676|4140755|P2|COMPLETED|Overall Study||17
1694387|NCT00481676|4140756|P1|COMPLETED|Overall Study||25
1694388|NCT00481676|4140755|P2|STARTED|Overall Study||22
1694389|NCT00481676|4140756|P1|STARTED|Overall Study||27
1694390|NCT00481507|4140780|P2|NOT COMPLETED|Overall Study||0
1694391|NCT00481507|4140781|P1|NOT COMPLETED|Overall Study||0
1694392|NCT00481507|4140780|P2|COMPLETED|Overall Study||61
1694393|NCT00481507|4140781|P1|COMPLETED|Overall Study||64
1694394|NCT00481507|4140780|P2|STARTED|Overall Study||61
1694395|NCT00481507|4140781|P1|STARTED|Overall Study||64
1694396|NCT00481351|4140789|P2|NOT COMPLETED|Overall Study||0
1694397|NCT00481351|4140790|P1|NOT COMPLETED|Overall Study||0
1694398|NCT00481351|4140789|P2|COMPLETED|Overall Study||12
1694399|NCT00481351|4140790|P1|COMPLETED|Overall Study||13
1694400|NCT00481351|4140789|P2|STARTED|Overall Study||12
1694401|NCT00481351|4140790|P1|STARTED|Overall Study||13
1694402|NCT00481247|4140806|P2|NOT COMPLETED|Overall Study||260
1694403|NCT00481247|4140807|P1|NOT COMPLETED|Overall Study||259
1694404|NCT00481247|4140806|P2|COMPLETED|Overall Study||0
1694405|NCT00481247|4140807|P1|COMPLETED|Overall Study||0
1694406|NCT00481247|4140806|P2|Received Treatment|Overall Study||258
1694407|NCT00481247|4140807|P1|Received Treatment|Overall Study||258
1694408|NCT00481247|4140806|P2|STARTED|Overall Study|Randomized|260
1694409|NCT00481247|4140807|P1|STARTED|Overall Study|Randomized|259
1694410|NCT00481195|4140831|P2|NOT COMPLETED|Overall Study||39
1694411|NCT00481195|4140832|P1|NOT COMPLETED|Overall Study||39
1694412|NCT00481195|4140831|P2|COMPLETED|Overall Study||90
1694413|NCT00481195|4140832|P1|COMPLETED|Overall Study||89
1694414|NCT00481195|4140831|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
1694415|NCT00481195|4140832|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
1694416|NCT00481078|4140918|P2|NOT COMPLETED|Overall Study||20
1694417|NCT00481078|4140919|P1|NOT COMPLETED|Overall Study||42
1694418|NCT00481078|4140918|P2|COMPLETED|Overall Study||12
1694419|NCT00481078|4140919|P1|COMPLETED|Overall Study||20
1694420|NCT00481078|4140918|P2|STARTED|Overall Study||32
1694421|NCT00481078|4140919|P1|STARTED|Overall Study||62
1694422|NCT00481065|4140937|P8|NOT COMPLETED|Overall Study||19
1694423|NCT00481065|4140938|P7|NOT COMPLETED|Overall Study||16
1694424|NCT00481065|4140939|P6|NOT COMPLETED|Overall Study||24
1694425|NCT00481065|4140940|P5|NOT COMPLETED|Overall Study||23
1694426|NCT00481065|4140941|P4|NOT COMPLETED|Overall Study||15
1694427|NCT00481065|4140942|P3|NOT COMPLETED|Overall Study||19
1694428|NCT00481065|4140943|P2|NOT COMPLETED|Overall Study||17
1694429|NCT00481065|4140944|P1|NOT COMPLETED|Overall Study||22
1694430|NCT00481065|4140937|P8|COMPLETED|Overall Study||30
1694431|NCT00481065|4140938|P7|COMPLETED|Overall Study||34
1694432|NCT00481065|4140939|P6|COMPLETED|Overall Study||27
1694433|NCT00481065|4140940|P5|COMPLETED|Overall Study||28
1694434|NCT00481065|4140941|P4|COMPLETED|Overall Study||37
1694435|NCT00481065|4140942|P3|COMPLETED|Overall Study||32
1694436|NCT00481065|4140943|P2|COMPLETED|Overall Study||33
1694437|NCT00481065|4140944|P1|COMPLETED|Overall Study||29
1694438|NCT00481065|4140937|P8|STARTED|Overall Study||49
1694439|NCT00481065|4140938|P7|STARTED|Overall Study||50
1694440|NCT00481065|4140939|P6|STARTED|Overall Study||51
1694441|NCT00481065|4140940|P5|STARTED|Overall Study||51
1694442|NCT00481065|4140941|P4|STARTED|Overall Study||52
1694443|NCT00481065|4140942|P3|STARTED|Overall Study||51
1694444|NCT00481065|4140943|P2|STARTED|Overall Study||50
1694445|NCT00481065|4140944|P1|STARTED|Overall Study||51
1694446|NCT00480987|4141030|P1|NOT COMPLETED|Overall Study||0
1694447|NCT00480987|4141030|P1|COMPLETED|Overall Study||27
1694448|NCT00480987|4141030|P1|STARTED|Overall Study||27
1694449|NCT00480857|4141034|P1|NOT COMPLETED|Overall Study||2
1694450|NCT00480857|4141034|P1|COMPLETED|Overall Study||17
1694451|NCT00480857|4141034|P1|STARTED|Overall Study||19
1694452|NCT00480779|4141044|P2|NOT COMPLETED|Overall Study||3
1694453|NCT00480779|4141045|P1|NOT COMPLETED|Overall Study||2
1694454|NCT00480779|4141044|P2|COMPLETED|Overall Study||19
1694455|NCT00480779|4141045|P1|COMPLETED|Overall Study||24
1694456|NCT00480779|4141044|P2|STARTED|Overall Study||22
1694457|NCT00480779|4141045|P1|STARTED|Overall Study||26
1694458|NCT00480740|4141072|P3|NOT COMPLETED|Overall Study||0
1694459|NCT00480740|4141073|P2|NOT COMPLETED|Overall Study||0
1694460|NCT00480740|4141074|P1|NOT COMPLETED|Overall Study||0
1694461|NCT00480740|4141072|P3|COMPLETED|Overall Study||6
1694462|NCT00480740|4141073|P2|COMPLETED|Overall Study||9
1694463|NCT00480740|4141074|P1|COMPLETED|Overall Study||26
1694464|NCT00480740|4141072|P3|STARTED|Overall Study||6
1694465|NCT00480740|4141073|P2|STARTED|Overall Study||9
1694466|NCT00480740|4141074|P1|STARTED|Overall Study||26
1694467|NCT00480636|4141082|P1|NOT COMPLETED|Overall Study||19
1694468|NCT00480636|4141082|P1|COMPLETED|Overall Study||83
1694469|NCT00480636|4141082|P1|STARTED|Overall Study||102
1694470|NCT00480532|4141094|P4|NOT COMPLETED|Overall Study||1
1694471|NCT00480532|4141095|P3|NOT COMPLETED|Overall Study||4
1694472|NCT00480532|4141096|P2|NOT COMPLETED|Overall Study||4
1694473|NCT00480532|4141097|P1|NOT COMPLETED|Overall Study||2
1694474|NCT00480532|4141094|P4|COMPLETED|Overall Study||31
1694475|NCT00480532|4141095|P3|COMPLETED|Overall Study||29
1694476|NCT00480532|4141096|P2|COMPLETED|Overall Study||29
1694477|NCT00480532|4141097|P1|COMPLETED|Overall Study||31
1694478|NCT00480532|4141094|P4|STARTED|Overall Study||32
1694479|NCT00480532|4141095|P3|STARTED|Overall Study||33
1694480|NCT00480532|4141096|P2|STARTED|Overall Study||33
1694481|NCT00480532|4141097|P1|STARTED|Overall Study||33
1694482|NCT00480493|4141117|P2|NOT COMPLETED|Overall Study||7
1694483|NCT00480493|4141118|P1|NOT COMPLETED|Overall Study||2
1694484|NCT00480493|4141117|P2|COMPLETED|Overall Study||21
1694485|NCT00480493|4141118|P1|COMPLETED|Overall Study||30
1694486|NCT00480493|4141117|P2|Randomized|Overall Study||28
1694487|NCT00480493|4141118|P1|Randomized|Overall Study||32
1694488|NCT00480493|4141117|P2|STARTED|Overall Study||28
1694489|NCT00480493|4141118|P1|STARTED|Overall Study||32
1694490|NCT00480324|4141130|P2|NOT COMPLETED|Overall Study||16
1694491|NCT00480324|4141131|P1|NOT COMPLETED|Overall Study||32
1694492|NCT00480324|4141130|P2|COMPLETED|Overall Study||241
1694493|NCT00480324|4141131|P1|COMPLETED|Overall Study||476
1694494|NCT00480324|4141130|P2|STARTED|Overall Study||257
1694495|NCT00480324|4141131|P1|STARTED|Overall Study||508
1694496|NCT00479882|4141161|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
1694497|NCT00479882|4141162|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
1694498|NCT00479882|4141163|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
1694499|NCT00479882|4141164|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
1694500|NCT00479882|4141161|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
1694501|NCT00479882|4141162|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
1694502|NCT00479882|4141163|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
1694503|NCT00479882|4141164|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
1694504|NCT00479882|4141161|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
1694505|NCT00479882|4141162|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
1694506|NCT00479882|4141163|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
1694507|NCT00479882|4141164|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
1694508|NCT00479882|4141161|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
1694509|NCT00479882|4141162|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
1694510|NCT00479882|4141163|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
1694511|NCT00479882|4141164|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
1694512|NCT00479882|4141161|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
1694513|NCT00479882|4141162|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
1694514|NCT00479882|4141163|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
1694515|NCT00479882|4141164|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
1694516|NCT00479882|4141161|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
1694517|NCT00479882|4141162|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
1694518|NCT00479882|4141163|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
1694519|NCT00479882|4141164|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
1694520|NCT00479856|4141294|P1|NOT COMPLETED|Overall Study||3
1694521|NCT00479856|4141294|P1|COMPLETED|Overall Study||6
1694522|NCT00479856|4141294|P1|STARTED|Overall Study||9
1694523|NCT00479765|4141303|P1|NOT COMPLETED|Overall Study||4
1694524|NCT00479765|4141303|P1|COMPLETED|Overall Study||0
1694525|NCT00479765|4141303|P1|STARTED|Overall Study||4
1694526|NCT00479713|4141309|P2|NOT COMPLETED|Overall Study||9
1694527|NCT00479713|4141310|P1|NOT COMPLETED|Overall Study||13
1694528|NCT00479713|4141309|P2|COMPLETED|Overall Study||295
1694529|NCT00479713|4141310|P1|COMPLETED|Overall Study||301
1694530|NCT00479713|4141309|P2|STARTED|Overall Study||304
1694531|NCT00479713|4141310|P1|STARTED|Overall Study||314
1694532|NCT00479674|4141334|P1|NOT COMPLETED|Overall Study||41
1694533|NCT00479674|4141334|P1|COMPLETED|Overall Study||0
1694534|NCT00479674|4141334|P1|STARTED|Overall Study||41
1694535|NCT00479557|4141349|P7|NOT COMPLETED|Overall Study||2
1694536|NCT00479557|4141350|P6|NOT COMPLETED|Overall Study||13
1694537|NCT00479557|4141351|P5|NOT COMPLETED|Overall Study||4
1694538|NCT00479557|4141352|P4|NOT COMPLETED|Overall Study||5
1694539|NCT00479557|4141353|P3|NOT COMPLETED|Overall Study||8
1694540|NCT00479557|4141354|P2|NOT COMPLETED|Overall Study||10
1694541|NCT00479557|4141355|P1|NOT COMPLETED|Overall Study||10
1694542|NCT00479557|4141349|P7|COMPLETED|Overall Study||15
1694543|NCT00479557|4141350|P6|COMPLETED|Overall Study||31
1694544|NCT00479557|4141351|P5|COMPLETED|Overall Study||8
1694545|NCT00479557|4141352|P4|COMPLETED|Overall Study||30
1694546|NCT00479557|4141353|P3|COMPLETED|Overall Study||32
1694547|NCT00479557|4141354|P2|COMPLETED|Overall Study||51
1694548|NCT00479557|4141355|P1|COMPLETED|Overall Study||26
1694549|NCT00479557|4141349|P7|Treated|Overall Study||17
1694550|NCT00479557|4141350|P6|Treated|Overall Study||44
1694551|NCT00479557|4141351|P5|Treated|Overall Study||12
1694552|NCT00479557|4141352|P4|Treated|Overall Study||35
1694553|NCT00479557|4141353|P3|Treated|Overall Study||40
1694554|NCT00479557|4141354|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
1694555|NCT00479557|4141355|P1|Treated|Overall Study||36
1694556|NCT00479557|4141349|P7|STARTED|Overall Study||17
1694557|NCT00479557|4141350|P6|STARTED|Overall Study||44
1694558|NCT00479557|4141351|P5|STARTED|Overall Study||12
1694559|NCT00479557|4141352|P4|STARTED|Overall Study||35
1694560|NCT00479557|4141353|P3|STARTED|Overall Study||40
1694561|NCT00479557|4141354|P2|STARTED|Overall Study||61
1694562|NCT00479557|4141355|P1|STARTED|Overall Study||36
1694563|NCT00479466|4141398|P6|NOT COMPLETED|Overall Study||4
1694564|NCT00479466|4141399|P5|NOT COMPLETED|Overall Study||8
1694565|NCT00479466|4141400|P4|NOT COMPLETED|Overall Study||3
1694566|NCT00479466|4141401|P3|NOT COMPLETED|Overall Study||3
1694567|NCT00479466|4141402|P2|NOT COMPLETED|Overall Study||8
1694568|NCT00479466|4141403|P1|NOT COMPLETED|Overall Study||13
1694569|NCT00479466|4141398|P6|COMPLETED|Overall Study||53
1694570|NCT00479466|4141399|P5|COMPLETED|Overall Study||48
1694571|NCT00479466|4141400|P4|COMPLETED|Overall Study||55
1694572|NCT00479466|4141401|P3|COMPLETED|Overall Study||54
1694573|NCT00479466|4141402|P2|COMPLETED|Overall Study||49
1694574|NCT00479466|4141403|P1|COMPLETED|Overall Study||44
1694575|NCT00479466|4141398|P6|STARTED|Overall Study||57
1694576|NCT00479466|4141399|P5|STARTED|Overall Study||56
1694577|NCT00479466|4141400|P4|STARTED|Overall Study||58
1694578|NCT00479466|4141401|P3|STARTED|Overall Study||57
1694579|NCT00479466|4141402|P2|STARTED|Overall Study||57
1694580|NCT00479466|4141403|P1|STARTED|Overall Study||57
1694581|NCT00479401|4141432|P3|NOT COMPLETED|Overall Study||12
1694582|NCT00479401|4141433|P2|NOT COMPLETED|Overall Study||37
1694583|NCT00479401|4141434|P1|NOT COMPLETED|Overall Study||49
1694584|NCT00479401|4141432|P3|COMPLETED|Overall Study||91
1694585|NCT00479401|4141433|P2|COMPLETED|Overall Study||176
1694586|NCT00479401|4141434|P1|COMPLETED|Overall Study||174
1694587|NCT00479401|4141432|P3|STARTED|Overall Study||103
1694588|NCT00479401|4141433|P2|STARTED|Overall Study||213
1694589|NCT00479401|4141434|P1|STARTED|Overall Study||223
1694590|NCT00479388|4141489|P2|NOT COMPLETED|Overall Study||73
1694591|NCT00479388|4141490|P1|NOT COMPLETED|Overall Study||132
1694592|NCT00479388|4141489|P2|COMPLETED|Overall Study||537
1694593|NCT00479388|4141490|P1|COMPLETED|Overall Study||474
1694594|NCT00479388|4141489|P2|STARTED|Overall Study||610
1694595|NCT00479388|4141490|P1|STARTED|Overall Study||606
1694596|NCT00479336|4141504|P4|NOT COMPLETED|Overall Study||5
1694597|NCT00479336|4141505|P3|NOT COMPLETED|Overall Study||1
1694598|NCT00479336|4141506|P2|NOT COMPLETED|Overall Study||6
1694599|NCT00479336|4141507|P1|NOT COMPLETED|Overall Study||4
1694600|NCT00479336|4141504|P4|COMPLETED|Overall Study||21
1694601|NCT00479336|4141505|P3|COMPLETED|Overall Study||24
1694602|NCT00479336|4141506|P2|COMPLETED|Overall Study||20
1694603|NCT00479336|4141507|P1|COMPLETED|Overall Study||23
1694604|NCT00479336|4141504|P4|STARTED|Overall Study||26
1694605|NCT00479336|4141505|P3|STARTED|Overall Study||25
1694606|NCT00479336|4141506|P2|STARTED|Overall Study||26
1694607|NCT00479336|4141507|P1|STARTED|Overall Study||27
1694608|NCT00479258|4141523|P2|NOT COMPLETED|Overall Study||0
1694609|NCT00479258|4141524|P1|NOT COMPLETED|Overall Study||0
1694610|NCT00479258|4141523|P2|COMPLETED|Overall Study||0
1694611|NCT00479258|4141524|P1|COMPLETED|Overall Study||0
1694612|NCT00479258|4141523|P2|STARTED|Overall Study||0
1694613|NCT00479258|4141524|P1|STARTED|Overall Study||0
1694614|NCT00479232|4141530|P6|NOT COMPLETED|Overall Study||30
1694615|NCT00479232|4141531|P5|NOT COMPLETED|Overall Study||4
1694616|NCT00479232|4141532|P4|NOT COMPLETED|Overall Study||3
1694617|NCT00479232|4141533|P3|NOT COMPLETED|Overall Study||28
1694618|NCT00479232|4141534|P2|NOT COMPLETED|Overall Study||3
1694619|NCT00479232|4141535|P1|NOT COMPLETED|Overall Study||3
1694620|NCT00479232|4141530|P6|COMPLETED|Overall Study||0
1694621|NCT00479232|4141531|P5|COMPLETED|Overall Study||0
1694622|NCT00479232|4141532|P4|COMPLETED|Overall Study||0
1694623|NCT00479232|4141533|P3|COMPLETED|Overall Study||0
1694624|NCT00479232|4141534|P2|COMPLETED|Overall Study||0
1694625|NCT00479232|4141535|P1|COMPLETED|Overall Study||0
1694626|NCT00479232|4141530|P6|STARTED|Overall Study||30
1694627|NCT00479232|4141531|P5|STARTED|Overall Study||4
1694628|NCT00479232|4141532|P4|STARTED|Overall Study||3
1694629|NCT00479232|4141533|P3|STARTED|Overall Study||28
1694630|NCT00479232|4141534|P2|STARTED|Overall Study||3
1694631|NCT00479232|4141535|P1|STARTED|Overall Study||3
1694632|NCT00479154|4141555|P2|NOT COMPLETED|Overall Study||0
1694633|NCT00479154|4141556|P1|NOT COMPLETED|Overall Study||0
1694634|NCT00479154|4141555|P2|COMPLETED|Overall Study||3
1694635|NCT00479154|4141556|P1|COMPLETED|Overall Study||3
1694636|NCT00479154|4141555|P2|STARTED|Overall Study||3
1694637|NCT00479154|4141556|P1|STARTED|Overall Study||3
1694638|NCT00479089|4141564|P2|NOT COMPLETED|Overall Study||0
1694639|NCT00479089|4141565|P1|NOT COMPLETED|Overall Study||0
1694640|NCT00479089|4141564|P2|COMPLETED|Overall Study||25
1694641|NCT00479089|4141565|P1|COMPLETED|Overall Study||25
1694642|NCT00479089|4141564|P2|STARTED|Overall Study||25
1694643|NCT00479089|4141565|P1|STARTED|Overall Study||25
1694644|NCT00479037|4141577|P2|NOT COMPLETED|Overall Study||6
1694645|NCT00479037|4141578|P1|NOT COMPLETED|Overall Study||3
1694646|NCT00479037|4141577|P2|COMPLETED|Overall Study||34
1694647|NCT00479037|4141578|P1|COMPLETED|Overall Study||38
1694648|NCT00479037|4141577|P2|STARTED|Overall Study||40
1694649|NCT00479037|4141578|P1|STARTED|Overall Study||41
1694650|NCT00478933|4141588|P1|NOT COMPLETED|Overall Study||78
1694651|NCT00478933|4141588|P1|COMPLETED|Overall Study||1145
1694652|NCT00478933|4141588|P1|STARTED|Overall Study||1223
1694653|NCT00478881|4141614|P2|NOT COMPLETED|Overall Study||22
1694654|NCT00478881|4141615|P1|NOT COMPLETED|Overall Study||39
1694655|NCT00478881|4141614|P2|COMPLETED|Overall Study||176
1694656|NCT00478881|4141615|P1|COMPLETED|Overall Study||160
1694657|NCT00478881|4141614|P2|Received Medication|Overall Study||198
1694658|NCT00478881|4141615|P1|Received Medication|Overall Study||198
1694659|NCT00478881|4141614|P2|STARTED|Overall Study||198
1694660|NCT00478881|4141615|P1|STARTED|Overall Study||199
1694661|NCT00478777|4141639|P1|NOT COMPLETED|Overall Study||77
1694662|NCT00478777|4141639|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
1694663|NCT00478777|4141639|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
1694664|NCT00478777|4141639|P1|STARTED|Overall Study||150
1694665|NCT00478673|4141646|P1|NOT COMPLETED|12-Months Post-Procedure||64
1694666|NCT00478673|4141646|P1|COMPLETED|12-Months Post-Procedure||231
1694667|NCT00478673|4141646|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
1694668|NCT00478673|4141646|P1|NOT COMPLETED|30-Days Post-Procedure||10
1694669|NCT00478673|4141646|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
1694670|NCT00478673|4141646|P1|STARTED|30-Days Post-Procedure||298
1694671|NCT00478647|4141651|P1|NOT COMPLETED|Overall Study||2
1694672|NCT00478647|4141651|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
1694673|NCT00478647|4141651|P1|STARTED|Overall Study||40
1694674|NCT00478608|4141659|P1|NOT COMPLETED|Overall Study||20
1694675|NCT00478608|4141659|P1|COMPLETED|Overall Study||59
1694676|NCT00478608|4141659|P1|STARTED|Overall Study||79
1694677|NCT00478569|4141667|P1|NOT COMPLETED|Overall Study||409
1694678|NCT00478569|4141667|P1|COMPLETED|Overall Study||761
1694679|NCT00478569|4141667|P1|STARTED|Overall Study||1170
1694680|NCT00478556|4141683|P2|NOT COMPLETED|Overall Study||0
1694681|NCT00478556|4141684|P1|NOT COMPLETED|Overall Study||0
1694682|NCT00478556|4141683|P2|COMPLETED|Overall Study||149
1694683|NCT00478556|4141684|P1|COMPLETED|Overall Study||151
1694684|NCT00478556|4141683|P2|STARTED|Overall Study||149
1694685|NCT00478556|4141684|P1|STARTED|Overall Study||151
1694686|NCT00478335|4141694|P2|NOT COMPLETED|Period 2 (4 Days)||0
1694687|NCT00478335|4141695|P1|NOT COMPLETED|Period 2 (4 Days)||0
1694688|NCT00478335|4141694|P2|COMPLETED|Period 2 (4 Days)||2
1694689|NCT00478335|4141695|P1|COMPLETED|Period 2 (4 Days)||2
1694690|NCT00478335|4141694|P2|STARTED|Period 2 (4 Days)||2
1694691|NCT00478335|4141695|P1|STARTED|Period 2 (4 Days)||2
1694692|NCT00478335|4141694|P2|NOT COMPLETED|Period 1 (4 Days)||0
1694693|NCT00478335|4141695|P1|NOT COMPLETED|Period 1 (4 Days)||0
1694694|NCT00478335|4141694|P2|COMPLETED|Period 1 (4 Days)||2
1694695|NCT00478335|4141695|P1|COMPLETED|Period 1 (4 Days)||2
1694696|NCT00478335|4141694|P2|STARTED|Period 1 (4 Days)||2
1694697|NCT00478335|4141695|P1|STARTED|Period 1 (4 Days)||2
1694698|NCT00478257|4141703|P2|NOT COMPLETED|Overall Study||3
1694699|NCT00478257|4141704|P1|NOT COMPLETED|Overall Study||8
1694700|NCT00478257|4141703|P2|COMPLETED|Overall Study||13
1694701|NCT00478257|4141704|P1|COMPLETED|Overall Study||15
1694702|NCT00478257|4141703|P2|STARTED|Overall Study||16
1694703|NCT00478257|4141704|P1|STARTED|Overall Study||23
1694704|NCT00478244|4141710|P1|NOT COMPLETED|Overall Study||1
1694705|NCT00478244|4141710|P1|COMPLETED|Overall Study||6
1694706|NCT00478244|4141710|P1|STARTED|Overall Study||7
1694707|NCT00478231|4141723|P1|NOT COMPLETED|Overall Study||84
1694708|NCT00478231|4141723|P1|COMPLETED|Overall Study||125
1694709|NCT00478231|4141723|P1|Treated|Overall Study||206
1694710|NCT00478231|4141723|P1|STARTED|Overall Study||209
1694711|NCT00478218|4141744|P2|NOT COMPLETED|Overall Study||0
1694712|NCT00478218|4141745|P1|NOT COMPLETED|Overall Study||0
1694713|NCT00478218|4141744|P2|COMPLETED|Overall Study||19
1694714|NCT00478218|4141745|P1|COMPLETED|Overall Study||34
1694715|NCT00478218|4141744|P2|STARTED|Overall Study||19
1694716|NCT00478218|4141745|P1|STARTED|Overall Study||34
1694717|NCT00478205|4141759|P2|NOT COMPLETED|Overall Study||87
1694718|NCT00478205|4141760|P1|NOT COMPLETED|Overall Study||296
1694719|NCT00478205|4141759|P2|COMPLETED|Overall Study||399
1694720|NCT00478205|4141760|P1|COMPLETED|Overall Study||685
1694721|NCT00478205|4141759|P2|STARTED|Overall Study||486
1694722|NCT00478205|4141760|P1|STARTED|Overall Study||981
1694723|NCT00478192|4141775|P3|NOT COMPLETED|Overall Study||2
1694724|NCT00478192|4141776|P2|NOT COMPLETED|Overall Study||5
1694725|NCT00478192|4141777|P1|NOT COMPLETED|Overall Study||4
1694726|NCT00478192|4141775|P3|COMPLETED|Overall Study||8
1694727|NCT00478192|4141776|P2|COMPLETED|Overall Study||15
1694728|NCT00478192|4141777|P1|COMPLETED|Overall Study||16
1694729|NCT00478192|4141775|P3|End of Treatment|Overall Study||8
1694730|NCT00478192|4141776|P2|End of Treatment|Overall Study||16
1694731|NCT00478192|4141777|P1|End of Treatment|Overall Study||18
1694732|NCT00478192|4141775|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
1694733|NCT00478192|4141776|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
1694734|NCT00478192|4141777|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
1694735|NCT00478192|4141775|P3|STARTED|Overall Study||10
1694736|NCT00478192|4141776|P2|STARTED|Overall Study||20
1694737|NCT00478192|4141777|P1|STARTED|Overall Study||20
1694738|NCT00478140|4141804|P1|NOT COMPLETED|Overall Study||3
1694739|NCT00478140|4141804|P1|COMPLETED|Overall Study||1
1694740|NCT00478140|4141804|P1|STARTED|Overall Study||4
1694741|NCT00478062|4141808|P1|NOT COMPLETED|Overall Study||0
1694742|NCT00478062|4141808|P1|COMPLETED|Overall Study||1
1694743|NCT00478062|4141808|P1|STARTED|Overall Study||1
1694744|NCT00478036|4141818|P3|NOT COMPLETED|Overall Study||0
1694745|NCT00478036|4141819|P2|NOT COMPLETED|Overall Study||0
1694746|NCT00478036|4141820|P1|NOT COMPLETED|Overall Study||0
1694747|NCT00478036|4141818|P3|COMPLETED|Overall Study||14
1694748|NCT00478036|4141819|P2|COMPLETED|Overall Study||7
1694749|NCT00478036|4141820|P1|COMPLETED|Overall Study||10
1694750|NCT00478036|4141818|P3|STARTED|Overall Study||14
1694751|NCT00478036|4141819|P2|STARTED|Overall Study||7
1694752|NCT00478036|4141820|P1|STARTED|Overall Study||10
1694753|NCT00478023|4141833|P5|NOT COMPLETED|Overall Study||55
1694754|NCT00478023|4141834|P4|NOT COMPLETED|Overall Study||30
1694755|NCT00478023|4141835|P3|NOT COMPLETED|Overall Study||20
1694756|NCT00478023|4141836|P2|NOT COMPLETED|Overall Study||24
1694757|NCT00478023|4141837|P1|NOT COMPLETED|Overall Study||35
1694758|NCT00478023|4141833|P5|COMPLETED|Overall Study||114
1694759|NCT00478023|4141834|P4|COMPLETED|Overall Study||146
1694760|NCT00478023|4141835|P3|COMPLETED|Overall Study||151
1694761|NCT00478023|4141836|P2|COMPLETED|Overall Study||144
1694762|NCT00478023|4141837|P1|COMPLETED|Overall Study||135
1694763|NCT00478023|4141833|P5|STARTED|Overall Study||169
1694764|NCT00478023|4141834|P4|STARTED|Overall Study||176
1694765|NCT00478023|4141835|P3|STARTED|Overall Study||171
1694766|NCT00478023|4141836|P2|STARTED|Overall Study||168
1694767|NCT00478023|4141837|P1|STARTED|Overall Study||170
1694768|NCT00477971|4141856|P2|NOT COMPLETED|Overall Study||6
1694769|NCT00477971|4141857|P1|NOT COMPLETED|Overall Study||17
1694770|NCT00477971|4141856|P2|COMPLETED|Overall Study||49
1694771|NCT00477971|4141857|P1|COMPLETED|Overall Study||17
1694772|NCT00477971|4141856|P2|STARTED|Overall Study||55
1694773|NCT00477971|4141857|P1|STARTED|Overall Study||34
1694774|NCT00477750|4141869|P1|NOT COMPLETED|Overall Study||11
1694775|NCT00477750|4141869|P1|COMPLETED|Overall Study||15
1694776|NCT00477750|4141869|P1|STARTED|Overall Study||26
1694777|NCT00477685|4141873|P1|NOT COMPLETED|Overall Study||0
1694778|NCT00477685|4141873|P1|COMPLETED|Overall Study||10
1694779|NCT00477685|4141873|P1|STARTED|Overall Study||10
1694780|NCT00477672|4141881|P3|NOT COMPLETED|Overall Study||16
1694781|NCT00477672|4141882|P2|NOT COMPLETED|Overall Study||16
1694782|NCT00477672|4141883|P1|NOT COMPLETED|Overall Study||7
1694783|NCT00477672|4141881|P3|COMPLETED|Overall Study||83
1694784|NCT00477672|4141882|P2|COMPLETED|Overall Study||85
1694785|NCT00477672|4141883|P1|COMPLETED|Overall Study||91
1694786|NCT00477672|4141881|P3|STARTED|Overall Study||99
1694787|NCT00477672|4141882|P2|STARTED|Overall Study||101
1694788|NCT00477672|4141883|P1|STARTED|Overall Study||98
1694789|NCT00477633|4141894|P1|NOT COMPLETED|Overall Study||709
1694790|NCT00477633|4141894|P1|COMPLETED|Overall Study||991
1694791|NCT00477633|4141894|P1|STARTED|Overall Study||1700
1694792|NCT00477607|4141902|P2|NOT COMPLETED|Overall Study||7
1694793|NCT00477607|4141903|P1|NOT COMPLETED|Overall Study||7
1694794|NCT00477607|4141902|P2|COMPLETED|Overall Study||13
1694795|NCT00477607|4141903|P1|COMPLETED|Overall Study||12
1694796|NCT00477607|4141902|P2|STARTED|Overall Study||20
1694797|NCT00477607|4141903|P1|STARTED|Overall Study||19
1694798|NCT00477594|4141915|P2|NOT COMPLETED|Follow-up Period||1
1694799|NCT00477594|4141916|P1|NOT COMPLETED|Follow-up Period||3
1694800|NCT00477594|4141915|P2|COMPLETED|Follow-up Period||4
1694801|NCT00477594|4141916|P1|COMPLETED|Follow-up Period||13
1694802|NCT00477594|4141915|P2|STARTED|Follow-up Period||5
1694803|NCT00477594|4141916|P1|STARTED|Follow-up Period||16
1694804|NCT00477594|4141915|P2|NOT COMPLETED|Year 3||0
1694805|NCT00477594|4141916|P1|NOT COMPLETED|Year 3||2
1694806|NCT00477594|4141915|P2|COMPLETED|Year 3||0
1694807|NCT00477594|4141916|P1|COMPLETED|Year 3||2
1694808|NCT00477594|4141915|P2|STARTED|Year 3||0
1694809|NCT00477594|4141916|P1|STARTED|Year 3||4
1694810|NCT00477594|4141915|P2|NOT COMPLETED|Year 1 and Year 2||4
1694811|NCT00477594|4141916|P1|NOT COMPLETED|Year 1 and Year 2||9
1694812|NCT00477594|4141915|P2|COMPLETED|Year 1 and Year 2||1
1694813|NCT00477594|4141916|P1|COMPLETED|Year 1 and Year 2||7
1694814|NCT00477594|4141915|P2|STARTED|Year 1 and Year 2||5
1694815|NCT00477594|4141916|P1|STARTED|Year 1 and Year 2||16
1694816|NCT00477490|4141977|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
1694817|NCT00477490|4141978|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
1694818|NCT00477490|4141979|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
1694819|NCT00477490|4141980|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
1694820|NCT00477490|4141981|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
1694821|NCT00477490|4141982|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
1694822|NCT00477490|4141983|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
1694823|NCT00477490|4141984|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
1694824|NCT00477490|4141985|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
1694825|NCT00477490|4141977|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
1694826|NCT00477490|4141978|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
1694827|NCT00477490|4141979|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
1694828|NCT00477490|4141980|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
1694829|NCT00477490|4141981|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
1694830|NCT00477490|4141982|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
1694831|NCT00477490|4141983|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
1694832|NCT00477490|4141984|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
1694833|NCT00477490|4141985|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
1694834|NCT00477490|4141977|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
1694835|NCT00477490|4141978|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
1694836|NCT00477490|4141979|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
1694837|NCT00477490|4141980|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
1694838|NCT00477490|4141981|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
1694839|NCT00477490|4141982|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
1694840|NCT00477490|4141983|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
1694841|NCT00477490|4141984|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
1694842|NCT00477490|4141985|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
1694843|NCT00477490|4141977|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
1694844|NCT00477490|4141978|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
1694845|NCT00477490|4141979|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
1694846|NCT00477490|4141980|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
1694847|NCT00477490|4141981|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
1694848|NCT00477490|4141982|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
1694849|NCT00477490|4141983|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
1694850|NCT00477490|4141984|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
1694851|NCT00477490|4141985|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
1694852|NCT00477490|4141977|P9|COMPLETED|Part I: 4 Week Efficacy||0
1694853|NCT00477490|4141978|P8|COMPLETED|Part I: 4 Week Efficacy||0
1694854|NCT00477490|4141979|P7|COMPLETED|Part I: 4 Week Efficacy||0
1694855|NCT00477490|4141980|P6|COMPLETED|Part I: 4 Week Efficacy||0
1694856|NCT00477490|4141981|P5|COMPLETED|Part I: 4 Week Efficacy||135
1694857|NCT00477490|4141982|P4|COMPLETED|Part I: 4 Week Efficacy||138
1694858|NCT00477490|4141983|P3|COMPLETED|Part I: 4 Week Efficacy||148
1694859|NCT00477490|4141984|P2|COMPLETED|Part I: 4 Week Efficacy||144
1694860|NCT00477490|4141985|P1|COMPLETED|Part I: 4 Week Efficacy||145
1694861|NCT00477490|4141977|P9|ITT Population|Part I: 4 Week Efficacy||0
1694862|NCT00477490|4141978|P8|ITT Population|Part I: 4 Week Efficacy||0
1694863|NCT00477490|4141979|P7|ITT Population|Part I: 4 Week Efficacy||0
1694864|NCT00477490|4141980|P6|ITT Population|Part I: 4 Week Efficacy||0
1694865|NCT00477490|4141981|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
1694866|NCT00477490|4141982|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
1694867|NCT00477490|4141983|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
1694868|NCT00477490|4141984|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
1694869|NCT00477490|4141985|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
1694870|NCT00477490|4141977|P9|STARTED|Part I: 4 Week Efficacy||0
1694871|NCT00477490|4141978|P8|STARTED|Part I: 4 Week Efficacy||0
1694872|NCT00477490|4141979|P7|STARTED|Part I: 4 Week Efficacy||0
1694873|NCT00477490|4141980|P6|STARTED|Part I: 4 Week Efficacy||0
1694874|NCT00477490|4141981|P5|STARTED|Part I: 4 Week Efficacy||160
1694875|NCT00477490|4141982|P4|STARTED|Part I: 4 Week Efficacy||158
1694876|NCT00477490|4141983|P3|STARTED|Part I: 4 Week Efficacy||158
1694877|NCT00477490|4141984|P2|STARTED|Part I: 4 Week Efficacy||163
1694878|NCT00477490|4141985|P1|STARTED|Part I: 4 Week Efficacy||160
1694879|NCT00477464|4142069|P1|NOT COMPLETED|Overall Study||51
1694880|NCT00477464|4142069|P1|COMPLETED|Overall Study||0
1694881|NCT00477464|4142069|P1|STARTED|Overall Study||51
1694882|NCT00477451|4142096|P4|NOT COMPLETED|Overall Study||0
1694883|NCT00477451|4142097|P3|NOT COMPLETED|Overall Study||0
1694884|NCT00477451|4142098|P2|NOT COMPLETED|Overall Study||0
1694885|NCT00477451|4142099|P1|NOT COMPLETED|Overall Study||0
1694886|NCT00477451|4142096|P4|COMPLETED|Overall Study||2
1694887|NCT00477451|4142097|P3|COMPLETED|Overall Study||7
1694888|NCT00477451|4142098|P2|COMPLETED|Overall Study||20
1694889|NCT00477451|4142099|P1|COMPLETED|Overall Study||20
1694890|NCT00477451|4142096|P4|STARTED|Overall Study||2
1694891|NCT00477451|4142097|P3|STARTED|Overall Study||7
1694892|NCT00477451|4142098|P2|STARTED|Overall Study||20
1694893|NCT00477451|4142099|P1|STARTED|Overall Study||20
1694894|NCT00477386|4142113|P2|NOT COMPLETED|Overall Study||17
1694895|NCT00477386|4142114|P1|NOT COMPLETED|Overall Study||11
1694896|NCT00477386|4142113|P2|COMPLETED|Overall Study||0
1694897|NCT00477386|4142114|P1|COMPLETED|Overall Study||0
1694898|NCT00477386|4142113|P2|STARTED|Overall Study||17
1694899|NCT00477386|4142114|P1|STARTED|Overall Study||11
1694900|NCT00477334|4142124|P2|NOT COMPLETED|Overall Study||76
1694901|NCT00477334|4142125|P1|NOT COMPLETED|Overall Study||170
1694902|NCT00477334|4142124|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
1694903|NCT00477334|4142125|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
1694904|NCT00477334|4142124|P2|Modified Intent to Treat Population|Overall Study||78
1694905|NCT00477334|4142125|P1|Modified Intent to Treat Population|Overall Study||152
1694906|NCT00477334|4142124|P2|Participants Completing First Recurrence|Overall Study||92
1694907|NCT00477334|4142125|P1|Participants Completing First Recurrence|Overall Study||187
1694908|NCT00477334|4142124|P2|Intent to Treat Population|Overall Study||98
1694909|NCT00477334|4142125|P1|Intent to Treat Population|Overall Study||201
1694910|NCT00477334|4142124|P2|Randomized and Took Study Drug|Overall Study||98
1694911|NCT00477334|4142125|P1|Randomized and Took Study Drug|Overall Study||206
1694912|NCT00477334|4142124|P2|STARTED|Overall Study||151
1694913|NCT00477334|4142125|P1|STARTED|Overall Study||312
1694914|NCT00477295|4142151|P2|NOT COMPLETED|Overall Study||109
1694915|NCT00477295|4142152|P1|NOT COMPLETED|Overall Study||121
1694916|NCT00477295|4142151|P2|COMPLETED|Overall Study||192
1694917|NCT00477295|4142152|P1|COMPLETED|Overall Study||161
1694918|NCT00477295|4142151|P2|STARTED|Overall Study||301
1694919|NCT00477295|4142152|P1|STARTED|Overall Study||282
1694920|NCT00477269|4142180|P3|NOT COMPLETED|Open Label Extension||13
1694921|NCT00477269|4142181|P2|NOT COMPLETED|Open Label Extension||0
1694922|NCT00477269|4142182|P1|NOT COMPLETED|Open Label Extension||0
1694923|NCT00477269|4142180|P3|COMPLETED|Open Label Extension||9
1694924|NCT00477269|4142181|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
1694925|NCT00477269|4142182|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
1694926|NCT00477269|4142180|P3|STARTED|Open Label Extension||22
1694927|NCT00477269|4142181|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
1694928|NCT00477269|4142182|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
1694929|NCT00477269|4142180|P3|NOT COMPLETED|Core Study||0
1694930|NCT00477269|4142181|P2|NOT COMPLETED|Core Study||8
1694931|NCT00477269|4142182|P1|NOT COMPLETED|Core Study||9
1694932|NCT00477269|4142180|P3|COMPLETED|Core Study||0
1694933|NCT00477269|4142181|P2|COMPLETED|Core Study||23
1694934|NCT00477269|4142182|P1|COMPLETED|Core Study||19
1694935|NCT00477269|4142180|P3|STARTED|Core Study||0
1694936|NCT00477269|4142181|P2|STARTED|Core Study||31
1694937|NCT00477269|4142182|P1|STARTED|Core Study||28
1694938|NCT00477230|4142236|P2|NOT COMPLETED|Overall Study||31
1694939|NCT00477230|4142237|P1|NOT COMPLETED|Overall Study||20
1694940|NCT00477230|4142236|P2|COMPLETED|Overall Study||1
1694941|NCT00477230|4142237|P1|COMPLETED|Overall Study||12
1694942|NCT00477230|4142236|P2|STARTED|Overall Study||32
1694943|NCT00477230|4142237|P1|STARTED|Overall Study||32
1694944|NCT00477204|4142245|P2|NOT COMPLETED|Overall Study||0
1694945|NCT00477204|4142246|P1|NOT COMPLETED|Overall Study||0
1694946|NCT00477204|4142245|P2|COMPLETED|Overall Study||5
1694947|NCT00477204|4142246|P1|COMPLETED|Overall Study||4
1694948|NCT00477204|4142245|P2|STARTED|Overall Study||5
1694949|NCT00477204|4142246|P1|STARTED|Overall Study||4
1694950|NCT00477191|4142252|P1|NOT COMPLETED|Overall Study||5
1694951|NCT00477191|4142252|P1|COMPLETED|Overall Study||13
1694952|NCT00477191|4142252|P1|STARTED|Overall Study||18
1694953|NCT00477165|4142261|P2|NOT COMPLETED|Overall Study||2
1694954|NCT00477165|4142262|P1|NOT COMPLETED|Overall Study||7
1694955|NCT00477165|4142261|P2|COMPLETED|Overall Study||25
1694956|NCT00477165|4142262|P1|COMPLETED|Overall Study||20
1694957|NCT00477165|4142261|P2|STARTED|Overall Study||27
1694958|NCT00477165|4142262|P1|STARTED|Overall Study||27
1694959|NCT00477152|4142274|P1|NOT COMPLETED|Overall Study||3
1694960|NCT00477152|4142274|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
1694961|NCT00477152|4142274|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
1694962|NCT00477087|4142281|P1|NOT COMPLETED|Overall Study||0
1694963|NCT00477087|4142281|P1|COMPLETED|Overall Study||10
1694964|NCT00477087|4142281|P1|STARTED|Overall Study||10
1694965|NCT00476957|4142289|P2|NOT COMPLETED|Overall Study||193
1694966|NCT00476957|4142290|P1|NOT COMPLETED|Overall Study||176
1694967|NCT00476957|4142289|P2|COMPLETED|Overall Study||4159
1694968|NCT00476957|4142290|P1|COMPLETED|Overall Study||4181
1694969|NCT00476957|4142289|P2|STARTED|Overall Study||4352
1694970|NCT00476957|4142290|P1|STARTED|Overall Study||4357
1694971|NCT00476827|4142304|P6|NOT COMPLETED|Overall Study||0
1694972|NCT00476827|4142305|P5|NOT COMPLETED|Overall Study||0
1694973|NCT00476827|4142306|P4|NOT COMPLETED|Overall Study||0
1694974|NCT00476827|4142307|P3|NOT COMPLETED|Overall Study||0
1694975|NCT00476827|4142308|P2|NOT COMPLETED|Overall Study||0
1694976|NCT00476827|4142309|P1|NOT COMPLETED|Overall Study||0
1694977|NCT00476827|4142304|P6|COMPLETED|Overall Study||2
1694978|NCT00476827|4142305|P5|COMPLETED|Overall Study||2
1694979|NCT00476827|4142306|P4|COMPLETED|Overall Study||0
1694980|NCT00476827|4142307|P3|COMPLETED|Overall Study||1
1694981|NCT00476827|4142308|P2|COMPLETED|Overall Study||0
1694982|NCT00476827|4142309|P1|COMPLETED|Overall Study||3
1694983|NCT00476827|4142304|P6|STARTED|Overall Study||2
1694984|NCT00476827|4142305|P5|STARTED|Overall Study||2
1694985|NCT00476827|4142306|P4|STARTED|Overall Study||0
1694986|NCT00476827|4142307|P3|STARTED|Overall Study||1
1694987|NCT00476827|4142308|P2|STARTED|Overall Study||0
1694988|NCT00476827|4142309|P1|STARTED|Overall Study||3
1694989|NCT00476788|4142339|P1|NOT COMPLETED|Overall Study||3
1694990|NCT00476788|4142339|P1|COMPLETED|Overall Study||11
1694991|NCT00476788|4142339|P1|STARTED|Overall Study||14
1694992|NCT00476645|4142344|P1|NOT COMPLETED|Overall Study||0
1694993|NCT00476645|4142344|P1|COMPLETED|Overall Study||10
1694994|NCT00476645|4142344|P1|STARTED|Overall Study||10
1694995|NCT00476593|4142354|P4|NOT COMPLETED|Overall Study||22
1694996|NCT00476593|4142355|P3|NOT COMPLETED|Overall Study||8
1694997|NCT00476593|4142356|P2|NOT COMPLETED|Overall Study||2
1694998|NCT00476593|4142357|P1|NOT COMPLETED|Overall Study||10
1694999|NCT00476593|4142354|P4|COMPLETED|Overall Study||107
1695000|NCT00476593|4142355|P3|COMPLETED|Overall Study||30
1695001|NCT00476593|4142356|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
1695002|NCT00476593|4142357|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
1695003|NCT00476593|4142354|P4|STARTED|Overall Study||129
1695004|NCT00476593|4142355|P3|STARTED|Overall Study||38
1695005|NCT00476593|4142356|P2|STARTED|Overall Study||19
1695006|NCT00476593|4142357|P1|STARTED|Overall Study||32
1695007|NCT00476476|4142369|P2|NOT COMPLETED|Overall Study||24
1695008|NCT00476476|4142370|P1|NOT COMPLETED|Overall Study||2
1695009|NCT00476476|4142369|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
1695010|NCT00476476|4142370|P1|COMPLETED|Overall Study||15
1695011|NCT00476476|4142369|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
1695012|NCT00476476|4142370|P1|Response Evaluable|Overall Study||17
1695013|NCT00476476|4142369|P2|STARTED|Overall Study||24
1695014|NCT00476476|4142370|P1|STARTED|Overall Study||17
1695015|NCT00476242|4142377|P2|NOT COMPLETED|Overall Study||16
1695016|NCT00476242|4142378|P1|NOT COMPLETED|Overall Study||8
1695017|NCT00476242|4142377|P2|COMPLETED|Overall Study||12
1695018|NCT00476242|4142378|P1|COMPLETED|Overall Study||19
1695019|NCT00476242|4142377|P2|STARTED|Overall Study||28
1695020|NCT00476242|4142378|P1|STARTED|Overall Study||27
1695021|NCT00476229|4142388|P1|NOT COMPLETED|Overall Study||1
1695022|NCT00476229|4142388|P1|COMPLETED|Overall Study||19
1695023|NCT00476229|4142388|P1|STARTED|Overall Study||20
1695024|NCT00476151|4142394|P2|NOT COMPLETED|Overall Study||7
1695025|NCT00476151|4142395|P1|NOT COMPLETED|Overall Study||3
1695026|NCT00476151|4142394|P2|COMPLETED|Overall Study||107
1695027|NCT00476151|4142395|P1|COMPLETED|Overall Study||109
1695028|NCT00476151|4142394|P2|STARTED|Overall Study||114
1695029|NCT00476151|4142395|P1|STARTED|Overall Study||112
1695030|NCT00476086|4142401|P1|NOT COMPLETED|Overall Study||5
1695031|NCT00476086|4142401|P1|COMPLETED|Overall Study||15
1695032|NCT00476086|4142401|P1|Received Radiation|Overall Study||15
1695033|NCT00476086|4142401|P1|Received Chemotherapy|Overall Study||19
1695034|NCT00476086|4142401|P1|STARTED|Overall Study||20
1695035|NCT00476047|4142407|P1|NOT COMPLETED|Overall Study||1
1695036|NCT00476047|4142407|P1|COMPLETED|Overall Study||15
1695037|NCT00476047|4142407|P1|Completed Treatment|Overall Study||16
1695038|NCT00476047|4142407|P1|STARTED|Overall Study||16
1695039|NCT00476021|4142416|P2|NOT COMPLETED|Overall Study||0
1695040|NCT00476021|4142417|P1|NOT COMPLETED|Overall Study||0
1695041|NCT00476021|4142416|P2|COMPLETED|Overall Study||51
1695042|NCT00476021|4142417|P1|COMPLETED|Overall Study||51
1695043|NCT00476021|4142416|P2|STARTED|Overall Study||51
1695044|NCT00476021|4142417|P1|STARTED|Overall Study||51
1695045|NCT00476008|4142433|P2|NOT COMPLETED|Overall Study||8
1695046|NCT00476008|4142434|P1|NOT COMPLETED|Overall Study||9
1695047|NCT00476008|4142433|P2|COMPLETED|Overall Study||13
1695048|NCT00476008|4142434|P1|COMPLETED|Overall Study||13
1695049|NCT00476008|4142433|P2|6 Month Testing|Overall Study||14
1695050|NCT00476008|4142434|P1|6 Month Testing|Overall Study||15
1695051|NCT00476008|4142433|P2|STARTED|Overall Study||21
1695052|NCT00476008|4142434|P1|STARTED|Overall Study||22
1695053|NCT00475904|4142461|P3|NOT COMPLETED|Overall Study||4
1695054|NCT00475904|4142462|P2|NOT COMPLETED|Overall Study||13
1695055|NCT00475904|4142463|P1|NOT COMPLETED|Overall Study||15
1695056|NCT00475904|4142461|P3|COMPLETED|Overall Study||72
1695057|NCT00475904|4142462|P2|COMPLETED|Overall Study||131
1695058|NCT00475904|4142463|P1|COMPLETED|Overall Study||125
1695059|NCT00475904|4142461|P3|STARTED|Overall Study||76
1695060|NCT00475904|4142462|P2|STARTED|Overall Study||144
1695061|NCT00475904|4142463|P1|STARTED|Overall Study||140
1695062|NCT00475878|4142476|P2|NOT COMPLETED|Overall Study||0
1695063|NCT00475878|4142477|P1|NOT COMPLETED|Overall Study||0
1695064|NCT00475878|4142476|P2|COMPLETED|Overall Study||72
1695065|NCT00475878|4142477|P1|COMPLETED|Overall Study||75
1695066|NCT00475878|4142476|P2|STARTED|Overall Study||72
1695067|NCT00475878|4142477|P1|STARTED|Overall Study||75
1695068|NCT00475865|4142488|P3|NOT COMPLETED|Overall Study||6
1695069|NCT00475865|4142489|P2|NOT COMPLETED|Overall Study||5
1695070|NCT00475865|4142490|P1|NOT COMPLETED|Overall Study||2
1695071|NCT00475865|4142488|P3|COMPLETED|Overall Study|completed treatment period|34
1695072|NCT00475865|4142489|P2|COMPLETED|Overall Study|completed treatment period|37
1695073|NCT00475865|4142490|P1|COMPLETED|Overall Study||39
1695074|NCT00475865|4142488|P3|Treated|Overall Study||40
1695075|NCT00475865|4142489|P2|Treated|Overall Study||42
1695076|NCT00475865|4142490|P1|Treated|Overall Study|completed treatment period|41
1695077|NCT00475865|4142488|P3|STARTED|Overall Study|randomized|40
1695078|NCT00475865|4142489|P2|STARTED|Overall Study|randomized|42
1695079|NCT00475865|4142490|P1|STARTED|Overall Study|randomized|41
1695080|NCT00475852|4142520|P2|NOT COMPLETED|Overall Study||548
1695081|NCT00475852|4142521|P1|NOT COMPLETED|Overall Study||517
1695082|NCT00475852|4142520|P2|COMPLETED|Overall Study||3029
1695083|NCT00475852|4142521|P1|COMPLETED|Overall Study||3047
1695084|NCT00475852|4142520|P2|STARTED|Overall Study||3577
1695085|NCT00475852|4142521|P1|STARTED|Overall Study||3564
1695086|NCT00475787|4142551|P2|NOT COMPLETED|Overall Study||7
1695087|NCT00475787|4142552|P1|NOT COMPLETED|Overall Study||8
1695088|NCT00475787|4142551|P2|COMPLETED|Overall Study||60
1695089|NCT00475787|4142552|P1|COMPLETED|Overall Study||61
1695090|NCT00475787|4142551|P2|STARTED|Overall Study||67
1695091|NCT00475787|4142552|P1|STARTED|Overall Study||69
1695092|NCT00475735|4142572|P6|NOT COMPLETED|Treatment Period 2||1
1695093|NCT00475735|4142573|P5|NOT COMPLETED|Treatment Period 2||1
1695094|NCT00475735|4142574|P4|NOT COMPLETED|Treatment Period 2||2
1695095|NCT00475735|4142575|P3|NOT COMPLETED|Treatment Period 2||0
1695096|NCT00475735|4142576|P2|NOT COMPLETED|Treatment Period 2||1
1695097|NCT00475735|4142577|P1|NOT COMPLETED|Treatment Period 2||0
1695098|NCT00475735|4142572|P6|COMPLETED|Treatment Period 2||13
1695099|NCT00475735|4142573|P5|COMPLETED|Treatment Period 2||15
1695100|NCT00475735|4142574|P4|COMPLETED|Treatment Period 2||4
1695101|NCT00475735|4142575|P3|COMPLETED|Treatment Period 2||7
1695102|NCT00475735|4142576|P2|COMPLETED|Treatment Period 2||9
1695103|NCT00475735|4142577|P1|COMPLETED|Treatment Period 2||10
1695104|NCT00475735|4142572|P6|STARTED|Treatment Period 2||14
1695105|NCT00475735|4142573|P5|STARTED|Treatment Period 2||16
1695106|NCT00475735|4142574|P4|STARTED|Treatment Period 2||6
1695107|NCT00475735|4142575|P3|STARTED|Treatment Period 2||7
1695108|NCT00475735|4142576|P2|STARTED|Treatment Period 2||10
1695109|NCT00475735|4142577|P1|STARTED|Treatment Period 2||10
1695110|NCT00475735|4142572|P6|NOT COMPLETED|Treatment Washout||0
1695111|NCT00475735|4142573|P5|NOT COMPLETED|Treatment Washout||0
1695112|NCT00475735|4142574|P4|NOT COMPLETED|Treatment Washout||0
1695113|NCT00475735|4142575|P3|NOT COMPLETED|Treatment Washout||0
1695114|NCT00475735|4142576|P2|NOT COMPLETED|Treatment Washout||2
1695115|NCT00475735|4142577|P1|NOT COMPLETED|Treatment Washout||0
1695116|NCT00475735|4142572|P6|COMPLETED|Treatment Washout||14
1695117|NCT00475735|4142573|P5|COMPLETED|Treatment Washout||16
1695118|NCT00475735|4142574|P4|COMPLETED|Treatment Washout||6
1695119|NCT00475735|4142575|P3|COMPLETED|Treatment Washout||7
1695120|NCT00475735|4142576|P2|COMPLETED|Treatment Washout||10
1695121|NCT00475735|4142577|P1|COMPLETED|Treatment Washout||10
1695122|NCT00475735|4142572|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
1695123|NCT00475735|4142573|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
1695124|NCT00475735|4142574|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
1695125|NCT00475735|4142575|P3|STARTED|Treatment Washout||7
1695126|NCT00475735|4142576|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
1695127|NCT00475735|4142577|P1|STARTED|Treatment Washout||10
1695128|NCT00475735|4142572|P6|NOT COMPLETED|Treatment Period 1||3
1695129|NCT00475735|4142573|P5|NOT COMPLETED|Treatment Period 1||2
1695130|NCT00475735|4142574|P4|NOT COMPLETED|Treatment Period 1||2
1695131|NCT00475735|4142575|P3|NOT COMPLETED|Treatment Period 1||0
1695132|NCT00475735|4142576|P2|NOT COMPLETED|Treatment Period 1||2
1695133|NCT00475735|4142577|P1|NOT COMPLETED|Treatment Period 1||4
1695134|NCT00475735|4142572|P6|COMPLETED|Treatment Period 1||12
1695135|NCT00475735|4142573|P5|COMPLETED|Treatment Period 1||14
1695136|NCT00475735|4142574|P4|COMPLETED|Treatment Period 1||5
1695137|NCT00475735|4142575|P3|COMPLETED|Treatment Period 1||7
1695138|NCT00475735|4142576|P2|COMPLETED|Treatment Period 1||11
1695139|NCT00475735|4142577|P1|COMPLETED|Treatment Period 1||10
1695140|NCT00475735|4142572|P6|STARTED|Treatment Period 1||15
1695141|NCT00475735|4142573|P5|STARTED|Treatment Period 1||16
1695142|NCT00475735|4142574|P4|STARTED|Treatment Period 1||7
1695143|NCT00475735|4142575|P3|STARTED|Treatment Period 1||7
1695144|NCT00475735|4142576|P2|STARTED|Treatment Period 1||13
1695145|NCT00475735|4142577|P1|STARTED|Treatment Period 1||14
1695146|NCT00475722|4142590|P2|NOT COMPLETED|Overall Study||12
1695147|NCT00475722|4142591|P1|NOT COMPLETED|Overall Study||15
1695148|NCT00475722|4142590|P2|COMPLETED|Overall Study||47
1695149|NCT00475722|4142591|P1|COMPLETED|Overall Study||46
1695150|NCT00475722|4142590|P2|STARTED|Overall Study||59
1695151|NCT00475722|4142591|P1|STARTED|Overall Study||61
1695152|NCT00475709|4142597|P1|NOT COMPLETED|Overall Study||76
1695153|NCT00475709|4142597|P1|COMPLETED|Overall Study||946
1695154|NCT00475709|4142597|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
1695155|NCT00475709|4142597|P1|STARTED|Overall Study||1022
1695156|NCT00475670|4142605|P2|NOT COMPLETED|Overall Study||41
1695157|NCT00475670|4142606|P1|NOT COMPLETED|Overall Study||3
1695158|NCT00475670|4142605|P2|COMPLETED|Overall Study||0
1695159|NCT00475670|4142606|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
1695160|NCT00475670|4142605|P2|STARTED|Overall Study||41
1695161|NCT00475670|4142606|P1|STARTED|Overall Study||3
1695162|NCT00475657|4142630|P1|NOT COMPLETED|Overall Study||4
1695163|NCT00475657|4142630|P1|COMPLETED|Overall Study||1
1695164|NCT00475657|4142630|P1|STARTED|Overall Study||5
1695165|NCT00475644|4142638|P1|NOT COMPLETED|Overall Study||13
1695166|NCT00475644|4142638|P1|COMPLETED|Overall Study||53
1695167|NCT00475644|4142638|P1|Received at Least One Dose of Study Drug|Overall Study||66
1695168|NCT00475644|4142638|P1|STARTED|Overall Study||66
1695169|NCT00475501|4142650|P4|NOT COMPLETED|Overall Study||4
1695170|NCT00475501|4142651|P3|NOT COMPLETED|Overall Study||4
1695171|NCT00475501|4142652|P2|NOT COMPLETED|Overall Study||5
1695172|NCT00475501|4142653|P1|NOT COMPLETED|Overall Study||7
1695173|NCT00475501|4142650|P4|COMPLETED|Overall Study||12
1695174|NCT00475501|4142651|P3|COMPLETED|Overall Study||13
1695175|NCT00475501|4142652|P2|COMPLETED|Overall Study||8
1695176|NCT00475501|4142653|P1|COMPLETED|Overall Study||7
1695177|NCT00475501|4142650|P4|STARTED|Overall Study||16
1695178|NCT00475501|4142651|P3|STARTED|Overall Study||17
1695179|NCT00475501|4142652|P2|STARTED|Overall Study||13
1695180|NCT00475501|4142653|P1|STARTED|Overall Study||14
1695181|NCT00475423|4142703|P1|NOT COMPLETED|Overall Study||32
1695182|NCT00475423|4142703|P1|COMPLETED|Overall Study||90
1695183|NCT00475423|4142703|P1|STARTED|Overall Study||122
1695184|NCT00475332|4142724|P1|NOT COMPLETED|Overall Study||0
1695185|NCT00475332|4142724|P1|COMPLETED|Overall Study||2
1695186|NCT00475332|4142724|P1|STARTED|Overall Study||2
1695187|NCT00475319|4142732|P3|NOT COMPLETED|Overall Study||4
1695188|NCT00475319|4142733|P2|NOT COMPLETED|Overall Study||1
1695189|NCT00475319|4142734|P1|NOT COMPLETED|Overall Study||2
1695190|NCT00475319|4142732|P3|COMPLETED|Overall Study||99
1695191|NCT00475319|4142733|P2|COMPLETED|Overall Study||101
1695192|NCT00475319|4142734|P1|COMPLETED|Overall Study||101
1695193|NCT00475319|4142732|P3|STARTED|Overall Study||103
1695194|NCT00475319|4142733|P2|STARTED|Overall Study||102
1695195|NCT00475319|4142734|P1|STARTED|Overall Study||103
1695196|NCT00475306|4142749|P4|NOT COMPLETED|Overall Study||1
1695197|NCT00475306|4142750|P3|NOT COMPLETED|Overall Study||0
1695198|NCT00475306|4142751|P2|NOT COMPLETED|Overall Study||1
1695199|NCT00475306|4142752|P1|NOT COMPLETED|Overall Study||1
1695200|NCT00475306|4142749|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
1695201|NCT00475306|4142750|P3|COMPLETED|Overall Study||72
1695202|NCT00475306|4142751|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
1695203|NCT00475306|4142752|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
1695204|NCT00475306|4142749|P4|STARTED|Overall Study||72
1695205|NCT00475306|4142750|P3|STARTED|Overall Study||72
1695206|NCT00475306|4142751|P2|STARTED|Overall Study||72
1695207|NCT00475306|4142752|P1|STARTED|Overall Study||73
1695208|NCT00475241|4142768|P2|NOT COMPLETED|Overall Study||3
1695209|NCT00475241|4142769|P1|NOT COMPLETED|Overall Study||7
1695210|NCT00475241|4142768|P2|COMPLETED|Overall Study||15
1695211|NCT00475241|4142769|P1|COMPLETED|Overall Study||11
1695212|NCT00475241|4142768|P2|STARTED|Overall Study||18
1695213|NCT00475241|4142769|P1|STARTED|Overall Study||18
1695214|NCT00475228|4142777|P2|NOT COMPLETED|Overall Study||17
1695215|NCT00475228|4142778|P1|NOT COMPLETED|Overall Study||17
1695216|NCT00475228|4142777|P2|COMPLETED|Overall Study||27
1695217|NCT00475228|4142778|P1|COMPLETED|Overall Study||27
1695218|NCT00475228|4142777|P2|STARTED|Overall Study||44
1695219|NCT00475228|4142778|P1|STARTED|Overall Study||44
1695220|NCT00475176|4142788|P1|NOT COMPLETED|Overall Study||4
1695221|NCT00475176|4142788|P1|COMPLETED|Overall Study||20
1695222|NCT00475176|4142788|P1|STARTED|Overall Study||24
1695223|NCT00475150|4142795|P2|NOT COMPLETED|Overall Study||0
1695224|NCT00475150|4142796|P1|NOT COMPLETED|Overall Study||0
1695225|NCT00475150|4142795|P2|COMPLETED|Overall Study||16
1695226|NCT00475150|4142796|P1|COMPLETED|Overall Study||23
1695227|NCT00475150|4142795|P2|STARTED|Overall Study||16
1695228|NCT00475150|4142796|P1|STARTED|Overall Study||23
1695229|NCT00475085|4142813|P4|NOT COMPLETED|Overall Study||20
1695230|NCT00475085|4142814|P3|NOT COMPLETED|Overall Study||19
1695231|NCT00475085|4142815|P2|NOT COMPLETED|Overall Study||20
1695232|NCT00475085|4142816|P1|NOT COMPLETED|Overall Study||18
1695233|NCT00475085|4142813|P4|COMPLETED|Overall Study||234
1695234|NCT00475085|4142814|P3|COMPLETED|Overall Study||241
1695235|NCT00475085|4142815|P2|COMPLETED|Overall Study||234
1695236|NCT00475085|4142816|P1|COMPLETED|Overall Study||235
1695237|NCT00475085|4142813|P4|STARTED|Overall Study||254
1695238|NCT00475085|4142814|P3|STARTED|Overall Study||260
1695239|NCT00475085|4142815|P2|STARTED|Overall Study||254
1695240|NCT00475085|4142816|P1|STARTED|Overall Study||253
1695241|NCT00475033|4142828|P2|NOT COMPLETED|Toddler Dose||0
1695242|NCT00475033|4142829|P1|NOT COMPLETED|Toddler Dose||4
1695243|NCT00475033|4142828|P2|COMPLETED|Toddler Dose||282
1695244|NCT00475033|4142829|P1|COMPLETED|Toddler Dose||283
1695245|NCT00475033|4142828|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
1695246|NCT00475033|4142829|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
1695247|NCT00475033|4142828|P2|NOT COMPLETED|After the Infant Series||8
1695248|NCT00475033|4142829|P1|NOT COMPLETED|After the Infant Series||6
1695249|NCT00475033|4142828|P2|COMPLETED|After the Infant Series||282
1695250|NCT00475033|4142829|P1|COMPLETED|After the Infant Series||287
1695251|NCT00475033|4142828|P2|Withdrawn After Infant Series|After the Infant Series||8
1695252|NCT00475033|4142829|P1|Withdrawn After Infant Series|After the Infant Series||6
1695253|NCT00475033|4142828|P2|STARTED|After the Infant Series||290
1695254|NCT00475033|4142829|P1|STARTED|After the Infant Series||293
1695255|NCT00475033|4142828|P2|NOT COMPLETED|Infant Series||13
1695256|NCT00475033|4142829|P1|NOT COMPLETED|Infant Series||7
1695257|NCT00475033|4142828|P2|COMPLETED|Infant Series||290
1695258|NCT00475033|4142829|P1|COMPLETED|Infant Series||293
1695259|NCT00475033|4142828|P2|Vaccinated Dose 3|Infant Series||294
1695260|NCT00475033|4142829|P1|Vaccinated Dose 3|Infant Series||293
1695261|NCT00475033|4142828|P2|Vaccinated Dose 2|Infant Series||296
1695262|NCT00475033|4142829|P1|Vaccinated Dose 2|Infant Series||297
1695263|NCT00475033|4142828|P2|Vaccinated Dose 1|Infant Series||303
1695264|NCT00475033|4142829|P1|Vaccinated Dose 1|Infant Series||300
1695265|NCT00475033|4142828|P2|STARTED|Infant Series||303
1695266|NCT00475033|4142829|P1|STARTED|Infant Series||300
1695267|NCT00475020|4142877|P1|NOT COMPLETED|Overall Study||5
1695268|NCT00475020|4142877|P1|COMPLETED|Overall Study||58
1695269|NCT00475020|4142877|P1|STARTED|Overall Study||63
1695270|NCT00474994|4142882|P1|NOT COMPLETED|Overall Study||5
1695271|NCT00474994|4142882|P1|COMPLETED|Overall Study||48
1695272|NCT00474994|4142882|P1|STARTED|Overall Study||53
1695273|NCT00474968|4142888|P2|NOT COMPLETED|Overall Study||16
1695274|NCT00474968|4142889|P1|NOT COMPLETED|Overall Study||18
1695275|NCT00474968|4142888|P2|COMPLETED|Overall Study||355
1695276|NCT00474968|4142889|P1|COMPLETED|Overall Study||348
1695277|NCT00474968|4142888|P2|STARTED|Overall Study||371
1695278|NCT00474968|4142889|P1|STARTED|Overall Study||366
1695279|NCT00474955|4142899|P1|NOT COMPLETED|Overall Study||8
1695280|NCT00474955|4142899|P1|COMPLETED|Overall Study||19
1695281|NCT00474955|4142899|P1|STARTED|Overall Study||27
1695282|NCT00474929|4142915|P5|NOT COMPLETED|Overall Study||0
1695283|NCT00474929|4142916|P4|NOT COMPLETED|Overall Study||2
1695284|NCT00474929|4142917|P3|NOT COMPLETED|Overall Study||2
1695285|NCT00474929|4142918|P2|NOT COMPLETED|Overall Study||1
1695286|NCT00474929|4142919|P1|NOT COMPLETED|Overall Study||0
1695287|NCT00474929|4142915|P5|COMPLETED|Overall Study||77
1695288|NCT00474929|4142916|P4|COMPLETED|Overall Study||5
1695289|NCT00474929|4142917|P3|COMPLETED|Overall Study||5
1695290|NCT00474929|4142918|P2|COMPLETED|Overall Study||5
1695291|NCT00474929|4142919|P1|COMPLETED|Overall Study||6
1695292|NCT00474929|4142915|P5|STARTED|Overall Study||77
1695293|NCT00474929|4142916|P4|STARTED|Overall Study||7
1695294|NCT00474929|4142917|P3|STARTED|Overall Study||7
1695295|NCT00474929|4142918|P2|STARTED|Overall Study||6
1695296|NCT00474929|4142919|P1|STARTED|Overall Study||6
1695297|NCT00474903|4142936|P3|NOT COMPLETED|Overall Study||2
1695298|NCT00474903|4142937|P2|NOT COMPLETED|Overall Study||5
1695299|NCT00474903|4142938|P1|NOT COMPLETED|Overall Study||1
1695300|NCT00474903|4142936|P3|COMPLETED|Overall Study||43
1695301|NCT00474903|4142937|P2|COMPLETED|Overall Study||42
1695302|NCT00474903|4142938|P1|COMPLETED|Overall Study||29
1695303|NCT00474903|4142936|P3|STARTED|Overall Study||45
1695304|NCT00474903|4142937|P2|STARTED|Overall Study||47
1695305|NCT00474903|4142938|P1|STARTED|Overall Study||30
1695306|NCT00474851|4142951|P2|NOT COMPLETED|Overall Study||11
1695307|NCT00474851|4142952|P1|NOT COMPLETED|Overall Study||8
1695308|NCT00474851|4142951|P2|COMPLETED|Overall Study||16
1695309|NCT00474851|4142952|P1|COMPLETED|Overall Study||18
1695310|NCT00474851|4142951|P2|Completed Baseline|Overall Study||26
1695311|NCT00474851|4142952|P1|Completed Baseline|Overall Study||25
1695312|NCT00474851|4142951|P2|STARTED|Overall Study||27
1695313|NCT00474851|4142952|P1|STARTED|Overall Study||26
1695314|NCT00474812|4142960|P1|NOT COMPLETED|Overall Study||7
1695315|NCT00474812|4142960|P1|COMPLETED|Overall Study||44
1695316|NCT00474812|4142960|P1|STARTED|Overall Study||51
1695317|NCT00474786|4142970|P2|NOT COMPLETED|Overall Study||253
1695318|NCT00474786|4142971|P1|NOT COMPLETED|Overall Study||259
1695319|NCT00474786|4142970|P2|COMPLETED|Overall Study||0
1695320|NCT00474786|4142971|P1|COMPLETED|Overall Study||0
1695321|NCT00474786|4142970|P2|STARTED|Overall Study||253
1695322|NCT00474786|4142971|P1|STARTED|Overall Study||259
1695323|NCT00474760|4142996|P7|NOT COMPLETED|Overall Study||10
1695324|NCT00474760|4142997|P6|NOT COMPLETED|Overall Study||29
1695325|NCT00474760|4142998|P5|NOT COMPLETED|Overall Study||12
1695326|NCT00474760|4142999|P4|NOT COMPLETED|Overall Study||3
1695327|NCT00474760|4143000|P3|NOT COMPLETED|Overall Study||3
1695328|NCT00474760|4143001|P2|NOT COMPLETED|Overall Study||3
1695329|NCT00474760|4143002|P1|NOT COMPLETED|Overall Study||3
1695330|NCT00474760|4142996|P7|COMPLETED|Overall Study||1
1695331|NCT00474760|4142997|P6|COMPLETED|Overall Study||0
1695332|NCT00474760|4142998|P5|COMPLETED|Overall Study||1
1695333|NCT00474760|4142999|P4|COMPLETED|Overall Study||0
1695334|NCT00474760|4143000|P3|COMPLETED|Overall Study||0
1695335|NCT00474760|4143001|P2|COMPLETED|Overall Study||0
1695336|NCT00474760|4143002|P1|COMPLETED|Overall Study||0
1695337|NCT00474760|4142996|P7|STARTED|Overall Study||11
1695338|NCT00474760|4142997|P6|STARTED|Overall Study||29
1695339|NCT00474760|4142998|P5|STARTED|Overall Study||13
1695340|NCT00474760|4142999|P4|STARTED|Overall Study||3
1695341|NCT00474760|4143000|P3|STARTED|Overall Study||3
1695342|NCT00474760|4143001|P2|STARTED|Overall Study||3
1695343|NCT00474760|4143002|P1|STARTED|Overall Study||3
1695344|NCT00474708|4143109|P2|NOT COMPLETED|Overall Study||25
1695345|NCT00474708|4143110|P1|NOT COMPLETED|Overall Study||57
1695346|NCT00474708|4143109|P2|COMPLETED|Overall Study||342
1695347|NCT00474708|4143110|P1|COMPLETED|Overall Study||734
1695348|NCT00474708|4143109|P2|STARTED|Overall Study||367
1695349|NCT00474708|4143110|P1|STARTED|Overall Study||791
1695350|NCT00474630|4143120|P2|NOT COMPLETED|Overall Study||70
1695351|NCT00474630|4143121|P1|NOT COMPLETED|Overall Study||160
1695352|NCT00474630|4143120|P2|COMPLETED|Overall Study||100
1695353|NCT00474630|4143121|P1|COMPLETED|Overall Study||175
1695354|NCT00474630|4143120|P2|STARTED|Overall Study||170
1695355|NCT00474630|4143121|P1|STARTED|Overall Study||335
1695356|NCT00474539|4143177|P2|NOT COMPLETED|Toddler Dose||0
1695357|NCT00474539|4143178|P1|NOT COMPLETED|Toddler Dose||1
1695358|NCT00474539|4143177|P2|COMPLETED|Toddler Dose||220
1695359|NCT00474539|4143178|P1|COMPLETED|Toddler Dose||208
1695360|NCT00474539|4143177|P2|STARTED|Toddler Dose||220
1695361|NCT00474539|4143178|P1|STARTED|Toddler Dose||209
1695362|NCT00474539|4143177|P2|NOT COMPLETED|After Infant Series||0
1695363|NCT00474539|4143178|P1|NOT COMPLETED|After Infant Series||4
1695364|NCT00474539|4143177|P2|COMPLETED|After Infant Series||220
1695365|NCT00474539|4143178|P1|COMPLETED|After Infant Series||209
1695366|NCT00474539|4143177|P2|STARTED|After Infant Series||220
1695367|NCT00474539|4143178|P1|STARTED|After Infant Series||213
1695368|NCT00474539|4143177|P2|NOT COMPLETED|Infant Series||6
1695369|NCT00474539|4143178|P1|NOT COMPLETED|Infant Series||10
1695370|NCT00474539|4143177|P2|COMPLETED|Infant Series||220
1695371|NCT00474539|4143178|P1|COMPLETED|Infant Series||213
1695372|NCT00474539|4143177|P2|Vaccinated Dose 3|Infant Series||221
1695373|NCT00474539|4143178|P1|Vaccinated Dose 3|Infant Series||214
1695374|NCT00474539|4143177|P2|Vaccinated Dose 2|Infant Series||222
1695375|NCT00474539|4143178|P1|Vaccinated Dose 2|Infant Series||217
1695376|NCT00474539|4143177|P2|Vaccinated Dose 1|Infant Series||226
1695377|NCT00474539|4143178|P1|Vaccinated Dose 1|Infant Series||218
1695378|NCT00474539|4143177|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
1695379|NCT00474539|4143178|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
1695380|NCT00474526|4143243|P17|NOT COMPLETED|Overall Study||9
1695381|NCT00474526|4143244|P16|NOT COMPLETED|Overall Study||18
1695382|NCT00474526|4143245|P15|NOT COMPLETED|Overall Study||77
1695383|NCT00474526|4143246|P14|NOT COMPLETED|Overall Study||156
1695384|NCT00474526|4143247|P13|NOT COMPLETED|Overall Study||15
1695385|NCT00474526|4143248|P12|NOT COMPLETED|Overall Study||11
1695386|NCT00474526|4143249|P11|NOT COMPLETED|Overall Study||10
1695387|NCT00474526|4143250|P10|NOT COMPLETED|Overall Study||27
1695388|NCT00474526|4143251|P9|NOT COMPLETED|Overall Study||6
1695389|NCT00474526|4143252|P8|NOT COMPLETED|Overall Study||6
1695390|NCT00474526|4143253|P7|NOT COMPLETED|Overall Study||25
1695391|NCT00474526|4143254|P6|NOT COMPLETED|Overall Study||16
1695392|NCT00474526|4143255|P5|NOT COMPLETED|Overall Study||68
1695393|NCT00474526|4143256|P4|NOT COMPLETED|Overall Study||119
1695394|NCT00474526|4143257|P3|NOT COMPLETED|Overall Study||49
1695395|NCT00474526|4143258|P2|NOT COMPLETED|Overall Study||46
1695396|NCT00474526|4143259|P1|NOT COMPLETED|Overall Study||33
1695397|NCT00474526|4143243|P17|COMPLETED|Overall Study||174
1695398|NCT00474526|4143244|P16|COMPLETED|Overall Study||152
1695399|NCT00474526|4143245|P15|COMPLETED|Overall Study||281
1695400|NCT00474526|4143246|P14|COMPLETED|Overall Study||1270
1695401|NCT00474526|4143247|P13|COMPLETED|Overall Study||135
1695402|NCT00474526|4143248|P12|COMPLETED|Overall Study||139
1695403|NCT00474526|4143249|P11|COMPLETED|Overall Study||141
1695404|NCT00474526|4143250|P10|COMPLETED|Overall Study||121
1695405|NCT00474526|4143251|P9|COMPLETED|Overall Study||144
1695406|NCT00474526|4143252|P8|COMPLETED|Overall Study||145
1695407|NCT00474526|4143253|P7|COMPLETED|Overall Study||178
1695408|NCT00474526|4143254|P6|COMPLETED|Overall Study||54
1695409|NCT00474526|4143255|P5|COMPLETED|Overall Study||8
1695410|NCT00474526|4143256|P4|COMPLETED|Overall Study||561
1695411|NCT00474526|4143257|P3|COMPLETED|Overall Study||110
1695412|NCT00474526|4143258|P2|COMPLETED|Overall Study||120
1695413|NCT00474526|4143259|P1|COMPLETED|Overall Study||121
1695414|NCT00474526|4143243|P17|STARTED|Overall Study||183
1695415|NCT00474526|4143244|P16|STARTED|Overall Study||170
1695416|NCT00474526|4143245|P15|STARTED|Overall Study||358
1695417|NCT00474526|4143246|P14|STARTED|Overall Study||1426
1695418|NCT00474526|4143247|P13|STARTED|Overall Study||150
1695419|NCT00474526|4143248|P12|STARTED|Overall Study||150
1695420|NCT00474526|4143249|P11|STARTED|Overall Study||151
1695421|NCT00474526|4143250|P10|STARTED|Overall Study||148
1695422|NCT00474526|4143251|P9|STARTED|Overall Study||150
1695423|NCT00474526|4143252|P8|STARTED|Overall Study||151
1695424|NCT00474526|4143253|P7|STARTED|Overall Study||203
1695425|NCT00474526|4143254|P6|STARTED|Overall Study||70
1695426|NCT00474526|4143255|P5|STARTED|Overall Study||76
1695427|NCT00474526|4143256|P4|STARTED|Overall Study||680
1695428|NCT00474526|4143257|P3|STARTED|Overall Study||159
1695429|NCT00474526|4143258|P2|STARTED|Overall Study||166
1695430|NCT00474526|4143259|P1|STARTED|Overall Study||154
1695431|NCT00474487|4143424|P4|NOT COMPLETED|Overall Study||0
1695432|NCT00474487|4143425|P3|NOT COMPLETED|Overall Study||14
1695433|NCT00474487|4143426|P2|NOT COMPLETED|Overall Study||2
1695434|NCT00474487|4143427|P1|NOT COMPLETED|Overall Study||30
1695435|NCT00474487|4143424|P4|COMPLETED|Overall Study||109
1695436|NCT00474487|4143425|P3|COMPLETED|Overall Study||885
1695437|NCT00474487|4143426|P2|COMPLETED|Overall Study||215
1695438|NCT00474487|4143427|P1|COMPLETED|Overall Study||1576
1695439|NCT00474487|4143424|P4|STARTED|Overall Study||109
1695440|NCT00474487|4143425|P3|STARTED|Overall Study||899
1695441|NCT00474487|4143426|P2|STARTED|Overall Study||217
1695442|NCT00474487|4143427|P1|STARTED|Overall Study||1606
1695443|NCT00474383|4143447|P2|NOT COMPLETED|Extension||5
1695444|NCT00474383|4143448|P1|NOT COMPLETED|Extension||0
1695445|NCT00474383|4143447|P2|COMPLETED|Extension||0
1695446|NCT00474383|4143448|P1|COMPLETED|Extension||0
1695447|NCT00474383|4143447|P2|STARTED|Extension||5
1695448|NCT00474383|4143448|P1|STARTED|Extension||0
1695449|NCT00474383|4143447|P2|NOT COMPLETED|Between Main Study and Extension||0
1695450|NCT00474383|4143448|P1|NOT COMPLETED|Between Main Study and Extension||6
1695451|NCT00474383|4143447|P2|COMPLETED|Between Main Study and Extension||0
1695452|NCT00474383|4143448|P1|COMPLETED|Between Main Study and Extension||5
1695453|NCT00474383|4143447|P2|STARTED|Between Main Study and Extension||0
1695454|NCT00474383|4143448|P1|STARTED|Between Main Study and Extension||11
1695455|NCT00474383|4143447|P2|NOT COMPLETED|Main Study||0
1695456|NCT00474383|4143448|P1|NOT COMPLETED|Main Study||36
1695457|NCT00474383|4143447|P2|COMPLETED|Main Study||0
1695458|NCT00474383|4143448|P1|COMPLETED|Main Study||11
1695459|NCT00474383|4143447|P2|STARTED|Main Study||0
1695460|NCT00474383|4143448|P1|STARTED|Main Study||47
1695461|NCT00474266|4143463|P4|NOT COMPLETED|Overall Study||7
1695462|NCT00474266|4143464|P3|NOT COMPLETED|Overall Study||4
1695463|NCT00474266|4143465|P2|NOT COMPLETED|Overall Study||20
1695464|NCT00474266|4143466|P1|NOT COMPLETED|Overall Study||7
1695465|NCT00474266|4143463|P4|COMPLETED|Overall Study||118
1695466|NCT00474266|4143464|P3|COMPLETED|Overall Study||122
1695467|NCT00474266|4143465|P2|COMPLETED|Overall Study||354
1695468|NCT00474266|4143466|P1|COMPLETED|Overall Study||368
1695469|NCT00474266|4143463|P4|STARTED|Overall Study||125
1695470|NCT00474266|4143464|P3|STARTED|Overall Study||126
1695471|NCT00474266|4143465|P2|STARTED|Overall Study||374
1695472|NCT00474266|4143466|P1|STARTED|Overall Study||375
1695473|NCT00474240|4143574|P6|NOT COMPLETED|Overall Study||18
1695474|NCT00474240|4143575|P5|NOT COMPLETED|Overall Study||8
1695475|NCT00474240|4143576|P4|NOT COMPLETED|Overall Study||16
1695476|NCT00474240|4143577|P3|NOT COMPLETED|Overall Study||9
1695477|NCT00474240|4143578|P2|NOT COMPLETED|Overall Study||1
1695478|NCT00474240|4143579|P1|NOT COMPLETED|Overall Study||1
1695479|NCT00474240|4143574|P6|COMPLETED|Overall Study||8
1695480|NCT00474240|4143575|P5|COMPLETED|Overall Study||18
1695481|NCT00474240|4143576|P4|COMPLETED|Overall Study||10
1695482|NCT00474240|4143577|P3|COMPLETED|Overall Study||17
1695483|NCT00474240|4143578|P2|COMPLETED|Overall Study||25
1695484|NCT00474240|4143579|P1|COMPLETED|Overall Study||26
1695485|NCT00474240|4143574|P6|STARTED|Overall Study||26
1695486|NCT00474240|4143575|P5|STARTED|Overall Study||26
1695487|NCT00474240|4143576|P4|STARTED|Overall Study||26
1695488|NCT00474240|4143577|P3|STARTED|Overall Study||26
1695489|NCT00474240|4143578|P2|STARTED|Overall Study||26
1695490|NCT00474240|4143579|P1|STARTED|Overall Study||27
1695491|NCT00474201|4143599|P1|NOT COMPLETED|Overall Study||0
1695492|NCT00474201|4143599|P1|COMPLETED|Overall Study||15
1695493|NCT00474201|4143599|P1|STARTED|Overall Study||15
1695494|NCT00474188|4143604|P1|NOT COMPLETED|Overall Study||6
1695495|NCT00474188|4143604|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
1695496|NCT00474188|4143604|P1|STARTED|Overall Study||26
1695497|NCT00474175|4143614|P3|NOT COMPLETED|Overall Study||4
1695498|NCT00474175|4143615|P2|NOT COMPLETED|Overall Study||7
1695499|NCT00474175|4143616|P1|NOT COMPLETED|Overall Study||1
1695500|NCT00474175|4143614|P3|COMPLETED|Overall Study||225
1695501|NCT00474175|4143615|P2|COMPLETED|Overall Study||226
1695502|NCT00474175|4143616|P1|COMPLETED|Overall Study||114
1695503|NCT00474175|4143614|P3|Treated|Overall Study||228
1695504|NCT00474175|4143615|P2|Treated|Overall Study||233
1695505|NCT00474175|4143616|P1|Treated|Overall Study||115
1695506|NCT00474175|4143614|P3|STARTED|Overall Study||229
1695507|NCT00474175|4143615|P2|STARTED|Overall Study||233
1695508|NCT00474175|4143616|P1|STARTED|Overall Study||115
1695509|NCT00474123|4143653|P2|NOT COMPLETED|Overall Study||0
1695510|NCT00474123|4143654|P1|NOT COMPLETED|Overall Study||0
1695511|NCT00474123|4143653|P2|COMPLETED|Overall Study||40
1695512|NCT00474123|4143654|P1|COMPLETED|Overall Study||38
1695513|NCT00474123|4143653|P2|STARTED|Overall Study||40
1695514|NCT00474123|4143654|P1|STARTED|Overall Study||38
1695515|NCT00474058|4143680|P2|NOT COMPLETED|Overall Study||17
1695516|NCT00474058|4143681|P1|NOT COMPLETED|Overall Study||24
1695517|NCT00474058|4143680|P2|COMPLETED|Overall Study||80
1695518|NCT00474058|4143681|P1|COMPLETED|Overall Study||166
1695519|NCT00474058|4143680|P2|STARTED|Overall Study||97
1695520|NCT00474058|4143681|P1|STARTED|Overall Study||190
1695521|NCT00474045|4143695|P2|NOT COMPLETED|Overall Study||101
1695522|NCT00474045|4143696|P1|NOT COMPLETED|Overall Study||106
1695523|NCT00474045|4143695|P2|COMPLETED|Overall Study||136
1695524|NCT00474045|4143696|P1|COMPLETED|Overall Study||127
1695525|NCT00474045|4143695|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
1695526|NCT00474045|4143696|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
1695527|NCT00474045|4143695|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
1695528|NCT00474045|4143696|P1|Exposed-Pregnant Subjects|Overall Study||152
1695529|NCT00474045|4143695|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
1695530|NCT00474045|4143696|P1|Exposed-All Subjects|Overall Study||233
1695531|NCT00474045|4143695|P2|STARTED|Overall Study||237
1695532|NCT00474045|4143696|P1|STARTED|Overall Study||233
1695533|NCT00473889|4143796|P2|NOT COMPLETED|Overall Study||64
1695534|NCT00473889|4143797|P1|NOT COMPLETED|Overall Study||83
1695535|NCT00473889|4143796|P2|COMPLETED|Overall Study||63
1695536|NCT00473889|4143797|P1|COMPLETED|Overall Study||43
1695537|NCT00473889|4143796|P2|STARTED|Overall Study||127
1695538|NCT00473889|4143797|P1|STARTED|Overall Study||126
1695539|NCT00473876|4143809|P2|NOT COMPLETED|Overall Study||1
1695540|NCT00473876|4143810|P1|NOT COMPLETED|Overall Study||3
1695541|NCT00473876|4143809|P2|COMPLETED|Overall Study||22
1695542|NCT00473876|4143810|P1|COMPLETED|Overall Study||36
1695543|NCT00473876|4143809|P2|STARTED|Overall Study||23
1695544|NCT00473876|4143810|P1|STARTED|Overall Study||39
1695545|NCT00473837|4143820|P2|NOT COMPLETED|Overall Study||3
1695546|NCT00473837|4143821|P1|NOT COMPLETED|Overall Study||1
1695547|NCT00473837|4143820|P2|COMPLETED|Overall Study||43
1695548|NCT00473837|4143821|P1|COMPLETED|Overall Study||49
1695549|NCT00473837|4143820|P2|STARTED|Overall Study||46
1695550|NCT00473837|4143821|P1|STARTED|Overall Study||50
1695551|NCT00473824|4143829|P2|NOT COMPLETED|Overall Study||0
1695552|NCT00473824|4143830|P1|NOT COMPLETED|Overall Study||5
1695553|NCT00473824|4143829|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
1695554|NCT00473824|4143830|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
1695555|NCT00473824|4143829|P2|STARTED|Overall Study||2
1695556|NCT00473824|4143830|P1|STARTED|Overall Study||5
1695557|NCT00473746|4143841|P5|NOT COMPLETED|Period 2 (Phase 2)||27
1695558|NCT00473746|4143842|P4|NOT COMPLETED|Period 2 (Phase 2)||0
1695559|NCT00473746|4143843|P3|NOT COMPLETED|Period 2 (Phase 2)||0
1695560|NCT00473746|4143844|P2|NOT COMPLETED|Period 2 (Phase 2)||0
1695561|NCT00473746|4143845|P1|NOT COMPLETED|Period 2 (Phase 2)||0
1695562|NCT00473746|4143841|P5|COMPLETED|Period 2 (Phase 2)||6
1695563|NCT00473746|4143842|P4|COMPLETED|Period 2 (Phase 2)||0
1695564|NCT00473746|4143843|P3|COMPLETED|Period 2 (Phase 2)||0
1695565|NCT00473746|4143844|P2|COMPLETED|Period 2 (Phase 2)||0
1695566|NCT00473746|4143845|P1|COMPLETED|Period 2 (Phase 2)||0
1695567|NCT00473746|4143841|P5|STARTED|Period 2 (Phase 2)||33
1695568|NCT00473746|4143842|P4|STARTED|Period 2 (Phase 2)||0
1695569|NCT00473746|4143843|P3|STARTED|Period 2 (Phase 2)||0
1695570|NCT00473746|4143844|P2|STARTED|Period 2 (Phase 2)||0
1695571|NCT00473746|4143845|P1|STARTED|Period 2 (Phase 2)||0
1695572|NCT00473746|4143841|P5|NOT COMPLETED|Period 1 (Phase 1)||0
1695573|NCT00473746|4143842|P4|NOT COMPLETED|Period 1 (Phase 1)||10
1695574|NCT00473746|4143843|P3|NOT COMPLETED|Period 1 (Phase 1)||6
1695575|NCT00473746|4143844|P2|NOT COMPLETED|Period 1 (Phase 1)||9
1695576|NCT00473746|4143845|P1|NOT COMPLETED|Period 1 (Phase 1)||6
1695577|NCT00473746|4143841|P5|COMPLETED|Period 1 (Phase 1)||0
1695578|NCT00473746|4143842|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
1695579|NCT00473746|4143843|P3|COMPLETED|Period 1 (Phase 1)||0
1695580|NCT00473746|4143844|P2|COMPLETED|Period 1 (Phase 1)||0
1695581|NCT00473746|4143845|P1|COMPLETED|Period 1 (Phase 1)||0
1695582|NCT00473746|4143841|P5|STARTED|Period 1 (Phase 1)||0
1695583|NCT00473746|4143842|P4|STARTED|Period 1 (Phase 1)||12
1695584|NCT00473746|4143843|P3|STARTED|Period 1 (Phase 1)||6
1695585|NCT00473746|4143844|P2|STARTED|Period 1 (Phase 1)||9
1695586|NCT00473746|4143845|P1|STARTED|Period 1 (Phase 1)||6
1695587|NCT00473668|4143893|P3|NOT COMPLETED|Overall Study||10
1695588|NCT00473668|4143894|P2|NOT COMPLETED|Overall Study||11
1695589|NCT00473668|4143895|P1|NOT COMPLETED|Overall Study||5
1695590|NCT00473668|4143893|P3|COMPLETED|Overall Study||89
1695591|NCT00473668|4143894|P2|COMPLETED|Overall Study||89
1695592|NCT00473668|4143895|P1|COMPLETED|Overall Study||95
1695593|NCT00473668|4143893|P3|STARTED|Overall Study||99
1695594|NCT00473668|4143894|P2|STARTED|Overall Study||100
1695595|NCT00473668|4143895|P1|STARTED|Overall Study||100
1695596|NCT00473655|4143948|P3|NOT COMPLETED|Overall Study||8
1695597|NCT00473655|4143949|P2|NOT COMPLETED|Overall Study||5
1695598|NCT00473655|4143950|P1|NOT COMPLETED|Overall Study||9
1695599|NCT00473655|4143948|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
1695600|NCT00473655|4143949|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
1695601|NCT00473655|4143950|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
1695602|NCT00473655|4143948|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
1695603|NCT00473655|4143949|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
1695604|NCT00473655|4143950|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
1695605|NCT00473642|4143985|P3|NOT COMPLETED|Overall Study||2
1695606|NCT00473642|4143986|P2|NOT COMPLETED|Overall Study||1
1695607|NCT00473642|4143987|P1|NOT COMPLETED|Overall Study||2
1695608|NCT00473642|4143985|P3|COMPLETED|Overall Study||8
1695609|NCT00473642|4143986|P2|COMPLETED|Overall Study||10
1695610|NCT00473642|4143987|P1|COMPLETED|Overall Study||8
1695611|NCT00473642|4143985|P3|STARTED|Overall Study||10
1695612|NCT00473642|4143986|P2|STARTED|Overall Study||11
1695613|NCT00473642|4143987|P1|STARTED|Overall Study||10
1695614|NCT00473590|4143997|P2|NOT COMPLETED|Overall Study||38
1695615|NCT00473590|4143998|P1|NOT COMPLETED|Overall Study||45
1695616|NCT00473590|4143997|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
1695617|NCT00473590|4143998|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
1695618|NCT00473590|4143997|P2|Safety Population|Overall Study||50
1695619|NCT00473590|4143998|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
1695620|NCT00473590|4143997|P2|Treated|Overall Study||48
1695621|NCT00473590|4143998|P1|Treated|Overall Study||52
1695622|NCT00473590|4143997|P2|STARTED|Overall Study||49
1695623|NCT00473590|4143998|P1|STARTED|Overall Study||53
1695624|NCT00473564|4144014|P1|NOT COMPLETED|Overall Study||23
1695625|NCT00473564|4144014|P1|COMPLETED|Overall Study||147
1695626|NCT00473564|4144014|P1|STARTED|Overall Study||170
1695627|NCT00473512|4144024|P5|NOT COMPLETED|Period 2 (Phase 2)||2
1695628|NCT00473512|4144025|P4|NOT COMPLETED|Period 2 (Phase 2)||23
1695629|NCT00473512|4144026|P3|NOT COMPLETED|Period 2 (Phase 2)||2
1695630|NCT00473512|4144027|P2|NOT COMPLETED|Period 2 (Phase 2)||2
1695631|NCT00473512|4144028|P1|NOT COMPLETED|Period 2 (Phase 2)||1
1695632|NCT00473512|4144024|P5|COMPLETED|Period 2 (Phase 2)||0
1695633|NCT00473512|4144025|P4|COMPLETED|Period 2 (Phase 2)||0
1695634|NCT00473512|4144026|P3|COMPLETED|Period 2 (Phase 2)||0
1695635|NCT00473512|4144027|P2|COMPLETED|Period 2 (Phase 2)||0
1695636|NCT00473512|4144028|P1|COMPLETED|Period 2 (Phase 2)||0
1695637|NCT00473512|4144024|P5|STARTED|Period 2 (Phase 2)||2
1695638|NCT00473512|4144025|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
1695639|NCT00473512|4144026|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
1695640|NCT00473512|4144027|P2|STARTED|Period 2 (Phase 2)||2
1695641|NCT00473512|4144028|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
1695642|NCT00473512|4144024|P5|NOT COMPLETED|Period 1 (Phase 1)||1
1695643|NCT00473512|4144025|P4|NOT COMPLETED|Period 1 (Phase 1)||17
1695644|NCT00473512|4144026|P3|NOT COMPLETED|Period 1 (Phase 1)||0
1695645|NCT00473512|4144027|P2|NOT COMPLETED|Period 1 (Phase 1)||1
1695646|NCT00473512|4144028|P1|NOT COMPLETED|Period 1 (Phase 1)||1
1695647|NCT00473512|4144024|P5|COMPLETED|Period 1 (Phase 1)||2
1695648|NCT00473512|4144025|P4|COMPLETED|Period 1 (Phase 1)||25
1695649|NCT00473512|4144026|P3|COMPLETED|Period 1 (Phase 1)||3
1695650|NCT00473512|4144027|P2|COMPLETED|Period 1 (Phase 1)||2
1695651|NCT00473512|4144028|P1|COMPLETED|Period 1 (Phase 1)||2
1695652|NCT00473512|4144024|P5|STARTED|Period 1 (Phase 1)||3
1695653|NCT00473512|4144025|P4|STARTED|Period 1 (Phase 1)||42
1695654|NCT00473512|4144026|P3|STARTED|Period 1 (Phase 1)||3
1695655|NCT00473512|4144027|P2|STARTED|Period 1 (Phase 1)||3
1695656|NCT00473512|4144028|P1|STARTED|Period 1 (Phase 1)||3
1695657|NCT00473434|4144086|P1|NOT COMPLETED|Overall Study||32
1695658|NCT00473434|4144086|P1|COMPLETED|Overall Study||32
1695659|NCT00473434|4144086|P1|STARTED|Overall Study||64
1695660|NCT00473382|4144151|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
1695661|NCT00473382|4144152|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
1695662|NCT00473382|4144153|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
1695663|NCT00473382|4144151|P3|COMPLETED|Open-label Extension Through Month 60||2
1695664|NCT00473382|4144152|P2|COMPLETED|Open-label Extension Through Month 60||1
1695665|NCT00473382|4144153|P1|COMPLETED|Open-label Extension Through Month 60||2
1695666|NCT00473382|4144151|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
1695667|NCT00473382|4144152|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
1695668|NCT00473382|4144153|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
1695669|NCT00473382|4144151|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
1695670|NCT00473382|4144152|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
1695671|NCT00473382|4144153|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
1695672|NCT00473382|4144151|P3|COMPLETED|Open-label Extension Through Month 48||37
1695673|NCT00473382|4144152|P2|COMPLETED|Open-label Extension Through Month 48||42
1695674|NCT00473382|4144153|P1|COMPLETED|Open-label Extension Through Month 48||38
1695675|NCT00473382|4144151|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
1695676|NCT00473382|4144152|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
1695677|NCT00473382|4144153|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
1695678|NCT00473382|4144151|P3|NOT COMPLETED|Core Study||29
1695679|NCT00473382|4144152|P2|NOT COMPLETED|Core Study||27
1695680|NCT00473382|4144153|P1|NOT COMPLETED|Core Study||28
1695681|NCT00473382|4144151|P3|COMPLETED|Core Study||98
1695682|NCT00473382|4144152|P2|COMPLETED|Core Study||98
1695683|NCT00473382|4144153|P1|COMPLETED|Core Study||102
1695684|NCT00473382|4144151|P3|STARTED|Core Study||127
1695685|NCT00473382|4144152|P2|STARTED|Core Study||125
1695686|NCT00473382|4144153|P1|STARTED|Core Study||130
1695687|NCT00473330|4144211|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
1695688|NCT00473330|4144212|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
1695689|NCT00473330|4144213|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
1695690|NCT00473330|4144211|P3|COMPLETED|Open-label Extension Through Month 60||0
1695691|NCT00473330|4144212|P2|COMPLETED|Open-label Extension Through Month 60||1
1695692|NCT00473330|4144213|P1|COMPLETED|Open-label Extension Through Month 60||1
1695693|NCT00473330|4144211|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
1695694|NCT00473330|4144212|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
1695695|NCT00473330|4144213|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
1695696|NCT00473330|4144211|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
1695697|NCT00473330|4144212|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
1695698|NCT00473330|4144213|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
1695699|NCT00473330|4144211|P3|COMPLETED|Open-label Extension Through Month 48||50
1695700|NCT00473330|4144212|P2|COMPLETED|Open-label Extension Through Month 48||59
1695701|NCT00473330|4144213|P1|COMPLETED|Open-label Extension Through Month 48||63
1695702|NCT00473330|4144211|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
1695703|NCT00473330|4144212|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
1695704|NCT00473330|4144213|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
1695705|NCT00473330|4144211|P3|NOT COMPLETED|Core Study||41
1695706|NCT00473330|4144212|P2|NOT COMPLETED|Core Study||25
1695707|NCT00473330|4144213|P1|NOT COMPLETED|Core Study||27
1695708|NCT00473330|4144211|P3|COMPLETED|Core Study||86
1695709|NCT00473330|4144212|P2|COMPLETED|Core Study||100
1695710|NCT00473330|4144213|P1|COMPLETED|Core Study||98
1695711|NCT00473330|4144211|P3|STARTED|Core Study||127
1695712|NCT00473330|4144212|P2|STARTED|Core Study||125
1695713|NCT00473330|4144213|P1|STARTED|Core Study||125
1695714|NCT00473265|4144268|P1|NOT COMPLETED|Overall Study||20
1695715|NCT00473265|4144268|P1|COMPLETED|Overall Study||48
1695716|NCT00473265|4144268|P1|STARTED|Overall Study||68
1695717|NCT00473083|4144280|P3|NOT COMPLETED|Overall Study||0
1695718|NCT00473083|4144281|P2|NOT COMPLETED|Overall Study||0
1695719|NCT00473083|4144282|P1|NOT COMPLETED|Overall Study||1
1695720|NCT00473083|4144280|P3|COMPLETED|Overall Study||50
1695721|NCT00473083|4144281|P2|COMPLETED|Overall Study||50
1695722|NCT00473083|4144282|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
1695723|NCT00473083|4144280|P3|STARTED|Overall Study||50
1695724|NCT00473083|4144281|P2|STARTED|Overall Study||50
1695725|NCT00473083|4144282|P1|STARTED|Overall Study||50
1695726|NCT00472849|4144310|P2|NOT COMPLETED|Overall Study||0
1695727|NCT00472849|4144311|P1|NOT COMPLETED|Overall Study||0
1695728|NCT00472849|4144310|P2|COMPLETED|Overall Study||78
1695729|NCT00472849|4144311|P1|COMPLETED|Overall Study||12
1695730|NCT00472849|4144310|P2|STARTED|Overall Study||78
1695731|NCT00472849|4144311|P1|STARTED|Overall Study||12
1695732|NCT00472797|4144319|P2|NOT COMPLETED|Overall Study||1
1695733|NCT00472797|4144320|P1|NOT COMPLETED|Overall Study||4
1695734|NCT00472797|4144319|P2|COMPLETED|Overall Study||112
1695735|NCT00472797|4144320|P1|COMPLETED|Overall Study||115
1695736|NCT00472797|4144319|P2|STARTED|Overall Study||113
1695737|NCT00472797|4144320|P1|STARTED|Overall Study||119
1695738|NCT00472732|4144346|P2|NOT COMPLETED|Overall Study||0
1695739|NCT00472732|4144347|P1|NOT COMPLETED|Overall Study||0
1695740|NCT00472732|4144346|P2|COMPLETED|Overall Study||22
1695741|NCT00472732|4144347|P1|COMPLETED|Overall Study||24
1695742|NCT00472732|4144346|P2|STARTED|Overall Study||22
1695743|NCT00472732|4144347|P1|STARTED|Overall Study||24
1695744|NCT00472641|4144357|P1|NOT COMPLETED|Overall Study||7
1695745|NCT00472641|4144357|P1|COMPLETED|Overall Study||18
1695746|NCT00472641|4144357|P1|STARTED|Overall Study||25
1695747|NCT00472576|4144364|P2|NOT COMPLETED|Second Intervention||0
1695748|NCT00472576|4144365|P1|NOT COMPLETED|Second Intervention||0
1695749|NCT00472576|4144364|P2|COMPLETED|Second Intervention||3
1695750|NCT00472576|4144365|P1|COMPLETED|Second Intervention||2
1695751|NCT00472576|4144364|P2|STARTED|Second Intervention||3
1695752|NCT00472576|4144365|P1|STARTED|Second Intervention||2
1695753|NCT00472576|4144364|P2|NOT COMPLETED|First Intervention||0
1695754|NCT00472576|4144365|P1|NOT COMPLETED|First Intervention||0
1695755|NCT00472576|4144364|P2|COMPLETED|First Intervention||3
1695756|NCT00472576|4144365|P1|COMPLETED|First Intervention||2
1695757|NCT00472576|4144364|P2|STARTED|First Intervention||3
1695758|NCT00472576|4144365|P1|STARTED|First Intervention||2
1695759|NCT00472446|4144377|P4|NOT COMPLETED|Overall Study||6
1695760|NCT00472446|4144378|P3|NOT COMPLETED|Overall Study||7
1695761|NCT00472446|4144379|P2|NOT COMPLETED|Overall Study||6
1695762|NCT00472446|4144380|P1|NOT COMPLETED|Overall Study||5
1695763|NCT00472446|4144377|P4|COMPLETED|Overall Study||39
1695764|NCT00472446|4144378|P3|COMPLETED|Overall Study||38
1695765|NCT00472446|4144379|P2|COMPLETED|Overall Study||41
1695766|NCT00472446|4144380|P1|COMPLETED|Overall Study||41
1695767|NCT00472446|4144377|P4|STARTED|Overall Study||45
1695768|NCT00472446|4144378|P3|STARTED|Overall Study||45
1695769|NCT00472446|4144379|P2|STARTED|Overall Study||47
1695770|NCT00472446|4144380|P1|STARTED|Overall Study||46
1695771|NCT00472420|4144410|P1|NOT COMPLETED|Follow-up Period||17
1695772|NCT00472420|4144410|P1|COMPLETED|Follow-up Period||15
1695773|NCT00472420|4144410|P1|STARTED|Follow-up Period||32
1695774|NCT00472420|4144410|P1|NOT COMPLETED|Induction Treatment Period||16
1695775|NCT00472420|4144410|P1|COMPLETED|Induction Treatment Period||32
1695776|NCT00472420|4144410|P1|STARTED|Induction Treatment Period||48
1695777|NCT00472303|4144418|P3|NOT COMPLETED|Maintenance Phase||17
1695778|NCT00472303|4144419|P2|NOT COMPLETED|Maintenance Phase||16
1695779|NCT00472303|4144420|P1|NOT COMPLETED|Maintenance Phase||17
1695780|NCT00472303|4144418|P3|COMPLETED|Maintenance Phase||95
1695781|NCT00472303|4144419|P2|COMPLETED|Maintenance Phase||93
1695782|NCT00472303|4144420|P1|COMPLETED|Maintenance Phase||89
1695783|NCT00472303|4144418|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
1695784|NCT00472303|4144419|P2|STARTED|Maintenance Phase||109
1695785|NCT00472303|4144420|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
1695786|NCT00472303|4144418|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
1695787|NCT00472303|4144419|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
1695788|NCT00472303|4144420|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
1695789|NCT00472303|4144418|P3|COMPLETED|Discontinuations After Titration Phase||0
1695790|NCT00472303|4144419|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
1695791|NCT00472303|4144420|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
1695792|NCT00472303|4144418|P3|STARTED|Discontinuations After Titration Phase||0
1695793|NCT00472303|4144419|P2|STARTED|Discontinuations After Titration Phase||129
1695794|NCT00472303|4144420|P1|STARTED|Discontinuations After Titration Phase||279
1695795|NCT00472303|4144418|P3|NOT COMPLETED|Titration Phase||0
1695796|NCT00472303|4144419|P2|NOT COMPLETED|Titration Phase||29
1695797|NCT00472303|4144420|P1|NOT COMPLETED|Titration Phase||59
1695798|NCT00472303|4144418|P3|COMPLETED|Titration Phase||0
1695799|NCT00472303|4144419|P2|COMPLETED|Titration Phase||129
1695800|NCT00472303|4144420|P1|COMPLETED|Titration Phase||279
1695801|NCT00472303|4144418|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
1695802|NCT00472303|4144419|P2|STARTED|Titration Phase||158
1695803|NCT00472303|4144420|P1|STARTED|Titration Phase||338
1695804|NCT00472290|4144483|P1|NOT COMPLETED|Overall Study||72
1695805|NCT00472290|4144483|P1|COMPLETED|Overall Study||0
1695806|NCT00472290|4144483|P1|STARTED|Overall Study||72
1695807|NCT00472199|4144495|P2|NOT COMPLETED|Overall Study||60
1695808|NCT00472199|4144496|P1|NOT COMPLETED|Overall Study||35
1695809|NCT00472199|4144495|P2|COMPLETED|Overall Study||103
1695810|NCT00472199|4144496|P1|COMPLETED|Overall Study||131
1695811|NCT00472199|4144495|P2|STARTED|Overall Study||163
1695812|NCT00472199|4144496|P1|STARTED|Overall Study||166
1695813|NCT00472082|4144562|P1|NOT COMPLETED|Overall Study||5
1695814|NCT00472082|4144562|P1|COMPLETED|Overall Study||0
1695815|NCT00472082|4144562|P1|STARTED|Overall Study||5
1695816|NCT00472056|4144571|P4|NOT COMPLETED|Overall Study||0
1695817|NCT00472056|4144572|P3|NOT COMPLETED|Overall Study||0
1695818|NCT00472056|4144573|P2|NOT COMPLETED|Overall Study||0
1695819|NCT00472056|4144574|P1|NOT COMPLETED|Overall Study||0
1695820|NCT00472056|4144571|P4|COMPLETED|Overall Study||17
1695821|NCT00472056|4144572|P3|COMPLETED|Overall Study||32
1695822|NCT00472056|4144573|P2|COMPLETED|Overall Study||19
1695823|NCT00472056|4144574|P1|COMPLETED|Overall Study||25
1695824|NCT00472056|4144571|P4|STARTED|Overall Study||17
1695825|NCT00472056|4144572|P3|STARTED|Overall Study||32
1695826|NCT00472056|4144573|P2|STARTED|Overall Study||19
1695827|NCT00472056|4144574|P1|STARTED|Overall Study||25
1695828|NCT00472030|4144584|P2|NOT COMPLETED|Overall Study||0
1695829|NCT00472030|4144585|P1|NOT COMPLETED|Overall Study||1
1695830|NCT00472030|4144584|P2|COMPLETED|Overall Study||0
1695831|NCT00472030|4144585|P1|COMPLETED|Overall Study||1
1695832|NCT00472030|4144584|P2|STARTED|Overall Study||0
1695833|NCT00472030|4144585|P1|STARTED|Overall Study||2
1695834|NCT00471822|4144601|P1|NOT COMPLETED|Overall Study||2
1695835|NCT00471822|4144601|P1|COMPLETED|Overall Study||9705
1695836|NCT00471822|4144601|P1|Treated|Overall Study||9705
1695837|NCT00471822|4144601|P1|STARTED|Overall Study||9707
1695838|NCT00471718|4144609|P1|NOT COMPLETED|Overall Study||27
1695839|NCT00471718|4144609|P1|COMPLETED|Overall Study||0
1695840|NCT00471718|4144609|P1|STARTED|Overall Study||27
1695841|NCT00471705|4144621|P3|NOT COMPLETED|Overall Study||15
1695842|NCT00471705|4144622|P2|NOT COMPLETED|Overall Study||22
1695843|NCT00471705|4144623|P1|NOT COMPLETED|Overall Study||24
1695844|NCT00471705|4144621|P3|COMPLETED|Overall Study||134
1695845|NCT00471705|4144622|P2|COMPLETED|Overall Study||121
1695846|NCT00471705|4144623|P1|COMPLETED|Overall Study||121
1695847|NCT00471705|4144621|P3|STARTED|Overall Study||149
1695848|NCT00471705|4144622|P2|STARTED|Overall Study||143
1695849|NCT00471705|4144623|P1|STARTED|Overall Study||145
1695850|NCT00471536|4144637|P1|NOT COMPLETED|Overall Study||1
1695851|NCT00471536|4144637|P1|COMPLETED|Overall Study||18
1695852|NCT00471536|4144637|P1|STARTED|Overall Study||19
1695853|NCT00471497|4144649|P3|NOT COMPLETED|Overall Study||40
1695854|NCT00471497|4144650|P2|NOT COMPLETED|Overall Study||35
1695855|NCT00471497|4144651|P1|NOT COMPLETED|Overall Study||46
1695856|NCT00471497|4144649|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
1695857|NCT00471497|4144650|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
1695858|NCT00471497|4144651|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
1695859|NCT00471497|4144649|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
1695860|NCT00471497|4144650|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
1695861|NCT00471497|4144651|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
1695862|NCT00471497|4144649|P3|STARTED|Overall Study||281
1695863|NCT00471497|4144650|P2|STARTED|Overall Study||282
1695864|NCT00471497|4144651|P1|STARTED|Overall Study||283
1695865|NCT00471445|4144661|P2|NOT COMPLETED|Overall Study||2
1695866|NCT00471445|4144662|P1|NOT COMPLETED|Overall Study||2
1695867|NCT00471445|4144661|P2|COMPLETED|Overall Study||231
1695868|NCT00471445|4144662|P1|COMPLETED|Overall Study||227
1695869|NCT00471445|4144661|P2|STARTED|Overall Study||233
1695870|NCT00471445|4144662|P1|STARTED|Overall Study||229
1695871|NCT00471380|4144668|P2|NOT COMPLETED|Third Intervention||2
1695872|NCT00471380|4144669|P1|NOT COMPLETED|Third Intervention||1
1695873|NCT00471380|4144668|P2|COMPLETED|Third Intervention||14
1695874|NCT00471380|4144669|P1|COMPLETED|Third Intervention||17
1695875|NCT00471380|4144668|P2|STARTED|Third Intervention||16
1695876|NCT00471380|4144669|P1|STARTED|Third Intervention||18
1695877|NCT00471380|4144668|P2|NOT COMPLETED|Second Intervention||4
1695878|NCT00471380|4144669|P1|NOT COMPLETED|Second Intervention||0
1695879|NCT00471380|4144668|P2|COMPLETED|Second Intervention||16
1695880|NCT00471380|4144669|P1|COMPLETED|Second Intervention||18
1695881|NCT00471380|4144668|P2|STARTED|Second Intervention||20
1695882|NCT00471380|4144669|P1|STARTED|Second Intervention||18
1695883|NCT00471380|4144668|P2|NOT COMPLETED|First Intervention||4
1695884|NCT00471380|4144669|P1|NOT COMPLETED|First Intervention||4
1695885|NCT00471380|4144668|P2|COMPLETED|First Intervention||20
1695886|NCT00471380|4144669|P1|COMPLETED|First Intervention||18
1695887|NCT00471380|4144668|P2|STARTED|First Intervention||24
1695888|NCT00471380|4144669|P1|STARTED|First Intervention||22
1695889|NCT00471354|4144675|P1|NOT COMPLETED|Overall Study||52
1695890|NCT00471354|4144675|P1|COMPLETED|Overall Study||176
1695891|NCT00471354|4144675|P1|STARTED|Overall Study||228
1695892|NCT00471328|4144687|P2|NOT COMPLETED|Extension Phase||67
1695893|NCT00471328|4144688|P1|NOT COMPLETED|Extension Phase||41
1695894|NCT00471328|4144687|P2|COMPLETED|Extension Phase||0
1695895|NCT00471328|4144688|P1|COMPLETED|Extension Phase||0
1695896|NCT00471328|4144687|P2|Started:CrossOver During Extension|Extension Phase||10
1695897|NCT00471328|4144688|P1|Started:CrossOver During Extension|Extension Phase||0
1695898|NCT00471328|4144687|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
1695899|NCT00471328|4144688|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
1695900|NCT00471328|4144687|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
1695901|NCT00471328|4144688|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
1695902|NCT00471328|4144687|P2|STARTED|Extension Phase||67
1695903|NCT00471328|4144688|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
1695904|NCT00471328|4144687|P2|NOT COMPLETED|Core Phase||67
1695905|NCT00471328|4144688|P1|NOT COMPLETED|Core Phase||107
1695906|NCT00471328|4144687|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
1695907|NCT00471328|4144688|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
1695908|NCT00471328|4144687|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
1695909|NCT00471328|4144688|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
1695910|NCT00471328|4144687|P2|STARTED|Core Phase||83
1695911|NCT00471328|4144688|P1|STARTED|Core Phase||165
1695912|NCT00471315|4144707|P1|NOT COMPLETED|Overall Study||8
1695913|NCT00471315|4144707|P1|COMPLETED|Overall Study||10
1695914|NCT00471315|4144707|P1|STARTED|Overall Study||18
1695915|NCT00471276|4144712|P1|NOT COMPLETED|Overall Study||83
1695916|NCT00471276|4144712|P1|COMPLETED|Overall Study||0
1695917|NCT00471276|4144712|P1|STARTED|Overall Study||83
1695918|NCT00471237|4144742|P7|NOT COMPLETED|Overall Study||3
1695919|NCT00471237|4144743|P6|NOT COMPLETED|Overall Study||39
1695920|NCT00471237|4144744|P5|NOT COMPLETED|Overall Study||41
1695921|NCT00471237|4144745|P4|NOT COMPLETED|Overall Study||45
1695922|NCT00471237|4144746|P3|NOT COMPLETED|Overall Study||34
1695923|NCT00471237|4144747|P2|NOT COMPLETED|Overall Study||42
1695924|NCT00471237|4144748|P1|NOT COMPLETED|Overall Study||41
1695925|NCT00471237|4144742|P7|COMPLETED|Overall Study||38
1695926|NCT00471237|4144743|P6|COMPLETED|Overall Study||50
1695927|NCT00471237|4144744|P5|COMPLETED|Overall Study||46
1695928|NCT00471237|4144745|P4|COMPLETED|Overall Study||43
1695929|NCT00471237|4144746|P3|COMPLETED|Overall Study||48
1695930|NCT00471237|4144747|P2|COMPLETED|Overall Study||45
1695931|NCT00471237|4144748|P1|COMPLETED|Overall Study||49
1695932|NCT00471237|4144742|P7|STARTED|Overall Study||41
1695933|NCT00471237|4144743|P6|STARTED|Overall Study||89
1695934|NCT00471237|4144744|P5|STARTED|Overall Study||87
1695935|NCT00471237|4144745|P4|STARTED|Overall Study||88
1695936|NCT00471237|4144746|P3|STARTED|Overall Study||82
1695937|NCT00471237|4144747|P2|STARTED|Overall Study||87
1695938|NCT00471237|4144748|P1|STARTED|Overall Study||90
1695939|NCT00471146|4144898|P2|NOT COMPLETED|Overall Study||174
1695940|NCT00471146|4144899|P1|NOT COMPLETED|Overall Study||172
1695941|NCT00471146|4144898|P2|COMPLETED|Overall Study||142
1695942|NCT00471146|4144899|P1|COMPLETED|Overall Study||142
1695943|NCT00471146|4144898|P2|Treated|Overall Study||308
1695944|NCT00471146|4144899|P1|Treated|Overall Study||305
1695945|NCT00471146|4144898|P2|STARTED|Overall Study||316
1695946|NCT00471146|4144899|P1|STARTED|Overall Study||314
1695947|NCT00471107|4144924|P3|NOT COMPLETED|Overall Study||3
1695948|NCT00471107|4144925|P2|NOT COMPLETED|Overall Study||1
1695949|NCT00471107|4144926|P1|NOT COMPLETED|Overall Study||3
1695950|NCT00471107|4144924|P3|COMPLETED|Overall Study||12
1695951|NCT00471107|4144925|P2|COMPLETED|Overall Study||14
1695952|NCT00471107|4144926|P1|COMPLETED|Overall Study||12
1695953|NCT00471107|4144924|P3|STARTED|Overall Study||15
1695954|NCT00471107|4144925|P2|STARTED|Overall Study||15
1695955|NCT00471107|4144926|P1|STARTED|Overall Study||15
1695956|NCT00471081|4144936|P2|NOT COMPLETED|Extended Safety Follow-Up||13
1695957|NCT00471081|4144937|P1|NOT COMPLETED|Extended Safety Follow-Up||2
1695958|NCT00471081|4144936|P2|COMPLETED|Extended Safety Follow-Up||176
1695959|NCT00471081|4144937|P1|COMPLETED|Extended Safety Follow-Up||158
1695960|NCT00471081|4144936|P2|STARTED|Extended Safety Follow-Up||189
1695961|NCT00471081|4144937|P1|STARTED|Extended Safety Follow-Up||160
1695962|NCT00471081|4144936|P2|NOT COMPLETED|Active Phase||13
1695963|NCT00471081|4144937|P1|NOT COMPLETED|Active Phase||2
1695964|NCT00471081|4144936|P2|COMPLETED|Active Phase||176
1695965|NCT00471081|4144937|P1|COMPLETED|Active Phase||158
1695966|NCT00471081|4144936|P2|STARTED|Active Phase||189
1695967|NCT00471081|4144937|P1|STARTED|Active Phase||160
1695968|NCT00471068|4144976|P2|NOT COMPLETED|Overall Study||1
1695969|NCT00471068|4144977|P1|NOT COMPLETED|Overall Study||1
1695970|NCT00471068|4144976|P2|COMPLETED|Overall Study||24
1695971|NCT00471068|4144977|P1|COMPLETED|Overall Study||20
1695972|NCT00471068|4144976|P2|STARTED|Overall Study||25
1695973|NCT00471068|4144977|P1|STARTED|Overall Study||21
1695974|NCT00470847|4144983|P1|NOT COMPLETED|Overall Study||1
1695975|NCT00470847|4144983|P1|COMPLETED|Overall Study||34
1695976|NCT00470847|4144983|P1|STARTED|Overall Study||35
1695977|NCT00470834|4144996|P2|NOT COMPLETED|Extension Period (24 Months)||23
1695978|NCT00470834|4144997|P1|NOT COMPLETED|Extension Period (24 Months)||15
1695979|NCT00470834|4144996|P2|COMPLETED|Extension Period (24 Months)||7
1695980|NCT00470834|4144997|P1|COMPLETED|Extension Period (24 Months)||11
1695981|NCT00470834|4144996|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
1695982|NCT00470834|4144997|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
1695983|NCT00470834|4144996|P2|NOT COMPLETED|Treatment Period (18 Months)||31
1695984|NCT00470834|4144997|P1|NOT COMPLETED|Treatment Period (18 Months)||38
1695985|NCT00470834|4144996|P2|COMPLETED|Treatment Period (18 Months)||31
1695986|NCT00470834|4144997|P1|COMPLETED|Treatment Period (18 Months)||27
1695987|NCT00470834|4144996|P2|STARTED|Treatment Period (18 Months)||62
1695988|NCT00470834|4144997|P1|STARTED|Treatment Period (18 Months)||65
1695989|NCT00470626|4145011|P1|NOT COMPLETED|Overall Study||17
1695990|NCT00470626|4145011|P1|COMPLETED|Overall Study||112
1695991|NCT00470626|4145011|P1|STARTED|Overall Study||129
1695992|NCT00470600|4145019|P2|NOT COMPLETED|Overall Study||0
1695993|NCT00470600|4145020|P1|NOT COMPLETED|Overall Study||0
1696079|NCT00470067|4145173|P1|STARTED|Overall Study||9
1695994|NCT00470600|4145019|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
1695995|NCT00470600|4145020|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
1695996|NCT00470600|4145019|P2|STARTED|Overall Study||99
1695997|NCT00470600|4145020|P1|STARTED|Overall Study||86
1695998|NCT00470548|4145032|P4|NOT COMPLETED|Overall Study||0
1695999|NCT00470548|4145033|P3|NOT COMPLETED|Overall Study||0
1696000|NCT00470548|4145034|P2|NOT COMPLETED|Overall Study||0
1696001|NCT00470548|4145035|P1|NOT COMPLETED|Overall Study||0
1696002|NCT00470548|4145032|P4|COMPLETED|Overall Study||37
1696003|NCT00470548|4145033|P3|COMPLETED|Overall Study||6
1696004|NCT00470548|4145034|P2|COMPLETED|Overall Study||3
1696005|NCT00470548|4145035|P1|COMPLETED|Overall Study||3
1696006|NCT00470548|4145032|P4|STARTED|Overall Study||37
1696007|NCT00470548|4145033|P3|STARTED|Overall Study||6
1696008|NCT00470548|4145034|P2|STARTED|Overall Study||3
1696009|NCT00470548|4145035|P1|STARTED|Overall Study||3
1696010|NCT00470535|4145053|P1|NOT COMPLETED|Overall Study||18
1696011|NCT00470535|4145053|P1|COMPLETED|Overall Study||0
1696012|NCT00470535|4145053|P1|STARTED|Overall Study||18
1696013|NCT00470470|4145062|P1|NOT COMPLETED|Overall Study||5
1696014|NCT00470470|4145062|P1|COMPLETED|Overall Study||25
1696015|NCT00470470|4145062|P1|STARTED|Overall Study||30
1696016|NCT00470418|4145069|P2|NOT COMPLETED|Overall Study||0
1696017|NCT00470418|4145070|P1|NOT COMPLETED|Overall Study||1
1696018|NCT00470418|4145069|P2|COMPLETED|Overall Study||3
1696019|NCT00470418|4145070|P1|COMPLETED|Overall Study||6
1696020|NCT00470418|4145069|P2|STARTED|Overall Study||3
1696021|NCT00470418|4145070|P1|STARTED|Overall Study||7
1696022|NCT00470392|4145080|P2|NOT COMPLETED|Overall Study||0
1696023|NCT00470392|4145081|P1|NOT COMPLETED|Overall Study||0
1696024|NCT00470392|4145080|P2|COMPLETED|Overall Study||2
1696025|NCT00470392|4145081|P1|COMPLETED|Overall Study||7
1696026|NCT00470392|4145080|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
1696027|NCT00470392|4145081|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
1696028|NCT00470366|4145091|P1|NOT COMPLETED|Overall Study||4
1696029|NCT00470366|4145091|P1|COMPLETED|Overall Study||56
1696030|NCT00470366|4145091|P1|STARTED|Overall Study||60
1696031|NCT00470301|4145098|P1|NOT COMPLETED|Overall Study||5
1696032|NCT00470301|4145098|P1|COMPLETED|Overall Study||55
1696033|NCT00470301|4145098|P1|STARTED|Overall Study||60
1696034|NCT00470275|4145102|P1|NOT COMPLETED|Overall Study||10
1696035|NCT00470275|4145102|P1|COMPLETED|Overall Study||0
1696036|NCT00470275|4145102|P1|STARTED|Overall Study||10
1696037|NCT00470262|4145108|P2|NOT COMPLETED|Overall Study||0
1696038|NCT00470262|4145109|P1|NOT COMPLETED|Overall Study||2
1696039|NCT00470262|4145108|P2|COMPLETED|Overall Study||12
1696040|NCT00470262|4145109|P1|COMPLETED|Overall Study||13
1696041|NCT00470262|4145108|P2|STARTED|Overall Study||12
1696042|NCT00470262|4145109|P1|STARTED|Overall Study||15
1696043|NCT00470184|4145117|P1|NOT COMPLETED|Overall Study||22
1696044|NCT00470184|4145117|P1|COMPLETED|Overall Study||19
1696045|NCT00470184|4145117|P1|Treated With Study Therapy|Overall Study||36
1696046|NCT00470184|4145117|P1|STARTED|Overall Study||41
1696047|NCT00470158|4145129|P5|NOT COMPLETED|Overall Study||6
1696048|NCT00470158|4145130|P4|NOT COMPLETED|Overall Study||5
1696049|NCT00470158|4145131|P3|NOT COMPLETED|Overall Study||8
1696050|NCT00470158|4145132|P2|NOT COMPLETED|Overall Study||8
1696051|NCT00470158|4145133|P1|NOT COMPLETED|Overall Study||8
1696052|NCT00470158|4145129|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
1696053|NCT00470158|4145130|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
1696054|NCT00470158|4145131|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
1696055|NCT00470158|4145132|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
1696056|NCT00470158|4145133|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
1696057|NCT00470158|4145129|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
1696058|NCT00470158|4145130|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
1696059|NCT00470158|4145131|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
1696060|NCT00470158|4145132|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
1696061|NCT00470158|4145133|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
1696062|NCT00470106|4145149|P4|NOT COMPLETED|Overall Study||2
1696063|NCT00470106|4145150|P3|NOT COMPLETED|Overall Study||7
1696064|NCT00470106|4145151|P2|NOT COMPLETED|Overall Study||5
1696065|NCT00470106|4145152|P1|NOT COMPLETED|Overall Study||3
1696066|NCT00470106|4145149|P4|COMPLETED|Overall Study||19
1696067|NCT00470106|4145150|P3|COMPLETED|Overall Study||14
1696068|NCT00470106|4145151|P2|COMPLETED|Overall Study||19
1696069|NCT00470106|4145152|P1|COMPLETED|Overall Study||16
1696070|NCT00470106|4145149|P4|STARTED|Overall Study||21
1696071|NCT00470106|4145150|P3|STARTED|Overall Study||21
1696072|NCT00470106|4145151|P2|STARTED|Overall Study||24
1696073|NCT00470106|4145152|P1|STARTED|Overall Study||19
1696074|NCT00470093|4145166|P1|NOT COMPLETED|Overall Study||2
1696075|NCT00470093|4145166|P1|COMPLETED|Overall Study||0
1696076|NCT00470093|4145166|P1|STARTED|Overall Study||2
1696077|NCT00470067|4145173|P1|NOT COMPLETED|Overall Study||7
1696078|NCT00470067|4145173|P1|COMPLETED|Overall Study||2
1696080|NCT00470054|4145177|P1|NOT COMPLETED|Overall Study||1
1696081|NCT00470054|4145177|P1|COMPLETED|Overall Study||43
1696082|NCT00470054|4145177|P1|STARTED|Overall Study||44
1696083|NCT00469911|4145187|P2|NOT COMPLETED|Overall Study||0
1696084|NCT00469911|4145188|P1|NOT COMPLETED|Overall Study||0
1696085|NCT00469911|4145187|P2|COMPLETED|Overall Study||10
1696086|NCT00469911|4145188|P1|COMPLETED|Overall Study||8
1696087|NCT00469911|4145187|P2|STARTED|Overall Study||10
1696088|NCT00469911|4145188|P1|STARTED|Overall Study||8
1696089|NCT00469898|4145193|P1|NOT COMPLETED|Overall Study||25
1696090|NCT00469898|4145193|P1|COMPLETED|Overall Study||25
1696091|NCT00469898|4145193|P1|STARTED|Overall Study||50
1696092|NCT00469859|4145202|P2|NOT COMPLETED|Overall Study||2
1696093|NCT00469859|4145203|P1|NOT COMPLETED|Overall Study||0
1696094|NCT00469859|4145202|P2|COMPLETED|Overall Study||6
1696095|NCT00469859|4145203|P1|COMPLETED|Overall Study||6
1696096|NCT00469859|4145202|P2|STARTED|Overall Study||8
1696097|NCT00469859|4145203|P1|STARTED|Overall Study||6
1696098|NCT00469833|4145211|P1|NOT COMPLETED|Overall Study||2
1696099|NCT00469833|4145211|P1|COMPLETED|Overall Study||15
1696100|NCT00469833|4145211|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
1696101|NCT00469612|4145223|P2|NOT COMPLETED|Overall Study||0
1696102|NCT00469612|4145224|P1|NOT COMPLETED|Overall Study||2
1696103|NCT00469612|4145223|P2|COMPLETED|Overall Study||0
1696104|NCT00469612|4145224|P1|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
1696105|NCT00469612|4145223|P2|STARTED|Overall Study||0
1696106|NCT00469612|4145224|P1|STARTED|Overall Study||2
1696107|NCT00469508|4145236|P2|NOT COMPLETED|Overall Study||24
1696108|NCT00469508|4145237|P1|NOT COMPLETED|Overall Study||20
1696109|NCT00469508|4145236|P2|COMPLETED|Overall Study||13
1696110|NCT00469508|4145237|P1|COMPLETED|Overall Study||14
1696111|NCT00469508|4145236|P2|STARTED|Overall Study||37
1696112|NCT00469508|4145237|P1|STARTED|Overall Study||34
1696113|NCT00469456|4145251|P2|NOT COMPLETED|Overall Study||4
1696114|NCT00469456|4145252|P1|NOT COMPLETED|Overall Study||9
1696115|NCT00469456|4145251|P2|COMPLETED|Overall Study||131
1696116|NCT00469456|4145252|P1|COMPLETED|Overall Study||120
1696117|NCT00469456|4145251|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
1696118|NCT00469456|4145252|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
1696119|NCT00469391|4145262|P2|NOT COMPLETED|Overall Study||5
1696120|NCT00469391|4145263|P1|NOT COMPLETED|Overall Study||14
1696121|NCT00469391|4145262|P2|COMPLETED|Overall Study||24
1696122|NCT00469391|4145263|P1|COMPLETED|Overall Study||13
1696123|NCT00469391|4145262|P2|Patient Preference|Overall Study||1
1696124|NCT00469391|4145263|P1|Patient Preference|Overall Study||0
1696125|NCT00469391|4145262|P2|Lost to Follow up|Overall Study||1
1696126|NCT00469391|4145263|P1|Lost to Follow up|Overall Study||0
1696127|NCT00469391|4145262|P2|Adverse Event|Overall Study||0
1696128|NCT00469391|4145263|P1|Adverse Event|Overall Study||8
1696129|NCT00469391|4145262|P2|Unsuccessful Implant Procedure|Overall Study||0
1696130|NCT00469391|4145263|P1|Unsuccessful Implant Procedure|Overall Study||4
1696131|NCT00469391|4145262|P2|Discontinued Prior to Procedure|Overall Study||3
1696132|NCT00469391|4145263|P1|Discontinued Prior to Procedure|Overall Study||2
1696133|NCT00469391|4145262|P2|STARTED|Overall Study||29
1696134|NCT00469391|4145263|P1|STARTED|Overall Study||27
1696135|NCT00469274|4145271|P2|NOT COMPLETED|Overall Study||0
1696136|NCT00469274|4145272|P1|NOT COMPLETED|Overall Study||0
1696137|NCT00469274|4145271|P2|COMPLETED|Overall Study||42
1696138|NCT00469274|4145272|P1|COMPLETED|Overall Study||44
1696139|NCT00469274|4145271|P2|STARTED|Overall Study||42
1696140|NCT00469274|4145272|P1|STARTED|Overall Study||44
1696141|NCT00469209|4145281|P3|NOT COMPLETED|Overall Study||1
1696142|NCT00469209|4145282|P2|NOT COMPLETED|Overall Study||0
1696143|NCT00469209|4145283|P1|NOT COMPLETED|Overall Study||1
1696144|NCT00469209|4145281|P3|COMPLETED|Overall Study||19
1696145|NCT00469209|4145282|P2|COMPLETED|Overall Study||20
1696146|NCT00469209|4145283|P1|COMPLETED|Overall Study||19
1696147|NCT00469209|4145281|P3|STARTED|Overall Study||20
1696148|NCT00469209|4145282|P2|STARTED|Overall Study||20
1696149|NCT00469209|4145283|P1|STARTED|Overall Study||20
1696150|NCT00469092|4145293|P2|NOT COMPLETED|Overall Study||21
1696151|NCT00469092|4145294|P1|NOT COMPLETED|Overall Study||26
1696152|NCT00469092|4145293|P2|COMPLETED|Overall Study||220
1696153|NCT00469092|4145294|P1|COMPLETED|Overall Study||213
1696154|NCT00469092|4145293|P2|Exposed to Study Drug|Overall Study||238
1696155|NCT00469092|4145294|P1|Exposed to Study Drug|Overall Study||231
1696156|NCT00469092|4145293|P2|STARTED|Overall Study||241
1696157|NCT00469092|4145294|P1|STARTED|Overall Study||239
1696158|NCT00469079|4145313|P3|NOT COMPLETED|Overall Study||19
1696159|NCT00469079|4145314|P2|NOT COMPLETED|Overall Study||22
1696160|NCT00469079|4145315|P1|NOT COMPLETED|Overall Study||9
1696161|NCT00469079|4145313|P3|COMPLETED|Overall Study||32
1696162|NCT00469079|4145314|P2|COMPLETED|Overall Study||30
1696163|NCT00469079|4145315|P1|COMPLETED|Overall Study||18
1696164|NCT00469079|4145313|P3|STARTED|Overall Study||51
1696165|NCT00469079|4145314|P2|STARTED|Overall Study||52
1696166|NCT00469079|4145315|P1|STARTED|Overall Study||27
1696167|NCT00468910|4145334|P2|NOT COMPLETED|Overall Study||3
1696168|NCT00468910|4145335|P1|NOT COMPLETED|Overall Study||4
1696169|NCT00468910|4145334|P2|COMPLETED|Overall Study||36
1696170|NCT00468910|4145335|P1|COMPLETED|Overall Study||36
1696171|NCT00468910|4145334|P2|Follow-up|Overall Study||36
1696172|NCT00468910|4145335|P1|Follow-up|Overall Study||36
1696173|NCT00468910|4145334|P2|Post-Treatment Biopsy|Overall Study||36
1696174|NCT00468910|4145335|P1|Post-Treatment Biopsy|Overall Study||36
1696175|NCT00468910|4145334|P2|Treatment|Overall Study||36
1696176|NCT00468910|4145335|P1|Treatment|Overall Study||36
1696177|NCT00468910|4145334|P2|Randomization|Overall Study||39
1696178|NCT00468910|4145335|P1|Randomization|Overall Study||40
1696179|NCT00468910|4145334|P2|STARTED|Overall Study||39
1696180|NCT00468910|4145335|P1|STARTED|Overall Study||40
1696181|NCT00468858|4145354|P3|NOT COMPLETED|Overall Study||14
1696182|NCT00468858|4145355|P2|NOT COMPLETED|Overall Study||10
1696183|NCT00468858|4145356|P1|NOT COMPLETED|Overall Study||9
1696184|NCT00468858|4145354|P3|COMPLETED|Overall Study||199
1696185|NCT00468858|4145355|P2|COMPLETED|Overall Study||202
1696186|NCT00468858|4145356|P1|COMPLETED|Overall Study||202
1696187|NCT00468858|4145354|P3|STARTED|Overall Study||213
1696188|NCT00468858|4145355|P2|STARTED|Overall Study||212
1696189|NCT00468858|4145356|P1|STARTED|Overall Study||211
1696190|NCT00468845|4145477|P3|NOT COMPLETED|Overall Study||30
1696191|NCT00468845|4145478|P2|NOT COMPLETED|Overall Study||34
1696192|NCT00468845|4145479|P1|NOT COMPLETED|Overall Study||21
1696193|NCT00468845|4145477|P3|COMPLETED|Overall Study||139
1696194|NCT00468845|4145478|P2|COMPLETED|Overall Study||136
1696195|NCT00468845|4145479|P1|COMPLETED|Overall Study||141
1696196|NCT00468845|4145477|P3|Received Treatment|Overall Study||167
1696197|NCT00468845|4145478|P2|Received Treatment|Overall Study||166
1696198|NCT00468845|4145479|P1|Received Treatment|Overall Study||161
1696199|NCT00468845|4145477|P3|STARTED|Overall Study||169
1696200|NCT00468845|4145478|P2|STARTED|Overall Study||170
1696201|NCT00468845|4145479|P1|STARTED|Overall Study||162
1696202|NCT00468819|4145616|P3|NOT COMPLETED|Overall Study||2
1696203|NCT00468819|4145617|P2|NOT COMPLETED|Overall Study||0
1696204|NCT00468819|4145618|P1|NOT COMPLETED|Overall Study||6
1696205|NCT00468819|4145616|P3|COMPLETED|Overall Study||46
1696206|NCT00468819|4145617|P2|COMPLETED|Overall Study||44
1696207|NCT00468819|4145618|P1|COMPLETED|Overall Study||42
1696208|NCT00468819|4145616|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
1696209|NCT00468819|4145617|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
1696210|NCT00468819|4145618|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
1696211|NCT00468819|4145616|P3|STARTED|Overall Study|Enrolled participants|48
1696212|NCT00468819|4145617|P2|STARTED|Overall Study|Enrolled participants|44
1696213|NCT00468819|4145618|P1|STARTED|Overall Study|Enrolled participants|48
1696214|NCT00468728|4145698|P2|NOT COMPLETED|Follow-up||31
1696215|NCT00468728|4145699|P1|NOT COMPLETED|Follow-up||34
1696216|NCT00468728|4145698|P2|COMPLETED|Follow-up||222
1696217|NCT00468728|4145699|P1|COMPLETED|Follow-up||222
1696218|NCT00468728|4145698|P2|STARTED|Follow-up||253
1696219|NCT00468728|4145699|P1|STARTED|Follow-up||256
1696220|NCT00468728|4145698|P2|NOT COMPLETED|Treatment||11
1696221|NCT00468728|4145699|P1|NOT COMPLETED|Treatment||4
1696222|NCT00468728|4145698|P2|COMPLETED|Treatment||253
1696223|NCT00468728|4145699|P1|COMPLETED|Treatment||256
1696224|NCT00468728|4145698|P2|STARTED|Treatment||264
1696225|NCT00468728|4145699|P1|STARTED|Treatment||260
1696226|NCT00468728|4145698|P2|NOT COMPLETED|Enrollment||7
1696227|NCT00468728|4145699|P1|NOT COMPLETED|Enrollment||4
1696228|NCT00468728|4145698|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
1696229|NCT00468728|4145699|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
1696230|NCT00468728|4145698|P2|STARTED|Enrollment||271
1696231|NCT00468728|4145699|P1|STARTED|Enrollment||264
1696232|NCT00468676|4145711|P2|NOT COMPLETED|Overall Study||12
1696233|NCT00468676|4145712|P1|NOT COMPLETED|Overall Study||16
1696234|NCT00468676|4145711|P2|COMPLETED|Overall Study||94
1696235|NCT00468676|4145712|P1|COMPLETED|Overall Study||92
1696236|NCT00468676|4145711|P2|STARTED|Overall Study||106
1696237|NCT00468676|4145712|P1|STARTED|Overall Study||108
1696238|NCT00468650|4145729|P1|NOT COMPLETED|Overall Study||7
1696239|NCT00468650|4145729|P1|COMPLETED|Overall Study||110
1696240|NCT00468650|4145729|P1|STARTED|Overall Study||117
1696241|NCT00468585|4145777|P4|NOT COMPLETED|Overall Study||1
1696242|NCT00468585|4145778|P3|NOT COMPLETED|Overall Study||5
1696243|NCT00468585|4145779|P2|NOT COMPLETED|Overall Study||0
1696244|NCT00468585|4145780|P1|NOT COMPLETED|Overall Study||1
1696245|NCT00468585|4145777|P4|COMPLETED|Overall Study||5
1696246|NCT00468585|4145778|P3|COMPLETED|Overall Study||45
1696247|NCT00468585|4145779|P2|COMPLETED|Overall Study||3
1696248|NCT00468585|4145780|P1|COMPLETED|Overall Study||3
1696249|NCT00468585|4145777|P4|STARTED|Overall Study||6
1696250|NCT00468585|4145778|P3|STARTED|Overall Study||50
1696251|NCT00468585|4145779|P2|STARTED|Overall Study||3
1696252|NCT00468585|4145780|P1|STARTED|Overall Study||4
1696253|NCT00468559|4145792|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
1696254|NCT00468559|4145793|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
1696255|NCT00468559|4145794|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
1696256|NCT00468559|4145792|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
1696257|NCT00468559|4145793|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
1696258|NCT00468559|4145794|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
1696259|NCT00468559|4145792|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
1696260|NCT00468559|4145793|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
1696261|NCT00468559|4145794|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
1696262|NCT00468559|4145792|P3|NOT COMPLETED|Open-label Treatment Phase||0
1696263|NCT00468559|4145793|P2|NOT COMPLETED|Open-label Treatment Phase||0
1696264|NCT00468559|4145794|P1|NOT COMPLETED|Open-label Treatment Phase||18
1696265|NCT00468559|4145792|P3|COMPLETED|Open-label Treatment Phase||0
1696266|NCT00468559|4145793|P2|COMPLETED|Open-label Treatment Phase||0
1696267|NCT00468559|4145794|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
1696268|NCT00468559|4145792|P3|STARTED|Open-label Treatment Phase||0
1696269|NCT00468559|4145793|P2|STARTED|Open-label Treatment Phase||0
1696270|NCT00468559|4145794|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
1696271|NCT00468546|4145822|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
1696272|NCT00468546|4145823|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
1696273|NCT00468546|4145822|P2|COMPLETED|Week 24 to Week 104 Analysis||83
1696274|NCT00468546|4145823|P1|COMPLETED|Week 24 to Week 104 Analysis||103
1696275|NCT00468546|4145822|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
1696276|NCT00468546|4145823|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
1696277|NCT00468546|4145822|P2|NOT COMPLETED|Week 24 Analysis||55
1696278|NCT00468546|4145823|P1|NOT COMPLETED|Week 24 Analysis||97
1696279|NCT00468546|4145822|P2|COMPLETED|Week 24 Analysis||253
1696280|NCT00468546|4145823|P1|COMPLETED|Week 24 Analysis||111
1696281|NCT00468546|4145822|P2|STARTED|Week 24 Analysis||308
1696282|NCT00468546|4145823|P1|STARTED|Week 24 Analysis||208
1696283|NCT00468481|4145853|P2|NOT COMPLETED|Overall Study||24
1696284|NCT00468481|4145854|P1|NOT COMPLETED|Overall Study||88
1696285|NCT00468481|4145853|P2|COMPLETED|Overall Study||70
1696286|NCT00468481|4145854|P1|COMPLETED|Overall Study||203
1696287|NCT00468481|4145853|P2|Subjects Treated|Overall Study||94
1696288|NCT00468481|4145854|P1|Subjects Treated|Overall Study||285
1696289|NCT00468481|4145853|P2|STARTED|Overall Study||94
1696290|NCT00468481|4145854|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
1696291|NCT00468312|4145954|P2|NOT COMPLETED|Overall Study||5
1696292|NCT00468312|4145955|P1|NOT COMPLETED|Overall Study||4
1696293|NCT00468312|4145954|P2|COMPLETED|Overall Study||204
1696294|NCT00468312|4145955|P1|COMPLETED|Overall Study||216
1696295|NCT00468312|4145954|P2|STARTED|Overall Study||209
1696296|NCT00468312|4145955|P1|STARTED|Overall Study||220
1696297|NCT00468299|4145971|P2|NOT COMPLETED|Overall Study||1
1696298|NCT00468299|4145972|P1|NOT COMPLETED|Overall Study||0
1696299|NCT00468299|4145971|P2|COMPLETED|Overall Study||7
1696300|NCT00468299|4145972|P1|COMPLETED|Overall Study||9
1696301|NCT00468299|4145971|P2|STARTED|Overall Study||8
1696302|NCT00468299|4145972|P1|STARTED|Overall Study||9
1696303|NCT00468286|4145982|P2|NOT COMPLETED|Overall Study||12
1696304|NCT00468286|4145983|P1|NOT COMPLETED|Overall Study||7
1696305|NCT00468286|4145982|P2|COMPLETED|Overall Study||54
1696306|NCT00468286|4145983|P1|COMPLETED|Overall Study||60
1696307|NCT00468286|4145982|P2|STARTED|Overall Study||66
1696308|NCT00468286|4145983|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
1696309|NCT00468208|4146005|P1|NOT COMPLETED|Overall Study||0
1696310|NCT00468208|4146005|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
1696311|NCT00468208|4146005|P1|STARTED|Overall Study||20
1696312|NCT00468143|4146013|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
1696313|NCT00468143|4146014|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
1696314|NCT00468143|4146013|P2|COMPLETED|Second Intervention (3 Weeks)||24
1696315|NCT00468143|4146014|P1|COMPLETED|Second Intervention (3 Weeks)||25
1696316|NCT00468143|4146013|P2|STARTED|Second Intervention (3 Weeks)||27
1696317|NCT00468143|4146014|P1|STARTED|Second Intervention (3 Weeks)||28
1696318|NCT00468143|4146013|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
1696319|NCT00468143|4146014|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
1696320|NCT00468143|4146013|P2|COMPLETED|First Intervention (3 Weeks)||27
1696321|NCT00468143|4146014|P1|COMPLETED|First Intervention (3 Weeks)||28
1696322|NCT00468143|4146013|P2|STARTED|First Intervention (3 Weeks)||31
1696323|NCT00468143|4146014|P1|STARTED|First Intervention (3 Weeks)||31
1696324|NCT00468104|4146028|P2|NOT COMPLETED|Second Intervention||4
1696325|NCT00468104|4146029|P1|NOT COMPLETED|Second Intervention||5
1696326|NCT00468104|4146028|P2|COMPLETED|Second Intervention||37
1696327|NCT00468104|4146029|P1|COMPLETED|Second Intervention||3
1696328|NCT00468104|4146028|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
1696329|NCT00468104|4146029|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
1696330|NCT00468104|4146028|P2|NOT COMPLETED|First Intervention||1
1696331|NCT00468104|4146029|P1|NOT COMPLETED|First Intervention||9
1696332|NCT00468104|4146028|P2|COMPLETED|First Intervention||45
1696333|NCT00468104|4146029|P1|COMPLETED|First Intervention||45
1696334|NCT00468104|4146028|P2|STARTED|First Intervention||46
1696335|NCT00468104|4146029|P1|STARTED|First Intervention||54
1696336|NCT00468052|4146046|P2|NOT COMPLETED|Overall Study||8
1696337|NCT00468052|4146047|P1|NOT COMPLETED|Overall Study||7
1696338|NCT00468052|4146046|P2|COMPLETED|Overall Study||61
1696339|NCT00468052|4146047|P1|COMPLETED|Overall Study||61
1696340|NCT00468052|4146046|P2|Target Enrollment|Overall Study||70
1696341|NCT00468052|4146047|P1|Target Enrollment|Overall Study||70
1696342|NCT00468052|4146046|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
1696343|NCT00468052|4146047|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
1696344|NCT00467961|4146065|P1|NOT COMPLETED|Overall Study||7
1696345|NCT00467961|4146065|P1|COMPLETED|Overall Study||24
1696346|NCT00467961|4146065|P1|STARTED|Overall Study||31
1696347|NCT00467896|4146069|P1|NOT COMPLETED|Overall Study||51
1696348|NCT00467896|4146069|P1|COMPLETED|Overall Study||11
1696349|NCT00467896|4146069|P1|STARTED|Overall Study||62
1696350|NCT00467870|4146095|P6|NOT COMPLETED|Overall Study||2
1696351|NCT00467870|4146096|P5|NOT COMPLETED|Overall Study||37
1696352|NCT00467870|4146097|P4|NOT COMPLETED|Overall Study||33
1696353|NCT00467870|4146098|P3|NOT COMPLETED|Overall Study||4
1696354|NCT00467870|4146099|P2|NOT COMPLETED|Overall Study||43
1696355|NCT00467870|4146100|P1|NOT COMPLETED|Overall Study||45
1696356|NCT00467870|4146095|P6|COMPLETED|Overall Study||21
1696357|NCT00467870|4146096|P5|COMPLETED|Overall Study||93
1696358|NCT00467870|4146097|P4|COMPLETED|Overall Study||79
1696359|NCT00467870|4146098|P3|COMPLETED|Overall Study||18
1696360|NCT00467870|4146099|P2|COMPLETED|Overall Study||74
1696361|NCT00467870|4146100|P1|COMPLETED|Overall Study||75
1696362|NCT00467870|4146095|P6|STARTED|Overall Study||23
1696363|NCT00467870|4146096|P5|STARTED|Overall Study||130
1696364|NCT00467870|4146097|P4|STARTED|Overall Study||112
1696365|NCT00467870|4146098|P3|STARTED|Overall Study||22
1696366|NCT00467870|4146099|P2|STARTED|Overall Study||117
1696367|NCT00467870|4146100|P1|STARTED|Overall Study||120
1696368|NCT00467857|4146143|P2|NOT COMPLETED|Overall Study||8
1696369|NCT00467857|4146144|P1|NOT COMPLETED|Overall Study||3
1696370|NCT00467857|4146143|P2|COMPLETED|Overall Study||139
1696371|NCT00467857|4146144|P1|COMPLETED|Overall Study||143
1696372|NCT00467857|4146143|P2|STARTED|Overall Study||147
1696373|NCT00467857|4146144|P1|STARTED|Overall Study||146
1696374|NCT00467844|4146179|P3|NOT COMPLETED|Overall Study||14
1696375|NCT00467844|4146180|P2|NOT COMPLETED|Overall Study||20
1696376|NCT00467844|4146181|P1|NOT COMPLETED|Overall Study||19
1696377|NCT00467844|4146179|P3|COMPLETED|Overall Study||38
1696378|NCT00467844|4146180|P2|COMPLETED|Overall Study||34
1696379|NCT00467844|4146181|P1|COMPLETED|Overall Study||34
1696380|NCT00467844|4146179|P3|STARTED|Overall Study||52
1696381|NCT00467844|4146180|P2|STARTED|Overall Study||54
1696382|NCT00467844|4146181|P1|STARTED|Overall Study||53
1696383|NCT00467831|4146192|P1|NOT COMPLETED|Overall Study||3
1696384|NCT00467831|4146192|P1|COMPLETED|Overall Study||0
1696385|NCT00467831|4146192|P1|STARTED|Overall Study||3
1696386|NCT00467779|4146211|P15|NOT COMPLETED|Stage 3||17
1696387|NCT00467779|4146212|P14|NOT COMPLETED|Stage 3||0
1696388|NCT00467779|4146213|P13|NOT COMPLETED|Stage 3||0
1696389|NCT00467779|4146214|P12|NOT COMPLETED|Stage 3||0
1696390|NCT00467779|4146215|P11|NOT COMPLETED|Stage 3||0
1696391|NCT00467779|4146216|P10|NOT COMPLETED|Stage 3||0
1696392|NCT00467779|4146217|P9|NOT COMPLETED|Stage 3||0
1696393|NCT00467779|4146218|P8|NOT COMPLETED|Stage 3||0
1696394|NCT00467779|4146219|P7|NOT COMPLETED|Stage 3||0
1696395|NCT00467779|4146220|P6|NOT COMPLETED|Stage 3||0
1696396|NCT00467779|4146221|P5|NOT COMPLETED|Stage 3||0
1696397|NCT00467779|4146222|P4|NOT COMPLETED|Stage 3||0
1696398|NCT00467779|4146223|P3|NOT COMPLETED|Stage 3||0
1696399|NCT00467779|4146224|P2|NOT COMPLETED|Stage 3||0
1696400|NCT00467779|4146225|P1|NOT COMPLETED|Stage 3||0
1696401|NCT00467779|4146211|P15|COMPLETED|Stage 3||3
1696402|NCT00467779|4146212|P14|COMPLETED|Stage 3||0
1696403|NCT00467779|4146213|P13|COMPLETED|Stage 3||0
1696404|NCT00467779|4146214|P12|COMPLETED|Stage 3||0
1696405|NCT00467779|4146215|P11|COMPLETED|Stage 3||0
1696406|NCT00467779|4146216|P10|COMPLETED|Stage 3||0
1696407|NCT00467779|4146217|P9|COMPLETED|Stage 3||0
1696408|NCT00467779|4146218|P8|COMPLETED|Stage 3||0
1696409|NCT00467779|4146219|P7|COMPLETED|Stage 3||0
1696410|NCT00467779|4146220|P6|COMPLETED|Stage 3||0
1696411|NCT00467779|4146221|P5|COMPLETED|Stage 3||0
1696412|NCT00467779|4146222|P4|COMPLETED|Stage 3||0
1696413|NCT00467779|4146223|P3|COMPLETED|Stage 3||0
1696414|NCT00467779|4146224|P2|COMPLETED|Stage 3||0
1696415|NCT00467779|4146225|P1|COMPLETED|Stage 3||0
1696416|NCT00467779|4146211|P15|STARTED|Stage 3||20
1696417|NCT00467779|4146212|P14|STARTED|Stage 3||0
1696418|NCT00467779|4146213|P13|STARTED|Stage 3||0
1696419|NCT00467779|4146214|P12|STARTED|Stage 3||0
1696420|NCT00467779|4146215|P11|STARTED|Stage 3||0
1696421|NCT00467779|4146216|P10|STARTED|Stage 3||0
1696422|NCT00467779|4146217|P9|STARTED|Stage 3||0
1696423|NCT00467779|4146218|P8|STARTED|Stage 3||0
1696424|NCT00467779|4146219|P7|STARTED|Stage 3||0
1696425|NCT00467779|4146220|P6|STARTED|Stage 3||0
1696426|NCT00467779|4146221|P5|STARTED|Stage 3||0
1696427|NCT00467779|4146222|P4|STARTED|Stage 3||0
1696428|NCT00467779|4146223|P3|STARTED|Stage 3||0
1696429|NCT00467779|4146224|P2|STARTED|Stage 3||0
1696430|NCT00467779|4146225|P1|STARTED|Stage 3||0
1696431|NCT00467779|4146211|P15|NOT COMPLETED|Stage 2A||0
1696432|NCT00467779|4146212|P14|NOT COMPLETED|Stage 2A||21
1696433|NCT00467779|4146213|P13|NOT COMPLETED|Stage 2A||0
1696434|NCT00467779|4146214|P12|NOT COMPLETED|Stage 2A||0
1696435|NCT00467779|4146215|P11|NOT COMPLETED|Stage 2A||0
1696436|NCT00467779|4146216|P10|NOT COMPLETED|Stage 2A||0
1696437|NCT00467779|4146217|P9|NOT COMPLETED|Stage 2A||0
1696438|NCT00467779|4146218|P8|NOT COMPLETED|Stage 2A||0
1696439|NCT00467779|4146219|P7|NOT COMPLETED|Stage 2A||0
1696440|NCT00467779|4146220|P6|NOT COMPLETED|Stage 2A||0
1696441|NCT00467779|4146221|P5|NOT COMPLETED|Stage 2A||0
1696442|NCT00467779|4146222|P4|NOT COMPLETED|Stage 2A||0
1696443|NCT00467779|4146223|P3|NOT COMPLETED|Stage 2A||0
1696444|NCT00467779|4146224|P2|NOT COMPLETED|Stage 2A||0
1696445|NCT00467779|4146225|P1|NOT COMPLETED|Stage 2A||0
1696446|NCT00467779|4146211|P15|COMPLETED|Stage 2A||0
1696447|NCT00467779|4146212|P14|COMPLETED|Stage 2A||1
1696448|NCT00467779|4146213|P13|COMPLETED|Stage 2A||0
1696449|NCT00467779|4146214|P12|COMPLETED|Stage 2A||0
1696450|NCT00467779|4146215|P11|COMPLETED|Stage 2A||0
1696451|NCT00467779|4146216|P10|COMPLETED|Stage 2A||0
1696452|NCT00467779|4146217|P9|COMPLETED|Stage 2A||0
1696453|NCT00467779|4146218|P8|COMPLETED|Stage 2A||0
1696454|NCT00467779|4146219|P7|COMPLETED|Stage 2A||0
1696455|NCT00467779|4146220|P6|COMPLETED|Stage 2A||0
1696456|NCT00467779|4146221|P5|COMPLETED|Stage 2A||0
1696457|NCT00467779|4146222|P4|COMPLETED|Stage 2A||0
1696458|NCT00467779|4146223|P3|COMPLETED|Stage 2A||0
1696459|NCT00467779|4146224|P2|COMPLETED|Stage 2A||0
1696460|NCT00467779|4146225|P1|COMPLETED|Stage 2A||0
1696461|NCT00467779|4146211|P15|STARTED|Stage 2A||0
1696462|NCT00467779|4146212|P14|STARTED|Stage 2A||22
1696463|NCT00467779|4146213|P13|STARTED|Stage 2A||0
1696464|NCT00467779|4146214|P12|STARTED|Stage 2A||0
1696465|NCT00467779|4146215|P11|STARTED|Stage 2A||0
1696466|NCT00467779|4146216|P10|STARTED|Stage 2A||0
1696467|NCT00467779|4146217|P9|STARTED|Stage 2A||0
1696468|NCT00467779|4146218|P8|STARTED|Stage 2A||0
1696469|NCT00467779|4146219|P7|STARTED|Stage 2A||0
1696470|NCT00467779|4146220|P6|STARTED|Stage 2A||0
1696471|NCT00467779|4146221|P5|STARTED|Stage 2A||0
1696472|NCT00467779|4146222|P4|STARTED|Stage 2A||0
1696473|NCT00467779|4146223|P3|STARTED|Stage 2A||0
1696474|NCT00467779|4146224|P2|STARTED|Stage 2A||0
1696475|NCT00467779|4146225|P1|STARTED|Stage 2A||0
1696476|NCT00467779|4146211|P15|NOT COMPLETED|Stage 2||0
1696477|NCT00467779|4146212|P14|NOT COMPLETED|Stage 2||0
1696478|NCT00467779|4146213|P13|NOT COMPLETED|Stage 2||0
1696479|NCT00467779|4146214|P12|NOT COMPLETED|Stage 2||0
1696480|NCT00467779|4146215|P11|NOT COMPLETED|Stage 2||0
1696481|NCT00467779|4146216|P10|NOT COMPLETED|Stage 2||0
1696482|NCT00467779|4146217|P9|NOT COMPLETED|Stage 2||21
1696483|NCT00467779|4146218|P8|NOT COMPLETED|Stage 2||0
1696484|NCT00467779|4146219|P7|NOT COMPLETED|Stage 2||0
1696485|NCT00467779|4146220|P6|NOT COMPLETED|Stage 2||0
1696486|NCT00467779|4146221|P5|NOT COMPLETED|Stage 2||0
1696487|NCT00467779|4146222|P4|NOT COMPLETED|Stage 2||0
1696488|NCT00467779|4146223|P3|NOT COMPLETED|Stage 2||0
1696489|NCT00467779|4146224|P2|NOT COMPLETED|Stage 2||0
1696490|NCT00467779|4146225|P1|NOT COMPLETED|Stage 2||0
1696491|NCT00467779|4146211|P15|COMPLETED|Stage 2||0
1696492|NCT00467779|4146212|P14|COMPLETED|Stage 2||0
1696493|NCT00467779|4146213|P13|COMPLETED|Stage 2||0
1696494|NCT00467779|4146214|P12|COMPLETED|Stage 2||0
1696495|NCT00467779|4146215|P11|COMPLETED|Stage 2||0
1696496|NCT00467779|4146216|P10|COMPLETED|Stage 2||0
1696497|NCT00467779|4146217|P9|COMPLETED|Stage 2||0
1696498|NCT00467779|4146218|P8|COMPLETED|Stage 2||0
1696499|NCT00467779|4146219|P7|COMPLETED|Stage 2||0
1696500|NCT00467779|4146220|P6|COMPLETED|Stage 2||0
1696501|NCT00467779|4146221|P5|COMPLETED|Stage 2||0
1696502|NCT00467779|4146222|P4|COMPLETED|Stage 2||0
1696503|NCT00467779|4146223|P3|COMPLETED|Stage 2||0
1696504|NCT00467779|4146224|P2|COMPLETED|Stage 2||0
1696505|NCT00467779|4146225|P1|COMPLETED|Stage 2||0
1696506|NCT00467779|4146211|P15|STARTED|Stage 2||0
1696507|NCT00467779|4146212|P14|STARTED|Stage 2||0
1696508|NCT00467779|4146213|P13|STARTED|Stage 2||0
1696509|NCT00467779|4146214|P12|STARTED|Stage 2||0
1696510|NCT00467779|4146215|P11|STARTED|Stage 2||0
1696511|NCT00467779|4146216|P10|STARTED|Stage 2||0
1696512|NCT00467779|4146217|P9|STARTED|Stage 2||21
1696513|NCT00467779|4146218|P8|STARTED|Stage 2||0
1696514|NCT00467779|4146219|P7|STARTED|Stage 2||0
1696515|NCT00467779|4146220|P6|STARTED|Stage 2||0
1696516|NCT00467779|4146221|P5|STARTED|Stage 2||0
1696517|NCT00467779|4146222|P4|STARTED|Stage 2||0
1696518|NCT00467779|4146223|P3|STARTED|Stage 2||0
1696519|NCT00467779|4146224|P2|STARTED|Stage 2||0
1696520|NCT00467779|4146225|P1|STARTED|Stage 2||0
1696521|NCT00467779|4146211|P15|NOT COMPLETED|Stage 1A||0
1696522|NCT00467779|4146212|P14|NOT COMPLETED|Stage 1A||0
1696523|NCT00467779|4146213|P13|NOT COMPLETED|Stage 1A||6
1696524|NCT00467779|4146214|P12|NOT COMPLETED|Stage 1A||8
1696525|NCT00467779|4146215|P11|NOT COMPLETED|Stage 1A||3
1696526|NCT00467779|4146216|P10|NOT COMPLETED|Stage 1A||3
1696527|NCT00467779|4146217|P9|NOT COMPLETED|Stage 1A||0
1696528|NCT00467779|4146218|P8|NOT COMPLETED|Stage 1A||0
1696529|NCT00467779|4146219|P7|NOT COMPLETED|Stage 1A||0
1696530|NCT00467779|4146220|P6|NOT COMPLETED|Stage 1A||0
1696531|NCT00467779|4146221|P5|NOT COMPLETED|Stage 1A||0
1696532|NCT00467779|4146222|P4|NOT COMPLETED|Stage 1A||0
1696533|NCT00467779|4146223|P3|NOT COMPLETED|Stage 1A||0
1696534|NCT00467779|4146224|P2|NOT COMPLETED|Stage 1A||0
1696535|NCT00467779|4146225|P1|NOT COMPLETED|Stage 1A||0
1696536|NCT00467779|4146211|P15|COMPLETED|Stage 1A||0
1696537|NCT00467779|4146212|P14|COMPLETED|Stage 1A||0
1696538|NCT00467779|4146213|P13|COMPLETED|Stage 1A||0
1696539|NCT00467779|4146214|P12|COMPLETED|Stage 1A||0
1696540|NCT00467779|4146215|P11|COMPLETED|Stage 1A||0
1696541|NCT00467779|4146216|P10|COMPLETED|Stage 1A||0
1696542|NCT00467779|4146217|P9|COMPLETED|Stage 1A||0
1696543|NCT00467779|4146218|P8|COMPLETED|Stage 1A||0
1696544|NCT00467779|4146219|P7|COMPLETED|Stage 1A||0
1696545|NCT00467779|4146220|P6|COMPLETED|Stage 1A||0
1696546|NCT00467779|4146221|P5|COMPLETED|Stage 1A||0
1696547|NCT00467779|4146222|P4|COMPLETED|Stage 1A||0
1696548|NCT00467779|4146223|P3|COMPLETED|Stage 1A||0
1696549|NCT00467779|4146224|P2|COMPLETED|Stage 1A||0
1696550|NCT00467779|4146225|P1|COMPLETED|Stage 1A||0
1696551|NCT00467779|4146211|P15|STARTED|Stage 1A||0
1696552|NCT00467779|4146212|P14|STARTED|Stage 1A||0
1696553|NCT00467779|4146213|P13|STARTED|Stage 1A||6
1696554|NCT00467779|4146214|P12|STARTED|Stage 1A||8
1696555|NCT00467779|4146215|P11|STARTED|Stage 1A||3
1696556|NCT00467779|4146216|P10|STARTED|Stage 1A||3
1696557|NCT00467779|4146217|P9|STARTED|Stage 1A||0
1696558|NCT00467779|4146218|P8|STARTED|Stage 1A||0
1696559|NCT00467779|4146219|P7|STARTED|Stage 1A||0
1696560|NCT00467779|4146220|P6|STARTED|Stage 1A||0
1696561|NCT00467779|4146221|P5|STARTED|Stage 1A||0
1696562|NCT00467779|4146222|P4|STARTED|Stage 1A||0
1696563|NCT00467779|4146223|P3|STARTED|Stage 1A||0
1696564|NCT00467779|4146224|P2|STARTED|Stage 1A||0
1696565|NCT00467779|4146225|P1|STARTED|Stage 1A||0
1696566|NCT00467779|4146211|P15|NOT COMPLETED|Stage 1||0
1696567|NCT00467779|4146212|P14|NOT COMPLETED|Stage 1||0
1696568|NCT00467779|4146213|P13|NOT COMPLETED|Stage 1||0
1696569|NCT00467779|4146214|P12|NOT COMPLETED|Stage 1||0
1696570|NCT00467779|4146215|P11|NOT COMPLETED|Stage 1||0
1696571|NCT00467779|4146216|P10|NOT COMPLETED|Stage 1||0
1696572|NCT00467779|4146217|P9|NOT COMPLETED|Stage 1||0
1696573|NCT00467779|4146218|P8|NOT COMPLETED|Stage 1||7
1696574|NCT00467779|4146219|P7|NOT COMPLETED|Stage 1||7
1696575|NCT00467779|4146220|P6|NOT COMPLETED|Stage 1||5
1696576|NCT00467779|4146221|P5|NOT COMPLETED|Stage 1||3
1696577|NCT00467779|4146222|P4|NOT COMPLETED|Stage 1||3
1696578|NCT00467779|4146223|P3|NOT COMPLETED|Stage 1||3
1696579|NCT00467779|4146224|P2|NOT COMPLETED|Stage 1||3
1696580|NCT00467779|4146225|P1|NOT COMPLETED|Stage 1||4
1696581|NCT00467779|4146211|P15|COMPLETED|Stage 1||0
1696582|NCT00467779|4146212|P14|COMPLETED|Stage 1||0
1696583|NCT00467779|4146213|P13|COMPLETED|Stage 1||0
1696584|NCT00467779|4146214|P12|COMPLETED|Stage 1||0
1696585|NCT00467779|4146215|P11|COMPLETED|Stage 1||0
1696586|NCT00467779|4146216|P10|COMPLETED|Stage 1||0
1696587|NCT00467779|4146217|P9|COMPLETED|Stage 1||0
1696588|NCT00467779|4146218|P8|COMPLETED|Stage 1||0
1696589|NCT00467779|4146219|P7|COMPLETED|Stage 1||0
1696590|NCT00467779|4146220|P6|COMPLETED|Stage 1||1
1696591|NCT00467779|4146221|P5|COMPLETED|Stage 1||0
1696592|NCT00467779|4146222|P4|COMPLETED|Stage 1||0
1696593|NCT00467779|4146223|P3|COMPLETED|Stage 1||0
1696594|NCT00467779|4146224|P2|COMPLETED|Stage 1||0
1696595|NCT00467779|4146225|P1|COMPLETED|Stage 1||0
1696596|NCT00467779|4146211|P15|STARTED|Stage 1||0
1696597|NCT00467779|4146212|P14|STARTED|Stage 1||0
1696598|NCT00467779|4146213|P13|STARTED|Stage 1||0
1696599|NCT00467779|4146214|P12|STARTED|Stage 1||0
1696600|NCT00467779|4146215|P11|STARTED|Stage 1||0
1696601|NCT00467779|4146216|P10|STARTED|Stage 1||0
1696602|NCT00467779|4146217|P9|STARTED|Stage 1||0
1696603|NCT00467779|4146218|P8|STARTED|Stage 1||7
1696604|NCT00467779|4146219|P7|STARTED|Stage 1||7
1696605|NCT00467779|4146220|P6|STARTED|Stage 1||6
1696606|NCT00467779|4146221|P5|STARTED|Stage 1||3
1696607|NCT00467779|4146222|P4|STARTED|Stage 1||3
1696608|NCT00467779|4146223|P3|STARTED|Stage 1||3
1696609|NCT00467779|4146224|P2|STARTED|Stage 1||3
1696610|NCT00467779|4146225|P1|STARTED|Stage 1||4
1696611|NCT00467753|4146399|P2|NOT COMPLETED|Overall Study||2
1696612|NCT00467753|4146400|P1|NOT COMPLETED|Overall Study||3
1696613|NCT00467753|4146399|P2|COMPLETED|Overall Study||0
1696614|NCT00467753|4146400|P1|COMPLETED|Overall Study||0
1696615|NCT00467753|4146399|P2|STARTED|Overall Study||2
1696616|NCT00467753|4146400|P1|STARTED|Overall Study||3
1696617|NCT00467740|4146411|P5|NOT COMPLETED|Overall Study||0
1696618|NCT00467740|4146412|P4|NOT COMPLETED|Overall Study||1
1696619|NCT00467740|4146413|P3|NOT COMPLETED|Overall Study||2
1696620|NCT00467740|4146414|P2|NOT COMPLETED|Overall Study||3
1696621|NCT00467740|4146415|P1|NOT COMPLETED|Overall Study||1
1696622|NCT00467740|4146411|P5|COMPLETED|Overall Study||61
1696623|NCT00467740|4146412|P4|COMPLETED|Overall Study||59
1696624|NCT00467740|4146413|P3|COMPLETED|Overall Study||58
1696625|NCT00467740|4146414|P2|COMPLETED|Overall Study||58
1696626|NCT00467740|4146415|P1|COMPLETED|Overall Study||53
1696627|NCT00467740|4146411|P5|STARTED|Overall Study||61
1696628|NCT00467740|4146412|P4|STARTED|Overall Study||60
1696629|NCT00467740|4146413|P3|STARTED|Overall Study||60
1696630|NCT00467740|4146414|P2|STARTED|Overall Study||61
1696631|NCT00467740|4146415|P1|STARTED|Overall Study||54
1696632|NCT00467649|4146604|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
1696633|NCT00467649|4146605|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1696634|NCT00467649|4146606|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
1696635|NCT00467649|4146607|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1696636|NCT00467649|4146608|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1696637|NCT00467649|4146609|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1696638|NCT00467649|4146604|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
1696639|NCT00467649|4146605|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
1696640|NCT00467649|4146606|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
1696641|NCT00467649|4146607|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
1696642|NCT00467649|4146608|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1696643|NCT00467649|4146609|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
1696644|NCT00467649|4146604|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
1696645|NCT00467649|4146605|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
1696646|NCT00467649|4146606|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
1696647|NCT00467649|4146607|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
1696648|NCT00467649|4146608|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
1696649|NCT00467649|4146609|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
1696650|NCT00467649|4146604|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
1696651|NCT00467649|4146605|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
1696652|NCT00467649|4146606|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
1696653|NCT00467649|4146607|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
1696654|NCT00467649|4146608|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
1696655|NCT00467649|4146609|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
1696656|NCT00467649|4146604|P6|COMPLETED|Phase 1 (Randomized Population)||0
1696657|NCT00467649|4146605|P5|COMPLETED|Phase 1 (Randomized Population)||0
1696658|NCT00467649|4146606|P4|COMPLETED|Phase 1 (Randomized Population)||0
1696659|NCT00467649|4146607|P3|COMPLETED|Phase 1 (Randomized Population)||0
1696660|NCT00467649|4146608|P2|COMPLETED|Phase 1 (Randomized Population)||50
1696661|NCT00467649|4146609|P1|COMPLETED|Phase 1 (Randomized Population)||48
1696662|NCT00467649|4146604|P6|Intent to Treat|Phase 1 (Randomized Population)||0
1696663|NCT00467649|4146605|P5|Intent to Treat|Phase 1 (Randomized Population)||0
1696664|NCT00467649|4146606|P4|Intent to Treat|Phase 1 (Randomized Population)||0
1696665|NCT00467649|4146607|P3|Intent to Treat|Phase 1 (Randomized Population)||0
1696666|NCT00467649|4146608|P2|Intent to Treat|Phase 1 (Randomized Population)||56
1696667|NCT00467649|4146609|P1|Intent to Treat|Phase 1 (Randomized Population)||56
1696668|NCT00467649|4146604|P6|STARTED|Phase 1 (Randomized Population)||0
1696669|NCT00467649|4146605|P5|STARTED|Phase 1 (Randomized Population)||0
1696670|NCT00467649|4146606|P4|STARTED|Phase 1 (Randomized Population)||0
1696671|NCT00467649|4146607|P3|STARTED|Phase 1 (Randomized Population)||0
1696672|NCT00467649|4146608|P2|STARTED|Phase 1 (Randomized Population)||56
1696673|NCT00467649|4146609|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
1696674|NCT00467610|4146649|P1|NOT COMPLETED|Overall Study||1
1696675|NCT00467610|4146649|P1|COMPLETED|Overall Study||5
1696676|NCT00467610|4146649|P1|STARTED|Overall Study||6
1696677|NCT00467597|4146660|P2|NOT COMPLETED|Overall Study||0
1696678|NCT00467597|4146661|P1|NOT COMPLETED|Overall Study||2
1696679|NCT00467597|4146660|P2|COMPLETED|Overall Study||6
1696680|NCT00467597|4146661|P1|COMPLETED|Overall Study||24
1696681|NCT00467597|4146660|P2|STARTED|Overall Study||6
1696682|NCT00467597|4146661|P1|STARTED|Overall Study||26
1696683|NCT00467584|4146674|P3|NOT COMPLETED|Overall Study||1
1696684|NCT00467584|4146675|P2|NOT COMPLETED|Overall Study||5
1696685|NCT00467584|4146676|P1|NOT COMPLETED|Overall Study||4
1696686|NCT00467584|4146674|P3|COMPLETED|Overall Study||20
1696687|NCT00467584|4146675|P2|COMPLETED|Overall Study||15
1696688|NCT00467584|4146676|P1|COMPLETED|Overall Study||17
1696689|NCT00467584|4146674|P3|STARTED|Overall Study||21
1696690|NCT00467584|4146675|P2|STARTED|Overall Study||20
1696691|NCT00467584|4146676|P1|STARTED|Overall Study||21
1696692|NCT00467558|4146686|P2|NOT COMPLETED|Overall Study||0
1696693|NCT00467558|4146687|P1|NOT COMPLETED|Overall Study||2
1696694|NCT00467558|4146686|P2|COMPLETED|Overall Study||3
1696695|NCT00467558|4146687|P1|COMPLETED|Overall Study||2
1696696|NCT00467558|4146686|P2|STARTED|Overall Study||3
1696697|NCT00467558|4146687|P1|STARTED|Overall Study||4
1696698|NCT00467519|4146697|P2|NOT COMPLETED|Overall Study||23
1696699|NCT00467519|4146698|P1|NOT COMPLETED|Overall Study||14
1696700|NCT00467519|4146697|P2|COMPLETED|Overall Study||488
1696701|NCT00467519|4146698|P1|COMPLETED|Overall Study||517
1696702|NCT00467519|4146697|P2|STARTED|Overall Study||511
1696703|NCT00467519|4146698|P1|STARTED|Overall Study||531
1696704|NCT00467389|4146714|P2|NOT COMPLETED|Overall Study||0
1696705|NCT00467389|4146715|P1|NOT COMPLETED|Overall Study||0
1696706|NCT00467389|4146714|P2|COMPLETED|Overall Study||6
1696707|NCT00467389|4146715|P1|COMPLETED|Overall Study||6
1696708|NCT00467389|4146714|P2|STARTED|Overall Study||6
1696709|NCT00467389|4146715|P1|STARTED|Overall Study||6
1696710|NCT00467363|4146727|P2|NOT COMPLETED|Overall Study||70
1696711|NCT00467363|4146728|P1|NOT COMPLETED|Overall Study||80
1696712|NCT00467363|4146727|P2|COMPLETED|Overall Study||543
1696713|NCT00467363|4146728|P1|COMPLETED|Overall Study||535
1696714|NCT00467363|4146727|P2|STARTED|Overall Study||613
1696715|NCT00467363|4146728|P1|STARTED|Overall Study||615
1696716|NCT00467298|4146764|P2|NOT COMPLETED|Overall Study||6
1696717|NCT00467298|4146765|P1|NOT COMPLETED|Overall Study||4
1696718|NCT00467298|4146764|P2|COMPLETED|Overall Study||38
1696719|NCT00467298|4146765|P1|COMPLETED|Overall Study||42
1696720|NCT00467298|4146764|P2|STARTED|Overall Study||44
1696721|NCT00467298|4146765|P1|STARTED|Overall Study||46
1696722|NCT00467285|4146775|P2|NOT COMPLETED|Overall Study||4
1696723|NCT00467285|4146776|P1|NOT COMPLETED|Overall Study||4
1696724|NCT00467285|4146775|P2|COMPLETED|Overall Study||60
1696725|NCT00467285|4146776|P1|COMPLETED|Overall Study||28
1696726|NCT00467285|4146775|P2|STARTED|Overall Study||64
1696727|NCT00467285|4146776|P1|STARTED|Overall Study||32
1696728|NCT00467259|4146796|P2|NOT COMPLETED|Overall Study||242
1696729|NCT00467259|4146797|P1|NOT COMPLETED|Overall Study||75
1696730|NCT00467259|4146796|P2|COMPLETED|Overall Study||778
1696731|NCT00467259|4146797|P1|COMPLETED|Overall Study||176
1696732|NCT00467259|4146796|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
1696733|NCT00467259|4146797|P1|ITT Population|Overall Study||251
1696734|NCT00467259|4146796|P2|STARTED|Overall Study||1020
1696735|NCT00467259|4146797|P1|STARTED|Overall Study||251
1696736|NCT00467077|4146807|P1|NOT COMPLETED|Overall Study||0
1696737|NCT00467077|4146807|P1|COMPLETED|Overall Study||21
1696738|NCT00467077|4146807|P1|STARTED|Overall Study||21
1696739|NCT00467051|4146814|P1|NOT COMPLETED|Overall Study||2
1696740|NCT00467051|4146814|P1|COMPLETED|Overall Study||18
1696741|NCT00467051|4146814|P1|STARTED|Overall Study||20
1696742|NCT00467038|4146821|P2|NOT COMPLETED|Overall Study||0
1696743|NCT00467038|4146822|P1|NOT COMPLETED|Overall Study||0
1696744|NCT00467038|4146821|P2|COMPLETED|Overall Study||11
1696745|NCT00467038|4146822|P1|COMPLETED|Overall Study||11
1696746|NCT00467038|4146821|P2|STARTED|Overall Study||11
1696747|NCT00467038|4146822|P1|STARTED|Overall Study||11
1696748|NCT00466960|4146830|P1|NOT COMPLETED|Overall Study||0
1696749|NCT00466960|4146830|P1|COMPLETED|Overall Study||21
1696750|NCT00466960|4146830|P1|STARTED|Overall Study||21
1696751|NCT00466947|4146841|P2|NOT COMPLETED|Study End Analysis Period||2534
1696752|NCT00466947|4146842|P1|NOT COMPLETED|Study End Analysis Period||2496
1696753|NCT00466947|4146841|P2|COMPLETED|Study End Analysis Period||9265
1696754|NCT00466947|4146842|P1|COMPLETED|Study End Analysis Period||9302
1696755|NCT00466947|4146841|P2|STARTED|Study End Analysis Period||11799
1696756|NCT00466947|4146842|P1|STARTED|Study End Analysis Period||11798
1696757|NCT00466947|4146841|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
1696758|NCT00466947|4146842|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
1696759|NCT00466947|4146841|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
1696760|NCT00466947|4146842|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
1696761|NCT00466947|4146841|P2|Ongoing|Primary Outcome Analysis Period||11863
1696762|NCT00466947|4146842|P1|Ongoing|Primary Outcome Analysis Period||11875
1696763|NCT00466947|4146841|P2|STARTED|Primary Outcome Analysis Period||11863
1696764|NCT00466947|4146842|P1|STARTED|Primary Outcome Analysis Period||11875
1696765|NCT00466817|4146966|P2|NOT COMPLETED|Overall Study||4
1696766|NCT00466817|4146967|P1|NOT COMPLETED|Overall Study||5
1696767|NCT00466817|4146966|P2|COMPLETED|Overall Study||43
1696768|NCT00466817|4146967|P1|COMPLETED|Overall Study||44
1696769|NCT00466817|4146966|P2|STARTED|Overall Study||47
1696770|NCT00466817|4146967|P1|STARTED|Overall Study||49
1696771|NCT00466752|4147022|P2|NOT COMPLETED|Overall Study||0
1696772|NCT00466752|4147023|P1|NOT COMPLETED|Overall Study||0
1696773|NCT00466752|4147022|P2|COMPLETED|Overall Study||0
1696774|NCT00466752|4147023|P1|COMPLETED|Overall Study||5
1696775|NCT00466752|4147022|P2|STARTED|Overall Study||0
1696776|NCT00466752|4147023|P1|STARTED|Overall Study||5
1696777|NCT00466726|4147033|P1|NOT COMPLETED|Overall Study||14
1696778|NCT00466726|4147033|P1|COMPLETED|Overall Study||43
1696779|NCT00466726|4147033|P1|STARTED|Overall Study||57
1696780|NCT00466687|4147039|P1|NOT COMPLETED|Overall Study||34
1696781|NCT00466687|4147039|P1|COMPLETED|Overall Study||0
1696782|NCT00466687|4147039|P1|STARTED|Overall Study||34
1696783|NCT00466661|4147048|P2|NOT COMPLETED|Overall Study||6
1696784|NCT00466661|4147049|P1|NOT COMPLETED|Overall Study||4
1696785|NCT00466661|4147048|P2|COMPLETED|Overall Study||11
1696786|NCT00466661|4147049|P1|COMPLETED|Overall Study||12
1696787|NCT00466661|4147048|P2|At Least 1 Postrandomization Visit|Overall Study||16
1696788|NCT00466661|4147049|P1|At Least 1 Postrandomization Visit|Overall Study||14
1696789|NCT00466661|4147048|P2|STARTED|Overall Study||17
1696790|NCT00466661|4147049|P1|STARTED|Overall Study||16
1696791|NCT00466505|4147071|P1|NOT COMPLETED|Overall Study||17
1696792|NCT00466505|4147071|P1|COMPLETED|Overall Study||0
1696793|NCT00466505|4147071|P1|STARTED|Overall Study||17
1696794|NCT00466323|4147085|P2|NOT COMPLETED|Overall Study||23
1696795|NCT00466323|4147086|P1|NOT COMPLETED|Overall Study||28
1696796|NCT00466323|4147085|P2|COMPLETED|Overall Study||92
1696797|NCT00466323|4147086|P1|COMPLETED|Overall Study||89
1696798|NCT00466323|4147085|P2|STARTED|Overall Study||115
1696799|NCT00466323|4147086|P1|STARTED|Overall Study||117
1696800|NCT00466310|4147101|P3|NOT COMPLETED|Overall Study||0
1696801|NCT00466310|4147102|P2|NOT COMPLETED|Overall Study||0
1696802|NCT00466310|4147103|P1|NOT COMPLETED|Overall Study||0
1696803|NCT00466310|4147101|P3|COMPLETED|Overall Study||31
1696804|NCT00466310|4147102|P2|COMPLETED|Overall Study||20
1696805|NCT00466310|4147103|P1|COMPLETED|Overall Study||20
1696806|NCT00466310|4147101|P3|STARTED|Overall Study||31
1696807|NCT00466310|4147102|P2|STARTED|Overall Study||20
1696808|NCT00466310|4147103|P1|STARTED|Overall Study||20
1696809|NCT00466206|4147111|P1|NOT COMPLETED|Overall Study||0
1696810|NCT00466206|4147111|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
1696811|NCT00466206|4147111|P1|STARTED|Overall Study||10
1696812|NCT00466193|4147121|P2|NOT COMPLETED|Overall Study||8
1696813|NCT00466193|4147122|P1|NOT COMPLETED|Overall Study||12
1696814|NCT00466193|4147121|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
1696815|NCT00466193|4147122|P1|COMPLETED|Overall Study||138
1696816|NCT00466193|4147121|P2|STARTED|Overall Study||145
1696817|NCT00466193|4147122|P1|STARTED|Overall Study||150
1696818|NCT00466167|4147149|P3|NOT COMPLETED|Overall Study||21
1696819|NCT00466167|4147150|P2|NOT COMPLETED|Overall Study||12
1696820|NCT00466167|4147151|P1|NOT COMPLETED|Overall Study||20
1696821|NCT00466167|4147149|P3|COMPLETED|Overall Study||157
1696822|NCT00466167|4147150|P2|COMPLETED|Overall Study||163
1696823|NCT00466167|4147151|P1|COMPLETED|Overall Study||145
1696824|NCT00466167|4147149|P3|STARTED|Overall Study||178
1696825|NCT00466167|4147150|P2|STARTED|Overall Study||175
1696826|NCT00466167|4147151|P1|STARTED|Overall Study||165
1696827|NCT00465998|4147207|P1|NOT COMPLETED|Overall Study||0
1696828|NCT00465998|4147207|P1|COMPLETED|Overall Study||275
1696829|NCT00465998|4147207|P1|STARTED|Overall Study||275
1696830|NCT00465985|4147212|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
1696831|NCT00465985|4147213|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
1696832|NCT00465985|4147212|P2|COMPLETED|Part III - Open-label Treatment Period||0
1696833|NCT00465985|4147213|P1|COMPLETED|Part III - Open-label Treatment Period||29
1696834|NCT00465985|4147212|P2|STARTED|Part III - Open-label Treatment Period||0
1696835|NCT00465985|4147213|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
1696836|NCT00465985|4147212|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
1696837|NCT00465985|4147213|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
1696838|NCT00465985|4147212|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
1696839|NCT00465985|4147213|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
1696840|NCT00465985|4147212|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
1696841|NCT00465985|4147213|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
1696842|NCT00465985|4147212|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
1696843|NCT00465985|4147213|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
1696844|NCT00465985|4147212|P2|COMPLETED|Part I - Open-label Treatment Period||0
1696845|NCT00465985|4147213|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
1696846|NCT00465985|4147212|P2|STARTED|Part I - Open-label Treatment Period||0
1696847|NCT00465985|4147213|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
1696848|NCT00465972|4147236|P2|NOT COMPLETED|Overall Study||1
1696849|NCT00465972|4147237|P1|NOT COMPLETED|Overall Study||2
1696850|NCT00465972|4147236|P2|COMPLETED|Overall Study||23
1696851|NCT00465972|4147237|P1|COMPLETED|Overall Study||18
1696852|NCT00465972|4147236|P2|STARTED|Overall Study||24
1696853|NCT00465972|4147237|P1|STARTED|Overall Study||20
1696854|NCT00465894|4147247|P2|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
1696855|NCT00465894|4147248|P1|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
1696856|NCT00465894|4147247|P2|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
1696857|NCT00465894|4147248|P1|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
1696858|NCT00465894|4147247|P2|STARTED|Treatment From 24 Weeks to 52 Weeks||14
1696859|NCT00465894|4147248|P1|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
1696860|NCT00465894|4147247|P2|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
1696861|NCT00465894|4147248|P1|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
1696862|NCT00465894|4147247|P2|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
1696863|NCT00465894|4147248|P1|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
1696864|NCT00465894|4147247|P2|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
1696865|NCT00465894|4147248|P1|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
1696866|NCT00465894|4147247|P2|NOT COMPLETED|Treatment For 12 Weeks||3
1696867|NCT00465894|4147248|P1|NOT COMPLETED|Treatment For 12 Weeks||5
1696868|NCT00465894|4147247|P2|COMPLETED|Treatment For 12 Weeks||25
1696869|NCT00465894|4147248|P1|COMPLETED|Treatment For 12 Weeks||25
1696870|NCT00465894|4147247|P2|STARTED|Treatment For 12 Weeks||28
1696871|NCT00465894|4147248|P1|STARTED|Treatment For 12 Weeks||30
1696872|NCT00465816|4147281|P3|NOT COMPLETED|Overall Study||2
1696873|NCT00465816|4147282|P2|NOT COMPLETED|Overall Study||0
1696874|NCT00465816|4147283|P1|NOT COMPLETED|Overall Study||0
1696875|NCT00465816|4147281|P3|COMPLETED|Overall Study||120
1696876|NCT00465816|4147282|P2|COMPLETED|Overall Study||122
1696877|NCT00465816|4147283|P1|COMPLETED|Overall Study||367
1696878|NCT00465816|4147281|P3|STARTED|Overall Study||122
1696879|NCT00465816|4147282|P2|STARTED|Overall Study||122
1696880|NCT00465816|4147283|P1|STARTED|Overall Study||367
1696881|NCT00465738|4147346|P2|NOT COMPLETED|Overall Study||6
1696882|NCT00465738|4147347|P1|NOT COMPLETED|Overall Study||6
1696883|NCT00465738|4147346|P2|COMPLETED|Overall Study||89
1696884|NCT00465738|4147347|P1|COMPLETED|Overall Study||91
1696885|NCT00465738|4147346|P2|STARTED|Overall Study||95
1696886|NCT00465738|4147347|P1|STARTED|Overall Study||97
1696887|NCT00465647|4147441|P4|NOT COMPLETED|Overall Study||13
1696888|NCT00465647|4147442|P3|NOT COMPLETED|Overall Study||11
1696889|NCT00465647|4147443|P2|NOT COMPLETED|Overall Study||8
1696890|NCT00465647|4147444|P1|NOT COMPLETED|Overall Study||13
1696891|NCT00465647|4147441|P4|COMPLETED|Overall Study||12
1696892|NCT00465647|4147442|P3|COMPLETED|Overall Study||18
1696893|NCT00465647|4147443|P2|COMPLETED|Overall Study||15
1696894|NCT00465647|4147444|P1|COMPLETED|Overall Study||26
1696895|NCT00465647|4147441|P4|STARTED|Overall Study||25
1696896|NCT00465647|4147442|P3|STARTED|Overall Study||29
1696897|NCT00465647|4147443|P2|STARTED|Overall Study||23
1696898|NCT00465647|4147444|P1|STARTED|Overall Study||39
1696899|NCT00465595|4147469|P2|NOT COMPLETED|Overall Study||5
1696900|NCT00465595|4147470|P1|NOT COMPLETED|Overall Study||5
1696901|NCT00465595|4147469|P2|COMPLETED|Overall Study||24
1696902|NCT00465595|4147470|P1|COMPLETED|Overall Study||22
1696903|NCT00465595|4147469|P2|STARTED|Overall Study||29
1696904|NCT00465595|4147470|P1|STARTED|Overall Study||27
1696905|NCT00465569|4147492|P2|NOT COMPLETED|Overall Study||0
1696906|NCT00465569|4147493|P1|NOT COMPLETED|Overall Study||1
1696907|NCT00465569|4147492|P2|COMPLETED|Overall Study||7
1696908|NCT00465569|4147493|P1|COMPLETED|Overall Study||12
1696909|NCT00465569|4147492|P2|STARTED|Overall Study||7
1696910|NCT00465569|4147493|P1|STARTED|Overall Study||13
1696911|NCT00465530|4147505|P2|NOT COMPLETED|Overall Study||4
1696912|NCT00465530|4147506|P1|NOT COMPLETED|Overall Study||2
1696913|NCT00465530|4147505|P2|COMPLETED|Overall Study||15
1696914|NCT00465530|4147506|P1|COMPLETED|Overall Study||19
1696915|NCT00465530|4147505|P2|STARTED|Overall Study||19
1696916|NCT00465530|4147506|P1|STARTED|Overall Study||21
1696917|NCT00465361|4147516|P1|NOT COMPLETED|Post-Intervention Assessment||0
1696918|NCT00465361|4147516|P1|COMPLETED|Post-Intervention Assessment||3
1696919|NCT00465361|4147516|P1|STARTED|Post-Intervention Assessment||3
1696920|NCT00465361|4147516|P1|NOT COMPLETED|Baseline Assessment||4
1696921|NCT00465361|4147516|P1|COMPLETED|Baseline Assessment||3
1696922|NCT00465361|4147516|P1|STARTED|Baseline Assessment||7
1696923|NCT00465270|4147522|P2|NOT COMPLETED|Overall Study||160
1696924|NCT00465270|4147523|P1|NOT COMPLETED|Overall Study||104
1696925|NCT00465270|4147522|P2|COMPLETED|Overall Study||321
1696926|NCT00465270|4147523|P1|COMPLETED|Overall Study||395
1696927|NCT00465270|4147522|P2|STARTED|Overall Study||481
1696928|NCT00465270|4147523|P1|STARTED|Overall Study||499
1696929|NCT00465179|4147532|P1|NOT COMPLETED|Overall Study||53
1696930|NCT00465179|4147532|P1|COMPLETED|Overall Study||4
1696931|NCT00465179|4147532|P1|STARTED|Overall Study||57
1696932|NCT00465101|4147538|P1|NOT COMPLETED|Overall Study||59
1696933|NCT00465101|4147538|P1|COMPLETED|Overall Study||91
1696934|NCT00465101|4147538|P1|STARTED|Overall Study||150
1696935|NCT00465088|4147573|P2|NOT COMPLETED|Overall Study||9
1696936|NCT00465088|4147574|P1|NOT COMPLETED|Overall Study||32
1696937|NCT00465088|4147573|P2|COMPLETED|Overall Study||70
1696938|NCT00465088|4147574|P1|COMPLETED|Overall Study||82
1696939|NCT00465088|4147573|P2|STARTED|Overall Study||79
1696940|NCT00465088|4147574|P1|STARTED|Overall Study|For both arms, started means treated.|114
1696941|NCT00464945|4147608|P2|NOT COMPLETED|Toddler Dose||1
1696942|NCT00464945|4147609|P1|NOT COMPLETED|Toddler Dose||0
1696943|NCT00464945|4147608|P2|COMPLETED|Toddler Dose||130
1696944|NCT00464945|4147609|P1|COMPLETED|Toddler Dose||131
1696945|NCT00464945|4147608|P2|STARTED|Toddler Dose||131
1696946|NCT00464945|4147609|P1|STARTED|Toddler Dose||131
1696947|NCT00464945|4147608|P2|NOT COMPLETED|After Infant Series||2
1696948|NCT00464945|4147609|P1|NOT COMPLETED|After Infant Series||0
1696949|NCT00464945|4147608|P2|COMPLETED|After Infant Series||131
1696950|NCT00464945|4147609|P1|COMPLETED|After Infant Series||131
1696951|NCT00464945|4147608|P2|STARTED|After Infant Series||133
1696952|NCT00464945|4147609|P1|STARTED|After Infant Series||131
1696953|NCT00464945|4147608|P2|NOT COMPLETED|Infant Series||1
1696954|NCT00464945|4147609|P1|NOT COMPLETED|Infant Series||4
1696955|NCT00464945|4147608|P2|COMPLETED|Infant Series||133
1696956|NCT00464945|4147609|P1|COMPLETED|Infant Series||131
1696957|NCT00464945|4147608|P2|Vaccinated Dose 3|Infant Series||133
1696958|NCT00464945|4147609|P1|Vaccinated Dose 3|Infant Series||132
1696959|NCT00464945|4147608|P2|Vaccinated Dose 2|Infant Series||133
1696960|NCT00464945|4147609|P1|Vaccinated Dose 2|Infant Series||132
1696961|NCT00464945|4147608|P2|Vaccinated Dose 1|Infant Series||134
1696962|NCT00464945|4147609|P1|Vaccinated Dose 1|Infant Series||134
1696963|NCT00464945|4147608|P2|STARTED|Infant Series||134
1696964|NCT00464945|4147609|P1|STARTED|Infant Series||135
1696965|NCT00464815|4147639|P2|NOT COMPLETED|Overall Study||3
1696966|NCT00464815|4147640|P1|NOT COMPLETED|Overall Study||6
1696967|NCT00464815|4147639|P2|COMPLETED|Overall Study||254
1696968|NCT00464815|4147640|P1|COMPLETED|Overall Study||762
1696969|NCT00464815|4147639|P2|STARTED|Overall Study||257
1696970|NCT00464815|4147640|P1|STARTED|Overall Study||768
1696971|NCT00464737|4147673|P3|NOT COMPLETED|Overall Study||55
1696972|NCT00464737|4147674|P2|NOT COMPLETED|Overall Study||32
1696973|NCT00464737|4147675|P1|NOT COMPLETED|Overall Study||32
1696974|NCT00464737|4147673|P3|COMPLETED|Overall Study||19
1696975|NCT00464737|4147674|P2|COMPLETED|Overall Study||42
1696976|NCT00464737|4147675|P1|COMPLETED|Overall Study||50
1696977|NCT00464737|4147673|P3|STARTED|Overall Study||74
1696978|NCT00464737|4147674|P2|STARTED|Overall Study||74
1696979|NCT00464737|4147675|P1|STARTED|Overall Study||82
1696980|NCT00464711|4147722|P1|NOT COMPLETED|Overall Study||15
1696981|NCT00464711|4147722|P1|COMPLETED|Overall Study||25
1696982|NCT00464711|4147722|P1|STARTED|Overall Study||40
1696983|NCT00464698|4147726|P1|NOT COMPLETED|Period 3: 120mg||2
1696984|NCT00464698|4147726|P1|COMPLETED|Period 3: 120mg||12
1696985|NCT00464698|4147726|P1|STARTED|Period 3: 120mg||14
1696986|NCT00464698|4147726|P1|NOT COMPLETED|Period 2: 60 mg||0
1696987|NCT00464698|4147726|P1|COMPLETED|Period 2: 60 mg||17
1696988|NCT00464698|4147726|P1|STARTED|Period 2: 60 mg||17
1696989|NCT00464698|4147726|P1|NOT COMPLETED|Period 1: 30 mg||3
1696990|NCT00464698|4147726|P1|COMPLETED|Period 1: 30 mg||17
1696991|NCT00464698|4147726|P1|STARTED|Period 1: 30 mg||20
1696992|NCT00464685|4147738|P2|NOT COMPLETED|Overall Study||33
1696993|NCT00464685|4147739|P1|NOT COMPLETED|Overall Study||23
1696994|NCT00464685|4147738|P2|COMPLETED|Overall Study||94
1696995|NCT00464685|4147739|P1|COMPLETED|Overall Study||103
1696996|NCT00464685|4147738|P2|STARTED|Overall Study||127
1696997|NCT00464685|4147739|P1|STARTED|Overall Study||126
1696998|NCT00464672|4147755|P6|NOT COMPLETED|Overall Study||4
1696999|NCT00464672|4147756|P5|NOT COMPLETED|Overall Study||10
1697000|NCT00464672|4147757|P4|NOT COMPLETED|Overall Study||1
1697001|NCT00464672|4147758|P3|NOT COMPLETED|Overall Study||0
1697002|NCT00464672|4147759|P2|NOT COMPLETED|Overall Study||10
1697003|NCT00464672|4147760|P1|NOT COMPLETED|Overall Study||25
1697004|NCT00464672|4147755|P6|COMPLETED|Overall Study||195
1697005|NCT00464672|4147756|P5|COMPLETED|Overall Study||392
1697006|NCT00464672|4147757|P4|COMPLETED|Overall Study||199
1697007|NCT00464672|4147758|P3|COMPLETED|Overall Study||400
1697008|NCT00464672|4147759|P2|COMPLETED|Overall Study||222
1697009|NCT00464672|4147760|P1|COMPLETED|Overall Study||435
1697010|NCT00464672|4147755|P6|STARTED|Overall Study||199
1697011|NCT00464672|4147756|P5|STARTED|Overall Study||402
1697012|NCT00464672|4147757|P4|STARTED|Overall Study||200
1697013|NCT00464672|4147758|P3|STARTED|Overall Study||400
1697014|NCT00464672|4147759|P2|STARTED|Overall Study||232
1697015|NCT00464672|4147760|P1|STARTED|Overall Study||460
1697016|NCT00464646|4147832|P2|NOT COMPLETED|Overall Study||0
1697017|NCT00464646|4147833|P1|NOT COMPLETED|Overall Study||0
1697018|NCT00464646|4147832|P2|COMPLETED|Overall Study||29
1697019|NCT00464646|4147833|P1|COMPLETED|Overall Study||76
1697020|NCT00464646|4147832|P2|STARTED|Overall Study||29
1697021|NCT00464646|4147833|P1|STARTED|Overall Study||76
1697022|NCT00464620|4147839|P3|NOT COMPLETED|Overall Study||7
1697023|NCT00464620|4147840|P2|NOT COMPLETED|Overall Study||2
1697024|NCT00464620|4147841|P1|NOT COMPLETED|Overall Study||2
1697025|NCT00464620|4147839|P3|COMPLETED|Overall Study||109
1697026|NCT00464620|4147840|P2|COMPLETED|Overall Study||198
1697027|NCT00464620|4147841|P1|COMPLETED|Overall Study|48 patients were evaluable.|48
1697028|NCT00464620|4147839|P3|STARTED|Overall Study||116
1697029|NCT00464620|4147840|P2|STARTED|Overall Study||200
1697030|NCT00464620|4147841|P1|STARTED|Overall Study||50
1697031|NCT00464568|4147868|P1|NOT COMPLETED|Overall Study||2
1697032|NCT00464568|4147868|P1|COMPLETED|Overall Study||30
1697033|NCT00464568|4147868|P1|STARTED|Overall Study||32
1697034|NCT00464542|4147941|P1|NOT COMPLETED|Post-treatment||0
1697035|NCT00464542|4147941|P1|COMPLETED|Post-treatment||10
1697036|NCT00464542|4147941|P1|STARTED|Post-treatment||10
1697037|NCT00464542|4147941|P1|NOT COMPLETED|Pre-treatment||2
1697038|NCT00464542|4147941|P1|COMPLETED|Pre-treatment||10
1697039|NCT00464542|4147941|P1|STARTED|Pre-treatment||12
1697040|NCT00464490|4147948|P2|NOT COMPLETED|Overall Study||11
1697041|NCT00464490|4147949|P1|NOT COMPLETED|Overall Study||11
1697042|NCT00464490|4147948|P2|COMPLETED|Overall Study||10
1697043|NCT00464490|4147949|P1|COMPLETED|Overall Study||10
1697044|NCT00464490|4147948|P2|STARTED|Overall Study||21
1697045|NCT00464490|4147949|P1|STARTED|Overall Study||21
1697046|NCT00464464|4147957|P2|NOT COMPLETED|Overall Study||3
1697047|NCT00464464|4147958|P1|NOT COMPLETED|Overall Study||5
1697048|NCT00464464|4147957|P2|COMPLETED|Overall Study||36
1697049|NCT00464464|4147958|P1|COMPLETED|Overall Study||36
1697050|NCT00464464|4147957|P2|STARTED|Overall Study||39
1697051|NCT00464464|4147958|P1|STARTED|Overall Study||41
1697052|NCT00464438|4147972|P2|NOT COMPLETED|Overall Study||6
1697053|NCT00464438|4147973|P1|NOT COMPLETED|Overall Study||2
1697054|NCT00464438|4147972|P2|COMPLETED|Overall Study||80
1697055|NCT00464438|4147973|P1|COMPLETED|Overall Study||83
1697056|NCT00464438|4147972|P2|STARTED|Overall Study||86
1697057|NCT00464438|4147973|P1|STARTED|Overall Study||85
1697058|NCT00464334|4147996|P11|NOT COMPLETED|Overall Study||4
1697059|NCT00464334|4147997|P10|NOT COMPLETED|Overall Study||1
1697060|NCT00464334|4147998|P9|NOT COMPLETED|Overall Study||6
1697061|NCT00464334|4147999|P8|NOT COMPLETED|Overall Study||1
1697062|NCT00464334|4148000|P7|NOT COMPLETED|Overall Study||3
1697063|NCT00464334|4148001|P6|NOT COMPLETED|Overall Study||4
1697064|NCT00464334|4148002|P5|NOT COMPLETED|Overall Study||4
1697065|NCT00464334|4148003|P4|NOT COMPLETED|Overall Study||4
1697066|NCT00464334|4148004|P3|NOT COMPLETED|Overall Study||5
1697067|NCT00464334|4148005|P2|NOT COMPLETED|Overall Study||8
1697068|NCT00464334|4148006|P1|NOT COMPLETED|Overall Study||1
1697069|NCT00464334|4147996|P11|COMPLETED|Overall Study||4
1697070|NCT00464334|4147997|P10|COMPLETED|Overall Study||4
1697071|NCT00464334|4147998|P9|COMPLETED|Overall Study||2
1697072|NCT00464334|4147999|P8|COMPLETED|Overall Study||7
1697073|NCT00464334|4148000|P7|COMPLETED|Overall Study||6
1697074|NCT00464334|4148001|P6|COMPLETED|Overall Study||3
1697075|NCT00464334|4148002|P5|COMPLETED|Overall Study||3
1697076|NCT00464334|4148003|P4|COMPLETED|Overall Study||4
1697077|NCT00464334|4148004|P3|COMPLETED|Overall Study||3
1697078|NCT00464334|4148005|P2|COMPLETED|Overall Study||5
1697079|NCT00464334|4148006|P1|COMPLETED|Overall Study||4
1697080|NCT00464334|4147996|P11|STARTED|Overall Study||8
1697081|NCT00464334|4147997|P10|STARTED|Overall Study||5
1697082|NCT00464334|4147998|P9|STARTED|Overall Study||8
1697083|NCT00464334|4147999|P8|STARTED|Overall Study||8
1697084|NCT00464334|4148000|P7|STARTED|Overall Study||9
1697085|NCT00464334|4148001|P6|STARTED|Overall Study||7
1697086|NCT00464334|4148002|P5|STARTED|Overall Study||7
1697087|NCT00464334|4148003|P4|STARTED|Overall Study||8
1697088|NCT00464334|4148004|P3|STARTED|Overall Study||8
1697089|NCT00464334|4148005|P2|STARTED|Overall Study||13
1697090|NCT00464334|4148006|P1|STARTED|Overall Study||5
1697091|NCT00464308|4148066|P3|NOT COMPLETED|Overall Study||59
1697092|NCT00464308|4148067|P2|NOT COMPLETED|Overall Study||63
1697093|NCT00464308|4148068|P1|NOT COMPLETED|Overall Study||69
1697094|NCT00464308|4148066|P3|COMPLETED|Overall Study||400
1697095|NCT00464308|4148067|P2|COMPLETED|Overall Study||406
1697096|NCT00464308|4148068|P1|COMPLETED|Overall Study||395
1697097|NCT00464308|4148066|P3|STARTED|Overall Study||459
1697098|NCT00464308|4148067|P2|STARTED|Overall Study||469
1697099|NCT00464308|4148068|P1|STARTED|Overall Study||464
1697100|NCT00464269|4148098|P4|NOT COMPLETED|Overall Study||9
1697101|NCT00464269|4148099|P3|NOT COMPLETED|Overall Study||7
1697102|NCT00464269|4148100|P2|NOT COMPLETED|Overall Study||17
1697103|NCT00464269|4148101|P1|NOT COMPLETED|Overall Study||6
1697104|NCT00464269|4148098|P4|COMPLETED|Overall Study||93
1697105|NCT00464269|4148099|P3|COMPLETED|Overall Study||93
1697106|NCT00464269|4148100|P2|COMPLETED|Overall Study||82
1697107|NCT00464269|4148101|P1|COMPLETED|Overall Study||93
1697108|NCT00464269|4148098|P4|STARTED|Overall Study||102
1697109|NCT00464269|4148099|P3|STARTED|Overall Study||100
1697110|NCT00464269|4148100|P2|STARTED|Overall Study||99
1697111|NCT00464269|4148101|P1|STARTED|Overall Study||99
1697112|NCT00464204|4148201|P2|NOT COMPLETED|Overall Study||32
1697113|NCT00464204|4148202|P1|NOT COMPLETED|Overall Study||49
1697114|NCT00464204|4148201|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
1697115|NCT00464204|4148202|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
1697116|NCT00464204|4148201|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
1697117|NCT00464204|4148202|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
1697118|NCT00464204|4148201|P2|Day 90 Follow-up Performed|Overall Study||74
1697119|NCT00464204|4148202|P1|Day 90 Follow-up Performed|Overall Study||69
1697120|NCT00464204|4148201|P2|Day 30 Follow-up Performed|Overall Study||83
1697121|NCT00464204|4148202|P1|Day 30 Follow-up Performed|Overall Study||89
1697122|NCT00464204|4148201|P2|Completed Treatment|Overall Study||83
1697123|NCT00464204|4148202|P1|Completed Treatment|Overall Study||81
1697124|NCT00464204|4148201|P2|STARTED|Overall Study||96
1697125|NCT00464204|4148202|P1|STARTED|Overall Study||100
1697126|NCT00464087|4148239|P3|NOT COMPLETED|Overall Study||29
1697127|NCT00464087|4148240|P2|NOT COMPLETED|Overall Study||0
1697128|NCT00464087|4148241|P1|NOT COMPLETED|Overall Study||0
1697129|NCT00464087|4148239|P3|COMPLETED|Overall Study||0
1697130|NCT00464087|4148240|P2|COMPLETED|Overall Study||51
1697131|NCT00464087|4148241|P1|COMPLETED|Overall Study||49
1697132|NCT00464087|4148239|P3|STARTED|Overall Study||29
1697133|NCT00464087|4148240|P2|STARTED|Overall Study||51
1697134|NCT00464087|4148241|P1|STARTED|Overall Study||49
1697135|NCT00463866|4148259|P2|NOT COMPLETED|Overall Study||340
1697136|NCT00463866|4148260|P1|NOT COMPLETED|Overall Study||309
1697137|NCT00463866|4148259|P2|COMPLETED|Overall Study||3705
1697138|NCT00463866|4148260|P1|COMPLETED|Overall Study||3699
1697139|NCT00463866|4148259|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
1697140|NCT00463866|4148260|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
1697141|NCT00463840|4148280|P1|NOT COMPLETED|Overall Study||12
1697142|NCT00463840|4148280|P1|COMPLETED|Overall Study||12
1697143|NCT00463840|4148280|P1|STARTED|Overall Study||24
1697144|NCT00463801|4148285|P1|NOT COMPLETED|Overall Study||13
1697145|NCT00463801|4148285|P1|COMPLETED|Overall Study||39
1697146|NCT00463801|4148285|P1|STARTED|Overall Study||52
1697147|NCT00463788|4148291|P2|NOT COMPLETED|Overall Study||54
1697148|NCT00463788|4148292|P1|NOT COMPLETED|Overall Study||109
1697149|NCT00463788|4148291|P2|COMPLETED|Overall Study||4
1697150|NCT00463788|4148292|P1|COMPLETED|Overall Study||6
1697151|NCT00463788|4148291|P2|Treated|Overall Study||57
1697152|NCT00463788|4148292|P1|Treated|Overall Study||114
1697153|NCT00463788|4148291|P2|STARTED|Overall Study||58
1697154|NCT00463788|4148292|P1|STARTED|Overall Study||115
1697155|NCT00463606|4148310|P3|NOT COMPLETED|Overall Study||20
1697156|NCT00463606|4148311|P2|NOT COMPLETED|Overall Study||34
1697157|NCT00463606|4148312|P1|NOT COMPLETED|Overall Study||41
1697158|NCT00463606|4148310|P3|COMPLETED|Overall Study||231
1697159|NCT00463606|4148311|P2|COMPLETED|Overall Study||220
1697160|NCT00463606|4148312|P1|COMPLETED|Overall Study||212
1697161|NCT00463606|4148310|P3|STARTED|Overall Study||251
1697162|NCT00463606|4148311|P2|STARTED|Overall Study||254
1697163|NCT00463606|4148312|P1|STARTED|Overall Study||253
1697164|NCT00463580|4148337|P2|NOT COMPLETED|Overall Study||2
1697165|NCT00463580|4148338|P1|NOT COMPLETED|Overall Study||3
1697166|NCT00463580|4148337|P2|COMPLETED|Overall Study||28
1697167|NCT00463580|4148338|P1|COMPLETED|Overall Study||27
1697168|NCT00463580|4148337|P2|STARTED|Overall Study||30
1697169|NCT00463580|4148338|P1|STARTED|Overall Study||30
1697170|NCT00463567|4148371|P7|NOT COMPLETED|Overall Study||11
1697171|NCT00463567|4148372|P6|NOT COMPLETED|Overall Study||21
1697172|NCT00463567|4148373|P5|NOT COMPLETED|Overall Study||23
1697173|NCT00463567|4148374|P4|NOT COMPLETED|Overall Study||131
1697174|NCT00463567|4148375|P3|NOT COMPLETED|Overall Study||89
1697175|NCT00463567|4148376|P2|NOT COMPLETED|Overall Study||77
1697176|NCT00463567|4148377|P1|NOT COMPLETED|Overall Study||95
1697177|NCT00463567|4148371|P7|COMPLETED|Overall Study||112
1697178|NCT00463567|4148372|P6|COMPLETED|Overall Study||102
1697179|NCT00463567|4148373|P5|COMPLETED|Overall Study||107
1697180|NCT00463567|4148374|P4|COMPLETED|Overall Study||294
1697181|NCT00463567|4148375|P3|COMPLETED|Overall Study||331
1697182|NCT00463567|4148376|P2|COMPLETED|Overall Study||341
1697183|NCT00463567|4148377|P1|COMPLETED|Overall Study||325
1697184|NCT00463567|4148371|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
1697185|NCT00463567|4148372|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
1697186|NCT00463567|4148373|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
1697187|NCT00463567|4148374|P4|Safety Population: Received Study Drug|Overall Study||418
1697188|NCT00463567|4148375|P3|Safety Population: Received Study Drug|Overall Study||415
1697189|NCT00463567|4148376|P2|Safety Population: Received Study Drug|Overall Study||416
1697190|NCT00463567|4148377|P1|Safety Population: Received Study Drug|Overall Study||416
1697191|NCT00463567|4148371|P7|STARTED|Overall Study||123
1697192|NCT00463567|4148372|P6|STARTED|Overall Study||123
1697193|NCT00463567|4148373|P5|STARTED|Overall Study||130
1697194|NCT00463567|4148374|P4|STARTED|Overall Study||425
1697195|NCT00463567|4148375|P3|STARTED|Overall Study||420
1697196|NCT00463567|4148376|P2|STARTED|Overall Study||418
1697197|NCT00463567|4148377|P1|STARTED|Overall Study|Randomized Participants|420
1697198|NCT00463437|4148412|P4|NOT COMPLETED|Overall Study||7
1697199|NCT00463437|4148413|P3|NOT COMPLETED|Overall Study||6
1697200|NCT00463437|4148414|P2|NOT COMPLETED|Overall Study||11
1697201|NCT00463437|4148415|P1|NOT COMPLETED|Overall Study||4
1697202|NCT00463437|4148412|P4|COMPLETED|Overall Study||350
1697203|NCT00463437|4148413|P3|COMPLETED|Overall Study||352
1697204|NCT00463437|4148414|P2|COMPLETED|Overall Study||352
1697205|NCT00463437|4148415|P1|COMPLETED|Overall Study||355
1697206|NCT00463437|4148412|P4|STARTED|Overall Study||357
1697207|NCT00463437|4148413|P3|STARTED|Overall Study||358
1697208|NCT00463437|4148414|P2|STARTED|Overall Study||363
1697209|NCT00463437|4148415|P1|STARTED|Overall Study||359
1697210|NCT00463385|4148481|P4|NOT COMPLETED|Overall Study||22
1697211|NCT00463385|4148482|P3|NOT COMPLETED|Overall Study||22
1697212|NCT00463385|4148483|P2|NOT COMPLETED|Overall Study||22
1697213|NCT00463385|4148484|P1|NOT COMPLETED|Overall Study||22
1697214|NCT00463385|4148481|P4|COMPLETED|Overall Study||0
1697215|NCT00463385|4148482|P3|COMPLETED|Overall Study||0
1697216|NCT00463385|4148483|P2|COMPLETED|Overall Study||0
1697217|NCT00463385|4148484|P1|COMPLETED|Overall Study||0
1697218|NCT00463385|4148481|P4|Treated|Overall Study||22
1697219|NCT00463385|4148482|P3|Treated|Overall Study||19
1697220|NCT00463385|4148483|P2|Treated|Overall Study||22
1697221|NCT00463385|4148484|P1|Treated|Overall Study||22
1697222|NCT00463385|4148481|P4|STARTED|Overall Study||22
1697223|NCT00463385|4148482|P3|STARTED|Overall Study||22
1697224|NCT00463385|4148483|P2|STARTED|Overall Study||22
1697225|NCT00463385|4148484|P1|STARTED|Overall Study||22
1697226|NCT00463346|4148536|P2|NOT COMPLETED|Overall Study||3
1697227|NCT00463346|4148537|P1|NOT COMPLETED|Overall Study||3
1697228|NCT00463346|4148536|P2|COMPLETED|Overall Study||8
1697229|NCT00463346|4148537|P1|COMPLETED|Overall Study||9
1697230|NCT00463346|4148536|P2|STARTED|Overall Study||11
1697231|NCT00463346|4148537|P1|STARTED|Overall Study||12
1697232|NCT00463229|4148547|P2|NOT COMPLETED|Overall Study||10
1697233|NCT00463229|4148548|P1|NOT COMPLETED|Overall Study||9
1697234|NCT00463229|4148547|P2|COMPLETED|Overall Study||39
1697235|NCT00463229|4148548|P1|COMPLETED|Overall Study||43
1697236|NCT00463229|4148547|P2|STARTED|Overall Study||49
1697237|NCT00463229|4148548|P1|STARTED|Overall Study||52
1697238|NCT00463060|4148568|P1|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
1697239|NCT00463060|4148568|P1|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
1697240|NCT00463060|4148568|P1|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
1697241|NCT00463060|4148568|P1|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
1697242|NCT00463060|4148568|P1|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
1697243|NCT00463060|4148568|P1|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
1697244|NCT00463060|4148568|P1|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
1697245|NCT00463060|4148568|P1|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
1697246|NCT00463060|4148568|P1|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
1697247|NCT00463060|4148568|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
1697248|NCT00463060|4148568|P1|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
1697249|NCT00463060|4148568|P1|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
1697250|NCT00463060|4148568|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
1697251|NCT00463060|4148568|P1|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
1697252|NCT00463060|4148568|P1|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
1697253|NCT00463047|4148582|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
1697254|NCT00463047|4148583|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
1697255|NCT00463047|4148582|P2|COMPLETED|Double-Blind Treatment Period 2||88
1697256|NCT00463047|4148583|P1|COMPLETED|Double-Blind Treatment Period 2||92
1697257|NCT00463047|4148582|P2|STARTED|Double-Blind Treatment Period 2||90
1697258|NCT00463047|4148583|P1|STARTED|Double-Blind Treatment Period 2||93
1697259|NCT00463047|4148582|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
1697260|NCT00463047|4148583|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
1697261|NCT00463047|4148582|P2|COMPLETED|Double-Blind Treatment Period 1||90
1697262|NCT00463047|4148583|P1|COMPLETED|Double-Blind Treatment Period 1||93
1697263|NCT00463047|4148582|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
1697354|NCT00462722|4148826|P2|STARTED|Overall Study||55
1697355|NCT00462722|4148827|P1|STARTED|Overall Study||50
1697264|NCT00463047|4148583|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
1697265|NCT00463047|4148582|P2|NOT COMPLETED|Titration Period 2||23
1697266|NCT00463047|4148583|P1|NOT COMPLETED|Titration Period 2||30
1697267|NCT00463047|4148582|P2|COMPLETED|Titration Period 2||98
1697268|NCT00463047|4148583|P1|COMPLETED|Titration Period 2||93
1697269|NCT00463047|4148582|P2|STARTED|Titration Period 2||121
1697270|NCT00463047|4148583|P1|STARTED|Titration Period 2||123
1697271|NCT00463047|4148582|P2|NOT COMPLETED|Titration Period 1||39
1697272|NCT00463047|4148583|P1|NOT COMPLETED|Titration Period 1||37
1697273|NCT00463047|4148582|P2|COMPLETED|Titration Period 1||121
1697274|NCT00463047|4148583|P1|COMPLETED|Titration Period 1||123
1697275|NCT00463047|4148582|P2|STARTED|Titration Period 1||160
1697276|NCT00463047|4148583|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
1697277|NCT00462982|4148668|P1|NOT COMPLETED|Overall Study||3
1697278|NCT00462982|4148668|P1|COMPLETED|Overall Study||5
1697279|NCT00462982|4148668|P1|STARTED|Overall Study||8
1697280|NCT00462943|4148675|P3|NOT COMPLETED|Overall Study||23
1697281|NCT00462943|4148676|P2|NOT COMPLETED|Overall Study||30
1697282|NCT00462943|4148677|P1|NOT COMPLETED|Overall Study||45
1697283|NCT00462943|4148675|P3|COMPLETED|Overall Study||0
1697284|NCT00462943|4148676|P2|COMPLETED|Overall Study||1
1697285|NCT00462943|4148677|P1|COMPLETED|Overall Study||1
1697286|NCT00462943|4148675|P3|STARTED|Overall Study||23
1697287|NCT00462943|4148676|P2|STARTED|Overall Study||31
1697288|NCT00462943|4148677|P1|STARTED|Overall Study||46
1697289|NCT00462917|4148748|P4|NOT COMPLETED|Overall Study||11
1697290|NCT00462917|4148749|P3|NOT COMPLETED|Overall Study||12
1697291|NCT00462917|4148750|P2|NOT COMPLETED|Overall Study||10
1697292|NCT00462917|4148751|P1|NOT COMPLETED|Overall Study||10
1697293|NCT00462917|4148748|P4|COMPLETED|Overall Study||66
1697294|NCT00462917|4148749|P3|COMPLETED|Overall Study||54
1697295|NCT00462917|4148750|P2|COMPLETED|Overall Study||65
1697296|NCT00462917|4148751|P1|COMPLETED|Overall Study||62
1697297|NCT00462917|4148748|P4|Completed 6 Month Follow-up|Overall Study||66
1697298|NCT00462917|4148749|P3|Completed 6 Month Follow-up|Overall Study||55
1697299|NCT00462917|4148750|P2|Completed 6 Month Follow-up|Overall Study||68
1697300|NCT00462917|4148751|P1|Completed 6 Month Follow-up|Overall Study||63
1697301|NCT00462917|4148748|P4|Completed 6 Week Follow-up|Overall Study||68
1697302|NCT00462917|4148749|P3|Completed 6 Week Follow-up|Overall Study||55
1697303|NCT00462917|4148750|P2|Completed 6 Week Follow-up|Overall Study||70
1697304|NCT00462917|4148751|P1|Completed 6 Week Follow-up|Overall Study||63
1697305|NCT00462917|4148748|P4|Received Risk Information|Overall Study||68
1697306|NCT00462917|4148749|P3|Received Risk Information|Overall Study||55
1697307|NCT00462917|4148750|P2|Received Risk Information|Overall Study||70
1697308|NCT00462917|4148751|P1|Received Risk Information|Overall Study||64
1697309|NCT00462917|4148748|P4|Met With Genetic Counselor|Overall Study||71
1697310|NCT00462917|4148749|P3|Met With Genetic Counselor|Overall Study||56
1697311|NCT00462917|4148750|P2|Met With Genetic Counselor|Overall Study||71
1697312|NCT00462917|4148751|P1|Met With Genetic Counselor|Overall Study||66
1697313|NCT00462917|4148748|P4|STARTED|Overall Study||77
1697314|NCT00462917|4148749|P3|STARTED|Overall Study||66
1697315|NCT00462917|4148750|P2|STARTED|Overall Study||75
1697316|NCT00462917|4148751|P1|STARTED|Overall Study||72
1697317|NCT00462865|4148769|P1|NOT COMPLETED|Overall Study||1
1697318|NCT00462865|4148769|P1|COMPLETED|Overall Study||17
1697319|NCT00462865|4148769|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
1697320|NCT00462839|4148775|P2|NOT COMPLETED|Viewed Second||0
1697321|NCT00462839|4148776|P1|NOT COMPLETED|Viewed Second||0
1697322|NCT00462839|4148775|P2|COMPLETED|Viewed Second||53
1697323|NCT00462839|4148776|P1|COMPLETED|Viewed Second||53
1697324|NCT00462839|4148775|P2|STARTED|Viewed Second||53
1697325|NCT00462839|4148776|P1|STARTED|Viewed Second||53
1697326|NCT00462839|4148775|P2|NOT COMPLETED|Viewed First||0
1697327|NCT00462839|4148776|P1|NOT COMPLETED|Viewed First||0
1697328|NCT00462839|4148775|P2|COMPLETED|Viewed First||53
1697329|NCT00462839|4148776|P1|COMPLETED|Viewed First||53
1697330|NCT00462839|4148775|P2|STARTED|Viewed First||53
1697331|NCT00462839|4148776|P1|STARTED|Viewed First||53
1697332|NCT00462826|4148788|P1|NOT COMPLETED|Overall Study||5
1697333|NCT00462826|4148788|P1|COMPLETED|Overall Study||44
1697334|NCT00462826|4148788|P1|STARTED|Overall Study||49
1697335|NCT00462748|4148804|P3|NOT COMPLETED|Overall Study||11
1697336|NCT00462748|4148805|P2|NOT COMPLETED|Overall Study||11
1697337|NCT00462748|4148806|P1|NOT COMPLETED|Overall Study||12
1697338|NCT00462748|4148804|P3|COMPLETED|Overall Study||251
1697339|NCT00462748|4148805|P2|COMPLETED|Overall Study||252
1697340|NCT00462748|4148806|P1|COMPLETED|Overall Study||249
1697341|NCT00462748|4148804|P3|STARTED|Overall Study||262
1697342|NCT00462748|4148805|P2|STARTED|Overall Study||263
1697343|NCT00462748|4148806|P1|STARTED|Overall Study||261
1697344|NCT00462735|4148814|P1|NOT COMPLETED|Overall Study||0
1697345|NCT00462735|4148814|P1|COMPLETED|Overall Study||33
1697346|NCT00462735|4148814|P1|STARTED|Overall Study||33
1697347|NCT00462722|4148825|P3|NOT COMPLETED|Overall Study||12
1697348|NCT00462722|4148826|P2|NOT COMPLETED|Overall Study||4
1697349|NCT00462722|4148827|P1|NOT COMPLETED|Overall Study||13
1697350|NCT00462722|4148825|P3|COMPLETED|Overall Study||42
1697351|NCT00462722|4148826|P2|COMPLETED|Overall Study||51
1697352|NCT00462722|4148827|P1|COMPLETED|Overall Study||37
1697353|NCT00462722|4148825|P3|STARTED|Overall Study||54
1697356|NCT00462709|4148859|P1|NOT COMPLETED|Overall Study||67
1697357|NCT00462709|4148859|P1|COMPLETED|Overall Study||79
1697358|NCT00462709|4148859|P1|STARTED|Overall Study||146
1697359|NCT00462670|4148868|P2|NOT COMPLETED|Overall Study||7
1697360|NCT00462670|4148869|P1|NOT COMPLETED|Overall Study||5
1697361|NCT00462670|4148868|P2|COMPLETED|Overall Study||46
1697362|NCT00462670|4148869|P1|COMPLETED|Overall Study||52
1697363|NCT00462670|4148868|P2|STARTED|Overall Study||53
1697364|NCT00462670|4148869|P1|STARTED|Overall Study||57
1697365|NCT00462644|4148879|P2|NOT COMPLETED|Overall Study||0
1697366|NCT00462644|4148880|P1|NOT COMPLETED|Overall Study||0
1697367|NCT00462644|4148879|P2|COMPLETED|Overall Study||12
1697368|NCT00462644|4148880|P1|COMPLETED|Overall Study||18
1697369|NCT00462644|4148879|P2|STARTED|Overall Study||12
1697370|NCT00462644|4148880|P1|STARTED|Overall Study||18
1697371|NCT00462605|4148898|P1|NOT COMPLETED|Overall Study||14
1697372|NCT00462605|4148898|P1|COMPLETED|Overall Study||10
1697373|NCT00462605|4148898|P1|STARTED|Overall Study||24
1697374|NCT00462501|4148906|P1|NOT COMPLETED|Overall Study||5
1697375|NCT00462501|4148906|P1|COMPLETED|Overall Study||30
1697376|NCT00462501|4148906|P1|STARTED|Overall Study||35
1697377|NCT00462462|4148912|P2|NOT COMPLETED|Overall Study||1
1697378|NCT00462462|4148913|P1|NOT COMPLETED|Overall Study||0
1697379|NCT00462462|4148912|P2|COMPLETED|Overall Study||13
1697380|NCT00462462|4148913|P1|COMPLETED|Overall Study||17
1697381|NCT00462462|4148912|P2|STARTED|Overall Study||14
1697382|NCT00462462|4148913|P1|STARTED|Overall Study||17
1697383|NCT00462449|4148923|P2|NOT COMPLETED|Overall Study||0
1697384|NCT00462449|4148924|P1|NOT COMPLETED|Overall Study||0
1697385|NCT00462449|4148923|P2|COMPLETED|Overall Study||10
1697386|NCT00462449|4148924|P1|COMPLETED|Overall Study||13
1697387|NCT00462449|4148923|P2|STARTED|Overall Study||10
1697388|NCT00462449|4148924|P1|STARTED|Overall Study||13
1697389|NCT00462423|4148934|P1|NOT COMPLETED|Overall Study||0
1697390|NCT00462423|4148934|P1|COMPLETED|Overall Study||50
1697391|NCT00462423|4148934|P1|STARTED|Overall Study||50
1697392|NCT00462384|4148941|P1|NOT COMPLETED|Overall Study||9
1697393|NCT00462384|4148941|P1|COMPLETED|Overall Study||30
1697394|NCT00462384|4148941|P1|STARTED|Overall Study||39
1697395|NCT00462345|4148949|P1|NOT COMPLETED|Overall Study||3
1697396|NCT00462345|4148949|P1|COMPLETED|Overall Study||37
1697397|NCT00462345|4148949|P1|Completed First Course|Overall Study||38
1697398|NCT00462345|4148949|P1|STARTED|Overall Study||40
1697399|NCT00462332|4148973|P2|NOT COMPLETED|Overall Study||0
1697400|NCT00462332|4148974|P1|NOT COMPLETED|Overall Study||0
1697401|NCT00462332|4148973|P2|COMPLETED|Overall Study||41
1697402|NCT00462332|4148974|P1|COMPLETED|Overall Study||45
1697403|NCT00462332|4148973|P2|STARTED|Overall Study||41
1697404|NCT00462332|4148974|P1|STARTED|Overall Study||45
1697405|NCT00462306|4148984|P2|NOT COMPLETED|Overall Study||13
1697406|NCT00462306|4148985|P1|NOT COMPLETED|Overall Study||0
1697407|NCT00462306|4148984|P2|COMPLETED|Overall Study||490
1697408|NCT00462306|4148985|P1|COMPLETED|Overall Study||4074
1697409|NCT00462306|4148984|P2|STARTED|Overall Study||503
1697410|NCT00462306|4148985|P1|STARTED|Overall Study||4074
1697411|NCT00462280|4148997|P4|NOT COMPLETED|Overall Study||3
1697412|NCT00462280|4148998|P3|NOT COMPLETED|Overall Study||0
1697413|NCT00462280|4148999|P2|NOT COMPLETED|Overall Study||7
1697414|NCT00462280|4149000|P1|NOT COMPLETED|Overall Study||10
1697415|NCT00462280|4148997|P4|COMPLETED|Overall Study||4
1697416|NCT00462280|4148998|P3|COMPLETED|Overall Study||7
1697417|NCT00462280|4148999|P2|COMPLETED|Overall Study||25
1697418|NCT00462280|4149000|P1|COMPLETED|Overall Study||24
1697419|NCT00462280|4148997|P4|STARTED|Overall Study||7
1697420|NCT00462280|4148998|P3|STARTED|Overall Study||7
1697421|NCT00462280|4148999|P2|STARTED|Overall Study||32
1697422|NCT00462280|4149000|P1|STARTED|Overall Study||34
1697423|NCT00462228|4149060|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
1697424|NCT00462228|4149060|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
1697425|NCT00462228|4149060|P1|STARTED|No Treatment (Washout) 4 Weeks||11
1697426|NCT00462228|4149060|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
1697427|NCT00462228|4149060|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
1697428|NCT00462228|4149060|P1|STARTED|Placebo or Memantine 12 Weeks||11
1697429|NCT00462228|4149060|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
1697430|NCT00462228|4149060|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
1697431|NCT00462228|4149060|P1|STARTED|No Treatment (Washout) 4 Weeks||11
1697432|NCT00462228|4149060|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
1697433|NCT00462228|4149060|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
1697434|NCT00462228|4149060|P1|STARTED|Memantine or Placebo 12 Weeks||11
1697435|NCT00462072|4149084|P3|NOT COMPLETED|Week 10||0
1697436|NCT00462072|4149085|P2|NOT COMPLETED|Week 10||0
1697437|NCT00462072|4149086|P1|NOT COMPLETED|Week 10||0
1697438|NCT00462072|4149084|P3|COMPLETED|Week 10||9
1697439|NCT00462072|4149085|P2|COMPLETED|Week 10||12
1697440|NCT00462072|4149086|P1|COMPLETED|Week 10||10
1697441|NCT00462072|4149084|P3|STARTED|Week 10||9
1697442|NCT00462072|4149085|P2|STARTED|Week 10||12
1697443|NCT00462072|4149086|P1|STARTED|Week 10||10
1697444|NCT00462072|4149084|P3|NOT COMPLETED|Baseline (Week 0)||0
1697445|NCT00462072|4149085|P2|NOT COMPLETED|Baseline (Week 0)||0
1697446|NCT00462072|4149086|P1|NOT COMPLETED|Baseline (Week 0)||0
1697447|NCT00462072|4149084|P3|COMPLETED|Baseline (Week 0)||9
1697448|NCT00462072|4149085|P2|COMPLETED|Baseline (Week 0)||12
1697449|NCT00462072|4149086|P1|COMPLETED|Baseline (Week 0)||10
1697450|NCT00462072|4149084|P3|STARTED|Baseline (Week 0)||9
1697451|NCT00462072|4149085|P2|STARTED|Baseline (Week 0)||12
1697452|NCT00462072|4149086|P1|STARTED|Baseline (Week 0)||10
1697453|NCT00462020|4149102|P2|NOT COMPLETED|Overall Study||0
1697454|NCT00462020|4149103|P1|NOT COMPLETED|Overall Study||0
1697455|NCT00462020|4149102|P2|COMPLETED|Overall Study||50
1697456|NCT00462020|4149103|P1|COMPLETED|Overall Study||52
1697457|NCT00462020|4149102|P2|STARTED|Overall Study||50
1697458|NCT00462020|4149103|P1|STARTED|Overall Study||52
1697459|NCT00461981|4149111|P2|NOT COMPLETED|Overall Study||9
1697460|NCT00461981|4149112|P1|NOT COMPLETED|Overall Study||11
1697461|NCT00461981|4149111|P2|COMPLETED|Overall Study||42
1697462|NCT00461981|4149112|P1|COMPLETED|Overall Study||39
1697463|NCT00461981|4149111|P2|STARTED|Overall Study||51
1697464|NCT00461981|4149112|P1|STARTED|Overall Study||50
1697465|NCT00461851|4149222|P1|NOT COMPLETED|Overall Study||0
1697466|NCT00461851|4149222|P1|COMPLETED|Overall Study||17
1697467|NCT00461851|4149222|P1|STARTED|Overall Study||17
1697468|NCT00461812|4149228|P1|NOT COMPLETED|Overall Study||10
1697469|NCT00461812|4149228|P1|COMPLETED|Overall Study||0
1697470|NCT00461812|4149228|P1|STARTED|Overall Study||10
1697471|NCT00461786|4149233|P1|NOT COMPLETED|Overall Study||3
1697472|NCT00461786|4149233|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
1697473|NCT00461786|4149233|P1|STARTED|Overall Study||51
1697474|NCT00461734|4149243|P2|NOT COMPLETED|Overall Study||60
1697475|NCT00461734|4149244|P1|NOT COMPLETED|Overall Study||58
1697476|NCT00461734|4149243|P2|COMPLETED|Overall Study||60
1697477|NCT00461734|4149244|P1|COMPLETED|Overall Study||62
1697478|NCT00461734|4149243|P2|STARTED|Overall Study||120
1697479|NCT00461734|4149244|P1|STARTED|Overall Study||120
1697480|NCT00461708|4149278|P2|NOT COMPLETED|Overall Study||38
1697481|NCT00461708|4149279|P1|NOT COMPLETED|Overall Study||115
1697482|NCT00461708|4149278|P2|COMPLETED|Overall Study||0
1697483|NCT00461708|4149279|P1|COMPLETED|Overall Study||0
1697484|NCT00461708|4149278|P2|STARTED|Overall Study||38
1697485|NCT00461708|4149279|P1|STARTED|Overall Study||115
1697486|NCT00461682|4149305|P1|NOT COMPLETED|Overall Study||1
1697487|NCT00461682|4149305|P1|COMPLETED|Overall Study||0
1697488|NCT00461682|4149305|P1|STARTED|Overall Study||1
1697489|NCT00461630|4149333|P2|NOT COMPLETED|Overall Study||827
1697490|NCT00461630|4149334|P1|NOT COMPLETED|Overall Study||906
1697491|NCT00461630|4149333|P2|COMPLETED|Overall Study||12008
1697492|NCT00461630|4149334|P1|COMPLETED|Overall Study||11932
1697493|NCT00461630|4149333|P2|STARTED|Overall Study||12835
1697494|NCT00461630|4149334|P1|STARTED|Overall Study||12838
1697495|NCT00461591|4149350|P2|NOT COMPLETED|Overall Study||85
1697496|NCT00461591|4149351|P1|NOT COMPLETED|Overall Study||89
1697497|NCT00461591|4149350|P2|COMPLETED|Overall Study||311
1697498|NCT00461591|4149351|P1|COMPLETED|Overall Study||317
1697499|NCT00461591|4149350|P2|STARTED|Overall Study||396
1697500|NCT00461591|4149351|P1|STARTED|Overall Study||406
1697501|NCT00461513|4149373|P2|NOT COMPLETED|Overall Study||25
1697502|NCT00461513|4149374|P1|NOT COMPLETED|Overall Study||22
1697503|NCT00461513|4149373|P2|COMPLETED|Overall Study||172
1697504|NCT00461513|4149374|P1|COMPLETED|Overall Study||165
1697505|NCT00461513|4149373|P2|STARTED|Overall Study|2 patients dropped at time of randomization|197
1697506|NCT00461513|4149374|P1|STARTED|Overall Study|6 patients dropped at time of randomization|187
1697507|NCT00461500|4149386|P2|NOT COMPLETED|Overall Study||6
1697508|NCT00461500|4149387|P1|NOT COMPLETED|Overall Study||7
1697509|NCT00461500|4149386|P2|COMPLETED|Overall Study||38
1697510|NCT00461500|4149387|P1|COMPLETED|Overall Study||30
1697511|NCT00461500|4149386|P2|STARTED|Overall Study||44
1697512|NCT00461500|4149387|P1|STARTED|Overall Study||37
1697513|NCT00461331|4149417|P2|NOT COMPLETED|Intervention 2||0
1697514|NCT00461331|4149418|P1|NOT COMPLETED|Intervention 2||0
1697515|NCT00461331|4149417|P2|COMPLETED|Intervention 2||10
1697516|NCT00461331|4149418|P1|COMPLETED|Intervention 2||10
1697517|NCT00461331|4149417|P2|STARTED|Intervention 2||10
1697518|NCT00461331|4149418|P1|STARTED|Intervention 2||10
1697519|NCT00461331|4149417|P2|NOT COMPLETED|Washout||0
1697520|NCT00461331|4149418|P1|NOT COMPLETED|Washout||0
1697521|NCT00461331|4149417|P2|COMPLETED|Washout||10
1697522|NCT00461331|4149418|P1|COMPLETED|Washout||10
1697523|NCT00461331|4149417|P2|STARTED|Washout||10
1697524|NCT00461331|4149418|P1|STARTED|Washout||10
1697525|NCT00461331|4149417|P2|NOT COMPLETED|Intervention 1||0
1697526|NCT00461331|4149418|P1|NOT COMPLETED|Intervention 1||0
1697527|NCT00461331|4149417|P2|COMPLETED|Intervention 1||10
1697528|NCT00461331|4149418|P1|COMPLETED|Intervention 1||10
1697529|NCT00461331|4149417|P2|STARTED|Intervention 1||10
1697530|NCT00461331|4149418|P1|STARTED|Intervention 1||10
1697531|NCT00461305|4149430|P2|NOT COMPLETED|Continued Treatment||0
1697532|NCT00461305|4149431|P1|NOT COMPLETED|Continued Treatment||95
1697533|NCT00461305|4149430|P2|COMPLETED|Continued Treatment||0
1697534|NCT00461305|4149431|P1|COMPLETED|Continued Treatment||254
1697535|NCT00461305|4149430|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
1697536|NCT00461305|4149431|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
1697537|NCT00461305|4149430|P2|NOT COMPLETED|Treatment||9
1697538|NCT00461305|4149431|P1|NOT COMPLETED|Treatment||101
1697539|NCT00461305|4149430|P2|COMPLETED|Treatment||56
1697540|NCT00461305|4149431|P1|COMPLETED|Treatment||254
1697541|NCT00461305|4149430|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
1697542|NCT00461305|4149431|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
1697543|NCT00461305|4149430|P2|Subjects Dispensed Drugs|Treatment||65
1697544|NCT00461305|4149431|P1|Subjects Dispensed Drugs|Treatment||350
1697545|NCT00461305|4149430|P2|STARTED|Treatment|Enrolled|65
1697546|NCT00461305|4149431|P1|STARTED|Treatment|Enrolled|355
1697547|NCT00461292|4149494|P3|NOT COMPLETED|Treatment Cycle 2||0
1697548|NCT00461292|4149495|P2|NOT COMPLETED|Treatment Cycle 2||2
1697549|NCT00461292|4149496|P1|NOT COMPLETED|Treatment Cycle 2||5
1697550|NCT00461292|4149494|P3|COMPLETED|Treatment Cycle 2||0
1697551|NCT00461292|4149495|P2|COMPLETED|Treatment Cycle 2||72
1697552|NCT00461292|4149496|P1|COMPLETED|Treatment Cycle 2||58
1697553|NCT00461292|4149494|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
1697554|NCT00461292|4149495|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
1697555|NCT00461292|4149496|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
1697556|NCT00461292|4149494|P3|NOT COMPLETED|Treatment Cycle 1||11
1697557|NCT00461292|4149495|P2|NOT COMPLETED|Treatment Cycle 1||12
1697558|NCT00461292|4149496|P1|NOT COMPLETED|Treatment Cycle 1||15
1697559|NCT00461292|4149494|P3|COMPLETED|Treatment Cycle 1||81
1697560|NCT00461292|4149495|P2|COMPLETED|Treatment Cycle 1||80
1697561|NCT00461292|4149496|P1|COMPLETED|Treatment Cycle 1||76
1697562|NCT00461292|4149494|P3|STARTED|Treatment Cycle 1||92
1697563|NCT00461292|4149495|P2|STARTED|Treatment Cycle 1||92
1697564|NCT00461292|4149496|P1|STARTED|Treatment Cycle 1||91
1697565|NCT00461253|4149515|P2|NOT COMPLETED|Overall Study||19798
1697566|NCT00461253|4149516|P1|NOT COMPLETED|Overall Study||4980
1697567|NCT00461253|4149515|P2|COMPLETED|Overall Study|Analyzed controls|20452
1697568|NCT00461253|4149516|P1|COMPLETED|Overall Study|Analyzed cases|5113
1697569|NCT00461253|4149515|P2|STARTED|Overall Study|Identified controls|40250
1697570|NCT00461253|4149516|P1|STARTED|Overall Study|Identified cases|10093
1697571|NCT00461175|4149524|P2|NOT COMPLETED|Overall Study||365
1697572|NCT00461175|4149525|P1|NOT COMPLETED|Overall Study||522
1697573|NCT00461175|4149524|P2|COMPLETED|Overall Study||18370
1697574|NCT00461175|4149525|P1|COMPLETED|Overall Study||43078
1697575|NCT00461175|4149524|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
1697576|NCT00461175|4149525|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
1697577|NCT00461123|4149535|P2|NOT COMPLETED|Overall Study||6
1697578|NCT00461123|4149536|P1|NOT COMPLETED|Overall Study||6
1697579|NCT00461123|4149535|P2|COMPLETED|Overall Study||19
1697580|NCT00461123|4149536|P1|COMPLETED|Overall Study||19
1697581|NCT00461123|4149535|P2|STARTED|Overall Study||25
1697582|NCT00461123|4149536|P1|STARTED|Overall Study||25
1697583|NCT00461097|4149552|P2|NOT COMPLETED|Overall Study||0
1697584|NCT00461097|4149553|P1|NOT COMPLETED|Overall Study||0
1697585|NCT00461097|4149552|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
1697586|NCT00461097|4149553|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
1697587|NCT00461097|4149552|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
1697588|NCT00461097|4149553|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
1697589|NCT00461097|4149552|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
1697590|NCT00461097|4149553|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
1697591|NCT00461097|4149552|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
1697592|NCT00461097|4149553|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
1697593|NCT00461097|4149552|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
1697594|NCT00461097|4149553|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
1697595|NCT00461097|4149552|P2|STARTED|Overall Study||15
1697596|NCT00461097|4149553|P1|STARTED|Overall Study||40
1697597|NCT00461045|4149569|P1|NOT COMPLETED|Overall Study||0
1697598|NCT00461045|4149569|P1|COMPLETED|Overall Study||15
1697599|NCT00461045|4149569|P1|STARTED|Overall Study||15
1697600|NCT00461032|4149581|P2|NOT COMPLETED|Overall Study||44
1697601|NCT00461032|4149582|P1|NOT COMPLETED|Overall Study||37
1697602|NCT00461032|4149581|P2|COMPLETED|Overall Study||536
1697603|NCT00461032|4149582|P1|COMPLETED|Overall Study||545
1697604|NCT00461032|4149581|P2|STARTED|Overall Study||580
1697605|NCT00461032|4149582|P1|STARTED|Overall Study||582
1697606|NCT00460993|4149596|P2|NOT COMPLETED|Phase 2 (6 Days)||0
1697607|NCT00460993|4149597|P1|NOT COMPLETED|Phase 2 (6 Days)||0
1697608|NCT00460993|4149596|P2|COMPLETED|Phase 2 (6 Days)||17
1697609|NCT00460993|4149597|P1|COMPLETED|Phase 2 (6 Days)||14
1697610|NCT00460993|4149596|P2|STARTED|Phase 2 (6 Days)||17
1697611|NCT00460993|4149597|P1|STARTED|Phase 2 (6 Days)||14
1697612|NCT00460993|4149596|P2|NOT COMPLETED|Phase 1 (6 Days)||0
1697613|NCT00460993|4149597|P1|NOT COMPLETED|Phase 1 (6 Days)||0
1697614|NCT00460993|4149596|P2|COMPLETED|Phase 1 (6 Days)||17
1697615|NCT00460993|4149597|P1|COMPLETED|Phase 1 (6 Days)||14
1697616|NCT00460993|4149596|P2|STARTED|Phase 1 (6 Days)||17
1697617|NCT00460993|4149597|P1|STARTED|Phase 1 (6 Days)||14
1697618|NCT00460811|4149608|P5|NOT COMPLETED|Overall Study||20
1697619|NCT00460811|4149609|P4|NOT COMPLETED|Overall Study||18
1697620|NCT00460811|4149610|P3|NOT COMPLETED|Overall Study||14
1697621|NCT00460811|4149611|P2|NOT COMPLETED|Overall Study||15
1697622|NCT00460811|4149612|P1|NOT COMPLETED|Overall Study||16
1697623|NCT00460811|4149608|P5|COMPLETED|Overall Study||65
1697624|NCT00460811|4149609|P4|COMPLETED|Overall Study||71
1697625|NCT00460811|4149610|P3|COMPLETED|Overall Study||71
1697626|NCT00460811|4149611|P2|COMPLETED|Overall Study||67
1697627|NCT00460811|4149612|P1|COMPLETED|Overall Study||63
1697628|NCT00460811|4149608|P5|STARTED|Overall Study||85
1697629|NCT00460811|4149609|P4|STARTED|Overall Study||89
1697630|NCT00460811|4149610|P3|STARTED|Overall Study||85
1697631|NCT00460811|4149611|P2|STARTED|Overall Study||82
1697632|NCT00460811|4149612|P1|STARTED|Overall Study||79
1697633|NCT00460798|4149654|P1|NOT COMPLETED|Overall Study||340
1697634|NCT00460798|4149654|P1|COMPLETED|Overall Study||108
1697635|NCT00460798|4149654|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
1697636|NCT00460798|4149654|P1|STARTED|Overall Study||448
1697637|NCT00460746|4149662|P1|NOT COMPLETED|Overall Study||2
1697638|NCT00460746|4149662|P1|COMPLETED|Overall Study||8
1697639|NCT00460746|4149662|P1|STARTED|Overall Study||10
1697640|NCT00460655|4149677|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
1697641|NCT00460655|4149678|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
1697642|NCT00460655|4149679|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1697643|NCT00460655|4149680|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1697644|NCT00460655|4149677|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
1697645|NCT00460655|4149678|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
1697646|NCT00460655|4149679|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
1697647|NCT00460655|4149680|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
1697648|NCT00460655|4149677|P4|STARTED|Open-Label Phase (36 Weeks)||61
1697649|NCT00460655|4149678|P3|STARTED|Open-Label Phase (36 Weeks)||52
1697650|NCT00460655|4149679|P2|STARTED|Open-Label Phase (36 Weeks)||0
1697651|NCT00460655|4149680|P1|STARTED|Open-Label Phase (36 Weeks)||0
1697652|NCT00460655|4149677|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1697653|NCT00460655|4149678|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1697654|NCT00460655|4149679|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
1697655|NCT00460655|4149680|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
1697656|NCT00460655|4149677|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
1697657|NCT00460655|4149678|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
1697658|NCT00460655|4149679|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
1697659|NCT00460655|4149680|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
1697660|NCT00460655|4149677|P4|STARTED|Double-Blind Phase (12 Weeks)||0
1697661|NCT00460655|4149678|P3|STARTED|Double-Blind Phase (12 Weeks)||0
1697662|NCT00460655|4149679|P2|STARTED|Double-Blind Phase (12 Weeks)||62
1697663|NCT00460655|4149680|P1|STARTED|Double-Blind Phase (12 Weeks)||58
1697664|NCT00460603|4149724|P12|NOT COMPLETED|Phase 2||41
1697665|NCT00460603|4149725|P11|NOT COMPLETED|Phase 2||43
1697666|NCT00460603|4149726|P10|NOT COMPLETED|Phase 2||42
1697667|NCT00460603|4149727|P9|NOT COMPLETED|Phase 2||0
1697668|NCT00460603|4149728|P8|NOT COMPLETED|Phase 2||0
1697669|NCT00460603|4149729|P7|NOT COMPLETED|Phase 2||0
1697670|NCT00460603|4149730|P6|NOT COMPLETED|Phase 2||0
1697671|NCT00460603|4149731|P5|NOT COMPLETED|Phase 2||0
1697672|NCT00460603|4149732|P4|NOT COMPLETED|Phase 2||0
1697673|NCT00460603|4149733|P3|NOT COMPLETED|Phase 2||0
1697674|NCT00460603|4149734|P2|NOT COMPLETED|Phase 2||0
1697675|NCT00460603|4149735|P1|NOT COMPLETED|Phase 2||0
1697676|NCT00460603|4149724|P12|COMPLETED|Phase 2||0
1697677|NCT00460603|4149725|P11|COMPLETED|Phase 2||0
1697678|NCT00460603|4149726|P10|COMPLETED|Phase 2||0
1697679|NCT00460603|4149727|P9|COMPLETED|Phase 2||0
1697680|NCT00460603|4149728|P8|COMPLETED|Phase 2||0
1697681|NCT00460603|4149729|P7|COMPLETED|Phase 2||0
1697682|NCT00460603|4149730|P6|COMPLETED|Phase 2||0
1697683|NCT00460603|4149731|P5|COMPLETED|Phase 2||0
1697684|NCT00460603|4149732|P4|COMPLETED|Phase 2||0
1697685|NCT00460603|4149733|P3|COMPLETED|Phase 2||0
1697686|NCT00460603|4149734|P2|COMPLETED|Phase 2||0
1697687|NCT00460603|4149735|P1|COMPLETED|Phase 2||0
1697688|NCT00460603|4149724|P12|Treated|Phase 2||41
1697689|NCT00460603|4149725|P11|Treated|Phase 2||43
1697690|NCT00460603|4149726|P10|Treated|Phase 2||39
1697691|NCT00460603|4149727|P9|Treated|Phase 2||0
1697692|NCT00460603|4149728|P8|Treated|Phase 2||0
1697693|NCT00460603|4149729|P7|Treated|Phase 2||0
1697694|NCT00460603|4149730|P6|Treated|Phase 2||0
1697695|NCT00460603|4149731|P5|Treated|Phase 2||0
1697696|NCT00460603|4149732|P4|Treated|Phase 2||0
1697697|NCT00460603|4149733|P3|Treated|Phase 2||0
1697698|NCT00460603|4149734|P2|Treated|Phase 2||0
1697699|NCT00460603|4149735|P1|Treated|Phase 2||0
1697700|NCT00460603|4149724|P12|STARTED|Phase 2||41
1697701|NCT00460603|4149725|P11|STARTED|Phase 2||43
1697702|NCT00460603|4149726|P10|STARTED|Phase 2||42
1697703|NCT00460603|4149727|P9|STARTED|Phase 2||0
1697704|NCT00460603|4149728|P8|STARTED|Phase 2||0
1697705|NCT00460603|4149729|P7|STARTED|Phase 2||0
1697706|NCT00460603|4149730|P6|STARTED|Phase 2||0
1697707|NCT00460603|4149731|P5|STARTED|Phase 2||0
1697708|NCT00460603|4149732|P4|STARTED|Phase 2||0
1697709|NCT00460603|4149733|P3|STARTED|Phase 2||0
1697710|NCT00460603|4149734|P2|STARTED|Phase 2||0
1697711|NCT00460603|4149735|P1|STARTED|Phase 2||0
1697712|NCT00460603|4149724|P12|NOT COMPLETED|Phase 1||0
1697713|NCT00460603|4149725|P11|NOT COMPLETED|Phase 1||0
1697714|NCT00460603|4149726|P10|NOT COMPLETED|Phase 1||0
1697715|NCT00460603|4149727|P9|NOT COMPLETED|Phase 1||18
1697716|NCT00460603|4149728|P8|NOT COMPLETED|Phase 1||3
1697717|NCT00460603|4149729|P7|NOT COMPLETED|Phase 1||6
1697718|NCT00460603|4149730|P6|NOT COMPLETED|Phase 1||4
1697719|NCT00460603|4149731|P5|NOT COMPLETED|Phase 1||6
1697720|NCT00460603|4149732|P4|NOT COMPLETED|Phase 1||8
1697721|NCT00460603|4149733|P3|NOT COMPLETED|Phase 1||4
1697722|NCT00460603|4149734|P2|NOT COMPLETED|Phase 1||6
1697723|NCT00460603|4149735|P1|NOT COMPLETED|Phase 1||6
1697724|NCT00460603|4149724|P12|COMPLETED|Phase 1||0
1697725|NCT00460603|4149725|P11|COMPLETED|Phase 1||0
1697726|NCT00460603|4149726|P10|COMPLETED|Phase 1||0
1697727|NCT00460603|4149727|P9|COMPLETED|Phase 1||0
1697728|NCT00460603|4149728|P8|COMPLETED|Phase 1||0
1697729|NCT00460603|4149729|P7|COMPLETED|Phase 1||0
1697730|NCT00460603|4149730|P6|COMPLETED|Phase 1||0
1697731|NCT00460603|4149731|P5|COMPLETED|Phase 1||0
1697732|NCT00460603|4149732|P4|COMPLETED|Phase 1||0
1697733|NCT00460603|4149733|P3|COMPLETED|Phase 1||0
1697734|NCT00460603|4149734|P2|COMPLETED|Phase 1||0
1697735|NCT00460603|4149735|P1|COMPLETED|Phase 1||0
1697736|NCT00460603|4149724|P12|STARTED|Phase 1||0
1697737|NCT00460603|4149725|P11|STARTED|Phase 1||0
1697738|NCT00460603|4149726|P10|STARTED|Phase 1||0
1697739|NCT00460603|4149727|P9|STARTED|Phase 1||18
1697740|NCT00460603|4149728|P8|STARTED|Phase 1||3
1697741|NCT00460603|4149729|P7|STARTED|Phase 1||6
1697742|NCT00460603|4149730|P6|STARTED|Phase 1||4
1697743|NCT00460603|4149731|P5|STARTED|Phase 1||6
1697744|NCT00460603|4149732|P4|STARTED|Phase 1||8
1697745|NCT00460603|4149733|P3|STARTED|Phase 1||4
1697746|NCT00460603|4149734|P2|STARTED|Phase 1||6
1697747|NCT00460603|4149735|P1|STARTED|Phase 1||6
1697748|NCT00460577|4149829|P2|NOT COMPLETED|Overall Study||6
1697749|NCT00460577|4149830|P1|NOT COMPLETED|Overall Study||2
1697750|NCT00460577|4149829|P2|COMPLETED|Overall Study||24
1697751|NCT00460577|4149830|P1|COMPLETED|Overall Study||28
1697752|NCT00460577|4149829|P2|STARTED|Overall Study||30
1697753|NCT00460577|4149830|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
1697754|NCT00460564|4149848|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1697755|NCT00460564|4149849|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
1697756|NCT00460564|4149850|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
1697757|NCT00460564|4149851|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
1697758|NCT00460564|4149852|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1697759|NCT00460564|4149853|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1697760|NCT00460564|4149854|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1697761|NCT00460564|4149855|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
1697762|NCT00460564|4149848|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
1697763|NCT00460564|4149849|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
1697764|NCT00460564|4149850|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
1697765|NCT00460564|4149851|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
1697766|NCT00460564|4149852|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
1697767|NCT00460564|4149853|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
1697768|NCT00460564|4149854|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
1697769|NCT00460564|4149855|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
1697770|NCT00460564|4149848|P8|STARTED|Open-Label Phase (36 Weeks)||11
1697771|NCT00460564|4149849|P7|STARTED|Open-Label Phase (36 Weeks)||21
1697772|NCT00460564|4149850|P6|STARTED|Open-Label Phase (36 Weeks)||25
1697773|NCT00460564|4149851|P5|STARTED|Open-Label Phase (36 Weeks)||47
1697774|NCT00460564|4149852|P4|STARTED|Open-Label Phase (36 Weeks)||0
1697775|NCT00460564|4149853|P3|STARTED|Open-Label Phase (36 Weeks)||0
1697776|NCT00460564|4149854|P2|STARTED|Open-Label Phase (36 Weeks)||0
1697777|NCT00460564|4149855|P1|STARTED|Open-Label Phase (36 Weeks)||0
1697778|NCT00460564|4149848|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1697779|NCT00460564|4149849|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1697780|NCT00460564|4149850|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1697781|NCT00460564|4149851|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1697782|NCT00460564|4149852|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1697783|NCT00460564|4149853|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
1697784|NCT00460564|4149854|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
1697785|NCT00460564|4149855|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
1697786|NCT00460564|4149848|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
1697787|NCT00460564|4149849|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
1697788|NCT00460564|4149850|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
1697789|NCT00460564|4149851|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
1697790|NCT00460564|4149852|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
1697791|NCT00460564|4149853|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
1697792|NCT00460564|4149854|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
1697793|NCT00460564|4149855|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
1697794|NCT00460564|4149848|P8|STARTED|Double-Blind Phase (12 Weeks)||0
1697795|NCT00460564|4149849|P7|STARTED|Double-Blind Phase (12 Weeks)||0
1697796|NCT00460564|4149850|P6|STARTED|Double-Blind Phase (12 Weeks)||0
1697797|NCT00460564|4149851|P5|STARTED|Double-Blind Phase (12 Weeks)||0
1697798|NCT00460564|4149852|P4|STARTED|Double-Blind Phase (12 Weeks)||11
1697799|NCT00460564|4149853|P3|STARTED|Double-Blind Phase (12 Weeks)||21
1697800|NCT00460564|4149854|P2|STARTED|Double-Blind Phase (12 Weeks)||26
1697801|NCT00460564|4149855|P1|STARTED|Double-Blind Phase (12 Weeks)||51
1697802|NCT00460551|4149949|P1|NOT COMPLETED|Overall Study||0
1697803|NCT00460551|4149949|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
1697804|NCT00460551|4149949|P1|STARTED|Overall Study||13
1697805|NCT00460525|4149956|P2|NOT COMPLETED|Overall Study||5
1697806|NCT00460525|4149957|P1|NOT COMPLETED|Overall Study||11
1697807|NCT00460525|4149956|P2|COMPLETED|Overall Study||194
1697808|NCT00460525|4149957|P1|COMPLETED|Overall Study||190
1697809|NCT00460525|4149956|P2|STARTED|Overall Study||199
1697810|NCT00460525|4149957|P1|STARTED|Overall Study||201
1697811|NCT00460434|4149999|P2|NOT COMPLETED|Overall Study||7
1697812|NCT00460434|4150000|P1|NOT COMPLETED|Overall Study||3
1697813|NCT00460434|4149999|P2|COMPLETED|Overall Study||165
1697814|NCT00460434|4150000|P1|COMPLETED|Overall Study||162
1697815|NCT00460434|4149999|P2|12 Months|Overall Study||165
1697816|NCT00460434|4150000|P1|12 Months|Overall Study||162
1697817|NCT00460434|4149999|P2|3 Months|Overall Study||171
1697818|NCT00460434|4150000|P1|3 Months|Overall Study||163
1697819|NCT00460434|4149999|P2|STARTED|Overall Study||172
1697820|NCT00460434|4150000|P1|STARTED|Overall Study||165
1697821|NCT00460421|4150029|P3|NOT COMPLETED|Overall Study||0
1697822|NCT00460421|4150030|P2|NOT COMPLETED|Overall Study||0
1697823|NCT00460421|4150031|P1|NOT COMPLETED|Overall Study||0
1697824|NCT00460421|4150029|P3|COMPLETED|Overall Study||9
1697825|NCT00460421|4150030|P2|COMPLETED|Overall Study||9
1697826|NCT00460421|4150031|P1|COMPLETED|Overall Study||9
1697827|NCT00460421|4150029|P3|STARTED|Overall Study||9
1697828|NCT00460421|4150030|P2|STARTED|Overall Study||9
1697829|NCT00460421|4150031|P1|STARTED|Overall Study||9
1697830|NCT00460408|4150079|P4|NOT COMPLETED|Overall Study||0
1697831|NCT00460408|4150080|P3|NOT COMPLETED|Overall Study||6
1697832|NCT00460408|4150081|P2|NOT COMPLETED|Overall Study||3
1697833|NCT00460408|4150082|P1|NOT COMPLETED|Overall Study||67
1697834|NCT00460408|4150079|P4|COMPLETED|Overall Study||7
1697835|NCT00460408|4150080|P3|COMPLETED|Overall Study||69
1697836|NCT00460408|4150081|P2|COMPLETED|Overall Study||13
1697837|NCT00460408|4150082|P1|COMPLETED|Overall Study||336
1697838|NCT00460408|4150079|P4|STARTED|Overall Study||7
1697839|NCT00460408|4150080|P3|STARTED|Overall Study||75
1697840|NCT00460408|4150081|P2|STARTED|Overall Study||16
1697841|NCT00460408|4150082|P1|STARTED|Overall Study||403
1697842|NCT00460265|4150119|P2|NOT COMPLETED|Overall Study||89
1697843|NCT00460265|4150120|P1|NOT COMPLETED|Overall Study||85
1697844|NCT00460265|4150119|P2|COMPLETED|Overall Study|Completed study=death|241
1697845|NCT00460265|4150120|P1|COMPLETED|Overall Study|Completed study=death|243
1697846|NCT00460265|4150119|P2|Received Study Medication|Overall Study||325
1697847|NCT00460265|4150120|P1|Received Study Medication|Overall Study||325
1697848|NCT00460265|4150119|P2|Randomized While Alive|Overall Study||330
1697849|NCT00460265|4150120|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
1697850|NCT00460265|4150119|P2|STARTED|Overall Study||330
1697851|NCT00460265|4150120|P1|STARTED|Overall Study||328
1697852|NCT00460239|4150136|P9|NOT COMPLETED|Overall Study||0
1697853|NCT00460239|4150137|P8|NOT COMPLETED|Overall Study||0
1697854|NCT00460239|4150138|P7|NOT COMPLETED|Overall Study||0
1697855|NCT00460239|4150139|P6|NOT COMPLETED|Overall Study||3
1697856|NCT00460239|4150140|P5|NOT COMPLETED|Overall Study||0
1697857|NCT00460239|4150141|P4|NOT COMPLETED|Overall Study||0
1697858|NCT00460239|4150142|P3|NOT COMPLETED|Overall Study||0
1697859|NCT00460239|4150143|P2|NOT COMPLETED|Overall Study||1
1697860|NCT00460239|4150144|P1|NOT COMPLETED|Overall Study||0
1697861|NCT00460239|4150136|P9|COMPLETED|Overall Study||1
1697862|NCT00460239|4150137|P8|COMPLETED|Overall Study||1
1697863|NCT00460239|4150138|P7|COMPLETED|Overall Study||1
1697864|NCT00460239|4150139|P6|COMPLETED|Overall Study||1
1697865|NCT00460239|4150140|P5|COMPLETED|Overall Study||1
1697866|NCT00460239|4150141|P4|COMPLETED|Overall Study||0
1697867|NCT00460239|4150142|P3|COMPLETED|Overall Study||1
1697868|NCT00460239|4150143|P2|COMPLETED|Overall Study||2
1697869|NCT00460239|4150144|P1|COMPLETED|Overall Study||0
1697870|NCT00460239|4150136|P9|STARTED|Overall Study||1
1697871|NCT00460239|4150137|P8|STARTED|Overall Study||1
1697872|NCT00460239|4150138|P7|STARTED|Overall Study||1
1697873|NCT00460239|4150139|P6|STARTED|Overall Study||4
1697874|NCT00460239|4150140|P5|STARTED|Overall Study||1
1697875|NCT00460239|4150141|P4|STARTED|Overall Study||0
1697876|NCT00460239|4150142|P3|STARTED|Overall Study||1
1697877|NCT00460239|4150143|P2|STARTED|Overall Study||3
1697878|NCT00460239|4150144|P1|STARTED|Overall Study||0
1697879|NCT00460109|4150213|P1|NOT COMPLETED|Overall Study||1
1697880|NCT00460109|4150213|P1|COMPLETED|Overall Study||23
1697881|NCT00460109|4150213|P1|STARTED|Overall Study||24
1697882|NCT00460031|4150221|P1|NOT COMPLETED|Overall Study||11
1697883|NCT00460031|4150221|P1|COMPLETED|Overall Study||23
1697884|NCT00460031|4150221|P1|STARTED|Overall Study||34
1697885|NCT00459979|4150229|P1|NOT COMPLETED|Overall Study||2
1697886|NCT00459979|4150229|P1|COMPLETED|Overall Study||28
1697887|NCT00459979|4150229|P1|STARTED|Overall Study||30
1697888|NCT00459953|4150241|P2|NOT COMPLETED|Overall Study||1
1697889|NCT00459953|4150242|P1|NOT COMPLETED|Overall Study||1
1697890|NCT00459953|4150241|P2|COMPLETED|Overall Study||70
1697891|NCT00459953|4150242|P1|COMPLETED|Overall Study||71
1697892|NCT00459953|4150241|P2|STARTED|Overall Study||71
1697893|NCT00459953|4150242|P1|STARTED|Overall Study||72
1697894|NCT00459875|4150248|P1|NOT COMPLETED|Overall Study||3
1697895|NCT00459875|4150248|P1|COMPLETED|Overall Study||21
1697896|NCT00459875|4150248|P1|STARTED|Overall Study||24
1697897|NCT00459862|4150252|P1|NOT COMPLETED|Overall Study||0
1697898|NCT00459862|4150252|P1|COMPLETED|Overall Study||34
1697899|NCT00459862|4150252|P1|STARTED|Overall Study||34
1697900|NCT00459810|4150261|P1|NOT COMPLETED|Overall Study||0
1697901|NCT00459810|4150261|P1|COMPLETED|Overall Study||21
1697902|NCT00459810|4150261|P1|STARTED|Overall Study||21
1697903|NCT00459732|4150271|P2|NOT COMPLETED|Overall Study||3
1697904|NCT00459732|4150272|P1|NOT COMPLETED|Overall Study||4
1697990|NCT00459186|4150592|P1|STARTED|Single Agent RAD001||19
1697905|NCT00459732|4150271|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
1697906|NCT00459732|4150272|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
1697907|NCT00459732|4150271|P2|STARTED|Overall Study||17
1697908|NCT00459732|4150272|P1|STARTED|Overall Study||23
1697909|NCT00459706|4150284|P2|NOT COMPLETED|Overall Study||21
1697910|NCT00459706|4150285|P1|NOT COMPLETED|Overall Study||26
1697911|NCT00459706|4150284|P2|COMPLETED|Overall Study||294
1697912|NCT00459706|4150285|P1|COMPLETED|Overall Study||299
1697913|NCT00459706|4150284|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
1697914|NCT00459706|4150285|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
1697915|NCT00459706|4150284|P2|STARTED|Overall Study||315
1697916|NCT00459706|4150285|P1|STARTED|Overall Study||325
1697917|NCT00459667|4150428|P3|NOT COMPLETED|Overall Study||20
1697918|NCT00459667|4150429|P2|NOT COMPLETED|Overall Study||47
1697919|NCT00459667|4150430|P1|NOT COMPLETED|Overall Study||38
1697920|NCT00459667|4150428|P3|COMPLETED|Overall Study||161
1697921|NCT00459667|4150429|P2|COMPLETED|Overall Study||600
1697922|NCT00459667|4150430|P1|COMPLETED|Overall Study||554
1697923|NCT00459667|4150428|P3|Started Treatment|Overall Study||180
1697924|NCT00459667|4150429|P2|Started Treatment|Overall Study||644
1697925|NCT00459667|4150430|P1|Started Treatment|Overall Study||586
1697926|NCT00459667|4150428|P3|Study Medication Dispensed|Overall Study||180
1697927|NCT00459667|4150429|P2|Study Medication Dispensed|Overall Study||645
1697928|NCT00459667|4150430|P1|Study Medication Dispensed|Overall Study||586
1697929|NCT00459667|4150428|P3|STARTED|Overall Study||181
1697930|NCT00459667|4150429|P2|STARTED|Overall Study||647
1697931|NCT00459667|4150430|P1|STARTED|Overall Study||592
1697932|NCT00459537|4150452|P2|NOT COMPLETED|Overall Study||76
1697933|NCT00459537|4150453|P1|NOT COMPLETED|Overall Study||66
1697934|NCT00459537|4150452|P2|COMPLETED|Overall Study||446
1697935|NCT00459537|4150453|P1|COMPLETED|Overall Study||441
1697936|NCT00459537|4150452|P2|Safety Population|Overall Study||512
1697937|NCT00459537|4150453|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
1697938|NCT00459537|4150452|P2|STARTED|Overall Study||522
1697939|NCT00459537|4150453|P1|STARTED|Overall Study||507
1697940|NCT00459381|4150467|P1|NOT COMPLETED|Overall Study||0
1697941|NCT00459381|4150467|P1|COMPLETED|Overall Study||35
1697942|NCT00459381|4150467|P1|STARTED|Overall Study||35
1697943|NCT00459368|4150479|P2|NOT COMPLETED|Overall Study||329
1697944|NCT00459368|4150480|P1|NOT COMPLETED|Overall Study||295
1697945|NCT00459368|4150479|P2|COMPLETED|Overall Study||1034
1697946|NCT00459368|4150480|P1|COMPLETED|Overall Study||1040
1697947|NCT00459368|4150479|P2|STARTED|Overall Study||1363
1697948|NCT00459368|4150480|P1|STARTED|Overall Study||1335
1697949|NCT00459355|4150488|P2|NOT COMPLETED|Overall Study||18
1697950|NCT00459355|4150489|P1|NOT COMPLETED|Overall Study||20
1697951|NCT00459355|4150488|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
1697952|NCT00459355|4150489|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
1697953|NCT00459355|4150488|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
1697954|NCT00459355|4150489|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
1697955|NCT00459342|4150501|P1|NOT COMPLETED|Overall Study||1
1697956|NCT00459342|4150501|P1|COMPLETED|Overall Study||34
1697957|NCT00459342|4150501|P1|STARTED|Overall Study||35
1697958|NCT00459316|4150510|P3|NOT COMPLETED|Step 3||1
1697959|NCT00459316|4150511|P2|NOT COMPLETED|Step 3||0
1697960|NCT00459316|4150512|P1|NOT COMPLETED|Step 3||3
1697961|NCT00459316|4150510|P3|COMPLETED|Step 3||39
1697962|NCT00459316|4150511|P2|COMPLETED|Step 3||0
1697963|NCT00459316|4150512|P1|COMPLETED|Step 3||149
1697964|NCT00459316|4150510|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
1697965|NCT00459316|4150511|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
1697966|NCT00459316|4150512|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
1697967|NCT00459316|4150510|P3|NOT COMPLETED|Steps 1 & 2||2
1697968|NCT00459316|4150511|P2|NOT COMPLETED|Steps 1 & 2||7
1697969|NCT00459316|4150512|P1|NOT COMPLETED|Steps 1 & 2||21
1697970|NCT00459316|4150510|P3|COMPLETED|Steps 1 & 2||57
1697971|NCT00459316|4150511|P2|COMPLETED|Steps 1 & 2||32
1697972|NCT00459316|4150512|P1|COMPLETED|Steps 1 & 2||259
1697973|NCT00459316|4150510|P3|STARTED|Steps 1 & 2||59
1697974|NCT00459316|4150511|P2|STARTED|Steps 1 & 2||39
1697975|NCT00459316|4150512|P1|STARTED|Steps 1 & 2||280
1697976|NCT00459303|4150566|P1|NOT COMPLETED|Overall Study||0
1697977|NCT00459303|4150566|P1|COMPLETED|Overall Study||20
1697978|NCT00459303|4150566|P1|STARTED|Overall Study||20
1697979|NCT00459290|4150577|P1|NOT COMPLETED|Overall Study||5
1697980|NCT00459290|4150577|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
1697981|NCT00459290|4150577|P1|STARTED|Overall Study||24
1697982|NCT00459186|4150592|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
1697983|NCT00459186|4150592|P1|COMPLETED|Combination RAD001 + Docetaxel||15
1697984|NCT00459186|4150592|P1|STARTED|Combination RAD001 + Docetaxel||15
1697985|NCT00459186|4150592|P1|NOT COMPLETED|PET Imaging and Assessment||3
1697986|NCT00459186|4150592|P1|COMPLETED|PET Imaging and Assessment||15
1697987|NCT00459186|4150592|P1|STARTED|PET Imaging and Assessment||18
1697988|NCT00459186|4150592|P1|NOT COMPLETED|Single Agent RAD001||1
1697989|NCT00459186|4150592|P1|COMPLETED|Single Agent RAD001||18
1697991|NCT00459134|4150599|P2|NOT COMPLETED|Overall Study||25
1697992|NCT00459134|4150600|P1|NOT COMPLETED|Overall Study||23
1697993|NCT00459134|4150599|P2|COMPLETED|Overall Study||67
1697994|NCT00459134|4150600|P1|COMPLETED|Overall Study||71
1697995|NCT00459134|4150599|P2|STARTED|Overall Study||92
1697996|NCT00459134|4150600|P1|STARTED|Overall Study||94
1697997|NCT00459121|4150608|P1|NOT COMPLETED|Overall Study||0
1697998|NCT00459121|4150608|P1|COMPLETED|Overall Study||2
1697999|NCT00459121|4150608|P1|STARTED|Overall Study||2
1698000|NCT00459108|4150612|P1|NOT COMPLETED|Overall Study||11
1698001|NCT00459108|4150612|P1|COMPLETED|Overall Study||14
1698002|NCT00459108|4150612|P1|STARTED|Overall Study||25
1698003|NCT00459056|4150622|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
1698004|NCT00459056|4150623|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
1698005|NCT00459056|4150622|P2|COMPLETED|Second Intervention (Final Three Months)||14
1698006|NCT00459056|4150623|P1|COMPLETED|Second Intervention (Final Three Months)||9
1698007|NCT00459056|4150622|P2|STARTED|Second Intervention (Final Three Months)||14
1698008|NCT00459056|4150623|P1|STARTED|Second Intervention (Final Three Months)||9
1698009|NCT00459056|4150622|P2|NOT COMPLETED|Washout (1 Month)||0
1698010|NCT00459056|4150623|P1|NOT COMPLETED|Washout (1 Month)||0
1698011|NCT00459056|4150622|P2|COMPLETED|Washout (1 Month)||14
1698012|NCT00459056|4150623|P1|COMPLETED|Washout (1 Month)||9
1698013|NCT00459056|4150622|P2|STARTED|Washout (1 Month)||14
1698014|NCT00459056|4150623|P1|STARTED|Washout (1 Month)||9
1698015|NCT00459056|4150622|P2|NOT COMPLETED|First Intervention (First Three Months)||1
1698016|NCT00459056|4150623|P1|NOT COMPLETED|First Intervention (First Three Months)||1
1698017|NCT00459056|4150622|P2|COMPLETED|First Intervention (First Three Months)||14
1698018|NCT00459056|4150623|P1|COMPLETED|First Intervention (First Three Months)||9
1698019|NCT00459056|4150622|P2|STARTED|First Intervention (First Three Months)||15
1698020|NCT00459056|4150623|P1|STARTED|First Intervention (First Three Months)||10
1698021|NCT00459043|4150631|P2|NOT COMPLETED|Overall Study||0
1698022|NCT00459043|4150632|P1|NOT COMPLETED|Overall Study||1
1698023|NCT00459043|4150631|P2|COMPLETED|Overall Study||15
1698024|NCT00459043|4150632|P1|COMPLETED|Overall Study||14
1698025|NCT00459043|4150631|P2|STARTED|Overall Study||15
1698026|NCT00459043|4150632|P1|STARTED|Overall Study||15
1698027|NCT00458952|4150644|P2|NOT COMPLETED|Overall Study||5
1698028|NCT00458952|4150645|P1|NOT COMPLETED|Overall Study||2
1698029|NCT00458952|4150644|P2|COMPLETED|Overall Study||9
1698030|NCT00458952|4150645|P1|COMPLETED|Overall Study||5
1698031|NCT00458952|4150644|P2|STARTED|Overall Study||14
1698032|NCT00458952|4150645|P1|STARTED|Overall Study||7
1698033|NCT00458822|4150649|P1|NOT COMPLETED|Overall Study||0
1698034|NCT00458822|4150649|P1|COMPLETED|Overall Study||40
1698035|NCT00458822|4150649|P1|STARTED|Overall Study||40
1698036|NCT00458705|4150653|P1|NOT COMPLETED|Overall Study||5
1698037|NCT00458705|4150653|P1|COMPLETED|Overall Study||40
1698038|NCT00458705|4150653|P1|STARTED|Overall Study||45
1698039|NCT00458536|4150657|P1|NOT COMPLETED|Overall Study||19
1698040|NCT00458536|4150657|P1|COMPLETED|Overall Study||19
1698041|NCT00458536|4150657|P1|STARTED|Overall Study||38
1698042|NCT00458406|4150663|P2|NOT COMPLETED|Month 3||0
1698043|NCT00458406|4150664|P1|NOT COMPLETED|Month 3||0
1698044|NCT00458406|4150663|P2|COMPLETED|Month 3||13
1698045|NCT00458406|4150664|P1|COMPLETED|Month 3||43
1698046|NCT00458406|4150663|P2|STARTED|Month 3||13
1698047|NCT00458406|4150664|P1|STARTED|Month 3||43
1698048|NCT00458406|4150663|P2|NOT COMPLETED|Month 1||0
1698049|NCT00458406|4150664|P1|NOT COMPLETED|Month 1||0
1698050|NCT00458406|4150663|P2|COMPLETED|Month 1||13
1698051|NCT00458406|4150664|P1|COMPLETED|Month 1||43
1698052|NCT00458406|4150663|P2|STARTED|Month 1||13
1698053|NCT00458406|4150664|P1|STARTED|Month 1||43
1698054|NCT00458393|4150684|P2|NOT COMPLETED|Overall Study||295
1698055|NCT00458393|4150685|P1|NOT COMPLETED|Overall Study||309
1698056|NCT00458393|4150684|P2|COMPLETED|Overall Study||953
1698057|NCT00458393|4150685|P1|COMPLETED|Overall Study||942
1698058|NCT00458393|4150684|P2|STARTED|Overall Study||1248
1698059|NCT00458393|4150685|P1|STARTED|Overall Study||1251
1698060|NCT00458302|4150733|P2|NOT COMPLETED|Overall Study||24
1698061|NCT00458302|4150734|P1|NOT COMPLETED|Overall Study||20
1698062|NCT00458302|4150733|P2|COMPLETED|Overall Study||103
1698063|NCT00458302|4150734|P1|COMPLETED|Overall Study||109
1698064|NCT00458302|4150733|P2|STARTED|Overall Study||127
1698065|NCT00458302|4150734|P1|STARTED|Overall Study||129
1698066|NCT00458237|4150768|P3|NOT COMPLETED|Overall Study||0
1698067|NCT00458237|4150769|P2|NOT COMPLETED|Overall Study||0
1698068|NCT00458237|4150770|P1|NOT COMPLETED|Overall Study||0
1698069|NCT00458237|4150768|P3|COMPLETED|Overall Study||5
1698070|NCT00458237|4150769|P2|COMPLETED|Overall Study||3
1698071|NCT00458237|4150770|P1|COMPLETED|Overall Study||3
1698072|NCT00458237|4150768|P3|STARTED|Overall Study||5
1698073|NCT00458237|4150769|P2|STARTED|Overall Study||3
1698074|NCT00458237|4150770|P1|STARTED|Overall Study||3
1698075|NCT00458211|4150779|P1|NOT COMPLETED|Overall Study||16
1698076|NCT00458211|4150779|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
1698077|NCT00458211|4150779|P1|STARTED|Overall Study||40
1698078|NCT00457977|4150792|P2|NOT COMPLETED|Overall Study||25
1698079|NCT00457977|4150793|P1|NOT COMPLETED|Overall Study||28
1698080|NCT00457977|4150792|P2|COMPLETED|Overall Study||66
1698081|NCT00457977|4150793|P1|COMPLETED|Overall Study||62
1698082|NCT00457977|4150792|P2|2-Year|Overall Study||66
1698083|NCT00457977|4150793|P1|2-Year|Overall Study||62
1698084|NCT00457977|4150792|P2|1-Year|Overall Study||76
1698085|NCT00457977|4150793|P1|1-Year|Overall Study||69
1698086|NCT00457977|4150792|P2|1-Month|Overall Study||87
1698087|NCT00457977|4150793|P1|1-Month|Overall Study||88
1698088|NCT00457977|4150792|P2|STARTED|Overall Study||91
1698089|NCT00457977|4150793|P1|STARTED|Overall Study||90
1698090|NCT00457951|4150804|P3|NOT COMPLETED|Overall Study||12
1698091|NCT00457951|4150805|P2|NOT COMPLETED|Overall Study||16
1698092|NCT00457951|4150806|P1|NOT COMPLETED|Overall Study||0
1698093|NCT00457951|4150804|P3|COMPLETED|Overall Study||60
1698094|NCT00457951|4150805|P2|COMPLETED|Overall Study||50
1698095|NCT00457951|4150806|P1|COMPLETED|Overall Study||13
1698096|NCT00457951|4150804|P3|STARTED|Overall Study||72
1698097|NCT00457951|4150805|P2|STARTED|Overall Study||66
1698098|NCT00457951|4150806|P1|STARTED|Overall Study||13
1698099|NCT00457821|4150821|P8|NOT COMPLETED|Part 2||1
1698100|NCT00457821|4150822|P7|NOT COMPLETED|Part 2||0
1698101|NCT00457821|4150823|P6|NOT COMPLETED|Part 2||0
1698102|NCT00457821|4150824|P5|NOT COMPLETED|Part 2||0
1698103|NCT00457821|4150825|P4|NOT COMPLETED|Part 2||0
1698104|NCT00457821|4150826|P3|NOT COMPLETED|Part 2||0
1698105|NCT00457821|4150827|P2|NOT COMPLETED|Part 2||0
1698106|NCT00457821|4150828|P1|NOT COMPLETED|Part 2||0
1698107|NCT00457821|4150821|P8|COMPLETED|Part 2||4
1698108|NCT00457821|4150822|P7|COMPLETED|Part 2||7
1698109|NCT00457821|4150823|P6|COMPLETED|Part 2||8
1698110|NCT00457821|4150824|P5|COMPLETED|Part 2||0
1698111|NCT00457821|4150825|P4|COMPLETED|Part 2||0
1698112|NCT00457821|4150826|P3|COMPLETED|Part 2||0
1698113|NCT00457821|4150827|P2|COMPLETED|Part 2||0
1698114|NCT00457821|4150828|P1|COMPLETED|Part 2||0
1698115|NCT00457821|4150821|P8|Completed Study Drug Treatment|Part 2||4
1698116|NCT00457821|4150822|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
1698117|NCT00457821|4150823|P6|Completed Study Drug Treatment|Part 2||8
1698118|NCT00457821|4150824|P5|Completed Study Drug Treatment|Part 2||0
1698119|NCT00457821|4150825|P4|Completed Study Drug Treatment|Part 2||0
1698120|NCT00457821|4150826|P3|Completed Study Drug Treatment|Part 2||0
1698121|NCT00457821|4150827|P2|Completed Study Drug Treatment|Part 2||0
1698122|NCT00457821|4150828|P1|Completed Study Drug Treatment|Part 2||0
1698123|NCT00457821|4150821|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
1698124|NCT00457821|4150822|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
1698125|NCT00457821|4150823|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
1698126|NCT00457821|4150824|P5|STARTED|Part 2|Arm in Part 1 only|0
1698127|NCT00457821|4150825|P4|STARTED|Part 2|Arm in Part 1 only|0
1698128|NCT00457821|4150826|P3|STARTED|Part 2|Arm in Part 1 only|0
1698129|NCT00457821|4150827|P2|STARTED|Part 2|Arm in Part 1 only|0
1698130|NCT00457821|4150828|P1|STARTED|Part 2|Arm in Part 1 only|0
1698131|NCT00457821|4150821|P8|NOT COMPLETED|Part 1||0
1698132|NCT00457821|4150822|P7|NOT COMPLETED|Part 1||0
1698133|NCT00457821|4150823|P6|NOT COMPLETED|Part 1||0
1698134|NCT00457821|4150824|P5|NOT COMPLETED|Part 1||0
1698135|NCT00457821|4150825|P4|NOT COMPLETED|Part 1||0
1698136|NCT00457821|4150826|P3|NOT COMPLETED|Part 1||1
1698137|NCT00457821|4150827|P2|NOT COMPLETED|Part 1||0
1698138|NCT00457821|4150828|P1|NOT COMPLETED|Part 1||0
1698139|NCT00457821|4150821|P8|COMPLETED|Part 1||0
1698140|NCT00457821|4150822|P7|COMPLETED|Part 1||0
1698141|NCT00457821|4150823|P6|COMPLETED|Part 1||0
1698142|NCT00457821|4150824|P5|COMPLETED|Part 1||4
1698143|NCT00457821|4150825|P4|COMPLETED|Part 1||4
1698144|NCT00457821|4150826|P3|COMPLETED|Part 1||4
1698145|NCT00457821|4150827|P2|COMPLETED|Part 1||4
1698146|NCT00457821|4150828|P1|COMPLETED|Part 1||4
1698147|NCT00457821|4150821|P8|STARTED|Part 1|Arm in Part 2 only|0
1698148|NCT00457821|4150822|P7|STARTED|Part 1|Arm in Part 2 only|0
1698149|NCT00457821|4150823|P6|STARTED|Part 1|Arm in Part 2 only|0
1698150|NCT00457821|4150824|P5|STARTED|Part 1|Number of subjects randomized|4
1698151|NCT00457821|4150825|P4|STARTED|Part 1|Number of subjects randomized|4
1698152|NCT00457821|4150826|P3|STARTED|Part 1|Number of subjects randomized|5
1698153|NCT00457821|4150827|P2|STARTED|Part 1|Number of subjects randomized|4
1698154|NCT00457821|4150828|P1|STARTED|Part 1|Number of subjects randomized|4
1698155|NCT00457795|4150857|P1|NOT COMPLETED|Overall Study||0
1698156|NCT00457795|4150857|P1|COMPLETED|Overall Study||15
1698157|NCT00457795|4150857|P1|STARTED|Overall Study||15
1698158|NCT00457743|4150867|P3|NOT COMPLETED|Overall Study||3
1698159|NCT00457743|4150868|P2|NOT COMPLETED|Overall Study||27
1698160|NCT00457743|4150869|P1|NOT COMPLETED|Overall Study||3
1698161|NCT00457743|4150867|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
1698162|NCT00457743|4150868|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
1698163|NCT00457743|4150869|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
1698164|NCT00457743|4150867|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
1698165|NCT00457743|4150868|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
1698166|NCT00457743|4150869|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
1698167|NCT00457743|4150867|P3|Completed Phase 1|Overall Study||3
1698168|NCT00457743|4150868|P2|Completed Phase 1|Overall Study||6
1698169|NCT00457743|4150869|P1|Completed Phase 1|Overall Study||3
1698170|NCT00457743|4150867|P3|Enrolled in Phase 1|Overall Study||3
1698171|NCT00457743|4150868|P2|Enrolled in Phase 1|Overall Study||6
1698172|NCT00457743|4150869|P1|Enrolled in Phase 1|Overall Study||3
1698173|NCT00457743|4150867|P3|STARTED|Overall Study|Overall study|3
1698174|NCT00457743|4150868|P2|STARTED|Overall Study|Overall study|30
1698175|NCT00457743|4150869|P1|STARTED|Overall Study|Overall study|3
1698176|NCT00457730|4150913|P2|NOT COMPLETED|Overall Study||1
1698177|NCT00457730|4150914|P1|NOT COMPLETED|Overall Study||4
1698178|NCT00457730|4150913|P2|COMPLETED|Overall Study||19
1698179|NCT00457730|4150914|P1|COMPLETED|Overall Study||14
1698180|NCT00457730|4150913|P2|STARTED|Overall Study||20
1698181|NCT00457730|4150914|P1|STARTED|Overall Study||18
1698182|NCT00457691|4150926|P2|NOT COMPLETED|Overall Study||382
1698183|NCT00457691|4150927|P1|NOT COMPLETED|Overall Study||386
1698184|NCT00457691|4150926|P2|COMPLETED|Overall Study||0
1698185|NCT00457691|4150927|P1|COMPLETED|Overall Study||0
1698186|NCT00457691|4150926|P2|STARTED|Overall Study||382
1698187|NCT00457691|4150927|P1|STARTED|Overall Study||386
1698188|NCT00457418|4150947|P1|NOT COMPLETED|Post PK Maintenance||28
1698189|NCT00457418|4150947|P1|COMPLETED|Post PK Maintenance||3
1698190|NCT00457418|4150947|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
1698191|NCT00457418|4150947|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
1698192|NCT00457418|4150947|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
1698193|NCT00457418|4150947|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
1698194|NCT00457392|4150959|P2|NOT COMPLETED|Overall Study||480
1698195|NCT00457392|4150960|P1|NOT COMPLETED|Overall Study||480
1698196|NCT00457392|4150959|P2|COMPLETED|Overall Study||0
1698197|NCT00457392|4150960|P1|COMPLETED|Overall Study||0
1698198|NCT00457392|4150959|P2|Treated|Overall Study||477
1698199|NCT00457392|4150960|P1|Treated|Overall Study||473
1698200|NCT00457392|4150959|P2|STARTED|Overall Study||480
1698201|NCT00457392|4150960|P1|STARTED|Overall Study||480
1698202|NCT00457301|4150978|P2|NOT COMPLETED|Overall Study||24
1698203|NCT00457301|4150979|P1|NOT COMPLETED|Overall Study||23
1698204|NCT00457301|4150978|P2|COMPLETED|Overall Study||84
1698205|NCT00457301|4150979|P1|COMPLETED|Overall Study||82
1698206|NCT00457301|4150978|P2|STARTED|Overall Study||108
1698207|NCT00457301|4150979|P1|STARTED|Overall Study||105
1698208|NCT00457249|4150993|P2|NOT COMPLETED|Overall Study||2
1698209|NCT00457249|4150994|P1|NOT COMPLETED|Overall Study||12
1698210|NCT00457249|4150993|P2|COMPLETED|Overall Study||389
1698211|NCT00457249|4150994|P1|COMPLETED|Overall Study||1158
1698212|NCT00457249|4150993|P2|STARTED|Overall Study||391
1698213|NCT00457249|4150994|P1|STARTED|Overall Study||1170
1698214|NCT00457197|4151008|P2|NOT COMPLETED|Overall Study||1
1698215|NCT00457197|4151009|P1|NOT COMPLETED|Overall Study||1
1698216|NCT00457197|4151008|P2|COMPLETED|Overall Study||44
1698217|NCT00457197|4151009|P1|COMPLETED|Overall Study||44
1698218|NCT00457197|4151008|P2|STARTED|Overall Study||45
1698219|NCT00457197|4151009|P1|STARTED|Overall Study||45
1698220|NCT00457015|4151033|P2|NOT COMPLETED|Overall Study||1
1698221|NCT00457015|4151034|P1|NOT COMPLETED|Overall Study||0
1698222|NCT00457015|4151033|P2|COMPLETED|Overall Study||47
1698223|NCT00457015|4151034|P1|COMPLETED|Overall Study||48
1698224|NCT00457015|4151033|P2|STARTED|Overall Study||48
1698225|NCT00457015|4151034|P1|STARTED|Overall Study||48
1698226|NCT00457002|4151050|P2|NOT COMPLETED|Overall Study||757
1698227|NCT00457002|4151051|P1|NOT COMPLETED|Overall Study||813
1698228|NCT00457002|4151050|P2|COMPLETED|Overall Study||2516
1698229|NCT00457002|4151051|P1|COMPLETED|Overall Study||2442
1698230|NCT00457002|4151050|P2|STARTED|Overall Study||3273
1698231|NCT00457002|4151051|P1|STARTED|Overall Study||3255
1698232|NCT00456989|4151119|P1|NOT COMPLETED|Overall Study||0
1698233|NCT00456989|4151119|P1|COMPLETED|Overall Study||39
1698234|NCT00456989|4151119|P1|STARTED|Overall Study||39
1698235|NCT00456885|4151123|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
1698236|NCT00456885|4151124|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
1698237|NCT00456885|4151123|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
1698238|NCT00456885|4151124|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
1698239|NCT00456885|4151123|P2|STARTED|Second Treatment Period, 16 Weeks||17
1698240|NCT00456885|4151124|P1|STARTED|Second Treatment Period, 16 Weeks||24
1698241|NCT00456885|4151123|P2|NOT COMPLETED|Washout, 3 Weeks||0
1698242|NCT00456885|4151124|P1|NOT COMPLETED|Washout, 3 Weeks||0
1698243|NCT00456885|4151123|P2|COMPLETED|Washout, 3 Weeks||17
1698244|NCT00456885|4151124|P1|COMPLETED|Washout, 3 Weeks||24
1698245|NCT00456885|4151123|P2|STARTED|Washout, 3 Weeks||17
1698246|NCT00456885|4151124|P1|STARTED|Washout, 3 Weeks||24
1698247|NCT00456885|4151123|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
1698248|NCT00456885|4151124|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
1698249|NCT00456885|4151123|P2|COMPLETED|First Treatment Period, 16 Weeks||17
1698250|NCT00456885|4151124|P1|COMPLETED|First Treatment Period, 16 Weeks||24
1698251|NCT00456885|4151123|P2|STARTED|First Treatment Period, 16 Weeks||17
1698252|NCT00456885|4151124|P1|STARTED|First Treatment Period, 16 Weeks||24
1698253|NCT00456846|4151155|P2|NOT COMPLETED|Overall Study||28
1698254|NCT00456846|4151156|P1|NOT COMPLETED|Overall Study||16
1698255|NCT00456846|4151155|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
1698256|NCT00456846|4151156|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
1698257|NCT00456846|4151155|P2|STARTED|Overall Study||76
1698258|NCT00456846|4151156|P1|STARTED|Overall Study||47
1698259|NCT00456807|4151178|P2|NOT COMPLETED|Overall Study||0
1698260|NCT00456807|4151179|P1|NOT COMPLETED|Overall Study||1
1698261|NCT00456807|4151178|P2|COMPLETED|Overall Study||47
1698262|NCT00456807|4151179|P1|COMPLETED|Overall Study||52
1698263|NCT00456807|4151178|P2|STARTED|Overall Study||47
1698264|NCT00456807|4151179|P1|STARTED|Overall Study||53
1698265|NCT00456755|4151197|P2|NOT COMPLETED|Overall Study||1
1698266|NCT00456755|4151198|P1|NOT COMPLETED|Overall Study||2
1698267|NCT00456755|4151197|P2|COMPLETED|Overall Study||62
1698268|NCT00456755|4151198|P1|COMPLETED|Overall Study||61
1698269|NCT00456755|4151197|P2|STARTED|Overall Study||63
1698270|NCT00456755|4151198|P1|STARTED|Overall Study||63
1698271|NCT00456625|4151206|P1|NOT COMPLETED|Overall Study||0
1698272|NCT00456625|4151206|P1|COMPLETED|Overall Study||76
1698273|NCT00456625|4151206|P1|STARTED|Overall Study||76
1698274|NCT00456612|4151212|P1|NOT COMPLETED|Overall Study||3
1698275|NCT00456612|4151212|P1|COMPLETED|Overall Study||1
1698276|NCT00456612|4151212|P1|STARTED|Overall Study||4
1698277|NCT00456599|4151217|P1|NOT COMPLETED|Overall Study||3
1698278|NCT00456599|4151217|P1|COMPLETED|Overall Study||68
1698279|NCT00456599|4151217|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
1698280|NCT00456599|4151217|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
1698281|NCT00456599|4151217|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
1698282|NCT00456599|4151217|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
1698283|NCT00456599|4151217|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
1698284|NCT00456599|4151217|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
1698285|NCT00456599|4151217|P1|STARTED|Overall Study||71
1698286|NCT00456547|4151225|P2|NOT COMPLETED|Overall Study||0
1698287|NCT00456547|4151226|P1|NOT COMPLETED|Overall Study||0
1698288|NCT00456547|4151225|P2|COMPLETED|Overall Study||12
1698289|NCT00456547|4151226|P1|COMPLETED|Overall Study||12
1698290|NCT00456547|4151225|P2|STARTED|Overall Study||12
1698291|NCT00456547|4151226|P1|STARTED|Overall Study||12
1698292|NCT00456521|4151240|P2|NOT COMPLETED|Overall Study||84
1698293|NCT00456521|4151241|P1|NOT COMPLETED|Overall Study||249
1698294|NCT00456521|4151240|P2|COMPLETED|Overall Study||118
1698295|NCT00456521|4151241|P1|COMPLETED|Overall Study||342
1698296|NCT00456521|4151240|P2|STARTED|Overall Study||202
1698297|NCT00456521|4151241|P1|STARTED|Overall Study||591
1698298|NCT00456508|4151281|P1|NOT COMPLETED|Overall Study||0
1698299|NCT00456508|4151281|P1|COMPLETED|Overall Study||147
1698300|NCT00456508|4151281|P1|STARTED|Overall Study||147
1698301|NCT00456495|4151287|P1|NOT COMPLETED|Overall Study||2
1698302|NCT00456495|4151287|P1|COMPLETED|Overall Study||3
1698303|NCT00456495|4151287|P1|STARTED|Overall Study||5
1698304|NCT00456365|4151294|P2|NOT COMPLETED|Overall Study||12
1698305|NCT00456365|4151295|P1|NOT COMPLETED|Overall Study||7
1698306|NCT00456365|4151294|P2|COMPLETED|Overall Study||42
1698307|NCT00456365|4151295|P1|COMPLETED|Overall Study||49
1698308|NCT00456365|4151294|P2|STARTED|Overall Study||54
1698309|NCT00456365|4151295|P1|STARTED|Overall Study||56
1698310|NCT00456261|4151309|P2|NOT COMPLETED|Maintenance Therapy||0
1698311|NCT00456261|4151310|P1|NOT COMPLETED|Maintenance Therapy||0
1698312|NCT00456261|4151309|P2|COMPLETED|Maintenance Therapy||29
1698313|NCT00456261|4151310|P1|COMPLETED|Maintenance Therapy||3
1698314|NCT00456261|4151309|P2|STARTED|Maintenance Therapy||29
1698315|NCT00456261|4151310|P1|STARTED|Maintenance Therapy||3
1698316|NCT00456261|4151309|P2|NOT COMPLETED|Combination Therapy||26
1698317|NCT00456261|4151310|P1|NOT COMPLETED|Combination Therapy||52
1698318|NCT00456261|4151309|P2|COMPLETED|Combination Therapy||29
1698319|NCT00456261|4151310|P1|COMPLETED|Combination Therapy||3
1698320|NCT00456261|4151309|P2|STARTED|Combination Therapy||55
1698321|NCT00456261|4151310|P1|STARTED|Combination Therapy||55
1698322|NCT00456014|4151320|P1|NOT COMPLETED|Tricyclic Phase||3
1698323|NCT00456014|4151320|P1|COMPLETED|Tricyclic Phase||1
1698324|NCT00456014|4151320|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
1698325|NCT00456014|4151320|P1|NOT COMPLETED|SSRI Phase||9
1698326|NCT00456014|4151320|P1|COMPLETED|SSRI Phase||28
1698327|NCT00456014|4151320|P1|STARTED|SSRI Phase||37
1698328|NCT00455975|4151328|P2|NOT COMPLETED|Overall Study||21
1698329|NCT00455975|4151329|P1|NOT COMPLETED|Overall Study||18
1698330|NCT00455975|4151328|P2|COMPLETED|Overall Study||40
1698331|NCT00455975|4151329|P1|COMPLETED|Overall Study||40
1698332|NCT00455975|4151328|P2|STARTED|Overall Study||61
1698333|NCT00455975|4151329|P1|STARTED|Overall Study||58
1698334|NCT00455962|4151343|P2|NOT COMPLETED|Overall Study||0
1698335|NCT00455962|4151344|P1|NOT COMPLETED|Overall Study||0
1698336|NCT00455962|4151343|P2|COMPLETED|Overall Study||13
1698337|NCT00455962|4151344|P1|COMPLETED|Overall Study||10
1698338|NCT00455962|4151343|P2|STARTED|Overall Study||13
1698339|NCT00455962|4151344|P1|STARTED|Overall Study||10
1698340|NCT00455923|4151352|P2|NOT COMPLETED|Overall Study||3
1698341|NCT00455923|4151353|P1|NOT COMPLETED|Overall Study||3
1698342|NCT00455923|4151352|P2|COMPLETED|Overall Study||47
1698343|NCT00455923|4151353|P1|COMPLETED|Overall Study||47
1698344|NCT00455923|4151352|P2|STARTED|Overall Study||50
1698345|NCT00455923|4151353|P1|STARTED|Overall Study||50
1698346|NCT00455858|4151369|P1|NOT COMPLETED|Overall Study||6
1698347|NCT00455858|4151369|P1|COMPLETED|Overall Study||81
1698348|NCT00455858|4151369|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
1698349|NCT00455741|4151379|P2|NOT COMPLETED|Overall Study||1
1698350|NCT00455741|4151380|P1|NOT COMPLETED|Overall Study||0
1698351|NCT00455741|4151379|P2|COMPLETED|Overall Study||11
1698352|NCT00455741|4151380|P1|COMPLETED|Overall Study||13
1698353|NCT00455741|4151379|P2|STARTED|Overall Study||12
1698354|NCT00455741|4151380|P1|STARTED|Overall Study||13
1698355|NCT00455702|4151398|P2|NOT COMPLETED|Overall Study||3
1698356|NCT00455702|4151399|P1|NOT COMPLETED|Overall Study||3
1698357|NCT00455702|4151398|P2|COMPLETED|Overall Study||16
1698358|NCT00455702|4151399|P1|COMPLETED|Overall Study||16
1698359|NCT00455702|4151398|P2|STARTED|Overall Study||19
1698360|NCT00455702|4151399|P1|STARTED|Overall Study||19
1698361|NCT00455689|4151409|P2|NOT COMPLETED|Overall Study||0
1698362|NCT00455689|4151410|P1|NOT COMPLETED|Overall Study||0
1698363|NCT00455689|4151409|P2|COMPLETED|Overall Study||6
1698364|NCT00455689|4151410|P1|COMPLETED|Overall Study||14
1698365|NCT00455689|4151409|P2|STARTED|Overall Study||6
1698366|NCT00455689|4151410|P1|STARTED|Overall Study||14
1698367|NCT00455663|4151420|P3|NOT COMPLETED|Overall Study||3
1698368|NCT00455663|4151421|P2|NOT COMPLETED|Overall Study||4
1698369|NCT00455663|4151422|P1|NOT COMPLETED|Overall Study||3
1698370|NCT00455663|4151420|P3|COMPLETED|Overall Study||29
1698371|NCT00455663|4151421|P2|COMPLETED|Overall Study||32
1698372|NCT00455663|4151422|P1|COMPLETED|Overall Study||34
1698373|NCT00455663|4151420|P3|STARTED|Overall Study||32
1698374|NCT00455663|4151421|P2|STARTED|Overall Study||36
1698375|NCT00455663|4151422|P1|STARTED|Overall Study||37
1698376|NCT00455650|4151441|P6|NOT COMPLETED|Week 3||0
1698377|NCT00455650|4151442|P5|NOT COMPLETED|Week 3||0
1698378|NCT00455650|4151443|P4|NOT COMPLETED|Week 3||0
1698379|NCT00455650|4151444|P3|NOT COMPLETED|Week 3||0
1698380|NCT00455650|4151445|P2|NOT COMPLETED|Week 3||0
1698381|NCT00455650|4151446|P1|NOT COMPLETED|Week 3||0
1698382|NCT00455650|4151441|P6|COMPLETED|Week 3||13
1698383|NCT00455650|4151442|P5|COMPLETED|Week 3||14
1698384|NCT00455650|4151443|P4|COMPLETED|Week 3||14
1698385|NCT00455650|4151444|P3|COMPLETED|Week 3||10
1698386|NCT00455650|4151445|P2|COMPLETED|Week 3||10
1698387|NCT00455650|4151446|P1|COMPLETED|Week 3||10
1698388|NCT00455650|4151441|P6|STARTED|Week 3||13
1698389|NCT00455650|4151442|P5|STARTED|Week 3||14
1698390|NCT00455650|4151443|P4|STARTED|Week 3||14
1698391|NCT00455650|4151444|P3|STARTED|Week 3||10
1698392|NCT00455650|4151445|P2|STARTED|Week 3||10
1698393|NCT00455650|4151446|P1|STARTED|Week 3||10
1698394|NCT00455650|4151441|P6|NOT COMPLETED|Week 2||0
1698395|NCT00455650|4151442|P5|NOT COMPLETED|Week 2||0
1698396|NCT00455650|4151443|P4|NOT COMPLETED|Week 2||0
1698397|NCT00455650|4151444|P3|NOT COMPLETED|Week 2||0
1698398|NCT00455650|4151445|P2|NOT COMPLETED|Week 2||0
1698399|NCT00455650|4151446|P1|NOT COMPLETED|Week 2||0
1698400|NCT00455650|4151441|P6|COMPLETED|Week 2||13
1698401|NCT00455650|4151442|P5|COMPLETED|Week 2||14
1698402|NCT00455650|4151443|P4|COMPLETED|Week 2||14
1698403|NCT00455650|4151444|P3|COMPLETED|Week 2||10
1698404|NCT00455650|4151445|P2|COMPLETED|Week 2||10
1698405|NCT00455650|4151446|P1|COMPLETED|Week 2||10
1698406|NCT00455650|4151441|P6|STARTED|Week 2||13
1698407|NCT00455650|4151442|P5|STARTED|Week 2||14
1698408|NCT00455650|4151443|P4|STARTED|Week 2||14
1698409|NCT00455650|4151444|P3|STARTED|Week 2||10
1698410|NCT00455650|4151445|P2|STARTED|Week 2||10
1698411|NCT00455650|4151446|P1|STARTED|Week 2||10
1698412|NCT00455650|4151441|P6|NOT COMPLETED|Week 1||0
1698413|NCT00455650|4151442|P5|NOT COMPLETED|Week 1||0
1698414|NCT00455650|4151443|P4|NOT COMPLETED|Week 1||0
1698415|NCT00455650|4151444|P3|NOT COMPLETED|Week 1||0
1698416|NCT00455650|4151445|P2|NOT COMPLETED|Week 1||0
1698417|NCT00455650|4151446|P1|NOT COMPLETED|Week 1||0
1698418|NCT00455650|4151441|P6|COMPLETED|Week 1||13
1698419|NCT00455650|4151442|P5|COMPLETED|Week 1||14
1698420|NCT00455650|4151443|P4|COMPLETED|Week 1||14
1698421|NCT00455650|4151444|P3|COMPLETED|Week 1||10
1698422|NCT00455650|4151445|P2|COMPLETED|Week 1||10
1698423|NCT00455650|4151446|P1|COMPLETED|Week 1||10
1698424|NCT00455650|4151441|P6|STARTED|Week 1||13
1698425|NCT00455650|4151442|P5|STARTED|Week 1||14
1698426|NCT00455650|4151443|P4|STARTED|Week 1||14
1698427|NCT00455650|4151444|P3|STARTED|Week 1||10
1698428|NCT00455650|4151445|P2|STARTED|Week 1||10
1698429|NCT00455650|4151446|P1|STARTED|Week 1||10
1698430|NCT00455533|4151476|P3|NOT COMPLETED|Period Two: Randomized Period||6
1698431|NCT00455533|4151477|P2|NOT COMPLETED|Period Two: Randomized Period||6
1698432|NCT00455533|4151478|P1|NOT COMPLETED|Period Two: Randomized Period||0
1698433|NCT00455533|4151476|P3|COMPLETED|Period Two: Randomized Period||138
1698434|NCT00455533|4151477|P2|COMPLETED|Period Two: Randomized Period||139
1698435|NCT00455533|4151478|P1|COMPLETED|Period Two: Randomized Period||0
1698436|NCT00455533|4151476|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
1698437|NCT00455533|4151477|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
1698438|NCT00455533|4151478|P1|STARTED|Period Two: Randomized Period||0
1698439|NCT00455533|4151476|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
1698440|NCT00455533|4151477|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
1698441|NCT00455533|4151478|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
1698442|NCT00455533|4151476|P3|COMPLETED|Period One: Initial Chemotherapy||0
1698443|NCT00455533|4151477|P2|COMPLETED|Period One: Initial Chemotherapy||0
1698444|NCT00455533|4151478|P1|COMPLETED|Period One: Initial Chemotherapy||295
1698445|NCT00455533|4151476|P3|STARTED|Period One: Initial Chemotherapy||0
1698446|NCT00455533|4151477|P2|STARTED|Period One: Initial Chemotherapy||0
1698447|NCT00455533|4151478|P1|STARTED|Period One: Initial Chemotherapy||313
1698448|NCT00455520|4151527|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
1698449|NCT00455520|4151528|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
1698450|NCT00455520|4151527|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
1698451|NCT00455520|4151528|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
1698452|NCT00455520|4151527|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
1698453|NCT00455520|4151528|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
1698454|NCT00455520|4151527|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
1698455|NCT00455520|4151528|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
1698456|NCT00455520|4151527|P2|COMPLETED|Open Label Tapentadol Extended Release||0
1698457|NCT00455520|4151528|P1|COMPLETED|Open Label Tapentadol Extended Release||395
1698458|NCT00455520|4151527|P2|STARTED|Open Label Tapentadol Extended Release||0
1698459|NCT00455520|4151528|P1|STARTED|Open Label Tapentadol Extended Release||591
1698460|NCT00455455|4151544|P2|NOT COMPLETED|Second Intervention||0
1698461|NCT00455455|4151545|P1|NOT COMPLETED|Second Intervention||0
1698462|NCT00455455|4151544|P2|COMPLETED|Second Intervention||24
1698463|NCT00455455|4151545|P1|COMPLETED|Second Intervention||24
1698464|NCT00455455|4151544|P2|STARTED|Second Intervention||24
1698465|NCT00455455|4151545|P1|STARTED|Second Intervention||24
1698466|NCT00455455|4151544|P2|NOT COMPLETED|Washout||0
1698467|NCT00455455|4151545|P1|NOT COMPLETED|Washout||1
1698468|NCT00455455|4151544|P2|COMPLETED|Washout||24
1698469|NCT00455455|4151545|P1|COMPLETED|Washout||24
1698470|NCT00455455|4151544|P2|STARTED|Washout||24
1698471|NCT00455455|4151545|P1|STARTED|Washout||25
1698472|NCT00455455|4151544|P2|NOT COMPLETED|First Intervention||0
1698473|NCT00455455|4151545|P1|NOT COMPLETED|First Intervention||0
1698474|NCT00455455|4151544|P2|COMPLETED|First Intervention||24
1698475|NCT00455455|4151545|P1|COMPLETED|First Intervention||25
1698476|NCT00455455|4151544|P2|STARTED|First Intervention||24
1698477|NCT00455455|4151545|P1|STARTED|First Intervention||25
1698478|NCT00455455|4151544|P2|NOT COMPLETED|Washout||1
1698479|NCT00455455|4151545|P1|NOT COMPLETED|Washout||0
1698480|NCT00455455|4151544|P2|COMPLETED|Washout||24
1698481|NCT00455455|4151545|P1|COMPLETED|Washout||25
1698482|NCT00455455|4151544|P2|STARTED|Washout||25
1698483|NCT00455455|4151545|P1|STARTED|Washout||25
1698484|NCT00455429|4151565|P4|NOT COMPLETED|Overall Study||14
1698485|NCT00455429|4151566|P3|NOT COMPLETED|Overall Study||1
1698486|NCT00455429|4151567|P2|NOT COMPLETED|Overall Study||5
1698487|NCT00455429|4151568|P1|NOT COMPLETED|Overall Study||2
1698488|NCT00455429|4151565|P4|COMPLETED|Overall Study||20
1698489|NCT00455429|4151566|P3|COMPLETED|Overall Study||16
1698490|NCT00455429|4151567|P2|COMPLETED|Overall Study||10
1698491|NCT00455429|4151568|P1|COMPLETED|Overall Study||16
1698492|NCT00455429|4151565|P4|Treated|Overall Study||32
1698493|NCT00455429|4151566|P3|Treated|Overall Study||17
1698494|NCT00455429|4151567|P2|Treated|Overall Study||15
1698495|NCT00455429|4151568|P1|Treated|Overall Study||18
1698496|NCT00455429|4151565|P4|STARTED|Overall Study||34
1698497|NCT00455429|4151566|P3|STARTED|Overall Study||17
1698498|NCT00455429|4151567|P2|STARTED|Overall Study||15
1698499|NCT00455429|4151568|P1|STARTED|Overall Study||18
1698500|NCT00455312|4151627|P2|NOT COMPLETED|Overall Study||1
1698501|NCT00455312|4151628|P1|NOT COMPLETED|Overall Study||0
1698502|NCT00455312|4151627|P2|COMPLETED|Overall Study||20
1698503|NCT00455312|4151628|P1|COMPLETED|Overall Study||15
1698504|NCT00455312|4151627|P2|STARTED|Overall Study||21
1698505|NCT00455312|4151628|P1|STARTED|Overall Study||15
1698506|NCT00455195|4151654|P2|NOT COMPLETED|Extension Study AGLU03206||0
1698507|NCT00455195|4151655|P1|NOT COMPLETED|Extension Study AGLU03206||0
1698508|NCT00455195|4151654|P2|COMPLETED|Extension Study AGLU03206||26
1698509|NCT00455195|4151655|P1|COMPLETED|Extension Study AGLU03206||55
1698510|NCT00455195|4151654|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
1698511|NCT00455195|4151655|P1|STARTED|Extension Study AGLU03206||55
1698512|NCT00455195|4151654|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
1698513|NCT00455195|4151655|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
1698514|NCT00455195|4151654|P2|COMPLETED|Double-blind Study AGLU02704||26
1698515|NCT00455195|4151655|P1|COMPLETED|Double-blind Study AGLU02704||55
1698516|NCT00455195|4151654|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
1698517|NCT00455195|4151655|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
1698518|NCT00455013|4151672|P3|NOT COMPLETED|Long Term Extension (LTE)||7
1698519|NCT00455013|4151673|P2|NOT COMPLETED|Long Term Extension (LTE)||3
1698520|NCT00455013|4151674|P1|NOT COMPLETED|Long Term Extension (LTE)||2
1698521|NCT00455013|4151672|P3|COMPLETED|Long Term Extension (LTE)||20
1698522|NCT00455013|4151673|P2|COMPLETED|Long Term Extension (LTE)||16
1698523|NCT00455013|4151674|P1|COMPLETED|Long Term Extension (LTE)||25
1698524|NCT00455013|4151672|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
1698525|NCT00455013|4151673|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
1698526|NCT00455013|4151674|P1|STARTED|Long Term Extension (LTE)||27
1698527|NCT00455013|4151672|P3|NOT COMPLETED|Short Term Period||2
1698528|NCT00455013|4151673|P2|NOT COMPLETED|Short Term Period||5
1698529|NCT00455013|4151674|P1|NOT COMPLETED|Short Term Period||6
1698530|NCT00455013|4151672|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
1698531|NCT00455013|4151673|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
1698532|NCT00455013|4151674|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
1698533|NCT00455013|4151672|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
1698534|NCT00455013|4151673|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
1698535|NCT00455013|4151674|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
1698536|NCT00454987|4151742|P3|NOT COMPLETED|Year 4||0
1698537|NCT00454987|4151743|P2|NOT COMPLETED|Year 4||0
1698538|NCT00454987|4151744|P1|NOT COMPLETED|Year 4||0
1698539|NCT00454987|4151742|P3|COMPLETED|Year 4||0
1698540|NCT00454987|4151743|P2|COMPLETED|Year 4||62
1698541|NCT00454987|4151744|P1|COMPLETED|Year 4||206
1698542|NCT00454987|4151742|P3|STARTED|Year 4||0
1698543|NCT00454987|4151743|P2|STARTED|Year 4||62
1698544|NCT00454987|4151744|P1|STARTED|Year 4||206
1698545|NCT00454987|4151742|P3|NOT COMPLETED|Year 2||0
1698546|NCT00454987|4151743|P2|NOT COMPLETED|Year 2||0
1698547|NCT00454987|4151744|P1|NOT COMPLETED|Year 2||0
1698548|NCT00454987|4151742|P3|COMPLETED|Year 2||74
1698549|NCT00454987|4151743|P2|COMPLETED|Year 2||77
1698550|NCT00454987|4151744|P1|COMPLETED|Year 2||235
1698551|NCT00454987|4151742|P3|STARTED|Year 2||74
1698552|NCT00454987|4151743|P2|STARTED|Year 2||77
1698553|NCT00454987|4151744|P1|STARTED|Year 2||235
1698554|NCT00454987|4151742|P3|NOT COMPLETED|Year 1||0
1698555|NCT00454987|4151743|P2|NOT COMPLETED|Year 1||0
1698556|NCT00454987|4151744|P1|NOT COMPLETED|Year 1||0
1698557|NCT00454987|4151742|P3|COMPLETED|Year 1||0
1698558|NCT00454987|4151743|P2|COMPLETED|Year 1||67
1698559|NCT00454987|4151744|P1|COMPLETED|Year 1||221
1698560|NCT00454987|4151742|P3|STARTED|Year 1||0
1698561|NCT00454987|4151743|P2|STARTED|Year 1||67
1698562|NCT00454987|4151744|P1|STARTED|Year 1||221
1698563|NCT00454987|4151742|P3|NOT COMPLETED|Booster Period||0
1698564|NCT00454987|4151743|P2|NOT COMPLETED|Booster Period||1
1698565|NCT00454987|4151744|P1|NOT COMPLETED|Booster Period||2
1698566|NCT00454987|4151742|P3|COMPLETED|Booster Period||0
1698567|NCT00454987|4151743|P2|COMPLETED|Booster Period||116
1698568|NCT00454987|4151744|P1|COMPLETED|Booster Period||357
1698569|NCT00454987|4151742|P3|STARTED|Booster Period||0
1698570|NCT00454987|4151743|P2|STARTED|Booster Period||117
1698571|NCT00454987|4151744|P1|STARTED|Booster Period||359
1698572|NCT00454909|4151818|P3|NOT COMPLETED|Overall Study||2
1698573|NCT00454909|4151819|P2|NOT COMPLETED|Overall Study||3
1698574|NCT00454909|4151820|P1|NOT COMPLETED|Overall Study||7
1698575|NCT00454909|4151818|P3|COMPLETED|Overall Study||86
1698576|NCT00454909|4151819|P2|COMPLETED|Overall Study||194
1698577|NCT00454909|4151820|P1|COMPLETED|Overall Study||580
1698578|NCT00454909|4151818|P3|STARTED|Overall Study||88
1698579|NCT00454909|4151819|P2|STARTED|Overall Study||197
1698580|NCT00454909|4151820|P1|STARTED|Overall Study||587
1698581|NCT00454857|4151858|P1|NOT COMPLETED|Overall Study||54
1698582|NCT00454857|4151858|P1|COMPLETED|Overall Study||272
1698583|NCT00454857|4151858|P1|Completed ≥1 Observational Study Visit|Overall Study||319
1698584|NCT00454857|4151858|P1|Completed Retrospective Chart Review|Overall Study||324
1698585|NCT00454857|4151858|P1|STARTED|Overall Study||326
1698586|NCT00454818|4151883|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
1698587|NCT00454818|4151884|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
1698588|NCT00454818|4151885|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
1698589|NCT00454818|4151886|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
1698590|NCT00454818|4151887|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
1698591|NCT00454818|4151883|P5|COMPLETED|Phase 2: Randomized Double-blind||10
1698592|NCT00454818|4151884|P4|COMPLETED|Phase 2: Randomized Double-blind||8
1698593|NCT00454818|4151885|P3|COMPLETED|Phase 2: Randomized Double-blind||5
1698594|NCT00454818|4151886|P2|COMPLETED|Phase 2: Randomized Double-blind||6
1698595|NCT00454818|4151887|P1|COMPLETED|Phase 2: Randomized Double-blind||0
1698596|NCT00454818|4151883|P5|STARTED|Phase 2: Randomized Double-blind||14
1698597|NCT00454818|4151884|P4|STARTED|Phase 2: Randomized Double-blind||9
1698598|NCT00454818|4151885|P3|STARTED|Phase 2: Randomized Double-blind||8
1698599|NCT00454818|4151886|P2|STARTED|Phase 2: Randomized Double-blind||8
1698600|NCT00454818|4151887|P1|STARTED|Phase 2: Randomized Double-blind||0
1698601|NCT00454818|4151883|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
1698602|NCT00454818|4151884|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
1698603|NCT00454818|4151885|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
1698604|NCT00454818|4151886|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
1698605|NCT00454818|4151887|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
1698606|NCT00454818|4151883|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
1698607|NCT00454818|4151884|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
1698608|NCT00454818|4151885|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
1698609|NCT00454818|4151886|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
1698610|NCT00454818|4151887|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
1698611|NCT00454818|4151883|P5|STARTED|Phase I: Open-label Dose-escalation||0
1698612|NCT00454818|4151884|P4|STARTED|Phase I: Open-label Dose-escalation||3
1698613|NCT00454818|4151885|P3|STARTED|Phase I: Open-label Dose-escalation||3
1698614|NCT00454818|4151886|P2|STARTED|Phase I: Open-label Dose-escalation||3
1698615|NCT00454818|4151887|P1|STARTED|Phase I: Open-label Dose-escalation||3
1698616|NCT00454805|4151966|P2|NOT COMPLETED|Overall Study||23
1698617|NCT00454805|4151967|P1|NOT COMPLETED|Overall Study||26
1698618|NCT00454805|4151966|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
1698619|NCT00454805|4151967|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
1698620|NCT00454805|4151966|P2|STARTED|Overall Study|Randomised|31
1698621|NCT00454805|4151967|P1|STARTED|Overall Study|Randomised|31
1698622|NCT00454779|4151983|P2|NOT COMPLETED|Second-line Treatment Phase||3
1698623|NCT00454779|4151984|P1|NOT COMPLETED|Second-line Treatment Phase||0
1698624|NCT00454779|4151983|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
1698625|NCT00454779|4151984|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
1698626|NCT00454779|4151983|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
1698627|NCT00454779|4151984|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
1698628|NCT00454779|4151983|P2|NOT COMPLETED|First-line Treatment Phase||8
1698629|NCT00454779|4151984|P1|NOT COMPLETED|First-line Treatment Phase||5
1698630|NCT00454779|4151983|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
1698631|NCT00454779|4151984|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
1698632|NCT00454779|4151983|P2|Received Study Medication|First-line Treatment Phase||55
1698633|NCT00454779|4151984|P1|Received Study Medication|First-line Treatment Phase||56
1698634|NCT00454779|4151983|P2|STARTED|First-line Treatment Phase||57
1698635|NCT00454779|4151984|P1|STARTED|First-line Treatment Phase||56
1698636|NCT00454649|4152022|P10|NOT COMPLETED|Overall Study||5
1698637|NCT00454649|4152023|P9|NOT COMPLETED|Overall Study||20
1698638|NCT00454649|4152024|P8|NOT COMPLETED|Overall Study||19
1698639|NCT00454649|4152025|P7|NOT COMPLETED|Overall Study||9
1698640|NCT00454649|4152026|P6|NOT COMPLETED|Overall Study||7
1698641|NCT00454649|4152027|P5|NOT COMPLETED|Overall Study||1
1698642|NCT00454649|4152028|P4|NOT COMPLETED|Overall Study||6
1698643|NCT00454649|4152029|P3|NOT COMPLETED|Overall Study||19
1698644|NCT00454649|4152030|P2|NOT COMPLETED|Overall Study||4
1698645|NCT00454649|4152031|P1|NOT COMPLETED|Overall Study||3
1698646|NCT00454649|4152022|P10|COMPLETED|Overall Study||1
1698647|NCT00454649|4152023|P9|COMPLETED|Overall Study||1
1698648|NCT00454649|4152024|P8|COMPLETED|Overall Study||0
1698649|NCT00454649|4152025|P7|COMPLETED|Overall Study||0
1698650|NCT00454649|4152026|P6|COMPLETED|Overall Study||0
1698651|NCT00454649|4152027|P5|COMPLETED|Overall Study||0
1698652|NCT00454649|4152028|P4|COMPLETED|Overall Study||1
1698653|NCT00454649|4152029|P3|COMPLETED|Overall Study||1
1698654|NCT00454649|4152030|P2|COMPLETED|Overall Study||1
1698655|NCT00454649|4152031|P1|COMPLETED|Overall Study||0
1698656|NCT00454649|4152022|P10|STARTED|Overall Study||6
1698657|NCT00454649|4152023|P9|STARTED|Overall Study||21
1698658|NCT00454649|4152024|P8|STARTED|Overall Study||19
1698659|NCT00454649|4152025|P7|STARTED|Overall Study||9
1698660|NCT00454649|4152026|P6|STARTED|Overall Study||7
1698661|NCT00454649|4152027|P5|STARTED|Overall Study||1
1698662|NCT00454649|4152028|P4|STARTED|Overall Study||7
1698663|NCT00454649|4152029|P3|STARTED|Overall Study||20
1698664|NCT00454649|4152030|P2|STARTED|Overall Study||5
1698665|NCT00454649|4152031|P1|STARTED|Overall Study||3
1698666|NCT00454636|4152160|P4|NOT COMPLETED|Overall Study||32
1698667|NCT00454636|4152161|P3|NOT COMPLETED|Overall Study||20
1698668|NCT00454636|4152162|P2|NOT COMPLETED|Overall Study||23
1698669|NCT00454636|4152163|P1|NOT COMPLETED|Overall Study||31
1698670|NCT00454636|4152160|P4|COMPLETED|Overall Study||26
1698671|NCT00454636|4152161|P3|COMPLETED|Overall Study||7
1698672|NCT00454636|4152162|P2|COMPLETED|Overall Study||9
1698673|NCT00454636|4152163|P1|COMPLETED|Overall Study||10
1698674|NCT00454636|4152160|P4|STARTED|Overall Study||58
1698675|NCT00454636|4152161|P3|STARTED|Overall Study||27
1698676|NCT00454636|4152162|P2|STARTED|Overall Study||32
1698677|NCT00454636|4152163|P1|STARTED|Overall Study||41
1698678|NCT00454584|4152196|P6|NOT COMPLETED|After Controlled Period||32
1698679|NCT00454584|4152197|P5|NOT COMPLETED|After Controlled Period||12
1698680|NCT00454584|4152198|P4|NOT COMPLETED|After Controlled Period||26
1698681|NCT00454584|4152199|P3|NOT COMPLETED|After Controlled Period||0
1698682|NCT00454584|4152200|P2|NOT COMPLETED|After Controlled Period||0
1698683|NCT00454584|4152201|P1|NOT COMPLETED|After Controlled Period||0
1698684|NCT00454584|4152196|P6|COMPLETED|After Controlled Period||310
1698685|NCT00454584|4152197|P5|COMPLETED|After Controlled Period||189
1698686|NCT00454584|4152198|P4|COMPLETED|After Controlled Period||310
1698687|NCT00454584|4152199|P3|COMPLETED|After Controlled Period||0
1698688|NCT00454584|4152200|P2|COMPLETED|After Controlled Period||0
1698689|NCT00454584|4152201|P1|COMPLETED|After Controlled Period||0
1698690|NCT00454584|4152196|P6|STARTED|After Controlled Period||342
1698691|NCT00454584|4152197|P5|STARTED|After Controlled Period||201
1698692|NCT00454584|4152198|P4|STARTED|After Controlled Period||336
1698693|NCT00454584|4152199|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1698694|NCT00454584|4152200|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1698784|NCT00454051|4152416|P1|NOT COMPLETED|Overall Study||3
1698695|NCT00454584|4152201|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1698696|NCT00454584|4152196|P6|NOT COMPLETED|Controlled Period||0
1698697|NCT00454584|4152197|P5|NOT COMPLETED|Controlled Period||0
1698698|NCT00454584|4152198|P4|NOT COMPLETED|Controlled Period||0
1698699|NCT00454584|4152199|P3|NOT COMPLETED|Controlled Period||5
1698700|NCT00454584|4152200|P2|NOT COMPLETED|Controlled Period||8
1698701|NCT00454584|4152201|P1|NOT COMPLETED|Controlled Period||11
1698702|NCT00454584|4152196|P6|COMPLETED|Controlled Period||0
1698703|NCT00454584|4152197|P5|COMPLETED|Controlled Period||0
1698704|NCT00454584|4152198|P4|COMPLETED|Controlled Period||0
1698705|NCT00454584|4152199|P3|COMPLETED|Controlled Period||342
1698706|NCT00454584|4152200|P2|COMPLETED|Controlled Period||201
1698707|NCT00454584|4152201|P1|COMPLETED|Controlled Period||336
1698708|NCT00454584|4152196|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1698709|NCT00454584|4152197|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1698710|NCT00454584|4152198|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1698711|NCT00454584|4152199|P3|STARTED|Controlled Period||347
1698712|NCT00454584|4152200|P2|STARTED|Controlled Period||209
1698713|NCT00454584|4152201|P1|STARTED|Controlled Period||347
1698714|NCT00454571|4152223|P2|NOT COMPLETED|Overall Study||6
1698715|NCT00454571|4152224|P1|NOT COMPLETED|Overall Study||13
1698716|NCT00454571|4152223|P2|COMPLETED|Overall Study||13
1698717|NCT00454571|4152224|P1|COMPLETED|Overall Study||5
1698718|NCT00454571|4152223|P2|STARTED|Overall Study||19
1698719|NCT00454571|4152224|P1|STARTED|Overall Study||18
1698720|NCT00454532|4152236|P4|NOT COMPLETED|Overall Study||0
1698721|NCT00454532|4152237|P3|NOT COMPLETED|Overall Study||0
1698722|NCT00454532|4152238|P2|NOT COMPLETED|Overall Study||0
1698723|NCT00454532|4152239|P1|NOT COMPLETED|Overall Study||0
1698724|NCT00454532|4152236|P4|COMPLETED|Overall Study||7
1698725|NCT00454532|4152237|P3|COMPLETED|Overall Study||3
1698726|NCT00454532|4152238|P2|COMPLETED|Overall Study||6
1698727|NCT00454532|4152239|P1|COMPLETED|Overall Study||11
1698728|NCT00454532|4152236|P4|STARTED|Overall Study||7
1698729|NCT00454532|4152237|P3|STARTED|Overall Study||3
1698730|NCT00454532|4152238|P2|STARTED|Overall Study||6
1698731|NCT00454532|4152239|P1|STARTED|Overall Study||11
1698732|NCT00454363|4152259|P2|NOT COMPLETED|Overall Study||2
1698733|NCT00454363|4152260|P1|NOT COMPLETED|Overall Study||5
1698734|NCT00454363|4152259|P2|COMPLETED|Overall Study||29
1698735|NCT00454363|4152260|P1|COMPLETED|Overall Study||15
1698736|NCT00454363|4152259|P2|STARTED|Overall Study||31
1698737|NCT00454363|4152260|P1|STARTED|Overall Study||20
1698738|NCT00454324|4152269|P2|NOT COMPLETED|Overall Study||0
1698739|NCT00454324|4152270|P1|NOT COMPLETED|Overall Study||0
1698740|NCT00454324|4152269|P2|COMPLETED|Overall Study||13
1698741|NCT00454324|4152270|P1|COMPLETED|Overall Study||14
1698742|NCT00454324|4152269|P2|STARTED|Overall Study||13
1698743|NCT00454324|4152270|P1|STARTED|Overall Study||14
1698744|NCT00454246|4152285|P3|NOT COMPLETED|Overall Study||9
1698745|NCT00454246|4152286|P2|NOT COMPLETED|Overall Study||29
1698746|NCT00454246|4152287|P1|NOT COMPLETED|Overall Study||73
1698747|NCT00454246|4152285|P3|COMPLETED|Overall Study||0
1698748|NCT00454246|4152286|P2|COMPLETED|Overall Study||0
1698749|NCT00454246|4152287|P1|COMPLETED|Overall Study||0
1698750|NCT00454246|4152285|P3|STARTED|Overall Study||9
1698751|NCT00454246|4152286|P2|STARTED|Overall Study||29
1698752|NCT00454246|4152287|P1|STARTED|Overall Study||73
1698753|NCT00454207|4152303|P2|NOT COMPLETED|Overall Study||2
1698754|NCT00454207|4152304|P1|NOT COMPLETED|Overall Study||4
1698755|NCT00454207|4152303|P2|COMPLETED|Overall Study||21
1698756|NCT00454207|4152304|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
1698757|NCT00454207|4152303|P2|STARTED|Overall Study||23
1698758|NCT00454207|4152304|P1|STARTED|Overall Study||21
1698759|NCT00454194|4152349|P2|NOT COMPLETED|Overall Study||14
1698760|NCT00454194|4152350|P1|NOT COMPLETED|Overall Study||22
1698761|NCT00454194|4152349|P2|COMPLETED|Overall Study||37
1698762|NCT00454194|4152350|P1|COMPLETED|Overall Study||25
1698763|NCT00454194|4152349|P2|STARTED|Overall Study||51
1698764|NCT00454194|4152350|P1|STARTED|Overall Study||47
1698765|NCT00454181|4152368|P2|NOT COMPLETED|Overall Study||3
1698766|NCT00454181|4152369|P1|NOT COMPLETED|Overall Study||15
1698767|NCT00454181|4152368|P2|COMPLETED|Overall Study||11
1698768|NCT00454181|4152369|P1|COMPLETED|Overall Study||30
1698769|NCT00454181|4152368|P2|STARTED|Overall Study||14
1698770|NCT00454181|4152369|P1|STARTED|Overall Study||45
1698771|NCT00454142|4152385|P1|NOT COMPLETED|Overall Study||1
1698772|NCT00454142|4152385|P1|COMPLETED|Overall Study||32
1698773|NCT00454142|4152385|P1|STARTED|Overall Study||33
1698774|NCT00454116|4152403|P3|NOT COMPLETED|Overall Study||28
1698775|NCT00454116|4152404|P2|NOT COMPLETED|Overall Study||29
1698776|NCT00454116|4152405|P1|NOT COMPLETED|Overall Study||27
1698777|NCT00454116|4152403|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
1698778|NCT00454116|4152404|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
1698779|NCT00454116|4152405|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
1698780|NCT00454116|4152403|P3|STARTED|Overall Study|randomised patients|35
1698781|NCT00454116|4152404|P2|STARTED|Overall Study|randomised patients|36
1698782|NCT00454116|4152405|P1|STARTED|Overall Study|randomised patients|35
1698783|NCT00454051|4152415|P2|NOT COMPLETED|Overall Study||3
1698785|NCT00454051|4152415|P2|COMPLETED|Overall Study||8
1698786|NCT00454051|4152416|P1|COMPLETED|Overall Study||17
1698787|NCT00454051|4152415|P2|STARTED|Overall Study||11
1698788|NCT00454051|4152416|P1|STARTED|Overall Study||20
1698789|NCT00453999|4152449|P3|NOT COMPLETED|Overall Study||3
1698790|NCT00453999|4152450|P2|NOT COMPLETED|Overall Study||5
1698791|NCT00453999|4152451|P1|NOT COMPLETED|Overall Study||5
1698792|NCT00453999|4152449|P3|COMPLETED|Overall Study||43
1698793|NCT00453999|4152450|P2|COMPLETED|Overall Study||41
1698794|NCT00453999|4152451|P1|COMPLETED|Overall Study||40
1698795|NCT00453999|4152449|P3|STARTED|Overall Study||46
1698796|NCT00453999|4152450|P2|STARTED|Overall Study||46
1698797|NCT00453999|4152451|P1|STARTED|Overall Study||45
1698798|NCT00453986|4152479|P5|NOT COMPLETED|Overall Study||0
1698799|NCT00453986|4152480|P4|NOT COMPLETED|Overall Study||2
1698800|NCT00453986|4152481|P3|NOT COMPLETED|Overall Study||6
1698801|NCT00453986|4152482|P2|NOT COMPLETED|Overall Study||5
1698802|NCT00453986|4152483|P1|NOT COMPLETED|Overall Study||6
1698803|NCT00453986|4152479|P5|COMPLETED|Overall Study||105
1698804|NCT00453986|4152480|P4|COMPLETED|Overall Study||310
1698805|NCT00453986|4152481|P3|COMPLETED|Overall Study||307
1698806|NCT00453986|4152482|P2|COMPLETED|Overall Study||306
1698807|NCT00453986|4152483|P1|COMPLETED|Overall Study||305
1698808|NCT00453986|4152479|P5|STARTED|Overall Study||105
1698809|NCT00453986|4152480|P4|STARTED|Overall Study||312
1698810|NCT00453986|4152481|P3|STARTED|Overall Study||313
1698811|NCT00453986|4152482|P2|STARTED|Overall Study||311
1698812|NCT00453986|4152483|P1|STARTED|Overall Study||311
1698813|NCT00453973|4152576|P2|NOT COMPLETED|Overall Study||48
1698814|NCT00453973|4152577|P1|NOT COMPLETED|Overall Study||51
1698815|NCT00453973|4152576|P2|COMPLETED|Overall Study||15
1698816|NCT00453973|4152577|P1|COMPLETED|Overall Study||0
1698817|NCT00453973|4152576|P2|STARTED|Overall Study||63
1698818|NCT00453973|4152577|P1|STARTED|Overall Study||51
1698819|NCT00453921|4152587|P4|NOT COMPLETED|Overall Study||1
1698820|NCT00453921|4152588|P3|NOT COMPLETED|Overall Study||2
1698821|NCT00453921|4152589|P2|NOT COMPLETED|Overall Study||1
1698822|NCT00453921|4152590|P1|NOT COMPLETED|Overall Study||1
1698823|NCT00453921|4152587|P4|COMPLETED|Overall Study||18
1698824|NCT00453921|4152588|P3|COMPLETED|Overall Study||18
1698825|NCT00453921|4152589|P2|COMPLETED|Overall Study||17
1698826|NCT00453921|4152590|P1|COMPLETED|Overall Study||18
1698827|NCT00453921|4152587|P4|STARTED|Overall Study||19
1698828|NCT00453921|4152588|P3|STARTED|Overall Study||20
1698829|NCT00453921|4152589|P2|STARTED|Overall Study||18
1698830|NCT00453921|4152590|P1|STARTED|Overall Study||19
1698831|NCT00453479|4152627|P3|NOT COMPLETED|Overall Study||0
1698832|NCT00453479|4152628|P2|NOT COMPLETED|Overall Study||0
1698833|NCT00453479|4152629|P1|NOT COMPLETED|Overall Study||0
1698834|NCT00453479|4152627|P3|COMPLETED|Overall Study||8
1698835|NCT00453479|4152628|P2|COMPLETED|Overall Study||9
1698836|NCT00453479|4152629|P1|COMPLETED|Overall Study||6
1698837|NCT00453479|4152627|P3|STARTED|Overall Study||8
1698838|NCT00453479|4152628|P2|STARTED|Overall Study||9
1698839|NCT00453479|4152629|P1|STARTED|Overall Study||6
1698840|NCT00453388|4152704|P4|NOT COMPLETED|Overall Study||0
1698841|NCT00453388|4152705|P3|NOT COMPLETED|Overall Study||0
1698842|NCT00453388|4152706|P2|NOT COMPLETED|Overall Study||0
1698843|NCT00453388|4152707|P1|NOT COMPLETED|Overall Study||0
1698844|NCT00453388|4152704|P4|COMPLETED|Overall Study||0
1698845|NCT00453388|4152705|P3|COMPLETED|Overall Study||1
1698846|NCT00453388|4152706|P2|COMPLETED|Overall Study||5
1698847|NCT00453388|4152707|P1|COMPLETED|Overall Study||0
1698848|NCT00453388|4152704|P4|STARTED|Overall Study||0
1698849|NCT00453388|4152705|P3|STARTED|Overall Study||1
1698850|NCT00453388|4152706|P2|STARTED|Overall Study||5
1698851|NCT00453388|4152707|P1|STARTED|Overall Study||0
1698852|NCT00453362|4152729|P1|NOT COMPLETED|Overall Study||87
1698853|NCT00453362|4152729|P1|COMPLETED|Overall Study||1
1698854|NCT00453362|4152729|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
1698855|NCT00453362|4152729|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
1698856|NCT00453362|4152729|P1|Treated With Erlotinib|Overall Study||74
1698857|NCT00453362|4152729|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
1698858|NCT00453349|4152755|P2|NOT COMPLETED|Completed Study||34
1698859|NCT00453349|4152756|P1|NOT COMPLETED|Completed Study||27
1698860|NCT00453349|4152755|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
1698861|NCT00453349|4152756|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
1698862|NCT00453349|4152755|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
1698863|NCT00453349|4152756|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
1698864|NCT00453349|4152755|P2|STARTED|Completed Study||232
1698865|NCT00453349|4152756|P1|STARTED|Completed Study||228
1698866|NCT00453349|4152755|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
1698867|NCT00453349|4152756|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
1698868|NCT00453349|4152755|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
1698869|NCT00453349|4152756|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
1698870|NCT00453349|4152755|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
1698871|NCT00453349|4152756|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
1698872|NCT00453349|4152755|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
1698873|NCT00453349|4152756|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
1698874|NCT00453349|4152755|P2|NOT COMPLETED|Randomized||23
1698875|NCT00453349|4152756|P1|NOT COMPLETED|Randomized||25
1698876|NCT00453349|4152755|P2|COMPLETED|Randomized||209
1698877|NCT00453349|4152756|P1|COMPLETED|Randomized||203
1698878|NCT00453349|4152755|P2|STARTED|Randomized||232
1698879|NCT00453349|4152756|P1|STARTED|Randomized||228
1698880|NCT00453336|4152782|P1|NOT COMPLETED|Overall Study||0
1698881|NCT00453336|4152782|P1|COMPLETED|Overall Study||45
1698882|NCT00453336|4152782|P1|STARTED|Overall Study||45
1698883|NCT00453310|4152787|P1|NOT COMPLETED|Overall Study||10
1698884|NCT00453310|4152787|P1|COMPLETED|Overall Study||0
1698885|NCT00453310|4152787|P1|STARTED|Overall Study||10
1698886|NCT00453206|4152791|P1|NOT COMPLETED|Overall Study||1
1698887|NCT00453206|4152791|P1|COMPLETED|Overall Study||65
1698888|NCT00453206|4152791|P1|STARTED|Overall Study||66
1698889|NCT00453193|4152795|P1|NOT COMPLETED|Overall Study||0
1698890|NCT00453193|4152795|P1|COMPLETED|Overall Study||24
1698891|NCT00453193|4152795|P1|STARTED|Overall Study||24
1698892|NCT00453180|4152801|P2|NOT COMPLETED|Overall Study||3
1698893|NCT00453180|4152802|P1|NOT COMPLETED|Overall Study||3
1698894|NCT00453180|4152801|P2|COMPLETED|Overall Study||12
1698895|NCT00453180|4152802|P1|COMPLETED|Overall Study||13
1698896|NCT00453180|4152801|P2|STARTED|Overall Study||15
1698897|NCT00453180|4152802|P1|STARTED|Overall Study||16
1698898|NCT00453154|4152821|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
1698899|NCT00453154|4152822|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
1698900|NCT00453154|4152823|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
1698901|NCT00453154|4152824|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
1698902|NCT00453154|4152821|P4|COMPLETED|Open Label Sunitinib Crossover||0
1698903|NCT00453154|4152822|P3|COMPLETED|Open Label Sunitinib Crossover||18
1698904|NCT00453154|4152823|P2|COMPLETED|Open Label Sunitinib Crossover||0
1698905|NCT00453154|4152824|P1|COMPLETED|Open Label Sunitinib Crossover||0
1698906|NCT00453154|4152821|P4|STARTED|Open Label Sunitinib Crossover||0
1698907|NCT00453154|4152822|P3|STARTED|Open Label Sunitinib Crossover||18
1698908|NCT00453154|4152823|P2|STARTED|Open Label Sunitinib Crossover||0
1698909|NCT00453154|4152824|P1|STARTED|Open Label Sunitinib Crossover||0
1698910|NCT00453154|4152821|P4|NOT COMPLETED|Double BIind Maintenance||49
1698911|NCT00453154|4152822|P3|NOT COMPLETED|Double BIind Maintenance||46
1698912|NCT00453154|4152823|P2|NOT COMPLETED|Double BIind Maintenance||0
1698913|NCT00453154|4152824|P1|NOT COMPLETED|Double BIind Maintenance||0
1698914|NCT00453154|4152821|P4|COMPLETED|Double BIind Maintenance||0
1698915|NCT00453154|4152822|P3|COMPLETED|Double BIind Maintenance||0
1698916|NCT00453154|4152823|P2|COMPLETED|Double BIind Maintenance||0
1698917|NCT00453154|4152824|P1|COMPLETED|Double BIind Maintenance||0
1698918|NCT00453154|4152821|P4|STARTED|Double BIind Maintenance||49
1698919|NCT00453154|4152822|P3|STARTED|Double BIind Maintenance||46
1698920|NCT00453154|4152823|P2|STARTED|Double BIind Maintenance||0
1698921|NCT00453154|4152824|P1|STARTED|Double BIind Maintenance||0
1698922|NCT00453154|4152821|P4|NOT COMPLETED|Combination Chemotherapy||0
1698923|NCT00453154|4152822|P3|NOT COMPLETED|Combination Chemotherapy||0
1698924|NCT00453154|4152823|P2|NOT COMPLETED|Combination Chemotherapy||49
1698925|NCT00453154|4152824|P1|NOT COMPLETED|Combination Chemotherapy||0
1698926|NCT00453154|4152821|P4|COMPLETED|Combination Chemotherapy||0
1698927|NCT00453154|4152822|P3|COMPLETED|Combination Chemotherapy||0
1698928|NCT00453154|4152823|P2|COMPLETED|Combination Chemotherapy||95
1698929|NCT00453154|4152824|P1|COMPLETED|Combination Chemotherapy||12
1698930|NCT00453154|4152821|P4|STARTED|Combination Chemotherapy||0
1698931|NCT00453154|4152822|P3|STARTED|Combination Chemotherapy||0
1698932|NCT00453154|4152823|P2|STARTED|Combination Chemotherapy||144
1698933|NCT00453154|4152824|P1|STARTED|Combination Chemotherapy||12
1698934|NCT00453102|4152837|P1|NOT COMPLETED|Overall Study||2
1698935|NCT00453102|4152837|P1|COMPLETED|Overall Study||16
1698936|NCT00453102|4152837|P1|STARTED|Overall Study||18
1698937|NCT00453063|4152848|P2|NOT COMPLETED|Overall Study||3
1698938|NCT00453063|4152849|P1|NOT COMPLETED|Overall Study||3
1698939|NCT00453063|4152848|P2|COMPLETED|Overall Study||212
1698940|NCT00453063|4152849|P1|COMPLETED|Overall Study||208
1698941|NCT00453063|4152848|P2|STARTED|Overall Study||215
1698942|NCT00453063|4152849|P1|STARTED|Overall Study||211
1698943|NCT00452868|4152863|P1|NOT COMPLETED|Overall Study||2
1698944|NCT00452868|4152863|P1|COMPLETED|Overall Study||11
1698945|NCT00452868|4152863|P1|STARTED|Overall Study||13
1698946|NCT00452790|4152869|P2|NOT COMPLETED|Toddler Dose||2
1698947|NCT00452790|4152870|P1|NOT COMPLETED|Toddler Dose||0
1698948|NCT00452790|4152869|P2|COMPLETED|Toddler Dose||198
1698949|NCT00452790|4152870|P1|COMPLETED|Toddler Dose||198
1698950|NCT00452790|4152869|P2|STARTED|Toddler Dose||200
1698951|NCT00452790|4152870|P1|STARTED|Toddler Dose||198
1698952|NCT00452790|4152869|P2|NOT COMPLETED|After Infant Series||14
1698953|NCT00452790|4152870|P1|NOT COMPLETED|After Infant Series||21
1698954|NCT00452790|4152869|P2|COMPLETED|After Infant Series||200
1698955|NCT00452790|4152870|P1|COMPLETED|After Infant Series||198
1698956|NCT00452790|4152869|P2|STARTED|After Infant Series||214
1698957|NCT00452790|4152870|P1|STARTED|After Infant Series||219
1698958|NCT00452790|4152869|P2|NOT COMPLETED|Infant Series||141
1698959|NCT00452790|4152870|P1|NOT COMPLETED|Infant Series||135
1698960|NCT00452790|4152869|P2|COMPLETED|Infant Series||214
1698961|NCT00452790|4152870|P1|COMPLETED|Infant Series||219
1698962|NCT00452790|4152869|P2|Vaccinated Dose 3|Infant Series||218
1698963|NCT00452790|4152870|P1|Vaccinated Dose 3|Infant Series||221
1698964|NCT00452790|4152869|P2|Vaccinated Dose 2|Infant Series||300
1698965|NCT00452790|4152870|P1|Vaccinated Dose 2|Infant Series||300
1698966|NCT00452790|4152869|P2|Vaccinated Dose 1|Infant Series||353
1698967|NCT00452790|4152870|P1|Vaccinated Dose 1|Infant Series||353
1698968|NCT00452790|4152869|P2|STARTED|Infant Series||355
1698969|NCT00452790|4152870|P1|STARTED|Infant Series||354
1698970|NCT00452699|4152906|P2|NOT COMPLETED|Overall Study||73
1698971|NCT00452699|4152907|P1|NOT COMPLETED|Overall Study||81
1698972|NCT00452699|4152906|P2|COMPLETED|Overall Study||242
1698973|NCT00452699|4152907|P1|COMPLETED|Overall Study||225
1698974|NCT00452699|4152906|P2|STARTED|Overall Study||315
1698975|NCT00452699|4152907|P1|STARTED|Overall Study||306
1698976|NCT00452673|4152923|P5|NOT COMPLETED|Dose Expansion Period||21
1698977|NCT00452673|4152924|P4|NOT COMPLETED|Dose Expansion Period||0
1698978|NCT00452673|4152925|P3|NOT COMPLETED|Dose Expansion Period||0
1698979|NCT00452673|4152926|P2|NOT COMPLETED|Dose Expansion Period||0
1698980|NCT00452673|4152927|P1|NOT COMPLETED|Dose Expansion Period||0
1698981|NCT00452673|4152923|P5|COMPLETED|Dose Expansion Period||0
1698982|NCT00452673|4152924|P4|COMPLETED|Dose Expansion Period||0
1698983|NCT00452673|4152925|P3|COMPLETED|Dose Expansion Period||0
1698984|NCT00452673|4152926|P2|COMPLETED|Dose Expansion Period||0
1698985|NCT00452673|4152927|P1|COMPLETED|Dose Expansion Period||0
1698986|NCT00452673|4152923|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
1698987|NCT00452673|4152924|P4|STARTED|Dose Expansion Period||0
1698988|NCT00452673|4152925|P3|STARTED|Dose Expansion Period||0
1698989|NCT00452673|4152926|P2|STARTED|Dose Expansion Period||0
1698990|NCT00452673|4152927|P1|STARTED|Dose Expansion Period||0
1698991|NCT00452673|4152923|P5|NOT COMPLETED|Dose Escalation Period||0
1698992|NCT00452673|4152924|P4|NOT COMPLETED|Dose Escalation Period||9
1698993|NCT00452673|4152925|P3|NOT COMPLETED|Dose Escalation Period||6
1698994|NCT00452673|4152926|P2|NOT COMPLETED|Dose Escalation Period||9
1698995|NCT00452673|4152927|P1|NOT COMPLETED|Dose Escalation Period||7
1698996|NCT00452673|4152923|P5|COMPLETED|Dose Escalation Period||0
1698997|NCT00452673|4152924|P4|COMPLETED|Dose Escalation Period||0
1698998|NCT00452673|4152925|P3|COMPLETED|Dose Escalation Period||0
1698999|NCT00452673|4152926|P2|COMPLETED|Dose Escalation Period||0
1699000|NCT00452673|4152927|P1|COMPLETED|Dose Escalation Period||0
1699001|NCT00452673|4152923|P5|STARTED|Dose Escalation Period||0
1699002|NCT00452673|4152924|P4|STARTED|Dose Escalation Period||9
1699003|NCT00452673|4152925|P3|STARTED|Dose Escalation Period||6
1699004|NCT00452673|4152926|P2|STARTED|Dose Escalation Period||9
1699005|NCT00452673|4152927|P1|STARTED|Dose Escalation Period||7
1699006|NCT00452543|4152959|P2|NOT COMPLETED|Overall Study||6
1699007|NCT00452543|4152960|P1|NOT COMPLETED|Overall Study||5
1699008|NCT00452543|4152959|P2|COMPLETED|Overall Study||5
1699009|NCT00452543|4152960|P1|COMPLETED|Overall Study||7
1699010|NCT00452543|4152959|P2|STARTED|Overall Study||11
1699011|NCT00452543|4152960|P1|STARTED|Overall Study||12
1699012|NCT00452530|4152974|P2|NOT COMPLETED|Overall Study||136
1699013|NCT00452530|4152975|P1|NOT COMPLETED|Overall Study||136
1699014|NCT00452530|4152974|P2|COMPLETED|Overall Study||1393
1699015|NCT00452530|4152975|P1|COMPLETED|Overall Study||1392
1699016|NCT00452530|4152974|P2|Primary Participants|Overall Study||997
1699017|NCT00452530|4152975|P1|Primary Participants|Overall Study||976
1699018|NCT00452530|4152974|P2|Evaluable Participants|Overall Study||921
1699019|NCT00452530|4152975|P1|Evaluable Participants|Overall Study||907
1699020|NCT00452530|4152974|P2|Received Treatment|Overall Study||1508
1699021|NCT00452530|4152975|P1|Received Treatment|Overall Study||1501
1699022|NCT00452530|4152974|P2|STARTED|Overall Study|Randomized|1529
1699023|NCT00452530|4152975|P1|STARTED|Overall Study|Randomized|1528
1699024|NCT00452452|4152996|P3|NOT COMPLETED|Overall Study||1
1699025|NCT00452452|4152997|P2|NOT COMPLETED|Overall Study||0
1699026|NCT00452452|4152998|P1|NOT COMPLETED|Overall Study||2
1699027|NCT00452452|4152996|P3|COMPLETED|Overall Study||152
1699028|NCT00452452|4152997|P2|COMPLETED|Overall Study||112
1699029|NCT00452452|4152998|P1|COMPLETED|Overall Study||88
1699030|NCT00452452|4152996|P3|Vaccinated Dose 3|Overall Study||0
1699031|NCT00452452|4152997|P2|Vaccinated Dose 3|Overall Study||0
1699032|NCT00452452|4152998|P1|Vaccinated Dose 3|Overall Study||89
1699033|NCT00452452|4152996|P3|Vaccinated Dose 2|Overall Study||0
1699034|NCT00452452|4152997|P2|Vaccinated Dose 2|Overall Study||112
1699035|NCT00452452|4152998|P1|Vaccinated Dose 2|Overall Study||90
1699036|NCT00452452|4152996|P3|Vaccinated Dose 1|Overall Study||152
1699037|NCT00452452|4152997|P2|Vaccinated Dose 1|Overall Study||112
1699038|NCT00452452|4152998|P1|Vaccinated Dose 1|Overall Study||90
1699039|NCT00452452|4152996|P3|STARTED|Overall Study||153
1699040|NCT00452452|4152997|P2|STARTED|Overall Study||112
1699041|NCT00452452|4152998|P1|STARTED|Overall Study||90
1699042|NCT00452426|4153023|P2|NOT COMPLETED|Overall Study||11
1699043|NCT00452426|4153024|P1|NOT COMPLETED|Overall Study||7
1699044|NCT00452426|4153023|P2|COMPLETED|Overall Study||493
1699045|NCT00452426|4153024|P1|COMPLETED|Overall Study||489
1699046|NCT00452426|4153023|P2|STARTED|Overall Study||504
1699047|NCT00452426|4153024|P1|STARTED|Overall Study||496
1699048|NCT00452400|4153043|P5|NOT COMPLETED|Overall Study||3
1699049|NCT00452400|4153044|P4|NOT COMPLETED|Overall Study||1
1699050|NCT00452400|4153045|P3|NOT COMPLETED|Overall Study||7
1699051|NCT00452400|4153046|P2|NOT COMPLETED|Overall Study||1
1699052|NCT00452400|4153047|P1|NOT COMPLETED|Overall Study||5
1699053|NCT00452400|4153043|P5|COMPLETED|Overall Study||76
1699054|NCT00452400|4153044|P4|COMPLETED|Overall Study||85
1699055|NCT00452400|4153045|P3|COMPLETED|Overall Study||73
1699056|NCT00452400|4153046|P2|COMPLETED|Overall Study||80
1699057|NCT00452400|4153047|P1|COMPLETED|Overall Study||74
1699058|NCT00452400|4153043|P5|STARTED|Overall Study||79
1699059|NCT00452400|4153044|P4|STARTED|Overall Study||86
1699060|NCT00452400|4153045|P3|STARTED|Overall Study||80
1699061|NCT00452400|4153046|P2|STARTED|Overall Study||81
1699062|NCT00452400|4153047|P1|STARTED|Overall Study||79
1699063|NCT00452387|4153219|P1|NOT COMPLETED|Overall Study||0
1699064|NCT00452387|4153219|P1|COMPLETED|Overall Study||22
1699065|NCT00452387|4153219|P1|STARTED|Overall Study||22
1699066|NCT00452374|4153227|P1|NOT COMPLETED|Overall Study||0
1699067|NCT00452374|4153227|P1|COMPLETED|Overall Study||48
1699068|NCT00452374|4153227|P1|STARTED|Overall Study||48
1699069|NCT00452361|4153234|P2|NOT COMPLETED|Overall Study||10
1699070|NCT00452361|4153235|P1|NOT COMPLETED|Overall Study||21
1699071|NCT00452361|4153234|P2|COMPLETED|Overall Study||0
1699072|NCT00452361|4153235|P1|COMPLETED|Overall Study||0
1699073|NCT00452361|4153234|P2|STARTED|Overall Study||10
1699074|NCT00452361|4153235|P1|STARTED|Overall Study||21
1699075|NCT00452348|4153279|P2|NOT COMPLETED|Overall Study||84
1699076|NCT00452348|4153280|P1|NOT COMPLETED|Overall Study||79
1699077|NCT00452348|4153279|P2|COMPLETED|Overall Study||234
1699078|NCT00452348|4153280|P1|COMPLETED|Overall Study||231
1699079|NCT00452348|4153279|P2|STARTED|Overall Study||318
1699080|NCT00452348|4153280|P1|STARTED|Overall Study||310
1699081|NCT00452335|4153295|P3|NOT COMPLETED|Overall Study||9
1699082|NCT00452335|4153296|P2|NOT COMPLETED|Overall Study||4
1699083|NCT00452335|4153297|P1|NOT COMPLETED|Overall Study||2
1699084|NCT00452335|4153295|P3|COMPLETED|Overall Study||23
1699085|NCT00452335|4153296|P2|COMPLETED|Overall Study||61
1699086|NCT00452335|4153297|P1|COMPLETED|Overall Study||25
1699087|NCT00452335|4153295|P3|STARTED|Overall Study||32
1699088|NCT00452335|4153296|P2|STARTED|Overall Study||65
1699089|NCT00452335|4153297|P1|STARTED|Overall Study||27
1699090|NCT00452114|4153334|P2|NOT COMPLETED|Overall Study||3
1699091|NCT00452114|4153335|P1|NOT COMPLETED|Overall Study||3
1699092|NCT00452114|4153334|P2|COMPLETED|Overall Study||10
1699093|NCT00452114|4153335|P1|COMPLETED|Overall Study||12
1699094|NCT00452114|4153334|P2|STARTED|Overall Study||13
1699095|NCT00452114|4153335|P1|STARTED|Overall Study||15
1699096|NCT00451958|4153351|P5|NOT COMPLETED|CS21A (NCT00451958)||0
1699097|NCT00451958|4153352|P4|NOT COMPLETED|CS21A (NCT00451958)||39
1699098|NCT00451958|4153353|P3|NOT COMPLETED|CS21A (NCT00451958)||42
1699099|NCT00451958|4153354|P2|NOT COMPLETED|CS21A (NCT00451958)||77
1699100|NCT00451958|4153355|P1|NOT COMPLETED|CS21A (NCT00451958)||65
1699101|NCT00451958|4153351|P5|COMPLETED|CS21A (NCT00451958)||0
1699102|NCT00451958|4153352|P4|COMPLETED|CS21A (NCT00451958)||27
1699103|NCT00451958|4153353|P3|COMPLETED|CS21A (NCT00451958)||27
1699104|NCT00451958|4153354|P2|COMPLETED|CS21A (NCT00451958)||49
1699105|NCT00451958|4153355|P1|COMPLETED|CS21A (NCT00451958)||60
1699106|NCT00451958|4153351|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
1699107|NCT00451958|4153352|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
1699108|NCT00451958|4153353|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
1699109|NCT00451958|4153354|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
1699110|NCT00451958|4153355|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
1699111|NCT00451958|4153351|P5|NOT COMPLETED|CS21 (NCT00295750)||32
1699112|NCT00451958|4153352|P4|NOT COMPLETED|CS21 (NCT00295750)||0
1699113|NCT00451958|4153353|P3|NOT COMPLETED|CS21 (NCT00295750)||0
1699114|NCT00451958|4153354|P2|NOT COMPLETED|CS21 (NCT00295750)||43
1699115|NCT00451958|4153355|P1|NOT COMPLETED|CS21 (NCT00295750)||41
1699116|NCT00451958|4153351|P5|COMPLETED|CS21 (NCT00295750)||172
1699117|NCT00451958|4153352|P4|COMPLETED|CS21 (NCT00295750)||0
1699118|NCT00451958|4153353|P3|COMPLETED|CS21 (NCT00295750)||0
1699119|NCT00451958|4153354|P2|COMPLETED|CS21 (NCT00295750)||163
1699120|NCT00451958|4153355|P1|COMPLETED|CS21 (NCT00295750)||169
1699121|NCT00451958|4153351|P5|STARTED|CS21 (NCT00295750)||204
1699122|NCT00451958|4153352|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
1699123|NCT00451958|4153353|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
1699124|NCT00451958|4153354|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
1699125|NCT00451958|4153355|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
1699126|NCT00451906|4153385|P1|NOT COMPLETED|Overall Study||2239
1699127|NCT00451906|4153385|P1|COMPLETED|Overall Study||13
1699128|NCT00451906|4153385|P1|STARTED|Overall Study||2252
1699129|NCT00451698|4153395|P2|NOT COMPLETED|Overall Study||0
1699130|NCT00451698|4153396|P1|NOT COMPLETED|Overall Study||0
1699131|NCT00451698|4153395|P2|COMPLETED|Overall Study||6
1699132|NCT00451698|4153396|P1|COMPLETED|Overall Study||3
1699133|NCT00451698|4153395|P2|STARTED|Overall Study||6
1699134|NCT00451698|4153396|P1|STARTED|Overall Study||3
1699135|NCT00451451|4153414|P4|NOT COMPLETED|Overall Study||58
1699136|NCT00451451|4153415|P3|NOT COMPLETED|Overall Study||72
1699137|NCT00451451|4153416|P2|NOT COMPLETED|Overall Study||75
1699138|NCT00451451|4153417|P1|NOT COMPLETED|Overall Study||85
1699139|NCT00451451|4153414|P4|COMPLETED|Overall Study||292
1699140|NCT00451451|4153415|P3|COMPLETED|Overall Study||273
1699141|NCT00451451|4153416|P2|COMPLETED|Overall Study||284
1699142|NCT00451451|4153417|P1|COMPLETED|Overall Study||278
1699143|NCT00451451|4153414|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
1699144|NCT00451451|4153415|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
1699145|NCT00451451|4153416|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
1699146|NCT00451451|4153417|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
1699147|NCT00451321|4153452|P8|NOT COMPLETED|Overall Study||6
1699148|NCT00451321|4153453|P7|NOT COMPLETED|Overall Study||6
1699149|NCT00451321|4153454|P6|NOT COMPLETED|Overall Study||9
1699150|NCT00451321|4153455|P5|NOT COMPLETED|Overall Study||7
1699151|NCT00451321|4153456|P4|NOT COMPLETED|Overall Study||12
1699152|NCT00451321|4153457|P3|NOT COMPLETED|Overall Study||18
1699153|NCT00451321|4153458|P2|NOT COMPLETED|Overall Study||5
1699154|NCT00451321|4153459|P1|NOT COMPLETED|Overall Study||7
1699155|NCT00451321|4153452|P8|COMPLETED|Overall Study||0
1699156|NCT00451321|4153453|P7|COMPLETED|Overall Study||0
1699157|NCT00451321|4153454|P6|COMPLETED|Overall Study||0
1699158|NCT00451321|4153455|P5|COMPLETED|Overall Study||0
1699159|NCT00451321|4153456|P4|COMPLETED|Overall Study||7
1699160|NCT00451321|4153457|P3|COMPLETED|Overall Study||0
1699161|NCT00451321|4153458|P2|COMPLETED|Overall Study||10
1699162|NCT00451321|4153459|P1|COMPLETED|Overall Study||1
1699163|NCT00451321|4153452|P8|STARTED|Overall Study||6
1699164|NCT00451321|4153453|P7|STARTED|Overall Study||6
1699165|NCT00451321|4153454|P6|STARTED|Overall Study||9
1699166|NCT00451321|4153455|P5|STARTED|Overall Study||7
1699167|NCT00451321|4153456|P4|STARTED|Overall Study||19
1699168|NCT00451321|4153457|P3|STARTED|Overall Study||18
1699169|NCT00451321|4153458|P2|STARTED|Overall Study||15
1699170|NCT00451321|4153459|P1|STARTED|Overall Study||8
1699171|NCT00451282|4153631|P2|NOT COMPLETED|Overall Study||5
1699172|NCT00451282|4153632|P1|NOT COMPLETED|Overall Study||6
1699173|NCT00451282|4153631|P2|COMPLETED|Overall Study||34
1699174|NCT00451282|4153632|P1|COMPLETED|Overall Study||40
1699175|NCT00451282|4153631|P2|STARTED|Overall Study||39
1699176|NCT00451282|4153632|P1|STARTED|Overall Study||46
1699177|NCT00451204|4153646|P2|NOT COMPLETED|Overall Study||20
1699178|NCT00451204|4153647|P1|NOT COMPLETED|Overall Study||22
1699179|NCT00451204|4153646|P2|COMPLETED|Overall Study||56
1699180|NCT00451204|4153647|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
1699181|NCT00451204|4153646|P2|STARTED|Overall Study||76
1699182|NCT00451204|4153647|P1|STARTED|Overall Study||82
1699183|NCT00451191|4153665|P2|NOT COMPLETED|Overall Study||11
1699184|NCT00451191|4153666|P1|NOT COMPLETED|Overall Study||15
1699185|NCT00451191|4153665|P2|COMPLETED|Overall Study||55
1699186|NCT00451191|4153666|P1|COMPLETED|Overall Study||53
1699187|NCT00451191|4153665|P2|STARTED|Overall Study||66
1699188|NCT00451191|4153666|P1|STARTED|Overall Study||68
1699189|NCT00451048|4153672|P1|NOT COMPLETED|Overall Study||0
1699190|NCT00451048|4153672|P1|COMPLETED|Overall Study||10
1699191|NCT00451048|4153672|P1|STARTED|Overall Study||10
1699192|NCT00450983|4153681|P1|NOT COMPLETED|Overall Study||0
1699193|NCT00450983|4153681|P1|COMPLETED|Overall Study||1
1699194|NCT00450983|4153681|P1|STARTED|Overall Study||1
1699195|NCT00450866|4153693|P2|NOT COMPLETED|Overall Study||3
1699196|NCT00450866|4153694|P1|NOT COMPLETED|Overall Study||7
1699197|NCT00450866|4153693|P2|COMPLETED|Overall Study||7
1699198|NCT00450866|4153694|P1|COMPLETED|Overall Study||38
1699199|NCT00450866|4153693|P2|STARTED|Overall Study||10
1699200|NCT00450866|4153694|P1|STARTED|Overall Study||45
1699201|NCT00450801|4153704|P1|NOT COMPLETED|Overall Study||1
1699202|NCT00450801|4153704|P1|COMPLETED|Overall Study||21
1699203|NCT00450801|4153704|P1|STARTED|Overall Study||22
1699204|NCT00450749|4153718|P3|NOT COMPLETED|Overall Study||2
1699205|NCT00450749|4153719|P2|NOT COMPLETED|Overall Study||1
1699206|NCT00450749|4153720|P1|NOT COMPLETED|Overall Study||0
1699207|NCT00450749|4153718|P3|COMPLETED|Overall Study||2
1699208|NCT00450749|4153719|P2|COMPLETED|Overall Study||2
1699209|NCT00450749|4153720|P1|COMPLETED|Overall Study||3
1699210|NCT00450749|4153718|P3|STARTED|Overall Study||4
1699211|NCT00450749|4153719|P2|STARTED|Overall Study||3
1699212|NCT00450749|4153720|P1|STARTED|Overall Study||3
1699213|NCT00450723|4153728|P1|NOT COMPLETED|Overall Study||5
1699214|NCT00450723|4153728|P1|COMPLETED|Overall Study||34
1699215|NCT00450723|4153728|P1|STARTED|Overall Study||39
1699216|NCT00450658|4153736|P2|NOT COMPLETED|Overall Study||90
1699217|NCT00450658|4153737|P1|NOT COMPLETED|Overall Study||143
1699218|NCT00450658|4153736|P2|COMPLETED|Overall Study||122
1699219|NCT00450658|4153737|P1|COMPLETED|Overall Study||272
1699220|NCT00450658|4153736|P2|STARTED|Overall Study||212
1699221|NCT00450658|4153737|P1|STARTED|Overall Study||415
1699222|NCT00450619|4153751|P2|NOT COMPLETED|Overall Study||1
1699223|NCT00450619|4153752|P1|NOT COMPLETED|Overall Study||4
1699224|NCT00450619|4153751|P2|COMPLETED|Overall Study||21
1699225|NCT00450619|4153752|P1|COMPLETED|Overall Study||18
1699226|NCT00450619|4153751|P2|STARTED|Overall Study||22
1699227|NCT00450619|4153752|P1|STARTED|Overall Study||22
1699228|NCT00450580|4153778|P2|NOT COMPLETED|Overall Study||16
1699229|NCT00450580|4153779|P1|NOT COMPLETED|Overall Study||16
1699230|NCT00450580|4153778|P2|COMPLETED|Overall Study||90
1699231|NCT00450580|4153779|P1|COMPLETED|Overall Study||90
1699232|NCT00450580|4153778|P2|STARTED|Overall Study||106
1699233|NCT00450580|4153779|P1|STARTED|Overall Study||106
1699234|NCT00450463|4153799|P2|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
1699235|NCT00450463|4153800|P1|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
1699236|NCT00450463|4153799|P2|COMPLETED|Progressed to Receive Vaccine Alone||0
1699237|NCT00450463|4153800|P1|COMPLETED|Progressed to Receive Vaccine Alone||11
1699238|NCT00450463|4153799|P2|STARTED|Progressed to Receive Vaccine Alone||0
1699239|NCT00450463|4153800|P1|STARTED|Progressed to Receive Vaccine Alone||11
1699240|NCT00450463|4153799|P2|NOT COMPLETED|Initial Drug Administration||0
1699241|NCT00450463|4153800|P1|NOT COMPLETED|Initial Drug Administration||0
1699242|NCT00450463|4153799|P2|COMPLETED|Initial Drug Administration||31
1699243|NCT00450463|4153800|P1|COMPLETED|Initial Drug Administration||33
1699244|NCT00450463|4153799|P2|STARTED|Initial Drug Administration||31
1699245|NCT00450463|4153800|P1|STARTED|Initial Drug Administration||33
1699246|NCT00450450|4153816|P2|NOT COMPLETED|Overall Study||3
1699247|NCT00450450|4153817|P1|NOT COMPLETED|Overall Study||5
1699248|NCT00450450|4153816|P2|COMPLETED|Overall Study||11
1699249|NCT00450450|4153817|P1|COMPLETED|Overall Study||8
1699250|NCT00450450|4153816|P2|STARTED|Overall Study||14
1699251|NCT00450450|4153817|P1|STARTED|Overall Study||13
1699252|NCT00450437|4153841|P4|NOT COMPLETED|Overall Study||11
1699253|NCT00450437|4153842|P3|NOT COMPLETED|Overall Study||24
1699254|NCT00450437|4153843|P2|NOT COMPLETED|Overall Study||16
1699255|NCT00450437|4153844|P1|NOT COMPLETED|Overall Study||46
1699256|NCT00450437|4153841|P4|COMPLETED|Overall Study||325
1699257|NCT00450437|4153842|P3|COMPLETED|Overall Study||999
1699258|NCT00450437|4153843|P2|COMPLETED|Overall Study||524
1699259|NCT00450437|4153844|P1|COMPLETED|Overall Study||1594
1699260|NCT00450437|4153841|P4|STARTED|Overall Study||336
1699261|NCT00450437|4153842|P3|STARTED|Overall Study||1023
1699262|NCT00450437|4153843|P2|STARTED|Overall Study||540
1699263|NCT00450437|4153844|P1|STARTED|Overall Study||1640
1699264|NCT00450424|4153868|P2|NOT COMPLETED|Overall Study||11
1699265|NCT00450424|4153869|P1|NOT COMPLETED|Overall Study||20
1699266|NCT00450424|4153868|P2|COMPLETED|Overall Study||106
1699267|NCT00450424|4153869|P1|COMPLETED|Overall Study||102
1699268|NCT00450424|4153868|P2|STARTED|Overall Study||117
1699269|NCT00450424|4153869|P1|STARTED|Overall Study||122
1699270|NCT00450411|4153875|P1|NOT COMPLETED|Overall Study||8
1699271|NCT00450411|4153875|P1|COMPLETED|Overall Study||92
1699272|NCT00450411|4153875|P1|STARTED|Overall Study||100
1699273|NCT00450385|4153880|P1|NOT COMPLETED|Overall Study||13
1699274|NCT00450385|4153880|P1|COMPLETED|Overall Study||44
1699275|NCT00450385|4153880|P1|STARTED|Overall Study||57
1699276|NCT00450372|4153889|P1|NOT COMPLETED|Overall Study||1
1699277|NCT00450372|4153889|P1|COMPLETED|Overall Study||37
1699278|NCT00450372|4153889|P1|STARTED|Overall Study||38
1699279|NCT00450333|4153902|P4|NOT COMPLETED|Overall Study||28
1699280|NCT00450333|4153903|P3|NOT COMPLETED|Overall Study||25
1699281|NCT00450333|4153904|P2|NOT COMPLETED|Overall Study||63
1699282|NCT00450333|4153905|P1|NOT COMPLETED|Overall Study||54
1699283|NCT00450333|4153902|P4|COMPLETED|Overall Study||74
1699284|NCT00450333|4153903|P3|COMPLETED|Overall Study||75
1699285|NCT00450333|4153904|P2|COMPLETED|Overall Study||44
1699286|NCT00450333|4153905|P1|COMPLETED|Overall Study||44
1699287|NCT00450333|4153902|P4|STARTED|Overall Study||102
1699288|NCT00450333|4153903|P3|STARTED|Overall Study||100
1699289|NCT00450333|4153904|P2|STARTED|Overall Study||107
1699290|NCT00450333|4153905|P1|STARTED|Overall Study||98
1699291|NCT00450294|4153923|P1|NOT COMPLETED|Overall Study||0
1699292|NCT00450294|4153923|P1|COMPLETED|Overall Study||10
1699293|NCT00450294|4153923|P1|STARTED|Overall Study||10
1699294|NCT00450255|4153928|P1|NOT COMPLETED|Overall Study||1
1699295|NCT00450255|4153928|P1|COMPLETED|Overall Study||40
1699296|NCT00450255|4153928|P1|STARTED|Overall Study||41
1699297|NCT00450242|4153938|P2|NOT COMPLETED|Overall Study||1
1699298|NCT00450242|4153939|P1|NOT COMPLETED|Overall Study||3
1699299|NCT00450242|4153938|P2|COMPLETED|Overall Study||6
1699300|NCT00450242|4153939|P1|COMPLETED|Overall Study||4
1699301|NCT00450242|4153938|P2|STARTED|Overall Study||7
1699302|NCT00450242|4153939|P1|STARTED|Overall Study||7
1699303|NCT00450216|4153953|P2|NOT COMPLETED|Overall Study||129
1699304|NCT00450216|4153954|P1|NOT COMPLETED|Overall Study||174
1699305|NCT00450216|4153953|P2|COMPLETED|Overall Study||170
1699306|NCT00450216|4153954|P1|COMPLETED|Overall Study||433
1699307|NCT00450216|4153953|P2|STARTED|Overall Study||299
1699308|NCT00450216|4153954|P1|STARTED|Overall Study||607
1699309|NCT00450190|4153966|P1|NOT COMPLETED|Overall Study||2
1699310|NCT00450190|4153966|P1|COMPLETED|Overall Study||18
1699311|NCT00450190|4153966|P1|STARTED|Overall Study||20
1699312|NCT00450112|4153976|P2|NOT COMPLETED|Overall Study||6
1699313|NCT00450112|4153977|P1|NOT COMPLETED|Overall Study||13
1699314|NCT00450112|4153976|P2|COMPLETED|Overall Study||71
1699315|NCT00450112|4153977|P1|COMPLETED|Overall Study||112
1699316|NCT00450112|4153976|P2|Analyzed Participants|Overall Study||74
1699317|NCT00450112|4153977|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
1699318|NCT00450112|4153976|P2|Received Injection|Overall Study||74
1699319|NCT00450112|4153977|P1|Received Injection|Overall Study||125
1699320|NCT00450112|4153976|P2|STARTED|Overall Study||77
1699321|NCT00450112|4153977|P1|STARTED|Overall Study||125
1699322|NCT00450073|4154002|P3|NOT COMPLETED|Overall Study||1
1699323|NCT00450073|4154003|P2|NOT COMPLETED|Overall Study||0
1699324|NCT00450073|4154004|P1|NOT COMPLETED|Overall Study||1
1699325|NCT00450073|4154002|P3|COMPLETED|Overall Study||9
1699326|NCT00450073|4154003|P2|COMPLETED|Overall Study||10
1699327|NCT00450073|4154004|P1|COMPLETED|Overall Study||9
1699328|NCT00450073|4154002|P3|STARTED|Overall Study||10
1699329|NCT00450073|4154003|P2|STARTED|Overall Study||10
1699330|NCT00450073|4154004|P1|STARTED|Overall Study||10
1699331|NCT00449956|4154015|P3|NOT COMPLETED|Overall Study||9
1699332|NCT00449956|4154016|P2|NOT COMPLETED|Overall Study||4
1699333|NCT00449956|4154017|P1|NOT COMPLETED|Overall Study||10
1699334|NCT00449956|4154015|P3|COMPLETED|Overall Study||184
1699335|NCT00449956|4154016|P2|COMPLETED|Overall Study||88
1699336|NCT00449956|4154017|P1|COMPLETED|Overall Study||179
1699337|NCT00449956|4154015|P3|STARTED|Overall Study||193
1699338|NCT00449956|4154016|P2|STARTED|Overall Study||92
1699339|NCT00449956|4154017|P1|STARTED|Overall Study||189
1699340|NCT00449930|4154033|P2|NOT COMPLETED|Overall Study||75
1699341|NCT00449930|4154034|P1|NOT COMPLETED|Overall Study||61
1699342|NCT00449930|4154033|P2|COMPLETED|Overall Study||447
1699343|NCT00449930|4154034|P1|COMPLETED|Overall Study||467
1699344|NCT00449930|4154033|P2|STARTED|Overall Study||522
1699345|NCT00449930|4154034|P1|STARTED|Overall Study||528
1699346|NCT00449865|4154050|P2|NOT COMPLETED|Overall Study||534
1699347|NCT00449865|4154051|P1|NOT COMPLETED|Overall Study||522
1699348|NCT00449865|4154050|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
1699349|NCT00449865|4154051|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
1699350|NCT00449865|4154050|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
1699351|NCT00449865|4154051|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
1699352|NCT00449865|4154050|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
1699353|NCT00449865|4154051|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
1699354|NCT00449865|4154050|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
1699355|NCT00449865|4154051|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
1699356|NCT00449865|4154050|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
1699357|NCT00449865|4154051|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
1699358|NCT00449865|4154050|P2|STARTED|Overall Study||874
1699359|NCT00449865|4154051|P1|STARTED|Overall Study||867
1699360|NCT00449787|4154059|P2|NOT COMPLETED|Overall Study||100
1699361|NCT00449787|4154060|P1|NOT COMPLETED|Overall Study||105
1699362|NCT00449787|4154059|P2|COMPLETED|Overall Study||98
1699363|NCT00449787|4154060|P1|COMPLETED|Overall Study||98
1699364|NCT00449787|4154059|P2|STARTED|Overall Study||198
1699365|NCT00449787|4154060|P1|STARTED|Overall Study||203
1699366|NCT00449748|4154070|P1|NOT COMPLETED|Overall Study||0
1699367|NCT00449748|4154070|P1|COMPLETED|Overall Study||10
1699368|NCT00449748|4154070|P1|STARTED|Overall Study||10
1699369|NCT00449696|4154076|P2|NOT COMPLETED|Overall Study||9
1699370|NCT00449696|4154077|P1|NOT COMPLETED|Overall Study||20
1699371|NCT00449696|4154076|P2|COMPLETED|Overall Study||119
1699372|NCT00449696|4154077|P1|COMPLETED|Overall Study||231
1699373|NCT00449696|4154076|P2|Analyzed Participants|Overall Study||128
1699374|NCT00449696|4154077|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
1699375|NCT00449696|4154076|P2|Received Injection|Overall Study||128
1699376|NCT00449696|4154077|P1|Received Injection|Overall Study||249
1699377|NCT00449696|4154076|P2|STARTED|Overall Study||128
1699378|NCT00449696|4154077|P1|STARTED|Overall Study||251
1699379|NCT00449644|4154103|P4|NOT COMPLETED|Overall Study||32
1699380|NCT00449644|4154104|P3|NOT COMPLETED|Overall Study||29
1699381|NCT00449644|4154105|P2|NOT COMPLETED|Overall Study||13
1699382|NCT00449644|4154106|P1|NOT COMPLETED|Overall Study||10
1699383|NCT00449644|4154103|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
1699384|NCT00449644|4154104|P3|COMPLETED|Overall Study||50
1699385|NCT00449644|4154105|P2|COMPLETED|Overall Study||11
1699386|NCT00449644|4154106|P1|COMPLETED|Overall Study||13
1699387|NCT00449644|4154103|P4|Rollover|Overall Study||1
1699388|NCT00449644|4154104|P3|Rollover|Overall Study||0
1699389|NCT00449644|4154105|P2|Rollover|Overall Study||0
1699390|NCT00449644|4154106|P1|Rollover|Overall Study||0
1699391|NCT00449644|4154103|P4|STARTED|Overall Study||81
1699392|NCT00449644|4154104|P3|STARTED|Overall Study||79
1699393|NCT00449644|4154105|P2|STARTED|Overall Study||24
1699394|NCT00449644|4154106|P1|STARTED|Overall Study||23
1699395|NCT00449540|4154126|P3|NOT COMPLETED|Treatment Phase||17
1699396|NCT00449540|4154127|P2|NOT COMPLETED|Treatment Phase||20
1699397|NCT00449540|4154128|P1|NOT COMPLETED|Treatment Phase||0
1699398|NCT00449540|4154126|P3|COMPLETED|Treatment Phase||82
1699399|NCT00449540|4154127|P2|COMPLETED|Treatment Phase||82
1699400|NCT00449540|4154128|P1|COMPLETED|Treatment Phase||0
1699401|NCT00449540|4154126|P3|STARTED|Treatment Phase||99
1699402|NCT00449540|4154127|P2|STARTED|Treatment Phase||102
1699403|NCT00449540|4154128|P1|STARTED|Treatment Phase||0
1699404|NCT00449540|4154126|P3|NOT COMPLETED|Pretreatment Phase||0
1699405|NCT00449540|4154127|P2|NOT COMPLETED|Pretreatment Phase||0
1699406|NCT00449540|4154128|P1|NOT COMPLETED|Pretreatment Phase||66
1699407|NCT00449540|4154126|P3|COMPLETED|Pretreatment Phase||0
1699408|NCT00449540|4154127|P2|COMPLETED|Pretreatment Phase||0
1699409|NCT00449540|4154128|P1|COMPLETED|Pretreatment Phase||201
1699410|NCT00449540|4154126|P3|STARTED|Pretreatment Phase||0
1699411|NCT00449540|4154127|P2|STARTED|Pretreatment Phase||0
1699412|NCT00449540|4154128|P1|STARTED|Pretreatment Phase||267
1699413|NCT00449176|4154145|P3|NOT COMPLETED|Overall Study||167
1699414|NCT00449176|4154146|P2|NOT COMPLETED|Overall Study||195
1699415|NCT00449176|4154147|P1|NOT COMPLETED|Overall Study||152
1699416|NCT00449176|4154145|P3|COMPLETED|Overall Study||152
1699417|NCT00449176|4154146|P2|COMPLETED|Overall Study||133
1699418|NCT00449176|4154147|P1|COMPLETED|Overall Study||166
1699419|NCT00449176|4154145|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
1699420|NCT00449176|4154146|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
1699421|NCT00449176|4154147|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
1699422|NCT00449163|4154173|P1|NOT COMPLETED|Overall Study||3
1699423|NCT00449163|4154173|P1|COMPLETED|Overall Study||22
1699424|NCT00449163|4154173|P1|STARTED|Overall Study||25
1699425|NCT00449150|4154183|P3|NOT COMPLETED|Overall Study||47
1699426|NCT00449150|4154184|P2|NOT COMPLETED|Overall Study||53
1699427|NCT00449150|4154185|P1|NOT COMPLETED|Overall Study||46
1699428|NCT00449150|4154183|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
1699429|NCT00449150|4154184|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
1699430|NCT00449150|4154185|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
1699431|NCT00449150|4154183|P3|STARTED|Overall Study||218
1699432|NCT00449150|4154184|P2|STARTED|Overall Study||230
1699433|NCT00449150|4154185|P1|STARTED|Overall Study||219
1699434|NCT00449072|4154198|P2|NOT COMPLETED|Overall Study||42
1699435|NCT00449072|4154199|P1|NOT COMPLETED|Overall Study||41
1699436|NCT00449072|4154198|P2|COMPLETED|Overall Study||109
1699437|NCT00449072|4154199|P1|COMPLETED|Overall Study||107
1699438|NCT00449072|4154198|P2|STARTED|Overall Study||151
1699439|NCT00449072|4154199|P1|STARTED|Overall Study||148
1699440|NCT00449046|4154223|P1|NOT COMPLETED|Overall Study||0
1699441|NCT00449046|4154223|P1|COMPLETED|Overall Study||40
1699442|NCT00449046|4154223|P1|STARTED|Overall Study||40
1699443|NCT00449033|4154236|P2|NOT COMPLETED|Follow-up Period||434
1699444|NCT00449033|4154237|P1|NOT COMPLETED|Follow-up Period||425
1699445|NCT00449033|4154236|P2|COMPLETED|Follow-up Period||0
1699446|NCT00449033|4154237|P1|COMPLETED|Follow-up Period||0
1699447|NCT00449033|4154236|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
1699448|NCT00449033|4154237|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
1699449|NCT00449033|4154236|P2|NOT COMPLETED|Treatment Period||452
1699450|NCT00449033|4154237|P1|NOT COMPLETED|Treatment Period||452
1699451|NCT00449033|4154236|P2|COMPLETED|Treatment Period||0
1699452|NCT00449033|4154237|P1|COMPLETED|Treatment Period||0
1699453|NCT00449033|4154236|P2|Received Treatment|Treatment Period||449
1699454|NCT00449033|4154237|P1|Received Treatment|Treatment Period||452
1699455|NCT00449033|4154236|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
1699456|NCT00449033|4154237|P1|STARTED|Treatment Period||452
1699457|NCT00448916|4154275|P4|NOT COMPLETED|Overall Study||6
1699458|NCT00448916|4154276|P3|NOT COMPLETED|Overall Study||6
1699459|NCT00448916|4154277|P2|NOT COMPLETED|Overall Study||6
1699460|NCT00448916|4154278|P1|NOT COMPLETED|Overall Study||7
1699461|NCT00448916|4154275|P4|COMPLETED|Overall Study||5
1699462|NCT00448916|4154276|P3|COMPLETED|Overall Study||6
1699463|NCT00448916|4154277|P2|COMPLETED|Overall Study||9
1699464|NCT00448916|4154278|P1|COMPLETED|Overall Study||9
1699465|NCT00448916|4154275|P4|STARTED|Overall Study||11
1699466|NCT00448916|4154276|P3|STARTED|Overall Study||12
1699467|NCT00448916|4154277|P2|STARTED|Overall Study||15
1699468|NCT00448916|4154278|P1|STARTED|Overall Study||16
1699469|NCT00448864|4154352|P3|NOT COMPLETED|Overall Study||1
1699470|NCT00448864|4154353|P2|NOT COMPLETED|Overall Study||5
1699471|NCT00448864|4154354|P1|NOT COMPLETED|Overall Study||5
1699472|NCT00448864|4154352|P3|COMPLETED|Overall Study||18
1699473|NCT00448864|4154353|P2|COMPLETED|Overall Study||24
1699474|NCT00448864|4154354|P1|COMPLETED|Overall Study||22
1699475|NCT00448864|4154352|P3|Completed Post-operative Period|Overall Study||18
1699476|NCT00448864|4154353|P2|Completed Post-operative Period|Overall Study||25
1699477|NCT00448864|4154354|P1|Completed Post-operative Period|Overall Study||26
1699478|NCT00448864|4154352|P3|Started Post-operative Period|Overall Study||18
1699479|NCT00448864|4154353|P2|Started Post-operative Period|Overall Study||25
1699480|NCT00448864|4154354|P1|Started Post-operative Period|Overall Study||26
1699481|NCT00448864|4154352|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
1699482|NCT00448864|4154353|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
1699483|NCT00448864|4154354|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
1699484|NCT00448864|4154352|P3|STARTED|Overall Study||19
1699485|NCT00448864|4154353|P2|STARTED|Overall Study||29
1699486|NCT00448864|4154354|P1|STARTED|Overall Study||27
1699487|NCT00448760|4154370|P1|NOT COMPLETED|Overall Study||3
1699488|NCT00448760|4154370|P1|COMPLETED|Overall Study||26
1699489|NCT00448760|4154370|P1|STARTED|Overall Study||29
1699490|NCT00448708|4154379|P2|NOT COMPLETED|Overall Study||31
1699491|NCT00448708|4154380|P1|NOT COMPLETED|Overall Study||35
1699492|NCT00448708|4154379|P2|COMPLETED|Overall Study||79
1699493|NCT00448708|4154380|P1|COMPLETED|Overall Study||77
1699494|NCT00448708|4154379|P2|STARTED|Overall Study||110
1699495|NCT00448708|4154380|P1|STARTED|Overall Study||112
1699496|NCT00448682|4154388|P1|NOT COMPLETED|Overall Study||0
1699497|NCT00448682|4154388|P1|COMPLETED|Overall Study||25
1699498|NCT00448682|4154388|P1|STARTED|Overall Study||25
1699499|NCT00448630|4154394|P1|NOT COMPLETED|Overall Study||27
1699500|NCT00448630|4154394|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
1699501|NCT00448630|4154394|P1|STARTED|Overall Study||328
1699502|NCT00448591|4154439|P1|NOT COMPLETED|Overall Study||2296
1699503|NCT00448591|4154439|P1|COMPLETED|Overall Study||0
1699504|NCT00448591|4154439|P1|STARTED|Overall Study||2296
1699505|NCT00448539|4154450|P2|NOT COMPLETED|Overall Study||152
1699506|NCT00448539|4154451|P1|NOT COMPLETED|Overall Study||134
1699507|NCT00448539|4154450|P2|COMPLETED|Overall Study||0
1699508|NCT00448539|4154451|P1|COMPLETED|Overall Study||0
1699509|NCT00448539|4154450|P2|STARTED|Overall Study||152
1699510|NCT00448539|4154451|P1|STARTED|Overall Study||134
1699511|NCT00448448|4154459|P2|NOT COMPLETED|Overall Study||41
1699512|NCT00448448|4154460|P1|NOT COMPLETED|Overall Study||100
1699513|NCT00448448|4154459|P2|COMPLETED|Overall Study||96
1699514|NCT00448448|4154460|P1|COMPLETED|Overall Study||146
1699515|NCT00448448|4154459|P2|STARTED|Overall Study||137
1699516|NCT00448448|4154460|P1|STARTED|Overall Study||246
1699517|NCT00448435|4154466|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
1699518|NCT00448435|4154467|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
1699519|NCT00448435|4154466|P2|COMPLETED|Extension Period - 20 Weeks||0
1699520|NCT00448435|4154467|P1|COMPLETED|Extension Period - 20 Weeks||50
1699521|NCT00448435|4154466|P2|STARTED|Extension Period - 20 Weeks||0
1699522|NCT00448435|4154467|P1|STARTED|Extension Period - 20 Weeks||50
1699523|NCT00448435|4154466|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
1699524|NCT00448435|4154467|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
1699525|NCT00448435|4154466|P2|COMPLETED|Treatment Period II - 4 Weeks||25
1699526|NCT00448435|4154467|P1|COMPLETED|Treatment Period II - 4 Weeks||25
1699527|NCT00448435|4154466|P2|STARTED|Treatment Period II - 4 Weeks||25
1699528|NCT00448435|4154467|P1|STARTED|Treatment Period II - 4 Weeks||25
1699529|NCT00448435|4154466|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
1699530|NCT00448435|4154467|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
1699531|NCT00448435|4154466|P2|COMPLETED|Washout Period - 2 Weeks||25
1699532|NCT00448435|4154467|P1|COMPLETED|Washout Period - 2 Weeks||25
1699533|NCT00448435|4154466|P2|STARTED|Washout Period - 2 Weeks||25
1699534|NCT00448435|4154467|P1|STARTED|Washout Period - 2 Weeks||26
1699535|NCT00448435|4154466|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
1699536|NCT00448435|4154467|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
1699537|NCT00448435|4154466|P2|COMPLETED|Treatment Period I - 4 Weeks||25
1699538|NCT00448435|4154467|P1|COMPLETED|Treatment Period I - 4 Weeks||26
1699539|NCT00448435|4154466|P2|STARTED|Treatment Period I - 4 Weeks||25
1699540|NCT00448435|4154467|P1|STARTED|Treatment Period I - 4 Weeks||26
1699541|NCT00448357|4154493|P1|NOT COMPLETED|Overall Study||0
1699542|NCT00448357|4154493|P1|COMPLETED|Overall Study||54
1699543|NCT00448357|4154493|P1|STARTED|Overall Study||54
1699544|NCT00448344|4154518|P2|NOT COMPLETED|Overall Study||36
1699545|NCT00448344|4154519|P1|NOT COMPLETED|Overall Study||30
1699546|NCT00448344|4154518|P2|COMPLETED|Overall Study||200
1699547|NCT00448344|4154519|P1|COMPLETED|Overall Study||205
1699548|NCT00448344|4154518|P2|STARTED|Overall Study||236
1699549|NCT00448344|4154519|P1|STARTED|Overall Study||235
1699550|NCT00448279|4154529|P2|NOT COMPLETED|Overall Study||29
1699551|NCT00448279|4154530|P1|NOT COMPLETED|Overall Study||29
1699552|NCT00448279|4154529|P2|COMPLETED|Overall Study||0
1699553|NCT00448279|4154530|P1|COMPLETED|Overall Study||0
1699554|NCT00448279|4154529|P2|STARTED|Overall Study||29
1699555|NCT00448279|4154530|P1|STARTED|Overall Study||29
1699556|NCT00448227|4154546|P1|NOT COMPLETED|Overall Study||0
1699557|NCT00448227|4154546|P1|COMPLETED|Overall Study||18
1699558|NCT00448227|4154546|P1|STARTED|Overall Study||18
1699559|NCT00448201|4154573|P1|NOT COMPLETED|Overall Study||0
1699560|NCT00448201|4154573|P1|COMPLETED|Overall Study||71
1699561|NCT00448201|4154573|P1|STARTED|Overall Study||71
1699562|NCT00448175|4154584|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
1699563|NCT00448175|4154585|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
1699564|NCT00448175|4154584|P2|COMPLETED|Continued PTNS Through 12 Months||0
1699565|NCT00448175|4154585|P1|COMPLETED|Continued PTNS Through 12 Months||25
1699566|NCT00448175|4154584|P2|STARTED|Continued PTNS Through 12 Months||0
1699567|NCT00448175|4154585|P1|STARTED|Continued PTNS Through 12 Months||35
1699568|NCT00448175|4154584|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
1699569|NCT00448175|4154585|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
1699570|NCT00448175|4154584|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
1699571|NCT00448175|4154585|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
1699572|NCT00448175|4154584|P2|STARTED|12 Weeks PTNS vs. Drug||50
1699573|NCT00448175|4154585|P1|STARTED|12 Weeks PTNS vs. Drug||50
1699574|NCT00448136|4154593|P2|NOT COMPLETED|Overall Study||8
1699575|NCT00448136|4154594|P1|NOT COMPLETED|Overall Study||4
1699576|NCT00448136|4154593|P2|COMPLETED|Overall Study||41
1699577|NCT00448136|4154594|P1|COMPLETED|Overall Study||30
1699578|NCT00448136|4154593|P2|STARTED|Overall Study||49
1699579|NCT00448136|4154594|P1|STARTED|Overall Study||34
1699580|NCT00448123|4154632|P2|NOT COMPLETED|Overall Study||12
1699581|NCT00448123|4154633|P1|NOT COMPLETED|Overall Study||15
1699582|NCT00448123|4154632|P2|COMPLETED|Overall Study||53
1699583|NCT00448123|4154633|P1|COMPLETED|Overall Study||47
1699584|NCT00448123|4154632|P2|STARTED|Overall Study||65
1699585|NCT00448123|4154633|P1|STARTED|Overall Study||62
1699586|NCT00448019|4154643|P1|NOT COMPLETED|Overall Study||7
1699587|NCT00448019|4154643|P1|COMPLETED|Overall Study||57
1699588|NCT00448019|4154643|P1|STARTED|Overall Study||64
1699589|NCT00447902|4154651|P2|NOT COMPLETED|Overall Study||6
1699590|NCT00447902|4154652|P1|NOT COMPLETED|Overall Study||4
1699591|NCT00447902|4154651|P2|COMPLETED|Overall Study||0
1699592|NCT00447902|4154652|P1|COMPLETED|Overall Study||1
1699593|NCT00447902|4154651|P2|STARTED|Overall Study||6
1699594|NCT00447902|4154652|P1|STARTED|Overall Study||5
1699595|NCT00447876|4154694|P2|NOT COMPLETED|Overall Study||4
1699596|NCT00447876|4154695|P1|NOT COMPLETED|Overall Study||3
1699597|NCT00447876|4154694|P2|COMPLETED|Overall Study||16
1699598|NCT00447876|4154695|P1|COMPLETED|Overall Study||17
1699599|NCT00447876|4154694|P2|STARTED|Overall Study||20
1699600|NCT00447876|4154695|P1|STARTED|Overall Study||20
1699601|NCT00447772|4154725|P1|NOT COMPLETED|Overall Study||27
1699602|NCT00447772|4154725|P1|COMPLETED|Overall Study||489
1699603|NCT00447772|4154725|P1|STARTED|Overall Study||516
1699604|NCT00447603|4154745|P3|NOT COMPLETED|Filter Period||15
1699605|NCT00447603|4154746|P2|NOT COMPLETED|Filter Period||4
1699606|NCT00447603|4154747|P1|NOT COMPLETED|Filter Period||0
1699607|NCT00447603|4154745|P3|COMPLETED|Filter Period||0
1699608|NCT00447603|4154746|P2|COMPLETED|Filter Period||0
1699609|NCT00447603|4154747|P1|COMPLETED|Filter Period||0
1699610|NCT00447603|4154745|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
1699611|NCT00447603|4154746|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
1699612|NCT00447603|4154747|P1|STARTED|Filter Period||0
1699613|NCT00447603|4154745|P3|NOT COMPLETED|Screening||0
1699614|NCT00447603|4154746|P2|NOT COMPLETED|Screening||0
1699615|NCT00447603|4154747|P1|NOT COMPLETED|Screening||21
1699616|NCT00447603|4154745|P3|COMPLETED|Screening||0
1699617|NCT00447603|4154746|P2|COMPLETED|Screening||0
1699618|NCT00447603|4154747|P1|COMPLETED|Screening||19
1699619|NCT00447603|4154745|P3|STARTED|Screening||0
1699620|NCT00447603|4154746|P2|STARTED|Screening||0
1699621|NCT00447603|4154747|P1|STARTED|Screening||40
1699622|NCT00447590|4154767|P1|NOT COMPLETED|Overall Study||60
1699623|NCT00447590|4154767|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
1699624|NCT00447590|4154767|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
1699625|NCT00447499|4154776|P1|NOT COMPLETED|Overall Study||7
1699626|NCT00447499|4154776|P1|COMPLETED|Overall Study||52
1699627|NCT00447499|4154776|P1|STARTED|Overall Study||59
1699628|NCT00447421|4154786|P1|NOT COMPLETED|Overall Study||6
1699629|NCT00447421|4154786|P1|COMPLETED|Overall Study||3
1699630|NCT00447421|4154786|P1|STARTED|Overall Study||9
1699631|NCT00447382|4154798|P2|NOT COMPLETED|Overall Study||6
1699632|NCT00447382|4154799|P1|NOT COMPLETED|Overall Study||6
1699633|NCT00447382|4154798|P2|COMPLETED|Overall Study||160
1699634|NCT00447382|4154799|P1|COMPLETED|Overall Study||158
1699635|NCT00447382|4154798|P2|STARTED|Overall Study||166
1699636|NCT00447382|4154799|P1|STARTED|Overall Study||164
1699637|NCT00447330|4154851|P1|NOT COMPLETED|Overall Study||2
1699638|NCT00447330|4154851|P1|COMPLETED|Overall Study||58
1699639|NCT00447330|4154851|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
1699640|NCT00447278|4154860|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
1699641|NCT00447278|4154861|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
1699642|NCT00447278|4154860|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
1699643|NCT00447278|4154861|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
1699644|NCT00447278|4154860|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
1699645|NCT00447278|4154861|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
1699646|NCT00447278|4154860|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
1699647|NCT00447278|4154861|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
1699648|NCT00447278|4154860|P2|COMPLETED|Period II (6 Month Open-Label)||171
1699649|NCT00447278|4154861|P1|COMPLETED|Period II (6 Month Open-Label)||157
1699650|NCT00447278|4154860|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
1699651|NCT00447278|4154861|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
1699652|NCT00447278|4154860|P2|STARTED|Period II (6 Month Open-Label)||200
1699653|NCT00447278|4154861|P1|STARTED|Period II (6 Month Open-Label)||199
1699654|NCT00447265|4154882|P2|NOT COMPLETED|Overall Study||0
1699655|NCT00447265|4154883|P1|NOT COMPLETED|Overall Study||1
1699656|NCT00447265|4154882|P2|COMPLETED|Overall Study||0
1699657|NCT00447265|4154883|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
1699658|NCT00447265|4154882|P2|STARTED|Overall Study||0
1699659|NCT00447265|4154883|P1|STARTED|Overall Study||1
1699660|NCT00447226|4154896|P2|NOT COMPLETED|Double-blind Phase||3
1699661|NCT00447226|4154897|P1|NOT COMPLETED|Double-blind Phase||4
1699662|NCT00447226|4154896|P2|COMPLETED|Double-blind Phase||0
1699663|NCT00447226|4154897|P1|COMPLETED|Double-blind Phase||0
1699664|NCT00447226|4154896|P2|STARTED|Double-blind Phase||3
1699665|NCT00447226|4154897|P1|STARTED|Double-blind Phase||4
1699666|NCT00447226|4154896|P2|NOT COMPLETED|12-Week Open-label Phase||25
1699667|NCT00447226|4154897|P1|NOT COMPLETED|12-Week Open-label Phase||0
1699668|NCT00447226|4154896|P2|COMPLETED|12-Week Open-label Phase||7
1699669|NCT00447226|4154897|P1|COMPLETED|12-Week Open-label Phase||0
1699670|NCT00447226|4154896|P2|STARTED|12-Week Open-label Phase||32
1699671|NCT00447226|4154897|P1|STARTED|12-Week Open-label Phase||0
1699672|NCT00447122|4154915|P1|NOT COMPLETED|Overall Study||2
1699673|NCT00447122|4154915|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
1699674|NCT00447122|4154915|P1|STARTED|Overall Study||31
1699675|NCT00447083|4154921|P4|NOT COMPLETED|Phase II||1
1699676|NCT00447083|4154922|P3|NOT COMPLETED|Phase II||1
1699677|NCT00447083|4154923|P2|NOT COMPLETED|Phase II||0
1699678|NCT00447083|4154924|P1|NOT COMPLETED|Phase II||0
1699679|NCT00447083|4154921|P4|COMPLETED|Phase II||7
1699680|NCT00447083|4154922|P3|COMPLETED|Phase II||7
1699681|NCT00447083|4154923|P2|COMPLETED|Phase II||0
1699682|NCT00447083|4154924|P1|COMPLETED|Phase II||0
1699683|NCT00447083|4154921|P4|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
1699684|NCT00447083|4154922|P3|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
1699685|NCT00447083|4154923|P2|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
1699686|NCT00447083|4154924|P1|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
1699687|NCT00447083|4154921|P4|NOT COMPLETED|Phase I||0
1699688|NCT00447083|4154922|P3|NOT COMPLETED|Phase I||0
1699689|NCT00447083|4154923|P2|NOT COMPLETED|Phase I||0
1699690|NCT00447083|4154924|P1|NOT COMPLETED|Phase I||0
1699691|NCT00447083|4154921|P4|COMPLETED|Phase I||0
1699692|NCT00447083|4154922|P3|COMPLETED|Phase I||0
1699693|NCT00447083|4154923|P2|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
1699694|NCT00447083|4154924|P1|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
1699695|NCT00447083|4154921|P4|STARTED|Phase I||0
1699696|NCT00447083|4154922|P3|STARTED|Phase I||0
1699697|NCT00447083|4154923|P2|STARTED|Phase I||9
1699698|NCT00447083|4154924|P1|STARTED|Phase I||10
1699699|NCT00447057|4154940|P4|NOT COMPLETED|Overall Study||26
1699700|NCT00447057|4154941|P3|NOT COMPLETED|Overall Study||19
1699701|NCT00447057|4154942|P2|NOT COMPLETED|Overall Study||73
1699702|NCT00447057|4154943|P1|NOT COMPLETED|Overall Study||83
1699703|NCT00447057|4154940|P4|COMPLETED|Overall Study||0
1699704|NCT00447057|4154941|P3|COMPLETED|Overall Study||0
1699705|NCT00447057|4154942|P2|COMPLETED|Overall Study||3
1699706|NCT00447057|4154943|P1|COMPLETED|Overall Study||0
1699707|NCT00447057|4154940|P4|STARTED|Overall Study||26
1699708|NCT00447057|4154941|P3|STARTED|Overall Study||19
1699709|NCT00447057|4154942|P2|STARTED|Overall Study||76
1699710|NCT00447057|4154943|P1|STARTED|Overall Study||83
1699711|NCT00447005|4154961|P1|NOT COMPLETED|Overall Study||12
1699712|NCT00447005|4154961|P1|COMPLETED|Overall Study||0
1699713|NCT00447005|4154961|P1|STARTED|Overall Study||12
1699714|NCT00446992|4154975|P1|NOT COMPLETED|Overall Study||16
1699715|NCT00446992|4154975|P1|COMPLETED|Overall Study|Intervention Completion|14
1699716|NCT00446992|4154975|P1|STARTED|Overall Study|Beginning of Intervention|30
1699717|NCT00446966|4154989|P2|NOT COMPLETED|Overall Study||7
1699718|NCT00446966|4154990|P1|NOT COMPLETED|Overall Study||10
1699719|NCT00446966|4154989|P2|COMPLETED|Overall Study||123
1699720|NCT00446966|4154990|P1|COMPLETED|Overall Study||120
1699721|NCT00446966|4154989|P2|STARTED|Overall Study||130
1699722|NCT00446966|4154990|P1|STARTED|Overall Study||130
1699723|NCT00446849|4154996|P1|NOT COMPLETED|Maintenance Phase||70
1699724|NCT00446849|4154996|P1|COMPLETED|Maintenance Phase||138
1699725|NCT00446849|4154996|P1|STARTED|Maintenance Phase||208
1699726|NCT00446849|4154996|P1|NOT COMPLETED|Acute Phase||82
1699727|NCT00446849|4154996|P1|COMPLETED|Acute Phase||56
1699728|NCT00446849|4154996|P1|STARTED|Acute Phase||138
1699729|NCT00446797|4155008|P2|NOT COMPLETED|Overall Study||12
1699730|NCT00446797|4155009|P1|NOT COMPLETED|Overall Study||8
1699731|NCT00446797|4155008|P2|COMPLETED|Overall Study||125
1699732|NCT00446797|4155009|P1|COMPLETED|Overall Study||133
1699733|NCT00446797|4155008|P2|STARTED|Overall Study||137
1699734|NCT00446797|4155009|P1|STARTED|Overall Study||141
1699735|NCT00446654|4155055|P2|NOT COMPLETED|Overall Study||0
1699736|NCT00446654|4155056|P1|NOT COMPLETED|Overall Study||2
1699737|NCT00446654|4155055|P2|COMPLETED|Overall Study||22
1699738|NCT00446654|4155056|P1|COMPLETED|Overall Study||19
1699739|NCT00446654|4155055|P2|STARTED|Overall Study||22
1699740|NCT00446654|4155056|P1|STARTED|Overall Study||21
1699741|NCT00446641|4155064|P2|NOT COMPLETED|Overall Study||10
1699742|NCT00446641|4155065|P1|NOT COMPLETED|Overall Study||17
1699743|NCT00446641|4155064|P2|COMPLETED|Overall Study||109
1699744|NCT00446641|4155065|P1|COMPLETED|Overall Study||108
1699745|NCT00446641|4155064|P2|STARTED|Overall Study||119
1699746|NCT00446641|4155065|P1|STARTED|Overall Study||125
1699747|NCT00446563|4155085|P2|NOT COMPLETED|Overall Study||9
1699748|NCT00446563|4155086|P1|NOT COMPLETED|Overall Study||7
1699749|NCT00446563|4155085|P2|COMPLETED|Overall Study||38
1699750|NCT00446563|4155086|P1|COMPLETED|Overall Study||36
1699751|NCT00446563|4155085|P2|STARTED|Overall Study||47
1699752|NCT00446563|4155086|P1|STARTED|Overall Study||43
1699753|NCT00446550|4155122|P2|NOT COMPLETED|Overall Study||0
1699754|NCT00446550|4155123|P1|NOT COMPLETED|Overall Study||1
1699755|NCT00446550|4155122|P2|COMPLETED|Overall Study||8
1699756|NCT00446550|4155123|P1|COMPLETED|Overall Study||10
1699757|NCT00446550|4155122|P2|PD Population|Overall Study||8
1699758|NCT00446550|4155123|P1|PD Population|Overall Study||11
1699759|NCT00446550|4155122|P2|Safety Population|Overall Study||8
1699760|NCT00446550|4155123|P1|Safety Population|Overall Study||11
1699761|NCT00446550|4155122|P2|STARTED|Overall Study||8
1699762|NCT00446550|4155123|P1|STARTED|Overall Study||11
1699763|NCT00446511|4155135|P4|NOT COMPLETED|Overall Study||6
1699764|NCT00446511|4155136|P3|NOT COMPLETED|Overall Study||7
1699765|NCT00446511|4155137|P2|NOT COMPLETED|Overall Study||2
1699766|NCT00446511|4155138|P1|NOT COMPLETED|Overall Study||10
1699767|NCT00446511|4155135|P4|COMPLETED|Overall Study||103
1699768|NCT00446511|4155136|P3|COMPLETED|Overall Study||96
1699769|NCT00446511|4155137|P2|COMPLETED|Overall Study||15
1699770|NCT00446511|4155138|P1|COMPLETED|Overall Study||11
1699771|NCT00446511|4155135|P4|STARTED|Overall Study||109
1699772|NCT00446511|4155136|P3|STARTED|Overall Study||103
1699773|NCT00446511|4155137|P2|STARTED|Overall Study||17
1699774|NCT00446511|4155138|P1|STARTED|Overall Study||21
1699775|NCT00446459|4155162|P1|NOT COMPLETED|12 Months||18
1699776|NCT00446459|4155162|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
1699777|NCT00446459|4155162|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
1699778|NCT00446459|4155162|P1|NOT COMPLETED|8 Months||12
1699779|NCT00446459|4155162|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
1699780|NCT00446459|4155162|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
1699781|NCT00446446|4155170|P1|NOT COMPLETED|Overall Study||24
1699782|NCT00446446|4155170|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
1699783|NCT00446446|4155170|P1|STARTED|Overall Study||52
1699784|NCT00446290|4155181|P1|NOT COMPLETED|Overall Study||0
1699785|NCT00446290|4155181|P1|COMPLETED|Overall Study||22
1699786|NCT00446290|4155181|P1|STARTED|Overall Study||22
1699787|NCT00446264|4155185|P1|NOT COMPLETED|Overall Study||0
1699788|NCT00446264|4155185|P1|COMPLETED|Overall Study||14
1699789|NCT00446264|4155185|P1|STARTED|Overall Study||14
1699790|NCT00446251|4155194|P1|NOT COMPLETED|Overall Study||5
1699791|NCT00446251|4155194|P1|COMPLETED|Overall Study||9
1699792|NCT00446251|4155194|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
1699793|NCT00446199|4155204|P4|NOT COMPLETED|Overall Study||30
1699794|NCT00446199|4155205|P3|NOT COMPLETED|Overall Study||27
1699795|NCT00446199|4155206|P2|NOT COMPLETED|Overall Study||20
1699796|NCT00446199|4155207|P1|NOT COMPLETED|Overall Study||23
1699797|NCT00446199|4155204|P4|COMPLETED|Overall Study||153
1699798|NCT00446199|4155205|P3|COMPLETED|Overall Study||158
1699799|NCT00446199|4155206|P2|COMPLETED|Overall Study||164
1699800|NCT00446199|4155207|P1|COMPLETED|Overall Study||160
1699801|NCT00446199|4155204|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
1699802|NCT00446199|4155205|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
1699803|NCT00446199|4155206|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
1699804|NCT00446199|4155207|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
1699805|NCT00446199|4155204|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
1699806|NCT00446199|4155205|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
1699807|NCT00446199|4155206|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
1699808|NCT00446199|4155207|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
1699809|NCT00446199|4155204|P4|STARTED|Overall Study||183
1699810|NCT00446199|4155205|P3|STARTED|Overall Study||185
1699811|NCT00446199|4155206|P2|STARTED|Overall Study||184
1699812|NCT00446199|4155207|P1|STARTED|Overall Study||183
1699813|NCT00446147|4155287|P2|NOT COMPLETED|Overall Study||14
1699814|NCT00446147|4155288|P1|NOT COMPLETED|Overall Study||15
1699815|NCT00446147|4155287|P2|COMPLETED|Overall Study||180
1699816|NCT00446147|4155288|P1|COMPLETED|Overall Study||180
1699817|NCT00446147|4155287|P2|STARTED|Overall Study||194
1699818|NCT00446147|4155288|P1|STARTED|Overall Study||195
1699819|NCT00446134|4155300|P4|NOT COMPLETED|Overall Study||45
1699820|NCT00446134|4155301|P3|NOT COMPLETED|Overall Study||43
1699821|NCT00446134|4155302|P2|NOT COMPLETED|Overall Study||45
1699822|NCT00446134|4155303|P1|NOT COMPLETED|Overall Study||34
1699823|NCT00446134|4155300|P4|COMPLETED|Overall Study||25
1699824|NCT00446134|4155301|P3|COMPLETED|Overall Study||26
1699825|NCT00446134|4155302|P2|COMPLETED|Overall Study||25
1699826|NCT00446134|4155303|P1|COMPLETED|Overall Study||35
1699827|NCT00446134|4155300|P4|STARTED|Overall Study||70
1699828|NCT00446134|4155301|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
1699829|NCT00446134|4155302|P2|STARTED|Overall Study||70
1699830|NCT00446134|4155303|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
1699831|NCT00446095|4155330|P5|NOT COMPLETED|Phase I (28 Days)||3
1699832|NCT00446095|4155331|P4|NOT COMPLETED|Phase I (28 Days)||1
1699833|NCT00446095|4155332|P3|NOT COMPLETED|Phase I (28 Days)||0
1699834|NCT00446095|4155333|P2|NOT COMPLETED|Phase I (28 Days)||0
1699835|NCT00446095|4155334|P1|NOT COMPLETED|Phase I (28 Days)||0
1699836|NCT00446095|4155330|P5|COMPLETED|Phase I (28 Days)||4
1699837|NCT00446095|4155331|P4|COMPLETED|Phase I (28 Days)||5
1699838|NCT00446095|4155332|P3|COMPLETED|Phase I (28 Days)||0
1699839|NCT00446095|4155333|P2|COMPLETED|Phase I (28 Days)||0
1699840|NCT00446095|4155334|P1|COMPLETED|Phase I (28 Days)||0
1699841|NCT00446095|4155330|P5|STARTED|Phase I (28 Days)||7
1699842|NCT00446095|4155331|P4|STARTED|Phase I (28 Days)||6
1699843|NCT00446095|4155332|P3|STARTED|Phase I (28 Days)||0
1699844|NCT00446095|4155333|P2|STARTED|Phase I (28 Days)||0
1699845|NCT00446095|4155334|P1|STARTED|Phase I (28 Days)||0
1699846|NCT00446095|4155330|P5|NOT COMPLETED|Phase II (8 Weeks)||0
1699847|NCT00446095|4155331|P4|NOT COMPLETED|Phase II (8 Weeks)||0
1699848|NCT00446095|4155332|P3|NOT COMPLETED|Phase II (8 Weeks)||3
1699849|NCT00446095|4155333|P2|NOT COMPLETED|Phase II (8 Weeks)||3
1699850|NCT00446095|4155334|P1|NOT COMPLETED|Phase II (8 Weeks)||12
1699851|NCT00446095|4155330|P5|COMPLETED|Phase II (8 Weeks)||0
1699852|NCT00446095|4155331|P4|COMPLETED|Phase II (8 Weeks)||0
1699853|NCT00446095|4155332|P3|COMPLETED|Phase II (8 Weeks)||21
1699854|NCT00446095|4155333|P2|COMPLETED|Phase II (8 Weeks)||18
1699855|NCT00446095|4155334|P1|COMPLETED|Phase II (8 Weeks)||11
1699856|NCT00446095|4155330|P5|STARTED|Phase II (8 Weeks)||0
1699857|NCT00446095|4155331|P4|STARTED|Phase II (8 Weeks)||0
1699858|NCT00446095|4155332|P3|STARTED|Phase II (8 Weeks)||24
1699859|NCT00446095|4155333|P2|STARTED|Phase II (8 Weeks)||21
1699860|NCT00446095|4155334|P1|STARTED|Phase II (8 Weeks)||23
1699861|NCT00446030|4155357|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
1699862|NCT00446030|4155358|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
1699863|NCT00446030|4155357|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
1699864|NCT00446030|4155358|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
1699865|NCT00446030|4155357|P2|STARTED|FOLLOW-UP (up to 2-years)||34
1699866|NCT00446030|4155358|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
1699867|NCT00446030|4155357|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
1699868|NCT00446030|4155358|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
1699869|NCT00446030|4155357|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
1699870|NCT00446030|4155358|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
1699871|NCT00446030|4155357|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
1699872|NCT00446030|4155358|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
1699873|NCT00446030|4155357|P2|STARTED|TREATMENT (up to 52 Weeks)||34
1699874|NCT00446030|4155358|P1|STARTED|TREATMENT (up to 52 Weeks)||93
1699875|NCT00445939|4155369|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
1699876|NCT00445939|4155370|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
1699877|NCT00445939|4155371|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
1699878|NCT00445939|4155372|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
1699879|NCT00445939|4155369|P4|COMPLETED|Period B - Week 4 - Week 8||20
1699880|NCT00445939|4155370|P3|COMPLETED|Period B - Week 4 - Week 8||0
1699881|NCT00445939|4155371|P2|COMPLETED|Period B - Week 4 - Week 8||0
1699882|NCT00445939|4155372|P1|COMPLETED|Period B - Week 4 - Week 8||14
1699883|NCT00445939|4155369|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
1699884|NCT00445939|4155370|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
1699885|NCT00445939|4155371|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
1699886|NCT00445939|4155372|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
1699887|NCT00445939|4155369|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
1699888|NCT00445939|4155370|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
1699889|NCT00445939|4155371|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
1699890|NCT00445939|4155372|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
1699891|NCT00445939|4155369|P4|COMPLETED|Period A - Week 0 - Week 4||0
1699892|NCT00445939|4155370|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
1699893|NCT00445939|4155371|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
1699894|NCT00445939|4155372|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
1699895|NCT00445939|4155369|P4|STARTED|Period A - Week 0 - Week 4||0
1699896|NCT00445939|4155370|P3|STARTED|Period A - Week 0 - Week 4||23
1699897|NCT00445939|4155371|P2|STARTED|Period A - Week 0 - Week 4||34
1699898|NCT00445939|4155372|P1|STARTED|Period A - Week 0 - Week 4||33
1699899|NCT00445887|4155397|P2|NOT COMPLETED|Overall Study||0
1699900|NCT00445887|4155398|P1|NOT COMPLETED|Overall Study||0
1699901|NCT00445887|4155397|P2|COMPLETED|Overall Study||31
1699902|NCT00445887|4155398|P1|COMPLETED|Overall Study||33
1699903|NCT00445887|4155397|P2|STARTED|Overall Study||31
1699904|NCT00445887|4155398|P1|STARTED|Overall Study||33
1699905|NCT00445848|4155420|P1|NOT COMPLETED|Overall Study||85
1699906|NCT00445848|4155420|P1|COMPLETED|Overall Study||0
1699907|NCT00445848|4155420|P1|STARTED|Overall Study||85
1699908|NCT00445770|4155430|P3|NOT COMPLETED|Overall Study||31
1699909|NCT00445770|4155431|P2|NOT COMPLETED|Overall Study||35
1699910|NCT00445770|4155432|P1|NOT COMPLETED|Overall Study||53
1699911|NCT00445770|4155430|P3|COMPLETED|Overall Study||151
1699912|NCT00445770|4155431|P2|COMPLETED|Overall Study||157
1699913|NCT00445770|4155432|P1|COMPLETED|Overall Study||123
1699914|NCT00445770|4155430|P3|STARTED|Overall Study||182
1699915|NCT00445770|4155431|P2|STARTED|Overall Study||192
1699916|NCT00445770|4155432|P1|STARTED|Overall Study||176
1699917|NCT00445744|4155499|P1|NOT COMPLETED|Overall Study||1
1699918|NCT00445744|4155499|P1|COMPLETED|Overall Study||51
1699919|NCT00445744|4155499|P1|STARTED|Overall Study||52
1699920|NCT00445705|4155508|P4|NOT COMPLETED|Overall Study||14
1699921|NCT00445705|4155509|P3|NOT COMPLETED|Overall Study||11
1699922|NCT00445705|4155510|P2|NOT COMPLETED|Overall Study||11
1699923|NCT00445705|4155511|P1|NOT COMPLETED|Overall Study||9
1699924|NCT00445705|4155508|P4|COMPLETED|Overall Study||39
1699925|NCT00445705|4155509|P3|COMPLETED|Overall Study||41
1699926|NCT00445705|4155510|P2|COMPLETED|Overall Study||42
1699927|NCT00445705|4155511|P1|COMPLETED|Overall Study||44
1699928|NCT00445705|4155508|P4|STARTED|Overall Study||53
1699929|NCT00445705|4155509|P3|STARTED|Overall Study||52
1699930|NCT00445705|4155510|P2|STARTED|Overall Study||53
1699931|NCT00445705|4155511|P1|STARTED|Overall Study||53
1699932|NCT00445692|4155533|P1|NOT COMPLETED|Overall Study||16
1699933|NCT00445692|4155533|P1|COMPLETED|Overall Study||15
1699934|NCT00445692|4155533|P1|STARTED|Overall Study||31
1699935|NCT00445679|4155543|P4|NOT COMPLETED|Overall Study||47
1699936|NCT00445679|4155544|P3|NOT COMPLETED|Overall Study||66
1699937|NCT00445679|4155545|P2|NOT COMPLETED|Overall Study||46
1699938|NCT00445679|4155546|P1|NOT COMPLETED|Overall Study||48
1699939|NCT00445679|4155543|P4|COMPLETED|Overall Study||149
1699940|NCT00445679|4155544|P3|COMPLETED|Overall Study||139
1699941|NCT00445679|4155545|P2|COMPLETED|Overall Study||157
1699942|NCT00445679|4155546|P1|COMPLETED|Overall Study||155
1699943|NCT00445679|4155543|P4|STARTED|Overall Study||196
1699944|NCT00445679|4155544|P3|STARTED|Overall Study||205
1699945|NCT00445679|4155545|P2|STARTED|Overall Study||203
1699946|NCT00445679|4155546|P1|STARTED|Overall Study||203
1699947|NCT00445601|4155582|P2|NOT COMPLETED|Overall Study||28
1699948|NCT00445601|4155583|P1|NOT COMPLETED|Overall Study||33
1699949|NCT00445601|4155582|P2|COMPLETED|Overall Study||177
1699950|NCT00445601|4155583|P1|COMPLETED|Overall Study||168
1699951|NCT00445601|4155582|P2|Received TURBT|Overall Study||193
1699952|NCT00445601|4155583|P1|Received TURBT|Overall Study||190
1699953|NCT00445601|4155582|P2|STARTED|Overall Study||205
1699954|NCT00445601|4155583|P1|STARTED|Overall Study||201
1699955|NCT00445588|4155595|P1|NOT COMPLETED|Overall Study||0
1699956|NCT00445588|4155595|P1|COMPLETED|Overall Study||56
1699957|NCT00445588|4155595|P1|STARTED|Overall Study||56
1699958|NCT00445549|4155600|P1|NOT COMPLETED|Overall Study||12
1699959|NCT00445549|4155600|P1|COMPLETED|Overall Study||0
1699960|NCT00445549|4155600|P1|STARTED|Overall Study||12
1699961|NCT00445484|4155607|P2|NOT COMPLETED|Overall Study||1
1699962|NCT00445484|4155608|P1|NOT COMPLETED|Overall Study||4
1699963|NCT00445484|4155607|P2|COMPLETED|Overall Study||10
1699964|NCT00445484|4155608|P1|COMPLETED|Overall Study||7
1699965|NCT00445484|4155607|P2|STARTED|Overall Study||11
1699966|NCT00445484|4155608|P1|STARTED|Overall Study||11
1699967|NCT00445458|4155624|P4|NOT COMPLETED|Overall Study||28
1699968|NCT00445458|4155625|P3|NOT COMPLETED|Overall Study||68
1699969|NCT00445458|4155626|P2|NOT COMPLETED|Overall Study||5
1699970|NCT00445458|4155627|P1|NOT COMPLETED|Overall Study||3
1699971|NCT00445458|4155624|P4|COMPLETED|Overall Study||3
1699972|NCT00445458|4155625|P3|COMPLETED|Overall Study||3
1699973|NCT00445458|4155626|P2|COMPLETED|Overall Study||0
1699974|NCT00445458|4155627|P1|COMPLETED|Overall Study||0
1699975|NCT00445458|4155624|P4|STARTED|Overall Study||31
1699976|NCT00445458|4155625|P3|STARTED|Overall Study||71
1699977|NCT00445458|4155626|P2|STARTED|Overall Study||5
1699978|NCT00445458|4155627|P1|STARTED|Overall Study||3
1699979|NCT00445432|4155645|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
1699980|NCT00445432|4155646|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
1699981|NCT00445432|4155647|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
1699982|NCT00445432|4155648|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
1699983|NCT00445432|4155645|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
1699984|NCT00445432|4155646|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
1699985|NCT00445432|4155647|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
1699986|NCT00445432|4155648|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
1699987|NCT00445432|4155645|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
1699988|NCT00445432|4155646|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
1699989|NCT00445432|4155647|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
1699990|NCT00445432|4155648|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
1699991|NCT00445432|4155645|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
1699992|NCT00445432|4155646|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
1699993|NCT00445432|4155647|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
1699994|NCT00445432|4155648|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
1699995|NCT00445432|4155645|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
1699996|NCT00445432|4155646|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
1699997|NCT00445432|4155647|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
1699998|NCT00445432|4155648|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
1699999|NCT00445432|4155645|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
1700000|NCT00445432|4155646|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
1700001|NCT00445432|4155647|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
1700002|NCT00445432|4155648|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
1700003|NCT00445341|4155681|P1|NOT COMPLETED|Overall Study||2
1700004|NCT00445341|4155681|P1|COMPLETED|Overall Study||26
1700005|NCT00445341|4155681|P1|STARTED|Overall Study||28
1700006|NCT00445328|4155688|P2|NOT COMPLETED|Overall Study||6
1700007|NCT00445328|4155689|P1|NOT COMPLETED|Overall Study||3
1700008|NCT00445328|4155688|P2|COMPLETED|Overall Study||36
1700009|NCT00445328|4155689|P1|COMPLETED|Overall Study||39
1700010|NCT00445328|4155688|P2|Received Treatment|Overall Study||42
1700011|NCT00445328|4155689|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
1700012|NCT00445328|4155688|P2|STARTED|Overall Study||42
1700013|NCT00445328|4155689|P1|STARTED|Overall Study||42
1700014|NCT00445315|4155712|P5|NOT COMPLETED|Overall Study||0
1700015|NCT00445315|4155713|P4|NOT COMPLETED|Overall Study||0
1700016|NCT00445315|4155714|P3|NOT COMPLETED|Overall Study||0
1700017|NCT00445315|4155715|P2|NOT COMPLETED|Overall Study||0
1700018|NCT00445315|4155716|P1|NOT COMPLETED|Overall Study||0
1700019|NCT00445315|4155712|P5|COMPLETED|Overall Study||8
1700020|NCT00445315|4155713|P4|COMPLETED|Overall Study||6
1700021|NCT00445315|4155714|P3|COMPLETED|Overall Study||6
1700022|NCT00445315|4155715|P2|COMPLETED|Overall Study||6
1700023|NCT00445315|4155716|P1|COMPLETED|Overall Study||6
1700024|NCT00445315|4155712|P5|STARTED|Overall Study||8
1700025|NCT00445315|4155713|P4|STARTED|Overall Study||6
1700026|NCT00445315|4155714|P3|STARTED|Overall Study||6
1700027|NCT00445315|4155715|P2|STARTED|Overall Study||6
1700028|NCT00445315|4155716|P1|STARTED|Overall Study||6
1700029|NCT00445302|4155810|P4|NOT COMPLETED|Overall Study||0
1700030|NCT00445302|4155811|P3|NOT COMPLETED|Overall Study||0
1700031|NCT00445302|4155812|P2|NOT COMPLETED|Overall Study||0
1700032|NCT00445302|4155813|P1|NOT COMPLETED|Overall Study||0
1700033|NCT00445302|4155810|P4|COMPLETED|Overall Study||6
1700034|NCT00445302|4155811|P3|COMPLETED|Overall Study||6
1700035|NCT00445302|4155812|P2|COMPLETED|Overall Study||5
1700036|NCT00445302|4155813|P1|COMPLETED|Overall Study||6
1700037|NCT00445302|4155810|P4|STARTED|Overall Study||6
1700038|NCT00445302|4155811|P3|STARTED|Overall Study||6
1700039|NCT00445302|4155812|P2|STARTED|Overall Study||5
1700040|NCT00445302|4155813|P1|STARTED|Overall Study||6
1700041|NCT00445263|4155841|P2|NOT COMPLETED|Overall Study||1
1700042|NCT00445263|4155842|P1|NOT COMPLETED|Overall Study||0
1700043|NCT00445263|4155841|P2|COMPLETED|Overall Study||86
1700044|NCT00445263|4155842|P1|COMPLETED|Overall Study||83
1700045|NCT00445263|4155841|P2|STARTED|Overall Study||87
1700046|NCT00445263|4155842|P1|STARTED|Overall Study||83
1700047|NCT00445224|4155850|P2|NOT COMPLETED|Combined Exercises||0
1700048|NCT00445224|4155851|P1|NOT COMPLETED|Combined Exercises||0
1700049|NCT00445224|4155850|P2|COMPLETED|Combined Exercises||13
1700050|NCT00445224|4155851|P1|COMPLETED|Combined Exercises||13
1700051|NCT00445224|4155850|P2|STARTED|Combined Exercises||13
1700052|NCT00445224|4155851|P1|STARTED|Combined Exercises||13
1700053|NCT00445224|4155850|P2|NOT COMPLETED|Specific Exercises||3
1700054|NCT00445224|4155851|P1|NOT COMPLETED|Specific Exercises||4
1700055|NCT00445224|4155850|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
1700056|NCT00445224|4155851|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
1700057|NCT00445224|4155850|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
1700058|NCT00445224|4155851|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
1700059|NCT00445224|4155850|P2|Baseline|Specific Exercises||16
1700060|NCT00445224|4155851|P1|Baseline|Specific Exercises||17
1700061|NCT00445224|4155850|P2|STARTED|Specific Exercises||16
1700062|NCT00445224|4155851|P1|STARTED|Specific Exercises||17
1700063|NCT00445211|4155863|P2|NOT COMPLETED|Overall Study||0
1700064|NCT00445211|4155864|P1|NOT COMPLETED|Overall Study||0
1700065|NCT00445211|4155863|P2|COMPLETED|Overall Study||23
1700066|NCT00445211|4155864|P1|COMPLETED|Overall Study||23
1700067|NCT00445211|4155863|P2|STARTED|Overall Study||23
1700068|NCT00445211|4155864|P1|STARTED|Overall Study||23
1700069|NCT00445146|4155878|P1|NOT COMPLETED|Overall Study||119
1700070|NCT00445146|4155878|P1|COMPLETED|Overall Study||73
1700071|NCT00445146|4155878|P1|STARTED|Overall Study||192
1700072|NCT00445003|4155900|P3|NOT COMPLETED|Overall Study||4
1700073|NCT00445003|4155901|P2|NOT COMPLETED|Overall Study||10
1700074|NCT00445003|4155902|P1|NOT COMPLETED|Overall Study||5
1700075|NCT00445003|4155900|P3|COMPLETED|Overall Study||105
1700076|NCT00445003|4155901|P2|COMPLETED|Overall Study||103
1700077|NCT00445003|4155902|P1|COMPLETED|Overall Study||118
1700078|NCT00445003|4155900|P3|STARTED|Overall Study||109
1700079|NCT00445003|4155901|P2|STARTED|Overall Study||113
1700080|NCT00445003|4155902|P1|STARTED|Overall Study||123
1700081|NCT00444951|4155934|P3|NOT COMPLETED|Overall Study||3
1700082|NCT00444951|4155935|P2|NOT COMPLETED|Overall Study||6
1700083|NCT00444951|4155936|P1|NOT COMPLETED|Overall Study||5
1700084|NCT00444951|4155934|P3|COMPLETED|Overall Study||160
1700085|NCT00444951|4155935|P2|COMPLETED|Overall Study||136
1700086|NCT00444951|4155936|P1|COMPLETED|Overall Study||140
1700087|NCT00444951|4155934|P3|STARTED|Overall Study||163
1700088|NCT00444951|4155935|P2|STARTED|Overall Study||142
1700089|NCT00444951|4155936|P1|STARTED|Overall Study||145
1700090|NCT00444925|4155953|P3|NOT COMPLETED|Double-blind Treatment Period||81
1700091|NCT00444925|4155954|P2|NOT COMPLETED|Double-blind Treatment Period||56
1700092|NCT00444925|4155955|P1|NOT COMPLETED|Double-blind Treatment Period||30
1700093|NCT00444925|4155953|P3|COMPLETED|Double-blind Treatment Period||598
1700094|NCT00444925|4155954|P2|COMPLETED|Double-blind Treatment Period||628
1700095|NCT00444925|4155955|P1|COMPLETED|Double-blind Treatment Period||304
1700096|NCT00444925|4155953|P3|STARTED|Double-blind Treatment Period||679
1700097|NCT00444925|4155954|P2|STARTED|Double-blind Treatment Period||684
1700098|NCT00444925|4155955|P1|STARTED|Double-blind Treatment Period||334
1700099|NCT00444925|4155953|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
1700100|NCT00444925|4155954|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
1700101|NCT00444925|4155955|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
1700102|NCT00444925|4155953|P3|COMPLETED|Randomized to Double-blind Treatment||679
1700103|NCT00444925|4155954|P2|COMPLETED|Randomized to Double-blind Treatment||684
1700104|NCT00444925|4155955|P1|COMPLETED|Randomized to Double-blind Treatment||334
1700105|NCT00444925|4155953|P3|STARTED|Randomized to Double-blind Treatment||685
1700106|NCT00444925|4155954|P2|STARTED|Randomized to Double-blind Treatment||690
1700107|NCT00444925|4155955|P1|STARTED|Randomized to Double-blind Treatment||337
1700108|NCT00444925|4155953|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
1700109|NCT00444925|4155954|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
1700110|NCT00444925|4155955|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
1700111|NCT00444925|4155953|P3|COMPLETED|Single-blind Placebo Run-In Period||0
1700112|NCT00444925|4155954|P2|COMPLETED|Single-blind Placebo Run-In Period||0
1700113|NCT00444925|4155955|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
1700114|NCT00444925|4155953|P3|STARTED|Single-blind Placebo Run-In Period||0
1700115|NCT00444925|4155954|P2|STARTED|Single-blind Placebo Run-In Period||0
1700116|NCT00444925|4155955|P1|STARTED|Single-blind Placebo Run-In Period||2446
1700117|NCT00444912|4156019|P2|NOT COMPLETED|Overall Study||2
1700118|NCT00444912|4156020|P1|NOT COMPLETED|Overall Study||3
1700119|NCT00444912|4156019|P2|COMPLETED|Overall Study||13
1700120|NCT00444912|4156020|P1|COMPLETED|Overall Study||12
1700121|NCT00444912|4156019|P2|Received Transplant|Overall Study||14
1700122|NCT00444912|4156020|P1|Received Transplant|Overall Study||14
1700123|NCT00444912|4156019|P2|Received Plerixafor|Overall Study||15
1700124|NCT00444912|4156020|P1|Received Plerixafor|Overall Study||15
1700125|NCT00444912|4156019|P2|STARTED|Overall Study||15
1700126|NCT00444912|4156020|P1|STARTED|Overall Study||15
1700127|NCT00444821|4156050|P2|NOT COMPLETED|Overall Study||366
1700128|NCT00444821|4156051|P1|NOT COMPLETED|Overall Study||362
1700129|NCT00444821|4156050|P2|COMPLETED|Overall Study||0
1700130|NCT00444821|4156051|P1|COMPLETED|Overall Study||0
1700131|NCT00444821|4156050|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
1700132|NCT00444821|4156051|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
1700133|NCT00444821|4156050|P2|STARTED|Overall Study||366
1700134|NCT00444821|4156051|P1|STARTED|Overall Study||362
1700135|NCT00444795|4156061|P1|NOT COMPLETED|Overall Study||3
1700136|NCT00444795|4156061|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
1700137|NCT00444795|4156061|P1|STARTED|Overall Study||620
1700138|NCT00444626|4156066|P1|NOT COMPLETED|Repeat Treatment Period||0
1700139|NCT00444626|4156066|P1|COMPLETED|Repeat Treatment Period||105
1700140|NCT00444626|4156066|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
1700141|NCT00444626|4156066|P1|NOT COMPLETED|Initial Treatment Period||12
1700142|NCT00444626|4156066|P1|COMPLETED|Initial Treatment Period||128
1700143|NCT00444626|4156066|P1|STARTED|Initial Treatment Period||140
1700144|NCT00444600|4156096|P4|NOT COMPLETED|Overall Study||10
1700145|NCT00444600|4156097|P3|NOT COMPLETED|Overall Study||10
1700146|NCT00444600|4156098|P2|NOT COMPLETED|Overall Study||16
1700147|NCT00444600|4156099|P1|NOT COMPLETED|Overall Study||19
1700148|NCT00444600|4156096|P4|COMPLETED|Overall Study|Number of eyes|176
1700149|NCT00444600|4156097|P3|COMPLETED|Overall Study|Number of eyes|178
1700150|NCT00444600|4156098|P2|COMPLETED|Overall Study|Number of eyes|171
1700151|NCT00444600|4156099|P1|COMPLETED|Overall Study|Number of eyes|274
1700152|NCT00444600|4156096|P4|STARTED|Overall Study|Number of eyes|186
1700153|NCT00444600|4156097|P3|STARTED|Overall Study|Number of eyes|188
1700154|NCT00444600|4156098|P2|STARTED|Overall Study|Number of eyes|187
1700155|NCT00444600|4156099|P1|STARTED|Overall Study|Number of eyes|293
1700156|NCT00444587|4156191|P2|NOT COMPLETED|Overall Study||15
1700157|NCT00444587|4156192|P1|NOT COMPLETED|Overall Study||83
1700158|NCT00444587|4156191|P2|COMPLETED|Overall Study||1
1700159|NCT00444587|4156192|P1|COMPLETED|Overall Study||10
1700160|NCT00444587|4156191|P2|STARTED|Overall Study||16
1700161|NCT00444587|4156192|P1|STARTED|Overall Study||93
1700162|NCT00444535|4156213|P1|NOT COMPLETED|Overall Study||24
1700163|NCT00444535|4156213|P1|COMPLETED|Overall Study||28
1700164|NCT00444535|4156213|P1|STARTED|Overall Study||52
1700165|NCT00444457|4156224|P4|NOT COMPLETED|Toddler Dose||8
1700166|NCT00444457|4156225|P3|NOT COMPLETED|Toddler Dose||4
1700167|NCT00444457|4156226|P2|NOT COMPLETED|Toddler Dose||6
1700168|NCT00444457|4156227|P1|NOT COMPLETED|Toddler Dose||7
1700169|NCT00444457|4156224|P4|COMPLETED|Toddler Dose||200
1700170|NCT00444457|4156225|P3|COMPLETED|Toddler Dose||404
1700171|NCT00444457|4156226|P2|COMPLETED|Toddler Dose||391
1700172|NCT00444457|4156227|P1|COMPLETED|Toddler Dose||408
1700173|NCT00444457|4156224|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
1700174|NCT00444457|4156225|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
1700175|NCT00444457|4156226|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
1700176|NCT00444457|4156227|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
1700177|NCT00444457|4156224|P4|NOT COMPLETED|After Infant Series||10
1700178|NCT00444457|4156225|P3|NOT COMPLETED|After Infant Series||19
1700179|NCT00444457|4156226|P2|NOT COMPLETED|After Infant Series||30
1700180|NCT00444457|4156227|P1|NOT COMPLETED|After Infant Series||20
1700181|NCT00444457|4156224|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
1700182|NCT00444457|4156225|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
1700183|NCT00444457|4156226|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
1700184|NCT00444457|4156227|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
1700185|NCT00444457|4156224|P4|STARTED|After Infant Series||218
1700186|NCT00444457|4156225|P3|STARTED|After Infant Series||427
1700187|NCT00444457|4156226|P2|STARTED|After Infant Series||427
1700188|NCT00444457|4156227|P1|STARTED|After Infant Series||435
1700189|NCT00444457|4156224|P4|NOT COMPLETED|Infant Series||28
1700190|NCT00444457|4156225|P3|NOT COMPLETED|Infant Series||61
1700191|NCT00444457|4156226|P2|NOT COMPLETED|Infant Series||61
1700192|NCT00444457|4156227|P1|NOT COMPLETED|Infant Series||54
1700193|NCT00444457|4156224|P4|COMPLETED|Infant Series||218
1700194|NCT00444457|4156225|P3|COMPLETED|Infant Series||428
1700195|NCT00444457|4156226|P2|COMPLETED|Infant Series||427
1700196|NCT00444457|4156227|P1|COMPLETED|Infant Series||435
1700197|NCT00444457|4156224|P4|Vaccinated Dose 3|Infant Series||225
1700198|NCT00444457|4156225|P3|Vaccinated Dose 3|Infant Series||438
1700199|NCT00444457|4156226|P2|Vaccinated Dose 3|Infant Series||435
1700200|NCT00444457|4156227|P1|Vaccinated Dose 3|Infant Series||442
1700201|NCT00444457|4156224|P4|Vaccinated Dose 2|Infant Series||228
1700202|NCT00444457|4156225|P3|Vaccinated Dose 2|Infant Series||455
1700203|NCT00444457|4156226|P2|Vaccinated Dose 2|Infant Series||447
1700204|NCT00444457|4156227|P1|Vaccinated Dose 2|Infant Series||455
1700205|NCT00444457|4156224|P4|Vaccinated Dose 1|Infant Series||244
1700206|NCT00444457|4156225|P3|Vaccinated Dose 1|Infant Series||485
1700207|NCT00444457|4156226|P2|Vaccinated Dose 1|Infant Series||484
1700208|NCT00444457|4156227|P1|Vaccinated Dose 1|Infant Series||486
1700209|NCT00444457|4156224|P4|STARTED|Infant Series||246
1700210|NCT00444457|4156225|P3|STARTED|Infant Series||489
1700211|NCT00444457|4156226|P2|STARTED|Infant Series||488
1700212|NCT00444457|4156227|P1|STARTED|Infant Series||489
1700213|NCT00444275|4156292|P5|NOT COMPLETED|Maintenance Treatment Phase||179
1700214|NCT00444275|4156293|P4|NOT COMPLETED|Maintenance Treatment Phase||133
1700215|NCT00444275|4156294|P3|NOT COMPLETED|Maintenance Treatment Phase||161
1700216|NCT00444275|4156295|P2|NOT COMPLETED|Maintenance Treatment Phase||0
1700217|NCT00444275|4156296|P1|NOT COMPLETED|Maintenance Treatment Phase||0
1700218|NCT00444275|4156292|P5|COMPLETED|Maintenance Treatment Phase||701
1700219|NCT00444275|4156293|P4|COMPLETED|Maintenance Treatment Phase||764
1700220|NCT00444275|4156294|P3|COMPLETED|Maintenance Treatment Phase||747
1700221|NCT00444275|4156295|P2|COMPLETED|Maintenance Treatment Phase||0
1700222|NCT00444275|4156296|P1|COMPLETED|Maintenance Treatment Phase||0
1700223|NCT00444275|4156292|P5|STARTED|Maintenance Treatment Phase||880
1700224|NCT00444275|4156293|P4|STARTED|Maintenance Treatment Phase||897
1700225|NCT00444275|4156294|P3|STARTED|Maintenance Treatment Phase||908
1700226|NCT00444275|4156295|P2|STARTED|Maintenance Treatment Phase||0
1700227|NCT00444275|4156296|P1|STARTED|Maintenance Treatment Phase||0
1700228|NCT00444275|4156292|P5|NOT COMPLETED|Initial Treatment Phase||0
1700229|NCT00444275|4156293|P4|NOT COMPLETED|Initial Treatment Phase||0
1700230|NCT00444275|4156294|P3|NOT COMPLETED|Initial Treatment Phase||0
1700231|NCT00444275|4156295|P2|NOT COMPLETED|Initial Treatment Phase||96
1700232|NCT00444275|4156296|P1|NOT COMPLETED|Initial Treatment Phase||248
1700233|NCT00444275|4156292|P5|COMPLETED|Initial Treatment Phase||0
1700234|NCT00444275|4156293|P4|COMPLETED|Initial Treatment Phase||0
1700235|NCT00444275|4156294|P3|COMPLETED|Initial Treatment Phase||0
1700236|NCT00444275|4156295|P2|COMPLETED|Initial Treatment Phase||777
1700237|NCT00444275|4156296|P1|COMPLETED|Initial Treatment Phase||1908
1700238|NCT00444275|4156292|P5|STARTED|Initial Treatment Phase||0
1700239|NCT00444275|4156293|P4|STARTED|Initial Treatment Phase||0
1700240|NCT00444275|4156294|P3|STARTED|Initial Treatment Phase||0
1700241|NCT00444275|4156295|P2|STARTED|Initial Treatment Phase||873
1700242|NCT00444275|4156296|P1|STARTED|Initial Treatment Phase||2156
1700243|NCT00444145|4156346|P1|NOT COMPLETED|Overall Study||19
1700244|NCT00444145|4156346|P1|COMPLETED|Overall Study||19
1700245|NCT00444145|4156346|P1|STARTED|Overall Study||38
1700246|NCT00444106|4156353|P3|NOT COMPLETED|Overall Study||1
1700247|NCT00444106|4156354|P2|NOT COMPLETED|Overall Study||1
1700248|NCT00444106|4156355|P1|NOT COMPLETED|Overall Study||2
1700249|NCT00444106|4156353|P3|COMPLETED|Overall Study||52
1700250|NCT00444106|4156354|P2|COMPLETED|Overall Study||52
1700251|NCT00444106|4156355|P1|COMPLETED|Overall Study||157
1700252|NCT00444106|4156353|P3|Completed Treatment Period|Overall Study||53
1700253|NCT00444106|4156354|P2|Completed Treatment Period|Overall Study||53
1700254|NCT00444106|4156355|P1|Completed Treatment Period|Overall Study||159
1700255|NCT00444106|4156353|P3|STARTED|Overall Study||53
1700256|NCT00444106|4156354|P2|STARTED|Overall Study||53
1700257|NCT00444106|4156355|P1|STARTED|Overall Study||159
1700258|NCT00444067|4156372|P2|NOT COMPLETED|Overall Study||1
1700259|NCT00444067|4156373|P1|NOT COMPLETED|Overall Study||0
1700260|NCT00444067|4156372|P2|COMPLETED|Overall Study||23
1700261|NCT00444067|4156373|P1|COMPLETED|Overall Study||74
1700262|NCT00444067|4156372|P2|STARTED|Overall Study||24
1700263|NCT00444067|4156373|P1|STARTED|Overall Study||74
1700264|NCT00444028|4156389|P6|NOT COMPLETED|Overall Study||0
1700265|NCT00444028|4156390|P5|NOT COMPLETED|Overall Study||0
1700266|NCT00444028|4156391|P4|NOT COMPLETED|Overall Study||0
1700267|NCT00444028|4156392|P3|NOT COMPLETED|Overall Study||0
1700268|NCT00444028|4156393|P2|NOT COMPLETED|Overall Study||0
1700269|NCT00444028|4156394|P1|NOT COMPLETED|Overall Study||0
1700270|NCT00444028|4156389|P6|COMPLETED|Overall Study||8
1700271|NCT00444028|4156390|P5|COMPLETED|Overall Study||7
1700272|NCT00444028|4156391|P4|COMPLETED|Overall Study||6
1700273|NCT00444028|4156392|P3|COMPLETED|Overall Study||8
1700274|NCT00444028|4156393|P2|COMPLETED|Overall Study||7
1700275|NCT00444028|4156394|P1|COMPLETED|Overall Study||14
1700276|NCT00444028|4156389|P6|STARTED|Overall Study||8
1700277|NCT00444028|4156390|P5|STARTED|Overall Study||7
1700278|NCT00444028|4156391|P4|STARTED|Overall Study||6
1700279|NCT00444028|4156392|P3|STARTED|Overall Study||8
1700280|NCT00444028|4156393|P2|STARTED|Overall Study||7
1700281|NCT00444028|4156394|P1|STARTED|Overall Study||14
1700282|NCT00443898|4156436|P4|NOT COMPLETED|Overall Study||18
1700283|NCT00443898|4156437|P3|NOT COMPLETED|Overall Study||29
1700284|NCT00443898|4156438|P2|NOT COMPLETED|Overall Study||25
1700285|NCT00443898|4156439|P1|NOT COMPLETED|Overall Study||24
1700286|NCT00443898|4156436|P4|COMPLETED|Overall Study||110
1700287|NCT00443898|4156437|P3|COMPLETED|Overall Study||107
1700288|NCT00443898|4156438|P2|COMPLETED|Overall Study||103
1700289|NCT00443898|4156439|P1|COMPLETED|Overall Study||102
1700290|NCT00443898|4156436|P4|STARTED|Overall Study||128
1700291|NCT00443898|4156437|P3|STARTED|Overall Study||136
1700292|NCT00443898|4156438|P2|STARTED|Overall Study||128
1700293|NCT00443898|4156439|P1|STARTED|Overall Study||126
1700294|NCT00443872|4156461|P1|NOT COMPLETED|Overall Study||17
1700295|NCT00443872|4156461|P1|COMPLETED|Overall Study||60
1700296|NCT00443872|4156461|P1|STARTED|Overall Study||77
1700297|NCT00443846|4156476|P2|NOT COMPLETED|Overall Study||6
1700298|NCT00443846|4156477|P1|NOT COMPLETED|Overall Study||11
1700299|NCT00443846|4156476|P2|COMPLETED|Overall Study||117
1700300|NCT00443846|4156477|P1|COMPLETED|Overall Study||113
1700301|NCT00443846|4156476|P2|Vaccinated|Overall Study||123
1700302|NCT00443846|4156477|P1|Vaccinated|Overall Study||116
1700303|NCT00443846|4156476|P2|STARTED|Overall Study||123
1700304|NCT00443846|4156477|P1|STARTED|Overall Study||124
1700305|NCT00443820|4156487|P4|NOT COMPLETED|Overall Study||17
1700306|NCT00443820|4156488|P3|NOT COMPLETED|Overall Study||18
1700307|NCT00443820|4156489|P2|NOT COMPLETED|Overall Study||19
1700308|NCT00443820|4156490|P1|NOT COMPLETED|Overall Study||21
1700309|NCT00443820|4156487|P4|COMPLETED|Overall Study||111
1700310|NCT00443820|4156488|P3|COMPLETED|Overall Study||117
1700311|NCT00443820|4156489|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
1700312|NCT00443820|4156490|P1|COMPLETED|Overall Study||112
1700313|NCT00443820|4156487|P4|Safety Population|Overall Study||126
1700314|NCT00443820|4156488|P3|Safety Population|Overall Study||134
1700315|NCT00443820|4156489|P2|Safety Population|Overall Study||129
1700316|NCT00443820|4156490|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
1700317|NCT00443820|4156487|P4|STARTED|Overall Study||128
1700318|NCT00443820|4156488|P3|STARTED|Overall Study||135
1700319|NCT00443820|4156489|P2|STARTED|Overall Study||130
1700320|NCT00443820|4156490|P1|STARTED|Overall Study||133
1700321|NCT00443781|4156512|P1|NOT COMPLETED|Overall Study||25
1700322|NCT00443781|4156512|P1|COMPLETED|Overall Study||37
1700323|NCT00443781|4156512|P1|STARTED|Overall Study||62
1700324|NCT00443755|4156518|P2|NOT COMPLETED|Overall Study||1
1700325|NCT00443755|4156519|P1|NOT COMPLETED|Overall Study||2
1700326|NCT00443755|4156518|P2|COMPLETED|Overall Study||13
1700327|NCT00443755|4156519|P1|COMPLETED|Overall Study||12
1700328|NCT00443755|4156518|P2|STARTED|Overall Study||14
1700329|NCT00443755|4156519|P1|STARTED|Overall Study||14
1700330|NCT00443729|4156553|P2|NOT COMPLETED|Overall Study||7
1700331|NCT00443729|4156554|P1|NOT COMPLETED|Overall Study||10
1700332|NCT00443729|4156553|P2|COMPLETED|Overall Study||172
1700333|NCT00443729|4156554|P1|COMPLETED|Overall Study||166
1700334|NCT00443729|4156553|P2|Treated|Overall Study||178
1700335|NCT00443729|4156554|P1|Treated|Overall Study||176
1700336|NCT00443729|4156553|P2|STARTED|Overall Study||179
1700337|NCT00443729|4156554|P1|STARTED|Overall Study||176
1700338|NCT00443703|4156602|P2|NOT COMPLETED|Overall Study||18
1700339|NCT00443703|4156603|P1|NOT COMPLETED|Overall Study||28
1700340|NCT00443703|4156602|P2|COMPLETED|Overall Study||157
1700341|NCT00443703|4156603|P1|COMPLETED|Overall Study||149
1700342|NCT00443703|4156602|P2|Treated|Overall Study||174
1700343|NCT00443703|4156603|P1|Treated|Overall Study||174
1700344|NCT00443703|4156602|P2|STARTED|Overall Study||175
1700345|NCT00443703|4156603|P1|STARTED|Overall Study||177
1700346|NCT00443651|4156655|P2|NOT COMPLETED|Overall Study||58
1700347|NCT00443651|4156656|P1|NOT COMPLETED|Overall Study||95
1700348|NCT00443651|4156655|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
1700349|NCT00443651|4156656|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
1700350|NCT00443651|4156655|P2|Week 48|Overall Study||134
1700351|NCT00443651|4156656|P1|Week 48|Overall Study||338
1700352|NCT00443651|4156655|P2|Week 24|Overall Study||160
1700353|NCT00443651|4156656|P1|Week 24|Overall Study||376
1700354|NCT00443651|4156655|P2|STARTED|Overall Study||176
1700355|NCT00443651|4156656|P1|STARTED|Overall Study||401
1700356|NCT00443599|4156676|P2|NOT COMPLETED|Overall Study||3
1700357|NCT00443599|4156677|P1|NOT COMPLETED|Overall Study||6
1700358|NCT00443599|4156676|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
1700359|NCT00443599|4156677|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
1700360|NCT00443599|4156676|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
1700361|NCT00443599|4156677|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
1700362|NCT00443560|4156711|P2|NOT COMPLETED|Overall Study||30
1700363|NCT00443560|4156712|P1|NOT COMPLETED|Overall Study||60
1700364|NCT00443560|4156711|P2|COMPLETED|Overall Study||1051
1700365|NCT00443560|4156712|P1|COMPLETED|Overall Study||1021
1700366|NCT00443560|4156711|P2|STARTED|Overall Study||1081
1700367|NCT00443560|4156712|P1|STARTED|Overall Study||1081
1700368|NCT00443534|4156722|P1|NOT COMPLETED|Overall Study||123
1700369|NCT00443534|4156722|P1|COMPLETED|Overall Study||0
1700370|NCT00443534|4156722|P1|Treated|Overall Study||122
1700371|NCT00443534|4156722|P1|STARTED|Overall Study||123
1700372|NCT00443456|4156729|P1|NOT COMPLETED|Overall Study||18
1700373|NCT00443456|4156729|P1|COMPLETED|Overall Study||116
1700374|NCT00443456|4156729|P1|STARTED|Overall Study||134
1700375|NCT00443430|4156764|P2|NOT COMPLETED|Overall Study||4
1700376|NCT00443430|4156765|P1|NOT COMPLETED|Overall Study||4
1700377|NCT00443430|4156764|P2|COMPLETED|Overall Study||38
1700378|NCT00443430|4156765|P1|COMPLETED|Overall Study||39
1700379|NCT00443430|4156764|P2|STARTED|Overall Study||42
1700380|NCT00443430|4156765|P1|STARTED|Overall Study||43
1700381|NCT00443352|4156775|P1|NOT COMPLETED|Overall Study||5
1700382|NCT00443352|4156775|P1|COMPLETED|Overall Study||22
1700383|NCT00443352|4156775|P1|STARTED|Overall Study||27
1700384|NCT00443261|4156779|P1|NOT COMPLETED|Overall Study||1
1700385|NCT00443261|4156779|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
1700386|NCT00443261|4156779|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
1700387|NCT00443261|4156779|P1|STARTED|Overall Study||1
1700388|NCT00443209|4156785|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
1700389|NCT00443209|4156786|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
1700390|NCT00443209|4156785|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
1700391|NCT00443209|4156786|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
1700392|NCT00443209|4156785|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
1700393|NCT00443209|4156786|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
1700394|NCT00443209|4156785|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
1700395|NCT00443209|4156786|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
1700396|NCT00443209|4156785|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
1700397|NCT00443209|4156786|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
1700398|NCT00443209|4156785|P2|Treated|Months 1 to 12 Treatment Period||313
1700399|NCT00443209|4156786|P1|Treated|Months 1 to 12 Treatment Period||641
1700400|NCT00443209|4156785|P2|STARTED|Months 1 to 12 Treatment Period||356
1700401|NCT00443209|4156786|P1|STARTED|Months 1 to 12 Treatment Period||712
1700402|NCT00443118|4156803|P3|NOT COMPLETED|Overall Study||0
1700403|NCT00443118|4156804|P2|NOT COMPLETED|Overall Study||1
1700404|NCT00443118|4156805|P1|NOT COMPLETED|Overall Study||4
1700405|NCT00443118|4156803|P3|COMPLETED|Overall Study||226
1700406|NCT00443118|4156804|P2|COMPLETED|Overall Study||290
1700407|NCT00443118|4156805|P1|COMPLETED|Overall Study||511
1700408|NCT00443118|4156803|P3|STARTED|Overall Study||226
1700409|NCT00443118|4156804|P2|STARTED|Overall Study||291
1700410|NCT00443118|4156805|P1|STARTED|Overall Study||515
1700411|NCT00443053|4156854|P2|NOT COMPLETED|Overall Study||33
1700412|NCT00443053|4156855|P1|NOT COMPLETED|Overall Study||21
1700413|NCT00443053|4156854|P2|COMPLETED|Overall Study||1467
1700414|NCT00443053|4156855|P1|COMPLETED|Overall Study||1481
1700415|NCT00443053|4156854|P2|STARTED|Overall Study||1500
1700416|NCT00443053|4156855|P1|STARTED|Overall Study||1502
1700417|NCT00443040|4156876|P3|NOT COMPLETED|Overall Study||1
1700418|NCT00443040|4156877|P2|NOT COMPLETED|Overall Study||0
1700419|NCT00443040|4156878|P1|NOT COMPLETED|Overall Study||4
1700420|NCT00443040|4156876|P3|COMPLETED|Overall Study||9
1700421|NCT00443040|4156877|P2|COMPLETED|Overall Study||11
1700422|NCT00443040|4156878|P1|COMPLETED|Overall Study||10
1700423|NCT00443040|4156876|P3|STARTED|Overall Study||10
1700424|NCT00443040|4156877|P2|STARTED|Overall Study||11
1700425|NCT00443040|4156878|P1|STARTED|Overall Study||14
1700426|NCT00442962|4156886|P1|NOT COMPLETED|Overall Study||8
1700427|NCT00442962|4156886|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
1700428|NCT00442962|4156886|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
1700429|NCT00442962|4156886|P1|STARTED|Overall Study||54
1700430|NCT00442936|4156904|P4|NOT COMPLETED|Overall Study||1
1700431|NCT00442936|4156905|P3|NOT COMPLETED|Overall Study||1
1700432|NCT00442936|4156906|P2|NOT COMPLETED|Overall Study||0
1700433|NCT00442936|4156907|P1|NOT COMPLETED|Overall Study||1
1700434|NCT00442936|4156904|P4|COMPLETED|Overall Study||347
1700435|NCT00442936|4156905|P3|COMPLETED|Overall Study||344
1700436|NCT00442936|4156906|P2|COMPLETED|Overall Study||354
1700437|NCT00442936|4156907|P1|COMPLETED|Overall Study||332
1700438|NCT00442936|4156904|P4|STARTED|Overall Study||348
1700439|NCT00442936|4156905|P3|STARTED|Overall Study||345
1700440|NCT00442936|4156906|P2|STARTED|Overall Study||354
1700441|NCT00442936|4156907|P1|STARTED|Overall Study||333
1700442|NCT00442897|4156955|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
1700443|NCT00442897|4156956|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
1700444|NCT00442897|4156955|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
1700445|NCT00442897|4156956|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
1700446|NCT00442897|4156955|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
1700447|NCT00442897|4156956|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
1700448|NCT00442897|4156955|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
1700449|NCT00442897|4156956|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
1700450|NCT00442897|4156955|P2|COMPLETED|Base Study (12 Week Follow-up)||99
1700451|NCT00442897|4156956|P1|COMPLETED|Base Study (12 Week Follow-up)||101
1700452|NCT00442897|4156955|P2|STARTED|Base Study (12 Week Follow-up)||111
1700453|NCT00442897|4156956|P1|STARTED|Base Study (12 Week Follow-up)||118
1700454|NCT00442767|4156964|P1|NOT COMPLETED|Overall Study||0
1700455|NCT00442767|4156964|P1|COMPLETED|Overall Study||8
1700456|NCT00442767|4156964|P1|STARTED|Overall Study||8
1700457|NCT00442702|4156974|P2|NOT COMPLETED|Evaluation Period||4
1700458|NCT00442702|4156975|P1|NOT COMPLETED|Evaluation Period||5
1700459|NCT00442702|4156974|P2|COMPLETED|Evaluation Period||107
1700460|NCT00442702|4156975|P1|COMPLETED|Evaluation Period||97
1700461|NCT00442702|4156974|P2|STARTED|Evaluation Period||111
1700462|NCT00442702|4156975|P1|STARTED|Evaluation Period||102
1700463|NCT00442702|4156974|P2|NOT COMPLETED|Titration Period||3
1700464|NCT00442702|4156975|P1|NOT COMPLETED|Titration Period||12
1700465|NCT00442702|4156974|P2|COMPLETED|Titration Period||111
1700466|NCT00442702|4156975|P1|COMPLETED|Titration Period||102
1700467|NCT00442702|4156974|P2|Safety Population|Titration Period||113
1700468|NCT00442702|4156975|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
1700469|NCT00442702|4156974|P2|STARTED|Titration Period||114
1700470|NCT00442702|4156975|P1|STARTED|Titration Period||114
1700471|NCT00442689|4156990|P3|NOT COMPLETED|Overall Study||9
1700472|NCT00442689|4156991|P2|NOT COMPLETED|Overall Study||11
1700473|NCT00442689|4156992|P1|NOT COMPLETED|Overall Study||10
1700474|NCT00442689|4156990|P3|COMPLETED|Overall Study||13
1700475|NCT00442689|4156991|P2|COMPLETED|Overall Study||13
1700476|NCT00442689|4156992|P1|COMPLETED|Overall Study||11
1700477|NCT00442689|4156990|P3|STARTED|Overall Study||22
1700478|NCT00442689|4156991|P2|STARTED|Overall Study||24
1700479|NCT00442689|4156992|P1|STARTED|Overall Study||21
1700480|NCT00442611|4157020|P2|NOT COMPLETED|Overall Study||0
1700481|NCT00442611|4157021|P1|NOT COMPLETED|Overall Study||1
1700482|NCT00442611|4157020|P2|COMPLETED|Overall Study||3
1700483|NCT00442611|4157021|P1|COMPLETED|Overall Study||6
1700484|NCT00442611|4157020|P2|STARTED|Overall Study||3
1700485|NCT00442611|4157021|P1|STARTED|Overall Study||7
1700486|NCT00442598|4157040|P3|NOT COMPLETED|Overall Study||0
1700487|NCT00442598|4157041|P2|NOT COMPLETED|Overall Study||8
1700488|NCT00442598|4157042|P1|NOT COMPLETED|Overall Study||6
1700489|NCT00442598|4157040|P3|COMPLETED|Overall Study||0
1700490|NCT00442598|4157041|P2|COMPLETED|Overall Study||2
1700491|NCT00442598|4157042|P1|COMPLETED|Overall Study||1
1700492|NCT00442598|4157040|P3|Two Cycles|Overall Study||0
1700493|NCT00442598|4157041|P2|Two Cycles|Overall Study||6
1700494|NCT00442598|4157042|P1|Two Cycles|Overall Study||5
1700495|NCT00442598|4157040|P3|STARTED|Overall Study||0
1700496|NCT00442598|4157041|P2|STARTED|Overall Study||10
1700497|NCT00442598|4157042|P1|STARTED|Overall Study||7
1700498|NCT00442572|4157060|P2|NOT COMPLETED|Overall Study||3
1700499|NCT00442572|4157061|P1|NOT COMPLETED|Overall Study||8
1700500|NCT00442572|4157060|P2|COMPLETED|Overall Study||1
1700501|NCT00442572|4157061|P1|COMPLETED|Overall Study||9
1700502|NCT00442572|4157060|P2|STARTED|Overall Study||4
1700503|NCT00442572|4157061|P1|STARTED|Overall Study||17
1700504|NCT00442559|4157101|P2|NOT COMPLETED|Overall Study||35
1700505|NCT00442559|4157102|P1|NOT COMPLETED|Overall Study||34
1700506|NCT00442559|4157101|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
1700507|NCT00442559|4157102|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
1700508|NCT00442559|4157101|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
1700509|NCT00442559|4157102|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
1700510|NCT00442559|4157101|P2|STARTED|Overall Study||91
1700511|NCT00442559|4157102|P1|STARTED|Overall Study||100
1700512|NCT00442546|4157117|P3|NOT COMPLETED|Overall Study||33
1700513|NCT00442546|4157118|P2|NOT COMPLETED|Overall Study||37
1700514|NCT00442546|4157119|P1|NOT COMPLETED|Overall Study||26
1700515|NCT00442546|4157117|P3|COMPLETED|Overall Study||71
1700516|NCT00442546|4157118|P2|COMPLETED|Overall Study||63
1700517|NCT00442546|4157119|P1|COMPLETED|Overall Study||77
1700518|NCT00442546|4157117|P3|Received Treatment|Overall Study||98
1700519|NCT00442546|4157118|P2|Received Treatment|Overall Study||96
1700520|NCT00442546|4157119|P1|Received Treatment|Overall Study||98
1700521|NCT00442546|4157117|P3|STARTED|Overall Study||104
1700522|NCT00442546|4157118|P2|STARTED|Overall Study||100
1700523|NCT00442546|4157119|P1|STARTED|Overall Study||103
1700524|NCT00442507|4157241|P1|NOT COMPLETED|Overall Study||0
1700525|NCT00442507|4157241|P1|COMPLETED|Overall Study||6
1700526|NCT00442507|4157241|P1|STARTED|Overall Study||6
1700527|NCT00442468|4157248|P1|NOT COMPLETED|Overall Study||183
1700528|NCT00442468|4157248|P1|COMPLETED|Overall Study||1100
1700529|NCT00442468|4157248|P1|STARTED|Overall Study||1283
1700530|NCT00442416|4157278|P2|NOT COMPLETED|Overall Study||39
1700531|NCT00442416|4157279|P1|NOT COMPLETED|Overall Study||37
1700532|NCT00442416|4157278|P2|COMPLETED|Overall Study||2
1700533|NCT00442416|4157279|P1|COMPLETED|Overall Study||2
1700534|NCT00442416|4157278|P2|STARTED|Overall Study||41
1700535|NCT00442416|4157279|P1|STARTED|Overall Study||39
1700536|NCT00442364|4157312|P1|NOT COMPLETED|Overall Study||0
1700537|NCT00442364|4157312|P1|COMPLETED|Overall Study||60
1700538|NCT00442364|4157312|P1|STARTED|Overall Study||60
1700539|NCT00442351|4157318|P2|NOT COMPLETED|Overall Study||6
1700540|NCT00442351|4157319|P1|NOT COMPLETED|Overall Study||7
1700541|NCT00442351|4157318|P2|COMPLETED|Overall Study||3
1700542|NCT00442351|4157319|P1|COMPLETED|Overall Study||10
1700543|NCT00442351|4157318|P2|STARTED|Overall Study||9
1700544|NCT00442351|4157319|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
1700545|NCT00442338|4157328|P3|NOT COMPLETED|Overall Study||0
1700546|NCT00442338|4157329|P2|NOT COMPLETED|Overall Study||0
1700547|NCT00442338|4157330|P1|NOT COMPLETED|Overall Study||0
1700548|NCT00442338|4157328|P3|COMPLETED|Overall Study||31
1700549|NCT00442338|4157329|P2|COMPLETED|Overall Study||30
1700550|NCT00442338|4157330|P1|COMPLETED|Overall Study||30
1700551|NCT00442338|4157328|P3|STARTED|Overall Study||31
1700552|NCT00442338|4157329|P2|STARTED|Overall Study||30
1700553|NCT00442338|4157330|P1|STARTED|Overall Study||30
1700554|NCT00442286|4157341|P2|NOT COMPLETED|Overall Study||2
1700555|NCT00442286|4157342|P1|NOT COMPLETED|Overall Study||7
1700556|NCT00442286|4157341|P2|COMPLETED|Overall Study||82
1700557|NCT00442286|4157342|P1|COMPLETED|Overall Study||174
1700558|NCT00442286|4157341|P2|12 Months|Overall Study||82
1700559|NCT00442286|4157342|P1|12 Months|Overall Study||174
1700560|NCT00442286|4157341|P2|6 Months|Overall Study||83
1700561|NCT00442286|4157342|P1|6 Months|Overall Study||177
1700562|NCT00442286|4157341|P2|STARTED|Overall Study||84
1700563|NCT00442286|4157342|P1|STARTED|Overall Study||181
1700564|NCT00442169|4157359|P6|NOT COMPLETED|Part 2||0
1700565|NCT00442169|4157360|P5|NOT COMPLETED|Part 2||0
1700566|NCT00442169|4157361|P4|NOT COMPLETED|Part 2||0
1700567|NCT00442169|4157362|P3|NOT COMPLETED|Part 2||0
1700568|NCT00442169|4157363|P2|NOT COMPLETED|Part 2||0
1700569|NCT00442169|4157364|P1|NOT COMPLETED|Part 2||0
1700570|NCT00442169|4157359|P6|COMPLETED|Part 2||57
1700571|NCT00442169|4157360|P5|COMPLETED|Part 2||25
1700572|NCT00442169|4157361|P4|COMPLETED|Part 2||0
1700573|NCT00442169|4157362|P3|COMPLETED|Part 2||0
1700574|NCT00442169|4157363|P2|COMPLETED|Part 2||0
1700575|NCT00442169|4157364|P1|COMPLETED|Part 2||0
1700576|NCT00442169|4157359|P6|STARTED|Part 2||57
1700577|NCT00442169|4157360|P5|STARTED|Part 2||25
1700578|NCT00442169|4157361|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
1700579|NCT00442169|4157362|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
1700580|NCT00442169|4157363|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
1700581|NCT00442169|4157364|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
1700582|NCT00442169|4157359|P6|NOT COMPLETED|Part 1||0
1700583|NCT00442169|4157360|P5|NOT COMPLETED|Part 1||0
1700584|NCT00442169|4157361|P4|NOT COMPLETED|Part 1||0
1700585|NCT00442169|4157362|P3|NOT COMPLETED|Part 1||0
1700586|NCT00442169|4157363|P2|NOT COMPLETED|Part 1||0
1700587|NCT00442169|4157364|P1|NOT COMPLETED|Part 1||0
1700588|NCT00442169|4157359|P6|COMPLETED|Part 1||0
1700589|NCT00442169|4157360|P5|COMPLETED|Part 1||0
1700590|NCT00442169|4157361|P4|COMPLETED|Part 1||31
1700591|NCT00442169|4157362|P3|COMPLETED|Part 1||40
1700592|NCT00442169|4157363|P2|COMPLETED|Part 1||24
1700593|NCT00442169|4157364|P1|COMPLETED|Part 1||17
1700594|NCT00442169|4157359|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
1700595|NCT00442169|4157360|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
1700596|NCT00442169|4157361|P4|STARTED|Part 1||31
1700597|NCT00442169|4157362|P3|STARTED|Part 1||40
1700598|NCT00442169|4157363|P2|STARTED|Part 1||24
1700599|NCT00442169|4157364|P1|STARTED|Part 1||17
1700600|NCT00442117|4157404|P2|NOT COMPLETED|Overall Study||38
1700601|NCT00442117|4157405|P1|NOT COMPLETED|Overall Study||38
1700602|NCT00442117|4157404|P2|COMPLETED|Overall Study||49
1700603|NCT00442117|4157405|P1|COMPLETED|Overall Study||47
1700604|NCT00442117|4157404|P2|STARTED|Overall Study||87
1700605|NCT00442117|4157405|P1|STARTED|Overall Study||85
1700606|NCT00442013|4157419|P2|NOT COMPLETED|Overall Study||17
1700607|NCT00442013|4157420|P1|NOT COMPLETED|Overall Study||26
1700608|NCT00442013|4157419|P2|COMPLETED|Overall Study||132
1700609|NCT00442013|4157420|P1|COMPLETED|Overall Study||131
1700610|NCT00442013|4157419|P2|STARTED|Overall Study||149
1700611|NCT00442013|4157420|P1|STARTED|Overall Study||157
1700612|NCT00441974|4157436|P1|NOT COMPLETED|Overall Study||128
1700613|NCT00441974|4157436|P1|COMPLETED|Overall Study||1342
1700614|NCT00441974|4157436|P1|STARTED|Overall Study||1470
1700615|NCT00441792|4157452|P2|NOT COMPLETED|Overall Study||2
1700616|NCT00441792|4157453|P1|NOT COMPLETED|Overall Study||0
1700617|NCT00441792|4157452|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
1700618|NCT00441792|4157453|P1|COMPLETED|Overall Study||59
1700619|NCT00441792|4157452|P2|STARTED|Overall Study||63
1700620|NCT00441792|4157453|P1|STARTED|Overall Study||59
1700621|NCT00441766|4157465|P4|NOT COMPLETED|Overall Study||6
1700622|NCT00441766|4157466|P3|NOT COMPLETED|Overall Study||9
1700623|NCT00441766|4157467|P2|NOT COMPLETED|Overall Study||7
1700624|NCT00441766|4157468|P1|NOT COMPLETED|Overall Study||14
1700625|NCT00441766|4157465|P4|COMPLETED|Overall Study||48
1700626|NCT00441766|4157466|P3|COMPLETED|Overall Study||44
1700627|NCT00441766|4157467|P2|COMPLETED|Overall Study||46
1700628|NCT00441766|4157468|P1|COMPLETED|Overall Study||39
1700629|NCT00441766|4157465|P4|STARTED|Overall Study||54
1700630|NCT00441766|4157466|P3|STARTED|Overall Study||53
1700631|NCT00441766|4157467|P2|STARTED|Overall Study||53
1700632|NCT00441766|4157468|P1|STARTED|Overall Study||53
1700633|NCT00441727|4157493|P3|NOT COMPLETED|Overall Study||168
1700634|NCT00441727|4157494|P2|NOT COMPLETED|Overall Study||118
1700635|NCT00441727|4157495|P1|NOT COMPLETED|Overall Study||106
1700636|NCT00441727|4157493|P3|COMPLETED|Overall Study|ITT/randomised|637
1700637|NCT00441727|4157494|P2|COMPLETED|Overall Study|ITT/randomised|686
1700638|NCT00441727|4157495|P1|COMPLETED|Overall Study|ITT/randomised|711
1700639|NCT00441727|4157493|P3|STARTED|Overall Study|ITT/randomised|805
1700640|NCT00441727|4157494|P2|STARTED|Overall Study|ITT/randomised|804
1700641|NCT00441727|4157495|P1|STARTED|Overall Study|ITT/randomised|817
1700642|NCT00441701|4157528|P10|NOT COMPLETED|Overall Study||0
1700643|NCT00441701|4157529|P9|NOT COMPLETED|Overall Study||0
1700644|NCT00441701|4157530|P8|NOT COMPLETED|Overall Study||0
1700645|NCT00441701|4157531|P7|NOT COMPLETED|Overall Study||0
1700646|NCT00441701|4157532|P6|NOT COMPLETED|Overall Study||3
1700647|NCT00441701|4157533|P5|NOT COMPLETED|Overall Study||2
1700648|NCT00441701|4157534|P4|NOT COMPLETED|Overall Study||3
1700649|NCT00441701|4157535|P3|NOT COMPLETED|Overall Study||4
1700650|NCT00441701|4157536|P2|NOT COMPLETED|Overall Study||4
1700651|NCT00441701|4157537|P1|NOT COMPLETED|Overall Study||5
1700652|NCT00441701|4157528|P10|COMPLETED|Overall Study||0
1700653|NCT00441701|4157529|P9|COMPLETED|Overall Study||0
1700654|NCT00441701|4157530|P8|COMPLETED|Overall Study||0
1700655|NCT00441701|4157531|P7|COMPLETED|Overall Study||0
1700656|NCT00441701|4157532|P6|COMPLETED|Overall Study||8
1700657|NCT00441701|4157533|P5|COMPLETED|Overall Study||20
1700658|NCT00441701|4157534|P4|COMPLETED|Overall Study||8
1700659|NCT00441701|4157535|P3|COMPLETED|Overall Study||18
1700660|NCT00441701|4157536|P2|COMPLETED|Overall Study||7
1700661|NCT00441701|4157537|P1|COMPLETED|Overall Study||17
1700662|NCT00441701|4157528|P10|STARTED|Overall Study||0
1700663|NCT00441701|4157529|P9|STARTED|Overall Study||0
1700664|NCT00441701|4157530|P8|STARTED|Overall Study||0
1700665|NCT00441701|4157531|P7|STARTED|Overall Study||0
1700666|NCT00441701|4157532|P6|STARTED|Overall Study||11
1700667|NCT00441701|4157533|P5|STARTED|Overall Study||22
1700668|NCT00441701|4157534|P4|STARTED|Overall Study||11
1700669|NCT00441701|4157535|P3|STARTED|Overall Study||22
1700670|NCT00441701|4157536|P2|STARTED|Overall Study||11
1700671|NCT00441701|4157537|P1|STARTED|Overall Study||22
1700672|NCT00441584|4157619|P1|NOT COMPLETED|Overall Study||105
1700673|NCT00441584|4157619|P1|COMPLETED|Overall Study||12
1700674|NCT00441584|4157619|P1|STARTED|Overall Study||117
1700675|NCT00441558|4157623|P1|NOT COMPLETED|Overall Study||1056
1700676|NCT00441558|4157623|P1|COMPLETED|Overall Study||667
1700677|NCT00441558|4157623|P1|STARTED|Overall Study||1723
1700678|NCT00441545|4157627|P2|NOT COMPLETED|Second Intervention||7
1700679|NCT00441545|4157628|P1|NOT COMPLETED|Second Intervention||12
1700680|NCT00441545|4157627|P2|COMPLETED|Second Intervention||68
1700681|NCT00441545|4157628|P1|COMPLETED|Second Intervention||65
1700682|NCT00441545|4157627|P2|STARTED|Second Intervention||75
1700683|NCT00441545|4157628|P1|STARTED|Second Intervention||77
1700684|NCT00441545|4157627|P2|NOT COMPLETED|Washout||0
1700685|NCT00441545|4157628|P1|NOT COMPLETED|Washout||0
1700686|NCT00441545|4157627|P2|COMPLETED|Washout||75
1700687|NCT00441545|4157628|P1|COMPLETED|Washout||77
1700688|NCT00441545|4157627|P2|STARTED|Washout||75
1700689|NCT00441545|4157628|P1|STARTED|Washout||77
1700690|NCT00441545|4157627|P2|NOT COMPLETED|First Intervention||12
1700691|NCT00441545|4157628|P1|NOT COMPLETED|First Intervention||18
1700692|NCT00441545|4157627|P2|COMPLETED|First Intervention||75
1700693|NCT00441545|4157628|P1|COMPLETED|First Intervention||77
1700694|NCT00441545|4157627|P2|STARTED|First Intervention||87
1700695|NCT00441545|4157628|P1|STARTED|First Intervention||95
1700696|NCT00441480|4157642|P2|NOT COMPLETED|Overall Study||4
1700697|NCT00441480|4157643|P1|NOT COMPLETED|Overall Study||3
1700698|NCT00441480|4157642|P2|COMPLETED|Overall Study||41
1700699|NCT00441480|4157643|P1|COMPLETED|Overall Study||43
1700700|NCT00441480|4157642|P2|STARTED|Overall Study||45
1700701|NCT00441480|4157643|P1|STARTED|Overall Study||46
1700702|NCT00441467|4157675|P1|NOT COMPLETED|Overall Study||18
1700703|NCT00441467|4157675|P1|COMPLETED|Overall Study||4
1700704|NCT00441467|4157675|P1|4 Cycles|Overall Study||7
1700705|NCT00441467|4157675|P1|2 Cycles|Overall Study||17
1700706|NCT00441467|4157675|P1|STARTED|Overall Study||22
1700707|NCT00441441|4157683|P2|NOT COMPLETED|Overall Study||14
1700708|NCT00441441|4157684|P1|NOT COMPLETED|Overall Study||11
1700709|NCT00441441|4157683|P2|COMPLETED|Overall Study||163
1700710|NCT00441441|4157684|P1|COMPLETED|Overall Study||162
1700711|NCT00441441|4157683|P2|STARTED|Overall Study||177
1700712|NCT00441441|4157684|P1|STARTED|Overall Study||173
1700713|NCT00441363|4157744|P2|NOT COMPLETED|Overall Study||15
1700714|NCT00441363|4157745|P1|NOT COMPLETED|Overall Study||17
1700715|NCT00441363|4157744|P2|COMPLETED|Overall Study||19
1700716|NCT00441363|4157745|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
1700717|NCT00441363|4157744|P2|STARTED|Overall Study||34
1700718|NCT00441363|4157745|P1|STARTED|Overall Study||32
1700719|NCT00441337|4157757|P4|NOT COMPLETED|Overall Study||21
1700720|NCT00441337|4157758|P3|NOT COMPLETED|Overall Study||6
1700721|NCT00441337|4157759|P2|NOT COMPLETED|Overall Study||6
1700722|NCT00441337|4157760|P1|NOT COMPLETED|Overall Study||6
1700723|NCT00441337|4157757|P4|COMPLETED|Overall Study||0
1700724|NCT00441337|4157758|P3|COMPLETED|Overall Study||0
1700725|NCT00441337|4157759|P2|COMPLETED|Overall Study||0
1700726|NCT00441337|4157760|P1|COMPLETED|Overall Study||0
1700727|NCT00441337|4157757|P4|STARTED|Overall Study||21
1700728|NCT00441337|4157758|P3|STARTED|Overall Study||6
1700729|NCT00441337|4157759|P2|STARTED|Overall Study||6
1700730|NCT00441337|4157760|P1|STARTED|Overall Study||6
1700731|NCT00441285|4157843|P5|NOT COMPLETED|Overall Study||0
1700732|NCT00441285|4157844|P4|NOT COMPLETED|Overall Study||0
1700733|NCT00441285|4157845|P3|NOT COMPLETED|Overall Study||0
1700734|NCT00441285|4157846|P2|NOT COMPLETED|Overall Study||0
1700735|NCT00441285|4157847|P1|NOT COMPLETED|Overall Study||0
1700736|NCT00441285|4157843|P5|COMPLETED|Overall Study||43
1700737|NCT00441285|4157844|P4|COMPLETED|Overall Study||40
1700738|NCT00441285|4157845|P3|COMPLETED|Overall Study||41
1700739|NCT00441285|4157846|P2|COMPLETED|Overall Study||16
1700740|NCT00441285|4157847|P1|COMPLETED|Overall Study||16
1700741|NCT00441285|4157843|P5|STARTED|Overall Study||43
1700742|NCT00441285|4157844|P4|STARTED|Overall Study||40
1700743|NCT00441285|4157845|P3|STARTED|Overall Study||41
1700744|NCT00441285|4157846|P2|STARTED|Overall Study||16
1700745|NCT00441285|4157847|P1|STARTED|Overall Study||16
1700746|NCT00441272|4157873|P2|NOT COMPLETED|Overall Study||25
1700747|NCT00441272|4157874|P1|NOT COMPLETED|Overall Study||25
1700748|NCT00441272|4157873|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
1700749|NCT00441272|4157874|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
1700750|NCT00441272|4157873|P2|STARTED|Overall Study||25
1700751|NCT00441272|4157874|P1|STARTED|Overall Study||25
1700752|NCT00441259|4157882|P2|NOT COMPLETED|Overall Study||0
1700753|NCT00441259|4157883|P1|NOT COMPLETED|Overall Study||0
1700754|NCT00441259|4157882|P2|COMPLETED|Overall Study||48
1700755|NCT00441259|4157883|P1|COMPLETED|Overall Study||48
1700756|NCT00441259|4157882|P2|STARTED|Overall Study||48
1700757|NCT00441259|4157883|P1|STARTED|Overall Study||48
1700758|NCT00441168|4157901|P2|NOT COMPLETED|Follow-up Period||9
1700759|NCT00441168|4157902|P1|NOT COMPLETED|Follow-up Period||12
1700760|NCT00441168|4157901|P2|COMPLETED|Follow-up Period||4
1700761|NCT00441168|4157902|P1|COMPLETED|Follow-up Period||5
1700762|NCT00441168|4157901|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
1700763|NCT00441168|4157902|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
1700764|NCT00441168|4157901|P2|NOT COMPLETED|Treatment Period||6
1700765|NCT00441168|4157902|P1|NOT COMPLETED|Treatment Period||11
1700766|NCT00441168|4157901|P2|COMPLETED|Treatment Period||7
1700767|NCT00441168|4157902|P1|COMPLETED|Treatment Period||6
1700768|NCT00441168|4157901|P2|TREATED|Treatment Period||13
1700769|NCT00441168|4157902|P1|TREATED|Treatment Period||16
1700770|NCT00441168|4157901|P2|STARTED|Treatment Period||13
1700771|NCT00441168|4157902|P1|STARTED|Treatment Period||17
1700772|NCT00441142|4157916|P4|NOT COMPLETED|Overall Study||68
1700773|NCT00441142|4157917|P3|NOT COMPLETED|Overall Study||22
1700774|NCT00441142|4157918|P2|NOT COMPLETED|Overall Study||7
1700775|NCT00441142|4157919|P1|NOT COMPLETED|Overall Study||6
1700776|NCT00441142|4157916|P4|COMPLETED|Overall Study||1
1700777|NCT00441142|4157917|P3|COMPLETED|Overall Study||7
1700778|NCT00441142|4157918|P2|COMPLETED|Overall Study||0
1700779|NCT00441142|4157919|P1|COMPLETED|Overall Study||0
1700780|NCT00441142|4157916|P4|STARTED|Overall Study||69
1700781|NCT00441142|4157917|P3|STARTED|Overall Study||29
1700782|NCT00441142|4157918|P2|STARTED|Overall Study||7
1700783|NCT00441142|4157919|P1|STARTED|Overall Study||6
1700784|NCT00441129|4157937|P2|NOT COMPLETED|Overall Study||14
1700785|NCT00441129|4157938|P1|NOT COMPLETED|Overall Study||6
1700786|NCT00441129|4157937|P2|COMPLETED|Overall Study||41
1700787|NCT00441129|4157938|P1|COMPLETED|Overall Study||54
1700788|NCT00441129|4157937|P2|STARTED|Overall Study||55
1700789|NCT00441129|4157938|P1|STARTED|Overall Study||60
1700790|NCT00441116|4157950|P2|NOT COMPLETED|Overall Study||2
1700791|NCT00441116|4157951|P1|NOT COMPLETED|Overall Study||3
1700792|NCT00441116|4157950|P2|COMPLETED|Overall Study||75
1700793|NCT00441116|4157951|P1|COMPLETED|Overall Study||73
1700794|NCT00441116|4157950|P2|STARTED|Overall Study||77
1700795|NCT00441116|4157951|P1|STARTED|Overall Study||76
1700796|NCT00441103|4158019|P2|NOT COMPLETED|Overall Study||4
1700797|NCT00441103|4158020|P1|NOT COMPLETED|Overall Study||11
1700798|NCT00441103|4158019|P2|COMPLETED|Overall Study||56
1700799|NCT00441103|4158020|P1|COMPLETED|Overall Study||109
1700800|NCT00441103|4158019|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
1700801|NCT00441103|4158020|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
1700802|NCT00441090|4158036|P5|NOT COMPLETED|Overall Study||0
1700803|NCT00441090|4158037|P4|NOT COMPLETED|Overall Study||2
1700804|NCT00441090|4158038|P3|NOT COMPLETED|Overall Study||2
1700805|NCT00441090|4158039|P2|NOT COMPLETED|Overall Study||1
1700806|NCT00441090|4158040|P1|NOT COMPLETED|Overall Study||2
1700807|NCT00441090|4158036|P5|COMPLETED|Overall Study||5
1700808|NCT00441090|4158037|P4|COMPLETED|Overall Study||13
1700809|NCT00441090|4158038|P3|COMPLETED|Overall Study||12
1700810|NCT00441090|4158039|P2|COMPLETED|Overall Study||14
1700811|NCT00441090|4158040|P1|COMPLETED|Overall Study||13
1700812|NCT00441090|4158036|P5|STARTED|Overall Study||5
1700813|NCT00441090|4158037|P4|STARTED|Overall Study||15
1700814|NCT00441090|4158038|P3|STARTED|Overall Study||14
1700815|NCT00441090|4158039|P2|STARTED|Overall Study||15
1700816|NCT00441090|4158040|P1|STARTED|Overall Study||15
1700817|NCT00441064|4158084|P2|NOT COMPLETED|Overall Study||7
1700818|NCT00441064|4158085|P1|NOT COMPLETED|Overall Study||10
1700819|NCT00441064|4158084|P2|COMPLETED|Overall Study||56
1700820|NCT00441064|4158085|P1|COMPLETED|Overall Study||59
1700821|NCT00441064|4158084|P2|Intent-to-treat (ITT) Population|Overall Study||57
1700822|NCT00441064|4158085|P1|Intent-to-treat (ITT) Population|Overall Study||61
1700823|NCT00441064|4158084|P2|Safety Population (SP)|Overall Study||63
1700824|NCT00441064|4158085|P1|Safety Population (SP)|Overall Study||69
1700825|NCT00441064|4158084|P2|STARTED|Overall Study||63
1700826|NCT00441064|4158085|P1|STARTED|Overall Study||69
1700827|NCT00441012|4158097|P2|NOT COMPLETED|Overall Study||13
1700828|NCT00441012|4158098|P1|NOT COMPLETED|Overall Study||18
1700829|NCT00441012|4158097|P2|COMPLETED|Overall Study||263
1700830|NCT00441012|4158098|P1|COMPLETED|Overall Study||252
1700831|NCT00441012|4158097|P2|Vaccination Visit 3|Overall Study||269
1700832|NCT00441012|4158098|P1|Vaccination Visit 3|Overall Study||265
1700833|NCT00441012|4158097|P2|Vaccination Visit 2|Overall Study||272
1700834|NCT00441012|4158098|P1|Vaccination Visit 2|Overall Study||267
1700835|NCT00441012|4158097|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
1700836|NCT00441012|4158098|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
1700837|NCT00441012|4158097|P2|STARTED|Overall Study||276
1700838|NCT00441012|4158098|P1|STARTED|Overall Study||270
1700839|NCT00440947|4158112|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
1700840|NCT00440947|4158113|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
1700841|NCT00440947|4158114|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
1700842|NCT00440947|4158115|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
1700843|NCT00440947|4158116|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
1700844|NCT00440947|4158112|P5|COMPLETED|Optional 60-Week Extension Phase||154
1700845|NCT00440947|4158113|P4|COMPLETED|Optional 60-Week Extension Phase||160
1700846|NCT00440947|4158114|P3|COMPLETED|Optional 60-Week Extension Phase||0
1700847|NCT00440947|4158115|P2|COMPLETED|Optional 60-Week Extension Phase||0
1700848|NCT00440947|4158116|P1|COMPLETED|Optional 60-Week Extension Phase||0
1700849|NCT00440947|4158112|P5|STARTED|Optional 60-Week Extension Phase||180
1700850|NCT00440947|4158113|P4|STARTED|Optional 60-Week Extension Phase||189
1700851|NCT00440947|4158114|P3|STARTED|Optional 60-Week Extension Phase||0
1700852|NCT00440947|4158115|P2|STARTED|Optional 60-Week Extension Phase||0
1700853|NCT00440947|4158116|P1|STARTED|Optional 60-Week Extension Phase||0
1700854|NCT00440947|4158112|P5|NOT COMPLETED|48-Week Randomization Phase||0
1700855|NCT00440947|4158113|P4|NOT COMPLETED|48-Week Randomization Phase||0
1700856|NCT00440947|4158114|P3|NOT COMPLETED|48-Week Randomization Phase||24
1700857|NCT00440947|4158115|P2|NOT COMPLETED|48-Week Randomization Phase||16
1700858|NCT00440947|4158116|P1|NOT COMPLETED|48-Week Randomization Phase||0
1700859|NCT00440947|4158112|P5|COMPLETED|48-Week Randomization Phase||0
1700860|NCT00440947|4158113|P4|COMPLETED|48-Week Randomization Phase||0
1700861|NCT00440947|4158114|P3|COMPLETED|48-Week Randomization Phase||185
1700862|NCT00440947|4158115|P2|COMPLETED|48-Week Randomization Phase||194
1700863|NCT00440947|4158116|P1|COMPLETED|48-Week Randomization Phase||0
1700864|NCT00440947|4158112|P5|STARTED|48-Week Randomization Phase||0
1700865|NCT00440947|4158113|P4|STARTED|48-Week Randomization Phase||0
1700866|NCT00440947|4158114|P3|STARTED|48-Week Randomization Phase||209
1700867|NCT00440947|4158115|P2|STARTED|48-Week Randomization Phase||210
1700868|NCT00440947|4158116|P1|STARTED|48-Week Randomization Phase||0
1700869|NCT00440947|4158112|P5|NOT COMPLETED|36-Week Induction Phase||0
1700870|NCT00440947|4158113|P4|NOT COMPLETED|36-Week Induction Phase||0
1700871|NCT00440947|4158114|P3|NOT COMPLETED|36-Week Induction Phase||0
1700872|NCT00440947|4158115|P2|NOT COMPLETED|36-Week Induction Phase||0
1700873|NCT00440947|4158116|P1|NOT COMPLETED|36-Week Induction Phase||73
1700874|NCT00440947|4158112|P5|COMPLETED|36-Week Induction Phase||0
1700875|NCT00440947|4158113|P4|COMPLETED|36-Week Induction Phase||0
1700876|NCT00440947|4158114|P3|COMPLETED|36-Week Induction Phase||0
1700877|NCT00440947|4158115|P2|COMPLETED|36-Week Induction Phase||0
1700878|NCT00440947|4158116|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
1700879|NCT00440947|4158112|P5|STARTED|36-Week Induction Phase||0
1700880|NCT00440947|4158113|P4|STARTED|36-Week Induction Phase||0
1700881|NCT00440947|4158114|P3|STARTED|36-Week Induction Phase||0
1700882|NCT00440947|4158115|P2|STARTED|36-Week Induction Phase||0
1700883|NCT00440947|4158116|P1|STARTED|36-Week Induction Phase||515
1700884|NCT00440830|4158171|P4|NOT COMPLETED|Overall Study||0
1700885|NCT00440830|4158172|P3|NOT COMPLETED|Overall Study||0
1700886|NCT00440830|4158173|P2|NOT COMPLETED|Overall Study||0
1700887|NCT00440830|4158174|P1|NOT COMPLETED|Overall Study||0
1700888|NCT00440830|4158171|P4|COMPLETED|Overall Study||10
1700889|NCT00440830|4158172|P3|COMPLETED|Overall Study||30
1700890|NCT00440830|4158173|P2|COMPLETED|Overall Study||8
1700891|NCT00440830|4158174|P1|COMPLETED|Overall Study||20
1700892|NCT00440830|4158171|P4|STARTED|Overall Study||10
1700893|NCT00440830|4158172|P3|STARTED|Overall Study||30
1700894|NCT00440830|4158173|P2|STARTED|Overall Study||8
1700895|NCT00440830|4158174|P1|STARTED|Overall Study||20
1700896|NCT00440700|4158191|P3|NOT COMPLETED|Overall Study||4
1700897|NCT00440700|4158192|P2|NOT COMPLETED|Overall Study||8
1700898|NCT00440700|4158193|P1|NOT COMPLETED|Overall Study||8
1700899|NCT00440700|4158191|P3|COMPLETED|Overall Study||120
1700900|NCT00440700|4158192|P2|COMPLETED|Overall Study||110
1700901|NCT00440700|4158193|P1|COMPLETED|Overall Study||114
1700902|NCT00440700|4158191|P3|STARTED|Overall Study||124
1700903|NCT00440700|4158192|P2|STARTED|Overall Study||118
1700904|NCT00440700|4158193|P1|STARTED|Overall Study||122
1700905|NCT00440557|4158216|P3|NOT COMPLETED|Overall Study||35
1700906|NCT00440557|4158217|P2|NOT COMPLETED|Overall Study||29
1700907|NCT00440557|4158218|P1|NOT COMPLETED|Overall Study||25
1700908|NCT00440557|4158216|P3|COMPLETED|Overall Study||90
1700909|NCT00440557|4158217|P2|COMPLETED|Overall Study||96
1700910|NCT00440557|4158218|P1|COMPLETED|Overall Study||98
1700911|NCT00440557|4158216|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
1700912|NCT00440557|4158217|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
1700913|NCT00440557|4158218|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
1700914|NCT00440531|4158250|P3|NOT COMPLETED|Overall Study||7
1700915|NCT00440531|4158251|P2|NOT COMPLETED|Overall Study||5
1700916|NCT00440531|4158252|P1|NOT COMPLETED|Overall Study||10
1700917|NCT00440531|4158250|P3|COMPLETED|Overall Study||165
1700918|NCT00440531|4158251|P2|COMPLETED|Overall Study||178
1700919|NCT00440531|4158252|P1|COMPLETED|Overall Study||175
1700920|NCT00440531|4158250|P3|Vaccination 3|Overall Study||166
1700921|NCT00440531|4158251|P2|Vaccination 3|Overall Study||178
1700922|NCT00440531|4158252|P1|Vaccination 3|Overall Study||176
1700923|NCT00440531|4158250|P3|Vaccination 2|Overall Study||171
1700924|NCT00440531|4158251|P2|Vaccination 2|Overall Study||182
1700925|NCT00440531|4158252|P1|Vaccination 2|Overall Study||181
1700926|NCT00440531|4158250|P3|Vaccination 1|Overall Study||172
1700927|NCT00440531|4158251|P2|Vaccination 1|Overall Study||183
1700928|NCT00440531|4158252|P1|Vaccination 1|Overall Study||183
1700929|NCT00440531|4158250|P3|STARTED|Overall Study||172
1700930|NCT00440531|4158251|P2|STARTED|Overall Study||183
1700931|NCT00440531|4158252|P1|STARTED|Overall Study||185
1700932|NCT00440518|4158269|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
1700933|NCT00440518|4158270|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
1700934|NCT00440518|4158271|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
1700935|NCT00440518|4158269|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
1700936|NCT00440518|4158270|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
1700937|NCT00440518|4158271|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
1700938|NCT00440518|4158269|P3|STARTED|Maintenance and Safety Follow-up Periods||70
1700939|NCT00440518|4158270|P2|STARTED|Maintenance and Safety Follow-up Periods||63
1700940|NCT00440518|4158271|P1|STARTED|Maintenance and Safety Follow-up Periods||59
1700941|NCT00440518|4158269|P3|NOT COMPLETED|Randomized /Titration Period||4
1700942|NCT00440518|4158270|P2|NOT COMPLETED|Randomized /Titration Period||9
1700943|NCT00440518|4158271|P1|NOT COMPLETED|Randomized /Titration Period||13
1700944|NCT00440518|4158269|P3|COMPLETED|Randomized /Titration Period||70
1700945|NCT00440518|4158270|P2|COMPLETED|Randomized /Titration Period||63
1700946|NCT00440518|4158271|P1|COMPLETED|Randomized /Titration Period||59
1700947|NCT00440518|4158269|P3|STARTED|Randomized /Titration Period||74
1700948|NCT00440518|4158270|P2|STARTED|Randomized /Titration Period||72
1700949|NCT00440518|4158271|P1|STARTED|Randomized /Titration Period||72
1700950|NCT00440505|4158291|P6|NOT COMPLETED|Third Intervention||0
1700951|NCT00440505|4158292|P5|NOT COMPLETED|Third Intervention||0
1700952|NCT00440505|4158293|P4|NOT COMPLETED|Third Intervention||1
1700953|NCT00440505|4158294|P3|NOT COMPLETED|Third Intervention||0
1700954|NCT00440505|4158295|P2|NOT COMPLETED|Third Intervention||0
1700955|NCT00440505|4158296|P1|NOT COMPLETED|Third Intervention||0
1700956|NCT00440505|4158291|P6|COMPLETED|Third Intervention||5
1700957|NCT00440505|4158292|P5|COMPLETED|Third Intervention||5
1700958|NCT00440505|4158293|P4|COMPLETED|Third Intervention||1
1700959|NCT00440505|4158294|P3|COMPLETED|Third Intervention||1
1700960|NCT00440505|4158295|P2|COMPLETED|Third Intervention||2
1700961|NCT00440505|4158296|P1|COMPLETED|Third Intervention||5
1700962|NCT00440505|4158291|P6|STARTED|Third Intervention||5
1700963|NCT00440505|4158292|P5|STARTED|Third Intervention||5
1700964|NCT00440505|4158293|P4|STARTED|Third Intervention||2
1700965|NCT00440505|4158294|P3|STARTED|Third Intervention||1
1700966|NCT00440505|4158295|P2|STARTED|Third Intervention||2
1700967|NCT00440505|4158296|P1|STARTED|Third Intervention||5
1700968|NCT00440505|4158291|P6|NOT COMPLETED|Second Intervention||0
1700969|NCT00440505|4158292|P5|NOT COMPLETED|Second Intervention||0
1700970|NCT00440505|4158293|P4|NOT COMPLETED|Second Intervention||0
1700971|NCT00440505|4158294|P3|NOT COMPLETED|Second Intervention||0
1700972|NCT00440505|4158295|P2|NOT COMPLETED|Second Intervention||0
1700973|NCT00440505|4158296|P1|NOT COMPLETED|Second Intervention||0
1700974|NCT00440505|4158291|P6|COMPLETED|Second Intervention||5
1700975|NCT00440505|4158292|P5|COMPLETED|Second Intervention||5
1700976|NCT00440505|4158293|P4|COMPLETED|Second Intervention||2
1700977|NCT00440505|4158294|P3|COMPLETED|Second Intervention||1
1700978|NCT00440505|4158295|P2|COMPLETED|Second Intervention||2
1700979|NCT00440505|4158296|P1|COMPLETED|Second Intervention||5
1700980|NCT00440505|4158291|P6|STARTED|Second Intervention||5
1700981|NCT00440505|4158292|P5|STARTED|Second Intervention||5
1700982|NCT00440505|4158293|P4|STARTED|Second Intervention||2
1700983|NCT00440505|4158294|P3|STARTED|Second Intervention||1
1700984|NCT00440505|4158295|P2|STARTED|Second Intervention||2
1700985|NCT00440505|4158296|P1|STARTED|Second Intervention||5
1700986|NCT00440505|4158291|P6|NOT COMPLETED|First Intervention||0
1700987|NCT00440505|4158292|P5|NOT COMPLETED|First Intervention||0
1700988|NCT00440505|4158293|P4|NOT COMPLETED|First Intervention||0
1700989|NCT00440505|4158294|P3|NOT COMPLETED|First Intervention||0
1700990|NCT00440505|4158295|P2|NOT COMPLETED|First Intervention||0
1700991|NCT00440505|4158296|P1|NOT COMPLETED|First Intervention||0
1700992|NCT00440505|4158291|P6|COMPLETED|First Intervention||5
1700993|NCT00440505|4158292|P5|COMPLETED|First Intervention||5
1700994|NCT00440505|4158293|P4|COMPLETED|First Intervention||2
1700995|NCT00440505|4158294|P3|COMPLETED|First Intervention||1
1700996|NCT00440505|4158295|P2|COMPLETED|First Intervention||2
1700997|NCT00440505|4158296|P1|COMPLETED|First Intervention||5
1700998|NCT00440505|4158291|P6|STARTED|First Intervention||5
1700999|NCT00440505|4158292|P5|STARTED|First Intervention||5
1701000|NCT00440505|4158293|P4|STARTED|First Intervention||2
1701001|NCT00440505|4158294|P3|STARTED|First Intervention||1
1701002|NCT00440505|4158295|P2|STARTED|First Intervention||2
1701003|NCT00440505|4158296|P1|STARTED|First Intervention||5
1701004|NCT00440466|4158316|P3|NOT COMPLETED|Overall Study||41
1701005|NCT00440466|4158317|P2|NOT COMPLETED|Overall Study||15
1701006|NCT00440466|4158318|P1|NOT COMPLETED|Overall Study||13
1701007|NCT00440466|4158316|P3|COMPLETED|Overall Study||174
1701008|NCT00440466|4158317|P2|COMPLETED|Overall Study||92
1701009|NCT00440466|4158318|P1|COMPLETED|Overall Study||95
1701010|NCT00440466|4158316|P3|STARTED|Overall Study||215
1701011|NCT00440466|4158317|P2|STARTED|Overall Study||107
1701012|NCT00440466|4158318|P1|STARTED|Overall Study||108
1701013|NCT00440401|4158352|P2|NOT COMPLETED|Overall Study||6
1701014|NCT00440401|4158353|P1|NOT COMPLETED|Overall Study||4
1701015|NCT00440401|4158352|P2|COMPLETED|Overall Study||54
1701016|NCT00440401|4158353|P1|COMPLETED|Overall Study||55
1701017|NCT00440401|4158352|P2|STARTED|Overall Study||60
1701018|NCT00440401|4158353|P1|STARTED|Overall Study||59
1701019|NCT00440310|4158363|P2|NOT COMPLETED|Overall Study||30
1701020|NCT00440310|4158364|P1|NOT COMPLETED|Overall Study||28
1701021|NCT00440310|4158363|P2|COMPLETED|Overall Study||209
1701022|NCT00440310|4158364|P1|COMPLETED|Overall Study||216
1701023|NCT00440310|4158363|P2|Treated|Overall Study||232
1701024|NCT00440310|4158364|P1|Treated|Overall Study||222
1701025|NCT00440310|4158363|P2|STARTED|Overall Study||239
1701026|NCT00440310|4158364|P1|STARTED|Overall Study||244
1701027|NCT00440297|4158372|P2|NOT COMPLETED|Overall Study||18
1701028|NCT00440297|4158373|P1|NOT COMPLETED|Overall Study||23
1701029|NCT00440297|4158372|P2|COMPLETED|Overall Study||120
1701030|NCT00440297|4158373|P1|COMPLETED|Overall Study||116
1701031|NCT00440297|4158372|P2|Vaccination Visit 4|Overall Study||122
1701032|NCT00440297|4158373|P1|Vaccination Visit 4|Overall Study||116
1701033|NCT00440297|4158372|P2|Vaccination Visit 3|Overall Study||125
1701034|NCT00440297|4158373|P1|Vaccination Visit 3|Overall Study||124
1701035|NCT00440297|4158372|P2|Vaccination Visit 2|Overall Study||134
1701036|NCT00440297|4158373|P1|Vaccination Visit 2|Overall Study||136
1701037|NCT00440297|4158372|P2|Vaccination Visit 1|Overall Study||138
1701038|NCT00440297|4158373|P1|Vaccination Visit 1|Overall Study||138
1701039|NCT00440297|4158372|P2|STARTED|Overall Study||138
1701040|NCT00440297|4158373|P1|STARTED|Overall Study||139
1701041|NCT00440271|4158389|P2|NOT COMPLETED|Overall Study||15
1701042|NCT00440271|4158390|P1|NOT COMPLETED|Overall Study||12
1701043|NCT00440271|4158389|P2|COMPLETED|Overall Study||3
1701044|NCT00440271|4158390|P1|COMPLETED|Overall Study||3
1701045|NCT00440271|4158389|P2|STARTED|Overall Study||18
1701046|NCT00440271|4158390|P1|STARTED|Overall Study||15
1701047|NCT00440232|4158424|P2|NOT COMPLETED|Overall Study||4
1701048|NCT00440232|4158425|P1|NOT COMPLETED|Overall Study||3
1701049|NCT00440232|4158424|P2|COMPLETED|Overall Study||34
1701050|NCT00440232|4158425|P1|COMPLETED|Overall Study||33
1701051|NCT00440232|4158424|P2|STARTED|Overall Study||38
1701052|NCT00440232|4158425|P1|STARTED|Overall Study||36
1701053|NCT00440193|4158435|P2|NOT COMPLETED|Observational Period||38
1701054|NCT00440193|4158436|P1|NOT COMPLETED|Observational Period||45
1701055|NCT00440193|4158435|P2|COMPLETED|Observational Period||1369
1701056|NCT00440193|4158436|P1|COMPLETED|Observational Period||1380
1701057|NCT00440193|4158435|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
1701058|NCT00440193|4158436|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
1701059|NCT00440193|4158435|P2|NOT COMPLETED|Treatment Period||351
1701060|NCT00440193|4158436|P1|NOT COMPLETED|Treatment Period||305
1701061|NCT00440193|4158435|P2|COMPLETED|Treatment Period||1367
1701062|NCT00440193|4158436|P1|COMPLETED|Treatment Period||1426
1701063|NCT00440193|4158435|P2|Participants Received Treatment|Treatment Period||1711
1701064|NCT00440193|4158436|P1|Participants Received Treatment|Treatment Period||1718
1701065|NCT00440193|4158435|P2|STARTED|Treatment Period||1718
1701066|NCT00440193|4158436|P1|STARTED|Treatment Period||1731
1701067|NCT00440180|4158472|P2|NOT COMPLETED|Overall Study||0
1701068|NCT00440180|4158473|P1|NOT COMPLETED|Overall Study||0
1701069|NCT00440180|4158472|P2|COMPLETED|Overall Study||10
1701070|NCT00440180|4158473|P1|COMPLETED|Overall Study||10
1701071|NCT00440180|4158472|P2|STARTED|Overall Study||10
1701072|NCT00440180|4158473|P1|STARTED|Overall Study||10
1701073|NCT00440115|4158482|P3|NOT COMPLETED|Overall Study||6
1701074|NCT00440115|4158483|P2|NOT COMPLETED|Overall Study||11
1701075|NCT00440115|4158484|P1|NOT COMPLETED|Overall Study||7
1701076|NCT00440115|4158482|P3|COMPLETED|Overall Study||244
1701077|NCT00440115|4158483|P2|COMPLETED|Overall Study||238
1701078|NCT00440115|4158484|P1|COMPLETED|Overall Study||244
1701079|NCT00440115|4158482|P3|STARTED|Overall Study||250
1701080|NCT00440115|4158483|P2|STARTED|Overall Study||249
1701081|NCT00440115|4158484|P1|STARTED|Overall Study||251
1701082|NCT00440050|4158500|P2|NOT COMPLETED|Overall Study||67
1701083|NCT00440050|4158501|P1|NOT COMPLETED|Overall Study||40
1701084|NCT00440050|4158500|P2|COMPLETED|Overall Study||171
1701085|NCT00440050|4158501|P1|COMPLETED|Overall Study||124
1701086|NCT00440050|4158500|P2|STARTED|Overall Study||238
1701087|NCT00440050|4158501|P1|STARTED|Overall Study||164
1701088|NCT00440011|4158515|P2|NOT COMPLETED|Overall Study||3
1701089|NCT00440011|4158516|P1|NOT COMPLETED|Overall Study||4
1701090|NCT00440011|4158515|P2|COMPLETED|Overall Study||132
1701091|NCT00440011|4158516|P1|COMPLETED|Overall Study||127
1701092|NCT00440011|4158515|P2|STARTED|Overall Study||135
1701093|NCT00440011|4158516|P1|STARTED|Overall Study||131
1701094|NCT00439946|4158524|P1|NOT COMPLETED|Overall Study||0
1701095|NCT00439946|4158524|P1|COMPLETED|Overall Study||8
1701096|NCT00439946|4158524|P1|STARTED|Overall Study||8
1701097|NCT00439777|4158543|P2|NOT COMPLETED|Observational Period||41
1701098|NCT00439777|4158544|P1|NOT COMPLETED|Observational Period||41
1701099|NCT00439777|4158543|P2|COMPLETED|Observational Period||2156
1701100|NCT00439777|4158544|P1|COMPLETED|Observational Period||2165
1701101|NCT00439777|4158543|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
1701102|NCT00439777|4158544|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
1701103|NCT00439777|4158543|P2|NOT COMPLETED|Treatment Period||459
1701104|NCT00439777|4158544|P1|NOT COMPLETED|Treatment Period||419
1701105|NCT00439777|4158543|P2|COMPLETED|Treatment Period||1954
1701106|NCT00439777|4158544|P1|COMPLETED|Treatment Period||2001
1701107|NCT00439777|4158543|P2|Participants Received Treatment|Treatment Period||2405
1701108|NCT00439777|4158544|P1|Participants Received Treatment|Treatment Period||2412
1701109|NCT00439777|4158543|P2|STARTED|Treatment Period||2413
1701110|NCT00439777|4158544|P1|STARTED|Treatment Period||2420
1701111|NCT00439738|4158582|P2|NOT COMPLETED|Overall Study||28
1701112|NCT00439738|4158583|P1|NOT COMPLETED|Overall Study||36
1701113|NCT00439738|4158582|P2|COMPLETED|Overall Study||178
1701114|NCT00439738|4158583|P1|COMPLETED|Overall Study||170
1701115|NCT00439738|4158582|P2|STARTED|Overall Study||206
1701116|NCT00439738|4158583|P1|STARTED|Overall Study||206
1701117|NCT00439725|4158601|P2|NOT COMPLETED|Observational Period||7
1701118|NCT00439725|4158602|P1|NOT COMPLETED|Observational Period||8
1701119|NCT00439725|4158601|P2|COMPLETED|Observational Period||553
1701120|NCT00439725|4158602|P1|COMPLETED|Observational Period||569
1701121|NCT00439725|4158601|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
1701122|NCT00439725|4158602|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
1701123|NCT00439725|4158601|P2|NOT COMPLETED|Treatment Period||246
1701124|NCT00439725|4158602|P1|NOT COMPLETED|Treatment Period||236
1701125|NCT00439725|4158601|P2|COMPLETED|Treatment Period||349
1701126|NCT00439725|4158602|P1|COMPLETED|Treatment Period||366
1701127|NCT00439725|4158601|P2|Participants Received Treatment|Treatment Period|Safety population|590
1701128|NCT00439725|4158602|P1|Participants Received Treatment|Treatment Period|Safety population|598
1701129|NCT00439725|4158601|P2|STARTED|Treatment Period||595
1701130|NCT00439725|4158602|P1|STARTED|Treatment Period||602
1701131|NCT00439673|4158646|P1|NOT COMPLETED|Overall Study||36
1701132|NCT00439673|4158646|P1|COMPLETED|Overall Study||26
1701133|NCT00439673|4158646|P1|STARTED|Overall Study||62
1701134|NCT00439647|4158653|P2|NOT COMPLETED|Overall Study||71
1701135|NCT00439647|4158654|P1|NOT COMPLETED|Overall Study||58
1701136|NCT00439647|4158653|P2|COMPLETED|Overall Study||540
1701137|NCT00439647|4158654|P1|COMPLETED|Overall Study||530
1701138|NCT00439647|4158653|P2|Modified Intent to Treat (mITT)|Overall Study||574
1701139|NCT00439647|4158654|P1|Modified Intent to Treat (mITT)|Overall Study||553
1701140|NCT00439647|4158653|P2|STARTED|Overall Study||611
1701141|NCT00439647|4158654|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
1701142|NCT00439608|4158686|P1|NOT COMPLETED|Overall Study||0
1701143|NCT00439608|4158686|P1|COMPLETED|Overall Study||60
1701144|NCT00439608|4158686|P1|STARTED|Overall Study||60
1701145|NCT00439569|4158691|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
1701146|NCT00439569|4158691|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
1701147|NCT00439569|4158691|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
1701148|NCT00439569|4158691|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
1701149|NCT00439569|4158691|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
1701150|NCT00439569|4158691|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
1701151|NCT00439517|4158704|P2|NOT COMPLETED|Overall Study||0
1701152|NCT00439517|4158705|P1|NOT COMPLETED|Overall Study||2
1701153|NCT00439517|4158704|P2|COMPLETED|Overall Study||150
1701154|NCT00439517|4158705|P1|COMPLETED|Overall Study||150
1701155|NCT00439517|4158704|P2|STARTED|Overall Study||150
1701156|NCT00439517|4158705|P1|STARTED|Overall Study||152
1701157|NCT00439413|4158729|P2|NOT COMPLETED|Overall Study||37
1701158|NCT00439413|4158730|P1|NOT COMPLETED|Overall Study||31
1701159|NCT00439413|4158729|P2|COMPLETED|Overall Study||88
1701160|NCT00439413|4158730|P1|COMPLETED|Overall Study||90
1701161|NCT00439413|4158729|P2|STARTED|Overall Study||125
1701162|NCT00439413|4158730|P1|STARTED|Overall Study||121
1701163|NCT00439335|4158740|P2|NOT COMPLETED|Overall Study||0
1701164|NCT00439335|4158741|P1|NOT COMPLETED|Overall Study||2
1701165|NCT00439335|4158740|P2|COMPLETED|Overall Study||114
1701166|NCT00439335|4158741|P1|COMPLETED|Overall Study||111
1701167|NCT00439335|4158740|P2|STARTED|Overall Study||114
1701168|NCT00439335|4158741|P1|STARTED|Overall Study||113
1701169|NCT00439309|4158773|P2|NOT COMPLETED|Follow-Up||2
1701170|NCT00439309|4158774|P1|NOT COMPLETED|Follow-Up||3
1701171|NCT00439309|4158773|P2|COMPLETED|Follow-Up||13
1701172|NCT00439309|4158774|P1|COMPLETED|Follow-Up||51
1701173|NCT00439309|4158773|P2|STARTED|Follow-Up||15
1701174|NCT00439309|4158774|P1|STARTED|Follow-Up||54
1701175|NCT00439309|4158773|P2|NOT COMPLETED|Treatment||0
1701176|NCT00439309|4158774|P1|NOT COMPLETED|Treatment||0
1701177|NCT00439309|4158773|P2|COMPLETED|Treatment||15
1701178|NCT00439309|4158774|P1|COMPLETED|Treatment||54
1701179|NCT00439309|4158773|P2|STARTED|Treatment||15
1701180|NCT00439309|4158774|P1|STARTED|Treatment||54
1701181|NCT00439270|4158793|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
1701182|NCT00439270|4158794|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
1701183|NCT00439270|4158795|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
1701184|NCT00439270|4158796|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
1701185|NCT00439270|4158797|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
1701186|NCT00439270|4158793|P5|COMPLETED|Phase 2 (51.6 Months)||0
1701187|NCT00439270|4158794|P4|COMPLETED|Phase 2 (51.6 Months)||0
1701188|NCT00439270|4158795|P3|COMPLETED|Phase 2 (51.6 Months)||0
1701189|NCT00439270|4158796|P2|COMPLETED|Phase 2 (51.6 Months)||0
1701190|NCT00439270|4158797|P1|COMPLETED|Phase 2 (51.6 Months)||0
1701191|NCT00439270|4158793|P5|STARTED|Phase 2 (51.6 Months)||0
1701192|NCT00439270|4158794|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
1701193|NCT00439270|4158795|P3|STARTED|Phase 2 (51.6 Months)||0
1701194|NCT00439270|4158796|P2|STARTED|Phase 2 (51.6 Months)||0
1701195|NCT00439270|4158797|P1|STARTED|Phase 2 (51.6 Months)||0
1701196|NCT00439270|4158793|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
1701197|NCT00439270|4158794|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
1701198|NCT00439270|4158795|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
1701199|NCT00439270|4158796|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
1701200|NCT00439270|4158797|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
1701201|NCT00439270|4158793|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
1701202|NCT00439270|4158794|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
1701203|NCT00439270|4158795|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
1701204|NCT00439270|4158796|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
1701205|NCT00439270|4158797|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
1701206|NCT00439270|4158793|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
1701207|NCT00439270|4158794|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
1701208|NCT00439270|4158795|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
1701209|NCT00439270|4158796|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
1701210|NCT00439270|4158797|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
1701211|NCT00439244|4158839|P3|NOT COMPLETED|Overall Study||7
1701212|NCT00439244|4158840|P2|NOT COMPLETED|Overall Study||6
1701213|NCT00439244|4158841|P1|NOT COMPLETED|Overall Study||11
1701214|NCT00439244|4158839|P3|COMPLETED|Overall Study||131
1701215|NCT00439244|4158840|P2|COMPLETED|Overall Study||131
1701216|NCT00439244|4158841|P1|COMPLETED|Overall Study||126
1701217|NCT00439244|4158839|P3|Safety Population|Overall Study||137
1701218|NCT00439244|4158840|P2|Safety Population|Overall Study||137
1701219|NCT00439244|4158841|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
1701220|NCT00439244|4158839|P3|STARTED|Overall Study||138
1701221|NCT00439244|4158840|P2|STARTED|Overall Study||137
1701222|NCT00439244|4158841|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
1701223|NCT00439231|4158861|P1|NOT COMPLETED|Overall Study||28
1701224|NCT00439231|4158861|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
1701225|NCT00439231|4158861|P1|STARTED|Overall Study||33
1701226|NCT00439218|4158865|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
1701227|NCT00439218|4158865|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
1701228|NCT00439218|4158865|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
1701229|NCT00439218|4158865|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
1701230|NCT00439218|4158865|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
1701231|NCT00439218|4158865|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
1701232|NCT00439179|4158880|P4|NOT COMPLETED|Overall Study||0
1701233|NCT00439179|4158881|P3|NOT COMPLETED|Overall Study||0
1701234|NCT00439179|4158882|P2|NOT COMPLETED|Overall Study||2
1701235|NCT00439179|4158883|P1|NOT COMPLETED|Overall Study||0
1701236|NCT00439179|4158880|P4|COMPLETED|Overall Study||5
1701237|NCT00439179|4158881|P3|COMPLETED|Overall Study||6
1701238|NCT00439179|4158882|P2|COMPLETED|Overall Study||11
1701239|NCT00439179|4158883|P1|COMPLETED|Overall Study||3
1701240|NCT00439179|4158880|P4|STARTED|Overall Study|2 with biliry|5
1701241|NCT00439179|4158881|P3|STARTED|Overall Study|2 with biliary|6
1701242|NCT00439179|4158882|P2|STARTED|Overall Study|2 with biliary|13
1701243|NCT00439179|4158883|P1|STARTED|Overall Study|1 with biliary|3
1701244|NCT00439140|4158900|P3|NOT COMPLETED|Treatment Cycle 2||0
1701245|NCT00439140|4158901|P2|NOT COMPLETED|Treatment Cycle 2||1
1701246|NCT00439140|4158902|P1|NOT COMPLETED|Treatment Cycle 2||2
1701247|NCT00439140|4158900|P3|COMPLETED|Treatment Cycle 2||0
1701248|NCT00439140|4158901|P2|COMPLETED|Treatment Cycle 2||6
1701249|NCT00439140|4158902|P1|COMPLETED|Treatment Cycle 2||11
1701250|NCT00439140|4158900|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
1701251|NCT00439140|4158901|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
1701252|NCT00439140|4158902|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
1701253|NCT00439140|4158900|P3|NOT COMPLETED|Treatment Cycle 1||1
1701254|NCT00439140|4158901|P2|NOT COMPLETED|Treatment Cycle 1||4
1701255|NCT00439140|4158902|P1|NOT COMPLETED|Treatment Cycle 1||1
1701256|NCT00439140|4158900|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
1701257|NCT00439140|4158901|P2|COMPLETED|Treatment Cycle 1||10
1701258|NCT00439140|4158902|P1|COMPLETED|Treatment Cycle 1||14
1701259|NCT00439140|4158900|P3|STARTED|Treatment Cycle 1||12
1701260|NCT00439140|4158901|P2|STARTED|Treatment Cycle 1||14
1701261|NCT00439140|4158902|P1|STARTED|Treatment Cycle 1||15
1701262|NCT00438971|4158931|P1|NOT COMPLETED|Overall Study||2
1701263|NCT00438971|4158931|P1|COMPLETED|Overall Study||15
1701264|NCT00438971|4158931|P1|STARTED|Overall Study||17
1701265|NCT00438932|4158946|P4|NOT COMPLETED|Overall Study||0
1701266|NCT00438932|4158947|P3|NOT COMPLETED|Overall Study||0
1701267|NCT00438932|4158948|P2|NOT COMPLETED|Overall Study||0
1701268|NCT00438932|4158949|P1|NOT COMPLETED|Overall Study||0
1701269|NCT00438932|4158946|P4|COMPLETED|Overall Study||4
1701270|NCT00438932|4158947|P3|COMPLETED|Overall Study||4
1701271|NCT00438932|4158948|P2|COMPLETED|Overall Study||4
1701272|NCT00438932|4158949|P1|COMPLETED|Overall Study||4
1701273|NCT00438932|4158946|P4|STARTED|Overall Study||4
1701274|NCT00438932|4158947|P3|STARTED|Overall Study||4
1701275|NCT00438932|4158948|P2|STARTED|Overall Study||4
1701276|NCT00438932|4158949|P1|STARTED|Overall Study||4
1701277|NCT00438880|4158965|P2|NOT COMPLETED|Overall Study||0
1701278|NCT00438880|4158966|P1|NOT COMPLETED|Overall Study||0
1701279|NCT00438880|4158965|P2|COMPLETED|Overall Study||8
1701280|NCT00438880|4158966|P1|COMPLETED|Overall Study||30
1701281|NCT00438880|4158965|P2|STARTED|Overall Study||8
1701282|NCT00438880|4158966|P1|STARTED|Overall Study||30
1701283|NCT00438854|4158978|P1|NOT COMPLETED|Overall Study||0
1701284|NCT00438854|4158978|P1|COMPLETED|Overall Study||15
1701285|NCT00438854|4158978|P1|STARTED|Overall Study||15
1701286|NCT00438815|4158985|P1|NOT COMPLETED|Overall Study||70
1701287|NCT00438815|4158985|P1|COMPLETED|Overall Study||43
1701288|NCT00438815|4158985|P1|STARTED|Overall Study||113
1701289|NCT00438802|4158998|P3|NOT COMPLETED|Overall Study||0
1701290|NCT00438802|4158999|P2|NOT COMPLETED|Overall Study||0
1701291|NCT00438802|4159000|P1|NOT COMPLETED|Overall Study||0
1701292|NCT00438802|4158998|P3|COMPLETED|Overall Study||9
1701293|NCT00438802|4158999|P2|COMPLETED|Overall Study||8
1701294|NCT00438802|4159000|P1|COMPLETED|Overall Study||6
1701295|NCT00438802|4158998|P3|STARTED|Overall Study||9
1701296|NCT00438802|4158999|P2|STARTED|Overall Study||8
1701297|NCT00438802|4159000|P1|STARTED|Overall Study||6
1701298|NCT00438750|4159014|P2|NOT COMPLETED|Overall Study||9
1701299|NCT00438750|4159015|P1|NOT COMPLETED|Overall Study||9
1701300|NCT00438750|4159014|P2|COMPLETED|Overall Study||37
1701301|NCT00438750|4159015|P1|COMPLETED|Overall Study||39
1701302|NCT00438750|4159014|P2|STARTED|Overall Study||46
1701303|NCT00438750|4159015|P1|STARTED|Overall Study||48
1701304|NCT00438672|4159035|P2|NOT COMPLETED|Overall Study||9
1701305|NCT00438672|4159036|P1|NOT COMPLETED|Overall Study||7
1701306|NCT00438672|4159035|P2|COMPLETED|Overall Study||24
1701307|NCT00438672|4159036|P1|COMPLETED|Overall Study||24
1701308|NCT00438672|4159035|P2|STARTED|Overall Study||33
1701309|NCT00438672|4159036|P1|STARTED|Overall Study||31
1701310|NCT00438659|4159046|P2|NOT COMPLETED|Overall Study||4
1701311|NCT00438659|4159047|P1|NOT COMPLETED|Overall Study||6
1701312|NCT00438659|4159046|P2|COMPLETED|Overall Study||82
1701313|NCT00438659|4159047|P1|COMPLETED|Overall Study||84
1701314|NCT00438659|4159046|P2|STARTED|Overall Study||86
1701315|NCT00438659|4159047|P1|STARTED|Overall Study||90
1701316|NCT00438490|4159071|P2|NOT COMPLETED|Overall Study||0
1701317|NCT00438490|4159072|P1|NOT COMPLETED|Overall Study||0
1701318|NCT00438490|4159071|P2|COMPLETED|Overall Study||9
1701319|NCT00438490|4159072|P1|COMPLETED|Overall Study||12
1701320|NCT00438490|4159071|P2|STARTED|Overall Study||9
1701321|NCT00438490|4159072|P1|STARTED|Overall Study||12
1701322|NCT00438464|4159086|P2|NOT COMPLETED|Overall Study||7
1701323|NCT00438464|4159087|P1|NOT COMPLETED|Overall Study||14
1701324|NCT00438464|4159086|P2|COMPLETED|Overall Study||94
1701325|NCT00438464|4159087|P1|COMPLETED|Overall Study||89
1701326|NCT00438464|4159086|P2|Received Assigned Intervention|Overall Study||94
1701327|NCT00438464|4159087|P1|Received Assigned Intervention|Overall Study||89
1701328|NCT00438464|4159086|P2|STARTED|Overall Study||101
1701329|NCT00438464|4159087|P1|STARTED|Overall Study||103
1701330|NCT00438451|4159142|P3|NOT COMPLETED|Overall Study||53
1701331|NCT00438451|4159143|P2|NOT COMPLETED|Overall Study||66
1701332|NCT00438451|4159144|P1|NOT COMPLETED|Overall Study||47
1701333|NCT00438451|4159142|P3|COMPLETED|Overall Study||65
1701334|NCT00438451|4159143|P2|COMPLETED|Overall Study||55
1701335|NCT00438451|4159144|P1|COMPLETED|Overall Study||75
1701336|NCT00438451|4159142|P3|Maintenance Phase (Week 7-58)|Overall Study||93
1701337|NCT00438451|4159143|P2|Maintenance Phase (Week 7-58)|Overall Study||89
1701338|NCT00438451|4159144|P1|Maintenance Phase (Week 7-58)|Overall Study||93
1701339|NCT00438451|4159142|P3|ITT Population|Overall Study||117
1701340|NCT00438451|4159143|P2|ITT Population|Overall Study||120
1701341|NCT00438451|4159144|P1|ITT Population|Overall Study||122
1701342|NCT00438451|4159142|P3|Safety Population|Overall Study||117
1701343|NCT00438451|4159143|P2|Safety Population|Overall Study||121
1701344|NCT00438451|4159144|P1|Safety Population|Overall Study||122
1701345|NCT00438451|4159142|P3|STARTED|Overall Study||118
1701346|NCT00438451|4159143|P2|STARTED|Overall Study||121
1701347|NCT00438451|4159144|P1|STARTED|Overall Study||122
1701348|NCT00438399|4159188|P6|NOT COMPLETED|Overall Study||6
1701349|NCT00438399|4159189|P5|NOT COMPLETED|Overall Study||3
1701350|NCT00438399|4159190|P4|NOT COMPLETED|Overall Study||4
1701351|NCT00438399|4159191|P3|NOT COMPLETED|Overall Study||7
1701352|NCT00438399|4159192|P2|NOT COMPLETED|Overall Study||8
1701353|NCT00438399|4159193|P1|NOT COMPLETED|Overall Study||8
1701354|NCT00438399|4159188|P6|COMPLETED|Overall Study||31
1701355|NCT00438399|4159189|P5|COMPLETED|Overall Study||30
1701356|NCT00438399|4159190|P4|COMPLETED|Overall Study||32
1701357|NCT00438399|4159191|P3|COMPLETED|Overall Study||28
1701358|NCT00438399|4159192|P2|COMPLETED|Overall Study||32
1701359|NCT00438399|4159193|P1|COMPLETED|Overall Study||30
1701360|NCT00438399|4159188|P6|TREATED & ANALYZED|Overall Study||31
1701361|NCT00438399|4159189|P5|TREATED & ANALYZED|Overall Study||30
1701362|NCT00438399|4159190|P4|TREATED & ANALYZED|Overall Study||32
1701363|NCT00438399|4159191|P3|TREATED & ANALYZED|Overall Study||28
1701364|NCT00438399|4159192|P2|TREATED & ANALYZED|Overall Study||32
1701365|NCT00438399|4159193|P1|TREATED & ANALYZED|Overall Study||30
1701366|NCT00438399|4159188|P6|STARTED|Overall Study||37
1701367|NCT00438399|4159189|P5|STARTED|Overall Study||33
1701368|NCT00438399|4159190|P4|STARTED|Overall Study||36
1701369|NCT00438399|4159191|P3|STARTED|Overall Study||35
1701370|NCT00438399|4159192|P2|STARTED|Overall Study||40
1701371|NCT00438399|4159193|P1|STARTED|Overall Study||38
1701372|NCT00438360|4159204|P2|NOT COMPLETED|Overall Study||43
1701373|NCT00438360|4159205|P1|NOT COMPLETED|Overall Study||72
1701374|NCT00438360|4159204|P2|COMPLETED|Overall Study||38
1701375|NCT00438360|4159205|P1|COMPLETED|Overall Study||90
1701376|NCT00438360|4159204|P2|Intention to Treat (ITT) Population|Overall Study||79
1701377|NCT00438360|4159205|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
1701378|NCT00438360|4159204|P2|STARTED|Overall Study||81
1701379|NCT00438360|4159205|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
1701380|NCT00438204|4159219|P1|NOT COMPLETED|Overall Study||0
1701381|NCT00438204|4159219|P1|COMPLETED|Overall Study||39
1701382|NCT00438204|4159219|P1|STARTED|Overall Study||39
1701383|NCT00438191|4159229|P2|NOT COMPLETED|Overall Study||14
1701384|NCT00438191|4159230|P1|NOT COMPLETED|Overall Study||11
1701385|NCT00438191|4159229|P2|COMPLETED|Overall Study||26
1701386|NCT00438191|4159230|P1|COMPLETED|Overall Study||32
1701387|NCT00438191|4159229|P2|STARTED|Overall Study||40
1701388|NCT00438191|4159230|P1|STARTED|Overall Study||43
1701389|NCT00438100|4159244|P2|NOT COMPLETED|Overall Study||4
1701390|NCT00438100|4159245|P1|NOT COMPLETED|Overall Study||2
1701391|NCT00438100|4159244|P2|COMPLETED|Overall Study||65
1701392|NCT00438100|4159245|P1|COMPLETED|Overall Study||71
1701393|NCT00438100|4159244|P2|STARTED|Overall Study||69
1701394|NCT00438100|4159245|P1|STARTED|Overall Study||73
1701395|NCT00437983|4159253|P2|NOT COMPLETED|Overall Study||13
1701396|NCT00437983|4159254|P1|NOT COMPLETED|Overall Study||13
1701397|NCT00437983|4159253|P2|COMPLETED|Overall Study||65
1701398|NCT00437983|4159254|P1|COMPLETED|Overall Study||66
1701399|NCT00437983|4159253|P2|STARTED|Overall Study||78
1701400|NCT00437983|4159254|P1|STARTED|Overall Study||79
1701401|NCT00437658|4159267|P3|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
1701402|NCT00437658|4159268|P2|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
1701403|NCT00437658|4159269|P1|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
1701404|NCT00437658|4159267|P3|COMPLETED|Post-treatment Period (24 Weeks)||37
1701405|NCT00437658|4159268|P2|COMPLETED|Post-treatment Period (24 Weeks)||54
1701406|NCT00437658|4159269|P1|COMPLETED|Post-treatment Period (24 Weeks)||32
1701407|NCT00437658|4159267|P3|STARTED|Post-treatment Period (24 Weeks)||51
1701408|NCT00437658|4159268|P2|STARTED|Post-treatment Period (24 Weeks)||62
1701409|NCT00437658|4159269|P1|STARTED|Post-treatment Period (24 Weeks)||56
1701410|NCT00437658|4159267|P3|NOT COMPLETED|Treatment Period (24 Weeks)||33
1701411|NCT00437658|4159268|P2|NOT COMPLETED|Treatment Period (24 Weeks)||22
1701412|NCT00437658|4159269|P1|NOT COMPLETED|Treatment Period (24 Weeks)||28
1701413|NCT00437658|4159267|P3|COMPLETED|Treatment Period (24 Weeks)||51
1701414|NCT00437658|4159268|P2|COMPLETED|Treatment Period (24 Weeks)||62
1701415|NCT00437658|4159269|P1|COMPLETED|Treatment Period (24 Weeks)||56
1701416|NCT00437658|4159267|P3|Received Study Drug|Treatment Period (24 Weeks)||84
1701417|NCT00437658|4159268|P2|Received Study Drug|Treatment Period (24 Weeks)||84
1701418|NCT00437658|4159269|P1|Received Study Drug|Treatment Period (24 Weeks)||84
1701419|NCT00437658|4159267|P3|STARTED|Treatment Period (24 Weeks)||84
1701420|NCT00437658|4159268|P2|STARTED|Treatment Period (24 Weeks)||84
1701421|NCT00437658|4159269|P1|STARTED|Treatment Period (24 Weeks)||84
1701422|NCT00437645|4159363|P2|NOT COMPLETED|Overall Study||115
1701423|NCT00437645|4159364|P1|NOT COMPLETED|Overall Study||35
1701424|NCT00437645|4159363|P2|COMPLETED|Overall Study||476
1701425|NCT00437645|4159364|P1|COMPLETED|Overall Study||557
1701426|NCT00437645|4159363|P2|STARTED|Overall Study||591
1701427|NCT00437645|4159364|P1|STARTED|Overall Study||592
1701428|NCT00437489|4159380|P2|NOT COMPLETED|Overall Study||22
1701429|NCT00437489|4159381|P1|NOT COMPLETED|Overall Study||23
1701430|NCT00437489|4159380|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
1701431|NCT00437489|4159381|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
1701432|NCT00437489|4159380|P2|STARTED|Overall Study||24
1701433|NCT00437489|4159381|P1|STARTED|Overall Study||25
1701434|NCT00437398|4159393|P1|NOT COMPLETED|Overall Study||0
1701435|NCT00437398|4159393|P1|COMPLETED|Overall Study||2
1701436|NCT00437398|4159393|P1|STARTED|Overall Study||2
1701437|NCT00437281|4159418|P20|NOT COMPLETED|Overall Study||1
1701438|NCT00437281|4159419|P19|NOT COMPLETED|Overall Study||1
1701439|NCT00437281|4159420|P18|NOT COMPLETED|Overall Study||0
1701440|NCT00437281|4159421|P17|NOT COMPLETED|Overall Study||0
1701441|NCT00437281|4159422|P16|NOT COMPLETED|Overall Study||0
1701442|NCT00437281|4159423|P15|NOT COMPLETED|Overall Study||1
1701443|NCT00437281|4159424|P14|NOT COMPLETED|Overall Study||1
1701444|NCT00437281|4159425|P13|NOT COMPLETED|Overall Study||0
1701445|NCT00437281|4159426|P12|NOT COMPLETED|Overall Study||0
1701446|NCT00437281|4159427|P11|NOT COMPLETED|Overall Study||0
1701447|NCT00437281|4159428|P10|NOT COMPLETED|Overall Study||1
1701448|NCT00437281|4159429|P9|NOT COMPLETED|Overall Study||0
1701449|NCT00437281|4159430|P8|NOT COMPLETED|Overall Study||0
1701450|NCT00437281|4159431|P7|NOT COMPLETED|Overall Study||0
1701451|NCT00437281|4159432|P6|NOT COMPLETED|Overall Study||1
1701452|NCT00437281|4159433|P5|NOT COMPLETED|Overall Study||0
1701453|NCT00437281|4159434|P4|NOT COMPLETED|Overall Study||1
1701454|NCT00437281|4159435|P3|NOT COMPLETED|Overall Study||0
1701455|NCT00437281|4159436|P2|NOT COMPLETED|Overall Study||0
1701456|NCT00437281|4159437|P1|NOT COMPLETED|Overall Study||0
1701457|NCT00437281|4159418|P20|COMPLETED|Overall Study||2
1701458|NCT00437281|4159419|P19|COMPLETED|Overall Study||1
1701459|NCT00437281|4159420|P18|COMPLETED|Overall Study||4
1701460|NCT00437281|4159421|P17|COMPLETED|Overall Study||3
1701461|NCT00437281|4159422|P16|COMPLETED|Overall Study||3
1701462|NCT00437281|4159423|P15|COMPLETED|Overall Study||4
1701463|NCT00437281|4159424|P14|COMPLETED|Overall Study||2
1701464|NCT00437281|4159425|P13|COMPLETED|Overall Study||2
1701465|NCT00437281|4159426|P12|COMPLETED|Overall Study||3
1701466|NCT00437281|4159427|P11|COMPLETED|Overall Study||3
1701467|NCT00437281|4159428|P10|COMPLETED|Overall Study||4
1701468|NCT00437281|4159429|P9|COMPLETED|Overall Study||3
1701469|NCT00437281|4159430|P8|COMPLETED|Overall Study||3
1701470|NCT00437281|4159431|P7|COMPLETED|Overall Study||3
1701471|NCT00437281|4159432|P6|COMPLETED|Overall Study||3
1701472|NCT00437281|4159433|P5|COMPLETED|Overall Study||4
1701473|NCT00437281|4159434|P4|COMPLETED|Overall Study||2
1701474|NCT00437281|4159435|P3|COMPLETED|Overall Study||3
1701475|NCT00437281|4159436|P2|COMPLETED|Overall Study||3
1701476|NCT00437281|4159437|P1|COMPLETED|Overall Study||3
1701477|NCT00437281|4159418|P20|STARTED|Overall Study||3
1701478|NCT00437281|4159419|P19|STARTED|Overall Study||2
1701479|NCT00437281|4159420|P18|STARTED|Overall Study||4
1701480|NCT00437281|4159421|P17|STARTED|Overall Study||3
1701481|NCT00437281|4159422|P16|STARTED|Overall Study||3
1701482|NCT00437281|4159423|P15|STARTED|Overall Study||5
1701483|NCT00437281|4159424|P14|STARTED|Overall Study||3
1701484|NCT00437281|4159425|P13|STARTED|Overall Study||2
1701485|NCT00437281|4159426|P12|STARTED|Overall Study||3
1701486|NCT00437281|4159427|P11|STARTED|Overall Study||3
1701487|NCT00437281|4159428|P10|STARTED|Overall Study||5
1701488|NCT00437281|4159429|P9|STARTED|Overall Study||3
1701489|NCT00437281|4159430|P8|STARTED|Overall Study||3
1701490|NCT00437281|4159431|P7|STARTED|Overall Study||3
1701491|NCT00437281|4159432|P6|STARTED|Overall Study||4
1701492|NCT00437281|4159433|P5|STARTED|Overall Study||4
1701493|NCT00437281|4159434|P4|STARTED|Overall Study||3
1701494|NCT00437281|4159435|P3|STARTED|Overall Study||3
1701495|NCT00437281|4159436|P2|STARTED|Overall Study||3
1701496|NCT00437281|4159437|P1|STARTED|Overall Study||3
1701497|NCT00437203|4159741|P10|NOT COMPLETED|Overall Study||4
1701498|NCT00437203|4159742|P9|NOT COMPLETED|Overall Study||3
1701499|NCT00437203|4159743|P8|NOT COMPLETED|Overall Study||3
1701500|NCT00437203|4159744|P7|NOT COMPLETED|Overall Study||7
1701501|NCT00437203|4159745|P6|NOT COMPLETED|Overall Study||3
1701502|NCT00437203|4159746|P5|NOT COMPLETED|Overall Study||3
1701503|NCT00437203|4159747|P4|NOT COMPLETED|Overall Study||3
1701504|NCT00437203|4159748|P3|NOT COMPLETED|Overall Study||3
1701505|NCT00437203|4159749|P2|NOT COMPLETED|Overall Study||8
1701506|NCT00437203|4159750|P1|NOT COMPLETED|Overall Study||6
1701507|NCT00437203|4159741|P10|COMPLETED|Overall Study||0
1701508|NCT00437203|4159742|P9|COMPLETED|Overall Study||0
1701509|NCT00437203|4159743|P8|COMPLETED|Overall Study||0
1701510|NCT00437203|4159744|P7|COMPLETED|Overall Study||0
1701511|NCT00437203|4159745|P6|COMPLETED|Overall Study||0
1701512|NCT00437203|4159746|P5|COMPLETED|Overall Study||0
1701513|NCT00437203|4159747|P4|COMPLETED|Overall Study||0
1701514|NCT00437203|4159748|P3|COMPLETED|Overall Study||0
1701515|NCT00437203|4159749|P2|COMPLETED|Overall Study||0
1701516|NCT00437203|4159750|P1|COMPLETED|Overall Study||0
1701517|NCT00437203|4159741|P10|STARTED|Overall Study||4
1701518|NCT00437203|4159742|P9|STARTED|Overall Study||3
1701519|NCT00437203|4159743|P8|STARTED|Overall Study||3
1701520|NCT00437203|4159744|P7|STARTED|Overall Study||7
1701521|NCT00437203|4159745|P6|STARTED|Overall Study||3
1701522|NCT00437203|4159746|P5|STARTED|Overall Study||3
1701523|NCT00437203|4159747|P4|STARTED|Overall Study||3
1701524|NCT00437203|4159748|P3|STARTED|Overall Study||3
1701525|NCT00437203|4159749|P2|STARTED|Overall Study||8
1701526|NCT00437203|4159750|P1|STARTED|Overall Study||6
1701527|NCT00437125|4159854|P1|NOT COMPLETED|Overall Study||32
1701528|NCT00437125|4159854|P1|COMPLETED|Overall Study||119
1701529|NCT00437125|4159854|P1|STARTED|Overall Study||151
1701530|NCT00437073|4159875|P2|NOT COMPLETED|Overall Study||1
1701531|NCT00437073|4159876|P1|NOT COMPLETED|Overall Study||1
1701532|NCT00437073|4159875|P2|COMPLETED|Overall Study||8
1701533|NCT00437073|4159876|P1|COMPLETED|Overall Study||12
1701534|NCT00437073|4159875|P2|STARTED|Overall Study||9
1701535|NCT00437073|4159876|P1|STARTED|Overall Study||13
1701536|NCT00437034|4159904|P1|NOT COMPLETED|Overall Study||6
1701537|NCT00437034|4159904|P1|COMPLETED|Overall Study||0
1701538|NCT00437034|4159904|P1|STARTED|Overall Study||6
1701539|NCT00436982|4159910|P2|NOT COMPLETED|Overall Study||4
1701540|NCT00436982|4159911|P1|NOT COMPLETED|Overall Study||4
1701541|NCT00436982|4159910|P2|COMPLETED|Overall Study||26
1701542|NCT00436982|4159911|P1|COMPLETED|Overall Study||26
1701543|NCT00436982|4159910|P2|STARTED|Overall Study||30
1701544|NCT00436982|4159911|P1|STARTED|Overall Study||30
1701545|NCT00436969|4159933|P2|NOT COMPLETED|Overall Study||52
1701546|NCT00436969|4159934|P1|NOT COMPLETED|Overall Study||22
1701547|NCT00436969|4159933|P2|COMPLETED|Overall Study||134
1701548|NCT00436969|4159934|P1|COMPLETED|Overall Study||66
1701549|NCT00436969|4159933|P2|Randomized But Not Treated|Overall Study||3
1701550|NCT00436969|4159934|P1|Randomized But Not Treated|Overall Study||1
1701551|NCT00436969|4159933|P2|STARTED|Overall Study||186
1701552|NCT00436969|4159934|P1|STARTED|Overall Study||88
1701553|NCT00436956|4159982|P2|NOT COMPLETED|Overall Study||0
1701554|NCT00436956|4159983|P1|NOT COMPLETED|Overall Study||1
1701555|NCT00436956|4159982|P2|COMPLETED|Overall Study||23
1701556|NCT00436956|4159983|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
1701557|NCT00436956|4159982|P2|STARTED|Overall Study||23
1701558|NCT00436956|4159983|P1|STARTED|Overall Study||36
1701559|NCT00436917|4159997|P1|NOT COMPLETED|Overall Study||54
1701560|NCT00436917|4159997|P1|COMPLETED|Overall Study||0
1701561|NCT00436917|4159997|P1|STARTED|Overall Study|6 participants with cancellation, protocol violation and ineligible were excluded from all analysis.|54
1701562|NCT00436904|4160001|P1|NOT COMPLETED|Overall Study||0
1701563|NCT00436904|4160001|P1|COMPLETED|Overall Study||30
1701564|NCT00436904|4160001|P1|STARTED|Overall Study||30
1701565|NCT00436852|4160012|P2|NOT COMPLETED|Overall Study||45
1701566|NCT00436852|4160013|P1|NOT COMPLETED|Overall Study||35
1701567|NCT00436852|4160012|P2|COMPLETED|Overall Study||2
1701568|NCT00436852|4160013|P1|COMPLETED|Overall Study||10
1701569|NCT00436852|4160012|P2|STARTED|Overall Study||47
1701570|NCT00436852|4160013|P1|STARTED|Overall Study||45
1701571|NCT00436826|4160023|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
1701572|NCT00436826|4160024|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
1701573|NCT00436826|4160025|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
1701574|NCT00436826|4160026|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
1701575|NCT00436826|4160027|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
1701576|NCT00436826|4160028|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
1701577|NCT00436826|4160023|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1701578|NCT00436826|4160024|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
1701579|NCT00436826|4160025|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1701580|NCT00436826|4160026|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1701581|NCT00436826|4160027|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1701582|NCT00436826|4160028|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
1701583|NCT00436826|4160023|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
1701584|NCT00436826|4160024|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
1701585|NCT00436826|4160025|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
1701586|NCT00436826|4160026|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
1701587|NCT00436826|4160027|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
1701588|NCT00436826|4160028|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
1701589|NCT00436826|4160023|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
1701590|NCT00436826|4160024|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
1701591|NCT00436826|4160025|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
1701592|NCT00436826|4160026|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
1701593|NCT00436826|4160027|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
1701594|NCT00436826|4160028|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
1701595|NCT00436826|4160023|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
1701596|NCT00436826|4160024|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
1701597|NCT00436826|4160025|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
1701598|NCT00436826|4160026|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
1701599|NCT00436826|4160027|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
1701600|NCT00436826|4160028|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
1701601|NCT00436826|4160023|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
1701602|NCT00436826|4160024|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
1701603|NCT00436826|4160025|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
1701604|NCT00436826|4160026|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
1701605|NCT00436826|4160027|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
1701606|NCT00436826|4160028|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
1701607|NCT00436826|4160023|P6|NOT COMPLETED|Double Blind Period||0
1701608|NCT00436826|4160024|P5|NOT COMPLETED|Double Blind Period||0
1701609|NCT00436826|4160025|P4|NOT COMPLETED|Double Blind Period||0
1701610|NCT00436826|4160026|P3|NOT COMPLETED|Double Blind Period||0
1701611|NCT00436826|4160027|P2|NOT COMPLETED|Double Blind Period||11
1701612|NCT00436826|4160028|P1|NOT COMPLETED|Double Blind Period||13
1701613|NCT00436826|4160023|P6|COMPLETED|Double Blind Period||0
1701614|NCT00436826|4160024|P5|COMPLETED|Double Blind Period||0
1701615|NCT00436826|4160025|P4|COMPLETED|Double Blind Period||0
1701616|NCT00436826|4160026|P3|COMPLETED|Double Blind Period||0
1701617|NCT00436826|4160027|P2|COMPLETED|Double Blind Period||37
1701618|NCT00436826|4160028|P1|COMPLETED|Double Blind Period||111
1701619|NCT00436826|4160023|P6|STARTED|Double Blind Period||0
1701620|NCT00436826|4160024|P5|STARTED|Double Blind Period||0
1701621|NCT00436826|4160025|P4|STARTED|Double Blind Period||0
1701622|NCT00436826|4160026|P3|STARTED|Double Blind Period||0
1701623|NCT00436826|4160027|P2|STARTED|Double Blind Period||48
1701624|NCT00436826|4160028|P1|STARTED|Double Blind Period||124
1701625|NCT00436748|4160050|P2|NOT COMPLETED|Overall Study||12
1701626|NCT00436748|4160051|P1|NOT COMPLETED|Overall Study||11
1701627|NCT00436748|4160050|P2|COMPLETED|Overall Study||45
1701628|NCT00436748|4160051|P1|COMPLETED|Overall Study||48
1701629|NCT00436748|4160050|P2|Received Treatment|Overall Study||56
1701630|NCT00436748|4160051|P1|Received Treatment|Overall Study||58
1701631|NCT00436748|4160050|P2|STARTED|Overall Study||57
1701632|NCT00436748|4160051|P1|STARTED|Overall Study||59
1701633|NCT00436644|4160085|P1|NOT COMPLETED|Overall Study||3
1701634|NCT00436644|4160085|P1|COMPLETED|Overall Study||15
1701635|NCT00436644|4160085|P1|STARTED|Overall Study||18
1701636|NCT00436618|4160095|P3|NOT COMPLETED|Overall Study||61
1701637|NCT00436618|4160096|P2|NOT COMPLETED|Overall Study||27
1701638|NCT00436618|4160097|P1|NOT COMPLETED|Overall Study||30
1701639|NCT00436618|4160095|P3|COMPLETED|Overall Study||46
1701640|NCT00436618|4160096|P2|COMPLETED|Overall Study||28
1701641|NCT00436618|4160097|P1|COMPLETED|Overall Study||84
1701642|NCT00436618|4160095|P3|STARTED|Overall Study||107
1701643|NCT00436618|4160096|P2|STARTED|Overall Study||55
1701644|NCT00436618|4160097|P1|STARTED|Overall Study||114
1701645|NCT00436605|4160114|P1|NOT COMPLETED|Overall Study||3
1701646|NCT00436605|4160114|P1|COMPLETED|Overall Study||36
1701647|NCT00436605|4160114|P1|STARTED|Overall Study||39
1701648|NCT00436566|4160119|P1|NOT COMPLETED|Overall Study||3
1701649|NCT00436566|4160119|P1|COMPLETED|Overall Study||109
1701650|NCT00436566|4160119|P1|STARTED|Overall Study||112
1701651|NCT00436553|4160126|P3|NOT COMPLETED|Overall Study||10
1701652|NCT00436553|4160127|P2|NOT COMPLETED|Overall Study||12
1701653|NCT00436553|4160128|P1|NOT COMPLETED|Overall Study||13
1701654|NCT00436553|4160126|P3|COMPLETED|Overall Study||102
1701655|NCT00436553|4160127|P2|COMPLETED|Overall Study||93
1701656|NCT00436553|4160128|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
1701657|NCT00436553|4160126|P3|STARTED|Overall Study||112
1701658|NCT00436553|4160127|P2|STARTED|Overall Study||105
1701659|NCT00436553|4160128|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
1701660|NCT00436501|4160149|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
1701661|NCT00436501|4160150|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
1701662|NCT00436501|4160149|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
1701663|NCT00436501|4160150|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
1701664|NCT00436501|4160149|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
1701665|NCT00436501|4160150|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
1701666|NCT00436501|4160149|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
1701667|NCT00436501|4160150|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
1701668|NCT00436501|4160149|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
1701669|NCT00436501|4160150|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
1701670|NCT00436501|4160149|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
1701671|NCT00436501|4160150|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
1701672|NCT00436501|4160149|P2|NOT COMPLETED|Complete Study Participation||0
1701673|NCT00436501|4160150|P1|NOT COMPLETED|Complete Study Participation||0
1701674|NCT00436501|4160149|P2|COMPLETED|Complete Study Participation||49
1701675|NCT00436501|4160150|P1|COMPLETED|Complete Study Participation||9
1701676|NCT00436501|4160149|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
1701677|NCT00436501|4160150|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
1701678|NCT00436436|4160161|P1|NOT COMPLETED|Overall Study||12
1701679|NCT00436436|4160161|P1|COMPLETED|Overall Study||0
1701680|NCT00436436|4160161|P1|STARTED|Overall Study||12
1701681|NCT00436345|4160172|P2|NOT COMPLETED|Overall Study||0
1701682|NCT00436345|4160173|P1|NOT COMPLETED|Overall Study||3
1701683|NCT00436345|4160172|P2|COMPLETED|Overall Study||18
1701684|NCT00436345|4160173|P1|COMPLETED|Overall Study||18
1701685|NCT00436345|4160172|P2|STARTED|Overall Study||18
1701686|NCT00436345|4160173|P1|STARTED|Overall Study||21
1701687|NCT00436332|4160226|P1|NOT COMPLETED|Overall Study||83
1701688|NCT00436332|4160226|P1|COMPLETED|Overall Study||1
1701689|NCT00436332|4160226|P1|Eligible and Began Protocol Therapy|Overall Study||79
1701690|NCT00436332|4160226|P1|Eligible|Overall Study||82
1701691|NCT00436332|4160226|P1|STARTED|Overall Study||84
1701692|NCT00436215|4160233|P1|NOT COMPLETED|Overall Study||4
1701693|NCT00436215|4160233|P1|COMPLETED|Overall Study||51
1701694|NCT00436215|4160233|P1|STARTED|Overall Study||55
1701695|NCT00436163|4160239|P1|NOT COMPLETED|Overall Study||3
1701696|NCT00436163|4160239|P1|COMPLETED|Overall Study||36
1701697|NCT00436163|4160239|P1|STARTED|Overall Study||39
1701698|NCT00436046|4160253|P3|NOT COMPLETED|Overall Study||0
1701699|NCT00436046|4160254|P2|NOT COMPLETED|Overall Study||0
1701700|NCT00436046|4160255|P1|NOT COMPLETED|Overall Study||0
1701701|NCT00436046|4160253|P3|COMPLETED|Overall Study||31
1701702|NCT00436046|4160254|P2|COMPLETED|Overall Study||32
1701703|NCT00436046|4160255|P1|COMPLETED|Overall Study||32
1701704|NCT00436046|4160253|P3|STARTED|Overall Study||31
1701705|NCT00436046|4160254|P2|STARTED|Overall Study||32
1701706|NCT00436046|4160255|P1|STARTED|Overall Study||32
1701707|NCT00436007|4160287|P3|NOT COMPLETED|Overall Study||23
1701708|NCT00436007|4160288|P2|NOT COMPLETED|Overall Study||14
1701709|NCT00436007|4160289|P1|NOT COMPLETED|Overall Study||19
1701710|NCT00436007|4160287|P3|COMPLETED|Overall Study||148
1701711|NCT00436007|4160288|P2|COMPLETED|Overall Study||156
1701712|NCT00436007|4160289|P1|COMPLETED|Overall Study||151
1701713|NCT00436007|4160287|P3|STARTED|Overall Study||171
1701714|NCT00436007|4160288|P2|STARTED|Overall Study||170
1701715|NCT00436007|4160289|P1|STARTED|Overall Study||170
1701716|NCT00435994|4160337|P3|NOT COMPLETED|Overall Study||0
1701717|NCT00435994|4160338|P2|NOT COMPLETED|Overall Study||0
1701718|NCT00435994|4160339|P1|NOT COMPLETED|Overall Study||7
1701719|NCT00435994|4160337|P3|COMPLETED|Overall Study||12
1701720|NCT00435994|4160338|P2|COMPLETED|Overall Study||25
1701721|NCT00435994|4160339|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
1701722|NCT00435994|4160337|P3|STARTED|Overall Study||12
1701723|NCT00435994|4160338|P2|STARTED|Overall Study||25
1701724|NCT00435994|4160339|P1|STARTED|Overall Study||22
1701725|NCT00435942|4160350|P2|NOT COMPLETED|Overall Study||27
1701726|NCT00435942|4160351|P1|NOT COMPLETED|Overall Study||23
1701727|NCT00435942|4160350|P2|COMPLETED|Overall Study||33
1701728|NCT00435942|4160351|P1|COMPLETED|Overall Study||97
1701729|NCT00435942|4160350|P2|STARTED|Overall Study||60
1701730|NCT00435942|4160351|P1|STARTED|Overall Study||120
1701731|NCT00435929|4160360|P2|NOT COMPLETED|Overall Study||0
1701732|NCT00435929|4160361|P1|NOT COMPLETED|Overall Study||0
1701733|NCT00435929|4160360|P2|COMPLETED|Overall Study||9
1701734|NCT00435929|4160361|P1|COMPLETED|Overall Study||7
1701735|NCT00435929|4160360|P2|STARTED|Overall Study||9
1701736|NCT00435929|4160361|P1|STARTED|Overall Study||7
1701737|NCT00435825|4160391|P4|NOT COMPLETED|Overall Study||16
1701738|NCT00435825|4160392|P3|NOT COMPLETED|Overall Study||11
1701739|NCT00435825|4160393|P2|NOT COMPLETED|Overall Study||12
1701740|NCT00435825|4160394|P1|NOT COMPLETED|Overall Study||18
1701741|NCT00435825|4160391|P4|COMPLETED|Overall Study||120
1701742|NCT00435825|4160392|P3|COMPLETED|Overall Study||127
1701743|NCT00435825|4160393|P2|COMPLETED|Overall Study||124
1701744|NCT00435825|4160394|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
1701745|NCT00435825|4160391|P4|Completed 48 Weeks Treatment|Overall Study||117
1701746|NCT00435825|4160392|P3|Completed 48 Weeks Treatment|Overall Study||124
1701747|NCT00435825|4160393|P2|Completed 48 Weeks Treatment|Overall Study||0
1701748|NCT00435825|4160394|P1|Completed 48 Weeks Treatment|Overall Study||0
1701749|NCT00435825|4160391|P4|Completed 24 Weeks Treatment|Overall Study||131
1701750|NCT00435825|4160392|P3|Completed 24 Weeks Treatment|Overall Study||134
1701751|NCT00435825|4160393|P2|Completed 24 Weeks Treatment|Overall Study||126
1701752|NCT00435825|4160394|P1|Completed 24 Weeks Treatment|Overall Study||128
1701753|NCT00435825|4160391|P4|Entered Follow-up|Overall Study||133
1701754|NCT00435825|4160392|P3|Entered Follow-up|Overall Study||135
1701755|NCT00435825|4160393|P2|Entered Follow-up|Overall Study||132
1701756|NCT00435825|4160394|P1|Entered Follow-up|Overall Study||140
1701757|NCT00435825|4160391|P4|Received Study Drug|Overall Study||136
1701758|NCT00435825|4160392|P3|Received Study Drug|Overall Study||136
1701759|NCT00435825|4160393|P2|Received Study Drug|Overall Study||136
1701760|NCT00435825|4160394|P1|Received Study Drug|Overall Study||140
1701761|NCT00435825|4160391|P4|STARTED|Overall Study||136
1701762|NCT00435825|4160392|P3|STARTED|Overall Study||138
1701763|NCT00435825|4160393|P2|STARTED|Overall Study||136
1701764|NCT00435825|4160394|P1|STARTED|Overall Study||141
1701765|NCT00435812|4160450|P2|NOT COMPLETED|Overall Study||18
1701766|NCT00435812|4160451|P1|NOT COMPLETED|Overall Study||63
1701767|NCT00435812|4160450|P2|COMPLETED|Overall Study||590
1701768|NCT00435812|4160451|P1|COMPLETED|Overall Study||1757
1701769|NCT00435812|4160450|P2|STARTED|Overall Study||608
1701770|NCT00435812|4160451|P1|STARTED|Overall Study||1820
1701771|NCT00435591|4160463|P4|NOT COMPLETED|Overall Study||11
1701772|NCT00435591|4160464|P3|NOT COMPLETED|Overall Study||5
1701773|NCT00435591|4160465|P2|NOT COMPLETED|Overall Study||4
1701774|NCT00435591|4160466|P1|NOT COMPLETED|Overall Study||7
1701775|NCT00435591|4160463|P4|COMPLETED|Overall Study||19
1701776|NCT00435591|4160464|P3|COMPLETED|Overall Study||25
1701777|NCT00435591|4160465|P2|COMPLETED|Overall Study||27
1701778|NCT00435591|4160466|P1|COMPLETED|Overall Study||23
1701779|NCT00435591|4160463|P4|End of Treatment|Overall Study||23
1701780|NCT00435591|4160464|P3|End of Treatment|Overall Study||27
1701781|NCT00435591|4160465|P2|End of Treatment|Overall Study||27
1701782|NCT00435591|4160466|P1|End of Treatment|Overall Study||25
1701783|NCT00435591|4160463|P4|Full Analysis Set|Overall Study||29
1701784|NCT00435591|4160464|P3|Full Analysis Set|Overall Study||30
1701785|NCT00435591|4160465|P2|Full Analysis Set|Overall Study||29
1701786|NCT00435591|4160466|P1|Full Analysis Set|Overall Study||28
1701787|NCT00435591|4160463|P4|Safety Analysis Set|Overall Study||29
1701788|NCT00435591|4160464|P3|Safety Analysis Set|Overall Study||30
1701789|NCT00435591|4160465|P2|Safety Analysis Set|Overall Study||30
1701790|NCT00435591|4160466|P1|Safety Analysis Set|Overall Study||28
1701791|NCT00435591|4160463|P4|STARTED|Overall Study||30
1701792|NCT00435591|4160464|P3|STARTED|Overall Study||30
1701793|NCT00435591|4160465|P2|STARTED|Overall Study||31
1701794|NCT00435591|4160466|P1|STARTED|Overall Study||30
1701795|NCT00435539|4160496|P5|NOT COMPLETED|Overall Study||0
1701796|NCT00435539|4160497|P4|NOT COMPLETED|Overall Study||0
1701797|NCT00435539|4160498|P3|NOT COMPLETED|Overall Study||0
1701798|NCT00435539|4160499|P2|NOT COMPLETED|Overall Study||0
1701799|NCT00435539|4160500|P1|NOT COMPLETED|Overall Study||0
1701800|NCT00435539|4160496|P5|COMPLETED|Overall Study||12
1701801|NCT00435539|4160497|P4|COMPLETED|Overall Study||12
1701802|NCT00435539|4160498|P3|COMPLETED|Overall Study||11
1701803|NCT00435539|4160499|P2|COMPLETED|Overall Study||13
1701804|NCT00435539|4160500|P1|COMPLETED|Overall Study||12
1701805|NCT00435539|4160496|P5|STARTED|Overall Study||12
1701806|NCT00435539|4160497|P4|STARTED|Overall Study||12
1701807|NCT00435539|4160498|P3|STARTED|Overall Study||11
1701808|NCT00435539|4160499|P2|STARTED|Overall Study||13
1701809|NCT00435539|4160500|P1|STARTED|Overall Study||12
1701810|NCT00435487|4160517|P2|NOT COMPLETED|Overall Study||15
1701811|NCT00435487|4160518|P1|NOT COMPLETED|Overall Study||12
1701812|NCT00435487|4160517|P2|COMPLETED|Overall Study||71
1701813|NCT00435487|4160518|P1|COMPLETED|Overall Study||76
1701814|NCT00435487|4160517|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
1701815|NCT00435487|4160518|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
1701816|NCT00435487|4160517|P2|STARTED|Overall Study||86
1701817|NCT00435487|4160518|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
1701818|NCT00435461|4160537|P3|NOT COMPLETED|Overall Study||24
1701819|NCT00435461|4160538|P2|NOT COMPLETED|Overall Study||14
1701820|NCT00435461|4160539|P1|NOT COMPLETED|Overall Study||23
1701821|NCT00435461|4160537|P3|COMPLETED|Overall Study||287
1701822|NCT00435461|4160538|P2|COMPLETED|Overall Study||298
1701823|NCT00435461|4160539|P1|COMPLETED|Overall Study||290
1701824|NCT00435461|4160537|P3|STARTED|Overall Study||311
1701825|NCT00435461|4160538|P2|STARTED|Overall Study||312
1701826|NCT00435461|4160539|P1|STARTED|Overall Study||313
1701827|NCT00435409|4160576|P3|NOT COMPLETED|Overall Study||78
1701828|NCT00435409|4160577|P2|NOT COMPLETED|Overall Study||143
1701829|NCT00435409|4160578|P1|NOT COMPLETED|Overall Study||221
1701830|NCT00435409|4160576|P3|COMPLETED|Overall Study||0
1701831|NCT00435409|4160577|P2|COMPLETED|Overall Study||0
1701832|NCT00435409|4160578|P1|COMPLETED|Overall Study||0
1701833|NCT00435409|4160576|P3|Treated|Overall Study||78
1701834|NCT00435409|4160577|P2|Treated|Overall Study||139
1701835|NCT00435409|4160578|P1|Treated|Overall Study||217
1701836|NCT00435409|4160576|P3|STARTED|Overall Study||78
1701837|NCT00435409|4160577|P2|STARTED|Overall Study||143
1701838|NCT00435409|4160578|P1|STARTED|Overall Study||221
1701839|NCT00435370|4160600|P2|NOT COMPLETED|Overall Study||20
1701840|NCT00435370|4160601|P1|NOT COMPLETED|Overall Study||22
1701841|NCT00435370|4160600|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
1701842|NCT00435370|4160601|P1|COMPLETED|Overall Study||68
1701843|NCT00435370|4160600|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
1701844|NCT00435370|4160601|P1|STARTED|Overall Study||90
1701845|NCT00435188|4160609|P2|NOT COMPLETED|Overall Study||23
1701846|NCT00435188|4160610|P1|NOT COMPLETED|Overall Study||22
1701847|NCT00435188|4160609|P2|COMPLETED|Overall Study||176
1701848|NCT00435188|4160610|P1|COMPLETED|Overall Study||177
1701849|NCT00435188|4160609|P2|STARTED|Overall Study||199
1701850|NCT00435188|4160610|P1|STARTED|Overall Study||199
1701851|NCT00435162|4160653|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
1701852|NCT00435162|4160654|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
1701853|NCT00435162|4160655|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
1701854|NCT00435162|4160656|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
1701855|NCT00435162|4160657|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
1701856|NCT00435162|4160658|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
1701857|NCT00435162|4160653|P6|COMPLETED|Period 2 (2 Weeks)||15
1701858|NCT00435162|4160654|P5|COMPLETED|Period 2 (2 Weeks)||15
1701859|NCT00435162|4160655|P4|COMPLETED|Period 2 (2 Weeks)||8
1701860|NCT00435162|4160656|P3|COMPLETED|Period 2 (2 Weeks)||6
1701861|NCT00435162|4160657|P2|COMPLETED|Period 2 (2 Weeks)||14
1701862|NCT00435162|4160658|P1|COMPLETED|Period 2 (2 Weeks)||15
1701863|NCT00435162|4160653|P6|STARTED|Period 2 (2 Weeks)||15
1701864|NCT00435162|4160654|P5|STARTED|Period 2 (2 Weeks)||15
1701865|NCT00435162|4160655|P4|STARTED|Period 2 (2 Weeks)||8
1701866|NCT00435162|4160656|P3|STARTED|Period 2 (2 Weeks)||6
1701867|NCT00435162|4160657|P2|STARTED|Period 2 (2 Weeks)||15
1701868|NCT00435162|4160658|P1|STARTED|Period 2 (2 Weeks)||15
1701869|NCT00435162|4160653|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
1701870|NCT00435162|4160654|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
1701871|NCT00435162|4160655|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
1701872|NCT00435162|4160656|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
1701873|NCT00435162|4160657|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
1701874|NCT00435162|4160658|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
1701875|NCT00435162|4160653|P6|COMPLETED|Period 1 (6 Weeks)||15
1701876|NCT00435162|4160654|P5|COMPLETED|Period 1 (6 Weeks)||15
1701877|NCT00435162|4160655|P4|COMPLETED|Period 1 (6 Weeks)||8
1701878|NCT00435162|4160656|P3|COMPLETED|Period 1 (6 Weeks)||6
1701879|NCT00435162|4160657|P2|COMPLETED|Period 1 (6 Weeks)||15
1701880|NCT00435162|4160658|P1|COMPLETED|Period 1 (6 Weeks)||15
1701881|NCT00435162|4160653|P6|STARTED|Period 1 (6 Weeks)||15
1701882|NCT00435162|4160654|P5|STARTED|Period 1 (6 Weeks)||15
1701883|NCT00435162|4160655|P4|STARTED|Period 1 (6 Weeks)||8
1701884|NCT00435162|4160656|P3|STARTED|Period 1 (6 Weeks)||6
1701885|NCT00435162|4160657|P2|STARTED|Period 1 (6 Weeks)||15
1701886|NCT00435162|4160658|P1|STARTED|Period 1 (6 Weeks)||15
1701887|NCT00435045|4160678|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
1701888|NCT00435045|4160679|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
1701889|NCT00435045|4160678|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
1701890|NCT00435045|4160679|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
1701891|NCT00435045|4160678|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
1701892|NCT00435045|4160679|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
1701893|NCT00435045|4160678|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
1701894|NCT00435045|4160679|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
1701895|NCT00435045|4160678|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
1701896|NCT00435045|4160679|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
1701897|NCT00435045|4160678|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
1701898|NCT00435045|4160679|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
1701899|NCT00435045|4160678|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
1701900|NCT00435045|4160679|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
1701901|NCT00435045|4160678|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
1701902|NCT00435045|4160679|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
1701903|NCT00435045|4160678|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
1701904|NCT00435045|4160679|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
1701905|NCT00435019|4160735|P2|NOT COMPLETED|Overall Study||10
1701906|NCT00435019|4160736|P1|NOT COMPLETED|Overall Study||13
1701907|NCT00435019|4160735|P2|COMPLETED|Overall Study||161
1701908|NCT00435019|4160736|P1|COMPLETED|Overall Study||164
1701909|NCT00435019|4160735|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
1701910|NCT00435019|4160736|P1|Exposed to Study Drug|Overall Study||177
1701911|NCT00435019|4160735|P2|STARTED|Overall Study|Randomised|171
1701912|NCT00435019|4160736|P1|STARTED|Overall Study|Randomised|177
1701913|NCT00434993|4160748|P2|NOT COMPLETED|Overall Study||0
1701914|NCT00434993|4160749|P1|NOT COMPLETED|Overall Study||0
1701915|NCT00434993|4160748|P2|COMPLETED|Overall Study||130
1701916|NCT00434993|4160749|P1|COMPLETED|Overall Study||152
1701917|NCT00434993|4160748|P2|STARTED|Overall Study||130
1701918|NCT00434993|4160749|P1|STARTED|Overall Study||152
1701919|NCT00434967|4160777|P4|NOT COMPLETED|Overall Study||14
1701920|NCT00434967|4160778|P3|NOT COMPLETED|Overall Study||9
1701921|NCT00434967|4160779|P2|NOT COMPLETED|Overall Study||8
1701922|NCT00434967|4160780|P1|NOT COMPLETED|Overall Study||7
1701923|NCT00434967|4160777|P4|COMPLETED|Overall Study||478
1701924|NCT00434967|4160778|P3|COMPLETED|Overall Study||461
1701925|NCT00434967|4160779|P2|COMPLETED|Overall Study||457
1701926|NCT00434967|4160780|P1|COMPLETED|Overall Study||90
1701927|NCT00434967|4160777|P4|STARTED|Overall Study||492
1701928|NCT00434967|4160778|P3|STARTED|Overall Study||470
1701929|NCT00434967|4160779|P2|STARTED|Overall Study||465
1701930|NCT00434967|4160780|P1|STARTED|Overall Study||97
1701931|NCT00434954|4160800|P2|NOT COMPLETED|Overall Study||71
1701932|NCT00434954|4160801|P1|NOT COMPLETED|Overall Study||82
1701933|NCT00434954|4160800|P2|COMPLETED|Overall Study||175
1701934|NCT00434954|4160801|P1|COMPLETED|Overall Study||166
1701935|NCT00434954|4160800|P2|Completed - Previous Treatment MET + SU|Overall Study||38
1701936|NCT00434954|4160801|P1|Completed - Previous Treatment MET + SU|Overall Study||31
1701937|NCT00434954|4160800|P2|Completed - Previous Treatment MET Only|Overall Study||137
1701938|NCT00434954|4160801|P1|Completed - Previous Treatment MET Only|Overall Study||135
1701939|NCT00434954|4160800|P2|FAS - Previous Treatment MET + SU|Overall Study||60
1701940|NCT00434954|4160801|P1|FAS - Previous Treatment MET + SU|Overall Study||66
1701941|NCT00434954|4160800|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
1701942|NCT00434954|4160801|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
1701943|NCT00434954|4160800|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
1701944|NCT00434954|4160801|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
1701945|NCT00434954|4160800|P2|Started - Previous Treatment MET + SU|Overall Study||65
1701946|NCT00434954|4160801|P1|Started - Previous Treatment MET + SU|Overall Study||66
1701947|NCT00434954|4160800|P2|Started - Previous Treatment MET Only|Overall Study||181
1701948|NCT00434954|4160801|P1|Started - Previous Treatment MET Only|Overall Study||182
1701949|NCT00434954|4160800|P2|STARTED|Overall Study||246
1701950|NCT00434954|4160801|P1|STARTED|Overall Study||248
1701951|NCT00434876|4160831|P2|NOT COMPLETED|Overall Study||1
1701952|NCT00434876|4160832|P1|NOT COMPLETED|Overall Study||1
1701953|NCT00434876|4160831|P2|COMPLETED|Overall Study||10
1701954|NCT00434876|4160832|P1|COMPLETED|Overall Study||10
1701955|NCT00434876|4160831|P2|STARTED|Overall Study||11
1701956|NCT00434876|4160832|P1|STARTED|Overall Study||11
1701957|NCT00434759|4160846|P2|NOT COMPLETED|Overall Study||5
1701958|NCT00434759|4160847|P1|NOT COMPLETED|Overall Study||24
1701959|NCT00434759|4160846|P2|COMPLETED|Overall Study||38
1701960|NCT00434759|4160847|P1|COMPLETED|Overall Study||22
1701961|NCT00434759|4160846|P2|STARTED|Overall Study||43
1701962|NCT00434759|4160847|P1|STARTED|Overall Study||46
1701963|NCT00434642|4160863|P2|NOT COMPLETED|Open-label Treatment Phase||11
1701964|NCT00434642|4160864|P1|NOT COMPLETED|Open-label Treatment Phase||0
1701965|NCT00434642|4160863|P2|COMPLETED|Open-label Treatment Phase||1
1701966|NCT00434642|4160864|P1|COMPLETED|Open-label Treatment Phase||0
1701967|NCT00434642|4160863|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
1701968|NCT00434642|4160864|P1|STARTED|Open-label Treatment Phase||0
1701969|NCT00434642|4160863|P2|NOT COMPLETED|Blinded Treatment Phase||229
1701970|NCT00434642|4160864|P1|NOT COMPLETED|Blinded Treatment Phase||242
1701971|NCT00434642|4160863|P2|COMPLETED|Blinded Treatment Phase||13
1701972|NCT00434642|4160864|P1|COMPLETED|Blinded Treatment Phase||0
1701973|NCT00434642|4160863|P2|STARTED|Blinded Treatment Phase||242
1701974|NCT00434642|4160864|P1|STARTED|Blinded Treatment Phase||242
1701975|NCT00434590|4160882|P2|NOT COMPLETED|Overall Study||5
1701976|NCT00434590|4160883|P1|NOT COMPLETED|Overall Study||5
1701977|NCT00434590|4160882|P2|COMPLETED|Overall Study||0
1701978|NCT00434590|4160883|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
1701979|NCT00434590|4160882|P2|STARTED|Overall Study||5
1701980|NCT00434590|4160883|P1|STARTED|Overall Study||5
1701981|NCT00434434|4160892|P3|NOT COMPLETED|Overall Study||1
1701982|NCT00434434|4160893|P2|NOT COMPLETED|Overall Study||0
1701983|NCT00434434|4160894|P1|NOT COMPLETED|Overall Study||2
1701984|NCT00434434|4160892|P3|COMPLETED|Overall Study||13
1701985|NCT00434434|4160893|P2|COMPLETED|Overall Study||24
1701986|NCT00434434|4160894|P1|COMPLETED|Overall Study||21
1701987|NCT00434434|4160892|P3|STARTED|Overall Study||14
1701988|NCT00434434|4160893|P2|STARTED|Overall Study||24
1701989|NCT00434434|4160894|P1|STARTED|Overall Study||23
1701990|NCT00434421|4160905|P1|NOT COMPLETED|Overall Study||2
1701991|NCT00434421|4160905|P1|COMPLETED|Overall Study||26
1701992|NCT00434421|4160905|P1|STARTED|Overall Study||28
1701993|NCT00434356|4160911|P2|NOT COMPLETED|Overall Study||23
1701994|NCT00434356|4160912|P1|NOT COMPLETED|Overall Study||23
1701995|NCT00434356|4160911|P2|COMPLETED|Overall Study||0
1701996|NCT00434356|4160912|P1|COMPLETED|Overall Study||0
1701997|NCT00434356|4160911|P2|STARTED|Overall Study||23
1701998|NCT00434356|4160912|P1|STARTED|Overall Study||23
1701999|NCT00434330|4160933|P6|NOT COMPLETED|Overall Study||1
1702000|NCT00434330|4160934|P5|NOT COMPLETED|Overall Study||1
1702001|NCT00434330|4160935|P4|NOT COMPLETED|Overall Study||2
1702002|NCT00434330|4160936|P3|NOT COMPLETED|Overall Study||3
1702003|NCT00434330|4160937|P2|NOT COMPLETED|Overall Study||0
1702004|NCT00434330|4160938|P1|NOT COMPLETED|Overall Study||1
1702005|NCT00434330|4160933|P6|COMPLETED|Overall Study||14
1702006|NCT00434330|4160934|P5|COMPLETED|Overall Study||14
1702007|NCT00434330|4160935|P4|COMPLETED|Overall Study||13
1702008|NCT00434330|4160936|P3|COMPLETED|Overall Study||13
1702009|NCT00434330|4160937|P2|COMPLETED|Overall Study||15
1702010|NCT00434330|4160938|P1|COMPLETED|Overall Study||14
1702011|NCT00434330|4160933|P6|STARTED|Overall Study||15
1702012|NCT00434330|4160934|P5|STARTED|Overall Study||15
1702013|NCT00434330|4160935|P4|STARTED|Overall Study||15
1702014|NCT00434330|4160936|P3|STARTED|Overall Study||16
1702015|NCT00434330|4160937|P2|STARTED|Overall Study||15
1702016|NCT00434330|4160938|P1|STARTED|Overall Study||15
1702017|NCT00434304|4160970|P1|NOT COMPLETED|Overall Study||20
1702018|NCT00434304|4160970|P1|COMPLETED|Overall Study||42
1702019|NCT00434304|4160970|P1|STARTED|Overall Study||62
1702020|NCT00434278|4161008|P2|NOT COMPLETED|Overall Study||0
1702021|NCT00434278|4161009|P1|NOT COMPLETED|Overall Study||2
1702022|NCT00434278|4161008|P2|COMPLETED|Overall Study||13
1702023|NCT00434278|4161009|P1|COMPLETED|Overall Study||12
1702024|NCT00434278|4161008|P2|STARTED|Overall Study||13
1702025|NCT00434278|4161009|P1|STARTED|Overall Study||14
1702026|NCT00434252|4161019|P2|NOT COMPLETED|Overall Study||131
1702027|NCT00434252|4161020|P1|NOT COMPLETED|Overall Study||64
1702028|NCT00434252|4161019|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
1702029|NCT00434252|4161020|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
1702030|NCT00434252|4161019|P2|Treated|Overall Study||143
1702031|NCT00434252|4161020|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
1702032|NCT00434252|4161019|P2|STARTED|Overall Study||143
1702033|NCT00434252|4161020|P1|STARTED|Overall Study||71
1702034|NCT00434226|4161042|P2|NOT COMPLETED|Overall Study||26
1702035|NCT00434226|4161043|P1|NOT COMPLETED|Overall Study||30
1702036|NCT00434226|4161042|P2|COMPLETED|Overall Study||0
1702037|NCT00434226|4161043|P1|COMPLETED|Overall Study||0
1702038|NCT00434226|4161042|P2|STARTED|Overall Study||26
1702039|NCT00434226|4161043|P1|STARTED|Overall Study||30
1702040|NCT00434213|4161054|P1|NOT COMPLETED|Overall Study||49
1702041|NCT00434213|4161054|P1|COMPLETED|Overall Study||260
1702042|NCT00434213|4161054|P1|STARTED|Overall Study||309
1702043|NCT00434161|4161062|P3|NOT COMPLETED|Overall Study||11
1702044|NCT00434161|4161063|P2|NOT COMPLETED|Overall Study||3
1702045|NCT00434161|4161064|P1|NOT COMPLETED|Overall Study||10
1702046|NCT00434161|4161062|P3|COMPLETED|Overall Study||104
1702047|NCT00434161|4161063|P2|COMPLETED|Overall Study||54
1702048|NCT00434161|4161064|P1|COMPLETED|Overall Study||99
1702049|NCT00434161|4161062|P3|STARTED|Overall Study||115
1702050|NCT00434161|4161063|P2|STARTED|Overall Study||57
1702051|NCT00434161|4161064|P1|STARTED|Overall Study||109
1702052|NCT00434148|4161108|P2|NOT COMPLETED|Overall Study||73
1702053|NCT00434148|4161109|P1|NOT COMPLETED|Overall Study||69
1702054|NCT00434148|4161108|P2|COMPLETED|Overall Study||7
1702055|NCT00434148|4161109|P1|COMPLETED|Overall Study||13
1702056|NCT00434148|4161108|P2|Completed Month 12; Entered Extension|Overall Study||32
1702057|NCT00434148|4161109|P1|Completed Month 12; Entered Extension|Overall Study||26
1702058|NCT00434148|4161108|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
1702059|NCT00434148|4161109|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
1702060|NCT00434148|4161108|P2|Completed Month 12|Overall Study||39
1702061|NCT00434148|4161109|P1|Completed Month 12|Overall Study||39
1702062|NCT00434148|4161108|P2|STARTED|Overall Study||80
1702063|NCT00434148|4161109|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
1702064|NCT00434122|4161145|P2|NOT COMPLETED|Overall Study||7
1702065|NCT00434122|4161146|P1|NOT COMPLETED|Overall Study||6
1702066|NCT00434122|4161145|P2|COMPLETED|Overall Study||36
1702067|NCT00434122|4161146|P1|COMPLETED|Overall Study||36
1702068|NCT00434122|4161145|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
1702069|NCT00434122|4161146|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
1702070|NCT00434122|4161145|P2|STARTED|Overall Study|Randomised|43
1702071|NCT00434122|4161146|P1|STARTED|Overall Study|Randomised|42
1702072|NCT00434109|4161155|P1|NOT COMPLETED|Overall Study||18
1702073|NCT00434109|4161155|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
1702074|NCT00434109|4161155|P1|STARTED|Overall Study||39
1702075|NCT00434057|4161164|P1|NOT COMPLETED|Overall Study||1
1702076|NCT00434057|4161164|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
1702077|NCT00434057|4161164|P1|STARTED|Overall Study||1383
1702078|NCT00434018|4161170|P2|NOT COMPLETED|Overall Study||12
1702079|NCT00434018|4161171|P1|NOT COMPLETED|Overall Study||17
1702080|NCT00434018|4161170|P2|COMPLETED|Overall Study||57
1702081|NCT00434018|4161171|P1|COMPLETED|Overall Study||52
1702082|NCT00434018|4161170|P2|STARTED|Overall Study||69
1702083|NCT00434018|4161171|P1|STARTED|Overall Study||69
1702084|NCT00433992|4161189|P2|NOT COMPLETED|Overall Study||8
1702085|NCT00433992|4161190|P1|NOT COMPLETED|Overall Study||9
1702086|NCT00433992|4161189|P2|COMPLETED|Overall Study||20
1702087|NCT00433992|4161190|P1|COMPLETED|Overall Study||19
1702088|NCT00433992|4161189|P2|STARTED|Overall Study||28
1702089|NCT00433992|4161190|P1|STARTED|Overall Study||28
1702090|NCT00433966|4161202|P4|NOT COMPLETED|Stent Intervention/Randomization||62
1702091|NCT00433966|4161203|P3|NOT COMPLETED|Stent Intervention/Randomization||154
1702092|NCT00433966|4161204|P2|NOT COMPLETED|Stent Intervention/Randomization||0
1702093|NCT00433966|4161205|P1|NOT COMPLETED|Stent Intervention/Randomization||0
1702094|NCT00433966|4161202|P4|COMPLETED|Stent Intervention/Randomization||687
1702095|NCT00433966|4161203|P3|COMPLETED|Stent Intervention/Randomization||2103
1702096|NCT00433966|4161204|P2|COMPLETED|Stent Intervention/Randomization||0
1702097|NCT00433966|4161205|P1|COMPLETED|Stent Intervention/Randomization||0
1702098|NCT00433966|4161202|P4|3-Year Follow-up|Stent Intervention/Randomization||687
1702099|NCT00433966|4161203|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
1702100|NCT00433966|4161204|P2|3-Year Follow-up|Stent Intervention/Randomization||0
1702101|NCT00433966|4161205|P1|3-Year Follow-up|Stent Intervention/Randomization||0
1702102|NCT00433966|4161202|P4|1-Year Follow-up|Stent Intervention/Randomization||715
1702103|NCT00433966|4161203|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
1702104|NCT00433966|4161204|P2|1-Year Follow-up|Stent Intervention/Randomization||0
1702105|NCT00433966|4161205|P1|1-Year Follow-up|Stent Intervention/Randomization||0
1702106|NCT00433966|4161202|P4|STARTED|Stent Intervention/Randomization||749
1702107|NCT00433966|4161203|P3|STARTED|Stent Intervention/Randomization||2257
1702108|NCT00433966|4161204|P2|STARTED|Stent Intervention/Randomization||0
1702109|NCT00433966|4161205|P1|STARTED|Stent Intervention/Randomization||0
1702110|NCT00433966|4161202|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
1702111|NCT00433966|4161203|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
1702112|NCT00433966|4161204|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
1702113|NCT00433966|4161205|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
1702114|NCT00433966|4161202|P4|COMPLETED|Pharmacology Intervention/Randomization||0
1702115|NCT00433966|4161203|P3|COMPLETED|Pharmacology Intervention/Randomization||0
1702116|NCT00433966|4161204|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
1702117|NCT00433966|4161205|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
1702118|NCT00433966|4161202|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
1702119|NCT00433966|4161203|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
1702120|NCT00433966|4161204|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
1702121|NCT00433966|4161205|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
1702122|NCT00433966|4161202|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
1702123|NCT00433966|4161203|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
1702124|NCT00433966|4161204|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
1702125|NCT00433966|4161205|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
1702126|NCT00433966|4161202|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
1702127|NCT00433966|4161203|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
1702128|NCT00433966|4161204|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
1702129|NCT00433966|4161205|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
1702130|NCT00433966|4161202|P4|STARTED|Pharmacology Intervention/Randomization||0
1702131|NCT00433966|4161203|P3|STARTED|Pharmacology Intervention/Randomization||0
1702132|NCT00433966|4161204|P2|STARTED|Pharmacology Intervention/Randomization||1802
1702133|NCT00433966|4161205|P1|STARTED|Pharmacology Intervention/Randomization||1800
1702134|NCT00433914|4161227|P2|NOT COMPLETED|Overall Study||3
1702135|NCT00433914|4161228|P1|NOT COMPLETED|Overall Study||0
1702136|NCT00433914|4161227|P2|COMPLETED|Overall Study||27
1702137|NCT00433914|4161228|P1|COMPLETED|Overall Study||30
1702138|NCT00433914|4161227|P2|STARTED|Overall Study||30
1702139|NCT00433914|4161228|P1|STARTED|Overall Study||30
1702140|NCT00433836|4161248|P2|NOT COMPLETED|Overall Study||6
1702141|NCT00433836|4161249|P1|NOT COMPLETED|Overall Study||13
1702142|NCT00433836|4161248|P2|COMPLETED|Overall Study||143
1702143|NCT00433836|4161249|P1|COMPLETED|Overall Study||138
1702144|NCT00433836|4161248|P2|STARTED|Overall Study||149
1702145|NCT00433836|4161249|P1|STARTED|Overall Study||151
1702146|NCT00433771|4161261|P1|NOT COMPLETED|Overall Study||19
1702147|NCT00433771|4161261|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
1702148|NCT00433771|4161261|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
1702149|NCT00433745|4161277|P1|NOT COMPLETED|Overall Study||0
1702150|NCT00433745|4161277|P1|COMPLETED|Overall Study||4
1702151|NCT00433745|4161277|P1|STARTED|Overall Study||4
1702152|NCT00433654|4161284|P2|NOT COMPLETED|Overall Study||5
1702153|NCT00433654|4161285|P1|NOT COMPLETED|Overall Study||15
1702154|NCT00433654|4161284|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
1702155|NCT00433654|4161285|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
1702156|NCT00433654|4161284|P2|STARTED|Overall Study||206
1702157|NCT00433654|4161285|P1|STARTED|Overall Study||258
1702158|NCT00433550|4161319|P3|NOT COMPLETED|Overall Study||0
1702159|NCT00433550|4161320|P2|NOT COMPLETED|Overall Study||0
1702160|NCT00433550|4161321|P1|NOT COMPLETED|Overall Study||0
1702161|NCT00433550|4161319|P3|COMPLETED|Overall Study||6
1702162|NCT00433550|4161320|P2|COMPLETED|Overall Study||10
1702163|NCT00433550|4161321|P1|COMPLETED|Overall Study||17
1702164|NCT00433550|4161319|P3|STARTED|Overall Study||6
1702165|NCT00433550|4161320|P2|STARTED|Overall Study||10
1702166|NCT00433550|4161321|P1|STARTED|Overall Study||17
1702167|NCT00433537|4161331|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
1702168|NCT00433537|4161332|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
1702169|NCT00433537|4161333|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
1702170|NCT00433537|4161331|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
1702171|NCT00433537|4161332|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
1702172|NCT00433537|4161333|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
1702173|NCT00433537|4161331|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
1702174|NCT00433537|4161332|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
1702175|NCT00433537|4161333|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
1702176|NCT00433537|4161331|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
1702177|NCT00433537|4161332|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
1702178|NCT00433537|4161333|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
1702179|NCT00433537|4161331|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
1702180|NCT00433537|4161332|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
1702181|NCT00433537|4161333|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
1702182|NCT00433537|4161331|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
1702183|NCT00433537|4161332|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
1702184|NCT00433537|4161333|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
1702185|NCT00433537|4161331|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
1702186|NCT00433537|4161332|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
1702187|NCT00433537|4161333|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
1702188|NCT00433537|4161331|P3|STARTED|Step 1 - VcR-CVAD Induction||10
1702189|NCT00433537|4161332|P2|STARTED|Step 1 - VcR-CVAD Induction||22
1702190|NCT00433537|4161333|P1|STARTED|Step 1 - VcR-CVAD Induction||45
1702191|NCT00433446|4161342|P1|NOT COMPLETED|Overall Study||61
1702192|NCT00433446|4161342|P1|COMPLETED|Overall Study||1
1702193|NCT00433446|4161342|P1|Eligible and Began Protocol Therapy|Overall Study||53
1702194|NCT00433446|4161342|P1|Eligible|Overall Study||53
1702195|NCT00433446|4161342|P1|STARTED|Overall Study||62
1702196|NCT00433381|4161352|P2|NOT COMPLETED|Overall Study||3
1702197|NCT00433381|4161353|P1|NOT COMPLETED|Overall Study||3
1702198|NCT00433381|4161352|P2|COMPLETED|Overall Study||57
1702199|NCT00433381|4161353|P1|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
1702200|NCT00433381|4161352|P2|STARTED|Overall Study||60
1702201|NCT00433381|4161353|P1|STARTED|Overall Study||63
1702202|NCT00433329|4161372|P1|NOT COMPLETED|Overall Study||21
1702203|NCT00433329|4161372|P1|COMPLETED|Overall Study||79
1702204|NCT00433329|4161372|P1|STARTED|Overall Study||100
1702205|NCT00433290|4161378|P2|NOT COMPLETED|Overall Study||17
1702206|NCT00433290|4161379|P1|NOT COMPLETED|Overall Study||35
1702207|NCT00433290|4161378|P2|COMPLETED|Overall Study||111
1702208|NCT00433290|4161379|P1|COMPLETED|Overall Study||93
1702209|NCT00433290|4161378|P2|STARTED|Overall Study||128
1702210|NCT00433290|4161379|P1|STARTED|Overall Study||128
1702211|NCT00433199|4161448|P2|NOT COMPLETED|Open-Label Period||34
1702212|NCT00433199|4161449|P1|NOT COMPLETED|Open-Label Period||0
1702213|NCT00433199|4161448|P2|COMPLETED|Open-Label Period||185
1702214|NCT00433199|4161449|P1|COMPLETED|Open-Label Period||0
1702215|NCT00433199|4161448|P2|STARTED|Open-Label Period||219
1702216|NCT00433199|4161449|P1|STARTED|Open-Label Period||0
1702217|NCT00433199|4161448|P2|NOT COMPLETED|Double-Blind Period||66
1702218|NCT00433199|4161449|P1|NOT COMPLETED|Double-Blind Period||12
1702219|NCT00433199|4161448|P2|COMPLETED|Double-Blind Period||168
1702220|NCT00433199|4161449|P1|COMPLETED|Double-Blind Period||28
1702221|NCT00433199|4161448|P2|STARTED|Double-Blind Period||234
1702222|NCT00433199|4161449|P1|STARTED|Double-Blind Period||40
1702223|NCT00433160|4161469|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
1702224|NCT00433160|4161470|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
1702225|NCT00433160|4161469|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
1702226|NCT00433160|4161470|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
1702227|NCT00433160|4161469|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
1702228|NCT00433160|4161470|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
1702229|NCT00433160|4161469|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
1702230|NCT00433160|4161470|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
1702231|NCT00433160|4161469|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
1702232|NCT00433160|4161470|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
1702233|NCT00433160|4161469|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
1702234|NCT00433160|4161470|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
1702235|NCT00433160|4161469|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
1702236|NCT00433160|4161470|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
1702237|NCT00433160|4161469|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
1702238|NCT00433160|4161470|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
1702239|NCT00433160|4161469|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
1702240|NCT00433160|4161470|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
1702241|NCT00433160|4161469|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
1702242|NCT00433160|4161470|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
1702243|NCT00433160|4161469|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
1702244|NCT00433160|4161470|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
1702245|NCT00433160|4161469|P2|STARTED|52-Week Double-Blind (DB) Period||70
1702246|NCT00433160|4161470|P1|STARTED|52-Week Double-Blind (DB) Period||137
1702247|NCT00433147|4161522|P4|NOT COMPLETED|Overall Study||0
1702248|NCT00433147|4161523|P3|NOT COMPLETED|Overall Study||0
1702249|NCT00433147|4161524|P2|NOT COMPLETED|Overall Study||1
1702250|NCT00433147|4161525|P1|NOT COMPLETED|Overall Study||0
1702251|NCT00433147|4161522|P4|COMPLETED|Overall Study||7
1702252|NCT00433147|4161523|P3|COMPLETED|Overall Study||9
1702253|NCT00433147|4161524|P2|COMPLETED|Overall Study||6
1702254|NCT00433147|4161525|P1|COMPLETED|Overall Study||7
1702255|NCT00433147|4161522|P4|Received at Least One Dose of Study Drug|Overall Study||7
1702256|NCT00433147|4161523|P3|Received at Least One Dose of Study Drug|Overall Study||9
1702257|NCT00433147|4161524|P2|Received at Least One Dose of Study Drug|Overall Study||7
1702258|NCT00433147|4161525|P1|Received at Least One Dose of Study Drug|Overall Study||7
1702259|NCT00433147|4161522|P4|PD Population|Overall Study||7
1702260|NCT00433147|4161523|P3|PD Population|Overall Study||9
1702261|NCT00433147|4161524|P2|PD Population|Overall Study||6
1702262|NCT00433147|4161525|P1|PD Population|Overall Study||7
1702263|NCT00433147|4161522|P4|Safety Population|Overall Study||7
1702264|NCT00433147|4161523|P3|Safety Population|Overall Study||9
1702265|NCT00433147|4161524|P2|Safety Population|Overall Study||7
1702266|NCT00433147|4161525|P1|Safety Population|Overall Study||7
1702267|NCT00433147|4161522|P4|STARTED|Overall Study||7
1702268|NCT00433147|4161523|P3|STARTED|Overall Study||9
1702269|NCT00433147|4161524|P2|STARTED|Overall Study||7
1702270|NCT00433147|4161525|P1|STARTED|Overall Study||7
1702271|NCT00433017|4161541|P2|NOT COMPLETED|Overall Study||101
1702272|NCT00433017|4161542|P1|NOT COMPLETED|Overall Study||96
1702273|NCT00433017|4161541|P2|COMPLETED|Overall Study||32
1702274|NCT00433017|4161542|P1|COMPLETED|Overall Study||26
1702275|NCT00433017|4161541|P2|Completed 12 Month Phase|Overall Study||126
1702276|NCT00433017|4161542|P1|Completed 12 Month Phase|Overall Study||114
1702277|NCT00433017|4161541|P2|STARTED|Overall Study||133
1702278|NCT00433017|4161542|P1|STARTED|Overall Study||122
1702279|NCT00433004|4161558|P2|NOT COMPLETED|Overall Study||7
1702280|NCT00433004|4161559|P1|NOT COMPLETED|Overall Study||5
1702281|NCT00433004|4161558|P2|COMPLETED|Overall Study||16
1702282|NCT00433004|4161559|P1|COMPLETED|Overall Study||22
1702283|NCT00433004|4161558|P2|STARTED|Overall Study||23
1702284|NCT00433004|4161559|P1|STARTED|Overall Study||27
1702285|NCT00432991|4161571|P2|NOT COMPLETED|Overall Study||12
1702286|NCT00432991|4161572|P1|NOT COMPLETED|Overall Study||7
1702287|NCT00432991|4161571|P2|COMPLETED|Overall Study||19
1702288|NCT00432991|4161572|P1|COMPLETED|Overall Study||15
1702289|NCT00432991|4161571|P2|STARTED|Overall Study||31
1702290|NCT00432991|4161572|P1|STARTED|Overall Study||22
1702291|NCT00432965|4161584|P2|NOT COMPLETED|Overall Study||86
1702292|NCT00432965|4161585|P1|NOT COMPLETED|Overall Study||94
1702293|NCT00432965|4161584|P2|COMPLETED|Overall Study||80
1702294|NCT00432965|4161585|P1|COMPLETED|Overall Study||75
1702295|NCT00432965|4161584|P2|STARTED|Overall Study||166
1702296|NCT00432965|4161585|P1|STARTED|Overall Study||169
1702297|NCT00432835|4161593|P2|NOT COMPLETED|Overall Study||7
1702298|NCT00432835|4161594|P1|NOT COMPLETED|Overall Study||6
1702299|NCT00432835|4161593|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
1702300|NCT00432835|4161594|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
1702301|NCT00432835|4161593|P2|Completed 2nd Intervention|Overall Study||23
1702302|NCT00432835|4161594|P1|Completed 2nd Intervention|Overall Study||22
1702303|NCT00432835|4161593|P2|Completed 1st Intervention|Overall Study||23
1702304|NCT00432835|4161594|P1|Completed 1st Intervention|Overall Study||22
1702305|NCT00432835|4161593|P2|STARTED|Overall Study||30
1702306|NCT00432835|4161594|P1|STARTED|Overall Study||28
1702307|NCT00432809|4161607|P3|NOT COMPLETED|2 Year Sub-study||1
1702308|NCT00432809|4161608|P2|NOT COMPLETED|2 Year Sub-study||2
1702309|NCT00432809|4161609|P1|NOT COMPLETED|2 Year Sub-study||3
1702310|NCT00432809|4161607|P3|COMPLETED|2 Year Sub-study||19
1702311|NCT00432809|4161608|P2|COMPLETED|2 Year Sub-study||18
1702312|NCT00432809|4161609|P1|COMPLETED|2 Year Sub-study||17
1702313|NCT00432809|4161607|P3|STARTED|2 Year Sub-study||20
1702314|NCT00432809|4161608|P2|STARTED|2 Year Sub-study||20
1702315|NCT00432809|4161609|P1|STARTED|2 Year Sub-study||20
1702316|NCT00432809|4161607|P3|NOT COMPLETED|1 Year Follow-up||1
1702317|NCT00432809|4161608|P2|NOT COMPLETED|1 Year Follow-up||0
1702318|NCT00432809|4161609|P1|NOT COMPLETED|1 Year Follow-up||9
1702319|NCT00432809|4161607|P3|COMPLETED|1 Year Follow-up||49
1702320|NCT00432809|4161608|P2|COMPLETED|1 Year Follow-up||50
1702321|NCT00432809|4161609|P1|COMPLETED|1 Year Follow-up||41
1702322|NCT00432809|4161607|P3|STARTED|1 Year Follow-up||50
1702323|NCT00432809|4161608|P2|STARTED|1 Year Follow-up||50
1702324|NCT00432809|4161609|P1|STARTED|1 Year Follow-up||50
1702325|NCT00432744|4161682|P2|NOT COMPLETED|Months 7 - 12||1
1702326|NCT00432744|4161683|P1|NOT COMPLETED|Months 7 - 12||1
1702327|NCT00432744|4161682|P2|COMPLETED|Months 7 - 12||7
1702328|NCT00432744|4161683|P1|COMPLETED|Months 7 - 12||6
1702329|NCT00432744|4161682|P2|STARTED|Months 7 - 12||8
1702330|NCT00432744|4161683|P1|STARTED|Months 7 - 12||7
1702331|NCT00432744|4161682|P2|NOT COMPLETED|Months 0-6||4
1702332|NCT00432744|4161683|P1|NOT COMPLETED|Months 0-6||5
1702333|NCT00432744|4161682|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
1702334|NCT00432744|4161683|P1|COMPLETED|Months 0-6||7
1702335|NCT00432744|4161682|P2|STARTED|Months 0-6||12
1702336|NCT00432744|4161683|P1|STARTED|Months 0-6||12
1702337|NCT00432666|4161695|P2|NOT COMPLETED|Open-Label Extension Period||0
1702338|NCT00432666|4161696|P1|NOT COMPLETED|Open-Label Extension Period||25
1702339|NCT00432666|4161695|P2|COMPLETED|Open-Label Extension Period||0
1702340|NCT00432666|4161696|P1|COMPLETED|Open-Label Extension Period||120
1702341|NCT00432666|4161695|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
1702342|NCT00432666|4161696|P1|STARTED|Open-Label Extension Period||145
1702343|NCT00432666|4161695|P2|NOT COMPLETED|Main Period||1
1702344|NCT00432666|4161696|P1|NOT COMPLETED|Main Period||2
1702345|NCT00432666|4161695|P2|COMPLETED|Main Period||74
1702346|NCT00432666|4161696|P1|COMPLETED|Main Period||71
1702347|NCT00432666|4161695|P2|STARTED|Main Period||75
1702348|NCT00432666|4161696|P1|STARTED|Main Period||73
1702349|NCT00432601|4161860|P2|NOT COMPLETED|Time 2 to Time 3||22
1702350|NCT00432601|4161861|P1|NOT COMPLETED|Time 2 to Time 3||19
1702351|NCT00432601|4161860|P2|COMPLETED|Time 2 to Time 3||122
1702352|NCT00432601|4161861|P1|COMPLETED|Time 2 to Time 3||122
1702353|NCT00432601|4161860|P2|STARTED|Time 2 to Time 3||144
1702354|NCT00432601|4161861|P1|STARTED|Time 2 to Time 3||141
1702355|NCT00432601|4161860|P2|NOT COMPLETED|Time 1 to Time 2||368
1702356|NCT00432601|4161861|P1|NOT COMPLETED|Time 1 to Time 2||369
1702357|NCT00432601|4161860|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
1702358|NCT00432601|4161861|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
1702359|NCT00432601|4161860|P2|STARTED|Time 1 to Time 2||512
1702360|NCT00432601|4161861|P1|STARTED|Time 1 to Time 2||510
1702361|NCT00432562|4161869|P2|NOT COMPLETED|Overall Study||0
1702362|NCT00432562|4161870|P1|NOT COMPLETED|Overall Study||3
1702363|NCT00432562|4161869|P2|COMPLETED|Overall Study||15
1702364|NCT00432562|4161870|P1|COMPLETED|Overall Study||13
1702365|NCT00432562|4161869|P2|STARTED|Overall Study||15
1702366|NCT00432562|4161870|P1|STARTED|Overall Study||16
1702367|NCT00432458|4161896|P2|NOT COMPLETED|Overall Study||1
1702368|NCT00432458|4161897|P1|NOT COMPLETED|Overall Study||5
1702369|NCT00432458|4161896|P2|COMPLETED|Overall Study||32
1702370|NCT00432458|4161897|P1|COMPLETED|Overall Study||30
1702371|NCT00432458|4161896|P2|STARTED|Overall Study||33
1702372|NCT00432458|4161897|P1|STARTED|Overall Study||35
1702373|NCT00432445|4161915|P1|NOT COMPLETED|Overall Study||0
1702374|NCT00432445|4161915|P1|COMPLETED|Overall Study||2
1702375|NCT00432445|4161915|P1|STARTED|Overall Study||2
1702376|NCT00432380|4161922|P3|NOT COMPLETED|Overall Study||1
1702377|NCT00432380|4161923|P2|NOT COMPLETED|Overall Study||4
1702378|NCT00432380|4161924|P1|NOT COMPLETED|Overall Study||4
1702379|NCT00432380|4161922|P3|COMPLETED|Overall Study||74
1702380|NCT00432380|4161923|P2|COMPLETED|Overall Study||146
1702381|NCT00432380|4161924|P1|COMPLETED|Overall Study||146
1702382|NCT00432380|4161922|P3|STARTED|Overall Study||75
1702383|NCT00432380|4161923|P2|STARTED|Overall Study||150
1702384|NCT00432380|4161924|P1|STARTED|Overall Study||150
1702385|NCT00432341|4161950|P2|NOT COMPLETED|Overall Study||0
1702386|NCT00432341|4161951|P1|NOT COMPLETED|Overall Study||0
1702387|NCT00432341|4161950|P2|COMPLETED|Overall Study||30
1702388|NCT00432341|4161951|P1|COMPLETED|Overall Study||24
1702389|NCT00432341|4161950|P2|STARTED|Overall Study||30
1702390|NCT00432341|4161951|P1|STARTED|Overall Study||24
1702391|NCT00432276|4161977|P2|NOT COMPLETED|Overall Study||156
1702392|NCT00432276|4161978|P1|NOT COMPLETED|Overall Study||121
1702393|NCT00432276|4161977|P2|COMPLETED|Overall Study||243
1702394|NCT00432276|4161978|P1|COMPLETED|Overall Study||283
1702395|NCT00432276|4161977|P2|Per Protocol Set|Overall Study||306
1702396|NCT00432276|4161978|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
1702397|NCT00432276|4161977|P2|STARTED|Overall Study||399
1702398|NCT00432276|4161978|P1|STARTED|Overall Study||404
1702399|NCT00432237|4162068|P4|NOT COMPLETED|Overall Study||124
1702400|NCT00432237|4162069|P3|NOT COMPLETED|Overall Study||109
1702401|NCT00432237|4162070|P2|NOT COMPLETED|Overall Study||101
1702402|NCT00432237|4162071|P1|NOT COMPLETED|Overall Study||67
1702403|NCT00432237|4162068|P4|COMPLETED|Overall Study||366
1702404|NCT00432237|4162069|P3|COMPLETED|Overall Study||375
1702405|NCT00432237|4162070|P2|COMPLETED|Overall Study||384
1702406|NCT00432237|4162071|P1|COMPLETED|Overall Study||177
1702407|NCT00432237|4162068|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
1702408|NCT00432237|4162069|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
1702409|NCT00432237|4162070|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
1702410|NCT00432237|4162071|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
1702411|NCT00432237|4162068|P4|Completed--With Data|Overall Study||365
1702412|NCT00432237|4162069|P3|Completed--With Data|Overall Study||370
1702413|NCT00432237|4162070|P2|Completed--With Data|Overall Study||381
1702414|NCT00432237|4162071|P1|Completed--With Data|Overall Study||176
1702415|NCT00432237|4162068|P4|STARTED|Overall Study||490
1702416|NCT00432237|4162069|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
1702417|NCT00432237|4162070|P2|STARTED|Overall Study||485
1702418|NCT00432237|4162071|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
1702419|NCT00432159|4162114|P5|NOT COMPLETED|Overall Study||10
1702420|NCT00432159|4162115|P4|NOT COMPLETED|Overall Study||5
1702421|NCT00432159|4162116|P3|NOT COMPLETED|Overall Study||4
1702422|NCT00432159|4162117|P2|NOT COMPLETED|Overall Study||30
1702423|NCT00432159|4162118|P1|NOT COMPLETED|Overall Study||22
1702424|NCT00432159|4162114|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
1702425|NCT00432159|4162115|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
1702426|NCT00432159|4162116|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
1702427|NCT00432159|4162117|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
1702428|NCT00432159|4162118|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
1702429|NCT00432159|4162114|P5|STARTED|Overall Study||89
1702430|NCT00432159|4162115|P4|STARTED|Overall Study||20
1702431|NCT00432159|4162116|P3|STARTED|Overall Study||39
1702432|NCT00432159|4162117|P2|STARTED|Overall Study||167
1702433|NCT00432159|4162118|P1|STARTED|Overall Study||185
1702434|NCT00432042|4162225|P3|NOT COMPLETED|Overall Study||2
1702435|NCT00432042|4162226|P2|NOT COMPLETED|Overall Study||1
1702436|NCT00432042|4162227|P1|NOT COMPLETED|Overall Study||7
1702437|NCT00432042|4162225|P3|COMPLETED|Overall Study||239
1702438|NCT00432042|4162226|P2|COMPLETED|Overall Study||234
1702439|NCT00432042|4162227|P1|COMPLETED|Overall Study||472
1702440|NCT00432042|4162225|P3|Vaccinated|Overall Study||240
1702441|NCT00432042|4162226|P2|Vaccinated|Overall Study||235
1702442|NCT00432042|4162227|P1|Vaccinated|Overall Study||477
1702443|NCT00432042|4162225|P3|STARTED|Overall Study|Number randomized.|241
1702444|NCT00432042|4162226|P2|STARTED|Overall Study|Number randomized.|235
1702445|NCT00432042|4162227|P1|STARTED|Overall Study|Number randomized.|479
1702446|NCT00431964|4162240|P2|NOT COMPLETED|Overall Study||8
1702447|NCT00431964|4162241|P1|NOT COMPLETED|Overall Study||6
1702448|NCT00431964|4162240|P2|COMPLETED|Overall Study||124
1702449|NCT00431964|4162241|P1|COMPLETED|Overall Study||125
1702450|NCT00431964|4162240|P2|Withdrew From Study|Overall Study||5
1702451|NCT00431964|4162241|P1|Withdrew From Study|Overall Study||6
1702452|NCT00431964|4162240|P2|Did Not Receive Drug|Overall Study||3
1702453|NCT00431964|4162241|P1|Did Not Receive Drug|Overall Study||0
1702454|NCT00431964|4162240|P2|Randomized/Received Drug|Overall Study||129
1702455|NCT00431964|4162241|P1|Randomized/Received Drug|Overall Study||131
1702456|NCT00431964|4162240|P2|STARTED|Overall Study||132
1702457|NCT00431964|4162241|P1|STARTED|Overall Study||131
1702458|NCT00431951|4162251|P4|NOT COMPLETED|Overall Study||2
1702459|NCT00431951|4162252|P3|NOT COMPLETED|Overall Study||2
1702460|NCT00431951|4162253|P2|NOT COMPLETED|Overall Study||2
1702461|NCT00431951|4162254|P1|NOT COMPLETED|Overall Study||1
1702462|NCT00431951|4162251|P4|COMPLETED|Overall Study||4
1702463|NCT00431951|4162252|P3|COMPLETED|Overall Study||6
1702464|NCT00431951|4162253|P2|COMPLETED|Overall Study||6
1702465|NCT00431951|4162254|P1|COMPLETED|Overall Study||7
1702466|NCT00431951|4162251|P4|STARTED|Overall Study||6
1702467|NCT00431951|4162252|P3|STARTED|Overall Study||8
1702468|NCT00431951|4162253|P2|STARTED|Overall Study||8
1702469|NCT00431951|4162254|P1|STARTED|Overall Study||8
1702470|NCT00431847|4162316|P5|NOT COMPLETED|Overall Study||1
1702471|NCT00431847|4162317|P4|NOT COMPLETED|Overall Study||14
1702472|NCT00431847|4162318|P3|NOT COMPLETED|Overall Study||4
1702473|NCT00431847|4162319|P2|NOT COMPLETED|Overall Study||3
1702474|NCT00431847|4162320|P1|NOT COMPLETED|Overall Study||6
1702475|NCT00431847|4162316|P5|COMPLETED|Overall Study||0
1702476|NCT00431847|4162317|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
1702477|NCT00431847|4162318|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
1702478|NCT00431847|4162319|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
1702479|NCT00431847|4162320|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
1702480|NCT00431847|4162316|P5|STARTED|Overall Study||1
1702481|NCT00431847|4162317|P4|STARTED|Overall Study||184
1702482|NCT00431847|4162318|P3|STARTED|Overall Study||24
1702483|NCT00431847|4162319|P2|STARTED|Overall Study||45
1702484|NCT00431847|4162320|P1|STARTED|Overall Study||132
1702485|NCT00431834|4162394|P1|NOT COMPLETED|Overall Study||13
1702486|NCT00431834|4162394|P1|COMPLETED|Overall Study||62
1702487|NCT00431834|4162394|P1|STARTED|Overall Study||75
1702488|NCT00431626|4162403|P2|NOT COMPLETED|Overall Study||0
1702489|NCT00431626|4162404|P1|NOT COMPLETED|Overall Study||0
1702490|NCT00431626|4162403|P2|COMPLETED|Overall Study||0
1702491|NCT00431626|4162404|P1|COMPLETED|Overall Study||4
1702492|NCT00431626|4162403|P2|STARTED|Overall Study||0
1702493|NCT00431626|4162404|P1|STARTED|Overall Study||4
1702494|NCT00431496|4162410|P1|NOT COMPLETED|Overall Study||11
1702495|NCT00431496|4162410|P1|COMPLETED|Overall Study||60
1702496|NCT00431496|4162410|P1|STARTED|Overall Study||71
1702497|NCT00431444|4162421|P2|NOT COMPLETED|Overall Study||7
1702498|NCT00431444|4162422|P1|NOT COMPLETED|Overall Study||5
1702499|NCT00431444|4162421|P2|COMPLETED|Overall Study||46
1702500|NCT00431444|4162422|P1|COMPLETED|Overall Study||51
1702501|NCT00431444|4162421|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
1702502|NCT00431444|4162422|P1|STARTED|Overall Study||56
1702503|NCT00431184|4162448|P2|NOT COMPLETED|Second Intervention (Day 2)||0
1702504|NCT00431184|4162449|P1|NOT COMPLETED|Second Intervention (Day 2)||0
1702505|NCT00431184|4162448|P2|COMPLETED|Second Intervention (Day 2)||9
1702506|NCT00431184|4162449|P1|COMPLETED|Second Intervention (Day 2)||10
1702507|NCT00431184|4162448|P2|STARTED|Second Intervention (Day 2)||9
1702508|NCT00431184|4162449|P1|STARTED|Second Intervention (Day 2)||10
1702509|NCT00431184|4162448|P2|NOT COMPLETED|1st Intervention (Day 1)||0
1702510|NCT00431184|4162449|P1|NOT COMPLETED|1st Intervention (Day 1)||0
1702511|NCT00431184|4162448|P2|COMPLETED|1st Intervention (Day 1)||9
1702512|NCT00431184|4162449|P1|COMPLETED|1st Intervention (Day 1)||10
1702513|NCT00431184|4162448|P2|STARTED|1st Intervention (Day 1)||9
1702514|NCT00431184|4162449|P1|STARTED|1st Intervention (Day 1)||10
1702515|NCT00431132|4162457|P1|NOT COMPLETED|Overall Study||44
1702516|NCT00431132|4162457|P1|COMPLETED|Overall Study||292
1702517|NCT00431132|4162457|P1|STARTED|Overall Study||336
1702518|NCT00431067|4162462|P1|NOT COMPLETED|Overall Study||41
1702519|NCT00431067|4162462|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
1702520|NCT00431067|4162462|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
1702521|NCT00431041|4162472|P2|NOT COMPLETED|Overall Study||24
1702522|NCT00431041|4162473|P1|NOT COMPLETED|Overall Study||16
1702523|NCT00431041|4162472|P2|COMPLETED|Overall Study||40
1702524|NCT00431041|4162473|P1|COMPLETED|Overall Study||52
1702525|NCT00431041|4162472|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
1702526|NCT00431041|4162473|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
1702527|NCT00430950|4162487|P2|NOT COMPLETED|Overall Study||13
1702528|NCT00430950|4162488|P1|NOT COMPLETED|Overall Study||13
1702529|NCT00430950|4162487|P2|COMPLETED|Overall Study||495
1702530|NCT00430950|4162488|P1|COMPLETED|Overall Study||489
1702531|NCT00430950|4162487|P2|STARTED|Overall Study||508
1702532|NCT00430950|4162488|P1|STARTED|Overall Study||502
1702533|NCT00430937|4162502|P2|NOT COMPLETED|Overall Study||28
1702534|NCT00430937|4162503|P1|NOT COMPLETED|Overall Study||27
1702535|NCT00430937|4162502|P2|COMPLETED|Overall Study||64
1702536|NCT00430937|4162503|P1|COMPLETED|Overall Study||70
1702537|NCT00430937|4162502|P2|STARTED|Overall Study||92
1702538|NCT00430937|4162503|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
1702539|NCT00430781|4162514|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
1702540|NCT00430781|4162515|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
1702541|NCT00430781|4162516|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
1702542|NCT00430781|4162514|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
1702543|NCT00430781|4162515|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
1702544|NCT00430781|4162516|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
1702545|NCT00430781|4162514|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
1702546|NCT00430781|4162515|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
1702547|NCT00430781|4162516|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
1702548|NCT00430781|4162514|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
1702549|NCT00430781|4162515|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
1702550|NCT00430781|4162516|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
1702551|NCT00430781|4162514|P3|COMPLETED|Final Analysis; 31 July 2008||26
1702552|NCT00430781|4162515|P2|COMPLETED|Final Analysis; 31 July 2008||39
1702553|NCT00430781|4162516|P1|COMPLETED|Final Analysis; 31 July 2008||0
1702554|NCT00430781|4162514|P3|Ongoing|Final Analysis; 31 July 2008||32
1702555|NCT00430781|4162515|P2|Ongoing|Final Analysis; 31 July 2008||29
1702556|NCT00430781|4162516|P1|Ongoing|Final Analysis; 31 July 2008||0
1702557|NCT00430781|4162514|P3|STARTED|Final Analysis; 31 July 2008||74
1702558|NCT00430781|4162515|P2|STARTED|Final Analysis; 31 July 2008||78
1702559|NCT00430781|4162516|P1|STARTED|Final Analysis; 31 July 2008||0
1702560|NCT00430781|4162514|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
1702561|NCT00430781|4162515|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
1702562|NCT00430781|4162516|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
1702563|NCT00430781|4162514|P3|COMPLETED|Interim Analysis; 11 February 2008||0
1702564|NCT00430781|4162515|P2|COMPLETED|Interim Analysis; 11 February 2008||0
1702565|NCT00430781|4162516|P1|COMPLETED|Interim Analysis; 11 February 2008||0
1702566|NCT00430781|4162514|P3|Ongoing|Interim Analysis; 11 February 2008||25
1702567|NCT00430781|4162515|P2|Ongoing|Interim Analysis; 11 February 2008||20
1702568|NCT00430781|4162516|P1|Ongoing|Interim Analysis; 11 February 2008||23
1702569|NCT00430781|4162514|P3|STARTED|Interim Analysis; 11 February 2008||60
1702570|NCT00430781|4162515|P2|STARTED|Interim Analysis; 11 February 2008||58
1702571|NCT00430781|4162516|P1|STARTED|Interim Analysis; 11 February 2008||59
1702572|NCT00430768|4162542|P3|NOT COMPLETED|Overall Study||0
1702573|NCT00430768|4162543|P2|NOT COMPLETED|Overall Study||0
1702574|NCT00430768|4162544|P1|NOT COMPLETED|Overall Study||0
1702575|NCT00430768|4162542|P3|COMPLETED|Overall Study||3
1702576|NCT00430768|4162543|P2|COMPLETED|Overall Study||3
1702577|NCT00430768|4162544|P1|COMPLETED|Overall Study||3
1702578|NCT00430768|4162542|P3|STARTED|Overall Study||3
1702579|NCT00430768|4162543|P2|STARTED|Overall Study||3
1702580|NCT00430768|4162544|P1|STARTED|Overall Study||3
1702581|NCT00430755|4162558|P1|NOT COMPLETED|Overall Study||53
1702582|NCT00430755|4162558|P1|COMPLETED|Overall Study||45
1702583|NCT00430755|4162558|P1|STARTED|Overall Study||98
1702584|NCT00430716|4162565|P3|NOT COMPLETED|Open Label Phase||7
1702585|NCT00430716|4162566|P2|NOT COMPLETED|Open Label Phase||7
1702586|NCT00430716|4162567|P1|NOT COMPLETED|Open Label Phase||9
1702587|NCT00430716|4162565|P3|COMPLETED|Open Label Phase||32
1702588|NCT00430716|4162566|P2|COMPLETED|Open Label Phase||31
1702589|NCT00430716|4162567|P1|COMPLETED|Open Label Phase||27
1702590|NCT00430716|4162565|P3|STARTED|Open Label Phase||39
1702591|NCT00430716|4162566|P2|STARTED|Open Label Phase||38
1702592|NCT00430716|4162567|P1|STARTED|Open Label Phase||36
1702593|NCT00430716|4162565|P3|NOT COMPLETED|Double Blind Phase||6
1702594|NCT00430716|4162566|P2|NOT COMPLETED|Double Blind Phase||5
1702595|NCT00430716|4162567|P1|NOT COMPLETED|Double Blind Phase||6
1702596|NCT00430716|4162565|P3|COMPLETED|Double Blind Phase||39
1702597|NCT00430716|4162566|P2|COMPLETED|Double Blind Phase||38
1702598|NCT00430716|4162567|P1|COMPLETED|Double Blind Phase||36
1702599|NCT00430716|4162565|P3|Treated|Double Blind Phase||45
1702600|NCT00430716|4162566|P2|Treated|Double Blind Phase||43
1702601|NCT00430716|4162567|P1|Treated|Double Blind Phase||41
1702602|NCT00430716|4162565|P3|STARTED|Double Blind Phase||45
1702603|NCT00430716|4162566|P2|STARTED|Double Blind Phase||43
1702604|NCT00430716|4162567|P1|STARTED|Double Blind Phase||42
1702605|NCT00430677|4162599|P3|NOT COMPLETED|Long-term Extension Period||63
1702606|NCT00430677|4162600|P2|NOT COMPLETED|Long-term Extension Period||58
1702607|NCT00430677|4162601|P1|NOT COMPLETED|Long-term Extension Period||60
1702608|NCT00430677|4162599|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
1702609|NCT00430677|4162600|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
1702610|NCT00430677|4162601|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
1702611|NCT00430677|4162599|P3|STARTED|Long-term Extension Period||74
1702612|NCT00430677|4162600|P2|STARTED|Long-term Extension Period||67
1702613|NCT00430677|4162601|P1|STARTED|Long-term Extension Period||70
1702614|NCT00430677|4162599|P3|NOT COMPLETED|Short-term Period||22
1702615|NCT00430677|4162600|P2|NOT COMPLETED|Short-term Period||25
1702616|NCT00430677|4162601|P1|NOT COMPLETED|Short-term Period||23
1702617|NCT00430677|4162599|P3|COMPLETED|Short-term Period|Completed the short-term period|78
1702618|NCT00430677|4162600|P2|COMPLETED|Short-term Period|Completed the short-term period|74
1702619|NCT00430677|4162601|P1|COMPLETED|Short-term Period|Completed the short-term period|76
1702620|NCT00430677|4162599|P3|STARTED|Short-term Period||100
1702621|NCT00430677|4162600|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
1702622|NCT00430677|4162601|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
1702623|NCT00430638|4162724|P2|NOT COMPLETED|Overall Study||48
1702624|NCT00430638|4162725|P1|NOT COMPLETED|Overall Study||78
1702625|NCT00430638|4162724|P2|COMPLETED|Overall Study||92
1702626|NCT00430638|4162725|P1|COMPLETED|Overall Study||60
1702627|NCT00430638|4162724|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
1702628|NCT00430638|4162725|P1|STARTED|Overall Study||138
1702629|NCT00430625|4162743|P2|NOT COMPLETED|Overall Study||0
1702630|NCT00430625|4162744|P1|NOT COMPLETED|Overall Study||0
1702631|NCT00430625|4162743|P2|COMPLETED|Overall Study||12
1702632|NCT00430625|4162744|P1|COMPLETED|Overall Study||13
1702633|NCT00430625|4162743|P2|STARTED|Overall Study||12
1702634|NCT00430625|4162744|P1|STARTED|Overall Study||13
1702635|NCT00430573|4162760|P1|NOT COMPLETED|Overall Study||5
1702636|NCT00430573|4162760|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
1702637|NCT00430573|4162760|P1|STARTED|Overall Study||10
1702638|NCT00430508|4162769|P4|NOT COMPLETED|Overall Study||5
1702639|NCT00430508|4162770|P3|NOT COMPLETED|Overall Study||13
1702640|NCT00430508|4162771|P2|NOT COMPLETED|Overall Study||6
1702641|NCT00430508|4162772|P1|NOT COMPLETED|Overall Study||3
1702642|NCT00430508|4162769|P4|COMPLETED|Overall Study||269
1702643|NCT00430508|4162770|P3|COMPLETED|Overall Study||266
1702644|NCT00430508|4162771|P2|COMPLETED|Overall Study||272
1702645|NCT00430508|4162772|P1|COMPLETED|Overall Study||137
1702646|NCT00430508|4162769|P4|STARTED|Overall Study||274
1702647|NCT00430508|4162770|P3|STARTED|Overall Study||279
1702648|NCT00430508|4162771|P2|STARTED|Overall Study||278
1702649|NCT00430508|4162772|P1|STARTED|Overall Study||140
1702650|NCT00430495|4162810|P4|NOT COMPLETED|Overall Study||4
1702651|NCT00430495|4162811|P3|NOT COMPLETED|Overall Study||13
1702652|NCT00430495|4162812|P2|NOT COMPLETED|Overall Study||7
1702653|NCT00430495|4162813|P1|NOT COMPLETED|Overall Study||14
1702654|NCT00430495|4162810|P4|COMPLETED|Overall Study||60
1702655|NCT00430495|4162811|P3|COMPLETED|Overall Study||49
1702656|NCT00430495|4162812|P2|COMPLETED|Overall Study||59
1702657|NCT00430495|4162813|P1|COMPLETED|Overall Study||50
1702658|NCT00430495|4162810|P4|Treated|Overall Study||64
1702659|NCT00430495|4162811|P3|Treated|Overall Study||62
1702660|NCT00430495|4162812|P2|Treated|Overall Study||66
1702661|NCT00430495|4162813|P1|Treated|Overall Study||62
1702662|NCT00430495|4162810|P4|STARTED|Overall Study||64
1702663|NCT00430495|4162811|P3|STARTED|Overall Study||62
1702664|NCT00430495|4162812|P2|STARTED|Overall Study||66
1702665|NCT00430495|4162813|P1|STARTED|Overall Study||64
1702666|NCT00430352|4162851|P1|NOT COMPLETED|Overall Study||138
1702667|NCT00430352|4162851|P1|COMPLETED|Overall Study||407
1702668|NCT00430352|4162851|P1|STARTED|Overall Study||545
1702669|NCT00430300|4162869|P4|NOT COMPLETED|Overall Study||2
1702670|NCT00430300|4162870|P3|NOT COMPLETED|Overall Study||6
1702671|NCT00430300|4162871|P2|NOT COMPLETED|Overall Study||2
1702672|NCT00430300|4162872|P1|NOT COMPLETED|Overall Study||2
1702673|NCT00430300|4162869|P4|COMPLETED|Overall Study||15
1702674|NCT00430300|4162870|P3|COMPLETED|Overall Study||29
1702675|NCT00430300|4162871|P2|COMPLETED|Overall Study||16
1702676|NCT00430300|4162872|P1|COMPLETED|Overall Study||15
1702677|NCT00430300|4162869|P4|STARTED|Overall Study||17
1702678|NCT00430300|4162870|P3|STARTED|Overall Study||35
1702679|NCT00430300|4162871|P2|STARTED|Overall Study||18
1702680|NCT00430300|4162872|P1|STARTED|Overall Study||17
1702681|NCT00430248|4162977|P3|NOT COMPLETED|Overall Study||135
1702682|NCT00430248|4162978|P2|NOT COMPLETED|Overall Study||158
1702683|NCT00430248|4162979|P1|NOT COMPLETED|Overall Study||125
1702684|NCT00430248|4162977|P3|COMPLETED|Overall Study||621
1702685|NCT00430248|4162978|P2|COMPLETED|Overall Study||598
1702686|NCT00430248|4162979|P1|COMPLETED|Overall Study||632
1702687|NCT00430248|4162977|P3|STARTED|Overall Study||756
1702688|NCT00430248|4162978|P2|STARTED|Overall Study||756
1702689|NCT00430248|4162979|P1|STARTED|Overall Study||757
1702690|NCT00430092|4163038|P3|NOT COMPLETED|Overall Study||57
1702691|NCT00430092|4163039|P2|NOT COMPLETED|Overall Study||4
1702692|NCT00430092|4163040|P1|NOT COMPLETED|Overall Study||6
1702693|NCT00430092|4163038|P3|COMPLETED|Overall Study||56
1702694|NCT00430092|4163039|P2|COMPLETED|Overall Study||48
1702695|NCT00430092|4163040|P1|COMPLETED|Overall Study||48
1702696|NCT00430092|4163038|P3|STARTED|Overall Study||113
1702697|NCT00430092|4163039|P2|STARTED|Overall Study||52
1702698|NCT00430092|4163040|P1|STARTED|Overall Study||54
1702699|NCT00430027|4163045|P1|NOT COMPLETED|Overall Study||8
1702700|NCT00430027|4163045|P1|COMPLETED|Overall Study||0
1702701|NCT00430027|4163045|P1|STARTED|Overall Study||8
1702702|NCT00429949|4163049|P1|NOT COMPLETED|Overall Study||0
1702703|NCT00429949|4163049|P1|COMPLETED|Overall Study||21
1702704|NCT00429949|4163049|P1|STARTED|Overall Study||21
1702705|NCT00429923|4163062|P3|NOT COMPLETED|Overall Study||39
1702706|NCT00429923|4163063|P2|NOT COMPLETED|Overall Study||4
1702707|NCT00429923|4163064|P1|NOT COMPLETED|Overall Study||5
1702708|NCT00429923|4163062|P3|COMPLETED|Overall Study||68
1702709|NCT00429923|4163063|P2|COMPLETED|Overall Study||51
1702710|NCT00429923|4163064|P1|COMPLETED|Overall Study||52
1702711|NCT00429923|4163062|P3|STARTED|Overall Study||107
1702712|NCT00429923|4163063|P2|STARTED|Overall Study||55
1702713|NCT00429923|4163064|P1|STARTED|Overall Study||57
1702714|NCT00429793|4163069|P1|NOT COMPLETED|Overall Study||6
1702715|NCT00429793|4163069|P1|COMPLETED|Overall Study||54
1702716|NCT00429793|4163069|P1|STARTED|Overall Study||60
1702717|NCT00429702|4163085|P2|NOT COMPLETED|Overall Study||0
1702718|NCT00429702|4163086|P1|NOT COMPLETED|Overall Study||0
1702719|NCT00429702|4163085|P2|COMPLETED|Overall Study||4
1702720|NCT00429702|4163086|P1|COMPLETED|Overall Study||3
1702721|NCT00429702|4163085|P2|STARTED|Overall Study||4
1702722|NCT00429702|4163086|P1|STARTED|Overall Study||3
1702723|NCT00429663|4163096|P2|NOT COMPLETED|Overall Study||39
1702724|NCT00429663|4163097|P1|NOT COMPLETED|Overall Study||36
1702725|NCT00429663|4163096|P2|COMPLETED|Overall Study||41
1702726|NCT00429663|4163097|P1|COMPLETED|Overall Study||40
1702727|NCT00429663|4163096|P2|STARTED|Overall Study||80
1702728|NCT00429663|4163097|P1|STARTED|Overall Study||76
1702729|NCT00429572|4163111|P1|NOT COMPLETED|Overall Study||1
1702730|NCT00429572|4163111|P1|COMPLETED|Overall Study||18
1702731|NCT00429572|4163111|P1|STARTED|Overall Study||19
1702732|NCT00429507|4163119|P1|NOT COMPLETED|Overall Study||0
1702733|NCT00429507|4163119|P1|COMPLETED|Overall Study||12
1702734|NCT00429507|4163119|P1|STARTED|Overall Study||12
1702735|NCT00429494|4163123|P1|NOT COMPLETED|Overall Study||15
1702736|NCT00429494|4163123|P1|COMPLETED|Overall Study||44
1702737|NCT00429494|4163123|P1|STARTED|Overall Study||59
1702738|NCT00429416|4163127|P1|NOT COMPLETED|Overall Study||1
1702739|NCT00429416|4163127|P1|COMPLETED|Overall Study||13
1702740|NCT00429416|4163127|P1|STARTED|Overall Study||14
1702741|NCT00429403|4163137|P2|NOT COMPLETED|Overall Study||0
1702742|NCT00429403|4163138|P1|NOT COMPLETED|Overall Study||0
1702743|NCT00429403|4163137|P2|COMPLETED|Overall Study||0
1702744|NCT00429403|4163138|P1|COMPLETED|Overall Study||1
1702745|NCT00429403|4163137|P2|STARTED|Overall Study||0
1702746|NCT00429403|4163138|P1|STARTED|Overall Study||1
1702747|NCT00429364|4163146|P2|NOT COMPLETED|Overall Study||33
1702748|NCT00429364|4163147|P1|NOT COMPLETED|Overall Study||32
1702749|NCT00429364|4163146|P2|COMPLETED|Overall Study||272
1702750|NCT00429364|4163147|P1|COMPLETED|Overall Study||271
1702751|NCT00429364|4163146|P2|STARTED|Overall Study||305
1702752|NCT00429364|4163147|P1|STARTED|Overall Study||303
1702753|NCT00429299|4163206|P3|NOT COMPLETED|Overall Study||4
1702754|NCT00429299|4163207|P2|NOT COMPLETED|Overall Study||7
1702755|NCT00429299|4163208|P1|NOT COMPLETED|Overall Study||4
1702756|NCT00429299|4163206|P3|COMPLETED|Overall Study||42
1702757|NCT00429299|4163207|P2|COMPLETED|Overall Study||32
1702758|NCT00429299|4163208|P1|COMPLETED|Overall Study||32
1702759|NCT00429299|4163206|P3|STARTED|Overall Study||46
1702760|NCT00429299|4163207|P2|STARTED|Overall Study||39
1702761|NCT00429299|4163208|P1|STARTED|Overall Study||36
1702762|NCT00429273|4163240|P3|NOT COMPLETED|Overall Study||9
1702763|NCT00429273|4163241|P2|NOT COMPLETED|Overall Study||8
1702764|NCT00429273|4163242|P1|NOT COMPLETED|Overall Study||8
1702765|NCT00429273|4163240|P3|COMPLETED|Overall Study||61
1702766|NCT00429273|4163241|P2|COMPLETED|Overall Study||61
1702767|NCT00429273|4163242|P1|COMPLETED|Overall Study||60
1702768|NCT00429273|4163240|P3|STARTED|Overall Study||70
1702769|NCT00429273|4163241|P2|STARTED|Overall Study||69
1702770|NCT00429273|4163242|P1|STARTED|Overall Study||68
1702771|NCT00429182|4163250|P1|NOT COMPLETED|Overall Study||7
1702772|NCT00429182|4163250|P1|COMPLETED|Overall Study||25
1702773|NCT00429182|4163250|P1|STARTED|Overall Study||32
1702774|NCT00429169|4163257|P2|NOT COMPLETED|Overall Study||2
1702775|NCT00429169|4163258|P1|NOT COMPLETED|Overall Study||2
1702776|NCT00429169|4163257|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
1702777|NCT00429169|4163258|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
1702778|NCT00429169|4163257|P2|STARTED|Overall Study||40
1702779|NCT00429169|4163258|P1|STARTED|Overall Study||38
1702780|NCT00429143|4163270|P1|NOT COMPLETED|Overall Study||0
1702781|NCT00429143|4163270|P1|COMPLETED|Overall Study||27
1702782|NCT00429143|4163270|P1|STARTED|Overall Study||27
1702783|NCT00429104|4163278|P1|NOT COMPLETED|Overall Study||1
1702784|NCT00429104|4163278|P1|COMPLETED|Overall Study||17
1702785|NCT00429104|4163278|P1|STARTED|Overall Study||18
1702786|NCT00429026|4163283|P1|NOT COMPLETED|Overall Study||40
1702787|NCT00429026|4163283|P1|COMPLETED|Overall Study||0
1702788|NCT00429026|4163283|P1|STARTED|Overall Study||40
1702789|NCT00428974|4163291|P4|NOT COMPLETED|Overall Study||3
1702790|NCT00428974|4163292|P3|NOT COMPLETED|Overall Study||1
1702791|NCT00428974|4163293|P2|NOT COMPLETED|Overall Study||0
1702792|NCT00428974|4163294|P1|NOT COMPLETED|Overall Study||8
1702793|NCT00428974|4163291|P4|COMPLETED|Overall Study||16
1702794|NCT00428974|4163292|P3|COMPLETED|Overall Study||14
1702795|NCT00428974|4163293|P2|COMPLETED|Overall Study||17
1702796|NCT00428974|4163294|P1|COMPLETED|Overall Study||17
1702797|NCT00428974|4163291|P4|STARTED|Overall Study||19
1702798|NCT00428974|4163292|P3|STARTED|Overall Study||15
1702799|NCT00428974|4163293|P2|STARTED|Overall Study||17
1702800|NCT00428974|4163294|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
1702801|NCT00428948|4163310|P2|NOT COMPLETED|Overall Study||67
1702802|NCT00428948|4163311|P1|NOT COMPLETED|Overall Study||221
1702803|NCT00428948|4163310|P2|COMPLETED|Overall Study||417
1702804|NCT00428948|4163311|P1|COMPLETED|Overall Study||740
1702805|NCT00428948|4163310|P2|Received Treatment|Overall Study||483
1702806|NCT00428948|4163311|P1|Received Treatment|Overall Study||961
1702807|NCT00428948|4163310|P2|STARTED|Overall Study||484
1702808|NCT00428948|4163311|P1|STARTED|Overall Study||961
1702809|NCT00428922|4163329|P1|NOT COMPLETED|Overall Study||0
1702810|NCT00428922|4163329|P1|COMPLETED|Overall Study||26
1702811|NCT00428922|4163329|P1|STARTED|Overall Study||26
1702812|NCT00428844|4163339|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
1702813|NCT00428844|4163340|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
1702814|NCT00428844|4163341|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
1702815|NCT00428844|4163339|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
1702816|NCT00428844|4163340|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
1702817|NCT00428844|4163341|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
1702818|NCT00428844|4163339|P3|STARTED|Completed Test of Cure (TOC) Visit||19
1702819|NCT00428844|4163340|P2|STARTED|Completed Test of Cure (TOC) Visit||18
1702820|NCT00428844|4163341|P1|STARTED|Completed Test of Cure (TOC) Visit||23
1702821|NCT00428844|4163339|P3|NOT COMPLETED|Completed Study Drug Treatment||7
1702822|NCT00428844|4163340|P2|NOT COMPLETED|Completed Study Drug Treatment||6
1702823|NCT00428844|4163341|P1|NOT COMPLETED|Completed Study Drug Treatment||2
1702824|NCT00428844|4163339|P3|COMPLETED|Completed Study Drug Treatment||19
1702825|NCT00428844|4163340|P2|COMPLETED|Completed Study Drug Treatment||18
1702826|NCT00428844|4163341|P1|COMPLETED|Completed Study Drug Treatment||23
1702827|NCT00428844|4163339|P3|Received First Dose|Completed Study Drug Treatment||25
1702828|NCT00428844|4163340|P2|Received First Dose|Completed Study Drug Treatment||24
1702829|NCT00428844|4163341|P1|Received First Dose|Completed Study Drug Treatment||25
1702830|NCT00428844|4163339|P3|STARTED|Completed Study Drug Treatment||26
1702831|NCT00428844|4163340|P2|STARTED|Completed Study Drug Treatment||24
1702832|NCT00428844|4163341|P1|STARTED|Completed Study Drug Treatment||25
1702833|NCT00428792|4163364|P2|NOT COMPLETED|Overall Study||4
1702834|NCT00428792|4163365|P1|NOT COMPLETED|Overall Study||1
1702835|NCT00428792|4163364|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
1702836|NCT00428792|4163365|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
1702837|NCT00428792|4163364|P2|STARTED|Overall Study||70
1702838|NCT00428792|4163365|P1|STARTED|Overall Study||80
1702839|NCT00428610|4163392|P3|NOT COMPLETED|Overall Study||32
1702840|NCT00428610|4163393|P2|NOT COMPLETED|Overall Study||18
1702841|NCT00428610|4163394|P1|NOT COMPLETED|Overall Study||53
1702842|NCT00428610|4163392|P3|COMPLETED|Overall Study||0
1702843|NCT00428610|4163393|P2|COMPLETED|Overall Study||0
1702844|NCT00428610|4163394|P1|COMPLETED|Overall Study||0
1702845|NCT00428610|4163392|P3|Received at Least One Dose of Study Drug|Overall Study||32
1702846|NCT00428610|4163393|P2|Received at Least One Dose of Study Drug|Overall Study||18
1702847|NCT00428610|4163394|P1|Received at Least One Dose of Study Drug|Overall Study||53
1702848|NCT00428610|4163392|P3|STARTED|Overall Study||32
1702849|NCT00428610|4163393|P2|STARTED|Overall Study||18
1702850|NCT00428610|4163394|P1|STARTED|Overall Study||53
1702851|NCT00428597|4163428|P2|NOT COMPLETED|Overall Study||85
1702852|NCT00428597|4163429|P1|NOT COMPLETED|Overall Study||86
1702853|NCT00428597|4163428|P2|COMPLETED|Overall Study||0
1702854|NCT00428597|4163429|P1|COMPLETED|Overall Study||0
1702855|NCT00428597|4163428|P2|Received Treatment|Overall Study||82
1702856|NCT00428597|4163429|P1|Received Treatment|Overall Study||83
1702857|NCT00428597|4163428|P2|STARTED|Overall Study||85
1702858|NCT00428597|4163429|P1|STARTED|Overall Study||86
1702859|NCT00428584|4163471|P2|NOT COMPLETED|Extension Phase||29
1702860|NCT00428584|4163472|P1|NOT COMPLETED|Extension Phase||21
1702861|NCT00428584|4163471|P2|COMPLETED|Extension Phase||34
1702862|NCT00428584|4163472|P1|COMPLETED|Extension Phase||35
1702863|NCT00428584|4163471|P2|STARTED|Extension Phase||63
1702864|NCT00428584|4163472|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
1702865|NCT00428584|4163471|P2|NOT COMPLETED|Comparative Phase||1
1702866|NCT00428584|4163472|P1|NOT COMPLETED|Comparative Phase||9
1702867|NCT00428584|4163471|P2|COMPLETED|Comparative Phase||63
1702868|NCT00428584|4163472|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
1702869|NCT00428584|4163471|P2|STARTED|Comparative Phase||64
1702870|NCT00428584|4163472|P1|STARTED|Comparative Phase||65
1702871|NCT00428441|4163496|P1|NOT COMPLETED|Overall Study||1
1702872|NCT00428441|4163496|P1|COMPLETED|Overall Study||74
1702873|NCT00428441|4163496|P1|STARTED|Overall Study||75
1702874|NCT00428389|4163502|P2|NOT COMPLETED|Extension Phase||26
1702875|NCT00428389|4163503|P1|NOT COMPLETED|Extension Phase||32
1702876|NCT00428389|4163502|P2|COMPLETED|Extension Phase||91
1702877|NCT00428389|4163503|P1|COMPLETED|Extension Phase||85
1702878|NCT00428389|4163502|P2|STARTED|Extension Phase||117
1702879|NCT00428389|4163503|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
1702880|NCT00428389|4163502|P2|NOT COMPLETED|Core Phase||11
1702881|NCT00428389|4163503|P1|NOT COMPLETED|Core Phase||11
1702882|NCT00428389|4163502|P2|COMPLETED|Core Phase||120
1702883|NCT00428389|4163503|P1|COMPLETED|Core Phase||120
1702884|NCT00428389|4163502|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
1702885|NCT00428389|4163503|P1|Intent-to-treat Population|Core Phase||131
1702886|NCT00428389|4163502|P2|STARTED|Core Phase||131
1702887|NCT00428389|4163503|P1|STARTED|Core Phase||131
1702888|NCT00428298|4163523|P2|NOT COMPLETED|Overall Study||11
1702889|NCT00428298|4163524|P1|NOT COMPLETED|Overall Study||14
1702890|NCT00428298|4163523|P2|COMPLETED|Overall Study||19
1702891|NCT00428298|4163524|P1|COMPLETED|Overall Study||16
1702892|NCT00428298|4163523|P2|Second RBANS at Study Exit|Overall Study||3
1702893|NCT00428298|4163524|P1|Second RBANS at Study Exit|Overall Study||3
1702894|NCT00428298|4163523|P2|STARTED|Overall Study||30
1702895|NCT00428298|4163524|P1|STARTED|Overall Study||30
1702896|NCT00428246|4163537|P3|NOT COMPLETED|Overall Study||1
1702897|NCT00428246|4163538|P2|NOT COMPLETED|Overall Study||0
1702898|NCT00428246|4163539|P1|NOT COMPLETED|Overall Study||1
1702899|NCT00428246|4163537|P3|COMPLETED|Overall Study||7
1702900|NCT00428246|4163538|P2|COMPLETED|Overall Study||8
1702901|NCT00428246|4163539|P1|COMPLETED|Overall Study||7
1702902|NCT00428246|4163537|P3|STARTED|Overall Study||8
1702903|NCT00428246|4163538|P2|STARTED|Overall Study||8
1702904|NCT00428246|4163539|P1|STARTED|Overall Study||8
1702905|NCT00428220|4163547|P1|NOT COMPLETED|Overall Study||223
1702906|NCT00428220|4163547|P1|COMPLETED|Overall Study||0
1702907|NCT00428220|4163547|P1|STARTED|Overall Study||223
1702908|NCT00428207|4163563|P2|NOT COMPLETED|Overall Study||0
1702909|NCT00428207|4163564|P1|NOT COMPLETED|Overall Study||0
1702910|NCT00428207|4163563|P2|COMPLETED|Overall Study||2
1702911|NCT00428207|4163564|P1|COMPLETED|Overall Study||2
1702912|NCT00428207|4163563|P2|STARTED|Overall Study||2
1702913|NCT00428207|4163564|P1|STARTED|Overall Study||2
1702914|NCT00428116|4163572|P2|NOT COMPLETED|Overall Study||0
1702915|NCT00428116|4163573|P1|NOT COMPLETED|Overall Study||3
1702916|NCT00428116|4163572|P2|COMPLETED|Overall Study||21
1702917|NCT00428116|4163573|P1|COMPLETED|Overall Study||18
1702918|NCT00428116|4163572|P2|STARTED|Overall Study||21
1702919|NCT00428116|4163573|P1|STARTED|Overall Study||21
1702920|NCT00428090|4163585|P4|NOT COMPLETED|Overall Study||28
1702921|NCT00428090|4163586|P3|NOT COMPLETED|Overall Study||38
1702922|NCT00428090|4163587|P2|NOT COMPLETED|Overall Study||31
1702923|NCT00428090|4163588|P1|NOT COMPLETED|Overall Study||34
1702924|NCT00428090|4163585|P4|COMPLETED|Overall Study||55
1702925|NCT00428090|4163586|P3|COMPLETED|Overall Study||127
1702926|NCT00428090|4163587|P2|COMPLETED|Overall Study||135
1702927|NCT00428090|4163588|P1|COMPLETED|Overall Study||131
1702928|NCT00428090|4163585|P4|STARTED|Overall Study||83
1702929|NCT00428090|4163586|P3|STARTED|Overall Study||165
1702930|NCT00428090|4163587|P2|STARTED|Overall Study||166
1702931|NCT00428090|4163588|P1|STARTED|Overall Study||165
1702932|NCT00428077|4163702|P1|NOT COMPLETED|Overall Study||0
1702933|NCT00428077|4163702|P1|COMPLETED|Overall Study||4
1702934|NCT00428077|4163702|P1|STARTED|Overall Study||4
1702935|NCT00427999|4163706|P1|NOT COMPLETED|Overall Study||32
1702936|NCT00427999|4163706|P1|COMPLETED|Overall Study||33
1702937|NCT00427999|4163706|P1|Extension Follow-up|Overall Study||19
1702938|NCT00427999|4163706|P1|Intent to Treat (ITT)|Overall Study||61
1702939|NCT00427999|4163706|P1|STARTED|Overall Study||65
1702940|NCT00427973|4163715|P1|NOT COMPLETED|Overall Study||0
1702941|NCT00427973|4163715|P1|COMPLETED|Overall Study||17
1702942|NCT00427973|4163715|P1|STARTED|Overall Study||17
1702943|NCT00427960|4163724|P2|NOT COMPLETED|Overall Study||4
1702944|NCT00427960|4163725|P1|NOT COMPLETED|Overall Study||2
1702945|NCT00427960|4163724|P2|COMPLETED|Overall Study||21
1702946|NCT00427960|4163725|P1|COMPLETED|Overall Study||28
1702947|NCT00427960|4163724|P2|STARTED|Overall Study||25
1702948|NCT00427960|4163725|P1|STARTED|Overall Study||30
1702949|NCT00427934|4163763|P4|NOT COMPLETED|Overall Study||15
1702950|NCT00427934|4163764|P3|NOT COMPLETED|Overall Study||23
1702951|NCT00427934|4163765|P2|NOT COMPLETED|Overall Study||0
1702952|NCT00427934|4163766|P1|NOT COMPLETED|Overall Study||1
1702953|NCT00427934|4163763|P4|COMPLETED|Overall Study||19
1702954|NCT00427934|4163764|P3|COMPLETED|Overall Study||55
1702955|NCT00427934|4163765|P2|COMPLETED|Overall Study||8
1702956|NCT00427934|4163766|P1|COMPLETED|Overall Study||7
1702957|NCT00427934|4163763|P4|Treated|Overall Study||33
1702958|NCT00427934|4163764|P3|Treated|Overall Study||77
1702959|NCT00427934|4163765|P2|Treated|Overall Study||8
1702960|NCT00427934|4163766|P1|Treated|Overall Study||8
1702961|NCT00427934|4163763|P4|STARTED|Overall Study||34
1702962|NCT00427934|4163764|P3|STARTED|Overall Study||78
1702963|NCT00427934|4163765|P2|STARTED|Overall Study||8
1702964|NCT00427934|4163766|P1|STARTED|Overall Study||8
1702965|NCT00427921|4163834|P1|NOT COMPLETED|Overall Study||50
1702966|NCT00427921|4163834|P1|COMPLETED|Overall Study||254
1702967|NCT00427921|4163834|P1|STARTED|Overall Study||304
1702968|NCT00427908|4163857|P4|NOT COMPLETED|Persistence Phase Year 5||0
1702969|NCT00427908|4163858|P3|NOT COMPLETED|Persistence Phase Year 5||0
1702970|NCT00427908|4163859|P2|NOT COMPLETED|Persistence Phase Year 5||0
1702971|NCT00427908|4163860|P1|NOT COMPLETED|Persistence Phase Year 5||0
1702972|NCT00427908|4163857|P4|COMPLETED|Persistence Phase Year 5||13
1702973|NCT00427908|4163858|P3|COMPLETED|Persistence Phase Year 5||12
1702974|NCT00427908|4163859|P2|COMPLETED|Persistence Phase Year 5||99
1702975|NCT00427908|4163860|P1|COMPLETED|Persistence Phase Year 5||52
1702976|NCT00427908|4163857|P4|STARTED|Persistence Phase Year 5||13
1702977|NCT00427908|4163858|P3|STARTED|Persistence Phase Year 5||12
1702978|NCT00427908|4163859|P2|STARTED|Persistence Phase Year 5||99
1702979|NCT00427908|4163860|P1|STARTED|Persistence Phase Year 5||52
1702980|NCT00427908|4163857|P4|NOT COMPLETED|Persistence Phase Year 4||0
1702981|NCT00427908|4163858|P3|NOT COMPLETED|Persistence Phase Year 4||0
1702982|NCT00427908|4163859|P2|NOT COMPLETED|Persistence Phase Year 4||0
1702983|NCT00427908|4163860|P1|NOT COMPLETED|Persistence Phase Year 4||0
1702984|NCT00427908|4163857|P4|COMPLETED|Persistence Phase Year 4||32
1702985|NCT00427908|4163858|P3|COMPLETED|Persistence Phase Year 4||34
1702986|NCT00427908|4163859|P2|COMPLETED|Persistence Phase Year 4||192
1702987|NCT00427908|4163860|P1|COMPLETED|Persistence Phase Year 4||165
1702988|NCT00427908|4163857|P4|STARTED|Persistence Phase Year 4||32
1702989|NCT00427908|4163858|P3|STARTED|Persistence Phase Year 4||34
1702990|NCT00427908|4163859|P2|STARTED|Persistence Phase Year 4||192
1702991|NCT00427908|4163860|P1|STARTED|Persistence Phase Year 4||165
1702992|NCT00427908|4163857|P4|NOT COMPLETED|Persistence Phase Year 3||0
1702993|NCT00427908|4163858|P3|NOT COMPLETED|Persistence Phase Year 3||0
1702994|NCT00427908|4163859|P2|NOT COMPLETED|Persistence Phase Year 3||0
1702995|NCT00427908|4163860|P1|NOT COMPLETED|Persistence Phase Year 3||0
1702996|NCT00427908|4163857|P4|COMPLETED|Persistence Phase Year 3||38
1702997|NCT00427908|4163858|P3|COMPLETED|Persistence Phase Year 3||38
1702998|NCT00427908|4163859|P2|COMPLETED|Persistence Phase Year 3||201
1702999|NCT00427908|4163860|P1|COMPLETED|Persistence Phase Year 3||185
1703000|NCT00427908|4163857|P4|STARTED|Persistence Phase Year 3||38
1703001|NCT00427908|4163858|P3|STARTED|Persistence Phase Year 3||38
1703002|NCT00427908|4163859|P2|STARTED|Persistence Phase Year 3||201
1703003|NCT00427908|4163860|P1|STARTED|Persistence Phase Year 3||185
1703004|NCT00427908|4163857|P4|NOT COMPLETED|Persistence Phase Year 2||0
1703005|NCT00427908|4163858|P3|NOT COMPLETED|Persistence Phase Year 2||0
1703006|NCT00427908|4163859|P2|NOT COMPLETED|Persistence Phase Year 2||0
1703007|NCT00427908|4163860|P1|NOT COMPLETED|Persistence Phase Year 2||0
1703008|NCT00427908|4163857|P4|COMPLETED|Persistence Phase Year 2||61
1703009|NCT00427908|4163858|P3|COMPLETED|Persistence Phase Year 2||53
1703010|NCT00427908|4163859|P2|COMPLETED|Persistence Phase Year 2||215
1703011|NCT00427908|4163860|P1|COMPLETED|Persistence Phase Year 2||208
1703012|NCT00427908|4163857|P4|STARTED|Persistence Phase Year 2||61
1703013|NCT00427908|4163858|P3|STARTED|Persistence Phase Year 2||53
1703014|NCT00427908|4163859|P2|STARTED|Persistence Phase Year 2||215
1703015|NCT00427908|4163860|P1|STARTED|Persistence Phase Year 2||208
1703016|NCT00427908|4163857|P4|NOT COMPLETED|Persistence Phase Year 1||0
1703017|NCT00427908|4163858|P3|NOT COMPLETED|Persistence Phase Year 1||0
1703018|NCT00427908|4163859|P2|NOT COMPLETED|Persistence Phase Year 1||0
1703019|NCT00427908|4163860|P1|NOT COMPLETED|Persistence Phase Year 1||0
1703020|NCT00427908|4163857|P4|COMPLETED|Persistence Phase Year 1||78
1703021|NCT00427908|4163858|P3|COMPLETED|Persistence Phase Year 1||71
1703022|NCT00427908|4163859|P2|COMPLETED|Persistence Phase Year 1||221
1703023|NCT00427908|4163860|P1|COMPLETED|Persistence Phase Year 1||222
1703024|NCT00427908|4163857|P4|STARTED|Persistence Phase Year 1||78
1703025|NCT00427908|4163858|P3|STARTED|Persistence Phase Year 1||71
1703026|NCT00427908|4163859|P2|STARTED|Persistence Phase Year 1||221
1703027|NCT00427908|4163860|P1|STARTED|Persistence Phase Year 1||222
1703028|NCT00427908|4163857|P4|NOT COMPLETED|Primary Phase||0
1703029|NCT00427908|4163858|P3|NOT COMPLETED|Primary Phase||3
1703030|NCT00427908|4163859|P2|NOT COMPLETED|Primary Phase||3
1703031|NCT00427908|4163860|P1|NOT COMPLETED|Primary Phase||5
1703032|NCT00427908|4163857|P4|COMPLETED|Primary Phase||78
1703033|NCT00427908|4163858|P3|COMPLETED|Primary Phase||72
1703034|NCT00427908|4163859|P2|COMPLETED|Primary Phase||228
1703035|NCT00427908|4163860|P1|COMPLETED|Primary Phase||224
1703036|NCT00427908|4163857|P4|STARTED|Primary Phase||78
1703037|NCT00427908|4163858|P3|STARTED|Primary Phase||75
1703038|NCT00427908|4163859|P2|STARTED|Primary Phase||231
1703039|NCT00427908|4163860|P1|STARTED|Primary Phase||229
1703040|NCT00427895|4164060|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
1703041|NCT00427895|4164061|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
1703042|NCT00427895|4164062|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
1703043|NCT00427895|4164063|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
1703044|NCT00427895|4164064|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
1703045|NCT00427895|4164065|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
1703046|NCT00427895|4164066|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
1703047|NCT00427895|4164067|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
1703048|NCT00427895|4164060|P8|COMPLETED|Vax 2/Year 3 to 4||212
1703049|NCT00427895|4164061|P7|COMPLETED|Vax 2/Year 3 to 4||189
1703050|NCT00427895|4164062|P6|COMPLETED|Vax 2/Year 3 to 4||108
1703051|NCT00427895|4164063|P5|COMPLETED|Vax 2/Year 3 to 4||107
1703052|NCT00427895|4164064|P4|COMPLETED|Vax 2/Year 3 to 4||0
1703053|NCT00427895|4164065|P3|COMPLETED|Vax 2/Year 3 to 4||0
1703054|NCT00427895|4164066|P2|COMPLETED|Vax 2/Year 3 to 4||0
1703055|NCT00427895|4164067|P1|COMPLETED|Vax 2/Year 3 to 4||0
1703056|NCT00427895|4164060|P8|STARTED|Vax 2/Year 3 to 4||214
1703057|NCT00427895|4164061|P7|STARTED|Vax 2/Year 3 to 4||189
1703058|NCT00427895|4164062|P6|STARTED|Vax 2/Year 3 to 4||108
1703059|NCT00427895|4164063|P5|STARTED|Vax 2/Year 3 to 4||108
1703060|NCT00427895|4164064|P4|STARTED|Vax 2/Year 3 to 4||0
1703061|NCT00427895|4164065|P3|STARTED|Vax 2/Year 3 to 4||0
1703062|NCT00427895|4164066|P2|STARTED|Vax 2/Year 3 to 4||0
1703063|NCT00427895|4164067|P1|STARTED|Vax 2/Year 3 to 4||0
1703064|NCT00427895|4164060|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1703065|NCT00427895|4164061|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1703066|NCT00427895|4164062|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1703067|NCT00427895|4164063|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1703068|NCT00427895|4164064|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
1703069|NCT00427895|4164065|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
1703070|NCT00427895|4164066|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
1703071|NCT00427895|4164067|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
1703072|NCT00427895|4164060|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1703073|NCT00427895|4164061|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1703074|NCT00427895|4164062|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1703075|NCT00427895|4164063|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1703076|NCT00427895|4164064|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
1703077|NCT00427895|4164065|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
1703078|NCT00427895|4164066|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
1703079|NCT00427895|4164067|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
1703080|NCT00427895|4164060|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
1703081|NCT00427895|4164061|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
1703082|NCT00427895|4164062|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
1703083|NCT00427895|4164063|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
1703084|NCT00427895|4164064|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
1703085|NCT00427895|4164065|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
1703086|NCT00427895|4164066|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
1703087|NCT00427895|4164067|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
1703088|NCT00427895|4164060|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
1703089|NCT00427895|4164061|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
1703090|NCT00427895|4164062|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
1703091|NCT00427895|4164063|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
1703092|NCT00427895|4164064|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
1703093|NCT00427895|4164065|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
1703094|NCT00427895|4164066|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
1703095|NCT00427895|4164067|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
1703096|NCT00427895|4164060|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
1703097|NCT00427895|4164061|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
1703098|NCT00427895|4164062|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
1703099|NCT00427895|4164063|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
1703100|NCT00427895|4164064|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
1703101|NCT00427895|4164065|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
1703102|NCT00427895|4164066|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
1703103|NCT00427895|4164067|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
1703104|NCT00427895|4164060|P8|STARTED|Vax 1/Year 1 Follow-up||0
1703105|NCT00427895|4164061|P7|STARTED|Vax 1/Year 1 Follow-up||0
1703106|NCT00427895|4164062|P6|STARTED|Vax 1/Year 1 Follow-up||0
1703107|NCT00427895|4164063|P5|STARTED|Vax 1/Year 1 Follow-up||0
1703108|NCT00427895|4164064|P4|STARTED|Vax 1/Year 1 Follow-up||502
1703109|NCT00427895|4164065|P3|STARTED|Vax 1/Year 1 Follow-up||392
1703110|NCT00427895|4164066|P2|STARTED|Vax 1/Year 1 Follow-up||411
1703111|NCT00427895|4164067|P1|STARTED|Vax 1/Year 1 Follow-up||411
1703112|NCT00427895|4164060|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1703113|NCT00427895|4164061|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1703114|NCT00427895|4164062|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1703115|NCT00427895|4164063|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1703116|NCT00427895|4164064|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
1703117|NCT00427895|4164065|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1703118|NCT00427895|4164066|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1703119|NCT00427895|4164067|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
1703120|NCT00427895|4164060|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
1703121|NCT00427895|4164061|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
1703122|NCT00427895|4164062|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
1703123|NCT00427895|4164063|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
1703124|NCT00427895|4164064|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
1703125|NCT00427895|4164065|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
1703126|NCT00427895|4164066|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
1703127|NCT00427895|4164067|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
1703128|NCT00427895|4164060|P8|STARTED|Between 6-Month Follow-up - Year 1||0
1703129|NCT00427895|4164061|P7|STARTED|Between 6-Month Follow-up - Year 1||0
1703130|NCT00427895|4164062|P6|STARTED|Between 6-Month Follow-up - Year 1||0
1703131|NCT00427895|4164063|P5|STARTED|Between 6-Month Follow-up - Year 1||0
1703132|NCT00427895|4164064|P4|STARTED|Between 6-Month Follow-up - Year 1||854
1703133|NCT00427895|4164065|P3|STARTED|Between 6-Month Follow-up - Year 1||392
1703134|NCT00427895|4164066|P2|STARTED|Between 6-Month Follow-up - Year 1||411
1703135|NCT00427895|4164067|P1|STARTED|Between 6-Month Follow-up - Year 1||411
1703136|NCT00427895|4164060|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1703137|NCT00427895|4164061|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1703138|NCT00427895|4164062|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1703139|NCT00427895|4164063|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1703140|NCT00427895|4164064|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
1703141|NCT00427895|4164065|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
1703142|NCT00427895|4164066|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
1703143|NCT00427895|4164067|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
1703144|NCT00427895|4164060|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1703145|NCT00427895|4164061|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1703146|NCT00427895|4164062|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1703147|NCT00427895|4164063|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
1703148|NCT00427895|4164064|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
1703149|NCT00427895|4164065|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
1703150|NCT00427895|4164066|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
1703151|NCT00427895|4164067|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
1703152|NCT00427895|4164060|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
1703153|NCT00427895|4164061|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
1703154|NCT00427895|4164062|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
1703155|NCT00427895|4164063|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
1703156|NCT00427895|4164064|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
1703157|NCT00427895|4164065|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
1703158|NCT00427895|4164066|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
1703159|NCT00427895|4164067|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
1703160|NCT00427895|4164060|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
1703161|NCT00427895|4164061|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
1703162|NCT00427895|4164062|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
1703163|NCT00427895|4164063|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
1703164|NCT00427895|4164064|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
1703165|NCT00427895|4164065|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
1703166|NCT00427895|4164066|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
1703167|NCT00427895|4164067|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
1703168|NCT00427804|4164124|P2|NOT COMPLETED|Overall Study||0
1703169|NCT00427804|4164125|P1|NOT COMPLETED|Overall Study||0
1703170|NCT00427804|4164124|P2|COMPLETED|Overall Study||5
1703171|NCT00427804|4164125|P1|COMPLETED|Overall Study||4
1703172|NCT00427804|4164124|P2|STARTED|Overall Study||5
1703173|NCT00427804|4164125|P1|STARTED|Overall Study||4
1703174|NCT00427791|4164133|P2|NOT COMPLETED|Overall Study||0
1703175|NCT00427791|4164134|P1|NOT COMPLETED|Overall Study||0
1703176|NCT00427791|4164133|P2|COMPLETED|Overall Study||13
1703177|NCT00427791|4164134|P1|COMPLETED|Overall Study||10
1703178|NCT00427791|4164133|P2|STARTED|Overall Study||13
1703179|NCT00427791|4164134|P1|STARTED|Overall Study||10
1703180|NCT00427778|4164142|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
1703181|NCT00427778|4164143|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
1703182|NCT00427778|4164142|P2|COMPLETED|Second Intervention (4 Weeks)||14
1703183|NCT00427778|4164143|P1|COMPLETED|Second Intervention (4 Weeks)||10
1703184|NCT00427778|4164142|P2|STARTED|Second Intervention (4 Weeks)||14
1703185|NCT00427778|4164143|P1|STARTED|Second Intervention (4 Weeks)||10
1703186|NCT00427778|4164142|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
1703187|NCT00427778|4164143|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
1703188|NCT00427778|4164142|P2|COMPLETED|Wash Out (2 Weeks)||14
1703189|NCT00427778|4164143|P1|COMPLETED|Wash Out (2 Weeks)||10
1703190|NCT00427778|4164142|P2|STARTED|Wash Out (2 Weeks)||14
1703191|NCT00427778|4164143|P1|STARTED|Wash Out (2 Weeks)||10
1703192|NCT00427778|4164142|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
1703193|NCT00427778|4164143|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
1703194|NCT00427778|4164142|P2|COMPLETED|First Intervention (4 Weeks)||14
1703195|NCT00427778|4164143|P1|COMPLETED|First Intervention (4 Weeks)||10
1703196|NCT00427778|4164142|P2|STARTED|First Intervention (4 Weeks)||15
1703197|NCT00427778|4164143|P1|STARTED|First Intervention (4 Weeks)||14
1703198|NCT00427765|4164162|P1|NOT COMPLETED|Overall Study||0
1703199|NCT00427765|4164162|P1|COMPLETED|Overall Study||164
1703200|NCT00427765|4164162|P1|STARTED|Overall Study||164
1703201|NCT00427700|4164168|P2|NOT COMPLETED|Overall Study||11
1703202|NCT00427700|4164169|P1|NOT COMPLETED|Overall Study||3
1703203|NCT00427700|4164168|P2|COMPLETED|Overall Study||31
1703204|NCT00427700|4164169|P1|COMPLETED|Overall Study||37
1703205|NCT00427700|4164168|P2|STARTED|Overall Study||42
1703206|NCT00427700|4164169|P1|STARTED|Overall Study||40
1703207|NCT00427661|4164177|P1|NOT COMPLETED|Overall Study||0
1703208|NCT00427661|4164177|P1|COMPLETED|Overall Study||8
1703209|NCT00427661|4164177|P1|STARTED|Overall Study||8
1703210|NCT00427635|4164185|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
1703211|NCT00427635|4164186|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
1703212|NCT00427635|4164185|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
1703213|NCT00427635|4164186|P1|COMPLETED|Study Completion to Safety Follow-up||25
1703214|NCT00427635|4164185|P2|STARTED|Study Completion to Safety Follow-up||26
1703215|NCT00427635|4164186|P1|STARTED|Study Completion to Safety Follow-up||25
1703216|NCT00427635|4164185|P2|NOT COMPLETED|Treatment Phase||0
1703217|NCT00427635|4164186|P1|NOT COMPLETED|Treatment Phase||1
1703218|NCT00427635|4164185|P2|COMPLETED|Treatment Phase|ITT population|26
1703219|NCT00427635|4164186|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
1703220|NCT00427635|4164185|P2|STARTED|Treatment Phase|Randomised|26
1703221|NCT00427635|4164186|P1|STARTED|Treatment Phase|Randomised|26
1703222|NCT00427557|4164214|P1|NOT COMPLETED|Overall Study||0
1703223|NCT00427557|4164214|P1|COMPLETED|Overall Study||30
1703224|NCT00427557|4164214|P1|STARTED|Overall Study||30
1703225|NCT00427349|4164218|P1|NOT COMPLETED|Overall Study||46
1703226|NCT00427349|4164218|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
1703227|NCT00427349|4164218|P1|Eligible and Treated|Overall Study||44
1703228|NCT00427349|4164218|P1|Treated|Overall Study||45
1703229|NCT00427349|4164218|P1|Eligible|Overall Study||45
1703230|NCT00427349|4164218|P1|STARTED|Overall Study||46
1703231|NCT00427336|4164224|P1|NOT COMPLETED|Overall Study||0
1703232|NCT00427336|4164224|P1|COMPLETED|Overall Study||9
1703233|NCT00427336|4164224|P1|STARTED|Overall Study||9
1703234|NCT00427297|4164230|P2|NOT COMPLETED|Overall Study||0
1703235|NCT00427297|4164231|P1|NOT COMPLETED|Overall Study||0
1703236|NCT00427297|4164230|P2|COMPLETED|Overall Study||17
1703237|NCT00427297|4164231|P1|COMPLETED|Overall Study||17
1703238|NCT00427297|4164230|P2|STARTED|Overall Study||17
1703239|NCT00427297|4164231|P1|STARTED|Overall Study||17
1703240|NCT00427193|4164245|P2|NOT COMPLETED|Overall Study||4
1703241|NCT00427193|4164246|P1|NOT COMPLETED|Overall Study||26
1703242|NCT00427193|4164245|P2|COMPLETED|Overall Study||71
1703243|NCT00427193|4164246|P1|COMPLETED|Overall Study||117
1703244|NCT00427193|4164245|P2|STARTED|Overall Study||75
1703245|NCT00427193|4164246|P1|STARTED|Overall Study||143
1703246|NCT00427037|4164266|P2|NOT COMPLETED|Overall Study||7
1703247|NCT00427037|4164267|P1|NOT COMPLETED|Overall Study||7
1703248|NCT00427037|4164266|P2|COMPLETED|Overall Study||10
1703249|NCT00427037|4164267|P1|COMPLETED|Overall Study||10
1703250|NCT00427037|4164266|P2|STARTED|Overall Study||17
1703251|NCT00427037|4164267|P1|STARTED|Overall Study||17
1703252|NCT00427011|4164275|P1|NOT COMPLETED|Overall Study||25
1703253|NCT00427011|4164275|P1|COMPLETED|Overall Study||0
1703254|NCT00427011|4164275|P1|STARTED|Overall Study||25
1703255|NCT00426855|4164286|P1|NOT COMPLETED|Overall Study||0
1703256|NCT00426855|4164286|P1|COMPLETED|Overall Study||12
1703257|NCT00426855|4164286|P1|STARTED|Overall Study||12
1703258|NCT00426842|4164290|P1|NOT COMPLETED|Overall Study||1
1703259|NCT00426842|4164290|P1|COMPLETED|Overall Study||10
1703260|NCT00426842|4164290|P1|STARTED|Overall Study||11
1703261|NCT00426764|4164296|P1|NOT COMPLETED|Overall Study||98
1703262|NCT00426764|4164296|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6 (data cutoff of October 31 2010).|33
1703263|NCT00426764|4164296|P1|Received 6 or More Treatment Cycles|Overall Study||36
1703264|NCT00426764|4164296|P1|Received 4 or More Treatment Cycles|Overall Study||50
1703265|NCT00426764|4164296|P1|Histopathologically-Confirmed Population|Overall Study|Central histologic confirmation of peripheral T-cell lymphoma (PTCL).|130
1703266|NCT00426764|4164296|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
1703267|NCT00426751|4164312|P2|NOT COMPLETED|Overall Study||20
1703268|NCT00426751|4164313|P1|NOT COMPLETED|Overall Study||22
1703269|NCT00426751|4164312|P2|COMPLETED|Overall Study||183
1703270|NCT00426751|4164313|P1|COMPLETED|Overall Study||204
1703271|NCT00426751|4164312|P2|STARTED|Overall Study||203
1703272|NCT00426751|4164313|P1|STARTED|Overall Study||226
1703273|NCT00426660|4164357|P1|NOT COMPLETED|Overall Study||131
1703274|NCT00426660|4164357|P1|COMPLETED|Overall Study||916
1703275|NCT00426660|4164357|P1|Safety Analysis Set|Overall Study||1032
1703276|NCT00426660|4164357|P1|Treated|Overall Study||1032
1703277|NCT00426660|4164357|P1|STARTED|Overall Study||1047
1703278|NCT00426556|4164388|P4|NOT COMPLETED|Phase II - Extension Phase||23
1703279|NCT00426556|4164389|P3|NOT COMPLETED|Phase II - Extension Phase||0
1703280|NCT00426556|4164390|P2|NOT COMPLETED|Phase II - Extension Phase||0
1703281|NCT00426556|4164391|P1|NOT COMPLETED|Phase II - Extension Phase||0
1703282|NCT00426556|4164388|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
1703283|NCT00426556|4164389|P3|COMPLETED|Phase II - Extension Phase||0
1703284|NCT00426556|4164390|P2|COMPLETED|Phase II - Extension Phase||0
1703285|NCT00426556|4164391|P1|COMPLETED|Phase II - Extension Phase||0
1703286|NCT00426556|4164388|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
1703287|NCT00426556|4164389|P3|STARTED|Phase II - Extension Phase||0
1703288|NCT00426556|4164390|P2|STARTED|Phase II - Extension Phase||0
1703289|NCT00426556|4164391|P1|STARTED|Phase II - Extension Phase||0
1703290|NCT00426556|4164388|P4|NOT COMPLETED|Phase II - Core Phase||27
1703291|NCT00426556|4164389|P3|NOT COMPLETED|Phase II - Core Phase||0
1703292|NCT00426556|4164390|P2|NOT COMPLETED|Phase II - Core Phase||0
1703293|NCT00426556|4164391|P1|NOT COMPLETED|Phase II - Core Phase||0
1703294|NCT00426556|4164388|P4|COMPLETED|Phase II - Core Phase||28
1703295|NCT00426556|4164389|P3|COMPLETED|Phase II - Core Phase||0
1703296|NCT00426556|4164390|P2|COMPLETED|Phase II - Core Phase||0
1703297|NCT00426556|4164391|P1|COMPLETED|Phase II - Core Phase||0
1703298|NCT00426556|4164388|P4|STARTED|Phase II - Core Phase||55
1703299|NCT00426556|4164389|P3|STARTED|Phase II - Core Phase||0
1703300|NCT00426556|4164390|P2|STARTED|Phase II - Core Phase||0
1703301|NCT00426556|4164391|P1|STARTED|Phase II - Core Phase||0
1703302|NCT00426556|4164388|P4|NOT COMPLETED|Phase I - Extension Phase||0
1703303|NCT00426556|4164389|P3|NOT COMPLETED|Phase I - Extension Phase||7
1703304|NCT00426556|4164390|P2|NOT COMPLETED|Phase I - Extension Phase||6
1703305|NCT00426556|4164391|P1|NOT COMPLETED|Phase I - Extension Phase||5
1703306|NCT00426556|4164388|P4|COMPLETED|Phase I - Extension Phase||0
1703307|NCT00426556|4164389|P3|COMPLETED|Phase I - Extension Phase||0
1703308|NCT00426556|4164390|P2|COMPLETED|Phase I - Extension Phase||1
1703309|NCT00426556|4164391|P1|COMPLETED|Phase I - Extension Phase||0
1703310|NCT00426556|4164388|P4|STARTED|Phase I - Extension Phase||0
1703311|NCT00426556|4164389|P3|STARTED|Phase I - Extension Phase||7
1703312|NCT00426556|4164390|P2|STARTED|Phase I - Extension Phase||7
1703313|NCT00426556|4164391|P1|STARTED|Phase I - Extension Phase||5
1703314|NCT00426556|4164388|P4|NOT COMPLETED|Phase I - Core Phase||0
1703315|NCT00426556|4164389|P3|NOT COMPLETED|Phase I - Core Phase||3
1703316|NCT00426556|4164390|P2|NOT COMPLETED|Phase I - Core Phase||10
1703317|NCT00426556|4164391|P1|NOT COMPLETED|Phase I - Core Phase||1
1703318|NCT00426556|4164388|P4|COMPLETED|Phase I - Core Phase||0
1703319|NCT00426556|4164389|P3|COMPLETED|Phase I - Core Phase||7
1703320|NCT00426556|4164390|P2|COMPLETED|Phase I - Core Phase||7
1703321|NCT00426556|4164391|P1|COMPLETED|Phase I - Core Phase||5
1703322|NCT00426556|4164388|P4|STARTED|Phase I - Core Phase||0
1703323|NCT00426556|4164389|P3|STARTED|Phase I - Core Phase||10
1703324|NCT00426556|4164390|P2|STARTED|Phase I - Core Phase||17
1703325|NCT00426556|4164391|P1|STARTED|Phase I - Core Phase||6
1703326|NCT00426361|4164416|P3|NOT COMPLETED|Overall Study||5
1703327|NCT00426361|4164417|P2|NOT COMPLETED|Overall Study||5
1703328|NCT00426361|4164418|P1|NOT COMPLETED|Overall Study||4
1703329|NCT00426361|4164416|P3|COMPLETED|Overall Study||243
1703330|NCT00426361|4164417|P2|COMPLETED|Overall Study||250
1703331|NCT00426361|4164418|P1|COMPLETED|Overall Study||244
1703332|NCT00426361|4164416|P3|STARTED|Overall Study||248
1703333|NCT00426361|4164417|P2|STARTED|Overall Study||255
1703334|NCT00426361|4164418|P1|STARTED|Overall Study||248
1703335|NCT00426283|4164470|P2|NOT COMPLETED|Overall Study||1
1703336|NCT00426283|4164471|P1|NOT COMPLETED|Overall Study||5
1703337|NCT00426283|4164470|P2|COMPLETED|Overall Study||13
1703338|NCT00426283|4164471|P1|COMPLETED|Overall Study||23
1703339|NCT00426283|4164470|P2|STARTED|Overall Study||14
1703340|NCT00426283|4164471|P1|STARTED|Overall Study||28
1703341|NCT00426270|4164477|P1|NOT COMPLETED|Overall Study||6
1703342|NCT00426270|4164477|P1|COMPLETED|Overall Study||110
1703343|NCT00426270|4164477|P1|STARTED|Overall Study||116
1703344|NCT00426231|4164487|P2|NOT COMPLETED|Overall Study||12
1703345|NCT00426231|4164488|P1|NOT COMPLETED|Overall Study||9
1703346|NCT00426231|4164487|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
1703347|NCT00426231|4164488|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
1703348|NCT00426231|4164487|P2|STARTED|Overall Study||37
1703349|NCT00426231|4164488|P1|STARTED|Overall Study||36
1703350|NCT00426153|4164498|P2|NOT COMPLETED|Overall Study||0
1703351|NCT00426153|4164499|P1|NOT COMPLETED|Overall Study||0
1703352|NCT00426153|4164498|P2|COMPLETED|Overall Study||14
1703353|NCT00426153|4164499|P1|COMPLETED|Overall Study||28
1703354|NCT00426153|4164498|P2|STARTED|Overall Study||14
1703355|NCT00426153|4164499|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
1703356|NCT00426127|4164511|P1|NOT COMPLETED|Overall Study||2
1703357|NCT00426127|4164511|P1|COMPLETED|Overall Study||0
1703358|NCT00426127|4164511|P1|STARTED|Overall Study||2
1703359|NCT00425945|4164519|P2|NOT COMPLETED|Overall Study||5
1703360|NCT00425945|4164520|P1|NOT COMPLETED|Overall Study||4
1703361|NCT00425945|4164519|P2|COMPLETED|Overall Study||61
1703362|NCT00425945|4164520|P1|COMPLETED|Overall Study||60
1703363|NCT00425945|4164519|P2|STARTED|Overall Study||66
1703364|NCT00425945|4164520|P1|STARTED|Overall Study||64
1703365|NCT00425854|4164558|P2|NOT COMPLETED|Overall Study||21
1703366|NCT00425854|4164559|P1|NOT COMPLETED|Overall Study||29
1703367|NCT00425854|4164558|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
1703368|NCT00425854|4164559|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
1703369|NCT00425854|4164558|P2|STARTED|Overall Study|Treated|21
1703370|NCT00425854|4164559|P1|STARTED|Overall Study|Treated|29
1703371|NCT00425802|4164580|P1|NOT COMPLETED|Overall Study||0
1703372|NCT00425802|4164580|P1|COMPLETED|Overall Study||61
1703373|NCT00425802|4164580|P1|STARTED|Overall Study||61
1703374|NCT00425750|4164592|P1|NOT COMPLETED|Overall Study||25
1703375|NCT00425750|4164592|P1|COMPLETED|Overall Study||0
1703376|NCT00425750|4164592|P1|STARTED|Overall Study||25
1703377|NCT00425698|4164600|P2|NOT COMPLETED|Overall Study||2
1703378|NCT00425698|4164601|P1|NOT COMPLETED|Overall Study||3
1703379|NCT00425698|4164600|P2|COMPLETED|Overall Study||42
1703380|NCT00425698|4164601|P1|COMPLETED|Overall Study||41
1703381|NCT00425698|4164600|P2|STARTED|Overall Study||44
1703382|NCT00425698|4164601|P1|STARTED|Overall Study||44
1703383|NCT00425672|4164607|P1|NOT COMPLETED|Overall Study||1
1703384|NCT00425672|4164607|P1|COMPLETED|Overall Study||14
1703385|NCT00425672|4164607|P1|STARTED|Overall Study||15
1703386|NCT00425607|4164616|P1|NOT COMPLETED|Overall Study||2
1703387|NCT00425607|4164616|P1|COMPLETED|Overall Study||27
1703388|NCT00425607|4164616|P1|Received Treatment|Overall Study||28
1703389|NCT00425607|4164616|P1|STARTED|Overall Study||29
1703390|NCT00425503|4164620|P1|NOT COMPLETED|Overall Study||3
1703391|NCT00425503|4164620|P1|COMPLETED|Overall Study||37
1703392|NCT00425503|4164620|P1|STARTED|Overall Study||40
1703393|NCT00425477|4164624|P1|NOT COMPLETED|Overall Study||13
1703394|NCT00425477|4164624|P1|COMPLETED|Overall Study||13
1703395|NCT00425477|4164624|P1|STARTED|Overall Study||26
1703396|NCT00425438|4164632|P2|NOT COMPLETED|Overall Study||27
1703397|NCT00425438|4164633|P1|NOT COMPLETED|Overall Study||25
1703398|NCT00425438|4164632|P2|COMPLETED|Overall Study||0
1703399|NCT00425438|4164633|P1|COMPLETED|Overall Study||0
1703400|NCT00425438|4164632|P2|STARTED|Overall Study||27
1703401|NCT00425438|4164633|P1|STARTED|Overall Study||25
1703402|NCT00425386|4164649|P1|NOT COMPLETED|Overall Study||3
1703403|NCT00425386|4164649|P1|COMPLETED|Overall Study||43
1703404|NCT00425386|4164649|P1|STARTED|Overall Study||46
1703405|NCT00425373|4164667|P9|NOT COMPLETED|Overall Study||18
1703406|NCT00425373|4164668|P8|NOT COMPLETED|Overall Study||10
1703407|NCT00425373|4164669|P7|NOT COMPLETED|Overall Study||7
1703408|NCT00425373|4164670|P6|NOT COMPLETED|Overall Study||9
1703409|NCT00425373|4164671|P5|NOT COMPLETED|Overall Study||10
1703410|NCT00425373|4164672|P4|NOT COMPLETED|Overall Study||2
1703411|NCT00425373|4164673|P3|NOT COMPLETED|Overall Study||3
1703412|NCT00425373|4164674|P2|NOT COMPLETED|Overall Study||3
1703413|NCT00425373|4164675|P1|NOT COMPLETED|Overall Study||5
1703414|NCT00425373|4164667|P9|COMPLETED|Overall Study||148
1703415|NCT00425373|4164668|P8|COMPLETED|Overall Study||151
1703416|NCT00425373|4164669|P7|COMPLETED|Overall Study||154
1703417|NCT00425373|4164670|P6|COMPLETED|Overall Study||154
1703418|NCT00425373|4164671|P5|COMPLETED|Overall Study||159
1703419|NCT00425373|4164672|P4|COMPLETED|Overall Study||160
1703420|NCT00425373|4164673|P3|COMPLETED|Overall Study||157
1703421|NCT00425373|4164674|P2|COMPLETED|Overall Study||164
1703422|NCT00425373|4164675|P1|COMPLETED|Overall Study||154
1703423|NCT00425373|4164667|P9|STARTED|Overall Study||166
1703424|NCT00425373|4164668|P8|STARTED|Overall Study||161
1703425|NCT00425373|4164669|P7|STARTED|Overall Study||161
1703426|NCT00425373|4164670|P6|STARTED|Overall Study||163
1703427|NCT00425373|4164671|P5|STARTED|Overall Study||169
1703428|NCT00425373|4164672|P4|STARTED|Overall Study||162
1703429|NCT00425373|4164673|P3|STARTED|Overall Study||160
1703430|NCT00425373|4164674|P2|STARTED|Overall Study||167
1703431|NCT00425373|4164675|P1|STARTED|Overall Study||159
1703432|NCT00425308|4164733|P2|NOT COMPLETED|Overall Study||1
1703433|NCT00425308|4164734|P1|NOT COMPLETED|Overall Study||4
1703434|NCT00425308|4164733|P2|COMPLETED|Overall Study||14
1703435|NCT00425308|4164734|P1|COMPLETED|Overall Study||11
1703436|NCT00425308|4164733|P2|STARTED|Overall Study||15
1703437|NCT00425308|4164734|P1|STARTED|Overall Study||15
1703438|NCT00425269|4164764|P2|NOT COMPLETED|Overall Study||20
1703439|NCT00425269|4164765|P1|NOT COMPLETED|Overall Study||19
1703440|NCT00425269|4164764|P2|COMPLETED|Overall Study||77
1703441|NCT00425269|4164765|P1|COMPLETED|Overall Study||82
1703442|NCT00425269|4164764|P2|STARTED|Overall Study||97
1703443|NCT00425269|4164765|P1|STARTED|Overall Study||101
1703444|NCT00425113|4164843|P2|NOT COMPLETED|Overall Study||2
1703445|NCT00425113|4164844|P1|NOT COMPLETED|Overall Study||2
1703446|NCT00425113|4164843|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
1703447|NCT00425113|4164844|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
1703448|NCT00425113|4164843|P2|Exposed to Study Drug|Overall Study||17
1703449|NCT00425113|4164844|P1|Exposed to Study Drug|Overall Study||16
1703450|NCT00425113|4164843|P2|STARTED|Overall Study||18
1703451|NCT00425113|4164844|P1|STARTED|Overall Study||17
1703452|NCT00425100|4164852|P1|NOT COMPLETED|Overall Study||53
1703453|NCT00425100|4164852|P1|COMPLETED|Overall Study||463
1703454|NCT00425100|4164852|P1|STARTED|Overall Study||516
1703455|NCT00425061|4164896|P7|NOT COMPLETED|Overall Study||19
1703456|NCT00425061|4164897|P6|NOT COMPLETED|Overall Study||4
1703457|NCT00425061|4164898|P5|NOT COMPLETED|Overall Study||26
1703458|NCT00425061|4164899|P4|NOT COMPLETED|Overall Study||2
1703459|NCT00425061|4164900|P3|NOT COMPLETED|Overall Study||0
1703460|NCT00425061|4164901|P2|NOT COMPLETED|Overall Study||2
1703461|NCT00425061|4164902|P1|NOT COMPLETED|Overall Study||2
1703462|NCT00425061|4164896|P7|COMPLETED|Overall Study||26
1703463|NCT00425061|4164897|P6|COMPLETED|Overall Study||0
1703464|NCT00425061|4164898|P5|COMPLETED|Overall Study||19
1703465|NCT00425061|4164899|P4|COMPLETED|Overall Study||14
1703466|NCT00425061|4164900|P3|COMPLETED|Overall Study||16
1703467|NCT00425061|4164901|P2|COMPLETED|Overall Study||15
1703468|NCT00425061|4164902|P1|COMPLETED|Overall Study||14
1703469|NCT00425061|4164896|P7|STARTED|Overall Study||45
1703470|NCT00425061|4164897|P6|STARTED|Overall Study||4
1703471|NCT00425061|4164898|P5|STARTED|Overall Study||45
1703472|NCT00425061|4164899|P4|STARTED|Overall Study||16
1703473|NCT00425061|4164900|P3|STARTED|Overall Study||16
1703474|NCT00425061|4164901|P2|STARTED|Overall Study||17
1703475|NCT00425061|4164902|P1|STARTED|Overall Study||16
1703476|NCT00424827|4165018|P1|NOT COMPLETED|Overall Study||1
1703477|NCT00424827|4165018|P1|COMPLETED|Overall Study||10
1703478|NCT00424827|4165018|P1|STARTED|Overall Study||11
1703479|NCT00424775|4165026|P2|NOT COMPLETED|Overall Study||0
1703480|NCT00424775|4165027|P1|NOT COMPLETED|Overall Study||3
1703481|NCT00424775|4165026|P2|COMPLETED|Overall Study||0
1703482|NCT00424775|4165027|P1|COMPLETED|Overall Study||0
1703483|NCT00424775|4165026|P2|STARTED|Overall Study||0
1703484|NCT00424775|4165027|P1|STARTED|Overall Study||3
1703485|NCT00424762|4165037|P2|NOT COMPLETED|Overall Study||22
1703486|NCT00424762|4165038|P1|NOT COMPLETED|Overall Study||20
1703487|NCT00424762|4165037|P2|COMPLETED|Overall Study||54
1703488|NCT00424762|4165038|P1|COMPLETED|Overall Study||54
1703489|NCT00424762|4165037|P2|STARTED|Overall Study||76
1703490|NCT00424762|4165038|P1|STARTED|Overall Study||74
1703491|NCT00424749|4165048|P1|NOT COMPLETED|Overall Study||1
1703492|NCT00424749|4165048|P1|COMPLETED|Overall Study||3
1703493|NCT00424749|4165048|P1|STARTED|Overall Study||4
1703494|NCT00424645|4165055|P2|NOT COMPLETED|Overall Study||0
1703495|NCT00424645|4165056|P1|NOT COMPLETED|Overall Study||1
1703496|NCT00424645|4165055|P2|COMPLETED|Overall Study||0
1703497|NCT00424645|4165056|P1|COMPLETED|Overall Study||2
1703498|NCT00424645|4165055|P2|STARTED|Overall Study||0
1703499|NCT00424645|4165056|P1|STARTED|Overall Study||3
1703500|NCT00424632|4165064|P10|NOT COMPLETED|Overall Study||6
1703501|NCT00424632|4165065|P9|NOT COMPLETED|Overall Study||16
1703502|NCT00424632|4165066|P8|NOT COMPLETED|Overall Study||3
1703503|NCT00424632|4165067|P7|NOT COMPLETED|Overall Study||7
1703504|NCT00424632|4165068|P6|NOT COMPLETED|Overall Study||15
1703505|NCT00424632|4165069|P5|NOT COMPLETED|Overall Study||3
1703506|NCT00424632|4165070|P4|NOT COMPLETED|Overall Study||4
1703507|NCT00424632|4165071|P3|NOT COMPLETED|Overall Study||1
1703508|NCT00424632|4165072|P2|NOT COMPLETED|Overall Study||1
1703509|NCT00424632|4165073|P1|NOT COMPLETED|Overall Study||1
1703510|NCT00424632|4165064|P10|COMPLETED|Overall Study||0
1703511|NCT00424632|4165065|P9|COMPLETED|Overall Study||0
1703512|NCT00424632|4165066|P8|COMPLETED|Overall Study||0
1703513|NCT00424632|4165067|P7|COMPLETED|Overall Study||0
1703514|NCT00424632|4165068|P6|COMPLETED|Overall Study||0
1703515|NCT00424632|4165069|P5|COMPLETED|Overall Study||0
1703516|NCT00424632|4165070|P4|COMPLETED|Overall Study||0
1703517|NCT00424632|4165071|P3|COMPLETED|Overall Study||0
1703518|NCT00424632|4165072|P2|COMPLETED|Overall Study||0
1703519|NCT00424632|4165073|P1|COMPLETED|Overall Study||0
1703520|NCT00424632|4165064|P10|STARTED|Overall Study||6
1703521|NCT00424632|4165065|P9|STARTED|Overall Study||16
1703522|NCT00424632|4165066|P8|STARTED|Overall Study||3
1703523|NCT00424632|4165067|P7|STARTED|Overall Study||7
1703524|NCT00424632|4165068|P6|STARTED|Overall Study||15
1703525|NCT00424632|4165069|P5|STARTED|Overall Study||3
1703526|NCT00424632|4165070|P4|STARTED|Overall Study||4
1703527|NCT00424632|4165071|P3|STARTED|Overall Study||1
1703528|NCT00424632|4165072|P2|STARTED|Overall Study||1
1703529|NCT00424632|4165073|P1|STARTED|Overall Study||1
1703530|NCT00424619|4165207|P3|NOT COMPLETED|3 Month||0
1703531|NCT00424619|4165208|P2|NOT COMPLETED|3 Month||0
1703532|NCT00424619|4165209|P1|NOT COMPLETED|3 Month||0
1703533|NCT00424619|4165207|P3|COMPLETED|3 Month||17
1703534|NCT00424619|4165208|P2|COMPLETED|3 Month||18
1703535|NCT00424619|4165209|P1|COMPLETED|3 Month||12
1703536|NCT00424619|4165207|P3|STARTED|3 Month||17
1703537|NCT00424619|4165208|P2|STARTED|3 Month||18
1703538|NCT00424619|4165209|P1|STARTED|3 Month||12
1703539|NCT00424619|4165207|P3|NOT COMPLETED|4 Week||0
1703540|NCT00424619|4165208|P2|NOT COMPLETED|4 Week||0
1703541|NCT00424619|4165209|P1|NOT COMPLETED|4 Week||0
1703542|NCT00424619|4165207|P3|COMPLETED|4 Week||17
1703543|NCT00424619|4165208|P2|COMPLETED|4 Week||17
1703544|NCT00424619|4165209|P1|COMPLETED|4 Week||18
1703545|NCT00424619|4165207|P3|STARTED|4 Week||17
1703546|NCT00424619|4165208|P2|STARTED|4 Week||17
1703547|NCT00424619|4165209|P1|STARTED|4 Week||18
1703548|NCT00424619|4165207|P3|NOT COMPLETED|Baseline||1
1703549|NCT00424619|4165208|P2|NOT COMPLETED|Baseline||0
1703550|NCT00424619|4165209|P1|NOT COMPLETED|Baseline||0
1703551|NCT00424619|4165207|P3|COMPLETED|Baseline||20
1703552|NCT00424619|4165208|P2|COMPLETED|Baseline||22
1703553|NCT00424619|4165209|P1|COMPLETED|Baseline||22
1703554|NCT00424619|4165207|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
1703555|NCT00424619|4165208|P2|STARTED|Baseline||22
1703556|NCT00424619|4165209|P1|STARTED|Baseline||22
1703557|NCT00424593|4165243|P2|NOT COMPLETED|Dose-Blind Extension Period||0
1703558|NCT00424593|4165244|P1|NOT COMPLETED|Dose-Blind Extension Period||64
1703559|NCT00424593|4165243|P2|COMPLETED|Dose-Blind Extension Period||0
1703560|NCT00424593|4165244|P1|COMPLETED|Dose-Blind Extension Period||117
1703561|NCT00424593|4165243|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
1703562|NCT00424593|4165244|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
1703563|NCT00424593|4165243|P2|NOT COMPLETED|Acute Double-Blind Period||23
1703564|NCT00424593|4165244|P1|NOT COMPLETED|Acute Double-Blind Period||31
1703565|NCT00424593|4165243|P2|COMPLETED|Acute Double-Blind Period||98
1703566|NCT00424593|4165244|P1|COMPLETED|Acute Double-Blind Period||84
1703567|NCT00424593|4165243|P2|STARTED|Acute Double-Blind Period||121
1703568|NCT00424593|4165244|P1|STARTED|Acute Double-Blind Period||115
1703569|NCT00424554|4165290|P2|NOT COMPLETED|Overall Study||0
1703570|NCT00424554|4165291|P1|NOT COMPLETED|Overall Study||0
1703571|NCT00424554|4165290|P2|COMPLETED|Overall Study||6
1703572|NCT00424554|4165291|P1|COMPLETED|Overall Study||34
1703573|NCT00424554|4165290|P2|STARTED|Overall Study||6
1703574|NCT00424554|4165291|P1|STARTED|Overall Study||34
1703575|NCT00424528|4165308|P3|NOT COMPLETED|Overall Study||4
1703576|NCT00424528|4165309|P2|NOT COMPLETED|Overall Study||4
1703577|NCT00424528|4165310|P1|NOT COMPLETED|Overall Study||5
1703578|NCT00424528|4165308|P3|COMPLETED|Overall Study||74
1703579|NCT00424528|4165309|P2|COMPLETED|Overall Study||76
1703580|NCT00424528|4165310|P1|COMPLETED|Overall Study||71
1703581|NCT00424528|4165308|P3|STARTED|Overall Study||78
1703582|NCT00424528|4165309|P2|STARTED|Overall Study||80
1703583|NCT00424528|4165310|P1|STARTED|Overall Study||76
1703584|NCT00424515|4165365|P2|NOT COMPLETED|Overall Study||13
1703585|NCT00424515|4165366|P1|NOT COMPLETED|Overall Study||11
1703586|NCT00424515|4165365|P2|COMPLETED|Overall Study||0
1703587|NCT00424515|4165366|P1|COMPLETED|Overall Study||0
1703588|NCT00424515|4165365|P2|STARTED|Overall Study||13
1703589|NCT00424515|4165366|P1|STARTED|Overall Study||11
1703590|NCT00424502|4165376|P1|NOT COMPLETED|Overall Study||0
1703591|NCT00424502|4165376|P1|COMPLETED|Overall Study||20
1703592|NCT00424502|4165376|P1|STARTED|Overall Study||20
1703593|NCT00424489|4165385|P1|NOT COMPLETED|Overall Study||3
1703594|NCT00424489|4165385|P1|COMPLETED|Overall Study||6
1703595|NCT00424489|4165385|P1|STARTED|Overall Study||9
1703596|NCT00424476|4165392|P3|NOT COMPLETED|Overall Study||49
1703597|NCT00424476|4165393|P2|NOT COMPLETED|Overall Study||48
1703598|NCT00424476|4165394|P1|NOT COMPLETED|Overall Study||61
1703599|NCT00424476|4165392|P3|COMPLETED|Overall Study||241
1703600|NCT00424476|4165393|P2|COMPLETED|Overall Study||240
1703601|NCT00424476|4165394|P1|COMPLETED|Overall Study||226
1703602|NCT00424476|4165392|P3|STARTED|Overall Study||290
1703603|NCT00424476|4165393|P2|STARTED|Overall Study||288
1703604|NCT00424476|4165394|P1|STARTED|Overall Study||287
1703605|NCT00424463|4165420|P3|NOT COMPLETED|Overall Study||16
1703606|NCT00424463|4165421|P2|NOT COMPLETED|Overall Study||14
1703607|NCT00424463|4165422|P1|NOT COMPLETED|Overall Study||7
1703608|NCT00424463|4165420|P3|COMPLETED|Overall Study||72
1703609|NCT00424463|4165421|P2|COMPLETED|Overall Study||34
1703610|NCT00424463|4165422|P1|COMPLETED|Overall Study||38
1703611|NCT00424463|4165420|P3|STARTED|Overall Study||88
1703612|NCT00424463|4165421|P2|STARTED|Overall Study||48
1703613|NCT00424463|4165422|P1|STARTED|Overall Study||45
1703614|NCT00424398|4165451|P3|NOT COMPLETED|Overall Study||0
1703615|NCT00424398|4165452|P2|NOT COMPLETED|Overall Study||1
1703616|NCT00424398|4165453|P1|NOT COMPLETED|Overall Study||3
1703617|NCT00424398|4165451|P3|COMPLETED|Overall Study||36
1703618|NCT00424398|4165452|P2|COMPLETED|Overall Study||35
1703619|NCT00424398|4165453|P1|COMPLETED|Overall Study||32
1703620|NCT00424398|4165451|P3|STARTED|Overall Study||36
1703621|NCT00424398|4165452|P2|STARTED|Overall Study||36
1703622|NCT00424398|4165453|P1|STARTED|Overall Study||35
1703623|NCT00424385|4165497|P1|NOT COMPLETED|Cohort 1||1
1703624|NCT00424385|4165497|P1|COMPLETED|Cohort 1||4
1703625|NCT00424385|4165497|P1|STARTED|Cohort 1||5
1703626|NCT00424385|4165497|P1|NOT COMPLETED|Cohort 0||6
1703627|NCT00424385|4165497|P1|COMPLETED|Cohort 0||6
1703628|NCT00424385|4165497|P1|STARTED|Cohort 0||12
1703629|NCT00424372|4165504|P1|NOT COMPLETED|Overall Study||31
1703630|NCT00424372|4165504|P1|COMPLETED|Overall Study||95
1703631|NCT00424372|4165504|P1|STARTED|Overall Study||126
1703632|NCT00424346|4165516|P4|NOT COMPLETED|Extension Phase||55
1703633|NCT00424346|4165517|P3|NOT COMPLETED|Extension Phase||55
1703634|NCT00424346|4165518|P2|NOT COMPLETED|Extension Phase||102
1703635|NCT00424346|4165519|P1|NOT COMPLETED|Extension Phase||0
1703636|NCT00424346|4165516|P4|COMPLETED|Extension Phase||3
1703637|NCT00424346|4165517|P3|COMPLETED|Extension Phase||4
1703638|NCT00424346|4165518|P2|COMPLETED|Extension Phase||8
1703639|NCT00424346|4165519|P1|COMPLETED|Extension Phase||0
1703640|NCT00424346|4165516|P4|STARTED|Extension Phase||58
1703641|NCT00424346|4165517|P3|STARTED|Extension Phase||59
1703642|NCT00424346|4165518|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
1703643|NCT00424346|4165519|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
1703644|NCT00424346|4165516|P4|NOT COMPLETED|Core Study||7
1703645|NCT00424346|4165517|P3|NOT COMPLETED|Core Study||4
1703646|NCT00424346|4165518|P2|NOT COMPLETED|Core Study||8
1703647|NCT00424346|4165519|P1|NOT COMPLETED|Core Study||9
1703648|NCT00424346|4165516|P4|COMPLETED|Core Study||63
1703649|NCT00424346|4165517|P3|COMPLETED|Core Study||65
1703650|NCT00424346|4165518|P2|COMPLETED|Core Study||56
1703651|NCT00424346|4165519|P1|COMPLETED|Core Study||62
1703652|NCT00424346|4165516|P4|STARTED|Core Study||70
1703653|NCT00424346|4165517|P3|STARTED|Core Study||69
1703654|NCT00424346|4165518|P2|STARTED|Core Study||64
1703655|NCT00424346|4165519|P1|STARTED|Core Study||71
1703656|NCT00424294|4165634|P2|NOT COMPLETED|Overall Study||15
1703657|NCT00424294|4165635|P1|NOT COMPLETED|Overall Study||8
1703658|NCT00424294|4165634|P2|COMPLETED|Overall Study||19
1703659|NCT00424294|4165635|P1|COMPLETED|Overall Study||28
1703660|NCT00424294|4165634|P2|Treated|Overall Study||34
1703661|NCT00424294|4165635|P1|Treated|Overall Study||35
1703662|NCT00424294|4165634|P2|STARTED|Overall Study||34
1703663|NCT00424294|4165635|P1|STARTED|Overall Study||36
1703664|NCT00424268|4165685|P2|NOT COMPLETED|Overall Study||39
1703665|NCT00424268|4165686|P1|NOT COMPLETED|Overall Study||62
1703666|NCT00424268|4165685|P2|COMPLETED|Overall Study||333
1703667|NCT00424268|4165686|P1|COMPLETED|Overall Study||309
1703668|NCT00424268|4165685|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
1703669|NCT00424268|4165686|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
1703670|NCT00424255|4165702|P2|NOT COMPLETED|Overall Study||346
1703671|NCT00424255|4165703|P1|NOT COMPLETED|Overall Study||342
1703672|NCT00424255|4165702|P2|COMPLETED|Overall Study||0
1703673|NCT00424255|4165703|P1|COMPLETED|Overall Study||0
1703674|NCT00424255|4165702|P2|STARTED|Overall Study||346
1703675|NCT00424255|4165703|P1|STARTED|Overall Study||342
1703676|NCT00424190|4165751|P2|NOT COMPLETED|Overall Study||30
1703677|NCT00424190|4165752|P1|NOT COMPLETED|Overall Study||22
1703678|NCT00424190|4165751|P2|COMPLETED|Overall Study||317
1703679|NCT00424190|4165752|P1|COMPLETED|Overall Study||329
1703680|NCT00424190|4165751|P2|STARTED|Overall Study||347
1703681|NCT00424190|4165752|P1|STARTED|Overall Study||351
1703682|NCT00424177|4165758|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
1703683|NCT00424177|4165758|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
1703684|NCT00424177|4165758|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
1703685|NCT00424177|4165758|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
1703686|NCT00424177|4165758|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
1703687|NCT00424177|4165758|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
1703688|NCT00424177|4165758|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
1703689|NCT00424177|4165758|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
1703690|NCT00424177|4165758|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
1703691|NCT00424047|4165787|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
1703692|NCT00424047|4165788|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
1703693|NCT00424047|4165787|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
1703694|NCT00424047|4165788|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
1703695|NCT00424047|4165787|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
1703696|NCT00424047|4165788|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
1703697|NCT00424047|4165787|P2|NOT COMPLETED|On Study at Time of Unblinding||167
1703698|NCT00424047|4165788|P1|NOT COMPLETED|On Study at Time of Unblinding||155
1703699|NCT00424047|4165787|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
1703700|NCT00424047|4165788|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
1703701|NCT00424047|4165787|P2|STARTED|On Study at Time of Unblinding||175
1703702|NCT00424047|4165788|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
1703703|NCT00424047|4165787|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
1703704|NCT00424047|4165788|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
1703705|NCT00424047|4165787|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
1703706|NCT00424047|4165788|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
1703707|NCT00424047|4165787|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
1703708|NCT00424047|4165788|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
1703709|NCT00424047|4165787|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
1703710|NCT00424047|4165788|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
1703711|NCT00424047|4165787|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
1703712|NCT00424047|4165788|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
1703713|NCT00424021|4165820|P4|NOT COMPLETED|AMB-220-E Study Period||10
1703714|NCT00424021|4165821|P3|NOT COMPLETED|AMB-220-E Study Period||5
1703715|NCT00424021|4165822|P2|NOT COMPLETED|AMB-220-E Study Period||2
1703716|NCT00424021|4165823|P1|NOT COMPLETED|AMB-220-E Study Period||1
1703717|NCT00424021|4165820|P4|COMPLETED|AMB-220-E Study Period||16
1703718|NCT00424021|4165821|P3|COMPLETED|AMB-220-E Study Period||14
1703719|NCT00424021|4165822|P2|COMPLETED|AMB-220-E Study Period||5
1703720|NCT00424021|4165823|P1|COMPLETED|AMB-220-E Study Period||1
1703721|NCT00424021|4165820|P4|STARTED|AMB-220-E Study Period||26
1703722|NCT00424021|4165821|P3|STARTED|AMB-220-E Study Period||19
1703723|NCT00424021|4165822|P2|STARTED|AMB-220-E Study Period||7
1703724|NCT00424021|4165823|P1|STARTED|AMB-220-E Study Period||2
1703725|NCT00424021|4165820|P4|NOT COMPLETED|NCT00046319 Study Period||1
1703726|NCT00424021|4165821|P3|NOT COMPLETED|NCT00046319 Study Period||1
1703727|NCT00424021|4165822|P2|NOT COMPLETED|NCT00046319 Study Period||3
1703728|NCT00424021|4165823|P1|NOT COMPLETED|NCT00046319 Study Period||1
1703729|NCT00424021|4165820|P4|COMPLETED|NCT00046319 Study Period||12
1703730|NCT00424021|4165821|P3|COMPLETED|NCT00046319 Study Period||15
1703731|NCT00424021|4165822|P2|COMPLETED|NCT00046319 Study Period||16
1703732|NCT00424021|4165823|P1|COMPLETED|NCT00046319 Study Period||15
1703733|NCT00424021|4165820|P4|STARTED|NCT00046319 Study Period||13
1703734|NCT00424021|4165821|P3|STARTED|NCT00046319 Study Period||16
1703735|NCT00424021|4165822|P2|STARTED|NCT00046319 Study Period||19
1703736|NCT00424021|4165823|P1|STARTED|NCT00046319 Study Period||16
1703737|NCT00424008|4165866|P2|NOT COMPLETED|Overall Study||335
1703738|NCT00424008|4165867|P1|NOT COMPLETED|Overall Study||349
1703739|NCT00424008|4165866|P2|COMPLETED|Overall Study||16
1703740|NCT00424008|4165867|P1|COMPLETED|Overall Study||22
1703741|NCT00424008|4165866|P2|STARTED|Overall Study||351
1703742|NCT00424008|4165867|P1|STARTED|Overall Study||371
1703743|NCT00423943|4165882|P2|NOT COMPLETED|Overall Study||1
1703744|NCT00423943|4165883|P1|NOT COMPLETED|Overall Study||3
1703745|NCT00423943|4165882|P2|COMPLETED|Overall Study||13
1703746|NCT00423943|4165883|P1|COMPLETED|Overall Study||16
1703747|NCT00423943|4165882|P2|STARTED|Overall Study||14
1703748|NCT00423943|4165883|P1|STARTED|Overall Study||19
1703749|NCT00423930|4165897|P1|NOT COMPLETED|Overall Study||2
1703750|NCT00423930|4165897|P1|COMPLETED|Overall Study||42
1703751|NCT00423930|4165897|P1|STARTED|Overall Study||44
1703752|NCT00423917|4165902|P1|NOT COMPLETED|Overall Study||3
1703753|NCT00423917|4165902|P1|COMPLETED|Overall Study||33
1703754|NCT00423917|4165902|P1|STARTED|Overall Study||36
1703755|NCT00423891|4165915|P3|NOT COMPLETED|Post-Dosing Follow Up||2
1703756|NCT00423891|4165916|P2|NOT COMPLETED|Post-Dosing Follow Up||3
1703757|NCT00423891|4165917|P1|NOT COMPLETED|Post-Dosing Follow Up||2
1703758|NCT00423891|4165915|P3|COMPLETED|Post-Dosing Follow Up||3
1703759|NCT00423891|4165916|P2|COMPLETED|Post-Dosing Follow Up||15
1703760|NCT00423891|4165917|P1|COMPLETED|Post-Dosing Follow Up||20
1703761|NCT00423891|4165915|P3|STARTED|Post-Dosing Follow Up||5
1703762|NCT00423891|4165916|P2|STARTED|Post-Dosing Follow Up||18
1703763|NCT00423891|4165917|P1|STARTED|Post-Dosing Follow Up||22
1703764|NCT00423891|4165915|P3|NOT COMPLETED|Treatment||0
1703765|NCT00423891|4165916|P2|NOT COMPLETED|Treatment||0
1703766|NCT00423891|4165917|P1|NOT COMPLETED|Treatment||2
1703767|NCT00423891|4165915|P3|COMPLETED|Treatment||5
1703768|NCT00423891|4165916|P2|COMPLETED|Treatment||19
1703769|NCT00423891|4165917|P1|COMPLETED|Treatment||22
1703770|NCT00423891|4165915|P3|STARTED|Treatment||5
1703771|NCT00423891|4165916|P2|STARTED|Treatment||19
1703772|NCT00423891|4165917|P1|STARTED|Treatment||24
1703773|NCT00423891|4165915|P3|NOT COMPLETED|Enrolled||3
1703774|NCT00423891|4165916|P2|NOT COMPLETED|Enrolled||2
1703775|NCT00423891|4165917|P1|NOT COMPLETED|Enrolled||11
1703776|NCT00423891|4165915|P3|COMPLETED|Enrolled||5
1703777|NCT00423891|4165916|P2|COMPLETED|Enrolled||19
1703778|NCT00423891|4165917|P1|COMPLETED|Enrolled||24
1703779|NCT00423891|4165915|P3|STARTED|Enrolled||8
1703780|NCT00423891|4165916|P2|STARTED|Enrolled||21
1703781|NCT00423891|4165917|P1|STARTED|Enrolled||35
1703782|NCT00423878|4165986|P2|NOT COMPLETED|Overall Study||8
1703783|NCT00423878|4165987|P1|NOT COMPLETED|Overall Study||20
1703784|NCT00423878|4165986|P2|COMPLETED|Overall Study||98
1703785|NCT00423878|4165987|P1|COMPLETED|Overall Study||89
1703786|NCT00423878|4165986|P2|STARTED|Overall Study||106
1703787|NCT00423878|4165987|P1|STARTED|Overall Study||109
1703788|NCT00423852|4165995|P1|NOT COMPLETED|Overall Study||3
1703789|NCT00423852|4165995|P1|COMPLETED|Overall Study||23
1703790|NCT00423852|4165995|P1|STARTED|Overall Study||26
1703791|NCT00423813|4166003|P3|NOT COMPLETED|Overall Study||74
1703792|NCT00423813|4166004|P2|NOT COMPLETED|Overall Study||66
1703793|NCT00423813|4166005|P1|NOT COMPLETED|Overall Study||57
1703794|NCT00423813|4166003|P3|COMPLETED|Overall Study||116
1703795|NCT00423813|4166004|P2|COMPLETED|Overall Study||129
1703796|NCT00423813|4166005|P1|COMPLETED|Overall Study||131
1703797|NCT00423813|4166003|P3|Treated|Overall Study||189
1703798|NCT00423813|4166004|P2|Treated|Overall Study||194
1703799|NCT00423813|4166005|P1|Treated|Overall Study||188
1703800|NCT00423813|4166003|P3|STARTED|Overall Study||190
1703801|NCT00423813|4166004|P2|STARTED|Overall Study||195
1703802|NCT00423813|4166005|P1|STARTED|Overall Study||188
1703803|NCT00423800|4166015|P2|NOT COMPLETED|Overall Study||1
1703804|NCT00423800|4166016|P1|NOT COMPLETED|Overall Study||0
1703805|NCT00423800|4166015|P2|COMPLETED|Overall Study||1
1703806|NCT00423800|4166016|P1|COMPLETED|Overall Study||3
1703807|NCT00423800|4166015|P2|STARTED|Overall Study||2
1703808|NCT00423800|4166016|P1|STARTED|Overall Study||3
1703809|NCT00423735|4166028|P3|NOT COMPLETED|Overall Study||0
1703810|NCT00423735|4166029|P2|NOT COMPLETED|Overall Study||6
1703811|NCT00423735|4166030|P1|NOT COMPLETED|Overall Study||8
1703812|NCT00423735|4166028|P3|COMPLETED|Overall Study||0
1703813|NCT00423735|4166029|P2|COMPLETED|Overall Study||29
1703814|NCT00423735|4166030|P1|COMPLETED|Overall Study||21
1703815|NCT00423735|4166028|P3|STARTED|Overall Study||0
1703816|NCT00423735|4166029|P2|STARTED|Overall Study||35
1703817|NCT00423735|4166030|P1|STARTED|Overall Study||29
1703818|NCT00423722|4166053|P2|NOT COMPLETED|Overall Study||13
1703819|NCT00423722|4166054|P1|NOT COMPLETED|Overall Study||14
1703820|NCT00423722|4166053|P2|COMPLETED|Overall Study||53
1703821|NCT00423722|4166054|P1|COMPLETED|Overall Study||49
1703822|NCT00423722|4166053|P2|STARTED|Overall Study||66
1703823|NCT00423722|4166054|P1|STARTED|Overall Study||63
1703824|NCT00423683|4166076|P2|NOT COMPLETED|Overall Study||0
1703825|NCT00423683|4166077|P1|NOT COMPLETED|Overall Study||1
1703826|NCT00423683|4166076|P2|COMPLETED|Overall Study||33
1703827|NCT00423683|4166077|P1|COMPLETED|Overall Study||30
1703828|NCT00423683|4166076|P2|STARTED|Overall Study||33
1703829|NCT00423683|4166077|P1|STARTED|Overall Study||31
1703830|NCT00423670|4166096|P8|NOT COMPLETED|Follow-up Period||3
1703831|NCT00423670|4166097|P7|NOT COMPLETED|Follow-up Period||9
1703832|NCT00423670|4166098|P6|NOT COMPLETED|Follow-up Period||0
1703833|NCT00423670|4166099|P5|NOT COMPLETED|Follow-up Period||2
1703834|NCT00423670|4166100|P4|NOT COMPLETED|Follow-up Period||5
1703835|NCT00423670|4166101|P3|NOT COMPLETED|Follow-up Period||11
1703836|NCT00423670|4166102|P2|NOT COMPLETED|Follow-up Period||16
1703837|NCT00423670|4166103|P1|NOT COMPLETED|Follow-up Period||3
1703838|NCT00423670|4166096|P8|COMPLETED|Follow-up Period||32
1703839|NCT00423670|4166097|P7|COMPLETED|Follow-up Period||41
1703840|NCT00423670|4166098|P6|COMPLETED|Follow-up Period||14
1703841|NCT00423670|4166099|P5|COMPLETED|Follow-up Period||89
1703842|NCT00423670|4166100|P4|COMPLETED|Follow-up Period||91
1703843|NCT00423670|4166101|P3|COMPLETED|Follow-up Period||85
1703844|NCT00423670|4166102|P2|COMPLETED|Follow-up Period||84
1703845|NCT00423670|4166103|P1|COMPLETED|Follow-up Period||94
1703846|NCT00423670|4166096|P8|STARTED|Follow-up Period||35
1703847|NCT00423670|4166097|P7|STARTED|Follow-up Period||50
1703848|NCT00423670|4166098|P6|STARTED|Follow-up Period||14
1703849|NCT00423670|4166099|P5|STARTED|Follow-up Period||91
1703850|NCT00423670|4166100|P4|STARTED|Follow-up Period||96
1703851|NCT00423670|4166101|P3|STARTED|Follow-up Period||96
1703852|NCT00423670|4166102|P2|STARTED|Follow-up Period||100
1703853|NCT00423670|4166103|P1|STARTED|Follow-up Period||97
1703854|NCT00423670|4166096|P8|NOT COMPLETED|Treatment Period||21
1703855|NCT00423670|4166097|P7|NOT COMPLETED|Treatment Period||31
1703856|NCT00423670|4166098|P6|NOT COMPLETED|Treatment Period||8
1703857|NCT00423670|4166099|P5|NOT COMPLETED|Treatment Period||27
1703858|NCT00423670|4166100|P4|NOT COMPLETED|Treatment Period||40
1703859|NCT00423670|4166101|P3|NOT COMPLETED|Treatment Period||27
1703860|NCT00423670|4166102|P2|NOT COMPLETED|Treatment Period||30
1703861|NCT00423670|4166103|P1|NOT COMPLETED|Treatment Period||52
1703862|NCT00423670|4166096|P8|COMPLETED|Treatment Period||15
1703863|NCT00423670|4166097|P7|COMPLETED|Treatment Period||28
1703864|NCT00423670|4166098|P6|COMPLETED|Treatment Period||8
1703865|NCT00423670|4166099|P5|COMPLETED|Treatment Period||76
1703866|NCT00423670|4166100|P4|COMPLETED|Treatment Period||63
1703867|NCT00423670|4166101|P3|COMPLETED|Treatment Period||76
1703868|NCT00423670|4166102|P2|COMPLETED|Treatment Period||77
1703869|NCT00423670|4166103|P1|COMPLETED|Treatment Period||52
1703870|NCT00423670|4166096|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
1703871|NCT00423670|4166097|P7|STARTED|Treatment Period||59
1703872|NCT00423670|4166098|P6|STARTED|Treatment Period||16
1703873|NCT00423670|4166099|P5|STARTED|Treatment Period||103
1703874|NCT00423670|4166100|P4|STARTED|Treatment Period||103
1703875|NCT00423670|4166101|P3|STARTED|Treatment Period||103
1703876|NCT00423670|4166102|P2|STARTED|Treatment Period||107
1703877|NCT00423670|4166103|P1|STARTED|Treatment Period||104
1703878|NCT00423657|4166161|P2|NOT COMPLETED|Overall Study||25
1703879|NCT00423657|4166162|P1|NOT COMPLETED|Overall Study||26
1703880|NCT00423657|4166161|P2|COMPLETED|Overall Study||313
1703881|NCT00423657|4166162|P1|COMPLETED|Overall Study||316
1703882|NCT00423657|4166161|P2|STARTED|Overall Study||338
1703883|NCT00423657|4166162|P1|STARTED|Overall Study||342
1703884|NCT00423605|4166168|P1|NOT COMPLETED|Overall Study||241
1703885|NCT00423605|4166168|P1|COMPLETED|Overall Study||319
1703886|NCT00423605|4166168|P1|STARTED|Overall Study||560
1703887|NCT00423592|4166172|P1|NOT COMPLETED|Overall Study||7
1703888|NCT00423592|4166172|P1|COMPLETED|Overall Study|Completed study|29
1703889|NCT00423592|4166172|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
1703890|NCT00423592|4166172|P1|STARTED|Overall Study|Enrolled|36
1703891|NCT00423579|4166193|P2|NOT COMPLETED|Overall Study||4
1703892|NCT00423579|4166194|P1|NOT COMPLETED|Overall Study||4
1703893|NCT00423579|4166193|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
1703894|NCT00423579|4166194|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
1703895|NCT00423579|4166193|P2|STARTED|Overall Study||60
1703896|NCT00423579|4166194|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
1703897|NCT00423488|4166202|P2|NOT COMPLETED|Overall Study||1
1703898|NCT00423488|4166203|P1|NOT COMPLETED|Overall Study||5
1703899|NCT00423488|4166202|P2|COMPLETED|Overall Study||50
1703900|NCT00423488|4166203|P1|COMPLETED|Overall Study||37
1703901|NCT00423488|4166202|P2|STARTED|Overall Study||51
1703902|NCT00423488|4166203|P1|STARTED|Overall Study||42
1703903|NCT00423449|4166209|P5|NOT COMPLETED|Overall Study||7
1703904|NCT00423449|4166210|P4|NOT COMPLETED|Overall Study||22
1703905|NCT00423449|4166211|P3|NOT COMPLETED|Overall Study||15
1703906|NCT00423449|4166212|P2|NOT COMPLETED|Overall Study||4
1703907|NCT00423449|4166213|P1|NOT COMPLETED|Overall Study||3
1703908|NCT00423449|4166209|P5|COMPLETED|Overall Study||0
1703909|NCT00423449|4166210|P4|COMPLETED|Overall Study||5
1703910|NCT00423449|4166211|P3|COMPLETED|Overall Study||2
1703911|NCT00423449|4166212|P2|COMPLETED|Overall Study||2
1703912|NCT00423449|4166213|P1|COMPLETED|Overall Study||1
1703913|NCT00423449|4166209|P5|STARTED|Overall Study||7
1703914|NCT00423449|4166210|P4|STARTED|Overall Study||27
1703915|NCT00423449|4166211|P3|STARTED|Overall Study||17
1703916|NCT00423449|4166212|P2|STARTED|Overall Study||6
1703917|NCT00423449|4166213|P1|STARTED|Overall Study||4
1703918|NCT00423436|4166238|P2|NOT COMPLETED|Overall Study||0
1703919|NCT00423436|4166239|P1|NOT COMPLETED|Overall Study||0
1703920|NCT00423436|4166238|P2|COMPLETED|Overall Study||33
1703921|NCT00423436|4166239|P1|COMPLETED|Overall Study||35
1703922|NCT00423436|4166238|P2|STARTED|Overall Study||33
1703923|NCT00423436|4166239|P1|STARTED|Overall Study||35
1703924|NCT00423358|4166247|P2|NOT COMPLETED|Overall Study||0
1703925|NCT00423358|4166248|P1|NOT COMPLETED|Overall Study||0
1703926|NCT00423358|4166247|P2|COMPLETED|Overall Study||11
1703927|NCT00423358|4166248|P1|COMPLETED|Overall Study||11
1703928|NCT00423358|4166247|P2|STARTED|Overall Study||11
1703929|NCT00423358|4166248|P1|STARTED|Overall Study||11
1703930|NCT00423332|4166260|P2|NOT COMPLETED|Overall Study||7
1703931|NCT00423332|4166261|P1|NOT COMPLETED|Overall Study||9
1703932|NCT00423332|4166260|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
1703933|NCT00423332|4166261|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
1703934|NCT00423332|4166260|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
1703935|NCT00423332|4166261|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
1703936|NCT00423332|4166260|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
1703937|NCT00423332|4166261|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
1703938|NCT00423332|4166260|P2|STARTED|Overall Study|Number randomised|18
1703939|NCT00423332|4166261|P1|STARTED|Overall Study|Randomised|53
1703940|NCT00423319|4166280|P2|NOT COMPLETED|Overall Study||252
1703941|NCT00423319|4166281|P1|NOT COMPLETED|Overall Study||224
1703942|NCT00423319|4166280|P2|COMPLETED|Overall Study||2447
1703943|NCT00423319|4166281|P1|COMPLETED|Overall Study||2484
1703944|NCT00423319|4166280|P2|Participants Who Received Treatment|Overall Study||2659
1703945|NCT00423319|4166281|P1|Participants Who Received Treatment|Overall Study||2673
1703946|NCT00423319|4166280|P2|STARTED|Overall Study|Randomized|2699
1703947|NCT00423319|4166281|P1|STARTED|Overall Study|Randomized|2708
1703948|NCT00423293|4166313|P1|NOT COMPLETED|Overall Study||11
1703949|NCT00423293|4166313|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
1703950|NCT00423293|4166313|P1|STARTED|Overall Study||63
1703951|NCT00423267|4166319|P2|NOT COMPLETED|Period B||0
1703952|NCT00423267|4166320|P1|NOT COMPLETED|Period B||0
1703953|NCT00423267|4166319|P2|COMPLETED|Period B||0
1703954|NCT00423267|4166320|P1|COMPLETED|Period B||12
1703955|NCT00423267|4166319|P2|STARTED|Period B||0
1703956|NCT00423267|4166320|P1|STARTED|Period B||12
1703957|NCT00423267|4166319|P2|NOT COMPLETED|Period A||1
1703958|NCT00423267|4166320|P1|NOT COMPLETED|Period A||2
1703959|NCT00423267|4166319|P2|COMPLETED|Period A||6
1703960|NCT00423267|4166320|P1|COMPLETED|Period A||7
1703961|NCT00423267|4166319|P2|STARTED|Period A||7
1703962|NCT00423267|4166320|P1|STARTED|Period A||9
1703963|NCT00423189|4166340|P3|NOT COMPLETED|Overall Study||0
1703964|NCT00423189|4166341|P2|NOT COMPLETED|Overall Study||1
1703965|NCT00423189|4166342|P1|NOT COMPLETED|Overall Study||0
1703966|NCT00423189|4166340|P3|COMPLETED|Overall Study||2
1703967|NCT00423189|4166341|P2|COMPLETED|Overall Study||2
1703968|NCT00423189|4166342|P1|COMPLETED|Overall Study||2
1703969|NCT00423189|4166340|P3|STARTED|Overall Study||2
1703970|NCT00423189|4166341|P2|STARTED|Overall Study||3
1703971|NCT00423189|4166342|P1|STARTED|Overall Study||2
1703972|NCT00423176|4166364|P2|NOT COMPLETED|Overall Study||29
1703973|NCT00423176|4166365|P1|NOT COMPLETED|Overall Study||16
1703974|NCT00423176|4166364|P2|COMPLETED|Overall Study||94
1703975|NCT00423176|4166365|P1|COMPLETED|Overall Study||98
1703976|NCT00423176|4166364|P2|STARTED|Overall Study||123
1703977|NCT00423176|4166365|P1|STARTED|Overall Study||114
1703978|NCT00423150|4166373|P1|NOT COMPLETED|Overall Study||86
1703979|NCT00423150|4166373|P1|COMPLETED|Overall Study||0
1703980|NCT00423150|4166373|P1|STARTED|Overall Study||86
1703981|NCT00423098|4166379|P2|NOT COMPLETED|Overall Study||4
1703982|NCT00423098|4166380|P1|NOT COMPLETED|Overall Study||3
1703983|NCT00423098|4166379|P2|COMPLETED|Overall Study||35
1703984|NCT00423098|4166380|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
1703985|NCT00423098|4166379|P2|STARTED|Overall Study||39
1703986|NCT00423098|4166380|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
1703987|NCT00423085|4166407|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
1703988|NCT00423085|4166408|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
1703989|NCT00423085|4166409|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
1703990|NCT00423085|4166410|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
1703991|NCT00423085|4166407|P4|COMPLETED|52-Week Open-Label Extension Phase||474
1703992|NCT00423085|4166408|P3|COMPLETED|52-Week Open-Label Extension Phase||0
1703993|NCT00423085|4166409|P2|COMPLETED|52-Week Open-Label Extension Phase||0
1703994|NCT00423085|4166410|P1|COMPLETED|52-Week Open-Label Extension Phase||0
1703995|NCT00423085|4166407|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
1703996|NCT00423085|4166408|P3|STARTED|52-Week Open-Label Extension Phase||0
1703997|NCT00423085|4166409|P2|STARTED|52-Week Open-Label Extension Phase||0
1703998|NCT00423085|4166410|P1|STARTED|52-Week Open-Label Extension Phase||0
1703999|NCT00423085|4166407|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
1704000|NCT00423085|4166408|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
1704001|NCT00423085|4166409|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
1704002|NCT00423085|4166410|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
1704003|NCT00423085|4166407|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
1704004|NCT00423085|4166408|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
1704005|NCT00423085|4166409|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
1704006|NCT00423085|4166410|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
1704007|NCT00423085|4166407|P4|STARTED|24-Week Double-Blind Treatment Phase||0
1704008|NCT00423085|4166408|P3|STARTED|24-Week Double-Blind Treatment Phase||287
1704009|NCT00423085|4166409|P2|STARTED|24-Week Double-Blind Treatment Phase||284
1704010|NCT00423085|4166410|P1|STARTED|24-Week Double-Blind Treatment Phase||288
1704011|NCT00423046|4166439|P2|NOT COMPLETED|Overall Study||345
1704012|NCT00423046|4166440|P1|NOT COMPLETED|Overall Study||340
1704013|NCT00423046|4166439|P2|COMPLETED|Overall Study|Completed until Month 60|208
1704014|NCT00423046|4166440|P1|COMPLETED|Overall Study|Completed until Month 60|213
1704015|NCT00423046|4166439|P2|STARTED|Overall Study||553
1704016|NCT00423046|4166440|P1|STARTED|Overall Study||553
1704017|NCT00422942|4166506|P1|NOT COMPLETED|Overall Study||3
1704018|NCT00422942|4166506|P1|COMPLETED|Overall Study||0
1704019|NCT00422942|4166506|P1|STARTED|Overall Study||3
1704020|NCT00422903|4166525|P2|NOT COMPLETED|Overall Study||5
1704021|NCT00422903|4166526|P1|NOT COMPLETED|Overall Study||4
1704022|NCT00422903|4166525|P2|COMPLETED|Overall Study||38
1704023|NCT00422903|4166526|P1|COMPLETED|Overall Study||45
1704024|NCT00422903|4166525|P2|STARTED|Overall Study||43
1704025|NCT00422903|4166526|P1|STARTED|Overall Study||49
1704026|NCT00422812|4166554|P4|NOT COMPLETED|Overall Study||2
1704027|NCT00422812|4166555|P3|NOT COMPLETED|Overall Study||2
1704028|NCT00422812|4166556|P2|NOT COMPLETED|Overall Study||1
1704029|NCT00422812|4166557|P1|NOT COMPLETED|Overall Study||0
1704030|NCT00422812|4166554|P4|COMPLETED|Overall Study||103
1704031|NCT00422812|4166555|P3|COMPLETED|Overall Study||91
1704032|NCT00422812|4166556|P2|COMPLETED|Overall Study||103
1704033|NCT00422812|4166557|P1|COMPLETED|Overall Study||98
1704034|NCT00422812|4166554|P4|STARTED|Overall Study||105
1704035|NCT00422812|4166555|P3|STARTED|Overall Study||93
1704036|NCT00422812|4166556|P2|STARTED|Overall Study||104
1704037|NCT00422812|4166557|P1|STARTED|Overall Study||98
1704038|NCT00422799|4166575|P1|NOT COMPLETED|Overall Study||13
1704039|NCT00422799|4166575|P1|COMPLETED|Overall Study||50
1704040|NCT00422799|4166575|P1|STARTED|Overall Study||63
1704041|NCT00422734|4166584|P2|NOT COMPLETED|Overall Study||21
1704042|NCT00422734|4166585|P1|NOT COMPLETED|Overall Study||14
1704043|NCT00422734|4166584|P2|COMPLETED|Overall Study||243
1704044|NCT00422734|4166585|P1|COMPLETED|Overall Study||64
1704045|NCT00422734|4166584|P2|STARTED|Overall Study||264
1704046|NCT00422734|4166585|P1|STARTED|Overall Study||78
1704047|NCT00422695|4166619|P2|NOT COMPLETED|Overall Study||0
1704048|NCT00422695|4166620|P1|NOT COMPLETED|Overall Study||0
1704049|NCT00422695|4166619|P2|COMPLETED|Overall Study||38
1704050|NCT00422695|4166620|P1|COMPLETED|Overall Study||105
1704051|NCT00422695|4166619|P2|STARTED|Overall Study||38
1704052|NCT00422695|4166620|P1|STARTED|Overall Study||105
1704053|NCT00422669|4166631|P3|NOT COMPLETED|Overall Study||7
1704054|NCT00422669|4166632|P2|NOT COMPLETED|Overall Study||100
1704055|NCT00422669|4166633|P1|NOT COMPLETED|Overall Study||98
1704056|NCT00422669|4166631|P3|COMPLETED|Overall Study||0
1704057|NCT00422669|4166632|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
1704058|NCT00422669|4166633|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
1704059|NCT00422669|4166631|P3|STARTED|Overall Study||7
1704060|NCT00422669|4166632|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
1704061|NCT00422669|4166633|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
1704062|NCT00422656|4166654|P1|NOT COMPLETED|Overall Study||0
1704063|NCT00422656|4166654|P1|COMPLETED|Overall Study||37
1704064|NCT00422656|4166654|P1|STARTED|Overall Study||37
1704065|NCT00422591|4166661|P1|NOT COMPLETED|Overall Study||6
1704066|NCT00422591|4166661|P1|COMPLETED|Overall Study||169
1704067|NCT00422591|4166661|P1|STARTED|Overall Study||175
1704068|NCT00422513|4166669|P2|NOT COMPLETED|Overall Study||106
1704069|NCT00422513|4166670|P1|NOT COMPLETED|Overall Study||107
1704070|NCT00422513|4166669|P2|COMPLETED|Overall Study||24
1704071|NCT00422513|4166670|P1|COMPLETED|Overall Study||23
1704072|NCT00422513|4166669|P2|STARTED|Overall Study||130
1704073|NCT00422513|4166670|P1|STARTED|Overall Study||130
1704074|NCT00422448|4166682|P1|NOT COMPLETED|Overall Study||0
1704075|NCT00422448|4166682|P1|COMPLETED|Overall Study||43
1704076|NCT00422448|4166682|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
1704077|NCT00422422|4166687|P1|NOT COMPLETED|Overall Study||10
1704078|NCT00422422|4166687|P1|COMPLETED|Overall Study||90
1704079|NCT00422422|4166687|P1|STARTED|Overall Study||100
1704080|NCT00422383|4166704|P5|NOT COMPLETED|Overall Study||3
1704081|NCT00422383|4166705|P4|NOT COMPLETED|Overall Study||2
1704082|NCT00422383|4166706|P3|NOT COMPLETED|Overall Study||4
1704083|NCT00422383|4166707|P2|NOT COMPLETED|Overall Study||14
1704084|NCT00422383|4166708|P1|NOT COMPLETED|Overall Study||15
1704085|NCT00422383|4166704|P5|COMPLETED|Overall Study||22
1704086|NCT00422383|4166705|P4|COMPLETED|Overall Study||4
1704087|NCT00422383|4166706|P3|COMPLETED|Overall Study||89
1704088|NCT00422383|4166707|P2|COMPLETED|Overall Study||106
1704089|NCT00422383|4166708|P1|COMPLETED|Overall Study||119
1704090|NCT00422383|4166704|P5|STARTED|Overall Study||25
1704091|NCT00422383|4166705|P4|STARTED|Overall Study||6
1704092|NCT00422383|4166706|P3|STARTED|Overall Study||93
1704093|NCT00422383|4166707|P2|STARTED|Overall Study||120
1704094|NCT00422383|4166708|P1|STARTED|Overall Study||134
1704095|NCT00422292|4166851|P4|NOT COMPLETED|Overall Study||24
1704096|NCT00422292|4166852|P3|NOT COMPLETED|Overall Study||22
1704097|NCT00422292|4166853|P2|NOT COMPLETED|Overall Study||66
1704098|NCT00422292|4166854|P1|NOT COMPLETED|Overall Study||18
1704099|NCT00422292|4166851|P4|COMPLETED|Overall Study||452
1704100|NCT00422292|4166852|P3|COMPLETED|Overall Study||224
1704101|NCT00422292|4166853|P2|COMPLETED|Overall Study||598
1704102|NCT00422292|4166854|P1|COMPLETED|Overall Study||239
1704103|NCT00422292|4166851|P4|STARTED|Overall Study||476
1704104|NCT00422292|4166852|P3|STARTED|Overall Study||246
1704105|NCT00422292|4166853|P2|STARTED|Overall Study||664
1704106|NCT00422292|4166854|P1|STARTED|Overall Study||257
1704107|NCT00422279|4166882|P2|NOT COMPLETED|Overall Study||0
1704108|NCT00422279|4166883|P1|NOT COMPLETED|Overall Study||0
1704109|NCT00422279|4166882|P2|COMPLETED|Overall Study||2
1704110|NCT00422279|4166883|P1|COMPLETED|Overall Study||2
1704111|NCT00422279|4166882|P2|24 Month After Loading Period|Overall Study||2
1704112|NCT00422279|4166883|P1|24 Month After Loading Period|Overall Study||2
1704113|NCT00422279|4166882|P2|STARTED|Overall Study||2
1704114|NCT00422279|4166883|P1|STARTED|Overall Study||2
1704115|NCT00422227|4166893|P2|NOT COMPLETED|Overall Study||15
1704116|NCT00422227|4166894|P1|NOT COMPLETED|Overall Study||4
1704117|NCT00422227|4166893|P2|COMPLETED|Overall Study||88
1704118|NCT00422227|4166894|P1|COMPLETED|Overall Study||193
1704119|NCT00422227|4166893|P2|STARTED|Overall Study||103
1704120|NCT00422227|4166894|P1|STARTED|Overall Study||197
1704121|NCT00422201|4166918|P1|NOT COMPLETED|Overall Study||11
1704122|NCT00422201|4166918|P1|COMPLETED|Overall Study||7
1704123|NCT00422201|4166918|P1|STARTED|Overall Study||18
1704124|NCT00422162|4166924|P2|NOT COMPLETED|Overall Study||30
1704125|NCT00422162|4166925|P1|NOT COMPLETED|Overall Study||24
1704126|NCT00422162|4166924|P2|COMPLETED|Overall Study||142
1704127|NCT00422162|4166925|P1|COMPLETED|Overall Study||143
1704128|NCT00422162|4166924|P2|Received Treatment|Overall Study||171
1704129|NCT00422162|4166925|P1|Received Treatment|Overall Study||167
1704130|NCT00422162|4166924|P2|STARTED|Overall Study||172
1704131|NCT00422162|4166925|P1|STARTED|Overall Study||167
1704132|NCT00422097|4166985|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1704133|NCT00422097|4166986|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1704134|NCT00422097|4166987|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1704135|NCT00422097|4166988|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1704136|NCT00422097|4166989|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1704137|NCT00422097|4166990|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1704138|NCT00422097|4166991|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1704139|NCT00422097|4166992|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
1704140|NCT00422097|4166985|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
1704141|NCT00422097|4166986|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
1704142|NCT00422097|4166987|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
1704143|NCT00422097|4166988|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
1704144|NCT00422097|4166989|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
1704145|NCT00422097|4166990|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
1704146|NCT00422097|4166991|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
1704147|NCT00422097|4166992|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
1704148|NCT00422097|4166985|P8|STARTED|Ixabepilone With Famotidine or Food||7
1704149|NCT00422097|4166986|P7|STARTED|Ixabepilone With Famotidine or Food||8
1704150|NCT00422097|4166987|P6|STARTED|Ixabepilone With Famotidine or Food||0
1704151|NCT00422097|4166988|P5|STARTED|Ixabepilone With Famotidine or Food||0
1704152|NCT00422097|4166989|P4|STARTED|Ixabepilone With Famotidine or Food||0
1704153|NCT00422097|4166990|P3|STARTED|Ixabepilone With Famotidine or Food||0
1704154|NCT00422097|4166991|P2|STARTED|Ixabepilone With Famotidine or Food||0
1704155|NCT00422097|4166992|P1|STARTED|Ixabepilone With Famotidine or Food||0
1704156|NCT00422097|4166985|P8|NOT COMPLETED|Dose Level 6||0
1704157|NCT00422097|4166986|P7|NOT COMPLETED|Dose Level 6||0
1704158|NCT00422097|4166987|P6|NOT COMPLETED|Dose Level 6||0
1704159|NCT00422097|4166988|P5|NOT COMPLETED|Dose Level 6||0
1704160|NCT00422097|4166989|P4|NOT COMPLETED|Dose Level 6||0
1704161|NCT00422097|4166990|P3|NOT COMPLETED|Dose Level 6||0
1704162|NCT00422097|4166991|P2|NOT COMPLETED|Dose Level 6||0
1704163|NCT00422097|4166992|P1|NOT COMPLETED|Dose Level 6||0
1704164|NCT00422097|4166985|P8|COMPLETED|Dose Level 6||0
1704165|NCT00422097|4166986|P7|COMPLETED|Dose Level 6||0
1704166|NCT00422097|4166987|P6|COMPLETED|Dose Level 6||6
1704167|NCT00422097|4166988|P5|COMPLETED|Dose Level 6||0
1704168|NCT00422097|4166989|P4|COMPLETED|Dose Level 6||0
1704169|NCT00422097|4166990|P3|COMPLETED|Dose Level 6||0
1704170|NCT00422097|4166991|P2|COMPLETED|Dose Level 6||0
1704171|NCT00422097|4166992|P1|COMPLETED|Dose Level 6||0
1704172|NCT00422097|4166985|P8|STARTED|Dose Level 6||0
1704173|NCT00422097|4166986|P7|STARTED|Dose Level 6||0
1704174|NCT00422097|4166987|P6|STARTED|Dose Level 6||6
1704175|NCT00422097|4166988|P5|STARTED|Dose Level 6||0
1704176|NCT00422097|4166989|P4|STARTED|Dose Level 6||0
1704177|NCT00422097|4166990|P3|STARTED|Dose Level 6||0
1704178|NCT00422097|4166991|P2|STARTED|Dose Level 6||0
1704179|NCT00422097|4166992|P1|STARTED|Dose Level 6||0
1704180|NCT00422097|4166985|P8|NOT COMPLETED|Dose Level 5||0
1704181|NCT00422097|4166986|P7|NOT COMPLETED|Dose Level 5||0
1704182|NCT00422097|4166987|P6|NOT COMPLETED|Dose Level 5||0
1704183|NCT00422097|4166988|P5|NOT COMPLETED|Dose Level 5||0
1704184|NCT00422097|4166989|P4|NOT COMPLETED|Dose Level 5||0
1704185|NCT00422097|4166990|P3|NOT COMPLETED|Dose Level 5||0
1704186|NCT00422097|4166991|P2|NOT COMPLETED|Dose Level 5||0
1704187|NCT00422097|4166992|P1|NOT COMPLETED|Dose Level 5||0
1704188|NCT00422097|4166985|P8|COMPLETED|Dose Level 5||0
1704189|NCT00422097|4166986|P7|COMPLETED|Dose Level 5||0
1704190|NCT00422097|4166987|P6|COMPLETED|Dose Level 5||0
1704191|NCT00422097|4166988|P5|COMPLETED|Dose Level 5||23
1704192|NCT00422097|4166989|P4|COMPLETED|Dose Level 5||0
1704193|NCT00422097|4166990|P3|COMPLETED|Dose Level 5||0
1704194|NCT00422097|4166991|P2|COMPLETED|Dose Level 5||0
1704195|NCT00422097|4166992|P1|COMPLETED|Dose Level 5||0
1704196|NCT00422097|4166985|P8|STARTED|Dose Level 5||0
1704197|NCT00422097|4166986|P7|STARTED|Dose Level 5||0
1704198|NCT00422097|4166987|P6|STARTED|Dose Level 5||0
1704199|NCT00422097|4166988|P5|STARTED|Dose Level 5||23
1704200|NCT00422097|4166989|P4|STARTED|Dose Level 5||0
1704201|NCT00422097|4166990|P3|STARTED|Dose Level 5||0
1704202|NCT00422097|4166991|P2|STARTED|Dose Level 5||0
1704203|NCT00422097|4166992|P1|STARTED|Dose Level 5||0
1704204|NCT00422097|4166985|P8|NOT COMPLETED|Dose Level 4||0
1704205|NCT00422097|4166986|P7|NOT COMPLETED|Dose Level 4||0
1704206|NCT00422097|4166987|P6|NOT COMPLETED|Dose Level 4||0
1704207|NCT00422097|4166988|P5|NOT COMPLETED|Dose Level 4||0
1704208|NCT00422097|4166989|P4|NOT COMPLETED|Dose Level 4||0
1704209|NCT00422097|4166990|P3|NOT COMPLETED|Dose Level 4||0
1704210|NCT00422097|4166991|P2|NOT COMPLETED|Dose Level 4||0
1704211|NCT00422097|4166992|P1|NOT COMPLETED|Dose Level 4||0
1704212|NCT00422097|4166985|P8|COMPLETED|Dose Level 4||0
1704213|NCT00422097|4166986|P7|COMPLETED|Dose Level 4||0
1704214|NCT00422097|4166987|P6|COMPLETED|Dose Level 4||0
1704215|NCT00422097|4166988|P5|COMPLETED|Dose Level 4||0
1704216|NCT00422097|4166989|P4|COMPLETED|Dose Level 4||3
1704217|NCT00422097|4166990|P3|COMPLETED|Dose Level 4||0
1704218|NCT00422097|4166991|P2|COMPLETED|Dose Level 4||0
1704219|NCT00422097|4166992|P1|COMPLETED|Dose Level 4||0
1704220|NCT00422097|4166985|P8|STARTED|Dose Level 4||0
1704221|NCT00422097|4166986|P7|STARTED|Dose Level 4||0
1704222|NCT00422097|4166987|P6|STARTED|Dose Level 4||0
1704223|NCT00422097|4166988|P5|STARTED|Dose Level 4||0
1704224|NCT00422097|4166989|P4|STARTED|Dose Level 4||3
1704225|NCT00422097|4166990|P3|STARTED|Dose Level 4||0
1704226|NCT00422097|4166991|P2|STARTED|Dose Level 4||0
1704227|NCT00422097|4166992|P1|STARTED|Dose Level 4||0
1704228|NCT00422097|4166985|P8|NOT COMPLETED|Dose Level 3||0
1704229|NCT00422097|4166986|P7|NOT COMPLETED|Dose Level 3||0
1704230|NCT00422097|4166987|P6|NOT COMPLETED|Dose Level 3||0
1704231|NCT00422097|4166988|P5|NOT COMPLETED|Dose Level 3||0
1704232|NCT00422097|4166989|P4|NOT COMPLETED|Dose Level 3||0
1704233|NCT00422097|4166990|P3|NOT COMPLETED|Dose Level 3||0
1704234|NCT00422097|4166991|P2|NOT COMPLETED|Dose Level 3||0
1704235|NCT00422097|4166992|P1|NOT COMPLETED|Dose Level 3||0
1704236|NCT00422097|4166985|P8|COMPLETED|Dose Level 3||0
1704237|NCT00422097|4166986|P7|COMPLETED|Dose Level 3||0
1704238|NCT00422097|4166987|P6|COMPLETED|Dose Level 3||0
1704239|NCT00422097|4166988|P5|COMPLETED|Dose Level 3||0
1704240|NCT00422097|4166989|P4|COMPLETED|Dose Level 3||0
1704241|NCT00422097|4166990|P3|COMPLETED|Dose Level 3||3
1704242|NCT00422097|4166991|P2|COMPLETED|Dose Level 3||0
1704243|NCT00422097|4166992|P1|COMPLETED|Dose Level 3||0
1704244|NCT00422097|4166985|P8|STARTED|Dose Level 3||0
1704245|NCT00422097|4166986|P7|STARTED|Dose Level 3||0
1704246|NCT00422097|4166987|P6|STARTED|Dose Level 3||0
1704247|NCT00422097|4166988|P5|STARTED|Dose Level 3||0
1704248|NCT00422097|4166989|P4|STARTED|Dose Level 3||0
1704249|NCT00422097|4166990|P3|STARTED|Dose Level 3||3
1704250|NCT00422097|4166991|P2|STARTED|Dose Level 3||0
1704251|NCT00422097|4166992|P1|STARTED|Dose Level 3||0
1704252|NCT00422097|4166985|P8|NOT COMPLETED|Dose Level 2||0
1704253|NCT00422097|4166986|P7|NOT COMPLETED|Dose Level 2||0
1704254|NCT00422097|4166987|P6|NOT COMPLETED|Dose Level 2||0
1704255|NCT00422097|4166988|P5|NOT COMPLETED|Dose Level 2||0
1704256|NCT00422097|4166989|P4|NOT COMPLETED|Dose Level 2||0
1704257|NCT00422097|4166990|P3|NOT COMPLETED|Dose Level 2||0
1704258|NCT00422097|4166991|P2|NOT COMPLETED|Dose Level 2||1
1704259|NCT00422097|4166992|P1|NOT COMPLETED|Dose Level 2||0
1704260|NCT00422097|4166985|P8|COMPLETED|Dose Level 2||0
1704261|NCT00422097|4166986|P7|COMPLETED|Dose Level 2||0
1704262|NCT00422097|4166987|P6|COMPLETED|Dose Level 2||0
1704263|NCT00422097|4166988|P5|COMPLETED|Dose Level 2||0
1704264|NCT00422097|4166989|P4|COMPLETED|Dose Level 2||0
1704265|NCT00422097|4166990|P3|COMPLETED|Dose Level 2||0
1704266|NCT00422097|4166991|P2|COMPLETED|Dose Level 2||5
1704267|NCT00422097|4166992|P1|COMPLETED|Dose Level 2||0
1704268|NCT00422097|4166985|P8|STARTED|Dose Level 2||0
1704269|NCT00422097|4166986|P7|STARTED|Dose Level 2||0
1704270|NCT00422097|4166987|P6|STARTED|Dose Level 2||0
1704271|NCT00422097|4166988|P5|STARTED|Dose Level 2||0
1704272|NCT00422097|4166989|P4|STARTED|Dose Level 2||0
1704273|NCT00422097|4166990|P3|STARTED|Dose Level 2||0
1704274|NCT00422097|4166991|P2|STARTED|Dose Level 2||6
1704275|NCT00422097|4166992|P1|STARTED|Dose Level 2||0
1704276|NCT00422097|4166985|P8|NOT COMPLETED|Dose Level 1||0
1704277|NCT00422097|4166986|P7|NOT COMPLETED|Dose Level 1||0
1704278|NCT00422097|4166987|P6|NOT COMPLETED|Dose Level 1||0
1704279|NCT00422097|4166988|P5|NOT COMPLETED|Dose Level 1||0
1704280|NCT00422097|4166989|P4|NOT COMPLETED|Dose Level 1||0
1704281|NCT00422097|4166990|P3|NOT COMPLETED|Dose Level 1||0
1704282|NCT00422097|4166991|P2|NOT COMPLETED|Dose Level 1||0
1704283|NCT00422097|4166992|P1|NOT COMPLETED|Dose Level 1||0
1704284|NCT00422097|4166985|P8|COMPLETED|Dose Level 1||0
1704285|NCT00422097|4166986|P7|COMPLETED|Dose Level 1||0
1704286|NCT00422097|4166987|P6|COMPLETED|Dose Level 1||0
1704287|NCT00422097|4166988|P5|COMPLETED|Dose Level 1||0
1704288|NCT00422097|4166989|P4|COMPLETED|Dose Level 1||0
1704289|NCT00422097|4166990|P3|COMPLETED|Dose Level 1||0
1704290|NCT00422097|4166991|P2|COMPLETED|Dose Level 1||0
1704291|NCT00422097|4166992|P1|COMPLETED|Dose Level 1||3
1704292|NCT00422097|4166985|P8|STARTED|Dose Level 1||0
1704293|NCT00422097|4166986|P7|STARTED|Dose Level 1||0
1704294|NCT00422097|4166987|P6|STARTED|Dose Level 1||0
1704295|NCT00422097|4166988|P5|STARTED|Dose Level 1||0
1704296|NCT00422097|4166989|P4|STARTED|Dose Level 1||0
1704297|NCT00422097|4166990|P3|STARTED|Dose Level 1||0
1704298|NCT00422097|4166991|P2|STARTED|Dose Level 1||0
1704299|NCT00422097|4166992|P1|STARTED|Dose Level 1||3
1704300|NCT00422058|4167057|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
1704301|NCT00422058|4167058|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
1704302|NCT00422058|4167059|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
1704303|NCT00422058|4167060|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
1704304|NCT00422058|4167061|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
1704305|NCT00422058|4167062|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
1704306|NCT00422058|4167057|P6|COMPLETED|Open-Label Extension, Week 20-104||45
1704307|NCT00422058|4167058|P5|COMPLETED|Open-Label Extension, Week 20-104||47
1704308|NCT00422058|4167059|P4|COMPLETED|Open-Label Extension, Week 20-104||45
1704309|NCT00422058|4167060|P3|COMPLETED|Open-Label Extension, Week 20-104||38
1704310|NCT00422058|4167061|P2|COMPLETED|Open-Label Extension, Week 20-104||46
1704311|NCT00422058|4167062|P1|COMPLETED|Open-Label Extension, Week 20-104||47
1704312|NCT00422058|4167057|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
1704313|NCT00422058|4167058|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
1704314|NCT00422058|4167059|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
1704315|NCT00422058|4167060|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
1704316|NCT00422058|4167061|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
1704317|NCT00422058|4167062|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
1704318|NCT00422058|4167057|P6|STARTED|Open-Label Extension, Week 20-104||79
1704319|NCT00422058|4167058|P5|STARTED|Open-Label Extension, Week 20-104||82
1704320|NCT00422058|4167059|P4|STARTED|Open-Label Extension, Week 20-104||73
1704321|NCT00422058|4167060|P3|STARTED|Open-Label Extension, Week 20-104||74
1704322|NCT00422058|4167061|P2|STARTED|Open-Label Extension, Week 20-104||85
1704323|NCT00422058|4167062|P1|STARTED|Open-Label Extension, Week 20-104||79
1704324|NCT00422058|4167057|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
1704325|NCT00422058|4167058|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
1704326|NCT00422058|4167059|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
1704327|NCT00422058|4167060|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
1704328|NCT00422058|4167061|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
1704329|NCT00422058|4167062|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
1704330|NCT00422058|4167057|P6|COMPLETED|Double-Blind, Week 0-20||79
1704331|NCT00422058|4167058|P5|COMPLETED|Double-Blind, Week 0-20||82
1704332|NCT00422058|4167059|P4|COMPLETED|Double-Blind, Week 0-20||73
1704333|NCT00422058|4167060|P3|COMPLETED|Double-Blind, Week 0-20||74
1704334|NCT00422058|4167061|P2|COMPLETED|Double-Blind, Week 0-20||85
1704335|NCT00422058|4167062|P1|COMPLETED|Double-Blind, Week 0-20||79
1704336|NCT00422058|4167057|P6|STARTED|Double-Blind, Week 0-20||95
1704337|NCT00422058|4167058|P5|STARTED|Double-Blind, Week 0-20||93
1704338|NCT00422058|4167059|P4|STARTED|Double-Blind, Week 0-20||93
1704339|NCT00422058|4167060|P3|STARTED|Double-Blind, Week 0-20||90
1704340|NCT00422058|4167061|P2|STARTED|Double-Blind, Week 0-20||95
1704341|NCT00422058|4167062|P1|STARTED|Double-Blind, Week 0-20||98
1704342|NCT00422032|4167192|P2|NOT COMPLETED|Overall Study||0
1704343|NCT00422032|4167193|P1|NOT COMPLETED|Overall Study||0
1704344|NCT00422032|4167192|P2|COMPLETED|Overall Study||21
1704345|NCT00422032|4167193|P1|COMPLETED|Overall Study||37
1704346|NCT00422032|4167192|P2|STARTED|Overall Study||21
1704347|NCT00422032|4167193|P1|STARTED|Overall Study||37
1704348|NCT00421993|4167203|P4|NOT COMPLETED|Overall Study||57
1704349|NCT00421993|4167204|P3|NOT COMPLETED|Overall Study||52
1704350|NCT00421993|4167205|P2|NOT COMPLETED|Overall Study||49
1704351|NCT00421993|4167206|P1|NOT COMPLETED|Overall Study||53
1704352|NCT00421993|4167203|P4|COMPLETED|Overall Study||361
1704353|NCT00421993|4167204|P3|COMPLETED|Overall Study||363
1704354|NCT00421993|4167205|P2|COMPLETED|Overall Study||369
1704355|NCT00421993|4167206|P1|COMPLETED|Overall Study||366
1704356|NCT00421993|4167203|P4|STARTED|Overall Study||418
1704357|NCT00421993|4167204|P3|STARTED|Overall Study||415
1704358|NCT00421993|4167205|P2|STARTED|Overall Study||418
1704359|NCT00421993|4167206|P1|STARTED|Overall Study||419
1704360|NCT00421954|4167236|P1|NOT COMPLETED|Overall Study||0
1704361|NCT00421954|4167236|P1|COMPLETED|Overall Study||0
1704362|NCT00421954|4167236|P1|STARTED|Overall Study||0
1704363|NCT00421928|4167243|P3|NOT COMPLETED|Overall Study||134
1704364|NCT00421928|4167244|P2|NOT COMPLETED|Overall Study||224
1704365|NCT00421928|4167245|P1|NOT COMPLETED|Overall Study||163
1704366|NCT00421928|4167243|P3|COMPLETED|Overall Study||203
1704367|NCT00421928|4167244|P2|COMPLETED|Overall Study||118
1704368|NCT00421928|4167245|P1|COMPLETED|Overall Study||181
1704369|NCT00421928|4167243|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
1704370|NCT00421928|4167244|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
1704371|NCT00421928|4167245|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
1704372|NCT00421889|4167280|P9|NOT COMPLETED|Overall Study||11
1704373|NCT00421889|4167281|P8|NOT COMPLETED|Overall Study||2
1704374|NCT00421889|4167282|P7|NOT COMPLETED|Overall Study||4
1704375|NCT00421889|4167283|P6|NOT COMPLETED|Overall Study||35
1704376|NCT00421889|4167284|P5|NOT COMPLETED|Overall Study||6
1704377|NCT00421889|4167285|P4|NOT COMPLETED|Overall Study||4
1704378|NCT00421889|4167286|P3|NOT COMPLETED|Overall Study||3
1704379|NCT00421889|4167287|P2|NOT COMPLETED|Overall Study||5
1704380|NCT00421889|4167288|P1|NOT COMPLETED|Overall Study||5
1704381|NCT00421889|4167280|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
1704382|NCT00421889|4167281|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
1704383|NCT00421889|4167282|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
1704384|NCT00421889|4167283|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
1704385|NCT00421889|4167284|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
1704386|NCT00421889|4167285|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
1704387|NCT00421889|4167286|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
1704388|NCT00421889|4167287|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
1704389|NCT00421889|4167288|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
1704390|NCT00421889|4167280|P9|STARTED|Overall Study||15
1704391|NCT00421889|4167281|P8|STARTED|Overall Study||3
1704392|NCT00421889|4167282|P7|STARTED|Overall Study||4
1704393|NCT00421889|4167283|P6|STARTED|Overall Study||35
1704394|NCT00421889|4167284|P5|STARTED|Overall Study||6
1704395|NCT00421889|4167285|P4|STARTED|Overall Study||4
1704396|NCT00421889|4167286|P3|STARTED|Overall Study||3
1704397|NCT00421889|4167287|P2|STARTED|Overall Study||5
1704398|NCT00421889|4167288|P1|STARTED|Overall Study||5
1704399|NCT00421733|4167333|P3|NOT COMPLETED|Overall Study||20
1704400|NCT00421733|4167334|P2|NOT COMPLETED|Overall Study||26
1704401|NCT00421733|4167335|P1|NOT COMPLETED|Overall Study||15
1704402|NCT00421733|4167333|P3|COMPLETED|Overall Study||73
1704403|NCT00421733|4167334|P2|COMPLETED|Overall Study||69
1704404|NCT00421733|4167335|P1|COMPLETED|Overall Study||78
1704405|NCT00421733|4167333|P3|STARTED|Overall Study||93
1704406|NCT00421733|4167334|P2|STARTED|Overall Study||95
1704407|NCT00421733|4167335|P1|STARTED|Overall Study||93
1704408|NCT00421707|4167355|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
1704409|NCT00421707|4167356|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
1704410|NCT00421707|4167355|P2|COMPLETED|Period 3:Treatment Period 2||49
1704411|NCT00421707|4167356|P1|COMPLETED|Period 3:Treatment Period 2||53
1704412|NCT00421707|4167355|P2|STARTED|Period 3:Treatment Period 2||52
1704413|NCT00421707|4167356|P1|STARTED|Period 3:Treatment Period 2||55
1704414|NCT00421707|4167355|P2|NOT COMPLETED|Period 2: Washout||4
1704415|NCT00421707|4167356|P1|NOT COMPLETED|Period 2: Washout||1
1704416|NCT00421707|4167355|P2|COMPLETED|Period 2: Washout||52
1704417|NCT00421707|4167356|P1|COMPLETED|Period 2: Washout||55
1704418|NCT00421707|4167355|P2|STARTED|Period 2: Washout||56
1704419|NCT00421707|4167356|P1|STARTED|Period 2: Washout||56
1704420|NCT00421707|4167355|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
1704421|NCT00421707|4167356|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
1704422|NCT00421707|4167355|P2|COMPLETED|Period 1: Treatment Period 1||56
1704423|NCT00421707|4167356|P1|COMPLETED|Period 1: Treatment Period 1||56
1704424|NCT00421707|4167355|P2|STARTED|Period 1: Treatment Period 1||65
1704425|NCT00421707|4167356|P1|STARTED|Period 1: Treatment Period 1||67
1704426|NCT00421603|4167398|P2|NOT COMPLETED|Overall Study||12
1704427|NCT00421603|4167399|P1|NOT COMPLETED|Overall Study||11
1704428|NCT00421603|4167398|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
1704429|NCT00421603|4167399|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
1704430|NCT00421603|4167398|P2|STARTED|Overall Study||42
1704431|NCT00421603|4167399|P1|STARTED|Overall Study||39
1704432|NCT00421408|4167407|P2|NOT COMPLETED|Overall Study||45
1704433|NCT00421408|4167408|P1|NOT COMPLETED|Overall Study||42
1704434|NCT00421408|4167407|P2|COMPLETED|Overall Study||61
1704435|NCT00421408|4167408|P1|COMPLETED|Overall Study||60
1704436|NCT00421408|4167407|P2|STARTED|Overall Study||106
1704437|NCT00421408|4167408|P1|STARTED|Overall Study||102
1704438|NCT00421343|4167426|P1|NOT COMPLETED|Overall Study||6
1704439|NCT00421343|4167426|P1|COMPLETED|Overall Study||23
1704440|NCT00421343|4167426|P1|STARTED|Overall Study||29
1704441|NCT00421174|4167432|P2|NOT COMPLETED|Overall Study||1
1704442|NCT00421174|4167433|P1|NOT COMPLETED|Overall Study||2
1704443|NCT00421174|4167432|P2|COMPLETED|Overall Study||18
1704444|NCT00421174|4167433|P1|COMPLETED|Overall Study||16
1704445|NCT00421174|4167432|P2|STARTED|Overall Study||19
1704446|NCT00421174|4167433|P1|STARTED|Overall Study||18
1704447|NCT00420992|4167463|P2|NOT COMPLETED|Maintenance Phase||75
1704448|NCT00420992|4167464|P1|NOT COMPLETED|Maintenance Phase||61
1704449|NCT00420992|4167463|P2|COMPLETED|Maintenance Phase||98
1704450|NCT00420992|4167464|P1|COMPLETED|Maintenance Phase||110
1704451|NCT00420992|4167463|P2|STARTED|Maintenance Phase||173
1704452|NCT00420992|4167464|P1|STARTED|Maintenance Phase||171
1704453|NCT00420992|4167463|P2|NOT COMPLETED|Titration Phase||0
1704454|NCT00420992|4167464|P1|NOT COMPLETED|Titration Phase||203
1704455|NCT00420992|4167463|P2|COMPLETED|Titration Phase||0
1704456|NCT00420992|4167464|P1|COMPLETED|Titration Phase||344
1704457|NCT00420992|4167463|P2|STARTED|Titration Phase||0
1704458|NCT00420992|4167464|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
1704459|NCT00420927|4167478|P7|NOT COMPLETED|Period 2||53
1704460|NCT00420927|4167479|P6|NOT COMPLETED|Period 2||15
1704461|NCT00420927|4167480|P5|NOT COMPLETED|Period 2||43
1704462|NCT00420927|4167481|P4|NOT COMPLETED|Period 2||10
1704463|NCT00420927|4167482|P3|NOT COMPLETED|Period 2||13
1704464|NCT00420927|4167483|P2|NOT COMPLETED|Period 2||0
1704465|NCT00420927|4167484|P1|NOT COMPLETED|Period 2||0
1704466|NCT00420927|4167478|P7|COMPLETED|Period 2||295
1704467|NCT00420927|4167479|P6|COMPLETED|Period 2||97
1704468|NCT00420927|4167480|P5|COMPLETED|Period 2||216
1704469|NCT00420927|4167481|P4|COMPLETED|Period 2||95
1704470|NCT00420927|4167482|P3|COMPLETED|Period 2||89
1704471|NCT00420927|4167483|P2|COMPLETED|Period 2||0
1704472|NCT00420927|4167484|P1|COMPLETED|Period 2||0
1704473|NCT00420927|4167478|P7|STARTED|Period 2||348
1704474|NCT00420927|4167479|P6|STARTED|Period 2||112
1704475|NCT00420927|4167480|P5|STARTED|Period 2||259
1704476|NCT00420927|4167481|P4|STARTED|Period 2||105
1704477|NCT00420927|4167482|P3|STARTED|Period 2||102
1704478|NCT00420927|4167483|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
1704479|NCT00420927|4167484|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
1704480|NCT00420927|4167478|P7|NOT COMPLETED|Period 1||0
1704481|NCT00420927|4167479|P6|NOT COMPLETED|Period 1||0
1704482|NCT00420927|4167480|P5|NOT COMPLETED|Period 1||0
1704483|NCT00420927|4167481|P4|NOT COMPLETED|Period 1||0
1704484|NCT00420927|4167482|P3|NOT COMPLETED|Period 1||0
1704485|NCT00420927|4167483|P2|NOT COMPLETED|Period 1||57
1704486|NCT00420927|4167484|P1|NOT COMPLETED|Period 1||49
1704487|NCT00420927|4167478|P7|COMPLETED|Period 1||0
1704488|NCT00420927|4167479|P6|COMPLETED|Period 1||0
1704489|NCT00420927|4167480|P5|COMPLETED|Period 1||0
1704490|NCT00420927|4167481|P4|COMPLETED|Period 1||0
1704491|NCT00420927|4167482|P3|COMPLETED|Period 1||0
1704492|NCT00420927|4167483|P2|COMPLETED|Period 1||460
1704493|NCT00420927|4167484|P1|COMPLETED|Period 1||466
1704494|NCT00420927|4167478|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1704495|NCT00420927|4167479|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1704496|NCT00420927|4167480|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1704497|NCT00420927|4167481|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1704498|NCT00420927|4167482|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
1704499|NCT00420927|4167483|P2|STARTED|Period 1||517
1704500|NCT00420927|4167484|P1|STARTED|Period 1||515
1704501|NCT00420849|4167588|P1|NOT COMPLETED|Overall Study||331
1704502|NCT00420849|4167588|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
1704503|NCT00420849|4167588|P1|STARTED|Overall Study||587
1704504|NCT00420784|4167657|P4|NOT COMPLETED|Overall Study||78
1704505|NCT00420784|4167658|P3|NOT COMPLETED|Overall Study||53
1704506|NCT00420784|4167659|P2|NOT COMPLETED|Overall Study||58
1704507|NCT00420784|4167660|P1|NOT COMPLETED|Overall Study||29
1704508|NCT00420784|4167657|P4|COMPLETED|Overall Study||36
1704509|NCT00420784|4167658|P3|COMPLETED|Overall Study||58
1704510|NCT00420784|4167659|P2|COMPLETED|Overall Study||55
1704511|NCT00420784|4167660|P1|COMPLETED|Overall Study||86
1704512|NCT00420784|4167657|P4|STARTED|Overall Study||114
1704513|NCT00420784|4167658|P3|STARTED|Overall Study||111
1704514|NCT00420784|4167659|P2|STARTED|Overall Study||113
1704515|NCT00420784|4167660|P1|STARTED|Overall Study||115
1704516|NCT00420771|4167689|P2|NOT COMPLETED|Overall Study||4
1704517|NCT00420771|4167690|P1|NOT COMPLETED|Overall Study||3
1704518|NCT00420771|4167689|P2|COMPLETED|Overall Study||7
1704519|NCT00420771|4167690|P1|COMPLETED|Overall Study||5
1704520|NCT00420771|4167689|P2|STARTED|Overall Study||11
1704521|NCT00420771|4167690|P1|STARTED|Overall Study||8
1704522|NCT00420745|4167698|P2|NOT COMPLETED|Overall Study||6
1704523|NCT00420745|4167699|P1|NOT COMPLETED|Overall Study||15
1704524|NCT00420745|4167698|P2|COMPLETED|Overall Study||333
1704525|NCT00420745|4167699|P1|COMPLETED|Overall Study||655
1704526|NCT00420745|4167698|P2|STARTED|Overall Study||339
1704527|NCT00420745|4167699|P1|STARTED|Overall Study||670
1704528|NCT00420641|4167718|P3|NOT COMPLETED|Overall Study||44
1704529|NCT00420641|4167719|P2|NOT COMPLETED|Overall Study||72
1704530|NCT00420641|4167720|P1|NOT COMPLETED|Overall Study||45
1704531|NCT00420641|4167718|P3|COMPLETED|Overall Study||128
1704532|NCT00420641|4167719|P2|COMPLETED|Overall Study||100
1704533|NCT00420641|4167720|P1|COMPLETED|Overall Study||115
1704534|NCT00420641|4167718|P3|STARTED|Overall Study||172
1704535|NCT00420641|4167719|P2|STARTED|Overall Study||172
1704536|NCT00420641|4167720|P1|STARTED|Overall Study||160
1704537|NCT00420628|4167796|P2|NOT COMPLETED|Overall Study||4
1704538|NCT00420628|4167797|P1|NOT COMPLETED|Overall Study||9
1704539|NCT00420628|4167796|P2|COMPLETED|Overall Study||32
1704540|NCT00420628|4167797|P1|COMPLETED|Overall Study||63
1704541|NCT00420628|4167796|P2|STARTED|Overall Study||36
1704542|NCT00420628|4167797|P1|STARTED|Overall Study||72
1704543|NCT00420511|4167813|P2|NOT COMPLETED|Overall Study||1
1704544|NCT00420511|4167814|P1|NOT COMPLETED|Overall Study||2
1704545|NCT00420511|4167813|P2|COMPLETED|Overall Study||10
1704546|NCT00420511|4167814|P1|COMPLETED|Overall Study||8
1704547|NCT00420511|4167813|P2|STARTED|Overall Study||11
1704548|NCT00420511|4167814|P1|STARTED|Overall Study||10
1704549|NCT00420459|4167824|P1|NOT COMPLETED|Overall Study||0
1704550|NCT00420459|4167824|P1|COMPLETED|Overall Study||12
1704551|NCT00420459|4167824|P1|STARTED|Overall Study||12
1704552|NCT00420420|4167835|P2|NOT COMPLETED|Overall Study||4
1704553|NCT00420420|4167836|P1|NOT COMPLETED|Overall Study||8
1704554|NCT00420420|4167835|P2|COMPLETED|Overall Study||67
1704555|NCT00420420|4167836|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
1704556|NCT00420420|4167835|P2|STARTED|Overall Study|Number of patients randomized.|71
1704557|NCT00420420|4167836|P1|STARTED|Overall Study|Number of patients randomized.|73
1704558|NCT00420407|4167854|P2|NOT COMPLETED|Overall Study||6
1704559|NCT00420407|4167855|P1|NOT COMPLETED|Overall Study||4
1704560|NCT00420407|4167854|P2|COMPLETED|Overall Study||34
1704561|NCT00420407|4167855|P1|COMPLETED|Overall Study||37
1704562|NCT00420407|4167854|P2|STARTED|Overall Study||40
1704563|NCT00420407|4167855|P1|STARTED|Overall Study||41
1704564|NCT00420342|4167864|P3|NOT COMPLETED|Overall Study||1
1704565|NCT00420342|4167865|P2|NOT COMPLETED|Overall Study||2
1704566|NCT00420342|4167866|P1|NOT COMPLETED|Overall Study||1
1704567|NCT00420342|4167864|P3|COMPLETED|Overall Study||28
1704568|NCT00420342|4167865|P2|COMPLETED|Overall Study||31
1704569|NCT00420342|4167866|P1|COMPLETED|Overall Study||29
1704570|NCT00420342|4167864|P3|Received Treatment|Overall Study||29
1704571|NCT00420342|4167865|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
1704572|NCT00420342|4167866|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
1704573|NCT00420342|4167864|P3|STARTED|Overall Study||29
1704574|NCT00420342|4167865|P2|STARTED|Overall Study||33
1704575|NCT00420342|4167866|P1|STARTED|Overall Study||30
1704576|NCT00420316|4167909|P2|NOT COMPLETED|Overall Study||9
1704577|NCT00420316|4167910|P1|NOT COMPLETED|Overall Study||12
1704578|NCT00420316|4167909|P2|COMPLETED|Overall Study||522
1704579|NCT00420316|4167910|P1|COMPLETED|Overall Study||1070
1704580|NCT00420316|4167909|P2|STARTED|Overall Study||531
1704581|NCT00420316|4167910|P1|STARTED|Overall Study||1082
1704582|NCT00420303|4167934|P2|NOT COMPLETED|Overall Study||4
1704583|NCT00420303|4167935|P1|NOT COMPLETED|Overall Study||1
1704584|NCT00420303|4167934|P2|COMPLETED|Overall Study||8
1704585|NCT00420303|4167935|P1|COMPLETED|Overall Study||11
1704586|NCT00420303|4167934|P2|STARTED|Overall Study||12
1704587|NCT00420303|4167935|P1|STARTED|Overall Study||12
1704588|NCT00420290|4167947|P2|NOT COMPLETED|Overall Study||4
1704589|NCT00420290|4167948|P1|NOT COMPLETED|Overall Study||4
1704590|NCT00420290|4167947|P2|COMPLETED|Overall Study||7
1704591|NCT00420290|4167948|P1|COMPLETED|Overall Study||7
1704592|NCT00420290|4167947|P2|STARTED|Overall Study||11
1704593|NCT00420290|4167948|P1|STARTED|Overall Study||11
1704594|NCT00420238|4167964|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
1704595|NCT00420238|4167965|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
1704596|NCT00420238|4167964|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
1704597|NCT00420238|4167965|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
1704598|NCT00420238|4167964|P2|STARTED|12 Week Open-Label Treatment Period 2||39
1704599|NCT00420238|4167965|P1|STARTED|12 Week Open-Label Treatment Period 2||38
1704600|NCT00420238|4167964|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
1704601|NCT00420238|4167965|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
1704602|NCT00420238|4167964|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
1704603|NCT00420238|4167965|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
1704604|NCT00420238|4167964|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
1704605|NCT00420238|4167965|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
1704606|NCT00420212|4168104|P3|NOT COMPLETED|Overall Study||96
1704607|NCT00420212|4168105|P2|NOT COMPLETED|Overall Study||95
1704608|NCT00420212|4168106|P1|NOT COMPLETED|Overall Study||91
1704609|NCT00420212|4168104|P3|COMPLETED|Overall Study||320
1704610|NCT00420212|4168105|P2|COMPLETED|Overall Study||315
1704611|NCT00420212|4168106|P1|COMPLETED|Overall Study||317
1704612|NCT00420212|4168104|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
1704613|NCT00420212|4168105|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
1704614|NCT00420212|4168106|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
1704615|NCT00420199|4168132|P2|NOT COMPLETED|Overall Study||0
1704616|NCT00420199|4168133|P1|NOT COMPLETED|Overall Study||1
1704617|NCT00420199|4168132|P2|COMPLETED|Overall Study||23
1704618|NCT00420199|4168133|P1|COMPLETED|Overall Study||26
1704619|NCT00420199|4168132|P2|STARTED|Overall Study||23
1704620|NCT00420199|4168133|P1|STARTED|Overall Study||27
1704621|NCT00420147|4168188|P2|NOT COMPLETED|Overall Study||0
1704622|NCT00420147|4168189|P1|NOT COMPLETED|Overall Study||0
1704623|NCT00420147|4168188|P2|COMPLETED|Overall Study||19
1704624|NCT00420147|4168189|P1|COMPLETED|Overall Study||19
1704625|NCT00420147|4168188|P2|STARTED|Overall Study||19
1704626|NCT00420147|4168189|P1|STARTED|Overall Study||19
1704627|NCT00420095|4168199|P2|NOT COMPLETED|Overall Study||1
1704628|NCT00420095|4168200|P1|NOT COMPLETED|Overall Study||3
1704629|NCT00420095|4168199|P2|COMPLETED|Overall Study||59
1704630|NCT00420095|4168200|P1|COMPLETED|Overall Study||54
1704631|NCT00420095|4168199|P2|STARTED|Overall Study||60
1704632|NCT00420095|4168200|P1|STARTED|Overall Study||57
1704633|NCT00420056|4168218|P1|NOT COMPLETED|Overall Study||17
1704634|NCT00420056|4168218|P1|COMPLETED|Overall Study||0
1704635|NCT00420056|4168218|P1|STARTED|Overall Study||17
1704636|NCT00420017|4168242|P2|NOT COMPLETED|Overall Study||0
1704637|NCT00420017|4168243|P1|NOT COMPLETED|Overall Study||2
1704638|NCT00420017|4168242|P2|COMPLETED|Overall Study||40
1704639|NCT00420017|4168243|P1|COMPLETED|Overall Study|40 completed analysis|38
1704640|NCT00420017|4168242|P2|STARTED|Overall Study||40
1704641|NCT00420017|4168243|P1|STARTED|Overall Study||40
1704642|NCT00420004|4168258|P3|NOT COMPLETED|Overall Study||32
1704643|NCT00420004|4168259|P2|NOT COMPLETED|Overall Study||71
1704644|NCT00420004|4168260|P1|NOT COMPLETED|Overall Study||129
1704645|NCT00420004|4168258|P3|COMPLETED|Overall Study||30
1704646|NCT00420004|4168259|P2|COMPLETED|Overall Study||67
1704647|NCT00420004|4168260|P1|COMPLETED|Overall Study||140
1704648|NCT00420004|4168258|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
1704649|NCT00420004|4168259|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
1704650|NCT00420004|4168260|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
1704651|NCT00420004|4168258|P3|STARTED|Overall Study||62
1704652|NCT00420004|4168259|P2|STARTED|Overall Study||138
1704653|NCT00420004|4168260|P1|STARTED|Overall Study||269
1704654|NCT00419952|4168325|P2|NOT COMPLETED|Overall Study||125
1704655|NCT00419952|4168326|P1|NOT COMPLETED|Overall Study||149
1704656|NCT00419952|4168325|P2|COMPLETED|Overall Study||240
1704657|NCT00419952|4168326|P1|COMPLETED|Overall Study||228
1704658|NCT00419952|4168325|P2|STARTED|Overall Study||365
1704659|NCT00419952|4168326|P1|STARTED|Overall Study||377
1704660|NCT00419926|4168360|P2|NOT COMPLETED|Overall Study||10
1704661|NCT00419926|4168361|P1|NOT COMPLETED|Overall Study||14
1704662|NCT00419926|4168360|P2|COMPLETED|Overall Study||148
1704663|NCT00419926|4168361|P1|COMPLETED|Overall Study||141
1704664|NCT00419926|4168360|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
1704665|NCT00419926|4168361|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
1704666|NCT00419770|4168377|P2|NOT COMPLETED|Overall Study||1
1704667|NCT00419770|4168378|P1|NOT COMPLETED|Overall Study||5
1704668|NCT00419770|4168377|P2|COMPLETED|Overall Study||8
1704669|NCT00419770|4168378|P1|COMPLETED|Overall Study||6
1704670|NCT00419770|4168377|P2|STARTED|Overall Study||9
1704671|NCT00419770|4168378|P1|STARTED|Overall Study||11
1704672|NCT00419757|4168386|P2|NOT COMPLETED|Overall Study||21
1704673|NCT00419757|4168387|P1|NOT COMPLETED|Overall Study||18
1704674|NCT00419757|4168386|P2|COMPLETED|Overall Study|Randomized patients|102
1704675|NCT00419757|4168387|P1|COMPLETED|Overall Study|Randomized patients|109
1704676|NCT00419757|4168386|P2|STARTED|Overall Study|Randomized patients|123
1704677|NCT00419757|4168387|P1|STARTED|Overall Study|Randomized patients|127
1704678|NCT00419744|4168426|P3|NOT COMPLETED|Overall Study||133
1704679|NCT00419744|4168427|P2|NOT COMPLETED|Overall Study||118
1704680|NCT00419744|4168428|P1|NOT COMPLETED|Overall Study||117
1704681|NCT00419744|4168426|P3|COMPLETED|Overall Study||271
1704682|NCT00419744|4168427|P2|COMPLETED|Overall Study||290
1704683|NCT00419744|4168428|P1|COMPLETED|Overall Study||290
1704684|NCT00419744|4168426|P3|STARTED|Overall Study||404
1704685|NCT00419744|4168427|P2|STARTED|Overall Study||408
1704686|NCT00419744|4168428|P1|STARTED|Overall Study||407
1704687|NCT00419445|4168460|P3|NOT COMPLETED|Overall Study||1
1704688|NCT00419445|4168461|P2|NOT COMPLETED|Overall Study||2
1704689|NCT00419445|4168462|P1|NOT COMPLETED|Overall Study||1
1704690|NCT00419445|4168460|P3|COMPLETED|Overall Study||7
1704691|NCT00419445|4168461|P2|COMPLETED|Overall Study||14
1704692|NCT00419445|4168462|P1|COMPLETED|Overall Study||7
1704693|NCT00419445|4168460|P3|STARTED|Overall Study||8
1704694|NCT00419445|4168461|P2|STARTED|Overall Study||16
1704695|NCT00419445|4168462|P1|STARTED|Overall Study||8
1704696|NCT00419393|4168470|P1|NOT COMPLETED|Overall Study||24
1704697|NCT00419393|4168470|P1|COMPLETED|Overall Study||166
1704698|NCT00419393|4168470|P1|STARTED|Overall Study|One subject did not receive medication|190
1704699|NCT00419380|4168480|P2|NOT COMPLETED|Overall Study||10
1704700|NCT00419380|4168481|P1|NOT COMPLETED|Overall Study||1
1704701|NCT00419380|4168480|P2|COMPLETED|Overall Study||12
1704702|NCT00419380|4168481|P1|COMPLETED|Overall Study||18
1704703|NCT00419380|4168480|P2|STARTED|Overall Study||22
1704704|NCT00419380|4168481|P1|STARTED|Overall Study||19
1704705|NCT00419341|4168489|P1|NOT COMPLETED|Efficacy Period||10
1704706|NCT00419341|4168489|P1|COMPLETED|Efficacy Period||28
1704707|NCT00419341|4168489|P1|STARTED|Efficacy Period||38
1704708|NCT00419341|4168489|P1|NOT COMPLETED|Wash in/Wash Out Period||11
1704709|NCT00419341|4168489|P1|COMPLETED|Wash in/Wash Out Period||38
1704710|NCT00419341|4168489|P1|STARTED|Wash in/Wash Out Period||49
1704711|NCT00419315|4168512|P2|NOT COMPLETED|Overall Study||0
1704712|NCT00419315|4168513|P1|NOT COMPLETED|Overall Study||0
1704713|NCT00419315|4168512|P2|COMPLETED|Overall Study||78
1704714|NCT00419315|4168513|P1|COMPLETED|Overall Study||85
1704715|NCT00419315|4168512|P2|STARTED|Overall Study||78
1704716|NCT00419315|4168513|P1|STARTED|Overall Study||85
1704717|NCT00419263|4168524|P3|NOT COMPLETED|Overall Study||3
1704718|NCT00419263|4168525|P2|NOT COMPLETED|Overall Study||2
1704719|NCT00419263|4168526|P1|NOT COMPLETED|Overall Study||3
1704720|NCT00419263|4168524|P3|COMPLETED|Overall Study||112
1704721|NCT00419263|4168525|P2|COMPLETED|Overall Study||112
1704722|NCT00419263|4168526|P1|COMPLETED|Overall Study||112
1704723|NCT00419263|4168524|P3|STARTED|Overall Study||115
1704724|NCT00419263|4168525|P2|STARTED|Overall Study||114
1704725|NCT00419263|4168526|P1|STARTED|Overall Study||115
1704726|NCT00419159|4168555|P2|NOT COMPLETED|Overall Study||100
1704727|NCT00419159|4168556|P1|NOT COMPLETED|Overall Study||99
1704728|NCT00419159|4168555|P2|COMPLETED|Overall Study||0
1704729|NCT00419159|4168556|P1|COMPLETED|Overall Study||0
1704730|NCT00419159|4168555|P2|STARTED|Overall Study||100
1704731|NCT00419159|4168556|P1|STARTED|Overall Study|Full Analysis Set|99
1704732|NCT00419120|4168570|P1|NOT COMPLETED|Long Term Follow up Period||10
1704733|NCT00419120|4168570|P1|COMPLETED|Long Term Follow up Period||0
1704734|NCT00419120|4168570|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
1704735|NCT00419120|4168570|P1|NOT COMPLETED|Primary Study Period||0
1704736|NCT00419120|4168570|P1|COMPLETED|Primary Study Period||10
1704737|NCT00419120|4168570|P1|STARTED|Primary Study Period||10
1704738|NCT00419094|4168577|P2|NOT COMPLETED|Overall Study||30
1704739|NCT00419094|4168578|P1|NOT COMPLETED|Overall Study||7
1704740|NCT00419094|4168577|P2|COMPLETED|Overall Study||141
1704741|NCT00419094|4168578|P1|COMPLETED|Overall Study||50
1704742|NCT00419094|4168577|P2|STARTED|Overall Study||171
1704743|NCT00419094|4168578|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
1704744|NCT00419003|4168592|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
1704745|NCT00419003|4168593|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
1704746|NCT00419003|4168592|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
1704747|NCT00419003|4168593|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
1704748|NCT00419003|4168592|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
1704749|NCT00419003|4168593|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
1704750|NCT00419003|4168592|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
1704751|NCT00419003|4168593|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
1704752|NCT00419003|4168592|P2|COMPLETED|Phase I, Ketamine Infusion||7
1704753|NCT00419003|4168593|P1|COMPLETED|Phase I, Ketamine Infusion||7
1704754|NCT00419003|4168592|P2|STARTED|Phase I, Ketamine Infusion||13
1704755|NCT00419003|4168593|P1|STARTED|Phase I, Ketamine Infusion||13
1704756|NCT00418977|4168604|P2|NOT COMPLETED|Overall Study||3
1704757|NCT00418977|4168605|P1|NOT COMPLETED|Overall Study||3
1704758|NCT00418977|4168604|P2|COMPLETED|Overall Study||13
1704759|NCT00418977|4168605|P1|COMPLETED|Overall Study||40
1704760|NCT00418977|4168604|P2|STARTED|Overall Study||16
1704761|NCT00418977|4168605|P1|STARTED|Overall Study||43
1704762|NCT00418964|4168622|P3|NOT COMPLETED|Overall Study||6
1704763|NCT00418964|4168623|P2|NOT COMPLETED|Overall Study||3
1704764|NCT00418964|4168624|P1|NOT COMPLETED|Overall Study||1
1704765|NCT00418964|4168622|P3|COMPLETED|Overall Study||14
1704766|NCT00418964|4168623|P2|COMPLETED|Overall Study||17
1704767|NCT00418964|4168624|P1|COMPLETED|Overall Study||21
1704768|NCT00418964|4168622|P3|STARTED|Overall Study||20
1704769|NCT00418964|4168623|P2|STARTED|Overall Study||20
1704770|NCT00418964|4168624|P1|STARTED|Overall Study||22
1704771|NCT00418951|4168635|P3|NOT COMPLETED|Overall Study||0
1704772|NCT00418951|4168636|P2|NOT COMPLETED|Overall Study||0
1704773|NCT00418951|4168637|P1|NOT COMPLETED|Overall Study||0
1704774|NCT00418951|4168635|P3|COMPLETED|Overall Study||40
1704775|NCT00418951|4168636|P2|COMPLETED|Overall Study||33
1704776|NCT00418951|4168637|P1|COMPLETED|Overall Study||39
1704777|NCT00418951|4168635|P3|STARTED|Overall Study||40
1704778|NCT00418951|4168636|P2|STARTED|Overall Study||33
1704779|NCT00418951|4168637|P1|STARTED|Overall Study||39
1704780|NCT00418938|4168647|P2|NOT COMPLETED|Overall Study||23
1704781|NCT00418938|4168648|P1|NOT COMPLETED|Overall Study||24
1704782|NCT00418938|4168647|P2|COMPLETED|Overall Study||108
1704783|NCT00418938|4168648|P1|COMPLETED|Overall Study||109
1704784|NCT00418938|4168647|P2|STARTED|Overall Study||131
1704785|NCT00418938|4168648|P1|STARTED|Overall Study||133
1704786|NCT00418886|4168668|P2|NOT COMPLETED|Overall Study||255
1704787|NCT00418886|4168669|P1|NOT COMPLETED|Overall Study||226
1704788|NCT00418886|4168668|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
1704789|NCT00418886|4168669|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
1704790|NCT00418886|4168668|P2|STARTED|Overall Study|randomised patients|278
1704791|NCT00418886|4168669|P1|STARTED|Overall Study|randomised patients|256
1704792|NCT00418834|4168695|P2|NOT COMPLETED|Overall Study||20
1704793|NCT00418834|4168696|P1|NOT COMPLETED|Overall Study||23
1704794|NCT00418834|4168695|P2|COMPLETED|Overall Study||507
1704795|NCT00418834|4168696|P1|COMPLETED|Overall Study||503
1704796|NCT00418834|4168695|P2|STARTED|Overall Study||527
1704797|NCT00418834|4168696|P1|STARTED|Overall Study||526
1704798|NCT00418717|4168756|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
1704799|NCT00418717|4168756|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
1704800|NCT00418717|4168756|P1|STARTED|Treatment Period B - Weeks 5-12||41
1704801|NCT00418717|4168756|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
1704802|NCT00418717|4168756|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
1704803|NCT00418717|4168756|P1|STARTED|Treatment Period A - Weeks 1-4||42
1704804|NCT00418691|4168764|P3|NOT COMPLETED|Overall Study||5
1704805|NCT00418691|4168765|P2|NOT COMPLETED|Overall Study||2
1704806|NCT00418691|4168766|P1|NOT COMPLETED|Overall Study||2
1704807|NCT00418691|4168764|P3|COMPLETED|Overall Study||5
1704808|NCT00418691|4168765|P2|COMPLETED|Overall Study||10
1704809|NCT00418691|4168766|P1|COMPLETED|Overall Study||9
1704810|NCT00418691|4168764|P3|STARTED|Overall Study||10
1704811|NCT00418691|4168765|P2|STARTED|Overall Study||12
1704812|NCT00418691|4168766|P1|STARTED|Overall Study||11
1704813|NCT00418665|4168777|P3|NOT COMPLETED|Treatment Extension||2
1704814|NCT00418665|4168778|P2|NOT COMPLETED|Treatment Extension||4
1704815|NCT00418665|4168779|P1|NOT COMPLETED|Treatment Extension||6
1704816|NCT00418665|4168777|P3|COMPLETED|Treatment Extension||7
1704817|NCT00418665|4168778|P2|COMPLETED|Treatment Extension||4
1704818|NCT00418665|4168779|P1|COMPLETED|Treatment Extension||1
1704819|NCT00418665|4168777|P3|STARTED|Treatment Extension||9
1704820|NCT00418665|4168778|P2|STARTED|Treatment Extension||8
1704821|NCT00418665|4168779|P1|STARTED|Treatment Extension||7
1704822|NCT00418665|4168777|P3|NOT COMPLETED|Treatment Period||4
1704823|NCT00418665|4168778|P2|NOT COMPLETED|Treatment Period||6
1704824|NCT00418665|4168779|P1|NOT COMPLETED|Treatment Period||5
1704825|NCT00418665|4168777|P3|COMPLETED|Treatment Period||9
1704826|NCT00418665|4168778|P2|COMPLETED|Treatment Period||8
1704827|NCT00418665|4168779|P1|COMPLETED|Treatment Period||7
1704828|NCT00418665|4168777|P3|Received Study Medication|Treatment Period||13
1704829|NCT00418665|4168778|P2|Received Study Medication|Treatment Period||13
1704830|NCT00418665|4168779|P1|Received Study Medication|Treatment Period||11
1704831|NCT00418665|4168777|P3|STARTED|Treatment Period||13
1704832|NCT00418665|4168778|P2|STARTED|Treatment Period||14
1704833|NCT00418665|4168779|P1|STARTED|Treatment Period||12
1704834|NCT00418574|4168798|P2|NOT COMPLETED|Overall Study||23
1704835|NCT00418574|4168799|P1|NOT COMPLETED|Overall Study||48
1704836|NCT00418574|4168798|P2|COMPLETED|Overall Study||272
1704837|NCT00418574|4168799|P1|COMPLETED|Overall Study||545
1704838|NCT00418574|4168798|P2|TREATED|Overall Study||294
1704839|NCT00418574|4168799|P1|TREATED|Overall Study||592
1704840|NCT00418574|4168798|P2|STARTED|Overall Study||295
1704841|NCT00418574|4168799|P1|STARTED|Overall Study||593
1704842|NCT00418561|4168813|P3|NOT COMPLETED|Overall Study||0
1704843|NCT00418561|4168814|P2|NOT COMPLETED|Overall Study||1
1704844|NCT00418561|4168815|P1|NOT COMPLETED|Overall Study||0
1704845|NCT00418561|4168813|P3|COMPLETED|Overall Study||4
1704846|NCT00418561|4168814|P2|COMPLETED|Overall Study||4
1704847|NCT00418561|4168815|P1|COMPLETED|Overall Study||4
1704848|NCT00418561|4168813|P3|STARTED|Overall Study||4
1704849|NCT00418561|4168814|P2|STARTED|Overall Study||5
1704850|NCT00418561|4168815|P1|STARTED|Overall Study||4
1704851|NCT00418522|4168885|P2|NOT COMPLETED|Overall Study||42
1704852|NCT00418522|4168886|P1|NOT COMPLETED|Overall Study||83
1704853|NCT00418522|4168885|P2|COMPLETED|Overall Study||152
1704854|NCT00418522|4168886|P1|COMPLETED|Overall Study||136
1704855|NCT00418522|4168885|P2|Received Treatment|Overall Study||190
1704856|NCT00418522|4168886|P1|Received Treatment|Overall Study||212
1704857|NCT00418522|4168885|P2|STARTED|Overall Study||194
1704858|NCT00418522|4168886|P1|STARTED|Overall Study||219
1704859|NCT00418379|4168933|P3|NOT COMPLETED|Year 5||3
1704860|NCT00418379|4168934|P2|NOT COMPLETED|Year 5||5
1704861|NCT00418379|4168935|P1|NOT COMPLETED|Year 5||2
1704862|NCT00418379|4168933|P3|COMPLETED|Year 5||131
1704863|NCT00418379|4168934|P2|COMPLETED|Year 5||115
1704864|NCT00418379|4168935|P1|COMPLETED|Year 5||126
1704865|NCT00418379|4168933|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
1704866|NCT00418379|4168934|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
1704867|NCT00418379|4168935|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
1704868|NCT00418379|4168933|P3|NOT COMPLETED|Year 4||2
1704869|NCT00418379|4168934|P2|NOT COMPLETED|Year 4||5
1704870|NCT00418379|4168935|P1|NOT COMPLETED|Year 4||3
1704871|NCT00418379|4168933|P3|COMPLETED|Year 4||154
1704872|NCT00418379|4168934|P2|COMPLETED|Year 4||136
1704873|NCT00418379|4168935|P1|COMPLETED|Year 4||142
1704874|NCT00418379|4168933|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
1704875|NCT00418379|4168934|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
1704876|NCT00418379|4168935|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
1704877|NCT00418379|4168933|P3|NOT COMPLETED|Year 3||3
1704878|NCT00418379|4168934|P2|NOT COMPLETED|Year 3||2
1704879|NCT00418379|4168935|P1|NOT COMPLETED|Year 3||3
1704880|NCT00418379|4168933|P3|COMPLETED|Year 3||163
1704881|NCT00418379|4168934|P2|COMPLETED|Year 3||146
1704882|NCT00418379|4168935|P1|COMPLETED|Year 3||148
1704883|NCT00418379|4168933|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
1704884|NCT00418379|4168934|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
1704885|NCT00418379|4168935|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
1704886|NCT00418379|4168933|P3|NOT COMPLETED|Year 2||10
1704887|NCT00418379|4168934|P2|NOT COMPLETED|Year 2||4
1704888|NCT00418379|4168935|P1|NOT COMPLETED|Year 2||8
1704889|NCT00418379|4168933|P3|COMPLETED|Year 2||172
1704890|NCT00418379|4168934|P2|COMPLETED|Year 2||155
1704891|NCT00418379|4168935|P1|COMPLETED|Year 2||159
1704892|NCT00418379|4168933|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
1704893|NCT00418379|4168934|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
1704894|NCT00418379|4168935|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
1704895|NCT00418379|4168933|P3|NOT COMPLETED|Year 1||15
1704896|NCT00418379|4168934|P2|NOT COMPLETED|Year 1||28
1704897|NCT00418379|4168935|P1|NOT COMPLETED|Year 1||18
1704898|NCT00418379|4168933|P3|COMPLETED|Year 1||204
1704899|NCT00418379|4168934|P2|COMPLETED|Year 1||179
1704900|NCT00418379|4168935|P1|COMPLETED|Year 1||189
1704901|NCT00418379|4168933|P3|STARTED|Year 1||219
1704902|NCT00418379|4168934|P2|STARTED|Year 1||207
1704903|NCT00418379|4168935|P1|STARTED|Year 1||207
1704904|NCT00418314|4168945|P2|NOT COMPLETED|Overall Study||2
1704905|NCT00418314|4168946|P1|NOT COMPLETED|Overall Study||1
1704906|NCT00418314|4168945|P2|COMPLETED|Overall Study||828
1704907|NCT00418314|4168946|P1|COMPLETED|Overall Study||816
1704908|NCT00418314|4168945|P2|STARTED|Overall Study||830
1704909|NCT00418314|4168946|P1|STARTED|Overall Study||817
1704910|NCT00418262|4168956|P1|NOT COMPLETED|Visits 8 Thru 10||5
1704911|NCT00418262|4168956|P1|COMPLETED|Visits 8 Thru 10||11
1704912|NCT00418262|4168956|P1|STARTED|Visits 8 Thru 10||16
1704913|NCT00418262|4168956|P1|NOT COMPLETED|Visits 5 Thru 8||9
1704914|NCT00418262|4168956|P1|COMPLETED|Visits 5 Thru 8||16
1704915|NCT00418262|4168956|P1|STARTED|Visits 5 Thru 8||25
1704916|NCT00418262|4168956|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
1704917|NCT00418262|4168956|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
1704918|NCT00418262|4168956|P1|STARTED|Visits 1 (Baseline) Thru 5||27
1704919|NCT00418184|4168976|P2|NOT COMPLETED|Open-label Phase||5
1704920|NCT00418184|4168977|P1|NOT COMPLETED|Open-label Phase||5
1704921|NCT00418184|4168976|P2|COMPLETED|Open-label Phase|5 dropped out|43
1704922|NCT00418184|4168977|P1|COMPLETED|Open-label Phase|5 dropped out|97
1704923|NCT00418184|4168976|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
1704924|NCT00418184|4168977|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
1704925|NCT00418184|4168976|P2|NOT COMPLETED|Double-blind Phase||11
1704926|NCT00418184|4168977|P1|NOT COMPLETED|Double-blind Phase||27
1704927|NCT00418184|4168976|P2|COMPLETED|Double-blind Phase||52
1704928|NCT00418184|4168977|P1|COMPLETED|Double-blind Phase||110
1704929|NCT00418184|4168976|P2|STARTED|Double-blind Phase||63
1704930|NCT00418184|4168977|P1|STARTED|Double-blind Phase||137
1704931|NCT00418145|4168985|P1|NOT COMPLETED|Overall Study||6
1704932|NCT00418145|4168985|P1|COMPLETED|Overall Study||10
1704933|NCT00418145|4168985|P1|STARTED|Overall Study||16
1704934|NCT00418093|4168997|P1|NOT COMPLETED|Overall Study||0
1704935|NCT00418093|4168997|P1|COMPLETED|Overall Study||19
1704936|NCT00418093|4168997|P1|Completed Study|Overall Study||19
1704937|NCT00418093|4168997|P1|STARTED|Overall Study||19
1704938|NCT00418028|4169006|P2|NOT COMPLETED|Overall Study||1
1704939|NCT00418028|4169007|P1|NOT COMPLETED|Overall Study||2
1704940|NCT00418028|4169006|P2|COMPLETED|Overall Study||97
1704941|NCT00418028|4169007|P1|COMPLETED|Overall Study||95
1704942|NCT00418028|4169006|P2|STARTED|Overall Study||98
1704943|NCT00418028|4169007|P1|STARTED|Overall Study||97
1704944|NCT00418015|4169029|P4|NOT COMPLETED|Overall Study||0
1704945|NCT00418015|4169030|P3|NOT COMPLETED|Overall Study||0
1704946|NCT00418015|4169031|P2|NOT COMPLETED|Overall Study||0
1704947|NCT00418015|4169032|P1|NOT COMPLETED|Overall Study||0
1704948|NCT00418015|4169029|P4|COMPLETED|Overall Study||25
1704949|NCT00418015|4169030|P3|COMPLETED|Overall Study||78
1704950|NCT00418015|4169031|P2|COMPLETED|Overall Study||46
1704951|NCT00418015|4169032|P1|COMPLETED|Overall Study||144
1704952|NCT00418015|4169029|P4|STARTED|Overall Study||25
1704953|NCT00418015|4169030|P3|STARTED|Overall Study||78
1704954|NCT00418015|4169031|P2|STARTED|Overall Study||46
1704955|NCT00418015|4169032|P1|STARTED|Overall Study||144
1704956|NCT00417989|4169060|P2|NOT COMPLETED|Overall Study||22
1704957|NCT00417989|4169061|P1|NOT COMPLETED|Overall Study||20
1704958|NCT00417989|4169060|P2|COMPLETED|Overall Study||219
1704959|NCT00417989|4169061|P1|COMPLETED|Overall Study||224
1704960|NCT00417989|4169060|P2|STARTED|Overall Study||241
1704961|NCT00417989|4169061|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
1704962|NCT00417976|4169083|P1|NOT COMPLETED|Overall Study||3
1704963|NCT00417976|4169083|P1|COMPLETED|Overall Study||39
1704964|NCT00417976|4169083|P1|STARTED|Overall Study||42
1704965|NCT00417963|4169088|P1|NOT COMPLETED|Overall Study||41
1704966|NCT00417963|4169088|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
1704967|NCT00417963|4169088|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
1704968|NCT00417885|4169105|P1|NOT COMPLETED|Overall Study||6
1704969|NCT00417885|4169105|P1|COMPLETED|Overall Study||0
1704970|NCT00417885|4169105|P1|STARTED|Overall Study||6
1704971|NCT00417612|4169116|P2|NOT COMPLETED|Overall Study||3
1704972|NCT00417612|4169117|P1|NOT COMPLETED|Overall Study||3
1704973|NCT00417612|4169116|P2|COMPLETED|Overall Study||8
1704974|NCT00417612|4169117|P1|COMPLETED|Overall Study||19
1704975|NCT00417612|4169116|P2|STARTED|Overall Study||11
1704976|NCT00417612|4169117|P1|STARTED|Overall Study||22
1704977|NCT00417482|4169143|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
1704978|NCT00417482|4169144|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
1704979|NCT00417482|4169145|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
1704980|NCT00417482|4169143|P3|COMPLETED|Phase B 2nd 16 Weeks||10
1704981|NCT00417482|4169144|P2|COMPLETED|Phase B 2nd 16 Weeks||14
1704982|NCT00417482|4169145|P1|COMPLETED|Phase B 2nd 16 Weeks||10
1704983|NCT00417482|4169143|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
1704984|NCT00417482|4169144|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
1704985|NCT00417482|4169145|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
1704986|NCT00417482|4169143|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
1704987|NCT00417482|4169144|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
1704988|NCT00417482|4169145|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
1704989|NCT00417482|4169143|P3|COMPLETED|Phase B 1st 16 Weeks||13
1704990|NCT00417482|4169144|P2|COMPLETED|Phase B 1st 16 Weeks||27
1704991|NCT00417482|4169145|P1|COMPLETED|Phase B 1st 16 Weeks||13
1704992|NCT00417482|4169143|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
1704993|NCT00417482|4169144|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
1704994|NCT00417482|4169145|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
1704995|NCT00417417|4169171|P2|NOT COMPLETED|Overall Study||0
1704996|NCT00417417|4169172|P1|NOT COMPLETED|Overall Study||0
1704997|NCT00417417|4169171|P2|COMPLETED|Overall Study||6
1704998|NCT00417417|4169172|P1|COMPLETED|Overall Study||4
1704999|NCT00417417|4169171|P2|STARTED|Overall Study||6
1705000|NCT00417417|4169172|P1|STARTED|Overall Study||4
1705001|NCT00417274|4169180|P1|NOT COMPLETED|Overall Study||0
1705002|NCT00417274|4169180|P1|COMPLETED|Overall Study||31
1705003|NCT00417274|4169180|P1|STARTED|Overall Study||31
1705004|NCT00417248|4169184|P1|NOT COMPLETED|Overall Study||8
1705005|NCT00417248|4169184|P1|COMPLETED|Overall Study||0
1705006|NCT00417248|4169184|P1|STARTED|Overall Study||8
1705007|NCT00417170|4169191|P2|NOT COMPLETED|Overall Study||3
1705008|NCT00417170|4169192|P1|NOT COMPLETED|Overall Study||2
1705009|NCT00417170|4169191|P2|COMPLETED|Overall Study||22
1705010|NCT00417170|4169192|P1|COMPLETED|Overall Study||21
1705011|NCT00417170|4169191|P2|Pharmacodynamics Population|Overall Study||23
1705012|NCT00417170|4169192|P1|Pharmacodynamics Population|Overall Study||21
1705013|NCT00417170|4169191|P2|STARTED|Overall Study||25
1705014|NCT00417170|4169192|P1|STARTED|Overall Study|"Started indicates Safety population."|23
1705015|NCT00417079|4169208|P2|NOT COMPLETED|Overall Study||273
1705016|NCT00417079|4169209|P1|NOT COMPLETED|Overall Study||331
1705017|NCT00417079|4169208|P2|COMPLETED|Overall Study|Randomized patients|105
1705018|NCT00417079|4169209|P1|COMPLETED|Overall Study|Randomized patients|46
1705019|NCT00417079|4169208|P2|STARTED|Overall Study|Randomized patients|378
1705020|NCT00417079|4169209|P1|STARTED|Overall Study|Randomized patients|377
1705021|NCT00417027|4169232|P3|NOT COMPLETED|Overall Study||5
1705022|NCT00417027|4169233|P2|NOT COMPLETED|Overall Study||5
1705023|NCT00417027|4169234|P1|NOT COMPLETED|Overall Study||0
1705024|NCT00417027|4169232|P3|COMPLETED|Overall Study||54
1705025|NCT00417027|4169233|P2|COMPLETED|Overall Study||60
1705026|NCT00417027|4169234|P1|COMPLETED|Overall Study||66
1705027|NCT00417027|4169232|P3|STARTED|Overall Study||59
1705028|NCT00417027|4169233|P2|STARTED|Overall Study||65
1705029|NCT00417027|4169234|P1|STARTED|Overall Study||66
1705030|NCT00416949|4169260|P1|NOT COMPLETED|Overall Study||5
1705031|NCT00416949|4169260|P1|COMPLETED|Overall Study||4
1705032|NCT00416949|4169260|P1|STARTED|Overall Study||9
1705033|NCT00416884|4169264|P1|NOT COMPLETED|Overall Study||1
1705034|NCT00416884|4169264|P1|COMPLETED|Overall Study||0
1705035|NCT00416884|4169264|P1|STARTED|Overall Study||1
1705036|NCT00416793|4169268|P1|NOT COMPLETED|Overall Study||0
1705037|NCT00416793|4169268|P1|COMPLETED|Overall Study||9
1705038|NCT00416793|4169268|P1|STARTED|Overall Study||9
1705039|NCT00416715|4169272|P1|NOT COMPLETED|Overall Study||15
1705040|NCT00416715|4169272|P1|COMPLETED|Overall Study||85
1705041|NCT00416715|4169272|P1|STARTED|Overall Study||100
1705042|NCT00416624|4169283|P4|NOT COMPLETED|Overall Study||17
1705043|NCT00416624|4169284|P3|NOT COMPLETED|Overall Study||18
1705044|NCT00416624|4169285|P2|NOT COMPLETED|Overall Study||27
1705045|NCT00416624|4169286|P1|NOT COMPLETED|Overall Study||22
1705046|NCT00416624|4169283|P4|COMPLETED|Overall Study||40
1705047|NCT00416624|4169284|P3|COMPLETED|Overall Study||40
1705048|NCT00416624|4169285|P2|COMPLETED|Overall Study||33
1705049|NCT00416624|4169286|P1|COMPLETED|Overall Study||39
1705050|NCT00416624|4169283|P4|STARTED|Overall Study||57
1705051|NCT00416624|4169284|P3|STARTED|Overall Study||58
1705052|NCT00416624|4169285|P2|STARTED|Overall Study||60
1705053|NCT00416624|4169286|P1|STARTED|Overall Study||61
1705054|NCT00416598|4169340|P1|NOT COMPLETED|Decitabine Maintenance||72
1705055|NCT00416598|4169340|P1|COMPLETED|Decitabine Maintenance||62
1705056|NCT00416598|4169340|P1|STARTED|Decitabine Maintenance||134
1705057|NCT00416598|4169340|P1|NOT COMPLETED|Induction & Intensification||412
1705058|NCT00416598|4169340|P1|COMPLETED|Induction & Intensification||134
1705059|NCT00416598|4169340|P1|STARTED|Induction & Intensification||546
1705060|NCT00416572|4169348|P3|NOT COMPLETED|Overall Study||8
1705061|NCT00416572|4169349|P2|NOT COMPLETED|Overall Study||7
1705062|NCT00416572|4169350|P1|NOT COMPLETED|Overall Study||13
1705063|NCT00416572|4169348|P3|COMPLETED|Overall Study||76
1705064|NCT00416572|4169349|P2|COMPLETED|Overall Study||78
1705065|NCT00416572|4169350|P1|COMPLETED|Overall Study||70
1705066|NCT00416572|4169348|P3|STARTED|Overall Study||84
1705067|NCT00416572|4169349|P2|STARTED|Overall Study||85
1705068|NCT00416572|4169350|P1|STARTED|Overall Study||83
1705069|NCT00416520|4169366|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
1705070|NCT00416520|4169367|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
1705071|NCT00416520|4169368|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
1705072|NCT00416520|4169369|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
1705073|NCT00416520|4169366|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
1705074|NCT00416520|4169367|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
1705075|NCT00416520|4169368|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
1705076|NCT00416520|4169369|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
1705077|NCT00416520|4169366|P4|STARTED|Placebo-controlled Withdrawal Period||54
1705078|NCT00416520|4169367|P3|STARTED|Placebo-controlled Withdrawal Period||50
1705079|NCT00416520|4169368|P2|STARTED|Placebo-controlled Withdrawal Period||0
1705080|NCT00416520|4169369|P1|STARTED|Placebo-controlled Withdrawal Period||0
1705081|NCT00416520|4169366|P4|NOT COMPLETED|Open-label Period||0
1705082|NCT00416520|4169367|P3|NOT COMPLETED|Open-label Period||0
1705083|NCT00416520|4169368|P2|NOT COMPLETED|Open-label Period||32
1705084|NCT00416520|4169369|P1|NOT COMPLETED|Open-label Period||60
1705085|NCT00416520|4169366|P4|COMPLETED|Open-label Period||0
1705086|NCT00416520|4169367|P3|COMPLETED|Open-label Period||0
1705087|NCT00416520|4169368|P2|COMPLETED|Open-label Period||139
1705088|NCT00416520|4169369|P1|COMPLETED|Open-label Period||105
1705089|NCT00416520|4169366|P4|STARTED|Open-label Period||0
1705090|NCT00416520|4169367|P3|STARTED|Open-label Period||0
1705091|NCT00416520|4169368|P2|STARTED|Open-label Period||171
1705092|NCT00416520|4169369|P1|STARTED|Open-label Period||165
1705093|NCT00416494|4169381|P2|NOT COMPLETED|Overall Study||0
1705094|NCT00416494|4169382|P1|NOT COMPLETED|Overall Study||0
1705095|NCT00416494|4169381|P2|COMPLETED|Overall Study||31
1705096|NCT00416494|4169382|P1|COMPLETED|Overall Study||19
1705097|NCT00416494|4169381|P2|STARTED|Overall Study||31
1705098|NCT00416494|4169382|P1|STARTED|Overall Study||19
1705099|NCT00416455|4169398|P2|NOT COMPLETED|Overall Study||8
1705100|NCT00416455|4169399|P1|NOT COMPLETED|Overall Study||16
1705101|NCT00416455|4169398|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
1705102|NCT00416455|4169399|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
1705103|NCT00416455|4169398|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
1705104|NCT00416455|4169399|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
1705105|NCT00416312|4169434|P1|NOT COMPLETED|Overall Study||2
1705106|NCT00416312|4169434|P1|COMPLETED|Overall Study||7
1705107|NCT00416312|4169434|P1|Patient-specific Dosimetry|Overall Study||9
1705108|NCT00416312|4169434|P1|Conventional Dosimetry|Overall Study||9
1705109|NCT00416312|4169434|P1|STARTED|Overall Study||9
1705110|NCT00416195|4169440|P2|NOT COMPLETED|Overall Study||4
1705111|NCT00416195|4169441|P1|NOT COMPLETED|Overall Study||2
1705112|NCT00416195|4169440|P2|COMPLETED|Overall Study||34
1705113|NCT00416195|4169441|P1|COMPLETED|Overall Study||8
1705114|NCT00416195|4169440|P2|STARTED|Overall Study||38
1705115|NCT00416195|4169441|P1|STARTED|Overall Study||10
1705116|NCT00416182|4169451|P2|NOT COMPLETED|Overall Study||2
1705117|NCT00416182|4169452|P1|NOT COMPLETED|Overall Study||3
1705118|NCT00416182|4169451|P2|COMPLETED|Overall Study||6
1705119|NCT00416182|4169452|P1|COMPLETED|Overall Study||5
1705120|NCT00416182|4169451|P2|STARTED|Overall Study||8
1705121|NCT00416182|4169452|P1|STARTED|Overall Study||8
1705122|NCT00416078|4169466|P2|NOT COMPLETED|Overall Study||8
1705123|NCT00416078|4169467|P1|NOT COMPLETED|Overall Study||11
1705124|NCT00416078|4169466|P2|COMPLETED|Overall Study||16
1705125|NCT00416078|4169467|P1|COMPLETED|Overall Study||18
1705126|NCT00416078|4169466|P2|STARTED|Overall Study||24
1705127|NCT00416078|4169467|P1|STARTED|Overall Study||29
1705128|NCT00415909|4169483|P1|NOT COMPLETED|Overall Study||3
1705129|NCT00415909|4169483|P1|COMPLETED|Overall Study||0
1705130|NCT00415909|4169483|P1|STARTED|Overall Study||3
1705131|NCT00415870|4169489|P2|NOT COMPLETED|Overall Study||7
1705132|NCT00415870|4169490|P1|NOT COMPLETED|Overall Study||6
1705133|NCT00415870|4169489|P2|COMPLETED|Overall Study||26
1705134|NCT00415870|4169490|P1|COMPLETED|Overall Study||26
1705135|NCT00415870|4169489|P2|STARTED|Overall Study||33
1705136|NCT00415870|4169490|P1|STARTED|Overall Study||32
1705137|NCT00415857|4169498|P2|NOT COMPLETED|Overall Study||0
1705138|NCT00415857|4169499|P1|NOT COMPLETED|Overall Study||0
1705139|NCT00415857|4169498|P2|COMPLETED|Overall Study||3
1705140|NCT00415857|4169499|P1|COMPLETED|Overall Study||2
1705141|NCT00415857|4169498|P2|STARTED|Overall Study||3
1705142|NCT00415857|4169499|P1|STARTED|Overall Study||2
1705143|NCT00415636|4169513|P6|NOT COMPLETED|Overall Study||2
1705144|NCT00415636|4169514|P5|NOT COMPLETED|Overall Study||2
1705145|NCT00415636|4169515|P4|NOT COMPLETED|Overall Study||6
1705146|NCT00415636|4169516|P3|NOT COMPLETED|Overall Study||1
1705147|NCT00415636|4169517|P2|NOT COMPLETED|Overall Study||0
1705148|NCT00415636|4169518|P1|NOT COMPLETED|Overall Study||1
1705149|NCT00415636|4169513|P6|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
1705150|NCT00415636|4169514|P5|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
1705151|NCT00415636|4169515|P4|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
1705152|NCT00415636|4169516|P3|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
1705153|NCT00415636|4169517|P2|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
1705154|NCT00415636|4169518|P1|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
1705155|NCT00415636|4169513|P6|STARTED|Overall Study||3
1705156|NCT00415636|4169514|P5|STARTED|Overall Study||6
1705157|NCT00415636|4169515|P4|STARTED|Overall Study||13
1705158|NCT00415636|4169516|P3|STARTED|Overall Study||3
1705159|NCT00415636|4169517|P2|STARTED|Overall Study||3
1705160|NCT00415636|4169518|P1|STARTED|Overall Study||3
1705161|NCT00415623|4169552|P2|NOT COMPLETED|Overall Study||5
1705162|NCT00415623|4169553|P1|NOT COMPLETED|Overall Study||5
1705163|NCT00415623|4169552|P2|COMPLETED|Overall Study||146
1705164|NCT00415623|4169553|P1|COMPLETED|Overall Study||149
1705165|NCT00415623|4169552|P2|STARTED|Overall Study||151
1705166|NCT00415623|4169553|P1|STARTED|Overall Study||154
1705167|NCT00415610|4169580|P3|NOT COMPLETED|Overall Study||5
1705168|NCT00415610|4169581|P2|NOT COMPLETED|Overall Study||2
1705169|NCT00415610|4169582|P1|NOT COMPLETED|Overall Study||3
1705170|NCT00415610|4169580|P3|COMPLETED|Overall Study||17
1705171|NCT00415610|4169581|P2|COMPLETED|Overall Study||18
1705172|NCT00415610|4169582|P1|COMPLETED|Overall Study||15
1705173|NCT00415610|4169580|P3|STARTED|Overall Study||22
1705174|NCT00415610|4169581|P2|STARTED|Overall Study||20
1705175|NCT00415610|4169582|P1|STARTED|Overall Study||18
1705176|NCT00415597|4169602|P1|NOT COMPLETED|Treatment||305
1705177|NCT00415597|4169602|P1|COMPLETED|Treatment||160
1705178|NCT00415597|4169602|P1|STARTED|Treatment||465
1705179|NCT00415597|4169602|P1|NOT COMPLETED|Enrollment||2
1705180|NCT00415597|4169602|P1|COMPLETED|Enrollment||465
1705181|NCT00415597|4169602|P1|STARTED|Enrollment||467
1705182|NCT00415532|4169610|P2|NOT COMPLETED|Safety Follow Up Period||12
1705183|NCT00415532|4169611|P1|NOT COMPLETED|Safety Follow Up Period||9
1705184|NCT00415532|4169610|P2|COMPLETED|Safety Follow Up Period||18
1705185|NCT00415532|4169611|P1|COMPLETED|Safety Follow Up Period||34
1705186|NCT00415532|4169610|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
1705187|NCT00415532|4169611|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
1705188|NCT00415532|4169610|P2|NOT COMPLETED|Treatment Period||15
1705189|NCT00415532|4169611|P1|NOT COMPLETED|Treatment Period||17
1705190|NCT00415532|4169610|P2|COMPLETED|Treatment Period||142
1705191|NCT00415532|4169611|P1|COMPLETED|Treatment Period||60
1705192|NCT00415532|4169610|P2|Switched to Romiplostim Group|Treatment Period||0
1705193|NCT00415532|4169611|P1|Switched to Romiplostim Group|Treatment Period||2
1705194|NCT00415532|4169610|P2|Received Treatment|Treatment Period||154
1705195|NCT00415532|4169611|P1|Received Treatment|Treatment Period||75
1705196|NCT00415532|4169610|P2|STARTED|Treatment Period||157
1705197|NCT00415532|4169611|P1|STARTED|Treatment Period||77
1705198|NCT00415519|4169633|P2|NOT COMPLETED|Overall Study||0
1705199|NCT00415519|4169634|P1|NOT COMPLETED|Overall Study||4
1705200|NCT00415519|4169633|P2|COMPLETED|Overall Study||12
1705201|NCT00415519|4169634|P1|COMPLETED|Overall Study||9
1705202|NCT00415519|4169633|P2|STARTED|Overall Study||12
1705203|NCT00415519|4169634|P1|STARTED|Overall Study||13
1705204|NCT00415506|4169654|P2|NOT COMPLETED|Overall Study||1
1705205|NCT00415506|4169655|P1|NOT COMPLETED|Overall Study||3
1705206|NCT00415506|4169654|P2|COMPLETED|Overall Study||9
1705207|NCT00415506|4169655|P1|COMPLETED|Overall Study||9
1705208|NCT00415506|4169654|P2|STARTED|Overall Study||10
1705209|NCT00415506|4169655|P1|STARTED|Overall Study||12
1705210|NCT00415493|4169665|P2|NOT COMPLETED|Overall Study||0
1705211|NCT00415493|4169666|P1|NOT COMPLETED|Overall Study||0
1705212|NCT00415493|4169665|P2|COMPLETED|Overall Study||12
1705213|NCT00415493|4169666|P1|COMPLETED|Overall Study||12
1705214|NCT00415493|4169665|P2|STARTED|Overall Study||12
1705215|NCT00415493|4169666|P1|STARTED|Overall Study||12
1705216|NCT00415194|4169674|P2|NOT COMPLETED|Overall Study||342
1705217|NCT00415194|4169675|P1|NOT COMPLETED|Overall Study||328
1705218|NCT00415194|4169674|P2|COMPLETED|Overall Study||55
1705219|NCT00415194|4169675|P1|COMPLETED|Overall Study||70
1705220|NCT00415194|4169674|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
1705221|NCT00415194|4169675|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
1705222|NCT00415194|4169674|P2|STARTED|Overall Study||397
1705223|NCT00415194|4169675|P1|STARTED|Overall Study||398
1705224|NCT00415168|4169691|P1|NOT COMPLETED|Overall Study||52
1705225|NCT00415168|4169691|P1|COMPLETED|Overall Study||1
1705226|NCT00415168|4169691|P1|Completed Treatment|Overall Study||15
1705227|NCT00415168|4169691|P1|STARTED|Overall Study||53
1705228|NCT00415051|4169701|P1|NOT COMPLETED|Overall Study||1
1705229|NCT00415051|4169701|P1|COMPLETED|Overall Study||19
1705230|NCT00415051|4169701|P1|STARTED|Overall Study||20
1705231|NCT00414973|4169712|P4|NOT COMPLETED|Overall Study||0
1705232|NCT00414973|4169713|P3|NOT COMPLETED|Overall Study||3
1705233|NCT00414973|4169714|P2|NOT COMPLETED|Overall Study||10
1705234|NCT00414973|4169715|P1|NOT COMPLETED|Overall Study||28
1705235|NCT00414973|4169712|P4|COMPLETED|Overall Study||11
1705236|NCT00414973|4169713|P3|COMPLETED|Overall Study||21
1705237|NCT00414973|4169714|P2|COMPLETED|Overall Study||99
1705238|NCT00414973|4169715|P1|COMPLETED|Overall Study||190
1705239|NCT00414973|4169712|P4|STARTED|Overall Study||11
1705240|NCT00414973|4169713|P3|STARTED|Overall Study||24
1705241|NCT00414973|4169714|P2|STARTED|Overall Study||109
1705242|NCT00414973|4169715|P1|STARTED|Overall Study||218
1705243|NCT00414908|4169735|P2|NOT COMPLETED|Overall Study||1
1705244|NCT00414908|4169736|P1|NOT COMPLETED|Overall Study||1
1705245|NCT00414908|4169735|P2|COMPLETED|Overall Study||28
1705246|NCT00414908|4169736|P1|COMPLETED|Overall Study||24
1705247|NCT00414908|4169735|P2|STARTED|Overall Study||29
1705248|NCT00414908|4169736|P1|STARTED|Overall Study||25
1705249|NCT00414817|4169760|P2|NOT COMPLETED|Overall Study||3016
1705250|NCT00414817|4169761|P1|NOT COMPLETED|Overall Study||3130
1705251|NCT00414817|4169760|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
1705252|NCT00414817|4169761|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
1705253|NCT00414817|4169760|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
1705254|NCT00414817|4169761|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
1705255|NCT00414817|4169760|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
1705256|NCT00414817|4169761|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
1705257|NCT00414817|4169760|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
1705258|NCT00414817|4169761|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
1705259|NCT00414817|4169760|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
1705260|NCT00414817|4169761|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
1705261|NCT00414817|4169760|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
1705262|NCT00414817|4169761|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
1705263|NCT00414817|4169760|P2|STARTED|Overall Study||7031
1705264|NCT00414817|4169761|P1|STARTED|Overall Study||7033
1705265|NCT00414726|4169773|P2|NOT COMPLETED|Overall Study||1
1705266|NCT00414726|4169774|P1|NOT COMPLETED|Overall Study||0
1705267|NCT00414726|4169773|P2|COMPLETED|Overall Study||41
1705268|NCT00414726|4169774|P1|COMPLETED|Overall Study||43
1705269|NCT00414726|4169773|P2|STARTED|Overall Study||42
1705270|NCT00414726|4169774|P1|STARTED|Overall Study||43
1705271|NCT00414700|4169784|P2|NOT COMPLETED|Overall Study||3
1705272|NCT00414700|4169785|P1|NOT COMPLETED|Overall Study||6
1705273|NCT00414700|4169784|P2|COMPLETED|Overall Study||58
1705274|NCT00414700|4169785|P1|COMPLETED|Overall Study||51
1705275|NCT00414700|4169784|P2|STARTED|Overall Study||61
1705276|NCT00414700|4169785|P1|STARTED|Overall Study||57
1705277|NCT00414661|4169809|P4|NOT COMPLETED|Overall Study||3
1705278|NCT00414661|4169810|P3|NOT COMPLETED|Overall Study||2
1705279|NCT00414661|4169811|P2|NOT COMPLETED|Overall Study||14
1705280|NCT00414661|4169812|P1|NOT COMPLETED|Overall Study||14
1705281|NCT00414661|4169809|P4|COMPLETED|Overall Study||0
1705282|NCT00414661|4169810|P3|COMPLETED|Overall Study||20
1705283|NCT00414661|4169811|P2|COMPLETED|Overall Study||75
1705284|NCT00414661|4169812|P1|COMPLETED|Overall Study||34
1705285|NCT00414661|4169809|P4|STARTED|Overall Study||3
1705286|NCT00414661|4169810|P3|STARTED|Overall Study||22
1705287|NCT00414661|4169811|P2|STARTED|Overall Study||89
1705288|NCT00414661|4169812|P1|STARTED|Overall Study||48
1705289|NCT00414635|4169836|P2|NOT COMPLETED|Overall Study||2
1705290|NCT00414635|4169837|P1|NOT COMPLETED|Overall Study||5
1705291|NCT00414635|4169836|P2|COMPLETED|Overall Study||28
1705292|NCT00414635|4169837|P1|COMPLETED|Overall Study||25
1705293|NCT00414635|4169836|P2|STARTED|Overall Study||30
1705294|NCT00414635|4169837|P1|STARTED|Overall Study||30
1705295|NCT00414609|4169857|P3|NOT COMPLETED|Extension Study||57
1705296|NCT00414609|4169858|P2|NOT COMPLETED|Extension Study||0
1705297|NCT00414609|4169859|P1|NOT COMPLETED|Extension Study||0
1705298|NCT00414609|4169857|P3|COMPLETED|Extension Study||365
1705299|NCT00414609|4169858|P2|COMPLETED|Extension Study||0
1705300|NCT00414609|4169859|P1|COMPLETED|Extension Study||0
1705301|NCT00414609|4169857|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
1705302|NCT00414609|4169858|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
1705303|NCT00414609|4169859|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
1705304|NCT00414609|4169857|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
1705305|NCT00414609|4169858|P2|STARTED|Extension Study||0
1705306|NCT00414609|4169859|P1|STARTED|Extension Study||0
1705307|NCT00414609|4169857|P3|NOT COMPLETED|Core Study||0
1705308|NCT00414609|4169858|P2|NOT COMPLETED|Core Study||45
1705309|NCT00414609|4169859|P1|NOT COMPLETED|Core Study||34
1705310|NCT00414609|4169857|P3|COMPLETED|Core Study||0
1705311|NCT00414609|4169858|P2|COMPLETED|Core Study||378
1705312|NCT00414609|4169859|P1|COMPLETED|Core Study||363
1705313|NCT00414609|4169857|P3|Echocardiogram Evaluable Set|Core Study||0
1705314|NCT00414609|4169858|P2|Echocardiogram Evaluable Set|Core Study||343
1705315|NCT00414609|4169859|P1|Echocardiogram Evaluable Set|Core Study||330
1705316|NCT00414609|4169857|P3|Received Study Drug|Core Study||0
1705317|NCT00414609|4169858|P2|Received Study Drug|Core Study||422
1705318|NCT00414609|4169859|P1|Received Study Drug|Core Study||397
1705319|NCT00414609|4169857|P3|STARTED|Core Study||0
1705320|NCT00414609|4169858|P2|STARTED|Core Study||423
1705321|NCT00414609|4169859|P1|STARTED|Core Study||397
1705322|NCT00414596|4169882|P1|NOT COMPLETED|Overall Study||2
1705323|NCT00414596|4169882|P1|COMPLETED|Overall Study|April 2007|18
1705324|NCT00414596|4169882|P1|STARTED|Overall Study|December 2006|20
1705325|NCT00414544|4169891|P1|NOT COMPLETED|Overall Study||14
1705326|NCT00414544|4169891|P1|COMPLETED|Overall Study||131
1705327|NCT00414544|4169891|P1|STARTED|Overall Study||145
1705328|NCT00414518|4169899|P2|NOT COMPLETED|Overall Study||0
1705329|NCT00414518|4169900|P1|NOT COMPLETED|Overall Study||0
1705330|NCT00414518|4169899|P2|COMPLETED|Overall Study||9
1705331|NCT00414518|4169900|P1|COMPLETED|Overall Study||7
1705332|NCT00414518|4169899|P2|STARTED|Overall Study||9
1705333|NCT00414518|4169900|P1|STARTED|Overall Study||7
1705334|NCT00414466|4169914|P4|NOT COMPLETED|Overall Study||1
1705335|NCT00414466|4169915|P3|NOT COMPLETED|Overall Study||1
1705336|NCT00414466|4169916|P2|NOT COMPLETED|Overall Study||0
1705337|NCT00414466|4169917|P1|NOT COMPLETED|Overall Study||2
1705338|NCT00414466|4169914|P4|COMPLETED|Overall Study||42
1705339|NCT00414466|4169915|P3|COMPLETED|Overall Study||40
1705340|NCT00414466|4169916|P2|COMPLETED|Overall Study||42
1705341|NCT00414466|4169917|P1|COMPLETED|Overall Study||42
1705342|NCT00414466|4169914|P4|STARTED|Overall Study||43
1705343|NCT00414466|4169915|P3|STARTED|Overall Study||41
1705344|NCT00414466|4169916|P2|STARTED|Overall Study||42
1705345|NCT00414466|4169917|P1|STARTED|Overall Study||44
1705346|NCT00414453|4169935|P1|NOT COMPLETED|Overall Study||16
1705347|NCT00414453|4169935|P1|COMPLETED|Overall Study||3
1705348|NCT00414453|4169935|P1|STARTED|Overall Study||19
1705349|NCT00414440|4169983|P2|NOT COMPLETED|Extension Period||140
1705350|NCT00414440|4169984|P1|NOT COMPLETED|Extension Period||150
1705351|NCT00414440|4169983|P2|COMPLETED|Extension Period|Extension|77
1705352|NCT00414440|4169984|P1|COMPLETED|Extension Period|Extension|64
1705353|NCT00414440|4169983|P2|STARTED|Extension Period|Extension|217
1705354|NCT00414440|4169984|P1|STARTED|Extension Period|Extension|214
1705355|NCT00414440|4169983|P2|NOT COMPLETED|Core Period||32
1705356|NCT00414440|4169984|P1|NOT COMPLETED|Core Period||70
1705357|NCT00414440|4169983|P2|COMPLETED|Core Period|Core period|185
1705358|NCT00414440|4169984|P1|COMPLETED|Core Period|Core period|144
1705359|NCT00414440|4169983|P2|STARTED|Core Period|Core period|217
1705360|NCT00414440|4169984|P1|STARTED|Core Period|Core period|214
1705361|NCT00414388|4169998|P1|NOT COMPLETED|Overall Study||1
1705362|NCT00414388|4169998|P1|COMPLETED|Overall Study||21
1705363|NCT00414388|4169998|P1|STARTED|Overall Study||22
1705364|NCT00414310|4170006|P2|NOT COMPLETED|Overall Study||0
1705365|NCT00414310|4170007|P1|NOT COMPLETED|Overall Study||1
1705366|NCT00414310|4170006|P2|COMPLETED|Overall Study||79
1705367|NCT00414310|4170007|P1|COMPLETED|Overall Study||70
1705368|NCT00414310|4170006|P2|STARTED|Overall Study||79
1705369|NCT00414310|4170007|P1|STARTED|Overall Study||71
1705370|NCT00414206|4170016|P3|NOT COMPLETED|Overall Study||55
1705371|NCT00414206|4170017|P2|NOT COMPLETED|Overall Study||56
1705372|NCT00414206|4170018|P1|NOT COMPLETED|Overall Study||58
1705373|NCT00414206|4170016|P3|COMPLETED|Overall Study||59
1705374|NCT00414206|4170017|P2|COMPLETED|Overall Study||58
1705375|NCT00414206|4170018|P1|COMPLETED|Overall Study||57
1705376|NCT00414206|4170016|P3|STARTED|Overall Study||114
1705377|NCT00414206|4170017|P2|STARTED|Overall Study||114
1705378|NCT00414206|4170018|P1|STARTED|Overall Study||115
1705379|NCT00414167|4170028|P2|NOT COMPLETED|Overall Study||3
1705380|NCT00414167|4170029|P1|NOT COMPLETED|Overall Study||4
1705381|NCT00414167|4170028|P2|COMPLETED|Overall Study||27
1705382|NCT00414167|4170029|P1|COMPLETED|Overall Study||27
1705383|NCT00414167|4170028|P2|STARTED|Overall Study||30
1705384|NCT00414167|4170029|P1|STARTED|Overall Study||31
1705385|NCT00414076|4170039|P2|NOT COMPLETED|Overall Study||5
1705386|NCT00414076|4170040|P1|NOT COMPLETED|Overall Study||3
1705387|NCT00414076|4170039|P2|COMPLETED|Overall Study||0
1705388|NCT00414076|4170040|P1|COMPLETED|Overall Study||1
1705389|NCT00414076|4170039|P2|STARTED|Overall Study||5
1705390|NCT00414076|4170040|P1|STARTED|Overall Study||4
1705391|NCT00414050|4170050|P4|NOT COMPLETED|Overall Study||8
1705392|NCT00414050|4170051|P3|NOT COMPLETED|Overall Study||6
1705393|NCT00414050|4170052|P2|NOT COMPLETED|Overall Study||8
1705394|NCT00414050|4170053|P1|NOT COMPLETED|Overall Study||9
1705395|NCT00414050|4170050|P4|COMPLETED|Overall Study||423
1705396|NCT00414050|4170051|P3|COMPLETED|Overall Study||423
1705397|NCT00414050|4170052|P2|COMPLETED|Overall Study||419
1705398|NCT00414050|4170053|P1|COMPLETED|Overall Study||422
1705399|NCT00414050|4170050|P4|Received Vaccination 3|Overall Study||424
1705400|NCT00414050|4170051|P3|Received Vaccination 3|Overall Study||425
1705401|NCT00414050|4170052|P2|Received Vaccination 3|Overall Study||419
1705402|NCT00414050|4170053|P1|Received Vaccination 3|Overall Study||424
1705403|NCT00414050|4170050|P4|Received Vaccination 2|Overall Study||425
1705404|NCT00414050|4170051|P3|Received Vaccination 2|Overall Study||425
1705405|NCT00414050|4170052|P2|Received Vaccination 2|Overall Study||421
1705406|NCT00414050|4170053|P1|Received Vaccination 2|Overall Study||425
1705407|NCT00414050|4170050|P4|Received Vaccination 1|Overall Study||431
1705408|NCT00414050|4170051|P3|Received Vaccination 1|Overall Study||429
1705409|NCT00414050|4170052|P2|Received Vaccination 1|Overall Study||426
1705410|NCT00414050|4170053|P1|Received Vaccination 1|Overall Study||431
1705411|NCT00414050|4170050|P4|STARTED|Overall Study||431
1705412|NCT00414050|4170051|P3|STARTED|Overall Study||429
1705413|NCT00414050|4170052|P2|STARTED|Overall Study||427
1705414|NCT00414050|4170053|P1|STARTED|Overall Study||431
1705415|NCT00414011|4170067|P1|NOT COMPLETED|Overall Study||5
1705416|NCT00414011|4170067|P1|COMPLETED|Overall Study||35
1705417|NCT00414011|4170067|P1|STARTED|Overall Study||40
1705418|NCT00413972|4170076|P4|NOT COMPLETED|Overall Study||3
1705419|NCT00413972|4170077|P3|NOT COMPLETED|Overall Study||10
1705420|NCT00413972|4170078|P2|NOT COMPLETED|Overall Study||8
1705421|NCT00413972|4170079|P1|NOT COMPLETED|Overall Study||7
1705422|NCT00413972|4170076|P4|COMPLETED|Overall Study||95
1705423|NCT00413972|4170077|P3|COMPLETED|Overall Study||88
1705424|NCT00413972|4170078|P2|COMPLETED|Overall Study||90
1705425|NCT00413972|4170079|P1|COMPLETED|Overall Study||91
1705426|NCT00413972|4170076|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
1705427|NCT00413972|4170077|P3|STARTED|Overall Study||98
1705428|NCT00413972|4170078|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
1705429|NCT00413972|4170079|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
1705430|NCT00413959|4170089|P1|NOT COMPLETED|Overall Study||1
1705431|NCT00413959|4170089|P1|COMPLETED|Overall Study||11
1705432|NCT00413959|4170089|P1|STARTED|Overall Study||12
1705433|NCT00413920|4170096|P2|NOT COMPLETED|Overall Study||28
1705434|NCT00413920|4170097|P1|NOT COMPLETED|Overall Study||28
1705435|NCT00413920|4170096|P2|COMPLETED|Overall Study||82
1705436|NCT00413920|4170097|P1|COMPLETED|Overall Study||84
1705437|NCT00413920|4170096|P2|STARTED|Overall Study||110
1705438|NCT00413920|4170097|P1|STARTED|Overall Study||112
1705439|NCT00413894|4170112|P1|NOT COMPLETED|Overall Study||80
1705440|NCT00413894|4170112|P1|COMPLETED|Overall Study||344
1705441|NCT00413894|4170112|P1|STARTED|Overall Study||424
1705442|NCT00413777|4170129|P2|NOT COMPLETED|Extension Period||0
1705443|NCT00413777|4170130|P1|NOT COMPLETED|Extension Period||0
1705444|NCT00413777|4170129|P2|COMPLETED|Extension Period||18
1705445|NCT00413777|4170130|P1|COMPLETED|Extension Period||17
1705446|NCT00413777|4170129|P2|STARTED|Extension Period||18
1705447|NCT00413777|4170130|P1|STARTED|Extension Period||17
1705448|NCT00413777|4170129|P2|NOT COMPLETED|Fixed-dose Period||3
1705449|NCT00413777|4170130|P1|NOT COMPLETED|Fixed-dose Period||4
1705450|NCT00413777|4170129|P2|COMPLETED|Fixed-dose Period||21
1705451|NCT00413777|4170130|P1|COMPLETED|Fixed-dose Period||18
1705452|NCT00413777|4170129|P2|STARTED|Fixed-dose Period||24
1705453|NCT00413777|4170130|P1|STARTED|Fixed-dose Period||22
1705454|NCT00413699|4170178|P3|NOT COMPLETED|Extension Period||5
1705455|NCT00413699|4170179|P2|NOT COMPLETED|Extension Period||0
1705456|NCT00413699|4170180|P1|NOT COMPLETED|Extension Period||0
1705457|NCT00413699|4170178|P3|COMPLETED|Extension Period||43
1705458|NCT00413699|4170179|P2|COMPLETED|Extension Period||0
1705459|NCT00413699|4170180|P1|COMPLETED|Extension Period||0
1705460|NCT00413699|4170178|P3|STARTED|Extension Period||48
1705461|NCT00413699|4170179|P2|STARTED|Extension Period||0
1705462|NCT00413699|4170180|P1|STARTED|Extension Period||0
1705463|NCT00413699|4170178|P3|NOT COMPLETED|Initial Period||0
1705464|NCT00413699|4170179|P2|NOT COMPLETED|Initial Period||1705
1705465|NCT00413699|4170180|P1|NOT COMPLETED|Initial Period||639
1705466|NCT00413699|4170178|P3|COMPLETED|Initial Period||0
1705467|NCT00413699|4170179|P2|COMPLETED|Initial Period||1653
1705468|NCT00413699|4170180|P1|COMPLETED|Initial Period||484
1705469|NCT00413699|4170178|P3|STARTED|Initial Period||0
1705470|NCT00413699|4170179|P2|STARTED|Initial Period||3358
1705471|NCT00413699|4170180|P1|STARTED|Initial Period||1123
1705472|NCT00413660|4170262|P11|NOT COMPLETED|Post Week 12||1
1705473|NCT00413660|4170263|P10|NOT COMPLETED|Post Week 12||1
1705474|NCT00413660|4170264|P9|NOT COMPLETED|Post Week 12||0
1705475|NCT00413660|4170265|P8|NOT COMPLETED|Post Week 12||0
1705476|NCT00413660|4170266|P7|NOT COMPLETED|Post Week 12||3
1705477|NCT00413660|4170267|P6|NOT COMPLETED|Post Week 12||3
1705478|NCT00413660|4170268|P5|NOT COMPLETED|Post Week 12||6
1705479|NCT00413660|4170269|P4|NOT COMPLETED|Post Week 12||1
1705480|NCT00413660|4170270|P3|NOT COMPLETED|Post Week 12||8
1705481|NCT00413660|4170271|P2|NOT COMPLETED|Post Week 12||4
1705482|NCT00413660|4170272|P1|NOT COMPLETED|Post Week 12||3
1705483|NCT00413660|4170262|P11|COMPLETED|Post Week 12||17
1705484|NCT00413660|4170263|P10|COMPLETED|Post Week 12||12
1705485|NCT00413660|4170264|P9|COMPLETED|Post Week 12||13
1705486|NCT00413660|4170265|P8|COMPLETED|Post Week 12||21
1705487|NCT00413660|4170266|P7|COMPLETED|Post Week 12||37
1705488|NCT00413660|4170267|P6|COMPLETED|Post Week 12||54
1705489|NCT00413660|4170268|P5|COMPLETED|Post Week 12||60
1705490|NCT00413660|4170269|P4|COMPLETED|Post Week 12||66
1705491|NCT00413660|4170270|P3|COMPLETED|Post Week 12||56
1705492|NCT00413660|4170271|P2|COMPLETED|Post Week 12||44
1705493|NCT00413660|4170272|P1|COMPLETED|Post Week 12||40
1705494|NCT00413660|4170262|P11|STARTED|Post Week 12||18
1705495|NCT00413660|4170263|P10|STARTED|Post Week 12||13
1705496|NCT00413660|4170264|P9|STARTED|Post Week 12||13
1705497|NCT00413660|4170265|P8|STARTED|Post Week 12||21
1705498|NCT00413660|4170266|P7|STARTED|Post Week 12||40
1705499|NCT00413660|4170267|P6|STARTED|Post Week 12||57
1705500|NCT00413660|4170268|P5|STARTED|Post Week 12||66
1705501|NCT00413660|4170269|P4|STARTED|Post Week 12||67
1705502|NCT00413660|4170270|P3|STARTED|Post Week 12||64
1705503|NCT00413660|4170271|P2|STARTED|Post Week 12||48
1705504|NCT00413660|4170272|P1|STARTED|Post Week 12||43
1705505|NCT00413660|4170262|P11|NOT COMPLETED|Up To Week 12||0
1705506|NCT00413660|4170263|P10|NOT COMPLETED|Up To Week 12||0
1705507|NCT00413660|4170264|P9|NOT COMPLETED|Up To Week 12||0
1705508|NCT00413660|4170265|P8|NOT COMPLETED|Up To Week 12||0
1705509|NCT00413660|4170266|P7|NOT COMPLETED|Up To Week 12||11
1705510|NCT00413660|4170267|P6|NOT COMPLETED|Up To Week 12||10
1705511|NCT00413660|4170268|P5|NOT COMPLETED|Up To Week 12||9
1705512|NCT00413660|4170269|P4|NOT COMPLETED|Up To Week 12||8
1705513|NCT00413660|4170270|P3|NOT COMPLETED|Up To Week 12||7
1705514|NCT00413660|4170271|P2|NOT COMPLETED|Up To Week 12||7
1705515|NCT00413660|4170272|P1|NOT COMPLETED|Up To Week 12||7
1705516|NCT00413660|4170262|P11|COMPLETED|Up To Week 12||0
1705517|NCT00413660|4170263|P10|COMPLETED|Up To Week 12||0
1705518|NCT00413660|4170264|P9|COMPLETED|Up To Week 12||0
1705519|NCT00413660|4170265|P8|COMPLETED|Up To Week 12||0
1705520|NCT00413660|4170266|P7|COMPLETED|Up To Week 12||58
1705521|NCT00413660|4170267|P6|COMPLETED|Up To Week 12||70
1705522|NCT00413660|4170268|P5|COMPLETED|Up To Week 12||66
1705523|NCT00413660|4170269|P4|COMPLETED|Up To Week 12||67
1705524|NCT00413660|4170270|P3|COMPLETED|Up To Week 12||64
1705525|NCT00413660|4170271|P2|COMPLETED|Up To Week 12||61
1705526|NCT00413660|4170272|P1|COMPLETED|Up To Week 12||64
1705527|NCT00413660|4170262|P11|Treated|Up To Week 12||0
1705528|NCT00413660|4170263|P10|Treated|Up To Week 12||0
1705529|NCT00413660|4170264|P9|Treated|Up To Week 12||0
1705530|NCT00413660|4170265|P8|Treated|Up To Week 12||0
1705531|NCT00413660|4170266|P7|Treated|Up To Week 12||69
1705532|NCT00413660|4170267|P6|Treated|Up To Week 12||80
1705533|NCT00413660|4170268|P5|Treated|Up To Week 12||75
1705534|NCT00413660|4170269|P4|Treated|Up To Week 12||74
1705535|NCT00413660|4170270|P3|Treated|Up To Week 12||71
1705536|NCT00413660|4170271|P2|Treated|Up To Week 12||68
1705537|NCT00413660|4170272|P1|Treated|Up To Week 12||70
1705538|NCT00413660|4170262|P11|STARTED|Up To Week 12||0
1705539|NCT00413660|4170263|P10|STARTED|Up To Week 12||0
1705540|NCT00413660|4170264|P9|STARTED|Up To Week 12||0
1705541|NCT00413660|4170265|P8|STARTED|Up To Week 12||0
1705542|NCT00413660|4170266|P7|STARTED|Up To Week 12||69
1705543|NCT00413660|4170267|P6|STARTED|Up To Week 12||80
1705544|NCT00413660|4170268|P5|STARTED|Up To Week 12||75
1705545|NCT00413660|4170269|P4|STARTED|Up To Week 12||75
1705546|NCT00413660|4170270|P3|STARTED|Up To Week 12||71
1705547|NCT00413660|4170271|P2|STARTED|Up To Week 12||68
1705548|NCT00413660|4170272|P1|STARTED|Up To Week 12||71
1705549|NCT00413634|4170620|P2|NOT COMPLETED|Overall Study||0
1705550|NCT00413634|4170621|P1|NOT COMPLETED|Overall Study||0
1705551|NCT00413634|4170620|P2|COMPLETED|Overall Study||12
1705552|NCT00413634|4170621|P1|COMPLETED|Overall Study||12
1705553|NCT00413634|4170620|P2|STARTED|Overall Study||12
1705554|NCT00413634|4170621|P1|STARTED|Overall Study||12
1705555|NCT00413582|4170659|P2|NOT COMPLETED|Overall Study||0
1705556|NCT00413582|4170660|P1|NOT COMPLETED|Overall Study||0
1705557|NCT00413582|4170659|P2|COMPLETED|Overall Study|all enrolled completed|55
1705558|NCT00413582|4170660|P1|COMPLETED|Overall Study|all enrolled completed|55
1705559|NCT00413582|4170659|P2|Completion of Study|Overall Study|all enrolled completed|55
1705560|NCT00413582|4170660|P1|Completion of Study|Overall Study|all enrolled completed|55
1705561|NCT00413582|4170659|P2|STARTED|Overall Study|all enrolled completed|55
1705562|NCT00413582|4170660|P1|STARTED|Overall Study|all enrolled completed|55
1705563|NCT00413478|4170668|P1|NOT COMPLETED|Overall Study||0
1705564|NCT00413478|4170668|P1|COMPLETED|Overall Study||9
1705565|NCT00413478|4170668|P1|STARTED|Overall Study||9
1705566|NCT00413413|4170675|P3|NOT COMPLETED|Double-Blind||18
1705567|NCT00413413|4170676|P2|NOT COMPLETED|Double-Blind||14
1705568|NCT00413413|4170677|P1|NOT COMPLETED|Double-Blind||15
1705569|NCT00413413|4170675|P3|COMPLETED|Double-Blind||285
1705570|NCT00413413|4170676|P2|COMPLETED|Double-Blind||293
1705571|NCT00413413|4170677|P1|COMPLETED|Double-Blind||293
1705572|NCT00413413|4170675|P3|STARTED|Double-Blind||303
1705573|NCT00413413|4170676|P2|STARTED|Double-Blind||307
1705574|NCT00413413|4170677|P1|STARTED|Double-Blind||308
1705575|NCT00413413|4170675|P3|NOT COMPLETED|Single-Blind||0
1705576|NCT00413413|4170676|P2|NOT COMPLETED|Single-Blind||216
1705577|NCT00413413|4170677|P1|NOT COMPLETED|Single-Blind||0
1705578|NCT00413413|4170675|P3|COMPLETED|Single-Blind||0
1705579|NCT00413413|4170676|P2|COMPLETED|Single-Blind||918
1705580|NCT00413413|4170677|P1|COMPLETED|Single-Blind||0
1705581|NCT00413413|4170675|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
1705582|NCT00413413|4170676|P2|STARTED|Single-Blind||1134
1705583|NCT00413413|4170677|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
1705584|NCT00413400|4170699|P2|NOT COMPLETED|Overall Study||4
1705585|NCT00413400|4170700|P1|NOT COMPLETED|Overall Study||2
1705586|NCT00413400|4170699|P2|COMPLETED|Overall Study||12
1705587|NCT00413400|4170700|P1|COMPLETED|Overall Study||22
1705588|NCT00413400|4170699|P2|3 Month Visit|Overall Study||12
1705589|NCT00413400|4170700|P1|3 Month Visit|Overall Study||22
1705590|NCT00413400|4170699|P2|STARTED|Overall Study||16
1705591|NCT00413400|4170700|P1|STARTED|Overall Study||24
1705592|NCT00413374|4170730|P2|NOT COMPLETED|Overall Study||0
1705593|NCT00413374|4170731|P1|NOT COMPLETED|Overall Study||6
1705594|NCT00413374|4170730|P2|COMPLETED|Overall Study||80
1705595|NCT00413374|4170731|P1|COMPLETED|Overall Study||34
1705596|NCT00413374|4170730|P2|STARTED|Overall Study||80
1705597|NCT00413374|4170731|P1|STARTED|Overall Study||40
1705598|NCT00413335|4170743|P2|NOT COMPLETED|Overall Study||0
1705599|NCT00413335|4170744|P1|NOT COMPLETED|Overall Study||0
1705600|NCT00413335|4170743|P2|COMPLETED|Overall Study||9
1705601|NCT00413335|4170744|P1|COMPLETED|Overall Study||12
1705602|NCT00413335|4170743|P2|STARTED|Overall Study||9
1705603|NCT00413335|4170744|P1|STARTED|Overall Study||12
1705604|NCT00413283|4170762|P4|NOT COMPLETED|Overall Study||4
1705605|NCT00413283|4170763|P3|NOT COMPLETED|Overall Study||2
1705606|NCT00413283|4170764|P2|NOT COMPLETED|Overall Study||3
1705607|NCT00413283|4170765|P1|NOT COMPLETED|Overall Study||1
1705608|NCT00413283|4170762|P4|COMPLETED|Overall Study||13
1705609|NCT00413283|4170763|P3|COMPLETED|Overall Study||16
1705610|NCT00413283|4170764|P2|COMPLETED|Overall Study||13
1705611|NCT00413283|4170765|P1|COMPLETED|Overall Study||11
1705612|NCT00413283|4170762|P4|Received Study Drug|Overall Study||16
1705613|NCT00413283|4170763|P3|Received Study Drug|Overall Study||18
1705614|NCT00413283|4170764|P2|Received Study Drug|Overall Study||16
1705615|NCT00413283|4170765|P1|Received Study Drug|Overall Study||12
1705616|NCT00413283|4170762|P4|STARTED|Overall Study||17
1705617|NCT00413283|4170763|P3|STARTED|Overall Study||18
1705618|NCT00413283|4170764|P2|STARTED|Overall Study||16
1705619|NCT00413283|4170765|P1|STARTED|Overall Study||12
1705620|NCT00413244|4170797|P2|NOT COMPLETED|Overall Study||1
1705621|NCT00413244|4170798|P1|NOT COMPLETED|Overall Study||10
1705622|NCT00413244|4170797|P2|COMPLETED|Overall Study||19
1705623|NCT00413244|4170798|P1|COMPLETED|Overall Study||21
1705624|NCT00413244|4170797|P2|STARTED|Overall Study||20
1705625|NCT00413244|4170798|P1|STARTED|Overall Study||31
1705626|NCT00413231|4170826|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
1705627|NCT00413231|4170826|P1|COMPLETED|365-day to 60-month Post Treatment||93
1705628|NCT00413231|4170826|P1|STARTED|365-day to 60-month Post Treatment||139
1705629|NCT00413231|4170826|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
1705630|NCT00413231|4170826|P1|COMPLETED|30-day to 365-day Post Treatment||139
1705631|NCT00413231|4170826|P1|STARTED|30-day to 365-day Post Treatment||152
1705632|NCT00413231|4170826|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
1705633|NCT00413231|4170826|P1|COMPLETED|0 to 30-day Post Treatment||152
1705634|NCT00413231|4170826|P1|STARTED|0 to 30-day Post Treatment||160
1705635|NCT00413218|4170858|P2|NOT COMPLETED|Overall Study||96
1705636|NCT00413218|4170859|P1|NOT COMPLETED|Overall Study||103
1705637|NCT00413218|4170858|P2|COMPLETED|Overall Study||131
1705638|NCT00413218|4170859|P1|COMPLETED|Overall Study||120
1705639|NCT00413218|4170858|P2|Intent to Treat Population (ITT)|Overall Study||219
1705640|NCT00413218|4170859|P1|Intent to Treat Population (ITT)|Overall Study||221
1705641|NCT00413218|4170858|P2|STARTED|Overall Study||227
1705642|NCT00413218|4170859|P1|STARTED|Overall Study||223
1705643|NCT00413192|4170885|P4|NOT COMPLETED|Overall Study||32
1705644|NCT00413192|4170886|P3|NOT COMPLETED|Overall Study||19
1705645|NCT00413192|4170887|P2|NOT COMPLETED|Overall Study||40
1705646|NCT00413192|4170888|P1|NOT COMPLETED|Overall Study||37
1705647|NCT00413192|4170885|P4|COMPLETED|Overall Study||0
1705648|NCT00413192|4170886|P3|COMPLETED|Overall Study||0
1705649|NCT00413192|4170887|P2|COMPLETED|Overall Study||0
1705650|NCT00413192|4170888|P1|COMPLETED|Overall Study||0
1705651|NCT00413192|4170885|P4|STARTED|Overall Study||32
1705652|NCT00413192|4170886|P3|STARTED|Overall Study||19
1705653|NCT00413192|4170887|P2|STARTED|Overall Study||40
1705654|NCT00413192|4170888|P1|STARTED|Overall Study||37
1705655|NCT00413153|4170928|P2|NOT COMPLETED|Overall Study||1
1705656|NCT00413153|4170929|P1|NOT COMPLETED|Overall Study||2
1705657|NCT00413153|4170928|P2|COMPLETED|Overall Study||7
1705658|NCT00413153|4170929|P1|COMPLETED|Overall Study||5
1705659|NCT00413153|4170928|P2|STARTED|Overall Study||8
1705660|NCT00413153|4170929|P1|STARTED|Overall Study||7
1705661|NCT00413062|4170953|P2|NOT COMPLETED|Overall Study||210
1705662|NCT00413062|4170954|P1|NOT COMPLETED|Overall Study||678
1705663|NCT00413062|4170953|P2|COMPLETED|Overall Study||344
1705664|NCT00413062|4170954|P1|COMPLETED|Overall Study||988
1705665|NCT00413062|4170953|P2|STARTED|Overall Study||554
1705666|NCT00413062|4170954|P1|STARTED|Overall Study||1666
1705667|NCT00413049|4170980|P2|NOT COMPLETED|Overall Study||18
1705668|NCT00413049|4170981|P1|NOT COMPLETED|Overall Study||24
1705669|NCT00413049|4170980|P2|COMPLETED|Overall Study||331
1705670|NCT00413049|4170981|P1|COMPLETED|Overall Study||325
1705671|NCT00413049|4170980|P2|STARTED|Overall Study||349
1705672|NCT00413049|4170981|P1|STARTED|Overall Study||349
1705673|NCT00413036|4170997|P1|NOT COMPLETED|Overall Study||217
1705674|NCT00413036|4170997|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
1705675|NCT00413036|4170997|P1|STARTED|Overall Study||217
1705676|NCT00413010|4171007|P2|NOT COMPLETED|Overall Study||63
1705677|NCT00413010|4171008|P1|NOT COMPLETED|Overall Study||72
1705678|NCT00413010|4171007|P2|COMPLETED|Overall Study||113
1705679|NCT00413010|4171008|P1|COMPLETED|Overall Study||108
1705680|NCT00413010|4171007|P2|STARTED|Overall Study||176
1705681|NCT00413010|4171008|P1|STARTED|Overall Study||180
1705682|NCT00412984|4171030|P2|NOT COMPLETED|Overall Study||2493
1705683|NCT00412984|4171031|P1|NOT COMPLETED|Overall Study||2310
1705684|NCT00412984|4171030|P2|COMPLETED|Overall Study||6588
1705685|NCT00412984|4171031|P1|COMPLETED|Overall Study||6810
1705686|NCT00412984|4171030|P2|STARTED|Overall Study|Randomized participants|9081
1705687|NCT00412984|4171031|P1|STARTED|Overall Study|Randomized participants|9120
1705688|NCT00412971|4171075|P2|NOT COMPLETED|Overall Study||10
1705689|NCT00412971|4171076|P1|NOT COMPLETED|Overall Study||30
1705690|NCT00412971|4171075|P2|COMPLETED|Overall Study||108
1705691|NCT00412971|4171076|P1|COMPLETED|Overall Study||85
1705692|NCT00412971|4171075|P2|STARTED|Overall Study||118
1705693|NCT00412971|4171076|P1|STARTED|Overall Study||115
1705694|NCT00412958|4171089|P4|NOT COMPLETED|Overall Study||1
1705695|NCT00412958|4171090|P3|NOT COMPLETED|Overall Study||0
1705696|NCT00412958|4171091|P2|NOT COMPLETED|Overall Study||4
1705697|NCT00412958|4171092|P1|NOT COMPLETED|Overall Study||3
1705698|NCT00412958|4171089|P4|COMPLETED|Overall Study||30
1705699|NCT00412958|4171090|P3|COMPLETED|Overall Study||32
1705700|NCT00412958|4171091|P2|COMPLETED|Overall Study||29
1705701|NCT00412958|4171092|P1|COMPLETED|Overall Study||26
1705702|NCT00412958|4171089|P4|STARTED|Overall Study||31
1705703|NCT00412958|4171090|P3|STARTED|Overall Study||32
1705704|NCT00412958|4171091|P2|STARTED|Overall Study||33
1705705|NCT00412958|4171092|P1|STARTED|Overall Study||29
1705706|NCT00412932|4171102|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
1705707|NCT00412932|4171102|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
1705708|NCT00412932|4171102|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
1705709|NCT00412932|4171102|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
1705710|NCT00412932|4171102|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
1705711|NCT00412932|4171102|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
1705712|NCT00412932|4171102|P1|NOT COMPLETED|Olmesartan 40 mg||8
1705713|NCT00412932|4171102|P1|COMPLETED|Olmesartan 40 mg||161
1705714|NCT00412932|4171102|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
1705715|NCT00412932|4171102|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
1705716|NCT00412932|4171102|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
1705717|NCT00412932|4171102|P1|STARTED|Olmesartan (Olm) 20 mg||178
1705718|NCT00412893|4171113|P2|NOT COMPLETED|Overall Study||144
1705719|NCT00412893|4171114|P1|NOT COMPLETED|Overall Study||145
1705720|NCT00412893|4171113|P2|COMPLETED|Overall Study|Defined as completed treatment|120
1705721|NCT00412893|4171114|P1|COMPLETED|Overall Study|Defined as completed treatment|118
1705722|NCT00412893|4171113|P2|Received Treatment|Overall Study||258
1705723|NCT00412893|4171114|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
1705724|NCT00412893|4171113|P2|STARTED|Overall Study||264
1705725|NCT00412893|4171114|P1|STARTED|Overall Study||263
1705726|NCT00412867|4171140|P1|NOT COMPLETED|Overall Study||0
1705727|NCT00412867|4171140|P1|COMPLETED|Overall Study||58
1705728|NCT00412867|4171140|P1|STARTED|Overall Study||58
1705729|NCT00412854|4171152|P2|NOT COMPLETED|Overall Study||16
1705730|NCT00412854|4171153|P1|NOT COMPLETED|Overall Study||14
1705731|NCT00412854|4171152|P2|COMPLETED|Overall Study||314
1705732|NCT00412854|4171153|P1|COMPLETED|Overall Study||316
1705733|NCT00412854|4171152|P2|STARTED|Overall Study||330
1705734|NCT00412854|4171153|P1|STARTED|Overall Study||330
1705735|NCT00412841|4171181|P2|NOT COMPLETED|Overall Study||5
1705736|NCT00412841|4171182|P1|NOT COMPLETED|Overall Study||10
1705737|NCT00412841|4171181|P2|COMPLETED|Overall Study||16
1705738|NCT00412841|4171182|P1|COMPLETED|Overall Study||12
1705739|NCT00412841|4171181|P2|STARTED|Overall Study||21
1705740|NCT00412841|4171182|P1|STARTED|Overall Study||22
1705741|NCT00412750|4171197|P3|NOT COMPLETED|Overall Study||23
1705742|NCT00412750|4171198|P2|NOT COMPLETED|Overall Study||21
1705743|NCT00412750|4171199|P1|NOT COMPLETED|Overall Study||31
1705744|NCT00412750|4171197|P3|COMPLETED|Overall Study||31
1705745|NCT00412750|4171198|P2|COMPLETED|Overall Study||34
1705746|NCT00412750|4171199|P1|COMPLETED|Overall Study||19
1705747|NCT00412750|4171197|P3|STARTED|Overall Study||54
1705748|NCT00412750|4171198|P2|STARTED|Overall Study||55
1705749|NCT00412750|4171199|P1|STARTED|Overall Study||50
1705750|NCT00412737|4171224|P2|NOT COMPLETED|Overall Study||6
1705751|NCT00412737|4171225|P1|NOT COMPLETED|Overall Study||16
1705752|NCT00412737|4171224|P2|COMPLETED|Overall Study||232
1705753|NCT00412737|4171225|P1|COMPLETED|Overall Study||221
1705754|NCT00412737|4171224|P2|STARTED|Overall Study||238
1705755|NCT00412737|4171225|P1|STARTED|Overall Study||237
1705756|NCT00412607|4171243|P1|NOT COMPLETED|Overall Study||104
1705757|NCT00412607|4171243|P1|COMPLETED|Overall Study||145
1705758|NCT00412607|4171243|P1|Started Study Catheter|Overall Study||233
1705759|NCT00412607|4171243|P1|STARTED|Overall Study||249
1705760|NCT00412542|4171256|P2|NOT COMPLETED|Overall Study||3
1705761|NCT00412542|4171257|P1|NOT COMPLETED|Overall Study||0
1705762|NCT00412542|4171256|P2|COMPLETED|Overall Study||42
1705763|NCT00412542|4171257|P1|COMPLETED|Overall Study||33
1705764|NCT00412542|4171256|P2|STARTED|Overall Study||45
1705765|NCT00412542|4171257|P1|STARTED|Overall Study||33
1705766|NCT00412529|4171263|P2|NOT COMPLETED|Overall Study||0
1705767|NCT00412529|4171264|P1|NOT COMPLETED|Overall Study||0
1705768|NCT00412529|4171263|P2|COMPLETED|Overall Study||21
1705769|NCT00412529|4171264|P1|COMPLETED|Overall Study||23
1705770|NCT00412529|4171263|P2|STARTED|Overall Study||21
1705771|NCT00412529|4171264|P1|STARTED|Overall Study||23
1705772|NCT00412516|4171287|P3|NOT COMPLETED|Overall Study||0
1705773|NCT00412516|4171288|P2|NOT COMPLETED|Overall Study||0
1705774|NCT00412516|4171289|P1|NOT COMPLETED|Overall Study||0
1705775|NCT00412516|4171287|P3|COMPLETED|Overall Study||214
1705776|NCT00412516|4171288|P2|COMPLETED|Overall Study||212
1705777|NCT00412516|4171289|P1|COMPLETED|Overall Study||93
1705778|NCT00412516|4171287|P3|STARTED|Overall Study||214
1705779|NCT00412516|4171288|P2|STARTED|Overall Study||212
1705780|NCT00412516|4171289|P1|STARTED|Overall Study||93
1705781|NCT00412464|4171306|P1|NOT COMPLETED|Overall Study||0
1705782|NCT00412464|4171306|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
1705783|NCT00412464|4171306|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
1705784|NCT00412451|4171318|P4|NOT COMPLETED|Overall Study||2
1705785|NCT00412451|4171319|P3|NOT COMPLETED|Overall Study||1
1705786|NCT00412451|4171320|P2|NOT COMPLETED|Overall Study||0
1705787|NCT00412451|4171321|P1|NOT COMPLETED|Overall Study||0
1705788|NCT00412451|4171318|P4|COMPLETED|Overall Study||11
1705789|NCT00412451|4171319|P3|COMPLETED|Overall Study||14
1705790|NCT00412451|4171320|P2|COMPLETED|Overall Study||15
1705791|NCT00412451|4171321|P1|COMPLETED|Overall Study||8
1705792|NCT00412451|4171318|P4|STARTED|Overall Study||13
1705793|NCT00412451|4171319|P3|STARTED|Overall Study||15
1705794|NCT00412451|4171320|P2|STARTED|Overall Study||15
1705795|NCT00412451|4171321|P1|STARTED|Overall Study||8
1705796|NCT00412425|4171333|P2|NOT COMPLETED|Overall Study||0
1705797|NCT00412425|4171334|P1|NOT COMPLETED|Overall Study||0
1705798|NCT00412425|4171333|P2|COMPLETED|Overall Study||15
1705799|NCT00412425|4171334|P1|COMPLETED|Overall Study||15
1705800|NCT00412425|4171333|P2|STARTED|Overall Study||15
1705801|NCT00412425|4171334|P1|STARTED|Overall Study||15
1705802|NCT00412373|4171342|P2|NOT COMPLETED|Overall Study||77
1705803|NCT00412373|4171343|P1|NOT COMPLETED|Overall Study||41
1705804|NCT00412373|4171342|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
1705805|NCT00412373|4171343|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
1705806|NCT00412373|4171342|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
1705807|NCT00412373|4171343|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
1705808|NCT00412360|4171385|P2|NOT COMPLETED|Overall Study||3
1705809|NCT00412360|4171386|P1|NOT COMPLETED|Overall Study||1
1705810|NCT00412360|4171385|P2|COMPLETED|Overall Study||108
1705811|NCT00412360|4171386|P1|COMPLETED|Overall Study||112
1705812|NCT00412360|4171385|P2|STARTED|Overall Study||111
1705813|NCT00412360|4171386|P1|STARTED|Overall Study||113
1705814|NCT00412243|4171410|P1|NOT COMPLETED|Overall Study||0
1705815|NCT00412243|4171410|P1|COMPLETED|Overall Study||50
1705816|NCT00412243|4171410|P1|STARTED|Overall Study||50
1705817|NCT00412217|4171416|P2|NOT COMPLETED|Overall Study||48
1705818|NCT00412217|4171417|P1|NOT COMPLETED|Overall Study||46
1705819|NCT00412217|4171416|P2|COMPLETED|Overall Study||0
1705820|NCT00412217|4171417|P1|COMPLETED|Overall Study||0
1705821|NCT00412217|4171416|P2|STARTED|Overall Study||48
1705822|NCT00412217|4171417|P1|STARTED|Overall Study||46
1705823|NCT00412113|4171431|P2|NOT COMPLETED|Overall Study||15
1705824|NCT00412113|4171432|P1|NOT COMPLETED|Overall Study||12
1705825|NCT00412113|4171431|P2|COMPLETED|Overall Study|15-April-2008|107
1705826|NCT00412113|4171432|P1|COMPLETED|Overall Study|15-April-2008|111
1705827|NCT00412113|4171431|P2|Received Treatment|Overall Study||122
1705828|NCT00412113|4171432|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
1705829|NCT00412113|4171431|P2|STARTED|Overall Study|15-January-2007|122
1705830|NCT00412113|4171432|P1|STARTED|Overall Study|15-January-2007|123
1705831|NCT00412087|4171486|P2|NOT COMPLETED|Overall Study||65
1705832|NCT00412087|4171487|P1|NOT COMPLETED|Overall Study||62
1705833|NCT00412087|4171486|P2|COMPLETED|Overall Study||66
1705834|NCT00412087|4171487|P1|COMPLETED|Overall Study||72
1705835|NCT00412087|4171486|P2|STARTED|Overall Study||131
1705836|NCT00412087|4171487|P1|STARTED|Overall Study||134
1705837|NCT00412074|4171498|P3|NOT COMPLETED|Overall Study||67
1705838|NCT00412074|4171499|P2|NOT COMPLETED|Overall Study||22
1705839|NCT00412074|4171500|P1|NOT COMPLETED|Overall Study||77
1705840|NCT00412074|4171498|P3|COMPLETED|Overall Study||128
1705841|NCT00412074|4171499|P2|COMPLETED|Overall Study||44
1705842|NCT00412074|4171500|P1|COMPLETED|Overall Study||122
1705843|NCT00412074|4171498|P3|STARTED|Overall Study||195
1705844|NCT00412074|4171499|P2|STARTED|Overall Study||66
1705845|NCT00412074|4171500|P1|STARTED|Overall Study||199
1705846|NCT00412061|4171516|P2|NOT COMPLETED|Open Label Phase||170
1705847|NCT00412061|4171517|P1|NOT COMPLETED|Open Label Phase||0
1705848|NCT00412061|4171516|P2|COMPLETED|Open Label Phase||0
1705849|NCT00412061|4171517|P1|COMPLETED|Open Label Phase||0
1705850|NCT00412061|4171516|P2|STARTED|Open Label Phase||170
1705851|NCT00412061|4171517|P1|STARTED|Open Label Phase||0
1705852|NCT00412061|4171516|P2|NOT COMPLETED|Double Blind Phase||213
1705853|NCT00412061|4171517|P1|NOT COMPLETED|Double Blind Phase||216
1705854|NCT00412061|4171516|P2|COMPLETED|Double Blind Phase||0
1705855|NCT00412061|4171517|P1|COMPLETED|Double Blind Phase||0
1705856|NCT00412061|4171516|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
1705857|NCT00412061|4171517|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
1705858|NCT00412061|4171516|P2|STARTED|Double Blind Phase||213
1705859|NCT00412061|4171517|P1|STARTED|Double Blind Phase||216
1705860|NCT00411788|4171535|P1|NOT COMPLETED|Overall Study||2
1705861|NCT00411788|4171535|P1|COMPLETED|Overall Study||9
1705862|NCT00411788|4171535|P1|STARTED|Overall Study||11
1705863|NCT00411762|4171544|P1|NOT COMPLETED|Overall Study||5
1705864|NCT00411762|4171544|P1|COMPLETED|Overall Study||20
1705865|NCT00411762|4171544|P1|STARTED|Overall Study||25
1705866|NCT00411749|4171551|P2|NOT COMPLETED|Overall Study||0
1705867|NCT00411749|4171552|P1|NOT COMPLETED|Overall Study||0
1705868|NCT00411749|4171551|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
1705869|NCT00411749|4171552|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
1705870|NCT00411749|4171551|P2|Vaccinated|Overall Study||25
1705871|NCT00411749|4171552|P1|Vaccinated|Overall Study||82
1705872|NCT00411749|4171551|P2|STARTED|Overall Study||25
1705873|NCT00411749|4171552|P1|STARTED|Overall Study||82
1705874|NCT00411671|4171568|P1|NOT COMPLETED|Overall Study||20
1705875|NCT00411671|4171568|P1|COMPLETED|Overall Study||85
1705876|NCT00411671|4171568|P1|STARTED|Overall Study||105
1705877|NCT00411645|4171576|P2|NOT COMPLETED|Overall Study||164
1705878|NCT00411645|4171577|P1|NOT COMPLETED|Overall Study||81
1705879|NCT00411645|4171576|P2|COMPLETED|Overall Study||290
1705880|NCT00411645|4171577|P1|COMPLETED|Overall Study||146
1705881|NCT00411645|4171576|P2|STARTED|Overall Study||454
1705882|NCT00411645|4171577|P1|STARTED|Overall Study||227
1705883|NCT00411619|4171601|P1|NOT COMPLETED|Overall Study||6
1705884|NCT00411619|4171601|P1|COMPLETED|Overall Study||22
1705885|NCT00411619|4171601|P1|STARTED|Overall Study||28
1705886|NCT00411554|4171608|P2|NOT COMPLETED|Overall Study||9
1705887|NCT00411554|4171609|P1|NOT COMPLETED|Overall Study||8
1705888|NCT00411554|4171608|P2|COMPLETED|Overall Study||147
1705889|NCT00411554|4171609|P1|COMPLETED|Overall Study||155
1705890|NCT00411554|4171608|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
1705891|NCT00411554|4171609|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
1705892|NCT00411463|4171621|P2|NOT COMPLETED|Overall Study||3
1705893|NCT00411463|4171622|P1|NOT COMPLETED|Overall Study||3
1705894|NCT00411463|4171621|P2|COMPLETED|Overall Study||8
1705895|NCT00411463|4171622|P1|COMPLETED|Overall Study||11
1705896|NCT00411463|4171621|P2|STARTED|Overall Study||11
1705897|NCT00411463|4171622|P1|STARTED|Overall Study||14
1705898|NCT00411450|4171635|P1|NOT COMPLETED|Overall Study||3
1705899|NCT00411450|4171635|P1|COMPLETED|Overall Study|Ended second-line treatment|113
1705900|NCT00411450|4171635|P1|Received Treatment|Overall Study||115
1705901|NCT00411450|4171635|P1|STARTED|Overall Study||116
1705902|NCT00411411|4171663|P2|NOT COMPLETED|Overall Study||0
1705903|NCT00411411|4171664|P1|NOT COMPLETED|Overall Study||0
1705904|NCT00411411|4171663|P2|COMPLETED|Overall Study||25
1705905|NCT00411411|4171664|P1|COMPLETED|Overall Study||24
1705906|NCT00411411|4171663|P2|STARTED|Overall Study||25
1705907|NCT00411411|4171664|P1|STARTED|Overall Study||24
1705908|NCT00411398|4171672|P1|NOT COMPLETED|Overall Study||5
1705909|NCT00411398|4171672|P1|COMPLETED|Overall Study||10
1705910|NCT00411398|4171672|P1|STARTED|Overall Study||15
1705911|NCT00411216|4171678|P2|NOT COMPLETED|Overall Study||2
1705912|NCT00411216|4171679|P1|NOT COMPLETED|Overall Study||0
1705913|NCT00411216|4171678|P2|COMPLETED|Overall Study||8
1705914|NCT00411216|4171679|P1|COMPLETED|Overall Study||13
1705915|NCT00411216|4171678|P2|STARTED|Overall Study||10
1705916|NCT00411216|4171679|P1|STARTED|Overall Study||13
1705917|NCT00411151|4171685|P1|NOT COMPLETED|Overall Study||47
1705918|NCT00411151|4171685|P1|COMPLETED|Overall Study||5
1705919|NCT00411151|4171685|P1|STARTED|Overall Study||52
1705920|NCT00411086|4171695|P1|NOT COMPLETED|Overall Study||0
1705921|NCT00411086|4171695|P1|COMPLETED|Overall Study||52
1705922|NCT00411086|4171695|P1|STARTED|Overall Study||52
1705923|NCT00410904|4171703|P2|NOT COMPLETED|Overall Study||0
1705924|NCT00410904|4171704|P1|NOT COMPLETED|Overall Study||0
1705925|NCT00410904|4171703|P2|COMPLETED|Overall Study||20
1705926|NCT00410904|4171704|P1|COMPLETED|Overall Study||40
1705927|NCT00410904|4171703|P2|STARTED|Overall Study||20
1705928|NCT00410904|4171704|P1|STARTED|Overall Study||40
1705929|NCT00410891|4171712|P1|NOT COMPLETED|Overall Study||0
1705930|NCT00410891|4171712|P1|COMPLETED|Overall Study||129
1705931|NCT00410891|4171712|P1|STARTED|Overall Study||129
1705932|NCT00410826|4171718|P2|NOT COMPLETED|Overall Study||4
1705933|NCT00410826|4171719|P1|NOT COMPLETED|Overall Study||9
1705934|NCT00410826|4171718|P2|COMPLETED|Overall Study||95
1705935|NCT00410826|4171719|P1|COMPLETED|Overall Study||96
1705936|NCT00410826|4171718|P2|STARTED|Overall Study||99
1705937|NCT00410826|4171719|P1|STARTED|Overall Study||105
1705938|NCT00410813|4171729|P2|NOT COMPLETED|Overall Study||42
1705939|NCT00410813|4171730|P1|NOT COMPLETED|Overall Study||43
1705940|NCT00410813|4171729|P2|COMPLETED|Overall Study||0
1705941|NCT00410813|4171730|P1|COMPLETED|Overall Study|Patients treated until progression.|0
1705942|NCT00410813|4171729|P2|Eligible|Overall Study||38
1705943|NCT00410813|4171730|P1|Eligible|Overall Study||41
1705944|NCT00410813|4171729|P2|STARTED|Overall Study||42
1705945|NCT00410813|4171730|P1|STARTED|Overall Study||43
1705946|NCT00410761|4171767|P2|NOT COMPLETED|Overall Study||72
1705947|NCT00410761|4171768|P1|NOT COMPLETED|Overall Study||120
1705948|NCT00410761|4171767|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
1705949|NCT00410761|4171768|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
1705950|NCT00410761|4171767|P2|STARTED|Overall Study|randomised patients|100
1705951|NCT00410761|4171768|P1|STARTED|Overall Study|randomised patients|231
1705952|NCT00410605|4171788|P1|NOT COMPLETED|Overall Study||25
1705953|NCT00410605|4171788|P1|COMPLETED|Overall Study||14
1705954|NCT00410605|4171788|P1|STARTED|Overall Study||39
1705955|NCT00410514|4171800|P3|NOT COMPLETED|Overall Study||7
1705956|NCT00410514|4171801|P2|NOT COMPLETED|Overall Study||3
1705957|NCT00410514|4171802|P1|NOT COMPLETED|Overall Study||2
1705958|NCT00410514|4171800|P3|COMPLETED|Overall Study||58
1705959|NCT00410514|4171801|P2|COMPLETED|Overall Study||67
1705960|NCT00410514|4171802|P1|COMPLETED|Overall Study||63
1705961|NCT00410514|4171800|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
1705962|NCT00410514|4171801|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
1705963|NCT00410514|4171802|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
1705964|NCT00410514|4171800|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
1705965|NCT00410514|4171801|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
1705966|NCT00410514|4171802|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
1705967|NCT00410514|4171800|P3|STARTED|Overall Study||65
1705968|NCT00410514|4171801|P2|STARTED|Overall Study||70
1705969|NCT00410514|4171802|P1|STARTED|Overall Study||65
1705970|NCT00410488|4171863|P2|NOT COMPLETED|Overall Study||0
1705971|NCT00410488|4171864|P1|NOT COMPLETED|Overall Study||0
1705972|NCT00410488|4171863|P2|COMPLETED|Overall Study||34
1705973|NCT00410488|4171864|P1|COMPLETED|Overall Study||16
1705974|NCT00410488|4171863|P2|STARTED|Overall Study||34
1705975|NCT00410488|4171864|P1|STARTED|Overall Study||16
1705976|NCT00410423|4171869|P4|NOT COMPLETED|Phase 2||0
1705977|NCT00410423|4171870|P3|NOT COMPLETED|Phase 2||0
1705978|NCT00410423|4171871|P2|NOT COMPLETED|Phase 2||0
1705979|NCT00410423|4171872|P1|NOT COMPLETED|Phase 2||0
1705980|NCT00410423|4171869|P4|COMPLETED|Phase 2||44
1705981|NCT00410423|4171870|P3|COMPLETED|Phase 2||0
1705982|NCT00410423|4171871|P2|COMPLETED|Phase 2||0
1705983|NCT00410423|4171872|P1|COMPLETED|Phase 2||0
1705984|NCT00410423|4171869|P4|STARTED|Phase 2||44
1705985|NCT00410423|4171870|P3|STARTED|Phase 2||0
1705986|NCT00410423|4171871|P2|STARTED|Phase 2||0
1705987|NCT00410423|4171872|P1|STARTED|Phase 2||0
1705988|NCT00410423|4171869|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
1705989|NCT00410423|4171870|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
1705990|NCT00410423|4171871|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
1705991|NCT00410423|4171872|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
1705992|NCT00410423|4171869|P4|COMPLETED|Phase 1 - Dose Level 3||0
1705993|NCT00410423|4171870|P3|COMPLETED|Phase 1 - Dose Level 3||3
1705994|NCT00410423|4171871|P2|COMPLETED|Phase 1 - Dose Level 3||0
1705995|NCT00410423|4171872|P1|COMPLETED|Phase 1 - Dose Level 3||0
1705996|NCT00410423|4171869|P4|STARTED|Phase 1 - Dose Level 3||0
1705997|NCT00410423|4171870|P3|STARTED|Phase 1 - Dose Level 3||3
1705998|NCT00410423|4171871|P2|STARTED|Phase 1 - Dose Level 3||0
1705999|NCT00410423|4171872|P1|STARTED|Phase 1 - Dose Level 3||0
1706000|NCT00410423|4171869|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
1706001|NCT00410423|4171870|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
1706002|NCT00410423|4171871|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
1706003|NCT00410423|4171872|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
1706004|NCT00410423|4171869|P4|COMPLETED|Phase 1 - Dose Level 2||0
1706005|NCT00410423|4171870|P3|COMPLETED|Phase 1 - Dose Level 2||0
1706006|NCT00410423|4171871|P2|COMPLETED|Phase 1 - Dose Level 2||5
1706007|NCT00410423|4171872|P1|COMPLETED|Phase 1 - Dose Level 2||0
1706008|NCT00410423|4171869|P4|STARTED|Phase 1 - Dose Level 2||0
1706009|NCT00410423|4171870|P3|STARTED|Phase 1 - Dose Level 2||0
1706010|NCT00410423|4171871|P2|STARTED|Phase 1 - Dose Level 2||5
1706011|NCT00410423|4171872|P1|STARTED|Phase 1 - Dose Level 2||0
1706012|NCT00410423|4171869|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
1706013|NCT00410423|4171870|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
1706014|NCT00410423|4171871|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
1706015|NCT00410423|4171872|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
1706016|NCT00410423|4171869|P4|COMPLETED|Phase 1 - Dose Level 1||0
1706017|NCT00410423|4171870|P3|COMPLETED|Phase 1 - Dose Level 1||0
1706018|NCT00410423|4171871|P2|COMPLETED|Phase 1 - Dose Level 1||0
1706019|NCT00410423|4171872|P1|COMPLETED|Phase 1 - Dose Level 1||3
1706020|NCT00410423|4171869|P4|STARTED|Phase 1 - Dose Level 1||0
1706021|NCT00410423|4171870|P3|STARTED|Phase 1 - Dose Level 1||0
1706022|NCT00410423|4171871|P2|STARTED|Phase 1 - Dose Level 1||0
1706023|NCT00410423|4171872|P1|STARTED|Phase 1 - Dose Level 1||3
1706024|NCT00410410|4171885|P9|NOT COMPLETED|Open-Label Period (OL)||349
1706025|NCT00410410|4171886|P8|NOT COMPLETED|Open-Label Period (OL)||0
1706026|NCT00410410|4171887|P7|NOT COMPLETED|Open-Label Period (OL)||0
1706027|NCT00410410|4171888|P6|NOT COMPLETED|Open-Label Period (OL)||0
1706028|NCT00410410|4171889|P5|NOT COMPLETED|Open-Label Period (OL)||0
1706029|NCT00410410|4171890|P4|NOT COMPLETED|Open-Label Period (OL)||0
1706030|NCT00410410|4171891|P3|NOT COMPLETED|Open-Label Period (OL)||0
1706031|NCT00410410|4171892|P2|NOT COMPLETED|Open-Label Period (OL)||0
1706032|NCT00410410|4171893|P1|NOT COMPLETED|Open-Label Period (OL)||0
1706033|NCT00410410|4171885|P9|COMPLETED|Open-Label Period (OL)||0
1706034|NCT00410410|4171886|P8|COMPLETED|Open-Label Period (OL)||0
1706035|NCT00410410|4171887|P7|COMPLETED|Open-Label Period (OL)||0
1706036|NCT00410410|4171888|P6|COMPLETED|Open-Label Period (OL)||0
1706037|NCT00410410|4171889|P5|COMPLETED|Open-Label Period (OL)||0
1706038|NCT00410410|4171890|P4|COMPLETED|Open-Label Period (OL)||0
1706039|NCT00410410|4171891|P3|COMPLETED|Open-Label Period (OL)||0
1706040|NCT00410410|4171892|P2|COMPLETED|Open-Label Period (OL)||0
1706041|NCT00410410|4171893|P1|COMPLETED|Open-Label Period (OL)||0
1706042|NCT00410410|4171885|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
1706043|NCT00410410|4171886|P8|STARTED|Open-Label Period (OL)||0
1706044|NCT00410410|4171887|P7|STARTED|Open-Label Period (OL)||0
1706045|NCT00410410|4171888|P6|STARTED|Open-Label Period (OL)||0
1706046|NCT00410410|4171889|P5|STARTED|Open-Label Period (OL)||0
1706047|NCT00410410|4171890|P4|STARTED|Open-Label Period (OL)||0
1706048|NCT00410410|4171891|P3|STARTED|Open-Label Period (OL)||0
1706049|NCT00410410|4171892|P2|STARTED|Open-Label Period (OL)||0
1706050|NCT00410410|4171893|P1|STARTED|Open-Label Period (OL)||0
1706051|NCT00410410|4171885|P9|NOT COMPLETED|Maintenance Period (MP)||0
1706052|NCT00410410|4171886|P8|NOT COMPLETED|Maintenance Period (MP)||55
1706053|NCT00410410|4171887|P7|NOT COMPLETED|Maintenance Period (MP)||50
1706054|NCT00410410|4171888|P6|NOT COMPLETED|Maintenance Period (MP)||0
1706055|NCT00410410|4171889|P5|NOT COMPLETED|Maintenance Period (MP)||0
1706056|NCT00410410|4171890|P4|NOT COMPLETED|Maintenance Period (MP)||0
1706057|NCT00410410|4171891|P3|NOT COMPLETED|Maintenance Period (MP)||0
1706058|NCT00410410|4171892|P2|NOT COMPLETED|Maintenance Period (MP)||0
1706059|NCT00410410|4171893|P1|NOT COMPLETED|Maintenance Period (MP)||0
1706060|NCT00410410|4171885|P9|COMPLETED|Maintenance Period (MP)||0
1706061|NCT00410410|4171886|P8|COMPLETED|Maintenance Period (MP)||11
1706062|NCT00410410|4171887|P7|COMPLETED|Maintenance Period (MP)||15
1706063|NCT00410410|4171888|P6|COMPLETED|Maintenance Period (MP)||0
1706064|NCT00410410|4171889|P5|COMPLETED|Maintenance Period (MP)||0
1706065|NCT00410410|4171890|P4|COMPLETED|Maintenance Period (MP)||0
1706066|NCT00410410|4171891|P3|COMPLETED|Maintenance Period (MP)||0
1706067|NCT00410410|4171892|P2|COMPLETED|Maintenance Period (MP)||0
1706068|NCT00410410|4171893|P1|COMPLETED|Maintenance Period (MP)||0
1706069|NCT00410410|4171885|P9|STARTED|Maintenance Period (MP)||0
1706070|NCT00410410|4171886|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
1706071|NCT00410410|4171887|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
1706072|NCT00410410|4171888|P6|STARTED|Maintenance Period (MP)||0
1706073|NCT00410410|4171889|P5|STARTED|Maintenance Period (MP)||0
1706074|NCT00410410|4171890|P4|STARTED|Maintenance Period (MP)||0
1706075|NCT00410410|4171891|P3|STARTED|Maintenance Period (MP)||0
1706076|NCT00410410|4171892|P2|STARTED|Maintenance Period (MP)||0
1706077|NCT00410410|4171893|P1|STARTED|Maintenance Period (MP)||0
1706078|NCT00410410|4171885|P9|NOT COMPLETED|Induction Period (IP)||0
1706079|NCT00410410|4171886|P8|NOT COMPLETED|Induction Period (IP)||0
1706080|NCT00410410|4171887|P7|NOT COMPLETED|Induction Period (IP)||0
1706081|NCT00410410|4171888|P6|NOT COMPLETED|Induction Period (IP)||29
1706082|NCT00410410|4171889|P5|NOT COMPLETED|Induction Period (IP)||32
1706083|NCT00410410|4171890|P4|NOT COMPLETED|Induction Period (IP)||20
1706084|NCT00410410|4171891|P3|NOT COMPLETED|Induction Period (IP)||17
1706085|NCT00410410|4171892|P2|NOT COMPLETED|Induction Period (IP)||35
1706086|NCT00410410|4171893|P1|NOT COMPLETED|Induction Period (IP)||35
1706087|NCT00410410|4171885|P9|COMPLETED|Induction Period (IP)||0
1706088|NCT00410410|4171886|P8|COMPLETED|Induction Period (IP)||0
1706089|NCT00410410|4171887|P7|COMPLETED|Induction Period (IP)||0
1706090|NCT00410410|4171888|P6|COMPLETED|Induction Period (IP)||21
1706091|NCT00410410|4171889|P5|COMPLETED|Induction Period (IP)||19
1706092|NCT00410410|4171890|P4|COMPLETED|Induction Period (IP)||120
1706093|NCT00410410|4171891|P3|COMPLETED|Induction Period (IP)||53
1706094|NCT00410410|4171892|P2|COMPLETED|Induction Period (IP)||104
1706095|NCT00410410|4171893|P1|COMPLETED|Induction Period (IP)||106
1706096|NCT00410410|4171885|P9|STARTED|Induction Period (IP)||0
1706097|NCT00410410|4171886|P8|STARTED|Induction Period (IP)||0
1706098|NCT00410410|4171887|P7|STARTED|Induction Period (IP)||0
1706099|NCT00410410|4171888|P6|STARTED|Induction Period (IP)||50
1706100|NCT00410410|4171889|P5|STARTED|Induction Period (IP)||51
1706101|NCT00410410|4171890|P4|STARTED|Induction Period (IP)||140
1706102|NCT00410410|4171891|P3|STARTED|Induction Period (IP)||70
1706103|NCT00410410|4171892|P2|STARTED|Induction Period (IP)||139
1706104|NCT00410410|4171893|P1|STARTED|Induction Period (IP)||141
1706105|NCT00410384|4172054|P3|NOT COMPLETED|Overall Study||82
1706106|NCT00410384|4172055|P2|NOT COMPLETED|Overall Study||72
1706107|NCT00410384|4172056|P1|NOT COMPLETED|Overall Study||89
1706108|NCT00410384|4172054|P3|COMPLETED|Overall Study||191
1706109|NCT00410384|4172055|P2|COMPLETED|Overall Study||199
1706110|NCT00410384|4172056|P1|COMPLETED|Overall Study||186
1706111|NCT00410384|4172054|P3|STARTED|Overall Study||273
1706112|NCT00410384|4172055|P2|STARTED|Overall Study||271
1706113|NCT00410384|4172056|P1|STARTED|Overall Study||275
1706114|NCT00410280|4172084|P2|NOT COMPLETED|Overall Study||0
1706115|NCT00410280|4172085|P1|NOT COMPLETED|Overall Study||0
1706116|NCT00410280|4172084|P2|COMPLETED|Overall Study||13
1706117|NCT00410280|4172085|P1|COMPLETED|Overall Study||14
1706118|NCT00410280|4172084|P2|STARTED|Overall Study||13
1706119|NCT00410280|4172085|P1|STARTED|Overall Study||14
1706120|NCT00410202|4172129|P3|NOT COMPLETED|Off-treatment Follow up||12
1706121|NCT00410202|4172130|P2|NOT COMPLETED|Off-treatment Follow up||8
1706122|NCT00410202|4172131|P1|NOT COMPLETED|Off-treatment Follow up||14
1706123|NCT00410202|4172129|P3|COMPLETED|Off-treatment Follow up||2
1706124|NCT00410202|4172130|P2|COMPLETED|Off-treatment Follow up||0
1706125|NCT00410202|4172131|P1|COMPLETED|Off-treatment Follow up||1
1706126|NCT00410202|4172129|P3|STARTED|Off-treatment Follow up||14
1706127|NCT00410202|4172130|P2|STARTED|Off-treatment Follow up||8
1706128|NCT00410202|4172131|P1|STARTED|Off-treatment Follow up||15
1706129|NCT00410202|4172129|P3|NOT COMPLETED|On-Treatment||71
1706130|NCT00410202|4172130|P2|NOT COMPLETED|On-Treatment||79
1706131|NCT00410202|4172131|P1|NOT COMPLETED|On-Treatment||75
1706132|NCT00410202|4172129|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
1706133|NCT00410202|4172130|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
1706134|NCT00410202|4172131|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
1706135|NCT00410202|4172129|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
1706136|NCT00410202|4172130|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
1706137|NCT00410202|4172131|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
1706138|NCT00410202|4172129|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
1706139|NCT00410202|4172130|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
1706140|NCT00410202|4172131|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
1706141|NCT00410202|4172129|P3|STARTED|On-Treatment||137
1706142|NCT00410202|4172130|P2|STARTED|On-Treatment||140
1706143|NCT00410202|4172131|P1|STARTED|On-Treatment||138
1706144|NCT00410189|4172211|P1|NOT COMPLETED|Overall Study||0
1706145|NCT00410189|4172211|P1|COMPLETED|Overall Study||54
1706146|NCT00410189|4172211|P1|STARTED|Overall Study||54
1706147|NCT00410163|4172218|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
1706148|NCT00410163|4172219|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
1706149|NCT00410163|4172218|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
1706150|NCT00410163|4172219|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
1706151|NCT00410163|4172218|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
1706152|NCT00410163|4172219|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
1706153|NCT00410163|4172218|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
1706154|NCT00410163|4172219|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
1706155|NCT00410163|4172218|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
1706156|NCT00410163|4172219|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
1706157|NCT00410163|4172218|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
1706158|NCT00410163|4172219|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
1706159|NCT00410150|4172263|P2|NOT COMPLETED|Overall Study||3
1706160|NCT00410150|4172264|P1|NOT COMPLETED|Overall Study||2
1706161|NCT00410150|4172263|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
1706162|NCT00410150|4172264|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
1706163|NCT00410150|4172263|P2|STARTED|Overall Study||20
1706164|NCT00410150|4172264|P1|STARTED|Overall Study||22
1706165|NCT00410124|4172272|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
1706166|NCT00410124|4172273|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
1706167|NCT00410124|4172272|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
1706168|NCT00410124|4172273|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
1706169|NCT00410124|4172272|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
1706170|NCT00410124|4172273|P1|STARTED|Extension Phase - Open Label (45 Months)||67
1706171|NCT00410124|4172272|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
1706172|NCT00410124|4172273|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
1706173|NCT00410124|4172272|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
1706174|NCT00410124|4172273|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
1706175|NCT00410124|4172272|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
1706176|NCT00410124|4172273|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
1706177|NCT00410124|4172272|P2|Ongoing|Core Phase Double Blind (15 Months)||4
1706178|NCT00410124|4172273|P1|Ongoing|Core Phase Double Blind (15 Months)||13
1706179|NCT00410124|4172272|P2|STARTED|Core Phase Double Blind (15 Months)||139
1706180|NCT00410124|4172273|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
1706181|NCT00410072|4172304|P2|NOT COMPLETED|After Week 48 to Week 96||11
1706182|NCT00410072|4172305|P1|NOT COMPLETED|After Week 48 to Week 96||6
1706183|NCT00410072|4172304|P2|COMPLETED|After Week 48 to Week 96||174
1706184|NCT00410072|4172305|P1|COMPLETED|After Week 48 to Week 96||170
1706185|NCT00410072|4172304|P2|STARTED|After Week 48 to Week 96||185
1706186|NCT00410072|4172305|P1|STARTED|After Week 48 to Week 96||176
1706187|NCT00410072|4172304|P2|NOT COMPLETED|Day 1 to Week 48||12
1706188|NCT00410072|4172305|P1|NOT COMPLETED|Day 1 to Week 48||6
1706189|NCT00410072|4172304|P2|COMPLETED|Day 1 to Week 48||185
1706190|NCT00410072|4172305|P1|COMPLETED|Day 1 to Week 48||176
1706279|NCT00409578|4172602|P3|STARTED|Overall Study||269
1706191|NCT00410072|4172304|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
1706192|NCT00410072|4172305|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
1706193|NCT00410059|4172341|P1|NOT COMPLETED|Overall Study||0
1706194|NCT00410059|4172341|P1|COMPLETED|Overall Study||59
1706195|NCT00410059|4172341|P1|STARTED|Overall Study||59
1706196|NCT00410046|4172345|P1|NOT COMPLETED|Overall Study||5
1706197|NCT00410046|4172345|P1|COMPLETED|Overall Study||79
1706198|NCT00410046|4172345|P1|STARTED|Overall Study||84
1706199|NCT00409838|4172376|P2|NOT COMPLETED|Long-term Extension Period||0
1706200|NCT00409838|4172377|P1|NOT COMPLETED|Long-term Extension Period||18
1706201|NCT00409838|4172376|P2|COMPLETED|Long-term Extension Period||0
1706202|NCT00409838|4172377|P1|COMPLETED|Long-term Extension Period||87
1706203|NCT00409838|4172376|P2|STARTED|Long-term Extension Period||0
1706204|NCT00409838|4172377|P1|STARTED|Long-term Extension Period||105
1706205|NCT00409838|4172376|P2|NOT COMPLETED|Short-term Period||5
1706206|NCT00409838|4172377|P1|NOT COMPLETED|Short-term Period||3
1706207|NCT00409838|4172376|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
1706208|NCT00409838|4172377|P1|COMPLETED|Short-term Period||53
1706209|NCT00409838|4172376|P2|Treated (Baseline) Population|Short-term Period||57
1706210|NCT00409838|4172377|P1|Treated (Baseline) Population|Short-term Period||55
1706211|NCT00409838|4172376|P2|STARTED|Short-term Period|Randomized|57
1706212|NCT00409838|4172377|P1|STARTED|Short-term Period|Randomized|56
1706213|NCT00409825|4172438|P1|NOT COMPLETED|Overall Study||0
1706214|NCT00409825|4172438|P1|COMPLETED|Overall Study||61
1706215|NCT00409825|4172438|P1|STARTED|Overall Study||61
1706216|NCT00409786|4172442|P1|NOT COMPLETED|Overall Study||3
1706217|NCT00409786|4172442|P1|COMPLETED|Overall Study||47
1706218|NCT00409786|4172442|P1|STARTED|Overall Study||50
1706219|NCT00409773|4172451|P5|NOT COMPLETED|Overall Study||10
1706220|NCT00409773|4172452|P4|NOT COMPLETED|Overall Study||12
1706221|NCT00409773|4172453|P3|NOT COMPLETED|Overall Study||9
1706222|NCT00409773|4172454|P2|NOT COMPLETED|Overall Study||7
1706223|NCT00409773|4172455|P1|NOT COMPLETED|Overall Study||9
1706224|NCT00409773|4172451|P5|COMPLETED|Overall Study||218
1706225|NCT00409773|4172452|P4|COMPLETED|Overall Study||216
1706226|NCT00409773|4172453|P3|COMPLETED|Overall Study||220
1706227|NCT00409773|4172454|P2|COMPLETED|Overall Study||222
1706228|NCT00409773|4172455|P1|COMPLETED|Overall Study||220
1706229|NCT00409773|4172451|P5|STARTED|Overall Study||228
1706230|NCT00409773|4172452|P4|STARTED|Overall Study||228
1706231|NCT00409773|4172453|P3|STARTED|Overall Study||229
1706232|NCT00409773|4172454|P2|STARTED|Overall Study||229
1706233|NCT00409773|4172455|P1|STARTED|Overall Study||229
1706234|NCT00409747|4172537|P1|NOT COMPLETED|Overall Study||1
1706235|NCT00409747|4172537|P1|COMPLETED|Overall Study||10
1706236|NCT00409747|4172537|P1|STARTED|Overall Study||11
1706237|NCT00409708|4172544|P2|NOT COMPLETED|Washout||10
1706238|NCT00409708|4172545|P1|NOT COMPLETED|Washout||21
1706239|NCT00409708|4172544|P2|COMPLETED|Washout||29
1706240|NCT00409708|4172545|P1|COMPLETED|Washout||17
1706241|NCT00409708|4172544|P2|STARTED|Washout||39
1706242|NCT00409708|4172545|P1|STARTED|Washout||38
1706243|NCT00409708|4172544|P2|NOT COMPLETED|Treatment||17
1706244|NCT00409708|4172545|P1|NOT COMPLETED|Treatment||15
1706245|NCT00409708|4172544|P2|COMPLETED|Treatment||39
1706246|NCT00409708|4172545|P1|COMPLETED|Treatment||38
1706247|NCT00409708|4172544|P2|STARTED|Treatment||56
1706248|NCT00409708|4172545|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
1706249|NCT00409682|4172566|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
1706250|NCT00409682|4172567|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
1706251|NCT00409682|4172568|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
1706252|NCT00409682|4172566|P3|COMPLETED|EOW Double-blind Maintenance Period||66
1706253|NCT00409682|4172567|P2|COMPLETED|EOW Double-blind Maintenance Period||58
1706254|NCT00409682|4172568|P1|COMPLETED|EOW Double-blind Maintenance Period||0
1706255|NCT00409682|4172566|P3|STARTED|EOW Double-blind Maintenance Period||93
1706256|NCT00409682|4172567|P2|STARTED|EOW Double-blind Maintenance Period||95
1706257|NCT00409682|4172568|P1|STARTED|EOW Double-blind Maintenance Period||0
1706258|NCT00409682|4172566|P3|NOT COMPLETED|Open-label Induction Period||0
1706259|NCT00409682|4172567|P2|NOT COMPLETED|Open-label Induction Period||0
1706260|NCT00409682|4172568|P1|NOT COMPLETED|Open-label Induction Period||4
1706261|NCT00409682|4172566|P3|COMPLETED|Open-label Induction Period||0
1706262|NCT00409682|4172567|P2|COMPLETED|Open-label Induction Period||0
1706263|NCT00409682|4172568|P1|COMPLETED|Open-label Induction Period||188
1706264|NCT00409682|4172566|P3|STARTED|Open-label Induction Period||0
1706265|NCT00409682|4172567|P2|STARTED|Open-label Induction Period||0
1706266|NCT00409682|4172568|P1|STARTED|Open-label Induction Period||192
1706267|NCT00409617|4172585|P1|NOT COMPLETED|Overall Study||160
1706268|NCT00409617|4172585|P1|COMPLETED|Overall Study||785
1706269|NCT00409617|4172585|P1|STARTED|Overall Study||945
1706270|NCT00409578|4172601|P4|NOT COMPLETED|Overall Study||67
1706271|NCT00409578|4172602|P3|NOT COMPLETED|Overall Study||54
1706272|NCT00409578|4172603|P2|NOT COMPLETED|Overall Study||70
1706273|NCT00409578|4172604|P1|NOT COMPLETED|Overall Study||52
1706274|NCT00409578|4172601|P4|COMPLETED|Overall Study||214
1706275|NCT00409578|4172602|P3|COMPLETED|Overall Study||215
1706276|NCT00409578|4172603|P2|COMPLETED|Overall Study||201
1706277|NCT00409578|4172604|P1|COMPLETED|Overall Study||228
1706278|NCT00409578|4172601|P4|STARTED|Overall Study||281
1706280|NCT00409578|4172603|P2|STARTED|Overall Study||271
1706281|NCT00409578|4172604|P1|STARTED|Overall Study||280
1706282|NCT00409565|4172626|P1|NOT COMPLETED|Overall Study||1
1706283|NCT00409565|4172626|P1|COMPLETED|Overall Study||45
1706284|NCT00409565|4172626|P1|Overall Response Rate|Overall Study||7
1706285|NCT00409565|4172626|P1|STARTED|Overall Study||46
1706286|NCT00409539|4172639|P5|NOT COMPLETED|Overall Study||25
1706287|NCT00409539|4172640|P4|NOT COMPLETED|Overall Study||12
1706288|NCT00409539|4172641|P3|NOT COMPLETED|Overall Study||14
1706289|NCT00409539|4172642|P2|NOT COMPLETED|Overall Study||11
1706290|NCT00409539|4172643|P1|NOT COMPLETED|Overall Study||11
1706291|NCT00409539|4172639|P5|COMPLETED|Overall Study||85
1706292|NCT00409539|4172640|P4|COMPLETED|Overall Study||97
1706293|NCT00409539|4172641|P3|COMPLETED|Overall Study||95
1706294|NCT00409539|4172642|P2|COMPLETED|Overall Study||100
1706295|NCT00409539|4172643|P1|COMPLETED|Overall Study||100
1706296|NCT00409539|4172639|P5|STARTED|Overall Study||110
1706297|NCT00409539|4172640|P4|STARTED|Overall Study||109
1706298|NCT00409539|4172641|P3|STARTED|Overall Study||109
1706299|NCT00409539|4172642|P2|STARTED|Overall Study||111
1706300|NCT00409539|4172643|P1|STARTED|Overall Study||111
1706301|NCT00409409|4172662|P2|NOT COMPLETED|Overall Study||4
1706302|NCT00409409|4172663|P1|NOT COMPLETED|Overall Study||8
1706303|NCT00409409|4172662|P2|COMPLETED|Overall Study||135
1706304|NCT00409409|4172663|P1|COMPLETED|Overall Study||131
1706305|NCT00409409|4172662|P2|STARTED|Overall Study||139
1706306|NCT00409409|4172663|P1|STARTED|Overall Study||139
1706307|NCT00409344|4172671|P2|NOT COMPLETED|Overall Study||0
1706308|NCT00409344|4172672|P1|NOT COMPLETED|Overall Study||0
1706309|NCT00409344|4172671|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
1706310|NCT00409344|4172672|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
1706311|NCT00409344|4172671|P2|STARTED|Overall Study|No participants enrolled|0
1706312|NCT00409344|4172672|P1|STARTED|Overall Study|No participants enrolled|0
1706313|NCT00409331|4172690|P1|NOT COMPLETED|Overall Study||1
1706314|NCT00409331|4172690|P1|COMPLETED|Overall Study||0
1706315|NCT00409331|4172690|P1|STARTED|Overall Study||1
1706316|NCT00409292|4172694|P1|NOT COMPLETED|Overall Study||0
1706317|NCT00409292|4172694|P1|COMPLETED|Overall Study||33
1706318|NCT00409292|4172694|P1|STARTED|Overall Study||33
1706319|NCT00409240|4172703|P2|NOT COMPLETED|Overall Study||1
1706320|NCT00409240|4172704|P1|NOT COMPLETED|Overall Study||3
1706321|NCT00409240|4172703|P2|COMPLETED|Overall Study||49
1706322|NCT00409240|4172704|P1|COMPLETED|Overall Study||50
1706323|NCT00409240|4172703|P2|STARTED|Overall Study||50
1706324|NCT00409240|4172704|P1|STARTED|Overall Study||53
1706325|NCT00409188|4172712|P2|NOT COMPLETED|Overall Study||175
1706326|NCT00409188|4172713|P1|NOT COMPLETED|Overall Study||383
1706327|NCT00409188|4172712|P2|COMPLETED|Overall Study||332
1706328|NCT00409188|4172713|P1|COMPLETED|Overall Study||623
1706329|NCT00409188|4172712|P2|STARTED|Overall Study||507
1706330|NCT00409188|4172713|P1|STARTED|Overall Study||1006
1706331|NCT00409175|4172729|P2|NOT COMPLETED|Overall Study||19
1706332|NCT00409175|4172730|P1|NOT COMPLETED|Overall Study||18
1706333|NCT00409175|4172729|P2|COMPLETED|Overall Study||44
1706334|NCT00409175|4172730|P1|COMPLETED|Overall Study||47
1706335|NCT00409175|4172729|P2|STARTED|Overall Study||63
1706336|NCT00409175|4172730|P1|STARTED|Overall Study||65
1706337|NCT00409006|4172756|P2|NOT COMPLETED|Overall Study||12
1706338|NCT00409006|4172757|P1|NOT COMPLETED|Overall Study||20
1706339|NCT00409006|4172756|P2|COMPLETED|Overall Study||19
1706340|NCT00409006|4172757|P1|COMPLETED|Overall Study||19
1706341|NCT00409006|4172756|P2|STARTED|Overall Study||31
1706342|NCT00409006|4172757|P1|STARTED|Overall Study||39
1706343|NCT00408993|4172773|P2|NOT COMPLETED|Overall Study||17
1706344|NCT00408993|4172774|P1|NOT COMPLETED|Overall Study||19
1706345|NCT00408993|4172773|P2|COMPLETED|Overall Study||92
1706346|NCT00408993|4172774|P1|COMPLETED|Overall Study||87
1706347|NCT00408993|4172773|P2|STARTED|Overall Study||109
1706348|NCT00408993|4172774|P1|STARTED|Overall Study||106
1706349|NCT00408928|4172806|P1|NOT COMPLETED|Overall Study||3
1706350|NCT00408928|4172806|P1|COMPLETED|Overall Study||8
1706351|NCT00408928|4172806|P1|STARTED|Overall Study||11
1706352|NCT00408902|4172811|P1|NOT COMPLETED|Overall Study||10
1706353|NCT00408902|4172811|P1|COMPLETED|Overall Study||0
1706354|NCT00408902|4172811|P1|STARTED|Overall Study||10
1706355|NCT00408876|4172821|P4|NOT COMPLETED|Overall Study||35
1706356|NCT00408876|4172822|P3|NOT COMPLETED|Overall Study||50
1706357|NCT00408876|4172823|P2|NOT COMPLETED|Overall Study||36
1706358|NCT00408876|4172824|P1|NOT COMPLETED|Overall Study||16
1706359|NCT00408876|4172821|P4|COMPLETED|Overall Study||82
1706360|NCT00408876|4172822|P3|COMPLETED|Overall Study||62
1706361|NCT00408876|4172823|P2|COMPLETED|Overall Study||80
1706362|NCT00408876|4172824|P1|COMPLETED|Overall Study||43
1706363|NCT00408876|4172821|P4|STARTED|Overall Study||117
1706364|NCT00408876|4172822|P3|STARTED|Overall Study||112
1706365|NCT00408876|4172823|P2|STARTED|Overall Study||116
1706366|NCT00408876|4172824|P1|STARTED|Overall Study||59
1706367|NCT00408694|4173074|P1|NOT COMPLETED|Overall Study||2
1706368|NCT00408694|4173074|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
1706369|NCT00408694|4173074|P1|STARTED|Overall Study||46
1706370|NCT00408681|4173086|P1|NOT COMPLETED|Overall Study||9
1706371|NCT00408681|4173086|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
1706372|NCT00408681|4173086|P1|STARTED|Overall Study||20
1706373|NCT00408629|4173105|P2|NOT COMPLETED|Overall Study||125
1706374|NCT00408629|4173106|P1|NOT COMPLETED|Overall Study||97
1706375|NCT00408629|4173105|P2|COMPLETED|Overall Study||135
1706376|NCT00408629|4173106|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
1706377|NCT00408629|4173105|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
1706378|NCT00408629|4173106|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
1706379|NCT00408603|4173148|P3|NOT COMPLETED|Overall Study||40
1706380|NCT00408603|4173149|P2|NOT COMPLETED|Overall Study||2
1706381|NCT00408603|4173150|P1|NOT COMPLETED|Overall Study||4
1706382|NCT00408603|4173148|P3|COMPLETED|Overall Study||35
1706383|NCT00408603|4173149|P2|COMPLETED|Overall Study||37
1706384|NCT00408603|4173150|P1|COMPLETED|Overall Study||65
1706385|NCT00408603|4173148|P3|STARTED|Overall Study||75
1706386|NCT00408603|4173149|P2|STARTED|Overall Study||39
1706387|NCT00408603|4173150|P1|STARTED|Overall Study||69
1706388|NCT00408590|4173166|P9|NOT COMPLETED|Overall Study||0
1706389|NCT00408590|4173167|P8|NOT COMPLETED|Overall Study||0
1706390|NCT00408590|4173168|P7|NOT COMPLETED|Overall Study||0
1706391|NCT00408590|4173169|P6|NOT COMPLETED|Overall Study||0
1706392|NCT00408590|4173170|P5|NOT COMPLETED|Overall Study||0
1706393|NCT00408590|4173171|P4|NOT COMPLETED|Overall Study||0
1706394|NCT00408590|4173172|P3|NOT COMPLETED|Overall Study||0
1706395|NCT00408590|4173173|P2|NOT COMPLETED|Overall Study||0
1706396|NCT00408590|4173174|P1|NOT COMPLETED|Overall Study||0
1706397|NCT00408590|4173166|P9|COMPLETED|Overall Study||13
1706398|NCT00408590|4173167|P8|COMPLETED|Overall Study||3
1706399|NCT00408590|4173168|P7|COMPLETED|Overall Study||3
1706400|NCT00408590|4173169|P6|COMPLETED|Overall Study||3
1706401|NCT00408590|4173170|P5|COMPLETED|Overall Study||3
1706402|NCT00408590|4173171|P4|COMPLETED|Overall Study||3
1706403|NCT00408590|4173172|P3|COMPLETED|Overall Study||3
1706404|NCT00408590|4173173|P2|COMPLETED|Overall Study||3
1706405|NCT00408590|4173174|P1|COMPLETED|Overall Study||3
1706406|NCT00408590|4173166|P9|STARTED|Overall Study||13
1706407|NCT00408590|4173167|P8|STARTED|Overall Study||3
1706408|NCT00408590|4173168|P7|STARTED|Overall Study||3
1706409|NCT00408590|4173169|P6|STARTED|Overall Study||3
1706410|NCT00408590|4173170|P5|STARTED|Overall Study||3
1706411|NCT00408590|4173171|P4|STARTED|Overall Study||3
1706412|NCT00408590|4173172|P3|STARTED|Overall Study||3
1706413|NCT00408590|4173173|P2|STARTED|Overall Study||3
1706414|NCT00408590|4173174|P1|STARTED|Overall Study||3
1706415|NCT00408564|4173193|P1|NOT COMPLETED|Overall Study||0
1706416|NCT00408564|4173193|P1|COMPLETED|Overall Study||39
1706417|NCT00408564|4173193|P1|STARTED|Overall Study||39
1706418|NCT00408499|4173202|P5|NOT COMPLETED|Phase II- MTD Expansion||20
1706419|NCT00408499|4173203|P4|NOT COMPLETED|Phase II- MTD Expansion||0
1706420|NCT00408499|4173204|P3|NOT COMPLETED|Phase II- MTD Expansion||0
1706421|NCT00408499|4173205|P2|NOT COMPLETED|Phase II- MTD Expansion||0
1706422|NCT00408499|4173206|P1|NOT COMPLETED|Phase II- MTD Expansion||0
1706423|NCT00408499|4173202|P5|COMPLETED|Phase II- MTD Expansion||24
1706424|NCT00408499|4173203|P4|COMPLETED|Phase II- MTD Expansion||0
1706425|NCT00408499|4173204|P3|COMPLETED|Phase II- MTD Expansion||0
1706426|NCT00408499|4173205|P2|COMPLETED|Phase II- MTD Expansion||0
1706427|NCT00408499|4173206|P1|COMPLETED|Phase II- MTD Expansion||0
1706428|NCT00408499|4173202|P5|STARTED|Phase II- MTD Expansion||44
1706429|NCT00408499|4173203|P4|STARTED|Phase II- MTD Expansion||0
1706430|NCT00408499|4173204|P3|STARTED|Phase II- MTD Expansion||0
1706431|NCT00408499|4173205|P2|STARTED|Phase II- MTD Expansion||0
1706432|NCT00408499|4173206|P1|STARTED|Phase II- MTD Expansion||0
1706433|NCT00408499|4173202|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
1706434|NCT00408499|4173203|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
1706435|NCT00408499|4173204|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
1706436|NCT00408499|4173205|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
1706437|NCT00408499|4173206|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
1706438|NCT00408499|4173202|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
1706439|NCT00408499|4173203|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
1706440|NCT00408499|4173204|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
1706441|NCT00408499|4173205|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
1706442|NCT00408499|4173206|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
1706443|NCT00408499|4173202|P5|STARTED|Phase 1: Dose Levels 1-4||0
1706444|NCT00408499|4173203|P4|STARTED|Phase 1: Dose Levels 1-4||6
1706445|NCT00408499|4173204|P3|STARTED|Phase 1: Dose Levels 1-4||3
1706446|NCT00408499|4173205|P2|STARTED|Phase 1: Dose Levels 1-4||7
1706447|NCT00408499|4173206|P1|STARTED|Phase 1: Dose Levels 1-4||4
1706448|NCT00408460|4173215|P1|NOT COMPLETED|Overall Study||0
1706449|NCT00408460|4173215|P1|COMPLETED|Overall Study||34
1706450|NCT00408460|4173215|P1|STARTED|Overall Study||34
1706451|NCT00408421|4173223|P3|NOT COMPLETED|Treatment Re-Randomization||5
1706452|NCT00408421|4173224|P2|NOT COMPLETED|Treatment Re-Randomization||7
1706453|NCT00408421|4173225|P1|NOT COMPLETED|Treatment Re-Randomization||7
1706454|NCT00408421|4173223|P3|COMPLETED|Treatment Re-Randomization||38
1706455|NCT00408421|4173224|P2|COMPLETED|Treatment Re-Randomization||39
1706456|NCT00408421|4173225|P1|COMPLETED|Treatment Re-Randomization||96
1706457|NCT00408421|4173223|P3|STARTED|Treatment Re-Randomization||43
1706458|NCT00408421|4173224|P2|STARTED|Treatment Re-Randomization||46
1706459|NCT00408421|4173225|P1|STARTED|Treatment Re-Randomization||103
1706460|NCT00408421|4173223|P3|NOT COMPLETED|Treatment Initial Randomization||0
1706461|NCT00408421|4173224|P2|NOT COMPLETED|Treatment Initial Randomization||22
1706462|NCT00408421|4173225|P1|NOT COMPLETED|Treatment Initial Randomization||17
1706463|NCT00408421|4173223|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
1706464|NCT00408421|4173224|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
1706465|NCT00408421|4173225|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
1706466|NCT00408421|4173223|P3|STARTED|Treatment Initial Randomization||0
1706467|NCT00408421|4173224|P2|STARTED|Treatment Initial Randomization||111
1706468|NCT00408421|4173225|P1|STARTED|Treatment Initial Randomization||120
1706469|NCT00408408|4173305|P6|NOT COMPLETED|Overall Study||3
1706470|NCT00408408|4173306|P5|NOT COMPLETED|Overall Study||5
1706471|NCT00408408|4173307|P4|NOT COMPLETED|Overall Study||7
1706472|NCT00408408|4173308|P3|NOT COMPLETED|Overall Study||0
1706473|NCT00408408|4173309|P2|NOT COMPLETED|Overall Study||3
1706474|NCT00408408|4173310|P1|NOT COMPLETED|Overall Study||2
1706475|NCT00408408|4173305|P6|COMPLETED|Overall Study||201
1706476|NCT00408408|4173306|P5|COMPLETED|Overall Study||192
1706477|NCT00408408|4173307|P4|COMPLETED|Overall Study||194
1706478|NCT00408408|4173308|P3|COMPLETED|Overall Study||204
1706479|NCT00408408|4173309|P2|COMPLETED|Overall Study||196
1706480|NCT00408408|4173310|P1|COMPLETED|Overall Study||199
1706481|NCT00408408|4173305|P6|STARTED|Overall Study||204
1706482|NCT00408408|4173306|P5|STARTED|Overall Study||197
1706483|NCT00408408|4173307|P4|STARTED|Overall Study||201
1706484|NCT00408408|4173308|P3|STARTED|Overall Study||204
1706485|NCT00408408|4173309|P2|STARTED|Overall Study||199
1706486|NCT00408408|4173310|P1|STARTED|Overall Study||201
1706487|NCT00408317|4173372|P2|NOT COMPLETED|Second Intervention Period||2
1706488|NCT00408317|4173373|P1|NOT COMPLETED|Second Intervention Period||2
1706489|NCT00408317|4173372|P2|COMPLETED|Second Intervention Period||14
1706490|NCT00408317|4173373|P1|COMPLETED|Second Intervention Period||12
1706491|NCT00408317|4173372|P2|STARTED|Second Intervention Period||16
1706492|NCT00408317|4173373|P1|STARTED|Second Intervention Period||14
1706493|NCT00408317|4173372|P2|NOT COMPLETED|First Intervention Period||1
1706494|NCT00408317|4173373|P1|NOT COMPLETED|First Intervention Period||0
1706495|NCT00408317|4173372|P2|COMPLETED|First Intervention Period||16
1706496|NCT00408317|4173373|P1|COMPLETED|First Intervention Period||14
1706497|NCT00408317|4173372|P2|STARTED|First Intervention Period||17
1706498|NCT00408317|4173373|P1|STARTED|First Intervention Period||14
1706499|NCT00408200|4173387|P2|NOT COMPLETED|Overall Study||0
1706500|NCT00408200|4173388|P1|NOT COMPLETED|Overall Study||0
1706501|NCT00408200|4173387|P2|COMPLETED|Overall Study||53
1706502|NCT00408200|4173388|P1|COMPLETED|Overall Study||57
1706503|NCT00408200|4173387|P2|STARTED|Overall Study||53
1706504|NCT00408200|4173388|P1|STARTED|Overall Study||57
1706505|NCT00408070|4173396|P1|NOT COMPLETED|Overall Study||0
1706506|NCT00408070|4173396|P1|COMPLETED|Overall Study||5
1706507|NCT00408070|4173396|P1|STARTED|Overall Study||5
1706508|NCT00407966|4173404|P1|NOT COMPLETED|Overall Study||0
1706509|NCT00407966|4173404|P1|COMPLETED|Overall Study||45
1706510|NCT00407966|4173404|P1|CR|Overall Study||30
1706511|NCT00407966|4173404|P1|STARTED|Overall Study||45
1706512|NCT00407888|4173408|P1|NOT COMPLETED|Overall Study||0
1706513|NCT00407888|4173408|P1|COMPLETED|Overall Study||60
1706514|NCT00407888|4173408|P1|STARTED|Overall Study||60
1706515|NCT00407797|4173416|P1|NOT COMPLETED|Overall Study||18
1706516|NCT00407797|4173416|P1|COMPLETED|Overall Study||118
1706517|NCT00407797|4173416|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
1706518|NCT00407797|4173416|P1|STARTED|Overall Study||136
1706519|NCT00407758|4173431|P1|NOT COMPLETED|Overall Study||1
1706520|NCT00407758|4173431|P1|COMPLETED|Overall Study||27
1706521|NCT00407758|4173431|P1|STARTED|Overall Study||28
1706522|NCT00407745|4173444|P2|NOT COMPLETED|Overall Study||17
1706523|NCT00407745|4173445|P1|NOT COMPLETED|Overall Study||19
1706524|NCT00407745|4173444|P2|COMPLETED|Overall Study||91
1706525|NCT00407745|4173445|P1|COMPLETED|Overall Study||93
1706526|NCT00407745|4173444|P2|Treated|Overall Study||107
1706527|NCT00407745|4173445|P1|Treated|Overall Study||112
1706528|NCT00407745|4173444|P2|STARTED|Overall Study||108
1706529|NCT00407745|4173445|P1|STARTED|Overall Study||112
1706530|NCT00407654|4173517|P1|NOT COMPLETED|Overall Study||0
1706531|NCT00407654|4173517|P1|COMPLETED|Overall Study||75
1706532|NCT00407654|4173517|P1|STARTED|Overall Study||75
1706533|NCT00407563|4173531|P1|NOT COMPLETED|Overall Study||1
1706534|NCT00407563|4173531|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
1706535|NCT00407563|4173531|P1|STARTED|Overall Study||48
1706536|NCT00407550|4173541|P2|NOT COMPLETED|Overall Study||4
1706537|NCT00407550|4173542|P1|NOT COMPLETED|Overall Study||3
1706538|NCT00407550|4173541|P2|COMPLETED|Overall Study||5
1706539|NCT00407550|4173542|P1|COMPLETED|Overall Study||7
1706540|NCT00407550|4173541|P2|STARTED|Overall Study||9
1706541|NCT00407550|4173542|P1|STARTED|Overall Study||10
1706542|NCT00407537|4173550|P2|NOT COMPLETED|Overall Study||44
1706543|NCT00407537|4173551|P1|NOT COMPLETED|Overall Study||93
1706544|NCT00407537|4173550|P2|COMPLETED|Overall Study||638
1706545|NCT00407537|4173551|P1|COMPLETED|Overall Study||686
1706546|NCT00407537|4173550|P2|Eligible for Efficacy Analysis|Overall Study||657
1706547|NCT00407537|4173551|P1|Eligible for Efficacy Analysis|Overall Study||760
1706548|NCT00407537|4173550|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
1706549|NCT00407537|4173551|P1|STARTED|Overall Study||779
1706550|NCT00407511|4173599|P1|NOT COMPLETED|Overall Study||22
1706551|NCT00407511|4173599|P1|COMPLETED|Overall Study||99
1706552|NCT00407511|4173599|P1|STARTED|Overall Study||121
1706553|NCT00407485|4173613|P1|NOT COMPLETED|Overall Study||0
1706554|NCT00407485|4173613|P1|COMPLETED|Overall Study||22
1706555|NCT00407485|4173613|P1|STARTED|Overall Study||22
1706556|NCT00407381|4173621|P3|NOT COMPLETED|Overall Study||2
1706557|NCT00407381|4173622|P2|NOT COMPLETED|Overall Study||4
1706558|NCT00407381|4173623|P1|NOT COMPLETED|Overall Study||3
1706559|NCT00407381|4173621|P3|COMPLETED|Overall Study||40
1706560|NCT00407381|4173622|P2|COMPLETED|Overall Study||38
1706561|NCT00407381|4173623|P1|COMPLETED|Overall Study||39
1706562|NCT00407381|4173621|P3|STARTED|Overall Study||42
1706563|NCT00407381|4173622|P2|STARTED|Overall Study||42
1706564|NCT00407381|4173623|P1|STARTED|Overall Study||42
1706565|NCT00407355|4173633|P2|NOT COMPLETED|Overall Study||11
1706566|NCT00407355|4173634|P1|NOT COMPLETED|Overall Study||10
1706567|NCT00407355|4173633|P2|COMPLETED|Overall Study||9
1706568|NCT00407355|4173634|P1|COMPLETED|Overall Study||10
1706569|NCT00407355|4173633|P2|STARTED|Overall Study||20
1706570|NCT00407355|4173634|P1|STARTED|Overall Study||20
1706571|NCT00407030|4173645|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
1706572|NCT00407030|4173646|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
1706573|NCT00407030|4173647|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
1706574|NCT00407030|4173645|P3|COMPLETED|Extension Period - up to 68 Weeks||0
1706575|NCT00407030|4173646|P2|COMPLETED|Extension Period - up to 68 Weeks||74
1706576|NCT00407030|4173647|P1|COMPLETED|Extension Period - up to 68 Weeks||84
1706577|NCT00407030|4173645|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
1706578|NCT00407030|4173646|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
1706579|NCT00407030|4173647|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
1706580|NCT00407030|4173645|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
1706581|NCT00407030|4173646|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
1706582|NCT00407030|4173647|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
1706583|NCT00407030|4173645|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
1706584|NCT00407030|4173646|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
1706585|NCT00407030|4173647|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
1706586|NCT00407030|4173645|P3|STARTED|Main Period - 8 to 20 Weeks||74
1706587|NCT00407030|4173646|P2|STARTED|Main Period - 8 to 20 Weeks||78
1706588|NCT00407030|4173647|P1|STARTED|Main Period - 8 to 20 Weeks||81
1706589|NCT00406848|4173675|P2|NOT COMPLETED|Overall Study||54
1706590|NCT00406848|4173676|P1|NOT COMPLETED|Overall Study||93
1706591|NCT00406848|4173675|P2|COMPLETED|Overall Study||67
1706592|NCT00406848|4173676|P1|COMPLETED|Overall Study||156
1706593|NCT00406848|4173675|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
1706594|NCT00406848|4173676|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
1706595|NCT00406783|4173740|P2|NOT COMPLETED|Overall Study||15
1706596|NCT00406783|4173741|P1|NOT COMPLETED|Overall Study||14
1706597|NCT00406783|4173740|P2|COMPLETED|Overall Study||256
1706598|NCT00406783|4173741|P1|COMPLETED|Overall Study||262
1706599|NCT00406783|4173740|P2|STARTED|Overall Study||271
1706600|NCT00406783|4173741|P1|STARTED|Overall Study||276
1706601|NCT00406718|4173756|P3|NOT COMPLETED|Overall Study||8
1706602|NCT00406718|4173757|P2|NOT COMPLETED|Overall Study||14
1706603|NCT00406718|4173758|P1|NOT COMPLETED|Overall Study||4
1706604|NCT00406718|4173756|P3|COMPLETED|Overall Study||39
1706605|NCT00406718|4173757|P2|COMPLETED|Overall Study||34
1706606|NCT00406718|4173758|P1|COMPLETED|Overall Study||43
1706607|NCT00406718|4173756|P3|STARTED|Overall Study||47
1706608|NCT00406718|4173757|P2|STARTED|Overall Study||48
1706609|NCT00406718|4173758|P1|STARTED|Overall Study||47
1706610|NCT00406692|4173772|P1|NOT COMPLETED|Overall Study||7
1706611|NCT00406692|4173772|P1|COMPLETED|Overall Study||9
1706612|NCT00406692|4173772|P1|STARTED|Overall Study||16
1706613|NCT00406653|4173782|P7|NOT COMPLETED|Open-Label Period||324
1706614|NCT00406653|4173783|P6|NOT COMPLETED|Open-Label Period||0
1706615|NCT00406653|4173784|P5|NOT COMPLETED|Open-Label Period||0
1706616|NCT00406653|4173785|P4|NOT COMPLETED|Open-Label Period||0
1706617|NCT00406653|4173786|P3|NOT COMPLETED|Open-Label Period||0
1706618|NCT00406653|4173787|P2|NOT COMPLETED|Open-Label Period||0
1706619|NCT00406653|4173788|P1|NOT COMPLETED|Open-Label Period||0
1706620|NCT00406653|4173782|P7|COMPLETED|Open-Label Period||0
1706621|NCT00406653|4173783|P6|COMPLETED|Open-Label Period||0
1706622|NCT00406653|4173784|P5|COMPLETED|Open-Label Period||0
1706623|NCT00406653|4173785|P4|COMPLETED|Open-Label Period||0
1706624|NCT00406653|4173786|P3|COMPLETED|Open-Label Period||0
1706625|NCT00406653|4173787|P2|COMPLETED|Open-Label Period||0
1706626|NCT00406653|4173788|P1|COMPLETED|Open-Label Period||0
1706627|NCT00406653|4173782|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
1706628|NCT00406653|4173783|P6|STARTED|Open-Label Period||0
1706629|NCT00406653|4173784|P5|STARTED|Open-Label Period||0
1706630|NCT00406653|4173785|P4|STARTED|Open-Label Period||0
1706631|NCT00406653|4173786|P3|STARTED|Open-Label Period||0
1706632|NCT00406653|4173787|P2|STARTED|Open-Label Period||0
1706633|NCT00406653|4173788|P1|STARTED|Open-Label Period||0
1706634|NCT00406653|4173782|P7|NOT COMPLETED|Maintenance Period||0
1706635|NCT00406653|4173783|P6|NOT COMPLETED|Maintenance Period||36
1706636|NCT00406653|4173784|P5|NOT COMPLETED|Maintenance Period||30
1706637|NCT00406653|4173785|P4|NOT COMPLETED|Maintenance Period||0
1706638|NCT00406653|4173786|P3|NOT COMPLETED|Maintenance Period||0
1706639|NCT00406653|4173787|P2|NOT COMPLETED|Maintenance Period||0
1706640|NCT00406653|4173788|P1|NOT COMPLETED|Maintenance Period||0
1706641|NCT00406653|4173782|P7|COMPLETED|Maintenance Period||0
1706642|NCT00406653|4173783|P6|COMPLETED|Maintenance Period||10
1706643|NCT00406653|4173784|P5|COMPLETED|Maintenance Period||14
1706644|NCT00406653|4173785|P4|COMPLETED|Maintenance Period||0
1706645|NCT00406653|4173786|P3|COMPLETED|Maintenance Period||0
1706646|NCT00406653|4173787|P2|COMPLETED|Maintenance Period||0
1706647|NCT00406653|4173788|P1|COMPLETED|Maintenance Period||0
1706648|NCT00406653|4173782|P7|STARTED|Maintenance Period||0
1706649|NCT00406653|4173783|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
1706650|NCT00406653|4173784|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
1706651|NCT00406653|4173785|P4|STARTED|Maintenance Period||0
1706652|NCT00406653|4173786|P3|STARTED|Maintenance Period||0
1706653|NCT00406653|4173787|P2|STARTED|Maintenance Period||0
1706654|NCT00406653|4173788|P1|STARTED|Maintenance Period||0
1706655|NCT00406653|4173782|P7|NOT COMPLETED|Induction Period||0
1706656|NCT00406653|4173783|P6|NOT COMPLETED|Induction Period||0
1706657|NCT00406653|4173784|P5|NOT COMPLETED|Induction Period||0
1706658|NCT00406653|4173785|P4|NOT COMPLETED|Induction Period||26
1706659|NCT00406653|4173786|P3|NOT COMPLETED|Induction Period||18
1706660|NCT00406653|4173787|P2|NOT COMPLETED|Induction Period||34
1706661|NCT00406653|4173788|P1|NOT COMPLETED|Induction Period||15
1706662|NCT00406653|4173782|P7|COMPLETED|Induction Period||0
1706663|NCT00406653|4173783|P6|COMPLETED|Induction Period||0
1706664|NCT00406653|4173784|P5|COMPLETED|Induction Period||0
1706665|NCT00406653|4173785|P4|COMPLETED|Induction Period||102
1706666|NCT00406653|4173786|P3|COMPLETED|Induction Period||112
1706667|NCT00406653|4173787|P2|COMPLETED|Induction Period||94
1706668|NCT00406653|4173788|P1|COMPLETED|Induction Period||50
1706669|NCT00406653|4173782|P7|STARTED|Induction Period||0
1706670|NCT00406653|4173783|P6|STARTED|Induction Period||0
1706671|NCT00406653|4173784|P5|STARTED|Induction Period||0
1706672|NCT00406653|4173785|P4|STARTED|Induction Period||128
1706673|NCT00406653|4173786|P3|STARTED|Induction Period||130
1706674|NCT00406653|4173787|P2|STARTED|Induction Period||128
1706675|NCT00406653|4173788|P1|STARTED|Induction Period||65
1706676|NCT00406640|4173869|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
1706677|NCT00406640|4173870|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
1706678|NCT00406640|4173869|P2|COMPLETED|OL Extension Phase for Non-Responders||36
1706679|NCT00406640|4173870|P1|COMPLETED|OL Extension Phase for Non-Responders||47
1706680|NCT00406640|4173869|P2|STARTED|OL Extension Phase for Non-Responders||60
1706681|NCT00406640|4173870|P1|STARTED|OL Extension Phase for Non-Responders||69
1706682|NCT00406640|4173869|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
1706683|NCT00406640|4173870|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
1706684|NCT00406640|4173869|P2|COMPLETED|DB Continuation Phase for Responders||151
1706685|NCT00406640|4173870|P1|COMPLETED|DB Continuation Phase for Responders||139
1706686|NCT00406640|4173869|P2|STARTED|DB Continuation Phase for Responders||188
1706687|NCT00406640|4173870|P1|STARTED|DB Continuation Phase for Responders||172
1706688|NCT00406640|4173869|P2|NOT COMPLETED|Acute Phase||43
1706689|NCT00406640|4173870|P1|NOT COMPLETED|Acute Phase||51
1706690|NCT00406640|4173869|P2|COMPLETED|Acute Phase||256
1706691|NCT00406640|4173870|P1|COMPLETED|Acute Phase||245
1706692|NCT00406640|4173869|P2|STARTED|Acute Phase||299
1706693|NCT00406640|4173870|P1|STARTED|Acute Phase||296
1706694|NCT00406393|4173902|P2|NOT COMPLETED|Overall Study||1
1706695|NCT00406393|4173903|P1|NOT COMPLETED|Overall Study||2
1706696|NCT00406393|4173902|P2|COMPLETED|Overall Study||152
1706697|NCT00406393|4173903|P1|COMPLETED|Overall Study||149
1706698|NCT00406393|4173902|P2|STARTED|Overall Study||153
1706699|NCT00406393|4173903|P1|STARTED|Overall Study||151
1706700|NCT00406367|4173933|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
1706701|NCT00406367|4173934|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
1706702|NCT00406367|4173933|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
1706703|NCT00406367|4173934|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
1706704|NCT00406367|4173933|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
1706705|NCT00406367|4173934|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
1706706|NCT00406367|4173933|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
1706707|NCT00406367|4173934|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
1706708|NCT00406367|4173933|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
1706709|NCT00406367|4173934|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
1706710|NCT00406367|4173933|P2|STARTED|Main Period - 6 to 20 Weeks||34
1706711|NCT00406367|4173934|P1|STARTED|Main Period - 6 to 20 Weeks||75
1706712|NCT00406354|4173949|P3|NOT COMPLETED|All Randomized and Treated Patients||22
1706713|NCT00406354|4173950|P2|NOT COMPLETED|All Randomized and Treated Patients||13
1706714|NCT00406354|4173951|P1|NOT COMPLETED|All Randomized and Treated Patients||16
1706715|NCT00406354|4173949|P3|COMPLETED|All Randomized and Treated Patients||37
1706716|NCT00406354|4173950|P2|COMPLETED|All Randomized and Treated Patients||48
1706717|NCT00406354|4173951|P1|COMPLETED|All Randomized and Treated Patients||44
1706718|NCT00406354|4173949|P3|STARTED|All Randomized and Treated Patients||59
1706719|NCT00406354|4173950|P2|STARTED|All Randomized and Treated Patients||61
1706720|NCT00406354|4173951|P1|STARTED|All Randomized and Treated Patients||60
1706721|NCT00406354|4173949|P3|NOT COMPLETED|All Randomized Patients||1
1706722|NCT00406354|4173950|P2|NOT COMPLETED|All Randomized Patients||0
1706723|NCT00406354|4173951|P1|NOT COMPLETED|All Randomized Patients||0
1706724|NCT00406354|4173949|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
1706725|NCT00406354|4173950|P2|COMPLETED|All Randomized Patients||61
1706726|NCT00406354|4173951|P1|COMPLETED|All Randomized Patients||60
1706727|NCT00406354|4173949|P3|STARTED|All Randomized Patients||60
1706728|NCT00406354|4173950|P2|STARTED|All Randomized Patients||61
1706729|NCT00406354|4173951|P1|STARTED|All Randomized Patients||60
1706730|NCT00406315|4174022|P1|NOT COMPLETED|Overall Study||141
1706731|NCT00406315|4174022|P1|COMPLETED|Overall Study||100
1706732|NCT00406315|4174022|P1|STARTED|Overall Study|Started = Treated|241
1706733|NCT00406276|4174040|P1|NOT COMPLETED|Overall Study||4
1706734|NCT00406276|4174040|P1|COMPLETED|Overall Study||24
1706735|NCT00406276|4174040|P1|STARTED|Overall Study||28
1706736|NCT00406133|4174049|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
1706737|NCT00406133|4174050|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
1706738|NCT00406133|4174051|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
1706739|NCT00406133|4174052|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
1706740|NCT00406133|4174049|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
1706741|NCT00406133|4174050|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
1706742|NCT00406133|4174051|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
1706743|NCT00406133|4174052|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
1706744|NCT00406133|4174049|P4|STARTED|Phase 2 (Second 26 Week Period)||60
1706745|NCT00406133|4174050|P3|STARTED|Phase 2 (Second 26 Week Period)||67
1706746|NCT00406133|4174051|P2|STARTED|Phase 2 (Second 26 Week Period)||155
1706747|NCT00406133|4174052|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
1706748|NCT00406133|4174049|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
1706749|NCT00406133|4174050|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
1706750|NCT00406133|4174051|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
1706751|NCT00406133|4174052|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
1706752|NCT00406133|4174049|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
1706753|NCT00406133|4174050|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
1706754|NCT00406133|4174051|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
1706755|NCT00406133|4174052|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
1706756|NCT00406133|4174049|P4|STARTED|Phase 1 (First 26 Week Period)||62
1706757|NCT00406133|4174050|P3|STARTED|Phase 1 (First 26 Week Period)||67
1706758|NCT00406133|4174051|P2|STARTED|Phase 1 (First 26 Week Period)||157
1706759|NCT00406133|4174052|P1|STARTED|Phase 1 (First 26 Week Period)||165
1706760|NCT00406107|4174116|P2|NOT COMPLETED|Overall Study||1
1706761|NCT00406107|4174117|P1|NOT COMPLETED|Overall Study||1
1706762|NCT00406107|4174116|P2|COMPLETED|Overall Study||4
1706763|NCT00406107|4174117|P1|COMPLETED|Overall Study||14
1706764|NCT00406107|4174116|P2|STARTED|Overall Study||5
1706765|NCT00406107|4174117|P1|STARTED|Overall Study||15
1706766|NCT00406029|4174132|P5|NOT COMPLETED|Overall Study||8
1706767|NCT00406029|4174133|P4|NOT COMPLETED|Overall Study||17
1706768|NCT00406029|4174134|P3|NOT COMPLETED|Overall Study||10
1706769|NCT00406029|4174135|P2|NOT COMPLETED|Overall Study||8
1706770|NCT00406029|4174136|P1|NOT COMPLETED|Overall Study||16
1706771|NCT00406029|4174132|P5|COMPLETED|Overall Study||41
1706772|NCT00406029|4174133|P4|COMPLETED|Overall Study||40
1706773|NCT00406029|4174134|P3|COMPLETED|Overall Study||39
1706774|NCT00406029|4174135|P2|COMPLETED|Overall Study||41
1706775|NCT00406029|4174136|P1|COMPLETED|Overall Study||33
1706776|NCT00406029|4174132|P5|Treated|Overall Study||47
1706777|NCT00406029|4174133|P4|Treated|Overall Study||54
1706778|NCT00406029|4174134|P3|Treated|Overall Study||47
1706779|NCT00406029|4174135|P2|Treated|Overall Study||49
1706780|NCT00406029|4174136|P1|Treated|Overall Study||49
1706781|NCT00406029|4174132|P5|STARTED|Overall Study||49
1706782|NCT00406029|4174133|P4|STARTED|Overall Study||57
1706783|NCT00406029|4174134|P3|STARTED|Overall Study||49
1706784|NCT00406029|4174135|P2|STARTED|Overall Study||49
1706785|NCT00406029|4174136|P1|STARTED|Overall Study||49
1706786|NCT00405964|4174240|P2|NOT COMPLETED|Overall Study||95
1706787|NCT00405964|4174241|P1|NOT COMPLETED|Overall Study||59
1706788|NCT00405964|4174240|P2|COMPLETED|Overall Study||261
1706789|NCT00405964|4174241|P1|COMPLETED|Overall Study||301
1706790|NCT00405964|4174240|P2|STARTED|Overall Study||356
1706791|NCT00405964|4174241|P1|STARTED|Overall Study||360
1706792|NCT00405938|4174253|P2|NOT COMPLETED|Overall Study||0
1706793|NCT00405938|4174254|P1|NOT COMPLETED|Overall Study||0
1706794|NCT00405938|4174253|P2|COMPLETED|Overall Study||41
1706795|NCT00405938|4174254|P1|COMPLETED|Overall Study||38
1706796|NCT00405938|4174253|P2|STARTED|Overall Study||41
1706797|NCT00405938|4174254|P1|STARTED|Overall Study||38
1706798|NCT00405912|4174263|P3|NOT COMPLETED|Overall Study||16
1706799|NCT00405912|4174264|P2|NOT COMPLETED|Overall Study||19
1706800|NCT00405912|4174265|P1|NOT COMPLETED|Overall Study||16
1706801|NCT00405912|4174263|P3|COMPLETED|Overall Study||23
1706802|NCT00405912|4174264|P2|COMPLETED|Overall Study||21
1706803|NCT00405912|4174265|P1|COMPLETED|Overall Study||23
1706804|NCT00405912|4174263|P3|STARTED|Overall Study||39
1706805|NCT00405912|4174264|P2|STARTED|Overall Study||40
1706806|NCT00405912|4174265|P1|STARTED|Overall Study||39
1706807|NCT00405821|4174278|P2|NOT COMPLETED|Overall Study||22
1706808|NCT00405821|4174279|P1|NOT COMPLETED|Overall Study||22
1706809|NCT00405821|4174278|P2|COMPLETED|Overall Study||198
1706810|NCT00405821|4174279|P1|COMPLETED|Overall Study||198
1706811|NCT00405821|4174278|P2|STARTED|Overall Study||220
1706812|NCT00405821|4174279|P1|STARTED|Overall Study||220
1706813|NCT00405756|4174292|P3|NOT COMPLETED|Follow-up||88
1706814|NCT00405756|4174293|P2|NOT COMPLETED|Follow-up||90
1706815|NCT00405756|4174294|P1|NOT COMPLETED|Follow-up||75
1706816|NCT00405756|4174292|P3|COMPLETED|Follow-up||0
1706817|NCT00405756|4174293|P2|COMPLETED|Follow-up||0
1706818|NCT00405756|4174294|P1|COMPLETED|Follow-up||0
1706819|NCT00405756|4174292|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
1706820|NCT00405756|4174293|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
1706821|NCT00405756|4174294|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
1706822|NCT00405756|4174292|P3|NOT COMPLETED|Open-label Extension||72
1706823|NCT00405756|4174293|P2|NOT COMPLETED|Open-label Extension||47
1706824|NCT00405756|4174294|P1|NOT COMPLETED|Open-label Extension||19
1706825|NCT00405756|4174292|P3|COMPLETED|Open-label Extension||0
1706826|NCT00405756|4174293|P2|COMPLETED|Open-label Extension||0
1706827|NCT00405756|4174294|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
1706828|NCT00405756|4174292|P3|STARTED|Open-label Extension||72
1706829|NCT00405756|4174293|P2|STARTED|Open-label Extension||47
1706830|NCT00405756|4174294|P1|STARTED|Open-label Extension||19
1706831|NCT00405756|4174292|P3|NOT COMPLETED|Double-blind Treatment||154
1706832|NCT00405756|4174293|P2|NOT COMPLETED|Double-blind Treatment||153
1706833|NCT00405756|4174294|P1|NOT COMPLETED|Double-blind Treatment||152
1706834|NCT00405756|4174292|P3|COMPLETED|Double-blind Treatment||0
1706835|NCT00405756|4174293|P2|COMPLETED|Double-blind Treatment||0
1706836|NCT00405756|4174294|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
1706837|NCT00405756|4174292|P3|Safety Population|Double-blind Treatment||153
1706838|NCT00405756|4174293|P2|Safety Population|Double-blind Treatment||152
1706839|NCT00405756|4174294|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
1706840|NCT00405756|4174292|P3|STARTED|Double-blind Treatment||154
1706841|NCT00405756|4174293|P2|STARTED|Double-blind Treatment||153
1706842|NCT00405756|4174294|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
1706843|NCT00405704|4174384|P2|NOT COMPLETED|Overall Study||46
1706844|NCT00405704|4174385|P1|NOT COMPLETED|Overall Study||41
1706845|NCT00405704|4174384|P2|COMPLETED|Overall Study||259
1706846|NCT00405704|4174385|P1|COMPLETED|Overall Study||261
1706847|NCT00405704|4174384|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
1706848|NCT00405704|4174385|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
1706849|NCT00405704|4174384|P2|Recurrent UTI With E. Coli|Overall Study||57
1706850|NCT00405704|4174385|P1|Recurrent UTI With E. Coli|Overall Study||30
1706851|NCT00405704|4174384|P2|Outcome Stool Assessed|Overall Study||210
1706852|NCT00405704|4174385|P1|Outcome Stool Assessed|Overall Study||203
1706853|NCT00405704|4174384|P2|Completed Assessments for New Scarring|Overall Study||227
1706854|NCT00405704|4174385|P1|Completed Assessments for New Scarring|Overall Study||220
1706855|NCT00405704|4174384|P2|Completed Outcome Renal Scan|Overall Study||235
1706856|NCT00405704|4174385|P1|Completed Outcome Renal Scan|Overall Study||227
1706857|NCT00405704|4174384|P2|STARTED|Overall Study||305
1706858|NCT00405704|4174385|P1|STARTED|Overall Study||302
1706859|NCT00405652|4174405|P1|NOT COMPLETED|Overall Study||4
1706860|NCT00405652|4174405|P1|COMPLETED|Overall Study||30
1706861|NCT00405652|4174405|P1|STARTED|Overall Study||34
1706862|NCT00405639|4174412|P2|NOT COMPLETED|Overall Study||0
1706863|NCT00405639|4174413|P1|NOT COMPLETED|Overall Study||3
1706864|NCT00405639|4174412|P2|COMPLETED|Overall Study||12
1706865|NCT00405639|4174413|P1|COMPLETED|Overall Study||22
1706866|NCT00405639|4174412|P2|STARTED|Overall Study||12
1706867|NCT00405639|4174413|P1|STARTED|Overall Study||25
1706868|NCT00405587|4174429|P4|NOT COMPLETED|Overall Study||20
1706869|NCT00405587|4174430|P3|NOT COMPLETED|Overall Study||22
1706870|NCT00405587|4174431|P2|NOT COMPLETED|Overall Study||28
1706871|NCT00405587|4174432|P1|NOT COMPLETED|Overall Study||26
1706872|NCT00405587|4174429|P4|COMPLETED|Overall Study||1
1706873|NCT00405587|4174430|P3|COMPLETED|Overall Study||10
1706874|NCT00405587|4174431|P2|COMPLETED|Overall Study||2
1706875|NCT00405587|4174432|P1|COMPLETED|Overall Study||0
1706876|NCT00405587|4174429|P4|STARTED|Overall Study||21
1706877|NCT00405587|4174430|P3|STARTED|Overall Study||32
1706878|NCT00405587|4174431|P2|STARTED|Overall Study||30
1706879|NCT00405587|4174432|P1|STARTED|Overall Study||26
1706880|NCT00405548|4174550|P2|NOT COMPLETED|Overall Study||1
1706881|NCT00405548|4174551|P1|NOT COMPLETED|Overall Study||4
1706882|NCT00405548|4174550|P2|COMPLETED|Overall Study||12
1706883|NCT00405548|4174551|P1|COMPLETED|Overall Study||24
1706884|NCT00405548|4174550|P2|STARTED|Overall Study||13
1706885|NCT00405548|4174551|P1|STARTED|Overall Study||28
1706886|NCT00405509|4174565|P2|NOT COMPLETED|Overall Study||0
1706887|NCT00405509|4174566|P1|NOT COMPLETED|Overall Study||0
1706888|NCT00405509|4174565|P2|COMPLETED|Overall Study||22
1706889|NCT00405509|4174566|P1|COMPLETED|Overall Study||11
1706890|NCT00405509|4174565|P2|STARTED|Overall Study||22
1706891|NCT00405509|4174566|P1|STARTED|Overall Study||11
1706892|NCT00405392|4174582|P2|NOT COMPLETED|Overall Study||27
1706893|NCT00405392|4174583|P1|NOT COMPLETED|Overall Study||30
1706894|NCT00405392|4174582|P2|COMPLETED|Overall Study||155
1706895|NCT00405392|4174583|P1|COMPLETED|Overall Study||153
1706896|NCT00405392|4174582|P2|STARTED|Overall Study||182
1706897|NCT00405392|4174583|P1|STARTED|Overall Study||183
1706898|NCT00405288|4174595|P2|NOT COMPLETED|Overall Study||0
1706899|NCT00405288|4174596|P1|NOT COMPLETED|Overall Study||0
1706900|NCT00405288|4174595|P2|COMPLETED|Overall Study||204
1706901|NCT00405288|4174596|P1|COMPLETED|Overall Study||204
1706902|NCT00405288|4174595|P2|STARTED|Overall Study||204
1706903|NCT00405288|4174596|P1|STARTED|Overall Study||204
1706904|NCT00405275|4174626|P2|NOT COMPLETED|Overall Study||19
1706905|NCT00405275|4174627|P1|NOT COMPLETED|Overall Study||23
1706906|NCT00405275|4174626|P2|COMPLETED|Overall Study||156
1706907|NCT00405275|4174627|P1|COMPLETED|Overall Study||155
1706908|NCT00405275|4174626|P2|24 Week (Switch)|Overall Study||44
1706909|NCT00405275|4174627|P1|24 Week (Switch)|Overall Study||44
1706910|NCT00405275|4174626|P2|24 Week (no Switch)|Overall Study||121
1706911|NCT00405275|4174627|P1|24 Week (no Switch)|Overall Study||119
1706912|NCT00405275|4174626|P2|24 Weeks (Total)|Overall Study||165
1706913|NCT00405275|4174627|P1|24 Weeks (Total)|Overall Study||163
1706914|NCT00405275|4174626|P2|STARTED|Overall Study||175
1706915|NCT00405275|4174627|P1|STARTED|Overall Study||178
1706916|NCT00405067|4174636|P3|NOT COMPLETED|Overall Study||5
1706917|NCT00405067|4174637|P2|NOT COMPLETED|Overall Study||9
1706918|NCT00405067|4174638|P1|NOT COMPLETED|Overall Study||4
1706919|NCT00405067|4174636|P3|COMPLETED|Overall Study||24
1706920|NCT00405067|4174637|P2|COMPLETED|Overall Study||19
1706921|NCT00405067|4174638|P1|COMPLETED|Overall Study||24
1706922|NCT00405067|4174636|P3|STARTED|Overall Study||29
1706923|NCT00405067|4174637|P2|STARTED|Overall Study||28
1706924|NCT00405067|4174638|P1|STARTED|Overall Study||28
1706925|NCT00404924|4174675|P2|NOT COMPLETED|Overall Study||306
1706926|NCT00404924|4174676|P1|NOT COMPLETED|Overall Study||603
1706927|NCT00404924|4174675|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
1706928|NCT00404924|4174676|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
1706929|NCT00404924|4174675|P2|STARTED|Overall Study|randomised patients|307
1706930|NCT00404924|4174676|P1|STARTED|Overall Study|randomised patients|617
1706931|NCT00404820|4174694|P2|NOT COMPLETED|Overall Study||24
1706932|NCT00404820|4174695|P1|NOT COMPLETED|Overall Study||19
1706933|NCT00404820|4174694|P2|COMPLETED|Overall Study||172
1706934|NCT00404820|4174695|P1|COMPLETED|Overall Study||389
1706935|NCT00404820|4174694|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
1706936|NCT00404820|4174695|P1|Started Treatment|Overall Study||408
1706937|NCT00404820|4174694|P2|STARTED|Overall Study||196
1706938|NCT00404820|4174695|P1|STARTED|Overall Study||408
1706939|NCT00404768|4174717|P4|NOT COMPLETED|Part C||14
1706940|NCT00404768|4174718|P3|NOT COMPLETED|Part C||8
1706941|NCT00404768|4174719|P2|NOT COMPLETED|Part C||0
1706942|NCT00404768|4174720|P1|NOT COMPLETED|Part C||0
1706943|NCT00404768|4174717|P4|COMPLETED|Part C||20
1706944|NCT00404768|4174718|P3|COMPLETED|Part C||22
1706945|NCT00404768|4174719|P2|COMPLETED|Part C||0
1706946|NCT00404768|4174720|P1|COMPLETED|Part C||0
1706947|NCT00404768|4174717|P4|STARTED|Part C||34
1706948|NCT00404768|4174718|P3|STARTED|Part C||30
1706949|NCT00404768|4174719|P2|STARTED|Part C||0
1706950|NCT00404768|4174720|P1|STARTED|Part C||0
1706951|NCT00404768|4174717|P4|NOT COMPLETED|Part A and B||0
1706952|NCT00404768|4174718|P3|NOT COMPLETED|Part A and B||0
1706953|NCT00404768|4174719|P2|NOT COMPLETED|Part A and B||1
1706954|NCT00404768|4174720|P1|NOT COMPLETED|Part A and B||1
1706955|NCT00404768|4174717|P4|COMPLETED|Part A and B||0
1706956|NCT00404768|4174718|P3|COMPLETED|Part A and B||0
1706957|NCT00404768|4174719|P2|COMPLETED|Part A and B||8
1706958|NCT00404768|4174720|P1|COMPLETED|Part A and B||19
1706959|NCT00404768|4174717|P4|STARTED|Part A and B||0
1706960|NCT00404768|4174718|P3|STARTED|Part A and B||0
1706961|NCT00404768|4174719|P2|STARTED|Part A and B||9
1706962|NCT00404768|4174720|P1|STARTED|Part A and B||20
1706963|NCT00404755|4174781|P1|NOT COMPLETED|Phase III (Imipramine)||0
1706964|NCT00404755|4174781|P1|COMPLETED|Phase III (Imipramine)||3
1706965|NCT00404755|4174781|P1|STARTED|Phase III (Imipramine)||3
1706966|NCT00404755|4174781|P1|NOT COMPLETED|Phase II (Escitalopram)||2
1706967|NCT00404755|4174781|P1|COMPLETED|Phase II (Escitalopram)||9
1706968|NCT00404755|4174781|P1|STARTED|Phase II (Escitalopram)||11
1706969|NCT00404755|4174781|P1|NOT COMPLETED|Phase I (Bupropion)||4
1706970|NCT00404755|4174781|P1|COMPLETED|Phase I (Bupropion)||13
1706971|NCT00404755|4174781|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
1706972|NCT00404651|4174796|P4|NOT COMPLETED|Overall Study||21
1706973|NCT00404651|4174797|P3|NOT COMPLETED|Overall Study||45
1706974|NCT00404651|4174798|P2|NOT COMPLETED|Overall Study||28
1706975|NCT00404651|4174799|P1|NOT COMPLETED|Overall Study||39
1706976|NCT00404651|4174796|P4|COMPLETED|Overall Study||146
1706977|NCT00404651|4174797|P3|COMPLETED|Overall Study||294
1706978|NCT00404651|4174798|P2|COMPLETED|Overall Study||315
1706979|NCT00404651|4174799|P1|COMPLETED|Overall Study||301
1706980|NCT00404651|4174796|P4|STARTED|Overall Study||167
1706981|NCT00404651|4174797|P3|STARTED|Overall Study||339
1706982|NCT00404651|4174798|P2|STARTED|Overall Study||343
1706983|NCT00404651|4174799|P1|STARTED|Overall Study||340
1706984|NCT00404547|4174827|P2|NOT COMPLETED|Overall Study||25
1706985|NCT00404547|4174828|P1|NOT COMPLETED|Overall Study||90
1706986|NCT00404547|4174827|P2|COMPLETED|Overall Study||334
1706987|NCT00404547|4174828|P1|COMPLETED|Overall Study||672
1706988|NCT00404547|4174827|P2|STARTED|Overall Study||359
1706989|NCT00404547|4174828|P1|STARTED|Overall Study||762
1706990|NCT00404495|4174838|P2|NOT COMPLETED|Overall Study||11
1706991|NCT00404495|4174839|P1|NOT COMPLETED|Overall Study||44
1706992|NCT00404495|4174838|P2|COMPLETED|Overall Study||6
1706993|NCT00404495|4174839|P1|COMPLETED|Overall Study||22
1706994|NCT00404495|4174838|P2|STARTED|Overall Study||17
1706995|NCT00404495|4174839|P1|STARTED|Overall Study||66
1706996|NCT00404352|4174858|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
1706997|NCT00404352|4174859|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
1706998|NCT00404352|4174860|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
1706999|NCT00404352|4174861|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1707000|NCT00404352|4174862|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1707001|NCT00404352|4174863|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1707002|NCT00404352|4174864|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1707003|NCT00404352|4174865|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1707004|NCT00404352|4174866|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
1707005|NCT00404352|4174858|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
1707006|NCT00404352|4174859|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
1707007|NCT00404352|4174860|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
1707008|NCT00404352|4174861|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
1707009|NCT00404352|4174862|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
1707010|NCT00404352|4174863|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
1707011|NCT00404352|4174864|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
1707012|NCT00404352|4174865|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
1707013|NCT00404352|4174866|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
1707014|NCT00404352|4174858|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
1707015|NCT00404352|4174859|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
1707016|NCT00404352|4174860|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
1707017|NCT00404352|4174861|P6|STARTED|Open Label Extension (up to 36 Months)||0
1707018|NCT00404352|4174862|P5|STARTED|Open Label Extension (up to 36 Months)||0
1707019|NCT00404352|4174863|P4|STARTED|Open Label Extension (up to 36 Months)||0
1707020|NCT00404352|4174864|P3|STARTED|Open Label Extension (up to 36 Months)||0
1707021|NCT00404352|4174865|P2|STARTED|Open Label Extension (up to 36 Months)||0
1707022|NCT00404352|4174866|P1|STARTED|Open Label Extension (up to 36 Months)||0
1707023|NCT00404352|4174858|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
1707024|NCT00404352|4174859|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
1707025|NCT00404352|4174860|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
1707026|NCT00404352|4174861|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
1707027|NCT00404352|4174862|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
1707028|NCT00404352|4174863|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
1707029|NCT00404352|4174864|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
1707030|NCT00404352|4174865|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
1707031|NCT00404352|4174866|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
1707032|NCT00404352|4174858|P9|COMPLETED|Open Label (up to 24 Month)||0
1707033|NCT00404352|4174859|P8|COMPLETED|Open Label (up to 24 Month)||0
1707034|NCT00404352|4174860|P7|COMPLETED|Open Label (up to 24 Month)||0
1707035|NCT00404352|4174861|P6|COMPLETED|Open Label (up to 24 Month)||52
1707036|NCT00404352|4174862|P5|COMPLETED|Open Label (up to 24 Month)||28
1707037|NCT00404352|4174863|P4|COMPLETED|Open Label (up to 24 Month)||28
1707038|NCT00404352|4174864|P3|COMPLETED|Open Label (up to 24 Month)||0
1707039|NCT00404352|4174865|P2|COMPLETED|Open Label (up to 24 Month)||0
1707040|NCT00404352|4174866|P1|COMPLETED|Open Label (up to 24 Month)||0
1707041|NCT00404352|4174858|P9|STARTED|Open Label (up to 24 Month)||0
1707042|NCT00404352|4174859|P8|STARTED|Open Label (up to 24 Month)||0
1707043|NCT00404352|4174860|P7|STARTED|Open Label (up to 24 Month)||0
1707044|NCT00404352|4174861|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
1707045|NCT00404352|4174862|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
1707046|NCT00404352|4174863|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
1707047|NCT00404352|4174864|P3|STARTED|Open Label (up to 24 Month)||0
1707048|NCT00404352|4174865|P2|STARTED|Open Label (up to 24 Month)||0
1707049|NCT00404352|4174866|P1|STARTED|Open Label (up to 24 Month)||0
1707050|NCT00404352|4174858|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
1707051|NCT00404352|4174859|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
1707052|NCT00404352|4174860|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
1707053|NCT00404352|4174861|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
1707054|NCT00404352|4174862|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
1707055|NCT00404352|4174863|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
1707056|NCT00404352|4174864|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
1707057|NCT00404352|4174865|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
1707058|NCT00404352|4174866|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
1707059|NCT00404352|4174858|P9|COMPLETED|Double Blind (up to 24 Month)||0
1707060|NCT00404352|4174859|P8|COMPLETED|Double Blind (up to 24 Month)||0
1707061|NCT00404352|4174860|P7|COMPLETED|Double Blind (up to 24 Month)||0
1707062|NCT00404352|4174861|P6|COMPLETED|Double Blind (up to 24 Month)||0
1707063|NCT00404352|4174862|P5|COMPLETED|Double Blind (up to 24 Month)||0
1707064|NCT00404352|4174863|P4|COMPLETED|Double Blind (up to 24 Month)||0
1707065|NCT00404352|4174864|P3|COMPLETED|Double Blind (up to 24 Month)||92
1707066|NCT00404352|4174865|P2|COMPLETED|Double Blind (up to 24 Month)||128
1707067|NCT00404352|4174866|P1|COMPLETED|Double Blind (up to 24 Month)||119
1707068|NCT00404352|4174858|P9|Treated|Double Blind (up to 24 Month)||0
1707069|NCT00404352|4174859|P8|Treated|Double Blind (up to 24 Month)||0
1707070|NCT00404352|4174860|P7|Treated|Double Blind (up to 24 Month)||0
1707071|NCT00404352|4174861|P6|Treated|Double Blind (up to 24 Month)||0
1707072|NCT00404352|4174862|P5|Treated|Double Blind (up to 24 Month)||0
1707073|NCT00404352|4174863|P4|Treated|Double Blind (up to 24 Month)||0
1707074|NCT00404352|4174864|P3|Treated|Double Blind (up to 24 Month)||171
1707075|NCT00404352|4174865|P2|Treated|Double Blind (up to 24 Month)||173
1707076|NCT00404352|4174866|P1|Treated|Double Blind (up to 24 Month)||171
1707077|NCT00404352|4174858|P9|STARTED|Double Blind (up to 24 Month)||0
1707078|NCT00404352|4174859|P8|STARTED|Double Blind (up to 24 Month)||0
1707079|NCT00404352|4174860|P7|STARTED|Double Blind (up to 24 Month)||0
1707080|NCT00404352|4174861|P6|STARTED|Double Blind (up to 24 Month)||0
1707081|NCT00404352|4174862|P5|STARTED|Double Blind (up to 24 Month)||0
1707082|NCT00404352|4174863|P4|STARTED|Double Blind (up to 24 Month)||0
1707083|NCT00404352|4174864|P3|STARTED|Double Blind (up to 24 Month)||171
1707084|NCT00404352|4174865|P2|STARTED|Double Blind (up to 24 Month)||175
1707085|NCT00404352|4174866|P1|STARTED|Double Blind (up to 24 Month)||171
1707086|NCT00404248|4174901|P9|NOT COMPLETED|Overall Study||0
1707087|NCT00404248|4174902|P8|NOT COMPLETED|Overall Study||0
1707088|NCT00404248|4174903|P7|NOT COMPLETED|Overall Study||0
1707089|NCT00404248|4174904|P6|NOT COMPLETED|Overall Study||0
1707090|NCT00404248|4174905|P5|NOT COMPLETED|Overall Study||0
1707091|NCT00404248|4174906|P4|NOT COMPLETED|Overall Study||0
1707092|NCT00404248|4174907|P3|NOT COMPLETED|Overall Study||0
1707093|NCT00404248|4174908|P2|NOT COMPLETED|Overall Study||1
1707094|NCT00404248|4174909|P1|NOT COMPLETED|Overall Study||0
1707095|NCT00404248|4174901|P9|COMPLETED|Overall Study||3
1707096|NCT00404248|4174902|P8|COMPLETED|Overall Study||6
1707097|NCT00404248|4174903|P7|COMPLETED|Overall Study||6
1707098|NCT00404248|4174904|P6|COMPLETED|Overall Study||3
1707099|NCT00404248|4174905|P5|COMPLETED|Overall Study||3
1707100|NCT00404248|4174906|P4|COMPLETED|Overall Study||2
1707101|NCT00404248|4174907|P3|COMPLETED|Overall Study||5
1707102|NCT00404248|4174908|P2|COMPLETED|Overall Study||3
1707103|NCT00404248|4174909|P1|COMPLETED|Overall Study||3
1707104|NCT00404248|4174901|P9|STARTED|Overall Study||3
1707105|NCT00404248|4174902|P8|STARTED|Overall Study||6
1707106|NCT00404248|4174903|P7|STARTED|Overall Study||6
1707107|NCT00404248|4174904|P6|STARTED|Overall Study||3
1707108|NCT00404248|4174905|P5|STARTED|Overall Study||3
1707109|NCT00404248|4174906|P4|STARTED|Overall Study||2
1707110|NCT00404248|4174907|P3|STARTED|Overall Study||5
1707111|NCT00404248|4174908|P2|STARTED|Overall Study||4
1707112|NCT00404248|4174909|P1|STARTED|Overall Study||3
1707113|NCT00404235|4174942|P2|NOT COMPLETED|Overall Study||2
1707114|NCT00404235|4174943|P1|NOT COMPLETED|Overall Study||1
1707115|NCT00404235|4174942|P2|COMPLETED|Overall Study||39
1707116|NCT00404235|4174943|P1|COMPLETED|Overall Study||34
1707117|NCT00404235|4174942|P2|STARTED|Overall Study||41
1707118|NCT00404235|4174943|P1|STARTED|Overall Study||35
1707119|NCT00404092|4174961|P4|NOT COMPLETED|Overall Study||0
1707120|NCT00404092|4174962|P3|NOT COMPLETED|Overall Study||1
1707121|NCT00404092|4174963|P2|NOT COMPLETED|Overall Study||0
1707122|NCT00404092|4174964|P1|NOT COMPLETED|Overall Study||1
1707123|NCT00404092|4174961|P4|COMPLETED|Overall Study||20
1707124|NCT00404092|4174962|P3|COMPLETED|Overall Study||8
1707125|NCT00404092|4174963|P2|COMPLETED|Overall Study||8
1707126|NCT00404092|4174964|P1|COMPLETED|Overall Study||8
1707127|NCT00404092|4174961|P4|STARTED|Overall Study||20
1707128|NCT00404092|4174962|P3|STARTED|Overall Study||9
1707129|NCT00404092|4174963|P2|STARTED|Overall Study||8
1707130|NCT00404092|4174964|P1|STARTED|Overall Study||9
1707131|NCT00404079|4174980|P2|NOT COMPLETED|Overall Study||20
1707132|NCT00404079|4174981|P1|NOT COMPLETED|Overall Study||22
1707133|NCT00404079|4174980|P2|COMPLETED|Overall Study||105
1707134|NCT00404079|4174981|P1|COMPLETED|Overall Study||103
1707135|NCT00404079|4174980|P2|STARTED|Overall Study||125
1707136|NCT00404079|4174981|P1|STARTED|Overall Study||125
1707137|NCT00404066|4174987|P1|NOT COMPLETED|Overall Study||3
1707138|NCT00404066|4174987|P1|COMPLETED|Overall Study||18
1707139|NCT00404066|4174987|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
1707140|NCT00403845|4174992|P4|NOT COMPLETED|Treatment Period 4||0
1707141|NCT00403845|4174993|P3|NOT COMPLETED|Treatment Period 4||0
1707142|NCT00403845|4174994|P2|NOT COMPLETED|Treatment Period 4||0
1707143|NCT00403845|4174995|P1|NOT COMPLETED|Treatment Period 4||0
1707144|NCT00403845|4174992|P4|COMPLETED|Treatment Period 4||11
1707145|NCT00403845|4174993|P3|COMPLETED|Treatment Period 4||11
1707146|NCT00403845|4174994|P2|COMPLETED|Treatment Period 4||13
1707147|NCT00403845|4174995|P1|COMPLETED|Treatment Period 4||10
1707148|NCT00403845|4174992|P4|STARTED|Treatment Period 4||11
1707149|NCT00403845|4174993|P3|STARTED|Treatment Period 4||11
1707150|NCT00403845|4174994|P2|STARTED|Treatment Period 4||13
1707151|NCT00403845|4174995|P1|STARTED|Treatment Period 4||10
1707152|NCT00403845|4174992|P4|NOT COMPLETED|Treatment Period 3||2
1707153|NCT00403845|4174993|P3|NOT COMPLETED|Treatment Period 3||0
1707154|NCT00403845|4174994|P2|NOT COMPLETED|Treatment Period 3||0
1707155|NCT00403845|4174995|P1|NOT COMPLETED|Treatment Period 3||0
1707156|NCT00403845|4174992|P4|COMPLETED|Treatment Period 3||11
1707157|NCT00403845|4174993|P3|COMPLETED|Treatment Period 3||11
1707158|NCT00403845|4174994|P2|COMPLETED|Treatment Period 3||13
1707159|NCT00403845|4174995|P1|COMPLETED|Treatment Period 3||10
1707160|NCT00403845|4174992|P4|STARTED|Treatment Period 3||13
1707161|NCT00403845|4174993|P3|STARTED|Treatment Period 3||11
1707162|NCT00403845|4174994|P2|STARTED|Treatment Period 3||13
1707163|NCT00403845|4174995|P1|STARTED|Treatment Period 3||10
1707164|NCT00403845|4174992|P4|NOT COMPLETED|Treatment Period 2||0
1707165|NCT00403845|4174993|P3|NOT COMPLETED|Treatment Period 2||0
1707166|NCT00403845|4174994|P2|NOT COMPLETED|Treatment Period 2||0
1707167|NCT00403845|4174995|P1|NOT COMPLETED|Treatment Period 2||1
1707168|NCT00403845|4174992|P4|COMPLETED|Treatment Period 2||13
1707169|NCT00403845|4174993|P3|COMPLETED|Treatment Period 2||11
1707170|NCT00403845|4174994|P2|COMPLETED|Treatment Period 2||13
1707171|NCT00403845|4174995|P1|COMPLETED|Treatment Period 2||10
1707172|NCT00403845|4174992|P4|STARTED|Treatment Period 2||13
1707173|NCT00403845|4174993|P3|STARTED|Treatment Period 2||11
1707174|NCT00403845|4174994|P2|STARTED|Treatment Period 2||13
1707175|NCT00403845|4174995|P1|STARTED|Treatment Period 2||11
1707176|NCT00403845|4174992|P4|NOT COMPLETED|Treatment Period 1||1
1707177|NCT00403845|4174993|P3|NOT COMPLETED|Treatment Period 1||0
1707178|NCT00403845|4174994|P2|NOT COMPLETED|Treatment Period 1||0
1707179|NCT00403845|4174995|P1|NOT COMPLETED|Treatment Period 1||1
1707180|NCT00403845|4174992|P4|COMPLETED|Treatment Period 1||13
1707181|NCT00403845|4174993|P3|COMPLETED|Treatment Period 1||11
1707182|NCT00403845|4174994|P2|COMPLETED|Treatment Period 1||13
1707183|NCT00403845|4174995|P1|COMPLETED|Treatment Period 1||11
1707184|NCT00403845|4174992|P4|STARTED|Treatment Period 1||14
1707185|NCT00403845|4174993|P3|STARTED|Treatment Period 1||11
1707186|NCT00403845|4174994|P2|STARTED|Treatment Period 1||13
1707187|NCT00403845|4174995|P1|STARTED|Treatment Period 1||12
1707188|NCT00403767|4175019|P2|NOT COMPLETED|Overall Study||2468
1707189|NCT00403767|4175020|P1|NOT COMPLETED|Overall Study||2520
1707190|NCT00403767|4175019|P2|COMPLETED|Overall Study||4657
1707191|NCT00403767|4175020|P1|COMPLETED|Overall Study||4591
1707192|NCT00403767|4175019|P2|STARTED|Overall Study||7125
1707193|NCT00403767|4175020|P1|STARTED|Overall Study||7111
1707194|NCT00403754|4175044|P4|NOT COMPLETED|Open Label: Salmeterol||0
1707195|NCT00403754|4175045|P3|NOT COMPLETED|Open Label: Salmeterol||0
1707196|NCT00403754|4175046|P2|NOT COMPLETED|Open Label: Salmeterol||0
1707197|NCT00403754|4175047|P1|NOT COMPLETED|Open Label: Salmeterol||0
1707198|NCT00403754|4175044|P4|COMPLETED|Open Label: Salmeterol||11
1707199|NCT00403754|4175045|P3|COMPLETED|Open Label: Salmeterol||8
1707200|NCT00403754|4175046|P2|COMPLETED|Open Label: Salmeterol||9
1707201|NCT00403754|4175047|P1|COMPLETED|Open Label: Salmeterol||11
1707202|NCT00403754|4175044|P4|STARTED|Open Label: Salmeterol||11
1707203|NCT00403754|4175045|P3|STARTED|Open Label: Salmeterol||8
1707204|NCT00403754|4175046|P2|STARTED|Open Label: Salmeterol||9
1707205|NCT00403754|4175047|P1|STARTED|Open Label: Salmeterol||11
1707206|NCT00403754|4175044|P4|NOT COMPLETED|Core Treatment Period 4||0
1707207|NCT00403754|4175045|P3|NOT COMPLETED|Core Treatment Period 4||0
1707208|NCT00403754|4175046|P2|NOT COMPLETED|Core Treatment Period 4||0
1707209|NCT00403754|4175047|P1|NOT COMPLETED|Core Treatment Period 4||0
1707210|NCT00403754|4175044|P4|COMPLETED|Core Treatment Period 4||11
1707211|NCT00403754|4175045|P3|COMPLETED|Core Treatment Period 4||8
1707212|NCT00403754|4175046|P2|COMPLETED|Core Treatment Period 4||9
1707213|NCT00403754|4175047|P1|COMPLETED|Core Treatment Period 4||11
1707214|NCT00403754|4175044|P4|STARTED|Core Treatment Period 4||11
1707215|NCT00403754|4175045|P3|STARTED|Core Treatment Period 4||8
1707216|NCT00403754|4175046|P2|STARTED|Core Treatment Period 4||9
1707217|NCT00403754|4175047|P1|STARTED|Core Treatment Period 4||11
1707218|NCT00403754|4175044|P4|NOT COMPLETED|Core Treatment Period 3||0
1707219|NCT00403754|4175045|P3|NOT COMPLETED|Core Treatment Period 3||0
1707220|NCT00403754|4175046|P2|NOT COMPLETED|Core Treatment Period 3||0
1707221|NCT00403754|4175047|P1|NOT COMPLETED|Core Treatment Period 3||0
1707222|NCT00403754|4175044|P4|COMPLETED|Core Treatment Period 3||11
1707223|NCT00403754|4175045|P3|COMPLETED|Core Treatment Period 3||8
1707224|NCT00403754|4175046|P2|COMPLETED|Core Treatment Period 3||9
1707225|NCT00403754|4175047|P1|COMPLETED|Core Treatment Period 3||11
1707226|NCT00403754|4175044|P4|STARTED|Core Treatment Period 3||11
1707227|NCT00403754|4175045|P3|STARTED|Core Treatment Period 3||8
1707228|NCT00403754|4175046|P2|STARTED|Core Treatment Period 3||9
1707229|NCT00403754|4175047|P1|STARTED|Core Treatment Period 3||11
1707230|NCT00403754|4175044|P4|NOT COMPLETED|Core Treatment Period 2||0
1707231|NCT00403754|4175045|P3|NOT COMPLETED|Core Treatment Period 2||1
1707232|NCT00403754|4175046|P2|NOT COMPLETED|Core Treatment Period 2||0
1707233|NCT00403754|4175047|P1|NOT COMPLETED|Core Treatment Period 2||0
1707234|NCT00403754|4175044|P4|COMPLETED|Core Treatment Period 2||11
1707235|NCT00403754|4175045|P3|COMPLETED|Core Treatment Period 2||8
1707236|NCT00403754|4175046|P2|COMPLETED|Core Treatment Period 2||9
1707237|NCT00403754|4175047|P1|COMPLETED|Core Treatment Period 2||11
1707238|NCT00403754|4175044|P4|STARTED|Core Treatment Period 2||11
1707239|NCT00403754|4175045|P3|STARTED|Core Treatment Period 2||9
1707240|NCT00403754|4175046|P2|STARTED|Core Treatment Period 2||9
1707241|NCT00403754|4175047|P1|STARTED|Core Treatment Period 2||11
1707242|NCT00403754|4175044|P4|NOT COMPLETED|Core Treatment Period 1||0
1707243|NCT00403754|4175045|P3|NOT COMPLETED|Core Treatment Period 1||0
1707244|NCT00403754|4175046|P2|NOT COMPLETED|Core Treatment Period 1||1
1707245|NCT00403754|4175047|P1|NOT COMPLETED|Core Treatment Period 1||0
1707246|NCT00403754|4175044|P4|COMPLETED|Core Treatment Period 1||11
1707247|NCT00403754|4175045|P3|COMPLETED|Core Treatment Period 1||9
1707248|NCT00403754|4175046|P2|COMPLETED|Core Treatment Period 1||9
1707249|NCT00403754|4175047|P1|COMPLETED|Core Treatment Period 1||11
1707250|NCT00403754|4175044|P4|STARTED|Core Treatment Period 1||11
1707251|NCT00403754|4175045|P3|STARTED|Core Treatment Period 1||9
1707252|NCT00403754|4175046|P2|STARTED|Core Treatment Period 1||10
1707253|NCT00403754|4175047|P1|STARTED|Core Treatment Period 1||11
1707254|NCT00403585|4175074|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
1707255|NCT00403585|4175074|P1|COMPLETED|Open-Label Phase; Extension Study||74
1707256|NCT00403585|4175074|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
1707257|NCT00403585|4175074|P1|NOT COMPLETED|Initial Treatment Phase||2
1707258|NCT00403585|4175074|P1|COMPLETED|Initial Treatment Phase||102
1707259|NCT00403585|4175074|P1|STARTED|Initial Treatment Phase||104
1707260|NCT00403546|4175085|P3|NOT COMPLETED|Randomized Trial||16
1707261|NCT00403546|4175086|P2|NOT COMPLETED|Randomized Trial||17
1707262|NCT00403546|4175087|P1|NOT COMPLETED|Randomized Trial||0
1707263|NCT00403546|4175085|P3|COMPLETED|Randomized Trial||21
1707264|NCT00403546|4175086|P2|COMPLETED|Randomized Trial||21
1707265|NCT00403546|4175087|P1|COMPLETED|Randomized Trial||0
1707266|NCT00403546|4175085|P3|STARTED|Randomized Trial||37
1707267|NCT00403546|4175086|P2|STARTED|Randomized Trial||38
1707268|NCT00403546|4175087|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
1707269|NCT00403546|4175085|P3|NOT COMPLETED|Screening Phase||0
1707270|NCT00403546|4175086|P2|NOT COMPLETED|Screening Phase||0
1707271|NCT00403546|4175087|P1|NOT COMPLETED|Screening Phase||28
1707272|NCT00403546|4175085|P3|COMPLETED|Screening Phase||0
1707273|NCT00403546|4175086|P2|COMPLETED|Screening Phase||0
1707274|NCT00403546|4175087|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
1707275|NCT00403546|4175085|P3|STARTED|Screening Phase||0
1707276|NCT00403546|4175086|P2|STARTED|Screening Phase||0
1707277|NCT00403546|4175087|P1|STARTED|Screening Phase||103
1707278|NCT00403546|4175085|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
1707279|NCT00403546|4175086|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
1707280|NCT00403546|4175087|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
1707281|NCT00403546|4175085|P3|COMPLETED|Signed Informed Consent/Open-Label||0
1707282|NCT00403546|4175086|P2|COMPLETED|Signed Informed Consent/Open-Label||0
1707283|NCT00403546|4175087|P1|COMPLETED|Signed Informed Consent/Open-Label||103
1707284|NCT00403546|4175085|P3|STARTED|Signed Informed Consent/Open-Label||0
1707285|NCT00403546|4175086|P2|STARTED|Signed Informed Consent/Open-Label||0
1707286|NCT00403546|4175087|P1|STARTED|Signed Informed Consent/Open-Label||131
1707287|NCT00403481|4175127|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
1707288|NCT00403481|4175127|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
1707289|NCT00403481|4175127|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
1707290|NCT00403481|4175127|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
1707291|NCT00403481|4175127|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
1707292|NCT00403481|4175127|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
1707293|NCT00403481|4175127|P1|NOT COMPLETED|Olm 40 mg||5
1707294|NCT00403481|4175127|P1|COMPLETED|Olm 40 mg||177
1707295|NCT00403481|4175127|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
1707296|NCT00403481|4175127|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
1707297|NCT00403481|4175127|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
1707298|NCT00403481|4175127|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
1707299|NCT00403455|4175142|P1|NOT COMPLETED|Overall Study||1
1707300|NCT00403455|4175142|P1|COMPLETED|Overall Study||37
1707301|NCT00403455|4175142|P1|STARTED|Overall Study||38
1707302|NCT00403403|4175148|P2|NOT COMPLETED|Overall Study||0
1707303|NCT00403403|4175149|P1|NOT COMPLETED|Overall Study||0
1707304|NCT00403403|4175148|P2|COMPLETED|Overall Study||52
1707305|NCT00403403|4175149|P1|COMPLETED|Overall Study||50
1707306|NCT00403403|4175148|P2|Safety-Evaluable Patients|Overall Study||51
1707307|NCT00403403|4175149|P1|Safety-Evaluable Patients|Overall Study||47
1707308|NCT00403403|4175148|P2|STARTED|Overall Study||52
1707309|NCT00403403|4175149|P1|STARTED|Overall Study||50
1707310|NCT00403390|4175165|P2|NOT COMPLETED|Overall Study||0
1707311|NCT00403390|4175166|P1|NOT COMPLETED|Overall Study||3
1707312|NCT00403390|4175165|P2|COMPLETED|Overall Study||18
1707313|NCT00403390|4175166|P1|COMPLETED|Overall Study||13
1707314|NCT00403390|4175165|P2|STARTED|Overall Study||18
1707315|NCT00403390|4175166|P1|STARTED|Overall Study||16
1707316|NCT00403273|4175174|P2|NOT COMPLETED|Overall Study||4
1707317|NCT00403273|4175175|P1|NOT COMPLETED|Overall Study||3
1707318|NCT00403273|4175174|P2|COMPLETED|Overall Study||25
1707319|NCT00403273|4175175|P1|COMPLETED|Overall Study||22
1707320|NCT00403273|4175174|P2|STARTED|Overall Study||29
1707321|NCT00403273|4175175|P1|STARTED|Overall Study||25
1707322|NCT00403234|4175217|P4|NOT COMPLETED|Overall Study||0
1707323|NCT00403234|4175218|P3|NOT COMPLETED|Overall Study||1
1707324|NCT00403234|4175219|P2|NOT COMPLETED|Overall Study||1
1707325|NCT00403234|4175220|P1|NOT COMPLETED|Overall Study||1
1707326|NCT00403234|4175217|P4|COMPLETED|Overall Study||2
1707327|NCT00403234|4175218|P3|COMPLETED|Overall Study||2
1707328|NCT00403234|4175219|P2|COMPLETED|Overall Study||2
1707329|NCT00403234|4175220|P1|COMPLETED|Overall Study||1
1707330|NCT00403234|4175217|P4|STARTED|Overall Study||2
1707331|NCT00403234|4175218|P3|STARTED|Overall Study||3
1707332|NCT00403234|4175219|P2|STARTED|Overall Study||3
1707333|NCT00403234|4175220|P1|STARTED|Overall Study||2
1707334|NCT00403130|4175230|P1|NOT COMPLETED|Overall Study||5
1707335|NCT00403130|4175230|P1|COMPLETED|Overall Study||26
1707336|NCT00403130|4175230|P1|STARTED|Overall Study||31
1707337|NCT00403117|4175237|P1|NOT COMPLETED|Overall Study||20
1707338|NCT00403117|4175237|P1|COMPLETED|Overall Study||29
1707339|NCT00403117|4175237|P1|STARTED|Overall Study||49
1707340|NCT00402987|4175283|P4|NOT COMPLETED|Overall Study||0
1707341|NCT00402987|4175284|P3|NOT COMPLETED|Overall Study||1
1707342|NCT00402987|4175285|P2|NOT COMPLETED|Overall Study||0
1707343|NCT00402987|4175286|P1|NOT COMPLETED|Overall Study||0
1707344|NCT00402987|4175283|P4|COMPLETED|Overall Study||89
1707345|NCT00402987|4175284|P3|COMPLETED|Overall Study||44
1707346|NCT00402987|4175285|P2|COMPLETED|Overall Study||45
1707347|NCT00402987|4175286|P1|COMPLETED|Overall Study||90
1707348|NCT00402987|4175283|P4|STARTED|Overall Study||89
1707349|NCT00402987|4175284|P3|STARTED|Overall Study||45
1707350|NCT00402987|4175285|P2|STARTED|Overall Study||45
1707351|NCT00402987|4175286|P1|STARTED|Overall Study||90
1707352|NCT00402896|4175448|P1|NOT COMPLETED|Overall Study||0
1707353|NCT00402896|4175448|P1|COMPLETED|Overall Study||20
1707354|NCT00402896|4175448|P1|STARTED|Overall Study||20
1707355|NCT00402883|4175452|P1|NOT COMPLETED|Maintenance Therapy||0
1707356|NCT00402883|4175452|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
1707357|NCT00402883|4175452|P1|STARTED|Maintenance Therapy||5
1707358|NCT00402883|4175452|P1|NOT COMPLETED|Consolidation Therapy||0
1707359|NCT00402883|4175452|P1|COMPLETED|Consolidation Therapy||5
1707360|NCT00402883|4175452|P1|STARTED|Consolidation Therapy||5
1707361|NCT00402883|4175452|P1|NOT COMPLETED|Induction Therapy||0
1707362|NCT00402883|4175452|P1|COMPLETED|Induction Therapy||5
1707363|NCT00402883|4175452|P1|STARTED|Induction Therapy||5
1707364|NCT00402831|4175458|P2|NOT COMPLETED|Overall Study||3
1707365|NCT00402831|4175459|P1|NOT COMPLETED|Overall Study||1
1707366|NCT00402831|4175458|P2|COMPLETED|Overall Study||200
1707367|NCT00402831|4175459|P1|COMPLETED|Overall Study||201
1707368|NCT00402831|4175458|P2|ProQuad® Dose 1 (Day 30)|Overall Study||203
1707369|NCT00402831|4175459|P1|ProQuad® Dose 1 (Day 30)|Overall Study||202
1707370|NCT00402831|4175458|P2|ProQuad® Dose 1 (Day 1)|Overall Study||203
1707371|NCT00402831|4175459|P1|ProQuad® Dose 1 (Day 1)|Overall Study||202
1707372|NCT00402831|4175458|P2|STARTED|Overall Study||203
1707373|NCT00402831|4175459|P1|STARTED|Overall Study||202
1707374|NCT00402740|4175491|P1|NOT COMPLETED|Overall Study||80
1707375|NCT00402740|4175491|P1|COMPLETED|Overall Study||242
1707376|NCT00402740|4175491|P1|STARTED|Overall Study||322
1707377|NCT00402727|4175503|P2|NOT COMPLETED|Overall Study||34
1707378|NCT00402727|4175504|P1|NOT COMPLETED|Overall Study||42
1707379|NCT00402727|4175503|P2|COMPLETED|Overall Study||347
1707380|NCT00402727|4175504|P1|COMPLETED|Overall Study||390
1707381|NCT00402727|4175503|P2|Achieving Test Of Cure (TOC)|Overall Study||347
1707382|NCT00402727|4175504|P1|Achieving Test Of Cure (TOC)|Overall Study||390
1707383|NCT00402727|4175503|P2|Achieving End Of Treatment (EOT)|Overall Study||355
1707384|NCT00402727|4175504|P1|Achieving End Of Treatment (EOT)|Overall Study||408
1707385|NCT00402727|4175503|P2|STARTED|Overall Study||381
1707386|NCT00402727|4175504|P1|STARTED|Overall Study||432
1707387|NCT00402714|4175534|P2|NOT COMPLETED|Overall Study||0
1707388|NCT00402714|4175535|P1|NOT COMPLETED|Overall Study||0
1707389|NCT00402714|4175534|P2|COMPLETED|Overall Study||11
1707390|NCT00402714|4175535|P1|COMPLETED|Overall Study||3
1707391|NCT00402714|4175534|P2|STARTED|Overall Study||11
1707392|NCT00402714|4175535|P1|STARTED|Overall Study||3
1707393|NCT00402688|4175546|P3|NOT COMPLETED|Overall Study||15
1707394|NCT00402688|4175547|P2|NOT COMPLETED|Overall Study||16
1707395|NCT00402688|4175548|P1|NOT COMPLETED|Overall Study||21
1707396|NCT00402688|4175546|P3|COMPLETED|Overall Study||65
1707397|NCT00402688|4175547|P2|COMPLETED|Overall Study||65
1707398|NCT00402688|4175548|P1|COMPLETED|Overall Study||60
1707399|NCT00402688|4175546|P3|STARTED|Overall Study||80
1707400|NCT00402688|4175547|P2|STARTED|Overall Study||81
1707401|NCT00402688|4175548|P1|STARTED|Overall Study||81
1707402|NCT00402649|4175571|P1|NOT COMPLETED|Overall Study||2
1707403|NCT00402649|4175571|P1|COMPLETED|Overall Study||33
1707404|NCT00402649|4175571|P1|STARTED|Overall Study||35
1707405|NCT00402597|4175586|P5|NOT COMPLETED|Overall Study||124
1707406|NCT00402597|4175587|P4|NOT COMPLETED|Overall Study||74
1707407|NCT00402597|4175588|P3|NOT COMPLETED|Overall Study||212
1707408|NCT00402597|4175589|P2|NOT COMPLETED|Overall Study||46
1707409|NCT00402597|4175590|P1|NOT COMPLETED|Overall Study||191
1707410|NCT00402597|4175586|P5|COMPLETED|Overall Study||479
1707411|NCT00402597|4175587|P4|COMPLETED|Overall Study||279
1707412|NCT00402597|4175588|P3|COMPLETED|Overall Study||834
1707413|NCT00402597|4175589|P2|COMPLETED|Overall Study||261
1707414|NCT00402597|4175590|P1|COMPLETED|Overall Study||962
1707415|NCT00402597|4175586|P5|STARTED|Overall Study||603
1707416|NCT00402597|4175587|P4|STARTED|Overall Study||353
1707417|NCT00402597|4175588|P3|STARTED|Overall Study||1046
1707418|NCT00402597|4175589|P2|STARTED|Overall Study||307
1707419|NCT00402597|4175590|P1|STARTED|Overall Study||1153
1707420|NCT00402363|4175631|P4|NOT COMPLETED|Overall Study||10
1707421|NCT00402363|4175632|P3|NOT COMPLETED|Overall Study||6
1707422|NCT00402363|4175633|P2|NOT COMPLETED|Overall Study||30
1707423|NCT00402363|4175634|P1|NOT COMPLETED|Overall Study||33
1707424|NCT00402363|4175631|P4|COMPLETED|Overall Study||45
1707425|NCT00402363|4175632|P3|COMPLETED|Overall Study||60
1707426|NCT00402363|4175633|P2|COMPLETED|Overall Study||246
1707427|NCT00402363|4175634|P1|COMPLETED|Overall Study||233
1707428|NCT00402363|4175631|P4|STARTED|Overall Study||55
1707429|NCT00402363|4175632|P3|STARTED|Overall Study||66
1707430|NCT00402363|4175633|P2|STARTED|Overall Study||276
1707431|NCT00402363|4175634|P1|STARTED|Overall Study||266
1707432|NCT00402337|4175697|P5|NOT COMPLETED|Overall Study||8
1707433|NCT00402337|4175698|P4|NOT COMPLETED|Overall Study||12
1707434|NCT00402337|4175699|P3|NOT COMPLETED|Overall Study||4
1707435|NCT00402337|4175700|P2|NOT COMPLETED|Overall Study||6
1707436|NCT00402337|4175701|P1|NOT COMPLETED|Overall Study||5
1707437|NCT00402337|4175697|P5|COMPLETED|Overall Study||61
1707438|NCT00402337|4175698|P4|COMPLETED|Overall Study||51
1707439|NCT00402337|4175699|P3|COMPLETED|Overall Study||58
1707440|NCT00402337|4175700|P2|COMPLETED|Overall Study||51
1707441|NCT00402337|4175701|P1|COMPLETED|Overall Study||54
1707442|NCT00402337|4175697|P5|STARTED|Overall Study||69
1707443|NCT00402337|4175698|P4|STARTED|Overall Study||63
1707444|NCT00402337|4175699|P3|STARTED|Overall Study||62
1707445|NCT00402337|4175700|P2|STARTED|Overall Study||57
1707446|NCT00402337|4175701|P1|STARTED|Overall Study||59
1707447|NCT00402324|4175740|P2|NOT COMPLETED|Overall Study||41
1707448|NCT00402324|4175741|P1|NOT COMPLETED|Overall Study||43
1707449|NCT00402324|4175740|P2|COMPLETED|Overall Study||60
1707450|NCT00402324|4175741|P1|COMPLETED|Overall Study||58
1707451|NCT00402324|4175740|P2|STARTED|Overall Study||101
1707452|NCT00402324|4175741|P1|STARTED|Overall Study||101
1707453|NCT00402285|4175774|P3|NOT COMPLETED|Overall Study||2
1707454|NCT00402285|4175775|P2|NOT COMPLETED|Overall Study||6
1707455|NCT00402285|4175776|P1|NOT COMPLETED|Overall Study||7
1707456|NCT00402285|4175774|P3|COMPLETED|Overall Study||26
1707457|NCT00402285|4175775|P2|COMPLETED|Overall Study||21
1707458|NCT00402285|4175776|P1|COMPLETED|Overall Study||22
1707459|NCT00402285|4175774|P3|STARTED|Overall Study||28
1707460|NCT00402285|4175775|P2|STARTED|Overall Study||27
1707461|NCT00402285|4175776|P1|STARTED|Overall Study||29
1707462|NCT00402246|4175784|P2|NOT COMPLETED|Overall Study||234
1707463|NCT00402246|4175785|P1|NOT COMPLETED|Overall Study||220
1707464|NCT00402246|4175784|P2|COMPLETED|Overall Study||749
1707465|NCT00402246|4175785|P1|COMPLETED|Overall Study||794
1707466|NCT00402246|4175784|P2|STARTED|Overall Study||983
1707467|NCT00402246|4175785|P1|STARTED|Overall Study||1014
1707468|NCT00402233|4175819|P4|NOT COMPLETED|Overall Study||11
1707469|NCT00402233|4175820|P3|NOT COMPLETED|Overall Study||11
1707470|NCT00402233|4175821|P2|NOT COMPLETED|Overall Study||10
1707471|NCT00402233|4175822|P1|NOT COMPLETED|Overall Study||5
1707472|NCT00402233|4175819|P4|COMPLETED|Overall Study||62
1707473|NCT00402233|4175820|P3|COMPLETED|Overall Study||70
1707474|NCT00402233|4175821|P2|COMPLETED|Overall Study||70
1707475|NCT00402233|4175822|P1|COMPLETED|Overall Study||72
1707476|NCT00402233|4175819|P4|STARTED|Overall Study||73
1707477|NCT00402233|4175820|P3|STARTED|Overall Study||81
1707478|NCT00402233|4175821|P2|STARTED|Overall Study||80
1707479|NCT00402233|4175822|P1|STARTED|Overall Study||77
1707480|NCT00402194|4175846|P2|NOT COMPLETED|Overall Study||0
1707481|NCT00402194|4175847|P1|NOT COMPLETED|Overall Study||0
1707482|NCT00402194|4175846|P2|COMPLETED|Overall Study||8
1707483|NCT00402194|4175847|P1|COMPLETED|Overall Study||9
1707484|NCT00402194|4175846|P2|STARTED|Overall Study||8
1707485|NCT00402194|4175847|P1|STARTED|Overall Study||9
1707486|NCT00402168|4175857|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
1707487|NCT00402168|4175858|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
1707488|NCT00402168|4175857|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
1707489|NCT00402168|4175858|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
1707490|NCT00402168|4175857|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
1707491|NCT00402168|4175858|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
1707492|NCT00402168|4175857|P2|NOT COMPLETED|Long Term (LT)||17
1707493|NCT00402168|4175858|P1|NOT COMPLETED|Long Term (LT)||11
1707494|NCT00402168|4175857|P2|COMPLETED|Long Term (LT)||64
1707495|NCT00402168|4175858|P1|COMPLETED|Long Term (LT)||70
1707496|NCT00402168|4175857|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
1707497|NCT00402168|4175858|P1|STARTED|Long Term (LT)||81
1707498|NCT00402168|4175857|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
1707499|NCT00402168|4175858|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
1707500|NCT00402168|4175857|P2|COMPLETED|Treatment (up to 12 Months)||86
1707501|NCT00402168|4175858|P1|COMPLETED|Treatment (up to 12 Months)||81
1707502|NCT00402168|4175857|P2|STARTED|Treatment (up to 12 Months)||88
1707503|NCT00402168|4175858|P1|STARTED|Treatment (up to 12 Months)||83
1707504|NCT00402168|4175857|P2|NOT COMPLETED|Randomized||1
1707505|NCT00402168|4175858|P1|NOT COMPLETED|Randomized||1
1707506|NCT00402168|4175857|P2|COMPLETED|Randomized||88
1707507|NCT00402168|4175858|P1|COMPLETED|Randomized||83
1707508|NCT00402168|4175857|P2|STARTED|Randomized||89
1707509|NCT00402168|4175858|P1|STARTED|Randomized||84
1707510|NCT00402103|4175915|P2|NOT COMPLETED|Overall Study||13
1707511|NCT00402103|4175916|P1|NOT COMPLETED|Overall Study||91
1707512|NCT00402103|4175915|P2|COMPLETED|Overall Study||73
1707513|NCT00402103|4175916|P1|COMPLETED|Overall Study||379
1707514|NCT00402103|4175915|P2|STARTED|Overall Study||86
1707515|NCT00402103|4175916|P1|STARTED|Overall Study||470
1707516|NCT00402051|4175932|P2|NOT COMPLETED|Overall Study||35
1707517|NCT00402051|4175933|P1|NOT COMPLETED|Overall Study||38
1707518|NCT00402051|4175932|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
1707519|NCT00402051|4175933|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
1707520|NCT00402051|4175932|P2|Received Treatment|Overall Study||65
1707521|NCT00402051|4175933|P1|Received Treatment|Overall Study||65
1707522|NCT00402051|4175932|P2|STARTED|Overall Study||67
1707523|NCT00402051|4175933|P1|STARTED|Overall Study||66
1707524|NCT00402025|4175950|P3|NOT COMPLETED|Overall Study||10
1707525|NCT00402025|4175951|P2|NOT COMPLETED|Overall Study||3
1707526|NCT00402025|4175952|P1|NOT COMPLETED|Overall Study||2
1707527|NCT00402025|4175950|P3|COMPLETED|Overall Study||0
1707528|NCT00402025|4175951|P2|COMPLETED|Overall Study||1
1707529|NCT00402025|4175952|P1|COMPLETED|Overall Study||1
1707530|NCT00402025|4175950|P3|STARTED|Overall Study||10
1707531|NCT00402025|4175951|P2|STARTED|Overall Study||4
1707532|NCT00402025|4175952|P1|STARTED|Overall Study||3
1707533|NCT00401973|4175978|P3|NOT COMPLETED|Overall Study||23
1707534|NCT00401973|4175979|P2|NOT COMPLETED|Overall Study||26
1707535|NCT00401973|4175980|P1|NOT COMPLETED|Overall Study||11
1707536|NCT00401973|4175978|P3|COMPLETED|Overall Study||50
1707537|NCT00401973|4175979|P2|COMPLETED|Overall Study||50
1707538|NCT00401973|4175980|P1|COMPLETED|Overall Study||39
1707539|NCT00401973|4175978|P3|STARTED|Overall Study||73
1707540|NCT00401973|4175979|P2|STARTED|Overall Study||76
1707541|NCT00401973|4175980|P1|STARTED|Overall Study||50
1707542|NCT00401960|4176019|P2|NOT COMPLETED|Overall Study||0
1707543|NCT00401960|4176020|P1|NOT COMPLETED|Overall Study||5
1707544|NCT00401960|4176019|P2|COMPLETED|Overall Study||1
1707545|NCT00401960|4176020|P1|COMPLETED|Overall Study||0
1707546|NCT00401960|4176019|P2|STARTED|Overall Study||1
1707547|NCT00401960|4176020|P1|STARTED|Overall Study||5
1707548|NCT00401882|4176030|P2|NOT COMPLETED|Overall Study||0
1707549|NCT00401882|4176031|P1|NOT COMPLETED|Overall Study||0
1707550|NCT00401882|4176030|P2|COMPLETED|Overall Study||5
1707551|NCT00401882|4176031|P1|COMPLETED|Overall Study||2
1707552|NCT00401882|4176030|P2|STARTED|Overall Study||5
1707553|NCT00401882|4176031|P1|STARTED|Overall Study||2
1707554|NCT00401843|4176050|P3|NOT COMPLETED|Overall Study||142
1707555|NCT00401843|4176051|P2|NOT COMPLETED|Overall Study||144
1707556|NCT00401843|4176052|P1|NOT COMPLETED|Overall Study||21
1707557|NCT00401843|4176050|P3|COMPLETED|Overall Study||0
1707558|NCT00401843|4176051|P2|COMPLETED|Overall Study||0
1707559|NCT00401843|4176052|P1|COMPLETED|Overall Study||0
1707560|NCT00401843|4176050|P3|Treated|Overall Study||139
1707561|NCT00401843|4176051|P2|Treated|Overall Study||142
1707562|NCT00401843|4176052|P1|Treated|Overall Study||21
1707563|NCT00401843|4176050|P3|STARTED|Overall Study||142
1707564|NCT00401843|4176051|P2|STARTED|Overall Study||144
1707565|NCT00401843|4176052|P1|STARTED|Overall Study||21
1707566|NCT00401830|4176070|P2|NOT COMPLETED|Overall Study||32
1707567|NCT00401830|4176071|P1|NOT COMPLETED|Overall Study||31
1707568|NCT00401830|4176070|P2|COMPLETED|Overall Study||46
1707569|NCT00401830|4176071|P1|COMPLETED|Overall Study||50
1707570|NCT00401830|4176070|P2|STARTED|Overall Study||78
1707571|NCT00401830|4176071|P1|STARTED|Overall Study||81
1707572|NCT00401817|4176103|P1|NOT COMPLETED|Overall Study||0
1707573|NCT00401817|4176103|P1|COMPLETED|Overall Study||11
1707574|NCT00401817|4176103|P1|STARTED|Overall Study||11
1707575|NCT00401778|4176113|P3|NOT COMPLETED|Overall Study||1
1707576|NCT00401778|4176114|P2|NOT COMPLETED|Overall Study||1
1707577|NCT00401778|4176115|P1|NOT COMPLETED|Overall Study||1
1707578|NCT00401778|4176113|P3|COMPLETED|Overall Study||10
1707579|NCT00401778|4176114|P2|COMPLETED|Overall Study||11
1707580|NCT00401778|4176115|P1|COMPLETED|Overall Study||9
1707581|NCT00401778|4176113|P3|STARTED|Overall Study||11
1707582|NCT00401778|4176114|P2|STARTED|Overall Study||12
1707583|NCT00401778|4176115|P1|STARTED|Overall Study||10
1707584|NCT00401752|4176129|P2|NOT COMPLETED|Overall Study||18
1707585|NCT00401752|4176130|P1|NOT COMPLETED|Overall Study||10
1707586|NCT00401752|4176129|P2|COMPLETED|Overall Study||94
1707587|NCT00401752|4176130|P1|COMPLETED|Overall Study||97
1707588|NCT00401752|4176129|P2|Patients Included in Per-Protocol Popula|Overall Study||99
1707589|NCT00401752|4176130|P1|Patients Included in Per-Protocol Popula|Overall Study||100
1707590|NCT00401752|4176129|P2|Patients Included in Safety Population|Overall Study||110
1707591|NCT00401752|4176130|P1|Patients Included in Safety Population|Overall Study||107
1707592|NCT00401752|4176129|P2|Patients Included in ITT Population|Overall Study||111
1707593|NCT00401752|4176130|P1|Patients Included in ITT Population|Overall Study||106
1707594|NCT00401752|4176129|P2|Number of Patients Received Treatment|Overall Study||111
1707595|NCT00401752|4176130|P1|Number of Patients Received Treatment|Overall Study||107
1707596|NCT00401752|4176129|P2|STARTED|Overall Study||112
1707597|NCT00401752|4176130|P1|STARTED|Overall Study||107
1707598|NCT00401726|4176148|P2|NOT COMPLETED|Overall Study||112
1707599|NCT00401726|4176149|P1|NOT COMPLETED|Overall Study||97
1707600|NCT00401726|4176148|P2|COMPLETED|Overall Study||156
1707601|NCT00401726|4176149|P1|COMPLETED|Overall Study||172
1707602|NCT00401726|4176148|P2|STARTED|Overall Study||268
1707603|NCT00401726|4176149|P1|STARTED|Overall Study||269
1707604|NCT00401622|4176171|P2|NOT COMPLETED|Overall Study||43
1707605|NCT00401622|4176172|P1|NOT COMPLETED|Overall Study||34
1707606|NCT00401622|4176171|P2|COMPLETED|Overall Study||117
1707607|NCT00401622|4176172|P1|COMPLETED|Overall Study||126
1707608|NCT00401622|4176171|P2|STARTED|Overall Study||160
1707609|NCT00401622|4176172|P1|STARTED|Overall Study||160
1707610|NCT00401544|4176184|P4|NOT COMPLETED|Overall Study||16
1707611|NCT00401544|4176185|P3|NOT COMPLETED|Overall Study||12
1707612|NCT00401544|4176186|P2|NOT COMPLETED|Overall Study||18
1707613|NCT00401544|4176187|P1|NOT COMPLETED|Overall Study||18
1707614|NCT00401544|4176184|P4|COMPLETED|Overall Study||44
1707615|NCT00401544|4176185|P3|COMPLETED|Overall Study||48
1707616|NCT00401544|4176186|P2|COMPLETED|Overall Study||44
1707617|NCT00401544|4176187|P1|COMPLETED|Overall Study||38
1707618|NCT00401544|4176184|P4|STARTED|Overall Study|Randomized and treated|60
1707619|NCT00401544|4176185|P3|STARTED|Overall Study|Randomized and treated|60
1707620|NCT00401544|4176186|P2|STARTED|Overall Study|Randomized and treated|62
1707621|NCT00401544|4176187|P1|STARTED|Overall Study|Randomized and treated|56
1707622|NCT00401531|4176227|P2|NOT COMPLETED|Overall Study||10
1707623|NCT00401531|4176228|P1|NOT COMPLETED|Overall Study||9
1707624|NCT00401531|4176227|P2|COMPLETED|Overall Study||196
1707625|NCT00401531|4176228|P1|COMPLETED|Overall Study||197
1707626|NCT00401531|4176227|P2|STARTED|Overall Study||206
1707627|NCT00401531|4176228|P1|STARTED|Overall Study||206
1707628|NCT00401414|4176247|P3|NOT COMPLETED|Overall Study||0
1707629|NCT00401414|4176248|P2|NOT COMPLETED|Overall Study||0
1707630|NCT00401414|4176249|P1|NOT COMPLETED|Overall Study||0
1707631|NCT00401414|4176247|P3|COMPLETED|Overall Study||79
1707632|NCT00401414|4176248|P2|COMPLETED|Overall Study||147
1707633|NCT00401414|4176249|P1|COMPLETED|Overall Study||118
1707634|NCT00401414|4176247|P3|STARTED|Overall Study||79
1707635|NCT00401414|4176248|P2|STARTED|Overall Study||147
1707636|NCT00401414|4176249|P1|STARTED|Overall Study||118
1707637|NCT00401401|4176273|P4|NOT COMPLETED|Overall Study||3
1707638|NCT00401401|4176274|P3|NOT COMPLETED|Overall Study||1
1707639|NCT00401401|4176275|P2|NOT COMPLETED|Overall Study||0
1707640|NCT00401401|4176276|P1|NOT COMPLETED|Overall Study||0
1707641|NCT00401401|4176273|P4|COMPLETED|Overall Study||9
1707642|NCT00401401|4176274|P3|COMPLETED|Overall Study||5
1707643|NCT00401401|4176275|P2|COMPLETED|Overall Study||6
1707644|NCT00401401|4176276|P1|COMPLETED|Overall Study||6
1707645|NCT00401401|4176273|P4|STARTED|Overall Study||12
1707646|NCT00401401|4176274|P3|STARTED|Overall Study||6
1707647|NCT00401401|4176275|P2|STARTED|Overall Study||6
1707648|NCT00401401|4176276|P1|STARTED|Overall Study||6
1707649|NCT00401258|4176298|P1|NOT COMPLETED|Overall Study||7
1707650|NCT00401258|4176298|P1|COMPLETED|Overall Study||8
1707651|NCT00401258|4176298|P1|STARTED|Overall Study||15
1707652|NCT00401245|4176313|P8|NOT COMPLETED|Double Blind Tapering Phase||7
1707653|NCT00401245|4176314|P7|NOT COMPLETED|Double Blind Tapering Phase||7
1707654|NCT00401245|4176315|P6|NOT COMPLETED|Double Blind Tapering Phase||4
1707655|NCT00401245|4176316|P5|NOT COMPLETED|Double Blind Tapering Phase||4
1707656|NCT00401245|4176317|P4|NOT COMPLETED|Double Blind Tapering Phase||0
1707657|NCT00401245|4176318|P3|NOT COMPLETED|Double Blind Tapering Phase||0
1707658|NCT00401245|4176319|P2|NOT COMPLETED|Double Blind Tapering Phase||0
1707659|NCT00401245|4176320|P1|NOT COMPLETED|Double Blind Tapering Phase||0
1707660|NCT00401245|4176313|P8|COMPLETED|Double Blind Tapering Phase||95
1707661|NCT00401245|4176314|P7|COMPLETED|Double Blind Tapering Phase||80
1707662|NCT00401245|4176315|P6|COMPLETED|Double Blind Tapering Phase||90
1707663|NCT00401245|4176316|P5|COMPLETED|Double Blind Tapering Phase||97
1707664|NCT00401245|4176317|P4|COMPLETED|Double Blind Tapering Phase||0
1707665|NCT00401245|4176318|P3|COMPLETED|Double Blind Tapering Phase||0
1707666|NCT00401245|4176319|P2|COMPLETED|Double Blind Tapering Phase||0
1707667|NCT00401245|4176320|P1|COMPLETED|Double Blind Tapering Phase||0
1707668|NCT00401245|4176313|P8|STARTED|Double Blind Tapering Phase||102
1707669|NCT00401245|4176314|P7|STARTED|Double Blind Tapering Phase||87
1707670|NCT00401245|4176315|P6|STARTED|Double Blind Tapering Phase||94
1707671|NCT00401245|4176316|P5|STARTED|Double Blind Tapering Phase||101
1707672|NCT00401245|4176317|P4|STARTED|Double Blind Tapering Phase||0
1707673|NCT00401245|4176318|P3|STARTED|Double Blind Tapering Phase||0
1707674|NCT00401245|4176319|P2|STARTED|Double Blind Tapering Phase||0
1707675|NCT00401245|4176320|P1|STARTED|Double Blind Tapering Phase||0
1707676|NCT00401245|4176313|P8|NOT COMPLETED|Open Label Phase||0
1707677|NCT00401245|4176314|P7|NOT COMPLETED|Open Label Phase||0
1707678|NCT00401245|4176315|P6|NOT COMPLETED|Open Label Phase||0
1707679|NCT00401245|4176316|P5|NOT COMPLETED|Open Label Phase||0
1707680|NCT00401245|4176317|P4|NOT COMPLETED|Open Label Phase||21
1707681|NCT00401245|4176318|P3|NOT COMPLETED|Open Label Phase||23
1707682|NCT00401245|4176319|P2|NOT COMPLETED|Open Label Phase||35
1707683|NCT00401245|4176320|P1|NOT COMPLETED|Open Label Phase||21
1707684|NCT00401245|4176313|P8|COMPLETED|Open Label Phase||0
1707685|NCT00401245|4176314|P7|COMPLETED|Open Label Phase||0
1707686|NCT00401245|4176315|P6|COMPLETED|Open Label Phase||0
1707687|NCT00401245|4176316|P5|COMPLETED|Open Label Phase||0
1707688|NCT00401245|4176317|P4|COMPLETED|Open Label Phase||84
1707689|NCT00401245|4176318|P3|COMPLETED|Open Label Phase||95
1707690|NCT00401245|4176319|P2|COMPLETED|Open Label Phase||81
1707691|NCT00401245|4176320|P1|COMPLETED|Open Label Phase||101
1707692|NCT00401245|4176313|P8|STARTED|Open Label Phase||0
1707693|NCT00401245|4176314|P7|STARTED|Open Label Phase||0
1707694|NCT00401245|4176315|P6|STARTED|Open Label Phase||0
1707695|NCT00401245|4176316|P5|STARTED|Open Label Phase||0
1707696|NCT00401245|4176317|P4|STARTED|Open Label Phase||105
1707697|NCT00401245|4176318|P3|STARTED|Open Label Phase||118
1707698|NCT00401245|4176319|P2|STARTED|Open Label Phase||116
1707699|NCT00401245|4176320|P1|STARTED|Open Label Phase||122
1707700|NCT00401245|4176313|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
1707701|NCT00401245|4176314|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
1707702|NCT00401245|4176315|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
1707703|NCT00401245|4176316|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
1707704|NCT00401245|4176317|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
1707705|NCT00401245|4176318|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
1707706|NCT00401245|4176319|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
1707707|NCT00401245|4176320|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
1707708|NCT00401245|4176313|P8|COMPLETED|Between Titration and Open Label Phase||0
1707709|NCT00401245|4176314|P7|COMPLETED|Between Titration and Open Label Phase||0
1707710|NCT00401245|4176315|P6|COMPLETED|Between Titration and Open Label Phase||0
1707711|NCT00401245|4176316|P5|COMPLETED|Between Titration and Open Label Phase||0
1707712|NCT00401245|4176317|P4|COMPLETED|Between Titration and Open Label Phase||105
1707713|NCT00401245|4176318|P3|COMPLETED|Between Titration and Open Label Phase||118
1707714|NCT00401245|4176319|P2|COMPLETED|Between Titration and Open Label Phase||116
1707715|NCT00401245|4176320|P1|COMPLETED|Between Titration and Open Label Phase||122
1707716|NCT00401245|4176313|P8|STARTED|Between Titration and Open Label Phase||0
1707717|NCT00401245|4176314|P7|STARTED|Between Titration and Open Label Phase||0
1707718|NCT00401245|4176315|P6|STARTED|Between Titration and Open Label Phase||0
1707719|NCT00401245|4176316|P5|STARTED|Between Titration and Open Label Phase||0
1707720|NCT00401245|4176317|P4|STARTED|Between Titration and Open Label Phase||107
1707721|NCT00401245|4176318|P3|STARTED|Between Titration and Open Label Phase||118
1707722|NCT00401245|4176319|P2|STARTED|Between Titration and Open Label Phase||118
1707723|NCT00401245|4176320|P1|STARTED|Between Titration and Open Label Phase||122
1707724|NCT00401245|4176313|P8|NOT COMPLETED|Double Blind Titration Phase||0
1707725|NCT00401245|4176314|P7|NOT COMPLETED|Double Blind Titration Phase||0
1707726|NCT00401245|4176315|P6|NOT COMPLETED|Double Blind Titration Phase||0
1707727|NCT00401245|4176316|P5|NOT COMPLETED|Double Blind Titration Phase||0
1707728|NCT00401245|4176317|P4|NOT COMPLETED|Double Blind Titration Phase||15
1707729|NCT00401245|4176318|P3|NOT COMPLETED|Double Blind Titration Phase||6
1707730|NCT00401245|4176319|P2|NOT COMPLETED|Double Blind Titration Phase||3
1707731|NCT00401245|4176320|P1|NOT COMPLETED|Double Blind Titration Phase||4
1707732|NCT00401245|4176313|P8|COMPLETED|Double Blind Titration Phase||0
1707733|NCT00401245|4176314|P7|COMPLETED|Double Blind Titration Phase||0
1707734|NCT00401245|4176315|P6|COMPLETED|Double Blind Titration Phase||0
1707735|NCT00401245|4176316|P5|COMPLETED|Double Blind Titration Phase||0
1707736|NCT00401245|4176317|P4|COMPLETED|Double Blind Titration Phase||107
1707737|NCT00401245|4176318|P3|COMPLETED|Double Blind Titration Phase||118
1707738|NCT00401245|4176319|P2|COMPLETED|Double Blind Titration Phase||118
1707739|NCT00401245|4176320|P1|COMPLETED|Double Blind Titration Phase||122
1707740|NCT00401245|4176313|P8|STARTED|Double Blind Titration Phase||0
1707741|NCT00401245|4176314|P7|STARTED|Double Blind Titration Phase||0
1707742|NCT00401245|4176315|P6|STARTED|Double Blind Titration Phase||0
1707743|NCT00401245|4176316|P5|STARTED|Double Blind Titration Phase||0
1707744|NCT00401245|4176317|P4|STARTED|Double Blind Titration Phase||122
1707745|NCT00401245|4176318|P3|STARTED|Double Blind Titration Phase||124
1707746|NCT00401245|4176319|P2|STARTED|Double Blind Titration Phase||121
1707747|NCT00401245|4176320|P1|STARTED|Double Blind Titration Phase||126
1707748|NCT00401193|4176388|P3|NOT COMPLETED|Overall Study||6
1707749|NCT00401193|4176389|P2|NOT COMPLETED|Overall Study||11
1707750|NCT00401193|4176390|P1|NOT COMPLETED|Overall Study||15
1707751|NCT00401193|4176388|P3|COMPLETED|Overall Study||63
1707752|NCT00401193|4176389|P2|COMPLETED|Overall Study||106
1707753|NCT00401193|4176390|P1|COMPLETED|Overall Study||103
1707754|NCT00401193|4176388|P3|Modified Intent to Treat Population|Overall Study||67
1707755|NCT00401193|4176389|P2|Modified Intent to Treat Population|Overall Study||115
1707756|NCT00401193|4176390|P1|Modified Intent to Treat Population|Overall Study||112
1707757|NCT00401193|4176388|P3|Intent to Treat Population|Overall Study||67
1707758|NCT00401193|4176389|P2|Intent to Treat Population|Overall Study||115
1707759|NCT00401193|4176390|P1|Intent to Treat Population|Overall Study||115
1707760|NCT00401193|4176388|P3|STARTED|Overall Study||69
1707761|NCT00401193|4176389|P2|STARTED|Overall Study||117
1707762|NCT00401193|4176390|P1|STARTED|Overall Study||118
1707763|NCT00401102|4176404|P1|NOT COMPLETED|Overall Study||7
1707764|NCT00401102|4176404|P1|COMPLETED|Overall Study||5
1707765|NCT00401102|4176404|P1|STARTED|Overall Study||12
1707766|NCT00400985|4176408|P1|NOT COMPLETED|Overall Study||52
1707767|NCT00400985|4176408|P1|COMPLETED|Overall Study||449
1707768|NCT00400985|4176408|P1|STARTED|Overall Study||501
1707769|NCT00400946|4176417|P5|NOT COMPLETED|Overall Study||38
1707770|NCT00400946|4176418|P4|NOT COMPLETED|Overall Study||47
1707771|NCT00400946|4176419|P3|NOT COMPLETED|Overall Study||2
1707772|NCT00400946|4176420|P2|NOT COMPLETED|Overall Study||11
1707773|NCT00400946|4176421|P1|NOT COMPLETED|Overall Study||14
1707774|NCT00400946|4176417|P5|COMPLETED|Overall Study||206
1707775|NCT00400946|4176418|P4|COMPLETED|Overall Study||4
1707776|NCT00400946|4176419|P3|COMPLETED|Overall Study||40
1707777|NCT00400946|4176420|P2|COMPLETED|Overall Study||221
1707778|NCT00400946|4176421|P1|COMPLETED|Overall Study||217
1707779|NCT00400946|4176417|P5|Eligible and Treated|Overall Study||243
1707780|NCT00400946|4176418|P4|Eligible and Treated|Overall Study||46
1707781|NCT00400946|4176419|P3|Eligible and Treated|Overall Study||42
1707782|NCT00400946|4176420|P2|Eligible and Treated|Overall Study||232
1707783|NCT00400946|4176421|P1|Eligible and Treated|Overall Study||231
1707784|NCT00400946|4176417|P5|Evaluable for Day 32 MRD|Overall Study||168
1707785|NCT00400946|4176418|P4|Evaluable for Day 32 MRD|Overall Study||12
1707786|NCT00400946|4176419|P3|Evaluable for Day 32 MRD|Overall Study||33
1707787|NCT00400946|4176420|P2|Evaluable for Day 32 MRD|Overall Study||167
1707788|NCT00400946|4176421|P1|Evaluable for Day 32 MRD|Overall Study||166
1707789|NCT00400946|4176417|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
1707790|NCT00400946|4176418|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
1707791|NCT00400946|4176419|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
1707792|NCT00400946|4176420|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
1707793|NCT00400946|4176421|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
1707794|NCT00400946|4176417|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
1707795|NCT00400946|4176418|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
1707796|NCT00400946|4176419|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
1707797|NCT00400946|4176420|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
1707798|NCT00400946|4176421|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
1707799|NCT00400946|4176417|P5|STARTED|Overall Study||244
1707800|NCT00400946|4176418|P4|STARTED|Overall Study||51
1707801|NCT00400946|4176419|P3|STARTED|Overall Study||42
1707802|NCT00400946|4176420|P2|STARTED|Overall Study||232
1707803|NCT00400946|4176421|P1|STARTED|Overall Study||231
1707804|NCT00400881|4176449|P2|NOT COMPLETED|Overall Study||0
1707805|NCT00400881|4176450|P1|NOT COMPLETED|Overall Study||0
1707806|NCT00400881|4176449|P2|COMPLETED|Overall Study||60
1707807|NCT00400881|4176450|P1|COMPLETED|Overall Study||62
1707808|NCT00400881|4176449|P2|STARTED|Overall Study||60
1707809|NCT00400881|4176450|P1|STARTED|Overall Study||62
1707810|NCT00400829|4176458|P1|NOT COMPLETED|Overall Study||0
1707811|NCT00400829|4176458|P1|COMPLETED|Overall Study||66
1707812|NCT00400829|4176458|P1|STARTED|Overall Study||66
1707813|NCT00400803|4176464|P1|NOT COMPLETED|Overall Study||0
1707814|NCT00400803|4176464|P1|COMPLETED|Overall Study||35
1707815|NCT00400803|4176464|P1|STARTED|Overall Study||35
1707816|NCT00400764|4176480|P5|NOT COMPLETED|Phase II||11
1707817|NCT00400764|4176481|P4|NOT COMPLETED|Phase II||26
1707818|NCT00400764|4176482|P3|NOT COMPLETED|Phase II||23
1707819|NCT00400764|4176483|P2|NOT COMPLETED|Phase II||0
1707820|NCT00400764|4176484|P1|NOT COMPLETED|Phase II||0
1707821|NCT00400764|4176480|P5|COMPLETED|Phase II||0
1707822|NCT00400764|4176481|P4|COMPLETED|Phase II||0
1707823|NCT00400764|4176482|P3|COMPLETED|Phase II||0
1707824|NCT00400764|4176483|P2|COMPLETED|Phase II||0
1707825|NCT00400764|4176484|P1|COMPLETED|Phase II||0
1707826|NCT00400764|4176480|P5|Treated|Phase II||11
1707827|NCT00400764|4176481|P4|Treated|Phase II||26
1707828|NCT00400764|4176482|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
1707829|NCT00400764|4176483|P2|Treated|Phase II||0
1707830|NCT00400764|4176484|P1|Treated|Phase II||0
1707831|NCT00400764|4176480|P5|STARTED|Phase II||11
1707832|NCT00400764|4176481|P4|STARTED|Phase II||26
1707833|NCT00400764|4176482|P3|STARTED|Phase II||23
1707834|NCT00400764|4176483|P2|STARTED|Phase II||0
1707835|NCT00400764|4176484|P1|STARTED|Phase II||0
1707836|NCT00400764|4176480|P5|NOT COMPLETED|Phase Ib||0
1707837|NCT00400764|4176481|P4|NOT COMPLETED|Phase Ib||0
1707838|NCT00400764|4176482|P3|NOT COMPLETED|Phase Ib||0
1707839|NCT00400764|4176483|P2|NOT COMPLETED|Phase Ib||4
1707840|NCT00400764|4176484|P1|NOT COMPLETED|Phase Ib||6
1707841|NCT00400764|4176480|P5|COMPLETED|Phase Ib||0
1707842|NCT00400764|4176481|P4|COMPLETED|Phase Ib||0
1707843|NCT00400764|4176482|P3|COMPLETED|Phase Ib||0
1707844|NCT00400764|4176483|P2|COMPLETED|Phase Ib||2
1707845|NCT00400764|4176484|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
1707846|NCT00400764|4176480|P5|Treated|Phase Ib||0
1707847|NCT00400764|4176481|P4|Treated|Phase Ib||0
1707848|NCT00400764|4176482|P3|Treated|Phase Ib||0
1707849|NCT00400764|4176483|P2|Treated|Phase Ib||6
1707850|NCT00400764|4176484|P1|Treated|Phase Ib||6
1707851|NCT00400764|4176480|P5|STARTED|Phase Ib||0
1707852|NCT00400764|4176481|P4|STARTED|Phase Ib||0
1707853|NCT00400764|4176482|P3|STARTED|Phase Ib||0
1707854|NCT00400764|4176483|P2|STARTED|Phase Ib||6
1707855|NCT00400764|4176484|P1|STARTED|Phase Ib||6
1707856|NCT00400712|4176537|P2|NOT COMPLETED|Overall Study||16
1707857|NCT00400712|4176538|P1|NOT COMPLETED|Overall Study||17
1707858|NCT00400712|4176537|P2|COMPLETED|Overall Study||35
1707859|NCT00400712|4176538|P1|COMPLETED|Overall Study||35
1707860|NCT00400712|4176537|P2|STARTED|Overall Study||51
1707861|NCT00400712|4176538|P1|STARTED|Overall Study||52
1707862|NCT00400686|4176556|P1|NOT COMPLETED|Overall Study||0
1707863|NCT00400686|4176556|P1|COMPLETED|Overall Study||31
1707864|NCT00400686|4176556|P1|STARTED|Overall Study||31
1707865|NCT00400634|4176564|P2|NOT COMPLETED|Overall Study||1
1707866|NCT00400634|4176565|P1|NOT COMPLETED|Overall Study||4
1707867|NCT00400634|4176564|P2|COMPLETED|Overall Study||19
1707868|NCT00400634|4176565|P1|COMPLETED|Overall Study||34
1707869|NCT00400634|4176564|P2|STARTED|Overall Study||20
1707870|NCT00400634|4176565|P1|STARTED|Overall Study||38
1707871|NCT00400569|4176573|P1|NOT COMPLETED|Overall Study||1
1707872|NCT00400569|4176573|P1|COMPLETED|Overall Study||47
1707873|NCT00400569|4176573|P1|STARTED|Overall Study||48
1707874|NCT00400517|4176584|P1|NOT COMPLETED|Overall Study||2
1707875|NCT00400517|4176584|P1|COMPLETED|Overall Study||26
1707876|NCT00400517|4176584|P1|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
1707877|NCT00400400|4176593|P2|NOT COMPLETED|Overall Study||15
1707878|NCT00400400|4176594|P1|NOT COMPLETED|Overall Study||14
1707879|NCT00400400|4176593|P2|COMPLETED|Overall Study||185
1707880|NCT00400400|4176594|P1|COMPLETED|Overall Study||186
1707881|NCT00400400|4176593|P2|Intent-to-Treat Population|Overall Study||197
1707882|NCT00400400|4176594|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
1707883|NCT00400400|4176593|P2|STARTED|Overall Study||200
1707884|NCT00400400|4176594|P1|STARTED|Overall Study||200
1707885|NCT00400205|4176612|P1|NOT COMPLETED|Overall Study||5
1707886|NCT00400205|4176612|P1|COMPLETED|Overall Study||9
1707887|NCT00400205|4176612|P1|STARTED|Overall Study||14
1707888|NCT00400179|4176619|P2|NOT COMPLETED|Overall Study||18
1707889|NCT00400179|4176620|P1|NOT COMPLETED|Overall Study||6
1707890|NCT00400179|4176619|P2|COMPLETED|Overall Study||508
1707891|NCT00400179|4176620|P1|COMPLETED|Overall Study|Received Treatment|521
1707892|NCT00400179|4176619|P2|STARTED|Overall Study||526
1707893|NCT00400179|4176620|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
1707894|NCT00400153|4176637|P3|NOT COMPLETED|Overall Study||61
1707895|NCT00400153|4176638|P2|NOT COMPLETED|Overall Study||55
1707896|NCT00400153|4176639|P1|NOT COMPLETED|Overall Study||48
1707897|NCT00400153|4176637|P3|COMPLETED|Overall Study||422
1707898|NCT00400153|4176638|P2|COMPLETED|Overall Study||436
1707899|NCT00400153|4176639|P1|COMPLETED|Overall Study||438
1707900|NCT00400153|4176637|P3|STARTED|Overall Study||483
1707901|NCT00400153|4176638|P2|STARTED|Overall Study||491
1707902|NCT00400153|4176639|P1|STARTED|Overall Study||486
1707903|NCT00399893|4176886|P2|NOT COMPLETED|Overall Study||0
1707904|NCT00399893|4176887|P1|NOT COMPLETED|Overall Study||1
1707905|NCT00399893|4176886|P2|COMPLETED|Overall Study||3
1707906|NCT00399893|4176887|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
1707907|NCT00399893|4176886|P2|STARTED|Overall Study||3
1707908|NCT00399893|4176887|P1|STARTED|Overall Study||2
1707909|NCT00399880|4176915|P2|NOT COMPLETED|Overall Study||0
1707910|NCT00399880|4176916|P1|NOT COMPLETED|Overall Study||0
1707911|NCT00399880|4176915|P2|COMPLETED|Overall Study||65
1707912|NCT00399880|4176916|P1|COMPLETED|Overall Study||65
1707913|NCT00399880|4176915|P2|STARTED|Overall Study||65
1707914|NCT00399880|4176916|P1|STARTED|Overall Study||65
1707915|NCT00399802|4176926|P2|NOT COMPLETED|Overall Study||3
1707916|NCT00399802|4176927|P1|NOT COMPLETED|Overall Study||0
1707917|NCT00399802|4176926|P2|COMPLETED|Overall Study||26
1707918|NCT00399802|4176927|P1|COMPLETED|Overall Study||14
1707919|NCT00399802|4176926|P2|STARTED|Overall Study||29
1707920|NCT00399802|4176927|P1|STARTED|Overall Study||14
1707921|NCT00399763|4176941|P2|NOT COMPLETED|Overall Study||3
1707922|NCT00399763|4176942|P1|NOT COMPLETED|Overall Study||2
1707923|NCT00399763|4176941|P2|COMPLETED|Overall Study||32
1707924|NCT00399763|4176942|P1|COMPLETED|Overall Study||33
1707925|NCT00399763|4176941|P2|STARTED|Overall Study||35
1707926|NCT00399763|4176942|P1|STARTED|Overall Study||35
1707927|NCT00399568|4176954|P2|NOT COMPLETED|Overall Study||9
1707928|NCT00399568|4176955|P1|NOT COMPLETED|Overall Study||12
1707929|NCT00399568|4176954|P2|COMPLETED|Overall Study||156
1707930|NCT00399568|4176955|P1|COMPLETED|Overall Study||154
1707931|NCT00399568|4176954|P2|STARTED|Overall Study||165
1707932|NCT00399568|4176955|P1|STARTED|Overall Study||166
1707933|NCT00399542|4176969|P2|NOT COMPLETED|Overall Study||43
1707934|NCT00399542|4176970|P1|NOT COMPLETED|Overall Study||84
1707935|NCT00399542|4176969|P2|COMPLETED|Overall Study||151
1707936|NCT00399542|4176970|P1|COMPLETED|Overall Study||303
1707937|NCT00399542|4176969|P2|STARTED|Overall Study||194
1707938|NCT00399542|4176970|P1|STARTED|Overall Study||387
1707939|NCT00399516|4177032|P1|NOT COMPLETED|Overall Study||2
1707940|NCT00399516|4177032|P1|COMPLETED|Overall Study||19
1707941|NCT00399516|4177032|P1|STARTED|Overall Study||21
1707942|NCT00399360|4177040|P4|NOT COMPLETED|Overall Study||6
1707943|NCT00399360|4177041|P3|NOT COMPLETED|Overall Study||3
1707944|NCT00399360|4177042|P2|NOT COMPLETED|Overall Study||3
1707945|NCT00399360|4177043|P1|NOT COMPLETED|Overall Study||2
1707946|NCT00399360|4177040|P4|COMPLETED|Overall Study||9
1707947|NCT00399360|4177041|P3|COMPLETED|Overall Study||10
1707948|NCT00399360|4177042|P2|COMPLETED|Overall Study||8
1707949|NCT00399360|4177043|P1|COMPLETED|Overall Study||9
1707950|NCT00399360|4177040|P4|STARTED|Overall Study||15
1707951|NCT00399360|4177041|P3|STARTED|Overall Study||13
1707952|NCT00399360|4177042|P2|STARTED|Overall Study||11
1707953|NCT00399360|4177043|P1|STARTED|Overall Study||11
1707954|NCT00399308|4177092|P3|NOT COMPLETED|Overall Study||1
1707955|NCT00399308|4177093|P2|NOT COMPLETED|Overall Study||0
1707956|NCT00399308|4177094|P1|NOT COMPLETED|Overall Study||0
1707957|NCT00399308|4177092|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
1707958|NCT00399308|4177093|P2|COMPLETED|Overall Study||15
1707959|NCT00399308|4177094|P1|COMPLETED|Overall Study||13
1707960|NCT00399308|4177092|P3|STARTED|Overall Study||12
1707961|NCT00399308|4177093|P2|STARTED|Overall Study||15
1707962|NCT00399308|4177094|P1|STARTED|Overall Study||13
1707963|NCT00399035|4177114|P3|NOT COMPLETED|Overall Study||252
1707964|NCT00399035|4177115|P2|NOT COMPLETED|Overall Study||158
1707965|NCT00399035|4177116|P1|NOT COMPLETED|Overall Study||313
1707966|NCT00399035|4177114|P3|COMPLETED|Overall Study||106
1707967|NCT00399035|4177115|P2|COMPLETED|Overall Study||58
1707968|NCT00399035|4177116|P1|COMPLETED|Overall Study||189
1707969|NCT00399035|4177114|P3|STARTED|Overall Study||358
1707970|NCT00399035|4177115|P2|STARTED|Overall Study||216
1707971|NCT00399035|4177116|P1|STARTED|Overall Study||502
1707972|NCT00398983|4177137|P2|NOT COMPLETED|Overall Study||0
1707973|NCT00398983|4177138|P1|NOT COMPLETED|Overall Study||0
1707974|NCT00398983|4177137|P2|COMPLETED|Overall Study||25
1707975|NCT00398983|4177138|P1|COMPLETED|Overall Study||20
1707976|NCT00398983|4177137|P2|STARTED|Overall Study||25
1707977|NCT00398983|4177138|P1|STARTED|Overall Study||20
1707978|NCT00398918|4177144|P1|NOT COMPLETED|Overall Study||0
1707979|NCT00398918|4177144|P1|COMPLETED|Overall Study||10
1707980|NCT00398918|4177144|P1|STARTED|Overall Study||10
1707981|NCT00398866|4177152|P3|NOT COMPLETED|Overall Study||8
1707982|NCT00398866|4177153|P2|NOT COMPLETED|Overall Study||8
1707983|NCT00398866|4177154|P1|NOT COMPLETED|Overall Study||14
1707984|NCT00398866|4177152|P3|COMPLETED|Overall Study||58
1707985|NCT00398866|4177153|P2|COMPLETED|Overall Study||60
1707986|NCT00398866|4177154|P1|COMPLETED|Overall Study||52
1707987|NCT00398866|4177152|P3|STARTED|Overall Study||66
1707988|NCT00398866|4177153|P2|STARTED|Overall Study||68
1707989|NCT00398866|4177154|P1|STARTED|Overall Study||66
1707990|NCT00398632|4177165|P1|NOT COMPLETED|Overall Study||2
1707991|NCT00398632|4177165|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
1707992|NCT00398632|4177165|P1|STARTED|Overall Study||6
1707993|NCT00398567|4177173|P3|NOT COMPLETED|Overall Study||34
1707994|NCT00398567|4177174|P2|NOT COMPLETED|Overall Study||4
1707995|NCT00398567|4177175|P1|NOT COMPLETED|Overall Study||4
1707996|NCT00398567|4177173|P3|COMPLETED|Overall Study||3
1707997|NCT00398567|4177174|P2|COMPLETED|Overall Study||0
1707998|NCT00398567|4177175|P1|COMPLETED|Overall Study||0
1707999|NCT00398567|4177173|P3|STARTED|Overall Study||37
1708000|NCT00398567|4177174|P2|STARTED|Overall Study||4
1708001|NCT00398567|4177175|P1|STARTED|Overall Study||4
1708002|NCT00398476|4177187|P2|NOT COMPLETED|Treatment Period 2||0
1708003|NCT00398476|4177188|P1|NOT COMPLETED|Treatment Period 2||0
1708004|NCT00398476|4177187|P2|COMPLETED|Treatment Period 2||64
1708005|NCT00398476|4177188|P1|COMPLETED|Treatment Period 2||63
1708006|NCT00398476|4177187|P2|STARTED|Treatment Period 2||64
1708007|NCT00398476|4177188|P1|STARTED|Treatment Period 2||63
1708008|NCT00398476|4177187|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
1708009|NCT00398476|4177188|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
1708010|NCT00398476|4177187|P2|COMPLETED|Washout Period (20 Minutes)||64
1708011|NCT00398476|4177188|P1|COMPLETED|Washout Period (20 Minutes)||63
1708012|NCT00398476|4177187|P2|STARTED|Washout Period (20 Minutes)||64
1708013|NCT00398476|4177188|P1|STARTED|Washout Period (20 Minutes)||63
1708014|NCT00398476|4177187|P2|NOT COMPLETED|Treatment Period 1||0
1708015|NCT00398476|4177188|P1|NOT COMPLETED|Treatment Period 1||0
1708016|NCT00398476|4177187|P2|COMPLETED|Treatment Period 1||64
1708017|NCT00398476|4177188|P1|COMPLETED|Treatment Period 1||63
1708018|NCT00398476|4177187|P2|STARTED|Treatment Period 1||64
1708019|NCT00398476|4177188|P1|STARTED|Treatment Period 1||63
1708020|NCT00398411|4177229|P2|NOT COMPLETED|Overall Study||1
1708021|NCT00398411|4177230|P1|NOT COMPLETED|Overall Study||0
1708022|NCT00398411|4177229|P2|COMPLETED|Overall Study||31
1708023|NCT00398411|4177230|P1|COMPLETED|Overall Study||34
1708024|NCT00398411|4177229|P2|STARTED|Overall Study||32
1708025|NCT00398411|4177230|P1|STARTED|Overall Study||34
1708026|NCT00398398|4177246|P1|NOT COMPLETED|Overall Study||0
1708027|NCT00398398|4177246|P1|COMPLETED|Overall Study||44
1708028|NCT00398398|4177246|P1|STARTED|Overall Study||44
1708029|NCT00398320|4177253|P1|NOT COMPLETED|Overall Study||6
1708030|NCT00398320|4177253|P1|COMPLETED|Overall Study||34
1708031|NCT00398320|4177253|P1|STARTED|Overall Study||40
1708032|NCT00398216|4177266|P5|NOT COMPLETED|Overall Study||15
1708033|NCT00398216|4177267|P4|NOT COMPLETED|Overall Study||22
1708034|NCT00398216|4177268|P3|NOT COMPLETED|Overall Study||21
1708035|NCT00398216|4177269|P2|NOT COMPLETED|Overall Study||19
1708036|NCT00398216|4177270|P1|NOT COMPLETED|Overall Study||11
1708037|NCT00398216|4177266|P5|COMPLETED|Overall Study||157
1708038|NCT00398216|4177267|P4|COMPLETED|Overall Study||155
1708039|NCT00398216|4177268|P3|COMPLETED|Overall Study||164
1708040|NCT00398216|4177269|P2|COMPLETED|Overall Study||151
1708041|NCT00398216|4177270|P1|COMPLETED|Overall Study||181
1708042|NCT00398216|4177266|P5|STARTED|Overall Study||172
1708043|NCT00398216|4177267|P4|STARTED|Overall Study||177
1708044|NCT00398216|4177268|P3|STARTED|Overall Study||185
1708045|NCT00398216|4177269|P2|STARTED|Overall Study||170
1708046|NCT00398216|4177270|P1|STARTED|Overall Study||192
1708047|NCT00398138|4177297|P1|NOT COMPLETED|Overall Study||2
1708048|NCT00398138|4177297|P1|COMPLETED|Overall Study||10
1708049|NCT00398138|4177297|P1|STARTED|Overall Study||12
1708050|NCT00398112|4177302|P1|NOT COMPLETED|Overall Study||18
1708051|NCT00398112|4177302|P1|COMPLETED|Overall Study||0
1708052|NCT00398112|4177302|P1|STARTED|Overall Study||18
1708053|NCT00398086|4177313|P3|NOT COMPLETED|Overall Study||2
1708054|NCT00398086|4177314|P2|NOT COMPLETED|Overall Study||23
1708055|NCT00398086|4177315|P1|NOT COMPLETED|Overall Study||9
1708056|NCT00398086|4177313|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
1708057|NCT00398086|4177314|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
1708058|NCT00398086|4177315|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
1708059|NCT00398086|4177313|P3|Phase 1, Dose Escalation Population|Overall Study||3
1708060|NCT00398086|4177314|P2|Phase 1, Dose Escalation Population|Overall Study||7
1708061|NCT00398086|4177315|P1|Phase 1, Dose Escalation Population|Overall Study||20
1708062|NCT00398086|4177313|P3|STARTED|Overall Study||3
1708063|NCT00398086|4177314|P2|STARTED|Overall Study||44
1708064|NCT00398086|4177315|P1|STARTED|Overall Study||20
1708065|NCT00398073|4177349|P2|NOT COMPLETED|Overall Study||0
1708066|NCT00398073|4177350|P1|NOT COMPLETED|Overall Study||1
1708067|NCT00398073|4177349|P2|COMPLETED|Overall Study||17
1708068|NCT00398073|4177350|P1|COMPLETED|Overall Study||17
1708069|NCT00398073|4177349|P2|STARTED|Overall Study||17
1708070|NCT00398073|4177350|P1|STARTED|Overall Study||18
1708071|NCT00398047|4177360|P1|NOT COMPLETED|Overall Study||3
1708072|NCT00398047|4177360|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
1708073|NCT00398047|4177360|P1|STARTED|Overall Study||3
1708074|NCT00397982|4177370|P1|NOT COMPLETED|Overall Study||4
1708075|NCT00397982|4177370|P1|COMPLETED|Overall Study||13
1708076|NCT00397982|4177370|P1|STARTED|Overall Study||17
1708077|NCT00397943|4177384|P5|NOT COMPLETED|Overall Study||0
1708078|NCT00397943|4177385|P4|NOT COMPLETED|Overall Study||0
1708079|NCT00397943|4177386|P3|NOT COMPLETED|Overall Study||0
1708080|NCT00397943|4177387|P2|NOT COMPLETED|Overall Study||9
1708081|NCT00397943|4177388|P1|NOT COMPLETED|Overall Study||12
1708082|NCT00397943|4177384|P5|COMPLETED|Overall Study||10
1708083|NCT00397943|4177385|P4|COMPLETED|Overall Study||10
1708084|NCT00397943|4177386|P3|COMPLETED|Overall Study||10
1708085|NCT00397943|4177387|P2|COMPLETED|Overall Study||31
1708086|NCT00397943|4177388|P1|COMPLETED|Overall Study||28
1708087|NCT00397943|4177384|P5|STARTED|Overall Study||10
1708088|NCT00397943|4177385|P4|STARTED|Overall Study||10
1708089|NCT00397943|4177386|P3|STARTED|Overall Study||10
1708090|NCT00397943|4177387|P2|STARTED|Overall Study||40
1708091|NCT00397943|4177388|P1|STARTED|Overall Study||40
1708092|NCT00397930|4177544|P2|NOT COMPLETED|Overall Study||51
1708093|NCT00397930|4177545|P1|NOT COMPLETED|Overall Study||38
1708094|NCT00397930|4177544|P2|COMPLETED|Overall Study||153
1708095|NCT00397930|4177545|P1|COMPLETED|Overall Study||168
1708096|NCT00397930|4177544|P2|STARTED|Overall Study||204
1708097|NCT00397930|4177545|P1|STARTED|Overall Study||206
1708098|NCT00397904|4177551|P1|NOT COMPLETED|Overall Study||0
1708099|NCT00397904|4177551|P1|COMPLETED|Overall Study||16
1708100|NCT00397904|4177551|P1|STARTED|Overall Study||16
1708101|NCT00397891|4177560|P5|NOT COMPLETED|Overall Study||1
1708102|NCT00397891|4177561|P4|NOT COMPLETED|Overall Study||0
1708103|NCT00397891|4177562|P3|NOT COMPLETED|Overall Study||0
1708104|NCT00397891|4177563|P2|NOT COMPLETED|Overall Study||0
1708105|NCT00397891|4177564|P1|NOT COMPLETED|Overall Study||1
1708106|NCT00397891|4177560|P5|COMPLETED|Overall Study||7
1708107|NCT00397891|4177561|P4|COMPLETED|Overall Study||6
1708108|NCT00397891|4177562|P3|COMPLETED|Overall Study||6
1708109|NCT00397891|4177563|P2|COMPLETED|Overall Study||6
1708110|NCT00397891|4177564|P1|COMPLETED|Overall Study||5
1708111|NCT00397891|4177560|P5|STARTED|Overall Study||8
1708112|NCT00397891|4177561|P4|STARTED|Overall Study||6
1708113|NCT00397891|4177562|P3|STARTED|Overall Study||6
1708114|NCT00397891|4177563|P2|STARTED|Overall Study||6
1708115|NCT00397891|4177564|P1|STARTED|Overall Study||6
1708116|NCT00397878|4177662|P1|NOT COMPLETED|Overall Study||0
1708117|NCT00397878|4177662|P1|COMPLETED|Overall Study||10
1708118|NCT00397878|4177662|P1|STARTED|Overall Study||10
1708119|NCT00397839|4177668|P2|NOT COMPLETED|Overall Study||18
1708120|NCT00397839|4177669|P1|NOT COMPLETED|Overall Study||7
1708121|NCT00397839|4177668|P2|COMPLETED|Overall Study||69
1708122|NCT00397839|4177669|P1|COMPLETED|Overall Study||41
1708123|NCT00397839|4177668|P2|STARTED|Overall Study||87
1708124|NCT00397839|4177669|P1|STARTED|Overall Study||48
1708125|NCT00397813|4177689|P6|NOT COMPLETED|Overall Study||0
1708126|NCT00397813|4177690|P5|NOT COMPLETED|Overall Study||0
1708127|NCT00397813|4177691|P4|NOT COMPLETED|Overall Study||0
1708128|NCT00397813|4177692|P3|NOT COMPLETED|Overall Study||0
1708129|NCT00397813|4177693|P2|NOT COMPLETED|Overall Study||0
1708130|NCT00397813|4177694|P1|NOT COMPLETED|Overall Study||0
1708131|NCT00397813|4177689|P6|COMPLETED|Overall Study||24
1708132|NCT00397813|4177690|P5|COMPLETED|Overall Study||5
1708133|NCT00397813|4177691|P4|COMPLETED|Overall Study||12
1708134|NCT00397813|4177692|P3|COMPLETED|Overall Study||0
1708135|NCT00397813|4177693|P2|COMPLETED|Overall Study||0
1708136|NCT00397813|4177694|P1|COMPLETED|Overall Study||36
1708137|NCT00397813|4177689|P6|STARTED|Overall Study||24
1708138|NCT00397813|4177690|P5|STARTED|Overall Study||5
1708139|NCT00397813|4177691|P4|STARTED|Overall Study||12
1708140|NCT00397813|4177692|P3|STARTED|Overall Study||0
1708141|NCT00397813|4177693|P2|STARTED|Overall Study||0
1708142|NCT00397813|4177694|P1|STARTED|Overall Study||36
1708143|NCT00397631|4177734|P2|NOT COMPLETED|Overall Study||44
1708144|NCT00397631|4177735|P1|NOT COMPLETED|Overall Study||30
1708145|NCT00397631|4177734|P2|COMPLETED|Overall Study||215
1708146|NCT00397631|4177735|P1|COMPLETED|Overall Study||231
1708147|NCT00397631|4177734|P2|STARTED|Overall Study||259
1708148|NCT00397631|4177735|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
1708149|NCT00397540|4177747|P2|NOT COMPLETED|Overall Study||0
1708150|NCT00397540|4177748|P1|NOT COMPLETED|Overall Study||1
1708151|NCT00397540|4177747|P2|COMPLETED|Overall Study||85
1708152|NCT00397540|4177748|P1|COMPLETED|Overall Study||59
1708153|NCT00397540|4177747|P2|STARTED|Overall Study||85
1708154|NCT00397540|4177748|P1|STARTED|Overall Study||60
1708155|NCT00397514|4177754|P1|NOT COMPLETED|Overall Study||9
1708156|NCT00397514|4177754|P1|COMPLETED|Overall Study||25
1708157|NCT00397514|4177754|P1|STARTED|Overall Study||34
1708158|NCT00397488|4177764|P1|NOT COMPLETED|Overall Study||7
1708159|NCT00397488|4177764|P1|COMPLETED|Overall Study||71
1708160|NCT00397488|4177764|P1|STARTED|Overall Study||78
1708161|NCT00397462|4177771|P3|NOT COMPLETED|Overall Study||0
1708162|NCT00397462|4177772|P2|NOT COMPLETED|Overall Study||0
1708163|NCT00397462|4177773|P1|NOT COMPLETED|Overall Study||0
1708164|NCT00397462|4177771|P3|COMPLETED|Overall Study||15
1708165|NCT00397462|4177772|P2|COMPLETED|Overall Study||13
1708166|NCT00397462|4177773|P1|COMPLETED|Overall Study||16
1708167|NCT00397462|4177771|P3|STARTED|Overall Study||15
1708168|NCT00397462|4177772|P2|STARTED|Overall Study||13
1708169|NCT00397462|4177773|P1|STARTED|Overall Study||16
1708170|NCT00397254|4177784|P2|NOT COMPLETED|Overall Study||2
1708171|NCT00397254|4177785|P1|NOT COMPLETED|Overall Study||2
1708172|NCT00397254|4177784|P2|COMPLETED|Overall Study||74
1708173|NCT00397254|4177785|P1|COMPLETED|Overall Study||77
1708174|NCT00397254|4177784|P2|STARTED|Overall Study||76
1708175|NCT00397254|4177785|P1|STARTED|Overall Study||79
1708176|NCT00397215|4177807|P4|NOT COMPLETED|Month 24 (Day 720)||0
1708177|NCT00397215|4177808|P3|NOT COMPLETED|Month 24 (Day 720)||0
1708178|NCT00397215|4177809|P2|NOT COMPLETED|Month 24 (Day 720)||0
1708179|NCT00397215|4177810|P1|NOT COMPLETED|Month 24 (Day 720)||0
1708180|NCT00397215|4177807|P4|COMPLETED|Month 24 (Day 720)||36
1708181|NCT00397215|4177808|P3|COMPLETED|Month 24 (Day 720)||117
1708182|NCT00397215|4177809|P2|COMPLETED|Month 24 (Day 720)||45
1708183|NCT00397215|4177810|P1|COMPLETED|Month 24 (Day 720)||122
1708184|NCT00397215|4177807|P4|STARTED|Month 24 (Day 720)||36
1708185|NCT00397215|4177808|P3|STARTED|Month 24 (Day 720)||117
1708186|NCT00397215|4177809|P2|STARTED|Month 24 (Day 720)||45
1708187|NCT00397215|4177810|P1|STARTED|Month 24 (Day 720)||122
1708188|NCT00397215|4177807|P4|NOT COMPLETED|Month 12 (Day 360)||0
1708189|NCT00397215|4177808|P3|NOT COMPLETED|Month 12 (Day 360)||0
1708190|NCT00397215|4177809|P2|NOT COMPLETED|Month 12 (Day 360)||0
1708191|NCT00397215|4177810|P1|NOT COMPLETED|Month 12 (Day 360)||0
1708192|NCT00397215|4177807|P4|COMPLETED|Month 12 (Day 360)||42
1708193|NCT00397215|4177808|P3|COMPLETED|Month 12 (Day 360)||125
1708194|NCT00397215|4177809|P2|COMPLETED|Month 12 (Day 360)||48
1708195|NCT00397215|4177810|P1|COMPLETED|Month 12 (Day 360)||130
1708196|NCT00397215|4177807|P4|STARTED|Month 12 (Day 360)||42
1708197|NCT00397215|4177808|P3|STARTED|Month 12 (Day 360)||125
1708198|NCT00397215|4177809|P2|STARTED|Month 12 (Day 360)||48
1708199|NCT00397215|4177810|P1|STARTED|Month 12 (Day 360)||130
1708200|NCT00397215|4177807|P4|NOT COMPLETED|Month 6 (Day 180)||0
1708201|NCT00397215|4177808|P3|NOT COMPLETED|Month 6 (Day 180)||5
1708202|NCT00397215|4177809|P2|NOT COMPLETED|Month 6 (Day 180)||3
1708203|NCT00397215|4177810|P1|NOT COMPLETED|Month 6 (Day 180)||2
1708204|NCT00397215|4177807|P4|COMPLETED|Month 6 (Day 180)||51
1708205|NCT00397215|4177808|P3|COMPLETED|Month 6 (Day 180)||153
1708206|NCT00397215|4177809|P2|COMPLETED|Month 6 (Day 180)||55
1708207|NCT00397215|4177810|P1|COMPLETED|Month 6 (Day 180)||162
1708208|NCT00397215|4177807|P4|STARTED|Month 6 (Day 180)||51
1708209|NCT00397215|4177808|P3|STARTED|Month 6 (Day 180)||158
1708210|NCT00397215|4177809|P2|STARTED|Month 6 (Day 180)||58
1708211|NCT00397215|4177810|P1|STARTED|Month 6 (Day 180)||164
1708212|NCT00397215|4177807|P4|NOT COMPLETED|Month 0 (Day 0)||4
1708213|NCT00397215|4177808|P3|NOT COMPLETED|Month 0 (Day 0)||6
1708214|NCT00397215|4177809|P2|NOT COMPLETED|Month 0 (Day 0)||5
1708215|NCT00397215|4177810|P1|NOT COMPLETED|Month 0 (Day 0)||7
1708216|NCT00397215|4177807|P4|COMPLETED|Month 0 (Day 0)||48
1708217|NCT00397215|4177808|P3|COMPLETED|Month 0 (Day 0)||153
1708218|NCT00397215|4177809|P2|COMPLETED|Month 0 (Day 0)||56
1708219|NCT00397215|4177810|P1|COMPLETED|Month 0 (Day 0)||158
1708220|NCT00397215|4177807|P4|STARTED|Month 0 (Day 0)||52
1708221|NCT00397215|4177808|P3|STARTED|Month 0 (Day 0)||159
1708222|NCT00397215|4177809|P2|STARTED|Month 0 (Day 0)||61
1708223|NCT00397215|4177810|P1|STARTED|Month 0 (Day 0)||165
1708224|NCT00397189|4177946|P2|NOT COMPLETED|Extension Period||43
1708225|NCT00397189|4177947|P1|NOT COMPLETED|Extension Period||113
1708226|NCT00397189|4177946|P2|COMPLETED|Extension Period||134
1708227|NCT00397189|4177947|P1|COMPLETED|Extension Period||421
1708228|NCT00397189|4177946|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
1708229|NCT00397189|4177947|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
1708230|NCT00397189|4177946|P2|NOT COMPLETED|3 Weeks Period||22
1708231|NCT00397189|4177947|P1|NOT COMPLETED|3 Weeks Period||21
1708232|NCT00397189|4177946|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
1708233|NCT00397189|4177947|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
1708234|NCT00397189|4177946|P2|STARTED|3 Weeks Period||395
1708235|NCT00397189|4177947|P1|STARTED|3 Weeks Period||394
1708236|NCT00397150|4177957|P2|NOT COMPLETED|Overall Study||145
1708237|NCT00397150|4177958|P1|NOT COMPLETED|Overall Study||135
1708238|NCT00397150|4177957|P2|COMPLETED|Overall Study||1111
1708239|NCT00397150|4177958|P1|COMPLETED|Overall Study||1188
1708240|NCT00397150|4177957|P2|STARTED|Overall Study||1256
1708241|NCT00397150|4177958|P1|STARTED|Overall Study||1323
1708242|NCT00397046|4177974|P4|NOT COMPLETED|Overall Study||5
1708243|NCT00397046|4177975|P3|NOT COMPLETED|Overall Study||10
1708244|NCT00397046|4177976|P2|NOT COMPLETED|Overall Study||3
1708245|NCT00397046|4177977|P1|NOT COMPLETED|Overall Study||3
1708246|NCT00397046|4177974|P4|COMPLETED|Overall Study||0
1708247|NCT00397046|4177975|P3|COMPLETED|Overall Study||0
1708248|NCT00397046|4177976|P2|COMPLETED|Overall Study||0
1708249|NCT00397046|4177977|P1|COMPLETED|Overall Study||0
1708250|NCT00397046|4177974|P4|STARTED|Overall Study||5
1708251|NCT00397046|4177975|P3|STARTED|Overall Study||10
1708252|NCT00397046|4177976|P2|STARTED|Overall Study||3
1708253|NCT00397046|4177977|P1|STARTED|Overall Study||3
1708254|NCT00397033|4177999|P3|NOT COMPLETED|Overall Study||23
1708255|NCT00397033|4178000|P2|NOT COMPLETED|Overall Study||37
1708256|NCT00397033|4178001|P1|NOT COMPLETED|Overall Study||44
1708257|NCT00397033|4177999|P3|COMPLETED|Overall Study||77
1708258|NCT00397033|4178000|P2|COMPLETED|Overall Study||72
1708259|NCT00397033|4178001|P1|COMPLETED|Overall Study||63
1708260|NCT00397033|4177999|P3|ITT Population|Overall Study||98
1708261|NCT00397033|4178000|P2|ITT Population|Overall Study||105
1708262|NCT00397033|4178001|P1|ITT Population|Overall Study||107
1708263|NCT00397033|4177999|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
1708264|NCT00397033|4178000|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
1708265|NCT00397033|4178001|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
1708266|NCT00397033|4177999|P3|STARTED|Overall Study||100
1708267|NCT00397033|4178000|P2|STARTED|Overall Study||109
1708268|NCT00397033|4178001|P1|STARTED|Overall Study||107
1708269|NCT00396981|4178062|P2|NOT COMPLETED|Overall Study||9
1708270|NCT00396981|4178063|P1|NOT COMPLETED|Overall Study||15
1708271|NCT00396981|4178062|P2|COMPLETED|Overall Study||306
1708272|NCT00396981|4178063|P1|COMPLETED|Overall Study||296
1708273|NCT00396981|4178062|P2|STARTED|Overall Study||315
1708274|NCT00396981|4178063|P1|STARTED|Overall Study||311
1708275|NCT00396877|4178083|P2|NOT COMPLETED|Overall Study||8
1708276|NCT00396877|4178084|P1|NOT COMPLETED|Overall Study||6
1708277|NCT00396877|4178083|P2|COMPLETED|Overall Study|Completed follow-up|459
1708278|NCT00396877|4178084|P1|COMPLETED|Overall Study|Completed follow-up|433
1708279|NCT00396877|4178083|P2|Completed Treatment|Overall Study||352
1708280|NCT00396877|4178084|P1|Completed Treatment|Overall Study||356
1708281|NCT00396877|4178083|P2|Treated|Overall Study||464
1708282|NCT00396877|4178084|P1|Treated|Overall Study||436
1708283|NCT00396877|4178083|P2|STARTED|Overall Study|Randomized|467
1708284|NCT00396877|4178084|P1|STARTED|Overall Study|Randomized|439
1708285|NCT00396812|4178094|P1|NOT COMPLETED|Overall Study||1
1708286|NCT00396812|4178094|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
1708287|NCT00396812|4178094|P1|STARTED|Overall Study||4
1708288|NCT00396656|4178106|P2|NOT COMPLETED|Second Treatment Period||1
1708289|NCT00396656|4178107|P1|NOT COMPLETED|Second Treatment Period||0
1708290|NCT00396656|4178106|P2|COMPLETED|Second Treatment Period||12
1708291|NCT00396656|4178107|P1|COMPLETED|Second Treatment Period||15
1708292|NCT00396656|4178106|P2|STARTED|Second Treatment Period||13
1708293|NCT00396656|4178107|P1|STARTED|Second Treatment Period||15
1708294|NCT00396656|4178106|P2|NOT COMPLETED|First Treatment Period||2
1708295|NCT00396656|4178107|P1|NOT COMPLETED|First Treatment Period||0
1708296|NCT00396656|4178106|P2|COMPLETED|First Treatment Period||13
1708297|NCT00396656|4178107|P1|COMPLETED|First Treatment Period||15
1708298|NCT00396656|4178106|P2|STARTED|First Treatment Period||15
1708299|NCT00396656|4178107|P1|STARTED|First Treatment Period||15
1708300|NCT00396630|4178125|P2|NOT COMPLETED|Overall Study||5
1708301|NCT00396630|4178126|P1|NOT COMPLETED|Overall Study||5
1708302|NCT00396630|4178125|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
1708303|NCT00396630|4178126|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
1708304|NCT00396630|4178125|P2|STARTED|Overall Study||100
1708305|NCT00396630|4178126|P1|STARTED|Overall Study||100
1708306|NCT00396591|4178146|P1|NOT COMPLETED|Overall Study||16
1708307|NCT00396591|4178146|P1|COMPLETED|Overall Study||0
1708308|NCT00396591|4178146|P1|STARTED|Overall Study||16
1708309|NCT00396565|4178159|P3|NOT COMPLETED|Overall Study||17
1708310|NCT00396565|4178160|P2|NOT COMPLETED|Overall Study||91
1708311|NCT00396565|4178161|P1|NOT COMPLETED|Overall Study||48
1708312|NCT00396565|4178159|P3|COMPLETED|Overall Study||30
1708313|NCT00396565|4178160|P2|COMPLETED|Overall Study||47
1708314|NCT00396565|4178161|P1|COMPLETED|Overall Study||88
1708315|NCT00396565|4178159|P3|STARTED|Overall Study||47
1708316|NCT00396565|4178160|P2|STARTED|Overall Study||138
1708317|NCT00396565|4178161|P1|STARTED|Overall Study||136
1708318|NCT00396409|4178186|P2|NOT COMPLETED|Period 2 - 2008||2
1708319|NCT00396409|4178187|P1|NOT COMPLETED|Period 2 - 2008||7
1708320|NCT00396409|4178186|P2|COMPLETED|Period 2 - 2008||53
1708321|NCT00396409|4178187|P1|COMPLETED|Period 2 - 2008||52
1708322|NCT00396409|4178186|P2|STARTED|Period 2 - 2008||55
1708323|NCT00396409|4178187|P1|STARTED|Period 2 - 2008||59
1708324|NCT00396409|4178186|P2|NOT COMPLETED|Between Period 1 and Period 2||2
1708325|NCT00396409|4178187|P1|NOT COMPLETED|Between Period 1 and Period 2||3
1708326|NCT00396409|4178186|P2|COMPLETED|Between Period 1 and Period 2||55
1708327|NCT00396409|4178187|P1|COMPLETED|Between Period 1 and Period 2||59
1708328|NCT00396409|4178186|P2|STARTED|Between Period 1 and Period 2||57
1708329|NCT00396409|4178187|P1|STARTED|Between Period 1 and Period 2||62
1708330|NCT00396409|4178186|P2|NOT COMPLETED|Period 1 - 2007||6
1708331|NCT00396409|4178187|P1|NOT COMPLETED|Period 1 - 2007||3
1708332|NCT00396409|4178186|P2|COMPLETED|Period 1 - 2007||57
1708333|NCT00396409|4178187|P1|COMPLETED|Period 1 - 2007||62
1708334|NCT00396409|4178186|P2|STARTED|Period 1 - 2007||63
1708335|NCT00396409|4178187|P1|STARTED|Period 1 - 2007||65
1708336|NCT00396383|4178217|P1|NOT COMPLETED|Overall Study||3
1708337|NCT00396383|4178217|P1|COMPLETED|Overall Study||6
1708338|NCT00396383|4178217|P1|STARTED|Overall Study||9
1708339|NCT00396331|4178230|P1|NOT COMPLETED|Overall Study||32
1708340|NCT00396331|4178230|P1|COMPLETED|Overall Study||68
1708341|NCT00396331|4178230|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
1708342|NCT00396331|4178230|P1|Number of Participants Treated|Overall Study||100
1708343|NCT00396331|4178230|P1|STARTED|Overall Study||100
1708344|NCT00396318|4178283|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
1708345|NCT00396318|4178283|P1|COMPLETED|7-Day Post-Treatment Contact||240
1708346|NCT00396318|4178283|P1|STARTED|7-Day Post-Treatment Contact||241
1708347|NCT00396318|4178283|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
1708348|NCT00396318|4178283|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
1708349|NCT00396318|4178283|P1|STARTED|48- to 96-Hour Follow-Up Period||246
1708350|NCT00396318|4178283|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
1708351|NCT00396318|4178283|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
1708352|NCT00396318|4178283|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
1708353|NCT00396292|4178296|P2|NOT COMPLETED|Overall Study||16
1708354|NCT00396292|4178297|P1|NOT COMPLETED|Overall Study||9
1708355|NCT00396292|4178296|P2|COMPLETED|Overall Study||162
1708356|NCT00396292|4178297|P1|COMPLETED|Overall Study||165
1708357|NCT00396292|4178296|P2|STARTED|Overall Study||178
1708358|NCT00396292|4178297|P1|STARTED|Overall Study||174
1708359|NCT00396279|4178303|P1|NOT COMPLETED|Overall Study||30
1708360|NCT00396279|4178303|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
1708361|NCT00396279|4178303|P1|STARTED|Overall Study||37
1708362|NCT00396266|4178314|P2|NOT COMPLETED|Overall Study||0
1708363|NCT00396266|4178315|P1|NOT COMPLETED|Overall Study||0
1708364|NCT00396266|4178314|P2|COMPLETED|Overall Study||14
1708365|NCT00396266|4178315|P1|COMPLETED|Overall Study||8
1708366|NCT00396266|4178314|P2|STARTED|Overall Study||14
1708367|NCT00396266|4178315|P1|STARTED|Overall Study||8
1708368|NCT00396253|4178336|P1|NOT COMPLETED|Overall Study||13
1708369|NCT00396253|4178336|P1|COMPLETED|Overall Study||210
1708370|NCT00396253|4178336|P1|STARTED|Overall Study||223
1708371|NCT00396201|4178348|P1|NOT COMPLETED|Follow-up Period||0
1708372|NCT00396201|4178348|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
1708373|NCT00396201|4178348|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
1708374|NCT00396201|4178348|P1|NOT COMPLETED|Treatment Period||0
1708375|NCT00396201|4178348|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
1708376|NCT00396201|4178348|P1|STARTED|Treatment Period||22
1708377|NCT00396162|4178367|P2|NOT COMPLETED|Overall Study||3
1708378|NCT00396162|4178368|P1|NOT COMPLETED|Overall Study||2
1708379|NCT00396162|4178367|P2|COMPLETED|Overall Study||35
1708380|NCT00396162|4178368|P1|COMPLETED|Overall Study||37
1708381|NCT00396162|4178367|P2|STARTED|Overall Study||38
1708382|NCT00396162|4178368|P1|STARTED|Overall Study||39
1708383|NCT00396136|4178380|P1|NOT COMPLETED|Overall Study||125
1708384|NCT00396136|4178380|P1|COMPLETED|Overall Study||96
1708385|NCT00396136|4178380|P1|STARTED|Overall Study||221
1708386|NCT00396097|4178387|P2|NOT COMPLETED|Overall Study||46
1708387|NCT00396097|4178388|P1|NOT COMPLETED|Overall Study||26
1708388|NCT00396097|4178387|P2|COMPLETED|Overall Study||156
1708389|NCT00396097|4178388|P1|COMPLETED|Overall Study||88
1708390|NCT00396097|4178387|P2|STARTED|Overall Study||202
1708391|NCT00396097|4178388|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
1708392|NCT00396084|4178416|P6|NOT COMPLETED|Overall Study||2
1708393|NCT00396084|4178417|P5|NOT COMPLETED|Overall Study||1
1708394|NCT00396084|4178418|P4|NOT COMPLETED|Overall Study||1
1708395|NCT00396084|4178419|P3|NOT COMPLETED|Overall Study||0
1708396|NCT00396084|4178420|P2|NOT COMPLETED|Overall Study||0
1708397|NCT00396084|4178421|P1|NOT COMPLETED|Overall Study||0
1708398|NCT00396084|4178416|P6|COMPLETED|Overall Study||18
1708399|NCT00396084|4178417|P5|COMPLETED|Overall Study||9
1708400|NCT00396084|4178418|P4|COMPLETED|Overall Study||9
1708401|NCT00396084|4178419|P3|COMPLETED|Overall Study||10
1708402|NCT00396084|4178420|P2|COMPLETED|Overall Study||10
1708403|NCT00396084|4178421|P1|COMPLETED|Overall Study||10
1708404|NCT00396084|4178416|P6|STARTED|Overall Study||20
1708405|NCT00396084|4178417|P5|STARTED|Overall Study||10
1708406|NCT00396084|4178418|P4|STARTED|Overall Study||10
1708407|NCT00396084|4178419|P3|STARTED|Overall Study||10
1708408|NCT00396084|4178420|P2|STARTED|Overall Study||10
1708409|NCT00396084|4178421|P1|STARTED|Overall Study||10
1708410|NCT00396032|4178496|P2|NOT COMPLETED|Overall Study||5
1708411|NCT00396032|4178497|P1|NOT COMPLETED|Overall Study||4
1708412|NCT00396032|4178496|P2|COMPLETED|Overall Study||71
1708413|NCT00396032|4178497|P1|COMPLETED|Overall Study||70
1708414|NCT00396032|4178496|P2|STARTED|Overall Study||76
1708415|NCT00396032|4178497|P1|STARTED|Overall Study||74
1708416|NCT00396019|4178514|P3|NOT COMPLETED|Overall Study||1
1708417|NCT00396019|4178515|P2|NOT COMPLETED|Overall Study||3
1708418|NCT00396019|4178516|P1|NOT COMPLETED|Overall Study||0
1708419|NCT00396019|4178514|P3|COMPLETED|Overall Study||29
1708420|NCT00396019|4178515|P2|COMPLETED|Overall Study||26
1708421|NCT00396019|4178516|P1|COMPLETED|Overall Study||27
1708422|NCT00396019|4178514|P3|STARTED|Overall Study||30
1708423|NCT00396019|4178515|P2|STARTED|Overall Study||29
1708424|NCT00396019|4178516|P1|STARTED|Overall Study||27
1708425|NCT00396006|4178526|P1|NOT COMPLETED|Overall Study||0
1708426|NCT00396006|4178526|P1|COMPLETED|Overall Study||13
1708427|NCT00396006|4178526|P1|STARTED|Overall Study||13
1708428|NCT00395993|4178543|P2|NOT COMPLETED|Overall Study||19
1708429|NCT00395993|4178544|P1|NOT COMPLETED|Overall Study||35
1708430|NCT00395993|4178543|P2|COMPLETED|Overall Study||212
1708431|NCT00395993|4178544|P1|COMPLETED|Overall Study||211
1708432|NCT00395993|4178543|P2|STARTED|Overall Study||231
1708433|NCT00395993|4178544|P1|STARTED|Overall Study||246
1708434|NCT00395967|4178550|P1|NOT COMPLETED|Follow-up Period||2
1708435|NCT00395967|4178550|P1|COMPLETED|Follow-up Period||3
1708436|NCT00395967|4178550|P1|STARTED|Follow-up Period|Participants who had transplants.|5
1708437|NCT00395967|4178550|P1|NOT COMPLETED|Treatment Period||1
1708438|NCT00395967|4178550|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
1708439|NCT00395967|4178550|P1|STARTED|Treatment Period||5
1708440|NCT00395876|4178561|P2|NOT COMPLETED|Overall Study||0
1708441|NCT00395876|4178562|P1|NOT COMPLETED|Overall Study||3
1708442|NCT00395876|4178561|P2|COMPLETED|Overall Study||50
1708443|NCT00395876|4178562|P1|COMPLETED|Overall Study||47
1708444|NCT00395876|4178561|P2|STARTED|Overall Study||50
1708445|NCT00395876|4178562|P1|STARTED|Overall Study||50
1708446|NCT00395863|4178590|P2|NOT COMPLETED|Overall Study||3
1708447|NCT00395863|4178591|P1|NOT COMPLETED|Overall Study||2
1708448|NCT00395863|4178590|P2|COMPLETED|Overall Study||20
1708449|NCT00395863|4178591|P1|COMPLETED|Overall Study||21
1708450|NCT00395863|4178590|P2|STARTED|Overall Study||23
1708451|NCT00395863|4178591|P1|STARTED|Overall Study||23
1708452|NCT00395850|4178626|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
1708453|NCT00395850|4178627|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
1708454|NCT00395850|4178628|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
1708455|NCT00395850|4178629|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
1708456|NCT00395850|4178626|P4|COMPLETED|Disulfiram/Placebo Treatment||8
1708457|NCT00395850|4178627|P3|COMPLETED|Disulfiram/Placebo Treatment||5
1708458|NCT00395850|4178628|P2|COMPLETED|Disulfiram/Placebo Treatment||9
1708459|NCT00395850|4178629|P1|COMPLETED|Disulfiram/Placebo Treatment||11
1708460|NCT00395850|4178626|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
1708461|NCT00395850|4178627|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
1708462|NCT00395850|4178628|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
1708463|NCT00395850|4178629|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
1708464|NCT00395850|4178626|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
1708465|NCT00395850|4178627|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
1708466|NCT00395850|4178628|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
1708467|NCT00395850|4178629|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
1708468|NCT00395850|4178626|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
1708469|NCT00395850|4178627|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
1708470|NCT00395850|4178628|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
1708471|NCT00395850|4178629|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
1708472|NCT00395850|4178626|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
1708473|NCT00395850|4178627|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
1708474|NCT00395850|4178628|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
1708475|NCT00395850|4178629|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
1708476|NCT00395850|4178626|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
1708477|NCT00395850|4178627|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
1708478|NCT00395850|4178628|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
1708479|NCT00395850|4178629|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
1708480|NCT00395850|4178626|P4|COMPLETED|Pre-randomization Baseline/Induction||0
1708481|NCT00395850|4178627|P3|COMPLETED|Pre-randomization Baseline/Induction||0
1708482|NCT00395850|4178628|P2|COMPLETED|Pre-randomization Baseline/Induction||0
1708483|NCT00395850|4178629|P1|COMPLETED|Pre-randomization Baseline/Induction||107
1708484|NCT00395850|4178626|P4|STARTED|Pre-randomization Baseline/Induction||0
1708485|NCT00395850|4178627|P3|STARTED|Pre-randomization Baseline/Induction||0
1708486|NCT00395850|4178628|P2|STARTED|Pre-randomization Baseline/Induction||0
1708487|NCT00395850|4178629|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
1708488|NCT00395746|4178646|P3|NOT COMPLETED|Overall Study||22
1708489|NCT00395746|4178647|P2|NOT COMPLETED|Overall Study||4
1708490|NCT00395746|4178648|P1|NOT COMPLETED|Overall Study||10
1708491|NCT00395746|4178646|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
1708492|NCT00395746|4178647|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
1708493|NCT00395746|4178648|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
1708494|NCT00395746|4178646|P3|STARTED|Overall Study|Exposed to study drug|88
1708495|NCT00395746|4178647|P2|STARTED|Overall Study|Exposed to study drug|88
1708496|NCT00395746|4178648|P1|STARTED|Overall Study|Exposed to study drug|88
1708497|NCT00395733|4178694|P2|NOT COMPLETED|Period 2||5
1708498|NCT00395733|4178695|P1|NOT COMPLETED|Period 2||2
1708499|NCT00395733|4178694|P2|COMPLETED|Period 2||37
1708500|NCT00395733|4178695|P1|COMPLETED|Period 2||39
1708501|NCT00395733|4178694|P2|STARTED|Period 2||42
1708502|NCT00395733|4178695|P1|STARTED|Period 2||41
1708503|NCT00395733|4178694|P2|NOT COMPLETED|Period 1||0
1708504|NCT00395733|4178695|P1|NOT COMPLETED|Period 1||0
1708505|NCT00395733|4178694|P2|COMPLETED|Period 1||42
1708506|NCT00395733|4178695|P1|COMPLETED|Period 1||41
1708507|NCT00395733|4178694|P2|STARTED|Period 1||42
1708508|NCT00395733|4178695|P1|STARTED|Period 1||41
1708509|NCT00395694|4178719|P2|NOT COMPLETED|Continuation Phase||13
1708510|NCT00395694|4178720|P1|NOT COMPLETED|Continuation Phase||15
1708511|NCT00395694|4178719|P2|COMPLETED|Continuation Phase||35
1708512|NCT00395694|4178720|P1|COMPLETED|Continuation Phase||34
1708513|NCT00395694|4178719|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
1708514|NCT00395694|4178720|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
1708515|NCT00395694|4178719|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
1708516|NCT00395694|4178720|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
1708517|NCT00395694|4178719|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
1708518|NCT00395694|4178720|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
1708519|NCT00395694|4178719|P2|STARTED|Escalation Phase + Maintenance Phase||51
1708520|NCT00395694|4178720|P1|STARTED|Escalation Phase + Maintenance Phase||51
1708521|NCT00395642|4178751|P1|NOT COMPLETED|Overall Study||13
1708522|NCT00395642|4178751|P1|COMPLETED|Overall Study||53
1708523|NCT00395642|4178751|P1|STARTED|Overall Study||66
1708524|NCT00395629|4178758|P3|NOT COMPLETED|Extension Study||3
1708525|NCT00395629|4178759|P2|NOT COMPLETED|Extension Study||0
1708526|NCT00395629|4178760|P1|NOT COMPLETED|Extension Study||0
1708527|NCT00395629|4178758|P3|COMPLETED|Extension Study||8
1708528|NCT00395629|4178759|P2|COMPLETED|Extension Study||6
1708529|NCT00395629|4178760|P1|COMPLETED|Extension Study||9
1708530|NCT00395629|4178758|P3|STARTED|Extension Study||11
1708531|NCT00395629|4178759|P2|STARTED|Extension Study||6
1708532|NCT00395629|4178760|P1|STARTED|Extension Study||9
1708533|NCT00395629|4178758|P3|NOT COMPLETED|Core Study||7
1708534|NCT00395629|4178759|P2|NOT COMPLETED|Core Study||4
1708535|NCT00395629|4178760|P1|NOT COMPLETED|Core Study||1
1708536|NCT00395629|4178758|P3|COMPLETED|Core Study||16
1708537|NCT00395629|4178759|P2|COMPLETED|Core Study||11
1708538|NCT00395629|4178760|P1|COMPLETED|Core Study||10
1708539|NCT00395629|4178758|P3|STARTED|Core Study||23
1708540|NCT00395629|4178759|P2|STARTED|Core Study||15
1708541|NCT00395629|4178760|P1|STARTED|Core Study||11
1708542|NCT00395512|4178778|P4|NOT COMPLETED|Overall Study||38
1708543|NCT00395512|4178779|P3|NOT COMPLETED|Overall Study||28
1708544|NCT00395512|4178780|P2|NOT COMPLETED|Overall Study||37
1708545|NCT00395512|4178781|P1|NOT COMPLETED|Overall Study||38
1708546|NCT00395512|4178778|P4|COMPLETED|Overall Study||126
1708547|NCT00395512|4178779|P3|COMPLETED|Overall Study||136
1708548|NCT00395512|4178780|P2|COMPLETED|Overall Study||126
1708549|NCT00395512|4178781|P1|COMPLETED|Overall Study||126
1708550|NCT00395512|4178778|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
1708551|NCT00395512|4178779|P3|Safety Set|Overall Study||164
1708552|NCT00395512|4178780|P2|Safety Set|Overall Study||163
1708553|NCT00395512|4178781|P1|Safety Set|Overall Study||164
1708554|NCT00395512|4178778|P4|STARTED|Overall Study||164
1708555|NCT00395512|4178779|P3|STARTED|Overall Study||164
1708556|NCT00395512|4178780|P2|STARTED|Overall Study||163
1708557|NCT00395512|4178781|P1|STARTED|Overall Study||164
1708558|NCT00395486|4178953|P2|NOT COMPLETED|Overall Study||5
1708559|NCT00395486|4178954|P1|NOT COMPLETED|Overall Study||6
1708560|NCT00395486|4178953|P2|COMPLETED|Overall Study|Completed subjects|121
1708561|NCT00395486|4178954|P1|COMPLETED|Overall Study|Completed subjects|126
1708562|NCT00395486|4178953|P2|STARTED|Overall Study|Randomized subjects|126
1708563|NCT00395486|4178954|P1|STARTED|Overall Study|Randomized subjects|132
1708564|NCT00395460|4178984|P2|NOT COMPLETED|Overall Study||0
1708565|NCT00395460|4178985|P1|NOT COMPLETED|Overall Study||1
1708566|NCT00395460|4178984|P2|COMPLETED|Overall Study||75
1708567|NCT00395460|4178985|P1|COMPLETED|Overall Study||71
1708568|NCT00395460|4178984|P2|Received Treatment|Overall Study||75
1708569|NCT00395460|4178985|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
1708570|NCT00395460|4178984|P2|STARTED|Overall Study||75
1708571|NCT00395460|4178985|P1|STARTED|Overall Study||72
1708572|NCT00395447|4179009|P2|NOT COMPLETED|Overall Study||111
1708573|NCT00395447|4179010|P1|NOT COMPLETED|Overall Study||121
1708574|NCT00395447|4179009|P2|COMPLETED|Overall Study||602
1708575|NCT00395447|4179010|P1|COMPLETED|Overall Study||910
1708576|NCT00395447|4179009|P2|STARTED|Overall Study||713
1708577|NCT00395447|4179010|P1|STARTED|Overall Study||1031
1708578|NCT00395343|4179018|P2|NOT COMPLETED|Overall Study||36
1708579|NCT00395343|4179019|P1|NOT COMPLETED|Overall Study||41
1708580|NCT00395343|4179018|P2|COMPLETED|Overall Study||283
1708581|NCT00395343|4179019|P1|COMPLETED|Overall Study||281
1708582|NCT00395343|4179018|P2|STARTED|Overall Study||319
1708583|NCT00395343|4179019|P1|STARTED|Overall Study||322
1708584|NCT00395304|4179037|P6|NOT COMPLETED|Treatment Period 3||1
1708585|NCT00395304|4179038|P5|NOT COMPLETED|Treatment Period 3||0
1708586|NCT00395304|4179039|P4|NOT COMPLETED|Treatment Period 3||2
1708587|NCT00395304|4179040|P3|NOT COMPLETED|Treatment Period 3||0
1708588|NCT00395304|4179041|P2|NOT COMPLETED|Treatment Period 3||2
1708589|NCT00395304|4179042|P1|NOT COMPLETED|Treatment Period 3||1
1708590|NCT00395304|4179037|P6|COMPLETED|Treatment Period 3||27
1708591|NCT00395304|4179038|P5|COMPLETED|Treatment Period 3||27
1708592|NCT00395304|4179039|P4|COMPLETED|Treatment Period 3||25
1708593|NCT00395304|4179040|P3|COMPLETED|Treatment Period 3||29
1708594|NCT00395304|4179041|P2|COMPLETED|Treatment Period 3||20
1708595|NCT00395304|4179042|P1|COMPLETED|Treatment Period 3||29
1708596|NCT00395304|4179037|P6|STARTED|Treatment Period 3||28
1708597|NCT00395304|4179038|P5|STARTED|Treatment Period 3||27
1708598|NCT00395304|4179039|P4|STARTED|Treatment Period 3||27
1708599|NCT00395304|4179040|P3|STARTED|Treatment Period 3||29
1708600|NCT00395304|4179041|P2|STARTED|Treatment Period 3||22
1708601|NCT00395304|4179042|P1|STARTED|Treatment Period 3||30
1708602|NCT00395304|4179037|P6|NOT COMPLETED|Treatment Period 2||2
1708603|NCT00395304|4179038|P5|NOT COMPLETED|Treatment Period 2||0
1708604|NCT00395304|4179039|P4|NOT COMPLETED|Treatment Period 2||1
1708605|NCT00395304|4179040|P3|NOT COMPLETED|Treatment Period 2||1
1708606|NCT00395304|4179041|P2|NOT COMPLETED|Treatment Period 2||4
1708607|NCT00395304|4179042|P1|NOT COMPLETED|Treatment Period 2||0
1708608|NCT00395304|4179037|P6|COMPLETED|Treatment Period 2||28
1708609|NCT00395304|4179038|P5|COMPLETED|Treatment Period 2||27
1708610|NCT00395304|4179039|P4|COMPLETED|Treatment Period 2||27
1708611|NCT00395304|4179040|P3|COMPLETED|Treatment Period 2||29
1708612|NCT00395304|4179041|P2|COMPLETED|Treatment Period 2||22
1708613|NCT00395304|4179042|P1|COMPLETED|Treatment Period 2||30
1708614|NCT00395304|4179037|P6|STARTED|Treatment Period 2||30
1708615|NCT00395304|4179038|P5|STARTED|Treatment Period 2||27
1708616|NCT00395304|4179039|P4|STARTED|Treatment Period 2||28
1708617|NCT00395304|4179040|P3|STARTED|Treatment Period 2||30
1708618|NCT00395304|4179041|P2|STARTED|Treatment Period 2||26
1708619|NCT00395304|4179042|P1|STARTED|Treatment Period 2||30
1708620|NCT00395304|4179037|P6|NOT COMPLETED|Treatment Period 1||2
1708621|NCT00395304|4179038|P5|NOT COMPLETED|Treatment Period 1||1
1708622|NCT00395304|4179039|P4|NOT COMPLETED|Treatment Period 1||3
1708623|NCT00395304|4179040|P3|NOT COMPLETED|Treatment Period 1||0
1708624|NCT00395304|4179041|P2|NOT COMPLETED|Treatment Period 1||4
1708625|NCT00395304|4179042|P1|NOT COMPLETED|Treatment Period 1||1
1708626|NCT00395304|4179037|P6|COMPLETED|Treatment Period 1||30
1708627|NCT00395304|4179038|P5|COMPLETED|Treatment Period 1||27
1708628|NCT00395304|4179039|P4|COMPLETED|Treatment Period 1||28
1708629|NCT00395304|4179040|P3|COMPLETED|Treatment Period 1||30
1708630|NCT00395304|4179041|P2|COMPLETED|Treatment Period 1||26
1708631|NCT00395304|4179042|P1|COMPLETED|Treatment Period 1||30
1708632|NCT00395304|4179037|P6|STARTED|Treatment Period 1||32
1708633|NCT00395304|4179038|P5|STARTED|Treatment Period 1||28
1708634|NCT00395304|4179039|P4|STARTED|Treatment Period 1||31
1708635|NCT00395304|4179040|P3|STARTED|Treatment Period 1||30
1708636|NCT00395304|4179041|P2|STARTED|Treatment Period 1||30
1708637|NCT00395304|4179042|P1|STARTED|Treatment Period 1||31
1708638|NCT00395291|4179085|P2|NOT COMPLETED|Second Intervention||0
1708639|NCT00395291|4179086|P1|NOT COMPLETED|Second Intervention||0
1708640|NCT00395291|4179085|P2|COMPLETED|Second Intervention||9
1708641|NCT00395291|4179086|P1|COMPLETED|Second Intervention||13
1708642|NCT00395291|4179085|P2|STARTED|Second Intervention||9
1708643|NCT00395291|4179086|P1|STARTED|Second Intervention||13
1708644|NCT00395291|4179085|P2|NOT COMPLETED|Washout Period for 30 Days||0
1708645|NCT00395291|4179086|P1|NOT COMPLETED|Washout Period for 30 Days||2
1708646|NCT00395291|4179085|P2|COMPLETED|Washout Period for 30 Days||9
1708647|NCT00395291|4179086|P1|COMPLETED|Washout Period for 30 Days||13
1708648|NCT00395291|4179085|P2|STARTED|Washout Period for 30 Days||9
1708649|NCT00395291|4179086|P1|STARTED|Washout Period for 30 Days||15
1708650|NCT00395291|4179085|P2|NOT COMPLETED|First Intervention||0
1708651|NCT00395291|4179086|P1|NOT COMPLETED|First Intervention||2
1708652|NCT00395291|4179085|P2|COMPLETED|First Intervention||9
1708653|NCT00395291|4179086|P1|COMPLETED|First Intervention||15
1708654|NCT00395291|4179085|P2|STARTED|First Intervention||9
1708655|NCT00395291|4179086|P1|STARTED|First Intervention||17
1708656|NCT00395226|4179118|P2|NOT COMPLETED|Overall Study||5
1708657|NCT00395226|4179119|P1|NOT COMPLETED|Overall Study||4
1708658|NCT00395226|4179118|P2|COMPLETED|Overall Study||22
1708659|NCT00395226|4179119|P1|COMPLETED|Overall Study||22
1708660|NCT00395226|4179118|P2|STARTED|Overall Study||27
1708661|NCT00395226|4179119|P1|STARTED|Overall Study||26
1708662|NCT00395161|4179127|P2|NOT COMPLETED|Overall Study||0
1708663|NCT00395161|4179128|P1|NOT COMPLETED|Overall Study||0
1708664|NCT00395161|4179127|P2|COMPLETED|Overall Study||144
1708665|NCT00395161|4179128|P1|COMPLETED|Overall Study||149
1708666|NCT00395161|4179127|P2|STARTED|Overall Study||144
1708667|NCT00395161|4179128|P1|STARTED|Overall Study||149
1708668|NCT00395135|4179144|P5|NOT COMPLETED|Year 2||190
1708669|NCT00395135|4179145|P4|NOT COMPLETED|Year 2||88
1708670|NCT00395135|4179146|P3|NOT COMPLETED|Year 2||147
1708671|NCT00395135|4179147|P2|NOT COMPLETED|Year 2||0
1708672|NCT00395135|4179148|P1|NOT COMPLETED|Year 2||0
1708673|NCT00395135|4179144|P5|COMPLETED|Year 2||507
1708674|NCT00395135|4179145|P4|COMPLETED|Year 2||195
1708675|NCT00395135|4179146|P3|COMPLETED|Year 2||426
1708676|NCT00395135|4179147|P2|COMPLETED|Year 2||0
1708677|NCT00395135|4179148|P1|COMPLETED|Year 2||0
1708678|NCT00395135|4179144|P5|STARTED|Year 2||697
1708679|NCT00395135|4179145|P4|STARTED|Year 2||283
1708680|NCT00395135|4179146|P3|STARTED|Year 2||573
1708681|NCT00395135|4179147|P2|STARTED|Year 2||0
1708682|NCT00395135|4179148|P1|STARTED|Year 2||0
1708683|NCT00395135|4179144|P5|NOT COMPLETED|Year 1||0
1708684|NCT00395135|4179145|P4|NOT COMPLETED|Year 1||0
1708685|NCT00395135|4179146|P3|NOT COMPLETED|Year 1||0
1708686|NCT00395135|4179147|P2|NOT COMPLETED|Year 1||871
1708687|NCT00395135|4179148|P1|NOT COMPLETED|Year 1||712
1708688|NCT00395135|4179144|P5|COMPLETED|Year 1||0
1708689|NCT00395135|4179145|P4|COMPLETED|Year 1||0
1708690|NCT00395135|4179146|P3|COMPLETED|Year 1||0
1708691|NCT00395135|4179147|P2|COMPLETED|Year 1||716
1708692|NCT00395135|4179148|P1|COMPLETED|Year 1||883
1708693|NCT00395135|4179144|P5|STARTED|Year 1||0
1708694|NCT00395135|4179145|P4|STARTED|Year 1||0
1708695|NCT00395135|4179146|P3|STARTED|Year 1||0
1708696|NCT00395135|4179147|P2|STARTED|Year 1||1587
1708697|NCT00395135|4179148|P1|STARTED|Year 1||1595
1708698|NCT00395083|4179166|P2|NOT COMPLETED|Overall Study||8
1708699|NCT00395083|4179167|P1|NOT COMPLETED|Overall Study||10
1708700|NCT00395083|4179166|P2|COMPLETED|Overall Study||201
1708701|NCT00395083|4179167|P1|COMPLETED|Overall Study||207
1708702|NCT00395083|4179166|P2|STARTED|Overall Study||209
1708703|NCT00395083|4179167|P1|STARTED|Overall Study||217
1708704|NCT00395057|4179183|P4|NOT COMPLETED|Overall Study||33
1708705|NCT00395057|4179184|P3|NOT COMPLETED|Overall Study||33
1708706|NCT00395057|4179185|P2|NOT COMPLETED|Overall Study||34
1708707|NCT00395057|4179186|P1|NOT COMPLETED|Overall Study||32
1708708|NCT00395057|4179183|P4|COMPLETED|Overall Study||1
1708709|NCT00395057|4179184|P3|COMPLETED|Overall Study||2
1708710|NCT00395057|4179185|P2|COMPLETED|Overall Study||1
1708711|NCT00395057|4179186|P1|COMPLETED|Overall Study||2
1708712|NCT00395057|4179183|P4|STARTED|Overall Study||34
1708713|NCT00395057|4179184|P3|STARTED|Overall Study||35
1708714|NCT00395057|4179185|P2|STARTED|Overall Study||35
1708715|NCT00395057|4179186|P1|STARTED|Overall Study||34
1708716|NCT00395044|4179214|P2|NOT COMPLETED|Overall Study||14
1708717|NCT00395044|4179215|P1|NOT COMPLETED|Overall Study||18
1708718|NCT00395044|4179214|P2|COMPLETED|Overall Study||11
1708719|NCT00395044|4179215|P1|COMPLETED|Overall Study||7
1708720|NCT00395044|4179214|P2|STARTED|Overall Study||25
1708721|NCT00395044|4179215|P1|STARTED|Overall Study||25
1708722|NCT00395018|4179233|P1|NOT COMPLETED|Off-Treatment Follow-up||4
1708723|NCT00395018|4179233|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
1708724|NCT00395018|4179233|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
1708725|NCT00395018|4179233|P1|NOT COMPLETED|On-Treatment||10
1708726|NCT00395018|4179233|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
1708727|NCT00395018|4179233|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
1708728|NCT00395018|4179233|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
1708729|NCT00395018|4179233|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
1708730|NCT00394953|4179254|P2|NOT COMPLETED|Second Treatment Period||74
1708731|NCT00394953|4179255|P1|NOT COMPLETED|Second Treatment Period||29
1708732|NCT00394953|4179254|P2|COMPLETED|Second Treatment Period||148
1708733|NCT00394953|4179255|P1|COMPLETED|Second Treatment Period||187
1708734|NCT00394953|4179254|P2|STARTED|Second Treatment Period||222
1708735|NCT00394953|4179255|P1|STARTED|Second Treatment Period||216
1708736|NCT00394953|4179254|P2|NOT COMPLETED|First Treatment Period||22
1708737|NCT00394953|4179255|P1|NOT COMPLETED|First Treatment Period||29
1708738|NCT00394953|4179254|P2|COMPLETED|First Treatment Period||222
1708739|NCT00394953|4179255|P1|COMPLETED|First Treatment Period||216
1708740|NCT00394953|4179254|P2|STARTED|First Treatment Period||244
1708741|NCT00394953|4179255|P1|STARTED|First Treatment Period||245
1708742|NCT00394914|4179273|P3|NOT COMPLETED|Treatment Period||6
1708743|NCT00394914|4179274|P2|NOT COMPLETED|Treatment Period||10
1708744|NCT00394914|4179275|P1|NOT COMPLETED|Treatment Period||0
1708745|NCT00394914|4179273|P3|COMPLETED|Treatment Period||151
1708746|NCT00394914|4179274|P2|COMPLETED|Treatment Period||144
1708747|NCT00394914|4179275|P1|COMPLETED|Treatment Period||0
1708748|NCT00394914|4179273|P3|STARTED|Treatment Period||157
1708749|NCT00394914|4179274|P2|STARTED|Treatment Period||154
1708750|NCT00394914|4179275|P1|STARTED|Treatment Period||0
1708751|NCT00394914|4179273|P3|NOT COMPLETED|Pre-exposure Period||0
1708752|NCT00394914|4179274|P2|NOT COMPLETED|Pre-exposure Period||0
1708753|NCT00394914|4179275|P1|NOT COMPLETED|Pre-exposure Period||0
1708754|NCT00394914|4179273|P3|COMPLETED|Pre-exposure Period||0
1708755|NCT00394914|4179274|P2|COMPLETED|Pre-exposure Period||0
1708756|NCT00394914|4179275|P1|COMPLETED|Pre-exposure Period||311
1708757|NCT00394914|4179273|P3|STARTED|Pre-exposure Period||0
1708758|NCT00394914|4179274|P2|STARTED|Pre-exposure Period||0
1708759|NCT00394914|4179275|P1|STARTED|Pre-exposure Period||311
1708760|NCT00394914|4179273|P3|NOT COMPLETED|Screening Period||0
1708761|NCT00394914|4179274|P2|NOT COMPLETED|Screening Period||0
1708762|NCT00394914|4179275|P1|NOT COMPLETED|Screening Period||0
1708763|NCT00394914|4179273|P3|COMPLETED|Screening Period||0
1708764|NCT00394914|4179274|P2|COMPLETED|Screening Period||0
1708765|NCT00394914|4179275|P1|COMPLETED|Screening Period||311
1708766|NCT00394914|4179273|P3|STARTED|Screening Period||0
1708767|NCT00394914|4179274|P2|STARTED|Screening Period||0
1708768|NCT00394914|4179275|P1|STARTED|Screening Period||311
1708769|NCT00394901|4179303|P4|NOT COMPLETED|Double-blind Phase||27
1708770|NCT00394901|4179304|P3|NOT COMPLETED|Double-blind Phase||18
1708771|NCT00394901|4179305|P2|NOT COMPLETED|Double-blind Phase||14
1708772|NCT00394901|4179306|P1|NOT COMPLETED|Double-blind Phase||15
1708773|NCT00394901|4179303|P4|COMPLETED|Double-blind Phase||70
1708774|NCT00394901|4179304|P3|COMPLETED|Double-blind Phase||71
1708775|NCT00394901|4179305|P2|COMPLETED|Double-blind Phase||73
1708776|NCT00394901|4179306|P1|COMPLETED|Double-blind Phase||83
1708777|NCT00394901|4179303|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
1708778|NCT00394901|4179304|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
1708779|NCT00394901|4179305|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
1708780|NCT00394901|4179306|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
1708781|NCT00394901|4179303|P4|NOT COMPLETED|Baseline Phase||0
1708782|NCT00394901|4179304|P3|NOT COMPLETED|Baseline Phase||1
1708783|NCT00394901|4179305|P2|NOT COMPLETED|Baseline Phase||0
1708784|NCT00394901|4179306|P1|NOT COMPLETED|Baseline Phase||0
1708785|NCT00394901|4179303|P4|COMPLETED|Baseline Phase||97
1708786|NCT00394901|4179304|P3|COMPLETED|Baseline Phase||89
1708787|NCT00394901|4179305|P2|COMPLETED|Baseline Phase||87
1708788|NCT00394901|4179306|P1|COMPLETED|Baseline Phase||98
1708789|NCT00394901|4179303|P4|STARTED|Baseline Phase|Subjects randomized|97
1708790|NCT00394901|4179304|P3|STARTED|Baseline Phase|Subjects randomized|90
1708791|NCT00394901|4179305|P2|STARTED|Baseline Phase|Subjects randomized|87
1708792|NCT00394901|4179306|P1|STARTED|Baseline Phase|Subjects randomized|98
1708793|NCT00394888|4179534|P3|NOT COMPLETED|Overall Study||0
1708794|NCT00394888|4179535|P2|NOT COMPLETED|Overall Study||0
1708795|NCT00394888|4179536|P1|NOT COMPLETED|Overall Study||0
1708796|NCT00394888|4179534|P3|COMPLETED|Overall Study||201
1708797|NCT00394888|4179535|P2|COMPLETED|Overall Study||48
1708798|NCT00394888|4179536|P1|COMPLETED|Overall Study||108
1708799|NCT00394888|4179534|P3|STARTED|Overall Study||201
1708800|NCT00394888|4179535|P2|STARTED|Overall Study||48
1708801|NCT00394888|4179536|P1|STARTED|Overall Study||108
1708802|NCT00394836|4179549|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
1708803|NCT00394836|4179550|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
1708804|NCT00394836|4179549|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
1708805|NCT00394836|4179550|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
1708806|NCT00394836|4179549|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
1708807|NCT00394836|4179550|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
1708808|NCT00394836|4179549|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
1708809|NCT00394836|4179550|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
1708810|NCT00394836|4179549|P2|COMPLETED|Teatment or Follow-up Phase||8
1708811|NCT00394836|4179550|P1|COMPLETED|Teatment or Follow-up Phase||2
1708812|NCT00394836|4179549|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
1708813|NCT00394836|4179550|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
1708814|NCT00394836|4179549|P2|STARTED|Teatment or Follow-up Phase||86
1708815|NCT00394836|4179550|P1|STARTED|Teatment or Follow-up Phase||30
1708816|NCT00394771|4179596|P4|NOT COMPLETED|Overall Study||39
1708817|NCT00394771|4179597|P3|NOT COMPLETED|Overall Study||47
1708818|NCT00394771|4179598|P2|NOT COMPLETED|Overall Study||34
1708819|NCT00394771|4179599|P1|NOT COMPLETED|Overall Study||41
1708820|NCT00394771|4179596|P4|COMPLETED|Overall Study||109
1708821|NCT00394771|4179597|P3|COMPLETED|Overall Study||96
1708822|NCT00394771|4179598|P2|COMPLETED|Overall Study||102
1708823|NCT00394771|4179599|P1|COMPLETED|Overall Study||99
1708824|NCT00394771|4179596|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
1708825|NCT00394771|4179597|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
1708826|NCT00394771|4179598|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
1708827|NCT00394771|4179599|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
1708828|NCT00394771|4179596|P4|STARTED|Overall Study|Safety population of treated participants|148
1708829|NCT00394771|4179597|P3|STARTED|Overall Study|Safety population of treated participants|143
1708830|NCT00394771|4179598|P2|STARTED|Overall Study|Safety population of treated participants|136
1708831|NCT00394771|4179599|P1|STARTED|Overall Study|Safety population of treated participants|140
1708832|NCT00394706|4179669|P8|NOT COMPLETED|Overall Study||0
1708833|NCT00394706|4179670|P7|NOT COMPLETED|Overall Study||3
1708834|NCT00394706|4179671|P6|NOT COMPLETED|Overall Study||7
1708835|NCT00394706|4179672|P5|NOT COMPLETED|Overall Study||2
1708836|NCT00394706|4179673|P4|NOT COMPLETED|Overall Study||1
1708837|NCT00394706|4179674|P3|NOT COMPLETED|Overall Study||9
1708838|NCT00394706|4179675|P2|NOT COMPLETED|Overall Study||2
1708839|NCT00394706|4179676|P1|NOT COMPLETED|Overall Study||4
1708840|NCT00394706|4179669|P8|COMPLETED|Overall Study||851
1708841|NCT00394706|4179670|P7|COMPLETED|Overall Study||926
1708842|NCT00394706|4179671|P6|COMPLETED|Overall Study||1377
1708843|NCT00394706|4179672|P5|COMPLETED|Overall Study||1634
1708844|NCT00394706|4179673|P4|COMPLETED|Overall Study||1632
1708845|NCT00394706|4179674|P3|COMPLETED|Overall Study||1615
1708846|NCT00394706|4179675|P2|COMPLETED|Overall Study||1860
1708847|NCT00394706|4179676|P1|COMPLETED|Overall Study||1815
1708848|NCT00394706|4179669|P8|STARTED|Overall Study||851
1708849|NCT00394706|4179670|P7|STARTED|Overall Study||929
1708850|NCT00394706|4179671|P6|STARTED|Overall Study||1384
1708851|NCT00394706|4179672|P5|STARTED|Overall Study||1636
1708852|NCT00394706|4179673|P4|STARTED|Overall Study||1633
1708853|NCT00394706|4179674|P3|STARTED|Overall Study||1624
1708854|NCT00394706|4179675|P2|STARTED|Overall Study||1862
1708855|NCT00394706|4179676|P1|STARTED|Overall Study||1819
1708856|NCT00394654|4179708|P2|NOT COMPLETED|Overall Study||0
1708857|NCT00394654|4179709|P1|NOT COMPLETED|Overall Study||2
1708858|NCT00394654|4179708|P2|COMPLETED|Overall Study||15
1708859|NCT00394654|4179709|P1|COMPLETED|Overall Study||13
1708860|NCT00394654|4179708|P2|STARTED|Overall Study||15
1708861|NCT00394654|4179709|P1|STARTED|Overall Study||15
1708862|NCT00394589|4179774|P3|NOT COMPLETED|Overall Study||7
1708863|NCT00394589|4179775|P2|NOT COMPLETED|Overall Study||3
1708864|NCT00394589|4179776|P1|NOT COMPLETED|Overall Study||8
1708865|NCT00394589|4179774|P3|COMPLETED|Overall Study||11
1708866|NCT00394589|4179775|P2|COMPLETED|Overall Study||8
1708867|NCT00394589|4179776|P1|COMPLETED|Overall Study||6
1708868|NCT00394589|4179774|P3|STARTED|Overall Study||18
1708869|NCT00394589|4179775|P2|STARTED|Overall Study||11
1708870|NCT00394589|4179776|P1|STARTED|Overall Study||14
1708871|NCT00394524|4179786|P2|NOT COMPLETED|Overall Study||4
1708872|NCT00394524|4179787|P1|NOT COMPLETED|Overall Study||3
1708873|NCT00394524|4179786|P2|COMPLETED|Overall Study||76
1708874|NCT00394524|4179787|P1|COMPLETED|Overall Study||77
1708875|NCT00394524|4179786|P2|STARTED|Overall Study||80
1708876|NCT00394524|4179787|P1|STARTED|Overall Study||80
1708877|NCT00394472|4179801|P2|NOT COMPLETED|Overall Study||11
1708878|NCT00394472|4179802|P1|NOT COMPLETED|Overall Study||9
1708879|NCT00394472|4179801|P2|COMPLETED|Overall Study||111
1708880|NCT00394472|4179802|P1|COMPLETED|Overall Study||113
1708881|NCT00394472|4179801|P2|STARTED|Overall Study||122
1708882|NCT00394472|4179802|P1|STARTED|Overall Study||122
1708883|NCT00394433|4179810|P1|NOT COMPLETED|Overall Study||3
1708884|NCT00394433|4179810|P1|COMPLETED|Overall Study||35
1708885|NCT00394433|4179810|P1|Evaluable and Treated|Overall Study||35
1708886|NCT00394433|4179810|P1|STARTED|Overall Study||38
1708887|NCT00394355|4179821|P4|NOT COMPLETED|Overall Study||31
1708888|NCT00394355|4179822|P3|NOT COMPLETED|Overall Study||38
1708889|NCT00394355|4179823|P2|NOT COMPLETED|Overall Study||34
1708890|NCT00394355|4179824|P1|NOT COMPLETED|Overall Study||35
1708891|NCT00394355|4179821|P4|COMPLETED|Overall Study||111
1708892|NCT00394355|4179822|P3|COMPLETED|Overall Study||109
1708893|NCT00394355|4179823|P2|COMPLETED|Overall Study||103
1708894|NCT00394355|4179824|P1|COMPLETED|Overall Study||105
1708895|NCT00394355|4179821|P4|STARTED|Overall Study||142
1708896|NCT00394355|4179822|P3|STARTED|Overall Study||147
1708897|NCT00394355|4179823|P2|STARTED|Overall Study||137
1708898|NCT00394355|4179824|P1|STARTED|Overall Study||140
1708899|NCT00394329|4179850|P4|NOT COMPLETED|Overall Study||24
1708900|NCT00394329|4179851|P3|NOT COMPLETED|Overall Study||13
1708901|NCT00394329|4179852|P2|NOT COMPLETED|Overall Study||9
1708902|NCT00394329|4179853|P1|NOT COMPLETED|Overall Study||8
1708903|NCT00394329|4179850|P4|COMPLETED|Overall Study||50
1708904|NCT00394329|4179851|P3|COMPLETED|Overall Study||58
1708905|NCT00394329|4179852|P2|COMPLETED|Overall Study||63
1708906|NCT00394329|4179853|P1|COMPLETED|Overall Study||63
1708907|NCT00394329|4179850|P4|STARTED|Overall Study||74
1708908|NCT00394329|4179851|P3|STARTED|Overall Study||71
1708909|NCT00394329|4179852|P2|STARTED|Overall Study||72
1708910|NCT00394329|4179853|P1|STARTED|Overall Study||71
1708911|NCT00394277|4179903|P4|NOT COMPLETED|Overall Study||125
1708912|NCT00394277|4179904|P3|NOT COMPLETED|Overall Study||120
1708913|NCT00394277|4179905|P2|NOT COMPLETED|Overall Study||60
1708914|NCT00394277|4179906|P1|NOT COMPLETED|Overall Study||58
1708915|NCT00394277|4179903|P4|COMPLETED|Overall Study||266
1708916|NCT00394277|4179904|P3|COMPLETED|Overall Study||273
1708917|NCT00394277|4179905|P2|COMPLETED|Overall Study||136
1708918|NCT00394277|4179906|P1|COMPLETED|Overall Study||137
1708919|NCT00394277|4179903|P4|STARTED|Overall Study||391
1708920|NCT00394277|4179904|P3|STARTED|Overall Study||393
1708921|NCT00394277|4179905|P2|STARTED|Overall Study||196
1708922|NCT00394277|4179906|P1|STARTED|Overall Study||195
1708923|NCT00394251|4179930|P2|NOT COMPLETED|Overall Study||38
1708924|NCT00394251|4179931|P1|NOT COMPLETED|Overall Study||37
1708925|NCT00394251|4179930|P2|COMPLETED|Overall Study||61
1708926|NCT00394251|4179931|P1|COMPLETED|Overall Study||61
1708927|NCT00394251|4179930|P2|At Least One Dose of Taxane|Overall Study||93
1708928|NCT00394251|4179931|P1|At Least One Dose of Taxane|Overall Study||93
1708929|NCT00394251|4179930|P2|STARTED|Overall Study||99
1708930|NCT00394251|4179931|P1|STARTED|Overall Study||98
1708931|NCT00394212|4179959|P2|NOT COMPLETED|Overall Study||1
1708932|NCT00394212|4179960|P1|NOT COMPLETED|Overall Study||7
1708933|NCT00394212|4179959|P2|COMPLETED|Overall Study||26
1708934|NCT00394212|4179960|P1|COMPLETED|Overall Study||43
1708935|NCT00394212|4179959|P2|6 Month Follow-up|Overall Study||26
1708936|NCT00394212|4179960|P1|6 Month Follow-up|Overall Study||43
1708937|NCT00394212|4179959|P2|3 Month Follow-up|Overall Study||26
1708938|NCT00394212|4179960|P1|3 Month Follow-up|Overall Study||45
1708939|NCT00394212|4179959|P2|6 Week Follow-up|Overall Study||26
1708940|NCT00394212|4179960|P1|6 Week Follow-up|Overall Study||45
1708941|NCT00394212|4179959|P2|STARTED|Overall Study||27
1708942|NCT00394212|4179960|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
1708943|NCT00394095|4179974|P2|NOT COMPLETED|Overall Study||0
1708944|NCT00394095|4179975|P1|NOT COMPLETED|Overall Study||1
1708945|NCT00394095|4179974|P2|COMPLETED|Overall Study||14
1708946|NCT00394095|4179975|P1|COMPLETED|Overall Study||16
1708947|NCT00394095|4179974|P2|Screened|Overall Study||14
1708948|NCT00394095|4179975|P1|Screened|Overall Study||17
1708949|NCT00394095|4179974|P2|STARTED|Overall Study||14
1708950|NCT00394095|4179975|P1|STARTED|Overall Study||17
1708951|NCT00394082|4179983|P1|NOT COMPLETED|Overall Study||26
1708952|NCT00394082|4179983|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
1708953|NCT00394082|4179983|P1|At Least One Response Assessment|Overall Study||43
1708954|NCT00394082|4179983|P1|STARTED|Overall Study||50
1708955|NCT00393978|4179994|P2|NOT COMPLETED|Overall Study||20
1708956|NCT00393978|4179995|P1|NOT COMPLETED|Overall Study||16
1708957|NCT00393978|4179994|P2|COMPLETED|Overall Study||18
1708958|NCT00393978|4179995|P1|COMPLETED|Overall Study||21
1708959|NCT00393978|4179994|P2|STARTED|Overall Study||38
1708960|NCT00393978|4179995|P1|STARTED|Overall Study||37
1708961|NCT00393939|4180005|P2|NOT COMPLETED|Overall Study||297
1708962|NCT00393939|4180006|P1|NOT COMPLETED|Overall Study||296
1708963|NCT00393939|4180005|P2|COMPLETED|Overall Study||0
1708964|NCT00393939|4180006|P1|COMPLETED|Overall Study||0
1708965|NCT00393939|4180005|P2|Treated|Overall Study||293
1708966|NCT00393939|4180006|P1|Treated|Overall Study||295
1708967|NCT00393939|4180005|P2|STARTED|Overall Study||297
1708968|NCT00393939|4180006|P1|STARTED|Overall Study||296
1708969|NCT00393913|4180024|P1|NOT COMPLETED|CPAP Withdrawal||0
1708970|NCT00393913|4180024|P1|COMPLETED|CPAP Withdrawal||42
1708971|NCT00393913|4180024|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
1708972|NCT00393913|4180024|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
1708973|NCT00393913|4180024|P1|NOT COMPLETED|CPAP||7
1708974|NCT00393913|4180024|P1|COMPLETED|CPAP||93
1708975|NCT00393913|4180024|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
1708976|NCT00393913|4180024|P1|NOT COMPLETED|Initial Assessment||37
1708977|NCT00393913|4180024|P1|COMPLETED|Initial Assessment||107
1708978|NCT00393913|4180024|P1|STARTED|Initial Assessment||144
1708979|NCT00393887|4180032|P2|NOT COMPLETED|Overall Study||9
1708980|NCT00393887|4180033|P1|NOT COMPLETED|Overall Study||16
1708981|NCT00393887|4180032|P2|COMPLETED|Overall Study||41
1708982|NCT00393887|4180033|P1|COMPLETED|Overall Study||34
1708983|NCT00393887|4180032|P2|1 Year|Overall Study||50
1708984|NCT00393887|4180033|P1|1 Year|Overall Study||45
1708985|NCT00393887|4180032|P2|STARTED|Overall Study||50
1708986|NCT00393887|4180033|P1|STARTED|Overall Study||50
1708987|NCT00393874|4180042|P3|NOT COMPLETED|Overall Study||2
1708988|NCT00393874|4180043|P2|NOT COMPLETED|Overall Study||4
1708989|NCT00393874|4180044|P1|NOT COMPLETED|Overall Study||3
1708990|NCT00393874|4180042|P3|COMPLETED|Overall Study||13
1708991|NCT00393874|4180043|P2|COMPLETED|Overall Study||13
1708992|NCT00393874|4180044|P1|COMPLETED|Overall Study||15
1708993|NCT00393874|4180042|P3|STARTED|Overall Study||15
1708994|NCT00393874|4180043|P2|STARTED|Overall Study||17
1708995|NCT00393874|4180044|P1|STARTED|Overall Study||18
1708996|NCT00393861|4180061|P1|NOT COMPLETED|Overall Study||26
1708997|NCT00393861|4180061|P1|COMPLETED|Overall Study||3
1708998|NCT00393861|4180061|P1|STARTED|Overall Study||29
1708999|NCT00393848|4180072|P4|NOT COMPLETED|Overall Study||1
1709000|NCT00393848|4180073|P3|NOT COMPLETED|Overall Study||2
1709001|NCT00393848|4180074|P2|NOT COMPLETED|Overall Study||0
1709002|NCT00393848|4180075|P1|NOT COMPLETED|Overall Study||0
1709003|NCT00393848|4180072|P4|COMPLETED|Overall Study||8
1709004|NCT00393848|4180073|P3|COMPLETED|Overall Study||4
1709005|NCT00393848|4180074|P2|COMPLETED|Overall Study||9
1709006|NCT00393848|4180075|P1|COMPLETED|Overall Study||16
1709007|NCT00393848|4180072|P4|STARTED|Overall Study||9
1709008|NCT00393848|4180073|P3|STARTED|Overall Study||6
1709009|NCT00393848|4180074|P2|STARTED|Overall Study||9
1709010|NCT00393848|4180075|P1|STARTED|Overall Study||16
1709011|NCT00393796|4180089|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
1709012|NCT00393796|4180090|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
1709013|NCT00393796|4180089|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
1709014|NCT00393796|4180090|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
1709015|NCT00393796|4180089|P2|STARTED|Open Label Period - Placebo to SUTENT||16
1709016|NCT00393796|4180090|P1|STARTED|Open Label Period - Placebo to SUTENT||0
1709017|NCT00393796|4180089|P2|NOT COMPLETED|Double Blind Period||0
1709018|NCT00393796|4180090|P1|NOT COMPLETED|Double Blind Period||0
1709019|NCT00393796|4180089|P2|COMPLETED|Double Blind Period||28
1709020|NCT00393796|4180090|P1|COMPLETED|Double Blind Period||26
1709021|NCT00393796|4180089|P2|STARTED|Double Blind Period||28
1709022|NCT00393796|4180090|P1|STARTED|Double Blind Period||26
1709023|NCT00393718|4180098|P2|NOT COMPLETED|Overall Study||22
1709024|NCT00393718|4180099|P1|NOT COMPLETED|Overall Study||43
1709025|NCT00393718|4180098|P2|COMPLETED|Overall Study||110
1709026|NCT00393718|4180099|P1|COMPLETED|Overall Study||225
1709027|NCT00393718|4180098|P2|STARTED|Overall Study||132
1709028|NCT00393718|4180099|P1|STARTED|Overall Study||268
1709029|NCT00393705|4180131|P2|NOT COMPLETED|Overall Study||23
1709030|NCT00393705|4180132|P1|NOT COMPLETED|Overall Study||23
1709031|NCT00393705|4180131|P2|COMPLETED|Overall Study||128
1709032|NCT00393705|4180132|P1|COMPLETED|Overall Study||128
1709033|NCT00393705|4180131|P2|Received at Least One Dose of Study Drug|Overall Study||139
1709034|NCT00393705|4180132|P1|Received at Least One Dose of Study Drug|Overall Study||139
1709035|NCT00393705|4180131|P2|STARTED|Overall Study||151
1709036|NCT00393705|4180132|P1|STARTED|Overall Study||151
1709037|NCT00393523|4180161|P5|NOT COMPLETED|Overall Study||1
1709038|NCT00393523|4180162|P4|NOT COMPLETED|Overall Study||6
1709039|NCT00393523|4180163|P3|NOT COMPLETED|Overall Study||4
1709040|NCT00393523|4180164|P2|NOT COMPLETED|Overall Study||9
1709041|NCT00393523|4180165|P1|NOT COMPLETED|Overall Study||12
1709042|NCT00393523|4180161|P5|COMPLETED|Overall Study||19
1709043|NCT00393523|4180162|P4|COMPLETED|Overall Study||348
1709044|NCT00393523|4180163|P3|COMPLETED|Overall Study||349
1709045|NCT00393523|4180164|P2|COMPLETED|Overall Study||366
1709046|NCT00393523|4180165|P1|COMPLETED|Overall Study||364
1709047|NCT00393523|4180161|P5|Vaccination Visit 1|Overall Study||20
1709048|NCT00393523|4180162|P4|Vaccination Visit 1|Overall Study||352
1709049|NCT00393523|4180163|P3|Vaccination Visit 1|Overall Study||349
1709050|NCT00393523|4180164|P2|Vaccination Visit 1|Overall Study||375
1709051|NCT00393523|4180165|P1|Vaccination Visit 1|Overall Study||374
1709052|NCT00393523|4180161|P5|STARTED|Overall Study||20
1709053|NCT00393523|4180162|P4|STARTED|Overall Study||354
1709054|NCT00393523|4180163|P3|STARTED|Overall Study||353
1709055|NCT00393523|4180164|P2|STARTED|Overall Study||375
1709056|NCT00393523|4180165|P1|STARTED|Overall Study||376
1709057|NCT00393510|4180182|P2|NOT COMPLETED|Overall Study||9
1709058|NCT00393510|4180183|P1|NOT COMPLETED|Overall Study||3
1709059|NCT00393510|4180182|P2|COMPLETED|Overall Study||31
1709060|NCT00393510|4180183|P1|COMPLETED|Overall Study||37
1709061|NCT00393510|4180182|P2|STARTED|Overall Study||40
1709062|NCT00393510|4180183|P1|STARTED|Overall Study||40
1709063|NCT00393484|4180195|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
1709064|NCT00393484|4180196|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
1709065|NCT00393484|4180195|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
1709066|NCT00393484|4180196|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
1709067|NCT00393484|4180195|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
1709068|NCT00393484|4180196|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
1709069|NCT00393484|4180195|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
1709070|NCT00393484|4180196|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
1709071|NCT00393484|4180195|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
1709072|NCT00393484|4180196|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
1709073|NCT00393484|4180195|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
1709074|NCT00393484|4180196|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
1709075|NCT00393484|4180195|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
1709076|NCT00393484|4180196|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
1709077|NCT00393484|4180195|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
1709078|NCT00393484|4180196|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
1709079|NCT00393484|4180195|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
1709080|NCT00393484|4180196|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
1709081|NCT00393458|4180232|P4|NOT COMPLETED|Overall Study||137
1709082|NCT00393458|4180233|P3|NOT COMPLETED|Overall Study||112
1709083|NCT00393458|4180234|P2|NOT COMPLETED|Overall Study||102
1709084|NCT00393458|4180235|P1|NOT COMPLETED|Overall Study||99
1709085|NCT00393458|4180232|P4|COMPLETED|Overall Study||295
1709086|NCT00393458|4180233|P3|COMPLETED|Overall Study||323
1709087|NCT00393458|4180234|P2|COMPLETED|Overall Study||326
1709088|NCT00393458|4180235|P1|COMPLETED|Overall Study||338
1709089|NCT00393458|4180232|P4|Exposed to Study Medication or Placebo|Overall Study||432
1709090|NCT00393458|4180233|P3|Exposed to Study Medication or Placebo|Overall Study||434
1709091|NCT00393458|4180234|P2|Exposed to Study Medication or Placebo|Overall Study||425
1709092|NCT00393458|4180235|P1|Exposed to Study Medication or Placebo|Overall Study||437
1709093|NCT00393458|4180232|P4|STARTED|Overall Study||432
1709094|NCT00393458|4180233|P3|STARTED|Overall Study||435
1709095|NCT00393458|4180234|P2|STARTED|Overall Study||428
1709096|NCT00393458|4180235|P1|STARTED|Overall Study||437
1709097|NCT00393380|4180249|P1|NOT COMPLETED|Overall Study||0
1709098|NCT00393380|4180249|P1|COMPLETED|Overall Study||13
1709099|NCT00393380|4180249|P1|STARTED|Overall Study||13
1709100|NCT00393367|4180262|P2|NOT COMPLETED|Overall Study||7
1709101|NCT00393367|4180263|P1|NOT COMPLETED|Overall Study||2
1709102|NCT00393367|4180262|P2|COMPLETED|Overall Study||81
1709103|NCT00393367|4180263|P1|COMPLETED|Overall Study||89
1709104|NCT00393367|4180262|P2|STARTED|Overall Study||88
1709105|NCT00393367|4180263|P1|STARTED|Overall Study||91
1709106|NCT00393094|4180291|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
1709107|NCT00393094|4180291|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
1709108|NCT00393094|4180291|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
1709109|NCT00393094|4180291|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
1709110|NCT00393094|4180291|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
1709111|NCT00393094|4180291|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
1709112|NCT00393068|4180298|P1|NOT COMPLETED|Overall Study||18
1709113|NCT00393068|4180298|P1|COMPLETED|Overall Study||44
1709114|NCT00393068|4180298|P1|STARTED|Overall Study||62
1709115|NCT00393042|4180302|P2|NOT COMPLETED|Second Intervetion||8
1709116|NCT00393042|4180303|P1|NOT COMPLETED|Second Intervetion||2
1709117|NCT00393042|4180302|P2|COMPLETED|Second Intervetion||19
1709118|NCT00393042|4180303|P1|COMPLETED|Second Intervetion||24
1709119|NCT00393042|4180302|P2|Completed 25/30 mg Dosage|Second Intervetion||20
1709120|NCT00393042|4180303|P1|Completed 25/30 mg Dosage|Second Intervetion||24
1709121|NCT00393042|4180302|P2|Completed the 20mg Dosage|Second Intervetion||21
1709122|NCT00393042|4180303|P1|Completed the 20mg Dosage|Second Intervetion||24
1709123|NCT00393042|4180302|P2|Completed 10 mg Dosage|Second Intervetion||24
1709124|NCT00393042|4180303|P1|Completed 10 mg Dosage|Second Intervetion||26
1709125|NCT00393042|4180302|P2|Completed Placebo Dosage|Second Intervetion||21
1709126|NCT00393042|4180303|P1|Completed Placebo Dosage|Second Intervetion||25
1709127|NCT00393042|4180302|P2|STARTED|Second Intervetion||27
1709128|NCT00393042|4180303|P1|STARTED|Second Intervetion||26
1709129|NCT00393042|4180302|P2|NOT COMPLETED|First Intervention||6
1709130|NCT00393042|4180303|P1|NOT COMPLETED|First Intervention||5
1709131|NCT00393042|4180302|P2|COMPLETED|First Intervention||27
1709132|NCT00393042|4180303|P1|COMPLETED|First Intervention||26
1709133|NCT00393042|4180302|P2|Completed 25/30mg Dosage|First Intervention||27
1709134|NCT00393042|4180303|P1|Completed 25/30mg Dosage|First Intervention||27
1709135|NCT00393042|4180302|P2|Completed 20 mg Dosage|First Intervention||28
1709136|NCT00393042|4180303|P1|Completed 20 mg Dosage|First Intervention||26
1709137|NCT00393042|4180302|P2|Completed 10mg Dosage|First Intervention||29
1709138|NCT00393042|4180303|P1|Completed 10mg Dosage|First Intervention||29
1709139|NCT00393042|4180302|P2|Completed the Placebo Dosage|First Intervention||29
1709140|NCT00393042|4180303|P1|Completed the Placebo Dosage|First Intervention||27
1709141|NCT00393042|4180302|P2|STARTED|First Intervention||33
1709142|NCT00393042|4180303|P1|STARTED|First Intervention||31
1709143|NCT00393029|4180375|P2|NOT COMPLETED|Overall Study||1
1709144|NCT00393029|4180376|P1|NOT COMPLETED|Overall Study||0
1709145|NCT00393029|4180375|P2|COMPLETED|Overall Study||9
1709146|NCT00393029|4180376|P1|COMPLETED|Overall Study||2
1709147|NCT00393029|4180375|P2|STARTED|Overall Study||10
1709148|NCT00393029|4180376|P1|STARTED|Overall Study||2
1709149|NCT00392951|4180385|P1|NOT COMPLETED|Overall Study||0
1709150|NCT00392951|4180385|P1|COMPLETED|Overall Study||30
1709151|NCT00392951|4180385|P1|STARTED|Overall Study||30
1709152|NCT00392925|4180397|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
1709153|NCT00392925|4180398|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
1709154|NCT00392925|4180399|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
1709155|NCT00392925|4180400|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
1709156|NCT00392925|4180397|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
1709157|NCT00392925|4180398|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
1709158|NCT00392925|4180399|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
1709159|NCT00392925|4180400|P1|COMPLETED|Randomization to Treatment Group Period||0
1709160|NCT00392925|4180397|P4|STARTED|Randomization to Treatment Group Period||56
1709161|NCT00392925|4180398|P3|STARTED|Randomization to Treatment Group Period||56
1709162|NCT00392925|4180399|P2|STARTED|Randomization to Treatment Group Period||27
1709163|NCT00392925|4180400|P1|STARTED|Randomization to Treatment Group Period||0
1709164|NCT00392925|4180397|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1709165|NCT00392925|4180398|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1709166|NCT00392925|4180399|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1709167|NCT00392925|4180400|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
1709168|NCT00392925|4180397|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1709169|NCT00392925|4180398|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1709170|NCT00392925|4180399|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
1709171|NCT00392925|4180400|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
1709172|NCT00392925|4180397|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
1709173|NCT00392925|4180398|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
1709174|NCT00392925|4180399|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
1709175|NCT00392925|4180400|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
1709176|NCT00392860|4180488|P3|NOT COMPLETED|Overall Study||0
1709177|NCT00392860|4180489|P2|NOT COMPLETED|Overall Study||0
1709178|NCT00392860|4180490|P1|NOT COMPLETED|Overall Study||0
1709179|NCT00392860|4180488|P3|COMPLETED|Overall Study||1
1709180|NCT00392860|4180489|P2|COMPLETED|Overall Study||0
1709181|NCT00392860|4180490|P1|COMPLETED|Overall Study||3
1709182|NCT00392860|4180488|P3|STARTED|Overall Study||1
1709183|NCT00392860|4180489|P2|STARTED|Overall Study||0
1709184|NCT00392860|4180490|P1|STARTED|Overall Study||3
1709185|NCT00392834|4180498|P2|NOT COMPLETED|Overall Study||0
1709186|NCT00392834|4180499|P1|NOT COMPLETED|Overall Study||0
1709187|NCT00392834|4180498|P2|COMPLETED|Overall Study||32
1709188|NCT00392834|4180499|P1|COMPLETED|Overall Study||2
1709189|NCT00392834|4180498|P2|STARTED|Overall Study||32
1709190|NCT00392834|4180499|P1|STARTED|Overall Study||2
1709191|NCT00392821|4180505|P1|NOT COMPLETED|Overall Study||19
1709192|NCT00392821|4180505|P1|COMPLETED|Overall Study||59
1709193|NCT00392821|4180505|P1|STARTED|Overall Study||78
1709194|NCT00392808|4180514|P4|NOT COMPLETED|Overall Study||4
1709195|NCT00392808|4180515|P3|NOT COMPLETED|Overall Study||2
1709196|NCT00392808|4180516|P2|NOT COMPLETED|Overall Study||3
1709197|NCT00392808|4180517|P1|NOT COMPLETED|Overall Study||6
1709198|NCT00392808|4180514|P4|COMPLETED|Overall Study||100
1709199|NCT00392808|4180515|P3|COMPLETED|Overall Study||107
1709200|NCT00392808|4180516|P2|COMPLETED|Overall Study||86
1709201|NCT00392808|4180517|P1|COMPLETED|Overall Study||81
1709202|NCT00392808|4180514|P4|STARTED|Overall Study||104
1709203|NCT00392808|4180515|P3|STARTED|Overall Study||109
1709204|NCT00392808|4180516|P2|STARTED|Overall Study||89
1709205|NCT00392808|4180517|P1|STARTED|Overall Study||87
1709206|NCT00392782|4180531|P1|NOT COMPLETED|Overall Study||0
1709207|NCT00392782|4180531|P1|COMPLETED|Overall Study||24
1709208|NCT00392782|4180531|P1|STARTED|Overall Study||24
1709209|NCT00392769|4180541|P1|NOT COMPLETED|Overall Study||10
1709210|NCT00392769|4180541|P1|COMPLETED|Overall Study||23
1709211|NCT00392769|4180541|P1|STARTED|Overall Study||33
1709212|NCT00392704|4180545|P1|NOT COMPLETED|Combined Modality Therapy||5
1709213|NCT00392704|4180545|P1|COMPLETED|Combined Modality Therapy||49
1709214|NCT00392704|4180545|P1|STARTED|Combined Modality Therapy||54
1709215|NCT00392704|4180545|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
1709216|NCT00392704|4180545|P1|COMPLETED|Neoadjuvant Chemotherapy||54
1709217|NCT00392704|4180545|P1|STARTED|Neoadjuvant Chemotherapy||60
1709218|NCT00392678|4180554|P4|NOT COMPLETED|Overall Study||1
1709219|NCT00392678|4180555|P3|NOT COMPLETED|Overall Study||2
1709220|NCT00392678|4180556|P2|NOT COMPLETED|Overall Study||1
1709221|NCT00392678|4180557|P1|NOT COMPLETED|Overall Study||0
1709222|NCT00392678|4180554|P4|COMPLETED|Overall Study||26
1709223|NCT00392678|4180555|P3|COMPLETED|Overall Study||25
1709224|NCT00392678|4180556|P2|COMPLETED|Overall Study||26
1709225|NCT00392678|4180557|P1|COMPLETED|Overall Study||27
1709226|NCT00392678|4180554|P4|STARTED|Overall Study||27
1709227|NCT00392678|4180555|P3|STARTED|Overall Study||27
1709228|NCT00392678|4180556|P2|STARTED|Overall Study||27
1709229|NCT00392678|4180557|P1|STARTED|Overall Study||27
1709230|NCT00392665|4180593|P2|NOT COMPLETED|Overall Study||15
1709231|NCT00392665|4180594|P1|NOT COMPLETED|Overall Study||17
1709232|NCT00392665|4180593|P2|COMPLETED|Overall Study||3
1709233|NCT00392665|4180594|P1|COMPLETED|Overall Study||1
1709234|NCT00392665|4180593|P2|STARTED|Overall Study||18
1709235|NCT00392665|4180594|P1|STARTED|Overall Study||18
1709236|NCT00392496|4180606|P1|NOT COMPLETED|Overall Study||0
1709237|NCT00392496|4180606|P1|COMPLETED|Overall Study||19
1709238|NCT00392496|4180606|P1|STARTED|Overall Study||19
1709239|NCT00392444|4180610|P1|NOT COMPLETED|Overall Study||0
1709240|NCT00392444|4180610|P1|COMPLETED|Overall Study||39
1709241|NCT00392444|4180610|P1|STARTED|Overall Study||39
1709242|NCT00392392|4180614|P1|NOT COMPLETED|Overall Study||20
1709243|NCT00392392|4180614|P1|COMPLETED|Overall Study||9
1709244|NCT00392392|4180614|P1|STARTED|Overall Study||29
1709245|NCT00392379|4180620|P2|NOT COMPLETED|Overall Study||38
1709246|NCT00392379|4180621|P1|NOT COMPLETED|Overall Study||22
1709247|NCT00392379|4180620|P2|COMPLETED|Overall Study|Medication period|96
1709248|NCT00392379|4180621|P1|COMPLETED|Overall Study|Medication period|114
1709249|NCT00392379|4180620|P2|STARTED|Overall Study|Medication period|134
1709250|NCT00392379|4180621|P1|STARTED|Overall Study|Medication period|136
1709251|NCT00392288|4180634|P3|NOT COMPLETED|Overall Study||17
1709252|NCT00392288|4180635|P2|NOT COMPLETED|Overall Study||22
1709253|NCT00392288|4180636|P1|NOT COMPLETED|Overall Study||32
1709254|NCT00392288|4180634|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
1709255|NCT00392288|4180635|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
1709256|NCT00392288|4180636|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
1709257|NCT00392288|4180634|P3|Treatment Period|Overall Study||175
1709258|NCT00392288|4180635|P2|Treatment Period|Overall Study||174
1709259|NCT00392288|4180636|P1|Treatment Period|Overall Study||172
1709260|NCT00392288|4180634|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
1709261|NCT00392288|4180635|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
1709262|NCT00392288|4180636|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
1709263|NCT00392236|4180652|P2|NOT COMPLETED|Overall Study||6
1709264|NCT00392236|4180653|P1|NOT COMPLETED|Overall Study||12
1709265|NCT00392236|4180652|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
1709266|NCT00392236|4180653|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
1709267|NCT00392236|4180652|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
1709268|NCT00392236|4180653|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
1709269|NCT00392223|4180661|P2|NOT COMPLETED|Overall Study||13
1709270|NCT00392223|4180662|P1|NOT COMPLETED|Overall Study||9
1709271|NCT00392223|4180661|P2|COMPLETED|Overall Study||47
1709272|NCT00392223|4180662|P1|COMPLETED|Overall Study||49
1709273|NCT00392223|4180661|P2|STARTED|Overall Study||60
1709274|NCT00392223|4180662|P1|STARTED|Overall Study||58
1709275|NCT00392210|4180680|P2|NOT COMPLETED|Second Voiding Trial||0
1709276|NCT00392210|4180681|P1|NOT COMPLETED|Second Voiding Trial||0
1709277|NCT00392210|4180680|P2|COMPLETED|Second Voiding Trial||31
1709278|NCT00392210|4180681|P1|COMPLETED|Second Voiding Trial||34
1709279|NCT00392210|4180680|P2|STARTED|Second Voiding Trial||31
1709280|NCT00392210|4180681|P1|STARTED|Second Voiding Trial||34
1709281|NCT00392210|4180680|P2|NOT COMPLETED|First Voiding Trial||2
1709282|NCT00392210|4180681|P1|NOT COMPLETED|First Voiding Trial||2
1709283|NCT00392210|4180680|P2|COMPLETED|First Voiding Trial||31
1709284|NCT00392210|4180681|P1|COMPLETED|First Voiding Trial||34
1709285|NCT00392210|4180680|P2|STARTED|First Voiding Trial||33
1709286|NCT00392210|4180681|P1|STARTED|First Voiding Trial||36
1709287|NCT00392197|4180689|P2|NOT COMPLETED|Overall Study||30
1709288|NCT00392197|4180690|P1|NOT COMPLETED|Overall Study||21
1709289|NCT00392197|4180689|P2|COMPLETED|Overall Study||33
1709290|NCT00392197|4180690|P1|COMPLETED|Overall Study||27
1709291|NCT00392197|4180689|P2|STARTED|Overall Study||63
1709292|NCT00392197|4180690|P1|STARTED|Overall Study||48
1709293|NCT00392171|4180698|P1|NOT COMPLETED|Overall Study||105
1709294|NCT00392171|4180698|P1|COMPLETED|Overall Study||15
1709295|NCT00392171|4180698|P1|STARTED|Overall Study||120
1709296|NCT00391989|4180702|P1|NOT COMPLETED|Overall Study||2
1709297|NCT00391989|4180702|P1|COMPLETED|Overall Study||53
1709298|NCT00391989|4180702|P1|STARTED|Overall Study||55
1709299|NCT00391976|4180709|P3|NOT COMPLETED|Overall Study||35
1709300|NCT00391976|4180710|P2|NOT COMPLETED|Overall Study||25
1709301|NCT00391976|4180711|P1|NOT COMPLETED|Overall Study||27
1709302|NCT00391976|4180709|P3|COMPLETED|Overall Study||0
1709303|NCT00391976|4180710|P2|COMPLETED|Overall Study||18
1709304|NCT00391976|4180711|P1|COMPLETED|Overall Study||18
1709305|NCT00391976|4180709|P3|Safety Population|Overall Study||35
1709306|NCT00391976|4180710|P2|Safety Population|Overall Study||43
1709307|NCT00391976|4180711|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
1709308|NCT00391976|4180709|P3|Randomized|Overall Study||0
1709309|NCT00391976|4180710|P2|Randomized|Overall Study||43
1709310|NCT00391976|4180711|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
1709311|NCT00391976|4180709|P3|STARTED|Overall Study||35
1709312|NCT00391976|4180710|P2|STARTED|Overall Study||43
1709313|NCT00391976|4180711|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
1709314|NCT00391898|4180735|P2|NOT COMPLETED|Overall Study||10
1709315|NCT00391898|4180736|P1|NOT COMPLETED|Overall Study||11
1709316|NCT00391898|4180735|P2|COMPLETED|Overall Study||39
1709317|NCT00391898|4180736|P1|COMPLETED|Overall Study||35
1709318|NCT00391898|4180735|P2|STARTED|Overall Study||49
1709319|NCT00391898|4180736|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
1709320|NCT00391872|4180756|P2|NOT COMPLETED|Overall Study||255
1709321|NCT00391872|4180757|P1|NOT COMPLETED|Overall Study||307
1709322|NCT00391872|4180756|P2|COMPLETED|Overall Study||9036
1709323|NCT00391872|4180757|P1|COMPLETED|Overall Study||9026
1709324|NCT00391872|4180756|P2|STARTED|Overall Study||9291
1709325|NCT00391872|4180757|P1|STARTED|Overall Study||9333
1709326|NCT00391846|4180795|P2|NOT COMPLETED|Overall Study||7
1709327|NCT00391846|4180796|P1|NOT COMPLETED|Overall Study||8
1709328|NCT00391846|4180795|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
1709329|NCT00391846|4180796|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
1709330|NCT00391846|4180795|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
1709331|NCT00391846|4180796|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
1709332|NCT00391807|4180816|P1|NOT COMPLETED|Overall Study||715
1709333|NCT00391807|4180816|P1|COMPLETED|Overall Study||968
1709334|NCT00391807|4180816|P1|STARTED|Overall Study||1683
1709335|NCT00391768|4180843|P7|NOT COMPLETED|Overall Study||4
1709336|NCT00391768|4180844|P6|NOT COMPLETED|Overall Study||3
1709337|NCT00391768|4180845|P5|NOT COMPLETED|Overall Study||2
1709338|NCT00391768|4180846|P4|NOT COMPLETED|Overall Study||1
1709339|NCT00391768|4180847|P3|NOT COMPLETED|Overall Study||1
1709340|NCT00391768|4180848|P2|NOT COMPLETED|Overall Study||0
1709341|NCT00391768|4180849|P1|NOT COMPLETED|Overall Study||0
1709342|NCT00391768|4180843|P7|COMPLETED|Overall Study||19
1709343|NCT00391768|4180844|P6|COMPLETED|Overall Study||7
1709344|NCT00391768|4180845|P5|COMPLETED|Overall Study||22
1709345|NCT00391768|4180846|P4|COMPLETED|Overall Study||7
1709346|NCT00391768|4180847|P3|COMPLETED|Overall Study||6
1709347|NCT00391768|4180848|P2|COMPLETED|Overall Study||3
1709348|NCT00391768|4180849|P1|COMPLETED|Overall Study||12
1709349|NCT00391768|4180843|P7|STARTED|Overall Study||23
1709350|NCT00391768|4180844|P6|STARTED|Overall Study||10
1709351|NCT00391768|4180845|P5|STARTED|Overall Study||24
1709352|NCT00391768|4180846|P4|STARTED|Overall Study||8
1709353|NCT00391768|4180847|P3|STARTED|Overall Study||7
1709354|NCT00391768|4180848|P2|STARTED|Overall Study||3
1709355|NCT00391768|4180849|P1|STARTED|Overall Study||12
1709356|NCT00391716|4180917|P3|NOT COMPLETED|Overall Study||19
1709357|NCT00391716|4180918|P2|NOT COMPLETED|Overall Study||19
1709358|NCT00391716|4180919|P1|NOT COMPLETED|Overall Study||27
1709359|NCT00391716|4180917|P3|COMPLETED|Overall Study||30
1709360|NCT00391716|4180918|P2|COMPLETED|Overall Study||28
1709361|NCT00391716|4180919|P1|COMPLETED|Overall Study||27
1709362|NCT00391716|4180917|P3|STARTED|Overall Study||49
1709363|NCT00391716|4180918|P2|STARTED|Overall Study||47
1709364|NCT00391716|4180919|P1|STARTED|Overall Study||54
1709365|NCT00391625|4180936|P1|NOT COMPLETED|Month 84||0
1709366|NCT00391625|4180936|P1|COMPLETED|Month 84||8
1709367|NCT00391625|4180936|P1|STARTED|Month 84||8
1709368|NCT00391625|4180936|P1|NOT COMPLETED|Month 50||1
1709369|NCT00391625|4180936|P1|COMPLETED|Month 50||8
1709370|NCT00391625|4180936|P1|STARTED|Month 50||9
1709371|NCT00391625|4180936|P1|NOT COMPLETED|Month 14||1
1709372|NCT00391625|4180936|P1|COMPLETED|Month 14||9
1709373|NCT00391625|4180936|P1|STARTED|Month 14||10
1709374|NCT00391625|4180936|P1|NOT COMPLETED|Baseline||0
1709375|NCT00391625|4180936|P1|COMPLETED|Baseline||10
1709376|NCT00391625|4180936|P1|STARTED|Baseline||10
1709377|NCT00391599|4180978|P2|NOT COMPLETED|Overall Study||0
1709378|NCT00391599|4180979|P1|NOT COMPLETED|Overall Study||0
1709379|NCT00391599|4180978|P2|COMPLETED|Overall Study||65
1709380|NCT00391599|4180979|P1|COMPLETED|Overall Study||65
1709381|NCT00391599|4180978|P2|STARTED|Overall Study||65
1709382|NCT00391599|4180979|P1|STARTED|Overall Study||65
1709383|NCT00391586|4180989|P1|NOT COMPLETED|Overall Study||24
1709384|NCT00391586|4180989|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
1709385|NCT00391586|4180989|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
1709386|NCT00391586|4180989|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
1709387|NCT00391586|4180989|P1|STARTED|Overall Study||45
1709388|NCT00391469|4180998|P2|NOT COMPLETED|Overall Study||0
1709389|NCT00391469|4180999|P1|NOT COMPLETED|Overall Study||0
1709390|NCT00391469|4180998|P2|COMPLETED|Overall Study||671
1709391|NCT00391469|4180999|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
1709392|NCT00391469|4180998|P2|STARTED|Overall Study||671
1709393|NCT00391469|4180999|P1|STARTED|Overall Study||688
1709394|NCT00391443|4181013|P2|NOT COMPLETED|Overall Study||0
1709395|NCT00391443|4181014|P1|NOT COMPLETED|Overall Study||0
1709396|NCT00391443|4181013|P2|COMPLETED|Overall Study||407
1709397|NCT00391443|4181014|P1|COMPLETED|Overall Study||209
1709398|NCT00391443|4181013|P2|STARTED|Overall Study||407
1709399|NCT00391443|4181014|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
1709400|NCT00391391|4181026|P4|NOT COMPLETED|Overall Study||19
1709401|NCT00391391|4181027|P3|NOT COMPLETED|Overall Study||23
1709402|NCT00391391|4181028|P2|NOT COMPLETED|Overall Study||10
1709403|NCT00391391|4181029|P1|NOT COMPLETED|Overall Study||9
1709404|NCT00391391|4181026|P4|COMPLETED|Overall Study||145
1709405|NCT00391391|4181027|P3|COMPLETED|Overall Study||138
1709406|NCT00391391|4181028|P2|COMPLETED|Overall Study||87
1709407|NCT00391391|4181029|P1|COMPLETED|Overall Study||89
1709408|NCT00391391|4181026|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
1709409|NCT00391391|4181027|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
1709410|NCT00391391|4181028|P2|STARTED|Overall Study||97
1709411|NCT00391391|4181029|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
1709412|NCT00391365|4181061|P2|NOT COMPLETED|Overall Study||19
1709413|NCT00391365|4181062|P1|NOT COMPLETED|Overall Study||25
1709414|NCT00391365|4181061|P2|COMPLETED|Overall Study||151
1709415|NCT00391365|4181062|P1|COMPLETED|Overall Study||78
1709416|NCT00391365|4181061|P2|STARTED|Overall Study||170
1709417|NCT00391365|4181062|P1|STARTED|Overall Study||103
1709418|NCT00391274|4181074|P2|NOT COMPLETED|Overall Study||57
1709419|NCT00391274|4181075|P1|NOT COMPLETED|Overall Study||61
1709420|NCT00391274|4181074|P2|COMPLETED|Overall Study||47
1709421|NCT00391274|4181075|P1|COMPLETED|Overall Study||46
1709422|NCT00391274|4181074|P2|Received at Least One Dose of Study Drug|Overall Study||102
1709423|NCT00391274|4181075|P1|Received at Least One Dose of Study Drug|Overall Study||106
1709424|NCT00391274|4181074|P2|STARTED|Overall Study||104
1709425|NCT00391274|4181075|P1|STARTED|Overall Study||107
1709426|NCT00391222|4181094|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
1709427|NCT00391222|4181095|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
1709428|NCT00391222|4181096|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
1709429|NCT00391222|4181097|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
1709430|NCT00391222|4181094|P4|COMPLETED|Period III (Double-Blind Treatment)||0
1709431|NCT00391222|4181095|P3|COMPLETED|Period III (Double-Blind Treatment)||108
1709432|NCT00391222|4181096|P2|COMPLETED|Period III (Double-Blind Treatment)||113
1709433|NCT00391222|4181097|P1|COMPLETED|Period III (Double-Blind Treatment)||104
1709434|NCT00391222|4181094|P4|STARTED|Period III (Double-Blind Treatment)||0
1709435|NCT00391222|4181095|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
1709436|NCT00391222|4181096|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
1709437|NCT00391222|4181097|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
1709438|NCT00391222|4181094|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
1709439|NCT00391222|4181095|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
1709440|NCT00391222|4181096|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
1709441|NCT00391222|4181097|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
1709442|NCT00391222|4181094|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
1709443|NCT00391222|4181095|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
1709444|NCT00391222|4181096|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
1709445|NCT00391222|4181097|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
1709446|NCT00391222|4181094|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
1709447|NCT00391222|4181095|P3|STARTED|Period II (Open-label Risperidone LAI)||0
1709448|NCT00391222|4181096|P2|STARTED|Period II (Open-label Risperidone LAI)||0
1709449|NCT00391222|4181097|P1|STARTED|Period II (Open-label Risperidone LAI)||0
1709450|NCT00391092|4181123|P2|NOT COMPLETED|Overall Study||216
1709451|NCT00391092|4181124|P1|NOT COMPLETED|Overall Study||208
1709452|NCT00391092|4181123|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
1709453|NCT00391092|4181124|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
1709454|NCT00391092|4181123|P2|Received Treatment|Overall Study||215
1709455|NCT00391092|4181124|P1|Received Treatment|Overall Study||206
1709456|NCT00391092|4181123|P2|STARTED|Overall Study||216
1709457|NCT00391092|4181124|P1|STARTED|Overall Study||208
1709458|NCT00391079|4181144|P2|NOT COMPLETED|Overall Study||16
1709459|NCT00391079|4181145|P1|NOT COMPLETED|Overall Study||26
1709460|NCT00391079|4181144|P2|COMPLETED|Overall Study||156
1709461|NCT00391079|4181145|P1|COMPLETED|Overall Study||141
1709462|NCT00391079|4181144|P2|STARTED|Overall Study||172
1709463|NCT00391079|4181145|P1|STARTED|Overall Study||167
1709464|NCT00391053|4181167|P4|NOT COMPLETED|Overall Study||10
1709465|NCT00391053|4181168|P3|NOT COMPLETED|Overall Study||2
1709466|NCT00391053|4181169|P2|NOT COMPLETED|Overall Study||1
1709467|NCT00391053|4181170|P1|NOT COMPLETED|Overall Study||9
1709468|NCT00391053|4181167|P4|COMPLETED|Overall Study||1252
1709469|NCT00391053|4181168|P3|COMPLETED|Overall Study||868
1709470|NCT00391053|4181169|P2|COMPLETED|Overall Study||847
1709471|NCT00391053|4181170|P1|COMPLETED|Overall Study||848
1709472|NCT00391053|4181167|P4|STARTED|Overall Study||1262
1709473|NCT00391053|4181168|P3|STARTED|Overall Study||870
1709474|NCT00391053|4181169|P2|STARTED|Overall Study||848
1709475|NCT00391053|4181170|P1|STARTED|Overall Study||857
1709476|NCT00391027|4181194|P2|NOT COMPLETED|Overall Study||12
1709477|NCT00391027|4181195|P1|NOT COMPLETED|Overall Study||25
1709478|NCT00391027|4181194|P2|COMPLETED|Overall Study||110
1709479|NCT00391027|4181195|P1|COMPLETED|Overall Study||110
1709480|NCT00391027|4181194|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
1709481|NCT00391027|4181195|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
1709482|NCT00390910|4181236|P3|NOT COMPLETED|Overall Study||10
1709483|NCT00390910|4181237|P2|NOT COMPLETED|Overall Study||4
1709484|NCT00390910|4181238|P1|NOT COMPLETED|Overall Study||2
1709485|NCT00390910|4181236|P3|COMPLETED|Overall Study||139
1709486|NCT00390910|4181237|P2|COMPLETED|Overall Study||83
1709487|NCT00390910|4181238|P1|COMPLETED|Overall Study||48
1709488|NCT00390910|4181236|P3|STARTED|Overall Study||149
1709489|NCT00390910|4181237|P2|STARTED|Overall Study||87
1709490|NCT00390910|4181238|P1|STARTED|Overall Study||50
1709491|NCT00390884|4181326|P2|NOT COMPLETED|Overall Study||2
1709492|NCT00390884|4181327|P1|NOT COMPLETED|Overall Study||2
1709493|NCT00390884|4181326|P2|COMPLETED|Overall Study||55
1709494|NCT00390884|4181327|P1|COMPLETED|Overall Study||114
1709495|NCT00390884|4181326|P2|STARTED|Overall Study||57
1709496|NCT00390884|4181327|P1|STARTED|Overall Study||116
1709497|NCT00390858|4181339|P2|NOT COMPLETED|Overall Study||7
1709498|NCT00390858|4181340|P1|NOT COMPLETED|Overall Study||9
1709499|NCT00390858|4181339|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
1709500|NCT00390858|4181340|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
1709501|NCT00390858|4181339|P2|Completed Core & Entered Extension Study|Overall Study||20
1709502|NCT00390858|4181340|P1|Completed Core & Entered Extension Study|Overall Study||19
1709503|NCT00390858|4181339|P2|STARTED|Overall Study|20 Participants started the Core Study|20
1709504|NCT00390858|4181340|P1|STARTED|Overall Study|20 participants started the Core Study|20
1709505|NCT00390806|4181354|P2|NOT COMPLETED|Overall Study||32
1709506|NCT00390806|4181355|P1|NOT COMPLETED|Overall Study||30
1709507|NCT00390806|4181354|P2|COMPLETED|Overall Study||204
1709508|NCT00390806|4181355|P1|COMPLETED|Overall Study||206
1709509|NCT00390806|4181354|P2|Ongoing|Overall Study||2
1709510|NCT00390806|4181355|P1|Ongoing|Overall Study||4
1709511|NCT00390806|4181354|P2|STARTED|Overall Study||236
1709512|NCT00390806|4181355|P1|STARTED|Overall Study||236
1709513|NCT00390780|4181423|P2|NOT COMPLETED|Overall Study||27
1709514|NCT00390780|4181424|P1|NOT COMPLETED|Overall Study||23
1709515|NCT00390780|4181423|P2|COMPLETED|Overall Study||260
1709516|NCT00390780|4181424|P1|COMPLETED|Overall Study||268
1709517|NCT00390780|4181423|P2|Treatment|Overall Study||287
1709518|NCT00390780|4181424|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
1709519|NCT00390780|4181423|P2|STARTED|Overall Study||287
1709520|NCT00390780|4181424|P1|STARTED|Overall Study||291
1709521|NCT00390689|4181457|P3|NOT COMPLETED|Overall Study||3
1709522|NCT00390689|4181458|P2|NOT COMPLETED|Overall Study||5
1709523|NCT00390689|4181459|P1|NOT COMPLETED|Overall Study||5
1709524|NCT00390689|4181457|P3|COMPLETED|Overall Study||50
1709525|NCT00390689|4181458|P2|COMPLETED|Overall Study||48
1709526|NCT00390689|4181459|P1|COMPLETED|Overall Study||43
1709527|NCT00390689|4181457|P3|STARTED|Overall Study||53
1709528|NCT00390689|4181458|P2|STARTED|Overall Study||53
1709529|NCT00390689|4181459|P1|STARTED|Overall Study||48
1709530|NCT00390611|4181519|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
1709531|NCT00390611|4181520|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
1709532|NCT00390611|4181519|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
1709533|NCT00390611|4181520|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
1709534|NCT00390611|4181519|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
1709535|NCT00390611|4181520|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
1709536|NCT00390611|4181519|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
1709537|NCT00390611|4181520|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
1709538|NCT00390611|4181519|P2|COMPLETED|6 Cycles of Study Treatment||37
1709539|NCT00390611|4181520|P1|COMPLETED|6 Cycles of Study Treatment||34
1709540|NCT00390611|4181519|P2|STARTED|6 Cycles of Study Treatment||42
1709541|NCT00390611|4181520|P1|STARTED|6 Cycles of Study Treatment||43
1709542|NCT00390572|4181534|P2|NOT COMPLETED|Overall Study||5
1709543|NCT00390572|4181535|P1|NOT COMPLETED|Overall Study||8
1709544|NCT00390572|4181534|P2|COMPLETED|Overall Study||64
1709545|NCT00390572|4181535|P1|COMPLETED|Overall Study||60
1709546|NCT00390572|4181534|P2|STARTED|Overall Study||69
1709547|NCT00390572|4181535|P1|STARTED|Overall Study||68
1709548|NCT00390559|4181549|P1|NOT COMPLETED|Overall Study||44
1709549|NCT00390559|4181549|P1|COMPLETED|Overall Study||80
1709550|NCT00390559|4181549|P1|ActiveP/PlaceboC|Overall Study||90
1709551|NCT00390559|4181549|P1|PlaceboP/PlaceboC|Overall Study||93
1709552|NCT00390559|4181549|P1|ActiveP/ActiveC|Overall Study||87
1709553|NCT00390559|4181549|P1|Received PlaceboP/Active C|Overall Study||93
1709554|NCT00390559|4181549|P1|STARTED|Overall Study||124
1709555|NCT00390546|4181561|P2|NOT COMPLETED|Overall Study||5
1709556|NCT00390546|4181562|P1|NOT COMPLETED|Overall Study||6
1709557|NCT00390546|4181561|P2|COMPLETED|Overall Study||34
1709558|NCT00390546|4181562|P1|COMPLETED|Overall Study||27
1709559|NCT00390546|4181561|P2|STARTED|Overall Study||39
1709560|NCT00390546|4181562|P1|STARTED|Overall Study||33
1709561|NCT00390468|4181572|P1|NOT COMPLETED|Overall Study||3
1709562|NCT00390468|4181572|P1|COMPLETED|Overall Study||15
1709563|NCT00390468|4181572|P1|STARTED|Overall Study||18
1709564|NCT00390455|4181578|P2|NOT COMPLETED|Overall Study||23
1709565|NCT00390455|4181579|P1|NOT COMPLETED|Overall Study||32
1709566|NCT00390455|4181578|P2|COMPLETED|Overall Study||124
1709567|NCT00390455|4181579|P1|COMPLETED|Overall Study||116
1709568|NCT00390455|4181578|P2|STARTED|Overall Study||147
1709569|NCT00390455|4181579|P1|STARTED|Overall Study||148
1709570|NCT00390429|4181600|P4|NOT COMPLETED|Overall Study||0
1709571|NCT00390429|4181601|P3|NOT COMPLETED|Overall Study||0
1709572|NCT00390429|4181602|P2|NOT COMPLETED|Overall Study||0
1709573|NCT00390429|4181603|P1|NOT COMPLETED|Overall Study||0
1709574|NCT00390429|4181600|P4|COMPLETED|Overall Study||39
1709575|NCT00390429|4181601|P3|COMPLETED|Overall Study||25
1709576|NCT00390429|4181602|P2|COMPLETED|Overall Study||12
1709577|NCT00390429|4181603|P1|COMPLETED|Overall Study||5
1709578|NCT00390429|4181600|P4|STARTED|Overall Study||39
1709579|NCT00390429|4181601|P3|STARTED|Overall Study||25
1709580|NCT00390429|4181602|P2|STARTED|Overall Study||12
1709581|NCT00390429|4181603|P1|STARTED|Overall Study||5
1709582|NCT00390416|4181624|P1|NOT COMPLETED|Overall Study||4
1709583|NCT00390416|4181624|P1|COMPLETED|Overall Study||44
1709584|NCT00390416|4181624|P1|STARTED|Overall Study||48
1709585|NCT00390364|4181630|P1|NOT COMPLETED|Overall Study||0
1709586|NCT00390364|4181630|P1|COMPLETED|Overall Study||1
1709587|NCT00390364|4181630|P1|STARTED|Overall Study||1
1709588|NCT00390325|4181636|P2|NOT COMPLETED|Overall Study||0
1709589|NCT00390325|4181637|P1|NOT COMPLETED|Overall Study||0
1709590|NCT00390325|4181636|P2|COMPLETED|Overall Study||16
1709591|NCT00390325|4181637|P1|COMPLETED|Overall Study||5
1709592|NCT00390325|4181636|P2|STARTED|Overall Study||16
1709593|NCT00390325|4181637|P1|STARTED|Overall Study||5
1709594|NCT00390234|4181657|P1|NOT COMPLETED|Overall Study||0
1709595|NCT00390234|4181657|P1|COMPLETED|Overall Study||63
1709596|NCT00390234|4181657|P1|STARTED|Overall Study||63
1709597|NCT00390221|4181668|P3|NOT COMPLETED|Overall Study||15
1709598|NCT00390221|4181669|P2|NOT COMPLETED|Overall Study||20
1709599|NCT00390221|4181670|P1|NOT COMPLETED|Overall Study||18
1709600|NCT00390221|4181668|P3|COMPLETED|Overall Study||194
1709601|NCT00390221|4181669|P2|COMPLETED|Overall Study||188
1709602|NCT00390221|4181670|P1|COMPLETED|Overall Study||186
1709603|NCT00390221|4181668|P3|STARTED|Overall Study||209
1709604|NCT00390221|4181669|P2|STARTED|Overall Study||208
1709605|NCT00390221|4181670|P1|STARTED|Overall Study||204
1709606|NCT00390182|4181691|P1|NOT COMPLETED|Overall Study||5
1709607|NCT00390182|4181691|P1|COMPLETED|Overall Study||33
1709608|NCT00390182|4181691|P1|STARTED|Overall Study||38
1709609|NCT00390013|4181700|P4|NOT COMPLETED|Phase 2 Second Treatment||0
1709610|NCT00390013|4181701|P3|NOT COMPLETED|Phase 2 Second Treatment||0
1709611|NCT00390013|4181702|P2|NOT COMPLETED|Phase 2 Second Treatment||0
1709612|NCT00390013|4181703|P1|NOT COMPLETED|Phase 2 Second Treatment||0
1709613|NCT00390013|4181700|P4|COMPLETED|Phase 2 Second Treatment||0
1709614|NCT00390013|4181701|P3|COMPLETED|Phase 2 Second Treatment||0
1709615|NCT00390013|4181702|P2|COMPLETED|Phase 2 Second Treatment||1
1709616|NCT00390013|4181703|P1|COMPLETED|Phase 2 Second Treatment||2
1709617|NCT00390013|4181700|P4|STARTED|Phase 2 Second Treatment||0
1709618|NCT00390013|4181701|P3|STARTED|Phase 2 Second Treatment||0
1709619|NCT00390013|4181702|P2|STARTED|Phase 2 Second Treatment||1
1709620|NCT00390013|4181703|P1|STARTED|Phase 2 Second Treatment||2
1709621|NCT00390013|4181700|P4|NOT COMPLETED|Phase 2 First Treatment||0
1709622|NCT00390013|4181701|P3|NOT COMPLETED|Phase 2 First Treatment||0
1709623|NCT00390013|4181702|P2|NOT COMPLETED|Phase 2 First Treatment||1
1709624|NCT00390013|4181703|P1|NOT COMPLETED|Phase 2 First Treatment||1
1709625|NCT00390013|4181700|P4|COMPLETED|Phase 2 First Treatment||0
1709626|NCT00390013|4181701|P3|COMPLETED|Phase 2 First Treatment||0
1709627|NCT00390013|4181702|P2|COMPLETED|Phase 2 First Treatment||1
1709628|NCT00390013|4181703|P1|COMPLETED|Phase 2 First Treatment||2
1709629|NCT00390013|4181700|P4|STARTED|Phase 2 First Treatment||0
1709630|NCT00390013|4181701|P3|STARTED|Phase 2 First Treatment||0
1709631|NCT00390013|4181702|P2|STARTED|Phase 2 First Treatment||2
1709632|NCT00390013|4181703|P1|STARTED|Phase 2 First Treatment||3
1709633|NCT00390013|4181700|P4|NOT COMPLETED|Phase 1||1
1709634|NCT00390013|4181701|P3|NOT COMPLETED|Phase 1||0
1709635|NCT00390013|4181702|P2|NOT COMPLETED|Phase 1||0
1709636|NCT00390013|4181703|P1|NOT COMPLETED|Phase 1||0
1709637|NCT00390013|4181700|P4|COMPLETED|Phase 1||1
1709638|NCT00390013|4181701|P3|COMPLETED|Phase 1||2
1709639|NCT00390013|4181702|P2|COMPLETED|Phase 1||0
1709640|NCT00390013|4181703|P1|COMPLETED|Phase 1||0
1709641|NCT00390013|4181700|P4|STARTED|Phase 1||2
1709642|NCT00390013|4181701|P3|STARTED|Phase 1||2
1709643|NCT00390013|4181702|P2|STARTED|Phase 1||0
1709644|NCT00390013|4181703|P1|STARTED|Phase 1||0
1709645|NCT00389974|4181709|P1|NOT COMPLETED|Overall Study||0
1709646|NCT00389974|4181709|P1|COMPLETED|Overall Study||19
1709647|NCT00389974|4181709|P1|STARTED|Overall Study||19
1709648|NCT00389857|4181715|P2|NOT COMPLETED|Overall Study||0
1709649|NCT00389857|4181716|P1|NOT COMPLETED|Overall Study||0
1709650|NCT00389857|4181715|P2|COMPLETED|Overall Study||17
1709651|NCT00389857|4181716|P1|COMPLETED|Overall Study||14
1709652|NCT00389857|4181715|P2|STARTED|Overall Study||17
1709653|NCT00389857|4181716|P1|STARTED|Overall Study||14
1709654|NCT00389831|4181728|P2|NOT COMPLETED|Overall Study||7
1709655|NCT00389831|4181729|P1|NOT COMPLETED|Overall Study||0
1709656|NCT00389831|4181728|P2|COMPLETED|Overall Study||27
1709657|NCT00389831|4181729|P1|COMPLETED|Overall Study||10
1709658|NCT00389831|4181728|P2|STARTED|Overall Study||34
1709659|NCT00389831|4181729|P1|STARTED|Overall Study||10
1709660|NCT00389818|4181755|P1|NOT COMPLETED|Overall Study||3
1709661|NCT00389818|4181755|P1|COMPLETED|Overall Study||40
1709662|NCT00389818|4181755|P1|STARTED|Overall Study||43
1709663|NCT00389805|4181761|P2|NOT COMPLETED|Phase II||0
1709664|NCT00389805|4181762|P1|NOT COMPLETED|Phase II||0
1709665|NCT00389805|4181761|P2|COMPLETED|Phase II||0
1709666|NCT00389805|4181762|P1|COMPLETED|Phase II||0
1709667|NCT00389805|4181761|P2|STARTED|Phase II|The Phase II study was not conducted.|0
1709668|NCT00389805|4181762|P1|STARTED|Phase II|The Phase II study was not conducted.|0
1709669|NCT00389805|4181761|P2|NOT COMPLETED|Phase I||0
1709670|NCT00389805|4181762|P1|NOT COMPLETED|Phase I||0
1709671|NCT00389805|4181761|P2|COMPLETED|Phase I||12
1709672|NCT00389805|4181762|P1|COMPLETED|Phase I||15
1709673|NCT00389805|4181761|P2|STARTED|Phase I||12
1709674|NCT00389805|4181762|P1|STARTED|Phase I||15
1709675|NCT00389597|4181792|P4|NOT COMPLETED|Overall Study||6
1709676|NCT00389597|4181793|P3|NOT COMPLETED|Overall Study||4
1709677|NCT00389597|4181794|P2|NOT COMPLETED|Overall Study||6
1709678|NCT00389597|4181795|P1|NOT COMPLETED|Overall Study||8
1709679|NCT00389597|4181792|P4|COMPLETED|Overall Study||99
1709680|NCT00389597|4181793|P3|COMPLETED|Overall Study||221
1709681|NCT00389597|4181794|P2|COMPLETED|Overall Study||75
1709682|NCT00389597|4181795|P1|COMPLETED|Overall Study||156
1709683|NCT00389597|4181792|P4|24 mo|Overall Study||99
1709684|NCT00389597|4181793|P3|24 mo|Overall Study||221
1709685|NCT00389597|4181794|P2|24 mo|Overall Study||75
1709686|NCT00389597|4181795|P1|24 mo|Overall Study||156
1709687|NCT00389597|4181792|P4|STARTED|Overall Study||105
1709688|NCT00389597|4181793|P3|STARTED|Overall Study||225
1709689|NCT00389597|4181794|P2|STARTED|Overall Study||81
1709690|NCT00389597|4181795|P1|STARTED|Overall Study||164
1709691|NCT00389532|4181807|P2|NOT COMPLETED|Overall Study||0
1709692|NCT00389532|4181808|P1|NOT COMPLETED|Overall Study||0
1709693|NCT00389532|4181807|P2|COMPLETED|Overall Study||56
1709694|NCT00389532|4181808|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
1709695|NCT00389532|4181807|P2|STARTED|Overall Study||56
1709696|NCT00389532|4181808|P1|STARTED|Overall Study||60
1709697|NCT00389519|4181820|P4|NOT COMPLETED|Treated||4
1709698|NCT00389519|4181821|P3|NOT COMPLETED|Treated||0
1709699|NCT00389519|4181822|P2|NOT COMPLETED|Treated||1
1709700|NCT00389519|4181823|P1|NOT COMPLETED|Treated||2
1709701|NCT00389519|4181820|P4|COMPLETED|Treated||76
1709702|NCT00389519|4181821|P3|COMPLETED|Treated||40
1709703|NCT00389519|4181822|P2|COMPLETED|Treated||40
1709704|NCT00389519|4181823|P1|COMPLETED|Treated||79
1709705|NCT00389519|4181820|P4|STARTED|Treated||80
1709706|NCT00389519|4181821|P3|STARTED|Treated||40
1709707|NCT00389519|4181822|P2|STARTED|Treated||41
1709708|NCT00389519|4181823|P1|STARTED|Treated||81
1709709|NCT00389519|4181820|P4|NOT COMPLETED|Randomized||0
1709710|NCT00389519|4181821|P3|NOT COMPLETED|Randomized||0
1709711|NCT00389519|4181822|P2|NOT COMPLETED|Randomized||0
1709712|NCT00389519|4181823|P1|NOT COMPLETED|Randomized||2
1709713|NCT00389519|4181820|P4|COMPLETED|Randomized||80
1709714|NCT00389519|4181821|P3|COMPLETED|Randomized||40
1709715|NCT00389519|4181822|P2|COMPLETED|Randomized||41
1709716|NCT00389519|4181823|P1|COMPLETED|Randomized||81
1709717|NCT00389519|4181820|P4|STARTED|Randomized||80
1709718|NCT00389519|4181821|P3|STARTED|Randomized||40
1709719|NCT00389519|4181822|P2|STARTED|Randomized||41
1709720|NCT00389519|4181823|P1|STARTED|Randomized||83
1709721|NCT00389519|4181820|P4|NOT COMPLETED|Placebo Run-In||0
1709722|NCT00389519|4181821|P3|NOT COMPLETED|Placebo Run-In||0
1709723|NCT00389519|4181822|P2|NOT COMPLETED|Placebo Run-In||0
1709724|NCT00389519|4181823|P1|NOT COMPLETED|Placebo Run-In||178
1709725|NCT00389519|4181820|P4|COMPLETED|Placebo Run-In||0
1709726|NCT00389519|4181821|P3|COMPLETED|Placebo Run-In||0
1709727|NCT00389519|4181822|P2|COMPLETED|Placebo Run-In||0
1709728|NCT00389519|4181823|P1|COMPLETED|Placebo Run-In||244
1709729|NCT00389519|4181820|P4|STARTED|Placebo Run-In||0
1709730|NCT00389519|4181821|P3|STARTED|Placebo Run-In||0
1709731|NCT00389519|4181822|P2|STARTED|Placebo Run-In||0
1709732|NCT00389519|4181823|P1|STARTED|Placebo Run-In||422
1709733|NCT00389493|4181852|P3|NOT COMPLETED|Overall Study||3
1709734|NCT00389493|4181853|P2|NOT COMPLETED|Overall Study||8
1709735|NCT00389493|4181854|P1|NOT COMPLETED|Overall Study||3
1709736|NCT00389493|4181852|P3|COMPLETED|Overall Study||17
1709737|NCT00389493|4181853|P2|COMPLETED|Overall Study||32
1709738|NCT00389493|4181854|P1|COMPLETED|Overall Study||37
1709739|NCT00389493|4181852|P3|STARTED|Overall Study||20
1709740|NCT00389493|4181853|P2|STARTED|Overall Study||40
1709741|NCT00389493|4181854|P1|STARTED|Overall Study||40
1709742|NCT00389467|4181878|P4|NOT COMPLETED|Overall Study||0
1709743|NCT00389467|4181879|P3|NOT COMPLETED|Overall Study||0
1709744|NCT00389467|4181880|P2|NOT COMPLETED|Overall Study||0
1709745|NCT00389467|4181881|P1|NOT COMPLETED|Overall Study||0
1709746|NCT00389467|4181878|P4|COMPLETED|Overall Study||20
1709747|NCT00389467|4181879|P3|COMPLETED|Overall Study||30
1709748|NCT00389467|4181880|P2|COMPLETED|Overall Study||34
1709749|NCT00389467|4181881|P1|COMPLETED|Overall Study||34
1709750|NCT00389467|4181878|P4|STARTED|Overall Study||20
1709751|NCT00389467|4181879|P3|STARTED|Overall Study||30
1709752|NCT00389467|4181880|P2|STARTED|Overall Study||34
1709753|NCT00389467|4181881|P1|STARTED|Overall Study||34
1709754|NCT00389441|4181900|P1|NOT COMPLETED|Overall Study||52
1709755|NCT00389441|4181900|P1|COMPLETED|Overall Study||0
1709756|NCT00389441|4181900|P1|STARTED|Overall Study||52
1709757|NCT00389324|4181909|P1|NOT COMPLETED|Subcutaneous Phase||7
1709758|NCT00389324|4181909|P1|COMPLETED|Subcutaneous Phase||25
1709759|NCT00389324|4181909|P1|STARTED|Subcutaneous Phase||32
1709760|NCT00389324|4181909|P1|NOT COMPLETED|Intravenous Phase||0
1709761|NCT00389324|4181909|P1|COMPLETED|Intravenous Phase||32
1709762|NCT00389324|4181909|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
1709763|NCT00389324|4181909|P1|NOT COMPLETED|Run-In Phase||3
1709764|NCT00389324|4181909|P1|COMPLETED|Run-In Phase||18
1709765|NCT00389324|4181909|P1|STARTED|Run-In Phase||21
1709766|NCT00389207|4181919|P3|NOT COMPLETED|Overall Study||41
1709767|NCT00389207|4181920|P2|NOT COMPLETED|Overall Study||72
1709768|NCT00389207|4181921|P1|NOT COMPLETED|Overall Study||63
1709769|NCT00389207|4181919|P3|COMPLETED|Overall Study||152
1709770|NCT00389207|4181920|P2|COMPLETED|Overall Study||116
1709771|NCT00389207|4181921|P1|COMPLETED|Overall Study||125
1709772|NCT00389207|4181919|P3|STARTED|Overall Study||193
1709773|NCT00389207|4181920|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
1709774|NCT00389207|4181921|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
1709775|NCT00389168|4182025|P2|NOT COMPLETED|Overall Study||5
1709776|NCT00389168|4182026|P1|NOT COMPLETED|Overall Study||9
1709777|NCT00389168|4182025|P2|COMPLETED|Overall Study||53
1709778|NCT00389168|4182026|P1|COMPLETED|Overall Study||47
1709779|NCT00389168|4182025|P2|STARTED|Overall Study||58
1709780|NCT00389168|4182026|P1|STARTED|Overall Study||56
1709781|NCT00389064|4182044|P2|NOT COMPLETED|Overall Study||59
1709782|NCT00389064|4182045|P1|NOT COMPLETED|Overall Study||45
1709783|NCT00389064|4182044|P2|COMPLETED|Overall Study||168
1709784|NCT00389064|4182045|P1|COMPLETED|Overall Study||178
1709785|NCT00389064|4182044|P2|STARTED|Overall Study||227
1709786|NCT00389064|4182045|P1|STARTED|Overall Study||223
1709787|NCT00388973|4182073|P2|NOT COMPLETED|Overall Study||58
1709788|NCT00388973|4182074|P1|NOT COMPLETED|Overall Study||56
1709789|NCT00388973|4182073|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
1709790|NCT00388973|4182074|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
1709791|NCT00388973|4182073|P2|Completed Study|Overall Study||114
1709792|NCT00388973|4182074|P1|Completed Study|Overall Study||110
1709793|NCT00388973|4182073|P2|STARTED|Overall Study|Randomized|172
1709794|NCT00388973|4182074|P1|STARTED|Overall Study|Randomized|166
1709795|NCT00388947|4182094|P1|NOT COMPLETED|Overall Study||47
1709796|NCT00388947|4182094|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
1709797|NCT00388947|4182094|P1|STARTED|Overall Study||1590
1709798|NCT00388804|4182101|P2|NOT COMPLETED|Overall Study||0
1709799|NCT00388804|4182102|P1|NOT COMPLETED|Overall Study||0
1709800|NCT00388804|4182101|P2|COMPLETED|Overall Study||21
1709801|NCT00388804|4182102|P1|COMPLETED|Overall Study||17
1709802|NCT00388804|4182101|P2|STARTED|Overall Study||21
1709803|NCT00388804|4182102|P1|STARTED|Overall Study||17
1709804|NCT00388726|4182110|P2|NOT COMPLETED|Overall Study||244
1709805|NCT00388726|4182111|P1|NOT COMPLETED|Overall Study||484
1709806|NCT00388726|4182110|P2|COMPLETED|Overall Study||10
1709807|NCT00388726|4182111|P1|COMPLETED|Overall Study||24
1709808|NCT00388726|4182110|P2|STARTED|Overall Study||254
1709809|NCT00388726|4182111|P1|STARTED|Overall Study||508
1709810|NCT00388674|4182125|P2|NOT COMPLETED|End of Study||2169
1709811|NCT00388674|4182126|P1|NOT COMPLETED|End of Study||1734
1709812|NCT00388674|4182125|P2|COMPLETED|End of Study|Completed=Reason of ‘other: end of study’|3993
1709813|NCT00388674|4182126|P1|COMPLETED|End of Study|Completed=Reason of ‘other: end of study’|4482
1709814|NCT00388674|4182125|P2|STARTED|End of Study||6162
1709815|NCT00388674|4182126|P1|STARTED|End of Study||6216
1709816|NCT00388674|4182125|P2|NOT COMPLETED|Initial Treatment||2586
1709817|NCT00388674|4182126|P1|NOT COMPLETED|Initial Treatment||1828
1709818|NCT00388674|4182125|P2|COMPLETED|Initial Treatment|Completed=discontinued initial treatment reason of “successful treatment” or “end of study”|3576
1709819|NCT00388674|4182126|P1|COMPLETED|Initial Treatment|Completed=Reason of ‘successful treatment’, ‘other: successful treatment’ or ‘other: end of study’|4388
1709820|NCT00388674|4182125|P2|STARTED|Initial Treatment||6162
1709821|NCT00388674|4182126|P1|STARTED|Initial Treatment||6216
1709822|NCT00388583|4182144|P2|NOT COMPLETED|Overall Study||4
1709823|NCT00388583|4182145|P1|NOT COMPLETED|Overall Study||6
1709824|NCT00388583|4182144|P2|COMPLETED|Overall Study||406
1709825|NCT00388583|4182145|P1|COMPLETED|Overall Study||401
1709826|NCT00388583|4182144|P2|STARTED|Overall Study||410
1709827|NCT00388583|4182145|P1|STARTED|Overall Study||407
1709828|NCT00388505|4182159|P2|NOT COMPLETED|Overall Study||38
1709829|NCT00388505|4182160|P1|NOT COMPLETED|Overall Study||83
1709830|NCT00388505|4182159|P2|COMPLETED|Overall Study||171
1709831|NCT00388505|4182160|P1|COMPLETED|Overall Study||225
1709832|NCT00388505|4182159|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
1709833|NCT00388505|4182160|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
1709834|NCT00388453|4182185|P3|NOT COMPLETED|Overall Study||0
1709835|NCT00388453|4182186|P2|NOT COMPLETED|Overall Study||0
1709836|NCT00388453|4182187|P1|NOT COMPLETED|Overall Study||0
1709837|NCT00388453|4182185|P3|COMPLETED|Overall Study||10
1709838|NCT00388453|4182186|P2|COMPLETED|Overall Study||17
1709839|NCT00388453|4182187|P1|COMPLETED|Overall Study||20
1709840|NCT00388453|4182185|P3|STARTED|Overall Study||10
1709841|NCT00388453|4182186|P2|STARTED|Overall Study||17
1709842|NCT00388453|4182187|P1|STARTED|Overall Study||20
1709843|NCT00388414|4182206|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
1709844|NCT00388414|4182207|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
1709845|NCT00388414|4182206|P2|COMPLETED|Second Intervention (8 Weeks)||7
1709846|NCT00388414|4182207|P1|COMPLETED|Second Intervention (8 Weeks)||7
1709847|NCT00388414|4182206|P2|STARTED|Second Intervention (8 Weeks)||7
1709848|NCT00388414|4182207|P1|STARTED|Second Intervention (8 Weeks)||7
1709849|NCT00388414|4182206|P2|NOT COMPLETED|Washout (1 Week)||0
1709850|NCT00388414|4182207|P1|NOT COMPLETED|Washout (1 Week)||0
1709851|NCT00388414|4182206|P2|COMPLETED|Washout (1 Week)||7
1709852|NCT00388414|4182207|P1|COMPLETED|Washout (1 Week)||7
1709853|NCT00388414|4182206|P2|STARTED|Washout (1 Week)||7
1709854|NCT00388414|4182207|P1|STARTED|Washout (1 Week)||7
1709855|NCT00388414|4182206|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
1709856|NCT00388414|4182207|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
1709857|NCT00388414|4182206|P2|COMPLETED|First Intervention (8 Weeks)||7
1709858|NCT00388414|4182207|P1|COMPLETED|First Intervention (8 Weeks)||7
1709859|NCT00388414|4182206|P2|STARTED|First Intervention (8 Weeks)||7
1709860|NCT00388414|4182207|P1|STARTED|First Intervention (8 Weeks)||7
1709861|NCT00388362|4182215|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
1709862|NCT00388362|4182215|P1|COMPLETED|Remained on Study Median of 514 Days||21
1709863|NCT00388362|4182215|P1|STARTED|Remained on Study Median of 514 Days||23
1709864|NCT00388362|4182215|P1|NOT COMPLETED|Enrolled||13
1709865|NCT00388362|4182215|P1|COMPLETED|Enrolled||23
1709866|NCT00388362|4182215|P1|STARTED|Enrolled||36
1709867|NCT00388349|4182220|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
1709868|NCT00388349|4182221|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
1709869|NCT00388349|4182220|P2|COMPLETED|Phase 2 Dose Expansion||0
1709870|NCT00388349|4182221|P1|COMPLETED|Phase 2 Dose Expansion||139
1709871|NCT00388349|4182220|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
1709872|NCT00388349|4182221|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
1709873|NCT00388349|4182220|P2|NOT COMPLETED|Phase I Dose Escalation||3
1709874|NCT00388349|4182221|P1|NOT COMPLETED|Phase I Dose Escalation||0
1709875|NCT00388349|4182220|P2|COMPLETED|Phase I Dose Escalation||1
1709876|NCT00388349|4182221|P1|COMPLETED|Phase I Dose Escalation||3
1709877|NCT00388349|4182220|P2|STARTED|Phase I Dose Escalation||4
1709878|NCT00388349|4182221|P1|STARTED|Phase I Dose Escalation||3
1709879|NCT00388154|4182230|P1|NOT COMPLETED|Overall Study||1
1709880|NCT00388154|4182230|P1|COMPLETED|Overall Study||20
1709881|NCT00388154|4182230|P1|STARTED|Overall Study||21
1709882|NCT00388037|4182235|P1|NOT COMPLETED|Overall Study||1
1709883|NCT00388037|4182235|P1|COMPLETED|Overall Study||30
1709884|NCT00388037|4182235|P1|STARTED|Overall Study||31
1709885|NCT00387959|4182239|P1|NOT COMPLETED|Overall Study||1
1709886|NCT00387959|4182239|P1|COMPLETED|Overall Study||16
1709887|NCT00387959|4182239|P1|STARTED|Overall Study||17
1709888|NCT00387894|4182243|P1|NOT COMPLETED|Overall Study||1
1709889|NCT00387894|4182243|P1|COMPLETED|Overall Study||5
1709890|NCT00387894|4182243|P1|STARTED|Overall Study||6
1709891|NCT00387881|4182250|P2|NOT COMPLETED|Overall Study||102
1709892|NCT00387881|4182251|P1|NOT COMPLETED|Overall Study||89
1709893|NCT00387881|4182250|P2|COMPLETED|Overall Study||243
1709894|NCT00387881|4182251|P1|COMPLETED|Overall Study||245
1709895|NCT00387881|4182250|P2|STARTED|Overall Study||345
1709896|NCT00387881|4182251|P1|STARTED|Overall Study||334
1709897|NCT00387829|4182275|P2|NOT COMPLETED|Intent-to-treat Population||30
1709898|NCT00387829|4182276|P1|NOT COMPLETED|Intent-to-treat Population||38
1709899|NCT00387829|4182275|P2|COMPLETED|Intent-to-treat Population||136
1709900|NCT00387829|4182276|P1|COMPLETED|Intent-to-treat Population||139
1709901|NCT00387829|4182275|P2|STARTED|Intent-to-treat Population||166
1709902|NCT00387829|4182276|P1|STARTED|Intent-to-treat Population||177
1709903|NCT00387829|4182275|P2|NOT COMPLETED|Safety Population||33
1709904|NCT00387829|4182276|P1|NOT COMPLETED|Safety Population||39
1709905|NCT00387829|4182275|P2|COMPLETED|Safety Population||136
1709906|NCT00387829|4182276|P1|COMPLETED|Safety Population||139
1709907|NCT00387829|4182275|P2|STARTED|Safety Population||169
1709908|NCT00387829|4182276|P1|STARTED|Safety Population||178
1709909|NCT00387790|4182284|P1|NOT COMPLETED|Overall Study||14
1709910|NCT00387790|4182284|P1|COMPLETED|Overall Study||50
1709911|NCT00387790|4182284|P1|STARTED|Overall Study||64
1709912|NCT00387764|4182290|P1|NOT COMPLETED|Overall Study||31
1709913|NCT00387764|4182290|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
1709914|NCT00387764|4182290|P1|STARTED|Overall Study||80
1709915|NCT00387751|4182308|P1|NOT COMPLETED|Overall Study||0
1709916|NCT00387751|4182308|P1|COMPLETED|Overall Study||14
1709917|NCT00387751|4182308|P1|STARTED|Overall Study||14
1709918|NCT00387725|4182318|P4|NOT COMPLETED|Overall Study||2
1709919|NCT00387725|4182319|P3|NOT COMPLETED|Overall Study||2
1709920|NCT00387725|4182320|P2|NOT COMPLETED|Overall Study||1
1709921|NCT00387725|4182321|P1|NOT COMPLETED|Overall Study||1
1709922|NCT00387725|4182318|P4|COMPLETED|Overall Study||43
1709923|NCT00387725|4182319|P3|COMPLETED|Overall Study||43
1709924|NCT00387725|4182320|P2|COMPLETED|Overall Study||15
1709925|NCT00387725|4182321|P1|COMPLETED|Overall Study||20
1709926|NCT00387725|4182318|P4|STARTED|Overall Study||45
1709927|NCT00387725|4182319|P3|STARTED|Overall Study||45
1709928|NCT00387725|4182320|P2|STARTED|Overall Study||16
1709929|NCT00387725|4182321|P1|STARTED|Overall Study||21
1709930|NCT00387712|4182341|P2|NOT COMPLETED|Overall Study||36
1709931|NCT00387712|4182342|P1|NOT COMPLETED|Overall Study||29
1709932|NCT00387712|4182341|P2|COMPLETED|Overall Study||16
1709933|NCT00387712|4182342|P1|COMPLETED|Overall Study||18
1709934|NCT00387712|4182341|P2|STARTED|Overall Study||52
1709935|NCT00387712|4182342|P1|STARTED|Overall Study||47
1709936|NCT00387673|4182352|P3|NOT COMPLETED|Overall Study||0
1709937|NCT00387673|4182353|P2|NOT COMPLETED|Overall Study||0
1709938|NCT00387673|4182354|P1|NOT COMPLETED|Overall Study||0
1709939|NCT00387673|4182352|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1709940|NCT00387673|4182353|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1709941|NCT00387673|4182354|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1709942|NCT00387673|4182352|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1709943|NCT00387673|4182353|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1709944|NCT00387673|4182354|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
1709945|NCT00387660|4182362|P2|NOT COMPLETED|Overall Study||0
1709946|NCT00387660|4182363|P1|NOT COMPLETED|Overall Study||0
1709947|NCT00387660|4182362|P2|COMPLETED|Overall Study||40
1709948|NCT00387660|4182363|P1|COMPLETED|Overall Study||40
1709949|NCT00387660|4182362|P2|STARTED|Overall Study||40
1709950|NCT00387660|4182363|P1|STARTED|Overall Study||40
1709951|NCT00387647|4182373|P1|NOT COMPLETED|Overall Study||18
1709952|NCT00387647|4182373|P1|COMPLETED|Overall Study||6
1709953|NCT00387647|4182373|P1|STARTED|Overall Study||24
1709954|NCT00387621|4182382|P2|NOT COMPLETED|Second Intervention||0
1709955|NCT00387621|4182383|P1|NOT COMPLETED|Second Intervention||0
1709956|NCT00387621|4182382|P2|COMPLETED|Second Intervention||29
1709957|NCT00387621|4182383|P1|COMPLETED|Second Intervention||29
1709958|NCT00387621|4182382|P2|STARTED|Second Intervention||29
1709959|NCT00387621|4182383|P1|STARTED|Second Intervention||29
1709960|NCT00387621|4182382|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1709961|NCT00387621|4182383|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1709962|NCT00387621|4182382|P2|COMPLETED|Washout Period of 2 Weeks||29
1709963|NCT00387621|4182383|P1|COMPLETED|Washout Period of 2 Weeks||29
1709964|NCT00387621|4182382|P2|STARTED|Washout Period of 2 Weeks||29
1709965|NCT00387621|4182383|P1|STARTED|Washout Period of 2 Weeks||29
1709966|NCT00387621|4182382|P2|NOT COMPLETED|First Intervention||0
1709967|NCT00387621|4182383|P1|NOT COMPLETED|First Intervention||0
1709968|NCT00387621|4182382|P2|COMPLETED|First Intervention||29
1709969|NCT00387621|4182383|P1|COMPLETED|First Intervention||29
1709970|NCT00387621|4182382|P2|STARTED|First Intervention||29
1709971|NCT00387621|4182383|P1|STARTED|First Intervention||29
1709972|NCT00387426|4182413|P1|NOT COMPLETED|Overall Study||14
1709973|NCT00387426|4182413|P1|COMPLETED|Overall Study||0
1709974|NCT00387426|4182413|P1|STARTED|Overall Study||14
1709975|NCT00387348|4182420|P3|NOT COMPLETED|Overall Study||4
1709976|NCT00387348|4182421|P2|NOT COMPLETED|Overall Study||3
1709977|NCT00387348|4182422|P1|NOT COMPLETED|Overall Study||3
1709978|NCT00387348|4182420|P3|COMPLETED|Overall Study||7
1709979|NCT00387348|4182421|P2|COMPLETED|Overall Study||2
1709980|NCT00387348|4182422|P1|COMPLETED|Overall Study||5
1709981|NCT00387348|4182420|P3|STARTED|Overall Study||11
1709982|NCT00387348|4182421|P2|STARTED|Overall Study||5
1709983|NCT00387348|4182422|P1|STARTED|Overall Study||8
1709984|NCT00387335|4182438|P2|NOT COMPLETED|Overall Study||0
1709985|NCT00387335|4182439|P1|NOT COMPLETED|Overall Study||0
1709986|NCT00387335|4182438|P2|COMPLETED|Overall Study||7
1709987|NCT00387335|4182439|P1|COMPLETED|Overall Study||15
1709988|NCT00387335|4182438|P2|STARTED|Overall Study||7
1709989|NCT00387335|4182439|P1|STARTED|Overall Study||15
1709990|NCT00387153|4182451|P1|NOT COMPLETED|Overall Study||8
1709991|NCT00387153|4182451|P1|COMPLETED|Overall Study||0
1709992|NCT00387153|4182451|P1|STARTED|Overall Study||8
1709993|NCT00387127|4182457|P2|NOT COMPLETED|Overall Study||34
1709994|NCT00387127|4182458|P1|NOT COMPLETED|Overall Study||33
1709995|NCT00387127|4182457|P2|COMPLETED|Overall Study||0
1709996|NCT00387127|4182458|P1|COMPLETED|Overall Study||0
1709997|NCT00387127|4182457|P2|STARTED|Overall Study||34
1709998|NCT00387127|4182458|P1|STARTED|Overall Study||33
1709999|NCT00387088|4182500|P2|NOT COMPLETED|Overall Study||373
1710000|NCT00387088|4182501|P1|NOT COMPLETED|Overall Study||318
1710001|NCT00387088|4182500|P2|COMPLETED|Overall Study||1629
1710002|NCT00387088|4182501|P1|COMPLETED|Overall Study||1671
1710003|NCT00387088|4182500|P2|STARTED|Overall Study||2002
1710004|NCT00387088|4182501|P1|STARTED|Overall Study||1989
1710005|NCT00387036|4182545|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
1710006|NCT00387036|4182546|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
1710007|NCT00387036|4182545|P2|COMPLETED|2-Week Crossover Second Intervention||6
1710008|NCT00387036|4182546|P1|COMPLETED|2-Week Crossover Second Intervention||6
1710009|NCT00387036|4182545|P2|STARTED|2-Week Crossover Second Intervention||6
1710010|NCT00387036|4182546|P1|STARTED|2-Week Crossover Second Intervention||6
1710011|NCT00387036|4182545|P2|NOT COMPLETED|2-Week Placebo Washout||0
1710012|NCT00387036|4182546|P1|NOT COMPLETED|2-Week Placebo Washout||0
1710013|NCT00387036|4182545|P2|COMPLETED|2-Week Placebo Washout||6
1710014|NCT00387036|4182546|P1|COMPLETED|2-Week Placebo Washout||6
1710015|NCT00387036|4182545|P2|STARTED|2-Week Placebo Washout||6
1710016|NCT00387036|4182546|P1|STARTED|2-Week Placebo Washout||6
1710017|NCT00387036|4182545|P2|NOT COMPLETED|2-Week First Intervention||0
1710018|NCT00387036|4182546|P1|NOT COMPLETED|2-Week First Intervention||0
1710019|NCT00387036|4182545|P2|COMPLETED|2-Week First Intervention||6
1710020|NCT00387036|4182546|P1|COMPLETED|2-Week First Intervention||6
1710021|NCT00387036|4182545|P2|STARTED|2-Week First Intervention||6
1710022|NCT00387036|4182546|P1|STARTED|2-Week First Intervention||6
1710023|NCT00387023|4182554|P1|NOT COMPLETED|Overall Study||0
1710024|NCT00387023|4182554|P1|COMPLETED|Overall Study||12
1710025|NCT00387023|4182554|P1|STARTED|Overall Study||12
1710026|NCT00387010|4182558|P1|NOT COMPLETED|Treatment Period||11
1710027|NCT00387010|4182558|P1|COMPLETED|Treatment Period||169
1710028|NCT00387010|4182558|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
1710029|NCT00387010|4182558|P1|STARTED|Treatment Period||180
1710030|NCT00387010|4182558|P1|NOT COMPLETED|Dose Titration Period||38
1710031|NCT00387010|4182558|P1|COMPLETED|Dose Titration Period||180
1710032|NCT00387010|4182558|P1|STARTED|Dose Titration Period||218
1710033|NCT00386880|4182579|P2|NOT COMPLETED|Overall Study||0
1710034|NCT00386880|4182580|P1|NOT COMPLETED|Overall Study||0
1710035|NCT00386880|4182579|P2|COMPLETED|Overall Study||8
1710036|NCT00386880|4182580|P1|COMPLETED|Overall Study||30
1710037|NCT00386880|4182579|P2|STARTED|Overall Study||8
1710038|NCT00386880|4182580|P1|STARTED|Overall Study||30
1710039|NCT00386776|4182585|P1|NOT COMPLETED|Overall Study||8
1710040|NCT00386776|4182585|P1|COMPLETED|Overall Study||32
1710041|NCT00386776|4182585|P1|STARTED|Overall Study||40
1710042|NCT00386607|4182595|P2|NOT COMPLETED|Extension||17
1710043|NCT00386607|4182596|P1|NOT COMPLETED|Extension||0
1710044|NCT00386607|4182595|P2|COMPLETED|Extension||145
1710045|NCT00386607|4182596|P1|COMPLETED|Extension||0
1710046|NCT00386607|4182595|P2|STARTED|Extension||162
1710047|NCT00386607|4182596|P1|STARTED|Extension||0
1710048|NCT00386607|4182595|P2|NOT COMPLETED|Core||0
1710049|NCT00386607|4182596|P1|NOT COMPLETED|Core||115
1710050|NCT00386607|4182595|P2|COMPLETED|Core||0
1710051|NCT00386607|4182596|P1|COMPLETED|Core||486
1710052|NCT00386607|4182595|P2|STARTED|Core||0
1710053|NCT00386607|4182596|P1|STARTED|Core||601
1710054|NCT00386477|4182614|P2|NOT COMPLETED|Overall Study||0
1710055|NCT00386477|4182615|P1|NOT COMPLETED|Overall Study||0
1710056|NCT00386477|4182614|P2|COMPLETED|Overall Study||145
1710057|NCT00386477|4182615|P1|COMPLETED|Overall Study||155
1710058|NCT00386477|4182614|P2|STARTED|Overall Study||145
1710059|NCT00386477|4182615|P1|STARTED|Overall Study||155
1710060|NCT00386425|4182624|P3|NOT COMPLETED|Overall Study||0
1710061|NCT00386425|4182625|P2|NOT COMPLETED|Overall Study||1
1710062|NCT00386425|4182626|P1|NOT COMPLETED|Overall Study||3
1710063|NCT00386425|4182624|P3|COMPLETED|Overall Study||53
1710064|NCT00386425|4182625|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
1710065|NCT00386425|4182626|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
1710066|NCT00386425|4182624|P3|Received Study Drug|Overall Study||53
1710067|NCT00386425|4182625|P2|Received Study Drug|Overall Study||206
1710068|NCT00386425|4182626|P1|Received Study Drug|Overall Study||227
1710069|NCT00386425|4182624|P3|STARTED|Overall Study||53
1710070|NCT00386425|4182625|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
1710071|NCT00386425|4182626|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
1710072|NCT00386360|4182652|P2|NOT COMPLETED|Overall Study||17
1710073|NCT00386360|4182653|P1|NOT COMPLETED|Overall Study||9
1710074|NCT00386360|4182652|P2|COMPLETED|Overall Study||95
1710075|NCT00386360|4182653|P1|COMPLETED|Overall Study||40
1710076|NCT00386360|4182652|P2|Primary Efficacy|Overall Study||77
1710077|NCT00386360|4182653|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
1710078|NCT00386360|4182652|P2|Intent to Treat Population (ITT)|Overall Study||110
1710079|NCT00386360|4182653|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
1710080|NCT00386360|4182652|P2|STARTED|Overall Study||112
1710081|NCT00386360|4182653|P1|STARTED|Overall Study||49
1710082|NCT00386334|4182687|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
1710083|NCT00386334|4182688|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
1710084|NCT00386334|4182687|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
1710085|NCT00386334|4182688|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
1710086|NCT00386334|4182687|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
1710176|NCT00385944|4183025|P3|COMPLETED|1st Maintenance Dose Period||0
1710087|NCT00386334|4182688|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
1710088|NCT00386334|4182687|P2|NOT COMPLETED|Double Blind Period||47
1710089|NCT00386334|4182688|P1|NOT COMPLETED|Double Blind Period||46
1710090|NCT00386334|4182687|P2|COMPLETED|Double Blind Period||147
1710091|NCT00386334|4182688|P1|COMPLETED|Double Blind Period||148
1710092|NCT00386334|4182687|P2|STARTED|Double Blind Period||194
1710093|NCT00386334|4182688|P1|STARTED|Double Blind Period||194
1710094|NCT00386308|4182832|P2|NOT COMPLETED|Overall Study||19
1710095|NCT00386308|4182833|P1|NOT COMPLETED|Overall Study||29
1710096|NCT00386308|4182832|P2|COMPLETED|Overall Study||54
1710097|NCT00386308|4182833|P1|COMPLETED|Overall Study||94
1710098|NCT00386308|4182832|P2|Modified Intent to Treat Population|Overall Study||72
1710099|NCT00386308|4182833|P1|Modified Intent to Treat Population|Overall Study||115
1710100|NCT00386308|4182832|P2|Intent to Treat Population|Overall Study||72
1710101|NCT00386308|4182833|P1|Intent to Treat Population|Overall Study||117
1710102|NCT00386308|4182832|P2|STARTED|Overall Study||73
1710103|NCT00386308|4182833|P1|STARTED|Overall Study||123
1710104|NCT00386256|4182849|P4|NOT COMPLETED|Overall Study||0
1710105|NCT00386256|4182850|P3|NOT COMPLETED|Overall Study||0
1710106|NCT00386256|4182851|P2|NOT COMPLETED|Overall Study||0
1710107|NCT00386256|4182852|P1|NOT COMPLETED|Overall Study||0
1710108|NCT00386256|4182849|P4|COMPLETED|Overall Study||3
1710109|NCT00386256|4182850|P3|COMPLETED|Overall Study||4
1710110|NCT00386256|4182851|P2|COMPLETED|Overall Study||15
1710111|NCT00386256|4182852|P1|COMPLETED|Overall Study||16
1710112|NCT00386256|4182849|P4|STARTED|Overall Study||3
1710113|NCT00386256|4182850|P3|STARTED|Overall Study||4
1710114|NCT00386256|4182851|P2|STARTED|Overall Study||15
1710115|NCT00386256|4182852|P1|STARTED|Overall Study||16
1710116|NCT00386243|4182868|P2|NOT COMPLETED|Overall Study||13
1710117|NCT00386243|4182869|P1|NOT COMPLETED|Overall Study||7
1710118|NCT00386243|4182868|P2|COMPLETED|Overall Study||108
1710119|NCT00386243|4182869|P1|COMPLETED|Overall Study||114
1710120|NCT00386243|4182868|P2|STARTED|Overall Study||121
1710121|NCT00386243|4182869|P1|STARTED|Overall Study||121
1710122|NCT00386152|4182880|P3|NOT COMPLETED|Overall Study||33
1710123|NCT00386152|4182881|P2|NOT COMPLETED|Overall Study||40
1710124|NCT00386152|4182882|P1|NOT COMPLETED|Overall Study||44
1710125|NCT00386152|4182880|P3|COMPLETED|Overall Study||42
1710126|NCT00386152|4182881|P2|COMPLETED|Overall Study||37
1710127|NCT00386152|4182882|P1|COMPLETED|Overall Study||31
1710128|NCT00386152|4182880|P3|STARTED|Overall Study|number of subjects treated|75
1710129|NCT00386152|4182881|P2|STARTED|Overall Study|number of subjects treated|77
1710130|NCT00386152|4182882|P1|STARTED|Overall Study|number of subjects treated|75
1710131|NCT00386100|4182901|P2|NOT COMPLETED|Overall Study||131
1710132|NCT00386100|4182902|P1|NOT COMPLETED|Overall Study||154
1710133|NCT00386100|4182901|P2|COMPLETED|Overall Study||217
1710134|NCT00386100|4182902|P1|COMPLETED|Overall Study||186
1710135|NCT00386100|4182901|P2|STARTED|Overall Study||348
1710136|NCT00386100|4182902|P1|STARTED|Overall Study||340
1710137|NCT00386022|4182966|P2|NOT COMPLETED|Plus Estrogen||1
1710138|NCT00386022|4182967|P1|NOT COMPLETED|Plus Estrogen||2
1710139|NCT00386022|4182966|P2|COMPLETED|Plus Estrogen||8
1710140|NCT00386022|4182967|P1|COMPLETED|Plus Estrogen||8
1710141|NCT00386022|4182966|P2|All Doses GnRH|Plus Estrogen||8
1710142|NCT00386022|4182967|P1|All Doses GnRH|Plus Estrogen||8
1710143|NCT00386022|4182966|P2|Estrogen Patch|Plus Estrogen||9
1710144|NCT00386022|4182967|P1|Estrogen Patch|Plus Estrogen||8
1710145|NCT00386022|4182966|P2|STARTED|Plus Estrogen||9
1710146|NCT00386022|4182967|P1|STARTED|Plus Estrogen||10
1710147|NCT00386022|4182966|P2|NOT COMPLETED|Baseline||0
1710148|NCT00386022|4182967|P1|NOT COMPLETED|Baseline||0
1710149|NCT00386022|4182966|P2|COMPLETED|Baseline||9
1710150|NCT00386022|4182967|P1|COMPLETED|Baseline||10
1710151|NCT00386022|4182966|P2|All Doses of GnRH|Baseline||9
1710152|NCT00386022|4182967|P1|All Doses of GnRH|Baseline||10
1710153|NCT00386022|4182966|P2|STARTED|Baseline||9
1710154|NCT00386022|4182967|P1|STARTED|Baseline||10
1710155|NCT00386009|4182977|P2|NOT COMPLETED|Overall Study||10
1710156|NCT00386009|4182978|P1|NOT COMPLETED|Overall Study||9
1710157|NCT00386009|4182977|P2|COMPLETED|Overall Study||89
1710158|NCT00386009|4182978|P1|COMPLETED|Overall Study||92
1710159|NCT00386009|4182977|P2|STARTED|Overall Study||99
1710160|NCT00386009|4182978|P1|STARTED|Overall Study||101
1710161|NCT00385996|4183016|P1|NOT COMPLETED|Overall Study||0
1710162|NCT00385996|4183016|P1|COMPLETED|Overall Study||22
1710163|NCT00385996|4183016|P1|STARTED|Overall Study||22
1710164|NCT00385944|4183025|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
1710165|NCT00385944|4183026|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
1710166|NCT00385944|4183027|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
1710167|NCT00385944|4183025|P3|COMPLETED|2nd Maintenance Dose Period||0
1710168|NCT00385944|4183026|P2|COMPLETED|2nd Maintenance Dose Period||19
1710169|NCT00385944|4183027|P1|COMPLETED|2nd Maintenance Dose Period||22
1710170|NCT00385944|4183025|P3|STARTED|2nd Maintenance Dose Period||0
1710171|NCT00385944|4183026|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
1710172|NCT00385944|4183027|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
1710173|NCT00385944|4183025|P3|NOT COMPLETED|1st Maintenance Dose Period||0
1710174|NCT00385944|4183026|P2|NOT COMPLETED|1st Maintenance Dose Period||1
1710175|NCT00385944|4183027|P1|NOT COMPLETED|1st Maintenance Dose Period||4
1710177|NCT00385944|4183026|P2|COMPLETED|1st Maintenance Dose Period||24
1710178|NCT00385944|4183027|P1|COMPLETED|1st Maintenance Dose Period||25
1710179|NCT00385944|4183025|P3|STARTED|1st Maintenance Dose Period||0
1710180|NCT00385944|4183026|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
1710181|NCT00385944|4183027|P1|STARTED|1st Maintenance Dose Period||29
1710182|NCT00385944|4183025|P3|NOT COMPLETED|Loading Dose||0
1710183|NCT00385944|4183026|P2|NOT COMPLETED|Loading Dose||0
1710184|NCT00385944|4183027|P1|NOT COMPLETED|Loading Dose||0
1710185|NCT00385944|4183025|P3|COMPLETED|Loading Dose||56
1710186|NCT00385944|4183026|P2|COMPLETED|Loading Dose||0
1710187|NCT00385944|4183027|P1|COMPLETED|Loading Dose||0
1710188|NCT00385944|4183025|P3|STARTED|Loading Dose||56
1710189|NCT00385944|4183026|P2|STARTED|Loading Dose||0
1710190|NCT00385944|4183027|P1|STARTED|Loading Dose||0
1710191|NCT00385918|4183070|P3|NOT COMPLETED|Intervention Phase After Randomization||0
1710192|NCT00385918|4183071|P2|NOT COMPLETED|Intervention Phase After Randomization||0
1710193|NCT00385918|4183072|P1|NOT COMPLETED|Intervention Phase After Randomization||3
1710194|NCT00385918|4183070|P3|COMPLETED|Intervention Phase After Randomization||0
1710195|NCT00385918|4183071|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
1710196|NCT00385918|4183072|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
1710197|NCT00385918|4183070|P3|STARTED|Intervention Phase After Randomization||0
1710198|NCT00385918|4183071|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
1710199|NCT00385918|4183072|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
1710200|NCT00385918|4183070|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
1710201|NCT00385918|4183071|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
1710202|NCT00385918|4183072|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
1710203|NCT00385918|4183070|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
1710204|NCT00385918|4183071|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
1710205|NCT00385918|4183072|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
1710206|NCT00385918|4183070|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
1710207|NCT00385918|4183071|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
1710208|NCT00385918|4183072|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
1710209|NCT00385918|4183070|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
1710210|NCT00385918|4183071|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
1710211|NCT00385918|4183072|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
1710212|NCT00385918|4183070|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
1710213|NCT00385918|4183071|P2|STARTED|Feasibility & Baseline Measurement Phase||0
1710214|NCT00385918|4183072|P1|STARTED|Feasibility & Baseline Measurement Phase||0
1710215|NCT00385840|4183096|P2|NOT COMPLETED|Overall Study||14
1710216|NCT00385840|4183097|P1|NOT COMPLETED|Overall Study||4
1710217|NCT00385840|4183096|P2|COMPLETED|Overall Study||531
1710218|NCT00385840|4183097|P1|COMPLETED|Overall Study||129
1710219|NCT00385840|4183096|P2|STARTED|Overall Study||545
1710220|NCT00385840|4183097|P1|STARTED|Overall Study||133
1710221|NCT00385827|4183120|P3|NOT COMPLETED|Part 2||48
1710222|NCT00385827|4183121|P2|NOT COMPLETED|Part 2||33
1710223|NCT00385827|4183122|P1|NOT COMPLETED|Part 2||0
1710224|NCT00385827|4183120|P3|COMPLETED|Part 2||0
1710225|NCT00385827|4183121|P2|COMPLETED|Part 2||16
1710226|NCT00385827|4183122|P1|COMPLETED|Part 2||0
1710227|NCT00385827|4183120|P3|Treated|Part 2||46
1710228|NCT00385827|4183121|P2|Treated|Part 2||47
1710229|NCT00385827|4183122|P1|Treated|Part 2||0
1710230|NCT00385827|4183120|P3|STARTED|Part 2||48
1710231|NCT00385827|4183121|P2|STARTED|Part 2||49
1710232|NCT00385827|4183122|P1|STARTED|Part 2||0
1710233|NCT00385827|4183120|P3|NOT COMPLETED|Part 1||0
1710234|NCT00385827|4183121|P2|NOT COMPLETED|Part 1||0
1710235|NCT00385827|4183122|P1|NOT COMPLETED|Part 1||9
1710236|NCT00385827|4183120|P3|COMPLETED|Part 1||0
1710237|NCT00385827|4183121|P2|COMPLETED|Part 1||0
1710238|NCT00385827|4183122|P1|COMPLETED|Part 1||0
1710239|NCT00385827|4183120|P3|Treated|Part 1||0
1710240|NCT00385827|4183121|P2|Treated|Part 1||0
1710241|NCT00385827|4183122|P1|Treated|Part 1||9
1710242|NCT00385827|4183120|P3|STARTED|Part 1||0
1710243|NCT00385827|4183121|P2|STARTED|Part 1||0
1710244|NCT00385827|4183122|P1|STARTED|Part 1||9
1710245|NCT00385801|4183144|P2|NOT COMPLETED|Overall Study||8
1710246|NCT00385801|4183145|P1|NOT COMPLETED|Overall Study||9
1710247|NCT00385801|4183144|P2|COMPLETED|Overall Study||8
1710248|NCT00385801|4183145|P1|COMPLETED|Overall Study||6
1710249|NCT00385801|4183144|P2|STARTED|Overall Study||16
1710250|NCT00385801|4183145|P1|STARTED|Overall Study||15
1710251|NCT00385788|4183159|P2|NOT COMPLETED|Overall Study||0
1710252|NCT00385788|4183160|P1|NOT COMPLETED|Overall Study||0
1710253|NCT00385788|4183159|P2|COMPLETED|Overall Study||40
1710254|NCT00385788|4183160|P1|COMPLETED|Overall Study||12
1710255|NCT00385788|4183159|P2|STARTED|Overall Study||40
1710256|NCT00385788|4183160|P1|STARTED|Overall Study||12
1710257|NCT00385762|4183166|P1|NOT COMPLETED|Overall Study||2
1710258|NCT00385762|4183166|P1|COMPLETED|Overall Study||33
1710259|NCT00385762|4183166|P1|STARTED|Overall Study||35
1710260|NCT00385736|4183176|P3|NOT COMPLETED|Safety Analysis Set||80
1710261|NCT00385736|4183177|P2|NOT COMPLETED|Safety Analysis Set||44
1710262|NCT00385736|4183178|P1|NOT COMPLETED|Safety Analysis Set||70
1710263|NCT00385736|4183176|P3|COMPLETED|Safety Analysis Set||143
1710264|NCT00385736|4183177|P2|COMPLETED|Safety Analysis Set||86
1710265|NCT00385736|4183178|P1|COMPLETED|Safety Analysis Set||153
1710266|NCT00385736|4183176|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
1710267|NCT00385736|4183177|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
1710268|NCT00385736|4183178|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
1710269|NCT00385736|4183176|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
1710270|NCT00385736|4183177|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
1710271|NCT00385736|4183178|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
1710272|NCT00385736|4183176|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
1710273|NCT00385736|4183177|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
1710274|NCT00385736|4183178|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
1710275|NCT00385736|4183176|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
1710276|NCT00385736|4183177|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
1710277|NCT00385736|4183178|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
1710278|NCT00385736|4183176|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
1710279|NCT00385736|4183177|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
1710280|NCT00385736|4183178|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
1710281|NCT00385736|4183176|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
1710282|NCT00385736|4183177|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
1710283|NCT00385736|4183178|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
1710284|NCT00385736|4183176|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
1710285|NCT00385736|4183177|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
1710286|NCT00385736|4183178|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
1710287|NCT00385723|4183223|P3|NOT COMPLETED|Overall Study||2
1710288|NCT00385723|4183224|P2|NOT COMPLETED|Overall Study||1
1710289|NCT00385723|4183225|P1|NOT COMPLETED|Overall Study||2
1710290|NCT00385723|4183223|P3|COMPLETED|Overall Study||44
1710291|NCT00385723|4183224|P2|COMPLETED|Overall Study||45
1710292|NCT00385723|4183225|P1|COMPLETED|Overall Study||44
1710293|NCT00385723|4183223|P3|STARTED|Overall Study||46
1710294|NCT00385723|4183224|P2|STARTED|Overall Study||46
1710295|NCT00385723|4183225|P1|STARTED|Overall Study||46
1710296|NCT00385684|4183239|P2|NOT COMPLETED|PHASE B||0
1710297|NCT00385684|4183240|P1|NOT COMPLETED|PHASE B||0
1710298|NCT00385684|4183239|P2|COMPLETED|PHASE B||3
1710299|NCT00385684|4183240|P1|COMPLETED|PHASE B||5
1710300|NCT00385684|4183239|P2|STARTED|PHASE B||3
1710301|NCT00385684|4183240|P1|STARTED|PHASE B||5
1710302|NCT00385684|4183239|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
1710303|NCT00385684|4183240|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
1710304|NCT00385684|4183239|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
1710305|NCT00385684|4183240|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
1710306|NCT00385684|4183239|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
1710307|NCT00385684|4183240|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
1710308|NCT00385684|4183239|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
1710309|NCT00385684|4183240|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
1710310|NCT00385684|4183239|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
1710311|NCT00385684|4183240|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
1710312|NCT00385684|4183239|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
1710313|NCT00385684|4183240|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
1710314|NCT00385671|4183249|P3|NOT COMPLETED|Overall Study||36
1710315|NCT00385671|4183250|P2|NOT COMPLETED|Overall Study||51
1710316|NCT00385671|4183251|P1|NOT COMPLETED|Overall Study||38
1710317|NCT00385671|4183249|P3|COMPLETED|Overall Study||99
1710318|NCT00385671|4183250|P2|COMPLETED|Overall Study||87
1710319|NCT00385671|4183251|P1|COMPLETED|Overall Study||96
1710320|NCT00385671|4183249|P3|STARTED|Overall Study||135
1710321|NCT00385671|4183250|P2|STARTED|Overall Study||138
1710322|NCT00385671|4183251|P1|STARTED|Overall Study||134
1710323|NCT00385593|4183407|P2|NOT COMPLETED|Overall Study||37
1710324|NCT00385593|4183408|P1|NOT COMPLETED|Overall Study||58
1710325|NCT00385593|4183407|P2|COMPLETED|Overall Study||289
1710326|NCT00385593|4183408|P1|COMPLETED|Overall Study||270
1710327|NCT00385593|4183407|P2|STARTED|Overall Study||326
1710328|NCT00385593|4183408|P1|STARTED|Overall Study||328
1710329|NCT00385580|4183426|P2|NOT COMPLETED|Overall Study||0
1710330|NCT00385580|4183427|P1|NOT COMPLETED|Overall Study||0
1710331|NCT00385580|4183426|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
1710332|NCT00385580|4183427|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
1710333|NCT00385580|4183426|P2|STARTED|Overall Study|Number of participants treated.|47
1710334|NCT00385580|4183427|P1|STARTED|Overall Study|Number of participants treated.|48
1710335|NCT00385541|4183518|P2|NOT COMPLETED|Overall Study||1
1710336|NCT00385541|4183519|P1|NOT COMPLETED|Overall Study||0
1710337|NCT00385541|4183518|P2|COMPLETED|Overall Study||24
1710338|NCT00385541|4183519|P1|COMPLETED|Overall Study||25
1710339|NCT00385541|4183518|P2|STARTED|Overall Study||25
1710340|NCT00385541|4183519|P1|STARTED|Overall Study||25
1710341|NCT00385515|4183535|P2|NOT COMPLETED|Overall Study||3
1710342|NCT00385515|4183536|P1|NOT COMPLETED|Overall Study||4
1710343|NCT00385515|4183535|P2|COMPLETED|Overall Study||21
1710344|NCT00385515|4183536|P1|COMPLETED|Overall Study||53
1710345|NCT00385515|4183535|P2|STARTED|Overall Study||24
1710346|NCT00385515|4183536|P1|STARTED|Overall Study||57
1710347|NCT00385268|4183544|P2|NOT COMPLETED|Overall Study||8
1710348|NCT00385268|4183545|P1|NOT COMPLETED|Overall Study||16
1710349|NCT00385268|4183544|P2|COMPLETED|Overall Study||18
1710350|NCT00385268|4183545|P1|COMPLETED|Overall Study||18
1710351|NCT00385268|4183544|P2|STARTED|Overall Study||26
1710352|NCT00385268|4183545|P1|STARTED|Overall Study||34
1710353|NCT00385255|4183553|P2|NOT COMPLETED|Overall Study||73
1710354|NCT00385255|4183554|P1|NOT COMPLETED|Overall Study||21
1710355|NCT00385255|4183553|P2|COMPLETED|Overall Study||785
1710356|NCT00385255|4183554|P1|COMPLETED|Overall Study||839
1710357|NCT00385255|4183553|P2|19-64 Years of Age (YOA) Cohort|Overall Study||749
1710358|NCT00385255|4183554|P1|19-64 Years of Age (YOA) Cohort|Overall Study||748
1710359|NCT00385255|4183553|P2|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
1710360|NCT00385255|4183554|P1|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
1710361|NCT00385255|4183553|P2|STARTED|Overall Study||858
1710362|NCT00385255|4183554|P1|STARTED|Overall Study||860
1710363|NCT00385216|4183618|P2|NOT COMPLETED|Second Intervention||0
1710364|NCT00385216|4183619|P1|NOT COMPLETED|Second Intervention||0
1710365|NCT00385216|4183618|P2|COMPLETED|Second Intervention||9
1710366|NCT00385216|4183619|P1|COMPLETED|Second Intervention||11
1710367|NCT00385216|4183618|P2|STARTED|Second Intervention||9
1710368|NCT00385216|4183619|P1|STARTED|Second Intervention||11
1710369|NCT00385216|4183618|P2|NOT COMPLETED|First Intervention||0
1710370|NCT00385216|4183619|P1|NOT COMPLETED|First Intervention||0
1710371|NCT00385216|4183618|P2|COMPLETED|First Intervention||9
1710372|NCT00385216|4183619|P1|COMPLETED|First Intervention||11
1710373|NCT00385216|4183618|P2|STARTED|First Intervention||9
1710374|NCT00385216|4183619|P1|STARTED|First Intervention||11
1710375|NCT00385203|4183633|P2|NOT COMPLETED|Overall Study||7
1710376|NCT00385203|4183634|P1|NOT COMPLETED|Overall Study||26
1710377|NCT00385203|4183633|P2|COMPLETED|Overall Study||3
1710378|NCT00385203|4183634|P1|COMPLETED|Overall Study||0
1710379|NCT00385203|4183633|P2|STARTED|Overall Study||10
1710380|NCT00385203|4183634|P1|STARTED|Overall Study||26
1710381|NCT00385138|4183654|P2|NOT COMPLETED|Overall Study||28
1710382|NCT00385138|4183655|P1|NOT COMPLETED|Overall Study||30
1710383|NCT00385138|4183654|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
1710384|NCT00385138|4183655|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
1710385|NCT00385138|4183654|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
1710386|NCT00385138|4183655|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
1710387|NCT00385138|4183654|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
1710388|NCT00385138|4183655|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
1710389|NCT00385138|4183654|P2|Intent-to-treat (ITT)|Overall Study||2669
1710390|NCT00385138|4183655|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
1710391|NCT00385138|4183654|P2|STARTED|Overall Study||2669
1710392|NCT00385138|4183655|P1|STARTED|Overall Study||2695
1710393|NCT00385008|4183701|P2|NOT COMPLETED|Overall Study||0
1710394|NCT00385008|4183702|P1|NOT COMPLETED|Overall Study||0
1710395|NCT00385008|4183701|P2|COMPLETED|Overall Study||10
1710396|NCT00385008|4183702|P1|COMPLETED|Overall Study||10
1710397|NCT00385008|4183701|P2|In Presence of Migraine|Overall Study||5
1710398|NCT00385008|4183702|P1|In Presence of Migraine|Overall Study||5
1710399|NCT00385008|4183701|P2|In Absence of Migraine|Overall Study||10
1710400|NCT00385008|4183702|P1|In Absence of Migraine|Overall Study||10
1710401|NCT00385008|4183701|P2|STARTED|Overall Study||10
1710402|NCT00385008|4183702|P1|STARTED|Overall Study||10
1710403|NCT00384956|4183722|P1|NOT COMPLETED|Overall Study||3
1710404|NCT00384956|4183722|P1|COMPLETED|Overall Study||22
1710405|NCT00384956|4183722|P1|STARTED|Overall Study||25
1710406|NCT00384930|4183739|P5|NOT COMPLETED|Overall Study||47
1710407|NCT00384930|4183740|P4|NOT COMPLETED|Overall Study||41
1710408|NCT00384930|4183741|P3|NOT COMPLETED|Overall Study||30
1710409|NCT00384930|4183742|P2|NOT COMPLETED|Overall Study||27
1710410|NCT00384930|4183743|P1|NOT COMPLETED|Overall Study||27
1710411|NCT00384930|4183739|P5|COMPLETED|Overall Study||162
1710412|NCT00384930|4183740|P4|COMPLETED|Overall Study||175
1710413|NCT00384930|4183741|P3|COMPLETED|Overall Study||182
1710414|NCT00384930|4183742|P2|COMPLETED|Overall Study||182
1710415|NCT00384930|4183743|P1|COMPLETED|Overall Study||185
1710416|NCT00384930|4183739|P5|Received Double-Blind Study Drug|Overall Study||209
1710417|NCT00384930|4183740|P4|Received Double-Blind Study Drug|Overall Study||216
1710418|NCT00384930|4183741|P3|Received Double-Blind Study Drug|Overall Study||212
1710419|NCT00384930|4183742|P2|Received Double-Blind Study Drug|Overall Study||208
1710420|NCT00384930|4183743|P1|Received Double-Blind Study Drug|Overall Study||211
1710421|NCT00384930|4183739|P5|STARTED|Overall Study||209
1710422|NCT00384930|4183740|P4|STARTED|Overall Study||216
1710423|NCT00384930|4183741|P3|STARTED|Overall Study||212
1710424|NCT00384930|4183742|P2|STARTED|Overall Study||209
1710425|NCT00384930|4183743|P1|STARTED|Overall Study||212
1710426|NCT00384865|4183801|P4|NOT COMPLETED|Overall Study||0
1710427|NCT00384865|4183802|P3|NOT COMPLETED|Overall Study||0
1710428|NCT00384865|4183803|P2|NOT COMPLETED|Overall Study||0
1710429|NCT00384865|4183804|P1|NOT COMPLETED|Overall Study||0
1710430|NCT00384865|4183801|P4|COMPLETED|Overall Study||16
1710431|NCT00384865|4183802|P3|COMPLETED|Overall Study||16
1710432|NCT00384865|4183803|P2|COMPLETED|Overall Study||16
1710433|NCT00384865|4183804|P1|COMPLETED|Overall Study||16
1710434|NCT00384865|4183801|P4|Completed Six Month Assessment|Overall Study||11
1710435|NCT00384865|4183802|P3|Completed Six Month Assessment|Overall Study||15
1710436|NCT00384865|4183803|P2|Completed Six Month Assessment|Overall Study||12
1710437|NCT00384865|4183804|P1|Completed Six Month Assessment|Overall Study||11
1710438|NCT00384865|4183801|P4|STARTED|Overall Study||16
1710439|NCT00384865|4183802|P3|STARTED|Overall Study||16
1710440|NCT00384865|4183803|P2|STARTED|Overall Study||16
1710441|NCT00384865|4183804|P1|STARTED|Overall Study||16
1710442|NCT00384839|4183822|P1|NOT COMPLETED|Overall Study||8
1710443|NCT00384839|4183822|P1|COMPLETED|Overall Study||28
1710444|NCT00384839|4183822|P1|STARTED|Overall Study||36
1710445|NCT00384813|4183833|P2|NOT COMPLETED|Overall Study||0
1710446|NCT00384813|4183834|P1|NOT COMPLETED|Overall Study||2
1710447|NCT00384813|4183833|P2|COMPLETED|Overall Study||20
1710448|NCT00384813|4183834|P1|COMPLETED|Overall Study||21
1710449|NCT00384813|4183833|P2|STARTED|Overall Study||20
1710450|NCT00384813|4183834|P1|STARTED|Overall Study||23
1710451|NCT00384748|4183842|P2|NOT COMPLETED|Overall Study||0
1710452|NCT00384748|4183843|P1|NOT COMPLETED|Overall Study||0
1710453|NCT00384748|4183842|P2|COMPLETED|Overall Study||23
1710454|NCT00384748|4183843|P1|COMPLETED|Overall Study||25
1710455|NCT00384748|4183842|P2|STARTED|Overall Study||23
1710456|NCT00384748|4183843|P1|STARTED|Overall Study||25
1710457|NCT00384670|4183849|P1|NOT COMPLETED|Overall Study||0
1710458|NCT00384670|4183849|P1|COMPLETED|Overall Study||7
1710459|NCT00384670|4183849|P1|STARTED|Overall Study||7
1710460|NCT00384397|4183862|P3|NOT COMPLETED|Overall Study||33
1710461|NCT00384397|4183863|P2|NOT COMPLETED|Overall Study||46
1710462|NCT00384397|4183864|P1|NOT COMPLETED|Overall Study||32
1710463|NCT00384397|4183862|P3|COMPLETED|Overall Study||385
1710464|NCT00384397|4183863|P2|COMPLETED|Overall Study||247
1710465|NCT00384397|4183864|P1|COMPLETED|Overall Study||375
1710466|NCT00384397|4183862|P3|STARTED|Overall Study||418
1710467|NCT00384397|4183863|P2|STARTED|Overall Study||293
1710468|NCT00384397|4183864|P1|STARTED|Overall Study||407
1710469|NCT00384332|4183883|P2|NOT COMPLETED|Overall Study||0
1710470|NCT00384332|4183884|P1|NOT COMPLETED|Overall Study||4
1710471|NCT00384332|4183883|P2|COMPLETED|Overall Study||10
1710472|NCT00384332|4183884|P1|COMPLETED|Overall Study||9
1710473|NCT00384332|4183883|P2|STARTED|Overall Study||10
1710474|NCT00384332|4183884|P1|STARTED|Overall Study||13
1710475|NCT00384293|4183894|P3|NOT COMPLETED|Post-randomization Period||219
1710476|NCT00384293|4183895|P2|NOT COMPLETED|Post-randomization Period||214
1710477|NCT00384293|4183896|P1|NOT COMPLETED|Post-randomization Period||0
1710478|NCT00384293|4183894|P3|COMPLETED|Post-randomization Period||0
1710479|NCT00384293|4183895|P2|COMPLETED|Post-randomization Period||0
1710480|NCT00384293|4183896|P1|COMPLETED|Post-randomization Period||0
1710481|NCT00384293|4183894|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
1710482|NCT00384293|4183895|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
1710483|NCT00384293|4183896|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
1710484|NCT00384293|4183894|P3|STARTED|Post-randomization Period||219
1710485|NCT00384293|4183895|P2|STARTED|Post-randomization Period||214
1710486|NCT00384293|4183896|P1|STARTED|Post-randomization Period||0
1710487|NCT00384293|4183894|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
1710488|NCT00384293|4183895|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
1710489|NCT00384293|4183896|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
1710490|NCT00384293|4183894|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
1710491|NCT00384293|4183895|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
1710492|NCT00384293|4183896|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
1710493|NCT00384293|4183894|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
1710494|NCT00384293|4183895|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
1710495|NCT00384293|4183896|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
1710496|NCT00384293|4183894|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
1710497|NCT00384293|4183895|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
1710498|NCT00384293|4183896|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
1710499|NCT00384293|4183894|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
1710500|NCT00384293|4183895|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
1710501|NCT00384293|4183896|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
1710502|NCT00384241|4183909|P2|NOT COMPLETED|Overall Study||0
1710503|NCT00384241|4183910|P1|NOT COMPLETED|Overall Study||0
1710504|NCT00384241|4183909|P2|COMPLETED|Overall Study||599
1710505|NCT00384241|4183910|P1|COMPLETED|Overall Study||500
1710506|NCT00384241|4183909|P2|STARTED|Overall Study||599
1710507|NCT00384241|4183910|P1|STARTED|Overall Study||500
1710508|NCT00384189|4183920|P4|NOT COMPLETED|Overall Study||40
1710509|NCT00384189|4183921|P3|NOT COMPLETED|Overall Study||58
1710510|NCT00384189|4183922|P2|NOT COMPLETED|Overall Study||57
1710511|NCT00384189|4183923|P1|NOT COMPLETED|Overall Study||50
1710512|NCT00384189|4183920|P4|COMPLETED|Overall Study||110
1710513|NCT00384189|4183921|P3|COMPLETED|Overall Study||255
1710514|NCT00384189|4183922|P2|COMPLETED|Overall Study||255
1710515|NCT00384189|4183923|P1|COMPLETED|Overall Study||255
1710516|NCT00384189|4183920|P4|Actual Treatment Received|Overall Study||146
1710517|NCT00384189|4183921|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
1710518|NCT00384189|4183922|P2|Actual Treatment Received|Overall Study||312
1710519|NCT00384189|4183923|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
1710520|NCT00384189|4183920|P4|Randomized, Not Treated|Overall Study||4
1710521|NCT00384189|4183921|P3|Randomized, Not Treated|Overall Study||2
1710522|NCT00384189|4183922|P2|Randomized, Not Treated|Overall Study||0
1710523|NCT00384189|4183923|P1|Randomized, Not Treated|Overall Study||1
1710524|NCT00384189|4183920|P4|STARTED|Overall Study||150
1710525|NCT00384189|4183921|P3|STARTED|Overall Study||313
1710526|NCT00384189|4183922|P2|STARTED|Overall Study||312
1710527|NCT00384189|4183923|P1|STARTED|Overall Study||305
1710528|NCT00384176|4183984|P3|NOT COMPLETED|Overall Study||132
1710529|NCT00384176|4183985|P2|NOT COMPLETED|Overall Study||319
1710530|NCT00384176|4183986|P1|NOT COMPLETED|Overall Study||312
1710531|NCT00384176|4183984|P3|COMPLETED|Overall Study||60
1710532|NCT00384176|4183985|P2|COMPLETED|Overall Study||394
1710533|NCT00384176|4183986|P1|COMPLETED|Overall Study||397
1710534|NCT00384176|4183984|P3|STARTED|Overall Study||192
1710535|NCT00384176|4183985|P2|STARTED|Overall Study||713
1710536|NCT00384176|4183986|P1|STARTED|Overall Study||709
1710537|NCT00384085|4184012|P3|NOT COMPLETED|Overall Study||56
1710538|NCT00384085|4184013|P2|NOT COMPLETED|Overall Study||46
1710539|NCT00384085|4184014|P1|NOT COMPLETED|Overall Study||39
1710540|NCT00384085|4184012|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
1710541|NCT00384085|4184013|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
1710542|NCT00384085|4184014|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
1710543|NCT00384085|4184012|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
1710544|NCT00384085|4184013|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
1710545|NCT00384085|4184014|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
1710546|NCT00384085|4184012|P3|Treated (Safety Population)|Overall Study||194
1710547|NCT00384085|4184013|P2|Treated (Safety Population)|Overall Study||194
1710548|NCT00384085|4184014|P1|Treated (Safety Population)|Overall Study||194
1710549|NCT00384085|4184012|P3|Intent-To-Treat (ITT)|Overall Study||197
1710550|NCT00384085|4184013|P2|Intent-To-Treat (ITT)|Overall Study||196
1710551|NCT00384085|4184014|P1|Intent-To-Treat (ITT)|Overall Study||195
1710552|NCT00384085|4184012|P3|STARTED|Overall Study|Randomized|197
1710553|NCT00384085|4184013|P2|STARTED|Overall Study|Randomized|196
1710554|NCT00384085|4184014|P1|STARTED|Overall Study|Randomized|195
1710555|NCT00384059|4184040|P2|NOT COMPLETED|Toddler Dose||2
1710556|NCT00384059|4184041|P1|NOT COMPLETED|Toddler Dose||1
1710557|NCT00384059|4184040|P2|COMPLETED|Toddler Dose||120
1710558|NCT00384059|4184041|P1|COMPLETED|Toddler Dose||130
1710559|NCT00384059|4184040|P2|STARTED|Toddler Dose||122
1710560|NCT00384059|4184041|P1|STARTED|Toddler Dose||131
1710561|NCT00384059|4184040|P2|NOT COMPLETED|After Infant Series||10
1710562|NCT00384059|4184041|P1|NOT COMPLETED|After Infant Series||4
1710563|NCT00384059|4184040|P2|COMPLETED|After Infant Series||122
1710564|NCT00384059|4184041|P1|COMPLETED|After Infant Series||131
1710565|NCT00384059|4184040|P2|STARTED|After Infant Series||132
1710566|NCT00384059|4184041|P1|STARTED|After Infant Series||135
1710567|NCT00384059|4184040|P2|NOT COMPLETED|Infant Series||13
1710568|NCT00384059|4184041|P1|NOT COMPLETED|Infant Series||6
1710569|NCT00384059|4184040|P2|COMPLETED|Infant Series||132
1710570|NCT00384059|4184041|P1|COMPLETED|Infant Series||135
1710571|NCT00384059|4184040|P2|Vaccinated Dose 2|Infant Series||135
1710572|NCT00384059|4184041|P1|Vaccinated Dose 2|Infant Series||136
1710573|NCT00384059|4184040|P2|Vaccinated Dose 1|Infant Series||139
1710574|NCT00384059|4184041|P1|Vaccinated Dose 1|Infant Series||139
1710575|NCT00384059|4184040|P2|STARTED|Infant Series||145
1710576|NCT00384059|4184041|P1|STARTED|Infant Series||141
1710577|NCT00384033|4184091|P4|NOT COMPLETED|Overall Study||40
1710578|NCT00384033|4184092|P3|NOT COMPLETED|Overall Study||43
1710579|NCT00384033|4184093|P2|NOT COMPLETED|Overall Study||35
1710580|NCT00384033|4184094|P1|NOT COMPLETED|Overall Study||41
1710581|NCT00384033|4184091|P4|COMPLETED|Overall Study||119
1710582|NCT00384033|4184092|P3|COMPLETED|Overall Study||117
1710583|NCT00384033|4184093|P2|COMPLETED|Overall Study||120
1710584|NCT00384033|4184094|P1|COMPLETED|Overall Study||123
1710585|NCT00384033|4184091|P4|Treated|Overall Study||157
1710586|NCT00384033|4184092|P3|Treated|Overall Study||150
1710587|NCT00384033|4184093|P2|Treated|Overall Study||148
1710588|NCT00384033|4184094|P1|Treated|Overall Study||161
1710589|NCT00384033|4184091|P4|STARTED|Overall Study||159
1710590|NCT00384033|4184092|P3|STARTED|Overall Study||160
1710591|NCT00384033|4184093|P2|STARTED|Overall Study||155
1710592|NCT00384033|4184094|P1|STARTED|Overall Study||164
1710593|NCT00383942|4184138|P2|NOT COMPLETED|Overall Study||0
1710594|NCT00383942|4184139|P1|NOT COMPLETED|Overall Study||0
1710595|NCT00383942|4184138|P2|COMPLETED|Overall Study||40
1710596|NCT00383942|4184139|P1|COMPLETED|Overall Study||40
1710597|NCT00383942|4184138|P2|STARTED|Overall Study||40
1710598|NCT00383942|4184139|P1|STARTED|Overall Study||40
1710599|NCT00383786|4184147|P2|NOT COMPLETED|Overall Study||12
1710600|NCT00383786|4184148|P1|NOT COMPLETED|Overall Study||4
1710601|NCT00383786|4184147|P2|COMPLETED|Overall Study||13
1710602|NCT00383786|4184148|P1|COMPLETED|Overall Study||18
1710603|NCT00383786|4184147|P2|STARTED|Overall Study||25
1710604|NCT00383786|4184148|P1|STARTED|Overall Study||22
1710605|NCT00383760|4184154|P1|NOT COMPLETED|Overall Study||0
1710606|NCT00383760|4184154|P1|COMPLETED|Overall Study||15
1710607|NCT00383760|4184154|P1|STARTED|Overall Study||15
1710608|NCT00383747|4184170|P4|NOT COMPLETED|Visit 2||0
1710609|NCT00383747|4184171|P3|NOT COMPLETED|Visit 2||0
1710610|NCT00383747|4184172|P2|NOT COMPLETED|Visit 2||0
1710611|NCT00383747|4184173|P1|NOT COMPLETED|Visit 2||0
1710612|NCT00383747|4184170|P4|COMPLETED|Visit 2||16
1710613|NCT00383747|4184171|P3|COMPLETED|Visit 2||16
1710614|NCT00383747|4184172|P2|COMPLETED|Visit 2||14
1710615|NCT00383747|4184173|P1|COMPLETED|Visit 2||14
1710616|NCT00383747|4184170|P4|STARTED|Visit 2||16
1710617|NCT00383747|4184171|P3|STARTED|Visit 2||16
1710618|NCT00383747|4184172|P2|STARTED|Visit 2||14
1710619|NCT00383747|4184173|P1|STARTED|Visit 2||14
1710620|NCT00383747|4184170|P4|NOT COMPLETED|Visit 1||0
1710621|NCT00383747|4184171|P3|NOT COMPLETED|Visit 1||0
1710622|NCT00383747|4184172|P2|NOT COMPLETED|Visit 1||0
1710623|NCT00383747|4184173|P1|NOT COMPLETED|Visit 1||0
1710624|NCT00383747|4184170|P4|COMPLETED|Visit 1||16
1710625|NCT00383747|4184171|P3|COMPLETED|Visit 1||16
1710626|NCT00383747|4184172|P2|COMPLETED|Visit 1||14
1710627|NCT00383747|4184173|P1|COMPLETED|Visit 1||14
1710628|NCT00383747|4184170|P4|STARTED|Visit 1||16
1710629|NCT00383747|4184171|P3|STARTED|Visit 1||16
1710630|NCT00383747|4184172|P2|STARTED|Visit 1||14
1710631|NCT00383747|4184173|P1|STARTED|Visit 1||14
1710632|NCT00383721|4184198|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
1710633|NCT00383721|4184199|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
1710634|NCT00383721|4184200|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
1710635|NCT00383721|4184201|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
1710636|NCT00383721|4184202|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
1710637|NCT00383721|4184198|P5|COMPLETED|26-Week Treatment Safety Extension||8
1710638|NCT00383721|4184199|P4|COMPLETED|26-Week Treatment Safety Extension||131
1710639|NCT00383721|4184200|P3|COMPLETED|26-Week Treatment Safety Extension||126
1710640|NCT00383721|4184201|P2|COMPLETED|26-Week Treatment Safety Extension||136
1710641|NCT00383721|4184202|P1|COMPLETED|26-Week Treatment Safety Extension||126
1710642|NCT00383721|4184198|P5|STARTED|26-Week Treatment Safety Extension||8
1710643|NCT00383721|4184199|P4|STARTED|26-Week Treatment Safety Extension||148
1710644|NCT00383721|4184200|P3|STARTED|26-Week Treatment Safety Extension||149
1710645|NCT00383721|4184201|P2|STARTED|26-Week Treatment Safety Extension||153
1710646|NCT00383721|4184202|P1|STARTED|26-Week Treatment Safety Extension||145
1710647|NCT00383721|4184198|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
1710648|NCT00383721|4184199|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
1710649|NCT00383721|4184200|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
1710650|NCT00383721|4184201|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
1710651|NCT00383721|4184202|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
1710652|NCT00383721|4184198|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
1710653|NCT00383721|4184199|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
1710654|NCT00383721|4184200|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
1710655|NCT00383721|4184201|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
1710656|NCT00383721|4184202|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
1710657|NCT00383721|4184198|P5|STARTED|26-Week Double-Blind Treatment Period||236
1710658|NCT00383721|4184199|P4|STARTED|26-Week Double-Blind Treatment Period||243
1710659|NCT00383721|4184200|P3|STARTED|26-Week Double-Blind Treatment Period||253
1710660|NCT00383721|4184201|P2|STARTED|26-Week Double-Blind Treatment Period||239
1710661|NCT00383721|4184202|P1|STARTED|26-Week Double-Blind Treatment Period||225
1710662|NCT00383708|4184239|P1|NOT COMPLETED|Co-administration Period||5
1710663|NCT00383708|4184239|P1|COMPLETED|Co-administration Period||52
1710664|NCT00383708|4184239|P1|STARTED|Co-administration Period||57
1710665|NCT00383708|4184239|P1|NOT COMPLETED|Run-in Period||7
1710666|NCT00383708|4184239|P1|COMPLETED|Run-in Period||85
1710667|NCT00383708|4184239|P1|STARTED|Run-in Period||92
1710668|NCT00383708|4184239|P1|NOT COMPLETED|Enrolment Through Start Treatment||33
1710669|NCT00383708|4184239|P1|COMPLETED|Enrolment Through Start Treatment||92
1710670|NCT00383708|4184239|P1|STARTED|Enrolment Through Start Treatment||125
1710671|NCT00383643|4184276|P3|NOT COMPLETED|Overall Study||1
1710672|NCT00383643|4184277|P2|NOT COMPLETED|Overall Study||1
1710673|NCT00383643|4184278|P1|NOT COMPLETED|Overall Study||1
1710674|NCT00383643|4184276|P3|COMPLETED|Overall Study||13
1710675|NCT00383643|4184277|P2|COMPLETED|Overall Study||15
1710676|NCT00383643|4184278|P1|COMPLETED|Overall Study||17
1710677|NCT00383643|4184276|P3|STARTED|Overall Study||14
1710678|NCT00383643|4184277|P2|STARTED|Overall Study||16
1710679|NCT00383643|4184278|P1|STARTED|Overall Study||18
1710680|NCT00383565|4184298|P1|NOT COMPLETED|Overall Study||0
1710681|NCT00383565|4184298|P1|COMPLETED|Overall Study||9
1710682|NCT00383565|4184298|P1|STARTED|Overall Study||9
1710683|NCT00383552|4184308|P4|NOT COMPLETED|Overall Study||72
1710684|NCT00383552|4184309|P3|NOT COMPLETED|Overall Study||61
1710685|NCT00383552|4184310|P2|NOT COMPLETED|Overall Study||41
1710686|NCT00383552|4184311|P1|NOT COMPLETED|Overall Study||36
1710687|NCT00383552|4184308|P4|COMPLETED|Overall Study||116
1710688|NCT00383552|4184309|P3|COMPLETED|Overall Study||127
1710689|NCT00383552|4184310|P2|COMPLETED|Overall Study||147
1710690|NCT00383552|4184311|P1|COMPLETED|Overall Study||146
1710691|NCT00383552|4184308|P4|STARTED|Overall Study||188
1710692|NCT00383552|4184309|P3|STARTED|Overall Study||188
1710693|NCT00383552|4184310|P2|STARTED|Overall Study||188
1710694|NCT00383552|4184311|P1|STARTED|Overall Study||182
1710695|NCT00383500|4184353|P3|NOT COMPLETED|Overall Study||2
1710696|NCT00383500|4184354|P2|NOT COMPLETED|Overall Study||3
1710697|NCT00383500|4184355|P1|NOT COMPLETED|Overall Study||8
1710698|NCT00383500|4184353|P3|COMPLETED|Overall Study||22
1710699|NCT00383500|4184354|P2|COMPLETED|Overall Study||21
1710700|NCT00383500|4184355|P1|COMPLETED|Overall Study||19
1710701|NCT00383500|4184353|P3|STARTED|Overall Study||24
1710702|NCT00383500|4184354|P2|STARTED|Overall Study||24
1710703|NCT00383500|4184355|P1|STARTED|Overall Study||27
1710704|NCT00383435|4184371|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
1710705|NCT00383435|4184372|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
1710706|NCT00383435|4184373|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
1710707|NCT00383435|4184374|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
1710708|NCT00383435|4184375|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
1710709|NCT00383435|4184371|P5|COMPLETED|26-Week Treatment Safety Extension||10
1710710|NCT00383435|4184372|P4|COMPLETED|26-Week Treatment Safety Extension||116
1710711|NCT00383435|4184373|P3|COMPLETED|26-Week Treatment Safety Extension||108
1710712|NCT00383435|4184374|P2|COMPLETED|26-Week Treatment Safety Extension||121
1710713|NCT00383435|4184375|P1|COMPLETED|26-Week Treatment Safety Extension||117
1710714|NCT00383435|4184371|P5|STARTED|26-Week Treatment Safety Extension||13
1710715|NCT00383435|4184372|P4|STARTED|26-Week Treatment Safety Extension||131
1710716|NCT00383435|4184373|P3|STARTED|26-Week Treatment Safety Extension||124
1710717|NCT00383435|4184374|P2|STARTED|26-Week Treatment Safety Extension||130
1710718|NCT00383435|4184375|P1|STARTED|26-Week Treatment Safety Extension||131
1710719|NCT00383435|4184371|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
1710720|NCT00383435|4184372|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
1710721|NCT00383435|4184373|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
1710722|NCT00383435|4184374|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
1710723|NCT00383435|4184375|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
1710724|NCT00383435|4184371|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
1710725|NCT00383435|4184372|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
1710726|NCT00383435|4184373|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
1710727|NCT00383435|4184374|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
1710728|NCT00383435|4184375|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
1710729|NCT00383435|4184371|P5|STARTED|26-Week Double-Blind Treatment Period||212
1710730|NCT00383435|4184372|P4|STARTED|26-Week Double-Blind Treatment Period||209
1710731|NCT00383435|4184373|P3|STARTED|26-Week Double-Blind Treatment Period||210
1710732|NCT00383435|4184374|P2|STARTED|26-Week Double-Blind Treatment Period||207
1710733|NCT00383435|4184375|P1|STARTED|26-Week Double-Blind Treatment Period||217
1710734|NCT00383331|4184414|P2|NOT COMPLETED|Overall Study||1
1710735|NCT00383331|4184415|P1|NOT COMPLETED|Overall Study||0
1710736|NCT00383331|4184414|P2|COMPLETED|Overall Study||8
1710737|NCT00383331|4184415|P1|COMPLETED|Overall Study||10
1710738|NCT00383331|4184414|P2|STARTED|Overall Study||9
1710739|NCT00383331|4184415|P1|STARTED|Overall Study||10
1710740|NCT00383292|4184434|P3|NOT COMPLETED|Overall Study||8
1710741|NCT00383292|4184435|P2|NOT COMPLETED|Overall Study||6
1710742|NCT00383292|4184436|P1|NOT COMPLETED|Overall Study||15
1710743|NCT00383292|4184434|P3|COMPLETED|Overall Study||22
1710744|NCT00383292|4184435|P2|COMPLETED|Overall Study||26
1710745|NCT00383292|4184436|P1|COMPLETED|Overall Study||53
1710746|NCT00383292|4184434|P3|Received at Least One Dose of Study Drug|Overall Study||30
1710747|NCT00383292|4184435|P2|Received at Least One Dose of Study Drug|Overall Study||32
1710748|NCT00383292|4184436|P1|Received at Least One Dose of Study Drug|Overall Study||68
1710749|NCT00383292|4184434|P3|STARTED|Overall Study||30
1710750|NCT00383292|4184435|P2|STARTED|Overall Study||32
1710751|NCT00383292|4184436|P1|STARTED|Overall Study||68
1710752|NCT00383266|4184464|P1|NOT COMPLETED|Overall Study||0
1710753|NCT00383266|4184464|P1|COMPLETED|Overall Study||9
1710754|NCT00383266|4184464|P1|STARTED|Overall Study||9
1710755|NCT00383240|4184477|P4|NOT COMPLETED|Overall Study||77
1710756|NCT00383240|4184478|P3|NOT COMPLETED|Overall Study||85
1710757|NCT00383240|4184479|P2|NOT COMPLETED|Overall Study||33
1710758|NCT00383240|4184480|P1|NOT COMPLETED|Overall Study||35
1710759|NCT00383240|4184477|P4|COMPLETED|Overall Study||119
1710760|NCT00383240|4184478|P3|COMPLETED|Overall Study||117
1710761|NCT00383240|4184479|P2|COMPLETED|Overall Study||159
1710762|NCT00383240|4184480|P1|COMPLETED|Overall Study||156
1710763|NCT00383240|4184477|P4|STARTED|Overall Study||196
1710764|NCT00383240|4184478|P3|STARTED|Overall Study||202
1710765|NCT00383240|4184479|P2|STARTED|Overall Study||192
1710766|NCT00383240|4184480|P1|STARTED|Overall Study||191
1710767|NCT00383162|4184511|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
1710768|NCT00383162|4184512|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
1710769|NCT00383162|4184511|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
1710770|NCT00383162|4184512|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
1710771|NCT00383162|4184511|P2|STARTED|Migraine Attack 2 (Period 2)||73
1710772|NCT00383162|4184512|P1|STARTED|Migraine Attack 2 (Period 2)||67
1710773|NCT00383162|4184511|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
1710774|NCT00383162|4184512|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
1710775|NCT00383162|4184511|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
1710776|NCT00383162|4184512|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
1710777|NCT00383162|4184511|P2|STARTED|Migraine Attack 1 (Period 1)||86
1710778|NCT00383162|4184512|P1|STARTED|Migraine Attack 1 (Period 1)||87
1710779|NCT00383149|4184554|P1|NOT COMPLETED|Overall Study||54
1710780|NCT00383149|4184554|P1|COMPLETED|Overall Study||0
1710781|NCT00383149|4184554|P1|STARTED|Overall Study||54
1710782|NCT00383123|4184573|P2|NOT COMPLETED|Overall Study||86
1710783|NCT00383123|4184574|P1|NOT COMPLETED|Overall Study||111
1710784|NCT00383123|4184573|P2|COMPLETED|Overall Study||1124
1710785|NCT00383123|4184574|P1|COMPLETED|Overall Study||2004
1710786|NCT00383123|4184573|P2|STARTED|Overall Study||1210
1710787|NCT00383123|4184574|P1|STARTED|Overall Study||2115
1710788|NCT00383110|4184596|P2|NOT COMPLETED|Overall Study||0
1710789|NCT00383110|4184597|P1|NOT COMPLETED|Overall Study||0
1710790|NCT00383110|4184596|P2|COMPLETED|Overall Study||150
1710791|NCT00383110|4184597|P1|COMPLETED|Overall Study||150
1710792|NCT00383110|4184596|P2|STARTED|Overall Study||150
1710793|NCT00383110|4184597|P1|STARTED|Overall Study||150
1710794|NCT00383084|4184615|P2|NOT COMPLETED|Overall Study||10
1710795|NCT00383084|4184616|P1|NOT COMPLETED|Overall Study||12
1710796|NCT00383084|4184615|P2|COMPLETED|Overall Study||28
1710797|NCT00383084|4184616|P1|COMPLETED|Overall Study||34
1710798|NCT00383084|4184615|P2|STARTED|Overall Study||38
1710799|NCT00383084|4184616|P1|STARTED|Overall Study||46
1710800|NCT00383071|4184632|P4|NOT COMPLETED|Overall Study||3
1710801|NCT00383071|4184633|P3|NOT COMPLETED|Overall Study||7
1710802|NCT00383071|4184634|P2|NOT COMPLETED|Overall Study||4
1710803|NCT00383071|4184635|P1|NOT COMPLETED|Overall Study||0
1710804|NCT00383071|4184632|P4|COMPLETED|Overall Study||22
1710805|NCT00383071|4184633|P3|COMPLETED|Overall Study||44
1710806|NCT00383071|4184634|P2|COMPLETED|Overall Study||21
1710807|NCT00383071|4184635|P1|COMPLETED|Overall Study||25
1710808|NCT00383071|4184632|P4|STARTED|Overall Study||25
1710809|NCT00383071|4184633|P3|STARTED|Overall Study||51
1710810|NCT00383071|4184634|P2|STARTED|Overall Study||25
1710811|NCT00383071|4184635|P1|STARTED|Overall Study||25
1710812|NCT00383019|4184647|P2|NOT COMPLETED|Overall Study||2
1710813|NCT00383019|4184648|P1|NOT COMPLETED|Overall Study||5
1710814|NCT00383019|4184647|P2|COMPLETED|Overall Study||143
1710815|NCT00383019|4184648|P1|COMPLETED|Overall Study||139
1710816|NCT00383019|4184647|P2|STARTED|Overall Study||145
1710817|NCT00383019|4184648|P1|STARTED|Overall Study||144
1710818|NCT00382993|4184670|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
1710819|NCT00382993|4184671|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
1710820|NCT00382993|4184670|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
1710821|NCT00382993|4184671|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
1710822|NCT00382993|4184670|P2|STARTED|Migraine Attack 2 (Period 2)||67
1710823|NCT00382993|4184671|P1|STARTED|Migraine Attack 2 (Period 2)||70
1710824|NCT00382993|4184670|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
1710825|NCT00382993|4184671|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
1710826|NCT00382993|4184670|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
1710827|NCT00382993|4184671|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
1710828|NCT00382993|4184670|P2|STARTED|Migraine Attack 1 (Period 1)||85
1710829|NCT00382993|4184671|P1|STARTED|Migraine Attack 1 (Period 1)||84
1710830|NCT00382967|4184715|P2|NOT COMPLETED|Overall Study||1
1710831|NCT00382967|4184716|P1|NOT COMPLETED|Overall Study||1
1710832|NCT00382967|4184715|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
1710833|NCT00382967|4184716|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
1710834|NCT00382967|4184715|P2|STARTED|Overall Study||138
1710835|NCT00382967|4184716|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
1710836|NCT00382928|4184726|P2|NOT COMPLETED|Overall Study||0
1710837|NCT00382928|4184727|P1|NOT COMPLETED|Overall Study||0
1710838|NCT00382928|4184726|P2|COMPLETED|Overall Study||95
1710839|NCT00382928|4184727|P1|COMPLETED|Overall Study||97
1710840|NCT00382928|4184726|P2|STARTED|Overall Study||95
1710841|NCT00382928|4184727|P1|STARTED|Overall Study||97
1710842|NCT00382863|4184741|P2|NOT COMPLETED|Overall Study||36
1710843|NCT00382863|4184742|P1|NOT COMPLETED|Overall Study||15
1710844|NCT00382863|4184741|P2|COMPLETED|Overall Study||78
1710845|NCT00382863|4184742|P1|COMPLETED|Overall Study||81
1710846|NCT00382863|4184741|P2|STARTED|Overall Study||114
1710847|NCT00382863|4184742|P1|STARTED|Overall Study||96
1710848|NCT00382785|4184798|P2|NOT COMPLETED|Overall Study||0
1710849|NCT00382785|4184799|P1|NOT COMPLETED|Overall Study||0
1710850|NCT00382785|4184798|P2|COMPLETED|Overall Study||26
1710851|NCT00382785|4184799|P1|COMPLETED|Overall Study||25
1710852|NCT00382785|4184798|P2|STARTED|Overall Study||26
1710853|NCT00382785|4184799|P1|STARTED|Overall Study||25
1710854|NCT00382733|4184809|P5|NOT COMPLETED|Overall Study||0
1710855|NCT00382733|4184810|P4|NOT COMPLETED|Overall Study||0
1710856|NCT00382733|4184811|P3|NOT COMPLETED|Overall Study||0
1710857|NCT00382733|4184812|P2|NOT COMPLETED|Overall Study||1
1710858|NCT00382733|4184813|P1|NOT COMPLETED|Overall Study||0
1710859|NCT00382733|4184809|P5|COMPLETED|Overall Study||2
1710860|NCT00382733|4184810|P4|COMPLETED|Overall Study||14
1710861|NCT00382733|4184811|P3|COMPLETED|Overall Study||3
1710862|NCT00382733|4184812|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
1710863|NCT00382733|4184813|P1|COMPLETED|Overall Study||3
1710864|NCT00382733|4184809|P5|STARTED|Overall Study||2
1710865|NCT00382733|4184810|P4|STARTED|Overall Study||14
1710866|NCT00382733|4184811|P3|STARTED|Overall Study||3
1710867|NCT00382733|4184812|P2|STARTED|Overall Study||4
1710868|NCT00382733|4184813|P1|STARTED|Overall Study||3
1710869|NCT00382720|4184834|P3|NOT COMPLETED|Overall Study||86
1710870|NCT00382720|4184835|P2|NOT COMPLETED|Overall Study||89
1710871|NCT00382720|4184836|P1|NOT COMPLETED|Overall Study||79
1710872|NCT00382720|4184834|P3|COMPLETED|Overall Study||0
1710873|NCT00382720|4184835|P2|COMPLETED|Overall Study||0
1710874|NCT00382720|4184836|P1|COMPLETED|Overall Study||0
1710875|NCT00382720|4184834|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
1710876|NCT00382720|4184835|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
1710877|NCT00382720|4184836|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
1710878|NCT00382720|4184834|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
1710879|NCT00382720|4184835|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
1710880|NCT00382720|4184836|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
1710881|NCT00382720|4184834|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
1710882|NCT00382720|4184835|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
1710883|NCT00382720|4184836|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
1710884|NCT00382720|4184834|P3|STARTED|Overall Study||86
1710885|NCT00382720|4184835|P2|STARTED|Overall Study||89
1710886|NCT00382720|4184836|P1|STARTED|Overall Study||79
1710887|NCT00382590|4184852|P2|NOT COMPLETED|Overall Study||0
1710888|NCT00382590|4184853|P1|NOT COMPLETED|Overall Study||0
1710889|NCT00382590|4184852|P2|COMPLETED|Overall Study||6
1710890|NCT00382590|4184853|P1|COMPLETED|Overall Study||4
1710891|NCT00382590|4184852|P2|STARTED|Overall Study||6
1710892|NCT00382590|4184853|P1|STARTED|Overall Study||4
1710893|NCT00382408|4184861|P2|NOT COMPLETED|Overall Study||54
1710894|NCT00382408|4184862|P1|NOT COMPLETED|Overall Study||144
1710895|NCT00382408|4184861|P2|COMPLETED|Overall Study||955
1710896|NCT00382408|4184862|P1|COMPLETED|Overall Study||2887
1710897|NCT00382408|4184861|P2|STARTED|Overall Study||1009
1710898|NCT00382408|4184862|P1|STARTED|Overall Study||3031
1710899|NCT00382291|4184889|P3|NOT COMPLETED|Overall Study||8
1710900|NCT00382291|4184890|P2|NOT COMPLETED|Overall Study||7
1710901|NCT00382291|4184891|P1|NOT COMPLETED|Overall Study||4
1710902|NCT00382291|4184889|P3|COMPLETED|Overall Study||13
1710903|NCT00382291|4184890|P2|COMPLETED|Overall Study||10
1710904|NCT00382291|4184891|P1|COMPLETED|Overall Study||14
1710905|NCT00382291|4184889|P3|STARTED|Overall Study||21
1710906|NCT00382291|4184890|P2|STARTED|Overall Study||17
1710907|NCT00382291|4184891|P1|STARTED|Overall Study||18
1710908|NCT00382265|4184904|P2|NOT COMPLETED|Overall Study||6
1710909|NCT00382265|4184905|P1|NOT COMPLETED|Overall Study||9
1710910|NCT00382265|4184904|P2|COMPLETED|Overall Study||239
1710911|NCT00382265|4184905|P1|COMPLETED|Overall Study||258
1710912|NCT00382265|4184904|P2|STARTED|Overall Study||245
1710913|NCT00382265|4184905|P1|STARTED|Overall Study||267
1710914|NCT00382174|4184923|P3|NOT COMPLETED|Overall Study||21
1710915|NCT00382174|4184924|P2|NOT COMPLETED|Overall Study||17
1710916|NCT00382174|4184925|P1|NOT COMPLETED|Overall Study||4
1710917|NCT00382174|4184923|P3|COMPLETED|Overall Study||51
1710918|NCT00382174|4184924|P2|COMPLETED|Overall Study||37
1710919|NCT00382174|4184925|P1|COMPLETED|Overall Study||14
1710920|NCT00382174|4184923|P3|STARTED|Overall Study||72
1710921|NCT00382174|4184924|P2|STARTED|Overall Study||54
1710922|NCT00382174|4184925|P1|STARTED|Overall Study||18
1710923|NCT00382148|4184938|P2|NOT COMPLETED|Overall Study||0
1710924|NCT00382148|4184939|P1|NOT COMPLETED|Overall Study||1
1710925|NCT00382148|4184938|P2|COMPLETED|Overall Study||7
1710926|NCT00382148|4184939|P1|COMPLETED|Overall Study||3
1710927|NCT00382148|4184938|P2|STARTED|Overall Study||7
1710928|NCT00382148|4184939|P1|STARTED|Overall Study||4
1710929|NCT00382109|4184953|P2|NOT COMPLETED|Overall Study||4
1710930|NCT00382109|4184954|P1|NOT COMPLETED|Overall Study||12
1710931|NCT00382109|4184953|P2|COMPLETED|Overall Study||66
1710932|NCT00382109|4184954|P1|COMPLETED|Overall Study||64
1710933|NCT00382109|4184953|P2|STARTED|Overall Study||70
1710934|NCT00382109|4184954|P1|STARTED|Overall Study||76
1710935|NCT00382031|4184976|P2|NOT COMPLETED|Overall Study||0
1710936|NCT00382031|4184977|P1|NOT COMPLETED|Overall Study||0
1710937|NCT00382031|4184976|P2|COMPLETED|Overall Study||95
1710938|NCT00382031|4184977|P1|COMPLETED|Overall Study||191
1710939|NCT00382031|4184976|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
1710940|NCT00382031|4184977|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
1710941|NCT00382018|4184993|P4|NOT COMPLETED|Overall Study||59
1710942|NCT00382018|4184994|P3|NOT COMPLETED|Overall Study||64
1710943|NCT00382018|4184995|P2|NOT COMPLETED|Overall Study||165
1710944|NCT00382018|4184996|P1|NOT COMPLETED|Overall Study||0
1710945|NCT00382018|4184993|P4|COMPLETED|Overall Study||0
1710946|NCT00382018|4184994|P3|COMPLETED|Overall Study||0
1710947|NCT00382018|4184995|P2|COMPLETED|Overall Study||0
1710948|NCT00382018|4184996|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
1710949|NCT00382018|4184993|P4|STARTED|Overall Study||59
1710950|NCT00382018|4184994|P3|STARTED|Overall Study||64
1710951|NCT00382018|4184995|P2|STARTED|Overall Study||165
1710952|NCT00382018|4184996|P1|STARTED|Overall Study||276
1710953|NCT00381966|4185014|P1|NOT COMPLETED|Overall Study||0
1710954|NCT00381966|4185014|P1|COMPLETED|Overall Study||5
1710955|NCT00381966|4185014|P1|STARTED|Overall Study||5
1710956|NCT00381940|4185019|P1|NOT COMPLETED|Overall Study||5
1710957|NCT00381940|4185019|P1|COMPLETED|Overall Study||21
1710958|NCT00381940|4185019|P1|STARTED|Overall Study||26
1710959|NCT00381888|4185023|P1|NOT COMPLETED|Overall Study||17
1710960|NCT00381888|4185023|P1|COMPLETED|Overall Study||27
1710961|NCT00381888|4185023|P1|STARTED|Overall Study||44
1710962|NCT00381862|4185028|P1|NOT COMPLETED|Overall Study||10
1710963|NCT00381862|4185028|P1|COMPLETED|Overall Study||44
1710964|NCT00381862|4185028|P1|STARTED|Overall Study||54
1710965|NCT00381849|4185034|P2|NOT COMPLETED|Open-label||0
1710966|NCT00381849|4185035|P1|NOT COMPLETED|Open-label||0
1710967|NCT00381849|4185034|P2|COMPLETED|Open-label||9
1710968|NCT00381849|4185035|P1|COMPLETED|Open-label||10
1710969|NCT00381849|4185034|P2|STARTED|Open-label||9
1710970|NCT00381849|4185035|P1|STARTED|Open-label||10
1710971|NCT00381849|4185034|P2|NOT COMPLETED|Second Intervention||0
1710972|NCT00381849|4185035|P1|NOT COMPLETED|Second Intervention||0
1710973|NCT00381849|4185034|P2|COMPLETED|Second Intervention||9
1710974|NCT00381849|4185035|P1|COMPLETED|Second Intervention||10
1710975|NCT00381849|4185034|P2|STARTED|Second Intervention||9
1710976|NCT00381849|4185035|P1|STARTED|Second Intervention||10
1710977|NCT00381849|4185034|P2|NOT COMPLETED|Wash Out||1
1710978|NCT00381849|4185035|P1|NOT COMPLETED|Wash Out||0
1710979|NCT00381849|4185034|P2|COMPLETED|Wash Out||9
1710980|NCT00381849|4185035|P1|COMPLETED|Wash Out||10
1710981|NCT00381849|4185034|P2|STARTED|Wash Out||10
1710982|NCT00381849|4185035|P1|STARTED|Wash Out||10
1710983|NCT00381849|4185034|P2|NOT COMPLETED|First Intervention||0
1710984|NCT00381849|4185035|P1|NOT COMPLETED|First Intervention||0
1710985|NCT00381849|4185034|P2|COMPLETED|First Intervention||10
1710986|NCT00381849|4185035|P1|COMPLETED|First Intervention||10
1710987|NCT00381849|4185034|P2|STARTED|First Intervention||10
1710988|NCT00381849|4185035|P1|STARTED|First Intervention||10
1710989|NCT00381810|4185053|P1|NOT COMPLETED|B Cell Follow-up||7
1710990|NCT00381810|4185053|P1|COMPLETED|B Cell Follow-up||0
1710991|NCT00381810|4185053|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
1710992|NCT00381810|4185053|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
1710993|NCT00381810|4185053|P1|COMPLETED|Treatment and Safety Follow-up||16
1710994|NCT00381810|4185053|P1|STARTED|Treatment and Safety Follow-up||31
1710995|NCT00381797|4185062|P5|NOT COMPLETED|Overall Study||2
1710996|NCT00381797|4185063|P4|NOT COMPLETED|Overall Study||1
1710997|NCT00381797|4185064|P3|NOT COMPLETED|Overall Study||0
1710998|NCT00381797|4185065|P2|NOT COMPLETED|Overall Study||1
1710999|NCT00381797|4185066|P1|NOT COMPLETED|Overall Study||1
1711000|NCT00381797|4185062|P5|COMPLETED|Overall Study||35
1711001|NCT00381797|4185063|P4|COMPLETED|Overall Study||14
1711002|NCT00381797|4185064|P3|COMPLETED|Overall Study||10
1711003|NCT00381797|4185065|P2|COMPLETED|Overall Study||16
1711004|NCT00381797|4185066|P1|COMPLETED|Overall Study||17
1711005|NCT00381797|4185062|P5|STARTED|Overall Study||37
1711006|NCT00381797|4185063|P4|STARTED|Overall Study||15
1711007|NCT00381797|4185064|P3|STARTED|Overall Study||10
1711008|NCT00381797|4185065|P2|STARTED|Overall Study||17
1711009|NCT00381797|4185066|P1|STARTED|Overall Study||18
1711010|NCT00381706|4185141|P3|NOT COMPLETED|Overall Study||1
1711011|NCT00381706|4185142|P2|NOT COMPLETED|Overall Study||2
1711012|NCT00381706|4185143|P1|NOT COMPLETED|Overall Study||7
1711013|NCT00381706|4185141|P3|COMPLETED|Overall Study||79
1711014|NCT00381706|4185142|P2|COMPLETED|Overall Study||81
1711015|NCT00381706|4185143|P1|COMPLETED|Overall Study||75
1711016|NCT00381706|4185141|P3|STARTED|Overall Study||80
1711017|NCT00381706|4185142|P2|STARTED|Overall Study||83
1711018|NCT00381706|4185143|P1|STARTED|Overall Study||82
1711019|NCT00381693|4185166|P1|NOT COMPLETED|Overall Study||8
1711020|NCT00381693|4185166|P1|COMPLETED|Overall Study||2
1711021|NCT00381693|4185166|P1|STARTED|Overall Study||10
1711022|NCT00381680|4185175|P2|NOT COMPLETED|Overall Study||50
1711023|NCT00381680|4185176|P1|NOT COMPLETED|Overall Study||125
1711024|NCT00381680|4185175|P2|COMPLETED|Overall Study||19
1711025|NCT00381680|4185176|P1|COMPLETED|Overall Study||81
1711026|NCT00381680|4185175|P2|STARTED|Overall Study||69
1711027|NCT00381680|4185176|P1|STARTED|Overall Study||206
1711028|NCT00381641|4185193|P2|NOT COMPLETED|Overall Study||2
1711029|NCT00381641|4185194|P1|NOT COMPLETED|Overall Study||0
1711030|NCT00381641|4185193|P2|COMPLETED|Overall Study||23
1711031|NCT00381641|4185194|P1|COMPLETED|Overall Study||38
1711032|NCT00381641|4185193|P2|STARTED|Overall Study||25
1711033|NCT00381641|4185194|P1|STARTED|Overall Study||38
1711034|NCT00381628|4185210|P4|NOT COMPLETED|Overall Study||0
1711035|NCT00381628|4185211|P3|NOT COMPLETED|Overall Study||0
1711036|NCT00381628|4185212|P2|NOT COMPLETED|Overall Study||0
1711037|NCT00381628|4185213|P1|NOT COMPLETED|Overall Study||0
1711038|NCT00381628|4185210|P4|COMPLETED|Overall Study||14
1711039|NCT00381628|4185211|P3|COMPLETED|Overall Study||0
1711040|NCT00381628|4185212|P2|COMPLETED|Overall Study||27
1711041|NCT00381628|4185213|P1|COMPLETED|Overall Study||18
1711042|NCT00381628|4185210|P4|STARTED|Overall Study||14
1711043|NCT00381628|4185211|P3|STARTED|Overall Study||0
1711044|NCT00381628|4185212|P2|STARTED|Overall Study||27
1711045|NCT00381628|4185213|P1|STARTED|Overall Study||18
1711046|NCT00381615|4185227|P4|NOT COMPLETED|Overall Study||2
1711047|NCT00381615|4185228|P3|NOT COMPLETED|Overall Study||1
1711048|NCT00381615|4185229|P2|NOT COMPLETED|Overall Study||5
1711049|NCT00381615|4185230|P1|NOT COMPLETED|Overall Study||4
1711050|NCT00381615|4185227|P4|COMPLETED|Overall Study||22
1711051|NCT00381615|4185228|P3|COMPLETED|Overall Study||24
1711052|NCT00381615|4185229|P2|COMPLETED|Overall Study||45
1711053|NCT00381615|4185230|P1|COMPLETED|Overall Study||44
1711054|NCT00381615|4185227|P4|STARTED|Overall Study||24
1711055|NCT00381615|4185228|P3|STARTED|Overall Study||25
1711056|NCT00381615|4185229|P2|STARTED|Overall Study||50
1711057|NCT00381615|4185230|P1|STARTED|Overall Study||48
1711058|NCT00381563|4185282|P2|NOT COMPLETED|Overall Study||6
1711059|NCT00381563|4185283|P1|NOT COMPLETED|Overall Study||7
1711060|NCT00381563|4185282|P2|COMPLETED|Overall Study||33
1711061|NCT00381563|4185283|P1|COMPLETED|Overall Study||34
1711062|NCT00381563|4185282|P2|STARTED|Overall Study||39
1711063|NCT00381563|4185283|P1|STARTED|Overall Study||41
1711064|NCT00381550|4185290|P1|NOT COMPLETED|Overall Study||0
1711065|NCT00381550|4185290|P1|COMPLETED|Overall Study||35
1711066|NCT00381550|4185290|P1|STARTED|Overall Study||35
1711067|NCT00381485|4185298|P4|NOT COMPLETED|Double-Blind Treatment Period||33
1711068|NCT00381485|4185299|P3|NOT COMPLETED|Double-Blind Treatment Period||25
1711069|NCT00381485|4185300|P2|NOT COMPLETED|Double-Blind Treatment Period||27
1711070|NCT00381485|4185301|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1711071|NCT00381485|4185298|P4|COMPLETED|Double-Blind Treatment Period||207
1711072|NCT00381485|4185299|P3|COMPLETED|Double-Blind Treatment Period||208
1711073|NCT00381485|4185300|P2|COMPLETED|Double-Blind Treatment Period||228
1711074|NCT00381485|4185301|P1|COMPLETED|Double-Blind Treatment Period||0
1711075|NCT00381485|4185298|P4|STARTED|Double-Blind Treatment Period||240
1711076|NCT00381485|4185299|P3|STARTED|Double-Blind Treatment Period||233
1711077|NCT00381485|4185300|P2|STARTED|Double-Blind Treatment Period||255
1711078|NCT00381485|4185301|P1|STARTED|Double-Blind Treatment Period||0
1711079|NCT00381485|4185298|P4|NOT COMPLETED|Open-Label Run-In Period||0
1711080|NCT00381485|4185299|P3|NOT COMPLETED|Open-Label Run-In Period||0
1711081|NCT00381485|4185300|P2|NOT COMPLETED|Open-Label Run-In Period||0
1711082|NCT00381485|4185301|P1|NOT COMPLETED|Open-Label Run-In Period||106
1711083|NCT00381485|4185298|P4|COMPLETED|Open-Label Run-In Period||0
1711084|NCT00381485|4185299|P3|COMPLETED|Open-Label Run-In Period||0
1711085|NCT00381485|4185300|P2|COMPLETED|Open-Label Run-In Period||0
1711086|NCT00381485|4185301|P1|COMPLETED|Open-Label Run-In Period||728
1711087|NCT00381485|4185298|P4|STARTED|Open-Label Run-In Period||0
1711088|NCT00381485|4185299|P3|STARTED|Open-Label Run-In Period||0
1711089|NCT00381485|4185300|P2|STARTED|Open-Label Run-In Period||0
1711090|NCT00381485|4185301|P1|STARTED|Open-Label Run-In Period||834
1711091|NCT00381381|4185319|P1|NOT COMPLETED|Overall Study||64
1711092|NCT00381381|4185319|P1|COMPLETED|Overall Study||135
1711093|NCT00381381|4185319|P1|STARTED|Overall Study||199
1711094|NCT00381303|4185328|P2|NOT COMPLETED|Overall Study||33
1711095|NCT00381303|4185329|P1|NOT COMPLETED|Overall Study||94
1711096|NCT00381303|4185328|P2|COMPLETED|Overall Study||109
1711097|NCT00381303|4185329|P1|COMPLETED|Overall Study||193
1711098|NCT00381303|4185328|P2|STARTED|Overall Study||142
1711099|NCT00381303|4185329|P1|STARTED|Overall Study||287
1711100|NCT00381238|4185389|P1|NOT COMPLETED|Overall Study||12
1711101|NCT00381238|4185389|P1|COMPLETED|Overall Study||21
1711102|NCT00381238|4185389|P1|STARTED|Overall Study||33
1711103|NCT00381095|4185405|P2|NOT COMPLETED|Overall Study||21
1711104|NCT00381095|4185406|P1|NOT COMPLETED|Overall Study||13
1711105|NCT00381095|4185405|P2|COMPLETED|Overall Study||59
1711106|NCT00381095|4185406|P1|COMPLETED|Overall Study||59
1711107|NCT00381095|4185405|P2|STARTED|Overall Study||80
1711108|NCT00381095|4185406|P1|STARTED|Overall Study||72
1711109|NCT00381043|4185438|P2|NOT COMPLETED|Overall Study||8
1711110|NCT00381043|4185439|P1|NOT COMPLETED|Overall Study||12
1711111|NCT00381043|4185438|P2|COMPLETED|Overall Study||41
1711112|NCT00381043|4185439|P1|COMPLETED|Overall Study||39
1711113|NCT00381043|4185438|P2|STARTED|Overall Study||49
1711114|NCT00381043|4185439|P1|STARTED|Overall Study||51
1711115|NCT00381004|4185457|P1|NOT COMPLETED|Overall Study||0
1711116|NCT00381004|4185457|P1|COMPLETED|Overall Study||60
1711117|NCT00381004|4185457|P1|STARTED|Overall Study||60
1711118|NCT00380978|4185465|P2|NOT COMPLETED|Overall Study||10
1711119|NCT00380978|4185466|P1|NOT COMPLETED|Overall Study||2
1711120|NCT00380978|4185465|P2|COMPLETED|Overall Study||400
1711121|NCT00380978|4185466|P1|COMPLETED|Overall Study||406
1711122|NCT00380978|4185465|P2|STARTED|Overall Study||410
1711123|NCT00380978|4185466|P1|STARTED|Overall Study||408
1711124|NCT00380874|4185488|P2|NOT COMPLETED|Overall Study||10
1711125|NCT00380874|4185489|P1|NOT COMPLETED|Overall Study||13
1711126|NCT00380874|4185488|P2|COMPLETED|Overall Study||19
1711127|NCT00380874|4185489|P1|COMPLETED|Overall Study||19
1711128|NCT00380874|4185488|P2|STARTED|Overall Study||29
1711129|NCT00380874|4185489|P1|STARTED|Overall Study||32
1711130|NCT00380861|4185507|P2|NOT COMPLETED|Overall Study||17
1711131|NCT00380861|4185508|P1|NOT COMPLETED|Overall Study||18
1711132|NCT00380861|4185507|P2|COMPLETED|Overall Study||74
1711133|NCT00380861|4185508|P1|COMPLETED|Overall Study||75
1711134|NCT00380861|4185507|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
1711135|NCT00380861|4185508|P1|STARTED|Overall Study||93
1711136|NCT00380718|4185514|P1|NOT COMPLETED|Overall Study||18
1711137|NCT00380718|4185514|P1|COMPLETED|Overall Study||15
1711138|NCT00380718|4185514|P1|Received Escalated Dose in Cycle 2|Overall Study||25
1711139|NCT00380718|4185514|P1|Received at Least One Dose of Study Drug|Overall Study||33
1711140|NCT00380718|4185514|P1|STARTED|Overall Study||33
1711141|NCT00380692|4185526|P2|NOT COMPLETED|Study Period III - Open Label||12
1711142|NCT00380692|4185527|P1|NOT COMPLETED|Study Period III - Open Label||6
1711143|NCT00380692|4185526|P2|COMPLETED|Study Period III - Open Label||34
1711144|NCT00380692|4185527|P1|COMPLETED|Study Period III - Open Label||36
1711145|NCT00380692|4185526|P2|STARTED|Study Period III - Open Label||46
1711146|NCT00380692|4185527|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
1711147|NCT00380692|4185526|P2|NOT COMPLETED|Study Period II - Double Blind||3
1711148|NCT00380692|4185527|P1|NOT COMPLETED|Study Period II - Double Blind||5
1711149|NCT00380692|4185526|P2|COMPLETED|Study Period II - Double Blind||46
1711150|NCT00380692|4185527|P1|COMPLETED|Study Period II - Double Blind||43
1711151|NCT00380692|4185526|P2|STARTED|Study Period II - Double Blind||49
1711152|NCT00380692|4185527|P1|STARTED|Study Period II - Double Blind||48
1711153|NCT00380588|4185575|P2|NOT COMPLETED|Overall Study||40
1711154|NCT00380588|4185576|P1|NOT COMPLETED|Overall Study||39
1711155|NCT00380588|4185575|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
1711156|NCT00380588|4185576|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
1711157|NCT00380588|4185575|P2|Received at Least One Dose of Study Drug|Overall Study||42
1711158|NCT00380588|4185576|P1|Received at Least One Dose of Study Drug|Overall Study||41
1711159|NCT00380588|4185575|P2|STARTED|Overall Study||42
1711160|NCT00380588|4185576|P1|STARTED|Overall Study||42
1711161|NCT00380393|4185590|P2|NOT COMPLETED|Month 14||56
1711162|NCT00380393|4185591|P1|NOT COMPLETED|Month 14||57
1711163|NCT00380393|4185590|P2|COMPLETED|Month 14||391
1711164|NCT00380393|4185591|P1|COMPLETED|Month 14||390
1711165|NCT00380393|4185590|P2|STARTED|Month 14||447
1711166|NCT00380393|4185591|P1|STARTED|Month 14||447
1711167|NCT00380393|4185590|P2|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
1711168|NCT00380393|4185591|P1|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
1711169|NCT00380393|4185590|P2|COMPLETED|Month 8 (Cross-sectional Visit)||407
1711170|NCT00380393|4185591|P1|COMPLETED|Month 8 (Cross-sectional Visit)||398
1711171|NCT00380393|4185590|P2|STARTED|Month 8 (Cross-sectional Visit)||447
1711172|NCT00380393|4185591|P1|STARTED|Month 8 (Cross-sectional Visit)||447
1711173|NCT00380367|4185639|P1|NOT COMPLETED|Overall Study||2
1711174|NCT00380367|4185639|P1|COMPLETED|Overall Study||108
1711175|NCT00380367|4185639|P1|STARTED|Overall Study||110
1711176|NCT00380250|4185646|P2|NOT COMPLETED|Overall Study||55
1711177|NCT00380250|4185647|P1|NOT COMPLETED|Overall Study||99
1711178|NCT00380250|4185646|P2|COMPLETED|Overall Study||139
1711179|NCT00380250|4185647|P1|COMPLETED|Overall Study||297
1711180|NCT00380250|4185646|P2|STARTED|Overall Study||194
1711181|NCT00380250|4185647|P1|STARTED|Overall Study||396
1711182|NCT00380081|4185715|P6|NOT COMPLETED|Overall Study||1
1711183|NCT00380081|4185716|P5|NOT COMPLETED|Overall Study||1
1711184|NCT00380081|4185717|P4|NOT COMPLETED|Overall Study||0
1711185|NCT00380081|4185718|P3|NOT COMPLETED|Overall Study||0
1711186|NCT00380081|4185719|P2|NOT COMPLETED|Overall Study||0
1711187|NCT00380081|4185720|P1|NOT COMPLETED|Overall Study||0
1711188|NCT00380081|4185715|P6|COMPLETED|Overall Study||13
1711189|NCT00380081|4185716|P5|COMPLETED|Overall Study||12
1711190|NCT00380081|4185717|P4|COMPLETED|Overall Study||15
1711191|NCT00380081|4185718|P3|COMPLETED|Overall Study||13
1711192|NCT00380081|4185719|P2|COMPLETED|Overall Study||13
1711193|NCT00380081|4185720|P1|COMPLETED|Overall Study||14
1711194|NCT00380081|4185715|P6|STARTED|Overall Study||14
1711195|NCT00380081|4185716|P5|STARTED|Overall Study||13
1711196|NCT00380081|4185717|P4|STARTED|Overall Study||15
1711197|NCT00380081|4185718|P3|STARTED|Overall Study||13
1711198|NCT00380081|4185719|P2|STARTED|Overall Study||13
1711199|NCT00380081|4185720|P1|STARTED|Overall Study||14
1711200|NCT00380068|4185770|P1|NOT COMPLETED|Overall Study||69
1711201|NCT00380068|4185770|P1|COMPLETED|Overall Study||155
1711202|NCT00380068|4185770|P1|STARTED|Overall Study||224
1711203|NCT00380029|4185790|P1|NOT COMPLETED|Overall Study||0
1711204|NCT00380029|4185790|P1|COMPLETED|Overall Study||20
1711205|NCT00380029|4185790|P1|STARTED|Overall Study||20
1711206|NCT00379912|4185802|P2|NOT COMPLETED|Overall Study||0
1711207|NCT00379912|4185803|P1|NOT COMPLETED|Overall Study||1
1711208|NCT00379912|4185802|P2|COMPLETED|Overall Study||8
1711209|NCT00379912|4185803|P1|COMPLETED|Overall Study||6
1711210|NCT00379912|4185802|P2|STARTED|Overall Study||8
1711211|NCT00379912|4185803|P1|STARTED|Overall Study||7
1711212|NCT00379899|4185825|P2|NOT COMPLETED|Overall Study||40
1711213|NCT00379899|4185826|P1|NOT COMPLETED|Overall Study||40
1711214|NCT00379899|4185825|P2|COMPLETED|Overall Study||140
1711215|NCT00379899|4185826|P1|COMPLETED|Overall Study||140
1711216|NCT00379899|4185825|P2|STARTED|Overall Study||180
1711217|NCT00379899|4185826|P1|STARTED|Overall Study||180
1711218|NCT00379834|4185854|P1|NOT COMPLETED|Overall Study||2
1711219|NCT00379834|4185854|P1|COMPLETED|Overall Study||8
1711220|NCT00379834|4185854|P1|STARTED|Overall Study||10
1711221|NCT00379821|4185862|P4|NOT COMPLETED|Overall Study||79
1711222|NCT00379821|4185863|P3|NOT COMPLETED|Overall Study||67
1711223|NCT00379821|4185864|P2|NOT COMPLETED|Overall Study||89
1711224|NCT00379821|4185865|P1|NOT COMPLETED|Overall Study||73
1711225|NCT00379821|4185862|P4|COMPLETED|Overall Study||81
1711226|NCT00379821|4185863|P3|COMPLETED|Overall Study||93
1711227|NCT00379821|4185864|P2|COMPLETED|Overall Study||71
1711228|NCT00379821|4185865|P1|COMPLETED|Overall Study||87
1711229|NCT00379821|4185862|P4|STARTED|Overall Study||160
1711230|NCT00379821|4185863|P3|STARTED|Overall Study||160
1711231|NCT00379821|4185864|P2|STARTED|Overall Study||160
1711232|NCT00379821|4185865|P1|STARTED|Overall Study||160
1711233|NCT00379808|4186006|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
1711234|NCT00379808|4186007|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
1711235|NCT00379808|4186006|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
1711236|NCT00379808|4186007|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
1711237|NCT00379808|4186006|P2|STARTED|Intervention Period 2 (4 Weeks)||11
1711238|NCT00379808|4186007|P1|STARTED|Intervention Period 2 (4 Weeks)||11
1711239|NCT00379808|4186006|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
1711240|NCT00379808|4186007|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
1711241|NCT00379808|4186006|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
1711242|NCT00379808|4186007|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
1711243|NCT00379808|4186006|P2|STARTED|Intervention Period 1 (4 Weeks)||11
1711244|NCT00379808|4186007|P1|STARTED|Intervention Period 1 (4 Weeks)||11
1711245|NCT00379795|4186028|P5|NOT COMPLETED|Overall Study||49
1711246|NCT00379795|4186029|P4|NOT COMPLETED|Overall Study||68
1711247|NCT00379795|4186030|P3|NOT COMPLETED|Overall Study||93
1711248|NCT00379795|4186031|P2|NOT COMPLETED|Overall Study||51
1711249|NCT00379795|4186032|P1|NOT COMPLETED|Overall Study||476
1711250|NCT00379795|4186028|P5|COMPLETED|Overall Study||14
1711251|NCT00379795|4186029|P4|COMPLETED|Overall Study||6
1711252|NCT00379795|4186030|P3|COMPLETED|Overall Study||23
1711253|NCT00379795|4186031|P2|COMPLETED|Overall Study||23
1711254|NCT00379795|4186032|P1|COMPLETED|Overall Study||50
1711255|NCT00379795|4186028|P5|Received Ranibizumab in Extension Study|Overall Study||0
1711256|NCT00379795|4186029|P4|Received Ranibizumab in Extension Study|Overall Study||55
1711257|NCT00379795|4186030|P3|Received Ranibizumab in Extension Study|Overall Study||113
1711258|NCT00379795|4186031|P2|Received Ranibizumab in Extension Study|Overall Study||41
1711259|NCT00379795|4186032|P1|Received Ranibizumab in Extension Study|Overall Study||377
1711260|NCT00379795|4186028|P5|STARTED|Overall Study||63
1711261|NCT00379795|4186029|P4|STARTED|Overall Study||74
1711262|NCT00379795|4186030|P3|STARTED|Overall Study||116
1711263|NCT00379795|4186031|P2|STARTED|Overall Study||74
1711264|NCT00379795|4186032|P1|STARTED|Overall Study||526
1711265|NCT00379769|4186062|P6|NOT COMPLETED|Observational Follow-up||148
1711266|NCT00379769|4186063|P5|NOT COMPLETED|Observational Follow-up||149
1711267|NCT00379769|4186064|P4|NOT COMPLETED|Observational Follow-up||0
1711268|NCT00379769|4186065|P3|NOT COMPLETED|Observational Follow-up||0
1711269|NCT00379769|4186066|P2|NOT COMPLETED|Observational Follow-up||0
1711270|NCT00379769|4186067|P1|NOT COMPLETED|Observational Follow-up||0
1711271|NCT00379769|4186062|P6|COMPLETED|Observational Follow-up||1102
1711272|NCT00379769|4186063|P5|COMPLETED|Observational Follow-up||1131
1711273|NCT00379769|4186064|P4|COMPLETED|Observational Follow-up||0
1711274|NCT00379769|4186065|P3|COMPLETED|Observational Follow-up||0
1711275|NCT00379769|4186066|P2|COMPLETED|Observational Follow-up||0
1711276|NCT00379769|4186067|P1|COMPLETED|Observational Follow-up||0
1711277|NCT00379769|4186062|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
1711278|NCT00379769|4186063|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
1711279|NCT00379769|4186064|P4|STARTED|Observational Follow-up||0
1711280|NCT00379769|4186065|P3|STARTED|Observational Follow-up||0
1711281|NCT00379769|4186066|P2|STARTED|Observational Follow-up||0
1711282|NCT00379769|4186067|P1|STARTED|Observational Follow-up||0
1711283|NCT00379769|4186062|P6|NOT COMPLETED|Main Study||0
1711284|NCT00379769|4186063|P5|NOT COMPLETED|Main Study||0
1711285|NCT00379769|4186064|P4|NOT COMPLETED|Main Study||230
1711286|NCT00379769|4186065|P3|NOT COMPLETED|Main Study||207
1711287|NCT00379769|4186066|P2|NOT COMPLETED|Main Study||199
1711288|NCT00379769|4186067|P1|NOT COMPLETED|Main Study||178
1711289|NCT00379769|4186062|P6|COMPLETED|Main Study||0
1711290|NCT00379769|4186063|P5|COMPLETED|Main Study||0
1711291|NCT00379769|4186064|P4|COMPLETED|Main Study||892
1711292|NCT00379769|4186065|P3|COMPLETED|Main Study||896
1711293|NCT00379769|4186066|P2|COMPLETED|Main Study||906
1711294|NCT00379769|4186067|P1|COMPLETED|Main Study||939
1711295|NCT00379769|4186062|P6|STARTED|Main Study||0
1711296|NCT00379769|4186063|P5|STARTED|Main Study||0
1711297|NCT00379769|4186064|P4|STARTED|Main Study||1122
1711298|NCT00379769|4186065|P3|STARTED|Main Study||1103
1711299|NCT00379769|4186066|P2|STARTED|Main Study||1105
1711300|NCT00379769|4186067|P1|STARTED|Main Study||1117
1711301|NCT00379639|4186226|P5|NOT COMPLETED|Overall Study||6
1711302|NCT00379639|4186227|P4|NOT COMPLETED|Overall Study||6
1711303|NCT00379639|4186228|P3|NOT COMPLETED|Overall Study||9
1711304|NCT00379639|4186229|P2|NOT COMPLETED|Overall Study||5
1711305|NCT00379639|4186230|P1|NOT COMPLETED|Overall Study||3
1711306|NCT00379639|4186226|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
1711307|NCT00379639|4186227|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
1711308|NCT00379639|4186228|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
1711309|NCT00379639|4186229|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
1711310|NCT00379639|4186230|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
1711311|NCT00379639|4186226|P5|Completed 6 Cycles of Therapy|Overall Study||0
1711312|NCT00379639|4186227|P4|Completed 6 Cycles of Therapy|Overall Study||0
1711313|NCT00379639|4186228|P3|Completed 6 Cycles of Therapy|Overall Study||1
1711314|NCT00379639|4186229|P2|Completed 6 Cycles of Therapy|Overall Study||2
1711315|NCT00379639|4186230|P1|Completed 6 Cycles of Therapy|Overall Study||4
1711316|NCT00379639|4186226|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
1711317|NCT00379639|4186227|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
1711318|NCT00379639|4186228|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
1711319|NCT00379639|4186229|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
1711320|NCT00379639|4186230|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
1711321|NCT00379639|4186226|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
1711322|NCT00379639|4186227|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
1711323|NCT00379639|4186228|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
1711324|NCT00379639|4186229|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
1711325|NCT00379639|4186230|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
1711326|NCT00379587|4186252|P1|NOT COMPLETED|Overall Study||2
1711327|NCT00379587|4186252|P1|COMPLETED|Overall Study||63
1711328|NCT00379587|4186252|P1|STARTED|Overall Study||65
1711329|NCT00379574|4186259|P1|NOT COMPLETED|Overall Study||0
1711330|NCT00379574|4186259|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
1711331|NCT00379574|4186259|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
1711332|NCT00379353|4186266|P2|NOT COMPLETED|Overall Study||6
1711333|NCT00379353|4186267|P1|NOT COMPLETED|Overall Study||11
1711334|NCT00379353|4186266|P2|COMPLETED|Overall Study||9
1711335|NCT00379353|4186267|P1|COMPLETED|Overall Study||5
1711336|NCT00379353|4186266|P2|STARTED|Overall Study||15
1711337|NCT00379353|4186267|P1|STARTED|Overall Study||16
1711338|NCT00379340|4186302|P5|NOT COMPLETED|Overall Study||14
1711339|NCT00379340|4186303|P4|NOT COMPLETED|Overall Study||13
1711340|NCT00379340|4186304|P3|NOT COMPLETED|Overall Study||2
1711341|NCT00379340|4186305|P2|NOT COMPLETED|Overall Study||3
1711342|NCT00379340|4186306|P1|NOT COMPLETED|Overall Study||13
1711343|NCT00379340|4186302|P5|COMPLETED|Overall Study||9
1711344|NCT00379340|4186303|P4|COMPLETED|Overall Study||37
1711345|NCT00379340|4186304|P3|COMPLETED|Overall Study||50
1711346|NCT00379340|4186305|P2|COMPLETED|Overall Study||132
1711347|NCT00379340|4186306|P1|COMPLETED|Overall Study||107
1711348|NCT00379340|4186302|P5|STARTED|Overall Study||23
1711349|NCT00379340|4186303|P4|STARTED|Overall Study||50
1711350|NCT00379340|4186304|P3|STARTED|Overall Study||52
1711351|NCT00379340|4186305|P2|STARTED|Overall Study||135
1711352|NCT00379340|4186306|P1|STARTED|Overall Study||120
1711353|NCT00379288|4186323|P4|NOT COMPLETED|Overall Study||8
1711354|NCT00379288|4186324|P3|NOT COMPLETED|Overall Study||10
1711355|NCT00379288|4186325|P2|NOT COMPLETED|Overall Study||22
1711356|NCT00379288|4186326|P1|NOT COMPLETED|Overall Study||19
1711357|NCT00379288|4186323|P4|COMPLETED|Overall Study||57
1711358|NCT00379288|4186324|P3|COMPLETED|Overall Study||58
1711359|NCT00379288|4186325|P2|COMPLETED|Overall Study||108
1711360|NCT00379288|4186326|P1|COMPLETED|Overall Study||122
1711361|NCT00379288|4186323|P4|STARTED|Overall Study||65
1711362|NCT00379288|4186324|P3|STARTED|Overall Study||68
1711363|NCT00379288|4186325|P2|STARTED|Overall Study||130
1711364|NCT00379288|4186326|P1|STARTED|Overall Study||141
1711365|NCT00379236|4186338|P3|NOT COMPLETED|Open-label Extension||55
1711366|NCT00379236|4186339|P2|NOT COMPLETED|Open-label Extension||0
1711367|NCT00379236|4186340|P1|NOT COMPLETED|Open-label Extension||0
1711368|NCT00379236|4186338|P3|COMPLETED|Open-label Extension||378
1711369|NCT00379236|4186339|P2|COMPLETED|Open-label Extension||0
1711370|NCT00379236|4186340|P1|COMPLETED|Open-label Extension||0
1711371|NCT00379236|4186338|P3|STARTED|Open-label Extension||433
1711372|NCT00379236|4186339|P2|STARTED|Open-label Extension||0
1711373|NCT00379236|4186340|P1|STARTED|Open-label Extension||0
1711374|NCT00379236|4186338|P3|NOT COMPLETED|Double-blind||0
1711375|NCT00379236|4186339|P2|NOT COMPLETED|Double-blind||36
1711376|NCT00379236|4186340|P1|NOT COMPLETED|Double-blind||36
1711377|NCT00379236|4186338|P3|COMPLETED|Double-blind||0
1711378|NCT00379236|4186339|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
1711379|NCT00379236|4186340|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
1711380|NCT00379236|4186338|P3|STARTED|Double-blind||0
1711381|NCT00379236|4186339|P2|STARTED|Double-blind||295
1711382|NCT00379236|4186340|P1|STARTED|Double-blind||293
1711383|NCT00379210|4186385|P2|NOT COMPLETED|Overall Study||7
1711384|NCT00379210|4186386|P1|NOT COMPLETED|Overall Study||10
1711385|NCT00379210|4186385|P2|COMPLETED|Overall Study||23
1711386|NCT00379210|4186386|P1|COMPLETED|Overall Study||20
1711387|NCT00379210|4186385|P2|STARTED|Overall Study||30
1711388|NCT00379210|4186386|P1|STARTED|Overall Study||30
1711389|NCT00379197|4186392|P1|NOT COMPLETED|Overall Study||5
1711390|NCT00379197|4186392|P1|COMPLETED|Overall Study||8
1711391|NCT00379197|4186392|P1|STARTED|Overall Study||13
1711392|NCT00379145|4186397|P1|NOT COMPLETED|Overall Study||0
1711393|NCT00379145|4186397|P1|COMPLETED|Overall Study||20
1711394|NCT00379145|4186397|P1|STARTED|Overall Study||20
1711395|NCT00379080|4186409|P3|NOT COMPLETED|Overall Study||0
1711396|NCT00379080|4186410|P2|NOT COMPLETED|Overall Study||4
1711397|NCT00379080|4186411|P1|NOT COMPLETED|Overall Study||0
1711398|NCT00379080|4186409|P3|COMPLETED|Overall Study||31
1711399|NCT00379080|4186410|P2|COMPLETED|Overall Study||15
1711400|NCT00379080|4186411|P1|COMPLETED|Overall Study||6
1711401|NCT00379080|4186409|P3|STARTED|Overall Study||31
1711402|NCT00379080|4186410|P2|STARTED|Overall Study||19
1711403|NCT00379080|4186411|P1|STARTED|Overall Study||6
1711404|NCT00378898|4186456|P2|NOT COMPLETED|Overall Study||6
1711405|NCT00378898|4186457|P1|NOT COMPLETED|Overall Study||11
1711406|NCT00378898|4186456|P2|COMPLETED|Overall Study||11
1711407|NCT00378898|4186457|P1|COMPLETED|Overall Study||11
1711408|NCT00378898|4186456|P2|STARTED|Overall Study||17
1711409|NCT00378898|4186457|P1|STARTED|Overall Study||22
1711410|NCT00378703|4186469|P4|NOT COMPLETED|Overall Study||91
1711411|NCT00378703|4186470|P3|NOT COMPLETED|Overall Study||90
1711412|NCT00378703|4186471|P2|NOT COMPLETED|Overall Study||91
1711413|NCT00378703|4186472|P1|NOT COMPLETED|Overall Study||89
1711414|NCT00378703|4186469|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
1711415|NCT00378703|4186470|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
1711416|NCT00378703|4186471|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
1711417|NCT00378703|4186472|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
1711418|NCT00378703|4186469|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
1711419|NCT00378703|4186470|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
1711420|NCT00378703|4186471|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
1711421|NCT00378703|4186472|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
1711422|NCT00378703|4186469|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
1711423|NCT00378703|4186470|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
1711424|NCT00378703|4186471|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
1711425|NCT00378703|4186472|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
1711426|NCT00378703|4186469|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
1711427|NCT00378703|4186470|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
1711428|NCT00378703|4186471|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
1711429|NCT00378703|4186472|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
1711430|NCT00378599|4186494|P1|NOT COMPLETED|Overall Study||52
1711431|NCT00378599|4186494|P1|COMPLETED|Overall Study||73
1711432|NCT00378599|4186494|P1|STARTED|Overall Study||125
1711433|NCT00378573|4186498|P1|NOT COMPLETED|Follow-up||14
1711434|NCT00378573|4186498|P1|COMPLETED|Follow-up||3
1711435|NCT00378573|4186498|P1|STARTED|Follow-up||17
1711436|NCT00378573|4186498|P1|NOT COMPLETED|Treatment Period||17
1711437|NCT00378573|4186498|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
1711438|NCT00378573|4186498|P1|STARTED|Treatment Period||17
1711439|NCT00378560|4186506|P2|NOT COMPLETED|Overall Study||58
1711440|NCT00378560|4186507|P1|NOT COMPLETED|Overall Study||56
1711441|NCT00378560|4186506|P2|COMPLETED|Overall Study||454
1711442|NCT00378560|4186507|P1|COMPLETED|Overall Study||453
1711443|NCT00378560|4186506|P2|Vaccinated|Overall Study||512
1711444|NCT00378560|4186507|P1|Vaccinated|Overall Study||509
1711445|NCT00378560|4186506|P2|STARTED|Overall Study||512
1711446|NCT00378560|4186507|P1|STARTED|Overall Study||509
1711447|NCT00378534|4186521|P1|NOT COMPLETED|Overall Study||60
1711448|NCT00378534|4186521|P1|COMPLETED|Overall Study|Transplantation Recipients|55
1711449|NCT00378534|4186521|P1|STARTED|Overall Study||115
1711450|NCT00378508|4186527|P2|NOT COMPLETED|Overall Study||3
1711451|NCT00378508|4186528|P1|NOT COMPLETED|Overall Study||2
1711452|NCT00378508|4186527|P2|COMPLETED|Overall Study||31
1711453|NCT00378508|4186528|P1|COMPLETED|Overall Study||27
1711454|NCT00378508|4186527|P2|Received Intervention/Placebo|Overall Study||31
1711455|NCT00378508|4186528|P1|Received Intervention/Placebo|Overall Study||28
1711456|NCT00378508|4186527|P2|Randomized|Overall Study||34
1711457|NCT00378508|4186528|P1|Randomized|Overall Study||29
1711458|NCT00378508|4186527|P2|STARTED|Overall Study||34
1711459|NCT00378508|4186528|P1|STARTED|Overall Study||29
1711460|NCT00378378|4186547|P3|NOT COMPLETED|Overall Study||2
1711461|NCT00378378|4186548|P2|NOT COMPLETED|Overall Study||1
1711462|NCT00378378|4186549|P1|NOT COMPLETED|Overall Study||0
1711463|NCT00378378|4186547|P3|COMPLETED|Overall Study||24
1711464|NCT00378378|4186548|P2|COMPLETED|Overall Study||49
1711465|NCT00378378|4186549|P1|COMPLETED|Overall Study||51
1711466|NCT00378378|4186547|P3|STARTED|Overall Study||26
1711467|NCT00378378|4186548|P2|STARTED|Overall Study||50
1711468|NCT00378378|4186549|P1|STARTED|Overall Study||51
1711469|NCT00378352|4186562|P6|NOT COMPLETED|Efficacy Phase||7
1711470|NCT00378352|4186563|P5|NOT COMPLETED|Efficacy Phase||11
1711471|NCT00378352|4186564|P4|NOT COMPLETED|Efficacy Phase||0
1711472|NCT00378352|4186565|P3|NOT COMPLETED|Efficacy Phase||0
1711473|NCT00378352|4186566|P2|NOT COMPLETED|Efficacy Phase||0
1711474|NCT00378352|4186567|P1|NOT COMPLETED|Efficacy Phase||0
1711475|NCT00378352|4186562|P6|COMPLETED|Efficacy Phase||59
1711476|NCT00378352|4186563|P5|COMPLETED|Efficacy Phase||54
1711477|NCT00378352|4186564|P4|COMPLETED|Efficacy Phase||0
1711478|NCT00378352|4186565|P3|COMPLETED|Efficacy Phase||0
1711479|NCT00378352|4186566|P2|COMPLETED|Efficacy Phase||0
1711480|NCT00378352|4186567|P1|COMPLETED|Efficacy Phase||0
1711481|NCT00378352|4186562|P6|Safety Analysis|Efficacy Phase||64
1711482|NCT00378352|4186563|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
1711483|NCT00378352|4186564|P4|Safety Analysis|Efficacy Phase||0
1711484|NCT00378352|4186565|P3|Safety Analysis|Efficacy Phase||0
1711485|NCT00378352|4186566|P2|Safety Analysis|Efficacy Phase||0
1711486|NCT00378352|4186567|P1|Safety Analysis|Efficacy Phase||0
1711487|NCT00378352|4186562|P6|STARTED|Efficacy Phase||66
1711488|NCT00378352|4186563|P5|STARTED|Efficacy Phase||65
1711489|NCT00378352|4186564|P4|STARTED|Efficacy Phase||0
1711490|NCT00378352|4186565|P3|STARTED|Efficacy Phase||0
1711491|NCT00378352|4186566|P2|STARTED|Efficacy Phase||0
1711492|NCT00378352|4186567|P1|STARTED|Efficacy Phase||0
1711493|NCT00378352|4186562|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
1711494|NCT00378352|4186563|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
1711495|NCT00378352|4186564|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
1711496|NCT00378352|4186565|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
1711497|NCT00378352|4186566|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
1711498|NCT00378352|4186567|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
1711499|NCT00378352|4186562|P6|COMPLETED|Dose Escalation 60,000 Units||0
1711500|NCT00378352|4186563|P5|COMPLETED|Dose Escalation 60,000 Units||0
1711501|NCT00378352|4186564|P4|COMPLETED|Dose Escalation 60,000 Units||10
1711502|NCT00378352|4186565|P3|COMPLETED|Dose Escalation 60,000 Units||17
1711503|NCT00378352|4186566|P2|COMPLETED|Dose Escalation 60,000 Units||0
1711504|NCT00378352|4186567|P1|COMPLETED|Dose Escalation 60,000 Units||0
1711505|NCT00378352|4186562|P6|Safety Analysis|Dose Escalation 60,000 Units||0
1711506|NCT00378352|4186563|P5|Safety Analysis|Dose Escalation 60,000 Units||0
1711507|NCT00378352|4186564|P4|Safety Analysis|Dose Escalation 60,000 Units||11
1711508|NCT00378352|4186565|P3|Safety Analysis|Dose Escalation 60,000 Units||19
1711509|NCT00378352|4186566|P2|Safety Analysis|Dose Escalation 60,000 Units||0
1711510|NCT00378352|4186567|P1|Safety Analysis|Dose Escalation 60,000 Units||0
1711511|NCT00378352|4186562|P6|STARTED|Dose Escalation 60,000 Units||0
1711512|NCT00378352|4186563|P5|STARTED|Dose Escalation 60,000 Units||0
1711513|NCT00378352|4186564|P4|STARTED|Dose Escalation 60,000 Units||11
1711514|NCT00378352|4186565|P3|STARTED|Dose Escalation 60,000 Units||20
1711515|NCT00378352|4186566|P2|STARTED|Dose Escalation 60,000 Units||0
1711516|NCT00378352|4186567|P1|STARTED|Dose Escalation 60,000 Units||0
1711517|NCT00378352|4186562|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
1711518|NCT00378352|4186563|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
1711519|NCT00378352|4186564|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
1711520|NCT00378352|4186565|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
1711521|NCT00378352|4186566|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
1711522|NCT00378352|4186567|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
1711523|NCT00378352|4186562|P6|COMPLETED|Dose Escalation 30,000 Units||0
1711524|NCT00378352|4186563|P5|COMPLETED|Dose Escalation 30,000 Units||0
1711525|NCT00378352|4186564|P4|COMPLETED|Dose Escalation 30,000 Units||9
1711526|NCT00378352|4186565|P3|COMPLETED|Dose Escalation 30,000 Units||0
1711527|NCT00378352|4186566|P2|COMPLETED|Dose Escalation 30,000 Units||16
1711528|NCT00378352|4186567|P1|COMPLETED|Dose Escalation 30,000 Units||0
1711529|NCT00378352|4186562|P6|Safety Analysis|Dose Escalation 30,000 Units||0
1711530|NCT00378352|4186563|P5|Safety Analysis|Dose Escalation 30,000 Units||0
1711531|NCT00378352|4186564|P4|Safety Analysis|Dose Escalation 30,000 Units||11
1711532|NCT00378352|4186565|P3|Safety Analysis|Dose Escalation 30,000 Units||0
1711533|NCT00378352|4186566|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
1711534|NCT00378352|4186567|P1|Safety Analysis|Dose Escalation 30,000 Units||0
1711535|NCT00378352|4186562|P6|STARTED|Dose Escalation 30,000 Units||0
1711536|NCT00378352|4186563|P5|STARTED|Dose Escalation 30,000 Units||0
1711537|NCT00378352|4186564|P4|STARTED|Dose Escalation 30,000 Units||11
1711538|NCT00378352|4186565|P3|STARTED|Dose Escalation 30,000 Units||0
1711539|NCT00378352|4186566|P2|STARTED|Dose Escalation 30,000 Units||19
1711540|NCT00378352|4186567|P1|STARTED|Dose Escalation 30,000 Units||0
1711541|NCT00378352|4186562|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
1711542|NCT00378352|4186563|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
1711543|NCT00378352|4186564|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
1711544|NCT00378352|4186565|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
1711545|NCT00378352|4186566|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
1711546|NCT00378352|4186567|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
1711547|NCT00378352|4186562|P6|COMPLETED|Dose Escalation 15,000 Units||0
1711548|NCT00378352|4186563|P5|COMPLETED|Dose Escalation 15,000 Units||0
1711549|NCT00378352|4186564|P4|COMPLETED|Dose Escalation 15,000 Units||10
1711550|NCT00378352|4186565|P3|COMPLETED|Dose Escalation 15,000 Units||0
1711551|NCT00378352|4186566|P2|COMPLETED|Dose Escalation 15,000 Units||0
1711552|NCT00378352|4186567|P1|COMPLETED|Dose Escalation 15,000 Units||15
1711553|NCT00378352|4186562|P6|Safety Analysis|Dose Escalation 15,000 Units||0
1711554|NCT00378352|4186563|P5|Safety Analysis|Dose Escalation 15,000 Units||0
1711555|NCT00378352|4186564|P4|Safety Analysis|Dose Escalation 15,000 Units||11
1711556|NCT00378352|4186565|P3|Safety Analysis|Dose Escalation 15,000 Units||0
1711557|NCT00378352|4186566|P2|Safety Analysis|Dose Escalation 15,000 Units||0
1711558|NCT00378352|4186567|P1|Safety Analysis|Dose Escalation 15,000 Units||19
1711559|NCT00378352|4186562|P6|STARTED|Dose Escalation 15,000 Units||0
1711560|NCT00378352|4186563|P5|STARTED|Dose Escalation 15,000 Units||0
1711561|NCT00378352|4186564|P4|STARTED|Dose Escalation 15,000 Units||11
1711562|NCT00378352|4186565|P3|STARTED|Dose Escalation 15,000 Units||0
1711563|NCT00378352|4186566|P2|STARTED|Dose Escalation 15,000 Units||0
1711564|NCT00378352|4186567|P1|STARTED|Dose Escalation 15,000 Units||20
1711565|NCT00378326|4186589|P1|NOT COMPLETED|Overall Study||0
1711566|NCT00378326|4186589|P1|COMPLETED|Overall Study||26
1711567|NCT00378326|4186589|P1|STARTED|Overall Study||26
1711568|NCT00378209|4186595|P1|NOT COMPLETED|Overall Study||22
1711569|NCT00378209|4186595|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
1711570|NCT00378209|4186595|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
1711571|NCT00378105|4186605|P2|NOT COMPLETED|Overall Study||30
1711572|NCT00378105|4186606|P1|NOT COMPLETED|Overall Study||20
1711573|NCT00378105|4186605|P2|COMPLETED|Overall Study||5
1711574|NCT00378105|4186606|P1|COMPLETED|Overall Study||11
1711575|NCT00378105|4186605|P2|STARTED|Overall Study||35
1711576|NCT00378105|4186606|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
1711577|NCT00378079|4186618|P3|NOT COMPLETED|Overall Study||0
1711578|NCT00378079|4186619|P2|NOT COMPLETED|Overall Study||1
1711579|NCT00378079|4186620|P1|NOT COMPLETED|Overall Study||6
1711580|NCT00378079|4186618|P3|COMPLETED|Overall Study||71
1711581|NCT00378079|4186619|P2|COMPLETED|Overall Study||69
1711582|NCT00378079|4186620|P1|COMPLETED|Overall Study||64
1711583|NCT00378079|4186618|P3|STARTED|Overall Study||71
1711584|NCT00378079|4186619|P2|STARTED|Overall Study||70
1711585|NCT00378079|4186620|P1|STARTED|Overall Study||70
1711586|NCT00378014|4186642|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
1711587|NCT00378014|4186643|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
1711588|NCT00378014|4186642|P2|COMPLETED|Extension (Month 12 to Month 59)||26
1711589|NCT00378014|4186643|P1|COMPLETED|Extension (Month 12 to Month 59)||27
1711590|NCT00378014|4186642|P2|STARTED|Extension (Month 12 to Month 59)||40
1711591|NCT00378014|4186643|P1|STARTED|Extension (Month 12 to Month 59)||41
1711592|NCT00378014|4186642|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
1711593|NCT00378014|4186643|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
1711594|NCT00378014|4186642|P2|COMPLETED|Core (Randomization to Month 11)||90
1711595|NCT00378014|4186643|P1|COMPLETED|Core (Randomization to Month 11)||87
1711596|NCT00378014|4186642|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
1711597|NCT00378014|4186643|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
1711598|NCT00378014|4186642|P2|STARTED|Core (Randomization to Month 11)||102
1711599|NCT00378014|4186643|P1|STARTED|Core (Randomization to Month 11)||101
1711600|NCT00377962|4186669|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
1711601|NCT00377962|4186670|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
1711602|NCT00377962|4186669|P2|COMPLETED|Extension Study: 12-24 Months||123
1711603|NCT00377962|4186670|P1|COMPLETED|Extension Study: 12-24 Months||98
1711604|NCT00377962|4186669|P2|STARTED|Extension Study: 12-24 Months||127
1711605|NCT00377962|4186670|P1|STARTED|Extension Study: 12-24 Months||108
1711606|NCT00377962|4186669|P2|NOT COMPLETED|Core Study: 0-12 Months||9
1711607|NCT00377962|4186670|P1|NOT COMPLETED|Core Study: 0-12 Months||28
1711608|NCT00377962|4186669|P2|COMPLETED|Core Study: 0-12 Months||133
1711609|NCT00377962|4186670|P1|COMPLETED|Core Study: 0-12 Months||112
1711610|NCT00377962|4186669|P2|STARTED|Core Study: 0-12 Months||142
1711611|NCT00377962|4186670|P1|STARTED|Core Study: 0-12 Months||140
1711612|NCT00377858|4186706|P2|NOT COMPLETED|Overall Study||27
1711613|NCT00377858|4186707|P1|NOT COMPLETED|Overall Study||31
1711614|NCT00377858|4186706|P2|COMPLETED|Overall Study||215
1711615|NCT00377858|4186707|P1|COMPLETED|Overall Study||211
1711616|NCT00377858|4186706|P2|Had at Least One Post-Baseline Value|Overall Study||240
1711617|NCT00377858|4186707|P1|Had at Least One Post-Baseline Value|Overall Study||239
1711618|NCT00377858|4186706|P2|STARTED|Overall Study||242
1711619|NCT00377858|4186707|P1|STARTED|Overall Study||242
1711620|NCT00377832|4186737|P2|NOT COMPLETED|Overall Study||0
1711621|NCT00377832|4186738|P1|NOT COMPLETED|Overall Study||0
1711622|NCT00377832|4186737|P2|COMPLETED|Overall Study||6
1711623|NCT00377832|4186738|P1|COMPLETED|Overall Study||7
1711624|NCT00377832|4186737|P2|STARTED|Overall Study||6
1711625|NCT00377832|4186738|P1|STARTED|Overall Study||7
1711626|NCT00377819|4186760|P2|NOT COMPLETED|Overall Study||10
1711627|NCT00377819|4186761|P1|NOT COMPLETED|Overall Study||13
1711628|NCT00377819|4186760|P2|COMPLETED|Overall Study||243
1711629|NCT00377819|4186761|P1|COMPLETED|Overall Study||238
1711630|NCT00377819|4186760|P2|Received Study Medication|Overall Study||253
1711631|NCT00377819|4186761|P1|Received Study Medication|Overall Study||249
1711632|NCT00377819|4186760|P2|STARTED|Overall Study||253
1711633|NCT00377819|4186761|P1|STARTED|Overall Study||251
1711634|NCT00377741|4186773|P2|NOT COMPLETED|Overall Study||0
1711635|NCT00377741|4186774|P1|NOT COMPLETED|Overall Study||0
1711636|NCT00377741|4186773|P2|COMPLETED|Overall Study||15
1711637|NCT00377741|4186774|P1|COMPLETED|Overall Study||16
1711638|NCT00377741|4186773|P2|STARTED|Overall Study||15
1711639|NCT00377741|4186774|P1|STARTED|Overall Study||16
1711640|NCT00377676|4186790|P2|NOT COMPLETED|Overall Study||322
1711641|NCT00377676|4186791|P1|NOT COMPLETED|Overall Study||961
1711642|NCT00377676|4186790|P2|COMPLETED|Overall Study||694
1711643|NCT00377676|4186791|P1|COMPLETED|Overall Study||1093
1711644|NCT00377676|4186790|P2|STARTED|Overall Study||1016
1711645|NCT00377676|4186791|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
1711646|NCT00377637|4186807|P4|NOT COMPLETED|Maintenance Phase||57
1711647|NCT00377637|4186808|P3|NOT COMPLETED|Maintenance Phase||43
1711648|NCT00377637|4186809|P2|NOT COMPLETED|Maintenance Phase||0
1711649|NCT00377637|4186810|P1|NOT COMPLETED|Maintenance Phase||0
1711650|NCT00377637|4186807|P4|COMPLETED|Maintenance Phase||54
1711651|NCT00377637|4186808|P3|COMPLETED|Maintenance Phase||73
1711652|NCT00377637|4186809|P2|COMPLETED|Maintenance Phase||0
1711653|NCT00377637|4186810|P1|COMPLETED|Maintenance Phase||0
1711654|NCT00377637|4186807|P4|STARTED|Maintenance Phase||111
1711655|NCT00377637|4186808|P3|STARTED|Maintenance Phase||116
1711656|NCT00377637|4186809|P2|STARTED|Maintenance Phase||0
1711657|NCT00377637|4186810|P1|STARTED|Maintenance Phase||0
1711658|NCT00377637|4186807|P4|NOT COMPLETED|Induction Phase||0
1711659|NCT00377637|4186808|P3|NOT COMPLETED|Induction Phase||0
1711660|NCT00377637|4186809|P2|NOT COMPLETED|Induction Phase||35
1711661|NCT00377637|4186810|P1|NOT COMPLETED|Induction Phase||29
1711662|NCT00377637|4186807|P4|COMPLETED|Induction Phase||0
1711663|NCT00377637|4186808|P3|COMPLETED|Induction Phase||0
1711664|NCT00377637|4186809|P2|COMPLETED|Induction Phase||150
1711665|NCT00377637|4186810|P1|COMPLETED|Induction Phase||156
1711666|NCT00377637|4186807|P4|Safety Population|Induction Phase||0
1711667|NCT00377637|4186808|P3|Safety Population|Induction Phase||0
1711668|NCT00377637|4186809|P2|Safety Population|Induction Phase||184
1711669|NCT00377637|4186810|P1|Safety Population|Induction Phase||180
1711670|NCT00377637|4186807|P4|STARTED|Induction Phase||0
1711671|NCT00377637|4186808|P3|STARTED|Induction Phase||0
1711672|NCT00377637|4186809|P2|STARTED|Induction Phase|Intent-To-Treat|185
1711673|NCT00377637|4186810|P1|STARTED|Induction Phase|Intent-To-Treat|185
1711674|NCT00377611|4186846|P2|NOT COMPLETED|Overall Study||33
1711675|NCT00377611|4186847|P1|NOT COMPLETED|Overall Study||22
1711676|NCT00377611|4186846|P2|COMPLETED|Overall Study||1974
1711677|NCT00377611|4186847|P1|COMPLETED|Overall Study||1025
1711678|NCT00377611|4186846|P2|STARTED|Overall Study||2007
1711679|NCT00377611|4186847|P1|STARTED|Overall Study||1047
1711680|NCT00377572|4186910|P2|NOT COMPLETED|Overall Study||54
1711681|NCT00377572|4186911|P1|NOT COMPLETED|Overall Study||53
1711682|NCT00377572|4186910|P2|COMPLETED|Overall Study||157
1711683|NCT00377572|4186911|P1|COMPLETED|Overall Study||155
1711684|NCT00377572|4186910|P2|STARTED|Overall Study||211
1711685|NCT00377572|4186911|P1|STARTED|Overall Study||208
1711686|NCT00377520|4186949|P1|NOT COMPLETED|Overall Study||1
1711687|NCT00377520|4186949|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
1711688|NCT00377520|4186949|P1|STARTED|Overall Study||27
1711689|NCT00377455|4186954|P1|NOT COMPLETED|Overall Study||1
1711690|NCT00377455|4186954|P1|COMPLETED|Overall Study||4
1711691|NCT00377455|4186954|P1|STARTED|Overall Study||5
1711692|NCT00377429|4186962|P1|NOT COMPLETED|Overall Study||15
1711693|NCT00377429|4186962|P1|COMPLETED|Overall Study|Completed main study|32
1711694|NCT00377429|4186962|P1|STARTED|Overall Study|Treated|47
1711695|NCT00377403|4186973|P2|NOT COMPLETED|Overall Study||7
1711696|NCT00377403|4186974|P1|NOT COMPLETED|Overall Study||4
1711697|NCT00377403|4186973|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
1711698|NCT00377403|4186974|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
1711699|NCT00377403|4186973|P2|Day 28 Assessment|Overall Study||77
1711700|NCT00377403|4186974|P1|Day 28 Assessment|Overall Study||82
1711701|NCT00377403|4186973|P2|Day 10 Assessment|Overall Study||71
1711702|NCT00377403|4186974|P1|Day 10 Assessment|Overall Study||81
1711703|NCT00377403|4186973|P2|Day 7 Assessment|Overall Study||75
1711704|NCT00377403|4186974|P1|Day 7 Assessment|Overall Study||80
1711705|NCT00377403|4186973|P2|Day -3 Assessment|Overall Study||74
1711706|NCT00377403|4186974|P1|Day -3 Assessment|Overall Study||81
1711707|NCT00377403|4186973|P2|STARTED|Overall Study||81
1711708|NCT00377403|4186974|P1|STARTED|Overall Study||85
1711709|NCT00377364|4186982|P2|NOT COMPLETED|Overall Study||0
1711710|NCT00377364|4186983|P1|NOT COMPLETED|Overall Study||2
1711711|NCT00377364|4186982|P2|COMPLETED|Overall Study||14
1711712|NCT00377364|4186983|P1|COMPLETED|Overall Study||14
1711713|NCT00377364|4186982|P2|STARTED|Overall Study||14
1711714|NCT00377364|4186983|P1|STARTED|Overall Study||16
1711715|NCT00377312|4187009|P2|NOT COMPLETED|Overall Study||1
1711716|NCT00377312|4187010|P1|NOT COMPLETED|Overall Study||1
1711717|NCT00377312|4187009|P2|COMPLETED|Overall Study||4
1711718|NCT00377312|4187010|P1|COMPLETED|Overall Study||5
1711719|NCT00377312|4187009|P2|STARTED|Overall Study||5
1711720|NCT00377312|4187010|P1|STARTED|Overall Study||6
1711721|NCT00377299|4187042|P2|NOT COMPLETED|Overall Study||24
1711722|NCT00377299|4187043|P1|NOT COMPLETED|Overall Study||19
1711723|NCT00377299|4187042|P2|COMPLETED|Overall Study||4
1711724|NCT00377299|4187043|P1|COMPLETED|Overall Study||13
1711725|NCT00377299|4187042|P2|STARTED|Overall Study||28
1711726|NCT00377299|4187043|P1|STARTED|Overall Study||32
1711727|NCT00377260|4187059|P2|NOT COMPLETED|Overall Study||5
1711728|NCT00377260|4187060|P1|NOT COMPLETED|Overall Study||2
1711729|NCT00377260|4187059|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
1711730|NCT00377260|4187060|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
1711731|NCT00377260|4187059|P2|STARTED|Overall Study||147
1711732|NCT00377260|4187060|P1|STARTED|Overall Study||144
1711733|NCT00377234|4187114|P2|NOT COMPLETED|Overall Study||31
1711734|NCT00377234|4187115|P1|NOT COMPLETED|Overall Study||34
1711735|NCT00377234|4187114|P2|COMPLETED|Overall Study||145
1711736|NCT00377234|4187115|P1|COMPLETED|Overall Study||146
1711737|NCT00377234|4187114|P2|Safety Analysis Set: Risedronate|Overall Study||174
1711738|NCT00377234|4187115|P1|Safety Analysis Set: Risedronate|Overall Study||153
1711739|NCT00377234|4187114|P2|Safety Analysis Set: Ibandronate|Overall Study||150
1711740|NCT00377234|4187115|P1|Safety Analysis Set: Ibandronate|Overall Study||177
1711741|NCT00377234|4187114|P2|Safety Analysis Set: Period 2|Overall Study||150
1711742|NCT00377234|4187115|P1|Safety Analysis Set: Period 2|Overall Study||153
1711743|NCT00377234|4187114|P2|Safety Analysis Set: Period 1|Overall Study||174
1711744|NCT00377234|4187115|P1|Safety Analysis Set: Period 1|Overall Study||177
1711745|NCT00377234|4187114|P2|Received Treatment|Overall Study||174
1711746|NCT00377234|4187115|P1|Received Treatment|Overall Study||177
1711747|NCT00377234|4187114|P2|Did Not Receive Study Treatment|Overall Study||2
1711748|NCT00377234|4187115|P1|Did Not Receive Study Treatment|Overall Study||3
1711749|NCT00377234|4187114|P2|Randomized|Overall Study||176
1711750|NCT00377234|4187115|P1|Randomized|Overall Study||180
1711751|NCT00377234|4187114|P2|STARTED|Overall Study||176
1711752|NCT00377234|4187115|P1|STARTED|Overall Study||180
1711753|NCT00377156|4187133|P2|NOT COMPLETED|Overall Study||54
1711754|NCT00377156|4187134|P1|NOT COMPLETED|Overall Study||48
1711755|NCT00377156|4187133|P2|COMPLETED|Overall Study||48
1711756|NCT00377156|4187134|P1|COMPLETED|Overall Study||63
1711757|NCT00377156|4187133|P2|STARTED|Overall Study||102
1711758|NCT00377156|4187134|P1|STARTED|Overall Study||111
1711759|NCT00376961|4187148|P2|NOT COMPLETED|Maintenance||23
1711760|NCT00376961|4187149|P1|NOT COMPLETED|Maintenance||0
1711761|NCT00376961|4187148|P2|COMPLETED|Maintenance||27
1711762|NCT00376961|4187149|P1|COMPLETED|Maintenance||0
1711763|NCT00376961|4187148|P2|Eligible|Maintenance||47
1711764|NCT00376961|4187149|P1|Eligible|Maintenance||0
1711765|NCT00376961|4187148|P2|STARTED|Maintenance||50
1711766|NCT00376961|4187149|P1|STARTED|Maintenance||0
1711767|NCT00376961|4187148|P2|NOT COMPLETED|Initial Registration||0
1711768|NCT00376961|4187149|P1|NOT COMPLETED|Initial Registration||7
1711769|NCT00376961|4187148|P2|COMPLETED|Initial Registration||0
1711770|NCT00376961|4187149|P1|COMPLETED|Initial Registration||61
1711771|NCT00376961|4187148|P2|Eligible|Initial Registration||0
1711772|NCT00376961|4187149|P1|Eligible|Initial Registration||65
1711773|NCT00376961|4187148|P2|STARTED|Initial Registration||0
1711774|NCT00376961|4187149|P1|STARTED|Initial Registration||68
1711775|NCT00376948|4187158|P1|NOT COMPLETED|Overall Study||0
1711776|NCT00376948|4187158|P1|COMPLETED|Overall Study||20
1711777|NCT00376948|4187158|P1|STARTED|Overall Study||20
1711778|NCT00376935|4187167|P4|NOT COMPLETED|Overall Study||0
1711779|NCT00376935|4187168|P3|NOT COMPLETED|Overall Study||0
1711780|NCT00376935|4187169|P2|NOT COMPLETED|Overall Study||0
1711781|NCT00376935|4187170|P1|NOT COMPLETED|Overall Study||0
1711782|NCT00376935|4187167|P4|COMPLETED|Overall Study||24
1711783|NCT00376935|4187168|P3|COMPLETED|Overall Study||25
1711784|NCT00376935|4187169|P2|COMPLETED|Overall Study||25
1711785|NCT00376935|4187170|P1|COMPLETED|Overall Study||25
1711786|NCT00376935|4187167|P4|STARTED|Overall Study||24
1711787|NCT00376935|4187168|P3|STARTED|Overall Study||25
1711788|NCT00376935|4187169|P2|STARTED|Overall Study||25
1711789|NCT00376935|4187170|P1|STARTED|Overall Study||25
1711790|NCT00376805|4187208|P1|NOT COMPLETED|Overall Study||0
1711791|NCT00376805|4187208|P1|COMPLETED|Overall Study||6
1711792|NCT00376805|4187208|P1|STARTED|Overall Study||6
1711793|NCT00376688|4187215|P1|NOT COMPLETED|Overall Study||4
1711794|NCT00376688|4187215|P1|COMPLETED|Overall Study||27
1711795|NCT00376688|4187215|P1|STARTED|Overall Study||31
1711796|NCT00376675|4187221|P2|NOT COMPLETED|Overall Study||14
1711797|NCT00376675|4187222|P1|NOT COMPLETED|Overall Study||20
1711798|NCT00376675|4187221|P2|COMPLETED|Overall Study||56
1711799|NCT00376675|4187222|P1|COMPLETED|Overall Study||49
1711800|NCT00376675|4187221|P2|STARTED|Overall Study||70
1711801|NCT00376675|4187222|P1|STARTED|Overall Study||69
1711802|NCT00376597|4187246|P2|NOT COMPLETED|Overall Study||3
1711803|NCT00376597|4187247|P1|NOT COMPLETED|Overall Study||11
1711804|NCT00376597|4187246|P2|COMPLETED|Overall Study||312
1711805|NCT00376597|4187247|P1|COMPLETED|Overall Study||242
1711806|NCT00376597|4187246|P2|STARTED|Overall Study||315
1711807|NCT00376597|4187247|P1|STARTED|Overall Study||253
1711808|NCT00376558|4187261|P2|NOT COMPLETED|Overall Study||0
1711809|NCT00376558|4187262|P1|NOT COMPLETED|Overall Study||0
1711810|NCT00376558|4187261|P2|COMPLETED|Overall Study||25
1711811|NCT00376558|4187262|P1|COMPLETED|Overall Study||25
1711812|NCT00376558|4187261|P2|STARTED|Overall Study||25
1711813|NCT00376558|4187262|P1|STARTED|Overall Study||25
1711814|NCT00376532|4187271|P2|NOT COMPLETED|Overall Study||6
1711815|NCT00376532|4187272|P1|NOT COMPLETED|Overall Study||6
1711816|NCT00376532|4187271|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
1711817|NCT00376532|4187272|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
1711818|NCT00376532|4187271|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
1711819|NCT00376532|4187272|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
1711820|NCT00376506|4187282|P2|NOT COMPLETED|Overall Study||2
1711821|NCT00376506|4187283|P1|NOT COMPLETED|Overall Study||0
1711822|NCT00376506|4187282|P2|COMPLETED|Overall Study||4
1711823|NCT00376506|4187283|P1|COMPLETED|Overall Study||4
1711824|NCT00376506|4187282|P2|STARTED|Overall Study||6
1711825|NCT00376506|4187283|P1|STARTED|Overall Study||4
1711826|NCT00376363|4187301|P2|NOT COMPLETED|Overall Study||46
1711827|NCT00376363|4187302|P1|NOT COMPLETED|Overall Study||56
1711828|NCT00376363|4187301|P2|COMPLETED|Overall Study||87
1711829|NCT00376363|4187302|P1|COMPLETED|Overall Study||87
1711830|NCT00376363|4187301|P2|STARTED|Overall Study||133
1711831|NCT00376363|4187302|P1|STARTED|Overall Study||143
1711832|NCT00376259|4187314|P2|NOT COMPLETED|Overall Study||21
1711833|NCT00376259|4187315|P1|NOT COMPLETED|Overall Study||22
1711834|NCT00376259|4187314|P2|COMPLETED|Overall Study||0
1711835|NCT00376259|4187315|P1|COMPLETED|Overall Study||0
1711836|NCT00376259|4187314|P2|Received Study Drug|Overall Study||21
1711837|NCT00376259|4187315|P1|Received Study Drug|Overall Study||21
1711838|NCT00376259|4187314|P2|STARTED|Overall Study||21
1711839|NCT00376259|4187315|P1|STARTED|Overall Study||22
1711840|NCT00376220|4187329|P2|NOT COMPLETED|Overall Study||12
1711841|NCT00376220|4187330|P1|NOT COMPLETED|Overall Study||10
1711842|NCT00376220|4187329|P2|COMPLETED|Overall Study||35
1711843|NCT00376220|4187330|P1|COMPLETED|Overall Study||37
1711844|NCT00376220|4187329|P2|STARTED|Overall Study||47
1711845|NCT00376220|4187330|P1|STARTED|Overall Study||47
1711846|NCT00376168|4187338|P2|NOT COMPLETED|Overall Study||1
1711847|NCT00376168|4187339|P1|NOT COMPLETED|Overall Study||2
1711848|NCT00376168|4187338|P2|COMPLETED|Overall Study||15
1711849|NCT00376168|4187339|P1|COMPLETED|Overall Study||14
1711850|NCT00376168|4187338|P2|STARTED|Overall Study|One patient randomized but not treated|16
1711851|NCT00376168|4187339|P1|STARTED|Overall Study||16
1711852|NCT00375999|4187353|P1|NOT COMPLETED|Overall Study||2
1711853|NCT00375999|4187353|P1|COMPLETED|Overall Study||32
1711854|NCT00375999|4187353|P1|STARTED|Overall Study||34
1711855|NCT00375973|4187359|P2|NOT COMPLETED|Overall Study||2
1711856|NCT00375973|4187360|P1|NOT COMPLETED|Overall Study||10
1711857|NCT00375973|4187359|P2|COMPLETED|Overall Study||28
1711858|NCT00375973|4187360|P1|COMPLETED|Overall Study||20
1711859|NCT00375973|4187359|P2|STARTED|Overall Study||30
1711860|NCT00375973|4187360|P1|STARTED|Overall Study||30
1711861|NCT00375934|4187380|P2|NOT COMPLETED|Overall Study||6
1711862|NCT00375934|4187381|P1|NOT COMPLETED|Overall Study||3
1711863|NCT00375934|4187380|P2|COMPLETED|Overall Study||95
1711864|NCT00375934|4187381|P1|COMPLETED|Overall Study||96
1711865|NCT00375934|4187380|P2|STARTED|Overall Study||101
1711866|NCT00375934|4187381|P1|STARTED|Overall Study||99
1711867|NCT00375752|4187409|P2|NOT COMPLETED|Overall Study||15
1711868|NCT00375752|4187410|P1|NOT COMPLETED|Overall Study||12
1711869|NCT00375752|4187409|P2|COMPLETED|Overall Study||74
1711870|NCT00375752|4187410|P1|COMPLETED|Overall Study||67
1711871|NCT00375752|4187409|P2|STARTED|Overall Study||89
1711872|NCT00375752|4187410|P1|STARTED|Overall Study||79
1711873|NCT00375713|4187426|P2|NOT COMPLETED|Overall Study||23
1711874|NCT00375713|4187427|P1|NOT COMPLETED|Overall Study||20
1711875|NCT00375713|4187426|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
1711876|NCT00375713|4187427|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
1711877|NCT00375713|4187426|P2|STARTED|Overall Study|Randomized population (N=234).|234
1711878|NCT00375713|4187427|P1|STARTED|Overall Study|Randomized population (N=232).|232
1711879|NCT00375674|4187441|P2|NOT COMPLETED|Overall Study||141
1711880|NCT00375674|4187442|P1|NOT COMPLETED|Overall Study||144
1711881|NCT00375674|4187441|P2|COMPLETED|Overall Study||165
1711882|NCT00375674|4187442|P1|COMPLETED|Overall Study||165
1711883|NCT00375674|4187441|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
1711884|NCT00375674|4187442|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
1711885|NCT00375674|4187441|P2|Intent-to-Treat Population|Overall Study||306
1711886|NCT00375674|4187442|P1|Intent-to-Treat Population|Overall Study||309
1711887|NCT00375674|4187441|P2|STARTED|Overall Study||306
1711888|NCT00375674|4187442|P1|STARTED|Overall Study||309
1711889|NCT00375609|4187471|P3|NOT COMPLETED|Overall Study||1
1711890|NCT00375609|4187472|P2|NOT COMPLETED|Overall Study||7
1711891|NCT00375609|4187473|P1|NOT COMPLETED|Overall Study||4
1711892|NCT00375609|4187471|P3|COMPLETED|Overall Study||42
1711893|NCT00375609|4187472|P2|COMPLETED|Overall Study||77
1711894|NCT00375609|4187473|P1|COMPLETED|Overall Study||84
1711895|NCT00375609|4187471|P3|STARTED|Overall Study||43
1711896|NCT00375609|4187472|P2|STARTED|Overall Study||84
1711897|NCT00375609|4187473|P1|STARTED|Overall Study||88
1711898|NCT00375518|4187489|P2|NOT COMPLETED|Overall Study||17
1711899|NCT00375518|4187490|P1|NOT COMPLETED|Overall Study||8
1711900|NCT00375518|4187489|P2|COMPLETED|Overall Study||65
1711901|NCT00375518|4187490|P1|COMPLETED|Overall Study||72
1711902|NCT00375518|4187489|P2|STARTED|Overall Study||82
1711903|NCT00375518|4187490|P1|STARTED|Overall Study||80
1711904|NCT00375505|4187498|P2|NOT COMPLETED|Overall Study||2
1711905|NCT00375505|4187499|P1|NOT COMPLETED|Overall Study||1
1711906|NCT00375505|4187498|P2|COMPLETED|Overall Study||32
1711907|NCT00375505|4187499|P1|COMPLETED|Overall Study||35
1711908|NCT00375505|4187498|P2|STARTED|Overall Study||34
1711909|NCT00375505|4187499|P1|STARTED|Overall Study||36
1711910|NCT00375492|4187543|P2|NOT COMPLETED|Overall Study||26
1711911|NCT00375492|4187544|P1|NOT COMPLETED|Overall Study||26
1711912|NCT00375492|4187543|P2|COMPLETED|Overall Study||72
1711913|NCT00375492|4187544|P1|COMPLETED|Overall Study||70
1711914|NCT00375492|4187543|P2|STARTED|Overall Study||98
1711915|NCT00375492|4187544|P1|STARTED|Overall Study||96
1711916|NCT00375427|4187574|P2|NOT COMPLETED|Overall Study||74
1711917|NCT00375427|4187575|P1|NOT COMPLETED|Overall Study||60
1711918|NCT00375427|4187574|P2|COMPLETED|Overall Study||142
1711919|NCT00375427|4187575|P1|COMPLETED|Overall Study||149
1711920|NCT00375427|4187574|P2|STARTED|Overall Study||216
1711921|NCT00375427|4187575|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
1711922|NCT00375219|4187600|P3|NOT COMPLETED|Overall Study||21
1711923|NCT00375219|4187601|P2|NOT COMPLETED|Overall Study||20
1711924|NCT00375219|4187602|P1|NOT COMPLETED|Overall Study||59
1711925|NCT00375219|4187600|P3|COMPLETED|Overall Study||0
1711926|NCT00375219|4187601|P2|COMPLETED|Overall Study||0
1711927|NCT00375219|4187602|P1|COMPLETED|Overall Study||3
1711928|NCT00375219|4187600|P3|STARTED|Overall Study||21
1711929|NCT00375219|4187601|P2|STARTED|Overall Study||20
1711930|NCT00375219|4187602|P1|STARTED|Overall Study||62
1711931|NCT00374907|4187670|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
1711932|NCT00374907|4187671|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
1711933|NCT00374907|4187670|P2|COMPLETED|116-Week Short-term + Long-term Period||2
1711934|NCT00374907|4187671|P1|COMPLETED|116-Week Short-term + Long-term Period||7
1711935|NCT00374907|4187670|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
1711936|NCT00374907|4187671|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
1711937|NCT00374907|4187670|P2|STARTED|116-Week Short-term + Long-term Period||16
1711938|NCT00374907|4187671|P1|STARTED|116-Week Short-term + Long-term Period||20
1711939|NCT00374907|4187670|P2|NOT COMPLETED|12-Week Short-term Period||1
1711940|NCT00374907|4187671|P1|NOT COMPLETED|12-Week Short-term Period||3
1711941|NCT00374907|4187670|P2|COMPLETED|12-Week Short-term Period||15
1711942|NCT00374907|4187671|P1|COMPLETED|12-Week Short-term Period||17
1711943|NCT00374907|4187670|P2|STARTED|12-Week Short-term Period||16
1711944|NCT00374907|4187671|P1|STARTED|12-Week Short-term Period||20
1711945|NCT00374868|4187683|P1|NOT COMPLETED|Overall Study||36
1711946|NCT00374868|4187683|P1|COMPLETED|Overall Study||2
1711947|NCT00374868|4187683|P1|STARTED|Overall Study||38
1711948|NCT00374842|4187697|P3|NOT COMPLETED|Overall Study||0
1711949|NCT00374842|4187698|P2|NOT COMPLETED|Overall Study||0
1711950|NCT00374842|4187699|P1|NOT COMPLETED|Overall Study||0
1711951|NCT00374842|4187697|P3|COMPLETED|Overall Study||100
1711952|NCT00374842|4187698|P2|COMPLETED|Overall Study||100
1711953|NCT00374842|4187699|P1|COMPLETED|Overall Study||100
1711954|NCT00374842|4187697|P3|STARTED|Overall Study||100
1711955|NCT00374842|4187698|P2|STARTED|Overall Study||100
1711956|NCT00374842|4187699|P1|STARTED|Overall Study||100
1711957|NCT00374803|4187730|P2|NOT COMPLETED|Overall Study||0
1711958|NCT00374803|4187731|P1|NOT COMPLETED|Overall Study||0
1711959|NCT00374803|4187730|P2|COMPLETED|Overall Study||23
1711960|NCT00374803|4187731|P1|COMPLETED|Overall Study||22
1711961|NCT00374803|4187730|P2|STARTED|Overall Study||23
1711962|NCT00374803|4187731|P1|STARTED|Overall Study||22
1711963|NCT00374556|4187747|P2|NOT COMPLETED|Overall Study||1
1711964|NCT00374556|4187748|P1|NOT COMPLETED|Overall Study||1
1711965|NCT00374556|4187747|P2|COMPLETED|Overall Study||15
1711966|NCT00374556|4187748|P1|COMPLETED|Overall Study||13
1711967|NCT00374556|4187747|P2|STARTED|Overall Study||16
1711968|NCT00374556|4187748|P1|STARTED|Overall Study||14
1711969|NCT00374543|4187800|P2|NOT COMPLETED|Overall Study||0
1711970|NCT00374543|4187801|P1|NOT COMPLETED|Overall Study||0
1711971|NCT00374543|4187800|P2|COMPLETED|Overall Study||1
1711972|NCT00374543|4187801|P1|COMPLETED|Overall Study||2
1711973|NCT00374543|4187800|P2|STARTED|Overall Study||1
1711974|NCT00374543|4187801|P1|STARTED|Overall Study||2
1711975|NCT00374452|4187809|P2|NOT COMPLETED|Overall Study||5
1711976|NCT00374452|4187810|P1|NOT COMPLETED|Overall Study||5
1711977|NCT00374452|4187809|P2|COMPLETED|Overall Study||43
1711978|NCT00374452|4187810|P1|COMPLETED|Overall Study||29
1711979|NCT00374452|4187809|P2|Intervention Started|Overall Study||46
1711980|NCT00374452|4187810|P1|Intervention Started|Overall Study||30
1711981|NCT00374452|4187809|P2|STARTED|Overall Study||48
1711982|NCT00374452|4187810|P1|STARTED|Overall Study||34
1711983|NCT00374335|4187816|P1|NOT COMPLETED|Overall Study||0
1711984|NCT00374335|4187816|P1|COMPLETED|Overall Study||261
1711985|NCT00374335|4187816|P1|STARTED|Overall Study||261
1711986|NCT00374322|4187823|P2|NOT COMPLETED|Overall Study||1304
1711987|NCT00374322|4187824|P1|NOT COMPLETED|Overall Study||1257
1711988|NCT00374322|4187823|P2|COMPLETED|Overall Study||278
1711989|NCT00374322|4187824|P1|COMPLETED|Overall Study||322
1711990|NCT00374322|4187823|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
1711991|NCT00374322|4187824|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
1711992|NCT00374322|4187823|P2|STARTED|Overall Study||1582
1711993|NCT00374322|4187824|P1|STARTED|Overall Study||1579
1711994|NCT00374244|4187862|P2|NOT COMPLETED|Overall Study||0
1711995|NCT00374244|4187863|P1|NOT COMPLETED|Overall Study||0
1711996|NCT00374244|4187862|P2|COMPLETED|Overall Study||14
1711997|NCT00374244|4187863|P1|COMPLETED|Overall Study||14
1711998|NCT00374244|4187862|P2|STARTED|Overall Study||14
1711999|NCT00374244|4187863|P1|STARTED|Overall Study||14
1712000|NCT00374231|4187909|P1|NOT COMPLETED|Overall Study||0
1712001|NCT00374231|4187909|P1|COMPLETED|Overall Study||40
1712002|NCT00374231|4187909|P1|STARTED|Overall Study||40
1712003|NCT00374140|4187915|P1|NOT COMPLETED|Overall Study||2
1712004|NCT00374140|4187915|P1|COMPLETED|Overall Study||38
1712005|NCT00374140|4187915|P1|STARTED|Overall Study||40
1712006|NCT00374127|4187922|P1|NOT COMPLETED|Overall Study||11
1712007|NCT00374127|4187922|P1|COMPLETED|Overall Study||24
1712008|NCT00374127|4187922|P1|STARTED|Overall Study||35
1712009|NCT00374088|4187958|P2|NOT COMPLETED|Overall Study||1
1712010|NCT00374088|4187959|P1|NOT COMPLETED|Overall Study||1
1712011|NCT00374088|4187958|P2|COMPLETED|Overall Study||10
1712012|NCT00374088|4187959|P1|COMPLETED|Overall Study||9
1712013|NCT00374088|4187958|P2|STARTED|Overall Study||11
1712014|NCT00374088|4187959|P1|STARTED|Overall Study||10
1712015|NCT00373958|4187971|P2|NOT COMPLETED|Toddler Dose||38
1712016|NCT00373958|4187972|P1|NOT COMPLETED|Toddler Dose||30
1712017|NCT00373958|4187971|P2|COMPLETED|Toddler Dose||252
1712018|NCT00373958|4187972|P1|COMPLETED|Toddler Dose||264
1712019|NCT00373958|4187971|P2|Vaccinated Toddler Dose|Toddler Dose||265
1712020|NCT00373958|4187972|P1|Vaccinated Toddler Dose|Toddler Dose||272
1712021|NCT00373958|4187971|P2|Withdrawn After Infant Series|Toddler Dose||25
1712022|NCT00373958|4187972|P1|Withdrawn After Infant Series|Toddler Dose||22
1712023|NCT00373958|4187971|P2|STARTED|Toddler Dose||290
1712024|NCT00373958|4187972|P1|STARTED|Toddler Dose||294
1712025|NCT00373958|4187971|P2|NOT COMPLETED|Infant Series||42
1712026|NCT00373958|4187972|P1|NOT COMPLETED|Infant Series||40
1712027|NCT00373958|4187971|P2|COMPLETED|Infant Series||290
1712028|NCT00373958|4187972|P1|COMPLETED|Infant Series||294
1712029|NCT00373958|4187971|P2|Vaccinated Dose 3|Infant Series||300
1712030|NCT00373958|4187972|P1|Vaccinated Dose 3|Infant Series||298
1712031|NCT00373958|4187971|P2|Vaccinated Dose 2|Infant Series||305
1712032|NCT00373958|4187972|P1|Vaccinated Dose 2|Infant Series||309
1712033|NCT00373958|4187971|P2|Vaccinated Dose 1|Infant Series||331
1712034|NCT00373958|4187972|P1|Vaccinated Dose 1|Infant Series||332
1712035|NCT00373958|4187971|P2|STARTED|Infant Series||332
1712036|NCT00373958|4187972|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
1712037|NCT00373880|4188020|P1|NOT COMPLETED|Overall Study||18
1712038|NCT00373880|4188020|P1|COMPLETED|Overall Study||8
1712039|NCT00373880|4188020|P1|STARTED|Overall Study||26
1712040|NCT00373698|4188050|P2|NOT COMPLETED|Overall Study||0
1712041|NCT00373698|4188051|P1|NOT COMPLETED|Overall Study||11
1712042|NCT00373698|4188050|P2|COMPLETED|Overall Study||99
1712043|NCT00373698|4188051|P1|COMPLETED|Overall Study||85
1712044|NCT00373698|4188050|P2|STARTED|Overall Study||99
1712045|NCT00373698|4188051|P1|STARTED|Overall Study||96
1712046|NCT00373685|4188065|P2|NOT COMPLETED|Overall Study||1421
1712047|NCT00373685|4188066|P1|NOT COMPLETED|Overall Study||1439
1712048|NCT00373685|4188065|P2|COMPLETED|Overall Study||2611
1712049|NCT00373685|4188066|P1|COMPLETED|Overall Study||2596
1712050|NCT00373685|4188065|P2|Treated|Overall Study||3955
1712051|NCT00373685|4188066|P1|Treated|Overall Study||3984
1712052|NCT00373685|4188065|P2|STARTED|Overall Study||4032
1712053|NCT00373685|4188066|P1|STARTED|Overall Study||4035
1712054|NCT00373529|4188100|P1|NOT COMPLETED|Overall Study||108
1712055|NCT00373529|4188100|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
1712056|NCT00373529|4188100|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
1712057|NCT00373529|4188100|P1|STARTED|Overall Study||116
1712058|NCT00373490|4188112|P2|NOT COMPLETED|Overall Study||6
1712059|NCT00373490|4188113|P1|NOT COMPLETED|Overall Study||9
1712060|NCT00373490|4188112|P2|COMPLETED|Overall Study||0
1712061|NCT00373490|4188113|P1|COMPLETED|Overall Study||1
1712062|NCT00373490|4188112|P2|STARTED|Overall Study||6
1712063|NCT00373490|4188113|P1|STARTED|Overall Study||10
1712064|NCT00373425|4188136|P5|NOT COMPLETED|Overall Study||72
1712065|NCT00373425|4188137|P4|NOT COMPLETED|Overall Study||11
1712066|NCT00373425|4188138|P3|NOT COMPLETED|Overall Study||134
1712067|NCT00373425|4188139|P2|NOT COMPLETED|Overall Study||153
1712068|NCT00373425|4188140|P1|NOT COMPLETED|Overall Study||370
1712069|NCT00373425|4188136|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
1712070|NCT00373425|4188137|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
1712071|NCT00373425|4188138|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
1712072|NCT00373425|4188139|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
1712073|NCT00373425|4188140|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
1712074|NCT00373425|4188136|P5|Received Treatment|Overall Study||132
1712075|NCT00373425|4188137|P4|Received Treatment|Overall Study||7
1712076|NCT00373425|4188138|P3|Received Treatment|Overall Study||134
1712077|NCT00373425|4188139|P2|Received Treatment|Overall Study||342
1712078|NCT00373425|4188140|P1|Received Treatment|Overall Study||612
1712079|NCT00373425|4188136|P5|STARTED|Overall Study||132
1712080|NCT00373425|4188137|P4|STARTED|Overall Study||11
1712081|NCT00373425|4188138|P3|STARTED|Overall Study||134
1712082|NCT00373425|4188139|P2|STARTED|Overall Study||350
1712083|NCT00373425|4188140|P1|STARTED|Overall Study||623
1712084|NCT00373399|4188165|P6|NOT COMPLETED|Overall Study||0
1712085|NCT00373399|4188166|P5|NOT COMPLETED|Overall Study||0
1712086|NCT00373399|4188167|P4|NOT COMPLETED|Overall Study||0
1712087|NCT00373399|4188168|P3|NOT COMPLETED|Overall Study||0
1712088|NCT00373399|4188169|P2|NOT COMPLETED|Overall Study||0
1712089|NCT00373399|4188170|P1|NOT COMPLETED|Overall Study||0
1712090|NCT00373399|4188165|P6|COMPLETED|Overall Study||7
1712091|NCT00373399|4188166|P5|COMPLETED|Overall Study||7
1712092|NCT00373399|4188167|P4|COMPLETED|Overall Study||6
1712093|NCT00373399|4188168|P3|COMPLETED|Overall Study||4
1712094|NCT00373399|4188169|P2|COMPLETED|Overall Study||7
1712095|NCT00373399|4188170|P1|COMPLETED|Overall Study||5
1712096|NCT00373399|4188165|P6|STARTED|Overall Study||7
1712097|NCT00373399|4188166|P5|STARTED|Overall Study||7
1712098|NCT00373399|4188167|P4|STARTED|Overall Study||6
1712099|NCT00373399|4188168|P3|STARTED|Overall Study||4
1712100|NCT00373399|4188169|P2|STARTED|Overall Study||7
1712101|NCT00373399|4188170|P1|STARTED|Overall Study||5
1712102|NCT00373386|4188178|P1|NOT COMPLETED|Overall Study||0
1712103|NCT00373386|4188178|P1|COMPLETED|Overall Study||9
1712104|NCT00373386|4188178|P1|STARTED|Overall Study||9
1712105|NCT00373360|4188188|P1|NOT COMPLETED|Overall Study||0
1712106|NCT00373360|4188188|P1|COMPLETED|Overall Study||10
1712107|NCT00373360|4188188|P1|STARTED|Overall Study||10
1712108|NCT00373334|4188219|P3|NOT COMPLETED|Overall Study||13
1712109|NCT00373334|4188220|P2|NOT COMPLETED|Overall Study||18
1712110|NCT00373334|4188221|P1|NOT COMPLETED|Overall Study||10
1712111|NCT00373334|4188219|P3|COMPLETED|Overall Study||32
1712112|NCT00373334|4188220|P2|COMPLETED|Overall Study||32
1712113|NCT00373334|4188221|P1|COMPLETED|Overall Study||33
1712114|NCT00373334|4188219|P3|STARTED|Overall Study||45
1712115|NCT00373334|4188220|P2|STARTED|Overall Study||50
1712116|NCT00373334|4188221|P1|STARTED|Overall Study||43
1712117|NCT00373295|4188235|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
1712118|NCT00373295|4188236|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
1712119|NCT00373295|4188237|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
1712120|NCT00373295|4188238|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
1712121|NCT00373295|4188239|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
1712122|NCT00373295|4188240|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
1712123|NCT00373295|4188235|P6|COMPLETED|Intervention 3 (8 Days)||2
1712124|NCT00373295|4188236|P5|COMPLETED|Intervention 3 (8 Days)||2
1712125|NCT00373295|4188237|P4|COMPLETED|Intervention 3 (8 Days)||2
1712126|NCT00373295|4188238|P3|COMPLETED|Intervention 3 (8 Days)||1
1712127|NCT00373295|4188239|P2|COMPLETED|Intervention 3 (8 Days)||1
1712128|NCT00373295|4188240|P1|COMPLETED|Intervention 3 (8 Days)||2
1712129|NCT00373295|4188235|P6|STARTED|Intervention 3 (8 Days)||2
1712130|NCT00373295|4188236|P5|STARTED|Intervention 3 (8 Days)||2
1712131|NCT00373295|4188237|P4|STARTED|Intervention 3 (8 Days)||2
1712132|NCT00373295|4188238|P3|STARTED|Intervention 3 (8 Days)||1
1712133|NCT00373295|4188239|P2|STARTED|Intervention 3 (8 Days)||1
1712134|NCT00373295|4188240|P1|STARTED|Intervention 3 (8 Days)||2
1712135|NCT00373295|4188235|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
1712136|NCT00373295|4188236|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
1712137|NCT00373295|4188237|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
1712138|NCT00373295|4188238|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
1712139|NCT00373295|4188239|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
1712140|NCT00373295|4188240|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
1712141|NCT00373295|4188235|P6|COMPLETED|Intervention 2 (8 Days)||2
1712142|NCT00373295|4188236|P5|COMPLETED|Intervention 2 (8 Days)||2
1712143|NCT00373295|4188237|P4|COMPLETED|Intervention 2 (8 Days)||2
1712144|NCT00373295|4188238|P3|COMPLETED|Intervention 2 (8 Days)||1
1712145|NCT00373295|4188239|P2|COMPLETED|Intervention 2 (8 Days)||1
1712146|NCT00373295|4188240|P1|COMPLETED|Intervention 2 (8 Days)||2
1712147|NCT00373295|4188235|P6|STARTED|Intervention 2 (8 Days)||2
1712148|NCT00373295|4188236|P5|STARTED|Intervention 2 (8 Days)||2
1712149|NCT00373295|4188237|P4|STARTED|Intervention 2 (8 Days)||2
1712150|NCT00373295|4188238|P3|STARTED|Intervention 2 (8 Days)||1
1712151|NCT00373295|4188239|P2|STARTED|Intervention 2 (8 Days)||1
1712152|NCT00373295|4188240|P1|STARTED|Intervention 2 (8 Days)||2
1712153|NCT00373295|4188235|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
1712154|NCT00373295|4188236|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
1712155|NCT00373295|4188237|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
1712156|NCT00373295|4188238|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
1712157|NCT00373295|4188239|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
1712158|NCT00373295|4188240|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
1712159|NCT00373295|4188235|P6|COMPLETED|Intervention 1 (8 Days)||2
1712160|NCT00373295|4188236|P5|COMPLETED|Intervention 1 (8 Days)||2
1712161|NCT00373295|4188237|P4|COMPLETED|Intervention 1 (8 Days)||2
1712162|NCT00373295|4188238|P3|COMPLETED|Intervention 1 (8 Days)||1
1712163|NCT00373295|4188239|P2|COMPLETED|Intervention 1 (8 Days)||1
1712164|NCT00373295|4188240|P1|COMPLETED|Intervention 1 (8 Days)||2
1712165|NCT00373295|4188235|P6|STARTED|Intervention 1 (8 Days)||2
1712166|NCT00373295|4188236|P5|STARTED|Intervention 1 (8 Days)||3
1712167|NCT00373295|4188237|P4|STARTED|Intervention 1 (8 Days)||2
1712168|NCT00373295|4188238|P3|STARTED|Intervention 1 (8 Days)||1
1712169|NCT00373295|4188239|P2|STARTED|Intervention 1 (8 Days)||3
1712170|NCT00373295|4188240|P1|STARTED|Intervention 1 (8 Days)||2
1712171|NCT00373269|4188250|P2|NOT COMPLETED|Overall Study||0
1712172|NCT00373269|4188251|P1|NOT COMPLETED|Overall Study||0
1712173|NCT00373269|4188250|P2|COMPLETED|Overall Study||10
1712174|NCT00373269|4188251|P1|COMPLETED|Overall Study||11
1712175|NCT00373269|4188250|P2|STARTED|Overall Study||10
1712176|NCT00373269|4188251|P1|STARTED|Overall Study||11
1712177|NCT00373256|4188261|P2|NOT COMPLETED|Overall Study||247
1712178|NCT00373256|4188262|P1|NOT COMPLETED|Overall Study||241
1712179|NCT00373256|4188261|P2|COMPLETED|Overall Study||0
1712180|NCT00373256|4188262|P1|COMPLETED|Overall Study||0
1712181|NCT00373256|4188261|P2|Treated|Overall Study||236
1712182|NCT00373256|4188262|P1|Treated|Overall Study||235
1712183|NCT00373256|4188261|P2|STARTED|Overall Study||247
1712184|NCT00373256|4188262|P1|STARTED|Overall Study||241
1712185|NCT00373113|4188288|P2|NOT COMPLETED|Overall Study||244
1712186|NCT00373113|4188289|P1|NOT COMPLETED|Overall Study||238
1712187|NCT00373113|4188288|P2|COMPLETED|Overall Study||0
1712188|NCT00373113|4188289|P1|COMPLETED|Overall Study||0
1712189|NCT00373113|4188288|P2|Received Treatment|Overall Study||240
1712190|NCT00373113|4188289|P1|Received Treatment|Overall Study||238
1712191|NCT00373113|4188288|P2|STARTED|Overall Study||244
1712192|NCT00373113|4188289|P1|STARTED|Overall Study||238
1712193|NCT00372996|4188311|P4|NOT COMPLETED|Overall Study||20
1712194|NCT00372996|4188312|P3|NOT COMPLETED|Overall Study||28
1712195|NCT00372996|4188313|P2|NOT COMPLETED|Overall Study||14
1712196|NCT00372996|4188314|P1|NOT COMPLETED|Overall Study||37
1712197|NCT00372996|4188311|P4|COMPLETED|Overall Study||23
1712198|NCT00372996|4188312|P3|COMPLETED|Overall Study||33
1712199|NCT00372996|4188313|P2|COMPLETED|Overall Study||22
1712200|NCT00372996|4188314|P1|COMPLETED|Overall Study||42
1712201|NCT00372996|4188311|P4|STARTED|Overall Study||43
1712202|NCT00372996|4188312|P3|STARTED|Overall Study||61
1712203|NCT00372996|4188313|P2|STARTED|Overall Study||36
1712204|NCT00372996|4188314|P1|STARTED|Overall Study||79
1712205|NCT00372970|4188340|P2|NOT COMPLETED|Overall Study||0
1712206|NCT00372970|4188341|P1|NOT COMPLETED|Overall Study||0
1712207|NCT00372970|4188340|P2|COMPLETED|Overall Study||16
1712208|NCT00372970|4188341|P1|COMPLETED|Overall Study||16
1712209|NCT00372970|4188340|P2|STARTED|Overall Study||16
1712210|NCT00372970|4188341|P1|STARTED|Overall Study||16
1712211|NCT00372957|4188350|P3|NOT COMPLETED|Overall Study||0
1712212|NCT00372957|4188351|P2|NOT COMPLETED|Overall Study||0
1712213|NCT00372957|4188352|P1|NOT COMPLETED|Overall Study||0
1712214|NCT00372957|4188350|P3|COMPLETED|Overall Study||10
1712215|NCT00372957|4188351|P2|COMPLETED|Overall Study||10
1712216|NCT00372957|4188352|P1|COMPLETED|Overall Study||10
1712217|NCT00372957|4188350|P3|STARTED|Overall Study||10
1712218|NCT00372957|4188351|P2|STARTED|Overall Study||10
1712219|NCT00372957|4188352|P1|STARTED|Overall Study||10
1712220|NCT00372905|4188399|P4|NOT COMPLETED|Follow up Until Relapse or Progression||3
1712221|NCT00372905|4188400|P3|NOT COMPLETED|Follow up Until Relapse or Progression||0
1712222|NCT00372905|4188401|P2|NOT COMPLETED|Follow up Until Relapse or Progression||1
1712223|NCT00372905|4188402|P1|NOT COMPLETED|Follow up Until Relapse or Progression||0
1712224|NCT00372905|4188399|P4|COMPLETED|Follow up Until Relapse or Progression||5
1712225|NCT00372905|4188400|P3|COMPLETED|Follow up Until Relapse or Progression||3
1712226|NCT00372905|4188401|P2|COMPLETED|Follow up Until Relapse or Progression||2
1712227|NCT00372905|4188402|P1|COMPLETED|Follow up Until Relapse or Progression||3
1712228|NCT00372905|4188399|P4|STARTED|Follow up Until Relapse or Progression||8
1712229|NCT00372905|4188400|P3|STARTED|Follow up Until Relapse or Progression||3
1712230|NCT00372905|4188401|P2|STARTED|Follow up Until Relapse or Progression||3
1712231|NCT00372905|4188402|P1|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
1712232|NCT00372905|4188399|P4|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
1712233|NCT00372905|4188400|P3|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1712234|NCT00372905|4188401|P2|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1712235|NCT00372905|4188402|P1|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1712236|NCT00372905|4188399|P4|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
1712237|NCT00372905|4188400|P3|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1712238|NCT00372905|4188401|P2|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1712239|NCT00372905|4188402|P1|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
1712240|NCT00372905|4188399|P4|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
1712241|NCT00372905|4188400|P3|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
1712242|NCT00372905|4188401|P2|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
1712243|NCT00372905|4188402|P1|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
1712244|NCT00372905|4188399|P4|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
1712245|NCT00372905|4188400|P3|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
1712246|NCT00372905|4188401|P2|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
1712247|NCT00372905|4188402|P1|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
1712248|NCT00372905|4188399|P4|Registration|Expansion Phase at Dose 1.3mg/m2||8
1712249|NCT00372905|4188400|P3|Registration|Expansion Phase at Dose 1.3mg/m2||0
1712250|NCT00372905|4188401|P2|Registration|Expansion Phase at Dose 1.3mg/m2||0
1712251|NCT00372905|4188402|P1|Registration|Expansion Phase at Dose 1.3mg/m2||0
1712252|NCT00372905|4188399|P4|STARTED|Expansion Phase at Dose 1.3mg/m2||8
1712253|NCT00372905|4188400|P3|STARTED|Expansion Phase at Dose 1.3mg/m2||0
1712254|NCT00372905|4188401|P2|STARTED|Expansion Phase at Dose 1.3mg/m2||0
1712255|NCT00372905|4188402|P1|STARTED|Expansion Phase at Dose 1.3mg/m2||0
1712256|NCT00372905|4188399|P4|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1712257|NCT00372905|4188400|P3|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
1712258|NCT00372905|4188401|P2|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1712259|NCT00372905|4188402|P1|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1712260|NCT00372905|4188399|P4|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1712261|NCT00372905|4188400|P3|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
1712262|NCT00372905|4188401|P2|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1712263|NCT00372905|4188402|P1|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
1712264|NCT00372905|4188399|P4|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
1712265|NCT00372905|4188400|P3|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
1712266|NCT00372905|4188401|P2|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
1712267|NCT00372905|4188402|P1|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
1712268|NCT00372905|4188399|P4|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
1712269|NCT00372905|4188400|P3|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
1712270|NCT00372905|4188401|P2|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
1712271|NCT00372905|4188402|P1|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
1712272|NCT00372905|4188399|P4|Registered|Cohort 3: Dose Level 1.6mg/m2||0
1712273|NCT00372905|4188400|P3|Registered|Cohort 3: Dose Level 1.6mg/m2||4
1712274|NCT00372905|4188401|P2|Registered|Cohort 3: Dose Level 1.6mg/m2||0
1712275|NCT00372905|4188402|P1|Registered|Cohort 3: Dose Level 1.6mg/m2||0
1712276|NCT00372905|4188399|P4|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
1712277|NCT00372905|4188400|P3|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
1712278|NCT00372905|4188401|P2|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
1712279|NCT00372905|4188402|P1|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
1712280|NCT00372905|4188399|P4|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1712281|NCT00372905|4188400|P3|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1712282|NCT00372905|4188401|P2|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1712283|NCT00372905|4188402|P1|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1712284|NCT00372905|4188399|P4|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1712285|NCT00372905|4188400|P3|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1712286|NCT00372905|4188401|P2|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
1712287|NCT00372905|4188402|P1|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
1712288|NCT00372905|4188399|P4|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
1712289|NCT00372905|4188400|P3|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
1712290|NCT00372905|4188401|P2|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
1712291|NCT00372905|4188402|P1|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
1712292|NCT00372905|4188399|P4|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
1712293|NCT00372905|4188400|P3|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
1712294|NCT00372905|4188401|P2|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
1712295|NCT00372905|4188402|P1|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
1712296|NCT00372905|4188399|P4|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
1712297|NCT00372905|4188400|P3|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
1712298|NCT00372905|4188401|P2|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
1712299|NCT00372905|4188402|P1|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
1712300|NCT00372905|4188399|P4|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
1712301|NCT00372905|4188400|P3|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
1712302|NCT00372905|4188401|P2|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
1712303|NCT00372905|4188402|P1|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
1712304|NCT00372905|4188399|P4|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1712305|NCT00372905|4188400|P3|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1712306|NCT00372905|4188401|P2|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1712307|NCT00372905|4188402|P1|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
1712308|NCT00372905|4188399|P4|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1712309|NCT00372905|4188400|P3|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1712310|NCT00372905|4188401|P2|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
1712311|NCT00372905|4188402|P1|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
1712312|NCT00372905|4188399|P4|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
1712313|NCT00372905|4188400|P3|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
1712314|NCT00372905|4188401|P2|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
1712315|NCT00372905|4188402|P1|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
1712316|NCT00372905|4188399|P4|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
1712317|NCT00372905|4188400|P3|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
1712318|NCT00372905|4188401|P2|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
1712319|NCT00372905|4188402|P1|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
1712320|NCT00372905|4188399|P4|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
1712321|NCT00372905|4188400|P3|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
1712322|NCT00372905|4188401|P2|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
1712323|NCT00372905|4188402|P1|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
1712324|NCT00372905|4188399|P4|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
1712325|NCT00372905|4188400|P3|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
1712326|NCT00372905|4188401|P2|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
1712327|NCT00372905|4188402|P1|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
1712328|NCT00372775|4188414|P1|NOT COMPLETED|Overall Study||63
1712329|NCT00372775|4188414|P1|COMPLETED|Overall Study||3
1712330|NCT00372775|4188414|P1|Received Treatment|Overall Study||64
1712331|NCT00372775|4188414|P1|STARTED|Overall Study||66
1712332|NCT00372697|4188436|P2|NOT COMPLETED|Overall Study||1
1712333|NCT00372697|4188437|P1|NOT COMPLETED|Overall Study||1
1712334|NCT00372697|4188436|P2|COMPLETED|Overall Study||11
1712335|NCT00372697|4188437|P1|COMPLETED|Overall Study||15
1712336|NCT00372697|4188436|P2|STARTED|Overall Study||12
1712337|NCT00372697|4188437|P1|STARTED|Overall Study||16
1712338|NCT00372619|4188462|P7|NOT COMPLETED|Overall Study||0
1712339|NCT00372619|4188463|P6|NOT COMPLETED|Overall Study||3
1712340|NCT00372619|4188464|P5|NOT COMPLETED|Overall Study||0
1712341|NCT00372619|4188465|P4|NOT COMPLETED|Overall Study||0
1712342|NCT00372619|4188466|P3|NOT COMPLETED|Overall Study||0
1712343|NCT00372619|4188467|P2|NOT COMPLETED|Overall Study||0
1712344|NCT00372619|4188468|P1|NOT COMPLETED|Overall Study||0
1712345|NCT00372619|4188462|P7|COMPLETED|Overall Study||2
1712346|NCT00372619|4188463|P6|COMPLETED|Overall Study||39
1712347|NCT00372619|4188464|P5|COMPLETED|Overall Study||7
1712348|NCT00372619|4188465|P4|COMPLETED|Overall Study||10
1712349|NCT00372619|4188466|P3|COMPLETED|Overall Study||3
1712350|NCT00372619|4188467|P2|COMPLETED|Overall Study||2
1712351|NCT00372619|4188468|P1|COMPLETED|Overall Study||8
1712352|NCT00372619|4188462|P7|STARTED|Overall Study||2
1712353|NCT00372619|4188463|P6|STARTED|Overall Study||42
1712354|NCT00372619|4188464|P5|STARTED|Overall Study||7
1712355|NCT00372619|4188465|P4|STARTED|Overall Study||10
1712356|NCT00372619|4188466|P3|STARTED|Overall Study||3
1712357|NCT00372619|4188467|P2|STARTED|Overall Study||2
1712358|NCT00372619|4188468|P1|STARTED|Overall Study||8
1712359|NCT00372593|4188501|P3|NOT COMPLETED|Overall Study||4
1712360|NCT00372593|4188502|P2|NOT COMPLETED|Overall Study||198
1712361|NCT00372593|4188503|P1|NOT COMPLETED|Overall Study||204
1712362|NCT00372593|4188501|P3|COMPLETED|Overall Study||3
1712363|NCT00372593|4188502|P2|COMPLETED|Overall Study||334
1712364|NCT00372593|4188503|P1|COMPLETED|Overall Study||327
1712365|NCT00372593|4188501|P3|STARTED|Overall Study||7
1712366|NCT00372593|4188502|P2|STARTED|Overall Study||532
1712367|NCT00372593|4188503|P1|STARTED|Overall Study||531
1712368|NCT00372567|4188532|P3|NOT COMPLETED|Phase 3 Study||12
1712369|NCT00372567|4188533|P2|NOT COMPLETED|Phase 3 Study||26
1712370|NCT00372567|4188534|P1|NOT COMPLETED|Phase 3 Study||31
1712371|NCT00372567|4188532|P3|COMPLETED|Phase 3 Study||0
1712372|NCT00372567|4188533|P2|COMPLETED|Phase 3 Study||0
1712373|NCT00372567|4188534|P1|COMPLETED|Phase 3 Study||0
1712374|NCT00372567|4188532|P3|Received Treatment|Phase 3 Study||12
1712375|NCT00372567|4188533|P2|Received Treatment|Phase 3 Study||25
1712376|NCT00372567|4188534|P1|Received Treatment|Phase 3 Study||31
1712377|NCT00372567|4188532|P3|STARTED|Phase 3 Study||12
1712378|NCT00372567|4188533|P2|STARTED|Phase 3 Study||26
1712379|NCT00372567|4188534|P1|STARTED|Phase 3 Study||31
1712380|NCT00372567|4188532|P3|NOT COMPLETED|Phase 1 Sub-study||0
1712381|NCT00372567|4188533|P2|NOT COMPLETED|Phase 1 Sub-study||0
1712382|NCT00372567|4188534|P1|NOT COMPLETED|Phase 1 Sub-study||0
1712383|NCT00372567|4188532|P3|COMPLETED|Phase 1 Sub-study||12
1712384|NCT00372567|4188533|P2|COMPLETED|Phase 1 Sub-study||0
1712385|NCT00372567|4188534|P1|COMPLETED|Phase 1 Sub-study||0
1712386|NCT00372567|4188532|P3|STARTED|Phase 1 Sub-study||12
1712387|NCT00372567|4188533|P2|STARTED|Phase 1 Sub-study||0
1712388|NCT00372567|4188534|P1|STARTED|Phase 1 Sub-study||0
1712389|NCT00372528|4188562|P1|NOT COMPLETED|Overall Study||21
1712390|NCT00372528|4188562|P1|COMPLETED|Overall Study||0
1712391|NCT00372528|4188562|P1|STARTED|Overall Study||21
1712392|NCT00372489|4188567|P1|NOT COMPLETED|Overall Study||79
1712393|NCT00372489|4188567|P1|COMPLETED|Overall Study||2
1712394|NCT00372489|4188567|P1|STARTED|Overall Study||81
1712395|NCT00372424|4188571|P1|NOT COMPLETED|Overall Study||26
1712396|NCT00372424|4188571|P1|COMPLETED|Overall Study||0
1712397|NCT00372424|4188571|P1|Treated|Overall Study||25
1712398|NCT00372424|4188571|P1|STARTED|Overall Study||26
1712399|NCT00372411|4188585|P3|NOT COMPLETED|Overall Study||3
1712400|NCT00372411|4188586|P2|NOT COMPLETED|Overall Study||8
1712401|NCT00372411|4188587|P1|NOT COMPLETED|Overall Study||5
1712402|NCT00372411|4188585|P3|COMPLETED|Overall Study||25
1712403|NCT00372411|4188586|P2|COMPLETED|Overall Study||42
1712404|NCT00372411|4188587|P1|COMPLETED|Overall Study||44
1712405|NCT00372411|4188585|P3|STARTED|Overall Study||28
1712406|NCT00372411|4188586|P2|STARTED|Overall Study||50
1712407|NCT00372411|4188587|P1|STARTED|Overall Study||49
1712408|NCT00372385|4188611|P4|NOT COMPLETED|Overall Study||8
1712409|NCT00372385|4188612|P3|NOT COMPLETED|Overall Study||10
1712410|NCT00372385|4188613|P2|NOT COMPLETED|Overall Study||20
1712411|NCT00372385|4188614|P1|NOT COMPLETED|Overall Study||33
1712412|NCT00372385|4188611|P4|COMPLETED|Overall Study||70
1712413|NCT00372385|4188612|P3|COMPLETED|Overall Study||72
1712414|NCT00372385|4188613|P2|COMPLETED|Overall Study||61
1712415|NCT00372385|4188614|P1|COMPLETED|Overall Study||49
1712416|NCT00372385|4188611|P4|STARTED|Overall Study||78
1712417|NCT00372385|4188612|P3|STARTED|Overall Study||82
1712418|NCT00372385|4188613|P2|STARTED|Overall Study||81
1712419|NCT00372385|4188614|P1|STARTED|Overall Study||82
1712420|NCT00372190|4188643|P2|NOT COMPLETED|Overall Study||1
1712421|NCT00372190|4188644|P1|NOT COMPLETED|Overall Study||3
1712422|NCT00372190|4188643|P2|COMPLETED|Overall Study||96
1712423|NCT00372190|4188644|P1|COMPLETED|Overall Study||90
1712424|NCT00372190|4188643|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
1712425|NCT00372190|4188644|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
1712426|NCT00372112|4188660|P4|NOT COMPLETED|Overall Study||4
1712427|NCT00372112|4188661|P3|NOT COMPLETED|Overall Study||4
1712428|NCT00372112|4188662|P2|NOT COMPLETED|Overall Study||1
1712429|NCT00372112|4188663|P1|NOT COMPLETED|Overall Study||1
1712430|NCT00372112|4188660|P4|COMPLETED|Overall Study||14
1712431|NCT00372112|4188661|P3|COMPLETED|Overall Study||13
1712432|NCT00372112|4188662|P2|COMPLETED|Overall Study||15
1712433|NCT00372112|4188663|P1|COMPLETED|Overall Study||16
1712434|NCT00372112|4188660|P4|STARTED|Overall Study||18
1712435|NCT00372112|4188661|P3|STARTED|Overall Study||17
1712436|NCT00372112|4188662|P2|STARTED|Overall Study||16
1712437|NCT00372112|4188663|P1|STARTED|Overall Study||17
1712438|NCT00372060|4188794|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
1712439|NCT00372060|4188795|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
1712440|NCT00372060|4188794|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
1712441|NCT00372060|4188795|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
1712442|NCT00372060|4188794|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
1712443|NCT00372060|4188795|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
1712444|NCT00372060|4188794|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
1712445|NCT00372060|4188795|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
1712446|NCT00372060|4188794|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
1712447|NCT00372060|4188795|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
1712448|NCT00372060|4188794|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
1712449|NCT00372060|4188795|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
1712450|NCT00371865|4188810|P2|NOT COMPLETED|Overall Study||14
1712451|NCT00371865|4188811|P1|NOT COMPLETED|Overall Study||15
1712452|NCT00371865|4188810|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
1712453|NCT00371865|4188811|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
1712454|NCT00371865|4188810|P2|STARTED|Overall Study||57
1712455|NCT00371865|4188811|P1|STARTED|Overall Study||57
1712456|NCT00371839|4188828|P3|NOT COMPLETED|Overall Study||2
1712457|NCT00371839|4188829|P2|NOT COMPLETED|Overall Study||7
1712458|NCT00371839|4188830|P1|NOT COMPLETED|Overall Study||17
1712459|NCT00371839|4188828|P3|COMPLETED|Overall Study||7
1712460|NCT00371839|4188829|P2|COMPLETED|Overall Study||13
1712461|NCT00371839|4188830|P1|COMPLETED|Overall Study||32
1712462|NCT00371839|4188828|P3|STARTED|Overall Study||9
1712463|NCT00371839|4188829|P2|STARTED|Overall Study||20
1712464|NCT00371839|4188830|P1|STARTED|Overall Study||49
1712465|NCT00371826|4188839|P3|NOT COMPLETED|Extension Phase (24 Months)||2
1712466|NCT00371826|4188840|P2|NOT COMPLETED|Extension Phase (24 Months)||10
1712467|NCT00371826|4188841|P1|NOT COMPLETED|Extension Phase (24 Months)||5
1712468|NCT00371826|4188839|P3|COMPLETED|Extension Phase (24 Months)||3
1712469|NCT00371826|4188840|P2|COMPLETED|Extension Phase (24 Months)||29
1712470|NCT00371826|4188841|P1|COMPLETED|Extension Phase (24 Months)||18
1712471|NCT00371826|4188839|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
1712472|NCT00371826|4188840|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
1712473|NCT00371826|4188841|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
1712474|NCT00371826|4188839|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
1712475|NCT00371826|4188840|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
1712476|NCT00371826|4188841|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
1712477|NCT00371826|4188839|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
1712478|NCT00371826|4188840|P2|STARTED|Extension Phase (24 Months)||39
1712479|NCT00371826|4188841|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
1712480|NCT00371826|4188839|P3|NOT COMPLETED|Core Phase (12 Months)||24
1712481|NCT00371826|4188840|P2|NOT COMPLETED|Core Phase (12 Months)||8
1712482|NCT00371826|4188841|P1|NOT COMPLETED|Core Phase (12 Months)||24
1712483|NCT00371826|4188839|P3|COMPLETED|Core Phase (12 Months)||6
1712484|NCT00371826|4188840|P2|COMPLETED|Core Phase (12 Months)||39
1712485|NCT00371826|4188841|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
1712486|NCT00371826|4188839|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
1712487|NCT00371826|4188840|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
1712488|NCT00371826|4188841|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
1712489|NCT00371826|4188839|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
1712490|NCT00371826|4188840|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
1712491|NCT00371826|4188841|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
1712492|NCT00371826|4188839|P3|STARTED|Core Phase (12 Months)||30
1712493|NCT00371826|4188840|P2|STARTED|Core Phase (12 Months)||47
1712494|NCT00371826|4188841|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
1712495|NCT00371787|4188965|P2|NOT COMPLETED|Overall Study||1
1712496|NCT00371787|4188966|P1|NOT COMPLETED|Overall Study||3
1712497|NCT00371787|4188965|P2|COMPLETED|Overall Study||11
1712498|NCT00371787|4188966|P1|COMPLETED|Overall Study||23
1712499|NCT00371787|4188965|P2|STARTED|Overall Study||12
1712500|NCT00371787|4188966|P1|STARTED|Overall Study||26
1712501|NCT00371761|4188980|P2|NOT COMPLETED|Overall Study||10
1712502|NCT00371761|4188981|P1|NOT COMPLETED|Overall Study||8
1712503|NCT00371761|4188980|P2|COMPLETED|Overall Study||2
1712504|NCT00371761|4188981|P1|COMPLETED|Overall Study||5
1712505|NCT00371761|4188980|P2|STARTED|Overall Study||12
1712506|NCT00371761|4188981|P1|STARTED|Overall Study||13
1712507|NCT00371683|4188989|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
1712508|NCT00371683|4188990|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
1712509|NCT00371683|4188989|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
1712510|NCT00371683|4188990|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
1712511|NCT00371683|4188989|P2|STARTED|Follow-Up Period - Randomized Patients||1533
1712512|NCT00371683|4188990|P1|STARTED|Follow-Up Period - Randomized Patients||1553
1712513|NCT00371683|4188989|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
1712514|NCT00371683|4188990|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
1712515|NCT00371683|4188989|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
1712516|NCT00371683|4188990|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
1712517|NCT00371683|4188989|P2|STARTED|DB Treatment Period-Randomized Patients||1596
1712518|NCT00371683|4188990|P1|STARTED|DB Treatment Period-Randomized Patients||1599
1712519|NCT00371644|4189044|P2|NOT COMPLETED|Overall Study||13
1712520|NCT00371644|4189045|P1|NOT COMPLETED|Overall Study||28
1712521|NCT00371644|4189044|P2|COMPLETED|Overall Study||44
1712522|NCT00371644|4189045|P1|COMPLETED|Overall Study||44
1712523|NCT00371644|4189044|P2|STARTED|Overall Study||57
1712524|NCT00371644|4189045|P1|STARTED|Overall Study||72
1712525|NCT00371631|4189051|P1|NOT COMPLETED|Overall Study||0
1712526|NCT00371631|4189051|P1|COMPLETED|Overall Study||13
1712527|NCT00371631|4189051|P1|STARTED|Overall Study||13
1712528|NCT00371566|4189058|P2|NOT COMPLETED|Follow Up Phase||7
1712529|NCT00371566|4189059|P1|NOT COMPLETED|Follow Up Phase||3
1712530|NCT00371566|4189058|P2|COMPLETED|Follow Up Phase||58
1712531|NCT00371566|4189059|P1|COMPLETED|Follow Up Phase||28
1712532|NCT00371566|4189058|P2|STARTED|Follow Up Phase||65
1712533|NCT00371566|4189059|P1|STARTED|Follow Up Phase||31
1712534|NCT00371566|4189058|P2|NOT COMPLETED|Chemoradiation Phase||3
1712535|NCT00371566|4189059|P1|NOT COMPLETED|Chemoradiation Phase||5
1712536|NCT00371566|4189058|P2|COMPLETED|Chemoradiation Phase||65
1712537|NCT00371566|4189059|P1|COMPLETED|Chemoradiation Phase||31
1712538|NCT00371566|4189058|P2|STARTED|Chemoradiation Phase||68
1712539|NCT00371566|4189059|P1|STARTED|Chemoradiation Phase||36
1712540|NCT00371566|4189058|P2|NOT COMPLETED|Treatment Phase||3
1712541|NCT00371566|4189059|P1|NOT COMPLETED|Treatment Phase||0
1712542|NCT00371566|4189058|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
1712543|NCT00371566|4189059|P1|COMPLETED|Treatment Phase||36
1712544|NCT00371566|4189058|P2|STARTED|Treatment Phase||71
1712545|NCT00371566|4189059|P1|STARTED|Treatment Phase||36
1712546|NCT00371540|4189131|P2|NOT COMPLETED|Overall Study||9
1712547|NCT00371540|4189132|P1|NOT COMPLETED|Overall Study||10
1712548|NCT00371540|4189131|P2|COMPLETED|Overall Study||87
1712549|NCT00371540|4189132|P1|COMPLETED|Overall Study||102
1712550|NCT00371540|4189131|P2|STARTED|Overall Study||96
1712551|NCT00371540|4189132|P1|STARTED|Overall Study||112
1712552|NCT00371462|4189144|P2|NOT COMPLETED|Overall Study||8
1712553|NCT00371462|4189145|P1|NOT COMPLETED|Overall Study||8
1712554|NCT00371462|4189144|P2|COMPLETED|Overall Study||27
1712555|NCT00371462|4189145|P1|COMPLETED|Overall Study||27
1712556|NCT00371462|4189144|P2|STARTED|Overall Study||35
1712557|NCT00371462|4189145|P1|STARTED|Overall Study||35
1712558|NCT00371449|4189151|P1|NOT COMPLETED|Overall Study||0
1712559|NCT00371449|4189151|P1|COMPLETED|Overall Study||120
1712560|NCT00371449|4189151|P1|STARTED|Overall Study||120
1712561|NCT00371436|4189162|P2|NOT COMPLETED|Overall Study||21
1712562|NCT00371436|4189163|P1|NOT COMPLETED|Overall Study||34
1712563|NCT00371436|4189162|P2|COMPLETED|Overall Study||68
1712564|NCT00371436|4189163|P1|COMPLETED|Overall Study||58
1712565|NCT00371436|4189162|P2|STARTED|Overall Study||89
1712566|NCT00371436|4189163|P1|STARTED|Overall Study||92
1712567|NCT00371397|4189169|P12|NOT COMPLETED|Session 3||0
1712568|NCT00371397|4189170|P11|NOT COMPLETED|Session 3||0
1712569|NCT00371397|4189171|P10|NOT COMPLETED|Session 3||0
1712570|NCT00371397|4189172|P9|NOT COMPLETED|Session 3||0
1712571|NCT00371397|4189173|P8|NOT COMPLETED|Session 3||0
1712572|NCT00371397|4189174|P7|NOT COMPLETED|Session 3||0
1712573|NCT00371397|4189175|P6|NOT COMPLETED|Session 3||0
1712574|NCT00371397|4189176|P5|NOT COMPLETED|Session 3||0
1712575|NCT00371397|4189177|P4|NOT COMPLETED|Session 3||0
1712576|NCT00371397|4189178|P3|NOT COMPLETED|Session 3||0
1712577|NCT00371397|4189179|P2|NOT COMPLETED|Session 3||0
1712578|NCT00371397|4189180|P1|NOT COMPLETED|Session 3||0
1712579|NCT00371397|4189169|P12|COMPLETED|Session 3||2
1712580|NCT00371397|4189170|P11|COMPLETED|Session 3||4
1712581|NCT00371397|4189171|P10|COMPLETED|Session 3||5
1712582|NCT00371397|4189172|P9|COMPLETED|Session 3||6
1712583|NCT00371397|4189173|P8|COMPLETED|Session 3||4
1712584|NCT00371397|4189174|P7|COMPLETED|Session 3||4
1712585|NCT00371397|4189175|P6|COMPLETED|Session 3||4
1712586|NCT00371397|4189176|P5|COMPLETED|Session 3||3
1712587|NCT00371397|4189177|P4|COMPLETED|Session 3||2
1712588|NCT00371397|4189178|P3|COMPLETED|Session 3||5
1712589|NCT00371397|4189179|P2|COMPLETED|Session 3||7
1712590|NCT00371397|4189180|P1|COMPLETED|Session 3||4
1712591|NCT00371397|4189169|P12|STARTED|Session 3||2
1712592|NCT00371397|4189170|P11|STARTED|Session 3||4
1712593|NCT00371397|4189171|P10|STARTED|Session 3||5
1712594|NCT00371397|4189172|P9|STARTED|Session 3||6
1712595|NCT00371397|4189173|P8|STARTED|Session 3||4
1712596|NCT00371397|4189174|P7|STARTED|Session 3||4
1712597|NCT00371397|4189175|P6|STARTED|Session 3||4
1712598|NCT00371397|4189176|P5|STARTED|Session 3||3
1712599|NCT00371397|4189177|P4|STARTED|Session 3||2
1712600|NCT00371397|4189178|P3|STARTED|Session 3||5
1712601|NCT00371397|4189179|P2|STARTED|Session 3||7
1712602|NCT00371397|4189180|P1|STARTED|Session 3||4
1712603|NCT00371397|4189169|P12|NOT COMPLETED|Session 2||0
1712604|NCT00371397|4189170|P11|NOT COMPLETED|Session 2||0
1712605|NCT00371397|4189171|P10|NOT COMPLETED|Session 2||0
1712606|NCT00371397|4189172|P9|NOT COMPLETED|Session 2||0
1712607|NCT00371397|4189173|P8|NOT COMPLETED|Session 2||0
1712608|NCT00371397|4189174|P7|NOT COMPLETED|Session 2||0
1712609|NCT00371397|4189175|P6|NOT COMPLETED|Session 2||0
1712610|NCT00371397|4189176|P5|NOT COMPLETED|Session 2||0
1712611|NCT00371397|4189177|P4|NOT COMPLETED|Session 2||0
1712612|NCT00371397|4189178|P3|NOT COMPLETED|Session 2||0
1712613|NCT00371397|4189179|P2|NOT COMPLETED|Session 2||0
1712614|NCT00371397|4189180|P1|NOT COMPLETED|Session 2||0
1712615|NCT00371397|4189169|P12|COMPLETED|Session 2||2
1712616|NCT00371397|4189170|P11|COMPLETED|Session 2||4
1712617|NCT00371397|4189171|P10|COMPLETED|Session 2||5
1712618|NCT00371397|4189172|P9|COMPLETED|Session 2||6
1712619|NCT00371397|4189173|P8|COMPLETED|Session 2||4
1712620|NCT00371397|4189174|P7|COMPLETED|Session 2||4
1712621|NCT00371397|4189175|P6|COMPLETED|Session 2||4
1712622|NCT00371397|4189176|P5|COMPLETED|Session 2||3
1712623|NCT00371397|4189177|P4|COMPLETED|Session 2||2
1712624|NCT00371397|4189178|P3|COMPLETED|Session 2||5
1712625|NCT00371397|4189179|P2|COMPLETED|Session 2||7
1712626|NCT00371397|4189180|P1|COMPLETED|Session 2||4
1712627|NCT00371397|4189169|P12|STARTED|Session 2||2
1712628|NCT00371397|4189170|P11|STARTED|Session 2||4
1712629|NCT00371397|4189171|P10|STARTED|Session 2||5
1712630|NCT00371397|4189172|P9|STARTED|Session 2||6
1712631|NCT00371397|4189173|P8|STARTED|Session 2||4
1712632|NCT00371397|4189174|P7|STARTED|Session 2||4
1712633|NCT00371397|4189175|P6|STARTED|Session 2||4
1712634|NCT00371397|4189176|P5|STARTED|Session 2||3
1712635|NCT00371397|4189177|P4|STARTED|Session 2||2
1712636|NCT00371397|4189178|P3|STARTED|Session 2||5
1712637|NCT00371397|4189179|P2|STARTED|Session 2||7
1712638|NCT00371397|4189180|P1|STARTED|Session 2||4
1712639|NCT00371397|4189169|P12|NOT COMPLETED|Session 1||0
1712640|NCT00371397|4189170|P11|NOT COMPLETED|Session 1||0
1712641|NCT00371397|4189171|P10|NOT COMPLETED|Session 1||0
1712642|NCT00371397|4189172|P9|NOT COMPLETED|Session 1||0
1712643|NCT00371397|4189173|P8|NOT COMPLETED|Session 1||1
1712644|NCT00371397|4189174|P7|NOT COMPLETED|Session 1||0
1712645|NCT00371397|4189175|P6|NOT COMPLETED|Session 1||0
1712646|NCT00371397|4189176|P5|NOT COMPLETED|Session 1||0
1712647|NCT00371397|4189177|P4|NOT COMPLETED|Session 1||0
1712648|NCT00371397|4189178|P3|NOT COMPLETED|Session 1||0
1712649|NCT00371397|4189179|P2|NOT COMPLETED|Session 1||0
1712650|NCT00371397|4189180|P1|NOT COMPLETED|Session 1||1
1712651|NCT00371397|4189169|P12|COMPLETED|Session 1||2
1712652|NCT00371397|4189170|P11|COMPLETED|Session 1||4
1712653|NCT00371397|4189171|P10|COMPLETED|Session 1||5
1712654|NCT00371397|4189172|P9|COMPLETED|Session 1||6
1712655|NCT00371397|4189173|P8|COMPLETED|Session 1||4
1712656|NCT00371397|4189174|P7|COMPLETED|Session 1||4
1712657|NCT00371397|4189175|P6|COMPLETED|Session 1||4
1712658|NCT00371397|4189176|P5|COMPLETED|Session 1||3
1712659|NCT00371397|4189177|P4|COMPLETED|Session 1||2
1712660|NCT00371397|4189178|P3|COMPLETED|Session 1||5
1712661|NCT00371397|4189179|P2|COMPLETED|Session 1||7
1712662|NCT00371397|4189180|P1|COMPLETED|Session 1||4
1712663|NCT00371397|4189169|P12|STARTED|Session 1||2
1712664|NCT00371397|4189170|P11|STARTED|Session 1||4
1712665|NCT00371397|4189171|P10|STARTED|Session 1||5
1712666|NCT00371397|4189172|P9|STARTED|Session 1||6
1712667|NCT00371397|4189173|P8|STARTED|Session 1||5
1712668|NCT00371397|4189174|P7|STARTED|Session 1||4
1712669|NCT00371397|4189175|P6|STARTED|Session 1||4
1712670|NCT00371397|4189176|P5|STARTED|Session 1||3
1712671|NCT00371397|4189177|P4|STARTED|Session 1||2
1712672|NCT00371397|4189178|P3|STARTED|Session 1||5
1712673|NCT00371397|4189179|P2|STARTED|Session 1||7
1712674|NCT00371397|4189180|P1|STARTED|Session 1||5
1712675|NCT00371345|4189188|P2|NOT COMPLETED|Overall Study||46
1712676|NCT00371345|4189189|P1|NOT COMPLETED|Overall Study||24
1712677|NCT00371345|4189188|P2|COMPLETED|Overall Study||0
1712678|NCT00371345|4189189|P1|COMPLETED|Overall Study||0
1712679|NCT00371345|4189188|P2|STARTED|Overall Study||46
1712680|NCT00371345|4189189|P1|STARTED|Overall Study||24
1712681|NCT00371293|4189249|P3|NOT COMPLETED|Overall Study||16
1712682|NCT00371293|4189250|P2|NOT COMPLETED|Overall Study||19
1712683|NCT00371293|4189251|P1|NOT COMPLETED|Overall Study||10
1712684|NCT00371293|4189249|P3|COMPLETED|Overall Study||46
1712685|NCT00371293|4189250|P2|COMPLETED|Overall Study||42
1712686|NCT00371293|4189251|P1|COMPLETED|Overall Study||48
1712687|NCT00371293|4189249|P3|STARTED|Overall Study||62
1712688|NCT00371293|4189250|P2|STARTED|Overall Study||61
1712689|NCT00371293|4189251|P1|STARTED|Overall Study||58
1712690|NCT00371267|4189273|P2|NOT COMPLETED|Overall Study||18
1712691|NCT00371267|4189274|P1|NOT COMPLETED|Overall Study||9
1712692|NCT00371267|4189273|P2|COMPLETED|Overall Study||32
1712693|NCT00371267|4189274|P1|COMPLETED|Overall Study||39
1712694|NCT00371267|4189273|P2|STARTED|Overall Study||50
1712695|NCT00371267|4189274|P1|STARTED|Overall Study||48
1712696|NCT00371254|4189290|P2|NOT COMPLETED|Overall Study||21
1712697|NCT00371254|4189291|P1|NOT COMPLETED|Overall Study||23
1712698|NCT00371254|4189290|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
1712699|NCT00371254|4189291|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
1712700|NCT00371254|4189290|P2|STARTED|Overall Study|Number of participants treated|21
1712701|NCT00371254|4189291|P1|STARTED|Overall Study|Number of participants treated|23
1712702|NCT00371176|4189343|P2|NOT COMPLETED|Overall Study||8
1712703|NCT00371176|4189344|P1|NOT COMPLETED|Overall Study||5
1712704|NCT00371176|4189343|P2|COMPLETED|Overall Study||5
1712705|NCT00371176|4189344|P1|COMPLETED|Overall Study||8
1712706|NCT00371176|4189343|P2|Completed Treatment|Overall Study||9
1712707|NCT00371176|4189344|P1|Completed Treatment|Overall Study||10
1712708|NCT00371176|4189343|P2|STARTED|Overall Study||13
1712709|NCT00371176|4189344|P1|STARTED|Overall Study||13
1712710|NCT00371150|4189374|P2|NOT COMPLETED|Overall Study||2
1712711|NCT00371150|4189375|P1|NOT COMPLETED|Overall Study||3
1712712|NCT00371150|4189374|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
1712713|NCT00371150|4189375|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
1712714|NCT00371150|4189374|P2|Discontinued at or After Week 48 Visit|Overall Study||1
1712715|NCT00371150|4189375|P1|Discontinued at or After Week 48 Visit|Overall Study||2
1712716|NCT00371150|4189374|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
1712717|NCT00371150|4189375|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
1712718|NCT00371150|4189374|P2|STARTED|Overall Study||6
1712719|NCT00371150|4189375|P1|STARTED|Overall Study||40
1712720|NCT00371137|4189410|P3|NOT COMPLETED|Overall Study||79
1712721|NCT00371137|4189411|P2|NOT COMPLETED|Overall Study||63
1712722|NCT00371137|4189412|P1|NOT COMPLETED|Overall Study||72
1712723|NCT00371137|4189410|P3|COMPLETED|Overall Study||104
1712724|NCT00371137|4189411|P2|COMPLETED|Overall Study||119
1712725|NCT00371137|4189412|P1|COMPLETED|Overall Study||111
1712726|NCT00371137|4189410|P3|Treated|Overall Study||182
1712727|NCT00371137|4189411|P2|Treated|Overall Study||182
1712728|NCT00371137|4189412|P1|Treated|Overall Study||183
1712729|NCT00371137|4189410|P3|STARTED|Overall Study||183
1712730|NCT00371137|4189411|P2|STARTED|Overall Study||182
1712731|NCT00371137|4189412|P1|STARTED|Overall Study||183
1712732|NCT00370994|4189422|P2|NOT COMPLETED|Overall Study||0
1712733|NCT00370994|4189423|P1|NOT COMPLETED|Overall Study||0
1712734|NCT00370994|4189422|P2|COMPLETED|Overall Study||60
1712735|NCT00370994|4189423|P1|COMPLETED|Overall Study||60
1712736|NCT00370994|4189422|P2|STARTED|Overall Study||60
1712737|NCT00370994|4189423|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
1712738|NCT00370838|4189433|P2|NOT COMPLETED|Taper||0
1712739|NCT00370838|4189434|P1|NOT COMPLETED|Taper||0
1712740|NCT00370838|4189433|P2|COMPLETED|Taper||3
1712741|NCT00370838|4189434|P1|COMPLETED|Taper||7
1712742|NCT00370838|4189433|P2|STARTED|Taper||3
1712743|NCT00370838|4189434|P1|STARTED|Taper||7
1712744|NCT00370838|4189433|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
1712745|NCT00370838|4189434|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
1712746|NCT00370838|4189433|P2|COMPLETED|Period 2 (Days 65-107)||3
1712747|NCT00370838|4189434|P1|COMPLETED|Period 2 (Days 65-107)||7
1712748|NCT00370838|4189433|P2|STARTED|Period 2 (Days 65-107)||3
1712749|NCT00370838|4189434|P1|STARTED|Period 2 (Days 65-107)||7
1712750|NCT00370838|4189433|P2|NOT COMPLETED|Washout (Days 51-64)||0
1712751|NCT00370838|4189434|P1|NOT COMPLETED|Washout (Days 51-64)||0
1712752|NCT00370838|4189433|P2|COMPLETED|Washout (Days 51-64)||3
1712753|NCT00370838|4189434|P1|COMPLETED|Washout (Days 51-64)||7
1712754|NCT00370838|4189433|P2|STARTED|Washout (Days 51-64)||3
1712755|NCT00370838|4189434|P1|STARTED|Washout (Days 51-64)||7
1712756|NCT00370838|4189433|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
1712757|NCT00370838|4189434|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
1712758|NCT00370838|4189433|P2|COMPLETED|Period 1 (Days 8-50)||3
1712759|NCT00370838|4189434|P1|COMPLETED|Period 1 (Days 8-50)||7
1712760|NCT00370838|4189433|P2|STARTED|Period 1 (Days 8-50)||3
1712761|NCT00370838|4189434|P1|STARTED|Period 1 (Days 8-50)||7
1712762|NCT00370682|4189455|P3|NOT COMPLETED|Overall Study||1
1712763|NCT00370682|4189456|P2|NOT COMPLETED|Overall Study||3
1712764|NCT00370682|4189457|P1|NOT COMPLETED|Overall Study||0
1712765|NCT00370682|4189455|P3|COMPLETED|Overall Study||39
1712766|NCT00370682|4189456|P2|COMPLETED|Overall Study||37
1712767|NCT00370682|4189457|P1|COMPLETED|Overall Study||40
1712768|NCT00370682|4189455|P3|STARTED|Overall Study||40
1712769|NCT00370682|4189456|P2|STARTED|Overall Study||40
1712770|NCT00370682|4189457|P1|STARTED|Overall Study||40
1712771|NCT00370552|4189499|P3|NOT COMPLETED|Overall Study||32
1712772|NCT00370552|4189500|P2|NOT COMPLETED|Overall Study||45
1712773|NCT00370552|4189501|P1|NOT COMPLETED|Overall Study||46
1712774|NCT00370552|4189499|P3|COMPLETED|Overall Study||0
1712775|NCT00370552|4189500|P2|COMPLETED|Overall Study||0
1712776|NCT00370552|4189501|P1|COMPLETED|Overall Study||0
1712777|NCT00370552|4189499|P3|STARTED|Overall Study|Randomized|32
1712778|NCT00370552|4189500|P2|STARTED|Overall Study|Randomized|45
1712779|NCT00370552|4189501|P1|STARTED|Overall Study|Randomized|46
1712780|NCT00370396|4189542|P3|NOT COMPLETED|Overall Study||1
1712781|NCT00370396|4189543|P2|NOT COMPLETED|Overall Study||1
1712782|NCT00370396|4189544|P1|NOT COMPLETED|Overall Study||11
1712783|NCT00370396|4189542|P3|COMPLETED|Overall Study||282
1712784|NCT00370396|4189543|P2|COMPLETED|Overall Study||91
1712785|NCT00370396|4189544|P1|COMPLETED|Overall Study||726
1712786|NCT00370396|4189542|P3|STARTED|Overall Study||283
1712787|NCT00370396|4189543|P2|STARTED|Overall Study||92
1712788|NCT00370396|4189544|P1|STARTED|Overall Study||737
1712789|NCT00370331|4189598|P2|NOT COMPLETED|Overall Study||23
1712790|NCT00370331|4189599|P1|NOT COMPLETED|Overall Study||7
1712791|NCT00370331|4189598|P2|COMPLETED|Overall Study||112
1712792|NCT00370331|4189599|P1|COMPLETED|Overall Study||55
1712793|NCT00370331|4189598|P2|STARTED|Overall Study||135
1712794|NCT00370331|4189599|P1|STARTED|Overall Study||62
1712795|NCT00370292|4189625|P1|NOT COMPLETED|Overall Study||13
1712796|NCT00370292|4189625|P1|COMPLETED|Overall Study||6
1712797|NCT00370292|4189625|P1|STARTED|Overall Study||19
1712798|NCT00370149|4189638|P2|NOT COMPLETED|Overall Study||19
1712799|NCT00370149|4189639|P1|NOT COMPLETED|Overall Study||19
1712800|NCT00370149|4189638|P2|COMPLETED|Overall Study||142
1712801|NCT00370149|4189639|P1|COMPLETED|Overall Study||146
1712802|NCT00370149|4189638|P2|STARTED|Overall Study||161
1712803|NCT00370149|4189639|P1|STARTED|Overall Study||165
1712804|NCT00370071|4189649|P1|NOT COMPLETED|Overall Study||2
1712805|NCT00370071|4189649|P1|COMPLETED|Overall Study||37
1712806|NCT00370071|4189649|P1|STARTED|Overall Study||39
1712807|NCT00370032|4189666|P2|NOT COMPLETED|Follow-up Period||0
1712808|NCT00370032|4189667|P1|NOT COMPLETED|Follow-up Period||1
1712809|NCT00370032|4189666|P2|COMPLETED|Follow-up Period||22
1712810|NCT00370032|4189667|P1|COMPLETED|Follow-up Period||22
1712811|NCT00370032|4189666|P2|STARTED|Follow-up Period||22
1712812|NCT00370032|4189667|P1|STARTED|Follow-up Period||23
1712813|NCT00370032|4189666|P2|NOT COMPLETED|Treatment Period 2||0
1712814|NCT00370032|4189667|P1|NOT COMPLETED|Treatment Period 2||0
1712815|NCT00370032|4189666|P2|COMPLETED|Treatment Period 2||22
1712816|NCT00370032|4189667|P1|COMPLETED|Treatment Period 2||23
1712817|NCT00370032|4189666|P2|STARTED|Treatment Period 2||22
1712818|NCT00370032|4189667|P1|STARTED|Treatment Period 2||23
1712819|NCT00370032|4189666|P2|NOT COMPLETED|Washout Period||2
1712820|NCT00370032|4189667|P1|NOT COMPLETED|Washout Period||1
1712821|NCT00370032|4189666|P2|COMPLETED|Washout Period||22
1712822|NCT00370032|4189667|P1|COMPLETED|Washout Period||23
1712823|NCT00370032|4189666|P2|STARTED|Washout Period||24
1712824|NCT00370032|4189667|P1|STARTED|Washout Period||24
1712825|NCT00370032|4189666|P2|NOT COMPLETED|Treatment Period 1||1
1712826|NCT00370032|4189667|P1|NOT COMPLETED|Treatment Period 1||0
1712827|NCT00370032|4189666|P2|COMPLETED|Treatment Period 1||24
1712828|NCT00370032|4189667|P1|COMPLETED|Treatment Period 1||24
1712829|NCT00370032|4189666|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
1712830|NCT00370032|4189667|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
1712831|NCT00369967|4189687|P2|NOT COMPLETED|Overall Study||12
1712832|NCT00369967|4189688|P1|NOT COMPLETED|Overall Study||23
1712833|NCT00369967|4189687|P2|COMPLETED|Overall Study||5
1712834|NCT00369967|4189688|P1|COMPLETED|Overall Study||8
1712835|NCT00369967|4189687|P2|STARTED|Overall Study||17
1712836|NCT00369967|4189688|P1|STARTED|Overall Study||31
1712837|NCT00369941|4189706|P2|NOT COMPLETED|Overall Study||100
1712838|NCT00369941|4189707|P1|NOT COMPLETED|Overall Study||72
1712839|NCT00369941|4189706|P2|COMPLETED|Overall Study||184
1712840|NCT00369941|4189707|P1|COMPLETED|Overall Study||210
1712841|NCT00369941|4189706|P2|Treated|Overall Study||282
1712842|NCT00369941|4189707|P1|Treated|Overall Study||281
1712843|NCT00369941|4189706|P2|STARTED|Overall Study||284
1712844|NCT00369941|4189707|P1|STARTED|Overall Study||282
1712845|NCT00369928|4189860|P3|NOT COMPLETED|Overall Study||20
1712846|NCT00369928|4189861|P2|NOT COMPLETED|Overall Study||16
1712847|NCT00369928|4189862|P1|NOT COMPLETED|Overall Study||8
1712848|NCT00369928|4189860|P3|COMPLETED|Overall Study||66
1712849|NCT00369928|4189861|P2|COMPLETED|Overall Study||69
1712850|NCT00369928|4189862|P1|COMPLETED|Overall Study||77
1712851|NCT00369928|4189860|P3|STARTED|Overall Study||86
1712852|NCT00369928|4189861|P2|STARTED|Overall Study||85
1712853|NCT00369928|4189862|P1|STARTED|Overall Study||85
1712854|NCT00369915|4189872|P2|NOT COMPLETED|Overall Study||3
1712855|NCT00369915|4189873|P1|NOT COMPLETED|Overall Study||6
1712856|NCT00369915|4189872|P2|COMPLETED|Overall Study||4
1712857|NCT00369915|4189873|P1|COMPLETED|Overall Study||4
1712858|NCT00369915|4189872|P2|STARTED|Overall Study||7
1712859|NCT00369915|4189873|P1|STARTED|Overall Study||10
1712860|NCT00369824|4189887|P6|NOT COMPLETED|Overall Study||11
1712861|NCT00369824|4189888|P5|NOT COMPLETED|Overall Study||18
1712862|NCT00369824|4189889|P4|NOT COMPLETED|Overall Study||15
1712863|NCT00369824|4189890|P3|NOT COMPLETED|Overall Study||12
1712864|NCT00369824|4189891|P2|NOT COMPLETED|Overall Study||19
1712865|NCT00369824|4189892|P1|NOT COMPLETED|Overall Study||15
1712866|NCT00369824|4189887|P6|COMPLETED|Overall Study||204
1712867|NCT00369824|4189888|P5|COMPLETED|Overall Study||196
1712868|NCT00369824|4189889|P4|COMPLETED|Overall Study||199
1712869|NCT00369824|4189890|P3|COMPLETED|Overall Study||202
1712870|NCT00369824|4189891|P2|COMPLETED|Overall Study||195
1712871|NCT00369824|4189892|P1|COMPLETED|Overall Study||197
1712872|NCT00369824|4189887|P6|STARTED|Overall Study||215
1712873|NCT00369824|4189888|P5|STARTED|Overall Study||214
1712874|NCT00369824|4189889|P4|STARTED|Overall Study||214
1712875|NCT00369824|4189890|P3|STARTED|Overall Study||214
1712876|NCT00369824|4189891|P2|STARTED|Overall Study||214
1712877|NCT00369824|4189892|P1|STARTED|Overall Study||212
1712878|NCT00369785|4189992|P2|NOT COMPLETED|Overall Study||25
1712879|NCT00369785|4189993|P1|NOT COMPLETED|Overall Study||27
1712880|NCT00369785|4189992|P2|COMPLETED|Overall Study||74
1712881|NCT00369785|4189993|P1|COMPLETED|Overall Study||72
1712882|NCT00369785|4189992|P2|STARTED|Overall Study||99
1712883|NCT00369785|4189993|P1|STARTED|Overall Study||99
1712884|NCT00369746|4190003|P2|NOT COMPLETED|Overall Study||0
1712885|NCT00369746|4190004|P1|NOT COMPLETED|Overall Study||0
1712886|NCT00369746|4190003|P2|COMPLETED|Overall Study||536
1712887|NCT00369746|4190004|P1|COMPLETED|Overall Study||138
1712888|NCT00369746|4190003|P2|STARTED|Overall Study||536
1712889|NCT00369746|4190004|P1|STARTED|Overall Study||138
1712890|NCT00369707|4190014|P1|NOT COMPLETED|Follow up for 2 Years After Treatment||3
1712891|NCT00369707|4190014|P1|COMPLETED|Follow up for 2 Years After Treatment||38
1712892|NCT00369707|4190014|P1|STARTED|Follow up for 2 Years After Treatment||41
1712893|NCT00369707|4190014|P1|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
1712894|NCT00369707|4190014|P1|COMPLETED|Maintenance Period (up to 4 Cycles)||27
1712895|NCT00369707|4190014|P1|STARTED|Maintenance Period (up to 4 Cycles)||35
1712896|NCT00369707|4190014|P1|NOT COMPLETED|Induction Part B (2 Cycles)||7
1712897|NCT00369707|4190014|P1|COMPLETED|Induction Part B (2 Cycles)||35
1712898|NCT00369707|4190014|P1|STARTED|Induction Part B (2 Cycles)||42
1712899|NCT00369707|4190014|P1|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
1712900|NCT00369707|4190014|P1|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
1712901|NCT00369707|4190014|P1|STARTED|Induction Part A (1 Cycle -35 Days)||42
1712902|NCT00369681|4190027|P1|NOT COMPLETED|Overall Study||1
1712903|NCT00369681|4190027|P1|COMPLETED|Overall Study||49
1712904|NCT00369681|4190027|P1|STARTED|Overall Study||50
1712905|NCT00369668|4190037|P3|NOT COMPLETED|Overall Study||7
1712906|NCT00369668|4190038|P2|NOT COMPLETED|Overall Study||5
1712907|NCT00369668|4190039|P1|NOT COMPLETED|Overall Study||4
1712908|NCT00369668|4190037|P3|COMPLETED|Overall Study||3
1712909|NCT00369668|4190038|P2|COMPLETED|Overall Study||5
1712910|NCT00369668|4190039|P1|COMPLETED|Overall Study||6
1712911|NCT00369668|4190037|P3|STARTED|Overall Study||10
1712912|NCT00369668|4190038|P2|STARTED|Overall Study||10
1712913|NCT00369668|4190039|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
1712914|NCT00369655|4190053|P1|NOT COMPLETED|Overall Study||2
1712915|NCT00369655|4190053|P1|COMPLETED|Overall Study||19
1712916|NCT00369655|4190053|P1|STARTED|Overall Study||21
1712917|NCT00369629|4190062|P4|NOT COMPLETED|Follow up for 1 Year||0
1712918|NCT00369629|4190063|P3|NOT COMPLETED|Follow up for 1 Year||3
1712919|NCT00369629|4190064|P2|NOT COMPLETED|Follow up for 1 Year||2
1712920|NCT00369629|4190065|P1|NOT COMPLETED|Follow up for 1 Year||2
1712921|NCT00369629|4190062|P4|COMPLETED|Follow up for 1 Year||0
1712922|NCT00369629|4190063|P3|COMPLETED|Follow up for 1 Year||2
1712923|NCT00369629|4190064|P2|COMPLETED|Follow up for 1 Year||1
1712924|NCT00369629|4190065|P1|COMPLETED|Follow up for 1 Year||4
1712925|NCT00369629|4190062|P4|STARTED|Follow up for 1 Year||0
1712926|NCT00369629|4190063|P3|STARTED|Follow up for 1 Year||5
1712927|NCT00369629|4190064|P2|STARTED|Follow up for 1 Year||3
1712928|NCT00369629|4190065|P1|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
1712929|NCT00369629|4190062|P4|NOT COMPLETED|Completed 4 More Cycles||0
1712930|NCT00369629|4190063|P3|NOT COMPLETED|Completed 4 More Cycles||2
1712931|NCT00369629|4190064|P2|NOT COMPLETED|Completed 4 More Cycles||2
1712932|NCT00369629|4190065|P1|NOT COMPLETED|Completed 4 More Cycles||4
1712933|NCT00369629|4190062|P4|COMPLETED|Completed 4 More Cycles||0
1712934|NCT00369629|4190063|P3|COMPLETED|Completed 4 More Cycles||0
1712935|NCT00369629|4190064|P2|COMPLETED|Completed 4 More Cycles||0
1712936|NCT00369629|4190065|P1|COMPLETED|Completed 4 More Cycles||0
1712937|NCT00369629|4190062|P4|STARTED|Completed 4 More Cycles||0
1712938|NCT00369629|4190063|P3|STARTED|Completed 4 More Cycles||2
1712939|NCT00369629|4190064|P2|STARTED|Completed 4 More Cycles||2
1712940|NCT00369629|4190065|P1|STARTED|Completed 4 More Cycles||4
1712941|NCT00369629|4190062|P4|NOT COMPLETED|Moved on to 4 More Cycles||0
1712942|NCT00369629|4190063|P3|NOT COMPLETED|Moved on to 4 More Cycles||1
1712943|NCT00369629|4190064|P2|NOT COMPLETED|Moved on to 4 More Cycles||0
1712944|NCT00369629|4190065|P1|NOT COMPLETED|Moved on to 4 More Cycles||0
1712945|NCT00369629|4190062|P4|COMPLETED|Moved on to 4 More Cycles||0
1712946|NCT00369629|4190063|P3|COMPLETED|Moved on to 4 More Cycles||2
1712947|NCT00369629|4190064|P2|COMPLETED|Moved on to 4 More Cycles||2
1712948|NCT00369629|4190065|P1|COMPLETED|Moved on to 4 More Cycles||4
1712949|NCT00369629|4190062|P4|STARTED|Moved on to 4 More Cycles||0
1712950|NCT00369629|4190063|P3|STARTED|Moved on to 4 More Cycles||3
1712951|NCT00369629|4190064|P2|STARTED|Moved on to 4 More Cycles||2
1712952|NCT00369629|4190065|P1|STARTED|Moved on to 4 More Cycles||4
1712953|NCT00369629|4190062|P4|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
1712954|NCT00369629|4190063|P3|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
1712955|NCT00369629|4190064|P2|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
1712956|NCT00369629|4190065|P1|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
1712957|NCT00369629|4190062|P4|COMPLETED|Treated 2 Cycles/Reached First Response||0
1712958|NCT00369629|4190063|P3|COMPLETED|Treated 2 Cycles/Reached First Response||3
1712959|NCT00369629|4190064|P2|COMPLETED|Treated 2 Cycles/Reached First Response||2
1712960|NCT00369629|4190065|P1|COMPLETED|Treated 2 Cycles/Reached First Response||4
1712961|NCT00369629|4190062|P4|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
1712962|NCT00369629|4190063|P3|STARTED|Treated 2 Cycles/Reached First Response||5
1712963|NCT00369629|4190064|P2|STARTED|Treated 2 Cycles/Reached First Response||3
1712964|NCT00369629|4190065|P1|STARTED|Treated 2 Cycles/Reached First Response||6
1712965|NCT00369590|4190077|P2|NOT COMPLETED|Overall Study||0
1712966|NCT00369590|4190078|P1|NOT COMPLETED|Overall Study||0
1712967|NCT00369590|4190077|P2|COMPLETED|Overall Study||42
1712968|NCT00369590|4190078|P1|COMPLETED|Overall Study||16
1712969|NCT00369590|4190077|P2|STARTED|Overall Study||42
1712970|NCT00369590|4190078|P1|STARTED|Overall Study||16
1712971|NCT00369577|4190096|P3|NOT COMPLETED|Overall Study||1
1712972|NCT00369577|4190097|P2|NOT COMPLETED|Overall Study||0
1712973|NCT00369577|4190098|P1|NOT COMPLETED|Overall Study||0
1712974|NCT00369577|4190096|P3|COMPLETED|Overall Study||40
1712975|NCT00369577|4190097|P2|COMPLETED|Overall Study||45
1712976|NCT00369577|4190098|P1|COMPLETED|Overall Study||43
1712977|NCT00369577|4190096|P3|STARTED|Overall Study||41
1712978|NCT00369577|4190097|P2|STARTED|Overall Study||45
1712979|NCT00369577|4190098|P1|STARTED|Overall Study||43
1712980|NCT00369564|4190117|P2|NOT COMPLETED|Overall Study||23
1712981|NCT00369564|4190118|P1|NOT COMPLETED|Overall Study||43
1712982|NCT00369564|4190117|P2|COMPLETED|Overall Study||100
1712983|NCT00369564|4190118|P1|COMPLETED|Overall Study||84
1712984|NCT00369564|4190117|P2|STARTED|Overall Study||123
1712985|NCT00369564|4190118|P1|STARTED|Overall Study||127
1712986|NCT00369512|4190124|P1|NOT COMPLETED|Overall Study||0
1712987|NCT00369512|4190124|P1|COMPLETED|Overall Study||15
1712988|NCT00369512|4190124|P1|STARTED|Overall Study||15
1712989|NCT00369486|4190135|P5|NOT COMPLETED|34-Week Visit||3
1712990|NCT00369486|4190136|P4|NOT COMPLETED|34-Week Visit||3
1712991|NCT00369486|4190137|P3|NOT COMPLETED|34-Week Visit||1
1712992|NCT00369486|4190138|P2|NOT COMPLETED|34-Week Visit||1
1712993|NCT00369486|4190139|P1|NOT COMPLETED|34-Week Visit||0
1712994|NCT00369486|4190135|P5|COMPLETED|34-Week Visit|Number of eyes|22
1712995|NCT00369486|4190136|P4|COMPLETED|34-Week Visit|Number of eyes|19
1712996|NCT00369486|4190137|P3|COMPLETED|34-Week Visit|Number of eyes|22
1712997|NCT00369486|4190138|P2|COMPLETED|34-Week Visit|Number of eyes|20
1712998|NCT00369486|4190139|P1|COMPLETED|34-Week Visit|Number of eyes|38
1712999|NCT00369486|4190135|P5|STARTED|34-Week Visit|Number of eyes that|25
1713000|NCT00369486|4190136|P4|STARTED|34-Week Visit|Number of eyes|22
1713001|NCT00369486|4190137|P3|STARTED|34-Week Visit|Number of eyes|23
1713002|NCT00369486|4190138|P2|STARTED|34-Week Visit|Number of eyes|21
1713003|NCT00369486|4190139|P1|STARTED|34-Week Visit|Number of eyes|38
1713004|NCT00369486|4190135|P5|NOT COMPLETED|17-Week Visit||1
1713005|NCT00369486|4190136|P4|NOT COMPLETED|17-Week Visit||1
1713006|NCT00369486|4190137|P3|NOT COMPLETED|17-Week Visit||1
1713007|NCT00369486|4190138|P2|NOT COMPLETED|17-Week Visit||0
1713008|NCT00369486|4190139|P1|NOT COMPLETED|17-Week Visit||0
1713009|NCT00369486|4190135|P5|COMPLETED|17-Week Visit|Number of eyes|24
1713010|NCT00369486|4190136|P4|COMPLETED|17-Week Visit|Number of eyes|21
1713011|NCT00369486|4190137|P3|COMPLETED|17-Week Visit|Number of eyes|22
1713012|NCT00369486|4190138|P2|COMPLETED|17-Week Visit|Number of eyes|21
1713013|NCT00369486|4190139|P1|COMPLETED|17-Week Visit|Number of eyes|38
1713014|NCT00369486|4190135|P5|STARTED|17-Week Visit|Number of eyes|25
1713015|NCT00369486|4190136|P4|STARTED|17-Week Visit|Number of eyes|22
1713016|NCT00369486|4190137|P3|STARTED|17-Week Visit|Number of eyes|23
1713017|NCT00369486|4190138|P2|STARTED|17-Week Visit|Number of eyes|21
1713018|NCT00369486|4190139|P1|STARTED|17-Week Visit|Number of eyes|38
1713019|NCT00369486|4190135|P5|NOT COMPLETED|8-Week Visit||1
1713020|NCT00369486|4190136|P4|NOT COMPLETED|8-Week Visit||1
1713021|NCT00369486|4190137|P3|NOT COMPLETED|8-Week Visit||0
1713022|NCT00369486|4190138|P2|NOT COMPLETED|8-Week Visit||1
1713023|NCT00369486|4190139|P1|NOT COMPLETED|8-Week Visit||0
1713024|NCT00369486|4190135|P5|COMPLETED|8-Week Visit|Number of eyes|24
1713025|NCT00369486|4190136|P4|COMPLETED|8-Week Visit|Number of eyes|21
1713026|NCT00369486|4190137|P3|COMPLETED|8-Week Visit|Number of eyes|22
1713027|NCT00369486|4190138|P2|COMPLETED|8-Week Visit|Number of eyes|20
1713028|NCT00369486|4190139|P1|COMPLETED|8-Week Visit|Number of eyes|38
1713029|NCT00369486|4190135|P5|STARTED|8-Week Visit|Number of eyes|25
1713030|NCT00369486|4190136|P4|STARTED|8-Week Visit|Number of eyes|22
1713031|NCT00369486|4190137|P3|STARTED|8-Week Visit|Number of eyes|22
1713032|NCT00369486|4190138|P2|STARTED|8-Week Visit|Number of eyes|21
1713033|NCT00369486|4190139|P1|STARTED|8-Week Visit|Number of eyes|38
1713034|NCT00369486|4190135|P5|NOT COMPLETED|4-Week Visit||1
1713035|NCT00369486|4190136|P4|NOT COMPLETED|4-Week Visit||2
1713036|NCT00369486|4190137|P3|NOT COMPLETED|4-Week Visit||1
1713037|NCT00369486|4190138|P2|NOT COMPLETED|4-Week Visit||2
1713038|NCT00369486|4190139|P1|NOT COMPLETED|4-Week Visit||2
1713039|NCT00369486|4190135|P5|COMPLETED|4-Week Visit|Number of eyes|24
1713040|NCT00369486|4190136|P4|COMPLETED|4-Week Visit|Number of eyes|20
1713041|NCT00369486|4190137|P3|COMPLETED|4-Week Visit|Number of eyes|22
1713042|NCT00369486|4190138|P2|COMPLETED|4-Week Visit|Number of eyes;|19
1713043|NCT00369486|4190139|P1|COMPLETED|4-Week Visit|Number of eyes|36
1713044|NCT00369486|4190135|P5|STARTED|4-Week Visit|Number of eyes|25
1713045|NCT00369486|4190136|P4|STARTED|4-Week Visit|Number of eyes|22
1713046|NCT00369486|4190137|P3|STARTED|4-Week Visit|Number of eyes|23
1713047|NCT00369486|4190138|P2|STARTED|4-Week Visit|Number of eyes|21
1713048|NCT00369486|4190139|P1|STARTED|4-Week Visit|Number of eyes|38
1713049|NCT00369382|4190178|P2|NOT COMPLETED|Overall Study||3
1713050|NCT00369382|4190179|P1|NOT COMPLETED|Overall Study||10
1713051|NCT00369382|4190178|P2|COMPLETED|Overall Study||54
1713052|NCT00369382|4190179|P1|COMPLETED|Overall Study||49
1713053|NCT00369382|4190178|P2|Completed Assigned Treatment Regimen|Overall Study||33
1713054|NCT00369382|4190179|P1|Completed Assigned Treatment Regimen|Overall Study||48
1713055|NCT00369382|4190178|P2|Received Treatment|Overall Study||57
1713056|NCT00369382|4190179|P1|Received Treatment|Overall Study||57
1713057|NCT00369382|4190178|P2|STARTED|Overall Study||57
1713058|NCT00369382|4190179|P1|STARTED|Overall Study||59
1713059|NCT00369343|4190212|P2|NOT COMPLETED|Open-label Phase||30
1713060|NCT00369343|4190213|P1|NOT COMPLETED|Open-label Phase||57
1713061|NCT00369343|4190212|P2|COMPLETED|Open-label Phase||79
1713062|NCT00369343|4190213|P1|COMPLETED|Open-label Phase||155
1713063|NCT00369343|4190212|P2|STARTED|Open-label Phase||109
1713064|NCT00369343|4190213|P1|STARTED|Open-label Phase||212
1713065|NCT00369343|4190212|P2|NOT COMPLETED|Double-blind Phase||16
1713066|NCT00369343|4190213|P1|NOT COMPLETED|Double-blind Phase||44
1713067|NCT00369343|4190212|P2|COMPLETED|Double-blind Phase||109
1713068|NCT00369343|4190213|P1|COMPLETED|Double-blind Phase||212
1713069|NCT00369343|4190212|P2|STARTED|Double-blind Phase||125
1713070|NCT00369343|4190213|P1|STARTED|Double-blind Phase||256
1713071|NCT00369317|4190246|P1|NOT COMPLETED|Overall Study||20
1713072|NCT00369317|4190246|P1|COMPLETED|Overall Study||185
1713073|NCT00369317|4190246|P1|STARTED|Overall Study||205
1713074|NCT00369278|4190262|P2|NOT COMPLETED|Overall Study||21
1713075|NCT00369278|4190263|P1|NOT COMPLETED|Overall Study||24
1713076|NCT00369278|4190262|P2|COMPLETED|Overall Study||44
1713077|NCT00369278|4190263|P1|COMPLETED|Overall Study||39
1713078|NCT00369278|4190262|P2|STARTED|Overall Study||65
1713079|NCT00369278|4190263|P1|STARTED|Overall Study||63
1713080|NCT00369265|4190279|P2|NOT COMPLETED|Overall Study||7
1713081|NCT00369265|4190280|P1|NOT COMPLETED|Overall Study||4
1713082|NCT00369265|4190279|P2|COMPLETED|Overall Study||0
1713083|NCT00369265|4190280|P1|COMPLETED|Overall Study||0
1713084|NCT00369265|4190279|P2|STARTED|Overall Study||7
1713085|NCT00369265|4190280|P1|STARTED|Overall Study||4
1713086|NCT00369226|4190288|P2|NOT COMPLETED|Phase II (45 Days)||0
1713087|NCT00369226|4190289|P1|NOT COMPLETED|Phase II (45 Days)||0
1713088|NCT00369226|4190288|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
1713089|NCT00369226|4190289|P1|COMPLETED|Phase II (45 Days)||0
1713090|NCT00369226|4190288|P2|STARTED|Phase II (45 Days)||32
1713091|NCT00369226|4190289|P1|STARTED|Phase II (45 Days)||0
1713092|NCT00369226|4190288|P2|NOT COMPLETED|Phase I (45 Days)||0
1713093|NCT00369226|4190289|P1|NOT COMPLETED|Phase I (45 Days)||0
1713094|NCT00369226|4190288|P2|COMPLETED|Phase I (45 Days)||0
1713095|NCT00369226|4190289|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
1713096|NCT00369226|4190288|P2|STARTED|Phase I (45 Days)||0
1713097|NCT00369226|4190289|P1|STARTED|Phase I (45 Days)||13
1713098|NCT00369161|4190301|P2|NOT COMPLETED|Overall Study||24
1713099|NCT00369161|4190302|P1|NOT COMPLETED|Overall Study||27
1713100|NCT00369161|4190301|P2|COMPLETED|Overall Study||95
1713101|NCT00369161|4190302|P1|COMPLETED|Overall Study||82
1713102|NCT00369161|4190301|P2|Intention to Treat (ITT)|Overall Study||117
1713103|NCT00369161|4190302|P1|Intention to Treat (ITT)|Overall Study||107
1713104|NCT00369161|4190301|P2|STARTED|Overall Study||119
1713105|NCT00369161|4190302|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
1713106|NCT00369122|4190312|P1|NOT COMPLETED|Overall Study||11
1713107|NCT00369122|4190312|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
1713108|NCT00369122|4190312|P1|STARTED|Overall Study||60
1713109|NCT00368992|4190319|P1|NOT COMPLETED|Overall Study||110
1713110|NCT00368992|4190319|P1|COMPLETED|Overall Study||0
1713111|NCT00368992|4190319|P1|STARTED|Overall Study||110
1713112|NCT00368979|4190328|P2|NOT COMPLETED|Overall Study||30
1713113|NCT00368979|4190329|P1|NOT COMPLETED|Overall Study||25
1713114|NCT00368979|4190328|P2|COMPLETED|Overall Study||163
1713115|NCT00368979|4190329|P1|COMPLETED|Overall Study||160
1713116|NCT00368979|4190328|P2|STARTED|Overall Study||193
1713117|NCT00368979|4190329|P1|STARTED|Overall Study||185
1713118|NCT00368966|4190345|P2|NOT COMPLETED|Toddler Dose||3
1713119|NCT00368966|4190346|P1|NOT COMPLETED|Toddler Dose||1
1713120|NCT00368966|4190345|P2|COMPLETED|Toddler Dose||286
1713121|NCT00368966|4190346|P1|COMPLETED|Toddler Dose||292
1713122|NCT00368966|4190345|P2|STARTED|Toddler Dose||289
1713123|NCT00368966|4190346|P1|STARTED|Toddler Dose||293
1713124|NCT00368966|4190345|P2|NOT COMPLETED|After Infant||5
1713125|NCT00368966|4190346|P1|NOT COMPLETED|After Infant||6
1713126|NCT00368966|4190345|P2|COMPLETED|After Infant||289
1713127|NCT00368966|4190346|P1|COMPLETED|After Infant||293
1713128|NCT00368966|4190345|P2|STARTED|After Infant||294
1713129|NCT00368966|4190346|P1|STARTED|After Infant||299
1713130|NCT00368966|4190345|P2|NOT COMPLETED|Infant Series||10
1713131|NCT00368966|4190346|P1|NOT COMPLETED|Infant Series||16
1713132|NCT00368966|4190345|P2|COMPLETED|Infant Series||294
1713133|NCT00368966|4190346|P1|COMPLETED|Infant Series||299
1713134|NCT00368966|4190345|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
1713135|NCT00368966|4190346|P1|Vaccinated Dose 3|Infant Series||301
1713136|NCT00368966|4190345|P2|Vaccinated Dose 2|Infant Series||298
1713137|NCT00368966|4190346|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
1713138|NCT00368966|4190345|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
1713139|NCT00368966|4190346|P1|Vaccinated Dose 1|Infant Series||314
1713140|NCT00368966|4190345|P2|STARTED|Infant Series||304
1713141|NCT00368966|4190346|P1|STARTED|Infant Series||315
1713142|NCT00368940|4190402|P2|NOT COMPLETED|Completed 12-wk Treatment||5
1713143|NCT00368940|4190403|P1|NOT COMPLETED|Completed 12-wk Treatment||6
1713144|NCT00368940|4190402|P2|COMPLETED|Completed 12-wk Treatment||32
1713145|NCT00368940|4190403|P1|COMPLETED|Completed 12-wk Treatment||31
1713146|NCT00368940|4190402|P2|STARTED|Completed 12-wk Treatment||37
1713147|NCT00368940|4190403|P1|STARTED|Completed 12-wk Treatment||37
1713148|NCT00368940|4190402|P2|NOT COMPLETED|Intention-to-Treat||0
1713149|NCT00368940|4190403|P1|NOT COMPLETED|Intention-to-Treat||0
1713150|NCT00368940|4190402|P2|COMPLETED|Intention-to-Treat||37
1713151|NCT00368940|4190403|P1|COMPLETED|Intention-to-Treat||37
1713152|NCT00368940|4190402|P2|STARTED|Intention-to-Treat||37
1713153|NCT00368940|4190403|P1|STARTED|Intention-to-Treat||37
1713154|NCT00368927|4190417|P2|NOT COMPLETED|Overall Study||3
1713155|NCT00368927|4190418|P1|NOT COMPLETED|Overall Study||5
1713156|NCT00368927|4190417|P2|COMPLETED|Overall Study||27
1713157|NCT00368927|4190418|P1|COMPLETED|Overall Study||26
1713158|NCT00368927|4190417|P2|STARTED|Overall Study||30
1713159|NCT00368927|4190418|P1|STARTED|Overall Study||31
1713160|NCT00368875|4190426|P2|NOT COMPLETED|Overall Study||48
1713161|NCT00368875|4190427|P1|NOT COMPLETED|Overall Study||6
1713162|NCT00368875|4190426|P2|COMPLETED|Overall Study||0
1713163|NCT00368875|4190427|P1|COMPLETED|Overall Study||0
1713164|NCT00368875|4190426|P2|STARTED|Overall Study||48
1713165|NCT00368875|4190427|P1|STARTED|Overall Study||6
1713166|NCT00368849|4190435|P2|NOT COMPLETED|Overall Study||2
1713167|NCT00368849|4190436|P1|NOT COMPLETED|Overall Study||0
1713168|NCT00368849|4190435|P2|COMPLETED|Overall Study||8
1713169|NCT00368849|4190436|P1|COMPLETED|Overall Study||10
1713170|NCT00368849|4190435|P2|STARTED|Overall Study||10
1713171|NCT00368849|4190436|P1|STARTED|Overall Study||10
1713172|NCT00368745|4190452|P2|NOT COMPLETED|Double-blind Treatment Period||31
1713173|NCT00368745|4190453|P1|NOT COMPLETED|Double-blind Treatment Period||26
1713174|NCT00368745|4190452|P2|COMPLETED|Double-blind Treatment Period||19
1713175|NCT00368745|4190453|P1|COMPLETED|Double-blind Treatment Period||30
1713176|NCT00368745|4190452|P2|STARTED|Double-blind Treatment Period||50
1713177|NCT00368745|4190453|P1|STARTED|Double-blind Treatment Period||56
1713178|NCT00368745|4190452|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
1713179|NCT00368745|4190453|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
1713180|NCT00368745|4190452|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
1713181|NCT00368745|4190453|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
1713182|NCT00368745|4190452|P2|STARTED|Randomized to Double-blind Treatment||51
1713183|NCT00368745|4190453|P1|STARTED|Randomized to Double-blind Treatment||57
1713184|NCT00368654|4190487|P4|NOT COMPLETED|Overall Study||3
1713185|NCT00368654|4190488|P3|NOT COMPLETED|Overall Study||3
1713186|NCT00368654|4190489|P2|NOT COMPLETED|Overall Study||3
1713187|NCT00368654|4190490|P1|NOT COMPLETED|Overall Study||3
1713188|NCT00368654|4190487|P4|COMPLETED|Overall Study||0
1713189|NCT00368654|4190488|P3|COMPLETED|Overall Study||0
1713190|NCT00368654|4190489|P2|COMPLETED|Overall Study||0
1713191|NCT00368654|4190490|P1|COMPLETED|Overall Study||0
1713192|NCT00368654|4190487|P4|STARTED|Overall Study||3
1713193|NCT00368654|4190488|P3|STARTED|Overall Study||3
1713194|NCT00368654|4190489|P2|STARTED|Overall Study||3
1713195|NCT00368654|4190490|P1|STARTED|Overall Study||3
1713196|NCT00368641|4190506|P2|NOT COMPLETED|Overall Study||6
1713197|NCT00368641|4190507|P1|NOT COMPLETED|Overall Study||6
1713198|NCT00368641|4190506|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
1713199|NCT00368641|4190507|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
1713200|NCT00368641|4190506|P2|STARTED|Overall Study||6
1713201|NCT00368641|4190507|P1|STARTED|Overall Study||6
1713202|NCT00368550|4190515|P2|NOT COMPLETED|Overall Study||23
1713203|NCT00368550|4190516|P1|NOT COMPLETED|Overall Study||28
1713204|NCT00368550|4190515|P2|COMPLETED|Overall Study||48
1713205|NCT00368550|4190516|P1|COMPLETED|Overall Study||35
1713206|NCT00368550|4190515|P2|STARTED|Overall Study||71
1713207|NCT00368550|4190516|P1|STARTED|Overall Study||63
1713208|NCT00368537|4190528|P2|NOT COMPLETED|Baseline Participants||24
1713209|NCT00368537|4190529|P1|NOT COMPLETED|Baseline Participants||24
1713210|NCT00368537|4190528|P2|COMPLETED|Baseline Participants||239
1713211|NCT00368537|4190529|P1|COMPLETED|Baseline Participants||244
1713212|NCT00368537|4190528|P2|STARTED|Baseline Participants||263
1713213|NCT00368537|4190529|P1|STARTED|Baseline Participants||268
1713214|NCT00368537|4190528|P2|NOT COMPLETED|Randomization||6
1713215|NCT00368537|4190529|P1|NOT COMPLETED|Randomization||13
1713216|NCT00368537|4190528|P2|COMPLETED|Randomization||263
1713217|NCT00368537|4190529|P1|COMPLETED|Randomization||268
1713218|NCT00368537|4190528|P2|STARTED|Randomization||269
1713219|NCT00368537|4190529|P1|STARTED|Randomization||281
1713220|NCT00368472|4190543|P1|NOT COMPLETED|Overall Study||105
1713221|NCT00368472|4190543|P1|COMPLETED|Overall Study||33
1713222|NCT00368472|4190543|P1|STARTED|Overall Study||138
1713223|NCT00368459|4190551|P2|NOT COMPLETED|Overall Study||1
1713224|NCT00368459|4190552|P1|NOT COMPLETED|Overall Study||2
1713225|NCT00368459|4190551|P2|COMPLETED|Overall Study||20
1713226|NCT00368459|4190552|P1|COMPLETED|Overall Study||19
1713227|NCT00368459|4190551|P2|STARTED|Overall Study||21
1713228|NCT00368459|4190552|P1|STARTED|Overall Study||21
1713229|NCT00368316|4190578|P2|NOT COMPLETED|Overall Study||46
1713230|NCT00368316|4190579|P1|NOT COMPLETED|Overall Study||42
1713231|NCT00368316|4190578|P2|COMPLETED|Overall Study||1319
1713232|NCT00368316|4190579|P1|COMPLETED|Overall Study||1392
1713233|NCT00368316|4190578|P2|STARTED|Overall Study||1365
1713234|NCT00368316|4190579|P1|STARTED|Overall Study||1434
1713235|NCT00368290|4190591|P2|NOT COMPLETED|Overall Study||10
1713236|NCT00368290|4190592|P1|NOT COMPLETED|Overall Study||13
1713237|NCT00368290|4190591|P2|COMPLETED|Overall Study||37
1713238|NCT00368290|4190592|P1|COMPLETED|Overall Study||34
1713239|NCT00368290|4190591|P2|STARTED|Overall Study||47
1713240|NCT00368290|4190592|P1|STARTED|Overall Study||47
1713241|NCT00368277|4190602|P2|NOT COMPLETED|Overall Study||108
1713242|NCT00368277|4190603|P1|NOT COMPLETED|Overall Study||113
1713243|NCT00368277|4190602|P2|COMPLETED|Overall Study||336
1713244|NCT00368277|4190603|P1|COMPLETED|Overall Study||344
1713245|NCT00368277|4190602|P2|STARTED|Overall Study||444
1713246|NCT00368277|4190603|P1|STARTED|Overall Study||457
1713247|NCT00368251|4190618|P3|NOT COMPLETED|Overall Study||1
1713248|NCT00368251|4190619|P2|NOT COMPLETED|Overall Study||0
1713249|NCT00368251|4190620|P1|NOT COMPLETED|Overall Study||1
1713250|NCT00368251|4190618|P3|COMPLETED|Overall Study||17
1713251|NCT00368251|4190619|P2|COMPLETED|Overall Study||20
1713252|NCT00368251|4190620|P1|COMPLETED|Overall Study||17
1713253|NCT00368251|4190618|P3|STARTED|Overall Study||18
1713254|NCT00368251|4190619|P2|STARTED|Overall Study||20
1713255|NCT00368251|4190620|P1|STARTED|Overall Study||18
1713256|NCT00368108|4190643|P3|NOT COMPLETED|Overall Study||68
1713257|NCT00368108|4190644|P2|NOT COMPLETED|Overall Study||53
1713258|NCT00368108|4190645|P1|NOT COMPLETED|Overall Study||64
1713259|NCT00368108|4190643|P3|COMPLETED|Overall Study||182
1713260|NCT00368108|4190644|P2|COMPLETED|Overall Study||198
1713261|NCT00368108|4190645|P1|COMPLETED|Overall Study||187
1713262|NCT00368108|4190643|P3|STARTED|Overall Study||250
1713263|NCT00368108|4190644|P2|STARTED|Overall Study||251
1713264|NCT00368108|4190645|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
1713265|NCT00368069|4190664|P2|NOT COMPLETED|Overall Study||7
1713266|NCT00368069|4190665|P1|NOT COMPLETED|Overall Study||8
1713267|NCT00368069|4190664|P2|COMPLETED|Overall Study||72
1713268|NCT00368069|4190665|P1|COMPLETED|Overall Study||71
1713269|NCT00368069|4190664|P2|STARTED|Overall Study||79
1713270|NCT00368069|4190665|P1|STARTED|Overall Study||79
1713271|NCT00367991|4190683|P2|NOT COMPLETED|Overall Study||2
1713272|NCT00367991|4190684|P1|NOT COMPLETED|Overall Study||2
1713273|NCT00367991|4190683|P2|COMPLETED|Overall Study||13
1713274|NCT00367991|4190684|P1|COMPLETED|Overall Study||27
1713275|NCT00367991|4190683|P2|STARTED|Overall Study||15
1713276|NCT00367991|4190684|P1|STARTED|Overall Study||29
1713277|NCT00367835|4190702|P2|NOT COMPLETED|Overall Study||31
1713278|NCT00367835|4190703|P1|NOT COMPLETED|Overall Study||29
1713279|NCT00367835|4190702|P2|COMPLETED|Overall Study||48
1713280|NCT00367835|4190703|P1|COMPLETED|Overall Study||109
1713281|NCT00367835|4190702|P2|STARTED|Overall Study||79
1713282|NCT00367835|4190703|P1|STARTED|Overall Study||138
1713283|NCT00367770|4190729|P1|NOT COMPLETED|Overall Study||2
1713284|NCT00367770|4190729|P1|COMPLETED|Overall Study||35
1713285|NCT00367770|4190729|P1|STARTED|Overall Study||37
1713286|NCT00367744|4190737|P2|NOT COMPLETED|Overall Study||5
1713287|NCT00367744|4190738|P1|NOT COMPLETED|Overall Study||4
1713288|NCT00367744|4190737|P2|COMPLETED|Overall Study||32
1713289|NCT00367744|4190738|P1|COMPLETED|Overall Study||30
1713290|NCT00367744|4190737|P2|STARTED|Overall Study||37
1713291|NCT00367744|4190738|P1|STARTED|Overall Study||34
1713292|NCT00367679|4190746|P1|NOT COMPLETED|Overall Study||0
1713293|NCT00367679|4190746|P1|COMPLETED|Overall Study||35
1713294|NCT00367679|4190746|P1|STARTED|Overall Study||35
1713295|NCT00367640|4190767|P4|NOT COMPLETED|Overall Study||10
1713296|NCT00367640|4190768|P3|NOT COMPLETED|Overall Study||19
1713297|NCT00367640|4190769|P2|NOT COMPLETED|Overall Study||22
1713298|NCT00367640|4190770|P1|NOT COMPLETED|Overall Study||18
1713299|NCT00367640|4190767|P4|COMPLETED|Overall Study||146
1713300|NCT00367640|4190768|P3|COMPLETED|Overall Study||141
1713301|NCT00367640|4190769|P2|COMPLETED|Overall Study||133
1713302|NCT00367640|4190770|P1|COMPLETED|Overall Study||139
1713303|NCT00367640|4190767|P4|STARTED|Overall Study||156
1713304|NCT00367640|4190768|P3|STARTED|Overall Study||160
1713305|NCT00367640|4190769|P2|STARTED|Overall Study||155
1713306|NCT00367640|4190770|P1|STARTED|Overall Study||157
1713307|NCT00367601|4190780|P1|NOT COMPLETED|Overall Study||0
1713308|NCT00367601|4190780|P1|COMPLETED|Overall Study||25
1713309|NCT00367601|4190780|P1|STARTED|Overall Study||25
1713310|NCT00367484|4190786|P1|NOT COMPLETED|Overall Study||17
1713311|NCT00367484|4190786|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
1713312|NCT00367484|4190786|P1|STARTED|Overall Study||460
1713313|NCT00367432|4190790|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
1713314|NCT00367432|4190791|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
1713315|NCT00367432|4190790|P2|COMPLETED|Second Period (up to 54 Months)||69
1713316|NCT00367432|4190791|P1|COMPLETED|Second Period (up to 54 Months)||188
1713317|NCT00367432|4190790|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
1713318|NCT00367432|4190791|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
1713319|NCT00367432|4190790|P2|NOT COMPLETED|First Period (16 Weeks)||0
1713320|NCT00367432|4190791|P1|NOT COMPLETED|First Period (16 Weeks)||38
1713321|NCT00367432|4190790|P2|COMPLETED|First Period (16 Weeks)||0
1713322|NCT00367432|4190791|P1|COMPLETED|First Period (16 Weeks)||275
1713323|NCT00367432|4190790|P2|STARTED|First Period (16 Weeks)||0
1713324|NCT00367432|4190791|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
1713325|NCT00367380|4190806|P3|NOT COMPLETED|Overall Study||0
1713326|NCT00367380|4190807|P2|NOT COMPLETED|Overall Study||0
1713327|NCT00367380|4190808|P1|NOT COMPLETED|Overall Study||0
1713328|NCT00367380|4190806|P3|COMPLETED|Overall Study||6
1713329|NCT00367380|4190807|P2|COMPLETED|Overall Study||6
1713330|NCT00367380|4190808|P1|COMPLETED|Overall Study||6
1713331|NCT00367380|4190806|P3|STARTED|Overall Study||6
1713332|NCT00367380|4190807|P2|STARTED|Overall Study||6
1713333|NCT00367380|4190808|P1|STARTED|Overall Study||6
1713334|NCT00367341|4190818|P2|NOT COMPLETED|Overall Study||0
1713335|NCT00367341|4190819|P1|NOT COMPLETED|Overall Study||2
1713336|NCT00367341|4190818|P2|COMPLETED|Overall Study||40
1713337|NCT00367341|4190819|P1|COMPLETED|Overall Study||40
1713338|NCT00367341|4190818|P2|STARTED|Overall Study||40
1713339|NCT00367341|4190819|P1|STARTED|Overall Study||42
1713340|NCT00367237|4190829|P2|NOT COMPLETED|Overall Study||11
1713341|NCT00367237|4190830|P1|NOT COMPLETED|Overall Study||10
1713342|NCT00367237|4190829|P2|COMPLETED|Overall Study||47
1713343|NCT00367237|4190830|P1|COMPLETED|Overall Study||47
1713344|NCT00367237|4190829|P2|STARTED|Overall Study|Number of subjects randomized|58
1713345|NCT00367237|4190830|P1|STARTED|Overall Study|Number of subjects randomized|57
1713346|NCT00367133|4190839|P3|NOT COMPLETED|3 Years||18
1713347|NCT00367133|4190840|P2|NOT COMPLETED|3 Years||23
1713348|NCT00367133|4190841|P1|NOT COMPLETED|3 Years||28
1713349|NCT00367133|4190839|P3|COMPLETED|3 Years||98
1713350|NCT00367133|4190840|P2|COMPLETED|3 Years||93
1713351|NCT00367133|4190841|P1|COMPLETED|3 Years||115
1713352|NCT00367133|4190839|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
1713353|NCT00367133|4190840|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
1713354|NCT00367133|4190841|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
1713355|NCT00367133|4190839|P3|NOT COMPLETED|2 Years||49
1713356|NCT00367133|4190840|P2|NOT COMPLETED|2 Years||36
1713357|NCT00367133|4190841|P1|NOT COMPLETED|2 Years||58
1713358|NCT00367133|4190839|P3|COMPLETED|2 Years||205
1713359|NCT00367133|4190840|P2|COMPLETED|2 Years||220
1713360|NCT00367133|4190841|P1|COMPLETED|2 Years||272
1713361|NCT00367133|4190839|P3|STARTED|2 Years|Number of Eyes|254
1713362|NCT00367133|4190840|P2|STARTED|2 Years|Number of Eyes|256
1713363|NCT00367133|4190841|P1|STARTED|2 Years|Number of Eyes|330
1713364|NCT00367055|4190893|P2|NOT COMPLETED|Overall Study||11
1713365|NCT00367055|4190894|P1|NOT COMPLETED|Overall Study||11
1713366|NCT00367055|4190893|P2|COMPLETED|Overall Study||30
1713367|NCT00367055|4190894|P1|COMPLETED|Overall Study||32
1713368|NCT00367055|4190893|P2|STARTED|Overall Study||41
1713369|NCT00367055|4190894|P1|STARTED|Overall Study||43
1713370|NCT00366899|4190910|P2|NOT COMPLETED|Toddler Dose||1
1713371|NCT00366899|4190911|P1|NOT COMPLETED|Toddler Dose||2
1713372|NCT00366899|4190910|P2|COMPLETED|Toddler Dose||281
1713373|NCT00366899|4190911|P1|COMPLETED|Toddler Dose||285
1713374|NCT00366899|4190910|P2|STARTED|Toddler Dose||282
1713375|NCT00366899|4190911|P1|STARTED|Toddler Dose||287
1713376|NCT00366899|4190910|P2|NOT COMPLETED|After Infant Series||9
1713377|NCT00366899|4190911|P1|NOT COMPLETED|After Infant Series||7
1713378|NCT00366899|4190910|P2|COMPLETED|After Infant Series||282
1713379|NCT00366899|4190911|P1|COMPLETED|After Infant Series||287
1713380|NCT00366899|4190910|P2|STARTED|After Infant Series||291
1713381|NCT00366899|4190911|P1|STARTED|After Infant Series||294
1713382|NCT00366899|4190910|P2|NOT COMPLETED|Infant Series||12
1713383|NCT00366899|4190911|P1|NOT COMPLETED|Infant Series||9
1713384|NCT00366899|4190910|P2|COMPLETED|Infant Series||291
1713385|NCT00366899|4190911|P1|COMPLETED|Infant Series||294
1713386|NCT00366899|4190910|P2|Vaccinated Dose 2|Infant Series||293
1713387|NCT00366899|4190911|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
1713388|NCT00366899|4190910|P2|Vaccinated Dose 1|Infant Series||302
1713389|NCT00366899|4190911|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
1713390|NCT00366899|4190910|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
1713391|NCT00366899|4190911|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
1713392|NCT00366678|4190971|P3|NOT COMPLETED|Toddler Dose||0
1713393|NCT00366678|4190972|P2|NOT COMPLETED|Toddler Dose||1
1713394|NCT00366678|4190973|P1|NOT COMPLETED|Toddler Dose||5
1713395|NCT00366678|4190971|P3|COMPLETED|Toddler Dose||137
1713396|NCT00366678|4190972|P2|COMPLETED|Toddler Dose||151
1713397|NCT00366678|4190973|P1|COMPLETED|Toddler Dose||268
1713398|NCT00366678|4190971|P3|STARTED|Toddler Dose||137
1713399|NCT00366678|4190972|P2|STARTED|Toddler Dose||152
1713400|NCT00366678|4190973|P1|STARTED|Toddler Dose||273
1713401|NCT00366678|4190971|P3|NOT COMPLETED|After Infant||0
1713402|NCT00366678|4190972|P2|NOT COMPLETED|After Infant||10
1713403|NCT00366678|4190973|P1|NOT COMPLETED|After Infant||17
1713404|NCT00366678|4190971|P3|COMPLETED|After Infant||0
1713405|NCT00366678|4190972|P2|COMPLETED|After Infant||289
1713406|NCT00366678|4190973|P1|COMPLETED|After Infant||273
1713407|NCT00366678|4190971|P3|STARTED|After Infant||0
1713408|NCT00366678|4190972|P2|STARTED|After Infant||299
1713409|NCT00366678|4190973|P1|STARTED|After Infant||290
1713410|NCT00366678|4190971|P3|NOT COMPLETED|Infant Series||0
1713411|NCT00366678|4190972|P2|NOT COMPLETED|Infant Series||10
1713412|NCT00366678|4190973|P1|NOT COMPLETED|Infant Series||14
1713413|NCT00366678|4190971|P3|COMPLETED|Infant Series||0
1713414|NCT00366678|4190972|P2|COMPLETED|Infant Series||299
1713415|NCT00366678|4190973|P1|COMPLETED|Infant Series||290
1713416|NCT00366678|4190971|P3|Vaccinated Dose 3|Infant Series||0
1713417|NCT00366678|4190972|P2|Vaccinated Dose 3|Infant Series||302
1713418|NCT00366678|4190973|P1|Vaccinated Dose 3|Infant Series||291
1713419|NCT00366678|4190971|P3|Vaccinated Dose 2|Infant Series||0
1713420|NCT00366678|4190972|P2|Vaccinated Dose 2|Infant Series||304
1713421|NCT00366678|4190973|P1|Vaccinated Dose 2|Infant Series||295
1713422|NCT00366678|4190971|P3|Vaccinated Dose 1|Infant Series||0
1713423|NCT00366678|4190972|P2|Vaccinated Dose 1|Infant Series||309
1713424|NCT00366678|4190973|P1|Vaccinated Dose 1|Infant Series||302
1713425|NCT00366678|4190971|P3|STARTED|Infant Series||0
1713426|NCT00366678|4190972|P2|STARTED|Infant Series||309
1713427|NCT00366678|4190973|P1|STARTED|Infant Series||304
1713428|NCT00366626|4191040|P2|NOT COMPLETED|Overall Study||0
1713429|NCT00366626|4191041|P1|NOT COMPLETED|Overall Study||0
1713430|NCT00366626|4191040|P2|COMPLETED|Overall Study||45
1713431|NCT00366626|4191041|P1|COMPLETED|Overall Study||38
1713432|NCT00366626|4191040|P2|STARTED|Overall Study||45
1713433|NCT00366626|4191041|P1|STARTED|Overall Study||38
1713434|NCT00366548|4191055|P2|NOT COMPLETED|Toddler Dose||0
1713435|NCT00366548|4191056|P1|NOT COMPLETED|Toddler Dose||0
1713436|NCT00366548|4191055|P2|COMPLETED|Toddler Dose||244
1713437|NCT00366548|4191056|P1|COMPLETED|Toddler Dose||240
1713438|NCT00366548|4191055|P2|STARTED|Toddler Dose||244
1713439|NCT00366548|4191056|P1|STARTED|Toddler Dose||240
1713440|NCT00366548|4191055|P2|NOT COMPLETED|After Infant Series||1
1713441|NCT00366548|4191056|P1|NOT COMPLETED|After Infant Series||6
1713442|NCT00366548|4191055|P2|COMPLETED|After Infant Series||244
1713443|NCT00366548|4191056|P1|COMPLETED|After Infant Series||240
1713444|NCT00366548|4191055|P2|STARTED|After Infant Series||245
1713445|NCT00366548|4191056|P1|STARTED|After Infant Series||246
1713446|NCT00366548|4191055|P2|NOT COMPLETED|Infant Series||5
1713447|NCT00366548|4191056|P1|NOT COMPLETED|Infant Series||4
1713448|NCT00366548|4191055|P2|COMPLETED|Infant Series||245
1713449|NCT00366548|4191056|P1|COMPLETED|Infant Series||246
1713450|NCT00366548|4191055|P2|Vaccinated Dose 3|Infant Series||247
1713451|NCT00366548|4191056|P1|Vaccinated Dose 3|Infant Series||246
1713452|NCT00366548|4191055|P2|Vaccinated Dose 2|Infant Series||249
1713453|NCT00366548|4191056|P1|Vaccinated Dose 2|Infant Series||246
1713454|NCT00366548|4191055|P2|Vaccinated Dose 1|Infant Series||250
1713455|NCT00366548|4191056|P1|Vaccinated Dose 1|Infant Series||250
1713456|NCT00366548|4191055|P2|STARTED|Infant Series||250
1713457|NCT00366548|4191056|P1|STARTED|Infant Series||250
1713458|NCT00366535|4191092|P2|NOT COMPLETED|Second Phase: 12 Weeks||3
1713459|NCT00366535|4191093|P1|NOT COMPLETED|Second Phase: 12 Weeks||3
1713460|NCT00366535|4191092|P2|COMPLETED|Second Phase: 12 Weeks||18
1713461|NCT00366535|4191093|P1|COMPLETED|Second Phase: 12 Weeks||21
1713462|NCT00366535|4191092|P2|STARTED|Second Phase: 12 Weeks||21
1713463|NCT00366535|4191093|P1|STARTED|Second Phase: 12 Weeks||24
1713464|NCT00366535|4191092|P2|NOT COMPLETED|Washout Period (at Least a Week)||0
1713465|NCT00366535|4191093|P1|NOT COMPLETED|Washout Period (at Least a Week)||0
1713466|NCT00366535|4191092|P2|COMPLETED|Washout Period (at Least a Week)||21
1713467|NCT00366535|4191093|P1|COMPLETED|Washout Period (at Least a Week)||24
1713468|NCT00366535|4191092|P2|STARTED|Washout Period (at Least a Week)||21
1713469|NCT00366535|4191093|P1|STARTED|Washout Period (at Least a Week)||24
1713470|NCT00366535|4191092|P2|NOT COMPLETED|First Phase: 12 Weeks||8
1713471|NCT00366535|4191093|P1|NOT COMPLETED|First Phase: 12 Weeks||3
1713472|NCT00366535|4191092|P2|COMPLETED|First Phase: 12 Weeks||21
1713473|NCT00366535|4191093|P1|COMPLETED|First Phase: 12 Weeks||24
1713474|NCT00366535|4191092|P2|STARTED|First Phase: 12 Weeks||29
1713475|NCT00366535|4191093|P1|STARTED|First Phase: 12 Weeks||27
1713476|NCT00366457|4191107|P1|NOT COMPLETED|Overall Study||2
1713477|NCT00366457|4191107|P1|COMPLETED|Overall Study||30
1713478|NCT00366457|4191107|P1|STARTED|Overall Study||32
1713479|NCT00366444|4191116|P2|NOT COMPLETED|Overall Study||2
1713480|NCT00366444|4191117|P1|NOT COMPLETED|Overall Study||1
1713481|NCT00366444|4191116|P2|COMPLETED|Overall Study||97
1713482|NCT00366444|4191117|P1|COMPLETED|Overall Study||101
1713483|NCT00366444|4191116|P2|STARTED|Overall Study||99
1713484|NCT00366444|4191117|P1|STARTED|Overall Study||102
1713485|NCT00366340|4191145|P2|NOT COMPLETED|Toddler Dose||1
1713486|NCT00366340|4191146|P1|NOT COMPLETED|Toddler Dose||1
1713487|NCT00366340|4191145|P2|COMPLETED|Toddler Dose||286
1713488|NCT00366340|4191146|P1|COMPLETED|Toddler Dose||289
1713489|NCT00366340|4191145|P2|STARTED|Toddler Dose||287
1713490|NCT00366340|4191146|P1|STARTED|Toddler Dose||290
1713491|NCT00366340|4191145|P2|NOT COMPLETED|After the Infant Series||6
1713492|NCT00366340|4191146|P1|NOT COMPLETED|After the Infant Series||3
1713493|NCT00366340|4191145|P2|COMPLETED|After the Infant Series||287
1713494|NCT00366340|4191146|P1|COMPLETED|After the Infant Series||290
1713495|NCT00366340|4191145|P2|STARTED|After the Infant Series||293
1713496|NCT00366340|4191146|P1|STARTED|After the Infant Series||293
1713497|NCT00366340|4191145|P2|NOT COMPLETED|Infant Series||10
1713498|NCT00366340|4191146|P1|NOT COMPLETED|Infant Series||8
1713499|NCT00366340|4191145|P2|COMPLETED|Infant Series||293
1713500|NCT00366340|4191146|P1|COMPLETED|Infant Series||293
1713501|NCT00366340|4191145|P2|Vaccinated Dose 3|Infant Series||293
1713502|NCT00366340|4191146|P1|Vaccinated Dose 3|Infant Series||294
1713503|NCT00366340|4191145|P2|Vaccinated Dose 2|Infant Series||297
1713504|NCT00366340|4191146|P1|Vaccinated Dose 2|Infant Series||296
1713505|NCT00366340|4191145|P2|Vaccinated Dose 1|Infant Series||303
1713506|NCT00366340|4191146|P1|Vaccinated Dose 1|Infant Series||300
1713507|NCT00366340|4191145|P2|STARTED|Infant Series||303
1713508|NCT00366340|4191146|P1|STARTED|Infant Series||301
1713509|NCT00366301|4191204|P4|NOT COMPLETED|Overall Study||8
1713510|NCT00366301|4191205|P3|NOT COMPLETED|Overall Study||4
1713511|NCT00366301|4191206|P2|NOT COMPLETED|Overall Study||6
1713512|NCT00366301|4191207|P1|NOT COMPLETED|Overall Study||8
1713513|NCT00366301|4191204|P4|COMPLETED|Overall Study||116
1713514|NCT00366301|4191205|P3|COMPLETED|Overall Study||122
1713515|NCT00366301|4191206|P2|COMPLETED|Overall Study||120
1713516|NCT00366301|4191207|P1|COMPLETED|Overall Study||116
1713517|NCT00366301|4191204|P4|Either 6W or 14W CRP Obtained|Overall Study||119
1713518|NCT00366301|4191205|P3|Either 6W or 14W CRP Obtained|Overall Study||124
1713519|NCT00366301|4191206|P2|Either 6W or 14W CRP Obtained|Overall Study||124
1713520|NCT00366301|4191207|P1|Either 6W or 14W CRP Obtained|Overall Study||120
1713521|NCT00366301|4191204|P4|STARTED|Overall Study||124
1713522|NCT00366301|4191205|P3|STARTED|Overall Study||126
1713523|NCT00366301|4191206|P2|STARTED|Overall Study||126
1713524|NCT00366301|4191207|P1|STARTED|Overall Study||124
1713525|NCT00366275|4191217|P1|NOT COMPLETED|Overall Study||6
1713526|NCT00366275|4191217|P1|COMPLETED|Overall Study||58
1713527|NCT00366275|4191217|P1|STARTED|Overall Study||64
1713528|NCT00366249|4191223|P2|NOT COMPLETED|Overall Study||78
1713529|NCT00366249|4191224|P1|NOT COMPLETED|Overall Study||131
1713530|NCT00366249|4191223|P2|COMPLETED|Overall Study||430
1713531|NCT00366249|4191224|P1|COMPLETED|Overall Study||422
1713532|NCT00366249|4191223|P2|STARTED|Overall Study||508
1713533|NCT00366249|4191224|P1|STARTED|Overall Study||553
1713534|NCT00366106|4191238|P1|NOT COMPLETED|Overall Study||0
1713535|NCT00366106|4191238|P1|COMPLETED|Overall Study||32
1713536|NCT00366106|4191238|P1|STARTED|Overall Study||32
1713537|NCT00366028|4191247|P2|NOT COMPLETED|Overall Study||0
1713538|NCT00366028|4191248|P1|NOT COMPLETED|Overall Study||0
1713539|NCT00366028|4191247|P2|COMPLETED|Overall Study||735
1713540|NCT00366028|4191248|P1|COMPLETED|Overall Study||889
1713541|NCT00366028|4191247|P2|STARTED|Overall Study||735
1713542|NCT00366028|4191248|P1|STARTED|Overall Study||889
1713543|NCT00365976|4191258|P2|NOT COMPLETED|Overall Study||5
1713544|NCT00365976|4191259|P1|NOT COMPLETED|Overall Study||1
1713545|NCT00365976|4191258|P2|COMPLETED|Overall Study||20
1713546|NCT00365976|4191259|P1|COMPLETED|Overall Study||32
1713547|NCT00365976|4191258|P2|STARTED|Overall Study||25
1713548|NCT00365976|4191259|P1|STARTED|Overall Study||33
1713549|NCT00365872|4191290|P3|NOT COMPLETED|Overall Study||0
1713550|NCT00365872|4191291|P2|NOT COMPLETED|Overall Study||0
1713551|NCT00365872|4191292|P1|NOT COMPLETED|Overall Study||0
1713552|NCT00365872|4191290|P3|COMPLETED|Overall Study||6
1713553|NCT00365872|4191291|P2|COMPLETED|Overall Study||6
1713554|NCT00365872|4191292|P1|COMPLETED|Overall Study||5
1713555|NCT00365872|4191290|P3|STARTED|Overall Study||6
1713556|NCT00365872|4191291|P2|STARTED|Overall Study||6
1713557|NCT00365872|4191292|P1|STARTED|Overall Study||5
1713558|NCT00365859|4191305|P4|NOT COMPLETED|Overall Study||131
1713559|NCT00365859|4191306|P3|NOT COMPLETED|Overall Study||67
1713560|NCT00365859|4191307|P2|NOT COMPLETED|Overall Study||33
1713561|NCT00365859|4191308|P1|NOT COMPLETED|Overall Study||31
1713562|NCT00365859|4191305|P4|COMPLETED|Overall Study||199
1713563|NCT00365859|4191306|P3|COMPLETED|Overall Study||107
1713564|NCT00365859|4191307|P2|COMPLETED|Overall Study||37
1713565|NCT00365859|4191308|P1|COMPLETED|Overall Study||55
1713566|NCT00365859|4191305|P4|Efficacy Population|Overall Study||322
1713567|NCT00365859|4191306|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
1713568|NCT00365859|4191307|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
1713569|NCT00365859|4191308|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
1713570|NCT00365859|4191305|P4|Safety Population|Overall Study||330
1713571|NCT00365859|4191306|P3|Safety Population|Overall Study||174
1713572|NCT00365859|4191307|P2|Safety Population|Overall Study||70
1713573|NCT00365859|4191308|P1|Safety Population|Overall Study||86
1713574|NCT00365859|4191305|P4|STARTED|Overall Study||330
1713575|NCT00365859|4191306|P3|STARTED|Overall Study||174
1713576|NCT00365859|4191307|P2|STARTED|Overall Study||70
1713577|NCT00365859|4191308|P1|STARTED|Overall Study||86
1713578|NCT00365846|4191397|P1|NOT COMPLETED|Overall Study||1
1713579|NCT00365846|4191397|P1|COMPLETED|Overall Study||28
1713580|NCT00365846|4191397|P1|STARTED|Overall Study||29
1713581|NCT00365768|4191408|P2|NOT COMPLETED|Overall Study||0
1713582|NCT00365768|4191409|P1|NOT COMPLETED|Overall Study||0
1713583|NCT00365768|4191408|P2|COMPLETED|Overall Study||25
1713584|NCT00365768|4191409|P1|COMPLETED|Overall Study||24
1713585|NCT00365768|4191408|P2|STARTED|Overall Study||25
1713586|NCT00365768|4191409|P1|STARTED|Overall Study||24
1713587|NCT00365716|4191422|P7|NOT COMPLETED|Extension 2||10
1713588|NCT00365716|4191423|P6|NOT COMPLETED|Extension 2||0
1713589|NCT00365716|4191424|P5|NOT COMPLETED|Extension 2||0
1713590|NCT00365716|4191425|P4|NOT COMPLETED|Extension 2||0
1713591|NCT00365716|4191426|P3|NOT COMPLETED|Extension 2||0
1713592|NCT00365716|4191427|P2|NOT COMPLETED|Extension 2||0
1713593|NCT00365716|4191428|P1|NOT COMPLETED|Extension 2||0
1713594|NCT00365716|4191422|P7|COMPLETED|Extension 2||7
1713595|NCT00365716|4191423|P6|COMPLETED|Extension 2||0
1713596|NCT00365716|4191424|P5|COMPLETED|Extension 2||0
1713597|NCT00365716|4191425|P4|COMPLETED|Extension 2||0
1713598|NCT00365716|4191426|P3|COMPLETED|Extension 2||0
1713599|NCT00365716|4191427|P2|COMPLETED|Extension 2||0
1713600|NCT00365716|4191428|P1|COMPLETED|Extension 2||0
1713601|NCT00365716|4191422|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
1713602|NCT00365716|4191423|P6|STARTED|Extension 2||0
1713603|NCT00365716|4191424|P5|STARTED|Extension 2||0
1713604|NCT00365716|4191425|P4|STARTED|Extension 2||0
1713605|NCT00365716|4191426|P3|STARTED|Extension 2||0
1713606|NCT00365716|4191427|P2|STARTED|Extension 2||0
1713607|NCT00365716|4191428|P1|STARTED|Extension 2||0
1713608|NCT00365716|4191422|P7|NOT COMPLETED|Extension 1||0
1713609|NCT00365716|4191423|P6|NOT COMPLETED|Extension 1||22
1713610|NCT00365716|4191424|P5|NOT COMPLETED|Extension 1||0
1713611|NCT00365716|4191425|P4|NOT COMPLETED|Extension 1||0
1713612|NCT00365716|4191426|P3|NOT COMPLETED|Extension 1||0
1713613|NCT00365716|4191427|P2|NOT COMPLETED|Extension 1||0
1713614|NCT00365716|4191428|P1|NOT COMPLETED|Extension 1||0
1713615|NCT00365716|4191422|P7|COMPLETED|Extension 1||0
1713616|NCT00365716|4191423|P6|COMPLETED|Extension 1||219
1713617|NCT00365716|4191424|P5|COMPLETED|Extension 1||0
1713618|NCT00365716|4191425|P4|COMPLETED|Extension 1||0
1713619|NCT00365716|4191426|P3|COMPLETED|Extension 1||0
1713620|NCT00365716|4191427|P2|COMPLETED|Extension 1||0
1713621|NCT00365716|4191428|P1|COMPLETED|Extension 1||0
1713622|NCT00365716|4191422|P7|STARTED|Extension 1||0
1713623|NCT00365716|4191423|P6|STARTED|Extension 1||241
1713624|NCT00365716|4191424|P5|STARTED|Extension 1||0
1713625|NCT00365716|4191425|P4|STARTED|Extension 1||0
1713626|NCT00365716|4191426|P3|STARTED|Extension 1||0
1713627|NCT00365716|4191427|P2|STARTED|Extension 1||0
1713628|NCT00365716|4191428|P1|STARTED|Extension 1||0
1713629|NCT00365716|4191422|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
1713630|NCT00365716|4191423|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
1713631|NCT00365716|4191424|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
1713632|NCT00365716|4191425|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
1713633|NCT00365716|4191426|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
1713634|NCT00365716|4191427|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
1713635|NCT00365716|4191428|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
1713636|NCT00365716|4191422|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
1713637|NCT00365716|4191423|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
1713638|NCT00365716|4191424|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
1713639|NCT00365716|4191425|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
1713640|NCT00365716|4191426|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
1713641|NCT00365716|4191427|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
1713642|NCT00365716|4191428|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
1713643|NCT00365716|4191422|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
1713644|NCT00365716|4191423|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
1713645|NCT00365716|4191424|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
1713646|NCT00365716|4191425|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
1713647|NCT00365716|4191426|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
1713648|NCT00365716|4191427|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
1713649|NCT00365716|4191428|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
1713650|NCT00365716|4191422|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
1713651|NCT00365716|4191423|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
1713652|NCT00365716|4191424|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
1713653|NCT00365716|4191425|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
1713654|NCT00365716|4191426|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
1713655|NCT00365716|4191427|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
1713656|NCT00365716|4191428|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
1713657|NCT00365716|4191422|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
1713658|NCT00365716|4191423|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
1713659|NCT00365716|4191424|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
1713660|NCT00365716|4191425|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
1713661|NCT00365716|4191426|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
1713662|NCT00365716|4191427|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
1713663|NCT00365716|4191428|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
1713664|NCT00365716|4191422|P7|STARTED|Base Study (Day 1 to Month 7)||0
1713665|NCT00365716|4191423|P6|STARTED|Base Study (Day 1 to Month 7)||0
1713666|NCT00365716|4191424|P5|STARTED|Base Study (Day 1 to Month 7)||146
1713667|NCT00365716|4191425|P4|STARTED|Base Study (Day 1 to Month 7)||146
1713668|NCT00365716|4191426|P3|STARTED|Base Study (Day 1 to Month 7)||292
1713669|NCT00365716|4191427|P2|STARTED|Base Study (Day 1 to Month 7)||284
1713670|NCT00365716|4191428|P1|STARTED|Base Study (Day 1 to Month 7)||290
1713671|NCT00365599|4191443|P1|NOT COMPLETED|Overall Study||0
1713672|NCT00365599|4191443|P1|COMPLETED|Overall Study||43
1713673|NCT00365599|4191443|P1|STARTED|Overall Study||43
1713674|NCT00365547|4191449|P1|NOT COMPLETED|Overall Study||3
1713675|NCT00365547|4191449|P1|COMPLETED|Overall Study||43
1713676|NCT00365547|4191449|P1|STARTED|Overall Study||46
1713677|NCT00365508|4191459|P2|NOT COMPLETED|Overall Study||154
1713678|NCT00365508|4191460|P1|NOT COMPLETED|Overall Study||139
1713679|NCT00365508|4191459|P2|COMPLETED|Overall Study||167
1713680|NCT00365508|4191460|P1|COMPLETED|Overall Study||182
1713681|NCT00365508|4191459|P2|STARTED|Overall Study||321
1713682|NCT00365508|4191460|P1|STARTED|Overall Study||321
1713683|NCT00365456|4191468|P2|NOT COMPLETED|Trial Period III (12 Months)||5
1713684|NCT00365456|4191469|P1|NOT COMPLETED|Trial Period III (12 Months)||18
1713685|NCT00365456|4191468|P2|COMPLETED|Trial Period III (12 Months)||127
1713686|NCT00365456|4191469|P1|COMPLETED|Trial Period III (12 Months)||118
1713687|NCT00365456|4191468|P2|STARTED|Trial Period III (12 Months)||132
1713688|NCT00365456|4191469|P1|STARTED|Trial Period III (12 Months)||136
1713689|NCT00365456|4191468|P2|NOT COMPLETED|Trial Period II (12 Months)||14
1713690|NCT00365456|4191469|P1|NOT COMPLETED|Trial Period II (12 Months)||0
1713691|NCT00365456|4191468|P2|COMPLETED|Trial Period II (12 Months)||268
1713692|NCT00365456|4191469|P1|COMPLETED|Trial Period II (12 Months)||0
1713693|NCT00365456|4191468|P2|STARTED|Trial Period II (12 Months)||282
1713694|NCT00365456|4191469|P1|STARTED|Trial Period II (12 Months)||0
1713695|NCT00365456|4191468|P2|NOT COMPLETED|Trial Period I (12 Months)||0
1713696|NCT00365456|4191469|P1|NOT COMPLETED|Trial Period I (12 Months)||125
1713697|NCT00365456|4191468|P2|COMPLETED|Trial Period I (12 Months)||0
1713698|NCT00365456|4191469|P1|COMPLETED|Trial Period I (12 Months)||282
1713699|NCT00365456|4191468|P2|STARTED|Trial Period I (12 Months)||0
1713700|NCT00365456|4191469|P1|STARTED|Trial Period I (12 Months)||407
1713701|NCT00365417|4191475|P1|NOT COMPLETED|Overall Study||0
1713702|NCT00365417|4191475|P1|COMPLETED|Overall Study||45
1713703|NCT00365417|4191475|P1|STARTED|Overall Study||45
1713704|NCT00365391|4191481|P1|NOT COMPLETED|Overall Study||0
1713705|NCT00365391|4191481|P1|COMPLETED|Overall Study||27
1713706|NCT00365391|4191481|P1|STARTED|Overall Study||27
1713707|NCT00365378|4191491|P3|NOT COMPLETED|Extension||197
1713708|NCT00365378|4191492|P2|NOT COMPLETED|Extension||0
1713709|NCT00365378|4191493|P1|NOT COMPLETED|Extension||0
1713710|NCT00365378|4191491|P3|COMPLETED|Extension||203
1713711|NCT00365378|4191492|P2|COMPLETED|Extension||0
1713712|NCT00365378|4191493|P1|COMPLETED|Extension||0
1713713|NCT00365378|4191491|P3|STARTED|Extension||400
1713714|NCT00365378|4191492|P2|STARTED|Extension||0
1713715|NCT00365378|4191493|P1|STARTED|Extension||0
1713716|NCT00365378|4191491|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
1713717|NCT00365378|4191492|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
1713718|NCT00365378|4191493|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
1713719|NCT00365378|4191491|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
1713720|NCT00365378|4191492|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
1713721|NCT00365378|4191493|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
1713722|NCT00365378|4191491|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
1713723|NCT00365378|4191492|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
1713724|NCT00365378|4191493|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
1713725|NCT00365378|4191491|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
1713726|NCT00365378|4191492|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
1713727|NCT00365378|4191493|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
1713728|NCT00365378|4191491|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
1713729|NCT00365378|4191492|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
1713730|NCT00365378|4191493|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
1713731|NCT00365378|4191491|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
1713732|NCT00365378|4191492|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
1713733|NCT00365378|4191493|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
1713734|NCT00365378|4191491|P3|STARTED|Vaccination (Day 1 to Month 7)||0
1713735|NCT00365378|4191492|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
1713736|NCT00365378|4191493|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
1713737|NCT00365365|4191507|P3|NOT COMPLETED|Overall Study||15
1713738|NCT00365365|4191508|P2|NOT COMPLETED|Overall Study||36
1713739|NCT00365365|4191509|P1|NOT COMPLETED|Overall Study||34
1713740|NCT00365365|4191507|P3|COMPLETED|Overall Study||44
1713741|NCT00365365|4191508|P2|COMPLETED|Overall Study||41
1713742|NCT00365365|4191509|P1|COMPLETED|Overall Study||44
1713743|NCT00365365|4191507|P3|COMPLETED TREATMENT|Overall Study||45
1713744|NCT00365365|4191508|P2|COMPLETED TREATMENT|Overall Study||36
1713745|NCT00365365|4191509|P1|COMPLETED TREATMENT|Overall Study||38
1713746|NCT00365365|4191507|P3|TREATED (SAFETY POPULATION)|Overall Study||59
1713747|NCT00365365|4191508|P2|TREATED (SAFETY POPULATION)|Overall Study||75
1713748|NCT00365365|4191509|P1|TREATED (SAFETY POPULATION)|Overall Study||78
1713749|NCT00365365|4191507|P3|STARTED|Overall Study||59
1713750|NCT00365365|4191508|P2|STARTED|Overall Study||77
1713751|NCT00365365|4191509|P1|STARTED|Overall Study||78
1713752|NCT00365352|4191526|P3|NOT COMPLETED|Overall Study||15
1713753|NCT00365352|4191527|P2|NOT COMPLETED|Overall Study||11
1713754|NCT00365352|4191528|P1|NOT COMPLETED|Overall Study||20
1713755|NCT00365352|4191526|P3|COMPLETED|Overall Study||98
1713756|NCT00365352|4191527|P2|COMPLETED|Overall Study||104
1713757|NCT00365352|4191528|P1|COMPLETED|Overall Study||77
1713758|NCT00365352|4191526|P3|Modified Intent-to-Treat Population|Overall Study||111
1713759|NCT00365352|4191527|P2|Modified Intent-to-Treat Population|Overall Study||114
1713760|NCT00365352|4191528|P1|Modified Intent-to-Treat Population|Overall Study||96
1713761|NCT00365352|4191526|P3|Safety Population|Overall Study||111
1713762|NCT00365352|4191527|P2|Safety Population|Overall Study||115
1713763|NCT00365352|4191528|P1|Safety Population|Overall Study||96
1713764|NCT00365352|4191526|P3|STARTED|Overall Study||113
1713765|NCT00365352|4191527|P2|STARTED|Overall Study||115
1713766|NCT00365352|4191528|P1|STARTED|Overall Study||97
1713767|NCT00365300|4191612|P2|NOT COMPLETED|Double-blind Phase||9
1713768|NCT00365300|4191613|P1|NOT COMPLETED|Double-blind Phase||11
1713769|NCT00365300|4191612|P2|COMPLETED|Double-blind Phase||45
1713770|NCT00365300|4191613|P1|COMPLETED|Double-blind Phase||43
1713771|NCT00365300|4191612|P2|STARTED|Double-blind Phase||54
1713772|NCT00365300|4191613|P1|STARTED|Double-blind Phase||54
1713773|NCT00365300|4191612|P2|NOT COMPLETED|Open-label Phase||0
1713774|NCT00365300|4191613|P1|NOT COMPLETED|Open-label Phase||22
1713775|NCT00365300|4191612|P2|COMPLETED|Open-label Phase||0
1713776|NCT00365300|4191613|P1|COMPLETED|Open-label Phase||107
1713777|NCT00365300|4191612|P2|STARTED|Open-label Phase||0
1713778|NCT00365300|4191613|P1|STARTED|Open-label Phase||129
1713779|NCT00365274|4191622|P1|NOT COMPLETED|Overall Study||0
1713780|NCT00365274|4191622|P1|COMPLETED|Overall Study||6
1713781|NCT00365274|4191622|P1|STARTED|Overall Study||6
1713782|NCT00365261|4191628|P2|NOT COMPLETED|Overall Study||3
1713783|NCT00365261|4191629|P1|NOT COMPLETED|Overall Study||3
1713784|NCT00365261|4191628|P2|COMPLETED|Overall Study||19
1713785|NCT00365261|4191629|P1|COMPLETED|Overall Study||20
1713786|NCT00365261|4191628|P2|STARTED|Overall Study||22
1713787|NCT00365261|4191629|P1|STARTED|Overall Study||23
1713788|NCT00365209|4191639|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
1713789|NCT00365209|4191639|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
1713790|NCT00365209|4191639|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
1713791|NCT00365209|4191639|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
1713792|NCT00365209|4191639|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
1713793|NCT00365209|4191639|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
1713794|NCT00365144|4191668|P1|NOT COMPLETED|Overall Study||0
1713795|NCT00365144|4191668|P1|COMPLETED|Overall Study||36
1713796|NCT00365144|4191668|P1|STARTED|Overall Study||36
1713797|NCT00365105|4191678|P2|NOT COMPLETED|Overall Study||4
1713798|NCT00365105|4191679|P1|NOT COMPLETED|Overall Study||6
1713799|NCT00365105|4191678|P2|COMPLETED|Overall Study||128
1713800|NCT00365105|4191679|P1|COMPLETED|Overall Study||123
1713801|NCT00365105|4191678|P2|STARTED|Overall Study||132
1713802|NCT00365105|4191679|P1|STARTED|Overall Study||129
1713803|NCT00365053|4191685|P1|NOT COMPLETED|Overall Study||0
1713804|NCT00365053|4191685|P1|COMPLETED|Overall Study||13
1713805|NCT00365053|4191685|P1|STARTED|Overall Study||13
1713806|NCT00364949|4191696|P2|NOT COMPLETED|Overall Study||0
1713807|NCT00364949|4191697|P1|NOT COMPLETED|Overall Study||0
1713808|NCT00364949|4191696|P2|COMPLETED|Overall Study||39
1713809|NCT00364949|4191697|P1|COMPLETED|Overall Study||31
1713810|NCT00364949|4191696|P2|STARTED|Overall Study||39
1713811|NCT00364949|4191697|P1|STARTED|Overall Study||31
1713812|NCT00364923|4191715|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
1713813|NCT00364923|4191715|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
1713814|NCT00364923|4191715|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
1713815|NCT00364923|4191715|P1|NOT COMPLETED|Treatment With Pralatrexate||4
1713816|NCT00364923|4191715|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
1713817|NCT00364923|4191715|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
1713818|NCT00364858|4191724|P2|NOT COMPLETED|Overall Study||22
1713819|NCT00364858|4191725|P1|NOT COMPLETED|Overall Study||7
1713820|NCT00364858|4191724|P2|COMPLETED|Overall Study||40
1713821|NCT00364858|4191725|P1|COMPLETED|Overall Study||26
1713822|NCT00364858|4191724|P2|STARTED|Overall Study||62
1713823|NCT00364858|4191725|P1|STARTED|Overall Study||33
1713824|NCT00364845|4191740|P2|NOT COMPLETED|Overall Study||11
1713825|NCT00364845|4191741|P1|NOT COMPLETED|Overall Study||11
1713826|NCT00364845|4191740|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
1713827|NCT00364845|4191741|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
1713828|NCT00364845|4191740|P2|STARTED|Overall Study||23
1713829|NCT00364845|4191741|P1|STARTED|Overall Study||28
1713830|NCT00364832|4191762|P12|NOT COMPLETED|Extension Year 2||3
1713831|NCT00364832|4191763|P11|NOT COMPLETED|Extension Year 2||5
1713832|NCT00364832|4191764|P10|NOT COMPLETED|Extension Year 2||5
1713833|NCT00364832|4191765|P9|NOT COMPLETED|Extension Year 2||0
1713834|NCT00364832|4191766|P8|NOT COMPLETED|Extension Year 2||0
1713835|NCT00364832|4191767|P7|NOT COMPLETED|Extension Year 2||0
1713836|NCT00364832|4191768|P6|NOT COMPLETED|Extension Year 2||0
1713837|NCT00364832|4191769|P5|NOT COMPLETED|Extension Year 2||0
1713838|NCT00364832|4191770|P4|NOT COMPLETED|Extension Year 2||0
1713839|NCT00364832|4191771|P3|NOT COMPLETED|Extension Year 2||0
1713840|NCT00364832|4191772|P2|NOT COMPLETED|Extension Year 2||0
1713841|NCT00364832|4191773|P1|NOT COMPLETED|Extension Year 2||0
1713842|NCT00364832|4191762|P12|COMPLETED|Extension Year 2||11
1713843|NCT00364832|4191763|P11|COMPLETED|Extension Year 2||9
1713844|NCT00364832|4191764|P10|COMPLETED|Extension Year 2||9
1713845|NCT00364832|4191765|P9|COMPLETED|Extension Year 2||0
1713846|NCT00364832|4191766|P8|COMPLETED|Extension Year 2||0
1713847|NCT00364832|4191767|P7|COMPLETED|Extension Year 2||0
1713848|NCT00364832|4191768|P6|COMPLETED|Extension Year 2||0
1713849|NCT00364832|4191769|P5|COMPLETED|Extension Year 2||0
1713850|NCT00364832|4191770|P4|COMPLETED|Extension Year 2||0
1713851|NCT00364832|4191771|P3|COMPLETED|Extension Year 2||0
1713852|NCT00364832|4191772|P2|COMPLETED|Extension Year 2||0
1713853|NCT00364832|4191773|P1|COMPLETED|Extension Year 2||0
1713854|NCT00364832|4191762|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
1713855|NCT00364832|4191763|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
1713856|NCT00364832|4191764|P10|STARTED|Extension Year 2||14
1713857|NCT00364832|4191765|P9|STARTED|Extension Year 2||0
1713858|NCT00364832|4191766|P8|STARTED|Extension Year 2||0
1713859|NCT00364832|4191767|P7|STARTED|Extension Year 2||0
1713860|NCT00364832|4191768|P6|STARTED|Extension Year 2||0
1713861|NCT00364832|4191769|P5|STARTED|Extension Year 2||0
1713862|NCT00364832|4191770|P4|STARTED|Extension Year 2||0
1713863|NCT00364832|4191771|P3|STARTED|Extension Year 2||0
1713864|NCT00364832|4191772|P2|STARTED|Extension Year 2||0
1713865|NCT00364832|4191773|P1|STARTED|Extension Year 2||0
1713866|NCT00364832|4191762|P12|NOT COMPLETED|Extension Year 1||10
1713867|NCT00364832|4191763|P11|NOT COMPLETED|Extension Year 1||2
1713868|NCT00364832|4191764|P10|NOT COMPLETED|Extension Year 1||4
1713869|NCT00364832|4191765|P9|NOT COMPLETED|Extension Year 1||0
1713870|NCT00364832|4191766|P8|NOT COMPLETED|Extension Year 1||0
1713871|NCT00364832|4191767|P7|NOT COMPLETED|Extension Year 1||0
1713872|NCT00364832|4191768|P6|NOT COMPLETED|Extension Year 1||0
1713873|NCT00364832|4191769|P5|NOT COMPLETED|Extension Year 1||0
1713874|NCT00364832|4191770|P4|NOT COMPLETED|Extension Year 1||0
1713875|NCT00364832|4191771|P3|NOT COMPLETED|Extension Year 1||0
1713876|NCT00364832|4191772|P2|NOT COMPLETED|Extension Year 1||0
1713877|NCT00364832|4191773|P1|NOT COMPLETED|Extension Year 1||0
1713878|NCT00364832|4191762|P12|COMPLETED|Extension Year 1||17
1713879|NCT00364832|4191763|P11|COMPLETED|Extension Year 1||15
1713880|NCT00364832|4191764|P10|COMPLETED|Extension Year 1||14
1713881|NCT00364832|4191765|P9|COMPLETED|Extension Year 1||0
1713882|NCT00364832|4191766|P8|COMPLETED|Extension Year 1||0
1713883|NCT00364832|4191767|P7|COMPLETED|Extension Year 1||0
1713884|NCT00364832|4191768|P6|COMPLETED|Extension Year 1||0
1713885|NCT00364832|4191769|P5|COMPLETED|Extension Year 1||0
1713886|NCT00364832|4191770|P4|COMPLETED|Extension Year 1||0
1713887|NCT00364832|4191771|P3|COMPLETED|Extension Year 1||0
1713888|NCT00364832|4191772|P2|COMPLETED|Extension Year 1||0
1713889|NCT00364832|4191773|P1|COMPLETED|Extension Year 1||0
1713890|NCT00364832|4191762|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
1713891|NCT00364832|4191763|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
1713892|NCT00364832|4191764|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
1713893|NCT00364832|4191765|P9|STARTED|Extension Year 1||0
1713894|NCT00364832|4191766|P8|STARTED|Extension Year 1||0
1713895|NCT00364832|4191767|P7|STARTED|Extension Year 1||0
1713896|NCT00364832|4191768|P6|STARTED|Extension Year 1||0
1713897|NCT00364832|4191769|P5|STARTED|Extension Year 1||0
1713898|NCT00364832|4191770|P4|STARTED|Extension Year 1||0
1713899|NCT00364832|4191771|P3|STARTED|Extension Year 1||0
1713900|NCT00364832|4191772|P2|STARTED|Extension Year 1||0
1713901|NCT00364832|4191773|P1|STARTED|Extension Year 1||0
1713902|NCT00364832|4191762|P12|NOT COMPLETED|Core Period||0
1713903|NCT00364832|4191763|P11|NOT COMPLETED|Core Period||0
1713904|NCT00364832|4191764|P10|NOT COMPLETED|Core Period||0
1713905|NCT00364832|4191765|P9|NOT COMPLETED|Core Period||0
1713906|NCT00364832|4191766|P8|NOT COMPLETED|Core Period||1
1713907|NCT00364832|4191767|P7|NOT COMPLETED|Core Period||4
1713908|NCT00364832|4191768|P6|NOT COMPLETED|Core Period||0
1713909|NCT00364832|4191769|P5|NOT COMPLETED|Core Period||0
1713910|NCT00364832|4191770|P4|NOT COMPLETED|Core Period||1
1713911|NCT00364832|4191771|P3|NOT COMPLETED|Core Period||1
1713912|NCT00364832|4191772|P2|NOT COMPLETED|Core Period||2
1713913|NCT00364832|4191773|P1|NOT COMPLETED|Core Period||2
1713914|NCT00364832|4191762|P12|COMPLETED|Core Period||0
1713915|NCT00364832|4191763|P11|COMPLETED|Core Period||0
1713916|NCT00364832|4191764|P10|COMPLETED|Core Period||0
1713917|NCT00364832|4191765|P9|COMPLETED|Core Period||16
1713918|NCT00364832|4191766|P8|COMPLETED|Core Period||14
1713919|NCT00364832|4191767|P7|COMPLETED|Core Period||12
1713920|NCT00364832|4191768|P6|COMPLETED|Core Period||12
1713921|NCT00364832|4191769|P5|COMPLETED|Core Period||16
1713922|NCT00364832|4191770|P4|COMPLETED|Core Period||15
1713923|NCT00364832|4191771|P3|COMPLETED|Core Period||14
1713924|NCT00364832|4191772|P2|COMPLETED|Core Period||13
1713925|NCT00364832|4191773|P1|COMPLETED|Core Period||14
1713926|NCT00364832|4191762|P12|STARTED|Core Period||0
1713927|NCT00364832|4191763|P11|STARTED|Core Period||0
1713928|NCT00364832|4191764|P10|STARTED|Core Period||0
1713929|NCT00364832|4191765|P9|STARTED|Core Period||16
1713930|NCT00364832|4191766|P8|STARTED|Core Period||15
1713931|NCT00364832|4191767|P7|STARTED|Core Period||16
1713932|NCT00364832|4191768|P6|STARTED|Core Period||12
1713933|NCT00364832|4191769|P5|STARTED|Core Period||16
1713934|NCT00364832|4191770|P4|STARTED|Core Period||16
1713935|NCT00364832|4191771|P3|STARTED|Core Period||15
1713936|NCT00364832|4191772|P2|STARTED|Core Period||15
1713937|NCT00364832|4191773|P1|STARTED|Core Period||16
1713938|NCT00364819|4191826|P1|NOT COMPLETED|Overall Study||0
1713939|NCT00364819|4191826|P1|COMPLETED|Overall Study||6
1713940|NCT00364819|4191826|P1|STARTED|Overall Study||6
1713941|NCT00364793|4191838|P4|NOT COMPLETED|Overall Study||3
1713942|NCT00364793|4191839|P3|NOT COMPLETED|Overall Study||4
1713943|NCT00364793|4191840|P2|NOT COMPLETED|Overall Study||5
1713944|NCT00364793|4191841|P1|NOT COMPLETED|Overall Study||8
1713945|NCT00364793|4191838|P4|COMPLETED|Overall Study||5
1713946|NCT00364793|4191839|P3|COMPLETED|Overall Study||0
1713947|NCT00364793|4191840|P2|COMPLETED|Overall Study||5
1713948|NCT00364793|4191841|P1|COMPLETED|Overall Study||7
1713949|NCT00364793|4191838|P4|STARTED|Overall Study||8
1713950|NCT00364793|4191839|P3|STARTED|Overall Study||4
1713951|NCT00364793|4191840|P2|STARTED|Overall Study||10
1713952|NCT00364793|4191841|P1|STARTED|Overall Study||15
1713953|NCT00364611|4191977|P2|NOT COMPLETED|Overall Study||21
1713954|NCT00364611|4191978|P1|NOT COMPLETED|Overall Study||51
1713955|NCT00364611|4191977|P2|COMPLETED|Overall Study||0
1713956|NCT00364611|4191978|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
1713957|NCT00364611|4191977|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
1713958|NCT00364611|4191978|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
1713959|NCT00364611|4191977|P2|STARTED|Overall Study||21
1713960|NCT00364611|4191978|P1|STARTED|Overall Study||52
1713961|NCT00364533|4192001|P5|NOT COMPLETED|Overall Study||51
1713962|NCT00364533|4192002|P4|NOT COMPLETED|Overall Study||31
1713963|NCT00364533|4192003|P3|NOT COMPLETED|Overall Study||45
1713964|NCT00364533|4192004|P2|NOT COMPLETED|Overall Study||40
1713965|NCT00364533|4192005|P1|NOT COMPLETED|Overall Study||42
1713966|NCT00364533|4192001|P5|COMPLETED|Overall Study||24
1713967|NCT00364533|4192002|P4|COMPLETED|Overall Study||36
1713968|NCT00364533|4192003|P3|COMPLETED|Overall Study||30
1713969|NCT00364533|4192004|P2|COMPLETED|Overall Study||31
1713970|NCT00364533|4192005|P1|COMPLETED|Overall Study||35
1713971|NCT00364533|4192001|P5|STARTED|Overall Study||75
1713972|NCT00364533|4192002|P4|STARTED|Overall Study||67
1713973|NCT00364533|4192003|P3|STARTED|Overall Study||75
1713974|NCT00364533|4192004|P2|STARTED|Overall Study||71
1713975|NCT00364533|4192005|P1|STARTED|Overall Study||77
1713976|NCT00364377|4192029|P2|NOT COMPLETED|Overall Study||0
1713977|NCT00364377|4192030|P1|NOT COMPLETED|Overall Study||0
1713978|NCT00364377|4192029|P2|COMPLETED|Overall Study||11
1713979|NCT00364377|4192030|P1|COMPLETED|Overall Study||11
1713980|NCT00364377|4192029|P2|STARTED|Overall Study||11
1713981|NCT00364377|4192030|P1|STARTED|Overall Study||11
1713982|NCT00364351|4192038|P2|NOT COMPLETED|Overall Study||583
1713983|NCT00364351|4192039|P1|NOT COMPLETED|Overall Study||592
1713984|NCT00364351|4192038|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
1713985|NCT00364351|4192039|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
1713986|NCT00364351|4192038|P2|STARTED|Overall Study|randomised patients|617
1713987|NCT00364351|4192039|P1|STARTED|Overall Study|randomised patients|623
1713988|NCT00364286|4192057|P1|NOT COMPLETED|Overall Study||3
1713989|NCT00364286|4192057|P1|COMPLETED|Overall Study||14
1713990|NCT00364286|4192057|P1|STARTED|Overall Study||17
1713991|NCT00364182|4192064|P3|NOT COMPLETED|Fourth Intervention||0
1713992|NCT00364182|4192065|P2|NOT COMPLETED|Fourth Intervention||0
1713993|NCT00364182|4192066|P1|NOT COMPLETED|Fourth Intervention||0
1713994|NCT00364182|4192064|P3|COMPLETED|Fourth Intervention||22
1713995|NCT00364182|4192065|P2|COMPLETED|Fourth Intervention||19
1713996|NCT00364182|4192066|P1|COMPLETED|Fourth Intervention||0
1713997|NCT00364182|4192064|P3|STARTED|Fourth Intervention||22
1713998|NCT00364182|4192065|P2|STARTED|Fourth Intervention||19
1713999|NCT00364182|4192066|P1|STARTED|Fourth Intervention||0
1714000|NCT00364182|4192064|P3|NOT COMPLETED|Third Intervention||1
1714001|NCT00364182|4192065|P2|NOT COMPLETED|Third Intervention||1
1714002|NCT00364182|4192066|P1|NOT COMPLETED|Third Intervention||0
1714003|NCT00364182|4192064|P3|COMPLETED|Third Intervention||22
1714004|NCT00364182|4192065|P2|COMPLETED|Third Intervention||19
1714005|NCT00364182|4192066|P1|COMPLETED|Third Intervention||0
1714006|NCT00364182|4192064|P3|STARTED|Third Intervention||23
1714007|NCT00364182|4192065|P2|STARTED|Third Intervention||20
1714008|NCT00364182|4192066|P1|STARTED|Third Intervention||0
1714009|NCT00364182|4192064|P3|NOT COMPLETED|Second Intervention||2
1714010|NCT00364182|4192065|P2|NOT COMPLETED|Second Intervention||2
1714011|NCT00364182|4192066|P1|NOT COMPLETED|Second Intervention||0
1714012|NCT00364182|4192064|P3|COMPLETED|Second Intervention||23
1714013|NCT00364182|4192065|P2|COMPLETED|Second Intervention||20
1714014|NCT00364182|4192066|P1|COMPLETED|Second Intervention||0
1714015|NCT00364182|4192064|P3|Randomized|Second Intervention||25
1714016|NCT00364182|4192065|P2|Randomized|Second Intervention||22
1714017|NCT00364182|4192066|P1|Randomized|Second Intervention||0
1714018|NCT00364182|4192064|P3|STARTED|Second Intervention||25
1714019|NCT00364182|4192065|P2|STARTED|Second Intervention||22
1714020|NCT00364182|4192066|P1|STARTED|Second Intervention||0
1714021|NCT00364182|4192064|P3|NOT COMPLETED|First Intervention||0
1714022|NCT00364182|4192065|P2|NOT COMPLETED|First Intervention||0
1714023|NCT00364182|4192066|P1|NOT COMPLETED|First Intervention||3
1714024|NCT00364182|4192064|P3|COMPLETED|First Intervention||25
1714025|NCT00364182|4192065|P2|COMPLETED|First Intervention||22
1714026|NCT00364182|4192066|P1|COMPLETED|First Intervention||0
1714027|NCT00364182|4192064|P3|STARTED|First Intervention||25
1714028|NCT00364182|4192065|P2|STARTED|First Intervention||22
1714029|NCT00364182|4192066|P1|STARTED|First Intervention||3
1714030|NCT00364156|4192100|P2|NOT COMPLETED|Overall Study||81
1714031|NCT00364156|4192101|P1|NOT COMPLETED|Overall Study||79
1714032|NCT00364156|4192100|P2|COMPLETED|Overall Study||205
1714033|NCT00364156|4192101|P1|COMPLETED|Overall Study||203
1714034|NCT00364156|4192100|P2|STARTED|Overall Study||286
1714035|NCT00364156|4192101|P1|STARTED|Overall Study||282
1714036|NCT00364130|4192109|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
1714037|NCT00364130|4192110|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
1714038|NCT00364130|4192109|P2|COMPLETED|Post Intervention Follow-up Period||50
1714039|NCT00364130|4192110|P1|COMPLETED|Post Intervention Follow-up Period||55
1714040|NCT00364130|4192109|P2|STARTED|Post Intervention Follow-up Period||61
1714041|NCT00364130|4192110|P1|STARTED|Post Intervention Follow-up Period||60
1714042|NCT00364130|4192109|P2|NOT COMPLETED|Intervention Period||8
1714043|NCT00364130|4192110|P1|NOT COMPLETED|Intervention Period||9
1714044|NCT00364130|4192109|P2|COMPLETED|Intervention Period||61
1714045|NCT00364130|4192110|P1|COMPLETED|Intervention Period||60
1714046|NCT00364130|4192109|P2|STARTED|Intervention Period||69
1714047|NCT00364130|4192110|P1|STARTED|Intervention Period||69
1714048|NCT00364013|4192132|P2|NOT COMPLETED|Overall Study||95
1714049|NCT00364013|4192133|P1|NOT COMPLETED|Overall Study||101
1714050|NCT00364013|4192132|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
1714051|NCT00364013|4192133|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
1714052|NCT00364013|4192132|P2|Received Study Drug|Overall Study||583
1714053|NCT00364013|4192133|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
1714054|NCT00364013|4192132|P2|STARTED|Overall Study||590
1714055|NCT00364013|4192133|P1|STARTED|Overall Study||593
1714056|NCT00363896|4192161|P2|NOT COMPLETED|Overall Study||47
1714057|NCT00363896|4192162|P1|NOT COMPLETED|Overall Study||89
1714058|NCT00363896|4192161|P2|COMPLETED|Overall Study||169
1714059|NCT00363896|4192162|P1|COMPLETED|Overall Study||538
1714060|NCT00363896|4192161|P2|STARTED|Overall Study||216
1714061|NCT00363896|4192162|P1|STARTED|Overall Study||627
1714062|NCT00363883|4192174|P1|NOT COMPLETED|Overall Study||0
1714063|NCT00363883|4192174|P1|COMPLETED|Overall Study||14
1714064|NCT00363883|4192174|P1|STARTED|Overall Study||14
1714065|NCT00363805|4192183|P3|NOT COMPLETED|Overall Study||3
1714066|NCT00363805|4192184|P2|NOT COMPLETED|Overall Study||6
1714067|NCT00363805|4192185|P1|NOT COMPLETED|Overall Study||4
1714068|NCT00363805|4192183|P3|COMPLETED|Overall Study||70
1714069|NCT00363805|4192184|P2|COMPLETED|Overall Study||57
1714070|NCT00363805|4192185|P1|COMPLETED|Overall Study||38
1714071|NCT00363805|4192183|P3|STARTED|Overall Study||73
1714072|NCT00363805|4192184|P2|STARTED|Overall Study||63
1714073|NCT00363805|4192185|P1|STARTED|Overall Study||42
1714074|NCT00363779|4192196|P1|NOT COMPLETED|Overall Study||0
1714075|NCT00363779|4192196|P1|COMPLETED|Overall Study||5
1714076|NCT00363779|4192196|P1|STARTED|Overall Study||5
1714077|NCT00363766|4192203|P2|NOT COMPLETED|Overall Study||20
1714078|NCT00363766|4192204|P1|NOT COMPLETED|Overall Study||32
1714079|NCT00363766|4192203|P2|COMPLETED|Overall Study||0
1714080|NCT00363766|4192204|P1|COMPLETED|Overall Study||0
1714081|NCT00363766|4192203|P2|STARTED|Overall Study||20
1714082|NCT00363766|4192204|P1|STARTED|Overall Study||32
1714083|NCT00363675|4192224|P1|NOT COMPLETED|Overall Study||0
1714084|NCT00363675|4192224|P1|COMPLETED|Overall Study||3
1714085|NCT00363675|4192224|P1|Completed Testing|Overall Study||3
1714086|NCT00363675|4192224|P1|STARTED|Overall Study||3
1714087|NCT00363649|4192233|P2|NOT COMPLETED|Overall Study||1
1714088|NCT00363649|4192234|P1|NOT COMPLETED|Overall Study||7
1714089|NCT00363649|4192233|P2|COMPLETED|Overall Study||15
1714090|NCT00363649|4192234|P1|COMPLETED|Overall Study||11
1714091|NCT00363649|4192233|P2|Did Not Cross Over|Overall Study||3
1714092|NCT00363649|4192234|P1|Did Not Cross Over|Overall Study||2
1714093|NCT00363649|4192233|P2|Crossed Over to Arm A|Overall Study||12
1714094|NCT00363649|4192234|P1|Crossed Over to Arm A|Overall Study||0
1714095|NCT00363649|4192233|P2|Crossed Over to Arm B|Overall Study||0
1714096|NCT00363649|4192234|P1|Crossed Over to Arm B|Overall Study||9
1714097|NCT00363649|4192233|P2|STARTED|Overall Study||16
1714098|NCT00363649|4192234|P1|STARTED|Overall Study||18
1714099|NCT00363545|4192250|P2|NOT COMPLETED|Overall Study||57
1714100|NCT00363545|4192251|P1|NOT COMPLETED|Overall Study||44
1714101|NCT00363545|4192250|P2|COMPLETED|Overall Study||581
1714102|NCT00363545|4192251|P1|COMPLETED|Overall Study||592
1714103|NCT00363545|4192250|P2|STARTED|Overall Study||638
1714104|NCT00363545|4192251|P1|STARTED|Overall Study||636
1714105|NCT00363480|4192269|P1|NOT COMPLETED|Overall Study||17
1714106|NCT00363480|4192269|P1|COMPLETED|Overall Study||204
1714107|NCT00363480|4192269|P1|STARTED|Overall Study||221
1714108|NCT00363467|4192289|P1|NOT COMPLETED|Overall Study||1
1714109|NCT00363467|4192289|P1|COMPLETED|Overall Study||2
1714110|NCT00363467|4192289|P1|STARTED|Overall Study||3
1714111|NCT00363415|4192299|P2|NOT COMPLETED|Overall Study||249
1714112|NCT00363415|4192300|P1|NOT COMPLETED|Overall Study||361
1714113|NCT00363415|4192299|P2|COMPLETED|Overall Study||206
1714114|NCT00363415|4192300|P1|COMPLETED|Overall Study||92
1714115|NCT00363415|4192299|P2|Received at Least One Dose of Study Drug|Overall Study||447
1714116|NCT00363415|4192300|P1|Received at Least One Dose of Study Drug|Overall Study||433
1714117|NCT00363415|4192299|P2|STARTED|Overall Study||455
1714118|NCT00363415|4192300|P1|STARTED|Overall Study||453
1714119|NCT00363311|4192318|P2|NOT COMPLETED|Overall Study||45
1714120|NCT00363311|4192319|P1|NOT COMPLETED|Overall Study||76
1714121|NCT00363311|4192318|P2|COMPLETED|Overall Study||102
1714122|NCT00363311|4192319|P1|COMPLETED|Overall Study||79
1714123|NCT00363311|4192318|P2|STARTED|Overall Study||147
1714124|NCT00363311|4192319|P1|STARTED|Overall Study||155
1714125|NCT00363298|4192385|P2|NOT COMPLETED|4-week Study Continuation Phase||0
1714126|NCT00363298|4192386|P1|NOT COMPLETED|4-week Study Continuation Phase||1
1714127|NCT00363298|4192385|P2|COMPLETED|4-week Study Continuation Phase||7
1714128|NCT00363298|4192386|P1|COMPLETED|4-week Study Continuation Phase||5
1714129|NCT00363298|4192385|P2|STARTED|4-week Study Continuation Phase||7
1714130|NCT00363298|4192386|P1|STARTED|4-week Study Continuation Phase||6
1714131|NCT00363298|4192385|P2|NOT COMPLETED|First Study Week||5
1714132|NCT00363298|4192386|P1|NOT COMPLETED|First Study Week||6
1714133|NCT00363298|4192385|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
1714134|NCT00363298|4192386|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
1714135|NCT00363298|4192385|P2|STARTED|First Study Week||12
1714136|NCT00363298|4192386|P1|STARTED|First Study Week||12
1714137|NCT00363246|4192394|P1|NOT COMPLETED|Overall Study||97
1714138|NCT00363246|4192394|P1|COMPLETED|Overall Study||669
1714139|NCT00363246|4192394|P1|STARTED|Overall Study||766
1714140|NCT00363168|4192401|P2|NOT COMPLETED|Overall Study||0
1714141|NCT00363168|4192402|P1|NOT COMPLETED|Overall Study||0
1714142|NCT00363168|4192401|P2|COMPLETED|Overall Study||2
1714143|NCT00363168|4192402|P1|COMPLETED|Overall Study||5
1714144|NCT00363168|4192401|P2|STARTED|Overall Study||2
1714145|NCT00363168|4192402|P1|STARTED|Overall Study||5
1714146|NCT00363142|4192412|P2|NOT COMPLETED|Overall Study||3
1714147|NCT00363142|4192413|P1|NOT COMPLETED|Overall Study||7
1714148|NCT00363142|4192412|P2|COMPLETED|Overall Study||66
1714149|NCT00363142|4192413|P1|COMPLETED|Overall Study||133
1714150|NCT00363142|4192412|P2|STARTED|Overall Study||69
1714151|NCT00363142|4192413|P1|STARTED|Overall Study||140
1714152|NCT00363129|4192442|P2|NOT COMPLETED|Overall Study||33
1714153|NCT00363129|4192443|P1|NOT COMPLETED|Overall Study||29
1714154|NCT00363129|4192442|P2|COMPLETED|Overall Study||60
1714155|NCT00363129|4192443|P1|COMPLETED|Overall Study||67
1714156|NCT00363129|4192442|P2|STARTED|Overall Study||93
1714157|NCT00363129|4192443|P1|STARTED|Overall Study||96
1714158|NCT00363077|4192459|P2|NOT COMPLETED|Overall Study||0
1714159|NCT00363077|4192460|P1|NOT COMPLETED|Overall Study||0
1714160|NCT00363077|4192459|P2|COMPLETED|Overall Study||75
1714161|NCT00363077|4192460|P1|COMPLETED|Overall Study||75
1714162|NCT00363077|4192459|P2|STARTED|Overall Study||75
1714163|NCT00363077|4192460|P1|STARTED|Overall Study||75
1714164|NCT00363051|4192486|P2|NOT COMPLETED|Overall Study||22
1714165|NCT00363051|4192487|P1|NOT COMPLETED|Overall Study||38
1714166|NCT00363051|4192486|P2|COMPLETED|Overall Study||23
1714167|NCT00363051|4192487|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
1714168|NCT00363051|4192486|P2|STARTED|Overall Study||45
1714169|NCT00363051|4192487|P1|STARTED|Overall Study||115
1714170|NCT00363038|4192504|P1|NOT COMPLETED|Overall Study||0
1714171|NCT00363038|4192504|P1|COMPLETED|Overall Study||16
1714172|NCT00363038|4192504|P1|STARTED|Overall Study||16
1714173|NCT00362882|4192510|P2|NOT COMPLETED|Overall Study||0
1714174|NCT00362882|4192511|P1|NOT COMPLETED|Overall Study||0
1714175|NCT00362882|4192510|P2|COMPLETED|Overall Study||41
1714176|NCT00362882|4192511|P1|COMPLETED|Overall Study||40
1714177|NCT00362882|4192510|P2|STARTED|Overall Study||41
1714178|NCT00362882|4192511|P1|STARTED|Overall Study||40
1714179|NCT00362817|4192523|P1|NOT COMPLETED|Overall Study||0
1714180|NCT00362817|4192523|P1|COMPLETED|Overall Study||17
1714181|NCT00362817|4192523|P1|STARTED|Overall Study||17
1714182|NCT00362648|4192536|P4|NOT COMPLETED|Overall Study||11
1714183|NCT00362648|4192537|P3|NOT COMPLETED|Overall Study||9
1714184|NCT00362648|4192538|P2|NOT COMPLETED|Overall Study||134
1714185|NCT00362648|4192539|P1|NOT COMPLETED|Overall Study||126
1714186|NCT00362648|4192536|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
1714187|NCT00362648|4192537|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
1714188|NCT00362648|4192538|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
1714189|NCT00362648|4192539|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
1714190|NCT00362648|4192536|P4|Vaccinated at Visit 3|Overall Study||1007
1714191|NCT00362648|4192537|P3|Vaccinated at Visit 3|Overall Study||1009
1714192|NCT00362648|4192538|P2|Vaccinated at Visit 3|Overall Study||2612
1714193|NCT00362648|4192539|P1|Vaccinated at Visit 3|Overall Study||2613
1714194|NCT00362648|4192536|P4|Vaccinated at Visit 2|Overall Study||1009
1714195|NCT00362648|4192537|P3|Vaccinated at Visit 2|Overall Study||1013
1714196|NCT00362648|4192538|P2|Vaccinated at Visit 2|Overall Study||2666
1714197|NCT00362648|4192539|P1|Vaccinated at Visit 2|Overall Study||2657
1714198|NCT00362648|4192536|P4|Vaccinated at Visit 1|Overall Study||1018
1714199|NCT00362648|4192537|P3|Vaccinated at Visit 1|Overall Study||1018
1714200|NCT00362648|4192538|P2|Vaccinated at Visit 1|Overall Study||2735
1714201|NCT00362648|4192539|P1|Vaccinated at Visit 1|Overall Study||2733
1714202|NCT00362648|4192536|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
1714203|NCT00362648|4192537|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
1714204|NCT00362648|4192538|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
1714205|NCT00362648|4192539|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
1714206|NCT00362609|4192557|P2|NOT COMPLETED|Overall Study||2
1714207|NCT00362609|4192558|P1|NOT COMPLETED|Overall Study||0
1714208|NCT00362609|4192557|P2|COMPLETED|Overall Study||38
1714209|NCT00362609|4192558|P1|COMPLETED|Overall Study||19
1714210|NCT00362609|4192557|P2|STARTED|Overall Study||40
1714211|NCT00362609|4192558|P1|STARTED|Overall Study||19
1714212|NCT00362466|4192572|P2|NOT COMPLETED|Overall Study||0
1714213|NCT00362466|4192573|P1|NOT COMPLETED|Overall Study||0
1714214|NCT00362466|4192572|P2|COMPLETED|Overall Study||1
1714215|NCT00362466|4192573|P1|COMPLETED|Overall Study||2
1714216|NCT00362466|4192572|P2|STARTED|Overall Study||1
1714217|NCT00362466|4192573|P1|STARTED|Overall Study||2
1714218|NCT00362453|4192595|P2|NOT COMPLETED|Overall Study||0
1714219|NCT00362453|4192596|P1|NOT COMPLETED|Overall Study||0
1714220|NCT00362453|4192595|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
1714221|NCT00362453|4192596|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
1714222|NCT00362453|4192595|P2|STARTED|Overall Study||20
1714223|NCT00362453|4192596|P1|STARTED|Overall Study||20
1714224|NCT00362440|4192628|P2|NOT COMPLETED|Overall Study||1
1714225|NCT00362440|4192629|P1|NOT COMPLETED|Overall Study||2
1714226|NCT00362440|4192628|P2|COMPLETED|Overall Study||3
1714227|NCT00362440|4192629|P1|COMPLETED|Overall Study||3
1714228|NCT00362440|4192628|P2|STARTED|Overall Study||4
1714229|NCT00362440|4192629|P1|STARTED|Overall Study||5
1714230|NCT00362414|4192639|P1|NOT COMPLETED|Overall Study||3
1714231|NCT00362414|4192639|P1|COMPLETED|Overall Study||12
1714232|NCT00362414|4192639|P1|STARTED|Overall Study||15
1714233|NCT00362401|4192659|P3|NOT COMPLETED|Overall Study||0
1714234|NCT00362401|4192660|P2|NOT COMPLETED|Overall Study||0
1714235|NCT00362401|4192661|P1|NOT COMPLETED|Overall Study||0
1714236|NCT00362401|4192659|P3|COMPLETED|Overall Study||40
1714237|NCT00362401|4192660|P2|COMPLETED|Overall Study||29
1714238|NCT00362401|4192661|P1|COMPLETED|Overall Study||15
1714239|NCT00362401|4192659|P3|STARTED|Overall Study||40
1714240|NCT00362401|4192660|P2|STARTED|Overall Study||29
1714241|NCT00362401|4192661|P1|STARTED|Overall Study||15
1714242|NCT00362375|4192668|P2|NOT COMPLETED|Overall Study||35
1714243|NCT00362375|4192669|P1|NOT COMPLETED|Overall Study||40
1714244|NCT00362375|4192668|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
1714245|NCT00362375|4192669|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
1714246|NCT00362375|4192668|P2|STARTED|Overall Study|Number eligible and randomized|152
1714247|NCT00362375|4192669|P1|STARTED|Overall Study|Number eligible and randomized|161
1714248|NCT00362336|4192686|P3|NOT COMPLETED|Overall Study||3
1714249|NCT00362336|4192687|P2|NOT COMPLETED|Overall Study||7
1714250|NCT00362336|4192688|P1|NOT COMPLETED|Overall Study||10
1714251|NCT00362336|4192686|P3|COMPLETED|Overall Study||134
1714252|NCT00362336|4192687|P2|COMPLETED|Overall Study||235
1714253|NCT00362336|4192688|P1|COMPLETED|Overall Study||233
1714254|NCT00362336|4192686|P3|STARTED|Overall Study||137
1714255|NCT00362336|4192687|P2|STARTED|Overall Study||242
1714256|NCT00362336|4192688|P1|STARTED|Overall Study||243
1714257|NCT00362297|4192716|P2|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
1714258|NCT00362297|4192717|P1|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
1714259|NCT00362297|4192716|P2|COMPLETED|Arm 2 (Cross-over to Other Dose)||11
1714260|NCT00362297|4192717|P1|COMPLETED|Arm 2 (Cross-over to Other Dose)||16
1714261|NCT00362297|4192716|P2|STARTED|Arm 2 (Cross-over to Other Dose)||11
1714262|NCT00362297|4192717|P1|STARTED|Arm 2 (Cross-over to Other Dose)||16
1714263|NCT00362297|4192716|P2|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||4
1714264|NCT00362297|4192717|P1|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||0
1714265|NCT00362297|4192716|P2|COMPLETED|Arm 1 (Initial Drug Assignment)||11
1714266|NCT00362297|4192717|P1|COMPLETED|Arm 1 (Initial Drug Assignment)||16
1714267|NCT00362297|4192716|P2|STARTED|Arm 1 (Initial Drug Assignment)||15
1714268|NCT00362297|4192717|P1|STARTED|Arm 1 (Initial Drug Assignment)||16
1714269|NCT00362232|4192725|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
1714270|NCT00362232|4192726|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
1714271|NCT00362232|4192725|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
1714272|NCT00362232|4192726|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
1714273|NCT00362232|4192725|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
1714274|NCT00362232|4192726|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
1714275|NCT00362232|4192725|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
1714276|NCT00362232|4192726|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
1714277|NCT00362232|4192725|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
1714278|NCT00362232|4192726|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
1714279|NCT00362232|4192725|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
1714280|NCT00362232|4192726|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
1714281|NCT00362232|4192725|P2|STARTED|Treatment (12 +/- 2 Days)||1564
1714282|NCT00362232|4192726|P1|STARTED|Treatment (12 +/- 2 Days)||1584
1714283|NCT00362180|4192771|P9|NOT COMPLETED|20 Week Safety Follow-up||0
1714284|NCT00362180|4192772|P8|NOT COMPLETED|20 Week Safety Follow-up||0
1714285|NCT00362180|4192773|P7|NOT COMPLETED|20 Week Safety Follow-up||0
1714286|NCT00362180|4192774|P6|NOT COMPLETED|20 Week Safety Follow-up||0
1714287|NCT00362180|4192775|P5|NOT COMPLETED|20 Week Safety Follow-up||0
1714288|NCT00362180|4192776|P4|NOT COMPLETED|20 Week Safety Follow-up||0
1714289|NCT00362180|4192777|P3|NOT COMPLETED|20 Week Safety Follow-up||0
1714290|NCT00362180|4192778|P2|NOT COMPLETED|20 Week Safety Follow-up||0
1714291|NCT00362180|4192779|P1|NOT COMPLETED|20 Week Safety Follow-up||0
1714292|NCT00362180|4192771|P9|COMPLETED|20 Week Safety Follow-up||1
1714293|NCT00362180|4192772|P8|COMPLETED|20 Week Safety Follow-up||3
1714294|NCT00362180|4192773|P7|COMPLETED|20 Week Safety Follow-up||0
1714295|NCT00362180|4192774|P6|COMPLETED|20 Week Safety Follow-up||9
1714296|NCT00362180|4192775|P5|COMPLETED|20 Week Safety Follow-up||11
1714297|NCT00362180|4192776|P4|COMPLETED|20 Week Safety Follow-up||0
1714298|NCT00362180|4192777|P3|COMPLETED|20 Week Safety Follow-up||1
1714299|NCT00362180|4192778|P2|COMPLETED|20 Week Safety Follow-up||2
1714300|NCT00362180|4192779|P1|COMPLETED|20 Week Safety Follow-up||3
1714301|NCT00362180|4192771|P9|STARTED|20 Week Safety Follow-up||1
1714302|NCT00362180|4192772|P8|STARTED|20 Week Safety Follow-up||3
1714303|NCT00362180|4192773|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
1714304|NCT00362180|4192774|P6|STARTED|20 Week Safety Follow-up||9
1714305|NCT00362180|4192775|P5|STARTED|20 Week Safety Follow-up||11
1714306|NCT00362180|4192776|P4|STARTED|20 Week Safety Follow-up||0
1714307|NCT00362180|4192777|P3|STARTED|20 Week Safety Follow-up||1
1714308|NCT00362180|4192778|P2|STARTED|20 Week Safety Follow-up||2
1714309|NCT00362180|4192779|P1|STARTED|20 Week Safety Follow-up||3
1714310|NCT00362180|4192771|P9|NOT COMPLETED|Treated Period||0
1714311|NCT00362180|4192772|P8|NOT COMPLETED|Treated Period||1
1714312|NCT00362180|4192773|P7|NOT COMPLETED|Treated Period||0
1714313|NCT00362180|4192774|P6|NOT COMPLETED|Treated Period||1
1714314|NCT00362180|4192775|P5|NOT COMPLETED|Treated Period||0
1714315|NCT00362180|4192776|P4|NOT COMPLETED|Treated Period||0
1714316|NCT00362180|4192777|P3|NOT COMPLETED|Treated Period||0
1714317|NCT00362180|4192778|P2|NOT COMPLETED|Treated Period||0
1714318|NCT00362180|4192779|P1|NOT COMPLETED|Treated Period||1
1714319|NCT00362180|4192771|P9|COMPLETED|Treated Period||1
1714320|NCT00362180|4192772|P8|COMPLETED|Treated Period||2
1714321|NCT00362180|4192773|P7|COMPLETED|Treated Period||6
1714322|NCT00362180|4192774|P6|COMPLETED|Treated Period||9
1714323|NCT00362180|4192775|P5|COMPLETED|Treated Period||11
1714324|NCT00362180|4192776|P4|COMPLETED|Treated Period||0
1714325|NCT00362180|4192777|P3|COMPLETED|Treated Period||1
1714326|NCT00362180|4192778|P2|COMPLETED|Treated Period||2
1714327|NCT00362180|4192779|P1|COMPLETED|Treated Period||3
1714328|NCT00362180|4192771|P9|STARTED|Treated Period||1
1714329|NCT00362180|4192772|P8|STARTED|Treated Period||3
1714330|NCT00362180|4192773|P7|STARTED|Treated Period||6
1714331|NCT00362180|4192774|P6|STARTED|Treated Period||10
1714332|NCT00362180|4192775|P5|STARTED|Treated Period||11
1714333|NCT00362180|4192776|P4|STARTED|Treated Period||0
1714334|NCT00362180|4192777|P3|STARTED|Treated Period||1
1714335|NCT00362180|4192778|P2|STARTED|Treated Period||2
1714336|NCT00362180|4192779|P1|STARTED|Treated Period||4
1714337|NCT00362128|4192840|P1|NOT COMPLETED|Overall Study||0
1714338|NCT00362128|4192840|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
1714339|NCT00362128|4192840|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
1714340|NCT00362115|4192851|P7|NOT COMPLETED|Overall Study||12
1714341|NCT00362115|4192852|P6|NOT COMPLETED|Overall Study||7
1714342|NCT00362115|4192853|P5|NOT COMPLETED|Overall Study||7
1714343|NCT00362115|4192854|P4|NOT COMPLETED|Overall Study||4
1714344|NCT00362115|4192855|P3|NOT COMPLETED|Overall Study||7
1714345|NCT00362115|4192856|P2|NOT COMPLETED|Overall Study||6
1714346|NCT00362115|4192857|P1|NOT COMPLETED|Overall Study||2
1714347|NCT00362115|4192851|P7|COMPLETED|Overall Study||52
1714348|NCT00362115|4192852|P6|COMPLETED|Overall Study||57
1714349|NCT00362115|4192853|P5|COMPLETED|Overall Study||57
1714350|NCT00362115|4192854|P4|COMPLETED|Overall Study||59
1714351|NCT00362115|4192855|P3|COMPLETED|Overall Study||57
1714352|NCT00362115|4192856|P2|COMPLETED|Overall Study||59
1714353|NCT00362115|4192857|P1|COMPLETED|Overall Study||63
1714354|NCT00362115|4192851|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
1714355|NCT00362115|4192852|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
1714356|NCT00362115|4192853|P5|STARTED|Overall Study||64
1714357|NCT00362115|4192854|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
1714358|NCT00362115|4192855|P3|STARTED|Overall Study||64
1714359|NCT00362115|4192856|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
1714360|NCT00362115|4192857|P1|STARTED|Overall Study||65
1714361|NCT00361972|4193008|P2|NOT COMPLETED|Overall Study||0
1714362|NCT00361972|4193009|P1|NOT COMPLETED|Overall Study||0
1714363|NCT00361972|4193008|P2|COMPLETED|Overall Study||9
1714364|NCT00361972|4193009|P1|COMPLETED|Overall Study||8
1714365|NCT00361972|4193008|P2|STARTED|Overall Study||9
1714366|NCT00361972|4193009|P1|STARTED|Overall Study||8
1714367|NCT00361712|4193019|P2|NOT COMPLETED|Overall Study||0
1714368|NCT00361712|4193020|P1|NOT COMPLETED|Overall Study||0
1714369|NCT00361712|4193019|P2|COMPLETED|Overall Study||21
1714370|NCT00361712|4193020|P1|COMPLETED|Overall Study||20
1714371|NCT00361712|4193019|P2|STARTED|Overall Study||21
1714372|NCT00361712|4193020|P1|STARTED|Overall Study||20
1714373|NCT00361634|4193030|P1|NOT COMPLETED|Overall Study||2
1714374|NCT00361634|4193030|P1|COMPLETED|Overall Study||12
1714375|NCT00361634|4193030|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
1714376|NCT00361634|4193030|P1|STARTED|Overall Study||14
1714377|NCT00361595|4193048|P1|NOT COMPLETED|Overall Study||0
1714378|NCT00361595|4193048|P1|COMPLETED|Overall Study||35
1714379|NCT00361595|4193048|P1|STARTED|Overall Study||35
1714380|NCT00361569|4193059|P4|NOT COMPLETED|Overall Study||21
1714381|NCT00361569|4193060|P3|NOT COMPLETED|Overall Study||18
1714382|NCT00361569|4193061|P2|NOT COMPLETED|Overall Study||11
1714383|NCT00361569|4193062|P1|NOT COMPLETED|Overall Study||12
1714384|NCT00361569|4193059|P4|COMPLETED|Overall Study||135
1714385|NCT00361569|4193060|P3|COMPLETED|Overall Study||137
1714386|NCT00361569|4193061|P2|COMPLETED|Overall Study||150
1714387|NCT00361569|4193062|P1|COMPLETED|Overall Study||138
1714388|NCT00361569|4193059|P4|STARTED|Overall Study||156
1714389|NCT00361569|4193060|P3|STARTED|Overall Study||155
1714390|NCT00361569|4193061|P2|STARTED|Overall Study||161
1714391|NCT00361569|4193062|P1|STARTED|Overall Study||150
1714392|NCT00361504|4193086|P2|NOT COMPLETED|Overall Study||145
1714393|NCT00361504|4193087|P1|NOT COMPLETED|Overall Study||481
1714394|NCT00361504|4193086|P2|COMPLETED|Overall Study||78
1714395|NCT00361504|4193087|P1|COMPLETED|Overall Study||413
1714396|NCT00361504|4193086|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
1714397|NCT00361504|4193087|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
1714398|NCT00361439|4193097|P2|NOT COMPLETED|Overall Study||0
1714399|NCT00361439|4193098|P1|NOT COMPLETED|Overall Study||0
1714400|NCT00361439|4193097|P2|COMPLETED|Overall Study||9
1714401|NCT00361439|4193098|P1|COMPLETED|Overall Study||8
1714402|NCT00361439|4193097|P2|STARTED|Overall Study||9
1714403|NCT00361439|4193098|P1|STARTED|Overall Study||8
1714404|NCT00361374|4193113|P3|NOT COMPLETED|Overall Study||12
1714405|NCT00361374|4193114|P2|NOT COMPLETED|Overall Study||15
1714406|NCT00361374|4193115|P1|NOT COMPLETED|Overall Study||15
1714407|NCT00361374|4193113|P3|COMPLETED|Overall Study||53
1714408|NCT00361374|4193114|P2|COMPLETED|Overall Study||50
1714409|NCT00361374|4193115|P1|COMPLETED|Overall Study||51
1714410|NCT00361374|4193113|P3|STARTED|Overall Study||65
1714411|NCT00361374|4193114|P2|STARTED|Overall Study||65
1714412|NCT00361374|4193115|P1|STARTED|Overall Study||66
1714413|NCT00361335|4193128|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
1714414|NCT00361335|4193129|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
1714415|NCT00361335|4193130|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
1714416|NCT00361335|4193131|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
1714417|NCT00361335|4193132|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
1714418|NCT00361335|4193133|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
1714419|NCT00361335|4193134|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
1714420|NCT00361335|4193128|P7|COMPLETED|SC Period: Week E0 to Week E24||164
1714421|NCT00361335|4193129|P6|COMPLETED|SC Period: Week E0 to Week E24||23
1714422|NCT00361335|4193130|P5|COMPLETED|SC Period: Week E0 to Week E24||3
1714423|NCT00361335|4193131|P4|COMPLETED|SC Period: Week E0 to Week E24||59
1714424|NCT00361335|4193132|P3|COMPLETED|SC Period: Week E0 to Week E24||99
1714425|NCT00361335|4193133|P2|COMPLETED|SC Period: Week E0 to Week E24||56
1714426|NCT00361335|4193134|P1|COMPLETED|SC Period: Week E0 to Week E24||80
1714427|NCT00361335|4193128|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
1714428|NCT00361335|4193129|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
1714429|NCT00361335|4193130|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
1714430|NCT00361335|4193131|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
1714431|NCT00361335|4193132|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
1714432|NCT00361335|4193133|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
1714433|NCT00361335|4193134|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
1714434|NCT00361335|4193128|P7|NOT COMPLETED|IV Period: Baseline to E0||0
1714435|NCT00361335|4193129|P6|NOT COMPLETED|IV Period: Baseline to E0||0
1714436|NCT00361335|4193130|P5|NOT COMPLETED|IV Period: Baseline to E0||24
1714437|NCT00361335|4193131|P4|NOT COMPLETED|IV Period: Baseline to E0||27
1714438|NCT00361335|4193132|P3|NOT COMPLETED|IV Period: Baseline to E0||21
1714439|NCT00361335|4193133|P2|NOT COMPLETED|IV Period: Baseline to E0||29
1714440|NCT00361335|4193134|P1|NOT COMPLETED|IV Period: Baseline to E0||20
1714441|NCT00361335|4193128|P7|COMPLETED|IV Period: Baseline to E0||0
1714442|NCT00361335|4193129|P6|COMPLETED|IV Period: Baseline to E0||0
1714443|NCT00361335|4193130|P5|COMPLETED|IV Period: Baseline to E0||105
1714444|NCT00361335|4193131|P4|COMPLETED|IV Period: Baseline to E0||102
1714445|NCT00361335|4193132|P3|COMPLETED|IV Period: Baseline to E0||107
1714446|NCT00361335|4193133|P2|COMPLETED|IV Period: Baseline to E0||99
1714447|NCT00361335|4193134|P1|COMPLETED|IV Period: Baseline to E0||109
1714448|NCT00361335|4193128|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
1714449|NCT00361335|4193129|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
1714450|NCT00361335|4193130|P5|STARTED|IV Period: Baseline to E0||129
1714451|NCT00361335|4193131|P4|STARTED|IV Period: Baseline to E0||129
1714452|NCT00361335|4193132|P3|STARTED|IV Period: Baseline to E0||128
1714453|NCT00361335|4193133|P2|STARTED|IV Period: Baseline to E0||128
1714454|NCT00361335|4193134|P1|STARTED|IV Period: Baseline to E0||129
1714455|NCT00361296|4193178|P1|NOT COMPLETED|Overall Study||3
1714456|NCT00361296|4193178|P1|COMPLETED|Overall Study||2
1714457|NCT00361296|4193178|P1|STARTED|Overall Study||5
1714458|NCT00361283|4193185|P1|NOT COMPLETED|Overall Study||27
1714459|NCT00361283|4193185|P1|COMPLETED|Overall Study||81
1714460|NCT00361283|4193185|P1|STARTED|Overall Study||108
1714461|NCT00361270|4193193|P4|NOT COMPLETED|Overall Study||13
1714462|NCT00361270|4193194|P3|NOT COMPLETED|Overall Study||10
1714463|NCT00361270|4193195|P2|NOT COMPLETED|Overall Study||14
1714464|NCT00361270|4193196|P1|NOT COMPLETED|Overall Study||24
1714465|NCT00361270|4193193|P4|COMPLETED|Overall Study||25
1714466|NCT00361270|4193194|P3|COMPLETED|Overall Study||25
1714467|NCT00361270|4193195|P2|COMPLETED|Overall Study||25
1714468|NCT00361270|4193196|P1|COMPLETED|Overall Study||25
1714469|NCT00361270|4193193|P4|STARTED|Overall Study||38
1714470|NCT00361270|4193194|P3|STARTED|Overall Study||35
1714471|NCT00361270|4193195|P2|STARTED|Overall Study||39
1714472|NCT00361270|4193196|P1|STARTED|Overall Study||49
1714473|NCT00361257|4193216|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
1714474|NCT00361257|4193217|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
1714475|NCT00361257|4193216|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
1714476|NCT00361257|4193217|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
1714477|NCT00361257|4193216|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
1714478|NCT00361257|4193217|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
1714479|NCT00361257|4193216|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
1714480|NCT00361257|4193217|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
1714481|NCT00361257|4193216|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
1714482|NCT00361257|4193217|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
1714483|NCT00361257|4193216|P2|STARTED|Step 1: Minocycline vs. Placebo||55
1714484|NCT00361257|4193217|P1|STARTED|Step 1: Minocycline vs. Placebo||52
1714485|NCT00361231|4193269|P1|NOT COMPLETED|Overall Study||34
1714486|NCT00361231|4193269|P1|COMPLETED|Overall Study||1
1714487|NCT00361231|4193269|P1|STARTED|Overall Study||35
1714488|NCT00361218|4193274|P1|NOT COMPLETED|Overall Study||23
1714489|NCT00361218|4193274|P1|COMPLETED|Overall Study||30
1714490|NCT00361218|4193274|P1|Completed Baseline Assessment|Overall Study||47
1714491|NCT00361218|4193274|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
1714492|NCT00361140|4193282|P3|NOT COMPLETED|Overall Study||0
1714493|NCT00361140|4193283|P2|NOT COMPLETED|Overall Study||0
1714494|NCT00361140|4193284|P1|NOT COMPLETED|Overall Study||0
1714495|NCT00361140|4193282|P3|COMPLETED|Overall Study||3
1714496|NCT00361140|4193283|P2|COMPLETED|Overall Study||29
1714497|NCT00361140|4193284|P1|COMPLETED|Overall Study||40
1714498|NCT00361140|4193282|P3|STARTED|Overall Study||3
1714499|NCT00361140|4193283|P2|STARTED|Overall Study||29
1714500|NCT00361140|4193284|P1|STARTED|Overall Study||40
1714501|NCT00360971|4193297|P2|NOT COMPLETED|Overall Study||0
1714502|NCT00360971|4193298|P1|NOT COMPLETED|Overall Study||0
1714503|NCT00360971|4193297|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
1714504|NCT00360971|4193298|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
1714505|NCT00360971|4193297|P2|STARTED|Overall Study||11
1714506|NCT00360971|4193298|P1|STARTED|Overall Study||10
1714507|NCT00360828|4193314|P1|NOT COMPLETED|Overall Study||1
1714508|NCT00360828|4193314|P1|COMPLETED|Overall Study||9
1714509|NCT00360828|4193314|P1|STARTED|Overall Study||10
1714510|NCT00360724|4193324|P2|NOT COMPLETED|Overall Study||4
1714511|NCT00360724|4193325|P1|NOT COMPLETED|Overall Study||4
1714512|NCT00360724|4193324|P2|COMPLETED|Overall Study||28
1714513|NCT00360724|4193325|P1|COMPLETED|Overall Study||29
1714514|NCT00360724|4193324|P2|STARTED|Overall Study||32
1714515|NCT00360724|4193325|P1|STARTED|Overall Study||33
1714516|NCT00360698|4193353|P2|NOT COMPLETED|Treatment Period||1
1714517|NCT00360698|4193354|P1|NOT COMPLETED|Treatment Period||1
1714518|NCT00360698|4193353|P2|COMPLETED|Treatment Period||56
1714519|NCT00360698|4193354|P1|COMPLETED|Treatment Period||48
1714520|NCT00360698|4193353|P2|STARTED|Treatment Period||57
1714521|NCT00360698|4193354|P1|STARTED|Treatment Period||49
1714522|NCT00360698|4193353|P2|NOT COMPLETED|Run-In||10
1714523|NCT00360698|4193354|P1|NOT COMPLETED|Run-In||0
1714524|NCT00360698|4193353|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
1714525|NCT00360698|4193354|P1|COMPLETED|Run-In||0
1714526|NCT00360698|4193353|P2|STARTED|Run-In||135
1714527|NCT00360698|4193354|P1|STARTED|Run-In||0
1714528|NCT00360685|4193382|P2|NOT COMPLETED|Overall Study||0
1714529|NCT00360685|4193383|P1|NOT COMPLETED|Overall Study||0
1714530|NCT00360685|4193382|P2|COMPLETED|Overall Study||42
1714531|NCT00360685|4193383|P1|COMPLETED|Overall Study||47
1714532|NCT00360685|4193382|P2|STARTED|Overall Study||42
1714533|NCT00360685|4193383|P1|STARTED|Overall Study||47
1714534|NCT00360672|4193393|P1|NOT COMPLETED|Overall Study||0
1714535|NCT00360672|4193393|P1|COMPLETED|Overall Study||27
1714536|NCT00360672|4193393|P1|STARTED|Overall Study||27
1714537|NCT00360568|4193399|P2|NOT COMPLETED|Overall Study||5
1714538|NCT00360568|4193400|P1|NOT COMPLETED|Overall Study||2
1714539|NCT00360568|4193399|P2|COMPLETED|Overall Study||24
1714540|NCT00360568|4193400|P1|COMPLETED|Overall Study||31
1714541|NCT00360568|4193399|P2|STARTED|Overall Study||29
1714542|NCT00360568|4193400|P1|STARTED|Overall Study||33
1714543|NCT00360555|4193511|P4|NOT COMPLETED|Overall Study||112
1714544|NCT00360555|4193512|P3|NOT COMPLETED|Overall Study||145
1714545|NCT00360555|4193513|P2|NOT COMPLETED|Overall Study||134
1714546|NCT00360555|4193514|P1|NOT COMPLETED|Overall Study||122
1714547|NCT00360555|4193511|P4|COMPLETED|Overall Study||287
1714548|NCT00360555|4193512|P3|COMPLETED|Overall Study||251
1714549|NCT00360555|4193513|P2|COMPLETED|Overall Study||259
1714550|NCT00360555|4193514|P1|COMPLETED|Overall Study||274
1714551|NCT00360555|4193511|P4|STARTED|Overall Study||399
1714552|NCT00360555|4193512|P3|STARTED|Overall Study||396
1714553|NCT00360555|4193513|P2|STARTED|Overall Study||393
1714554|NCT00360555|4193514|P1|STARTED|Overall Study||396
1714555|NCT00360529|4193531|P3|NOT COMPLETED|Overall Study||91
1714556|NCT00360529|4193532|P2|NOT COMPLETED|Overall Study||65
1714557|NCT00360529|4193533|P1|NOT COMPLETED|Overall Study||61
1714558|NCT00360529|4193531|P3|COMPLETED|Overall Study||199
1714559|NCT00360529|4193532|P2|COMPLETED|Overall Study||230
1714560|NCT00360529|4193533|P1|COMPLETED|Overall Study||234
1714561|NCT00360529|4193531|P3|STARTED|Overall Study||290
1714562|NCT00360529|4193532|P2|STARTED|Overall Study||295
1714563|NCT00360529|4193533|P1|STARTED|Overall Study||295
1714564|NCT00360490|4193561|P2|NOT COMPLETED|Overall Study||11
1714565|NCT00360490|4193562|P1|NOT COMPLETED|Overall Study||9
1714566|NCT00360490|4193561|P2|COMPLETED|Overall Study||72
1714567|NCT00360490|4193562|P1|COMPLETED|Overall Study||73
1714568|NCT00360490|4193561|P2|STARTED|Overall Study||83
1714569|NCT00360490|4193562|P1|STARTED|Overall Study||82
1714570|NCT00360412|4193597|P2|NOT COMPLETED|Overall Study||662
1714571|NCT00360412|4193598|P1|NOT COMPLETED|Overall Study||333
1714572|NCT00360412|4193597|P2|COMPLETED|Overall Study||2
1714573|NCT00360412|4193598|P1|COMPLETED|Overall Study||0
1714574|NCT00360412|4193597|P2|STARTED|Overall Study||664
1714575|NCT00360412|4193598|P1|STARTED|Overall Study||333
1714576|NCT00360399|4193613|P3|NOT COMPLETED|Overall Study||46
1714577|NCT00360399|4193614|P2|NOT COMPLETED|Overall Study||36
1714578|NCT00360399|4193615|P1|NOT COMPLETED|Overall Study||28
1714579|NCT00360399|4193613|P3|COMPLETED|Overall Study||69
1714580|NCT00360399|4193614|P2|COMPLETED|Overall Study||79
1714581|NCT00360399|4193615|P1|COMPLETED|Overall Study||86
1714582|NCT00360399|4193613|P3|Had Post-randomization Assessment|Overall Study||105
1714583|NCT00360399|4193614|P2|Had Post-randomization Assessment|Overall Study||106
1714584|NCT00360399|4193615|P1|Had Post-randomization Assessment|Overall Study||105
1714585|NCT00360399|4193613|P3|STARTED|Overall Study||115
1714586|NCT00360399|4193614|P2|STARTED|Overall Study||115
1714587|NCT00360399|4193615|P1|STARTED|Overall Study||114
1714588|NCT00360360|4193638|P1|NOT COMPLETED|Overall Study||6
1714589|NCT00360360|4193638|P1|COMPLETED|Overall Study||54
1714590|NCT00360360|4193638|P1|STARTED|Overall Study||60
1714591|NCT00360334|4193645|P2|NOT COMPLETED|Overall Study||13
1714592|NCT00360334|4193646|P1|NOT COMPLETED|Overall Study||19
1714593|NCT00360334|4193645|P2|COMPLETED|Overall Study||104
1714594|NCT00360334|4193646|P1|COMPLETED|Overall Study||99
1714595|NCT00360334|4193645|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
1714596|NCT00360334|4193646|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
1714597|NCT00360334|4193645|P2|STARTED|Overall Study||117
1714598|NCT00360334|4193646|P1|STARTED|Overall Study||118
1714599|NCT00360308|4193709|P3|NOT COMPLETED|Overall Study||88
1714600|NCT00360308|4193710|P2|NOT COMPLETED|Overall Study||79
1714601|NCT00360308|4193711|P1|NOT COMPLETED|Overall Study||76
1714602|NCT00360308|4193709|P3|COMPLETED|Overall Study||154
1714603|NCT00360308|4193710|P2|COMPLETED|Overall Study||155
1714604|NCT00360308|4193711|P1|COMPLETED|Overall Study||171
1714605|NCT00360308|4193709|P3|STARTED|Overall Study||242
1714606|NCT00360308|4193710|P2|STARTED|Overall Study||234
1714607|NCT00360308|4193711|P1|STARTED|Overall Study||247
1714608|NCT00360282|4193728|P4|NOT COMPLETED|Second Intervention||0
1714609|NCT00360282|4193729|P3|NOT COMPLETED|Second Intervention||0
1714610|NCT00360282|4193730|P2|NOT COMPLETED|Second Intervention||1
1714611|NCT00360282|4193731|P1|NOT COMPLETED|Second Intervention||0
1714612|NCT00360282|4193728|P4|COMPLETED|Second Intervention||6
1714613|NCT00360282|4193729|P3|COMPLETED|Second Intervention||6
1714614|NCT00360282|4193730|P2|COMPLETED|Second Intervention||7
1714615|NCT00360282|4193731|P1|COMPLETED|Second Intervention||6
1714616|NCT00360282|4193728|P4|STARTED|Second Intervention||6
1714617|NCT00360282|4193729|P3|STARTED|Second Intervention||6
1714618|NCT00360282|4193730|P2|STARTED|Second Intervention||8
1714619|NCT00360282|4193731|P1|STARTED|Second Intervention||6
1714620|NCT00360282|4193728|P4|NOT COMPLETED|Washout 1-3 Weeks||0
1714621|NCT00360282|4193729|P3|NOT COMPLETED|Washout 1-3 Weeks||1
1714622|NCT00360282|4193730|P2|NOT COMPLETED|Washout 1-3 Weeks||0
1714623|NCT00360282|4193731|P1|NOT COMPLETED|Washout 1-3 Weeks||0
1714624|NCT00360282|4193728|P4|COMPLETED|Washout 1-3 Weeks||6
1714625|NCT00360282|4193729|P3|COMPLETED|Washout 1-3 Weeks||6
1714626|NCT00360282|4193730|P2|COMPLETED|Washout 1-3 Weeks||8
1714627|NCT00360282|4193731|P1|COMPLETED|Washout 1-3 Weeks||6
1714628|NCT00360282|4193728|P4|STARTED|Washout 1-3 Weeks||6
1714629|NCT00360282|4193729|P3|STARTED|Washout 1-3 Weeks||7
1714630|NCT00360282|4193730|P2|STARTED|Washout 1-3 Weeks||8
1714631|NCT00360282|4193731|P1|STARTED|Washout 1-3 Weeks||6
1714632|NCT00360282|4193728|P4|NOT COMPLETED|First Intervention||0
1714633|NCT00360282|4193729|P3|NOT COMPLETED|First Intervention||0
1714634|NCT00360282|4193730|P2|NOT COMPLETED|First Intervention||0
1714635|NCT00360282|4193731|P1|NOT COMPLETED|First Intervention||0
1714636|NCT00360282|4193728|P4|COMPLETED|First Intervention||6
1714637|NCT00360282|4193729|P3|COMPLETED|First Intervention||7
1714638|NCT00360282|4193730|P2|COMPLETED|First Intervention||8
1714639|NCT00360282|4193731|P1|COMPLETED|First Intervention||6
1714640|NCT00360282|4193728|P4|STARTED|First Intervention||6
1714641|NCT00360282|4193729|P3|STARTED|First Intervention||7
1714642|NCT00360282|4193730|P2|STARTED|First Intervention||8
1714643|NCT00360282|4193731|P1|STARTED|First Intervention||6
1714644|NCT00360269|4193743|P2|NOT COMPLETED|Overall Study||12
1714645|NCT00360269|4193744|P1|NOT COMPLETED|Overall Study||10
1714646|NCT00360269|4193743|P2|COMPLETED|Overall Study||7
1714647|NCT00360269|4193744|P1|COMPLETED|Overall Study||9
1714648|NCT00360269|4193743|P2|STARTED|Overall Study||19
1714649|NCT00360269|4193744|P1|STARTED|Overall Study||19
1714650|NCT00360243|4193762|P4|NOT COMPLETED|Overall Study||125
1714651|NCT00360243|4193763|P3|NOT COMPLETED|Overall Study||156
1714652|NCT00360243|4193764|P2|NOT COMPLETED|Overall Study||120
1714653|NCT00360243|4193765|P1|NOT COMPLETED|Overall Study||102
1714654|NCT00360243|4193762|P4|COMPLETED|Overall Study||224
1714655|NCT00360243|4193763|P3|COMPLETED|Overall Study||180
1714656|NCT00360243|4193764|P2|COMPLETED|Overall Study||243
1714657|NCT00360243|4193765|P1|COMPLETED|Overall Study||235
1714658|NCT00360243|4193762|P4|STARTED|Overall Study||349
1714659|NCT00360243|4193763|P3|STARTED|Overall Study||336
1714660|NCT00360243|4193764|P2|STARTED|Overall Study||363
1714661|NCT00360243|4193765|P1|STARTED|Overall Study||337
1714662|NCT00360230|4193786|P7|NOT COMPLETED|Overall Study||2
1714663|NCT00360230|4193787|P6|NOT COMPLETED|Overall Study||4
1714664|NCT00360230|4193788|P5|NOT COMPLETED|Overall Study||5
1714665|NCT00360230|4193789|P4|NOT COMPLETED|Overall Study||2
1714666|NCT00360230|4193790|P3|NOT COMPLETED|Overall Study||3
1714667|NCT00360230|4193791|P2|NOT COMPLETED|Overall Study||3
1714668|NCT00360230|4193792|P1|NOT COMPLETED|Overall Study||6
1714669|NCT00360230|4193786|P7|COMPLETED|Overall Study||43
1714670|NCT00360230|4193787|P6|COMPLETED|Overall Study||86
1714671|NCT00360230|4193788|P5|COMPLETED|Overall Study||85
1714672|NCT00360230|4193789|P4|COMPLETED|Overall Study||88
1714673|NCT00360230|4193790|P3|COMPLETED|Overall Study||42
1714674|NCT00360230|4193791|P2|COMPLETED|Overall Study||87
1714675|NCT00360230|4193792|P1|COMPLETED|Overall Study||84
1714676|NCT00360230|4193786|P7|STARTED|Overall Study||45
1714677|NCT00360230|4193787|P6|STARTED|Overall Study||90
1714678|NCT00360230|4193788|P5|STARTED|Overall Study||90
1714679|NCT00360230|4193789|P4|STARTED|Overall Study||90
1714680|NCT00360230|4193790|P3|STARTED|Overall Study||45
1714681|NCT00360230|4193791|P2|STARTED|Overall Study||90
1714682|NCT00360230|4193792|P1|STARTED|Overall Study||90
1714683|NCT00360126|4193843|P1|NOT COMPLETED|Overall Study||0
1714684|NCT00360126|4193843|P1|COMPLETED|Overall Study||11
1714685|NCT00360126|4193843|P1|STARTED|Overall Study||11
1714686|NCT00360009|4193850|P3|NOT COMPLETED|Overall Study||3
1714687|NCT00360009|4193851|P2|NOT COMPLETED|Overall Study||4
1714688|NCT00360009|4193852|P1|NOT COMPLETED|Overall Study||0
1714689|NCT00360009|4193850|P3|COMPLETED|Overall Study||23
1714690|NCT00360009|4193851|P2|COMPLETED|Overall Study||22
1714691|NCT00360009|4193852|P1|COMPLETED|Overall Study||10
1714692|NCT00360009|4193850|P3|STARTED|Overall Study||26
1714693|NCT00360009|4193851|P2|STARTED|Overall Study||26
1714694|NCT00360009|4193852|P1|STARTED|Overall Study||10
1714695|NCT00359983|4193893|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
1714696|NCT00359983|4193894|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
1714697|NCT00359983|4193895|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
1714698|NCT00359983|4193893|P3|COMPLETED|Year 5 Persistence Follow-up||42
1714699|NCT00359983|4193894|P2|COMPLETED|Year 5 Persistence Follow-up||44
1714700|NCT00359983|4193895|P1|COMPLETED|Year 5 Persistence Follow-up||95
1714701|NCT00359983|4193893|P3|STARTED|Year 5 Persistence Follow-up||42
1714702|NCT00359983|4193894|P2|STARTED|Year 5 Persistence Follow-up||44
1714703|NCT00359983|4193895|P1|STARTED|Year 5 Persistence Follow-up||95
1714704|NCT00359983|4193893|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
1714705|NCT00359983|4193894|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
1714706|NCT00359983|4193895|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
1714707|NCT00359983|4193893|P3|COMPLETED|Year 3 Persistence Follow-up||51
1714708|NCT00359983|4193894|P2|COMPLETED|Year 3 Persistence Follow-up||47
1714709|NCT00359983|4193895|P1|COMPLETED|Year 3 Persistence Follow-up||103
1714710|NCT00359983|4193893|P3|STARTED|Year 3 Persistence Follow-up||51
1714711|NCT00359983|4193894|P2|STARTED|Year 3 Persistence Follow-up||47
1714712|NCT00359983|4193895|P1|STARTED|Year 3 Persistence Follow-up||103
1714713|NCT00359983|4193893|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
1714714|NCT00359983|4193894|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
1714715|NCT00359983|4193895|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
1714716|NCT00359983|4193893|P3|COMPLETED|Year 1 Persistence Follow-up||62
1714717|NCT00359983|4193894|P2|COMPLETED|Year 1 Persistence Follow-up||70
1714718|NCT00359983|4193895|P1|COMPLETED|Year 1 Persistence Follow-up||138
1714719|NCT00359983|4193893|P3|STARTED|Year 1 Persistence Follow-up||62
1714720|NCT00359983|4193894|P2|STARTED|Year 1 Persistence Follow-up||70
1714721|NCT00359983|4193895|P1|STARTED|Year 1 Persistence Follow-up||138
1714722|NCT00359944|4193930|P3|NOT COMPLETED|Overall Study||19
1714723|NCT00359944|4193931|P2|NOT COMPLETED|Overall Study||19
1714724|NCT00359944|4193932|P1|NOT COMPLETED|Overall Study||16
1714725|NCT00359944|4193930|P3|COMPLETED|Overall Study||38
1714726|NCT00359944|4193931|P2|COMPLETED|Overall Study||28
1714727|NCT00359944|4193932|P1|COMPLETED|Overall Study||34
1714728|NCT00359944|4193930|P3|STARTED|Overall Study||57
1714729|NCT00359944|4193931|P2|STARTED|Overall Study||47
1714730|NCT00359944|4193932|P1|STARTED|Overall Study||50
1714731|NCT00359801|4193948|P2|NOT COMPLETED|Overall Study||220
1714732|NCT00359801|4193949|P1|NOT COMPLETED|Overall Study||305
1714733|NCT00359801|4193948|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
1714734|NCT00359801|4193949|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
1714735|NCT00359801|4193948|P2|STARTED|Overall Study||989
1714736|NCT00359801|4193949|P1|STARTED|Overall Study||987
1714737|NCT00359788|4193983|P2|NOT COMPLETED|Overall Study||17
1714738|NCT00359788|4193984|P1|NOT COMPLETED|Overall Study||23
1714739|NCT00359788|4193983|P2|COMPLETED|Overall Study||159
1714740|NCT00359788|4193984|P1|COMPLETED|Overall Study||150
1714741|NCT00359788|4193983|P2|STARTED|Overall Study||176
1714742|NCT00359788|4193984|P1|STARTED|Overall Study||173
1714743|NCT00359762|4194218|P5|NOT COMPLETED|Period I||0
1714744|NCT00359762|4194219|P4|NOT COMPLETED|Period I||0
1714745|NCT00359762|4194220|P3|NOT COMPLETED|Period I||0
1714746|NCT00359762|4194221|P2|NOT COMPLETED|Period I||0
1714747|NCT00359762|4194222|P1|NOT COMPLETED|Period I||0
1714748|NCT00359762|4194218|P5|COMPLETED|Period I||0
1714749|NCT00359762|4194219|P4|COMPLETED|Period I||0
1714750|NCT00359762|4194220|P3|COMPLETED|Period I||0
1714751|NCT00359762|4194221|P2|COMPLETED|Period I||0
1714752|NCT00359762|4194222|P1|COMPLETED|Period I||0
1714753|NCT00359762|4194218|P5|STARTED|Period I||0
1714754|NCT00359762|4194219|P4|STARTED|Period I||0
1714755|NCT00359762|4194220|P3|STARTED|Period I||0
1714756|NCT00359762|4194221|P2|STARTED|Period I||0
1714757|NCT00359762|4194222|P1|STARTED|Period I||0
1714758|NCT00359762|4194218|P5|NOT COMPLETED|Period III||0
1714759|NCT00359762|4194219|P4|NOT COMPLETED|Period III||65
1714760|NCT00359762|4194220|P3|NOT COMPLETED|Period III||30
1714761|NCT00359762|4194221|P2|NOT COMPLETED|Period III||29
1714762|NCT00359762|4194222|P1|NOT COMPLETED|Period III||0
1714763|NCT00359762|4194218|P5|COMPLETED|Period III||0
1714764|NCT00359762|4194219|P4|COMPLETED|Period III||101
1714765|NCT00359762|4194220|P3|COMPLETED|Period III||47
1714766|NCT00359762|4194221|P2|COMPLETED|Period III||48
1714767|NCT00359762|4194222|P1|COMPLETED|Period III||0
1714768|NCT00359762|4194218|P5|Extension ITT Efficacy Population|Period III||0
1714769|NCT00359762|4194219|P4|Extension ITT Efficacy Population|Period III||164
1714770|NCT00359762|4194220|P3|Extension ITT Efficacy Population|Period III||75
1714771|NCT00359762|4194221|P2|Extension ITT Efficacy Population|Period III||73
1714772|NCT00359762|4194222|P1|Extension ITT Efficacy Population|Period III||0
1714773|NCT00359762|4194218|P5|Extension ITT Safety Population|Period III||0
1714774|NCT00359762|4194219|P4|Extension ITT Safety Population|Period III||166
1714775|NCT00359762|4194220|P3|Extension ITT Safety Population|Period III||76
1714776|NCT00359762|4194221|P2|Extension ITT Safety Population|Period III||74
1714777|NCT00359762|4194222|P1|Extension ITT Safety Population|Period III||0
1714778|NCT00359762|4194218|P5|STARTED|Period III||0
1714779|NCT00359762|4194219|P4|STARTED|Period III||166
1714780|NCT00359762|4194220|P3|STARTED|Period III||77
1714781|NCT00359762|4194221|P2|STARTED|Period III||77
1714782|NCT00359762|4194222|P1|STARTED|Period III||0
1714783|NCT00359762|4194218|P5|NOT COMPLETED|Period II||174
1714784|NCT00359762|4194219|P4|NOT COMPLETED|Period II||0
1714785|NCT00359762|4194220|P3|NOT COMPLETED|Period II||0
1714786|NCT00359762|4194221|P2|NOT COMPLETED|Period II||0
1714787|NCT00359762|4194222|P1|NOT COMPLETED|Period II||128
1714788|NCT00359762|4194218|P5|COMPLETED|Period II||341
1714789|NCT00359762|4194219|P4|COMPLETED|Period II||0
1714790|NCT00359762|4194220|P3|COMPLETED|Period II||0
1714791|NCT00359762|4194221|P2|COMPLETED|Period II||0
1714792|NCT00359762|4194222|P1|COMPLETED|Period II||386
1714793|NCT00359762|4194218|P5|Without Treatment Failure|Period II||138
1714794|NCT00359762|4194219|P4|Without Treatment Failure|Period II||0
1714795|NCT00359762|4194220|P3|Without Treatment Failure|Period II||0
1714796|NCT00359762|4194221|P2|Without Treatment Failure|Period II||0
1714797|NCT00359762|4194222|P1|Without Treatment Failure|Period II||124
1714798|NCT00359762|4194218|P5|Met Primary Endpoint|Period II||203
1714799|NCT00359762|4194219|P4|Met Primary Endpoint|Period II||0
1714800|NCT00359762|4194220|P3|Met Primary Endpoint|Period II||0
1714801|NCT00359762|4194221|P2|Met Primary Endpoint|Period II||0
1714802|NCT00359762|4194222|P1|Met Primary Endpoint|Period II||262
1714803|NCT00359762|4194218|P5|ITT Efficacy Population|Period II||490
1714804|NCT00359762|4194219|P4|ITT Efficacy Population|Period II||0
1714805|NCT00359762|4194220|P3|ITT Efficacy Population|Period II||0
1714806|NCT00359762|4194221|P2|ITT Efficacy Population|Period II||0
1714807|NCT00359762|4194222|P1|ITT Efficacy Population|Period II||487
1714808|NCT00359762|4194218|P5|Intent to Treat (ITT) Safety Population|Period II||511
1714809|NCT00359762|4194219|P4|Intent to Treat (ITT) Safety Population|Period II||0
1714810|NCT00359762|4194220|P3|Intent to Treat (ITT) Safety Population|Period II||0
1714811|NCT00359762|4194221|P2|Intent to Treat (ITT) Safety Population|Period II||0
1714812|NCT00359762|4194222|P1|Intent to Treat (ITT) Safety Population|Period II||508
1714813|NCT00359762|4194218|P5|STARTED|Period II||515
1714814|NCT00359762|4194219|P4|STARTED|Period II||0
1714815|NCT00359762|4194220|P3|STARTED|Period II||0
1714816|NCT00359762|4194221|P2|STARTED|Period II||0
1714817|NCT00359762|4194222|P1|STARTED|Period II||514
1714818|NCT00359736|4194285|P2|NOT COMPLETED|Overall Study||0
1714819|NCT00359736|4194286|P1|NOT COMPLETED|Overall Study||0
1714820|NCT00359736|4194285|P2|COMPLETED|Overall Study||15
1714821|NCT00359736|4194286|P1|COMPLETED|Overall Study||14
1714822|NCT00359736|4194285|P2|STARTED|Overall Study||15
1714823|NCT00359736|4194286|P1|STARTED|Overall Study||14
1714824|NCT00359632|4194296|P2|NOT COMPLETED|Overall Study||0
1714825|NCT00359632|4194297|P1|NOT COMPLETED|Overall Study||4
1714826|NCT00359632|4194296|P2|COMPLETED|Overall Study||9
1714827|NCT00359632|4194297|P1|COMPLETED|Overall Study||20
1714828|NCT00359632|4194296|P2|STARTED|Overall Study||9
1714829|NCT00359632|4194297|P1|STARTED|Overall Study||24
1714830|NCT00359619|4194311|P7|NOT COMPLETED|Overall Study||4
1714831|NCT00359619|4194312|P6|NOT COMPLETED|Overall Study||5
1714832|NCT00359619|4194313|P5|NOT COMPLETED|Overall Study||3
1714833|NCT00359619|4194314|P4|NOT COMPLETED|Overall Study||3
1714834|NCT00359619|4194315|P3|NOT COMPLETED|Overall Study||7
1714835|NCT00359619|4194316|P2|NOT COMPLETED|Overall Study||5
1714836|NCT00359619|4194317|P1|NOT COMPLETED|Overall Study||8
1714837|NCT00359619|4194311|P7|COMPLETED|Overall Study||46
1714838|NCT00359619|4194312|P6|COMPLETED|Overall Study||45
1714839|NCT00359619|4194313|P5|COMPLETED|Overall Study||45
1714840|NCT00359619|4194314|P4|COMPLETED|Overall Study||45
1714841|NCT00359619|4194315|P3|COMPLETED|Overall Study||42
1714842|NCT00359619|4194316|P2|COMPLETED|Overall Study||45
1714843|NCT00359619|4194317|P1|COMPLETED|Overall Study||80
1714844|NCT00359619|4194311|P7|STARTED|Overall Study||50
1714845|NCT00359619|4194312|P6|STARTED|Overall Study||50
1714846|NCT00359619|4194313|P5|STARTED|Overall Study||48
1714847|NCT00359619|4194314|P4|STARTED|Overall Study||48
1714848|NCT00359619|4194315|P3|STARTED|Overall Study||49
1714849|NCT00359619|4194316|P2|STARTED|Overall Study||50
1714850|NCT00359619|4194317|P1|STARTED|Overall Study||88
1714851|NCT00359424|4194447|P2|NOT COMPLETED|Overall Study||67
1714852|NCT00359424|4194448|P1|NOT COMPLETED|Overall Study||130
1714853|NCT00359424|4194447|P2|COMPLETED|Overall Study||155
1714854|NCT00359424|4194448|P1|COMPLETED|Overall Study||304
1714855|NCT00359424|4194447|P2|270 Day Follow up|Overall Study||159
1714856|NCT00359424|4194448|P1|270 Day Follow up|Overall Study||313
1714857|NCT00359424|4194447|P2|180 Day Follow up|Overall Study||167
1714858|NCT00359424|4194448|P1|180 Day Follow up|Overall Study||325
1714859|NCT00359424|4194447|P2|90 Day Follow up|Overall Study||172
1714860|NCT00359424|4194448|P1|90 Day Follow up|Overall Study||343
1714861|NCT00359424|4194447|P2|STARTED|Overall Study||222
1714862|NCT00359424|4194448|P1|STARTED|Overall Study||434
1714863|NCT00359281|4194487|P9|NOT COMPLETED|Overall Study||0
1714864|NCT00359281|4194488|P8|NOT COMPLETED|Overall Study||0
1714865|NCT00359281|4194489|P7|NOT COMPLETED|Overall Study||2
1714866|NCT00359281|4194490|P6|NOT COMPLETED|Overall Study||0
1714867|NCT00359281|4194491|P5|NOT COMPLETED|Overall Study||0
1714868|NCT00359281|4194492|P4|NOT COMPLETED|Overall Study||0
1714869|NCT00359281|4194493|P3|NOT COMPLETED|Overall Study||0
1714870|NCT00359281|4194494|P2|NOT COMPLETED|Overall Study||0
1714871|NCT00359281|4194495|P1|NOT COMPLETED|Overall Study||1
1714872|NCT00359281|4194487|P9|COMPLETED|Overall Study||20
1714873|NCT00359281|4194488|P8|COMPLETED|Overall Study||15
1714874|NCT00359281|4194489|P7|COMPLETED|Overall Study||16
1714875|NCT00359281|4194490|P6|COMPLETED|Overall Study||15
1714876|NCT00359281|4194491|P5|COMPLETED|Overall Study||10
1714877|NCT00359281|4194492|P4|COMPLETED|Overall Study||10
1714878|NCT00359281|4194493|P3|COMPLETED|Overall Study||10
1714879|NCT00359281|4194494|P2|COMPLETED|Overall Study||15
1714880|NCT00359281|4194495|P1|COMPLETED|Overall Study||15
1714881|NCT00359281|4194487|P9|STARTED|Overall Study||20
1714882|NCT00359281|4194488|P8|STARTED|Overall Study||15
1714883|NCT00359281|4194489|P7|STARTED|Overall Study||18
1714884|NCT00359281|4194490|P6|STARTED|Overall Study||15
1714885|NCT00359281|4194491|P5|STARTED|Overall Study||10
1714886|NCT00359281|4194492|P4|STARTED|Overall Study||10
1714887|NCT00359281|4194493|P3|STARTED|Overall Study||10
1714888|NCT00359281|4194494|P2|STARTED|Overall Study||15
1714889|NCT00359281|4194495|P1|STARTED|Overall Study||16
1714890|NCT00359216|4194527|P2|NOT COMPLETED|Overall Study||1
1714891|NCT00359216|4194528|P1|NOT COMPLETED|Overall Study||0
1714892|NCT00359216|4194527|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
1714893|NCT00359216|4194528|P1|COMPLETED|Overall Study||20
1714894|NCT00359216|4194527|P2|STARTED|Overall Study||10
1714895|NCT00359216|4194528|P1|STARTED|Overall Study||20
1714896|NCT00359203|4194536|P2|NOT COMPLETED|Overall Study||0
1714897|NCT00359203|4194537|P1|NOT COMPLETED|Overall Study||0
1714898|NCT00359203|4194536|P2|COMPLETED|Overall Study||38
1714899|NCT00359203|4194537|P1|COMPLETED|Overall Study||39
1714900|NCT00359203|4194536|P2|STARTED|Overall Study||38
1714901|NCT00359203|4194537|P1|STARTED|Overall Study||39
1714902|NCT00359138|4194546|P3|NOT COMPLETED|Overall Study||0
1714903|NCT00359138|4194547|P2|NOT COMPLETED|Overall Study||0
1714904|NCT00359138|4194548|P1|NOT COMPLETED|Overall Study||0
1714905|NCT00359138|4194546|P3|COMPLETED|Overall Study||12
1714906|NCT00359138|4194547|P2|COMPLETED|Overall Study||12
1714907|NCT00359138|4194548|P1|COMPLETED|Overall Study||12
1714908|NCT00359138|4194546|P3|STARTED|Overall Study||12
1714909|NCT00359138|4194547|P2|STARTED|Overall Study||12
1714910|NCT00359138|4194548|P1|STARTED|Overall Study||12
1714911|NCT00359073|4194558|P2|NOT COMPLETED|Overall Study||2
1714912|NCT00359073|4194559|P1|NOT COMPLETED|Overall Study||4
1714913|NCT00359073|4194558|P2|COMPLETED|Overall Study||11
1714914|NCT00359073|4194559|P1|COMPLETED|Overall Study||8
1714915|NCT00359073|4194558|P2|STARTED|Overall Study||13
1714916|NCT00359073|4194559|P1|STARTED|Overall Study||12
1714917|NCT00359021|4194571|P2|NOT COMPLETED|Overall Study||52
1714918|NCT00359021|4194572|P1|NOT COMPLETED|Overall Study||81
1714919|NCT00359021|4194571|P2|COMPLETED|Overall Study||195
1714920|NCT00359021|4194572|P1|COMPLETED|Overall Study||175
1714921|NCT00359021|4194571|P2|STARTED|Overall Study||247
1714922|NCT00359021|4194572|P1|STARTED|Overall Study||256
1714923|NCT00358956|4194584|P1|NOT COMPLETED|Overall Study||8
1714924|NCT00358956|4194584|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
1714925|NCT00358956|4194584|P1|STARTED|Overall Study||19
1714926|NCT00358917|4194596|P2|NOT COMPLETED|Overall Study||69
1714927|NCT00358917|4194597|P1|NOT COMPLETED|Overall Study||66
1714928|NCT00358917|4194596|P2|COMPLETED|Overall Study||230
1714929|NCT00358917|4194597|P1|COMPLETED|Overall Study||234
1714930|NCT00358917|4194596|P2|STARTED|Overall Study||299
1714931|NCT00358917|4194597|P1|STARTED|Overall Study||300
1714932|NCT00358826|4194615|P8|NOT COMPLETED|MDCT Substudy||0
1714933|NCT00358826|4194616|P7|NOT COMPLETED|MDCT Substudy||0
1714934|NCT00358826|4194617|P6|NOT COMPLETED|MDCT Substudy||2
1714935|NCT00358826|4194618|P5|NOT COMPLETED|MDCT Substudy||1
1714936|NCT00358826|4194619|P4|NOT COMPLETED|MDCT Substudy||0
1714937|NCT00358826|4194620|P3|NOT COMPLETED|MDCT Substudy||0
1714938|NCT00358826|4194621|P2|NOT COMPLETED|MDCT Substudy||0
1714939|NCT00358826|4194622|P1|NOT COMPLETED|MDCT Substudy||0
1714940|NCT00358826|4194615|P8|COMPLETED|MDCT Substudy||27
1714941|NCT00358826|4194616|P7|COMPLETED|MDCT Substudy||19
1714942|NCT00358826|4194617|P6|COMPLETED|MDCT Substudy||20
1714943|NCT00358826|4194618|P5|COMPLETED|MDCT Substudy||24
1714944|NCT00358826|4194619|P4|COMPLETED|MDCT Substudy||0
1714945|NCT00358826|4194620|P3|COMPLETED|MDCT Substudy||0
1714946|NCT00358826|4194621|P2|COMPLETED|MDCT Substudy||0
1714947|NCT00358826|4194622|P1|COMPLETED|MDCT Substudy||0
1714948|NCT00358826|4194615|P8|STARTED|MDCT Substudy||27
1714949|NCT00358826|4194616|P7|STARTED|MDCT Substudy||19
1714950|NCT00358826|4194617|P6|STARTED|MDCT Substudy||22
1714951|NCT00358826|4194618|P5|STARTED|MDCT Substudy||25
1714952|NCT00358826|4194619|P4|STARTED|MDCT Substudy||0
1714953|NCT00358826|4194620|P3|STARTED|MDCT Substudy||0
1714954|NCT00358826|4194621|P2|STARTED|MDCT Substudy||0
1714955|NCT00358826|4194622|P1|STARTED|MDCT Substudy||0
1714956|NCT00358826|4194615|P8|NOT COMPLETED|Core Study||0
1714957|NCT00358826|4194616|P7|NOT COMPLETED|Core Study||0
1714958|NCT00358826|4194617|P6|NOT COMPLETED|Core Study||0
1714959|NCT00358826|4194618|P5|NOT COMPLETED|Core Study||0
1714960|NCT00358826|4194619|P4|NOT COMPLETED|Core Study||2
1714961|NCT00358826|4194620|P3|NOT COMPLETED|Core Study||2
1714962|NCT00358826|4194621|P2|NOT COMPLETED|Core Study||5
1714963|NCT00358826|4194622|P1|NOT COMPLETED|Core Study||3
1714964|NCT00358826|4194615|P8|COMPLETED|Core Study||0
1714965|NCT00358826|4194616|P7|COMPLETED|Core Study||0
1714966|NCT00358826|4194617|P6|COMPLETED|Core Study||0
1714967|NCT00358826|4194618|P5|COMPLETED|Core Study||0
1714968|NCT00358826|4194619|P4|COMPLETED|Core Study||50
1714969|NCT00358826|4194620|P3|COMPLETED|Core Study||42
1714970|NCT00358826|4194621|P2|COMPLETED|Core Study||41
1714971|NCT00358826|4194622|P1|COMPLETED|Core Study||46
1714972|NCT00358826|4194615|P8|STARTED|Core Study||0
1714973|NCT00358826|4194616|P7|STARTED|Core Study||0
1714974|NCT00358826|4194617|P6|STARTED|Core Study||0
1714975|NCT00358826|4194618|P5|STARTED|Core Study||0
1714976|NCT00358826|4194619|P4|STARTED|Core Study||52
1714977|NCT00358826|4194620|P3|STARTED|Core Study||44
1714978|NCT00358826|4194621|P2|STARTED|Core Study||46
1714979|NCT00358826|4194622|P1|STARTED|Core Study||49
1714980|NCT00358735|4194658|P2|NOT COMPLETED|Overall Study||17
1714981|NCT00358735|4194659|P1|NOT COMPLETED|Overall Study||8
1714982|NCT00358735|4194658|P2|COMPLETED|Overall Study|Efficacy|190
1714983|NCT00358735|4194659|P1|COMPLETED|Overall Study|Efficacy|196
1714984|NCT00358735|4194658|P2|Not Completed Safety|Overall Study||13
1714985|NCT00358735|4194659|P1|Not Completed Safety|Overall Study||6
1714986|NCT00358735|4194658|P2|Completed Safety|Overall Study||194
1714987|NCT00358735|4194659|P1|Completed Safety|Overall Study||198
1714988|NCT00358735|4194658|P2|STARTED|Overall Study||207
1714989|NCT00358735|4194659|P1|STARTED|Overall Study||204
1714990|NCT00358670|4194689|P2|NOT COMPLETED|Overall Study||219
1714991|NCT00358670|4194690|P1|NOT COMPLETED|Overall Study||222
1714992|NCT00358670|4194689|P2|COMPLETED|Overall Study||0
1714993|NCT00358670|4194690|P1|COMPLETED|Overall Study||0
1714994|NCT00358670|4194689|P2|STARTED|Overall Study||219
1714995|NCT00358670|4194690|P1|STARTED|Overall Study||222
1714996|NCT00358644|4194704|P1|NOT COMPLETED|Overall Study||50
1714997|NCT00358644|4194704|P1|COMPLETED|Overall Study||5
1714998|NCT00358644|4194704|P1|STARTED|Overall Study||55
1714999|NCT00358579|4194710|P2|NOT COMPLETED|Overall Study||0
1715000|NCT00358579|4194711|P1|NOT COMPLETED|Overall Study||0
1715001|NCT00358579|4194710|P2|COMPLETED|Overall Study||374
1715002|NCT00358579|4194711|P1|COMPLETED|Overall Study||353
1715003|NCT00358579|4194710|P2|STARTED|Overall Study||374
1715004|NCT00358579|4194711|P1|STARTED|Overall Study||353
1715005|NCT00358527|4194727|P2|NOT COMPLETED|Overall Study||3
1715006|NCT00358527|4194728|P1|NOT COMPLETED|Overall Study||13
1715007|NCT00358527|4194727|P2|COMPLETED|Overall Study||131
1715008|NCT00358527|4194728|P1|COMPLETED|Overall Study||254
1715009|NCT00358527|4194727|P2|STARTED|Overall Study||134
1715010|NCT00358527|4194728|P1|STARTED|Overall Study||267
1715011|NCT00358501|4194738|P2|NOT COMPLETED|Overall Study||0
1715012|NCT00358501|4194739|P1|NOT COMPLETED|Overall Study||0
1715013|NCT00358501|4194738|P2|COMPLETED|Overall Study||32
1715014|NCT00358501|4194739|P1|COMPLETED|Overall Study||102
1715015|NCT00358501|4194738|P2|STARTED|Overall Study||32
1715016|NCT00358501|4194739|P1|STARTED|Overall Study||102
1715017|NCT00358462|4194754|P2|NOT COMPLETED|Overall Study||64
1715018|NCT00358462|4194755|P1|NOT COMPLETED|Overall Study||59
1715019|NCT00358462|4194754|P2|COMPLETED|Overall Study||238
1715020|NCT00358462|4194755|P1|COMPLETED|Overall Study||245
1715021|NCT00358462|4194754|P2|STARTED|Overall Study||302
1715022|NCT00358462|4194755|P1|STARTED|Overall Study||304
1715023|NCT00358449|4194778|P3|NOT COMPLETED|Overall Study||2
1715024|NCT00358449|4194779|P2|NOT COMPLETED|Overall Study||1
1715025|NCT00358449|4194780|P1|NOT COMPLETED|Overall Study||4
1715026|NCT00358449|4194778|P3|COMPLETED|Overall Study||18
1715027|NCT00358449|4194779|P2|COMPLETED|Overall Study||19
1715028|NCT00358449|4194780|P1|COMPLETED|Overall Study||15
1715029|NCT00358449|4194778|P3|STARTED|Overall Study||20
1715030|NCT00358449|4194779|P2|STARTED|Overall Study||20
1715031|NCT00358449|4194780|P1|STARTED|Overall Study||19
1715032|NCT00358436|4194883|P2|NOT COMPLETED|Overall Study||86
1715033|NCT00358436|4194884|P1|NOT COMPLETED|Overall Study||154
1715034|NCT00358436|4194883|P2|COMPLETED|Overall Study||118
1715035|NCT00358436|4194884|P1|COMPLETED|Overall Study||446
1715036|NCT00358436|4194883|P2|STARTED|Overall Study||204
1715037|NCT00358436|4194884|P1|STARTED|Overall Study||600
1715038|NCT00358332|4194900|P4|NOT COMPLETED|Overall Study||0
1715039|NCT00358332|4194901|P3|NOT COMPLETED|Overall Study||1
1715040|NCT00358332|4194902|P2|NOT COMPLETED|Overall Study||3
1715041|NCT00358332|4194903|P1|NOT COMPLETED|Overall Study||0
1715042|NCT00358332|4194900|P4|COMPLETED|Overall Study||25
1715043|NCT00358332|4194901|P3|COMPLETED|Overall Study||29
1715044|NCT00358332|4194902|P2|COMPLETED|Overall Study||27
1715045|NCT00358332|4194903|P1|COMPLETED|Overall Study||15
1715046|NCT00358332|4194900|P4|STARTED|Overall Study||25
1715047|NCT00358332|4194901|P3|STARTED|Overall Study||30
1715048|NCT00358332|4194902|P2|STARTED|Overall Study||30
1715049|NCT00358332|4194903|P1|STARTED|Overall Study||15
1715050|NCT00358215|4194955|P2|NOT COMPLETED|Overall Study||652
1715051|NCT00358215|4194956|P1|NOT COMPLETED|Overall Study||679
1715052|NCT00358215|4194955|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
1715053|NCT00358215|4194956|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
1715054|NCT00358215|4194955|P2|Received Investigational Product|Overall Study||1133
1715055|NCT00358215|4194956|P1|Received Investigational Product|Overall Study||1140
1715056|NCT00358215|4194955|P2|STARTED|Overall Study||1136
1715057|NCT00358215|4194956|P1|STARTED|Overall Study||1142
1715058|NCT00358150|4194970|P1|NOT COMPLETED|Overall Study||7
1715059|NCT00358150|4194970|P1|COMPLETED|Overall Study||19
1715060|NCT00358150|4194970|P1|STARTED|Overall Study||26
1715061|NCT00358007|4194992|P1|NOT COMPLETED|Overall Study||2
1715062|NCT00358007|4194992|P1|COMPLETED|Overall Study||28
1715063|NCT00358007|4194992|P1|STARTED|Overall Study||30
1715064|NCT00357994|4194999|P2|NOT COMPLETED|Overall Study||3
1715065|NCT00357994|4195000|P1|NOT COMPLETED|Overall Study||2
1715066|NCT00357994|4194999|P2|COMPLETED|Overall Study||31
1715067|NCT00357994|4195000|P1|COMPLETED|Overall Study||35
1715068|NCT00357994|4194999|P2|STARTED|Overall Study||34
1715069|NCT00357994|4195000|P1|STARTED|Overall Study||37
1715070|NCT00357968|4195054|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
1715071|NCT00357968|4195055|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
1715072|NCT00357968|4195054|P2|COMPLETED|Crossover Maintenance Dose Phase||55
1715073|NCT00357968|4195055|P1|COMPLETED|Crossover Maintenance Dose Phase||54
1715074|NCT00357968|4195054|P2|STARTED|Crossover Maintenance Dose Phase||55
1715075|NCT00357968|4195055|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
1715076|NCT00357968|4195054|P2|NOT COMPLETED|First Maintenance Dose Phase||44
1715077|NCT00357968|4195055|P1|NOT COMPLETED|First Maintenance Dose Phase||48
1715078|NCT00357968|4195054|P2|COMPLETED|First Maintenance Dose Phase||55
1715079|NCT00357968|4195055|P1|COMPLETED|First Maintenance Dose Phase||54
1715080|NCT00357968|4195054|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
1715081|NCT00357968|4195055|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
1715082|NCT00357968|4195054|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
1715083|NCT00357968|4195055|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
1715084|NCT00357968|4195054|P2|Received Loading Dose|First Maintenance Dose Phase||99
1715085|NCT00357968|4195055|P1|Received Loading Dose|First Maintenance Dose Phase||102
1715086|NCT00357968|4195054|P2|STARTED|First Maintenance Dose Phase||99
1715087|NCT00357968|4195055|P1|STARTED|First Maintenance Dose Phase||102
1715088|NCT00357955|4195099|P2|NOT COMPLETED|Overall Study||3
1715089|NCT00357955|4195100|P1|NOT COMPLETED|Overall Study||6
1715090|NCT00357955|4195099|P2|COMPLETED|Overall Study||51
1715091|NCT00357955|4195100|P1|COMPLETED|Overall Study||58
1715092|NCT00357955|4195099|P2|STARTED|Overall Study||54
1715093|NCT00357955|4195100|P1|STARTED|Overall Study||64
1715094|NCT00357903|4195108|P2|NOT COMPLETED|Overall Study||43
1715095|NCT00357903|4195109|P1|NOT COMPLETED|Overall Study||363
1715096|NCT00357903|4195108|P2|COMPLETED|Overall Study||15
1715097|NCT00357903|4195109|P1|COMPLETED|Overall Study||218
1715098|NCT00357903|4195108|P2|STARTED|Overall Study||58
1715099|NCT00357903|4195109|P1|STARTED|Overall Study||581
1715100|NCT00357877|4195149|P2|NOT COMPLETED|Overall Study||30
1715101|NCT00357877|4195150|P1|NOT COMPLETED|Overall Study||26
1715102|NCT00357877|4195149|P2|COMPLETED|Overall Study||460
1715103|NCT00357877|4195150|P1|COMPLETED|Overall Study||467
1715104|NCT00357877|4195149|P2|STARTED|Overall Study||490
1715105|NCT00357877|4195150|P1|STARTED|Overall Study||493
1715106|NCT00357760|4195164|P2|NOT COMPLETED|Overall Study||35
1715107|NCT00357760|4195165|P1|NOT COMPLETED|Overall Study||59
1715108|NCT00357760|4195164|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
1715109|NCT00357760|4195165|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
1715110|NCT00357760|4195164|P2|Patients Who Undergo Dose Escalation|Overall Study||16
1715201|NCT00356915|4195398|P1|NOT COMPLETED|Overall Study||76
1715111|NCT00357760|4195165|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
1715112|NCT00357760|4195164|P2|Eligible and Treated Patients|Overall Study||32
1715113|NCT00357760|4195165|P1|Eligible and Treated Patients|Overall Study||57
1715114|NCT00357760|4195164|P2|Patients Who Started Treatment|Overall Study||34
1715115|NCT00357760|4195165|P1|Patients Who Started Treatment|Overall Study||57
1715116|NCT00357760|4195164|P2|STARTED|Overall Study||35
1715117|NCT00357760|4195165|P1|STARTED|Overall Study||59
1715118|NCT00357734|4195175|P1|NOT COMPLETED|Overall Study||4
1715119|NCT00357734|4195175|P1|COMPLETED|Overall Study||10
1715120|NCT00357734|4195175|P1|Patient Received 500 mg of ZD1839|Overall Study||1
1715121|NCT00357734|4195175|P1|Patients Received 250 mg of ZD1839|Overall Study||13
1715122|NCT00357734|4195175|P1|STARTED|Overall Study||14
1715123|NCT00357656|4195186|P2|NOT COMPLETED|Overall Study||3
1715124|NCT00357656|4195187|P1|NOT COMPLETED|Overall Study||0
1715125|NCT00357656|4195186|P2|COMPLETED|Overall Study||29
1715126|NCT00357656|4195187|P1|COMPLETED|Overall Study||31
1715127|NCT00357656|4195186|P2|STARTED|Overall Study||32
1715128|NCT00357656|4195187|P1|STARTED|Overall Study||31
1715129|NCT00357552|4195238|P1|NOT COMPLETED|Weeks 24 to 104||5
1715130|NCT00357552|4195238|P1|COMPLETED|Weeks 24 to 104||117
1715131|NCT00357552|4195238|P1|STARTED|Weeks 24 to 104||122
1715132|NCT00357552|4195238|P1|NOT COMPLETED|Weeks 0 to 24||1
1715133|NCT00357552|4195238|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
1715134|NCT00357552|4195238|P1|STARTED|Weeks 0 to 24||123
1715135|NCT00357552|4195238|P1|NOT COMPLETED|Screening||84
1715136|NCT00357552|4195238|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
1715137|NCT00357552|4195238|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
1715138|NCT00357500|4195253|P1|NOT COMPLETED|Overall Study||77
1715139|NCT00357500|4195253|P1|COMPLETED|Overall Study||24
1715140|NCT00357500|4195253|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
1715141|NCT00357500|4195253|P1|STARTED|Overall Study||101
1715142|NCT00357396|4195262|P2|NOT COMPLETED|Overall Study||0
1715143|NCT00357396|4195263|P1|NOT COMPLETED|Overall Study||1
1715144|NCT00357396|4195262|P2|COMPLETED|Overall Study||4
1715145|NCT00357396|4195263|P1|COMPLETED|Overall Study||5
1715146|NCT00357396|4195262|P2|STARTED|Overall Study||4
1715147|NCT00357396|4195263|P1|STARTED|Overall Study||6
1715148|NCT00357370|4195271|P3|NOT COMPLETED|Cohort 2||2
1715149|NCT00357370|4195272|P2|NOT COMPLETED|Cohort 2||7
1715150|NCT00357370|4195273|P1|NOT COMPLETED|Cohort 2||2
1715151|NCT00357370|4195271|P3|COMPLETED|Cohort 2||22
1715152|NCT00357370|4195272|P2|COMPLETED|Cohort 2||16
1715153|NCT00357370|4195273|P1|COMPLETED|Cohort 2||22
1715154|NCT00357370|4195271|P3|STARTED|Cohort 2||24
1715155|NCT00357370|4195272|P2|STARTED|Cohort 2||23
1715156|NCT00357370|4195273|P1|STARTED|Cohort 2||24
1715157|NCT00357370|4195271|P3|NOT COMPLETED|Cohort 1||0
1715158|NCT00357370|4195272|P2|NOT COMPLETED|Cohort 1||0
1715159|NCT00357370|4195273|P1|NOT COMPLETED|Cohort 1||0
1715160|NCT00357370|4195271|P3|COMPLETED|Cohort 1||0
1715161|NCT00357370|4195272|P2|COMPLETED|Cohort 1||0
1715162|NCT00357370|4195273|P1|COMPLETED|Cohort 1||4
1715163|NCT00357370|4195271|P3|STARTED|Cohort 1||0
1715164|NCT00357370|4195272|P2|STARTED|Cohort 1||0
1715165|NCT00357370|4195273|P1|STARTED|Cohort 1||4
1715166|NCT00357331|4195298|P2|NOT COMPLETED|Overall Study||0
1715167|NCT00357331|4195299|P1|NOT COMPLETED|Overall Study||0
1715168|NCT00357331|4195298|P2|COMPLETED|Overall Study||41
1715169|NCT00357331|4195299|P1|COMPLETED|Overall Study||42
1715170|NCT00357331|4195298|P2|STARTED|Overall Study||41
1715171|NCT00357331|4195299|P1|STARTED|Overall Study||42
1715172|NCT00357162|4195309|P1|NOT COMPLETED|Overall Study||0
1715173|NCT00357162|4195309|P1|COMPLETED|Overall Study||21
1715174|NCT00357162|4195309|P1|STARTED|Overall Study||21
1715175|NCT00357110|4195319|P2|NOT COMPLETED|Overall Study||5
1715176|NCT00357110|4195320|P1|NOT COMPLETED|Overall Study||5
1715177|NCT00357110|4195319|P2|COMPLETED|Overall Study||2
1715178|NCT00357110|4195320|P1|COMPLETED|Overall Study||1
1715179|NCT00357110|4195319|P2|STARTED|Overall Study||7
1715180|NCT00357110|4195320|P1|STARTED|Overall Study||6
1715181|NCT00357097|4195328|P2|NOT COMPLETED|Overall Study||29
1715182|NCT00357097|4195329|P1|NOT COMPLETED|Overall Study||54
1715183|NCT00357097|4195328|P2|COMPLETED|Overall Study||38
1715184|NCT00357097|4195329|P1|COMPLETED|Overall Study||145
1715185|NCT00357097|4195328|P2|STARTED|Overall Study||67
1715186|NCT00357097|4195329|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
1715187|NCT00357032|4195373|P1|NOT COMPLETED|Overall Study||0
1715188|NCT00357032|4195373|P1|COMPLETED|Overall Study||12
1715189|NCT00357032|4195373|P1|STARTED|Overall Study||12
1715190|NCT00357006|4195383|P3|NOT COMPLETED|Overall Study||3
1715191|NCT00357006|4195384|P2|NOT COMPLETED|Overall Study||5
1715192|NCT00357006|4195385|P1|NOT COMPLETED|Overall Study||2
1715193|NCT00357006|4195383|P3|COMPLETED|Overall Study||59
1715194|NCT00357006|4195384|P2|COMPLETED|Overall Study||51
1715195|NCT00357006|4195385|P1|COMPLETED|Overall Study||60
1715196|NCT00357006|4195383|P3|STARTED|Overall Study||62
1715197|NCT00357006|4195384|P2|STARTED|Overall Study||56
1715198|NCT00357006|4195385|P1|STARTED|Overall Study||62
1715199|NCT00356915|4195396|P3|NOT COMPLETED|Overall Study||42
1715200|NCT00356915|4195397|P2|NOT COMPLETED|Overall Study||94
1715202|NCT00356915|4195396|P3|COMPLETED|Overall Study||156
1715203|NCT00356915|4195397|P2|COMPLETED|Overall Study||496
1715204|NCT00356915|4195398|P1|COMPLETED|Overall Study||517
1715205|NCT00356915|4195396|P3|STARTED|Overall Study||198
1715206|NCT00356915|4195397|P2|STARTED|Overall Study||590
1715207|NCT00356915|4195398|P1|STARTED|Overall Study||593
1715208|NCT00356889|4195415|P1|NOT COMPLETED|Overall Study||3
1715209|NCT00356889|4195415|P1|COMPLETED|Overall Study||53
1715210|NCT00356889|4195415|P1|STARTED|Overall Study||56
1715211|NCT00356863|4195424|P2|NOT COMPLETED|Overall Study||75
1715212|NCT00356863|4195425|P1|NOT COMPLETED|Overall Study||92
1715213|NCT00356863|4195424|P2|COMPLETED|Overall Study||445
1715214|NCT00356863|4195425|P1|COMPLETED|Overall Study||412
1715215|NCT00356863|4195424|P2|STARTED|Overall Study||520
1715216|NCT00356863|4195425|P1|STARTED|Overall Study||504
1715217|NCT00356811|4195451|P1|NOT COMPLETED|Overall Study||49
1715218|NCT00356811|4195451|P1|COMPLETED|Overall Study||8
1715219|NCT00356811|4195451|P1|STARTED|Overall Study||57
1715220|NCT00356759|4195466|P2|NOT COMPLETED|Overall Study||10
1715221|NCT00356759|4195467|P1|NOT COMPLETED|Overall Study||14
1715222|NCT00356759|4195466|P2|COMPLETED|Overall Study||114
1715223|NCT00356759|4195467|P1|COMPLETED|Overall Study||112
1715224|NCT00356759|4195466|P2|STARTED|Overall Study||124
1715225|NCT00356759|4195467|P1|STARTED|Overall Study||126
1715226|NCT00356603|4195485|P2|NOT COMPLETED|Overall Study||3
1715227|NCT00356603|4195486|P1|NOT COMPLETED|Overall Study||6
1715228|NCT00356603|4195485|P2|COMPLETED|Overall Study||33
1715229|NCT00356603|4195486|P1|COMPLETED|Overall Study||33
1715230|NCT00356603|4195485|P2|STARTED|Overall Study||36
1715231|NCT00356603|4195486|P1|STARTED|Overall Study||39
1715232|NCT00356590|4195500|P1|NOT COMPLETED|Overall Study||274
1715233|NCT00356590|4195500|P1|COMPLETED|Overall Study||194
1715234|NCT00356590|4195500|P1|STARTED|Overall Study||468
1715235|NCT00356525|4195536|P4|NOT COMPLETED|Overall Study||9
1715236|NCT00356525|4195537|P3|NOT COMPLETED|Overall Study||7
1715237|NCT00356525|4195538|P2|NOT COMPLETED|Overall Study||11
1715238|NCT00356525|4195539|P1|NOT COMPLETED|Overall Study||14
1715239|NCT00356525|4195536|P4|COMPLETED|Overall Study||0
1715240|NCT00356525|4195537|P3|COMPLETED|Overall Study||0
1715241|NCT00356525|4195538|P2|COMPLETED|Overall Study||0
1715242|NCT00356525|4195539|P1|COMPLETED|Overall Study||0
1715243|NCT00356525|4195536|P4|STARTED|Overall Study||9
1715244|NCT00356525|4195537|P3|STARTED|Overall Study||7
1715245|NCT00356525|4195538|P2|STARTED|Overall Study||11
1715246|NCT00356525|4195539|P1|STARTED|Overall Study||14
1715247|NCT00356434|4195567|P2|NOT COMPLETED|Overall Study||0
1715248|NCT00356434|4195568|P1|NOT COMPLETED|Overall Study||0
1715249|NCT00356434|4195567|P2|COMPLETED|Overall Study||7
1715250|NCT00356434|4195568|P1|COMPLETED|Overall Study||4
1715251|NCT00356434|4195567|P2|STARTED|Overall Study||7
1715252|NCT00356434|4195568|P1|STARTED|Overall Study||4
1715253|NCT00356421|4195580|P2|NOT COMPLETED|Overall Study||17
1715254|NCT00356421|4195581|P1|NOT COMPLETED|Overall Study||32
1715255|NCT00356421|4195580|P2|COMPLETED|Overall Study||3
1715256|NCT00356421|4195581|P1|COMPLETED|Overall Study||6
1715257|NCT00356421|4195580|P2|STARTED|Overall Study||20
1715258|NCT00356421|4195581|P1|STARTED|Overall Study||38
1715259|NCT00356408|4195621|P1|NOT COMPLETED|Overall Study||60
1715260|NCT00356408|4195621|P1|COMPLETED|Overall Study||43
1715261|NCT00356408|4195621|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
1715262|NCT00356369|4195638|P2|NOT COMPLETED|Year 5||0
1715263|NCT00356369|4195639|P1|NOT COMPLETED|Year 5||0
1715264|NCT00356369|4195638|P2|COMPLETED|Year 5||105
1715265|NCT00356369|4195639|P1|COMPLETED|Year 5||299
1715266|NCT00356369|4195638|P2|STARTED|Year 5||105
1715267|NCT00356369|4195639|P1|STARTED|Year 5||299
1715268|NCT00356369|4195638|P2|NOT COMPLETED|Year 4||0
1715269|NCT00356369|4195639|P1|NOT COMPLETED|Year 4||0
1715270|NCT00356369|4195638|P2|COMPLETED|Year 4||109
1715271|NCT00356369|4195639|P1|COMPLETED|Year 4||317
1715272|NCT00356369|4195638|P2|STARTED|Year 4||109
1715273|NCT00356369|4195639|P1|STARTED|Year 4||317
1715274|NCT00356369|4195638|P2|NOT COMPLETED|Year 3||0
1715275|NCT00356369|4195639|P1|NOT COMPLETED|Year 3||0
1715276|NCT00356369|4195638|P2|COMPLETED|Year 3||116
1715277|NCT00356369|4195639|P1|COMPLETED|Year 3||344
1715278|NCT00356369|4195638|P2|STARTED|Year 3||116
1715279|NCT00356369|4195639|P1|STARTED|Year 3||344
1715280|NCT00356369|4195638|P2|NOT COMPLETED|Year 2||0
1715281|NCT00356369|4195639|P1|NOT COMPLETED|Year 2||0
1715282|NCT00356369|4195638|P2|COMPLETED|Year 2||117
1715283|NCT00356369|4195639|P1|COMPLETED|Year 2||354
1715284|NCT00356369|4195638|P2|STARTED|Year 2||117
1715285|NCT00356369|4195639|P1|STARTED|Year 2||354
1715286|NCT00356369|4195638|P2|NOT COMPLETED|Year 1||0
1715287|NCT00356369|4195639|P1|NOT COMPLETED|Year 1||0
1715288|NCT00356369|4195638|P2|COMPLETED|Year 1||121
1715289|NCT00356369|4195639|P1|COMPLETED|Year 1||364
1715290|NCT00356369|4195638|P2|STARTED|Year 1||121
1715291|NCT00356369|4195639|P1|STARTED|Year 1||364
1715292|NCT00356369|4195638|P2|NOT COMPLETED|Active Phase||1
1715293|NCT00356369|4195639|P1|NOT COMPLETED|Active Phase||2
1715294|NCT00356369|4195638|P2|COMPLETED|Active Phase||125
1715295|NCT00356369|4195639|P1|COMPLETED|Active Phase||372
1715296|NCT00356369|4195638|P2|STARTED|Active Phase||126
1715297|NCT00356369|4195639|P1|STARTED|Active Phase||374
1715298|NCT00356304|4195709|P2|NOT COMPLETED|Overall Study||4
1715299|NCT00356304|4195710|P1|NOT COMPLETED|Overall Study||2
1715300|NCT00356304|4195709|P2|COMPLETED|Overall Study||20
1715301|NCT00356304|4195710|P1|COMPLETED|Overall Study||24
1715302|NCT00356304|4195709|P2|STARTED|Overall Study||24
1715303|NCT00356304|4195710|P1|STARTED|Overall Study||26
1715304|NCT00356278|4195721|P3|NOT COMPLETED|Overall Study||19
1715305|NCT00356278|4195722|P2|NOT COMPLETED|Overall Study||15
1715306|NCT00356278|4195723|P1|NOT COMPLETED|Overall Study||25
1715307|NCT00356278|4195721|P3|COMPLETED|Overall Study||34
1715308|NCT00356278|4195722|P2|COMPLETED|Overall Study||35
1715309|NCT00356278|4195723|P1|COMPLETED|Overall Study||28
1715310|NCT00356278|4195721|P3|STARTED|Overall Study||53
1715311|NCT00356278|4195722|P2|STARTED|Overall Study||50
1715312|NCT00356278|4195723|P1|STARTED|Overall Study||53
1715313|NCT00356265|4195761|P3|NOT COMPLETED|Overall Study||1
1715314|NCT00356265|4195762|P2|NOT COMPLETED|Overall Study||0
1715315|NCT00356265|4195763|P1|NOT COMPLETED|Overall Study||0
1715316|NCT00356265|4195761|P3|COMPLETED|Overall Study||5
1715317|NCT00356265|4195762|P2|COMPLETED|Overall Study||2
1715318|NCT00356265|4195763|P1|COMPLETED|Overall Study||7
1715319|NCT00356265|4195761|P3|STARTED|Overall Study||6
1715320|NCT00356265|4195762|P2|STARTED|Overall Study||2
1715321|NCT00356265|4195763|P1|STARTED|Overall Study||7
1715322|NCT00356200|4195775|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
1715323|NCT00356200|4195776|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
1715324|NCT00356200|4195775|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
1715325|NCT00356200|4195776|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
1715326|NCT00356200|4195775|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
1715327|NCT00356200|4195776|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
1715328|NCT00356200|4195775|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
1715329|NCT00356200|4195776|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
1715330|NCT00356200|4195775|P2|COMPLETED|Cohort 1: 10 ug/ml||0
1715331|NCT00356200|4195776|P1|COMPLETED|Cohort 1: 10 ug/ml||4
1715332|NCT00356200|4195775|P2|STARTED|Cohort 1: 10 ug/ml||0
1715333|NCT00356200|4195776|P1|STARTED|Cohort 1: 10 ug/ml||5
1715334|NCT00356187|4195790|P2|NOT COMPLETED|Overall Study||0
1715335|NCT00356187|4195791|P1|NOT COMPLETED|Overall Study||0
1715336|NCT00356187|4195790|P2|COMPLETED|Overall Study||0
1715337|NCT00356187|4195791|P1|COMPLETED|Overall Study||0
1715338|NCT00356187|4195790|P2|STARTED|Overall Study||0
1715339|NCT00356187|4195791|P1|STARTED|Overall Study||0
1715340|NCT00356148|4195805|P2|NOT COMPLETED|Overall Study||1
1715341|NCT00356148|4195806|P1|NOT COMPLETED|Overall Study||2
1715342|NCT00356148|4195805|P2|COMPLETED|Overall Study||182
1715343|NCT00356148|4195806|P1|COMPLETED|Overall Study||187
1715344|NCT00356148|4195805|P2|STARTED|Overall Study||183
1715345|NCT00356148|4195806|P1|STARTED|Overall Study||189
1715346|NCT00356135|4195817|P3|NOT COMPLETED|Overall Study||5
1715347|NCT00356135|4195818|P2|NOT COMPLETED|Overall Study||2
1715348|NCT00356135|4195819|P1|NOT COMPLETED|Overall Study||4
1715349|NCT00356135|4195817|P3|COMPLETED|Overall Study||39
1715350|NCT00356135|4195818|P2|COMPLETED|Overall Study||46
1715351|NCT00356135|4195819|P1|COMPLETED|Overall Study||43
1715352|NCT00356135|4195817|P3|STARTED|Overall Study||44
1715353|NCT00356135|4195818|P2|STARTED|Overall Study||48
1715354|NCT00356135|4195819|P1|STARTED|Overall Study||47
1715355|NCT00356122|4195841|P1|NOT COMPLETED|FOLLOW-UP||41
1715356|NCT00356122|4195841|P1|COMPLETED|FOLLOW-UP||12
1715357|NCT00356122|4195841|P1|STARTED|FOLLOW-UP||53
1715358|NCT00356122|4195841|P1|NOT COMPLETED|TREATMENT||45
1715359|NCT00356122|4195841|P1|COMPLETED|TREATMENT||8
1715360|NCT00356122|4195841|P1|STARTED|TREATMENT||53
1715361|NCT00356057|4195852|P3|NOT COMPLETED|Overall Study||12
1715362|NCT00356057|4195853|P2|NOT COMPLETED|Overall Study||14
1715363|NCT00356057|4195854|P1|NOT COMPLETED|Overall Study||13
1715364|NCT00356057|4195852|P3|COMPLETED|Overall Study||22
1715365|NCT00356057|4195853|P2|COMPLETED|Overall Study||47
1715366|NCT00356057|4195854|P1|COMPLETED|Overall Study||45
1715367|NCT00356057|4195852|P3|IMPLANTED|Overall Study||25
1715368|NCT00356057|4195853|P2|IMPLANTED|Overall Study||52
1715369|NCT00356057|4195854|P1|IMPLANTED|Overall Study||49
1715370|NCT00356057|4195852|P3|STARTED|Overall Study||34
1715371|NCT00356057|4195853|P2|STARTED|Overall Study||61
1715372|NCT00356057|4195854|P1|STARTED|Overall Study||58
1715373|NCT00356031|4195892|P1|NOT COMPLETED|Overall Study||0
1715374|NCT00356031|4195892|P1|COMPLETED|Overall Study||20
1715375|NCT00356031|4195892|P1|STARTED|Overall Study||20
1715376|NCT00355914|4195903|P2|NOT COMPLETED|Overall Study||0
1715377|NCT00355914|4195904|P1|NOT COMPLETED|Overall Study||0
1715378|NCT00355914|4195903|P2|COMPLETED|Overall Study||60
1715379|NCT00355914|4195904|P1|COMPLETED|Overall Study||60
1715380|NCT00355914|4195903|P2|STARTED|Overall Study||60
1715381|NCT00355914|4195904|P1|STARTED|Overall Study||60
1715382|NCT00355797|4195915|P3|NOT COMPLETED|Overall Study||142
1715383|NCT00355797|4195916|P2|NOT COMPLETED|Overall Study||148
1715384|NCT00355797|4195917|P1|NOT COMPLETED|Overall Study||240
1715385|NCT00355797|4195915|P3|COMPLETED|Overall Study||239
1715386|NCT00355797|4195916|P2|COMPLETED|Overall Study||221
1715387|NCT00355797|4195917|P1|COMPLETED|Overall Study||501
1715388|NCT00355797|4195915|P3|STARTED|Overall Study||381
1715389|NCT00355797|4195916|P2|STARTED|Overall Study||369
1715390|NCT00355797|4195917|P1|STARTED|Overall Study||741
1715391|NCT00355784|4195949|P3|NOT COMPLETED|Overall Study||2
1715392|NCT00355784|4195950|P2|NOT COMPLETED|Overall Study||0
1715393|NCT00355784|4195951|P1|NOT COMPLETED|Overall Study||0
1715394|NCT00355784|4195949|P3|COMPLETED|Overall Study||5
1715395|NCT00355784|4195950|P2|COMPLETED|Overall Study||8
1715396|NCT00355784|4195951|P1|COMPLETED|Overall Study||9
1715397|NCT00355784|4195949|P3|STARTED|Overall Study||7
1715398|NCT00355784|4195950|P2|STARTED|Overall Study||8
1715399|NCT00355784|4195951|P1|STARTED|Overall Study||9
1715400|NCT00355706|4195985|P2|NOT COMPLETED|Overall Study||0
1715401|NCT00355706|4195986|P1|NOT COMPLETED|Overall Study||0
1715402|NCT00355706|4195985|P2|COMPLETED|Overall Study||50
1715403|NCT00355706|4195986|P1|COMPLETED|Overall Study||50
1715404|NCT00355706|4195985|P2|STARTED|Overall Study||50
1715405|NCT00355706|4195986|P1|STARTED|Overall Study||50
1715406|NCT00355615|4196000|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
1715407|NCT00355615|4196001|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
1715408|NCT00355615|4196002|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
1715409|NCT00355615|4196003|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
1715410|NCT00355615|4196004|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
1715411|NCT00355615|4196000|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
1715412|NCT00355615|4196001|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
1715413|NCT00355615|4196002|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
1715414|NCT00355615|4196003|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
1715415|NCT00355615|4196004|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
1715416|NCT00355615|4196000|P5|STARTED|40-week Rosuvastatin Open Label Period||173
1715417|NCT00355615|4196001|P4|STARTED|40-week Rosuvastatin Open Label Period||0
1715418|NCT00355615|4196002|P3|STARTED|40-week Rosuvastatin Open Label Period||0
1715419|NCT00355615|4196003|P2|STARTED|40-week Rosuvastatin Open Label Period||0
1715420|NCT00355615|4196004|P1|STARTED|40-week Rosuvastatin Open Label Period||0
1715421|NCT00355615|4196000|P5|NOT COMPLETED|Randomized Double Blind Period||0
1715422|NCT00355615|4196001|P4|NOT COMPLETED|Randomized Double Blind Period||1
1715423|NCT00355615|4196002|P3|NOT COMPLETED|Randomized Double Blind Period||1
1715424|NCT00355615|4196003|P2|NOT COMPLETED|Randomized Double Blind Period||0
1715425|NCT00355615|4196004|P1|NOT COMPLETED|Randomized Double Blind Period||1
1715426|NCT00355615|4196000|P5|COMPLETED|Randomized Double Blind Period||0
1715427|NCT00355615|4196001|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
1715428|NCT00355615|4196002|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
1715429|NCT00355615|4196003|P2|COMPLETED|Randomized Double Blind Period||44
1715430|NCT00355615|4196004|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
1715431|NCT00355615|4196000|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
1715432|NCT00355615|4196001|P4|STARTED|Randomized Double Blind Period||46
1715433|NCT00355615|4196002|P3|STARTED|Randomized Double Blind Period||45
1715434|NCT00355615|4196003|P2|STARTED|Randomized Double Blind Period||44
1715435|NCT00355615|4196004|P1|STARTED|Randomized Double Blind Period||42
1715436|NCT00355472|4196063|P1|NOT COMPLETED|Overall Study||1
1715437|NCT00355472|4196063|P1|COMPLETED|Overall Study||15
1715438|NCT00355472|4196063|P1|STARTED|Overall Study||16
1715439|NCT00355394|4196090|P2|NOT COMPLETED|Overall Study||0
1715440|NCT00355394|4196091|P1|NOT COMPLETED|Overall Study||0
1715441|NCT00355394|4196090|P2|COMPLETED|Overall Study||16
1715442|NCT00355394|4196091|P1|COMPLETED|Overall Study||15
1715443|NCT00355394|4196090|P2|STARTED|Overall Study||16
1715444|NCT00355394|4196091|P1|STARTED|Overall Study||15
1715445|NCT00355368|4196109|P2|NOT COMPLETED|Overall Study||9
1715446|NCT00355368|4196110|P1|NOT COMPLETED|Overall Study||10
1715447|NCT00355368|4196109|P2|COMPLETED|Overall Study||201
1715448|NCT00355368|4196110|P1|COMPLETED|Overall Study||200
1715449|NCT00355368|4196109|P2|STARTED|Overall Study||210
1715450|NCT00355368|4196110|P1|STARTED|Overall Study||210
1715451|NCT00355342|4196124|P2|NOT COMPLETED|Overall Study||36
1715452|NCT00355342|4196125|P1|NOT COMPLETED|Overall Study||39
1715453|NCT00355342|4196124|P2|COMPLETED|Overall Study||56
1715454|NCT00355342|4196125|P1|COMPLETED|Overall Study||55
1715455|NCT00355342|4196124|P2|STARTED|Overall Study||92
1715456|NCT00355342|4196125|P1|STARTED|Overall Study||94
1715457|NCT00355199|4196135|P2|NOT COMPLETED|Overall Study||4
1715458|NCT00355199|4196136|P1|NOT COMPLETED|Overall Study||7
1715459|NCT00355199|4196135|P2|COMPLETED|Overall Study||122
1715460|NCT00355199|4196136|P1|COMPLETED|Overall Study||113
1715461|NCT00355199|4196135|P2|STARTED|Overall Study||126
1715462|NCT00355199|4196136|P1|STARTED|Overall Study||120
1715463|NCT00355147|4196152|P2|NOT COMPLETED|Overall Study||20
1715464|NCT00355147|4196153|P1|NOT COMPLETED|Overall Study||18
1715465|NCT00355147|4196152|P2|COMPLETED|Overall Study||67
1715466|NCT00355147|4196153|P1|COMPLETED|Overall Study||69
1715467|NCT00355147|4196152|P2|STARTED|Overall Study||87
1715468|NCT00355147|4196153|P1|STARTED|Overall Study||87
1715469|NCT00355134|4196172|P5|NOT COMPLETED|Extension Phase||19
1715470|NCT00355134|4196173|P4|NOT COMPLETED|Extension Phase||16
1715471|NCT00355134|4196174|P3|NOT COMPLETED|Extension Phase||0
1715472|NCT00355134|4196175|P2|NOT COMPLETED|Extension Phase||37
1715473|NCT00355134|4196176|P1|NOT COMPLETED|Extension Phase||31
1715474|NCT00355134|4196172|P5|COMPLETED|Extension Phase||88
1715475|NCT00355134|4196173|P4|COMPLETED|Extension Phase||89
1715476|NCT00355134|4196174|P3|COMPLETED|Extension Phase||0
1715477|NCT00355134|4196175|P2|COMPLETED|Extension Phase||180
1715478|NCT00355134|4196176|P1|COMPLETED|Extension Phase||172
1715479|NCT00355134|4196172|P5|STARTED|Extension Phase||107
1715480|NCT00355134|4196173|P4|STARTED|Extension Phase||105
1715481|NCT00355134|4196174|P3|STARTED|Extension Phase||0
1715482|NCT00355134|4196175|P2|STARTED|Extension Phase||217
1715483|NCT00355134|4196176|P1|STARTED|Extension Phase||203
1715484|NCT00355134|4196172|P5|NOT COMPLETED|Core Phase||0
1715485|NCT00355134|4196173|P4|NOT COMPLETED|Core Phase||0
1715486|NCT00355134|4196174|P3|NOT COMPLETED|Core Phase||100
1715487|NCT00355134|4196175|P2|NOT COMPLETED|Core Phase||86
1715488|NCT00355134|4196176|P1|NOT COMPLETED|Core Phase||119
1715489|NCT00355134|4196172|P5|COMPLETED|Core Phase||0
1715490|NCT00355134|4196173|P4|COMPLETED|Core Phase||0
1715491|NCT00355134|4196174|P3|COMPLETED|Core Phase||255
1715492|NCT00355134|4196175|P2|COMPLETED|Core Phase||272
1715493|NCT00355134|4196176|P1|COMPLETED|Core Phase||251
1715494|NCT00355134|4196172|P5|STARTED|Core Phase||0
1715495|NCT00355134|4196173|P4|STARTED|Core Phase||0
1715496|NCT00355134|4196174|P3|STARTED|Core Phase||355
1715497|NCT00355134|4196175|P2|STARTED|Core Phase||358
1715498|NCT00355134|4196176|P1|STARTED|Core Phase||370
1715499|NCT00355121|4196219|P3|NOT COMPLETED|Overall Study||5
1715500|NCT00355121|4196220|P2|NOT COMPLETED|Overall Study||29
1715501|NCT00355121|4196221|P1|NOT COMPLETED|Overall Study||21
1715502|NCT00355121|4196219|P3|COMPLETED|Overall Study||170
1715503|NCT00355121|4196220|P2|COMPLETED|Overall Study||324
1715504|NCT00355121|4196221|P1|COMPLETED|Overall Study||332
1715505|NCT00355121|4196219|P3|STARTED|Overall Study||175
1715506|NCT00355121|4196220|P2|STARTED|Overall Study||353
1715507|NCT00355121|4196221|P1|STARTED|Overall Study||353
1715508|NCT00355082|4196252|P3|NOT COMPLETED|Continuation Phase||3
1715509|NCT00355082|4196253|P2|NOT COMPLETED|Continuation Phase||0
1715510|NCT00355082|4196254|P1|NOT COMPLETED|Continuation Phase||24
1715511|NCT00355082|4196252|P3|COMPLETED|Continuation Phase||8
1715512|NCT00355082|4196253|P2|COMPLETED|Continuation Phase||0
1715513|NCT00355082|4196254|P1|COMPLETED|Continuation Phase||160
1715514|NCT00355082|4196252|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
1715515|NCT00355082|4196253|P2|STARTED|Continuation Phase||0
1715516|NCT00355082|4196254|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
1715517|NCT00355082|4196252|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
1715518|NCT00355082|4196253|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
1715519|NCT00355082|4196254|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
1715520|NCT00355082|4196252|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
1715521|NCT00355082|4196253|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
1715522|NCT00355082|4196254|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
1715523|NCT00355082|4196252|P3|STARTED|Double-Blind (DB) Treatment Phase||0
1715524|NCT00355082|4196253|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
1715525|NCT00355082|4196254|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
1715526|NCT00355030|4196276|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
1715527|NCT00355030|4196277|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
1715528|NCT00355030|4196276|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
1715529|NCT00355030|4196277|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
1715530|NCT00355030|4196276|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
1715531|NCT00355030|4196277|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
1715532|NCT00355030|4196276|P2|NOT COMPLETED|Study Period 1 Treatment||44
1715533|NCT00355030|4196277|P1|NOT COMPLETED|Study Period 1 Treatment||45
1715534|NCT00355030|4196276|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
1715535|NCT00355030|4196277|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
1715536|NCT00355030|4196276|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
1715537|NCT00355030|4196277|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
1715538|NCT00355030|4196276|P2|STARTED|Study Period 1 Treatment||45
1715539|NCT00355030|4196277|P1|STARTED|Study Period 1 Treatment||46
1715540|NCT00354978|4196299|P1|NOT COMPLETED|Overall Study||0
1715541|NCT00354978|4196299|P1|COMPLETED|Overall Study||43
1715542|NCT00354978|4196299|P1|STARTED|Overall Study||43
1715543|NCT00354913|4196303|P1|NOT COMPLETED|Overall Study||0
1715544|NCT00354913|4196303|P1|COMPLETED|Overall Study||21
1715545|NCT00354913|4196303|P1|STARTED|Overall Study||21
1715546|NCT00354887|4196310|P1|NOT COMPLETED|Overall Study||1
1715547|NCT00354887|4196310|P1|COMPLETED|Overall Study||29
1715548|NCT00354887|4196310|P1|STARTED|Overall Study||30
1715549|NCT00354835|4196316|P2|NOT COMPLETED|Overall Study||61
1715550|NCT00354835|4196317|P1|NOT COMPLETED|Overall Study||52
1715551|NCT00354835|4196316|P2|COMPLETED|Overall Study||181
1715552|NCT00354835|4196317|P1|COMPLETED|Overall Study||187
1715553|NCT00354835|4196316|P2|STARTED|Overall Study||242
1715554|NCT00354835|4196317|P1|STARTED|Overall Study||239
1715555|NCT00354770|4196349|P2|NOT COMPLETED|Overall Study||3
1715556|NCT00354770|4196350|P1|NOT COMPLETED|Overall Study||3
1715557|NCT00354770|4196349|P2|COMPLETED|Overall Study||22
1715558|NCT00354770|4196350|P1|COMPLETED|Overall Study||22
1715559|NCT00354770|4196349|P2|STARTED|Overall Study||25
1715560|NCT00354770|4196350|P1|STARTED|Overall Study||25
1715561|NCT00354744|4196356|P1|NOT COMPLETED|Overall Study||42
1715562|NCT00354744|4196356|P1|COMPLETED|Overall Study||67
1715563|NCT00354744|4196356|P1|STARTED|Overall Study||109
1715564|NCT00354679|4196361|P1|NOT COMPLETED|Overall Study||1
1715565|NCT00354679|4196361|P1|COMPLETED|Overall Study||33
1715566|NCT00354679|4196361|P1|STARTED|Overall Study||34
1715567|NCT00354640|4196365|P1|NOT COMPLETED|Overall Study||0
1715568|NCT00354640|4196365|P1|COMPLETED|Overall Study||11
1715569|NCT00354640|4196365|P1|STARTED|Overall Study||11
1715570|NCT00354614|4196370|P1|NOT COMPLETED|Overall Study||28
1715571|NCT00354614|4196370|P1|COMPLETED|Overall Study||53
1715572|NCT00354614|4196370|P1|STARTED|Overall Study||81
1715573|NCT00354601|4196374|P1|NOT COMPLETED|Overall Study||2
1715574|NCT00354601|4196374|P1|COMPLETED|Overall Study||0
1715575|NCT00354601|4196374|P1|STARTED|Overall Study||2
1715576|NCT00354484|4196383|P2|NOT COMPLETED|Overall Study||3
1715577|NCT00354484|4196384|P1|NOT COMPLETED|Overall Study||4
1715578|NCT00354484|4196383|P2|COMPLETED|Overall Study||144
1715579|NCT00354484|4196384|P1|COMPLETED|Overall Study||138
1715580|NCT00354484|4196383|P2|STARTED|Overall Study||147
1715581|NCT00354484|4196384|P1|STARTED|Overall Study||142
1715582|NCT00354432|4196394|P4|NOT COMPLETED|Overall Study||10
1715583|NCT00354432|4196395|P3|NOT COMPLETED|Overall Study||10
1715584|NCT00354432|4196396|P2|NOT COMPLETED|Overall Study||8
1715585|NCT00354432|4196397|P1|NOT COMPLETED|Overall Study||6
1715586|NCT00354432|4196394|P4|COMPLETED|Overall Study||20
1715587|NCT00354432|4196395|P3|COMPLETED|Overall Study||20
1715588|NCT00354432|4196396|P2|COMPLETED|Overall Study||22
1715589|NCT00354432|4196397|P1|COMPLETED|Overall Study||24
1715590|NCT00354432|4196394|P4|STARTED|Overall Study||30
1715591|NCT00354432|4196395|P3|STARTED|Overall Study||30
1715592|NCT00354432|4196396|P2|STARTED|Overall Study||30
1715593|NCT00354432|4196397|P1|STARTED|Overall Study||30
1715594|NCT00354341|4196413|P2|NOT COMPLETED|Overall Study||7
1715595|NCT00354341|4196414|P1|NOT COMPLETED|Overall Study||3
1715596|NCT00354341|4196413|P2|COMPLETED|Overall Study||75
1715597|NCT00354341|4196414|P1|COMPLETED|Overall Study||85
1715598|NCT00354341|4196413|P2|STARTED|Overall Study||82
1715599|NCT00354341|4196414|P1|STARTED|Overall Study||88
1715600|NCT00354224|4196430|P1|NOT COMPLETED|Overall Study||0
1715601|NCT00354224|4196430|P1|COMPLETED|Overall Study||10
1715602|NCT00354224|4196430|P1|STARTED|Overall Study||10
1715603|NCT00354172|4196436|P1|NOT COMPLETED|Overall Study||1
1715604|NCT00354172|4196436|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
1715605|NCT00354172|4196436|P1|STARTED|Overall Study||16
1715606|NCT00354159|4196456|P2|NOT COMPLETED|Long-term Follow-up||176
1715607|NCT00354159|4196457|P1|NOT COMPLETED|Long-term Follow-up||180
1715608|NCT00354159|4196456|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
1715609|NCT00354159|4196457|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
1715610|NCT00354159|4196456|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
1715611|NCT00354159|4196457|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
1715612|NCT00354159|4196456|P2|NOT COMPLETED|Randomized Study Period||22
1715613|NCT00354159|4196457|P1|NOT COMPLETED|Randomized Study Period||22
1715614|NCT00354159|4196456|P2|COMPLETED|Randomized Study Period||176
1715615|NCT00354159|4196457|P1|COMPLETED|Randomized Study Period||180
1715616|NCT00354159|4196456|P2|STARTED|Randomized Study Period||198
1715617|NCT00354159|4196457|P1|STARTED|Randomized Study Period||202
1715618|NCT00354107|4196500|P1|NOT COMPLETED|Overall Study||5
1715619|NCT00354107|4196500|P1|COMPLETED|Overall Study||0
1715620|NCT00354107|4196500|P1|STARTED|Overall Study||5
1715621|NCT00354029|4196510|P2|NOT COMPLETED|Overall Study||2
1715622|NCT00354029|4196511|P1|NOT COMPLETED|Overall Study||4
1715623|NCT00354029|4196510|P2|COMPLETED|Overall Study||38
1715624|NCT00354029|4196511|P1|COMPLETED|Overall Study||39
1715625|NCT00354029|4196510|P2|STARTED|Overall Study||40
1715626|NCT00354029|4196511|P1|STARTED|Overall Study||43
1715627|NCT00353977|4196517|P1|NOT COMPLETED|Overall Study||0
1715628|NCT00353977|4196517|P1|COMPLETED|Overall Study||38
1715629|NCT00353977|4196517|P1|STARTED|Overall Study||38
1715630|NCT00353873|4196523|P2|NOT COMPLETED|Overall Study||3
1715631|NCT00353873|4196524|P1|NOT COMPLETED|Overall Study||6
1715632|NCT00353873|4196523|P2|COMPLETED|Overall Study||147
1715633|NCT00353873|4196524|P1|COMPLETED|Overall Study||147
1715634|NCT00353873|4196523|P2|STARTED|Overall Study||150
1715635|NCT00353873|4196524|P1|STARTED|Overall Study||153
1715636|NCT00353834|4196538|P2|NOT COMPLETED|Overall Study||0
1715637|NCT00353834|4196539|P1|NOT COMPLETED|Overall Study||0
1715638|NCT00353834|4196538|P2|COMPLETED|Overall Study||27
1715639|NCT00353834|4196539|P1|COMPLETED|Overall Study||26
1715640|NCT00353834|4196538|P2|STARTED|Overall Study||27
1715641|NCT00353834|4196539|P1|STARTED|Overall Study||26
1715642|NCT00353795|4196547|P1|NOT COMPLETED|Overall Study||0
1715643|NCT00353795|4196547|P1|COMPLETED|Overall Study||179
1715644|NCT00353795|4196547|P1|STARTED|Overall Study||179
1715645|NCT00353704|4196553|P2|NOT COMPLETED|Overall Study||1
1715646|NCT00353704|4196554|P1|NOT COMPLETED|Overall Study||3
1715647|NCT00353704|4196553|P2|COMPLETED|Overall Study||24
1715648|NCT00353704|4196554|P1|COMPLETED|Overall Study||22
1715649|NCT00353704|4196553|P2|STARTED|Overall Study||25
1715650|NCT00353704|4196554|P1|STARTED|Overall Study||25
1715651|NCT00353652|4196568|P6|NOT COMPLETED|Overall Study||5
1715652|NCT00353652|4196569|P5|NOT COMPLETED|Overall Study||5
1715653|NCT00353652|4196570|P4|NOT COMPLETED|Overall Study||0
1715654|NCT00353652|4196571|P3|NOT COMPLETED|Overall Study||0
1715655|NCT00353652|4196572|P2|NOT COMPLETED|Overall Study||0
1715656|NCT00353652|4196573|P1|NOT COMPLETED|Overall Study||0
1715657|NCT00353652|4196568|P6|COMPLETED|Overall Study||18
1715658|NCT00353652|4196569|P5|COMPLETED|Overall Study||18
1715659|NCT00353652|4196570|P4|COMPLETED|Overall Study||7
1715660|NCT00353652|4196571|P3|COMPLETED|Overall Study||17
1715661|NCT00353652|4196572|P2|COMPLETED|Overall Study||17
1715662|NCT00353652|4196573|P1|COMPLETED|Overall Study||17
1715663|NCT00353652|4196568|P6|STARTED|Overall Study||23
1715664|NCT00353652|4196569|P5|STARTED|Overall Study||23
1715665|NCT00353652|4196570|P4|STARTED|Overall Study||7
1715666|NCT00353652|4196571|P3|STARTED|Overall Study||17
1715667|NCT00353652|4196572|P2|STARTED|Overall Study||17
1715668|NCT00353652|4196573|P1|STARTED|Overall Study||17
1715669|NCT00353496|4196589|P2|NOT COMPLETED|Overall Study||17
1715670|NCT00353496|4196590|P1|NOT COMPLETED|Overall Study||16
1715671|NCT00353496|4196589|P2|COMPLETED|Overall Study||86
1715672|NCT00353496|4196590|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
1715673|NCT00353496|4196589|P2|STARTED|Overall Study||103
1715674|NCT00353496|4196590|P1|STARTED|Overall Study||101
1715675|NCT00353431|4196607|P2|NOT COMPLETED|Overall Study||0
1715676|NCT00353431|4196608|P1|NOT COMPLETED|Overall Study||0
1715677|NCT00353431|4196607|P2|COMPLETED|Overall Study||67
1715678|NCT00353431|4196608|P1|COMPLETED|Overall Study||63
1715679|NCT00353431|4196607|P2|STARTED|Overall Study||67
1715680|NCT00353431|4196608|P1|STARTED|Overall Study||63
1715681|NCT00353418|4196624|P2|NOT COMPLETED|Overall Study||158
1715682|NCT00353418|4196625|P1|NOT COMPLETED|Overall Study||83
1715683|NCT00353418|4196624|P2|COMPLETED|Overall Study||119
1715684|NCT00353418|4196625|P1|COMPLETED|Overall Study||55
1715685|NCT00353418|4196624|P2|STARTED|Overall Study||277
1715686|NCT00353418|4196625|P1|STARTED|Overall Study||138
1715687|NCT00353366|4196643|P1|NOT COMPLETED|Overall Study||143
1715688|NCT00353366|4196643|P1|COMPLETED|Overall Study||1289
1715689|NCT00353366|4196643|P1|STARTED|Overall Study||1432
1715690|NCT00353301|4196650|P1|NOT COMPLETED|Overall Study||0
1715691|NCT00353301|4196650|P1|COMPLETED|Overall Study||25
1715692|NCT00353301|4196650|P1|STARTED|Overall Study||25
1715693|NCT00353275|4196657|P2|NOT COMPLETED|Overall Study||0
1715694|NCT00353275|4196658|P1|NOT COMPLETED|Overall Study||0
1715695|NCT00353275|4196657|P2|COMPLETED|Overall Study||3
1715696|NCT00353275|4196658|P1|COMPLETED|Overall Study||2
1715697|NCT00353275|4196657|P2|STARTED|Overall Study||3
1715698|NCT00353275|4196658|P1|STARTED|Overall Study||2
1715699|NCT00353262|4196670|P1|NOT COMPLETED|Overall Study||29
1715700|NCT00353262|4196670|P1|COMPLETED|Overall Study||7
1715701|NCT00353262|4196670|P1|STARTED|Overall Study||36
1715702|NCT00353119|4196689|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
1715703|NCT00353119|4196690|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
1715704|NCT00353119|4196689|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
1715705|NCT00353119|4196690|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
1715706|NCT00353119|4196689|P2|STARTED|Second Intervention Week 12 to Week 28||10
1715707|NCT00353119|4196690|P1|STARTED|Second Intervention Week 12 to Week 28||5
1715708|NCT00353119|4196689|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
1715709|NCT00353119|4196690|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
1715710|NCT00353119|4196689|P2|COMPLETED|First Intervention Day 0 to Week 12||10
1715711|NCT00353119|4196690|P1|COMPLETED|First Intervention Day 0 to Week 12||5
1715712|NCT00353119|4196689|P2|STARTED|First Intervention Day 0 to Week 12||10
1715713|NCT00353119|4196690|P1|STARTED|First Intervention Day 0 to Week 12||5
1715714|NCT00352911|4196702|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
1715715|NCT00352911|4196703|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
1715716|NCT00352911|4196702|P2|COMPLETED|300mg Twice Daily (14 Days)||3
1715717|NCT00352911|4196703|P1|COMPLETED|300mg Twice Daily (14 Days)||15
1715718|NCT00352911|4196702|P2|STARTED|300mg Twice Daily (14 Days)||3
1715719|NCT00352911|4196703|P1|STARTED|300mg Twice Daily (14 Days)||16
1715720|NCT00352911|4196702|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
1715721|NCT00352911|4196703|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
1715722|NCT00352911|4196702|P2|COMPLETED|150mg Twice Daily (14 Days)||3
1715723|NCT00352911|4196703|P1|COMPLETED|150mg Twice Daily (14 Days)||16
1715724|NCT00352911|4196702|P2|STARTED|150mg Twice Daily (14 Days)||3
1715725|NCT00352911|4196703|P1|STARTED|150mg Twice Daily (14 Days)||16
1715726|NCT00352885|4196711|P2|NOT COMPLETED|Overall Study||7
1715727|NCT00352885|4196712|P1|NOT COMPLETED|Overall Study||6
1715728|NCT00352885|4196711|P2|COMPLETED|Overall Study||4
1715729|NCT00352885|4196712|P1|COMPLETED|Overall Study||3
1715730|NCT00352885|4196711|P2|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
1715731|NCT00352885|4196712|P1|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
1715732|NCT00352885|4196711|P2|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
1715733|NCT00352885|4196712|P1|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
1715734|NCT00352885|4196711|P2|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
1715735|NCT00352885|4196712|P1|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
1715736|NCT00352885|4196711|P2|STARTED|Overall Study||11
1715737|NCT00352885|4196712|P1|STARTED|Overall Study||9
1715738|NCT00352846|4196730|P2|NOT COMPLETED|Overall Study||13
1715739|NCT00352846|4196731|P1|NOT COMPLETED|Overall Study||8
1715740|NCT00352846|4196730|P2|COMPLETED|Overall Study||24
1715741|NCT00352846|4196731|P1|COMPLETED|Overall Study||29
1715742|NCT00352846|4196730|P2|STARTED|Overall Study||37
1715743|NCT00352846|4196731|P1|STARTED|Overall Study||37
1715744|NCT00352781|4196737|P1|NOT COMPLETED|Overall Study||883
1715745|NCT00352781|4196737|P1|COMPLETED|Overall Study||884
1715746|NCT00352781|4196737|P1|STARTED|Overall Study||1767
1715747|NCT00352755|4196742|P1|NOT COMPLETED|Overall Study||2
1715748|NCT00352755|4196742|P1|COMPLETED|Overall Study||16
1715749|NCT00352755|4196742|P1|STARTED|Overall Study||18
1715750|NCT00352690|4196752|P2|NOT COMPLETED|Overall Study||0
1715751|NCT00352690|4196753|P1|NOT COMPLETED|Overall Study||2
1715752|NCT00352690|4196752|P2|COMPLETED|Overall Study||0
1715753|NCT00352690|4196753|P1|COMPLETED|Overall Study||8
1715754|NCT00352690|4196752|P2|STARTED|Overall Study||0
1715755|NCT00352690|4196753|P1|STARTED|Overall Study||10
1715756|NCT00352664|4196773|P2|NOT COMPLETED|Overall Study||0
1715757|NCT00352664|4196774|P1|NOT COMPLETED|Overall Study||7
1715758|NCT00352664|4196773|P2|COMPLETED|Overall Study||0
1715759|NCT00352664|4196774|P1|COMPLETED|Overall Study||20
1715760|NCT00352664|4196773|P2|STARTED|Overall Study||0
1715761|NCT00352664|4196774|P1|STARTED|Overall Study||27
1715762|NCT00352612|4196782|P2|NOT COMPLETED|Overall Study||0
1715763|NCT00352612|4196783|P1|NOT COMPLETED|Overall Study||0
1715764|NCT00352612|4196782|P2|COMPLETED|Overall Study||100
1715765|NCT00352612|4196783|P1|COMPLETED|Overall Study||100
1715766|NCT00352612|4196782|P2|STARTED|Overall Study||100
1715767|NCT00352612|4196783|P1|STARTED|Overall Study||100
1715768|NCT00352534|4196791|P7|NOT COMPLETED|Final Risk Group Assignment||39
1715769|NCT00352534|4196792|P6|NOT COMPLETED|Final Risk Group Assignment||45
1715770|NCT00352534|4196793|P5|NOT COMPLETED|Final Risk Group Assignment||1
1715771|NCT00352534|4196794|P4|NOT COMPLETED|Final Risk Group Assignment||3
1715772|NCT00352534|4196795|P3|NOT COMPLETED|Final Risk Group Assignment||3
1715773|NCT00352534|4196796|P2|NOT COMPLETED|Final Risk Group Assignment||0
1715774|NCT00352534|4196797|P1|NOT COMPLETED|Final Risk Group Assignment||0
1715775|NCT00352534|4196791|P7|COMPLETED|Final Risk Group Assignment||1
1715776|NCT00352534|4196792|P6|COMPLETED|Final Risk Group Assignment||503
1715777|NCT00352534|4196793|P5|COMPLETED|Final Risk Group Assignment||31
1715778|NCT00352534|4196794|P4|COMPLETED|Final Risk Group Assignment||49
1715779|NCT00352534|4196795|P3|COMPLETED|Final Risk Group Assignment||116
1715780|NCT00352534|4196796|P2|COMPLETED|Final Risk Group Assignment||0
1715781|NCT00352534|4196797|P1|COMPLETED|Final Risk Group Assignment||0
1715782|NCT00352534|4196791|P7|STARTED|Final Risk Group Assignment||40
1715783|NCT00352534|4196792|P6|STARTED|Final Risk Group Assignment||548
1715784|NCT00352534|4196793|P5|STARTED|Final Risk Group Assignment||32
1715785|NCT00352534|4196794|P4|STARTED|Final Risk Group Assignment||52
1715786|NCT00352534|4196795|P3|STARTED|Final Risk Group Assignment||119
1715787|NCT00352534|4196796|P2|STARTED|Final Risk Group Assignment||0
1715788|NCT00352534|4196797|P1|STARTED|Final Risk Group Assignment||0
1715789|NCT00352534|4196791|P7|NOT COMPLETED|Initial Staging||0
1715790|NCT00352534|4196792|P6|NOT COMPLETED|Initial Staging||0
1715791|NCT00352534|4196793|P5|NOT COMPLETED|Initial Staging||0
1715792|NCT00352534|4196794|P4|NOT COMPLETED|Initial Staging||0
1715793|NCT00352534|4196795|P3|NOT COMPLETED|Initial Staging||0
1715794|NCT00352534|4196796|P2|NOT COMPLETED|Initial Staging||9
1715795|NCT00352534|4196797|P1|NOT COMPLETED|Initial Staging||8
1715796|NCT00352534|4196791|P7|COMPLETED|Initial Staging||0
1715797|NCT00352534|4196792|P6|COMPLETED|Initial Staging||0
1715798|NCT00352534|4196793|P5|COMPLETED|Initial Staging||0
1715799|NCT00352534|4196794|P4|COMPLETED|Initial Staging||0
1715800|NCT00352534|4196795|P3|COMPLETED|Initial Staging||0
1715801|NCT00352534|4196796|P2|COMPLETED|Initial Staging||588
1715802|NCT00352534|4196797|P1|COMPLETED|Initial Staging||203
1715803|NCT00352534|4196791|P7|STARTED|Initial Staging||0
1715804|NCT00352534|4196792|P6|STARTED|Initial Staging||0
1715805|NCT00352534|4196793|P5|STARTED|Initial Staging||0
1715806|NCT00352534|4196794|P4|STARTED|Initial Staging||0
1715807|NCT00352534|4196795|P3|STARTED|Initial Staging||0
1715808|NCT00352534|4196796|P2|STARTED|Initial Staging||597
1715809|NCT00352534|4196797|P1|STARTED|Initial Staging||211
1715810|NCT00352417|4196814|P2|NOT COMPLETED|Overall Study||5
1715811|NCT00352417|4196815|P1|NOT COMPLETED|Overall Study||5
1715812|NCT00352417|4196814|P2|COMPLETED|Overall Study||21
1715813|NCT00352417|4196815|P1|COMPLETED|Overall Study||19
1715814|NCT00352417|4196814|P2|STARTED|Overall Study||26
1715815|NCT00352417|4196815|P1|STARTED|Overall Study||24
1715816|NCT00352365|4196829|P1|NOT COMPLETED|Maintenance Therapy||12
1715817|NCT00352365|4196829|P1|COMPLETED|Maintenance Therapy||0
1715818|NCT00352365|4196829|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
1715819|NCT00352365|4196829|P1|STARTED|Maintenance Therapy||12
1715820|NCT00352365|4196829|P1|NOT COMPLETED|Induction Therapy||27
1715821|NCT00352365|4196829|P1|COMPLETED|Induction Therapy||14
1715822|NCT00352365|4196829|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
1715823|NCT00352365|4196829|P1|Eligible|Induction Therapy||38
1715824|NCT00352365|4196829|P1|STARTED|Induction Therapy||41
1715825|NCT00352118|4196839|P1|NOT COMPLETED|Overall Study||4
1715826|NCT00352118|4196839|P1|COMPLETED|Overall Study||0
1715827|NCT00352118|4196839|P1|STARTED|Overall Study||4
1715828|NCT00352105|4196849|P1|NOT COMPLETED|Overall Study||40
1715829|NCT00352105|4196849|P1|COMPLETED|Overall Study||20
1715830|NCT00352105|4196849|P1|STARTED|Overall Study||60
1715831|NCT00352053|4196860|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
1715832|NCT00352053|4196861|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
1715833|NCT00352053|4196860|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
1715834|NCT00352053|4196861|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
1715835|NCT00352053|4196860|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
1715836|NCT00352053|4196861|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
1715837|NCT00352053|4196860|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
1715838|NCT00352053|4196861|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
1715839|NCT00352053|4196860|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
1715840|NCT00352053|4196861|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
1715841|NCT00352053|4196860|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
1715842|NCT00352053|4196861|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
1715843|NCT00352053|4196860|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
1715844|NCT00352053|4196861|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
1715845|NCT00352053|4196860|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
1715846|NCT00352053|4196861|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
1715847|NCT00352053|4196860|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
1715848|NCT00352053|4196861|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
1715849|NCT00352053|4196860|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
1715850|NCT00352053|4196861|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
1715851|NCT00352053|4196860|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
1715852|NCT00352053|4196861|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
1715853|NCT00352053|4196860|P2|STARTED|Double-Blind Phase (Through Week 48)||42
1715854|NCT00352053|4196861|P1|STARTED|Double-Blind Phase (Through Week 48)||45
1715855|NCT00352027|4197028|P1|NOT COMPLETED|Overall Study||3
1715856|NCT00352027|4197028|P1|COMPLETED|Overall Study||77
1715857|NCT00352027|4197028|P1|STARTED|Overall Study||80
1715858|NCT00352001|4197297|P1|NOT COMPLETED|Overall Study||0
1715859|NCT00352001|4197297|P1|COMPLETED|Overall Study||37
1715860|NCT00352001|4197297|P1|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
1715861|NCT00352001|4197297|P1|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
1715862|NCT00352001|4197297|P1|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
1715863|NCT00352001|4197297|P1|STARTED|Overall Study||37
1715864|NCT00351936|4197308|P1|NOT COMPLETED|Overall Study||0
1715865|NCT00351936|4197308|P1|COMPLETED|Overall Study||15
1715866|NCT00351936|4197308|P1|STARTED|Overall Study||15
1715867|NCT00351819|4197327|P2|NOT COMPLETED|Overall Study||12
1715868|NCT00351819|4197328|P1|NOT COMPLETED|Overall Study||7
1715869|NCT00351819|4197327|P2|COMPLETED|Overall Study||29
1715870|NCT00351819|4197328|P1|COMPLETED|Overall Study||36
1715871|NCT00351819|4197327|P2|STARTED|Overall Study||41
1715872|NCT00351819|4197328|P1|STARTED|Overall Study||43
1715873|NCT00351741|4197378|P2|NOT COMPLETED|Overall Study||0
1715874|NCT00351741|4197379|P1|NOT COMPLETED|Overall Study||0
1715875|NCT00351741|4197378|P2|COMPLETED|Overall Study||31
1715876|NCT00351741|4197379|P1|COMPLETED|Overall Study||31
1715877|NCT00351741|4197378|P2|STARTED|Overall Study||31
1715878|NCT00351741|4197379|P1|STARTED|Overall Study||31
1715879|NCT00351533|4197399|P2|NOT COMPLETED|Overall Study||5
1715880|NCT00351533|4197400|P1|NOT COMPLETED|Overall Study||2
1715881|NCT00351533|4197399|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
1715882|NCT00351533|4197400|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
1715883|NCT00351533|4197399|P2|STARTED|Overall Study||49
1715884|NCT00351533|4197400|P1|STARTED|Overall Study||41
1715885|NCT00351468|4197460|P1|NOT COMPLETED|Overall Study||167
1715886|NCT00351468|4197460|P1|COMPLETED|Overall Study||135
1715887|NCT00351468|4197460|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
1715888|NCT00351468|4197460|P1|Subjects From TRA108057 Repeat|Overall Study||43
1715889|NCT00351468|4197460|P1|Subjects From TRA102537 Raise|Overall Study||146
1715890|NCT00351468|4197460|P1|Subjects From TRA100773B|Overall Study||61
1715891|NCT00351468|4197460|P1|Subjects From TRA100773A|Overall Study||51
1715892|NCT00351468|4197460|P1|STARTED|Overall Study||302
1715893|NCT00351416|4197477|P2|NOT COMPLETED|Overall Study||0
1715894|NCT00351416|4197478|P1|NOT COMPLETED|Overall Study||0
1715895|NCT00351416|4197477|P2|COMPLETED|Overall Study||9
1715896|NCT00351416|4197478|P1|COMPLETED|Overall Study||6
1715897|NCT00351416|4197477|P2|STARTED|Overall Study||9
1715898|NCT00351416|4197478|P1|STARTED|Overall Study||6
1715899|NCT00351377|4197484|P1|NOT COMPLETED|Overall Study||7
1715900|NCT00351377|4197484|P1|COMPLETED|Overall Study||104
1715901|NCT00351377|4197484|P1|STARTED|Overall Study||111
1715902|NCT00351351|4197498|P2|NOT COMPLETED|Overall Study||4
1715903|NCT00351351|4197499|P1|NOT COMPLETED|Overall Study||9
1715904|NCT00351351|4197498|P2|COMPLETED|Overall Study||32
1715905|NCT00351351|4197499|P1|COMPLETED|Overall Study||25
1715906|NCT00351351|4197498|P2|STARTED|Overall Study||36
1715907|NCT00351351|4197499|P1|STARTED|Overall Study||34
1715908|NCT00351299|4197507|P2|NOT COMPLETED|Overall Study||0
1715909|NCT00351299|4197508|P1|NOT COMPLETED|Overall Study||0
1715910|NCT00351299|4197507|P2|COMPLETED|Overall Study||28
1715911|NCT00351299|4197508|P1|COMPLETED|Overall Study||25
1715912|NCT00351299|4197507|P2|STARTED|Overall Study||28
1715913|NCT00351299|4197508|P1|STARTED|Overall Study||25
1715914|NCT00351273|4197525|P3|NOT COMPLETED|Overall Study||5
1715915|NCT00351273|4197526|P2|NOT COMPLETED|Overall Study||2
1715916|NCT00351273|4197527|P1|NOT COMPLETED|Overall Study||1
1715917|NCT00351273|4197525|P3|COMPLETED|Overall Study||10
1715918|NCT00351273|4197526|P2|COMPLETED|Overall Study||10
1715919|NCT00351273|4197527|P1|COMPLETED|Overall Study||14
1715920|NCT00351273|4197525|P3|STARTED|Overall Study||15
1715921|NCT00351273|4197526|P2|STARTED|Overall Study||12
1715922|NCT00351273|4197527|P1|STARTED|Overall Study||15
1715923|NCT00351039|4197550|P1|NOT COMPLETED|Overall Study||0
1715924|NCT00351039|4197550|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
1715925|NCT00351039|4197550|P1|STARTED|Overall Study||8
1715926|NCT00351000|4197559|P1|NOT COMPLETED|Overall Study||3
1715927|NCT00351000|4197559|P1|COMPLETED|Overall Study||21
1715928|NCT00351000|4197559|P1|STARTED|Overall Study||24
1715929|NCT00350870|4197570|P4|NOT COMPLETED|Overall Study||15
1715930|NCT00350870|4197571|P3|NOT COMPLETED|Overall Study||16
1715931|NCT00350870|4197572|P2|NOT COMPLETED|Overall Study||17
1715932|NCT00350870|4197573|P1|NOT COMPLETED|Overall Study||22
1715933|NCT00350870|4197570|P4|COMPLETED|Overall Study||7
1715934|NCT00350870|4197571|P3|COMPLETED|Overall Study||6
1715935|NCT00350870|4197572|P2|COMPLETED|Overall Study||11
1715936|NCT00350870|4197573|P1|COMPLETED|Overall Study||5
1715937|NCT00350870|4197570|P4|Had at Least 1 Day of Med|Overall Study||19
1715938|NCT00350870|4197571|P3|Had at Least 1 Day of Med|Overall Study||18
1715939|NCT00350870|4197572|P2|Had at Least 1 Day of Med|Overall Study||24
1715940|NCT00350870|4197573|P1|Had at Least 1 Day of Med|Overall Study||19
1715941|NCT00350870|4197570|P4|STARTED|Overall Study||22
1715942|NCT00350870|4197571|P3|STARTED|Overall Study||22
1715943|NCT00350870|4197572|P2|STARTED|Overall Study||28
1715944|NCT00350870|4197573|P1|STARTED|Overall Study||27
1715945|NCT00350844|4197587|P1|NOT COMPLETED|Overall Study||1
1715946|NCT00350844|4197587|P1|COMPLETED|Overall Study||5
1715947|NCT00350844|4197587|P1|STARTED|Overall Study||6
1715948|NCT00350792|4197591|P1|NOT COMPLETED|Overall Study||33
1715949|NCT00350792|4197591|P1|COMPLETED|Overall Study||29
1715950|NCT00350792|4197591|P1|STARTED|Overall Study||62
1715951|NCT00350779|4197601|P2|NOT COMPLETED|Overall Study||21
1715952|NCT00350779|4197602|P1|NOT COMPLETED|Overall Study||22
1715953|NCT00350779|4197601|P2|COMPLETED|Overall Study||71
1715954|NCT00350779|4197602|P1|COMPLETED|Overall Study||148
1715955|NCT00350779|4197601|P2|STARTED|Overall Study||92
1715956|NCT00350779|4197602|P1|STARTED|Overall Study||170
1715957|NCT00350727|4197623|P3|NOT COMPLETED|Phase II||22
1715958|NCT00350727|4197624|P2|NOT COMPLETED|Phase II||19
1715959|NCT00350727|4197625|P1|NOT COMPLETED|Phase II||0
1715960|NCT00350727|4197623|P3|COMPLETED|Phase II||0
1715961|NCT00350727|4197624|P2|COMPLETED|Phase II||0
1715962|NCT00350727|4197625|P1|COMPLETED|Phase II||0
1715963|NCT00350727|4197623|P3|STARTED|Phase II||22
1715964|NCT00350727|4197624|P2|STARTED|Phase II||19
1715965|NCT00350727|4197625|P1|STARTED|Phase II||0
1715966|NCT00350727|4197623|P3|NOT COMPLETED|Phase I: Dose Escalation||0
1715967|NCT00350727|4197624|P2|NOT COMPLETED|Phase I: Dose Escalation||0
1715968|NCT00350727|4197625|P1|NOT COMPLETED|Phase I: Dose Escalation||34
1715969|NCT00350727|4197623|P3|COMPLETED|Phase I: Dose Escalation||0
1715970|NCT00350727|4197624|P2|COMPLETED|Phase I: Dose Escalation||0
1715971|NCT00350727|4197625|P1|COMPLETED|Phase I: Dose Escalation||0
1715972|NCT00350727|4197623|P3|STARTED|Phase I: Dose Escalation||0
1715973|NCT00350727|4197624|P2|STARTED|Phase I: Dose Escalation||0
1715974|NCT00350727|4197625|P1|STARTED|Phase I: Dose Escalation||34
1715975|NCT00350636|4197769|P2|NOT COMPLETED|Overall Study||45
1715976|NCT00350636|4197770|P1|NOT COMPLETED|Overall Study||43
1715977|NCT00350636|4197769|P2|COMPLETED|Overall Study||355
1715978|NCT00350636|4197770|P1|COMPLETED|Overall Study||346
1715979|NCT00350636|4197769|P2|STARTED|Overall Study||400
1715980|NCT00350636|4197770|P1|STARTED|Overall Study||389
1715981|NCT00350623|4197789|P3|NOT COMPLETED|Overall Study||6
1715982|NCT00350623|4197790|P2|NOT COMPLETED|Overall Study||4
1715983|NCT00350623|4197791|P1|NOT COMPLETED|Overall Study||8
1715984|NCT00350623|4197789|P3|COMPLETED|Overall Study||62
1715985|NCT00350623|4197790|P2|COMPLETED|Overall Study||67
1715986|NCT00350623|4197791|P1|COMPLETED|Overall Study||63
1715987|NCT00350623|4197789|P3|STARTED|Overall Study||68
1715988|NCT00350623|4197790|P2|STARTED|Overall Study||71
1715989|NCT00350623|4197791|P1|STARTED|Overall Study||71
1715990|NCT00350545|4197799|P1|NOT COMPLETED|Overall Study||2
1715991|NCT00350545|4197799|P1|COMPLETED|Overall Study||35
1715992|NCT00350545|4197799|P1|STARTED|Overall Study||37
1715993|NCT00350532|4197809|P2|NOT COMPLETED|Overall Study||0
1715994|NCT00350532|4197810|P1|NOT COMPLETED|Overall Study||0
1715995|NCT00350532|4197809|P2|COMPLETED|Overall Study||19
1715996|NCT00350532|4197810|P1|COMPLETED|Overall Study||24
1715997|NCT00350532|4197809|P2|STARTED|Overall Study||19
1715998|NCT00350532|4197810|P1|STARTED|Overall Study||24
1715999|NCT00350519|4197818|P2|NOT COMPLETED|Overall Study||6
1716000|NCT00350519|4197819|P1|NOT COMPLETED|Overall Study||4
1716001|NCT00350519|4197818|P2|COMPLETED|Overall Study||13
1716002|NCT00350519|4197819|P1|COMPLETED|Overall Study||14
1716003|NCT00350519|4197818|P2|STARTED|Overall Study||19
1716004|NCT00350519|4197819|P1|STARTED|Overall Study||18
1716005|NCT00350402|4197833|P2|NOT COMPLETED|Overall Study||1
1716006|NCT00350402|4197834|P1|NOT COMPLETED|Overall Study||1
1716007|NCT00350402|4197833|P2|COMPLETED|Overall Study||20
1716008|NCT00350402|4197834|P1|COMPLETED|Overall Study||20
1716009|NCT00350402|4197833|P2|STARTED|Overall Study||21
1716010|NCT00350402|4197834|P1|STARTED|Overall Study||21
1716011|NCT00350363|4197846|P1|NOT COMPLETED|Overall Study||0
1716012|NCT00350363|4197846|P1|COMPLETED|Overall Study||60
1716013|NCT00350363|4197846|P1|STARTED|Overall Study||60
1716014|NCT00350337|4197854|P4|NOT COMPLETED|Overall Study||0
1716015|NCT00350337|4197855|P3|NOT COMPLETED|Overall Study||3
1716016|NCT00350337|4197856|P2|NOT COMPLETED|Overall Study||3
1716017|NCT00350337|4197857|P1|NOT COMPLETED|Overall Study||5
1716018|NCT00350337|4197854|P4|COMPLETED|Overall Study||21
1716019|NCT00350337|4197855|P3|COMPLETED|Overall Study||18
1716020|NCT00350337|4197856|P2|COMPLETED|Overall Study||19
1716021|NCT00350337|4197857|P1|COMPLETED|Overall Study||17
1716022|NCT00350337|4197854|P4|STARTED|Overall Study||21
1716023|NCT00350337|4197855|P3|STARTED|Overall Study||21
1716024|NCT00350337|4197856|P2|STARTED|Overall Study||22
1716025|NCT00350337|4197857|P1|STARTED|Overall Study||22
1716026|NCT00350272|4197907|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
1716027|NCT00350272|4197908|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
1716028|NCT00350272|4197907|P2|COMPLETED|Open-Label 84 Week Treatment||27
1716029|NCT00350272|4197908|P1|COMPLETED|Open-Label 84 Week Treatment||21
1716030|NCT00350272|4197907|P2|STARTED|Open-Label 84 Week Treatment||35
1716031|NCT00350272|4197908|P1|STARTED|Open-Label 84 Week Treatment||30
1716032|NCT00350272|4197907|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
1716033|NCT00350272|4197908|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
1716034|NCT00350272|4197907|P2|COMPLETED|Blinded 12 Week Treatment||35
1716035|NCT00350272|4197908|P1|COMPLETED|Blinded 12 Week Treatment||30
1716036|NCT00350272|4197907|P2|STARTED|Blinded 12 Week Treatment||37
1716037|NCT00350272|4197908|P1|STARTED|Blinded 12 Week Treatment||39
1716038|NCT00350220|4197918|P2|NOT COMPLETED|Overall Study||0
1716039|NCT00350220|4197919|P1|NOT COMPLETED|Overall Study||0
1716040|NCT00350220|4197918|P2|COMPLETED|Overall Study||30
1716041|NCT00350220|4197919|P1|COMPLETED|Overall Study||30
1716042|NCT00350220|4197918|P2|STARTED|Overall Study||30
1716043|NCT00350220|4197919|P1|STARTED|Overall Study||30
1716044|NCT00350207|4197930|P3|NOT COMPLETED|Overall Study||7
1716045|NCT00350207|4197931|P2|NOT COMPLETED|Overall Study||6
1716046|NCT00350207|4197932|P1|NOT COMPLETED|Overall Study||8
1716047|NCT00350207|4197930|P3|COMPLETED|Overall Study||119
1716048|NCT00350207|4197931|P2|COMPLETED|Overall Study||128
1716049|NCT00350207|4197932|P1|COMPLETED|Overall Study||120
1716050|NCT00350207|4197930|P3|STARTED|Overall Study||126
1716051|NCT00350207|4197931|P2|STARTED|Overall Study||134
1716052|NCT00350207|4197932|P1|STARTED|Overall Study||128
1716053|NCT00350142|4198126|P1|NOT COMPLETED|Overall Study||0
1716054|NCT00350142|4198126|P1|COMPLETED|Overall Study||20
1716055|NCT00350142|4198126|P1|STARTED|Overall Study||20
1716056|NCT00350025|4198133|P2|NOT COMPLETED|Overall Study||2
1716057|NCT00350025|4198134|P1|NOT COMPLETED|Overall Study||0
1716058|NCT00350025|4198133|P2|COMPLETED|Overall Study||28
1716059|NCT00350025|4198134|P1|COMPLETED|Overall Study||11
1716060|NCT00350025|4198133|P2|STARTED|Overall Study||30
1716061|NCT00350025|4198134|P1|STARTED|Overall Study||11
1716062|NCT00349973|4198144|P2|NOT COMPLETED|Overall Study||3
1716063|NCT00349973|4198145|P1|NOT COMPLETED|Overall Study||4
1716064|NCT00349973|4198144|P2|COMPLETED|Overall Study||5
1716065|NCT00349973|4198145|P1|COMPLETED|Overall Study||8
1716066|NCT00349973|4198144|P2|STARTED|Overall Study||8
1716067|NCT00349973|4198145|P1|STARTED|Overall Study||12
1716068|NCT00349921|4198159|P4|NOT COMPLETED|Second Spinal Injection||0
1716069|NCT00349921|4198160|P3|NOT COMPLETED|Second Spinal Injection||0
1716070|NCT00349921|4198161|P2|NOT COMPLETED|Second Spinal Injection||0
1716071|NCT00349921|4198162|P1|NOT COMPLETED|Second Spinal Injection||0
1716072|NCT00349921|4198159|P4|COMPLETED|Second Spinal Injection||1
1716073|NCT00349921|4198160|P3|COMPLETED|Second Spinal Injection||0
1716074|NCT00349921|4198161|P2|COMPLETED|Second Spinal Injection||10
1716075|NCT00349921|4198162|P1|COMPLETED|Second Spinal Injection||9
1716076|NCT00349921|4198159|P4|STARTED|Second Spinal Injection||1
1716077|NCT00349921|4198160|P3|STARTED|Second Spinal Injection||0
1716078|NCT00349921|4198161|P2|STARTED|Second Spinal Injection||10
1716079|NCT00349921|4198162|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
1716080|NCT00349921|4198159|P4|NOT COMPLETED|First Spinal Injection||0
1716081|NCT00349921|4198160|P3|NOT COMPLETED|First Spinal Injection||1
1716082|NCT00349921|4198161|P2|NOT COMPLETED|First Spinal Injection||0
1716083|NCT00349921|4198162|P1|NOT COMPLETED|First Spinal Injection||1
1716084|NCT00349921|4198159|P4|COMPLETED|First Spinal Injection||1
1716085|NCT00349921|4198160|P3|COMPLETED|First Spinal Injection||0
1716086|NCT00349921|4198161|P2|COMPLETED|First Spinal Injection||10
1716087|NCT00349921|4198162|P1|COMPLETED|First Spinal Injection||9
1716088|NCT00349921|4198159|P4|STARTED|First Spinal Injection||1
1716089|NCT00349921|4198160|P3|STARTED|First Spinal Injection||1
1716090|NCT00349921|4198161|P2|STARTED|First Spinal Injection||10
1716091|NCT00349921|4198162|P1|STARTED|First Spinal Injection||10
1716092|NCT00349908|4198173|P2|NOT COMPLETED|Overall Study||4
1716093|NCT00349908|4198174|P1|NOT COMPLETED|Overall Study||0
1716094|NCT00349908|4198173|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
1716095|NCT00349908|4198174|P1|COMPLETED|Overall Study||10
1716096|NCT00349908|4198173|P2|STARTED|Overall Study||10
1716097|NCT00349908|4198174|P1|STARTED|Overall Study||10
1716098|NCT00349778|4198192|P1|NOT COMPLETED|Overall Study||0
1716099|NCT00349778|4198192|P1|COMPLETED|Overall Study||102
1716100|NCT00349778|4198192|P1|STARTED|Overall Study||102
1716101|NCT00349752|4198200|P2|NOT COMPLETED|Overall Study||64
1716102|NCT00349752|4198201|P1|NOT COMPLETED|Overall Study||59
1716103|NCT00349752|4198200|P2|COMPLETED|Overall Study||23
1716104|NCT00349752|4198201|P1|COMPLETED|Overall Study||28
1716105|NCT00349752|4198200|P2|STARTED|Overall Study||87
1716106|NCT00349752|4198201|P1|STARTED|Overall Study||87
1716107|NCT00349713|4198230|P3|NOT COMPLETED|Overall Study||0
1716108|NCT00349713|4198231|P2|NOT COMPLETED|Overall Study||0
1716109|NCT00349713|4198232|P1|NOT COMPLETED|Overall Study||0
1716110|NCT00349713|4198230|P3|COMPLETED|Overall Study||20
1716111|NCT00349713|4198231|P2|COMPLETED|Overall Study||20
1716112|NCT00349713|4198232|P1|COMPLETED|Overall Study||20
1716113|NCT00349713|4198230|P3|STARTED|Overall Study||20
1716114|NCT00349713|4198231|P2|STARTED|Overall Study||20
1716115|NCT00349713|4198232|P1|STARTED|Overall Study||20
1716116|NCT00349622|4198254|P2|NOT COMPLETED|Overall Study||96
1716117|NCT00349622|4198255|P1|NOT COMPLETED|Overall Study||178
1716118|NCT00349622|4198254|P2|COMPLETED|Overall Study||77
1716119|NCT00349622|4198255|P1|COMPLETED|Overall Study||162
1716120|NCT00349622|4198254|P2|STARTED|Overall Study||173
1716121|NCT00349622|4198255|P1|STARTED|Overall Study||340
1716122|NCT00349466|4198273|P2|NOT COMPLETED|Overall Study||3
1716123|NCT00349466|4198274|P1|NOT COMPLETED|Overall Study||9
1716124|NCT00349466|4198273|P2|COMPLETED|Overall Study||35
1716125|NCT00349466|4198274|P1|COMPLETED|Overall Study||33
1716126|NCT00349466|4198273|P2|STARTED|Overall Study||38
1716127|NCT00349466|4198274|P1|STARTED|Overall Study||42
1716128|NCT00349388|4198282|P2|NOT COMPLETED|Overall Study||0
1716129|NCT00349388|4198283|P1|NOT COMPLETED|Overall Study||0
1716130|NCT00349388|4198282|P2|COMPLETED|Overall Study||1
1716131|NCT00349388|4198283|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
1716132|NCT00349388|4198282|P2|STARTED|Overall Study||1
1716133|NCT00349388|4198283|P1|STARTED|Overall Study|no patients enrolled|0
1716134|NCT00349349|4198292|P3|NOT COMPLETED|Overall Study||6
1716135|NCT00349349|4198293|P2|NOT COMPLETED|Overall Study||62
1716136|NCT00349349|4198294|P1|NOT COMPLETED|Overall Study||53
1716137|NCT00349349|4198292|P3|COMPLETED|Overall Study||10
1716138|NCT00349349|4198293|P2|COMPLETED|Overall Study||50
1716139|NCT00349349|4198294|P1|COMPLETED|Overall Study||42
1716140|NCT00349349|4198292|P3|STARTED|Overall Study||16
1716141|NCT00349349|4198293|P2|STARTED|Overall Study||112
1716142|NCT00349349|4198294|P1|STARTED|Overall Study||95
1716143|NCT00349336|4198360|P2|NOT COMPLETED|Overall Study||14
1716144|NCT00349336|4198361|P1|NOT COMPLETED|Overall Study||13
1716145|NCT00349336|4198360|P2|COMPLETED|Overall Study||18
1716146|NCT00349336|4198361|P1|COMPLETED|Overall Study||19
1716147|NCT00349336|4198360|P2|STARTED|Overall Study||32
1716148|NCT00349336|4198361|P1|STARTED|Overall Study||32
1716149|NCT00348933|4198383|P1|NOT COMPLETED|Overall Study||25
1716150|NCT00348933|4198383|P1|COMPLETED|Overall Study||65
1716151|NCT00348933|4198383|P1|STARTED|Overall Study||90
1716152|NCT00348881|4198391|P2|NOT COMPLETED|Overall Study||12
1716153|NCT00348881|4198392|P1|NOT COMPLETED|Overall Study||17
1716154|NCT00348881|4198391|P2|COMPLETED|Overall Study||697
1716155|NCT00348881|4198392|P1|COMPLETED|Overall Study||1407
1716156|NCT00348881|4198391|P2|STARTED|Overall Study||709
1716157|NCT00348881|4198392|P1|STARTED|Overall Study||1424
1716158|NCT00348816|4198404|P1|NOT COMPLETED|Overall Study||1
1716159|NCT00348816|4198404|P1|COMPLETED|Overall Study||19
1716160|NCT00348816|4198404|P1|STARTED|Overall Study||20
1716161|NCT00348790|4198411|P1|NOT COMPLETED|Completed Treatment||25
1716162|NCT00348790|4198411|P1|COMPLETED|Completed Treatment||0
1716163|NCT00348790|4198411|P1|STARTED|Completed Treatment||25
1716164|NCT00348790|4198411|P1|NOT COMPLETED|Began Treatment||0
1716165|NCT00348790|4198411|P1|COMPLETED|Began Treatment||25
1716166|NCT00348790|4198411|P1|STARTED|Began Treatment||25
1716167|NCT00348686|4198423|P1|NOT COMPLETED|Overall Study||66
1716168|NCT00348686|4198423|P1|COMPLETED|Overall Study||249
1716169|NCT00348686|4198423|P1|STARTED|Overall Study||315
1716170|NCT00348673|4198440|P9|NOT COMPLETED|Stage 2||0
1716171|NCT00348673|4198441|P8|NOT COMPLETED|Stage 2||0
1716172|NCT00348673|4198442|P7|NOT COMPLETED|Stage 2||0
1716173|NCT00348673|4198443|P6|NOT COMPLETED|Stage 2||0
1716174|NCT00348673|4198444|P5|NOT COMPLETED|Stage 2||0
1716175|NCT00348673|4198445|P4|NOT COMPLETED|Stage 2||0
1716176|NCT00348673|4198446|P3|NOT COMPLETED|Stage 2||0
1716177|NCT00348673|4198447|P2|NOT COMPLETED|Stage 2||0
1716178|NCT00348673|4198448|P1|NOT COMPLETED|Stage 2||0
1716179|NCT00348673|4198440|P9|COMPLETED|Stage 2||2
1716180|NCT00348673|4198441|P8|COMPLETED|Stage 2||6
1716181|NCT00348673|4198442|P7|COMPLETED|Stage 2||6
1716182|NCT00348673|4198443|P6|COMPLETED|Stage 2||6
1716183|NCT00348673|4198444|P5|COMPLETED|Stage 2||0
1716184|NCT00348673|4198445|P4|COMPLETED|Stage 2||0
1716185|NCT00348673|4198446|P3|COMPLETED|Stage 2||0
1716186|NCT00348673|4198447|P2|COMPLETED|Stage 2||0
1716187|NCT00348673|4198448|P1|COMPLETED|Stage 2||0
1716188|NCT00348673|4198440|P9|STARTED|Stage 2||2
1716189|NCT00348673|4198441|P8|STARTED|Stage 2||6
1716190|NCT00348673|4198442|P7|STARTED|Stage 2||6
1716191|NCT00348673|4198443|P6|STARTED|Stage 2||6
1716192|NCT00348673|4198444|P5|STARTED|Stage 2||0
1716193|NCT00348673|4198445|P4|STARTED|Stage 2||0
1716194|NCT00348673|4198446|P3|STARTED|Stage 2||0
1716195|NCT00348673|4198447|P2|STARTED|Stage 2||0
1716196|NCT00348673|4198448|P1|STARTED|Stage 2||0
1716197|NCT00348673|4198440|P9|NOT COMPLETED|Stage 1||0
1716198|NCT00348673|4198441|P8|NOT COMPLETED|Stage 1||0
1716199|NCT00348673|4198442|P7|NOT COMPLETED|Stage 1||0
1716200|NCT00348673|4198443|P6|NOT COMPLETED|Stage 1||0
1716201|NCT00348673|4198444|P5|NOT COMPLETED|Stage 1||0
1716202|NCT00348673|4198445|P4|NOT COMPLETED|Stage 1||0
1716203|NCT00348673|4198446|P3|NOT COMPLETED|Stage 1||1
1716204|NCT00348673|4198447|P2|NOT COMPLETED|Stage 1||0
1716205|NCT00348673|4198448|P1|NOT COMPLETED|Stage 1||0
1716206|NCT00348673|4198440|P9|COMPLETED|Stage 1||0
1716207|NCT00348673|4198441|P8|COMPLETED|Stage 1||0
1716208|NCT00348673|4198442|P7|COMPLETED|Stage 1||0
1716209|NCT00348673|4198443|P6|COMPLETED|Stage 1||0
1716210|NCT00348673|4198444|P5|COMPLETED|Stage 1||4
1716211|NCT00348673|4198445|P4|COMPLETED|Stage 1||6
1716212|NCT00348673|4198446|P3|COMPLETED|Stage 1||6
1716213|NCT00348673|4198447|P2|COMPLETED|Stage 1||6
1716214|NCT00348673|4198448|P1|COMPLETED|Stage 1||6
1716215|NCT00348673|4198440|P9|Treated|Stage 1||0
1716216|NCT00348673|4198441|P8|Treated|Stage 1||0
1716217|NCT00348673|4198442|P7|Treated|Stage 1||0
1716218|NCT00348673|4198443|P6|Treated|Stage 1||0
1716219|NCT00348673|4198444|P5|Treated|Stage 1||4
1716220|NCT00348673|4198445|P4|Treated|Stage 1||6
1716221|NCT00348673|4198446|P3|Treated|Stage 1||6
1716222|NCT00348673|4198447|P2|Treated|Stage 1||6
1716223|NCT00348673|4198448|P1|Treated|Stage 1||6
1716224|NCT00348673|4198440|P9|STARTED|Stage 1||0
1716225|NCT00348673|4198441|P8|STARTED|Stage 1||0
1716226|NCT00348673|4198442|P7|STARTED|Stage 1||0
1716227|NCT00348673|4198443|P6|STARTED|Stage 1||0
1716228|NCT00348673|4198444|P5|STARTED|Stage 1||4
1716229|NCT00348673|4198445|P4|STARTED|Stage 1||6
1716230|NCT00348673|4198446|P3|STARTED|Stage 1||7
1716231|NCT00348673|4198447|P2|STARTED|Stage 1||6
1716232|NCT00348673|4198448|P1|STARTED|Stage 1||6
1716233|NCT00348556|4198495|P1|NOT COMPLETED|Overall Study||1
1716234|NCT00348556|4198495|P1|COMPLETED|Overall Study||3
1716235|NCT00348556|4198495|P1|STARTED|Overall Study||4
1716236|NCT00348374|4198502|P2|NOT COMPLETED|Overall Study||32
1716237|NCT00348374|4198503|P1|NOT COMPLETED|Overall Study||19
1716238|NCT00348374|4198502|P2|COMPLETED|Overall Study||71
1716239|NCT00348374|4198503|P1|COMPLETED|Overall Study||69
1716240|NCT00348374|4198502|P2|Received Study Treatment|Overall Study||96
1716241|NCT00348374|4198503|P1|Received Study Treatment|Overall Study||88
1716242|NCT00348374|4198502|P2|STARTED|Overall Study||103
1716243|NCT00348374|4198503|P1|STARTED|Overall Study||88
1716244|NCT00348348|4198550|P2|NOT COMPLETED|Overall Study||27
1716245|NCT00348348|4198551|P1|NOT COMPLETED|Overall Study||25
1716246|NCT00348348|4198550|P2|COMPLETED|Overall Study||555
1716247|NCT00348348|4198551|P1|COMPLETED|Overall Study||554
1716248|NCT00348348|4198550|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
1716249|NCT00348348|4198551|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
1716250|NCT00348309|4198566|P3|NOT COMPLETED|Overall Study||143
1716251|NCT00348309|4198567|P2|NOT COMPLETED|Overall Study||98
1716252|NCT00348309|4198568|P1|NOT COMPLETED|Overall Study||134
1716253|NCT00348309|4198566|P3|COMPLETED|Overall Study||346
1716254|NCT00348309|4198567|P2|COMPLETED|Overall Study||396
1716255|NCT00348309|4198568|P1|COMPLETED|Overall Study||362
1716256|NCT00348309|4198566|P3|STARTED|Overall Study||489
1716257|NCT00348309|4198567|P2|STARTED|Overall Study||494
1716258|NCT00348309|4198568|P1|STARTED|Overall Study||496
1716259|NCT00348283|4198641|P2|NOT COMPLETED|Open Label||34
1716260|NCT00348283|4198642|P1|NOT COMPLETED|Open Label||0
1716261|NCT00348283|4198641|P2|COMPLETED|Open Label||66
1716262|NCT00348283|4198642|P1|COMPLETED|Open Label||0
1716263|NCT00348283|4198641|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
1716264|NCT00348283|4198642|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
1716265|NCT00348283|4198641|P2|NOT COMPLETED|Double Blind||10
1716266|NCT00348283|4198642|P1|NOT COMPLETED|Double Blind||5
1716267|NCT00348283|4198641|P2|COMPLETED|Double Blind||54
1716268|NCT00348283|4198642|P1|COMPLETED|Double Blind||60
1716269|NCT00348283|4198641|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
1716270|NCT00348283|4198642|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
1716271|NCT00348283|4198641|P2|NOT COMPLETED|Induction||6
1716272|NCT00348283|4198642|P1|NOT COMPLETED|Induction||0
1716273|NCT00348283|4198641|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
1716274|NCT00348283|4198642|P1|COMPLETED|Induction||0
1716275|NCT00348283|4198641|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
1716276|NCT00348283|4198642|P1|STARTED|Induction||0
1716277|NCT00348140|4198661|P3|NOT COMPLETED|Overall Study||163
1716278|NCT00348140|4198662|P2|NOT COMPLETED|Overall Study||139
1716279|NCT00348140|4198663|P1|NOT COMPLETED|Overall Study||126
1716280|NCT00348140|4198661|P3|COMPLETED|Overall Study||328
1716281|NCT00348140|4198662|P2|COMPLETED|Overall Study||351
1716282|NCT00348140|4198663|P1|COMPLETED|Overall Study||361
1716283|NCT00348140|4198661|P3|STARTED|Overall Study||491
1716284|NCT00348140|4198662|P2|STARTED|Overall Study||490
1716285|NCT00348140|4198663|P1|STARTED|Overall Study||487
1716286|NCT00347958|4198761|P1|NOT COMPLETED|Overall Study||4
1716287|NCT00347958|4198761|P1|COMPLETED|Overall Study||540
1716288|NCT00347958|4198761|P1|STARTED|Overall Study||544
1716289|NCT00347932|4198770|P2|NOT COMPLETED|Overall Study||52
1716290|NCT00347932|4198771|P1|NOT COMPLETED|Overall Study||31
1716291|NCT00347932|4198770|P2|COMPLETED|Overall Study||430
1716292|NCT00347932|4198771|P1|COMPLETED|Overall Study||444
1716293|NCT00347932|4198770|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
1716294|NCT00347932|4198771|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
1716295|NCT00347919|4198786|P3|NOT COMPLETED|Overall Study||38
1716296|NCT00347919|4198787|P2|NOT COMPLETED|Overall Study||76
1716297|NCT00347919|4198788|P1|NOT COMPLETED|Overall Study||71
1716298|NCT00347919|4198786|P3|COMPLETED|Overall Study||2
1716299|NCT00347919|4198787|P2|COMPLETED|Overall Study||0
1716300|NCT00347919|4198788|P1|COMPLETED|Overall Study||2
1716301|NCT00347919|4198786|P3|STARTED|Overall Study|Safety Population|40
1716302|NCT00347919|4198787|P2|STARTED|Overall Study|Safety Population|76
1716303|NCT00347919|4198788|P1|STARTED|Overall Study|Safety Population|73
1716304|NCT00347776|4198811|P3|NOT COMPLETED|12 Month Follow-up||19
1716305|NCT00347776|4198812|P2|NOT COMPLETED|12 Month Follow-up||16
1716306|NCT00347776|4198813|P1|NOT COMPLETED|12 Month Follow-up||23
1716307|NCT00347776|4198811|P3|COMPLETED|12 Month Follow-up||436
1716308|NCT00347776|4198812|P2|COMPLETED|12 Month Follow-up||446
1716309|NCT00347776|4198813|P1|COMPLETED|12 Month Follow-up||425
1716310|NCT00347776|4198811|P3|STARTED|12 Month Follow-up||455
1716311|NCT00347776|4198812|P2|STARTED|12 Month Follow-up||462
1716312|NCT00347776|4198813|P1|STARTED|12 Month Follow-up||448
1716313|NCT00347776|4198811|P3|NOT COMPLETED|6 Month Follow-up||18
1716314|NCT00347776|4198812|P2|NOT COMPLETED|6 Month Follow-up||13
1716315|NCT00347776|4198813|P1|NOT COMPLETED|6 Month Follow-up||22
1716316|NCT00347776|4198811|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
1716317|NCT00347776|4198812|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
1716318|NCT00347776|4198813|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
1716319|NCT00347776|4198811|P3|STARTED|6 Month Follow-up||473
1716320|NCT00347776|4198812|P2|STARTED|6 Month Follow-up||475
1716321|NCT00347776|4198813|P1|STARTED|6 Month Follow-up||470
1716322|NCT00347776|4198811|P3|NOT COMPLETED|1.5 Month Follow-up||12
1716323|NCT00347776|4198812|P2|NOT COMPLETED|1.5 Month Follow-up||8
1716324|NCT00347776|4198813|P1|NOT COMPLETED|1.5 Month Follow-up||14
1716325|NCT00347776|4198811|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
1716326|NCT00347776|4198812|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
1716327|NCT00347776|4198813|P1|COMPLETED|1.5 Month Follow-up||470
1716328|NCT00347776|4198811|P3|STARTED|1.5 Month Follow-up||485
1716329|NCT00347776|4198812|P2|STARTED|1.5 Month Follow-up||483
1716330|NCT00347776|4198813|P1|STARTED|1.5 Month Follow-up||484
1716331|NCT00347438|4198825|P1|NOT COMPLETED|Overall Study||2
1716332|NCT00347438|4198825|P1|COMPLETED|Overall Study||16
1716333|NCT00347438|4198825|P1|STARTED|Overall Study||18
1716334|NCT00347360|4198847|P15|NOT COMPLETED|Overall Study||4
1716335|NCT00347360|4198848|P14|NOT COMPLETED|Overall Study||8
1716336|NCT00347360|4198849|P13|NOT COMPLETED|Overall Study||10
1716337|NCT00347360|4198850|P12|NOT COMPLETED|Overall Study||6
1716338|NCT00347360|4198851|P11|NOT COMPLETED|Overall Study||5
1716339|NCT00347360|4198852|P10|NOT COMPLETED|Overall Study||9
1716340|NCT00347360|4198853|P9|NOT COMPLETED|Overall Study||6
1716341|NCT00347360|4198854|P8|NOT COMPLETED|Overall Study||3
1716342|NCT00347360|4198855|P7|NOT COMPLETED|Overall Study||7
1716343|NCT00347360|4198856|P6|NOT COMPLETED|Overall Study||8
1716344|NCT00347360|4198857|P5|NOT COMPLETED|Overall Study||5
1716345|NCT00347360|4198858|P4|NOT COMPLETED|Overall Study||13
1716346|NCT00347360|4198859|P3|NOT COMPLETED|Overall Study||6
1716347|NCT00347360|4198860|P2|NOT COMPLETED|Overall Study||8
1716348|NCT00347360|4198861|P1|NOT COMPLETED|Overall Study||5
1716349|NCT00347360|4198847|P15|COMPLETED|Overall Study||39
1716350|NCT00347360|4198848|P14|COMPLETED|Overall Study||36
1716351|NCT00347360|4198849|P13|COMPLETED|Overall Study||34
1716352|NCT00347360|4198850|P12|COMPLETED|Overall Study||37
1716353|NCT00347360|4198851|P11|COMPLETED|Overall Study||39
1716354|NCT00347360|4198852|P10|COMPLETED|Overall Study||35
1716355|NCT00347360|4198853|P9|COMPLETED|Overall Study||38
1716356|NCT00347360|4198854|P8|COMPLETED|Overall Study||40
1716357|NCT00347360|4198855|P7|COMPLETED|Overall Study||37
1716358|NCT00347360|4198856|P6|COMPLETED|Overall Study||36
1716359|NCT00347360|4198857|P5|COMPLETED|Overall Study||39
1716360|NCT00347360|4198858|P4|COMPLETED|Overall Study||30
1716361|NCT00347360|4198859|P3|COMPLETED|Overall Study||37
1716362|NCT00347360|4198860|P2|COMPLETED|Overall Study||35
1716363|NCT00347360|4198861|P1|COMPLETED|Overall Study||39
1716364|NCT00347360|4198847|P15|STARTED|Overall Study||43
1716365|NCT00347360|4198848|P14|STARTED|Overall Study||44
1716366|NCT00347360|4198849|P13|STARTED|Overall Study||44
1716367|NCT00347360|4198850|P12|STARTED|Overall Study||43
1716368|NCT00347360|4198851|P11|STARTED|Overall Study||44
1716369|NCT00347360|4198852|P10|STARTED|Overall Study||44
1716370|NCT00347360|4198853|P9|STARTED|Overall Study||44
1716371|NCT00347360|4198854|P8|STARTED|Overall Study||43
1716372|NCT00347360|4198855|P7|STARTED|Overall Study||44
1716373|NCT00347360|4198856|P6|STARTED|Overall Study||44
1716374|NCT00347360|4198857|P5|STARTED|Overall Study||44
1716375|NCT00347360|4198858|P4|STARTED|Overall Study||43
1716376|NCT00347360|4198859|P3|STARTED|Overall Study||43
1716377|NCT00347360|4198860|P2|STARTED|Overall Study||43
1716378|NCT00347360|4198861|P1|STARTED|Overall Study||44
1716379|NCT00347308|4199043|P1|NOT COMPLETED|Overall Study||0
1716380|NCT00347308|4199043|P1|COMPLETED|Overall Study||40
1716381|NCT00347308|4199043|P1|STARTED|Overall Study||40
1716382|NCT00347269|4199049|P2|NOT COMPLETED|Overall Study||106
1716383|NCT00347269|4199050|P1|NOT COMPLETED|Overall Study||94
1716384|NCT00347269|4199049|P2|COMPLETED|Overall Study||395
1716385|NCT00347269|4199050|P1|COMPLETED|Overall Study||409
1716386|NCT00347269|4199049|P2|STARTED|Overall Study||501
1716387|NCT00347269|4199050|P1|STARTED|Overall Study||503
1716388|NCT00347022|4199058|P2|NOT COMPLETED|Overall Study||5
1716389|NCT00347022|4199059|P1|NOT COMPLETED|Overall Study||12
1716390|NCT00347022|4199058|P2|COMPLETED|Overall Study||66
1716391|NCT00347022|4199059|P1|COMPLETED|Overall Study||62
1716392|NCT00347022|4199058|P2|STARTED|Overall Study||71
1716393|NCT00347022|4199059|P1|STARTED|Overall Study||74
1716394|NCT00347009|4199065|P1|NOT COMPLETED|Overall Study||27
1716395|NCT00347009|4199065|P1|COMPLETED|Overall Study||128
1716396|NCT00347009|4199065|P1|STARTED|Overall Study||155
1716397|NCT00346905|4199082|P1|NOT COMPLETED|Overall Study||4
1716398|NCT00346905|4199082|P1|COMPLETED|Overall Study||12
1716399|NCT00346905|4199082|P1|STARTED|Overall Study||16
1716400|NCT00346775|4199086|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
1716401|NCT00346775|4199087|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
1716402|NCT00346775|4199086|P2|COMPLETED|Period 3: Intervention Period 2||45
1716403|NCT00346775|4199087|P1|COMPLETED|Period 3: Intervention Period 2||44
1716404|NCT00346775|4199086|P2|STARTED|Period 3: Intervention Period 2||45
1716405|NCT00346775|4199087|P1|STARTED|Period 3: Intervention Period 2||44
1716406|NCT00346775|4199086|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1716407|NCT00346775|4199087|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1716408|NCT00346775|4199086|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
1716409|NCT00346775|4199087|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
1716410|NCT00346775|4199086|P2|STARTED|Period 2: Washout Period (7 Days)||45
1716411|NCT00346775|4199087|P1|STARTED|Period 2: Washout Period (7 Days)||44
1716412|NCT00346775|4199086|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
1716413|NCT00346775|4199087|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
1716414|NCT00346775|4199086|P2|COMPLETED|Period 1: Intervention Period 1||45
1716415|NCT00346775|4199087|P1|COMPLETED|Period 1: Intervention Period 1||44
1716416|NCT00346775|4199086|P2|STARTED|Period 1: Intervention Period 1||48
1716417|NCT00346775|4199087|P1|STARTED|Period 1: Intervention Period 1||49
1716418|NCT00346697|4199099|P2|NOT COMPLETED|Overall Study||1
1716419|NCT00346697|4199100|P1|NOT COMPLETED|Overall Study||0
1716420|NCT00346697|4199099|P2|COMPLETED|Overall Study||23
1716421|NCT00346697|4199100|P1|COMPLETED|Overall Study||24
1716422|NCT00346697|4199099|P2|STARTED|Overall Study||24
1716423|NCT00346697|4199100|P1|STARTED|Overall Study||24
1716424|NCT00346632|4199136|P10|NOT COMPLETED|Overall Study||3
1716425|NCT00346632|4199137|P9|NOT COMPLETED|Overall Study||4
1716426|NCT00346632|4199138|P8|NOT COMPLETED|Overall Study||4
1716427|NCT00346632|4199139|P7|NOT COMPLETED|Overall Study||5
1716428|NCT00346632|4199140|P6|NOT COMPLETED|Overall Study||2
1716429|NCT00346632|4199141|P5|NOT COMPLETED|Overall Study||4
1716430|NCT00346632|4199142|P4|NOT COMPLETED|Overall Study||3
1716431|NCT00346632|4199143|P3|NOT COMPLETED|Overall Study||6
1716432|NCT00346632|4199144|P2|NOT COMPLETED|Overall Study||3
1716433|NCT00346632|4199145|P1|NOT COMPLETED|Overall Study||3
1716434|NCT00346632|4199136|P10|COMPLETED|Overall Study||0
1716435|NCT00346632|4199137|P9|COMPLETED|Overall Study||0
1716436|NCT00346632|4199138|P8|COMPLETED|Overall Study||0
1716437|NCT00346632|4199139|P7|COMPLETED|Overall Study||0
1716438|NCT00346632|4199140|P6|COMPLETED|Overall Study||0
1716439|NCT00346632|4199141|P5|COMPLETED|Overall Study||0
1716440|NCT00346632|4199142|P4|COMPLETED|Overall Study||0
1716441|NCT00346632|4199143|P3|COMPLETED|Overall Study||0
1716442|NCT00346632|4199144|P2|COMPLETED|Overall Study||0
1716443|NCT00346632|4199145|P1|COMPLETED|Overall Study||0
1716444|NCT00346632|4199136|P10|STARTED|Overall Study||3
1716445|NCT00346632|4199137|P9|STARTED|Overall Study||4
1716446|NCT00346632|4199138|P8|STARTED|Overall Study||4
1716447|NCT00346632|4199139|P7|STARTED|Overall Study||5
1716448|NCT00346632|4199140|P6|STARTED|Overall Study||2
1716449|NCT00346632|4199141|P5|STARTED|Overall Study||4
1716450|NCT00346632|4199142|P4|STARTED|Overall Study||3
1716451|NCT00346632|4199143|P3|STARTED|Overall Study||6
1716452|NCT00346632|4199144|P2|STARTED|Overall Study||3
1716453|NCT00346632|4199145|P1|STARTED|Overall Study||3
1716454|NCT00346476|4199288|P1|NOT COMPLETED|Overall Study||0
1716455|NCT00346476|4199288|P1|COMPLETED|Overall Study||1250
1716456|NCT00346476|4199288|P1|STARTED|Overall Study||1250
1716457|NCT00346398|4199295|P2|NOT COMPLETED|Overall Study||2
1716458|NCT00346398|4199296|P1|NOT COMPLETED|Overall Study||3
1716459|NCT00346398|4199295|P2|COMPLETED|Overall Study||24
1716460|NCT00346398|4199296|P1|COMPLETED|Overall Study||22
1716461|NCT00346398|4199295|P2|STARTED|Overall Study||26
1716462|NCT00346398|4199296|P1|STARTED|Overall Study||25
1716463|NCT00346333|4199308|P2|NOT COMPLETED|Overall Study||8
1716464|NCT00346333|4199309|P1|NOT COMPLETED|Overall Study||5
1716465|NCT00346333|4199308|P2|COMPLETED|Overall Study||111
1716466|NCT00346333|4199309|P1|COMPLETED|Overall Study||116
1716467|NCT00346333|4199308|P2|STARTED|Overall Study||119
1716468|NCT00346333|4199309|P1|STARTED|Overall Study||121
1716469|NCT00346268|4199325|P2|NOT COMPLETED|Overall Study||3
1716470|NCT00346268|4199326|P1|NOT COMPLETED|Overall Study||2
1716471|NCT00346268|4199325|P2|COMPLETED|Overall Study||50
1716472|NCT00346268|4199326|P1|COMPLETED|Overall Study||50
1716473|NCT00346268|4199325|P2|STARTED|Overall Study||53
1716474|NCT00346268|4199326|P1|STARTED|Overall Study||52
1716475|NCT00346216|4199361|P3|NOT COMPLETED|Overall Study||2348
1716476|NCT00346216|4199362|P2|NOT COMPLETED|Overall Study||2460
1716477|NCT00346216|4199363|P1|NOT COMPLETED|Overall Study||2408
1716478|NCT00346216|4199361|P3|COMPLETED|Overall Study||5621
1716479|NCT00346216|4199362|P2|COMPLETED|Overall Study||5580
1716480|NCT00346216|4199363|P1|COMPLETED|Overall Study||5664
1716481|NCT00346216|4199361|P3|STARTED|Overall Study||7969
1716482|NCT00346216|4199362|P2|STARTED|Overall Study||8040
1716483|NCT00346216|4199363|P1|STARTED|Overall Study||8072
1716484|NCT00346164|4199384|P4|NOT COMPLETED|Overall Study||106
1716485|NCT00346164|4199385|P3|NOT COMPLETED|Overall Study||26
1716486|NCT00346164|4199386|P2|NOT COMPLETED|Overall Study||7
1716487|NCT00346164|4199387|P1|NOT COMPLETED|Overall Study||17
1716488|NCT00346164|4199384|P4|COMPLETED|Overall Study||117
1716489|NCT00346164|4199385|P3|COMPLETED|Overall Study||96
1716490|NCT00346164|4199386|P2|COMPLETED|Overall Study||14
1716491|NCT00346164|4199387|P1|COMPLETED|Overall Study||205
1716492|NCT00346164|4199384|P4|STARTED|Overall Study||223
1716493|NCT00346164|4199385|P3|STARTED|Overall Study||122
1716494|NCT00346164|4199386|P2|STARTED|Overall Study||21
1716495|NCT00346164|4199387|P1|STARTED|Overall Study||222
1716496|NCT00346151|4199422|P1|NOT COMPLETED|Overall Study||3
1716497|NCT00346151|4199422|P1|COMPLETED|Overall Study||2
1716498|NCT00346151|4199422|P1|STARTED|Overall Study||5
1716499|NCT00346073|4199442|P2|NOT COMPLETED|Overall Study||24
1716500|NCT00346073|4199443|P1|NOT COMPLETED|Overall Study||41
1716501|NCT00346073|4199442|P2|COMPLETED|Overall Study||738
1716502|NCT00346073|4199443|P1|COMPLETED|Overall Study||1481
1716503|NCT00346073|4199442|P2|STARTED|Overall Study||762
1716504|NCT00346073|4199443|P1|STARTED|Overall Study||1522
1716505|NCT00346034|4199477|P1|NOT COMPLETED|Overall Study||57
1716506|NCT00346034|4199477|P1|COMPLETED|Overall Study||300
1716507|NCT00346034|4199477|P1|STARTED|Overall Study||357
1716508|NCT00345969|4199484|P2|NOT COMPLETED|Overall Study||2
1716509|NCT00345969|4199485|P1|NOT COMPLETED|Overall Study||1
1716510|NCT00345969|4199484|P2|COMPLETED|Overall Study||11
1716511|NCT00345969|4199485|P1|COMPLETED|Overall Study||11
1716512|NCT00345969|4199484|P2|STARTED|Overall Study||13
1716513|NCT00345969|4199485|P1|STARTED|Overall Study||12
1716514|NCT00345878|4199517|P2|NOT COMPLETED|Overall Study||1
1716515|NCT00345878|4199518|P1|NOT COMPLETED|Overall Study||4
1716516|NCT00345878|4199517|P2|COMPLETED|Overall Study||135
1716517|NCT00345878|4199518|P1|COMPLETED|Overall Study||131
1716518|NCT00345878|4199517|P2|STARTED|Overall Study||136
1716519|NCT00345878|4199518|P1|STARTED|Overall Study||135
1716520|NCT00345839|4199536|P2|NOT COMPLETED|Overall Study||159
1716521|NCT00345839|4199537|P1|NOT COMPLETED|Overall Study||149
1716522|NCT00345839|4199536|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
1716523|NCT00345839|4199537|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
1716524|NCT00345839|4199536|P2|STARTED|Overall Study|Randomized to placebo|1935
1716525|NCT00345839|4199537|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
1716526|NCT00345683|4199563|P2|NOT COMPLETED|Overall Study||9
1716527|NCT00345683|4199564|P1|NOT COMPLETED|Overall Study||25
1716528|NCT00345683|4199563|P2|COMPLETED|Overall Study||1001
1716529|NCT00345683|4199564|P1|COMPLETED|Overall Study||2985
1716530|NCT00345683|4199563|P2|STARTED|Overall Study||1010
1716531|NCT00345683|4199564|P1|STARTED|Overall Study||3010
1716532|NCT00345631|4199587|P3|NOT COMPLETED|Overall Study||6
1716533|NCT00345631|4199588|P2|NOT COMPLETED|Overall Study||8
1716534|NCT00345631|4199589|P1|NOT COMPLETED|Overall Study||4
1716535|NCT00345631|4199587|P3|COMPLETED|Overall Study||128
1716536|NCT00345631|4199588|P2|COMPLETED|Overall Study||259
1716537|NCT00345631|4199589|P1|COMPLETED|Overall Study||83
1716538|NCT00345631|4199587|P3|STARTED|Overall Study||134
1716539|NCT00345631|4199588|P2|STARTED|Overall Study||267
1716540|NCT00345631|4199589|P1|STARTED|Overall Study||87
1716541|NCT00345605|4199621|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
1716542|NCT00345605|4199622|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
1716543|NCT00345605|4199621|P2|COMPLETED|Arm 2, Opposite Treatment||6
1716544|NCT00345605|4199622|P1|COMPLETED|Arm 2, Opposite Treatment||5
1716545|NCT00345605|4199621|P2|STARTED|Arm 2, Opposite Treatment||6
1716546|NCT00345605|4199622|P1|STARTED|Arm 2, Opposite Treatment||6
1716547|NCT00345605|4199621|P2|NOT COMPLETED|Crossover Wash-out||0
1716548|NCT00345605|4199622|P1|NOT COMPLETED|Crossover Wash-out||0
1716549|NCT00345605|4199621|P2|COMPLETED|Crossover Wash-out||6
1716550|NCT00345605|4199622|P1|COMPLETED|Crossover Wash-out||6
1716551|NCT00345605|4199621|P2|STARTED|Crossover Wash-out||6
1716552|NCT00345605|4199622|P1|STARTED|Crossover Wash-out||6
1716553|NCT00345605|4199621|P2|NOT COMPLETED|Interval||0
1716554|NCT00345605|4199622|P1|NOT COMPLETED|Interval||0
1716555|NCT00345605|4199621|P2|COMPLETED|Interval||6
1716556|NCT00345605|4199622|P1|COMPLETED|Interval||6
1716557|NCT00345605|4199621|P2|STARTED|Interval||6
1716558|NCT00345605|4199622|P1|STARTED|Interval||6
1716559|NCT00345605|4199621|P2|NOT COMPLETED|Arm 1||1
1716560|NCT00345605|4199622|P1|NOT COMPLETED|Arm 1||0
1716561|NCT00345605|4199621|P2|COMPLETED|Arm 1||5
1716562|NCT00345605|4199622|P1|COMPLETED|Arm 1||6
1716563|NCT00345605|4199621|P2|STARTED|Arm 1||6
1716564|NCT00345605|4199622|P1|STARTED|Arm 1||6
1716565|NCT00345605|4199621|P2|NOT COMPLETED|Initial Washout||0
1716566|NCT00345605|4199622|P1|NOT COMPLETED|Initial Washout||0
1716567|NCT00345605|4199621|P2|COMPLETED|Initial Washout||6
1716568|NCT00345605|4199622|P1|COMPLETED|Initial Washout||6
1716569|NCT00345605|4199621|P2|STARTED|Initial Washout||6
1716570|NCT00345605|4199622|P1|STARTED|Initial Washout||6
1716571|NCT00345592|4199642|P2|NOT COMPLETED|Overall Study||24
1716572|NCT00345592|4199643|P1|NOT COMPLETED|Overall Study||25
1716573|NCT00345592|4199642|P2|COMPLETED|Overall Study||173
1716574|NCT00345592|4199643|P1|COMPLETED|Overall Study||174
1716575|NCT00345592|4199642|P2|STARTED|Overall Study||197
1716576|NCT00345592|4199643|P1|STARTED|Overall Study||199
1716577|NCT00345579|4199651|P2|NOT COMPLETED|Overall Study||65
1716578|NCT00345579|4199652|P1|NOT COMPLETED|Overall Study||164
1716579|NCT00345579|4199651|P2|COMPLETED|Overall Study||1048
1716580|NCT00345579|4199652|P1|COMPLETED|Overall Study||3114
1716581|NCT00345579|4199651|P2|STARTED|Overall Study||1113
1716582|NCT00345579|4199652|P1|STARTED|Overall Study||3278
1716583|NCT00345540|4199672|P1|NOT COMPLETED|Overall Study||1
1716584|NCT00345540|4199672|P1|COMPLETED|Overall Study||15
1716585|NCT00345540|4199672|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
1716586|NCT00345397|4199678|P1|NOT COMPLETED|Overall Study||1
1716587|NCT00345397|4199678|P1|COMPLETED|Overall Study||6
1716588|NCT00345397|4199678|P1|STARTED|Overall Study||7
1716589|NCT00345384|4199685|P2|NOT COMPLETED|Overall Study||0
1716590|NCT00345384|4199686|P1|NOT COMPLETED|Overall Study||0
1716591|NCT00345384|4199685|P2|COMPLETED|Overall Study||19
1716592|NCT00345384|4199686|P1|COMPLETED|Overall Study||19
1716593|NCT00345384|4199685|P2|STARTED|Overall Study||19
1716594|NCT00345384|4199686|P1|STARTED|Overall Study||19
1716595|NCT00345371|4199696|P2|NOT COMPLETED|Overall Study||33
1716596|NCT00345371|4199697|P1|NOT COMPLETED|Overall Study||30
1716597|NCT00345371|4199696|P2|COMPLETED|Overall Study||38
1716598|NCT00345371|4199697|P1|COMPLETED|Overall Study||39
1716599|NCT00345371|4199696|P2|STARTED|Overall Study||71
1716600|NCT00345371|4199697|P1|STARTED|Overall Study||69
1716601|NCT00345332|4199707|P2|NOT COMPLETED|Overall Study||0
1716602|NCT00345332|4199708|P1|NOT COMPLETED|Overall Study||0
1716603|NCT00345332|4199707|P2|COMPLETED|Overall Study||20
1716604|NCT00345332|4199708|P1|COMPLETED|Overall Study||11
1716605|NCT00345332|4199707|P2|STARTED|Overall Study||20
1716606|NCT00345332|4199708|P1|STARTED|Overall Study||11
1716607|NCT00345293|4199716|P2|NOT COMPLETED|Overall Study||0
1716608|NCT00345293|4199717|P1|NOT COMPLETED|Overall Study||2
1716609|NCT00345293|4199716|P2|COMPLETED|Overall Study||3
1716610|NCT00345293|4199717|P1|COMPLETED|Overall Study||8
1716611|NCT00345293|4199716|P2|STARTED|Overall Study||3
1716612|NCT00345293|4199717|P1|STARTED|Overall Study||10
1716613|NCT00345254|4199726|P2|NOT COMPLETED|Overall Study||0
1716614|NCT00345254|4199727|P1|NOT COMPLETED|Overall Study||0
1716615|NCT00345254|4199726|P2|COMPLETED|Overall Study||30
1716616|NCT00345254|4199727|P1|COMPLETED|Overall Study||30
1716617|NCT00345254|4199726|P2|STARTED|Overall Study||30
1716618|NCT00345254|4199727|P1|STARTED|Overall Study||30
1716619|NCT00345176|4199737|P4|NOT COMPLETED|Overall Study||10
1716620|NCT00345176|4199738|P3|NOT COMPLETED|Overall Study||6
1716621|NCT00345176|4199739|P2|NOT COMPLETED|Overall Study||6
1716622|NCT00345176|4199740|P1|NOT COMPLETED|Overall Study||5
1716623|NCT00345176|4199737|P4|COMPLETED|Overall Study||1069
1716624|NCT00345176|4199738|P3|COMPLETED|Overall Study||1062
1716625|NCT00345176|4199739|P2|COMPLETED|Overall Study||1038
1716626|NCT00345176|4199740|P1|COMPLETED|Overall Study||1007
1716627|NCT00345176|4199737|P4|STARTED|Overall Study||1079
1716628|NCT00345176|4199738|P3|STARTED|Overall Study||1068
1716629|NCT00345176|4199739|P2|STARTED|Overall Study||1044
1716630|NCT00345176|4199740|P1|STARTED|Overall Study||1012
1716631|NCT00345046|4199763|P3|NOT COMPLETED|Overall Study||2
1716632|NCT00345046|4199764|P2|NOT COMPLETED|Overall Study||1
1716633|NCT00345046|4199765|P1|NOT COMPLETED|Overall Study||1
1716634|NCT00345046|4199763|P3|COMPLETED|Overall Study||14
1716635|NCT00345046|4199764|P2|COMPLETED|Overall Study||21
1716636|NCT00345046|4199765|P1|COMPLETED|Overall Study||17
1716637|NCT00345046|4199763|P3|STARTED|Overall Study||16
1716638|NCT00345046|4199764|P2|STARTED|Overall Study||22
1716639|NCT00345046|4199765|P1|STARTED|Overall Study||18
1716640|NCT00345033|4199775|P2|NOT COMPLETED|Overall Study||4
1716641|NCT00345033|4199776|P1|NOT COMPLETED|Overall Study||4
1716642|NCT00345033|4199775|P2|COMPLETED|Overall Study||14
1716643|NCT00345033|4199776|P1|COMPLETED|Overall Study||16
1716644|NCT00345033|4199775|P2|STARTED|Overall Study||18
1716645|NCT00345033|4199776|P1|STARTED|Overall Study||20
1716646|NCT00344968|4199795|P3|NOT COMPLETED|Overall Study||116
1716647|NCT00344968|4199796|P2|NOT COMPLETED|Overall Study||102
1716648|NCT00344968|4199797|P1|NOT COMPLETED|Overall Study||59
1716649|NCT00344968|4199795|P3|COMPLETED|Overall Study||279
1716650|NCT00344968|4199796|P2|COMPLETED|Overall Study||274
1716651|NCT00344968|4199797|P1|COMPLETED|Overall Study||126
1716652|NCT00344968|4199795|P3|STARTED|Overall Study||395
1716653|NCT00344968|4199796|P2|STARTED|Overall Study||376
1716654|NCT00344968|4199797|P1|STARTED|Overall Study||185
1716655|NCT00344773|4199808|P1|NOT COMPLETED|Overall Study||21
1716656|NCT00344773|4199808|P1|COMPLETED|Overall Study||25
1716657|NCT00344773|4199808|P1|STARTED|Overall Study||46
1716658|NCT00344682|4199816|P2|NOT COMPLETED|Overall Study||1
1716659|NCT00344682|4199817|P1|NOT COMPLETED|Overall Study||4
1716660|NCT00344682|4199816|P2|COMPLETED|Overall Study||14
1716661|NCT00344682|4199817|P1|COMPLETED|Overall Study||12
1716662|NCT00344682|4199816|P2|STARTED|Overall Study||15
1716663|NCT00344682|4199817|P1|STARTED|Overall Study||16
1716664|NCT00344500|4199831|P3|NOT COMPLETED|Overall Study||2
1716665|NCT00344500|4199832|P2|NOT COMPLETED|Overall Study||35
1716666|NCT00344500|4199833|P1|NOT COMPLETED|Overall Study||23
1716667|NCT00344500|4199831|P3|COMPLETED|Overall Study||12
1716668|NCT00344500|4199832|P2|COMPLETED|Overall Study||25
1716669|NCT00344500|4199833|P1|COMPLETED|Overall Study||25
1716670|NCT00344500|4199831|P3|STARTED|Overall Study||14
1716671|NCT00344500|4199832|P2|STARTED|Overall Study||60
1716672|NCT00344500|4199833|P1|STARTED|Overall Study||48
1716673|NCT00344487|4199844|P1|NOT COMPLETED|Overall Study||1
1716674|NCT00344487|4199844|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
1716675|NCT00344487|4199844|P1|STARTED|Overall Study||3
1716676|NCT00344461|4199848|P1|NOT COMPLETED|Overall Study||21
1716677|NCT00344461|4199848|P1|COMPLETED|Overall Study||33
1716678|NCT00344461|4199848|P1|STARTED|Overall Study||54
1716679|NCT00344448|4199859|P2|NOT COMPLETED|Open Label||1
1716680|NCT00344448|4199860|P1|NOT COMPLETED|Open Label||2
1716681|NCT00344448|4199859|P2|COMPLETED|Open Label||2
1716682|NCT00344448|4199860|P1|COMPLETED|Open Label||2
1716683|NCT00344448|4199859|P2|STARTED|Open Label||3
1716684|NCT00344448|4199860|P1|STARTED|Open Label||4
1716685|NCT00344448|4199859|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
1716686|NCT00344448|4199860|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
1716687|NCT00344448|4199859|P2|COMPLETED|Double Blind, Placebo Controlled||3
1716688|NCT00344448|4199860|P1|COMPLETED|Double Blind, Placebo Controlled||4
1716689|NCT00344448|4199859|P2|STARTED|Double Blind, Placebo Controlled||3
1716690|NCT00344448|4199860|P1|STARTED|Double Blind, Placebo Controlled||6
1716691|NCT00344448|4199859|P2|NOT COMPLETED|Screening||1
1716692|NCT00344448|4199860|P1|NOT COMPLETED|Screening||0
1716693|NCT00344448|4199859|P2|COMPLETED|Screening||3
1716694|NCT00344448|4199860|P1|COMPLETED|Screening||6
1716695|NCT00344448|4199859|P2|STARTED|Screening||4
1716696|NCT00344448|4199860|P1|STARTED|Screening|No randomization during the screening phase|6
1716697|NCT00344370|4199868|P2|NOT COMPLETED|Overall Study||3
1716698|NCT00344370|4199869|P1|NOT COMPLETED|Overall Study||15
1716699|NCT00344370|4199868|P2|COMPLETED|Overall Study||68
1716700|NCT00344370|4199869|P1|COMPLETED|Overall Study||128
1716701|NCT00344370|4199868|P2|STARTED|Overall Study||71
1716702|NCT00344370|4199869|P1|STARTED|Overall Study||143
1716703|NCT00344318|4199881|P4|NOT COMPLETED|Overall Study||3
1716704|NCT00344318|4199882|P3|NOT COMPLETED|Overall Study||1
1716705|NCT00344318|4199883|P2|NOT COMPLETED|Overall Study||5
1716706|NCT00344318|4199884|P1|NOT COMPLETED|Overall Study||4
1716707|NCT00344318|4199881|P4|COMPLETED|Overall Study||100
1716708|NCT00344318|4199882|P3|COMPLETED|Overall Study||99
1716709|NCT00344318|4199883|P2|COMPLETED|Overall Study||298
1716710|NCT00344318|4199884|P1|COMPLETED|Overall Study||296
1716711|NCT00344318|4199881|P4|STARTED|Overall Study||103
1716712|NCT00344318|4199882|P3|STARTED|Overall Study||100
1716713|NCT00344318|4199883|P2|STARTED|Overall Study||303
1716714|NCT00344318|4199884|P1|STARTED|Overall Study||300
1716715|NCT00344305|4200006|P2|NOT COMPLETED|Overall Study||1
1716716|NCT00344305|4200007|P1|NOT COMPLETED|Overall Study||2
1716717|NCT00344305|4200006|P2|COMPLETED|Overall Study||99
1716718|NCT00344305|4200007|P1|COMPLETED|Overall Study||98
1716719|NCT00344305|4200006|P2|STARTED|Overall Study||100
1716720|NCT00344305|4200007|P1|STARTED|Overall Study||100
1716721|NCT00344175|4200044|P2|NOT COMPLETED|Overall Study||10
1716722|NCT00344175|4200045|P1|NOT COMPLETED|Overall Study||12
1716723|NCT00344175|4200044|P2|COMPLETED|Overall Study||47
1716724|NCT00344175|4200045|P1|COMPLETED|Overall Study||109
1716725|NCT00344175|4200044|P2|STARTED|Overall Study||57
1716726|NCT00344175|4200045|P1|STARTED|Overall Study||121
1716727|NCT00344032|4200057|P2|NOT COMPLETED|Overall Study||10
1716728|NCT00344032|4200058|P1|NOT COMPLETED|Overall Study||14
1716729|NCT00344032|4200057|P2|COMPLETED|Overall Study||168
1716730|NCT00344032|4200058|P1|COMPLETED|Overall Study||162
1716731|NCT00344032|4200057|P2|STARTED|Overall Study||178
1716732|NCT00344032|4200058|P1|STARTED|Overall Study||176
1716733|NCT00344019|4200077|P3|NOT COMPLETED|Overall Study||74
1716734|NCT00344019|4200078|P2|NOT COMPLETED|Overall Study||0
1716735|NCT00344019|4200079|P1|NOT COMPLETED|Overall Study||0
1716736|NCT00344019|4200077|P3|COMPLETED|Overall Study||0
1716737|NCT00344019|4200078|P2|COMPLETED|Overall Study||11
1716738|NCT00344019|4200079|P1|COMPLETED|Overall Study||12
1716739|NCT00344019|4200077|P3|STARTED|Overall Study||74
1716740|NCT00344019|4200078|P2|STARTED|Overall Study||11
1716741|NCT00344019|4200079|P1|STARTED|Overall Study||12
1716742|NCT00343915|4200097|P2|NOT COMPLETED|Month 66 Follow-up||0
1716743|NCT00343915|4200098|P1|NOT COMPLETED|Month 66 Follow-up||0
1716744|NCT00343915|4200097|P2|COMPLETED|Month 66 Follow-up||76
1716745|NCT00343915|4200098|P1|COMPLETED|Month 66 Follow-up||158
1716746|NCT00343915|4200097|P2|STARTED|Month 66 Follow-up||76
1716747|NCT00343915|4200098|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
1716748|NCT00343915|4200097|P2|NOT COMPLETED|Month 54 Follow-up||0
1716749|NCT00343915|4200098|P1|NOT COMPLETED|Month 54 Follow-up||0
1716750|NCT00343915|4200097|P2|COMPLETED|Month 54 Follow-up||79
1716751|NCT00343915|4200098|P1|COMPLETED|Month 54 Follow-up||166
1716752|NCT00343915|4200097|P2|STARTED|Month 54 Follow-up||79
1716753|NCT00343915|4200098|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
1716754|NCT00343915|4200097|P2|NOT COMPLETED|Month 42 Follow-up||0
1716755|NCT00343915|4200098|P1|NOT COMPLETED|Month 42 Follow-up||0
1716756|NCT00343915|4200097|P2|COMPLETED|Month 42 Follow-up||84
1716757|NCT00343915|4200098|P1|COMPLETED|Month 42 Follow-up||174
1716758|NCT00343915|4200097|P2|STARTED|Month 42 Follow-up||84
1716759|NCT00343915|4200098|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
1716760|NCT00343915|4200097|P2|NOT COMPLETED|Month 30 Follow-up||0
1716761|NCT00343915|4200098|P1|NOT COMPLETED|Month 30 Follow-up||0
1716762|NCT00343915|4200097|P2|COMPLETED|Month 30 Follow-up||88
1716763|NCT00343915|4200098|P1|COMPLETED|Month 30 Follow-up||179
1716764|NCT00343915|4200097|P2|STARTED|Month 30 Follow-up||88
1716765|NCT00343915|4200098|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
1716766|NCT00343915|4200097|P2|NOT COMPLETED|Primary Study||3
1716767|NCT00343915|4200098|P1|NOT COMPLETED|Primary Study||4
1716768|NCT00343915|4200097|P2|COMPLETED|Primary Study||123
1716769|NCT00343915|4200098|P1|COMPLETED|Primary Study||254
1716770|NCT00343915|4200097|P2|STARTED|Primary Study||126
1716771|NCT00343915|4200098|P1|STARTED|Primary Study||258
1716772|NCT00343889|4200124|P2|NOT COMPLETED|Overall Study||1
1716773|NCT00343889|4200125|P1|NOT COMPLETED|Overall Study||3
1716774|NCT00343889|4200124|P2|COMPLETED|Overall Study||188
1716775|NCT00343889|4200125|P1|COMPLETED|Overall Study||187
1716776|NCT00343889|4200124|P2|STARTED|Overall Study||189
1716777|NCT00343889|4200125|P1|STARTED|Overall Study||190
1716778|NCT00343863|4200143|P2|NOT COMPLETED|Overall Study||0
1716779|NCT00343863|4200144|P1|NOT COMPLETED|Overall Study||0
1716780|NCT00343863|4200143|P2|COMPLETED|Overall Study||34
1716781|NCT00343863|4200144|P1|COMPLETED|Overall Study||7
1716782|NCT00343863|4200143|P2|STARTED|Overall Study||34
1716783|NCT00343863|4200144|P1|STARTED|Overall Study||7
1716784|NCT00343785|4200166|P1|NOT COMPLETED|Overall Study||0
1716785|NCT00343785|4200166|P1|COMPLETED|Overall Study||21
1716786|NCT00343785|4200166|P1|STARTED|Overall Study||21
1716787|NCT00343564|4200183|P11|NOT COMPLETED|Overall Study||0
1716788|NCT00343564|4200184|P10|NOT COMPLETED|Overall Study||0
1716789|NCT00343564|4200185|P9|NOT COMPLETED|Overall Study||0
1716790|NCT00343564|4200186|P8|NOT COMPLETED|Overall Study||0
1716791|NCT00343564|4200187|P7|NOT COMPLETED|Overall Study||0
1716792|NCT00343564|4200188|P6|NOT COMPLETED|Overall Study||0
1716793|NCT00343564|4200189|P5|NOT COMPLETED|Overall Study||0
1716794|NCT00343564|4200190|P4|NOT COMPLETED|Overall Study||0
1716795|NCT00343564|4200191|P3|NOT COMPLETED|Overall Study||0
1716796|NCT00343564|4200192|P2|NOT COMPLETED|Overall Study||0
1716797|NCT00343564|4200193|P1|NOT COMPLETED|Overall Study||0
1716798|NCT00343564|4200183|P11|COMPLETED|Overall Study||8
1716799|NCT00343564|4200184|P10|COMPLETED|Overall Study||8
1716800|NCT00343564|4200185|P9|COMPLETED|Overall Study||3
1716801|NCT00343564|4200186|P8|COMPLETED|Overall Study||3
1716802|NCT00343564|4200187|P7|COMPLETED|Overall Study||4
1716803|NCT00343564|4200188|P6|COMPLETED|Overall Study||9
1716804|NCT00343564|4200189|P5|COMPLETED|Overall Study||10
1716805|NCT00343564|4200190|P4|COMPLETED|Overall Study||7
1716806|NCT00343564|4200191|P3|COMPLETED|Overall Study||3
1716807|NCT00343564|4200192|P2|COMPLETED|Overall Study||7
1716808|NCT00343564|4200193|P1|COMPLETED|Overall Study||6
1716809|NCT00343564|4200183|P11|STARTED|Overall Study||8
1716810|NCT00343564|4200184|P10|STARTED|Overall Study||8
1716811|NCT00343564|4200185|P9|STARTED|Overall Study||3
1716812|NCT00343564|4200186|P8|STARTED|Overall Study||3
1716813|NCT00343564|4200187|P7|STARTED|Overall Study||4
1716814|NCT00343564|4200188|P6|STARTED|Overall Study||9
1716815|NCT00343564|4200189|P5|STARTED|Overall Study||10
1716816|NCT00343564|4200190|P4|STARTED|Overall Study||7
1716817|NCT00343564|4200191|P3|STARTED|Overall Study||3
1716818|NCT00343564|4200192|P2|STARTED|Overall Study||7
1716819|NCT00343564|4200193|P1|STARTED|Overall Study||6
1716820|NCT00343512|4200208|P1|NOT COMPLETED|Overall Study||2
1716821|NCT00343512|4200208|P1|COMPLETED|Overall Study||32
1716822|NCT00343512|4200208|P1|STARTED|Overall Study||34
1716823|NCT00343460|4200220|P3|NOT COMPLETED|Cycle 2 - 4||0
1716824|NCT00343460|4200221|P2|NOT COMPLETED|Cycle 2 - 4||50
1716825|NCT00343460|4200222|P1|NOT COMPLETED|Cycle 2 - 4||56
1716826|NCT00343460|4200220|P3|COMPLETED|Cycle 2 - 4||0
1716827|NCT00343460|4200221|P2|COMPLETED|Cycle 2 - 4||515
1716828|NCT00343460|4200222|P1|COMPLETED|Cycle 2 - 4||528
1716829|NCT00343460|4200220|P3|STARTED|Cycle 2 - 4||0
1716830|NCT00343460|4200221|P2|STARTED|Cycle 2 - 4||565
1716831|NCT00343460|4200222|P1|STARTED|Cycle 2 - 4||584
1716832|NCT00343460|4200220|P3|NOT COMPLETED|Cycle 1||18
1716833|NCT00343460|4200221|P2|NOT COMPLETED|Cycle 1||22
1716834|NCT00343460|4200222|P1|NOT COMPLETED|Cycle 1||22
1716835|NCT00343460|4200220|P3|COMPLETED|Cycle 1||454
1716836|NCT00343460|4200221|P2|COMPLETED|Cycle 1||459
1716837|NCT00343460|4200222|P1|COMPLETED|Cycle 1||453
1716838|NCT00343460|4200220|P3|STARTED|Cycle 1||472
1716839|NCT00343460|4200221|P2|STARTED|Cycle 1||481
1716840|NCT00343460|4200222|P1|STARTED|Cycle 1||475
1716841|NCT00343382|4200296|P3|NOT COMPLETED|Overall Study||17
1716842|NCT00343382|4200297|P2|NOT COMPLETED|Overall Study||14
1716843|NCT00343382|4200298|P1|NOT COMPLETED|Overall Study||4
1716844|NCT00343382|4200296|P3|COMPLETED|Overall Study||49
1716845|NCT00343382|4200297|P2|COMPLETED|Overall Study||51
1716846|NCT00343382|4200298|P1|COMPLETED|Overall Study||60
1716847|NCT00343382|4200296|P3|STARTED|Overall Study||66
1716848|NCT00343382|4200297|P2|STARTED|Overall Study||65
1716849|NCT00343382|4200298|P1|STARTED|Overall Study||64
1716850|NCT00343291|4200317|P2|NOT COMPLETED|Overall Study||56
1716851|NCT00343291|4200318|P1|NOT COMPLETED|Overall Study||57
1716852|NCT00343291|4200317|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
1716853|NCT00343291|4200318|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
1716854|NCT00343291|4200317|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
1716855|NCT00343291|4200318|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
1716856|NCT00343291|4200317|P2|STARTED|Overall Study||61
1716857|NCT00343291|4200318|P1|STARTED|Overall Study||60
1716858|NCT00343252|4200334|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
1716859|NCT00343252|4200335|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
1716860|NCT00343252|4200334|P2|COMPLETED|18 Months (All Treated Participants)||269
1716861|NCT00343252|4200335|P1|COMPLETED|18 Months (All Treated Participants)||259
1716862|NCT00343252|4200334|P2|STARTED|18 Months (All Treated Participants)||350
1716863|NCT00343252|4200335|P1|STARTED|18 Months (All Treated Participants)||360
1716864|NCT00343252|4200334|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
1716865|NCT00343252|4200335|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
1716866|NCT00343252|4200334|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
1716867|NCT00343252|4200335|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
1716868|NCT00343252|4200334|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
1716869|NCT00343252|4200335|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
1716870|NCT00343252|4200334|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
1716871|NCT00343252|4200335|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
1716872|NCT00343252|4200334|P2|COMPLETED|6 Months (All Treated Participants)||306
1716873|NCT00343252|4200335|P1|COMPLETED|6 Months (All Treated Participants)||304
1716874|NCT00343252|4200334|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
1716875|NCT00343252|4200335|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
1716876|NCT00343252|4200334|P2|NOT COMPLETED|All Randomized Participants||82
1716877|NCT00343252|4200335|P1|NOT COMPLETED|All Randomized Participants||102
1716878|NCT00343252|4200334|P2|COMPLETED|All Randomized Participants||269
1716879|NCT00343252|4200335|P1|COMPLETED|All Randomized Participants||259
1716880|NCT00343252|4200334|P2|STARTED|All Randomized Participants||351
1716881|NCT00343252|4200335|P1|STARTED|All Randomized Participants||361
1716882|NCT00343083|4200381|P1|NOT COMPLETED|Overall Study||21
1716883|NCT00343083|4200381|P1|COMPLETED|Overall Study||22
1716884|NCT00343083|4200381|P1|STARTED|Overall Study||43
1716885|NCT00343044|4200390|P1|NOT COMPLETED|Overall Study||0
1716886|NCT00343044|4200390|P1|COMPLETED|Overall Study||40
1716887|NCT00343044|4200390|P1|STARTED|Overall Study||40
1716888|NCT00342628|4200400|P3|NOT COMPLETED|Overall Study||19
1716889|NCT00342628|4200401|P2|NOT COMPLETED|Overall Study||21
1716890|NCT00342628|4200402|P1|NOT COMPLETED|Overall Study||20
1716891|NCT00342628|4200400|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
1716892|NCT00342628|4200401|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
1716893|NCT00342628|4200402|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
1716894|NCT00342628|4200400|P3|STARTED|Overall Study||100
1716895|NCT00342628|4200401|P2|STARTED|Overall Study||101
1716896|NCT00342628|4200402|P1|STARTED|Overall Study||100
1716897|NCT00342563|4200423|P4|NOT COMPLETED|Overall Study||6
1716898|NCT00342563|4200424|P3|NOT COMPLETED|Overall Study||14
1716899|NCT00342563|4200425|P2|NOT COMPLETED|Overall Study||8
1716900|NCT00342563|4200426|P1|NOT COMPLETED|Overall Study||6
1716901|NCT00342563|4200423|P4|COMPLETED|Overall Study||22
1716902|NCT00342563|4200424|P3|COMPLETED|Overall Study||26
1716903|NCT00342563|4200425|P2|COMPLETED|Overall Study||19
1716904|NCT00342563|4200426|P1|COMPLETED|Overall Study||35
1716905|NCT00342563|4200423|P4|STARTED|Overall Study||28
1716906|NCT00342563|4200424|P3|STARTED|Overall Study||40
1716907|NCT00342563|4200425|P2|STARTED|Overall Study||27
1716908|NCT00342563|4200426|P1|STARTED|Overall Study||41
1716909|NCT00342355|4200446|P4|NOT COMPLETED|Overall Study||0
1716910|NCT00342355|4200447|P3|NOT COMPLETED|Overall Study||0
1716911|NCT00342355|4200448|P2|NOT COMPLETED|Overall Study||0
1716912|NCT00342355|4200449|P1|NOT COMPLETED|Overall Study||0
1716913|NCT00342355|4200446|P4|COMPLETED|Overall Study||443
1716914|NCT00342355|4200447|P3|COMPLETED|Overall Study||444
1716915|NCT00342355|4200448|P2|COMPLETED|Overall Study||440
1716916|NCT00342355|4200449|P1|COMPLETED|Overall Study||444
1716917|NCT00342355|4200446|P4|STARTED|Overall Study||443
1716918|NCT00342355|4200447|P3|STARTED|Overall Study||444
1716919|NCT00342355|4200448|P2|STARTED|Overall Study||440
1716920|NCT00342355|4200449|P1|STARTED|Overall Study||444
1716921|NCT00340834|4200468|P5|NOT COMPLETED|Extension Phase of Study||44
1716922|NCT00340834|4200469|P4|NOT COMPLETED|Extension Phase of Study||53
1716923|NCT00340834|4200470|P3|NOT COMPLETED|Extension Phase of Study||0
1716924|NCT00340834|4200471|P2|NOT COMPLETED|Extension Phase of Study||76
1716925|NCT00340834|4200472|P1|NOT COMPLETED|Extension Phase of Study||85
1716926|NCT00340834|4200468|P5|COMPLETED|Extension Phase of Study||123
1716927|NCT00340834|4200469|P4|COMPLETED|Extension Phase of Study||123
1716928|NCT00340834|4200470|P3|COMPLETED|Extension Phase of Study||0
1716929|NCT00340834|4200471|P2|COMPLETED|Extension Phase of Study||281
1716930|NCT00340834|4200472|P1|COMPLETED|Extension Phase of Study||245
1716931|NCT00340834|4200468|P5|Received Study Drug|Extension Phase of Study||167
1716932|NCT00340834|4200469|P4|Received Study Drug|Extension Phase of Study||174
1716933|NCT00340834|4200470|P3|Received Study Drug|Extension Phase of Study||0
1716934|NCT00340834|4200471|P2|Received Study Drug|Extension Phase of Study||356
1716935|NCT00340834|4200472|P1|Received Study Drug|Extension Phase of Study||330
1716936|NCT00340834|4200468|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
1716937|NCT00340834|4200469|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
1716938|NCT00340834|4200470|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
1716939|NCT00340834|4200471|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
1716940|NCT00340834|4200472|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
1716941|NCT00340834|4200468|P5|NOT COMPLETED|Core Phase of Study||0
1716942|NCT00340834|4200469|P4|NOT COMPLETED|Core Phase of Study||0
1716943|NCT00340834|4200470|P3|NOT COMPLETED|Core Phase of Study||49
1716944|NCT00340834|4200471|P2|NOT COMPLETED|Core Phase of Study||33
1716945|NCT00340834|4200472|P1|NOT COMPLETED|Core Phase of Study||57
1716946|NCT00340834|4200468|P5|COMPLETED|Core Phase of Study||0
1716947|NCT00340834|4200469|P4|COMPLETED|Core Phase of Study||0
1716948|NCT00340834|4200470|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
1716949|NCT00340834|4200471|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
1716950|NCT00340834|4200472|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
1716951|NCT00340834|4200468|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
1716952|NCT00340834|4200469|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
1716953|NCT00340834|4200470|P3|STARTED|Core Phase of Study||435
1716954|NCT00340834|4200471|P2|STARTED|Core Phase of Study||431
1716955|NCT00340834|4200472|P1|STARTED|Core Phase of Study||426
1716956|NCT00340704|4200506|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
1716957|NCT00340704|4200507|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
1716958|NCT00340704|4200508|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
1716959|NCT00340704|4200509|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
1716960|NCT00340704|4200510|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
1716961|NCT00340704|4200511|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
1716962|NCT00340704|4200512|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1716963|NCT00340704|4200513|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1716964|NCT00340704|4200514|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1716965|NCT00340704|4200506|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1716966|NCT00340704|4200507|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
1716967|NCT00340704|4200508|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
1716968|NCT00340704|4200509|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
1716969|NCT00340704|4200510|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
1716970|NCT00340704|4200511|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
1716971|NCT00340704|4200512|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1716972|NCT00340704|4200513|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1716973|NCT00340704|4200514|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
1716974|NCT00340704|4200506|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1716975|NCT00340704|4200507|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1716976|NCT00340704|4200508|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1716977|NCT00340704|4200509|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
1716978|NCT00340704|4200510|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
1716979|NCT00340704|4200511|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
1716980|NCT00340704|4200512|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1716981|NCT00340704|4200513|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1716982|NCT00340704|4200514|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
1716983|NCT00340704|4200506|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
1716984|NCT00340704|4200507|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
1716985|NCT00340704|4200508|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
1716986|NCT00340704|4200509|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
1716987|NCT00340704|4200510|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
1716988|NCT00340704|4200511|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
1716989|NCT00340704|4200512|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
1716990|NCT00340704|4200513|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
1716991|NCT00340704|4200514|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
1716992|NCT00340704|4200506|P9|NOT COMPLETED|PK Study||0
1716993|NCT00340704|4200507|P8|NOT COMPLETED|PK Study||0
1716994|NCT00340704|4200508|P7|NOT COMPLETED|PK Study||0
1716995|NCT00340704|4200509|P6|NOT COMPLETED|PK Study||0
1716996|NCT00340704|4200510|P5|NOT COMPLETED|PK Study||0
1716997|NCT00340704|4200511|P4|NOT COMPLETED|PK Study||0
1716998|NCT00340704|4200512|P3|NOT COMPLETED|PK Study||1
1716999|NCT00340704|4200513|P2|NOT COMPLETED|PK Study||1
1717000|NCT00340704|4200514|P1|NOT COMPLETED|PK Study||0
1717001|NCT00340704|4200506|P9|COMPLETED|PK Study||0
1717002|NCT00340704|4200507|P8|COMPLETED|PK Study||0
1717003|NCT00340704|4200508|P7|COMPLETED|PK Study||0
1717004|NCT00340704|4200509|P6|COMPLETED|PK Study||0
1717005|NCT00340704|4200510|P5|COMPLETED|PK Study||0
1717006|NCT00340704|4200511|P4|COMPLETED|PK Study||0
1717007|NCT00340704|4200512|P3|COMPLETED|PK Study||10
1717008|NCT00340704|4200513|P2|COMPLETED|PK Study||9
1717009|NCT00340704|4200514|P1|COMPLETED|PK Study||10
1717010|NCT00340704|4200506|P9|STARTED|PK Study||0
1717011|NCT00340704|4200507|P8|STARTED|PK Study||0
1717012|NCT00340704|4200508|P7|STARTED|PK Study||0
1717013|NCT00340704|4200509|P6|STARTED|PK Study||0
1717014|NCT00340704|4200510|P5|STARTED|PK Study||0
1717015|NCT00340704|4200511|P4|STARTED|PK Study||0
1717016|NCT00340704|4200512|P3|STARTED|PK Study||11
1717017|NCT00340704|4200513|P2|STARTED|PK Study||10
1717018|NCT00340704|4200514|P1|STARTED|PK Study||10
1717019|NCT00340678|4200620|P4|NOT COMPLETED|Overall Study||0
1717020|NCT00340678|4200621|P3|NOT COMPLETED|Overall Study||0
1717021|NCT00340678|4200622|P2|NOT COMPLETED|Overall Study||0
1717022|NCT00340678|4200623|P1|NOT COMPLETED|Overall Study||1
1717023|NCT00340678|4200620|P4|COMPLETED|Overall Study||39
1717024|NCT00340678|4200621|P3|COMPLETED|Overall Study||39
1717025|NCT00340678|4200622|P2|COMPLETED|Overall Study||46
1717026|NCT00340678|4200623|P1|COMPLETED|Overall Study||45
1717027|NCT00340678|4200620|P4|STARTED|Overall Study||39
1717028|NCT00340678|4200621|P3|STARTED|Overall Study||39
1717029|NCT00340678|4200622|P2|STARTED|Overall Study||46
1717030|NCT00340678|4200623|P1|STARTED|Overall Study||46
1717031|NCT00340379|4200637|P2|NOT COMPLETED|Overall Study||9
1717032|NCT00340379|4200638|P1|NOT COMPLETED|Overall Study||8
1717033|NCT00340379|4200637|P2|COMPLETED|Overall Study||28
1717034|NCT00340379|4200638|P1|COMPLETED|Overall Study||27
1717035|NCT00340379|4200637|P2|STARTED|Overall Study||37
1717036|NCT00340379|4200638|P1|STARTED|Overall Study||35
1717037|NCT00339833|4200650|P2|NOT COMPLETED|Overall Study||8
1717038|NCT00339833|4200651|P1|NOT COMPLETED|Overall Study||6
1717039|NCT00339833|4200650|P2|COMPLETED|Overall Study||18
1717040|NCT00339833|4200651|P1|COMPLETED|Overall Study||22
1717041|NCT00339833|4200650|P2|STARTED|Overall Study||26
1717042|NCT00339833|4200651|P1|STARTED|Overall Study||28
1717043|NCT00339183|4200661|P2|NOT COMPLETED|Overall Study||105
1717044|NCT00339183|4200662|P1|NOT COMPLETED|Overall Study||121
1717045|NCT00339183|4200661|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
1717046|NCT00339183|4200662|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
1717047|NCT00339183|4200661|P2|Received Study Drug|Overall Study||593
1717048|NCT00339183|4200662|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
1717049|NCT00339183|4200661|P2|STARTED|Overall Study||595
1717050|NCT00339183|4200662|P1|STARTED|Overall Study||591
1717051|NCT00339144|4200691|P3|NOT COMPLETED|Overall Study||4
1717052|NCT00339144|4200692|P2|NOT COMPLETED|Overall Study||3
1717053|NCT00339144|4200693|P1|NOT COMPLETED|Overall Study||9
1717054|NCT00339144|4200691|P3|COMPLETED|Overall Study||0
1717055|NCT00339144|4200692|P2|COMPLETED|Overall Study||0
1717056|NCT00339144|4200693|P1|COMPLETED|Overall Study||0
1717057|NCT00339144|4200691|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
1717058|NCT00339144|4200692|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
1717059|NCT00339144|4200693|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
1717060|NCT00339079|4200779|P4|NOT COMPLETED|Overall Study||24
1717061|NCT00339079|4200780|P3|NOT COMPLETED|Overall Study||18
1717062|NCT00339079|4200781|P2|NOT COMPLETED|Overall Study||23
1717063|NCT00339079|4200782|P1|NOT COMPLETED|Overall Study||33
1717064|NCT00339079|4200779|P4|COMPLETED|Overall Study||29
1717065|NCT00339079|4200780|P3|COMPLETED|Overall Study||27
1717066|NCT00339079|4200781|P2|COMPLETED|Overall Study||21
1717067|NCT00339079|4200782|P1|COMPLETED|Overall Study||20
1717068|NCT00339079|4200779|P4|STARTED|Overall Study||53
1717069|NCT00339079|4200780|P3|STARTED|Overall Study||45
1717070|NCT00339079|4200781|P2|STARTED|Overall Study||44
1717071|NCT00339079|4200782|P1|STARTED|Overall Study||53
1717072|NCT00339040|4200798|P2|NOT COMPLETED|Stage II||2
1717073|NCT00339040|4200799|P1|NOT COMPLETED|Stage II||10
1717074|NCT00339040|4200798|P2|COMPLETED|Stage II||27
1717075|NCT00339040|4200799|P1|COMPLETED|Stage II||84
1717076|NCT00339040|4200798|P2|Vaccination 6 at Week 120|Stage II||27
1717077|NCT00339040|4200799|P1|Vaccination 6 at Week 120|Stage II||0
1717078|NCT00339040|4200798|P2|Vaccination 5 at Week 104|Stage II||28
1717079|NCT00339040|4200799|P1|Vaccination 5 at Week 104|Stage II||0
1717080|NCT00339040|4200798|P2|Vaccination 4 at Week 96|Stage II||29
1717081|NCT00339040|4200799|P1|Vaccination 4 at Week 96|Stage II||84
1717082|NCT00339040|4200798|P2|STARTED|Stage II||29
1717083|NCT00339040|4200799|P1|STARTED|Stage II||94
1717084|NCT00339040|4200798|P2|NOT COMPLETED|Stage I||1
1717085|NCT00339040|4200799|P1|NOT COMPLETED|Stage I||2
1717086|NCT00339040|4200798|P2|COMPLETED|Stage I||29
1717087|NCT00339040|4200799|P1|COMPLETED|Stage I||94
1717088|NCT00339040|4200798|P2|Vaccination 3 at Week 24|Stage I||30
1717089|NCT00339040|4200799|P1|Vaccination 3 at Week 24|Stage I||94
1717090|NCT00339040|4200798|P2|Vaccination 2 at Week 8|Stage I||30
1717091|NCT00339040|4200799|P1|Vaccination 2 at Week 8|Stage I||95
1717092|NCT00339040|4200798|P2|Vaccination 1 at Week 0|Stage I||30
1717093|NCT00339040|4200799|P1|Vaccination 1 at Week 0|Stage I||96
1717094|NCT00339040|4200798|P2|STARTED|Stage I||30
1717095|NCT00339040|4200799|P1|STARTED|Stage I||96
1717096|NCT00338988|4200817|P1|NOT COMPLETED|Overall Study||1
1717097|NCT00338988|4200817|P1|COMPLETED|Overall Study||43
1717098|NCT00338988|4200817|P1|STARTED|Overall Study||44
1717099|NCT00338962|4200826|P4|NOT COMPLETED|Overall Study||3
1717100|NCT00338962|4200827|P3|NOT COMPLETED|Overall Study||6
1717101|NCT00338962|4200828|P2|NOT COMPLETED|Overall Study||4
1717102|NCT00338962|4200829|P1|NOT COMPLETED|Overall Study||8
1717103|NCT00338962|4200826|P4|COMPLETED|Overall Study||21
1717104|NCT00338962|4200827|P3|COMPLETED|Overall Study||16
1717105|NCT00338962|4200828|P2|COMPLETED|Overall Study||16
1717106|NCT00338962|4200829|P1|COMPLETED|Overall Study||14
1717107|NCT00338962|4200826|P4|STARTED|Overall Study||24
1717108|NCT00338962|4200827|P3|STARTED|Overall Study||22
1717109|NCT00338962|4200828|P2|STARTED|Overall Study||20
1717110|NCT00338962|4200829|P1|STARTED|Overall Study||22
1717111|NCT00338884|4200851|P1|NOT COMPLETED|Overall Study||78
1717112|NCT00338884|4200851|P1|COMPLETED|Overall Study||42
1717113|NCT00338884|4200851|P1|Received Treatment|Overall Study||119
1717114|NCT00338884|4200851|P1|STARTED|Overall Study||120
1717115|NCT00338806|4200885|P2|NOT COMPLETED|Follow-up||3
1717116|NCT00338806|4200886|P1|NOT COMPLETED|Follow-up||1
1717117|NCT00338806|4200885|P2|COMPLETED|Follow-up||1
1717118|NCT00338806|4200886|P1|COMPLETED|Follow-up||1
1717119|NCT00338806|4200885|P2|STARTED|Follow-up||4
1717120|NCT00338806|4200886|P1|STARTED|Follow-up||2
1717121|NCT00338806|4200885|P2|NOT COMPLETED|Acute Phase||1
1717122|NCT00338806|4200886|P1|NOT COMPLETED|Acute Phase||0
1717123|NCT00338806|4200885|P2|COMPLETED|Acute Phase||4
1717124|NCT00338806|4200886|P1|COMPLETED|Acute Phase||2
1717125|NCT00338806|4200885|P2|STARTED|Acute Phase||5
1717126|NCT00338806|4200886|P1|STARTED|Acute Phase||2
1717127|NCT00338741|4200948|P2|NOT COMPLETED|Overall Study||0
1717128|NCT00338741|4200949|P1|NOT COMPLETED|Overall Study||2
1717129|NCT00338741|4200948|P2|COMPLETED|Overall Study||2
1717130|NCT00338741|4200949|P1|COMPLETED|Overall Study||32
1717131|NCT00338741|4200948|P2|STARTED|Overall Study||2
1717132|NCT00338741|4200949|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
1717133|NCT00338598|4200959|P2|NOT COMPLETED|Overall Study||2
1717134|NCT00338598|4200960|P1|NOT COMPLETED|Overall Study||0
1717135|NCT00338598|4200959|P2|COMPLETED|Overall Study||8
1717136|NCT00338598|4200960|P1|COMPLETED|Overall Study||10
1717137|NCT00338598|4200959|P2|STARTED|Overall Study||10
1717138|NCT00338598|4200960|P1|STARTED|Overall Study||10
1717139|NCT00338455|4200980|P2|NOT COMPLETED|Overall Study||1
1717140|NCT00338455|4200981|P1|NOT COMPLETED|Overall Study||3
1717141|NCT00338455|4200980|P2|COMPLETED|Overall Study||6
1717142|NCT00338455|4200981|P1|COMPLETED|Overall Study||6
1717143|NCT00338455|4200980|P2|Administered Study Drug|Overall Study||7
1717144|NCT00338455|4200981|P1|Administered Study Drug|Overall Study||8
1717145|NCT00338455|4200980|P2|STARTED|Overall Study||7
1717146|NCT00338455|4200981|P1|STARTED|Overall Study||9
1717147|NCT00338286|4200995|P2|NOT COMPLETED|Overall Study||213
1717148|NCT00338286|4200996|P1|NOT COMPLETED|Overall Study||233
1717149|NCT00338286|4200995|P2|COMPLETED|Overall Study||837
1717150|NCT00338286|4200996|P1|COMPLETED|Overall Study||815
1717151|NCT00338286|4200995|P2|STARTED|Overall Study||1050
1717152|NCT00338286|4200996|P1|STARTED|Overall Study||1048
1717153|NCT00338104|4201013|P3|NOT COMPLETED|Overall Study||3
1717154|NCT00338104|4201014|P2|NOT COMPLETED|Overall Study||1
1717155|NCT00338104|4201015|P1|NOT COMPLETED|Overall Study||2
1717156|NCT00338104|4201013|P3|COMPLETED|Overall Study||22
1717157|NCT00338104|4201014|P2|COMPLETED|Overall Study||24
1717158|NCT00338104|4201015|P1|COMPLETED|Overall Study||23
1717159|NCT00338104|4201013|P3|STARTED|Overall Study||25
1717160|NCT00338104|4201014|P2|STARTED|Overall Study||25
1717161|NCT00338104|4201015|P1|STARTED|Overall Study||25
1717162|NCT00338039|4201026|P1|NOT COMPLETED|Overall Study||0
1717163|NCT00338039|4201026|P1|COMPLETED|Overall Study||69
1717164|NCT00338039|4201026|P1|STARTED|Overall Study||69
1717165|NCT00337987|4201031|P1|NOT COMPLETED|Overall Study||0
1717166|NCT00337987|4201031|P1|COMPLETED|Overall Study||49
1717167|NCT00337987|4201031|P1|STARTED|Overall Study||49
1717168|NCT00337935|4201038|P2|NOT COMPLETED|Overall Study||27
1717169|NCT00337935|4201039|P1|NOT COMPLETED|Overall Study||10
1717170|NCT00337935|4201038|P2|COMPLETED|Overall Study||91
1717171|NCT00337935|4201039|P1|COMPLETED|Overall Study||29
1717172|NCT00337935|4201038|P2|STARTED|Overall Study||118
1717173|NCT00337935|4201039|P1|STARTED|Overall Study||39
1717174|NCT00337818|4201052|P3|NOT COMPLETED|Overall Study||107
1717175|NCT00337818|4201053|P2|NOT COMPLETED|Overall Study||91
1717176|NCT00337818|4201054|P1|NOT COMPLETED|Overall Study||289
1717177|NCT00337818|4201052|P3|COMPLETED|Overall Study||51
1717178|NCT00337818|4201053|P2|COMPLETED|Overall Study||63
1717179|NCT00337818|4201054|P1|COMPLETED|Overall Study||169
1717180|NCT00337818|4201052|P3|STARTED|Overall Study||158
1717181|NCT00337818|4201053|P2|STARTED|Overall Study||154
1717182|NCT00337818|4201054|P1|STARTED|Overall Study||458
1717183|NCT00337779|4201076|P2|NOT COMPLETED|Overall Study||79
1717184|NCT00337779|4201077|P1|NOT COMPLETED|Overall Study||52
1717185|NCT00337779|4201076|P2|COMPLETED|Overall Study||490
1717186|NCT00337779|4201077|P1|COMPLETED|Overall Study||534
1717187|NCT00337779|4201076|P2|STARTED|Overall Study||569
1717188|NCT00337779|4201077|P1|STARTED|Overall Study||586
1717189|NCT00337727|4201089|P2|NOT COMPLETED|Overall Study||12
1717190|NCT00337727|4201090|P1|NOT COMPLETED|Overall Study||18
1717191|NCT00337727|4201089|P2|COMPLETED|Overall Study||406
1717192|NCT00337727|4201090|P1|COMPLETED|Overall Study||412
1717193|NCT00337727|4201089|P2|STARTED|Overall Study||418
1717194|NCT00337727|4201090|P1|STARTED|Overall Study||430
1717195|NCT00337675|4201101|P3|NOT COMPLETED|Overall Study||99
1717196|NCT00337675|4201102|P2|NOT COMPLETED|Overall Study||103
1717197|NCT00337675|4201103|P1|NOT COMPLETED|Overall Study||97
1717198|NCT00337675|4201101|P3|COMPLETED|Overall Study||492
1717199|NCT00337675|4201102|P2|COMPLETED|Overall Study||488
1717200|NCT00337675|4201103|P1|COMPLETED|Overall Study||492
1717201|NCT00337675|4201101|P3|STARTED|Overall Study||591
1717202|NCT00337675|4201102|P2|STARTED|Overall Study||591
1717203|NCT00337675|4201103|P1|STARTED|Overall Study||589
1717204|NCT00337662|4201120|P4|NOT COMPLETED|Study Period III||0
1717205|NCT00337662|4201121|P3|NOT COMPLETED|Study Period III||44
1717206|NCT00337662|4201122|P2|NOT COMPLETED|Study Period III||58
1717207|NCT00337662|4201123|P1|NOT COMPLETED|Study Period III||60
1717208|NCT00337662|4201120|P4|COMPLETED|Study Period III||0
1717209|NCT00337662|4201121|P3|COMPLETED|Study Period III||100
1717210|NCT00337662|4201122|P2|COMPLETED|Study Period III||134
1717211|NCT00337662|4201123|P1|COMPLETED|Study Period III||126
1717212|NCT00337662|4201120|P4|STARTED|Study Period III||0
1717213|NCT00337662|4201121|P3|STARTED|Study Period III||144
1717214|NCT00337662|4201122|P2|STARTED|Study Period III||192
1717215|NCT00337662|4201123|P1|STARTED|Study Period III||186
1717216|NCT00337662|4201120|P4|NOT COMPLETED|Study Period II||106
1717217|NCT00337662|4201121|P3|NOT COMPLETED|Study Period II||0
1717218|NCT00337662|4201122|P2|NOT COMPLETED|Study Period II||0
1717219|NCT00337662|4201123|P1|NOT COMPLETED|Study Period II||0
1717220|NCT00337662|4201120|P4|COMPLETED|Study Period II||522
1717221|NCT00337662|4201121|P3|COMPLETED|Study Period II||0
1717222|NCT00337662|4201122|P2|COMPLETED|Study Period II||0
1717223|NCT00337662|4201123|P1|COMPLETED|Study Period II||0
1717224|NCT00337662|4201120|P4|STARTED|Study Period II||628
1717225|NCT00337662|4201121|P3|STARTED|Study Period II||0
1717226|NCT00337662|4201122|P2|STARTED|Study Period II||0
1717227|NCT00337662|4201123|P1|STARTED|Study Period II||0
1717228|NCT00337610|4201177|P2|NOT COMPLETED|Overall Study||14
1717229|NCT00337610|4201178|P1|NOT COMPLETED|Overall Study||17
1717230|NCT00337610|4201177|P2|COMPLETED|Overall Study||80
1717231|NCT00337610|4201178|P1|COMPLETED|Overall Study||79
1717232|NCT00337610|4201177|P2|Completed Week 18|Overall Study||82
1717233|NCT00337610|4201178|P1|Completed Week 18|Overall Study||89
1717234|NCT00337610|4201177|P2|STARTED|Overall Study||94
1717235|NCT00337610|4201178|P1|STARTED|Overall Study||96
1717236|NCT00337571|4201194|P4|NOT COMPLETED|Overall Study||7
1717237|NCT00337571|4201195|P3|NOT COMPLETED|Overall Study||10
1717238|NCT00337571|4201196|P2|NOT COMPLETED|Overall Study||9
1717239|NCT00337571|4201197|P1|NOT COMPLETED|Overall Study||14
1717240|NCT00337571|4201194|P4|COMPLETED|Overall Study||47
1717241|NCT00337571|4201195|P3|COMPLETED|Overall Study||49
1717242|NCT00337571|4201196|P2|COMPLETED|Overall Study||44
1717243|NCT00337571|4201197|P1|COMPLETED|Overall Study||38
1717244|NCT00337571|4201194|P4|STARTED|Overall Study||54
1717245|NCT00337571|4201195|P3|STARTED|Overall Study||59
1717246|NCT00337571|4201196|P2|STARTED|Overall Study||53
1717247|NCT00337571|4201197|P1|STARTED|Overall Study||52
1717248|NCT00337467|4201235|P1|NOT COMPLETED|Overall Study||10
1717249|NCT00337467|4201235|P1|COMPLETED|Overall Study||51
1717250|NCT00337467|4201235|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
1717251|NCT00337467|4201235|P1|STARTED|Overall Study||61
1717252|NCT00337428|4201254|P2|NOT COMPLETED|Overall Study||3
1717253|NCT00337428|4201255|P1|NOT COMPLETED|Overall Study||4
1717254|NCT00337428|4201254|P2|COMPLETED|Overall Study||421
1717255|NCT00337428|4201255|P1|COMPLETED|Overall Study||415
1717256|NCT00337428|4201254|P2|STARTED|Overall Study||424
1717257|NCT00337428|4201255|P1|STARTED|Overall Study||419
1717258|NCT00337350|4201295|P2|NOT COMPLETED|Overall Study||1
1717259|NCT00337350|4201296|P1|NOT COMPLETED|Overall Study||1
1717260|NCT00337350|4201295|P2|COMPLETED|Overall Study||10
1717261|NCT00337350|4201296|P1|COMPLETED|Overall Study||8
1717262|NCT00337350|4201295|P2|STARTED|Overall Study||11
1717263|NCT00337350|4201296|P1|STARTED|Overall Study||9
1717264|NCT00337285|4201306|P1|NOT COMPLETED|Overall Study||158
1717265|NCT00337285|4201306|P1|COMPLETED|Overall Study||191
1717266|NCT00337285|4201306|P1|STARTED|Overall Study||349
1717267|NCT00337272|4201314|P2|NOT COMPLETED|Withdrawal Period||1
1717268|NCT00337272|4201315|P1|NOT COMPLETED|Withdrawal Period||0
1717269|NCT00337272|4201314|P2|COMPLETED|Withdrawal Period||6
1717270|NCT00337272|4201315|P1|COMPLETED|Withdrawal Period||6
1717271|NCT00337272|4201314|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
1717272|NCT00337272|4201315|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
1717273|NCT00337272|4201314|P2|NOT COMPLETED|Treatment Period||2
1717274|NCT00337272|4201315|P1|NOT COMPLETED|Treatment Period||1
1717275|NCT00337272|4201314|P2|COMPLETED|Treatment Period||7
1717276|NCT00337272|4201315|P1|COMPLETED|Treatment Period||6
1717277|NCT00337272|4201314|P2|Randomization|Treatment Period||9
1717278|NCT00337272|4201315|P1|Randomization|Treatment Period||7
1717279|NCT00337272|4201314|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
1717280|NCT00337272|4201315|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
1717281|NCT00337272|4201314|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
1717282|NCT00337272|4201315|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
1717283|NCT00337272|4201314|P2|COMPLETED|Screening Period (Pre-randomization)||0
1717284|NCT00337272|4201315|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
1717285|NCT00337272|4201314|P2|STARTED|Screening Period (Pre-randomization)||0
1717286|NCT00337272|4201315|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
1717287|NCT00337207|4201335|P1|NOT COMPLETED|Overall Study||3
1717288|NCT00337207|4201335|P1|COMPLETED|Overall Study||52
1717289|NCT00337207|4201335|P1|STARTED|Overall Study||55
1717290|NCT00337194|4201343|P2|NOT COMPLETED|Overall Study||4
1717291|NCT00337194|4201344|P1|NOT COMPLETED|Overall Study||12
1717292|NCT00337194|4201343|P2|COMPLETED|Overall Study||3
1717293|NCT00337194|4201344|P1|COMPLETED|Overall Study||11
1717294|NCT00337194|4201343|P2|STARTED|Overall Study||7
1717295|NCT00337194|4201344|P1|STARTED|Overall Study||23
1717296|NCT00337181|4201361|P2|NOT COMPLETED|Overall Study||0
1717297|NCT00337181|4201362|P1|NOT COMPLETED|Overall Study||0
1717298|NCT00337181|4201361|P2|COMPLETED|Overall Study||65
1717299|NCT00337181|4201362|P1|COMPLETED|Overall Study||49
1717300|NCT00337181|4201361|P2|STARTED|Overall Study||65
1717301|NCT00337181|4201362|P1|STARTED|Overall Study||49
1717302|NCT00337168|4201368|P1|NOT COMPLETED|Overall Study||8
1717303|NCT00337168|4201368|P1|COMPLETED|Overall Study||29
1717304|NCT00337168|4201368|P1|Eligible and Treated|Overall Study||36
1717305|NCT00337168|4201368|P1|Eligible|Overall Study||37
1717306|NCT00337168|4201368|P1|STARTED|Overall Study||37
1717307|NCT00337129|4201375|P1|NOT COMPLETED|Overall Study||40
1717308|NCT00337129|4201375|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
1717309|NCT00337129|4201375|P1|STARTED|Overall Study||40
1717310|NCT00337103|4201384|P2|NOT COMPLETED|Overall Study||543
1717311|NCT00337103|4201385|P1|NOT COMPLETED|Overall Study||549
1717312|NCT00337103|4201384|P2|COMPLETED|Overall Study||5
1717313|NCT00337103|4201385|P1|COMPLETED|Overall Study||5
1717314|NCT00337103|4201384|P2|STARTED|Overall Study||548
1717315|NCT00337103|4201385|P1|STARTED|Overall Study||554
1717316|NCT00337077|4201396|P3|NOT COMPLETED|Overall Study||25
1717317|NCT00337077|4201397|P2|NOT COMPLETED|Overall Study||53
1717318|NCT00337077|4201398|P1|NOT COMPLETED|Overall Study||43
1717319|NCT00337077|4201396|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
1717320|NCT00337077|4201397|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
1717321|NCT00337077|4201398|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
1717322|NCT00337077|4201396|P3|Patients With Measurable Disease|Overall Study||13
1717323|NCT00337077|4201397|P2|Patients With Measurable Disease|Overall Study||38
1717324|NCT00337077|4201398|P1|Patients With Measurable Disease|Overall Study||26
1717325|NCT00337077|4201396|P3|Eligible and Treated|Overall Study||24
1717326|NCT00337077|4201397|P2|Eligible and Treated|Overall Study||51
1717327|NCT00337077|4201398|P1|Eligible and Treated|Overall Study||41
1717328|NCT00337077|4201396|P3|Toxicity Assessed|Overall Study||25
1717329|NCT00337077|4201397|P2|Toxicity Assessed|Overall Study||51
1717330|NCT00337077|4201398|P1|Toxicity Assessed|Overall Study||42
1717331|NCT00337077|4201396|P3|Treated|Overall Study||25
1717332|NCT00337077|4201397|P2|Treated|Overall Study||52
1717333|NCT00337077|4201398|P1|Treated|Overall Study||42
1717334|NCT00337077|4201396|P3|STARTED|Overall Study||25
1717335|NCT00337077|4201397|P2|STARTED|Overall Study||53
1717336|NCT00337077|4201398|P1|STARTED|Overall Study||43
1717337|NCT00336973|4201407|P1|NOT COMPLETED|Overall Study||33
1717338|NCT00336973|4201407|P1|COMPLETED|Overall Study||33
1717339|NCT00336973|4201407|P1|STARTED|Overall Study||66
1717340|NCT00336895|4201413|P1|NOT COMPLETED|Overall Study||4
1717341|NCT00336895|4201413|P1|COMPLETED|Overall Study||26
1717342|NCT00336895|4201413|P1|STARTED|Overall Study||30
1717343|NCT00336856|4201419|P1|NOT COMPLETED|Overall Study||4
1717344|NCT00336856|4201419|P1|COMPLETED|Overall Study||31
1717345|NCT00336856|4201419|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
1717346|NCT00336817|4201427|P2|NOT COMPLETED|Overall Study||2
1717347|NCT00336817|4201428|P1|NOT COMPLETED|Overall Study||1
1717348|NCT00336817|4201427|P2|COMPLETED|Overall Study||13
1717349|NCT00336817|4201428|P1|COMPLETED|Overall Study||14
1717350|NCT00336817|4201427|P2|STARTED|Overall Study||15
1717351|NCT00336817|4201428|P1|STARTED|Overall Study||15
1717352|NCT00336700|4201458|P1|NOT COMPLETED|Overall Study||0
1717353|NCT00336700|4201458|P1|COMPLETED|Overall Study||25
1717354|NCT00336700|4201458|P1|STARTED|Overall Study||25
1717355|NCT00336583|4201467|P1|NOT COMPLETED|Overall Study||2
1717356|NCT00336583|4201467|P1|COMPLETED|Overall Study||25
1717357|NCT00336583|4201467|P1|STARTED|Overall Study||27
1717358|NCT00336544|4201474|P2|NOT COMPLETED|Overall Study||22
1717359|NCT00336544|4201475|P1|NOT COMPLETED|Overall Study||19
1717360|NCT00336544|4201474|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
1717361|NCT00336544|4201475|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
1717362|NCT00336544|4201474|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
1717363|NCT00336544|4201475|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
1717364|NCT00336505|4201489|P2|NOT COMPLETED|Overall Study||27
1717365|NCT00336505|4201490|P1|NOT COMPLETED|Overall Study||37
1717366|NCT00336505|4201489|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
1717367|NCT00336505|4201490|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
1717368|NCT00336505|4201489|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
1717369|NCT00336505|4201490|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
1717370|NCT00336492|4201505|P3|NOT COMPLETED|Overall Study||11
1717371|NCT00336492|4201506|P2|NOT COMPLETED|Overall Study||4
1717372|NCT00336492|4201507|P1|NOT COMPLETED|Overall Study||15
1717373|NCT00336492|4201505|P3|COMPLETED|Overall Study||12
1717374|NCT00336492|4201506|P2|COMPLETED|Overall Study||18
1717375|NCT00336492|4201507|P1|COMPLETED|Overall Study||0
1717376|NCT00336492|4201505|P3|STARTED|Overall Study||23
1717377|NCT00336492|4201506|P2|STARTED|Overall Study||22
1717378|NCT00336492|4201507|P1|STARTED|Overall Study||15
1717379|NCT00336479|4201519|P4|NOT COMPLETED|Overall Study||4
1717380|NCT00336479|4201520|P3|NOT COMPLETED|Overall Study||26
1717381|NCT00336479|4201521|P2|NOT COMPLETED|Overall Study||25
1717382|NCT00336479|4201522|P1|NOT COMPLETED|Overall Study||37
1717383|NCT00336479|4201519|P4|COMPLETED|Overall Study||13
1717384|NCT00336479|4201520|P3|COMPLETED|Overall Study||53
1717385|NCT00336479|4201521|P2|COMPLETED|Overall Study||54
1717386|NCT00336479|4201522|P1|COMPLETED|Overall Study||38
1717387|NCT00336479|4201519|P4|STARTED|Overall Study||17
1717388|NCT00336479|4201520|P3|STARTED|Overall Study||79
1717389|NCT00336479|4201521|P2|STARTED|Overall Study||79
1717390|NCT00336479|4201522|P1|STARTED|Overall Study||75
1717391|NCT00336323|4201550|P5|NOT COMPLETED|Overall Study||3
1717392|NCT00336323|4201551|P4|NOT COMPLETED|Overall Study||0
1717393|NCT00336323|4201552|P3|NOT COMPLETED|Overall Study||1
1717394|NCT00336323|4201553|P2|NOT COMPLETED|Overall Study||1
1717395|NCT00336323|4201554|P1|NOT COMPLETED|Overall Study||0
1717396|NCT00336323|4201550|P5|COMPLETED|Overall Study||19
1717397|NCT00336323|4201551|P4|COMPLETED|Overall Study||22
1717398|NCT00336323|4201552|P3|COMPLETED|Overall Study||23
1717399|NCT00336323|4201553|P2|COMPLETED|Overall Study||21
1717400|NCT00336323|4201554|P1|COMPLETED|Overall Study||19
1717401|NCT00336323|4201550|P5|24 Week Visit|Overall Study||19
1717402|NCT00336323|4201551|P4|24 Week Visit|Overall Study||22
1717403|NCT00336323|4201552|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
1717404|NCT00336323|4201553|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
1717405|NCT00336323|4201554|P1|24 Week Visit|Overall Study||18
1717406|NCT00336323|4201550|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
1717407|NCT00336323|4201551|P4|18 Week Visit|Overall Study||21
1717408|NCT00336323|4201552|P3|18 Week Visit|Overall Study||23
1717409|NCT00336323|4201553|P2|18 Week Visit|Overall Study||22
1717410|NCT00336323|4201554|P1|18 Week Visit|Overall Study||19
1717411|NCT00336323|4201550|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
1717412|NCT00336323|4201551|P4|12 Week Visit|Overall Study||22
1717413|NCT00336323|4201552|P3|12 Week Visit|Overall Study||24
1717414|NCT00336323|4201553|P2|12 Week Visit|Overall Study||21
1717415|NCT00336323|4201554|P1|12 Week Visit|Overall Study||19
1717416|NCT00336323|4201550|P5|9 Week Visit|Overall Study||19
1717417|NCT00336323|4201551|P4|9 Week Visit|Overall Study||21
1717418|NCT00336323|4201552|P3|9 Week Visit|Overall Study||23
1717419|NCT00336323|4201553|P2|9 Week Visit|Overall Study||21
1717420|NCT00336323|4201554|P1|9 Week Visit|Overall Study||18
1717421|NCT00336323|4201550|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
1717422|NCT00336323|4201551|P4|6 Week Visit|Overall Study||22
1717423|NCT00336323|4201552|P3|6 Week Visit|Overall Study||24
1717424|NCT00336323|4201553|P2|6 Week Visit|Overall Study||22
1717425|NCT00336323|4201554|P1|6 Week Visit|Overall Study||18
1717426|NCT00336323|4201550|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
1717427|NCT00336323|4201551|P4|3 Week Visit|Overall Study||22
1717428|NCT00336323|4201552|P3|3 Week Visit|Overall Study||24
1717429|NCT00336323|4201553|P2|3 Week Visit|Overall Study||21
1717430|NCT00336323|4201554|P1|3 Week Visit|Overall Study||18
1717431|NCT00336323|4201550|P5|STARTED|Overall Study||22
1717432|NCT00336323|4201551|P4|STARTED|Overall Study||22
1717433|NCT00336323|4201552|P3|STARTED|Overall Study||24
1717434|NCT00336323|4201553|P2|STARTED|Overall Study||22
1717435|NCT00336323|4201554|P1|STARTED|Overall Study||19
1717436|NCT00336284|4201611|P2|NOT COMPLETED|Overall Study||151
1717437|NCT00336284|4201612|P1|NOT COMPLETED|Overall Study||236
1717438|NCT00336284|4201611|P2|COMPLETED|Overall Study||322
1717439|NCT00336284|4201612|P1|COMPLETED|Overall Study||741
1717440|NCT00336284|4201611|P2|STARTED|Overall Study||473
1717441|NCT00336284|4201612|P1|STARTED|Overall Study||977
1717442|NCT00336232|4201624|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
1717443|NCT00336232|4201624|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
1717444|NCT00336232|4201624|P1|STARTED|High Vitamin K (500mcg Daily)||42
1717445|NCT00336232|4201624|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
1717446|NCT00336232|4201624|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
1717447|NCT00336232|4201624|P1|STARTED|Low Vitamin K (10mcg Daily)||42
1717448|NCT00336232|4201624|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
1717449|NCT00336232|4201624|P1|COMPLETED|Baseline (200mcg Daily)||42
1717450|NCT00336232|4201624|P1|STARTED|Baseline (200mcg Daily)||59
1717451|NCT00336024|4201630|P2|NOT COMPLETED|Overall Study||19
1717452|NCT00336024|4201631|P1|NOT COMPLETED|Overall Study||20
1717453|NCT00336024|4201630|P2|COMPLETED|Overall Study||26
1717454|NCT00336024|4201631|P1|COMPLETED|Overall Study||26
1717455|NCT00336024|4201630|P2|STARTED|Overall Study||45
1717456|NCT00336024|4201631|P1|STARTED|Overall Study||46
1717457|NCT00335972|4201665|P2|NOT COMPLETED|Overall Study||3
1717458|NCT00335972|4201666|P1|NOT COMPLETED|Overall Study||0
1717459|NCT00335972|4201665|P2|COMPLETED|Overall Study||68
1717460|NCT00335972|4201666|P1|COMPLETED|Overall Study||71
1717461|NCT00335972|4201665|P2|STARTED|Overall Study||71
1717462|NCT00335972|4201666|P1|STARTED|Overall Study||71
1717463|NCT00335959|4201676|P1|NOT COMPLETED|Overall Study||3
1717464|NCT00335959|4201676|P1|COMPLETED|Overall Study||4
1717465|NCT00335959|4201676|P1|Eligible and Began Protocol Therapy|Overall Study||6
1717466|NCT00335959|4201676|P1|Eligible|Overall Study||6
1717467|NCT00335959|4201676|P1|STARTED|Overall Study||7
1717468|NCT00335829|4201681|P1|NOT COMPLETED|Overall Study||3
1717469|NCT00335829|4201681|P1|COMPLETED|Overall Study||23
1717470|NCT00335829|4201681|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
1717471|NCT00335829|4201681|P1|Received Bevacizumab|Overall Study||26
1717472|NCT00335829|4201681|P1|STARTED|Overall Study||26
1717473|NCT00335777|4201695|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
1717474|NCT00335777|4201695|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
1717475|NCT00335777|4201695|P1|STARTED|Treated 2 Headaches Per Protocol||35
1717476|NCT00335777|4201695|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
1717477|NCT00335777|4201695|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
1717478|NCT00335777|4201695|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
1717479|NCT00335764|4201705|P5|NOT COMPLETED|Overall Study||1
1717480|NCT00335764|4201706|P4|NOT COMPLETED|Overall Study||0
1717481|NCT00335764|4201707|P3|NOT COMPLETED|Overall Study||0
1717482|NCT00335764|4201708|P2|NOT COMPLETED|Overall Study||0
1717483|NCT00335764|4201709|P1|NOT COMPLETED|Overall Study||1
1717484|NCT00335764|4201705|P5|COMPLETED|Overall Study||18
1717485|NCT00335764|4201706|P4|COMPLETED|Overall Study||19
1717486|NCT00335764|4201707|P3|COMPLETED|Overall Study||24
1717487|NCT00335764|4201708|P2|COMPLETED|Overall Study||13
1717488|NCT00335764|4201709|P1|COMPLETED|Overall Study||16
1717489|NCT00335764|4201705|P5|STARTED|Overall Study||19
1717490|NCT00335764|4201706|P4|STARTED|Overall Study||19
1717491|NCT00335764|4201707|P3|STARTED|Overall Study||24
1717492|NCT00335764|4201708|P2|STARTED|Overall Study||13
1717493|NCT00335764|4201709|P1|STARTED|Overall Study||17
1717494|NCT00335738|4201758|P2|NOT COMPLETED|Overall Study||4
1717495|NCT00335738|4201759|P1|NOT COMPLETED|Overall Study||11
1717496|NCT00335738|4201758|P2|COMPLETED|Overall Study||219
1717497|NCT00335738|4201759|P1|COMPLETED|Overall Study||97
1717498|NCT00335738|4201758|P2|STARTED|Overall Study||223
1717499|NCT00335738|4201759|P1|STARTED|Overall Study||108
1717500|NCT00335725|4201776|P2|NOT COMPLETED|Overall Study||5
1717501|NCT00335725|4201777|P1|NOT COMPLETED|Overall Study||4
1717502|NCT00335725|4201776|P2|COMPLETED|Overall Study||71
1717503|NCT00335725|4201777|P1|COMPLETED|Overall Study||71
1717504|NCT00335725|4201776|P2|STARTED|Overall Study||76
1717505|NCT00335725|4201777|P1|STARTED|Overall Study||75
1717506|NCT00335556|4201791|P6|NOT COMPLETED|Overall Study||1
1717507|NCT00335556|4201792|P5|NOT COMPLETED|Overall Study||1
1717508|NCT00335556|4201793|P4|NOT COMPLETED|Overall Study||5
1717509|NCT00335556|4201794|P3|NOT COMPLETED|Overall Study||5
1717510|NCT00335556|4201795|P2|NOT COMPLETED|Overall Study||34
1717511|NCT00335556|4201796|P1|NOT COMPLETED|Overall Study||2
1717512|NCT00335556|4201791|P6|COMPLETED|Overall Study||29
1717513|NCT00335556|4201792|P5|COMPLETED|Overall Study||77
1717514|NCT00335556|4201793|P4|COMPLETED|Overall Study||5
1717515|NCT00335556|4201794|P3|COMPLETED|Overall Study||2
1717516|NCT00335556|4201795|P2|COMPLETED|Overall Study||64
1717517|NCT00335556|4201796|P1|COMPLETED|Overall Study||66
1717518|NCT00335556|4201791|P6|STARTED|Overall Study||30
1717519|NCT00335556|4201792|P5|STARTED|Overall Study||78
1717520|NCT00335556|4201793|P4|STARTED|Overall Study||10
1717521|NCT00335556|4201794|P3|STARTED|Overall Study||7
1717522|NCT00335556|4201795|P2|STARTED|Overall Study||98
1717523|NCT00335556|4201796|P1|STARTED|Overall Study||68
1717524|NCT00335517|4201817|P1|NOT COMPLETED|Overall Study||2
1717525|NCT00335517|4201817|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
1717526|NCT00335517|4201817|P1|STARTED|Overall Study||100
1717527|NCT00335504|4201825|P4|NOT COMPLETED|Overall Study||0
1717528|NCT00335504|4201826|P3|NOT COMPLETED|Overall Study||0
1717529|NCT00335504|4201827|P2|NOT COMPLETED|Overall Study||0
1717530|NCT00335504|4201828|P1|NOT COMPLETED|Overall Study||0
1717531|NCT00335504|4201825|P4|COMPLETED|Overall Study||22
1717532|NCT00335504|4201826|P3|COMPLETED|Overall Study||20
1717533|NCT00335504|4201827|P2|COMPLETED|Overall Study||21
1717534|NCT00335504|4201828|P1|COMPLETED|Overall Study||22
1717535|NCT00335504|4201825|P4|STARTED|Overall Study||22
1717536|NCT00335504|4201826|P3|STARTED|Overall Study||20
1717537|NCT00335504|4201827|P2|STARTED|Overall Study||21
1717538|NCT00335504|4201828|P1|STARTED|Overall Study||22
1717539|NCT00335478|4201850|P1|NOT COMPLETED|Overall Study||24
1717540|NCT00335478|4201850|P1|COMPLETED|Overall Study||30
1717541|NCT00335478|4201850|P1|STARTED|Overall Study||54
1717542|NCT00335452|4201858|P4|NOT COMPLETED|Overall Study||131
1717543|NCT00335452|4201859|P3|NOT COMPLETED|Overall Study||159
1717544|NCT00335452|4201860|P2|NOT COMPLETED|Overall Study||147
1717545|NCT00335452|4201861|P1|NOT COMPLETED|Overall Study||158
1717546|NCT00335452|4201858|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
1717547|NCT00335452|4201859|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
1717548|NCT00335452|4201860|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
1717549|NCT00335452|4201861|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
1717550|NCT00335452|4201858|P4|TREATED WITH ASA|Overall Study||6247
1717551|NCT00335452|4201859|P3|TREATED WITH ASA|Overall Study||6261
1717552|NCT00335452|4201860|P2|TREATED WITH ASA|Overall Study||6251
1717553|NCT00335452|4201861|P1|TREATED WITH ASA|Overall Study||6302
1717554|NCT00335452|4201858|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
1717555|NCT00335452|4201859|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
1717556|NCT00335452|4201860|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
1717557|NCT00335452|4201861|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
1717558|NCT00335452|4201858|P4|STARTED|Overall Study|Randomized|6253
1717559|NCT00335452|4201859|P3|STARTED|Overall Study|Randomized|6267
1717560|NCT00335452|4201860|P2|STARTED|Overall Study|Randomized|6254
1717561|NCT00335452|4201861|P1|STARTED|Overall Study|Randomized|6312
1717562|NCT00335322|4201886|P3|NOT COMPLETED|Overall Study||2
1717563|NCT00335322|4201887|P2|NOT COMPLETED|Overall Study||2
1717564|NCT00335322|4201888|P1|NOT COMPLETED|Overall Study||1
1717565|NCT00335322|4201886|P3|COMPLETED|Overall Study||103
1717566|NCT00335322|4201887|P2|COMPLETED|Overall Study||105
1717567|NCT00335322|4201888|P1|COMPLETED|Overall Study||114
1717568|NCT00335322|4201886|P3|STARTED|Overall Study||105
1717569|NCT00335322|4201887|P2|STARTED|Overall Study||107
1717570|NCT00335322|4201888|P1|STARTED|Overall Study||115
1717571|NCT00335283|4201898|P2|NOT COMPLETED|Overall Study||5
1717572|NCT00335283|4201899|P1|NOT COMPLETED|Overall Study||6
1717573|NCT00335283|4201898|P2|COMPLETED|Overall Study||34
1717574|NCT00335283|4201899|P1|COMPLETED|Overall Study||30
1717575|NCT00335283|4201898|P2|STARTED|Overall Study||39
1717576|NCT00335283|4201899|P1|STARTED|Overall Study||36
1717577|NCT00335257|4201914|P3|NOT COMPLETED|Overall Study||0
1717578|NCT00335257|4201915|P2|NOT COMPLETED|Overall Study||0
1717579|NCT00335257|4201916|P1|NOT COMPLETED|Overall Study||0
1717580|NCT00335257|4201914|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
1717581|NCT00335257|4201915|P2|COMPLETED|Overall Study||9377
1717582|NCT00335257|4201916|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
1717583|NCT00335257|4201914|P3|STARTED|Overall Study||60190
1717584|NCT00335257|4201915|P2|STARTED|Overall Study||9377
1717585|NCT00335257|4201916|P1|STARTED|Overall Study||15542
1717586|NCT00335153|4201933|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
1717587|NCT00335153|4201933|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
1717588|NCT00335153|4201933|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
1717589|NCT00335153|4201933|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
1717590|NCT00335153|4201933|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
1717591|NCT00335153|4201933|P1|STARTED|Nasojejunal (NJ) Test Period||354
1717592|NCT00335140|4201970|P1|NOT COMPLETED|Overall Study||1
1717593|NCT00335140|4201970|P1|COMPLETED|Overall Study||25
1717594|NCT00335140|4201970|P1|Treated|Overall Study||25
1717595|NCT00335140|4201970|P1|Eligible|Overall Study||25
1717596|NCT00335140|4201970|P1|STARTED|Overall Study||26
1717597|NCT00334958|4201976|P2|NOT COMPLETED|Overall Study||24
1717598|NCT00334958|4201977|P1|NOT COMPLETED|Overall Study||37
1717599|NCT00334958|4201976|P2|COMPLETED|Overall Study||156
1717600|NCT00334958|4201977|P1|COMPLETED|Overall Study||139
1717601|NCT00334958|4201976|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
1717602|NCT00334958|4201977|P1|STARTED|Overall Study||176
1717603|NCT00334893|4201991|P2|NOT COMPLETED|Overall Study||0
1717604|NCT00334893|4201992|P1|NOT COMPLETED|Overall Study||1
1717605|NCT00334893|4201991|P2|COMPLETED|Overall Study||37
1717606|NCT00334893|4201992|P1|COMPLETED|Overall Study||36
1717607|NCT00334893|4201991|P2|STARTED|Overall Study||37
1717608|NCT00334893|4201992|P1|STARTED|Overall Study||37
1717609|NCT00334815|4202002|P2|NOT COMPLETED|Overall Study||10
1717610|NCT00334815|4202003|P1|NOT COMPLETED|Overall Study||7
1717611|NCT00334815|4202002|P2|COMPLETED|Overall Study||3
1717612|NCT00334815|4202003|P1|COMPLETED|Overall Study||9
1717613|NCT00334815|4202002|P2|STARTED|Overall Study||13
1717614|NCT00334815|4202003|P1|STARTED|Overall Study||16
1717615|NCT00334802|4202017|P2|NOT COMPLETED|Overall Study||40
1717616|NCT00334802|4202018|P1|NOT COMPLETED|Overall Study||6
1717617|NCT00334802|4202017|P2|COMPLETED|Overall Study||16
1717618|NCT00334802|4202018|P1|COMPLETED|Overall Study||0
1717619|NCT00334802|4202017|P2|STARTED|Overall Study||56
1717620|NCT00334802|4202018|P1|STARTED|Overall Study||6
1717621|NCT00334633|4202038|P3|NOT COMPLETED|Overall Study||82
1717622|NCT00334633|4202039|P2|NOT COMPLETED|Overall Study||82
1717623|NCT00334633|4202040|P1|NOT COMPLETED|Overall Study||80
1717624|NCT00334633|4202038|P3|COMPLETED|Overall Study||114
1717625|NCT00334633|4202039|P2|COMPLETED|Overall Study||118
1717626|NCT00334633|4202040|P1|COMPLETED|Overall Study||117
1717627|NCT00334633|4202038|P3|STARTED|Overall Study||196
1717628|NCT00334633|4202039|P2|STARTED|Overall Study||200
1717629|NCT00334633|4202040|P1|STARTED|Overall Study||197
1717630|NCT00334542|4202051|P1|NOT COMPLETED|Overall Study||5
1717631|NCT00334542|4202051|P1|COMPLETED|Overall Study||45
1717632|NCT00334542|4202051|P1|STARTED|Overall Study||50
1717633|NCT00334295|4202056|P1|NOT COMPLETED|Overall Study||5
1717634|NCT00334295|4202056|P1|COMPLETED|Overall Study||30
1717635|NCT00334295|4202056|P1|STARTED|Overall Study||35
1717636|NCT00334282|4202066|P2|NOT COMPLETED|Overall Study||108
1717637|NCT00334282|4202067|P1|NOT COMPLETED|Overall Study||222
1717638|NCT00334282|4202066|P2|COMPLETED|Overall Study||37
1717639|NCT00334282|4202067|P1|COMPLETED|Overall Study||68
1717640|NCT00334282|4202066|P2|STARTED|Overall Study||145
1717641|NCT00334282|4202067|P1|STARTED|Overall Study||290
1717642|NCT00334204|4202090|P1|NOT COMPLETED|Overall Study||2
1717643|NCT00334204|4202090|P1|COMPLETED|Overall Study||56
1717644|NCT00334204|4202090|P1|STARTED|Overall Study||58
1717645|NCT00334113|4202098|P2|NOT COMPLETED|Overall Study||3
1717646|NCT00334113|4202099|P1|NOT COMPLETED|Overall Study||2
1717647|NCT00334113|4202098|P2|COMPLETED|Overall Study||31
1717648|NCT00334113|4202099|P1|COMPLETED|Overall Study||30
1717649|NCT00334113|4202098|P2|STARTED|Overall Study||34
1717650|NCT00334113|4202099|P1|STARTED|Overall Study||32
1717651|NCT00334074|4202105|P1|NOT COMPLETED|Overall Study||0
1717652|NCT00334074|4202105|P1|COMPLETED|Overall Study||30
1717653|NCT00334074|4202105|P1|STARTED|Overall Study||30
1717654|NCT00334061|4202110|P1|NOT COMPLETED|Overall Study||0
1717655|NCT00334061|4202110|P1|COMPLETED|Overall Study|November 2007|125
1717656|NCT00334061|4202110|P1|STARTED|Overall Study|June 2006|125
1717657|NCT00333983|4202122|P3|NOT COMPLETED|Overall Study||2
1717658|NCT00333983|4202123|P2|NOT COMPLETED|Overall Study||5
1717659|NCT00333983|4202124|P1|NOT COMPLETED|Overall Study||3
1717660|NCT00333983|4202122|P3|COMPLETED|Overall Study||19
1717661|NCT00333983|4202123|P2|COMPLETED|Overall Study||16
1717662|NCT00333983|4202124|P1|COMPLETED|Overall Study||17
1717663|NCT00333983|4202122|P3|STARTED|Overall Study||21
1717664|NCT00333983|4202123|P2|STARTED|Overall Study||21
1717665|NCT00333983|4202124|P1|STARTED|Overall Study||20
1717666|NCT00333970|4202134|P2|NOT COMPLETED|Overall Study||7
1717667|NCT00333970|4202135|P1|NOT COMPLETED|Overall Study||13
1717668|NCT00333970|4202134|P2|COMPLETED|Overall Study||18
1717669|NCT00333970|4202135|P1|COMPLETED|Overall Study||37
1717670|NCT00333970|4202134|P2|STARTED|Overall Study||25
1717671|NCT00333970|4202135|P1|STARTED|Overall Study||50
1717672|NCT00333879|4202141|P1|NOT COMPLETED|Overall Study||0
1717673|NCT00333879|4202141|P1|COMPLETED|Overall Study||4
1717674|NCT00333879|4202141|P1|STARTED|Overall Study||4
1717675|NCT00333866|4202150|P4|NOT COMPLETED|Overall Study||66
1717676|NCT00333866|4202151|P3|NOT COMPLETED|Overall Study||51
1717677|NCT00333866|4202152|P2|NOT COMPLETED|Overall Study||64
1717678|NCT00333866|4202153|P1|NOT COMPLETED|Overall Study||48
1717679|NCT00333866|4202150|P4|COMPLETED|Overall Study||121
1717680|NCT00333866|4202151|P3|COMPLETED|Overall Study||133
1717681|NCT00333866|4202152|P2|COMPLETED|Overall Study||123
1717682|NCT00333866|4202153|P1|COMPLETED|Overall Study||141
1717683|NCT00333866|4202150|P4|TREATED|Overall Study||186
1717684|NCT00333866|4202151|P3|TREATED|Overall Study||182
1717685|NCT00333866|4202152|P2|TREATED|Overall Study||184
1717686|NCT00333866|4202153|P1|TREATED|Overall Study||184
1717687|NCT00333866|4202150|P4|STARTED|Overall Study||187
1717688|NCT00333866|4202151|P3|STARTED|Overall Study||184
1717689|NCT00333866|4202152|P2|STARTED|Overall Study||187
1717690|NCT00333866|4202153|P1|STARTED|Overall Study||189
1717691|NCT00333840|4202213|P4|NOT COMPLETED|Second-line Treatment Period||188
1717692|NCT00333840|4202214|P3|NOT COMPLETED|Second-line Treatment Period||14
1717693|NCT00333840|4202215|P2|NOT COMPLETED|Second-line Treatment Period||0
1717694|NCT00333840|4202216|P1|NOT COMPLETED|Second-line Treatment Period||0
1717695|NCT00333840|4202213|P4|COMPLETED|Second-line Treatment Period||175
1717696|NCT00333840|4202214|P3|COMPLETED|Second-line Treatment Period||0
1717697|NCT00333840|4202215|P2|COMPLETED|Second-line Treatment Period||0
1717698|NCT00333840|4202216|P1|COMPLETED|Second-line Treatment Period||0
1717699|NCT00333840|4202213|P4|STARTED|Second-line Treatment Period||363
1717700|NCT00333840|4202214|P3|STARTED|Second-line Treatment Period||14
1717701|NCT00333840|4202215|P2|STARTED|Second-line Treatment Period||0
1717702|NCT00333840|4202216|P1|STARTED|Second-line Treatment Period||0
1717703|NCT00333840|4202213|P4|NOT COMPLETED|First-line Treatment Period||0
1717704|NCT00333840|4202214|P3|NOT COMPLETED|First-line Treatment Period||0
1717705|NCT00333840|4202215|P2|NOT COMPLETED|First-line Treatment Period||546
1717706|NCT00333840|4202216|P1|NOT COMPLETED|First-line Treatment Period||286
1717707|NCT00333840|4202213|P4|COMPLETED|First-line Treatment Period||0
1717708|NCT00333840|4202214|P3|COMPLETED|First-line Treatment Period||0
1717709|NCT00333840|4202215|P2|COMPLETED|First-line Treatment Period||7
1717710|NCT00333840|4202216|P1|COMPLETED|First-line Treatment Period||267
1717711|NCT00333840|4202213|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
1717712|NCT00333840|4202214|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
1717713|NCT00333840|4202215|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
1717714|NCT00333840|4202216|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
1717715|NCT00333840|4202213|P4|STARTED|First-line Treatment Period||0
1717716|NCT00333840|4202214|P3|STARTED|First-line Treatment Period||0
1717717|NCT00333840|4202215|P2|STARTED|First-line Treatment Period||553
1717718|NCT00333840|4202216|P1|STARTED|First-line Treatment Period||553
1717719|NCT00333814|4202244|P3|NOT COMPLETED|Overall Study||5
1717720|NCT00333814|4202245|P2|NOT COMPLETED|Overall Study||4
1717721|NCT00333814|4202246|P1|NOT COMPLETED|Overall Study||3
1717722|NCT00333814|4202244|P3|COMPLETED|Overall Study||71
1717723|NCT00333814|4202245|P2|COMPLETED|Overall Study||73
1717724|NCT00333814|4202246|P1|COMPLETED|Overall Study||73
1717725|NCT00333814|4202244|P3|STARTED|Overall Study||76
1717726|NCT00333814|4202245|P2|STARTED|Overall Study||77
1717727|NCT00333814|4202246|P1|STARTED|Overall Study||76
1717728|NCT00333801|4202262|P2|NOT COMPLETED|Overall Study||6
1717729|NCT00333801|4202263|P1|NOT COMPLETED|Overall Study||8
1717730|NCT00333801|4202262|P2|COMPLETED|Overall Study||36
1717731|NCT00333801|4202263|P1|COMPLETED|Overall Study||35
1717732|NCT00333801|4202262|P2|STARTED|Overall Study||42
1717733|NCT00333801|4202263|P1|STARTED|Overall Study||43
1717734|NCT00333788|4202281|P1|NOT COMPLETED|Overall Study||162
1717735|NCT00333788|4202281|P1|COMPLETED|Overall Study||71
1717736|NCT00333788|4202281|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
1717737|NCT00333775|4202311|P3|NOT COMPLETED|Overall Study||247
1717738|NCT00333775|4202312|P2|NOT COMPLETED|Overall Study||248
1717739|NCT00333775|4202313|P1|NOT COMPLETED|Overall Study||241
1717740|NCT00333775|4202311|P3|COMPLETED|Overall Study||0
1717741|NCT00333775|4202312|P2|COMPLETED|Overall Study||0
1717742|NCT00333775|4202313|P1|COMPLETED|Overall Study||0
1717743|NCT00333775|4202311|P3|Received Treatment|Overall Study||245
1717744|NCT00333775|4202312|P2|Received Treatment|Overall Study||247
1717745|NCT00333775|4202313|P1|Received Treatment|Overall Study||238
1717746|NCT00333775|4202311|P3|STARTED|Overall Study||247
1717747|NCT00333775|4202312|P2|STARTED|Overall Study||248
1717748|NCT00333775|4202313|P1|STARTED|Overall Study||241
1717749|NCT00333762|4202333|P1|NOT COMPLETED|Overall Study||4
1717750|NCT00333762|4202333|P1|COMPLETED|Overall Study||0
1717751|NCT00333762|4202333|P1|STARTED|Overall Study||4
1717752|NCT00333710|4202340|P3|NOT COMPLETED|Overall Study||1
1717753|NCT00333710|4202341|P2|NOT COMPLETED|Overall Study||4
1717754|NCT00333710|4202342|P1|NOT COMPLETED|Overall Study||11
1717755|NCT00333710|4202340|P3|COMPLETED|Overall Study||15
1717756|NCT00333710|4202341|P2|COMPLETED|Overall Study||14
1717757|NCT00333710|4202342|P1|COMPLETED|Overall Study||8
1717758|NCT00333710|4202340|P3|STARTED|Overall Study||16
1717759|NCT00333710|4202341|P2|STARTED|Overall Study||18
1717760|NCT00333710|4202342|P1|STARTED|Overall Study||19
1717761|NCT00333619|4202352|P2|NOT COMPLETED|Overall Study||10
1717762|NCT00333619|4202353|P1|NOT COMPLETED|Overall Study||21
1717763|NCT00333619|4202352|P2|COMPLETED|Overall Study||99
1717764|NCT00333619|4202353|P1|COMPLETED|Overall Study||89
1717765|NCT00333619|4202352|P2|3-month Follow-up|Overall Study||105
1717766|NCT00333619|4202353|P1|3-month Follow-up|Overall Study||101
1717767|NCT00333619|4202352|P2|Post-treatment|Overall Study||109
1717768|NCT00333619|4202353|P1|Post-treatment|Overall Study||109
1717769|NCT00333619|4202352|P2|STARTED|Overall Study||109
1717770|NCT00333619|4202353|P1|STARTED|Overall Study||110
1717771|NCT00333437|4202361|P1|NOT COMPLETED|Overall Study||0
1717772|NCT00333437|4202361|P1|COMPLETED|Overall Study||7
1717773|NCT00333437|4202361|P1|STARTED|Overall Study||7
1717774|NCT00333359|4202371|P2|NOT COMPLETED|Overall Study||122
1717775|NCT00333359|4202372|P1|NOT COMPLETED|Overall Study||73
1717776|NCT00333359|4202371|P2|COMPLETED|Overall Study||260
1717777|NCT00333359|4202372|P1|COMPLETED|Overall Study||126
1717778|NCT00333359|4202371|P2|STARTED|Overall Study||382
1717779|NCT00333359|4202372|P1|STARTED|Overall Study||199
1717780|NCT00333229|4202415|P2|NOT COMPLETED|Overall Study||1
1717781|NCT00333229|4202416|P1|NOT COMPLETED|Overall Study||0
1717782|NCT00333229|4202415|P2|COMPLETED|Overall Study||4
1717783|NCT00333229|4202416|P1|COMPLETED|Overall Study||6
1717784|NCT00333229|4202415|P2|STARTED|Overall Study||5
1717785|NCT00333229|4202416|P1|STARTED|Overall Study||6
1717786|NCT00333138|4202433|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
1717787|NCT00333138|4202434|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
1717788|NCT00333138|4202435|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
1717789|NCT00333138|4202433|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
1717790|NCT00333138|4202434|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
1717791|NCT00333138|4202435|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
1717792|NCT00333138|4202433|P3|STARTED|Extension Study (Month6 to End of Study)||80
1717793|NCT00333138|4202434|P2|STARTED|Extension Study (Month6 to End of Study)||87
1717794|NCT00333138|4202435|P1|STARTED|Extension Study (Month6 to End of Study)||83
1717795|NCT00333138|4202433|P3|NOT COMPLETED|Core Study (6 Months)||12
1717796|NCT00333138|4202434|P2|NOT COMPLETED|Core Study (6 Months)||6
1717797|NCT00333138|4202435|P1|NOT COMPLETED|Core Study (6 Months)||7
1717798|NCT00333138|4202433|P3|COMPLETED|Core Study (6 Months)||82
1717799|NCT00333138|4202434|P2|COMPLETED|Core Study (6 Months)||88
1717800|NCT00333138|4202435|P1|COMPLETED|Core Study (6 Months)||86
1717801|NCT00333138|4202433|P3|STARTED|Core Study (6 Months)||94
1717802|NCT00333138|4202434|P2|STARTED|Core Study (6 Months)||94
1717803|NCT00333138|4202435|P1|STARTED|Core Study (6 Months)||93
1717804|NCT00332839|4202474|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
1717805|NCT00332839|4202475|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
1717806|NCT00332839|4202474|P2|COMPLETED|Follow-up (Months 12 - 60)||31
1717807|NCT00332839|4202475|P1|COMPLETED|Follow-up (Months 12 - 60)||29
1717808|NCT00332839|4202474|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
1717809|NCT00332839|4202475|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
1717810|NCT00332839|4202474|P2|NOT COMPLETED|Core (Months 0 - 12)||18
1717811|NCT00332839|4202475|P1|NOT COMPLETED|Core (Months 0 - 12)||10
1717812|NCT00332839|4202474|P2|COMPLETED|Core (Months 0 - 12)||28
1717813|NCT00332839|4202475|P1|COMPLETED|Core (Months 0 - 12)||37
1717814|NCT00332839|4202474|P2|Safety Set|Core (Months 0 - 12)||46
1717815|NCT00332839|4202475|P1|Safety Set|Core (Months 0 - 12)||47
1717816|NCT00332839|4202474|P2|STARTED|Core (Months 0 - 12)||46
1717817|NCT00332839|4202475|P1|STARTED|Core (Months 0 - 12)||47
1717818|NCT00332722|4202495|P2|NOT COMPLETED|Overall Study||0
1717819|NCT00332722|4202496|P1|NOT COMPLETED|Overall Study||0
1717820|NCT00332722|4202495|P2|COMPLETED|Overall Study||60
1717821|NCT00332722|4202496|P1|COMPLETED|Overall Study||60
1717822|NCT00332722|4202495|P2|STARTED|Overall Study||60
1717823|NCT00332722|4202496|P1|STARTED|Overall Study||60
1717824|NCT00332709|4202506|P2|NOT COMPLETED|Overall Study||20
1717825|NCT00332709|4202507|P1|NOT COMPLETED|Overall Study||16
1717826|NCT00332709|4202506|P2|COMPLETED|Overall Study||21
1717827|NCT00332709|4202507|P1|COMPLETED|Overall Study||24
1717828|NCT00332709|4202506|P2|STARTED|Overall Study||41
1717829|NCT00332709|4202507|P1|STARTED|Overall Study||40
1717830|NCT00332696|4202531|P2|NOT COMPLETED|Overall Study||30
1717831|NCT00332696|4202532|P1|NOT COMPLETED|Overall Study||30
1717832|NCT00332696|4202531|P2|COMPLETED|Overall Study||2
1717833|NCT00332696|4202532|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
1717834|NCT00332696|4202531|P2|Completed Day 14 Visit|Overall Study||15
1717835|NCT00332696|4202532|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
1717836|NCT00332696|4202531|P2|STARTED|Overall Study||32
1717837|NCT00332696|4202532|P1|STARTED|Overall Study||32
1717838|NCT00332644|4202564|P6|NOT COMPLETED|Overall Study||15
1717839|NCT00332644|4202565|P5|NOT COMPLETED|Overall Study||12
1717840|NCT00332644|4202566|P4|NOT COMPLETED|Overall Study||20
1717841|NCT00332644|4202567|P3|NOT COMPLETED|Overall Study||9
1717842|NCT00332644|4202568|P2|NOT COMPLETED|Overall Study||22
1717843|NCT00332644|4202569|P1|NOT COMPLETED|Overall Study||12
1717844|NCT00332644|4202564|P6|COMPLETED|Overall Study||174
1717845|NCT00332644|4202565|P5|COMPLETED|Overall Study||250
1717846|NCT00332644|4202566|P4|COMPLETED|Overall Study||244
1717847|NCT00332644|4202567|P3|COMPLETED|Overall Study||258
1717848|NCT00332644|4202568|P2|COMPLETED|Overall Study||238
1717849|NCT00332644|4202569|P1|COMPLETED|Overall Study||250
1717850|NCT00332644|4202564|P6|STARTED|Overall Study||189
1717851|NCT00332644|4202565|P5|STARTED|Overall Study||262
1717852|NCT00332644|4202566|P4|STARTED|Overall Study||264
1717853|NCT00332644|4202567|P3|STARTED|Overall Study||267
1717854|NCT00332644|4202568|P2|STARTED|Overall Study||260
1717855|NCT00332644|4202569|P1|STARTED|Overall Study||262
1717856|NCT00332605|4202586|P3|NOT COMPLETED|Overall Study||8
1717857|NCT00332605|4202587|P2|NOT COMPLETED|Overall Study||2
1717858|NCT00332605|4202588|P1|NOT COMPLETED|Overall Study||2
1717859|NCT00332605|4202586|P3|COMPLETED|Overall Study||9
1717860|NCT00332605|4202587|P2|COMPLETED|Overall Study||12
1717861|NCT00332605|4202588|P1|COMPLETED|Overall Study||12
1717862|NCT00332605|4202586|P3|STARTED|Overall Study||17
1717863|NCT00332605|4202587|P2|STARTED|Overall Study||14
1717864|NCT00332605|4202588|P1|STARTED|Overall Study||14
1717865|NCT00332579|4202598|P2|NOT COMPLETED|Overall Study||1
1717866|NCT00332579|4202599|P1|NOT COMPLETED|Overall Study||1
1717867|NCT00332579|4202598|P2|COMPLETED|Overall Study||12
1717868|NCT00332579|4202599|P1|COMPLETED|Overall Study||11
1717869|NCT00332579|4202598|P2|STARTED|Overall Study||13
1717870|NCT00332579|4202599|P1|STARTED|Overall Study||12
1717871|NCT00332488|4202608|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
1717872|NCT00332488|4202609|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
1717873|NCT00332488|4202610|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
1717874|NCT00332488|4202608|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
1717875|NCT00332488|4202609|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
1717876|NCT00332488|4202610|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
1717877|NCT00332488|4202608|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
1717878|NCT00332488|4202609|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
1717879|NCT00332488|4202610|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
1717880|NCT00332488|4202608|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
1717881|NCT00332488|4202609|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
1717882|NCT00332488|4202610|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
1717883|NCT00332488|4202608|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
1717884|NCT00332488|4202609|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
1717885|NCT00332488|4202610|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
1717886|NCT00332488|4202608|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
1717887|NCT00332488|4202609|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
1717888|NCT00332488|4202610|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
1717889|NCT00332462|4202622|P1|NOT COMPLETED|Overall Study||16
1717890|NCT00332462|4202622|P1|COMPLETED|Overall Study||18
1717891|NCT00332462|4202622|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
1717892|NCT00332462|4202622|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
1717893|NCT00332462|4202622|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
1717894|NCT00332332|4202629|P1|NOT COMPLETED|Overall Study||68
1717895|NCT00332332|4202629|P1|COMPLETED|Overall Study||178
1717896|NCT00332332|4202629|P1|Received Study Medication|Overall Study||230
1717897|NCT00332332|4202629|P1|STARTED|Overall Study||246
1717898|NCT00332241|4202638|P2|NOT COMPLETED|Overall Study||8
1717899|NCT00332241|4202639|P1|NOT COMPLETED|Overall Study||15
1717900|NCT00332241|4202638|P2|COMPLETED|Overall Study||39
1717901|NCT00332241|4202639|P1|COMPLETED|Overall Study||36
1717902|NCT00332241|4202638|P2|STARTED|Overall Study||47
1717903|NCT00332241|4202639|P1|STARTED|Overall Study||51
1717904|NCT00332202|4202661|P2|NOT COMPLETED|Overall Study||125
1717905|NCT00332202|4202662|P1|NOT COMPLETED|Overall Study||241
1717906|NCT00332202|4202661|P2|COMPLETED|Overall Study||129
1717907|NCT00332202|4202662|P1|COMPLETED|Overall Study||263
1717908|NCT00332202|4202661|P2|Received At Least One Dose of Study Drug|Overall Study||249
1717909|NCT00332202|4202662|P1|Received At Least One Dose of Study Drug|Overall Study||493
1717910|NCT00332202|4202661|P2|STARTED|Overall Study||254
1717911|NCT00332202|4202662|P1|STARTED|Overall Study||504
1717912|NCT00332189|4202691|P1|NOT COMPLETED|Overall Study||21
1717913|NCT00332189|4202691|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
1717914|NCT00332189|4202691|P1|STARTED|Overall Study||111
1717915|NCT00332163|4202698|P2|NOT COMPLETED|Overall Study||0
1717916|NCT00332163|4202699|P1|NOT COMPLETED|Overall Study||0
1717917|NCT00332163|4202698|P2|COMPLETED|Overall Study||47
1717918|NCT00332163|4202699|P1|COMPLETED|Overall Study||48
1717919|NCT00332163|4202698|P2|Received Treatment|Overall Study||47
1717920|NCT00332163|4202699|P1|Received Treatment|Overall Study||48
1717921|NCT00332163|4202698|P2|STARTED|Overall Study||47
1717922|NCT00332163|4202699|P1|STARTED|Overall Study||48
1717923|NCT00331864|4202733|P2|NOT COMPLETED|Overall Study||4
1717924|NCT00331864|4202734|P1|NOT COMPLETED|Overall Study||58
1717925|NCT00331864|4202733|P2|COMPLETED|Overall Study||14
1717926|NCT00331864|4202734|P1|COMPLETED|Overall Study||455
1717927|NCT00331864|4202733|P2|STARTED|Overall Study||18
1717928|NCT00331864|4202734|P1|STARTED|Overall Study||513
1717929|NCT00331799|4202753|P1|NOT COMPLETED|Overall Study||3
1717930|NCT00331799|4202753|P1|COMPLETED|Overall Study||15
1717931|NCT00331799|4202753|P1|STARTED|Overall Study||18
1717932|NCT00331773|4202759|P2|NOT COMPLETED|Overall Study||7
1717933|NCT00331773|4202760|P1|NOT COMPLETED|Overall Study||16
1717934|NCT00331773|4202759|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
1717935|NCT00331773|4202760|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
1717936|NCT00331773|4202759|P2|STARTED|Overall Study||557
1717937|NCT00331773|4202760|P1|STARTED|Overall Study||558
1717938|NCT00331760|4202788|P2|NOT COMPLETED|Overall Study||8
1717939|NCT00331760|4202789|P1|NOT COMPLETED|Overall Study||15
1717940|NCT00331760|4202788|P2|COMPLETED|Overall Study||40
1717941|NCT00331760|4202789|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
1717942|NCT00331760|4202788|P2|STARTED|Overall Study||48
1717943|NCT00331760|4202789|P1|STARTED|Overall Study||58
1717944|NCT00331682|4202795|P1|NOT COMPLETED|Overall Study||1
1717945|NCT00331682|4202795|P1|COMPLETED|Overall Study||9
1717946|NCT00331682|4202795|P1|STARTED|Overall Study||10
1717947|NCT00331552|4202803|P2|NOT COMPLETED|Period 3: Phase II||0
1717948|NCT00331552|4202804|P1|NOT COMPLETED|Period 3: Phase II||2
1717949|NCT00331552|4202803|P2|COMPLETED|Period 3: Phase II||0
1717950|NCT00331552|4202804|P1|COMPLETED|Period 3: Phase II||22
1717951|NCT00331552|4202803|P2|STARTED|Period 3: Phase II||0
1717952|NCT00331552|4202804|P1|STARTED|Period 3: Phase II||24
1717953|NCT00331552|4202803|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
1717954|NCT00331552|4202804|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
1717955|NCT00331552|4202803|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
1717956|NCT00331552|4202804|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
1717957|NCT00331552|4202803|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
1717958|NCT00331552|4202804|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
1717959|NCT00331552|4202803|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
1717960|NCT00331552|4202804|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
1717961|NCT00331552|4202803|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
1717962|NCT00331552|4202804|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
1717963|NCT00331552|4202803|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
1717964|NCT00331552|4202804|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
1717965|NCT00331422|4202818|P1|NOT COMPLETED|Overall Study||5
1717966|NCT00331422|4202818|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
1717967|NCT00331422|4202818|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
1717968|NCT00331409|4202827|P1|NOT COMPLETED|Overall Study||4
1717969|NCT00331409|4202827|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
1717970|NCT00331409|4202827|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
1717971|NCT00331344|4202835|P9|NOT COMPLETED|Phase II||4
1717972|NCT00331344|4202836|P8|NOT COMPLETED|Phase II||0
1717973|NCT00331344|4202837|P7|NOT COMPLETED|Phase II||0
1717974|NCT00331344|4202838|P6|NOT COMPLETED|Phase II||0
1717975|NCT00331344|4202839|P5|NOT COMPLETED|Phase II||0
1717976|NCT00331344|4202840|P4|NOT COMPLETED|Phase II||0
1717977|NCT00331344|4202841|P3|NOT COMPLETED|Phase II||0
1717978|NCT00331344|4202842|P2|NOT COMPLETED|Phase II||0
1717979|NCT00331344|4202843|P1|NOT COMPLETED|Phase II||0
1717980|NCT00331344|4202835|P9|COMPLETED|Phase II||48
1717981|NCT00331344|4202836|P8|COMPLETED|Phase II||6
1717982|NCT00331344|4202837|P7|COMPLETED|Phase II||0
1717983|NCT00331344|4202838|P6|COMPLETED|Phase II||0
1717984|NCT00331344|4202839|P5|COMPLETED|Phase II||0
1717985|NCT00331344|4202840|P4|COMPLETED|Phase II||0
1717986|NCT00331344|4202841|P3|COMPLETED|Phase II||0
1717987|NCT00331344|4202842|P2|COMPLETED|Phase II||0
1717988|NCT00331344|4202843|P1|COMPLETED|Phase II||0
1717989|NCT00331344|4202835|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
1717990|NCT00331344|4202836|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
1717991|NCT00331344|4202837|P7|STARTED|Phase II||0
1717992|NCT00331344|4202838|P6|STARTED|Phase II||0
1717993|NCT00331344|4202839|P5|STARTED|Phase II||0
1717994|NCT00331344|4202840|P4|STARTED|Phase II||0
1717995|NCT00331344|4202841|P3|STARTED|Phase II||0
1717996|NCT00331344|4202842|P2|STARTED|Phase II||0
1717997|NCT00331344|4202843|P1|STARTED|Phase II||0
1717998|NCT00331344|4202835|P9|NOT COMPLETED|Phase I||0
1717999|NCT00331344|4202836|P8|NOT COMPLETED|Phase I||1
1718000|NCT00331344|4202837|P7|NOT COMPLETED|Phase I||0
1718001|NCT00331344|4202838|P6|NOT COMPLETED|Phase I||2
1718002|NCT00331344|4202839|P5|NOT COMPLETED|Phase I||2
1718003|NCT00331344|4202840|P4|NOT COMPLETED|Phase I||1
1718004|NCT00331344|4202841|P3|NOT COMPLETED|Phase I||0
1718005|NCT00331344|4202842|P2|NOT COMPLETED|Phase I||0
1718006|NCT00331344|4202843|P1|NOT COMPLETED|Phase I||0
1718007|NCT00331344|4202835|P9|COMPLETED|Phase I||0
1718008|NCT00331344|4202836|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
1718009|NCT00331344|4202837|P7|COMPLETED|Phase I||4
1718010|NCT00331344|4202838|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
1718011|NCT00331344|4202839|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
1718012|NCT00331344|4202840|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
1718013|NCT00331344|4202841|P3|COMPLETED|Phase I||3
1718014|NCT00331344|4202842|P2|COMPLETED|Phase I||3
1718015|NCT00331344|4202843|P1|COMPLETED|Phase I||3
1718016|NCT00331344|4202835|P9|STARTED|Phase I||0
1718017|NCT00331344|4202836|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
1718018|NCT00331344|4202837|P7|STARTED|Phase I||4
1718019|NCT00331344|4202838|P6|STARTED|Phase I||5
1718020|NCT00331344|4202839|P5|STARTED|Phase I||6
1718021|NCT00331344|4202840|P4|STARTED|Phase I||6
1718022|NCT00331344|4202841|P3|STARTED|Phase I||3
1718023|NCT00331344|4202842|P2|STARTED|Phase I||3
1718024|NCT00331344|4202843|P1|STARTED|Phase I||3
1718025|NCT00331162|4202859|P2|NOT COMPLETED|Overall Study||0
1718026|NCT00331162|4202860|P1|NOT COMPLETED|Overall Study||0
1718027|NCT00331162|4202859|P2|COMPLETED|Overall Study||109
1718028|NCT00331162|4202860|P1|COMPLETED|Overall Study||113
1718029|NCT00331162|4202859|P2|STARTED|Overall Study||109
1718030|NCT00331162|4202860|P1|STARTED|Overall Study||113
1718031|NCT00331006|4202880|P1|NOT COMPLETED|Follow-Up Phase II||3
1718032|NCT00331006|4202880|P1|COMPLETED|Follow-Up Phase II||11
1718033|NCT00331006|4202880|P1|STARTED|Follow-Up Phase II||14
1718034|NCT00331006|4202880|P1|NOT COMPLETED|Follow-Up Phase I||1
1718035|NCT00331006|4202880|P1|COMPLETED|Follow-Up Phase I||14
1718036|NCT00331006|4202880|P1|STARTED|Follow-Up Phase I||15
1718037|NCT00331006|4202880|P1|NOT COMPLETED|Treatment Phase||1
1718038|NCT00331006|4202880|P1|COMPLETED|Treatment Phase||15
1718039|NCT00331006|4202880|P1|STARTED|Treatment Phase||16
1718040|NCT00331006|4202880|P1|NOT COMPLETED|Screening Phase||7
1718041|NCT00331006|4202880|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
1718042|NCT00331006|4202880|P1|STARTED|Screening Phase||23
1718043|NCT00330967|4202893|P2|NOT COMPLETED|Overall Study||14
1718044|NCT00330967|4202894|P1|NOT COMPLETED|Overall Study||0
1718045|NCT00330967|4202893|P2|COMPLETED|Overall Study||11
1718046|NCT00330967|4202894|P1|COMPLETED|Overall Study||0
1718047|NCT00330967|4202893|P2|STARTED|Overall Study||25
1718048|NCT00330967|4202894|P1|STARTED|Overall Study||0
1718049|NCT00330928|4202905|P1|NOT COMPLETED|Overall Study||17
1718050|NCT00330928|4202905|P1|COMPLETED|Overall Study||89
1718051|NCT00330928|4202905|P1|1 Year Phone Contact|Overall Study||89
1718052|NCT00330928|4202905|P1|7 Day Phone Contact|Overall Study||99
1718053|NCT00330928|4202905|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
1718054|NCT00330915|4202910|P1|NOT COMPLETED|Overall Study||0
1718055|NCT00330915|4202910|P1|COMPLETED|Overall Study||37
1718056|NCT00330915|4202910|P1|STARTED|Overall Study||37
1718057|NCT00330876|4202917|P2|NOT COMPLETED|Overall Study||13
1718058|NCT00330876|4202918|P1|NOT COMPLETED|Overall Study||71
1718059|NCT00330876|4202917|P2|COMPLETED|Overall Study||77
1718060|NCT00330876|4202918|P1|COMPLETED|Overall Study||378
1718061|NCT00330876|4202917|P2|STARTED|Overall Study||90
1718062|NCT00330876|4202918|P1|STARTED|Overall Study||449
1718063|NCT00330863|4202928|P2|NOT COMPLETED|Overall Study||80
1718064|NCT00330863|4202929|P1|NOT COMPLETED|Overall Study||81
1718065|NCT00330863|4202928|P2|COMPLETED|Overall Study||72
1718066|NCT00330863|4202929|P1|COMPLETED|Overall Study||72
1718067|NCT00330863|4202928|P2|STARTED|Overall Study||152
1718068|NCT00330863|4202929|P1|STARTED|Overall Study||153
1718069|NCT00330759|4202947|P2|NOT COMPLETED|Overall Study||706
1718070|NCT00330759|4202948|P1|NOT COMPLETED|Overall Study||712
1718071|NCT00330759|4202947|P2|COMPLETED|Overall Study||180
1718072|NCT00330759|4202948|P1|COMPLETED|Overall Study||178
1718073|NCT00330759|4202947|P2|Received Investigational Product|Overall Study||878
1718074|NCT00330759|4202948|P1|Received Investigational Product|Overall Study||878
1718075|NCT00330759|4202947|P2|STARTED|Overall Study||886
1718076|NCT00330759|4202948|P1|STARTED|Overall Study||890
1718077|NCT00330733|4202960|P2|NOT COMPLETED|Overall Study||5
1718078|NCT00330733|4202961|P1|NOT COMPLETED|Overall Study||7
1718079|NCT00330733|4202960|P2|COMPLETED|Overall Study||29
1718080|NCT00330733|4202961|P1|COMPLETED|Overall Study||30
1718081|NCT00330733|4202960|P2|Received Study Medication|Overall Study||34
1718082|NCT00330733|4202961|P1|Received Study Medication|Overall Study||36
1718083|NCT00330733|4202960|P2|STARTED|Overall Study||34
1718084|NCT00330733|4202961|P1|STARTED|Overall Study||37
1718085|NCT00330681|4202969|P2|NOT COMPLETED|Overall Study||14
1718086|NCT00330681|4202970|P1|NOT COMPLETED|Overall Study||9
1718087|NCT00330681|4202969|P2|COMPLETED|Overall Study||90
1718088|NCT00330681|4202970|P1|COMPLETED|Overall Study||93
1718089|NCT00330681|4202969|P2|STARTED|Overall Study||104
1718090|NCT00330681|4202970|P1|STARTED|Overall Study||102
1718091|NCT00330668|4202992|P1|NOT COMPLETED|Overall Study||114
1718092|NCT00330668|4202992|P1|COMPLETED|Overall Study||0
1718093|NCT00330668|4202992|P1|STARTED|Overall Study||114
1718094|NCT00330616|4202999|P1|NOT COMPLETED|Overall Study||21
1718095|NCT00330616|4202999|P1|COMPLETED|Overall Study||14
1718096|NCT00330616|4202999|P1|STARTED|Overall Study||35
1718097|NCT00330564|4203018|P1|NOT COMPLETED|Overall Study||0
1718098|NCT00330564|4203018|P1|COMPLETED|Overall Study||15
1718099|NCT00330564|4203018|P1|STARTED|Overall Study||15
1718100|NCT00330460|4203025|P2|NOT COMPLETED|Overall Study||33
1718101|NCT00330460|4203026|P1|NOT COMPLETED|Overall Study||42
1718102|NCT00330460|4203025|P2|COMPLETED|Overall Study||561
1718103|NCT00330460|4203026|P1|COMPLETED|Overall Study||553
1718104|NCT00330460|4203025|P2|STARTED|Overall Study||594
1718105|NCT00330460|4203026|P1|STARTED|Overall Study||595
1718106|NCT00330421|4203040|P2|NOT COMPLETED|Overall Study||0
1718107|NCT00330421|4203041|P1|NOT COMPLETED|Overall Study||0
1718108|NCT00330421|4203040|P2|COMPLETED|Overall Study||0
1718109|NCT00330421|4203041|P1|COMPLETED|Overall Study||15
1718110|NCT00330421|4203040|P2|STARTED|Overall Study||0
1718111|NCT00330421|4203041|P1|STARTED|Overall Study||15
1718112|NCT00330382|4203047|P2|NOT COMPLETED|Overall Study||17
1718113|NCT00330382|4203048|P1|NOT COMPLETED|Overall Study||24
1718114|NCT00330382|4203047|P2|COMPLETED|Overall Study||48
1718115|NCT00330382|4203048|P1|COMPLETED|Overall Study||43
1718116|NCT00330382|4203047|P2|STARTED|Overall Study||65
1718117|NCT00330382|4203048|P1|STARTED|Overall Study||67
1718118|NCT00330343|4203069|P1|NOT COMPLETED|Overall Study||5
1718119|NCT00330343|4203069|P1|COMPLETED|Overall Study||59
1718120|NCT00330343|4203069|P1|STARTED|Overall Study||64
1718121|NCT00330187|4203077|P4|NOT COMPLETED|Overall Study||14
1718122|NCT00330187|4203078|P3|NOT COMPLETED|Overall Study||18
1718123|NCT00330187|4203079|P2|NOT COMPLETED|Overall Study||18
1718124|NCT00330187|4203080|P1|NOT COMPLETED|Overall Study||20
1718125|NCT00330187|4203077|P4|COMPLETED|Overall Study||18
1718126|NCT00330187|4203078|P3|COMPLETED|Overall Study||11
1718127|NCT00330187|4203079|P2|COMPLETED|Overall Study||18
1718128|NCT00330187|4203080|P1|COMPLETED|Overall Study||17
1718129|NCT00330187|4203077|P4|STARTED|Overall Study||32
1718130|NCT00330187|4203078|P3|STARTED|Overall Study||29
1718131|NCT00330187|4203079|P2|STARTED|Overall Study||36
1718132|NCT00330187|4203080|P1|STARTED|Overall Study||37
1718133|NCT00330174|4203092|P2|NOT COMPLETED|Overall Study||19
1718134|NCT00330174|4203093|P1|NOT COMPLETED|Overall Study||22
1718135|NCT00330174|4203092|P2|COMPLETED|Overall Study||26
1718136|NCT00330174|4203093|P1|COMPLETED|Overall Study||23
1718137|NCT00330174|4203092|P2|STARTED|Overall Study||45
1718138|NCT00330174|4203093|P1|STARTED|Overall Study||45
1718139|NCT00330161|4203105|P1|NOT COMPLETED|Overall Study||0
1718140|NCT00330161|4203105|P1|COMPLETED|Overall Study||29
1718141|NCT00330161|4203105|P1|STARTED|Overall Study||29
1718142|NCT00329901|4203117|P3|NOT COMPLETED|Overall Study||4
1718143|NCT00329901|4203118|P2|NOT COMPLETED|Overall Study||5
1718144|NCT00329901|4203119|P1|NOT COMPLETED|Overall Study||9
1718145|NCT00329901|4203117|P3|COMPLETED|Overall Study||353
1718146|NCT00329901|4203118|P2|COMPLETED|Overall Study||349
1718147|NCT00329901|4203119|P1|COMPLETED|Overall Study||352
1718148|NCT00329901|4203117|P3|STARTED|Overall Study||357
1718149|NCT00329901|4203118|P2|STARTED|Overall Study||354
1718150|NCT00329901|4203119|P1|STARTED|Overall Study||361
1718151|NCT00329849|4203149|P2|NOT COMPLETED|Overall Study||4
1718152|NCT00329849|4203150|P1|NOT COMPLETED|Overall Study||6
1718153|NCT00329849|4203149|P2|COMPLETED|Overall Study||546
1718154|NCT00329849|4203150|P1|COMPLETED|Overall Study||944
1718155|NCT00329849|4203149|P2|STARTED|Overall Study||550
1718156|NCT00329849|4203150|P1|STARTED|Overall Study||950
1718157|NCT00329836|4203170|P1|NOT COMPLETED|Overall Study||0
1718158|NCT00329836|4203170|P1|COMPLETED|Overall Study||41
1718159|NCT00329836|4203170|P1|STARTED|Overall Study||41
1718160|NCT00329797|4203176|P2|NOT COMPLETED|Overall Study||6
1718161|NCT00329797|4203177|P1|NOT COMPLETED|Overall Study||7
1718162|NCT00329797|4203176|P2|COMPLETED|Overall Study||46
1718163|NCT00329797|4203177|P1|COMPLETED|Overall Study||50
1718164|NCT00329797|4203176|P2|STARTED|Overall Study||52
1718165|NCT00329797|4203177|P1|STARTED|Overall Study||57
1718166|NCT00329784|4203193|P4|NOT COMPLETED|Overall Study||0
1718167|NCT00329784|4203194|P3|NOT COMPLETED|Overall Study||0
1718168|NCT00329784|4203195|P2|NOT COMPLETED|Overall Study||5
1718169|NCT00329784|4203196|P1|NOT COMPLETED|Overall Study||5
1718170|NCT00329784|4203193|P4|COMPLETED|Overall Study||47
1718171|NCT00329784|4203194|P3|COMPLETED|Overall Study||51
1718172|NCT00329784|4203195|P2|COMPLETED|Overall Study||267
1718173|NCT00329784|4203196|P1|COMPLETED|Overall Study||265
1718174|NCT00329784|4203193|P4|STARTED|Overall Study||47
1718175|NCT00329784|4203194|P3|STARTED|Overall Study||51
1718176|NCT00329784|4203195|P2|STARTED|Overall Study||272
1718177|NCT00329784|4203196|P1|STARTED|Overall Study||270
1718178|NCT00329771|4203218|P1|NOT COMPLETED|Overall Study||3
1718179|NCT00329771|4203218|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
1718180|NCT00329771|4203218|P1|STARTED|Overall Study||28
1718181|NCT00329745|4203224|P2|NOT COMPLETED|Overall Study||102
1718182|NCT00329745|4203225|P1|NOT COMPLETED|Overall Study||87
1718183|NCT00329745|4203224|P2|COMPLETED|Overall Study||4226
1718184|NCT00329745|4203225|P1|COMPLETED|Overall Study||4272
1718185|NCT00329745|4203224|P2|STARTED|Overall Study||4328
1718186|NCT00329745|4203225|P1|STARTED|Overall Study||4359
1718187|NCT00329732|4203235|P2|NOT COMPLETED|Overall Study||0
1718188|NCT00329732|4203236|P1|NOT COMPLETED|Overall Study||0
1718189|NCT00329732|4203235|P2|COMPLETED|Overall Study||0
1718190|NCT00329732|4203236|P1|COMPLETED|Overall Study||2
1718191|NCT00329732|4203235|P2|STARTED|Overall Study||0
1718192|NCT00329732|4203236|P1|STARTED|Overall Study||2
1718193|NCT00329719|4203245|P4|NOT COMPLETED|Overall Study||1
1718194|NCT00329719|4203246|P3|NOT COMPLETED|Overall Study||0
1718195|NCT00329719|4203247|P2|NOT COMPLETED|Overall Study||0
1718196|NCT00329719|4203248|P1|NOT COMPLETED|Overall Study||0
1718197|NCT00329719|4203245|P4|COMPLETED|Overall Study||44
1718198|NCT00329719|4203246|P3|COMPLETED|Overall Study||9
1718199|NCT00329719|4203247|P2|COMPLETED|Overall Study||49
1718200|NCT00329719|4203248|P1|COMPLETED|Overall Study||12
1718201|NCT00329719|4203245|P4|STARTED|Overall Study||45
1718202|NCT00329719|4203246|P3|STARTED|Overall Study||9
1718203|NCT00329719|4203247|P2|STARTED|Overall Study||49
1718204|NCT00329719|4203248|P1|STARTED|Overall Study||12
1718205|NCT00329641|4203270|P1|NOT COMPLETED|Overall Study||6
1718206|NCT00329641|4203270|P1|COMPLETED|Overall Study||19
1718207|NCT00329641|4203270|P1|Eligible and Received Treatment|Overall Study||24
1718208|NCT00329641|4203270|P1|Eligible|Overall Study||25
1718209|NCT00329641|4203270|P1|STARTED|Overall Study||25
1718210|NCT00329602|4203279|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
1718211|NCT00329602|4203280|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
1718212|NCT00329602|4203281|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
1718213|NCT00329602|4203279|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
1718214|NCT00329602|4203280|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
1718215|NCT00329602|4203281|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
1718216|NCT00329602|4203279|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
1718217|NCT00329602|4203280|P2|STARTED|40-Week Open-Label Treatment Phase||0
1718218|NCT00329602|4203281|P1|STARTED|40-Week Open-Label Treatment Phase||0
1718219|NCT00329602|4203279|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
1718220|NCT00329602|4203280|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
1718221|NCT00329602|4203281|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
1718222|NCT00329602|4203279|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
1718223|NCT00329602|4203280|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
1718224|NCT00329602|4203281|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
1718225|NCT00329602|4203279|P3|STARTED|26-Week Double-Blind Treatment Phase||0
1718226|NCT00329602|4203280|P2|STARTED|26-Week Double-Blind Treatment Phase||197
1718227|NCT00329602|4203281|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
1718228|NCT00329550|4203319|P3|NOT COMPLETED|Overall Study||4
1718229|NCT00329550|4203320|P2|NOT COMPLETED|Overall Study||4
1718230|NCT00329550|4203321|P1|NOT COMPLETED|Overall Study||4
1718231|NCT00329550|4203319|P3|COMPLETED|Overall Study||12
1718232|NCT00329550|4203320|P2|COMPLETED|Overall Study||11
1718233|NCT00329550|4203321|P1|COMPLETED|Overall Study||5
1718234|NCT00329550|4203319|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
1718235|NCT00329550|4203320|P2|STARTED|Overall Study||15
1718236|NCT00329550|4203321|P1|STARTED|Overall Study||9
1718237|NCT00329524|4203568|P1|NOT COMPLETED|Overall Study||0
1718238|NCT00329524|4203568|P1|COMPLETED|Overall Study||5
1718239|NCT00329524|4203568|P1|STARTED|Overall Study||5
1718240|NCT00329433|4203576|P2|NOT COMPLETED|Overall Study||0
1718241|NCT00329433|4203577|P1|NOT COMPLETED|Overall Study||0
1718242|NCT00329433|4203576|P2|COMPLETED|Overall Study||59
1718243|NCT00329433|4203577|P1|COMPLETED|Overall Study||61
1718244|NCT00329433|4203576|P2|STARTED|Overall Study||59
1718245|NCT00329433|4203577|P1|STARTED|Overall Study||61
1718246|NCT00329420|4203586|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
1718247|NCT00329420|4203587|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
1718248|NCT00329420|4203588|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
1718249|NCT00329420|4203586|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
1718250|NCT00329420|4203587|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
1718251|NCT00329420|4203588|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
1718252|NCT00329420|4203586|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
1718253|NCT00329420|4203587|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
1718254|NCT00329420|4203588|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
1718255|NCT00329420|4203586|P3|NOT COMPLETED|Re-induction Phase||8
1718256|NCT00329420|4203587|P2|NOT COMPLETED|Re-induction Phase||6
1718257|NCT00329420|4203588|P1|NOT COMPLETED|Re-induction Phase||6
1718258|NCT00329420|4203586|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
1718259|NCT00329420|4203587|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
1718260|NCT00329420|4203588|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
1718261|NCT00329420|4203586|P3|STARTED|Re-induction Phase||15
1718262|NCT00329420|4203587|P2|STARTED|Re-induction Phase||13
1718263|NCT00329420|4203588|P1|STARTED|Re-induction Phase||18
1718264|NCT00329407|4203967|P1|NOT COMPLETED|Overall Study||1
1718265|NCT00329407|4203967|P1|COMPLETED|Overall Study||9
1718266|NCT00329407|4203967|P1|STARTED|Overall Study||10
1718267|NCT00329238|4203974|P2|NOT COMPLETED|Overall Study||281
1718268|NCT00329238|4203975|P1|NOT COMPLETED|Overall Study||276
1718269|NCT00329238|4203974|P2|COMPLETED|Overall Study||1145
1718270|NCT00329238|4203975|P1|COMPLETED|Overall Study||1154
1718271|NCT00329238|4203974|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
1718272|NCT00329238|4203975|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
1718273|NCT00329160|4204011|P1|NOT COMPLETED|Overall Study||88
1718274|NCT00329160|4204011|P1|COMPLETED|Overall Study||126
1718275|NCT00329160|4204011|P1|Treatment Period|Overall Study||214
1718276|NCT00329160|4204011|P1|Observation Period|Overall Study||214
1718277|NCT00329160|4204011|P1|STARTED|Overall Study||214
1718278|NCT00329108|4204020|P2|NOT COMPLETED|Overall Study||12
1718279|NCT00329108|4204021|P1|NOT COMPLETED|Overall Study||10
1718280|NCT00329108|4204020|P2|COMPLETED|Overall Study||2
1718281|NCT00329108|4204021|P1|COMPLETED|Overall Study||5
1718282|NCT00329108|4204020|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
1718283|NCT00329108|4204021|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
1718284|NCT00329030|4204029|P2|NOT COMPLETED|Overall Study||6
1718285|NCT00329030|4204030|P1|NOT COMPLETED|Overall Study||8
1718286|NCT00329030|4204029|P2|COMPLETED|Overall Study||107
1718287|NCT00329030|4204030|P1|COMPLETED|Overall Study||103
1718288|NCT00329030|4204029|P2|STARTED|Overall Study||113
1718289|NCT00329030|4204030|P1|STARTED|Overall Study||111
1718290|NCT00328926|4204061|P3|NOT COMPLETED|Overall Study||2
1718291|NCT00328926|4204062|P2|NOT COMPLETED|Overall Study||3
1718292|NCT00328926|4204063|P1|NOT COMPLETED|Overall Study||2
1718293|NCT00328926|4204061|P3|COMPLETED|Overall Study||1
1718294|NCT00328926|4204062|P2|COMPLETED|Overall Study||0
1718295|NCT00328926|4204063|P1|COMPLETED|Overall Study||3
1718296|NCT00328926|4204061|P3|STARTED|Overall Study||3
1718297|NCT00328926|4204062|P2|STARTED|Overall Study||3
1718298|NCT00328926|4204063|P1|STARTED|Overall Study||5
1718299|NCT00328861|4204079|P2|NOT COMPLETED|Overall Study||0
1718300|NCT00328861|4204080|P1|NOT COMPLETED|Overall Study||0
1718301|NCT00328861|4204079|P2|COMPLETED|Overall Study||1
1718302|NCT00328861|4204080|P1|COMPLETED|Overall Study||7
1718303|NCT00328861|4204079|P2|STARTED|Overall Study||1
1718304|NCT00328861|4204080|P1|STARTED|Overall Study||7
1718305|NCT00328783|4204088|P1|NOT COMPLETED|Overall Study||26
1718306|NCT00328783|4204088|P1|COMPLETED|Overall Study||86
1718307|NCT00328783|4204088|P1|STARTED|Overall Study||112
1718308|NCT00328770|4204096|P1|NOT COMPLETED|Overall Study||0
1718309|NCT00328770|4204096|P1|COMPLETED|Overall Study||70
1718310|NCT00328770|4204096|P1|STARTED|Overall Study||70
1718311|NCT00328627|4204114|P12|NOT COMPLETED|Overall Study||16
1718312|NCT00328627|4204115|P11|NOT COMPLETED|Overall Study||18
1718313|NCT00328627|4204116|P10|NOT COMPLETED|Overall Study||32
1718314|NCT00328627|4204117|P9|NOT COMPLETED|Overall Study||17
1718315|NCT00328627|4204118|P8|NOT COMPLETED|Overall Study||14
1718316|NCT00328627|4204119|P7|NOT COMPLETED|Overall Study||35
1718317|NCT00328627|4204120|P6|NOT COMPLETED|Overall Study||20
1718318|NCT00328627|4204121|P5|NOT COMPLETED|Overall Study||15
1718319|NCT00328627|4204122|P4|NOT COMPLETED|Overall Study||37
1718320|NCT00328627|4204123|P3|NOT COMPLETED|Overall Study||28
1718321|NCT00328627|4204124|P2|NOT COMPLETED|Overall Study||31
1718322|NCT00328627|4204125|P1|NOT COMPLETED|Overall Study||59
1718323|NCT00328627|4204114|P12|COMPLETED|Overall Study||114
1718324|NCT00328627|4204115|P11|COMPLETED|Overall Study||112
1718325|NCT00328627|4204116|P10|COMPLETED|Overall Study||97
1718326|NCT00328627|4204117|P9|COMPLETED|Overall Study||113
1718327|NCT00328627|4204118|P8|COMPLETED|Overall Study||116
1718328|NCT00328627|4204119|P7|COMPLETED|Overall Study||94
1718329|NCT00328627|4204120|P6|COMPLETED|Overall Study||110
1718330|NCT00328627|4204121|P5|COMPLETED|Overall Study||115
1718331|NCT00328627|4204122|P4|COMPLETED|Overall Study||93
1718332|NCT00328627|4204123|P3|COMPLETED|Overall Study||101
1718333|NCT00328627|4204124|P2|COMPLETED|Overall Study||97
1718334|NCT00328627|4204125|P1|COMPLETED|Overall Study||70
1718335|NCT00328627|4204114|P12|Safety Set|Overall Study||130
1718336|NCT00328627|4204115|P11|Safety Set|Overall Study||130
1718337|NCT00328627|4204116|P10|Safety Set|Overall Study||129
1718338|NCT00328627|4204117|P9|Safety Set|Overall Study||130
1718339|NCT00328627|4204118|P8|Safety Set|Overall Study||130
1718340|NCT00328627|4204119|P7|Safety Set|Overall Study||129
1718341|NCT00328627|4204120|P6|Safety Set|Overall Study||130
1718342|NCT00328627|4204121|P5|Safety Set|Overall Study||130
1718343|NCT00328627|4204122|P4|Safety Set|Overall Study||129
1718344|NCT00328627|4204123|P3|Safety Set|Overall Study||129
1718345|NCT00328627|4204124|P2|Safety Set|Overall Study||128
1718346|NCT00328627|4204125|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
1718347|NCT00328627|4204114|P12|STARTED|Overall Study||130
1718348|NCT00328627|4204115|P11|STARTED|Overall Study||130
1718349|NCT00328627|4204116|P10|STARTED|Overall Study||129
1718350|NCT00328627|4204117|P9|STARTED|Overall Study||130
1718351|NCT00328627|4204118|P8|STARTED|Overall Study||130
1718352|NCT00328627|4204119|P7|STARTED|Overall Study||129
1718353|NCT00328627|4204120|P6|STARTED|Overall Study||130
1718354|NCT00328627|4204121|P5|STARTED|Overall Study||130
1718355|NCT00328627|4204122|P4|STARTED|Overall Study||130
1718356|NCT00328627|4204123|P3|STARTED|Overall Study||129
1718357|NCT00328627|4204124|P2|STARTED|Overall Study||128
1718358|NCT00328627|4204125|P1|STARTED|Overall Study||129
1718359|NCT00328614|4205648|P6|NOT COMPLETED|Overall Study||1
1718360|NCT00328614|4205649|P5|NOT COMPLETED|Overall Study||1
1718361|NCT00328614|4205650|P4|NOT COMPLETED|Overall Study||1
1718362|NCT00328614|4205651|P3|NOT COMPLETED|Overall Study||0
1718363|NCT00328614|4205652|P2|NOT COMPLETED|Overall Study||0
1718364|NCT00328614|4205653|P1|NOT COMPLETED|Overall Study||0
1718365|NCT00328614|4205648|P6|COMPLETED|Overall Study||5
1718366|NCT00328614|4205649|P5|COMPLETED|Overall Study||5
1718367|NCT00328614|4205650|P4|COMPLETED|Overall Study||5
1718368|NCT00328614|4205651|P3|COMPLETED|Overall Study||6
1718369|NCT00328614|4205652|P2|COMPLETED|Overall Study||4
1718370|NCT00328614|4205653|P1|COMPLETED|Overall Study||4
1718371|NCT00328614|4205648|P6|STARTED|Overall Study||6
1718372|NCT00328614|4205649|P5|STARTED|Overall Study||6
1718373|NCT00328614|4205650|P4|STARTED|Overall Study||6
1718374|NCT00328614|4205651|P3|STARTED|Overall Study||6
1718375|NCT00328614|4205652|P2|STARTED|Overall Study||4
1718376|NCT00328614|4205653|P1|STARTED|Overall Study||4
1718377|NCT00328562|4205662|P1|NOT COMPLETED|Overall Study||1
1718378|NCT00328562|4205662|P1|COMPLETED|Overall Study||12
1718379|NCT00328562|4205662|P1|STARTED|Overall Study||13
1718380|NCT00328510|4205671|P2|NOT COMPLETED|Overall Study||4
1718381|NCT00328510|4205672|P1|NOT COMPLETED|Overall Study||10
1718382|NCT00328510|4205671|P2|COMPLETED|Overall Study||37
1718383|NCT00328510|4205672|P1|COMPLETED|Overall Study||32
1718384|NCT00328510|4205671|P2|STARTED|Overall Study||41
1718385|NCT00328510|4205672|P1|STARTED|Overall Study||42
1718386|NCT00328263|4205680|P2|NOT COMPLETED|Overall Study||4
1718387|NCT00328263|4205681|P1|NOT COMPLETED|Overall Study||3
1718388|NCT00328263|4205680|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
1718389|NCT00328263|4205681|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
1718390|NCT00328263|4205680|P2|STARTED|Overall Study||221
1718391|NCT00328263|4205681|P1|STARTED|Overall Study||216
1718392|NCT00328198|4205687|P1|NOT COMPLETED|Follow-up||35
1718393|NCT00328198|4205687|P1|COMPLETED|Follow-up||43
1718394|NCT00328198|4205687|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
1718395|NCT00328198|4205687|P1|NOT COMPLETED|Treatment||38
1718396|NCT00328198|4205687|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
1718397|NCT00328198|4205687|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
1718398|NCT00328172|4205702|P5|NOT COMPLETED|Overall Study||5
1718399|NCT00328172|4205703|P4|NOT COMPLETED|Overall Study||13
1718400|NCT00328172|4205704|P3|NOT COMPLETED|Overall Study||10
1718401|NCT00328172|4205705|P2|NOT COMPLETED|Overall Study||14
1718402|NCT00328172|4205706|P1|NOT COMPLETED|Overall Study||22
1718403|NCT00328172|4205702|P5|COMPLETED|Overall Study||60
1718404|NCT00328172|4205703|P4|COMPLETED|Overall Study||42
1718405|NCT00328172|4205704|P3|COMPLETED|Overall Study||47
1718406|NCT00328172|4205705|P2|COMPLETED|Overall Study||44
1718407|NCT00328172|4205706|P1|COMPLETED|Overall Study||45
1718408|NCT00328172|4205702|P5|STARTED|Overall Study||65
1718409|NCT00328172|4205703|P4|STARTED|Overall Study||55
1718410|NCT00328172|4205704|P3|STARTED|Overall Study||57
1718411|NCT00328172|4205705|P2|STARTED|Overall Study||58
1718412|NCT00328172|4205706|P1|STARTED|Overall Study||67
1718413|NCT00328094|4205730|P2|NOT COMPLETED|Overall Study||3
1718414|NCT00328094|4205731|P1|NOT COMPLETED|Overall Study||3
1718415|NCT00328094|4205730|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
1718416|NCT00328094|4205731|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
1718417|NCT00328094|4205730|P2|STARTED|Overall Study||125
1718418|NCT00328094|4205731|P1|STARTED|Overall Study||117
1718419|NCT00328042|4205741|P2|NOT COMPLETED|Overall Study||2
1718420|NCT00328042|4205742|P1|NOT COMPLETED|Overall Study||0
1718421|NCT00328042|4205741|P2|COMPLETED|Overall Study||63
1718422|NCT00328042|4205742|P1|COMPLETED|Overall Study||69
1718423|NCT00328042|4205741|P2|STARTED|Overall Study||65
1718424|NCT00328042|4205742|P1|STARTED|Overall Study||69
1718425|NCT00328016|4205752|P2|NOT COMPLETED|Overall Study||0
1718426|NCT00328016|4205753|P1|NOT COMPLETED|Overall Study||0
1718427|NCT00328016|4205752|P2|COMPLETED|Overall Study||21
1718428|NCT00328016|4205753|P1|COMPLETED|Overall Study||23
1718429|NCT00328016|4205752|P2|STARTED|Overall Study||21
1718430|NCT00328016|4205753|P1|STARTED|Overall Study||23
1718431|NCT00327717|4205765|P2|NOT COMPLETED|Overall Study||14
1718432|NCT00327717|4205766|P1|NOT COMPLETED|Overall Study||9
1718433|NCT00327717|4205765|P2|COMPLETED|Overall Study||106
1718434|NCT00327717|4205766|P1|COMPLETED|Overall Study||111
1718435|NCT00327717|4205765|P2|STARTED|Overall Study||120
1718436|NCT00327717|4205766|P1|STARTED|Overall Study||120
1718437|NCT00327470|4205792|P2|NOT COMPLETED|Overall Study||63
1718438|NCT00327470|4205793|P1|NOT COMPLETED|Overall Study||29
1718439|NCT00327470|4205792|P2|COMPLETED|Overall Study||118
1718440|NCT00327470|4205793|P1|COMPLETED|Overall Study||78
1718441|NCT00327470|4205792|P2|Treated|Overall Study||179
1718442|NCT00327470|4205793|P1|Treated|Overall Study||107
1718443|NCT00327470|4205792|P2|STARTED|Overall Study||181
1718444|NCT00327470|4205793|P1|STARTED|Overall Study||107
1718445|NCT00327444|4205813|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
1718446|NCT00327444|4205814|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
1718447|NCT00327444|4205813|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
1718448|NCT00327444|4205814|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
1718449|NCT00327444|4205813|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
1718450|NCT00327444|4205814|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
1718451|NCT00327444|4205813|P2|STARTED|Open Label Treatment (OL) Period||10
1718452|NCT00327444|4205814|P1|STARTED|Open Label Treatment (OL) Period||11
1718453|NCT00327444|4205813|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
1718454|NCT00327444|4205814|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
1718455|NCT00327444|4205813|P2|COMPLETED|Double Blind Treatment (DB) Period||0
1718456|NCT00327444|4205814|P1|COMPLETED|Double Blind Treatment (DB) Period||0
1718457|NCT00327444|4205813|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
1718458|NCT00327444|4205814|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
1718459|NCT00327444|4205813|P2|STARTED|Double Blind Treatment (DB) Period||29
1718460|NCT00327444|4205814|P1|STARTED|Double Blind Treatment (DB) Period||26
1718461|NCT00327392|4205826|P1|NOT COMPLETED|Overall Study||0
1718462|NCT00327392|4205826|P1|COMPLETED|Overall Study||123
1718463|NCT00327392|4205826|P1|STARTED|Overall Study||123
1718464|NCT00327340|4205832|P2|NOT COMPLETED|Overall Study||30
1718465|NCT00327340|4205833|P1|NOT COMPLETED|Overall Study||15
1718466|NCT00327340|4205832|P2|COMPLETED|Overall Study||16
1718467|NCT00327340|4205833|P1|COMPLETED|Overall Study||8
1718468|NCT00327340|4205832|P2|STARTED|Overall Study||46
1718469|NCT00327340|4205833|P1|STARTED|Overall Study||23
1718470|NCT00327171|4205847|P2|NOT COMPLETED|Overall Study||109
1718471|NCT00327171|4205848|P1|NOT COMPLETED|Overall Study||108
1718472|NCT00327171|4205847|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
1718473|NCT00327171|4205848|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
1718474|NCT00327171|4205847|P2|STARTED|Overall Study||109
1718475|NCT00327171|4205848|P1|STARTED|Overall Study||109
1718476|NCT00327015|4205880|P4|NOT COMPLETED|Overall Study||109
1718477|NCT00327015|4205881|P3|NOT COMPLETED|Overall Study||126
1718478|NCT00327015|4205882|P2|NOT COMPLETED|Overall Study||92
1718479|NCT00327015|4205883|P1|NOT COMPLETED|Overall Study||91
1718480|NCT00327015|4205880|P4|COMPLETED|Overall Study||219
1718481|NCT00327015|4205881|P3|COMPLETED|Overall Study||209
1718482|NCT00327015|4205882|P2|COMPLETED|Overall Study||231
1718483|NCT00327015|4205883|P1|COMPLETED|Overall Study||229
1718484|NCT00327015|4205880|P4|Completed Study Without Being Rescued|Overall Study||144
1718485|NCT00327015|4205881|P3|Completed Study Without Being Rescued|Overall Study||113
1718486|NCT00327015|4205882|P2|Completed Study Without Being Rescued|Overall Study||177
1718487|NCT00327015|4205883|P1|Completed Study Without Being Rescued|Overall Study||179
1718488|NCT00327015|4205880|P4|STARTED|Overall Study||328
1718489|NCT00327015|4205881|P3|STARTED|Overall Study||335
1718490|NCT00327015|4205882|P2|STARTED|Overall Study||323
1718491|NCT00327015|4205883|P1|STARTED|Overall Study||320
1718492|NCT00326963|4205925|P1|NOT COMPLETED|Overall Study||33
1718493|NCT00326963|4205925|P1|COMPLETED|Overall Study||107
1718494|NCT00326963|4205925|P1|STARTED|Overall Study||140
1718495|NCT00326950|4205945|P1|NOT COMPLETED|Overall Study||1
1718496|NCT00326950|4205945|P1|COMPLETED|Overall Study||14
1718497|NCT00326950|4205945|P1|STARTED|Overall Study||15
1718498|NCT00326924|4205952|P2|NOT COMPLETED|Overall Study||1
1718499|NCT00326924|4205953|P1|NOT COMPLETED|Overall Study||1
1718500|NCT00326924|4205952|P2|COMPLETED|Overall Study||188
1718501|NCT00326924|4205953|P1|COMPLETED|Overall Study||187
1718502|NCT00326924|4205952|P2|STARTED|Overall Study||189
1718503|NCT00326924|4205953|P1|STARTED|Overall Study||188
1718504|NCT00326911|4205967|P2|NOT COMPLETED|Overall Study||2
1718505|NCT00326911|4205968|P1|NOT COMPLETED|Overall Study||1
1718506|NCT00326911|4205967|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
1718507|NCT00326911|4205968|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
1718508|NCT00326911|4205967|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
1718509|NCT00326911|4205968|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
1718510|NCT00326898|4206021|P3|NOT COMPLETED|Overall Study||203
1718511|NCT00326898|4206022|P2|NOT COMPLETED|Overall Study||343
1718512|NCT00326898|4206023|P1|NOT COMPLETED|Overall Study||351
1718513|NCT00326898|4206021|P3|COMPLETED|Overall Study||444
1718514|NCT00326898|4206022|P2|COMPLETED|Overall Study||306
1718515|NCT00326898|4206023|P1|COMPLETED|Overall Study||296
1718516|NCT00326898|4206021|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
1718517|NCT00326898|4206022|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
1718518|NCT00326898|4206023|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
1718519|NCT00326898|4206021|P3|Patients With Clear Cell Histology|Overall Study||540
1718520|NCT00326898|4206022|P2|Patients With Clear Cell Histology|Overall Study||540
1718521|NCT00326898|4206023|P1|Patients With Clear Cell Histology|Overall Study||542
1718522|NCT00326898|4206021|P3|Patients With Toxicity Data|Overall Study||626
1718523|NCT00326898|4206022|P2|Patients With Toxicity Data|Overall Study||628
1718524|NCT00326898|4206023|P1|Patients With Toxicity Data|Overall Study||625
1718525|NCT00326898|4206021|P3|STARTED|Overall Study||647
1718526|NCT00326898|4206022|P2|STARTED|Overall Study||649
1718527|NCT00326898|4206023|P1|STARTED|Overall Study||647
1718528|NCT00326885|4206040|P1|NOT COMPLETED|Overall Study||7
1718529|NCT00326885|4206040|P1|COMPLETED|Overall Study||25
1718530|NCT00326885|4206040|P1|STARTED|Overall Study||32
1718531|NCT00326872|4206049|P1|NOT COMPLETED|Overall Study||0
1718532|NCT00326872|4206049|P1|COMPLETED|Overall Study||26
1718533|NCT00326872|4206049|P1|STARTED|Overall Study||26
1718534|NCT00326781|4206060|P2|NOT COMPLETED|Overall Study||32
1718535|NCT00326781|4206061|P1|NOT COMPLETED|Overall Study||42
1718536|NCT00326781|4206060|P2|COMPLETED|Overall Study||298
1718537|NCT00326781|4206061|P1|COMPLETED|Overall Study||302
1718538|NCT00326781|4206060|P2|STARTED|Overall Study||330
1718539|NCT00326781|4206061|P1|STARTED|Overall Study||344
1718540|NCT00326716|4206071|P4|NOT COMPLETED|Infants||0
1718541|NCT00326716|4206072|P3|NOT COMPLETED|Infants||0
1718542|NCT00326716|4206073|P2|NOT COMPLETED|Infants||0
1718543|NCT00326716|4206074|P1|NOT COMPLETED|Infants||0
1718544|NCT00326716|4206071|P4|COMPLETED|Infants||20
1718545|NCT00326716|4206072|P3|COMPLETED|Infants||20
1718546|NCT00326716|4206073|P2|COMPLETED|Infants||0
1718547|NCT00326716|4206074|P1|COMPLETED|Infants||0
1718548|NCT00326716|4206071|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
1718549|NCT00326716|4206072|P3|STARTED|Infants|All infants were followed.|20
1718550|NCT00326716|4206073|P2|STARTED|Infants||0
1718551|NCT00326716|4206074|P1|STARTED|Infants||0
1718552|NCT00326716|4206071|P4|NOT COMPLETED|Pre-Natal Mothers||0
1718553|NCT00326716|4206072|P3|NOT COMPLETED|Pre-Natal Mothers||0
1718554|NCT00326716|4206073|P2|NOT COMPLETED|Pre-Natal Mothers||2
1718555|NCT00326716|4206074|P1|NOT COMPLETED|Pre-Natal Mothers||1
1718556|NCT00326716|4206071|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
1718557|NCT00326716|4206072|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
1718558|NCT00326716|4206073|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
1718559|NCT00326716|4206074|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
1718560|NCT00326716|4206071|P4|STARTED|Pre-Natal Mothers||0
1718561|NCT00326716|4206072|P3|STARTED|Pre-Natal Mothers||0
1718562|NCT00326716|4206073|P2|STARTED|Pre-Natal Mothers||21
1718563|NCT00326716|4206074|P1|STARTED|Pre-Natal Mothers||20
1718564|NCT00326612|4206146|P2|NOT COMPLETED|Overall Study||137
1718565|NCT00326612|4206147|P1|NOT COMPLETED|Overall Study||129
1718566|NCT00326612|4206146|P2|COMPLETED|Overall Study||42
1718567|NCT00326612|4206147|P1|COMPLETED|Overall Study||50
1718568|NCT00326612|4206146|P2|STARTED|Overall Study||179
1718569|NCT00326612|4206147|P1|STARTED|Overall Study||179
1718570|NCT00326599|4206169|P4|NOT COMPLETED|Overall Study||19
1718571|NCT00326599|4206170|P3|NOT COMPLETED|Overall Study||53
1718572|NCT00326599|4206171|P2|NOT COMPLETED|Overall Study||1
1718573|NCT00326599|4206172|P1|NOT COMPLETED|Overall Study||6
1718574|NCT00326599|4206169|P4|COMPLETED|Overall Study||10
1718575|NCT00326599|4206170|P3|COMPLETED|Overall Study||5
1718576|NCT00326599|4206171|P2|COMPLETED|Overall Study||2
1718577|NCT00326599|4206172|P1|COMPLETED|Overall Study||0
1718578|NCT00326599|4206169|P4|STARTED|Overall Study||29
1718579|NCT00326599|4206170|P3|STARTED|Overall Study||58
1718580|NCT00326599|4206171|P2|STARTED|Overall Study||3
1718581|NCT00326599|4206172|P1|STARTED|Overall Study||6
1718582|NCT00326495|4206191|P1|NOT COMPLETED|Overall Study||5
1718583|NCT00326495|4206191|P1|COMPLETED|Overall Study||46
1718584|NCT00326495|4206191|P1|STARTED|Overall Study||51
1718585|NCT00326417|4206198|P4|NOT COMPLETED|Overall Study||3
1718586|NCT00326417|4206199|P3|NOT COMPLETED|Overall Study||1
1718587|NCT00326417|4206200|P2|NOT COMPLETED|Overall Study||0
1718588|NCT00326417|4206201|P1|NOT COMPLETED|Overall Study||14
1718589|NCT00326417|4206198|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
1718590|NCT00326417|4206199|P3|COMPLETED|Overall Study||38
1718591|NCT00326417|4206200|P2|COMPLETED|Overall Study||41
1718592|NCT00326417|4206201|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
1718593|NCT00326417|4206198|P4|Phase II|Overall Study||0
1718594|NCT00326417|4206199|P3|Phase II|Overall Study||33
1718595|NCT00326417|4206200|P2|Phase II|Overall Study||35
1718596|NCT00326417|4206201|P1|Phase II|Overall Study||8
1718597|NCT00326417|4206198|P4|Phase I|Overall Study||3
1718598|NCT00326417|4206199|P3|Phase I|Overall Study||6
1718599|NCT00326417|4206200|P2|Phase I|Overall Study||6
1718600|NCT00326417|4206201|P1|Phase I|Overall Study||6
1718601|NCT00326417|4206198|P4|STARTED|Overall Study||3
1718602|NCT00326417|4206199|P3|STARTED|Overall Study||39
1718603|NCT00326417|4206200|P2|STARTED|Overall Study||41
1718604|NCT00326417|4206201|P1|STARTED|Overall Study||14
1718605|NCT00326196|4206219|P2|NOT COMPLETED|Overall Study||0
1718606|NCT00326196|4206220|P1|NOT COMPLETED|Overall Study||0
1718607|NCT00326196|4206219|P2|COMPLETED|Overall Study||97
1718608|NCT00326196|4206220|P1|COMPLETED|Overall Study||101
1718609|NCT00326196|4206219|P2|STARTED|Overall Study||97
1718610|NCT00326196|4206220|P1|STARTED|Overall Study||101
1718611|NCT00326183|4206228|P2|NOT COMPLETED|Overall Study||83
1718612|NCT00326183|4206229|P1|NOT COMPLETED|Overall Study||200
1718613|NCT00326183|4206228|P2|COMPLETED|Overall Study||264
1718614|NCT00326183|4206229|P1|COMPLETED|Overall Study||1253
1718615|NCT00326183|4206228|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
1718616|NCT00326183|4206229|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
1718617|NCT00326183|4206228|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
1718618|NCT00326183|4206229|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
1718619|NCT00326183|4206228|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
1718620|NCT00326183|4206229|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
1718621|NCT00326183|4206228|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
1718622|NCT00326183|4206229|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
1718623|NCT00326183|4206228|P2|STARTED|Overall Study||347
1718624|NCT00326183|4206229|P1|STARTED|Overall Study||1453
1718625|NCT00326170|4206255|P1|NOT COMPLETED|Overall Study||0
1718626|NCT00326170|4206255|P1|COMPLETED|Overall Study||34
1718627|NCT00326170|4206255|P1|STARTED|Overall Study||34
1718628|NCT00326118|4206261|P2|NOT COMPLETED|Year 5 Follow up||0
1718629|NCT00326118|4206262|P1|NOT COMPLETED|Year 5 Follow up||0
1718630|NCT00326118|4206261|P2|COMPLETED|Year 5 Follow up||78
1718631|NCT00326118|4206262|P1|COMPLETED|Year 5 Follow up||217
1718632|NCT00326118|4206261|P2|STARTED|Year 5 Follow up||78
1718633|NCT00326118|4206262|P1|STARTED|Year 5 Follow up||217
1718634|NCT00326118|4206261|P2|NOT COMPLETED|Year 4 Follow-up||0
1718635|NCT00326118|4206262|P1|NOT COMPLETED|Year 4 Follow-up||0
1718636|NCT00326118|4206261|P2|COMPLETED|Year 4 Follow-up||80
1718637|NCT00326118|4206262|P1|COMPLETED|Year 4 Follow-up||228
1718638|NCT00326118|4206261|P2|STARTED|Year 4 Follow-up||80
1718639|NCT00326118|4206262|P1|STARTED|Year 4 Follow-up||228
1718640|NCT00326118|4206261|P2|NOT COMPLETED|Year 3 Follow-up||0
1718641|NCT00326118|4206262|P1|NOT COMPLETED|Year 3 Follow-up||0
1718642|NCT00326118|4206261|P2|COMPLETED|Year 3 Follow-up||89
1718643|NCT00326118|4206262|P1|COMPLETED|Year 3 Follow-up||256
1718644|NCT00326118|4206261|P2|STARTED|Year 3 Follow-up||89
1718645|NCT00326118|4206262|P1|STARTED|Year 3 Follow-up||256
1718646|NCT00326118|4206261|P2|NOT COMPLETED|Year 2 Follow-up||0
1718647|NCT00326118|4206262|P1|NOT COMPLETED|Year 2 Follow-up||0
1718648|NCT00326118|4206261|P2|COMPLETED|Year 2 Follow-up||92
1718649|NCT00326118|4206262|P1|COMPLETED|Year 2 Follow-up||270
1718650|NCT00326118|4206261|P2|STARTED|Year 2 Follow-up||92
1718651|NCT00326118|4206262|P1|STARTED|Year 2 Follow-up||270
1718652|NCT00326118|4206261|P2|NOT COMPLETED|Year 1 Follow-up||0
1718653|NCT00326118|4206262|P1|NOT COMPLETED|Year 1 Follow-up||0
1718654|NCT00326118|4206261|P2|COMPLETED|Year 1 Follow-up||100
1718655|NCT00326118|4206262|P1|COMPLETED|Year 1 Follow-up||295
1718656|NCT00326118|4206261|P2|STARTED|Year 1 Follow-up||100
1718657|NCT00326118|4206262|P1|STARTED|Year 1 Follow-up||295
1718658|NCT00326118|4206261|P2|NOT COMPLETED|Active Phase||1
1718659|NCT00326118|4206262|P1|NOT COMPLETED|Active Phase||4
1718660|NCT00326118|4206261|P2|COMPLETED|Active Phase||108
1718661|NCT00326118|4206262|P1|COMPLETED|Active Phase||320
1718662|NCT00326118|4206261|P2|STARTED|Active Phase||109
1718663|NCT00326118|4206262|P1|STARTED|Active Phase||324
1718664|NCT00326001|4206298|P2|NOT COMPLETED|Overall Study||8
1718665|NCT00326001|4206299|P1|NOT COMPLETED|Overall Study||7
1718666|NCT00326001|4206298|P2|COMPLETED|Overall Study||219
1718667|NCT00326001|4206299|P1|COMPLETED|Overall Study||229
1718668|NCT00326001|4206298|P2|STARTED|Overall Study||227
1718669|NCT00326001|4206299|P1|STARTED|Overall Study||236
1718670|NCT00325897|4206313|P2|NOT COMPLETED|Overall Study||13
1718671|NCT00325897|4206314|P1|NOT COMPLETED|Overall Study||12
1718672|NCT00325897|4206313|P2|COMPLETED|Overall Study||559
1718673|NCT00325897|4206314|P1|COMPLETED|Overall Study||558
1718674|NCT00325897|4206313|P2|STARTED|Overall Study||572
1718675|NCT00325897|4206314|P1|STARTED|Overall Study||570
1718676|NCT00325819|4206334|P2|NOT COMPLETED|Overall Study||13
1718677|NCT00325819|4206335|P1|NOT COMPLETED|Overall Study||9
1718678|NCT00325819|4206334|P2|COMPLETED|Overall Study||176
1718679|NCT00325819|4206335|P1|COMPLETED|Overall Study||176
1718680|NCT00325819|4206334|P2|STARTED|Overall Study||189
1718681|NCT00325819|4206335|P1|STARTED|Overall Study||185
1718682|NCT00325780|4206355|P1|NOT COMPLETED|Overall Study||155
1718683|NCT00325780|4206355|P1|COMPLETED|Overall Study||1200
1718684|NCT00325780|4206355|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
1718685|NCT00325780|4206355|P1|STARTED|Overall Study||1355
1718686|NCT00325754|4206362|P2|NOT COMPLETED|Overall Study||1
1718687|NCT00325754|4206363|P1|NOT COMPLETED|Overall Study||4
1718688|NCT00325754|4206362|P2|COMPLETED|Overall Study||10
1718689|NCT00325754|4206363|P1|COMPLETED|Overall Study||7
1718690|NCT00325754|4206362|P2|STARTED|Overall Study||11
1718691|NCT00325754|4206363|P1|STARTED|Overall Study||11
1718692|NCT00325598|4206379|P2|NOT COMPLETED|Overall Study||0
1718693|NCT00325598|4206380|P1|NOT COMPLETED|Overall Study||0
1718694|NCT00325598|4206379|P2|COMPLETED|Overall Study||50
1718695|NCT00325598|4206380|P1|COMPLETED|Overall Study||50
1718696|NCT00325598|4206379|P2|STARTED|Overall Study||50
1718697|NCT00325598|4206380|P1|STARTED|Overall Study||50
1718698|NCT00325468|4206409|P5|NOT COMPLETED|Overall Study||8
1718699|NCT00325468|4206410|P4|NOT COMPLETED|Overall Study||34
1718700|NCT00325468|4206411|P3|NOT COMPLETED|Overall Study||4
1718701|NCT00325468|4206412|P2|NOT COMPLETED|Overall Study||5
1718702|NCT00325468|4206413|P1|NOT COMPLETED|Overall Study||11
1718703|NCT00325468|4206409|P5|COMPLETED|Overall Study||14
1718704|NCT00325468|4206410|P4|COMPLETED|Overall Study||90
1718705|NCT00325468|4206411|P3|COMPLETED|Overall Study||10
1718706|NCT00325468|4206412|P2|COMPLETED|Overall Study||12
1718707|NCT00325468|4206413|P1|COMPLETED|Overall Study||12
1718708|NCT00325468|4206409|P5|STARTED|Overall Study||22
1718709|NCT00325468|4206410|P4|STARTED|Overall Study||124
1718710|NCT00325468|4206411|P3|STARTED|Overall Study||14
1718711|NCT00325468|4206412|P2|STARTED|Overall Study||17
1718712|NCT00325468|4206413|P1|STARTED|Overall Study||23
1718713|NCT00325442|4206448|P2|NOT COMPLETED|Overall Study||21
1718714|NCT00325442|4206449|P1|NOT COMPLETED|Overall Study||9
1718715|NCT00325442|4206448|P2|COMPLETED|Overall Study||153
1718716|NCT00325442|4206449|P1|COMPLETED|Overall Study||167
1718717|NCT00325442|4206448|P2|STARTED|Overall Study||174
1718718|NCT00325442|4206449|P1|STARTED|Overall Study||176
1718719|NCT00325416|4206496|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
1718720|NCT00325416|4206497|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
1718721|NCT00325416|4206496|P2|COMPLETED|Phase II: Treatment at MTD||40
1718722|NCT00325416|4206497|P1|COMPLETED|Phase II: Treatment at MTD||78
1718723|NCT00325416|4206496|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
1718724|NCT00325416|4206497|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
1718725|NCT00325416|4206496|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
1718726|NCT00325416|4206497|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
1718727|NCT00325416|4206496|P2|STARTED|Phase II: Treatment at MTD||42
1718728|NCT00325416|4206497|P1|STARTED|Phase II: Treatment at MTD||78
1718729|NCT00325416|4206496|P2|NOT COMPLETED|Phase I: Dose Escalation||16
1718730|NCT00325416|4206497|P1|NOT COMPLETED|Phase I: Dose Escalation||22
1718731|NCT00325416|4206496|P2|COMPLETED|Phase I: Dose Escalation||44
1718732|NCT00325416|4206497|P1|COMPLETED|Phase I: Dose Escalation||48
1718733|NCT00325416|4206496|P2|STARTED|Phase I: Dose Escalation||60
1718734|NCT00325416|4206497|P1|STARTED|Phase I: Dose Escalation||70
1718735|NCT00325403|4206511|P2|NOT COMPLETED|Overall Study||51
1718736|NCT00325403|4206512|P1|NOT COMPLETED|Overall Study||18
1718737|NCT00325403|4206511|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
1718738|NCT00325403|4206512|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
1718739|NCT00325403|4206511|P2|STARTED|Overall Study||233
1718740|NCT00325403|4206512|P1|STARTED|Overall Study||116
1718741|NCT00325234|4206550|P2|NOT COMPLETED|Overall Study||66
1718742|NCT00325234|4206551|P1|NOT COMPLETED|Overall Study||69
1718743|NCT00325234|4206550|P2|COMPLETED|Overall Study||0
1718744|NCT00325234|4206551|P1|COMPLETED|Overall Study||0
1718745|NCT00325234|4206550|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
1718746|NCT00325234|4206551|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
1718747|NCT00325234|4206550|P2|STARTED|Overall Study||66
1718748|NCT00325234|4206551|P1|STARTED|Overall Study||69
1718749|NCT00325195|4206570|P3|NOT COMPLETED|Received Intervention: ITT Population||4
1718750|NCT00325195|4206571|P2|NOT COMPLETED|Received Intervention: ITT Population||25
1718751|NCT00325195|4206572|P1|NOT COMPLETED|Received Intervention: ITT Population||26
1718752|NCT00325195|4206570|P3|COMPLETED|Received Intervention: ITT Population||39
1718753|NCT00325195|4206571|P2|COMPLETED|Received Intervention: ITT Population||59
1718754|NCT00325195|4206572|P1|COMPLETED|Received Intervention: ITT Population||59
1718755|NCT00325195|4206570|P3|STARTED|Received Intervention: ITT Population||43
1718756|NCT00325195|4206571|P2|STARTED|Received Intervention: ITT Population||84
1718757|NCT00325195|4206572|P1|STARTED|Received Intervention: ITT Population||85
1718758|NCT00325195|4206570|P3|NOT COMPLETED|Randomized||3
1718759|NCT00325195|4206571|P2|NOT COMPLETED|Randomized||5
1718760|NCT00325195|4206572|P1|NOT COMPLETED|Randomized||5
1718761|NCT00325195|4206570|P3|COMPLETED|Randomized||43
1718762|NCT00325195|4206571|P2|COMPLETED|Randomized||84
1718763|NCT00325195|4206572|P1|COMPLETED|Randomized||85
1718764|NCT00325195|4206570|P3|STARTED|Randomized||46
1718765|NCT00325195|4206571|P2|STARTED|Randomized||89
1718766|NCT00325195|4206572|P1|STARTED|Randomized||90
1718767|NCT00325156|4206595|P1|NOT COMPLETED|Overall Study||112
1718768|NCT00325156|4206595|P1|COMPLETED|Overall Study||2478
1718769|NCT00325156|4206595|P1|STARTED|Overall Study||2590
1718770|NCT00325143|4206602|P1|NOT COMPLETED|Overall Study||26
1718771|NCT00325143|4206602|P1|COMPLETED|Overall Study||676
1718772|NCT00325143|4206602|P1|STARTED|Overall Study||702
1718773|NCT00325130|4206612|P2|NOT COMPLETED|Overall Study||30
1718774|NCT00325130|4206613|P1|NOT COMPLETED|Overall Study||19
1718775|NCT00325130|4206612|P2|COMPLETED|Overall Study||494
1718776|NCT00325130|4206613|P1|COMPLETED|Overall Study||499
1718777|NCT00325130|4206612|P2|STARTED|Overall Study||524
1718778|NCT00325130|4206613|P1|STARTED|Overall Study||518
1718779|NCT00325078|4206656|P3|NOT COMPLETED|Overall Study||2
1718780|NCT00325078|4206657|P2|NOT COMPLETED|Overall Study||5
1718781|NCT00325078|4206658|P1|NOT COMPLETED|Overall Study||5
1718782|NCT00325078|4206656|P3|COMPLETED|Overall Study||23
1718783|NCT00325078|4206657|P2|COMPLETED|Overall Study||2
1718784|NCT00325078|4206658|P1|COMPLETED|Overall Study||3
1718785|NCT00325078|4206656|P3|STARTED|Overall Study||25
1718786|NCT00325078|4206657|P2|STARTED|Overall Study||7
1718787|NCT00325078|4206658|P1|STARTED|Overall Study||8
1718788|NCT00325039|4206670|P2|NOT COMPLETED|Overall Study||14
1718789|NCT00325039|4206671|P1|NOT COMPLETED|Overall Study||18
1718790|NCT00325039|4206670|P2|COMPLETED|Overall Study||285
1718791|NCT00325039|4206671|P1|COMPLETED|Overall Study||280
1718792|NCT00325039|4206670|P2|STARTED|Overall Study||299
1718793|NCT00325039|4206671|P1|STARTED|Overall Study||298
1718794|NCT00324987|4206687|P2|NOT COMPLETED|Overall Study||6
1718795|NCT00324987|4206688|P1|NOT COMPLETED|Overall Study||6
1718796|NCT00324987|4206687|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
1718797|NCT00324987|4206688|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
1718798|NCT00324987|4206687|P2|STARTED|Overall Study||6
1718799|NCT00324987|4206688|P1|STARTED|Overall Study||6
1718800|NCT00324961|4206702|P1|NOT COMPLETED|Overall Study||43
1718801|NCT00324961|4206702|P1|COMPLETED|Overall Study||490
1718802|NCT00324961|4206702|P1|STARTED|Overall Study||533
1718803|NCT00324896|4206717|P2|NOT COMPLETED|Overall Study||8
1718804|NCT00324896|4206718|P1|NOT COMPLETED|Overall Study||3
1718805|NCT00324896|4206717|P2|COMPLETED|Overall Study||7
1718806|NCT00324896|4206718|P1|COMPLETED|Overall Study||12
1718807|NCT00324896|4206717|P2|STARTED|Overall Study||15
1718808|NCT00324896|4206718|P1|STARTED|Overall Study||15
1718809|NCT00324870|4206726|P1|NOT COMPLETED|Overall Study||0
1718810|NCT00324870|4206726|P1|COMPLETED|Overall Study||37
1718811|NCT00324870|4206726|P1|STARTED|Overall Study||37
1718812|NCT00324857|4206734|P4|NOT COMPLETED|Overall Study||5
1718813|NCT00324857|4206735|P3|NOT COMPLETED|Overall Study||7
1718814|NCT00324857|4206736|P2|NOT COMPLETED|Overall Study||6
1718815|NCT00324857|4206737|P1|NOT COMPLETED|Overall Study||6
1718816|NCT00324857|4206734|P4|COMPLETED|Overall Study||158
1718817|NCT00324857|4206735|P3|COMPLETED|Overall Study||158
1718818|NCT00324857|4206736|P2|COMPLETED|Overall Study||162
1718819|NCT00324857|4206737|P1|COMPLETED|Overall Study||161
1718820|NCT00324857|4206734|P4|STARTED|Overall Study||163
1718821|NCT00324857|4206735|P3|STARTED|Overall Study||165
1718822|NCT00324857|4206736|P2|STARTED|Overall Study||168
1718823|NCT00324857|4206737|P1|STARTED|Overall Study||167
1718824|NCT00324805|4206753|P2|NOT COMPLETED|Overall Study||483
1718825|NCT00324805|4206754|P1|NOT COMPLETED|Overall Study||150
1718826|NCT00324805|4206753|P2|COMPLETED|Overall Study||269
1718827|NCT00324805|4206754|P1|COMPLETED|Overall Study||599
1718828|NCT00324805|4206753|P2|Started Assigned Therapy|Overall Study||735
1718829|NCT00324805|4206754|P1|Started Assigned Therapy|Overall Study||737
1718830|NCT00324805|4206753|P2|STARTED|Overall Study||752
1718831|NCT00324805|4206754|P1|STARTED|Overall Study||749
1718832|NCT00324753|4206768|P2|NOT COMPLETED|Overall Study||0
1718833|NCT00324753|4206769|P1|NOT COMPLETED|Overall Study||0
1718834|NCT00324753|4206768|P2|COMPLETED|Overall Study||264
1718835|NCT00324753|4206769|P1|COMPLETED|Overall Study||190
1718836|NCT00324753|4206768|P2|STARTED|Overall Study||264
1718837|NCT00324753|4206769|P1|STARTED|Overall Study||190
1718838|NCT00324740|4206779|P3|NOT COMPLETED|Overall Study||1
1718839|NCT00324740|4206780|P2|NOT COMPLETED|Overall Study||0
1718840|NCT00324740|4206781|P1|NOT COMPLETED|Overall Study||1
1718841|NCT00324740|4206779|P3|COMPLETED|Overall Study||3
1718842|NCT00324740|4206780|P2|COMPLETED|Overall Study||3
1718843|NCT00324740|4206781|P1|COMPLETED|Overall Study||6
1718844|NCT00324740|4206779|P3|STARTED|Overall Study||4
1718845|NCT00324740|4206780|P2|STARTED|Overall Study||3
1718846|NCT00324740|4206781|P1|STARTED|Overall Study||7
1718847|NCT00324701|4206790|P2|NOT COMPLETED|Overall Study||17
1718848|NCT00324701|4206791|P1|NOT COMPLETED|Overall Study||20
1718849|NCT00324701|4206790|P2|COMPLETED|Overall Study||104
1718850|NCT00324701|4206791|P1|COMPLETED|Overall Study||100
1718851|NCT00324701|4206790|P2|Week 8 Assessment|Overall Study||107
1718852|NCT00324701|4206791|P1|Week 8 Assessment|Overall Study||108
1718853|NCT00324701|4206790|P2|STARTED|Overall Study||121
1718854|NCT00324701|4206791|P1|STARTED|Overall Study||120
1718855|NCT00324675|4206801|P2|NOT COMPLETED|Overall Study||0
1718856|NCT00324675|4206802|P1|NOT COMPLETED|Overall Study||1
1718857|NCT00324675|4206801|P2|COMPLETED|Overall Study||14
1718858|NCT00324675|4206802|P1|COMPLETED|Overall Study||13
1718859|NCT00324675|4206801|P2|STARTED|Overall Study||14
1718860|NCT00324675|4206802|P1|STARTED|Overall Study||14
1718861|NCT00324649|4206810|P2|NOT COMPLETED|Overall Study||5
1718862|NCT00324649|4206811|P1|NOT COMPLETED|Overall Study||2
1718863|NCT00324649|4206810|P2|COMPLETED|Overall Study||36
1718864|NCT00324649|4206811|P1|COMPLETED|Overall Study||37
1718865|NCT00324649|4206810|P2|STARTED|Overall Study||41
1718866|NCT00324649|4206811|P1|STARTED|Overall Study||39
1718867|NCT00324415|4206851|P1|NOT COMPLETED|Overall Study||0
1718868|NCT00324415|4206851|P1|COMPLETED|Overall Study||45
1718869|NCT00324415|4206851|P1|STARTED|Overall Study||45
1718870|NCT00324350|4206866|P2|NOT COMPLETED|Overall Study||0
1718871|NCT00324350|4206867|P1|NOT COMPLETED|Overall Study||0
1718872|NCT00324350|4206866|P2|COMPLETED|Overall Study||3632
1718873|NCT00324350|4206867|P1|COMPLETED|Overall Study||3655
1718874|NCT00324350|4206866|P2|Falls Follow-Up|Overall Study||3418
1718875|NCT00324350|4206867|P1|Falls Follow-Up|Overall Study||3364
1718876|NCT00324350|4206866|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
1718877|NCT00324350|4206867|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
1718878|NCT00324350|4206866|P2|STARTED|Overall Study||3632
1718879|NCT00324350|4206867|P1|STARTED|Overall Study||3655
1718880|NCT00324272|4206881|P4|NOT COMPLETED|Overall Study||0
1718881|NCT00324272|4206882|P3|NOT COMPLETED|Overall Study||0
1718882|NCT00324272|4206883|P2|NOT COMPLETED|Overall Study||0
1718883|NCT00324272|4206884|P1|NOT COMPLETED|Overall Study||0
1718884|NCT00324272|4206881|P4|COMPLETED|Overall Study||18
1718885|NCT00324272|4206882|P3|COMPLETED|Overall Study||18
1718886|NCT00324272|4206883|P2|COMPLETED|Overall Study||20
1718887|NCT00324272|4206884|P1|COMPLETED|Overall Study||18
1718888|NCT00324272|4206881|P4|STARTED|Overall Study||18
1718889|NCT00324272|4206882|P3|STARTED|Overall Study||18
1718890|NCT00324272|4206883|P2|STARTED|Overall Study||20
1718891|NCT00324272|4206884|P1|STARTED|Overall Study||18
1718892|NCT00324259|4206920|P2|NOT COMPLETED|Overall Study||0
1718893|NCT00324259|4206921|P1|NOT COMPLETED|Overall Study||0
1718894|NCT00324259|4206920|P2|COMPLETED|Overall Study||32
1718895|NCT00324259|4206921|P1|COMPLETED|Overall Study||34
1718896|NCT00324259|4206920|P2|STARTED|Overall Study||32
1718897|NCT00324259|4206921|P1|STARTED|Overall Study||34
1718898|NCT00324233|4206942|P2|NOT COMPLETED|Second Period||7
1718899|NCT00324233|4206943|P1|NOT COMPLETED|Second Period||5
1718900|NCT00324233|4206942|P2|COMPLETED|Second Period||11
1718901|NCT00324233|4206943|P1|COMPLETED|Second Period||12
1718902|NCT00324233|4206942|P2|STARTED|Second Period||18
1718903|NCT00324233|4206943|P1|STARTED|Second Period||17
1718904|NCT00324233|4206942|P2|NOT COMPLETED|First Period||0
1718905|NCT00324233|4206943|P1|NOT COMPLETED|First Period||1
1718906|NCT00324233|4206942|P2|COMPLETED|First Period||18
1718907|NCT00324233|4206943|P1|COMPLETED|First Period||17
1718908|NCT00324233|4206942|P2|STARTED|First Period||18
1718909|NCT00324233|4206943|P1|STARTED|First Period||18
1718910|NCT00324168|4206951|P2|NOT COMPLETED|Overall Study||30
1718911|NCT00324168|4206952|P1|NOT COMPLETED|Overall Study||28
1718912|NCT00324168|4206951|P2|COMPLETED|Overall Study||220
1718913|NCT00324168|4206952|P1|COMPLETED|Overall Study||222
1718914|NCT00324168|4206951|P2|STARTED|Overall Study||250
1718915|NCT00324168|4206952|P1|STARTED|Overall Study||250
1718916|NCT00324155|4206980|P2|NOT COMPLETED|Follow-up Phase||6
1718917|NCT00324155|4206981|P1|NOT COMPLETED|Follow-up Phase||11
1718918|NCT00324155|4206980|P2|COMPLETED|Follow-up Phase||245
1718919|NCT00324155|4206981|P1|COMPLETED|Follow-up Phase||236
1718920|NCT00324155|4206980|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
1718921|NCT00324155|4206981|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
1718922|NCT00324155|4206980|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
1718923|NCT00324155|4206981|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
1718924|NCT00324155|4206980|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
1718925|NCT00324155|4206981|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
1718926|NCT00324155|4206980|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
1718927|NCT00324155|4206981|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
1718928|NCT00324155|4206980|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
1718929|NCT00324155|4206981|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
1718930|NCT00324155|4206980|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
1718931|NCT00324155|4206981|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
1718932|NCT00324155|4206980|P2|STARTED|Received Treatment in Induction Phase||251
1718933|NCT00324155|4206981|P1|STARTED|Received Treatment in Induction Phase||247
1718934|NCT00324155|4206980|P2|NOT COMPLETED|Enrolled and Randomized||1
1718935|NCT00324155|4206981|P1|NOT COMPLETED|Enrolled and Randomized||3
1718936|NCT00324155|4206980|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
1718937|NCT00324155|4206981|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
1718938|NCT00324155|4206980|P2|STARTED|Enrolled and Randomized||252
1718939|NCT00324155|4206981|P1|STARTED|Enrolled and Randomized||250
1718940|NCT00324116|4207011|P1|NOT COMPLETED|Overall Study||32
1718941|NCT00324116|4207011|P1|COMPLETED|Overall Study||49
1718942|NCT00324116|4207011|P1|STARTED|Overall Study|subjects received treatment|81
1718943|NCT00324038|4207023|P2|NOT COMPLETED|Overall Study||51
1718944|NCT00324038|4207024|P1|NOT COMPLETED|Overall Study||49
1718945|NCT00324038|4207023|P2|COMPLETED|Overall Study||58
1718946|NCT00324038|4207024|P1|COMPLETED|Overall Study||61
1718947|NCT00324038|4207023|P2|STARTED|Overall Study||109
1718948|NCT00324038|4207024|P1|STARTED|Overall Study||110
1718949|NCT00323882|4207035|P5|NOT COMPLETED|Overall Study||32
1718950|NCT00323882|4207036|P4|NOT COMPLETED|Overall Study||7
1718951|NCT00323882|4207037|P3|NOT COMPLETED|Overall Study||13
1718952|NCT00323882|4207038|P2|NOT COMPLETED|Overall Study||6
1718953|NCT00323882|4207039|P1|NOT COMPLETED|Overall Study||8
1718954|NCT00323882|4207035|P5|COMPLETED|Overall Study||2
1718955|NCT00323882|4207036|P4|COMPLETED|Overall Study||0
1718956|NCT00323882|4207037|P3|COMPLETED|Overall Study||3
1718957|NCT00323882|4207038|P2|COMPLETED|Overall Study||0
1718958|NCT00323882|4207039|P1|COMPLETED|Overall Study||0
1718959|NCT00323882|4207035|P5|STARTED|Overall Study||34
1718960|NCT00323882|4207036|P4|STARTED|Overall Study||7
1718961|NCT00323882|4207037|P3|STARTED|Overall Study||16
1718962|NCT00323882|4207038|P2|STARTED|Overall Study||6
1718963|NCT00323882|4207039|P1|STARTED|Overall Study||8
1718964|NCT00323869|4207110|P1|NOT COMPLETED|Overall Study||1
1718965|NCT00323869|4207110|P1|COMPLETED|Overall Study||47
1718966|NCT00323869|4207110|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
1718967|NCT00323869|4207110|P1|STARTED|Overall Study|Enrollment|48
1718968|NCT00323739|4207122|P1|NOT COMPLETED|Overall Study||0
1718969|NCT00323739|4207122|P1|COMPLETED|Overall Study||80
1718970|NCT00323739|4207122|P1|STARTED|Overall Study||80
1718971|NCT00323635|4207129|P2|NOT COMPLETED|Overall Study||0
1718972|NCT00323635|4207130|P1|NOT COMPLETED|Overall Study||0
1718973|NCT00323635|4207129|P2|COMPLETED|Overall Study||9
1718974|NCT00323635|4207130|P1|COMPLETED|Overall Study||10
1718975|NCT00323635|4207129|P2|STARTED|Overall Study||9
1718976|NCT00323635|4207130|P1|STARTED|Overall Study||10
1718977|NCT00323622|4207166|P8|NOT COMPLETED|Overall Study||15
1718978|NCT00323622|4207167|P7|NOT COMPLETED|Overall Study||5
1718979|NCT00323622|4207168|P6|NOT COMPLETED|Overall Study||74
1718980|NCT00323622|4207169|P5|NOT COMPLETED|Overall Study||39
1718981|NCT00323622|4207170|P4|NOT COMPLETED|Overall Study||12
1718982|NCT00323622|4207171|P3|NOT COMPLETED|Overall Study||4
1718983|NCT00323622|4207172|P2|NOT COMPLETED|Overall Study||92
1718984|NCT00323622|4207173|P1|NOT COMPLETED|Overall Study||31
1718985|NCT00323622|4207166|P8|COMPLETED|Overall Study||125
1718986|NCT00323622|4207167|P7|COMPLETED|Overall Study||38
1718987|NCT00323622|4207168|P6|COMPLETED|Overall Study||454
1718988|NCT00323622|4207169|P5|COMPLETED|Overall Study||120
1718989|NCT00323622|4207170|P4|COMPLETED|Overall Study||122
1718990|NCT00323622|4207171|P3|COMPLETED|Overall Study||38
1718991|NCT00323622|4207172|P2|COMPLETED|Overall Study||423
1718992|NCT00323622|4207173|P1|COMPLETED|Overall Study||145
1718993|NCT00323622|4207166|P8|STARTED|Overall Study||140
1718994|NCT00323622|4207167|P7|STARTED|Overall Study||43
1718995|NCT00323622|4207168|P6|STARTED|Overall Study||528
1718996|NCT00323622|4207169|P5|STARTED|Overall Study||159
1718997|NCT00323622|4207170|P4|STARTED|Overall Study||134
1718998|NCT00323622|4207171|P3|STARTED|Overall Study||42
1718999|NCT00323622|4207172|P2|STARTED|Overall Study||515
1719000|NCT00323622|4207173|P1|STARTED|Overall Study||176
1719001|NCT00323609|4207215|P4|NOT COMPLETED|Overall Study||15
1719002|NCT00323609|4207216|P3|NOT COMPLETED|Overall Study||8
1719003|NCT00323609|4207217|P2|NOT COMPLETED|Overall Study||99
1719004|NCT00323609|4207218|P1|NOT COMPLETED|Overall Study||91
1719005|NCT00323609|4207215|P4|COMPLETED|Overall Study||0
1719006|NCT00323609|4207216|P3|COMPLETED|Overall Study||0
1719007|NCT00323609|4207217|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
1719008|NCT00323609|4207218|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
1719009|NCT00323609|4207215|P4|STARTED|Overall Study||15
1719010|NCT00323609|4207216|P3|STARTED|Overall Study||8
1719011|NCT00323609|4207217|P2|STARTED|Overall Study||190
1719012|NCT00323609|4207218|P1|STARTED|Overall Study||191
1719013|NCT00323557|4207254|P2|NOT COMPLETED|Overall Study||0
1719014|NCT00323557|4207255|P1|NOT COMPLETED|Overall Study||1
1719015|NCT00323557|4207254|P2|COMPLETED|Overall Study||7
1719016|NCT00323557|4207255|P1|COMPLETED|Overall Study||24
1719017|NCT00323557|4207254|P2|STARTED|Overall Study||7
1719018|NCT00323557|4207255|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
1719019|NCT00323492|4207264|P3|NOT COMPLETED|Study Phase 2||1
1719020|NCT00323492|4207265|P2|NOT COMPLETED|Study Phase 2||1
1719021|NCT00323492|4207266|P1|NOT COMPLETED|Study Phase 2||4
1719022|NCT00323492|4207264|P3|COMPLETED|Study Phase 2||24
1719023|NCT00323492|4207265|P2|COMPLETED|Study Phase 2||17
1719024|NCT00323492|4207266|P1|COMPLETED|Study Phase 2||40
1719025|NCT00323492|4207264|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
1719026|NCT00323492|4207265|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
1719027|NCT00323492|4207266|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
1719028|NCT00323492|4207264|P3|NOT COMPLETED|Study Phase 1||0
1719029|NCT00323492|4207265|P2|NOT COMPLETED|Study Phase 1||0
1719030|NCT00323492|4207266|P1|NOT COMPLETED|Study Phase 1||2
1719031|NCT00323492|4207264|P3|COMPLETED|Study Phase 1||0
1719032|NCT00323492|4207265|P2|COMPLETED|Study Phase 1||45
1719033|NCT00323492|4207266|P1|COMPLETED|Study Phase 1||45
1719034|NCT00323492|4207264|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
1719035|NCT00323492|4207265|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
1719036|NCT00323492|4207266|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
1719037|NCT00323492|4207264|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
1719038|NCT00323492|4207265|P2|STARTED|Study Phase 1||45
1719039|NCT00323492|4207266|P1|STARTED|Study Phase 1||47
1719040|NCT00323479|4207297|P1|NOT COMPLETED|Overall Study||8
1719041|NCT00323479|4207297|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
1719042|NCT00323479|4207297|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
1719043|NCT00323479|4207297|P1|STARTED|Overall Study||114
1719044|NCT00323453|4207308|P2|NOT COMPLETED|Overall Study||0
1719045|NCT00323453|4207309|P1|NOT COMPLETED|Overall Study||0
1719046|NCT00323453|4207308|P2|COMPLETED|Overall Study||48
1719047|NCT00323453|4207309|P1|COMPLETED|Overall Study||61
1719048|NCT00323453|4207308|P2|STARTED|Overall Study||48
1719049|NCT00323453|4207309|P1|STARTED|Overall Study||61
1719050|NCT00323427|4207317|P2|NOT COMPLETED|Overall Study||23
1719051|NCT00323427|4207318|P1|NOT COMPLETED|Overall Study||31
1719052|NCT00323427|4207317|P2|COMPLETED|Overall Study||43
1719053|NCT00323427|4207318|P1|COMPLETED|Overall Study||38
1719054|NCT00323427|4207317|P2|STARTED|Overall Study||66
1719055|NCT00323427|4207318|P1|STARTED|Overall Study||69
1719056|NCT00323414|4207330|P2|NOT COMPLETED|Overall Study||1
1719057|NCT00323414|4207331|P1|NOT COMPLETED|Overall Study||0
1719058|NCT00323414|4207330|P2|COMPLETED|Overall Study||18
1719059|NCT00323414|4207331|P1|COMPLETED|Overall Study||18
1719060|NCT00323414|4207330|P2|STARTED|Overall Study||19
1719061|NCT00323414|4207331|P1|STARTED|Overall Study||18
1719062|NCT00323362|4207347|P1|NOT COMPLETED|Overall Study||0
1719063|NCT00323362|4207347|P1|COMPLETED|Overall Study||17
1719064|NCT00323362|4207347|P1|STARTED|Overall Study||17
1719065|NCT00323310|4207353|P1|NOT COMPLETED|Overall Study||3
1719066|NCT00323310|4207353|P1|COMPLETED|Overall Study||89
1719067|NCT00323310|4207353|P1|STARTED|Overall Study||92
1719068|NCT00323297|4207368|P2|NOT COMPLETED|Part B (Open-label)||12
1719069|NCT00323297|4207369|P1|NOT COMPLETED|Part B (Open-label)||9
1719070|NCT00323297|4207368|P2|COMPLETED|Part B (Open-label)||31
1719071|NCT00323297|4207369|P1|COMPLETED|Part B (Open-label)||39
1719072|NCT00323297|4207368|P2|STARTED|Part B (Open-label)||43
1719073|NCT00323297|4207369|P1|STARTED|Part B (Open-label)||48
1719074|NCT00323297|4207368|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
1719075|NCT00323297|4207369|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
1719076|NCT00323297|4207368|P2|COMPLETED|Part A (Double Blind Randomized)||43
1719077|NCT00323297|4207369|P1|COMPLETED|Part A (Double Blind Randomized)||48
1719078|NCT00323297|4207368|P2|STARTED|Part A (Double Blind Randomized)||50
1719079|NCT00323297|4207369|P1|STARTED|Part A (Double Blind Randomized)||53
1719080|NCT00323284|4207387|P2|NOT COMPLETED|24 Months Follow-up||22
1719081|NCT00323284|4207388|P1|NOT COMPLETED|24 Months Follow-up||18
1719082|NCT00323284|4207387|P2|COMPLETED|24 Months Follow-up||101
1719083|NCT00323284|4207388|P1|COMPLETED|24 Months Follow-up||98
1719084|NCT00323284|4207387|P2|STARTED|24 Months Follow-up||123
1719085|NCT00323284|4207388|P1|STARTED|24 Months Follow-up||116
1719086|NCT00323284|4207387|P2|NOT COMPLETED|12 Months Follow-up||9
1719087|NCT00323284|4207388|P1|NOT COMPLETED|12 Months Follow-up||5
1719088|NCT00323284|4207387|P2|COMPLETED|12 Months Follow-up||114
1719089|NCT00323284|4207388|P1|COMPLETED|12 Months Follow-up||111
1719090|NCT00323284|4207387|P2|STARTED|12 Months Follow-up||123
1719091|NCT00323284|4207388|P1|STARTED|12 Months Follow-up||116
1719092|NCT00323271|4207398|P2|NOT COMPLETED|Overall Study||3
1719093|NCT00323271|4207399|P1|NOT COMPLETED|Overall Study||2
1719094|NCT00323271|4207398|P2|COMPLETED|Overall Study||9
1719095|NCT00323271|4207399|P1|COMPLETED|Overall Study||11
1719096|NCT00323271|4207398|P2|STARTED|Overall Study||12
1719097|NCT00323271|4207399|P1|STARTED|Overall Study||13
1719098|NCT00323258|4207409|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
1719099|NCT00323258|4207410|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
1719100|NCT00323258|4207409|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
1719101|NCT00323258|4207410|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
1719102|NCT00323258|4207409|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
1719103|NCT00323258|4207410|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
1719104|NCT00323258|4207409|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
1719105|NCT00323258|4207410|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
1719106|NCT00323258|4207409|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
1719107|NCT00323258|4207410|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
1719108|NCT00323258|4207409|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
1719109|NCT00323258|4207410|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
1719110|NCT00323193|4207426|P2|NOT COMPLETED|Overall Study||15
1719111|NCT00323193|4207427|P1|NOT COMPLETED|Overall Study||23
1719112|NCT00323193|4207426|P2|COMPLETED|Overall Study||41
1719113|NCT00323193|4207427|P1|COMPLETED|Overall Study||30
1719114|NCT00323193|4207426|P2|STARTED|Overall Study||56
1719115|NCT00323193|4207427|P1|STARTED|Overall Study||53
1719116|NCT00323115|4207435|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
1719117|NCT00323115|4207435|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
1719118|NCT00323115|4207435|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
1719119|NCT00323115|4207435|P1|NOT COMPLETED|Vaccine Administration||1
1719120|NCT00323115|4207435|P1|COMPLETED|Vaccine Administration||10
1719121|NCT00323115|4207435|P1|STARTED|Vaccine Administration||11
1719122|NCT00323063|4207462|P2|NOT COMPLETED|Overall Study||0
1719123|NCT00323063|4207463|P1|NOT COMPLETED|Overall Study||2
1719124|NCT00323063|4207462|P2|COMPLETED|Overall Study||23
1719125|NCT00323063|4207463|P1|COMPLETED|Overall Study||24
1719126|NCT00323063|4207462|P2|STARTED|Overall Study||23
1719127|NCT00323063|4207463|P1|STARTED|Overall Study||26
1719128|NCT00323037|4207475|P2|NOT COMPLETED|Overall Study||27
1719129|NCT00323037|4207476|P1|NOT COMPLETED|Overall Study||33
1719130|NCT00323037|4207475|P2|COMPLETED|Overall Study||126
1719131|NCT00323037|4207476|P1|COMPLETED|Overall Study||132
1719132|NCT00323037|4207475|P2|STARTED|Overall Study|Number randomized|153
1719133|NCT00323037|4207476|P1|STARTED|Overall Study|Number randomized|165
1719134|NCT00322881|4207480|P1|NOT COMPLETED|Overall Study||5
1719135|NCT00322881|4207480|P1|COMPLETED|Overall Study||7
1719136|NCT00322881|4207480|P1|STARTED|Overall Study||12
1719137|NCT00322868|4207484|P1|NOT COMPLETED|Overall Study||1
1719138|NCT00322868|4207484|P1|COMPLETED|Overall Study||20
1719139|NCT00322868|4207484|P1|STARTED|Overall Study||21
1719140|NCT00322855|4207503|P1|NOT COMPLETED|Overall Study||0
1719141|NCT00322855|4207503|P1|COMPLETED|Overall Study||1
1719142|NCT00322855|4207503|P1|STARTED|Overall Study||1
1719143|NCT00322842|4207509|P2|NOT COMPLETED|Overall Study||2
1719144|NCT00322842|4207510|P1|NOT COMPLETED|Overall Study||2
1719145|NCT00322842|4207509|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
1719146|NCT00322842|4207510|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
1719147|NCT00322842|4207509|P2|STARTED|Overall Study||31
1719148|NCT00322842|4207510|P1|STARTED|Overall Study||4
1719149|NCT00322777|4207537|P2|NOT COMPLETED|Overall Study||0
1719150|NCT00322777|4207538|P1|NOT COMPLETED|Overall Study||0
1719151|NCT00322777|4207537|P2|COMPLETED|Overall Study||45
1719152|NCT00322777|4207538|P1|COMPLETED|Overall Study||39
1719153|NCT00322777|4207537|P2|Data Collection at Week 24|Overall Study||45
1719154|NCT00322777|4207538|P1|Data Collection at Week 24|Overall Study||39
1719155|NCT00322777|4207537|P2|Data Collection at Week 16|Overall Study||45
1719156|NCT00322777|4207538|P1|Data Collection at Week 16|Overall Study||39
1719157|NCT00322777|4207537|P2|Data Collection at Week 8|Overall Study||45
1719158|NCT00322777|4207538|P1|Data Collection at Week 8|Overall Study||39
1719159|NCT00322777|4207537|P2|"Data Collection at BASELINE|"|Overall Study||45
1719160|NCT00322777|4207538|P1|"Data Collection at BASELINE|"|Overall Study||39
1719161|NCT00322777|4207537|P2|STARTED|Overall Study||45
1719162|NCT00322777|4207538|P1|STARTED|Overall Study||39
1719163|NCT00322712|4207548|P1|NOT COMPLETED|Overall Study||1
1719164|NCT00322712|4207548|P1|COMPLETED|Overall Study||11
1719165|NCT00322712|4207548|P1|STARTED|Overall Study||12
1719166|NCT00322621|4207552|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
1719167|NCT00322621|4207553|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
1719168|NCT00322621|4207554|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
1719169|NCT00322621|4207552|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
1719170|NCT00322621|4207553|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
1719171|NCT00322621|4207554|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
1719172|NCT00322621|4207552|P3|STARTED|Period III - Maintenance / Rescue Phase||69
1719173|NCT00322621|4207553|P2|STARTED|Period III - Maintenance / Rescue Phase||115
1719174|NCT00322621|4207554|P1|STARTED|Period III - Maintenance / Rescue Phase||0
1719175|NCT00322621|4207552|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
1719176|NCT00322621|4207553|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
1719177|NCT00322621|4207554|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
1719178|NCT00322621|4207552|P3|COMPLETED|Period II - Acute Therapy Phase||0
1719179|NCT00322621|4207553|P2|COMPLETED|Period II - Acute Therapy Phase||0
1719180|NCT00322621|4207554|P1|COMPLETED|Period II - Acute Therapy Phase||184
1719181|NCT00322621|4207552|P3|STARTED|Period II - Acute Therapy Phase||0
1719182|NCT00322621|4207553|P2|STARTED|Period II - Acute Therapy Phase||0
1719183|NCT00322621|4207554|P1|STARTED|Period II - Acute Therapy Phase||216
1719184|NCT00322556|4207606|P1|NOT COMPLETED|Overall Study||12
1719185|NCT00322556|4207606|P1|COMPLETED|Overall Study||43
1719186|NCT00322556|4207606|P1|STARTED|Overall Study||55
1719187|NCT00322491|4207622|P2|NOT COMPLETED|Overall Study||2
1719188|NCT00322491|4207623|P1|NOT COMPLETED|Overall Study||2
1719189|NCT00322491|4207622|P2|COMPLETED|Overall Study||24
1719190|NCT00322491|4207623|P1|COMPLETED|Overall Study||21
1719191|NCT00322491|4207622|P2|STARTED|Overall Study||26
1719192|NCT00322491|4207623|P1|STARTED|Overall Study||23
1719193|NCT00322465|4207649|P4|NOT COMPLETED|Overall Study||26
1719194|NCT00322465|4207650|P3|NOT COMPLETED|Overall Study||26
1719195|NCT00322465|4207651|P2|NOT COMPLETED|Overall Study||24
1719196|NCT00322465|4207652|P1|NOT COMPLETED|Overall Study||20
1719197|NCT00322465|4207649|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
1719198|NCT00322465|4207650|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
1719199|NCT00322465|4207651|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
1719200|NCT00322465|4207652|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
1719201|NCT00322465|4207649|P4|STARTED|Overall Study|Randomized|79
1719202|NCT00322465|4207650|P3|STARTED|Overall Study|Randomized|77
1719203|NCT00322465|4207651|P2|STARTED|Overall Study|Randomized|73
1719204|NCT00322465|4207652|P1|STARTED|Overall Study|Randomized|76
1719205|NCT00322452|4207713|P2|NOT COMPLETED|Overall Study||276
1719206|NCT00322452|4207714|P1|NOT COMPLETED|Overall Study||247
1719207|NCT00322452|4207713|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
1719208|NCT00322452|4207714|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
1719209|NCT00322452|4207713|P2|STARTED|Overall Study|Number of patients randomized|608
1719210|NCT00322452|4207714|P1|STARTED|Overall Study|Number of patients randomized|609
1719211|NCT00322439|4207750|P1|NOT COMPLETED|Overall Study||1056
1719212|NCT00322439|4207750|P1|COMPLETED|Overall Study||1455
1719213|NCT00322439|4207750|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
1719214|NCT00322439|4207750|P1|STARTED|Overall Study||2511
1719215|NCT00322387|4207765|P2|NOT COMPLETED|Follow-up Period||3
1719216|NCT00322387|4207766|P1|NOT COMPLETED|Follow-up Period||2
1719217|NCT00322387|4207765|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
1719218|NCT00322387|4207766|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
1719219|NCT00322387|4207765|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
1719220|NCT00322387|4207766|P1|STARTED|Follow-up Period|Participants who had transplants|14
1719221|NCT00322387|4207765|P2|NOT COMPLETED|Treatment Period||1
1719222|NCT00322387|4207766|P1|NOT COMPLETED|Treatment Period||0
1719223|NCT00322387|4207765|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
1719224|NCT00322387|4207766|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
1719225|NCT00322387|4207765|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
1719226|NCT00322387|4207766|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
1719227|NCT00322374|4207800|P4|NOT COMPLETED|Second Escalation||0
1719228|NCT00322374|4207801|P3|NOT COMPLETED|Second Escalation||6
1719229|NCT00322374|4207802|P2|NOT COMPLETED|Second Escalation||0
1719230|NCT00322374|4207803|P1|NOT COMPLETED|Second Escalation||0
1719231|NCT00322374|4207800|P4|COMPLETED|Second Escalation||0
1719232|NCT00322374|4207801|P3|COMPLETED|Second Escalation||0
1719233|NCT00322374|4207802|P2|COMPLETED|Second Escalation||0
1719234|NCT00322374|4207803|P1|COMPLETED|Second Escalation||0
1719235|NCT00322374|4207800|P4|STARTED|Second Escalation||0
1719236|NCT00322374|4207801|P3|STARTED|Second Escalation||6
1719237|NCT00322374|4207802|P2|STARTED|Second Escalation||0
1719238|NCT00322374|4207803|P1|STARTED|Second Escalation||0
1719239|NCT00322374|4207800|P4|NOT COMPLETED|First Escalation||0
1719240|NCT00322374|4207801|P3|NOT COMPLETED|First Escalation||0
1719241|NCT00322374|4207802|P2|NOT COMPLETED|First Escalation||30
1719242|NCT00322374|4207803|P1|NOT COMPLETED|First Escalation||0
1719243|NCT00322374|4207800|P4|COMPLETED|First Escalation||0
1719244|NCT00322374|4207801|P3|COMPLETED|First Escalation||0
1719245|NCT00322374|4207802|P2|COMPLETED|First Escalation||0
1719246|NCT00322374|4207803|P1|COMPLETED|First Escalation||0
1719247|NCT00322374|4207800|P4|STARTED|First Escalation||0
1719248|NCT00322374|4207801|P3|STARTED|First Escalation||0
1719249|NCT00322374|4207802|P2|STARTED|First Escalation||30
1719250|NCT00322374|4207803|P1|STARTED|First Escalation||0
1719251|NCT00322374|4207800|P4|NOT COMPLETED|Starting Dose||0
1719252|NCT00322374|4207801|P3|NOT COMPLETED|Starting Dose||0
1719253|NCT00322374|4207802|P2|NOT COMPLETED|Starting Dose||0
1719254|NCT00322374|4207803|P1|NOT COMPLETED|Starting Dose||6
1719255|NCT00322374|4207800|P4|COMPLETED|Starting Dose||0
1719256|NCT00322374|4207801|P3|COMPLETED|Starting Dose||0
1719257|NCT00322374|4207802|P2|COMPLETED|Starting Dose||0
1719258|NCT00322374|4207803|P1|COMPLETED|Starting Dose||0
1719259|NCT00322374|4207800|P4|STARTED|Starting Dose||0
1719260|NCT00322374|4207801|P3|STARTED|Starting Dose||0
1719261|NCT00322374|4207802|P2|STARTED|Starting Dose||0
1719262|NCT00322374|4207803|P1|STARTED|Starting Dose||6
1719263|NCT00322374|4207800|P4|NOT COMPLETED|Enrollment||0
1719264|NCT00322374|4207801|P3|NOT COMPLETED|Enrollment||0
1719265|NCT00322374|4207802|P2|NOT COMPLETED|Enrollment||0
1719266|NCT00322374|4207803|P1|NOT COMPLETED|Enrollment||0
1719267|NCT00322374|4207800|P4|COMPLETED|Enrollment||42
1719268|NCT00322374|4207801|P3|COMPLETED|Enrollment||0
1719269|NCT00322374|4207802|P2|COMPLETED|Enrollment||0
1719270|NCT00322374|4207803|P1|COMPLETED|Enrollment||0
1719271|NCT00322374|4207800|P4|STARTED|Enrollment||42
1719272|NCT00322374|4207801|P3|STARTED|Enrollment||0
1719273|NCT00322374|4207802|P2|STARTED|Enrollment||0
1719274|NCT00322374|4207803|P1|STARTED|Enrollment||0
1719275|NCT00322348|4207853|P2|NOT COMPLETED|Overall Study||33
1719276|NCT00322348|4207854|P1|NOT COMPLETED|Overall Study||37
1719277|NCT00322348|4207853|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
1719278|NCT00322348|4207854|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
1719279|NCT00322348|4207853|P2|Received Study Treatment|Overall Study||48
1719280|NCT00322348|4207854|P1|Received Study Treatment|Overall Study||50
1719281|NCT00322348|4207853|P2|STARTED|Overall Study||49
1719282|NCT00322348|4207854|P1|STARTED|Overall Study||49
1719283|NCT00322335|4207873|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
1719284|NCT00322335|4207874|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
1719285|NCT00322335|4207875|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
1719286|NCT00322335|4207873|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
1719287|NCT00322335|4207874|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
1719288|NCT00322335|4207875|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
1719289|NCT00322335|4207873|P3|STARTED|Subjects 66 Months After Booster Dose||53
1719290|NCT00322335|4207874|P2|STARTED|Subjects 66 Months After Booster Dose||104
1719291|NCT00322335|4207875|P1|STARTED|Subjects 66 Months After Booster Dose||48
1719292|NCT00322335|4207873|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
1719293|NCT00322335|4207874|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
1719294|NCT00322335|4207875|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
1719295|NCT00322335|4207873|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
1719296|NCT00322335|4207874|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
1719297|NCT00322335|4207875|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
1719298|NCT00322335|4207873|P3|STARTED|Subjects 54 Months After Booster Dose||56
1719299|NCT00322335|4207874|P2|STARTED|Subjects 54 Months After Booster Dose||108
1719300|NCT00322335|4207875|P1|STARTED|Subjects 54 Months After Booster Dose||50
1719301|NCT00322335|4207873|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
1719302|NCT00322335|4207874|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
1719303|NCT00322335|4207875|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
1719304|NCT00322335|4207873|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
1719305|NCT00322335|4207874|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
1719306|NCT00322335|4207875|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
1719307|NCT00322335|4207873|P3|STARTED|Subjects 42 Months After Booster Dose||56
1719308|NCT00322335|4207874|P2|STARTED|Subjects 42 Months After Booster Dose||113
1719309|NCT00322335|4207875|P1|STARTED|Subjects 42 Months After Booster Dose||51
1719310|NCT00322335|4207873|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
1719311|NCT00322335|4207874|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
1719312|NCT00322335|4207875|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
1719313|NCT00322335|4207873|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
1719314|NCT00322335|4207874|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
1719315|NCT00322335|4207875|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
1719316|NCT00322335|4207873|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
1719317|NCT00322335|4207874|P2|STARTED|Subjects 30 Months After Booster Dose||119
1719318|NCT00322335|4207875|P1|STARTED|Subjects 30 Months After Booster Dose||54
1719319|NCT00322335|4207873|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
1719320|NCT00322335|4207874|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
1719321|NCT00322335|4207875|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
1719322|NCT00322335|4207873|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
1719323|NCT00322335|4207874|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
1719324|NCT00322335|4207875|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
1719325|NCT00322335|4207873|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
1719326|NCT00322335|4207874|P2|STARTED|Subjects 18 Months After Booster Dose||123
1719327|NCT00322335|4207875|P1|STARTED|Subjects 18 Months After Booster Dose||58
1719328|NCT00322309|4207915|P2|NOT COMPLETED|Overall Study||4
1719329|NCT00322309|4207916|P1|NOT COMPLETED|Overall Study||2
1719330|NCT00322309|4207915|P2|COMPLETED|Overall Study||9
1719331|NCT00322309|4207916|P1|COMPLETED|Overall Study||9
1719332|NCT00322309|4207915|P2|STARTED|Overall Study||13
1719333|NCT00322309|4207916|P1|STARTED|Overall Study||11
1719334|NCT00322231|4207932|P2|NOT COMPLETED|Period 2||0
1719335|NCT00322231|4207933|P1|NOT COMPLETED|Period 2||0
1719336|NCT00322231|4207932|P2|COMPLETED|Period 2||49
1719337|NCT00322231|4207933|P1|COMPLETED|Period 2||51
1719338|NCT00322231|4207932|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
1719339|NCT00322231|4207933|P1|STARTED|Period 2||51
1719340|NCT00322231|4207932|P2|NOT COMPLETED|Period 1||0
1719341|NCT00322231|4207933|P1|NOT COMPLETED|Period 1||0
1719342|NCT00322231|4207932|P2|COMPLETED|Period 1||50
1719343|NCT00322231|4207933|P1|COMPLETED|Period 1||51
1719344|NCT00322231|4207932|P2|STARTED|Period 1||50
1719345|NCT00322231|4207933|P1|STARTED|Period 1||51
1719346|NCT00322153|4207945|P2|NOT COMPLETED|Overall Study||69
1719347|NCT00322153|4207946|P1|NOT COMPLETED|Overall Study||63
1719348|NCT00322153|4207945|P2|COMPLETED|Overall Study||273
1719349|NCT00322153|4207946|P1|COMPLETED|Overall Study||272
1719350|NCT00322153|4207945|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
1719351|NCT00322153|4207946|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
1719352|NCT00322153|4207945|P2|STARTED|Overall Study|Randomized to Memantine ER|342
1719353|NCT00322153|4207946|P1|STARTED|Overall Study|Randomized to placebo|335
1719354|NCT00322101|4207958|P2|NOT COMPLETED|Overall Study||0
1719355|NCT00322101|4207959|P1|NOT COMPLETED|Overall Study||0
1719356|NCT00322101|4207958|P2|COMPLETED|Overall Study||11
1719357|NCT00322101|4207959|P1|COMPLETED|Overall Study||14
1719358|NCT00322101|4207958|P2|STARTED|Overall Study||11
1719359|NCT00322101|4207959|P1|STARTED|Overall Study||14
1719360|NCT00322049|4207979|P4|NOT COMPLETED|Overall Study||1
1719361|NCT00322049|4207980|P3|NOT COMPLETED|Overall Study||0
1719362|NCT00322049|4207981|P2|NOT COMPLETED|Overall Study||1
1719363|NCT00322049|4207982|P1|NOT COMPLETED|Overall Study||0
1719364|NCT00322049|4207979|P4|COMPLETED|Overall Study||16
1719365|NCT00322049|4207980|P3|COMPLETED|Overall Study||20
1719366|NCT00322049|4207981|P2|COMPLETED|Overall Study||9
1719367|NCT00322049|4207982|P1|COMPLETED|Overall Study||4
1719368|NCT00322049|4207979|P4|STARTED|Overall Study||17
1719369|NCT00322049|4207980|P3|STARTED|Overall Study||20
1719370|NCT00322049|4207981|P2|STARTED|Overall Study||10
1719371|NCT00322049|4207982|P1|STARTED|Overall Study||4
1719372|NCT00321984|4208015|P3|NOT COMPLETED|Overall Study||26
1719373|NCT00321984|4208016|P2|NOT COMPLETED|Overall Study||21
1719374|NCT00321984|4208017|P1|NOT COMPLETED|Overall Study||27
1719375|NCT00321984|4208015|P3|COMPLETED|Overall Study||289
1719376|NCT00321984|4208016|P2|COMPLETED|Overall Study||294
1719377|NCT00321984|4208017|P1|COMPLETED|Overall Study||290
1719378|NCT00321984|4208015|P3|STARTED|Overall Study||315
1719379|NCT00321984|4208016|P2|STARTED|Overall Study||315
1719380|NCT00321984|4208017|P1|STARTED|Overall Study||317
1719381|NCT00321971|4208036|P2|NOT COMPLETED|Overall Study||11
1719382|NCT00321971|4208037|P1|NOT COMPLETED|Overall Study||8
1719383|NCT00321971|4208036|P2|COMPLETED|Overall Study||26
1719384|NCT00321971|4208037|P1|COMPLETED|Overall Study||28
1719385|NCT00321971|4208036|P2|STARTED|Overall Study||37
1719386|NCT00321971|4208037|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
1719387|NCT00321932|4208045|P2|NOT COMPLETED|Overall Study||21
1719388|NCT00321932|4208046|P1|NOT COMPLETED|Overall Study||10
1719389|NCT00321932|4208045|P2|COMPLETED|Overall Study||11
1719390|NCT00321932|4208046|P1|COMPLETED|Overall Study||19
1719391|NCT00321932|4208045|P2|STARTED|Overall Study||32
1719392|NCT00321932|4208046|P1|STARTED|Overall Study||29
1719393|NCT00321919|4208070|P2|NOT COMPLETED|Overall Study||52
1719394|NCT00321919|4208071|P1|NOT COMPLETED|Overall Study||75
1719395|NCT00321919|4208070|P2|COMPLETED|Overall Study||250
1719396|NCT00321919|4208071|P1|COMPLETED|Overall Study||226
1719397|NCT00321919|4208070|P2|STARTED|Overall Study||302
1719398|NCT00321919|4208071|P1|STARTED|Overall Study||301
1719399|NCT00321906|4208113|P2|NOT COMPLETED|Overall Study||56
1719400|NCT00321906|4208114|P1|NOT COMPLETED|Overall Study||46
1719401|NCT00321906|4208113|P2|COMPLETED|Overall Study||31
1719402|NCT00321906|4208114|P1|COMPLETED|Overall Study||48
1719403|NCT00321906|4208113|P2|STARTED|Overall Study||87
1719404|NCT00321906|4208114|P1|STARTED|Overall Study||94
1719405|NCT00321893|4208136|P2|NOT COMPLETED|Overall Study||14
1719406|NCT00321893|4208137|P1|NOT COMPLETED|Overall Study||24
1719407|NCT00321893|4208136|P2|COMPLETED|Overall Study||87
1719408|NCT00321893|4208137|P1|COMPLETED|Overall Study||77
1719409|NCT00321893|4208136|P2|STARTED|Overall Study||101
1719410|NCT00321893|4208137|P1|STARTED|Overall Study||101
1719411|NCT00321854|4208151|P2|NOT COMPLETED|Overall Study||82
1719412|NCT00321854|4208152|P1|NOT COMPLETED|Overall Study||63
1719413|NCT00321854|4208151|P2|COMPLETED|Overall Study||192
1719414|NCT00321854|4208152|P1|COMPLETED|Overall Study||198
1719415|NCT00321854|4208151|P2|STARTED|Overall Study||274
1719416|NCT00321854|4208152|P1|STARTED|Overall Study||261
1719417|NCT00321828|4208270|P1|NOT COMPLETED|Overall Study||4
1719418|NCT00321828|4208270|P1|COMPLETED|Overall Study||86
1719419|NCT00321828|4208270|P1|STARTED|Overall Study||90
1719420|NCT00321789|4208276|P2|NOT COMPLETED|Overall Study||16
1719421|NCT00321789|4208277|P1|NOT COMPLETED|Overall Study||15
1719422|NCT00321789|4208276|P2|COMPLETED|Overall Study||112
1719423|NCT00321789|4208277|P1|COMPLETED|Overall Study||112
1719424|NCT00321789|4208276|P2|STARTED|Overall Study||128
1719425|NCT00321789|4208277|P1|STARTED|Overall Study||127
1719426|NCT00321763|4208309|P4|NOT COMPLETED|Overall Study||5
1719427|NCT00321763|4208310|P3|NOT COMPLETED|Overall Study||6
1719428|NCT00321763|4208311|P2|NOT COMPLETED|Overall Study||2
1719429|NCT00321763|4208312|P1|NOT COMPLETED|Overall Study||6
1719430|NCT00321763|4208309|P4|COMPLETED|Overall Study||565
1719431|NCT00321763|4208310|P3|COMPLETED|Overall Study||848
1719432|NCT00321763|4208311|P2|COMPLETED|Overall Study||848
1719433|NCT00321763|4208312|P1|COMPLETED|Overall Study||844
1719434|NCT00321763|4208309|P4|STARTED|Overall Study||570
1719435|NCT00321763|4208310|P3|STARTED|Overall Study||854
1719436|NCT00321763|4208311|P2|STARTED|Overall Study||850
1719437|NCT00321763|4208312|P1|STARTED|Overall Study||850
1719438|NCT00321737|4208372|P3|NOT COMPLETED|Overall Study||54
1719439|NCT00321737|4208373|P2|NOT COMPLETED|Overall Study||48
1719440|NCT00321737|4208374|P1|NOT COMPLETED|Overall Study||122
1719441|NCT00321737|4208372|P3|COMPLETED|Overall Study||104
1719442|NCT00321737|4208373|P2|COMPLETED|Overall Study||92
1719443|NCT00321737|4208374|P1|COMPLETED|Overall Study||25
1719444|NCT00321737|4208372|P3|STARTED|Overall Study||158
1719445|NCT00321737|4208373|P2|STARTED|Overall Study||140
1719446|NCT00321737|4208374|P1|STARTED|Overall Study||147
1719447|NCT00321711|4208402|P5|NOT COMPLETED|Part B||5
1719448|NCT00321711|4208403|P4|NOT COMPLETED|Part B||6
1719449|NCT00321711|4208404|P3|NOT COMPLETED|Part B||0
1719450|NCT00321711|4208405|P2|NOT COMPLETED|Part B||0
1719451|NCT00321711|4208406|P1|NOT COMPLETED|Part B||0
1719452|NCT00321711|4208402|P5|COMPLETED|Part B||10
1719453|NCT00321711|4208403|P4|COMPLETED|Part B||8
1719454|NCT00321711|4208404|P3|COMPLETED|Part B||0
1719455|NCT00321711|4208405|P2|COMPLETED|Part B||0
1719456|NCT00321711|4208406|P1|COMPLETED|Part B||0
1719457|NCT00321711|4208402|P5|STARTED|Part B||15
1719458|NCT00321711|4208403|P4|STARTED|Part B||14
1719459|NCT00321711|4208404|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
1719460|NCT00321711|4208405|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
1719461|NCT00321711|4208406|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
1719462|NCT00321711|4208402|P5|NOT COMPLETED|Part A||0
1719463|NCT00321711|4208403|P4|NOT COMPLETED|Part A||0
1719464|NCT00321711|4208404|P3|NOT COMPLETED|Part A||11
1719465|NCT00321711|4208405|P2|NOT COMPLETED|Part A||10
1719466|NCT00321711|4208406|P1|NOT COMPLETED|Part A||5
1719467|NCT00321711|4208402|P5|COMPLETED|Part A||0
1719468|NCT00321711|4208403|P4|COMPLETED|Part A||0
1719469|NCT00321711|4208404|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
1719470|NCT00321711|4208405|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
1719471|NCT00321711|4208406|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
1719472|NCT00321711|4208402|P5|STARTED|Part A||0
1719473|NCT00321711|4208403|P4|STARTED|Part A||0
1719474|NCT00321711|4208404|P3|STARTED|Part A||14
1719475|NCT00321711|4208405|P2|STARTED|Part A||13
1719476|NCT00321711|4208406|P1|STARTED|Part A||13
1719477|NCT00321698|4208438|P5|NOT COMPLETED|Phase II, MTD Dose||0
1719478|NCT00321698|4208439|P4|NOT COMPLETED|Phase II, MTD Dose||0
1719479|NCT00321698|4208440|P3|NOT COMPLETED|Phase II, MTD Dose||0
1719480|NCT00321698|4208441|P2|NOT COMPLETED|Phase II, MTD Dose||0
1719481|NCT00321698|4208442|P1|NOT COMPLETED|Phase II, MTD Dose||0
1719482|NCT00321698|4208438|P5|COMPLETED|Phase II, MTD Dose||13
1719483|NCT00321698|4208439|P4|COMPLETED|Phase II, MTD Dose||0
1719484|NCT00321698|4208440|P3|COMPLETED|Phase II, MTD Dose||0
1719485|NCT00321698|4208441|P2|COMPLETED|Phase II, MTD Dose||0
1719486|NCT00321698|4208442|P1|COMPLETED|Phase II, MTD Dose||0
1719487|NCT00321698|4208438|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
1719488|NCT00321698|4208439|P4|STARTED|Phase II, MTD Dose||0
1719489|NCT00321698|4208440|P3|STARTED|Phase II, MTD Dose||0
1719490|NCT00321698|4208441|P2|STARTED|Phase II, MTD Dose||0
1719491|NCT00321698|4208442|P1|STARTED|Phase II, MTD Dose||0
1719492|NCT00321698|4208438|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1719493|NCT00321698|4208439|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1719494|NCT00321698|4208440|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1719495|NCT00321698|4208441|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1719496|NCT00321698|4208442|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
1719497|NCT00321698|4208438|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
1719498|NCT00321698|4208439|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
1719499|NCT00321698|4208440|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
1719500|NCT00321698|4208441|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
1719501|NCT00321698|4208442|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
1719502|NCT00321698|4208438|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
1719503|NCT00321698|4208439|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
1719504|NCT00321698|4208440|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
1719505|NCT00321698|4208441|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
1719506|NCT00321698|4208442|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
1719507|NCT00321685|4208456|P1|NOT COMPLETED|Overall Study||39
1719508|NCT00321685|4208456|P1|COMPLETED|Overall Study||18
1719509|NCT00321685|4208456|P1|Eligible and Treated|Overall Study||53
1719510|NCT00321685|4208456|P1|Started Protocol Therapy|Overall Study||55
1719511|NCT00321685|4208456|P1|Eligible|Overall Study||55
1719512|NCT00321685|4208456|P1|STARTED|Overall Study||57
1719513|NCT00321672|4208468|P4|NOT COMPLETED|Overall Study||2
1719514|NCT00321672|4208469|P3|NOT COMPLETED|Overall Study||11
1719515|NCT00321672|4208470|P2|NOT COMPLETED|Overall Study||8
1719516|NCT00321672|4208471|P1|NOT COMPLETED|Overall Study||12
1719517|NCT00321672|4208468|P4|COMPLETED|Overall Study||71
1719518|NCT00321672|4208469|P3|COMPLETED|Overall Study||156
1719519|NCT00321672|4208470|P2|COMPLETED|Overall Study||81
1719520|NCT00321672|4208471|P1|COMPLETED|Overall Study||153
1719521|NCT00321672|4208468|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
1719522|NCT00321672|4208469|P3|STARTED|Overall Study||167
1719523|NCT00321672|4208470|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
1719524|NCT00321672|4208471|P1|STARTED|Overall Study||165
1719525|NCT00321646|4208497|P1|NOT COMPLETED|Prostatectomy||0
1719526|NCT00321646|4208497|P1|COMPLETED|Prostatectomy||37
1719527|NCT00321646|4208497|P1|STARTED|Prostatectomy||37
1719528|NCT00321646|4208497|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
1719529|NCT00321646|4208497|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
1719530|NCT00321646|4208497|P1|STARTED|Neoadjuvant Chemotherapy||42
1719531|NCT00321620|4208504|P2|NOT COMPLETED|Overall Study||722
1719532|NCT00321620|4208505|P1|NOT COMPLETED|Overall Study||743
1719533|NCT00321620|4208504|P2|COMPLETED|Overall Study||228
1719534|NCT00321620|4208505|P1|COMPLETED|Overall Study||208
1719535|NCT00321620|4208504|P2|Received Investigational Product|Overall Study||942
1719536|NCT00321620|4208505|P1|Received Investigational Product|Overall Study||946
1719537|NCT00321620|4208504|P2|STARTED|Overall Study||950
1719538|NCT00321620|4208505|P1|STARTED|Overall Study||951
1719539|NCT00321594|4208517|P5|NOT COMPLETED|Phase II, MTD Dose||0
1719540|NCT00321594|4208518|P4|NOT COMPLETED|Phase II, MTD Dose||0
1719541|NCT00321594|4208519|P3|NOT COMPLETED|Phase II, MTD Dose||0
1719542|NCT00321594|4208520|P2|NOT COMPLETED|Phase II, MTD Dose||0
1719543|NCT00321594|4208521|P1|NOT COMPLETED|Phase II, MTD Dose||0
1719544|NCT00321594|4208517|P5|COMPLETED|Phase II, MTD Dose||36
1719545|NCT00321594|4208518|P4|COMPLETED|Phase II, MTD Dose||6
1719546|NCT00321594|4208519|P3|COMPLETED|Phase II, MTD Dose||0
1719547|NCT00321594|4208520|P2|COMPLETED|Phase II, MTD Dose||0
1719548|NCT00321594|4208521|P1|COMPLETED|Phase II, MTD Dose||0
1719549|NCT00321594|4208517|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
1719550|NCT00321594|4208518|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
1719551|NCT00321594|4208519|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
1719552|NCT00321594|4208520|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
1719553|NCT00321594|4208521|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
1719554|NCT00321594|4208517|P5|NOT COMPLETED|Phase I, Level 1-4||0
1719555|NCT00321594|4208518|P4|NOT COMPLETED|Phase I, Level 1-4||0
1719556|NCT00321594|4208519|P3|NOT COMPLETED|Phase I, Level 1-4||0
1719557|NCT00321594|4208520|P2|NOT COMPLETED|Phase I, Level 1-4||0
1719558|NCT00321594|4208521|P1|NOT COMPLETED|Phase I, Level 1-4||0
1719559|NCT00321594|4208517|P5|COMPLETED|Phase I, Level 1-4||0
1719560|NCT00321594|4208518|P4|COMPLETED|Phase I, Level 1-4||6
1719561|NCT00321594|4208519|P3|COMPLETED|Phase I, Level 1-4||6
1719562|NCT00321594|4208520|P2|COMPLETED|Phase I, Level 1-4||3
1719563|NCT00321594|4208521|P1|COMPLETED|Phase I, Level 1-4||3
1719564|NCT00321594|4208517|P5|STARTED|Phase I, Level 1-4||0
1719565|NCT00321594|4208518|P4|STARTED|Phase I, Level 1-4||6
1719566|NCT00321594|4208519|P3|STARTED|Phase I, Level 1-4||6
1719567|NCT00321594|4208520|P2|STARTED|Phase I, Level 1-4||3
1719568|NCT00321594|4208521|P1|STARTED|Phase I, Level 1-4||3
1719569|NCT00321464|4208535|P2|NOT COMPLETED|Overall Study||558
1719570|NCT00321464|4208536|P1|NOT COMPLETED|Overall Study||559
1719571|NCT00321464|4208535|P2|COMPLETED|Overall Study||468
1719572|NCT00321464|4208536|P1|COMPLETED|Overall Study||461
1719573|NCT00321464|4208535|P2|Received Investigational Product|Overall Study||1019
1719574|NCT00321464|4208536|P1|Received Investigational Product|Overall Study||1014
1719575|NCT00321464|4208535|P2|STARTED|Overall Study||1026
1719576|NCT00321464|4208536|P1|STARTED|Overall Study||1020
1719577|NCT00321373|4208549|P3|NOT COMPLETED|Overall Study||3
1719578|NCT00321373|4208550|P2|NOT COMPLETED|Overall Study||0
1719579|NCT00321373|4208551|P1|NOT COMPLETED|Overall Study||2
1719580|NCT00321373|4208549|P3|COMPLETED|Overall Study||404
1719581|NCT00321373|4208550|P2|COMPLETED|Overall Study||406
1719582|NCT00321373|4208551|P1|COMPLETED|Overall Study||405
1719583|NCT00321373|4208549|P3|STARTED|Overall Study||407
1719584|NCT00321373|4208550|P2|STARTED|Overall Study||406
1719585|NCT00321373|4208551|P1|STARTED|Overall Study||407
1719586|NCT00321321|4208574|P1|NOT COMPLETED|Overall Study||0
1719587|NCT00321321|4208574|P1|COMPLETED|Overall Study||12
1719588|NCT00321321|4208574|P1|STARTED|Overall Study||12
1719589|NCT00321269|4208580|P2|NOT COMPLETED|Overall Study||6
1719590|NCT00321269|4208581|P1|NOT COMPLETED|Overall Study||8
1719591|NCT00321269|4208580|P2|COMPLETED|Overall Study||68
1719592|NCT00321269|4208581|P1|COMPLETED|Overall Study||66
1719593|NCT00321269|4208580|P2|STARTED|Overall Study||74
1719594|NCT00321269|4208581|P1|STARTED|Overall Study||74
1719595|NCT00320801|4208591|P4|NOT COMPLETED|Extension Phase||48
1719596|NCT00320801|4208592|P3|NOT COMPLETED|Extension Phase||0
1719597|NCT00320801|4208593|P2|NOT COMPLETED|Extension Phase||0
1719598|NCT00320801|4208594|P1|NOT COMPLETED|Extension Phase||0
1719599|NCT00320801|4208591|P4|COMPLETED|Extension Phase||7
1719600|NCT00320801|4208592|P3|COMPLETED|Extension Phase||0
1719601|NCT00320801|4208593|P2|COMPLETED|Extension Phase||0
1719602|NCT00320801|4208594|P1|COMPLETED|Extension Phase||0
1719603|NCT00320801|4208591|P4|STARTED|Extension Phase||55
1719604|NCT00320801|4208592|P3|STARTED|Extension Phase||0
1719605|NCT00320801|4208593|P2|STARTED|Extension Phase||0
1719606|NCT00320801|4208594|P1|STARTED|Extension Phase||0
1719607|NCT00320801|4208591|P4|NOT COMPLETED|Double-blind Phase||0
1719608|NCT00320801|4208592|P3|NOT COMPLETED|Double-blind Phase||14
1719609|NCT00320801|4208593|P2|NOT COMPLETED|Double-blind Phase||11
1719610|NCT00320801|4208594|P1|NOT COMPLETED|Double-blind Phase||0
1719611|NCT00320801|4208591|P4|COMPLETED|Double-blind Phase||0
1719612|NCT00320801|4208592|P3|COMPLETED|Double-blind Phase||35
1719613|NCT00320801|4208593|P2|COMPLETED|Double-blind Phase||36
1719614|NCT00320801|4208594|P1|COMPLETED|Double-blind Phase||0
1719615|NCT00320801|4208591|P4|STARTED|Double-blind Phase||0
1719616|NCT00320801|4208592|P3|STARTED|Double-blind Phase||49
1719617|NCT00320801|4208593|P2|STARTED|Double-blind Phase||47
1719618|NCT00320801|4208594|P1|STARTED|Double-blind Phase||0
1719619|NCT00320801|4208591|P4|NOT COMPLETED|Open-label Run-in Period||0
1719620|NCT00320801|4208592|P3|NOT COMPLETED|Open-label Run-in Period||0
1719621|NCT00320801|4208593|P2|NOT COMPLETED|Open-label Run-in Period||0
1719622|NCT00320801|4208594|P1|NOT COMPLETED|Open-label Run-in Period||92
1719623|NCT00320801|4208591|P4|COMPLETED|Open-label Run-in Period||0
1719624|NCT00320801|4208592|P3|COMPLETED|Open-label Run-in Period||0
1719625|NCT00320801|4208593|P2|COMPLETED|Open-label Run-in Period||0
1719626|NCT00320801|4208594|P1|COMPLETED|Open-label Run-in Period||96
1719627|NCT00320801|4208591|P4|STARTED|Open-label Run-in Period||0
1719628|NCT00320801|4208592|P3|STARTED|Open-label Run-in Period||0
1719629|NCT00320801|4208593|P2|STARTED|Open-label Run-in Period||0
1719630|NCT00320801|4208594|P1|STARTED|Open-label Run-in Period||188
1719631|NCT00320788|4208609|P5|NOT COMPLETED|Overall Study||5
1719632|NCT00320788|4208610|P4|NOT COMPLETED|Overall Study||5
1719633|NCT00320788|4208611|P3|NOT COMPLETED|Overall Study||3
1719634|NCT00320788|4208612|P2|NOT COMPLETED|Overall Study||6
1719635|NCT00320788|4208613|P1|NOT COMPLETED|Overall Study||6
1719636|NCT00320788|4208609|P5|COMPLETED|Overall Study||26
1719637|NCT00320788|4208610|P4|COMPLETED|Overall Study||27
1719638|NCT00320788|4208611|P3|COMPLETED|Overall Study||29
1719639|NCT00320788|4208612|P2|COMPLETED|Overall Study||26
1719640|NCT00320788|4208613|P1|COMPLETED|Overall Study||26
1719641|NCT00320788|4208609|P5|Participants Received Treatment (SAF)|Overall Study||31
1719642|NCT00320788|4208610|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
1719643|NCT00320788|4208611|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
1719644|NCT00320788|4208612|P2|Participants Received Treatment (SAF)|Overall Study||32
1719645|NCT00320788|4208613|P1|Participants Received Treatment (SAF)|Overall Study||32
1719646|NCT00320788|4208609|P5|STARTED|Overall Study||31
1719647|NCT00320788|4208610|P4|STARTED|Overall Study|Participants Randomized|32
1719648|NCT00320788|4208611|P3|STARTED|Overall Study||32
1719649|NCT00320788|4208612|P2|STARTED|Overall Study||32
1719650|NCT00320788|4208613|P1|STARTED|Overall Study||32
1719651|NCT00320749|4208656|P3|NOT COMPLETED|Overall Study||9
1719652|NCT00320749|4208657|P2|NOT COMPLETED|Overall Study||2
1719653|NCT00320749|4208658|P1|NOT COMPLETED|Overall Study||0
1719654|NCT00320749|4208656|P3|COMPLETED|Overall Study||1
1719655|NCT00320749|4208657|P2|COMPLETED|Overall Study||6
1719656|NCT00320749|4208658|P1|COMPLETED|Overall Study||3
1719657|NCT00320749|4208656|P3|STARTED|Overall Study||10
1719658|NCT00320749|4208657|P2|STARTED|Overall Study||8
1719659|NCT00320749|4208658|P1|STARTED|Overall Study||3
1719660|NCT00320710|4208667|P3|NOT COMPLETED|Overall Study||5
1719661|NCT00320710|4208668|P2|NOT COMPLETED|Overall Study||76
1719662|NCT00320710|4208669|P1|NOT COMPLETED|Overall Study||94
1719663|NCT00320710|4208667|P3|COMPLETED|Overall Study||8
1719664|NCT00320710|4208668|P2|COMPLETED|Overall Study||127
1719665|NCT00320710|4208669|P1|COMPLETED|Overall Study||106
1719666|NCT00320710|4208667|P3|Treated (Safety Set)|Overall Study||13
1719667|NCT00320710|4208668|P2|Treated (Safety Set)|Overall Study||202
1719668|NCT00320710|4208669|P1|Treated (Safety Set)|Overall Study||198
1719669|NCT00320710|4208667|P3|STARTED|Overall Study||13
1719670|NCT00320710|4208668|P2|STARTED|Overall Study||203
1719671|NCT00320710|4208669|P1|STARTED|Overall Study||200
1719672|NCT00320671|4208692|P2|NOT COMPLETED|Overall Study||38
1719673|NCT00320671|4208693|P1|NOT COMPLETED|Overall Study||33
1719674|NCT00320671|4208692|P2|COMPLETED|Overall Study||58
1719675|NCT00320671|4208693|P1|COMPLETED|Overall Study||69
1719676|NCT00320671|4208692|P2|STARTED|Overall Study||96
1719677|NCT00320671|4208693|P1|STARTED|Overall Study||102
1719678|NCT00320606|4208699|P1|NOT COMPLETED|Overall Study||3
1719679|NCT00320606|4208699|P1|COMPLETED|Overall Study||17
1719680|NCT00320606|4208699|P1|STARTED|Overall Study||20
1719681|NCT00320593|4208715|P2|NOT COMPLETED|Overall Study||1
1719682|NCT00320593|4208716|P1|NOT COMPLETED|Overall Study||7
1719683|NCT00320593|4208715|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
1719684|NCT00320593|4208716|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
1719685|NCT00320593|4208715|P2|STARTED|Overall Study||59
1719686|NCT00320593|4208716|P1|STARTED|Overall Study||59
1719687|NCT00320541|4208740|P2|NOT COMPLETED|Overall Study||57
1719688|NCT00320541|4208741|P1|NOT COMPLETED|Overall Study||50
1719689|NCT00320541|4208740|P2|COMPLETED|Overall Study||36
1719690|NCT00320541|4208741|P1|COMPLETED|Overall Study||44
1719691|NCT00320541|4208740|P2|STARTED|Overall Study||93
1719692|NCT00320541|4208741|P1|STARTED|Overall Study||94
1719693|NCT00320528|4208768|P3|NOT COMPLETED|Study Period III||106
1719694|NCT00320528|4208769|P2|NOT COMPLETED|Study Period III||31
1719695|NCT00320528|4208770|P1|NOT COMPLETED|Study Period III||87
1719696|NCT00320528|4208768|P3|COMPLETED|Study Period III||2
1719697|NCT00320528|4208769|P2|COMPLETED|Study Period III||0
1719698|NCT00320528|4208770|P1|COMPLETED|Study Period III||0
1719699|NCT00320528|4208768|P3|STARTED|Study Period III||108
1719700|NCT00320528|4208769|P2|STARTED|Study Period III||31
1719701|NCT00320528|4208770|P1|STARTED|Study Period III||87
1719702|NCT00320528|4208768|P3|NOT COMPLETED|Study Period II||22
1719703|NCT00320528|4208769|P2|NOT COMPLETED|Study Period II||10
1719704|NCT00320528|4208770|P1|NOT COMPLETED|Study Period II||11
1719705|NCT00320528|4208768|P3|COMPLETED|Study Period II||108
1719706|NCT00320528|4208769|P2|COMPLETED|Study Period II||31
1719707|NCT00320528|4208770|P1|COMPLETED|Study Period II||87
1719708|NCT00320528|4208768|P3|Received at Least One Dose of Study Drug|Study Period II||128
1719709|NCT00320528|4208769|P2|Received at Least One Dose of Study Drug|Study Period II||38
1719710|NCT00320528|4208770|P1|Received at Least One Dose of Study Drug|Study Period II||97
1719711|NCT00320528|4208768|P3|STARTED|Study Period II||130
1719712|NCT00320528|4208769|P2|STARTED|Study Period II||41
1719713|NCT00320528|4208770|P1|STARTED|Study Period II||98
1719714|NCT00320515|4208805|P1|NOT COMPLETED|Overall Study||49
1719715|NCT00320515|4208805|P1|COMPLETED|Overall Study||20
1719716|NCT00320515|4208805|P1|STARTED|Overall Study||69
1719717|NCT00320489|4208814|P2|NOT COMPLETED|Overall Study||136
1719718|NCT00320489|4208815|P1|NOT COMPLETED|Overall Study||145
1719719|NCT00320489|4208814|P2|COMPLETED|Overall Study||124
1719720|NCT00320489|4208815|P1|COMPLETED|Overall Study||119
1719721|NCT00320489|4208814|P2|STARTED|Overall Study||260
1719722|NCT00320489|4208815|P1|STARTED|Overall Study||264
1719723|NCT00320424|4208871|P1|NOT COMPLETED|Overall Study||6
1719724|NCT00320424|4208871|P1|COMPLETED|Overall Study||42
1719725|NCT00320424|4208871|P1|STARTED|Overall Study||48
1719726|NCT00320411|4208885|P1|NOT COMPLETED|Overall Study||4
1719727|NCT00320411|4208885|P1|COMPLETED|Overall Study||58
1719728|NCT00320411|4208885|P1|STARTED|Overall Study||62
1719729|NCT00320398|4208908|P2|NOT COMPLETED|Overall Study||4
1719730|NCT00320398|4208909|P1|NOT COMPLETED|Overall Study||2
1719731|NCT00320398|4208908|P2|COMPLETED|Overall Study||52
1719732|NCT00320398|4208909|P1|COMPLETED|Overall Study||56
1719733|NCT00320398|4208908|P2|STARTED|Overall Study||56
1719734|NCT00320398|4208909|P1|STARTED|Overall Study||58
1719735|NCT00320385|4208937|P2|NOT COMPLETED|Overall Study||22
1719736|NCT00320385|4208938|P1|NOT COMPLETED|Overall Study||18
1719737|NCT00320385|4208937|P2|COMPLETED|Overall Study||126
1719738|NCT00320385|4208938|P1|COMPLETED|Overall Study||130
1719739|NCT00320385|4208937|P2|STARTED|Overall Study||148
1719740|NCT00320385|4208938|P1|STARTED|Overall Study||148
1719741|NCT00320372|4208961|P2|NOT COMPLETED|Overall Study||163
1719742|NCT00320372|4208962|P1|NOT COMPLETED|Overall Study||195
1719743|NCT00320372|4208961|P2|COMPLETED|Overall Study||138
1719744|NCT00320372|4208962|P1|COMPLETED|Overall Study||299
1719745|NCT00320372|4208961|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
1719746|NCT00320372|4208962|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
1719747|NCT00320372|4208961|P2|VNS Therapy D-23 Original|Overall Study||0
1719748|NCT00320372|4208962|P1|VNS Therapy D-23 Original|Overall Study||335
1719749|NCT00320372|4208961|P2|STARTED|Overall Study||301
1719750|NCT00320372|4208962|P1|STARTED|Overall Study||494
1719751|NCT00320281|4208989|P2|NOT COMPLETED|Overall Study||0
1719752|NCT00320281|4208990|P1|NOT COMPLETED|Overall Study||0
1719753|NCT00320281|4208989|P2|COMPLETED|Overall Study||9
1719754|NCT00320281|4208990|P1|COMPLETED|Overall Study||10
1719755|NCT00320281|4208989|P2|STARTED|Overall Study||9
1719756|NCT00320281|4208990|P1|STARTED|Overall Study||10
1719757|NCT00320255|4209002|P6|NOT COMPLETED|Overall Study||0
1719758|NCT00320255|4209003|P5|NOT COMPLETED|Overall Study||0
1719759|NCT00320255|4209004|P4|NOT COMPLETED|Overall Study||8
1719760|NCT00320255|4209005|P3|NOT COMPLETED|Overall Study||6
1719761|NCT00320255|4209006|P2|NOT COMPLETED|Overall Study||7
1719762|NCT00320255|4209007|P1|NOT COMPLETED|Overall Study||11
1719763|NCT00320255|4209002|P6|COMPLETED|Overall Study||3
1719764|NCT00320255|4209003|P5|COMPLETED|Overall Study||2
1719765|NCT00320255|4209004|P4|COMPLETED|Overall Study||25
1719766|NCT00320255|4209005|P3|COMPLETED|Overall Study||24
1719767|NCT00320255|4209006|P2|COMPLETED|Overall Study||25
1719768|NCT00320255|4209007|P1|COMPLETED|Overall Study||19
1719769|NCT00320255|4209002|P6|Received Treatment|Overall Study||3
1719770|NCT00320255|4209003|P5|Received Treatment|Overall Study||2
1719771|NCT00320255|4209004|P4|Received Treatment|Overall Study||32
1719772|NCT00320255|4209005|P3|Received Treatment|Overall Study||29
1719773|NCT00320255|4209006|P2|Received Treatment|Overall Study||32
1719774|NCT00320255|4209007|P1|Received Treatment|Overall Study||29
1719775|NCT00320255|4209002|P6|STARTED|Overall Study||3
1719776|NCT00320255|4209003|P5|STARTED|Overall Study||2
1719777|NCT00320255|4209004|P4|STARTED|Overall Study||33
1719778|NCT00320255|4209005|P3|STARTED|Overall Study||30
1719779|NCT00320255|4209006|P2|STARTED|Overall Study||32
1719780|NCT00320255|4209007|P1|STARTED|Overall Study||30
1719781|NCT00320242|4209087|P2|NOT COMPLETED|Overall Study||4
1719782|NCT00320242|4209088|P1|NOT COMPLETED|Overall Study||2
1719783|NCT00320242|4209087|P2|COMPLETED|Overall Study||12
1719784|NCT00320242|4209088|P1|COMPLETED|Overall Study||14
1719785|NCT00320242|4209087|P2|STARTED|Overall Study||16
1719786|NCT00320242|4209088|P1|STARTED|Overall Study||16
1719787|NCT00320216|4209100|P5|NOT COMPLETED|Overall Study||6
1719788|NCT00320216|4209101|P4|NOT COMPLETED|Overall Study||3
1719789|NCT00320216|4209102|P3|NOT COMPLETED|Overall Study||6
1719790|NCT00320216|4209103|P2|NOT COMPLETED|Overall Study||10
1719791|NCT00320216|4209104|P1|NOT COMPLETED|Overall Study||16
1719792|NCT00320216|4209100|P5|COMPLETED|Overall Study||58
1719793|NCT00320216|4209101|P4|COMPLETED|Overall Study||61
1719794|NCT00320216|4209102|P3|COMPLETED|Overall Study||58
1719795|NCT00320216|4209103|P2|COMPLETED|Overall Study||54
1719796|NCT00320216|4209104|P1|COMPLETED|Overall Study||48
1719797|NCT00320216|4209100|P5|STARTED|Overall Study||64
1719798|NCT00320216|4209101|P4|STARTED|Overall Study||64
1719799|NCT00320216|4209102|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
1719800|NCT00320216|4209103|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
1719801|NCT00320216|4209104|P1|STARTED|Overall Study||64
1719802|NCT00320190|4209138|P2|NOT COMPLETED|Long-term (12-month) Extension||2
1719803|NCT00320190|4209139|P1|NOT COMPLETED|Long-term (12-month) Extension||9
1719804|NCT00320190|4209138|P2|COMPLETED|Long-term (12-month) Extension||1
1719805|NCT00320190|4209139|P1|COMPLETED|Long-term (12-month) Extension||2
1719806|NCT00320190|4209138|P2|STARTED|Long-term (12-month) Extension||3
1719807|NCT00320190|4209139|P1|STARTED|Long-term (12-month) Extension||11
1719808|NCT00320190|4209138|P2|NOT COMPLETED|First 12 Months||10
1719809|NCT00320190|4209139|P1|NOT COMPLETED|First 12 Months||8
1719810|NCT00320190|4209138|P2|COMPLETED|First 12 Months||3
1719811|NCT00320190|4209139|P1|COMPLETED|First 12 Months||11
1719812|NCT00320190|4209138|P2|STARTED|First 12 Months||13
1719813|NCT00320190|4209139|P1|STARTED|First 12 Months||19
1719814|NCT00320112|4209159|P2|NOT COMPLETED|Overall Study||5
1719815|NCT00320112|4209160|P1|NOT COMPLETED|Overall Study||8
1719816|NCT00320112|4209159|P2|COMPLETED|Overall Study||114
1719817|NCT00320112|4209160|P1|COMPLETED|Overall Study||117
1719818|NCT00320112|4209159|P2|STARTED|Overall Study||119
1719819|NCT00320112|4209160|P1|STARTED|Overall Study||125
1719820|NCT00319982|4209174|P2|NOT COMPLETED|Overall Study||0
1719821|NCT00319982|4209175|P1|NOT COMPLETED|Overall Study||1
1719822|NCT00319982|4209174|P2|COMPLETED|Overall Study||20
1719823|NCT00319982|4209175|P1|COMPLETED|Overall Study||18
1719824|NCT00319982|4209174|P2|STARTED|Overall Study||20
1719825|NCT00319982|4209175|P1|STARTED|Overall Study||19
1719826|NCT00319956|4209195|P2|NOT COMPLETED|Overall Study||24
1719827|NCT00319956|4209196|P1|NOT COMPLETED|Overall Study||20
1719828|NCT00319956|4209195|P2|COMPLETED|Overall Study||85
1719829|NCT00319956|4209196|P1|COMPLETED|Overall Study||91
1719830|NCT00319956|4209195|P2|STARTED|Overall Study||109
1719831|NCT00319956|4209196|P1|STARTED|Overall Study||111
1719832|NCT00319839|4209208|P1|NOT COMPLETED|Overall Study||6
1719833|NCT00319839|4209208|P1|COMPLETED|Overall Study||1
1719834|NCT00319839|4209208|P1|STARTED|Overall Study||7
1719835|NCT00319748|4209214|P1|NOT COMPLETED|Overall Study||0
1719836|NCT00319748|4209214|P1|COMPLETED|Overall Study||13
1719837|NCT00319748|4209214|P1|STARTED|Overall Study||13
1719838|NCT00319735|4209224|P1|NOT COMPLETED|Overall Study||2
1719839|NCT00319735|4209224|P1|COMPLETED|Overall Study||39
1719840|NCT00319735|4209224|P1|STARTED|Overall Study||41
1719841|NCT00319696|4209237|P1|NOT COMPLETED|Overall Study||60
1719842|NCT00319696|4209237|P1|COMPLETED|Overall Study||56
1719843|NCT00319696|4209237|P1|STARTED|Overall Study||116
1719844|NCT00319644|4209262|P2|NOT COMPLETED|Overall Study||0
1719845|NCT00319644|4209263|P1|NOT COMPLETED|Overall Study||0
1719846|NCT00319644|4209262|P2|COMPLETED|Overall Study||16
1719847|NCT00319644|4209263|P1|COMPLETED|Overall Study||21
1719848|NCT00319644|4209262|P2|STARTED|Overall Study||16
1719849|NCT00319644|4209263|P1|STARTED|Overall Study||21
1719850|NCT00319592|4209273|P2|NOT COMPLETED|Overall Study||1
1719851|NCT00319592|4209274|P1|NOT COMPLETED|Overall Study||1
1719852|NCT00319592|4209273|P2|COMPLETED|Overall Study||29
1719853|NCT00319592|4209274|P1|COMPLETED|Overall Study||29
1719854|NCT00319592|4209273|P2|STARTED|Overall Study||30
1719855|NCT00319592|4209274|P1|STARTED|Overall Study||30
1719856|NCT00319553|4209290|P2|NOT COMPLETED|Overall Study||4
1719857|NCT00319553|4209291|P1|NOT COMPLETED|Overall Study||4
1719858|NCT00319553|4209290|P2|COMPLETED|Overall Study||317
1719859|NCT00319553|4209291|P1|COMPLETED|Overall Study||319
1719860|NCT00319553|4209290|P2|STARTED|Overall Study||321
1719861|NCT00319553|4209291|P1|STARTED|Overall Study||323
1719862|NCT00319501|4209305|P2|NOT COMPLETED|Open-label Extension Period||0
1719863|NCT00319501|4209306|P1|NOT COMPLETED|Open-label Extension Period||51
1719864|NCT00319501|4209305|P2|COMPLETED|Open-label Extension Period||0
1719865|NCT00319501|4209306|P1|COMPLETED|Open-label Extension Period||0
1719866|NCT00319501|4209305|P2|Received Treatment|Open-label Extension Period||0
1719867|NCT00319501|4209306|P1|Received Treatment|Open-label Extension Period||33
1719868|NCT00319501|4209305|P2|STARTED|Open-label Extension Period||0
1719869|NCT00319501|4209306|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
1719870|NCT00319501|4209305|P2|NOT COMPLETED|Open-label Period||0
1719871|NCT00319501|4209306|P1|NOT COMPLETED|Open-label Period||116
1719872|NCT00319501|4209305|P2|COMPLETED|Open-label Period||0
1719873|NCT00319501|4209306|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
1719874|NCT00319501|4209305|P2|Received Treatment|Open-label Period||0
1719875|NCT00319501|4209306|P1|Received Treatment|Open-label Period||128
1719876|NCT00319501|4209305|P2|STARTED|Open-label Period||0
1719877|NCT00319501|4209306|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
1719878|NCT00319501|4209305|P2|NOT COMPLETED|Double-blind Period||32
1719879|NCT00319501|4209306|P1|NOT COMPLETED|Double-blind Period||43
1719880|NCT00319501|4209305|P2|COMPLETED|Double-blind Period||78
1719881|NCT00319501|4209306|P1|COMPLETED|Double-blind Period||81
1719882|NCT00319501|4209305|P2|Received Treatment|Double-blind Period||81
1719883|NCT00319501|4209306|P1|Received Treatment|Double-blind Period||82
1719884|NCT00319501|4209305|P2|STARTED|Double-blind Period|Randomized participants|110
1719885|NCT00319501|4209306|P1|STARTED|Double-blind Period|Randomized participants|124
1719886|NCT00319449|4209332|P2|NOT COMPLETED|Overall Study||0
1719887|NCT00319449|4209333|P1|NOT COMPLETED|Overall Study||2
1719888|NCT00319449|4209332|P2|COMPLETED|Overall Study||12
1719889|NCT00319449|4209333|P1|COMPLETED|Overall Study||8
1719890|NCT00319449|4209332|P2|STARTED|Overall Study||12
1719891|NCT00319449|4209333|P1|STARTED|Overall Study||10
1719892|NCT00319436|4209345|P2|NOT COMPLETED|Overall Study||7
1719893|NCT00319436|4209346|P1|NOT COMPLETED|Overall Study||6
1719894|NCT00319436|4209345|P2|COMPLETED|Overall Study||17
1719895|NCT00319436|4209346|P1|COMPLETED|Overall Study||17
1719896|NCT00319436|4209345|P2|STARTED|Overall Study||24
1719897|NCT00319436|4209346|P1|STARTED|Overall Study||23
1719898|NCT00319254|4209364|P1|NOT COMPLETED|Overall Study||54
1719899|NCT00319254|4209364|P1|COMPLETED|Overall Study||21
1719900|NCT00319254|4209364|P1|Treated|Overall Study||73
1719901|NCT00319254|4209364|P1|STARTED|Overall Study||75
1719902|NCT00319111|4209377|P1|NOT COMPLETED|Overall Study||47
1719903|NCT00319111|4209377|P1|COMPLETED|Overall Study||104
1719904|NCT00319111|4209377|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
1719905|NCT00319098|4209391|P2|NOT COMPLETED|Overall Study||32
1719906|NCT00319098|4209392|P1|NOT COMPLETED|Overall Study||135
1719907|NCT00319098|4209391|P2|COMPLETED|Overall Study||1237
1719908|NCT00319098|4209392|P1|COMPLETED|Overall Study||3667
1719909|NCT00319098|4209391|P2|STARTED|Overall Study||1269
1719910|NCT00319098|4209392|P1|STARTED|Overall Study||3802
1719911|NCT00319046|4209450|P1|NOT COMPLETED|Overall Study||8
1719912|NCT00319046|4209450|P1|COMPLETED|Overall Study||34
1719913|NCT00319046|4209450|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
1719914|NCT00319020|4209459|P2|NOT COMPLETED|Overall Study||13
1719915|NCT00319020|4209460|P1|NOT COMPLETED|Overall Study||7
1719916|NCT00319020|4209459|P2|COMPLETED|Overall Study||8
1719917|NCT00319020|4209460|P1|COMPLETED|Overall Study||8
1719918|NCT00319020|4209459|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
1719919|NCT00319020|4209460|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
1719920|NCT00319020|4209459|P2|STARTED|Overall Study||21
1719921|NCT00319020|4209460|P1|STARTED|Overall Study||15
1719922|NCT00318929|4209489|P1|NOT COMPLETED|Overall Study||0
1719923|NCT00318929|4209489|P1|COMPLETED|Overall Study||14
1719924|NCT00318929|4209489|P1|STARTED|Overall Study||14
1719925|NCT00318812|4209498|P2|NOT COMPLETED|Overall Study||0
1719926|NCT00318812|4209499|P1|NOT COMPLETED|Overall Study||0
1719927|NCT00318812|4209498|P2|COMPLETED|Overall Study||22
1719928|NCT00318812|4209499|P1|COMPLETED|Overall Study||18
1719929|NCT00318812|4209498|P2|STARTED|Overall Study||22
1719930|NCT00318812|4209499|P1|STARTED|Overall Study||18
1719931|NCT00318708|4209511|P2|NOT COMPLETED|Overall Study||5
1719932|NCT00318708|4209512|P1|NOT COMPLETED|Overall Study||8
1719933|NCT00318708|4209511|P2|COMPLETED|Overall Study||40
1719934|NCT00318708|4209512|P1|COMPLETED|Overall Study||39
1719935|NCT00318708|4209511|P2|8-week Milestone|Overall Study||42
1719936|NCT00318708|4209512|P1|8-week Milestone|Overall Study||42
1719937|NCT00318708|4209511|P2|STARTED|Overall Study||45
1719938|NCT00318708|4209512|P1|STARTED|Overall Study||47
1719939|NCT00318656|4209532|P2|NOT COMPLETED|Overall Study||2
1719940|NCT00318656|4209533|P1|NOT COMPLETED|Overall Study||0
1719941|NCT00318656|4209532|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
1719942|NCT00318656|4209533|P1|COMPLETED|Overall Study||12
1719943|NCT00318656|4209532|P2|STARTED|Overall Study||11
1719944|NCT00318656|4209533|P1|STARTED|Overall Study||12
1719945|NCT00318591|4209571|P2|NOT COMPLETED|Overall Study||45
1719946|NCT00318591|4209572|P1|NOT COMPLETED|Overall Study||60
1719947|NCT00318591|4209571|P2|COMPLETED|Overall Study||69
1719948|NCT00318591|4209572|P1|COMPLETED|Overall Study||45
1719949|NCT00318591|4209571|P2|STARTED|Overall Study||114
1719950|NCT00318591|4209572|P1|STARTED|Overall Study||105
1719951|NCT00318565|4209590|P1|NOT COMPLETED|Overall Study||24
1719952|NCT00318565|4209590|P1|COMPLETED|Overall Study||267
1719953|NCT00318565|4209590|P1|STARTED|Overall Study||291
1719954|NCT00318474|4209597|P2|NOT COMPLETED|Overall Study||17
1719955|NCT00318474|4209598|P1|NOT COMPLETED|Overall Study||18
1719956|NCT00318474|4209597|P2|COMPLETED|Overall Study||10
1719957|NCT00318474|4209598|P1|COMPLETED|Overall Study||7
1719958|NCT00318474|4209597|P2|STARTED|Overall Study||27
1719959|NCT00318474|4209598|P1|STARTED|Overall Study||25
1719960|NCT00318461|4209609|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
1719961|NCT00318461|4209610|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
1719962|NCT00318461|4209611|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
1719963|NCT00318461|4209612|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
1719964|NCT00318461|4209613|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
1719965|NCT00318461|4209609|P5|COMPLETED|Open-Label Extension, 18 Months||113
1719966|NCT00318461|4209610|P4|COMPLETED|Open-Label Extension, 18 Months||31
1719967|NCT00318461|4209611|P3|COMPLETED|Open-Label Extension, 18 Months||118
1719968|NCT00318461|4209612|P2|COMPLETED|Open-Label Extension, 18 Months||137
1719969|NCT00318461|4209613|P1|COMPLETED|Open-Label Extension, 18 Months||130
1719970|NCT00318461|4209609|P5|STARTED|Open-Label Extension, 18 Months||210
1719971|NCT00318461|4209610|P4|STARTED|Open-Label Extension, 18 Months||74
1719972|NCT00318461|4209611|P3|STARTED|Open-Label Extension, 18 Months||191
1719973|NCT00318461|4209612|P2|STARTED|Open-Label Extension, 18 Months||197
1719974|NCT00318461|4209613|P1|STARTED|Open-Label Extension, 18 Months||208
1719975|NCT00318461|4209609|P5|NOT COMPLETED|Double-Blind, 6 Months||34
1719976|NCT00318461|4209610|P4|NOT COMPLETED|Double-Blind, 6 Months||48
1719977|NCT00318461|4209611|P3|NOT COMPLETED|Double-Blind, 6 Months||51
1719978|NCT00318461|4209612|P2|NOT COMPLETED|Double-Blind, 6 Months||44
1719979|NCT00318461|4209613|P1|NOT COMPLETED|Double-Blind, 6 Months||34
1719980|NCT00318461|4209609|P5|COMPLETED|Double-Blind, 6 Months||210
1719981|NCT00318461|4209610|P4|COMPLETED|Double-Blind, 6 Months||74
1719982|NCT00318461|4209611|P3|COMPLETED|Double-Blind, 6 Months||191
1719983|NCT00318461|4209612|P2|COMPLETED|Double-Blind, 6 Months||197
1719984|NCT00318461|4209613|P1|COMPLETED|Double-Blind, 6 Months||208
1719985|NCT00318461|4209609|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
1719986|NCT00318461|4209610|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
1719987|NCT00318461|4209611|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
1719988|NCT00318461|4209612|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
1719989|NCT00318461|4209613|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
1719990|NCT00318461|4209609|P5|STARTED|Double-Blind, 6 Months|Randomised|244
1719991|NCT00318461|4209610|P4|STARTED|Double-Blind, 6 Months|Randomised|122
1719992|NCT00318461|4209611|P3|STARTED|Double-Blind, 6 Months|Randomised|242
1719993|NCT00318461|4209612|P2|STARTED|Double-Blind, 6 Months|Randomised|241
1719994|NCT00318461|4209613|P1|STARTED|Double-Blind, 6 Months|Randomised|242
1719995|NCT00318409|4209692|P2|NOT COMPLETED|Overall Study||1
1719996|NCT00318409|4209693|P1|NOT COMPLETED|Overall Study||2
1719997|NCT00318409|4209692|P2|COMPLETED|Overall Study||9
1719998|NCT00318409|4209693|P1|COMPLETED|Overall Study||18
1719999|NCT00318409|4209692|P2|STARTED|Overall Study||10
1720000|NCT00318409|4209693|P1|STARTED|Overall Study||20
1720001|NCT00318370|4209712|P3|NOT COMPLETED|Period 3||33
1720002|NCT00318370|4209713|P2|NOT COMPLETED|Period 3||0
1720003|NCT00318370|4209714|P1|NOT COMPLETED|Period 3||0
1720004|NCT00318370|4209712|P3|COMPLETED|Period 3||3
1720005|NCT00318370|4209713|P2|COMPLETED|Period 3||0
1720006|NCT00318370|4209714|P1|COMPLETED|Period 3||0
1720007|NCT00318370|4209712|P3|STARTED|Period 3||36
1720008|NCT00318370|4209713|P2|STARTED|Period 3||0
1720009|NCT00318370|4209714|P1|STARTED|Period 3||0
1720010|NCT00318370|4209712|P3|NOT COMPLETED|Period 2||0
1720011|NCT00318370|4209713|P2|NOT COMPLETED|Period 2||11
1720012|NCT00318370|4209714|P1|NOT COMPLETED|Period 2||0
1720013|NCT00318370|4209712|P3|COMPLETED|Period 2||0
1720014|NCT00318370|4209713|P2|COMPLETED|Period 2||36
1720015|NCT00318370|4209714|P1|COMPLETED|Period 2||0
1720016|NCT00318370|4209712|P3|STARTED|Period 2||0
1720017|NCT00318370|4209713|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
1720018|NCT00318370|4209714|P1|STARTED|Period 2||0
1720019|NCT00318370|4209712|P3|NOT COMPLETED|Period 1||0
1720020|NCT00318370|4209713|P2|NOT COMPLETED|Period 1||0
1720021|NCT00318370|4209714|P1|NOT COMPLETED|Period 1||7
1720022|NCT00318370|4209712|P3|COMPLETED|Period 1||0
1720023|NCT00318370|4209713|P2|COMPLETED|Period 1||0
1720024|NCT00318370|4209714|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
1720025|NCT00318370|4209712|P3|STARTED|Period 1||0
1720026|NCT00318370|4209713|P2|STARTED|Period 1||0
1720027|NCT00318370|4209714|P1|STARTED|Period 1||28
1720028|NCT00318292|4209726|P2|NOT COMPLETED|Overall Study||0
1720029|NCT00318292|4209727|P1|NOT COMPLETED|Overall Study||0
1720030|NCT00318292|4209726|P2|COMPLETED|Overall Study||45
1720031|NCT00318292|4209727|P1|COMPLETED|Overall Study||45
1720032|NCT00318292|4209726|P2|STARTED|Overall Study||45
1720033|NCT00318292|4209727|P1|STARTED|Overall Study||45
1720034|NCT00318149|4209739|P6|NOT COMPLETED|Overall Study||2
1720035|NCT00318149|4209740|P5|NOT COMPLETED|Overall Study||0
1720036|NCT00318149|4209741|P4|NOT COMPLETED|Overall Study||0
1720037|NCT00318149|4209742|P3|NOT COMPLETED|Overall Study||0
1720038|NCT00318149|4209743|P2|NOT COMPLETED|Overall Study||0
1720039|NCT00318149|4209744|P1|NOT COMPLETED|Overall Study||0
1720040|NCT00318149|4209739|P6|COMPLETED|Overall Study||73
1720041|NCT00318149|4209740|P5|COMPLETED|Overall Study||75
1720042|NCT00318149|4209741|P4|COMPLETED|Overall Study||75
1720043|NCT00318149|4209742|P3|COMPLETED|Overall Study||75
1720044|NCT00318149|4209743|P2|COMPLETED|Overall Study||50
1720045|NCT00318149|4209744|P1|COMPLETED|Overall Study||75
1720046|NCT00318149|4209739|P6|STARTED|Overall Study||75
1720047|NCT00318149|4209740|P5|STARTED|Overall Study||75
1720048|NCT00318149|4209741|P4|STARTED|Overall Study||75
1720049|NCT00318149|4209742|P3|STARTED|Overall Study||75
1720050|NCT00318149|4209743|P2|STARTED|Overall Study||50
1720051|NCT00318149|4209744|P1|STARTED|Overall Study||75
1720052|NCT00318136|4209830|P1|NOT COMPLETED|Overall Study||45
1720053|NCT00318136|4209830|P1|COMPLETED|Overall Study||2
1720054|NCT00318136|4209830|P1|STARTED|Overall Study||47
1720055|NCT00317941|4209839|P3|NOT COMPLETED|Overall Study||8
1720056|NCT00317941|4209840|P2|NOT COMPLETED|Overall Study||5
1720057|NCT00317941|4209841|P1|NOT COMPLETED|Overall Study||7
1720058|NCT00317941|4209839|P3|COMPLETED|Overall Study||60
1720059|NCT00317941|4209840|P2|COMPLETED|Overall Study||74
1720060|NCT00317941|4209841|P1|COMPLETED|Overall Study||66
1720061|NCT00317941|4209839|P3|Fulfilled Requirements PP Population|Overall Study||63
1720062|NCT00317941|4209840|P2|Fulfilled Requirements PP Population|Overall Study||76
1720063|NCT00317941|4209841|P1|Fulfilled Requirements PP Population|Overall Study||66
1720064|NCT00317941|4209839|P3|Fulfilled Requirement Safety Population|Overall Study||65
1720065|NCT00317941|4209840|P2|Fulfilled Requirement Safety Population|Overall Study||77
1720066|NCT00317941|4209841|P1|Fulfilled Requirement Safety Population|Overall Study||73
1720067|NCT00317941|4209839|P3|Participants Received Treatment|Overall Study||68
1720068|NCT00317941|4209840|P2|Participants Received Treatment|Overall Study||79
1720069|NCT00317941|4209841|P1|Participants Received Treatment|Overall Study||73
1720070|NCT00317941|4209839|P3|STARTED|Overall Study||68
1720071|NCT00317941|4209840|P2|STARTED|Overall Study||79
1720072|NCT00317941|4209841|P1|STARTED|Overall Study||73
1720073|NCT00317720|4209882|P2|NOT COMPLETED|Overall Study||0
1720074|NCT00317720|4209883|P1|NOT COMPLETED|Overall Study||0
1720075|NCT00317720|4209882|P2|COMPLETED|Overall Study||7
1720076|NCT00317720|4209883|P1|COMPLETED|Overall Study||40
1720077|NCT00317720|4209882|P2|STARTED|Overall Study||7
1720078|NCT00317720|4209883|P1|STARTED|Overall Study||40
1720079|NCT00317642|4209890|P2|NOT COMPLETED|Overall Study||135
1720080|NCT00317642|4209891|P1|NOT COMPLETED|Overall Study||122
1720081|NCT00317642|4209890|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
1720082|NCT00317642|4209891|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
1720083|NCT00317642|4209890|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
1720084|NCT00317642|4209891|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
1720085|NCT00317642|4209890|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
1720086|NCT00317642|4209891|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
1720087|NCT00317642|4209890|P2|STARTED|Overall Study||163
1720088|NCT00317642|4209891|P1|STARTED|Overall Study||163
1720089|NCT00317473|4209970|P6|NOT COMPLETED|Overall Study||3
1720090|NCT00317473|4209971|P5|NOT COMPLETED|Overall Study||8
1720091|NCT00317473|4209972|P4|NOT COMPLETED|Overall Study||2
1720092|NCT00317473|4209973|P3|NOT COMPLETED|Overall Study||3
1720093|NCT00317473|4209974|P2|NOT COMPLETED|Overall Study||3
1720094|NCT00317473|4209975|P1|NOT COMPLETED|Overall Study||4
1720095|NCT00317473|4209970|P6|COMPLETED|Overall Study||12
1720096|NCT00317473|4209971|P5|COMPLETED|Overall Study||22
1720097|NCT00317473|4209972|P4|COMPLETED|Overall Study||13
1720098|NCT00317473|4209973|P3|COMPLETED|Overall Study||27
1720099|NCT00317473|4209974|P2|COMPLETED|Overall Study||12
1720100|NCT00317473|4209975|P1|COMPLETED|Overall Study||26
1720101|NCT00317473|4209970|P6|STARTED|Overall Study||15
1720102|NCT00317473|4209971|P5|STARTED|Overall Study||30
1720103|NCT00317473|4209972|P4|STARTED|Overall Study||15
1720104|NCT00317473|4209973|P3|STARTED|Overall Study||30
1720105|NCT00317473|4209974|P2|STARTED|Overall Study||15
1720106|NCT00317473|4209975|P1|STARTED|Overall Study||30
1720107|NCT00317239|4210001|P2|NOT COMPLETED|Overall Study||19
1720108|NCT00317239|4210002|P1|NOT COMPLETED|Overall Study||13
1720109|NCT00317239|4210001|P2|COMPLETED|Overall Study||84
1720110|NCT00317239|4210002|P1|COMPLETED|Overall Study||134
1720111|NCT00317239|4210001|P2|STARTED|Overall Study||103
1720112|NCT00317239|4210002|P1|STARTED|Overall Study||147
1720113|NCT00317226|4210008|P1|NOT COMPLETED|Overall Study||23
1720114|NCT00317226|4210008|P1|COMPLETED|Overall Study||104
1720115|NCT00317226|4210008|P1|STARTED|Overall Study||127
1720116|NCT00317109|4210014|P2|NOT COMPLETED|Overall Study||0
1720117|NCT00317109|4210015|P1|NOT COMPLETED|Overall Study||3
1720118|NCT00317109|4210014|P2|COMPLETED|Overall Study||84
1720119|NCT00317109|4210015|P1|COMPLETED|Overall Study||81
1720120|NCT00317109|4210014|P2|STARTED|Overall Study||84
1720121|NCT00317109|4210015|P1|STARTED|Overall Study||84
1720122|NCT00317044|4210052|P3|NOT COMPLETED|Overall Study||45
1720123|NCT00317044|4210053|P2|NOT COMPLETED|Overall Study||40
1720124|NCT00317044|4210054|P1|NOT COMPLETED|Overall Study||48
1720125|NCT00317044|4210052|P3|COMPLETED|Overall Study||283
1720126|NCT00317044|4210053|P2|COMPLETED|Overall Study||273
1720127|NCT00317044|4210054|P1|COMPLETED|Overall Study||272
1720128|NCT00317044|4210052|P3|STARTED|Overall Study||328
1720129|NCT00317044|4210053|P2|STARTED|Overall Study||313
1720130|NCT00317044|4210054|P1|STARTED|Overall Study||320
1720131|NCT00316914|4210100|P2|NOT COMPLETED|Overall Study||36
1720132|NCT00316914|4210101|P1|NOT COMPLETED|Overall Study||33
1720133|NCT00316914|4210100|P2|COMPLETED|Overall Study||16
1720134|NCT00316914|4210101|P1|COMPLETED|Overall Study||17
1720135|NCT00316914|4210100|P2|STARTED|Overall Study||52
1720136|NCT00316914|4210101|P1|STARTED|Overall Study||50
1720137|NCT00316888|4210131|P2|NOT COMPLETED|Overall Study||8
1720138|NCT00316888|4210132|P1|NOT COMPLETED|Overall Study||6
1720139|NCT00316888|4210131|P2|COMPLETED|Overall Study||27
1720140|NCT00316888|4210132|P1|COMPLETED|Overall Study||22
1720141|NCT00316888|4210131|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
1720142|NCT00316888|4210132|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
1720143|NCT00316888|4210131|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
1720144|NCT00316888|4210132|P1|Started Induction Chemotherapy|Overall Study||28
1720145|NCT00316888|4210131|P2|Treated|Overall Study||34
1720146|NCT00316888|4210132|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
1720147|NCT00316888|4210131|P2|Eligible|Overall Study||35
1720148|NCT00316888|4210132|P1|Eligible|Overall Study||28
1720149|NCT00316888|4210131|P2|STARTED|Overall Study||35
1720150|NCT00316888|4210132|P1|STARTED|Overall Study||28
1720151|NCT00316862|4210146|P1|NOT COMPLETED|Overall Study||0
1720152|NCT00316862|4210146|P1|COMPLETED|Overall Study||82
1720153|NCT00316862|4210146|P1|STARTED|Overall Study||82
1720154|NCT00316719|4210154|P2|NOT COMPLETED|Overall Study||6
1720155|NCT00316719|4210155|P1|NOT COMPLETED|Overall Study||2
1720156|NCT00316719|4210154|P2|COMPLETED|Overall Study||47
1720157|NCT00316719|4210155|P1|COMPLETED|Overall Study||50
1720158|NCT00316719|4210154|P2|STARTED|Overall Study||53
1720159|NCT00316719|4210155|P1|STARTED|Overall Study||52
1720160|NCT00316706|4210181|P2|NOT COMPLETED|Overall Study||48
1720161|NCT00316706|4210182|P1|NOT COMPLETED|Overall Study||38
1720162|NCT00316706|4210181|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
1720163|NCT00316706|4210182|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
1720164|NCT00316706|4210181|P2|STARTED|Overall Study||619
1720165|NCT00316706|4210182|P1|STARTED|Overall Study||626
1720166|NCT00316693|4210198|P2|NOT COMPLETED|Overall Study||85
1720167|NCT00316693|4210199|P1|NOT COMPLETED|Overall Study||77
1720168|NCT00316693|4210198|P2|COMPLETED|Overall Study||436
1720169|NCT00316693|4210199|P1|COMPLETED|Overall Study||442
1720170|NCT00316693|4210198|P2|STARTED|Overall Study||521
1720171|NCT00316693|4210199|P1|STARTED|Overall Study||519
1720172|NCT00316355|4210241|P2|NOT COMPLETED|Overall Study||7
1720173|NCT00316355|4210242|P1|NOT COMPLETED|Overall Study||5
1720174|NCT00316355|4210241|P2|COMPLETED|Overall Study||12
1720175|NCT00316355|4210242|P1|COMPLETED|Overall Study||10
1720176|NCT00316355|4210241|P2|Started Treatment|Overall Study||18
1720177|NCT00316355|4210242|P1|Started Treatment|Overall Study||12
1720178|NCT00316355|4210241|P2|STARTED|Overall Study||19
1720179|NCT00316355|4210242|P1|STARTED|Overall Study||15
1720180|NCT00316303|4210252|P2|NOT COMPLETED|Overall Study||16
1720181|NCT00316303|4210253|P1|NOT COMPLETED|Overall Study||11
1720182|NCT00316303|4210252|P2|COMPLETED|Overall Study||102
1720183|NCT00316303|4210253|P1|COMPLETED|Overall Study||107
1720184|NCT00316303|4210252|P2|STARTED|Overall Study||118
1720185|NCT00316303|4210253|P1|STARTED|Overall Study||118
1720186|NCT00316277|4210269|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
1720187|NCT00316277|4210270|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
1720188|NCT00316277|4210269|P2|COMPLETED|Phase 2 (24 Weeks)||161
1720189|NCT00316277|4210270|P1|COMPLETED|Phase 2 (24 Weeks)||161
1720190|NCT00316277|4210269|P2|STARTED|Phase 2 (24 Weeks)||180
1720191|NCT00316277|4210270|P1|STARTED|Phase 2 (24 Weeks)||180
1720192|NCT00316277|4210269|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
1720193|NCT00316277|4210270|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
1720194|NCT00316277|4210269|P2|COMPLETED|Phase 1 (12 Weeks)||24
1720195|NCT00316277|4210270|P1|COMPLETED|Phase 1 (12 Weeks)||19
1720196|NCT00316277|4210269|P2|STARTED|Phase 1 (12 Weeks)||324
1720197|NCT00316277|4210270|P1|STARTED|Phase 1 (12 Weeks)||329
1720198|NCT00316264|4210291|P3|NOT COMPLETED|Overall Study||6
1720199|NCT00316264|4210292|P2|NOT COMPLETED|Overall Study||7
1720200|NCT00316264|4210293|P1|NOT COMPLETED|Overall Study||6
1720201|NCT00316264|4210291|P3|COMPLETED|Overall Study||87
1720202|NCT00316264|4210292|P2|COMPLETED|Overall Study||77
1720203|NCT00316264|4210293|P1|COMPLETED|Overall Study||77
1720204|NCT00316264|4210291|P3|STARTED|Overall Study||93
1720205|NCT00316264|4210292|P2|STARTED|Overall Study||84
1720206|NCT00316264|4210293|P1|STARTED|Overall Study||83
1720207|NCT00316225|4210361|P1|NOT COMPLETED|Overall Study||25
1720208|NCT00316225|4210361|P1|COMPLETED|Overall Study||6
1720209|NCT00316225|4210361|P1|STARTED|Overall Study||31
1720210|NCT00316199|4210370|P1|NOT COMPLETED|Overall Study||12
1720211|NCT00316199|4210370|P1|COMPLETED|Overall Study||48
1720212|NCT00316199|4210370|P1|STARTED|Overall Study||60
1720213|NCT00316186|4210378|P1|NOT COMPLETED|Overall Study||12
1720214|NCT00316186|4210378|P1|COMPLETED|Overall Study||21
1720215|NCT00316186|4210378|P1|STARTED|Overall Study||33
1720216|NCT00316173|4210392|P2|NOT COMPLETED|Treatment Phase||42
1720217|NCT00316173|4210393|P1|NOT COMPLETED|Treatment Phase||0
1720218|NCT00316173|4210392|P2|COMPLETED|Treatment Phase||13
1720219|NCT00316173|4210393|P1|COMPLETED|Treatment Phase||0
1720220|NCT00316173|4210392|P2|STARTED|Treatment Phase||55
1720221|NCT00316173|4210393|P1|STARTED|Treatment Phase||0
1720222|NCT00316173|4210392|P2|NOT COMPLETED|Run-in Phase||0
1720223|NCT00316173|4210393|P1|NOT COMPLETED|Run-in Phase||7
1720224|NCT00316173|4210392|P2|COMPLETED|Run-in Phase||0
1720225|NCT00316173|4210393|P1|COMPLETED|Run-in Phase||15
1720226|NCT00316173|4210392|P2|STARTED|Run-in Phase||0
1720227|NCT00316173|4210393|P1|STARTED|Run-in Phase||22
1720228|NCT00316121|4210406|P2|NOT COMPLETED|Overall Study||9
1720229|NCT00316121|4210407|P1|NOT COMPLETED|Overall Study||22
1720230|NCT00316121|4210406|P2|COMPLETED|Overall Study||37
1720231|NCT00316121|4210407|P1|COMPLETED|Overall Study||70
1720232|NCT00316121|4210406|P2|STARTED|Overall Study||46
1720233|NCT00316121|4210407|P1|STARTED|Overall Study||92
1720234|NCT00316082|4210418|P5|NOT COMPLETED|Overall Study||26
1720235|NCT00316082|4210419|P4|NOT COMPLETED|Overall Study||26
1720236|NCT00316082|4210420|P3|NOT COMPLETED|Overall Study||27
1720237|NCT00316082|4210421|P2|NOT COMPLETED|Overall Study||22
1720238|NCT00316082|4210422|P1|NOT COMPLETED|Overall Study||33
1720239|NCT00316082|4210418|P5|COMPLETED|Overall Study||48
1720240|NCT00316082|4210419|P4|COMPLETED|Overall Study||46
1720241|NCT00316082|4210420|P3|COMPLETED|Overall Study||44
1720242|NCT00316082|4210421|P2|COMPLETED|Overall Study||52
1720243|NCT00316082|4210422|P1|COMPLETED|Overall Study||41
1720244|NCT00316082|4210418|P5|Completed Study Without Being Rescued|Overall Study||31
1720245|NCT00316082|4210419|P4|Completed Study Without Being Rescued|Overall Study||27
1720246|NCT00316082|4210420|P3|Completed Study Without Being Rescued|Overall Study||29
1720247|NCT00316082|4210421|P2|Completed Study Without Being Rescued|Overall Study||35
1720248|NCT00316082|4210422|P1|Completed Study Without Being Rescued|Overall Study||25
1720249|NCT00316082|4210418|P5|STARTED|Overall Study||74
1720250|NCT00316082|4210419|P4|STARTED|Overall Study||72
1720251|NCT00316082|4210420|P3|STARTED|Overall Study||71
1720252|NCT00316082|4210421|P2|STARTED|Overall Study||74
1720253|NCT00316082|4210422|P1|STARTED|Overall Study||74
1720254|NCT00316017|4210453|P3|NOT COMPLETED|Overall Study||19
1720255|NCT00316017|4210454|P2|NOT COMPLETED|Overall Study||13
1720256|NCT00316017|4210455|P1|NOT COMPLETED|Overall Study||11
1720257|NCT00316017|4210453|P3|COMPLETED|Overall Study||376
1720258|NCT00316017|4210454|P2|COMPLETED|Overall Study||256
1720259|NCT00316017|4210455|P1|COMPLETED|Overall Study||220
1720260|NCT00316017|4210453|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
1720261|NCT00316017|4210454|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
1720262|NCT00316017|4210455|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
1720263|NCT00316004|4210529|P3|NOT COMPLETED|Overall Study||21
1720264|NCT00316004|4210530|P2|NOT COMPLETED|Overall Study||14
1720265|NCT00316004|4210531|P1|NOT COMPLETED|Overall Study||14
1720266|NCT00316004|4210529|P3|COMPLETED|Overall Study||582
1720267|NCT00316004|4210530|P2|COMPLETED|Overall Study||341
1720268|NCT00316004|4210531|P1|COMPLETED|Overall Study||359
1720269|NCT00316004|4210529|P3|STARTED|Overall Study||603
1720270|NCT00316004|4210530|P2|STARTED|Overall Study||355
1720271|NCT00316004|4210531|P1|STARTED|Overall Study||373
1720272|NCT00315939|4210586|P2|NOT COMPLETED|Admission 3 (3 Months)||2
1720273|NCT00315939|4210587|P1|NOT COMPLETED|Admission 3 (3 Months)||4
1720274|NCT00315939|4210586|P2|COMPLETED|Admission 3 (3 Months)||49
1720275|NCT00315939|4210587|P1|COMPLETED|Admission 3 (3 Months)||48
1720276|NCT00315939|4210586|P2|STARTED|Admission 3 (3 Months)||51
1720277|NCT00315939|4210587|P1|STARTED|Admission 3 (3 Months)||52
1720278|NCT00315939|4210586|P2|NOT COMPLETED|Admission 2 (3 Months)||4
1720279|NCT00315939|4210587|P1|NOT COMPLETED|Admission 2 (3 Months)||4
1720280|NCT00315939|4210586|P2|COMPLETED|Admission 2 (3 Months)||51
1720281|NCT00315939|4210587|P1|COMPLETED|Admission 2 (3 Months)||52
1720282|NCT00315939|4210586|P2|STARTED|Admission 2 (3 Months)||55
1720283|NCT00315939|4210587|P1|STARTED|Admission 2 (3 Months)||56
1720284|NCT00315939|4210586|P2|NOT COMPLETED|Admission 1 (3 Months)||6
1720285|NCT00315939|4210587|P1|NOT COMPLETED|Admission 1 (3 Months)||3
1720286|NCT00315939|4210586|P2|COMPLETED|Admission 1 (3 Months)||55
1720287|NCT00315939|4210587|P1|COMPLETED|Admission 1 (3 Months)||56
1720288|NCT00315939|4210586|P2|STARTED|Admission 1 (3 Months)||61
1720289|NCT00315939|4210587|P1|STARTED|Admission 1 (3 Months)||59
1720290|NCT00315822|4210595|P2|NOT COMPLETED|Overall Study||0
1720291|NCT00315822|4210596|P1|NOT COMPLETED|Overall Study||0
1720292|NCT00315822|4210595|P2|COMPLETED|Overall Study||202
1720293|NCT00315822|4210596|P1|COMPLETED|Overall Study||198
1720294|NCT00315822|4210595|P2|STARTED|Overall Study||202
1720295|NCT00315822|4210596|P1|STARTED|Overall Study||198
1720296|NCT00315731|4210602|P1|NOT COMPLETED|Overall Study||6
1720297|NCT00315731|4210602|P1|COMPLETED|Overall Study||9
1720298|NCT00315731|4210602|P1|STARTED|Overall Study||15
1720299|NCT00315705|4210630|P1|NOT COMPLETED|Phase 2||25
1720300|NCT00315705|4210630|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
1720301|NCT00315705|4210630|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
1720302|NCT00315705|4210630|P1|NOT COMPLETED|Phase 1||25
1720303|NCT00315705|4210630|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
1720304|NCT00315705|4210630|P1|STARTED|Phase 1||25
1720305|NCT00315627|4210667|P1|NOT COMPLETED|Overall Study||0
1720306|NCT00315627|4210667|P1|COMPLETED|Overall Study||3
1720307|NCT00315627|4210667|P1|STARTED|Overall Study||3
1720308|NCT00315614|4210675|P1|NOT COMPLETED|Overall Study||0
1720309|NCT00315614|4210675|P1|COMPLETED|Overall Study||3
1720310|NCT00315614|4210675|P1|STARTED|Overall Study||3
1720311|NCT00315588|4210682|P1|NOT COMPLETED|Overall Study||0
1720312|NCT00315588|4210682|P1|COMPLETED|Overall Study||7
1720313|NCT00315588|4210682|P1|STARTED|Overall Study||7
1720314|NCT00315458|4210691|P4|NOT COMPLETED|Overall Study||29
1720315|NCT00315458|4210692|P3|NOT COMPLETED|Overall Study||52
1720316|NCT00315458|4210693|P2|NOT COMPLETED|Overall Study||12
1720317|NCT00315458|4210694|P1|NOT COMPLETED|Overall Study||3
1720318|NCT00315458|4210691|P4|COMPLETED|Overall Study||10
1720319|NCT00315458|4210692|P3|COMPLETED|Overall Study||107
1720320|NCT00315458|4210693|P2|COMPLETED|Overall Study||44
1720321|NCT00315458|4210694|P1|COMPLETED|Overall Study||48
1720322|NCT00315458|4210691|P4|STARTED|Overall Study||39
1720323|NCT00315458|4210692|P3|STARTED|Overall Study||159
1720324|NCT00315458|4210693|P2|STARTED|Overall Study||56
1720325|NCT00315458|4210694|P1|STARTED|Overall Study||51
1720326|NCT00315445|4210707|P3|NOT COMPLETED|Overall Study||24
1720327|NCT00315445|4210708|P2|NOT COMPLETED|Overall Study||16
1720328|NCT00315445|4210709|P1|NOT COMPLETED|Overall Study||27
1720329|NCT00315445|4210707|P3|COMPLETED|Overall Study||22
1720330|NCT00315445|4210708|P2|COMPLETED|Overall Study||27
1720331|NCT00315445|4210709|P1|COMPLETED|Overall Study||18
1720332|NCT00315445|4210707|P3|STARTED|Overall Study||46
1720333|NCT00315445|4210708|P2|STARTED|Overall Study||43
1720334|NCT00315445|4210709|P1|STARTED|Overall Study||45
1720335|NCT00315341|4210782|P2|NOT COMPLETED|Overall Study||138
1720336|NCT00315341|4210783|P1|NOT COMPLETED|Overall Study||400
1720337|NCT00315341|4210782|P2|COMPLETED|Overall Study||391
1720338|NCT00315341|4210783|P1|COMPLETED|Overall Study||340
1720339|NCT00315341|4210782|P2|STARTED|Overall Study||529
1720340|NCT00315341|4210783|P1|STARTED|Overall Study||740
1720341|NCT00315328|4210793|P4|NOT COMPLETED|Overall Study||2
1720342|NCT00315328|4210794|P3|NOT COMPLETED|Overall Study||5
1720343|NCT00315328|4210795|P2|NOT COMPLETED|Overall Study||7
1720344|NCT00315328|4210796|P1|NOT COMPLETED|Overall Study||14
1720345|NCT00315328|4210793|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
1720346|NCT00315328|4210794|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
1720347|NCT00315328|4210795|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
1720348|NCT00315328|4210796|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
1720349|NCT00315328|4210793|P4|5 Week Visit|Overall Study||19
1720350|NCT00315328|4210794|P3|5 Week Visit|Overall Study||17
1720351|NCT00315328|4210795|P2|5 Week Visit|Overall Study||89
1720352|NCT00315328|4210796|P1|5 Week Visit|Overall Study||91
1720353|NCT00315328|4210793|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
1720354|NCT00315328|4210794|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
1720355|NCT00315328|4210795|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
1720356|NCT00315328|4210796|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
1720357|NCT00315302|4210866|P4|NOT COMPLETED|Overall Study||3
1720358|NCT00315302|4210867|P3|NOT COMPLETED|Overall Study||2
1720359|NCT00315302|4210868|P2|NOT COMPLETED|Overall Study||2
1720360|NCT00315302|4210869|P1|NOT COMPLETED|Overall Study||6
1720361|NCT00315302|4210866|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
1720362|NCT00315302|4210867|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
1720363|NCT00315302|4210868|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
1720364|NCT00315302|4210869|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
1720365|NCT00315302|4210866|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
1720366|NCT00315302|4210867|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
1720367|NCT00315302|4210868|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
1720368|NCT00315302|4210869|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
1720369|NCT00315302|4210866|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
1720370|NCT00315302|4210867|P3|18 Week Primary Outcome Visit|Overall Study||24
1720371|NCT00315302|4210868|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
1720372|NCT00315302|4210869|P1|18 Week Primary Outcome Visit|Overall Study||84
1720373|NCT00315302|4210866|P4|10 Week Visit|Overall Study||29
1720374|NCT00315302|4210867|P3|10 Week Visit|Overall Study||24
1720375|NCT00315302|4210868|P2|10 Week Visit|Overall Study||85
1720376|NCT00315302|4210869|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
1720377|NCT00315302|4210866|P4|5 Week Visit|Overall Study||30
1720378|NCT00315302|4210867|P3|5 Week Visit|Overall Study||26
1720379|NCT00315302|4210868|P2|5 Week Visit|Overall Study||86
1720380|NCT00315302|4210869|P1|5 Week Visit|Overall Study||85
1720381|NCT00315302|4210866|P4|STARTED|Overall Study||34
1720382|NCT00315302|4210867|P3|STARTED|Overall Study||26
1720383|NCT00315302|4210868|P2|STARTED|Overall Study||90
1720384|NCT00315302|4210869|P1|STARTED|Overall Study||90
1720385|NCT00315146|4210915|P4|NOT COMPLETED|Overall Study||0
1720386|NCT00315146|4210916|P3|NOT COMPLETED|Overall Study||2
1720387|NCT00315146|4210917|P2|NOT COMPLETED|Overall Study||3
1720388|NCT00315146|4210918|P1|NOT COMPLETED|Overall Study||2
1720389|NCT00315146|4210915|P4|COMPLETED|Overall Study||22
1720390|NCT00315146|4210916|P3|COMPLETED|Overall Study||20
1720391|NCT00315146|4210917|P2|COMPLETED|Overall Study||19
1720392|NCT00315146|4210918|P1|COMPLETED|Overall Study||20
1720393|NCT00315146|4210915|P4|STARTED|Overall Study||22
1720394|NCT00315146|4210916|P3|STARTED|Overall Study||22
1720395|NCT00315146|4210917|P2|STARTED|Overall Study||22
1720396|NCT00315146|4210918|P1|STARTED|Overall Study||22
1720397|NCT00315120|4210936|P4|NOT COMPLETED|Overall Study||0
1720398|NCT00315120|4210937|P3|NOT COMPLETED|Overall Study||0
1720399|NCT00315120|4210938|P2|NOT COMPLETED|Overall Study||0
1720400|NCT00315120|4210939|P1|NOT COMPLETED|Overall Study||0
1720401|NCT00315120|4210936|P4|COMPLETED|Overall Study||107
1720402|NCT00315120|4210937|P3|COMPLETED|Overall Study||115
1720403|NCT00315120|4210938|P2|COMPLETED|Overall Study||118
1720404|NCT00315120|4210939|P1|COMPLETED|Overall Study||115
1720405|NCT00315120|4210936|P4|STARTED|Overall Study||107
1720406|NCT00315120|4210937|P3|STARTED|Overall Study||115
1720407|NCT00315120|4210938|P2|STARTED|Overall Study||118
1720408|NCT00315120|4210939|P1|STARTED|Overall Study||115
1720409|NCT00315055|4210999|P2|NOT COMPLETED|Overall Study||5
1720410|NCT00315055|4211000|P1|NOT COMPLETED|Overall Study||3
1720411|NCT00315055|4210999|P2|COMPLETED|Overall Study||150
1720412|NCT00315055|4211000|P1|COMPLETED|Overall Study||152
1720413|NCT00315055|4210999|P2|STARTED|Overall Study||155
1720414|NCT00315055|4211000|P1|STARTED|Overall Study||155
1720415|NCT00314951|4211018|P2|NOT COMPLETED|Follow-up||34
1720416|NCT00314951|4211019|P1|NOT COMPLETED|Follow-up||44
1720417|NCT00314951|4211018|P2|COMPLETED|Follow-up||255
1720418|NCT00314951|4211019|P1|COMPLETED|Follow-up||263
1720419|NCT00314951|4211018|P2|STARTED|Follow-up||289
1720420|NCT00314951|4211019|P1|STARTED|Follow-up||307
1720421|NCT00314951|4211018|P2|NOT COMPLETED|Treatment||11
1720422|NCT00314951|4211019|P1|NOT COMPLETED|Treatment||16
1720423|NCT00314951|4211018|P2|COMPLETED|Treatment||289
1720424|NCT00314951|4211019|P1|COMPLETED|Treatment||307
1720425|NCT00314951|4211018|P2|STARTED|Treatment||300
1720426|NCT00314951|4211019|P1|STARTED|Treatment||323
1720427|NCT00314951|4211018|P2|NOT COMPLETED|Enrollment||6
1720428|NCT00314951|4211019|P1|NOT COMPLETED|Enrollment||0
1720429|NCT00314951|4211018|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
1720430|NCT00314951|4211019|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
1720431|NCT00314951|4211018|P2|STARTED|Enrollment||306
1720432|NCT00314951|4211019|P1|STARTED|Enrollment||323
1720433|NCT00314808|4211029|P1|NOT COMPLETED|Overall Study||8
1720434|NCT00314808|4211029|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
1720435|NCT00314808|4211029|P1|STARTED|Overall Study||33
1720436|NCT00314574|4211039|P2|NOT COMPLETED|Overall Study||83
1720437|NCT00314574|4211040|P1|NOT COMPLETED|Overall Study||94
1720438|NCT00314574|4211039|P2|COMPLETED|Overall Study||344
1720439|NCT00314574|4211040|P1|COMPLETED|Overall Study||329
1720440|NCT00314574|4211039|P2|Safety Population|Overall Study||428
1720441|NCT00314574|4211040|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
1720442|NCT00314574|4211039|P2|Received at Least One Dose of Study Drug|Overall Study||427
1720443|NCT00314574|4211040|P1|Received at Least One Dose of Study Drug|Overall Study||421
1720444|NCT00314574|4211039|P2|STARTED|Overall Study||427
1720445|NCT00314574|4211040|P1|STARTED|Overall Study||423
1720446|NCT00314366|4211056|P2|NOT COMPLETED|Overall Study||0
1720447|NCT00314366|4211057|P1|NOT COMPLETED|Overall Study||1
1720448|NCT00314366|4211056|P2|COMPLETED|Overall Study||10
1720449|NCT00314366|4211057|P1|COMPLETED|Overall Study||10
1720450|NCT00314366|4211056|P2|STARTED|Overall Study||10
1720451|NCT00314366|4211057|P1|STARTED|Overall Study||11
1720452|NCT00314353|4211087|P2|NOT COMPLETED|Follow-up||0
1720453|NCT00314353|4211088|P1|NOT COMPLETED|Follow-up||0
1720454|NCT00314353|4211087|P2|COMPLETED|Follow-up||0
1720455|NCT00314353|4211088|P1|COMPLETED|Follow-up||3
1720456|NCT00314353|4211087|P2|STARTED|Follow-up||0
1720457|NCT00314353|4211088|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
1720458|NCT00314353|4211087|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
1720459|NCT00314353|4211088|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
1720460|NCT00314353|4211087|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
1720461|NCT00314353|4211088|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
1720462|NCT00314353|4211087|P2|STARTED|Protocol Therapy (8 Cycles)||3
1720463|NCT00314353|4211088|P1|STARTED|Protocol Therapy (8 Cycles)||4
1720464|NCT00314340|4211102|P1|NOT COMPLETED|Overall Study||1
1720465|NCT00314340|4211102|P1|COMPLETED|Overall Study||11
1720466|NCT00314340|4211102|P1|Placebo|Overall Study||12
1720467|NCT00314340|4211102|P1|Hydrocodone Plus APAP|Overall Study||12
1720468|NCT00314340|4211102|P1|ER Morphine|Overall Study||11
1720469|NCT00314340|4211102|P1|STARTED|Overall Study||12
1720470|NCT00314327|4211108|P1|NOT COMPLETED|Overall Study||1
1720471|NCT00314327|4211108|P1|COMPLETED|Overall Study||0
1720472|NCT00314327|4211108|P1|STARTED|Overall Study||1
1720473|NCT00314262|4211113|P1|NOT COMPLETED|Overall Study||5
1720474|NCT00314262|4211113|P1|COMPLETED|Overall Study||7
1720475|NCT00314262|4211113|P1|STARTED|Overall Study||12
1720476|NCT00314249|4211121|P2|NOT COMPLETED|Overall Study||163
1720477|NCT00314249|4211122|P1|NOT COMPLETED|Overall Study||152
1720478|NCT00314249|4211121|P2|COMPLETED|Overall Study||353
1720479|NCT00314249|4211122|P1|COMPLETED|Overall Study||357
1720480|NCT00314249|4211121|P2|STARTED|Overall Study||516
1720481|NCT00314249|4211122|P1|STARTED|Overall Study||509
1720482|NCT00314236|4211140|P2|NOT COMPLETED|Overall Study||2
1720483|NCT00314236|4211141|P1|NOT COMPLETED|Overall Study||0
1720484|NCT00314236|4211140|P2|COMPLETED|Overall Study||37
1720485|NCT00314236|4211141|P1|COMPLETED|Overall Study||41
1720486|NCT00314236|4211140|P2|STARTED|Overall Study||39
1720487|NCT00314236|4211141|P1|STARTED|Overall Study||41
1720488|NCT00314145|4211155|P2|NOT COMPLETED|Overall Study||29
1720489|NCT00314145|4211156|P1|NOT COMPLETED|Overall Study||21
1720490|NCT00314145|4211155|P2|COMPLETED|Overall Study||381
1720491|NCT00314145|4211156|P1|COMPLETED|Overall Study||389
1720492|NCT00314145|4211155|P2|STARTED|Overall Study||410
1720493|NCT00314145|4211156|P1|STARTED|Overall Study||410
1720494|NCT00314132|4211170|P2|NOT COMPLETED|Overall Study||18
1720495|NCT00314132|4211171|P1|NOT COMPLETED|Overall Study||8
1720496|NCT00314132|4211170|P2|COMPLETED|Overall Study||1583
1720497|NCT00314132|4211171|P1|COMPLETED|Overall Study||395
1720498|NCT00314132|4211170|P2|STARTED|Overall Study||1601
1720499|NCT00314132|4211171|P1|STARTED|Overall Study||403
1720500|NCT00314106|4211181|P2|NOT COMPLETED|Overall Study||0
1720501|NCT00314106|4211182|P1|NOT COMPLETED|Overall Study||0
1720502|NCT00314106|4211181|P2|COMPLETED|Overall Study||8
1720503|NCT00314106|4211182|P1|COMPLETED|Overall Study||18
1720504|NCT00314106|4211181|P2|STARTED|Overall Study||8
1720505|NCT00314106|4211182|P1|STARTED|Overall Study||18
1720506|NCT00313911|4211192|P2|NOT COMPLETED|Overall Study||41
1720507|NCT00313911|4211193|P1|NOT COMPLETED|Overall Study||94
1720508|NCT00313911|4211192|P2|COMPLETED|Overall Study||670
1720509|NCT00313911|4211193|P1|COMPLETED|Overall Study||1328
1720510|NCT00313911|4211192|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
1720511|NCT00313911|4211193|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
1720512|NCT00313846|4211207|P2|NOT COMPLETED|Overall Study||11
1720513|NCT00313846|4211208|P1|NOT COMPLETED|Overall Study||5
1720514|NCT00313846|4211207|P2|COMPLETED|Overall Study||153
1720515|NCT00313846|4211208|P1|COMPLETED|Overall Study||157
1720516|NCT00313846|4211207|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
1720517|NCT00313846|4211208|P1|STARTED|Overall Study||162
1720518|NCT00313820|4211219|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
1720519|NCT00313820|4211220|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
1720520|NCT00313820|4211219|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
1720521|NCT00313820|4211220|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
1720522|NCT00313820|4211219|P2|STARTED|Pregabalin or Placebo Treatment Period||109
1720523|NCT00313820|4211220|P1|STARTED|Pregabalin or Placebo Treatment Period||110
1720524|NCT00313820|4211219|P2|NOT COMPLETED|Assigned to Treatment||0
1720525|NCT00313820|4211220|P1|NOT COMPLETED|Assigned to Treatment||1
1720526|NCT00313820|4211219|P2|COMPLETED|Assigned to Treatment||109
1720527|NCT00313820|4211220|P1|COMPLETED|Assigned to Treatment||110
1720528|NCT00313820|4211219|P2|STARTED|Assigned to Treatment||109
1720529|NCT00313820|4211220|P1|STARTED|Assigned to Treatment||111
1720530|NCT00313781|4211258|P3|NOT COMPLETED|After Crossover||27
1720531|NCT00313781|4211259|P2|NOT COMPLETED|After Crossover||0
1720532|NCT00313781|4211260|P1|NOT COMPLETED|After Crossover||0
1720533|NCT00313781|4211258|P3|COMPLETED|After Crossover||10
1720534|NCT00313781|4211259|P2|COMPLETED|After Crossover||0
1720535|NCT00313781|4211260|P1|COMPLETED|After Crossover||0
1720536|NCT00313781|4211258|P3|STARTED|After Crossover||37
1720537|NCT00313781|4211259|P2|STARTED|After Crossover||0
1720538|NCT00313781|4211260|P1|STARTED|After Crossover||0
1720539|NCT00313781|4211258|P3|NOT COMPLETED|Before Crossover||0
1720540|NCT00313781|4211259|P2|NOT COMPLETED|Before Crossover||79
1720541|NCT00313781|4211260|P1|NOT COMPLETED|Before Crossover||75
1720542|NCT00313781|4211258|P3|COMPLETED|Before Crossover||0
1720543|NCT00313781|4211259|P2|COMPLETED|Before Crossover||23
1720544|NCT00313781|4211260|P1|COMPLETED|Before Crossover||27
1720545|NCT00313781|4211258|P3|Treated|Before Crossover||0
1720546|NCT00313781|4211259|P2|Treated|Before Crossover||102
1720547|NCT00313781|4211260|P1|Treated|Before Crossover||97
1720548|NCT00313781|4211258|P3|STARTED|Before Crossover||0
1720549|NCT00313781|4211259|P2|STARTED|Before Crossover||102
1720550|NCT00313781|4211260|P1|STARTED|Before Crossover||102
1720551|NCT00313716|4211300|P6|NOT COMPLETED|Overall Study||13
1720552|NCT00313716|4211301|P5|NOT COMPLETED|Overall Study||6
1720553|NCT00313716|4211302|P4|NOT COMPLETED|Overall Study||4
1720554|NCT00313716|4211303|P3|NOT COMPLETED|Overall Study||12
1720555|NCT00313716|4211304|P2|NOT COMPLETED|Overall Study||8
1720556|NCT00313716|4211305|P1|NOT COMPLETED|Overall Study||5
1720557|NCT00313716|4211300|P6|COMPLETED|Overall Study||35
1720558|NCT00313716|4211301|P5|COMPLETED|Overall Study||27
1720559|NCT00313716|4211302|P4|COMPLETED|Overall Study||16
1720560|NCT00313716|4211303|P3|COMPLETED|Overall Study||38
1720561|NCT00313716|4211304|P2|COMPLETED|Overall Study||23
1720562|NCT00313716|4211305|P1|COMPLETED|Overall Study||13
1720563|NCT00313716|4211300|P6|STARTED|Overall Study||48
1720564|NCT00313716|4211301|P5|STARTED|Overall Study||33
1720565|NCT00313716|4211302|P4|STARTED|Overall Study||20
1720566|NCT00313716|4211303|P3|STARTED|Overall Study||50
1720567|NCT00313716|4211304|P2|STARTED|Overall Study||31
1720568|NCT00313716|4211305|P1|STARTED|Overall Study||18
1720569|NCT00313703|4211332|P4|NOT COMPLETED|Overall Study||12
1720570|NCT00313703|4211333|P3|NOT COMPLETED|Overall Study||5
1720571|NCT00313703|4211334|P2|NOT COMPLETED|Overall Study||2
1720572|NCT00313703|4211335|P1|NOT COMPLETED|Overall Study||11
1720573|NCT00313703|4211332|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
1720574|NCT00313703|4211333|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
1720575|NCT00313703|4211334|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
1720576|NCT00313703|4211335|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
1720577|NCT00313703|4211332|P4|STARTED|Overall Study||12
1720578|NCT00313703|4211333|P3|STARTED|Overall Study||77
1720579|NCT00313703|4211334|P2|STARTED|Overall Study||34
1720580|NCT00313703|4211335|P1|STARTED|Overall Study||186
1720581|NCT00313612|4211351|P2|NOT COMPLETED|Overall Study||1
1720582|NCT00313612|4211352|P1|NOT COMPLETED|Overall Study||0
1720583|NCT00313612|4211351|P2|COMPLETED|Overall Study||19
1720584|NCT00313612|4211352|P1|COMPLETED|Overall Study||19
1720585|NCT00313612|4211351|P2|STARTED|Overall Study||20
1720586|NCT00313612|4211352|P1|STARTED|Overall Study||19
1720587|NCT00313586|4211364|P4|NOT COMPLETED|Overall Study||23
1720588|NCT00313586|4211365|P3|NOT COMPLETED|Overall Study||24
1720589|NCT00313586|4211366|P2|NOT COMPLETED|Overall Study||70
1720590|NCT00313586|4211367|P1|NOT COMPLETED|Overall Study||70
1720591|NCT00313586|4211364|P4|COMPLETED|Overall Study||0
1720592|NCT00313586|4211365|P3|COMPLETED|Overall Study||0
1720593|NCT00313586|4211366|P2|COMPLETED|Overall Study||5
1720594|NCT00313586|4211367|P1|COMPLETED|Overall Study||5
1720595|NCT00313586|4211364|P4|Treated|Overall Study||23
1720596|NCT00313586|4211365|P3|Treated|Overall Study||24
1720597|NCT00313586|4211366|P2|Treated|Overall Study||75
1720598|NCT00313586|4211367|P1|Treated|Overall Study||74
1720599|NCT00313586|4211364|P4|STARTED|Overall Study||23
1720600|NCT00313586|4211365|P3|STARTED|Overall Study||24
1720601|NCT00313586|4211366|P2|STARTED|Overall Study||75
1720602|NCT00313586|4211367|P1|STARTED|Overall Study||75
1720603|NCT00313443|4211375|P1|NOT COMPLETED|Overall Study||0
1720604|NCT00313443|4211375|P1|COMPLETED|Overall Study||30
1720605|NCT00313443|4211375|P1|STARTED|Overall Study||30
1720606|NCT00313313|4211386|P3|NOT COMPLETED|Overall Study||82
1720607|NCT00313313|4211387|P2|NOT COMPLETED|Overall Study||66
1720608|NCT00313313|4211388|P1|NOT COMPLETED|Overall Study||63
1720609|NCT00313313|4211386|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
1720610|NCT00313313|4211387|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
1720611|NCT00313313|4211388|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
1720612|NCT00313313|4211386|P3|STARTED|Overall Study||267
1720613|NCT00313313|4211387|P2|STARTED|Overall Study||253
1720614|NCT00313313|4211388|P1|STARTED|Overall Study||248
1720615|NCT00313300|4211410|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
1720616|NCT00313300|4211411|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
1720617|NCT00313300|4211412|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
1720618|NCT00313300|4211413|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
1720619|NCT00313300|4211414|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
1720620|NCT00313300|4211410|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
1720621|NCT00313300|4211411|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
1720622|NCT00313300|4211412|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
1720623|NCT00313300|4211413|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
1720624|NCT00313300|4211414|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
1720625|NCT00313300|4211410|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
1720626|NCT00313300|4211411|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
1720627|NCT00313300|4211412|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
1720628|NCT00313300|4211413|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
1720629|NCT00313300|4211414|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
1720630|NCT00313300|4211410|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
1720631|NCT00313300|4211411|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
1720632|NCT00313300|4211412|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
1720633|NCT00313300|4211413|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
1720634|NCT00313300|4211414|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
1720635|NCT00313300|4211410|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
1720636|NCT00313300|4211411|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
1720637|NCT00313300|4211412|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
1720638|NCT00313300|4211413|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
1720639|NCT00313300|4211414|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
1720640|NCT00313300|4211410|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
1720641|NCT00313300|4211411|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
1720642|NCT00313300|4211412|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
1720643|NCT00313300|4211413|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
1720644|NCT00313300|4211414|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
1720645|NCT00313300|4211410|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
1720646|NCT00313300|4211411|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
1720647|NCT00313300|4211412|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
1720648|NCT00313300|4211413|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
1720649|NCT00313300|4211414|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
1720650|NCT00313300|4211410|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
1720651|NCT00313300|4211411|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
1720652|NCT00313300|4211412|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
1720653|NCT00313300|4211413|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
1720654|NCT00313300|4211414|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
1720655|NCT00313300|4211410|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
1720656|NCT00313300|4211411|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
1720657|NCT00313300|4211412|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
1720658|NCT00313300|4211413|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
1720659|NCT00313300|4211414|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
1720660|NCT00313300|4211410|P5|STARTED|Randomized in Phase B (26 Weeks)||221
1720661|NCT00313300|4211411|P4|STARTED|Randomized in Phase B (26 Weeks)||248
1720662|NCT00313300|4211412|P3|STARTED|Randomized in Phase B (26 Weeks)||134
1720663|NCT00313300|4211413|P2|STARTED|Randomized in Phase B (26 Weeks)||138
1720664|NCT00313300|4211414|P1|STARTED|Randomized in Phase B (26 Weeks)||427
1720665|NCT00313300|4211410|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
1720666|NCT00313300|4211411|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
1720667|NCT00313300|4211412|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
1720668|NCT00313300|4211413|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
1720669|NCT00313300|4211414|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
1720670|NCT00313300|4211410|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
1720671|NCT00313300|4211411|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
1720672|NCT00313300|4211412|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
1720673|NCT00313300|4211413|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
1720674|NCT00313300|4211414|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
1720675|NCT00313300|4211410|P5|STARTED|Randomized in Phase A (26 Weeks)||0
1720676|NCT00313300|4211411|P4|STARTED|Randomized in Phase A (26 Weeks)||0
1720677|NCT00313300|4211412|P3|STARTED|Randomized in Phase A (26 Weeks)||184
1720678|NCT00313300|4211413|P2|STARTED|Randomized in Phase A (26 Weeks)||179
1720679|NCT00313300|4211414|P1|STARTED|Randomized in Phase A (26 Weeks)||184
1720680|NCT00313209|4211466|P2|NOT COMPLETED|Overall Study||82
1720681|NCT00313209|4211467|P1|NOT COMPLETED|Overall Study||107
1720682|NCT00313209|4211466|P2|COMPLETED|Overall Study||385
1720683|NCT00313209|4211467|P1|COMPLETED|Overall Study||359
1720684|NCT00313209|4211466|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
1720685|NCT00313209|4211467|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
1720686|NCT00313170|4211484|P3|NOT COMPLETED|Overall Study||32
1720687|NCT00313170|4211485|P2|NOT COMPLETED|Overall Study||34
1720688|NCT00313170|4211486|P1|NOT COMPLETED|Overall Study||36
1720689|NCT00313170|4211484|P3|COMPLETED|Overall Study||14
1720690|NCT00313170|4211485|P2|COMPLETED|Overall Study||16
1720691|NCT00313170|4211486|P1|COMPLETED|Overall Study||11
1720692|NCT00313170|4211484|P3|STARTED|Overall Study||46
1720693|NCT00313170|4211485|P2|STARTED|Overall Study||50
1720694|NCT00313170|4211486|P1|STARTED|Overall Study||47
1720695|NCT00313144|4211502|P1|NOT COMPLETED|Overall Study||110
1720696|NCT00313144|4211502|P1|COMPLETED|Overall Study||17
1720697|NCT00313144|4211502|P1|STARTED|Overall Study||127
1720698|NCT00313014|4211589|P3|NOT COMPLETED|Overall Study||61
1720699|NCT00313014|4211590|P2|NOT COMPLETED|Overall Study||73
1720700|NCT00313014|4211591|P1|NOT COMPLETED|Overall Study||93
1720701|NCT00313014|4211589|P3|COMPLETED|Overall Study||159
1720702|NCT00313014|4211590|P2|COMPLETED|Overall Study||146
1720703|NCT00313014|4211591|P1|COMPLETED|Overall Study||128
1720704|NCT00313014|4211589|P3|STARTED|Overall Study||220
1720705|NCT00313014|4211590|P2|STARTED|Overall Study||219
1720706|NCT00313014|4211591|P1|STARTED|Overall Study||221
1720707|NCT00312923|4211611|P2|NOT COMPLETED|Overall Study||6
1720708|NCT00312923|4211612|P1|NOT COMPLETED|Overall Study||9
1720709|NCT00312923|4211611|P2|COMPLETED|Overall Study||20
1720710|NCT00312923|4211612|P1|COMPLETED|Overall Study||19
1720711|NCT00312923|4211611|P2|STARTED|Overall Study||26
1720712|NCT00312923|4211612|P1|STARTED|Overall Study||28
1720713|NCT00312897|4211622|P2|NOT COMPLETED|Overall Study||6
1720714|NCT00312897|4211623|P1|NOT COMPLETED|Overall Study||6
1720715|NCT00312897|4211622|P2|COMPLETED|Overall Study||18
1720716|NCT00312897|4211623|P1|COMPLETED|Overall Study||21
1720717|NCT00312897|4211622|P2|STARTED|Overall Study||24
1720718|NCT00312897|4211623|P1|STARTED|Overall Study||27
1720719|NCT00312884|4211633|P2|NOT COMPLETED|Overall Study||12
1720720|NCT00312884|4211634|P1|NOT COMPLETED|Overall Study||17
1720721|NCT00312884|4211633|P2|COMPLETED|Overall Study||79
1720722|NCT00312884|4211634|P1|COMPLETED|Overall Study||74
1720723|NCT00312884|4211633|P2|STARTED|Overall Study||91
1720724|NCT00312884|4211634|P1|STARTED|Overall Study||91
1720725|NCT00312858|4211648|P2|NOT COMPLETED|Overall Study||93
1720726|NCT00312858|4211649|P1|NOT COMPLETED|Overall Study||68
1720727|NCT00312858|4211648|P2|COMPLETED|Overall Study||230
1720728|NCT00312858|4211649|P1|COMPLETED|Overall Study||262
1720729|NCT00312858|4211648|P2|Visit 4|Overall Study||240
1720730|NCT00312858|4211649|P1|Visit 4|Overall Study||262
1720731|NCT00312858|4211648|P2|Visit 3|Overall Study||261
1720732|NCT00312858|4211649|P1|Visit 3|Overall Study||273
1720733|NCT00312858|4211648|P2|Visit 2|Overall Study||294
1720734|NCT00312858|4211649|P1|Visit 2|Overall Study||305
1720735|NCT00312858|4211648|P2|Visit 1|Overall Study||323
1720736|NCT00312858|4211649|P1|Visit 1|Overall Study||330
1720737|NCT00312858|4211648|P2|STARTED|Overall Study||323
1720738|NCT00312858|4211649|P1|STARTED|Overall Study||330
1720739|NCT00312845|4211703|P2|NOT COMPLETED|Overall Study||95
1720740|NCT00312845|4211704|P1|NOT COMPLETED|Overall Study||99
1720741|NCT00312845|4211703|P2|COMPLETED|Overall Study||245
1720742|NCT00312845|4211704|P1|COMPLETED|Overall Study||237
1720743|NCT00312845|4211703|P2|STARTED|Overall Study||340
1720744|NCT00312845|4211704|P1|STARTED|Overall Study||336
1720745|NCT00312728|4211712|P1|NOT COMPLETED|Overall Study||110
1720746|NCT00312728|4211712|P1|COMPLETED|Overall Study||5
1720747|NCT00312728|4211712|P1|STARTED|Overall Study||115
1720748|NCT00312702|4211724|P3|NOT COMPLETED|Challenge Phase||0
1720749|NCT00312702|4211725|P2|NOT COMPLETED|Challenge Phase||0
1720750|NCT00312702|4211726|P1|NOT COMPLETED|Challenge Phase||0
1720751|NCT00312702|4211724|P3|COMPLETED|Challenge Phase||1
1720752|NCT00312702|4211725|P2|COMPLETED|Challenge Phase||12
1720753|NCT00312702|4211726|P1|COMPLETED|Challenge Phase||0
1720754|NCT00312702|4211724|P3|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
1720755|NCT00312702|4211725|P2|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
1720756|NCT00312702|4211726|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
1720757|NCT00312702|4211724|P3|NOT COMPLETED|Immunization Phase||0
1720758|NCT00312702|4211725|P2|NOT COMPLETED|Immunization Phase||1
1720759|NCT00312702|4211726|P1|NOT COMPLETED|Immunization Phase||0
1720760|NCT00312702|4211724|P3|COMPLETED|Immunization Phase||0
1720761|NCT00312702|4211725|P2|COMPLETED|Immunization Phase||12
1720762|NCT00312702|4211726|P1|COMPLETED|Immunization Phase||5
1720763|NCT00312702|4211724|P3|STARTED|Immunization Phase||0
1720764|NCT00312702|4211725|P2|STARTED|Immunization Phase||13
1720765|NCT00312702|4211726|P1|STARTED|Immunization Phase||5
1720766|NCT00312663|4211739|P3|NOT COMPLETED|Challenge Phase||0
1720767|NCT00312663|4211740|P2|NOT COMPLETED|Challenge Phase||0
1720768|NCT00312663|4211741|P1|NOT COMPLETED|Challenge Phase||0
1720769|NCT00312663|4211739|P3|COMPLETED|Challenge Phase||6
1720770|NCT00312663|4211740|P2|COMPLETED|Challenge Phase||10
1720771|NCT00312663|4211741|P1|COMPLETED|Challenge Phase||0
1720772|NCT00312663|4211739|P3|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
1720773|NCT00312663|4211740|P2|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
1720774|NCT00312663|4211741|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
1720775|NCT00312663|4211739|P3|NOT COMPLETED|Immunization Phase||0
1720776|NCT00312663|4211740|P2|NOT COMPLETED|Immunization Phase||1
1720777|NCT00312663|4211741|P1|NOT COMPLETED|Immunization Phase||0
1720778|NCT00312663|4211739|P3|COMPLETED|Immunization Phase||0
1720779|NCT00312663|4211740|P2|COMPLETED|Immunization Phase||12
1720780|NCT00312663|4211741|P1|COMPLETED|Immunization Phase||5
1720781|NCT00312663|4211739|P3|STARTED|Immunization Phase||0
1720782|NCT00312663|4211740|P2|STARTED|Immunization Phase||13
1720783|NCT00312663|4211741|P1|STARTED|Immunization Phase||5
1720784|NCT00312572|4211754|P2|NOT COMPLETED|Overall Study||21
1720785|NCT00312572|4211755|P1|NOT COMPLETED|Overall Study||16
1720786|NCT00312572|4211754|P2|COMPLETED|Overall Study||82
1720787|NCT00312572|4211755|P1|COMPLETED|Overall Study||85
1720788|NCT00312572|4211754|P2|STARTED|Overall Study||103
1720789|NCT00312572|4211755|P1|STARTED|Overall Study||101
1720790|NCT00312494|4211766|P3|NOT COMPLETED|Overall Study||43
1720791|NCT00312494|4211767|P2|NOT COMPLETED|Overall Study||58
1720792|NCT00312494|4211768|P1|NOT COMPLETED|Overall Study||71
1720793|NCT00312494|4211766|P3|COMPLETED|Overall Study||179
1720794|NCT00312494|4211767|P2|COMPLETED|Overall Study||168
1720795|NCT00312494|4211768|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
1720796|NCT00312494|4211766|P3|Received Study Treatment|Overall Study||217
1720797|NCT00312494|4211767|P2|Received Study Treatment|Overall Study||216
1720798|NCT00312494|4211768|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
1720799|NCT00312494|4211766|P3|STARTED|Overall Study||222
1720800|NCT00312494|4211767|P2|STARTED|Overall Study||226
1720801|NCT00312494|4211768|P1|STARTED|Overall Study||232
1720802|NCT00312377|4211802|P2|NOT COMPLETED|Overall Study||668
1720803|NCT00312377|4211803|P1|NOT COMPLETED|Overall Study||644
1720804|NCT00312377|4211802|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
1720805|NCT00312377|4211803|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
1720806|NCT00312377|4211802|P2|STARTED|Overall Study|randomised patients|697
1720807|NCT00312377|4211803|P1|STARTED|Overall Study|randomised patients|694
1720808|NCT00312338|4211827|P2|NOT COMPLETED|Overall Study||3
1720809|NCT00312338|4211828|P1|NOT COMPLETED|Overall Study||22
1720810|NCT00312338|4211827|P2|COMPLETED|Overall Study||54
1720811|NCT00312338|4211828|P1|COMPLETED|Overall Study||83
1720812|NCT00312338|4211827|P2|STARTED|Overall Study||57
1720813|NCT00312338|4211828|P1|STARTED|Overall Study||105
1720814|NCT00312221|4211841|P4|NOT COMPLETED|Double-blind Phase||70
1720815|NCT00312221|4211842|P3|NOT COMPLETED|Double-blind Phase||72
1720816|NCT00312221|4211843|P2|NOT COMPLETED|Double-blind Phase||59
1720817|NCT00312221|4211844|P1|NOT COMPLETED|Double-blind Phase||0
1720818|NCT00312221|4211841|P4|COMPLETED|Double-blind Phase||63
1720819|NCT00312221|4211842|P3|COMPLETED|Double-blind Phase||77
1720820|NCT00312221|4211843|P2|COMPLETED|Double-blind Phase||77
1720821|NCT00312221|4211844|P1|COMPLETED|Double-blind Phase||0
1720822|NCT00312221|4211841|P4|STARTED|Double-blind Phase||133
1720823|NCT00312221|4211842|P3|STARTED|Double-blind Phase||149
1720824|NCT00312221|4211843|P2|STARTED|Double-blind Phase||136
1720825|NCT00312221|4211844|P1|STARTED|Double-blind Phase||0
1720826|NCT00312221|4211841|P4|NOT COMPLETED|Open-label Run-in Period||0
1720827|NCT00312221|4211842|P3|NOT COMPLETED|Open-label Run-in Period||0
1720828|NCT00312221|4211843|P2|NOT COMPLETED|Open-label Run-in Period||0
1720829|NCT00312221|4211844|P1|NOT COMPLETED|Open-label Run-in Period||234
1720830|NCT00312221|4211841|P4|COMPLETED|Open-label Run-in Period||0
1720831|NCT00312221|4211842|P3|COMPLETED|Open-label Run-in Period||0
1720832|NCT00312221|4211843|P2|COMPLETED|Open-label Run-in Period||0
1720833|NCT00312221|4211844|P1|COMPLETED|Open-label Run-in Period||418
1720834|NCT00312221|4211841|P4|STARTED|Open-label Run-in Period||0
1720835|NCT00312221|4211842|P3|STARTED|Open-label Run-in Period||0
1720836|NCT00312221|4211843|P2|STARTED|Open-label Run-in Period||0
1720837|NCT00312221|4211844|P1|STARTED|Open-label Run-in Period||652
1720838|NCT00312208|4211864|P2|NOT COMPLETED|Overall Study||123
1720839|NCT00312208|4211865|P1|NOT COMPLETED|Overall Study||172
1720840|NCT00312208|4211864|P2|COMPLETED|Overall Study||1526
1720841|NCT00312208|4211865|P1|COMPLETED|Overall Study||1477
1720842|NCT00312208|4211864|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
1720843|NCT00312208|4211865|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
1720844|NCT00312195|4211875|P2|NOT COMPLETED|Overall Study||6
1720845|NCT00312195|4211876|P1|NOT COMPLETED|Overall Study||6
1720846|NCT00312195|4211875|P2|COMPLETED|Overall Study||123
1720847|NCT00312195|4211876|P1|COMPLETED|Overall Study||132
1720848|NCT00312195|4211875|P2|STARTED|Overall Study||129
1720849|NCT00312195|4211876|P1|STARTED|Overall Study||138
1720850|NCT00311766|4211892|P2|NOT COMPLETED|Overall Study||5
1720851|NCT00311766|4211893|P1|NOT COMPLETED|Overall Study||0
1720852|NCT00311766|4211892|P2|COMPLETED|Overall Study||17
1720853|NCT00311766|4211893|P1|COMPLETED|Overall Study||8
1720854|NCT00311766|4211892|P2|STARTED|Overall Study||22
1720855|NCT00311766|4211893|P1|STARTED|Overall Study||8
1720856|NCT00311584|4211903|P2|NOT COMPLETED|Overall Study||23
1720857|NCT00311584|4211904|P1|NOT COMPLETED|Overall Study||20
1720858|NCT00311584|4211903|P2|COMPLETED|Overall Study||7
1720859|NCT00311584|4211904|P1|COMPLETED|Overall Study||9
1720860|NCT00311584|4211903|P2|STARTED|Overall Study||30
1720861|NCT00311584|4211904|P1|STARTED|Overall Study||29
1720862|NCT00311402|4211912|P2|NOT COMPLETED|Overall Study||177
1720863|NCT00311402|4211913|P1|NOT COMPLETED|Overall Study||210
1720864|NCT00311402|4211912|P2|COMPLETED|Overall Study||462
1720865|NCT00311402|4211913|P1|COMPLETED|Overall Study||445
1720866|NCT00311402|4211912|P2|STARTED|Overall Study||639
1720867|NCT00311402|4211913|P1|STARTED|Overall Study||655
1720868|NCT00311376|4211940|P3|NOT COMPLETED|Treatment Cycle 2||0
1720869|NCT00311376|4211941|P2|NOT COMPLETED|Treatment Cycle 2||13
1720870|NCT00311376|4211942|P1|NOT COMPLETED|Treatment Cycle 2||9
1720871|NCT00311376|4211940|P3|COMPLETED|Treatment Cycle 2||0
1720872|NCT00311376|4211941|P2|COMPLETED|Treatment Cycle 2||112
1720873|NCT00311376|4211942|P1|COMPLETED|Treatment Cycle 2||106
1720874|NCT00311376|4211940|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
1720875|NCT00311376|4211941|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
1720876|NCT00311376|4211942|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
1720877|NCT00311376|4211940|P3|NOT COMPLETED|Treatment Cycle 1||17
1720878|NCT00311376|4211941|P2|NOT COMPLETED|Treatment Cycle 1||17
1720879|NCT00311376|4211942|P1|NOT COMPLETED|Treatment Cycle 1||27
1720880|NCT00311376|4211940|P3|COMPLETED|Treatment Cycle 1||132
1720881|NCT00311376|4211941|P2|COMPLETED|Treatment Cycle 1||118
1720882|NCT00311376|4211942|P1|COMPLETED|Treatment Cycle 1||105
1720883|NCT00311376|4211940|P3|STARTED|Treatment Cycle 1||149
1720884|NCT00311376|4211941|P2|STARTED|Treatment Cycle 1||135
1720885|NCT00311376|4211942|P1|STARTED|Treatment Cycle 1||132
1720886|NCT00311363|4211962|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
1720887|NCT00311363|4211963|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
1720888|NCT00311363|4211964|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
1720889|NCT00311363|4211962|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
1720890|NCT00311363|4211963|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
1720891|NCT00311363|4211964|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
1720892|NCT00311363|4211962|P3|STARTED|12-Week Double-Blind Treatment Period||96
1720893|NCT00311363|4211963|P2|STARTED|12-Week Double-Blind Treatment Period||98
1720894|NCT00311363|4211964|P1|STARTED|12-Week Double-Blind Treatment Period||0
1720895|NCT00311363|4211962|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
1720896|NCT00311363|4211963|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
1720897|NCT00311363|4211964|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
1720898|NCT00311363|4211962|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
1720899|NCT00311363|4211963|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
1720900|NCT00311363|4211964|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
1720901|NCT00311363|4211962|P3|STARTED|24-Week Single-Blind Treatment Period||0
1720902|NCT00311363|4211963|P2|STARTED|24-Week Single-Blind Treatment Period||0
1720903|NCT00311363|4211964|P1|STARTED|24-Week Single-Blind Treatment Period||327
1720904|NCT00311311|4212024|P2|NOT COMPLETED|Overall Study||9
1720905|NCT00311311|4212025|P1|NOT COMPLETED|Overall Study||8
1720906|NCT00311311|4212024|P2|COMPLETED|Overall Study||26
1720907|NCT00311311|4212025|P1|COMPLETED|Overall Study||29
1720908|NCT00311311|4212024|P2|STARTED|Overall Study||35
1720909|NCT00311311|4212025|P1|STARTED|Overall Study||37
1720910|NCT00311181|4212075|P1|NOT COMPLETED|Overall Study||96
1720911|NCT00311181|4212075|P1|COMPLETED|Overall Study||121
1720912|NCT00311181|4212075|P1|STARTED|Overall Study||217
1720913|NCT00311155|4212081|P1|NOT COMPLETED|Overall Study||93
1720914|NCT00311155|4212081|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
1720915|NCT00311155|4212081|P1|STARTED|Overall Study||694
1720916|NCT00310856|4212093|P3|NOT COMPLETED|Overall Study||8
1720917|NCT00310856|4212094|P2|NOT COMPLETED|Overall Study||5
1720918|NCT00310856|4212095|P1|NOT COMPLETED|Overall Study||5
1720919|NCT00310856|4212093|P3|COMPLETED|Overall Study||42
1720920|NCT00310856|4212094|P2|COMPLETED|Overall Study||56
1720921|NCT00310856|4212095|P1|COMPLETED|Overall Study||59
1720922|NCT00310856|4212093|P3|STARTED|Overall Study||50
1720923|NCT00310856|4212094|P2|STARTED|Overall Study||61
1720924|NCT00310856|4212095|P1|STARTED|Overall Study||64
1720925|NCT00310817|4212119|P4|NOT COMPLETED|Overall Study||8
1720926|NCT00310817|4212120|P3|NOT COMPLETED|Overall Study||8
1720927|NCT00310817|4212121|P2|NOT COMPLETED|Overall Study||8
1720928|NCT00310817|4212122|P1|NOT COMPLETED|Overall Study||11
1720929|NCT00310817|4212119|P4|COMPLETED|Overall Study||74
1720930|NCT00310817|4212120|P3|COMPLETED|Overall Study||120
1720931|NCT00310817|4212121|P2|COMPLETED|Overall Study||198
1720932|NCT00310817|4212122|P1|COMPLETED|Overall Study||196
1720933|NCT00310817|4212119|P4|STARTED|Overall Study||82
1720934|NCT00310817|4212120|P3|STARTED|Overall Study||128
1720935|NCT00310817|4212121|P2|STARTED|Overall Study||206
1720936|NCT00310817|4212122|P1|STARTED|Overall Study||207
1720937|NCT00310804|4212210|P2|NOT COMPLETED|Overall Study||0
1720938|NCT00310804|4212211|P1|NOT COMPLETED|Overall Study||5
1720939|NCT00310804|4212210|P2|COMPLETED|Overall Study||171
1720940|NCT00310804|4212211|P1|COMPLETED|Overall Study||1024
1720941|NCT00310804|4212210|P2|STARTED|Overall Study||171
1720942|NCT00310804|4212211|P1|STARTED|Overall Study||1029
1720943|NCT00310791|4212246|P2|NOT COMPLETED|Overall Study||10
1720944|NCT00310791|4212247|P1|NOT COMPLETED|Overall Study||10
1720945|NCT00310791|4212246|P2|COMPLETED|Overall Study||30
1720946|NCT00310791|4212247|P1|COMPLETED|Overall Study||30
1720947|NCT00310791|4212246|P2|STARTED|Overall Study||40
1720948|NCT00310791|4212247|P1|STARTED|Overall Study||40
1720949|NCT00310466|4212255|P2|NOT COMPLETED|Overall Study||12
1720950|NCT00310466|4212256|P1|NOT COMPLETED|Overall Study||18
1720951|NCT00310466|4212255|P2|COMPLETED|Overall Study||101
1720952|NCT00310466|4212256|P1|COMPLETED|Overall Study||95
1720953|NCT00310466|4212255|P2|STARTED|Overall Study||113
1720954|NCT00310466|4212256|P1|STARTED|Overall Study||113
1720955|NCT00310440|4212270|P2|NOT COMPLETED|Overall Study||13
1720956|NCT00310440|4212271|P1|NOT COMPLETED|Overall Study||26
1720957|NCT00310440|4212270|P2|COMPLETED|Overall Study||141
1720958|NCT00310440|4212271|P1|COMPLETED|Overall Study||139
1720959|NCT00310440|4212270|P2|STARTED|Overall Study||154
1720960|NCT00310440|4212271|P1|STARTED|Overall Study||165
1720961|NCT00310427|4212297|P2|NOT COMPLETED|Overall Study||1
1720962|NCT00310427|4212298|P1|NOT COMPLETED|Overall Study||2
1720963|NCT00310427|4212297|P2|COMPLETED|Overall Study||25
1720964|NCT00310427|4212298|P1|COMPLETED|Overall Study||25
1720965|NCT00310427|4212297|P2|STARTED|Overall Study||26
1720966|NCT00310427|4212298|P1|STARTED|Overall Study||27
1720967|NCT00310401|4212320|P2|NOT COMPLETED|Overall Study||0
1720968|NCT00310401|4212321|P1|NOT COMPLETED|Overall Study||0
1720969|NCT00310401|4212320|P2|COMPLETED|Overall Study||246
1720970|NCT00310401|4212321|P1|COMPLETED|Overall Study||260
1720971|NCT00310401|4212320|P2|STARTED|Overall Study||246
1720972|NCT00310401|4212321|P1|STARTED|Overall Study||260
1720973|NCT00310388|4212335|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||13
1720974|NCT00310388|4212336|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
1720975|NCT00310388|4212335|P2|COMPLETED|Safety Follow-up Continuation Phase||13
1720976|NCT00310388|4212336|P1|COMPLETED|Safety Follow-up Continuation Phase||0
1720977|NCT00310388|4212335|P2|STARTED|Safety Follow-up Continuation Phase||26
1720978|NCT00310388|4212336|P1|STARTED|Safety Follow-up Continuation Phase||0
1720979|NCT00310388|4212335|P2|NOT COMPLETED|Primary Reporting Phase||0
1720980|NCT00310388|4212336|P1|NOT COMPLETED|Primary Reporting Phase||346
1720981|NCT00310388|4212335|P2|COMPLETED|Primary Reporting Phase||0
1720982|NCT00310388|4212336|P1|COMPLETED|Primary Reporting Phase||30
1720983|NCT00310388|4212335|P2|STARTED|Primary Reporting Phase||0
1720984|NCT00310388|4212336|P1|STARTED|Primary Reporting Phase||376
1720985|NCT00310375|4212378|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
1720986|NCT00310375|4212379|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
1720987|NCT00310375|4212380|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
1720988|NCT00310375|4212378|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
1720989|NCT00310375|4212379|P2|COMPLETED|Safety Follow-up Continuation Phase||0
1720990|NCT00310375|4212380|P1|COMPLETED|Safety Follow-up Continuation Phase||0
1720991|NCT00310375|4212378|P3|STARTED|Safety Follow-up Continuation Phase||19
1720992|NCT00310375|4212379|P2|STARTED|Safety Follow-up Continuation Phase||0
1720993|NCT00310375|4212380|P1|STARTED|Safety Follow-up Continuation Phase||0
1720994|NCT00310375|4212378|P3|NOT COMPLETED|Primary Reporting Phase||0
1720995|NCT00310375|4212379|P2|NOT COMPLETED|Primary Reporting Phase||68
1720996|NCT00310375|4212380|P1|NOT COMPLETED|Primary Reporting Phase||91
1720997|NCT00310375|4212378|P3|COMPLETED|Primary Reporting Phase||0
1720998|NCT00310375|4212379|P2|COMPLETED|Primary Reporting Phase||11
1720999|NCT00310375|4212380|P1|COMPLETED|Primary Reporting Phase||11
1721000|NCT00310375|4212378|P3|STARTED|Primary Reporting Phase||0
1721001|NCT00310375|4212379|P2|STARTED|Primary Reporting Phase||79
1721002|NCT00310375|4212380|P1|STARTED|Primary Reporting Phase||102
1721003|NCT00310362|4212425|P3|NOT COMPLETED|Overall Study||0
1721004|NCT00310362|4212426|P2|NOT COMPLETED|Overall Study||0
1721005|NCT00310362|4212427|P1|NOT COMPLETED|Overall Study||0
1721006|NCT00310362|4212425|P3|COMPLETED|Overall Study||1206
1721007|NCT00310362|4212426|P2|COMPLETED|Overall Study||1205
1721008|NCT00310362|4212427|P1|COMPLETED|Overall Study||1199
1721009|NCT00310362|4212425|P3|STARTED|Overall Study||1206
1721010|NCT00310362|4212426|P2|STARTED|Overall Study||1205
1721011|NCT00310362|4212427|P1|STARTED|Overall Study||1199
1721012|NCT00310310|4212437|P2|NOT COMPLETED|Overall Study||20
1721013|NCT00310310|4212438|P1|NOT COMPLETED|Overall Study||30
1721014|NCT00310310|4212437|P2|COMPLETED|Overall Study||100
1721015|NCT00310310|4212438|P1|COMPLETED|Overall Study||90
1721016|NCT00310310|4212437|P2|STARTED|Overall Study||120
1721017|NCT00310310|4212438|P1|STARTED|Overall Study||120
1721018|NCT00310076|4212462|P1|NOT COMPLETED|Overall Study||3
1721019|NCT00310076|4212462|P1|COMPLETED|Overall Study||26
1721020|NCT00310076|4212462|P1|STARTED|Overall Study||29
1721021|NCT00310050|4212468|P1|NOT COMPLETED|Overall Study||1
1721022|NCT00310050|4212468|P1|COMPLETED|Overall Study||3
1721023|NCT00310050|4212468|P1|STARTED|Overall Study||4
1721024|NCT00310037|4212479|P2|NOT COMPLETED|Overall Study||17
1721025|NCT00310037|4212480|P1|NOT COMPLETED|Overall Study||18
1721026|NCT00310037|4212479|P2|COMPLETED|Overall Study||33
1721027|NCT00310037|4212480|P1|COMPLETED|Overall Study||34
1721028|NCT00310037|4212479|P2|STARTED|Overall Study||50
1721029|NCT00310037|4212480|P1|STARTED|Overall Study||52
1721030|NCT00309985|4212494|P2|NOT COMPLETED|Overall Study||1
1721031|NCT00309985|4212495|P1|NOT COMPLETED|Overall Study||62
1721032|NCT00309985|4212494|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
1721033|NCT00309985|4212495|P1|COMPLETED|Overall Study||335
1721034|NCT00309985|4212494|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
1721035|NCT00309985|4212495|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
1721036|NCT00309985|4212494|P2|Toxicity Analysis|Overall Study||392
1721037|NCT00309985|4212495|P1|Toxicity Analysis|Overall Study||390
1721038|NCT00309985|4212494|P2|STARTED|Overall Study||393
1721039|NCT00309985|4212495|P1|STARTED|Overall Study||397
1721040|NCT00309946|4212511|P1|NOT COMPLETED|Overall Study||1
1721041|NCT00309946|4212511|P1|COMPLETED|Overall Study||50
1721042|NCT00309946|4212511|P1|STARTED|Overall Study||51
1721043|NCT00309907|4212517|P1|NOT COMPLETED|Overall Study||20
1721044|NCT00309907|4212517|P1|COMPLETED|Overall Study||19
1721045|NCT00309907|4212517|P1|STARTED|Overall Study||39
1721046|NCT00309777|4212530|P4|NOT COMPLETED|Overall Study||4
1721047|NCT00309777|4212531|P3|NOT COMPLETED|Overall Study||19
1721048|NCT00309777|4212532|P2|NOT COMPLETED|Overall Study||9
1721049|NCT00309777|4212533|P1|NOT COMPLETED|Overall Study||23
1721050|NCT00309777|4212530|P4|COMPLETED|Overall Study||107
1721051|NCT00309777|4212531|P3|COMPLETED|Overall Study||304
1721052|NCT00309777|4212532|P2|COMPLETED|Overall Study||99
1721053|NCT00309777|4212533|P1|COMPLETED|Overall Study||292
1721054|NCT00309777|4212530|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
1721055|NCT00309777|4212531|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
1721056|NCT00309777|4212532|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
1721057|NCT00309777|4212533|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
1721058|NCT00309777|4212530|P4|STARTED|Overall Study||111
1721059|NCT00309777|4212531|P3|STARTED|Overall Study||323
1721060|NCT00309777|4212532|P2|STARTED|Overall Study||108
1721061|NCT00309777|4212533|P1|STARTED|Overall Study||315
1721062|NCT00309751|4212549|P2|NOT COMPLETED|Overall Study||15
1721063|NCT00309751|4212550|P1|NOT COMPLETED|Overall Study||31
1721064|NCT00309751|4212549|P2|COMPLETED|Overall Study||124
1721065|NCT00309751|4212550|P1|COMPLETED|Overall Study||248
1721066|NCT00309751|4212549|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
1721067|NCT00309751|4212550|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
1721068|NCT00309751|4212549|P2|STARTED|Overall Study||139
1721069|NCT00309751|4212550|P1|STARTED|Overall Study||279
1721070|NCT00309738|4212560|P2|NOT COMPLETED|Overall Study||12
1721071|NCT00309738|4212561|P1|NOT COMPLETED|Overall Study||13
1721072|NCT00309738|4212560|P2|COMPLETED|Overall Study||107
1721073|NCT00309738|4212561|P1|COMPLETED|Overall Study||223
1721074|NCT00309738|4212560|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
1721075|NCT00309738|4212561|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
1721076|NCT00309738|4212560|P2|STARTED|Overall Study||119
1721077|NCT00309738|4212561|P1|STARTED|Overall Study||236
1721078|NCT00309608|4212574|P5|NOT COMPLETED|Overall Study||4
1721079|NCT00309608|4212575|P4|NOT COMPLETED|Overall Study||6
1721080|NCT00309608|4212576|P3|NOT COMPLETED|Overall Study||10
1721081|NCT00309608|4212577|P2|NOT COMPLETED|Overall Study||13
1721082|NCT00309608|4212578|P1|NOT COMPLETED|Overall Study||14
1721083|NCT00309608|4212574|P5|COMPLETED|Overall Study||61
1721084|NCT00309608|4212575|P4|COMPLETED|Overall Study||60
1721085|NCT00309608|4212576|P3|COMPLETED|Overall Study||56
1721086|NCT00309608|4212577|P2|COMPLETED|Overall Study||52
1721087|NCT00309608|4212578|P1|COMPLETED|Overall Study||57
1721088|NCT00309608|4212574|P5|STARTED|Overall Study||65
1721089|NCT00309608|4212575|P4|STARTED|Overall Study||66
1721090|NCT00309608|4212576|P3|STARTED|Overall Study||66
1721091|NCT00309608|4212577|P2|STARTED|Overall Study||65
1721092|NCT00309608|4212578|P1|STARTED|Overall Study||71
1721093|NCT00309465|4212605|P6|NOT COMPLETED|Overall Study||0
1721094|NCT00309465|4212606|P5|NOT COMPLETED|Overall Study||0
1721095|NCT00309465|4212607|P4|NOT COMPLETED|Overall Study||1
1721096|NCT00309465|4212608|P3|NOT COMPLETED|Overall Study||0
1721097|NCT00309465|4212609|P2|NOT COMPLETED|Overall Study||0
1721098|NCT00309465|4212610|P1|NOT COMPLETED|Overall Study||0
1721099|NCT00309465|4212605|P6|COMPLETED|Overall Study||76
1721100|NCT00309465|4212606|P5|COMPLETED|Overall Study||76
1721101|NCT00309465|4212607|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
1721102|NCT00309465|4212608|P3|COMPLETED|Overall Study||58
1721103|NCT00309465|4212609|P2|COMPLETED|Overall Study||58
1721104|NCT00309465|4212610|P1|COMPLETED|Overall Study||58
1721105|NCT00309465|4212605|P6|STARTED|Overall Study||76
1721106|NCT00309465|4212606|P5|STARTED|Overall Study||76
1721107|NCT00309465|4212607|P4|STARTED|Overall Study||76
1721108|NCT00309465|4212608|P3|STARTED|Overall Study||58
1721109|NCT00309465|4212609|P2|STARTED|Overall Study||58
1721110|NCT00309465|4212610|P1|STARTED|Overall Study||58
1721111|NCT00309452|4212626|P2|NOT COMPLETED|Overall Study||0
1721112|NCT00309452|4212627|P1|NOT COMPLETED|Overall Study||3
1721113|NCT00309452|4212626|P2|COMPLETED|Overall Study||60
1721114|NCT00309452|4212627|P1|COMPLETED|Overall Study||57
1721115|NCT00309452|4212626|P2|STARTED|Overall Study||60
1721116|NCT00309452|4212627|P1|STARTED|Overall Study||60
1721117|NCT00309387|4212655|P2|NOT COMPLETED|Overall Study||159
1721118|NCT00309387|4212656|P1|NOT COMPLETED|Overall Study||142
1721119|NCT00309387|4212655|P2|COMPLETED|Overall Study||351
1721120|NCT00309387|4212656|P1|COMPLETED|Overall Study||368
1721121|NCT00309387|4212655|P2|STARTED|Overall Study||510
1721122|NCT00309387|4212656|P1|STARTED|Overall Study||510
1721123|NCT00309244|4212674|P2|NOT COMPLETED|Overall Study||97
1721124|NCT00309244|4212675|P1|NOT COMPLETED|Overall Study||118
1721125|NCT00309244|4212674|P2|COMPLETED|Overall Study||246
1721126|NCT00309244|4212675|P1|COMPLETED|Overall Study||216
1721127|NCT00309244|4212674|P2|STARTED|Overall Study||343
1721128|NCT00309244|4212675|P1|STARTED|Overall Study||334
1721129|NCT00309166|4212697|P2|NOT COMPLETED|Overall Study||3
1721130|NCT00309166|4212698|P1|NOT COMPLETED|Overall Study||5
1721131|NCT00309166|4212697|P2|COMPLETED|Overall Study||86
1721132|NCT00309166|4212698|P1|COMPLETED|Overall Study||176
1721133|NCT00309166|4212697|P2|STARTED|Overall Study||89
1721134|NCT00309166|4212698|P1|STARTED|Overall Study||181
1721135|NCT00308997|4212726|P2|NOT COMPLETED|Overall Study||1
1721136|NCT00308997|4212727|P1|NOT COMPLETED|Overall Study||1
1721137|NCT00308997|4212726|P2|COMPLETED|Overall Study||28
1721138|NCT00308997|4212727|P1|COMPLETED|Overall Study||55
1721139|NCT00308997|4212726|P2|STARTED|Overall Study||29
1721140|NCT00308997|4212727|P1|STARTED|Overall Study||56
1721141|NCT00308737|4212746|P3|NOT COMPLETED|Overall Study||37
1721142|NCT00308737|4212747|P2|NOT COMPLETED|Overall Study||289
1721143|NCT00308737|4212748|P1|NOT COMPLETED|Overall Study||463
1721144|NCT00308737|4212746|P3|COMPLETED|Overall Study||127
1721145|NCT00308737|4212747|P2|COMPLETED|Overall Study||662
1721146|NCT00308737|4212748|P1|COMPLETED|Overall Study||475
1721147|NCT00308737|4212746|P3|STARTED|Overall Study||164
1721148|NCT00308737|4212747|P2|STARTED|Overall Study||951
1721149|NCT00308737|4212748|P1|STARTED|Overall Study||938
1721150|NCT00308711|4212788|P3|NOT COMPLETED|Overall Study||5
1721151|NCT00308711|4212789|P2|NOT COMPLETED|Overall Study||4
1721152|NCT00308711|4212790|P1|NOT COMPLETED|Overall Study||2
1721153|NCT00308711|4212788|P3|COMPLETED|Overall Study||431
1721154|NCT00308711|4212789|P2|COMPLETED|Overall Study||440
1721155|NCT00308711|4212790|P1|COMPLETED|Overall Study||426
1721156|NCT00308711|4212788|P3|STARTED|Overall Study||436
1721157|NCT00308711|4212789|P2|STARTED|Overall Study||444
1721158|NCT00308711|4212790|P1|STARTED|Overall Study||428
1721159|NCT00308620|4212825|P3|NOT COMPLETED|Overall Study||1
1721160|NCT00308620|4212826|P2|NOT COMPLETED|Overall Study||1
1721161|NCT00308620|4212827|P1|NOT COMPLETED|Overall Study||1
1721162|NCT00308620|4212825|P3|COMPLETED|Overall Study||5
1721163|NCT00308620|4212826|P2|COMPLETED|Overall Study||3
1721164|NCT00308620|4212827|P1|COMPLETED|Overall Study||2
1721165|NCT00308620|4212825|P3|STARTED|Overall Study||6
1721166|NCT00308620|4212826|P2|STARTED|Overall Study||4
1721167|NCT00308620|4212827|P1|STARTED|Overall Study||3
1721168|NCT00308581|4212836|P3|NOT COMPLETED|Randomized Maintenance Phase||0
1721169|NCT00308581|4212837|P2|NOT COMPLETED|Randomized Maintenance Phase||103
1721170|NCT00308581|4212838|P1|NOT COMPLETED|Randomized Maintenance Phase||105
1721171|NCT00308581|4212836|P3|COMPLETED|Randomized Maintenance Phase||0
1721172|NCT00308581|4212837|P2|COMPLETED|Randomized Maintenance Phase||83
1721173|NCT00308581|4212838|P1|COMPLETED|Randomized Maintenance Phase||82
1721174|NCT00308581|4212836|P3|STARTED|Randomized Maintenance Phase||0
1721175|NCT00308581|4212837|P2|STARTED|Randomized Maintenance Phase||186
1721176|NCT00308581|4212838|P1|STARTED|Randomized Maintenance Phase||187
1721177|NCT00308581|4212836|P3|NOT COMPLETED|Induction Phase||166
1721178|NCT00308581|4212837|P2|NOT COMPLETED|Induction Phase||0
1721179|NCT00308581|4212838|P1|NOT COMPLETED|Induction Phase||0
1721180|NCT00308581|4212836|P3|COMPLETED|Induction Phase||373
1721181|NCT00308581|4212837|P2|COMPLETED|Induction Phase|Not applicable in this period|0
1721182|NCT00308581|4212838|P1|COMPLETED|Induction Phase|Not applicable in this period|0
1721183|NCT00308581|4212836|P3|STARTED|Induction Phase||539
1721184|NCT00308581|4212837|P2|STARTED|Induction Phase|Not applicable in this period|0
1721185|NCT00308581|4212838|P1|STARTED|Induction Phase|Not applicable in this period|0
1721186|NCT00308555|4212964|P2|NOT COMPLETED|Overall Study||0
1721187|NCT00308555|4212965|P1|NOT COMPLETED|Overall Study||3
1721188|NCT00308555|4212964|P2|COMPLETED|Overall Study||11
1721189|NCT00308555|4212965|P1|COMPLETED|Overall Study||10
1721190|NCT00308555|4212964|P2|STARTED|Overall Study||11
1721191|NCT00308555|4212965|P1|STARTED|Overall Study||13
1721192|NCT00308516|4212973|P2|NOT COMPLETED|Overall Study||21
1721193|NCT00308516|4212974|P1|NOT COMPLETED|Overall Study||29
1721194|NCT00308516|4212973|P2|COMPLETED|Overall Study||10
1721195|NCT00308516|4212974|P1|COMPLETED|Overall Study||6
1721196|NCT00308516|4212973|P2|STARTED|Overall Study||31
1721197|NCT00308516|4212974|P1|STARTED|Overall Study||35
1721198|NCT00308308|4212982|P2|NOT COMPLETED|Overall Study||68
1721199|NCT00308308|4212983|P1|NOT COMPLETED|Overall Study||103
1721200|NCT00308308|4212982|P2|COMPLETED|Overall Study||220
1721201|NCT00308308|4212983|P1|COMPLETED|Overall Study||198
1721202|NCT00308308|4212982|P2|STARTED|Overall Study||288
1721203|NCT00308308|4212983|P1|STARTED|Overall Study||301
1721204|NCT00308230|4213006|P3|NOT COMPLETED|Overall Study||0
1721205|NCT00308230|4213007|P2|NOT COMPLETED|Overall Study||0
1721206|NCT00308230|4213008|P1|NOT COMPLETED|Overall Study||0
1721207|NCT00308230|4213006|P3|COMPLETED|Overall Study||20
1721208|NCT00308230|4213007|P2|COMPLETED|Overall Study||8
1721209|NCT00308230|4213008|P1|COMPLETED|Overall Study||6
1721210|NCT00308230|4213006|P3|STARTED|Overall Study||20
1721211|NCT00308230|4213007|P2|STARTED|Overall Study||8
1721212|NCT00308230|4213008|P1|STARTED|Overall Study||6
1721213|NCT00308139|4213018|P2|NOT COMPLETED|Overall Study||87
1721214|NCT00308139|4213019|P1|NOT COMPLETED|Overall Study||94
1721215|NCT00308139|4213018|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
1721216|NCT00308139|4213019|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
1721217|NCT00308139|4213018|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
1721218|NCT00308139|4213019|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
1721219|NCT00308139|4213018|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
1721220|NCT00308139|4213019|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
1721221|NCT00308139|4213018|P2|Pharmacokinetics Population|Overall Study||0
1721222|NCT00308139|4213019|P1|Pharmacokinetics Population|Overall Study||129
1721223|NCT00308139|4213018|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
1721224|NCT00308139|4213019|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
1721225|NCT00308139|4213018|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
1721226|NCT00308139|4213019|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
1721227|NCT00308139|4213018|P2|STARTED|Overall Study||151
1721228|NCT00308139|4213019|P1|STARTED|Overall Study||152
1721229|NCT00308113|4213093|P4|NOT COMPLETED|Overall Study||1
1721230|NCT00308113|4213094|P3|NOT COMPLETED|Overall Study||0
1721231|NCT00308113|4213095|P2|NOT COMPLETED|Overall Study||0
1721232|NCT00308113|4213096|P1|NOT COMPLETED|Overall Study||0
1721233|NCT00308113|4213093|P4|COMPLETED|Overall Study||1
1721234|NCT00308113|4213094|P3|COMPLETED|Overall Study||1
1721235|NCT00308113|4213095|P2|COMPLETED|Overall Study||0
1721236|NCT00308113|4213096|P1|COMPLETED|Overall Study||0
1721237|NCT00308113|4213093|P4|STARTED|Overall Study||2
1721238|NCT00308113|4213094|P3|STARTED|Overall Study||1
1721239|NCT00308113|4213095|P2|STARTED|Overall Study||0
1721240|NCT00308113|4213096|P1|STARTED|Overall Study||0
1721241|NCT00308087|4213116|P2|NOT COMPLETED|Overall Study||37
1721242|NCT00308087|4213117|P1|NOT COMPLETED|Overall Study||36
1721243|NCT00308087|4213116|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
1721244|NCT00308087|4213117|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
1721245|NCT00308087|4213116|P2|STARTED|Overall Study||38
1721246|NCT00308087|4213117|P1|STARTED|Overall Study||37
1721247|NCT00308074|4213133|P1|NOT COMPLETED|Overall Study||1
1721248|NCT00308074|4213133|P1|COMPLETED|Overall Study||13
1721249|NCT00308074|4213133|P1|STARTED|Overall Study||14
1721250|NCT00308061|4213142|P2|NOT COMPLETED|Overall Study||0
1721251|NCT00308061|4213143|P1|NOT COMPLETED|Overall Study||0
1721252|NCT00308061|4213142|P2|COMPLETED|Overall Study||20
1721253|NCT00308061|4213143|P1|COMPLETED|Overall Study||20
1721254|NCT00308061|4213142|P2|STARTED|Overall Study||20
1721255|NCT00308061|4213143|P1|STARTED|Overall Study||20
1721256|NCT00307931|4213150|P1|NOT COMPLETED|Overall Study||1
1721257|NCT00307931|4213150|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
1721258|NCT00307931|4213150|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
1721259|NCT00307801|4213167|P2|NOT COMPLETED|Overall Study||17
1721260|NCT00307801|4213168|P1|NOT COMPLETED|Overall Study||32
1721261|NCT00307801|4213167|P2|COMPLETED|Overall Study||65
1721262|NCT00307801|4213168|P1|COMPLETED|Overall Study||117
1721263|NCT00307801|4213167|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
1721264|NCT00307801|4213168|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
1721265|NCT00307801|4213167|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
1721266|NCT00307801|4213168|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
1721267|NCT00307801|4213167|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
1721268|NCT00307801|4213168|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
1721269|NCT00307801|4213167|P2|Subjects Received Treatment|Overall Study||81
1721270|NCT00307801|4213168|P1|Subjects Received Treatment|Overall Study||145
1721271|NCT00307801|4213167|P2|STARTED|Overall Study||82
1721272|NCT00307801|4213168|P1|STARTED|Overall Study||149
1721273|NCT00307736|4213280|P4|NOT COMPLETED|Overall Study||3
1721274|NCT00307736|4213281|P3|NOT COMPLETED|Overall Study||3
1721275|NCT00307736|4213282|P2|NOT COMPLETED|Overall Study||0
1721276|NCT00307736|4213283|P1|NOT COMPLETED|Overall Study||0
1721277|NCT00307736|4213280|P4|COMPLETED|Overall Study||20
1721278|NCT00307736|4213281|P3|COMPLETED|Overall Study||0
1721279|NCT00307736|4213282|P2|COMPLETED|Overall Study||3
1721280|NCT00307736|4213283|P1|COMPLETED|Overall Study||3
1721281|NCT00307736|4213280|P4|STARTED|Overall Study||23
1721282|NCT00307736|4213281|P3|STARTED|Overall Study||3
1721283|NCT00307736|4213282|P2|STARTED|Overall Study||3
1721284|NCT00307736|4213283|P1|STARTED|Overall Study||3
1721285|NCT00307684|4213294|P3|NOT COMPLETED|Double Blind Phase||0
1721286|NCT00307684|4213295|P2|NOT COMPLETED|Double Blind Phase||5
1721287|NCT00307684|4213296|P1|NOT COMPLETED|Double Blind Phase||2
1721288|NCT00307684|4213294|P3|COMPLETED|Double Blind Phase||0
1721289|NCT00307684|4213295|P2|COMPLETED|Double Blind Phase||17
1721290|NCT00307684|4213296|P1|COMPLETED|Double Blind Phase||21
1721291|NCT00307684|4213294|P3|STARTED|Double Blind Phase||0
1721292|NCT00307684|4213295|P2|STARTED|Double Blind Phase||22
1721293|NCT00307684|4213296|P1|STARTED|Double Blind Phase||23
1721294|NCT00307684|4213294|P3|NOT COMPLETED|Open Label Phase||56
1721295|NCT00307684|4213295|P2|NOT COMPLETED|Open Label Phase||0
1721296|NCT00307684|4213296|P1|NOT COMPLETED|Open Label Phase||0
1721297|NCT00307684|4213294|P3|COMPLETED|Open Label Phase||99
1721298|NCT00307684|4213295|P2|COMPLETED|Open Label Phase||0
1721299|NCT00307684|4213296|P1|COMPLETED|Open Label Phase||0
1721300|NCT00307684|4213294|P3|STARTED|Open Label Phase|1 screening failure|155
1721301|NCT00307684|4213295|P2|STARTED|Open Label Phase||0
1721302|NCT00307684|4213296|P1|STARTED|Open Label Phase||0
1721303|NCT00307489|4213324|P2|NOT COMPLETED|Week 48 Through Week 168||6
1721304|NCT00307489|4213325|P1|NOT COMPLETED|Week 48 Through Week 168||6
1721305|NCT00307489|4213324|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
1721306|NCT00307489|4213325|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
1721307|NCT00307489|4213324|P2|STARTED|Week 48 Through Week 168||50
1721308|NCT00307489|4213325|P1|STARTED|Week 48 Through Week 168||52
1721309|NCT00307489|4213324|P2|NOT COMPLETED|Baseline Through Week 48||2
1721310|NCT00307489|4213325|P1|NOT COMPLETED|Baseline Through Week 48||1
1721311|NCT00307489|4213324|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
1721312|NCT00307489|4213325|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
1721313|NCT00307489|4213324|P2|STARTED|Baseline Through Week 48||52
1721314|NCT00307489|4213325|P1|STARTED|Baseline Through Week 48||53
1721315|NCT00307437|4213370|P7|NOT COMPLETED|After Controlled Period||113
1721316|NCT00307437|4213371|P6|NOT COMPLETED|After Controlled Period||122
1721317|NCT00307437|4213372|P5|NOT COMPLETED|After Controlled Period||55
1721318|NCT00307437|4213373|P4|NOT COMPLETED|After Controlled Period||58
1721319|NCT00307437|4213374|P3|NOT COMPLETED|After Controlled Period||0
1721320|NCT00307437|4213375|P2|NOT COMPLETED|After Controlled Period||0
1721321|NCT00307437|4213376|P1|NOT COMPLETED|After Controlled Period||0
1721322|NCT00307437|4213370|P7|COMPLETED|After Controlled Period||289
1721323|NCT00307437|4213371|P6|COMPLETED|After Controlled Period||281
1721324|NCT00307437|4213372|P5|COMPLETED|After Controlled Period||140
1721325|NCT00307437|4213373|P4|COMPLETED|After Controlled Period||139
1721326|NCT00307437|4213374|P3|COMPLETED|After Controlled Period||0
1721327|NCT00307437|4213375|P2|COMPLETED|After Controlled Period||0
1721328|NCT00307437|4213376|P1|COMPLETED|After Controlled Period||0
1721329|NCT00307437|4213370|P7|STARTED|After Controlled Period||402
1721330|NCT00307437|4213371|P6|STARTED|After Controlled Period||403
1721331|NCT00307437|4213372|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
1721332|NCT00307437|4213373|P4|STARTED|After Controlled Period||197
1721333|NCT00307437|4213374|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1721334|NCT00307437|4213375|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1721335|NCT00307437|4213376|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1721336|NCT00307437|4213370|P7|NOT COMPLETED|Controlled Period||0
1721337|NCT00307437|4213371|P6|NOT COMPLETED|Controlled Period||0
1721338|NCT00307437|4213372|P5|NOT COMPLETED|Controlled Period||0
1721339|NCT00307437|4213373|P4|NOT COMPLETED|Controlled Period||0
1721340|NCT00307437|4213374|P3|NOT COMPLETED|Controlled Period||9
1721341|NCT00307437|4213375|P2|NOT COMPLETED|Controlled Period||6
1721342|NCT00307437|4213376|P1|NOT COMPLETED|Controlled Period||16
1721343|NCT00307437|4213370|P7|COMPLETED|Controlled Period||0
1721344|NCT00307437|4213371|P6|COMPLETED|Controlled Period||0
1721345|NCT00307437|4213372|P5|COMPLETED|Controlled Period||0
1721346|NCT00307437|4213373|P4|COMPLETED|Controlled Period||0
1721347|NCT00307437|4213374|P3|COMPLETED|Controlled Period||402
1721348|NCT00307437|4213375|P2|COMPLETED|Controlled Period||403
1721349|NCT00307437|4213376|P1|COMPLETED|Controlled Period||394
1721350|NCT00307437|4213370|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1721351|NCT00307437|4213371|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1721352|NCT00307437|4213372|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1721353|NCT00307437|4213373|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1721354|NCT00307437|4213374|P3|STARTED|Controlled Period||411
1721355|NCT00307437|4213375|P2|STARTED|Controlled Period||409
1721356|NCT00307437|4213376|P1|STARTED|Controlled Period||410
1721357|NCT00307333|4213402|P2|NOT COMPLETED|Overall Study||3
1721358|NCT00307333|4213403|P1|NOT COMPLETED|Overall Study||11
1721359|NCT00307333|4213402|P2|COMPLETED|Overall Study||1489
1721360|NCT00307333|4213403|P1|COMPLETED|Overall Study||1500
1721361|NCT00307333|4213402|P2|STARTED|Overall Study||1492
1721362|NCT00307333|4213403|P1|STARTED|Overall Study||1511
1721363|NCT00307294|4213415|P1|NOT COMPLETED|Overall Study||1
1721364|NCT00307294|4213415|P1|COMPLETED|Overall Study||39
1721365|NCT00307294|4213415|P1|STARTED|Overall Study||40
1721366|NCT00307164|4213424|P2|NOT COMPLETED|Overall Study||14
1721367|NCT00307164|4213425|P1|NOT COMPLETED|Overall Study||15
1721368|NCT00307164|4213424|P2|COMPLETED|Overall Study||68
1721369|NCT00307164|4213425|P1|COMPLETED|Overall Study||68
1721370|NCT00307164|4213424|P2|STARTED|Overall Study||82
1721371|NCT00307164|4213425|P1|STARTED|Overall Study||83
1721372|NCT00307151|4213465|P4|NOT COMPLETED|Overall Study||11
1721373|NCT00307151|4213466|P3|NOT COMPLETED|Overall Study||20
1721374|NCT00307151|4213467|P2|NOT COMPLETED|Overall Study||7
1721375|NCT00307151|4213468|P1|NOT COMPLETED|Overall Study||11
1721376|NCT00307151|4213465|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
1721377|NCT00307151|4213466|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
1721378|NCT00307151|4213467|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
1721379|NCT00307151|4213468|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
1721380|NCT00307151|4213465|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
1721381|NCT00307151|4213466|P3|STARTED|Overall Study||147
1721382|NCT00307151|4213467|P2|STARTED|Overall Study||82
1721383|NCT00307151|4213468|P1|STARTED|Overall Study||82
1721384|NCT00307125|4213512|P3|NOT COMPLETED|Pilot Phase||1
1721385|NCT00307125|4213513|P2|NOT COMPLETED|Pilot Phase||2
1721386|NCT00307125|4213514|P1|NOT COMPLETED|Pilot Phase||0
1721387|NCT00307125|4213512|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
1721388|NCT00307125|4213513|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
1721389|NCT00307125|4213514|P1|COMPLETED|Pilot Phase||0
1721390|NCT00307125|4213512|P3|STARTED|Pilot Phase||7
1721391|NCT00307125|4213513|P2|STARTED|Pilot Phase||15
1721392|NCT00307125|4213514|P1|STARTED|Pilot Phase||0
1721393|NCT00307125|4213512|P3|NOT COMPLETED|Screening Phase||0
1721394|NCT00307125|4213513|P2|NOT COMPLETED|Screening Phase||0
1721395|NCT00307125|4213514|P1|NOT COMPLETED|Screening Phase||454
1721396|NCT00307125|4213512|P3|COMPLETED|Screening Phase||0
1721397|NCT00307125|4213513|P2|COMPLETED|Screening Phase||0
1721398|NCT00307125|4213514|P1|COMPLETED|Screening Phase||303
1721399|NCT00307125|4213512|P3|STARTED|Screening Phase||0
1721400|NCT00307125|4213513|P2|STARTED|Screening Phase||0
1721401|NCT00307125|4213514|P1|STARTED|Screening Phase||757
1721402|NCT00307086|4213536|P1|NOT COMPLETED|Overall Study||5
1721403|NCT00307086|4213536|P1|COMPLETED|Overall Study||25
1721404|NCT00307086|4213536|P1|STARTED|Overall Study||30
1721405|NCT00307047|4213542|P2|NOT COMPLETED|Overall Study||49
1721406|NCT00307047|4213543|P1|NOT COMPLETED|Overall Study||69
1721407|NCT00307047|4213542|P2|COMPLETED|Overall Study||1180
1721408|NCT00307047|4213543|P1|COMPLETED|Overall Study||2389
1721409|NCT00307047|4213542|P2|STARTED|Overall Study||1229
1721410|NCT00307047|4213543|P1|STARTED|Overall Study||2458
1721411|NCT00307034|4213681|P2|NOT COMPLETED|Overall Study||7
1721412|NCT00307034|4213682|P1|NOT COMPLETED|Overall Study||2
1721413|NCT00307034|4213681|P2|COMPLETED|Overall Study||169
1721414|NCT00307034|4213682|P1|COMPLETED|Overall Study||173
1721415|NCT00307034|4213681|P2|STARTED|Overall Study||176
1721416|NCT00307034|4213682|P1|STARTED|Overall Study||175
1721417|NCT00306917|4213722|P2|NOT COMPLETED|Overall Study||109
1721418|NCT00306917|4213723|P1|NOT COMPLETED|Overall Study||108
1721419|NCT00306917|4213722|P2|COMPLETED|Overall Study||15
1721420|NCT00306917|4213723|P1|COMPLETED|Overall Study||13
1721421|NCT00306917|4213722|P2|60 Month Follow up|Overall Study||15
1721422|NCT00306917|4213723|P1|60 Month Follow up|Overall Study||13
1721423|NCT00306917|4213722|P2|48 Month Follow up|Overall Study||22
1721424|NCT00306917|4213723|P1|48 Month Follow up|Overall Study||29
1721425|NCT00306917|4213722|P2|36 Month Follow up|Overall Study||42
1721426|NCT00306917|4213723|P1|36 Month Follow up|Overall Study||56
1721427|NCT00306917|4213722|P2|24 Month Follow up|Overall Study||71
1721428|NCT00306917|4213723|P1|24 Month Follow up|Overall Study||60
1721429|NCT00306917|4213722|P2|12 Month Follow|Overall Study||94
1721430|NCT00306917|4213723|P1|12 Month Follow|Overall Study||86
1721431|NCT00306917|4213722|P2|Postoperative to 6 Month Follow up|Overall Study||100
1721432|NCT00306917|4213723|P1|Postoperative to 6 Month Follow up|Overall Study||93
1721433|NCT00306917|4213722|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
1721434|NCT00306917|4213723|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
1721435|NCT00306891|4213733|P4|NOT COMPLETED|Part B||17
1721436|NCT00306891|4213734|P3|NOT COMPLETED|Part B||11
1721437|NCT00306891|4213735|P2|NOT COMPLETED|Part B||0
1721438|NCT00306891|4213736|P1|NOT COMPLETED|Part B||0
1721439|NCT00306891|4213733|P4|COMPLETED|Part B||14
1721440|NCT00306891|4213734|P3|COMPLETED|Part B||5
1721441|NCT00306891|4213735|P2|COMPLETED|Part B||0
1721442|NCT00306891|4213736|P1|COMPLETED|Part B||0
1721443|NCT00306891|4213733|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
1721444|NCT00306891|4213734|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
1721445|NCT00306891|4213735|P2|STARTED|Part B||0
1721446|NCT00306891|4213736|P1|STARTED|Part B||0
1721447|NCT00306891|4213733|P4|NOT COMPLETED|Part A||0
1721448|NCT00306891|4213734|P3|NOT COMPLETED|Part A||0
1721449|NCT00306891|4213735|P2|NOT COMPLETED|Part A||6
1721450|NCT00306891|4213736|P1|NOT COMPLETED|Part A||5
1721451|NCT00306891|4213733|P4|COMPLETED|Part A||0
1721452|NCT00306891|4213734|P3|COMPLETED|Part A||0
1721453|NCT00306891|4213735|P2|COMPLETED|Part A||16
1721454|NCT00306891|4213736|P1|COMPLETED|Part A||18
1721455|NCT00306891|4213733|P4|STARTED|Part A||0
1721456|NCT00306891|4213734|P3|STARTED|Part A||0
1721457|NCT00306891|4213735|P2|STARTED|Part A||22
1721458|NCT00306891|4213736|P1|STARTED|Part A||23
1721459|NCT00306852|4213759|P2|NOT COMPLETED|Overall Study||38
1721460|NCT00306852|4213760|P1|NOT COMPLETED|Overall Study||29
1721461|NCT00306852|4213759|P2|COMPLETED|Overall Study||69
1721462|NCT00306852|4213760|P1|COMPLETED|Overall Study||76
1721463|NCT00306852|4213759|P2|STARTED|Overall Study||107
1721464|NCT00306852|4213760|P1|STARTED|Overall Study||105
1721465|NCT00306787|4213778|P2|NOT COMPLETED|Overall Study||241
1721466|NCT00306787|4213779|P1|NOT COMPLETED|Overall Study||234
1721467|NCT00306787|4213778|P2|COMPLETED|Overall Study||359
1721468|NCT00306787|4213779|P1|COMPLETED|Overall Study||345
1721469|NCT00306787|4213778|P2|Intent to Treat (ITT) Population|Overall Study||381
1721470|NCT00306787|4213779|P1|Intent to Treat (ITT) Population|Overall Study||370
1721471|NCT00306787|4213778|P2|Received Study Drug (Safety Population)|Overall Study||385
1721472|NCT00306787|4213779|P1|Received Study Drug (Safety Population)|Overall Study||371
1721473|NCT00306787|4213778|P2|STARTED|Overall Study||600
1721474|NCT00306787|4213779|P1|STARTED|Overall Study||579
1721475|NCT00306670|4213797|P2|NOT COMPLETED|Overall Study||2
1721476|NCT00306670|4213798|P1|NOT COMPLETED|Overall Study||0
1721477|NCT00306670|4213797|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
1721478|NCT00306670|4213798|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
1721479|NCT00306670|4213797|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
1721480|NCT00306670|4213798|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
1721481|NCT00306592|4213804|P2|NOT COMPLETED|Overall Study||58
1721482|NCT00306592|4213805|P1|NOT COMPLETED|Overall Study||31
1721483|NCT00306592|4213804|P2|COMPLETED|Overall Study||632
1721484|NCT00306592|4213805|P1|COMPLETED|Overall Study||373
1721485|NCT00306592|4213804|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
1721486|NCT00306592|4213805|P1|Entered 101-MS-321 Extension Study|Overall Study||22
1721487|NCT00306592|4213804|P2|Completed at 48 Weeks|Overall Study||632
1721488|NCT00306592|4213805|P1|Completed at 48 Weeks|Overall Study||81
1721489|NCT00306592|4213804|P2|Completed Between 24 and 48 Weeks|Overall Study||0
1721490|NCT00306592|4213805|P1|Completed Between 24 and 48 Weeks|Overall Study||85
1721491|NCT00306592|4213804|P2|Completed at 24 Weeks|Overall Study||0
1721492|NCT00306592|4213805|P1|Completed at 24 Weeks|Overall Study||207
1721493|NCT00306592|4213804|P2|STARTED|Overall Study||690
1721494|NCT00306592|4213805|P1|STARTED|Overall Study||404
1721495|NCT00306527|4213815|P4|NOT COMPLETED|Overall Study||6
1721496|NCT00306527|4213816|P3|NOT COMPLETED|Overall Study||5
1721497|NCT00306527|4213817|P2|NOT COMPLETED|Overall Study||7
1721498|NCT00306527|4213818|P1|NOT COMPLETED|Overall Study||6
1721499|NCT00306527|4213815|P4|COMPLETED|Overall Study||590
1721500|NCT00306527|4213816|P3|COMPLETED|Overall Study|Additional death has been reported post study. Please refer to outcome measure-2.|567
1721501|NCT00306527|4213817|P2|COMPLETED|Overall Study||527
1721502|NCT00306527|4213818|P1|COMPLETED|Overall Study||527
1721503|NCT00306527|4213815|P4|STARTED|Overall Study||596
1721504|NCT00306527|4213816|P3|STARTED|Overall Study||572
1721505|NCT00306527|4213817|P2|STARTED|Overall Study||534
1721506|NCT00306527|4213818|P1|STARTED|Overall Study||533
1721507|NCT00306488|4213872|P2|NOT COMPLETED|Overall Study||1
1721508|NCT00306488|4213873|P1|NOT COMPLETED|Overall Study||1
1721509|NCT00306488|4213872|P2|COMPLETED|Overall Study||10
1721510|NCT00306488|4213873|P1|COMPLETED|Overall Study||10
1721511|NCT00306488|4213872|P2|STARTED|Overall Study||11
1721512|NCT00306488|4213873|P1|STARTED|Overall Study||11
1721513|NCT00306384|4213887|P3|NOT COMPLETED|Overall Study||277
1721514|NCT00306384|4213888|P2|NOT COMPLETED|Overall Study||508
1721515|NCT00306384|4213889|P1|NOT COMPLETED|Overall Study||542
1721516|NCT00306384|4213887|P3|COMPLETED|Overall Study||251
1721517|NCT00306384|4213888|P2|COMPLETED|Overall Study||891
1721518|NCT00306384|4213889|P1|COMPLETED|Overall Study||854
1721519|NCT00306384|4213887|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
1721520|NCT00306384|4213888|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
1721521|NCT00306384|4213889|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
1721522|NCT00306384|4213887|P3|STARTED|Overall Study||528
1721523|NCT00306384|4213888|P2|STARTED|Overall Study||1399
1721524|NCT00306384|4213889|P1|STARTED|Overall Study||1396
1721525|NCT00306293|4213921|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
1721526|NCT00306293|4213922|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
1721527|NCT00306293|4213921|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
1721528|NCT00306293|4213922|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
1721529|NCT00306293|4213921|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
1721530|NCT00306293|4213922|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
1721531|NCT00306293|4213921|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
1721532|NCT00306293|4213922|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
1721533|NCT00306293|4213921|P2|COMPLETED|Washout (Day 61 to Day 66)||27
1721534|NCT00306293|4213922|P1|COMPLETED|Washout (Day 61 to Day 66)||27
1721535|NCT00306293|4213921|P2|STARTED|Washout (Day 61 to Day 66)||27
1721536|NCT00306293|4213922|P1|STARTED|Washout (Day 61 to Day 66)||27
1721537|NCT00306293|4213921|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
1721538|NCT00306293|4213922|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
1721539|NCT00306293|4213921|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
1721540|NCT00306293|4213922|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
1721541|NCT00306293|4213921|P2|STARTED|Period 1 (Day 1 to Day 60)||35
1721542|NCT00306293|4213922|P1|STARTED|Period 1 (Day 1 to Day 60)||35
1721543|NCT00306202|4213943|P3|NOT COMPLETED|Overall Study||0
1721544|NCT00306202|4213944|P2|NOT COMPLETED|Overall Study||1
1721545|NCT00306202|4213945|P1|NOT COMPLETED|Overall Study||6
1721546|NCT00306202|4213943|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
1721547|NCT00306202|4213944|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
1721548|NCT00306202|4213945|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
1721549|NCT00306202|4213943|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
1721550|NCT00306202|4213944|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
1721551|NCT00306202|4213945|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
1721552|NCT00306189|4214105|P4|NOT COMPLETED|Overall Study||5
1721553|NCT00306189|4214106|P3|NOT COMPLETED|Overall Study||11
1721554|NCT00306189|4214107|P2|NOT COMPLETED|Overall Study||6
1721555|NCT00306189|4214108|P1|NOT COMPLETED|Overall Study||9
1721556|NCT00306189|4214105|P4|COMPLETED|Overall Study||52
1721557|NCT00306189|4214106|P3|COMPLETED|Overall Study||45
1721558|NCT00306189|4214107|P2|COMPLETED|Overall Study||50
1721559|NCT00306189|4214108|P1|COMPLETED|Overall Study||48
1721560|NCT00306189|4214105|P4|STARTED|Overall Study||57
1721561|NCT00306189|4214106|P3|STARTED|Overall Study||56
1721562|NCT00306189|4214107|P2|STARTED|Overall Study||56
1721563|NCT00306189|4214108|P1|STARTED|Overall Study||57
1721564|NCT00306163|4214120|P2|NOT COMPLETED|Overall Study||0
1721565|NCT00306163|4214121|P1|NOT COMPLETED|Overall Study||0
1721566|NCT00306163|4214120|P2|COMPLETED|Overall Study||18
1721567|NCT00306163|4214121|P1|COMPLETED|Overall Study||19
1721568|NCT00306163|4214120|P2|STARTED|Overall Study||18
1721569|NCT00306163|4214121|P1|STARTED|Overall Study||19
1721570|NCT00305942|4214127|P1|NOT COMPLETED|Overall Study||38
1721571|NCT00305942|4214127|P1|COMPLETED|Overall Study||23
1721572|NCT00305942|4214127|P1|STARTED|Overall Study||61
1721573|NCT00305877|4214135|P2|NOT COMPLETED|Overall Study||34
1721574|NCT00305877|4214136|P1|NOT COMPLETED|Overall Study||24
1721575|NCT00305877|4214135|P2|COMPLETED|Overall Study||34
1721576|NCT00305877|4214136|P1|COMPLETED|Overall Study||45
1721577|NCT00305877|4214135|P2|Included in Efficacy Analysis|Overall Study||62
1721578|NCT00305877|4214136|P1|Included in Efficacy Analysis|Overall Study||65
1721579|NCT00305877|4214135|P2|Eligible|Overall Study||66
1721580|NCT00305877|4214136|P1|Eligible|Overall Study||66
1721581|NCT00305877|4214135|P2|Treated|Overall Study||63
1721582|NCT00305877|4214136|P1|Treated|Overall Study||67
1721583|NCT00305877|4214135|P2|STARTED|Overall Study||68
1721584|NCT00305877|4214136|P1|STARTED|Overall Study||69
1721585|NCT00305864|4214150|P4|NOT COMPLETED|Overall Study||13
1721586|NCT00305864|4214151|P3|NOT COMPLETED|Overall Study||1
1721587|NCT00305864|4214152|P2|NOT COMPLETED|Overall Study||1
1721588|NCT00305864|4214153|P1|NOT COMPLETED|Overall Study||0
1721589|NCT00305864|4214150|P4|COMPLETED|Overall Study||81
1721590|NCT00305864|4214151|P3|COMPLETED|Overall Study||6
1721591|NCT00305864|4214152|P2|COMPLETED|Overall Study||9
1721592|NCT00305864|4214153|P1|COMPLETED|Overall Study||7
1721593|NCT00305864|4214150|P4|STARTED|Overall Study||94
1721594|NCT00305864|4214151|P3|STARTED|Overall Study||7
1721595|NCT00305864|4214152|P2|STARTED|Overall Study||10
1721596|NCT00305864|4214153|P1|STARTED|Overall Study||7
1721597|NCT00305773|4214166|P2|NOT COMPLETED|Overall Study||18
1721598|NCT00305773|4214167|P1|NOT COMPLETED|Overall Study||14
1721599|NCT00305773|4214166|P2|COMPLETED|Overall Study||4
1721600|NCT00305773|4214167|P1|COMPLETED|Overall Study||1
1721601|NCT00305773|4214166|P2|STARTED|Overall Study||22
1721602|NCT00305773|4214167|P1|STARTED|Overall Study||15
1721603|NCT00305760|4214181|P1|NOT COMPLETED|Overall Study||47
1721604|NCT00305760|4214181|P1|COMPLETED|Overall Study||13
1721605|NCT00305760|4214181|P1|STARTED|Overall Study||60
1721606|NCT00305643|4214187|P2|NOT COMPLETED|Overall Study||0
1721607|NCT00305643|4214188|P1|NOT COMPLETED|Overall Study||0
1721608|NCT00305643|4214187|P2|COMPLETED|Overall Study||5
1721609|NCT00305643|4214188|P1|COMPLETED|Overall Study||6
1721610|NCT00305643|4214187|P2|STARTED|Overall Study||5
1721611|NCT00305643|4214188|P1|STARTED|Overall Study||6
1721612|NCT00305604|4214198|P2|NOT COMPLETED|Overall Study||47
1721613|NCT00305604|4214199|P1|NOT COMPLETED|Overall Study||32
1721614|NCT00305604|4214198|P2|COMPLETED|Overall Study||57
1721615|NCT00305604|4214199|P1|COMPLETED|Overall Study||70
1721616|NCT00305604|4214198|P2|STARTED|Overall Study||104
1721617|NCT00305604|4214199|P1|STARTED|Overall Study||102
1721618|NCT00305578|4214213|P2|NOT COMPLETED|Overall Study||2
1721619|NCT00305578|4214214|P1|NOT COMPLETED|Overall Study||3
1721620|NCT00305578|4214213|P2|COMPLETED|Overall Study||12
1721621|NCT00305578|4214214|P1|COMPLETED|Overall Study||12
1721622|NCT00305578|4214213|P2|STARTED|Overall Study||14
1721623|NCT00305578|4214214|P1|STARTED|Overall Study||15
1721624|NCT00305565|4214223|P3|NOT COMPLETED|Overall Study (ITT Population)||5
1721625|NCT00305565|4214224|P2|NOT COMPLETED|Overall Study (ITT Population)||11
1721626|NCT00305565|4214225|P1|NOT COMPLETED|Overall Study (ITT Population)||13
1721627|NCT00305565|4214223|P3|COMPLETED|Overall Study (ITT Population)||102
1721628|NCT00305565|4214224|P2|COMPLETED|Overall Study (ITT Population)||90
1721629|NCT00305565|4214225|P1|COMPLETED|Overall Study (ITT Population)||89
1721630|NCT00305565|4214223|P3|STARTED|Overall Study (ITT Population)||107
1721631|NCT00305565|4214224|P2|STARTED|Overall Study (ITT Population)||101
1721632|NCT00305565|4214225|P1|STARTED|Overall Study (ITT Population)||102
1721633|NCT00305565|4214223|P3|NOT COMPLETED|Overall Study (Safety Population)||7
1721634|NCT00305565|4214224|P2|NOT COMPLETED|Overall Study (Safety Population)||12
1721635|NCT00305565|4214225|P1|NOT COMPLETED|Overall Study (Safety Population)||14
1721636|NCT00305565|4214223|P3|COMPLETED|Overall Study (Safety Population)||106
1721637|NCT00305565|4214224|P2|COMPLETED|Overall Study (Safety Population)||95
1721638|NCT00305565|4214225|P1|COMPLETED|Overall Study (Safety Population)||97
1721639|NCT00305565|4214223|P3|STARTED|Overall Study (Safety Population)||113
1721640|NCT00305565|4214224|P2|STARTED|Overall Study (Safety Population)||107
1721641|NCT00305565|4214225|P1|STARTED|Overall Study (Safety Population)||111
1721642|NCT00305448|4214343|P3|NOT COMPLETED|Overall Study||33
1721643|NCT00305448|4214344|P2|NOT COMPLETED|Overall Study||34
1721644|NCT00305448|4214345|P1|NOT COMPLETED|Overall Study||31
1721645|NCT00305448|4214343|P3|COMPLETED|Overall Study||14
1721646|NCT00305448|4214344|P2|COMPLETED|Overall Study||17
1721647|NCT00305448|4214345|P1|COMPLETED|Overall Study||14
1721648|NCT00305448|4214343|P3|STARTED|Overall Study||47
1721649|NCT00305448|4214344|P2|STARTED|Overall Study||51
1721650|NCT00305448|4214345|P1|STARTED|Overall Study||45
1721651|NCT00305344|4214361|P1|NOT COMPLETED|Overall Study||0
1721652|NCT00305344|4214361|P1|COMPLETED|Overall Study||23
1721653|NCT00305344|4214361|P1|STARTED|Overall Study||23
1721654|NCT00305253|4214367|P2|NOT COMPLETED|Overall Study||1
1721655|NCT00305253|4214368|P1|NOT COMPLETED|Overall Study||0
1721656|NCT00305253|4214367|P2|COMPLETED|Overall Study||558
1721657|NCT00305253|4214368|P1|COMPLETED|Overall Study||432
1721658|NCT00305253|4214367|P2|STARTED|Overall Study||559
1721659|NCT00305253|4214368|P1|STARTED|Overall Study||432
1721660|NCT00305227|4214380|P2|NOT COMPLETED|Overall Study||6
1721661|NCT00305227|4214381|P1|NOT COMPLETED|Overall Study||7
1721662|NCT00305227|4214380|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
1721663|NCT00305227|4214381|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
1721664|NCT00305227|4214380|P2|STARTED|Overall Study||50
1721665|NCT00305227|4214381|P1|STARTED|Overall Study||50
1721666|NCT00305162|4214389|P2|NOT COMPLETED|1 Year Follow-up Period||65
1721667|NCT00305162|4214390|P1|NOT COMPLETED|1 Year Follow-up Period||55
1721668|NCT00305162|4214389|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
1721669|NCT00305162|4214390|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
1721670|NCT00305162|4214389|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
1721671|NCT00305162|4214390|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
1721672|NCT00305162|4214389|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
1721673|NCT00305162|4214390|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
1721674|NCT00305162|4214389|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
1721675|NCT00305162|4214390|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
1721676|NCT00305162|4214389|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
1721677|NCT00305162|4214390|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
1721678|NCT00305162|4214389|P2|STARTED|1 Year Follow-up Period||4447
1721679|NCT00305162|4214390|P1|STARTED|1 Year Follow-up Period||4435
1721680|NCT00305162|4214389|P2|NOT COMPLETED|30-day Follow-up Period||63
1721681|NCT00305162|4214390|P1|NOT COMPLETED|30-day Follow-up Period||62
1721682|NCT00305162|4214389|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
1721683|NCT00305162|4214390|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
1721684|NCT00305162|4214389|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
1721685|NCT00305162|4214390|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
1721686|NCT00305162|4214389|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
1721687|NCT00305162|4214390|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
1721688|NCT00305162|4214389|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
1721689|NCT00305162|4214390|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
1721690|NCT00305162|4214389|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
1721691|NCT00305162|4214390|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
1721692|NCT00305162|4214389|P2|STARTED|30-day Follow-up Period||4447
1721693|NCT00305162|4214390|P1|STARTED|30-day Follow-up Period||4435
1721694|NCT00305162|4214389|P2|NOT COMPLETED|48 Hour Follow-up Period||16
1721695|NCT00305162|4214390|P1|NOT COMPLETED|48 Hour Follow-up Period||20
1721696|NCT00305162|4214389|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
1721697|NCT00305162|4214390|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
1721698|NCT00305162|4214389|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
1721699|NCT00305162|4214390|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
1721700|NCT00305162|4214389|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
1721701|NCT00305162|4214390|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
1721702|NCT00305162|4214389|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
1721703|NCT00305162|4214390|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
1721704|NCT00305162|4214389|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
1721705|NCT00305162|4214390|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
1721706|NCT00305162|4214389|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
1721707|NCT00305162|4214390|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
1721708|NCT00305162|4214389|P2|STARTED|48 Hour Follow-up Period||4447
1721709|NCT00305162|4214390|P1|STARTED|48 Hour Follow-up Period||4435
1721710|NCT00305110|4214428|P1|NOT COMPLETED|Overall Study||29
1721711|NCT00305110|4214428|P1|COMPLETED|Overall Study||269
1721712|NCT00305110|4214428|P1|All Necessary Data Collected|Overall Study||269
1721713|NCT00305110|4214428|P1|STARTED|Overall Study||298
1721714|NCT00305058|4214439|P2|NOT COMPLETED|Overall Study||4
1721715|NCT00305058|4214440|P1|NOT COMPLETED|Overall Study||7
1721716|NCT00305058|4214439|P2|COMPLETED|Overall Study||93
1721717|NCT00305058|4214440|P1|COMPLETED|Overall Study||90
1721718|NCT00305058|4214439|P2|Data Collection Forms Filed for Analysis|Overall Study||93
1721719|NCT00305058|4214440|P1|Data Collection Forms Filed for Analysis|Overall Study||90
1721720|NCT00305058|4214439|P2|All Outcome Data Collected|Overall Study||95
1721721|NCT00305058|4214440|P1|All Outcome Data Collected|Overall Study||93
1721722|NCT00305058|4214439|P2|Inclusion/Exclusion Verification|Overall Study||97
1721723|NCT00305058|4214440|P1|Inclusion/Exclusion Verification|Overall Study||96
1721724|NCT00305058|4214439|P2|STARTED|Overall Study||97
1721725|NCT00305058|4214440|P1|STARTED|Overall Study||97
1721726|NCT00304954|4214456|P4|NOT COMPLETED|Overall Study||0
1721727|NCT00304954|4214457|P3|NOT COMPLETED|Overall Study||1
1721728|NCT00304954|4214458|P2|NOT COMPLETED|Overall Study||0
1721729|NCT00304954|4214459|P1|NOT COMPLETED|Overall Study||1
1721730|NCT00304954|4214456|P4|COMPLETED|Overall Study||3
1721731|NCT00304954|4214457|P3|COMPLETED|Overall Study||2
1721732|NCT00304954|4214458|P2|COMPLETED|Overall Study||3
1721733|NCT00304954|4214459|P1|COMPLETED|Overall Study||3
1721734|NCT00304954|4214456|P4|STARTED|Overall Study||3
1721735|NCT00304954|4214457|P3|STARTED|Overall Study||3
1721736|NCT00304954|4214458|P2|STARTED|Overall Study||3
1721737|NCT00304954|4214459|P1|STARTED|Overall Study||4
1721738|NCT00304915|4214479|P2|NOT COMPLETED|Overall Study||16
1721739|NCT00304915|4214480|P1|NOT COMPLETED|Overall Study||18
1721740|NCT00304915|4214479|P2|COMPLETED|Overall Study||110
1721741|NCT00304915|4214480|P1|COMPLETED|Overall Study||105
1721742|NCT00304915|4214479|P2|STARTED|Overall Study||126
1721743|NCT00304915|4214480|P1|STARTED|Overall Study||123
1721744|NCT00304746|4214488|P2|NOT COMPLETED|Overall Study||0
1721745|NCT00304746|4214489|P1|NOT COMPLETED|Overall Study||0
1721746|NCT00304746|4214488|P2|COMPLETED|Overall Study||50
1721747|NCT00304746|4214489|P1|COMPLETED|Overall Study||50
1721748|NCT00304746|4214488|P2|STARTED|Overall Study||50
1721749|NCT00304746|4214489|P1|STARTED|Overall Study||50
1721750|NCT00304707|4214499|P2|NOT COMPLETED|Overall Study||6
1721751|NCT00304707|4214500|P1|NOT COMPLETED|Overall Study||7
1721752|NCT00304707|4214499|P2|COMPLETED|Overall Study||64
1721753|NCT00304707|4214500|P1|COMPLETED|Overall Study||66
1721754|NCT00304707|4214499|P2|STARTED|Overall Study||70
1721755|NCT00304707|4214500|P1|STARTED|Overall Study||73
1721756|NCT00304512|4214509|P3|NOT COMPLETED|Extension Period||0
1721757|NCT00304512|4214510|P2|NOT COMPLETED|Extension Period||0
1721758|NCT00304512|4214511|P1|NOT COMPLETED|Extension Period||0
1721759|NCT00304512|4214509|P3|COMPLETED|Extension Period||3
1721760|NCT00304512|4214510|P2|COMPLETED|Extension Period||4
1721761|NCT00304512|4214511|P1|COMPLETED|Extension Period||2
1721762|NCT00304512|4214509|P3|STARTED|Extension Period||3
1721763|NCT00304512|4214510|P2|STARTED|Extension Period||4
1721764|NCT00304512|4214511|P1|STARTED|Extension Period||2
1721765|NCT00304512|4214509|P3|NOT COMPLETED|Treatment Period||0
1721766|NCT00304512|4214510|P2|NOT COMPLETED|Treatment Period||0
1721767|NCT00304512|4214511|P1|NOT COMPLETED|Treatment Period||0
1721768|NCT00304512|4214509|P3|COMPLETED|Treatment Period||3
1721769|NCT00304512|4214510|P2|COMPLETED|Treatment Period||4
1721770|NCT00304512|4214511|P1|COMPLETED|Treatment Period||2
1721771|NCT00304512|4214509|P3|Pharmacodynamic (PD) Population|Treatment Period||3
1721772|NCT00304512|4214510|P2|Pharmacodynamic (PD) Population|Treatment Period||4
1721773|NCT00304512|4214511|P1|Pharmacodynamic (PD) Population|Treatment Period||2
1721774|NCT00304512|4214509|P3|Pharmacokinetic (PK) Population|Treatment Period||3
1721775|NCT00304512|4214510|P2|Pharmacokinetic (PK) Population|Treatment Period||4
1721776|NCT00304512|4214511|P1|Pharmacokinetic (PK) Population|Treatment Period||2
1721777|NCT00304512|4214509|P3|Safety Population|Treatment Period||3
1721778|NCT00304512|4214510|P2|Safety Population|Treatment Period||4
1721779|NCT00304512|4214511|P1|Safety Population|Treatment Period||2
1721780|NCT00304512|4214509|P3|STARTED|Treatment Period||3
1721781|NCT00304512|4214510|P2|STARTED|Treatment Period||4
1721782|NCT00304512|4214511|P1|STARTED|Treatment Period||2
1721783|NCT00304356|4214525|P1|NOT COMPLETED|Nitazoxanide||5
1721784|NCT00304356|4214525|P1|COMPLETED|Nitazoxanide||22
1721785|NCT00304356|4214525|P1|STARTED|Nitazoxanide||27
1721786|NCT00304356|4214525|P1|NOT COMPLETED|Nitazoxanide||5
1721787|NCT00304356|4214525|P1|COMPLETED|Nitazoxanide||22
1721788|NCT00304356|4214525|P1|STARTED|Nitazoxanide||27
1721789|NCT00304278|4214529|P1|NOT COMPLETED|Overall Study||2
1721790|NCT00304278|4214529|P1|COMPLETED|Overall Study||19
1721791|NCT00304278|4214529|P1|STARTED|Overall Study||21
1721792|NCT00304265|4214536|P2|NOT COMPLETED|Overall Study||0
1721793|NCT00304265|4214537|P1|NOT COMPLETED|Overall Study||0
1721794|NCT00304265|4214536|P2|COMPLETED|Overall Study||98
1721795|NCT00304265|4214537|P1|COMPLETED|Overall Study||117
1721796|NCT00304265|4214536|P2|STARTED|Overall Study||98
1721797|NCT00304265|4214537|P1|STARTED|Overall Study||117
1721798|NCT00304187|4214545|P2|NOT COMPLETED|Overall Study||1
1721799|NCT00304187|4214546|P1|NOT COMPLETED|Overall Study||2
1721800|NCT00304187|4214545|P2|COMPLETED|Overall Study||13
1721801|NCT00304187|4214546|P1|COMPLETED|Overall Study||13
1721802|NCT00304187|4214545|P2|STARTED|Overall Study||14
1721803|NCT00304187|4214546|P1|STARTED|Overall Study||15
1721804|NCT00304161|4214556|P2|NOT COMPLETED|Overall Study||6
1721805|NCT00304161|4214557|P1|NOT COMPLETED|Overall Study||6
1721806|NCT00304161|4214556|P2|COMPLETED|Overall Study||21
1721807|NCT00304161|4214557|P1|COMPLETED|Overall Study||22
1721808|NCT00304161|4214556|P2|STARTED|Overall Study||27
1721809|NCT00304161|4214557|P1|STARTED|Overall Study||28
1721810|NCT00304096|4214567|P2|NOT COMPLETED|Overall Study||0
1721811|NCT00304096|4214568|P1|NOT COMPLETED|Overall Study||0
1721812|NCT00304096|4214567|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
1721813|NCT00304096|4214568|P1|COMPLETED|Overall Study||6
1721814|NCT00304096|4214567|P2|STARTED|Overall Study||5
1721815|NCT00304096|4214568|P1|STARTED|Overall Study||6
1721816|NCT00304083|4214578|P2|NOT COMPLETED|Overall Study||8
1721817|NCT00304083|4214579|P1|NOT COMPLETED|Overall Study||22
1721818|NCT00304083|4214578|P2|COMPLETED|Overall Study||6
1721819|NCT00304083|4214579|P1|COMPLETED|Overall Study||12
1721820|NCT00304083|4214578|P2|Patients Had Neither RT or Surgery|Overall Study||1
1721821|NCT00304083|4214579|P1|Patients Had Neither RT or Surgery|Overall Study||6
1721822|NCT00304083|4214578|P2|Patients Treated With RT Only|Overall Study||2
1721823|NCT00304083|4214579|P1|Patients Treated With RT Only|Overall Study||4
1721824|NCT00304083|4214578|P2|Patients Treated With Surgery and RT|Overall Study||1
1721825|NCT00304083|4214579|P1|Patients Treated With Surgery and RT|Overall Study||5
1721826|NCT00304083|4214578|P2|Patients Treated With Surgery|Overall Study||3
1721827|NCT00304083|4214579|P1|Patients Treated With Surgery|Overall Study||7
1721828|NCT00304083|4214578|P2|Completed 4 Cycles|Overall Study||7
1721829|NCT00304083|4214579|P1|Completed 4 Cycles|Overall Study||22
1721830|NCT00304083|4214578|P2|STARTED|Overall Study||14
1721831|NCT00304083|4214579|P1|STARTED|Overall Study||34
1721832|NCT00304070|4214598|P3|NOT COMPLETED|Overall Study||12
1721833|NCT00304070|4214599|P2|NOT COMPLETED|Overall Study||7
1721834|NCT00304070|4214600|P1|NOT COMPLETED|Overall Study||3
1721835|NCT00304070|4214598|P3|COMPLETED|Overall Study||27
1721836|NCT00304070|4214599|P2|COMPLETED|Overall Study||8
1721837|NCT00304070|4214600|P1|COMPLETED|Overall Study||21
1721838|NCT00304070|4214598|P3|STARTED|Overall Study||39
1721839|NCT00304070|4214599|P2|STARTED|Overall Study||15
1721840|NCT00304070|4214600|P1|STARTED|Overall Study||24
1721841|NCT00304031|4214615|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
1721842|NCT00304031|4214616|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
1721843|NCT00304031|4214617|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
1721844|NCT00304031|4214615|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study|420
1721845|NCT00304031|4214616|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study.|411
1721846|NCT00304031|4214617|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
1721847|NCT00304031|4214615|P3|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|422
1721848|NCT00304031|4214616|P2|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|411
1721849|NCT00304031|4214617|P1|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|0
1721850|NCT00304031|4214615|P3|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
1721851|NCT00304031|4214616|P2|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
1721852|NCT00304031|4214617|P1|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||292
1721853|NCT00304031|4214615|P3|COMPLETED|Concomitant Radiation Therapy and TMZ||0
1721854|NCT00304031|4214616|P2|COMPLETED|Concomitant Radiation Therapy and TMZ||0
1721855|NCT00304031|4214617|P1|COMPLETED|Concomitant Radiation Therapy and TMZ|These patients successfully completed concomitant treatment and met requirements for randomization.|833
1721856|NCT00304031|4214615|P3|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
1721857|NCT00304031|4214616|P2|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
1721858|NCT00304031|4214617|P1|STARTED|Concomitant Radiation Therapy and TMZ|All patients were registered to concomitant treatment; randomized after completing this treatment.|1125
1721859|NCT00304031|4214615|P3|NOT COMPLETED|Registration||0
1721860|NCT00304031|4214616|P2|NOT COMPLETED|Registration||0
1721861|NCT00304031|4214617|P1|NOT COMPLETED|Registration||48
1721862|NCT00304031|4214615|P3|COMPLETED|Registration||0
1721863|NCT00304031|4214616|P2|COMPLETED|Registration||0
1721864|NCT00304031|4214617|P1|COMPLETED|Registration|Patients determined to be ineligible after registration were excluded.|1125
1721865|NCT00304031|4214615|P3|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
1721866|NCT00304031|4214616|P2|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
1721867|NCT00304031|4214617|P1|STARTED|Registration|All patients were registered to concomitant treatment; randomized after completing this treatment.|1173
1721868|NCT00303979|4214627|P3|NOT COMPLETED|Single Time Point (18 Month)||0
1721869|NCT00303979|4214628|P2|NOT COMPLETED|Single Time Point (18 Month)||0
1721870|NCT00303979|4214629|P1|NOT COMPLETED|Single Time Point (18 Month)||0
1721871|NCT00303979|4214627|P3|COMPLETED|Single Time Point (18 Month)||9641
1721872|NCT00303979|4214628|P2|COMPLETED|Single Time Point (18 Month)||0
1721873|NCT00303979|4214629|P1|COMPLETED|Single Time Point (18 Month)||0
1721874|NCT00303979|4214627|P3|STARTED|Single Time Point (18 Month)||9641
1721875|NCT00303979|4214628|P2|STARTED|Single Time Point (18 Month)||0
1721876|NCT00303979|4214629|P1|STARTED|Single Time Point (18 Month)||0
1721877|NCT00303979|4214627|P3|NOT COMPLETED|Single Time Point (6 Month)||0
1721878|NCT00303979|4214628|P2|NOT COMPLETED|Single Time Point (6 Month)||0
1721879|NCT00303979|4214629|P1|NOT COMPLETED|Single Time Point (6 Month)||0
1721880|NCT00303979|4214627|P3|COMPLETED|Single Time Point (6 Month)||0
1721881|NCT00303979|4214628|P2|COMPLETED|Single Time Point (6 Month)||9992
1721882|NCT00303979|4214629|P1|COMPLETED|Single Time Point (6 Month)||0
1721883|NCT00303979|4214627|P3|STARTED|Single Time Point (6 Month)||0
1721884|NCT00303979|4214628|P2|STARTED|Single Time Point (6 Month)||9992
1721885|NCT00303979|4214629|P1|STARTED|Single Time Point (6 Month)||0
1721886|NCT00303979|4214627|P3|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
1721887|NCT00303979|4214628|P2|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
1721888|NCT00303979|4214629|P1|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||7572
1721889|NCT00303979|4214627|P3|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
1721890|NCT00303979|4214628|P2|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
1721891|NCT00303979|4214629|P1|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)|at 24 Month|7605
1721892|NCT00303979|4214627|P3|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
1721893|NCT00303979|4214628|P2|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
1721894|NCT00303979|4214629|P1|STARTED|Longitudinal (Baseline, 12 and 24 Month)|at Baseline|15177
1721895|NCT00303966|4214639|P1|NOT COMPLETED|Overall Study||0
1721896|NCT00303966|4214639|P1|COMPLETED|Overall Study||5
1721897|NCT00303966|4214639|P1|STARTED|Overall Study||5
1721898|NCT00303953|4214648|P1|NOT COMPLETED|Overall Study||19
1721899|NCT00303953|4214648|P1|COMPLETED|Overall Study||3
1721900|NCT00303953|4214648|P1|Eligible and Treated|Overall Study||20
1721901|NCT00303953|4214648|P1|Eligible|Overall Study||21
1721902|NCT00303953|4214648|P1|STARTED|Overall Study||22
1721903|NCT00303901|4214654|P1|NOT COMPLETED|Overall Study||0
1721904|NCT00303901|4214654|P1|COMPLETED|Overall Study||40
1721905|NCT00303901|4214654|P1|STARTED|Overall Study||40
1721906|NCT00303862|4214659|P1|NOT COMPLETED|Overall Study||0
1721907|NCT00303862|4214659|P1|COMPLETED|Overall Study||10
1721908|NCT00303862|4214659|P1|STARTED|Overall Study||10
1721909|NCT00303823|4214668|P2|NOT COMPLETED|Overall Study||10
1721910|NCT00303823|4214669|P1|NOT COMPLETED|Overall Study||15
1721911|NCT00303823|4214668|P2|COMPLETED|Overall Study||38
1721912|NCT00303823|4214669|P1|COMPLETED|Overall Study||35
1721913|NCT00303823|4214668|P2|STARTED|Overall Study||48
1721914|NCT00303823|4214669|P1|STARTED|Overall Study||50
1721915|NCT00303667|4214683|P2|NOT COMPLETED|Overall Study||4
1721916|NCT00303667|4214684|P1|NOT COMPLETED|Overall Study||0
1721917|NCT00303667|4214683|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
1721918|NCT00303667|4214684|P1|COMPLETED|Overall Study||8
1721919|NCT00303667|4214683|P2|STARTED|Overall Study||39
1721920|NCT00303667|4214684|P1|STARTED|Overall Study||8
1721921|NCT00303628|4214708|P2|NOT COMPLETED|Overall Study||73
1721922|NCT00303628|4214709|P1|NOT COMPLETED|Overall Study||50
1721923|NCT00303628|4214708|P2|COMPLETED|Overall Study||106
1721924|NCT00303628|4214709|P1|COMPLETED|Overall Study||126
1721925|NCT00303628|4214708|P2|Treated|Overall Study||174
1721926|NCT00303628|4214709|P1|Treated|Overall Study||173
1721927|NCT00303628|4214708|P2|Eligible|Overall Study||177
1721928|NCT00303628|4214709|P1|Eligible|Overall Study||171
1721929|NCT00303628|4214708|P2|STARTED|Overall Study||179
1721930|NCT00303628|4214709|P1|STARTED|Overall Study||176
1721931|NCT00303602|4214727|P2|NOT COMPLETED|Overall Study||15
1721932|NCT00303602|4214728|P1|NOT COMPLETED|Overall Study||19
1721933|NCT00303602|4214727|P2|COMPLETED|Overall Study||50
1721934|NCT00303602|4214728|P1|COMPLETED|Overall Study||65
1721935|NCT00303602|4214727|P2|STARTED|Overall Study||65
1721936|NCT00303602|4214728|P1|STARTED|Overall Study||84
1721937|NCT00303511|4214768|P1|NOT COMPLETED|Overall Study||0
1721938|NCT00303511|4214768|P1|COMPLETED|Overall Study||10
1721939|NCT00303511|4214768|P1|STARTED|Overall Study||10
1721940|NCT00303485|4214774|P2|NOT COMPLETED|Overall Study||2
1721941|NCT00303485|4214775|P1|NOT COMPLETED|Overall Study||1
1721942|NCT00303485|4214774|P2|COMPLETED|Overall Study||15
1721943|NCT00303485|4214775|P1|COMPLETED|Overall Study||48
1721944|NCT00303485|4214774|P2|STARTED|Overall Study||17
1721945|NCT00303485|4214775|P1|STARTED|Overall Study||49
1721946|NCT00303472|4214806|P7|NOT COMPLETED|Treatment Extension (Optional)||0
1721947|NCT00303472|4214807|P6|NOT COMPLETED|Treatment Extension (Optional)||1
1721948|NCT00303472|4214808|P5|NOT COMPLETED|Treatment Extension (Optional)||4
1721949|NCT00303472|4214809|P4|NOT COMPLETED|Treatment Extension (Optional)||8
1721950|NCT00303472|4214810|P3|NOT COMPLETED|Treatment Extension (Optional)||9
1721951|NCT00303472|4214811|P2|NOT COMPLETED|Treatment Extension (Optional)||6
1721952|NCT00303472|4214812|P1|NOT COMPLETED|Treatment Extension (Optional)||5
1721953|NCT00303472|4214806|P7|COMPLETED|Treatment Extension (Optional)||1
1721954|NCT00303472|4214807|P6|COMPLETED|Treatment Extension (Optional)||4
1721955|NCT00303472|4214808|P5|COMPLETED|Treatment Extension (Optional)||1
1721956|NCT00303472|4214809|P4|COMPLETED|Treatment Extension (Optional)||5
1721957|NCT00303472|4214810|P3|COMPLETED|Treatment Extension (Optional)||2
1721958|NCT00303472|4214811|P2|COMPLETED|Treatment Extension (Optional)||5
1721959|NCT00303472|4214812|P1|COMPLETED|Treatment Extension (Optional)||1
1721960|NCT00303472|4214806|P7|STARTED|Treatment Extension (Optional)||1
1721961|NCT00303472|4214807|P6|STARTED|Treatment Extension (Optional)||5
1721962|NCT00303472|4214808|P5|STARTED|Treatment Extension (Optional)||5
1721963|NCT00303472|4214809|P4|STARTED|Treatment Extension (Optional)||13
1721964|NCT00303472|4214810|P3|STARTED|Treatment Extension (Optional)||11
1721965|NCT00303472|4214811|P2|STARTED|Treatment Extension (Optional)||11
1721966|NCT00303472|4214812|P1|STARTED|Treatment Extension (Optional)||6
1721967|NCT00303472|4214806|P7|NOT COMPLETED|Treatment Period||2
1721968|NCT00303472|4214807|P6|NOT COMPLETED|Treatment Period||1
1721969|NCT00303472|4214808|P5|NOT COMPLETED|Treatment Period||3
1721970|NCT00303472|4214809|P4|NOT COMPLETED|Treatment Period||2
1721971|NCT00303472|4214810|P3|NOT COMPLETED|Treatment Period||0
1721972|NCT00303472|4214811|P2|NOT COMPLETED|Treatment Period||0
1721973|NCT00303472|4214812|P1|NOT COMPLETED|Treatment Period||0
1721974|NCT00303472|4214806|P7|COMPLETED|Treatment Period||3
1721975|NCT00303472|4214807|P6|COMPLETED|Treatment Period||11
1721976|NCT00303472|4214808|P5|COMPLETED|Treatment Period||8
1721977|NCT00303472|4214809|P4|COMPLETED|Treatment Period||14
1721978|NCT00303472|4214810|P3|COMPLETED|Treatment Period||11
1721979|NCT00303472|4214811|P2|COMPLETED|Treatment Period||11
1721980|NCT00303472|4214812|P1|COMPLETED|Treatment Period||6
1721981|NCT00303472|4214806|P7|STARTED|Treatment Period||5
1721982|NCT00303472|4214807|P6|STARTED|Treatment Period||12
1721983|NCT00303472|4214808|P5|STARTED|Treatment Period||11
1721984|NCT00303472|4214809|P4|STARTED|Treatment Period||16
1721985|NCT00303472|4214810|P3|STARTED|Treatment Period||11
1721986|NCT00303472|4214811|P2|STARTED|Treatment Period||11
1721987|NCT00303472|4214812|P1|STARTED|Treatment Period||6
1721988|NCT00303459|4214872|P2|NOT COMPLETED|Overall Study||89
1721989|NCT00303459|4214873|P1|NOT COMPLETED|Overall Study||83
1721990|NCT00303459|4214872|P2|COMPLETED|Overall Study||86
1721991|NCT00303459|4214873|P1|COMPLETED|Overall Study||76
1721992|NCT00303459|4214872|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
1721993|NCT00303459|4214873|P1|STARTED|Overall Study||159
1721994|NCT00303446|4214899|P2|NOT COMPLETED|Overall Study||4
1721995|NCT00303446|4214900|P1|NOT COMPLETED|Overall Study||2
1721996|NCT00303446|4214899|P2|COMPLETED|Overall Study||21
1721997|NCT00303446|4214900|P1|COMPLETED|Overall Study||23
1721998|NCT00303446|4214899|P2|STARTED|Overall Study||25
1721999|NCT00303446|4214900|P1|STARTED|Overall Study||25
1722000|NCT00303329|4214936|P2|NOT COMPLETED|Overall Study||62
1722001|NCT00303329|4214937|P1|NOT COMPLETED|Overall Study||35
1722002|NCT00303329|4214936|P2|COMPLETED|Overall Study||37
1722003|NCT00303329|4214937|P1|COMPLETED|Overall Study||50
1722004|NCT00303329|4214936|P2|STARTED|Overall Study||99
1722005|NCT00303329|4214937|P1|STARTED|Overall Study||85
1722006|NCT00303316|4214951|P2|NOT COMPLETED|Overall Study||3
1722007|NCT00303316|4214952|P1|NOT COMPLETED|Overall Study||2
1722008|NCT00303316|4214951|P2|COMPLETED|Overall Study||223
1722009|NCT00303316|4214952|P1|COMPLETED|Overall Study||230
1722010|NCT00303316|4214951|P2|STARTED|Overall Study||226
1722011|NCT00303316|4214952|P1|STARTED|Overall Study||232
1722012|NCT00303186|4214964|P1|NOT COMPLETED|Overall Study||52
1722013|NCT00303186|4214964|P1|COMPLETED|Overall Study||55
1722014|NCT00303186|4214964|P1|STARTED|Overall Study||107
1722015|NCT00303108|4214998|P3|NOT COMPLETED|Overall Study||16
1722016|NCT00303108|4214999|P2|NOT COMPLETED|Overall Study||9
1722017|NCT00303108|4215000|P1|NOT COMPLETED|Overall Study||12
1722018|NCT00303108|4214998|P3|COMPLETED|Overall Study||31
1722019|NCT00303108|4214999|P2|COMPLETED|Overall Study||37
1722020|NCT00303108|4215000|P1|COMPLETED|Overall Study||31
1722021|NCT00303108|4214998|P3|STARTED|Overall Study||47
1722022|NCT00303108|4214999|P2|STARTED|Overall Study||46
1722023|NCT00303108|4215000|P1|STARTED|Overall Study||43
1722024|NCT00303069|4215020|P4|NOT COMPLETED|Overall Study||2
1722025|NCT00303069|4215021|P3|NOT COMPLETED|Overall Study||1
1722026|NCT00303069|4215022|P2|NOT COMPLETED|Overall Study||0
1722027|NCT00303069|4215023|P1|NOT COMPLETED|Overall Study||2
1722028|NCT00303069|4215020|P4|COMPLETED|Overall Study||29
1722029|NCT00303069|4215021|P3|COMPLETED|Overall Study||33
1722030|NCT00303069|4215022|P2|COMPLETED|Overall Study||28
1722031|NCT00303069|4215023|P1|COMPLETED|Overall Study||29
1722032|NCT00303069|4215020|P4|STARTED|Overall Study||31
1722033|NCT00303069|4215021|P3|STARTED|Overall Study||34
1722034|NCT00303069|4215022|P2|STARTED|Overall Study||28
1722035|NCT00303069|4215023|P1|STARTED|Overall Study||31
1722036|NCT00302952|4215043|P2|NOT COMPLETED|Overall Study||5
1722037|NCT00302952|4215044|P1|NOT COMPLETED|Overall Study||3
1722038|NCT00302952|4215043|P2|COMPLETED|Overall Study||25
1722039|NCT00302952|4215044|P1|COMPLETED|Overall Study||31
1722040|NCT00302952|4215043|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
1722041|NCT00302952|4215044|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
1722042|NCT00302952|4215043|P2|Started Intent-to-Treat (ITT)|Overall Study||30
1722043|NCT00302952|4215044|P1|Started Intent-to-Treat (ITT)|Overall Study||34
1722044|NCT00302952|4215043|P2|STARTED|Overall Study||30
1722045|NCT00302952|4215044|P1|STARTED|Overall Study||34
1722046|NCT00302848|4215081|P3|NOT COMPLETED|Overall Study||579
1722047|NCT00302848|4215082|P2|NOT COMPLETED|Overall Study||419
1722048|NCT00302848|4215083|P1|NOT COMPLETED|Overall Study||401
1722049|NCT00302848|4215081|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
1722050|NCT00302848|4215082|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
1722051|NCT00302848|4215083|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
1722052|NCT00302848|4215081|P3|STARTED|Overall Study||26341
1722053|NCT00302848|4215082|P2|STARTED|Overall Study||15428
1722054|NCT00302848|4215083|P1|STARTED|Overall Study||16534
1722055|NCT00302731|4215094|P4|NOT COMPLETED|Overall Study||0
1722056|NCT00302731|4215095|P3|NOT COMPLETED|Overall Study||3
1722057|NCT00302731|4215096|P2|NOT COMPLETED|Overall Study||5
1722058|NCT00302731|4215097|P1|NOT COMPLETED|Overall Study||4
1722059|NCT00302731|4215094|P4|COMPLETED|Overall Study||4
1722060|NCT00302731|4215095|P3|COMPLETED|Overall Study||2
1722061|NCT00302731|4215096|P2|COMPLETED|Overall Study||1
1722062|NCT00302731|4215097|P1|COMPLETED|Overall Study||2
1722063|NCT00302731|4215094|P4|STARTED|Overall Study||4
1722064|NCT00302731|4215095|P3|STARTED|Overall Study||5
1722065|NCT00302731|4215096|P2|STARTED|Overall Study||6
1722066|NCT00302731|4215097|P1|STARTED|Overall Study||6
1722067|NCT00302718|4215123|P4|NOT COMPLETED|Overall Study||2
1722068|NCT00302718|4215124|P3|NOT COMPLETED|Overall Study||2
1722069|NCT00302718|4215125|P2|NOT COMPLETED|Overall Study||1
1722070|NCT00302718|4215126|P1|NOT COMPLETED|Overall Study||1
1722071|NCT00302718|4215123|P4|COMPLETED|Overall Study||19
1722072|NCT00302718|4215124|P3|COMPLETED|Overall Study||19
1722073|NCT00302718|4215125|P2|COMPLETED|Overall Study||20
1722074|NCT00302718|4215126|P1|COMPLETED|Overall Study||19
1722075|NCT00302718|4215123|P4|STARTED|Overall Study||21
1722076|NCT00302718|4215124|P3|STARTED|Overall Study||21
1722077|NCT00302718|4215125|P2|STARTED|Overall Study||21
1722078|NCT00302718|4215126|P1|STARTED|Overall Study||20
1722079|NCT00302458|4215158|P1|NOT COMPLETED|Overall Study||3
1722080|NCT00302458|4215158|P1|COMPLETED|Overall Study||26
1722081|NCT00302458|4215158|P1|STARTED|Overall Study||29
1722082|NCT00302328|4215169|P3|NOT COMPLETED|Overall Study||0
1722083|NCT00302328|4215170|P2|NOT COMPLETED|Overall Study||1
1722084|NCT00302328|4215171|P1|NOT COMPLETED|Overall Study||0
1722085|NCT00302328|4215169|P3|COMPLETED|Overall Study||18
1722086|NCT00302328|4215170|P2|COMPLETED|Overall Study|developed cancer during the study|34
1722087|NCT00302328|4215171|P1|COMPLETED|Overall Study||25
1722088|NCT00302328|4215169|P3|STARTED|Overall Study||18
1722089|NCT00302328|4215170|P2|STARTED|Overall Study||35
1722090|NCT00302328|4215171|P1|STARTED|Overall Study||25
1722091|NCT00302211|4215188|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
1722092|NCT00302211|4215189|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
1722093|NCT00302211|4215190|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
1722094|NCT00302211|4215191|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
1722095|NCT00302211|4215192|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
1722096|NCT00302211|4215188|P5|COMPLETED|Open Label-Patients From Double-Blind||24
1722097|NCT00302211|4215189|P4|COMPLETED|Open Label-Patients From Double-Blind||18
1722098|NCT00302211|4215190|P3|COMPLETED|Open Label-Patients From Double-Blind||0
1722099|NCT00302211|4215191|P2|COMPLETED|Open Label-Patients From Double-Blind||0
1722100|NCT00302211|4215192|P1|COMPLETED|Open Label-Patients From Double-Blind||0
1722101|NCT00302211|4215188|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
1722102|NCT00302211|4215189|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
1722103|NCT00302211|4215190|P3|STARTED|Open Label-Patients From Double-Blind||0
1722104|NCT00302211|4215191|P2|STARTED|Open Label-Patients From Double-Blind||0
1722105|NCT00302211|4215192|P1|STARTED|Open Label-Patients From Double-Blind||0
1722106|NCT00302211|4215188|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
1722107|NCT00302211|4215189|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
1722108|NCT00302211|4215190|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
1722109|NCT00302211|4215191|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
1722110|NCT00302211|4215192|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
1722111|NCT00302211|4215188|P5|COMPLETED|Double Blind Period (New Patients)||0
1722112|NCT00302211|4215189|P4|COMPLETED|Double Blind Period (New Patients)||0
1722113|NCT00302211|4215190|P3|COMPLETED|Double Blind Period (New Patients)||10
1722114|NCT00302211|4215191|P2|COMPLETED|Double Blind Period (New Patients)||25
1722115|NCT00302211|4215192|P1|COMPLETED|Double Blind Period (New Patients)||23
1722116|NCT00302211|4215188|P5|STARTED|Double Blind Period (New Patients)||0
1722117|NCT00302211|4215189|P4|STARTED|Double Blind Period (New Patients)||0
1722118|NCT00302211|4215190|P3|STARTED|Double Blind Period (New Patients)|placebo plus sildenafil with or without bosentan|14
1722119|NCT00302211|4215191|P2|STARTED|Double Blind Period (New Patients)|iloprost 4x/day plus sildenafil with or without bosentan|27
1722120|NCT00302211|4215192|P1|STARTED|Double Blind Period (New Patients)|iloprost 6x/day plus sildenafil with or without bosentan|26
1722121|NCT00302159|4215204|P1|NOT COMPLETED|Overall Study||2
1722122|NCT00302159|4215204|P1|COMPLETED|Overall Study||41
1722123|NCT00302159|4215204|P1|STARTED|Overall Study||43
1722124|NCT00302133|4215215|P2|NOT COMPLETED|Overall Study||4
1722125|NCT00302133|4215216|P1|NOT COMPLETED|Overall Study||4
1722126|NCT00302133|4215215|P2|COMPLETED|Overall Study||5
1722127|NCT00302133|4215216|P1|COMPLETED|Overall Study||5
1722128|NCT00302133|4215215|P2|STARTED|Overall Study||9
1722129|NCT00302133|4215216|P1|STARTED|Overall Study||9
1722130|NCT00302107|4215226|P2|NOT COMPLETED|Overall Study||9
1722131|NCT00302107|4215227|P1|NOT COMPLETED|Overall Study||8
1722132|NCT00302107|4215226|P2|COMPLETED|Overall Study||30
1722133|NCT00302107|4215227|P1|COMPLETED|Overall Study||31
1722134|NCT00302107|4215226|P2|STARTED|Overall Study||39
1722135|NCT00302107|4215227|P1|STARTED|Overall Study||39
1722136|NCT00302081|4215236|P3|NOT COMPLETED|Overall Study||52
1722137|NCT00302081|4215237|P2|NOT COMPLETED|Overall Study||43
1722138|NCT00302081|4215238|P1|NOT COMPLETED|Overall Study||56
1722139|NCT00302081|4215236|P3|COMPLETED|Overall Study||178
1722140|NCT00302081|4215237|P2|COMPLETED|Overall Study||186
1722141|NCT00302081|4215238|P1|COMPLETED|Overall Study||181
1722142|NCT00302081|4215236|P3|STARTED|Overall Study||230
1722143|NCT00302081|4215237|P2|STARTED|Overall Study||229
1722144|NCT00302081|4215238|P1|STARTED|Overall Study||237
1722145|NCT00302068|4215249|P3|NOT COMPLETED|Overall Study||1
1722146|NCT00302068|4215250|P2|NOT COMPLETED|Overall Study||4
1722147|NCT00302068|4215251|P1|NOT COMPLETED|Overall Study||1
1722148|NCT00302068|4215249|P3|COMPLETED|Overall Study||23
1722149|NCT00302068|4215250|P2|COMPLETED|Overall Study||36
1722150|NCT00302068|4215251|P1|COMPLETED|Overall Study||36
1722151|NCT00302068|4215249|P3|STARTED|Overall Study||24
1722152|NCT00302068|4215250|P2|STARTED|Overall Study||40
1722153|NCT00302068|4215251|P1|STARTED|Overall Study||37
1722154|NCT00302055|4215279|P2|NOT COMPLETED|Overall Study||13
1722155|NCT00302055|4215280|P1|NOT COMPLETED|Overall Study||9
1722156|NCT00302055|4215279|P2|COMPLETED|Overall Study||36
1722157|NCT00302055|4215280|P1|COMPLETED|Overall Study||14
1722158|NCT00302055|4215279|P2|STARTED|Overall Study||49
1722159|NCT00302055|4215280|P1|STARTED|Overall Study||23
1722160|NCT00302042|4215288|P2|NOT COMPLETED|Overall Study||8
1722161|NCT00302042|4215289|P1|NOT COMPLETED|Overall Study||7
1722162|NCT00302042|4215288|P2|COMPLETED|Overall Study||38
1722163|NCT00302042|4215289|P1|COMPLETED|Overall Study||39
1722164|NCT00302042|4215288|P2|STARTED|Overall Study||46
1722165|NCT00302042|4215289|P1|STARTED|Overall Study||46
1722166|NCT00302003|4215295|P1|NOT COMPLETED|Overall Study||80
1722167|NCT00302003|4215295|P1|COMPLETED|Overall Study||207
1722168|NCT00302003|4215295|P1|STARTED|Overall Study||287
1722169|NCT00301964|4215302|P1|NOT COMPLETED|Overall Study||4
1722170|NCT00301964|4215302|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
1722171|NCT00301964|4215302|P1|STARTED|Overall Study||56
1722172|NCT00301873|4215317|P1|NOT COMPLETED|Overall Study||0
1722173|NCT00301873|4215317|P1|COMPLETED|Overall Study||59
1722174|NCT00301873|4215317|P1|STARTED|Overall Study||59
1722175|NCT00301834|4215323|P1|NOT COMPLETED|Overall Study||1
1722176|NCT00301834|4215323|P1|COMPLETED|Overall Study||34
1722177|NCT00301834|4215323|P1|STARTED|Overall Study||35
1722178|NCT00301821|4215332|P1|NOT COMPLETED|Overall Study||26
1722179|NCT00301821|4215332|P1|COMPLETED|Overall Study||81
1722180|NCT00301821|4215332|P1|STARTED|Overall Study||107
1722181|NCT00301808|4215339|P1|NOT COMPLETED|Overall Study||12
1722182|NCT00301808|4215339|P1|COMPLETED|Overall Study||17
1722183|NCT00301808|4215339|P1|STARTED|Overall Study||29
1722184|NCT00301756|4215346|P1|NOT COMPLETED|Overall Study||0
1722185|NCT00301756|4215346|P1|COMPLETED|Overall Study||32
1722186|NCT00301756|4215346|P1|STARTED|Overall Study||32
1722187|NCT00301418|4215358|P1|NOT COMPLETED|Overall Study||0
1722188|NCT00301418|4215358|P1|COMPLETED|Overall Study||11
1722189|NCT00301418|4215358|P1|STARTED|Overall Study||11
1722190|NCT00301366|4215364|P1|NOT COMPLETED|Overall Study||1
1722191|NCT00301366|4215364|P1|COMPLETED|Overall Study||37
1722192|NCT00301366|4215364|P1|STARTED|Overall Study||38
1722193|NCT00301262|4215370|P2|NOT COMPLETED|Open Label Phase (OL)||2
1722194|NCT00301262|4215371|P1|NOT COMPLETED|Open Label Phase (OL)||4
1722195|NCT00301262|4215370|P2|COMPLETED|Open Label Phase (OL)||67
1722196|NCT00301262|4215371|P1|COMPLETED|Open Label Phase (OL)||79
1722197|NCT00301262|4215370|P2|STARTED|Open Label Phase (OL)||69
1722198|NCT00301262|4215371|P1|STARTED|Open Label Phase (OL)||83
1722199|NCT00301262|4215370|P2|NOT COMPLETED|Double Blind Phase (DB)||13
1722200|NCT00301262|4215371|P1|NOT COMPLETED|Double Blind Phase (DB)||10
1722201|NCT00301262|4215370|P2|COMPLETED|Double Blind Phase (DB)||69
1722202|NCT00301262|4215371|P1|COMPLETED|Double Blind Phase (DB)||84
1722203|NCT00301262|4215370|P2|STARTED|Double Blind Phase (DB)||82
1722204|NCT00301262|4215371|P1|STARTED|Double Blind Phase (DB)||94
1722205|NCT00301080|4215529|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722206|NCT00301080|4215530|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722207|NCT00301080|4215531|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722208|NCT00301080|4215532|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722209|NCT00301080|4215533|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722210|NCT00301080|4215529|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722211|NCT00301080|4215530|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722212|NCT00301080|4215531|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722213|NCT00301080|4215532|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722214|NCT00301080|4215533|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
1722215|NCT00301080|4215529|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
1722216|NCT00301080|4215530|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
1722217|NCT00301080|4215531|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
1722218|NCT00301080|4215532|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
1722219|NCT00301080|4215533|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
1722220|NCT00301080|4215529|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1722221|NCT00301080|4215530|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1722222|NCT00301080|4215531|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1722223|NCT00301080|4215532|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1722224|NCT00301080|4215533|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
1722225|NCT00301080|4215529|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1722226|NCT00301080|4215530|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1722227|NCT00301080|4215531|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
1722228|NCT00301080|4215532|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
1722229|NCT00301080|4215533|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
1722230|NCT00301080|4215529|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
1722231|NCT00301080|4215530|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
1722232|NCT00301080|4215531|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
1722233|NCT00301080|4215532|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
1722234|NCT00301080|4215533|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
1722235|NCT00301080|4215529|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
1722236|NCT00301080|4215530|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
1722237|NCT00301080|4215531|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
1722238|NCT00301080|4215532|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
1722239|NCT00301080|4215533|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
1722240|NCT00301080|4215529|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
1722241|NCT00301080|4215530|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
1722242|NCT00301080|4215531|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
1722243|NCT00301080|4215532|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
1722244|NCT00301080|4215533|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
1722245|NCT00301067|4215562|P4|NOT COMPLETED|Follow up Until Death||1
1722246|NCT00301067|4215563|P3|NOT COMPLETED|Follow up Until Death||0
1722247|NCT00301067|4215564|P2|NOT COMPLETED|Follow up Until Death||0
1722248|NCT00301067|4215565|P1|NOT COMPLETED|Follow up Until Death||1
1722249|NCT00301067|4215562|P4|COMPLETED|Follow up Until Death||2
1722250|NCT00301067|4215563|P3|COMPLETED|Follow up Until Death||3
1722251|NCT00301067|4215564|P2|COMPLETED|Follow up Until Death||3
1722252|NCT00301067|4215565|P1|COMPLETED|Follow up Until Death||3
1722253|NCT00301067|4215562|P4|STARTED|Follow up Until Death||3
1722254|NCT00301067|4215563|P3|STARTED|Follow up Until Death||3
1722255|NCT00301067|4215564|P2|STARTED|Follow up Until Death||3
1722256|NCT00301067|4215565|P1|STARTED|Follow up Until Death||4
1722257|NCT00301067|4215562|P4|NOT COMPLETED|Completed 12 Cycles of Treatment||2
1722258|NCT00301067|4215563|P3|NOT COMPLETED|Completed 12 Cycles of Treatment||0
1722259|NCT00301067|4215564|P2|NOT COMPLETED|Completed 12 Cycles of Treatment||1
1722260|NCT00301067|4215565|P1|NOT COMPLETED|Completed 12 Cycles of Treatment||0
1722261|NCT00301067|4215562|P4|COMPLETED|Completed 12 Cycles of Treatment||0
1722262|NCT00301067|4215563|P3|COMPLETED|Completed 12 Cycles of Treatment||0
1722263|NCT00301067|4215564|P2|COMPLETED|Completed 12 Cycles of Treatment||0
1722264|NCT00301067|4215565|P1|COMPLETED|Completed 12 Cycles of Treatment||0
1722265|NCT00301067|4215562|P4|STARTED|Completed 12 Cycles of Treatment||2
1722266|NCT00301067|4215563|P3|STARTED|Completed 12 Cycles of Treatment||0
1722267|NCT00301067|4215564|P2|STARTED|Completed 12 Cycles of Treatment||1
1722268|NCT00301067|4215565|P1|STARTED|Completed 12 Cycles of Treatment||0
1722269|NCT00301067|4215562|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||5
1722270|NCT00301067|4215563|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||2
1722271|NCT00301067|4215564|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||1
1722272|NCT00301067|4215565|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||1
1722273|NCT00301067|4215562|P4|COMPLETED|Completed 4 Cycles of Treatment||2
1722274|NCT00301067|4215563|P3|COMPLETED|Completed 4 Cycles of Treatment||0
1722275|NCT00301067|4215564|P2|COMPLETED|Completed 4 Cycles of Treatment||1
1722276|NCT00301067|4215565|P1|COMPLETED|Completed 4 Cycles of Treatment||0
1722277|NCT00301067|4215562|P4|STARTED|Completed 4 Cycles of Treatment||7
1722278|NCT00301067|4215563|P3|STARTED|Completed 4 Cycles of Treatment||2
1722279|NCT00301067|4215564|P2|STARTED|Completed 4 Cycles of Treatment||2
1722280|NCT00301067|4215565|P1|STARTED|Completed 4 Cycles of Treatment||1
1722281|NCT00301067|4215562|P4|NOT COMPLETED|Reached 1st Response/2 Cycles||2
1722282|NCT00301067|4215563|P3|NOT COMPLETED|Reached 1st Response/2 Cycles||1
1722283|NCT00301067|4215564|P2|NOT COMPLETED|Reached 1st Response/2 Cycles||1
1722284|NCT00301067|4215565|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
1722285|NCT00301067|4215562|P4|COMPLETED|Reached 1st Response/2 Cycles||7
1722286|NCT00301067|4215563|P3|COMPLETED|Reached 1st Response/2 Cycles||2
1722287|NCT00301067|4215564|P2|COMPLETED|Reached 1st Response/2 Cycles||2
1722288|NCT00301067|4215565|P1|COMPLETED|Reached 1st Response/2 Cycles||1
1722289|NCT00301067|4215562|P4|STARTED|Reached 1st Response/2 Cycles||9
1722290|NCT00301067|4215563|P3|STARTED|Reached 1st Response/2 Cycles||3
1722291|NCT00301067|4215564|P2|STARTED|Reached 1st Response/2 Cycles||3
1722292|NCT00301067|4215565|P1|STARTED|Reached 1st Response/2 Cycles||3
1722293|NCT00301067|4215562|P4|NOT COMPLETED|Completed DLT Period/1st Cycle||1
1722294|NCT00301067|4215563|P3|NOT COMPLETED|Completed DLT Period/1st Cycle||0
1722295|NCT00301067|4215564|P2|NOT COMPLETED|Completed DLT Period/1st Cycle||0
1722296|NCT00301067|4215565|P1|NOT COMPLETED|Completed DLT Period/1st Cycle||1
1722297|NCT00301067|4215562|P4|COMPLETED|Completed DLT Period/1st Cycle||9
1722298|NCT00301067|4215563|P3|COMPLETED|Completed DLT Period/1st Cycle||3
1722299|NCT00301067|4215564|P2|COMPLETED|Completed DLT Period/1st Cycle||3
1722300|NCT00301067|4215565|P1|COMPLETED|Completed DLT Period/1st Cycle||3
1722301|NCT00301067|4215562|P4|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
1722302|NCT00301067|4215563|P3|STARTED|Completed DLT Period/1st Cycle||3
1722303|NCT00301067|4215564|P2|STARTED|Completed DLT Period/1st Cycle||3
1722304|NCT00301067|4215565|P1|STARTED|Completed DLT Period/1st Cycle||4
1722305|NCT00301028|4215584|P1|NOT COMPLETED|Overall Study||0
1722306|NCT00301028|4215584|P1|COMPLETED|Overall Study||47
1722307|NCT00301028|4215584|P1|STARTED|Overall Study||47
1722308|NCT00300885|4215590|P2|NOT COMPLETED|Follow-up||195
1722309|NCT00300885|4215591|P1|NOT COMPLETED|Follow-up||178
1722310|NCT00300885|4215590|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
1722311|NCT00300885|4215591|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
1722405|NCT00300430|4215876|P1|NOT COMPLETED|Overall Study||367
1722312|NCT00300885|4215590|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
1722313|NCT00300885|4215591|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
1722314|NCT00300885|4215590|P2|NOT COMPLETED|Treatment||374
1722315|NCT00300885|4215591|P1|NOT COMPLETED|Treatment||373
1722316|NCT00300885|4215590|P2|COMPLETED|Treatment||88
1722317|NCT00300885|4215591|P1|COMPLETED|Treatment||91
1722318|NCT00300885|4215590|P2|Received Treatment|Treatment||459
1722319|NCT00300885|4215591|P1|Received Treatment|Treatment||463
1722320|NCT00300885|4215590|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
1722321|NCT00300885|4215591|P1|STARTED|Treatment||464
1722322|NCT00300781|4215609|P2|NOT COMPLETED|Overall Study||62
1722323|NCT00300781|4215610|P1|NOT COMPLETED|Overall Study||63
1722324|NCT00300781|4215609|P2|COMPLETED|Overall Study||8
1722325|NCT00300781|4215610|P1|COMPLETED|Overall Study||3
1722326|NCT00300781|4215609|P2|STARTED|Overall Study||70
1722327|NCT00300781|4215610|P1|STARTED|Overall Study||66
1722328|NCT00300755|4215625|P3|NOT COMPLETED|Overall Study||2
1722329|NCT00300755|4215626|P2|NOT COMPLETED|Overall Study||4
1722330|NCT00300755|4215627|P1|NOT COMPLETED|Overall Study||1
1722331|NCT00300755|4215625|P3|COMPLETED|Overall Study||19
1722332|NCT00300755|4215626|P2|COMPLETED|Overall Study||17
1722333|NCT00300755|4215627|P1|COMPLETED|Overall Study||17
1722334|NCT00300755|4215625|P3|STARTED|Overall Study||21
1722335|NCT00300755|4215626|P2|STARTED|Overall Study||21
1722336|NCT00300755|4215627|P1|STARTED|Overall Study||18
1722337|NCT00300742|4215644|P1|NOT COMPLETED|Overall Study||2
1722338|NCT00300742|4215644|P1|COMPLETED|Overall Study||3
1722339|NCT00300742|4215644|P1|STARTED|Overall Study||5
1722340|NCT00300677|4215652|P1|NOT COMPLETED|Overall Study||0
1722341|NCT00300677|4215652|P1|COMPLETED|Overall Study||12
1722342|NCT00300677|4215652|P1|STARTED|Overall Study||12
1722343|NCT00300495|4215661|P2|NOT COMPLETED|Overall Study||1
1722344|NCT00300495|4215662|P1|NOT COMPLETED|Overall Study||4
1722345|NCT00300495|4215661|P2|COMPLETED|Overall Study||8
1722346|NCT00300495|4215662|P1|COMPLETED|Overall Study||6
1722347|NCT00300495|4215661|P2|STARTED|Overall Study||9
1722348|NCT00300495|4215662|P1|STARTED|Overall Study||10
1722349|NCT00300482|4215676|P6|NOT COMPLETED|Overall Study||16
1722350|NCT00300482|4215677|P5|NOT COMPLETED|Overall Study||23
1722351|NCT00300482|4215678|P4|NOT COMPLETED|Overall Study||24
1722352|NCT00300482|4215679|P3|NOT COMPLETED|Overall Study||51
1722353|NCT00300482|4215680|P2|NOT COMPLETED|Overall Study||41
1722354|NCT00300482|4215681|P1|NOT COMPLETED|Overall Study||41
1722355|NCT00300482|4215676|P6|COMPLETED|Overall Study||115
1722356|NCT00300482|4215677|P5|COMPLETED|Overall Study||243
1722357|NCT00300482|4215678|P4|COMPLETED|Overall Study||237
1722358|NCT00300482|4215679|P3|COMPLETED|Overall Study||208
1722359|NCT00300482|4215680|P2|COMPLETED|Overall Study||220
1722360|NCT00300482|4215681|P1|COMPLETED|Overall Study||220
1722361|NCT00300482|4215676|P6|STARTED|Overall Study||131
1722362|NCT00300482|4215677|P5|STARTED|Overall Study||266
1722363|NCT00300482|4215678|P4|STARTED|Overall Study||261
1722364|NCT00300482|4215679|P3|STARTED|Overall Study||259
1722365|NCT00300482|4215680|P2|STARTED|Overall Study||261
1722366|NCT00300482|4215681|P1|STARTED|Overall Study|"For all arms, started means treated."|261
1722367|NCT00300469|4215743|P6|NOT COMPLETED|Overall Study||9
1722368|NCT00300469|4215744|P5|NOT COMPLETED|Overall Study||14
1722369|NCT00300469|4215745|P4|NOT COMPLETED|Overall Study||9
1722370|NCT00300469|4215746|P3|NOT COMPLETED|Overall Study||17
1722371|NCT00300469|4215747|P2|NOT COMPLETED|Overall Study||21
1722372|NCT00300469|4215748|P1|NOT COMPLETED|Overall Study||21
1722373|NCT00300469|4215743|P6|COMPLETED|Overall Study||46
1722374|NCT00300469|4215744|P5|COMPLETED|Overall Study||95
1722375|NCT00300469|4215745|P4|COMPLETED|Overall Study||104
1722376|NCT00300469|4215746|P3|COMPLETED|Overall Study||95
1722377|NCT00300469|4215747|P2|COMPLETED|Overall Study||89
1722378|NCT00300469|4215748|P1|COMPLETED|Overall Study||89
1722379|NCT00300469|4215743|P6|STARTED|Overall Study||55
1722380|NCT00300469|4215744|P5|STARTED|Overall Study||109
1722381|NCT00300469|4215745|P4|STARTED|Overall Study||113
1722382|NCT00300469|4215746|P3|STARTED|Overall Study||112
1722383|NCT00300469|4215747|P2|STARTED|Overall Study||110
1722384|NCT00300469|4215748|P1|STARTED|Overall Study|"For all arms, started means treated."|110
1722385|NCT00300456|4215810|P6|NOT COMPLETED|Overall Study||11
1722386|NCT00300456|4215811|P5|NOT COMPLETED|Overall Study||17
1722387|NCT00300456|4215812|P4|NOT COMPLETED|Overall Study||14
1722388|NCT00300456|4215813|P3|NOT COMPLETED|Overall Study||21
1722389|NCT00300456|4215814|P2|NOT COMPLETED|Overall Study||16
1722390|NCT00300456|4215815|P1|NOT COMPLETED|Overall Study||16
1722391|NCT00300456|4215810|P6|COMPLETED|Overall Study||48
1722392|NCT00300456|4215811|P5|COMPLETED|Overall Study||99
1722393|NCT00300456|4215812|P4|COMPLETED|Overall Study||105
1722394|NCT00300456|4215813|P3|COMPLETED|Overall Study||98
1722395|NCT00300456|4215814|P2|COMPLETED|Overall Study||102
1722396|NCT00300456|4215815|P1|COMPLETED|Overall Study||103
1722397|NCT00300456|4215810|P6|STARTED|Overall Study||59
1722398|NCT00300456|4215811|P5|STARTED|Overall Study||116
1722399|NCT00300456|4215812|P4|STARTED|Overall Study||119
1722400|NCT00300456|4215813|P3|STARTED|Overall Study||119
1722401|NCT00300456|4215814|P2|STARTED|Overall Study||118
1722402|NCT00300456|4215815|P1|STARTED|Overall Study|"For all arms, started means treated."|119
1722403|NCT00300430|4215874|P3|NOT COMPLETED|Overall Study||151
1722404|NCT00300430|4215875|P2|NOT COMPLETED|Overall Study||169
1722406|NCT00300430|4215874|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
1722407|NCT00300430|4215875|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
1722408|NCT00300430|4215876|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
1722409|NCT00300430|4215874|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
1722410|NCT00300430|4215875|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
1722411|NCT00300430|4215876|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
1722412|NCT00300391|4215910|P2|NOT COMPLETED|Overall Study||0
1722413|NCT00300391|4215911|P1|NOT COMPLETED|Overall Study||0
1722414|NCT00300391|4215910|P2|COMPLETED|Overall Study||14
1722415|NCT00300391|4215911|P1|COMPLETED|Overall Study||16
1722416|NCT00300391|4215910|P2|STARTED|Overall Study||14
1722417|NCT00300391|4215911|P1|STARTED|Overall Study||16
1722418|NCT00300365|4215929|P2|NOT COMPLETED|Overall Study||2
1722419|NCT00300365|4215930|P1|NOT COMPLETED|Overall Study||4
1722420|NCT00300365|4215929|P2|COMPLETED|Overall Study||38
1722421|NCT00300365|4215930|P1|COMPLETED|Overall Study||34
1722422|NCT00300365|4215929|P2|STARTED|Overall Study||40
1722423|NCT00300365|4215930|P1|STARTED|Overall Study||38
1722424|NCT00300274|4215939|P3|NOT COMPLETED|Overall Study||45
1722425|NCT00300274|4215940|P2|NOT COMPLETED|Overall Study||27
1722426|NCT00300274|4215941|P1|NOT COMPLETED|Overall Study||46
1722427|NCT00300274|4215939|P3|COMPLETED|Overall Study||226
1722428|NCT00300274|4215940|P2|COMPLETED|Overall Study||141
1722429|NCT00300274|4215941|P1|COMPLETED|Overall Study||236
1722430|NCT00300274|4215939|P3|Completed 12 Month|Overall Study||248
1722431|NCT00300274|4215940|P2|Completed 12 Month|Overall Study||149
1722432|NCT00300274|4215941|P1|Completed 12 Month|Overall Study||250
1722433|NCT00300274|4215939|P3|STARTED|Overall Study||271
1722434|NCT00300274|4215940|P2|STARTED|Overall Study||168
1722435|NCT00300274|4215941|P1|STARTED|Overall Study||282
1722436|NCT00300235|4215981|P5|NOT COMPLETED|Overall Study||0
1722437|NCT00300235|4215982|P4|NOT COMPLETED|Overall Study||0
1722438|NCT00300235|4215983|P3|NOT COMPLETED|Overall Study||0
1722439|NCT00300235|4215984|P2|NOT COMPLETED|Overall Study||0
1722440|NCT00300235|4215985|P1|NOT COMPLETED|Overall Study||0
1722441|NCT00300235|4215981|P5|COMPLETED|Overall Study||251
1722442|NCT00300235|4215982|P4|COMPLETED|Overall Study||362
1722443|NCT00300235|4215983|P3|COMPLETED|Overall Study||398
1722444|NCT00300235|4215984|P2|COMPLETED|Overall Study||240
1722445|NCT00300235|4215985|P1|COMPLETED|Overall Study||208
1722446|NCT00300235|4215981|P5|STARTED|Overall Study||251
1722447|NCT00300235|4215982|P4|STARTED|Overall Study||362
1722448|NCT00300235|4215983|P3|STARTED|Overall Study||398
1722449|NCT00300235|4215984|P2|STARTED|Overall Study||240
1722450|NCT00300235|4215985|P1|STARTED|Overall Study||208
1722451|NCT00299975|4216000|P3|NOT COMPLETED|Overall Study||8
1722452|NCT00299975|4216001|P2|NOT COMPLETED|Overall Study||1
1722453|NCT00299975|4216002|P1|NOT COMPLETED|Overall Study||3
1722454|NCT00299975|4216000|P3|COMPLETED|Overall Study||25
1722455|NCT00299975|4216001|P2|COMPLETED|Overall Study||31
1722456|NCT00299975|4216002|P1|COMPLETED|Overall Study||29
1722457|NCT00299975|4216000|P3|Received Allocated Intervention|Overall Study||32
1722458|NCT00299975|4216001|P2|Received Allocated Intervention|Overall Study||32
1722459|NCT00299975|4216002|P1|Received Allocated Intervention|Overall Study||32
1722460|NCT00299975|4216000|P3|STARTED|Overall Study||33
1722461|NCT00299975|4216001|P2|STARTED|Overall Study||32
1722462|NCT00299975|4216002|P1|STARTED|Overall Study||32
1722463|NCT00299741|4216052|P1|NOT COMPLETED|Overall Study||0
1722464|NCT00299741|4216052|P1|COMPLETED|Overall Study||36
1722465|NCT00299741|4216052|P1|STARTED|Overall Study||36
1722466|NCT00299702|4216059|P2|NOT COMPLETED|Overall Study||50
1722467|NCT00299702|4216060|P1|NOT COMPLETED|Overall Study||53
1722468|NCT00299702|4216059|P2|COMPLETED|Overall Study||126
1722469|NCT00299702|4216060|P1|COMPLETED|Overall Study||126
1722470|NCT00299702|4216059|P2|STARTED|Overall Study||176
1722471|NCT00299702|4216060|P1|STARTED|Overall Study||179
1722472|NCT00299689|4216068|P1|NOT COMPLETED|Overall Study||0
1722473|NCT00299689|4216068|P1|COMPLETED|Overall Study||69
1722474|NCT00299689|4216068|P1|STARTED|Overall Study||69
1722475|NCT00299546|4216075|P3|NOT COMPLETED|Overall Study||86
1722476|NCT00299546|4216076|P2|NOT COMPLETED|Overall Study||92
1722477|NCT00299546|4216077|P1|NOT COMPLETED|Overall Study||100
1722478|NCT00299546|4216075|P3|COMPLETED|Overall Study||67
1722479|NCT00299546|4216076|P2|COMPLETED|Overall Study||61
1722480|NCT00299546|4216077|P1|COMPLETED|Overall Study||55
1722481|NCT00299546|4216075|P3|STARTED|Overall Study||153
1722482|NCT00299546|4216076|P2|STARTED|Overall Study||153
1722483|NCT00299546|4216077|P1|STARTED|Overall Study||155
1722484|NCT00299494|4216108|P6|NOT COMPLETED|Overall Study||26
1722485|NCT00299494|4216109|P5|NOT COMPLETED|Overall Study||27
1722486|NCT00299494|4216110|P4|NOT COMPLETED|Overall Study||10
1722487|NCT00299494|4216111|P3|NOT COMPLETED|Overall Study||4
1722488|NCT00299494|4216112|P2|NOT COMPLETED|Overall Study||1
1722489|NCT00299494|4216113|P1|NOT COMPLETED|Overall Study||3
1722490|NCT00299494|4216108|P6|COMPLETED|Overall Study||4
1722491|NCT00299494|4216109|P5|COMPLETED|Overall Study||13
1722492|NCT00299494|4216110|P4|COMPLETED|Overall Study||24
1722493|NCT00299494|4216111|P3|COMPLETED|Overall Study||3
1722494|NCT00299494|4216112|P2|COMPLETED|Overall Study||2
1722495|NCT00299494|4216113|P1|COMPLETED|Overall Study||2
1722496|NCT00299494|4216108|P6|STARTED|Overall Study||30
1722497|NCT00299494|4216109|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
1722498|NCT00299494|4216110|P4|STARTED|Overall Study||34
1722499|NCT00299494|4216111|P3|STARTED|Overall Study||7
1722500|NCT00299494|4216112|P2|STARTED|Overall Study||3
1722501|NCT00299494|4216113|P1|STARTED|Overall Study||5
1722502|NCT00299416|4216216|P1|NOT COMPLETED|Overall Study||0
1722503|NCT00299416|4216216|P1|COMPLETED|Overall Study||30
1722504|NCT00299416|4216216|P1|STARTED|Overall Study||30
1722505|NCT00299221|4216224|P2|NOT COMPLETED|Overall Study||0
1722506|NCT00299221|4216225|P1|NOT COMPLETED|Overall Study||0
1722507|NCT00299221|4216224|P2|COMPLETED|Overall Study||71
1722508|NCT00299221|4216225|P1|COMPLETED|Overall Study||79
1722509|NCT00299221|4216224|P2|STARTED|Overall Study||71
1722510|NCT00299221|4216225|P1|STARTED|Overall Study||79
1722511|NCT00299156|4216242|P3|NOT COMPLETED|Period 2 (Randomized)||0
1722512|NCT00299156|4216243|P2|NOT COMPLETED|Period 2 (Randomized)||1
1722513|NCT00299156|4216244|P1|NOT COMPLETED|Period 2 (Randomized)||0
1722514|NCT00299156|4216242|P3|COMPLETED|Period 2 (Randomized)||16
1722515|NCT00299156|4216243|P2|COMPLETED|Period 2 (Randomized)||16
1722516|NCT00299156|4216244|P1|COMPLETED|Period 2 (Randomized)||0
1722517|NCT00299156|4216242|P3|STARTED|Period 2 (Randomized)||16
1722518|NCT00299156|4216243|P2|STARTED|Period 2 (Randomized)||17
1722519|NCT00299156|4216244|P1|STARTED|Period 2 (Randomized)||0
1722520|NCT00299156|4216242|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
1722521|NCT00299156|4216243|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
1722522|NCT00299156|4216244|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
1722523|NCT00299156|4216242|P3|COMPLETED|Period 1 (Non-Randomized)||0
1722524|NCT00299156|4216243|P2|COMPLETED|Period 1 (Non-Randomized)||0
1722525|NCT00299156|4216244|P1|COMPLETED|Period 1 (Non-Randomized)||32
1722526|NCT00299156|4216242|P3|STARTED|Period 1 (Non-Randomized)||0
1722527|NCT00299156|4216243|P2|STARTED|Period 1 (Non-Randomized)||0
1722528|NCT00299156|4216244|P1|STARTED|Period 1 (Non-Randomized)||32
1722529|NCT00299130|4216255|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
1722530|NCT00299130|4216256|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
1722531|NCT00299130|4216257|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
1722532|NCT00299130|4216255|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
1722533|NCT00299130|4216256|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
1722534|NCT00299130|4216257|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
1722535|NCT00299130|4216255|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
1722536|NCT00299130|4216256|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
1722537|NCT00299130|4216257|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
1722538|NCT00299130|4216255|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
1722539|NCT00299130|4216256|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
1722540|NCT00299130|4216257|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
1722541|NCT00299130|4216255|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
1722542|NCT00299130|4216256|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
1722543|NCT00299130|4216257|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
1722544|NCT00299130|4216255|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
1722545|NCT00299130|4216256|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
1722546|NCT00299130|4216257|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
1722547|NCT00299130|4216255|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
1722548|NCT00299130|4216256|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
1722549|NCT00299130|4216257|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
1722550|NCT00299130|4216255|P3|COMPLETED|Treatment Period (up to 5 Years)||121
1722551|NCT00299130|4216256|P2|COMPLETED|Treatment Period (up to 5 Years)||125
1722552|NCT00299130|4216257|P1|COMPLETED|Treatment Period (up to 5 Years)||119
1722553|NCT00299130|4216255|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
1722554|NCT00299130|4216256|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
1722555|NCT00299130|4216257|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
1722556|NCT00299130|4216255|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
1722557|NCT00299130|4216256|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
1722558|NCT00299130|4216257|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
1722559|NCT00299130|4216255|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
1722560|NCT00299130|4216256|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
1722561|NCT00299130|4216257|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
1722562|NCT00299130|4216255|P3|Treated|Treatment Period (up to 5 Years)||170
1722563|NCT00299130|4216256|P2|Treated|Treatment Period (up to 5 Years)||167
1722564|NCT00299130|4216257|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
1722565|NCT00299130|4216255|P3|STARTED|Treatment Period (up to 5 Years)||171
1722566|NCT00299130|4216256|P2|STARTED|Treatment Period (up to 5 Years)||168
1722567|NCT00299130|4216257|P1|STARTED|Treatment Period (up to 5 Years)||172
1722568|NCT00299104|4216362|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
1722569|NCT00299104|4216363|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
1722570|NCT00299104|4216364|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
1722571|NCT00299104|4216362|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
1722572|NCT00299104|4216363|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
1722573|NCT00299104|4216364|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
1722574|NCT00299104|4216362|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
1722575|NCT00299104|4216363|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
1722576|NCT00299104|4216364|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
1722577|NCT00299104|4216362|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
1722578|NCT00299104|4216363|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
1722579|NCT00299104|4216364|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
1722580|NCT00299104|4216362|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
1722581|NCT00299104|4216363|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
1722582|NCT00299104|4216364|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
1722583|NCT00299104|4216362|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
1722584|NCT00299104|4216363|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
1722585|NCT00299104|4216364|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
1722586|NCT00299104|4216362|P3|NOT COMPLETED|Treatment Period||172
1722587|NCT00299104|4216363|P2|NOT COMPLETED|Treatment Period||175
1722588|NCT00299104|4216364|P1|NOT COMPLETED|Treatment Period||189
1722589|NCT00299104|4216362|P3|COMPLETED|Treatment Period||80
1722590|NCT00299104|4216363|P2|COMPLETED|Treatment Period||77
1722591|NCT00299104|4216364|P1|COMPLETED|Treatment Period|Completed Week 152|62
1722592|NCT00299104|4216362|P3|Completed Week 104|Treatment Period||216
1722593|NCT00299104|4216363|P2|Completed Week 104|Treatment Period||213
1722594|NCT00299104|4216364|P1|Completed Week 104|Treatment Period||178
1722595|NCT00299104|4216362|P3|Completed Week 52|Treatment Period||232
1722596|NCT00299104|4216363|P2|Completed Week 52|Treatment Period||227
1722597|NCT00299104|4216364|P1|Completed Week 52|Treatment Period||213
1722598|NCT00299104|4216362|P3|Completed Week 24|Treatment Period||241
1722599|NCT00299104|4216363|P2|Completed Week 24|Treatment Period||240
1722600|NCT00299104|4216364|P1|Completed Week 24|Treatment Period||227
1722601|NCT00299104|4216362|P3|Safety/ITT: Received Study Drug|Treatment Period||250
1722602|NCT00299104|4216363|P2|Safety/ITT: Received Study Drug|Treatment Period||249
1722603|NCT00299104|4216364|P1|Safety/ITT: Received Study Drug|Treatment Period||249
1722604|NCT00299104|4216362|P3|STARTED|Treatment Period||252
1722605|NCT00299104|4216363|P2|STARTED|Treatment Period||252
1722606|NCT00299104|4216364|P1|STARTED|Treatment Period||251
1722607|NCT00299000|4216461|P2|NOT COMPLETED|Overall Study||0
1722608|NCT00299000|4216462|P1|NOT COMPLETED|Overall Study||0
1722609|NCT00299000|4216461|P2|COMPLETED|Overall Study||2
1722610|NCT00299000|4216462|P1|COMPLETED|Overall Study||2
1722611|NCT00299000|4216461|P2|STARTED|Overall Study||2
1722612|NCT00299000|4216462|P1|STARTED|Overall Study||2
1722613|NCT00298896|4216474|P1|NOT COMPLETED|Overall Study||50
1722614|NCT00298896|4216474|P1|COMPLETED|Overall Study||5
1722615|NCT00298896|4216474|P1|STARTED|Overall Study||55
1722616|NCT00298766|4216479|P1|NOT COMPLETED|Overall Study||46
1722617|NCT00298766|4216479|P1|COMPLETED|Overall Study||24
1722618|NCT00298766|4216479|P1|STARTED|Overall Study||70
1722619|NCT00298740|4216488|P1|NOT COMPLETED|Overall Study||9
1722620|NCT00298740|4216488|P1|COMPLETED|Overall Study||3
1722621|NCT00298740|4216488|P1|STARTED|Overall Study||12
1722622|NCT00298610|4216492|P1|NOT COMPLETED|Overall Study||0
1722623|NCT00298610|4216492|P1|COMPLETED|Overall Study||30
1722624|NCT00298610|4216492|P1|STARTED|Overall Study||30
1722625|NCT00298558|4216506|P4|NOT COMPLETED|10th Annual (A10)||163
1722626|NCT00298558|4216507|P3|NOT COMPLETED|10th Annual (A10)||171
1722627|NCT00298558|4216508|P2|NOT COMPLETED|10th Annual (A10)||153
1722628|NCT00298558|4216509|P1|NOT COMPLETED|10th Annual (A10)||172
1722629|NCT00298558|4216506|P4|COMPLETED|10th Annual (A10)||285
1722630|NCT00298558|4216507|P3|COMPLETED|10th Annual (A10)||319
1722631|NCT00298558|4216508|P2|COMPLETED|10th Annual (A10)||316
1722632|NCT00298558|4216509|P1|COMPLETED|10th Annual (A10)||300
1722633|NCT00298558|4216506|P4|STARTED|10th Annual (A10)||448
1722634|NCT00298558|4216507|P3|STARTED|10th Annual (A10)||490
1722635|NCT00298558|4216508|P2|STARTED|10th Annual (A10)||469
1722636|NCT00298558|4216509|P1|STARTED|10th Annual (A10)||472
1722637|NCT00298558|4216506|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
1722638|NCT00298558|4216507|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
1722639|NCT00298558|4216508|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
1722640|NCT00298558|4216509|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
1722641|NCT00298558|4216506|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
1722642|NCT00298558|4216507|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
1722643|NCT00298558|4216508|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
1722644|NCT00298558|4216509|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
1722645|NCT00298558|4216506|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
1722646|NCT00298558|4216507|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
1722647|NCT00298558|4216508|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
1722648|NCT00298558|4216509|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
1722649|NCT00298558|4216506|P4|NOT COMPLETED|3rd Annual Booster||0
1722650|NCT00298558|4216507|P3|NOT COMPLETED|3rd Annual Booster||140
1722651|NCT00298558|4216508|P2|NOT COMPLETED|3rd Annual Booster||128
1722652|NCT00298558|4216509|P1|NOT COMPLETED|3rd Annual Booster||122
1722653|NCT00298558|4216506|P4|COMPLETED|3rd Annual Booster||0
1722654|NCT00298558|4216507|P3|COMPLETED|3rd Annual Booster||230
1722655|NCT00298558|4216508|P2|COMPLETED|3rd Annual Booster||243
1722656|NCT00298558|4216509|P1|COMPLETED|3rd Annual Booster||250
1722657|NCT00298558|4216506|P4|STARTED|3rd Annual Booster||0
1722658|NCT00298558|4216507|P3|STARTED|3rd Annual Booster||370
1722659|NCT00298558|4216508|P2|STARTED|3rd Annual Booster||371
1722660|NCT00298558|4216509|P1|STARTED|3rd Annual Booster||372
1722661|NCT00298558|4216506|P4|NOT COMPLETED|2nd Annual (A2)||32
1722662|NCT00298558|4216507|P3|NOT COMPLETED|2nd Annual (A2)||27
1722663|NCT00298558|4216508|P2|NOT COMPLETED|2nd Annual (A2)||11
1722664|NCT00298558|4216509|P1|NOT COMPLETED|2nd Annual (A2)||22
1722665|NCT00298558|4216506|P4|COMPLETED|2nd Annual (A2)||552
1722666|NCT00298558|4216507|P3|COMPLETED|2nd Annual (A2)||574
1722667|NCT00298558|4216508|P2|COMPLETED|2nd Annual (A2)||555
1722668|NCT00298558|4216509|P1|COMPLETED|2nd Annual (A2)||563
1722669|NCT00298558|4216506|P4|STARTED|2nd Annual (A2)||584
1722670|NCT00298558|4216507|P3|STARTED|2nd Annual (A2)||601
1722671|NCT00298558|4216508|P2|STARTED|2nd Annual (A2)||566
1722672|NCT00298558|4216509|P1|STARTED|2nd Annual (A2)||585
1722673|NCT00298558|4216506|P4|NOT COMPLETED|1st Annual (A1)||55
1722674|NCT00298558|4216507|P3|NOT COMPLETED|1st Annual (A1)||52
1722675|NCT00298558|4216508|P2|NOT COMPLETED|1st Annual (A1)||63
1722676|NCT00298558|4216509|P1|NOT COMPLETED|1st Annual (A1)||55
1722677|NCT00298558|4216506|P4|COMPLETED|1st Annual (A1)||584
1722678|NCT00298558|4216507|P3|COMPLETED|1st Annual (A1)||601
1722679|NCT00298558|4216508|P2|COMPLETED|1st Annual (A1)||566
1722680|NCT00298558|4216509|P1|COMPLETED|1st Annual (A1)||585
1722681|NCT00298558|4216506|P4|STARTED|1st Annual (A1)||639
1722682|NCT00298558|4216507|P3|STARTED|1st Annual (A1)||653
1722683|NCT00298558|4216508|P2|STARTED|1st Annual (A1)||629
1722684|NCT00298558|4216509|P1|STARTED|1st Annual (A1)||640
1722685|NCT00298558|4216506|P4|NOT COMPLETED|Booster||0
1722686|NCT00298558|4216507|P3|NOT COMPLETED|Booster||75
1722687|NCT00298558|4216508|P2|NOT COMPLETED|Booster||70
1722688|NCT00298558|4216509|P1|NOT COMPLETED|Booster||89
1722689|NCT00298558|4216506|P4|COMPLETED|Booster||0
1722690|NCT00298558|4216507|P3|COMPLETED|Booster||295
1722691|NCT00298558|4216508|P2|COMPLETED|Booster||301
1722692|NCT00298558|4216509|P1|COMPLETED|Booster||283
1722693|NCT00298558|4216506|P4|STARTED|Booster||0
1722694|NCT00298558|4216507|P3|STARTED|Booster||370
1722695|NCT00298558|4216508|P2|STARTED|Booster||371
1722696|NCT00298558|4216509|P1|STARTED|Booster||372
1722697|NCT00298558|4216506|P4|NOT COMPLETED|Immediate Post Test||65
1722698|NCT00298558|4216507|P3|NOT COMPLETED|Immediate Post Test||59
1722699|NCT00298558|4216508|P2|NOT COMPLETED|Immediate Post Test||76
1722700|NCT00298558|4216509|P1|NOT COMPLETED|Immediate Post Test||71
1722701|NCT00298558|4216506|P4|COMPLETED|Immediate Post Test||639
1722702|NCT00298558|4216507|P3|COMPLETED|Immediate Post Test||653
1722703|NCT00298558|4216508|P2|COMPLETED|Immediate Post Test||629
1722704|NCT00298558|4216509|P1|COMPLETED|Immediate Post Test||640
1722705|NCT00298558|4216506|P4|STARTED|Immediate Post Test||704
1722706|NCT00298558|4216507|P3|STARTED|Immediate Post Test||712
1722707|NCT00298558|4216508|P2|STARTED|Immediate Post Test||705
1722708|NCT00298558|4216509|P1|STARTED|Immediate Post Test||711
1722709|NCT00298558|4216506|P4|NOT COMPLETED|Intervention||419
1722710|NCT00298558|4216507|P3|NOT COMPLETED|Intervention||75
1722711|NCT00298558|4216508|P2|NOT COMPLETED|Intervention||78
1722712|NCT00298558|4216509|P1|NOT COMPLETED|Intervention||91
1722713|NCT00298558|4216506|P4|COMPLETED|Intervention||285
1722714|NCT00298558|4216507|P3|COMPLETED|Intervention||637
1722715|NCT00298558|4216508|P2|COMPLETED|Intervention||627
1722716|NCT00298558|4216509|P1|COMPLETED|Intervention||620
1722717|NCT00298558|4216506|P4|STARTED|Intervention||704
1722718|NCT00298558|4216507|P3|STARTED|Intervention||712
1722719|NCT00298558|4216508|P2|STARTED|Intervention||705
1722720|NCT00298558|4216509|P1|STARTED|Intervention||711
1722721|NCT00298558|4216506|P4|NOT COMPLETED|Baseline||0
1722722|NCT00298558|4216507|P3|NOT COMPLETED|Baseline||0
1722723|NCT00298558|4216508|P2|NOT COMPLETED|Baseline||0
1722724|NCT00298558|4216509|P1|NOT COMPLETED|Baseline||0
1722725|NCT00298558|4216506|P4|COMPLETED|Baseline||704
1722726|NCT00298558|4216507|P3|COMPLETED|Baseline||712
1722727|NCT00298558|4216508|P2|COMPLETED|Baseline||705
1722728|NCT00298558|4216509|P1|COMPLETED|Baseline||711
1722729|NCT00298558|4216506|P4|STARTED|Baseline||704
1722730|NCT00298558|4216507|P3|STARTED|Baseline||712
1722731|NCT00298558|4216508|P2|STARTED|Baseline||705
1722732|NCT00298558|4216509|P1|STARTED|Baseline||711
1722733|NCT00298363|4216542|P3|NOT COMPLETED|Overall Study||6
1722734|NCT00298363|4216543|P2|NOT COMPLETED|Overall Study||8
1722735|NCT00298363|4216544|P1|NOT COMPLETED|Overall Study||17
1722736|NCT00298363|4216542|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
1722737|NCT00298363|4216543|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
1722738|NCT00298363|4216544|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
1722739|NCT00298363|4216542|P3|STARTED|Overall Study||22
1722740|NCT00298363|4216543|P2|STARTED|Overall Study||45
1722741|NCT00298363|4216544|P1|STARTED|Overall Study||45
1722742|NCT00298272|4216702|P2|NOT COMPLETED|Safety Follow-up Phase||4
1722743|NCT00298272|4216703|P1|NOT COMPLETED|Safety Follow-up Phase||4
1722744|NCT00298272|4216702|P2|COMPLETED|Safety Follow-up Phase||13
1722745|NCT00298272|4216703|P1|COMPLETED|Safety Follow-up Phase||18
1722746|NCT00298272|4216702|P2|STARTED|Safety Follow-up Phase||17
1722747|NCT00298272|4216703|P1|STARTED|Safety Follow-up Phase||22
1722748|NCT00298272|4216702|P2|NOT COMPLETED|Open Label Retreatment Phase||4
1722749|NCT00298272|4216703|P1|NOT COMPLETED|Open Label Retreatment Phase||9
1722750|NCT00298272|4216702|P2|COMPLETED|Open Label Retreatment Phase||12
1722751|NCT00298272|4216703|P1|COMPLETED|Open Label Retreatment Phase||13
1722752|NCT00298272|4216702|P2|Completed to Week 56|Open Label Retreatment Phase||12
1722753|NCT00298272|4216703|P1|Completed to Week 56|Open Label Retreatment Phase||13
1722754|NCT00298272|4216702|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
1722755|NCT00298272|4216703|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
1722756|NCT00298272|4216702|P2|STARTED|Open Label Retreatment Phase||16
1722757|NCT00298272|4216703|P1|STARTED|Open Label Retreatment Phase||22
1722758|NCT00298272|4216702|P2|NOT COMPLETED|Double-blind Phase||0
1722759|NCT00298272|4216703|P1|NOT COMPLETED|Double-blind Phase||8
1722760|NCT00298272|4216702|P2|COMPLETED|Double-blind Phase||18
1722761|NCT00298272|4216703|P1|COMPLETED|Double-blind Phase||28
1722762|NCT00298272|4216702|P2|Completed to Week 56|Double-blind Phase||3
1722763|NCT00298272|4216703|P1|Completed to Week 56|Double-blind Phase||8
1722764|NCT00298272|4216702|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
1722765|NCT00298272|4216703|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
1722766|NCT00298272|4216702|P2|Safety Population|Double-blind Phase||18
1722767|NCT00298272|4216703|P1|Safety Population|Double-blind Phase|received treatment|33
1722768|NCT00298272|4216702|P2|STARTED|Double-blind Phase||18
1722769|NCT00298272|4216703|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
1722770|NCT00298233|4216726|P4|NOT COMPLETED|Overall Study||0
1722771|NCT00298233|4216727|P3|NOT COMPLETED|Overall Study||0
1722772|NCT00298233|4216728|P2|NOT COMPLETED|Overall Study||0
1722773|NCT00298233|4216729|P1|NOT COMPLETED|Overall Study||0
1722774|NCT00298233|4216726|P4|COMPLETED|Overall Study||124
1722775|NCT00298233|4216727|P3|COMPLETED|Overall Study||122
1722776|NCT00298233|4216728|P2|COMPLETED|Overall Study||41
1722777|NCT00298233|4216729|P1|COMPLETED|Overall Study||39
1722778|NCT00298233|4216726|P4|STARTED|Overall Study||124
1722779|NCT00298233|4216727|P3|STARTED|Overall Study||122
1722780|NCT00298233|4216728|P2|STARTED|Overall Study||41
1722781|NCT00298233|4216729|P1|STARTED|Overall Study||39
1722782|NCT00298155|4216748|P3|NOT COMPLETED|Overall Study||0
1722783|NCT00298155|4216749|P2|NOT COMPLETED|Overall Study||0
1722784|NCT00298155|4216750|P1|NOT COMPLETED|Overall Study||0
1722785|NCT00298155|4216748|P3|COMPLETED|Overall Study||13
1722786|NCT00298155|4216749|P2|COMPLETED|Overall Study||10
1722787|NCT00298155|4216750|P1|COMPLETED|Overall Study||12
1722788|NCT00298155|4216748|P3|STARTED|Overall Study||13
1722789|NCT00298155|4216749|P2|STARTED|Overall Study||10
1722790|NCT00298155|4216750|P1|STARTED|Overall Study||12
1722791|NCT00298090|4216761|P1|NOT COMPLETED|Overall Study||18
1722792|NCT00298090|4216761|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
1722793|NCT00298090|4216761|P1|STARTED|Overall Study||47
1722794|NCT00297830|4216768|P3|NOT COMPLETED|12 Month Visit||0
1722795|NCT00297830|4216769|P2|NOT COMPLETED|12 Month Visit||6
1722796|NCT00297830|4216770|P1|NOT COMPLETED|12 Month Visit||1
1722797|NCT00297830|4216768|P3|COMPLETED|12 Month Visit||24
1722798|NCT00297830|4216769|P2|COMPLETED|12 Month Visit||35
1722799|NCT00297830|4216770|P1|COMPLETED|12 Month Visit||37
1722800|NCT00297830|4216768|P3|STARTED|12 Month Visit||24
1722801|NCT00297830|4216769|P2|STARTED|12 Month Visit||41
1722802|NCT00297830|4216770|P1|STARTED|12 Month Visit||38
1722803|NCT00297830|4216768|P3|NOT COMPLETED|6 Month Visit||3
1722804|NCT00297830|4216769|P2|NOT COMPLETED|6 Month Visit||2
1722805|NCT00297830|4216770|P1|NOT COMPLETED|6 Month Visit||3
1722806|NCT00297830|4216768|P3|COMPLETED|6 Month Visit||24
1722807|NCT00297830|4216769|P2|COMPLETED|6 Month Visit||41
1722808|NCT00297830|4216770|P1|COMPLETED|6 Month Visit||38
1722809|NCT00297830|4216768|P3|STARTED|6 Month Visit||27
1722810|NCT00297830|4216769|P2|STARTED|6 Month Visit||43
1722811|NCT00297830|4216770|P1|STARTED|6 Month Visit||41
1722812|NCT00297830|4216768|P3|NOT COMPLETED|Baseline||0
1722813|NCT00297830|4216769|P2|NOT COMPLETED|Baseline||0
1722814|NCT00297830|4216770|P1|NOT COMPLETED|Baseline||0
1722815|NCT00297830|4216768|P3|COMPLETED|Baseline||27
1722816|NCT00297830|4216769|P2|COMPLETED|Baseline||43
1722817|NCT00297830|4216770|P1|COMPLETED|Baseline||41
1722818|NCT00297830|4216768|P3|STARTED|Baseline||27
1722819|NCT00297830|4216769|P2|STARTED|Baseline||43
1722820|NCT00297830|4216770|P1|STARTED|Baseline||41
1722821|NCT00297778|4216789|P2|NOT COMPLETED|Overall Study||20
1722822|NCT00297778|4216790|P1|NOT COMPLETED|Overall Study||19
1722823|NCT00297778|4216789|P2|COMPLETED|Overall Study||124
1722824|NCT00297778|4216790|P1|COMPLETED|Overall Study||133
1722825|NCT00297778|4216789|P2|STARTED|Overall Study||144
1722826|NCT00297778|4216790|P1|STARTED|Overall Study||152
1722827|NCT00297648|4216824|P1|NOT COMPLETED|Overall Study||36
1722828|NCT00297648|4216824|P1|COMPLETED|Overall Study||53
1722829|NCT00297648|4216824|P1|STARTED|Overall Study||89
1722830|NCT00297596|4216863|P1|NOT COMPLETED|Overall Study||0
1722831|NCT00297596|4216863|P1|COMPLETED|Overall Study||25
1722832|NCT00297596|4216863|P1|STARTED|Overall Study||25
1722833|NCT00297492|4216870|P3|NOT COMPLETED|6 Month Follow-up||27
1722834|NCT00297492|4216871|P2|NOT COMPLETED|6 Month Follow-up||49
1722835|NCT00297492|4216872|P1|NOT COMPLETED|6 Month Follow-up||63
1722836|NCT00297492|4216870|P3|COMPLETED|6 Month Follow-up||118
1722837|NCT00297492|4216871|P2|COMPLETED|6 Month Follow-up||237
1722838|NCT00297492|4216872|P1|COMPLETED|6 Month Follow-up||227
1722839|NCT00297492|4216870|P3|STARTED|6 Month Follow-up||145
1722840|NCT00297492|4216871|P2|STARTED|6 Month Follow-up||286
1722841|NCT00297492|4216872|P1|STARTED|6 Month Follow-up||290
1722842|NCT00297492|4216870|P3|NOT COMPLETED|Set Quit Date||5
1722843|NCT00297492|4216871|P2|NOT COMPLETED|Set Quit Date||13
1722844|NCT00297492|4216872|P1|NOT COMPLETED|Set Quit Date||7
1722845|NCT00297492|4216870|P3|COMPLETED|Set Quit Date||145
1722846|NCT00297492|4216871|P2|COMPLETED|Set Quit Date||286
1722847|NCT00297492|4216872|P1|COMPLETED|Set Quit Date||290
1722848|NCT00297492|4216870|P3|STARTED|Set Quit Date||150
1722849|NCT00297492|4216871|P2|STARTED|Set Quit Date||299
1722850|NCT00297492|4216872|P1|STARTED|Set Quit Date||297
1722851|NCT00297427|4216882|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
1722852|NCT00297427|4216883|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
1722853|NCT00297427|4216882|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
1722854|NCT00297427|4216883|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
1722855|NCT00297427|4216882|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
1722856|NCT00297427|4216883|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
1722857|NCT00297427|4216882|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
1722858|NCT00297427|4216883|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
1722859|NCT00297427|4216882|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
1722860|NCT00297427|4216883|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
1722861|NCT00297427|4216882|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
1722862|NCT00297427|4216883|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
1722863|NCT00297427|4216882|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
1722864|NCT00297427|4216883|P1|STARTED|Phase 2: Optional Crossover for Sham||54
1722865|NCT00297427|4216882|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
1722866|NCT00297427|4216883|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
1722867|NCT00297427|4216882|P2|COMPLETED|Phase 1: Initial Intervention||54
1722868|NCT00297427|4216883|P1|COMPLETED|Phase 1: Initial Intervention||56
1722869|NCT00297427|4216882|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
1722870|NCT00297427|4216883|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
1722871|NCT00297258|4216924|P1|NOT COMPLETED|Overall Study||142
1722872|NCT00297258|4216924|P1|COMPLETED|Overall Study||0
1722873|NCT00297258|4216924|P1|STARTED|Overall Study||142
1722874|NCT00297232|4216943|P1|NOT COMPLETED|Overall Study||605
1722875|NCT00297232|4216943|P1|COMPLETED|Overall Study||489
1722876|NCT00297232|4216943|P1|STARTED|Overall Study||1094
1722877|NCT00297167|4216949|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
1722878|NCT00297167|4216950|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
1722879|NCT00297167|4216951|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
1722880|NCT00297167|4216949|P3|COMPLETED|Open-label Dose Normalization Period 2||31
1722881|NCT00297167|4216950|P2|COMPLETED|Open-label Dose Normalization Period 2||0
1722882|NCT00297167|4216951|P1|COMPLETED|Open-label Dose Normalization Period 2||0
1722883|NCT00297167|4216949|P3|STARTED|Open-label Dose Normalization Period 2||31
1722884|NCT00297167|4216950|P2|STARTED|Open-label Dose Normalization Period 2||0
1722885|NCT00297167|4216951|P1|STARTED|Open-label Dose Normalization Period 2||0
1722886|NCT00297167|4216949|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
1722887|NCT00297167|4216950|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
1722888|NCT00297167|4216951|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
1722889|NCT00297167|4216949|P3|COMPLETED|Second Double-blind Intervention Period||0
1722890|NCT00297167|4216950|P2|COMPLETED|Second Double-blind Intervention Period||15
1722891|NCT00297167|4216951|P1|COMPLETED|Second Double-blind Intervention Period||16
1722892|NCT00297167|4216949|P3|STARTED|Second Double-blind Intervention Period||0
1722893|NCT00297167|4216950|P2|STARTED|Second Double-blind Intervention Period||15
1722894|NCT00297167|4216951|P1|STARTED|Second Double-blind Intervention Period||17
1722895|NCT00297167|4216949|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
1722896|NCT00297167|4216950|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
1722897|NCT00297167|4216951|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
1722898|NCT00297167|4216949|P3|COMPLETED|Open-label Dose Normalization Period 1||32
1722899|NCT00297167|4216950|P2|COMPLETED|Open-label Dose Normalization Period 1||0
1722900|NCT00297167|4216951|P1|COMPLETED|Open-label Dose Normalization Period 1||0
1722901|NCT00297167|4216949|P3|STARTED|Open-label Dose Normalization Period 1||33
1722902|NCT00297167|4216950|P2|STARTED|Open-label Dose Normalization Period 1||0
1722903|NCT00297167|4216951|P1|STARTED|Open-label Dose Normalization Period 1||0
1722904|NCT00297167|4216949|P3|NOT COMPLETED|First Double-blind Intervention Period||0
1722905|NCT00297167|4216950|P2|NOT COMPLETED|First Double-blind Intervention Period||0
1722906|NCT00297167|4216951|P1|NOT COMPLETED|First Double-blind Intervention Period||0
1722907|NCT00297167|4216949|P3|COMPLETED|First Double-blind Intervention Period||0
1722908|NCT00297167|4216950|P2|COMPLETED|First Double-blind Intervention Period||16
1722909|NCT00297167|4216951|P1|COMPLETED|First Double-blind Intervention Period||17
1722910|NCT00297167|4216949|P3|STARTED|First Double-blind Intervention Period||0
1722911|NCT00297167|4216950|P2|STARTED|First Double-blind Intervention Period||16
1722912|NCT00297167|4216951|P1|STARTED|First Double-blind Intervention Period||17
1722913|NCT00297115|4216977|P2|NOT COMPLETED|Overall Study||246
1722914|NCT00297115|4216978|P1|NOT COMPLETED|Overall Study||245
1722915|NCT00297115|4216977|P2|COMPLETED|Overall Study||550
1722916|NCT00297115|4216978|P1|COMPLETED|Overall Study||527
1722917|NCT00297115|4216977|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
1722918|NCT00297115|4216978|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
1722919|NCT00297102|4216996|P2|NOT COMPLETED|Overall Study||233
1722920|NCT00297102|4216997|P1|NOT COMPLETED|Overall Study||263
1722921|NCT00297102|4216996|P2|COMPLETED|Overall Study||525
1722922|NCT00297102|4216997|P1|COMPLETED|Overall Study||502
1722923|NCT00297102|4216996|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
1722924|NCT00297102|4216997|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
1722925|NCT00297037|4217015|P2|NOT COMPLETED|Overall Study||0
1722926|NCT00297037|4217016|P1|NOT COMPLETED|Overall Study||2
1722927|NCT00297037|4217015|P2|COMPLETED|Overall Study||11
1722928|NCT00297037|4217016|P1|COMPLETED|Overall Study||8
1722929|NCT00297037|4217015|P2|STARTED|Overall Study||11
1722930|NCT00297037|4217016|P1|STARTED|Overall Study||10
1722931|NCT00296816|4217028|P1|NOT COMPLETED|Overall Study||74
1722932|NCT00296816|4217028|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
1722933|NCT00296816|4217028|P1|STARTED|Overall Study||132
1722934|NCT00296647|4217045|P5|NOT COMPLETED|Overall Study||20
1722935|NCT00296647|4217046|P4|NOT COMPLETED|Overall Study||17
1722936|NCT00296647|4217047|P3|NOT COMPLETED|Overall Study||34
1722937|NCT00296647|4217048|P2|NOT COMPLETED|Overall Study||28
1722938|NCT00296647|4217049|P1|NOT COMPLETED|Overall Study||32
1722939|NCT00296647|4217045|P5|COMPLETED|Overall Study||248
1722940|NCT00296647|4217046|P4|COMPLETED|Overall Study||262
1722941|NCT00296647|4217047|P3|COMPLETED|Overall Study||222
1722942|NCT00296647|4217048|P2|COMPLETED|Overall Study||233
1722943|NCT00296647|4217049|P1|COMPLETED|Overall Study||250
1722944|NCT00296647|4217045|P5|STARTED|Overall Study||268
1722945|NCT00296647|4217046|P4|STARTED|Overall Study||279
1722946|NCT00296647|4217047|P3|STARTED|Overall Study||256
1722947|NCT00296647|4217048|P2|STARTED|Overall Study||261
1722948|NCT00296647|4217049|P1|STARTED|Overall Study||282
1722949|NCT00296517|4217063|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
1722950|NCT00296517|4217064|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
1722951|NCT00296517|4217063|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
1722952|NCT00296517|4217064|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
1722953|NCT00296517|4217063|P2|STARTED|Dose Level 3 - Weeks 3-12||161
1722954|NCT00296517|4217064|P1|STARTED|Dose Level 3 - Weeks 3-12||157
1722955|NCT00296517|4217063|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
1722956|NCT00296517|4217064|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
1722957|NCT00296517|4217063|P2|COMPLETED|Dose Level 2 - Week 2||161
1722958|NCT00296517|4217064|P1|COMPLETED|Dose Level 2 - Week 2||157
1722959|NCT00296517|4217063|P2|STARTED|Dose Level 2 - Week 2||166
1722960|NCT00296517|4217064|P1|STARTED|Dose Level 2 - Week 2||159
1722961|NCT00296517|4217063|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
1722962|NCT00296517|4217064|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
1722963|NCT00296517|4217063|P2|COMPLETED|Dose Level 1 - Week 1||166
1722964|NCT00296517|4217064|P1|COMPLETED|Dose Level 1 - Week 1||159
1722965|NCT00296517|4217063|P2|STARTED|Dose Level 1 - Week 1||166
1722966|NCT00296517|4217064|P1|STARTED|Dose Level 1 - Week 1||159
1722967|NCT00296504|4217100|P9|NOT COMPLETED|Final Analysis||21
1722968|NCT00296504|4217101|P8|NOT COMPLETED|Final Analysis||0
1722969|NCT00296504|4217102|P7|NOT COMPLETED|Final Analysis||0
1722970|NCT00296504|4217103|P6|NOT COMPLETED|Final Analysis||0
1722971|NCT00296504|4217104|P5|NOT COMPLETED|Final Analysis||0
1722972|NCT00296504|4217105|P4|NOT COMPLETED|Final Analysis||0
1722973|NCT00296504|4217106|P3|NOT COMPLETED|Final Analysis||0
1722974|NCT00296504|4217107|P2|NOT COMPLETED|Final Analysis||0
1722975|NCT00296504|4217108|P1|NOT COMPLETED|Final Analysis||0
1722976|NCT00296504|4217100|P9|COMPLETED|Final Analysis||90
1722977|NCT00296504|4217101|P8|COMPLETED|Final Analysis||0
1722978|NCT00296504|4217102|P7|COMPLETED|Final Analysis||0
1722979|NCT00296504|4217103|P6|COMPLETED|Final Analysis||0
1722980|NCT00296504|4217104|P5|COMPLETED|Final Analysis||0
1722981|NCT00296504|4217105|P4|COMPLETED|Final Analysis||0
1722982|NCT00296504|4217106|P3|COMPLETED|Final Analysis||0
1722983|NCT00296504|4217107|P2|COMPLETED|Final Analysis||0
1722984|NCT00296504|4217108|P1|COMPLETED|Final Analysis||0
1722985|NCT00296504|4217100|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
1722986|NCT00296504|4217101|P8|STARTED|Final Analysis||0
1722987|NCT00296504|4217102|P7|STARTED|Final Analysis||0
1722988|NCT00296504|4217103|P6|STARTED|Final Analysis||0
1722989|NCT00296504|4217104|P5|STARTED|Final Analysis||0
1722990|NCT00296504|4217105|P4|STARTED|Final Analysis||0
1722991|NCT00296504|4217106|P3|STARTED|Final Analysis||0
1722992|NCT00296504|4217107|P2|STARTED|Final Analysis||0
1722993|NCT00296504|4217108|P1|STARTED|Final Analysis||0
1722994|NCT00296504|4217100|P9|NOT COMPLETED|Interim Analysis||0
1722995|NCT00296504|4217101|P8|NOT COMPLETED|Interim Analysis||49
1722996|NCT00296504|4217102|P7|NOT COMPLETED|Interim Analysis||74
1722997|NCT00296504|4217103|P6|NOT COMPLETED|Interim Analysis||37
1722998|NCT00296504|4217104|P5|NOT COMPLETED|Interim Analysis||37
1722999|NCT00296504|4217105|P4|NOT COMPLETED|Interim Analysis||43
1723000|NCT00296504|4217106|P3|NOT COMPLETED|Interim Analysis||105
1723001|NCT00296504|4217107|P2|NOT COMPLETED|Interim Analysis||18
1723002|NCT00296504|4217108|P1|NOT COMPLETED|Interim Analysis||76
1723003|NCT00296504|4217100|P9|COMPLETED|Interim Analysis||0
1723004|NCT00296504|4217101|P8|COMPLETED|Interim Analysis||37
1723005|NCT00296504|4217102|P7|COMPLETED|Interim Analysis||30
1723006|NCT00296504|4217103|P6|COMPLETED|Interim Analysis||41
1723007|NCT00296504|4217104|P5|COMPLETED|Interim Analysis||36
1723008|NCT00296504|4217105|P4|COMPLETED|Interim Analysis||11
1723009|NCT00296504|4217106|P3|COMPLETED|Interim Analysis||116
1723010|NCT00296504|4217107|P2|COMPLETED|Interim Analysis||0
1723011|NCT00296504|4217108|P1|COMPLETED|Interim Analysis||43
1723012|NCT00296504|4217100|P9|Ongoing|Interim Analysis||0
1723013|NCT00296504|4217101|P8|Ongoing|Interim Analysis||1
1723014|NCT00296504|4217102|P7|Ongoing|Interim Analysis||30
1723015|NCT00296504|4217103|P6|Ongoing|Interim Analysis||0
1723016|NCT00296504|4217104|P5|Ongoing|Interim Analysis||0
1723017|NCT00296504|4217105|P4|Ongoing|Interim Analysis||22
1723018|NCT00296504|4217106|P3|Ongoing|Interim Analysis||16
1723019|NCT00296504|4217107|P2|Ongoing|Interim Analysis||12
1723020|NCT00296504|4217108|P1|Ongoing|Interim Analysis||32
1723021|NCT00296504|4217100|P9|STARTED|Interim Analysis||0
1723022|NCT00296504|4217101|P8|STARTED|Interim Analysis||86
1723023|NCT00296504|4217102|P7|STARTED|Interim Analysis||104
1723024|NCT00296504|4217103|P6|STARTED|Interim Analysis||78
1723025|NCT00296504|4217104|P5|STARTED|Interim Analysis||73
1723026|NCT00296504|4217105|P4|STARTED|Interim Analysis||54
1723027|NCT00296504|4217106|P3|STARTED|Interim Analysis||221
1723028|NCT00296504|4217107|P2|STARTED|Interim Analysis||18
1723029|NCT00296504|4217108|P1|STARTED|Interim Analysis||119
1723030|NCT00296491|4217201|P4|NOT COMPLETED|Overall Study||43
1723031|NCT00296491|4217202|P3|NOT COMPLETED|Overall Study||43
1723032|NCT00296491|4217203|P2|NOT COMPLETED|Overall Study||53
1723033|NCT00296491|4217204|P1|NOT COMPLETED|Overall Study||42
1723034|NCT00296491|4217201|P4|COMPLETED|Overall Study||138
1723035|NCT00296491|4217202|P3|COMPLETED|Overall Study||137
1723036|NCT00296491|4217203|P2|COMPLETED|Overall Study||129
1723037|NCT00296491|4217204|P1|COMPLETED|Overall Study||140
1723038|NCT00296491|4217201|P4|STARTED|Overall Study||181
1723039|NCT00296491|4217202|P3|STARTED|Overall Study||180
1723040|NCT00296491|4217203|P2|STARTED|Overall Study||182
1723041|NCT00296491|4217204|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
1723042|NCT00296400|4217233|P3|NOT COMPLETED|Overall Study||13
1723043|NCT00296400|4217234|P2|NOT COMPLETED|Overall Study||18
1723044|NCT00296400|4217235|P1|NOT COMPLETED|Overall Study||17
1723045|NCT00296400|4217233|P3|COMPLETED|Overall Study||67
1723046|NCT00296400|4217234|P2|COMPLETED|Overall Study||69
1723047|NCT00296400|4217235|P1|COMPLETED|Overall Study||53
1723048|NCT00296400|4217233|P3|STARTED|Overall Study||80
1723049|NCT00296400|4217234|P2|STARTED|Overall Study||87
1723050|NCT00296400|4217235|P1|STARTED|Overall Study||70
1723051|NCT00296374|4217459|P3|NOT COMPLETED|Overall Study||29
1723052|NCT00296374|4217460|P2|NOT COMPLETED|Overall Study||23
1723053|NCT00296374|4217461|P1|NOT COMPLETED|Overall Study||25
1723054|NCT00296374|4217459|P3|COMPLETED|Overall Study||82
1723055|NCT00296374|4217460|P2|COMPLETED|Overall Study||101
1723056|NCT00296374|4217461|P1|COMPLETED|Overall Study||93
1723057|NCT00296374|4217459|P3|STARTED|Overall Study||111
1723058|NCT00296374|4217460|P2|STARTED|Overall Study||124
1723059|NCT00296374|4217461|P1|STARTED|Overall Study||118
1723060|NCT00296335|4217684|P2|NOT COMPLETED|Overall Study||122
1723061|NCT00296335|4217685|P1|NOT COMPLETED|Overall Study||30
1723062|NCT00296335|4217684|P2|COMPLETED|Overall Study||309
1723063|NCT00296335|4217685|P1|COMPLETED|Overall Study||394
1723064|NCT00296335|4217684|P2|STARTED|Overall Study||431
1723065|NCT00296335|4217685|P1|STARTED|Overall Study||424
1723066|NCT00296322|4217697|P2|NOT COMPLETED|Overall Study||79
1723067|NCT00296322|4217698|P1|NOT COMPLETED|Overall Study||21
1723068|NCT00296322|4217697|P2|COMPLETED|Overall Study||184
1723069|NCT00296322|4217698|P1|COMPLETED|Overall Study||237
1723070|NCT00296322|4217697|P2|STARTED|Overall Study||263
1723071|NCT00296322|4217698|P1|STARTED|Overall Study||258
1723072|NCT00296296|4217710|P2|NOT COMPLETED|Overall Study||13
1723073|NCT00296296|4217711|P1|NOT COMPLETED|Overall Study||2
1723074|NCT00296296|4217710|P2|COMPLETED|Overall Study||5
1723075|NCT00296296|4217711|P1|COMPLETED|Overall Study||9
1723076|NCT00296296|4217710|P2|STARTED|Overall Study||18
1723077|NCT00296296|4217711|P1|STARTED|Overall Study||11
1723078|NCT00296244|4217725|P2|NOT COMPLETED|Overall Study||1
1723079|NCT00296244|4217726|P1|NOT COMPLETED|Overall Study||0
1723080|NCT00296244|4217725|P2|COMPLETED|Overall Study||19
1723081|NCT00296244|4217726|P1|COMPLETED|Overall Study||20
1723082|NCT00296244|4217725|P2|STARTED|Overall Study||20
1723083|NCT00296244|4217726|P1|STARTED|Overall Study||20
1723084|NCT00296231|4217742|P1|NOT COMPLETED|Overall Study||0
1723085|NCT00296231|4217742|P1|COMPLETED|Overall Study||14
1723086|NCT00296231|4217742|P1|STARTED|Overall Study||14
1723087|NCT00296192|4217752|P5|NOT COMPLETED|Overall Study||0
1723088|NCT00296192|4217753|P4|NOT COMPLETED|Overall Study||0
1723089|NCT00296192|4217754|P3|NOT COMPLETED|Overall Study||0
1723090|NCT00296192|4217755|P2|NOT COMPLETED|Overall Study||0
1723091|NCT00296192|4217756|P1|NOT COMPLETED|Overall Study||0
1723092|NCT00296192|4217752|P5|COMPLETED|Overall Study||16
1723093|NCT00296192|4217753|P4|COMPLETED|Overall Study||17
1723094|NCT00296192|4217754|P3|COMPLETED|Overall Study||16
1723095|NCT00296192|4217755|P2|COMPLETED|Overall Study||16
1723096|NCT00296192|4217756|P1|COMPLETED|Overall Study||17
1723097|NCT00296192|4217752|P5|STARTED|Overall Study||16
1723098|NCT00296192|4217753|P4|STARTED|Overall Study||17
1723099|NCT00296192|4217754|P3|STARTED|Overall Study||16
1723100|NCT00296192|4217755|P2|STARTED|Overall Study||16
1723101|NCT00296192|4217756|P1|STARTED|Overall Study||17
1723102|NCT00296140|4217790|P2|NOT COMPLETED|Overall Study||0
1723103|NCT00296140|4217791|P1|NOT COMPLETED|Overall Study||3
1723104|NCT00296140|4217790|P2|COMPLETED|Overall Study||33
1723105|NCT00296140|4217791|P1|COMPLETED|Overall Study||30
1723106|NCT00296140|4217790|P2|STARTED|Overall Study||33
1723107|NCT00296140|4217791|P1|STARTED|Overall Study||33
1723108|NCT00296036|4217803|P6|NOT COMPLETED|Overall Study||4
1723109|NCT00296036|4217804|P5|NOT COMPLETED|Overall Study||2
1723110|NCT00296036|4217805|P4|NOT COMPLETED|Overall Study||1
1723111|NCT00296036|4217806|P3|NOT COMPLETED|Overall Study||2
1723112|NCT00296036|4217807|P2|NOT COMPLETED|Overall Study||0
1723113|NCT00296036|4217808|P1|NOT COMPLETED|Overall Study||1
1723114|NCT00296036|4217803|P6|COMPLETED|Overall Study||28
1723115|NCT00296036|4217804|P5|COMPLETED|Overall Study||31
1723116|NCT00296036|4217805|P4|COMPLETED|Overall Study||16
1723117|NCT00296036|4217806|P3|COMPLETED|Overall Study||16
1723118|NCT00296036|4217807|P2|COMPLETED|Overall Study||18
1723119|NCT00296036|4217808|P1|COMPLETED|Overall Study||18
1723120|NCT00296036|4217803|P6|STARTED|Overall Study||32
1723121|NCT00296036|4217804|P5|STARTED|Overall Study||33
1723122|NCT00296036|4217805|P4|STARTED|Overall Study||17
1723123|NCT00296036|4217806|P3|STARTED|Overall Study||18
1723124|NCT00296036|4217807|P2|STARTED|Overall Study||18
1723125|NCT00296036|4217808|P1|STARTED|Overall Study||19
1723126|NCT00295932|4217845|P11|NOT COMPLETED|Overall Study||1
1723127|NCT00295932|4217846|P10|NOT COMPLETED|Overall Study||0
1723128|NCT00295932|4217847|P9|NOT COMPLETED|Overall Study||0
1723129|NCT00295932|4217848|P8|NOT COMPLETED|Overall Study||0
1723130|NCT00295932|4217849|P7|NOT COMPLETED|Overall Study||0
1723131|NCT00295932|4217850|P6|NOT COMPLETED|Overall Study||0
1723132|NCT00295932|4217851|P5|NOT COMPLETED|Overall Study||0
1723133|NCT00295932|4217852|P4|NOT COMPLETED|Overall Study||0
1723134|NCT00295932|4217853|P3|NOT COMPLETED|Overall Study||0
1723135|NCT00295932|4217854|P2|NOT COMPLETED|Overall Study||0
1723136|NCT00295932|4217855|P1|NOT COMPLETED|Overall Study||0
1723137|NCT00295932|4217845|P11|COMPLETED|Overall Study||12
1723138|NCT00295932|4217846|P10|COMPLETED|Overall Study||12
1723139|NCT00295932|4217847|P9|COMPLETED|Overall Study||10
1723140|NCT00295932|4217848|P8|COMPLETED|Overall Study||4
1723141|NCT00295932|4217849|P7|COMPLETED|Overall Study||3
1723142|NCT00295932|4217850|P6|COMPLETED|Overall Study||18
1723143|NCT00295932|4217851|P5|COMPLETED|Overall Study||2
1723144|NCT00295932|4217852|P4|COMPLETED|Overall Study||4
1723145|NCT00295932|4217853|P3|COMPLETED|Overall Study||3
1723146|NCT00295932|4217854|P2|COMPLETED|Overall Study||6
1723147|NCT00295932|4217855|P1|COMPLETED|Overall Study||4
1723148|NCT00295932|4217845|P11|STARTED|Overall Study||13
1723149|NCT00295932|4217846|P10|STARTED|Overall Study||12
1723150|NCT00295932|4217847|P9|STARTED|Overall Study||10
1723151|NCT00295932|4217848|P8|STARTED|Overall Study||4
1723152|NCT00295932|4217849|P7|STARTED|Overall Study||3
1723153|NCT00295932|4217850|P6|STARTED|Overall Study||18
1723154|NCT00295932|4217851|P5|STARTED|Overall Study||2
1723155|NCT00295932|4217852|P4|STARTED|Overall Study||4
1723156|NCT00295932|4217853|P3|STARTED|Overall Study||3
1723157|NCT00295932|4217854|P2|STARTED|Overall Study||6
1723158|NCT00295932|4217855|P1|STARTED|Overall Study||4
1723159|NCT00295880|4217889|P1|NOT COMPLETED|Overall Study||2
1723160|NCT00295880|4217889|P1|COMPLETED|Overall Study||10
1723161|NCT00295880|4217889|P1|STARTED|Overall Study||12
1723162|NCT00295854|4217903|P3|NOT COMPLETED|Overall Study||15
1723163|NCT00295854|4217904|P2|NOT COMPLETED|Overall Study||21
1723164|NCT00295854|4217905|P1|NOT COMPLETED|Overall Study||18
1723165|NCT00295854|4217903|P3|COMPLETED|Overall Study||87
1723166|NCT00295854|4217904|P2|COMPLETED|Overall Study||87
1723167|NCT00295854|4217905|P1|COMPLETED|Overall Study||77
1723168|NCT00295854|4217903|P3|ITT Population (N=296)|Overall Study||99
1723169|NCT00295854|4217904|P2|ITT Population (N=296)|Overall Study||105
1723170|NCT00295854|4217905|P1|ITT Population (N=296)|Overall Study||92
1723171|NCT00295854|4217903|P3|Safety Population (N=304)|Overall Study||101
1723172|NCT00295854|4217904|P2|Safety Population (N=304)|Overall Study||108
1723173|NCT00295854|4217905|P1|Safety Population (N=304)|Overall Study||95
1723174|NCT00295854|4217903|P3|STARTED|Overall Study||102
1723175|NCT00295854|4217904|P2|STARTED|Overall Study||108
1723176|NCT00295854|4217905|P1|STARTED|Overall Study||95
1723177|NCT00295750|4217919|P3|NOT COMPLETED|Overall Study||32
1723178|NCT00295750|4217920|P2|NOT COMPLETED|Overall Study||41
1723179|NCT00295750|4217921|P1|NOT COMPLETED|Overall Study||43
1723180|NCT00295750|4217919|P3|COMPLETED|Overall Study||172
1723181|NCT00295750|4217920|P2|COMPLETED|Overall Study||169
1723182|NCT00295750|4217921|P1|COMPLETED|Overall Study||163
1723183|NCT00295750|4217919|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
1723184|NCT00295750|4217920|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
1723185|NCT00295750|4217921|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
1723186|NCT00295750|4217919|P3|STARTED|Overall Study|randomized|204
1723187|NCT00295750|4217920|P2|STARTED|Overall Study|randomized|210
1723188|NCT00295750|4217921|P1|STARTED|Overall Study|randomized|206
1723189|NCT00295633|4217956|P3|NOT COMPLETED|Overall Study||76
1723190|NCT00295633|4217957|P2|NOT COMPLETED|Overall Study||67
1723191|NCT00295633|4217958|P1|NOT COMPLETED|Overall Study||62
1723192|NCT00295633|4217956|P3|COMPLETED|Overall Study||108
1723193|NCT00295633|4217957|P2|COMPLETED|Overall Study||119
1723194|NCT00295633|4217958|P1|COMPLETED|Overall Study||133
1723195|NCT00295633|4217956|P3|Completed Study Without Being Rescued|Overall Study||51
1723196|NCT00295633|4217957|P2|Completed Study Without Being Rescued|Overall Study||82
1723197|NCT00295633|4217958|P1|Completed Study Without Being Rescued|Overall Study||88
1723198|NCT00295633|4217956|P3|STARTED|Overall Study||184
1723199|NCT00295633|4217957|P2|STARTED|Overall Study||186
1723200|NCT00295633|4217958|P1|STARTED|Overall Study||195
1723201|NCT00295503|4217975|P1|NOT COMPLETED|Overall Study||0
1723202|NCT00295503|4217975|P1|COMPLETED|Overall Study||53
1723203|NCT00295503|4217975|P1|STARTED|Overall Study||53
1723204|NCT00295490|4217985|P4|NOT COMPLETED|Overall Study||5
1723205|NCT00295490|4217986|P3|NOT COMPLETED|Overall Study||4
1723206|NCT00295490|4217987|P2|NOT COMPLETED|Overall Study||4
1723207|NCT00295490|4217988|P1|NOT COMPLETED|Overall Study||1
1723208|NCT00295490|4217985|P4|COMPLETED|Overall Study||12
1723209|NCT00295490|4217986|P3|COMPLETED|Overall Study||12
1723210|NCT00295490|4217987|P2|COMPLETED|Overall Study||15
1723211|NCT00295490|4217988|P1|COMPLETED|Overall Study||14
1723212|NCT00295490|4217985|P4|STARTED|Overall Study||17
1723213|NCT00295490|4217986|P3|STARTED|Overall Study||16
1723214|NCT00295490|4217987|P2|STARTED|Overall Study||19
1723215|NCT00295490|4217988|P1|STARTED|Overall Study||15
1723216|NCT00295061|4218028|P2|NOT COMPLETED|Overall Study||0
1723217|NCT00295061|4218029|P1|NOT COMPLETED|Overall Study||0
1723218|NCT00295061|4218028|P2|COMPLETED|Overall Study||12
1723219|NCT00295061|4218029|P1|COMPLETED|Overall Study||12
1723220|NCT00295061|4218028|P2|STARTED|Overall Study||12
1723221|NCT00295061|4218029|P1|STARTED|Overall Study||12
1723222|NCT00295022|4218038|P3|NOT COMPLETED|Overall Study||5
1723223|NCT00295022|4218039|P2|NOT COMPLETED|Overall Study||1
1723224|NCT00295022|4218040|P1|NOT COMPLETED|Overall Study||1
1723225|NCT00295022|4218038|P3|COMPLETED|Overall Study||151
1723226|NCT00295022|4218039|P2|COMPLETED|Overall Study||156
1723227|NCT00295022|4218040|P1|COMPLETED|Overall Study||104
1723228|NCT00295022|4218038|P3|STARTED|Overall Study||156
1723229|NCT00295022|4218039|P2|STARTED|Overall Study||157
1723230|NCT00295022|4218040|P1|STARTED|Overall Study||105
1723231|NCT00295009|4218129|P6|NOT COMPLETED|Overall Study||269
1723232|NCT00295009|4218130|P5|NOT COMPLETED|Overall Study||58
1723233|NCT00295009|4218131|P4|NOT COMPLETED|Overall Study||25
1723234|NCT00295009|4218132|P3|NOT COMPLETED|Overall Study||12
1723235|NCT00295009|4218133|P2|NOT COMPLETED|Overall Study||49
1723236|NCT00295009|4218134|P1|NOT COMPLETED|Overall Study||41
1723237|NCT00295009|4218129|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
1723238|NCT00295009|4218130|P5|COMPLETED|Overall Study|Completed 60 month visit|116
1723239|NCT00295009|4218131|P4|COMPLETED|Overall Study|Completed 60 month visit|57
1723240|NCT00295009|4218132|P3|COMPLETED|Overall Study|Completed 60 month visit|39
1723241|NCT00295009|4218133|P2|COMPLETED|Overall Study|Completed 60 month visit|134
1723242|NCT00295009|4218134|P1|COMPLETED|Overall Study|Completed 60 month visit|52
1723243|NCT00295009|4218129|P6|Completed 24 Month Analysis|Overall Study||198
1723244|NCT00295009|4218130|P5|Completed 24 Month Analysis|Overall Study||133
1723245|NCT00295009|4218131|P4|Completed 24 Month Analysis|Overall Study||60
1723246|NCT00295009|4218132|P3|Completed 24 Month Analysis|Overall Study||45
1723247|NCT00295009|4218133|P2|Completed 24 Month Analysis|Overall Study||148
1723248|NCT00295009|4218134|P1|Completed 24 Month Analysis|Overall Study||71
1723249|NCT00295009|4218129|P6|Treated|Overall Study||259
1723250|NCT00295009|4218130|P5|Treated|Overall Study||165
1723251|NCT00295009|4218131|P4|Treated|Overall Study||72
1723252|NCT00295009|4218132|P3|Treated|Overall Study||50
1723253|NCT00295009|4218133|P2|Treated|Overall Study||162
1723254|NCT00295009|4218134|P1|Treated|Overall Study||80
1723255|NCT00295009|4218129|P6|STARTED|Overall Study||269
1723256|NCT00295009|4218130|P5|STARTED|Overall Study||174
1723257|NCT00295009|4218131|P4|STARTED|Overall Study||82
1723258|NCT00295009|4218132|P3|STARTED|Overall Study||51
1723259|NCT00295009|4218133|P2|STARTED|Overall Study||183
1723260|NCT00295009|4218134|P1|STARTED|Overall Study||93
1723261|NCT00294762|4218156|P2|NOT COMPLETED|Overall Study||3
1723262|NCT00294762|4218157|P1|NOT COMPLETED|Overall Study||3
1723263|NCT00294762|4218156|P2|COMPLETED|Overall Study||68
1723264|NCT00294762|4218157|P1|COMPLETED|Overall Study||69
1723265|NCT00294762|4218156|P2|STARTED|Overall Study||71
1723266|NCT00294762|4218157|P1|STARTED|Overall Study||72
1723267|NCT00294723|4218176|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
1723268|NCT00294723|4218177|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
1723269|NCT00294723|4218178|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
1723270|NCT00294723|4218176|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
1723271|NCT00294723|4218177|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
1723272|NCT00294723|4218178|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
1723273|NCT00294723|4218176|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
1723274|NCT00294723|4218177|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
1723275|NCT00294723|4218178|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
1723276|NCT00294723|4218176|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
1723277|NCT00294723|4218177|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
1723278|NCT00294723|4218178|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
1723279|NCT00294723|4218176|P3|COMPLETED|Open-Label Extension 52 Weeks||97
1723280|NCT00294723|4218177|P2|COMPLETED|Open-Label Extension 52 Weeks||110
1723281|NCT00294723|4218178|P1|COMPLETED|Open-Label Extension 52 Weeks||114
1723282|NCT00294723|4218176|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
1723283|NCT00294723|4218177|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
1723284|NCT00294723|4218178|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
1723285|NCT00294723|4218176|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
1723286|NCT00294723|4218177|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
1723287|NCT00294723|4218178|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
1723288|NCT00294723|4218176|P3|COMPLETED|Double-Blind Period 52 Weeks||152
1723289|NCT00294723|4218177|P2|COMPLETED|Double-Blind Period 52 Weeks||162
1723290|NCT00294723|4218178|P1|COMPLETED|Double-Blind Period 52 Weeks||173
1723291|NCT00294723|4218176|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
1723292|NCT00294723|4218177|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
1723293|NCT00294723|4218178|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
1723294|NCT00294723|4218176|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
1723295|NCT00294723|4218177|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
1723296|NCT00294723|4218178|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
1723297|NCT00294684|4218239|P2|NOT COMPLETED|Overall Study||8
1723298|NCT00294684|4218240|P1|NOT COMPLETED|Overall Study||5
1723299|NCT00294684|4218239|P2|COMPLETED|Overall Study||62
1723300|NCT00294684|4218240|P1|COMPLETED|Overall Study||65
1723301|NCT00294684|4218239|P2|STARTED|Overall Study||70
1723302|NCT00294684|4218240|P1|STARTED|Overall Study||70
1723303|NCT00294671|4218280|P2|NOT COMPLETED|Overall Study||40
1723304|NCT00294671|4218281|P1|NOT COMPLETED|Overall Study||27
1723305|NCT00294671|4218280|P2|COMPLETED|Overall Study||26
1723306|NCT00294671|4218281|P1|COMPLETED|Overall Study||37
1723307|NCT00294671|4218280|P2|STARTED|Overall Study||66
1723308|NCT00294671|4218281|P1|STARTED|Overall Study||64
1723309|NCT00294658|4218297|P2|NOT COMPLETED|Overall Study||9
1723310|NCT00294658|4218298|P1|NOT COMPLETED|Overall Study||6
1723311|NCT00294658|4218297|P2|COMPLETED|Overall Study||51
1723312|NCT00294658|4218298|P1|COMPLETED|Overall Study||60
1723313|NCT00294658|4218297|P2|STARTED|Overall Study||60
1723314|NCT00294658|4218298|P1|STARTED|Overall Study||66
1723315|NCT00294645|4218362|P2|NOT COMPLETED|Overall Study||92
1723316|NCT00294645|4218363|P1|NOT COMPLETED|Overall Study||48
1723317|NCT00294645|4218362|P2|COMPLETED|Overall Study||510
1723318|NCT00294645|4218363|P1|COMPLETED|Overall Study||247
1723319|NCT00294645|4218362|P2|STARTED|Overall Study||602
1723320|NCT00294645|4218363|P1|STARTED|Overall Study||295
1723321|NCT00294554|4218397|P2|NOT COMPLETED|Overall Study||2
1723322|NCT00294554|4218398|P1|NOT COMPLETED|Overall Study||0
1723323|NCT00294554|4218397|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
1723324|NCT00294554|4218398|P1|COMPLETED|Overall Study||10
1723325|NCT00294554|4218397|P2|STARTED|Overall Study||10
1723326|NCT00294554|4218398|P1|STARTED|Overall Study||10
1723327|NCT00294515|4218408|P2|NOT COMPLETED|Overall Study||28
1723328|NCT00294515|4218409|P1|NOT COMPLETED|Overall Study||34
1723329|NCT00294515|4218408|P2|COMPLETED|Overall Study||132
1723330|NCT00294515|4218409|P1|COMPLETED|Overall Study||132
1723331|NCT00294515|4218408|P2|STARTED|Overall Study|Randomized|160
1723332|NCT00294515|4218409|P1|STARTED|Overall Study|Randomized|166
1723333|NCT00294398|4218425|P2|NOT COMPLETED|Overall Study||26
1723334|NCT00294398|4218426|P1|NOT COMPLETED|Overall Study||21
1723335|NCT00294398|4218425|P2|COMPLETED|Overall Study||48
1723336|NCT00294398|4218426|P1|COMPLETED|Overall Study||57
1723337|NCT00294398|4218425|P2|STARTED|Overall Study||74
1723338|NCT00294398|4218426|P1|STARTED|Overall Study||78
1723339|NCT00294060|4218434|P1|NOT COMPLETED|Overall Study||1173
1723340|NCT00294060|4218434|P1|COMPLETED|Overall Study||840
1723341|NCT00294060|4218434|P1|STARTED|Overall Study||2013
1723342|NCT00294047|4218442|P2|NOT COMPLETED|Month 84||989
1723343|NCT00294047|4218443|P1|NOT COMPLETED|Month 84||973
1723344|NCT00294047|4218442|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
1723345|NCT00294047|4218443|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
1723346|NCT00294047|4218442|P2|STARTED|Month 84||2870
1723347|NCT00294047|4218443|P1|STARTED|Month 84||2877
1723348|NCT00294047|4218442|P2|NOT COMPLETED|Month 48||433
1723349|NCT00294047|4218443|P1|NOT COMPLETED|Month 48||425
1723350|NCT00294047|4218442|P2|COMPLETED|Month 48||2438
1723351|NCT00294047|4218443|P1|COMPLETED|Month 48||2456
1723352|NCT00294047|4218442|P2|Participated up to Month 48|Month 48||2281
1723353|NCT00294047|4218443|P1|Participated up to Month 48|Month 48||2305
1723354|NCT00294047|4218442|P2|STARTED|Month 48||2871
1723355|NCT00294047|4218443|P1|STARTED|Month 48||2881
1723356|NCT00293813|4218548|P3|NOT COMPLETED|Overall Study||8
1723357|NCT00293813|4218549|P2|NOT COMPLETED|Overall Study||9
1723358|NCT00293813|4218550|P1|NOT COMPLETED|Overall Study||13
1723359|NCT00293813|4218548|P3|COMPLETED|Overall Study||74
1723360|NCT00293813|4218549|P2|COMPLETED|Overall Study||74
1723361|NCT00293813|4218550|P1|COMPLETED|Overall Study||69
1723362|NCT00293813|4218548|P3|STARTED|Overall Study||82
1723363|NCT00293813|4218549|P2|STARTED|Overall Study||83
1723364|NCT00293813|4218550|P1|STARTED|Overall Study||82
1723365|NCT00293722|4218561|P1|NOT COMPLETED|Overall Study||427
1723366|NCT00293722|4218561|P1|COMPLETED|Overall Study||864
1723367|NCT00293722|4218561|P1|STARTED|Overall Study||1291
1723368|NCT00293709|4218575|P1|NOT COMPLETED|Overall Study||47
1723369|NCT00293709|4218575|P1|COMPLETED|Overall Study||102
1723370|NCT00293709|4218575|P1|STARTED|Overall Study||149
1723371|NCT00293579|4218589|P1|NOT COMPLETED|Overall Study||1
1723372|NCT00293579|4218589|P1|COMPLETED|Overall Study||4
1723373|NCT00293579|4218589|P1|STARTED|Overall Study||5
1723374|NCT00293540|4218598|P2|NOT COMPLETED|Overall Study||8
1723375|NCT00293540|4218599|P1|NOT COMPLETED|Overall Study||7
1723376|NCT00293540|4218598|P2|COMPLETED|Overall Study||119
1723377|NCT00293540|4218599|P1|COMPLETED|Overall Study||115
1723378|NCT00293540|4218598|P2|STARTED|Overall Study||127
1723379|NCT00293540|4218599|P1|STARTED|Overall Study||122
1723380|NCT00293462|4218608|P3|NOT COMPLETED|Overall Study||10
1723381|NCT00293462|4218609|P2|NOT COMPLETED|Overall Study||8
1723382|NCT00293462|4218610|P1|NOT COMPLETED|Overall Study||7
1723383|NCT00293462|4218608|P3|COMPLETED|Overall Study||21
1723384|NCT00293462|4218609|P2|COMPLETED|Overall Study||21
1723385|NCT00293462|4218610|P1|COMPLETED|Overall Study||24
1723386|NCT00293462|4218608|P3|STARTED|Overall Study||31
1723387|NCT00293462|4218609|P2|STARTED|Overall Study||29
1723388|NCT00293462|4218610|P1|STARTED|Overall Study||31
1723389|NCT00293397|4218629|P1|NOT COMPLETED|Overall Study||2
1723390|NCT00293397|4218629|P1|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
1723391|NCT00293397|4218629|P1|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
1723392|NCT00293397|4218629|P1|STARTED|Overall Study||20
1723393|NCT00293384|4218639|P1|NOT COMPLETED|Overall Study||5
1723394|NCT00293384|4218639|P1|COMPLETED|Overall Study||35
1723395|NCT00293384|4218639|P1|STARTED|Overall Study||40
1723396|NCT00293293|4218648|P2|NOT COMPLETED|Overall Study||2
1723397|NCT00293293|4218649|P1|NOT COMPLETED|Overall Study||2
1723398|NCT00293293|4218648|P2|COMPLETED|Overall Study||21
1723399|NCT00293293|4218649|P1|COMPLETED|Overall Study||18
1723400|NCT00293293|4218648|P2|STARTED|Overall Study||23
1723401|NCT00293293|4218649|P1|STARTED|Overall Study||20
1723402|NCT00293267|4218677|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
1723403|NCT00293267|4218678|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
1723404|NCT00293267|4218677|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
1723405|NCT00293267|4218678|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
1723406|NCT00293267|4218677|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
1723407|NCT00293267|4218678|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
1723408|NCT00293267|4218677|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
1723409|NCT00293267|4218678|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
1723410|NCT00293267|4218677|P2|COMPLETED|Extension - Open-Label Week 157-240||26
1723411|NCT00293267|4218678|P1|COMPLETED|Extension - Open-Label Week 157-240||111
1723412|NCT00293267|4218677|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
1723413|NCT00293267|4218678|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
1723414|NCT00293267|4218677|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
1723415|NCT00293267|4218678|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
1723416|NCT00293267|4218677|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
1723417|NCT00293267|4218678|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
1723418|NCT00293267|4218677|P2|STARTED|Extension - Double-Blind Week 49-156||50
1723419|NCT00293267|4218678|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
1723420|NCT00293267|4218677|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
1723421|NCT00293267|4218678|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
1723422|NCT00293267|4218677|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
1723423|NCT00293267|4218678|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
1723424|NCT00293267|4218677|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
1723425|NCT00293267|4218678|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
1723426|NCT00293267|4218677|P2|Treated|Primary Study - Double-Blind Week 0-48||118
1723427|NCT00293267|4218678|P1|Treated|Primary Study - Double-Blind Week 0-48||232
1723428|NCT00293267|4218677|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
1723429|NCT00293267|4218678|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
1723430|NCT00293254|4218718|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
1723431|NCT00293254|4218719|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
1723432|NCT00293254|4218718|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
1723433|NCT00293254|4218719|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
1723434|NCT00293254|4218718|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
1723603|NCT00291876|4219183|P1|STARTED|Month 198||135
1723435|NCT00293254|4218719|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
1723436|NCT00293254|4218718|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
1723437|NCT00293254|4218719|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
1723438|NCT00293254|4218718|P2|COMPLETED|Extension - Open-Label Week 157-240||18
1723439|NCT00293254|4218719|P1|COMPLETED|Extension - Open-Label Week 157-240||110
1723440|NCT00293254|4218718|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
1723441|NCT00293254|4218719|P1|STARTED|Extension - Open-Label Week 157-240||120
1723442|NCT00293254|4218718|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
1723443|NCT00293254|4218719|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
1723444|NCT00293254|4218718|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
1723445|NCT00293254|4218719|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
1723446|NCT00293254|4218718|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
1723447|NCT00293254|4218719|P1|STARTED|Extension - Double-Blind Week 49-156||177
1723448|NCT00293254|4218718|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
1723449|NCT00293254|4218719|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
1723450|NCT00293254|4218718|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
1723451|NCT00293254|4218719|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
1723452|NCT00293254|4218718|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
1723453|NCT00293254|4218719|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
1723454|NCT00293254|4218718|P2|Treated|Primary Study - Double-Blind Week 0-48||119
1723455|NCT00293254|4218719|P1|Treated|Primary Study - Double-Blind Week 0-48||230
1723456|NCT00293254|4218718|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
1723457|NCT00293254|4218719|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
1723458|NCT00293241|4218759|P2|NOT COMPLETED|Overall Study||41
1723459|NCT00293241|4218760|P1|NOT COMPLETED|Overall Study||36
1723460|NCT00293241|4218759|P2|COMPLETED|Overall Study||265
1723461|NCT00293241|4218760|P1|COMPLETED|Overall Study||263
1723462|NCT00293241|4218759|P2|STARTED|Overall Study||306
1723463|NCT00293241|4218760|P1|STARTED|Overall Study||299
1723464|NCT00293059|4218804|P2|NOT COMPLETED|Overall Study||19
1723465|NCT00293059|4218805|P1|NOT COMPLETED|Overall Study||35
1723466|NCT00293059|4218804|P2|COMPLETED|Overall Study||51
1723467|NCT00293059|4218805|P1|COMPLETED|Overall Study||85
1723468|NCT00293059|4218804|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
1723469|NCT00293059|4218805|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
1723470|NCT00293059|4218804|P2|Cycle 3/Treatment Day 84|Overall Study||55
1723471|NCT00293059|4218805|P1|Cycle 3/Treatment Day 84|Overall Study||100
1723472|NCT00293059|4218804|P2|Cycle 1/Treatment Day 28|Overall Study||64
1723473|NCT00293059|4218805|P1|Cycle 1/Treatment Day 28|Overall Study||115
1723474|NCT00293059|4218804|P2|Subjects Received Treatment|Overall Study||66
1723475|NCT00293059|4218805|P1|Subjects Received Treatment|Overall Study||119
1723476|NCT00293059|4218804|P2|STARTED|Overall Study||70
1723477|NCT00293059|4218805|P1|STARTED|Overall Study||120
1723478|NCT00293020|4218917|P1|NOT COMPLETED|Overall Study||162
1723479|NCT00293020|4218917|P1|COMPLETED|Overall Study||82
1723480|NCT00293020|4218917|P1|STARTED|Overall Study||244
1723481|NCT00292981|4218921|P1|NOT COMPLETED|Overall Study||39
1723482|NCT00292981|4218921|P1|COMPLETED|Overall Study||18
1723483|NCT00292981|4218921|P1|STARTED|Overall Study||57
1723484|NCT00292942|4218932|P4|NOT COMPLETED|Overall Study||1
1723485|NCT00292942|4218933|P3|NOT COMPLETED|Overall Study||1
1723486|NCT00292942|4218934|P2|NOT COMPLETED|Overall Study||0
1723487|NCT00292942|4218935|P1|NOT COMPLETED|Overall Study||0
1723488|NCT00292942|4218932|P4|COMPLETED|Overall Study||6
1723489|NCT00292942|4218933|P3|COMPLETED|Overall Study||6
1723490|NCT00292942|4218934|P2|COMPLETED|Overall Study||6
1723491|NCT00292942|4218935|P1|COMPLETED|Overall Study||6
1723492|NCT00292942|4218932|P4|STARTED|Overall Study||7
1723493|NCT00292942|4218933|P3|STARTED|Overall Study||7
1723494|NCT00292942|4218934|P2|STARTED|Overall Study||6
1723495|NCT00292942|4218935|P1|STARTED|Overall Study||6
1723496|NCT00292591|4218969|P3|NOT COMPLETED|Overall Study||58
1723497|NCT00292591|4218970|P2|NOT COMPLETED|Overall Study||56
1723498|NCT00292591|4218971|P1|NOT COMPLETED|Overall Study||64
1723499|NCT00292591|4218969|P3|COMPLETED|Overall Study||110
1723500|NCT00292591|4218970|P2|COMPLETED|Overall Study||111
1723501|NCT00292591|4218971|P1|COMPLETED|Overall Study||102
1723502|NCT00292591|4218969|P3|STARTED|Overall Study||168
1723503|NCT00292591|4218970|P2|STARTED|Overall Study||167
1723504|NCT00292591|4218971|P1|STARTED|Overall Study||166
1723505|NCT00292461|4218981|P2|NOT COMPLETED|Overall Study||6
1723506|NCT00292461|4218982|P1|NOT COMPLETED|Overall Study||10
1723507|NCT00292461|4218981|P2|COMPLETED|Overall Study||24
1723508|NCT00292461|4218982|P1|COMPLETED|Overall Study||24
1723509|NCT00292461|4218981|P2|STARTED|Overall Study||30
1723510|NCT00292461|4218982|P1|STARTED|Overall Study||34
1723511|NCT00292370|4218997|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
1723512|NCT00292370|4218998|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
1723513|NCT00292370|4218999|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
1723514|NCT00292370|4218997|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
1723515|NCT00292370|4218998|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
1723516|NCT00292370|4218999|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
1723517|NCT00292370|4218997|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
1723518|NCT00292370|4218998|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
1723519|NCT00292370|4218999|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
1723520|NCT00292370|4218997|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
1723521|NCT00292370|4218998|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
1723522|NCT00292370|4218999|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
1723523|NCT00292370|4218997|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
1723524|NCT00292370|4218998|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
1723525|NCT00292370|4218999|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
1723526|NCT00292370|4218997|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
1723527|NCT00292370|4218998|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
1723528|NCT00292370|4218999|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
1723529|NCT00292318|4219008|P2|NOT COMPLETED|Overall Study||1
1723530|NCT00292318|4219009|P1|NOT COMPLETED|Overall Study||2
1723531|NCT00292318|4219008|P2|COMPLETED|Overall Study||2
1723532|NCT00292318|4219009|P1|COMPLETED|Overall Study||2
1723533|NCT00292318|4219008|P2|STARTED|Overall Study||3
1723534|NCT00292318|4219009|P1|STARTED|Overall Study||4
1723535|NCT00292227|4219019|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
1723536|NCT00292227|4219020|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
1723537|NCT00292227|4219021|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
1723538|NCT00292227|4219019|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
1723539|NCT00292227|4219020|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
1723540|NCT00292227|4219021|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
1723541|NCT00292227|4219019|P3|STARTED|Cross-over Period 2 (Day 39)||30
1723542|NCT00292227|4219020|P2|STARTED|Cross-over Period 2 (Day 39)||31
1723543|NCT00292227|4219021|P1|STARTED|Cross-over Period 2 (Day 39)||65
1723544|NCT00292227|4219019|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
1723545|NCT00292227|4219020|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
1723546|NCT00292227|4219021|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
1723547|NCT00292227|4219019|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
1723548|NCT00292227|4219020|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
1723549|NCT00292227|4219021|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
1723550|NCT00292227|4219019|P3|STARTED|Cross-over Period 1 (Day 32)||30
1723551|NCT00292227|4219020|P2|STARTED|Cross-over Period 1 (Day 32)||31
1723552|NCT00292227|4219021|P1|STARTED|Cross-over Period 1 (Day 32)||65
1723553|NCT00292227|4219019|P3|NOT COMPLETED|Patch Period||3
1723554|NCT00292227|4219020|P2|NOT COMPLETED|Patch Period||0
1723555|NCT00292227|4219021|P1|NOT COMPLETED|Patch Period||1
1723556|NCT00292227|4219019|P3|COMPLETED|Patch Period||30
1723557|NCT00292227|4219020|P2|COMPLETED|Patch Period||31
1723558|NCT00292227|4219021|P1|COMPLETED|Patch Period||65
1723559|NCT00292227|4219019|P3|STARTED|Patch Period||33
1723560|NCT00292227|4219020|P2|STARTED|Patch Period||31
1723561|NCT00292227|4219021|P1|STARTED|Patch Period||66
1723562|NCT00292188|4219103|P3|NOT COMPLETED|Double-Blind||29
1723563|NCT00292188|4219104|P2|NOT COMPLETED|Double-Blind||31
1723564|NCT00292188|4219105|P1|NOT COMPLETED|Double-Blind||0
1723565|NCT00292188|4219103|P3|COMPLETED|Double-Blind||98
1723566|NCT00292188|4219104|P2|COMPLETED|Double-Blind||96
1723567|NCT00292188|4219105|P1|COMPLETED|Double-Blind||0
1723568|NCT00292188|4219103|P3|STARTED|Double-Blind||127
1723569|NCT00292188|4219104|P2|STARTED|Double-Blind||127
1723570|NCT00292188|4219105|P1|STARTED|Double-Blind||0
1723571|NCT00292188|4219103|P3|NOT COMPLETED|Single-Blind||0
1723572|NCT00292188|4219104|P2|NOT COMPLETED|Single-Blind||0
1723573|NCT00292188|4219105|P1|NOT COMPLETED|Single-Blind||114
1723574|NCT00292188|4219103|P3|COMPLETED|Single-Blind||0
1723575|NCT00292188|4219104|P2|COMPLETED|Single-Blind||0
1723576|NCT00292188|4219105|P1|COMPLETED|Single-Blind||254
1723577|NCT00292188|4219103|P3|Received Treatment|Single-Blind||0
1723578|NCT00292188|4219104|P2|Received Treatment|Single-Blind||0
1723579|NCT00292188|4219105|P1|Received Treatment|Single-Blind||367
1723580|NCT00292188|4219103|P3|STARTED|Single-Blind||0
1723581|NCT00292188|4219104|P2|STARTED|Single-Blind||0
1723582|NCT00292188|4219105|P1|STARTED|Single-Blind||368
1723583|NCT00292162|4219166|P2|NOT COMPLETED|Overall Study||2
1723584|NCT00292162|4219167|P1|NOT COMPLETED|Overall Study||1
1723585|NCT00292162|4219166|P2|COMPLETED|Overall Study||20
1723586|NCT00292162|4219167|P1|COMPLETED|Overall Study||18
1723587|NCT00292162|4219166|P2|STARTED|Overall Study||22
1723588|NCT00292162|4219167|P1|STARTED|Overall Study||19
1723589|NCT00291876|4219183|P1|NOT COMPLETED|Month 246||0
1723590|NCT00291876|4219183|P1|COMPLETED|Month 246||116
1723591|NCT00291876|4219183|P1|STARTED|Month 246||116
1723592|NCT00291876|4219183|P1|NOT COMPLETED|Month 234||0
1723593|NCT00291876|4219183|P1|COMPLETED|Month 234||110
1723594|NCT00291876|4219183|P1|STARTED|Month 234||110
1723595|NCT00291876|4219183|P1|NOT COMPLETED|Month 222||0
1723596|NCT00291876|4219183|P1|COMPLETED|Month 222||114
1723597|NCT00291876|4219183|P1|STARTED|Month 222||114
1723598|NCT00291876|4219183|P1|NOT COMPLETED|Month 210||0
1723599|NCT00291876|4219183|P1|COMPLETED|Month 210||124
1723600|NCT00291876|4219183|P1|STARTED|Month 210||124
1723601|NCT00291876|4219183|P1|NOT COMPLETED|Month 198||0
1723602|NCT00291876|4219183|P1|COMPLETED|Month 198||135
1723604|NCT00291876|4219183|P1|NOT COMPLETED|Month 186||0
1723605|NCT00291876|4219183|P1|COMPLETED|Month 186||129
1723606|NCT00291876|4219183|P1|STARTED|Month 186||129
1723607|NCT00291876|4219183|P1|NOT COMPLETED|Month 174||0
1723608|NCT00291876|4219183|P1|COMPLETED|Month 174||127
1723609|NCT00291876|4219183|P1|STARTED|Month 174||127
1723610|NCT00291876|4219183|P1|NOT COMPLETED|Month 162||0
1723611|NCT00291876|4219183|P1|COMPLETED|Month 162||127
1723612|NCT00291876|4219183|P1|STARTED|Month 162||127
1723613|NCT00291876|4219183|P1|NOT COMPLETED|Month 150||0
1723614|NCT00291876|4219183|P1|COMPLETED|Month 150||117
1723615|NCT00291876|4219183|P1|STARTED|Month 150||117
1723616|NCT00291876|4219183|P1|NOT COMPLETED|Month 138||0
1723617|NCT00291876|4219183|P1|COMPLETED|Month 138||107
1723618|NCT00291876|4219183|P1|STARTED|Month 138||107
1723619|NCT00291694|4219197|P2|NOT COMPLETED|Overall Study||5
1723620|NCT00291694|4219198|P1|NOT COMPLETED|Overall Study||3
1723621|NCT00291694|4219197|P2|COMPLETED|Overall Study||43
1723622|NCT00291694|4219198|P1|COMPLETED|Overall Study||21
1723623|NCT00291694|4219197|P2|STARTED|Overall Study||48
1723624|NCT00291694|4219198|P1|STARTED|Overall Study||24
1723625|NCT00291655|4219212|P1|NOT COMPLETED|Overall Study||15
1723626|NCT00291655|4219212|P1|COMPLETED|Overall Study||115
1723627|NCT00291655|4219212|P1|STARTED|Overall Study||130
1723628|NCT00291642|4219222|P5|NOT COMPLETED|Overall Study||1
1723629|NCT00291642|4219223|P4|NOT COMPLETED|Overall Study||0
1723630|NCT00291642|4219224|P3|NOT COMPLETED|Overall Study||2
1723631|NCT00291642|4219225|P2|NOT COMPLETED|Overall Study||0
1723632|NCT00291642|4219226|P1|NOT COMPLETED|Overall Study||2
1723633|NCT00291642|4219222|P5|COMPLETED|Overall Study||118
1723634|NCT00291642|4219223|P4|COMPLETED|Overall Study||119
1723635|NCT00291642|4219224|P3|COMPLETED|Overall Study||117
1723636|NCT00291642|4219225|P2|COMPLETED|Overall Study||116
1723637|NCT00291642|4219226|P1|COMPLETED|Overall Study||76
1723638|NCT00291642|4219222|P5|STARTED|Overall Study||119
1723639|NCT00291642|4219223|P4|STARTED|Overall Study||119
1723640|NCT00291642|4219224|P3|STARTED|Overall Study||119
1723641|NCT00291642|4219225|P2|STARTED|Overall Study||116
1723642|NCT00291642|4219226|P1|STARTED|Overall Study||78
1723643|NCT00291577|4219278|P1|NOT COMPLETED|Overall Study||21
1723644|NCT00291577|4219278|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
1723645|NCT00291577|4219278|P1|STARTED|Overall Study||22
1723646|NCT00291551|4219297|P1|NOT COMPLETED|Overall Study||13
1723647|NCT00291551|4219297|P1|COMPLETED|Overall Study||26
1723648|NCT00291551|4219297|P1|STARTED|Overall Study||39
1723649|NCT00291343|4219314|P2|NOT COMPLETED|Overall Study||0
1723650|NCT00291343|4219315|P1|NOT COMPLETED|Overall Study||0
1723651|NCT00291343|4219314|P2|COMPLETED|Overall Study||93
1723652|NCT00291343|4219315|P1|COMPLETED|Overall Study||203
1723653|NCT00291343|4219314|P2|STARTED|Overall Study||93
1723654|NCT00291343|4219315|P1|STARTED|Overall Study||203
1723655|NCT00291330|4219345|P2|NOT COMPLETED|Overall Study||97
1723656|NCT00291330|4219346|P1|NOT COMPLETED|Overall Study||101
1723657|NCT00291330|4219345|P2|COMPLETED|Overall Study|Completed planned observation time|1169
1723658|NCT00291330|4219346|P1|COMPLETED|Overall Study|Completed planned observation time|1172
1723659|NCT00291330|4219345|P2|STARTED|Overall Study|Started Treatment|1266
1723660|NCT00291330|4219346|P1|STARTED|Overall Study|Started Treatment|1273
1723661|NCT00291317|4219368|P1|NOT COMPLETED|Overall Study||0
1723662|NCT00291317|4219368|P1|COMPLETED|Overall Study||6
1723663|NCT00291317|4219368|P1|STARTED|Overall Study||6
1723664|NCT00291226|4219375|P2|NOT COMPLETED|Overall Study||1
1723665|NCT00291226|4219376|P1|NOT COMPLETED|Overall Study||1
1723666|NCT00291226|4219375|P2|COMPLETED|Overall Study||3
1723667|NCT00291226|4219376|P1|COMPLETED|Overall Study||3
1723668|NCT00291226|4219375|P2|STARTED|Overall Study||4
1723669|NCT00291226|4219376|P1|STARTED|Overall Study||4
1723670|NCT00291187|4219388|P4|NOT COMPLETED|Overall Study||0
1723671|NCT00291187|4219389|P3|NOT COMPLETED|Overall Study||1
1723672|NCT00291187|4219390|P2|NOT COMPLETED|Overall Study||0
1723673|NCT00291187|4219391|P1|NOT COMPLETED|Overall Study||0
1723674|NCT00291187|4219388|P4|COMPLETED|Overall Study||106
1723675|NCT00291187|4219389|P3|COMPLETED|Overall Study||102
1723676|NCT00291187|4219390|P2|COMPLETED|Overall Study||100
1723677|NCT00291187|4219391|P1|COMPLETED|Overall Study||103
1723678|NCT00291187|4219388|P4|STARTED|Overall Study||106
1723679|NCT00291187|4219389|P3|STARTED|Overall Study||103
1723680|NCT00291187|4219390|P2|STARTED|Overall Study||100
1723681|NCT00291187|4219391|P1|STARTED|Overall Study||103
1723682|NCT00291161|4219417|P4|NOT COMPLETED|Overall Study||65
1723683|NCT00291161|4219418|P3|NOT COMPLETED|Overall Study||93
1723684|NCT00291161|4219419|P2|NOT COMPLETED|Overall Study||58
1723685|NCT00291161|4219420|P1|NOT COMPLETED|Overall Study||81
1723686|NCT00291161|4219417|P4|COMPLETED|Overall Study||122
1723687|NCT00291161|4219418|P3|COMPLETED|Overall Study||206
1723688|NCT00291161|4219419|P2|COMPLETED|Overall Study||134
1723689|NCT00291161|4219420|P1|COMPLETED|Overall Study||235
1723690|NCT00291161|4219417|P4|STARTED|Overall Study||187
1723691|NCT00291161|4219418|P3|STARTED|Overall Study||299
1723692|NCT00291161|4219419|P2|STARTED|Overall Study||192
1723693|NCT00291161|4219420|P1|STARTED|Overall Study||316
1723694|NCT00291135|4219428|P1|NOT COMPLETED|Overall Study||0
1723695|NCT00291135|4219428|P1|COMPLETED|Overall Study||42
1723696|NCT00291135|4219428|P1|STARTED|Overall Study||42
1723697|NCT00291018|4219435|P3|NOT COMPLETED|Overall Study||43
1723698|NCT00291018|4219436|P2|NOT COMPLETED|Overall Study||42
1723699|NCT00291018|4219437|P1|NOT COMPLETED|Overall Study||25
1723700|NCT00291018|4219435|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
1723701|NCT00291018|4219436|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
1723702|NCT00291018|4219437|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
1723703|NCT00291018|4219435|P3|Evaluated at 24 Months|Overall Study||105
1723704|NCT00291018|4219436|P2|Evaluated at 24 Months|Overall Study||92
1723705|NCT00291018|4219437|P1|Evaluated at 24 Months|Overall Study||99
1723706|NCT00291018|4219435|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
1723707|NCT00291018|4219436|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
1723708|NCT00291018|4219437|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
1723709|NCT00290888|4219477|P2|NOT COMPLETED|Overall Study||1
1723710|NCT00290888|4219478|P1|NOT COMPLETED|Overall Study||3
1723711|NCT00290888|4219477|P2|COMPLETED|Overall Study||44
1723712|NCT00290888|4219478|P1|COMPLETED|Overall Study||38
1723713|NCT00290888|4219477|P2|STARTED|Overall Study||45
1723714|NCT00290888|4219478|P1|STARTED|Overall Study||41
1723715|NCT00290810|4219486|P1|NOT COMPLETED|Overall Study||0
1723716|NCT00290810|4219486|P1|COMPLETED|Overall Study||12
1723717|NCT00290810|4219486|P1|STARTED|Overall Study||12
1723718|NCT00290771|4219495|P2|NOT COMPLETED|Overall Study||97
1723719|NCT00290771|4219496|P1|NOT COMPLETED|Overall Study||127
1723720|NCT00290771|4219495|P2|COMPLETED|Overall Study||3
1723721|NCT00290771|4219496|P1|COMPLETED|Overall Study||4
1723722|NCT00290771|4219495|P2|STARTED|Overall Study||100
1723723|NCT00290771|4219496|P1|STARTED|Overall Study||131
1723724|NCT00290758|4219520|P2|NOT COMPLETED|Post Intervention rFNA||5
1723725|NCT00290758|4219521|P1|NOT COMPLETED|Post Intervention rFNA||6
1723726|NCT00290758|4219520|P2|COMPLETED|Post Intervention rFNA||49
1723727|NCT00290758|4219521|P1|COMPLETED|Post Intervention rFNA||49
1723728|NCT00290758|4219520|P2|STARTED|Post Intervention rFNA||54
1723729|NCT00290758|4219521|P1|STARTED|Post Intervention rFNA||55
1723730|NCT00290758|4219520|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
1723731|NCT00290758|4219521|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
1723732|NCT00290758|4219520|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
1723733|NCT00290758|4219521|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
1723734|NCT00290758|4219520|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
1723735|NCT00290758|4219521|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
1723736|NCT00290758|4219520|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
1723737|NCT00290758|4219521|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
1723738|NCT00290758|4219520|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
1723739|NCT00290758|4219521|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
1723740|NCT00290758|4219520|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
1723741|NCT00290758|4219521|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
1723742|NCT00290758|4219520|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
1723743|NCT00290758|4219521|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
1723744|NCT00290732|4219543|P5|NOT COMPLETED|Overall Study||0
1723745|NCT00290732|4219544|P4|NOT COMPLETED|Overall Study||0
1723746|NCT00290732|4219545|P3|NOT COMPLETED|Overall Study||1
1723747|NCT00290732|4219546|P2|NOT COMPLETED|Overall Study||1
1723748|NCT00290732|4219547|P1|NOT COMPLETED|Overall Study||0
1723749|NCT00290732|4219543|P5|COMPLETED|Overall Study||3
1723750|NCT00290732|4219544|P4|COMPLETED|Overall Study||6
1723751|NCT00290732|4219545|P3|COMPLETED|Overall Study||3
1723752|NCT00290732|4219546|P2|COMPLETED|Overall Study||3
1723753|NCT00290732|4219547|P1|COMPLETED|Overall Study||3
1723754|NCT00290732|4219543|P5|STARTED|Overall Study||3
1723755|NCT00290732|4219544|P4|STARTED|Overall Study||6
1723756|NCT00290732|4219545|P3|STARTED|Overall Study||4
1723757|NCT00290732|4219546|P2|STARTED|Overall Study||4
1723758|NCT00290732|4219547|P1|STARTED|Overall Study||3
1723759|NCT00290693|4219565|P1|NOT COMPLETED|Overall Study||2
1723760|NCT00290693|4219565|P1|COMPLETED|Overall Study||43
1723761|NCT00290693|4219565|P1|STARTED|Overall Study||45
1723762|NCT00290654|4219573|P1|NOT COMPLETED|Overall Study||0
1723763|NCT00290654|4219573|P1|COMPLETED|Overall Study||41
1723764|NCT00290654|4219573|P1|STARTED|Overall Study||41
1723765|NCT00290615|4219584|P1|NOT COMPLETED|Overall Study||0
1723766|NCT00290615|4219584|P1|COMPLETED|Overall Study||30
1723767|NCT00290615|4219584|P1|STARTED|Overall Study||30
1723768|NCT00290537|4219591|P2|NOT COMPLETED|Overall Study||0
1723769|NCT00290537|4219592|P1|NOT COMPLETED|Overall Study||0
1723770|NCT00290537|4219591|P2|COMPLETED|Overall Study||0
1723771|NCT00290537|4219592|P1|COMPLETED|Overall Study||4
1723772|NCT00290537|4219591|P2|STARTED|Overall Study||0
1723773|NCT00290537|4219592|P1|STARTED|Overall Study||4
1723774|NCT00290472|4219600|P3|NOT COMPLETED|Overall Study||0
1723775|NCT00290472|4219601|P2|NOT COMPLETED|Overall Study||0
1723776|NCT00290472|4219602|P1|NOT COMPLETED|Overall Study||0
1723777|NCT00290472|4219600|P3|COMPLETED|Overall Study||18
1723778|NCT00290472|4219601|P2|COMPLETED|Overall Study||39
1723779|NCT00290472|4219602|P1|COMPLETED|Overall Study||32
1723780|NCT00290472|4219600|P3|STARTED|Overall Study||18
1723781|NCT00290472|4219601|P2|STARTED|Overall Study||39
1723782|NCT00290472|4219602|P1|STARTED|Overall Study||32
1723783|NCT00290407|4219614|P1|NOT COMPLETED|Overall Study||2
1723784|NCT00290407|4219614|P1|COMPLETED|Overall Study||0
1723785|NCT00290407|4219614|P1|STARTED|Overall Study||2
1723786|NCT00290342|4219621|P2|NOT COMPLETED|Overall Study||5
1723787|NCT00290342|4219622|P1|NOT COMPLETED|Overall Study||7
1723788|NCT00290342|4219621|P2|COMPLETED|Overall Study||223
1723789|NCT00290342|4219622|P1|COMPLETED|Overall Study||217
1723790|NCT00290342|4219621|P2|STARTED|Overall Study||228
1723791|NCT00290342|4219622|P1|STARTED|Overall Study||224
1723792|NCT00290329|4219653|P3|NOT COMPLETED|Overall Study||0
1723793|NCT00290329|4219654|P2|NOT COMPLETED|Overall Study||0
1723794|NCT00290329|4219655|P1|NOT COMPLETED|Overall Study||0
1723795|NCT00290329|4219653|P3|COMPLETED|Overall Study||61
1723796|NCT00290329|4219654|P2|COMPLETED|Overall Study||86
1723797|NCT00290329|4219655|P1|COMPLETED|Overall Study||102
1723798|NCT00290329|4219653|P3|STARTED|Overall Study||61
1723799|NCT00290329|4219654|P2|STARTED|Overall Study||86
1723800|NCT00290329|4219655|P1|STARTED|Overall Study||102
1723801|NCT00290290|4219677|P2|NOT COMPLETED|Overall Study||18
1723802|NCT00290290|4219678|P1|NOT COMPLETED|Overall Study||18
1723803|NCT00290290|4219677|P2|COMPLETED|Overall Study||391
1723804|NCT00290290|4219678|P1|COMPLETED|Overall Study||422
1723805|NCT00290290|4219677|P2|STARTED|Overall Study||409
1723806|NCT00290290|4219678|P1|STARTED|Overall Study||440
1723807|NCT00290251|4219684|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
1723808|NCT00290251|4219685|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
1723809|NCT00290251|4219686|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
1723810|NCT00290251|4219684|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
1723811|NCT00290251|4219685|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
1723812|NCT00290251|4219686|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
1723813|NCT00290251|4219684|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
1723814|NCT00290251|4219685|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
1723815|NCT00290251|4219686|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
1723816|NCT00290251|4219684|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
1723817|NCT00290251|4219685|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
1723818|NCT00290251|4219686|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
1723819|NCT00290251|4219684|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
1723820|NCT00290251|4219685|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
1723821|NCT00290251|4219686|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
1723822|NCT00290251|4219684|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
1723823|NCT00290251|4219685|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
1723824|NCT00290251|4219686|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
1723825|NCT00290251|4219684|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
1723826|NCT00290251|4219685|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
1723827|NCT00290251|4219686|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
1723828|NCT00290251|4219684|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
1723829|NCT00290251|4219685|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
1723830|NCT00290251|4219686|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
1723831|NCT00290251|4219684|P3|STARTED|Treatment 1 (Months 1 - 3)||14
1723832|NCT00290251|4219685|P2|STARTED|Treatment 1 (Months 1 - 3)||14
1723833|NCT00290251|4219686|P1|STARTED|Treatment 1 (Months 1 - 3)||14
1723834|NCT00290238|4219698|P2|NOT COMPLETED|Overall Study||41
1723835|NCT00290238|4219699|P1|NOT COMPLETED|Overall Study||42
1723836|NCT00290238|4219698|P2|COMPLETED|Overall Study||24
1723837|NCT00290238|4219699|P1|COMPLETED|Overall Study||15
1723838|NCT00290238|4219698|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
1723839|NCT00290238|4219699|P1|STARTED|Overall Study||57
1723840|NCT00290199|4219709|P2|NOT COMPLETED|Overall Study||0
1723841|NCT00290199|4219710|P1|NOT COMPLETED|Overall Study||0
1723842|NCT00290199|4219709|P2|COMPLETED|Overall Study||82
1723843|NCT00290199|4219710|P1|COMPLETED|Overall Study||87
1723844|NCT00290199|4219709|P2|STARTED|Overall Study||82
1723845|NCT00290199|4219710|P1|STARTED|Overall Study||87
1723846|NCT00290186|4219724|P2|NOT COMPLETED|Overall Study||5
1723847|NCT00290186|4219725|P1|NOT COMPLETED|Overall Study||5
1723848|NCT00290186|4219724|P2|COMPLETED|Overall Study||19
1723849|NCT00290186|4219725|P1|COMPLETED|Overall Study||20
1723850|NCT00290186|4219724|P2|Completed 6-month Followup Assessments|Overall Study||19
1723851|NCT00290186|4219725|P1|Completed 6-month Followup Assessments|Overall Study||20
1723852|NCT00290186|4219724|P2|Completed 3-month Followup Assessments|Overall Study||21
1723853|NCT00290186|4219725|P1|Completed 3-month Followup Assessments|Overall Study||20
1723854|NCT00290186|4219724|P2|Completed Post-treatment Assessments|Overall Study||22
1723855|NCT00290186|4219725|P1|Completed Post-treatment Assessments|Overall Study||24
1723856|NCT00290186|4219724|P2|Completed 8 Weeks of Treatment|Overall Study||22
1723857|NCT00290186|4219725|P1|Completed 8 Weeks of Treatment|Overall Study||24
1723858|NCT00290186|4219724|P2|Completed Baseline Assessments|Overall Study||24
1723859|NCT00290186|4219725|P1|Completed Baseline Assessments|Overall Study||25
1723860|NCT00290186|4219724|P2|STARTED|Overall Study||24
1723861|NCT00290186|4219725|P1|STARTED|Overall Study||25
1723862|NCT00290147|4219765|P2|NOT COMPLETED|Overall Study||0
1723863|NCT00290147|4219766|P1|NOT COMPLETED|Overall Study||0
1723864|NCT00290147|4219765|P2|COMPLETED|Overall Study||12
1723865|NCT00290147|4219766|P1|COMPLETED|Overall Study||10
1723866|NCT00290147|4219765|P2|STARTED|Overall Study||12
1723867|NCT00290147|4219766|P1|STARTED|Overall Study||10
1723868|NCT00289991|4219776|P2|NOT COMPLETED|Overall Study||80
1723869|NCT00289991|4219777|P1|NOT COMPLETED|Overall Study||58
1723870|NCT00289991|4219776|P2|COMPLETED|Overall Study||175
1723871|NCT00289991|4219777|P1|COMPLETED|Overall Study||176
1723872|NCT00289991|4219776|P2|STARTED|Overall Study||255
1723873|NCT00289991|4219777|P1|STARTED|Overall Study||234
1723874|NCT00289978|4219802|P3|NOT COMPLETED|Overall Study||86
1723875|NCT00289978|4219803|P2|NOT COMPLETED|Overall Study||56
1723876|NCT00289978|4219804|P1|NOT COMPLETED|Overall Study||97
1723877|NCT00289978|4219802|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
1723878|NCT00289978|4219803|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
1723879|NCT00289978|4219804|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
1723880|NCT00289978|4219802|P3|STARTED|Overall Study||418
1723881|NCT00289978|4219803|P2|STARTED|Overall Study||425
1723882|NCT00289978|4219804|P1|STARTED|Overall Study||429
1723883|NCT00289913|4219823|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1723884|NCT00289913|4219824|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1723885|NCT00289913|4219825|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1723886|NCT00289913|4219826|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1723887|NCT00289913|4219827|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
1723888|NCT00289913|4219823|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
1723889|NCT00289913|4219824|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
1723890|NCT00289913|4219825|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
1723891|NCT00289913|4219826|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
1723892|NCT00289913|4219827|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
1723893|NCT00289913|4219823|P5|STARTED|Visit 4 (Stage I and Stage II)||597
1723894|NCT00289913|4219824|P4|STARTED|Visit 4 (Stage I and Stage II)||131
1723895|NCT00289913|4219825|P3|STARTED|Visit 4 (Stage I and Stage II)||138
1723896|NCT00289913|4219826|P2|STARTED|Visit 4 (Stage I and Stage II)||106
1723897|NCT00289913|4219827|P1|STARTED|Visit 4 (Stage I and Stage II)||122
1723898|NCT00289913|4219823|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
1723899|NCT00289913|4219824|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
1723900|NCT00289913|4219825|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
1723901|NCT00289913|4219826|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
1723902|NCT00289913|4219827|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
1723903|NCT00289913|4219823|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
1723904|NCT00289913|4219824|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
1723905|NCT00289913|4219825|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
1723906|NCT00289913|4219826|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
1723907|NCT00289913|4219827|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
1723908|NCT00289913|4219823|P5|STARTED|Visit 3 (Stage I and Stage II)||605
1723909|NCT00289913|4219824|P4|STARTED|Visit 3 (Stage I and Stage II)||135
1723910|NCT00289913|4219825|P3|STARTED|Visit 3 (Stage I and Stage II)||140
1723911|NCT00289913|4219826|P2|STARTED|Visit 3 (Stage I and Stage II)||114
1723912|NCT00289913|4219827|P1|STARTED|Visit 3 (Stage I and Stage II)||131
1723913|NCT00289913|4219823|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
1723914|NCT00289913|4219824|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
1723915|NCT00289913|4219825|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
1723916|NCT00289913|4219826|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
1723917|NCT00289913|4219827|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
1723918|NCT00289913|4219823|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
1723919|NCT00289913|4219824|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
1723920|NCT00289913|4219825|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
1723921|NCT00289913|4219826|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
1723922|NCT00289913|4219827|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
1723923|NCT00289913|4219823|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
1723924|NCT00289913|4219824|P4|STARTED|Visit 2 (Stage I and Stage II)||141
1723925|NCT00289913|4219825|P3|STARTED|Visit 2 (Stage I and Stage II)||150
1723926|NCT00289913|4219826|P2|STARTED|Visit 2 (Stage I and Stage II)||135
1723927|NCT00289913|4219827|P1|STARTED|Visit 2 (Stage I and Stage II)||146
1723928|NCT00289913|4219823|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
1723929|NCT00289913|4219824|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
1723930|NCT00289913|4219825|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
1723931|NCT00289913|4219826|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
1723932|NCT00289913|4219827|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
1723933|NCT00289913|4219823|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
1723934|NCT00289913|4219824|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
1723935|NCT00289913|4219825|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
1723936|NCT00289913|4219826|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
1723937|NCT00289913|4219827|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
1723938|NCT00289913|4219823|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
1723939|NCT00289913|4219824|P4|STARTED|Visit 1 (Stage I and Stage II)||152
1723940|NCT00289913|4219825|P3|STARTED|Visit 1 (Stage I and Stage II)||159
1723941|NCT00289913|4219826|P2|STARTED|Visit 1 (Stage I and Stage II)||151
1723942|NCT00289913|4219827|P1|STARTED|Visit 1 (Stage I and Stage II)||155
1723943|NCT00289900|4219858|P6|NOT COMPLETED|Overall Study||61
1723944|NCT00289900|4219859|P5|NOT COMPLETED|Overall Study||45
1723945|NCT00289900|4219860|P4|NOT COMPLETED|Overall Study||59
1723946|NCT00289900|4219861|P3|NOT COMPLETED|Overall Study||33
1723947|NCT00289900|4219862|P2|NOT COMPLETED|Overall Study||120
1723948|NCT00289900|4219863|P1|NOT COMPLETED|Overall Study||68
1723949|NCT00289900|4219858|P6|COMPLETED|Overall Study||372
1723950|NCT00289900|4219859|P5|COMPLETED|Overall Study||392
1723951|NCT00289900|4219860|P4|COMPLETED|Overall Study||380
1723952|NCT00289900|4219861|P3|COMPLETED|Overall Study||265
1723953|NCT00289900|4219862|P2|COMPLETED|Overall Study||316
1723954|NCT00289900|4219863|P1|COMPLETED|Overall Study||229
1723955|NCT00289900|4219858|P6|Treated|Overall Study||433
1723956|NCT00289900|4219859|P5|Treated|Overall Study||437
1723957|NCT00289900|4219860|P4|Treated|Overall Study||439
1723958|NCT00289900|4219861|P3|Treated|Overall Study||298
1723959|NCT00289900|4219862|P2|Treated|Overall Study||435
1723960|NCT00289900|4219863|P1|Treated|Overall Study||297
1723961|NCT00289900|4219858|P6|STARTED|Overall Study||433
1723962|NCT00289900|4219859|P5|STARTED|Overall Study||437
1723963|NCT00289900|4219860|P4|STARTED|Overall Study||439
1723964|NCT00289900|4219861|P3|STARTED|Overall Study||298
1723965|NCT00289900|4219862|P2|STARTED|Overall Study||436
1723966|NCT00289900|4219863|P1|STARTED|Overall Study||297
1723967|NCT00289887|4219967|P2|NOT COMPLETED|Overall Study||29
1723968|NCT00289887|4219968|P1|NOT COMPLETED|Overall Study||22
1723969|NCT00289887|4219967|P2|COMPLETED|Overall Study||105
1723970|NCT00289887|4219968|P1|COMPLETED|Overall Study||105
1723971|NCT00289887|4219967|P2|STARTED|Overall Study||134
1723972|NCT00289887|4219968|P1|STARTED|Overall Study||127
1723973|NCT00289874|4219986|P2|NOT COMPLETED|Overall Study||8
1723974|NCT00289874|4219987|P1|NOT COMPLETED|Overall Study||6
1723975|NCT00289874|4219986|P2|COMPLETED|Overall Study||210
1723976|NCT00289874|4219987|P1|COMPLETED|Overall Study||197
1723977|NCT00289874|4219986|P2|STARTED|Overall Study||218
1723978|NCT00289874|4219987|P1|STARTED|Overall Study||203
1723979|NCT00289848|4219997|P2|NOT COMPLETED|Overall Study||45
1723980|NCT00289848|4219998|P1|NOT COMPLETED|Overall Study||46
1723981|NCT00289848|4219997|P2|COMPLETED|Overall Study||133
1723982|NCT00289848|4219998|P1|COMPLETED|Overall Study||306
1723983|NCT00289848|4219997|P2|STARTED|Overall Study||178
1723984|NCT00289848|4219998|P1|STARTED|Overall Study||352
1723985|NCT00289783|4220010|P2|NOT COMPLETED|Fourth Dose Phase||24
1723986|NCT00289783|4220011|P1|NOT COMPLETED|Fourth Dose Phase||87
1723987|NCT00289783|4220010|P2|COMPLETED|Fourth Dose Phase||899
1723988|NCT00289783|4220011|P1|COMPLETED|Fourth Dose Phase||2682
1723989|NCT00289783|4220010|P2|STARTED|Fourth Dose Phase||923
1723990|NCT00289783|4220011|P1|STARTED|Fourth Dose Phase||2769
1723991|NCT00289783|4220010|P2|NOT COMPLETED|Primary Phase||83
1723992|NCT00289783|4220011|P1|NOT COMPLETED|Primary Phase||248
1723993|NCT00289783|4220010|P2|COMPLETED|Primary Phase||961
1723994|NCT00289783|4220011|P1|COMPLETED|Primary Phase||2888
1723995|NCT00289783|4220010|P2|STARTED|Primary Phase||1044
1723996|NCT00289783|4220011|P1|STARTED|Primary Phase||3136
1723997|NCT00289770|4220189|P1|NOT COMPLETED|Year 15||1
1723998|NCT00289770|4220189|P1|COMPLETED|Year 15||49
1723999|NCT00289770|4220189|P1|STARTED|Year 15||50
1724000|NCT00289770|4220189|P1|NOT COMPLETED|Year 14||0
1724001|NCT00289770|4220189|P1|COMPLETED|Year 14||43
1724002|NCT00289770|4220189|P1|STARTED|Year 14||43
1724003|NCT00289770|4220189|P1|NOT COMPLETED|Year 13||0
1724004|NCT00289770|4220189|P1|COMPLETED|Year 13||37
1724005|NCT00289770|4220189|P1|STARTED|Year 13||37
1724006|NCT00289770|4220189|P1|NOT COMPLETED|Year 12||0
1724007|NCT00289770|4220189|P1|COMPLETED|Year 12||40
1724008|NCT00289770|4220189|P1|STARTED|Year 12||40
1724009|NCT00289770|4220189|P1|NOT COMPLETED|Year 11||0
1724010|NCT00289770|4220189|P1|COMPLETED|Year 11||37
1724011|NCT00289770|4220189|P1|STARTED|Year 11||37
1724012|NCT00289757|4220201|P1|NOT COMPLETED|Overall Study||0
1724013|NCT00289757|4220201|P1|COMPLETED|Overall Study||78
1724014|NCT00289757|4220201|P1|STARTED|Overall Study||78
1724015|NCT00289744|4220212|P3|NOT COMPLETED|Additional Dose Phase||0
1724016|NCT00289744|4220213|P2|NOT COMPLETED|Additional Dose Phase||0
1724017|NCT00289744|4220214|P1|NOT COMPLETED|Additional Dose Phase||0
1724018|NCT00289744|4220212|P3|COMPLETED|Additional Dose Phase||6
1724019|NCT00289744|4220213|P2|COMPLETED|Additional Dose Phase||19
1724020|NCT00289744|4220214|P1|COMPLETED|Additional Dose Phase||0
1724021|NCT00289744|4220212|P3|STARTED|Additional Dose Phase||6
1724022|NCT00289744|4220213|P2|STARTED|Additional Dose Phase||19
1724023|NCT00289744|4220214|P1|STARTED|Additional Dose Phase||0
1724024|NCT00289744|4220212|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
1724025|NCT00289744|4220213|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
1724026|NCT00289744|4220214|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
1724027|NCT00289744|4220212|P3|COMPLETED|Year 10 Long-term Follow-up||0
1724028|NCT00289744|4220213|P2|COMPLETED|Year 10 Long-term Follow-up||0
1724029|NCT00289744|4220214|P1|COMPLETED|Year 10 Long-term Follow-up||171
1724030|NCT00289744|4220212|P3|STARTED|Year 10 Long-term Follow-up||0
1724031|NCT00289744|4220213|P2|STARTED|Year 10 Long-term Follow-up||0
1724032|NCT00289744|4220214|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
1724033|NCT00289744|4220212|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
1724034|NCT00289744|4220213|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
1724035|NCT00289744|4220214|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
1724036|NCT00289744|4220212|P3|COMPLETED|Year 9 Long-term Follow-up||0
1724037|NCT00289744|4220213|P2|COMPLETED|Year 9 Long-term Follow-up||0
1724038|NCT00289744|4220214|P1|COMPLETED|Year 9 Long-term Follow-up||173
1724039|NCT00289744|4220212|P3|STARTED|Year 9 Long-term Follow-up||0
1724040|NCT00289744|4220213|P2|STARTED|Year 9 Long-term Follow-up||0
1724041|NCT00289744|4220214|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
1724042|NCT00289744|4220212|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
1724043|NCT00289744|4220213|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
1724044|NCT00289744|4220214|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
1724045|NCT00289744|4220212|P3|COMPLETED|Year 8 Long-term Follow-up||0
1724046|NCT00289744|4220213|P2|COMPLETED|Year 8 Long-term Follow-up||0
1724047|NCT00289744|4220214|P1|COMPLETED|Year 8 Long-term Follow-up||174
1724048|NCT00289744|4220212|P3|STARTED|Year 8 Long-term Follow-up||0
1724049|NCT00289744|4220213|P2|STARTED|Year 8 Long-term Follow-up||0
1724050|NCT00289744|4220214|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
1724051|NCT00289744|4220212|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
1724052|NCT00289744|4220213|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
1724053|NCT00289744|4220214|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
1724054|NCT00289744|4220212|P3|COMPLETED|Year 7 Long-term Follow-up||0
1724055|NCT00289744|4220213|P2|COMPLETED|Year 7 Long-term Follow-up||0
1724056|NCT00289744|4220214|P1|COMPLETED|Year 7 Long-term Follow-up||175
1724057|NCT00289744|4220212|P3|STARTED|Year 7 Long-term Follow-up||0
1724058|NCT00289744|4220213|P2|STARTED|Year 7 Long-term Follow-up||0
1724059|NCT00289744|4220214|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
1724060|NCT00289744|4220212|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
1724061|NCT00289744|4220213|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
1724062|NCT00289744|4220214|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
1724063|NCT00289744|4220212|P3|COMPLETED|Year 6 Long-term Follow-up||0
1724064|NCT00289744|4220213|P2|COMPLETED|Year 6 Long-term Follow-up||0
1724065|NCT00289744|4220214|P1|COMPLETED|Year 6 Long-term Follow-up||178
1724066|NCT00289744|4220212|P3|STARTED|Year 6 Long-term Follow-up||0
1724067|NCT00289744|4220213|P2|STARTED|Year 6 Long-term Follow-up||0
1724068|NCT00289744|4220214|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
1724069|NCT00289731|4220235|P3|NOT COMPLETED|Overall Study||2
1724070|NCT00289731|4220236|P2|NOT COMPLETED|Overall Study||2
1724071|NCT00289731|4220237|P1|NOT COMPLETED|Overall Study||2
1724072|NCT00289731|4220235|P3|COMPLETED|Overall Study||195
1724073|NCT00289731|4220236|P2|COMPLETED|Overall Study||198
1724074|NCT00289731|4220237|P1|COMPLETED|Overall Study||197
1724075|NCT00289731|4220235|P3|STARTED|Overall Study||197
1724076|NCT00289731|4220236|P2|STARTED|Overall Study||200
1724077|NCT00289731|4220237|P1|STARTED|Overall Study||199
1724078|NCT00289718|4220329|P1|NOT COMPLETED|Overall Study||0
1724079|NCT00289718|4220329|P1|COMPLETED|Overall Study||51
1724080|NCT00289718|4220329|P1|STARTED|Overall Study||51
1724081|NCT00289653|4220344|P1|NOT COMPLETED|Overall Study||11
1724082|NCT00289653|4220344|P1|COMPLETED|Overall Study||12
1724083|NCT00289653|4220344|P1|STARTED|Overall Study||23
1724084|NCT00289536|4220349|P3|NOT COMPLETED|Period 3||1
1724085|NCT00289536|4220350|P2|NOT COMPLETED|Period 3||0
1724086|NCT00289536|4220351|P1|NOT COMPLETED|Period 3||0
1724087|NCT00289536|4220349|P3|COMPLETED|Period 3||9
1724088|NCT00289536|4220350|P2|COMPLETED|Period 3||9
1724089|NCT00289536|4220351|P1|COMPLETED|Period 3||7
1724090|NCT00289536|4220349|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
1724091|NCT00289536|4220350|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
1724092|NCT00289536|4220351|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
1724093|NCT00289536|4220349|P3|NOT COMPLETED|Period 2||0
1724094|NCT00289536|4220350|P2|NOT COMPLETED|Period 2||0
1724095|NCT00289536|4220351|P1|NOT COMPLETED|Period 2||0
1724096|NCT00289536|4220349|P3|COMPLETED|Period 2||7
1724097|NCT00289536|4220350|P2|COMPLETED|Period 2||9
1724098|NCT00289536|4220351|P1|COMPLETED|Period 2||10
1724099|NCT00289536|4220349|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
1724100|NCT00289536|4220350|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
1724101|NCT00289536|4220351|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
1724102|NCT00289536|4220349|P3|NOT COMPLETED|Period 1||0
1724103|NCT00289536|4220350|P2|NOT COMPLETED|Period 1||0
1724104|NCT00289536|4220351|P1|NOT COMPLETED|Period 1||0
1724105|NCT00289536|4220349|P3|COMPLETED|Period 1||9
1724106|NCT00289536|4220350|P2|COMPLETED|Period 1||8
1724107|NCT00289536|4220351|P1|COMPLETED|Period 1||9
1724108|NCT00289536|4220349|P3|STARTED|Period 1||9
1724109|NCT00289536|4220350|P2|STARTED|Period 1||8
1724110|NCT00289536|4220351|P1|STARTED|Period 1||9
1724111|NCT00289471|4220390|P1|NOT COMPLETED|Overall Study||0
1724112|NCT00289471|4220390|P1|COMPLETED|Overall Study||630
1724113|NCT00289471|4220390|P1|STARTED|Overall Study||630
1724114|NCT00289458|4220397|P3|NOT COMPLETED|Overall Study||6
1724115|NCT00289458|4220398|P2|NOT COMPLETED|Overall Study||6
1724116|NCT00289458|4220399|P1|NOT COMPLETED|Overall Study||6
1724117|NCT00289458|4220397|P3|COMPLETED|Overall Study||22
1724118|NCT00289458|4220398|P2|COMPLETED|Overall Study||20
1724119|NCT00289458|4220399|P1|COMPLETED|Overall Study||19
1724120|NCT00289458|4220397|P3|STARTED|Overall Study||28
1724121|NCT00289458|4220398|P2|STARTED|Overall Study||26
1724122|NCT00289458|4220399|P1|STARTED|Overall Study||25
1724123|NCT00289341|4220424|P2|NOT COMPLETED|Overall Study||0
1724124|NCT00289341|4220425|P1|NOT COMPLETED|Overall Study||0
1724125|NCT00289341|4220424|P2|COMPLETED|Overall Study||12
1724126|NCT00289341|4220425|P1|COMPLETED|Overall Study||12
1724127|NCT00289341|4220424|P2|STARTED|Overall Study||12
1724128|NCT00289341|4220425|P1|STARTED|Overall Study||12
1724129|NCT00289315|4220438|P3|NOT COMPLETED|Overall Study||140
1724130|NCT00289315|4220439|P2|NOT COMPLETED|Overall Study||122
1724131|NCT00289315|4220440|P1|NOT COMPLETED|Overall Study||101
1724132|NCT00289315|4220438|P3|COMPLETED|Overall Study||447
1724133|NCT00289315|4220439|P2|COMPLETED|Overall Study||638
1724134|NCT00289315|4220440|P1|COMPLETED|Overall Study||612
1724135|NCT00289315|4220438|P3|STARTED|Overall Study||587
1724136|NCT00289315|4220439|P2|STARTED|Overall Study||760
1724137|NCT00289315|4220440|P1|STARTED|Overall Study||713
1724138|NCT00289289|4220460|P3|NOT COMPLETED|Overall Study||49
1724139|NCT00289289|4220461|P2|NOT COMPLETED|Overall Study||10
1724140|NCT00289289|4220462|P1|NOT COMPLETED|Overall Study||19
1724141|NCT00289289|4220460|P3|COMPLETED|Overall Study||95
1724142|NCT00289289|4220461|P2|COMPLETED|Overall Study||114
1724143|NCT00289289|4220462|P1|COMPLETED|Overall Study||113
1724144|NCT00289289|4220460|P3|STARTED|Overall Study||144
1724145|NCT00289289|4220461|P2|STARTED|Overall Study||124
1724146|NCT00289289|4220462|P1|STARTED|Overall Study||132
1724147|NCT00289276|4220477|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
1724148|NCT00289276|4220478|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
1724149|NCT00289276|4220477|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
1724150|NCT00289276|4220478|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
1724151|NCT00289276|4220477|P2|STARTED|Second Part of FAST Study (Expansion)||109
1724152|NCT00289276|4220478|P1|STARTED|Second Part of FAST Study (Expansion)||0
1724153|NCT00289276|4220477|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
1724154|NCT00289276|4220478|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
1724155|NCT00289276|4220477|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
1724156|NCT00289276|4220478|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
1724157|NCT00289276|4220477|P2|STARTED|First Part of FAST Study (Pivotal)||0
1724158|NCT00289276|4220478|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
1724159|NCT00289211|4220493|P3|NOT COMPLETED|Overall Study||10
1724160|NCT00289211|4220494|P2|NOT COMPLETED|Overall Study||1
1724161|NCT00289211|4220495|P1|NOT COMPLETED|Overall Study||0
1724162|NCT00289211|4220493|P3|COMPLETED|Overall Study||2
1724163|NCT00289211|4220494|P2|COMPLETED|Overall Study||34
1724164|NCT00289211|4220495|P1|COMPLETED|Overall Study||36
1724165|NCT00289211|4220493|P3|STARTED|Overall Study||12
1724166|NCT00289211|4220494|P2|STARTED|Overall Study||35
1724167|NCT00289211|4220495|P1|STARTED|Overall Study||36
1724168|NCT00289198|4220513|P2|NOT COMPLETED|Overall Study||30
1724169|NCT00289198|4220514|P1|NOT COMPLETED|Overall Study||31
1724170|NCT00289198|4220513|P2|COMPLETED|Overall Study||121
1724171|NCT00289198|4220514|P1|COMPLETED|Overall Study||120
1724172|NCT00289198|4220513|P2|STARTED|Overall Study||151
1724173|NCT00289198|4220514|P1|STARTED|Overall Study||151
1724174|NCT00289185|4220564|P2|NOT COMPLETED|Overall Study||26
1724175|NCT00289185|4220565|P1|NOT COMPLETED|Overall Study||28
1724176|NCT00289185|4220564|P2|COMPLETED|Overall Study||144
1724177|NCT00289185|4220565|P1|COMPLETED|Overall Study||142
1724178|NCT00289185|4220564|P2|STARTED|Overall Study||170
1724179|NCT00289185|4220565|P1|STARTED|Overall Study||170
1724180|NCT00289133|4220612|P2|NOT COMPLETED|Overall Study||298
1724181|NCT00289133|4220613|P1|NOT COMPLETED|Overall Study||272
1724182|NCT00289133|4220612|P2|COMPLETED|Overall Study||179
1724183|NCT00289133|4220613|P1|COMPLETED|Overall Study||189
1724184|NCT00289133|4220612|P2|STARTED|Overall Study||477
1724185|NCT00289133|4220613|P1|STARTED|Overall Study||461
1724186|NCT00289120|4220635|P1|NOT COMPLETED|Overall Study||0
1724187|NCT00289120|4220635|P1|COMPLETED|Overall Study||13
1724188|NCT00289120|4220635|P1|STARTED|Overall Study||13
1724189|NCT00289107|4220653|P2|NOT COMPLETED|Overall Study||44
1724190|NCT00289107|4220654|P1|NOT COMPLETED|Overall Study||53
1724191|NCT00289107|4220653|P2|COMPLETED|Overall Study||28
1724192|NCT00289107|4220654|P1|COMPLETED|Overall Study||24
1724193|NCT00289107|4220653|P2|STARTED|Overall Study||72
1724194|NCT00289107|4220654|P1|STARTED|Overall Study||77
1724195|NCT00289094|4220662|P2|NOT COMPLETED|Overall Study||47
1724196|NCT00289094|4220663|P1|NOT COMPLETED|Overall Study||47
1724197|NCT00289094|4220662|P2|COMPLETED|Overall Study||2
1724198|NCT00289094|4220663|P1|COMPLETED|Overall Study||3
1724199|NCT00289094|4220662|P2|STARTED|Overall Study||49
1724200|NCT00289094|4220663|P1|STARTED|Overall Study||50
1724201|NCT00289016|4220669|P1|NOT COMPLETED|Overall Study||37
1724202|NCT00289016|4220669|P1|COMPLETED|Overall Study||13
1724203|NCT00289016|4220669|P1|STARTED|Overall Study||50
1724204|NCT00288912|4220681|P3|NOT COMPLETED|Overall Study||28
1724205|NCT00288912|4220682|P2|NOT COMPLETED|Overall Study||17
1724206|NCT00288912|4220683|P1|NOT COMPLETED|Overall Study||17
1724207|NCT00288912|4220681|P3|COMPLETED|Overall Study||146
1724208|NCT00288912|4220682|P2|COMPLETED|Overall Study||157
1724209|NCT00288912|4220683|P1|COMPLETED|Overall Study||158
1724210|NCT00288912|4220681|P3|STARTED|Overall Study||174
1724211|NCT00288912|4220682|P2|STARTED|Overall Study||174
1724212|NCT00288912|4220683|P1|STARTED|Overall Study||175
1724213|NCT00288886|4220702|P2|NOT COMPLETED|Overall Study||11
1724214|NCT00288886|4220703|P1|NOT COMPLETED|Overall Study||11
1724215|NCT00288886|4220702|P2|COMPLETED|Overall Study||81
1724216|NCT00288886|4220703|P1|COMPLETED|Overall Study||80
1724217|NCT00288886|4220702|P2|12-month Follow Up|Overall Study||81
1724218|NCT00288886|4220703|P1|12-month Follow Up|Overall Study||80
1724219|NCT00288886|4220702|P2|6-month Follow Up|Overall Study||84
1724220|NCT00288886|4220703|P1|6-month Follow Up|Overall Study||85
1724221|NCT00288886|4220702|P2|3-month Follow Up|Overall Study||85
1724222|NCT00288886|4220703|P1|3-month Follow Up|Overall Study||82
1724223|NCT00288886|4220702|P2|STARTED|Overall Study||92
1724224|NCT00288886|4220703|P1|STARTED|Overall Study||91
1724225|NCT00288860|4220723|P2|NOT COMPLETED|Overall Study||97
1724226|NCT00288860|4220724|P1|NOT COMPLETED|Overall Study||102
1724227|NCT00288860|4220723|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
1724228|NCT00288860|4220724|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
1724229|NCT00288860|4220723|P2|Completed 12 Month fu Survey|Overall Study||281
1724230|NCT00288860|4220724|P1|Completed 12 Month fu Survey|Overall Study||257
1724231|NCT00288860|4220723|P2|Completed 4 Month fu Survey|Overall Study||299
1724232|NCT00288860|4220724|P1|Completed 4 Month fu Survey|Overall Study||275
1724233|NCT00288860|4220723|P2|Completed Intake Survey|Overall Study||417
1724234|NCT00288860|4220724|P1|Completed Intake Survey|Overall Study||408
1724235|NCT00288860|4220723|P2|STARTED|Overall Study||425
1724236|NCT00288860|4220724|P1|STARTED|Overall Study||412
1724237|NCT00288704|4220737|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
1724238|NCT00288704|4220738|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
1724239|NCT00288704|4220739|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
1724240|NCT00288704|4220737|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
1724241|NCT00288704|4220738|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
1724242|NCT00288704|4220739|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
1724243|NCT00288704|4220737|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
1724244|NCT00288704|4220738|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
1724245|NCT00288704|4220739|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
1724246|NCT00288704|4220737|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
1724247|NCT00288704|4220738|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
1724248|NCT00288704|4220739|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
1724249|NCT00288704|4220737|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
1724250|NCT00288704|4220738|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
1724251|NCT00288704|4220739|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
1724252|NCT00288704|4220737|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
1724253|NCT00288704|4220738|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
1724254|NCT00288704|4220739|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
1724255|NCT00288704|4220737|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
1724256|NCT00288704|4220738|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
1724257|NCT00288704|4220739|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
1724258|NCT00288704|4220737|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
1724259|NCT00288704|4220738|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
1724260|NCT00288704|4220739|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
1724261|NCT00288704|4220737|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
1724262|NCT00288704|4220738|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
1724263|NCT00288704|4220739|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
1724264|NCT00288639|4220766|P1|NOT COMPLETED|Overall Study||12
1724265|NCT00288639|4220766|P1|COMPLETED|Overall Study||86
1724266|NCT00288639|4220766|P1|STARTED|Overall Study||98
1724267|NCT00288626|4220783|P1|NOT COMPLETED|Overall Study||7
1724268|NCT00288626|4220783|P1|COMPLETED|Overall Study||17
1724269|NCT00288626|4220783|P1|STARTED|Overall Study||24
1724270|NCT00288600|4220808|P2|NOT COMPLETED|Overall Study||0
1724271|NCT00288600|4220809|P1|NOT COMPLETED|Overall Study||0
1724272|NCT00288600|4220808|P2|COMPLETED|Overall Study||46
1724273|NCT00288600|4220809|P1|COMPLETED|Overall Study||46
1724274|NCT00288600|4220808|P2|STARTED|Overall Study||46
1724275|NCT00288600|4220809|P1|STARTED|Overall Study||46
1724276|NCT00288587|4220817|P2|NOT COMPLETED|Overall Study||10
1724277|NCT00288587|4220818|P1|NOT COMPLETED|Overall Study||5
1724278|NCT00288587|4220817|P2|COMPLETED|Overall Study||7
1724279|NCT00288587|4220818|P1|COMPLETED|Overall Study||14
1724280|NCT00288587|4220817|P2|STARTED|Overall Study||17
1724281|NCT00288587|4220818|P1|STARTED|Overall Study||19
1724282|NCT00288574|4220834|P2|NOT COMPLETED|Overall Study||0
1724283|NCT00288574|4220835|P1|NOT COMPLETED|Overall Study||0
1724284|NCT00288574|4220834|P2|COMPLETED|Overall Study||44
1724285|NCT00288574|4220835|P1|COMPLETED|Overall Study||49
1724286|NCT00288574|4220834|P2|STARTED|Overall Study||44
1724287|NCT00288574|4220835|P1|STARTED|Overall Study||49
1724288|NCT00288509|4220861|P1|NOT COMPLETED|Treatment Cycle 4||8
1724289|NCT00288509|4220861|P1|COMPLETED|Treatment Cycle 4||80
1724290|NCT00288509|4220861|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
1724291|NCT00288509|4220861|P1|NOT COMPLETED|Treatment Cycle 3||5
1724292|NCT00288509|4220861|P1|COMPLETED|Treatment Cycle 3||91
1724293|NCT00288509|4220861|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
1724294|NCT00288509|4220861|P1|NOT COMPLETED|Treatment Cycle 2||3
1724295|NCT00288509|4220861|P1|COMPLETED|Treatment Cycle 2||97
1724296|NCT00288509|4220861|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
1724297|NCT00288509|4220861|P1|NOT COMPLETED|Treatment Cycle 1||6
1724298|NCT00288509|4220861|P1|COMPLETED|Treatment Cycle 1||102
1724299|NCT00288509|4220861|P1|STARTED|Treatment Cycle 1||108
1724300|NCT00288080|4220870|P2|NOT COMPLETED|Overall Study||23
1724301|NCT00288080|4220871|P1|NOT COMPLETED|Overall Study||26
1724302|NCT00288080|4220870|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
1724303|NCT00288080|4220871|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
1724304|NCT00288080|4220870|P2|STARTED|Overall Study||305
1724305|NCT00288080|4220871|P1|STARTED|Overall Study||307
1724306|NCT00288067|4220887|P1|NOT COMPLETED|Overall Study||0
1724307|NCT00288067|4220887|P1|COMPLETED|Overall Study||32
1724308|NCT00288067|4220887|P1|STARTED|Overall Study||32
1724309|NCT00288054|4220893|P1|NOT COMPLETED|Overall Study||24
1724310|NCT00288054|4220893|P1|COMPLETED|Overall Study||0
1724311|NCT00288054|4220893|P1|STARTED|Overall Study||24
1724312|NCT00288015|4220901|P1|NOT COMPLETED|Follow up for Survival x 2 Years||26
1724313|NCT00288015|4220901|P1|COMPLETED|Follow up for Survival x 2 Years||3
1724314|NCT00288015|4220901|P1|STARTED|Follow up for Survival x 2 Years||29
1724315|NCT00288015|4220901|P1|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
1724316|NCT00288015|4220901|P1|COMPLETED|Continued Bevacizumab Cycle 3+||19
1724317|NCT00288015|4220901|P1|STARTED|Continued Bevacizumab Cycle 3+||26
1724318|NCT00288015|4220901|P1|NOT COMPLETED|First Response Assessment||4
1724319|NCT00288015|4220901|P1|COMPLETED|First Response Assessment||26
1724320|NCT00288015|4220901|P1|STARTED|First Response Assessment||30
1724321|NCT00288015|4220901|P1|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
1724322|NCT00288015|4220901|P1|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
1724323|NCT00288015|4220901|P1|STARTED|Bevacizumab Treatment Cycles 1-2||32
1724324|NCT00288015|4220901|P1|NOT COMPLETED|Registered to Study||0
1724325|NCT00288015|4220901|P1|COMPLETED|Registered to Study||32
1724326|NCT00288015|4220901|P1|STARTED|Registered to Study||32
1724327|NCT00287989|4220913|P3|NOT COMPLETED|Overall Study||0
1724328|NCT00287989|4220914|P2|NOT COMPLETED|Overall Study||0
1724329|NCT00287989|4220915|P1|NOT COMPLETED|Overall Study||0
1724330|NCT00287989|4220913|P3|COMPLETED|Overall Study||29
1724331|NCT00287989|4220914|P2|COMPLETED|Overall Study||29
1724332|NCT00287989|4220915|P1|COMPLETED|Overall Study||28
1724333|NCT00287989|4220913|P3|STARTED|Overall Study||29
1724334|NCT00287989|4220914|P2|STARTED|Overall Study||29
1724335|NCT00287989|4220915|P1|STARTED|Overall Study||28
1724336|NCT00287872|4220926|P1|NOT COMPLETED|Overall Study||0
1724337|NCT00287872|4220926|P1|COMPLETED|Overall Study||30
1724338|NCT00287872|4220926|P1|STARTED|Overall Study||30
1724339|NCT00287729|4220936|P2|NOT COMPLETED|Overall Study||31
1724340|NCT00287729|4220937|P1|NOT COMPLETED|Overall Study||34
1724341|NCT00287729|4220936|P2|COMPLETED|Overall Study||142
1724342|NCT00287729|4220937|P1|COMPLETED|Overall Study||137
1724343|NCT00287729|4220936|P2|STARTED|Overall Study||173
1724344|NCT00287729|4220937|P1|STARTED|Overall Study||171
1724345|NCT00287716|4220960|P3|NOT COMPLETED|Overall Study||31
1724346|NCT00287716|4220961|P2|NOT COMPLETED|Overall Study||17
1724347|NCT00287716|4220962|P1|NOT COMPLETED|Overall Study||38
1724348|NCT00287716|4220960|P3|COMPLETED|Overall Study||143
1724349|NCT00287716|4220961|P2|COMPLETED|Overall Study||70
1724350|NCT00287716|4220962|P1|COMPLETED|Overall Study||136
1724351|NCT00287716|4220960|P3|STARTED|Overall Study||174
1724352|NCT00287716|4220961|P2|STARTED|Overall Study||87
1724353|NCT00287716|4220962|P1|STARTED|Overall Study||174
1724354|NCT00287586|4220993|P2|NOT COMPLETED|Overall Study||52
1724355|NCT00287586|4220994|P1|NOT COMPLETED|Overall Study||45
1724356|NCT00287586|4220993|P2|COMPLETED|Overall Study||100
1724357|NCT00287586|4220994|P1|COMPLETED|Overall Study||111
1724358|NCT00287586|4220993|P2|Intent-to-treat: Received Study Drug|Overall Study||151
1724359|NCT00287586|4220994|P1|Intent-to-treat: Received Study Drug|Overall Study||155
1724360|NCT00287586|4220993|P2|STARTED|Overall Study||152
1724361|NCT00287586|4220994|P1|STARTED|Overall Study||156
1724362|NCT00287365|4221030|P1|NOT COMPLETED|Overall Study||13
1724363|NCT00287365|4221030|P1|COMPLETED|Overall Study||12
1724364|NCT00287365|4221030|P1|STARTED|Overall Study||25
1724365|NCT00287339|4221041|P2|NOT COMPLETED|Overall Study||0
1724366|NCT00287339|4221042|P1|NOT COMPLETED|Overall Study||0
1724367|NCT00287339|4221041|P2|COMPLETED|Overall Study||18
1724368|NCT00287339|4221042|P1|COMPLETED|Overall Study||22
1724369|NCT00287339|4221041|P2|STARTED|Overall Study||18
1724370|NCT00287339|4221042|P1|STARTED|Overall Study||22
1724371|NCT00287222|4221048|P1|NOT COMPLETED|Overall Study||0
1724372|NCT00287222|4221048|P1|COMPLETED|Overall Study||21
1724373|NCT00287222|4221048|P1|STARTED|Overall Study||21
1724374|NCT00287118|4221052|P1|NOT COMPLETED|Overall Study||52
1724375|NCT00287118|4221052|P1|COMPLETED|Overall Study||137
1724376|NCT00287118|4221052|P1|STARTED|Overall Study||189
1724377|NCT00287079|4221058|P2|NOT COMPLETED|Overall Study||1
1724378|NCT00287079|4221059|P1|NOT COMPLETED|Overall Study||22
1724379|NCT00287079|4221058|P2|COMPLETED|Overall Study||2
1724380|NCT00287079|4221059|P1|COMPLETED|Overall Study||10
1724381|NCT00287079|4221058|P2|STARTED|Overall Study||3
1724382|NCT00287079|4221059|P1|STARTED|Overall Study||32
1724383|NCT00287053|4221071|P2|NOT COMPLETED|Overall Study||1
1724384|NCT00287053|4221072|P1|NOT COMPLETED|Overall Study||4
1724385|NCT00287053|4221071|P2|COMPLETED|Overall Study||26
1724386|NCT00287053|4221072|P1|COMPLETED|Overall Study||26
1724387|NCT00287053|4221071|P2|STARTED|Overall Study||27
1724388|NCT00287053|4221072|P1|STARTED|Overall Study||30
1724389|NCT00286949|4221078|P1|NOT COMPLETED|Overall Study||0
1724390|NCT00286949|4221078|P1|COMPLETED|Overall Study||12
1724391|NCT00286949|4221078|P1|STARTED|Overall Study||12
1724392|NCT00286754|4221087|P3|NOT COMPLETED|Overall Study||10
1724393|NCT00286754|4221088|P2|NOT COMPLETED|Overall Study||18
1724394|NCT00286754|4221089|P1|NOT COMPLETED|Overall Study||20
1724395|NCT00286754|4221087|P3|COMPLETED|Overall Study||170
1724396|NCT00286754|4221088|P2|COMPLETED|Overall Study||159
1724397|NCT00286754|4221089|P1|COMPLETED|Overall Study||156
1724398|NCT00286754|4221087|P3|STARTED|Overall Study||180
1724399|NCT00286754|4221088|P2|STARTED|Overall Study||177
1724400|NCT00286754|4221089|P1|STARTED|Overall Study||176
1724401|NCT00286741|4221123|P2|NOT COMPLETED|Overall Study||17
1724402|NCT00286741|4221124|P1|NOT COMPLETED|Overall Study||11
1724403|NCT00286741|4221123|P2|COMPLETED|Overall Study||89
1724404|NCT00286741|4221124|P1|COMPLETED|Overall Study||122
1724405|NCT00286741|4221123|P2|STARTED|Overall Study||106
1724406|NCT00286741|4221124|P1|STARTED|Overall Study||133
1724407|NCT00286728|4221134|P2|NOT COMPLETED|Overall Study||29
1724408|NCT00286728|4221135|P1|NOT COMPLETED|Overall Study||36
1724409|NCT00286728|4221134|P2|COMPLETED|Overall Study||116
1724410|NCT00286728|4221135|P1|COMPLETED|Overall Study||106
1724411|NCT00286728|4221134|P2|STARTED|Overall Study||145
1724412|NCT00286728|4221135|P1|STARTED|Overall Study||142
1724413|NCT00286494|4221144|P3|NOT COMPLETED|Overall Study||39
1724414|NCT00286494|4221145|P2|NOT COMPLETED|Overall Study||44
1724415|NCT00286494|4221146|P1|NOT COMPLETED|Overall Study||26
1724416|NCT00286494|4221144|P3|COMPLETED|Overall Study||160
1724417|NCT00286494|4221145|P2|COMPLETED|Overall Study||153
1724418|NCT00286494|4221146|P1|COMPLETED|Overall Study||71
1724419|NCT00286494|4221144|P3|STARTED|Overall Study||199
1724420|NCT00286494|4221145|P2|STARTED|Overall Study||197
1724421|NCT00286494|4221146|P1|STARTED|Overall Study||97
1724422|NCT00286468|4221307|P3|NOT COMPLETED|Overall Study||50
1724423|NCT00286468|4221308|P2|NOT COMPLETED|Overall Study||50
1724424|NCT00286468|4221309|P1|NOT COMPLETED|Overall Study||37
1724425|NCT00286468|4221307|P3|COMPLETED|Overall Study||148
1724426|NCT00286468|4221308|P2|COMPLETED|Overall Study||153
1724427|NCT00286468|4221309|P1|COMPLETED|Overall Study||62
1724428|NCT00286468|4221307|P3|STARTED|Overall Study||198
1724429|NCT00286468|4221308|P2|STARTED|Overall Study||203
1724430|NCT00286468|4221309|P1|STARTED|Overall Study||99
1724431|NCT00286455|4221470|P3|NOT COMPLETED|Overall Study||24
1724432|NCT00286455|4221471|P2|NOT COMPLETED|Overall Study||28
1724433|NCT00286455|4221472|P1|NOT COMPLETED|Overall Study||25
1724434|NCT00286455|4221470|P3|COMPLETED|Overall Study||107
1724435|NCT00286455|4221471|P2|COMPLETED|Overall Study||105
1724436|NCT00286455|4221472|P1|COMPLETED|Overall Study||40
1724437|NCT00286455|4221470|P3|STARTED|Overall Study||131
1724438|NCT00286455|4221471|P2|STARTED|Overall Study||133
1724439|NCT00286455|4221472|P1|STARTED|Overall Study||65
1724440|NCT00286442|4221651|P3|NOT COMPLETED|Overall Study||32
1724441|NCT00286442|4221652|P2|NOT COMPLETED|Overall Study||45
1724442|NCT00286442|4221653|P1|NOT COMPLETED|Overall Study||37
1724443|NCT00286442|4221651|P3|COMPLETED|Overall Study||72
1724444|NCT00286442|4221652|P2|COMPLETED|Overall Study||165
1724445|NCT00286442|4221653|P1|COMPLETED|Overall Study||176
1724446|NCT00286442|4221651|P3|STARTED|Overall Study||104
1724447|NCT00286442|4221652|P2|STARTED|Overall Study||210
1724448|NCT00286442|4221653|P1|STARTED|Overall Study||213
1724449|NCT00286429|4221814|P3|NOT COMPLETED|Overall Study||52
1724450|NCT00286429|4221815|P2|NOT COMPLETED|Overall Study||48
1724451|NCT00286429|4221816|P1|NOT COMPLETED|Overall Study||75
1724452|NCT00286429|4221814|P3|COMPLETED|Overall Study||77
1724453|NCT00286429|4221815|P2|COMPLETED|Overall Study||83
1724454|NCT00286429|4221816|P1|COMPLETED|Overall Study||55
1724455|NCT00286429|4221814|P3|STARTED|Overall Study||129
1724456|NCT00286429|4221815|P2|STARTED|Overall Study||131
1724457|NCT00286429|4221816|P1|STARTED|Overall Study||130
1724458|NCT00286325|4221920|P1|NOT COMPLETED|Overall Study||0
1724459|NCT00286325|4221920|P1|COMPLETED|Overall Study||8
1724460|NCT00286325|4221920|P1|STARTED|Overall Study||8
1724461|NCT00286221|4221932|P4|NOT COMPLETED|Overall Study||6
1724462|NCT00286221|4221933|P3|NOT COMPLETED|Overall Study||9
1724463|NCT00286221|4221934|P2|NOT COMPLETED|Overall Study||5
1724464|NCT00286221|4221935|P1|NOT COMPLETED|Overall Study||10
1724465|NCT00286221|4221932|P4|COMPLETED|Overall Study||34
1724466|NCT00286221|4221933|P3|COMPLETED|Overall Study||31
1724467|NCT00286221|4221934|P2|COMPLETED|Overall Study||35
1724468|NCT00286221|4221935|P1|COMPLETED|Overall Study||29
1724469|NCT00286221|4221932|P4|STARTED|Overall Study||40
1724470|NCT00286221|4221933|P3|STARTED|Overall Study||40
1724471|NCT00286221|4221934|P2|STARTED|Overall Study||40
1724472|NCT00286221|4221935|P1|STARTED|Overall Study||39
1724473|NCT00286182|4221951|P2|NOT COMPLETED|Overall Study||3
1724474|NCT00286182|4221952|P1|NOT COMPLETED|Overall Study||5
1724475|NCT00286182|4221951|P2|COMPLETED|Overall Study||25
1724476|NCT00286182|4221952|P1|COMPLETED|Overall Study||23
1724477|NCT00286182|4221951|P2|STARTED|Overall Study||28
1724478|NCT00286182|4221952|P1|STARTED|Overall Study||28
1724479|NCT00286156|4221961|P3|NOT COMPLETED|Overall Study||1
1724480|NCT00286156|4221962|P2|NOT COMPLETED|Overall Study||1
1724481|NCT00286156|4221963|P1|NOT COMPLETED|Overall Study||2
1724482|NCT00286156|4221961|P3|COMPLETED|Overall Study||9
1724483|NCT00286156|4221962|P2|COMPLETED|Overall Study||9
1724484|NCT00286156|4221963|P1|COMPLETED|Overall Study||8
1724485|NCT00286156|4221961|P3|STARTED|Overall Study||10
1724486|NCT00286156|4221962|P2|STARTED|Overall Study||10
1724487|NCT00286156|4221963|P1|STARTED|Overall Study||10
1724488|NCT00286091|4221976|P2|NOT COMPLETED|Open-label Treatment Phase||71
1724489|NCT00286091|4221977|P1|NOT COMPLETED|Open-label Treatment Phase||77
1724490|NCT00286091|4221976|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
1724491|NCT00286091|4221977|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
1724492|NCT00286091|4221976|P2|Received Treatment|Open-label Treatment Phase||101
1724493|NCT00286091|4221977|P1|Received Treatment|Open-label Treatment Phase||109
1724494|NCT00286091|4221976|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
1724495|NCT00286091|4221977|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
1724496|NCT00286091|4221976|P2|NOT COMPLETED|Double-blind Treatment Phase||593
1724497|NCT00286091|4221977|P1|NOT COMPLETED|Double-blind Treatment Phase||584
1724498|NCT00286091|4221976|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
1724499|NCT00286091|4221977|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
1724500|NCT00286091|4221976|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
1724501|NCT00286091|4221977|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
1724502|NCT00286091|4221976|P2|Received Treatment|Double-blind Treatment Phase||716
1724503|NCT00286091|4221977|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
1724504|NCT00286091|4221976|P2|STARTED|Double-blind Treatment Phase||716
1724505|NCT00286091|4221977|P1|STARTED|Double-blind Treatment Phase||716
1724506|NCT00286078|4221991|P2|NOT COMPLETED|Overall Study||34
1724507|NCT00286078|4221992|P1|NOT COMPLETED|Overall Study||32
1724508|NCT00286078|4221991|P2|COMPLETED|Overall Study||34
1724509|NCT00286078|4221992|P1|COMPLETED|Overall Study||40
1724510|NCT00286078|4221991|P2|12 Weeks|Overall Study||62
1724511|NCT00286078|4221992|P1|12 Weeks|Overall Study||63
1724512|NCT00286078|4221991|P2|STARTED|Overall Study||68
1724513|NCT00286078|4221992|P1|STARTED|Overall Study||72
1724514|NCT00285857|4222000|P1|NOT COMPLETED|Overall Study||4
1724515|NCT00285857|4222000|P1|COMPLETED|Overall Study||26
1724516|NCT00285857|4222000|P1|STARTED|Overall Study||30
1724517|NCT00285818|4222013|P2|NOT COMPLETED|Overall Study||2
1724518|NCT00285818|4222014|P1|NOT COMPLETED|Overall Study||4
1724519|NCT00285818|4222013|P2|COMPLETED|Overall Study||3
1724520|NCT00285818|4222014|P1|COMPLETED|Overall Study||2
1724521|NCT00285818|4222013|P2|STARTED|Overall Study||5
1724522|NCT00285818|4222014|P1|STARTED|Overall Study||6
1724523|NCT00285779|4222022|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
1724524|NCT00285779|4222023|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
1724525|NCT00285779|4222022|P2|COMPLETED|Follow-up Period (wk 24-32)||10
1724526|NCT00285779|4222023|P1|COMPLETED|Follow-up Period (wk 24-32)||8
1724527|NCT00285779|4222022|P2|STARTED|Follow-up Period (wk 24-32)||10
1724528|NCT00285779|4222023|P1|STARTED|Follow-up Period (wk 24-32)||9
1724529|NCT00285779|4222022|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
1724530|NCT00285779|4222023|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
1724531|NCT00285779|4222022|P2|COMPLETED|Open Label Period (wk 12-24)||10
1724532|NCT00285779|4222023|P1|COMPLETED|Open Label Period (wk 12-24)||9
1724533|NCT00285779|4222022|P2|STARTED|Open Label Period (wk 12-24)||12
1724534|NCT00285779|4222023|P1|STARTED|Open Label Period (wk 12-24)||11
1724535|NCT00285779|4222022|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
1724536|NCT00285779|4222023|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
1724537|NCT00285779|4222022|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
1724538|NCT00285779|4222023|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
1724539|NCT00285779|4222022|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
1724540|NCT00285779|4222023|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
1724541|NCT00285649|4222059|P3|NOT COMPLETED|Overall Study||6
1724542|NCT00285649|4222060|P2|NOT COMPLETED|Overall Study||6
1724543|NCT00285649|4222061|P1|NOT COMPLETED|Overall Study||9
1724544|NCT00285649|4222059|P3|COMPLETED|Overall Study||42
1724545|NCT00285649|4222060|P2|COMPLETED|Overall Study||66
1724546|NCT00285649|4222061|P1|COMPLETED|Overall Study||63
1724547|NCT00285649|4222059|P3|STARTED|Overall Study||48
1724548|NCT00285649|4222060|P2|STARTED|Overall Study||72
1724549|NCT00285649|4222061|P1|STARTED|Overall Study||72
1724550|NCT00285584|4222071|P2|NOT COMPLETED|Month 9||3
1724551|NCT00285584|4222072|P1|NOT COMPLETED|Month 9||1
1724552|NCT00285584|4222071|P2|COMPLETED|Month 9||14
1724553|NCT00285584|4222072|P1|COMPLETED|Month 9||15
1724554|NCT00285584|4222071|P2|STARTED|Month 9||17
1724555|NCT00285584|4222072|P1|STARTED|Month 9||16
1724556|NCT00285584|4222071|P2|NOT COMPLETED|Month 6||1
1724557|NCT00285584|4222072|P1|NOT COMPLETED|Month 6||0
1724558|NCT00285584|4222071|P2|COMPLETED|Month 6||17
1724559|NCT00285584|4222072|P1|COMPLETED|Month 6||16
1724560|NCT00285584|4222071|P2|STARTED|Month 6||18
1724561|NCT00285584|4222072|P1|STARTED|Month 6||16
1724562|NCT00285584|4222071|P2|NOT COMPLETED|Month 3||3
1724563|NCT00285584|4222072|P1|NOT COMPLETED|Month 3||4
1724564|NCT00285584|4222071|P2|COMPLETED|Month 3||18
1724565|NCT00285584|4222072|P1|COMPLETED|Month 3||16
1724566|NCT00285584|4222071|P2|STARTED|Month 3||21
1724567|NCT00285584|4222072|P1|STARTED|Month 3||20
1724568|NCT00285584|4222071|P2|NOT COMPLETED|Enrollment (Month 0)||0
1724569|NCT00285584|4222072|P1|NOT COMPLETED|Enrollment (Month 0)||0
1724570|NCT00285584|4222071|P2|COMPLETED|Enrollment (Month 0)||21
1724571|NCT00285584|4222072|P1|COMPLETED|Enrollment (Month 0)||20
1724572|NCT00285584|4222071|P2|STARTED|Enrollment (Month 0)||21
1724573|NCT00285584|4222072|P1|STARTED|Enrollment (Month 0)||20
1724574|NCT00285467|4222086|P2|NOT COMPLETED|Overall Study||0
1724575|NCT00285467|4222087|P1|NOT COMPLETED|Overall Study||0
1724576|NCT00285467|4222086|P2|COMPLETED|Overall Study||22
1724577|NCT00285467|4222087|P1|COMPLETED|Overall Study||25
1724578|NCT00285467|4222086|P2|STARTED|Overall Study||22
1724579|NCT00285467|4222087|P1|STARTED|Overall Study||25
1724580|NCT00285246|4222095|P1|NOT COMPLETED|Overall Study||48
1724581|NCT00285246|4222095|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
1724582|NCT00285246|4222095|P1|STARTED|Overall Study||838
1724583|NCT00285207|4222104|P2|NOT COMPLETED|Overall Study||6
1724584|NCT00285207|4222105|P1|NOT COMPLETED|Overall Study||9
1724585|NCT00285207|4222104|P2|COMPLETED|Overall Study||71
1724586|NCT00285207|4222105|P1|COMPLETED|Overall Study||61
1724587|NCT00285207|4222104|P2|Treated|Overall Study||75
1724588|NCT00285207|4222105|P1|Treated|Overall Study||63
1724589|NCT00285207|4222104|P2|STARTED|Overall Study||77
1724590|NCT00285207|4222105|P1|STARTED|Overall Study||70
1724591|NCT00285012|4222113|P2|NOT COMPLETED|Received Study Tx||94
1724592|NCT00285012|4222114|P1|NOT COMPLETED|Received Study Tx||72
1724593|NCT00285012|4222113|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
1724594|NCT00285012|4222114|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
1724595|NCT00285012|4222113|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
1724596|NCT00285012|4222114|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
1724597|NCT00285012|4222113|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
1724598|NCT00285012|4222114|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
1724599|NCT00285012|4222113|P2|STARTED|Received Study Tx||251
1724600|NCT00285012|4222114|P1|STARTED|Received Study Tx||248
1724601|NCT00285012|4222113|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
1724602|NCT00285012|4222114|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
1724603|NCT00285012|4222113|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
1724604|NCT00285012|4222114|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
1724605|NCT00285012|4222113|P2|STARTED|Assigned to Study Treatment (Tx)||254
1724606|NCT00285012|4222114|P1|STARTED|Assigned to Study Treatment (Tx)||250
1724607|NCT00284934|4222140|P2|NOT COMPLETED|Overall Study||3
1724608|NCT00284934|4222141|P1|NOT COMPLETED|Overall Study||4
1724609|NCT00284934|4222140|P2|COMPLETED|Overall Study||43
1724610|NCT00284934|4222141|P1|COMPLETED|Overall Study||44
1724611|NCT00284934|4222140|P2|Intent-to-treat Population (ITT)|Overall Study||45
1724612|NCT00284934|4222141|P1|Intent-to-treat Population (ITT)|Overall Study||47
1724613|NCT00284934|4222140|P2|STARTED|Overall Study||46
1724614|NCT00284934|4222141|P1|STARTED|Overall Study||48
1724615|NCT00284856|4222156|P3|NOT COMPLETED|Overall Study||60
1724616|NCT00284856|4222157|P2|NOT COMPLETED|Overall Study||50
1724617|NCT00284856|4222158|P1|NOT COMPLETED|Overall Study||51
1724618|NCT00284856|4222156|P3|COMPLETED|Overall Study||276
1724619|NCT00284856|4222157|P2|COMPLETED|Overall Study||286
1724620|NCT00284856|4222158|P1|COMPLETED|Overall Study||296
1724621|NCT00284856|4222156|P3|STARTED|Overall Study||336
1724622|NCT00284856|4222157|P2|STARTED|Overall Study||336
1724623|NCT00284856|4222158|P1|STARTED|Overall Study||347
1724624|NCT00284739|4222174|P2|NOT COMPLETED|Overall Study||0
1724625|NCT00284739|4222175|P1|NOT COMPLETED|Overall Study||0
1724626|NCT00284739|4222174|P2|COMPLETED|Overall Study||9
1724627|NCT00284739|4222175|P1|COMPLETED|Overall Study||11
1724628|NCT00284739|4222174|P2|STARTED|Overall Study||9
1724629|NCT00284739|4222175|P1|STARTED|Overall Study||11
1724630|NCT00284557|4222187|P2|NOT COMPLETED|Overall Study||13
1724631|NCT00284557|4222188|P1|NOT COMPLETED|Overall Study||9
1724632|NCT00284557|4222187|P2|COMPLETED|Overall Study||50
1724633|NCT00284557|4222188|P1|COMPLETED|Overall Study||58
1724634|NCT00284557|4222187|P2|STARTED|Overall Study||63
1724635|NCT00284557|4222188|P1|STARTED|Overall Study||67
1724636|NCT00284518|4222200|P4|NOT COMPLETED|Overall Study||33
1724637|NCT00284518|4222201|P3|NOT COMPLETED|Overall Study||28
1724638|NCT00284518|4222202|P2|NOT COMPLETED|Overall Study||28
1724639|NCT00284518|4222203|P1|NOT COMPLETED|Overall Study||26
1724640|NCT00284518|4222200|P4|COMPLETED|Overall Study||61
1724641|NCT00284518|4222201|P3|COMPLETED|Overall Study||67
1724642|NCT00284518|4222202|P2|COMPLETED|Overall Study||66
1724643|NCT00284518|4222203|P1|COMPLETED|Overall Study||71
1724644|NCT00284518|4222200|P4|STARTED|Overall Study||94
1724645|NCT00284518|4222201|P3|STARTED|Overall Study||95
1724646|NCT00284518|4222202|P2|STARTED|Overall Study||94
1724647|NCT00284518|4222203|P1|STARTED|Overall Study||97
1724648|NCT00284180|4222243|P2|NOT COMPLETED|Overall Study||4
1724649|NCT00284180|4222244|P1|NOT COMPLETED|Overall Study||0
1724650|NCT00284180|4222243|P2|COMPLETED|Overall Study||17
1724651|NCT00284180|4222244|P1|COMPLETED|Overall Study||11
1724652|NCT00284180|4222243|P2|STARTED|Overall Study||21
1724653|NCT00284180|4222244|P1|STARTED|Overall Study||11
1724654|NCT00284154|4222250|P1|NOT COMPLETED|Overall Study||42
1724655|NCT00284154|4222250|P1|COMPLETED|Overall Study||9
1724656|NCT00284154|4222250|P1|STARTED|Overall Study||51
1724657|NCT00284141|4222257|P1|NOT COMPLETED|Overall Study||98
1724658|NCT00284141|4222257|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
1724659|NCT00284141|4222257|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
1724660|NCT00284141|4222257|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
1724661|NCT00284141|4222257|P1|STARTED|Overall Study||98
1724662|NCT00284089|4222280|P4|NOT COMPLETED|Extension Phase||12
1724663|NCT00284089|4222281|P3|NOT COMPLETED|Extension Phase||6
1724664|NCT00284089|4222282|P2|NOT COMPLETED|Extension Phase||0
1724665|NCT00284089|4222283|P1|NOT COMPLETED|Extension Phase||2
1724666|NCT00284089|4222280|P4|COMPLETED|Extension Phase||21
1724667|NCT00284089|4222281|P3|COMPLETED|Extension Phase||22
1724668|NCT00284089|4222282|P2|COMPLETED|Extension Phase||6
1724669|NCT00284089|4222283|P1|COMPLETED|Extension Phase||1
1724670|NCT00284089|4222280|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
1724671|NCT00284089|4222281|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
1724672|NCT00284089|4222282|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
1724673|NCT00284089|4222283|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
1724674|NCT00284089|4222280|P4|NOT COMPLETED|Multiple Dose Phase||4
1724675|NCT00284089|4222281|P3|NOT COMPLETED|Multiple Dose Phase||4
1724676|NCT00284089|4222282|P2|NOT COMPLETED|Multiple Dose Phase||0
1724677|NCT00284089|4222283|P1|NOT COMPLETED|Multiple Dose Phase||1
1724678|NCT00284089|4222280|P4|COMPLETED|Multiple Dose Phase||37
1724679|NCT00284089|4222281|P3|COMPLETED|Multiple Dose Phase||31
1724680|NCT00284089|4222282|P2|COMPLETED|Multiple Dose Phase||6
1724681|NCT00284089|4222283|P1|COMPLETED|Multiple Dose Phase||4
1724682|NCT00284089|4222280|P4|STARTED|Multiple Dose Phase||41
1724683|NCT00284089|4222281|P3|STARTED|Multiple Dose Phase||35
1724684|NCT00284089|4222282|P2|STARTED|Multiple Dose Phase||6
1724685|NCT00284089|4222283|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
1724686|NCT00284089|4222280|P4|NOT COMPLETED|Single Dose Phase||0
1724687|NCT00284089|4222281|P3|NOT COMPLETED|Single Dose Phase||0
1724688|NCT00284089|4222282|P2|NOT COMPLETED|Single Dose Phase||0
1724689|NCT00284089|4222283|P1|NOT COMPLETED|Single Dose Phase||0
1724690|NCT00284089|4222280|P4|COMPLETED|Single Dose Phase||0
1724691|NCT00284089|4222281|P3|COMPLETED|Single Dose Phase||0
1724692|NCT00284089|4222282|P2|COMPLETED|Single Dose Phase||6
1724693|NCT00284089|4222283|P1|COMPLETED|Single Dose Phase||6
1724694|NCT00284089|4222280|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
1724695|NCT00284089|4222281|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
1724696|NCT00284089|4222282|P2|STARTED|Single Dose Phase||6
1724697|NCT00284089|4222283|P1|STARTED|Single Dose Phase||6
1724698|NCT00284050|4222312|P3|NOT COMPLETED|Overall Study||9
1724699|NCT00284050|4222313|P2|NOT COMPLETED|Overall Study||5
1724700|NCT00284050|4222314|P1|NOT COMPLETED|Overall Study||5
1724701|NCT00284050|4222312|P3|COMPLETED|Overall Study||40
1724702|NCT00284050|4222313|P2|COMPLETED|Overall Study||46
1724703|NCT00284050|4222314|P1|COMPLETED|Overall Study||46
1724704|NCT00284050|4222312|P3|STARTED|Overall Study||49
1724705|NCT00284050|4222313|P2|STARTED|Overall Study||51
1724706|NCT00284050|4222314|P1|STARTED|Overall Study||51
1724707|NCT00283959|4222328|P1|NOT COMPLETED|Extension Period||1
1724708|NCT00283959|4222328|P1|COMPLETED|Extension Period||3
1724709|NCT00283959|4222328|P1|STARTED|Extension Period||4
1724710|NCT00283959|4222328|P1|NOT COMPLETED|Treatment Period||0
1724711|NCT00283959|4222328|P1|COMPLETED|Treatment Period||4
1724712|NCT00283959|4222328|P1|Pharmacodynamics (PD) Population|Treatment Period||4
1724713|NCT00283959|4222328|P1|Safety Population|Treatment Period||4
1724714|NCT00283959|4222328|P1|STARTED|Treatment Period||4
1724715|NCT00283933|4222333|P1|NOT COMPLETED|Extension Period||0
1724716|NCT00283933|4222333|P1|COMPLETED|Extension Period||5
1724717|NCT00283933|4222333|P1|STARTED|Extension Period||5
1724718|NCT00283933|4222333|P1|NOT COMPLETED|Treatment Period||0
1724719|NCT00283933|4222333|P1|COMPLETED|Treatment Period||5
1724720|NCT00283933|4222333|P1|Pharmacodynamic (PD) Population|Treatment Period||5
1724721|NCT00283933|4222333|P1|Safety Population|Treatment Period||5
1724722|NCT00283933|4222333|P1|STARTED|Treatment Period||5
1724723|NCT00283868|4222340|P2|NOT COMPLETED|Overall Study||8
1724724|NCT00283868|4222341|P1|NOT COMPLETED|Overall Study||7
1724725|NCT00283868|4222340|P2|COMPLETED|Overall Study||103
1724726|NCT00283868|4222341|P1|COMPLETED|Overall Study||104
1724727|NCT00283868|4222340|P2|STARTED|Overall Study||111
1724728|NCT00283868|4222341|P1|STARTED|Overall Study||111
1724729|NCT00283842|4222358|P5|NOT COMPLETED|Overall Study||15
1724730|NCT00283842|4222359|P4|NOT COMPLETED|Overall Study||27
1724731|NCT00283842|4222360|P3|NOT COMPLETED|Overall Study||31
1724732|NCT00283842|4222361|P2|NOT COMPLETED|Overall Study||18
1724733|NCT00283842|4222362|P1|NOT COMPLETED|Overall Study||12
1724734|NCT00283842|4222358|P5|COMPLETED|Overall Study||75
1724735|NCT00283842|4222359|P4|COMPLETED|Overall Study||42
1724736|NCT00283842|4222360|P3|COMPLETED|Overall Study||68
1724737|NCT00283842|4222361|P2|COMPLETED|Overall Study||69
1724738|NCT00283842|4222362|P1|COMPLETED|Overall Study||51
1724739|NCT00283842|4222358|P5|STARTED|Overall Study||90
1724740|NCT00283842|4222359|P4|STARTED|Overall Study||69
1724741|NCT00283842|4222360|P3|STARTED|Overall Study||99
1724742|NCT00283842|4222361|P2|STARTED|Overall Study||87
1724743|NCT00283842|4222362|P1|STARTED|Overall Study||63
1724744|NCT00283816|4222381|P2|NOT COMPLETED|Overall Study||2
1724745|NCT00283816|4222382|P1|NOT COMPLETED|Overall Study||2
1724746|NCT00283816|4222381|P2|COMPLETED|Overall Study||16
1724747|NCT00283816|4222382|P1|COMPLETED|Overall Study||16
1724748|NCT00283816|4222381|P2|STARTED|Overall Study||18
1724749|NCT00283816|4222382|P1|STARTED|Overall Study||18
1724750|NCT00283803|4222394|P1|NOT COMPLETED|Overall Study||13
1724751|NCT00283803|4222394|P1|COMPLETED|Overall Study||19
1724752|NCT00283803|4222394|P1|STARTED|Overall Study||32
1724753|NCT00283712|4222402|P2|NOT COMPLETED|Overall Study||1
1724754|NCT00283712|4222403|P1|NOT COMPLETED|Overall Study||0
1724755|NCT00283712|4222402|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
1724756|NCT00283712|4222403|P1|COMPLETED|Overall Study||10
1724757|NCT00283712|4222402|P2|Per-Protocol Sample|Overall Study||7
1724758|NCT00283712|4222403|P1|Per-Protocol Sample|Overall Study||6
1724759|NCT00283712|4222402|P2|Safety Sample|Overall Study||10
1724760|NCT00283712|4222403|P1|Safety Sample|Overall Study||10
1724761|NCT00283712|4222402|P2|Intent-to-treat Sample|Overall Study||10
1724762|NCT00283712|4222403|P1|Intent-to-treat Sample|Overall Study||10
1724763|NCT00283712|4222402|P2|STARTED|Overall Study||10
1724764|NCT00283712|4222403|P1|STARTED|Overall Study||10
1724765|NCT00283686|4222441|P4|NOT COMPLETED|Overall Study||32
1724766|NCT00283686|4222442|P3|NOT COMPLETED|Overall Study||33
1724767|NCT00283686|4222443|P2|NOT COMPLETED|Overall Study||41
1724768|NCT00283686|4222444|P1|NOT COMPLETED|Overall Study||29
1724769|NCT00283686|4222441|P4|COMPLETED|Overall Study||109
1724770|NCT00283686|4222442|P3|COMPLETED|Overall Study||111
1724771|NCT00283686|4222443|P2|COMPLETED|Overall Study||92
1724772|NCT00283686|4222444|P1|COMPLETED|Overall Study||111
1724773|NCT00283686|4222441|P4|STARTED|Overall Study||141
1724774|NCT00283686|4222442|P3|STARTED|Overall Study||144
1724775|NCT00283686|4222443|P2|STARTED|Overall Study||133
1724776|NCT00283686|4222444|P1|STARTED|Overall Study||140
1724777|NCT00283595|4222488|P2|NOT COMPLETED|Overall Study||2
1724778|NCT00283595|4222489|P1|NOT COMPLETED|Overall Study||1
1724779|NCT00283595|4222488|P2|COMPLETED|Overall Study||9
1724780|NCT00283595|4222489|P1|COMPLETED|Overall Study||9
1724781|NCT00283595|4222488|P2|STARTED|Overall Study||11
1724782|NCT00283595|4222489|P1|STARTED|Overall Study||10
1724783|NCT00283504|4222499|P2|NOT COMPLETED|Overall Study||0
1724784|NCT00283504|4222500|P1|NOT COMPLETED|Overall Study||0
1724785|NCT00283504|4222499|P2|COMPLETED|Overall Study||6
1724786|NCT00283504|4222500|P1|COMPLETED|Overall Study||7
1724787|NCT00283504|4222499|P2|STARTED|Overall Study||6
1724788|NCT00283504|4222500|P1|STARTED|Overall Study||7
1724789|NCT00283439|4222514|P4|NOT COMPLETED|Overall Study||9
1724790|NCT00283439|4222515|P3|NOT COMPLETED|Overall Study||11
1724791|NCT00283439|4222516|P2|NOT COMPLETED|Overall Study||11
1724792|NCT00283439|4222517|P1|NOT COMPLETED|Overall Study||8
1724793|NCT00283439|4222514|P4|COMPLETED|Overall Study||0
1724794|NCT00283439|4222515|P3|COMPLETED|Overall Study||0
1724795|NCT00283439|4222516|P2|COMPLETED|Overall Study||0
1724796|NCT00283439|4222517|P1|COMPLETED|Overall Study||0
1724797|NCT00283439|4222514|P4|STARTED|Overall Study||9
1724798|NCT00283439|4222515|P3|STARTED|Overall Study||11
1724799|NCT00283439|4222516|P2|STARTED|Overall Study||11
1724800|NCT00283439|4222517|P1|STARTED|Overall Study||8
1724801|NCT00283400|4222543|P4|NOT COMPLETED|Overall Study||0
1724802|NCT00283400|4222544|P3|NOT COMPLETED|Overall Study||1
1724803|NCT00283400|4222545|P2|NOT COMPLETED|Overall Study||1
1724804|NCT00283400|4222546|P1|NOT COMPLETED|Overall Study||2
1724805|NCT00283400|4222543|P4|COMPLETED|Overall Study||0
1724806|NCT00283400|4222544|P3|COMPLETED|Overall Study||6
1724807|NCT00283400|4222545|P2|COMPLETED|Overall Study||19
1724808|NCT00283400|4222546|P1|COMPLETED|Overall Study||18
1724809|NCT00283400|4222543|P4|STARTED|Overall Study||0
1724810|NCT00283400|4222544|P3|STARTED|Overall Study||7
1724811|NCT00283400|4222545|P2|STARTED|Overall Study||20
1724812|NCT00283400|4222546|P1|STARTED|Overall Study||20
1724813|NCT00283387|4222564|P2|NOT COMPLETED|Second Intervention||0
1724814|NCT00283387|4222565|P1|NOT COMPLETED|Second Intervention||0
1724815|NCT00283387|4222564|P2|COMPLETED|Second Intervention||5
1724816|NCT00283387|4222565|P1|COMPLETED|Second Intervention||5
1724817|NCT00283387|4222564|P2|STARTED|Second Intervention||5
1724818|NCT00283387|4222565|P1|STARTED|Second Intervention||5
1724819|NCT00283387|4222564|P2|NOT COMPLETED|Washout Period of 2 Months||0
1724820|NCT00283387|4222565|P1|NOT COMPLETED|Washout Period of 2 Months||0
1724821|NCT00283387|4222564|P2|COMPLETED|Washout Period of 2 Months||5
1724822|NCT00283387|4222565|P1|COMPLETED|Washout Period of 2 Months||5
1724823|NCT00283387|4222564|P2|STARTED|Washout Period of 2 Months||5
1724824|NCT00283387|4222565|P1|STARTED|Washout Period of 2 Months||5
1724825|NCT00283387|4222564|P2|NOT COMPLETED|First Intervention||2
1724826|NCT00283387|4222565|P1|NOT COMPLETED|First Intervention||1
1724827|NCT00283387|4222564|P2|COMPLETED|First Intervention||5
1724828|NCT00283387|4222565|P1|COMPLETED|First Intervention||5
1724829|NCT00283387|4222564|P2|STARTED|First Intervention||7
1724830|NCT00283387|4222565|P1|STARTED|First Intervention||6
1724831|NCT00283296|4222571|P1|NOT COMPLETED|Overall Study||5
1724832|NCT00283296|4222571|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
1724833|NCT00283296|4222571|P1|STARTED|Overall Study||14
1724834|NCT00283244|4222580|P3|NOT COMPLETED|Overall Study||51
1724835|NCT00283244|4222581|P2|NOT COMPLETED|Overall Study||51
1724836|NCT00283244|4222582|P1|NOT COMPLETED|Overall Study||18
1724837|NCT00283244|4222580|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
1724838|NCT00283244|4222581|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
1724839|NCT00283244|4222582|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
1724840|NCT00283244|4222580|P3|STARTED|Overall Study||51
1724841|NCT00283244|4222581|P2|STARTED|Overall Study||51
1724842|NCT00283244|4222582|P1|STARTED|Overall Study||44
1724843|NCT00283075|4222602|P2|NOT COMPLETED|Overall Study||0
1724844|NCT00283075|4222603|P1|NOT COMPLETED|Overall Study||0
1724845|NCT00283075|4222602|P2|COMPLETED|Overall Study||6
1724846|NCT00283075|4222603|P1|COMPLETED|Overall Study||25
1724847|NCT00283075|4222602|P2|STARTED|Overall Study||6
1724848|NCT00283075|4222603|P1|STARTED|Overall Study||25
1724849|NCT00283062|4222618|P4|NOT COMPLETED|Overall Study||49
1724850|NCT00283062|4222619|P3|NOT COMPLETED|Overall Study||41
1724851|NCT00283062|4222620|P2|NOT COMPLETED|Overall Study||7
1724852|NCT00283062|4222621|P1|NOT COMPLETED|Overall Study||12
1724853|NCT00283062|4222618|P4|COMPLETED|Overall Study||13
1724854|NCT00283062|4222619|P3|COMPLETED|Overall Study||15
1724855|NCT00283062|4222620|P2|COMPLETED|Overall Study||48
1724856|NCT00283062|4222621|P1|COMPLETED|Overall Study||43
1724857|NCT00283062|4222618|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
1724858|NCT00283062|4222619|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
1724859|NCT00283062|4222620|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
1724860|NCT00283062|4222621|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
1724861|NCT00283062|4222618|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
1724862|NCT00283062|4222619|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
1724863|NCT00283062|4222620|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
1724864|NCT00283062|4222621|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
1724865|NCT00283062|4222618|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
1724866|NCT00283062|4222619|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
1724867|NCT00283062|4222620|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
1724868|NCT00283062|4222621|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
1724869|NCT00283062|4222618|P4|STARTED|Overall Study||62
1724870|NCT00283062|4222619|P3|STARTED|Overall Study||56
1724871|NCT00283062|4222620|P2|STARTED|Overall Study||55
1724872|NCT00283062|4222621|P1|STARTED|Overall Study||55
1724873|NCT00283049|4222654|P3|NOT COMPLETED|Overall Study||54
1724874|NCT00283049|4222655|P2|NOT COMPLETED|Overall Study||45
1724875|NCT00283049|4222656|P1|NOT COMPLETED|Overall Study||58
1724876|NCT00283049|4222654|P3|COMPLETED|Overall Study||76
1724877|NCT00283049|4222655|P2|COMPLETED|Overall Study||83
1724878|NCT00283049|4222656|P1|COMPLETED|Overall Study||70
1724879|NCT00283049|4222654|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
1724880|NCT00283049|4222655|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
1724881|NCT00283049|4222656|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
1724882|NCT00282984|4222684|P2|NOT COMPLETED|Overall Study||61
1724883|NCT00282984|4222685|P1|NOT COMPLETED|Overall Study||51
1724884|NCT00282984|4222684|P2|COMPLETED|Overall Study||289
1724885|NCT00282984|4222685|P1|COMPLETED|Overall Study||302
1724886|NCT00282984|4222684|P2|STARTED|Overall Study||350
1724887|NCT00282984|4222685|P1|STARTED|Overall Study||353
1724888|NCT00282971|4222711|P2|NOT COMPLETED|Overall Study||22
1724889|NCT00282971|4222712|P1|NOT COMPLETED|Overall Study||34
1724890|NCT00282971|4222711|P2|COMPLETED|Overall Study||149
1724891|NCT00282971|4222712|P1|COMPLETED|Overall Study||146
1724892|NCT00282971|4222711|P2|STARTED|Overall Study||171
1724893|NCT00282971|4222712|P1|STARTED|Overall Study||180
1724894|NCT00282919|4222722|P1|NOT COMPLETED|Overall Study||7
1724895|NCT00282919|4222722|P1|COMPLETED|Overall Study||103
1724896|NCT00282919|4222722|P1|STARTED|Overall Study||110
1724897|NCT00282867|4222737|P3|NOT COMPLETED|Overall Study||0
1724898|NCT00282867|4222738|P2|NOT COMPLETED|Overall Study||1
1724899|NCT00282867|4222739|P1|NOT COMPLETED|Overall Study||1
1724900|NCT00282867|4222737|P3|COMPLETED|Overall Study||25
1724901|NCT00282867|4222738|P2|COMPLETED|Overall Study||24
1724902|NCT00282867|4222739|P1|COMPLETED|Overall Study||23
1724903|NCT00282867|4222737|P3|STARTED|Overall Study||25
1724904|NCT00282867|4222738|P2|STARTED|Overall Study||25
1724905|NCT00282867|4222739|P1|STARTED|Overall Study||24
1724906|NCT00282828|4222756|P3|NOT COMPLETED|Overall Study||9
1724907|NCT00282828|4222757|P2|NOT COMPLETED|Overall Study||12
1724908|NCT00282828|4222758|P1|NOT COMPLETED|Overall Study||6
1724909|NCT00282828|4222756|P3|COMPLETED|Overall Study||50
1724910|NCT00282828|4222757|P2|COMPLETED|Overall Study||47
1724911|NCT00282828|4222758|P1|COMPLETED|Overall Study||57
1724912|NCT00282828|4222756|P3|STARTED|Overall Study||59
1724913|NCT00282828|4222757|P2|STARTED|Overall Study||59
1724914|NCT00282828|4222758|P1|STARTED|Overall Study||63
1724915|NCT00282815|4222771|P2|NOT COMPLETED|Overall Study||6
1724916|NCT00282815|4222772|P1|NOT COMPLETED|Overall Study||7
1724917|NCT00282815|4222771|P2|COMPLETED|Overall Study||11
1724918|NCT00282815|4222772|P1|COMPLETED|Overall Study||8
1724919|NCT00282815|4222771|P2|STARTED|Overall Study||17
1724920|NCT00282815|4222772|P1|STARTED|Overall Study||15
1724921|NCT00282672|4222785|P4|NOT COMPLETED|5 Year: Follow up||5
1724922|NCT00282672|4222786|P3|NOT COMPLETED|5 Year: Follow up||0
1724923|NCT00282672|4222787|P2|NOT COMPLETED|5 Year: Follow up||5
1724924|NCT00282672|4222788|P1|NOT COMPLETED|5 Year: Follow up||1
1724925|NCT00282672|4222785|P4|COMPLETED|5 Year: Follow up||20
1724926|NCT00282672|4222786|P3|COMPLETED|5 Year: Follow up||12
1724927|NCT00282672|4222787|P2|COMPLETED|5 Year: Follow up||27
1724928|NCT00282672|4222788|P1|COMPLETED|5 Year: Follow up||14
1724929|NCT00282672|4222785|P4|STARTED|5 Year: Follow up|11 withdrew|25
1724930|NCT00282672|4222786|P3|STARTED|5 Year: Follow up|3 withdrew|12
1724931|NCT00282672|4222787|P2|STARTED|5 Year: Follow up|7 withdrew|32
1724932|NCT00282672|4222788|P1|STARTED|5 Year: Follow up|1 withdrew|15
1724933|NCT00282672|4222785|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
1724934|NCT00282672|4222786|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
1724935|NCT00282672|4222787|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
1724936|NCT00282672|4222788|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
1724937|NCT00282672|4222785|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
1724938|NCT00282672|4222786|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
1724939|NCT00282672|4222787|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
1724940|NCT00282672|4222788|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
1724941|NCT00282672|4222785|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
1724942|NCT00282672|4222786|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
1724943|NCT00282672|4222787|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
1724944|NCT00282672|4222788|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
1724945|NCT00282672|4222785|P4|NOT COMPLETED|1 Year||4
1724946|NCT00282672|4222786|P3|NOT COMPLETED|1 Year||1
1724947|NCT00282672|4222787|P2|NOT COMPLETED|1 Year||2
1724948|NCT00282672|4222788|P1|NOT COMPLETED|1 Year||3
1724949|NCT00282672|4222785|P4|COMPLETED|1 Year||38
1724950|NCT00282672|4222786|P3|COMPLETED|1 Year||20
1724951|NCT00282672|4222787|P2|COMPLETED|1 Year||40
1724952|NCT00282672|4222788|P1|COMPLETED|1 Year||19
1724953|NCT00282672|4222785|P4|STARTED|1 Year||42
1724954|NCT00282672|4222786|P3|STARTED|1 Year||21
1724955|NCT00282672|4222787|P2|STARTED|1 Year||42
1724956|NCT00282672|4222788|P1|STARTED|1 Year||22
1724957|NCT00282568|4222836|P1|NOT COMPLETED|Extended Treatment Period||24
1724958|NCT00282568|4222836|P1|COMPLETED|Extended Treatment Period||42
1724959|NCT00282568|4222836|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
1724960|NCT00282568|4222836|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
1724961|NCT00282568|4222836|P1|COMPLETED|Pharmacokinetic Treatment Period||67
1724962|NCT00282568|4222836|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
1724963|NCT00282568|4222836|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
1724964|NCT00282568|4222836|P1|STARTED|Pharmacokinetic Treatment Period||70
1724965|NCT00282464|4222862|P2|NOT COMPLETED|Overall Study||62
1724966|NCT00282464|4222863|P1|NOT COMPLETED|Overall Study||73
1724967|NCT00282464|4222862|P2|COMPLETED|Overall Study||134
1724968|NCT00282464|4222863|P1|COMPLETED|Overall Study||112
1724969|NCT00282464|4222862|P2|STARTED|Overall Study||196
1724970|NCT00282464|4222863|P1|STARTED|Overall Study||185
1724971|NCT00282438|4222913|P2|NOT COMPLETED|Overall Study||1
1724972|NCT00282438|4222914|P1|NOT COMPLETED|Overall Study||1
1724973|NCT00282438|4222913|P2|COMPLETED|Overall Study||0
1724974|NCT00282438|4222914|P1|COMPLETED|Overall Study||0
1724975|NCT00282438|4222913|P2|STARTED|Overall Study||1
1724976|NCT00282438|4222914|P1|STARTED|Overall Study||1
1724977|NCT00282412|4222924|P1|NOT COMPLETED|Overall Study||2
1724978|NCT00282412|4222924|P1|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
1724979|NCT00282412|4222924|P1|STARTED|Overall Study||4
1724980|NCT00282347|4222930|P2|NOT COMPLETED|B Cell Follow-up Period||0
1724981|NCT00282347|4222931|P1|NOT COMPLETED|B Cell Follow-up Period||5
1724982|NCT00282347|4222930|P2|COMPLETED|B Cell Follow-up Period||4
1724983|NCT00282347|4222931|P1|COMPLETED|B Cell Follow-up Period||15
1724984|NCT00282347|4222930|P2|STARTED|B Cell Follow-up Period||4
1724985|NCT00282347|4222931|P1|STARTED|B Cell Follow-up Period||20
1724986|NCT00282347|4222930|P2|NOT COMPLETED|Safety Follow-up Period||6
1724987|NCT00282347|4222931|P1|NOT COMPLETED|Safety Follow-up Period||3
1724988|NCT00282347|4222930|P2|COMPLETED|Safety Follow-up Period||57
1724989|NCT00282347|4222931|P1|COMPLETED|Safety Follow-up Period||64
1724990|NCT00282347|4222930|P2|STARTED|Safety Follow-up Period||63
1724991|NCT00282347|4222931|P1|STARTED|Safety Follow-up Period||67
1724992|NCT00282347|4222930|P2|NOT COMPLETED|Treatment Period||9
1724993|NCT00282347|4222931|P1|NOT COMPLETED|Treatment Period||5
1724994|NCT00282347|4222930|P2|COMPLETED|Treatment Period||63
1724995|NCT00282347|4222931|P1|COMPLETED|Treatment Period||67
1724996|NCT00282347|4222930|P2|STARTED|Treatment Period||72
1724997|NCT00282347|4222931|P1|STARTED|Treatment Period||72
1724998|NCT00282334|4222957|P2|NOT COMPLETED|Overall Study||5
1724999|NCT00282334|4222958|P1|NOT COMPLETED|Overall Study||8
1725000|NCT00282334|4222957|P2|COMPLETED|Overall Study||118
1725001|NCT00282334|4222958|P1|COMPLETED|Overall Study||105
1725002|NCT00282334|4222957|P2|STARTED|Overall Study||123
1725003|NCT00282334|4222958|P1|STARTED|Overall Study||113
1725004|NCT00282308|4222966|P3|NOT COMPLETED|Safety Follow-up Period||19
1725005|NCT00282308|4222967|P2|NOT COMPLETED|Safety Follow-up Period||0
1725006|NCT00282308|4222968|P1|NOT COMPLETED|Safety Follow-up Period||0
1725007|NCT00282308|4222966|P3|COMPLETED|Safety Follow-up Period||81
1725008|NCT00282308|4222967|P2|COMPLETED|Safety Follow-up Period||0
1725009|NCT00282308|4222968|P1|COMPLETED|Safety Follow-up Period||0
1725010|NCT00282308|4222966|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
1725011|NCT00282308|4222967|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
1725012|NCT00282308|4222968|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
1725013|NCT00282308|4222966|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
1725014|NCT00282308|4222967|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
1725015|NCT00282308|4222968|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
1725016|NCT00282308|4222966|P3|COMPLETED|Optional Extension Re-treatment Period||72
1725017|NCT00282308|4222967|P2|COMPLETED|Optional Extension Re-treatment Period||0
1725018|NCT00282308|4222968|P1|COMPLETED|Optional Extension Re-treatment Period||0
1725019|NCT00282308|4222966|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
1725020|NCT00282308|4222967|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
1725021|NCT00282308|4222968|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
1725022|NCT00282308|4222966|P3|NOT COMPLETED|Treatment Period||0
1725023|NCT00282308|4222967|P2|NOT COMPLETED|Treatment Period||6
1725024|NCT00282308|4222968|P1|NOT COMPLETED|Treatment Period||4
1725025|NCT00282308|4222966|P3|COMPLETED|Treatment Period||0
1725026|NCT00282308|4222967|P2|COMPLETED|Treatment Period||28
1725027|NCT00282308|4222968|P1|COMPLETED|Treatment Period||65
1725028|NCT00282308|4222966|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
1725029|NCT00282308|4222967|P2|STARTED|Treatment Period||34
1725030|NCT00282308|4222968|P1|STARTED|Treatment Period||69
1725031|NCT00282295|4222998|P3|NOT COMPLETED|Overall Study||8
1725032|NCT00282295|4222999|P2|NOT COMPLETED|Overall Study||17
1725033|NCT00282295|4223000|P1|NOT COMPLETED|Overall Study||3
1725034|NCT00282295|4222998|P3|COMPLETED|Overall Study||441
1725035|NCT00282295|4222999|P2|COMPLETED|Overall Study||429
1725036|NCT00282295|4223000|P1|COMPLETED|Overall Study||443
1725037|NCT00282295|4222998|P3|STARTED|Overall Study||449
1725038|NCT00282295|4222999|P2|STARTED|Overall Study||446
1725039|NCT00282295|4223000|P1|STARTED|Overall Study||446
1725040|NCT00282282|4223049|P1|NOT COMPLETED|Overall Study||0
1725041|NCT00282282|4223049|P1|COMPLETED|Overall Study||29
1725042|NCT00282282|4223049|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
1725043|NCT00282256|4223055|P1|NOT COMPLETED|Extension Treatment Period||2
1725044|NCT00282256|4223055|P1|COMPLETED|Extension Treatment Period||16
1725045|NCT00282256|4223055|P1|STARTED|Extension Treatment Period||18
1725046|NCT00282256|4223055|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
1725047|NCT00282256|4223055|P1|COMPLETED|Pharmacokinetic Treatment Period||18
1725048|NCT00282256|4223055|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
1725049|NCT00282256|4223055|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
1725050|NCT00282256|4223055|P1|STARTED|Pharmacokinetic Treatment Period||19
1725051|NCT00282243|4223076|P1|NOT COMPLETED|Extension Treatment Period||22
1725052|NCT00282243|4223076|P1|COMPLETED|Extension Treatment Period||43
1725053|NCT00282243|4223076|P1|STARTED|Extension Treatment Period||65
1725054|NCT00282243|4223076|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
1725055|NCT00282243|4223076|P1|COMPLETED|Pharmacokinetic Treatment Period||65
1725056|NCT00282243|4223076|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
1725057|NCT00282243|4223076|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
1725058|NCT00282243|4223076|P1|STARTED|Pharmacokinetic Treatment Period||70
1725059|NCT00282152|4223102|P2|NOT COMPLETED|Overall Study||0
1725060|NCT00282152|4223103|P1|NOT COMPLETED|Overall Study||1
1725061|NCT00282152|4223102|P2|COMPLETED|Overall Study||15
1725062|NCT00282152|4223103|P1|COMPLETED|Overall Study||14
1725063|NCT00282152|4223102|P2|STARTED|Overall Study||15
1725064|NCT00282152|4223103|P1|STARTED|Overall Study||15
1725065|NCT00282113|4223124|P3|NOT COMPLETED|Overall Study||0
1725066|NCT00282113|4223125|P2|NOT COMPLETED|Overall Study||0
1725067|NCT00282113|4223126|P1|NOT COMPLETED|Overall Study||1
1725068|NCT00282113|4223124|P3|COMPLETED|Overall Study||29
1725069|NCT00282113|4223125|P2|COMPLETED|Overall Study||30
1725070|NCT00282113|4223126|P1|COMPLETED|Overall Study||30
1725071|NCT00282113|4223124|P3|STARTED|Overall Study||29
1725072|NCT00282113|4223125|P2|STARTED|Overall Study||30
1725073|NCT00282113|4223126|P1|STARTED|Overall Study||31
1725074|NCT00282087|4223140|P1|NOT COMPLETED|Overall Study||1
1725075|NCT00282087|4223140|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
1725076|NCT00282087|4223140|P1|STARTED|Overall Study||47
1725077|NCT00282048|4223153|P1|NOT COMPLETED|Overall Study||62
1725078|NCT00282048|4223153|P1|COMPLETED|Overall Study||0
1725079|NCT00282048|4223153|P1|STARTED|Overall Study||62
1725080|NCT00281957|4223167|P2|NOT COMPLETED|Overall Study||42
1725081|NCT00281957|4223168|P1|NOT COMPLETED|Overall Study||67
1725082|NCT00281957|4223167|P2|COMPLETED|Overall Study||0
1725083|NCT00281957|4223168|P1|COMPLETED|Overall Study||0
1725084|NCT00281957|4223167|P2|Eligible and Received Treatment|Overall Study||39
1725085|NCT00281957|4223168|P1|Eligible and Received Treatment|Overall Study||63
1725086|NCT00281957|4223167|P2|Eligible|Overall Study||40
1725087|NCT00281957|4223168|P1|Eligible|Overall Study||66
1725088|NCT00281957|4223167|P2|STARTED|Overall Study||42
1725089|NCT00281957|4223168|P1|STARTED|Overall Study||67
1725090|NCT00281918|4223182|P2|NOT COMPLETED|Overall Study||108
1725091|NCT00281918|4223183|P1|NOT COMPLETED|Overall Study||142
1725092|NCT00281918|4223182|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
1725093|NCT00281918|4223183|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
1725094|NCT00281918|4223182|P2|Safety Population; Received Study Drug|Overall Study||402
1725095|NCT00281918|4223183|P1|Safety Population; Received Study Drug|Overall Study||398
1725096|NCT00281918|4223182|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
1725097|NCT00281918|4223183|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
1725098|NCT00281879|4223217|P8|NOT COMPLETED|Overall Study||1
1725099|NCT00281879|4223218|P7|NOT COMPLETED|Overall Study||0
1725100|NCT00281879|4223219|P6|NOT COMPLETED|Overall Study||9
1725101|NCT00281879|4223220|P5|NOT COMPLETED|Overall Study||6
1725102|NCT00281879|4223221|P4|NOT COMPLETED|Overall Study||0
1725103|NCT00281879|4223222|P3|NOT COMPLETED|Overall Study||20
1725104|NCT00281879|4223223|P2|NOT COMPLETED|Overall Study||36
1725105|NCT00281879|4223224|P1|NOT COMPLETED|Overall Study||128
1725106|NCT00281879|4223217|P8|COMPLETED|Overall Study||0
1725107|NCT00281879|4223218|P7|COMPLETED|Overall Study||0
1725108|NCT00281879|4223219|P6|COMPLETED|Overall Study||0
1725109|NCT00281879|4223220|P5|COMPLETED|Overall Study||0
1725110|NCT00281879|4223221|P4|COMPLETED|Overall Study||0
1725111|NCT00281879|4223222|P3|COMPLETED|Overall Study||0
1725112|NCT00281879|4223223|P2|COMPLETED|Overall Study||0
1725113|NCT00281879|4223224|P1|COMPLETED|Overall Study||0
1725114|NCT00281879|4223217|P8|STARTED|Overall Study||1
1725115|NCT00281879|4223218|P7|STARTED|Overall Study||0
1725116|NCT00281879|4223219|P6|STARTED|Overall Study||9
1725117|NCT00281879|4223220|P5|STARTED|Overall Study||6
1725118|NCT00281879|4223221|P4|STARTED|Overall Study||0
1725119|NCT00281879|4223222|P3|STARTED|Overall Study||20
1725120|NCT00281879|4223223|P2|STARTED|Overall Study||36
1725121|NCT00281879|4223224|P1|STARTED|Overall Study||128
1725122|NCT00281840|4223242|P1|NOT COMPLETED|Overall Study||25
1725123|NCT00281840|4223242|P1|COMPLETED|Overall Study||5
1725124|NCT00281840|4223242|P1|STARTED|Overall Study||30
1725125|NCT00281827|4223247|P1|NOT COMPLETED|Overall Study||0
1725126|NCT00281827|4223247|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
1725127|NCT00281827|4223247|P1|STARTED|Overall Study||22
1725128|NCT00281697|4223258|P2|NOT COMPLETED|Overall Study||197
1725129|NCT00281697|4223259|P1|NOT COMPLETED|Overall Study||401
1725130|NCT00281697|4223258|P2|COMPLETED|Overall Study||28
1725131|NCT00281697|4223259|P1|COMPLETED|Overall Study||58
1725132|NCT00281697|4223258|P2|STARTED|Overall Study||225
1725133|NCT00281697|4223259|P1|STARTED|Overall Study||459
1725134|NCT00281658|4223277|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
1725135|NCT00281658|4223278|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
1725136|NCT00281658|4223279|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
1725137|NCT00281658|4223277|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
1725138|NCT00281658|4223278|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
1725139|NCT00281658|4223279|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
1725140|NCT00281658|4223277|P3|STARTED|Open-label Monotherapy Extension Phase||149
1725141|NCT00281658|4223278|P2|STARTED|Open-label Monotherapy Extension Phase||0
1725142|NCT00281658|4223279|P1|STARTED|Open-label Monotherapy Extension Phase||0
1725143|NCT00281658|4223277|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
1725144|NCT00281658|4223278|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
1725145|NCT00281658|4223279|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
1725146|NCT00281658|4223277|P3|COMPLETED|Double-blind, Randomized Phase||0
1725147|NCT00281658|4223278|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
1725148|NCT00281658|4223279|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
1725149|NCT00281658|4223277|P3|STARTED|Double-blind, Randomized Phase||0
1725150|NCT00281658|4223278|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
1725151|NCT00281658|4223279|P1|STARTED|Double-blind, Randomized Phase||222
1725152|NCT00281632|4223296|P1|NOT COMPLETED|Overall Study||36
1725153|NCT00281632|4223296|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
1725154|NCT00281632|4223296|P1|STARTED|Overall Study||36
1725155|NCT00281580|4223338|P16|NOT COMPLETED|Overall Study||13
1725156|NCT00281580|4223339|P15|NOT COMPLETED|Overall Study||7
1725157|NCT00281580|4223340|P14|NOT COMPLETED|Overall Study||7
1725158|NCT00281580|4223341|P13|NOT COMPLETED|Overall Study||13
1725159|NCT00281580|4223342|P12|NOT COMPLETED|Overall Study||10
1725160|NCT00281580|4223343|P11|NOT COMPLETED|Overall Study||4
1725161|NCT00281580|4223344|P10|NOT COMPLETED|Overall Study||12
1725162|NCT00281580|4223345|P9|NOT COMPLETED|Overall Study||8
1725163|NCT00281580|4223346|P8|NOT COMPLETED|Overall Study||1
1725164|NCT00281580|4223347|P7|NOT COMPLETED|Overall Study||5
1725165|NCT00281580|4223348|P6|NOT COMPLETED|Overall Study||3
1725166|NCT00281580|4223349|P5|NOT COMPLETED|Overall Study||4
1725167|NCT00281580|4223350|P4|NOT COMPLETED|Overall Study||17
1725168|NCT00281580|4223351|P3|NOT COMPLETED|Overall Study||5
1725169|NCT00281580|4223352|P2|NOT COMPLETED|Overall Study||1
1725170|NCT00281580|4223353|P1|NOT COMPLETED|Overall Study||7
1725171|NCT00281580|4223338|P16|COMPLETED|Overall Study||116
1725172|NCT00281580|4223339|P15|COMPLETED|Overall Study||133
1725173|NCT00281580|4223340|P14|COMPLETED|Overall Study||43
1725174|NCT00281580|4223341|P13|COMPLETED|Overall Study||129
1725175|NCT00281580|4223342|P12|COMPLETED|Overall Study||136
1725176|NCT00281580|4223343|P11|COMPLETED|Overall Study||44
1725177|NCT00281580|4223344|P10|COMPLETED|Overall Study||117
1725178|NCT00281580|4223345|P9|COMPLETED|Overall Study||135
1725179|NCT00281580|4223346|P8|COMPLETED|Overall Study||46
1725180|NCT00281580|4223347|P7|COMPLETED|Overall Study||39
1725181|NCT00281580|4223348|P6|COMPLETED|Overall Study||43
1725182|NCT00281580|4223349|P5|COMPLETED|Overall Study||40
1725183|NCT00281580|4223350|P4|COMPLETED|Overall Study||118
1725184|NCT00281580|4223351|P3|COMPLETED|Overall Study||125
1725185|NCT00281580|4223352|P2|COMPLETED|Overall Study||41
1725186|NCT00281580|4223353|P1|COMPLETED|Overall Study||39
1725187|NCT00281580|4223338|P16|STARTED|Overall Study||129
1725188|NCT00281580|4223339|P15|STARTED|Overall Study||140
1725189|NCT00281580|4223340|P14|STARTED|Overall Study||50
1725190|NCT00281580|4223341|P13|STARTED|Overall Study||142
1725191|NCT00281580|4223342|P12|STARTED|Overall Study||146
1725192|NCT00281580|4223343|P11|STARTED|Overall Study||48
1725193|NCT00281580|4223344|P10|STARTED|Overall Study||129
1725194|NCT00281580|4223345|P9|STARTED|Overall Study||143
1725195|NCT00281580|4223346|P8|STARTED|Overall Study||47
1725196|NCT00281580|4223347|P7|STARTED|Overall Study||44
1725197|NCT00281580|4223348|P6|STARTED|Overall Study||46
1725198|NCT00281580|4223349|P5|STARTED|Overall Study||44
1725199|NCT00281580|4223350|P4|STARTED|Overall Study||135
1725200|NCT00281580|4223351|P3|STARTED|Overall Study||130
1725201|NCT00281580|4223352|P2|STARTED|Overall Study||42
1725202|NCT00281580|4223353|P1|STARTED|Overall Study||46
1725203|NCT00281528|4223700|P3|NOT COMPLETED|Overall Study||79
1725204|NCT00281528|4223701|P2|NOT COMPLETED|Overall Study||54
1725205|NCT00281528|4223702|P1|NOT COMPLETED|Overall Study||75
1725206|NCT00281528|4223700|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
1725207|NCT00281528|4223701|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
1725208|NCT00281528|4223702|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
1725209|NCT00281528|4223700|P3|STARTED|Overall Study||79
1725210|NCT00281528|4223701|P2|STARTED|Overall Study||54
1725211|NCT00281528|4223702|P1|STARTED|Overall Study||75
1725212|NCT00281463|4223746|P1|NOT COMPLETED|Overall Study||0
1725213|NCT00281463|4223746|P1|COMPLETED|Overall Study||45
1725214|NCT00281463|4223746|P1|STARTED|Overall Study||45
1725215|NCT00281320|4223753|P2|NOT COMPLETED|Overall Study||21
1725216|NCT00281320|4223754|P1|NOT COMPLETED|Overall Study||25
1725217|NCT00281320|4223753|P2|COMPLETED|Overall Study||40
1725218|NCT00281320|4223754|P1|COMPLETED|Overall Study||36
1725219|NCT00281320|4223753|P2|STARTED|Overall Study||61
1725220|NCT00281320|4223754|P1|STARTED|Overall Study||61
1725221|NCT00281099|4223776|P2|NOT COMPLETED|Overall Study||222
1725222|NCT00281099|4223777|P1|NOT COMPLETED|Overall Study||205
1725223|NCT00281099|4223776|P2|COMPLETED|Overall Study||296
1725224|NCT00281099|4223777|P1|COMPLETED|Overall Study||308
1725225|NCT00281099|4223776|P2|STARTED|Overall Study||518
1725226|NCT00281099|4223777|P1|STARTED|Overall Study||513
1725227|NCT00281021|4223818|P1|NOT COMPLETED|Overall Study||2
1725228|NCT00281021|4223818|P1|COMPLETED|Overall Study||24
1725229|NCT00281021|4223818|P1|STARTED|Overall Study||26
1725230|NCT00280917|4223826|P4|NOT COMPLETED|Overall Study||2
1725231|NCT00280917|4223827|P3|NOT COMPLETED|Overall Study||6
1725232|NCT00280917|4223828|P2|NOT COMPLETED|Overall Study||6
1725233|NCT00280917|4223829|P1|NOT COMPLETED|Overall Study||2
1725234|NCT00280917|4223826|P4|COMPLETED|Overall Study||61
1725235|NCT00280917|4223827|P3|COMPLETED|Overall Study||57
1725236|NCT00280917|4223828|P2|COMPLETED|Overall Study||57
1725237|NCT00280917|4223829|P1|COMPLETED|Overall Study||63
1725238|NCT00280917|4223826|P4|STARTED|Overall Study||63
1725239|NCT00280917|4223827|P3|STARTED|Overall Study||63
1725240|NCT00280917|4223828|P2|STARTED|Overall Study||63
1725241|NCT00280917|4223829|P1|STARTED|Overall Study||65
1725242|NCT00280904|4223839|P1|NOT COMPLETED|Overall Study||0
1725243|NCT00280904|4223839|P1|COMPLETED|Overall Study||433
1725244|NCT00280904|4223839|P1|STARTED|Overall Study||433
1725245|NCT00280826|4223844|P1|NOT COMPLETED|Overall Study||0
1725246|NCT00280826|4223844|P1|COMPLETED|Overall Study||6
1725247|NCT00280826|4223844|P1|STARTED|Overall Study||6
1725248|NCT00280748|4223852|P1|NOT COMPLETED|Overall Study||4
1725249|NCT00280748|4223852|P1|COMPLETED|Overall Study||6
1725250|NCT00280748|4223852|P1|STARTED|Overall Study||10
1725251|NCT00280735|4223862|P1|NOT COMPLETED|Overall Study||18
1725252|NCT00280735|4223862|P1|COMPLETED|Overall Study||57
1725253|NCT00280735|4223862|P1|Received Adequate Exposure|Overall Study||57
1725254|NCT00280735|4223862|P1|Received Treatment|Overall Study||72
1725255|NCT00280735|4223862|P1|STARTED|Overall Study||75
1725256|NCT00280683|4223874|P2|NOT COMPLETED|Overall Study||3
1725257|NCT00280683|4223875|P1|NOT COMPLETED|Overall Study||2
1725258|NCT00280683|4223874|P2|COMPLETED|Overall Study||7
1725259|NCT00280683|4223875|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
1725260|NCT00280683|4223874|P2|STARTED|Overall Study||10
1725261|NCT00280683|4223875|P1|STARTED|Overall Study||10
1725262|NCT00280566|4223885|P3|NOT COMPLETED|Period 2 Double Blind||57
1725263|NCT00280566|4223886|P2|NOT COMPLETED|Period 2 Double Blind||43
1725264|NCT00280566|4223887|P1|NOT COMPLETED|Period 2 Double Blind||0
1725265|NCT00280566|4223885|P3|COMPLETED|Period 2 Double Blind||54
1725266|NCT00280566|4223886|P2|COMPLETED|Period 2 Double Blind||84
1725267|NCT00280566|4223887|P1|COMPLETED|Period 2 Double Blind||0
1725268|NCT00280566|4223885|P3|STARTED|Period 2 Double Blind||111
1725269|NCT00280566|4223886|P2|STARTED|Period 2 Double Blind||127
1725270|NCT00280566|4223887|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
1725271|NCT00280566|4223885|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
1725272|NCT00280566|4223886|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
1725273|NCT00280566|4223887|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
1725274|NCT00280566|4223885|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
1725275|NCT00280566|4223886|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
1725276|NCT00280566|4223887|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
1725277|NCT00280566|4223885|P3|STARTED|Period 1 Open Label Ziprasidone||0
1725278|NCT00280566|4223886|P2|STARTED|Period 1 Open Label Ziprasidone||0
1725279|NCT00280566|4223887|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
1725280|NCT00280397|4223912|P1|NOT COMPLETED|Overall Study||1
1725281|NCT00280397|4223912|P1|COMPLETED|Overall Study||26
1725282|NCT00280397|4223912|P1|STARTED|Overall Study||27
1725283|NCT00280384|4223927|P8|NOT COMPLETED|Overall Study||0
1725284|NCT00280384|4223928|P7|NOT COMPLETED|Overall Study||0
1725285|NCT00280384|4223929|P6|NOT COMPLETED|Overall Study||0
1725286|NCT00280384|4223930|P5|NOT COMPLETED|Overall Study||0
1725287|NCT00280384|4223931|P4|NOT COMPLETED|Overall Study||0
1725288|NCT00280384|4223932|P3|NOT COMPLETED|Overall Study||0
1725289|NCT00280384|4223933|P2|NOT COMPLETED|Overall Study||0
1725290|NCT00280384|4223934|P1|NOT COMPLETED|Overall Study||0
1725291|NCT00280384|4223927|P8|COMPLETED|Overall Study||6
1725292|NCT00280384|4223928|P7|COMPLETED|Overall Study||6
1725293|NCT00280384|4223929|P6|COMPLETED|Overall Study||6
1725294|NCT00280384|4223930|P5|COMPLETED|Overall Study||6
1725295|NCT00280384|4223931|P4|COMPLETED|Overall Study||6
1725296|NCT00280384|4223932|P3|COMPLETED|Overall Study||6
1725297|NCT00280384|4223933|P2|COMPLETED|Overall Study||6
1725298|NCT00280384|4223934|P1|COMPLETED|Overall Study||6
1725299|NCT00280384|4223927|P8|STARTED|Overall Study||6
1725300|NCT00280384|4223928|P7|STARTED|Overall Study||6
1725301|NCT00280384|4223929|P6|STARTED|Overall Study||6
1725302|NCT00280384|4223930|P5|STARTED|Overall Study||6
1725303|NCT00280384|4223931|P4|STARTED|Overall Study||6
1725304|NCT00280384|4223932|P3|STARTED|Overall Study||6
1725305|NCT00280384|4223933|P2|STARTED|Overall Study||6
1725306|NCT00280384|4223934|P1|STARTED|Overall Study||6
1725307|NCT00280293|4223978|P2|NOT COMPLETED|Overall Study||23
1725308|NCT00280293|4223979|P1|NOT COMPLETED|Overall Study||26
1725309|NCT00280293|4223978|P2|COMPLETED|Overall Study||34
1725310|NCT00280293|4223979|P1|COMPLETED|Overall Study||29
1725311|NCT00280293|4223978|P2|STARTED|Overall Study||57
1725312|NCT00280293|4223979|P1|STARTED|Overall Study||55
1725313|NCT00280241|4223991|P1|NOT COMPLETED|Overall Study||10
1725314|NCT00280241|4223991|P1|COMPLETED|Overall Study||55
1725315|NCT00280241|4223991|P1|STARTED|Overall Study||65
1725316|NCT00280150|4224002|P4|NOT COMPLETED|Overall Study||10
1725317|NCT00280150|4224003|P3|NOT COMPLETED|Overall Study||5
1725318|NCT00280150|4224004|P2|NOT COMPLETED|Overall Study||1
1725319|NCT00280150|4224005|P1|NOT COMPLETED|Overall Study||3
1725320|NCT00280150|4224002|P4|COMPLETED|Overall Study||20
1725321|NCT00280150|4224003|P3|COMPLETED|Overall Study||1
1725322|NCT00280150|4224004|P2|COMPLETED|Overall Study||4
1725323|NCT00280150|4224005|P1|COMPLETED|Overall Study||2
1725324|NCT00280150|4224002|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
1725325|NCT00280150|4224003|P3|Consolidation Therapy|Overall Study||3
1725326|NCT00280150|4224004|P2|Consolidation Therapy|Overall Study||5
1725327|NCT00280150|4224005|P1|Consolidation Therapy|Overall Study||2
1725328|NCT00280150|4224002|P4|Cohort Induction|Overall Study||30
1725329|NCT00280150|4224003|P3|Cohort Induction|Overall Study||6
1725330|NCT00280150|4224004|P2|Cohort Induction|Overall Study||5
1725331|NCT00280150|4224005|P1|Cohort Induction|Overall Study||5
1725332|NCT00280150|4224002|P4|STARTED|Overall Study||30
1725333|NCT00280150|4224003|P3|STARTED|Overall Study||6
1725334|NCT00280150|4224004|P2|STARTED|Overall Study||5
1725335|NCT00280150|4224005|P1|STARTED|Overall Study||5
1725336|NCT00280059|4224020|P2|NOT COMPLETED|Extension Phase||38
1725337|NCT00280059|4224021|P1|NOT COMPLETED|Extension Phase||49
1725338|NCT00280059|4224020|P2|COMPLETED|Extension Phase||177
1725339|NCT00280059|4224021|P1|COMPLETED|Extension Phase||145
1725340|NCT00280059|4224020|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
1725428|NCT00279201|4224217|P4|NOT COMPLETED|Maintenance||0
1725341|NCT00280059|4224021|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
1725342|NCT00280059|4224020|P2|NOT COMPLETED|Efficacy Assessment Phase||80
1725343|NCT00280059|4224021|P1|NOT COMPLETED|Efficacy Assessment Phase||94
1725344|NCT00280059|4224020|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
1725345|NCT00280059|4224021|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
1725346|NCT00280059|4224020|P2|STARTED|Efficacy Assessment Phase||330
1725347|NCT00280059|4224021|P1|STARTED|Efficacy Assessment Phase||330
1725348|NCT00279955|4224070|P3|NOT COMPLETED|Overall Study||0
1725349|NCT00279955|4224071|P2|NOT COMPLETED|Overall Study||0
1725350|NCT00279955|4224072|P1|NOT COMPLETED|Overall Study||0
1725351|NCT00279955|4224070|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
1725352|NCT00279955|4224071|P2|COMPLETED|Overall Study||486
1725353|NCT00279955|4224072|P1|COMPLETED|Overall Study||157
1725354|NCT00279955|4224070|P3|STARTED|Overall Study||358
1725355|NCT00279955|4224071|P2|STARTED|Overall Study||486
1725356|NCT00279955|4224072|P1|STARTED|Overall Study||157
1725357|NCT00279916|4224085|P2|NOT COMPLETED|Overall Study||5
1725358|NCT00279916|4224086|P1|NOT COMPLETED|Overall Study||7
1725359|NCT00279916|4224085|P2|COMPLETED|Overall Study||41
1725360|NCT00279916|4224086|P1|COMPLETED|Overall Study||38
1725361|NCT00279916|4224085|P2|STARTED|Overall Study||46
1725362|NCT00279916|4224086|P1|STARTED|Overall Study||45
1725363|NCT00279812|4224112|P6|NOT COMPLETED|Overall Study||1
1725364|NCT00279812|4224113|P5|NOT COMPLETED|Overall Study||3
1725365|NCT00279812|4224114|P4|NOT COMPLETED|Overall Study||0
1725366|NCT00279812|4224115|P3|NOT COMPLETED|Overall Study||3
1725367|NCT00279812|4224116|P2|NOT COMPLETED|Overall Study||6
1725368|NCT00279812|4224117|P1|NOT COMPLETED|Overall Study||1
1725369|NCT00279812|4224112|P6|COMPLETED|Overall Study||18
1725370|NCT00279812|4224113|P5|COMPLETED|Overall Study||17
1725371|NCT00279812|4224114|P4|COMPLETED|Overall Study||23
1725372|NCT00279812|4224115|P3|COMPLETED|Overall Study||21
1725373|NCT00279812|4224116|P2|COMPLETED|Overall Study||20
1725374|NCT00279812|4224117|P1|COMPLETED|Overall Study||20
1725375|NCT00279812|4224112|P6|STARTED|Overall Study||19
1725376|NCT00279812|4224113|P5|STARTED|Overall Study||20
1725377|NCT00279812|4224114|P4|STARTED|Overall Study||23
1725378|NCT00279812|4224115|P3|STARTED|Overall Study||24
1725379|NCT00279812|4224116|P2|STARTED|Overall Study||26
1725380|NCT00279812|4224117|P1|STARTED|Overall Study||21
1725381|NCT00279708|4224145|P2|NOT COMPLETED|Overall Study||4
1725382|NCT00279708|4224146|P1|NOT COMPLETED|Overall Study||3
1725383|NCT00279708|4224145|P2|COMPLETED|Overall Study||24
1725384|NCT00279708|4224146|P1|COMPLETED|Overall Study||24
1725385|NCT00279708|4224145|P2|STARTED|Overall Study||28
1725386|NCT00279708|4224146|P1|STARTED|Overall Study|"Started meaning randomized"|27
1725387|NCT00279591|4224154|P2|NOT COMPLETED|Overall Study||0
1725388|NCT00279591|4224155|P1|NOT COMPLETED|Overall Study||0
1725389|NCT00279591|4224154|P2|COMPLETED|Overall Study||46
1725390|NCT00279591|4224155|P1|COMPLETED|Overall Study||48
1725391|NCT00279591|4224154|P2|STARTED|Overall Study||46
1725392|NCT00279591|4224155|P1|STARTED|Overall Study||48
1725393|NCT00279500|4224169|P1|NOT COMPLETED|Overall Study||0
1725394|NCT00279500|4224169|P1|COMPLETED|Overall Study|6 patients treated|6
1725395|NCT00279500|4224169|P1|STARTED|Overall Study|6 patients treated|6
1725396|NCT00279305|4224175|P2|NOT COMPLETED|Overall Study||1
1725397|NCT00279305|4224176|P1|NOT COMPLETED|Overall Study||8
1725398|NCT00279305|4224175|P2|COMPLETED|Overall Study||29
1725399|NCT00279305|4224176|P1|COMPLETED|Overall Study||49
1725400|NCT00279305|4224175|P2|STARTED|Overall Study||30
1725401|NCT00279305|4224176|P1|STARTED|Overall Study||57
1725402|NCT00279214|4224184|P2|NOT COMPLETED|Overall Study||2
1725403|NCT00279214|4224185|P1|NOT COMPLETED|Overall Study||3
1725404|NCT00279214|4224184|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
1725405|NCT00279214|4224185|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
1725406|NCT00279214|4224184|P2|STARTED|Overall Study||21
1725407|NCT00279214|4224185|P1|STARTED|Overall Study||22
1725408|NCT00279201|4224215|P6|NOT COMPLETED|Intensification Addendum||37
1725409|NCT00279201|4224216|P5|NOT COMPLETED|Intensification Addendum||29
1725410|NCT00279201|4224217|P4|NOT COMPLETED|Intensification Addendum||28
1725411|NCT00279201|4224218|P3|NOT COMPLETED|Intensification Addendum||23
1725412|NCT00279201|4224219|P2|NOT COMPLETED|Intensification Addendum||0
1725413|NCT00279201|4224220|P1|NOT COMPLETED|Intensification Addendum||0
1725414|NCT00279201|4224215|P6|COMPLETED|Intensification Addendum||162
1725415|NCT00279201|4224216|P5|COMPLETED|Intensification Addendum||142
1725416|NCT00279201|4224217|P4|COMPLETED|Intensification Addendum||172
1725417|NCT00279201|4224218|P3|COMPLETED|Intensification Addendum||151
1725418|NCT00279201|4224219|P2|COMPLETED|Intensification Addendum||0
1725419|NCT00279201|4224220|P1|COMPLETED|Intensification Addendum||0
1725420|NCT00279201|4224215|P6|STARTED|Intensification Addendum||199
1725421|NCT00279201|4224216|P5|STARTED|Intensification Addendum||171
1725422|NCT00279201|4224217|P4|STARTED|Intensification Addendum||200
1725423|NCT00279201|4224218|P3|STARTED|Intensification Addendum||174
1725424|NCT00279201|4224219|P2|STARTED|Intensification Addendum||0
1725425|NCT00279201|4224220|P1|STARTED|Intensification Addendum||0
1725426|NCT00279201|4224215|P6|NOT COMPLETED|Maintenance||0
1725427|NCT00279201|4224216|P5|NOT COMPLETED|Maintenance||0
1725429|NCT00279201|4224218|P3|NOT COMPLETED|Maintenance||0
1725430|NCT00279201|4224219|P2|NOT COMPLETED|Maintenance||234
1725431|NCT00279201|4224220|P1|NOT COMPLETED|Maintenance||231
1725432|NCT00279201|4224215|P6|COMPLETED|Maintenance||0
1725433|NCT00279201|4224216|P5|COMPLETED|Maintenance||0
1725434|NCT00279201|4224217|P4|COMPLETED|Maintenance||0
1725435|NCT00279201|4224218|P3|COMPLETED|Maintenance||0
1725436|NCT00279201|4224219|P2|COMPLETED|Maintenance||239
1725437|NCT00279201|4224220|P1|COMPLETED|Maintenance||188
1725438|NCT00279201|4224215|P6|STARTED|Maintenance||0
1725439|NCT00279201|4224216|P5|STARTED|Maintenance||0
1725440|NCT00279201|4224217|P4|STARTED|Maintenance||0
1725441|NCT00279201|4224218|P3|STARTED|Maintenance||0
1725442|NCT00279201|4224219|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
1725443|NCT00279201|4224220|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
1725444|NCT00279201|4224215|P6|NOT COMPLETED|Initiation||0
1725445|NCT00279201|4224216|P5|NOT COMPLETED|Initiation||0
1725446|NCT00279201|4224217|P4|NOT COMPLETED|Initiation||0
1725447|NCT00279201|4224218|P3|NOT COMPLETED|Initiation||0
1725448|NCT00279201|4224219|P2|NOT COMPLETED|Initiation||145
1725449|NCT00279201|4224220|P1|NOT COMPLETED|Initiation||128
1725450|NCT00279201|4224215|P6|COMPLETED|Initiation||0
1725451|NCT00279201|4224216|P5|COMPLETED|Initiation||0
1725452|NCT00279201|4224217|P4|COMPLETED|Initiation||0
1725453|NCT00279201|4224218|P3|COMPLETED|Initiation||0
1725454|NCT00279201|4224219|P2|COMPLETED|Initiation||900
1725455|NCT00279201|4224220|P1|COMPLETED|Initiation||918
1725456|NCT00279201|4224215|P6|STARTED|Initiation||0
1725457|NCT00279201|4224216|P5|STARTED|Initiation||0
1725458|NCT00279201|4224217|P4|STARTED|Initiation||0
1725459|NCT00279201|4224218|P3|STARTED|Initiation||0
1725460|NCT00279201|4224219|P2|STARTED|Initiation||1045
1725461|NCT00279201|4224220|P1|STARTED|Initiation||1046
1725462|NCT00278993|4224364|P1|NOT COMPLETED|Overall Study||107
1725463|NCT00278993|4224364|P1|COMPLETED|Overall Study||1
1725464|NCT00278993|4224364|P1|STARTED|Overall Study||108
1725465|NCT00278954|4224372|P1|NOT COMPLETED|Overall Study||5
1725466|NCT00278954|4224372|P1|COMPLETED|Overall Study||45
1725467|NCT00278954|4224372|P1|STARTED|Overall Study||50
1725468|NCT00278915|4224380|P1|NOT COMPLETED|Overall Study||1
1725469|NCT00278915|4224380|P1|COMPLETED|Overall Study||29
1725470|NCT00278915|4224380|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
1725471|NCT00278889|4224416|P3|NOT COMPLETED|Overall Study||20
1725472|NCT00278889|4224417|P2|NOT COMPLETED|Overall Study||27
1725473|NCT00278889|4224418|P1|NOT COMPLETED|Overall Study||25
1725474|NCT00278889|4224416|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
1725475|NCT00278889|4224417|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
1725476|NCT00278889|4224418|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
1725477|NCT00278889|4224416|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
1725478|NCT00278889|4224417|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
1725479|NCT00278889|4224418|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
1725480|NCT00278889|4224416|P3|STARTED|Overall Study|Randomised|68
1725481|NCT00278889|4224417|P2|STARTED|Overall Study|Randomised|74
1725482|NCT00278889|4224418|P1|STARTED|Overall Study|Randomised|73
1725483|NCT00278876|4224444|P1|NOT COMPLETED|Overall Study||9
1725484|NCT00278876|4224444|P1|COMPLETED|Overall Study||38
1725485|NCT00278876|4224444|P1|STARTED|Overall Study||47
1725486|NCT00278863|4224452|P2|NOT COMPLETED|Overall Study||2
1725487|NCT00278863|4224453|P1|NOT COMPLETED|Overall Study||5
1725488|NCT00278863|4224452|P2|COMPLETED|Overall Study||45
1725489|NCT00278863|4224453|P1|COMPLETED|Overall Study||44
1725490|NCT00278863|4224452|P2|STARTED|Overall Study||47
1725491|NCT00278863|4224453|P1|STARTED|Overall Study||49
1725492|NCT00278655|4224461|P1|NOT COMPLETED|Overall Study||0
1725493|NCT00278655|4224461|P1|COMPLETED|Overall Study||21
1725494|NCT00278655|4224461|P1|STARTED|Overall Study||21
1725495|NCT00278564|4224466|P1|NOT COMPLETED|Overall Study||4
1725496|NCT00278564|4224466|P1|COMPLETED|Overall Study||3
1725497|NCT00278564|4224466|P1|STARTED|Overall Study||7
1725498|NCT00278525|4224472|P2|NOT COMPLETED|Overall Study||0
1725499|NCT00278525|4224473|P1|NOT COMPLETED|Overall Study||0
1725500|NCT00278525|4224472|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
1725501|NCT00278525|4224473|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
1725502|NCT00278525|4224472|P2|STARTED|Overall Study||10
1725503|NCT00278525|4224473|P1|STARTED|Overall Study||9
1725504|NCT00278512|4224483|P2|NOT COMPLETED|Overall Study||0
1725505|NCT00278512|4224484|P1|NOT COMPLETED|Overall Study||1
1725506|NCT00278512|4224483|P2|COMPLETED|Overall Study||0
1725507|NCT00278512|4224484|P1|COMPLETED|Overall Study||6
1725508|NCT00278512|4224483|P2|STARTED|Overall Study||0
1725509|NCT00278512|4224484|P1|STARTED|Overall Study||7
1725510|NCT00278473|4224492|P2|NOT COMPLETED|Overall Study||3
1725511|NCT00278473|4224493|P1|NOT COMPLETED|Overall Study||4
1725512|NCT00278473|4224492|P2|COMPLETED|Overall Study||40
1725513|NCT00278473|4224493|P1|COMPLETED|Overall Study||41
1725514|NCT00278473|4224492|P2|STARTED|Overall Study||43
1725515|NCT00278473|4224493|P1|STARTED|Overall Study||45
1725516|NCT00278395|4224509|P1|NOT COMPLETED|Overall Study||3
1725517|NCT00278395|4224509|P1|COMPLETED|Overall Study||11
1725518|NCT00278395|4224509|P1|STARTED|Overall Study||14
1725519|NCT00278343|4224516|P1|NOT COMPLETED|Overall Study||0
1725520|NCT00278343|4224516|P1|COMPLETED|Overall Study||74
1725521|NCT00278343|4224516|P1|STARTED|Overall Study||74
1725522|NCT00278161|4224525|P1|NOT COMPLETED|Overall Study||11
1725523|NCT00278161|4224525|P1|COMPLETED|Overall Study||70
1725524|NCT00278161|4224525|P1|STARTED|Overall Study||81
1725525|NCT00277524|4224531|P4|NOT COMPLETED|Overall Study||0
1725526|NCT00277524|4224532|P3|NOT COMPLETED|Overall Study||0
1725527|NCT00277524|4224533|P2|NOT COMPLETED|Overall Study||0
1725528|NCT00277524|4224534|P1|NOT COMPLETED|Overall Study||0
1725529|NCT00277524|4224531|P4|COMPLETED|Overall Study||850
1725530|NCT00277524|4224532|P3|COMPLETED|Overall Study||1088
1725531|NCT00277524|4224533|P2|COMPLETED|Overall Study||324
1725532|NCT00277524|4224534|P1|COMPLETED|Overall Study||621
1725533|NCT00277524|4224531|P4|STARTED|Overall Study||850
1725534|NCT00277524|4224532|P3|STARTED|Overall Study||1088
1725535|NCT00277524|4224533|P2|STARTED|Overall Study||324
1725536|NCT00277524|4224534|P1|STARTED|Overall Study||621
1725537|NCT00277446|4224552|P1|NOT COMPLETED|Overall Study||0
1725538|NCT00277446|4224552|P1|COMPLETED|Overall Study||13
1725539|NCT00277446|4224552|P1|STARTED|Overall Study||13
1725540|NCT00277394|4224560|P2|NOT COMPLETED|Overall Study||24
1725541|NCT00277394|4224561|P1|NOT COMPLETED|Overall Study||37
1725542|NCT00277394|4224560|P2|COMPLETED|Overall Study||246
1725543|NCT00277394|4224561|P1|COMPLETED|Overall Study||232
1725544|NCT00277394|4224560|P2|STARTED|Overall Study||270
1725545|NCT00277394|4224561|P1|STARTED|Overall Study||269
1725546|NCT00277355|4224573|P2|NOT COMPLETED|Overall Study||5
1725547|NCT00277355|4224574|P1|NOT COMPLETED|Overall Study||14
1725548|NCT00277355|4224573|P2|COMPLETED|Overall Study||22
1725549|NCT00277355|4224574|P1|COMPLETED|Overall Study||73
1725550|NCT00277355|4224573|P2|STARTED|Overall Study||27
1725551|NCT00277355|4224574|P1|STARTED|Overall Study||87
1725552|NCT00277212|4224582|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
1725553|NCT00277212|4224583|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
1725554|NCT00277212|4224584|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
1725555|NCT00277212|4224582|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
1725556|NCT00277212|4224583|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
1725557|NCT00277212|4224584|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
1725558|NCT00277212|4224582|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
1725559|NCT00277212|4224583|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
1725560|NCT00277212|4224584|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
1725561|NCT00277212|4224582|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
1725562|NCT00277212|4224583|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
1725563|NCT00277212|4224584|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
1725564|NCT00277212|4224582|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
1725565|NCT00277212|4224583|P2|STARTED|Phase 2 - Double-Blind Treatment||173
1725566|NCT00277212|4224584|P1|STARTED|Phase 2 - Double-Blind Treatment||0
1725567|NCT00277212|4224582|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
1725568|NCT00277212|4224583|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
1725569|NCT00277212|4224584|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
1725570|NCT00277212|4224582|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
1725571|NCT00277212|4224583|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
1725572|NCT00277212|4224584|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
1725573|NCT00277212|4224582|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
1725574|NCT00277212|4224583|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
1725575|NCT00277212|4224584|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
1725576|NCT00277212|4224582|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
1725577|NCT00277212|4224583|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
1725578|NCT00277212|4224584|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
1725579|NCT00277212|4224582|P3|STARTED|Phase 1 - Single-Blind Treatment||0
1725580|NCT00277212|4224583|P2|STARTED|Phase 1 - Single-Blind Treatment||0
1725581|NCT00277212|4224584|P1|STARTED|Phase 1 - Single-Blind Treatment||787
1725582|NCT00277095|4224622|P1|NOT COMPLETED|Overall Study||21
1725583|NCT00277095|4224622|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
1725584|NCT00277095|4224622|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
1725585|NCT00276861|4224626|P1|NOT COMPLETED|Overall Study||0
1725586|NCT00276861|4224626|P1|COMPLETED|Overall Study||10
1725587|NCT00276861|4224626|P1|STARTED|Overall Study||10
1725588|NCT00276744|4224631|P1|NOT COMPLETED|PART B||0
1725589|NCT00276744|4224631|P1|COMPLETED|PART B||0
1725590|NCT00276744|4224631|P1|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
1725591|NCT00276744|4224631|P1|NOT COMPLETED|PART A||98
1725592|NCT00276744|4224631|P1|COMPLETED|PART A||142
1725593|NCT00276744|4224631|P1|STARTED|PART A||240
1725594|NCT00276614|4224635|P1|NOT COMPLETED|Overall Study||3
1725595|NCT00276614|4224635|P1|COMPLETED|Overall Study||1
1725596|NCT00276614|4224635|P1|STARTED|Overall Study||4
1725597|NCT00276549|4224639|P1|NOT COMPLETED|Overall Study||0
1725598|NCT00276549|4224639|P1|COMPLETED|Overall Study||35
1725599|NCT00276549|4224639|P1|STARTED|Overall Study||35
1725600|NCT00276484|4224646|P2|NOT COMPLETED|Overall Study||13
1725601|NCT00276484|4224647|P1|NOT COMPLETED|Overall Study||9
1725602|NCT00276484|4224646|P2|COMPLETED|Overall Study||278
1725603|NCT00276484|4224647|P1|COMPLETED|Overall Study||279
1725604|NCT00276484|4224646|P2|STARTED|Overall Study||291
1725605|NCT00276484|4224647|P1|STARTED|Overall Study||288
1725606|NCT00276458|4224679|P2|NOT COMPLETED|Overall Study||7
1725607|NCT00276458|4224680|P1|NOT COMPLETED|Overall Study||6
1725608|NCT00276458|4224679|P2|COMPLETED|Overall Study||91
1725609|NCT00276458|4224680|P1|COMPLETED|Overall Study||92
1725610|NCT00276458|4224679|P2|STARTED|Overall Study||98
1725611|NCT00276458|4224680|P1|STARTED|Overall Study||98
1725612|NCT00276419|4224714|P2|NOT COMPLETED|Second Intervention||0
1725613|NCT00276419|4224715|P1|NOT COMPLETED|Second Intervention||0
1725614|NCT00276419|4224714|P2|COMPLETED|Second Intervention||8
1725615|NCT00276419|4224715|P1|COMPLETED|Second Intervention||7
1725616|NCT00276419|4224714|P2|STARTED|Second Intervention||8
1725617|NCT00276419|4224715|P1|STARTED|Second Intervention||7
1725618|NCT00276419|4224714|P2|NOT COMPLETED|Wash-out Phase||0
1725619|NCT00276419|4224715|P1|NOT COMPLETED|Wash-out Phase||0
1725620|NCT00276419|4224714|P2|COMPLETED|Wash-out Phase||8
1725621|NCT00276419|4224715|P1|COMPLETED|Wash-out Phase||7
1725622|NCT00276419|4224714|P2|STARTED|Wash-out Phase||8
1725623|NCT00276419|4224715|P1|STARTED|Wash-out Phase||7
1725624|NCT00276419|4224714|P2|NOT COMPLETED|First Intervention||2
1725625|NCT00276419|4224715|P1|NOT COMPLETED|First Intervention||1
1725626|NCT00276419|4224714|P2|COMPLETED|First Intervention||8
1725627|NCT00276419|4224715|P1|COMPLETED|First Intervention||7
1725628|NCT00276419|4224714|P2|STARTED|First Intervention||10
1725629|NCT00276419|4224715|P1|STARTED|First Intervention||8
1725630|NCT00276406|4224727|P2|NOT COMPLETED|Overall Study||0
1725631|NCT00276406|4224728|P1|NOT COMPLETED|Overall Study||0
1725632|NCT00276406|4224727|P2|COMPLETED|Overall Study||14
1725633|NCT00276406|4224728|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
1725634|NCT00276406|4224727|P2|STARTED|Overall Study||14
1725635|NCT00276406|4224728|P1|STARTED|Overall Study||16
1725636|NCT00276380|4224758|P2|NOT COMPLETED|Overall Study||14
1725637|NCT00276380|4224759|P1|NOT COMPLETED|Overall Study||14
1725638|NCT00276380|4224758|P2|COMPLETED|Overall Study||88
1725639|NCT00276380|4224759|P1|COMPLETED|Overall Study||88
1725640|NCT00276380|4224758|P2|STARTED|Overall Study||102
1725641|NCT00276380|4224759|P1|STARTED|Overall Study||102
1725642|NCT00276250|4224780|P3|NOT COMPLETED|Overall Study||0
1725643|NCT00276250|4224781|P2|NOT COMPLETED|Overall Study||0
1725644|NCT00276250|4224782|P1|NOT COMPLETED|Overall Study||0
1725645|NCT00276250|4224780|P3|COMPLETED|Overall Study||0
1725646|NCT00276250|4224781|P2|COMPLETED|Overall Study||1
1725647|NCT00276250|4224782|P1|COMPLETED|Overall Study||4
1725648|NCT00276250|4224780|P3|STARTED|Overall Study||0
1725649|NCT00276250|4224781|P2|STARTED|Overall Study||1
1725650|NCT00276250|4224782|P1|STARTED|Overall Study||4
1725651|NCT00276159|4224814|P1|NOT COMPLETED|Overall Study||6
1725652|NCT00276159|4224814|P1|COMPLETED|Overall Study||0
1725653|NCT00276159|4224814|P1|STARTED|Overall Study||6
1725654|NCT00276094|4224824|P3|NOT COMPLETED|Overall Study||38
1725655|NCT00276094|4224825|P2|NOT COMPLETED|Overall Study||42
1725656|NCT00276094|4224826|P1|NOT COMPLETED|Overall Study||57
1725657|NCT00276094|4224824|P3|COMPLETED|Overall Study||230
1725658|NCT00276094|4224825|P2|COMPLETED|Overall Study||234
1725659|NCT00276094|4224826|P1|COMPLETED|Overall Study||225
1725660|NCT00276094|4224824|P3|STARTED|Overall Study||268
1725661|NCT00276094|4224825|P2|STARTED|Overall Study||276
1725662|NCT00276094|4224826|P1|STARTED|Overall Study||282
1725663|NCT00276016|4224879|P6|NOT COMPLETED|Intervention 3||0
1725664|NCT00276016|4224880|P5|NOT COMPLETED|Intervention 3||0
1725665|NCT00276016|4224881|P4|NOT COMPLETED|Intervention 3||0
1725666|NCT00276016|4224882|P3|NOT COMPLETED|Intervention 3||0
1725667|NCT00276016|4224883|P2|NOT COMPLETED|Intervention 3||0
1725668|NCT00276016|4224884|P1|NOT COMPLETED|Intervention 3||0
1725669|NCT00276016|4224879|P6|COMPLETED|Intervention 3||6
1725670|NCT00276016|4224880|P5|COMPLETED|Intervention 3||6
1725671|NCT00276016|4224881|P4|COMPLETED|Intervention 3||6
1725672|NCT00276016|4224882|P3|COMPLETED|Intervention 3||7
1725673|NCT00276016|4224883|P2|COMPLETED|Intervention 3||6
1725674|NCT00276016|4224884|P1|COMPLETED|Intervention 3||7
1725675|NCT00276016|4224879|P6|STARTED|Intervention 3||6
1725676|NCT00276016|4224880|P5|STARTED|Intervention 3||6
1725677|NCT00276016|4224881|P4|STARTED|Intervention 3||6
1725678|NCT00276016|4224882|P3|STARTED|Intervention 3||7
1725679|NCT00276016|4224883|P2|STARTED|Intervention 3||6
1725680|NCT00276016|4224884|P1|STARTED|Intervention 3||7
1725681|NCT00276016|4224879|P6|NOT COMPLETED|Wash Out 2||0
1725682|NCT00276016|4224880|P5|NOT COMPLETED|Wash Out 2||0
1725683|NCT00276016|4224881|P4|NOT COMPLETED|Wash Out 2||0
1725684|NCT00276016|4224882|P3|NOT COMPLETED|Wash Out 2||0
1725685|NCT00276016|4224883|P2|NOT COMPLETED|Wash Out 2||0
1725686|NCT00276016|4224884|P1|NOT COMPLETED|Wash Out 2||0
1725687|NCT00276016|4224879|P6|COMPLETED|Wash Out 2||6
1725688|NCT00276016|4224880|P5|COMPLETED|Wash Out 2||6
1725689|NCT00276016|4224881|P4|COMPLETED|Wash Out 2||6
1725690|NCT00276016|4224882|P3|COMPLETED|Wash Out 2||7
1725691|NCT00276016|4224883|P2|COMPLETED|Wash Out 2||6
1725692|NCT00276016|4224884|P1|COMPLETED|Wash Out 2||7
1725693|NCT00276016|4224879|P6|STARTED|Wash Out 2||6
1725694|NCT00276016|4224880|P5|STARTED|Wash Out 2||6
1725695|NCT00276016|4224881|P4|STARTED|Wash Out 2||6
1725696|NCT00276016|4224882|P3|STARTED|Wash Out 2||7
1725697|NCT00276016|4224883|P2|STARTED|Wash Out 2||6
1725698|NCT00276016|4224884|P1|STARTED|Wash Out 2||7
1725699|NCT00276016|4224879|P6|NOT COMPLETED|Intervention 2||0
1725700|NCT00276016|4224880|P5|NOT COMPLETED|Intervention 2||0
1725701|NCT00276016|4224881|P4|NOT COMPLETED|Intervention 2||0
1725702|NCT00276016|4224882|P3|NOT COMPLETED|Intervention 2||0
1725703|NCT00276016|4224883|P2|NOT COMPLETED|Intervention 2||0
1725704|NCT00276016|4224884|P1|NOT COMPLETED|Intervention 2||0
1725705|NCT00276016|4224879|P6|COMPLETED|Intervention 2||6
1725706|NCT00276016|4224880|P5|COMPLETED|Intervention 2||6
1725707|NCT00276016|4224881|P4|COMPLETED|Intervention 2||6
1725708|NCT00276016|4224882|P3|COMPLETED|Intervention 2||7
1725709|NCT00276016|4224883|P2|COMPLETED|Intervention 2||6
1725710|NCT00276016|4224884|P1|COMPLETED|Intervention 2||7
1725711|NCT00276016|4224879|P6|STARTED|Intervention 2||6
1725712|NCT00276016|4224880|P5|STARTED|Intervention 2||6
1725713|NCT00276016|4224881|P4|STARTED|Intervention 2||6
1725714|NCT00276016|4224882|P3|STARTED|Intervention 2||7
1725715|NCT00276016|4224883|P2|STARTED|Intervention 2||6
1725716|NCT00276016|4224884|P1|STARTED|Intervention 2||7
1725717|NCT00276016|4224879|P6|NOT COMPLETED|Wash Out 1||0
1725718|NCT00276016|4224880|P5|NOT COMPLETED|Wash Out 1||0
1725719|NCT00276016|4224881|P4|NOT COMPLETED|Wash Out 1||0
1725720|NCT00276016|4224882|P3|NOT COMPLETED|Wash Out 1||0
1725721|NCT00276016|4224883|P2|NOT COMPLETED|Wash Out 1||0
1725722|NCT00276016|4224884|P1|NOT COMPLETED|Wash Out 1||0
1725723|NCT00276016|4224879|P6|COMPLETED|Wash Out 1||6
1725724|NCT00276016|4224880|P5|COMPLETED|Wash Out 1||6
1725725|NCT00276016|4224881|P4|COMPLETED|Wash Out 1||6
1725726|NCT00276016|4224882|P3|COMPLETED|Wash Out 1||7
1725727|NCT00276016|4224883|P2|COMPLETED|Wash Out 1||6
1725728|NCT00276016|4224884|P1|COMPLETED|Wash Out 1||7
1725729|NCT00276016|4224879|P6|STARTED|Wash Out 1||6
1725730|NCT00276016|4224880|P5|STARTED|Wash Out 1||6
1725731|NCT00276016|4224881|P4|STARTED|Wash Out 1||6
1725732|NCT00276016|4224882|P3|STARTED|Wash Out 1||7
1725733|NCT00276016|4224883|P2|STARTED|Wash Out 1||6
1725734|NCT00276016|4224884|P1|STARTED|Wash Out 1||7
1725735|NCT00276016|4224879|P6|NOT COMPLETED|Intervention 1||0
1725736|NCT00276016|4224880|P5|NOT COMPLETED|Intervention 1||0
1725737|NCT00276016|4224881|P4|NOT COMPLETED|Intervention 1||0
1725738|NCT00276016|4224882|P3|NOT COMPLETED|Intervention 1||0
1725739|NCT00276016|4224883|P2|NOT COMPLETED|Intervention 1||1
1725740|NCT00276016|4224884|P1|NOT COMPLETED|Intervention 1||0
1725741|NCT00276016|4224879|P6|COMPLETED|Intervention 1||6
1725742|NCT00276016|4224880|P5|COMPLETED|Intervention 1||6
1725743|NCT00276016|4224881|P4|COMPLETED|Intervention 1||6
1725744|NCT00276016|4224882|P3|COMPLETED|Intervention 1||7
1725745|NCT00276016|4224883|P2|COMPLETED|Intervention 1||6
1725746|NCT00276016|4224884|P1|COMPLETED|Intervention 1||7
1725747|NCT00276016|4224879|P6|STARTED|Intervention 1||6
1725748|NCT00276016|4224880|P5|STARTED|Intervention 1||6
1725749|NCT00276016|4224881|P4|STARTED|Intervention 1||6
1725750|NCT00276016|4224882|P3|STARTED|Intervention 1||7
1725751|NCT00276016|4224883|P2|STARTED|Intervention 1||7
1725752|NCT00276016|4224884|P1|STARTED|Intervention 1||7
1725753|NCT00275834|4224896|P3|NOT COMPLETED|Overall Study||1
1725754|NCT00275834|4224897|P2|NOT COMPLETED|Overall Study||3
1725755|NCT00275834|4224898|P1|NOT COMPLETED|Overall Study||3
1725756|NCT00275834|4224896|P3|COMPLETED|Overall Study||74
1725757|NCT00275834|4224897|P2|COMPLETED|Overall Study||73
1725758|NCT00275834|4224898|P1|COMPLETED|Overall Study||71
1725759|NCT00275834|4224896|P3|Completed Study While on Study Drug|Overall Study||62
1725760|NCT00275834|4224897|P2|Completed Study While on Study Drug|Overall Study||51
1725761|NCT00275834|4224898|P1|Completed Study While on Study Drug|Overall Study||54
1725762|NCT00275834|4224896|P3|STARTED|Overall Study||75
1725763|NCT00275834|4224897|P2|STARTED|Overall Study||76
1725764|NCT00275834|4224898|P1|STARTED|Overall Study||74
1725765|NCT00275821|4224930|P3|NOT COMPLETED|Overall Study||12
1725766|NCT00275821|4224931|P2|NOT COMPLETED|Overall Study||23
1725767|NCT00275821|4224932|P1|NOT COMPLETED|Overall Study||14
1725768|NCT00275821|4224930|P3|COMPLETED|Overall Study||103
1725769|NCT00275821|4224931|P2|COMPLETED|Overall Study||95
1725770|NCT00275821|4224932|P1|COMPLETED|Overall Study||106
1725771|NCT00275821|4224930|P3|STARTED|Overall Study||115
1725772|NCT00275821|4224931|P2|STARTED|Overall Study||118
1725773|NCT00275821|4224932|P1|STARTED|Overall Study||120
1725774|NCT00275561|4224951|P2|NOT COMPLETED|Overall Study||6
1725775|NCT00275561|4224952|P1|NOT COMPLETED|Overall Study||2
1725776|NCT00275561|4224951|P2|COMPLETED|Overall Study||15
1725777|NCT00275561|4224952|P1|COMPLETED|Overall Study||19
1725778|NCT00275561|4224951|P2|STARTED|Overall Study||21
1725779|NCT00275561|4224952|P1|STARTED|Overall Study||21
1725780|NCT00275509|4224964|P2|NOT COMPLETED|Overall Study||1
1725781|NCT00275509|4224965|P1|NOT COMPLETED|Overall Study||0
1725782|NCT00275509|4224964|P2|COMPLETED|Overall Study||25
1725783|NCT00275509|4224965|P1|COMPLETED|Overall Study||30
1725784|NCT00275509|4224964|P2|STARTED|Overall Study||26
1725785|NCT00275509|4224965|P1|STARTED|Overall Study||30
1725786|NCT00275392|4224977|P2|NOT COMPLETED|Overall Study||2
1725787|NCT00275392|4224978|P1|NOT COMPLETED|Overall Study||0
1725788|NCT00275392|4224977|P2|COMPLETED|Overall Study||17
1725789|NCT00275392|4224978|P1|COMPLETED|Overall Study||20
1725790|NCT00275392|4224977|P2|STARTED|Overall Study||19
1725791|NCT00275392|4224978|P1|STARTED|Overall Study||20
1725792|NCT00275340|4224988|P2|NOT COMPLETED|Overall Study||4
1725793|NCT00275340|4224989|P1|NOT COMPLETED|Overall Study||2
1725794|NCT00275340|4224988|P2|COMPLETED|Overall Study||45
1725795|NCT00275340|4224989|P1|COMPLETED|Overall Study||50
1725796|NCT00275340|4224988|P2|STARTED|Overall Study||49
1725797|NCT00275340|4224989|P1|STARTED|Overall Study||52
1725798|NCT00275301|4224993|P1|NOT COMPLETED|Overall Study||5
1725799|NCT00275301|4224993|P1|COMPLETED|Overall Study||14
1725800|NCT00275301|4224993|P1|STARTED|Overall Study||19
1725801|NCT00275275|4225000|P3|NOT COMPLETED|Overall Study||6
1725802|NCT00275275|4225001|P2|NOT COMPLETED|Overall Study||2
1725803|NCT00275275|4225002|P1|NOT COMPLETED|Overall Study||6
1725804|NCT00275275|4225000|P3|COMPLETED|Overall Study||15
1725805|NCT00275275|4225001|P2|COMPLETED|Overall Study||18
1725806|NCT00275275|4225002|P1|COMPLETED|Overall Study||14
1725807|NCT00275275|4225000|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
1725808|NCT00275275|4225001|P2|STARTED|Overall Study||20
1725809|NCT00275275|4225002|P1|STARTED|Overall Study||20
1725810|NCT00275262|4225012|P2|NOT COMPLETED|Overall Study||9
1725811|NCT00275262|4225013|P1|NOT COMPLETED|Overall Study||6
1725812|NCT00275262|4225012|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
1725813|NCT00275262|4225013|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
1725814|NCT00275262|4225012|P2|STARTED|Overall Study||13
1725815|NCT00275262|4225013|P1|STARTED|Overall Study||12
1725816|NCT00275028|4225027|P1|NOT COMPLETED|Overall Study||47
1725817|NCT00275028|4225027|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
1725818|NCT00275028|4225027|P1|STARTED|Overall Study||47
1725819|NCT00275002|4225034|P2|NOT COMPLETED|Overall Study||16
1725820|NCT00275002|4225035|P1|NOT COMPLETED|Overall Study||22
1725821|NCT00275002|4225034|P2|COMPLETED|Overall Study||0
1725822|NCT00275002|4225035|P1|COMPLETED|Overall Study||3
1725823|NCT00275002|4225034|P2|STARTED|Overall Study||16
1725824|NCT00275002|4225035|P1|STARTED|Overall Study||25
1725825|NCT00274937|4225043|P1|NOT COMPLETED|Overall Study||20
1725826|NCT00274937|4225043|P1|COMPLETED|Overall Study||91
1725827|NCT00274937|4225043|P1|STARTED|Overall Study||111
1725828|NCT00274924|4225055|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
1725829|NCT00274924|4225056|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
1725830|NCT00274924|4225057|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
1725831|NCT00274924|4225055|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
1725832|NCT00274924|4225056|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
1725833|NCT00274924|4225057|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
1725834|NCT00274924|4225055|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
1725835|NCT00274924|4225056|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
1725836|NCT00274924|4225057|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
1725837|NCT00274924|4225055|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
1725838|NCT00274924|4225056|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
1725839|NCT00274924|4225057|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
1725840|NCT00274924|4225055|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
1725841|NCT00274924|4225056|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
1725842|NCT00274924|4225057|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
1725843|NCT00274924|4225055|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
1725844|NCT00274924|4225056|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
1725845|NCT00274924|4225057|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
1725846|NCT00274924|4225055|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
1725847|NCT00274924|4225056|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
1725848|NCT00274924|4225057|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
1725849|NCT00274924|4225055|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
1725850|NCT00274924|4225056|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
1725851|NCT00274924|4225057|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
1725852|NCT00274924|4225055|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
1725853|NCT00274924|4225056|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
1725854|NCT00274924|4225057|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
1725855|NCT00274846|4225066|P1|NOT COMPLETED|Overall Study||1
1725856|NCT00274846|4225066|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
1725857|NCT00274846|4225066|P1|STARTED|Overall Study||21
1725858|NCT00274781|4225074|P1|NOT COMPLETED|Overall Study||0
1725859|NCT00274781|4225074|P1|COMPLETED|Overall Study||30
1725860|NCT00274781|4225074|P1|STARTED|Overall Study||30
1725861|NCT00274768|4225080|P1|NOT COMPLETED|Overall Study||0
1725862|NCT00274768|4225080|P1|COMPLETED|Overall Study||26
1725863|NCT00274768|4225080|P1|STARTED|Overall Study||26
1725864|NCT00274742|4225090|P6|NOT COMPLETED|Overall Study||3
1725865|NCT00274742|4225091|P5|NOT COMPLETED|Overall Study||16
1725866|NCT00274742|4225092|P4|NOT COMPLETED|Overall Study||5
1725867|NCT00274742|4225093|P3|NOT COMPLETED|Overall Study||2
1725868|NCT00274742|4225094|P2|NOT COMPLETED|Overall Study||8
1725869|NCT00274742|4225095|P1|NOT COMPLETED|Overall Study||0
1725870|NCT00274742|4225090|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
1725871|NCT00274742|4225091|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
1725872|NCT00274742|4225092|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
1725965|NCT00273910|4225314|P2|NOT COMPLETED|Overall Study||0
1725873|NCT00274742|4225093|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
1725874|NCT00274742|4225094|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
1725875|NCT00274742|4225095|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
1725876|NCT00274742|4225090|P6|STARTED|Overall Study||4
1725877|NCT00274742|4225091|P5|STARTED|Overall Study||32
1725878|NCT00274742|4225092|P4|STARTED|Overall Study||9
1725879|NCT00274742|4225093|P3|STARTED|Overall Study||6
1725880|NCT00274742|4225094|P2|STARTED|Overall Study||13
1725881|NCT00274742|4225095|P1|STARTED|Overall Study||12
1725882|NCT00274716|4225133|P6|NOT COMPLETED|Phase B||1
1725883|NCT00274716|4225134|P5|NOT COMPLETED|Phase B||0
1725884|NCT00274716|4225135|P4|NOT COMPLETED|Phase B||1
1725885|NCT00274716|4225136|P3|NOT COMPLETED|Phase B||3
1725886|NCT00274716|4225137|P2|NOT COMPLETED|Phase B||4
1725887|NCT00274716|4225138|P1|NOT COMPLETED|Phase B||1
1725888|NCT00274716|4225133|P6|COMPLETED|Phase B||14
1725889|NCT00274716|4225134|P5|COMPLETED|Phase B||16
1725890|NCT00274716|4225135|P4|COMPLETED|Phase B||41
1725891|NCT00274716|4225136|P3|COMPLETED|Phase B||41
1725892|NCT00274716|4225137|P2|COMPLETED|Phase B||40
1725893|NCT00274716|4225138|P1|COMPLETED|Phase B||42
1725894|NCT00274716|4225133|P6|STARTED|Phase B||15
1725895|NCT00274716|4225134|P5|STARTED|Phase B||16
1725896|NCT00274716|4225135|P4|STARTED|Phase B||42
1725897|NCT00274716|4225136|P3|STARTED|Phase B||44
1725898|NCT00274716|4225137|P2|STARTED|Phase B||44
1725899|NCT00274716|4225138|P1|STARTED|Phase B||43
1725900|NCT00274716|4225133|P6|NOT COMPLETED|Phase A||4
1725901|NCT00274716|4225134|P5|NOT COMPLETED|Phase A||3
1725902|NCT00274716|4225135|P4|NOT COMPLETED|Phase A||9
1725903|NCT00274716|4225136|P3|NOT COMPLETED|Phase A||8
1725904|NCT00274716|4225137|P2|NOT COMPLETED|Phase A||10
1725905|NCT00274716|4225138|P1|NOT COMPLETED|Phase A||11
1725906|NCT00274716|4225133|P6|COMPLETED|Phase A||15
1725907|NCT00274716|4225134|P5|COMPLETED|Phase A||16
1725908|NCT00274716|4225135|P4|COMPLETED|Phase A||42
1725909|NCT00274716|4225136|P3|COMPLETED|Phase A||44
1725910|NCT00274716|4225137|P2|COMPLETED|Phase A||44
1725911|NCT00274716|4225138|P1|COMPLETED|Phase A||43
1725912|NCT00274716|4225133|P6|STARTED|Phase A||19
1725913|NCT00274716|4225134|P5|STARTED|Phase A||19
1725914|NCT00274716|4225135|P4|STARTED|Phase A||51
1725915|NCT00274716|4225136|P3|STARTED|Phase A||52
1725916|NCT00274716|4225137|P2|STARTED|Phase A||54
1725917|NCT00274716|4225138|P1|STARTED|Phase A||54
1725918|NCT00274651|4225200|P2|NOT COMPLETED|Overall Study||20
1725919|NCT00274651|4225201|P1|NOT COMPLETED|Overall Study||28
1725920|NCT00274651|4225200|P2|COMPLETED|Overall Study||4
1725921|NCT00274651|4225201|P1|COMPLETED|Overall Study||1
1725922|NCT00274651|4225200|P2|STARTED|Overall Study||24
1725923|NCT00274651|4225201|P1|STARTED|Overall Study||29
1725924|NCT00274625|4225216|P2|NOT COMPLETED|Overall Study||62
1725925|NCT00274625|4225217|P1|NOT COMPLETED|Overall Study||60
1725926|NCT00274625|4225216|P2|COMPLETED|Overall Study||141
1725927|NCT00274625|4225217|P1|COMPLETED|Overall Study||139
1725928|NCT00274625|4225216|P2|STARTED|Overall Study||203
1725929|NCT00274625|4225217|P1|STARTED|Overall Study||199
1725930|NCT00274469|4225225|P2|NOT COMPLETED|Overall Study||50
1725931|NCT00274469|4225226|P1|NOT COMPLETED|Overall Study||38
1725932|NCT00274469|4225225|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|53
1725933|NCT00274469|4225226|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|64
1725934|NCT00274469|4225225|P2|STARTED|Overall Study|Number of patients randomized|103
1725935|NCT00274469|4225226|P1|STARTED|Overall Study|Number of patients randomized|102
1725936|NCT00274456|4225244|P4|NOT COMPLETED|Overall Study||45
1725937|NCT00274456|4225245|P3|NOT COMPLETED|Overall Study||35
1725938|NCT00274456|4225246|P2|NOT COMPLETED|Overall Study||27
1725939|NCT00274456|4225247|P1|NOT COMPLETED|Overall Study||37
1725940|NCT00274456|4225244|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
1725941|NCT00274456|4225245|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
1725942|NCT00274456|4225246|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
1725943|NCT00274456|4225247|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
1725944|NCT00274456|4225244|P4|At Least One Response Assessment|Overall Study||70
1725945|NCT00274456|4225245|P3|At Least One Response Assessment|Overall Study||73
1725946|NCT00274456|4225246|P2|At Least One Response Assessment|Overall Study||76
1725947|NCT00274456|4225247|P1|At Least One Response Assessment|Overall Study||73
1725948|NCT00274456|4225244|P4|STARTED|Overall Study||74
1725949|NCT00274456|4225245|P3|STARTED|Overall Study||74
1725950|NCT00274456|4225246|P2|STARTED|Overall Study||76
1725951|NCT00274456|4225247|P1|STARTED|Overall Study||76
1725952|NCT00274287|4225289|P1|NOT COMPLETED|Overall Study||2
1725953|NCT00274287|4225289|P1|COMPLETED|Overall Study||13
1725954|NCT00274287|4225289|P1|STARTED|Overall Study||15
1725955|NCT00274261|4225295|P2|NOT COMPLETED|Overall Study||337
1725956|NCT00274261|4225296|P1|NOT COMPLETED|Overall Study||489
1725957|NCT00274261|4225295|P2|COMPLETED|Overall Study||296
1725958|NCT00274261|4225296|P1|COMPLETED|Overall Study||443
1725959|NCT00274261|4225295|P2|STARTED|Overall Study||633
1725960|NCT00274261|4225296|P1|STARTED|Overall Study||932
1725961|NCT00273910|4225310|P6|NOT COMPLETED|Overall Study||0
1725962|NCT00273910|4225311|P5|NOT COMPLETED|Overall Study||0
1725963|NCT00273910|4225312|P4|NOT COMPLETED|Overall Study||0
1725964|NCT00273910|4225313|P3|NOT COMPLETED|Overall Study||0
1725966|NCT00273910|4225315|P1|NOT COMPLETED|Overall Study||0
1725967|NCT00273910|4225310|P6|COMPLETED|Overall Study||14
1725968|NCT00273910|4225311|P5|COMPLETED|Overall Study||15
1725969|NCT00273910|4225312|P4|COMPLETED|Overall Study||19
1725970|NCT00273910|4225313|P3|COMPLETED|Overall Study||18
1725971|NCT00273910|4225314|P2|COMPLETED|Overall Study||19
1725972|NCT00273910|4225315|P1|COMPLETED|Overall Study||19
1725973|NCT00273910|4225310|P6|STARTED|Overall Study||14
1725974|NCT00273910|4225311|P5|STARTED|Overall Study||15
1725975|NCT00273910|4225312|P4|STARTED|Overall Study||19
1725976|NCT00273910|4225313|P3|STARTED|Overall Study||18
1725977|NCT00273910|4225314|P2|STARTED|Overall Study||19
1725978|NCT00273910|4225315|P1|STARTED|Overall Study||19
1725979|NCT00273858|4225335|P1|NOT COMPLETED|Overall Study||537
1725980|NCT00273858|4225335|P1|COMPLETED|Overall Study||343
1725981|NCT00273858|4225335|P1|STARTED|Overall Study||880
1725982|NCT00273793|4225350|P6|NOT COMPLETED|Overall Study||0
1725983|NCT00273793|4225351|P5|NOT COMPLETED|Overall Study||0
1725984|NCT00273793|4225352|P4|NOT COMPLETED|Overall Study||0
1725985|NCT00273793|4225353|P3|NOT COMPLETED|Overall Study||0
1725986|NCT00273793|4225354|P2|NOT COMPLETED|Overall Study||0
1725987|NCT00273793|4225355|P1|NOT COMPLETED|Overall Study||0
1725988|NCT00273793|4225350|P6|COMPLETED|Overall Study||29
1725989|NCT00273793|4225351|P5|COMPLETED|Overall Study||58
1725990|NCT00273793|4225352|P4|COMPLETED|Overall Study||60
1725991|NCT00273793|4225353|P3|COMPLETED|Overall Study||18
1725992|NCT00273793|4225354|P2|COMPLETED|Overall Study||38
1725993|NCT00273793|4225355|P1|COMPLETED|Overall Study||36
1725994|NCT00273793|4225350|P6|STARTED|Overall Study||29
1725995|NCT00273793|4225351|P5|STARTED|Overall Study||58
1725996|NCT00273793|4225352|P4|STARTED|Overall Study||60
1725997|NCT00273793|4225353|P3|STARTED|Overall Study||18
1725998|NCT00273793|4225354|P2|STARTED|Overall Study||38
1725999|NCT00273793|4225355|P1|STARTED|Overall Study||36
1726000|NCT00273754|4225377|P2|NOT COMPLETED|Overall Study||0
1726001|NCT00273754|4225378|P1|NOT COMPLETED|Overall Study||0
1726002|NCT00273754|4225377|P2|COMPLETED|Overall Study||36
1726003|NCT00273754|4225378|P1|COMPLETED|Overall Study||36
1726004|NCT00273754|4225377|P2|STARTED|Overall Study||36
1726005|NCT00273754|4225378|P1|STARTED|Overall Study||36
1726006|NCT00273182|4225394|P1|NOT COMPLETED|Overall Study||985
1726007|NCT00273182|4225394|P1|COMPLETED|Overall Study||1014
1726008|NCT00273182|4225394|P1|STARTED|Overall Study||1999
1726009|NCT00273052|4225404|P2|NOT COMPLETED|Overall Study||88
1726010|NCT00273052|4225405|P1|NOT COMPLETED|Overall Study||69
1726011|NCT00273052|4225404|P2|COMPLETED|Overall Study||190
1726012|NCT00273052|4225405|P1|COMPLETED|Overall Study||221
1726013|NCT00273052|4225404|P2|STARTED|Overall Study||278
1726014|NCT00273052|4225405|P1|STARTED|Overall Study||290
1726015|NCT00272987|4225440|P3|NOT COMPLETED|Overall Study||19
1726016|NCT00272987|4225441|P2|NOT COMPLETED|Overall Study||14
1726017|NCT00272987|4225442|P1|NOT COMPLETED|Overall Study||21
1726018|NCT00272987|4225440|P3|COMPLETED|Overall Study||1
1726019|NCT00272987|4225441|P2|COMPLETED|Overall Study||0
1726020|NCT00272987|4225442|P1|COMPLETED|Overall Study||8
1726021|NCT00272987|4225440|P3|Ongoing|Overall Study||15
1726022|NCT00272987|4225441|P2|Ongoing|Overall Study||14
1726023|NCT00272987|4225442|P1|Ongoing|Overall Study||20
1726024|NCT00272987|4225440|P3|STARTED|Overall Study||20
1726025|NCT00272987|4225441|P2|STARTED|Overall Study||14
1726026|NCT00272987|4225442|P1|STARTED|Overall Study||29
1726027|NCT00272961|4225506|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
1726028|NCT00272961|4225507|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
1726029|NCT00272961|4225508|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
1726030|NCT00272961|4225509|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
1726031|NCT00272961|4225510|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
1726032|NCT00272961|4225506|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
1726033|NCT00272961|4225507|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
1726034|NCT00272961|4225508|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
1726035|NCT00272961|4225509|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
1726036|NCT00272961|4225510|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
1726037|NCT00272961|4225506|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
1726038|NCT00272961|4225507|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
1726039|NCT00272961|4225508|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
1726040|NCT00272961|4225509|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
1726041|NCT00272961|4225510|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
1726042|NCT00272961|4225506|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1726043|NCT00272961|4225507|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1726044|NCT00272961|4225508|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1726045|NCT00272961|4225509|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1726046|NCT00272961|4225510|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
1726047|NCT00272961|4225506|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1726048|NCT00272961|4225507|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1726049|NCT00272961|4225508|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1726050|NCT00272961|4225509|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
1726051|NCT00272961|4225510|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
1726052|NCT00272961|4225506|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
1726053|NCT00272961|4225507|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
1726054|NCT00272961|4225508|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
1726055|NCT00272961|4225509|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
1726056|NCT00272961|4225510|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
1726057|NCT00272844|4225567|P1|NOT COMPLETED|Overall Study||5
1726058|NCT00272844|4225567|P1|COMPLETED|Overall Study||18
1726059|NCT00272844|4225567|P1|STARTED|Overall Study||23
1726060|NCT00272792|4225575|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
1726061|NCT00272792|4225576|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
1726062|NCT00272792|4225575|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
1726063|NCT00272792|4225576|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
1726064|NCT00272792|4225575|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
1726065|NCT00272792|4225576|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
1726066|NCT00272792|4225575|P2|NOT COMPLETED|Part 1: Responsiveness||0
1726067|NCT00272792|4225576|P1|NOT COMPLETED|Part 1: Responsiveness||1
1726068|NCT00272792|4225575|P2|COMPLETED|Part 1: Responsiveness||0
1726069|NCT00272792|4225576|P1|COMPLETED|Part 1: Responsiveness||89
1726070|NCT00272792|4225575|P2|STARTED|Part 1: Responsiveness||0
1726071|NCT00272792|4225576|P1|STARTED|Part 1: Responsiveness||90
1726072|NCT00272779|4225586|P2|NOT COMPLETED|Baseline Through Week 96||136
1726073|NCT00272779|4225587|P1|NOT COMPLETED|Baseline Through Week 96||139
1726074|NCT00272779|4225586|P2|COMPLETED|Baseline Through Week 96||307
1726075|NCT00272779|4225587|P1|COMPLETED|Baseline Through Week 96||301
1726076|NCT00272779|4225586|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
1726077|NCT00272779|4225587|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
1726078|NCT00272779|4225586|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
1726079|NCT00272779|4225587|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
1726080|NCT00272779|4225586|P2|NOT COMPLETED|Baseline Through Week 48||443
1726081|NCT00272779|4225587|P1|NOT COMPLETED|Baseline Through Week 48||440
1726082|NCT00272779|4225586|P2|COMPLETED|Baseline Through Week 48||0
1726083|NCT00272779|4225587|P1|COMPLETED|Baseline Through Week 48||0
1726084|NCT00272779|4225586|P2|STILL ON TREATMENT|Baseline Through Week 48||368
1726085|NCT00272779|4225587|P1|STILL ON TREATMENT|Baseline Through Week 48||385
1726086|NCT00272779|4225586|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
1726087|NCT00272779|4225587|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
1726088|NCT00272779|4225586|P2|Discontinued Before Week 48|Baseline Through Week 48||58
1726089|NCT00272779|4225587|P1|Discontinued Before Week 48|Baseline Through Week 48||39
1726090|NCT00272779|4225586|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
1726091|NCT00272779|4225587|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
1726092|NCT00272779|4225586|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
1726093|NCT00272779|4225587|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
1726094|NCT00272779|4225586|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
1726095|NCT00272779|4225587|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
1726096|NCT00272337|4225771|P5|NOT COMPLETED|Overall Study||0
1726097|NCT00272337|4225772|P4|NOT COMPLETED|Overall Study||0
1726098|NCT00272337|4225773|P3|NOT COMPLETED|Overall Study||0
1726099|NCT00272337|4225774|P2|NOT COMPLETED|Overall Study||0
1726100|NCT00272337|4225775|P1|NOT COMPLETED|Overall Study||0
1726101|NCT00272337|4225771|P5|COMPLETED|Overall Study||8
1726102|NCT00272337|4225772|P4|COMPLETED|Overall Study||7
1726103|NCT00272337|4225773|P3|COMPLETED|Overall Study||7
1726104|NCT00272337|4225774|P2|COMPLETED|Overall Study||7
1726105|NCT00272337|4225775|P1|COMPLETED|Overall Study||8
1726106|NCT00272337|4225771|P5|STARTED|Overall Study||8
1726107|NCT00272337|4225772|P4|STARTED|Overall Study||7
1726108|NCT00272337|4225773|P3|STARTED|Overall Study||7
1726109|NCT00272337|4225774|P2|STARTED|Overall Study||7
1726110|NCT00272337|4225775|P1|STARTED|Overall Study||8
1726111|NCT00272311|4225802|P5|NOT COMPLETED|Overall Study||0
1726112|NCT00272311|4225803|P4|NOT COMPLETED|Overall Study||0
1726113|NCT00272311|4225804|P3|NOT COMPLETED|Overall Study||0
1726114|NCT00272311|4225805|P2|NOT COMPLETED|Overall Study||0
1726115|NCT00272311|4225806|P1|NOT COMPLETED|Overall Study||0
1726116|NCT00272311|4225802|P5|COMPLETED|Overall Study||14
1726117|NCT00272311|4225803|P4|COMPLETED|Overall Study||14
1726118|NCT00272311|4225804|P3|COMPLETED|Overall Study||14
1726119|NCT00272311|4225805|P2|COMPLETED|Overall Study||14
1726120|NCT00272311|4225806|P1|COMPLETED|Overall Study||14
1726121|NCT00272311|4225802|P5|STARTED|Overall Study||14
1726122|NCT00272311|4225803|P4|STARTED|Overall Study||14
1726123|NCT00272311|4225804|P3|STARTED|Overall Study||14
1726124|NCT00272311|4225805|P2|STARTED|Overall Study||14
1726125|NCT00272311|4225806|P1|STARTED|Overall Study||14
1726126|NCT00272168|4225820|P2|NOT COMPLETED|Overall Study||10
1726127|NCT00272168|4225821|P1|NOT COMPLETED|Overall Study||10
1726128|NCT00272168|4225820|P2|COMPLETED|Overall Study||31
1726129|NCT00272168|4225821|P1|COMPLETED|Overall Study||37
1726130|NCT00272168|4225820|P2|STARTED|Overall Study||41
1726131|NCT00272168|4225821|P1|STARTED|Overall Study||47
1726132|NCT00272038|4225837|P1|NOT COMPLETED|Overall Study||7
1726133|NCT00272038|4225837|P1|COMPLETED|Overall Study||22
1726134|NCT00272038|4225837|P1|STARTED|Overall Study||29
1726135|NCT00271947|4225843|P1|NOT COMPLETED|Overall Study||1
1726136|NCT00271947|4225843|P1|COMPLETED|Overall Study||0
1726137|NCT00271947|4225843|P1|STARTED|Overall Study||1
1726138|NCT00271856|4225849|P2|NOT COMPLETED|Overall Study||18
1726139|NCT00271856|4225850|P1|NOT COMPLETED|Overall Study||11
1726140|NCT00271856|4225849|P2|COMPLETED|Overall Study||70
1726141|NCT00271856|4225850|P1|COMPLETED|Overall Study||78
1726142|NCT00271856|4225849|P2|STARTED|Overall Study||88
1726143|NCT00271856|4225850|P1|STARTED|Overall Study||89
1726144|NCT00271817|4225869|P3|NOT COMPLETED|Part 2||84
1726145|NCT00271817|4225870|P2|NOT COMPLETED|Part 2||32
1726146|NCT00271817|4225871|P1|NOT COMPLETED|Part 2||0
1726147|NCT00271817|4225869|P3|COMPLETED|Part 2||401
1726148|NCT00271817|4225870|P2|COMPLETED|Part 2||234
1726149|NCT00271817|4225871|P1|COMPLETED|Part 2||0
1726150|NCT00271817|4225869|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
1726151|NCT00271817|4225870|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
1726152|NCT00271817|4225871|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
1726153|NCT00271817|4225869|P3|NOT COMPLETED|Part 1||285
1726154|NCT00271817|4225870|P2|NOT COMPLETED|Part 1||59
1726155|NCT00271817|4225871|P1|NOT COMPLETED|Part 1||106
1726156|NCT00271817|4225869|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
1726157|NCT00271817|4225870|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
1726158|NCT00271817|4225871|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
1726159|NCT00271817|4225869|P3|STARTED|Part 1||676
1726160|NCT00271817|4225870|P2|STARTED|Part 1||272
1726161|NCT00271817|4225871|P1|STARTED|Part 1||272
1726162|NCT00271739|4225900|P2|NOT COMPLETED|Overall Study||105
1726163|NCT00271739|4225901|P1|NOT COMPLETED|Overall Study||115
1726164|NCT00271739|4225900|P2|COMPLETED|Overall Study||716
1726165|NCT00271739|4225901|P1|COMPLETED|Overall Study||729
1726166|NCT00271739|4225900|P2|STARTED|Overall Study||821
1726167|NCT00271739|4225901|P1|STARTED|Overall Study||844
1726168|NCT00271609|4225913|P2|NOT COMPLETED|Overall Study||3
1726169|NCT00271609|4225914|P1|NOT COMPLETED|Overall Study||13
1726170|NCT00271609|4225913|P2|COMPLETED|Overall Study||29
1726171|NCT00271609|4225914|P1|COMPLETED|Overall Study||43
1726172|NCT00271609|4225913|P2|STARTED|Overall Study||32
1726173|NCT00271609|4225914|P1|STARTED|Overall Study||56
1726174|NCT00271596|4225924|P2|NOT COMPLETED|Overall Study||1
1726175|NCT00271596|4225925|P1|NOT COMPLETED|Overall Study||1
1726176|NCT00271596|4225924|P2|COMPLETED|Overall Study||15
1726177|NCT00271596|4225925|P1|COMPLETED|Overall Study||16
1726178|NCT00271596|4225924|P2|STARTED|Overall Study||16
1726179|NCT00271596|4225925|P1|STARTED|Overall Study||17
1726180|NCT00271570|4225951|P2|NOT COMPLETED|Overall Study||0
1726181|NCT00271570|4225952|P1|NOT COMPLETED|Overall Study||0
1726182|NCT00271570|4225951|P2|COMPLETED|Overall Study||12
1726183|NCT00271570|4225952|P1|COMPLETED|Overall Study||12
1726184|NCT00271570|4225951|P2|STARTED|Overall Study||12
1726185|NCT00271570|4225952|P1|STARTED|Overall Study||12
1726186|NCT00271544|4225960|P1|NOT COMPLETED|Overall Study||20
1726187|NCT00271544|4225960|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
1726188|NCT00271544|4225960|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
1726189|NCT00271544|4225960|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
1726190|NCT00271544|4225960|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
1726191|NCT00271375|4225984|P3|NOT COMPLETED|Overall Study||0
1726192|NCT00271375|4225985|P2|NOT COMPLETED|Overall Study||0
1726193|NCT00271375|4225986|P1|NOT COMPLETED|Overall Study||0
1726194|NCT00271375|4225984|P3|COMPLETED|Overall Study||57
1726195|NCT00271375|4225985|P2|COMPLETED|Overall Study||83
1726196|NCT00271375|4225986|P1|COMPLETED|Overall Study||114
1726197|NCT00271375|4225984|P3|STARTED|Overall Study||57
1726198|NCT00271375|4225985|P2|STARTED|Overall Study||83
1726199|NCT00271375|4225986|P1|STARTED|Overall Study||114
1726200|NCT00271219|4226024|P2|NOT COMPLETED|Overall Study||28
1726201|NCT00271219|4226025|P1|NOT COMPLETED|Overall Study||16
1726202|NCT00271219|4226024|P2|COMPLETED|Overall Study||58
1726203|NCT00271219|4226025|P1|COMPLETED|Overall Study||73
1726204|NCT00271219|4226024|P2|STARTED|Overall Study||86
1726205|NCT00271219|4226025|P1|STARTED|Overall Study||89
1726206|NCT00271154|4226051|P2|NOT COMPLETED|Overall Study||0
1726207|NCT00271154|4226052|P1|NOT COMPLETED|Overall Study||0
1726208|NCT00271154|4226051|P2|COMPLETED|Overall Study||419
1726209|NCT00271154|4226052|P1|COMPLETED|Overall Study||191
1726210|NCT00271154|4226051|P2|STARTED|Overall Study||419
1726211|NCT00271154|4226052|P1|STARTED|Overall Study||191
1726212|NCT00271024|4226065|P4|NOT COMPLETED|Overall Study||24
1726213|NCT00271024|4226066|P3|NOT COMPLETED|Overall Study||23
1726214|NCT00271024|4226067|P2|NOT COMPLETED|Overall Study||26
1726215|NCT00271024|4226068|P1|NOT COMPLETED|Overall Study||22
1726216|NCT00271024|4226065|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
1726217|NCT00271024|4226066|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
1726218|NCT00271024|4226067|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
1726219|NCT00271024|4226068|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
1726220|NCT00271024|4226065|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
1726311|NCT00270231|4226317|P2|STARTED|Second Intervention||31
1726221|NCT00271024|4226066|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
1726222|NCT00271024|4226067|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
1726223|NCT00271024|4226068|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
1726224|NCT00271024|4226065|P4|STARTED|Overall Study||88
1726225|NCT00271024|4226066|P3|STARTED|Overall Study||88
1726226|NCT00271024|4226067|P2|STARTED|Overall Study||77
1726227|NCT00271024|4226068|P1|STARTED|Overall Study||80
1726228|NCT00271011|4226110|P1|NOT COMPLETED|Overall Study||0
1726229|NCT00271011|4226110|P1|COMPLETED|Overall Study||13
1726230|NCT00271011|4226110|P1|STARTED|Overall Study||13
1726231|NCT00270998|4226118|P3|NOT COMPLETED|12 Month Follow-up||21
1726232|NCT00270998|4226119|P2|NOT COMPLETED|12 Month Follow-up||25
1726233|NCT00270998|4226120|P1|NOT COMPLETED|12 Month Follow-up||14
1726234|NCT00270998|4226118|P3|COMPLETED|12 Month Follow-up||111
1726235|NCT00270998|4226119|P2|COMPLETED|12 Month Follow-up||99
1726236|NCT00270998|4226120|P1|COMPLETED|12 Month Follow-up||96
1726237|NCT00270998|4226118|P3|STARTED|12 Month Follow-up||132
1726238|NCT00270998|4226119|P2|STARTED|12 Month Follow-up||124
1726239|NCT00270998|4226120|P1|STARTED|12 Month Follow-up||110
1726240|NCT00270998|4226118|P3|NOT COMPLETED|3 Month Follow-up||18
1726241|NCT00270998|4226119|P2|NOT COMPLETED|3 Month Follow-up||22
1726242|NCT00270998|4226120|P1|NOT COMPLETED|3 Month Follow-up||39
1726243|NCT00270998|4226118|P3|COMPLETED|3 Month Follow-up||132
1726244|NCT00270998|4226119|P2|COMPLETED|3 Month Follow-up||124
1726245|NCT00270998|4226120|P1|COMPLETED|3 Month Follow-up||110
1726246|NCT00270998|4226118|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
1726247|NCT00270998|4226119|P2|STARTED|3 Month Follow-up||146
1726248|NCT00270998|4226120|P1|STARTED|3 Month Follow-up||149
1726249|NCT00270894|4226149|P1|NOT COMPLETED|Overall Study||2
1726250|NCT00270894|4226149|P1|COMPLETED|Overall Study||28
1726251|NCT00270894|4226149|P1|STARTED|Overall Study||30
1726252|NCT00270855|4226161|P2|NOT COMPLETED|Overall Study||8
1726253|NCT00270855|4226162|P1|NOT COMPLETED|Overall Study||8
1726254|NCT00270855|4226161|P2|COMPLETED|Overall Study||6
1726255|NCT00270855|4226162|P1|COMPLETED|Overall Study||7
1726256|NCT00270855|4226161|P2|STARTED|Overall Study||14
1726257|NCT00270855|4226162|P1|STARTED|Overall Study||15
1726258|NCT00270842|4226221|P3|NOT COMPLETED|Overall Study||16
1726259|NCT00270842|4226222|P2|NOT COMPLETED|Overall Study||16
1726260|NCT00270842|4226223|P1|NOT COMPLETED|Overall Study||15
1726261|NCT00270842|4226221|P3|COMPLETED|Overall Study||18
1726262|NCT00270842|4226222|P2|COMPLETED|Overall Study||18
1726263|NCT00270842|4226223|P1|COMPLETED|Overall Study||18
1726264|NCT00270842|4226221|P3|STARTED|Overall Study||34
1726265|NCT00270842|4226222|P2|STARTED|Overall Study||34
1726266|NCT00270842|4226223|P1|STARTED|Overall Study||33
1726267|NCT00270790|4226234|P1|NOT COMPLETED|Overall Study||5
1726268|NCT00270790|4226234|P1|COMPLETED|Overall Study||16
1726269|NCT00270790|4226234|P1|STARTED|Overall Study||21
1726270|NCT00270634|4226243|P4|NOT COMPLETED|Overall Study||5
1726271|NCT00270634|4226244|P3|NOT COMPLETED|Overall Study||22
1726272|NCT00270634|4226245|P2|NOT COMPLETED|Overall Study||13
1726273|NCT00270634|4226246|P1|NOT COMPLETED|Overall Study||17
1726274|NCT00270634|4226243|P4|COMPLETED|Overall Study||81
1726275|NCT00270634|4226244|P3|COMPLETED|Overall Study||62
1726276|NCT00270634|4226245|P2|COMPLETED|Overall Study||64
1726277|NCT00270634|4226246|P1|COMPLETED|Overall Study||70
1726278|NCT00270634|4226243|P4|STARTED|Overall Study||86
1726279|NCT00270634|4226244|P3|STARTED|Overall Study||84
1726280|NCT00270634|4226245|P2|STARTED|Overall Study||77
1726281|NCT00270634|4226246|P1|STARTED|Overall Study||87
1726282|NCT00270296|4226283|P3|NOT COMPLETED|Overall Study||61
1726283|NCT00270296|4226284|P2|NOT COMPLETED|Overall Study||90
1726284|NCT00270296|4226285|P1|NOT COMPLETED|Overall Study||99
1726285|NCT00270296|4226283|P3|COMPLETED|Overall Study||109
1726286|NCT00270296|4226284|P2|COMPLETED|Overall Study||185
1726287|NCT00270296|4226285|P1|COMPLETED|Overall Study||186
1726288|NCT00270296|4226283|P3|STARTED|Overall Study||170
1726289|NCT00270296|4226284|P2|STARTED|Overall Study||275
1726290|NCT00270296|4226285|P1|STARTED|Overall Study||285
1726291|NCT00270257|4226298|P2|NOT COMPLETED|Overall Study||424
1726292|NCT00270257|4226299|P1|NOT COMPLETED|Overall Study||412
1726293|NCT00270257|4226298|P2|COMPLETED|Overall Study||204
1726294|NCT00270257|4226299|P1|COMPLETED|Overall Study||211
1726295|NCT00270257|4226298|P2|Visit 104|Overall Study||204
1726296|NCT00270257|4226299|P1|Visit 104|Overall Study||211
1726297|NCT00270257|4226298|P2|Week 78|Overall Study||285
1726298|NCT00270257|4226299|P1|Week 78|Overall Study||283
1726299|NCT00270257|4226298|P2|Week 52|Overall Study||340
1726300|NCT00270257|4226299|P1|Week 52|Overall Study||362
1726301|NCT00270257|4226298|P2|Week 26|Overall Study||440
1726302|NCT00270257|4226299|P1|Week 26|Overall Study||460
1726303|NCT00270257|4226298|P2|Week 8|Overall Study||443
1726304|NCT00270257|4226299|P1|Week 8|Overall Study||510
1726305|NCT00270257|4226298|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
1726306|NCT00270257|4226299|P1|STARTED|Overall Study||623
1726307|NCT00270231|4226317|P2|NOT COMPLETED|Second Intervention||1
1726308|NCT00270231|4226318|P1|NOT COMPLETED|Second Intervention||0
1726309|NCT00270231|4226317|P2|COMPLETED|Second Intervention||30
1726310|NCT00270231|4226318|P1|COMPLETED|Second Intervention||30
1726312|NCT00270231|4226318|P1|STARTED|Second Intervention||30
1726313|NCT00270231|4226317|P2|NOT COMPLETED|Washout Period||0
1726314|NCT00270231|4226318|P1|NOT COMPLETED|Washout Period||1
1726315|NCT00270231|4226317|P2|COMPLETED|Washout Period||31
1726316|NCT00270231|4226318|P1|COMPLETED|Washout Period||30
1726317|NCT00270231|4226317|P2|STARTED|Washout Period||31
1726318|NCT00270231|4226318|P1|STARTED|Washout Period||31
1726319|NCT00270231|4226317|P2|NOT COMPLETED|First Intervention||1
1726320|NCT00270231|4226318|P1|NOT COMPLETED|First Intervention||1
1726321|NCT00270231|4226317|P2|COMPLETED|First Intervention||31
1726322|NCT00270231|4226318|P1|COMPLETED|First Intervention||31
1726323|NCT00270231|4226317|P2|STARTED|First Intervention||32
1726324|NCT00270231|4226318|P1|STARTED|First Intervention||32
1726325|NCT00270205|4226328|P4|NOT COMPLETED|Overall Study||1
1726326|NCT00270205|4226329|P3|NOT COMPLETED|Overall Study||0
1726327|NCT00270205|4226330|P2|NOT COMPLETED|Overall Study||0
1726328|NCT00270205|4226331|P1|NOT COMPLETED|Overall Study||1
1726329|NCT00270205|4226328|P4|COMPLETED|Overall Study||6
1726330|NCT00270205|4226329|P3|COMPLETED|Overall Study||6
1726331|NCT00270205|4226330|P2|COMPLETED|Overall Study||6
1726332|NCT00270205|4226331|P1|COMPLETED|Overall Study||5
1726333|NCT00270205|4226328|P4|STARTED|Overall Study||7
1726334|NCT00270205|4226329|P3|STARTED|Overall Study||6
1726335|NCT00270205|4226330|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
1726336|NCT00270205|4226331|P1|STARTED|Overall Study||6
1726337|NCT00269919|4226449|P1|NOT COMPLETED|Overall Study||27
1726338|NCT00269919|4226449|P1|COMPLETED|Overall Study||13
1726339|NCT00269919|4226449|P1|Treated|Overall Study||39
1726340|NCT00269919|4226449|P1|STARTED|Overall Study||40
1726341|NCT00269633|4226468|P2|NOT COMPLETED|Overall Study||0
1726342|NCT00269633|4226469|P1|NOT COMPLETED|Overall Study||1
1726343|NCT00269633|4226468|P2|COMPLETED|Overall Study||5
1726344|NCT00269633|4226469|P1|COMPLETED|Overall Study||3
1726345|NCT00269633|4226468|P2|STARTED|Overall Study||5
1726346|NCT00269633|4226469|P1|STARTED|Overall Study||4
1726347|NCT00269477|4226479|P4|NOT COMPLETED|Overall Study||0
1726348|NCT00269477|4226480|P3|NOT COMPLETED|Overall Study||1
1726349|NCT00269477|4226481|P2|NOT COMPLETED|Overall Study||6
1726350|NCT00269477|4226482|P1|NOT COMPLETED|Overall Study||5
1726351|NCT00269477|4226479|P4|COMPLETED|Overall Study||60
1726352|NCT00269477|4226480|P3|COMPLETED|Overall Study||57
1726353|NCT00269477|4226481|P2|COMPLETED|Overall Study||12
1726354|NCT00269477|4226482|P1|COMPLETED|Overall Study||4
1726355|NCT00269477|4226479|P4|STARTED|Overall Study||60
1726356|NCT00269477|4226480|P3|STARTED|Overall Study||58
1726357|NCT00269477|4226481|P2|STARTED|Overall Study||18
1726358|NCT00269477|4226482|P1|STARTED|Overall Study||9
1726359|NCT00269152|4226498|P2|NOT COMPLETED|Overall Study||10
1726360|NCT00269152|4226499|P1|NOT COMPLETED|Overall Study||18
1726361|NCT00269152|4226498|P2|COMPLETED|Overall Study||49
1726362|NCT00269152|4226499|P1|COMPLETED|Overall Study||45
1726363|NCT00269152|4226498|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
1726364|NCT00269152|4226499|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
1726365|NCT00269113|4226515|P2|NOT COMPLETED|Overall Study||37
1726366|NCT00269113|4226516|P1|NOT COMPLETED|Overall Study||74
1726367|NCT00269113|4226515|P2|COMPLETED|Overall Study||146
1726368|NCT00269113|4226516|P1|COMPLETED|Overall Study||103
1726369|NCT00269113|4226515|P2|STARTED|Overall Study||183
1726370|NCT00269113|4226516|P1|STARTED|Overall Study||177
1726371|NCT00268996|4226536|P2|NOT COMPLETED|Overall Study||20
1726372|NCT00268996|4226537|P1|NOT COMPLETED|Overall Study||21
1726373|NCT00268996|4226536|P2|COMPLETED|Overall Study||152
1726374|NCT00268996|4226537|P1|COMPLETED|Overall Study||130
1726375|NCT00268996|4226536|P2|STARTED|Overall Study||172
1726376|NCT00268996|4226537|P1|STARTED|Overall Study||151
1726377|NCT00268983|4226581|P2|NOT COMPLETED|Overall Study||0
1726378|NCT00268983|4226582|P1|NOT COMPLETED|Overall Study||3
1726379|NCT00268983|4226581|P2|COMPLETED|Overall Study||8
1726380|NCT00268983|4226582|P1|COMPLETED|Overall Study||3
1726381|NCT00268983|4226581|P2|STARTED|Overall Study||8
1726382|NCT00268983|4226582|P1|STARTED|Overall Study||6
1726383|NCT00268905|4226625|P3|NOT COMPLETED|Overall Study||12
1726384|NCT00268905|4226626|P2|NOT COMPLETED|Overall Study||9
1726385|NCT00268905|4226627|P1|NOT COMPLETED|Overall Study||43
1726386|NCT00268905|4226625|P3|COMPLETED|Overall Study||0
1726387|NCT00268905|4226626|P2|COMPLETED|Overall Study||0
1726388|NCT00268905|4226627|P1|COMPLETED|Overall Study||0
1726389|NCT00268905|4226625|P3|STARTED|Overall Study||12
1726390|NCT00268905|4226626|P2|STARTED|Overall Study||9
1726391|NCT00268905|4226627|P1|STARTED|Overall Study||43
1726392|NCT00268892|4226644|P3|NOT COMPLETED|Overall Study||39
1726393|NCT00268892|4226645|P2|NOT COMPLETED|Overall Study||42
1726394|NCT00268892|4226646|P1|NOT COMPLETED|Overall Study||39
1726395|NCT00268892|4226644|P3|COMPLETED|Overall Study||54
1726396|NCT00268892|4226645|P2|COMPLETED|Overall Study||53
1726397|NCT00268892|4226646|P1|COMPLETED|Overall Study||51
1726398|NCT00268892|4226644|P3|Switched to Higher Dose|Overall Study||76
1726399|NCT00268892|4226645|P2|Switched to Higher Dose|Overall Study||68
1726400|NCT00268892|4226646|P1|Switched to Higher Dose|Overall Study||59
1726401|NCT00268892|4226644|P3|STARTED|Overall Study||93
1726402|NCT00268892|4226645|P2|STARTED|Overall Study||95
1726403|NCT00268892|4226646|P1|STARTED|Overall Study||90
1726404|NCT00268762|4226657|P1|NOT COMPLETED|Overall Study||0
1726405|NCT00268762|4226657|P1|COMPLETED|Overall Study||65
1726406|NCT00268762|4226657|P1|STARTED|Overall Study||65
1726407|NCT00268463|4226665|P2|NOT COMPLETED|Overall Study||12
1726408|NCT00268463|4226666|P1|NOT COMPLETED|Overall Study||10
1726409|NCT00268463|4226665|P2|COMPLETED|Overall Study||0
1726410|NCT00268463|4226666|P1|COMPLETED|Overall Study||0
1726411|NCT00268463|4226665|P2|STARTED|Overall Study||12
1726412|NCT00268463|4226666|P1|STARTED|Overall Study||10
1726413|NCT00268450|4226672|P1|NOT COMPLETED|Overall Study||0
1726414|NCT00268450|4226672|P1|COMPLETED|Overall Study||21
1726415|NCT00268450|4226672|P1|STARTED|Overall Study||21
1726416|NCT00268437|4226682|P1|NOT COMPLETED|Overall Study||1
1726417|NCT00268437|4226682|P1|COMPLETED|Overall Study||26
1726418|NCT00268437|4226682|P1|STARTED|Overall Study||27
1726419|NCT00268346|4226689|P2|NOT COMPLETED|Overall Study||3
1726420|NCT00268346|4226690|P1|NOT COMPLETED|Overall Study||0
1726421|NCT00268346|4226689|P2|COMPLETED|Overall Study||37
1726422|NCT00268346|4226690|P1|COMPLETED|Overall Study||18
1726423|NCT00268346|4226689|P2|Started Treatment|Overall Study||40
1726424|NCT00268346|4226690|P1|Started Treatment|Overall Study||18
1726425|NCT00268346|4226689|P2|STARTED|Overall Study||40
1726426|NCT00268346|4226690|P1|STARTED|Overall Study||18
1726427|NCT00268242|4226696|P1|NOT COMPLETED|Overall Study||1
1726428|NCT00268242|4226696|P1|COMPLETED|Overall Study||23
1726429|NCT00268242|4226696|P1|STARTED|Overall Study||24
1726430|NCT00268203|4226705|P1|NOT COMPLETED|Overall Study||647
1726431|NCT00268203|4226705|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
1726432|NCT00268203|4226705|P1|Completed 2 Years of Follow-up|Overall Study||62
1726433|NCT00268203|4226705|P1|STARTED|Overall Study||765
1726434|NCT00267969|4226719|P7|NOT COMPLETED|After Controlled Period||72
1726435|NCT00267969|4226720|P6|NOT COMPLETED|After Controlled Period||82
1726436|NCT00267969|4226721|P5|NOT COMPLETED|After Controlled Period||35
1726437|NCT00267969|4226722|P4|NOT COMPLETED|After Controlled Period||36
1726438|NCT00267969|4226723|P3|NOT COMPLETED|After Controlled Period||0
1726439|NCT00267969|4226724|P2|NOT COMPLETED|After Controlled Period||0
1726440|NCT00267969|4226725|P1|NOT COMPLETED|After Controlled Period||0
1726441|NCT00267969|4226719|P7|COMPLETED|After Controlled Period||173
1726442|NCT00267969|4226720|P6|COMPLETED|After Controlled Period||172
1726443|NCT00267969|4226721|P5|COMPLETED|After Controlled Period||85
1726444|NCT00267969|4226722|P4|COMPLETED|After Controlled Period||87
1726445|NCT00267969|4226723|P3|COMPLETED|After Controlled Period||0
1726446|NCT00267969|4226724|P2|COMPLETED|After Controlled Period||0
1726447|NCT00267969|4226725|P1|COMPLETED|After Controlled Period||0
1726448|NCT00267969|4226719|P7|STARTED|After Controlled Period||245
1726449|NCT00267969|4226720|P6|STARTED|After Controlled Period||254
1726450|NCT00267969|4226721|P5|STARTED|After Controlled Period||120
1726451|NCT00267969|4226722|P4|STARTED|After Controlled Period||123
1726452|NCT00267969|4226723|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1726453|NCT00267969|4226724|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1726454|NCT00267969|4226725|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1726455|NCT00267969|4226719|P7|NOT COMPLETED|Controlled Period||0
1726456|NCT00267969|4226720|P6|NOT COMPLETED|Controlled Period||0
1726457|NCT00267969|4226721|P5|NOT COMPLETED|Controlled Period||0
1726458|NCT00267969|4226722|P4|NOT COMPLETED|Controlled Period||0
1726459|NCT00267969|4226723|P3|NOT COMPLETED|Controlled Period||11
1726460|NCT00267969|4226724|P2|NOT COMPLETED|Controlled Period||1
1726461|NCT00267969|4226725|P1|NOT COMPLETED|Controlled Period||12
1726462|NCT00267969|4226719|P7|COMPLETED|Controlled Period||0
1726463|NCT00267969|4226720|P6|COMPLETED|Controlled Period||0
1726464|NCT00267969|4226721|P5|COMPLETED|Controlled Period||0
1726465|NCT00267969|4226722|P4|COMPLETED|Controlled Period||0
1726466|NCT00267969|4226723|P3|COMPLETED|Controlled Period||245
1726467|NCT00267969|4226724|P2|COMPLETED|Controlled Period||254
1726468|NCT00267969|4226725|P1|COMPLETED|Controlled Period||243
1726469|NCT00267969|4226719|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1726470|NCT00267969|4226720|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1726471|NCT00267969|4226721|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1726472|NCT00267969|4226722|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1726473|NCT00267969|4226723|P3|STARTED|Controlled Period|Number of patients randomized|256
1726474|NCT00267969|4226724|P2|STARTED|Controlled Period|Number of patients randomized|255
1726475|NCT00267969|4226725|P1|STARTED|Controlled Period|Number of patients randomized|255
1726476|NCT00267956|4226751|P4|NOT COMPLETED|After Controlled Period||2
1726477|NCT00267956|4226752|P3|NOT COMPLETED|After Controlled Period||5
1726478|NCT00267956|4226753|P2|NOT COMPLETED|After Controlled Period||0
1726479|NCT00267956|4226754|P1|NOT COMPLETED|After Controlled Period||0
1726480|NCT00267956|4226751|P4|COMPLETED|After Controlled Period||70
1726481|NCT00267956|4226752|P3|COMPLETED|After Controlled Period||52
1726482|NCT00267956|4226753|P2|COMPLETED|After Controlled Period||0
1726483|NCT00267956|4226754|P1|COMPLETED|After Controlled Period||0
1726484|NCT00267956|4226751|P4|STARTED|After Controlled Period||72
1726485|NCT00267956|4226752|P3|STARTED|After Controlled Period||57
1726486|NCT00267956|4226753|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1726487|NCT00267956|4226754|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
1726488|NCT00267956|4226751|P4|NOT COMPLETED|Controlled Period||0
1726489|NCT00267956|4226752|P3|NOT COMPLETED|Controlled Period||0
1726490|NCT00267956|4226753|P2|NOT COMPLETED|Controlled Period||4
1726491|NCT00267956|4226754|P1|NOT COMPLETED|Controlled Period||13
1726492|NCT00267956|4226751|P4|COMPLETED|Controlled Period||0
1726493|NCT00267956|4226752|P3|COMPLETED|Controlled Period||0
1726494|NCT00267956|4226753|P2|COMPLETED|Controlled Period||72
1726495|NCT00267956|4226754|P1|COMPLETED|Controlled Period||57
1726496|NCT00267956|4226751|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1726497|NCT00267956|4226752|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
1726498|NCT00267956|4226753|P2|STARTED|Controlled Period||76
1726499|NCT00267956|4226754|P1|STARTED|Controlled Period||70
1726500|NCT00267774|4226774|P2|NOT COMPLETED|Overall Study||0
1726501|NCT00267774|4226775|P1|NOT COMPLETED|Overall Study||0
1726502|NCT00267774|4226774|P2|COMPLETED|Overall Study||496
1726503|NCT00267774|4226775|P1|COMPLETED|Overall Study||509
1726504|NCT00267774|4226774|P2|STARTED|Overall Study||496
1726505|NCT00267774|4226775|P1|STARTED|Overall Study||509
1726506|NCT00267748|4226786|P3|NOT COMPLETED|Randomized Period||132
1726507|NCT00267748|4226787|P2|NOT COMPLETED|Randomized Period||127
1726508|NCT00267748|4226788|P1|NOT COMPLETED|Randomized Period||0
1726509|NCT00267748|4226786|P3|COMPLETED|Randomized Period||14
1726510|NCT00267748|4226787|P2|COMPLETED|Randomized Period||19
1726511|NCT00267748|4226788|P1|COMPLETED|Randomized Period||0
1726512|NCT00267748|4226786|P3|Treated|Randomized Period||143
1726513|NCT00267748|4226787|P2|Treated|Randomized Period||146
1726514|NCT00267748|4226788|P1|Treated|Randomized Period||0
1726515|NCT00267748|4226786|P3|STARTED|Randomized Period||146
1726516|NCT00267748|4226787|P2|STARTED|Randomized Period||146
1726517|NCT00267748|4226788|P1|STARTED|Randomized Period||0
1726518|NCT00267748|4226786|P3|NOT COMPLETED|Non-randomized Period||0
1726519|NCT00267748|4226787|P2|NOT COMPLETED|Non-randomized Period||0
1726520|NCT00267748|4226788|P1|NOT COMPLETED|Non-randomized Period||23
1726521|NCT00267748|4226786|P3|COMPLETED|Non-randomized Period||0
1726522|NCT00267748|4226787|P2|COMPLETED|Non-randomized Period||0
1726523|NCT00267748|4226788|P1|COMPLETED|Non-randomized Period||2
1726524|NCT00267748|4226786|P3|STARTED|Non-randomized Period||0
1726525|NCT00267748|4226787|P2|STARTED|Non-randomized Period||0
1726526|NCT00267748|4226788|P1|STARTED|Non-randomized Period||25
1726527|NCT00267696|4226805|P1|NOT COMPLETED|Overall Study||0
1726528|NCT00267696|4226805|P1|COMPLETED|Overall Study||45
1726529|NCT00267696|4226805|P1|STARTED|Overall Study||45
1726530|NCT00267670|4226812|P2|NOT COMPLETED|Overall Study||0
1726531|NCT00267670|4226813|P1|NOT COMPLETED|Overall Study||4
1726532|NCT00267670|4226812|P2|COMPLETED|Overall Study||7
1726533|NCT00267670|4226813|P1|COMPLETED|Overall Study||15
1726534|NCT00267670|4226812|P2|STARTED|Overall Study||7
1726535|NCT00267670|4226813|P1|STARTED|Overall Study||19
1726536|NCT00267644|4226827|P2|NOT COMPLETED|Overall Study||0
1726537|NCT00267644|4226828|P1|NOT COMPLETED|Overall Study||0
1726538|NCT00267644|4226827|P2|COMPLETED|Overall Study||63
1726539|NCT00267644|4226828|P1|COMPLETED|Overall Study||13
1726540|NCT00267644|4226827|P2|STARTED|Overall Study||63
1726541|NCT00267644|4226828|P1|STARTED|Overall Study||13
1726542|NCT00267631|4226838|P2|NOT COMPLETED|Overall Study||0
1726543|NCT00267631|4226839|P1|NOT COMPLETED|Overall Study||0
1726544|NCT00267631|4226838|P2|COMPLETED|Overall Study||3031
1726545|NCT00267631|4226839|P1|COMPLETED|Overall Study||2361
1726546|NCT00267631|4226838|P2|STARTED|Overall Study||3031
1726547|NCT00267631|4226839|P1|STARTED|Overall Study||2361
1726548|NCT00267488|4226845|P1|NOT COMPLETED|Overall Study||11
1726549|NCT00267488|4226845|P1|COMPLETED|Overall Study||26
1726550|NCT00267488|4226845|P1|STARTED|Overall Study||37
1726551|NCT00267293|4226857|P3|NOT COMPLETED|Overall Study||0
1726552|NCT00267293|4226858|P2|NOT COMPLETED|Overall Study||0
1726553|NCT00267293|4226859|P1|NOT COMPLETED|Overall Study||0
1726554|NCT00267293|4226857|P3|COMPLETED|Overall Study||20
1726555|NCT00267293|4226858|P2|COMPLETED|Overall Study||20
1726556|NCT00267293|4226859|P1|COMPLETED|Overall Study||20
1726557|NCT00267293|4226857|P3|STARTED|Overall Study||20
1726558|NCT00267293|4226858|P2|STARTED|Overall Study||20
1726559|NCT00267293|4226859|P1|STARTED|Overall Study||20
1726560|NCT00267202|4226869|P2|NOT COMPLETED|Overall Study||34
1726561|NCT00267202|4226870|P1|NOT COMPLETED|Overall Study||53
1726562|NCT00267202|4226869|P2|COMPLETED|Overall Study||105
1726563|NCT00267202|4226870|P1|COMPLETED|Overall Study||83
1726564|NCT00267202|4226869|P2|STARTED|Overall Study||139
1726565|NCT00267202|4226870|P1|STARTED|Overall Study||136
1726566|NCT00267189|4226891|P2|NOT COMPLETED|Overall Study||1
1726567|NCT00267189|4226892|P1|NOT COMPLETED|Overall Study||5
1726568|NCT00267189|4226891|P2|COMPLETED|Overall Study||72
1726569|NCT00267189|4226892|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
1726570|NCT00267189|4226891|P2|Completed Study Medication|Overall Study||72
1726571|NCT00267189|4226892|P1|Completed Study Medication|Overall Study||54
1726572|NCT00267189|4226891|P2|STARTED|Overall Study||73
1726573|NCT00267189|4226892|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
1726574|NCT00267150|4226902|P1|NOT COMPLETED|Overall Study||1
1726575|NCT00267150|4226902|P1|COMPLETED|Overall Study||30
1726576|NCT00267150|4226902|P1|STARTED|Overall Study||31
1726577|NCT00267111|4226909|P2|NOT COMPLETED|Overall Study||0
1726578|NCT00267111|4226910|P1|NOT COMPLETED|Overall Study||0
1726579|NCT00267111|4226909|P2|COMPLETED|Overall Study||55
1726580|NCT00267111|4226910|P1|COMPLETED|Overall Study||55
1726581|NCT00267111|4226909|P2|STARTED|Overall Study||55
1726582|NCT00267111|4226910|P1|STARTED|Overall Study||55
1726583|NCT00267098|4226926|P8|NOT COMPLETED|Overall Study||15
1726584|NCT00267098|4226927|P7|NOT COMPLETED|Overall Study||46
1726585|NCT00267098|4226928|P6|NOT COMPLETED|Overall Study||40
1726586|NCT00267098|4226929|P5|NOT COMPLETED|Overall Study||37
1726587|NCT00267098|4226930|P4|NOT COMPLETED|Overall Study||106
1726588|NCT00267098|4226931|P3|NOT COMPLETED|Overall Study||94
1726589|NCT00267098|4226932|P2|NOT COMPLETED|Overall Study||51
1726590|NCT00267098|4226933|P1|NOT COMPLETED|Overall Study||109
1726591|NCT00267098|4226926|P8|COMPLETED|Overall Study||5
1726592|NCT00267098|4226927|P7|COMPLETED|Overall Study||55
1726593|NCT00267098|4226928|P6|COMPLETED|Overall Study||66
1726594|NCT00267098|4226929|P5|COMPLETED|Overall Study||10
1726595|NCT00267098|4226930|P4|COMPLETED|Overall Study||135
1726596|NCT00267098|4226931|P3|COMPLETED|Overall Study||149
1726597|NCT00267098|4226932|P2|COMPLETED|Overall Study||0
1726598|NCT00267098|4226933|P1|COMPLETED|Overall Study||0
1726599|NCT00267098|4226926|P8|STARTED|Overall Study||20
1726600|NCT00267098|4226927|P7|STARTED|Overall Study||101
1726601|NCT00267098|4226928|P6|STARTED|Overall Study||106
1726602|NCT00267098|4226929|P5|STARTED|Overall Study||47
1726603|NCT00267098|4226930|P4|STARTED|Overall Study||241
1726604|NCT00267098|4226931|P3|STARTED|Overall Study||243
1726605|NCT00267098|4226932|P2|STARTED|Overall Study||51
1726606|NCT00267098|4226933|P1|STARTED|Overall Study||109
1726607|NCT00267085|4227066|P1|NOT COMPLETED|Overall Study||0
1726608|NCT00267085|4227066|P1|COMPLETED|Overall Study||10
1726609|NCT00267085|4227066|P1|STARTED|Overall Study||10
1726610|NCT00267059|4227070|P1|NOT COMPLETED|Overall Study||0
1726611|NCT00267059|4227070|P1|COMPLETED|Overall Study||44
1726612|NCT00267059|4227070|P1|STARTED|Overall Study||44
1726613|NCT00267046|4227076|P2|NOT COMPLETED|Overall Study||11
1726614|NCT00267046|4227077|P1|NOT COMPLETED|Overall Study||12
1726615|NCT00267046|4227076|P2|COMPLETED|Overall Study||5
1726616|NCT00267046|4227077|P1|COMPLETED|Overall Study||20
1726617|NCT00267046|4227076|P2|STARTED|Overall Study||16
1726618|NCT00267046|4227077|P1|STARTED|Overall Study||32
1726619|NCT00267007|4227087|P2|NOT COMPLETED|Overall Study||1
1726620|NCT00267007|4227088|P1|NOT COMPLETED|Overall Study||8
1726621|NCT00267007|4227087|P2|COMPLETED|Overall Study||10
1726622|NCT00267007|4227088|P1|COMPLETED|Overall Study||11
1726623|NCT00267007|4227087|P2|STARTED|Overall Study||11
1726624|NCT00267007|4227088|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
1726625|NCT00266877|4227099|P3|NOT COMPLETED|Overall Study||28
1726626|NCT00266877|4227100|P2|NOT COMPLETED|Overall Study||48
1726627|NCT00266877|4227101|P1|NOT COMPLETED|Overall Study||91
1726628|NCT00266877|4227099|P3|COMPLETED|Overall Study||0
1726629|NCT00266877|4227100|P2|COMPLETED|Overall Study||0
1726630|NCT00266877|4227101|P1|COMPLETED|Overall Study||0
1726631|NCT00266877|4227099|P3|STARTED|Overall Study||28
1726632|NCT00266877|4227100|P2|STARTED|Overall Study||48
1726633|NCT00266877|4227101|P1|STARTED|Overall Study||91
1726634|NCT00266864|4227120|P2|NOT COMPLETED|Overall Study||2
1726635|NCT00266864|4227121|P1|NOT COMPLETED|Overall Study||5
1726636|NCT00266864|4227120|P2|COMPLETED|Overall Study||11
1726637|NCT00266864|4227121|P1|COMPLETED|Overall Study||13
1726638|NCT00266864|4227120|P2|STARTED|Overall Study||13
1726639|NCT00266864|4227121|P1|STARTED|Overall Study||18
1726640|NCT00266825|4227130|P2|NOT COMPLETED|Completed Follow-Up||24
1726641|NCT00266825|4227131|P1|NOT COMPLETED|Completed Follow-Up||25
1726642|NCT00266825|4227130|P2|COMPLETED|Completed Follow-Up||154
1726643|NCT00266825|4227131|P1|COMPLETED|Completed Follow-Up||147
1726644|NCT00266825|4227130|P2|STARTED|Completed Follow-Up||178
1726645|NCT00266825|4227131|P1|STARTED|Completed Follow-Up||172
1726646|NCT00266825|4227130|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
1726647|NCT00266825|4227131|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
1726648|NCT00266825|4227130|P2|COMPLETED|Enrolled and Allocated Intervention||178
1726649|NCT00266825|4227131|P1|COMPLETED|Enrolled and Allocated Intervention||172
1726650|NCT00266825|4227130|P2|STARTED|Enrolled and Allocated Intervention||178
1726651|NCT00266825|4227131|P1|STARTED|Enrolled and Allocated Intervention||172
1726652|NCT00266812|4227157|P2|NOT COMPLETED|Overall Study||11
1726653|NCT00266812|4227158|P1|NOT COMPLETED|Overall Study||21
1726654|NCT00266812|4227157|P2|COMPLETED|Overall Study||2
1726655|NCT00266812|4227158|P1|COMPLETED|Overall Study||1
1726656|NCT00266812|4227157|P2|STARTED|Overall Study||13
1726657|NCT00266812|4227158|P1|STARTED|Overall Study||22
1726658|NCT00266799|4227166|P2|NOT COMPLETED|Overall Study||34
1726659|NCT00266799|4227167|P1|NOT COMPLETED|Overall Study||36
1726660|NCT00266799|4227166|P2|COMPLETED|Overall Study||68
1726661|NCT00266799|4227167|P1|COMPLETED|Overall Study||62
1726662|NCT00266799|4227166|P2|STARTED|Overall Study||102
1726663|NCT00266799|4227167|P1|STARTED|Overall Study||98
1726664|NCT00266695|4227181|P1|NOT COMPLETED|Overall Study||29
1726665|NCT00266695|4227181|P1|COMPLETED|Overall Study||174
1726666|NCT00266695|4227181|P1|STARTED|Overall Study||203
1726667|NCT00266656|4227193|P2|NOT COMPLETED|Overall Study||13
1726668|NCT00266656|4227194|P1|NOT COMPLETED|Overall Study||14
1726669|NCT00266656|4227193|P2|COMPLETED|Overall Study||20
1726670|NCT00266656|4227194|P1|COMPLETED|Overall Study||22
1726671|NCT00266656|4227193|P2|STARTED|Overall Study||33
1726672|NCT00266656|4227194|P1|STARTED|Overall Study||36
1726673|NCT00266630|4227218|P2|NOT COMPLETED|Overall Study||28
1726674|NCT00266630|4227219|P1|NOT COMPLETED|Overall Study||42
1726675|NCT00266630|4227218|P2|COMPLETED|Overall Study||11
1726676|NCT00266630|4227219|P1|COMPLETED|Overall Study||58
1726677|NCT00266630|4227218|P2|STARTED|Overall Study||39
1726678|NCT00266630|4227219|P1|STARTED|Overall Study||100
1726679|NCT00266409|4227261|P4|NOT COMPLETED|Overall Study||22
1726680|NCT00266409|4227262|P3|NOT COMPLETED|Overall Study||17
1726681|NCT00266409|4227263|P2|NOT COMPLETED|Overall Study||46
1726682|NCT00266409|4227264|P1|NOT COMPLETED|Overall Study||45
1726683|NCT00266409|4227261|P4|COMPLETED|Overall Study||49
1726684|NCT00266409|4227262|P3|COMPLETED|Overall Study||55
1726685|NCT00266409|4227263|P2|COMPLETED|Overall Study||92
1726686|NCT00266409|4227264|P1|COMPLETED|Overall Study||92
1726687|NCT00266409|4227261|P4|STARTED|Overall Study||71
1726688|NCT00266409|4227262|P3|STARTED|Overall Study||72
1726689|NCT00266409|4227263|P2|STARTED|Overall Study||138
1726690|NCT00266409|4227264|P1|STARTED|Overall Study||137
1726691|NCT00266279|4227546|P1|NOT COMPLETED|Overall Study||2
1726692|NCT00266279|4227546|P1|COMPLETED|Overall Study||15
1726693|NCT00266279|4227546|P1|STARTED|Overall Study||17
1726694|NCT00266227|4227552|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
1726695|NCT00266227|4227553|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
1726696|NCT00266227|4227554|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
1726697|NCT00266227|4227552|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
1726698|NCT00266227|4227553|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
1726699|NCT00266227|4227554|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
1726700|NCT00266227|4227552|P3|STARTED|Retreatment: Week 48 to Week 72||0
1726701|NCT00266227|4227553|P2|STARTED|Retreatment: Week 48 to Week 72||134
1726702|NCT00266227|4227554|P1|STARTED|Retreatment: Week 48 to Week 72||291
1726703|NCT00266227|4227552|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
1726704|NCT00266227|4227553|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
1726705|NCT00266227|4227554|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
1726706|NCT00266227|4227552|P3|COMPLETED|Retreatment: Up to Week 48||0
1726707|NCT00266227|4227553|P2|COMPLETED|Retreatment: Up to Week 48||134
1726708|NCT00266227|4227554|P1|COMPLETED|Retreatment: Up to Week 48||291
1726709|NCT00266227|4227552|P3|STARTED|Retreatment: Up to Week 48||0
1726710|NCT00266227|4227553|P2|STARTED|Retreatment: Up to Week 48||157
1726711|NCT00266227|4227554|P1|STARTED|Retreatment: Up to Week 48||318
1726712|NCT00266227|4227552|P3|NOT COMPLETED|Initial Treatment||77
1726713|NCT00266227|4227553|P2|NOT COMPLETED|Initial Treatment||0
1726714|NCT00266227|4227554|P1|NOT COMPLETED|Initial Treatment||0
1726715|NCT00266227|4227552|P3|COMPLETED|Initial Treatment||482
1726716|NCT00266227|4227553|P2|COMPLETED|Initial Treatment||0
1726717|NCT00266227|4227554|P1|COMPLETED|Initial Treatment||0
1726718|NCT00266227|4227552|P3|STARTED|Initial Treatment||559
1726719|NCT00266227|4227553|P2|STARTED|Initial Treatment||0
1726720|NCT00266227|4227554|P1|STARTED|Initial Treatment||0
1726721|NCT00266110|4227599|P1|NOT COMPLETED|Overall Study||7
1726722|NCT00266110|4227599|P1|COMPLETED|Overall Study||10
1726723|NCT00266110|4227599|P1|STARTED|Overall Study||17
1726724|NCT00266032|4227608|P3|NOT COMPLETED|Open-label Safety Extension||25
1726725|NCT00266032|4227609|P2|NOT COMPLETED|Open-label Safety Extension||14
1726726|NCT00266032|4227610|P1|NOT COMPLETED|Open-label Safety Extension||41
1726727|NCT00266032|4227608|P3|COMPLETED|Open-label Safety Extension||140
1726728|NCT00266032|4227609|P2|COMPLETED|Open-label Safety Extension||115
1726729|NCT00266032|4227610|P1|COMPLETED|Open-label Safety Extension||448
1726730|NCT00266032|4227608|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
1726731|NCT00266032|4227609|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
1726732|NCT00266032|4227610|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
1726733|NCT00266032|4227608|P3|NOT COMPLETED|Treatment||47
1726734|NCT00266032|4227609|P2|NOT COMPLETED|Treatment||64
1726735|NCT00266032|4227610|P1|NOT COMPLETED|Treatment||111
1726736|NCT00266032|4227608|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
1726737|NCT00266032|4227609|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
1726738|NCT00266032|4227610|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
1726739|NCT00266032|4227608|P3|Patients Treated and in FAS|Treatment|FAS|216
1726740|NCT00266032|4227609|P2|Patients Treated and in FAS|Treatment|FAS|209
1726741|NCT00266032|4227610|P1|Patients Treated and in FAS|Treatment|FAS|642
1726742|NCT00266032|4227608|P3|Patients Treated|Treatment||229
1726743|NCT00266032|4227609|P2|Patients Treated|Treatment||221
1726744|NCT00266032|4227610|P1|Patients Treated|Treatment||684
1726745|NCT00266032|4227608|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
1726746|NCT00266032|4227609|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
1726747|NCT00266032|4227610|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
1726748|NCT00265941|4227640|P2|NOT COMPLETED|Overall Study||26
1726749|NCT00265941|4227641|P1|NOT COMPLETED|Overall Study||23
1726750|NCT00265941|4227640|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
1726751|NCT00265941|4227641|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
1726752|NCT00265941|4227640|P2|STARTED|Overall Study||470
1726753|NCT00265941|4227641|P1|STARTED|Overall Study||470
1726754|NCT00265889|4227673|P1|NOT COMPLETED|Overall Study||5
1726755|NCT00265889|4227673|P1|COMPLETED|Overall Study||37
1726756|NCT00265889|4227673|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
1726757|NCT00265889|4227673|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
1726758|NCT00265889|4227673|P1|STARTED|Overall Study||42
1726759|NCT00265850|4227682|P3|NOT COMPLETED|Overall Study||0
1726760|NCT00265850|4227683|P2|NOT COMPLETED|Overall Study||0
1726761|NCT00265850|4227684|P1|NOT COMPLETED|Overall Study||0
1726762|NCT00265850|4227682|P3|COMPLETED|Overall Study||533
1726763|NCT00265850|4227683|P2|COMPLETED|Overall Study||902
1726764|NCT00265850|4227684|P1|COMPLETED|Overall Study||899
1726765|NCT00265850|4227682|P3|STARTED|Overall Study||533
1726766|NCT00265850|4227683|P2|STARTED|Overall Study||902
1726767|NCT00265850|4227684|P1|STARTED|Overall Study||899
1726768|NCT00265798|4227694|P1|NOT COMPLETED|Overall Study||0
1726769|NCT00265798|4227694|P1|COMPLETED|Overall Study||38
1726770|NCT00265798|4227694|P1|STARTED|Overall Study||38
1726771|NCT00265785|4227700|P1|NOT COMPLETED|Overall Study||27
1726772|NCT00265785|4227700|P1|COMPLETED|Overall Study||0
1726773|NCT00265785|4227700|P1|Eligible and Began Protocol Treatment|Overall Study||24
1726774|NCT00265785|4227700|P1|Eligible|Overall Study||26
1726775|NCT00265785|4227700|P1|STARTED|Overall Study||27
1726776|NCT00265759|4227713|P4|NOT COMPLETED|Overall Study||9
1726777|NCT00265759|4227714|P3|NOT COMPLETED|Overall Study||2
1726778|NCT00265759|4227715|P2|NOT COMPLETED|Overall Study||1
1726779|NCT00265759|4227716|P1|NOT COMPLETED|Overall Study||0
1726780|NCT00265759|4227713|P4|COMPLETED|Overall Study||236
1726781|NCT00265759|4227714|P3|COMPLETED|Overall Study||123
1726782|NCT00265759|4227715|P2|COMPLETED|Overall Study||127
1726783|NCT00265759|4227716|P1|COMPLETED|Overall Study||124
1726784|NCT00265759|4227713|P4|STARTED|Overall Study||245
1726785|NCT00265759|4227714|P3|STARTED|Overall Study||125
1726786|NCT00265759|4227715|P2|STARTED|Overall Study||128
1726787|NCT00265759|4227716|P1|STARTED|Overall Study||124
1726788|NCT00265616|4227747|P2|NOT COMPLETED|Overall Study||0
1726789|NCT00265616|4227748|P1|NOT COMPLETED|Overall Study||0
1726790|NCT00265616|4227747|P2|COMPLETED|Overall Study||9
1726791|NCT00265616|4227748|P1|COMPLETED|Overall Study||14
1726792|NCT00265616|4227747|P2|STARTED|Overall Study||9
1726793|NCT00265616|4227748|P1|STARTED|Overall Study||14
1726794|NCT00265512|4227766|P2|NOT COMPLETED|Overall Study||95
1726795|NCT00265512|4227767|P1|NOT COMPLETED|Overall Study||45
1726796|NCT00265512|4227766|P2|COMPLETED|Overall Study||359
1726797|NCT00265512|4227767|P1|COMPLETED|Overall Study||168
1726798|NCT00265512|4227766|P2|STARTED|Overall Study||454
1726799|NCT00265512|4227767|P1|STARTED|Overall Study||213
1726800|NCT00265473|4227773|P1|NOT COMPLETED|Overall Study||0
1726801|NCT00265473|4227773|P1|COMPLETED|Overall Study||5
1726802|NCT00265473|4227773|P1|STARTED|Overall Study||5
1726803|NCT00265395|4227783|P2|NOT COMPLETED|Overall Study||17
1726804|NCT00265395|4227784|P1|NOT COMPLETED|Overall Study||8
1726805|NCT00265395|4227783|P2|COMPLETED|Overall Study||56
1726806|NCT00265395|4227784|P1|COMPLETED|Overall Study||78
1726807|NCT00265395|4227783|P2|STARTED|Overall Study||73
1726808|NCT00265395|4227784|P1|STARTED|Overall Study||86
1726809|NCT00265382|4227789|P1|NOT COMPLETED|Overall Study||145
1726810|NCT00265382|4227789|P1|COMPLETED|Overall Study||76
1726811|NCT00265382|4227789|P1|STARTED|Overall Study||221
1726812|NCT00265343|4227809|P2|NOT COMPLETED|Overall Study||19
1726813|NCT00265343|4227810|P1|NOT COMPLETED|Overall Study||21
1726814|NCT00265343|4227809|P2|COMPLETED|Overall Study||153
1726815|NCT00265343|4227810|P1|COMPLETED|Overall Study||113
1726816|NCT00265343|4227809|P2|STARTED|Overall Study||172
1726817|NCT00265343|4227810|P1|STARTED|Overall Study||134
1726818|NCT00265330|4227818|P1|NOT COMPLETED|Overall Study||95
1726819|NCT00265330|4227818|P1|COMPLETED|Overall Study||67
1726820|NCT00265330|4227818|P1|STARTED|Overall Study||162
1726821|NCT00265317|4227844|P4|NOT COMPLETED|Phase 2||65
1726822|NCT00265317|4227845|P3|NOT COMPLETED|Phase 2||64
1726823|NCT00265317|4227846|P2|NOT COMPLETED|Phase 2||0
1726824|NCT00265317|4227847|P1|NOT COMPLETED|Phase 2||0
1726825|NCT00265317|4227844|P4|COMPLETED|Phase 2||2
1726826|NCT00265317|4227845|P3|COMPLETED|Phase 2||1
1726827|NCT00265317|4227846|P2|COMPLETED|Phase 2||0
1726828|NCT00265317|4227847|P1|COMPLETED|Phase 2||0
1726829|NCT00265317|4227844|P4|STARTED|Phase 2||67
1726830|NCT00265317|4227845|P3|STARTED|Phase 2||65
1726831|NCT00265317|4227846|P2|STARTED|Phase 2||0
1726832|NCT00265317|4227847|P1|STARTED|Phase 2||0
1726833|NCT00265317|4227844|P4|NOT COMPLETED|Lead-In||0
1726834|NCT00265317|4227845|P3|NOT COMPLETED|Lead-In||0
1726835|NCT00265317|4227846|P2|NOT COMPLETED|Lead-In||17
1726836|NCT00265317|4227847|P1|NOT COMPLETED|Lead-In||12
1726837|NCT00265317|4227844|P4|COMPLETED|Lead-In||0
1726838|NCT00265317|4227845|P3|COMPLETED|Lead-In||0
1726839|NCT00265317|4227846|P2|COMPLETED|Lead-In||0
1726840|NCT00265317|4227847|P1|COMPLETED|Lead-In||1
1726841|NCT00265317|4227844|P4|STARTED|Lead-In||0
1726842|NCT00265317|4227845|P3|STARTED|Lead-In||0
1726843|NCT00265317|4227846|P2|STARTED|Lead-In||17
1726844|NCT00265317|4227847|P1|STARTED|Lead-In||13
1726845|NCT00265239|4227962|P2|NOT COMPLETED|Overall Study||1
1726846|NCT00265239|4227963|P1|NOT COMPLETED|Overall Study||2
1726847|NCT00265239|4227962|P2|COMPLETED|Overall Study||51
1726848|NCT00265239|4227963|P1|COMPLETED|Overall Study||50
1726849|NCT00265239|4227962|P2|STARTED|Overall Study||52
1726850|NCT00265239|4227963|P1|STARTED|Overall Study||52
1726851|NCT00265200|4227975|P1|NOT COMPLETED|Overall Study||4
1726852|NCT00265200|4227975|P1|COMPLETED|Overall Study||24
1726853|NCT00265200|4227975|P1|STARTED|Overall Study||28
1726854|NCT00265122|4227985|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
1726855|NCT00265122|4227986|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
1726856|NCT00265122|4227987|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
1726857|NCT00265122|4227988|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
1726858|NCT00265122|4227989|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
1726859|NCT00265122|4227990|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
1726860|NCT00265122|4227985|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
1726861|NCT00265122|4227986|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
1726862|NCT00265122|4227987|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
1726863|NCT00265122|4227988|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
1726864|NCT00265122|4227989|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
1726865|NCT00265122|4227990|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
1726866|NCT00265122|4227985|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
1726867|NCT00265122|4227986|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
1726868|NCT00265122|4227987|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
1726869|NCT00265122|4227988|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
1726870|NCT00265122|4227989|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
1726871|NCT00265122|4227990|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
1726872|NCT00265122|4227985|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
1726873|NCT00265122|4227986|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
1726874|NCT00265122|4227987|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
1726875|NCT00265122|4227988|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
1726876|NCT00265122|4227989|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
1726877|NCT00265122|4227990|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
1726878|NCT00265122|4227985|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
1726879|NCT00265122|4227986|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
1726880|NCT00265122|4227987|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
1726881|NCT00265122|4227988|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
1726882|NCT00265122|4227989|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
1726883|NCT00265122|4227990|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
1726884|NCT00265122|4227985|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
1726885|NCT00265122|4227986|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
1726886|NCT00265122|4227987|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
1726887|NCT00265122|4227988|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
1726888|NCT00265122|4227989|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
1726889|NCT00265122|4227990|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
1726890|NCT00265109|4228012|P1|NOT COMPLETED|Overall Study||6
1726891|NCT00265109|4228012|P1|COMPLETED|Overall Study||11
1726892|NCT00265109|4228012|P1|STARTED|Overall Study||17
1726893|NCT00265096|4228019|P3|NOT COMPLETED|Overall Study||39
1726894|NCT00265096|4228020|P2|NOT COMPLETED|Overall Study||51
1726895|NCT00265096|4228021|P1|NOT COMPLETED|Overall Study||36
1726896|NCT00265096|4228019|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
1726897|NCT00265096|4228020|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
1726898|NCT00265096|4228021|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
1726899|NCT00265096|4228019|P3|STARTED|Overall Study||146
1726900|NCT00265096|4228020|P2|STARTED|Overall Study||146
1726901|NCT00265096|4228021|P1|STARTED|Overall Study||113
1726902|NCT00265083|4228053|P3|NOT COMPLETED|Overall Study||42
1726903|NCT00265083|4228054|P2|NOT COMPLETED|Overall Study||42
1726904|NCT00265083|4228055|P1|NOT COMPLETED|Overall Study||17
1726905|NCT00265083|4228053|P3|COMPLETED|Overall Study||98
1726906|NCT00265083|4228054|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
1726907|NCT00265083|4228055|P1|COMPLETED|Overall Study||61
1726908|NCT00265083|4228053|P3|STARTED|Overall Study||140
1726909|NCT00265083|4228054|P2|STARTED|Overall Study|One patient did not receive study agent.|138
1726910|NCT00265083|4228055|P1|STARTED|Overall Study||78
1726911|NCT00264875|4228076|P1|NOT COMPLETED|Overall Study||30
1726912|NCT00264875|4228076|P1|COMPLETED|Overall Study||190
1726913|NCT00264875|4228076|P1|STARTED|Overall Study||220
1726914|NCT00264849|4228082|P2|NOT COMPLETED|Overall Study||25
1726915|NCT00264849|4228083|P1|NOT COMPLETED|Overall Study||22
1726916|NCT00264849|4228082|P2|COMPLETED|Overall Study||106
1726917|NCT00264849|4228083|P1|COMPLETED|Overall Study||253
1726918|NCT00264849|4228082|P2|STARTED|Overall Study||131
1726919|NCT00264849|4228083|P1|STARTED|Overall Study||275
1726920|NCT00264810|4228117|P2|NOT COMPLETED|Open Label Evaluation Period||6
1726921|NCT00264810|4228118|P1|NOT COMPLETED|Open Label Evaluation Period||6
1726922|NCT00264810|4228117|P2|COMPLETED|Open Label Evaluation Period||86
1726923|NCT00264810|4228118|P1|COMPLETED|Open Label Evaluation Period||89
1726924|NCT00264810|4228117|P2|1-year Post-implant|Open Label Evaluation Period||90
1726925|NCT00264810|4228118|P1|1-year Post-implant|Open Label Evaluation Period||92
1726926|NCT00264810|4228117|P2|STARTED|Open Label Evaluation Period||92
1726927|NCT00264810|4228118|P1|STARTED|Open Label Evaluation Period||95
1726928|NCT00264810|4228117|P2|NOT COMPLETED|Blinded Evaluation Period||1
1726929|NCT00264810|4228118|P1|NOT COMPLETED|Blinded Evaluation Period||1
1726930|NCT00264810|4228117|P2|COMPLETED|Blinded Evaluation Period||92
1726931|NCT00264810|4228118|P1|COMPLETED|Blinded Evaluation Period||95
1726932|NCT00264810|4228117|P2|STARTED|Blinded Evaluation Period||93
1726933|NCT00264810|4228118|P1|STARTED|Blinded Evaluation Period||96
1726934|NCT00264810|4228117|P2|NOT COMPLETED|Stimulation Optimization Period||1
1726935|NCT00264810|4228118|P1|NOT COMPLETED|Stimulation Optimization Period||1
1726936|NCT00264810|4228117|P2|COMPLETED|Stimulation Optimization Period||93
1726937|NCT00264810|4228118|P1|COMPLETED|Stimulation Optimization Period||96
1726938|NCT00264810|4228117|P2|STARTED|Stimulation Optimization Period||94
1726939|NCT00264810|4228118|P1|STARTED|Stimulation Optimization Period||97
1726940|NCT00264810|4228117|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
1726941|NCT00264810|4228118|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
1726942|NCT00264810|4228117|P2|COMPLETED|Post-Operative Stabilization Period||94
1726943|NCT00264810|4228118|P1|COMPLETED|Post-Operative Stabilization Period||97
1726944|NCT00264810|4228117|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
1726945|NCT00264810|4228118|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
1726946|NCT00264810|4228117|P2|NOT COMPLETED|Baseline||26
1726947|NCT00264810|4228118|P1|NOT COMPLETED|Baseline||23
1726948|NCT00264810|4228117|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
1726949|NCT00264810|4228118|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
1726950|NCT00264810|4228117|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
1726951|NCT00264810|4228118|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
1726952|NCT00264797|4228128|P2|NOT COMPLETED|Overall Study||43
1726953|NCT00264797|4228129|P1|NOT COMPLETED|Overall Study||33
1726954|NCT00264797|4228128|P2|COMPLETED|Overall Study||109
1726955|NCT00264797|4228129|P1|COMPLETED|Overall Study||118
1726956|NCT00264797|4228128|P2|STARTED|Overall Study||152
1726957|NCT00264797|4228129|P1|STARTED|Overall Study||151
1726958|NCT00264641|4228143|P2|NOT COMPLETED|Overall Study||0
1726959|NCT00264641|4228144|P1|NOT COMPLETED|Overall Study||0
1726960|NCT00264641|4228143|P2|COMPLETED|Overall Study||10
1726961|NCT00264641|4228144|P1|COMPLETED|Overall Study||10
1726962|NCT00264641|4228143|P2|Initiation of the Study|Overall Study||10
1726963|NCT00264641|4228144|P1|Initiation of the Study|Overall Study||10
1726964|NCT00264641|4228143|P2|STARTED|Overall Study||10
1726965|NCT00264641|4228144|P1|STARTED|Overall Study||10
1726966|NCT00264576|4228151|P2|NOT COMPLETED|Overall Study||1
1726967|NCT00264576|4228152|P1|NOT COMPLETED|Overall Study||1
1726968|NCT00264576|4228151|P2|COMPLETED|Overall Study||304
1726969|NCT00264576|4228152|P1|COMPLETED|Overall Study||307
1726970|NCT00264576|4228151|P2|STARTED|Overall Study||305
1726971|NCT00264576|4228152|P1|STARTED|Overall Study||308
1726972|NCT00264550|4228176|P4|NOT COMPLETED|Overall Study||30
1726973|NCT00264550|4228177|P3|NOT COMPLETED|Overall Study||17
1726974|NCT00264550|4228178|P2|NOT COMPLETED|Overall Study||41
1726975|NCT00264550|4228179|P1|NOT COMPLETED|Overall Study||43
1726976|NCT00264550|4228176|P4|COMPLETED|Overall Study||59
1726977|NCT00264550|4228177|P3|COMPLETED|Overall Study||72
1726978|NCT00264550|4228178|P2|COMPLETED|Overall Study||92
1726979|NCT00264550|4228179|P1|COMPLETED|Overall Study||90
1726980|NCT00264550|4228176|P4|STARTED|Overall Study||89
1726981|NCT00264550|4228177|P3|STARTED|Overall Study||89
1726982|NCT00264550|4228178|P2|STARTED|Overall Study||133
1726983|NCT00264550|4228179|P1|STARTED|Overall Study||133
1726984|NCT00264537|4228218|P4|NOT COMPLETED|Overall Study||60
1726985|NCT00264537|4228219|P3|NOT COMPLETED|Overall Study||50
1726986|NCT00264537|4228220|P2|NOT COMPLETED|Overall Study||58
1726987|NCT00264537|4228221|P1|NOT COMPLETED|Overall Study||50
1726988|NCT00264537|4228218|P4|COMPLETED|Overall Study||99
1726989|NCT00264537|4228219|P3|COMPLETED|Overall Study||109
1726990|NCT00264537|4228220|P2|COMPLETED|Overall Study||101
1726991|NCT00264537|4228221|P1|COMPLETED|Overall Study||110
1726992|NCT00264537|4228218|P4|STARTED|Overall Study||159
1726993|NCT00264537|4228219|P3|STARTED|Overall Study||159
1726994|NCT00264537|4228220|P2|STARTED|Overall Study||159
1726995|NCT00264537|4228221|P1|STARTED|Overall Study||160
1726996|NCT00264498|4228253|P2|NOT COMPLETED|Crossover Treatment||9
1726997|NCT00264498|4228254|P1|NOT COMPLETED|Crossover Treatment||6
1726998|NCT00264498|4228253|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1726999|NCT00264498|4228254|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1727000|NCT00264498|4228253|P2|STARTED|Crossover Treatment||9
1727001|NCT00264498|4228254|P1|STARTED|Crossover Treatment||6
1727002|NCT00264498|4228253|P2|NOT COMPLETED|Randomized Treatment||18
1727003|NCT00264498|4228254|P1|NOT COMPLETED|Randomized Treatment||17
1727004|NCT00264498|4228253|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1727005|NCT00264498|4228254|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1727006|NCT00264498|4228253|P2|STARTED|Randomized Treatment||18
1727007|NCT00264498|4228254|P1|STARTED|Randomized Treatment||17
1727008|NCT00264381|4228262|P2|NOT COMPLETED|Overall Study||0
1727009|NCT00264381|4228263|P1|NOT COMPLETED|Overall Study||0
1727010|NCT00264381|4228262|P2|COMPLETED|Overall Study||37
1727011|NCT00264381|4228263|P1|COMPLETED|Overall Study||35
1727012|NCT00264381|4228262|P2|STARTED|Overall Study||37
1727013|NCT00264381|4228263|P1|STARTED|Overall Study||35
1727014|NCT00264303|4228277|P2|NOT COMPLETED|Overall Study||29
1727015|NCT00264303|4228278|P1|NOT COMPLETED|Overall Study||25
1727016|NCT00264303|4228277|P2|COMPLETED|Overall Study||419
1727017|NCT00264303|4228278|P1|COMPLETED|Overall Study||413
1727018|NCT00264303|4228277|P2|STARTED|Overall Study||448
1727019|NCT00264303|4228278|P1|STARTED|Overall Study||438
1727020|NCT00264290|4228296|P2|NOT COMPLETED|Observation (4 Weeks)||0
1727021|NCT00264290|4228297|P1|NOT COMPLETED|Observation (4 Weeks)||0
1727022|NCT00264290|4228296|P2|COMPLETED|Observation (4 Weeks)||14
1727023|NCT00264290|4228297|P1|COMPLETED|Observation (4 Weeks)||15
1727024|NCT00264290|4228296|P2|STARTED|Observation (4 Weeks)||14
1727025|NCT00264290|4228297|P1|STARTED|Observation (4 Weeks)||15
1727026|NCT00264290|4228296|P2|NOT COMPLETED|Intervention (8 Weeks)||0
1727027|NCT00264290|4228297|P1|NOT COMPLETED|Intervention (8 Weeks)||1
1727028|NCT00264290|4228296|P2|COMPLETED|Intervention (8 Weeks)||14
1727029|NCT00264290|4228297|P1|COMPLETED|Intervention (8 Weeks)||15
1727030|NCT00264290|4228296|P2|STARTED|Intervention (8 Weeks)||14
1727031|NCT00264290|4228297|P1|STARTED|Intervention (8 Weeks)||16
1727032|NCT00264238|4228303|P1|NOT COMPLETED|Overall Study||1
1727033|NCT00264238|4228303|P1|COMPLETED|Overall Study||14
1727034|NCT00264238|4228303|P1|STARTED|Overall Study||15
1727035|NCT00264147|4228315|P6|NOT COMPLETED|Treatment II Period||33
1727036|NCT00264147|4228316|P5|NOT COMPLETED|Treatment II Period||33
1727037|NCT00264147|4228317|P4|NOT COMPLETED|Treatment II Period||0
1727038|NCT00264147|4228318|P3|NOT COMPLETED|Treatment II Period||0
1727039|NCT00264147|4228319|P2|NOT COMPLETED|Treatment II Period||0
1727040|NCT00264147|4228320|P1|NOT COMPLETED|Treatment II Period||0
1727041|NCT00264147|4228315|P6|COMPLETED|Treatment II Period||116
1727042|NCT00264147|4228316|P5|COMPLETED|Treatment II Period||147
1727043|NCT00264147|4228317|P4|COMPLETED|Treatment II Period||0
1727044|NCT00264147|4228318|P3|COMPLETED|Treatment II Period||0
1727045|NCT00264147|4228319|P2|COMPLETED|Treatment II Period||0
1727046|NCT00264147|4228320|P1|COMPLETED|Treatment II Period||0
1727047|NCT00264147|4228315|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
1727048|NCT00264147|4228316|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
1727049|NCT00264147|4228317|P4|STARTED|Treatment II Period||0
1727050|NCT00264147|4228318|P3|STARTED|Treatment II Period||0
1727051|NCT00264147|4228319|P2|STARTED|Treatment II Period||0
1727052|NCT00264147|4228320|P1|STARTED|Treatment II Period||0
1727053|NCT00264147|4228315|P6|NOT COMPLETED|Treatment I Period||0
1727054|NCT00264147|4228316|P5|NOT COMPLETED|Treatment I Period||56
1727055|NCT00264147|4228317|P4|NOT COMPLETED|Treatment I Period||72
1727056|NCT00264147|4228318|P3|NOT COMPLETED|Treatment I Period||77
1727057|NCT00264147|4228319|P2|NOT COMPLETED|Treatment I Period||83
1727058|NCT00264147|4228320|P1|NOT COMPLETED|Treatment I Period||98
1727059|NCT00264147|4228315|P6|COMPLETED|Treatment I Period||0
1727060|NCT00264147|4228316|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
1727061|NCT00264147|4228317|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
1727062|NCT00264147|4228318|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
1727063|NCT00264147|4228319|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
1727064|NCT00264147|4228320|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
1727065|NCT00264147|4228315|P6|STARTED|Treatment I Period||0
1727066|NCT00264147|4228316|P5|STARTED|Treatment I Period||155
1727067|NCT00264147|4228317|P4|STARTED|Treatment I Period||140
1727068|NCT00264147|4228318|P3|STARTED|Treatment I Period||151
1727069|NCT00264147|4228319|P2|STARTED|Treatment I Period||154
1727070|NCT00264147|4228320|P1|STARTED|Treatment I Period||161
1727071|NCT00264004|4228363|P4|NOT COMPLETED|Overall Study||15
1727072|NCT00264004|4228364|P3|NOT COMPLETED|Overall Study||14
1727073|NCT00264004|4228365|P2|NOT COMPLETED|Overall Study||11
1727074|NCT00264004|4228366|P1|NOT COMPLETED|Overall Study||17
1727075|NCT00264004|4228363|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
1727076|NCT00264004|4228364|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
1727077|NCT00264004|4228365|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
1727078|NCT00264004|4228366|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
1727079|NCT00264004|4228363|P4|STARTED|Overall Study|Randomised|34
1727080|NCT00264004|4228364|P3|STARTED|Overall Study|Randomised|30
1727081|NCT00264004|4228365|P2|STARTED|Overall Study|Randomised|32
1727082|NCT00264004|4228366|P1|STARTED|Overall Study|Randomised|30
1727083|NCT00263887|4228394|P2|NOT COMPLETED|Overall Study||7
1727084|NCT00263887|4228395|P1|NOT COMPLETED|Overall Study||3
1727085|NCT00263887|4228394|P2|COMPLETED|Overall Study||32
1727086|NCT00263887|4228395|P1|COMPLETED|Overall Study||35
1727087|NCT00263887|4228394|P2|STARTED|Overall Study||39
1727088|NCT00263887|4228395|P1|STARTED|Overall Study||38
1727089|NCT00263757|4228403|P2|NOT COMPLETED|Overall Study||8
1727090|NCT00263757|4228404|P1|NOT COMPLETED|Overall Study||8
1727091|NCT00263757|4228403|P2|COMPLETED|Overall Study||5
1727092|NCT00263757|4228404|P1|COMPLETED|Overall Study||4
1727093|NCT00263757|4228403|P2|STARTED|Overall Study||13
1727094|NCT00263757|4228404|P1|STARTED|Overall Study||12
1727095|NCT00263666|4228416|P2|NOT COMPLETED|Overall Study||11
1727096|NCT00263666|4228417|P1|NOT COMPLETED|Overall Study||7
1727097|NCT00263666|4228416|P2|COMPLETED|Overall Study||39
1727098|NCT00263666|4228417|P1|COMPLETED|Overall Study||43
1727099|NCT00263666|4228416|P2|STARTED|Overall Study||50
1727100|NCT00263666|4228417|P1|STARTED|Overall Study||50
1727101|NCT00263328|4228471|P3|NOT COMPLETED|Overall Study||7
1727102|NCT00263328|4228472|P2|NOT COMPLETED|Overall Study||2
1727103|NCT00263328|4228473|P1|NOT COMPLETED|Overall Study||8
1727104|NCT00263328|4228471|P3|COMPLETED|Overall Study||6
1727105|NCT00263328|4228472|P2|COMPLETED|Overall Study||12
1727106|NCT00263328|4228473|P1|COMPLETED|Overall Study||10
1727107|NCT00263328|4228471|P3|STARTED|Overall Study||13
1727108|NCT00263328|4228472|P2|STARTED|Overall Study||14
1727109|NCT00263328|4228473|P1|STARTED|Overall Study||18
1727110|NCT00263211|4228631|P2|NOT COMPLETED|Overall Study||1
1727111|NCT00263211|4228632|P1|NOT COMPLETED|Overall Study||5
1727112|NCT00263211|4228631|P2|COMPLETED|Overall Study||23
1727113|NCT00263211|4228632|P1|COMPLETED|Overall Study||19
1727114|NCT00263211|4228631|P2|STARTED|Overall Study||24
1727115|NCT00263211|4228632|P1|STARTED|Overall Study||24
1727116|NCT00262964|4228650|P4|NOT COMPLETED|Overall Study||0
1727117|NCT00262964|4228651|P3|NOT COMPLETED|Overall Study||0
1727118|NCT00262964|4228652|P2|NOT COMPLETED|Overall Study||0
1727119|NCT00262964|4228653|P1|NOT COMPLETED|Overall Study||0
1727120|NCT00262964|4228650|P4|COMPLETED|Overall Study||12
1727121|NCT00262964|4228651|P3|COMPLETED|Overall Study||17
1727122|NCT00262964|4228652|P2|COMPLETED|Overall Study||11
1727123|NCT00262964|4228653|P1|COMPLETED|Overall Study||11
1727124|NCT00262964|4228650|P4|STARTED|Overall Study||12
1727125|NCT00262964|4228651|P3|STARTED|Overall Study||17
1727126|NCT00262964|4228652|P2|STARTED|Overall Study||11
1727127|NCT00262964|4228653|P1|STARTED|Overall Study||11
1727128|NCT00262951|4228683|P1|NOT COMPLETED|Overall Study||16
1727129|NCT00262951|4228683|P1|COMPLETED|Overall Study||7
1727130|NCT00262951|4228683|P1|STARTED|Overall Study||23
1727131|NCT00262925|4228688|P1|NOT COMPLETED|Overall Study||11
1727132|NCT00262925|4228688|P1|COMPLETED|Overall Study||1
1727133|NCT00262925|4228688|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
1727134|NCT00262873|4228694|P1|NOT COMPLETED|Overall Study||8
1727135|NCT00262873|4228694|P1|COMPLETED|Overall Study||0
1727136|NCT00262873|4228694|P1|STARTED|Overall Study||8
1727137|NCT00262860|4228705|P1|NOT COMPLETED|Overall Study||2
1727138|NCT00262860|4228705|P1|COMPLETED|Overall Study||16
1727139|NCT00262860|4228705|P1|STARTED|Overall Study||18
1727140|NCT00262847|4228714|P3|NOT COMPLETED|Overall Study||396
1727141|NCT00262847|4228715|P2|NOT COMPLETED|Overall Study||513
1727142|NCT00262847|4228716|P1|NOT COMPLETED|Overall Study||518
1727143|NCT00262847|4228714|P3|COMPLETED|Overall Study||227
1727144|NCT00262847|4228715|P2|COMPLETED|Overall Study||112
1727145|NCT00262847|4228716|P1|COMPLETED|Overall Study||107
1727146|NCT00262847|4228714|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
1727147|NCT00262847|4228715|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
1727148|NCT00262847|4228716|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
1727149|NCT00262834|4228735|P2|NOT COMPLETED|Overall Study||4
1727150|NCT00262834|4228736|P1|NOT COMPLETED|Overall Study||1
1727151|NCT00262834|4228735|P2|COMPLETED|Overall Study||25
1727152|NCT00262834|4228736|P1|COMPLETED|Overall Study||24
1727153|NCT00262834|4228735|P2|STARTED|Overall Study||29
1727154|NCT00262834|4228736|P1|STARTED|Overall Study||25
1727155|NCT00262821|4228749|P2|NOT COMPLETED|Overall Study||19
1727156|NCT00262821|4228750|P1|NOT COMPLETED|Overall Study||4
1727157|NCT00262821|4228749|P2|COMPLETED|Overall Study||185
1727158|NCT00262821|4228750|P1|COMPLETED|Overall Study||194
1727159|NCT00262821|4228749|P2|STARTED|Overall Study||204
1727160|NCT00262821|4228750|P1|STARTED|Overall Study||198
1727161|NCT00262743|4228762|P2|NOT COMPLETED|Overall Study||12
1727162|NCT00262743|4228763|P1|NOT COMPLETED|Overall Study||0
1727163|NCT00262743|4228762|P2|COMPLETED|Overall Study||30
1727164|NCT00262743|4228763|P1|COMPLETED|Overall Study||27
1727165|NCT00262743|4228762|P2|STARTED|Overall Study||42
1727166|NCT00262743|4228763|P1|STARTED|Overall Study||27
1727167|NCT00262730|4228770|P1|NOT COMPLETED|Overall Study||0
1727168|NCT00262730|4228770|P1|COMPLETED|Overall Study||97
1727169|NCT00262730|4228770|P1|STARTED|Overall Study||97
1727170|NCT00262639|4228778|P4|NOT COMPLETED|Overall Study||0
1727171|NCT00262639|4228779|P3|NOT COMPLETED|Overall Study||0
1727172|NCT00262639|4228780|P2|NOT COMPLETED|Overall Study||0
1727173|NCT00262639|4228781|P1|NOT COMPLETED|Overall Study||0
1727174|NCT00262639|4228778|P4|COMPLETED|Overall Study||7
1727175|NCT00262639|4228779|P3|COMPLETED|Overall Study||9
1727176|NCT00262639|4228780|P2|COMPLETED|Overall Study||26
1727177|NCT00262639|4228781|P1|COMPLETED|Overall Study||18
1727178|NCT00262639|4228778|P4|STARTED|Overall Study||7
1727179|NCT00262639|4228779|P3|STARTED|Overall Study||9
1727180|NCT00262639|4228780|P2|STARTED|Overall Study||26
1727181|NCT00262639|4228781|P1|STARTED|Overall Study||18
1727182|NCT00262600|4228798|P3|NOT COMPLETED|Overall Study||266
1727183|NCT00262600|4228799|P2|NOT COMPLETED|Overall Study||252
1727184|NCT00262600|4228800|P1|NOT COMPLETED|Overall Study||235
1727185|NCT00262600|4228798|P3|COMPLETED|Overall Study||5756
1727186|NCT00262600|4228799|P2|COMPLETED|Overall Study||5824
1727187|NCT00262600|4228800|P1|COMPLETED|Overall Study||5780
1727188|NCT00262600|4228798|P3|STARTED|Overall Study||6022
1727189|NCT00262600|4228799|P2|STARTED|Overall Study||6076
1727190|NCT00262600|4228800|P1|STARTED|Overall Study||6015
1727191|NCT00262522|4228827|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
1727192|NCT00262522|4228828|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
1727193|NCT00262522|4228829|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
1727194|NCT00262522|4228830|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
1727195|NCT00262522|4228827|P4|COMPLETED|Study Start Through 96 Weeks||0
1727196|NCT00262522|4228828|P3|COMPLETED|Study Start Through 96 Weeks||254
1727197|NCT00262522|4228829|P2|COMPLETED|Study Start Through 96 Weeks||0
1727198|NCT00262522|4228830|P1|COMPLETED|Study Start Through 96 Weeks||256
1727199|NCT00262522|4228827|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
1727200|NCT00262522|4228828|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
1727201|NCT00262522|4228829|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
1727202|NCT00262522|4228830|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
1727203|NCT00262522|4228827|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
1727204|NCT00262522|4228828|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
1727205|NCT00262522|4228829|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
1727206|NCT00262522|4228830|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
1727207|NCT00262522|4228827|P4|COMPLETED|Study Start Through 48 Weeks||0
1727208|NCT00262522|4228828|P3|COMPLETED|Study Start Through 48 Weeks||276
1727209|NCT00262522|4228829|P2|COMPLETED|Study Start Through 48 Weeks||0
1727210|NCT00262522|4228830|P1|COMPLETED|Study Start Through 48 Weeks||284
1727211|NCT00262522|4228827|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
1727212|NCT00262522|4228828|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
1727213|NCT00262522|4228829|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
1727214|NCT00262522|4228830|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
1727215|NCT00262522|4228827|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
1727216|NCT00262522|4228828|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
1727217|NCT00262522|4228829|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
1727218|NCT00262522|4228830|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
1727219|NCT00262522|4228827|P4|COMPLETED|Study Start Through 8 Weeks||160
1727220|NCT00262522|4228828|P3|COMPLETED|Study Start Through 8 Weeks||155
1727221|NCT00262522|4228829|P2|COMPLETED|Study Start Through 8 Weeks||161
1727222|NCT00262522|4228830|P1|COMPLETED|Study Start Through 8 Weeks||163
1727223|NCT00262522|4228827|P4|STARTED|Study Start Through 8 Weeks||165
1727224|NCT00262522|4228828|P3|STARTED|Study Start Through 8 Weeks||166
1727225|NCT00262522|4228829|P2|STARTED|Study Start Through 8 Weeks||166
1727226|NCT00262522|4228830|P1|STARTED|Study Start Through 8 Weeks||167
1727227|NCT00262509|4228852|P2|NOT COMPLETED|Overall Study||0
1727228|NCT00262509|4228853|P1|NOT COMPLETED|Overall Study||0
1727229|NCT00262509|4228852|P2|COMPLETED|Overall Study||9
1727230|NCT00262509|4228853|P1|COMPLETED|Overall Study||8
1727231|NCT00262509|4228852|P2|STARTED|Overall Study||9
1727232|NCT00262509|4228853|P1|STARTED|Overall Study||8
1727233|NCT00262314|4228859|P1|NOT COMPLETED|Overall Study||337
1727234|NCT00262314|4228859|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
1727235|NCT00262314|4228859|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
1727236|NCT00262301|4228877|P3|NOT COMPLETED|Open-label Phase||0
1727237|NCT00262301|4228878|P2|NOT COMPLETED|Open-label Phase||0
1727238|NCT00262301|4228879|P1|NOT COMPLETED|Open-label Phase||0
1727239|NCT00262301|4228877|P3|COMPLETED|Open-label Phase||57
1727240|NCT00262301|4228878|P2|COMPLETED|Open-label Phase||0
1727241|NCT00262301|4228879|P1|COMPLETED|Open-label Phase||0
1727242|NCT00262301|4228877|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
1727243|NCT00262301|4228878|P2|STARTED|Open-label Phase||0
1727244|NCT00262301|4228879|P1|STARTED|Open-label Phase||0
1727245|NCT00262301|4228877|P3|NOT COMPLETED|Double-blind Phase||0
1727246|NCT00262301|4228878|P2|NOT COMPLETED|Double-blind Phase||1
1727247|NCT00262301|4228879|P1|NOT COMPLETED|Double-blind Phase||1
1727248|NCT00262301|4228877|P3|COMPLETED|Double-blind Phase||0
1727249|NCT00262301|4228878|P2|COMPLETED|Double-blind Phase||15
1727250|NCT00262301|4228879|P1|COMPLETED|Double-blind Phase||15
1727251|NCT00262301|4228877|P3|STARTED|Double-blind Phase||0
1727252|NCT00262301|4228878|P2|STARTED|Double-blind Phase||16
1727253|NCT00262301|4228879|P1|STARTED|Double-blind Phase||16
1727254|NCT00262223|4228892|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
1727255|NCT00262223|4228893|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
1727256|NCT00262223|4228892|P2|COMPLETED|12-month Post-treatment Follow-up||22
1727257|NCT00262223|4228893|P1|COMPLETED|12-month Post-treatment Follow-up||21
1727258|NCT00262223|4228892|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
1727259|NCT00262223|4228893|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
1727260|NCT00262223|4228892|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
1727261|NCT00262223|4228893|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
1727262|NCT00262223|4228892|P2|COMPLETED|6-month Post-treatment Follow-up||28
1727263|NCT00262223|4228893|P1|COMPLETED|6-month Post-treatment Follow-up||22
1727264|NCT00262223|4228892|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
1727265|NCT00262223|4228893|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
1727266|NCT00262223|4228892|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
1727267|NCT00262223|4228893|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
1727268|NCT00262223|4228892|P2|COMPLETED|1-week Post-treatment Follow-up||25
1727269|NCT00262223|4228893|P1|COMPLETED|1-week Post-treatment Follow-up||24
1727270|NCT00262223|4228892|P2|STARTED|1-week Post-treatment Follow-up||29
1727271|NCT00262223|4228893|P1|STARTED|1-week Post-treatment Follow-up||28
1727272|NCT00262223|4228892|P2|NOT COMPLETED|Treatment Phase||8
1727273|NCT00262223|4228893|P1|NOT COMPLETED|Treatment Phase||4
1727274|NCT00262223|4228892|P2|COMPLETED|Treatment Phase||29
1727275|NCT00262223|4228893|P1|COMPLETED|Treatment Phase||28
1727276|NCT00262223|4228892|P2|STARTED|Treatment Phase||37
1727277|NCT00262223|4228893|P1|STARTED|Treatment Phase||32
1727278|NCT00262119|4228904|P3|NOT COMPLETED|Overall Study||58
1727279|NCT00262119|4228905|P2|NOT COMPLETED|Overall Study||70
1727280|NCT00262119|4228906|P1|NOT COMPLETED|Overall Study||58
1727281|NCT00262119|4228904|P3|COMPLETED|Overall Study||325
1727282|NCT00262119|4228905|P2|COMPLETED|Overall Study||328
1727283|NCT00262119|4228906|P1|COMPLETED|Overall Study||327
1727284|NCT00262119|4228904|P3|STARTED|Overall Study||383
1727285|NCT00262119|4228905|P2|STARTED|Overall Study||398
1727286|NCT00262119|4228906|P1|STARTED|Overall Study||385
1727287|NCT00262080|4228926|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
1727288|NCT00262080|4228927|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
1727289|NCT00262080|4228928|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
1727290|NCT00262080|4228926|P3|COMPLETED|Repeat Dose Treatment Period||14
1727291|NCT00262080|4228927|P2|COMPLETED|Repeat Dose Treatment Period||25
1727292|NCT00262080|4228928|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
1727293|NCT00262080|4228926|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
1727294|NCT00262080|4228927|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
1727295|NCT00262080|4228928|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
1727296|NCT00262080|4228926|P3|NOT COMPLETED|Double Blind Treatment Period||0
1727297|NCT00262080|4228927|P2|NOT COMPLETED|Double Blind Treatment Period||0
1727298|NCT00262080|4228928|P1|NOT COMPLETED|Double Blind Treatment Period||1
1727299|NCT00262080|4228926|P3|COMPLETED|Double Blind Treatment Period||0
1727300|NCT00262080|4228927|P2|COMPLETED|Double Blind Treatment Period||36
1727301|NCT00262080|4228928|P1|COMPLETED|Double Blind Treatment Period||35
1727302|NCT00262080|4228926|P3|STARTED|Double Blind Treatment Period||0
1727303|NCT00262080|4228927|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
1727304|NCT00262080|4228928|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
1727305|NCT00262067|4228948|P4|NOT COMPLETED|Overall Study||113
1727306|NCT00262067|4228949|P3|NOT COMPLETED|Overall Study||216
1727307|NCT00262067|4228950|P2|NOT COMPLETED|Overall Study||100
1727308|NCT00262067|4228951|P1|NOT COMPLETED|Overall Study||219
1727309|NCT00262067|4228948|P4|COMPLETED|Overall Study||93
1727310|NCT00262067|4228949|P3|COMPLETED|Overall Study||193
1727311|NCT00262067|4228950|P2|COMPLETED|Overall Study||107
1727312|NCT00262067|4228951|P1|COMPLETED|Overall Study||196
1727313|NCT00262067|4228948|P4|STARTED|Overall Study||206
1727314|NCT00262067|4228949|P3|STARTED|Overall Study||409
1727315|NCT00262067|4228950|P2|STARTED|Overall Study||207
1727316|NCT00262067|4228951|P1|STARTED|Overall Study||415
1727317|NCT00262041|4228985|P3|NOT COMPLETED|Overall Study||6
1727318|NCT00262041|4228986|P2|NOT COMPLETED|Overall Study||4
1727319|NCT00262041|4228987|P1|NOT COMPLETED|Overall Study||2
1727320|NCT00262041|4228985|P3|COMPLETED|Overall Study||203
1727321|NCT00262041|4228986|P2|COMPLETED|Overall Study||147
1727322|NCT00262041|4228987|P1|COMPLETED|Overall Study||162
1727323|NCT00262041|4228985|P3|STARTED|Overall Study||209
1727324|NCT00262041|4228986|P2|STARTED|Overall Study||151
1727325|NCT00262041|4228987|P1|STARTED|Overall Study||164
1727326|NCT00262028|4229016|P9|NOT COMPLETED|Overall Study||19
1727327|NCT00262028|4229017|P8|NOT COMPLETED|Overall Study||18
1727328|NCT00262028|4229018|P7|NOT COMPLETED|Overall Study||12
1727329|NCT00262028|4229019|P6|NOT COMPLETED|Overall Study||13
1727330|NCT00262028|4229020|P5|NOT COMPLETED|Overall Study||12
1727331|NCT00262028|4229021|P4|NOT COMPLETED|Overall Study||23
1727332|NCT00262028|4229022|P3|NOT COMPLETED|Overall Study||20
1727333|NCT00262028|4229023|P2|NOT COMPLETED|Overall Study||27
1727334|NCT00262028|4229024|P1|NOT COMPLETED|Overall Study||24
1727335|NCT00262028|4229016|P9|COMPLETED|Overall Study||81
1727336|NCT00262028|4229017|P8|COMPLETED|Overall Study||55
1727337|NCT00262028|4229018|P7|COMPLETED|Overall Study||59
1727338|NCT00262028|4229019|P6|COMPLETED|Overall Study||60
1727339|NCT00262028|4229020|P5|COMPLETED|Overall Study||62
1727340|NCT00262028|4229021|P4|COMPLETED|Overall Study||134
1727341|NCT00262028|4229022|P3|COMPLETED|Overall Study||137
1727342|NCT00262028|4229023|P2|COMPLETED|Overall Study||126
1727343|NCT00262028|4229024|P1|COMPLETED|Overall Study||128
1727344|NCT00262028|4229016|P9|STARTED|Overall Study||100
1727345|NCT00262028|4229017|P8|STARTED|Overall Study||73
1727346|NCT00262028|4229018|P7|STARTED|Overall Study||71
1727347|NCT00262028|4229019|P6|STARTED|Overall Study||73
1727348|NCT00262028|4229020|P5|STARTED|Overall Study||74
1727349|NCT00262028|4229021|P4|STARTED|Overall Study||157
1727350|NCT00262028|4229022|P3|STARTED|Overall Study||157
1727351|NCT00262028|4229023|P2|STARTED|Overall Study||153
1727352|NCT00262028|4229024|P1|STARTED|Overall Study||152
1727353|NCT00262002|4229086|P7|NOT COMPLETED|Overall Study||6
1727354|NCT00262002|4229087|P6|NOT COMPLETED|Overall Study||7
1727355|NCT00262002|4229088|P5|NOT COMPLETED|Overall Study||7
1727356|NCT00262002|4229089|P4|NOT COMPLETED|Overall Study||5
1727357|NCT00262002|4229090|P3|NOT COMPLETED|Overall Study||0
1727358|NCT00262002|4229091|P2|NOT COMPLETED|Overall Study||6
1727359|NCT00262002|4229092|P1|NOT COMPLETED|Overall Study||11
1727360|NCT00262002|4229086|P7|COMPLETED|Overall Study||84
1727361|NCT00262002|4229087|P6|COMPLETED|Overall Study||83
1727362|NCT00262002|4229088|P5|COMPLETED|Overall Study||91
1727363|NCT00262002|4229089|P4|COMPLETED|Overall Study||93
1727364|NCT00262002|4229090|P3|COMPLETED|Overall Study||45
1727365|NCT00262002|4229091|P2|COMPLETED|Overall Study||84
1727366|NCT00262002|4229092|P1|COMPLETED|Overall Study||79
1727367|NCT00262002|4229086|P7|STARTED|Overall Study||90
1727368|NCT00262002|4229087|P6|STARTED|Overall Study||90
1727369|NCT00262002|4229088|P5|STARTED|Overall Study||98
1727370|NCT00262002|4229089|P4|STARTED|Overall Study||98
1727371|NCT00262002|4229090|P3|STARTED|Overall Study||45
1727372|NCT00262002|4229091|P2|STARTED|Overall Study||90
1727373|NCT00262002|4229092|P1|STARTED|Overall Study||90
1727374|NCT00261950|4229185|P1|NOT COMPLETED|Overall Study||26
1727375|NCT00261950|4229185|P1|COMPLETED|Overall Study||84
1727376|NCT00261950|4229185|P1|STARTED|Overall Study||110
1727377|NCT00261846|4229210|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
1727378|NCT00261846|4229211|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
1727379|NCT00261846|4229212|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
1727380|NCT00261846|4229213|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
1727381|NCT00261846|4229214|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
1727382|NCT00261846|4229215|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
1727383|NCT00261846|4229216|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
1727384|NCT00261846|4229217|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
1727385|NCT00261846|4229218|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
1727386|NCT00261846|4229219|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
1727387|NCT00261846|4229220|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
1727388|NCT00261846|4229221|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
1727389|NCT00261846|4229210|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
1727390|NCT00261846|4229211|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
1727391|NCT00261846|4229212|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
1727392|NCT00261846|4229213|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
1727393|NCT00261846|4229214|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
1727394|NCT00261846|4229215|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
1727395|NCT00261846|4229216|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
1727396|NCT00261846|4229217|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
1727397|NCT00261846|4229218|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
1727398|NCT00261846|4229219|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
1727399|NCT00261846|4229220|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
1727400|NCT00261846|4229221|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
1727401|NCT00261846|4229210|P12|STARTED|Period 2: Part 2 (Efficacy)||24
1727402|NCT00261846|4229211|P11|STARTED|Period 2: Part 2 (Efficacy)||64
1727403|NCT00261846|4229212|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
1727404|NCT00261846|4229213|P9|STARTED|Period 2: Part 2 (Efficacy)||26
1727405|NCT00261846|4229214|P8|STARTED|Period 2: Part 2 (Efficacy)||50
1727406|NCT00261846|4229215|P7|STARTED|Period 2: Part 2 (Efficacy)||38
1727407|NCT00261846|4229216|P6|STARTED|Period 2: Part 2 (Efficacy)||5
1727408|NCT00261846|4229217|P5|STARTED|Period 2: Part 2 (Efficacy)||89
1727409|NCT00261846|4229218|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
1727410|NCT00261846|4229219|P3|STARTED|Period 2: Part 2 (Efficacy)||0
1727411|NCT00261846|4229220|P2|STARTED|Period 2: Part 2 (Efficacy)||0
1727412|NCT00261846|4229221|P1|STARTED|Period 2: Part 2 (Efficacy)||0
1727413|NCT00261846|4229210|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727414|NCT00261846|4229211|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727415|NCT00261846|4229212|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727416|NCT00261846|4229213|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727417|NCT00261846|4229214|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727418|NCT00261846|4229215|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727419|NCT00261846|4229216|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727420|NCT00261846|4229217|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727421|NCT00261846|4229218|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727422|NCT00261846|4229219|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
1727423|NCT00261846|4229220|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
1727424|NCT00261846|4229221|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
1727425|NCT00261846|4229210|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727426|NCT00261846|4229211|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727427|NCT00261846|4229212|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727428|NCT00261846|4229213|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727429|NCT00261846|4229214|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727602|NCT00259298|4230123|P1|NOT COMPLETED|Overall Study||3
1727430|NCT00261846|4229215|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727431|NCT00261846|4229216|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727432|NCT00261846|4229217|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727433|NCT00261846|4229218|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727434|NCT00261846|4229219|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727435|NCT00261846|4229220|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727436|NCT00261846|4229221|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
1727437|NCT00261846|4229210|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
1727438|NCT00261846|4229211|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
1727439|NCT00261846|4229212|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
1727440|NCT00261846|4229213|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
1727441|NCT00261846|4229214|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
1727442|NCT00261846|4229215|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
1727443|NCT00261846|4229216|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
1727444|NCT00261846|4229217|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
1727445|NCT00261846|4229218|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
1727446|NCT00261846|4229219|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
1727447|NCT00261846|4229220|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
1727448|NCT00261846|4229221|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
1727449|NCT00261833|4229480|P2|NOT COMPLETED|Overall Study||18
1727450|NCT00261833|4229481|P1|NOT COMPLETED|Overall Study||9
1727451|NCT00261833|4229480|P2|COMPLETED|Overall Study||69
1727452|NCT00261833|4229481|P1|COMPLETED|Overall Study||84
1727453|NCT00261833|4229480|P2|STARTED|Overall Study||87
1727454|NCT00261833|4229481|P1|STARTED|Overall Study||93
1727455|NCT00261716|4229515|P2|NOT COMPLETED|Overall Study||10
1727456|NCT00261716|4229516|P1|NOT COMPLETED|Overall Study||6
1727457|NCT00261716|4229515|P2|COMPLETED|Overall Study||11
1727458|NCT00261716|4229516|P1|COMPLETED|Overall Study||11
1727459|NCT00261716|4229515|P2|STARTED|Overall Study||21
1727460|NCT00261716|4229516|P1|STARTED|Overall Study||17
1727461|NCT00261495|4229536|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
1727462|NCT00261495|4229537|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
1727463|NCT00261495|4229536|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
1727464|NCT00261495|4229537|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
1727465|NCT00261495|4229536|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
1727466|NCT00261495|4229537|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
1727467|NCT00261495|4229536|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
1727468|NCT00261495|4229537|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
1727469|NCT00261495|4229536|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
1727470|NCT00261495|4229537|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
1727471|NCT00261495|4229536|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
1727472|NCT00261495|4229537|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
1727473|NCT00261495|4229536|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
1727474|NCT00261495|4229537|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
1727475|NCT00261495|4229536|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
1727476|NCT00261495|4229537|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
1727477|NCT00261495|4229536|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
1727478|NCT00261495|4229537|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
1727479|NCT00261443|4229701|P3|NOT COMPLETED|4: Extension Phase||2
1727480|NCT00261443|4229702|P2|NOT COMPLETED|4: Extension Phase||3
1727481|NCT00261443|4229703|P1|NOT COMPLETED|4: Extension Phase||0
1727482|NCT00261443|4229701|P3|COMPLETED|4: Extension Phase||21
1727483|NCT00261443|4229702|P2|COMPLETED|4: Extension Phase||16
1727484|NCT00261443|4229703|P1|COMPLETED|4: Extension Phase||0
1727485|NCT00261443|4229701|P3|STARTED|4: Extension Phase||23
1727486|NCT00261443|4229702|P2|STARTED|4: Extension Phase||19
1727487|NCT00261443|4229703|P1|STARTED|4: Extension Phase||0
1727488|NCT00261443|4229701|P3|NOT COMPLETED|3: Assessment of Relapse||65
1727489|NCT00261443|4229702|P2|NOT COMPLETED|3: Assessment of Relapse||80
1727490|NCT00261443|4229703|P1|NOT COMPLETED|3: Assessment of Relapse||0
1727491|NCT00261443|4229701|P3|COMPLETED|3: Assessment of Relapse||103
1727492|NCT00261443|4229702|P2|COMPLETED|3: Assessment of Relapse||89
1727493|NCT00261443|4229703|P1|COMPLETED|3: Assessment of Relapse||0
1727494|NCT00261443|4229701|P3|STARTED|3: Assessment of Relapse||168
1727495|NCT00261443|4229702|P2|STARTED|3: Assessment of Relapse||169
1727496|NCT00261443|4229703|P1|STARTED|3: Assessment of Relapse||0
1727497|NCT00261443|4229701|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
1727498|NCT00261443|4229702|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
1727499|NCT00261443|4229703|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
1727500|NCT00261443|4229701|P3|COMPLETED|2: Stability & Maintenance of Stability||0
1727501|NCT00261443|4229702|P2|COMPLETED|2: Stability & Maintenance of Stability||0
1727502|NCT00261443|4229703|P1|COMPLETED|2: Stability & Maintenance of Stability||346
1727503|NCT00261443|4229701|P3|STARTED|2: Stability & Maintenance of Stability||0
1727504|NCT00261443|4229702|P2|STARTED|2: Stability & Maintenance of Stability||0
1727505|NCT00261443|4229703|P1|STARTED|2: Stability & Maintenance of Stability||686
1727506|NCT00261443|4229701|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
1727507|NCT00261443|4229702|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
1727508|NCT00261443|4229703|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
1727509|NCT00261443|4229701|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
1727510|NCT00261443|4229702|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
1727511|NCT00261443|4229703|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
1727512|NCT00261443|4229701|P3|STARTED|1: Confirmation of Partial Nonresponse||0
1727513|NCT00261443|4229702|P2|STARTED|1: Confirmation of Partial Nonresponse||0
1727514|NCT00261443|4229703|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
1727515|NCT00260962|4229960|P2|NOT COMPLETED|Overall Study||2
1727516|NCT00260962|4229961|P1|NOT COMPLETED|Overall Study||4
1727517|NCT00260962|4229960|P2|COMPLETED|Overall Study||14
1727518|NCT00260962|4229961|P1|COMPLETED|Overall Study||14
1727519|NCT00260962|4229960|P2|STARTED|Overall Study||16
1727520|NCT00260962|4229961|P1|STARTED|Overall Study||18
1727521|NCT00260832|4229971|P2|NOT COMPLETED|Overall Study||211
1727522|NCT00260832|4229972|P1|NOT COMPLETED|Overall Study||228
1727523|NCT00260832|4229971|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
1727524|NCT00260832|4229972|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
1727525|NCT00260832|4229971|P2|STARTED|Overall Study||242
1727526|NCT00260832|4229972|P1|STARTED|Overall Study||243
1727527|NCT00260689|4229981|P3|NOT COMPLETED|Overall Study||15
1727528|NCT00260689|4229982|P2|NOT COMPLETED|Overall Study||49
1727529|NCT00260689|4229983|P1|NOT COMPLETED|Overall Study||41
1727530|NCT00260689|4229981|P3|COMPLETED|Overall Study||1
1727531|NCT00260689|4229982|P2|COMPLETED|Overall Study||11
1727532|NCT00260689|4229983|P1|COMPLETED|Overall Study||19
1727533|NCT00260689|4229981|P3|STARTED|Overall Study||16
1727534|NCT00260689|4229982|P2|STARTED|Overall Study||60
1727535|NCT00260689|4229983|P1|STARTED|Overall Study||60
1727536|NCT00260533|4229999|P2|NOT COMPLETED|Overall Study||3
1727537|NCT00260533|4230000|P1|NOT COMPLETED|Overall Study||3
1727538|NCT00260533|4229999|P2|COMPLETED|Overall Study||10
1727539|NCT00260533|4230000|P1|COMPLETED|Overall Study||11
1727540|NCT00260533|4229999|P2|STARTED|Overall Study||13
1727541|NCT00260533|4230000|P1|STARTED|Overall Study||14
1727542|NCT00260429|4230008|P2|NOT COMPLETED|Overall Study||0
1727543|NCT00260429|4230009|P1|NOT COMPLETED|Overall Study||2
1727544|NCT00260429|4230008|P2|COMPLETED|Overall Study||12
1727545|NCT00260429|4230009|P1|COMPLETED|Overall Study||21
1727546|NCT00260429|4230008|P2|STARTED|Overall Study||12
1727547|NCT00260429|4230009|P1|STARTED|Overall Study||23
1727548|NCT00260208|4230017|P2|NOT COMPLETED|Overall Study||34
1727549|NCT00260208|4230018|P1|NOT COMPLETED|Overall Study||47
1727550|NCT00260208|4230017|P2|COMPLETED|Overall Study||138
1727551|NCT00260208|4230018|P1|COMPLETED|Overall Study||137
1727552|NCT00260208|4230017|P2|Modified ITT|Overall Study||96
1727553|NCT00260208|4230018|P1|Modified ITT|Overall Study||101
1727554|NCT00260208|4230017|P2|Intent to Treat (ITT) Population|Overall Study||169
1727555|NCT00260208|4230018|P1|Intent to Treat (ITT) Population|Overall Study||182
1727556|NCT00260208|4230017|P2|STARTED|Overall Study||172
1727557|NCT00260208|4230018|P1|STARTED|Overall Study|"Started indicates safety population."|184
1727558|NCT00260195|4230048|P2|NOT COMPLETED|Overall Study||0
1727559|NCT00260195|4230049|P1|NOT COMPLETED|Overall Study||0
1727560|NCT00260195|4230048|P2|COMPLETED|Overall Study||37
1727561|NCT00260195|4230049|P1|COMPLETED|Overall Study||39
1727562|NCT00260195|4230048|P2|STARTED|Overall Study||37
1727563|NCT00260195|4230049|P1|STARTED|Overall Study||39
1727564|NCT00260065|4230061|P1|NOT COMPLETED|Overall Study||93
1727565|NCT00260065|4230061|P1|COMPLETED|Overall Study||6
1727566|NCT00260065|4230061|P1|STARTED|Overall Study||99
1727567|NCT00259857|4230068|P2|NOT COMPLETED|24 Months Treatment||3
1727568|NCT00259857|4230069|P1|NOT COMPLETED|24 Months Treatment||0
1727569|NCT00259857|4230068|P2|COMPLETED|24 Months Treatment||6
1727570|NCT00259857|4230069|P1|COMPLETED|24 Months Treatment||10
1727571|NCT00259857|4230068|P2|STARTED|24 Months Treatment||9
1727572|NCT00259857|4230069|P1|STARTED|24 Months Treatment||10
1727573|NCT00259857|4230068|P2|NOT COMPLETED|12 Months Treatment||2
1727574|NCT00259857|4230069|P1|NOT COMPLETED|12 Months Treatment||1
1727575|NCT00259857|4230068|P2|COMPLETED|12 Months Treatment||9
1727576|NCT00259857|4230069|P1|COMPLETED|12 Months Treatment||10
1727577|NCT00259857|4230068|P2|STARTED|12 Months Treatment||11
1727578|NCT00259857|4230069|P1|STARTED|12 Months Treatment||11
1727579|NCT00259740|4230087|P2|NOT COMPLETED|Overall Study||53
1727580|NCT00259740|4230088|P1|NOT COMPLETED|Overall Study||43
1727581|NCT00259740|4230087|P2|COMPLETED|Overall Study||0
1727582|NCT00259740|4230088|P1|COMPLETED|Overall Study||0
1727583|NCT00259740|4230087|P2|Received Study Medication|Overall Study||53
1727584|NCT00259740|4230088|P1|Received Study Medication|Overall Study||42
1727585|NCT00259740|4230087|P2|STARTED|Overall Study||53
1727586|NCT00259740|4230088|P1|STARTED|Overall Study||43
1727587|NCT00259649|4230098|P1|NOT COMPLETED|Overall Study||10
1727588|NCT00259649|4230098|P1|COMPLETED|Overall Study||61
1727589|NCT00259649|4230098|P1|STARTED|Overall Study||71
1727590|NCT00259610|4230106|P4|NOT COMPLETED|Overall Study||43
1727591|NCT00259610|4230107|P3|NOT COMPLETED|Overall Study||73
1727592|NCT00259610|4230108|P2|NOT COMPLETED|Overall Study||46
1727593|NCT00259610|4230109|P1|NOT COMPLETED|Overall Study||76
1727594|NCT00259610|4230106|P4|COMPLETED|Overall Study||81
1727595|NCT00259610|4230107|P3|COMPLETED|Overall Study||182
1727596|NCT00259610|4230108|P2|COMPLETED|Overall Study||86
1727597|NCT00259610|4230109|P1|COMPLETED|Overall Study||168
1727598|NCT00259610|4230106|P4|STARTED|Overall Study||124
1727599|NCT00259610|4230107|P3|STARTED|Overall Study||255
1727600|NCT00259610|4230108|P2|STARTED|Overall Study||132
1727601|NCT00259610|4230109|P1|STARTED|Overall Study||244
1727603|NCT00259298|4230123|P1|COMPLETED|Overall Study||9
1727604|NCT00259298|4230123|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
1727605|NCT00259298|4230123|P1|STARTED|Overall Study||12
1727606|NCT00259285|4230131|P1|NOT COMPLETED|Overall Study||0
1727607|NCT00259285|4230131|P1|COMPLETED|Overall Study||10
1727608|NCT00259285|4230131|P1|STARTED|Overall Study||10
1727609|NCT00259272|4230141|P4|NOT COMPLETED|Overall Study||21
1727610|NCT00259272|4230142|P3|NOT COMPLETED|Overall Study||5
1727611|NCT00259272|4230143|P2|NOT COMPLETED|Overall Study||7
1727612|NCT00259272|4230144|P1|NOT COMPLETED|Overall Study||15
1727613|NCT00259272|4230141|P4|COMPLETED|Overall Study||27
1727614|NCT00259272|4230142|P3|COMPLETED|Overall Study||21
1727615|NCT00259272|4230143|P2|COMPLETED|Overall Study||24
1727616|NCT00259272|4230144|P1|COMPLETED|Overall Study||21
1727617|NCT00259272|4230141|P4|STARTED|Overall Study||48
1727618|NCT00259272|4230142|P3|STARTED|Overall Study||26
1727619|NCT00259272|4230143|P2|STARTED|Overall Study||31
1727620|NCT00259272|4230144|P1|STARTED|Overall Study||36
1727621|NCT00259090|4230222|P3|NOT COMPLETED|Overall Study||0
1727622|NCT00259090|4230223|P2|NOT COMPLETED|Overall Study||0
1727623|NCT00259090|4230224|P1|NOT COMPLETED|Overall Study||0
1727624|NCT00259090|4230222|P3|COMPLETED|Overall Study||37
1727625|NCT00259090|4230223|P2|COMPLETED|Overall Study||31
1727626|NCT00259090|4230224|P1|COMPLETED|Overall Study||35
1727627|NCT00259090|4230222|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
1727628|NCT00259090|4230223|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
1727629|NCT00259090|4230224|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
1727630|NCT00259012|4230240|P2|NOT COMPLETED|Overall Study||4
1727631|NCT00259012|4230241|P1|NOT COMPLETED|Overall Study||2
1727632|NCT00259012|4230240|P2|COMPLETED|Overall Study||30
1727633|NCT00259012|4230241|P1|COMPLETED|Overall Study||31
1727634|NCT00259012|4230240|P2|STARTED|Overall Study||34
1727635|NCT00259012|4230241|P1|STARTED|Overall Study||33
1727636|NCT00258908|4230273|P1|NOT COMPLETED|Overall Study||0
1727637|NCT00258908|4230273|P1|COMPLETED|Overall Study||112
1727638|NCT00258908|4230273|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
1727639|NCT00258895|4230281|P2|NOT COMPLETED|Overall Study||3
1727640|NCT00258895|4230282|P1|NOT COMPLETED|Overall Study||10
1727641|NCT00258895|4230281|P2|COMPLETED|Overall Study||159
1727642|NCT00258895|4230282|P1|COMPLETED|Overall Study||477
1727643|NCT00258895|4230281|P2|STARTED|Overall Study||162
1727644|NCT00258895|4230282|P1|STARTED|Overall Study||487
1727645|NCT00258882|4230298|P2|NOT COMPLETED|Pregnancy Surveillance||0
1727646|NCT00258882|4230299|P1|NOT COMPLETED|Pregnancy Surveillance||0
1727647|NCT00258882|4230298|P2|COMPLETED|Pregnancy Surveillance||675
1727648|NCT00258882|4230299|P1|COMPLETED|Pregnancy Surveillance||225
1727649|NCT00258882|4230298|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
1727650|NCT00258882|4230299|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
1727651|NCT00258882|4230298|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
1727652|NCT00258882|4230299|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
1727653|NCT00258882|4230298|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
1727654|NCT00258882|4230299|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
1727655|NCT00258882|4230298|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
1727656|NCT00258882|4230299|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
1727657|NCT00258882|4230298|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
1727658|NCT00258882|4230299|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
1727659|NCT00258882|4230298|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
1727660|NCT00258882|4230299|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
1727661|NCT00258882|4230298|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
1727662|NCT00258882|4230299|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
1727663|NCT00258856|4230318|P4|NOT COMPLETED|Overall Study||1
1727664|NCT00258856|4230319|P3|NOT COMPLETED|Overall Study||2
1727665|NCT00258856|4230320|P2|NOT COMPLETED|Overall Study||0
1727666|NCT00258856|4230321|P1|NOT COMPLETED|Overall Study||3
1727667|NCT00258856|4230318|P4|COMPLETED|Overall Study||58
1727668|NCT00258856|4230319|P3|COMPLETED|Overall Study||56
1727669|NCT00258856|4230320|P2|COMPLETED|Overall Study||58
1727670|NCT00258856|4230321|P1|COMPLETED|Overall Study||56
1727671|NCT00258856|4230318|P4|STARTED|Overall Study||59
1727672|NCT00258856|4230319|P3|STARTED|Overall Study||58
1727673|NCT00258856|4230320|P2|STARTED|Overall Study||58
1727674|NCT00258856|4230321|P1|STARTED|Overall Study||59
1727675|NCT00258830|4230333|P2|NOT COMPLETED|Overall Study||0
1727676|NCT00258830|4230334|P1|NOT COMPLETED|Overall Study||0
1727677|NCT00258830|4230333|P2|COMPLETED|Overall Study||60
1727678|NCT00258830|4230334|P1|COMPLETED|Overall Study||60
1727679|NCT00258830|4230333|P2|STARTED|Overall Study||60
1727680|NCT00258830|4230334|P1|STARTED|Overall Study||60
1727681|NCT00258817|4230348|P2|NOT COMPLETED|Overall Study||0
1727682|NCT00258817|4230349|P1|NOT COMPLETED|Overall Study||0
1727683|NCT00258817|4230348|P2|COMPLETED|Overall Study||15
1727684|NCT00258817|4230349|P1|COMPLETED|Overall Study||15
1727685|NCT00258817|4230348|P2|STARTED|Overall Study||15
1727686|NCT00258817|4230349|P1|STARTED|Overall Study||15
1727687|NCT00258674|4230362|P3|NOT COMPLETED|Overall Study||34
1727688|NCT00258674|4230363|P2|NOT COMPLETED|Overall Study||53
1727689|NCT00258674|4230364|P1|NOT COMPLETED|Overall Study||32
1727690|NCT00258674|4230362|P3|COMPLETED|Overall Study||568
1727691|NCT00258674|4230363|P2|COMPLETED|Overall Study||758
1727692|NCT00258674|4230364|P1|COMPLETED|Overall Study||565
1727693|NCT00258674|4230362|P3|STARTED|Overall Study||602
1727694|NCT00258674|4230363|P2|STARTED|Overall Study||811
1727695|NCT00258674|4230364|P1|STARTED|Overall Study||597
1727696|NCT00258440|4230423|P3|NOT COMPLETED|Overall Study||1
1727697|NCT00258440|4230424|P2|NOT COMPLETED|Overall Study||0
1727698|NCT00258440|4230425|P1|NOT COMPLETED|Overall Study||0
1727699|NCT00258440|4230423|P3|COMPLETED|Overall Study||5
1727700|NCT00258440|4230424|P2|COMPLETED|Overall Study||0
1727701|NCT00258440|4230425|P1|COMPLETED|Overall Study||1
1727702|NCT00258440|4230423|P3|STARTED|Overall Study||6
1727703|NCT00258440|4230424|P2|STARTED|Overall Study||0
1727704|NCT00258440|4230425|P1|STARTED|Overall Study||1
1727705|NCT00258362|4230436|P1|NOT COMPLETED|Overall Study||0
1727706|NCT00258362|4230436|P1|COMPLETED|Overall Study||41
1727707|NCT00258362|4230436|P1|STARTED|Overall Study||41
1727708|NCT00258349|4230441|P1|NOT COMPLETED|Overall Study||0
1727709|NCT00258349|4230441|P1|COMPLETED|Overall Study||16
1727710|NCT00258349|4230441|P1|HER2-positive by Central Review|Overall Study||10
1727711|NCT00258349|4230441|P1|STARTED|Overall Study||16
1727712|NCT00258310|4230448|P1|NOT COMPLETED|Overall Study||0
1727713|NCT00258310|4230448|P1|COMPLETED|Overall Study||35
1727714|NCT00258310|4230448|P1|STARTED|Overall Study||35
1727715|NCT00258206|4230452|P1|NOT COMPLETED|Overall Study||0
1727716|NCT00258206|4230452|P1|COMPLETED|Overall Study||21
1727717|NCT00258206|4230452|P1|STARTED|Overall Study||21
1727718|NCT00258154|4230458|P2|NOT COMPLETED|Overall Study||7
1727719|NCT00258154|4230459|P1|NOT COMPLETED|Overall Study||9
1727720|NCT00258154|4230458|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
1727721|NCT00258154|4230459|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
1727722|NCT00258154|4230458|P2|Vaccinated at Visit 3|Overall Study||197
1727723|NCT00258154|4230459|P1|Vaccinated at Visit 3|Overall Study||195
1727724|NCT00258154|4230458|P2|Vaccinated at Visit 2|Overall Study||198
1727725|NCT00258154|4230459|P1|Vaccinated at Visit 2|Overall Study||198
1727726|NCT00258154|4230458|P2|Vaccinated at Visit 1|Overall Study||202
1727727|NCT00258154|4230459|P1|Vaccinated at Visit 1|Overall Study||201
1727728|NCT00258154|4230458|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
1727729|NCT00258154|4230459|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
1727730|NCT00258011|4230527|P1|NOT COMPLETED|Overall Study||0
1727731|NCT00258011|4230527|P1|COMPLETED|Overall Study||3
1727732|NCT00258011|4230527|P1|STARTED|Overall Study||3
1727733|NCT00257933|4230534|P2|NOT COMPLETED|Overall Study||0
1727734|NCT00257933|4230535|P1|NOT COMPLETED|Overall Study||0
1727735|NCT00257933|4230534|P2|COMPLETED|Overall Study||78
1727736|NCT00257933|4230535|P1|COMPLETED|Overall Study||74
1727737|NCT00257933|4230534|P2|STARTED|Overall Study||78
1727738|NCT00257933|4230535|P1|STARTED|Overall Study||74
1727739|NCT00257920|4230543|P2|NOT COMPLETED|Period: Second Intervention||1
1727740|NCT00257920|4230544|P1|NOT COMPLETED|Period: Second Intervention||2
1727741|NCT00257920|4230543|P2|COMPLETED|Period: Second Intervention||18
1727742|NCT00257920|4230544|P1|COMPLETED|Period: Second Intervention||19
1727743|NCT00257920|4230543|P2|STARTED|Period: Second Intervention||19
1727744|NCT00257920|4230544|P1|STARTED|Period: Second Intervention||21
1727745|NCT00257920|4230543|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
1727746|NCT00257920|4230544|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
1727747|NCT00257920|4230543|P2|COMPLETED|Period: Washout Period of Two Weeks||19
1727748|NCT00257920|4230544|P1|COMPLETED|Period: Washout Period of Two Weeks||21
1727749|NCT00257920|4230543|P2|STARTED|Period: Washout Period of Two Weeks||20
1727750|NCT00257920|4230544|P1|STARTED|Period: Washout Period of Two Weeks||21
1727751|NCT00257920|4230543|P2|NOT COMPLETED|Period: First Intervention||0
1727752|NCT00257920|4230544|P1|NOT COMPLETED|Period: First Intervention||0
1727753|NCT00257920|4230543|P2|COMPLETED|Period: First Intervention||20
1727754|NCT00257920|4230544|P1|COMPLETED|Period: First Intervention||21
1727755|NCT00257920|4230543|P2|STARTED|Period: First Intervention||20
1727756|NCT00257920|4230544|P1|STARTED|Period: First Intervention||21
1727757|NCT00257894|4230554|P2|NOT COMPLETED|Overall Study||5
1727758|NCT00257894|4230555|P1|NOT COMPLETED|Overall Study||4
1727759|NCT00257894|4230554|P2|COMPLETED|Overall Study||15
1727760|NCT00257894|4230555|P1|COMPLETED|Overall Study||17
1727761|NCT00257894|4230554|P2|STARTED|Overall Study||20
1727762|NCT00257894|4230555|P1|STARTED|Overall Study||21
1727763|NCT00257686|4230573|P6|NOT COMPLETED|Overall Study||9
1727764|NCT00257686|4230574|P5|NOT COMPLETED|Overall Study||22
1727765|NCT00257686|4230575|P4|NOT COMPLETED|Overall Study||11
1727766|NCT00257686|4230576|P3|NOT COMPLETED|Overall Study||18
1727767|NCT00257686|4230577|P2|NOT COMPLETED|Overall Study||19
1727768|NCT00257686|4230578|P1|NOT COMPLETED|Overall Study||21
1727769|NCT00257686|4230573|P6|COMPLETED|Overall Study||95
1727770|NCT00257686|4230574|P5|COMPLETED|Overall Study||194
1727771|NCT00257686|4230575|P4|COMPLETED|Overall Study||88
1727772|NCT00257686|4230576|P3|COMPLETED|Overall Study||208
1727773|NCT00257686|4230577|P2|COMPLETED|Overall Study||89
1727774|NCT00257686|4230578|P1|COMPLETED|Overall Study||188
1727775|NCT00257686|4230573|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
1727776|NCT00257686|4230574|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
1727777|NCT00257686|4230575|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
1727778|NCT00257686|4230576|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
1727779|NCT00257686|4230577|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
1727780|NCT00257686|4230578|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
1727781|NCT00257686|4230573|P6|STARTED|Overall Study||104
1727782|NCT00257686|4230574|P5|STARTED|Overall Study||216
1727783|NCT00257686|4230575|P4|STARTED|Overall Study||99
1727784|NCT00257686|4230576|P3|STARTED|Overall Study||226
1727785|NCT00257686|4230577|P2|STARTED|Overall Study||108
1727786|NCT00257686|4230578|P1|STARTED|Overall Study||209
1727787|NCT00257660|4230600|P2|NOT COMPLETED|Overall Study||23
1727788|NCT00257660|4230601|P1|NOT COMPLETED|Overall Study||10
1727789|NCT00257660|4230600|P2|COMPLETED|Overall Study||38
1727790|NCT00257660|4230601|P1|COMPLETED|Overall Study||45
1727791|NCT00257660|4230600|P2|STARTED|Overall Study||61
1727792|NCT00257660|4230601|P1|STARTED|Overall Study||55
1727793|NCT00257608|4230631|P3|NOT COMPLETED|Post Chemotherapy Phase||244
1727794|NCT00257608|4230632|P2|NOT COMPLETED|Post Chemotherapy Phase||264
1727795|NCT00257608|4230633|P1|NOT COMPLETED|Post Chemotherapy Phase||0
1727796|NCT00257608|4230631|P3|COMPLETED|Post Chemotherapy Phase||126
1727797|NCT00257608|4230632|P2|COMPLETED|Post Chemotherapy Phase||109
1727798|NCT00257608|4230633|P1|COMPLETED|Post Chemotherapy Phase||0
1727799|NCT00257608|4230631|P3|STARTED|Post Chemotherapy Phase||370
1727800|NCT00257608|4230632|P2|STARTED|Post Chemotherapy Phase||373
1727801|NCT00257608|4230633|P1|STARTED|Post Chemotherapy Phase||0
1727802|NCT00257608|4230631|P3|NOT COMPLETED|Chemotherapy Phase||0
1727803|NCT00257608|4230632|P2|NOT COMPLETED|Chemotherapy Phase||0
1727804|NCT00257608|4230633|P1|NOT COMPLETED|Chemotherapy Phase||376
1727805|NCT00257608|4230631|P3|COMPLETED|Chemotherapy Phase||0
1727806|NCT00257608|4230632|P2|COMPLETED|Chemotherapy Phase||0
1727807|NCT00257608|4230633|P1|COMPLETED|Chemotherapy Phase||769
1727808|NCT00257608|4230631|P3|STARTED|Chemotherapy Phase||0
1727809|NCT00257608|4230632|P2|STARTED|Chemotherapy Phase||0
1727810|NCT00257608|4230633|P1|STARTED|Chemotherapy Phase||1145
1727811|NCT00257556|4230659|P2|NOT COMPLETED|Overall Study||10
1727812|NCT00257556|4230660|P1|NOT COMPLETED|Overall Study||14
1727813|NCT00257556|4230659|P2|COMPLETED|Overall Study||32
1727814|NCT00257556|4230660|P1|COMPLETED|Overall Study||24
1727815|NCT00257556|4230659|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
1727816|NCT00257556|4230660|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
1727817|NCT00257556|4230659|P2|STARTED|Overall Study||42
1727818|NCT00257556|4230660|P1|STARTED|Overall Study||38
1727819|NCT00257322|4230686|P1|NOT COMPLETED|Overall Study||4
1727820|NCT00257322|4230686|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
1727821|NCT00257322|4230686|P1|STARTED|Overall Study|20 subjects accrued.|20
1727822|NCT00257309|4230693|P2|NOT COMPLETED|Overall Study||2
1727823|NCT00257309|4230694|P1|NOT COMPLETED|Overall Study||2
1727824|NCT00257309|4230693|P2|COMPLETED|Overall Study||130
1727825|NCT00257309|4230694|P1|COMPLETED|Overall Study||132
1727826|NCT00257309|4230693|P2|STARTED|Overall Study||132
1727827|NCT00257309|4230694|P1|STARTED|Overall Study||134
1727828|NCT00257192|4230704|P2|NOT COMPLETED|Overall Study||39
1727829|NCT00257192|4230705|P1|NOT COMPLETED|Overall Study||58
1727830|NCT00257192|4230704|P2|COMPLETED|Overall Study||52
1727831|NCT00257192|4230705|P1|COMPLETED|Overall Study||135
1727832|NCT00257192|4230704|P2|Received Study Treatment|Overall Study||90
1727833|NCT00257192|4230705|P1|Received Study Treatment|Overall Study||193
1727834|NCT00257192|4230704|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
1727835|NCT00257192|4230705|P1|STARTED|Overall Study||193
1727836|NCT00257166|4230749|P2|NOT COMPLETED|Overall Study||37
1727837|NCT00257166|4230750|P1|NOT COMPLETED|Overall Study||53
1727838|NCT00257166|4230749|P2|COMPLETED|Overall Study||51
1727839|NCT00257166|4230750|P1|COMPLETED|Overall Study||97
1727840|NCT00257166|4230749|P2|Treated|Overall Study||88
1727841|NCT00257166|4230750|P1|Treated|Overall Study||149
1727842|NCT00257166|4230749|P2|STARTED|Overall Study||88
1727843|NCT00257166|4230750|P1|STARTED|Overall Study||150
1727844|NCT00257010|4230762|P1|NOT COMPLETED|Overall Study||128
1727845|NCT00257010|4230762|P1|COMPLETED|Overall Study||319
1727846|NCT00257010|4230762|P1|STARTED|Overall Study||447
1727847|NCT00256997|4230773|P2|NOT COMPLETED|Overall Study||55
1727848|NCT00256997|4230774|P1|NOT COMPLETED|Overall Study||48
1727849|NCT00256997|4230773|P2|COMPLETED|Overall Study||31
1727850|NCT00256997|4230774|P1|COMPLETED|Overall Study||33
1727851|NCT00256997|4230773|P2|Treated|Overall Study||86
1727852|NCT00256997|4230774|P1|Treated|Overall Study||79
1727853|NCT00256997|4230773|P2|STARTED|Overall Study||86
1727854|NCT00256997|4230774|P1|STARTED|Overall Study||81
1727855|NCT00256984|4230798|P1|NOT COMPLETED|Overall Study||16
1727856|NCT00256984|4230798|P1|COMPLETED|Overall Study||59
1727857|NCT00256984|4230798|P1|STARTED|Overall Study||75
1727858|NCT00256867|4230816|P8|NOT COMPLETED|Overall Study||11
1727859|NCT00256867|4230817|P7|NOT COMPLETED|Overall Study||5
1727860|NCT00256867|4230818|P6|NOT COMPLETED|Overall Study||6
1727861|NCT00256867|4230819|P5|NOT COMPLETED|Overall Study||7
1727862|NCT00256867|4230820|P4|NOT COMPLETED|Overall Study||6
1727863|NCT00256867|4230821|P3|NOT COMPLETED|Overall Study||5
1727864|NCT00256867|4230822|P2|NOT COMPLETED|Overall Study||5
1727865|NCT00256867|4230823|P1|NOT COMPLETED|Overall Study||2
1727866|NCT00256867|4230816|P8|COMPLETED|Overall Study||36
1727867|NCT00256867|4230817|P7|COMPLETED|Overall Study||41
1727868|NCT00256867|4230818|P6|COMPLETED|Overall Study||40
1727869|NCT00256867|4230819|P5|COMPLETED|Overall Study||41
1727870|NCT00256867|4230820|P4|COMPLETED|Overall Study||40
1727871|NCT00256867|4230821|P3|COMPLETED|Overall Study||40
1727872|NCT00256867|4230822|P2|COMPLETED|Overall Study||39
1727873|NCT00256867|4230823|P1|COMPLETED|Overall Study||45
1727874|NCT00256867|4230816|P8|STARTED|Overall Study||47
1727875|NCT00256867|4230817|P7|STARTED|Overall Study||46
1727876|NCT00256867|4230818|P6|STARTED|Overall Study||46
1727877|NCT00256867|4230819|P5|STARTED|Overall Study||48
1727878|NCT00256867|4230820|P4|STARTED|Overall Study||46
1727879|NCT00256867|4230821|P3|STARTED|Overall Study||45
1727880|NCT00256867|4230822|P2|STARTED|Overall Study||44
1727881|NCT00256867|4230823|P1|STARTED|Overall Study||47
1727882|NCT00256750|4230910|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
1727883|NCT00256750|4230911|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
1727884|NCT00256750|4230912|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
1727885|NCT00256750|4230910|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
1727886|NCT00256750|4230911|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
1727887|NCT00256750|4230912|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
1727888|NCT00256750|4230910|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
1727889|NCT00256750|4230911|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
1727890|NCT00256750|4230912|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
1727891|NCT00256750|4230910|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
1727892|NCT00256750|4230911|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
1727893|NCT00256750|4230912|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
1727894|NCT00256750|4230910|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
1727895|NCT00256750|4230911|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
1727896|NCT00256750|4230912|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
1727897|NCT00256750|4230910|P3|STARTED|Post-Transplant Treated (36 Months)||164
1727898|NCT00256750|4230911|P2|STARTED|Post-Transplant Treated (36 Months)||176
1727899|NCT00256750|4230912|P1|STARTED|Post-Transplant Treated (36 Months)||153
1727900|NCT00256750|4230910|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
1727901|NCT00256750|4230911|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
1727902|NCT00256750|4230912|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
1727903|NCT00256750|4230910|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
1727904|NCT00256750|4230911|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
1727905|NCT00256750|4230912|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
1727906|NCT00256750|4230910|P3|STARTED|Post-Transplant Treated (24 Months)||173
1727907|NCT00256750|4230911|P2|STARTED|Post-Transplant Treated (24 Months)||183
1727908|NCT00256750|4230912|P1|STARTED|Post-Transplant Treated (24 Months)||174
1727909|NCT00256750|4230910|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
1727910|NCT00256750|4230911|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
1727911|NCT00256750|4230912|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
1727912|NCT00256750|4230910|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
1727913|NCT00256750|4230911|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
1727914|NCT00256750|4230912|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
1727915|NCT00256750|4230910|P3|STARTED|Post-Transplant Treated (12 Months)||219
1727916|NCT00256750|4230911|P2|STARTED|Post-Transplant Treated (12 Months)||226
1727917|NCT00256750|4230912|P1|STARTED|Post-Transplant Treated (12 Months)||215
1727918|NCT00256750|4230910|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
1727919|NCT00256750|4230911|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
1727920|NCT00256750|4230912|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
1727921|NCT00256750|4230910|P3|COMPLETED|Transplanted Pre-Treatment||219
1727922|NCT00256750|4230911|P2|COMPLETED|Transplanted Pre-Treatment||226
1727923|NCT00256750|4230912|P1|COMPLETED|Transplanted Pre-Treatment||215
1727924|NCT00256750|4230910|P3|STARTED|Transplanted Pre-Treatment||219
1727925|NCT00256750|4230911|P2|STARTED|Transplanted Pre-Treatment||226
1727926|NCT00256750|4230912|P1|STARTED|Transplanted Pre-Treatment||221
1727927|NCT00256724|4231048|P2|NOT COMPLETED|Overall Study||8
1727928|NCT00256724|4231049|P1|NOT COMPLETED|Overall Study||5
1727929|NCT00256724|4231048|P2|COMPLETED|Overall Study||16
1727930|NCT00256724|4231049|P1|COMPLETED|Overall Study||18
1727931|NCT00256724|4231048|P2|STARTED|Overall Study||24
1727932|NCT00256724|4231049|P1|STARTED|Overall Study||23
1727933|NCT00256698|4231059|P2|NOT COMPLETED|Overall Study||172
1727934|NCT00256698|4231060|P1|NOT COMPLETED|Overall Study||167
1727935|NCT00256698|4231059|P2|COMPLETED|Overall Study||84
1727936|NCT00256698|4231060|P1|COMPLETED|Overall Study||91
1727937|NCT00256698|4231059|P2|STARTED|Overall Study||256
1727938|NCT00256698|4231060|P1|STARTED|Overall Study||258
1727939|NCT00256308|4231078|P1|NOT COMPLETED|Overall Study||2
1727940|NCT00256308|4231078|P1|COMPLETED|Overall Study||4
1727941|NCT00256308|4231078|P1|STARTED|Overall Study||6
1727942|NCT00256295|4231086|P1|NOT COMPLETED|Overall Study||4
1727943|NCT00256295|4231086|P1|COMPLETED|Overall Study||3
1727944|NCT00256295|4231086|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
1727945|NCT00256282|4231092|P1|NOT COMPLETED|Overall Study||16
1727946|NCT00256282|4231092|P1|COMPLETED|Overall Study||36
1727947|NCT00256282|4231092|P1|STARTED|Overall Study||52
1727948|NCT00256243|4231097|P1|NOT COMPLETED|Overall Study||10
1727949|NCT00256243|4231097|P1|COMPLETED|Overall Study||38
1727950|NCT00256243|4231097|P1|STARTED|Overall Study||48
1727951|NCT00256204|4231106|P4|NOT COMPLETED|Overall Study||49
1727952|NCT00256204|4231107|P3|NOT COMPLETED|Overall Study||54
1727953|NCT00256204|4231108|P2|NOT COMPLETED|Overall Study||50
1727954|NCT00256204|4231109|P1|NOT COMPLETED|Overall Study||67
1727955|NCT00256204|4231106|P4|COMPLETED|Overall Study||244
1727956|NCT00256204|4231107|P3|COMPLETED|Overall Study||241
1727957|NCT00256204|4231108|P2|COMPLETED|Overall Study||238
1727958|NCT00256204|4231109|P1|COMPLETED|Overall Study||231
1727959|NCT00256204|4231106|P4|STARTED|Overall Study||293
1727960|NCT00256204|4231107|P3|STARTED|Overall Study||295
1727961|NCT00256204|4231108|P2|STARTED|Overall Study||288
1727962|NCT00256204|4231109|P1|STARTED|Overall Study||298
1727963|NCT00256126|4231124|P2|NOT COMPLETED|Overall Study||2
1727964|NCT00256126|4231125|P1|NOT COMPLETED|Overall Study||2
1727965|NCT00256126|4231124|P2|COMPLETED|Overall Study||167
1727966|NCT00256126|4231125|P1|COMPLETED|Overall Study||147
1727967|NCT00256126|4231124|P2|STARTED|Overall Study||169
1727968|NCT00256126|4231125|P1|STARTED|Overall Study||149
1727969|NCT00255970|4231143|P2|NOT COMPLETED|Overall Study||0
1727970|NCT00255970|4231144|P1|NOT COMPLETED|Overall Study||0
1727971|NCT00255970|4231143|P2|COMPLETED|Overall Study||19
1727972|NCT00255970|4231144|P1|COMPLETED|Overall Study||21
1727973|NCT00255970|4231143|P2|Final Visit Week 24|Overall Study||19
1727974|NCT00255970|4231144|P1|Final Visit Week 24|Overall Study||21
1727975|NCT00255970|4231143|P2|Screening Visit|Overall Study||19
1727976|NCT00255970|4231144|P1|Screening Visit|Overall Study||21
1727977|NCT00255970|4231143|P2|STARTED|Overall Study||19
1727978|NCT00255970|4231144|P1|STARTED|Overall Study||21
1727979|NCT00255840|4231164|P2|NOT COMPLETED|Overall Study||70
1727980|NCT00255840|4231165|P1|NOT COMPLETED|Overall Study||63
1727981|NCT00255840|4231164|P2|COMPLETED|Overall Study||334
1727982|NCT00255840|4231165|P1|COMPLETED|Overall Study||345
1727983|NCT00255840|4231164|P2|STARTED|Overall Study||404
1727984|NCT00255840|4231165|P1|STARTED|Overall Study||408
1727985|NCT00255801|4231171|P1|NOT COMPLETED|Overall Study||0
1727986|NCT00255801|4231171|P1|COMPLETED|Overall Study||37
1727987|NCT00255801|4231171|P1|STARTED|Overall Study||37
1727988|NCT00255723|4231178|P2|NOT COMPLETED|Overall Study||2
1727989|NCT00255723|4231179|P1|NOT COMPLETED|Overall Study||2
1727990|NCT00255723|4231178|P2|COMPLETED|Overall Study||39
1727991|NCT00255723|4231179|P1|COMPLETED|Overall Study||54
1727992|NCT00255723|4231178|P2|STARTED|Overall Study||41
1727993|NCT00255723|4231179|P1|STARTED|Overall Study||56
1727994|NCT00255684|4231185|P1|NOT COMPLETED|Overall Study||0
1727995|NCT00255684|4231185|P1|COMPLETED|Overall Study||16
1727996|NCT00255684|4231185|P1|STARTED|Overall Study||16
1727997|NCT00255190|4231192|P2|NOT COMPLETED|Overall Study||157
1727998|NCT00255190|4231193|P1|NOT COMPLETED|Overall Study||50
1727999|NCT00255190|4231192|P2|COMPLETED|Overall Study||281
1728000|NCT00255190|4231193|P1|COMPLETED|Overall Study||103
1728001|NCT00255190|4231192|P2|STARTED|Overall Study||438
1728002|NCT00255190|4231193|P1|STARTED|Overall Study||153
1728003|NCT00255177|4231261|P4|NOT COMPLETED|Overall Study||2
1728004|NCT00255177|4231262|P3|NOT COMPLETED|Overall Study||1
1728005|NCT00255177|4231263|P2|NOT COMPLETED|Overall Study||1
1728006|NCT00255177|4231264|P1|NOT COMPLETED|Overall Study||2
1728007|NCT00255177|4231261|P4|COMPLETED|Overall Study||4
1728008|NCT00255177|4231262|P3|COMPLETED|Overall Study||12
1728009|NCT00255177|4231263|P2|COMPLETED|Overall Study||13
1728010|NCT00255177|4231264|P1|COMPLETED|Overall Study||9
1728011|NCT00255177|4231261|P4|STARTED|Overall Study||6
1728012|NCT00255177|4231262|P3|STARTED|Overall Study||13
1728013|NCT00255177|4231263|P2|STARTED|Overall Study||14
1728014|NCT00255177|4231264|P1|STARTED|Overall Study||11
1728015|NCT00255164|4231277|P3|NOT COMPLETED|Overall Study||49
1728016|NCT00255164|4231278|P2|NOT COMPLETED|Overall Study||49
1728017|NCT00255164|4231279|P1|NOT COMPLETED|Overall Study||123
1728018|NCT00255164|4231277|P3|COMPLETED|Overall Study||103
1728019|NCT00255164|4231278|P2|COMPLETED|Overall Study||110
1728020|NCT00255164|4231279|P1|COMPLETED|Overall Study||17
1728021|NCT00255164|4231277|P3|STARTED|Overall Study||152
1728022|NCT00255164|4231278|P2|STARTED|Overall Study||159
1728023|NCT00255164|4231279|P1|STARTED|Overall Study||140
1728024|NCT00255151|4231305|P3|NOT COMPLETED|Overall Study||49
1728025|NCT00255151|4231306|P2|NOT COMPLETED|Overall Study||49
1728026|NCT00255151|4231307|P1|NOT COMPLETED|Overall Study||123
1728027|NCT00255151|4231305|P3|COMPLETED|Overall Study||103
1728028|NCT00255151|4231306|P2|COMPLETED|Overall Study||110
1728029|NCT00255151|4231307|P1|COMPLETED|Overall Study||17
1728030|NCT00255151|4231305|P3|STARTED|Overall Study||152
1728031|NCT00255151|4231306|P2|STARTED|Overall Study||159
1728032|NCT00255151|4231307|P1|STARTED|Overall Study||140
1728033|NCT00255125|4231332|P2|NOT COMPLETED|Overall Study||0
1728034|NCT00255125|4231333|P1|NOT COMPLETED|Overall Study||0
1728035|NCT00255125|4231332|P2|COMPLETED|Overall Study||42
1728036|NCT00255125|4231333|P1|COMPLETED|Overall Study||44
1728037|NCT00255125|4231332|P2|STARTED|Overall Study||42
1728038|NCT00255125|4231333|P1|STARTED|Overall Study||44
1728039|NCT00255086|4231341|P2|NOT COMPLETED|Overall Study||2
1728040|NCT00255086|4231342|P1|NOT COMPLETED|Overall Study||2
1728041|NCT00255086|4231341|P2|COMPLETED|Overall Study||6
1728042|NCT00255086|4231342|P1|COMPLETED|Overall Study||7
1728043|NCT00255086|4231341|P2|STARTED|Overall Study||8
1728044|NCT00255086|4231342|P1|STARTED|Overall Study||9
1728045|NCT00255047|4231354|P4|NOT COMPLETED|Overall Study||46
1728046|NCT00255047|4231355|P3|NOT COMPLETED|Overall Study||50
1728047|NCT00255047|4231356|P2|NOT COMPLETED|Overall Study||48
1728048|NCT00255047|4231357|P1|NOT COMPLETED|Overall Study||48
1728049|NCT00255047|4231354|P4|COMPLETED|Overall Study||502
1728050|NCT00255047|4231355|P3|COMPLETED|Overall Study||496
1728051|NCT00255047|4231356|P2|COMPLETED|Overall Study||487
1728052|NCT00255047|4231357|P1|COMPLETED|Overall Study||490
1728053|NCT00255047|4231354|P4|STARTED|Overall Study||548
1728054|NCT00255047|4231355|P3|STARTED|Overall Study||546
1728055|NCT00255047|4231356|P2|STARTED|Overall Study||535
1728056|NCT00255047|4231357|P1|STARTED|Overall Study||538
1728057|NCT00255034|4231381|P2|NOT COMPLETED|Overall Study||38
1728058|NCT00255034|4231382|P1|NOT COMPLETED|Overall Study||15
1728059|NCT00255034|4231381|P2|COMPLETED|Overall Study||26
1728060|NCT00255034|4231382|P1|COMPLETED|Overall Study||64
1728061|NCT00255034|4231381|P2|STARTED|Overall Study||64
1728062|NCT00255034|4231382|P1|STARTED|Overall Study||79
1728063|NCT00255008|4231392|P4|NOT COMPLETED|Overall Study||22
1728064|NCT00255008|4231393|P3|NOT COMPLETED|Overall Study||16
1728065|NCT00255008|4231394|P2|NOT COMPLETED|Overall Study||9
1728066|NCT00255008|4231395|P1|NOT COMPLETED|Overall Study||32
1728067|NCT00255008|4231392|P4|COMPLETED|Overall Study||12
1728068|NCT00255008|4231393|P3|COMPLETED|Overall Study||17
1728069|NCT00255008|4231394|P2|COMPLETED|Overall Study||0
1728070|NCT00255008|4231395|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
1728071|NCT00255008|4231392|P4|STARTED|Overall Study||34
1728072|NCT00255008|4231393|P3|STARTED|Overall Study||33
1728073|NCT00255008|4231394|P2|STARTED|Overall Study||9
1728074|NCT00255008|4231395|P1|STARTED|Overall Study||45
1728075|NCT00254995|4231407|P2|NOT COMPLETED|Overall Study||0
1728076|NCT00254995|4231408|P1|NOT COMPLETED|Overall Study||0
1728077|NCT00254995|4231407|P2|COMPLETED|Overall Study||31065
1728078|NCT00254995|4231408|P1|COMPLETED|Overall Study||31561
1728079|NCT00254995|4231407|P2|STARTED|Overall Study||31065
1728080|NCT00254995|4231408|P1|STARTED|Overall Study||31561
1728081|NCT00254982|4231431|P2|NOT COMPLETED|Overall Study||31
1728082|NCT00254982|4231432|P1|NOT COMPLETED|Overall Study||36
1728083|NCT00254982|4231431|P2|COMPLETED|Overall Study||265
1728084|NCT00254982|4231432|P1|COMPLETED|Overall Study||261
1728085|NCT00254982|4231431|P2|STARTED|Overall Study||296
1728086|NCT00254982|4231432|P1|STARTED|Overall Study||297
1728087|NCT00254592|4231438|P1|NOT COMPLETED|Overall Study||2
1728088|NCT00254592|4231438|P1|COMPLETED|Overall Study||41
1728089|NCT00254592|4231438|P1|STARTED|Overall Study||43
1728090|NCT00254566|4231444|P2|NOT COMPLETED|Overall Study||26
1728091|NCT00254566|4231445|P1|NOT COMPLETED|Overall Study||31
1728092|NCT00254566|4231444|P2|COMPLETED|Overall Study||172
1728093|NCT00254566|4231445|P1|COMPLETED|Overall Study||167
1728094|NCT00254566|4231444|P2|STARTED|Overall Study||198
1728095|NCT00254566|4231445|P1|STARTED|Overall Study||198
1728096|NCT00254540|4231469|P2|NOT COMPLETED|Overall Study||22
1728097|NCT00254540|4231470|P1|NOT COMPLETED|Overall Study||19
1728098|NCT00254540|4231469|P2|COMPLETED|Overall Study||4
1728099|NCT00254540|4231470|P1|COMPLETED|Overall Study||6
1728100|NCT00254540|4231469|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
1728101|NCT00254540|4231470|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
1728102|NCT00254501|4231499|P2|NOT COMPLETED|Overall Study||1
1728103|NCT00254501|4231500|P1|NOT COMPLETED|Overall Study||1
1728104|NCT00254501|4231499|P2|COMPLETED|Overall Study||36
1728105|NCT00254501|4231500|P1|COMPLETED|Overall Study||31
1728106|NCT00254501|4231499|P2|STARTED|Overall Study||37
1728107|NCT00254501|4231500|P1|STARTED|Overall Study||32
1728108|NCT00254488|4231514|P2|NOT COMPLETED|Overall Study||49
1728109|NCT00254488|4231515|P1|NOT COMPLETED|Overall Study||57
1728110|NCT00254488|4231514|P2|COMPLETED|Overall Study||63
1728111|NCT00254488|4231515|P1|COMPLETED|Overall Study||55
1728112|NCT00254488|4231514|P2|STARTED|Overall Study||112
1728113|NCT00254488|4231515|P1|STARTED|Overall Study||112
1728114|NCT00254462|4231525|P2|NOT COMPLETED|Overall Study||10
1728115|NCT00254462|4231526|P1|NOT COMPLETED|Overall Study||8
1728116|NCT00254462|4231525|P2|COMPLETED|Overall Study||39
1728117|NCT00254462|4231526|P1|COMPLETED|Overall Study||36
1728118|NCT00254462|4231525|P2|STARTED|Overall Study||49
1728119|NCT00254462|4231526|P1|STARTED|Overall Study||44
1728120|NCT00254410|4231534|P1|NOT COMPLETED|Overall Study||0
1728121|NCT00254410|4231534|P1|COMPLETED|Overall Study||30
1728122|NCT00254410|4231534|P1|STARTED|Overall Study||30
1728123|NCT00254293|4231547|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
1728124|NCT00254293|4231548|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1728125|NCT00254293|4231549|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1728126|NCT00254293|4231550|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1728127|NCT00254293|4231551|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1728128|NCT00254293|4231552|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1728129|NCT00254293|4231553|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
1728130|NCT00254293|4231547|P7|COMPLETED|LTE Open Label Fixed Dosing||35
1728131|NCT00254293|4231548|P6|COMPLETED|LTE Open Label Fixed Dosing||0
1728132|NCT00254293|4231549|P5|COMPLETED|LTE Open Label Fixed Dosing||0
1728133|NCT00254293|4231550|P4|COMPLETED|LTE Open Label Fixed Dosing||0
1728134|NCT00254293|4231551|P3|COMPLETED|LTE Open Label Fixed Dosing||0
1728135|NCT00254293|4231552|P2|COMPLETED|LTE Open Label Fixed Dosing||0
1728136|NCT00254293|4231553|P1|COMPLETED|LTE Open Label Fixed Dosing||0
1728137|NCT00254293|4231547|P7|STARTED|LTE Open Label Fixed Dosing||48
1728138|NCT00254293|4231548|P6|STARTED|LTE Open Label Fixed Dosing||0
1728139|NCT00254293|4231549|P5|STARTED|LTE Open Label Fixed Dosing||0
1728140|NCT00254293|4231550|P4|STARTED|LTE Open Label Fixed Dosing||0
1728141|NCT00254293|4231551|P3|STARTED|LTE Open Label Fixed Dosing||0
1728142|NCT00254293|4231552|P2|STARTED|LTE Open Label Fixed Dosing||0
1728143|NCT00254293|4231553|P1|STARTED|LTE Open Label Fixed Dosing||0
1728144|NCT00254293|4231547|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
1728145|NCT00254293|4231548|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
1728146|NCT00254293|4231549|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
1728147|NCT00254293|4231550|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
1728148|NCT00254293|4231551|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
1728149|NCT00254293|4231552|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
1728150|NCT00254293|4231553|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
1728151|NCT00254293|4231547|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
1728152|NCT00254293|4231548|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
1728153|NCT00254293|4231549|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
1728154|NCT00254293|4231550|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
1728155|NCT00254293|4231551|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
1728156|NCT00254293|4231552|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
1728157|NCT00254293|4231553|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
1728158|NCT00254293|4231547|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
1728159|NCT00254293|4231548|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
1728160|NCT00254293|4231549|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
1728161|NCT00254293|4231550|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
1728162|NCT00254293|4231551|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
1728163|NCT00254293|4231552|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
1728164|NCT00254293|4231553|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
1728165|NCT00254293|4231547|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
1728166|NCT00254293|4231548|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
1728167|NCT00254293|4231549|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
1728168|NCT00254293|4231550|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
1728169|NCT00254293|4231551|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
1728170|NCT00254293|4231552|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
1728171|NCT00254293|4231553|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
1728172|NCT00254293|4231547|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
1728173|NCT00254293|4231548|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
1728174|NCT00254293|4231549|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
1728175|NCT00254293|4231550|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
1728176|NCT00254293|4231551|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
1728177|NCT00254293|4231552|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
1728178|NCT00254293|4231553|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
1728179|NCT00254293|4231547|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
1728180|NCT00254293|4231548|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
1728181|NCT00254293|4231549|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
1728182|NCT00254293|4231550|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
1728183|NCT00254293|4231551|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
1728184|NCT00254293|4231552|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
1728185|NCT00254293|4231553|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
1728186|NCT00254163|4231636|P2|NOT COMPLETED|Overall Study||46
1728187|NCT00254163|4231637|P1|NOT COMPLETED|Overall Study||45
1728188|NCT00254163|4231636|P2|COMPLETED|Overall Study||46
1728189|NCT00254163|4231637|P1|COMPLETED|Overall Study||47
1728190|NCT00254163|4231636|P2|STARTED|Overall Study||92
1728191|NCT00254163|4231637|P1|STARTED|Overall Study||92
1728192|NCT00254072|4231661|P2|NOT COMPLETED|Overall Study||0
1728193|NCT00254072|4231662|P1|NOT COMPLETED|Overall Study||0
1728194|NCT00254072|4231661|P2|COMPLETED|Overall Study||175
1728195|NCT00254072|4231662|P1|COMPLETED|Overall Study||180
1728196|NCT00254072|4231661|P2|STARTED|Overall Study||175
1728197|NCT00254072|4231662|P1|STARTED|Overall Study||180
1728198|NCT00253981|4231670|P2|NOT COMPLETED|Overall Study||0
1728199|NCT00253981|4231671|P1|NOT COMPLETED|Overall Study||0
1728200|NCT00253981|4231670|P2|COMPLETED|Overall Study||14
1728201|NCT00253981|4231671|P1|COMPLETED|Overall Study||16
1728202|NCT00253981|4231670|P2|STARTED|Overall Study||14
1728203|NCT00253981|4231671|P1|STARTED|Overall Study||16
1728204|NCT00253890|4231679|P2|NOT COMPLETED|Overall Study||7
1728205|NCT00253890|4231680|P1|NOT COMPLETED|Overall Study||7
1728206|NCT00253890|4231679|P2|COMPLETED|Overall Study||61
1728207|NCT00253890|4231680|P1|COMPLETED|Overall Study||62
1728208|NCT00253890|4231679|P2|STARTED|Overall Study||68
1728209|NCT00253890|4231680|P1|STARTED|Overall Study||69
1728210|NCT00253747|4231688|P2|NOT COMPLETED|Overall Study||27
1728211|NCT00253747|4231689|P1|NOT COMPLETED|Overall Study||24
1728212|NCT00253747|4231688|P2|COMPLETED|Overall Study||101
1728213|NCT00253747|4231689|P1|COMPLETED|Overall Study||103
1728214|NCT00253747|4231688|P2|STARTED|Overall Study||128
1728215|NCT00253747|4231689|P1|STARTED|Overall Study||127
1728216|NCT00253708|4231710|P3|NOT COMPLETED|Overall Study||1
1728217|NCT00253708|4231711|P2|NOT COMPLETED|Overall Study||0
1728218|NCT00253708|4231712|P1|NOT COMPLETED|Overall Study||0
1728219|NCT00253708|4231710|P3|COMPLETED|Overall Study||8
1728220|NCT00253708|4231711|P2|COMPLETED|Overall Study||10
1728221|NCT00253708|4231712|P1|COMPLETED|Overall Study||20
1728222|NCT00253708|4231710|P3|STARTED|Overall Study||9
1728223|NCT00253708|4231711|P2|STARTED|Overall Study||10
1728224|NCT00253708|4231712|P1|STARTED|Overall Study||20
1728225|NCT00253643|4231742|P4|NOT COMPLETED|Overall Study||3
1728226|NCT00253643|4231743|P3|NOT COMPLETED|Overall Study||1
1728227|NCT00253643|4231744|P2|NOT COMPLETED|Overall Study||0
1728228|NCT00253643|4231745|P1|NOT COMPLETED|Overall Study||0
1728229|NCT00253643|4231742|P4|COMPLETED|Overall Study||28
1728230|NCT00253643|4231743|P3|COMPLETED|Overall Study||28
1728231|NCT00253643|4231744|P2|COMPLETED|Overall Study||15
1728232|NCT00253643|4231745|P1|COMPLETED|Overall Study||14
1728233|NCT00253643|4231742|P4|STARTED|Overall Study||31
1728234|NCT00253643|4231743|P3|STARTED|Overall Study||29
1728235|NCT00253643|4231744|P2|STARTED|Overall Study||15
1728236|NCT00253643|4231745|P1|STARTED|Overall Study||14
1728237|NCT00253630|4231759|P1|NOT COMPLETED|Overall Study||2
1728238|NCT00253630|4231759|P1|COMPLETED|Overall Study||35
1728239|NCT00253630|4231759|P1|STARTED|Overall Study||37
1728240|NCT00253513|4231768|P1|NOT COMPLETED|Overall Study||0
1728241|NCT00253513|4231768|P1|COMPLETED|Overall Study||60
1728242|NCT00253513|4231768|P1|STARTED|Overall Study||60
1728243|NCT00253448|4231775|P1|NOT COMPLETED|Overall Study||1
1728244|NCT00253448|4231775|P1|COMPLETED|Overall Study||34
1728245|NCT00253448|4231775|P1|STARTED|Overall Study||35
1728246|NCT00253435|4231781|P2|NOT COMPLETED|Overall Study||0
1728247|NCT00253435|4231782|P1|NOT COMPLETED|Overall Study||0
1728248|NCT00253435|4231781|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
1728249|NCT00253435|4231782|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
1728250|NCT00253435|4231781|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
1728251|NCT00253435|4231782|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
1728252|NCT00253435|4231781|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
1728253|NCT00253435|4231782|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
1728254|NCT00253435|4231781|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
1728255|NCT00253435|4231782|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
1728256|NCT00253435|4231781|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
1728257|NCT00253435|4231782|P1|STARTED|Overall Study|Total number is 42|42
1728258|NCT00253370|4231794|P1|NOT COMPLETED|Overall Study||43
1728259|NCT00253370|4231794|P1|COMPLETED|Overall Study||1
1728260|NCT00253370|4231794|P1|STARTED|Overall Study||44
1728261|NCT00253019|4231803|P3|NOT COMPLETED|Overall Study||18
1728262|NCT00253019|4231804|P2|NOT COMPLETED|Overall Study||31
1728263|NCT00253019|4231805|P1|NOT COMPLETED|Overall Study||29
1728264|NCT00253019|4231803|P3|COMPLETED|Overall Study||83
1728265|NCT00253019|4231804|P2|COMPLETED|Overall Study||78
1728266|NCT00253019|4231805|P1|COMPLETED|Overall Study||82
1728267|NCT00253019|4231803|P3|STARTED|Overall Study||101
1728268|NCT00253019|4231804|P2|STARTED|Overall Study||109
1728269|NCT00253019|4231805|P1|STARTED|Overall Study||111
1728270|NCT00252967|4231815|P2|NOT COMPLETED|Overall Study||0
1728271|NCT00252967|4231816|P1|NOT COMPLETED|Overall Study||0
1728272|NCT00252967|4231815|P2|COMPLETED|Overall Study||33
1728273|NCT00252967|4231816|P1|COMPLETED|Overall Study||31
1728274|NCT00252967|4231815|P2|STARTED|Overall Study||33
1728275|NCT00252967|4231816|P1|STARTED|Overall Study||31
1728276|NCT00252733|4231840|P2|NOT COMPLETED|Overall Study||92
1728277|NCT00252733|4231841|P1|NOT COMPLETED|Overall Study||106
1728278|NCT00252733|4231840|P2|COMPLETED|Overall Study||618
1728279|NCT00252733|4231841|P1|COMPLETED|Overall Study||605
1728280|NCT00252733|4231840|P2|STARTED|Overall Study||710
1728281|NCT00252733|4231841|P1|STARTED|Overall Study||711
1728282|NCT00252720|4231851|P2|NOT COMPLETED|Overall Study||165
1728283|NCT00252720|4231852|P1|NOT COMPLETED|Overall Study||132
1728284|NCT00252720|4231851|P2|COMPLETED|Overall Study||789
1728285|NCT00252720|4231852|P1|COMPLETED|Overall Study||819
1728286|NCT00252720|4231851|P2|STARTED|Overall Study||954
1728287|NCT00252720|4231852|P1|STARTED|Overall Study||951
1728288|NCT00252694|4231866|P2|NOT COMPLETED|Overall Study||154
1728289|NCT00252694|4231867|P1|NOT COMPLETED|Overall Study||144
1728290|NCT00252694|4231866|P2|COMPLETED|Overall Study||800
1728291|NCT00252694|4231867|P1|COMPLETED|Overall Study||807
1728292|NCT00252694|4231866|P2|STARTED|Overall Study||954
1728293|NCT00252694|4231867|P1|STARTED|Overall Study||951
1728294|NCT00252629|4231882|P3|NOT COMPLETED|Overall Study||0
1728295|NCT00252629|4231883|P2|NOT COMPLETED|Overall Study||0
1728296|NCT00252629|4231884|P1|NOT COMPLETED|Overall Study||1
1728297|NCT00252629|4231882|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
1728298|NCT00252629|4231883|P2|COMPLETED|Overall Study||9
1728299|NCT00252629|4231884|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
1728300|NCT00252629|4231882|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
1728301|NCT00252629|4231883|P2|STARTED|Overall Study||9
1728302|NCT00252629|4231884|P1|STARTED|Overall Study||9
1728303|NCT00252590|4231900|P3|NOT COMPLETED|Overall Study||3
1728304|NCT00252590|4231901|P2|NOT COMPLETED|Overall Study||2
1728305|NCT00252590|4231902|P1|NOT COMPLETED|Overall Study||2
1728306|NCT00252590|4231900|P3|COMPLETED|Overall Study||31
1728307|NCT00252590|4231901|P2|COMPLETED|Overall Study||28
1728308|NCT00252590|4231902|P1|COMPLETED|Overall Study||33
1728309|NCT00252590|4231900|P3|STARTED|Overall Study||34
1728310|NCT00252590|4231901|P2|STARTED|Overall Study||30
1728311|NCT00252590|4231902|P1|STARTED|Overall Study||35
1728312|NCT00252564|4231915|P2|NOT COMPLETED|Overall Study||44
1728313|NCT00252564|4231916|P1|NOT COMPLETED|Overall Study||39
1728314|NCT00252564|4231915|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
1728315|NCT00252564|4231916|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
1728316|NCT00252564|4231915|P2|STARTED|Overall Study|From randomization|123
1728317|NCT00252564|4231916|P1|STARTED|Overall Study|From randomization|124
1728318|NCT00252538|4231928|P2|NOT COMPLETED|Overall Study||0
1728319|NCT00252538|4231929|P1|NOT COMPLETED|Overall Study||0
1728320|NCT00252538|4231928|P2|COMPLETED|Overall Study||114
1728321|NCT00252538|4231929|P1|COMPLETED|Overall Study||19
1728322|NCT00252538|4231928|P2|STARTED|Overall Study||114
1728323|NCT00252538|4231929|P1|STARTED|Overall Study||19
1728324|NCT00252512|4231936|P2|NOT COMPLETED|12 Month Follow up||1
1728325|NCT00252512|4231937|P1|NOT COMPLETED|12 Month Follow up||9
1728326|NCT00252512|4231936|P2|COMPLETED|12 Month Follow up||121
1728327|NCT00252512|4231937|P1|COMPLETED|12 Month Follow up||123
1728328|NCT00252512|4231936|P2|STARTED|12 Month Follow up||122
1728329|NCT00252512|4231937|P1|STARTED|12 Month Follow up||132
1728330|NCT00252512|4231936|P2|NOT COMPLETED|Six Month Follow up||12
1728331|NCT00252512|4231937|P1|NOT COMPLETED|Six Month Follow up||4
1728332|NCT00252512|4231936|P2|COMPLETED|Six Month Follow up||122
1728333|NCT00252512|4231937|P1|COMPLETED|Six Month Follow up||132
1728334|NCT00252512|4231936|P2|STARTED|Six Month Follow up||134
1728335|NCT00252512|4231937|P1|STARTED|Six Month Follow up||136
1728336|NCT00252512|4231936|P2|NOT COMPLETED|Intervention||31
1728337|NCT00252512|4231937|P1|NOT COMPLETED|Intervention||29
1728338|NCT00252512|4231936|P2|COMPLETED|Intervention||134
1728339|NCT00252512|4231937|P1|COMPLETED|Intervention||136
1728340|NCT00252512|4231936|P2|STARTED|Intervention||165
1728341|NCT00252512|4231937|P1|STARTED|Intervention||165
1728342|NCT00252499|4231956|P3|NOT COMPLETED|Overall Study||0
1728343|NCT00252499|4231957|P2|NOT COMPLETED|Overall Study||0
1728344|NCT00252499|4231958|P1|NOT COMPLETED|Overall Study||1
1728345|NCT00252499|4231956|P3|COMPLETED|Overall Study||6
1728346|NCT00252499|4231957|P2|COMPLETED|Overall Study||2
1728347|NCT00252499|4231958|P1|COMPLETED|Overall Study||4
1728348|NCT00252499|4231956|P3|STARTED|Overall Study||6
1728349|NCT00252499|4231957|P2|STARTED|Overall Study||2
1728350|NCT00252499|4231958|P1|STARTED|Overall Study||5
1728351|NCT00252382|4231981|P1|NOT COMPLETED|Overall Study||26
1728352|NCT00252382|4231981|P1|COMPLETED|Overall Study||5
1728353|NCT00252382|4231981|P1|STARTED|Overall Study||31
1728354|NCT00252239|4231990|P4|NOT COMPLETED|Overall Study||1
1728355|NCT00252239|4231991|P3|NOT COMPLETED|Overall Study||2
1728356|NCT00252239|4231992|P2|NOT COMPLETED|Overall Study||0
1728357|NCT00252239|4231993|P1|NOT COMPLETED|Overall Study||1
1728358|NCT00252239|4231990|P4|COMPLETED|Overall Study||30
1728359|NCT00252239|4231991|P3|COMPLETED|Overall Study||17
1728360|NCT00252239|4231992|P2|COMPLETED|Overall Study||31
1728361|NCT00252239|4231993|P1|COMPLETED|Overall Study||30
1728362|NCT00252239|4231990|P4|STARTED|Overall Study||31
1728363|NCT00252239|4231991|P3|STARTED|Overall Study||19
1728364|NCT00252239|4231992|P2|STARTED|Overall Study||31
1728365|NCT00252239|4231993|P1|STARTED|Overall Study||31
1728366|NCT00252187|4232005|P2|NOT COMPLETED|Overall Study||1
1728367|NCT00252187|4232006|P1|NOT COMPLETED|Overall Study||4
1728368|NCT00252187|4232005|P2|COMPLETED|Overall Study||20
1728369|NCT00252187|4232006|P1|COMPLETED|Overall Study||20
1728370|NCT00252187|4232005|P2|STARTED|Overall Study||21
1728371|NCT00252187|4232006|P1|STARTED|Overall Study||24
1728372|NCT00252174|4232029|P3|NOT COMPLETED|Overall Study||0
1728373|NCT00252174|4232030|P2|NOT COMPLETED|Overall Study||1
1728374|NCT00252174|4232031|P1|NOT COMPLETED|Overall Study||0
1728375|NCT00252174|4232029|P3|COMPLETED|Overall Study||0
1728376|NCT00252174|4232030|P2|COMPLETED|Overall Study||1
1728377|NCT00252174|4232031|P1|COMPLETED|Overall Study||0
1728378|NCT00252174|4232029|P3|STARTED|Overall Study|No subjects entered Stage 2|0
1728379|NCT00252174|4232030|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
1728380|NCT00252174|4232031|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
1728381|NCT00252057|4232071|P2|NOT COMPLETED|Overall Study||8
1728382|NCT00252057|4232072|P1|NOT COMPLETED|Overall Study||3
1728383|NCT00252057|4232071|P2|COMPLETED|Overall Study||368
1728384|NCT00252057|4232072|P1|COMPLETED|Overall Study||370
1728385|NCT00252057|4232071|P2|STARTED|Overall Study||376
1728386|NCT00252057|4232072|P1|STARTED|Overall Study||373
1728387|NCT00251979|4232080|P2|NOT COMPLETED|Overall Study||40
1728388|NCT00251979|4232081|P1|NOT COMPLETED|Overall Study||38
1728389|NCT00251979|4232080|P2|COMPLETED|Overall Study||349
1728390|NCT00251979|4232081|P1|COMPLETED|Overall Study||337
1728391|NCT00251979|4232080|P2|STARTED|Overall Study|ITT population|389
1728392|NCT00251979|4232081|P1|STARTED|Overall Study|ITT population|375
1728393|NCT00251927|4232113|P2|NOT COMPLETED|Overall Study||74
1728394|NCT00251927|4232114|P1|NOT COMPLETED|Overall Study||108
1728395|NCT00251927|4232113|P2|COMPLETED|Overall Study|Completed 5 year visit|192
1728396|NCT00251927|4232114|P1|COMPLETED|Overall Study|Completed 5 year visit|180
1728397|NCT00251927|4232113|P2|STARTED|Overall Study|Randomised|266
1728398|NCT00251927|4232114|P1|STARTED|Overall Study|Randomised|288
1728399|NCT00251862|4232144|P3|NOT COMPLETED|Overall Study||0
1728400|NCT00251862|4232145|P2|NOT COMPLETED|Overall Study||0
1728401|NCT00251862|4232146|P1|NOT COMPLETED|Overall Study||0
1728402|NCT00251862|4232144|P3|COMPLETED|Overall Study||276
1728403|NCT00251862|4232145|P2|COMPLETED|Overall Study||269
1728404|NCT00251862|4232146|P1|COMPLETED|Overall Study||280
1728405|NCT00251862|4232144|P3|STARTED|Overall Study||276
1728406|NCT00251862|4232145|P2|STARTED|Overall Study||269
1728407|NCT00251862|4232146|P1|STARTED|Overall Study||280
1728408|NCT00251758|4232166|P3|NOT COMPLETED|Overall Study||27
1728409|NCT00251758|4232167|P2|NOT COMPLETED|Overall Study||27
1728410|NCT00251758|4232168|P1|NOT COMPLETED|Overall Study||28
1728411|NCT00251758|4232166|P3|COMPLETED|Overall Study||277
1728412|NCT00251758|4232167|P2|COMPLETED|Overall Study||285
1728413|NCT00251758|4232168|P1|COMPLETED|Overall Study||264
1728414|NCT00251758|4232166|P3|STARTED|Overall Study||304
1728415|NCT00251758|4232167|P2|STARTED|Overall Study||312
1728416|NCT00251758|4232168|P1|STARTED|Overall Study||292
1728417|NCT00251745|4232188|P3|NOT COMPLETED|Overall Study||27
1728418|NCT00251745|4232189|P2|NOT COMPLETED|Overall Study||27
1728419|NCT00251745|4232190|P1|NOT COMPLETED|Overall Study||28
1728420|NCT00251745|4232188|P3|COMPLETED|Overall Study||277
1728421|NCT00251745|4232189|P2|COMPLETED|Overall Study||285
1728422|NCT00251745|4232190|P1|COMPLETED|Overall Study||264
1728423|NCT00251745|4232188|P3|STARTED|Overall Study||304
1728424|NCT00251745|4232189|P2|STARTED|Overall Study||312
1728425|NCT00251745|4232190|P1|STARTED|Overall Study||292
1728426|NCT00251719|4232210|P3|NOT COMPLETED|Overall Study||30
1728427|NCT00251719|4232211|P2|NOT COMPLETED|Overall Study||45
1728428|NCT00251719|4232212|P1|NOT COMPLETED|Overall Study||53
1728429|NCT00251719|4232210|P3|COMPLETED|Overall Study||643
1728430|NCT00251719|4232211|P2|COMPLETED|Overall Study||642
1728431|NCT00251719|4232212|P1|COMPLETED|Overall Study||641
1728432|NCT00251719|4232210|P3|STARTED|Overall Study||673
1728433|NCT00251719|4232211|P2|STARTED|Overall Study||687
1728434|NCT00251719|4232212|P1|STARTED|Overall Study||694
1728435|NCT00251693|4232238|P3|NOT COMPLETED|Overall Study||46
1728436|NCT00251693|4232239|P2|NOT COMPLETED|Overall Study||44
1728437|NCT00251693|4232240|P1|NOT COMPLETED|Overall Study||51
1728438|NCT00251693|4232238|P3|COMPLETED|Overall Study||644
1728439|NCT00251693|4232239|P2|COMPLETED|Overall Study||624
1728440|NCT00251693|4232240|P1|COMPLETED|Overall Study||629
1728441|NCT00251693|4232238|P3|STARTED|Overall Study||690
1728442|NCT00251693|4232239|P2|STARTED|Overall Study||668
1728443|NCT00251693|4232240|P1|STARTED|Overall Study||680
1728444|NCT00251641|4232265|P2|NOT COMPLETED|Overall Study||88
1728445|NCT00251641|4232266|P1|NOT COMPLETED|Overall Study||112
1728446|NCT00251641|4232265|P2|COMPLETED|Overall Study||127
1728447|NCT00251641|4232266|P1|COMPLETED|Overall Study||541
1728448|NCT00251641|4232265|P2|STARTED|Overall Study||215
1728449|NCT00251641|4232266|P1|STARTED|Overall Study||653
1728450|NCT00251589|4232284|P4|NOT COMPLETED|Overall Study||2
1728451|NCT00251589|4232285|P3|NOT COMPLETED|Overall Study||2
1728452|NCT00251589|4232286|P2|NOT COMPLETED|Overall Study||3
1728453|NCT00251589|4232287|P1|NOT COMPLETED|Overall Study||15
1728454|NCT00251589|4232284|P4|COMPLETED|Overall Study||0
1728455|NCT00251589|4232285|P3|COMPLETED|Overall Study||0
1728456|NCT00251589|4232286|P2|COMPLETED|Overall Study||0
1728457|NCT00251589|4232287|P1|COMPLETED|Overall Study||1
1728458|NCT00251589|4232284|P4|STARTED|Overall Study||2
1728459|NCT00251589|4232285|P3|STARTED|Overall Study||2
1728460|NCT00251589|4232286|P2|STARTED|Overall Study||3
1728461|NCT00251589|4232287|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
1728462|NCT00251316|4232324|P2|NOT COMPLETED|Overall Study||3
1728463|NCT00251316|4232325|P1|NOT COMPLETED|Overall Study||2
1728464|NCT00251316|4232324|P2|COMPLETED|Overall Study||14
1728465|NCT00251316|4232325|P1|COMPLETED|Overall Study||15
1728466|NCT00251316|4232324|P2|STARTED|Overall Study||17
1728467|NCT00251316|4232325|P1|STARTED|Overall Study||17
1728468|NCT00251303|4232333|P2|NOT COMPLETED|Overall Study||1
1728469|NCT00251303|4232334|P1|NOT COMPLETED|Overall Study||8
1728470|NCT00251303|4232333|P2|COMPLETED|Overall Study||29
1728471|NCT00251303|4232334|P1|COMPLETED|Overall Study||22
1728472|NCT00251303|4232333|P2|STARTED|Overall Study||30
1728473|NCT00251303|4232334|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
1728474|NCT00251238|4232344|P2|NOT COMPLETED|Overall Study||0
1728475|NCT00251238|4232345|P1|NOT COMPLETED|Overall Study||0
1728476|NCT00251238|4232344|P2|COMPLETED|Overall Study||20
1728477|NCT00251238|4232345|P1|COMPLETED|Overall Study||21
1728478|NCT00251238|4232344|P2|STARTED|Overall Study||20
1728479|NCT00251238|4232345|P1|STARTED|Overall Study||21
1728480|NCT00251225|4232355|P1|NOT COMPLETED|Overall Study||0
1728481|NCT00251225|4232355|P1|COMPLETED|Overall Study||49
1728482|NCT00251225|4232355|P1|STARTED|Overall Study||49
1728483|NCT00251004|4232364|P3|NOT COMPLETED|Overall Study||31
1728484|NCT00251004|4232365|P2|NOT COMPLETED|Overall Study||41
1728485|NCT00251004|4232366|P1|NOT COMPLETED|Overall Study||45
1728486|NCT00251004|4232364|P3|COMPLETED|Overall Study||246
1728487|NCT00251004|4232365|P2|COMPLETED|Overall Study||238
1728488|NCT00251004|4232366|P1|COMPLETED|Overall Study||232
1728489|NCT00251004|4232364|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
1728490|NCT00251004|4232365|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
1728491|NCT00251004|4232366|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
1728492|NCT00251004|4232364|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
1728493|NCT00251004|4232365|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
1728494|NCT00251004|4232366|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
1728495|NCT00251004|4232364|P3|STARTED|Overall Study||277
1728496|NCT00251004|4232365|P2|STARTED|Overall Study||279
1728497|NCT00251004|4232366|P1|STARTED|Overall Study||277
1728498|NCT00250926|4232383|P1|NOT COMPLETED|Overall Study||0
1728499|NCT00250926|4232383|P1|COMPLETED|Overall Study||23
1728500|NCT00250926|4232383|P1|STARTED|Overall Study||23
1728501|NCT00250835|4232390|P1|NOT COMPLETED|Overall Study||1
1728502|NCT00250835|4232390|P1|COMPLETED|Overall Study||37
1728503|NCT00250835|4232390|P1|STARTED|Overall Study||38
1728504|NCT00250718|4232399|P1|NOT COMPLETED|Overall Study||3
1728505|NCT00250718|4232399|P1|COMPLETED|Overall Study||14
1728506|NCT00250718|4232399|P1|Received Treatment|Overall Study||16
1728507|NCT00250718|4232399|P1|STARTED|Overall Study||17
1728508|NCT00250705|4232404|P1|NOT COMPLETED|Overall Study||2
1728509|NCT00250705|4232404|P1|COMPLETED|Overall Study||10
1728510|NCT00250705|4232404|P1|STARTED|Overall Study||12
1728511|NCT00250679|4232415|P3|NOT COMPLETED|Overall Study||44
1728512|NCT00250679|4232416|P2|NOT COMPLETED|Overall Study||49
1728513|NCT00250679|4232417|P1|NOT COMPLETED|Overall Study||39
1728514|NCT00250679|4232415|P3|COMPLETED|Overall Study||103
1728515|NCT00250679|4232416|P2|COMPLETED|Overall Study||100
1728516|NCT00250679|4232417|P1|COMPLETED|Overall Study||108
1728517|NCT00250679|4232415|P3|STARTED|Overall Study||147
1728518|NCT00250679|4232416|P2|STARTED|Overall Study||149
1728519|NCT00250679|4232417|P1|STARTED|Overall Study||147
1728520|NCT00250588|4232518|P3|NOT COMPLETED|Overall Study||13
1728521|NCT00250588|4232519|P2|NOT COMPLETED|Overall Study||19
1728522|NCT00250588|4232520|P1|NOT COMPLETED|Overall Study||9
1728523|NCT00250588|4232518|P3|COMPLETED|Overall Study||74
1728524|NCT00250588|4232519|P2|COMPLETED|Overall Study||65
1728525|NCT00250588|4232520|P1|COMPLETED|Overall Study||72
1728526|NCT00250588|4232518|P3|STARTED|Overall Study||87
1728527|NCT00250588|4232519|P2|STARTED|Overall Study||84
1728528|NCT00250588|4232520|P1|STARTED|Overall Study||81
1728529|NCT00250497|4232536|P2|NOT COMPLETED|Overall Study||15
1728530|NCT00250497|4232537|P1|NOT COMPLETED|Overall Study||5
1728531|NCT00250497|4232536|P2|COMPLETED|Overall Study||159
1728532|NCT00250497|4232537|P1|COMPLETED|Overall Study||177
1728533|NCT00250497|4232536|P2|STARTED|Overall Study||174
1728534|NCT00250497|4232537|P1|STARTED|Overall Study||182
1728535|NCT00250484|4232555|P2|NOT COMPLETED|Overall Study||0
1728536|NCT00250484|4232556|P1|NOT COMPLETED|Overall Study||0
1728537|NCT00250484|4232555|P2|COMPLETED|Overall Study||8
1728538|NCT00250484|4232556|P1|COMPLETED|Overall Study||9
1728539|NCT00250484|4232555|P2|STARTED|Overall Study||8
1728540|NCT00250484|4232556|P1|STARTED|Overall Study||9
1728541|NCT00250458|4232568|P2|NOT COMPLETED|Overall Study||17
1728542|NCT00250458|4232569|P1|NOT COMPLETED|Overall Study||32
1728543|NCT00250458|4232568|P2|COMPLETED|Overall Study||97
1728544|NCT00250458|4232569|P1|COMPLETED|Overall Study||200
1728545|NCT00250458|4232568|P2|STARTED|Overall Study||114
1728546|NCT00250458|4232569|P1|STARTED|Overall Study||232
1728547|NCT00250432|4232579|P2|NOT COMPLETED|Overall Study||47
1728548|NCT00250432|4232580|P1|NOT COMPLETED|Overall Study||45
1728549|NCT00250432|4232579|P2|COMPLETED|Overall Study||53
1728550|NCT00250432|4232580|P1|COMPLETED|Overall Study||59
1728551|NCT00250432|4232579|P2|STARTED|Overall Study||100
1728552|NCT00250432|4232580|P1|STARTED|Overall Study||104
1728553|NCT00250276|4232592|P4|NOT COMPLETED|Overall Study||19
1728554|NCT00250276|4232593|P3|NOT COMPLETED|Overall Study||19
1728555|NCT00250276|4232594|P2|NOT COMPLETED|Overall Study||21
1728556|NCT00250276|4232595|P1|NOT COMPLETED|Overall Study||17
1728557|NCT00250276|4232592|P4|COMPLETED|Overall Study||181
1728558|NCT00250276|4232593|P3|COMPLETED|Overall Study||182
1728559|NCT00250276|4232594|P2|COMPLETED|Overall Study||177
1728560|NCT00250276|4232595|P1|COMPLETED|Overall Study||182
1728561|NCT00250276|4232592|P4|STARTED|Overall Study||200
1728562|NCT00250276|4232593|P3|STARTED|Overall Study||201
1728563|NCT00250276|4232594|P2|STARTED|Overall Study||198
1728564|NCT00250276|4232595|P1|STARTED|Overall Study||199
1728565|NCT00249873|4232675|P2|NOT COMPLETED|Overall Study||1254
1728566|NCT00249873|4232676|P1|NOT COMPLETED|Overall Study||1330
1728567|NCT00249873|4232675|P2|COMPLETED|Overall Study|started and completed study drug|2528
1728568|NCT00249873|4232676|P1|COMPLETED|Overall Study|started and completed study drug|2442
1728660|NCT00249249|4232908|P2|COMPLETED|Overall Study||98
1728569|NCT00249873|4232675|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
1728570|NCT00249873|4232676|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
1728571|NCT00249834|4232696|P8|NOT COMPLETED|Overall Study||0
1728572|NCT00249834|4232697|P7|NOT COMPLETED|Overall Study||1
1728573|NCT00249834|4232698|P6|NOT COMPLETED|Overall Study||2
1728574|NCT00249834|4232699|P5|NOT COMPLETED|Overall Study||5
1728575|NCT00249834|4232700|P4|NOT COMPLETED|Overall Study||8
1728576|NCT00249834|4232701|P3|NOT COMPLETED|Overall Study||14
1728577|NCT00249834|4232702|P2|NOT COMPLETED|Overall Study||19
1728578|NCT00249834|4232703|P1|NOT COMPLETED|Overall Study||1
1728579|NCT00249834|4232696|P8|COMPLETED|Overall Study||2
1728580|NCT00249834|4232697|P7|COMPLETED|Overall Study||1
1728581|NCT00249834|4232698|P6|COMPLETED|Overall Study||8
1728582|NCT00249834|4232699|P5|COMPLETED|Overall Study||19
1728583|NCT00249834|4232700|P4|COMPLETED|Overall Study||26
1728584|NCT00249834|4232701|P3|COMPLETED|Overall Study||31
1728585|NCT00249834|4232702|P2|COMPLETED|Overall Study||29
1728586|NCT00249834|4232703|P1|COMPLETED|Overall Study||0
1728587|NCT00249834|4232696|P8|STARTED|Overall Study||2
1728588|NCT00249834|4232697|P7|STARTED|Overall Study||2
1728589|NCT00249834|4232698|P6|STARTED|Overall Study||10
1728590|NCT00249834|4232699|P5|STARTED|Overall Study||24
1728591|NCT00249834|4232700|P4|STARTED|Overall Study||34
1728592|NCT00249834|4232701|P3|STARTED|Overall Study||45
1728593|NCT00249834|4232702|P2|STARTED|Overall Study||48
1728594|NCT00249834|4232703|P1|STARTED|Overall Study||1
1728595|NCT00249821|4232752|P2|NOT COMPLETED|Overall Study||1
1728596|NCT00249821|4232753|P1|NOT COMPLETED|Overall Study||0
1728597|NCT00249821|4232752|P2|COMPLETED|Overall Study||11
1728598|NCT00249821|4232753|P1|COMPLETED|Overall Study||10
1728599|NCT00249821|4232752|P2|STARTED|Overall Study||12
1728600|NCT00249821|4232753|P1|STARTED|Overall Study||10
1728601|NCT00249808|4232773|P1|NOT COMPLETED|Overall Study||182
1728602|NCT00249808|4232773|P1|COMPLETED|Overall Study||1084
1728603|NCT00249808|4232773|P1|STARTED|Overall Study||1266
1728604|NCT00249795|4232781|P2|NOT COMPLETED|Overall Study||1390
1728605|NCT00249795|4232782|P1|NOT COMPLETED|Overall Study||1394
1728606|NCT00249795|4232781|P2|COMPLETED|Overall Study|started and completed study drug|3108
1728607|NCT00249795|4232782|P1|COMPLETED|Overall Study|started and completed study drug|3124
1728608|NCT00249795|4232781|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
1728609|NCT00249795|4232782|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
1728610|NCT00249613|4232802|P2|NOT COMPLETED|12 Month Follow-up||15
1728611|NCT00249613|4232803|P1|NOT COMPLETED|12 Month Follow-up||17
1728612|NCT00249613|4232802|P2|COMPLETED|12 Month Follow-up||124
1728613|NCT00249613|4232803|P1|COMPLETED|12 Month Follow-up||135
1728614|NCT00249613|4232802|P2|STARTED|12 Month Follow-up||139
1728615|NCT00249613|4232803|P1|STARTED|12 Month Follow-up||152
1728616|NCT00249613|4232802|P2|NOT COMPLETED|Baseline||0
1728617|NCT00249613|4232803|P1|NOT COMPLETED|Baseline||0
1728618|NCT00249613|4232802|P2|COMPLETED|Baseline||139
1728619|NCT00249613|4232803|P1|COMPLETED|Baseline||152
1728620|NCT00249613|4232802|P2|STARTED|Baseline||139
1728621|NCT00249613|4232803|P1|STARTED|Baseline||152
1728622|NCT00249496|4232814|P2|NOT COMPLETED|Overall Study||1
1728623|NCT00249496|4232815|P1|NOT COMPLETED|Overall Study||0
1728624|NCT00249496|4232814|P2|COMPLETED|Overall Study||26
1728625|NCT00249496|4232815|P1|COMPLETED|Overall Study||24
1728626|NCT00249496|4232814|P2|STARTED|Overall Study||27
1728627|NCT00249496|4232815|P1|STARTED|Overall Study||24
1728628|NCT00249470|4232831|P2|NOT COMPLETED|Overall Study||0
1728629|NCT00249470|4232832|P1|NOT COMPLETED|Overall Study||0
1728630|NCT00249470|4232831|P2|COMPLETED|Overall Study||28
1728631|NCT00249470|4232832|P1|COMPLETED|Overall Study||28
1728632|NCT00249470|4232831|P2|STARTED|Overall Study||28
1728633|NCT00249470|4232832|P1|STARTED|Overall Study||28
1728634|NCT00249444|4232844|P2|NOT COMPLETED|Overall Study||15
1728635|NCT00249444|4232845|P1|NOT COMPLETED|Overall Study||12
1728636|NCT00249444|4232844|P2|COMPLETED|Overall Study||29
1728637|NCT00249444|4232845|P1|COMPLETED|Overall Study||30
1728638|NCT00249444|4232844|P2|STARTED|Overall Study||44
1728639|NCT00249444|4232845|P1|STARTED|Overall Study||42
1728640|NCT00249379|4232855|P2|NOT COMPLETED|Overall Study||8
1728641|NCT00249379|4232856|P1|NOT COMPLETED|Overall Study||8
1728642|NCT00249379|4232855|P2|COMPLETED|Overall Study||4
1728643|NCT00249379|4232856|P1|COMPLETED|Overall Study||6
1728644|NCT00249379|4232855|P2|STARTED|Overall Study||12
1728645|NCT00249379|4232856|P1|STARTED|Overall Study||14
1728646|NCT00249288|4232870|P2|NOT COMPLETED|Overall Study||5
1728647|NCT00249288|4232871|P1|NOT COMPLETED|Overall Study||5
1728648|NCT00249288|4232870|P2|COMPLETED|Overall Study||14
1728649|NCT00249288|4232871|P1|COMPLETED|Overall Study||14
1728650|NCT00249288|4232870|P2|Initiated Treatment|Overall Study||15
1728651|NCT00249288|4232871|P1|Initiated Treatment|Overall Study||17
1728652|NCT00249288|4232870|P2|STARTED|Overall Study||19
1728653|NCT00249288|4232871|P1|STARTED|Overall Study||19
1728654|NCT00249249|4232906|P4|NOT COMPLETED|Overall Study||3
1728655|NCT00249249|4232907|P3|NOT COMPLETED|Overall Study||15
1728656|NCT00249249|4232908|P2|NOT COMPLETED|Overall Study||5
1728657|NCT00249249|4232909|P1|NOT COMPLETED|Overall Study||20
1728658|NCT00249249|4232906|P4|COMPLETED|Overall Study||100
1728659|NCT00249249|4232907|P3|COMPLETED|Overall Study||288
1728661|NCT00249249|4232909|P1|COMPLETED|Overall Study||301
1728662|NCT00249249|4232906|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
1728663|NCT00249249|4232907|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
1728664|NCT00249249|4232908|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
1728665|NCT00249249|4232909|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
1728666|NCT00249249|4232906|P4|STARTED|Overall Study||103
1728667|NCT00249249|4232907|P3|STARTED|Overall Study||303
1728668|NCT00249249|4232908|P2|STARTED|Overall Study||103
1728669|NCT00249249|4232909|P1|STARTED|Overall Study||321
1728670|NCT00249002|4232963|P1|NOT COMPLETED|Overall Study||7
1728671|NCT00249002|4232963|P1|COMPLETED|Overall Study||2
1728672|NCT00249002|4232963|P1|STARTED|Overall Study||9
1728673|NCT00248833|4232982|P3|NOT COMPLETED|Overall Study||2
1728674|NCT00248833|4232983|P2|NOT COMPLETED|Overall Study||3
1728675|NCT00248833|4232984|P1|NOT COMPLETED|Overall Study||3
1728676|NCT00248833|4232982|P3|COMPLETED|Overall Study||9
1728677|NCT00248833|4232983|P2|COMPLETED|Overall Study||8
1728678|NCT00248833|4232984|P1|COMPLETED|Overall Study||9
1728679|NCT00248833|4232982|P3|STARTED|Overall Study||11
1728680|NCT00248833|4232983|P2|STARTED|Overall Study||11
1728681|NCT00248833|4232984|P1|STARTED|Overall Study||12
1728682|NCT00248807|4233002|P2|NOT COMPLETED|Overall Study||0
1728683|NCT00248807|4233003|P1|NOT COMPLETED|Overall Study||0
1728684|NCT00248807|4233002|P2|COMPLETED|Overall Study||11
1728685|NCT00248807|4233003|P1|COMPLETED|Overall Study||19
1728686|NCT00248807|4233002|P2|STARTED|Overall Study||11
1728687|NCT00248807|4233003|P1|STARTED|Overall Study||19
1728688|NCT00248794|4233020|P3|NOT COMPLETED|Overall Study||3
1728689|NCT00248794|4233021|P2|NOT COMPLETED|Overall Study||8
1728690|NCT00248794|4233022|P1|NOT COMPLETED|Overall Study||6
1728691|NCT00248794|4233020|P3|COMPLETED|Overall Study||7
1728692|NCT00248794|4233021|P2|COMPLETED|Overall Study||16
1728693|NCT00248794|4233022|P1|COMPLETED|Overall Study||19
1728694|NCT00248794|4233020|P3|STARTED|Overall Study||10
1728695|NCT00248794|4233021|P2|STARTED|Overall Study||24
1728696|NCT00248794|4233022|P1|STARTED|Overall Study||25
1728697|NCT00248781|4233044|P2|NOT COMPLETED|Overall Study||4
1728698|NCT00248781|4233045|P1|NOT COMPLETED|Overall Study||10
1728699|NCT00248781|4233044|P2|COMPLETED|Overall Study||47
1728700|NCT00248781|4233045|P1|COMPLETED|Overall Study||42
1728701|NCT00248781|4233044|P2|STARTED|Overall Study||51
1728702|NCT00248781|4233045|P1|STARTED|Overall Study||52
1728703|NCT00248651|4233072|P3|NOT COMPLETED|Overall Study||32
1728704|NCT00248651|4233073|P2|NOT COMPLETED|Overall Study||40
1728705|NCT00248651|4233074|P1|NOT COMPLETED|Overall Study||28
1728706|NCT00248651|4233072|P3|COMPLETED|Overall Study||65
1728707|NCT00248651|4233073|P2|COMPLETED|Overall Study||58
1728708|NCT00248651|4233074|P1|COMPLETED|Overall Study||69
1728709|NCT00248651|4233072|P3|Completed 12 Weeks of Treatment|Overall Study||75
1728710|NCT00248651|4233073|P2|Completed 12 Weeks of Treatment|Overall Study||66
1728711|NCT00248651|4233074|P1|Completed 12 Weeks of Treatment|Overall Study||78
1728712|NCT00248651|4233072|P3|STARTED|Overall Study||97
1728713|NCT00248651|4233073|P2|STARTED|Overall Study||98
1728714|NCT00248651|4233074|P1|STARTED|Overall Study||97
1728715|NCT00248638|4233093|P2|NOT COMPLETED|Overall Study||0
1728716|NCT00248638|4233094|P1|NOT COMPLETED|Overall Study||0
1728717|NCT00248638|4233093|P2|COMPLETED|Overall Study||75
1728718|NCT00248638|4233094|P1|COMPLETED|Overall Study||75
1728719|NCT00248638|4233093|P2|STARTED|Overall Study||75
1728720|NCT00248638|4233094|P1|STARTED|Overall Study||75
1728721|NCT00248625|4233110|P2|NOT COMPLETED|Overall Study||2
1728722|NCT00248625|4233111|P1|NOT COMPLETED|Overall Study||0
1728723|NCT00248625|4233110|P2|COMPLETED|Overall Study||90
1728724|NCT00248625|4233111|P1|COMPLETED|Overall Study||92
1728725|NCT00248625|4233110|P2|STARTED|Overall Study||92
1728726|NCT00248625|4233111|P1|STARTED|Overall Study||92
1728727|NCT00248612|4233135|P4|NOT COMPLETED|Overall Study||0
1728728|NCT00248612|4233136|P3|NOT COMPLETED|Overall Study||0
1728729|NCT00248612|4233137|P2|NOT COMPLETED|Overall Study||0
1728730|NCT00248612|4233138|P1|NOT COMPLETED|Overall Study||0
1728731|NCT00248612|4233135|P4|COMPLETED|Overall Study||22
1728732|NCT00248612|4233136|P3|COMPLETED|Overall Study||14
1728733|NCT00248612|4233137|P2|COMPLETED|Overall Study||21
1728734|NCT00248612|4233138|P1|COMPLETED|Overall Study||24
1728735|NCT00248612|4233135|P4|STARTED|Overall Study||22
1728736|NCT00248612|4233136|P3|STARTED|Overall Study||14
1728737|NCT00248612|4233137|P2|STARTED|Overall Study||21
1728738|NCT00248612|4233138|P1|STARTED|Overall Study||24
1728739|NCT00248560|4233180|P1|NOT COMPLETED|Overall Study||0
1728740|NCT00248560|4233180|P1|COMPLETED|Overall Study||36
1728741|NCT00248560|4233180|P1|STARTED|Overall Study||36
1728742|NCT00248547|4233186|P2|NOT COMPLETED|Overall Study||0
1728743|NCT00248547|4233187|P1|NOT COMPLETED|Overall Study||0
1728744|NCT00248547|4233186|P2|COMPLETED|Overall Study||20
1728745|NCT00248547|4233187|P1|COMPLETED|Overall Study||20
1728746|NCT00248547|4233186|P2|STARTED|Overall Study||20
1728747|NCT00248547|4233187|P1|STARTED|Overall Study||20
1728748|NCT00248534|4233193|P1|NOT COMPLETED|Overall Study||0
1728749|NCT00248534|4233193|P1|COMPLETED|Overall Study||16
1728750|NCT00248534|4233193|P1|STARTED|Overall Study||16
1728751|NCT00248495|4233200|P1|NOT COMPLETED|Overall Study||1
1728752|NCT00248495|4233200|P1|COMPLETED|Overall Study||37
1728753|NCT00248495|4233200|P1|STARTED|Overall Study||38
1728754|NCT00248287|4233211|P2|NOT COMPLETED|Overall Study||19
1728755|NCT00248287|4233212|P1|NOT COMPLETED|Overall Study||24
1728756|NCT00248287|4233211|P2|COMPLETED|Overall Study||60
1728757|NCT00248287|4233212|P1|COMPLETED|Overall Study||51
1728758|NCT00248287|4233211|P2|STARTED|Overall Study||79
1728759|NCT00248287|4233212|P1|STARTED|Overall Study||75
1728760|NCT00248170|4233226|P2|NOT COMPLETED|Overall Study||808
1728761|NCT00248170|4233227|P1|NOT COMPLETED|Overall Study||761
1728762|NCT00248170|4233226|P2|COMPLETED|Overall Study||1286
1728763|NCT00248170|4233227|P1|COMPLETED|Overall Study||1317
1728764|NCT00248170|4233226|P2|Safety Set|Overall Study||2062
1728765|NCT00248170|4233227|P1|Safety Set|Overall Study||2049
1728766|NCT00248170|4233226|P2|Intent-to-treat (ITT)|Overall Study||2075
1728767|NCT00248170|4233227|P1|Intent-to-treat (ITT)|Overall Study||2061
1728768|NCT00248170|4233226|P2|STARTED|Overall Study||2094
1728769|NCT00248170|4233227|P1|STARTED|Overall Study||2078
1728770|NCT00247962|4233249|P2|NOT COMPLETED|Overall Study||19
1728771|NCT00247962|4233250|P1|NOT COMPLETED|Overall Study||26
1728772|NCT00247962|4233249|P2|COMPLETED|Overall Study||168
1728773|NCT00247962|4233250|P1|COMPLETED|Overall Study||353
1728774|NCT00247962|4233249|P2|STARTED|Overall Study||187
1728775|NCT00247962|4233250|P1|STARTED|Overall Study||379
1728776|NCT00247676|4233258|P1|NOT COMPLETED|Overall Study||36
1728777|NCT00247676|4233258|P1|COMPLETED|Overall Study||1
1728778|NCT00247676|4233258|P1|STARTED|Overall Study||37
1728779|NCT00247624|4233288|P2|NOT COMPLETED|Overall Study||4
1728780|NCT00247624|4233289|P1|NOT COMPLETED|Overall Study||5
1728781|NCT00247624|4233288|P2|COMPLETED|Overall Study||26
1728782|NCT00247624|4233289|P1|COMPLETED|Overall Study||25
1728783|NCT00247624|4233288|P2|STARTED|Overall Study||30
1728784|NCT00247624|4233289|P1|STARTED|Overall Study||30
1728785|NCT00247611|4233303|P2|NOT COMPLETED|On Protocol Sample||125
1728786|NCT00247611|4233304|P1|NOT COMPLETED|On Protocol Sample||111
1728787|NCT00247611|4233303|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
1728788|NCT00247611|4233304|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
1728789|NCT00247611|4233303|P2|STARTED|On Protocol Sample|ITT sample participants|277
1728790|NCT00247611|4233304|P1|STARTED|On Protocol Sample|ITT sample participants|287
1728791|NCT00247611|4233303|P2|NOT COMPLETED|Intention to Treat Sample||13
1728792|NCT00247611|4233304|P1|NOT COMPLETED|Intention to Treat Sample||17
1728793|NCT00247611|4233303|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
1728794|NCT00247611|4233304|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
1728795|NCT00247611|4233303|P2|STARTED|Intention to Treat Sample|Participants randomized|290
1728796|NCT00247611|4233304|P1|STARTED|Intention to Treat Sample|Participants randomized|304
1728797|NCT00247611|4233303|P2|NOT COMPLETED|Baselined||13
1728798|NCT00247611|4233304|P1|NOT COMPLETED|Baselined||17
1728799|NCT00247611|4233303|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
1728800|NCT00247611|4233304|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
1728801|NCT00247611|4233303|P2|STARTED|Baselined|Participants randomized|290
1728802|NCT00247611|4233304|P1|STARTED|Baselined|Participants randomized|304
1728803|NCT00247416|4233322|P2|NOT COMPLETED|Overall Study||2
1728804|NCT00247416|4233323|P1|NOT COMPLETED|Overall Study||1
1728805|NCT00247416|4233322|P2|COMPLETED|Overall Study||31
1728806|NCT00247416|4233323|P1|COMPLETED|Overall Study||25
1728807|NCT00247416|4233322|P2|STARTED|Overall Study||33
1728808|NCT00247416|4233323|P1|STARTED|Overall Study||26
1728809|NCT00247377|4233337|P2|NOT COMPLETED|Overall Study||0
1728810|NCT00247377|4233338|P1|NOT COMPLETED|Overall Study||0
1728811|NCT00247377|4233337|P2|COMPLETED|Overall Study||86
1728812|NCT00247377|4233338|P1|COMPLETED|Overall Study||111
1728813|NCT00247377|4233337|P2|STARTED|Overall Study||86
1728814|NCT00247377|4233338|P1|STARTED|Overall Study||111
1728815|NCT00247273|4233364|P2|NOT COMPLETED|Overall Study||137
1728816|NCT00247273|4233365|P1|NOT COMPLETED|Overall Study||146
1728817|NCT00247273|4233364|P2|COMPLETED|Overall Study||513
1728818|NCT00247273|4233365|P1|COMPLETED|Overall Study||498
1728819|NCT00247273|4233364|P2|Intent to Treat Population|Overall Study||650
1728820|NCT00247273|4233365|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
1728821|NCT00247273|4233364|P2|STARTED|Overall Study||650
1728822|NCT00247273|4233365|P1|STARTED|Overall Study||644
1728823|NCT00246805|4233411|P2|NOT COMPLETED|Phase 2||0
1728824|NCT00246805|4233412|P1|NOT COMPLETED|Phase 2||0
1728825|NCT00246805|4233411|P2|COMPLETED|Phase 2||33
1728826|NCT00246805|4233412|P1|COMPLETED|Phase 2||33
1728827|NCT00246805|4233411|P2|STARTED|Phase 2||33
1728828|NCT00246805|4233412|P1|STARTED|Phase 2||33
1728829|NCT00246805|4233411|P2|NOT COMPLETED|Phase 1||0
1728830|NCT00246805|4233412|P1|NOT COMPLETED|Phase 1||1
1728831|NCT00246805|4233411|P2|COMPLETED|Phase 1||33
1728832|NCT00246805|4233412|P1|COMPLETED|Phase 1||33
1728833|NCT00246805|4233411|P2|STARTED|Phase 1||33
1728834|NCT00246805|4233412|P1|STARTED|Phase 1||34
1728835|NCT00246753|4233418|P1|NOT COMPLETED|Overall Study||8
1728836|NCT00246753|4233418|P1|COMPLETED|Overall Study||21
1728837|NCT00246753|4233418|P1|STARTED|Overall Study||29
1728838|NCT00246740|4233426|P2|NOT COMPLETED|Experimental Phase||0
1728839|NCT00246740|4233427|P1|NOT COMPLETED|Experimental Phase||0
1728840|NCT00246740|4233426|P2|COMPLETED|Experimental Phase||20
1728841|NCT00246740|4233427|P1|COMPLETED|Experimental Phase||22
1728842|NCT00246740|4233426|P2|STARTED|Experimental Phase||20
1728843|NCT00246740|4233427|P1|STARTED|Experimental Phase||22
1728844|NCT00246740|4233426|P2|NOT COMPLETED|Initial Enrollment||8
1728845|NCT00246740|4233427|P1|NOT COMPLETED|Initial Enrollment||6
1728846|NCT00246740|4233426|P2|COMPLETED|Initial Enrollment||20
1728847|NCT00246740|4233427|P1|COMPLETED|Initial Enrollment||22
1728848|NCT00246740|4233426|P2|STARTED|Initial Enrollment||28
1728849|NCT00246740|4233427|P1|STARTED|Initial Enrollment||28
1728850|NCT00246571|4233451|P2|NOT COMPLETED|Overall Study||104
1728851|NCT00246571|4233452|P1|NOT COMPLETED|Overall Study||113
1728852|NCT00246571|4233451|P2|COMPLETED|Overall Study||0
1728853|NCT00246571|4233452|P1|COMPLETED|Overall Study||0
1728854|NCT00246571|4233451|P2|Randomized But Not Treated|Overall Study||1
1728855|NCT00246571|4233452|P1|Randomized But Not Treated|Overall Study||3
1728856|NCT00246571|4233451|P2|STARTED|Overall Study||104
1728857|NCT00246571|4233452|P1|STARTED|Overall Study||113
1728858|NCT00246519|4233492|P2|NOT COMPLETED|Overall Study||64
1728859|NCT00246519|4233493|P1|NOT COMPLETED|Overall Study||56
1728860|NCT00246519|4233492|P2|COMPLETED|Overall Study||382
1728861|NCT00246519|4233493|P1|COMPLETED|Overall Study||386
1728862|NCT00246519|4233492|P2|STARTED|Overall Study||446
1728863|NCT00246519|4233493|P1|STARTED|Overall Study||442
1728864|NCT00246441|4233501|P2|NOT COMPLETED|Overall Study||0
1728865|NCT00246441|4233502|P1|NOT COMPLETED|Overall Study||1
1728866|NCT00246441|4233501|P2|COMPLETED|Overall Study||22
1728867|NCT00246441|4233502|P1|COMPLETED|Overall Study||19
1728868|NCT00246441|4233501|P2|STARTED|Overall Study||22
1728869|NCT00246441|4233502|P1|STARTED|Overall Study||20
1728870|NCT00246376|4233517|P5|NOT COMPLETED|Overall Study||17
1728871|NCT00246376|4233518|P4|NOT COMPLETED|Overall Study||26
1728872|NCT00246376|4233519|P3|NOT COMPLETED|Overall Study||16
1728873|NCT00246376|4233520|P2|NOT COMPLETED|Overall Study||19
1728874|NCT00246376|4233521|P1|NOT COMPLETED|Overall Study||15
1728875|NCT00246376|4233517|P5|COMPLETED|Overall Study||28
1728876|NCT00246376|4233518|P4|COMPLETED|Overall Study||21
1728877|NCT00246376|4233519|P3|COMPLETED|Overall Study||29
1728878|NCT00246376|4233520|P2|COMPLETED|Overall Study||24
1728879|NCT00246376|4233521|P1|COMPLETED|Overall Study||26
1728880|NCT00246376|4233517|P5|After Dietary run-in at Two Weeks|Overall Study||42
1728881|NCT00246376|4233518|P4|After Dietary run-in at Two Weeks|Overall Study||40
1728882|NCT00246376|4233519|P3|After Dietary run-in at Two Weeks|Overall Study||41
1728883|NCT00246376|4233520|P2|After Dietary run-in at Two Weeks|Overall Study||38
1728884|NCT00246376|4233521|P1|After Dietary run-in at Two Weeks|Overall Study||30
1728885|NCT00246376|4233517|P5|STARTED|Overall Study||45
1728886|NCT00246376|4233518|P4|STARTED|Overall Study||47
1728887|NCT00246376|4233519|P3|STARTED|Overall Study||45
1728888|NCT00246376|4233520|P2|STARTED|Overall Study||43
1728889|NCT00246376|4233521|P1|STARTED|Overall Study||41
1728890|NCT00246337|4233572|P9|NOT COMPLETED|Overall Study||11
1728891|NCT00246337|4233573|P8|NOT COMPLETED|Overall Study||13
1728892|NCT00246337|4233574|P7|NOT COMPLETED|Overall Study||9
1728893|NCT00246337|4233575|P6|NOT COMPLETED|Overall Study||15
1728894|NCT00246337|4233576|P5|NOT COMPLETED|Overall Study||4
1728895|NCT00246337|4233577|P4|NOT COMPLETED|Overall Study||1
1728896|NCT00246337|4233578|P3|NOT COMPLETED|Overall Study||3
1728897|NCT00246337|4233579|P2|NOT COMPLETED|Overall Study||2
1728898|NCT00246337|4233580|P1|NOT COMPLETED|Overall Study||32
1728899|NCT00246337|4233572|P9|COMPLETED|Overall Study||34
1728900|NCT00246337|4233573|P8|COMPLETED|Overall Study||40
1728901|NCT00246337|4233574|P7|COMPLETED|Overall Study||45
1728902|NCT00246337|4233575|P6|COMPLETED|Overall Study||39
1728903|NCT00246337|4233576|P5|COMPLETED|Overall Study||12
1728904|NCT00246337|4233577|P4|COMPLETED|Overall Study||16
1728905|NCT00246337|4233578|P3|COMPLETED|Overall Study||15
1728906|NCT00246337|4233579|P2|COMPLETED|Overall Study||14
1728907|NCT00246337|4233580|P1|COMPLETED|Overall Study||115
1728908|NCT00246337|4233572|P9|Completed Period (Both Doses)|Overall Study||15
1728909|NCT00246337|4233573|P8|Completed Period (Both Doses)|Overall Study||13
1728910|NCT00246337|4233574|P7|Completed Period (Both Doses)|Overall Study||16
1728911|NCT00246337|4233575|P6|Completed Period (Both Doses)|Overall Study||10
1728912|NCT00246337|4233576|P5|Completed Period (Both Doses)|Overall Study||4
1728913|NCT00246337|4233577|P4|Completed Period (Both Doses)|Overall Study||11
1728914|NCT00246337|4233578|P3|Completed Period (Both Doses)|Overall Study||6
1728915|NCT00246337|4233579|P2|Completed Period (Both Doses)|Overall Study||10
1728916|NCT00246337|4233580|P1|Completed Period (Both Doses)|Overall Study||69
1728917|NCT00246337|4233572|P9|Completed Period (Initial Dose)|Overall Study||19
1728918|NCT00246337|4233573|P8|Completed Period (Initial Dose)|Overall Study||27
1728919|NCT00246337|4233574|P7|Completed Period (Initial Dose)|Overall Study||29
1728920|NCT00246337|4233575|P6|Completed Period (Initial Dose)|Overall Study||29
1728921|NCT00246337|4233576|P5|Completed Period (Initial Dose)|Overall Study||8
1728922|NCT00246337|4233577|P4|Completed Period (Initial Dose)|Overall Study||5
1728923|NCT00246337|4233578|P3|Completed Period (Initial Dose)|Overall Study||9
1728924|NCT00246337|4233579|P2|Completed Period (Initial Dose)|Overall Study||4
1728925|NCT00246337|4233580|P1|Completed Period (Initial Dose)|Overall Study||46
1728926|NCT00246337|4233572|P9|STARTED|Overall Study||45
1728927|NCT00246337|4233573|P8|STARTED|Overall Study||53
1728928|NCT00246337|4233574|P7|STARTED|Overall Study||54
1728929|NCT00246337|4233575|P6|STARTED|Overall Study||54
1728930|NCT00246337|4233576|P5|STARTED|Overall Study||16
1728931|NCT00246337|4233577|P4|STARTED|Overall Study||17
1728932|NCT00246337|4233578|P3|STARTED|Overall Study||18
1728933|NCT00246337|4233579|P2|STARTED|Overall Study||16
1728934|NCT00246337|4233580|P1|STARTED|Overall Study||147
1728935|NCT00246324|4233627|P1|NOT COMPLETED|Overall Study||1
1728936|NCT00246324|4233627|P1|COMPLETED|Overall Study||15
1728937|NCT00246324|4233627|P1|STARTED|Overall Study||16
1728938|NCT00246259|4233634|P2|NOT COMPLETED|Overall Study||26
1728939|NCT00246259|4233635|P1|NOT COMPLETED|Overall Study||28
1728940|NCT00246259|4233634|P2|COMPLETED|Overall Study||15
1728941|NCT00246259|4233635|P1|COMPLETED|Overall Study||16
1728942|NCT00246259|4233634|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
1728943|NCT00246259|4233635|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
1728944|NCT00246259|4233634|P2|STARTED|Overall Study||41
1728945|NCT00246259|4233635|P1|STARTED|Overall Study||44
1728946|NCT00246090|4233669|P1|NOT COMPLETED|Overall Study||295
1728947|NCT00246090|4233669|P1|COMPLETED|Overall Study||3
1728948|NCT00246090|4233669|P1|STARTED|Overall Study||298
1728949|NCT00246025|4233678|P4|NOT COMPLETED|Overall Study||13
1728950|NCT00246025|4233679|P3|NOT COMPLETED|Overall Study||10
1728951|NCT00246025|4233680|P2|NOT COMPLETED|Overall Study||9
1728952|NCT00246025|4233681|P1|NOT COMPLETED|Overall Study||10
1728953|NCT00246025|4233678|P4|COMPLETED|Overall Study||116
1728954|NCT00246025|4233679|P3|COMPLETED|Overall Study||116
1728955|NCT00246025|4233680|P2|COMPLETED|Overall Study||124
1728956|NCT00246025|4233681|P1|COMPLETED|Overall Study||114
1728957|NCT00246025|4233678|P4|STARTED|Overall Study||129
1728958|NCT00246025|4233679|P3|STARTED|Overall Study||126
1728959|NCT00246025|4233680|P2|STARTED|Overall Study||133
1728960|NCT00246025|4233681|P1|STARTED|Overall Study||124
1728961|NCT00246012|4233740|P9|NOT COMPLETED|Overall Study||28
1728962|NCT00246012|4233741|P8|NOT COMPLETED|Overall Study||28
1728963|NCT00246012|4233742|P7|NOT COMPLETED|Overall Study||31
1728964|NCT00246012|4233743|P6|NOT COMPLETED|Overall Study||28
1728965|NCT00246012|4233744|P5|NOT COMPLETED|Overall Study||3
1728966|NCT00246012|4233745|P4|NOT COMPLETED|Overall Study||3
1728967|NCT00246012|4233746|P3|NOT COMPLETED|Overall Study||2
1728968|NCT00246012|4233747|P2|NOT COMPLETED|Overall Study||1
1728969|NCT00246012|4233748|P1|NOT COMPLETED|Overall Study||3
1728970|NCT00246012|4233740|P9|COMPLETED|Overall Study||4
1728971|NCT00246012|4233741|P8|COMPLETED|Overall Study||5
1728972|NCT00246012|4233742|P7|COMPLETED|Overall Study||1
1728973|NCT00246012|4233743|P6|COMPLETED|Overall Study||4
1728974|NCT00246012|4233744|P5|COMPLETED|Overall Study||0
1728975|NCT00246012|4233745|P4|COMPLETED|Overall Study||0
1728976|NCT00246012|4233746|P3|COMPLETED|Overall Study||1
1728977|NCT00246012|4233747|P2|COMPLETED|Overall Study||2
1728978|NCT00246012|4233748|P1|COMPLETED|Overall Study||0
1728979|NCT00246012|4233740|P9|Treated|Overall Study||32
1728980|NCT00246012|4233741|P8|Treated|Overall Study||33
1728981|NCT00246012|4233742|P7|Treated|Overall Study||31
1728982|NCT00246012|4233743|P6|Treated|Overall Study||31
1728983|NCT00246012|4233744|P5|Treated|Overall Study||3
1728984|NCT00246012|4233745|P4|Treated|Overall Study||3
1728985|NCT00246012|4233746|P3|Treated|Overall Study||3
1728986|NCT00246012|4233747|P2|Treated|Overall Study||3
1728987|NCT00246012|4233748|P1|Treated|Overall Study||3
1728988|NCT00246012|4233740|P9|STARTED|Overall Study||32
1728989|NCT00246012|4233741|P8|STARTED|Overall Study||33
1728990|NCT00246012|4233742|P7|STARTED|Overall Study||32
1728991|NCT00246012|4233743|P6|STARTED|Overall Study||32
1728992|NCT00246012|4233744|P5|STARTED|Overall Study||3
1728993|NCT00246012|4233745|P4|STARTED|Overall Study||3
1728994|NCT00246012|4233746|P3|STARTED|Overall Study||3
1728995|NCT00246012|4233747|P2|STARTED|Overall Study||3
1728996|NCT00246012|4233748|P1|STARTED|Overall Study||3
1728997|NCT00245960|4233843|P2|NOT COMPLETED|Overall Study||28
1728998|NCT00245960|4233844|P1|NOT COMPLETED|Overall Study||29
1728999|NCT00245960|4233843|P2|COMPLETED|Overall Study||345
1729000|NCT00245960|4233844|P1|COMPLETED|Overall Study||350
1729001|NCT00245960|4233843|P2|STARTED|Overall Study||373
1729002|NCT00245960|4233844|P1|STARTED|Overall Study||379
1729003|NCT00245856|4233852|P2|NOT COMPLETED|Period Two||1
1729004|NCT00245856|4233853|P1|NOT COMPLETED|Period Two||0
1729005|NCT00245856|4233852|P2|COMPLETED|Period Two||38
1729006|NCT00245856|4233853|P1|COMPLETED|Period Two||0
1729007|NCT00245856|4233852|P2|STARTED|Period Two||39
1729008|NCT00245856|4233853|P1|STARTED|Period Two||0
1729009|NCT00245856|4233852|P2|NOT COMPLETED|Period One||0
1729010|NCT00245856|4233853|P1|NOT COMPLETED|Period One||0
1729011|NCT00245856|4233852|P2|COMPLETED|Period One||0
1729012|NCT00245856|4233853|P1|COMPLETED|Period One||28
1729013|NCT00245856|4233852|P2|STARTED|Period One||0
1729014|NCT00245856|4233853|P1|STARTED|Period One||28
1729015|NCT00245635|4233862|P2|NOT COMPLETED|Overall Study||0
1729016|NCT00245635|4233863|P1|NOT COMPLETED|Overall Study||0
1729017|NCT00245635|4233862|P2|COMPLETED|Overall Study||18
1729018|NCT00245635|4233863|P1|COMPLETED|Overall Study||25
1729019|NCT00245635|4233862|P2|STARTED|Overall Study||18
1729020|NCT00245635|4233863|P1|STARTED|Overall Study||25
1729021|NCT00245570|4233869|P6|NOT COMPLETED|Treatment Period IV||0
1729022|NCT00245570|4233870|P5|NOT COMPLETED|Treatment Period IV||0
1729023|NCT00245570|4233871|P4|NOT COMPLETED|Treatment Period IV||0
1729024|NCT00245570|4233872|P3|NOT COMPLETED|Treatment Period IV||0
1729025|NCT00245570|4233873|P2|NOT COMPLETED|Treatment Period IV||0
1729026|NCT00245570|4233874|P1|NOT COMPLETED|Treatment Period IV||0
1729027|NCT00245570|4233869|P6|COMPLETED|Treatment Period IV||8
1729028|NCT00245570|4233870|P5|COMPLETED|Treatment Period IV||8
1729029|NCT00245570|4233871|P4|COMPLETED|Treatment Period IV||8
1729030|NCT00245570|4233872|P3|COMPLETED|Treatment Period IV||8
1729031|NCT00245570|4233873|P2|COMPLETED|Treatment Period IV||7
1729032|NCT00245570|4233874|P1|COMPLETED|Treatment Period IV||7
1729033|NCT00245570|4233869|P6|STARTED|Treatment Period IV||8
1729034|NCT00245570|4233870|P5|STARTED|Treatment Period IV||8
1729035|NCT00245570|4233871|P4|STARTED|Treatment Period IV||8
1729036|NCT00245570|4233872|P3|STARTED|Treatment Period IV||8
1729037|NCT00245570|4233873|P2|STARTED|Treatment Period IV||7
1729038|NCT00245570|4233874|P1|STARTED|Treatment Period IV||7
1729039|NCT00245570|4233869|P6|NOT COMPLETED|Washout Between Periods III and IV||0
1729040|NCT00245570|4233870|P5|NOT COMPLETED|Washout Between Periods III and IV||0
1729041|NCT00245570|4233871|P4|NOT COMPLETED|Washout Between Periods III and IV||0
1729042|NCT00245570|4233872|P3|NOT COMPLETED|Washout Between Periods III and IV||0
1729043|NCT00245570|4233873|P2|NOT COMPLETED|Washout Between Periods III and IV||1
1729044|NCT00245570|4233874|P1|NOT COMPLETED|Washout Between Periods III and IV||0
1729045|NCT00245570|4233869|P6|COMPLETED|Washout Between Periods III and IV||8
1729046|NCT00245570|4233870|P5|COMPLETED|Washout Between Periods III and IV||8
1729047|NCT00245570|4233871|P4|COMPLETED|Washout Between Periods III and IV||8
1729048|NCT00245570|4233872|P3|COMPLETED|Washout Between Periods III and IV||8
1729049|NCT00245570|4233873|P2|COMPLETED|Washout Between Periods III and IV||7
1729050|NCT00245570|4233874|P1|COMPLETED|Washout Between Periods III and IV||7
1729051|NCT00245570|4233869|P6|STARTED|Washout Between Periods III and IV||8
1729052|NCT00245570|4233870|P5|STARTED|Washout Between Periods III and IV||8
1729053|NCT00245570|4233871|P4|STARTED|Washout Between Periods III and IV||8
1729054|NCT00245570|4233872|P3|STARTED|Washout Between Periods III and IV||8
1729055|NCT00245570|4233873|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
1729056|NCT00245570|4233874|P1|STARTED|Washout Between Periods III and IV||7
1729057|NCT00245570|4233869|P6|NOT COMPLETED|Treatment Period III||0
1729058|NCT00245570|4233870|P5|NOT COMPLETED|Treatment Period III||0
1729059|NCT00245570|4233871|P4|NOT COMPLETED|Treatment Period III||0
1729060|NCT00245570|4233872|P3|NOT COMPLETED|Treatment Period III||0
1729061|NCT00245570|4233873|P2|NOT COMPLETED|Treatment Period III||0
1729062|NCT00245570|4233874|P1|NOT COMPLETED|Treatment Period III||0
1729063|NCT00245570|4233869|P6|COMPLETED|Treatment Period III||8
1729064|NCT00245570|4233870|P5|COMPLETED|Treatment Period III||8
1729065|NCT00245570|4233871|P4|COMPLETED|Treatment Period III||8
1729066|NCT00245570|4233872|P3|COMPLETED|Treatment Period III||8
1729067|NCT00245570|4233873|P2|COMPLETED|Treatment Period III||8
1729068|NCT00245570|4233874|P1|COMPLETED|Treatment Period III||7
1729069|NCT00245570|4233869|P6|STARTED|Treatment Period III||8
1729070|NCT00245570|4233870|P5|STARTED|Treatment Period III||8
1729071|NCT00245570|4233871|P4|STARTED|Treatment Period III||8
1729072|NCT00245570|4233872|P3|STARTED|Treatment Period III||8
1729073|NCT00245570|4233873|P2|STARTED|Treatment Period III||8
1729074|NCT00245570|4233874|P1|STARTED|Treatment Period III||7
1729075|NCT00245570|4233869|P6|NOT COMPLETED|Washout Between Periods II and III||0
1729076|NCT00245570|4233870|P5|NOT COMPLETED|Washout Between Periods II and III||0
1729077|NCT00245570|4233871|P4|NOT COMPLETED|Washout Between Periods II and III||0
1729078|NCT00245570|4233872|P3|NOT COMPLETED|Washout Between Periods II and III||0
1729079|NCT00245570|4233873|P2|NOT COMPLETED|Washout Between Periods II and III||0
1729080|NCT00245570|4233874|P1|NOT COMPLETED|Washout Between Periods II and III||0
1729081|NCT00245570|4233869|P6|COMPLETED|Washout Between Periods II and III||8
1729082|NCT00245570|4233870|P5|COMPLETED|Washout Between Periods II and III||8
1729083|NCT00245570|4233871|P4|COMPLETED|Washout Between Periods II and III||8
1729084|NCT00245570|4233872|P3|COMPLETED|Washout Between Periods II and III||8
1729085|NCT00245570|4233873|P2|COMPLETED|Washout Between Periods II and III||8
1729086|NCT00245570|4233874|P1|COMPLETED|Washout Between Periods II and III||7
1729087|NCT00245570|4233869|P6|STARTED|Washout Between Periods II and III||8
1729088|NCT00245570|4233870|P5|STARTED|Washout Between Periods II and III||8
1729089|NCT00245570|4233871|P4|STARTED|Washout Between Periods II and III||8
1729090|NCT00245570|4233872|P3|STARTED|Washout Between Periods II and III||8
1729091|NCT00245570|4233873|P2|STARTED|Washout Between Periods II and III||8
1729092|NCT00245570|4233874|P1|STARTED|Washout Between Periods II and III||7
1729093|NCT00245570|4233869|P6|NOT COMPLETED|Treatment Period II||0
1729094|NCT00245570|4233870|P5|NOT COMPLETED|Treatment Period II||0
1729095|NCT00245570|4233871|P4|NOT COMPLETED|Treatment Period II||0
1729096|NCT00245570|4233872|P3|NOT COMPLETED|Treatment Period II||0
1729097|NCT00245570|4233873|P2|NOT COMPLETED|Treatment Period II||0
1729098|NCT00245570|4233874|P1|NOT COMPLETED|Treatment Period II||0
1729099|NCT00245570|4233869|P6|COMPLETED|Treatment Period II||8
1729100|NCT00245570|4233870|P5|COMPLETED|Treatment Period II||8
1729101|NCT00245570|4233871|P4|COMPLETED|Treatment Period II||8
1729102|NCT00245570|4233872|P3|COMPLETED|Treatment Period II||8
1729103|NCT00245570|4233873|P2|COMPLETED|Treatment Period II||8
1729104|NCT00245570|4233874|P1|COMPLETED|Treatment Period II||7
1729105|NCT00245570|4233869|P6|STARTED|Treatment Period II||8
1729106|NCT00245570|4233870|P5|STARTED|Treatment Period II||8
1729107|NCT00245570|4233871|P4|STARTED|Treatment Period II||8
1729108|NCT00245570|4233872|P3|STARTED|Treatment Period II||8
1729109|NCT00245570|4233873|P2|STARTED|Treatment Period II||8
1729110|NCT00245570|4233874|P1|STARTED|Treatment Period II||7
1729111|NCT00245557|4233920|P2|NOT COMPLETED|Overall Study||16
1729112|NCT00245557|4233921|P1|NOT COMPLETED|Overall Study||6
1729113|NCT00245557|4233920|P2|COMPLETED|Overall Study||10
1729114|NCT00245557|4233921|P1|COMPLETED|Overall Study||11
1729115|NCT00245557|4233920|P2|STARTED|Overall Study||26
1729116|NCT00245557|4233921|P1|STARTED|Overall Study||17
1729117|NCT00245518|4233934|P2|NOT COMPLETED|Overall Study||0
1729118|NCT00245518|4233935|P1|NOT COMPLETED|Overall Study||0
1729119|NCT00245518|4233934|P2|COMPLETED|Overall Study||16
1729120|NCT00245518|4233935|P1|COMPLETED|Overall Study||17
1729121|NCT00245518|4233934|P2|STARTED|Overall Study||16
1729122|NCT00245518|4233935|P1|STARTED|Overall Study||17
1729123|NCT00245466|4234008|P3|NOT COMPLETED|Overall Study||37
1729124|NCT00245466|4234009|P2|NOT COMPLETED|Overall Study||44
1729125|NCT00245466|4234010|P1|NOT COMPLETED|Overall Study||36
1729126|NCT00245466|4234008|P3|COMPLETED|Overall Study||3
1729127|NCT00245466|4234009|P2|COMPLETED|Overall Study||2
1729128|NCT00245466|4234010|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
1729129|NCT00245466|4234008|P3|Started FE200486 CS02A|Overall Study||26
1729130|NCT00245466|4234009|P2|Started FE200486 CS02A|Overall Study||30
1729131|NCT00245466|4234010|P1|Started FE200486 CS02A|Overall Study||32
1729132|NCT00245466|4234008|P3|STARTED|Overall Study||40
1729133|NCT00245466|4234009|P2|STARTED|Overall Study||46
1729134|NCT00245466|4234010|P1|STARTED|Overall Study||43
1729135|NCT00245219|4234027|P3|NOT COMPLETED|Overall Study||2
1729136|NCT00245219|4234028|P2|NOT COMPLETED|Overall Study||6
1729137|NCT00245219|4234029|P1|NOT COMPLETED|Overall Study||6
1729138|NCT00245219|4234027|P3|COMPLETED|Overall Study||58
1729139|NCT00245219|4234028|P2|COMPLETED|Overall Study||88
1729140|NCT00245219|4234029|P1|COMPLETED|Overall Study||85
1729141|NCT00245219|4234027|P3|STARTED|Overall Study||60
1729142|NCT00245219|4234028|P2|STARTED|Overall Study||94
1729143|NCT00245219|4234029|P1|STARTED|Overall Study||91
1729144|NCT00245128|4234043|P1|NOT COMPLETED|Overall Study||10
1729145|NCT00245128|4234043|P1|COMPLETED|Overall Study||0
1729146|NCT00245128|4234043|P1|STARTED|Overall Study||10
1729147|NCT00245102|4234053|P6|NOT COMPLETED|Overall Study||4
1729148|NCT00245102|4234054|P5|NOT COMPLETED|Overall Study||0
1729149|NCT00245102|4234055|P4|NOT COMPLETED|Overall Study||3
1729150|NCT00245102|4234056|P3|NOT COMPLETED|Overall Study||7
1729151|NCT00245102|4234057|P2|NOT COMPLETED|Overall Study||4
1729152|NCT00245102|4234058|P1|NOT COMPLETED|Overall Study||7
1729153|NCT00245102|4234053|P6|COMPLETED|Overall Study||19
1729154|NCT00245102|4234054|P5|COMPLETED|Overall Study||5
1729155|NCT00245102|4234055|P4|COMPLETED|Overall Study||10
1729156|NCT00245102|4234056|P3|COMPLETED|Overall Study||39
1729157|NCT00245102|4234057|P2|COMPLETED|Overall Study||12
1729158|NCT00245102|4234058|P1|COMPLETED|Overall Study||37
1729159|NCT00245102|4234053|P6|STARTED|Overall Study||23
1729160|NCT00245102|4234054|P5|STARTED|Overall Study||5
1729161|NCT00245102|4234055|P4|STARTED|Overall Study||13
1729162|NCT00245102|4234056|P3|STARTED|Overall Study||46
1729163|NCT00245102|4234057|P2|STARTED|Overall Study||16
1729164|NCT00245102|4234058|P1|STARTED|Overall Study||44
1729165|NCT00245063|4234074|P2|NOT COMPLETED|Overall Study||5
1729166|NCT00245063|4234075|P1|NOT COMPLETED|Overall Study||7
1729167|NCT00245063|4234074|P2|COMPLETED|Overall Study||8
1729168|NCT00245063|4234075|P1|COMPLETED|Overall Study||5
1729169|NCT00245063|4234074|P2|STARTED|Overall Study||13
1729170|NCT00245063|4234075|P1|STARTED|Overall Study||12
1729171|NCT00245050|4234083|P2|NOT COMPLETED|Overall Study||2
1729172|NCT00245050|4234084|P1|NOT COMPLETED|Overall Study||3
1729173|NCT00245050|4234083|P2|COMPLETED|Overall Study||14
1729174|NCT00245050|4234084|P1|COMPLETED|Overall Study||15
1729175|NCT00245050|4234083|P2|STARTED|Overall Study||16
1729176|NCT00245050|4234084|P1|STARTED|Overall Study||18
1729177|NCT00245037|4234092|P1|NOT COMPLETED|Overall Study||17
1729178|NCT00245037|4234092|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
1729179|NCT00245037|4234092|P1|STARTED|Overall Study||147
1729180|NCT00245011|4234102|P1|NOT COMPLETED|Overall Study||1
1729181|NCT00245011|4234102|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
1729182|NCT00245011|4234102|P1|STARTED|Overall Study||11
1729183|NCT00244985|4234106|P1|NOT COMPLETED|Overall Study||0
1729184|NCT00244985|4234106|P1|COMPLETED|Overall Study||42
1729185|NCT00244985|4234106|P1|STARTED|Overall Study||42
1729186|NCT00244933|4234114|P1|NOT COMPLETED|Overall Study||2
1729187|NCT00244933|4234114|P1|COMPLETED|Overall Study||17
1729188|NCT00244933|4234114|P1|STARTED|Overall Study||19
1729189|NCT00244881|4234118|P1|NOT COMPLETED|Overall Study||3
1729190|NCT00244881|4234118|P1|COMPLETED|Overall Study||23
1729191|NCT00244881|4234118|P1|STARTED|Overall Study||26
1729192|NCT00244855|4234126|P2|NOT COMPLETED|Overall Study||1
1729193|NCT00244855|4234127|P1|NOT COMPLETED|Overall Study||0
1729194|NCT00244855|4234126|P2|COMPLETED|Overall Study||24
1729195|NCT00244855|4234127|P1|COMPLETED|Overall Study||7
1729196|NCT00244855|4234126|P2|STARTED|Overall Study||25
1729197|NCT00244855|4234127|P1|STARTED|Overall Study||7
1729198|NCT00244764|4234135|P1|NOT COMPLETED|Overall Study||96
1729199|NCT00244764|4234135|P1|COMPLETED|Overall Study||129
1729200|NCT00244764|4234135|P1|STARTED|Overall Study||225
1729201|NCT00244751|4234145|P3|NOT COMPLETED|Overall Study||10
1729202|NCT00244751|4234146|P2|NOT COMPLETED|Overall Study||15
1729203|NCT00244751|4234147|P1|NOT COMPLETED|Overall Study||16
1729204|NCT00244751|4234145|P3|COMPLETED|Overall Study||78
1729205|NCT00244751|4234146|P2|COMPLETED|Overall Study||74
1729206|NCT00244751|4234147|P1|COMPLETED|Overall Study||72
1729207|NCT00244751|4234145|P3|STARTED|Overall Study||88
1729208|NCT00244751|4234146|P2|STARTED|Overall Study||89
1729209|NCT00244751|4234147|P1|STARTED|Overall Study||88
1729210|NCT00244725|4234248|P4|NOT COMPLETED|Overall Study||21
1729211|NCT00244725|4234249|P3|NOT COMPLETED|Overall Study||24
1729212|NCT00244725|4234250|P2|NOT COMPLETED|Overall Study||19
1729213|NCT00244725|4234251|P1|NOT COMPLETED|Overall Study||23
1729214|NCT00244725|4234248|P4|COMPLETED|Overall Study||216
1729215|NCT00244725|4234249|P3|COMPLETED|Overall Study||215
1729216|NCT00244725|4234250|P2|COMPLETED|Overall Study||226
1729217|NCT00244725|4234251|P1|COMPLETED|Overall Study||214
1729218|NCT00244725|4234248|P4|STARTED|Overall Study||237
1729219|NCT00244725|4234249|P3|STARTED|Overall Study||239
1729220|NCT00244725|4234250|P2|STARTED|Overall Study||245
1729221|NCT00244725|4234251|P1|STARTED|Overall Study||237
1729222|NCT00244712|4234307|P2|NOT COMPLETED|Overall Study||124
1729223|NCT00244712|4234308|P1|NOT COMPLETED|Overall Study||109
1729224|NCT00244712|4234307|P2|COMPLETED|Overall Study||221
1729225|NCT00244712|4234308|P1|COMPLETED|Overall Study||234
1729226|NCT00244712|4234307|P2|STARTED|Overall Study||345
1729227|NCT00244712|4234308|P1|STARTED|Overall Study||343
1729228|NCT00244621|4234343|P3|NOT COMPLETED|Open-label Treatment Period||2
1729229|NCT00244621|4234344|P2|NOT COMPLETED|Open-label Treatment Period||1
1729230|NCT00244621|4234345|P1|NOT COMPLETED|Open-label Treatment Period||1
1729231|NCT00244621|4234343|P3|COMPLETED|Open-label Treatment Period||28
1729232|NCT00244621|4234344|P2|COMPLETED|Open-label Treatment Period||28
1729233|NCT00244621|4234345|P1|COMPLETED|Open-label Treatment Period||25
1729234|NCT00244621|4234343|P3|STARTED|Open-label Treatment Period||30
1729235|NCT00244621|4234344|P2|STARTED|Open-label Treatment Period||29
1729236|NCT00244621|4234345|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
1729237|NCT00244621|4234343|P3|NOT COMPLETED|Double-blind Treatment Period||2
1729238|NCT00244621|4234344|P2|NOT COMPLETED|Double-blind Treatment Period||3
1729239|NCT00244621|4234345|P1|NOT COMPLETED|Double-blind Treatment Period||2
1729240|NCT00244621|4234343|P3|COMPLETED|Double-blind Treatment Period||30
1729241|NCT00244621|4234344|P2|COMPLETED|Double-blind Treatment Period||29
1729242|NCT00244621|4234345|P1|COMPLETED|Double-blind Treatment Period||27
1729243|NCT00244621|4234343|P3|STARTED|Double-blind Treatment Period||32
1729244|NCT00244621|4234344|P2|STARTED|Double-blind Treatment Period||32
1729245|NCT00244621|4234345|P1|STARTED|Double-blind Treatment Period||29
1729246|NCT00244374|4234362|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
1729247|NCT00244374|4234363|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
1729248|NCT00244374|4234364|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
1729249|NCT00244374|4234365|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
1729250|NCT00244374|4234366|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
1729251|NCT00244374|4234362|P5|COMPLETED|Vaccine Adherence Cohort||41
1729252|NCT00244374|4234363|P4|COMPLETED|Vaccine Adherence Cohort||36
1729253|NCT00244374|4234364|P3|COMPLETED|Vaccine Adherence Cohort||43
1729254|NCT00244374|4234365|P2|COMPLETED|Vaccine Adherence Cohort||47
1729255|NCT00244374|4234366|P1|COMPLETED|Vaccine Adherence Cohort||0
1729256|NCT00244374|4234362|P5|STARTED|Vaccine Adherence Cohort||41
1729257|NCT00244374|4234363|P4|STARTED|Vaccine Adherence Cohort||36
1729258|NCT00244374|4234364|P3|STARTED|Vaccine Adherence Cohort||43
1729259|NCT00244374|4234365|P2|STARTED|Vaccine Adherence Cohort||47
1729260|NCT00244374|4234366|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
1729261|NCT00244374|4234362|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1729262|NCT00244374|4234363|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1729263|NCT00244374|4234364|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1729264|NCT00244374|4234365|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1729265|NCT00244374|4234366|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
1729266|NCT00244374|4234362|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1729267|NCT00244374|4234363|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1729268|NCT00244374|4234364|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1729269|NCT00244374|4234365|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
1729270|NCT00244374|4234366|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
1729271|NCT00244374|4234362|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
1729272|NCT00244374|4234363|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
1729273|NCT00244374|4234364|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
1729274|NCT00244374|4234365|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
1729275|NCT00244374|4234366|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
1729276|NCT00244374|4234362|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
1729277|NCT00244374|4234363|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
1729278|NCT00244374|4234364|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
1729279|NCT00244374|4234365|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
1729280|NCT00244374|4234366|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
1729281|NCT00244374|4234362|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
1729282|NCT00244374|4234363|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
1729283|NCT00244374|4234364|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
1729284|NCT00244374|4234365|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
1729285|NCT00244374|4234366|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
1729286|NCT00244374|4234362|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
1729287|NCT00244374|4234363|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
1729288|NCT00244374|4234364|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
1729289|NCT00244374|4234365|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
1729290|NCT00244374|4234366|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
1729291|NCT00244374|4234362|P5|STARTED|Pre-Randomization Cross-sectional Study||0
1729292|NCT00244374|4234363|P4|STARTED|Pre-Randomization Cross-sectional Study||0
1729293|NCT00244374|4234364|P3|STARTED|Pre-Randomization Cross-sectional Study||0
1729294|NCT00244374|4234365|P2|STARTED|Pre-Randomization Cross-sectional Study||0
1729295|NCT00244374|4234366|P1|STARTED|Pre-Randomization Cross-sectional Study||546
1729296|NCT00244140|4234384|P2|NOT COMPLETED|Overall Study||0
1729297|NCT00244140|4234385|P1|NOT COMPLETED|Overall Study||0
1729298|NCT00244140|4234384|P2|COMPLETED|Overall Study||22
1729299|NCT00244140|4234385|P1|COMPLETED|Overall Study||412
1729300|NCT00244140|4234384|P2|STARTED|Overall Study||22
1729301|NCT00244140|4234385|P1|STARTED|Overall Study||412
1729302|NCT00244101|4234400|P3|NOT COMPLETED|Overall Study||0
1729303|NCT00244101|4234401|P2|NOT COMPLETED|Overall Study||0
1729304|NCT00244101|4234402|P1|NOT COMPLETED|Overall Study||0
1729305|NCT00244101|4234400|P3|COMPLETED|Overall Study||216
1729306|NCT00244101|4234401|P2|COMPLETED|Overall Study||223
1729307|NCT00244101|4234402|P1|COMPLETED|Overall Study||209
1729308|NCT00244101|4234400|P3|STARTED|Overall Study||216
1729309|NCT00244101|4234401|P2|STARTED|Overall Study||223
1729310|NCT00244101|4234402|P1|STARTED|Overall Study||209
1729311|NCT00244010|4234412|P2|NOT COMPLETED|Overall Study||0
1729312|NCT00244010|4234413|P1|NOT COMPLETED|Overall Study||0
1729313|NCT00244010|4234412|P2|COMPLETED|Overall Study||2
1729314|NCT00244010|4234413|P1|COMPLETED|Overall Study||2
1729315|NCT00244010|4234412|P2|STARTED|Overall Study||2
1729316|NCT00244010|4234413|P1|STARTED|Overall Study||2
1729317|NCT00243932|4234422|P3|NOT COMPLETED|Stage 2: Efficacy||0
1729318|NCT00243932|4234423|P2|NOT COMPLETED|Stage 2: Efficacy||0
1729319|NCT00243932|4234424|P1|NOT COMPLETED|Stage 2: Efficacy||0
1729320|NCT00243932|4234422|P3|COMPLETED|Stage 2: Efficacy||0
1729321|NCT00243932|4234423|P2|COMPLETED|Stage 2: Efficacy||40
1729322|NCT00243932|4234424|P1|COMPLETED|Stage 2: Efficacy||40
1729323|NCT00243932|4234422|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
1729324|NCT00243932|4234423|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
1729325|NCT00243932|4234424|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
1729326|NCT00243932|4234422|P3|NOT COMPLETED|Stage 1: Dose Selection||0
1729327|NCT00243932|4234423|P2|NOT COMPLETED|Stage 1: Dose Selection||0
1729328|NCT00243932|4234424|P1|NOT COMPLETED|Stage 1: Dose Selection||2
1729329|NCT00243932|4234422|P3|COMPLETED|Stage 1: Dose Selection||35
1729330|NCT00243932|4234423|P2|COMPLETED|Stage 1: Dose Selection||35
1729331|NCT00243932|4234424|P1|COMPLETED|Stage 1: Dose Selection||33
1729332|NCT00243932|4234422|P3|STARTED|Stage 1: Dose Selection||35
1729333|NCT00243932|4234423|P2|STARTED|Stage 1: Dose Selection||35
1729334|NCT00243932|4234424|P1|STARTED|Stage 1: Dose Selection||35
1729335|NCT00243919|4234435|P3|NOT COMPLETED|Overall Study||11
1729336|NCT00243919|4234436|P2|NOT COMPLETED|Overall Study||18
1729337|NCT00243919|4234437|P1|NOT COMPLETED|Overall Study||17
1729338|NCT00243919|4234435|P3|COMPLETED|Overall Study||115
1729339|NCT00243919|4234436|P2|COMPLETED|Overall Study||125
1729340|NCT00243919|4234437|P1|COMPLETED|Overall Study||122
1729341|NCT00243919|4234435|P3|STARTED|Overall Study||126
1729342|NCT00243919|4234436|P2|STARTED|Overall Study||143
1729343|NCT00243919|4234437|P1|STARTED|Overall Study||139
1729344|NCT00243841|4234481|P6|NOT COMPLETED|Overall Study||2
1729345|NCT00243841|4234482|P5|NOT COMPLETED|Overall Study||0
1729346|NCT00243841|4234483|P4|NOT COMPLETED|Overall Study||0
1729347|NCT00243841|4234484|P3|NOT COMPLETED|Overall Study||1
1729348|NCT00243841|4234485|P2|NOT COMPLETED|Overall Study||0
1729349|NCT00243841|4234486|P1|NOT COMPLETED|Overall Study||0
1729350|NCT00243841|4234481|P6|COMPLETED|Overall Study||19
1729351|NCT00243841|4234482|P5|COMPLETED|Overall Study||39
1729352|NCT00243841|4234483|P4|COMPLETED|Overall Study||3
1729353|NCT00243841|4234484|P3|COMPLETED|Overall Study||4
1729354|NCT00243841|4234485|P2|COMPLETED|Overall Study||6
1729355|NCT00243841|4234486|P1|COMPLETED|Overall Study||3
1729356|NCT00243841|4234481|P6|STARTED|Overall Study||21
1729357|NCT00243841|4234482|P5|STARTED|Overall Study||39
1729358|NCT00243841|4234483|P4|STARTED|Overall Study||3
1729359|NCT00243841|4234484|P3|STARTED|Overall Study||5
1729360|NCT00243841|4234485|P2|STARTED|Overall Study||6
1729361|NCT00243841|4234486|P1|STARTED|Overall Study||3
1729362|NCT00243659|4234508|P2|NOT COMPLETED|Overall Study||3
1729363|NCT00243659|4234509|P1|NOT COMPLETED|Overall Study||2
1729364|NCT00243659|4234508|P2|COMPLETED|Overall Study||5
1729365|NCT00243659|4234509|P1|COMPLETED|Overall Study||20
1729366|NCT00243659|4234508|P2|STARTED|Overall Study||8
1729367|NCT00243659|4234509|P1|STARTED|Overall Study||22
1729368|NCT00243503|4234517|P1|NOT COMPLETED|Overall Study||58
1729369|NCT00243503|4234517|P1|COMPLETED|Overall Study||2
1729370|NCT00243503|4234517|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
1729371|NCT00243412|4234534|P2|NOT COMPLETED|Overall Study||11
1729372|NCT00243412|4234535|P1|NOT COMPLETED|Overall Study||10
1729373|NCT00243412|4234534|P2|COMPLETED|Overall Study|Completed Week 104|10
1729374|NCT00243412|4234535|P1|COMPLETED|Overall Study|Completed Week 104|11
1729375|NCT00243412|4234534|P2|Safety Evaluable|Overall Study||20
1729376|NCT00243412|4234535|P1|Safety Evaluable|Overall Study||21
1729377|NCT00243412|4234534|P2|STARTED|Overall Study|Intent to treat|21
1729378|NCT00243412|4234535|P1|STARTED|Overall Study|Intent to treat|21
1729379|NCT00243386|4234561|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
1729380|NCT00243386|4234562|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
1729381|NCT00243386|4234563|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
1729382|NCT00243386|4234561|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
1729383|NCT00243386|4234562|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
1729384|NCT00243386|4234563|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
1729385|NCT00243386|4234561|P3|STARTED|PK-Driven or Standard Prophylaxis||32
1729386|NCT00243386|4234562|P2|STARTED|PK-Driven or Standard Prophylaxis||34
1729387|NCT00243386|4234563|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1729388|NCT00243386|4234561|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
1729389|NCT00243386|4234562|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
1729390|NCT00243386|4234563|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
1729391|NCT00243386|4234561|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
1729392|NCT00243386|4234562|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
1729393|NCT00243386|4234563|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
1729394|NCT00243386|4234561|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1729395|NCT00243386|4234562|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1729396|NCT00243386|4234563|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
1729397|NCT00243386|4234561|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
1729398|NCT00243386|4234562|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
1729399|NCT00243386|4234563|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
1729400|NCT00243386|4234561|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
1729401|NCT00243386|4234562|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
1729402|NCT00243386|4234563|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
1729403|NCT00243386|4234561|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1729404|NCT00243386|4234562|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
1729405|NCT00243386|4234563|P1|STARTED|On-Demand Regimen (Study Part 1)||73
1729406|NCT00243347|4234628|P1|NOT COMPLETED|Overall Study||19
1729407|NCT00243347|4234628|P1|COMPLETED|Overall Study|Completed study|0
1729408|NCT00243347|4234628|P1|STARTED|Overall Study|Treated|19
1729409|NCT00243269|4234637|P4|NOT COMPLETED|Overall Study||4
1729410|NCT00243269|4234638|P3|NOT COMPLETED|Overall Study||1
1729411|NCT00243269|4234639|P2|NOT COMPLETED|Overall Study||1
1729412|NCT00243269|4234640|P1|NOT COMPLETED|Overall Study||3
1729413|NCT00243269|4234637|P4|COMPLETED|Overall Study||25
1729414|NCT00243269|4234638|P3|COMPLETED|Overall Study||11
1729415|NCT00243269|4234639|P2|COMPLETED|Overall Study||10
1729416|NCT00243269|4234640|P1|COMPLETED|Overall Study||28
1729417|NCT00243269|4234637|P4|STARTED|Overall Study||29
1729418|NCT00243269|4234638|P3|STARTED|Overall Study||12
1729419|NCT00243269|4234639|P2|STARTED|Overall Study||11
1729420|NCT00243269|4234640|P1|STARTED|Overall Study||31
1729421|NCT00243243|4234656|P2|NOT COMPLETED|Overall Study||0
1729422|NCT00243243|4234657|P1|NOT COMPLETED|Overall Study||0
1729423|NCT00243243|4234656|P2|COMPLETED|Overall Study||10
1729424|NCT00243243|4234657|P1|COMPLETED|Overall Study||10
1729425|NCT00243243|4234656|P2|STARTED|Overall Study||10
1729426|NCT00243243|4234657|P1|STARTED|Overall Study||10
1729427|NCT00243191|4234663|P1|NOT COMPLETED|Overall Study||0
1729428|NCT00243191|4234663|P1|COMPLETED|Overall Study||18
1729429|NCT00243191|4234663|P1|STARTED|Overall Study||18
1729430|NCT00243152|4234667|P2|NOT COMPLETED|Overall Study||0
1729431|NCT00243152|4234668|P1|NOT COMPLETED|Overall Study||0
1729432|NCT00243152|4234667|P2|COMPLETED|Overall Study||3
1729433|NCT00243152|4234668|P1|COMPLETED|Overall Study||3
1729434|NCT00243152|4234667|P2|Scan 2: Placebo or Drug|Overall Study||3
1729435|NCT00243152|4234668|P1|Scan 2: Placebo or Drug|Overall Study||3
1729436|NCT00243152|4234667|P2|Scan 1: Drug or Placebo|Overall Study||3
1729437|NCT00243152|4234668|P1|Scan 1: Drug or Placebo|Overall Study||3
1729438|NCT00243152|4234667|P2|STARTED|Overall Study||3
1729439|NCT00243152|4234668|P1|STARTED|Overall Study||3
1729440|NCT00243074|4234675|P1|NOT COMPLETED|Overall Study||54
1729441|NCT00243074|4234675|P1|COMPLETED|Overall Study||0
1729442|NCT00243074|4234675|P1|STARTED|Overall Study||54
1729443|NCT00243061|4234685|P1|NOT COMPLETED|Overall Study||0
1729444|NCT00243061|4234685|P1|COMPLETED|Overall Study||24
1729445|NCT00243061|4234685|P1|STARTED|Overall Study||24
1729446|NCT00243022|4234701|P2|NOT COMPLETED|Overall Study||1
1729447|NCT00243022|4234702|P1|NOT COMPLETED|Overall Study||2
1729448|NCT00243022|4234701|P2|COMPLETED|Overall Study||4
1729449|NCT00243022|4234702|P1|COMPLETED|Overall Study||5
1729450|NCT00243022|4234701|P2|STARTED|Overall Study||5
1729451|NCT00243022|4234702|P1|STARTED|Overall Study||7
1729452|NCT00242710|4234724|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
1729453|NCT00242710|4234725|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
1729454|NCT00242710|4234726|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
1729455|NCT00242710|4234727|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
1729456|NCT00242710|4234724|P4|COMPLETED|Study Extension (up to Year 2)||84
1729457|NCT00242710|4234725|P3|COMPLETED|Study Extension (up to Year 2)||69
1729458|NCT00242710|4234726|P2|COMPLETED|Study Extension (up to Year 2)||148
1729459|NCT00242710|4234727|P1|COMPLETED|Study Extension (up to Year 2)||141
1729460|NCT00242710|4234724|P4|STARTED|Study Extension (up to Year 2)||94
1729461|NCT00242710|4234725|P3|STARTED|Study Extension (up to Year 2)||84
1729462|NCT00242710|4234726|P2|STARTED|Study Extension (up to Year 2)||177
1729463|NCT00242710|4234727|P1|STARTED|Study Extension (up to Year 2)||168
1729464|NCT00242710|4234724|P4|NOT COMPLETED|Period Between Core Study and Extension||49
1729465|NCT00242710|4234725|P3|NOT COMPLETED|Period Between Core Study and Extension||48
1729466|NCT00242710|4234726|P2|NOT COMPLETED|Period Between Core Study and Extension||112
1729467|NCT00242710|4234727|P1|NOT COMPLETED|Period Between Core Study and Extension||119
1729468|NCT00242710|4234724|P4|COMPLETED|Period Between Core Study and Extension||94
1729469|NCT00242710|4234725|P3|COMPLETED|Period Between Core Study and Extension||84
1729470|NCT00242710|4234726|P2|COMPLETED|Period Between Core Study and Extension||177
1729471|NCT00242710|4234727|P1|COMPLETED|Period Between Core Study and Extension||168
1729472|NCT00242710|4234724|P4|STARTED|Period Between Core Study and Extension||143
1729473|NCT00242710|4234725|P3|STARTED|Period Between Core Study and Extension||132
1729474|NCT00242710|4234726|P2|STARTED|Period Between Core Study and Extension||289
1729475|NCT00242710|4234727|P1|STARTED|Period Between Core Study and Extension||287
1729476|NCT00242710|4234724|P4|NOT COMPLETED|Core Study (up to Year 1)||31
1729477|NCT00242710|4234725|P3|NOT COMPLETED|Core Study (up to Year 1)||51
1729478|NCT00242710|4234726|P2|NOT COMPLETED|Core Study (up to Year 1)||64
1729479|NCT00242710|4234727|P1|NOT COMPLETED|Core Study (up to Year 1)||86
1729480|NCT00242710|4234724|P4|COMPLETED|Core Study (up to Year 1)||143
1729481|NCT00242710|4234725|P3|COMPLETED|Core Study (up to Year 1)||132
1729482|NCT00242710|4234726|P2|COMPLETED|Core Study (up to Year 1)||289
1729483|NCT00242710|4234727|P1|COMPLETED|Core Study (up to Year 1)||287
1729484|NCT00242710|4234724|P4|Treated|Core Study (up to Year 1)||172
1729485|NCT00242710|4234725|P3|Treated|Core Study (up to Year 1)||179
1729486|NCT00242710|4234726|P2|Treated|Core Study (up to Year 1)||349
1729487|NCT00242710|4234727|P1|Treated|Core Study (up to Year 1)||361
1729488|NCT00242710|4234724|P4|STARTED|Core Study (up to Year 1)||174
1729489|NCT00242710|4234725|P3|STARTED|Core Study (up to Year 1)||183
1729490|NCT00242710|4234726|P2|STARTED|Core Study (up to Year 1)||353
1729491|NCT00242710|4234727|P1|STARTED|Core Study (up to Year 1)||373
1729492|NCT00242684|4234777|P1|NOT COMPLETED|Overall Study||0
1729493|NCT00242684|4234777|P1|COMPLETED|Overall Study||446
1729494|NCT00242684|4234777|P1|STARTED|Overall Study||446
1729495|NCT00242658|4234784|P2|NOT COMPLETED|Overall Study||19
1729496|NCT00242658|4234785|P1|NOT COMPLETED|Overall Study||22
1729497|NCT00242658|4234784|P2|COMPLETED|Overall Study||188
1729498|NCT00242658|4234785|P1|COMPLETED|Overall Study||165
1729499|NCT00242658|4234784|P2|STARTED|Overall Study||207
1729500|NCT00242658|4234785|P1|STARTED|Overall Study||187
1729501|NCT00242632|4234795|P2|NOT COMPLETED|Overall Study||0
1729502|NCT00242632|4234796|P1|NOT COMPLETED|Overall Study||0
1729503|NCT00242632|4234795|P2|COMPLETED|Overall Study||11
1729504|NCT00242632|4234796|P1|COMPLETED|Overall Study||11
1729505|NCT00242632|4234795|P2|STARTED|Overall Study||11
1729506|NCT00242632|4234796|P1|STARTED|Overall Study||11
1729507|NCT00242619|4234804|P2|NOT COMPLETED|Overall Study||0
1729508|NCT00242619|4234805|P1|NOT COMPLETED|Overall Study||0
1729509|NCT00242619|4234804|P2|COMPLETED|Overall Study||4
1729510|NCT00242619|4234805|P1|COMPLETED|Overall Study||8
1729511|NCT00242619|4234804|P2|STARTED|Overall Study||4
1729512|NCT00242619|4234805|P1|STARTED|Overall Study||8
1729513|NCT00242580|4234816|P3|NOT COMPLETED|Overall Study||14
1729514|NCT00242580|4234817|P2|NOT COMPLETED|Overall Study||12
1729515|NCT00242580|4234818|P1|NOT COMPLETED|Overall Study||10
1729516|NCT00242580|4234816|P3|COMPLETED|Overall Study||24
1729517|NCT00242580|4234817|P2|COMPLETED|Overall Study||29
1729518|NCT00242580|4234818|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
1729519|NCT00242580|4234816|P3|STARTED|Overall Study||38
1729520|NCT00242580|4234817|P2|STARTED|Overall Study||41
1729521|NCT00242580|4234818|P1|STARTED|Overall Study||32
1729522|NCT00242567|4234843|P2|NOT COMPLETED|Overall Study||140
1729523|NCT00242567|4234844|P1|NOT COMPLETED|Overall Study||166
1729524|NCT00242567|4234843|P2|COMPLETED|Overall Study||123
1729525|NCT00242567|4234844|P1|COMPLETED|Overall Study||93
1729526|NCT00242567|4234843|P2|Never Received Study Drug|Overall Study||191
1729527|NCT00242567|4234844|P1|Never Received Study Drug|Overall Study||0
1729528|NCT00242567|4234843|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
1729529|NCT00242567|4234844|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
1729530|NCT00242567|4234843|P2|STARTED|Overall Study||263
1729531|NCT00242567|4234844|P1|STARTED|Overall Study||259
1729532|NCT00242502|4234860|P1|NOT COMPLETED|Overall Study||0
1729533|NCT00242502|4234860|P1|COMPLETED|Overall Study||59
1729534|NCT00242502|4234860|P1|STARTED|Overall Study||59
1729535|NCT00242385|4234864|P2|NOT COMPLETED|Period 2||0
1729536|NCT00242385|4234865|P1|NOT COMPLETED|Period 2||0
1729537|NCT00242385|4234864|P2|COMPLETED|Period 2||11
1729538|NCT00242385|4234865|P1|COMPLETED|Period 2||14
1729539|NCT00242385|4234864|P2|STARTED|Period 2||11
1729540|NCT00242385|4234865|P1|STARTED|Period 2||14
1729541|NCT00242385|4234864|P2|NOT COMPLETED|Period 1||0
1729542|NCT00242385|4234865|P1|NOT COMPLETED|Period 1||0
1729543|NCT00242385|4234864|P2|COMPLETED|Period 1||11
1729544|NCT00242385|4234865|P1|COMPLETED|Period 1||14
1729545|NCT00242385|4234864|P2|STARTED|Period 1||11
1729546|NCT00242385|4234865|P1|STARTED|Period 1||14
1729547|NCT00242216|4234891|P2|NOT COMPLETED|Overall Study||22
1729548|NCT00242216|4234892|P1|NOT COMPLETED|Overall Study||18
1729549|NCT00242216|4234891|P2|COMPLETED|Overall Study||15
1729550|NCT00242216|4234892|P1|COMPLETED|Overall Study||21
1729551|NCT00242216|4234891|P2|STARTED|Overall Study||37
1729552|NCT00242216|4234892|P1|STARTED|Overall Study||39
1729553|NCT00241969|4234902|P2|NOT COMPLETED|Overall Study||0
1729554|NCT00241969|4234903|P1|NOT COMPLETED|Overall Study||0
1729555|NCT00241969|4234902|P2|COMPLETED|Overall Study||42
1729556|NCT00241969|4234903|P1|COMPLETED|Overall Study||36
1729557|NCT00241969|4234902|P2|STARTED|Overall Study||42
1729558|NCT00241969|4234903|P1|STARTED|Overall Study||36
1729559|NCT00241904|4234915|P2|NOT COMPLETED|Overall Study||24
1729560|NCT00241904|4234916|P1|NOT COMPLETED|Overall Study||34
1729561|NCT00241904|4234915|P2|COMPLETED|Overall Study||240
1729562|NCT00241904|4234916|P1|COMPLETED|Overall Study||227
1729563|NCT00241904|4234915|P2|STARTED|Overall Study||264
1729564|NCT00241904|4234916|P1|STARTED|Overall Study||261
1729565|NCT00241839|4234930|P2|NOT COMPLETED|Overall Study||18
1729566|NCT00241839|4234931|P1|NOT COMPLETED|Overall Study||19
1729567|NCT00241839|4234930|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
1729568|NCT00241839|4234931|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
1729569|NCT00241839|4234930|P2|STARTED|Overall Study||71
1729570|NCT00241839|4234931|P1|STARTED|Overall Study||71
1729571|NCT00241644|4234947|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
1729572|NCT00241644|4234948|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
1729573|NCT00241644|4234949|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
1729574|NCT00241644|4234950|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
1729575|NCT00241644|4234947|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
1729576|NCT00241644|4234948|P3|COMPLETED|Second Efficacy Period (Year 2)||682
1729577|NCT00241644|4234949|P2|COMPLETED|Second Efficacy Period (Year 2)||697
1729578|NCT00241644|4234950|P1|COMPLETED|Second Efficacy Period (Year 2)||710
1729579|NCT00241644|4234947|P4|STARTED|Second Efficacy Period (Year 2)||1525
1729580|NCT00241644|4234948|P3|STARTED|Second Efficacy Period (Year 2)||746
1729581|NCT00241644|4234949|P2|STARTED|Second Efficacy Period (Year 2)||754
1729582|NCT00241644|4234950|P1|STARTED|Second Efficacy Period (Year 2)||771
1729583|NCT00241644|4234947|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
1729584|NCT00241644|4234948|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
1729585|NCT00241644|4234949|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
1729586|NCT00241644|4234950|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
1729587|NCT00241644|4234947|P4|COMPLETED|First Efficacy Period (Year 1)||2803
1729588|NCT00241644|4234948|P3|COMPLETED|First Efficacy Period (Year 1)||1392
1729589|NCT00241644|4234949|P2|COMPLETED|First Efficacy Period (Year 1)||1383
1729590|NCT00241644|4234950|P1|COMPLETED|First Efficacy Period (Year 1)||1420
1729591|NCT00241644|4234947|P4|STARTED|First Efficacy Period (Year 1)||3298
1729592|NCT00241644|4234948|P3|STARTED|First Efficacy Period (Year 1)||1641
1729593|NCT00241644|4234949|P2|STARTED|First Efficacy Period (Year 1)||1651
1729594|NCT00241644|4234950|P1|STARTED|First Efficacy Period (Year 1)||1647
1729595|NCT00241358|4235035|P3|NOT COMPLETED|Overall Study||1
1729596|NCT00241358|4235036|P2|NOT COMPLETED|Overall Study||1
1729597|NCT00241358|4235037|P1|NOT COMPLETED|Overall Study||0
1729598|NCT00241358|4235035|P3|COMPLETED|Overall Study||20
1729599|NCT00241358|4235036|P2|COMPLETED|Overall Study||45
1729600|NCT00241358|4235037|P1|COMPLETED|Overall Study||25
1729601|NCT00241358|4235035|P3|STARTED|Overall Study||21
1729602|NCT00241358|4235036|P2|STARTED|Overall Study||46
1729603|NCT00241358|4235037|P1|STARTED|Overall Study||25
1729604|NCT00241280|4235070|P2|NOT COMPLETED|Overall Study||68
1729605|NCT00241280|4235071|P1|NOT COMPLETED|Overall Study||48
1729606|NCT00241280|4235070|P2|COMPLETED|Overall Study||186
1729607|NCT00241280|4235071|P1|COMPLETED|Overall Study||199
1729608|NCT00241280|4235070|P2|STARTED|Overall Study||254
1729609|NCT00241280|4235071|P1|STARTED|Overall Study||247
1729610|NCT00241176|4235079|P1|NOT COMPLETED|Overall Study||0
1729611|NCT00241176|4235079|P1|COMPLETED|Overall Study||11
1729612|NCT00241176|4235079|P1|STARTED|Overall Study||11
1729613|NCT00240994|4235086|P1|NOT COMPLETED|Overall Study||3
1729614|NCT00240994|4235086|P1|COMPLETED|Overall Study||32
1729615|NCT00240994|4235086|P1|STARTED|Overall Study||35
1729616|NCT00240981|4235092|P2|NOT COMPLETED|Overall Study||33
1729617|NCT00240981|4235093|P1|NOT COMPLETED|Overall Study||38
1729618|NCT00240981|4235092|P2|COMPLETED|Overall Study||70
1729619|NCT00240981|4235093|P1|COMPLETED|Overall Study||68
1729620|NCT00240981|4235092|P2|Intent to Treat Sample|Overall Study||83
1729621|NCT00240981|4235093|P1|Intent to Treat Sample|Overall Study||82
1729622|NCT00240981|4235092|P2|STARTED|Overall Study||103
1729623|NCT00240981|4235093|P1|STARTED|Overall Study||106
1729624|NCT00240539|4235121|P4|NOT COMPLETED|Overall Study||0
1729625|NCT00240539|4235122|P3|NOT COMPLETED|Overall Study||0
1729626|NCT00240539|4235123|P2|NOT COMPLETED|Overall Study||0
1729627|NCT00240539|4235124|P1|NOT COMPLETED|Overall Study||0
1729628|NCT00240539|4235121|P4|COMPLETED|Overall Study||1
1729629|NCT00240539|4235122|P3|COMPLETED|Overall Study||31
1729630|NCT00240539|4235123|P2|COMPLETED|Overall Study||2
1729631|NCT00240539|4235124|P1|COMPLETED|Overall Study||2
1729632|NCT00240539|4235121|P4|STARTED|Overall Study||1
1729633|NCT00240539|4235122|P3|STARTED|Overall Study||31
1729634|NCT00240539|4235123|P2|STARTED|Overall Study||2
1729635|NCT00240539|4235124|P1|STARTED|Overall Study||2
1729636|NCT00240526|4235146|P4|NOT COMPLETED|Year 20||0
1729637|NCT00240526|4235147|P3|NOT COMPLETED|Year 20||0
1729638|NCT00240526|4235148|P2|NOT COMPLETED|Year 20||0
1729639|NCT00240526|4235149|P1|NOT COMPLETED|Year 20||0
1729640|NCT00240526|4235146|P4|COMPLETED|Year 20||20
1729641|NCT00240526|4235147|P3|COMPLETED|Year 20||13
1729642|NCT00240526|4235148|P2|COMPLETED|Year 20||17
1729643|NCT00240526|4235149|P1|COMPLETED|Year 20||19
1729644|NCT00240526|4235146|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
1729645|NCT00240526|4235147|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
1729646|NCT00240526|4235148|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
1729647|NCT00240526|4235149|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
1729648|NCT00240526|4235146|P4|NOT COMPLETED|Year 19||0
1729649|NCT00240526|4235147|P3|NOT COMPLETED|Year 19||0
1729650|NCT00240526|4235148|P2|NOT COMPLETED|Year 19||0
1729651|NCT00240526|4235149|P1|NOT COMPLETED|Year 19||0
1729652|NCT00240526|4235146|P4|COMPLETED|Year 19||18
1729653|NCT00240526|4235147|P3|COMPLETED|Year 19||12
1729654|NCT00240526|4235148|P2|COMPLETED|Year 19||16
1729655|NCT00240526|4235149|P1|COMPLETED|Year 19||17
1729656|NCT00240526|4235146|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
1729657|NCT00240526|4235147|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
1729658|NCT00240526|4235148|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
1729659|NCT00240526|4235149|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
1729660|NCT00240526|4235146|P4|NOT COMPLETED|Year 18||0
1729661|NCT00240526|4235147|P3|NOT COMPLETED|Year 18||0
1729662|NCT00240526|4235148|P2|NOT COMPLETED|Year 18||0
1729663|NCT00240526|4235149|P1|NOT COMPLETED|Year 18||0
1729664|NCT00240526|4235146|P4|COMPLETED|Year 18||20
1729665|NCT00240526|4235147|P3|COMPLETED|Year 18||14
1729666|NCT00240526|4235148|P2|COMPLETED|Year 18||17
1729667|NCT00240526|4235149|P1|COMPLETED|Year 18||16
1729668|NCT00240526|4235146|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
1729669|NCT00240526|4235147|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
1729670|NCT00240526|4235148|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
1729671|NCT00240526|4235149|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
1729672|NCT00240526|4235146|P4|NOT COMPLETED|Year 17||0
1729673|NCT00240526|4235147|P3|NOT COMPLETED|Year 17||0
1729674|NCT00240526|4235148|P2|NOT COMPLETED|Year 17||0
1729675|NCT00240526|4235149|P1|NOT COMPLETED|Year 17||0
1729676|NCT00240526|4235146|P4|COMPLETED|Year 17||20
1729677|NCT00240526|4235147|P3|COMPLETED|Year 17||13
1729678|NCT00240526|4235148|P2|COMPLETED|Year 17||17
1729679|NCT00240526|4235149|P1|COMPLETED|Year 17||19
1729680|NCT00240526|4235146|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
1729681|NCT00240526|4235147|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
1729682|NCT00240526|4235148|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
1729683|NCT00240526|4235149|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
1729684|NCT00240526|4235146|P4|NOT COMPLETED|Year 16||0
1729685|NCT00240526|4235147|P3|NOT COMPLETED|Year 16||0
1729686|NCT00240526|4235148|P2|NOT COMPLETED|Year 16||0
1729687|NCT00240526|4235149|P1|NOT COMPLETED|Year 16||0
1729688|NCT00240526|4235146|P4|COMPLETED|Year 16||22
1729689|NCT00240526|4235147|P3|COMPLETED|Year 16||16
1729690|NCT00240526|4235148|P2|COMPLETED|Year 16||19
1729691|NCT00240526|4235149|P1|COMPLETED|Year 16||17
1729692|NCT00240526|4235146|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
1729693|NCT00240526|4235147|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
1729694|NCT00240526|4235148|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
1729695|NCT00240526|4235149|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
1729696|NCT00240526|4235146|P4|NOT COMPLETED|Year 15||0
1729697|NCT00240526|4235147|P3|NOT COMPLETED|Year 15||0
1729698|NCT00240526|4235148|P2|NOT COMPLETED|Year 15||0
1729699|NCT00240526|4235149|P1|NOT COMPLETED|Year 15||0
1729700|NCT00240526|4235146|P4|COMPLETED|Year 15||21
1729701|NCT00240526|4235147|P3|COMPLETED|Year 15||14
1729702|NCT00240526|4235148|P2|COMPLETED|Year 15||19
1729703|NCT00240526|4235149|P1|COMPLETED|Year 15||19
1729704|NCT00240526|4235146|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
1729705|NCT00240526|4235147|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
1729706|NCT00240526|4235148|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
1729707|NCT00240526|4235149|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
1729708|NCT00240500|4235185|P6|NOT COMPLETED|Overall Study||1
1729709|NCT00240500|4235186|P5|NOT COMPLETED|Overall Study||3
1729710|NCT00240500|4235187|P4|NOT COMPLETED|Overall Study||4
1729711|NCT00240500|4235188|P3|NOT COMPLETED|Overall Study||3
1729712|NCT00240500|4235189|P2|NOT COMPLETED|Overall Study||3
1729713|NCT00240500|4235190|P1|NOT COMPLETED|Overall Study||1
1729714|NCT00240500|4235185|P6|COMPLETED|Overall Study||2
1729715|NCT00240500|4235186|P5|COMPLETED|Overall Study||26
1729716|NCT00240500|4235187|P4|COMPLETED|Overall Study||19
1729717|NCT00240500|4235188|P3|COMPLETED|Overall Study||14
1729718|NCT00240500|4235189|P2|COMPLETED|Overall Study||17
1729719|NCT00240500|4235190|P1|COMPLETED|Overall Study||16
1729720|NCT00240500|4235185|P6|STARTED|Overall Study||3
1729721|NCT00240500|4235186|P5|STARTED|Overall Study||29
1729722|NCT00240500|4235187|P4|STARTED|Overall Study||23
1729723|NCT00240500|4235188|P3|STARTED|Overall Study||17
1729724|NCT00240500|4235189|P2|STARTED|Overall Study||20
1729725|NCT00240500|4235190|P1|STARTED|Overall Study||17
1729726|NCT00240487|4235212|P2|NOT COMPLETED|Overall Study||0
1729727|NCT00240487|4235213|P1|NOT COMPLETED|Overall Study||0
1729728|NCT00240487|4235212|P2|COMPLETED|Overall Study||28
1729729|NCT00240487|4235213|P1|COMPLETED|Overall Study||24
1729730|NCT00240487|4235212|P2|STARTED|Overall Study||28
1729731|NCT00240487|4235213|P1|STARTED|Overall Study||24
1729732|NCT00240331|4235221|P2|NOT COMPLETED|Overall Study||134
1729733|NCT00240331|4235222|P1|NOT COMPLETED|Overall Study||126
1729734|NCT00240331|4235221|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
1729735|NCT00240331|4235222|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
1729736|NCT00240331|4235221|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
1729737|NCT00240331|4235222|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
1729738|NCT00240227|4235240|P1|NOT COMPLETED|Overall Study||0
1729739|NCT00240227|4235240|P1|COMPLETED|Overall Study||8
1729740|NCT00240227|4235240|P1|STARTED|Overall Study||8
1729741|NCT00240162|4235256|P1|NOT COMPLETED|Overall Study||0
1729742|NCT00240162|4235256|P1|COMPLETED|Overall Study||21
1729743|NCT00240162|4235256|P1|STARTED|Overall Study||21
1729744|NCT00240110|4235265|P2|NOT COMPLETED|Overall Study||7
1729745|NCT00240110|4235266|P1|NOT COMPLETED|Overall Study||6
1729746|NCT00240110|4235265|P2|COMPLETED|Overall Study||6
1729747|NCT00240110|4235266|P1|COMPLETED|Overall Study||7
1729748|NCT00240110|4235265|P2|STARTED|Overall Study||13
1729749|NCT00240110|4235266|P1|STARTED|Overall Study||13
1729750|NCT00240097|4235274|P1|NOT COMPLETED|Part II||23
1729751|NCT00240097|4235274|P1|COMPLETED|Part II||3
1729752|NCT00240097|4235274|P1|STARTED|Part II||26
1729753|NCT00240097|4235274|P1|NOT COMPLETED|Part I||4
1729754|NCT00240097|4235274|P1|COMPLETED|Part I||26
1729755|NCT00240097|4235274|P1|STARTED|Part I||30
1729756|NCT00240071|4235284|P1|NOT COMPLETED|Overall Study||3
1729757|NCT00240071|4235284|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
1729758|NCT00240071|4235284|P1|STARTED|Overall Study||30
1729759|NCT00239928|4235289|P1|NOT COMPLETED|Overall Study||10
1729760|NCT00239928|4235289|P1|COMPLETED|Overall Study||51
1729761|NCT00239928|4235289|P1|STARTED|Overall Study||61
1729762|NCT00239837|4235301|P2|NOT COMPLETED|Overall Study||7
1729763|NCT00239837|4235302|P1|NOT COMPLETED|Overall Study||3
1729764|NCT00239837|4235301|P2|COMPLETED|Overall Study|3-year follow-up|45
1729765|NCT00239837|4235302|P1|COMPLETED|Overall Study|3-year follow-up|45
1729766|NCT00239837|4235301|P2|6 Months|Overall Study||50
1729767|NCT00239837|4235302|P1|6 Months|Overall Study||48
1729768|NCT00239837|4235301|P2|STARTED|Overall Study||52
1729769|NCT00239837|4235302|P1|STARTED|Overall Study||48
1729770|NCT00239733|4235322|P1|NOT COMPLETED|Overall Study||0
1729771|NCT00239733|4235322|P1|COMPLETED|Overall Study||6
1729772|NCT00239733|4235322|P1|STARTED|Overall Study||6
1729773|NCT00239720|4235329|P2|NOT COMPLETED|Overall Study||1
1729774|NCT00239720|4235330|P1|NOT COMPLETED|Overall Study||1
1729775|NCT00239720|4235329|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
1729776|NCT00239720|4235330|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
1729777|NCT00239720|4235329|P2|STARTED|Overall Study||1
1729778|NCT00239720|4235330|P1|STARTED|Overall Study||3
1729779|NCT00239681|4235338|P2|NOT COMPLETED|Overall Study||715
1729780|NCT00239681|4235339|P1|NOT COMPLETED|Overall Study||693
1729781|NCT00239681|4235338|P2|COMPLETED|Overall Study||8186
1729782|NCT00239681|4235339|P1|COMPLETED|Overall Study||8208
1729783|NCT00239681|4235338|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
1729784|NCT00239681|4235339|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
1729785|NCT00239681|4235338|P2|STARTED|Overall Study||8901
1729786|NCT00239681|4235339|P1|STARTED|Overall Study||8901
1729787|NCT00239642|4235358|P3|NOT COMPLETED|Overall Study||2
1729788|NCT00239642|4235359|P2|NOT COMPLETED|Overall Study||0
1729789|NCT00239642|4235360|P1|NOT COMPLETED|Overall Study||2
1729790|NCT00239642|4235358|P3|COMPLETED|Overall Study||47
1729791|NCT00239642|4235359|P2|COMPLETED|Overall Study||47
1729792|NCT00239642|4235360|P1|COMPLETED|Overall Study||47
1729793|NCT00239642|4235358|P3|STARTED|Overall Study||49
1729794|NCT00239642|4235359|P2|STARTED|Overall Study||47
1729795|NCT00239642|4235360|P1|STARTED|Overall Study||49
1729796|NCT00239356|4235394|P2|NOT COMPLETED|Overall Study||9
1729797|NCT00239356|4235395|P1|NOT COMPLETED|Overall Study||39
1729798|NCT00239356|4235394|P2|COMPLETED|Overall Study||11
1729799|NCT00239356|4235395|P1|COMPLETED|Overall Study||58
1729800|NCT00239356|4235394|P2|STARTED|Overall Study||20
1729801|NCT00239356|4235395|P1|STARTED|Overall Study||97
1729802|NCT00239226|4235417|P4|NOT COMPLETED|Overall Study||3
1729803|NCT00239226|4235418|P3|NOT COMPLETED|Overall Study||1
1729804|NCT00239226|4235419|P2|NOT COMPLETED|Overall Study||0
1729805|NCT00239226|4235420|P1|NOT COMPLETED|Overall Study||1
1729806|NCT00239226|4235417|P4|COMPLETED|Overall Study||14
1729807|NCT00239226|4235418|P3|COMPLETED|Overall Study||36
1729808|NCT00239226|4235419|P2|COMPLETED|Overall Study||18
1729809|NCT00239226|4235420|P1|COMPLETED|Overall Study||29
1729810|NCT00239226|4235417|P4|STARTED|Overall Study||17
1729811|NCT00239226|4235418|P3|STARTED|Overall Study||37
1729812|NCT00239226|4235419|P2|STARTED|Overall Study||18
1729813|NCT00239226|4235420|P1|STARTED|Overall Study||30
1729814|NCT00239005|4235432|P2|NOT COMPLETED|Overall Study||12
1729815|NCT00239005|4235433|P1|NOT COMPLETED|Overall Study||12
1729816|NCT00239005|4235432|P2|COMPLETED|Overall Study||53
1729817|NCT00239005|4235433|P1|COMPLETED|Overall Study||57
1729818|NCT00239005|4235432|P2|Intention-to-treat Population (ITT)|Overall Study||61
1729819|NCT00239005|4235433|P1|Intention-to-treat Population (ITT)|Overall Study||68
1729820|NCT00239005|4235432|P2|STARTED|Overall Study||65
1729821|NCT00239005|4235433|P1|STARTED|Overall Study||69
1729822|NCT00238615|4235443|P1|NOT COMPLETED|Overall Study||0
1729823|NCT00238615|4235443|P1|COMPLETED|Overall Study||13
1729824|NCT00238615|4235443|P1|STARTED|Overall Study||13
1729825|NCT00238433|4235449|P1|NOT COMPLETED|Overall Study||3
1729826|NCT00238433|4235449|P1|COMPLETED|Overall Study||34
1729827|NCT00238433|4235449|P1|STARTED|Overall Study||37
1729828|NCT00238420|4235456|P2|NOT COMPLETED|Overall Study||1
1729829|NCT00238420|4235457|P1|NOT COMPLETED|Overall Study||1
1729830|NCT00238420|4235456|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
1729831|NCT00238420|4235457|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
1729832|NCT00238420|4235456|P2|STARTED|Overall Study||48
1729833|NCT00238420|4235457|P1|STARTED|Overall Study||22
1729834|NCT00238355|4235467|P1|NOT COMPLETED|Overall Study||3
1729835|NCT00238355|4235467|P1|COMPLETED|Overall Study||10
1729836|NCT00238355|4235467|P1|STARTED|Overall Study||13
1729837|NCT00238303|4235474|P3|NOT COMPLETED|Overall Study||9
1729838|NCT00238303|4235475|P2|NOT COMPLETED|Overall Study||2
1729839|NCT00238303|4235476|P1|NOT COMPLETED|Overall Study||15
1729840|NCT00238303|4235474|P3|COMPLETED|Overall Study||11
1729841|NCT00238303|4235475|P2|COMPLETED|Overall Study||13
1729842|NCT00238303|4235476|P1|COMPLETED|Overall Study||53
1729843|NCT00238303|4235474|P3|STARTED|Overall Study||20
1729844|NCT00238303|4235475|P2|STARTED|Overall Study||15
1729845|NCT00238303|4235476|P1|STARTED|Overall Study||68
1729846|NCT00238264|4235493|P1|NOT COMPLETED|Overall Study||36
1729847|NCT00238264|4235493|P1|COMPLETED|Overall Study||56
1729848|NCT00238264|4235493|P1|STARTED|Overall Study||92
1729849|NCT00238238|4235506|P3|NOT COMPLETED|Overall Study||0
1729850|NCT00238238|4235507|P2|NOT COMPLETED|Overall Study||3
1729851|NCT00238238|4235508|P1|NOT COMPLETED|Overall Study||0
1729852|NCT00238238|4235506|P3|COMPLETED|Overall Study||46
1729853|NCT00238238|4235507|P2|COMPLETED|Overall Study||45
1729854|NCT00238238|4235508|P1|COMPLETED|Overall Study||3
1729855|NCT00238238|4235506|P3|STARTED|Overall Study||46
1729856|NCT00238238|4235507|P2|STARTED|Overall Study||48
1729857|NCT00238238|4235508|P1|STARTED|Overall Study||3
1729858|NCT00238121|4235521|P2|NOT COMPLETED|Overall Study||2
1729859|NCT00238121|4235522|P1|NOT COMPLETED|Overall Study||3
1729860|NCT00238121|4235521|P2|COMPLETED|Overall Study||14
1729861|NCT00238121|4235522|P1|COMPLETED|Overall Study||37
1729862|NCT00238121|4235521|P2|STARTED|Overall Study||16
1729863|NCT00238121|4235522|P1|STARTED|Overall Study||40
1729864|NCT00238108|4235535|P2|NOT COMPLETED|Overall Study||0
1729865|NCT00238108|4235536|P1|NOT COMPLETED|Overall Study||0
1729866|NCT00238108|4235535|P2|COMPLETED|Overall Study||8
1729867|NCT00238108|4235536|P1|COMPLETED|Overall Study||8
1729868|NCT00238108|4235535|P2|STARTED|Overall Study||8
1729869|NCT00238108|4235536|P1|STARTED|Overall Study||8
1729870|NCT00237809|4235548|P4|NOT COMPLETED|Overall Study||9
1729871|NCT00237809|4235549|P3|NOT COMPLETED|Overall Study||9
1729872|NCT00237809|4235550|P2|NOT COMPLETED|Overall Study||10
1729873|NCT00237809|4235551|P1|NOT COMPLETED|Overall Study||11
1729874|NCT00237809|4235548|P4|COMPLETED|Overall Study||17
1729875|NCT00237809|4235549|P3|COMPLETED|Overall Study||15
1729876|NCT00237809|4235550|P2|COMPLETED|Overall Study||17
1729877|NCT00237809|4235551|P1|COMPLETED|Overall Study||16
1729878|NCT00237809|4235548|P4|STARTED|Overall Study||26
1729879|NCT00237809|4235549|P3|STARTED|Overall Study||24
1729880|NCT00237809|4235550|P2|STARTED|Overall Study||27
1729881|NCT00237809|4235551|P1|STARTED|Overall Study||27
1729882|NCT00237796|4235587|P2|NOT COMPLETED|Overall Study||5
1729883|NCT00237796|4235588|P1|NOT COMPLETED|Overall Study||10
1729884|NCT00237796|4235587|P2|COMPLETED|Overall Study||33
1729885|NCT00237796|4235588|P1|COMPLETED|Overall Study||31
1729886|NCT00237796|4235587|P2|STARTED|Overall Study||38
1729887|NCT00237796|4235588|P1|STARTED|Overall Study||41
1729888|NCT00237770|4235608|P2|NOT COMPLETED|Overall Study||0
1729889|NCT00237770|4235609|P1|NOT COMPLETED|Overall Study||0
1729890|NCT00237770|4235608|P2|COMPLETED|Overall Study||7
1729891|NCT00237770|4235609|P1|COMPLETED|Overall Study||9
1729892|NCT00237770|4235608|P2|STARTED|Overall Study||7
1729893|NCT00237770|4235609|P1|STARTED|Overall Study||9
1729894|NCT00237744|4235622|P3|NOT COMPLETED|Overall Study||0
1729895|NCT00237744|4235623|P2|NOT COMPLETED|Overall Study||1
1729896|NCT00237744|4235624|P1|NOT COMPLETED|Overall Study||3
1729897|NCT00237744|4235622|P3|COMPLETED|Overall Study||18
1729898|NCT00237744|4235623|P2|COMPLETED|Overall Study||10
1729899|NCT00237744|4235624|P1|COMPLETED|Overall Study||8
1729900|NCT00237744|4235622|P3|STARTED|Overall Study||18
1729901|NCT00237744|4235623|P2|STARTED|Overall Study||11
1729902|NCT00237744|4235624|P1|STARTED|Overall Study||11
1729903|NCT00237718|4235637|P2|NOT COMPLETED|Overall Study||41
1729904|NCT00237718|4235638|P1|NOT COMPLETED|Overall Study||46
1729905|NCT00237718|4235637|P2|COMPLETED|Overall Study||124
1729906|NCT00237718|4235638|P1|COMPLETED|Overall Study||114
1729907|NCT00237718|4235637|P2|STARTED|Overall Study||165
1729908|NCT00237718|4235638|P1|STARTED|Overall Study||160
1729909|NCT00237692|4235650|P4|NOT COMPLETED|Overall Study||19
1729910|NCT00237692|4235651|P3|NOT COMPLETED|Overall Study||22
1729911|NCT00237692|4235652|P2|NOT COMPLETED|Overall Study||14
1729912|NCT00237692|4235653|P1|NOT COMPLETED|Overall Study||18
1729913|NCT00237692|4235650|P4|COMPLETED|Overall Study||128
1729914|NCT00237692|4235651|P3|COMPLETED|Overall Study||127
1729915|NCT00237692|4235652|P2|COMPLETED|Overall Study||134
1729916|NCT00237692|4235653|P1|COMPLETED|Overall Study||129
1729917|NCT00237692|4235650|P4|18 Month f/u|Overall Study||122
1729918|NCT00237692|4235651|P3|18 Month f/u|Overall Study||126
1729919|NCT00237692|4235652|P2|18 Month f/u|Overall Study||131
1729920|NCT00237692|4235653|P1|18 Month f/u|Overall Study||124
1729921|NCT00237692|4235650|P4|12 Month f/u|Overall Study||127
1729922|NCT00237692|4235651|P3|12 Month f/u|Overall Study||132
1729923|NCT00237692|4235652|P2|12 Month f/u|Overall Study||127
1729924|NCT00237692|4235653|P1|12 Month f/u|Overall Study||137
1729925|NCT00237692|4235650|P4|6 Month f/u|Overall Study||134
1729926|NCT00237692|4235651|P3|6 Month f/u|Overall Study||135
1729927|NCT00237692|4235652|P2|6 Month f/u|Overall Study||134
1729928|NCT00237692|4235653|P1|6 Month f/u|Overall Study||132
1729929|NCT00237692|4235650|P4|STARTED|Overall Study||147
1729930|NCT00237692|4235651|P3|STARTED|Overall Study||149
1729931|NCT00237692|4235652|P2|STARTED|Overall Study||148
1729932|NCT00237692|4235653|P1|STARTED|Overall Study||147
1729933|NCT00237666|4235683|P1|NOT COMPLETED|Overall Study||6
1729934|NCT00237666|4235683|P1|COMPLETED|Overall Study||24
1729935|NCT00237666|4235683|P1|STARTED|Overall Study||30
1729936|NCT00237458|4235693|P1|NOT COMPLETED|Overall Study||3
1729937|NCT00237458|4235693|P1|COMPLETED|Overall Study||4
1729938|NCT00237458|4235693|P1|STARTED|Overall Study||7
1729939|NCT00237185|4235711|P2|NOT COMPLETED|Extension||19
1729940|NCT00237185|4235712|P1|NOT COMPLETED|Extension||16
1729941|NCT00237185|4235711|P2|COMPLETED|Extension||13
1729942|NCT00237185|4235712|P1|COMPLETED|Extension||8
1729943|NCT00237185|4235711|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
1729944|NCT00237185|4235712|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
1729945|NCT00237185|4235711|P2|NOT COMPLETED|Core||37
1729946|NCT00237185|4235712|P1|NOT COMPLETED|Core||44
1729947|NCT00237185|4235711|P2|COMPLETED|Core||37
1729948|NCT00237185|4235712|P1|COMPLETED|Core||30
1729949|NCT00237185|4235711|P2|Treated Participants|Core||74
1729950|NCT00237185|4235712|P1|Treated Participants|Core||73
1729951|NCT00237185|4235711|P2|STARTED|Core||74
1729952|NCT00237185|4235712|P1|STARTED|Core||74
1729953|NCT00237042|4235743|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
1729954|NCT00237042|4235744|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
1729955|NCT00237042|4235745|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
1729956|NCT00237042|4235743|P3|COMPLETED|Long Term (12 Month) Follow up||48
1729957|NCT00237042|4235744|P2|COMPLETED|Long Term (12 Month) Follow up||46
1729958|NCT00237042|4235745|P1|COMPLETED|Long Term (12 Month) Follow up||48
1729959|NCT00237042|4235743|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
1729960|NCT00237042|4235744|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
1729961|NCT00237042|4235745|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
1729962|NCT00237042|4235743|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
1729963|NCT00237042|4235744|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
1729964|NCT00237042|4235745|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
1729965|NCT00237042|4235743|P3|COMPLETED|Short Term (6 Month) Follow up||46
1729966|NCT00237042|4235744|P2|COMPLETED|Short Term (6 Month) Follow up||47
1729967|NCT00237042|4235745|P1|COMPLETED|Short Term (6 Month) Follow up||50
1729968|NCT00237042|4235743|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
1729969|NCT00237042|4235744|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
1729970|NCT00237042|4235745|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
1729971|NCT00237042|4235743|P3|NOT COMPLETED|Treatment||38
1729972|NCT00237042|4235744|P2|NOT COMPLETED|Treatment||7
1729973|NCT00237042|4235745|P1|NOT COMPLETED|Treatment||6
1729974|NCT00237042|4235743|P3|COMPLETED|Treatment||36
1729975|NCT00237042|4235744|P2|COMPLETED|Treatment||50
1729976|NCT00237042|4235745|P1|COMPLETED|Treatment||54
1729977|NCT00237042|4235743|P3|STARTED|Treatment||74
1729978|NCT00237042|4235744|P2|STARTED|Treatment||57
1729979|NCT00237042|4235745|P1|STARTED|Treatment||60
1729980|NCT00236977|4235764|P2|NOT COMPLETED|Overall Study||19
1729981|NCT00236977|4235765|P1|NOT COMPLETED|Overall Study||21
1729982|NCT00236977|4235764|P2|COMPLETED|Overall Study||72
1729983|NCT00236977|4235765|P1|COMPLETED|Overall Study||70
1729984|NCT00236977|4235764|P2|STARTED|Overall Study||91
1729985|NCT00236977|4235765|P1|STARTED|Overall Study||91
1729986|NCT00236951|4235787|P4|NOT COMPLETED|Overall Study||31
1729987|NCT00236951|4235788|P3|NOT COMPLETED|Overall Study||19
1729988|NCT00236951|4235789|P2|NOT COMPLETED|Overall Study||31
1729989|NCT00236951|4235790|P1|NOT COMPLETED|Overall Study||26
1729990|NCT00236951|4235787|P4|COMPLETED|Overall Study||17
1729991|NCT00236951|4235788|P3|COMPLETED|Overall Study||21
1729992|NCT00236951|4235789|P2|COMPLETED|Overall Study||46
1729993|NCT00236951|4235790|P1|COMPLETED|Overall Study||33
1729994|NCT00236951|4235787|P4|STARTED|Overall Study||48
1729995|NCT00236951|4235788|P3|STARTED|Overall Study||40
1729996|NCT00236951|4235789|P2|STARTED|Overall Study||77
1729997|NCT00236951|4235790|P1|STARTED|Overall Study||59
1729998|NCT00236938|4235802|P2|NOT COMPLETED|Overall Study||20
1729999|NCT00236938|4235803|P1|NOT COMPLETED|Overall Study||13
1730000|NCT00236938|4235802|P2|COMPLETED|Overall Study||26
1730001|NCT00236938|4235803|P1|COMPLETED|Overall Study||62
1730002|NCT00236938|4235802|P2|STARTED|Overall Study||46
1730003|NCT00236938|4235803|P1|STARTED|Overall Study||75
1730004|NCT00236899|4235819|P4|NOT COMPLETED|Overall Study||40
1730005|NCT00236899|4235820|P3|NOT COMPLETED|Overall Study||44
1730006|NCT00236899|4235821|P2|NOT COMPLETED|Overall Study||40
1730007|NCT00236899|4235822|P1|NOT COMPLETED|Overall Study||42
1730008|NCT00236899|4235819|P4|COMPLETED|Overall Study||19
1730009|NCT00236899|4235820|P3|COMPLETED|Overall Study||14
1730010|NCT00236899|4235821|P2|COMPLETED|Overall Study||24
1730011|NCT00236899|4235822|P1|COMPLETED|Overall Study||18
1730012|NCT00236899|4235819|P4|STARTED|Overall Study||59
1730013|NCT00236899|4235820|P3|STARTED|Overall Study||58
1730014|NCT00236899|4235821|P2|STARTED|Overall Study||64
1730015|NCT00236899|4235822|P1|STARTED|Overall Study||60
1730016|NCT00236197|4235854|P2|NOT COMPLETED|Overall Study||14
1730017|NCT00236197|4235855|P1|NOT COMPLETED|Overall Study||5
1730018|NCT00236197|4235854|P2|COMPLETED|Overall Study||293
1730019|NCT00236197|4235855|P1|COMPLETED|Overall Study||307
1730020|NCT00236197|4235854|P2|STARTED|Overall Study||307
1730021|NCT00236197|4235855|P1|STARTED|Overall Study||312
1730022|NCT00236184|4235863|P2|NOT COMPLETED|Overall Study||11
1730023|NCT00236184|4235864|P1|NOT COMPLETED|Overall Study||18
1730024|NCT00236184|4235863|P2|COMPLETED|Overall Study||308
1730025|NCT00236184|4235864|P1|COMPLETED|Overall Study||292
1730026|NCT00236184|4235863|P2|STARTED|Overall Study||319
1730027|NCT00236184|4235864|P1|STARTED|Overall Study||310
1730028|NCT00236080|4235875|P5|NOT COMPLETED|Overall Study||1
1730029|NCT00236080|4235876|P4|NOT COMPLETED|Overall Study||2
1730030|NCT00236080|4235877|P3|NOT COMPLETED|Overall Study||5
1730031|NCT00236080|4235878|P2|NOT COMPLETED|Overall Study||1
1730032|NCT00236080|4235879|P1|NOT COMPLETED|Overall Study||2
1730033|NCT00236080|4235875|P5|COMPLETED|Overall Study||26
1730034|NCT00236080|4235876|P4|COMPLETED|Overall Study||23
1730035|NCT00236080|4235877|P3|COMPLETED|Overall Study||22
1730036|NCT00236080|4235878|P2|COMPLETED|Overall Study||27
1730037|NCT00236080|4235879|P1|COMPLETED|Overall Study||27
1730038|NCT00236080|4235875|P5|STARTED|Overall Study||27
1730039|NCT00236080|4235876|P4|STARTED|Overall Study||25
1730040|NCT00236080|4235877|P3|STARTED|Overall Study||27
1730041|NCT00236080|4235878|P2|STARTED|Overall Study||28
1730042|NCT00236080|4235879|P1|STARTED|Overall Study||29
1730043|NCT00235989|4235900|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
1730044|NCT00235989|4235901|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
1730045|NCT00235989|4235902|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
1730046|NCT00235989|4235903|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
1730047|NCT00235989|4235904|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
1730048|NCT00235989|4235905|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
1730049|NCT00235989|4235900|P6|COMPLETED|Extension Treatment Period (ET)||0
1730050|NCT00235989|4235901|P5|COMPLETED|Extension Treatment Period (ET)||0
1730051|NCT00235989|4235902|P4|COMPLETED|Extension Treatment Period (ET)||14
1730052|NCT00235989|4235903|P3|COMPLETED|Extension Treatment Period (ET)||14
1730053|NCT00235989|4235904|P2|COMPLETED|Extension Treatment Period (ET)||2
1730054|NCT00235989|4235905|P1|COMPLETED|Extension Treatment Period (ET)||8
1730055|NCT00235989|4235900|P6|STARTED|Extension Treatment Period (ET)||0
1730056|NCT00235989|4235901|P5|STARTED|Extension Treatment Period (ET)||0
1730057|NCT00235989|4235902|P4|STARTED|Extension Treatment Period (ET)||20
1730058|NCT00235989|4235903|P3|STARTED|Extension Treatment Period (ET)||19
1730059|NCT00235989|4235904|P2|STARTED|Extension Treatment Period (ET)||6
1730060|NCT00235989|4235905|P1|STARTED|Extension Treatment Period (ET)||16
1730061|NCT00235989|4235900|P6|NOT COMPLETED|Core Treatment Period (CT)||2
1730062|NCT00235989|4235901|P5|NOT COMPLETED|Core Treatment Period (CT)||0
1730063|NCT00235989|4235902|P4|NOT COMPLETED|Core Treatment Period (CT)||0
1730064|NCT00235989|4235903|P3|NOT COMPLETED|Core Treatment Period (CT)||0
1730065|NCT00235989|4235904|P2|NOT COMPLETED|Core Treatment Period (CT)||0
1730066|NCT00235989|4235905|P1|NOT COMPLETED|Core Treatment Period (CT)||0
1730067|NCT00235989|4235900|P6|COMPLETED|Core Treatment Period (CT)||25
1730068|NCT00235989|4235901|P5|COMPLETED|Core Treatment Period (CT)||36
1730069|NCT00235989|4235902|P4|COMPLETED|Core Treatment Period (CT)||0
1730070|NCT00235989|4235903|P3|COMPLETED|Core Treatment Period (CT)||0
1730071|NCT00235989|4235904|P2|COMPLETED|Core Treatment Period (CT)||0
1730072|NCT00235989|4235905|P1|COMPLETED|Core Treatment Period (CT)||0
1730073|NCT00235989|4235900|P6|STARTED|Core Treatment Period (CT)||27
1730074|NCT00235989|4235901|P5|STARTED|Core Treatment Period (CT)||36
1730075|NCT00235989|4235902|P4|STARTED|Core Treatment Period (CT)||0
1730076|NCT00235989|4235903|P3|STARTED|Core Treatment Period (CT)||0
1730077|NCT00235989|4235904|P2|STARTED|Core Treatment Period (CT)||0
1730078|NCT00235989|4235905|P1|STARTED|Core Treatment Period (CT)||0
1730079|NCT00235872|4235919|P1|NOT COMPLETED|Overall Study||147
1730080|NCT00235872|4235919|P1|COMPLETED|Overall Study||162
1730081|NCT00235872|4235919|P1|STARTED|Overall Study||309
1730082|NCT00235833|4235934|P1|NOT COMPLETED|Overall Study||16
1730083|NCT00235833|4235934|P1|COMPLETED|Overall Study||9
1730084|NCT00235833|4235934|P1|STARTED|Overall Study||25
1730085|NCT00235755|4235950|P3|NOT COMPLETED|12-Week Maintenance Phase||31
1730086|NCT00235755|4235951|P2|NOT COMPLETED|12-Week Maintenance Phase||27
1730087|NCT00235755|4235952|P1|NOT COMPLETED|12-Week Maintenance Phase||16
1730088|NCT00235755|4235950|P3|COMPLETED|12-Week Maintenance Phase||122
1730089|NCT00235755|4235951|P2|COMPLETED|12-Week Maintenance Phase||135
1730090|NCT00235755|4235952|P1|COMPLETED|12-Week Maintenance Phase||152
1730091|NCT00235755|4235950|P3|STARTED|12-Week Maintenance Phase||153
1730092|NCT00235755|4235951|P2|STARTED|12-Week Maintenance Phase||162
1730093|NCT00235755|4235952|P1|STARTED|12-Week Maintenance Phase||168
1730094|NCT00235755|4235950|P3|NOT COMPLETED|4-Week Titration Phase||26
1730095|NCT00235755|4235951|P2|NOT COMPLETED|4-Week Titration Phase||19
1730096|NCT00235755|4235952|P1|NOT COMPLETED|4-Week Titration Phase||11
1730097|NCT00235755|4235950|P3|COMPLETED|4-Week Titration Phase||153
1730098|NCT00235755|4235951|P2|COMPLETED|4-Week Titration Phase||162
1730099|NCT00235755|4235952|P1|COMPLETED|4-Week Titration Phase||168
1730100|NCT00235755|4235950|P3|STARTED|4-Week Titration Phase||179
1730101|NCT00235755|4235951|P2|STARTED|4-Week Titration Phase||181
1730102|NCT00235755|4235952|P1|STARTED|4-Week Titration Phase||179
1730103|NCT00235716|4236030|P4|NOT COMPLETED|Overall Study||62
1730104|NCT00235716|4236031|P3|NOT COMPLETED|Overall Study||65
1730105|NCT00235716|4236032|P2|NOT COMPLETED|Overall Study||67
1730106|NCT00235716|4236033|P1|NOT COMPLETED|Overall Study||62
1730107|NCT00235716|4236030|P4|COMPLETED|Overall Study||90
1730108|NCT00235716|4236031|P3|COMPLETED|Overall Study||89
1730109|NCT00235716|4236032|P2|COMPLETED|Overall Study||88
1730110|NCT00235716|4236033|P1|COMPLETED|Overall Study||90
1730111|NCT00235716|4236030|P4|STARTED|Overall Study||152
1730112|NCT00235716|4236031|P3|STARTED|Overall Study||154
1730113|NCT00235716|4236032|P2|STARTED|Overall Study||155
1730114|NCT00235716|4236033|P1|STARTED|Overall Study||152
1730115|NCT00235573|4236067|P1|NOT COMPLETED|Overall Study||0
1730116|NCT00235573|4236067|P1|COMPLETED|Overall Study||21
1730117|NCT00235573|4236067|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
1730118|NCT00235456|4236073|P2|NOT COMPLETED|Overall Study||7
1730119|NCT00235456|4236074|P1|NOT COMPLETED|Overall Study||2
1730120|NCT00235456|4236073|P2|COMPLETED|Overall Study||143
1730121|NCT00235456|4236074|P1|COMPLETED|Overall Study||148
1730122|NCT00235456|4236073|P2|STARTED|Overall Study||150
1730123|NCT00235456|4236074|P1|STARTED|Overall Study||150
1730124|NCT00235443|4236096|P6|NOT COMPLETED|Overall Study||45
1730125|NCT00235443|4236097|P5|NOT COMPLETED|Overall Study||30
1730126|NCT00235443|4236098|P4|NOT COMPLETED|Overall Study||97
1730127|NCT00235443|4236099|P3|NOT COMPLETED|Overall Study||62
1730128|NCT00235443|4236100|P2|NOT COMPLETED|Overall Study||38
1730129|NCT00235443|4236101|P1|NOT COMPLETED|Overall Study||8
1730130|NCT00235443|4236096|P6|COMPLETED|Overall Study||9
1730131|NCT00235443|4236097|P5|COMPLETED|Overall Study||9
1730132|NCT00235443|4236098|P4|COMPLETED|Overall Study||108
1730133|NCT00235443|4236099|P3|COMPLETED|Overall Study||23
1730134|NCT00235443|4236100|P2|COMPLETED|Overall Study||19
1730135|NCT00235443|4236101|P1|COMPLETED|Overall Study||3
1730136|NCT00235443|4236096|P6|STARTED|Overall Study||54
1730137|NCT00235443|4236097|P5|STARTED|Overall Study||39
1730138|NCT00235443|4236098|P4|STARTED|Overall Study||205
1730139|NCT00235443|4236099|P3|STARTED|Overall Study||85
1730140|NCT00235443|4236100|P2|STARTED|Overall Study||57
1730141|NCT00235443|4236101|P1|STARTED|Overall Study||11
1730142|NCT00235391|4236242|P6|NOT COMPLETED|Overall Study||4
1730143|NCT00235391|4236243|P5|NOT COMPLETED|Overall Study||12
1730144|NCT00235391|4236244|P4|NOT COMPLETED|Overall Study||220
1730145|NCT00235391|4236245|P3|NOT COMPLETED|Overall Study||24
1730146|NCT00235391|4236246|P2|NOT COMPLETED|Overall Study||18
1730147|NCT00235391|4236247|P1|NOT COMPLETED|Overall Study||12
1730148|NCT00235391|4236242|P6|COMPLETED|Overall Study||3
1730149|NCT00235391|4236243|P5|COMPLETED|Overall Study||31
1730150|NCT00235391|4236244|P4|COMPLETED|Overall Study||944
1730151|NCT00235391|4236245|P3|COMPLETED|Overall Study||148
1730152|NCT00235391|4236246|P2|COMPLETED|Overall Study||182
1730153|NCT00235391|4236247|P1|COMPLETED|Overall Study||85
1730154|NCT00235391|4236242|P6|Deferasirox Treatment|Overall Study||7
1730155|NCT00235391|4236243|P5|Deferasirox Treatment|Overall Study||43
1730156|NCT00235391|4236244|P4|Deferasirox Treatment|Overall Study||1164
1730157|NCT00235391|4236245|P3|Deferasirox Treatment|Overall Study||172
1730158|NCT00235391|4236246|P2|Deferasirox Treatment|Overall Study||200
1730159|NCT00235391|4236247|P1|Deferasirox Treatment|Overall Study||97
1730160|NCT00235391|4236242|P6|STARTED|Overall Study||7
1730161|NCT00235391|4236243|P5|STARTED|Overall Study||43
1730162|NCT00235391|4236244|P4|STARTED|Overall Study||1164
1730163|NCT00235391|4236245|P3|STARTED|Overall Study||172
1730164|NCT00235391|4236246|P2|STARTED|Overall Study||200
1730165|NCT00235391|4236247|P1|STARTED|Overall Study||97
1730166|NCT00235326|4236264|P2|NOT COMPLETED|Overall Study||1400
1730167|NCT00235326|4236265|P1|NOT COMPLETED|Overall Study||746
1730168|NCT00235326|4236264|P2|COMPLETED|Overall Study||1586
1730169|NCT00235326|4236265|P1|COMPLETED|Overall Study||829
1730170|NCT00235326|4236264|P2|STARTED|Overall Study||2986
1730171|NCT00235326|4236265|P1|STARTED|Overall Study||1575
1730172|NCT00234884|4236269|P1|NOT COMPLETED|Overall Study||1630
1730173|NCT00234884|4236269|P1|COMPLETED|Overall Study||1805
1730174|NCT00234884|4236269|P1|STARTED|Overall Study||3435
1730175|NCT00234832|4236279|P2|NOT COMPLETED|Overall Study||996
1730176|NCT00234832|4236280|P1|NOT COMPLETED|Overall Study||1016
1730177|NCT00234832|4236279|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
1730178|NCT00234832|4236280|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
1730179|NCT00234832|4236279|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
1730180|NCT00234832|4236280|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
1730181|NCT00234533|4236305|P1|NOT COMPLETED|Overall Study||11
1730182|NCT00234533|4236305|P1|COMPLETED|Overall Study||240
1730183|NCT00234533|4236305|P1|STARTED|Overall Study||251
1730184|NCT00234494|4236324|P1|NOT COMPLETED|Overall Study||2
1730185|NCT00234494|4236324|P1|COMPLETED|Overall Study||43
1730186|NCT00234494|4236324|P1|STARTED|Overall Study||45
1730187|NCT00234286|4236331|P1|NOT COMPLETED|Overall Study||0
1730188|NCT00234286|4236331|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
1730189|NCT00234286|4236331|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
1730190|NCT00234104|4236370|P4|NOT COMPLETED|Overall Study||8
1730191|NCT00234104|4236371|P3|NOT COMPLETED|Overall Study||5
1730192|NCT00234104|4236372|P2|NOT COMPLETED|Overall Study||1
1730193|NCT00234104|4236373|P1|NOT COMPLETED|Overall Study||4
1730194|NCT00234104|4236370|P4|COMPLETED|Overall Study||21
1730195|NCT00234104|4236371|P3|COMPLETED|Overall Study||29
1730196|NCT00234104|4236372|P2|COMPLETED|Overall Study||28
1730197|NCT00234104|4236373|P1|COMPLETED|Overall Study||26
1730198|NCT00234104|4236370|P4|STARTED|Overall Study||29
1730199|NCT00234104|4236371|P3|STARTED|Overall Study||34
1730200|NCT00234104|4236372|P2|STARTED|Overall Study||29
1730201|NCT00234104|4236373|P1|STARTED|Overall Study||30
1730202|NCT00234078|4236387|P4|NOT COMPLETED|Overall Study||4
1730203|NCT00234078|4236388|P3|NOT COMPLETED|Overall Study||10
1730204|NCT00234078|4236389|P2|NOT COMPLETED|Overall Study||9
1730205|NCT00234078|4236390|P1|NOT COMPLETED|Overall Study||6
1730206|NCT00234078|4236387|P4|COMPLETED|Overall Study||68
1730207|NCT00234078|4236388|P3|COMPLETED|Overall Study||64
1730208|NCT00234078|4236389|P2|COMPLETED|Overall Study||63
1730209|NCT00234078|4236390|P1|COMPLETED|Overall Study||66
1730210|NCT00234078|4236387|P4|STARTED|Overall Study||72
1730211|NCT00234078|4236388|P3|STARTED|Overall Study||74
1730212|NCT00234078|4236389|P2|STARTED|Overall Study||72
1730213|NCT00234078|4236390|P1|STARTED|Overall Study||72
1730214|NCT00234065|4236414|P2|NOT COMPLETED|Overall Study||356
1730215|NCT00234065|4236415|P1|NOT COMPLETED|Overall Study||475
1730216|NCT00234065|4236414|P2|COMPLETED|Overall Study||1004
1730217|NCT00234065|4236415|P1|COMPLETED|Overall Study||881
1730218|NCT00234065|4236414|P2|STARTED|Overall Study||1360
1730219|NCT00234065|4236415|P1|STARTED|Overall Study||1356
1730220|NCT00234039|4236431|P1|NOT COMPLETED|Overall Study||50
1730221|NCT00234039|4236431|P1|COMPLETED|Overall Study||8
1730222|NCT00234039|4236431|P1|Eligible and Began Protocol Therapy|Overall Study||47
1730223|NCT00234039|4236431|P1|Eligible|Overall Study||49
1730224|NCT00234039|4236431|P1|STARTED|Overall Study||58
1730225|NCT00233987|4236438|P1|NOT COMPLETED|Overall Study||15
1730226|NCT00233987|4236438|P1|COMPLETED|Overall Study||83
1730227|NCT00233987|4236438|P1|Eligible and Treated|Overall Study||92
1730228|NCT00233987|4236438|P1|Eligible|Overall Study||94
1730229|NCT00233987|4236438|P1|STARTED|Overall Study||98
1730230|NCT00233948|4236447|P6|NOT COMPLETED|Overall Study||0
1730231|NCT00233948|4236448|P5|NOT COMPLETED|Overall Study||0
1730232|NCT00233948|4236449|P4|NOT COMPLETED|Overall Study||0
1730233|NCT00233948|4236450|P3|NOT COMPLETED|Overall Study||0
1730234|NCT00233948|4236451|P2|NOT COMPLETED|Overall Study||0
1730235|NCT00233948|4236452|P1|NOT COMPLETED|Overall Study||1
1730236|NCT00233948|4236447|P6|COMPLETED|Overall Study||12
1730237|NCT00233948|4236448|P5|COMPLETED|Overall Study||4
1730238|NCT00233948|4236449|P4|COMPLETED|Overall Study||3
1730239|NCT00233948|4236450|P3|COMPLETED|Overall Study||3
1730240|NCT00233948|4236451|P2|COMPLETED|Overall Study||3
1730241|NCT00233948|4236452|P1|COMPLETED|Overall Study||3
1730242|NCT00233948|4236447|P6|STARTED|Overall Study||12
1730243|NCT00233948|4236448|P5|STARTED|Overall Study||4
1730244|NCT00233948|4236449|P4|STARTED|Overall Study||3
1730245|NCT00233948|4236450|P3|STARTED|Overall Study||3
1730246|NCT00233948|4236451|P2|STARTED|Overall Study||3
1730247|NCT00233948|4236452|P1|STARTED|Overall Study||4
1730248|NCT00233519|4236469|P2|NOT COMPLETED|Overall Study||1
1730249|NCT00233519|4236470|P1|NOT COMPLETED|Overall Study||1
1730250|NCT00233519|4236469|P2|COMPLETED|Overall Study||9
1730251|NCT00233519|4236470|P1|COMPLETED|Overall Study||6
1730252|NCT00233519|4236469|P2|STARTED|Overall Study||10
1730253|NCT00233519|4236470|P1|STARTED|Overall Study||7
1730254|NCT00233454|4236476|P1|NOT COMPLETED|Overall Study||6
1730255|NCT00233454|4236476|P1|COMPLETED|Overall Study||20
1730256|NCT00233454|4236476|P1|2 Months (for Response Rate)|Overall Study||26
1730257|NCT00233454|4236476|P1|STARTED|Overall Study||26
1730258|NCT00233402|4236484|P2|NOT COMPLETED|Overall Study||124
1730259|NCT00233402|4236485|P1|NOT COMPLETED|Overall Study||104
1730260|NCT00233402|4236484|P2|COMPLETED|Overall Study||271
1730261|NCT00233402|4236485|P1|COMPLETED|Overall Study||280
1730262|NCT00233402|4236484|P2|STARTED|Overall Study||395
1730263|NCT00233402|4236485|P1|STARTED|Overall Study||384
1730264|NCT00233324|4236500|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
1730265|NCT00233324|4236501|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
1730266|NCT00233324|4236502|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
1730267|NCT00233324|4236503|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
1730268|NCT00233324|4236500|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
1730269|NCT00233324|4236501|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
1730270|NCT00233324|4236502|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
1730271|NCT00233324|4236503|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
1730272|NCT00233324|4236500|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
1730273|NCT00233324|4236501|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
1730274|NCT00233324|4236502|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
1730275|NCT00233324|4236503|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
1730276|NCT00233324|4236500|P4|NOT COMPLETED|Main Study||47
1730277|NCT00233324|4236501|P3|NOT COMPLETED|Main Study||62
1730278|NCT00233324|4236502|P2|NOT COMPLETED|Main Study||60
1730279|NCT00233324|4236503|P1|NOT COMPLETED|Main Study||68
1730280|NCT00233324|4236500|P4|COMPLETED|Main Study||280
1730281|NCT00233324|4236501|P3|COMPLETED|Main Study||274
1730282|NCT00233324|4236502|P2|COMPLETED|Main Study||275
1730283|NCT00233324|4236503|P1|COMPLETED|Main Study||250
1730284|NCT00233324|4236500|P4|STARTED|Main Study||327
1730285|NCT00233324|4236501|P3|STARTED|Main Study||336
1730286|NCT00233324|4236502|P2|STARTED|Main Study||335
1730287|NCT00233324|4236503|P1|STARTED|Main Study||318
1730288|NCT00233103|4236519|P2|NOT COMPLETED|Overall Study||6
1730289|NCT00233103|4236520|P1|NOT COMPLETED|Overall Study||5
1730290|NCT00233103|4236519|P2|COMPLETED|Overall Study||19
1730291|NCT00233103|4236520|P1|COMPLETED|Overall Study||22
1730292|NCT00233103|4236519|P2|STARTED|Overall Study||25
1730293|NCT00233103|4236520|P1|STARTED|Overall Study||27
1730294|NCT00233090|4236534|P2|NOT COMPLETED|Overall Study||0
1730295|NCT00233090|4236535|P1|NOT COMPLETED|Overall Study||0
1730296|NCT00233090|4236534|P2|COMPLETED|Overall Study||9
1730297|NCT00233090|4236535|P1|COMPLETED|Overall Study||12
1730298|NCT00233090|4236534|P2|STARTED|Overall Study||9
1730299|NCT00233090|4236535|P1|STARTED|Overall Study||12
1730300|NCT00233064|4236557|P2|NOT COMPLETED|Overall Study||12
1730301|NCT00233064|4236558|P1|NOT COMPLETED|Overall Study||14
1730302|NCT00233064|4236557|P2|COMPLETED|Overall Study||190
1730303|NCT00233064|4236558|P1|COMPLETED|Overall Study||197
1730304|NCT00233064|4236557|P2|STARTED|Overall Study||202
1730305|NCT00233064|4236558|P1|STARTED|Overall Study||211
1730306|NCT00232739|4236565|P1|NOT COMPLETED|Overall Study||9
1730307|NCT00232739|4236565|P1|COMPLETED|Overall Study||91
1730308|NCT00232739|4236565|P1|STARTED|Overall Study||100
1730309|NCT00232596|4236584|P2|NOT COMPLETED|12-Week Maintenance Phase||28
1730310|NCT00232596|4236585|P1|NOT COMPLETED|12-Week Maintenance Phase||12
1730311|NCT00232596|4236584|P2|COMPLETED|12-Week Maintenance Phase||97
1730312|NCT00232596|4236585|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
1730313|NCT00232596|4236584|P2|STARTED|12-Week Maintenance Phase||125
1730314|NCT00232596|4236585|P1|STARTED|12-Week Maintenance Phase||138
1730315|NCT00232596|4236584|P2|NOT COMPLETED|6-Week Titration Phase||29
1730316|NCT00232596|4236585|P1|NOT COMPLETED|6-Week Titration Phase||14
1730317|NCT00232596|4236584|P2|COMPLETED|6-Week Titration Phase||125
1730318|NCT00232596|4236585|P1|COMPLETED|6-Week Titration Phase||138
1730319|NCT00232596|4236584|P2|STARTED|6-Week Titration Phase||154
1730320|NCT00232596|4236585|P1|STARTED|6-Week Titration Phase||152
1730321|NCT00232583|4236637|P2|NOT COMPLETED|Overall Study||13
1730322|NCT00232583|4236638|P1|NOT COMPLETED|Overall Study||10
1730323|NCT00232583|4236637|P2|COMPLETED|Overall Study||16
1730324|NCT00232583|4236638|P1|COMPLETED|Overall Study||19
1730325|NCT00232583|4236637|P2|STARTED|Overall Study||29
1730326|NCT00232583|4236638|P1|STARTED|Overall Study||29
1730327|NCT00232557|4236676|P2|NOT COMPLETED|Overall Study||5
1730328|NCT00232557|4236677|P1|NOT COMPLETED|Overall Study||3
1730329|NCT00232557|4236676|P2|COMPLETED|Overall Study||60
1730330|NCT00232557|4236677|P1|COMPLETED|Overall Study||68
1730331|NCT00232557|4236676|P2|STARTED|Overall Study||65
1730332|NCT00232557|4236677|P1|STARTED|Overall Study||71
1730333|NCT00232544|4236687|P2|NOT COMPLETED|Overall Study||15
1730334|NCT00232544|4236688|P1|NOT COMPLETED|Overall Study||20
1730335|NCT00232544|4236687|P2|COMPLETED|Overall Study||111
1730336|NCT00232544|4236688|P1|COMPLETED|Overall Study||104
1730337|NCT00232544|4236687|P2|STARTED|Overall Study||126
1730338|NCT00232544|4236688|P1|STARTED|Overall Study||124
1730339|NCT00232505|4236698|P2|NOT COMPLETED|Overall Study||11
1730340|NCT00232505|4236699|P1|NOT COMPLETED|Overall Study||5
1730341|NCT00232505|4236698|P2|COMPLETED|Overall Study||60
1730342|NCT00232505|4236699|P1|COMPLETED|Overall Study||26
1730343|NCT00232505|4236698|P2|Off Protocol|Overall Study||0
1730344|NCT00232505|4236699|P1|Off Protocol|Overall Study||5
1730345|NCT00232505|4236698|P2|Early Progressors|Overall Study||5
1730346|NCT00232505|4236699|P1|Early Progressors|Overall Study||2
1730347|NCT00232505|4236698|P2|Not Evaluable|Overall Study||6
1730348|NCT00232505|4236699|P1|Not Evaluable|Overall Study||0
1730349|NCT00232505|4236698|P2|STARTED|Overall Study||71
1730350|NCT00232505|4236699|P1|STARTED|Overall Study||31
1730351|NCT00232479|4236712|P1|NOT COMPLETED|Overall Study||0
1730352|NCT00232479|4236712|P1|COMPLETED|Overall Study||44
1730353|NCT00232479|4236712|P1|STARTED|Overall Study||44
1730354|NCT00232180|4236719|P3|NOT COMPLETED|Open Label Phase||148
1730355|NCT00232180|4236720|P2|NOT COMPLETED|Open Label Phase||0
1730356|NCT00232180|4236721|P1|NOT COMPLETED|Open Label Phase||0
1730357|NCT00232180|4236719|P3|COMPLETED|Open Label Phase||1098
1730358|NCT00232180|4236720|P2|COMPLETED|Open Label Phase||0
1730359|NCT00232180|4236721|P1|COMPLETED|Open Label Phase||0
1730360|NCT00232180|4236719|P3|Treated|Open Label Phase||1245
1730361|NCT00232180|4236720|P2|Treated|Open Label Phase||0
1730362|NCT00232180|4236721|P1|Treated|Open Label Phase||0
1730363|NCT00232180|4236719|P3|STARTED|Open Label Phase||1246
1730364|NCT00232180|4236720|P2|STARTED|Open Label Phase||0
1730365|NCT00232180|4236721|P1|STARTED|Open Label Phase||0
1730366|NCT00232180|4236719|P3|NOT COMPLETED|Double-blind (DB) Phase||0
1730367|NCT00232180|4236720|P2|NOT COMPLETED|Double-blind (DB) Phase||605
1730368|NCT00232180|4236721|P1|NOT COMPLETED|Double-blind (DB) Phase||541
1730369|NCT00232180|4236719|P3|COMPLETED|Double-blind (DB) Phase||0
1730370|NCT00232180|4236720|P2|COMPLETED|Double-blind (DB) Phase||771
1730371|NCT00232180|4236721|P1|COMPLETED|Double-blind (DB) Phase||826
1730372|NCT00232180|4236719|P3|Treated|Double-blind (DB) Phase||0
1730373|NCT00232180|4236720|P2|Treated|Double-blind (DB) Phase||1372
1730374|NCT00232180|4236721|P1|Treated|Double-blind (DB) Phase||1364
1730375|NCT00232180|4236719|P3|STARTED|Double-blind (DB) Phase||0
1730376|NCT00232180|4236720|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
1730377|NCT00232180|4236721|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
1730378|NCT00232141|4236766|P2|NOT COMPLETED|Overall Study||26
1730379|NCT00232141|4236767|P1|NOT COMPLETED|Overall Study||31
1730380|NCT00232141|4236766|P2|COMPLETED|Overall Study||125
1730381|NCT00232141|4236767|P1|COMPLETED|Overall Study||120
1730382|NCT00232141|4236766|P2|STARTED|Overall Study||151
1730383|NCT00232141|4236767|P1|STARTED|Overall Study||151
1730384|NCT00231894|4236837|P2|NOT COMPLETED|Overall Study||1
1730385|NCT00231894|4236838|P1|NOT COMPLETED|Overall Study||1
1730386|NCT00231894|4236837|P2|COMPLETED|Overall Study||24
1730387|NCT00231894|4236838|P1|COMPLETED|Overall Study||30
1730388|NCT00231894|4236837|P2|STARTED|Overall Study||25
1730389|NCT00231894|4236838|P1|STARTED|Overall Study||31
1730390|NCT00231816|4236862|P2|NOT COMPLETED|Overall Study||12
1730391|NCT00231816|4236863|P1|NOT COMPLETED|Overall Study||16
1730392|NCT00231816|4236862|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
1730393|NCT00231816|4236863|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
1730394|NCT00231816|4236862|P2|Vaccinated at Visit 2|Overall Study||371
1730395|NCT00231816|4236863|P1|Vaccinated at Visit 2|Overall Study||369
1730396|NCT00231816|4236862|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
1730397|NCT00231816|4236863|P1|Vaccinated at Visit 1|Overall Study||382
1730398|NCT00231816|4236862|P2|STARTED|Overall Study||381
1730399|NCT00231816|4236863|P1|STARTED|Overall Study||382
1730400|NCT00231777|4236878|P2|NOT COMPLETED|Overall Study||2
1730401|NCT00231777|4236879|P1|NOT COMPLETED|Overall Study||6
1730402|NCT00231777|4236878|P2|COMPLETED|Overall Study||44
1730403|NCT00231777|4236879|P1|COMPLETED|Overall Study||164
1730404|NCT00231777|4236878|P2|STARTED|Overall Study||46
1730405|NCT00231777|4236879|P1|STARTED|Overall Study||170
1730406|NCT00231478|4236893|P2|NOT COMPLETED|Overall Study||6
1730407|NCT00231478|4236894|P1|NOT COMPLETED|Overall Study||8
1730408|NCT00231478|4236893|P2|COMPLETED|Overall Study||78
1730409|NCT00231478|4236894|P1|COMPLETED|Overall Study||79
1730410|NCT00231478|4236893|P2|STARTED|Overall Study||84
1730411|NCT00231478|4236894|P1|STARTED|Overall Study||87
1730412|NCT00231465|4236906|P1|NOT COMPLETED|Overall Study||2
1730413|NCT00231465|4236906|P1|COMPLETED|Overall Study||42
1730414|NCT00231465|4236906|P1|STARTED|Overall Study||44
1730415|NCT00231309|4236912|P1|NOT COMPLETED|Overall Study||0
1730416|NCT00231309|4236912|P1|COMPLETED|Overall Study||10
1730417|NCT00231309|4236912|P1|STARTED|Overall Study||10
1730418|NCT00231283|4236917|P1|NOT COMPLETED|Overall Study||5
1730419|NCT00231283|4236917|P1|COMPLETED|Overall Study||95
1730420|NCT00231283|4236917|P1|STARTED|Overall Study||100
1730421|NCT00231179|4236926|P2|NOT COMPLETED|Overall Study||24
1730422|NCT00231179|4236927|P1|NOT COMPLETED|Overall Study||24
1730423|NCT00231179|4236926|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
1730424|NCT00231179|4236927|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
1730425|NCT00231179|4236926|P2|STARTED|Overall Study||150
1730426|NCT00231179|4236927|P1|STARTED|Overall Study||152
1730427|NCT00231153|4236943|P2|NOT COMPLETED|Overall Study||188
1730428|NCT00231153|4236944|P1|NOT COMPLETED|Overall Study||217
1730429|NCT00231153|4236943|P2|COMPLETED|Overall Study||720
1730430|NCT00231153|4236944|P1|COMPLETED|Overall Study||690
1730431|NCT00231153|4236943|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
1730432|NCT00231153|4236944|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
1730433|NCT00231114|4236954|P2|NOT COMPLETED|Post-Treatment Period||1
1730434|NCT00231114|4236955|P1|NOT COMPLETED|Post-Treatment Period||8
1730435|NCT00231114|4236954|P2|COMPLETED|Post-Treatment Period||97
1730436|NCT00231114|4236955|P1|COMPLETED|Post-Treatment Period||181
1730437|NCT00231114|4236954|P2|STARTED|Post-Treatment Period||98
1730438|NCT00231114|4236955|P1|STARTED|Post-Treatment Period||189
1730439|NCT00231114|4236954|P2|NOT COMPLETED|Treatment Period||0
1730440|NCT00231114|4236955|P1|NOT COMPLETED|Treatment Period||1
1730441|NCT00231114|4236954|P2|COMPLETED|Treatment Period||98
1730442|NCT00231114|4236955|P1|COMPLETED|Treatment Period||189
1730443|NCT00231114|4236954|P2|STARTED|Treatment Period||98
1730444|NCT00231114|4236955|P1|STARTED|Treatment Period||190
1730445|NCT00231114|4236954|P2|NOT COMPLETED|Randomized||3
1730446|NCT00231114|4236955|P1|NOT COMPLETED|Randomized||6
1730447|NCT00231114|4236954|P2|COMPLETED|Randomized||98
1730448|NCT00231114|4236955|P1|COMPLETED|Randomized||190
1730449|NCT00231114|4236954|P2|STARTED|Randomized||101
1730450|NCT00231114|4236955|P1|STARTED|Randomized||196
1730451|NCT00231062|4236991|P1|NOT COMPLETED|Overall Study||6
1730452|NCT00231062|4236991|P1|COMPLETED|Overall Study||109
1730453|NCT00231062|4236991|P1|STARTED|Overall Study||115
1730454|NCT00230971|4236999|P2|NOT COMPLETED|Baseline Participants||19
1730455|NCT00230971|4237000|P1|NOT COMPLETED|Baseline Participants||22
1730456|NCT00230971|4236999|P2|COMPLETED|Baseline Participants||216
1730457|NCT00230971|4237000|P1|COMPLETED|Baseline Participants||210
1730458|NCT00230971|4236999|P2|STARTED|Baseline Participants||235
1730459|NCT00230971|4237000|P1|STARTED|Baseline Participants||232
1730460|NCT00230971|4236999|P2|NOT COMPLETED|Randomization||3
1730461|NCT00230971|4237000|P1|NOT COMPLETED|Randomization||3
1730462|NCT00230971|4236999|P2|COMPLETED|Randomization||235
1730463|NCT00230971|4237000|P1|COMPLETED|Randomization||232
1730464|NCT00230971|4236999|P2|STARTED|Randomization||238
1730465|NCT00230971|4237000|P1|STARTED|Randomization||235
1730466|NCT00230802|4237014|P2|NOT COMPLETED|Overall Study||0
1730467|NCT00230802|4237015|P1|NOT COMPLETED|Overall Study||0
1730468|NCT00230802|4237014|P2|COMPLETED|Overall Study||23
1730469|NCT00230802|4237015|P1|COMPLETED|Overall Study||25
1730470|NCT00230802|4237014|P2|STARTED|Overall Study||23
1730471|NCT00230802|4237015|P1|STARTED|Overall Study||25
1730472|NCT00230737|4237028|P3|NOT COMPLETED|Overall Study||0
1730473|NCT00230737|4237029|P2|NOT COMPLETED|Overall Study||0
1730474|NCT00230737|4237030|P1|NOT COMPLETED|Overall Study||0
1730475|NCT00230737|4237028|P3|COMPLETED|Overall Study||8
1730476|NCT00230737|4237029|P2|COMPLETED|Overall Study||10
1730477|NCT00230737|4237030|P1|COMPLETED|Overall Study||9
1730478|NCT00230737|4237028|P3|STARTED|Overall Study||8
1730479|NCT00230737|4237029|P2|STARTED|Overall Study||10
1730480|NCT00230737|4237030|P1|STARTED|Overall Study||9
1730481|NCT00230282|4237038|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
1730482|NCT00230282|4237038|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
1730483|NCT00230282|4237038|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
1730484|NCT00230282|4237038|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
1730485|NCT00230282|4237038|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
1730486|NCT00230282|4237038|P1|STARTED|Fludarabine + Cyclophosphamide||25
1730487|NCT00230178|4237046|P3|NOT COMPLETED|Overall Study||7
1730488|NCT00230178|4237047|P2|NOT COMPLETED|Overall Study||7
1730489|NCT00230178|4237048|P1|NOT COMPLETED|Overall Study||4
1730490|NCT00230178|4237046|P3|COMPLETED|Overall Study||86
1730491|NCT00230178|4237047|P2|COMPLETED|Overall Study||86
1730492|NCT00230178|4237048|P1|COMPLETED|Overall Study||90
1730493|NCT00230178|4237046|P3|Treated|Overall Study||91
1730494|NCT00230178|4237047|P2|Treated|Overall Study||92
1730495|NCT00230178|4237048|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
1730496|NCT00230178|4237046|P3|STARTED|Overall Study||93
1730497|NCT00230178|4237047|P2|STARTED|Overall Study||93
1730498|NCT00230178|4237048|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
1730499|NCT00230126|4237064|P2|NOT COMPLETED|Overall Study||1
1730500|NCT00230126|4237065|P1|NOT COMPLETED|Overall Study||2
1730501|NCT00230126|4237064|P2|COMPLETED|Overall Study||27
1730502|NCT00230126|4237065|P1|COMPLETED|Overall Study||28
1730503|NCT00230126|4237064|P2|STARTED|Overall Study||28
1730504|NCT00230126|4237065|P1|STARTED|Overall Study||30
1730505|NCT00230100|4237077|P2|NOT COMPLETED|Overall Study||0
1730506|NCT00230100|4237078|P1|NOT COMPLETED|Overall Study||0
1730507|NCT00230100|4237077|P2|COMPLETED|Overall Study||17
1730508|NCT00230100|4237078|P1|COMPLETED|Overall Study||29
1730509|NCT00230100|4237077|P2|STARTED|Overall Study||17
1730510|NCT00230100|4237078|P1|STARTED|Overall Study||29
1730511|NCT00230048|4237100|P2|NOT COMPLETED|Overall Study||18
1730512|NCT00230048|4237101|P1|NOT COMPLETED|Overall Study||13
1730513|NCT00230048|4237100|P2|COMPLETED|Overall Study||37
1730514|NCT00230048|4237101|P1|COMPLETED|Overall Study||39
1730515|NCT00230048|4237100|P2|Completed Intervention/Control Session|Overall Study||55
1730516|NCT00230048|4237101|P1|Completed Intervention/Control Session|Overall Study||52
1730517|NCT00230048|4237100|P2|STARTED|Overall Study||55
1730518|NCT00230048|4237101|P1|STARTED|Overall Study||52
1730519|NCT00230022|4237111|P2|NOT COMPLETED|Overall Study||0
1730520|NCT00230022|4237112|P1|NOT COMPLETED|Overall Study||0
1730521|NCT00230022|4237111|P2|COMPLETED|Overall Study||15
1730522|NCT00230022|4237112|P1|COMPLETED|Overall Study||15
1730523|NCT00230022|4237111|P2|STARTED|Overall Study||15
1730524|NCT00230022|4237112|P1|STARTED|Overall Study||15
1730525|NCT00230009|4237120|P2|NOT COMPLETED|Follow-up||26
1730526|NCT00230009|4237121|P1|NOT COMPLETED|Follow-up||31
1730527|NCT00230009|4237120|P2|COMPLETED|Follow-up||24
1730528|NCT00230009|4237121|P1|COMPLETED|Follow-up||19
1730529|NCT00230009|4237120|P2|STARTED|Follow-up||50
1730530|NCT00230009|4237121|P1|STARTED|Follow-up||50
1730531|NCT00230009|4237120|P2|NOT COMPLETED|Single Session Intervention/Control||0
1730532|NCT00230009|4237121|P1|NOT COMPLETED|Single Session Intervention/Control||0
1730533|NCT00230009|4237120|P2|COMPLETED|Single Session Intervention/Control||50
1730534|NCT00230009|4237121|P1|COMPLETED|Single Session Intervention/Control||50
1730535|NCT00230009|4237120|P2|STARTED|Single Session Intervention/Control||50
1730536|NCT00230009|4237121|P1|STARTED|Single Session Intervention/Control||50
1730537|NCT00229970|4237138|P3|NOT COMPLETED|Overall Study||0
1730538|NCT00229970|4237139|P2|NOT COMPLETED|Overall Study||0
1730539|NCT00229970|4237140|P1|NOT COMPLETED|Overall Study||0
1730540|NCT00229970|4237138|P3|COMPLETED|Overall Study||75
1730541|NCT00229970|4237139|P2|COMPLETED|Overall Study||72
1730542|NCT00229970|4237140|P1|COMPLETED|Overall Study||78
1730543|NCT00229970|4237138|P3|STARTED|Overall Study||75
1730544|NCT00229970|4237139|P2|STARTED|Overall Study||72
1730545|NCT00229970|4237140|P1|STARTED|Overall Study||78
1730546|NCT00229957|4237150|P2|NOT COMPLETED|Overall Study||12
1730547|NCT00229957|4237151|P1|NOT COMPLETED|Overall Study||20
1730548|NCT00229957|4237150|P2|COMPLETED|Overall Study||139
1730549|NCT00229957|4237151|P1|COMPLETED|Overall Study||132
1730550|NCT00229957|4237150|P2|STARTED|Overall Study||151
1730551|NCT00229957|4237151|P1|STARTED|Overall Study||152
1730552|NCT00229931|4237159|P2|NOT COMPLETED|Overall Study||2
1730553|NCT00229931|4237160|P1|NOT COMPLETED|Overall Study||4
1730554|NCT00229931|4237159|P2|COMPLETED|Overall Study||3
1730555|NCT00229931|4237160|P1|COMPLETED|Overall Study||2
1730556|NCT00229931|4237159|P2|STARTED|Overall Study||5
1730557|NCT00229931|4237160|P1|STARTED|Overall Study||6
1730558|NCT00229723|4237175|P7|NOT COMPLETED|Maintenance Phase||10
1730559|NCT00229723|4237176|P6|NOT COMPLETED|Maintenance Phase||19
1730560|NCT00229723|4237177|P5|NOT COMPLETED|Maintenance Phase||15
1730561|NCT00229723|4237178|P4|NOT COMPLETED|Maintenance Phase||17
1730562|NCT00229723|4237179|P3|NOT COMPLETED|Maintenance Phase||9
1730563|NCT00229723|4237180|P2|NOT COMPLETED|Maintenance Phase||14
1730564|NCT00229723|4237181|P1|NOT COMPLETED|Maintenance Phase||25
1730565|NCT00229723|4237175|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
1730566|NCT00229723|4237176|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
1730567|NCT00229723|4237177|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
1730568|NCT00229723|4237178|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
1730569|NCT00229723|4237179|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
1730570|NCT00229723|4237180|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
1730571|NCT00229723|4237181|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
1730572|NCT00229723|4237175|P7|STARTED|Maintenance Phase||19
1730573|NCT00229723|4237176|P6|STARTED|Maintenance Phase||31
1730574|NCT00229723|4237177|P5|STARTED|Maintenance Phase||22
1730575|NCT00229723|4237178|P4|STARTED|Maintenance Phase||26
1730576|NCT00229723|4237179|P3|STARTED|Maintenance Phase||25
1730577|NCT00229723|4237180|P2|STARTED|Maintenance Phase||19
1730578|NCT00229723|4237181|P1|STARTED|Maintenance Phase||50
1730579|NCT00229723|4237175|P7|NOT COMPLETED|Concomitant Phase||3
1730580|NCT00229723|4237176|P6|NOT COMPLETED|Concomitant Phase||3
1730581|NCT00229723|4237177|P5|NOT COMPLETED|Concomitant Phase||2
1730582|NCT00229723|4237178|P4|NOT COMPLETED|Concomitant Phase||5
1730583|NCT00229723|4237179|P3|NOT COMPLETED|Concomitant Phase||6
1730584|NCT00229723|4237180|P2|NOT COMPLETED|Concomitant Phase||5
1730585|NCT00229723|4237181|P1|NOT COMPLETED|Concomitant Phase||10
1730586|NCT00229723|4237175|P7|COMPLETED|Concomitant Phase||19
1730587|NCT00229723|4237176|P6|COMPLETED|Concomitant Phase||31
1730588|NCT00229723|4237177|P5|COMPLETED|Concomitant Phase||22
1730589|NCT00229723|4237178|P4|COMPLETED|Concomitant Phase||26
1730590|NCT00229723|4237179|P3|COMPLETED|Concomitant Phase||25
1730591|NCT00229723|4237180|P2|COMPLETED|Concomitant Phase||19
1730592|NCT00229723|4237181|P1|COMPLETED|Concomitant Phase||50
1730593|NCT00229723|4237175|P7|STARTED|Concomitant Phase|Received randomized treatment|22
1730594|NCT00229723|4237176|P6|STARTED|Concomitant Phase|Received randomized treatment|34
1730595|NCT00229723|4237177|P5|STARTED|Concomitant Phase|Received randomized treatment|24
1730596|NCT00229723|4237178|P4|STARTED|Concomitant Phase|Received randomized treatment|31
1730597|NCT00229723|4237179|P3|STARTED|Concomitant Phase|Received randomized treatment|31
1730598|NCT00229723|4237180|P2|STARTED|Concomitant Phase|Received randomized treatment|24
1730599|NCT00229723|4237181|P1|STARTED|Concomitant Phase|Received randomized treatment|60
1730600|NCT00229658|4237234|P2|NOT COMPLETED|Overall Study||167
1730601|NCT00229658|4237235|P1|NOT COMPLETED|Overall Study||225
1730602|NCT00229658|4237234|P2|COMPLETED|Overall Study||364
1730603|NCT00229658|4237235|P1|COMPLETED|Overall Study||541
1730604|NCT00229658|4237234|P2|STARTED|Overall Study||531
1730605|NCT00229658|4237235|P1|STARTED|Overall Study||766
1730606|NCT00229619|4237263|P1|NOT COMPLETED|Overall Study||0
1730607|NCT00229619|4237263|P1|COMPLETED|Overall Study||11
1730608|NCT00229619|4237263|P1|STARTED|Overall Study||11
1730609|NCT00229203|4237271|P2|NOT COMPLETED|Overall Study||19
1730610|NCT00229203|4237272|P1|NOT COMPLETED|Overall Study||32
1730611|NCT00229203|4237271|P2|COMPLETED|Overall Study||0
1730612|NCT00229203|4237272|P1|COMPLETED|Overall Study||0
1730613|NCT00229203|4237271|P2|STARTED|Overall Study||19
1730614|NCT00229203|4237272|P1|STARTED|Overall Study||32
1730615|NCT00228943|4237284|P1|NOT COMPLETED|Week 2||1
1730616|NCT00228943|4237284|P1|COMPLETED|Week 2||27
1730617|NCT00228943|4237284|P1|STARTED|Week 2||28
1730618|NCT00228943|4237284|P1|NOT COMPLETED|Week 1||0
1730619|NCT00228943|4237284|P1|COMPLETED|Week 1||28
1730620|NCT00228943|4237284|P1|STARTED|Week 1||28
1730621|NCT00228917|4237296|P4|NOT COMPLETED|Overall Study||0
1730622|NCT00228917|4237297|P3|NOT COMPLETED|Overall Study||0
1730623|NCT00228917|4237298|P2|NOT COMPLETED|Overall Study||3
1730624|NCT00228917|4237299|P1|NOT COMPLETED|Overall Study||1
1730625|NCT00228917|4237296|P4|COMPLETED|Overall Study||107
1730626|NCT00228917|4237297|P3|COMPLETED|Overall Study||213
1730627|NCT00228917|4237298|P2|COMPLETED|Overall Study||320
1730628|NCT00228917|4237299|P1|COMPLETED|Overall Study||646
1730629|NCT00228917|4237296|P4|STARTED|Overall Study||107
1730630|NCT00228917|4237297|P3|STARTED|Overall Study||213
1730631|NCT00228917|4237298|P2|STARTED|Overall Study||323
1730632|NCT00228917|4237299|P1|STARTED|Overall Study||647
1730633|NCT00228813|4237325|P1|NOT COMPLETED|Overall Study||4
1730634|NCT00228813|4237325|P1|COMPLETED|Overall Study||4
1730635|NCT00228813|4237325|P1|STARTED|Overall Study||8
1730636|NCT00228566|4237331|P1|NOT COMPLETED|Overall Study||71
1730637|NCT00228566|4237331|P1|COMPLETED|Overall Study||176
1730638|NCT00228566|4237331|P1|STARTED|Overall Study||247
1730639|NCT00228553|4237335|P1|NOT COMPLETED|Overall Study||430
1730640|NCT00228553|4237335|P1|COMPLETED|Overall Study||313
1730641|NCT00228553|4237335|P1|STARTED|Overall Study||743
1730642|NCT00228384|4237341|P2|NOT COMPLETED|Overall Study||29
1730643|NCT00228384|4237342|P1|NOT COMPLETED|Overall Study||29
1730644|NCT00228384|4237341|P2|COMPLETED|Overall Study||47
1730645|NCT00228384|4237342|P1|COMPLETED|Overall Study||43
1730646|NCT00228384|4237341|P2|Three Year Follow-up (Final)|Overall Study||47
1730647|NCT00228384|4237342|P1|Three Year Follow-up (Final)|Overall Study||43
1730648|NCT00228384|4237341|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
1730649|NCT00228384|4237342|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
1730650|NCT00228384|4237341|P2|Baseline|Overall Study||76
1730651|NCT00228384|4237342|P1|Baseline|Overall Study||72
1730652|NCT00228384|4237341|P2|STARTED|Overall Study||76
1730653|NCT00228384|4237342|P1|STARTED|Overall Study||72
1730654|NCT00227994|4237382|P2|NOT COMPLETED|Overall Study||7
1730655|NCT00227994|4237383|P1|NOT COMPLETED|Overall Study||7
1730656|NCT00227994|4237382|P2|COMPLETED|Overall Study||13
1730657|NCT00227994|4237383|P1|COMPLETED|Overall Study||13
1730658|NCT00227994|4237382|P2|STARTED|Overall Study||20
1730659|NCT00227994|4237383|P1|STARTED|Overall Study||20
1730660|NCT00227903|4237393|P2|NOT COMPLETED|Overall Study||10
1730661|NCT00227903|4237394|P1|NOT COMPLETED|Overall Study||5
1730662|NCT00227903|4237393|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
1730663|NCT00227903|4237394|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
1730664|NCT00227903|4237393|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
1730665|NCT00227903|4237394|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
1730666|NCT00227903|4237393|P2|STARTED|Overall Study||92
1730667|NCT00227903|4237394|P1|STARTED|Overall Study||91
1730668|NCT00227877|4237458|P4|NOT COMPLETED|12-months Follow-up||26
1730669|NCT00227877|4237459|P3|NOT COMPLETED|12-months Follow-up||31
1730670|NCT00227877|4237460|P2|NOT COMPLETED|12-months Follow-up||263
1730671|NCT00227877|4237461|P1|NOT COMPLETED|12-months Follow-up||310
1730672|NCT00227877|4237458|P4|COMPLETED|12-months Follow-up||266
1730673|NCT00227877|4237459|P3|COMPLETED|12-months Follow-up||266
1730674|NCT00227877|4237460|P2|COMPLETED|12-months Follow-up||765
1730675|NCT00227877|4237461|P1|COMPLETED|12-months Follow-up||758
1730676|NCT00227877|4237458|P4|STARTED|12-months Follow-up||292
1730677|NCT00227877|4237459|P3|STARTED|12-months Follow-up||297
1730678|NCT00227877|4237460|P2|STARTED|12-months Follow-up||1028
1730679|NCT00227877|4237461|P1|STARTED|12-months Follow-up||1068
1730680|NCT00227877|4237458|P4|NOT COMPLETED|3-months Follow-up||21
1730681|NCT00227877|4237459|P3|NOT COMPLETED|3-months Follow-up||52
1730682|NCT00227877|4237460|P2|NOT COMPLETED|3-months Follow-up||267
1730683|NCT00227877|4237461|P1|NOT COMPLETED|3-months Follow-up||313
1730684|NCT00227877|4237458|P4|COMPLETED|3-months Follow-up||271
1730685|NCT00227877|4237459|P3|COMPLETED|3-months Follow-up||245
1730686|NCT00227877|4237460|P2|COMPLETED|3-months Follow-up||761
1730687|NCT00227877|4237461|P1|COMPLETED|3-months Follow-up||755
1730688|NCT00227877|4237458|P4|STARTED|3-months Follow-up||292
1730689|NCT00227877|4237459|P3|STARTED|3-months Follow-up||297
1730690|NCT00227877|4237460|P2|STARTED|3-months Follow-up||1028
1730691|NCT00227877|4237461|P1|STARTED|3-months Follow-up||1068
1730692|NCT00227877|4237458|P4|NOT COMPLETED|Post-visit Checklist||0
1730693|NCT00227877|4237459|P3|NOT COMPLETED|Post-visit Checklist||1
1730694|NCT00227877|4237460|P2|NOT COMPLETED|Post-visit Checklist||13
1730695|NCT00227877|4237461|P1|NOT COMPLETED|Post-visit Checklist||24
1730696|NCT00227877|4237458|P4|COMPLETED|Post-visit Checklist||292
1730697|NCT00227877|4237459|P3|COMPLETED|Post-visit Checklist||296
1730698|NCT00227877|4237460|P2|COMPLETED|Post-visit Checklist||1015
1730699|NCT00227877|4237461|P1|COMPLETED|Post-visit Checklist||1044
1730700|NCT00227877|4237458|P4|STARTED|Post-visit Checklist||292
1730701|NCT00227877|4237459|P3|STARTED|Post-visit Checklist||297
1730702|NCT00227877|4237460|P2|STARTED|Post-visit Checklist||1028
1730703|NCT00227877|4237461|P1|STARTED|Post-visit Checklist||1068
1730704|NCT00227877|4237458|P4|NOT COMPLETED|Pre-visit Assessment||0
1730705|NCT00227877|4237459|P3|NOT COMPLETED|Pre-visit Assessment||0
1730706|NCT00227877|4237460|P2|NOT COMPLETED|Pre-visit Assessment||3
1730707|NCT00227877|4237461|P1|NOT COMPLETED|Pre-visit Assessment||7
1730708|NCT00227877|4237458|P4|COMPLETED|Pre-visit Assessment|Final analysis sample|292
1730709|NCT00227877|4237459|P3|COMPLETED|Pre-visit Assessment|Final analysis sample|297
1730710|NCT00227877|4237460|P2|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
1730711|NCT00227877|4237461|P1|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
1730712|NCT00227877|4237458|P4|STARTED|Pre-visit Assessment||292
1730713|NCT00227877|4237459|P3|STARTED|Pre-visit Assessment||297
1730714|NCT00227877|4237460|P2|STARTED|Pre-visit Assessment||1031
1730715|NCT00227877|4237461|P1|STARTED|Pre-visit Assessment||1075
1730716|NCT00227760|4237491|P1|NOT COMPLETED|Overall Study||0
1730717|NCT00227760|4237491|P1|COMPLETED|Overall Study||44
1730718|NCT00227760|4237491|P1|STARTED|Overall Study||44
1730719|NCT00227721|4237497|P1|NOT COMPLETED|Overall Study||1
1730720|NCT00227721|4237497|P1|COMPLETED|Overall Study||29
1730721|NCT00227721|4237497|P1|STARTED|Overall Study||30
1730722|NCT00227591|4237501|P1|NOT COMPLETED|Overall Study||1
1730723|NCT00227591|4237501|P1|COMPLETED|Overall Study||47
1730724|NCT00227591|4237501|P1|Began Treatment|Overall Study||47
1730725|NCT00227591|4237501|P1|STARTED|Overall Study|48 pts registered to the study|48
1730726|NCT00227539|4237505|P1|NOT COMPLETED|Overall Study||1
1730727|NCT00227539|4237505|P1|COMPLETED|Overall Study||24
1730728|NCT00227539|4237505|P1|STARTED|Overall Study||25
1730729|NCT00227370|4237513|P2|NOT COMPLETED|Overall Study||24
1730730|NCT00227370|4237514|P1|NOT COMPLETED|Overall Study||21
1730731|NCT00227370|4237513|P2|COMPLETED|Overall Study||46
1730732|NCT00227370|4237514|P1|COMPLETED|Overall Study||45
1730733|NCT00227370|4237513|P2|STARTED|Overall Study|Treatment Group|70
1730734|NCT00227370|4237514|P1|STARTED|Overall Study|Placebo Group|66
1730735|NCT00227344|4237534|P2|NOT COMPLETED|Overall Study||5
1730736|NCT00227344|4237535|P1|NOT COMPLETED|Overall Study||12
1730737|NCT00227344|4237534|P2|COMPLETED|Overall Study||37
1730738|NCT00227344|4237535|P1|COMPLETED|Overall Study||75
1730739|NCT00227344|4237534|P2|STARTED|Overall Study||42
1730740|NCT00227344|4237535|P1|STARTED|Overall Study||87
1730741|NCT00227305|4237555|P1|NOT COMPLETED|Overall Study||144
1730742|NCT00227305|4237555|P1|COMPLETED|Overall Study|Completed 26 weeks|237
1730743|NCT00227305|4237555|P1|Drug Received|Overall Study|safety population|380
1730744|NCT00227305|4237555|P1|STARTED|Overall Study|enrolled|381
1730745|NCT00227266|4237572|P3|NOT COMPLETED|Overall Study||4
1730746|NCT00227266|4237573|P2|NOT COMPLETED|Overall Study||0
1730747|NCT00227266|4237574|P1|NOT COMPLETED|Overall Study||1
1730748|NCT00227266|4237572|P3|COMPLETED|Overall Study||29
1730749|NCT00227266|4237573|P2|COMPLETED|Overall Study||30
1730750|NCT00227266|4237574|P1|COMPLETED|Overall Study||30
1730751|NCT00227266|4237572|P3|STARTED|Overall Study||33
1730752|NCT00227266|4237573|P2|STARTED|Overall Study||30
1730753|NCT00227266|4237574|P1|STARTED|Overall Study||31
1730754|NCT00227019|4237594|P1|NOT COMPLETED|Overall Study||0
1730755|NCT00227019|4237594|P1|COMPLETED|Overall Study||16
1730756|NCT00227019|4237594|P1|STARTED|Overall Study||16
1730757|NCT00226941|4237604|P4|NOT COMPLETED|Overall Study||2
1730758|NCT00226941|4237605|P3|NOT COMPLETED|Overall Study||0
1730759|NCT00226941|4237606|P2|NOT COMPLETED|Overall Study||0
1730760|NCT00226941|4237607|P1|NOT COMPLETED|Overall Study||0
1730761|NCT00226941|4237604|P4|COMPLETED|Overall Study||5
1730762|NCT00226941|4237605|P3|COMPLETED|Overall Study||4
1730763|NCT00226941|4237606|P2|COMPLETED|Overall Study||6
1730764|NCT00226941|4237607|P1|COMPLETED|Overall Study||6
1730765|NCT00226941|4237604|P4|STARTED|Overall Study||7
1730766|NCT00226941|4237605|P3|STARTED|Overall Study||4
1730767|NCT00226941|4237606|P2|STARTED|Overall Study||6
1730768|NCT00226941|4237607|P1|STARTED|Overall Study||6
1730769|NCT00226811|4237641|P1|NOT COMPLETED|Overall Study||76
1730770|NCT00226811|4237641|P1|COMPLETED|Overall Study||2
1730771|NCT00226811|4237641|P1|STARTED|Overall Study||78
1730772|NCT00226655|4237651|P1|NOT COMPLETED|Overall Study||79
1730773|NCT00226655|4237651|P1|COMPLETED|Overall Study||33
1730774|NCT00226655|4237651|P1|STARTED|Overall Study||112
1730775|NCT00226590|4237655|P1|NOT COMPLETED|Overall Study||0
1730776|NCT00226590|4237655|P1|COMPLETED|Overall Study||39
1730777|NCT00226590|4237655|P1|STARTED|Overall Study||39
1730778|NCT00226577|4237662|P1|NOT COMPLETED|Overall Study||0
1730779|NCT00226577|4237662|P1|COMPLETED|Overall Study||52
1730780|NCT00226577|4237662|P1|STARTED|Overall Study||52
1730781|NCT00226239|4237670|P1|NOT COMPLETED|Maintenance Cetuximab||14
1730782|NCT00226239|4237670|P1|COMPLETED|Maintenance Cetuximab||17
1730783|NCT00226239|4237670|P1|STARTED|Maintenance Cetuximab||31
1730784|NCT00226239|4237670|P1|NOT COMPLETED|XPE, Definitive Therapy||4
1730785|NCT00226239|4237670|P1|COMPLETED|XPE, Definitive Therapy||33
1730786|NCT00226239|4237670|P1|STARTED|XPE, Definitive Therapy||37
1730787|NCT00226239|4237670|P1|NOT COMPLETED|TPE, Induction Therapy||2
1730788|NCT00226239|4237670|P1|COMPLETED|TPE, Induction Therapy||37
1730789|NCT00226239|4237670|P1|STARTED|TPE, Induction Therapy||39
1730790|NCT00225784|4237679|P1|NOT COMPLETED|Overall Study||4
1730791|NCT00225784|4237679|P1|COMPLETED|Overall Study||33
1730792|NCT00225784|4237679|P1|STARTED|Overall Study||37
1730793|NCT00225758|4237690|P1|NOT COMPLETED|Overall Study||4
1730794|NCT00225758|4237690|P1|COMPLETED|Overall Study||23
1730795|NCT00225758|4237690|P1|STARTED|Overall Study||27
1730796|NCT00225732|4237700|P2|NOT COMPLETED|Overall Study||0
1730797|NCT00225732|4237701|P1|NOT COMPLETED|Overall Study||0
1730798|NCT00225732|4237700|P2|COMPLETED|Overall Study||166
1730799|NCT00225732|4237701|P1|COMPLETED|Overall Study||153
1730800|NCT00225732|4237700|P2|STARTED|Overall Study||166
1730801|NCT00225732|4237701|P1|STARTED|Overall Study||153
1730802|NCT00225498|4237707|P1|NOT COMPLETED|Overall Study||0
1730803|NCT00225498|4237707|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
1730804|NCT00225498|4237707|P1|STARTED|Overall Study||10
1730805|NCT00225420|4237711|P3|NOT COMPLETED|Overall Study||0
1730806|NCT00225420|4237712|P2|NOT COMPLETED|Overall Study||0
1730807|NCT00225420|4237713|P1|NOT COMPLETED|Overall Study||0
1730808|NCT00225420|4237711|P3|COMPLETED|Overall Study||3
1730809|NCT00225420|4237712|P2|COMPLETED|Overall Study||6
1730810|NCT00225420|4237713|P1|COMPLETED|Overall Study||9
1730811|NCT00225420|4237711|P3|STARTED|Overall Study||3
1730812|NCT00225420|4237712|P2|STARTED|Overall Study||6
1730813|NCT00225420|4237713|P1|STARTED|Overall Study||9
1730814|NCT00225277|4237722|P2|NOT COMPLETED|Overall Study||95
1730815|NCT00225277|4237723|P1|NOT COMPLETED|Overall Study||97
1730816|NCT00225277|4237722|P2|COMPLETED|Overall Study||178
1730817|NCT00225277|4237723|P1|COMPLETED|Overall Study||177
1730818|NCT00225277|4237722|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
1730819|NCT00225277|4237723|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
1730820|NCT00225251|4237741|P2|NOT COMPLETED|Overall Study||1
1730821|NCT00225251|4237742|P1|NOT COMPLETED|Overall Study||1
1730822|NCT00225251|4237741|P2|COMPLETED|Overall Study||6
1730823|NCT00225251|4237742|P1|COMPLETED|Overall Study||10
1730824|NCT00225251|4237741|P2|STARTED|Overall Study||7
1730825|NCT00225251|4237742|P1|STARTED|Overall Study||11
1730826|NCT00225212|4237756|P1|NOT COMPLETED|Overall Study||6
1730827|NCT00225212|4237756|P1|COMPLETED|Overall Study||29
1730828|NCT00225212|4237756|P1|STARTED|Overall Study||35
1730829|NCT00225147|4237765|P4|NOT COMPLETED|Open-label Phase||10
1730830|NCT00225147|4237766|P3|NOT COMPLETED|Open-label Phase||0
1730831|NCT00225147|4237767|P2|NOT COMPLETED|Open-label Phase||0
1730832|NCT00225147|4237768|P1|NOT COMPLETED|Open-label Phase||0
1730833|NCT00225147|4237765|P4|COMPLETED|Open-label Phase||52
1730834|NCT00225147|4237766|P3|COMPLETED|Open-label Phase||0
1730835|NCT00225147|4237767|P2|COMPLETED|Open-label Phase||0
1730836|NCT00225147|4237768|P1|COMPLETED|Open-label Phase||0
1730837|NCT00225147|4237765|P4|STARTED|Open-label Phase||62
1730838|NCT00225147|4237766|P3|STARTED|Open-label Phase||0
1730839|NCT00225147|4237767|P2|STARTED|Open-label Phase||0
1730840|NCT00225147|4237768|P1|STARTED|Open-label Phase||0
1730841|NCT00225147|4237765|P4|NOT COMPLETED|Double-blind Phase||0
1730842|NCT00225147|4237766|P3|NOT COMPLETED|Double-blind Phase||0
1730843|NCT00225147|4237767|P2|NOT COMPLETED|Double-blind Phase||0
1730844|NCT00225147|4237768|P1|NOT COMPLETED|Double-blind Phase||0
1730845|NCT00225147|4237765|P4|COMPLETED|Double-blind Phase||0
1730846|NCT00225147|4237766|P3|COMPLETED|Double-blind Phase||13
1730847|NCT00225147|4237767|P2|COMPLETED|Double-blind Phase||12
1730848|NCT00225147|4237768|P1|COMPLETED|Double-blind Phase||13
1730849|NCT00225147|4237765|P4|STARTED|Double-blind Phase||0
1730850|NCT00225147|4237766|P3|STARTED|Double-blind Phase||13
1730851|NCT00225147|4237767|P2|STARTED|Double-blind Phase||12
1730852|NCT00225147|4237768|P1|STARTED|Double-blind Phase||13
1730853|NCT00225017|4237784|P2|NOT COMPLETED|Overall Study||1
1730854|NCT00225017|4237785|P1|NOT COMPLETED|Overall Study||0
1730855|NCT00225017|4237784|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
1730856|NCT00225017|4237785|P1|COMPLETED|Overall Study||26
1730857|NCT00225017|4237784|P2|STARTED|Overall Study||24
1730858|NCT00225017|4237785|P1|STARTED|Overall Study||26
1730859|NCT00224952|4237798|P3|NOT COMPLETED|Overall Study||0
1730860|NCT00224952|4237799|P2|NOT COMPLETED|Overall Study||0
1730861|NCT00224952|4237800|P1|NOT COMPLETED|Overall Study||0
1730862|NCT00224952|4237798|P3|COMPLETED|Overall Study||134
1730863|NCT00224952|4237799|P2|COMPLETED|Overall Study||87
1730864|NCT00224952|4237800|P1|COMPLETED|Overall Study||53
1730865|NCT00224952|4237798|P3|STARTED|Overall Study||134
1730866|NCT00224952|4237799|P2|STARTED|Overall Study||87
1730867|NCT00224952|4237800|P1|STARTED|Overall Study||53
1730868|NCT00224874|4237815|P4|NOT COMPLETED|Overall Study||0
1730869|NCT00224874|4237816|P3|NOT COMPLETED|Overall Study||1
1730870|NCT00224874|4237817|P2|NOT COMPLETED|Overall Study||0
1730871|NCT00224874|4237818|P1|NOT COMPLETED|Overall Study||0
1730872|NCT00224874|4237815|P4|COMPLETED|Overall Study||42
1730873|NCT00224874|4237816|P3|COMPLETED|Overall Study||46
1730874|NCT00224874|4237817|P2|COMPLETED|Overall Study||45
1730875|NCT00224874|4237818|P1|COMPLETED|Overall Study||46
1730876|NCT00224874|4237815|P4|STARTED|Overall Study||42
1730877|NCT00224874|4237816|P3|STARTED|Overall Study||47
1730878|NCT00224874|4237817|P2|STARTED|Overall Study||45
1730879|NCT00224874|4237818|P1|STARTED|Overall Study||46
1730880|NCT00224770|4237863|P3|NOT COMPLETED|Overall Study||0
1730881|NCT00224770|4237864|P2|NOT COMPLETED|Overall Study||2
1730882|NCT00224770|4237865|P1|NOT COMPLETED|Overall Study||4
1730883|NCT00224770|4237863|P3|COMPLETED|Overall Study||14
1730884|NCT00224770|4237864|P2|COMPLETED|Overall Study||52
1730885|NCT00224770|4237865|P1|COMPLETED|Overall Study||38
1730886|NCT00224770|4237863|P3|STARTED|Overall Study||14
1730887|NCT00224770|4237864|P2|STARTED|Overall Study||54
1730888|NCT00224770|4237865|P1|STARTED|Overall Study||42
1730889|NCT00224484|4237900|P3|NOT COMPLETED|Overall Study||62
1730890|NCT00224484|4237901|P2|NOT COMPLETED|Overall Study||65
1730891|NCT00224484|4237902|P1|NOT COMPLETED|Overall Study||146
1730892|NCT00224484|4237900|P3|COMPLETED|Overall Study||1425
1730893|NCT00224484|4237901|P2|COMPLETED|Overall Study||1426
1730894|NCT00224484|4237902|P1|COMPLETED|Overall Study||2831
1730895|NCT00224484|4237900|P3|STARTED|Overall Study||1487
1730896|NCT00224484|4237901|P2|STARTED|Overall Study||1491
1730897|NCT00224484|4237902|P1|STARTED|Overall Study||2977
1730898|NCT00224289|4237961|P1|NOT COMPLETED|Overall Study||0
1730899|NCT00224289|4237961|P1|COMPLETED|Overall Study||17
1730900|NCT00224289|4237961|P1|STARTED|Overall Study||17
1730901|NCT00224133|4237966|P1|NOT COMPLETED|Overall Study||226
1730902|NCT00224133|4237966|P1|COMPLETED|Overall Study||435
1730903|NCT00224133|4237966|P1|STARTED|Overall Study||661
1730904|NCT00224120|4237972|P2|NOT COMPLETED|Overall Study||24
1730905|NCT00224120|4237973|P1|NOT COMPLETED|Overall Study||22
1730906|NCT00224120|4237972|P2|COMPLETED|Overall Study||205
1730907|NCT00224120|4237973|P1|COMPLETED|Overall Study||211
1730908|NCT00224120|4237972|P2|STARTED|Overall Study||229
1730909|NCT00224120|4237973|P1|STARTED|Overall Study||233
1730910|NCT00224107|4237983|P2|NOT COMPLETED|Overall Study||14
1730911|NCT00224107|4237984|P1|NOT COMPLETED|Overall Study||31
1730912|NCT00224107|4237983|P2|COMPLETED|Overall Study||214
1730913|NCT00224107|4237984|P1|COMPLETED|Overall Study||202
1730914|NCT00224107|4237983|P2|STARTED|Overall Study||228
1730915|NCT00224107|4237984|P1|STARTED|Overall Study||233
1730916|NCT00224055|4237994|P2|NOT COMPLETED|Overall Study||14
1730917|NCT00224055|4237995|P1|NOT COMPLETED|Overall Study||15
1730918|NCT00224055|4237994|P2|COMPLETED|Overall Study||31
1730919|NCT00224055|4237995|P1|COMPLETED|Overall Study||29
1730920|NCT00224055|4237994|P2|STARTED|Overall Study||45
1730921|NCT00224055|4237995|P1|STARTED|Overall Study||44
1730922|NCT00224042|4238005|P2|NOT COMPLETED|Overall Study||6
1730923|NCT00224042|4238006|P1|NOT COMPLETED|Overall Study||6
1730924|NCT00224042|4238005|P2|COMPLETED|Overall Study||20
1730925|NCT00224042|4238006|P1|COMPLETED|Overall Study||20
1730926|NCT00224042|4238005|P2|STARTED|Overall Study||26
1730927|NCT00224042|4238006|P1|STARTED|Overall Study||26
1730928|NCT00224029|4238018|P1|NOT COMPLETED|Overall Study||6
1730929|NCT00224029|4238018|P1|COMPLETED|Overall Study||18
1730930|NCT00224029|4238018|P1|STARTED|Overall Study||24
1730931|NCT00224016|4238024|P2|NOT COMPLETED|Follow-Up Period||0
1730932|NCT00224016|4238025|P1|NOT COMPLETED|Follow-Up Period||0
1730933|NCT00224016|4238024|P2|COMPLETED|Follow-Up Period||0
1730934|NCT00224016|4238025|P1|COMPLETED|Follow-Up Period||35
1730935|NCT00224016|4238024|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
1730936|NCT00224016|4238025|P1|STARTED|Follow-Up Period||35
1730937|NCT00224016|4238024|P2|NOT COMPLETED|Maintenance Period||1
1730938|NCT00224016|4238025|P1|NOT COMPLETED|Maintenance Period||2
1730939|NCT00224016|4238024|P2|COMPLETED|Maintenance Period||14
1730940|NCT00224016|4238025|P1|COMPLETED|Maintenance Period||36
1730941|NCT00224016|4238024|P2|STARTED|Maintenance Period||15
1730942|NCT00224016|4238025|P1|STARTED|Maintenance Period||38
1730943|NCT00224016|4238024|P2|NOT COMPLETED|Titration Period||1
1730944|NCT00224016|4238025|P1|NOT COMPLETED|Titration Period||1
1730945|NCT00224016|4238024|P2|COMPLETED|Titration Period||15
1730946|NCT00224016|4238025|P1|COMPLETED|Titration Period||38
1730947|NCT00224016|4238024|P2|STARTED|Titration Period||16
1730948|NCT00224016|4238025|P1|STARTED|Titration Period||39
1730949|NCT00224003|4238033|P1|NOT COMPLETED|Overall Study||7
1730950|NCT00224003|4238033|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
1730951|NCT00224003|4238033|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
1730952|NCT00223977|4238040|P3|NOT COMPLETED|Overall Study||3
1730953|NCT00223977|4238041|P2|NOT COMPLETED|Overall Study||11
1730954|NCT00223977|4238042|P1|NOT COMPLETED|Overall Study||9
1730955|NCT00223977|4238040|P3|COMPLETED|Overall Study||39
1730956|NCT00223977|4238041|P2|COMPLETED|Overall Study||47
1730957|NCT00223977|4238042|P1|COMPLETED|Overall Study||37
1730958|NCT00223977|4238040|P3|STARTED|Overall Study||42
1730959|NCT00223977|4238041|P2|STARTED|Overall Study||58
1730960|NCT00223977|4238042|P1|STARTED|Overall Study||46
1730961|NCT00223821|4238064|P2|NOT COMPLETED|Overall Study||10
1730962|NCT00223821|4238065|P1|NOT COMPLETED|Overall Study||4
1730963|NCT00223821|4238064|P2|COMPLETED|Overall Study||22
1730964|NCT00223821|4238065|P1|COMPLETED|Overall Study||28
1730965|NCT00223821|4238064|P2|Completed 6-month Follow-up|Overall Study||25
1730966|NCT00223821|4238065|P1|Completed 6-month Follow-up|Overall Study||28
1730967|NCT00223821|4238064|P2|Completed Post-treatment Assessment|Overall Study||27
1730968|NCT00223821|4238065|P1|Completed Post-treatment Assessment|Overall Study||31
1730969|NCT00223821|4238064|P2|Completed Therapy|Overall Study||28
1730970|NCT00223821|4238065|P1|Completed Therapy|Overall Study||31
1730971|NCT00223821|4238064|P2|STARTED|Overall Study||32
1730972|NCT00223821|4238065|P1|STARTED|Overall Study||32
1730973|NCT00223808|4238076|P3|NOT COMPLETED|Overall Study||5
1730974|NCT00223808|4238077|P2|NOT COMPLETED|Overall Study||5
1730975|NCT00223808|4238078|P1|NOT COMPLETED|Overall Study||3
1730976|NCT00223808|4238076|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
1730977|NCT00223808|4238077|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
1730978|NCT00223808|4238078|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
1730979|NCT00223808|4238076|P3|STARTED|Overall Study||23
1730980|NCT00223808|4238077|P2|STARTED|Overall Study||22
1730981|NCT00223808|4238078|P1|STARTED|Overall Study||22
1730982|NCT00223795|4238095|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
1730983|NCT00223795|4238096|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
1730984|NCT00223795|4238095|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
1730985|NCT00223795|4238096|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
1730986|NCT00223795|4238095|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
1730987|NCT00223795|4238096|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
1730988|NCT00223795|4238095|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
1730989|NCT00223795|4238096|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
1730990|NCT00223795|4238095|P2|COMPLETED|First Intervention - Eight Weeks||18
1730991|NCT00223795|4238096|P1|COMPLETED|First Intervention - Eight Weeks||19
1730992|NCT00223795|4238095|P2|STARTED|First Intervention - Eight Weeks||27
1730993|NCT00223795|4238096|P1|STARTED|First Intervention - Eight Weeks||26
1730994|NCT00223704|4238106|P3|NOT COMPLETED|Overall Study||0
1730995|NCT00223704|4238107|P2|NOT COMPLETED|Overall Study||0
1730996|NCT00223704|4238108|P1|NOT COMPLETED|Overall Study||0
1730997|NCT00223704|4238106|P3|COMPLETED|Overall Study||40
1730998|NCT00223704|4238107|P2|COMPLETED|Overall Study||37
1730999|NCT00223704|4238108|P1|COMPLETED|Overall Study||38
1731000|NCT00223704|4238106|P3|STARTED|Overall Study||40
1731001|NCT00223704|4238107|P2|STARTED|Overall Study||37
1731002|NCT00223704|4238108|P1|STARTED|Overall Study||38
1731003|NCT00223678|4238130|P2|NOT COMPLETED|Overall Study||0
1731004|NCT00223678|4238131|P1|NOT COMPLETED|Overall Study||0
1731005|NCT00223678|4238130|P2|COMPLETED|Overall Study||7
1731006|NCT00223678|4238131|P1|COMPLETED|Overall Study||13
1731007|NCT00223678|4238130|P2|STARTED|Overall Study||7
1731008|NCT00223678|4238131|P1|STARTED|Overall Study||13
1731009|NCT00223665|4238137|P1|NOT COMPLETED|Overall Study||0
1731010|NCT00223665|4238137|P1|COMPLETED|Overall Study||102
1731011|NCT00223665|4238137|P1|STARTED|Overall Study||102
1731012|NCT00223652|4238157|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
1731013|NCT00223652|4238158|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
1731014|NCT00223652|4238157|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
1731015|NCT00223652|4238158|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
1731016|NCT00223652|4238157|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
1731017|NCT00223652|4238158|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
1731018|NCT00223652|4238157|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
1731019|NCT00223652|4238158|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
1731020|NCT00223652|4238157|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
1731021|NCT00223652|4238158|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
1731022|NCT00223652|4238157|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
1731023|NCT00223652|4238158|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
1731024|NCT00223652|4238157|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
1731025|NCT00223652|4238158|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
1731026|NCT00223652|4238157|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
1731027|NCT00223652|4238158|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
1731028|NCT00223652|4238157|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
1731029|NCT00223652|4238158|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
1731030|NCT00223496|4238174|P1|NOT COMPLETED|Overall Study||22
1731031|NCT00223496|4238174|P1|COMPLETED|Overall Study||10
1731032|NCT00223496|4238174|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
1731033|NCT00223236|4238180|P2|NOT COMPLETED|Overall Study||14
1731034|NCT00223236|4238181|P1|NOT COMPLETED|Overall Study||7
1731035|NCT00223236|4238180|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
1731036|NCT00223236|4238181|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
1731037|NCT00223236|4238180|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
1731038|NCT00223236|4238181|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
1731039|NCT00223080|4238195|P2|NOT COMPLETED|Overall Study||797
1731040|NCT00223080|4238196|P1|NOT COMPLETED|Overall Study||796
1731041|NCT00223080|4238195|P2|COMPLETED|Overall Study||7401
1731042|NCT00223080|4238196|P1|COMPLETED|Overall Study||7401
1731043|NCT00223080|4238195|P2|STARTED|Overall Study||8198
1731044|NCT00223080|4238196|P1|STARTED|Overall Study||8197
1731045|NCT00222729|4238214|P1|NOT COMPLETED|Overall Study||3
1731046|NCT00222729|4238214|P1|COMPLETED|Overall Study||37
1731047|NCT00222729|4238214|P1|STARTED|Overall Study||40
1731048|NCT00222105|4238221|P1|NOT COMPLETED|Overall Study||14
1731049|NCT00222105|4238221|P1|COMPLETED|Overall Study||11
1731050|NCT00222105|4238221|P1|STARTED|Overall Study||25
1731051|NCT00221299|4238229|P4|NOT COMPLETED|Overall Study||1
1731052|NCT00221299|4238230|P3|NOT COMPLETED|Overall Study||0
1731053|NCT00221299|4238231|P2|NOT COMPLETED|Overall Study||2
1731054|NCT00221299|4238232|P1|NOT COMPLETED|Overall Study||1
1731055|NCT00221299|4238229|P4|COMPLETED|Overall Study||10
1731056|NCT00221299|4238230|P3|COMPLETED|Overall Study||14
1731057|NCT00221299|4238231|P2|COMPLETED|Overall Study||11
1731058|NCT00221299|4238232|P1|COMPLETED|Overall Study||10
1731059|NCT00221299|4238229|P4|STARTED|Overall Study||11
1731060|NCT00221299|4238230|P3|STARTED|Overall Study||14
1731061|NCT00221299|4238231|P2|STARTED|Overall Study||13
1731062|NCT00221299|4238232|P1|STARTED|Overall Study||11
1731063|NCT00221195|4238242|P2|NOT COMPLETED|Overall Study||3
1731064|NCT00221195|4238243|P1|NOT COMPLETED|Overall Study||5
1731065|NCT00221195|4238242|P2|COMPLETED|Overall Study||14
1731066|NCT00221195|4238243|P1|COMPLETED|Overall Study||12
1731067|NCT00221195|4238242|P2|STARTED|Overall Study||17
1731068|NCT00221195|4238243|P1|STARTED|Overall Study||17
1731069|NCT00221117|4238252|P2|NOT COMPLETED|Overall Study||0
1731070|NCT00221117|4238253|P1|NOT COMPLETED|Overall Study||0
1731071|NCT00221117|4238252|P2|COMPLETED|Overall Study||9
1731072|NCT00221117|4238253|P1|COMPLETED|Overall Study||12
1731073|NCT00221117|4238252|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
1731074|NCT00221117|4238253|P1|STARTED|Overall Study||12
1731075|NCT00221104|4238265|P2|NOT COMPLETED|Overall Study||76
1731076|NCT00221104|4238266|P1|NOT COMPLETED|Overall Study||83
1731077|NCT00221104|4238265|P2|COMPLETED|Overall Study||709
1731078|NCT00221104|4238266|P1|COMPLETED|Overall Study||710
1731079|NCT00221104|4238265|P2|STARTED|Overall Study||785
1731080|NCT00221104|4238266|P1|STARTED|Overall Study||793
1731081|NCT00220961|4238282|P2|NOT COMPLETED|Overall Study||90
1731082|NCT00220961|4238283|P1|NOT COMPLETED|Overall Study||71
1731083|NCT00220961|4238282|P2|COMPLETED|Overall Study||213
1731084|NCT00220961|4238283|P1|COMPLETED|Overall Study||228
1731085|NCT00220961|4238282|P2|STARTED|Overall Study||303
1731086|NCT00220961|4238283|P1|STARTED|Overall Study||299
1731087|NCT00220805|4238299|P2|NOT COMPLETED|Overall Study||11
1731088|NCT00220805|4238300|P1|NOT COMPLETED|Overall Study||8
1731089|NCT00220805|4238299|P2|COMPLETED|Overall Study||16
1731090|NCT00220805|4238300|P1|COMPLETED|Overall Study||22
1731091|NCT00220805|4238299|P2|STARTED|Overall Study||27
1731092|NCT00220805|4238300|P1|STARTED|Overall Study||30
1731093|NCT00220779|4238321|P3|NOT COMPLETED|Overall Study||4
1731094|NCT00220779|4238322|P2|NOT COMPLETED|Overall Study||4
1731095|NCT00220779|4238323|P1|NOT COMPLETED|Overall Study||7
1731096|NCT00220779|4238321|P3|COMPLETED|Overall Study||37
1731097|NCT00220779|4238322|P2|COMPLETED|Overall Study||38
1731098|NCT00220779|4238323|P1|COMPLETED|Overall Study||38
1731099|NCT00220779|4238321|P3|STARTED|Overall Study||41
1731100|NCT00220779|4238322|P2|STARTED|Overall Study||42
1731101|NCT00220779|4238323|P1|STARTED|Overall Study||45
1731102|NCT00220740|4238333|P2|NOT COMPLETED|Withdrawal Period||15
1731103|NCT00220740|4238334|P1|NOT COMPLETED|Withdrawal Period||6
1731104|NCT00220740|4238333|P2|COMPLETED|Withdrawal Period||16
1731105|NCT00220740|4238334|P1|COMPLETED|Withdrawal Period||37
1731106|NCT00220740|4238333|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
1731107|NCT00220740|4238334|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
1731108|NCT00220740|4238333|P2|NOT COMPLETED|Rescue Treatment||18
1731109|NCT00220740|4238334|P1|NOT COMPLETED|Rescue Treatment||19
1731110|NCT00220740|4238333|P2|COMPLETED|Rescue Treatment||5
1731111|NCT00220740|4238334|P1|COMPLETED|Rescue Treatment||26
1731112|NCT00220740|4238333|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
1731113|NCT00220740|4238334|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
1731114|NCT00220740|4238333|P2|NOT COMPLETED|Efficacy Period||46
1731115|NCT00220740|4238334|P1|NOT COMPLETED|Efficacy Period||26
1731116|NCT00220740|4238333|P2|COMPLETED|Efficacy Period||12
1731117|NCT00220740|4238334|P1|COMPLETED|Efficacy Period||33
1731118|NCT00220740|4238333|P2|STARTED|Efficacy Period||58
1731119|NCT00220740|4238334|P1|STARTED|Efficacy Period||59
1731120|NCT00220727|4238348|P2|NOT COMPLETED|Second Infusion (Week <6)||0
1731121|NCT00220727|4238349|P1|NOT COMPLETED|Second Infusion (Week <6)||1
1731122|NCT00220727|4238348|P2|COMPLETED|Second Infusion (Week <6)||4
1731123|NCT00220727|4238349|P1|COMPLETED|Second Infusion (Week <6)||3
1731124|NCT00220727|4238348|P2|STARTED|Second Infusion (Week <6)||4
1731125|NCT00220727|4238349|P1|STARTED|Second Infusion (Week <6)||4
1731126|NCT00220727|4238348|P2|NOT COMPLETED|First Infusion (Week 0)||0
1731127|NCT00220727|4238349|P1|NOT COMPLETED|First Infusion (Week 0)||0
1731128|NCT00220727|4238348|P2|COMPLETED|First Infusion (Week 0)||4
1731129|NCT00220727|4238349|P1|COMPLETED|First Infusion (Week 0)||4
1731130|NCT00220727|4238348|P2|STARTED|First Infusion (Week 0)||4
1731131|NCT00220727|4238349|P1|STARTED|First Infusion (Week 0)||4
1731132|NCT00220701|4238365|P2|NOT COMPLETED|Overall Study||4
1731133|NCT00220701|4238366|P1|NOT COMPLETED|Overall Study||5
1731134|NCT00220701|4238365|P2|COMPLETED|Overall Study||13
1731135|NCT00220701|4238366|P1|COMPLETED|Overall Study||12
1731136|NCT00220701|4238365|P2|STARTED|Overall Study||17
1731137|NCT00220701|4238366|P1|STARTED|Overall Study||17
1731138|NCT00220636|4238382|P1|NOT COMPLETED|Overall Study||4
1731139|NCT00220636|4238382|P1|COMPLETED|Overall Study||11
1731140|NCT00220636|4238382|P1|STARTED|Overall Study||15
1731141|NCT00219557|4238392|P3|NOT COMPLETED|Phase 2||33
1731142|NCT00219557|4238393|P2|NOT COMPLETED|Phase 2||69
1731143|NCT00219557|4238394|P1|NOT COMPLETED|Phase 2||0
1731144|NCT00219557|4238392|P3|COMPLETED|Phase 2||1
1731145|NCT00219557|4238393|P2|COMPLETED|Phase 2||0
1731146|NCT00219557|4238394|P1|COMPLETED|Phase 2||0
1731147|NCT00219557|4238392|P3|Treated|Phase 2||31
1731148|NCT00219557|4238393|P2|Treated|Phase 2||68
1731149|NCT00219557|4238394|P1|Treated|Phase 2||0
1731150|NCT00219557|4238392|P3|STARTED|Phase 2||34
1731151|NCT00219557|4238393|P2|STARTED|Phase 2||69
1731152|NCT00219557|4238394|P1|STARTED|Phase 2||0
1731153|NCT00219557|4238392|P3|NOT COMPLETED|Phase 1||0
1731154|NCT00219557|4238393|P2|NOT COMPLETED|Phase 1||0
1731155|NCT00219557|4238394|P1|NOT COMPLETED|Phase 1||7
1731156|NCT00219557|4238392|P3|COMPLETED|Phase 1||0
1731157|NCT00219557|4238393|P2|COMPLETED|Phase 1||0
1731158|NCT00219557|4238394|P1|COMPLETED|Phase 1||1
1731159|NCT00219557|4238392|P3|STARTED|Phase 1||0
1731160|NCT00219557|4238393|P2|STARTED|Phase 1||0
1731161|NCT00219557|4238394|P1|STARTED|Phase 1||8
1731162|NCT00219544|4238422|P2|NOT COMPLETED|Double Blind Treatment Period||0
1731163|NCT00219544|4238423|P1|NOT COMPLETED|Double Blind Treatment Period||0
1731164|NCT00219544|4238422|P2|COMPLETED|Double Blind Treatment Period||77
1731165|NCT00219544|4238423|P1|COMPLETED|Double Blind Treatment Period||80
1731166|NCT00219544|4238422|P2|STARTED|Double Blind Treatment Period||77
1731167|NCT00219544|4238423|P1|STARTED|Double Blind Treatment Period||80
1731168|NCT00219544|4238422|P2|NOT COMPLETED|Single Blind Treatment Period||0
1731169|NCT00219544|4238423|P1|NOT COMPLETED|Single Blind Treatment Period||22
1731170|NCT00219544|4238422|P2|COMPLETED|Single Blind Treatment Period||0
1731171|NCT00219544|4238423|P1|COMPLETED|Single Blind Treatment Period||234
1731172|NCT00219544|4238422|P2|STARTED|Single Blind Treatment Period||0
1731173|NCT00219544|4238423|P1|STARTED|Single Blind Treatment Period||256
1731174|NCT00219349|4238461|P1|NOT COMPLETED|Escitalopram Phase||3
1731175|NCT00219349|4238461|P1|COMPLETED|Escitalopram Phase||4
1731176|NCT00219349|4238461|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
1731177|NCT00219349|4238461|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
1731178|NCT00219349|4238461|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
1731179|NCT00219349|4238461|P1|STARTED|Cognitive Behavioral Therapy Phase||25
1731180|NCT00219284|4238474|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
1731181|NCT00219284|4238475|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
1731182|NCT00219284|4238474|P2|COMPLETED|Extension Phase - 8 Weeks||99
1731183|NCT00219284|4238475|P1|COMPLETED|Extension Phase - 8 Weeks||112
1731184|NCT00219284|4238474|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
1731185|NCT00219284|4238475|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
1731186|NCT00219284|4238474|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
1731187|NCT00219284|4238475|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
1731188|NCT00219284|4238474|P2|COMPLETED|Treatment Phase - 16 Weeks||128
1731189|NCT00219284|4238475|P1|COMPLETED|Treatment Phase - 16 Weeks||136
1731190|NCT00219284|4238474|P2|STARTED|Treatment Phase - 16 Weeks||179
1731191|NCT00219284|4238475|P1|STARTED|Treatment Phase - 16 Weeks||180
1731192|NCT00219141|4238500|P3|NOT COMPLETED|Overall Study||12
1731193|NCT00219141|4238501|P2|NOT COMPLETED|Overall Study||21
1731194|NCT00219141|4238502|P1|NOT COMPLETED|Overall Study||14
1731195|NCT00219141|4238500|P3|COMPLETED|Overall Study||142
1731196|NCT00219141|4238501|P2|COMPLETED|Overall Study||131
1731197|NCT00219141|4238502|P1|COMPLETED|Overall Study||140
1731198|NCT00219141|4238500|P3|STARTED|Overall Study||154
1731199|NCT00219141|4238501|P2|STARTED|Overall Study||152
1731200|NCT00219141|4238502|P1|STARTED|Overall Study||154
1731201|NCT00218634|4238548|P2|NOT COMPLETED|Overall Study||15
1731202|NCT00218634|4238549|P1|NOT COMPLETED|Overall Study||8
1731203|NCT00218634|4238548|P2|COMPLETED|Overall Study||30
1731204|NCT00218634|4238549|P1|COMPLETED|Overall Study||36
1731205|NCT00218634|4238548|P2|STARTED|Overall Study||45
1731206|NCT00218634|4238549|P1|STARTED|Overall Study||44
1731207|NCT00218543|4238569|P1|NOT COMPLETED|Overall Study||15
1731208|NCT00218543|4238569|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
1731209|NCT00218543|4238569|P1|STARTED|Overall Study||20
1731210|NCT00218465|4238576|P2|NOT COMPLETED|Overall Study||18
1731211|NCT00218465|4238577|P1|NOT COMPLETED|Overall Study||17
1731212|NCT00218465|4238576|P2|COMPLETED|Overall Study||30
1731213|NCT00218465|4238577|P1|COMPLETED|Overall Study||33
1731214|NCT00218465|4238576|P2|STARTED|Overall Study||48
1731215|NCT00218465|4238577|P1|STARTED|Overall Study||50
1731216|NCT00218439|4238589|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
1731217|NCT00218439|4238590|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
1731218|NCT00218439|4238589|P2|COMPLETED|Second Intervention (4 Weeks)||30
1731219|NCT00218439|4238590|P1|COMPLETED|Second Intervention (4 Weeks)||33
1731220|NCT00218439|4238589|P2|STARTED|Second Intervention (4 Weeks)||35
1731221|NCT00218439|4238590|P1|STARTED|Second Intervention (4 Weeks)||40
1731222|NCT00218439|4238589|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
1731223|NCT00218439|4238590|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
1731224|NCT00218439|4238589|P2|COMPLETED|First Intervention (4 Weeks)||35
1731225|NCT00218439|4238590|P1|COMPLETED|First Intervention (4 Weeks)||40
1731226|NCT00218439|4238589|P2|STARTED|First Intervention (4 Weeks)||47
1731227|NCT00218439|4238590|P1|STARTED|First Intervention (4 Weeks)||58
1731228|NCT00218335|4238608|P4|NOT COMPLETED|Overall Study||36
1731229|NCT00218335|4238609|P3|NOT COMPLETED|Overall Study||54
1731230|NCT00218335|4238610|P2|NOT COMPLETED|Overall Study||3
1731231|NCT00218335|4238611|P1|NOT COMPLETED|Overall Study||6
1731232|NCT00218335|4238608|P4|COMPLETED|Overall Study||388
1731233|NCT00218335|4238609|P3|COMPLETED|Overall Study||319
1731234|NCT00218335|4238610|P2|COMPLETED|Overall Study||110
1731235|NCT00218335|4238611|P1|COMPLETED|Overall Study||108
1731236|NCT00218335|4238608|P4|18 Month Follow-up|Overall Study||368
1731237|NCT00218335|4238609|P3|18 Month Follow-up|Overall Study||296
1731238|NCT00218335|4238610|P2|18 Month Follow-up|Overall Study||108
1731239|NCT00218335|4238611|P1|18 Month Follow-up|Overall Study||101
1731240|NCT00218335|4238608|P4|12 Month Follow-up|Overall Study||303
1731241|NCT00218335|4238609|P3|12 Month Follow-up|Overall Study||244
1731242|NCT00218335|4238610|P2|12 Month Follow-up|Overall Study||102
1731243|NCT00218335|4238611|P1|12 Month Follow-up|Overall Study||95
1731244|NCT00218335|4238608|P4|6 Month Follow-up|Overall Study||301
1731245|NCT00218335|4238609|P3|6 Month Follow-up|Overall Study||219
1731246|NCT00218335|4238610|P2|6 Month Follow-up|Overall Study||99
1731247|NCT00218335|4238611|P1|6 Month Follow-up|Overall Study||103
1731248|NCT00218335|4238608|P4|STARTED|Overall Study||424
1731249|NCT00218335|4238609|P3|STARTED|Overall Study||373
1731250|NCT00218335|4238610|P2|STARTED|Overall Study||113
1731251|NCT00218335|4238611|P1|STARTED|Overall Study||114
1731252|NCT00218296|4238675|P2|NOT COMPLETED|Overall Study||121
1731253|NCT00218296|4238676|P1|NOT COMPLETED|Overall Study||111
1731254|NCT00218296|4238675|P2|COMPLETED|Overall Study||48
1731255|NCT00218296|4238676|P1|COMPLETED|Overall Study||52
1731256|NCT00218296|4238675|P2|Attended Visti|Overall Study||102
1731257|NCT00218296|4238676|P1|Attended Visti|Overall Study||97
1731258|NCT00218296|4238675|P2|STARTED|Overall Study||169
1731259|NCT00218296|4238676|P1|STARTED|Overall Study||163
1731260|NCT00218062|4238696|P4|NOT COMPLETED|Overall Study||13
1731261|NCT00218062|4238697|P3|NOT COMPLETED|Overall Study||12
1731262|NCT00218062|4238698|P2|NOT COMPLETED|Overall Study||16
1731263|NCT00218062|4238699|P1|NOT COMPLETED|Overall Study||15
1731264|NCT00218062|4238696|P4|COMPLETED|Overall Study||3
1731265|NCT00218062|4238697|P3|COMPLETED|Overall Study||3
1731266|NCT00218062|4238698|P2|COMPLETED|Overall Study||4
1731267|NCT00218062|4238699|P1|COMPLETED|Overall Study||7
1731268|NCT00218062|4238696|P4|Received First Dose of Study Medication|Overall Study||12
1731269|NCT00218062|4238697|P3|Received First Dose of Study Medication|Overall Study||10
1731270|NCT00218062|4238698|P2|Received First Dose of Study Medication|Overall Study||11
1731271|NCT00218062|4238699|P1|Received First Dose of Study Medication|Overall Study||16
1731272|NCT00218062|4238696|P4|STARTED|Overall Study||16
1731273|NCT00218062|4238697|P3|STARTED|Overall Study||15
1731274|NCT00218062|4238698|P2|STARTED|Overall Study||20
1731275|NCT00218062|4238699|P1|STARTED|Overall Study||22
1731276|NCT00218036|4238730|P5|NOT COMPLETED|Overall Study||6
1731277|NCT00218036|4238731|P4|NOT COMPLETED|Overall Study||6
1731278|NCT00218036|4238732|P3|NOT COMPLETED|Overall Study||8
1731279|NCT00218036|4238733|P2|NOT COMPLETED|Overall Study||3
1731280|NCT00218036|4238734|P1|NOT COMPLETED|Overall Study||5
1731281|NCT00218036|4238730|P5|COMPLETED|Overall Study||3
1731282|NCT00218036|4238731|P4|COMPLETED|Overall Study||6
1731283|NCT00218036|4238732|P3|COMPLETED|Overall Study||5
1731284|NCT00218036|4238733|P2|COMPLETED|Overall Study||3
1731285|NCT00218036|4238734|P1|COMPLETED|Overall Study||6
1731286|NCT00218036|4238730|P5|STARTED|Overall Study||9
1731287|NCT00218036|4238731|P4|STARTED|Overall Study||12
1731288|NCT00218036|4238732|P3|STARTED|Overall Study||13
1731289|NCT00218036|4238733|P2|STARTED|Overall Study||6
1731290|NCT00218036|4238734|P1|STARTED|Overall Study||11
1731291|NCT00218023|4238760|P4|NOT COMPLETED|Overall Study||7
1731292|NCT00218023|4238761|P3|NOT COMPLETED|Overall Study||10
1731293|NCT00218023|4238762|P2|NOT COMPLETED|Overall Study||15
1731294|NCT00218023|4238763|P1|NOT COMPLETED|Overall Study||13
1731295|NCT00218023|4238760|P4|COMPLETED|Overall Study||11
1731296|NCT00218023|4238761|P3|COMPLETED|Overall Study||6
1731297|NCT00218023|4238762|P2|COMPLETED|Overall Study||10
1731298|NCT00218023|4238763|P1|COMPLETED|Overall Study||9
1731299|NCT00218023|4238760|P4|Received Drug or Placebo in Phase II|Overall Study||18
1731300|NCT00218023|4238761|P3|Received Drug or Placebo in Phase II|Overall Study||15
1731301|NCT00218023|4238762|P2|Received Drug or Placebo in Phase II|Overall Study||24
1731302|NCT00218023|4238763|P1|Received Drug or Placebo in Phase II|Overall Study||18
1731303|NCT00218023|4238760|P4|STARTED|Overall Study||18
1731304|NCT00218023|4238761|P3|STARTED|Overall Study||16
1731305|NCT00218023|4238762|P2|STARTED|Overall Study||25
1731306|NCT00218023|4238763|P1|STARTED|Overall Study||22
1731307|NCT00217971|4238779|P2|NOT COMPLETED|Overall Study||33
1731308|NCT00217971|4238780|P1|NOT COMPLETED|Overall Study||24
1731309|NCT00217971|4238779|P2|COMPLETED|Overall Study||44
1731310|NCT00217971|4238780|P1|COMPLETED|Overall Study||55
1731311|NCT00217971|4238779|P2|STARTED|Overall Study||77
1731312|NCT00217971|4238780|P1|STARTED|Overall Study||79
1731313|NCT00217724|4238786|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
1731314|NCT00217724|4238787|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
1731315|NCT00217724|4238786|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
1731316|NCT00217724|4238787|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
1731317|NCT00217724|4238786|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
1731318|NCT00217724|4238787|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
1731319|NCT00217724|4238786|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
1731320|NCT00217724|4238787|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
1731321|NCT00217724|4238786|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
1731322|NCT00217724|4238787|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
1731323|NCT00217724|4238786|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
1731324|NCT00217724|4238787|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
1731325|NCT00217672|4238795|P2|NOT COMPLETED|Follow-up||0
1731326|NCT00217672|4238796|P1|NOT COMPLETED|Follow-up||5
1731327|NCT00217672|4238795|P2|COMPLETED|Follow-up||0
1731328|NCT00217672|4238796|P1|COMPLETED|Follow-up||69
1731329|NCT00217672|4238795|P2|STARTED|Follow-up||0
1731330|NCT00217672|4238796|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
1731331|NCT00217672|4238795|P2|NOT COMPLETED|Treatment||7
1731332|NCT00217672|4238796|P1|NOT COMPLETED|Treatment||67
1731333|NCT00217672|4238795|P2|COMPLETED|Treatment||0
1731334|NCT00217672|4238796|P1|COMPLETED|Treatment||0
1731335|NCT00217672|4238795|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
1731336|NCT00217672|4238796|P1|STARTED|Treatment||67
1731337|NCT00217672|4238795|P2|NOT COMPLETED|Allocation||0
1731338|NCT00217672|4238796|P1|NOT COMPLETED|Allocation||2
1731339|NCT00217672|4238795|P2|COMPLETED|Allocation||7
1731340|NCT00217672|4238796|P1|COMPLETED|Allocation||67
1731341|NCT00217672|4238795|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
1731342|NCT00217672|4238796|P1|STARTED|Allocation||69
1731343|NCT00217620|4238802|P1|NOT COMPLETED|Overall Study||51
1731344|NCT00217620|4238802|P1|COMPLETED|Overall Study||0
1731345|NCT00217620|4238802|P1|Eligible and Began Protocol Therapy|Overall Study||37
1731346|NCT00217620|4238802|P1|Eligible|Overall Study||38
1731347|NCT00217620|4238802|P1|STARTED|Overall Study||51
1731348|NCT00217594|4238813|P1|NOT COMPLETED|Overall Study||0
1731349|NCT00217594|4238813|P1|COMPLETED|Overall Study||31
1731350|NCT00217594|4238813|P1|STARTED|Overall Study||31
1731351|NCT00217581|4238817|P1|NOT COMPLETED|Overall Study||1
1731352|NCT00217581|4238817|P1|COMPLETED|Overall Study||38
1731353|NCT00217581|4238817|P1|STARTED|Overall Study||39
1731354|NCT00217490|4238829|P4|NOT COMPLETED|Overall Study||23
1731355|NCT00217490|4238830|P3|NOT COMPLETED|Overall Study||24
1731356|NCT00217490|4238831|P2|NOT COMPLETED|Overall Study||25
1731357|NCT00217490|4238832|P1|NOT COMPLETED|Overall Study||17
1731358|NCT00217490|4238829|P4|COMPLETED|Overall Study||130
1731359|NCT00217490|4238830|P3|COMPLETED|Overall Study||131
1731360|NCT00217490|4238831|P2|COMPLETED|Overall Study||128
1731361|NCT00217490|4238832|P1|COMPLETED|Overall Study||137
1731362|NCT00217490|4238829|P4|STARTED|Overall Study||153
1731363|NCT00217490|4238830|P3|STARTED|Overall Study||155
1731364|NCT00217490|4238831|P2|STARTED|Overall Study||153
1731365|NCT00217490|4238832|P1|STARTED|Overall Study||154
1731366|NCT00217464|4238846|P1|NOT COMPLETED|Overall Study||17
1731367|NCT00217464|4238846|P1|COMPLETED|Overall Study||0
1731368|NCT00217464|4238846|P1|STARTED|Overall Study||17
1731369|NCT00217438|4238853|P2|NOT COMPLETED|Overall Study||1
1731370|NCT00217438|4238854|P1|NOT COMPLETED|Overall Study||0
1731371|NCT00217438|4238853|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
1731372|NCT00217438|4238854|P1|COMPLETED|Overall Study||66
1731373|NCT00217438|4238853|P2|STARTED|Overall Study||64
1731374|NCT00217438|4238854|P1|STARTED|Overall Study||66
1731375|NCT00217425|4238862|P1|NOT COMPLETED|Overall Study||37
1731376|NCT00217425|4238862|P1|COMPLETED|Overall Study||9
1731377|NCT00217425|4238862|P1|Eligible and Treated|Overall Study||39
1731378|NCT00217425|4238862|P1|Treated|Overall Study||44
1731379|NCT00217425|4238862|P1|STARTED|Overall Study||46
1731380|NCT00217399|4238868|P1|NOT COMPLETED|Overall Study||0
1731381|NCT00217399|4238868|P1|COMPLETED|Overall Study||35
1731382|NCT00217399|4238868|P1|STARTED|Overall Study||35
1731383|NCT00217087|4238876|P2|NOT COMPLETED|Overall Study||20
1731384|NCT00217087|4238877|P1|NOT COMPLETED|Overall Study||11
1731385|NCT00217087|4238876|P2|COMPLETED|Overall Study||17
1731386|NCT00217087|4238877|P1|COMPLETED|Overall Study||25
1731387|NCT00217087|4238876|P2|STARTED|Overall Study||37
1731388|NCT00217087|4238877|P1|STARTED|Overall Study||36
1731389|NCT00217022|4238891|P2|NOT COMPLETED|Overall Study||1
1731390|NCT00217022|4238892|P1|NOT COMPLETED|Overall Study||1
1731391|NCT00217022|4238891|P2|COMPLETED|Overall Study||3
1731392|NCT00217022|4238892|P1|COMPLETED|Overall Study||11
1731393|NCT00217022|4238891|P2|STARTED|Overall Study||4
1731394|NCT00217022|4238892|P1|STARTED|Overall Study||12
1731395|NCT00216736|4238902|P2|NOT COMPLETED|Overall Study||1
1731396|NCT00216736|4238903|P1|NOT COMPLETED|Overall Study||1
1731397|NCT00216736|4238902|P2|COMPLETED|Overall Study||30
1731398|NCT00216736|4238903|P1|COMPLETED|Overall Study||31
1731399|NCT00216736|4238902|P2|STARTED|Overall Study||31
1731400|NCT00216736|4238903|P1|STARTED|Overall Study||32
1731401|NCT00216671|4238917|P2|NOT COMPLETED|Overall Study||50
1731402|NCT00216671|4238918|P1|NOT COMPLETED|Overall Study||35
1731403|NCT00216671|4238917|P2|COMPLETED|Overall Study||60
1731404|NCT00216671|4238918|P1|COMPLETED|Overall Study||75
1731405|NCT00216671|4238917|P2|STARTED|Overall Study||110
1731406|NCT00216671|4238918|P1|STARTED|Overall Study||110
1731407|NCT00216476|4238936|P3|NOT COMPLETED|Overall Study||17
1731408|NCT00216476|4238937|P2|NOT COMPLETED|Overall Study||107
1731409|NCT00216476|4238938|P1|NOT COMPLETED|Overall Study||105
1731410|NCT00216476|4238936|P3|COMPLETED|Overall Study||28
1731411|NCT00216476|4238937|P2|COMPLETED|Overall Study||230
1731412|NCT00216476|4238938|P1|COMPLETED|Overall Study||224
1731413|NCT00216476|4238936|P3|STARTED|Overall Study||45
1731414|NCT00216476|4238937|P2|STARTED|Overall Study||337
1731415|NCT00216476|4238938|P1|STARTED|Overall Study||329
1731416|NCT00216320|4238958|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
1731417|NCT00216320|4238959|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
1731418|NCT00216320|4238960|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
1731419|NCT00216320|4238958|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
1731420|NCT00216320|4238959|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
1731421|NCT00216320|4238960|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
1731422|NCT00216320|4238958|P3|STARTED|Phase 2 (Weeks 6 -12)||25
1731423|NCT00216320|4238959|P2|STARTED|Phase 2 (Weeks 6 -12)||35
1731424|NCT00216320|4238960|P1|STARTED|Phase 2 (Weeks 6 -12)||43
1731425|NCT00216320|4238958|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
1731426|NCT00216320|4238959|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
1731427|NCT00216320|4238960|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
1731428|NCT00216320|4238958|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
1731429|NCT00216320|4238959|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
1731430|NCT00216320|4238960|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
1731431|NCT00216320|4238958|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
1731432|NCT00216320|4238959|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
1731433|NCT00216320|4238960|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
1731434|NCT00216203|4238975|P1|NOT COMPLETED|Overall Study||2
1731435|NCT00216203|4238975|P1|COMPLETED|Overall Study||34
1731436|NCT00216203|4238975|P1|STARTED|Overall Study||36
1731437|NCT00216125|4238983|P3|NOT COMPLETED|Randomization Phase||8
1731438|NCT00216125|4238984|P2|NOT COMPLETED|Randomization Phase||11
1731439|NCT00216125|4238985|P1|NOT COMPLETED|Randomization Phase||0
1731440|NCT00216125|4238983|P3|COMPLETED|Randomization Phase||74
1731441|NCT00216125|4238984|P2|COMPLETED|Randomization Phase||73
1731442|NCT00216125|4238985|P1|COMPLETED|Randomization Phase||0
1731443|NCT00216125|4238983|P3|DSMB Cohort for Futility|Randomization Phase||74
1731444|NCT00216125|4238984|P2|DSMB Cohort for Futility|Randomization Phase||73
1731445|NCT00216125|4238985|P1|DSMB Cohort for Futility|Randomization Phase||0
1731446|NCT00216125|4238983|P3|STARTED|Randomization Phase||82
1731447|NCT00216125|4238984|P2|STARTED|Randomization Phase||84
1731448|NCT00216125|4238985|P1|STARTED|Randomization Phase||0
1731449|NCT00216125|4238983|P3|NOT COMPLETED|Pre-Randomization Phase||0
1731450|NCT00216125|4238984|P2|NOT COMPLETED|Pre-Randomization Phase||0
1731451|NCT00216125|4238985|P1|NOT COMPLETED|Pre-Randomization Phase||77
1731452|NCT00216125|4238983|P3|COMPLETED|Pre-Randomization Phase||0
1731453|NCT00216125|4238984|P2|COMPLETED|Pre-Randomization Phase||0
1731454|NCT00216125|4238985|P1|COMPLETED|Pre-Randomization Phase||166
1731455|NCT00216125|4238983|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
1731456|NCT00216125|4238984|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
1731457|NCT00216125|4238985|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
1731458|NCT00216125|4238983|P3|STARTED|Pre-Randomization Phase||0
1731459|NCT00216125|4238984|P2|STARTED|Pre-Randomization Phase||0
1731460|NCT00216125|4238985|P1|STARTED|Pre-Randomization Phase||243
1731461|NCT00216099|4238994|P1|NOT COMPLETED|Overall Study||1
1731462|NCT00216099|4238994|P1|COMPLETED|Overall Study||48
1731463|NCT00216099|4238994|P1|Response Analysis|Overall Study||48
1731464|NCT00216099|4238994|P1|Toxicity Analysis|Overall Study||49
1731465|NCT00216099|4238994|P1|STARTED|Overall Study||49
1731466|NCT00216086|4239005|P1|NOT COMPLETED|Overall Study||4
1731467|NCT00216086|4239005|P1|COMPLETED|Overall Study||18
1731468|NCT00216086|4239005|P1|STARTED|Overall Study||22
1731469|NCT00216060|4239014|P2|NOT COMPLETED|Overall Study||0
1731470|NCT00216060|4239015|P1|NOT COMPLETED|Overall Study||0
1731471|NCT00216060|4239014|P2|COMPLETED|Overall Study||31
1731472|NCT00216060|4239015|P1|COMPLETED|Overall Study||32
1731473|NCT00216060|4239014|P2|STARTED|Overall Study||31
1731474|NCT00216060|4239015|P1|STARTED|Overall Study||32
1731475|NCT00215943|4239037|P2|NOT COMPLETED|Overall Study||14
1731476|NCT00215943|4239038|P1|NOT COMPLETED|Overall Study||9
1731477|NCT00215943|4239037|P2|COMPLETED|Overall Study||23
1731478|NCT00215943|4239038|P1|COMPLETED|Overall Study||27
1731479|NCT00215943|4239037|P2|STARTED|Overall Study||37
1731480|NCT00215943|4239038|P1|STARTED|Overall Study||36
1731481|NCT00215930|4239050|P1|NOT COMPLETED|Overall Study||0
1731482|NCT00215930|4239050|P1|COMPLETED|Overall Study||53
1731483|NCT00215930|4239050|P1|STARTED|Overall Study||53
1731484|NCT00215787|4239056|P1|NOT COMPLETED|Overall Study||0
1731485|NCT00215787|4239056|P1|COMPLETED|Overall Study||20
1731486|NCT00215787|4239056|P1|STARTED|Overall Study||20
1731487|NCT00215683|4239063|P3|NOT COMPLETED|Overall Study||32
1731488|NCT00215683|4239064|P2|NOT COMPLETED|Overall Study||26
1731489|NCT00215683|4239065|P1|NOT COMPLETED|Overall Study||29
1731490|NCT00215683|4239063|P3|COMPLETED|Overall Study||12
1731491|NCT00215683|4239064|P2|COMPLETED|Overall Study||22
1731492|NCT00215683|4239065|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
1731493|NCT00215683|4239063|P3|Switched to 160 mg|Overall Study||36
1731494|NCT00215683|4239064|P2|Switched to 160 mg|Overall Study||41
1731495|NCT00215683|4239065|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
1731496|NCT00215683|4239063|P3|STARTED|Overall Study||44
1731497|NCT00215683|4239064|P2|STARTED|Overall Study||48
1731498|NCT00215683|4239065|P1|STARTED|Overall Study|Safety analysis set|45
1731499|NCT00215657|4239084|P8|NOT COMPLETED|Overall Study||16
1731500|NCT00215657|4239085|P7|NOT COMPLETED|Overall Study||23
1731501|NCT00215657|4239086|P6|NOT COMPLETED|Overall Study||20
1731502|NCT00215657|4239087|P5|NOT COMPLETED|Overall Study||23
1731503|NCT00215657|4239088|P4|NOT COMPLETED|Overall Study||18
1731504|NCT00215657|4239089|P3|NOT COMPLETED|Overall Study||11
1731505|NCT00215657|4239090|P2|NOT COMPLETED|Overall Study||11
1731506|NCT00215657|4239091|P1|NOT COMPLETED|Overall Study||22
1731507|NCT00215657|4239084|P8|COMPLETED|Overall Study||11
1731508|NCT00215657|4239085|P7|COMPLETED|Overall Study||4
1731509|NCT00215657|4239086|P6|COMPLETED|Overall Study||4
1731510|NCT00215657|4239087|P5|COMPLETED|Overall Study||4
1731511|NCT00215657|4239088|P4|COMPLETED|Overall Study||6
1731512|NCT00215657|4239089|P3|COMPLETED|Overall Study||2
1731513|NCT00215657|4239090|P2|COMPLETED|Overall Study||1
1731514|NCT00215657|4239091|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
1731515|NCT00215657|4239084|P8|Started FE200486 CS07A|Overall Study||23
1731516|NCT00215657|4239085|P7|Started FE200486 CS07A|Overall Study||14
1731517|NCT00215657|4239086|P6|Started FE200486 CS07A|Overall Study||20
1731518|NCT00215657|4239087|P5|Started FE200486 CS07A|Overall Study||17
1731519|NCT00215657|4239088|P4|Started FE200486 CS07A|Overall Study||24
1731520|NCT00215657|4239089|P3|Started FE200486 CS07A|Overall Study||7
1731521|NCT00215657|4239090|P2|Started FE200486 CS07A|Overall Study||6
1731522|NCT00215657|4239091|P1|Started FE200486 CS07A|Overall Study||20
1731523|NCT00215657|4239084|P8|Intention-to-treat Population|Overall Study||27
1731524|NCT00215657|4239085|P7|Intention-to-treat Population|Overall Study||24
1731525|NCT00215657|4239086|P6|Intention-to-treat Population|Overall Study||24
1731526|NCT00215657|4239087|P5|Intention-to-treat Population|Overall Study||24
1731527|NCT00215657|4239088|P4|Intention-to-treat Population|Overall Study||24
1731528|NCT00215657|4239089|P3|Intention-to-treat Population|Overall Study||12
1731529|NCT00215657|4239090|P2|Intention-to-treat Population|Overall Study||12
1731530|NCT00215657|4239091|P1|Intention-to-treat Population|Overall Study||25
1731531|NCT00215657|4239084|P8|STARTED|Overall Study||27
1731532|NCT00215657|4239085|P7|STARTED|Overall Study||27
1731533|NCT00215657|4239086|P6|STARTED|Overall Study||24
1731534|NCT00215657|4239087|P5|STARTED|Overall Study||27
1731535|NCT00215657|4239088|P4|STARTED|Overall Study||24
1731536|NCT00215657|4239089|P3|STARTED|Overall Study||13
1731537|NCT00215657|4239090|P2|STARTED|Overall Study||12
1731538|NCT00215657|4239091|P1|STARTED|Overall Study||26
1731539|NCT00215644|4239119|P2|NOT COMPLETED|Overall Study||36
1731540|NCT00215644|4239120|P1|NOT COMPLETED|Overall Study||36
1731541|NCT00215644|4239119|P2|COMPLETED|Overall Study||0
1731542|NCT00215644|4239120|P1|COMPLETED|Overall Study||0
1731543|NCT00215644|4239119|P2|Treated|Overall Study||36
1731544|NCT00215644|4239120|P1|Treated|Overall Study||35
1731545|NCT00215644|4239119|P2|STARTED|Overall Study||36
1731546|NCT00215644|4239120|P1|STARTED|Overall Study||36
1731547|NCT00215553|4239147|P7|NOT COMPLETED|Overall Study||0
1731548|NCT00215553|4239148|P6|NOT COMPLETED|Overall Study||6
1731549|NCT00215553|4239149|P5|NOT COMPLETED|Overall Study||2
1731550|NCT00215553|4239150|P4|NOT COMPLETED|Overall Study||1
1731551|NCT00215553|4239151|P3|NOT COMPLETED|Overall Study||2
1731552|NCT00215553|4239152|P2|NOT COMPLETED|Overall Study||1
1731553|NCT00215553|4239153|P1|NOT COMPLETED|Overall Study||0
1731554|NCT00215553|4239147|P7|COMPLETED|Overall Study||36
1731555|NCT00215553|4239148|P6|COMPLETED|Overall Study||32
1731556|NCT00215553|4239149|P5|COMPLETED|Overall Study||26
1731557|NCT00215553|4239150|P4|COMPLETED|Overall Study||4
1731558|NCT00215553|4239151|P3|COMPLETED|Overall Study||4
1731559|NCT00215553|4239152|P2|COMPLETED|Overall Study||5
1731560|NCT00215553|4239153|P1|COMPLETED|Overall Study||5
1731561|NCT00215553|4239147|P7|STARTED|Overall Study||36
1731562|NCT00215553|4239148|P6|STARTED|Overall Study||38
1731563|NCT00215553|4239149|P5|STARTED|Overall Study||28
1731564|NCT00215553|4239150|P4|STARTED|Overall Study||5
1731565|NCT00215553|4239151|P3|STARTED|Overall Study||6
1731566|NCT00215553|4239152|P2|STARTED|Overall Study||6
1731567|NCT00215553|4239153|P1|STARTED|Overall Study||5
1731568|NCT00215540|4239186|P3|NOT COMPLETED|Overall Study||0
1731569|NCT00215540|4239187|P2|NOT COMPLETED|Overall Study||0
1731570|NCT00215540|4239188|P1|NOT COMPLETED|Overall Study||1
1731571|NCT00215540|4239186|P3|COMPLETED|Overall Study||44
1731572|NCT00215540|4239187|P2|COMPLETED|Overall Study||47
1731573|NCT00215540|4239188|P1|COMPLETED|Overall Study||44
1731574|NCT00215540|4239186|P3|STARTED|Overall Study||44
1731575|NCT00215540|4239187|P2|STARTED|Overall Study||47
1731576|NCT00215540|4239188|P1|STARTED|Overall Study||45
1731577|NCT00215150|4239223|P1|NOT COMPLETED|Randomization Phase Placebo||1
1731578|NCT00215150|4239223|P1|COMPLETED|Randomization Phase Placebo||10
1731579|NCT00215150|4239223|P1|STARTED|Randomization Phase Placebo||11
1731580|NCT00215150|4239223|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
1731581|NCT00215150|4239223|P1|COMPLETED|Randomization Phase Ziprasidone||7
1731582|NCT00215150|4239223|P1|STARTED|Randomization Phase Ziprasidone||10
1731583|NCT00215150|4239223|P1|NOT COMPLETED|Open Label Phase||30
1731584|NCT00215150|4239223|P1|COMPLETED|Open Label Phase||21
1731585|NCT00215150|4239223|P1|STARTED|Open Label Phase|Number of subjects consented|51
1731586|NCT00215137|4239231|P3|NOT COMPLETED|Randomization Period||0
1731587|NCT00215137|4239232|P2|NOT COMPLETED|Randomization Period||2
1731588|NCT00215137|4239233|P1|NOT COMPLETED|Randomization Period||0
1731589|NCT00215137|4239231|P3|COMPLETED|Randomization Period||5
1731590|NCT00215137|4239232|P2|COMPLETED|Randomization Period||5
1731591|NCT00215137|4239233|P1|COMPLETED|Randomization Period||0
1731592|NCT00215137|4239231|P3|STARTED|Randomization Period||5
1731593|NCT00215137|4239232|P2|STARTED|Randomization Period||7
1731594|NCT00215137|4239233|P1|STARTED|Randomization Period||0
1731595|NCT00215137|4239231|P3|NOT COMPLETED|Open Label Escitalopram||0
1731596|NCT00215137|4239232|P2|NOT COMPLETED|Open Label Escitalopram||0
1731597|NCT00215137|4239233|P1|NOT COMPLETED|Open Label Escitalopram||1
1731598|NCT00215137|4239231|P3|COMPLETED|Open Label Escitalopram||0
1731599|NCT00215137|4239232|P2|COMPLETED|Open Label Escitalopram||0
1731600|NCT00215137|4239233|P1|COMPLETED|Open Label Escitalopram||13
1731601|NCT00215137|4239231|P3|STARTED|Open Label Escitalopram||0
1731602|NCT00215137|4239232|P2|STARTED|Open Label Escitalopram||0
1731603|NCT00215137|4239233|P1|STARTED|Open Label Escitalopram||14
1731604|NCT00214903|4239245|P4|NOT COMPLETED|Overall Study||0
1731605|NCT00214903|4239246|P3|NOT COMPLETED|Overall Study||0
1731606|NCT00214903|4239247|P2|NOT COMPLETED|Overall Study||0
1731607|NCT00214903|4239248|P1|NOT COMPLETED|Overall Study||0
1731608|NCT00214903|4239245|P4|COMPLETED|Overall Study||3057
1731609|NCT00214903|4239246|P3|COMPLETED|Overall Study||4113
1731610|NCT00214903|4239247|P2|COMPLETED|Overall Study||13384
1731611|NCT00214903|4239248|P1|COMPLETED|Overall Study||10043
1731612|NCT00214903|4239245|P4|STARTED|Overall Study||3057
1731613|NCT00214903|4239246|P3|STARTED|Overall Study||4113
1731614|NCT00214903|4239247|P2|STARTED|Overall Study||13384
1731615|NCT00214903|4239248|P1|STARTED|Overall Study||10043
1731616|NCT00214786|4239262|P1|NOT COMPLETED|Overall Study||3
1731617|NCT00214786|4239262|P1|COMPLETED|Overall Study||1
1731618|NCT00214786|4239262|P1|STARTED|Overall Study||4
1731619|NCT00214539|4239277|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
1731620|NCT00214539|4239278|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
1731621|NCT00214539|4239277|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
1731622|NCT00214539|4239278|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
1731623|NCT00214539|4239277|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
1731624|NCT00214539|4239278|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
1731625|NCT00214539|4239277|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
1731626|NCT00214539|4239278|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
1731627|NCT00214539|4239277|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
1731628|NCT00214539|4239278|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
1731629|NCT00214539|4239277|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
1731630|NCT00214539|4239278|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
1731631|NCT00214539|4239277|P2|NOT COMPLETED|Treatment Period||0
1731632|NCT00214539|4239278|P1|NOT COMPLETED|Treatment Period||0
1731633|NCT00214539|4239277|P2|COMPLETED|Treatment Period||17
1731634|NCT00214539|4239278|P1|COMPLETED|Treatment Period||15
1731635|NCT00214539|4239277|P2|STARTED|Treatment Period||17
1731636|NCT00214539|4239278|P1|STARTED|Treatment Period||15
1731637|NCT00214539|4239277|P2|NOT COMPLETED|Randomized||0
1731638|NCT00214539|4239278|P1|NOT COMPLETED|Randomized||2
1731639|NCT00214539|4239277|P2|COMPLETED|Randomized||17
1731640|NCT00214539|4239278|P1|COMPLETED|Randomized||15
1731641|NCT00214539|4239277|P2|STARTED|Randomized||17
1731642|NCT00214539|4239278|P1|STARTED|Randomized||17
1731643|NCT00214526|4239304|P2|NOT COMPLETED|Post-Treatment Period||0
1731644|NCT00214526|4239305|P1|NOT COMPLETED|Post-Treatment Period||1
1731645|NCT00214526|4239304|P2|COMPLETED|Post-Treatment Period||49
1731646|NCT00214526|4239305|P1|COMPLETED|Post-Treatment Period||52
1731647|NCT00214526|4239304|P2|STARTED|Post-Treatment Period||49
1731648|NCT00214526|4239305|P1|STARTED|Post-Treatment Period||53
1731649|NCT00214526|4239304|P2|NOT COMPLETED|Treatment Period||5
1731650|NCT00214526|4239305|P1|NOT COMPLETED|Treatment Period||2
1731651|NCT00214526|4239304|P2|COMPLETED|Treatment Period||49
1731652|NCT00214526|4239305|P1|COMPLETED|Treatment Period||53
1731653|NCT00214526|4239304|P2|STARTED|Treatment Period||54
1731654|NCT00214526|4239305|P1|STARTED|Treatment Period||55
1731655|NCT00214526|4239304|P2|NOT COMPLETED|Randomized||2
1731656|NCT00214526|4239305|P1|NOT COMPLETED|Randomized||1
1731657|NCT00214526|4239304|P2|COMPLETED|Randomized||54
1731658|NCT00214526|4239305|P1|COMPLETED|Randomized||55
1731659|NCT00214526|4239304|P2|STARTED|Randomized||56
1731660|NCT00214526|4239305|P1|STARTED|Randomized||56
1731661|NCT00214500|4239331|P1|NOT COMPLETED|Extension Period||2
1731662|NCT00214500|4239331|P1|COMPLETED|Extension Period||6
1731663|NCT00214500|4239331|P1|STARTED|Extension Period||8
1731664|NCT00214500|4239331|P1|NOT COMPLETED|Treatment Period||1
1731665|NCT00214500|4239331|P1|COMPLETED|Treatment Period||8
1731666|NCT00214500|4239331|P1|Pharmacodynamic (PD) Population|Treatment Period||9
1731667|NCT00214500|4239331|P1|Pharmacokinetic (PK) Population|Treatment Period||9
1731668|NCT00214500|4239331|P1|Safety Population|Treatment Period||9
1731669|NCT00214500|4239331|P1|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
1731670|NCT00214487|4239341|P2|NOT COMPLETED|Overall Study||3
1731671|NCT00214487|4239342|P1|NOT COMPLETED|Overall Study||5
1731672|NCT00214487|4239341|P2|COMPLETED|Overall Study||40
1731673|NCT00214487|4239342|P1|COMPLETED|Overall Study||38
1731674|NCT00214487|4239341|P2|STARTED|Overall Study||43
1731675|NCT00214487|4239342|P1|STARTED|Overall Study||43
1731676|NCT00214461|4239352|P4|NOT COMPLETED|Overall Study||1
1731677|NCT00214461|4239353|P3|NOT COMPLETED|Overall Study||2
1731678|NCT00214461|4239354|P2|NOT COMPLETED|Overall Study||0
1731679|NCT00214461|4239355|P1|NOT COMPLETED|Overall Study||0
1731680|NCT00214461|4239352|P4|COMPLETED|Overall Study||11
1731681|NCT00214461|4239353|P3|COMPLETED|Overall Study||10
1731682|NCT00214461|4239354|P2|COMPLETED|Overall Study||12
1731683|NCT00214461|4239355|P1|COMPLETED|Overall Study||12
1731684|NCT00214461|4239352|P4|STARTED|Overall Study||12
1731685|NCT00214461|4239353|P3|STARTED|Overall Study||12
1731686|NCT00214461|4239354|P2|STARTED|Overall Study||12
1731687|NCT00214461|4239355|P1|STARTED|Overall Study||12
1731688|NCT00214383|4239371|P2|NOT COMPLETED|Overall Study||26
1731689|NCT00214383|4239372|P1|NOT COMPLETED|Overall Study||16
1731690|NCT00214383|4239371|P2|COMPLETED|Overall Study||127
1731691|NCT00214383|4239372|P1|COMPLETED|Overall Study||132
1731692|NCT00214383|4239371|P2|STARTED|Overall Study||153
1731693|NCT00214383|4239372|P1|STARTED|Overall Study||148
1731694|NCT00214201|4239384|P2|NOT COMPLETED|Overall Study||2
1731695|NCT00214201|4239385|P1|NOT COMPLETED|Overall Study||2
1731696|NCT00214201|4239384|P2|COMPLETED|Overall Study||18
1731697|NCT00214201|4239385|P1|COMPLETED|Overall Study||18
1731698|NCT00214201|4239384|P2|STARTED|Overall Study||20
1731699|NCT00214201|4239385|P1|STARTED|Overall Study||20
1731700|NCT00214149|4239395|P1|NOT COMPLETED|Overall Study||127
1731701|NCT00214149|4239395|P1|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
1731702|NCT00214149|4239395|P1|STARTED|Overall Study||127
1731703|NCT00214136|4239400|P1|NOT COMPLETED|Overall Study||5
1731704|NCT00214136|4239400|P1|COMPLETED|Overall Study||25
1731705|NCT00214136|4239400|P1|STARTED|Overall Study||30
1731706|NCT00214019|4239405|P1|NOT COMPLETED|Overall Study||30
1731707|NCT00214019|4239405|P1|COMPLETED|Overall Study||6
1731708|NCT00214019|4239405|P1|Fluticason/Salmeterol Arm|Overall Study||6
1731709|NCT00214019|4239405|P1|Fluticasone/Placebo Arm|Overall Study||6
1731710|NCT00214019|4239405|P1|Placebo/Salmeterol Arm|Overall Study||6
1731711|NCT00214019|4239405|P1|Placebo/Placebo Arm|Overall Study||6
1731712|NCT00214019|4239405|P1|STARTED|Overall Study||36
1731713|NCT00213980|4239414|P2|NOT COMPLETED|Overall Study||7
1731714|NCT00213980|4239415|P1|NOT COMPLETED|Overall Study||6
1731715|NCT00213980|4239414|P2|COMPLETED|Overall Study||29
1731716|NCT00213980|4239415|P1|COMPLETED|Overall Study||26
1731717|NCT00213980|4239414|P2|STARTED|Overall Study||36
1731718|NCT00213980|4239415|P1|STARTED|Overall Study||32
1731719|NCT00213239|4239429|P2|NOT COMPLETED|Overall Study||0
1731720|NCT00213239|4239430|P1|NOT COMPLETED|Overall Study||0
1731721|NCT00213239|4239429|P2|COMPLETED|Overall Study||32
1731722|NCT00213239|4239430|P1|COMPLETED|Overall Study||32
1731723|NCT00213239|4239429|P2|STARTED|Overall Study||32
1731724|NCT00213239|4239430|P1|STARTED|Overall Study||32
1731725|NCT00213148|4239442|P5|NOT COMPLETED|Cycle 3 (1 Month)||1
1731726|NCT00213148|4239443|P4|NOT COMPLETED|Cycle 3 (1 Month)||1
1731727|NCT00213148|4239444|P3|NOT COMPLETED|Cycle 3 (1 Month)||1
1731728|NCT00213148|4239445|P2|NOT COMPLETED|Cycle 3 (1 Month)||2
1731729|NCT00213148|4239446|P1|NOT COMPLETED|Cycle 3 (1 Month)||0
1731730|NCT00213148|4239442|P5|COMPLETED|Cycle 3 (1 Month)||21
1731731|NCT00213148|4239443|P4|COMPLETED|Cycle 3 (1 Month)||23
1731732|NCT00213148|4239444|P3|COMPLETED|Cycle 3 (1 Month)||25
1731733|NCT00213148|4239445|P2|COMPLETED|Cycle 3 (1 Month)||8
1731734|NCT00213148|4239446|P1|COMPLETED|Cycle 3 (1 Month)||23
1731735|NCT00213148|4239442|P5|STARTED|Cycle 3 (1 Month)||22
1731736|NCT00213148|4239443|P4|STARTED|Cycle 3 (1 Month)||24
1731737|NCT00213148|4239444|P3|STARTED|Cycle 3 (1 Month)||26
1731738|NCT00213148|4239445|P2|STARTED|Cycle 3 (1 Month)||10
1731739|NCT00213148|4239446|P1|STARTED|Cycle 3 (1 Month)||23
1731740|NCT00213148|4239442|P5|NOT COMPLETED|Cycle 2 (1 Month)||30
1731741|NCT00213148|4239443|P4|NOT COMPLETED|Cycle 2 (1 Month)||19
1731742|NCT00213148|4239444|P3|NOT COMPLETED|Cycle 2 (1 Month)||14
1731743|NCT00213148|4239445|P2|NOT COMPLETED|Cycle 2 (1 Month)||6
1731744|NCT00213148|4239446|P1|NOT COMPLETED|Cycle 2 (1 Month)||14
1731745|NCT00213148|4239442|P5|COMPLETED|Cycle 2 (1 Month)||11
1731746|NCT00213148|4239443|P4|COMPLETED|Cycle 2 (1 Month)||33
1731747|NCT00213148|4239444|P3|COMPLETED|Cycle 2 (1 Month)||28
1731748|NCT00213148|4239445|P2|COMPLETED|Cycle 2 (1 Month)||4
1731749|NCT00213148|4239446|P1|COMPLETED|Cycle 2 (1 Month)||29
1731750|NCT00213148|4239442|P5|STARTED|Cycle 2 (1 Month)||41
1731751|NCT00213148|4239443|P4|STARTED|Cycle 2 (1 Month)||52
1731752|NCT00213148|4239444|P3|STARTED|Cycle 2 (1 Month)||42
1731753|NCT00213148|4239445|P2|STARTED|Cycle 2 (1 Month)||10
1731754|NCT00213148|4239446|P1|STARTED|Cycle 2 (1 Month)||43
1731755|NCT00213148|4239442|P5|NOT COMPLETED|Cycle 1 (1 Month)||22
1731756|NCT00213148|4239443|P4|NOT COMPLETED|Cycle 1 (1 Month)||18
1731757|NCT00213148|4239444|P3|NOT COMPLETED|Cycle 1 (1 Month)||19
1731758|NCT00213148|4239445|P2|NOT COMPLETED|Cycle 1 (1 Month)||0
1731759|NCT00213148|4239446|P1|NOT COMPLETED|Cycle 1 (1 Month)||24
1731760|NCT00213148|4239442|P5|COMPLETED|Cycle 1 (1 Month)||17
1731761|NCT00213148|4239443|P4|COMPLETED|Cycle 1 (1 Month)||58
1731762|NCT00213148|4239444|P3|COMPLETED|Cycle 1 (1 Month)||60
1731763|NCT00213148|4239445|P2|COMPLETED|Cycle 1 (1 Month)||0
1731764|NCT00213148|4239446|P1|COMPLETED|Cycle 1 (1 Month)||53
1731765|NCT00213148|4239442|P5|STARTED|Cycle 1 (1 Month)||39
1731766|NCT00213148|4239443|P4|STARTED|Cycle 1 (1 Month)||76
1731767|NCT00213148|4239444|P3|STARTED|Cycle 1 (1 Month)||79
1731768|NCT00213148|4239445|P2|STARTED|Cycle 1 (1 Month)||0
1731769|NCT00213148|4239446|P1|STARTED|Cycle 1 (1 Month)||77
1731770|NCT00213135|4239473|P3|NOT COMPLETED|Overall Study||57
1731771|NCT00213135|4239474|P2|NOT COMPLETED|Overall Study||35
1731772|NCT00213135|4239475|P1|NOT COMPLETED|Overall Study||50
1731773|NCT00213135|4239473|P3|COMPLETED|Overall Study||380
1731774|NCT00213135|4239474|P2|COMPLETED|Overall Study||398
1731775|NCT00213135|4239475|P1|COMPLETED|Overall Study||406
1731776|NCT00213135|4239473|P3|STARTED|Overall Study||437
1731777|NCT00213135|4239474|P2|STARTED|Overall Study||433
1731778|NCT00213135|4239475|P1|STARTED|Overall Study||456
1731779|NCT00212758|4239492|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
1731780|NCT00212758|4239493|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
1731781|NCT00212758|4239492|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
1731782|NCT00212758|4239493|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
1731783|NCT00212758|4239492|P2|STARTED|Standard Therapy of GH (12 Months)||9
1731784|NCT00212758|4239493|P1|STARTED|Standard Therapy of GH (12 Months)||8
1731785|NCT00212758|4239492|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1731786|NCT00212758|4239493|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1731787|NCT00212758|4239492|P2|COMPLETED|Second Intervention (7 Days)||9
1731788|NCT00212758|4239493|P1|COMPLETED|Second Intervention (7 Days)||8
1731789|NCT00212758|4239492|P2|STARTED|Second Intervention (7 Days)||9
1731790|NCT00212758|4239493|P1|STARTED|Second Intervention (7 Days)||8
1731791|NCT00212758|4239492|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
1731792|NCT00212758|4239493|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
1731793|NCT00212758|4239492|P2|COMPLETED|Wash Out Period (2 Weeks)||9
1731794|NCT00212758|4239493|P1|COMPLETED|Wash Out Period (2 Weeks)||8
1731795|NCT00212758|4239492|P2|STARTED|Wash Out Period (2 Weeks)||9
1731796|NCT00212758|4239493|P1|STARTED|Wash Out Period (2 Weeks)||8
1731797|NCT00212758|4239492|P2|NOT COMPLETED|First Intervention (7 Days)||0
1731798|NCT00212758|4239493|P1|NOT COMPLETED|First Intervention (7 Days)||0
1731799|NCT00212758|4239492|P2|COMPLETED|First Intervention (7 Days)||9
1731800|NCT00212758|4239493|P1|COMPLETED|First Intervention (7 Days)||8
1731801|NCT00212758|4239492|P2|STARTED|First Intervention (7 Days)||9
1731802|NCT00212758|4239493|P1|STARTED|First Intervention (7 Days)||8
1731803|NCT00212446|4239499|P1|NOT COMPLETED|Overall Study||0
1731804|NCT00212446|4239499|P1|COMPLETED|Overall Study||8
1731805|NCT00212446|4239499|P1|STARTED|Overall Study||8
1731806|NCT00212355|4239509|P1|NOT COMPLETED|Overall Study||3
1731807|NCT00212355|4239509|P1|COMPLETED|Overall Study||34
1731808|NCT00212355|4239509|P1|STARTED|Overall Study||37
1731809|NCT00212264|4239516|P3|NOT COMPLETED|Overall Study||4
1731810|NCT00212264|4239517|P2|NOT COMPLETED|Overall Study||16
1731811|NCT00212264|4239518|P1|NOT COMPLETED|Overall Study||12
1731812|NCT00212264|4239516|P3|COMPLETED|Overall Study||64
1731813|NCT00212264|4239517|P2|COMPLETED|Overall Study||54
1731814|NCT00212264|4239518|P1|COMPLETED|Overall Study||58
1731815|NCT00212264|4239516|P3|STARTED|Overall Study||68
1731816|NCT00212264|4239517|P2|STARTED|Overall Study||70
1731817|NCT00212264|4239518|P1|STARTED|Overall Study||70
1731818|NCT00212134|4239530|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
1731819|NCT00212134|4239531|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
1731820|NCT00212134|4239530|P2|COMPLETED|Phase 3 (Age 10 Years)||35
1731821|NCT00212134|4239531|P1|COMPLETED|Phase 3 (Age 10 Years)||36
1731822|NCT00212134|4239530|P2|STARTED|Phase 3 (Age 10 Years)||56
1731823|NCT00212134|4239531|P1|STARTED|Phase 3 (Age 10 Years)||57
1731824|NCT00212134|4239530|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
1731825|NCT00212134|4239531|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
1731826|NCT00212134|4239530|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
1731827|NCT00212134|4239531|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
1731828|NCT00212134|4239530|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
1731829|NCT00212134|4239531|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
1731830|NCT00212134|4239530|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
1731831|NCT00212134|4239531|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
1731832|NCT00212134|4239530|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
1731833|NCT00212134|4239531|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
1731834|NCT00212134|4239530|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
1731835|NCT00212134|4239531|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
1731836|NCT00212134|4239530|P2|STARTED|Phase 1 (to Age 1 Year)||57
1731837|NCT00212134|4239531|P1|STARTED|Phase 1 (to Age 1 Year)||57
1731838|NCT00211887|4239552|P3|NOT COMPLETED|Overall Study||36
1731839|NCT00211887|4239553|P2|NOT COMPLETED|Overall Study||56
1731840|NCT00211887|4239554|P1|NOT COMPLETED|Overall Study||102
1731841|NCT00211887|4239552|P3|COMPLETED|Overall Study||223
1731842|NCT00211887|4239553|P2|COMPLETED|Overall Study||194
1731843|NCT00211887|4239554|P1|COMPLETED|Overall Study||397
1731844|NCT00211887|4239552|P3|STARTED|Overall Study||259
1731845|NCT00211887|4239553|P2|STARTED|Overall Study||250
1731846|NCT00211887|4239554|P1|STARTED|Overall Study||499
1731847|NCT00211809|4239571|P1|NOT COMPLETED|Overall Study||6
1731848|NCT00211809|4239571|P1|COMPLETED|Overall Study||11
1731849|NCT00211809|4239571|P1|STARTED|Overall Study||17
1731850|NCT00211757|4239587|P2|NOT COMPLETED|Overall Study||2
1731851|NCT00211757|4239588|P1|NOT COMPLETED|Overall Study||1
1731852|NCT00211757|4239587|P2|COMPLETED|Overall Study||14
1731853|NCT00211757|4239588|P1|COMPLETED|Overall Study||10
1731854|NCT00211757|4239587|P2|STARTED|Overall Study||16
1731855|NCT00211757|4239588|P1|STARTED|Overall Study||11
1731856|NCT00211692|4239598|P2|NOT COMPLETED|Overall Study||0
1731857|NCT00211692|4239599|P1|NOT COMPLETED|Overall Study||0
1731858|NCT00211692|4239598|P2|COMPLETED|Overall Study||31
1731859|NCT00211692|4239599|P1|COMPLETED|Overall Study||33
1731860|NCT00211692|4239598|P2|STARTED|Overall Study||31
1731861|NCT00211692|4239599|P1|STARTED|Overall Study||33
1731862|NCT00211536|4239609|P2|NOT COMPLETED|Overall Study||7
1731863|NCT00211536|4239610|P1|NOT COMPLETED|Overall Study||4
1731864|NCT00211536|4239609|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
1731865|NCT00211536|4239610|P1|COMPLETED|Overall Study||49
1731866|NCT00211536|4239609|P2|As Treated Data Analysis Set|Overall Study||48
1731867|NCT00211536|4239610|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
1731868|NCT00211536|4239609|P2|STARTED|Overall Study||54
1731869|NCT00211536|4239610|P1|STARTED|Overall Study||53
1731870|NCT00211510|4239626|P2|NOT COMPLETED|Overall Study||2
1731871|NCT00211510|4239627|P1|NOT COMPLETED|Overall Study||6
1731872|NCT00211510|4239626|P2|COMPLETED|Overall Study||72
1731873|NCT00211510|4239627|P1|COMPLETED|Overall Study||66
1731874|NCT00211510|4239626|P2|STARTED|Overall Study||74
1731875|NCT00211510|4239627|P1|STARTED|Overall Study||72
1731876|NCT00211237|4239645|P3|NOT COMPLETED|12 Months||6
1731877|NCT00211237|4239646|P2|NOT COMPLETED|12 Months||2
1731878|NCT00211237|4239647|P1|NOT COMPLETED|12 Months||9
1731879|NCT00211237|4239645|P3|COMPLETED|12 Months||28
1731880|NCT00211237|4239646|P2|COMPLETED|12 Months||6
1731881|NCT00211237|4239647|P1|COMPLETED|12 Months||40
1731882|NCT00211237|4239645|P3|STARTED|12 Months||34
1731883|NCT00211237|4239646|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
1731884|NCT00211237|4239647|P1|STARTED|12 Months||49
1731885|NCT00211237|4239645|P3|NOT COMPLETED|6 Months||3
1731886|NCT00211237|4239646|P2|NOT COMPLETED|6 Months||2
1731887|NCT00211237|4239647|P1|NOT COMPLETED|6 Months||8
1731888|NCT00211237|4239645|P3|COMPLETED|6 Months||33
1731889|NCT00211237|4239646|P2|COMPLETED|6 Months||9
1731890|NCT00211237|4239647|P1|COMPLETED|6 Months||49
1731891|NCT00211237|4239645|P3|STARTED|6 Months||36
1731892|NCT00211237|4239646|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
1731893|NCT00211237|4239647|P1|STARTED|6 Months||57
1731894|NCT00211237|4239645|P3|NOT COMPLETED|3 Months||1
1731895|NCT00211237|4239646|P2|NOT COMPLETED|3 Months||4
1731896|NCT00211237|4239647|P1|NOT COMPLETED|3 Months||8
1731897|NCT00211237|4239645|P3|COMPLETED|3 Months||33
1731898|NCT00211237|4239646|P2|COMPLETED|3 Months||14
1731899|NCT00211237|4239647|P1|COMPLETED|3 Months||57
1731900|NCT00211237|4239645|P3|STARTED|3 Months||34
1731901|NCT00211237|4239646|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
1731902|NCT00211237|4239647|P1|STARTED|3 Months||65
1731903|NCT00211237|4239645|P3|NOT COMPLETED|1 Month||0
1731904|NCT00211237|4239646|P2|NOT COMPLETED|1 Month||9
1731905|NCT00211237|4239647|P1|NOT COMPLETED|1 Month||3
1731906|NCT00211237|4239645|P3|COMPLETED|1 Month||0
1731907|NCT00211237|4239646|P2|COMPLETED|1 Month||52
1731908|NCT00211237|4239647|P1|COMPLETED|1 Month||65
1731909|NCT00211237|4239645|P3|STARTED|1 Month||0
1731910|NCT00211237|4239646|P2|STARTED|1 Month||61
1731911|NCT00211237|4239647|P1|STARTED|1 Month||68
1731912|NCT00211237|4239645|P3|NOT COMPLETED|Baseline||0
1731913|NCT00211237|4239646|P2|NOT COMPLETED|Baseline||3
1731914|NCT00211237|4239647|P1|NOT COMPLETED|Baseline||2
1731915|NCT00211237|4239645|P3|COMPLETED|Baseline||0
1731916|NCT00211237|4239646|P2|COMPLETED|Baseline||61
1731917|NCT00211237|4239647|P1|COMPLETED|Baseline||68
1731918|NCT00211237|4239645|P3|STARTED|Baseline||0
1731919|NCT00211237|4239646|P2|STARTED|Baseline||64
1731920|NCT00211237|4239647|P1|STARTED|Baseline||70
1731921|NCT00211172|4239739|P2|NOT COMPLETED|Overall Study||32
1731922|NCT00211172|4239740|P1|NOT COMPLETED|Overall Study||39
1731923|NCT00211172|4239739|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
1731924|NCT00211172|4239740|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
1731925|NCT00211172|4239739|P2|STARTED|Overall Study||458
1731926|NCT00211172|4239740|P1|STARTED|Overall Study||449
1731927|NCT00211081|4239746|P1|NOT COMPLETED|Overall Study||2
1731928|NCT00211081|4239746|P1|COMPLETED|Overall Study||10
1731929|NCT00211081|4239746|P1|STARTED|Overall Study||12
1731930|NCT00210639|4239758|P2|NOT COMPLETED|Overall Study||42
1731931|NCT00210639|4239759|P1|NOT COMPLETED|Overall Study||63
1731932|NCT00210639|4239758|P2|COMPLETED|Overall Study||41
1731933|NCT00210639|4239759|P1|COMPLETED|Overall Study||61
1731934|NCT00210639|4239758|P2|STARTED|Overall Study||83
1731935|NCT00210639|4239759|P1|STARTED|Overall Study||124
1731936|NCT00210626|4239767|P2|NOT COMPLETED|Overall Study||45
1731937|NCT00210626|4239768|P1|NOT COMPLETED|Overall Study||48
1731938|NCT00210626|4239767|P2|COMPLETED|Overall Study||50
1731939|NCT00210626|4239768|P1|COMPLETED|Overall Study||49
1731940|NCT00210626|4239767|P2|STARTED|Overall Study||95
1731941|NCT00210626|4239768|P1|STARTED|Overall Study||97
1731942|NCT00210470|4239776|P1|NOT COMPLETED|Overall Study||1
1731943|NCT00210470|4239776|P1|COMPLETED|Overall Study||26
1731944|NCT00210470|4239776|P1|STARTED|Overall Study||27
1731945|NCT00209560|4239782|P2|NOT COMPLETED|Overall Study||0
1731946|NCT00209560|4239783|P1|NOT COMPLETED|Overall Study||1
1731947|NCT00209560|4239782|P2|COMPLETED|Overall Study||42
1731948|NCT00209560|4239783|P1|COMPLETED|Overall Study||120
1731949|NCT00209560|4239782|P2|STARTED|Overall Study||42
1731950|NCT00209560|4239783|P1|STARTED|Overall Study||121
1731951|NCT00209417|4239793|P2|NOT COMPLETED|Overall Study||0
1731952|NCT00209417|4239794|P1|NOT COMPLETED|Overall Study||0
1731953|NCT00209417|4239793|P2|COMPLETED|Overall Study||327
1731954|NCT00209417|4239794|P1|COMPLETED|Overall Study||321
1731955|NCT00209417|4239793|P2|STARTED|Overall Study||327
1731956|NCT00209417|4239794|P1|STARTED|Overall Study||321
1731957|NCT00209339|4239802|P1|NOT COMPLETED|At 5 Years Follow-up||8
1731958|NCT00209339|4239802|P1|COMPLETED|At 5 Years Follow-up||15
1731959|NCT00209339|4239802|P1|STARTED|At 5 Years Follow-up||23
1731960|NCT00209339|4239802|P1|NOT COMPLETED|At 4 Years Follow-up||5
1731961|NCT00209339|4239802|P1|COMPLETED|At 4 Years Follow-up||23
1731962|NCT00209339|4239802|P1|STARTED|At 4 Years Follow-up||28
1731963|NCT00209339|4239802|P1|NOT COMPLETED|At 3 Years Follow-up||1
1731964|NCT00209339|4239802|P1|COMPLETED|At 3 Years Follow-up||28
1731965|NCT00209339|4239802|P1|STARTED|At 3 Years Follow-up||29
1731966|NCT00209339|4239802|P1|NOT COMPLETED|At 24 Months Follow-up||11
1731967|NCT00209339|4239802|P1|COMPLETED|At 24 Months Follow-up||29
1731968|NCT00209339|4239802|P1|STARTED|At 24 Months Follow-up||40
1731969|NCT00209339|4239802|P1|NOT COMPLETED|At 12 Months Follow-up||15
1731970|NCT00209339|4239802|P1|COMPLETED|At 12 Months Follow-up||40
1731971|NCT00209339|4239802|P1|STARTED|At 12 Months Follow-up||55
1731972|NCT00209274|4239886|P2|NOT COMPLETED|Overall Study||47
1731973|NCT00209274|4239887|P1|NOT COMPLETED|Overall Study||71
1731974|NCT00209274|4239886|P2|COMPLETED|Overall Study||48
1731975|NCT00209274|4239887|P1|COMPLETED|Overall Study||113
1731976|NCT00209274|4239886|P2|STARTED|Overall Study||95
1731977|NCT00209274|4239887|P1|STARTED|Overall Study||184
1731978|NCT00209170|4240207|P2|NOT COMPLETED|Overall Study||3
1731979|NCT00209170|4240208|P1|NOT COMPLETED|Overall Study||2
1731980|NCT00209170|4240207|P2|COMPLETED|Overall Study||4
1731981|NCT00209170|4240208|P1|COMPLETED|Overall Study||5
1731982|NCT00209170|4240207|P2|STARTED|Overall Study||7
1731983|NCT00209170|4240208|P1|STARTED|Overall Study||7
1731984|NCT00209131|4240216|P2|NOT COMPLETED|Overall Study||11
1731985|NCT00209131|4240217|P1|NOT COMPLETED|Overall Study||15
1731986|NCT00209131|4240216|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
1731987|NCT00209131|4240217|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
1731988|NCT00209131|4240216|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
1731989|NCT00209131|4240217|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
1731990|NCT00209092|4240227|P2|NOT COMPLETED|Overall Study||2
1731991|NCT00209092|4240228|P1|NOT COMPLETED|Overall Study||8
1731992|NCT00209092|4240227|P2|COMPLETED|Overall Study||24
1731993|NCT00209092|4240228|P1|COMPLETED|Overall Study||17
1731994|NCT00209092|4240227|P2|STARTED|Overall Study||26
1731995|NCT00209092|4240228|P1|STARTED|Overall Study||25
1731996|NCT00209027|4240238|P2|NOT COMPLETED|Overall Study||0
1731997|NCT00209027|4240239|P1|NOT COMPLETED|Overall Study||10
1731998|NCT00209027|4240238|P2|COMPLETED|Overall Study||10
1731999|NCT00209027|4240239|P1|COMPLETED|Overall Study||0
1732000|NCT00209027|4240238|P2|STARTED|Overall Study||10
1732001|NCT00209027|4240239|P1|STARTED|Overall Study||10
1732002|NCT00208975|4240245|P1|NOT COMPLETED|Overall Study||0
1732003|NCT00208975|4240245|P1|COMPLETED|Overall Study||15
1732004|NCT00208975|4240245|P1|STARTED|Overall Study||15
1732005|NCT00208949|4240252|P2|NOT COMPLETED|Overall Study||0
1732006|NCT00208949|4240253|P1|NOT COMPLETED|Overall Study||0
1732007|NCT00208949|4240252|P2|COMPLETED|Overall Study||25
1732008|NCT00208949|4240253|P1|COMPLETED|Overall Study||25
1732009|NCT00208949|4240252|P2|STARTED|Overall Study||25
1732010|NCT00208949|4240253|P1|STARTED|Overall Study||25
1732011|NCT00208767|4240263|P2|NOT COMPLETED|Overall Study||7
1732012|NCT00208767|4240264|P1|NOT COMPLETED|Overall Study||27
1732013|NCT00208767|4240263|P2|COMPLETED|Overall Study||33
1732014|NCT00208767|4240264|P1|COMPLETED|Overall Study||53
1732015|NCT00208767|4240263|P2|STARTED|Overall Study||40
1732016|NCT00208767|4240264|P1|STARTED|Overall Study||80
1732017|NCT00208507|4240272|P2|NOT COMPLETED|Overall Study||8
1732018|NCT00208507|4240273|P1|NOT COMPLETED|Overall Study||14
1732019|NCT00208507|4240272|P2|COMPLETED|Overall Study||79
1732020|NCT00208507|4240273|P1|COMPLETED|Overall Study||163
1732021|NCT00208507|4240272|P2|STARTED|Overall Study||87
1732022|NCT00208507|4240273|P1|STARTED|Overall Study||177
1732023|NCT00208494|4240281|P2|NOT COMPLETED|Overall Study||34
1732024|NCT00208494|4240282|P1|NOT COMPLETED|Overall Study||30
1732025|NCT00208494|4240281|P2|COMPLETED|Overall Study||162
1732026|NCT00208494|4240282|P1|COMPLETED|Overall Study||164
1732027|NCT00208494|4240281|P2|STARTED|Overall Study||196
1732028|NCT00208494|4240282|P1|STARTED|Overall Study||194
1732029|NCT00208325|4240292|P4|NOT COMPLETED|Overall Study||14
1732030|NCT00208325|4240293|P3|NOT COMPLETED|Overall Study||14
1732031|NCT00208325|4240294|P2|NOT COMPLETED|Overall Study||54
1732032|NCT00208325|4240295|P1|NOT COMPLETED|Overall Study||51
1732033|NCT00208325|4240292|P4|COMPLETED|Overall Study||147
1732034|NCT00208325|4240293|P3|COMPLETED|Overall Study||156
1732035|NCT00208325|4240294|P2|COMPLETED|Overall Study||142
1732036|NCT00208325|4240295|P1|COMPLETED|Overall Study||142
1732037|NCT00208325|4240292|P4|STARTED|Overall Study||161
1732038|NCT00208325|4240293|P3|STARTED|Overall Study||170
1732039|NCT00208325|4240294|P2|STARTED|Overall Study||196
1732040|NCT00208325|4240295|P1|STARTED|Overall Study||193
1732041|NCT00208091|4240403|P1|NOT COMPLETED|Overall Study||0
1732042|NCT00208091|4240403|P1|COMPLETED|Overall Study||16
1732043|NCT00208091|4240403|P1|STARTED|Overall Study||16
1732044|NCT00208026|4240411|P1|NOT COMPLETED|Overall Study||0
1732045|NCT00208026|4240411|P1|COMPLETED|Overall Study||3
1732046|NCT00208026|4240411|P1|STARTED|Overall Study||3
1732047|NCT00207883|4240417|P2|NOT COMPLETED|Overall Study||0
1732048|NCT00207883|4240418|P1|NOT COMPLETED|Overall Study||0
1732049|NCT00207883|4240417|P2|COMPLETED|Overall Study||119
1732050|NCT00207883|4240418|P1|COMPLETED|Overall Study||93
1732051|NCT00207883|4240417|P2|STARTED|Overall Study||119
1732052|NCT00207883|4240418|P1|STARTED|Overall Study||93
1732053|NCT00207740|4240430|P4|NOT COMPLETED|Overall Study||43
1732054|NCT00207740|4240431|P3|NOT COMPLETED|Overall Study||40
1732055|NCT00207740|4240432|P2|NOT COMPLETED|Overall Study||41
1732056|NCT00207740|4240433|P1|NOT COMPLETED|Overall Study||29
1732057|NCT00207740|4240430|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
1732140|NCT00206427|4240636|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
1732058|NCT00207740|4240431|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
1732059|NCT00207740|4240432|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
1732060|NCT00207740|4240433|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
1732061|NCT00207740|4240430|P4|STARTED|Overall Study||78
1732062|NCT00207740|4240431|P3|STARTED|Overall Study||76
1732063|NCT00207740|4240432|P2|STARTED|Overall Study||77
1732064|NCT00207740|4240433|P1|STARTED|Overall Study||78
1732065|NCT00207727|4240479|P5|NOT COMPLETED|Overall Study||34
1732066|NCT00207727|4240480|P4|NOT COMPLETED|Overall Study||37
1732067|NCT00207727|4240481|P3|NOT COMPLETED|Overall Study||41
1732068|NCT00207727|4240482|P2|NOT COMPLETED|Overall Study||42
1732069|NCT00207727|4240483|P1|NOT COMPLETED|Overall Study||38
1732070|NCT00207727|4240479|P5|COMPLETED|Overall Study||16
1732071|NCT00207727|4240480|P4|COMPLETED|Overall Study||13
1732072|NCT00207727|4240481|P3|COMPLETED|Overall Study||9
1732073|NCT00207727|4240482|P2|COMPLETED|Overall Study||8
1732074|NCT00207727|4240483|P1|COMPLETED|Overall Study||11
1732075|NCT00207727|4240479|P5|STARTED|Overall Study||50
1732076|NCT00207727|4240480|P4|STARTED|Overall Study||50
1732077|NCT00207727|4240481|P3|STARTED|Overall Study||50
1732078|NCT00207727|4240482|P2|STARTED|Overall Study||50
1732079|NCT00207727|4240483|P1|STARTED|Overall Study||49
1732080|NCT00207714|4240510|P5|NOT COMPLETED|Overall Study||5
1732081|NCT00207714|4240511|P4|NOT COMPLETED|Overall Study||8
1732082|NCT00207714|4240512|P3|NOT COMPLETED|Overall Study||10
1732083|NCT00207714|4240513|P2|NOT COMPLETED|Overall Study||7
1732084|NCT00207714|4240514|P1|NOT COMPLETED|Overall Study||14
1732085|NCT00207714|4240510|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
1732086|NCT00207714|4240511|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
1732087|NCT00207714|4240512|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
1732088|NCT00207714|4240513|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
1732089|NCT00207714|4240514|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
1732090|NCT00207714|4240510|P5|STARTED|Overall Study||34
1732091|NCT00207714|4240511|P4|STARTED|Overall Study||34
1732092|NCT00207714|4240512|P3|STARTED|Overall Study||34
1732093|NCT00207714|4240513|P2|STARTED|Overall Study||35
1732094|NCT00207714|4240514|P1|STARTED|Overall Study||35
1732095|NCT00207142|4240536|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
1732096|NCT00207142|4240537|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
1732097|NCT00207142|4240538|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
1732098|NCT00207142|4240539|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
1732099|NCT00207142|4240536|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
1732100|NCT00207142|4240537|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
1732101|NCT00207142|4240538|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
1732102|NCT00207142|4240539|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
1732103|NCT00207142|4240536|P4|STARTED|Maintenance Phase/Rescue Phase||50
1732104|NCT00207142|4240537|P3|STARTED|Maintenance Phase/Rescue Phase||85
1732105|NCT00207142|4240538|P2|STARTED|Maintenance Phase/Rescue Phase||87
1732106|NCT00207142|4240539|P1|STARTED|Maintenance Phase/Rescue Phase||0
1732107|NCT00207142|4240536|P4|NOT COMPLETED|Induction Phase||0
1732108|NCT00207142|4240537|P3|NOT COMPLETED|Induction Phase||0
1732109|NCT00207142|4240538|P2|NOT COMPLETED|Induction Phase||0
1732110|NCT00207142|4240539|P1|NOT COMPLETED|Induction Phase||30
1732111|NCT00207142|4240536|P4|COMPLETED|Induction Phase||0
1732112|NCT00207142|4240537|P3|COMPLETED|Induction Phase||0
1732113|NCT00207142|4240538|P2|COMPLETED|Induction Phase||0
1732114|NCT00207142|4240539|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
1732115|NCT00207142|4240536|P4|STARTED|Induction Phase||0
1732116|NCT00207142|4240537|P3|STARTED|Induction Phase||0
1732117|NCT00207142|4240538|P2|STARTED|Induction Phase||0
1732118|NCT00207142|4240539|P1|STARTED|Induction Phase||252
1732119|NCT00207090|4240576|P1|NOT COMPLETED|Overall Study||7
1732120|NCT00207090|4240576|P1|COMPLETED|Overall Study||8
1732121|NCT00207090|4240576|P1|STARTED|Overall Study|Number of participants treated|15
1732122|NCT00206726|4240605|P1|NOT COMPLETED|Overall Study||51
1732123|NCT00206726|4240605|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
1732124|NCT00206726|4240605|P1|4 Cycles Completed|Overall Study|per protocol population|41
1732125|NCT00206726|4240605|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
1732126|NCT00206726|4240605|P1|STARTED|Overall Study||60
1732127|NCT00206518|4240616|P2|NOT COMPLETED|Overall Study||6
1732128|NCT00206518|4240617|P1|NOT COMPLETED|Overall Study||10
1732129|NCT00206518|4240616|P2|COMPLETED|Overall Study||78
1732130|NCT00206518|4240617|P1|COMPLETED|Overall Study||73
1732131|NCT00206518|4240616|P2|STARTED|Overall Study||84
1732132|NCT00206518|4240617|P1|STARTED|Overall Study||83
1732133|NCT00206440|4240629|P2|NOT COMPLETED|Overall Study||4
1732134|NCT00206440|4240630|P1|NOT COMPLETED|Overall Study||5
1732135|NCT00206440|4240629|P2|COMPLETED|Overall Study||18
1732136|NCT00206440|4240630|P1|COMPLETED|Overall Study||16
1732137|NCT00206440|4240629|P2|STARTED|Overall Study||22
1732138|NCT00206440|4240630|P1|STARTED|Overall Study||21
1732139|NCT00206427|4240636|P1|NOT COMPLETED|Overall Study||2
1732141|NCT00206427|4240636|P1|STARTED|Overall Study|Received First Dose|49
1732142|NCT00206336|4240640|P1|NOT COMPLETED|Overall Study||0
1732143|NCT00206336|4240640|P1|COMPLETED|Overall Study||20
1732144|NCT00206336|4240640|P1|STARTED|Overall Study||20
1732145|NCT00206323|4240646|P2|NOT COMPLETED|Overall Study||3
1732146|NCT00206323|4240647|P1|NOT COMPLETED|Overall Study||6
1732147|NCT00206323|4240646|P2|COMPLETED|Overall Study||12
1732148|NCT00206323|4240647|P1|COMPLETED|Overall Study||8
1732149|NCT00206323|4240646|P2|STARTED|Overall Study||15
1732150|NCT00206323|4240647|P1|STARTED|Overall Study||14
1732151|NCT00206102|4240655|P2|NOT COMPLETED|Overall Study||315
1732152|NCT00206102|4240656|P1|NOT COMPLETED|Overall Study||408
1732153|NCT00206102|4240655|P2|COMPLETED|Overall Study||187
1732154|NCT00206102|4240656|P1|COMPLETED|Overall Study||188
1732155|NCT00206102|4240655|P2|STARTED|Overall Study||502
1732156|NCT00206102|4240656|P1|STARTED|Overall Study||596
1732157|NCT00206076|4240692|P2|NOT COMPLETED|Overall Study||1
1732158|NCT00206076|4240693|P1|NOT COMPLETED|Overall Study||3
1732159|NCT00206076|4240692|P2|COMPLETED|Overall Study||9
1732160|NCT00206076|4240693|P1|COMPLETED|Overall Study||6
1732161|NCT00206076|4240692|P2|STARTED|Overall Study||10
1732162|NCT00206076|4240693|P1|STARTED|Overall Study||9
1732163|NCT00205881|4240703|P1|NOT COMPLETED|Overall Study||16
1732164|NCT00205881|4240703|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
1732165|NCT00205881|4240703|P1|STARTED|Overall Study||32
1732166|NCT00205855|4240708|P1|NOT COMPLETED|Overall Study||21
1732167|NCT00205855|4240708|P1|COMPLETED|Overall Study||44
1732168|NCT00205855|4240708|P1|STARTED|Overall Study||65
1732169|NCT00205803|4240714|P2|NOT COMPLETED|Toddler Dose||3
1732170|NCT00205803|4240715|P1|NOT COMPLETED|Toddler Dose||2
1732171|NCT00205803|4240714|P2|COMPLETED|Toddler Dose||100
1732172|NCT00205803|4240715|P1|COMPLETED|Toddler Dose||84
1732173|NCT00205803|4240714|P2|STARTED|Toddler Dose||103
1732174|NCT00205803|4240715|P1|STARTED|Toddler Dose||86
1732175|NCT00205803|4240714|P2|NOT COMPLETED|After Infant Series||13
1732176|NCT00205803|4240715|P1|NOT COMPLETED|After Infant Series||18
1732177|NCT00205803|4240714|P2|COMPLETED|After Infant Series||103
1732178|NCT00205803|4240715|P1|COMPLETED|After Infant Series||86
1732179|NCT00205803|4240714|P2|STARTED|After Infant Series||116
1732180|NCT00205803|4240715|P1|STARTED|After Infant Series||104
1732181|NCT00205803|4240714|P2|NOT COMPLETED|Infant Series||11
1732182|NCT00205803|4240715|P1|NOT COMPLETED|Infant Series||18
1732183|NCT00205803|4240714|P2|COMPLETED|Infant Series||116
1732184|NCT00205803|4240715|P1|COMPLETED|Infant Series||104
1732185|NCT00205803|4240714|P2|Vaccinated Dose 3|Infant Series||118
1732186|NCT00205803|4240715|P1|Vaccinated Dose 3|Infant Series||110
1732187|NCT00205803|4240714|P2|Vaccinated Dose 2|Infant Series||122
1732188|NCT00205803|4240715|P1|Vaccinated Dose 2|Infant Series||115
1732189|NCT00205803|4240714|P2|Vaccinated Dose 1|Infant Series||126
1732190|NCT00205803|4240715|P1|Vaccinated Dose 1|Infant Series||121
1732191|NCT00205803|4240714|P2|STARTED|Infant Series||127
1732192|NCT00205803|4240715|P1|STARTED|Infant Series||122
1732193|NCT00205777|4240771|P6|NOT COMPLETED|Study Extension II||282
1732194|NCT00205777|4240772|P5|NOT COMPLETED|Study Extension II||0
1732195|NCT00205777|4240773|P4|NOT COMPLETED|Study Extension II||149
1732196|NCT00205777|4240774|P3|NOT COMPLETED|Study Extension II||0
1732197|NCT00205777|4240775|P2|NOT COMPLETED|Study Extension II||0
1732198|NCT00205777|4240776|P1|NOT COMPLETED|Study Extension II||0
1732199|NCT00205777|4240771|P6|COMPLETED|Study Extension II||860
1732200|NCT00205777|4240772|P5|COMPLETED|Study Extension II||0
1732201|NCT00205777|4240773|P4|COMPLETED|Study Extension II||441
1732202|NCT00205777|4240774|P3|COMPLETED|Study Extension II||0
1732203|NCT00205777|4240775|P2|COMPLETED|Study Extension II||0
1732204|NCT00205777|4240776|P1|COMPLETED|Study Extension II||0
1732205|NCT00205777|4240771|P6|TREATED|Study Extension II||1011
1732206|NCT00205777|4240772|P5|TREATED|Study Extension II||0
1732207|NCT00205777|4240773|P4|TREATED|Study Extension II||519
1732208|NCT00205777|4240774|P3|TREATED|Study Extension II||0
1732209|NCT00205777|4240775|P2|TREATED|Study Extension II||0
1732210|NCT00205777|4240776|P1|TREATED|Study Extension II||0
1732211|NCT00205777|4240771|P6|STARTED|Study Extension II||1142
1732212|NCT00205777|4240772|P5|STARTED|Study Extension II||0
1732213|NCT00205777|4240773|P4|STARTED|Study Extension II||590
1732214|NCT00205777|4240774|P3|STARTED|Study Extension II||0
1732215|NCT00205777|4240775|P2|STARTED|Study Extension II||0
1732216|NCT00205777|4240776|P1|STARTED|Study Extension II||0
1732217|NCT00205777|4240771|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
1732218|NCT00205777|4240772|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
1732219|NCT00205777|4240773|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
1732220|NCT00205777|4240774|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
1732221|NCT00205777|4240775|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
1732222|NCT00205777|4240776|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
1732223|NCT00205777|4240771|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
1732224|NCT00205777|4240772|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
1732225|NCT00205777|4240773|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
1732226|NCT00205777|4240774|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
1732227|NCT00205777|4240775|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
1732228|NCT00205777|4240776|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
1732229|NCT00205777|4240771|P6|STARTED|Completed SE I, Entered Extension SE II||0
1732230|NCT00205777|4240772|P5|STARTED|Completed SE I, Entered Extension SE II||840
1732231|NCT00205777|4240773|P4|STARTED|Completed SE I, Entered Extension SE II||830
1732232|NCT00205777|4240774|P3|STARTED|Completed SE I, Entered Extension SE II||0
1732233|NCT00205777|4240775|P2|STARTED|Completed SE I, Entered Extension SE II||0
1732234|NCT00205777|4240776|P1|STARTED|Completed SE I, Entered Extension SE II||833
1732235|NCT00205777|4240771|P6|NOT COMPLETED|Study Extension I||0
1732236|NCT00205777|4240772|P5|NOT COMPLETED|Study Extension I||201
1732237|NCT00205777|4240773|P4|NOT COMPLETED|Study Extension I||228
1732238|NCT00205777|4240774|P3|NOT COMPLETED|Study Extension I||1070
1732239|NCT00205777|4240775|P2|NOT COMPLETED|Study Extension I||0
1732240|NCT00205777|4240776|P1|NOT COMPLETED|Study Extension I||214
1732241|NCT00205777|4240771|P6|COMPLETED|Study Extension I||0
1732242|NCT00205777|4240772|P5|COMPLETED|Study Extension I||840
1732243|NCT00205777|4240773|P4|COMPLETED|Study Extension I||830
1732244|NCT00205777|4240774|P3|COMPLETED|Study Extension I||0
1732245|NCT00205777|4240775|P2|COMPLETED|Study Extension I||0
1732246|NCT00205777|4240776|P1|COMPLETED|Study Extension I||833
1732247|NCT00205777|4240771|P6|STARTED|Study Extension I||0
1732248|NCT00205777|4240772|P5|STARTED|Study Extension I||1041
1732249|NCT00205777|4240773|P4|STARTED|Study Extension I||1058
1732250|NCT00205777|4240774|P3|STARTED|Study Extension I||1070
1732251|NCT00205777|4240775|P2|STARTED|Study Extension I||0
1732252|NCT00205777|4240776|P1|STARTED|Study Extension I||1047
1732253|NCT00205777|4240771|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
1732254|NCT00205777|4240772|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
1732255|NCT00205777|4240773|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
1732256|NCT00205777|4240774|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
1732257|NCT00205777|4240775|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
1732258|NCT00205777|4240776|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
1732259|NCT00205777|4240771|P6|COMPLETED|Completed Core Study, Entered SE I||0
1732260|NCT00205777|4240772|P5|COMPLETED|Completed Core Study, Entered SE I||0
1732261|NCT00205777|4240773|P4|COMPLETED|Completed Core Study, Entered SE I||1058
1732262|NCT00205777|4240774|P3|COMPLETED|Completed Core Study, Entered SE I||1070
1732263|NCT00205777|4240775|P2|COMPLETED|Completed Core Study, Entered SE I||1041
1732264|NCT00205777|4240776|P1|COMPLETED|Completed Core Study, Entered SE I||1047
1732265|NCT00205777|4240771|P6|STARTED|Completed Core Study, Entered SE I||0
1732266|NCT00205777|4240772|P5|STARTED|Completed Core Study, Entered SE I||0
1732267|NCT00205777|4240773|P4|STARTED|Completed Core Study, Entered SE I||1282
1732268|NCT00205777|4240774|P3|STARTED|Completed Core Study, Entered SE I||1277
1732269|NCT00205777|4240775|P2|STARTED|Completed Core Study, Entered SE I||1245
1732270|NCT00205777|4240776|P1|STARTED|Completed Core Study, Entered SE I||1279
1732271|NCT00205777|4240771|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
1732272|NCT00205777|4240772|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
1732273|NCT00205777|4240773|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
1732274|NCT00205777|4240774|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
1732275|NCT00205777|4240775|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
1732276|NCT00205777|4240776|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
1732277|NCT00205777|4240771|P6|COMPLETED|Core Study (Up to 3 Years)||0
1732278|NCT00205777|4240772|P5|COMPLETED|Core Study (Up to 3 Years)||0
1732279|NCT00205777|4240773|P4|COMPLETED|Core Study (Up to 3 Years)||1282
1732280|NCT00205777|4240774|P3|COMPLETED|Core Study (Up to 3 Years)||1277
1732281|NCT00205777|4240775|P2|COMPLETED|Core Study (Up to 3 Years)||1245
1732282|NCT00205777|4240776|P1|COMPLETED|Core Study (Up to 3 Years)||1279
1732283|NCT00205777|4240771|P6|TREATED|Core Study (Up to 3 Years)||0
1732284|NCT00205777|4240772|P5|TREATED|Core Study (Up to 3 Years)||0
1732285|NCT00205777|4240773|P4|TREATED|Core Study (Up to 3 Years)||1885
1732286|NCT00205777|4240774|P3|TREATED|Core Study (Up to 3 Years)||1849
1732287|NCT00205777|4240775|P2|TREATED|Core Study (Up to 3 Years)||1872
1732288|NCT00205777|4240776|P1|TREATED|Core Study (Up to 3 Years)||1886
1732289|NCT00205777|4240771|P6|STARTED|Core Study (Up to 3 Years)||0
1732290|NCT00205777|4240772|P5|STARTED|Core Study (Up to 3 Years)||0
1732291|NCT00205777|4240773|P4|STARTED|Core Study (Up to 3 Years)||1914
1732292|NCT00205777|4240774|P3|STARTED|Core Study (Up to 3 Years)||1884
1732293|NCT00205777|4240775|P2|STARTED|Core Study (Up to 3 Years)||1904
1732294|NCT00205777|4240776|P1|STARTED|Core Study (Up to 3 Years)||1907
1732295|NCT00205712|4240985|P2|NOT COMPLETED|Overall Study||1
1732296|NCT00205712|4240986|P1|NOT COMPLETED|Overall Study||0
1732297|NCT00205712|4240985|P2|COMPLETED|Overall Study||19
1732298|NCT00205712|4240986|P1|COMPLETED|Overall Study||20
1732299|NCT00205712|4240985|P2|STARTED|Overall Study||20
1732300|NCT00205712|4240986|P1|STARTED|Overall Study||20
1732301|NCT00205699|4240999|P3|NOT COMPLETED|Overall Study||6
1732302|NCT00205699|4241000|P2|NOT COMPLETED|Overall Study||6
1732303|NCT00205699|4241001|P1|NOT COMPLETED|Overall Study||3
1732304|NCT00205699|4240999|P3|COMPLETED|Overall Study||43
1732305|NCT00205699|4241000|P2|COMPLETED|Overall Study||40
1732306|NCT00205699|4241001|P1|COMPLETED|Overall Study||46
1732307|NCT00205699|4240999|P3|STARTED|Overall Study||49
1732308|NCT00205699|4241000|P2|STARTED|Overall Study||46
1732309|NCT00205699|4241001|P1|STARTED|Overall Study||49
1732310|NCT00205504|4241026|P2|NOT COMPLETED|Overall Study||0
1732311|NCT00205504|4241027|P1|NOT COMPLETED|Overall Study||7
1732312|NCT00205504|4241026|P2|COMPLETED|Overall Study||15
1732313|NCT00205504|4241027|P1|COMPLETED|Overall Study||14
1732314|NCT00205504|4241026|P2|STARTED|Overall Study||15
1732315|NCT00205504|4241027|P1|STARTED|Overall Study||21
1732316|NCT00205374|4241053|P2|NOT COMPLETED|Overall Study||0
1732317|NCT00205374|4241054|P1|NOT COMPLETED|Overall Study||0
1732318|NCT00205374|4241053|P2|COMPLETED|Overall Study||9
1732319|NCT00205374|4241054|P1|COMPLETED|Overall Study||10
1732320|NCT00205374|4241053|P2|STARTED|Overall Study||9
1732321|NCT00205374|4241054|P1|STARTED|Overall Study||10
1732322|NCT00205348|4241062|P1|NOT COMPLETED|Overall Study||30
1732323|NCT00205348|4241062|P1|COMPLETED|Overall Study||116
1732324|NCT00205348|4241062|P1|STARTED|Overall Study||146
1732325|NCT00205049|4241068|P2|NOT COMPLETED|Overall Study||0
1732326|NCT00205049|4241069|P1|NOT COMPLETED|Overall Study||0
1732327|NCT00205049|4241068|P2|COMPLETED|Overall Study||0
1732328|NCT00205049|4241069|P1|COMPLETED|Overall Study||0
1732329|NCT00205049|4241068|P2|STARTED|Overall Study||0
1732330|NCT00205049|4241069|P1|STARTED|Overall Study||0
1732331|NCT00204932|4241077|P2|NOT COMPLETED|Overall Study||6
1732332|NCT00204932|4241078|P1|NOT COMPLETED|Overall Study||2
1732333|NCT00204932|4241077|P2|COMPLETED|Overall Study||18
1732334|NCT00204932|4241078|P1|COMPLETED|Overall Study||22
1732335|NCT00204932|4241077|P2|STARTED|Overall Study||24
1732336|NCT00204932|4241078|P1|STARTED|Overall Study||24
1732337|NCT00204373|4241084|P1|NOT COMPLETED|Overall Study||0
1732338|NCT00204373|4241084|P1|COMPLETED|Overall Study||72
1732339|NCT00204373|4241084|P1|STARTED|Overall Study||72
1732340|NCT00203996|4241095|P10|NOT COMPLETED|Overall Study||1
1732341|NCT00203996|4241096|P9|NOT COMPLETED|Overall Study||0
1732342|NCT00203996|4241097|P8|NOT COMPLETED|Overall Study||2
1732343|NCT00203996|4241098|P7|NOT COMPLETED|Overall Study||0
1732344|NCT00203996|4241099|P6|NOT COMPLETED|Overall Study||0
1732345|NCT00203996|4241100|P5|NOT COMPLETED|Overall Study||1
1732346|NCT00203996|4241101|P4|NOT COMPLETED|Overall Study||10
1732347|NCT00203996|4241102|P3|NOT COMPLETED|Overall Study||0
1732348|NCT00203996|4241103|P2|NOT COMPLETED|Overall Study||0
1732349|NCT00203996|4241104|P1|NOT COMPLETED|Overall Study||0
1732350|NCT00203996|4241095|P10|COMPLETED|Overall Study||2
1732351|NCT00203996|4241096|P9|COMPLETED|Overall Study||2
1732352|NCT00203996|4241097|P8|COMPLETED|Overall Study||2
1732353|NCT00203996|4241098|P7|COMPLETED|Overall Study||2
1732354|NCT00203996|4241099|P6|COMPLETED|Overall Study||3
1732355|NCT00203996|4241100|P5|COMPLETED|Overall Study||3
1732356|NCT00203996|4241101|P4|COMPLETED|Overall Study||9
1732357|NCT00203996|4241102|P3|COMPLETED|Overall Study||0
1732358|NCT00203996|4241103|P2|COMPLETED|Overall Study||0
1732359|NCT00203996|4241104|P1|COMPLETED|Overall Study||0
1732360|NCT00203996|4241095|P10|Aim 3 Only: Third Intervention|Overall Study||2
1732361|NCT00203996|4241096|P9|Aim 3 Only: Third Intervention|Overall Study||2
1732362|NCT00203996|4241097|P8|Aim 3 Only: Third Intervention|Overall Study||2
1732363|NCT00203996|4241098|P7|Aim 3 Only: Third Intervention|Overall Study||2
1732364|NCT00203996|4241099|P6|Aim 3 Only: Third Intervention|Overall Study||3
1732365|NCT00203996|4241100|P5|Aim 3 Only: Third Intervention|Overall Study||0
1732366|NCT00203996|4241101|P4|Aim 3 Only: Third Intervention|Overall Study||0
1732367|NCT00203996|4241102|P3|Aim 3 Only: Third Intervention|Overall Study||0
1732368|NCT00203996|4241103|P2|Aim 3 Only: Third Intervention|Overall Study||0
1732369|NCT00203996|4241104|P1|Aim 3 Only: Third Intervention|Overall Study||0
1732370|NCT00203996|4241095|P10|Aim 3 Only: Second Washout|Overall Study||2
1732371|NCT00203996|4241096|P9|Aim 3 Only: Second Washout|Overall Study||2
1732372|NCT00203996|4241097|P8|Aim 3 Only: Second Washout|Overall Study||2
1732373|NCT00203996|4241098|P7|Aim 3 Only: Second Washout|Overall Study||2
1732374|NCT00203996|4241099|P6|Aim 3 Only: Second Washout|Overall Study||3
1732375|NCT00203996|4241100|P5|Aim 3 Only: Second Washout|Overall Study||0
1732376|NCT00203996|4241101|P4|Aim 3 Only: Second Washout|Overall Study||0
1732377|NCT00203996|4241102|P3|Aim 3 Only: Second Washout|Overall Study||0
1732378|NCT00203996|4241103|P2|Aim 3 Only: Second Washout|Overall Study||0
1732379|NCT00203996|4241104|P1|Aim 3 Only: Second Washout|Overall Study||0
1732380|NCT00203996|4241095|P10|Aim 3 Only: Second Intervention|Overall Study||2
1732381|NCT00203996|4241096|P9|Aim 3 Only: Second Intervention|Overall Study||2
1732382|NCT00203996|4241097|P8|Aim 3 Only: Second Intervention|Overall Study||2
1732383|NCT00203996|4241098|P7|Aim 3 Only: Second Intervention|Overall Study||2
1732384|NCT00203996|4241099|P6|Aim 3 Only: Second Intervention|Overall Study||3
1732385|NCT00203996|4241100|P5|Aim 3 Only: Second Intervention|Overall Study||0
1732386|NCT00203996|4241101|P4|Aim 3 Only: Second Intervention|Overall Study||0
1732387|NCT00203996|4241102|P3|Aim 3 Only: Second Intervention|Overall Study||0
1732388|NCT00203996|4241103|P2|Aim 3 Only: Second Intervention|Overall Study||0
1732389|NCT00203996|4241104|P1|Aim 3 Only: Second Intervention|Overall Study||0
1732390|NCT00203996|4241095|P10|Aim 3 Only: Washout|Overall Study||2
1732391|NCT00203996|4241096|P9|Aim 3 Only: Washout|Overall Study||2
1732392|NCT00203996|4241097|P8|Aim 3 Only: Washout|Overall Study||2
1732393|NCT00203996|4241098|P7|Aim 3 Only: Washout|Overall Study||2
1732394|NCT00203996|4241099|P6|Aim 3 Only: Washout|Overall Study||3
1732395|NCT00203996|4241100|P5|Aim 3 Only: Washout|Overall Study||0
1732396|NCT00203996|4241101|P4|Aim 3 Only: Washout|Overall Study||0
1732397|NCT00203996|4241102|P3|Aim 3 Only: Washout|Overall Study||0
1732398|NCT00203996|4241103|P2|Aim 3 Only: Washout|Overall Study||0
1732399|NCT00203996|4241104|P1|Aim 3 Only: Washout|Overall Study||0
1732400|NCT00203996|4241095|P10|Aim 3 Only: First Intervention|Overall Study||3
1732401|NCT00203996|4241096|P9|Aim 3 Only: First Intervention|Overall Study||2
1732402|NCT00203996|4241097|P8|Aim 3 Only: First Intervention|Overall Study||4
1732403|NCT00203996|4241098|P7|Aim 3 Only: First Intervention|Overall Study||2
1732404|NCT00203996|4241099|P6|Aim 3 Only: First Intervention|Overall Study||3
1732405|NCT00203996|4241100|P5|Aim 3 Only: First Intervention|Overall Study||0
1732406|NCT00203996|4241101|P4|Aim 3 Only: First Intervention|Overall Study||0
1732407|NCT00203996|4241102|P3|Aim 3 Only: First Intervention|Overall Study||0
1732408|NCT00203996|4241103|P2|Aim 3 Only: First Intervention|Overall Study||0
1732409|NCT00203996|4241104|P1|Aim 3 Only: First Intervention|Overall Study||0
1732410|NCT00203996|4241095|P10|STARTED|Overall Study||3
1732411|NCT00203996|4241096|P9|STARTED|Overall Study||2
1732412|NCT00203996|4241097|P8|STARTED|Overall Study||4
1732413|NCT00203996|4241098|P7|STARTED|Overall Study||2
1732414|NCT00203996|4241099|P6|STARTED|Overall Study||3
1732415|NCT00203996|4241100|P5|STARTED|Overall Study||4
1732416|NCT00203996|4241101|P4|STARTED|Overall Study||19
1732417|NCT00203996|4241102|P3|STARTED|Overall Study||0
1732418|NCT00203996|4241103|P2|STARTED|Overall Study||0
1732419|NCT00203996|4241104|P1|STARTED|Overall Study||0
1732420|NCT00203931|4241153|P2|NOT COMPLETED|Overall Study||5
1732421|NCT00203931|4241154|P1|NOT COMPLETED|Overall Study||7
1732422|NCT00203931|4241153|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
1732423|NCT00203931|4241154|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
1732424|NCT00203931|4241153|P2|STARTED|Overall Study||28
1732425|NCT00203931|4241154|P1|STARTED|Overall Study||27
1732426|NCT00203892|4241171|P3|NOT COMPLETED|Overall Study||0
1732427|NCT00203892|4241172|P2|NOT COMPLETED|Overall Study||2
1732428|NCT00203892|4241173|P1|NOT COMPLETED|Overall Study||2
1732429|NCT00203892|4241171|P3|COMPLETED|Overall Study||6
1732430|NCT00203892|4241172|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
1732431|NCT00203892|4241173|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
1732432|NCT00203892|4241171|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
1732433|NCT00203892|4241172|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
1732434|NCT00203892|4241173|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
1732435|NCT00203892|4241171|P3|STARTED|Overall Study||6
1732436|NCT00203892|4241172|P2|STARTED|Overall Study||10
1732437|NCT00203892|4241173|P1|STARTED|Overall Study||7
1732438|NCT00203502|4241184|P1|NOT COMPLETED|Overall Study||1
1732439|NCT00203502|4241184|P1|COMPLETED|Overall Study||39
1732440|NCT00203502|4241184|P1|STARTED|Overall Study||40
1732441|NCT00203476|4241195|P3|NOT COMPLETED|Overall Study||0
1732442|NCT00203476|4241196|P2|NOT COMPLETED|Overall Study||1
1732443|NCT00203476|4241197|P1|NOT COMPLETED|Overall Study||1
1732444|NCT00203476|4241195|P3|COMPLETED|Overall Study||10
1732445|NCT00203476|4241196|P2|COMPLETED|Overall Study||9
1732446|NCT00203476|4241197|P1|COMPLETED|Overall Study||9
1732447|NCT00203476|4241195|P3|STARTED|Overall Study||10
1732448|NCT00203476|4241196|P2|STARTED|Overall Study||10
1732449|NCT00203476|4241197|P1|STARTED|Overall Study||10
1732450|NCT00203424|4241214|P1|NOT COMPLETED|Follow-up Period||6
1732451|NCT00203424|4241214|P1|COMPLETED|Follow-up Period||10
1732452|NCT00203424|4241214|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
1732453|NCT00203424|4241214|P1|NOT COMPLETED|Treatment Period||11
1732454|NCT00203424|4241214|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
1732455|NCT00203424|4241214|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
1732456|NCT00203411|4241221|P1|NOT COMPLETED|Follow-up||4
1732457|NCT00203411|4241221|P1|COMPLETED|Follow-up||41
1732458|NCT00203411|4241221|P1|STARTED|Follow-up||45
1732459|NCT00203411|4241221|P1|NOT COMPLETED|Treatment Period||0
1732460|NCT00203411|4241221|P1|COMPLETED|Treatment Period||45
1732461|NCT00203411|4241221|P1|STARTED|Treatment Period||45
1732462|NCT00203307|4241230|P2|NOT COMPLETED|Second Intervention||0
1732463|NCT00203307|4241231|P1|NOT COMPLETED|Second Intervention||0
1732464|NCT00203307|4241230|P2|COMPLETED|Second Intervention||0
1732465|NCT00203307|4241231|P1|COMPLETED|Second Intervention||1
1732466|NCT00203307|4241230|P2|STARTED|Second Intervention||0
1732467|NCT00203307|4241231|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
1732468|NCT00203307|4241230|P2|NOT COMPLETED|First Intervention||0
1732469|NCT00203307|4241231|P1|NOT COMPLETED|First Intervention||2
1732470|NCT00203307|4241230|P2|COMPLETED|First Intervention||0
1732471|NCT00203307|4241231|P1|COMPLETED|First Intervention||1
1732472|NCT00203307|4241230|P2|STARTED|First Intervention||0
1732473|NCT00203307|4241231|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
1732474|NCT00203294|4241239|P2|NOT COMPLETED|Overall Study||13
1732475|NCT00203294|4241240|P1|NOT COMPLETED|Overall Study||8
1732476|NCT00203294|4241239|P2|COMPLETED|Overall Study||10
1732477|NCT00203294|4241240|P1|COMPLETED|Overall Study||14
1732478|NCT00203294|4241239|P2|STARTED|Overall Study||23
1732479|NCT00203294|4241240|P1|STARTED|Overall Study||22
1732480|NCT00203268|4241246|P1|NOT COMPLETED|Late Treatment||0
1732481|NCT00203268|4241246|P1|COMPLETED|Late Treatment||9
1732482|NCT00203268|4241246|P1|STARTED|Late Treatment||9
1732483|NCT00203268|4241246|P1|NOT COMPLETED|Early Treatment||4
1732484|NCT00203268|4241246|P1|COMPLETED|Early Treatment||9
1732485|NCT00203268|4241246|P1|STARTED|Early Treatment||13
1732486|NCT00203242|4241252|P1|NOT COMPLETED|Overall Study||1
1732487|NCT00203242|4241252|P1|COMPLETED|Overall Study||14
1732488|NCT00203242|4241252|P1|STARTED|Overall Study||15
1732489|NCT00203229|4241258|P2|NOT COMPLETED|Overall Study||3
1732490|NCT00203229|4241259|P1|NOT COMPLETED|Overall Study||3
1732491|NCT00203229|4241258|P2|COMPLETED|Overall Study||7
1732492|NCT00203229|4241259|P1|COMPLETED|Overall Study||7
1732493|NCT00203229|4241258|P2|STARTED|Overall Study||10
1732494|NCT00203229|4241259|P1|STARTED|Overall Study||10
1732495|NCT00203216|4241265|P1|NOT COMPLETED|Overall Study||4
1732496|NCT00203216|4241265|P1|COMPLETED|Overall Study||27
1732497|NCT00203216|4241265|P1|STARTED|Overall Study||31
1732498|NCT00203203|4241271|P2|NOT COMPLETED|Overall Study||0
1732499|NCT00203203|4241272|P1|NOT COMPLETED|Overall Study||1
1732500|NCT00203203|4241271|P2|COMPLETED|Overall Study||20
1732501|NCT00203203|4241272|P1|COMPLETED|Overall Study||9
1732502|NCT00203203|4241271|P2|STARTED|Overall Study||20
1732503|NCT00203203|4241272|P1|STARTED|Overall Study||10
1732504|NCT00203047|4241304|P2|NOT COMPLETED|Overall Study||203
1732505|NCT00203047|4241305|P1|NOT COMPLETED|Overall Study||191
1732506|NCT00203047|4241304|P2|COMPLETED|Overall Study||7
1732507|NCT00203047|4241305|P1|COMPLETED|Overall Study||13
1732508|NCT00203047|4241304|P2|In Database as of January 29, 2009|Overall Study||209
1732509|NCT00203047|4241305|P1|In Database as of January 29, 2009|Overall Study||199
1732510|NCT00203047|4241304|P2|STARTED|Overall Study||210
1732511|NCT00203047|4241305|P1|STARTED|Overall Study||204
1732512|NCT00202878|4241319|P2|NOT COMPLETED|Overall Study||2217
1732513|NCT00202878|4241320|P1|NOT COMPLETED|Overall Study||2199
1732514|NCT00202878|4241319|P2|COMPLETED|Overall Study||6860
1732515|NCT00202878|4241320|P1|COMPLETED|Overall Study||6868
1732516|NCT00202878|4241319|P2|STARTED|Overall Study||9077
1732517|NCT00202878|4241320|P1|STARTED|Overall Study||9067
1732518|NCT00202839|4241334|P2|NOT COMPLETED|Overall Study||10
1732519|NCT00202839|4241335|P1|NOT COMPLETED|Overall Study||24
1732520|NCT00202839|4241334|P2|COMPLETED|Overall Study||72
1732521|NCT00202839|4241335|P1|COMPLETED|Overall Study||54
1732522|NCT00202839|4241334|P2|STARTED|Overall Study||82
1732523|NCT00202839|4241335|P1|STARTED|Overall Study||78
1732524|NCT00202722|4241343|P1|NOT COMPLETED|Overall Study||0
1732525|NCT00202722|4241343|P1|COMPLETED|Overall Study||41
1732526|NCT00202722|4241343|P1|STARTED|Overall Study||41
1732527|NCT00202644|4241350|P2|NOT COMPLETED|Overall Study||27
1732528|NCT00202644|4241351|P1|NOT COMPLETED|Overall Study||35
1732529|NCT00202644|4241350|P2|COMPLETED|Overall Study||43
1732530|NCT00202644|4241351|P1|COMPLETED|Overall Study||41
1732531|NCT00202644|4241350|P2|STARTED|Overall Study||70
1732532|NCT00202644|4241351|P1|STARTED|Overall Study|One participant not randomized but treated.|76
1732533|NCT00202449|4241378|P3|NOT COMPLETED|Overall Study||12
1732534|NCT00202449|4241379|P2|NOT COMPLETED|Overall Study||11
1732535|NCT00202449|4241380|P1|NOT COMPLETED|Overall Study||11
1732536|NCT00202449|4241378|P3|COMPLETED|Overall Study||9
1732537|NCT00202449|4241379|P2|COMPLETED|Overall Study||9
1732538|NCT00202449|4241380|P1|COMPLETED|Overall Study||7
1732539|NCT00202449|4241378|P3|STARTED|Overall Study||21
1732540|NCT00202449|4241379|P2|STARTED|Overall Study||20
1732541|NCT00202449|4241380|P1|STARTED|Overall Study||18
1732542|NCT00201877|4241394|P1|NOT COMPLETED|Overall Study||0
1732543|NCT00201877|4241394|P1|COMPLETED|Overall Study||25
1732544|NCT00201877|4241394|P1|STARTED|Overall Study||25
1732545|NCT00201864|4241401|P1|NOT COMPLETED|Overall Study||0
1732546|NCT00201864|4241401|P1|COMPLETED|Overall Study||40
1732547|NCT00201864|4241401|P1|STARTED|Overall Study||40
1732548|NCT00201851|4241412|P3|NOT COMPLETED|Overall Study||1
1732549|NCT00201851|4241413|P2|NOT COMPLETED|Overall Study||2
1732550|NCT00201851|4241414|P1|NOT COMPLETED|Overall Study||8
1732551|NCT00201851|4241412|P3|COMPLETED|Overall Study||230
1732552|NCT00201851|4241413|P2|COMPLETED|Overall Study||255
1732553|NCT00201851|4241414|P1|COMPLETED|Overall Study||244
1732554|NCT00201851|4241412|P3|STARTED|Overall Study||231
1732555|NCT00201851|4241413|P2|STARTED|Overall Study||257
1732556|NCT00201851|4241414|P1|STARTED|Overall Study||252
1732557|NCT00201838|4241424|P2|NOT COMPLETED|Overall Study||0
1732558|NCT00201838|4241425|P1|NOT COMPLETED|Overall Study||0
1732559|NCT00201838|4241424|P2|COMPLETED|Overall Study||8
1732560|NCT00201838|4241425|P1|COMPLETED|Overall Study||30
1732561|NCT00201838|4241424|P2|Treatment Cohort|Overall Study||8
1732562|NCT00201838|4241425|P1|Treatment Cohort|Overall Study||30
1732563|NCT00201838|4241424|P2|STARTED|Overall Study||8
1732564|NCT00201838|4241425|P1|STARTED|Overall Study||30
1732565|NCT00201825|4241439|P1|NOT COMPLETED|Overall Study||0
1732566|NCT00201825|4241439|P1|COMPLETED|Overall Study||29
1732567|NCT00201825|4241439|P1|STARTED|Overall Study||29
1732568|NCT00201773|4241446|P1|NOT COMPLETED|Overall Study||6
1732569|NCT00201773|4241446|P1|COMPLETED|Overall Study||16
1732570|NCT00201773|4241446|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
1732571|NCT00201773|4241446|P1|Received All Exemestane Therapy|Overall Study||5
1732572|NCT00201773|4241446|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
1732573|NCT00201773|4241446|P1|STARTED|Overall Study||22
1732574|NCT00201760|4241455|P2|NOT COMPLETED|Overall Study||0
1732575|NCT00201760|4241456|P1|NOT COMPLETED|Overall Study||0
1732576|NCT00201760|4241455|P2|COMPLETED|Overall Study||5
1732577|NCT00201760|4241456|P1|COMPLETED|Overall Study||5
1732578|NCT00201760|4241455|P2|STARTED|Overall Study||5
1732579|NCT00201760|4241456|P1|STARTED|Overall Study||5
1732580|NCT00201734|4241468|P2|NOT COMPLETED|Overall Study||0
1732581|NCT00201734|4241469|P1|NOT COMPLETED|Overall Study||3
1732582|NCT00201734|4241468|P2|COMPLETED|Overall Study||25
1732583|NCT00201734|4241469|P1|COMPLETED|Overall Study||29
1732584|NCT00201734|4241468|P2|Patients Not Evaluable|Overall Study||0
1732585|NCT00201734|4241469|P1|Patients Not Evaluable|Overall Study||3
1732586|NCT00201734|4241468|P2|STARTED|Overall Study||25
1732587|NCT00201734|4241469|P1|STARTED|Overall Study||32
1732588|NCT00201643|4241486|P2|NOT COMPLETED|Overall Study||4
1732589|NCT00201643|4241487|P1|NOT COMPLETED|Overall Study||5
1732590|NCT00201643|4241486|P2|COMPLETED|Overall Study||210
1732591|NCT00201643|4241487|P1|COMPLETED|Overall Study||218
1732592|NCT00201643|4241486|P2|STARTED|Overall Study||214
1732593|NCT00201643|4241487|P1|STARTED|Overall Study||223
1732594|NCT00201448|4241511|P2|NOT COMPLETED|Overall Study||0
1732595|NCT00201448|4241512|P1|NOT COMPLETED|Overall Study||0
1732596|NCT00201448|4241511|P2|COMPLETED|Overall Study||40
1732597|NCT00201448|4241512|P1|COMPLETED|Overall Study||42
1732598|NCT00201448|4241511|P2|STARTED|Overall Study||40
1732599|NCT00201448|4241512|P1|STARTED|Overall Study||42
1732600|NCT00201409|4241522|P2|NOT COMPLETED|Overall Study||1
1732601|NCT00201409|4241523|P1|NOT COMPLETED|Overall Study||1
1732602|NCT00201409|4241522|P2|COMPLETED|Overall Study||66
1732603|NCT00201409|4241523|P1|COMPLETED|Overall Study||64
1732604|NCT00201409|4241522|P2|STARTED|Overall Study||67
1732605|NCT00201409|4241523|P1|STARTED|Overall Study||65
1732606|NCT00201240|4241533|P1|NOT COMPLETED|Overall Study||3
1732607|NCT00201240|4241533|P1|COMPLETED|Overall Study||44
1732608|NCT00201240|4241533|P1|STARTED|Overall Study||47
1732609|NCT00201201|4241551|P2|NOT COMPLETED|Overall Study||7
1732610|NCT00201201|4241552|P1|NOT COMPLETED|Overall Study||5
1732611|NCT00201201|4241551|P2|COMPLETED|Overall Study||66
1732612|NCT00201201|4241552|P1|COMPLETED|Overall Study||82
1732613|NCT00201201|4241551|P2|STARTED|Overall Study||73
1732614|NCT00201201|4241552|P1|STARTED|Overall Study||87
1732615|NCT00201123|4241571|P3|NOT COMPLETED|Overall Study||9
1732616|NCT00201123|4241572|P2|NOT COMPLETED|Overall Study||4
1732617|NCT00201123|4241573|P1|NOT COMPLETED|Overall Study||6
1732618|NCT00201123|4241571|P3|COMPLETED|Overall Study||23
1732619|NCT00201123|4241572|P2|COMPLETED|Overall Study||28
1732620|NCT00201123|4241573|P1|COMPLETED|Overall Study||26
1732621|NCT00201123|4241571|P3|Did Not Meet Continuation Criteria|Overall Study||5
1732622|NCT00201123|4241572|P2|Did Not Meet Continuation Criteria|Overall Study||0
1732623|NCT00201123|4241573|P1|Did Not Meet Continuation Criteria|Overall Study||2
1732624|NCT00201123|4241571|P3|STARTED|Overall Study||32
1732625|NCT00201123|4241572|P2|STARTED|Overall Study||32
1732626|NCT00201123|4241573|P1|STARTED|Overall Study||32
1732627|NCT00201006|4241590|P3|NOT COMPLETED|Overall Study||4
1732628|NCT00201006|4241591|P2|NOT COMPLETED|Overall Study||2
1732629|NCT00201006|4241592|P1|NOT COMPLETED|Overall Study||8
1732630|NCT00201006|4241590|P3|COMPLETED|Overall Study||75
1732631|NCT00201006|4241591|P2|COMPLETED|Overall Study||70
1732632|NCT00201006|4241592|P1|COMPLETED|Overall Study||75
1732633|NCT00201006|4241590|P3|STARTED|Overall Study||79
1732634|NCT00201006|4241591|P2|STARTED|Overall Study||72
1732635|NCT00201006|4241592|P1|STARTED|Overall Study||83
1732636|NCT00200967|4241602|P2|NOT COMPLETED|Run-out Period||0
1732637|NCT00200967|4241603|P1|NOT COMPLETED|Run-out Period||1
1732638|NCT00200967|4241602|P2|COMPLETED|Run-out Period||41
1732639|NCT00200967|4241603|P1|COMPLETED|Run-out Period||34
1732640|NCT00200967|4241602|P2|STARTED|Run-out Period||41
1732641|NCT00200967|4241603|P1|STARTED|Run-out Period||35
1732642|NCT00200967|4241602|P2|NOT COMPLETED|Second Treatment Period||2
1732643|NCT00200967|4241603|P1|NOT COMPLETED|Second Treatment Period||1
1732644|NCT00200967|4241602|P2|COMPLETED|Second Treatment Period||41
1732645|NCT00200967|4241603|P1|COMPLETED|Second Treatment Period||35
1732646|NCT00200967|4241602|P2|STARTED|Second Treatment Period||43
1732647|NCT00200967|4241603|P1|STARTED|Second Treatment Period||36
1732648|NCT00200967|4241602|P2|NOT COMPLETED|Wash-out Period||1
1732649|NCT00200967|4241603|P1|NOT COMPLETED|Wash-out Period||0
1732650|NCT00200967|4241602|P2|COMPLETED|Wash-out Period||43
1732651|NCT00200967|4241603|P1|COMPLETED|Wash-out Period||36
1732652|NCT00200967|4241602|P2|STARTED|Wash-out Period||44
1732653|NCT00200967|4241603|P1|STARTED|Wash-out Period||36
1732654|NCT00200967|4241602|P2|NOT COMPLETED|First Treatment Period||1
1732655|NCT00200967|4241603|P1|NOT COMPLETED|First Treatment Period||6
1732656|NCT00200967|4241602|P2|COMPLETED|First Treatment Period||44
1732657|NCT00200967|4241603|P1|COMPLETED|First Treatment Period||36
1732658|NCT00200967|4241602|P2|First Treatment Period|First Treatment Period||45
1732659|NCT00200967|4241603|P1|First Treatment Period|First Treatment Period||42
1732660|NCT00200967|4241602|P2|STARTED|First Treatment Period||45
1732661|NCT00200967|4241603|P1|STARTED|First Treatment Period||42
1732662|NCT00200785|4241633|P2|NOT COMPLETED|Second Intervention||0
1732663|NCT00200785|4241634|P1|NOT COMPLETED|Second Intervention||0
1732664|NCT00200785|4241633|P2|COMPLETED|Second Intervention||6
1732665|NCT00200785|4241634|P1|COMPLETED|Second Intervention||9
1732666|NCT00200785|4241633|P2|STARTED|Second Intervention||6
1732667|NCT00200785|4241634|P1|STARTED|Second Intervention||9
1732668|NCT00200785|4241633|P2|NOT COMPLETED|Washout Period of 1 Week||0
1732669|NCT00200785|4241634|P1|NOT COMPLETED|Washout Period of 1 Week||0
1732670|NCT00200785|4241633|P2|COMPLETED|Washout Period of 1 Week||6
1732671|NCT00200785|4241634|P1|COMPLETED|Washout Period of 1 Week||9
1732672|NCT00200785|4241633|P2|STARTED|Washout Period of 1 Week||6
1732673|NCT00200785|4241634|P1|STARTED|Washout Period of 1 Week||9
1732674|NCT00200785|4241633|P2|NOT COMPLETED|First Intervention||0
1732675|NCT00200785|4241634|P1|NOT COMPLETED|First Intervention||0
1732676|NCT00200785|4241633|P2|COMPLETED|First Intervention||6
1732677|NCT00200785|4241634|P1|COMPLETED|First Intervention||9
1732678|NCT00200785|4241633|P2|STARTED|First Intervention||6
1732679|NCT00200785|4241634|P1|STARTED|First Intervention||9
1732680|NCT00200356|4241644|P2|NOT COMPLETED|Overall Study||7
1732681|NCT00200356|4241645|P1|NOT COMPLETED|Overall Study||8
1732682|NCT00200356|4241644|P2|COMPLETED|Overall Study||195
1732683|NCT00200356|4241645|P1|COMPLETED|Overall Study||191
1732684|NCT00200356|4241644|P2|Safety Analysis Set|Overall Study||198
1732685|NCT00200356|4241645|P1|Safety Analysis Set|Overall Study||194
1732686|NCT00200356|4241644|P2|STARTED|Overall Study||202
1732687|NCT00200356|4241645|P1|STARTED|Overall Study||199
1732688|NCT00200343|4241672|P3|NOT COMPLETED|Overall Study||13
1732689|NCT00200343|4241673|P2|NOT COMPLETED|Overall Study||8
1732690|NCT00200343|4241674|P1|NOT COMPLETED|Overall Study||16
1732691|NCT00200343|4241672|P3|COMPLETED|Overall Study||184
1732692|NCT00200343|4241673|P2|COMPLETED|Overall Study||192
1732693|NCT00200343|4241674|P1|COMPLETED|Overall Study||183
1732694|NCT00200343|4241672|P3|STARTED|Overall Study||197
1732695|NCT00200343|4241673|P2|STARTED|Overall Study||200
1732696|NCT00200343|4241674|P1|STARTED|Overall Study||199
1732697|NCT00200161|4241699|P2|NOT COMPLETED|Overall Study||0
1732698|NCT00200161|4241700|P1|NOT COMPLETED|Overall Study||0
1732699|NCT00200161|4241699|P2|COMPLETED|Overall Study||42
1732700|NCT00200161|4241700|P1|COMPLETED|Overall Study||43
1732701|NCT00200161|4241699|P2|STARTED|Overall Study||42
1732702|NCT00200161|4241700|P1|STARTED|Overall Study||43
1732703|NCT00200057|4241712|P1|NOT COMPLETED|Overall Study||9
1732704|NCT00200057|4241712|P1|COMPLETED|Overall Study||111
1732705|NCT00200057|4241712|P1|12 Month Follow-up|Overall Study||111
1732706|NCT00200057|4241712|P1|6 Month Follow-up|Overall Study||114
1732707|NCT00200057|4241712|P1|3 Month Follow-up|Overall Study||116
1732708|NCT00200057|4241712|P1|1 Month Follow-up|Overall Study||117
1732709|NCT00200057|4241712|P1|STARTED|Overall Study||120
1732710|NCT00199914|4241724|P2|NOT COMPLETED|Overall Study||6
1732711|NCT00199914|4241725|P1|NOT COMPLETED|Overall Study||3
1732712|NCT00199914|4241724|P2|COMPLETED|Overall Study||54
1732713|NCT00199914|4241725|P1|COMPLETED|Overall Study||50
1732714|NCT00199914|4241724|P2|STARTED|Overall Study||60
1732715|NCT00199914|4241725|P1|STARTED|Overall Study||53
1732716|NCT00199875|4241736|P5|NOT COMPLETED|Overall Study||1
1732717|NCT00199875|4241737|P4|NOT COMPLETED|Overall Study||0
1732718|NCT00199875|4241738|P3|NOT COMPLETED|Overall Study||0
1732719|NCT00199875|4241739|P2|NOT COMPLETED|Overall Study||0
1732720|NCT00199875|4241740|P1|NOT COMPLETED|Overall Study||0
1732721|NCT00199875|4241736|P5|COMPLETED|Overall Study||2
1732722|NCT00199875|4241737|P4|COMPLETED|Overall Study||3
1732723|NCT00199875|4241738|P3|COMPLETED|Overall Study||6
1732724|NCT00199875|4241739|P2|COMPLETED|Overall Study||3
1732725|NCT00199875|4241740|P1|COMPLETED|Overall Study||3
1732726|NCT00199875|4241736|P5|STARTED|Overall Study||3
1732727|NCT00199875|4241737|P4|STARTED|Overall Study||3
1732728|NCT00199875|4241738|P3|STARTED|Overall Study||6
1732729|NCT00199875|4241739|P2|STARTED|Overall Study||3
1732730|NCT00199875|4241740|P1|STARTED|Overall Study||3
1732731|NCT00199381|4241762|P1|NOT COMPLETED|Overall Study||504
1732732|NCT00199381|4241762|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
1732733|NCT00199381|4241762|P1|STARTED|Overall Study||504
1732734|NCT00198822|4241769|P3|NOT COMPLETED|Overall Study||21
1732735|NCT00198822|4241770|P2|NOT COMPLETED|Overall Study||20
1732736|NCT00198822|4241771|P1|NOT COMPLETED|Overall Study||14
1732737|NCT00198822|4241769|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
1732738|NCT00198822|4241770|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
1732739|NCT00198822|4241771|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
1732740|NCT00198822|4241769|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
1732741|NCT00198822|4241770|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
1732742|NCT00198822|4241771|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
1732743|NCT00198133|4241790|P2|NOT COMPLETED|Overall Study||8
1732744|NCT00198133|4241791|P1|NOT COMPLETED|Overall Study||5
1732745|NCT00198133|4241790|P2|COMPLETED|Overall Study||3
1732746|NCT00198133|4241791|P1|COMPLETED|Overall Study||11
1732747|NCT00198133|4241790|P2|STARTED|Overall Study||11
1732748|NCT00198133|4241791|P1|STARTED|Overall Study||16
1732749|NCT00198081|4241803|P2|NOT COMPLETED|Overall Study||0
1732750|NCT00198081|4241804|P1|NOT COMPLETED|Overall Study||1
1732751|NCT00198081|4241803|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
1732752|NCT00198081|4241804|P1|COMPLETED|Overall Study||4
1732753|NCT00198081|4241803|P2|STARTED|Overall Study|No enrollment on this arm.|0
1732754|NCT00198081|4241804|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
1732755|NCT00198042|4241830|P1|NOT COMPLETED|Overall Study||0
1732756|NCT00198042|4241830|P1|COMPLETED|Overall Study||18
1732757|NCT00198042|4241830|P1|STARTED|Overall Study||18
1732758|NCT00198029|4241834|P1|NOT COMPLETED|Overall Study||4
1732759|NCT00198029|4241834|P1|COMPLETED|Overall Study||28
1732760|NCT00198029|4241834|P1|STARTED|Overall Study||32
1732761|NCT00197496|4241841|P2|NOT COMPLETED|Follow-up||1
1732762|NCT00197496|4241842|P1|NOT COMPLETED|Follow-up||2
1732763|NCT00197496|4241841|P2|COMPLETED|Follow-up||4
1732764|NCT00197496|4241842|P1|COMPLETED|Follow-up||10
1732765|NCT00197496|4241841|P2|STARTED|Follow-up||5
1732766|NCT00197496|4241842|P1|STARTED|Follow-up||12
1732767|NCT00197496|4241841|P2|NOT COMPLETED|Baseline to Discharge||2
1732768|NCT00197496|4241842|P1|NOT COMPLETED|Baseline to Discharge||2
1732769|NCT00197496|4241841|P2|COMPLETED|Baseline to Discharge||5
1732770|NCT00197496|4241842|P1|COMPLETED|Baseline to Discharge||12
1732771|NCT00197496|4241841|P2|STARTED|Baseline to Discharge||7
1732772|NCT00197496|4241842|P1|STARTED|Baseline to Discharge||14
1732773|NCT00197392|4241857|P2|NOT COMPLETED|Overall Study||86
1732774|NCT00197392|4241858|P1|NOT COMPLETED|Overall Study||88
1732775|NCT00197392|4241857|P2|COMPLETED|Overall Study||134
1732776|NCT00197392|4241858|P1|COMPLETED|Overall Study||126
1732777|NCT00197392|4241857|P2|Per Protocol|Overall Study||134
1732778|NCT00197392|4241858|P1|Per Protocol|Overall Study||126
1732779|NCT00197392|4241857|P2|Evaluable|Overall Study||181
1732780|NCT00197392|4241858|P1|Evaluable|Overall Study||176
1732781|NCT00197392|4241857|P2|Modified Intent to Treat|Overall Study||210
1732782|NCT00197392|4241858|P1|Modified Intent to Treat|Overall Study||209
1732783|NCT00197392|4241857|P2|Safety Population|Overall Study||220
1732784|NCT00197392|4241858|P1|Safety Population|Overall Study||214
1732785|NCT00197392|4241857|P2|STARTED|Overall Study||220
1732786|NCT00197392|4241858|P1|STARTED|Overall Study||214
1732787|NCT00197236|4241890|P3|NOT COMPLETED|Overall Study||23
1732788|NCT00197236|4241891|P2|NOT COMPLETED|Overall Study||17
1732789|NCT00197236|4241892|P1|NOT COMPLETED|Overall Study||14
1732790|NCT00197236|4241890|P3|COMPLETED|Overall Study||109
1732791|NCT00197236|4241891|P2|COMPLETED|Overall Study||110
1732792|NCT00197236|4241892|P1|COMPLETED|Overall Study||121
1732793|NCT00197236|4241890|P3|STARTED|Overall Study||132
1732794|NCT00197236|4241891|P2|STARTED|Overall Study||127
1732795|NCT00197236|4241892|P1|STARTED|Overall Study||135
1732796|NCT00197184|4241941|P2|NOT COMPLETED|Overall Study||0
1732797|NCT00197184|4241942|P1|NOT COMPLETED|Overall Study||0
1732798|NCT00197184|4241941|P2|COMPLETED|Overall Study||137
1732799|NCT00197184|4241942|P1|COMPLETED|Overall Study||139
1732800|NCT00197184|4241941|P2|STARTED|Overall Study||137
1732801|NCT00197184|4241942|P1|STARTED|Overall Study||139
1732802|NCT00197145|4241966|P2|NOT COMPLETED|Period 2 : Open Label Phase||0
1732803|NCT00197145|4241967|P1|NOT COMPLETED|Period 2 : Open Label Phase||10
1732804|NCT00197145|4241966|P2|COMPLETED|Period 2 : Open Label Phase||0
1732805|NCT00197145|4241967|P1|COMPLETED|Period 2 : Open Label Phase||0
1732806|NCT00197145|4241966|P2|STARTED|Period 2 : Open Label Phase||0
1732807|NCT00197145|4241967|P1|STARTED|Period 2 : Open Label Phase||10
1732808|NCT00197145|4241966|P2|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
1732809|NCT00197145|4241967|P1|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
1732810|NCT00197145|4241966|P2|COMPLETED|Period 1: Randomized Treatment Phase||0
1732811|NCT00197145|4241967|P1|COMPLETED|Period 1: Randomized Treatment Phase||0
1732812|NCT00197145|4241966|P2|STARTED|Period 1: Randomized Treatment Phase||11
1732813|NCT00197145|4241967|P1|STARTED|Period 1: Randomized Treatment Phase||13
1732814|NCT00197119|4242025|P2|NOT COMPLETED|Year 10||0
1732815|NCT00197119|4242026|P1|NOT COMPLETED|Year 10||0
1732816|NCT00197119|4242025|P2|COMPLETED|Year 10||108
1732817|NCT00197119|4242026|P1|COMPLETED|Year 10||120
1732818|NCT00197119|4242025|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
1732819|NCT00197119|4242026|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
1732820|NCT00197119|4242025|P2|NOT COMPLETED|Year 9||0
1732821|NCT00197119|4242026|P1|NOT COMPLETED|Year 9||0
1732822|NCT00197119|4242025|P2|COMPLETED|Year 9||114
1732823|NCT00197119|4242026|P1|COMPLETED|Year 9||121
1732824|NCT00197119|4242025|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
1732825|NCT00197119|4242026|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
1732826|NCT00197119|4242025|P2|NOT COMPLETED|Year 8||0
1732827|NCT00197119|4242026|P1|NOT COMPLETED|Year 8||0
1732828|NCT00197119|4242025|P2|COMPLETED|Year 8||115
1732829|NCT00197119|4242026|P1|COMPLETED|Year 8||122
1732830|NCT00197119|4242025|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
1732831|NCT00197119|4242026|P1|STARTED|Year 8||122
1732832|NCT00197119|4242025|P2|NOT COMPLETED|Year 7||0
1732833|NCT00197119|4242026|P1|NOT COMPLETED|Year 7||0
1732834|NCT00197119|4242025|P2|COMPLETED|Year 7||114
1732835|NCT00197119|4242026|P1|COMPLETED|Year 7||122
1732836|NCT00197119|4242025|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
1732837|NCT00197119|4242026|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
1732838|NCT00197119|4242025|P2|NOT COMPLETED|Year 6||0
1732839|NCT00197119|4242026|P1|NOT COMPLETED|Year 6||0
1732840|NCT00197119|4242025|P2|COMPLETED|Year 6||118
1732841|NCT00197119|4242026|P1|COMPLETED|Year 6||126
1732842|NCT00197119|4242025|P2|STARTED|Year 6||118
1732843|NCT00197119|4242026|P1|STARTED|Year 6||126
1732844|NCT00197106|4242038|P3|NOT COMPLETED|Overall Treatment Period||6
1732845|NCT00197106|4242039|P2|NOT COMPLETED|Overall Treatment Period||1
1732846|NCT00197106|4242040|P1|NOT COMPLETED|Overall Treatment Period||0
1732847|NCT00197106|4242038|P3|COMPLETED|Overall Treatment Period||74
1732848|NCT00197106|4242039|P2|COMPLETED|Overall Treatment Period||77
1732849|NCT00197106|4242040|P1|COMPLETED|Overall Treatment Period||0
1732850|NCT00197106|4242038|P3|STARTED|Overall Treatment Period||80
1732851|NCT00197106|4242039|P2|STARTED|Overall Treatment Period||78
1732852|NCT00197106|4242040|P1|STARTED|Overall Treatment Period||0
1732853|NCT00197106|4242038|P3|NOT COMPLETED|4-Week Run-In Period||0
1732854|NCT00197106|4242039|P2|NOT COMPLETED|4-Week Run-In Period||0
1732855|NCT00197106|4242040|P1|NOT COMPLETED|4-Week Run-In Period||99
1732856|NCT00197106|4242038|P3|COMPLETED|4-Week Run-In Period||0
1732857|NCT00197106|4242039|P2|COMPLETED|4-Week Run-In Period||0
1732858|NCT00197106|4242040|P1|COMPLETED|4-Week Run-In Period||158
1732859|NCT00197106|4242038|P3|STARTED|4-Week Run-In Period||0
1732860|NCT00197106|4242039|P2|STARTED|4-Week Run-In Period||0
1732861|NCT00197106|4242040|P1|STARTED|4-Week Run-In Period||257
1732862|NCT00197028|4242076|P2|NOT COMPLETED|Overall Study||21
1732863|NCT00197028|4242077|P1|NOT COMPLETED|Overall Study||16
1732864|NCT00197028|4242076|P2|COMPLETED|Overall Study||86
1732865|NCT00197028|4242077|P1|COMPLETED|Overall Study||91
1732866|NCT00197028|4242076|P2|STARTED|Overall Study||107
1732867|NCT00197028|4242077|P1|STARTED|Overall Study||107
1732868|NCT00197015|4242120|P3|NOT COMPLETED|Overall Study||77
1732869|NCT00197015|4242121|P2|NOT COMPLETED|Overall Study||89
1732870|NCT00197015|4242122|P1|NOT COMPLETED|Overall Study||50
1732871|NCT00197015|4242120|P3|COMPLETED|Overall Study||385
1732872|NCT00197015|4242121|P2|COMPLETED|Overall Study||366
1732873|NCT00197015|4242122|P1|COMPLETED|Overall Study||274
1732874|NCT00197015|4242120|P3|STARTED|Overall Study||462
1732875|NCT00197015|4242121|P2|STARTED|Overall Study||455
1732876|NCT00197015|4242122|P1|STARTED|Overall Study||324
1732877|NCT00197002|4242181|P3|NOT COMPLETED|Overall Study||17
1732878|NCT00197002|4242182|P2|NOT COMPLETED|Overall Study||18
1732879|NCT00197002|4242183|P1|NOT COMPLETED|Overall Study||22
1732880|NCT00197002|4242181|P3|COMPLETED|Overall Study||132
1732881|NCT00197002|4242182|P2|COMPLETED|Overall Study||119
1732882|NCT00197002|4242183|P1|COMPLETED|Overall Study||125
1732883|NCT00197002|4242181|P3|STARTED|Overall Study||149
1732884|NCT00197002|4242182|P2|STARTED|Overall Study||137
1732885|NCT00197002|4242183|P1|STARTED|Overall Study||147
1732886|NCT00196976|4242234|P14|NOT COMPLETED|Booster Study||0
1732887|NCT00196976|4242235|P13|NOT COMPLETED|Booster Study||0
1732888|NCT00196976|4242236|P12|NOT COMPLETED|Booster Study||2
1732889|NCT00196976|4242237|P11|NOT COMPLETED|Booster Study||2
1732890|NCT00196976|4242238|P10|NOT COMPLETED|Booster Study||0
1732891|NCT00196976|4242239|P9|NOT COMPLETED|Booster Study||0
1732892|NCT00196976|4242240|P8|NOT COMPLETED|Booster Study||0
1732893|NCT00196976|4242241|P7|NOT COMPLETED|Booster Study||0
1732894|NCT00196976|4242242|P6|NOT COMPLETED|Booster Study||0
1732895|NCT00196976|4242243|P5|NOT COMPLETED|Booster Study||0
1732896|NCT00196976|4242244|P4|NOT COMPLETED|Booster Study||0
1732897|NCT00196976|4242245|P3|NOT COMPLETED|Booster Study||0
1732898|NCT00196976|4242246|P2|NOT COMPLETED|Booster Study||0
1732899|NCT00196976|4242247|P1|NOT COMPLETED|Booster Study||0
1732900|NCT00196976|4242234|P14|COMPLETED|Booster Study||43
1732901|NCT00196976|4242235|P13|COMPLETED|Booster Study||45
1732902|NCT00196976|4242236|P12|COMPLETED|Booster Study||30
1732903|NCT00196976|4242237|P11|COMPLETED|Booster Study||31
1732904|NCT00196976|4242238|P10|COMPLETED|Booster Study||0
1732905|NCT00196976|4242239|P9|COMPLETED|Booster Study||0
1732906|NCT00196976|4242240|P8|COMPLETED|Booster Study||0
1732907|NCT00196976|4242241|P7|COMPLETED|Booster Study||0
1732908|NCT00196976|4242242|P6|COMPLETED|Booster Study||0
1732909|NCT00196976|4242243|P5|COMPLETED|Booster Study||0
1732910|NCT00196976|4242244|P4|COMPLETED|Booster Study||0
1732911|NCT00196976|4242245|P3|COMPLETED|Booster Study||0
1732912|NCT00196976|4242246|P2|COMPLETED|Booster Study||0
1732913|NCT00196976|4242247|P1|COMPLETED|Booster Study||0
1732914|NCT00196976|4242234|P14|STARTED|Booster Study||43
1732915|NCT00196976|4242235|P13|STARTED|Booster Study||45
1732916|NCT00196976|4242236|P12|STARTED|Booster Study||32
1732917|NCT00196976|4242237|P11|STARTED|Booster Study||33
1732918|NCT00196976|4242238|P10|STARTED|Booster Study||0
1732919|NCT00196976|4242239|P9|STARTED|Booster Study||0
1732920|NCT00196976|4242240|P8|STARTED|Booster Study||0
1732921|NCT00196976|4242241|P7|STARTED|Booster Study||0
1732922|NCT00196976|4242242|P6|STARTED|Booster Study||0
1732923|NCT00196976|4242243|P5|STARTED|Booster Study||0
1732924|NCT00196976|4242244|P4|STARTED|Booster Study||0
1732925|NCT00196976|4242245|P3|STARTED|Booster Study||0
1732926|NCT00196976|4242246|P2|STARTED|Booster Study||0
1732927|NCT00196976|4242247|P1|STARTED|Booster Study||0
1732928|NCT00196976|4242234|P14|NOT COMPLETED|Primary Study||0
1732929|NCT00196976|4242235|P13|NOT COMPLETED|Primary Study||0
1732930|NCT00196976|4242236|P12|NOT COMPLETED|Primary Study||0
1732931|NCT00196976|4242237|P11|NOT COMPLETED|Primary Study||0
1732932|NCT00196976|4242238|P10|NOT COMPLETED|Primary Study||1
1732933|NCT00196976|4242239|P9|NOT COMPLETED|Primary Study||0
1732934|NCT00196976|4242240|P8|NOT COMPLETED|Primary Study||3
1732935|NCT00196976|4242241|P7|NOT COMPLETED|Primary Study||0
1732936|NCT00196976|4242242|P6|NOT COMPLETED|Primary Study||2
1732937|NCT00196976|4242243|P5|NOT COMPLETED|Primary Study||3
1732938|NCT00196976|4242244|P4|NOT COMPLETED|Primary Study||1
1732939|NCT00196976|4242245|P3|NOT COMPLETED|Primary Study||4
1732940|NCT00196976|4242246|P2|NOT COMPLETED|Primary Study||1
1732941|NCT00196976|4242247|P1|NOT COMPLETED|Primary Study||1
1732942|NCT00196976|4242234|P14|COMPLETED|Primary Study||0
1732943|NCT00196976|4242235|P13|COMPLETED|Primary Study||0
1732944|NCT00196976|4242236|P12|COMPLETED|Primary Study||0
1732945|NCT00196976|4242237|P11|COMPLETED|Primary Study||0
1732946|NCT00196976|4242238|P10|COMPLETED|Primary Study||51
1732947|NCT00196976|4242239|P9|COMPLETED|Primary Study||52
1732948|NCT00196976|4242240|P8|COMPLETED|Primary Study||49
1732949|NCT00196976|4242241|P7|COMPLETED|Primary Study||50
1732950|NCT00196976|4242242|P6|COMPLETED|Primary Study||52
1732951|NCT00196976|4242243|P5|COMPLETED|Primary Study||37
1732952|NCT00196976|4242244|P4|COMPLETED|Primary Study||39
1732953|NCT00196976|4242245|P3|COMPLETED|Primary Study||37
1732954|NCT00196976|4242246|P2|COMPLETED|Primary Study||40
1732955|NCT00196976|4242247|P1|COMPLETED|Primary Study||38
1732956|NCT00196976|4242234|P14|STARTED|Primary Study||0
1732957|NCT00196976|4242235|P13|STARTED|Primary Study||0
1732958|NCT00196976|4242236|P12|STARTED|Primary Study||0
1732959|NCT00196976|4242237|P11|STARTED|Primary Study||0
1732960|NCT00196976|4242238|P10|STARTED|Primary Study||52
1732961|NCT00196976|4242239|P9|STARTED|Primary Study||52
1732962|NCT00196976|4242240|P8|STARTED|Primary Study||52
1732963|NCT00196976|4242241|P7|STARTED|Primary Study||50
1732964|NCT00196976|4242242|P6|STARTED|Primary Study||54
1732965|NCT00196976|4242243|P5|STARTED|Primary Study||40
1732966|NCT00196976|4242244|P4|STARTED|Primary Study||40
1732967|NCT00196976|4242245|P3|STARTED|Primary Study||41
1732968|NCT00196976|4242246|P2|STARTED|Primary Study||41
1732969|NCT00196976|4242247|P1|STARTED|Primary Study||39
1732970|NCT00196937|4242443|P3|NOT COMPLETED|Overall Study||7
1732971|NCT00196937|4242444|P2|NOT COMPLETED|Overall Study||5
1732972|NCT00196937|4242445|P1|NOT COMPLETED|Overall Study||9
1732973|NCT00196937|4242443|P3|COMPLETED|Overall Study||204
1732974|NCT00196937|4242444|P2|COMPLETED|Overall Study||221
1732975|NCT00196937|4242445|P1|COMPLETED|Overall Study||220
1732976|NCT00196937|4242443|P3|STARTED|Overall Study||211
1732977|NCT00196937|4242444|P2|STARTED|Overall Study||226
1732978|NCT00196937|4242445|P1|STARTED|Overall Study||229
1732979|NCT00196716|4242483|P1|NOT COMPLETED|0.3 mg/kg Period||0
1732980|NCT00196716|4242483|P1|COMPLETED|0.3 mg/kg Period||21
1732981|NCT00196716|4242483|P1|STARTED|0.3 mg/kg Period||21
1732982|NCT00196716|4242483|P1|NOT COMPLETED|1.0 mg/kg Period||0
1732983|NCT00196716|4242483|P1|COMPLETED|1.0 mg/kg Period||21
1732984|NCT00196716|4242483|P1|STARTED|1.0 mg/kg Period||21
1732985|NCT00196326|4242493|P1|NOT COMPLETED|Overall Study||986
1732986|NCT00196326|4242493|P1|COMPLETED|Overall Study||1249
1732987|NCT00196326|4242493|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
1732988|NCT00196326|4242493|P1|Safety Population|Overall Study|Treated participants|2185
1732989|NCT00196326|4242493|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
1732990|NCT00196313|4242501|P2|NOT COMPLETED|Overall Study||8
1732991|NCT00196313|4242502|P1|NOT COMPLETED|Overall Study||11
1732992|NCT00196313|4242501|P2|COMPLETED|Overall Study||40
1732993|NCT00196313|4242502|P1|COMPLETED|Overall Study||36
1732994|NCT00196313|4242501|P2|STARTED|Overall Study||48
1732995|NCT00196313|4242502|P1|STARTED|Overall Study||47
1732996|NCT00196196|4242516|P1|NOT COMPLETED|Overall Study||7
1732997|NCT00196196|4242516|P1|COMPLETED|Overall Study||267
1732998|NCT00196196|4242516|P1|STARTED|Overall Study||274
1732999|NCT00196105|4242524|P3|NOT COMPLETED|Overall Study||7
1733000|NCT00196105|4242525|P2|NOT COMPLETED|Overall Study||5
1733001|NCT00196105|4242526|P1|NOT COMPLETED|Overall Study||4
1733002|NCT00196105|4242524|P3|COMPLETED|Overall Study||82
1733003|NCT00196105|4242525|P2|COMPLETED|Overall Study||83
1733004|NCT00196105|4242526|P1|COMPLETED|Overall Study||60
1733005|NCT00196105|4242524|P3|STARTED|Overall Study||89
1733006|NCT00196105|4242525|P2|STARTED|Overall Study||88
1733007|NCT00196105|4242526|P1|STARTED|Overall Study||64
1733008|NCT00195819|4242546|P2|NOT COMPLETED|Open-label||20
1733009|NCT00195819|4242547|P1|NOT COMPLETED|Open-label||0
1733010|NCT00195819|4242546|P2|COMPLETED|Open-label||62
1733011|NCT00195819|4242547|P1|COMPLETED|Open-label||0
1733012|NCT00195819|4242546|P2|STARTED|Open-label||82
1733013|NCT00195819|4242547|P1|STARTED|Open-label||0
1733014|NCT00195819|4242546|P2|NOT COMPLETED|Double-Blind||0
1733015|NCT00195819|4242547|P1|NOT COMPLETED|Double-Blind||2
1733016|NCT00195819|4242546|P2|COMPLETED|Double-Blind||38
1733017|NCT00195819|4242547|P1|COMPLETED|Double-Blind||42
1733018|NCT00195819|4242546|P2|STARTED|Double-Blind||38
1733019|NCT00195819|4242547|P1|STARTED|Double-Blind||44
1733020|NCT00195715|4242597|P1|NOT COMPLETED|Overall Study||377
1733021|NCT00195715|4242597|P1|COMPLETED|Overall Study||400
1733022|NCT00195715|4242597|P1|STARTED|Overall Study||777
1733023|NCT00195702|4242628|P6|NOT COMPLETED|Open-label Extension Phase||78
1733024|NCT00195702|4242629|P5|NOT COMPLETED|Open-label Extension Phase||78
1733025|NCT00195702|4242630|P4|NOT COMPLETED|Open-label Extension Phase||99
1733026|NCT00195702|4242631|P3|NOT COMPLETED|Open-label Extension Phase||0
1733027|NCT00195702|4242632|P2|NOT COMPLETED|Open-label Extension Phase||0
1733028|NCT00195702|4242633|P1|NOT COMPLETED|Open-label Extension Phase||0
1733029|NCT00195702|4242628|P6|COMPLETED|Open-label Extension Phase||56
1733030|NCT00195702|4242629|P5|COMPLETED|Open-label Extension Phase||80
1733031|NCT00195702|4242630|P4|COMPLETED|Open-label Extension Phase||66
1733032|NCT00195702|4242631|P3|COMPLETED|Open-label Extension Phase||0
1733033|NCT00195702|4242632|P2|COMPLETED|Open-label Extension Phase||0
1733034|NCT00195702|4242633|P1|COMPLETED|Open-label Extension Phase||0
1733035|NCT00195702|4242628|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
1733036|NCT00195702|4242629|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
1733037|NCT00195702|4242630|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
1733038|NCT00195702|4242631|P3|STARTED|Open-label Extension Phase||0
1733039|NCT00195702|4242632|P2|STARTED|Open-label Extension Phase||0
1733040|NCT00195702|4242633|P1|STARTED|Open-label Extension Phase||0
1733041|NCT00195702|4242628|P6|NOT COMPLETED|Double-blind Phase||0
1733042|NCT00195702|4242629|P5|NOT COMPLETED|Double-blind Phase||0
1733043|NCT00195702|4242630|P4|NOT COMPLETED|Double-blind Phase||0
1733044|NCT00195702|4242631|P3|NOT COMPLETED|Double-blind Phase||60
1733045|NCT00195702|4242632|P2|NOT COMPLETED|Double-blind Phase||48
1733046|NCT00195702|4242633|P1|NOT COMPLETED|Double-blind Phase||44
1733047|NCT00195702|4242628|P6|COMPLETED|Double-blind Phase||0
1733048|NCT00195702|4242629|P5|COMPLETED|Double-blind Phase||0
1733049|NCT00195702|4242630|P4|COMPLETED|Double-blind Phase||0
1733050|NCT00195702|4242631|P3|COMPLETED|Double-blind Phase||140
1733051|NCT00195702|4242632|P2|COMPLETED|Double-blind Phase||159
1733052|NCT00195702|4242633|P1|COMPLETED|Double-blind Phase||168
1733053|NCT00195702|4242628|P6|STARTED|Double-blind Phase||0
1733054|NCT00195702|4242629|P5|STARTED|Double-blind Phase||0
1733055|NCT00195702|4242630|P4|STARTED|Double-blind Phase||0
1733056|NCT00195702|4242631|P3|STARTED|Double-blind Phase||200
1733057|NCT00195702|4242632|P2|STARTED|Double-blind Phase||207
1733058|NCT00195702|4242633|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
1733059|NCT00195676|4242697|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
1733060|NCT00195676|4242697|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
1733061|NCT00195676|4242697|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
1733062|NCT00195676|4242697|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
1733063|NCT00195676|4242697|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
1733064|NCT00195676|4242697|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
1733065|NCT00195676|4242697|P1|NOT COMPLETED|Period O - Open-label Treatment||606
1733066|NCT00195676|4242697|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
1733067|NCT00195676|4242697|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
1733068|NCT00195663|4242711|P3|NOT COMPLETED|Open-Label Extension Period||97
1733069|NCT00195663|4242712|P2|NOT COMPLETED|Open-Label Extension Period||74
1733070|NCT00195663|4242713|P1|NOT COMPLETED|Open-Label Extension Period||76
1733071|NCT00195663|4242711|P3|COMPLETED|Open-Label Extension Period||86
1733072|NCT00195663|4242712|P2|COMPLETED|Open-Label Extension Period||85
1733073|NCT00195663|4242713|P1|COMPLETED|Open-Label Extension Period||79
1733074|NCT00195663|4242711|P3|STARTED|Open-Label Extension Period||183
1733075|NCT00195663|4242712|P2|STARTED|Open-Label Extension Period||159
1733076|NCT00195663|4242713|P1|STARTED|Open-Label Extension Period||155
1733077|NCT00195663|4242711|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
1733078|NCT00195663|4242712|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
1733079|NCT00195663|4242713|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
1733080|NCT00195663|4242711|P3|COMPLETED|2-year Double-blind Treatment Period||196
1733081|NCT00195663|4242712|P2|COMPLETED|2-year Double-blind Treatment Period||166
1733082|NCT00195663|4242713|P1|COMPLETED|2-year Double-blind Treatment Period||164
1733083|NCT00195663|4242711|P3|STARTED|2-year Double-blind Treatment Period||268
1733084|NCT00195663|4242712|P2|STARTED|2-year Double-blind Treatment Period||274
1733085|NCT00195663|4242713|P1|STARTED|2-year Double-blind Treatment Period||257
1733086|NCT00195650|4242807|P1|NOT COMPLETED|Overall Study||525
1733087|NCT00195650|4242807|P1|COMPLETED|Overall Study||321
1733088|NCT00195650|4242807|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
1733089|NCT00195507|4242823|P2|NOT COMPLETED|Overall Study||118
1733090|NCT00195507|4242824|P1|NOT COMPLETED|Overall Study||99
1733091|NCT00195507|4242823|P2|COMPLETED|Overall Study||245
1733092|NCT00195507|4242824|P1|COMPLETED|Overall Study||258
1733093|NCT00195507|4242823|P2|STARTED|Overall Study||363
1733094|NCT00195507|4242824|P1|STARTED|Overall Study||357
1733095|NCT00195494|4242838|P6|NOT COMPLETED|Year 2||0
1733096|NCT00195494|4242839|P5|NOT COMPLETED|Year 2||0
1733097|NCT00195494|4242840|P4|NOT COMPLETED|Year 2||23
1733098|NCT00195494|4242841|P3|NOT COMPLETED|Year 2||18
1733099|NCT00195494|4242842|P2|NOT COMPLETED|Year 2||16
1733100|NCT00195494|4242843|P1|NOT COMPLETED|Year 2||7
1733101|NCT00195494|4242838|P6|COMPLETED|Year 2||0
1733102|NCT00195494|4242839|P5|COMPLETED|Year 2||0
1733103|NCT00195494|4242840|P4|COMPLETED|Year 2||76
1733104|NCT00195494|4242841|P3|COMPLETED|Year 2||93
1733105|NCT00195494|4242842|P2|COMPLETED|Year 2||74
1733106|NCT00195494|4242843|P1|COMPLETED|Year 2||104
1733107|NCT00195494|4242838|P6|STARTED|Year 2||0
1733108|NCT00195494|4242839|P5|STARTED|Year 2||0
1733109|NCT00195494|4242840|P4|STARTED|Year 2||99
1733110|NCT00195494|4242841|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
1733111|NCT00195494|4242842|P2|STARTED|Year 2||90
1733112|NCT00195494|4242843|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
1733113|NCT00195494|4242838|P6|NOT COMPLETED|Year 1||53
1733114|NCT00195494|4242839|P5|NOT COMPLETED|Year 1||79
1733115|NCT00195494|4242840|P4|NOT COMPLETED|Year 1||0
1733116|NCT00195494|4242841|P3|NOT COMPLETED|Year 1||0
1733117|NCT00195494|4242842|P2|NOT COMPLETED|Year 1||0
1733118|NCT00195494|4242843|P1|NOT COMPLETED|Year 1||0
1733119|NCT00195494|4242838|P6|COMPLETED|Year 1||221
1733120|NCT00195494|4242839|P5|COMPLETED|Year 1||189
1733121|NCT00195494|4242840|P4|COMPLETED|Year 1||0
1733122|NCT00195494|4242841|P3|COMPLETED|Year 1||0
1733123|NCT00195494|4242842|P2|COMPLETED|Year 1||0
1733124|NCT00195494|4242843|P1|COMPLETED|Year 1||0
1733125|NCT00195494|4242838|P6|STARTED|Year 1||274
1733126|NCT00195494|4242839|P5|STARTED|Year 1||268
1733127|NCT00195494|4242840|P4|STARTED|Year 1||0
1733128|NCT00195494|4242841|P3|STARTED|Year 1||0
1733129|NCT00195494|4242842|P2|STARTED|Year 1||0
1733130|NCT00195494|4242843|P1|STARTED|Year 1||0
1733131|NCT00195442|4242861|P1|NOT COMPLETED|Overall Study||136
1733132|NCT00195442|4242861|P1|COMPLETED|Overall Study||152
1733133|NCT00195442|4242861|P1|STARTED|Overall Study||288
1733134|NCT00195429|4242880|P2|NOT COMPLETED|Overall Study||5
1733135|NCT00195429|4242881|P1|NOT COMPLETED|Overall Study||5
1733136|NCT00195429|4242880|P2|COMPLETED|Overall Study||18
1733137|NCT00195429|4242881|P1|COMPLETED|Overall Study||19
1733138|NCT00195429|4242880|P2|STARTED|Overall Study||23
1733139|NCT00195429|4242881|P1|STARTED|Overall Study||24
1733140|NCT00195403|4242889|P1|NOT COMPLETED|Overall Study||0
1733141|NCT00195403|4242889|P1|COMPLETED|Overall Study||1014
1733142|NCT00195403|4242889|P1|STARTED|Overall Study||1014
1733143|NCT00195351|4242897|P2|NOT COMPLETED|Overall Study||16
1733144|NCT00195351|4242898|P1|NOT COMPLETED|Overall Study||21
1733145|NCT00195351|4242897|P2|COMPLETED|Overall Study||215
1733146|NCT00195351|4242898|P1|COMPLETED|Overall Study||215
1733147|NCT00195351|4242897|P2|STARTED|Overall Study||231
1733148|NCT00195351|4242898|P1|STARTED|Overall Study||236
1733149|NCT00195338|4242908|P1|NOT COMPLETED|Overall Study||12
1733150|NCT00195338|4242908|P1|COMPLETED|Overall Study||13
1733151|NCT00195338|4242908|P1|STARTED|Overall Study||25
1733152|NCT00195273|4242918|P2|NOT COMPLETED|Overall Study||14
1733153|NCT00195273|4242919|P1|NOT COMPLETED|Overall Study||21
1733154|NCT00195273|4242918|P2|COMPLETED|Overall Study||16
1733155|NCT00195273|4242919|P1|COMPLETED|Overall Study||10
1733156|NCT00195273|4242918|P2|STARTED|Overall Study||30
1733157|NCT00195273|4242919|P1|STARTED|Overall Study||31
1733158|NCT00195260|4242933|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
1733159|NCT00195260|4242934|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
1733160|NCT00195260|4242935|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
1733161|NCT00195260|4242936|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733162|NCT00195260|4242937|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733163|NCT00195260|4242938|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733164|NCT00195260|4242939|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733165|NCT00195260|4242940|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733166|NCT00195260|4242941|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733167|NCT00195260|4242942|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733168|NCT00195260|4242943|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733169|NCT00195260|4242933|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
1733170|NCT00195260|4242934|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733171|NCT00195260|4242935|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
1733172|NCT00195260|4242936|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733173|NCT00195260|4242937|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733174|NCT00195260|4242938|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733175|NCT00195260|4242939|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733176|NCT00195260|4242940|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733177|NCT00195260|4242941|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733178|NCT00195260|4242942|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733179|NCT00195260|4242943|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733180|NCT00195260|4242933|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
1733181|NCT00195260|4242934|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
1733182|NCT00195260|4242935|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
1733183|NCT00195260|4242936|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733184|NCT00195260|4242937|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733185|NCT00195260|4242938|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733186|NCT00195260|4242939|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733187|NCT00195260|4242940|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733188|NCT00195260|4242941|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733189|NCT00195260|4242942|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733190|NCT00195260|4242943|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
1733191|NCT00195260|4242933|P11|NOT COMPLETED|Part 1: Dose Escalation||0
1733192|NCT00195260|4242934|P10|NOT COMPLETED|Part 1: Dose Escalation||0
1733193|NCT00195260|4242935|P9|NOT COMPLETED|Part 1: Dose Escalation||0
1733194|NCT00195260|4242936|P8|NOT COMPLETED|Part 1: Dose Escalation||6
1733195|NCT00195260|4242937|P7|NOT COMPLETED|Part 1: Dose Escalation||10
1733196|NCT00195260|4242938|P6|NOT COMPLETED|Part 1: Dose Escalation||7
1733197|NCT00195260|4242939|P5|NOT COMPLETED|Part 1: Dose Escalation||7
1733198|NCT00195260|4242940|P4|NOT COMPLETED|Part 1: Dose Escalation||7
1733199|NCT00195260|4242941|P3|NOT COMPLETED|Part 1: Dose Escalation||6
1733200|NCT00195260|4242942|P2|NOT COMPLETED|Part 1: Dose Escalation||4
1733201|NCT00195260|4242943|P1|NOT COMPLETED|Part 1: Dose Escalation||4
1733202|NCT00195260|4242933|P11|COMPLETED|Part 1: Dose Escalation||0
1733203|NCT00195260|4242934|P10|COMPLETED|Part 1: Dose Escalation||0
1733204|NCT00195260|4242935|P9|COMPLETED|Part 1: Dose Escalation||0
1733205|NCT00195260|4242936|P8|COMPLETED|Part 1: Dose Escalation||0
1733206|NCT00195260|4242937|P7|COMPLETED|Part 1: Dose Escalation||0
1733207|NCT00195260|4242938|P6|COMPLETED|Part 1: Dose Escalation||0
1733208|NCT00195260|4242939|P5|COMPLETED|Part 1: Dose Escalation||0
1733209|NCT00195260|4242940|P4|COMPLETED|Part 1: Dose Escalation||0
1733210|NCT00195260|4242941|P3|COMPLETED|Part 1: Dose Escalation||0
1733211|NCT00195260|4242942|P2|COMPLETED|Part 1: Dose Escalation||0
1733212|NCT00195260|4242943|P1|COMPLETED|Part 1: Dose Escalation||0
1733213|NCT00195260|4242933|P11|STARTED|Part 1: Dose Escalation||0
1733214|NCT00195260|4242934|P10|STARTED|Part 1: Dose Escalation||0
1733215|NCT00195260|4242935|P9|STARTED|Part 1: Dose Escalation||0
1733216|NCT00195260|4242936|P8|STARTED|Part 1: Dose Escalation||6
1733217|NCT00195260|4242937|P7|STARTED|Part 1: Dose Escalation||10
1733218|NCT00195260|4242938|P6|STARTED|Part 1: Dose Escalation||7
1733219|NCT00195260|4242939|P5|STARTED|Part 1: Dose Escalation||7
1733220|NCT00195260|4242940|P4|STARTED|Part 1: Dose Escalation||7
1733221|NCT00195260|4242941|P3|STARTED|Part 1: Dose Escalation||6
1733222|NCT00195260|4242942|P2|STARTED|Part 1: Dose Escalation||4
1733223|NCT00195260|4242943|P1|STARTED|Part 1: Dose Escalation||4
1733224|NCT00195039|4243089|P1|NOT COMPLETED|Overall Study||0
1733225|NCT00195039|4243089|P1|COMPLETED|Overall Study||47
1733226|NCT00195039|4243089|P1|STARTED|Overall Study||47
1733227|NCT00195013|4243102|P2|NOT COMPLETED|Overall Study||1
1733228|NCT00195013|4243103|P1|NOT COMPLETED|Overall Study||2
1733229|NCT00195013|4243102|P2|COMPLETED|Overall Study||15
1733230|NCT00195013|4243103|P1|COMPLETED|Overall Study||12
1733231|NCT00195013|4243102|P2|STARTED|Overall Study||16
1733232|NCT00195013|4243103|P1|STARTED|Overall Study||14
1733233|NCT00194987|4243111|P2|NOT COMPLETED|Overall Study||3
1733234|NCT00194987|4243112|P1|NOT COMPLETED|Overall Study||0
1733235|NCT00194987|4243111|P2|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
1733236|NCT00194987|4243112|P1|COMPLETED|Overall Study||51
1733237|NCT00194987|4243111|P2|STARTED|Overall Study||51
1733238|NCT00194987|4243112|P1|STARTED|Overall Study||51
1733239|NCT00194896|4243128|P4|NOT COMPLETED|Overall Study||12
1733240|NCT00194896|4243129|P3|NOT COMPLETED|Overall Study||6
1733241|NCT00194896|4243130|P2|NOT COMPLETED|Overall Study||5
1733242|NCT00194896|4243131|P1|NOT COMPLETED|Overall Study||11
1733243|NCT00194896|4243128|P4|COMPLETED|Overall Study||9
1733244|NCT00194896|4243129|P3|COMPLETED|Overall Study||7
1733245|NCT00194896|4243130|P2|COMPLETED|Overall Study||10
1733246|NCT00194896|4243131|P1|COMPLETED|Overall Study||4
1733247|NCT00194896|4243128|P4|STARTED|Overall Study||21
1733248|NCT00194896|4243129|P3|STARTED|Overall Study||13
1733249|NCT00194896|4243130|P2|STARTED|Overall Study||15
1733250|NCT00194896|4243131|P1|STARTED|Overall Study||15
1733251|NCT00194792|4243145|P1|NOT COMPLETED|Overall Study||1
1733252|NCT00194792|4243145|P1|COMPLETED|Overall Study||27
1733253|NCT00194792|4243145|P1|STARTED|Overall Study||28
1733254|NCT00194779|4243155|P1|NOT COMPLETED|Overall Study||0
1733255|NCT00194779|4243155|P1|COMPLETED|Overall Study||50
1733256|NCT00194779|4243155|P1|STARTED|Overall Study||50
1733257|NCT00194675|4243169|P2|NOT COMPLETED|Overall Study||2
1733258|NCT00194675|4243170|P1|NOT COMPLETED|Overall Study||5
1733259|NCT00194675|4243169|P2|COMPLETED|Overall Study||24
1733260|NCT00194675|4243170|P1|COMPLETED|Overall Study||22
1733261|NCT00194675|4243169|P2|STARTED|Overall Study||26
1733262|NCT00194675|4243170|P1|STARTED|Overall Study||27
1733263|NCT00194610|4243188|P2|NOT COMPLETED|Overall Study||0
1733264|NCT00194610|4243189|P1|NOT COMPLETED|Overall Study||0
1733265|NCT00194610|4243188|P2|COMPLETED|Overall Study||9
1733266|NCT00194610|4243189|P1|COMPLETED|Overall Study||11
1733267|NCT00194610|4243188|P2|STARTED|Overall Study||9
1733268|NCT00194610|4243189|P1|STARTED|Overall Study||11
1733269|NCT00194532|4243197|P2|NOT COMPLETED|Overall Study||0
1733270|NCT00194532|4243198|P1|NOT COMPLETED|Overall Study||0
1733271|NCT00194532|4243197|P2|COMPLETED|Overall Study||150
1733272|NCT00194532|4243198|P1|COMPLETED|Overall Study||150
1733273|NCT00194532|4243197|P2|STARTED|Overall Study||150
1733274|NCT00194532|4243198|P1|STARTED|Overall Study||150
1733275|NCT00194129|4243208|P2|NOT COMPLETED|Overall Study||13
1733276|NCT00194129|4243209|P1|NOT COMPLETED|Overall Study||10
1733277|NCT00194129|4243208|P2|COMPLETED|Overall Study||3
1733278|NCT00194129|4243209|P1|COMPLETED|Overall Study||5
1733279|NCT00194129|4243208|P2|STARTED|Overall Study||16
1733280|NCT00194129|4243209|P1|STARTED|Overall Study||15
1733281|NCT00194077|4243224|P2|NOT COMPLETED|Overall Study||30
1733282|NCT00194077|4243225|P1|NOT COMPLETED|Overall Study||24
1733283|NCT00194077|4243224|P2|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
1733284|NCT00194077|4243225|P1|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
1733285|NCT00194077|4243224|P2|STARTED|Overall Study||30
1733286|NCT00194077|4243225|P1|STARTED|Overall Study||30
1733287|NCT00194025|4243231|P1|NOT COMPLETED|Overall Study||5
1733288|NCT00194025|4243231|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
1733289|NCT00194025|4243231|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
1733290|NCT00194012|4243246|P2|NOT COMPLETED|Open Label Extension (OLE)||6
1733291|NCT00194012|4243247|P1|NOT COMPLETED|Open Label Extension (OLE)||5
1733292|NCT00194012|4243246|P2|COMPLETED|Open Label Extension (OLE)||15
1733293|NCT00194012|4243247|P1|COMPLETED|Open Label Extension (OLE)||17
1733294|NCT00194012|4243246|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
1733295|NCT00194012|4243247|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
1733296|NCT00194012|4243246|P2|NOT COMPLETED|Randomized Phase||25
1733297|NCT00194012|4243247|P1|NOT COMPLETED|Randomized Phase||16
1733298|NCT00194012|4243246|P2|COMPLETED|Randomized Phase||6
1733299|NCT00194012|4243247|P1|COMPLETED|Randomized Phase||15
1733300|NCT00194012|4243246|P2|Received More Than One Dose|Randomized Phase||29
1733301|NCT00194012|4243247|P1|Received More Than One Dose|Randomized Phase||30
1733302|NCT00194012|4243246|P2|STARTED|Randomized Phase||31
1733303|NCT00194012|4243247|P1|STARTED|Randomized Phase||31
1733304|NCT00193609|4243283|P1|NOT COMPLETED|Overall Study||4
1733305|NCT00193609|4243283|P1|COMPLETED|Overall Study||44
1733306|NCT00193609|4243283|P1|STARTED|Overall Study||48
1733307|NCT00193596|4243290|P2|NOT COMPLETED|Overall Study||66
1733308|NCT00193596|4243291|P1|NOT COMPLETED|Overall Study||56
1733309|NCT00193596|4243290|P2|COMPLETED|Overall Study||39
1733310|NCT00193596|4243291|P1|COMPLETED|Overall Study||37
1733311|NCT00193596|4243290|P2|STARTED|Overall Study||105
1733312|NCT00193596|4243291|P1|STARTED|Overall Study||93
1733313|NCT00193492|4243301|P2|NOT COMPLETED|Overall Study||15
1733314|NCT00193492|4243302|P1|NOT COMPLETED|Overall Study||17
1733315|NCT00193492|4243301|P2|COMPLETED|Overall Study||14
1733316|NCT00193492|4243302|P1|COMPLETED|Overall Study||14
1733317|NCT00193492|4243301|P2|STARTED|Overall Study||29
1733318|NCT00193492|4243302|P1|STARTED|Overall Study||31
1733319|NCT00193479|4243310|P1|NOT COMPLETED|Maintenance Rituximab||0
1733320|NCT00193479|4243310|P1|COMPLETED|Maintenance Rituximab||44
1733321|NCT00193479|4243310|P1|STARTED|Maintenance Rituximab||44
1733322|NCT00193479|4243310|P1|NOT COMPLETED|Induction Chemotherapy||3
1733323|NCT00193479|4243310|P1|COMPLETED|Induction Chemotherapy||48
1733324|NCT00193479|4243310|P1|STARTED|Induction Chemotherapy||51
1733325|NCT00193453|4243314|P1|NOT COMPLETED|Overall Study||48
1733326|NCT00193453|4243314|P1|COMPLETED|Overall Study||21
1733327|NCT00193453|4243314|P1|STARTED|Overall Study||69
1733328|NCT00193427|4243320|P1|NOT COMPLETED|Overall Study||49
1733329|NCT00193427|4243320|P1|COMPLETED|Overall Study||26
1733330|NCT00193427|4243320|P1|STARTED|Overall Study||75
1733331|NCT00193414|4243327|P1|NOT COMPLETED|Overall Study||58
1733332|NCT00193414|4243327|P1|COMPLETED|Overall Study||14
1733333|NCT00193414|4243327|P1|STARTED|Overall Study||72
1733334|NCT00193375|4243333|P1|NOT COMPLETED|Overall Study||19
1733335|NCT00193375|4243333|P1|COMPLETED|Overall Study||41
1733336|NCT00193375|4243333|P1|STARTED|Overall Study||60
1733337|NCT00193258|4243339|P1|NOT COMPLETED|Overall Study||0
1733338|NCT00193258|4243339|P1|COMPLETED|Overall Study||94
1733339|NCT00193258|4243339|P1|STARTED|Overall Study||94
1733340|NCT00193219|4243345|P1|NOT COMPLETED|Overall Study||30
1733341|NCT00193219|4243345|P1|COMPLETED|Overall Study||6
1733342|NCT00193219|4243345|P1|STARTED|Overall Study||36
1733343|NCT00193206|4243351|P1|NOT COMPLETED|Postoperative Therapy||14
1733344|NCT00193206|4243351|P1|COMPLETED|Postoperative Therapy||102
1733345|NCT00193206|4243351|P1|STARTED|Postoperative Therapy||116
1733346|NCT00193206|4243351|P1|NOT COMPLETED|Surgery||0
1733347|NCT00193206|4243351|P1|COMPLETED|Surgery||116
1733348|NCT00193206|4243351|P1|STARTED|Surgery||116
1733349|NCT00193206|4243351|P1|NOT COMPLETED|Preoperative Therapy||7
1733350|NCT00193206|4243351|P1|COMPLETED|Preoperative Therapy||116
1733351|NCT00193206|4243351|P1|STARTED|Preoperative Therapy||123
1733352|NCT00193180|4243355|P1|NOT COMPLETED|Overall Study||10
1733353|NCT00193180|4243355|P1|COMPLETED|Overall Study||27
1733354|NCT00193180|4243355|P1|STARTED|Overall Study||37
1733355|NCT00193128|4243363|P2|NOT COMPLETED|Overall Study||10
1733356|NCT00193128|4243364|P1|NOT COMPLETED|Overall Study||0
1733357|NCT00193128|4243363|P2|COMPLETED|Overall Study||39
1733358|NCT00193128|4243364|P1|COMPLETED|Overall Study||10
1733359|NCT00193128|4243363|P2|STARTED|Overall Study||49
1733360|NCT00193128|4243364|P1|STARTED|Overall Study||10
1733361|NCT00193063|4243370|P1|NOT COMPLETED|Overall Study||4
1733362|NCT00193063|4243370|P1|COMPLETED|Overall Study||37
1733363|NCT00193063|4243370|P1|STARTED|Overall Study||41
1733364|NCT00193050|4243376|P1|NOT COMPLETED|Adjuvant||10
1733365|NCT00193050|4243376|P1|COMPLETED|Adjuvant||77
1733366|NCT00193050|4243376|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
1733367|NCT00193050|4243376|P1|NOT COMPLETED|Surgery||0
1733368|NCT00193050|4243376|P1|COMPLETED|Surgery||103
1733369|NCT00193050|4243376|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
1733370|NCT00193050|4243376|P1|NOT COMPLETED|Neoadjuvant Treatment||9
1733371|NCT00193050|4243376|P1|COMPLETED|Neoadjuvant Treatment||101
1733372|NCT00193050|4243376|P1|STARTED|Neoadjuvant Treatment||110
1733373|NCT00193037|4243382|P2|NOT COMPLETED|Crossover Treatment||0
1733374|NCT00193037|4243383|P1|NOT COMPLETED|Crossover Treatment||0
1733375|NCT00193037|4243382|P2|COMPLETED|Crossover Treatment||24
1733376|NCT00193037|4243383|P1|COMPLETED|Crossover Treatment||32
1733377|NCT00193037|4243382|P2|STARTED|Crossover Treatment||24
1733378|NCT00193037|4243383|P1|STARTED|Crossover Treatment||32
1733379|NCT00193037|4243382|P2|NOT COMPLETED|Randomized Treatment||28
1733380|NCT00193037|4243383|P1|NOT COMPLETED|Randomized Treatment||18
1733381|NCT00193037|4243382|P2|COMPLETED|Randomized Treatment||24
1733382|NCT00193037|4243383|P1|COMPLETED|Randomized Treatment||32
1733383|NCT00193037|4243382|P2|STARTED|Randomized Treatment||52
1733384|NCT00193037|4243383|P1|STARTED|Randomized Treatment||50
1733385|NCT00192647|4243393|P2|NOT COMPLETED|Overall Study||146
1733386|NCT00192647|4243394|P1|NOT COMPLETED|Overall Study||128
1733387|NCT00192647|4243393|P2|COMPLETED|Overall Study||302
1733388|NCT00192647|4243394|P1|COMPLETED|Overall Study||320
1733389|NCT00192647|4243393|P2|Treated|Overall Study||438
1733390|NCT00192647|4243394|P1|Treated|Overall Study||433
1733391|NCT00192647|4243393|P2|STARTED|Overall Study||448
1733392|NCT00192647|4243394|P1|STARTED|Overall Study||448
1733393|NCT00192296|4243414|P4|NOT COMPLETED|Overall Study||0
1733394|NCT00192296|4243415|P3|NOT COMPLETED|Overall Study||0
1733395|NCT00192296|4243416|P2|NOT COMPLETED|Overall Study||1
1733396|NCT00192296|4243417|P1|NOT COMPLETED|Overall Study||0
1733397|NCT00192296|4243414|P4|COMPLETED|Overall Study||6
1733398|NCT00192296|4243415|P3|COMPLETED|Overall Study||6
1733399|NCT00192296|4243416|P2|COMPLETED|Overall Study||5
1733400|NCT00192296|4243417|P1|COMPLETED|Overall Study||6
1733401|NCT00192296|4243414|P4|STARTED|Overall Study||6
1733402|NCT00192296|4243415|P3|STARTED|Overall Study||6
1733403|NCT00192296|4243416|P2|STARTED|Overall Study||6
1733404|NCT00192296|4243417|P1|STARTED|Overall Study||6
1733405|NCT00192075|4243473|P2|NOT COMPLETED|Overall Study||19
1733406|NCT00192075|4243474|P1|NOT COMPLETED|Overall Study||39
1733407|NCT00192075|4243473|P2|COMPLETED|Overall Study||23
1733408|NCT00192075|4243474|P1|COMPLETED|Overall Study||3
1733409|NCT00192075|4243473|P2|STARTED|Overall Study||42
1733410|NCT00192075|4243474|P1|STARTED|Overall Study||42
1733411|NCT00192036|4243499|P1|NOT COMPLETED|Overall Study||21
1733412|NCT00192036|4243499|P1|COMPLETED|Overall Study||28
1733413|NCT00192036|4243499|P1|STARTED|Overall Study||49
1733414|NCT00192023|4243509|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
1733415|NCT00192023|4243510|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
1733416|NCT00192023|4243509|P2|COMPLETED|Period IV - Optional Open-Label||0
1733417|NCT00192023|4243510|P1|COMPLETED|Period IV - Optional Open-Label||49
1733418|NCT00192023|4243509|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
1733419|NCT00192023|4243510|P1|STARTED|Period IV - Optional Open-Label||124
1733420|NCT00192023|4243509|P2|NOT COMPLETED|Period III - Double-Blind||0
1733421|NCT00192023|4243510|P1|NOT COMPLETED|Period III - Double-Blind||7
1733422|NCT00192023|4243509|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
1733423|NCT00192023|4243510|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
1733424|NCT00192023|4243509|P2|STARTED|Period III - Double-Blind||32
1733425|NCT00192023|4243510|P1|STARTED|Period III - Double-Blind||107
1733426|NCT00191984|4243532|P1|NOT COMPLETED|Overall Study||39
1733427|NCT00191984|4243532|P1|COMPLETED|Overall Study||7
1733428|NCT00191984|4243532|P1|STARTED|Overall Study||46
1733429|NCT00191945|4243542|P2|NOT COMPLETED|Open-Label Treatment Extension||0
1733430|NCT00191945|4243543|P1|NOT COMPLETED|Open-Label Treatment Extension||0
1733431|NCT00191945|4243542|P2|COMPLETED|Open-Label Treatment Extension||48
1733432|NCT00191945|4243543|P1|COMPLETED|Open-Label Treatment Extension||94
1733433|NCT00191945|4243542|P2|STARTED|Open-Label Treatment Extension||48
1733434|NCT00191945|4243543|P1|STARTED|Open-Label Treatment Extension||94
1733435|NCT00191945|4243542|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
1733436|NCT00191945|4243543|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
1733437|NCT00191945|4243542|P2|COMPLETED|Double-Blind Acute Treatment||48
1733438|NCT00191945|4243543|P1|COMPLETED|Double-Blind Acute Treatment||94
1733439|NCT00191945|4243542|P2|STARTED|Double-Blind Acute Treatment||51
1733440|NCT00191945|4243543|P1|STARTED|Double-Blind Acute Treatment||100
1733441|NCT00191906|4243579|P4|NOT COMPLETED|Study Period III||0
1733442|NCT00191906|4243580|P3|NOT COMPLETED|Study Period III||0
1733443|NCT00191906|4243581|P2|NOT COMPLETED|Study Period III||4
1733444|NCT00191906|4243582|P1|NOT COMPLETED|Study Period III||5
1733445|NCT00191906|4243579|P4|COMPLETED|Study Period III||0
1733446|NCT00191906|4243580|P3|COMPLETED|Study Period III||0
1733447|NCT00191906|4243581|P2|COMPLETED|Study Period III||7
1733448|NCT00191906|4243582|P1|COMPLETED|Study Period III||9
1733449|NCT00191906|4243579|P4|STARTED|Study Period III||0
1733450|NCT00191906|4243580|P3|STARTED|Study Period III||0
1733451|NCT00191906|4243581|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
1733452|NCT00191906|4243582|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
1733453|NCT00191906|4243579|P4|NOT COMPLETED|Study Period II||0
1733454|NCT00191906|4243580|P3|NOT COMPLETED|Study Period II||1
1733455|NCT00191906|4243581|P2|NOT COMPLETED|Study Period II||5
1733456|NCT00191906|4243582|P1|NOT COMPLETED|Study Period II||0
1733457|NCT00191906|4243579|P4|COMPLETED|Study Period II||18
1733458|NCT00191906|4243580|P3|COMPLETED|Study Period II||26
1733459|NCT00191906|4243581|P2|COMPLETED|Study Period II||32
1733460|NCT00191906|4243582|P1|COMPLETED|Study Period II||39
1733461|NCT00191906|4243579|P4|STARTED|Study Period II||18
1733462|NCT00191906|4243580|P3|STARTED|Study Period II||27
1733463|NCT00191906|4243581|P2|STARTED|Study Period II||37
1733464|NCT00191906|4243582|P1|STARTED|Study Period II||39
1733465|NCT00191854|4243625|P3|NOT COMPLETED|Overall Study||39
1733466|NCT00191854|4243626|P2|NOT COMPLETED|Overall Study||30
1733467|NCT00191854|4243627|P1|NOT COMPLETED|Overall Study||37
1733468|NCT00191854|4243625|P3|COMPLETED|Overall Study||12
1733469|NCT00191854|4243626|P2|COMPLETED|Overall Study||17
1733470|NCT00191854|4243627|P1|COMPLETED|Overall Study||12
1733471|NCT00191854|4243625|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
1733472|NCT00191854|4243626|P2|Received at Least One Dose of Study Drug|Overall Study||47
1733473|NCT00191854|4243627|P1|Received at Least One Dose of Study Drug|Overall Study||49
1733474|NCT00191854|4243625|P3|STARTED|Overall Study||51
1733475|NCT00191854|4243626|P2|STARTED|Overall Study||47
1733476|NCT00191854|4243627|P1|STARTED|Overall Study||49
1733477|NCT00191815|4243647|P1|NOT COMPLETED|Overall Study||40
1733478|NCT00191815|4243647|P1|COMPLETED|Overall Study||30
1733479|NCT00191815|4243647|P1|Treated|Overall Study||67
1733480|NCT00191815|4243647|P1|STARTED|Overall Study||70
1733481|NCT00191789|4243659|P1|NOT COMPLETED|Overall Study||25
1733482|NCT00191789|4243659|P1|COMPLETED|Overall Study||40
1733483|NCT00191789|4243659|P1|STARTED|Overall Study||65
1733484|NCT00191724|4243676|P5|NOT COMPLETED|Overall Study||3
1733485|NCT00191724|4243677|P4|NOT COMPLETED|Overall Study||3
1733486|NCT00191724|4243678|P3|NOT COMPLETED|Overall Study||1
1733487|NCT00191724|4243679|P2|NOT COMPLETED|Overall Study||1
1733488|NCT00191724|4243680|P1|NOT COMPLETED|Overall Study||1
1733489|NCT00191724|4243676|P5|COMPLETED|Overall Study||12
1733490|NCT00191724|4243677|P4|COMPLETED|Overall Study||5
1733491|NCT00191724|4243678|P3|COMPLETED|Overall Study||8
1733492|NCT00191724|4243679|P2|COMPLETED|Overall Study||8
1733493|NCT00191724|4243680|P1|COMPLETED|Overall Study||5
1733494|NCT00191724|4243676|P5|STARTED|Overall Study||15
1733495|NCT00191724|4243677|P4|STARTED|Overall Study||8
1733496|NCT00191724|4243678|P3|STARTED|Overall Study||9
1733497|NCT00191724|4243679|P2|STARTED|Overall Study||9
1733498|NCT00191724|4243680|P1|STARTED|Overall Study||6
1733499|NCT00191646|4243709|P2|NOT COMPLETED|Overall Study||153
1733500|NCT00191646|4243710|P1|NOT COMPLETED|Overall Study||171
1733501|NCT00191646|4243709|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
1733502|NCT00191646|4243710|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
1733503|NCT00191646|4243709|P2|Received Crossover Therapy|Overall Study||78
1733504|NCT00191646|4243710|P1|Received Crossover Therapy|Overall Study||77
1733505|NCT00191646|4243709|P2|Received Consolidation Therapy|Overall Study||183
1733506|NCT00191646|4243710|P1|Received Consolidation Therapy|Overall Study||169
1733507|NCT00191646|4243709|P2|Received Induction Therapy|Overall Study||409
1733508|NCT00191646|4243710|P1|Received Induction Therapy|Overall Study||411
1733509|NCT00191646|4243709|P2|STARTED|Overall Study||414
1733510|NCT00191646|4243710|P1|STARTED|Overall Study||417
1733511|NCT00191477|4243730|P2|NOT COMPLETED|Overall Study||129
1733512|NCT00191477|4243731|P1|NOT COMPLETED|Overall Study||138
1733513|NCT00191477|4243730|P2|COMPLETED|Overall Study||47
1733514|NCT00191477|4243731|P1|COMPLETED|Overall Study||41
1733515|NCT00191477|4243730|P2|Received Study Drug|Overall Study||162
1733516|NCT00191477|4243731|P1|Received Study Drug|Overall Study||166
1733517|NCT00191477|4243730|P2|STARTED|Overall Study||176
1733518|NCT00191477|4243731|P1|STARTED|Overall Study||179
1733519|NCT00191451|4243750|P3|NOT COMPLETED|Overall Study||14
1733520|NCT00191451|4243751|P2|NOT COMPLETED|Overall Study||14
1733521|NCT00191451|4243752|P1|NOT COMPLETED|Overall Study||7
1733522|NCT00191451|4243750|P3|COMPLETED|Overall Study||35
1733523|NCT00191451|4243751|P2|COMPLETED|Overall Study||37
1733524|NCT00191451|4243752|P1|COMPLETED|Overall Study||43
1733525|NCT00191451|4243750|P3|Received at Least One Dose of Study Drug|Overall Study||47
1733526|NCT00191451|4243751|P2|Received at Least One Dose of Study Drug|Overall Study||48
1733527|NCT00191451|4243752|P1|Received at Least One Dose of Study Drug|Overall Study||50
1733528|NCT00191451|4243750|P3|STARTED|Overall Study||49
1733529|NCT00191451|4243751|P2|STARTED|Overall Study||51
1733530|NCT00191451|4243752|P1|STARTED|Overall Study||50
1733531|NCT00191386|4243772|P1|NOT COMPLETED|Overall Study||160
1733532|NCT00191386|4243772|P1|COMPLETED|Overall Study||68
1733533|NCT00191386|4243772|P1|3 Years|Overall Study||65
1733534|NCT00191386|4243772|P1|2 Years|Overall Study||105
1733535|NCT00191386|4243772|P1|12 Months|Overall Study||149
1733536|NCT00191386|4243772|P1|6 Months|Overall Study||183
1733537|NCT00191386|4243772|P1|STARTED|Overall Study||228
1733538|NCT00191334|4243779|P1|NOT COMPLETED|Overall Study||17
1733539|NCT00191334|4243779|P1|COMPLETED|Overall Study||33
1733540|NCT00191334|4243779|P1|STARTED|Overall Study||50
1733541|NCT00191308|4243787|P1|NOT COMPLETED|Overall Study||1
1733542|NCT00191308|4243787|P1|COMPLETED|Overall Study||29
1733543|NCT00191308|4243787|P1|STARTED|Overall Study||30
1733544|NCT00191282|4243797|P2|NOT COMPLETED|Overall Study||212
1733545|NCT00191282|4243798|P1|NOT COMPLETED|Overall Study||220
1733546|NCT00191282|4243797|P2|COMPLETED|Overall Study||346
1733547|NCT00191282|4243798|P1|COMPLETED|Overall Study||338
1733548|NCT00191282|4243797|P2|STARTED|Overall Study||558
1733549|NCT00191282|4243798|P1|STARTED|Overall Study||558
1733550|NCT00191269|4243858|P2|NOT COMPLETED|Overall Study||58
1733551|NCT00191269|4243859|P1|NOT COMPLETED|Overall Study||6
1733552|NCT00191269|4243858|P2|COMPLETED|Overall Study||4
1733553|NCT00191269|4243859|P1|COMPLETED|Overall Study||0
1733554|NCT00191269|4243858|P2|STARTED|Overall Study||62
1733555|NCT00191269|4243859|P1|STARTED|Overall Study||6
1733556|NCT00191191|4243875|P2|NOT COMPLETED|Overall Study||112
1733557|NCT00191191|4243876|P1|NOT COMPLETED|Overall Study||114
1733558|NCT00191191|4243875|P2|COMPLETED|Overall Study||0
1733559|NCT00191191|4243876|P1|COMPLETED|Overall Study||0
1733560|NCT00191191|4243875|P2|Full Analysis Set Population|Overall Study||108
1733561|NCT00191191|4243876|P1|Full Analysis Set Population|Overall Study||108
1733562|NCT00191191|4243875|P2|Safety Analysis Population|Overall Study||111
1733563|NCT00191191|4243876|P1|Safety Analysis Population|Overall Study||114
1733564|NCT00191191|4243875|P2|STARTED|Overall Study||112
1733565|NCT00191191|4243876|P1|STARTED|Overall Study||114
1733566|NCT00191165|4243892|P2|NOT COMPLETED|Overall Study||2
1733567|NCT00191165|4243893|P1|NOT COMPLETED|Overall Study||2
1733568|NCT00191165|4243892|P2|COMPLETED|Overall Study||11
1733569|NCT00191165|4243893|P1|COMPLETED|Overall Study||12
1733570|NCT00191165|4243892|P2|STARTED|Overall Study||13
1733571|NCT00191165|4243893|P1|STARTED|Overall Study||14
1733572|NCT00191152|4243905|P2|NOT COMPLETED|Crossover Treatment||28
1733573|NCT00191152|4243906|P1|NOT COMPLETED|Crossover Treatment||27
1733574|NCT00191152|4243905|P2|COMPLETED|Crossover Treatment||53
1733575|NCT00191152|4243906|P1|COMPLETED|Crossover Treatment||50
1733576|NCT00191152|4243905|P2|Received Treatment|Crossover Treatment||80
1733577|NCT00191152|4243906|P1|Received Treatment|Crossover Treatment||76
1733578|NCT00191152|4243905|P2|STARTED|Crossover Treatment||81
1733579|NCT00191152|4243906|P1|STARTED|Crossover Treatment||77
1733580|NCT00191152|4243905|P2|NOT COMPLETED|Initial Treatment||153
1733581|NCT00191152|4243906|P1|NOT COMPLETED|Initial Treatment||141
1733582|NCT00191152|4243905|P2|COMPLETED|Initial Treatment||83
1733583|NCT00191152|4243906|P1|COMPLETED|Initial Treatment||98
1733584|NCT00191152|4243905|P2|Received Initial Treatment|Initial Treatment||227
1733585|NCT00191152|4243906|P1|Received Initial Treatment|Initial Treatment||236
1733586|NCT00191152|4243905|P2|STARTED|Initial Treatment||236
1733587|NCT00191152|4243906|P1|STARTED|Initial Treatment||239
1733588|NCT00191139|4243938|P2|NOT COMPLETED|Overall Study||12
1733589|NCT00191139|4243939|P1|NOT COMPLETED|Overall Study||5
1733590|NCT00191139|4243938|P2|COMPLETED|Overall Study||20
1733591|NCT00191139|4243939|P1|COMPLETED|Overall Study||27
1733592|NCT00191139|4243938|P2|STARTED|Overall Study||32
1733593|NCT00191139|4243939|P1|STARTED|Overall Study||32
1733594|NCT00191113|4243955|P2|NOT COMPLETED|Addendum 3||0
1733595|NCT00191113|4243956|P1|NOT COMPLETED|Addendum 3||0
1733596|NCT00191113|4243955|P2|COMPLETED|Addendum 3||37
1733597|NCT00191113|4243956|P1|COMPLETED|Addendum 3||20
1733598|NCT00191113|4243955|P2|STARTED|Addendum 3||37
1733599|NCT00191113|4243956|P1|STARTED|Addendum 3||20
1733600|NCT00191113|4243955|P2|NOT COMPLETED|Addendum 2||17
1733601|NCT00191113|4243956|P1|NOT COMPLETED|Addendum 2||10
1733602|NCT00191113|4243955|P2|COMPLETED|Addendum 2||31
1733603|NCT00191113|4243956|P1|COMPLETED|Addendum 2||18
1733604|NCT00191113|4243955|P2|STARTED|Addendum 2||48
1733605|NCT00191113|4243956|P1|STARTED|Addendum 2||28
1733606|NCT00191113|4243955|P2|NOT COMPLETED|Addendum 1||0
1733607|NCT00191113|4243956|P1|NOT COMPLETED|Addendum 1||0
1733608|NCT00191113|4243955|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
1733609|NCT00191113|4243956|P1|COMPLETED|Addendum 1||2
1733610|NCT00191113|4243955|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
1733611|NCT00191113|4243956|P1|STARTED|Addendum 1||2
1733612|NCT00191113|4243955|P2|NOT COMPLETED|Core Study||15
1733613|NCT00191113|4243956|P1|NOT COMPLETED|Core Study||35
1733614|NCT00191113|4243955|P2|COMPLETED|Core Study||61
1733615|NCT00191113|4243956|P1|COMPLETED|Core Study||43
1733616|NCT00191113|4243955|P2|STARTED|Core Study||76
1733617|NCT00191113|4243956|P1|STARTED|Core Study||78
1733618|NCT00191100|4243998|P2|NOT COMPLETED|Overall Study||12
1733619|NCT00191100|4243999|P1|NOT COMPLETED|Overall Study||42
1733620|NCT00191100|4243998|P2|COMPLETED|Overall Study||244
1733621|NCT00191100|4243999|P1|COMPLETED|Overall Study||217
1733622|NCT00191100|4243998|P2|STARTED|Overall Study||256
1733623|NCT00191100|4243999|P1|STARTED|Overall Study||259
1733624|NCT00190983|4244015|P1|NOT COMPLETED|Overall Study||2
1733625|NCT00190983|4244015|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
1733626|NCT00190983|4244015|P1|STARTED|Overall Study||29
1733627|NCT00190775|4244024|P2|NOT COMPLETED|Overall Study||100
1733628|NCT00190775|4244025|P1|NOT COMPLETED|Overall Study||149
1733629|NCT00190775|4244024|P2|COMPLETED|Overall Study||134
1733630|NCT00190775|4244025|P1|COMPLETED|Overall Study||119
1733631|NCT00190775|4244024|P2|Received Study Drug|Overall Study||234
1733632|NCT00190775|4244025|P1|Received Study Drug|Overall Study||266
1733633|NCT00190775|4244024|P2|STARTED|Overall Study||234
1733634|NCT00190775|4244025|P1|STARTED|Overall Study||268
1733635|NCT00190749|4244096|P2|NOT COMPLETED|Overall Study||31
1733636|NCT00190749|4244097|P1|NOT COMPLETED|Overall Study||26
1733637|NCT00190749|4244096|P2|COMPLETED|Overall Study||31
1733638|NCT00190749|4244097|P1|COMPLETED|Overall Study||42
1733639|NCT00190749|4244096|P2|STARTED|Overall Study||62
1733640|NCT00190749|4244097|P1|STARTED|Overall Study||68
1733641|NCT00190684|4244161|P1|NOT COMPLETED|Overall Study||1489
1733642|NCT00190684|4244161|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
1733643|NCT00190684|4244161|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
1733644|NCT00190684|4244161|P1|STARTED|Overall Study||1553
1733645|NCT00190671|4244182|P2|NOT COMPLETED|Overall Study||42
1733646|NCT00190671|4244183|P1|NOT COMPLETED|Overall Study||27
1733647|NCT00190671|4244182|P2|COMPLETED|Overall Study||19
1733648|NCT00190671|4244183|P1|COMPLETED|Overall Study||15
1733649|NCT00190671|4244182|P2|STARTED|Overall Study||61
1733650|NCT00190671|4244183|P1|STARTED|Overall Study||42
1733651|NCT00189540|4244203|P2|NOT COMPLETED|Overall Study||1
1733652|NCT00189540|4244204|P1|NOT COMPLETED|Overall Study||7
1733653|NCT00189540|4244203|P2|COMPLETED|Overall Study||5
1733654|NCT00189540|4244204|P1|COMPLETED|Overall Study||14
1733655|NCT00189540|4244203|P2|STARTED|Overall Study||6
1733656|NCT00189540|4244204|P1|STARTED|Overall Study||21
1733657|NCT00189488|4244222|P2|NOT COMPLETED|Overall Study||22
1733658|NCT00189488|4244223|P1|NOT COMPLETED|Overall Study||15
1733659|NCT00189488|4244222|P2|COMPLETED|Overall Study||55
1733660|NCT00189488|4244223|P1|COMPLETED|Overall Study||63
1733661|NCT00189488|4244222|P2|Received Palifermin/Placebo|Overall Study||76
1733662|NCT00189488|4244223|P1|Received Palifermin/Placebo|Overall Study||75
1733663|NCT00189488|4244222|P2|STARTED|Overall Study||77
1733664|NCT00189488|4244223|P1|STARTED|Overall Study||78
1733665|NCT00189475|4244245|P2|NOT COMPLETED|Overall Study||0
1733666|NCT00189475|4244246|P1|NOT COMPLETED|Overall Study||0
1733667|NCT00189475|4244245|P2|COMPLETED|Overall Study||42
1733668|NCT00189475|4244246|P1|COMPLETED|Overall Study||42
1733669|NCT00189475|4244245|P2|STARTED|Overall Study||42
1733670|NCT00189475|4244246|P1|STARTED|Overall Study||42
1733671|NCT00189462|4244254|P2|NOT COMPLETED|Overall Study||21
1733672|NCT00189462|4244255|P1|NOT COMPLETED|Overall Study||23
1733673|NCT00189462|4244254|P2|COMPLETED|Overall Study||28
1733674|NCT00189462|4244255|P1|COMPLETED|Overall Study||27
1733675|NCT00189462|4244254|P2|STARTED|Overall Study||49
1733676|NCT00189462|4244255|P1|STARTED|Overall Study||50
1733677|NCT00189436|4244263|P2|NOT COMPLETED|Overall Study||5
1733678|NCT00189436|4244264|P1|NOT COMPLETED|Overall Study||8
1733679|NCT00189436|4244263|P2|COMPLETED|Overall Study||25
1733680|NCT00189436|4244264|P1|COMPLETED|Overall Study||23
1733681|NCT00189436|4244263|P2|STARTED|Overall Study||30
1733682|NCT00189436|4244264|P1|STARTED|Overall Study||31
1733683|NCT00189423|4244272|P2|NOT COMPLETED|Overall Study||766
1733684|NCT00189423|4244273|P1|NOT COMPLETED|Overall Study||765
1733685|NCT00189423|4244272|P2|COMPLETED|Overall Study||74
1733686|NCT00189423|4244273|P1|COMPLETED|Overall Study||48
1733687|NCT00189423|4244272|P2|STARTED|Overall Study||840
1733688|NCT00189423|4244273|P1|STARTED|Overall Study||813
1733689|NCT00189306|4244295|P1|NOT COMPLETED|Long-Term Follow-up||38
1733690|NCT00189306|4244295|P1|COMPLETED|Long-Term Follow-up||119
1733691|NCT00189306|4244295|P1|STARTED|Long-Term Follow-up||157
1733692|NCT00189306|4244295|P1|NOT COMPLETED|Posttreatment Period||12
1733693|NCT00189306|4244295|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
1733694|NCT00189306|4244295|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
1733695|NCT00189306|4244295|P1|NOT COMPLETED|Treatment Period||5
1733696|NCT00189306|4244295|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
1733697|NCT00189306|4244295|P1|STARTED|Treatment Period||169
1733698|NCT00189202|4244300|P1|NOT COMPLETED|Overall Study||5
1733699|NCT00189202|4244300|P1|COMPLETED|Overall Study||44
1733700|NCT00189202|4244300|P1|STARTED|Overall Study||49
1733701|NCT00189137|4244311|P2|NOT COMPLETED|Overall Study||0
1733702|NCT00189137|4244312|P1|NOT COMPLETED|Overall Study||0
1733703|NCT00189137|4244311|P2|COMPLETED|Overall Study||43
1733704|NCT00189137|4244312|P1|COMPLETED|Overall Study||37
1733705|NCT00189137|4244311|P2|STARTED|Overall Study||43
1733706|NCT00189137|4244312|P1|STARTED|Overall Study||37
1733707|NCT00189098|4244322|P2|NOT COMPLETED|Overall Study||6
1733708|NCT00189098|4244323|P1|NOT COMPLETED|Overall Study||5
1733709|NCT00189098|4244322|P2|COMPLETED|Overall Study||44
1733710|NCT00189098|4244323|P1|COMPLETED|Overall Study||46
1733711|NCT00189098|4244322|P2|STARTED|Overall Study||50
1733712|NCT00189098|4244323|P1|STARTED|Overall Study||51
1733713|NCT00187889|4244341|P2|NOT COMPLETED|Overall Study||4
1733714|NCT00187889|4244342|P1|NOT COMPLETED|Overall Study||6
1733715|NCT00187889|4244341|P2|COMPLETED|Overall Study||22
1733716|NCT00187889|4244342|P1|COMPLETED|Overall Study||19
1733717|NCT00187889|4244341|P2|STARTED|Overall Study||26
1733718|NCT00187889|4244342|P1|STARTED|Overall Study||25
1733719|NCT00187876|4244352|P2|NOT COMPLETED|Overall Study||0
1733720|NCT00187876|4244353|P1|NOT COMPLETED|Overall Study||0
1733721|NCT00187876|4244352|P2|COMPLETED|Overall Study||43
1733722|NCT00187876|4244353|P1|COMPLETED|Overall Study||24
1733723|NCT00187876|4244352|P2|STARTED|Overall Study||43
1733724|NCT00187876|4244353|P1|STARTED|Overall Study||24
1733725|NCT00187720|4244361|P2|NOT COMPLETED|Overall Study||0
1733726|NCT00187720|4244362|P1|NOT COMPLETED|Overall Study||0
1733727|NCT00187720|4244361|P2|COMPLETED|Overall Study||14
1733728|NCT00187720|4244362|P1|COMPLETED|Overall Study||9
1733729|NCT00187720|4244361|P2|STARTED|Overall Study||14
1733730|NCT00187720|4244362|P1|STARTED|Overall Study||9
1733731|NCT00187681|4244370|P2|NOT COMPLETED|Overall Study||0
1733732|NCT00187681|4244371|P1|NOT COMPLETED|Overall Study||0
1733733|NCT00187681|4244370|P2|COMPLETED|Overall Study||8
1733734|NCT00187681|4244371|P1|COMPLETED|Overall Study||12
1733735|NCT00187681|4244370|P2|STARTED|Overall Study||8
1733736|NCT00187681|4244371|P1|STARTED|Overall Study||12
1733737|NCT00187655|4244379|P1|NOT COMPLETED|Overall Study||0
1733738|NCT00187655|4244379|P1|COMPLETED|Overall Study||24
1733739|NCT00187655|4244379|P1|STARTED|Overall Study||24
1733740|NCT00187486|4244384|P1|NOT COMPLETED|Overall Study||1
1733741|NCT00187486|4244384|P1|COMPLETED|Overall Study||65
1733742|NCT00187486|4244384|P1|STARTED|Overall Study||66
1733743|NCT00187226|4244395|P6|NOT COMPLETED|Overall Study||0
1733744|NCT00187226|4244396|P5|NOT COMPLETED|Overall Study||0
1733745|NCT00187226|4244397|P4|NOT COMPLETED|Overall Study||0
1733746|NCT00187226|4244398|P3|NOT COMPLETED|Overall Study||0
1733747|NCT00187226|4244399|P2|NOT COMPLETED|Overall Study||0
1733748|NCT00187226|4244400|P1|NOT COMPLETED|Overall Study||0
1733749|NCT00187226|4244395|P6|COMPLETED|Overall Study||1
1733750|NCT00187226|4244396|P5|COMPLETED|Overall Study||34
1733751|NCT00187226|4244397|P4|COMPLETED|Overall Study||2
1733752|NCT00187226|4244398|P3|COMPLETED|Overall Study||28
1733753|NCT00187226|4244399|P2|COMPLETED|Overall Study||49
1733754|NCT00187226|4244400|P1|COMPLETED|Overall Study||88
1733755|NCT00187226|4244395|P6|STARTED|Overall Study||1
1733756|NCT00187226|4244396|P5|STARTED|Overall Study||34
1733757|NCT00187226|4244397|P4|STARTED|Overall Study||2
1733758|NCT00187226|4244398|P3|STARTED|Overall Study||28
1733759|NCT00187226|4244399|P2|STARTED|Overall Study||49
1733760|NCT00187226|4244400|P1|STARTED|Overall Study||88
1733761|NCT00187200|4244416|P2|NOT COMPLETED|Overall Study||18
1733762|NCT00187200|4244417|P1|NOT COMPLETED|Overall Study||18
1733763|NCT00187200|4244416|P2|COMPLETED|Overall Study||26
1733764|NCT00187200|4244417|P1|COMPLETED|Overall Study||31
1733765|NCT00187200|4244416|P2|STARTED|Overall Study||44
1733766|NCT00187200|4244417|P1|STARTED|Overall Study||49
1733767|NCT00187135|4244435|P6|NOT COMPLETED|Visit Three||6
1733768|NCT00187135|4244436|P5|NOT COMPLETED|Visit Three||8
1733769|NCT00187135|4244437|P4|NOT COMPLETED|Visit Three||9
1733770|NCT00187135|4244438|P3|NOT COMPLETED|Visit Three||9
1733771|NCT00187135|4244439|P2|NOT COMPLETED|Visit Three||7
1733772|NCT00187135|4244440|P1|NOT COMPLETED|Visit Three||7
1733773|NCT00187135|4244435|P6|COMPLETED|Visit Three||12
1733774|NCT00187135|4244436|P5|COMPLETED|Visit Three||11
1733775|NCT00187135|4244437|P4|COMPLETED|Visit Three||9
1733776|NCT00187135|4244438|P3|COMPLETED|Visit Three||14
1733777|NCT00187135|4244439|P2|COMPLETED|Visit Three||17
1733778|NCT00187135|4244440|P1|COMPLETED|Visit Three||14
1733779|NCT00187135|4244435|P6|STARTED|Visit Three||18
1733780|NCT00187135|4244436|P5|STARTED|Visit Three||19
1733781|NCT00187135|4244437|P4|STARTED|Visit Three||18
1733782|NCT00187135|4244438|P3|STARTED|Visit Three||23
1733783|NCT00187135|4244439|P2|STARTED|Visit Three||24
1733784|NCT00187135|4244440|P1|STARTED|Visit Three||21
1733785|NCT00187135|4244435|P6|NOT COMPLETED|Visit Two||8
1733786|NCT00187135|4244436|P5|NOT COMPLETED|Visit Two||6
1733787|NCT00187135|4244437|P4|NOT COMPLETED|Visit Two||8
1733788|NCT00187135|4244438|P3|NOT COMPLETED|Visit Two||2
1733789|NCT00187135|4244439|P2|NOT COMPLETED|Visit Two||3
1733790|NCT00187135|4244440|P1|NOT COMPLETED|Visit Two||5
1733791|NCT00187135|4244435|P6|COMPLETED|Visit Two||18
1733792|NCT00187135|4244436|P5|COMPLETED|Visit Two||19
1733793|NCT00187135|4244437|P4|COMPLETED|Visit Two||18
1733794|NCT00187135|4244438|P3|COMPLETED|Visit Two||23
1733795|NCT00187135|4244439|P2|COMPLETED|Visit Two||24
1733796|NCT00187135|4244440|P1|COMPLETED|Visit Two||21
1733797|NCT00187135|4244435|P6|STARTED|Visit Two||26
1733798|NCT00187135|4244436|P5|STARTED|Visit Two||25
1733799|NCT00187135|4244437|P4|STARTED|Visit Two||26
1733800|NCT00187135|4244438|P3|STARTED|Visit Two||25
1733801|NCT00187135|4244439|P2|STARTED|Visit Two||27
1733802|NCT00187135|4244440|P1|STARTED|Visit Two||26
1733803|NCT00187135|4244435|P6|NOT COMPLETED|Visit One||2
1733804|NCT00187135|4244436|P5|NOT COMPLETED|Visit One||0
1733805|NCT00187135|4244437|P4|NOT COMPLETED|Visit One||0
1733806|NCT00187135|4244438|P3|NOT COMPLETED|Visit One||0
1733807|NCT00187135|4244439|P2|NOT COMPLETED|Visit One||1
1733808|NCT00187135|4244440|P1|NOT COMPLETED|Visit One||4
1733809|NCT00187135|4244435|P6|COMPLETED|Visit One||26
1733810|NCT00187135|4244436|P5|COMPLETED|Visit One||25
1733811|NCT00187135|4244437|P4|COMPLETED|Visit One||26
1733812|NCT00187135|4244438|P3|COMPLETED|Visit One||25
1733813|NCT00187135|4244439|P2|COMPLETED|Visit One||27
1733814|NCT00187135|4244440|P1|COMPLETED|Visit One||26
1733815|NCT00187135|4244435|P6|STARTED|Visit One||28
1733816|NCT00187135|4244436|P5|STARTED|Visit One||25
1733817|NCT00187135|4244437|P4|STARTED|Visit One||26
1733818|NCT00187135|4244438|P3|STARTED|Visit One||25
1733819|NCT00187135|4244439|P2|STARTED|Visit One||28
1733820|NCT00187135|4244440|P1|STARTED|Visit One||30
1733821|NCT00187096|4244463|P3|NOT COMPLETED|Overall Study||1
1733822|NCT00187096|4244464|P2|NOT COMPLETED|Overall Study||0
1733823|NCT00187096|4244465|P1|NOT COMPLETED|Overall Study||0
1733824|NCT00187096|4244463|P3|COMPLETED|Overall Study||11
1733825|NCT00187096|4244464|P2|COMPLETED|Overall Study||3
1733826|NCT00187096|4244465|P1|COMPLETED|Overall Study||10
1733827|NCT00187096|4244463|P3|STARTED|Overall Study||12
1733828|NCT00187096|4244464|P2|STARTED|Overall Study||3
1733829|NCT00187096|4244465|P1|STARTED|Overall Study||10
1733830|NCT00186901|4244503|P3|NOT COMPLETED|Overall Study||149
1733831|NCT00186901|4244504|P2|NOT COMPLETED|Overall Study||45
1733832|NCT00186901|4244505|P1|NOT COMPLETED|Overall Study||49
1733833|NCT00186901|4244503|P3|COMPLETED|Overall Study||0
1733834|NCT00186901|4244504|P2|COMPLETED|Overall Study||96
1733835|NCT00186901|4244505|P1|COMPLETED|Overall Study||85
1733836|NCT00186901|4244503|P3|24 Month Follow-up|Overall Study||0
1733837|NCT00186901|4244504|P2|24 Month Follow-up|Overall Study||107
1733838|NCT00186901|4244505|P1|24 Month Follow-up|Overall Study||106
1733839|NCT00186901|4244503|P3|12 Month Follow-up|Overall Study||0
1733840|NCT00186901|4244504|P2|12 Month Follow-up|Overall Study||122
1733841|NCT00186901|4244505|P1|12 Month Follow-up|Overall Study||117
1733842|NCT00186901|4244503|P3|Baseline|Overall Study||0
1733843|NCT00186901|4244504|P2|Baseline|Overall Study||141
1733844|NCT00186901|4244505|P1|Baseline|Overall Study||134
1733845|NCT00186901|4244503|P3|STARTED|Overall Study||149
1733846|NCT00186901|4244504|P2|STARTED|Overall Study||141
1733847|NCT00186901|4244505|P1|STARTED|Overall Study||134
1733848|NCT00186888|4244545|P3|NOT COMPLETED|Overall Study||0
1733849|NCT00186888|4244546|P2|NOT COMPLETED|Overall Study||3
1733850|NCT00186888|4244547|P1|NOT COMPLETED|Overall Study||4
1733851|NCT00186888|4244545|P3|COMPLETED|Overall Study||55
1733852|NCT00186888|4244546|P2|COMPLETED|Overall Study||24
1733853|NCT00186888|4244547|P1|COMPLETED|Overall Study||19
1733854|NCT00186888|4244545|P3|Window Therapy|Overall Study||0
1733855|NCT00186888|4244546|P2|Window Therapy|Overall Study||27
1733856|NCT00186888|4244547|P1|Window Therapy|Overall Study||0
1733857|NCT00186888|4244545|P3|STARTED|Overall Study||55
1733858|NCT00186888|4244546|P2|STARTED|Overall Study||27
1733859|NCT00186888|4244547|P1|STARTED|Overall Study||23
1733860|NCT00186875|4244624|P2|NOT COMPLETED|Overall Study||0
1733861|NCT00186875|4244625|P1|NOT COMPLETED|Overall Study||0
1733862|NCT00186875|4244624|P2|COMPLETED|Overall Study||14
1733863|NCT00186875|4244625|P1|COMPLETED|Overall Study||26
1733864|NCT00186875|4244624|P2|STARTED|Overall Study||14
1733865|NCT00186875|4244625|P1|STARTED|Overall Study||26
1733866|NCT00186628|4244639|P1|NOT COMPLETED|Overall Study||3
1733867|NCT00186628|4244639|P1|COMPLETED|Overall Study||33
1733868|NCT00186628|4244639|P1|STARTED|Overall Study||36
1733869|NCT00186537|4244650|P3|NOT COMPLETED|Overall Study||3
1733870|NCT00186537|4244651|P2|NOT COMPLETED|Overall Study||0
1733871|NCT00186537|4244652|P1|NOT COMPLETED|Overall Study||7
1733872|NCT00186537|4244650|P3|COMPLETED|Overall Study||13
1733873|NCT00186537|4244651|P2|COMPLETED|Overall Study||12
1733874|NCT00186537|4244652|P1|COMPLETED|Overall Study||12
1733875|NCT00186537|4244650|P3|STARTED|Overall Study||16
1733876|NCT00186537|4244651|P2|STARTED|Overall Study||12
1733877|NCT00186537|4244652|P1|STARTED|Overall Study||19
1733878|NCT00186485|4244666|P1|NOT COMPLETED|Overall Study||3
1733879|NCT00186485|4244666|P1|COMPLETED|Overall Study||25
1733880|NCT00186485|4244666|P1|STARTED|Overall Study||28
1733881|NCT00186446|4244672|P1|NOT COMPLETED|Overall Study||9
1733882|NCT00186446|4244672|P1|COMPLETED|Overall Study||11
1733883|NCT00186446|4244672|P1|STARTED|Overall Study||20
1733884|NCT00186186|4244678|P1|NOT COMPLETED|Overall Study||8
1733885|NCT00186186|4244678|P1|COMPLETED|Overall Study||20
1733886|NCT00186186|4244678|P1|STARTED|Overall Study||28
1733887|NCT00186121|4244683|P1|NOT COMPLETED|Overall Study||3
1733888|NCT00186121|4244683|P1|COMPLETED|Overall Study||32
1733889|NCT00186121|4244683|P1|STARTED|Overall Study||35
1733890|NCT00186069|4244695|P2|NOT COMPLETED|Overall Study||0
1733891|NCT00186069|4244696|P1|NOT COMPLETED|Overall Study||0
1733892|NCT00186069|4244695|P2|COMPLETED|Overall Study||15
1733893|NCT00186069|4244696|P1|COMPLETED|Overall Study||15
1733894|NCT00186069|4244695|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
1733895|NCT00186069|4244696|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
1733896|NCT00186056|4244708|P2|NOT COMPLETED|Overall Study||1
1733897|NCT00186056|4244709|P1|NOT COMPLETED|Overall Study||2
1733898|NCT00186056|4244708|P2|COMPLETED|Overall Study||16
1733899|NCT00186056|4244709|P1|COMPLETED|Overall Study||12
1733900|NCT00186056|4244708|P2|STARTED|Overall Study||17
1733901|NCT00186056|4244709|P1|STARTED|Overall Study||14
1733902|NCT00186043|4244717|P2|NOT COMPLETED|Overall Study||13
1733903|NCT00186043|4244718|P1|NOT COMPLETED|Overall Study||15
1733904|NCT00186043|4244717|P2|COMPLETED|Overall Study||12
1733905|NCT00186043|4244718|P1|COMPLETED|Overall Study||15
1733906|NCT00186043|4244717|P2|STARTED|Overall Study||25
1733907|NCT00186043|4244718|P1|STARTED|Overall Study||30
1733908|NCT00186017|4244730|P2|NOT COMPLETED|Overall Study||3
1733909|NCT00186017|4244731|P1|NOT COMPLETED|Overall Study||2
1733910|NCT00186017|4244730|P2|COMPLETED|Overall Study||22
1733911|NCT00186017|4244731|P1|COMPLETED|Overall Study||23
1733912|NCT00186017|4244730|P2|STARTED|Overall Study||25
1733913|NCT00186017|4244731|P1|STARTED|Overall Study||25
1733914|NCT00185965|4244745|P2|NOT COMPLETED|Overall Study||1
1733915|NCT00185965|4244746|P1|NOT COMPLETED|Overall Study||0
1733916|NCT00185965|4244745|P2|COMPLETED|Overall Study||14
1733917|NCT00185965|4244746|P1|COMPLETED|Overall Study||15
1733918|NCT00185965|4244745|P2|STARTED|Overall Study||15
1733919|NCT00185965|4244746|P1|STARTED|Overall Study||15
1733920|NCT00185900|4244754|P2|NOT COMPLETED|Overall Study||0
1733921|NCT00185900|4244755|P1|NOT COMPLETED|Overall Study||0
1733922|NCT00185900|4244754|P2|COMPLETED|Overall Study||100
1733923|NCT00185900|4244755|P1|COMPLETED|Overall Study||92
1733924|NCT00185900|4244754|P2|STARTED|Overall Study||100
1733925|NCT00185900|4244755|P1|STARTED|Overall Study||92
1733926|NCT00185731|4244771|P1|NOT COMPLETED|Overall Study||2
1733927|NCT00185731|4244771|P1|COMPLETED|Overall Study||23
1733928|NCT00185731|4244771|P1|STARTED|Overall Study||25
1733929|NCT00185692|4244777|P1|NOT COMPLETED|Overall Study||16
1733930|NCT00185692|4244777|P1|COMPLETED|Overall Study||0
1733931|NCT00185692|4244777|P1|STARTED|Overall Study||16
1733932|NCT00185679|4244782|P1|NOT COMPLETED|Overall Study||0
1733933|NCT00185679|4244782|P1|COMPLETED|Overall Study||13
1733934|NCT00185679|4244782|P1|STARTED|Overall Study||13
1733935|NCT00185640|4244788|P1|NOT COMPLETED|Overall Study||145
1733936|NCT00185640|4244788|P1|COMPLETED|Overall Study||158
1733937|NCT00185640|4244788|P1|90 Days Post-transplant|Overall Study||161
1733938|NCT00185640|4244788|P1|Transplanted|Overall Study||296
1733939|NCT00185640|4244788|P1|STARTED|Overall Study||303
1733940|NCT00185614|4244797|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
1733941|NCT00185614|4244797|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
1733942|NCT00185614|4244797|P1|STARTED|Allogenic HCT (Allo-HCT)||59
1733943|NCT00185614|4244797|P1|NOT COMPLETED|Inter-treatment Period||4
1733944|NCT00185614|4244797|P1|COMPLETED|Inter-treatment Period||59
1733945|NCT00185614|4244797|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
1733946|NCT00185614|4244797|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
1733947|NCT00185614|4244797|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
1733948|NCT00185614|4244797|P1|STARTED|Autologous HCT (Auto-HCT)||63
1733949|NCT00185588|4244809|P4|NOT COMPLETED|Overall Study||4
1733950|NCT00185588|4244810|P3|NOT COMPLETED|Overall Study||6
1733951|NCT00185588|4244811|P2|NOT COMPLETED|Overall Study||2
1733952|NCT00185588|4244812|P1|NOT COMPLETED|Overall Study||3
1733953|NCT00185588|4244809|P4|COMPLETED|Overall Study||13
1733954|NCT00185588|4244810|P3|COMPLETED|Overall Study||0
1733955|NCT00185588|4244811|P2|COMPLETED|Overall Study||2
1733956|NCT00185588|4244812|P1|COMPLETED|Overall Study||3
1733957|NCT00185588|4244809|P4|STARTED|Overall Study||17
1733958|NCT00185588|4244810|P3|STARTED|Overall Study||6
1733959|NCT00185588|4244811|P2|STARTED|Overall Study||4
1733960|NCT00185588|4244812|P1|STARTED|Overall Study||6
1733961|NCT00185458|4244826|P1|NOT COMPLETED|HRT Phase||27
1733962|NCT00185458|4244826|P1|COMPLETED|HRT Phase||141
1733963|NCT00185458|4244826|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
1733964|NCT00185458|4244826|P1|NOT COMPLETED|Contraception Phase||58
1733965|NCT00185458|4244826|P1|COMPLETED|Contraception Phase||336
1733966|NCT00185458|4244826|P1|STARTED|Contraception Phase||394
1733967|NCT00185380|4244889|P3|NOT COMPLETED|Overall Study||74
1733968|NCT00185380|4244890|P2|NOT COMPLETED|Overall Study||72
1733969|NCT00185380|4244891|P1|NOT COMPLETED|Overall Study||66
1733970|NCT00185380|4244889|P3|COMPLETED|Overall Study||182
1733971|NCT00185380|4244890|P2|COMPLETED|Overall Study||174
1733972|NCT00185380|4244891|P1|COMPLETED|Overall Study||174
1733973|NCT00185380|4244889|P3|Subjects Received Treatment|Overall Study||254
1733974|NCT00185380|4244890|P2|Subjects Received Treatment|Overall Study||245
1733975|NCT00185380|4244891|P1|Subjects Received Treatment|Overall Study||239
1733976|NCT00185380|4244889|P3|STARTED|Overall Study||256
1733977|NCT00185380|4244890|P2|STARTED|Overall Study||246
1733978|NCT00185380|4244891|P1|STARTED|Overall Study||240
1733979|NCT00185211|4244919|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
1733980|NCT00185211|4244920|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
1733981|NCT00185211|4244919|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
1733982|NCT00185211|4244920|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
1733983|NCT00185211|4244919|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
1733984|NCT00185211|4244920|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
1733985|NCT00185211|4244919|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
1733986|NCT00185211|4244920|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
1733987|NCT00185211|4244919|P2|COMPLETED|Placebo-controlled Study (92012)||166
1733988|NCT00185211|4244920|P1|COMPLETED|Placebo-controlled Study (92012)||271
1733989|NCT00185211|4244919|P2|STARTED|Placebo-controlled Study (92012)||176
1733990|NCT00185211|4244920|P1|STARTED|Placebo-controlled Study (92012)||292
1733991|NCT00184717|4244948|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
1733992|NCT00184717|4244949|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
1733993|NCT00184717|4244950|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
1733994|NCT00184717|4244951|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
1733995|NCT00184717|4244952|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
1733996|NCT00184717|4244948|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
1733997|NCT00184717|4244949|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
1733998|NCT00184717|4244950|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
1733999|NCT00184717|4244951|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
1734000|NCT00184717|4244952|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
1734001|NCT00184717|4244948|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
1734002|NCT00184717|4244949|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
1734003|NCT00184717|4244950|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
1734004|NCT00184717|4244951|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
1734005|NCT00184717|4244952|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
1734006|NCT00184717|4244948|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
1734007|NCT00184717|4244949|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
1734008|NCT00184717|4244950|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
1734009|NCT00184717|4244951|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
1734010|NCT00184717|4244952|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
1734011|NCT00184717|4244948|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
1734012|NCT00184717|4244949|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
1734013|NCT00184717|4244950|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
1734014|NCT00184717|4244951|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
1734015|NCT00184717|4244952|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
1734016|NCT00184717|4244948|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
1734017|NCT00184717|4244949|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
1734018|NCT00184717|4244950|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
1734019|NCT00184717|4244951|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
1734020|NCT00184717|4244952|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
1734021|NCT00184717|4244948|P5|STARTED|Main Period (GHLIQUID-1516)||0
1734022|NCT00184717|4244949|P4|STARTED|Main Period (GHLIQUID-1516)||0
1734023|NCT00184717|4244950|P3|STARTED|Main Period (GHLIQUID-1516)||21
1734024|NCT00184717|4244951|P2|STARTED|Main Period (GHLIQUID-1516)||38
1734025|NCT00184717|4244952|P1|STARTED|Main Period (GHLIQUID-1516)||39
1734026|NCT00184600|4244993|P3|NOT COMPLETED|Overall Study||34
1734027|NCT00184600|4244994|P2|NOT COMPLETED|Overall Study||51
1734028|NCT00184600|4244995|P1|NOT COMPLETED|Overall Study||45
1734029|NCT00184600|4244993|P3|COMPLETED|Overall Study||201
1734030|NCT00184600|4244994|P2|COMPLETED|Overall Study||188
1734031|NCT00184600|4244995|P1|COMPLETED|Overall Study||189
1734032|NCT00184600|4244993|P3|STARTED|Overall Study||235
1734033|NCT00184600|4244994|P2|STARTED|Overall Study||239
1734034|NCT00184600|4244995|P1|STARTED|Overall Study||234
1734035|NCT00184548|4245049|P4|NOT COMPLETED|Overall Study||7
1734036|NCT00184548|4245050|P3|NOT COMPLETED|Overall Study||3
1734037|NCT00184548|4245051|P2|NOT COMPLETED|Overall Study||13
1734038|NCT00184548|4245052|P1|NOT COMPLETED|Overall Study||8
1734039|NCT00184548|4245049|P4|COMPLETED|Overall Study||38
1734040|NCT00184548|4245050|P3|COMPLETED|Overall Study||44
1734041|NCT00184548|4245051|P2|COMPLETED|Overall Study||242
1734042|NCT00184548|4245052|P1|COMPLETED|Overall Study||218
1734043|NCT00184548|4245049|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
1734044|NCT00184548|4245050|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
1734045|NCT00184548|4245051|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
1734046|NCT00184548|4245052|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
1734047|NCT00184548|4245049|P4|STARTED|Overall Study||45
1734048|NCT00184548|4245050|P3|STARTED|Overall Study||47
1734049|NCT00184548|4245051|P2|STARTED|Overall Study||255
1734050|NCT00184548|4245052|P1|STARTED|Overall Study||226
1734051|NCT00184093|4245086|P1|NOT COMPLETED|Overall Study||9
1734052|NCT00184093|4245086|P1|COMPLETED|Overall Study||26
1734053|NCT00184093|4245086|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
1734054|NCT00184054|4245091|P1|NOT COMPLETED|Overall Study||1
1734055|NCT00184054|4245091|P1|COMPLETED|Overall Study||10
1734056|NCT00184054|4245091|P1|STARTED|Overall Study||11
1734057|NCT00184028|4245096|P1|NOT COMPLETED|Overall Study||10
1734058|NCT00184028|4245096|P1|COMPLETED|Overall Study||2
1734059|NCT00184028|4245096|P1|STARTED|Overall Study||12
1734060|NCT00184002|4245101|P1|NOT COMPLETED|Overall Study||17
1734061|NCT00184002|4245101|P1|COMPLETED|Overall Study||51
1734062|NCT00184002|4245101|P1|STARTED|Overall Study||68
1734063|NCT00183963|4245110|P4|NOT COMPLETED|Overall Study||1
1734064|NCT00183963|4245111|P3|NOT COMPLETED|Overall Study||1
1734065|NCT00183963|4245112|P2|NOT COMPLETED|Overall Study||1
1734066|NCT00183963|4245113|P1|NOT COMPLETED|Overall Study||1
1734067|NCT00183963|4245110|P4|COMPLETED|Overall Study||0
1734068|NCT00183963|4245111|P3|COMPLETED|Overall Study||0
1734069|NCT00183963|4245112|P2|COMPLETED|Overall Study||0
1734070|NCT00183963|4245113|P1|COMPLETED|Overall Study||0
1734071|NCT00183963|4245110|P4|STARTED|Overall Study||1
1734072|NCT00183963|4245111|P3|STARTED|Overall Study||1
1734073|NCT00183963|4245112|P2|STARTED|Overall Study||1
1734074|NCT00183963|4245113|P1|STARTED|Overall Study||1
1734075|NCT00183872|4245127|P1|NOT COMPLETED|Overall Study||16
1734076|NCT00183872|4245127|P1|COMPLETED|Overall Study||24
1734077|NCT00183872|4245127|P1|STARTED|Overall Study||40
1734078|NCT00183794|4245132|P1|NOT COMPLETED|Overall Study||0
1734079|NCT00183794|4245132|P1|COMPLETED|Overall Study||20
1734080|NCT00183794|4245132|P1|STARTED|Overall Study||20
1734081|NCT00183729|4245139|P2|NOT COMPLETED|Overall Study||5
1734082|NCT00183729|4245140|P1|NOT COMPLETED|Overall Study||3
1734083|NCT00183729|4245139|P2|COMPLETED|Overall Study||13
1734084|NCT00183729|4245140|P1|COMPLETED|Overall Study||14
1734085|NCT00183729|4245139|P2|STARTED|Overall Study||18
1734086|NCT00183729|4245140|P1|STARTED|Overall Study||17
1734087|NCT00183677|4245150|P1|NOT COMPLETED|Overall Study||44
1734088|NCT00183677|4245150|P1|COMPLETED|Overall Study||53
1734089|NCT00183677|4245150|P1|STARTED|Overall Study||97
1734090|NCT00183625|4245156|P4|NOT COMPLETED|Overall Study||14
1734091|NCT00183625|4245157|P3|NOT COMPLETED|Overall Study||19
1734092|NCT00183625|4245158|P2|NOT COMPLETED|Overall Study||18
1734093|NCT00183625|4245159|P1|NOT COMPLETED|Overall Study||18
1734094|NCT00183625|4245156|P4|COMPLETED|Overall Study||10
1734095|NCT00183625|4245157|P3|COMPLETED|Overall Study||9
1734096|NCT00183625|4245158|P2|COMPLETED|Overall Study||10
1734097|NCT00183625|4245159|P1|COMPLETED|Overall Study||9
1734098|NCT00183625|4245156|P4|Obtained Employment|Overall Study||14
1734099|NCT00183625|4245157|P3|Obtained Employment|Overall Study||14
1734100|NCT00183625|4245158|P2|Obtained Employment|Overall Study||18
1734101|NCT00183625|4245159|P1|Obtained Employment|Overall Study||21
1734102|NCT00183625|4245156|P4|STARTED|Overall Study||24
1734103|NCT00183625|4245157|P3|STARTED|Overall Study||28
1734104|NCT00183625|4245158|P2|STARTED|Overall Study||28
1734105|NCT00183625|4245159|P1|STARTED|Overall Study||27
1734106|NCT00183469|4245169|P2|NOT COMPLETED|Overall Study||29
1734107|NCT00183469|4245170|P1|NOT COMPLETED|Overall Study||28
1734108|NCT00183469|4245169|P2|COMPLETED|Overall Study||16
1734109|NCT00183469|4245170|P1|COMPLETED|Overall Study||13
1734110|NCT00183469|4245169|P2|STARTED|Overall Study||45
1734111|NCT00183469|4245170|P1|STARTED|Overall Study||41
1734112|NCT00183456|4245180|P4|NOT COMPLETED|Overall Study||28
1734113|NCT00183456|4245181|P3|NOT COMPLETED|Overall Study||16
1734114|NCT00183456|4245182|P2|NOT COMPLETED|Overall Study||1
1734115|NCT00183456|4245183|P1|NOT COMPLETED|Overall Study||3
1734116|NCT00183456|4245180|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
1734117|NCT00183456|4245181|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
1734118|NCT00183456|4245182|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
1734119|NCT00183456|4245183|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
1734120|NCT00183456|4245180|P4|18 Month Follow-up|Overall Study||207
1734121|NCT00183456|4245181|P3|18 Month Follow-up|Overall Study||303
1734122|NCT00183456|4245182|P2|18 Month Follow-up|Overall Study||81
1734123|NCT00183456|4245183|P1|18 Month Follow-up|Overall Study||80
1734124|NCT00183456|4245180|P4|12 Month Follow-up|Overall Study||186
1734125|NCT00183456|4245181|P3|12 Month Follow-up|Overall Study||267
1734126|NCT00183456|4245182|P2|12 Month Follow-up|Overall Study||74
1734127|NCT00183456|4245183|P1|12 Month Follow-up|Overall Study||76
1734128|NCT00183456|4245180|P4|6 Month Follow-up|Overall Study||175
1734129|NCT00183456|4245181|P3|6 Month Follow-up|Overall Study||278
1734130|NCT00183456|4245182|P2|6 Month Follow-up|Overall Study||77
1734131|NCT00183456|4245183|P1|6 Month Follow-up|Overall Study||74
1734132|NCT00183456|4245180|P4|STARTED|Overall Study||248
1734133|NCT00183456|4245181|P3|STARTED|Overall Study||329
1734134|NCT00183456|4245182|P2|STARTED|Overall Study||84
1734135|NCT00183456|4245183|P1|STARTED|Overall Study||85
1734136|NCT00183443|4245232|P3|NOT COMPLETED|Overall Study||0
1734137|NCT00183443|4245233|P2|NOT COMPLETED|Overall Study||0
1734138|NCT00183443|4245234|P1|NOT COMPLETED|Overall Study||0
1734139|NCT00183443|4245232|P3|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
1734140|NCT00183443|4245233|P2|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
1734141|NCT00183443|4245234|P1|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
1734142|NCT00183443|4245232|P3|STARTED|Overall Study||25
1734143|NCT00183443|4245233|P2|STARTED|Overall Study||26
1734144|NCT00183443|4245234|P1|STARTED|Overall Study||24
1734145|NCT00183430|4245256|P2|NOT COMPLETED|Overall Study||0
1734146|NCT00183430|4245257|P1|NOT COMPLETED|Overall Study||6
1734147|NCT00183430|4245256|P2|COMPLETED|Overall Study||11
1734148|NCT00183430|4245257|P1|COMPLETED|Overall Study||3
1734149|NCT00183430|4245256|P2|STARTED|Overall Study||11
1734150|NCT00183430|4245257|P1|STARTED|Overall Study||9
1734151|NCT00183391|4245269|P2|NOT COMPLETED|Block 2 - 5 Weeks||2
1734152|NCT00183391|4245270|P1|NOT COMPLETED|Block 2 - 5 Weeks||4
1734153|NCT00183391|4245269|P2|COMPLETED|Block 2 - 5 Weeks||108
1734154|NCT00183391|4245270|P1|COMPLETED|Block 2 - 5 Weeks||91
1734155|NCT00183391|4245269|P2|STARTED|Block 2 - 5 Weeks||110
1734156|NCT00183391|4245270|P1|STARTED|Block 2 - 5 Weeks||95
1734157|NCT00183391|4245269|P2|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
1734158|NCT00183391|4245270|P1|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
1734159|NCT00183391|4245269|P2|COMPLETED|Crossover Placebo - 2 Weeks||110
1734160|NCT00183391|4245270|P1|COMPLETED|Crossover Placebo - 2 Weeks||95
1734161|NCT00183391|4245269|P2|STARTED|Crossover Placebo - 2 Weeks||110
1734162|NCT00183391|4245270|P1|STARTED|Crossover Placebo - 2 Weeks||95
1734163|NCT00183391|4245269|P2|NOT COMPLETED|Block 1 - 5 Weeks||14
1734164|NCT00183391|4245270|P1|NOT COMPLETED|Block 1 - 5 Weeks||13
1734165|NCT00183391|4245269|P2|COMPLETED|Block 1 - 5 Weeks||110
1734166|NCT00183391|4245270|P1|COMPLETED|Block 1 - 5 Weeks||95
1734167|NCT00183391|4245269|P2|STARTED|Block 1 - 5 Weeks||124
1734168|NCT00183391|4245270|P1|STARTED|Block 1 - 5 Weeks||108
1734169|NCT00183339|4245330|P2|NOT COMPLETED|Overall Study||4
1734170|NCT00183339|4245331|P1|NOT COMPLETED|Overall Study||6
1734171|NCT00183339|4245330|P2|COMPLETED|Overall Study||4
1734172|NCT00183339|4245331|P1|COMPLETED|Overall Study||4
1734173|NCT00183339|4245330|P2|STARTED|Overall Study||8
1734174|NCT00183339|4245331|P1|STARTED|Overall Study||10
1734175|NCT00183274|4245343|P6|NOT COMPLETED|Phase 3: Double-Blind||4
1734176|NCT00183274|4245344|P5|NOT COMPLETED|Phase 3: Double-Blind||20
1734177|NCT00183274|4245345|P4|NOT COMPLETED|Phase 3: Double-Blind||2
1734178|NCT00183274|4245346|P3|NOT COMPLETED|Phase 3: Double-Blind||0
1734179|NCT00183274|4245347|P2|NOT COMPLETED|Phase 3: Double-Blind||0
1734180|NCT00183274|4245348|P1|NOT COMPLETED|Phase 3: Double-Blind||0
1734181|NCT00183274|4245343|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
1734182|NCT00183274|4245344|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
1734183|NCT00183274|4245345|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
1734184|NCT00183274|4245346|P3|COMPLETED|Phase 3: Double-Blind||0
1734185|NCT00183274|4245347|P2|COMPLETED|Phase 3: Double-Blind||0
1734186|NCT00183274|4245348|P1|COMPLETED|Phase 3: Double-Blind||0
1734187|NCT00183274|4245343|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
1734188|NCT00183274|4245344|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
1734189|NCT00183274|4245345|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
1734190|NCT00183274|4245346|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
1734191|NCT00183274|4245347|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
1734192|NCT00183274|4245348|P1|STARTED|Phase 3: Double-Blind||0
1734193|NCT00183274|4245343|P6|NOT COMPLETED|Phase 2: Double-Blind||0
1734194|NCT00183274|4245344|P5|NOT COMPLETED|Phase 2: Double-Blind||0
1734195|NCT00183274|4245345|P4|NOT COMPLETED|Phase 2: Double-Blind||0
1734196|NCT00183274|4245346|P3|NOT COMPLETED|Phase 2: Double-Blind||43
1734197|NCT00183274|4245347|P2|NOT COMPLETED|Phase 2: Double-Blind||26
1734198|NCT00183274|4245348|P1|NOT COMPLETED|Phase 2: Double-Blind||0
1734199|NCT00183274|4245343|P6|COMPLETED|Phase 2: Double-Blind||0
1734200|NCT00183274|4245344|P5|COMPLETED|Phase 2: Double-Blind||0
1734201|NCT00183274|4245345|P4|COMPLETED|Phase 2: Double-Blind||0
1734202|NCT00183274|4245346|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
1734203|NCT00183274|4245347|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
1734204|NCT00183274|4245348|P1|COMPLETED|Phase 2: Double-Blind||0
1734205|NCT00183274|4245343|P6|STARTED|Phase 2: Double-Blind||0
1734206|NCT00183274|4245344|P5|STARTED|Phase 2: Double-Blind||0
1734207|NCT00183274|4245345|P4|STARTED|Phase 2: Double-Blind||0
1734208|NCT00183274|4245346|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
1734209|NCT00183274|4245347|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
1734210|NCT00183274|4245348|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
1734211|NCT00183274|4245343|P6|NOT COMPLETED|Phase 1: Open-Label||0
1734212|NCT00183274|4245344|P5|NOT COMPLETED|Phase 1: Open-Label||0
1734213|NCT00183274|4245345|P4|NOT COMPLETED|Phase 1: Open-Label||0
1734214|NCT00183274|4245346|P3|NOT COMPLETED|Phase 1: Open-Label||0
1734215|NCT00183274|4245347|P2|NOT COMPLETED|Phase 1: Open-Label||0
1734216|NCT00183274|4245348|P1|NOT COMPLETED|Phase 1: Open-Label||110
1734217|NCT00183274|4245343|P6|COMPLETED|Phase 1: Open-Label||0
1734218|NCT00183274|4245344|P5|COMPLETED|Phase 1: Open-Label||0
1734219|NCT00183274|4245345|P4|COMPLETED|Phase 1: Open-Label||0
1734220|NCT00183274|4245346|P3|COMPLETED|Phase 1: Open-Label||0
1734221|NCT00183274|4245347|P2|COMPLETED|Phase 1: Open-Label||0
1734222|NCT00183274|4245348|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
1734223|NCT00183274|4245343|P6|STARTED|Phase 1: Open-Label||0
1734224|NCT00183274|4245344|P5|STARTED|Phase 1: Open-Label||0
1734225|NCT00183274|4245345|P4|STARTED|Phase 1: Open-Label||0
1734226|NCT00183274|4245346|P3|STARTED|Phase 1: Open-Label||0
1734227|NCT00183274|4245347|P2|STARTED|Phase 1: Open-Label||0
1734228|NCT00183274|4245348|P1|STARTED|Phase 1: Open-Label||268
1734229|NCT00183248|4245365|P2|NOT COMPLETED|Overall Study||1
1734230|NCT00183248|4245366|P1|NOT COMPLETED|Overall Study||1
1734231|NCT00183248|4245365|P2|COMPLETED|Overall Study||4
1734232|NCT00183248|4245366|P1|COMPLETED|Overall Study||3
1734233|NCT00183248|4245365|P2|STARTED|Overall Study||5
1734234|NCT00183248|4245366|P1|STARTED|Overall Study||4
1734235|NCT00183196|4245387|P3|NOT COMPLETED|Overall Study||18
1734236|NCT00183196|4245388|P2|NOT COMPLETED|Overall Study||15
1734237|NCT00183196|4245389|P1|NOT COMPLETED|Overall Study||20
1734238|NCT00183196|4245387|P3|COMPLETED|Overall Study||32
1734239|NCT00183196|4245388|P2|COMPLETED|Overall Study||35
1734240|NCT00183196|4245389|P1|COMPLETED|Overall Study||30
1734241|NCT00183196|4245387|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
1734242|NCT00183196|4245388|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
1734243|NCT00183196|4245389|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
1734244|NCT00183092|4245399|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
1734245|NCT00183092|4245400|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
1734246|NCT00183092|4245401|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
1734247|NCT00183092|4245402|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
1734248|NCT00183092|4245399|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
1734249|NCT00183092|4245400|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
1734250|NCT00183092|4245401|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
1734251|NCT00183092|4245402|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
1734252|NCT00183092|4245399|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
1734253|NCT00183092|4245400|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
1734254|NCT00183092|4245401|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
1734255|NCT00183092|4245402|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
1734256|NCT00183092|4245399|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
1734257|NCT00183092|4245400|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
1734258|NCT00183092|4245401|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
1734259|NCT00183092|4245402|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
1734260|NCT00183092|4245399|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
1734261|NCT00183092|4245400|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
1734262|NCT00183092|4245401|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
1734263|NCT00183092|4245402|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
1734264|NCT00183092|4245399|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
1734265|NCT00183092|4245400|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
1734266|NCT00183092|4245401|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
1734267|NCT00183092|4245402|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
1734268|NCT00183092|4245399|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
1734269|NCT00183092|4245400|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
1734270|NCT00183092|4245401|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
1734271|NCT00183092|4245402|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
1734272|NCT00183092|4245399|P4|STARTED|Double-blind (Baseline - Month 2)||0
1734273|NCT00183092|4245400|P3|STARTED|Double-blind (Baseline - Month 2)||0
1734274|NCT00183092|4245401|P2|STARTED|Double-blind (Baseline - Month 2)||28
1734275|NCT00183092|4245402|P1|STARTED|Double-blind (Baseline - Month 2)||23
1734276|NCT00182793|4245423|P1|NOT COMPLETED|Overall Study||0
1734277|NCT00182793|4245423|P1|COMPLETED|Overall Study||32
1734278|NCT00182793|4245423|P1|STARTED|Overall Study||32
1734279|NCT00182767|4245428|P5|NOT COMPLETED|Overall Study||0
1734280|NCT00182767|4245429|P4|NOT COMPLETED|Overall Study||0
1734281|NCT00182767|4245430|P3|NOT COMPLETED|Overall Study||0
1734282|NCT00182767|4245431|P2|NOT COMPLETED|Overall Study||0
1734283|NCT00182767|4245432|P1|NOT COMPLETED|Overall Study||0
1734284|NCT00182767|4245428|P5|COMPLETED|Overall Study||24
1734285|NCT00182767|4245429|P4|COMPLETED|Overall Study||3
1734286|NCT00182767|4245430|P3|COMPLETED|Overall Study||6
1734287|NCT00182767|4245431|P2|COMPLETED|Overall Study||6
1734288|NCT00182767|4245432|P1|COMPLETED|Overall Study||6
1734289|NCT00182767|4245428|P5|STARTED|Overall Study||24
1734290|NCT00182767|4245429|P4|STARTED|Overall Study||3
1734291|NCT00182767|4245430|P3|STARTED|Overall Study||6
1734292|NCT00182767|4245431|P2|STARTED|Overall Study||6
1734293|NCT00182767|4245432|P1|STARTED|Overall Study||6
1734294|NCT00182754|4245449|P2|NOT COMPLETED|Overall Study||0
1734295|NCT00182754|4245450|P1|NOT COMPLETED|Overall Study||0
1734296|NCT00182754|4245449|P2|COMPLETED|Overall Study||17
1734297|NCT00182754|4245450|P1|COMPLETED|Overall Study||16
1734298|NCT00182754|4245449|P2|STARTED|Overall Study||17
1734299|NCT00182754|4245450|P1|STARTED|Overall Study||16
1734300|NCT00182728|4245460|P1|NOT COMPLETED|Overall Study||0
1734301|NCT00182728|4245460|P1|COMPLETED|Overall Study||71
1734302|NCT00182728|4245460|P1|STARTED|Overall Study||71
1734303|NCT00182689|4245472|P2|NOT COMPLETED|Overall Study||49
1734304|NCT00182689|4245473|P1|NOT COMPLETED|Overall Study||40
1734305|NCT00182689|4245472|P2|COMPLETED|Overall Study||0
1734306|NCT00182689|4245473|P1|COMPLETED|Overall Study||0
1734307|NCT00182689|4245472|P2|Eligible and Began Protocol Therapy|Overall Study||45
1734308|NCT00182689|4245473|P1|Eligible and Began Protocol Therapy|Overall Study||38
1734309|NCT00182689|4245472|P2|Eligible|Overall Study||45
1734310|NCT00182689|4245473|P1|Eligible|Overall Study||39
1734311|NCT00182689|4245472|P2|STARTED|Overall Study||49
1734312|NCT00182689|4245473|P1|STARTED|Overall Study||40
1734313|NCT00182637|4245483|P1|NOT COMPLETED|Overall Study||3
1734314|NCT00182637|4245483|P1|COMPLETED|Overall Study|off study date|2
1734315|NCT00182637|4245483|P1|STARTED|Overall Study|active/on treatment date|5
1734316|NCT00182091|4245493|P4|NOT COMPLETED|Overall Study||0
1734317|NCT00182091|4245494|P3|NOT COMPLETED|Overall Study||0
1734318|NCT00182091|4245495|P2|NOT COMPLETED|Overall Study||0
1734319|NCT00182091|4245496|P1|NOT COMPLETED|Overall Study||1
1734320|NCT00182091|4245493|P4|COMPLETED|Overall Study||20
1734321|NCT00182091|4245494|P3|COMPLETED|Overall Study||25
1734322|NCT00182091|4245495|P2|COMPLETED|Overall Study||15
1734323|NCT00182091|4245496|P1|COMPLETED|Overall Study||14
1734324|NCT00182091|4245493|P4|STARTED|Overall Study||20
1734325|NCT00182091|4245494|P3|STARTED|Overall Study||25
1734326|NCT00182091|4245495|P2|STARTED|Overall Study||15
1734327|NCT00182091|4245496|P1|STARTED|Overall Study||15
1734328|NCT00182078|4245512|P2|NOT COMPLETED|Overall Study||0
1734329|NCT00182078|4245513|P1|NOT COMPLETED|Overall Study||1
1734330|NCT00182078|4245512|P2|COMPLETED|Overall Study||17
1734331|NCT00182078|4245513|P1|COMPLETED|Overall Study||8
1734332|NCT00182078|4245512|P2|STARTED|Overall Study||17
1734333|NCT00182078|4245513|P1|STARTED|Overall Study||9
1734334|NCT00182000|4245525|P2|NOT COMPLETED|Overall Study||2
1734335|NCT00182000|4245526|P1|NOT COMPLETED|Overall Study||5
1734336|NCT00182000|4245525|P2|COMPLETED|Overall Study||13
1734337|NCT00182000|4245526|P1|COMPLETED|Overall Study||9
1734338|NCT00182000|4245525|P2|STARTED|Overall Study||15
1734339|NCT00182000|4245526|P1|STARTED|Overall Study||14
1734340|NCT00181883|4245532|P1|NOT COMPLETED|Overall Study||10
1734341|NCT00181883|4245532|P1|COMPLETED|Overall Study||20
1734342|NCT00181883|4245532|P1|STARTED|Overall Study||30
1734343|NCT00181844|4245536|P1|NOT COMPLETED|Exposed to Study Medication||17
1734344|NCT00181844|4245536|P1|COMPLETED|Exposed to Study Medication||22
1734345|NCT00181844|4245536|P1|STARTED|Exposed to Study Medication||39
1734346|NCT00181844|4245536|P1|NOT COMPLETED|Signed Consent||12
1734347|NCT00181844|4245536|P1|COMPLETED|Signed Consent||39
1734348|NCT00181844|4245536|P1|STARTED|Signed Consent||51
1734349|NCT00181766|4245540|P1|NOT COMPLETED|Overall Study||12
1734350|NCT00181766|4245540|P1|COMPLETED|Overall Study|Completed the trial.|33
1734351|NCT00181766|4245540|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
1734352|NCT00181714|4245545|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
1734353|NCT00181714|4245545|P1|COMPLETED|Began Treatment With OROS-MPH||30
1734354|NCT00181714|4245545|P1|STARTED|Began Treatment With OROS-MPH||154
1734355|NCT00181714|4245545|P1|NOT COMPLETED|Signed Consent/Enrolled||49
1734356|NCT00181714|4245545|P1|COMPLETED|Signed Consent/Enrolled||154
1734357|NCT00181714|4245545|P1|STARTED|Signed Consent/Enrolled||203
1734358|NCT00181623|4245549|P1|NOT COMPLETED|Overall Study||1
1734359|NCT00181623|4245549|P1|COMPLETED|Overall Study||5
1734360|NCT00181623|4245549|P1|STARTED|Overall Study||6
1734361|NCT00181610|4245557|P3|NOT COMPLETED|Overall Study||0
1734362|NCT00181610|4245558|P2|NOT COMPLETED|Overall Study||1
1734363|NCT00181610|4245559|P1|NOT COMPLETED|Overall Study||0
1734364|NCT00181610|4245557|P3|COMPLETED|Overall Study||3
1734365|NCT00181610|4245558|P2|COMPLETED|Overall Study||3
1734366|NCT00181610|4245559|P1|COMPLETED|Overall Study||4
1734367|NCT00181610|4245557|P3|STARTED|Overall Study||3
1734368|NCT00181610|4245558|P2|STARTED|Overall Study||4
1734369|NCT00181610|4245559|P1|STARTED|Overall Study||4
1734370|NCT00181285|4245572|P2|NOT COMPLETED|Overall Study||0
1734371|NCT00181285|4245573|P1|NOT COMPLETED|Overall Study||0
1734372|NCT00181285|4245572|P2|COMPLETED|Overall Study||25
1734373|NCT00181285|4245573|P1|COMPLETED|Overall Study||27
1734374|NCT00181285|4245572|P2|STARTED|Overall Study||25
1734375|NCT00181285|4245573|P1|STARTED|Overall Study||27
1734376|NCT00181207|4245583|P2|NOT COMPLETED|Overall Study||0
1734377|NCT00181207|4245584|P1|NOT COMPLETED|Overall Study||0
1734378|NCT00181207|4245583|P2|COMPLETED|Overall Study||26
1734379|NCT00181207|4245584|P1|COMPLETED|Overall Study||24
1734380|NCT00181207|4245583|P2|STARTED|Overall Study||26
1734381|NCT00181207|4245584|P1|STARTED|Overall Study||24
1734382|NCT00181168|4245594|P2|NOT COMPLETED|Overall Study||0
1734383|NCT00181168|4245595|P1|NOT COMPLETED|Overall Study||0
1734384|NCT00181168|4245594|P2|COMPLETED|Overall Study||33
1734385|NCT00181168|4245595|P1|COMPLETED|Overall Study||30
1734386|NCT00181168|4245594|P2|STARTED|Overall Study||33
1734387|NCT00181168|4245595|P1|STARTED|Overall Study||30
1734388|NCT00181155|4245601|P2|NOT COMPLETED|Overall Study||0
1734389|NCT00181155|4245602|P1|NOT COMPLETED|Overall Study||2
1734390|NCT00181155|4245601|P2|COMPLETED|Overall Study||3
1734391|NCT00181155|4245602|P1|COMPLETED|Overall Study||13
1734392|NCT00181155|4245601|P2|STARTED|Overall Study||3
1734393|NCT00181155|4245602|P1|STARTED|Overall Study||15
1734394|NCT00180687|4245614|P4|NOT COMPLETED|Overall Study||0
1734395|NCT00180687|4245615|P3|NOT COMPLETED|Overall Study||0
1734396|NCT00180687|4245616|P2|NOT COMPLETED|Overall Study||0
1734397|NCT00180687|4245617|P1|NOT COMPLETED|Overall Study||0
1734398|NCT00180687|4245614|P4|COMPLETED|Overall Study||20
1734399|NCT00180687|4245615|P3|COMPLETED|Overall Study||20
1734400|NCT00180687|4245616|P2|COMPLETED|Overall Study||20
1734401|NCT00180687|4245617|P1|COMPLETED|Overall Study||20
1734402|NCT00180687|4245614|P4|STARTED|Overall Study||20
1734403|NCT00180687|4245615|P3|STARTED|Overall Study||20
1734404|NCT00180687|4245616|P2|STARTED|Overall Study||20
1734405|NCT00180687|4245617|P1|STARTED|Overall Study||20
1734406|NCT00180479|4245641|P2|NOT COMPLETED|Overall Study||13
1734407|NCT00180479|4245642|P1|NOT COMPLETED|Overall Study||16
1734408|NCT00180479|4245641|P2|COMPLETED|Overall Study||320
1734409|NCT00180479|4245642|P1|COMPLETED|Overall Study||653
1734410|NCT00180479|4245641|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
1734411|NCT00180479|4245642|P1|STARTED|Overall Study||669
1734412|NCT00180323|4245734|P1|NOT COMPLETED|Overall Study||0
1734413|NCT00180323|4245734|P1|COMPLETED|Overall Study||43
1734414|NCT00180323|4245734|P1|STARTED|Overall Study||43
1734415|NCT00180271|4245743|P2|NOT COMPLETED|Overall Study||0
1734416|NCT00180271|4245744|P1|NOT COMPLETED|Overall Study||0
1734417|NCT00180271|4245743|P2|COMPLETED|Overall Study||731
1734418|NCT00180271|4245744|P1|COMPLETED|Overall Study||1089
1734419|NCT00180271|4245743|P2|STARTED|Overall Study||731
1734420|NCT00180271|4245744|P1|STARTED|Overall Study||1089
1734421|NCT00179959|4245754|P2|NOT COMPLETED|Overall Study||3
1734422|NCT00179959|4245755|P1|NOT COMPLETED|Overall Study||6
1734423|NCT00179959|4245754|P2|COMPLETED|Overall Study||13
1734424|NCT00179959|4245755|P1|COMPLETED|Overall Study||9
1734425|NCT00179959|4245754|P2|STARTED|Overall Study||16
1734426|NCT00179959|4245755|P1|STARTED|Overall Study||15
1734427|NCT00179673|4245761|P1|NOT COMPLETED|Overall Study||43
1734428|NCT00179673|4245761|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
1734429|NCT00179673|4245761|P1|Received Study Drug|Overall Study||43
1734430|NCT00179673|4245761|P1|STARTED|Overall Study||43
1734431|NCT00179660|4245769|P1|NOT COMPLETED|Overall Study||50
1734432|NCT00179660|4245769|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
1734433|NCT00179660|4245769|P1|Completed 12 Cycles of Treatment|Overall Study||12
1734434|NCT00179660|4245769|P1|Received Study Drug|Overall Study||49
1734435|NCT00179660|4245769|P1|STARTED|Overall Study||50
1734436|NCT00179647|4245778|P1|NOT COMPLETED|Overall Study||1913
1734437|NCT00179647|4245778|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
1734438|NCT00179647|4245778|P1|STARTED|Overall Study||1913
1734439|NCT00179621|4245785|P4|NOT COMPLETED|Open-Label Period||43
1734440|NCT00179621|4245786|P3|NOT COMPLETED|Open-Label Period||28
1734441|NCT00179621|4245787|P2|NOT COMPLETED|Open-Label Period||28
1734442|NCT00179621|4245788|P1|NOT COMPLETED|Open-Label Period||0
1734443|NCT00179621|4245785|P4|COMPLETED|Open-Label Period||13
1734444|NCT00179621|4245786|P3|COMPLETED|Open-Label Period||19
1734445|NCT00179621|4245787|P2|COMPLETED|Open-Label Period||14
1734446|NCT00179621|4245788|P1|COMPLETED|Open-Label Period||0
1734447|NCT00179621|4245785|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
1734448|NCT00179621|4245786|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
1734449|NCT00179621|4245787|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
1734450|NCT00179621|4245788|P1|STARTED|Open-Label Period||0
1734451|NCT00179621|4245785|P4|NOT COMPLETED|Double-Blind Period||0
1734452|NCT00179621|4245786|P3|NOT COMPLETED|Double-Blind Period||30
1734453|NCT00179621|4245787|P2|NOT COMPLETED|Double-Blind Period||46
1734454|NCT00179621|4245788|P1|NOT COMPLETED|Double-Blind Period||64
1734455|NCT00179621|4245785|P4|COMPLETED|Double-Blind Period||0
1734456|NCT00179621|4245786|P3|COMPLETED|Double-Blind Period||39
1734457|NCT00179621|4245787|P2|COMPLETED|Double-Blind Period||23
1734458|NCT00179621|4245788|P1|COMPLETED|Double-Blind Period||3
1734459|NCT00179621|4245785|P4|STARTED|Double-Blind Period||0
1734460|NCT00179621|4245786|P3|STARTED|Double-Blind Period||69
1734461|NCT00179621|4245787|P2|STARTED|Double-Blind Period||69
1734462|NCT00179621|4245788|P1|STARTED|Double-Blind Period||67
1734463|NCT00179517|4245841|P2|NOT COMPLETED|Overall Study||1
1734464|NCT00179517|4245842|P1|NOT COMPLETED|Overall Study||2
1734465|NCT00179517|4245841|P2|COMPLETED|Overall Study||19
1734466|NCT00179517|4245842|P1|COMPLETED|Overall Study||18
1734467|NCT00179517|4245841|P2|STARTED|Overall Study||20
1734468|NCT00179517|4245842|P1|STARTED|Overall Study||20
1734469|NCT00179478|4245866|P2|NOT COMPLETED|Overall Study||15
1734470|NCT00179478|4245867|P1|NOT COMPLETED|Overall Study||13
1734471|NCT00179478|4245866|P2|COMPLETED|Overall Study||59
1734472|NCT00179478|4245867|P1|COMPLETED|Overall Study||68
1734473|NCT00179478|4245866|P2|STARTED|Overall Study||74
1734474|NCT00179478|4245867|P1|STARTED|Overall Study||81
1734475|NCT00179413|4245880|P2|NOT COMPLETED|Overall Study||115
1734476|NCT00179413|4245881|P1|NOT COMPLETED|Overall Study||125
1734477|NCT00179413|4245880|P2|COMPLETED|Overall Study||152
1734478|NCT00179413|4245881|P1|COMPLETED|Overall Study||157
1734479|NCT00179413|4245880|P2|STARTED|Overall Study||267
1734480|NCT00179413|4245881|P1|STARTED|Overall Study||282
1734481|NCT00179309|4245893|P2|NOT COMPLETED|Crossover||0
1734482|NCT00179309|4245894|P1|NOT COMPLETED|Crossover||0
1734483|NCT00179309|4245893|P2|COMPLETED|Crossover||3
1734484|NCT00179309|4245894|P1|COMPLETED|Crossover||0
1734485|NCT00179309|4245893|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
1734486|NCT00179309|4245894|P1|STARTED|Crossover||0
1734487|NCT00179309|4245893|P2|NOT COMPLETED|Treatment||5
1734488|NCT00179309|4245894|P1|NOT COMPLETED|Treatment||4
1734489|NCT00179309|4245893|P2|COMPLETED|Treatment||18
1734490|NCT00179309|4245894|P1|COMPLETED|Treatment||21
1734491|NCT00179309|4245893|P2|STARTED|Treatment||23
1734492|NCT00179309|4245894|P1|STARTED|Treatment||25
1734493|NCT00179127|4245904|P2|NOT COMPLETED|Overall Study||0
1734494|NCT00179127|4245905|P1|NOT COMPLETED|Overall Study||0
1734495|NCT00179127|4245904|P2|COMPLETED|Overall Study||0
1734496|NCT00179127|4245905|P1|COMPLETED|Overall Study||0
1734497|NCT00179127|4245904|P2|STARTED|Overall Study||0
1734498|NCT00179127|4245905|P1|STARTED|Overall Study||0
1734499|NCT00178919|4245917|P2|NOT COMPLETED|Overall Study||25
1734500|NCT00178919|4245918|P1|NOT COMPLETED|Overall Study||0
1734501|NCT00178919|4245917|P2|COMPLETED|Overall Study||68
1734502|NCT00178919|4245918|P1|COMPLETED|Overall Study||19
1734503|NCT00178919|4245917|P2|STARTED|Overall Study||93
1734504|NCT00178919|4245918|P1|STARTED|Overall Study||19
1734505|NCT00178841|4245926|P1|NOT COMPLETED|Overall Study||0
1734506|NCT00178841|4245926|P1|COMPLETED|Overall Study||4
1734507|NCT00178841|4245926|P1|STARTED|Overall Study||4
1734508|NCT00178711|4245934|P2|NOT COMPLETED|Overall Study||0
1734509|NCT00178711|4245935|P1|NOT COMPLETED|Overall Study||0
1734510|NCT00178711|4245934|P2|COMPLETED|Overall Study||45
1734511|NCT00178711|4245935|P1|COMPLETED|Overall Study||52
1734512|NCT00178711|4245934|P2|STARTED|Overall Study||45
1734513|NCT00178711|4245935|P1|STARTED|Overall Study||52
1734514|NCT00178685|4245946|P3|NOT COMPLETED|Overall Study||196
1734515|NCT00178685|4245947|P2|NOT COMPLETED|Overall Study||204
1734516|NCT00178685|4245948|P1|NOT COMPLETED|Overall Study||111
1734517|NCT00178685|4245946|P3|COMPLETED|Overall Study||128
1734518|NCT00178685|4245947|P2|COMPLETED|Overall Study||120
1734519|NCT00178685|4245948|P1|COMPLETED|Overall Study||61
1734520|NCT00178685|4245946|P3|STARTED|Overall Study||324
1734521|NCT00178685|4245947|P2|STARTED|Overall Study||324
1734522|NCT00178685|4245948|P1|STARTED|Overall Study||172
1734523|NCT00178633|4245959|P1|NOT COMPLETED|Overall Study||6
1734524|NCT00178633|4245959|P1|COMPLETED|Overall Study||37
1734525|NCT00178633|4245959|P1|STARTED|Overall Study||43
1734526|NCT00178503|4245967|P1|NOT COMPLETED|MPH Trial: High Dose||0
1734527|NCT00178503|4245967|P1|COMPLETED|MPH Trial: High Dose||24
1734528|NCT00178503|4245967|P1|STARTED|MPH Trial: High Dose||24
1734529|NCT00178503|4245967|P1|NOT COMPLETED|MPH Trial: Med Dose||0
1734530|NCT00178503|4245967|P1|COMPLETED|MPH Trial: Med Dose||24
1734531|NCT00178503|4245967|P1|STARTED|MPH Trial: Med Dose||24
1734532|NCT00178503|4245967|P1|NOT COMPLETED|MPH Trial: Low Dose||0
1734533|NCT00178503|4245967|P1|COMPLETED|MPH Trial: Low Dose||24
1734534|NCT00178503|4245967|P1|STARTED|MPH Trial: Low Dose||24
1734535|NCT00178503|4245967|P1|NOT COMPLETED|MPH Trial: Placebo||0
1734536|NCT00178503|4245967|P1|COMPLETED|MPH Trial: Placebo||24
1734537|NCT00178503|4245967|P1|STARTED|MPH Trial: Placebo||24
1734538|NCT00178477|4245985|P1|NOT COMPLETED|Overall Study||5
1734539|NCT00178477|4245985|P1|COMPLETED|Overall Study||5
1734540|NCT00178477|4245985|P1|STARTED|Overall Study||10
1734541|NCT00178464|4245989|P1|NOT COMPLETED|Overall Study||2
1734542|NCT00178464|4245989|P1|COMPLETED|Overall Study||9
1734543|NCT00178464|4245989|P1|STARTED|Overall Study||11
1734544|NCT00178399|4245994|P1|NOT COMPLETED|Overall Study||13
1734545|NCT00178399|4245994|P1|COMPLETED|Overall Study||115
1734546|NCT00178399|4245994|P1|STARTED|Overall Study||128
1734547|NCT00178256|4246001|P4|NOT COMPLETED|Overall Study||2
1734548|NCT00178256|4246002|P3|NOT COMPLETED|Overall Study||0
1734549|NCT00178256|4246003|P2|NOT COMPLETED|Overall Study||1
1734550|NCT00178256|4246004|P1|NOT COMPLETED|Overall Study||4
1734551|NCT00178256|4246001|P4|COMPLETED|Overall Study||16
1734552|NCT00178256|4246002|P3|COMPLETED|Overall Study||6
1734553|NCT00178256|4246003|P2|COMPLETED|Overall Study||6
1734554|NCT00178256|4246004|P1|COMPLETED|Overall Study||6
1734555|NCT00178256|4246001|P4|STARTED|Overall Study||18
1734556|NCT00178256|4246002|P3|STARTED|Overall Study||6
1734557|NCT00178256|4246003|P2|STARTED|Overall Study||7
1734558|NCT00178256|4246004|P1|STARTED|Overall Study||10
1734559|NCT00178191|4246014|P3|NOT COMPLETED|Overall Study||0
1734560|NCT00178191|4246015|P2|NOT COMPLETED|Overall Study||0
1734561|NCT00178191|4246016|P1|NOT COMPLETED|Overall Study||0
1734562|NCT00178191|4246014|P3|COMPLETED|Overall Study||7
1734563|NCT00178191|4246015|P2|COMPLETED|Overall Study||10
1734564|NCT00178191|4246016|P1|COMPLETED|Overall Study||11
1734565|NCT00178191|4246014|P3|STARTED|Overall Study||7
1734566|NCT00178191|4246015|P2|STARTED|Overall Study||10
1734567|NCT00178191|4246016|P1|STARTED|Overall Study||11
1734568|NCT00178178|4246028|P4|NOT COMPLETED|Overall Study||0
1734569|NCT00178178|4246029|P3|NOT COMPLETED|Overall Study||0
1734570|NCT00178178|4246030|P2|NOT COMPLETED|Overall Study||0
1734571|NCT00178178|4246031|P1|NOT COMPLETED|Overall Study||0
1734572|NCT00178178|4246028|P4|COMPLETED|Overall Study||24
1734573|NCT00178178|4246029|P3|COMPLETED|Overall Study||24
1734574|NCT00178178|4246030|P2|COMPLETED|Overall Study||24
1734575|NCT00178178|4246031|P1|COMPLETED|Overall Study||24
1734576|NCT00178178|4246028|P4|STARTED|Overall Study||24
1734577|NCT00178178|4246029|P3|STARTED|Overall Study||24
1734578|NCT00178178|4246030|P2|STARTED|Overall Study||24
1734579|NCT00178178|4246031|P1|STARTED|Overall Study||24
1734580|NCT00178126|4246043|P2|NOT COMPLETED|Overall Study||27
1734581|NCT00178126|4246044|P1|NOT COMPLETED|Overall Study||25
1734582|NCT00178126|4246043|P2|COMPLETED|Overall Study||86
1734583|NCT00178126|4246044|P1|COMPLETED|Overall Study||94
1734584|NCT00178126|4246043|P2|STARTED|Overall Study||113
1734585|NCT00178126|4246044|P1|STARTED|Overall Study||119
1734586|NCT00177970|4246052|P2|NOT COMPLETED|Overall Study||0
1734587|NCT00177970|4246053|P1|NOT COMPLETED|Overall Study||0
1734588|NCT00177970|4246052|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
1734589|NCT00177970|4246053|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
1734590|NCT00177970|4246052|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
1734591|NCT00177970|4246053|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
1734592|NCT00177866|4246075|P2|NOT COMPLETED|Overall Study||0
1734593|NCT00177866|4246076|P1|NOT COMPLETED|Overall Study||0
1734594|NCT00177866|4246075|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
1734595|NCT00177866|4246076|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
1734596|NCT00177866|4246075|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
1734597|NCT00177866|4246076|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
1734598|NCT00177671|4246086|P2|NOT COMPLETED|Overall Study||14
1734599|NCT00177671|4246087|P1|NOT COMPLETED|Overall Study||25
1734600|NCT00177671|4246086|P2|COMPLETED|Overall Study||49
1734601|NCT00177671|4246087|P1|COMPLETED|Overall Study||42
1734602|NCT00177671|4246086|P2|Month 24|Overall Study||49
1734603|NCT00177671|4246087|P1|Month 24|Overall Study||42
1734604|NCT00177671|4246086|P2|Month 12|Overall Study||57
1734605|NCT00177671|4246087|P1|Month 12|Overall Study||45
1734606|NCT00177671|4246086|P2|STARTED|Overall Study||63
1734607|NCT00177671|4246087|P1|STARTED|Overall Study||67
1734608|NCT00177307|4246099|P1|NOT COMPLETED|Overall Study||1
1734609|NCT00177307|4246099|P1|COMPLETED|Overall Study||39
1734610|NCT00177307|4246099|P1|STARTED|Overall Study||40
1734611|NCT00177294|4246108|P2|NOT COMPLETED|Overall Study||5
1734612|NCT00177294|4246109|P1|NOT COMPLETED|Overall Study||7
1734613|NCT00177294|4246108|P2|COMPLETED|Overall Study||59
1734614|NCT00177294|4246109|P1|COMPLETED|Overall Study||53
1734615|NCT00177294|4246108|P2|STARTED|Overall Study||64
1734616|NCT00177294|4246109|P1|STARTED|Overall Study||60
1734617|NCT00177255|4246115|P1|NOT COMPLETED|Overall Study||0
1734618|NCT00177255|4246115|P1|COMPLETED|Overall Study||39
1734619|NCT00177255|4246115|P1|STARTED|Overall Study||39
1734620|NCT00177216|4246123|P3|NOT COMPLETED|Overall Study||1
1734621|NCT00177216|4246124|P2|NOT COMPLETED|Overall Study||3
1734622|NCT00177216|4246125|P1|NOT COMPLETED|Overall Study||6
1734623|NCT00177216|4246123|P3|COMPLETED|Overall Study||19
1734624|NCT00177216|4246124|P2|COMPLETED|Overall Study||20
1734625|NCT00177216|4246125|P1|COMPLETED|Overall Study||20
1734626|NCT00177216|4246123|P3|STARTED|Overall Study||20
1734627|NCT00177216|4246124|P2|STARTED|Overall Study||23
1734628|NCT00177216|4246125|P1|STARTED|Overall Study||26
1734629|NCT00177164|4246141|P2|NOT COMPLETED|Overall Study||16
1734630|NCT00177164|4246142|P1|NOT COMPLETED|Overall Study||9
1734631|NCT00177164|4246141|P2|COMPLETED|Overall Study||9
1734632|NCT00177164|4246142|P1|COMPLETED|Overall Study||14
1734633|NCT00177164|4246141|P2|STARTED|Overall Study||25
1734634|NCT00177164|4246142|P1|STARTED|Overall Study||23
1734635|NCT00176917|4246154|P1|NOT COMPLETED|Overall Study||0
1734636|NCT00176917|4246154|P1|COMPLETED|Overall Study||41
1734637|NCT00176917|4246154|P1|STARTED|Overall Study||41
1734638|NCT00176904|4246161|P1|NOT COMPLETED|Overall Study||0
1734639|NCT00176904|4246161|P1|COMPLETED|Overall Study||135
1734640|NCT00176904|4246161|P1|STARTED|Overall Study||135
1734641|NCT00176878|4246169|P1|NOT COMPLETED|Overall Study||0
1734642|NCT00176878|4246169|P1|COMPLETED|Overall Study||10
1734643|NCT00176878|4246169|P1|STARTED|Overall Study||10
1734644|NCT00176865|4246181|P3|NOT COMPLETED|Overall Study||0
1734645|NCT00176865|4246182|P2|NOT COMPLETED|Overall Study||0
1734646|NCT00176865|4246183|P1|NOT COMPLETED|Overall Study||0
1734647|NCT00176865|4246181|P3|COMPLETED|Overall Study||6
1734648|NCT00176865|4246182|P2|COMPLETED|Overall Study||10
1734649|NCT00176865|4246183|P1|COMPLETED|Overall Study||3
1734650|NCT00176865|4246181|P3|STARTED|Overall Study||6
1734651|NCT00176865|4246182|P2|STARTED|Overall Study||10
1734652|NCT00176865|4246183|P1|STARTED|Overall Study||3
1734653|NCT00176852|4246221|P3|NOT COMPLETED|Overall Study||0
1734654|NCT00176852|4246222|P2|NOT COMPLETED|Overall Study||0
1734655|NCT00176852|4246223|P1|NOT COMPLETED|Overall Study||0
1734656|NCT00176852|4246221|P3|COMPLETED|Overall Study||14
1734657|NCT00176852|4246222|P2|COMPLETED|Overall Study||5
1734658|NCT00176852|4246223|P1|COMPLETED|Overall Study||3
1734659|NCT00176852|4246221|P3|STARTED|Overall Study||14
1734660|NCT00176852|4246222|P2|STARTED|Overall Study||5
1734661|NCT00176852|4246223|P1|STARTED|Overall Study||3
1734662|NCT00176839|4246282|P1|NOT COMPLETED|Overall Study||0
1734663|NCT00176839|4246282|P1|COMPLETED|Overall Study||11
1734664|NCT00176839|4246282|P1|STARTED|Overall Study||11
1734665|NCT00176826|4246291|P1|NOT COMPLETED|Overall Study||0
1734666|NCT00176826|4246291|P1|COMPLETED|Overall Study||22
1734667|NCT00176826|4246291|P1|STARTED|Overall Study||22
1734668|NCT00176800|4246301|P1|NOT COMPLETED|Overall Study||0
1734669|NCT00176800|4246301|P1|COMPLETED|Overall Study||69
1734670|NCT00176800|4246301|P1|STARTED|Overall Study||69
1734671|NCT00176644|4246307|P1|NOT COMPLETED|Overall Study||1
1734672|NCT00176644|4246307|P1|COMPLETED|Overall Study||22
1734673|NCT00176644|4246307|P1|STARTED|Overall Study||23
1734674|NCT00176631|4246315|P1|NOT COMPLETED|Overall Study||0
1734675|NCT00176631|4246315|P1|COMPLETED|Overall Study||10
1734676|NCT00176631|4246315|P1|STARTED|Overall Study||10
1734677|NCT00176605|4246320|P1|NOT COMPLETED|Overall Study||2
1734678|NCT00176605|4246320|P1|COMPLETED|Overall Study||13
1734679|NCT00176605|4246320|P1|STARTED|Overall Study||15
1734680|NCT00176501|4246325|P1|NOT COMPLETED|Overall Study||0
1734681|NCT00176501|4246325|P1|COMPLETED|Overall Study||3
1734682|NCT00176501|4246325|P1|STARTED|Overall Study||3
1734683|NCT00176488|4246331|P1|NOT COMPLETED|Overall Study||1
1734684|NCT00176488|4246331|P1|COMPLETED|Overall Study||30
1734685|NCT00176488|4246331|P1|STARTED|Overall Study||31
1734686|NCT00176462|4246339|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
1734687|NCT00176462|4246340|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
1734688|NCT00176462|4246339|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
1734689|NCT00176462|4246340|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
1734690|NCT00176462|4246339|P2|STARTED|Continuation -up to 30mos Post Remission||26
1734691|NCT00176462|4246340|P1|STARTED|Continuation -up to 30mos Post Remission||19
1734692|NCT00176462|4246339|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
1734693|NCT00176462|4246340|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
1734694|NCT00176462|4246339|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
1734695|NCT00176462|4246340|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
1734696|NCT00176462|4246339|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
1734697|NCT00176462|4246340|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
1734698|NCT00176462|4246339|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
1734699|NCT00176462|4246340|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
1734700|NCT00176462|4246339|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
1734701|NCT00176462|4246340|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
1734702|NCT00176462|4246339|P2|STARTED|Delayed Intensification (8 Weeks)||29
1734703|NCT00176462|4246340|P1|STARTED|Delayed Intensification (8 Weeks)||20
1734704|NCT00176462|4246339|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
1734705|NCT00176462|4246340|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
1734706|NCT00176462|4246339|P2|COMPLETED|Consolidation (12 Weeks)||29
1734707|NCT00176462|4246340|P1|COMPLETED|Consolidation (12 Weeks)||20
1734708|NCT00176462|4246339|P2|STARTED|Consolidation (12 Weeks)||34
1734709|NCT00176462|4246340|P1|STARTED|Consolidation (12 Weeks)||20
1734710|NCT00176462|4246339|P2|NOT COMPLETED|Induction (4 Weeks)||5
1734711|NCT00176462|4246340|P1|NOT COMPLETED|Induction (4 Weeks)||1
1734712|NCT00176462|4246339|P2|COMPLETED|Induction (4 Weeks)||34
1734713|NCT00176462|4246340|P1|COMPLETED|Induction (4 Weeks)||20
1734714|NCT00176462|4246339|P2|STARTED|Induction (4 Weeks)||39
1734715|NCT00176462|4246340|P1|STARTED|Induction (4 Weeks)||21
1734716|NCT00176436|4246349|P2|NOT COMPLETED|Overall Study||5
1734717|NCT00176436|4246350|P1|NOT COMPLETED|Overall Study||6
1734718|NCT00176436|4246349|P2|COMPLETED|Overall Study||12
1734719|NCT00176436|4246350|P1|COMPLETED|Overall Study||14
1734720|NCT00176436|4246349|P2|STARTED|Overall Study||17
1734721|NCT00176436|4246350|P1|STARTED|Overall Study||20
1734722|NCT00176306|4246356|P1|NOT COMPLETED|Overall Study||0
1734723|NCT00176306|4246356|P1|COMPLETED|Overall Study||15
1734724|NCT00176306|4246356|P1|STARTED|Overall Study||15
1734725|NCT00176254|4246360|P1|NOT COMPLETED|Overall Study||1
1734726|NCT00176254|4246360|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
1734727|NCT00176254|4246360|P1|STARTED|Overall Study||40
1734728|NCT00176228|4246368|P1|NOT COMPLETED|Overall Study||2
1734729|NCT00176228|4246368|P1|COMPLETED|Overall Study|Study ended|46
1734730|NCT00176228|4246368|P1|STARTED|Overall Study|When study began|48
1734731|NCT00176202|4246375|P2|NOT COMPLETED|Overall Study||16
1734732|NCT00176202|4246376|P1|NOT COMPLETED|Overall Study||5
1734733|NCT00176202|4246375|P2|COMPLETED|Overall Study||17
1734734|NCT00176202|4246376|P1|COMPLETED|Overall Study||27
1734735|NCT00176202|4246375|P2|STARTED|Overall Study||33
1734736|NCT00176202|4246376|P1|STARTED|Overall Study||32
1734737|NCT00175877|4246388|P1|NOT COMPLETED|Overall Study||349
1734738|NCT00175877|4246388|P1|COMPLETED|Overall Study||497
1734739|NCT00175877|4246388|P1|STARTED|Overall Study||846
1734740|NCT00175825|4246423|P4|NOT COMPLETED|Overall Study||1
1734741|NCT00175825|4246424|P3|NOT COMPLETED|Overall Study||1
1734742|NCT00175825|4246425|P2|NOT COMPLETED|Overall Study||4
1734743|NCT00175825|4246426|P1|NOT COMPLETED|Overall Study||5
1734744|NCT00175825|4246423|P4|COMPLETED|Overall Study||51
1734745|NCT00175825|4246424|P3|COMPLETED|Overall Study||51
1734746|NCT00175825|4246425|P2|COMPLETED|Overall Study||46
1734747|NCT00175825|4246426|P1|COMPLETED|Overall Study||49
1734748|NCT00175825|4246423|P4|STARTED|Overall Study||52
1734749|NCT00175825|4246424|P3|STARTED|Overall Study||52
1734750|NCT00175825|4246425|P2|STARTED|Overall Study||50
1734751|NCT00175825|4246426|P1|STARTED|Overall Study||54
1734752|NCT00175019|4246479|P3|NOT COMPLETED|Overall Study||57
1734753|NCT00175019|4246480|P2|NOT COMPLETED|Overall Study||171
1734754|NCT00175019|4246481|P1|NOT COMPLETED|Overall Study||194
1734755|NCT00175019|4246479|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
1734756|NCT00175019|4246480|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
1734757|NCT00175019|4246481|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
1734758|NCT00175019|4246479|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
1734759|NCT00175019|4246480|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
1734760|NCT00175019|4246481|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
1734761|NCT00175006|4246525|P1|NOT COMPLETED|Overall Study||0
1734762|NCT00175006|4246525|P1|COMPLETED|Overall Study||13
1734763|NCT00175006|4246525|P1|STARTED|Overall Study||13
1734764|NCT00174967|4246534|P4|NOT COMPLETED|Overall Study||2
1734765|NCT00174967|4246535|P3|NOT COMPLETED|Overall Study||2
1734766|NCT00174967|4246536|P2|NOT COMPLETED|Overall Study||3
1734767|NCT00174967|4246537|P1|NOT COMPLETED|Overall Study||1
1734768|NCT00174967|4246534|P4|COMPLETED|Overall Study||36
1734769|NCT00174967|4246535|P3|COMPLETED|Overall Study||36
1734770|NCT00174967|4246536|P2|COMPLETED|Overall Study||37
1734771|NCT00174967|4246537|P1|COMPLETED|Overall Study||36
1734772|NCT00174967|4246534|P4|STARTED|Overall Study||38
1734773|NCT00174967|4246535|P3|STARTED|Overall Study||38
1734774|NCT00174967|4246536|P2|STARTED|Overall Study||40
1734775|NCT00174967|4246537|P1|STARTED|Overall Study||37
1734776|NCT00174954|4246583|P1|NOT COMPLETED|Overall Study||4
1734777|NCT00174954|4246583|P1|COMPLETED|Overall Study||28
1734778|NCT00174954|4246583|P1|STARTED|Overall Study||32
1734779|NCT00174941|4246591|P4|NOT COMPLETED|Overall Study||58
1734780|NCT00174941|4246592|P3|NOT COMPLETED|Overall Study||18
1734781|NCT00174941|4246593|P2|NOT COMPLETED|Overall Study||38
1734782|NCT00174941|4246594|P1|NOT COMPLETED|Overall Study||2
1734783|NCT00174941|4246591|P4|COMPLETED|Overall Study||58
1734784|NCT00174941|4246592|P3|COMPLETED|Overall Study||11
1734785|NCT00174941|4246593|P2|COMPLETED|Overall Study||41
1734786|NCT00174941|4246594|P1|COMPLETED|Overall Study||6
1734787|NCT00174941|4246591|P4|STARTED|Overall Study||116
1734788|NCT00174941|4246592|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
1734789|NCT00174941|4246593|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
1734790|NCT00174941|4246594|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
1734791|NCT00174915|4246669|P5|NOT COMPLETED|Overall Study||33
1734792|NCT00174915|4246670|P4|NOT COMPLETED|Overall Study||57
1734793|NCT00174915|4246671|P3|NOT COMPLETED|Overall Study||48
1734794|NCT00174915|4246672|P2|NOT COMPLETED|Overall Study||69
1734795|NCT00174915|4246673|P1|NOT COMPLETED|Overall Study||93
1734796|NCT00174915|4246669|P5|COMPLETED|Overall Study||101
1734797|NCT00174915|4246670|P4|COMPLETED|Overall Study||211
1734798|NCT00174915|4246671|P3|COMPLETED|Overall Study||86
1734799|NCT00174915|4246672|P2|COMPLETED|Overall Study||200
1734800|NCT00174915|4246673|P1|COMPLETED|Overall Study||174
1734801|NCT00174915|4246669|P5|STARTED|Overall Study||134
1734802|NCT00174915|4246670|P4|STARTED|Overall Study||268
1734803|NCT00174915|4246671|P3|STARTED|Overall Study||134
1734804|NCT00174915|4246672|P2|STARTED|Overall Study||269
1734805|NCT00174915|4246673|P1|STARTED|Overall Study||267
1734806|NCT00174785|4246732|P2|NOT COMPLETED|Overall Study||716
1734807|NCT00174785|4246733|P1|NOT COMPLETED|Overall Study||696
1734808|NCT00174785|4246732|P2|COMPLETED|Overall Study|completed study drug|1611
1734809|NCT00174785|4246733|P1|COMPLETED|Overall Study|completed study drug|1605
1734810|NCT00174785|4246732|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
1734811|NCT00174785|4246733|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
1734812|NCT00174460|4246749|P2|NOT COMPLETED|Overall Study||1
1734813|NCT00174460|4246750|P1|NOT COMPLETED|Overall Study||0
1734814|NCT00174460|4246749|P2|COMPLETED|Overall Study||14
1734815|NCT00174460|4246750|P1|COMPLETED|Overall Study||18
1734816|NCT00174460|4246749|P2|Received Study Treatment|Overall Study||14
1734817|NCT00174460|4246750|P1|Received Study Treatment|Overall Study||18
1734818|NCT00174460|4246749|P2|STARTED|Overall Study||15
1734819|NCT00174460|4246750|P1|STARTED|Overall Study||18
1734820|NCT00174447|4246796|P1|NOT COMPLETED|Overall Study||38
1734821|NCT00174447|4246796|P1|COMPLETED|Overall Study||5
1734822|NCT00174447|4246796|P1|STARTED|Overall Study||43
1734823|NCT00174382|4246805|P1|NOT COMPLETED|Overall Study||33
1734824|NCT00174382|4246805|P1|COMPLETED|Overall Study||116
1734825|NCT00174382|4246805|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
1734826|NCT00174291|4246824|P2|NOT COMPLETED|Overall Study||6
1734827|NCT00174291|4246825|P1|NOT COMPLETED|Overall Study||5
1734828|NCT00174291|4246824|P2|COMPLETED|Overall Study||4
1734829|NCT00174291|4246825|P1|COMPLETED|Overall Study||6
1734830|NCT00174291|4246824|P2|STARTED|Overall Study||10
1734831|NCT00174291|4246825|P1|STARTED|Overall Study||11
1734832|NCT00174265|4246855|P2|NOT COMPLETED|Overall Study||21
1734833|NCT00174265|4246856|P1|NOT COMPLETED|Overall Study||29
1734834|NCT00174265|4246855|P2|COMPLETED|Overall Study||89
1734835|NCT00174265|4246856|P1|COMPLETED|Overall Study||57
1734836|NCT00174265|4246855|P2|STARTED|Overall Study||110
1734837|NCT00174265|4246856|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
1734838|NCT00174252|4246864|P1|NOT COMPLETED|Overall Study||2
1734839|NCT00174252|4246864|P1|COMPLETED|Overall Study||55
1734840|NCT00174252|4246864|P1|STARTED|Overall Study||57
1734841|NCT00174187|4246899|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
1734842|NCT00174187|4246900|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
1734843|NCT00174187|4246901|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
1734844|NCT00174187|4246899|P3|COMPLETED|Period 2 (After 3 Years)||13
1734845|NCT00174187|4246900|P2|COMPLETED|Period 2 (After 3 Years)||0
1734846|NCT00174187|4246901|P1|COMPLETED|Period 2 (After 3 Years)||0
1734847|NCT00174187|4246899|P3|STARTED|Period 2 (After 3 Years)||21
1734848|NCT00174187|4246900|P2|STARTED|Period 2 (After 3 Years)||0
1734849|NCT00174187|4246901|P1|STARTED|Period 2 (After 3 Years)||0
1734850|NCT00174187|4246899|P3|NOT COMPLETED|Between Period 1 and Period 2||5
1734851|NCT00174187|4246900|P2|NOT COMPLETED|Between Period 1 and Period 2||0
1734852|NCT00174187|4246901|P1|NOT COMPLETED|Between Period 1 and Period 2||0
1734853|NCT00174187|4246899|P3|COMPLETED|Between Period 1 and Period 2||21
1734854|NCT00174187|4246900|P2|COMPLETED|Between Period 1 and Period 2||0
1734855|NCT00174187|4246901|P1|COMPLETED|Between Period 1 and Period 2||0
1734856|NCT00174187|4246899|P3|Consented|Between Period 1 and Period 2||24
1734857|NCT00174187|4246900|P2|Consented|Between Period 1 and Period 2||0
1734858|NCT00174187|4246901|P1|Consented|Between Period 1 and Period 2||0
1734859|NCT00174187|4246899|P3|STARTED|Between Period 1 and Period 2||26
1734860|NCT00174187|4246900|P2|STARTED|Between Period 1 and Period 2||0
1734861|NCT00174187|4246901|P1|STARTED|Between Period 1 and Period 2||0
1734862|NCT00174187|4246899|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
1734863|NCT00174187|4246900|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
1734864|NCT00174187|4246901|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
1734865|NCT00174187|4246899|P3|COMPLETED|Period 1 (up to 3 Years)||0
1734866|NCT00174187|4246900|P2|COMPLETED|Period 1 (up to 3 Years)||11
1734867|NCT00174187|4246901|P1|COMPLETED|Period 1 (up to 3 Years)||15
1734868|NCT00174187|4246899|P3|STARTED|Period 1 (up to 3 Years)||0
1734869|NCT00174187|4246900|P2|STARTED|Period 1 (up to 3 Years)||15
1734870|NCT00174187|4246901|P1|STARTED|Period 1 (up to 3 Years)||15
1734871|NCT00172185|4246966|P4|NOT COMPLETED|Overall Study||4
1734872|NCT00172185|4246967|P3|NOT COMPLETED|Overall Study||5
1734873|NCT00172185|4246968|P2|NOT COMPLETED|Overall Study||2
1734874|NCT00172185|4246969|P1|NOT COMPLETED|Overall Study||0
1734875|NCT00172185|4246966|P4|COMPLETED|Overall Study||23
1734876|NCT00172185|4246967|P3|COMPLETED|Overall Study||20
1734877|NCT00172185|4246968|P2|COMPLETED|Overall Study||5
1734878|NCT00172185|4246969|P1|COMPLETED|Overall Study||6
1734879|NCT00172185|4246966|P4|STARTED|Overall Study||27
1734880|NCT00172185|4246967|P3|STARTED|Overall Study||25
1734881|NCT00172185|4246968|P2|STARTED|Overall Study||7
1734882|NCT00172185|4246969|P1|STARTED|Overall Study||6
1734883|NCT00172042|4246985|P2|NOT COMPLETED|Overall Study||125
1734884|NCT00172042|4246986|P1|NOT COMPLETED|Overall Study||158
1734885|NCT00172042|4246985|P2|COMPLETED|Overall Study||86
1734886|NCT00172042|4246986|P1|COMPLETED|Overall Study||68
1734887|NCT00172042|4246985|P2|STARTED|Overall Study||211
1734888|NCT00172042|4246986|P1|STARTED|Overall Study||226
1734889|NCT00171925|4247008|P2|NOT COMPLETED|Overall Study||31
1734890|NCT00171925|4247009|P1|NOT COMPLETED|Overall Study||30
1734891|NCT00171925|4247008|P2|COMPLETED|Overall Study||40
1734892|NCT00171925|4247009|P1|COMPLETED|Overall Study||42
1734893|NCT00171925|4247008|P2|STARTED|Overall Study||71
1734894|NCT00171925|4247009|P1|STARTED|Overall Study||72
1734895|NCT00171873|4247021|P2|NOT COMPLETED|Overall Study||3
1734896|NCT00171873|4247022|P1|NOT COMPLETED|Overall Study||9
1734897|NCT00171873|4247021|P2|COMPLETED|Overall Study||40
1734898|NCT00171873|4247022|P1|COMPLETED|Overall Study||33
1734899|NCT00171873|4247021|P2|STARTED|Overall Study||43
1734900|NCT00171873|4247022|P1|STARTED|Overall Study||42
1734901|NCT00171834|4247035|P7|NOT COMPLETED|Overall Study||4
1734902|NCT00171834|4247036|P6|NOT COMPLETED|Overall Study||35
1734903|NCT00171834|4247037|P5|NOT COMPLETED|Overall Study||8
1734904|NCT00171834|4247038|P4|NOT COMPLETED|Overall Study||12
1734905|NCT00171834|4247039|P3|NOT COMPLETED|Overall Study||12
1734906|NCT00171834|4247040|P2|NOT COMPLETED|Overall Study||12
1734907|NCT00171834|4247041|P1|NOT COMPLETED|Overall Study||6
1734908|NCT00171834|4247035|P7|COMPLETED|Overall Study||0
1734909|NCT00171834|4247036|P6|COMPLETED|Overall Study||0
1734910|NCT00171834|4247037|P5|COMPLETED|Overall Study||0
1734911|NCT00171834|4247038|P4|COMPLETED|Overall Study||0
1734912|NCT00171834|4247039|P3|COMPLETED|Overall Study||0
1734913|NCT00171834|4247040|P2|COMPLETED|Overall Study||0
1734914|NCT00171834|4247041|P1|COMPLETED|Overall Study||0
1734915|NCT00171834|4247035|P7|Completed 6 Cycles of Treatment|Overall Study||0
1734916|NCT00171834|4247036|P6|Completed 6 Cycles of Treatment|Overall Study||1
1734917|NCT00171834|4247037|P5|Completed 6 Cycles of Treatment|Overall Study||2
1734918|NCT00171834|4247038|P4|Completed 6 Cycles of Treatment|Overall Study||0
1734919|NCT00171834|4247039|P3|Completed 6 Cycles of Treatment|Overall Study||1
1734920|NCT00171834|4247040|P2|Completed 6 Cycles of Treatment|Overall Study||0
1734921|NCT00171834|4247041|P1|Completed 6 Cycles of Treatment|Overall Study||0
1734922|NCT00171834|4247035|P7|STARTED|Overall Study||4
1734923|NCT00171834|4247036|P6|STARTED|Overall Study||35
1734924|NCT00171834|4247037|P5|STARTED|Overall Study||8
1734925|NCT00171834|4247038|P4|STARTED|Overall Study||12
1734926|NCT00171834|4247039|P3|STARTED|Overall Study||12
1734927|NCT00171834|4247040|P2|STARTED|Overall Study||12
1734928|NCT00171834|4247041|P1|STARTED|Overall Study||6
1734929|NCT00171704|4247081|P2|NOT COMPLETED|Overall Study||49
1734930|NCT00171704|4247082|P1|NOT COMPLETED|Overall Study||44
1734931|NCT00171704|4247081|P2|COMPLETED|Overall Study||81
1734932|NCT00171704|4247082|P1|COMPLETED|Overall Study||89
1734933|NCT00171704|4247081|P2|STARTED|Overall Study||130
1734934|NCT00171704|4247082|P1|STARTED|Overall Study||133
1734935|NCT00171340|4247104|P2|NOT COMPLETED|Overall Study||135
1734936|NCT00171340|4247105|P1|NOT COMPLETED|Overall Study||124
1734937|NCT00171340|4247104|P2|COMPLETED|Overall Study||398
1734938|NCT00171340|4247105|P1|COMPLETED|Overall Study||408
1734939|NCT00171340|4247104|P2|STARTED|Overall Study||533
1734940|NCT00171340|4247105|P1|STARTED|Overall Study||532
1734941|NCT00171314|4247121|P2|NOT COMPLETED|Overall Study||78
1734942|NCT00171314|4247122|P1|NOT COMPLETED|Overall Study||91
1734943|NCT00171314|4247121|P2|COMPLETED|Overall Study||186
1734944|NCT00171314|4247122|P1|COMPLETED|Overall Study||172
1734945|NCT00171314|4247121|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
1734946|NCT00171314|4247122|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
1734947|NCT00171314|4247121|P2|STARTED|Overall Study||264
1734948|NCT00171314|4247122|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
1734949|NCT00171301|4247138|P2|NOT COMPLETED|Overall Study||9
1734950|NCT00171301|4247139|P1|NOT COMPLETED|Overall Study||8
1734951|NCT00171301|4247138|P2|COMPLETED|Overall Study||62
1734952|NCT00171301|4247139|P1|COMPLETED|Overall Study||154
1734953|NCT00171301|4247138|P2|Received Deferasirox|Overall Study||69
1734954|NCT00171301|4247139|P1|Received Deferasirox|Overall Study||162
1734955|NCT00171301|4247138|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
1734956|NCT00171301|4247139|P1|STARTED|Overall Study||162
1734957|NCT00171210|4247152|P2|NOT COMPLETED|Overall Study||115
1734958|NCT00171210|4247153|P1|NOT COMPLETED|Overall Study||69
1734959|NCT00171210|4247152|P2|COMPLETED|Overall Study||181
1734960|NCT00171210|4247153|P1|COMPLETED|Overall Study||190
1734961|NCT00171210|4247152|P2|STARTED EXTENSION STUDY|Overall Study||247
1734962|NCT00171210|4247153|P1|STARTED EXTENSION STUDY|Overall Study||259
1734963|NCT00171210|4247152|P2|STARTED|Overall Study||296
1734964|NCT00171210|4247153|P1|STARTED|Overall Study||259
1734965|NCT00171054|4247183|P2|NOT COMPLETED|Overall Study||12
1734966|NCT00171054|4247184|P1|NOT COMPLETED|Overall Study||10
1734967|NCT00171054|4247183|P2|COMPLETED|Overall Study||50
1734968|NCT00171054|4247184|P1|COMPLETED|Overall Study||53
1734969|NCT00171054|4247183|P2|STARTED|Overall Study||62
1734970|NCT00171054|4247184|P1|STARTED|Overall Study||63
1734971|NCT00170950|4247216|P2|NOT COMPLETED|Overall Study||910
1734972|NCT00170950|4247217|P1|NOT COMPLETED|Overall Study||885
1734973|NCT00170950|4247216|P2|COMPLETED|Overall Study||4852
1734974|NCT00170950|4247217|P1|COMPLETED|Overall Study||4859
1734975|NCT00170950|4247216|P2|STARTED|Overall Study||5762
1734976|NCT00170950|4247217|P1|STARTED|Overall Study||5744
1734977|NCT00170846|4247230|P3|NOT COMPLETED|Overall Study||13
1734978|NCT00170846|4247231|P2|NOT COMPLETED|Overall Study||19
1734979|NCT00170846|4247232|P1|NOT COMPLETED|Overall Study||11
1734980|NCT00170846|4247230|P3|COMPLETED|Overall Study||131
1734981|NCT00170846|4247231|P2|COMPLETED|Overall Study||108
1734982|NCT00170846|4247232|P1|COMPLETED|Overall Study||112
1734983|NCT00170846|4247230|P3|STARTED|Overall Study||144
1734984|NCT00170846|4247231|P2|STARTED|Overall Study||127
1734985|NCT00170846|4247232|P1|STARTED|Overall Study||123
1734986|NCT00170625|4247246|P1|NOT COMPLETED|Overall Study||0
1734987|NCT00170625|4247246|P1|COMPLETED|Overall Study||26
1734988|NCT00170625|4247246|P1|STARTED|Overall Study||26
1734989|NCT00170157|4247251|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
1734990|NCT00170157|4247252|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
1734991|NCT00170157|4247251|P2|COMPLETED|Treatment Period 2 Crossover||41
1734992|NCT00170157|4247252|P1|COMPLETED|Treatment Period 2 Crossover||0
1734993|NCT00170157|4247251|P2|STARTED|Treatment Period 2 Crossover||41
1734994|NCT00170157|4247252|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
1734995|NCT00170157|4247251|P2|NOT COMPLETED|Washout Period of 14 Days||17
1734996|NCT00170157|4247252|P1|NOT COMPLETED|Washout Period of 14 Days||0
1734997|NCT00170157|4247251|P2|COMPLETED|Washout Period of 14 Days||41
1734998|NCT00170157|4247252|P1|COMPLETED|Washout Period of 14 Days||0
1734999|NCT00170157|4247251|P2|STARTED|Washout Period of 14 Days||58
1735000|NCT00170157|4247252|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
1735001|NCT00170157|4247251|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
1735002|NCT00170157|4247252|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
1735003|NCT00170157|4247251|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
1735004|NCT00170157|4247252|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
1735005|NCT00170157|4247251|P2|STARTED|Treatment Period 1 Initial Randomization||58
1735006|NCT00170157|4247252|P1|STARTED|Treatment Period 1 Initial Randomization||54
1735007|NCT00169442|4247264|P6|NOT COMPLETED|Overall Study||2
1735008|NCT00169442|4247265|P5|NOT COMPLETED|Overall Study||1
1735009|NCT00169442|4247266|P4|NOT COMPLETED|Overall Study||0
1735010|NCT00169442|4247267|P3|NOT COMPLETED|Overall Study||1
1735011|NCT00169442|4247268|P2|NOT COMPLETED|Overall Study||1
1735012|NCT00169442|4247269|P1|NOT COMPLETED|Overall Study||0
1735013|NCT00169442|4247264|P6|COMPLETED|Overall Study||41
1735014|NCT00169442|4247265|P5|COMPLETED|Overall Study||41
1735015|NCT00169442|4247266|P4|COMPLETED|Overall Study||250
1735016|NCT00169442|4247267|P3|COMPLETED|Overall Study||166
1735017|NCT00169442|4247268|P2|COMPLETED|Overall Study||123
1735018|NCT00169442|4247269|P1|COMPLETED|Overall Study||119
1735019|NCT00169442|4247264|P6|STARTED|Overall Study||43
1735020|NCT00169442|4247265|P5|STARTED|Overall Study||42
1735021|NCT00169442|4247266|P4|STARTED|Overall Study||250
1735022|NCT00169442|4247267|P3|STARTED|Overall Study||167
1735023|NCT00169442|4247268|P2|STARTED|Overall Study||124
1735024|NCT00169442|4247269|P1|STARTED|Overall Study||119
1735025|NCT00169104|4247378|P2|NOT COMPLETED|Overall Study||2
1735026|NCT00169104|4247379|P1|NOT COMPLETED|Overall Study||2
1735027|NCT00169104|4247378|P2|COMPLETED|Overall Study||8
1735028|NCT00169104|4247379|P1|COMPLETED|Overall Study||11
1735029|NCT00169104|4247378|P2|STARTED|Overall Study||10
1735030|NCT00169104|4247379|P1|STARTED|Overall Study||13
1735031|NCT00168844|4247393|P3|NOT COMPLETED|Overall Study||91
1735032|NCT00168844|4247394|P2|NOT COMPLETED|Overall Study||55
1735033|NCT00168844|4247395|P1|NOT COMPLETED|Overall Study||55
1735034|NCT00168844|4247393|P3|COMPLETED|Overall Study||228
1735035|NCT00168844|4247394|P2|COMPLETED|Overall Study||277
1735036|NCT00168844|4247395|P1|COMPLETED|Overall Study||277
1735037|NCT00168844|4247393|P3|STARTED|Overall Study||319
1735038|NCT00168844|4247394|P2|STARTED|Overall Study||332
1735039|NCT00168844|4247395|P1|STARTED|Overall Study||332
1735040|NCT00168831|4247577|P3|NOT COMPLETED|Overall Study||114
1735041|NCT00168831|4247578|P2|NOT COMPLETED|Overall Study||81
1735042|NCT00168831|4247579|P1|NOT COMPLETED|Overall Study||60
1735043|NCT00168831|4247577|P3|COMPLETED|Overall Study||220
1735044|NCT00168831|4247578|P2|COMPLETED|Overall Study||254
1735045|NCT00168831|4247579|P1|COMPLETED|Overall Study||278
1735046|NCT00168831|4247577|P3|STARTED|Overall Study||334
1735047|NCT00168831|4247578|P2|STARTED|Overall Study||335
1735048|NCT00168831|4247579|P1|STARTED|Overall Study||338
1735049|NCT00168818|4247761|P3|NOT COMPLETED|Treatment||133
1735050|NCT00168818|4247762|P2|NOT COMPLETED|Treatment||151
1735051|NCT00168818|4247763|P1|NOT COMPLETED|Treatment||133
1735052|NCT00168818|4247761|P3|COMPLETED|Treatment||1021
1735053|NCT00168818|4247762|P2|COMPLETED|Treatment||1012
1735054|NCT00168818|4247763|P1|COMPLETED|Treatment||1013
1735055|NCT00168818|4247761|P3|STARTED|Treatment||1154
1735056|NCT00168818|4247762|P2|STARTED|Treatment||1163
1735057|NCT00168818|4247763|P1|STARTED|Treatment||1146
1735058|NCT00168818|4247761|P3|NOT COMPLETED|Overall Study||124
1735059|NCT00168818|4247762|P2|NOT COMPLETED|Overall Study||109
1735060|NCT00168818|4247763|P1|NOT COMPLETED|Overall Study||117
1735061|NCT00168818|4247761|P3|COMPLETED|Overall Study||1030
1735062|NCT00168818|4247762|P2|COMPLETED|Overall Study||1054
1735063|NCT00168818|4247763|P1|COMPLETED|Overall Study||1029
1735064|NCT00168818|4247761|P3|STARTED|Overall Study||1154
1735065|NCT00168818|4247762|P2|STARTED|Overall Study||1163
1735066|NCT00168818|4247763|P1|STARTED|Overall Study||1146
1735067|NCT00168805|4247807|P3|NOT COMPLETED|Treatment||62
1735068|NCT00168805|4247808|P2|NOT COMPLETED|Treatment||56
1735069|NCT00168805|4247809|P1|NOT COMPLETED|Treatment||49
1735070|NCT00168805|4247807|P3|COMPLETED|Treatment||632
1735071|NCT00168805|4247808|P2|COMPLETED|Treatment||647
1735072|NCT00168805|4247809|P1|COMPLETED|Treatment||630
1735073|NCT00168805|4247807|P3|STARTED|Treatment||694
1735074|NCT00168805|4247808|P2|STARTED|Treatment||703
1735075|NCT00168805|4247809|P1|STARTED|Treatment||679
1735076|NCT00168805|4247807|P3|NOT COMPLETED|Overall Study||78
1735077|NCT00168805|4247808|P2|NOT COMPLETED|Overall Study||78
1735078|NCT00168805|4247809|P1|NOT COMPLETED|Overall Study||71
1735079|NCT00168805|4247807|P3|COMPLETED|Overall Study||616
1735080|NCT00168805|4247808|P2|COMPLETED|Overall Study||625
1735081|NCT00168805|4247809|P1|COMPLETED|Overall Study||608
1735082|NCT00168805|4247807|P3|STARTED|Overall Study||694
1735083|NCT00168805|4247808|P2|STARTED|Overall Study||703
1735084|NCT00168805|4247809|P1|STARTED|Overall Study||679
1735085|NCT00168454|4247856|P6|NOT COMPLETED|Overall Study||6
1735086|NCT00168454|4247857|P5|NOT COMPLETED|Overall Study||6
1735087|NCT00168454|4247858|P4|NOT COMPLETED|Overall Study||9
1735088|NCT00168454|4247859|P3|NOT COMPLETED|Overall Study||6
1735089|NCT00168454|4247860|P2|NOT COMPLETED|Overall Study||7
1735090|NCT00168454|4247861|P1|NOT COMPLETED|Overall Study||7
1735091|NCT00168454|4247856|P6|COMPLETED|Overall Study||50
1735092|NCT00168454|4247857|P5|COMPLETED|Overall Study||47
1735093|NCT00168454|4247858|P4|COMPLETED|Overall Study||40
1735094|NCT00168454|4247859|P3|COMPLETED|Overall Study||48
1735095|NCT00168454|4247860|P2|COMPLETED|Overall Study||50
1735096|NCT00168454|4247861|P1|COMPLETED|Overall Study||37
1735097|NCT00168454|4247856|P6|STARTED|Overall Study||56
1735098|NCT00168454|4247857|P5|STARTED|Overall Study||53
1735099|NCT00168454|4247858|P4|STARTED|Overall Study||49
1735100|NCT00168454|4247859|P3|STARTED|Overall Study||54
1735101|NCT00168454|4247860|P2|STARTED|Overall Study||57
1735102|NCT00168454|4247861|P1|STARTED|Overall Study||44
1735103|NCT00168428|4247907|P2|NOT COMPLETED|Open-Label Phase (OL)||68
1735104|NCT00168428|4247908|P1|NOT COMPLETED|Open-Label Phase (OL)||44
1735105|NCT00168428|4247907|P2|COMPLETED|Open-Label Phase (OL)||261
1735106|NCT00168428|4247908|P1|COMPLETED|Open-Label Phase (OL)||261
1735107|NCT00168428|4247907|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
1735108|NCT00168428|4247908|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
1735109|NCT00168428|4247907|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
1735110|NCT00168428|4247908|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
1735111|NCT00168428|4247907|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
1735112|NCT00168428|4247908|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
1735113|NCT00168428|4247907|P2|STARTED|Double-Blind Phase (DB)||358
1735114|NCT00168428|4247908|P1|STARTED|Double-Blind Phase (DB)||347
1735115|NCT00168389|4247927|P3|NOT COMPLETED|Overall Study||95
1735116|NCT00168389|4247928|P2|NOT COMPLETED|Overall Study||48
1735117|NCT00168389|4247929|P1|NOT COMPLETED|Overall Study||56
1735118|NCT00168389|4247927|P3|COMPLETED|Overall Study||70
1735119|NCT00168389|4247928|P2|COMPLETED|Overall Study||118
1735120|NCT00168389|4247929|P1|COMPLETED|Overall Study||107
1735121|NCT00168389|4247927|P3|STARTED|Overall Study||165
1735122|NCT00168389|4247928|P2|STARTED|Overall Study||166
1735123|NCT00168389|4247929|P1|STARTED|Overall Study||163
1735124|NCT00168337|4247958|P3|NOT COMPLETED|Overall Study||103
1735125|NCT00168337|4247959|P2|NOT COMPLETED|Overall Study||69
1735126|NCT00168337|4247960|P1|NOT COMPLETED|Overall Study||70
1735127|NCT00168337|4247958|P3|COMPLETED|Overall Study||82
1735128|NCT00168337|4247959|P2|COMPLETED|Overall Study||112
1735129|NCT00168337|4247960|P1|COMPLETED|Overall Study||118
1735130|NCT00168337|4247958|P3|STARTED|Overall Study||185
1735131|NCT00168337|4247959|P2|STARTED|Overall Study||181
1735132|NCT00168337|4247960|P1|STARTED|Overall Study||188
1735133|NCT00168324|4247989|P3|NOT COMPLETED|Open-Label Period||6
1735134|NCT00168324|4247990|P2|NOT COMPLETED|Open-Label Period||8
1735135|NCT00168324|4247991|P1|NOT COMPLETED|Open-Label Period||4
1735136|NCT00168324|4247989|P3|COMPLETED|Open-Label Period||152
1735137|NCT00168324|4247990|P2|COMPLETED|Open-Label Period||147
1735138|NCT00168324|4247991|P1|COMPLETED|Open-Label Period||160
1735139|NCT00168324|4247989|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
1735140|NCT00168324|4247990|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
1735141|NCT00168324|4247991|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
1735142|NCT00168324|4247989|P3|NOT COMPLETED|Double-Blind Period||13
1735143|NCT00168324|4247990|P2|NOT COMPLETED|Double-Blind Period||7
1735144|NCT00168324|4247991|P1|NOT COMPLETED|Double-Blind Period||12
1735145|NCT00168324|4247989|P3|COMPLETED|Double-Blind Period||189
1735146|NCT00168324|4247990|P2|COMPLETED|Double-Blind Period||189
1735147|NCT00168324|4247991|P1|COMPLETED|Double-Blind Period||189
1735148|NCT00168324|4247989|P3|STARTED|Double-Blind Period||202
1735149|NCT00168324|4247990|P2|STARTED|Double-Blind Period||196
1735150|NCT00168324|4247991|P1|STARTED|Double-Blind Period||201
1735151|NCT00168311|4248013|P2|NOT COMPLETED|Overall Study||2
1735152|NCT00168311|4248014|P1|NOT COMPLETED|Overall Study||0
1735153|NCT00168311|4248013|P2|COMPLETED|Overall Study||8
1735154|NCT00168311|4248014|P1|COMPLETED|Overall Study||12
1735155|NCT00168311|4248013|P2|STARTED|Overall Study||10
1735156|NCT00168311|4248014|P1|STARTED|Overall Study||12
1735157|NCT00168298|4248023|P3|NOT COMPLETED|Open-Label Period||8
1735158|NCT00168298|4248024|P2|NOT COMPLETED|Open-Label Period||5
1735159|NCT00168298|4248025|P1|NOT COMPLETED|Open-Label Period||7
1735160|NCT00168298|4248023|P3|COMPLETED|Open-Label Period||160
1735161|NCT00168298|4248024|P2|COMPLETED|Open-Label Period||168
1735162|NCT00168298|4248025|P1|COMPLETED|Open-Label Period||172
1735163|NCT00168298|4248023|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
1735164|NCT00168298|4248024|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
1735165|NCT00168298|4248025|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
1735166|NCT00168298|4248023|P3|NOT COMPLETED|Double-Blind Period||15
1735167|NCT00168298|4248024|P2|NOT COMPLETED|Double-Blind Period||12
1735168|NCT00168298|4248025|P1|NOT COMPLETED|Double-Blind Period||12
1735169|NCT00168298|4248023|P3|COMPLETED|Double-Blind Period||209
1735170|NCT00168298|4248024|P2|COMPLETED|Double-Blind Period||206
1735171|NCT00168298|4248025|P1|COMPLETED|Double-Blind Period||214
1735172|NCT00168298|4248023|P3|STARTED|Double-Blind Period||224
1735173|NCT00168298|4248024|P2|STARTED|Double-Blind Period||218
1735174|NCT00168298|4248025|P1|STARTED|Double-Blind Period||226
1735175|NCT00168103|4248045|P4|NOT COMPLETED|Overall Study||0
1735176|NCT00168103|4248046|P3|NOT COMPLETED|Overall Study||1
1735177|NCT00168103|4248047|P2|NOT COMPLETED|Overall Study||5
1735178|NCT00168103|4248048|P1|NOT COMPLETED|Overall Study||2
1735179|NCT00168103|4248045|P4|COMPLETED|Overall Study||1
1735180|NCT00168103|4248046|P3|COMPLETED|Overall Study||41
1735181|NCT00168103|4248047|P2|COMPLETED|Overall Study||38
1735182|NCT00168103|4248048|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
1735183|NCT00168103|4248045|P4|STARTED|Overall Study||1
1735184|NCT00168103|4248046|P3|STARTED|Overall Study||42
1735185|NCT00168103|4248047|P2|STARTED|Overall Study||43
1735186|NCT00168103|4248048|P1|STARTED|Overall Study||40
1735187|NCT00168064|4248070|P2|NOT COMPLETED|Overall Study||44
1735188|NCT00168064|4248071|P1|NOT COMPLETED|Overall Study||49
1735189|NCT00168064|4248070|P2|COMPLETED|Overall Study||86
1735190|NCT00168064|4248071|P1|COMPLETED|Overall Study||81
1735191|NCT00168064|4248070|P2|STARTED|Overall Study|127 participants received AP formulation|130
1735192|NCT00168064|4248071|P1|STARTED|Overall Study|128 participants received PG formulation|130
1735193|NCT00168038|4248079|P1|NOT COMPLETED|Overall Study||2
1735194|NCT00168038|4248079|P1|COMPLETED|Overall Study||55
1735195|NCT00168038|4248079|P1|STARTED|Overall Study||57
1735196|NCT00167778|4248091|P1|NOT COMPLETED|Overall Study||1
1735197|NCT00167778|4248091|P1|COMPLETED|Overall Study||10
1735198|NCT00167778|4248091|P1|STARTED|Overall Study||11
1735199|NCT00167544|4248142|P2|NOT COMPLETED|Overall Study||0
1735200|NCT00167544|4248143|P1|NOT COMPLETED|Overall Study||1
1735201|NCT00167544|4248142|P2|COMPLETED|Overall Study||33
1735202|NCT00167544|4248143|P1|COMPLETED|Overall Study||30
1735203|NCT00167544|4248142|P2|STARTED|Overall Study||33
1735204|NCT00167544|4248143|P1|STARTED|Overall Study||31
1735205|NCT00167414|4248157|P1|NOT COMPLETED|Overall Study||10
1735206|NCT00167414|4248157|P1|COMPLETED|Overall Study||39
1735207|NCT00167414|4248157|P1|STARTED|Overall Study||49
1735208|NCT00167388|4248169|P4|NOT COMPLETED|Overall Study||0
1735209|NCT00167388|4248170|P3|NOT COMPLETED|Overall Study||0
1735210|NCT00167388|4248171|P2|NOT COMPLETED|Overall Study||0
1735211|NCT00167388|4248172|P1|NOT COMPLETED|Overall Study||0
1735212|NCT00167388|4248169|P4|COMPLETED|Overall Study||6
1735213|NCT00167388|4248170|P3|COMPLETED|Overall Study||6
1735214|NCT00167388|4248171|P2|COMPLETED|Overall Study||5
1735215|NCT00167388|4248172|P1|COMPLETED|Overall Study||5
1735216|NCT00167388|4248169|P4|Completed Doppler Study|Overall Study||6
1735217|NCT00167388|4248170|P3|Completed Doppler Study|Overall Study||6
1735218|NCT00167388|4248171|P2|Completed Doppler Study|Overall Study||5
1735219|NCT00167388|4248172|P1|Completed Doppler Study|Overall Study||5
1735220|NCT00167388|4248169|P4|STARTED|Overall Study||6
1735221|NCT00167388|4248170|P3|STARTED|Overall Study||6
1735222|NCT00167388|4248171|P2|STARTED|Overall Study||5
1735223|NCT00167388|4248172|P1|STARTED|Overall Study||5
1735224|NCT00167310|4248182|P2|NOT COMPLETED|Overall Study||10
1735225|NCT00167310|4248183|P1|NOT COMPLETED|Overall Study||8
1735226|NCT00167310|4248182|P2|COMPLETED|Overall Study||18
1735227|NCT00167310|4248183|P1|COMPLETED|Overall Study||21
1735228|NCT00167310|4248182|P2|STARTED|Overall Study||28
1735229|NCT00167310|4248183|P1|STARTED|Overall Study||29
1735230|NCT00167245|4248193|P2|NOT COMPLETED|Overall Study||41
1735231|NCT00167245|4248194|P1|NOT COMPLETED|Overall Study||29
1735232|NCT00167245|4248193|P2|COMPLETED|Overall Study||46
1735233|NCT00167245|4248194|P1|COMPLETED|Overall Study||54
1735234|NCT00167245|4248193|P2|STARTED|Overall Study||87
1735235|NCT00167245|4248194|P1|STARTED|Overall Study||83
1735236|NCT00167206|4248202|P1|NOT COMPLETED|Overall Study||0
1735237|NCT00167206|4248202|P1|COMPLETED|Overall Study||16
1735238|NCT00167206|4248202|P1|STARTED|Overall Study||16
1735239|NCT00167180|4248216|P2|NOT COMPLETED|Overall Study||0
1735240|NCT00167180|4248217|P1|NOT COMPLETED|Overall Study||0
1735241|NCT00167180|4248216|P2|COMPLETED|Overall Study||57
1735242|NCT00167180|4248217|P1|COMPLETED|Overall Study||0
1735243|NCT00167180|4248216|P2|STARTED|Overall Study||57
1735244|NCT00167180|4248217|P1|STARTED|Overall Study||0
1735245|NCT00167102|4248233|P2|NOT COMPLETED|Overall Study||0
1735246|NCT00167102|4248234|P1|NOT COMPLETED|Overall Study||0
1735247|NCT00167102|4248233|P2|COMPLETED|Overall Study||22
1735248|NCT00167102|4248234|P1|COMPLETED|Overall Study||23
1735249|NCT00167102|4248233|P2|STARTED|Overall Study||22
1735250|NCT00167102|4248234|P1|STARTED|Overall Study||23
1735251|NCT00166712|4248244|P2|NOT COMPLETED|Overall Study||5
1735252|NCT00166712|4248245|P1|NOT COMPLETED|Overall Study||2
1735253|NCT00166712|4248244|P2|COMPLETED|Overall Study|Completed study participation.|11
1735254|NCT00166712|4248245|P1|COMPLETED|Overall Study|Completed study participation.|22
1735255|NCT00166712|4248244|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
1735256|NCT00166712|4248245|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
1735257|NCT00166712|4248244|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
1735258|NCT00166712|4248245|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
1735259|NCT00166712|4248244|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
1735260|NCT00166712|4248245|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
1735261|NCT00166712|4248244|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
1735262|NCT00166712|4248245|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
1735263|NCT00166712|4248244|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
1735264|NCT00166712|4248245|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
1735265|NCT00166517|4248262|P2|NOT COMPLETED|Overall Study||2
1735266|NCT00166517|4248263|P1|NOT COMPLETED|Overall Study||5
1735267|NCT00166517|4248262|P2|COMPLETED|Overall Study||61
1735268|NCT00166517|4248263|P1|COMPLETED|Overall Study||110
1735269|NCT00166517|4248262|P2|Vaccinated at Visit 3|Overall Study||61
1735270|NCT00166517|4248263|P1|Vaccinated at Visit 3|Overall Study||110
1735271|NCT00166517|4248262|P2|Vaccinated at Visit 2|Overall Study||61
1735272|NCT00166517|4248263|P1|Vaccinated at Visit 2|Overall Study||112
1735273|NCT00166517|4248262|P2|Vaccinated at Visit 1|Overall Study||63
1735274|NCT00166517|4248263|P1|Vaccinated at Visit 1|Overall Study||115
1735275|NCT00166517|4248262|P2|STARTED|Overall Study||63
1735276|NCT00166517|4248263|P1|STARTED|Overall Study||115
1735277|NCT00166504|4248273|P2|NOT COMPLETED|Overall Study||4
1735278|NCT00166504|4248274|P1|NOT COMPLETED|Overall Study||5
1735279|NCT00166504|4248273|P2|COMPLETED|Overall Study||91
1735280|NCT00166504|4248274|P1|COMPLETED|Overall Study||103
1735281|NCT00166504|4248273|P2|STARTED|Overall Study||95
1735282|NCT00166504|4248274|P1|STARTED|Overall Study||108
1735283|NCT00166361|4248282|P2|NOT COMPLETED|Overall Study||0
1735284|NCT00166361|4248283|P1|NOT COMPLETED|Overall Study||0
1735285|NCT00166361|4248282|P2|COMPLETED|Overall Study||10
1735286|NCT00166361|4248283|P1|COMPLETED|Overall Study||14
1735287|NCT00166361|4248282|P2|STARTED|Overall Study||10
1735288|NCT00166361|4248283|P1|STARTED|Overall Study||14
1735289|NCT00166296|4248291|P2|NOT COMPLETED|Overall Study||9
1735290|NCT00166296|4248292|P1|NOT COMPLETED|Overall Study||7
1735291|NCT00166296|4248291|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
1735292|NCT00166296|4248292|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
1735293|NCT00166296|4248291|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
1735294|NCT00166296|4248292|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
1735295|NCT00166296|4248291|P2|STARTED|Overall Study|Randomized patients|66
1735296|NCT00166296|4248292|P1|STARTED|Overall Study|Randomized patients|67
1735297|NCT00166205|4248304|P1|NOT COMPLETED|Overall Study||48
1735298|NCT00166205|4248304|P1|COMPLETED|Overall Study||228
1735299|NCT00166205|4248304|P1|Intervention - SAGB Surgery|Overall Study||276
1735300|NCT00166205|4248304|P1|STARTED|Overall Study||276
1735301|NCT00166166|4248320|P2|NOT COMPLETED|Overall Study||0
1735302|NCT00166166|4248321|P1|NOT COMPLETED|Overall Study||0
1735303|NCT00166166|4248320|P2|COMPLETED|Overall Study||71
1735304|NCT00166166|4248321|P1|COMPLETED|Overall Study||103
1735305|NCT00166166|4248320|P2|STARTED|Overall Study||71
1735306|NCT00166166|4248321|P1|STARTED|Overall Study||103
1735307|NCT00166114|4248344|P2|NOT COMPLETED|Overall Study||6
1735308|NCT00166114|4248345|P1|NOT COMPLETED|Overall Study||14
1735309|NCT00166114|4248344|P2|COMPLETED|Overall Study||13
1735310|NCT00166114|4248345|P1|COMPLETED|Overall Study||7
1735311|NCT00166114|4248344|P2|STARTED|Overall Study||19
1735312|NCT00166114|4248345|P1|STARTED|Overall Study||21
1735313|NCT00166036|4248353|P2|NOT COMPLETED|Overall Study||0
1735314|NCT00166036|4248354|P1|NOT COMPLETED|Overall Study||0
1735315|NCT00166036|4248353|P2|COMPLETED|Overall Study||19
1735316|NCT00166036|4248354|P1|COMPLETED|Overall Study||17
1735317|NCT00166036|4248353|P2|STARTED|Overall Study||19
1735318|NCT00166036|4248354|P1|STARTED|Overall Study||17
1735319|NCT00165984|4248362|P1|NOT COMPLETED|Overall Study||15
1735320|NCT00165984|4248362|P1|COMPLETED|Overall Study||150
1735321|NCT00165984|4248362|P1|STARTED|Overall Study||165
1735322|NCT00165958|4248371|P2|NOT COMPLETED|Overall Study||2
1735323|NCT00165958|4248372|P1|NOT COMPLETED|Overall Study||1
1735324|NCT00165958|4248371|P2|COMPLETED|Overall Study||19
1735325|NCT00165958|4248372|P1|COMPLETED|Overall Study||18
1735326|NCT00165958|4248371|P2|STARTED|Overall Study||21
1735327|NCT00165958|4248372|P1|STARTED|Overall Study||19
1735328|NCT00165841|4248380|P2|NOT COMPLETED|Overall Study||62
1735329|NCT00165841|4248381|P1|NOT COMPLETED|Overall Study||30
1735330|NCT00165841|4248380|P2|COMPLETED|Overall Study||35
1735331|NCT00165841|4248381|P1|COMPLETED|Overall Study||73
1735332|NCT00165841|4248380|P2|STARTED|Overall Study||97
1735333|NCT00165841|4248381|P1|STARTED|Overall Study||103
1735334|NCT00165789|4248391|P4|NOT COMPLETED|Overall Study||14
1735335|NCT00165789|4248392|P3|NOT COMPLETED|Overall Study||1
1735336|NCT00165789|4248393|P2|NOT COMPLETED|Overall Study||4
1735337|NCT00165789|4248394|P1|NOT COMPLETED|Overall Study||0
1735338|NCT00165789|4248391|P4|COMPLETED|Overall Study||21
1735339|NCT00165789|4248392|P3|COMPLETED|Overall Study||11
1735340|NCT00165789|4248393|P2|COMPLETED|Overall Study||16
1735341|NCT00165789|4248394|P1|COMPLETED|Overall Study||8
1735342|NCT00165789|4248391|P4|STARTED|Overall Study||35
1735343|NCT00165789|4248392|P3|STARTED|Overall Study||12
1735344|NCT00165789|4248393|P2|STARTED|Overall Study||20
1735345|NCT00165789|4248394|P1|STARTED|Overall Study||8
1735346|NCT00165776|4248448|P4|NOT COMPLETED|Overall Study||2
1735347|NCT00165776|4248449|P3|NOT COMPLETED|Overall Study||2
1735348|NCT00165776|4248450|P2|NOT COMPLETED|Overall Study||1
1735349|NCT00165776|4248451|P1|NOT COMPLETED|Overall Study||4
1735350|NCT00165776|4248448|P4|COMPLETED|Overall Study||29
1735351|NCT00165776|4248449|P3|COMPLETED|Overall Study||31
1735352|NCT00165776|4248450|P2|COMPLETED|Overall Study||33
1735353|NCT00165776|4248451|P1|COMPLETED|Overall Study||31
1735354|NCT00165776|4248448|P4|STARTED|Overall Study||31
1735355|NCT00165776|4248449|P3|STARTED|Overall Study||33
1735356|NCT00165776|4248450|P2|STARTED|Overall Study||34
1735357|NCT00165776|4248451|P1|STARTED|Overall Study||35
1735358|NCT00165698|4248487|P2|NOT COMPLETED|Overall Study||15
1735359|NCT00165698|4248488|P1|NOT COMPLETED|Overall Study||8
1735360|NCT00165698|4248487|P2|COMPLETED|Overall Study||105
1735361|NCT00165698|4248488|P1|COMPLETED|Overall Study||112
1735362|NCT00165698|4248487|P2|STARTED|Overall Study||120
1735363|NCT00165698|4248488|P1|STARTED|Overall Study||120
1735364|NCT00165672|4248514|P2|NOT COMPLETED|Overall Study||1
1735365|NCT00165672|4248515|P1|NOT COMPLETED|Overall Study||0
1735366|NCT00165672|4248514|P2|COMPLETED|Overall Study||12
1735367|NCT00165672|4248515|P1|COMPLETED|Overall Study||13
1735368|NCT00165672|4248514|P2|STARTED|Overall Study||13
1735369|NCT00165672|4248515|P1|STARTED|Overall Study||13
1735370|NCT00165646|4248524|P3|NOT COMPLETED|Overall Study||4
1735371|NCT00165646|4248525|P2|NOT COMPLETED|Overall Study||5
1735372|NCT00165646|4248526|P1|NOT COMPLETED|Overall Study||5
1735373|NCT00165646|4248524|P3|COMPLETED|Overall Study||98
1735374|NCT00165646|4248525|P2|COMPLETED|Overall Study||88
1735375|NCT00165646|4248526|P1|COMPLETED|Overall Study||88
1735376|NCT00165646|4248524|P3|STARTED|Overall Study||102
1735377|NCT00165646|4248525|P2|STARTED|Overall Study||93
1735378|NCT00165646|4248526|P1|STARTED|Overall Study||93
1735379|NCT00165503|4248534|P1|NOT COMPLETED|Overall Study||16
1735380|NCT00165503|4248534|P1|COMPLETED|Overall Study||0
1735381|NCT00165503|4248534|P1|STARTED|Overall Study||16
1735382|NCT00163657|4248541|P3|NOT COMPLETED|Overall Study||37
1735383|NCT00163657|4248542|P2|NOT COMPLETED|Overall Study||23
1735384|NCT00163657|4248543|P1|NOT COMPLETED|Overall Study||20
1735385|NCT00163657|4248541|P3|COMPLETED|Overall Study||116
1735386|NCT00163657|4248542|P2|COMPLETED|Overall Study||56
1735387|NCT00163657|4248543|P1|COMPLETED|Overall Study||60
1735388|NCT00163657|4248541|P3|STARTED|Overall Study||153
1735389|NCT00163657|4248542|P2|STARTED|Overall Study||79
1735390|NCT00163657|4248543|P1|STARTED|Overall Study||80
1735391|NCT00163293|4248557|P3|NOT COMPLETED|Overall Study||19
1735392|NCT00163293|4248558|P2|NOT COMPLETED|Overall Study||7
1735393|NCT00163293|4248559|P1|NOT COMPLETED|Overall Study||13
1735394|NCT00163293|4248557|P3|COMPLETED|Overall Study||66
1735395|NCT00163293|4248558|P2|COMPLETED|Overall Study||69
1735396|NCT00163293|4248559|P1|COMPLETED|Overall Study||66
1735397|NCT00163293|4248557|P3|STARTED|Overall Study||85
1735398|NCT00163293|4248558|P2|STARTED|Overall Study||76
1735399|NCT00163293|4248559|P1|STARTED|Overall Study||79
1735400|NCT00163215|4248633|P1|NOT COMPLETED|Overall Study||15
1735401|NCT00163215|4248633|P1|COMPLETED|Overall Study||31
1735402|NCT00163215|4248633|P1|STARTED|Overall Study||46
1735403|NCT00163189|4248653|P1|NOT COMPLETED|Overall Study||63
1735404|NCT00163189|4248653|P1|COMPLETED|Overall Study||35
1735405|NCT00163189|4248653|P1|STARTED|Overall Study||98
1735406|NCT00163020|4248677|P2|NOT COMPLETED|Overall Study||2
1735407|NCT00163020|4248678|P1|NOT COMPLETED|Overall Study||0
1735408|NCT00163020|4248677|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
1735409|NCT00163020|4248678|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
1735410|NCT00163020|4248677|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
1735411|NCT00163020|4248678|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
1735412|NCT00162981|4248718|P2|NOT COMPLETED|Overall Study||6
1735413|NCT00162981|4248719|P1|NOT COMPLETED|Overall Study||4
1735414|NCT00162981|4248718|P2|COMPLETED|Overall Study||30
1735415|NCT00162981|4248719|P1|COMPLETED|Overall Study||28
1735416|NCT00162981|4248718|P2|STARTED|Overall Study||36
1735417|NCT00162981|4248719|P1|STARTED|Overall Study||32
1735418|NCT00162942|4248735|P2|NOT COMPLETED|Overall Study||52
1735419|NCT00162942|4248736|P1|NOT COMPLETED|Overall Study||106
1735420|NCT00162942|4248735|P2|COMPLETED|Overall Study||26
1735421|NCT00162942|4248736|P1|COMPLETED|Overall Study||51
1735422|NCT00162942|4248735|P2|Week 12|Overall Study||61
1735423|NCT00162942|4248736|P1|Week 12|Overall Study||127
1735424|NCT00162942|4248735|P2|STARTED|Overall Study||78
1735425|NCT00162942|4248736|P1|STARTED|Overall Study||157
1735426|NCT00162773|4248784|P1|NOT COMPLETED|Overall Study||22
1735427|NCT00162773|4248784|P1|COMPLETED|Overall Study||7
1735428|NCT00162773|4248784|P1|STARTED|Overall Study||29
1735429|NCT00162370|4248788|P1|NOT COMPLETED|Efficacy Population||51
1735430|NCT00162370|4248788|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
1735431|NCT00162370|4248788|P1|STARTED|Efficacy Population||366
1735432|NCT00162370|4248788|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
1735433|NCT00162370|4248788|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
1735434|NCT00162370|4248788|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
1735435|NCT00162266|4248796|P4|NOT COMPLETED|Open-Label Period||137
1735436|NCT00162266|4248797|P3|NOT COMPLETED|Open-Label Period||0
1735437|NCT00162266|4248798|P2|NOT COMPLETED|Open-Label Period||0
1735438|NCT00162266|4248799|P1|NOT COMPLETED|Open-Label Period||0
1735439|NCT00162266|4248796|P4|COMPLETED|Open-Label Period||82
1735440|NCT00162266|4248797|P3|COMPLETED|Open-Label Period||0
1735441|NCT00162266|4248798|P2|COMPLETED|Open-Label Period||0
1735442|NCT00162266|4248799|P1|COMPLETED|Open-Label Period||0
1735443|NCT00162266|4248796|P4|STARTED|Open-Label Period||219
1735444|NCT00162266|4248797|P3|STARTED|Open-Label Period||0
1735445|NCT00162266|4248798|P2|STARTED|Open-Label Period||0
1735446|NCT00162266|4248799|P1|STARTED|Open-Label Period||0
1735447|NCT00162266|4248796|P4|NOT COMPLETED|Double-Blind Period||0
1735448|NCT00162266|4248797|P3|NOT COMPLETED|Double-Blind Period||48
1735449|NCT00162266|4248798|P2|NOT COMPLETED|Double-Blind Period||31
1735450|NCT00162266|4248799|P1|NOT COMPLETED|Double-Blind Period||25
1735451|NCT00162266|4248796|P4|COMPLETED|Double-Blind Period||0
1735452|NCT00162266|4248797|P3|COMPLETED|Double-Blind Period||71
1735453|NCT00162266|4248798|P2|COMPLETED|Double-Blind Period||74
1735454|NCT00162266|4248799|P1|COMPLETED|Double-Blind Period||90
1735455|NCT00162266|4248796|P4|Completed Day 1 to Day 181|Double-Blind Period||0
1735456|NCT00162266|4248797|P3|Completed Day 1 to Day 181|Double-Blind Period||78
1735457|NCT00162266|4248798|P2|Completed Day 1 to Day 181|Double-Blind Period||80
1735458|NCT00162266|4248799|P1|Completed Day 1 to Day 181|Double-Blind Period||98
1735459|NCT00162266|4248796|P4|STARTED|Double-Blind Period||0
1735460|NCT00162266|4248797|P3|STARTED|Double-Blind Period||119
1735461|NCT00162266|4248798|P2|STARTED|Double-Blind Period||105
1735462|NCT00162266|4248799|P1|STARTED|Double-Blind Period||115
1735463|NCT00162136|4249000|P1|NOT COMPLETED|Overall Study||35
1735464|NCT00162136|4249000|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
1735465|NCT00162136|4249000|P1|STARTED|Overall Study||35
1735466|NCT00162123|4249032|P8|NOT COMPLETED|Overall Study||58
1735467|NCT00162123|4249033|P7|NOT COMPLETED|Overall Study||4
1735468|NCT00162123|4249034|P6|NOT COMPLETED|Overall Study||9
1735469|NCT00162123|4249035|P5|NOT COMPLETED|Overall Study||31
1735470|NCT00162123|4249036|P4|NOT COMPLETED|Overall Study||8
1735471|NCT00162123|4249037|P3|NOT COMPLETED|Overall Study||21
1735472|NCT00162123|4249038|P2|NOT COMPLETED|Overall Study||29
1735473|NCT00162123|4249039|P1|NOT COMPLETED|Overall Study||44
1735474|NCT00162123|4249032|P8|COMPLETED|Overall Study|Still on treatment|0
1735475|NCT00162123|4249033|P7|COMPLETED|Overall Study|Still on treatment|0
1735476|NCT00162123|4249034|P6|COMPLETED|Overall Study|Still on treatment|4
1735477|NCT00162123|4249035|P5|COMPLETED|Overall Study|Still on treatment|14
1735478|NCT00162123|4249036|P4|COMPLETED|Overall Study|Still on treatment|3
1735479|NCT00162123|4249037|P3|COMPLETED|Overall Study|Still on treatment|3
1735480|NCT00162123|4249038|P2|COMPLETED|Overall Study|Still on treatment|5
1735481|NCT00162123|4249039|P1|COMPLETED|Overall Study|Still on treatment|9
1735482|NCT00162123|4249032|P8|Received Treatment|Overall Study||0
1735483|NCT00162123|4249033|P7|Received Treatment|Overall Study||4
1735484|NCT00162123|4249034|P6|Received Treatment|Overall Study||12
1735485|NCT00162123|4249035|P5|Received Treatment|Overall Study||33
1735486|NCT00162123|4249036|P4|Received Treatment|Overall Study||11
1735487|NCT00162123|4249037|P3|Received Treatment|Overall Study||24
1735488|NCT00162123|4249038|P2|Received Treatment|Overall Study||34
1735489|NCT00162123|4249039|P1|Received Treatment|Overall Study||53
1735490|NCT00162123|4249032|P8|STARTED|Overall Study|Enrolled|58
1735491|NCT00162123|4249033|P7|STARTED|Overall Study|Enrolled|4
1735492|NCT00162123|4249034|P6|STARTED|Overall Study|Enrolled|13
1735493|NCT00162123|4249035|P5|STARTED|Overall Study|Enrolled|45
1735494|NCT00162123|4249036|P4|STARTED|Overall Study|Enrolled|11
1735495|NCT00162123|4249037|P3|STARTED|Overall Study|Enrolled|24
1735496|NCT00162123|4249038|P2|STARTED|Overall Study|Enrolled|34
1735497|NCT00162123|4249039|P1|STARTED|Overall Study|Enrolled|53
1735498|NCT00162097|4249072|P4|NOT COMPLETED|Overall Study||1
1735499|NCT00162097|4249073|P3|NOT COMPLETED|Overall Study||0
1735500|NCT00162097|4249074|P2|NOT COMPLETED|Overall Study||0
1735501|NCT00162097|4249075|P1|NOT COMPLETED|Overall Study||0
1735502|NCT00162097|4249072|P4|COMPLETED|Overall Study||6
1735503|NCT00162097|4249073|P3|COMPLETED|Overall Study||1
1735504|NCT00162097|4249074|P2|COMPLETED|Overall Study||2
1735505|NCT00162097|4249075|P1|COMPLETED|Overall Study||6
1735506|NCT00162097|4249072|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
1735507|NCT00162097|4249073|P3|STARTED|Overall Study|Treated on Day 1|1
1735508|NCT00162097|4249074|P2|STARTED|Overall Study|Treated on Day 1|2
1735509|NCT00162097|4249075|P1|STARTED|Overall Study|Treated on Day 1|6
1735510|NCT00162032|4249137|P2|NOT COMPLETED|Overall Study||2
1735511|NCT00162032|4249138|P1|NOT COMPLETED|Overall Study||5
1735512|NCT00162032|4249137|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
1735513|NCT00162032|4249138|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
1735514|NCT00162032|4249137|P2|STARTED|Overall Study||116
1735515|NCT00162032|4249138|P1|STARTED|Overall Study||329
1735516|NCT00161616|4249148|P2|NOT COMPLETED|Overall Study||19
1735517|NCT00161616|4249149|P1|NOT COMPLETED|Overall Study||26
1735518|NCT00161616|4249148|P2|COMPLETED|Overall Study||119
1735519|NCT00161616|4249149|P1|COMPLETED|Overall Study||113
1735520|NCT00161616|4249148|P2|STARTED|Overall Study||138
1735521|NCT00161616|4249149|P1|STARTED|Overall Study||139
1735522|NCT00161473|4249159|P2|NOT COMPLETED|Overall Study||6
1735523|NCT00161473|4249160|P1|NOT COMPLETED|Overall Study||5
1735524|NCT00161473|4249159|P2|COMPLETED|Overall Study||6
1735525|NCT00161473|4249160|P1|COMPLETED|Overall Study||7
1735526|NCT00161473|4249159|P2|STARTED|Overall Study||12
1735527|NCT00161473|4249160|P1|STARTED|Overall Study||12
1735528|NCT00161382|4249174|P2|NOT COMPLETED|Overall Study||289
1735529|NCT00161382|4249175|P1|NOT COMPLETED|Overall Study||249
1735530|NCT00161382|4249174|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
1735531|NCT00161382|4249175|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
1735532|NCT00161382|4249174|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
1735533|NCT00161382|4249175|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
1735534|NCT00161213|4249181|P1|NOT COMPLETED|Overall Study||2
1735535|NCT00161213|4249181|P1|COMPLETED|Overall Study||42
1735536|NCT00161213|4249181|P1|STARTED|Overall Study||44
1735537|NCT00160706|4249188|P1|NOT COMPLETED|Overall Study||286
1735538|NCT00160706|4249188|P1|COMPLETED|Overall Study||24
1735539|NCT00160706|4249188|P1|STARTED|Overall Study||310
1735540|NCT00160693|4249200|P1|NOT COMPLETED|Overall Study||235
1735541|NCT00160693|4249200|P1|COMPLETED|Overall Study||167
1735542|NCT00160693|4249200|P1|STARTED|Overall Study||402
1735543|NCT00160641|4249217|P1|NOT COMPLETED|Overall Study||221
1735544|NCT00160641|4249217|P1|COMPLETED|Overall Study||346
1735545|NCT00160641|4249217|P1|STARTED|Overall Study||567
1735546|NCT00160563|4249251|P3|NOT COMPLETED|Overall Study||90
1735547|NCT00160563|4249252|P2|NOT COMPLETED|Overall Study||45
1735548|NCT00160563|4249253|P1|NOT COMPLETED|Overall Study||51
1735549|NCT00160563|4249251|P3|COMPLETED|Overall Study||11
1735550|NCT00160563|4249252|P2|COMPLETED|Overall Study||2
1735551|NCT00160563|4249253|P1|COMPLETED|Overall Study||8
1735552|NCT00160563|4249251|P3|STARTED|Overall Study||101
1735553|NCT00160563|4249252|P2|STARTED|Overall Study||47
1735554|NCT00160563|4249253|P1|STARTED|Overall Study||59
1735555|NCT00160524|4249265|P1|NOT COMPLETED|Overall Study||478
1735556|NCT00160524|4249265|P1|COMPLETED|Overall Study||117
1735557|NCT00160524|4249265|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
1735558|NCT00160251|4249282|P8|NOT COMPLETED|Post-amendment 2||55
1735559|NCT00160251|4249283|P7|NOT COMPLETED|Post-amendment 2||0
1735560|NCT00160251|4249284|P6|NOT COMPLETED|Post-amendment 2||0
1735561|NCT00160251|4249285|P5|NOT COMPLETED|Post-amendment 2||0
1735562|NCT00160251|4249286|P4|NOT COMPLETED|Post-amendment 2||0
1735563|NCT00160251|4249287|P3|NOT COMPLETED|Post-amendment 2||0
1735564|NCT00160251|4249288|P2|NOT COMPLETED|Post-amendment 2||0
1735565|NCT00160251|4249289|P1|NOT COMPLETED|Post-amendment 2||0
1735566|NCT00160251|4249282|P8|COMPLETED|Post-amendment 2||88
1735567|NCT00160251|4249283|P7|COMPLETED|Post-amendment 2||0
1735568|NCT00160251|4249284|P6|COMPLETED|Post-amendment 2||0
1735569|NCT00160251|4249285|P5|COMPLETED|Post-amendment 2||0
1735570|NCT00160251|4249286|P4|COMPLETED|Post-amendment 2||0
1735571|NCT00160251|4249287|P3|COMPLETED|Post-amendment 2||0
1735572|NCT00160251|4249288|P2|COMPLETED|Post-amendment 2||0
1735573|NCT00160251|4249289|P1|COMPLETED|Post-amendment 2||0
1735574|NCT00160251|4249282|P8|STARTED|Post-amendment 2||143
1735575|NCT00160251|4249283|P7|STARTED|Post-amendment 2||0
1735576|NCT00160251|4249284|P6|STARTED|Post-amendment 2||0
1735577|NCT00160251|4249285|P5|STARTED|Post-amendment 2||0
1735578|NCT00160251|4249286|P4|STARTED|Post-amendment 2||0
1735579|NCT00160251|4249287|P3|STARTED|Post-amendment 2||0
1735580|NCT00160251|4249288|P2|STARTED|Post-amendment 2||0
1735581|NCT00160251|4249289|P1|STARTED|Post-amendment 2||0
1735582|NCT00160251|4249282|P8|NOT COMPLETED|Prior to Amendment 2||0
1735583|NCT00160251|4249283|P7|NOT COMPLETED|Prior to Amendment 2||4
1735584|NCT00160251|4249284|P6|NOT COMPLETED|Prior to Amendment 2||83
1735585|NCT00160251|4249285|P5|NOT COMPLETED|Prior to Amendment 2||28
1735586|NCT00160251|4249286|P4|NOT COMPLETED|Prior to Amendment 2||40
1735587|NCT00160251|4249287|P3|NOT COMPLETED|Prior to Amendment 2||44
1735588|NCT00160251|4249288|P2|NOT COMPLETED|Prior to Amendment 2||6
1735589|NCT00160251|4249289|P1|NOT COMPLETED|Prior to Amendment 2||9
1735590|NCT00160251|4249282|P8|COMPLETED|Prior to Amendment 2||0
1735591|NCT00160251|4249283|P7|COMPLETED|Prior to Amendment 2||61
1735592|NCT00160251|4249284|P6|COMPLETED|Prior to Amendment 2||14
1735593|NCT00160251|4249285|P5|COMPLETED|Prior to Amendment 2||21
1735594|NCT00160251|4249286|P4|COMPLETED|Prior to Amendment 2||9
1735595|NCT00160251|4249287|P3|COMPLETED|Prior to Amendment 2||4
1735596|NCT00160251|4249288|P2|COMPLETED|Prior to Amendment 2||28
1735597|NCT00160251|4249289|P1|COMPLETED|Prior to Amendment 2||6
1735598|NCT00160251|4249282|P8|STARTED|Prior to Amendment 2||0
1735599|NCT00160251|4249283|P7|STARTED|Prior to Amendment 2||65
1735600|NCT00160251|4249284|P6|STARTED|Prior to Amendment 2||97
1735601|NCT00160251|4249285|P5|STARTED|Prior to Amendment 2||49
1735602|NCT00160251|4249286|P4|STARTED|Prior to Amendment 2||49
1735603|NCT00160251|4249287|P3|STARTED|Prior to Amendment 2||48
1735604|NCT00160251|4249288|P2|STARTED|Prior to Amendment 2||34
1735605|NCT00160251|4249289|P1|STARTED|Prior to Amendment 2||15
1735606|NCT00160199|4249365|P2|NOT COMPLETED|Overall Study||37
1735607|NCT00160199|4249366|P1|NOT COMPLETED|Overall Study||24
1735608|NCT00160199|4249365|P2|COMPLETED|Overall Study||81
1735609|NCT00160199|4249366|P1|COMPLETED|Overall Study||98
1735610|NCT00160199|4249365|P2|STARTED|Overall Study||118
1735611|NCT00160199|4249366|P1|STARTED|Overall Study||122
1735612|NCT00159965|4249386|P2|NOT COMPLETED|Overall Study||5
1735613|NCT00159965|4249387|P1|NOT COMPLETED|Overall Study||7
1735614|NCT00159965|4249386|P2|COMPLETED|Overall Study||14
1735615|NCT00159965|4249387|P1|COMPLETED|Overall Study||12
1735616|NCT00159965|4249386|P2|STARTED|Overall Study||19
1735617|NCT00159965|4249387|P1|STARTED|Overall Study||19
1735618|NCT00159913|4249423|P4|NOT COMPLETED|Overall Study||2
1735619|NCT00159913|4249424|P3|NOT COMPLETED|Overall Study||2
1735620|NCT00159913|4249425|P2|NOT COMPLETED|Overall Study||0
1735621|NCT00159913|4249426|P1|NOT COMPLETED|Overall Study||2
1735622|NCT00159913|4249423|P4|COMPLETED|Overall Study||58
1735623|NCT00159913|4249424|P3|COMPLETED|Overall Study||75
1735624|NCT00159913|4249425|P2|COMPLETED|Overall Study||55
1735625|NCT00159913|4249426|P1|COMPLETED|Overall Study||40
1735626|NCT00159913|4249423|P4|STARTED|Overall Study||60
1735627|NCT00159913|4249424|P3|STARTED|Overall Study||77
1735628|NCT00159913|4249425|P2|STARTED|Overall Study||55
1735629|NCT00159913|4249426|P1|STARTED|Overall Study||42
1735630|NCT00159874|4249500|P7|NOT COMPLETED|Overall Study||5
1735631|NCT00159874|4249501|P6|NOT COMPLETED|Overall Study||12
1735632|NCT00159874|4249502|P5|NOT COMPLETED|Overall Study||8
1735633|NCT00159874|4249503|P4|NOT COMPLETED|Overall Study||6
1735634|NCT00159874|4249504|P3|NOT COMPLETED|Overall Study||43
1735635|NCT00159874|4249505|P2|NOT COMPLETED|Overall Study||30
1735636|NCT00159874|4249506|P1|NOT COMPLETED|Overall Study||20
1735637|NCT00159874|4249500|P7|COMPLETED|Overall Study||0
1735638|NCT00159874|4249501|P6|COMPLETED|Overall Study||11
1735639|NCT00159874|4249502|P5|COMPLETED|Overall Study||11
1735640|NCT00159874|4249503|P4|COMPLETED|Overall Study||7
1735641|NCT00159874|4249504|P3|COMPLETED|Overall Study||34
1735642|NCT00159874|4249505|P2|COMPLETED|Overall Study||25
1735643|NCT00159874|4249506|P1|COMPLETED|Overall Study||22
1735644|NCT00159874|4249500|P7|Treated|Overall Study||5
1735645|NCT00159874|4249501|P6|Treated|Overall Study||23
1735646|NCT00159874|4249502|P5|Treated|Overall Study||19
1735647|NCT00159874|4249503|P4|Treated|Overall Study||13
1735648|NCT00159874|4249504|P3|Treated|Overall Study||77
1735649|NCT00159874|4249505|P2|Treated|Overall Study||55
1735650|NCT00159874|4249506|P1|Treated|Overall Study||42
1735651|NCT00159874|4249500|P7|STARTED|Overall Study||5
1735652|NCT00159874|4249501|P6|STARTED|Overall Study||23
1735653|NCT00159874|4249502|P5|STARTED|Overall Study||19
1735654|NCT00159874|4249503|P4|STARTED|Overall Study||13
1735655|NCT00159874|4249504|P3|STARTED|Overall Study||77
1735656|NCT00159874|4249505|P2|STARTED|Overall Study||55
1735657|NCT00159874|4249506|P1|STARTED|Overall Study||42
1735658|NCT00159861|4249676|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
1735659|NCT00159861|4249677|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
1735660|NCT00159861|4249676|P2|COMPLETED|Extension Study - up to 3 Years||56
1735661|NCT00159861|4249677|P1|COMPLETED|Extension Study - up to 3 Years||53
1735662|NCT00159861|4249676|P2|Treated|Extension Study - up to 3 Years||127
1735663|NCT00159861|4249677|P1|Treated|Extension Study - up to 3 Years||115
1735664|NCT00159861|4249676|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
1735665|NCT00159861|4249677|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
1735666|NCT00159861|4249676|P2|NOT COMPLETED|Core Study - 16 Weeks||12
1735667|NCT00159861|4249677|P1|NOT COMPLETED|Core Study - 16 Weeks||25
1735668|NCT00159861|4249676|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
1735669|NCT00159861|4249677|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
1735670|NCT00159861|4249676|P2|Treated|Core Study - 16 Weeks||134
1735671|NCT00159861|4249677|P1|Treated|Core Study - 16 Weeks||131
1735672|NCT00159861|4249676|P2|STARTED|Core Study - 16 Weeks||134
1735673|NCT00159861|4249677|P1|STARTED|Core Study - 16 Weeks||133
1735674|NCT00159822|4249698|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
1735675|NCT00159822|4249698|P1|COMPLETED|Post-treatment Follow-up Period||23
1735676|NCT00159822|4249698|P1|STARTED|Post-treatment Follow-up Period||26
1735677|NCT00159822|4249698|P1|NOT COMPLETED|Voriconazole Treatment Period||22
1735678|NCT00159822|4249698|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
1735679|NCT00159822|4249698|P1|STARTED|Voriconazole Treatment Period||48
1735680|NCT00159783|4249716|P3|NOT COMPLETED|Overall Study||39
1735681|NCT00159783|4249717|P2|NOT COMPLETED|Overall Study||27
1735682|NCT00159783|4249718|P1|NOT COMPLETED|Overall Study||19
1735683|NCT00159783|4249716|P3|COMPLETED|Overall Study||68
1735684|NCT00159783|4249717|P2|COMPLETED|Overall Study||52
1735685|NCT00159783|4249718|P1|COMPLETED|Overall Study||13
1735686|NCT00159783|4249716|P3|STARTED|Overall Study||107
1735687|NCT00159783|4249717|P2|STARTED|Overall Study||79
1735688|NCT00159783|4249718|P1|STARTED|Overall Study||32
1735689|NCT00159432|4249748|P1|NOT COMPLETED|Overall Study||10
1735690|NCT00159432|4249748|P1|COMPLETED|Overall Study||53
1735691|NCT00159432|4249748|P1|STARTED|Overall Study||63
1735692|NCT00159419|4249755|P2|NOT COMPLETED|Overall Study||0
1735693|NCT00159419|4249756|P1|NOT COMPLETED|Overall Study||0
1735694|NCT00159419|4249755|P2|COMPLETED|Overall Study||9
1735695|NCT00159419|4249756|P1|COMPLETED|Overall Study||9
1735696|NCT00159419|4249755|P2|STARTED|Overall Study||9
1735697|NCT00159419|4249756|P1|STARTED|Overall Study||9
1735698|NCT00158925|4249762|P1|NOT COMPLETED|Overall Study||12
1735699|NCT00158925|4249762|P1|COMPLETED|Overall Study||84
1735700|NCT00158925|4249762|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
1735701|NCT00158756|4249775|P5|NOT COMPLETED|Overall Study||3
1735702|NCT00158756|4249776|P4|NOT COMPLETED|Overall Study||1
1735703|NCT00158756|4249777|P3|NOT COMPLETED|Overall Study||8
1735704|NCT00158756|4249778|P2|NOT COMPLETED|Overall Study||0
1735705|NCT00158756|4249779|P1|NOT COMPLETED|Overall Study||5
1735706|NCT00158756|4249775|P5|COMPLETED|Overall Study||96
1735707|NCT00158756|4249776|P4|COMPLETED|Overall Study||22
1735708|NCT00158756|4249777|P3|COMPLETED|Overall Study||73
1735709|NCT00158756|4249778|P2|COMPLETED|Overall Study||25
1735710|NCT00158756|4249779|P1|COMPLETED|Overall Study||75
1735711|NCT00158756|4249775|P5|STARTED|Overall Study||99
1735712|NCT00158756|4249776|P4|STARTED|Overall Study||23
1735713|NCT00158756|4249777|P3|STARTED|Overall Study||81
1735714|NCT00158756|4249778|P2|STARTED|Overall Study||25
1735715|NCT00158756|4249779|P1|STARTED|Overall Study||80
1735716|NCT00158743|4249876|P2|NOT COMPLETED|Overall Study||7
1735717|NCT00158743|4249877|P1|NOT COMPLETED|Overall Study||9
1735718|NCT00158743|4249876|P2|COMPLETED|Overall Study||20
1735719|NCT00158743|4249877|P1|COMPLETED|Overall Study||15
1735720|NCT00158743|4249876|P2|STARTED|Overall Study||27
1735721|NCT00158743|4249877|P1|STARTED|Overall Study||24
1735722|NCT00158600|4249885|P2|NOT COMPLETED|Overall Study||4
1735723|NCT00158600|4249886|P1|NOT COMPLETED|Overall Study||5
1735724|NCT00158600|4249885|P2|COMPLETED|Overall Study||26
1735725|NCT00158600|4249886|P1|COMPLETED|Overall Study||55
1735726|NCT00158600|4249885|P2|STARTED|Overall Study||30
1735727|NCT00158600|4249886|P1|STARTED|Overall Study||60
1735728|NCT00158379|4249904|P1|NOT COMPLETED|Overall Study||0
1735729|NCT00158379|4249904|P1|COMPLETED|Overall Study||105
1735730|NCT00158379|4249904|P1|STARTED|Overall Study||105
1735731|NCT00158262|4249911|P2|NOT COMPLETED|Overall Study||1
1735732|NCT00158262|4249912|P1|NOT COMPLETED|Overall Study||1
1735733|NCT00158262|4249911|P2|COMPLETED|Overall Study||21
1735734|NCT00158262|4249912|P1|COMPLETED|Overall Study||20
1735735|NCT00158262|4249911|P2|STARTED|Overall Study||22
1735736|NCT00158262|4249912|P1|STARTED|Overall Study||21
1735737|NCT00158249|4249924|P2|NOT COMPLETED|Overall Study||0
1735738|NCT00158249|4249925|P1|NOT COMPLETED|Overall Study||2
1735739|NCT00158249|4249924|P2|COMPLETED|Overall Study||10
1735740|NCT00158249|4249925|P1|COMPLETED|Overall Study||9
1735741|NCT00158249|4249924|P2|STARTED|Overall Study||10
1735742|NCT00158249|4249925|P1|STARTED|Overall Study||11
1735743|NCT00158223|4249935|P2|NOT COMPLETED|Overall Study||3
1735744|NCT00158223|4249936|P1|NOT COMPLETED|Overall Study||5
1735745|NCT00158223|4249935|P2|COMPLETED|Overall Study||22
1735746|NCT00158223|4249936|P1|COMPLETED|Overall Study||23
1735747|NCT00158223|4249935|P2|STARTED|Overall Study||25
1735748|NCT00158223|4249936|P1|STARTED|Overall Study||28
1735749|NCT00158197|4249950|P4|NOT COMPLETED|Overall Study||0
1735750|NCT00158197|4249951|P3|NOT COMPLETED|Overall Study||0
1735751|NCT00158197|4249952|P2|NOT COMPLETED|Overall Study||0
1735752|NCT00158197|4249953|P1|NOT COMPLETED|Overall Study||0
1735753|NCT00158197|4249950|P4|COMPLETED|Overall Study||29
1735754|NCT00158197|4249951|P3|COMPLETED|Overall Study||28
1735755|NCT00158197|4249952|P2|COMPLETED|Overall Study||30
1735756|NCT00158197|4249953|P1|COMPLETED|Overall Study||32
1735757|NCT00158197|4249950|P4|STARTED|Overall Study||29
1735758|NCT00158197|4249951|P3|STARTED|Overall Study||28
1735759|NCT00158197|4249952|P2|STARTED|Overall Study||30
1735760|NCT00158197|4249953|P1|STARTED|Overall Study||32
1735761|NCT00158184|4249973|P2|NOT COMPLETED|Overall Study||2
1735762|NCT00158184|4249974|P1|NOT COMPLETED|Overall Study||6
1735763|NCT00158184|4249973|P2|COMPLETED|Overall Study||9
1735764|NCT00158184|4249974|P1|COMPLETED|Overall Study||10
1735765|NCT00158184|4249973|P2|STARTED|Overall Study||11
1735766|NCT00158184|4249974|P1|STARTED|Overall Study||16
1735767|NCT00158054|4249984|P2|NOT COMPLETED|Overall Study||3
1735768|NCT00158054|4249985|P1|NOT COMPLETED|Overall Study||10
1735769|NCT00158054|4249984|P2|COMPLETED|Overall Study||74
1735770|NCT00158054|4249985|P1|COMPLETED|Overall Study||70
1735771|NCT00158054|4249984|P2|STARTED|Overall Study||77
1735772|NCT00158054|4249985|P1|STARTED|Overall Study||80
1735773|NCT00157950|4249999|P2|NOT COMPLETED|Overall Study||0
1735774|NCT00157950|4250000|P1|NOT COMPLETED|Overall Study||1
1735775|NCT00157950|4249999|P2|COMPLETED|Overall Study||59
1735776|NCT00157950|4250000|P1|COMPLETED|Overall Study||116
1735777|NCT00157950|4249999|P2|Vaccinated at Dose 3|Overall Study||59
1735778|NCT00157950|4250000|P1|Vaccinated at Dose 3|Overall Study||116
1735779|NCT00157950|4249999|P2|Vaccinated at Dose 2|Overall Study||59
1735780|NCT00157950|4250000|P1|Vaccinated at Dose 2|Overall Study||117
1735781|NCT00157950|4249999|P2|Vaccinated at Dose 1|Overall Study||59
1735782|NCT00157950|4250000|P1|Vaccinated at Dose 1|Overall Study||117
1735783|NCT00157950|4249999|P2|STARTED|Overall Study||59
1735784|NCT00157950|4250000|P1|STARTED|Overall Study||117
1735785|NCT00157820|4250017|P3|NOT COMPLETED|2nd 8 Months||14
1735786|NCT00157820|4250018|P2|NOT COMPLETED|2nd 8 Months||13
1735787|NCT00157820|4250019|P1|NOT COMPLETED|2nd 8 Months||5
1735788|NCT00157820|4250017|P3|COMPLETED|2nd 8 Months||94
1735789|NCT00157820|4250018|P2|COMPLETED|2nd 8 Months||88
1735790|NCT00157820|4250019|P1|COMPLETED|2nd 8 Months||98
1735791|NCT00157820|4250017|P3|STARTED|2nd 8 Months||108
1735792|NCT00157820|4250018|P2|STARTED|2nd 8 Months||101
1735793|NCT00157820|4250019|P1|STARTED|2nd 8 Months||103
1735794|NCT00157820|4250017|P3|NOT COMPLETED|1 Month Wash Out Period||0
1735795|NCT00157820|4250018|P2|NOT COMPLETED|1 Month Wash Out Period||0
1735796|NCT00157820|4250019|P1|NOT COMPLETED|1 Month Wash Out Period||0
1735797|NCT00157820|4250017|P3|COMPLETED|1 Month Wash Out Period||108
1735798|NCT00157820|4250018|P2|COMPLETED|1 Month Wash Out Period||101
1735799|NCT00157820|4250019|P1|COMPLETED|1 Month Wash Out Period||103
1735800|NCT00157820|4250017|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
1735801|NCT00157820|4250018|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
1735802|NCT00157820|4250019|P1|STARTED|1 Month Wash Out Period||103
1735803|NCT00157820|4250017|P3|NOT COMPLETED|1st 8 Month||6
1735804|NCT00157820|4250018|P2|NOT COMPLETED|1st 8 Month||12
1735805|NCT00157820|4250019|P1|NOT COMPLETED|1st 8 Month||8
1735806|NCT00157820|4250017|P3|COMPLETED|1st 8 Month||106
1735807|NCT00157820|4250018|P2|COMPLETED|1st 8 Month||99
1735808|NCT00157820|4250019|P1|COMPLETED|1st 8 Month||103
1735809|NCT00157820|4250017|P3|STARTED|1st 8 Month||112
1735810|NCT00157820|4250018|P2|STARTED|1st 8 Month||111
1735811|NCT00157820|4250019|P1|STARTED|1st 8 Month||111
1735812|NCT00157820|4250017|P3|NOT COMPLETED|Randomized||8
1735813|NCT00157820|4250018|P2|NOT COMPLETED|Randomized||5
1735814|NCT00157820|4250019|P1|NOT COMPLETED|Randomized||7
1735815|NCT00157820|4250017|P3|COMPLETED|Randomized||112
1735816|NCT00157820|4250018|P2|COMPLETED|Randomized||111
1735817|NCT00157820|4250019|P1|COMPLETED|Randomized||111
1735818|NCT00157820|4250017|P3|STARTED|Randomized||120
1735819|NCT00157820|4250018|P2|STARTED|Randomized||116
1735820|NCT00157820|4250019|P1|STARTED|Randomized||118
1735821|NCT00157755|4250032|P6|NOT COMPLETED|Overall Study||5
1735822|NCT00157755|4250033|P5|NOT COMPLETED|Overall Study||2
1735823|NCT00157755|4250034|P4|NOT COMPLETED|Overall Study||4
1735824|NCT00157755|4250035|P3|NOT COMPLETED|Overall Study||7
1735825|NCT00157755|4250036|P2|NOT COMPLETED|Overall Study||4
1735826|NCT00157755|4250037|P1|NOT COMPLETED|Overall Study||2
1735827|NCT00157755|4250032|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
1735828|NCT00157755|4250033|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
1735829|NCT00157755|4250034|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
1735830|NCT00157755|4250035|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
1735831|NCT00157755|4250036|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
1735832|NCT00157755|4250037|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
1735833|NCT00157755|4250032|P6|STARTED|Overall Study||5
1735834|NCT00157755|4250033|P5|STARTED|Overall Study||12
1735835|NCT00157755|4250034|P4|STARTED|Overall Study||15
1735836|NCT00157755|4250035|P3|STARTED|Overall Study||10
1735837|NCT00157755|4250036|P2|STARTED|Overall Study||19
1735838|NCT00157755|4250037|P1|STARTED|Overall Study||26
1735839|NCT00157573|4250059|P2|NOT COMPLETED|Overall Study||0
1735840|NCT00157573|4250060|P1|NOT COMPLETED|Overall Study||0
1735841|NCT00157573|4250059|P2|COMPLETED|Overall Study||37
1735842|NCT00157573|4250060|P1|COMPLETED|Overall Study||35
1735843|NCT00157573|4250059|P2|STARTED|Overall Study||37
1735844|NCT00157573|4250060|P1|STARTED|Overall Study||35
1735845|NCT00157248|4250073|P4|NOT COMPLETED|Overall Study||47
1735846|NCT00157248|4250074|P3|NOT COMPLETED|Overall Study||21
1735847|NCT00157248|4250075|P2|NOT COMPLETED|Overall Study||37
1735848|NCT00157248|4250076|P1|NOT COMPLETED|Overall Study||48
1735849|NCT00157248|4250073|P4|COMPLETED|Overall Study||77
1735850|NCT00157248|4250074|P3|COMPLETED|Overall Study||29
1735851|NCT00157248|4250075|P2|COMPLETED|Overall Study||52
1735852|NCT00157248|4250076|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
1735853|NCT00157248|4250073|P4|STARTED|Overall Study||124
1735854|NCT00157248|4250074|P3|STARTED|Overall Study||50
1735855|NCT00157248|4250075|P2|STARTED|Overall Study||89
1735856|NCT00157248|4250076|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
1735857|NCT00157209|4250182|P2|NOT COMPLETED|Overall Study||0
1735858|NCT00157209|4250183|P1|NOT COMPLETED|Overall Study||10
1735859|NCT00157209|4250182|P2|COMPLETED|Overall Study||83
1735860|NCT00157209|4250183|P1|COMPLETED|Overall Study||78
1735861|NCT00157209|4250182|P2|STARTED|Overall Study||83
1735862|NCT00157209|4250183|P1|STARTED|Overall Study||88
1735863|NCT00157196|4250197|P1|NOT COMPLETED|Overall Study||9
1735864|NCT00157196|4250197|P1|COMPLETED|Overall Study||13
1735865|NCT00157196|4250197|P1|STARTED|Overall Study||22
1735866|NCT00157157|4250203|P1|NOT COMPLETED|Overall Study||11
1735867|NCT00157157|4250203|P1|COMPLETED|Overall Study||44
1735868|NCT00157157|4250203|P1|STARTED|Overall Study||55
1735869|NCT00157014|4250230|P4|NOT COMPLETED|Overall Study||1
1735870|NCT00157014|4250231|P3|NOT COMPLETED|Overall Study||1
1735871|NCT00157014|4250232|P2|NOT COMPLETED|Overall Study||5
1735872|NCT00157014|4250233|P1|NOT COMPLETED|Overall Study||7
1735873|NCT00157014|4250230|P4|COMPLETED|Overall Study||5
1735874|NCT00157014|4250231|P3|COMPLETED|Overall Study||4
1735875|NCT00157014|4250232|P2|COMPLETED|Overall Study||41
1735876|NCT00157014|4250233|P1|COMPLETED|Overall Study||45
1735877|NCT00157014|4250230|P4|STARTED|Overall Study||6
1735878|NCT00157014|4250231|P3|STARTED|Overall Study||5
1735879|NCT00157014|4250232|P2|STARTED|Overall Study||46
1735880|NCT00157014|4250233|P1|STARTED|Overall Study||52
1735881|NCT00156936|4250313|P2|NOT COMPLETED|Overall Study||11
1735882|NCT00156936|4250314|P1|NOT COMPLETED|Overall Study||72
1735883|NCT00156936|4250313|P2|COMPLETED|Overall Study||5
1735884|NCT00156936|4250314|P1|COMPLETED|Overall Study||20
1735885|NCT00156936|4250313|P2|STARTED|Overall Study||16
1735886|NCT00156936|4250314|P1|STARTED|Overall Study||92
1735887|NCT00156923|4250322|P2|NOT COMPLETED|Overall Study||32
1735888|NCT00156923|4250323|P1|NOT COMPLETED|Overall Study||34
1735889|NCT00156923|4250322|P2|COMPLETED|Overall Study||20
1735890|NCT00156923|4250323|P1|COMPLETED|Overall Study||22
1735891|NCT00156923|4250322|P2|STARTED|Overall Study||52
1735892|NCT00156923|4250323|P1|STARTED|Overall Study||56
1735893|NCT00156910|4250331|P2|NOT COMPLETED|Open-Label Phase (OL)||55
1735894|NCT00156910|4250332|P1|NOT COMPLETED|Open-Label Phase (OL)||33
1735895|NCT00156910|4250331|P2|COMPLETED|Open-Label Phase (OL)||231
1735896|NCT00156910|4250332|P1|COMPLETED|Open-Label Phase (OL)||252
1735897|NCT00156910|4250331|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
1735898|NCT00156910|4250332|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
1735899|NCT00156910|4250331|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
1735900|NCT00156910|4250332|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
1735901|NCT00156910|4250331|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
1735902|NCT00156910|4250332|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
1735903|NCT00156910|4250331|P2|STARTED|Double-Blind Phase (DB)||338
1735904|NCT00156910|4250332|P1|STARTED|Double-Blind Phase (DB)||341
1735905|NCT00156819|4250349|P3|NOT COMPLETED|Overall Study||3
1735906|NCT00156819|4250350|P2|NOT COMPLETED|Overall Study||1
1735907|NCT00156819|4250351|P1|NOT COMPLETED|Overall Study||1
1735908|NCT00156819|4250349|P3|COMPLETED|Overall Study||162
1735909|NCT00156819|4250350|P2|COMPLETED|Overall Study||165
1735910|NCT00156819|4250351|P1|COMPLETED|Overall Study||168
1735911|NCT00156819|4250349|P3|STARTED|Overall Study||165
1735912|NCT00156819|4250350|P2|STARTED|Overall Study||166
1735913|NCT00156819|4250351|P1|STARTED|Overall Study||169
1735914|NCT00156715|4250359|P1|NOT COMPLETED|Overall Study||7
1735915|NCT00156715|4250359|P1|COMPLETED|Overall Study||16
1735916|NCT00156715|4250359|P1|STARTED|Overall Study||23
1735917|NCT00156533|4250368|P4|NOT COMPLETED|Overall Study||2
1735918|NCT00156533|4250369|P3|NOT COMPLETED|Overall Study||2
1735919|NCT00156533|4250370|P2|NOT COMPLETED|Overall Study||2
1735920|NCT00156533|4250371|P1|NOT COMPLETED|Overall Study||2
1735921|NCT00156533|4250368|P4|COMPLETED|Overall Study||3
1735922|NCT00156533|4250369|P3|COMPLETED|Overall Study||3
1735923|NCT00156533|4250370|P2|COMPLETED|Overall Study||3
1735924|NCT00156533|4250371|P1|COMPLETED|Overall Study||3
1735925|NCT00156533|4250368|P4|STARTED|Overall Study||5
1735926|NCT00156533|4250369|P3|STARTED|Overall Study||5
1735927|NCT00156533|4250370|P2|STARTED|Overall Study||5
1735928|NCT00156533|4250371|P1|STARTED|Overall Study||5
1735929|NCT00156390|4250387|P2|NOT COMPLETED|Overall Study||8
1735930|NCT00156390|4250388|P1|NOT COMPLETED|Overall Study||14
1735931|NCT00156390|4250387|P2|COMPLETED|Overall Study||69
1735932|NCT00156390|4250388|P1|COMPLETED|Overall Study||96
1735933|NCT00156390|4250387|P2|STARTED|Overall Study||77
1735934|NCT00156390|4250388|P1|STARTED|Overall Study||110
1735935|NCT00156247|4250396|P1|NOT COMPLETED|Overall Study||4
1735936|NCT00156247|4250396|P1|COMPLETED|Overall Study||5
1735937|NCT00156247|4250396|P1|STARTED|Overall Study||9
1735938|NCT00156065|4250405|P3|NOT COMPLETED|Overall Study||27
1735939|NCT00156065|4250406|P2|NOT COMPLETED|Overall Study||63
1735940|NCT00156065|4250407|P1|NOT COMPLETED|Overall Study||31
1735941|NCT00156065|4250405|P3|COMPLETED|Overall Study||16
1735942|NCT00156065|4250406|P2|COMPLETED|Overall Study||30
1735943|NCT00156065|4250407|P1|COMPLETED|Overall Study||20
1735944|NCT00156065|4250405|P3|STARTED|Overall Study||43
1735945|NCT00156065|4250406|P2|STARTED|Overall Study||93
1735946|NCT00156065|4250407|P1|STARTED|Overall Study||51
1735947|NCT00156013|4250418|P1|NOT COMPLETED|Overall Study||2
1735948|NCT00156013|4250418|P1|COMPLETED|Overall Study||31
1735949|NCT00156013|4250418|P1|STARTED|Overall Study||33
1735950|NCT00154466|4250427|P3|NOT COMPLETED|Overall Study||0
1735951|NCT00154466|4250428|P2|NOT COMPLETED|Overall Study||0
1735952|NCT00154466|4250429|P1|NOT COMPLETED|Overall Study||0
1735953|NCT00154466|4250427|P3|COMPLETED|Overall Study||19
1735954|NCT00154466|4250428|P2|COMPLETED|Overall Study||19
1735955|NCT00154466|4250429|P1|COMPLETED|Overall Study||20
1735956|NCT00154466|4250427|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
1735957|NCT00154466|4250428|P2|STARTED|Overall Study||19
1735958|NCT00154466|4250429|P1|STARTED|Overall Study||20
1735959|NCT00154375|4250441|P2|NOT COMPLETED|Overall Study||106
1735960|NCT00154375|4250442|P1|NOT COMPLETED|Overall Study||113
1735961|NCT00154375|4250441|P2|COMPLETED|Overall Study||14
1735962|NCT00154375|4250442|P1|COMPLETED|Overall Study||7
1735963|NCT00154375|4250441|P2|Not Exposed to Study Treatment|Overall Study||2
1735964|NCT00154375|4250442|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
1735965|NCT00154375|4250441|P2|Discontinued Study Treatment|Overall Study||104
1735966|NCT00154375|4250442|P1|Discontinued Study Treatment|Overall Study||111
1735967|NCT00154375|4250441|P2|STARTED|Overall Study||120
1735968|NCT00154375|4250442|P1|STARTED|Overall Study||120
1735969|NCT00154310|4250453|P2|NOT COMPLETED|Overall Study||28
1735970|NCT00154310|4250454|P1|NOT COMPLETED|Overall Study||37
1735971|NCT00154310|4250453|P2|COMPLETED|Overall Study||117
1735972|NCT00154310|4250454|P1|COMPLETED|Overall Study||118
1735973|NCT00154310|4250453|P2|STARTED|Overall Study||145
1735974|NCT00154310|4250454|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
1735975|NCT00154297|4250470|P2|NOT COMPLETED|Overall Study||7
1735976|NCT00154297|4250471|P1|NOT COMPLETED|Overall Study||8
1735977|NCT00154297|4250470|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
1735978|NCT00154297|4250471|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
1735979|NCT00154297|4250470|P2|STARTED|Overall Study|Randomized population.|74
1735980|NCT00154297|4250471|P1|STARTED|Overall Study|Randomized population.|65
1735981|NCT00154284|4250489|P2|NOT COMPLETED|Overall Study||13
1735982|NCT00154284|4250490|P1|NOT COMPLETED|Overall Study||7
1735983|NCT00154284|4250489|P2|COMPLETED|Overall Study||42
1735984|NCT00154284|4250490|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
1735985|NCT00154284|4250489|P2|Intent to Treat (ITT) Population|Overall Study||53
1735986|NCT00154284|4250490|P1|Intent to Treat (ITT) Population|Overall Study||57
1735987|NCT00154284|4250489|P2|STARTED|Overall Study||55
1735988|NCT00154284|4250490|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
1735989|NCT00154102|4250504|P2|NOT COMPLETED|Overall Study||2
1735990|NCT00154102|4250505|P1|NOT COMPLETED|Overall Study||7
1735991|NCT00154102|4250504|P2|COMPLETED|Overall Study||597
1735992|NCT00154102|4250505|P1|COMPLETED|Overall Study||592
1735993|NCT00154102|4250504|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
1735994|NCT00154102|4250505|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
1735995|NCT00154063|4250541|P2|NOT COMPLETED|Overall Study||22
1735996|NCT00154063|4250542|P1|NOT COMPLETED|Overall Study||12
1735997|NCT00154063|4250541|P2|COMPLETED|Overall Study||80
1735998|NCT00154063|4250542|P1|COMPLETED|Overall Study||92
1735999|NCT00154063|4250541|P2|STARTED|Overall Study||102
1736000|NCT00154063|4250542|P1|STARTED|Overall Study||104
1736001|NCT00153985|4250598|P1|NOT COMPLETED|Overall Study||0
1736002|NCT00153985|4250598|P1|COMPLETED|Overall Study||2
1736003|NCT00153985|4250598|P1|STARTED|Overall Study||2
1736004|NCT00153920|4250604|P1|NOT COMPLETED|Overall Study||30
1736005|NCT00153920|4250604|P1|COMPLETED|Overall Study||36
1736006|NCT00153920|4250604|P1|Eligible and Treated|Overall Study||64
1736007|NCT00153920|4250604|P1|STARTED|Overall Study||66
1736008|NCT00153816|4250619|P6|NOT COMPLETED|Overall Study||27
1736009|NCT00153816|4250620|P5|NOT COMPLETED|Overall Study||17
1736010|NCT00153816|4250621|P4|NOT COMPLETED|Overall Study||31
1736011|NCT00153816|4250622|P3|NOT COMPLETED|Overall Study||32
1736012|NCT00153816|4250623|P2|NOT COMPLETED|Overall Study||32
1736013|NCT00153816|4250624|P1|NOT COMPLETED|Overall Study||32
1736014|NCT00153816|4250619|P6|COMPLETED|Overall Study||262
1736015|NCT00153816|4250620|P5|COMPLETED|Overall Study||278
1736016|NCT00153816|4250621|P4|COMPLETED|Overall Study||390
1736017|NCT00153816|4250622|P3|COMPLETED|Overall Study||388
1736018|NCT00153816|4250623|P2|COMPLETED|Overall Study||387
1736019|NCT00153816|4250624|P1|COMPLETED|Overall Study||383
1736020|NCT00153816|4250619|P6|STARTED|Overall Study||289
1736021|NCT00153816|4250620|P5|STARTED|Overall Study||295
1736022|NCT00153816|4250621|P4|STARTED|Overall Study||421
1736023|NCT00153816|4250622|P3|STARTED|Overall Study||420
1736024|NCT00153816|4250623|P2|STARTED|Overall Study||419
1736025|NCT00153816|4250624|P1|STARTED|Overall Study||415
1736026|NCT00153179|4250646|P4|NOT COMPLETED|Study Visit Day 2||2
1736027|NCT00153179|4250647|P3|NOT COMPLETED|Study Visit Day 2||2
1736028|NCT00153179|4250648|P2|NOT COMPLETED|Study Visit Day 2||0
1736029|NCT00153179|4250649|P1|NOT COMPLETED|Study Visit Day 2||1
1736030|NCT00153179|4250646|P4|COMPLETED|Study Visit Day 2||7
1736031|NCT00153179|4250647|P3|COMPLETED|Study Visit Day 2||11
1736032|NCT00153179|4250648|P2|COMPLETED|Study Visit Day 2||8
1736033|NCT00153179|4250649|P1|COMPLETED|Study Visit Day 2||9
1736034|NCT00153179|4250646|P4|STARTED|Study Visit Day 2||9
1736035|NCT00153179|4250647|P3|STARTED|Study Visit Day 2||13
1736036|NCT00153179|4250648|P2|STARTED|Study Visit Day 2||8
1736037|NCT00153179|4250649|P1|STARTED|Study Visit Day 2||10
1736038|NCT00153179|4250646|P4|NOT COMPLETED|Study Visit Day 1||0
1736039|NCT00153179|4250647|P3|NOT COMPLETED|Study Visit Day 1||0
1736040|NCT00153179|4250648|P2|NOT COMPLETED|Study Visit Day 1||0
1736041|NCT00153179|4250649|P1|NOT COMPLETED|Study Visit Day 1||0
1736042|NCT00153179|4250646|P4|COMPLETED|Study Visit Day 1||9
1736043|NCT00153179|4250647|P3|COMPLETED|Study Visit Day 1||13
1736044|NCT00153179|4250648|P2|COMPLETED|Study Visit Day 1||8
1736045|NCT00153179|4250649|P1|COMPLETED|Study Visit Day 1||10
1736046|NCT00153179|4250646|P4|STARTED|Study Visit Day 1||9
1736047|NCT00153179|4250647|P3|STARTED|Study Visit Day 1||13
1736048|NCT00153179|4250648|P2|STARTED|Study Visit Day 1||8
1736049|NCT00153179|4250649|P1|STARTED|Study Visit Day 1||10
1736050|NCT00153166|4250662|P3|NOT COMPLETED|Overall Study||0
1736051|NCT00153166|4250663|P2|NOT COMPLETED|Overall Study||0
1736052|NCT00153166|4250664|P1|NOT COMPLETED|Overall Study||0
1736053|NCT00153166|4250662|P3|COMPLETED|Overall Study||28
1736054|NCT00153166|4250663|P2|COMPLETED|Overall Study||37
1736055|NCT00153166|4250664|P1|COMPLETED|Overall Study||11
1736056|NCT00153166|4250662|P3|Received Placebo and Placebo|Overall Study||7
1736057|NCT00153166|4250663|P2|Received Placebo and Placebo|Overall Study||9
1736058|NCT00153166|4250664|P1|Received Placebo and Placebo|Overall Study||3
1736059|NCT00153166|4250662|P3|Received Placebo and Pioglitazone|Overall Study||7
1736060|NCT00153166|4250663|P2|Received Placebo and Pioglitazone|Overall Study||10
1736061|NCT00153166|4250664|P1|Received Placebo and Pioglitazone|Overall Study||3
1736062|NCT00153166|4250662|P3|Received Atorvastatin and Placebo|Overall Study||7
1736063|NCT00153166|4250663|P2|Received Atorvastatin and Placebo|Overall Study||9
1736064|NCT00153166|4250664|P1|Received Atorvastatin and Placebo|Overall Study||2
1736065|NCT00153166|4250662|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
1736066|NCT00153166|4250663|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
1736067|NCT00153166|4250664|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
1736068|NCT00153166|4250662|P3|STARTED|Overall Study||28
1736069|NCT00153166|4250663|P2|STARTED|Overall Study||37
1736070|NCT00153166|4250664|P1|STARTED|Overall Study||11
1736071|NCT00153101|4250681|P5|NOT COMPLETED|Overall Study||10
1736072|NCT00153101|4250682|P4|NOT COMPLETED|Overall Study||8
1736073|NCT00153101|4250683|P3|NOT COMPLETED|Overall Study||15
1736074|NCT00153101|4250684|P2|NOT COMPLETED|Overall Study||18
1736075|NCT00153101|4250685|P1|NOT COMPLETED|Overall Study||17
1736076|NCT00153101|4250681|P5|COMPLETED|Overall Study||2962
1736077|NCT00153101|4250682|P4|COMPLETED|Overall Study||2946
1736078|NCT00153101|4250683|P3|COMPLETED|Overall Study||8561
1736079|NCT00153101|4250684|P2|COMPLETED|Overall Study||8524
1736080|NCT00153101|4250685|P1|COMPLETED|Overall Study||8485
1736081|NCT00153101|4250681|P5|STARTED|Overall Study||2972
1736082|NCT00153101|4250682|P4|STARTED|Overall Study||2954
1736083|NCT00153101|4250683|P3|STARTED|Overall Study||8576
1736084|NCT00153101|4250684|P2|STARTED|Overall Study||8542
1736085|NCT00153101|4250685|P1|STARTED|Overall Study||8502
1736086|NCT00153062|4250793|P4|NOT COMPLETED|Overall Study||411
1736087|NCT00153062|4250794|P3|NOT COMPLETED|Overall Study||415
1736088|NCT00153062|4250795|P2|NOT COMPLETED|Overall Study||406
1736089|NCT00153062|4250796|P1|NOT COMPLETED|Overall Study||387
1736090|NCT00153062|4250793|P4|COMPLETED|Overall Study||4680
1736091|NCT00153062|4250794|P3|COMPLETED|Overall Study||4645
1736092|NCT00153062|4250795|P2|COMPLETED|Overall Study||4689
1736093|NCT00153062|4250796|P1|COMPLETED|Overall Study||4699
1736094|NCT00153062|4250793|P4|STARTED|Overall Study||5091
1736095|NCT00153062|4250794|P3|STARTED|Overall Study||5060
1736096|NCT00153062|4250795|P2|STARTED|Overall Study||5095
1736097|NCT00153062|4250796|P1|STARTED|Overall Study||5086
1736098|NCT00152971|4250815|P3|NOT COMPLETED|Treatment||80
1736099|NCT00152971|4250816|P2|NOT COMPLETED|Treatment||63
1736100|NCT00152971|4250817|P1|NOT COMPLETED|Treatment||71
1736101|NCT00152971|4250815|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
1736102|NCT00152971|4250816|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
1736103|NCT00152971|4250817|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
1736104|NCT00152971|4250815|P3|STARTED|Treatment||868
1736105|NCT00152971|4250816|P2|STARTED|Treatment||871
1736106|NCT00152971|4250817|P1|STARTED|Treatment||857
1736107|NCT00152971|4250815|P3|NOT COMPLETED|Overall Study||49
1736108|NCT00152971|4250816|P2|NOT COMPLETED|Overall Study||48
1736109|NCT00152971|4250817|P1|NOT COMPLETED|Overall Study||51
1736110|NCT00152971|4250815|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
1736111|NCT00152971|4250816|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
1736112|NCT00152971|4250817|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
1736113|NCT00152971|4250815|P3|STARTED|Overall Study||868
1736114|NCT00152971|4250816|P2|STARTED|Overall Study||871
1736115|NCT00152971|4250817|P1|STARTED|Overall Study||857
1736116|NCT00152763|4250853|P4|NOT COMPLETED|Overall Study||14
1736117|NCT00152763|4250854|P3|NOT COMPLETED|Overall Study||4
1736118|NCT00152763|4250855|P2|NOT COMPLETED|Overall Study||5
1736119|NCT00152763|4250856|P1|NOT COMPLETED|Overall Study||10
1736120|NCT00152763|4250853|P4|COMPLETED|Overall Study||63
1736121|NCT00152763|4250854|P3|COMPLETED|Overall Study||16
1736122|NCT00152763|4250855|P2|COMPLETED|Overall Study||14
1736123|NCT00152763|4250856|P1|COMPLETED|Overall Study||67
1736124|NCT00152763|4250853|P4|STARTED|Overall Study||77
1736125|NCT00152763|4250854|P3|STARTED|Overall Study||20
1736126|NCT00152763|4250855|P2|STARTED|Overall Study||19
1736127|NCT00152763|4250856|P1|STARTED|Overall Study||77
1736128|NCT00152516|4250972|P1|NOT COMPLETED|Overall Study||75
1736129|NCT00152516|4250972|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
1736130|NCT00152516|4250972|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
1736131|NCT00152009|4251000|P4|NOT COMPLETED|Overall Study||33
1736132|NCT00152009|4251001|P3|NOT COMPLETED|Overall Study||37
1736133|NCT00152009|4251002|P2|NOT COMPLETED|Overall Study||31
1736134|NCT00152009|4251003|P1|NOT COMPLETED|Overall Study||29
1736135|NCT00152009|4251000|P4|COMPLETED|Overall Study||53
1736136|NCT00152009|4251001|P3|COMPLETED|Overall Study||49
1736137|NCT00152009|4251002|P2|COMPLETED|Overall Study||55
1736138|NCT00152009|4251003|P1|COMPLETED|Overall Study||58
1736139|NCT00152009|4251000|P4|STARTED|Overall Study||86
1736140|NCT00152009|4251001|P3|STARTED|Overall Study||86
1736141|NCT00152009|4251002|P2|STARTED|Overall Study||86
1736142|NCT00152009|4251003|P1|STARTED|Overall Study||87
1736143|NCT00151996|4251035|P2|NOT COMPLETED|Overall Study||7
1736144|NCT00151996|4251036|P1|NOT COMPLETED|Overall Study||5
1736145|NCT00151996|4251035|P2|COMPLETED|Overall Study||26
1736146|NCT00151996|4251036|P1|COMPLETED|Overall Study||37
1736147|NCT00151996|4251035|P2|STARTED|Overall Study||33
1736148|NCT00151996|4251036|P1|STARTED|Overall Study||42
1736149|NCT00151892|4251052|P2|NOT COMPLETED|Overall Study||83
1736150|NCT00151892|4251053|P1|NOT COMPLETED|Overall Study||76
1736151|NCT00151892|4251052|P2|COMPLETED|Overall Study||330
1736152|NCT00151892|4251053|P1|COMPLETED|Overall Study||340
1736153|NCT00151892|4251052|P2|STARTED|Overall Study||413
1736154|NCT00151892|4251053|P1|STARTED|Overall Study||416
1736155|NCT00151814|4251070|P3|NOT COMPLETED|Overall Study||0
1736156|NCT00151814|4251071|P2|NOT COMPLETED|Overall Study||0
1736157|NCT00151814|4251072|P1|NOT COMPLETED|Overall Study||0
1736158|NCT00151814|4251070|P3|COMPLETED|Overall Study||10
1736159|NCT00151814|4251071|P2|COMPLETED|Overall Study||10
1736160|NCT00151814|4251072|P1|COMPLETED|Overall Study||4
1736161|NCT00151814|4251070|P3|STARTED|Overall Study||10
1736162|NCT00151814|4251071|P2|STARTED|Overall Study||10
1736163|NCT00151814|4251072|P1|STARTED|Overall Study||4
1736164|NCT00151775|4251098|P12|NOT COMPLETED|Period 4: Open Label||0
1736165|NCT00151775|4251099|P11|NOT COMPLETED|Period 4: Open Label||0
1736166|NCT00151775|4251100|P10|NOT COMPLETED|Period 4: Open Label||21
1736167|NCT00151775|4251101|P9|NOT COMPLETED|Period 4: Open Label||0
1736168|NCT00151775|4251102|P8|NOT COMPLETED|Period 4: Open Label||0
1736169|NCT00151775|4251103|P7|NOT COMPLETED|Period 4: Open Label||0
1736170|NCT00151775|4251104|P6|NOT COMPLETED|Period 4: Open Label||0
1736171|NCT00151775|4251105|P5|NOT COMPLETED|Period 4: Open Label||30
1736172|NCT00151775|4251106|P4|NOT COMPLETED|Period 4: Open Label||0
1736173|NCT00151775|4251107|P3|NOT COMPLETED|Period 4: Open Label||0
1736174|NCT00151775|4251108|P2|NOT COMPLETED|Period 4: Open Label||0
1736175|NCT00151775|4251109|P1|NOT COMPLETED|Period 4: Open Label||0
1736176|NCT00151775|4251098|P12|COMPLETED|Period 4: Open Label||0
1736177|NCT00151775|4251099|P11|COMPLETED|Period 4: Open Label||57
1736178|NCT00151775|4251100|P10|COMPLETED|Period 4: Open Label||83
1736179|NCT00151775|4251101|P9|COMPLETED|Period 4: Open Label||0
1736180|NCT00151775|4251102|P8|COMPLETED|Period 4: Open Label||0
1736181|NCT00151775|4251103|P7|COMPLETED|Period 4: Open Label||0
1736182|NCT00151775|4251104|P6|COMPLETED|Period 4: Open Label||0
1736183|NCT00151775|4251105|P5|COMPLETED|Period 4: Open Label||149
1736184|NCT00151775|4251106|P4|COMPLETED|Period 4: Open Label||0
1736185|NCT00151775|4251107|P3|COMPLETED|Period 4: Open Label||0
1736186|NCT00151775|4251108|P2|COMPLETED|Period 4: Open Label||0
1736187|NCT00151775|4251109|P1|COMPLETED|Period 4: Open Label||0
1736188|NCT00151775|4251098|P12|STARTED|Period 4: Open Label||0
1736189|NCT00151775|4251099|P11|STARTED|Period 4: Open Label||57
1736190|NCT00151775|4251100|P10|STARTED|Period 4: Open Label||104
1736191|NCT00151775|4251101|P9|STARTED|Period 4: Open Label||0
1736192|NCT00151775|4251102|P8|STARTED|Period 4: Open Label||0
1736193|NCT00151775|4251103|P7|STARTED|Period 4: Open Label||0
1736194|NCT00151775|4251104|P6|STARTED|Period 4: Open Label||0
1736195|NCT00151775|4251105|P5|STARTED|Period 4: Open Label||179
1736196|NCT00151775|4251106|P4|STARTED|Period 4: Open Label||0
1736197|NCT00151775|4251107|P3|STARTED|Period 4: Open Label||0
1736198|NCT00151775|4251108|P2|STARTED|Period 4: Open Label||0
1736199|NCT00151775|4251109|P1|STARTED|Period 4: Open Label||0
1736200|NCT00151775|4251098|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
1736201|NCT00151775|4251099|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1736202|NCT00151775|4251100|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1736203|NCT00151775|4251101|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1736204|NCT00151775|4251102|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
1736205|NCT00151775|4251103|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
1736206|NCT00151775|4251104|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
1736207|NCT00151775|4251105|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1736208|NCT00151775|4251106|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1736209|NCT00151775|4251107|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
1736210|NCT00151775|4251108|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1736211|NCT00151775|4251109|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
1736212|NCT00151775|4251098|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
1736213|NCT00151775|4251099|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
1736214|NCT00151775|4251100|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
1736215|NCT00151775|4251101|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
1736216|NCT00151775|4251102|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
1736217|NCT00151775|4251103|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
1736218|NCT00151775|4251104|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
1736219|NCT00151775|4251105|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
1736220|NCT00151775|4251106|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
1736221|NCT00151775|4251107|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
1736222|NCT00151775|4251108|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
1736223|NCT00151775|4251109|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
1736224|NCT00151775|4251098|P12|STARTED|Period 3: Double-blind, Withdrawal||29
1736225|NCT00151775|4251099|P11|STARTED|Period 3: Double-blind, Withdrawal||29
1736226|NCT00151775|4251100|P10|STARTED|Period 3: Double-blind, Withdrawal||0
1736227|NCT00151775|4251101|P9|STARTED|Period 3: Double-blind, Withdrawal||26
1736228|NCT00151775|4251102|P8|STARTED|Period 3: Double-blind, Withdrawal||28
1736229|NCT00151775|4251103|P7|STARTED|Period 3: Double-blind, Withdrawal||27
1736230|NCT00151775|4251104|P6|STARTED|Period 3: Double-blind, Withdrawal||26
1736231|NCT00151775|4251105|P5|STARTED|Period 3: Double-blind, Withdrawal||0
1736232|NCT00151775|4251106|P4|STARTED|Period 3: Double-blind, Withdrawal||44
1736233|NCT00151775|4251107|P3|STARTED|Period 3: Double-blind, Withdrawal||45
1736234|NCT00151775|4251108|P2|STARTED|Period 3: Double-blind, Withdrawal||45
1736235|NCT00151775|4251109|P1|STARTED|Period 3: Double-blind, Withdrawal||48
1736236|NCT00151775|4251098|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1736237|NCT00151775|4251099|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
1736238|NCT00151775|4251100|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1736239|NCT00151775|4251101|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1736240|NCT00151775|4251102|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1736241|NCT00151775|4251103|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
1736242|NCT00151775|4251104|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
1736243|NCT00151775|4251105|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1736244|NCT00151775|4251106|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1736245|NCT00151775|4251107|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
1736246|NCT00151775|4251108|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
1736247|NCT00151775|4251109|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
1736248|NCT00151775|4251098|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
1736249|NCT00151775|4251099|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
1736250|NCT00151775|4251100|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
1736251|NCT00151775|4251101|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
1736252|NCT00151775|4251102|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
1736253|NCT00151775|4251103|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
1736254|NCT00151775|4251104|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
1736255|NCT00151775|4251105|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
1736256|NCT00151775|4251106|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
1736257|NCT00151775|4251107|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
1736258|NCT00151775|4251108|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
1736259|NCT00151775|4251109|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
1736260|NCT00151775|4251098|P12|STARTED|Period 2 - Double-Blind Dose Response||0
1736261|NCT00151775|4251099|P11|STARTED|Period 2 - Double-Blind Dose Response||60
1736262|NCT00151775|4251100|P10|STARTED|Period 2 - Double-Blind Dose Response||0
1736263|NCT00151775|4251101|P9|STARTED|Period 2 - Double-Blind Dose Response||0
1736264|NCT00151775|4251102|P8|STARTED|Period 2 - Double-Blind Dose Response||0
1736265|NCT00151775|4251103|P7|STARTED|Period 2 - Double-Blind Dose Response||56
1736266|NCT00151775|4251104|P6|STARTED|Period 2 - Double-Blind Dose Response||56
1736267|NCT00151775|4251105|P5|STARTED|Period 2 - Double-Blind Dose Response||0
1736268|NCT00151775|4251106|P4|STARTED|Period 2 - Double-Blind Dose Response||0
1736269|NCT00151775|4251107|P3|STARTED|Period 2 - Double-Blind Dose Response||0
1736270|NCT00151775|4251108|P2|STARTED|Period 2 - Double-Blind Dose Response||95
1736271|NCT00151775|4251109|P1|STARTED|Period 2 - Double-Blind Dose Response||95
1736272|NCT00151476|4251153|P2|NOT COMPLETED|FAP Analyzed Subjects||3
1736273|NCT00151476|4251154|P1|NOT COMPLETED|FAP Analyzed Subjects||0
1736274|NCT00151476|4251153|P2|COMPLETED|FAP Analyzed Subjects||51
1736275|NCT00151476|4251154|P1|COMPLETED|FAP Analyzed Subjects||13
1736276|NCT00151476|4251153|P2|STARTED|FAP Analyzed Subjects||54
1736277|NCT00151476|4251154|P1|STARTED|FAP Analyzed Subjects||13
1736278|NCT00151476|4251153|P2|NOT COMPLETED|FAP Identified Subjects||1
1736279|NCT00151476|4251154|P1|NOT COMPLETED|FAP Identified Subjects||0
1736280|NCT00151476|4251153|P2|COMPLETED|FAP Identified Subjects||54
1736281|NCT00151476|4251154|P1|COMPLETED|FAP Identified Subjects||13
1736282|NCT00151476|4251153|P2|STARTED|FAP Identified Subjects||55
1736283|NCT00151476|4251154|P1|STARTED|FAP Identified Subjects||13
1736284|NCT00151411|4251211|P2|NOT COMPLETED|Overall Study||43
1736285|NCT00151411|4251212|P1|NOT COMPLETED|Overall Study||33
1736286|NCT00151411|4251211|P2|COMPLETED|Overall Study||16
1736287|NCT00151411|4251212|P1|COMPLETED|Overall Study||22
1736288|NCT00151411|4251211|P2|STARTED|Overall Study||59
1736289|NCT00151411|4251212|P1|STARTED|Overall Study||55
1736290|NCT00151372|4251224|P2|NOT COMPLETED|Overall Study||29
1736291|NCT00151372|4251225|P1|NOT COMPLETED|Overall Study||29
1736292|NCT00151372|4251224|P2|COMPLETED|Overall Study||45
1736293|NCT00151372|4251225|P1|COMPLETED|Overall Study||38
1736294|NCT00151372|4251224|P2|STARTED|Overall Study||74
1736295|NCT00151372|4251225|P1|STARTED|Overall Study||67
1736296|NCT00151320|4251235|P1|NOT COMPLETED|Overall Study||0
1736297|NCT00151320|4251235|P1|COMPLETED|Overall Study||76
1736298|NCT00151320|4251235|P1|STARTED|Overall Study||76
1736299|NCT00151281|4251240|P1|NOT COMPLETED|Overall Study||3
1736300|NCT00151281|4251240|P1|COMPLETED|Overall Study||22
1736301|NCT00151281|4251240|P1|STARTED|Overall Study||25
1736302|NCT00150969|4251249|P2|NOT COMPLETED|24-48 Month Extension||100
1736303|NCT00150969|4251250|P1|NOT COMPLETED|24-48 Month Extension||88
1736304|NCT00150969|4251249|P2|COMPLETED|24-48 Month Extension||40
1736305|NCT00150969|4251250|P1|COMPLETED|24-48 Month Extension||33
1736306|NCT00150969|4251249|P2|STARTED|24-48 Month Extension||140
1736307|NCT00150969|4251250|P1|STARTED|24-48 Month Extension||121
1736308|NCT00150969|4251249|P2|NOT COMPLETED|24 Month Main Study||21
1736309|NCT00150969|4251250|P1|NOT COMPLETED|24 Month Main Study||19
1736310|NCT00150969|4251249|P2|COMPLETED|24 Month Main Study||202
1736311|NCT00150969|4251250|P1|COMPLETED|24 Month Main Study||198
1736312|NCT00150969|4251249|P2|STARTED|24 Month Main Study||223
1736313|NCT00150969|4251250|P1|STARTED|24 Month Main Study||217
1736314|NCT00150813|4251282|P1|NOT COMPLETED|Overall Study||18
1736315|NCT00150813|4251282|P1|COMPLETED|Overall Study||48
1736316|NCT00150813|4251282|P1|STARTED|Overall Study||66
1736317|NCT00150800|4251286|P1|NOT COMPLETED|Overall Study||496
1736318|NCT00150800|4251286|P1|COMPLETED|Overall Study||171
1736319|NCT00150800|4251286|P1|STARTED|Overall Study||667
1736320|NCT00150618|4251300|P5|NOT COMPLETED|Overall Study||25
1736321|NCT00150618|4251301|P4|NOT COMPLETED|Overall Study||26
1736322|NCT00150618|4251302|P3|NOT COMPLETED|Overall Study||27
1736323|NCT00150618|4251303|P2|NOT COMPLETED|Overall Study||18
1736324|NCT00150618|4251304|P1|NOT COMPLETED|Overall Study||17
1736325|NCT00150618|4251300|P5|COMPLETED|Overall Study||41
1736326|NCT00150618|4251301|P4|COMPLETED|Overall Study||40
1736327|NCT00150618|4251302|P3|COMPLETED|Overall Study||38
1736328|NCT00150618|4251303|P2|COMPLETED|Overall Study||47
1736329|NCT00150618|4251304|P1|COMPLETED|Overall Study||45
1736330|NCT00150618|4251300|P5|STARTED|Overall Study||66
1736331|NCT00150618|4251301|P4|STARTED|Overall Study||66
1736332|NCT00150618|4251302|P3|STARTED|Overall Study||65
1736333|NCT00150618|4251303|P2|STARTED|Overall Study||65
1736334|NCT00150618|4251304|P1|STARTED|Overall Study||62
1736335|NCT00150592|4251338|P2|NOT COMPLETED|Overall Study||3
1736336|NCT00150592|4251339|P1|NOT COMPLETED|Overall Study||7
1736337|NCT00150592|4251338|P2|COMPLETED|Overall Study||54
1736338|NCT00150592|4251339|P1|COMPLETED|Overall Study||114
1736339|NCT00150592|4251338|P2|STARTED|Overall Study||57
1736340|NCT00150592|4251339|P1|STARTED|Overall Study||121
1736341|NCT00150462|4251370|P11|NOT COMPLETED|Overall Study||3
1736342|NCT00150462|4251371|P10|NOT COMPLETED|Overall Study||6
1736343|NCT00150462|4251372|P9|NOT COMPLETED|Overall Study||6
1736344|NCT00150462|4251373|P8|NOT COMPLETED|Overall Study||8
1736345|NCT00150462|4251374|P7|NOT COMPLETED|Overall Study||3
1736346|NCT00150462|4251375|P6|NOT COMPLETED|Overall Study||4
1736347|NCT00150462|4251376|P5|NOT COMPLETED|Overall Study||3
1736348|NCT00150462|4251377|P4|NOT COMPLETED|Overall Study||3
1736349|NCT00150462|4251378|P3|NOT COMPLETED|Overall Study||4
1736350|NCT00150462|4251379|P2|NOT COMPLETED|Overall Study||3
1736351|NCT00150462|4251380|P1|NOT COMPLETED|Overall Study||3
1736352|NCT00150462|4251370|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
1736353|NCT00150462|4251371|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
1736354|NCT00150462|4251372|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1736355|NCT00150462|4251373|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1736356|NCT00150462|4251374|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1736357|NCT00150462|4251375|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1736358|NCT00150462|4251376|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1736359|NCT00150462|4251377|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1736360|NCT00150462|4251378|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1736361|NCT00150462|4251379|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1736362|NCT00150462|4251380|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
1736363|NCT00150462|4251370|P11|STARTED|Overall Study||4
1736364|NCT00150462|4251371|P10|STARTED|Overall Study||7
1736365|NCT00150462|4251372|P9|STARTED|Overall Study||6
1736366|NCT00150462|4251373|P8|STARTED|Overall Study||8
1736367|NCT00150462|4251374|P7|STARTED|Overall Study||3
1736368|NCT00150462|4251375|P6|STARTED|Overall Study||4
1736369|NCT00150462|4251376|P5|STARTED|Overall Study||3
1736370|NCT00150462|4251377|P4|STARTED|Overall Study||3
1736371|NCT00150462|4251378|P3|STARTED|Overall Study||4
1736372|NCT00150462|4251379|P2|STARTED|Overall Study||3
1736373|NCT00150462|4251380|P1|STARTED|Overall Study||3
1736374|NCT00150345|4251490|P2|NOT COMPLETED|Overall Study||32
1736375|NCT00150345|4251491|P1|NOT COMPLETED|Overall Study||34
1736376|NCT00150345|4251490|P2|COMPLETED|Overall Study||34
1736377|NCT00150345|4251491|P1|COMPLETED|Overall Study||47
1736378|NCT00150345|4251490|P2|STARTED|Overall Study||66
1736379|NCT00150345|4251491|P1|STARTED|Overall Study||81
1736380|NCT00150176|4251555|P2|NOT COMPLETED|Overall Study||120
1736381|NCT00150176|4251556|P1|NOT COMPLETED|Overall Study||59
1736382|NCT00150176|4251555|P2|COMPLETED|Overall Study||72
1736383|NCT00150176|4251556|P1|COMPLETED|Overall Study||135
1736384|NCT00150176|4251555|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
1736385|NCT00150176|4251556|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
1736386|NCT00149994|4251567|P2|NOT COMPLETED|Overall Study||1
1736387|NCT00149994|4251568|P1|NOT COMPLETED|Overall Study||1
1736388|NCT00149994|4251567|P2|COMPLETED|Overall Study||85
1736389|NCT00149994|4251568|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
1736390|NCT00149994|4251567|P2|STARTED|Overall Study||86
1736391|NCT00149994|4251568|P1|STARTED|Overall Study|"Started indicates Safety population."|85
1736392|NCT00149890|4251576|P2|NOT COMPLETED|Overall Study||18
1736393|NCT00149890|4251577|P1|NOT COMPLETED|Overall Study||13
1736394|NCT00149890|4251576|P2|COMPLETED|Overall Study||20
1736395|NCT00149890|4251577|P1|COMPLETED|Overall Study||26
1736396|NCT00149890|4251576|P2|STARTED|Overall Study||38
1736397|NCT00149890|4251577|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
1736398|NCT00149838|4251597|P4|NOT COMPLETED|Phase III||24
1736399|NCT00149838|4251598|P3|NOT COMPLETED|Phase III||0
1736400|NCT00149838|4251599|P2|NOT COMPLETED|Phase III||0
1736401|NCT00149838|4251600|P1|NOT COMPLETED|Phase III||0
1736402|NCT00149838|4251597|P4|COMPLETED|Phase III||37
1736403|NCT00149838|4251598|P3|COMPLETED|Phase III||0
1736404|NCT00149838|4251599|P2|COMPLETED|Phase III||0
1736405|NCT00149838|4251600|P1|COMPLETED|Phase III||0
1736406|NCT00149838|4251597|P4|STARTED|Phase III||61
1736407|NCT00149838|4251598|P3|STARTED|Phase III||0
1736408|NCT00149838|4251599|P2|STARTED|Phase III||0
1736409|NCT00149838|4251600|P1|STARTED|Phase III||0
1736410|NCT00149838|4251597|P4|NOT COMPLETED|Phase II||0
1736411|NCT00149838|4251598|P3|NOT COMPLETED|Phase II||0
1736412|NCT00149838|4251599|P2|NOT COMPLETED|Phase II||0
1736413|NCT00149838|4251600|P1|NOT COMPLETED|Phase II||0
1736414|NCT00149838|4251597|P4|COMPLETED|Phase II||0
1736415|NCT00149838|4251598|P3|COMPLETED|Phase II||144
1736416|NCT00149838|4251599|P2|COMPLETED|Phase II||0
1736417|NCT00149838|4251600|P1|COMPLETED|Phase II||0
1736418|NCT00149838|4251597|P4|STARTED|Phase II||0
1736419|NCT00149838|4251598|P3|STARTED|Phase II||144
1736420|NCT00149838|4251599|P2|STARTED|Phase II||0
1736421|NCT00149838|4251600|P1|STARTED|Phase II||0
1736422|NCT00149838|4251597|P4|NOT COMPLETED|Phase I||0
1736423|NCT00149838|4251598|P3|NOT COMPLETED|Phase I||0
1736424|NCT00149838|4251599|P2|NOT COMPLETED|Phase I||16
1736425|NCT00149838|4251600|P1|NOT COMPLETED|Phase I||20
1736426|NCT00149838|4251597|P4|COMPLETED|Phase I||0
1736427|NCT00149838|4251598|P3|COMPLETED|Phase I||0
1736428|NCT00149838|4251599|P2|COMPLETED|Phase I||82
1736429|NCT00149838|4251600|P1|COMPLETED|Phase I||72
1736430|NCT00149838|4251597|P4|STARTED|Phase I||0
1736431|NCT00149838|4251598|P3|STARTED|Phase I||0
1736432|NCT00149838|4251599|P2|STARTED|Phase I||98
1736433|NCT00149838|4251600|P1|STARTED|Phase I||92
1736434|NCT00149825|4251612|P2|NOT COMPLETED|Overall Study||3
1736435|NCT00149825|4251613|P1|NOT COMPLETED|Overall Study||5
1736436|NCT00149825|4251612|P2|COMPLETED|Overall Study||12
1736437|NCT00149825|4251613|P1|COMPLETED|Overall Study||10
1736438|NCT00149825|4251612|P2|STARTED|Overall Study||15
1736439|NCT00149825|4251613|P1|STARTED|Overall Study||15
1736440|NCT00149799|4251623|P3|NOT COMPLETED|Discontinuation (Phase II)||9
1736441|NCT00149799|4251624|P2|NOT COMPLETED|Discontinuation (Phase II)||3
1736442|NCT00149799|4251625|P1|NOT COMPLETED|Discontinuation (Phase II)||0
1736443|NCT00149799|4251623|P3|COMPLETED|Discontinuation (Phase II)||21
1736444|NCT00149799|4251624|P2|COMPLETED|Discontinuation (Phase II)||25
1736445|NCT00149799|4251625|P1|COMPLETED|Discontinuation (Phase II)||0
1736446|NCT00149799|4251623|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
1736447|NCT00149799|4251624|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
1736448|NCT00149799|4251625|P1|STARTED|Discontinuation (Phase II)||0
1736449|NCT00149799|4251623|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
1736450|NCT00149799|4251624|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
1736451|NCT00149799|4251625|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
1736452|NCT00149799|4251623|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
1736453|NCT00149799|4251624|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
1736454|NCT00149799|4251625|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
1736455|NCT00149799|4251623|P3|STARTED|Open Label Escitalopram (Phase I)||0
1736456|NCT00149799|4251624|P2|STARTED|Open Label Escitalopram (Phase I)||0
1736457|NCT00149799|4251625|P1|STARTED|Open Label Escitalopram (Phase I)||100
1736458|NCT00149747|4251641|P2|NOT COMPLETED|Overall Study||3
1736459|NCT00149747|4251642|P1|NOT COMPLETED|Overall Study||4
1736460|NCT00149747|4251641|P2|COMPLETED|Overall Study||27
1736461|NCT00149747|4251642|P1|COMPLETED|Overall Study||32
1736462|NCT00149747|4251641|P2|STARTED|Overall Study||30
1736463|NCT00149747|4251642|P1|STARTED|Overall Study||36
1736464|NCT00149669|4251654|P2|NOT COMPLETED|Overall Study||5
1736465|NCT00149669|4251655|P1|NOT COMPLETED|Overall Study||3
1736466|NCT00149669|4251654|P2|COMPLETED|Overall Study||30
1736467|NCT00149669|4251655|P1|COMPLETED|Overall Study||29
1736468|NCT00149669|4251654|P2|STARTED|Overall Study||35
1736469|NCT00149669|4251655|P1|STARTED|Overall Study||32
1736470|NCT00149643|4251675|P2|NOT COMPLETED|Overall Study||36
1736471|NCT00149643|4251676|P1|NOT COMPLETED|Overall Study||34
1736472|NCT00149643|4251675|P2|COMPLETED|Overall Study||0
1736473|NCT00149643|4251676|P1|COMPLETED|Overall Study||0
1736474|NCT00149643|4251675|P2|STARTED|Overall Study||36
1736475|NCT00149643|4251676|P1|STARTED|Overall Study||34
1736476|NCT00149630|4251688|P2|NOT COMPLETED|Overall Study||5
1736477|NCT00149630|4251689|P1|NOT COMPLETED|Overall Study||8
1736478|NCT00149630|4251688|P2|COMPLETED|Overall Study||35
1736479|NCT00149630|4251689|P1|COMPLETED|Overall Study||26
1736480|NCT00149630|4251688|P2|STARTED|Overall Study||40
1736481|NCT00149630|4251689|P1|STARTED|Overall Study||34
1736482|NCT00149396|4251699|P1|NOT COMPLETED|Overall Study||23
1736483|NCT00149396|4251699|P1|COMPLETED|Overall Study||9
1736484|NCT00149396|4251699|P1|Completed NV1020 and Chemotherapy|Overall Study||9
1736485|NCT00149396|4251699|P1|Completed NV1020 Therapy|Overall Study||29
1736486|NCT00149396|4251699|P1|STARTED|Overall Study||32
1736487|NCT00149227|4251742|P2|NOT COMPLETED|Overall Study||0
1736488|NCT00149227|4251743|P1|NOT COMPLETED|Overall Study||0
1736489|NCT00149227|4251742|P2|COMPLETED|Overall Study||1514
1736490|NCT00149227|4251743|P1|COMPLETED|Overall Study||1517
1736491|NCT00149227|4251742|P2|STARTED|Overall Study||1514
1736492|NCT00149227|4251743|P1|STARTED|Overall Study||1517
1736493|NCT00149214|4251769|P2|NOT COMPLETED|Overall Study||17
1736494|NCT00149214|4251770|P1|NOT COMPLETED|Overall Study||26
1736495|NCT00149214|4251769|P2|COMPLETED|Overall Study||105
1736496|NCT00149214|4251770|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
1736497|NCT00149214|4251769|P2|STARTED|Overall Study||122
1736498|NCT00149214|4251770|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
1736499|NCT00148954|4251786|P2|NOT COMPLETED|Overall Study||300
1736500|NCT00148954|4251787|P1|NOT COMPLETED|Overall Study||307
1736501|NCT00148954|4251786|P2|COMPLETED|Overall Study||677
1736502|NCT00148954|4251787|P1|COMPLETED|Overall Study||678
1736503|NCT00148954|4251786|P2|STARTED|Overall Study||977
1736504|NCT00148954|4251787|P1|STARTED|Overall Study||985
1736505|NCT00148798|4251795|P2|NOT COMPLETED|Overall Study||0
1736506|NCT00148798|4251796|P1|NOT COMPLETED|Overall Study||0
1736507|NCT00148798|4251795|P2|COMPLETED|Overall Study||568
1736508|NCT00148798|4251796|P1|COMPLETED|Overall Study||557
1736509|NCT00148798|4251795|P2|STARTED|Overall Study|ITT Population|568
1736510|NCT00148798|4251796|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
1736511|NCT00148759|4251818|P2|NOT COMPLETED|Overall Study||1
1736512|NCT00148759|4251819|P1|NOT COMPLETED|Overall Study||2
1736513|NCT00148759|4251818|P2|COMPLETED|Overall Study||11
1736514|NCT00148759|4251819|P1|COMPLETED|Overall Study||9
1736515|NCT00148759|4251818|P2|24-hr PK Sampling|Overall Study||11
1736516|NCT00148759|4251819|P1|24-hr PK Sampling|Overall Study||9
1736517|NCT00148759|4251818|P2|STARTED|Overall Study||12
1736518|NCT00148759|4251819|P1|STARTED|Overall Study||11
1736519|NCT00148733|4251829|P2|NOT COMPLETED|Overall Study||15
1736520|NCT00148733|4251830|P1|NOT COMPLETED|Overall Study||14
1736521|NCT00148733|4251829|P2|COMPLETED|Overall Study||1299
1736522|NCT00148733|4251830|P1|COMPLETED|Overall Study||1300
1736523|NCT00148733|4251829|P2|STARTED|Overall Study||1314
1736524|NCT00148733|4251830|P1|STARTED|Overall Study||1314
1736525|NCT00148668|4251838|P2|NOT COMPLETED|Overall Study||0
1736526|NCT00148668|4251839|P1|NOT COMPLETED|Overall Study||0
1736527|NCT00148668|4251838|P2|COMPLETED|Overall Study||40
1736528|NCT00148668|4251839|P1|COMPLETED|Overall Study||41
1736529|NCT00148668|4251838|P2|STARTED|Overall Study||40
1736530|NCT00148668|4251839|P1|STARTED|Overall Study||41
1736531|NCT00148343|4251847|P2|NOT COMPLETED|Overall Study||11
1736532|NCT00148343|4251848|P1|NOT COMPLETED|Overall Study||15
1736533|NCT00148343|4251847|P2|COMPLETED|Overall Study||45
1736534|NCT00148343|4251848|P1|COMPLETED|Overall Study||39
1736535|NCT00148343|4251847|P2|STARTED|Overall Study||56
1736536|NCT00148343|4251848|P1|STARTED|Overall Study||54
1736537|NCT00148317|4251862|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
1736538|NCT00148317|4251862|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
1736539|NCT00148317|4251862|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
1736540|NCT00148317|4251862|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
1736541|NCT00148317|4251862|P1|COMPLETED|Consolidation (VEL + DEX)||38
1736542|NCT00148317|4251862|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
1736543|NCT00148317|4251862|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
1736544|NCT00148317|4251862|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
1736545|NCT00148317|4251862|P1|STARTED|Consolidation (VEL + DEX)||38
1736546|NCT00148122|4251869|P1|NOT COMPLETED|Overall Study||2
1736547|NCT00148122|4251869|P1|COMPLETED|Overall Study||38
1736548|NCT00148122|4251869|P1|STARTED|Overall Study||40
1736549|NCT00148109|4251877|P2|NOT COMPLETED|Overall Study||20
1736550|NCT00148109|4251878|P1|NOT COMPLETED|Overall Study||12
1736551|NCT00148109|4251877|P2|COMPLETED|Overall Study||1
1736552|NCT00148109|4251878|P1|COMPLETED|Overall Study||3
1736553|NCT00148109|4251877|P2|STARTED|Overall Study||21
1736554|NCT00148109|4251878|P1|STARTED|Overall Study||15
1736555|NCT00147966|4251888|P1|NOT COMPLETED|Overall Study||0
1736556|NCT00147966|4251888|P1|COMPLETED|Overall Study||24
1736557|NCT00147966|4251888|P1|STARTED|Overall Study||24
1736558|NCT00147823|4251894|P2|NOT COMPLETED|Overall Study||15
1736559|NCT00147823|4251895|P1|NOT COMPLETED|Overall Study||13
1736560|NCT00147823|4251894|P2|COMPLETED|Overall Study||16
1736561|NCT00147823|4251895|P1|COMPLETED|Overall Study||19
1736562|NCT00147823|4251894|P2|Month 24 Visit|Overall Study||18
1736563|NCT00147823|4251895|P1|Month 24 Visit|Overall Study||21
1736564|NCT00147823|4251894|P2|Month 18 Visit|Overall Study||20
1736565|NCT00147823|4251895|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
1736566|NCT00147823|4251894|P2|Month 12 CT Scan|Overall Study||25
1736567|NCT00147823|4251895|P1|Month 12 CT Scan|Overall Study||20
1736568|NCT00147823|4251894|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
1736569|NCT00147823|4251895|P1|Month 12 Visit|Overall Study||21
1736570|NCT00147823|4251894|P2|Month 6 Visit|Overall Study||21
1736571|NCT00147823|4251895|P1|Month 6 Visit|Overall Study||25
1736572|NCT00147823|4251894|P2|Month 3 Visit|Overall Study||24
1736573|NCT00147823|4251895|P1|Month 3 Visit|Overall Study||25
1736574|NCT00147823|4251894|P2|Week 6 Visit|Overall Study||28
1736575|NCT00147823|4251895|P1|Week 6 Visit|Overall Study||26
1736576|NCT00147823|4251894|P2|STARTED|Overall Study||31
1736577|NCT00147823|4251895|P1|STARTED|Overall Study||32
1736578|NCT00147745|4251926|P3|NOT COMPLETED|Overall Study||0
1736579|NCT00147745|4251927|P2|NOT COMPLETED|Overall Study||0
1736580|NCT00147745|4251928|P1|NOT COMPLETED|Overall Study||1
1736581|NCT00147745|4251926|P3|COMPLETED|Overall Study||6
1736582|NCT00147745|4251927|P2|COMPLETED|Overall Study||14
1736583|NCT00147745|4251928|P1|COMPLETED|Overall Study||15
1736584|NCT00147745|4251926|P3|STARTED|Overall Study||6
1736585|NCT00147745|4251927|P2|STARTED|Overall Study||14
1736586|NCT00147745|4251928|P1|STARTED|Overall Study||16
1736587|NCT00147537|4251950|P11|NOT COMPLETED|Phase 2||52
1736588|NCT00147537|4251951|P10|NOT COMPLETED|Phase 2||161
1736589|NCT00147537|4251952|P9|NOT COMPLETED|Phase 2||0
1736590|NCT00147537|4251953|P8|NOT COMPLETED|Phase 2||0
1736591|NCT00147537|4251954|P7|NOT COMPLETED|Phase 2||0
1736592|NCT00147537|4251955|P6|NOT COMPLETED|Phase 2||0
1736593|NCT00147537|4251956|P5|NOT COMPLETED|Phase 2||0
1736594|NCT00147537|4251957|P4|NOT COMPLETED|Phase 2||0
1736595|NCT00147537|4251958|P3|NOT COMPLETED|Phase 2||0
1736596|NCT00147537|4251959|P2|NOT COMPLETED|Phase 2||0
1736597|NCT00147537|4251960|P1|NOT COMPLETED|Phase 2||0
1736598|NCT00147537|4251950|P11|COMPLETED|Phase 2||3
1736599|NCT00147537|4251951|P10|COMPLETED|Phase 2||5
1736600|NCT00147537|4251952|P9|COMPLETED|Phase 2||0
1736601|NCT00147537|4251953|P8|COMPLETED|Phase 2||0
1736602|NCT00147537|4251954|P7|COMPLETED|Phase 2||0
1736603|NCT00147537|4251955|P6|COMPLETED|Phase 2||0
1736604|NCT00147537|4251956|P5|COMPLETED|Phase 2||0
1736605|NCT00147537|4251957|P4|COMPLETED|Phase 2||0
1736606|NCT00147537|4251958|P3|COMPLETED|Phase 2||0
1736607|NCT00147537|4251959|P2|COMPLETED|Phase 2||0
1736608|NCT00147537|4251960|P1|COMPLETED|Phase 2||0
1736609|NCT00147537|4251950|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
1736610|NCT00147537|4251951|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
1736611|NCT00147537|4251952|P9|STARTED|Phase 2||0
1736612|NCT00147537|4251953|P8|STARTED|Phase 2||0
1736613|NCT00147537|4251954|P7|STARTED|Phase 2||0
1736614|NCT00147537|4251955|P6|STARTED|Phase 2||0
1736615|NCT00147537|4251956|P5|STARTED|Phase 2||0
1736616|NCT00147537|4251957|P4|STARTED|Phase 2||0
1736617|NCT00147537|4251958|P3|STARTED|Phase 2||0
1736618|NCT00147537|4251959|P2|STARTED|Phase 2||0
1736619|NCT00147537|4251960|P1|STARTED|Phase 2||0
1736620|NCT00147537|4251950|P11|NOT COMPLETED|Phase 1b||0
1736621|NCT00147537|4251951|P10|NOT COMPLETED|Phase 1b||0
1736622|NCT00147537|4251952|P9|NOT COMPLETED|Phase 1b||17
1736623|NCT00147537|4251953|P8|NOT COMPLETED|Phase 1b||7
1736624|NCT00147537|4251954|P7|NOT COMPLETED|Phase 1b||18
1736625|NCT00147537|4251955|P6|NOT COMPLETED|Phase 1b||3
1736626|NCT00147537|4251956|P5|NOT COMPLETED|Phase 1b||3
1736627|NCT00147537|4251957|P4|NOT COMPLETED|Phase 1b||2
1736628|NCT00147537|4251958|P3|NOT COMPLETED|Phase 1b||4
1736629|NCT00147537|4251959|P2|NOT COMPLETED|Phase 1b||2
1736630|NCT00147537|4251960|P1|NOT COMPLETED|Phase 1b||2
1736631|NCT00147537|4251950|P11|COMPLETED|Phase 1b||0
1736632|NCT00147537|4251951|P10|COMPLETED|Phase 1b||0
1736633|NCT00147537|4251952|P9|COMPLETED|Phase 1b||1
1736634|NCT00147537|4251953|P8|COMPLETED|Phase 1b||0
1736635|NCT00147537|4251954|P7|COMPLETED|Phase 1b||0
1736636|NCT00147537|4251955|P6|COMPLETED|Phase 1b||0
1736637|NCT00147537|4251956|P5|COMPLETED|Phase 1b||0
1736638|NCT00147537|4251957|P4|COMPLETED|Phase 1b||1
1736639|NCT00147537|4251958|P3|COMPLETED|Phase 1b||0
1736640|NCT00147537|4251959|P2|COMPLETED|Phase 1b||0
1736641|NCT00147537|4251960|P1|COMPLETED|Phase 1b||1
1736642|NCT00147537|4251950|P11|STARTED|Phase 1b||0
1736643|NCT00147537|4251951|P10|STARTED|Phase 1b||0
1736644|NCT00147537|4251952|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
1736645|NCT00147537|4251953|P8|STARTED|Phase 1b||7
1736646|NCT00147537|4251954|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
1736647|NCT00147537|4251955|P6|STARTED|Phase 1b||3
1736648|NCT00147537|4251956|P5|STARTED|Phase 1b||3
1736649|NCT00147537|4251957|P4|STARTED|Phase 1b||3
1736650|NCT00147537|4251958|P3|STARTED|Phase 1b||4
1736651|NCT00147537|4251959|P2|STARTED|Phase 1b||2
1736652|NCT00147537|4251960|P1|STARTED|Phase 1b||3
1736653|NCT00147498|4252143|P4|NOT COMPLETED|Overall Study||17
1736654|NCT00147498|4252144|P3|NOT COMPLETED|Overall Study||17
1736655|NCT00147498|4252145|P2|NOT COMPLETED|Overall Study||9
1736656|NCT00147498|4252146|P1|NOT COMPLETED|Overall Study||3
1736657|NCT00147498|4252143|P4|COMPLETED|Overall Study||48
1736658|NCT00147498|4252144|P3|COMPLETED|Overall Study||52
1736659|NCT00147498|4252145|P2|COMPLETED|Overall Study||60
1736660|NCT00147498|4252146|P1|COMPLETED|Overall Study||58
1736661|NCT00147498|4252143|P4|STARTED|Overall Study||65
1736662|NCT00147498|4252144|P3|STARTED|Overall Study||69
1736663|NCT00147498|4252145|P2|STARTED|Overall Study||69
1736664|NCT00147498|4252146|P1|STARTED|Overall Study||61
1736665|NCT00147446|4252242|P2|NOT COMPLETED|Overall Study||0
1736666|NCT00147446|4252243|P1|NOT COMPLETED|Overall Study||0
1736667|NCT00147446|4252242|P2|COMPLETED|Overall Study||61
1736668|NCT00147446|4252243|P1|COMPLETED|Overall Study||60
1736669|NCT00147446|4252242|P2|STARTED|Overall Study||61
1736670|NCT00147446|4252243|P1|STARTED|Overall Study||60
1736671|NCT00147316|4252251|P1|NOT COMPLETED|Overall Study||0
1736672|NCT00147316|4252251|P1|COMPLETED|Overall Study||103
1736673|NCT00147316|4252251|P1|STARTED|Overall Study||103
1736674|NCT00147290|4252258|P2|NOT COMPLETED|Overall Study||0
1736675|NCT00147290|4252259|P1|NOT COMPLETED|Overall Study||0
1736676|NCT00147290|4252258|P2|COMPLETED|Overall Study||260
1736677|NCT00147290|4252259|P1|COMPLETED|Overall Study||266
1736678|NCT00147290|4252258|P2|STARTED|Overall Study||260
1736679|NCT00147290|4252259|P1|STARTED|Overall Study||266
1736680|NCT00147277|4252265|P2|NOT COMPLETED|Overall Study||0
1736681|NCT00147277|4252266|P1|NOT COMPLETED|Overall Study||0
1736682|NCT00147277|4252265|P2|COMPLETED|Overall Study||450
1736683|NCT00147277|4252266|P1|COMPLETED|Overall Study||475
1736684|NCT00147277|4252265|P2|STARTED|Overall Study||450
1736685|NCT00147277|4252266|P1|STARTED|Overall Study||475
1736686|NCT00147238|4252270|P1|NOT COMPLETED|Overall Study||8
1736687|NCT00147238|4252270|P1|COMPLETED|Overall Study||2
1736688|NCT00147238|4252270|P1|STARTED|Overall Study||10
1736689|NCT00147225|4252280|P6|NOT COMPLETED|Overall Study||2
1736690|NCT00147225|4252281|P5|NOT COMPLETED|Overall Study||1
1736691|NCT00147225|4252282|P4|NOT COMPLETED|Overall Study||1
1736692|NCT00147225|4252283|P3|NOT COMPLETED|Overall Study||2
1736693|NCT00147225|4252284|P2|NOT COMPLETED|Overall Study||0
1736694|NCT00147225|4252285|P1|NOT COMPLETED|Overall Study||1
1736695|NCT00147225|4252280|P6|COMPLETED|Overall Study||10
1736696|NCT00147225|4252281|P5|COMPLETED|Overall Study||10
1736697|NCT00147225|4252282|P4|COMPLETED|Overall Study||10
1736698|NCT00147225|4252283|P3|COMPLETED|Overall Study||6
1736699|NCT00147225|4252284|P2|COMPLETED|Overall Study||6
1736700|NCT00147225|4252285|P1|COMPLETED|Overall Study||6
1736701|NCT00147225|4252280|P6|STARTED|Overall Study||12
1736702|NCT00147225|4252281|P5|STARTED|Overall Study||11
1736703|NCT00147225|4252282|P4|STARTED|Overall Study||11
1736704|NCT00147225|4252283|P3|STARTED|Overall Study||8
1736705|NCT00147225|4252284|P2|STARTED|Overall Study||6
1736706|NCT00147225|4252285|P1|STARTED|Overall Study||7
1736707|NCT00147212|4252305|P1|NOT COMPLETED|Overall Study||0
1736708|NCT00147212|4252305|P1|COMPLETED|Overall Study||50
1736709|NCT00147212|4252305|P1|STARTED|Overall Study||50
1736710|NCT00147199|4252311|P2|NOT COMPLETED|Overall Study||10
1736711|NCT00147199|4252312|P1|NOT COMPLETED|Overall Study||13
1736712|NCT00147199|4252311|P2|COMPLETED|Overall Study||110
1736713|NCT00147199|4252312|P1|COMPLETED|Overall Study||102
1736714|NCT00147199|4252311|P2|STARTED|Overall Study||120
1736715|NCT00147199|4252312|P1|STARTED|Overall Study||115
1736716|NCT00147030|4252336|P2|NOT COMPLETED|Overall Study||0
1736717|NCT00147030|4252337|P1|NOT COMPLETED|Overall Study||0
1736718|NCT00147030|4252336|P2|COMPLETED|Overall Study||162
1736719|NCT00147030|4252337|P1|COMPLETED|Overall Study||163
1736720|NCT00147030|4252336|P2|STARTED|Overall Study||162
1736721|NCT00147030|4252337|P1|STARTED|Overall Study||163
1736722|NCT00146848|4252388|P3|NOT COMPLETED|Post-randomization||39
1736723|NCT00146848|4252389|P2|NOT COMPLETED|Post-randomization||47
1736724|NCT00146848|4252390|P1|NOT COMPLETED|Post-randomization||38
1736725|NCT00146848|4252388|P3|COMPLETED|Post-randomization||431
1736726|NCT00146848|4252389|P2|COMPLETED|Post-randomization||441
1736727|NCT00146848|4252390|P1|COMPLETED|Post-randomization||437
1736728|NCT00146848|4252388|P3|STARTED|Post-randomization||470
1736729|NCT00146848|4252389|P2|STARTED|Post-randomization||488
1736730|NCT00146848|4252390|P1|STARTED|Post-randomization||475
1736731|NCT00146848|4252388|P3|NOT COMPLETED|Pre-randomization||0
1736732|NCT00146848|4252389|P2|NOT COMPLETED|Pre-randomization||0
1736733|NCT00146848|4252390|P1|NOT COMPLETED|Pre-randomization||309
1736734|NCT00146848|4252388|P3|COMPLETED|Pre-randomization||0
1736735|NCT00146848|4252389|P2|COMPLETED|Pre-randomization||0
1736736|NCT00146848|4252390|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
1736737|NCT00146848|4252388|P3|STARTED|Pre-randomization||0
1736738|NCT00146848|4252389|P2|STARTED|Pre-randomization||0
1736739|NCT00146848|4252390|P1|STARTED|Pre-randomization|Registered|1742
1736740|NCT00146770|4252406|P2|NOT COMPLETED|Overall Study||0
1736741|NCT00146770|4252407|P1|NOT COMPLETED|Overall Study||5
1736742|NCT00146770|4252406|P2|COMPLETED|Overall Study||22
1736743|NCT00146770|4252407|P1|COMPLETED|Overall Study||18
1736744|NCT00146770|4252406|P2|STARTED|Overall Study||22
1736745|NCT00146770|4252407|P1|STARTED|Overall Study||23
1736746|NCT00146757|4252425|P2|NOT COMPLETED|Overall Study||0
1736747|NCT00146757|4252426|P1|NOT COMPLETED|Overall Study||2
1736748|NCT00146757|4252425|P2|COMPLETED|Overall Study||4
1736749|NCT00146757|4252426|P1|COMPLETED|Overall Study||14
1736750|NCT00146757|4252425|P2|STARTED|Overall Study||4
1736751|NCT00146757|4252426|P1|STARTED|Overall Study||16
1736752|NCT00146640|4252445|P2|NOT COMPLETED|Overall Study||14
1736753|NCT00146640|4252446|P1|NOT COMPLETED|Overall Study||23
1736754|NCT00146640|4252445|P2|COMPLETED|Overall Study||130
1736755|NCT00146640|4252446|P1|COMPLETED|Overall Study||121
1736756|NCT00146640|4252445|P2|STARTED|Overall Study||144
1736757|NCT00146640|4252446|P1|STARTED|Overall Study||144
1736758|NCT00146328|4252469|P3|NOT COMPLETED|Overall Study||291
1736759|NCT00146328|4252470|P2|NOT COMPLETED|Overall Study||154
1736760|NCT00146328|4252471|P1|NOT COMPLETED|Overall Study||141
1736761|NCT00146328|4252469|P3|COMPLETED|Overall Study||158
1736762|NCT00146328|4252470|P2|COMPLETED|Overall Study||101
1736763|NCT00146328|4252471|P1|COMPLETED|Overall Study||150
1736764|NCT00146328|4252469|P3|STARTED|Overall Study||449
1736765|NCT00146328|4252470|P2|STARTED|Overall Study||255
1736766|NCT00146328|4252471|P1|STARTED|Overall Study||291
1736767|NCT00146172|4252562|P8|NOT COMPLETED|Overall Study||40
1736768|NCT00146172|4252563|P7|NOT COMPLETED|Overall Study||6
1736769|NCT00146172|4252564|P6|NOT COMPLETED|Overall Study||7
1736770|NCT00146172|4252565|P5|NOT COMPLETED|Overall Study||3
1736771|NCT00146172|4252566|P4|NOT COMPLETED|Overall Study||6
1736772|NCT00146172|4252567|P3|NOT COMPLETED|Overall Study||4
1736773|NCT00146172|4252568|P2|NOT COMPLETED|Overall Study||4
1736774|NCT00146172|4252569|P1|NOT COMPLETED|Overall Study||3
1736775|NCT00146172|4252562|P8|COMPLETED|Overall Study||0
1736776|NCT00146172|4252563|P7|COMPLETED|Overall Study||0
1736777|NCT00146172|4252564|P6|COMPLETED|Overall Study||0
1736778|NCT00146172|4252565|P5|COMPLETED|Overall Study||0
1736779|NCT00146172|4252566|P4|COMPLETED|Overall Study||0
1736780|NCT00146172|4252567|P3|COMPLETED|Overall Study||0
1736781|NCT00146172|4252568|P2|COMPLETED|Overall Study||0
1736782|NCT00146172|4252569|P1|COMPLETED|Overall Study||0
1736783|NCT00146172|4252562|P8|Received Drug|Overall Study||39
1736784|NCT00146172|4252563|P7|Received Drug|Overall Study||6
1736785|NCT00146172|4252564|P6|Received Drug|Overall Study||7
1736786|NCT00146172|4252565|P5|Received Drug|Overall Study||3
1736787|NCT00146172|4252566|P4|Received Drug|Overall Study||6
1736788|NCT00146172|4252567|P3|Received Drug|Overall Study||4
1736789|NCT00146172|4252568|P2|Received Drug|Overall Study||4
1736790|NCT00146172|4252569|P1|Received Drug|Overall Study||3
1736791|NCT00146172|4252562|P8|STARTED|Overall Study||40
1736792|NCT00146172|4252563|P7|STARTED|Overall Study||6
1736793|NCT00146172|4252564|P6|STARTED|Overall Study||7
1736794|NCT00146172|4252565|P5|STARTED|Overall Study||3
1736795|NCT00146172|4252566|P4|STARTED|Overall Study||6
1736796|NCT00146172|4252567|P3|STARTED|Overall Study||4
1736797|NCT00146172|4252568|P2|STARTED|Overall Study||4
1736798|NCT00146172|4252569|P1|STARTED|Overall Study||3
1736799|NCT00145977|4252604|P2|NOT COMPLETED|Overall Study||4
1736800|NCT00145977|4252605|P1|NOT COMPLETED|Overall Study||2
1736801|NCT00145977|4252604|P2|COMPLETED|Overall Study||13
1736802|NCT00145977|4252605|P1|COMPLETED|Overall Study||17
1736803|NCT00145977|4252604|P2|STARTED|Overall Study||17
1736804|NCT00145977|4252605|P1|STARTED|Overall Study||19
1736805|NCT00145795|4252631|P2|NOT COMPLETED|Overall Study||0
1736806|NCT00145795|4252632|P1|NOT COMPLETED|Overall Study||1
1736807|NCT00145795|4252631|P2|COMPLETED|Overall Study||10
1736808|NCT00145795|4252632|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
1736809|NCT00145795|4252631|P2|STARTED|Overall Study||10
1736810|NCT00145795|4252632|P1|STARTED|Overall Study||10
1736811|NCT00145704|4252658|P2|NOT COMPLETED|Overall Study||3
1736812|NCT00145704|4252659|P1|NOT COMPLETED|Overall Study||3
1736813|NCT00145704|4252658|P2|COMPLETED|Overall Study||0
1736814|NCT00145704|4252659|P1|COMPLETED|Overall Study||0
1736815|NCT00145704|4252658|P2|STARTED|Overall Study||3
1736816|NCT00145704|4252659|P1|STARTED|Overall Study||3
1736817|NCT00145626|4252667|P1|NOT COMPLETED|Overall Study||5
1736818|NCT00145626|4252667|P1|COMPLETED|Overall Study||14
1736819|NCT00145626|4252667|P1|STARTED|Overall Study||19
1736820|NCT00145600|4252713|P4|NOT COMPLETED|Overall Study||16
1736821|NCT00145600|4252714|P3|NOT COMPLETED|Overall Study||5
1736822|NCT00145600|4252715|P2|NOT COMPLETED|Overall Study||10
1736823|NCT00145600|4252716|P1|NOT COMPLETED|Overall Study||8
1736824|NCT00145600|4252713|P4|COMPLETED|Overall Study||130
1736825|NCT00145600|4252714|P3|COMPLETED|Overall Study||8
1736826|NCT00145600|4252715|P2|COMPLETED|Overall Study||36
1736827|NCT00145600|4252716|P1|COMPLETED|Overall Study||83
1736828|NCT00145600|4252713|P4|STARTED|Overall Study||146
1736829|NCT00145600|4252714|P3|STARTED|Overall Study||13
1736830|NCT00145600|4252715|P2|STARTED|Overall Study||46
1736831|NCT00145600|4252716|P1|STARTED|Overall Study||91
1736832|NCT00145587|4252830|P2|NOT COMPLETED|Overall Study||0
1736833|NCT00145587|4252831|P1|NOT COMPLETED|Overall Study||0
1736834|NCT00145587|4252830|P2|COMPLETED|Overall Study||1
1736835|NCT00145587|4252831|P1|COMPLETED|Overall Study||5
1736836|NCT00145587|4252830|P2|STARTED|Overall Study||1
1736837|NCT00145587|4252831|P1|STARTED|Overall Study||5
1736838|NCT00145574|4252840|P3|NOT COMPLETED|Open Label Long-term Extension||11
1736839|NCT00145574|4252841|P2|NOT COMPLETED|Open Label Long-term Extension||0
1736840|NCT00145574|4252842|P1|NOT COMPLETED|Open Label Long-term Extension||0
1736841|NCT00145574|4252840|P3|COMPLETED|Open Label Long-term Extension||173
1736842|NCT00145574|4252841|P2|COMPLETED|Open Label Long-term Extension||0
1736843|NCT00145574|4252842|P1|COMPLETED|Open Label Long-term Extension||0
1736844|NCT00145574|4252840|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
1736845|NCT00145574|4252841|P2|STARTED|Open Label Long-term Extension||0
1736846|NCT00145574|4252842|P1|STARTED|Open Label Long-term Extension||0
1736847|NCT00145574|4252840|P3|NOT COMPLETED|Double Blind||2
1736848|NCT00145574|4252841|P2|NOT COMPLETED|Double Blind||5
1736849|NCT00145574|4252842|P1|NOT COMPLETED|Double Blind||1
1736850|NCT00145574|4252840|P3|COMPLETED|Double Blind||62
1736851|NCT00145574|4252841|P2|COMPLETED|Double Blind||60
1736852|NCT00145574|4252842|P1|COMPLETED|Double Blind||64
1736853|NCT00145574|4252840|P3|STARTED|Double Blind||64
1736854|NCT00145574|4252841|P2|STARTED|Double Blind||65
1736855|NCT00145574|4252842|P1|STARTED|Double Blind||65
1736856|NCT00145509|4252899|P2|NOT COMPLETED|Overall Study||21
1736857|NCT00145509|4252900|P1|NOT COMPLETED|Overall Study||22
1736858|NCT00145509|4252899|P2|COMPLETED|Overall Study||15
1736859|NCT00145509|4252900|P1|COMPLETED|Overall Study||19
1736860|NCT00145509|4252899|P2|STARTED|Overall Study||36
1736861|NCT00145509|4252900|P1|STARTED|Overall Study||41
1736862|NCT00145496|4252914|P2|NOT COMPLETED|Overall Study||81
1736863|NCT00145496|4252915|P1|NOT COMPLETED|Overall Study||123
1736864|NCT00145496|4252914|P2|COMPLETED|Overall Study||143
1736865|NCT00145496|4252915|P1|COMPLETED|Overall Study||121
1736866|NCT00145496|4252914|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
1736867|NCT00145496|4252915|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
1736868|NCT00145418|4252925|P1|NOT COMPLETED|Overall Study||0
1736869|NCT00145418|4252925|P1|COMPLETED|Overall Study||15
1736870|NCT00145418|4252925|P1|STARTED|Overall Study||15
1736871|NCT00145327|4252935|P3|NOT COMPLETED|Overall Study||248
1736872|NCT00145327|4252936|P2|NOT COMPLETED|Overall Study||124
1736873|NCT00145327|4252937|P1|NOT COMPLETED|Overall Study||142
1736874|NCT00145327|4252935|P3|COMPLETED|Overall Study||975
1736875|NCT00145327|4252936|P2|COMPLETED|Overall Study||493
1736876|NCT00145327|4252937|P1|COMPLETED|Overall Study||474
1736877|NCT00145327|4252935|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
1736878|NCT00145327|4252936|P2|STARTED|Overall Study||617
1736879|NCT00145327|4252937|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
1736880|NCT00145249|4252993|P3|NOT COMPLETED|Overall Study||17
1736881|NCT00145249|4252994|P2|NOT COMPLETED|Overall Study||15
1736882|NCT00145249|4252995|P1|NOT COMPLETED|Overall Study||11
1736883|NCT00145249|4252993|P3|COMPLETED|Overall Study||31
1736884|NCT00145249|4252994|P2|COMPLETED|Overall Study||33
1736885|NCT00145249|4252995|P1|COMPLETED|Overall Study||36
1736886|NCT00145249|4252993|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
1736887|NCT00145249|4252994|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
1736888|NCT00145249|4252995|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
1736889|NCT00145119|4253036|P1|NOT COMPLETED|Overall Study||45
1736890|NCT00145119|4253036|P1|COMPLETED|Overall Study||267
1736891|NCT00145119|4253036|P1|STARTED|Overall Study||312
1736892|NCT00145041|4253040|P1|NOT COMPLETED|Overall Study||0
1736893|NCT00145041|4253040|P1|COMPLETED|Overall Study||7
1736894|NCT00145041|4253040|P1|STARTED|Overall Study||7
1736895|NCT00144963|4253046|P1|NOT COMPLETED|Overall Study||0
1736896|NCT00144963|4253046|P1|COMPLETED|Overall Study||36
1736897|NCT00144963|4253046|P1|STARTED|Overall Study||36
1736898|NCT00144781|4253054|P4|NOT COMPLETED|Overall Study||0
1736899|NCT00144781|4253055|P3|NOT COMPLETED|Overall Study||0
1736900|NCT00144781|4253056|P2|NOT COMPLETED|Overall Study||2
1736901|NCT00144781|4253057|P1|NOT COMPLETED|Overall Study||0
1736902|NCT00144781|4253054|P4|COMPLETED|Overall Study||9
1736903|NCT00144781|4253055|P3|COMPLETED|Overall Study||8
1736904|NCT00144781|4253056|P2|COMPLETED|Overall Study||7
1736905|NCT00144781|4253057|P1|COMPLETED|Overall Study||8
1736906|NCT00144781|4253054|P4|STARTED|Overall Study||9
1736907|NCT00144781|4253055|P3|STARTED|Overall Study||8
1736908|NCT00144781|4253056|P2|STARTED|Overall Study||9
1736909|NCT00144781|4253057|P1|STARTED|Overall Study||8
1736910|NCT00144391|4253077|P2|NOT COMPLETED|Overall Study||0
1736911|NCT00144391|4253078|P1|NOT COMPLETED|Overall Study||0
1736912|NCT00144391|4253077|P2|COMPLETED|Overall Study||9
1736913|NCT00144391|4253078|P1|COMPLETED|Overall Study||11
1736914|NCT00144391|4253077|P2|STARTED|Overall Study||9
1736915|NCT00144391|4253078|P1|STARTED|Overall Study||11
1736916|NCT00144339|4253086|P2|NOT COMPLETED|Overall Study||1099
1736917|NCT00144339|4253087|P1|NOT COMPLETED|Overall Study||1358
1736918|NCT00144339|4253086|P2|COMPLETED|Overall Study||1887
1736919|NCT00144339|4253087|P1|COMPLETED|Overall Study||1648
1736920|NCT00144339|4253086|P2|STARTED|Overall Study||2986
1736921|NCT00144339|4253087|P1|STARTED|Overall Study||3006
1736922|NCT00144300|4253295|P2|NOT COMPLETED|Overall Study||28
1736923|NCT00144300|4253296|P1|NOT COMPLETED|Overall Study||29
1736924|NCT00144300|4253295|P2|COMPLETED|Overall Study||97
1736925|NCT00144300|4253296|P1|COMPLETED|Overall Study||92
1736926|NCT00144300|4253295|P2|STARTED|Overall Study||125
1736927|NCT00144300|4253296|P1|STARTED|Overall Study||121
1736928|NCT00144170|4253344|P2|NOT COMPLETED|Overall Study||396
1736929|NCT00144170|4253345|P1|NOT COMPLETED|Overall Study||352
1736930|NCT00144170|4253344|P2|COMPLETED|Overall Study||32
1736931|NCT00144170|4253345|P1|COMPLETED|Overall Study||86
1736932|NCT00144170|4253344|P2|STARTED|Overall Study||428
1736933|NCT00144170|4253345|P1|STARTED|Overall Study||438
1736934|NCT00144027|4253535|P2|NOT COMPLETED|Overall Study||11
1736935|NCT00144027|4253536|P1|NOT COMPLETED|Overall Study||3
1736936|NCT00144027|4253535|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
1736937|NCT00144027|4253536|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
1736938|NCT00144027|4253535|P2|Completed 6 Month Assessment|Overall Study||24
1736939|NCT00144027|4253536|P1|Completed 6 Month Assessment|Overall Study||37
1736940|NCT00144027|4253535|P2|Completed Baseline Assessment|Overall Study||29
1736941|NCT00144027|4253536|P1|Completed Baseline Assessment|Overall Study||39
1736942|NCT00144027|4253535|P2|STARTED|Overall Study|participants who consented|36
1736943|NCT00144027|4253536|P1|STARTED|Overall Study|participants who consented|39
1736944|NCT00143845|4253542|P1|NOT COMPLETED|Overall Study||0
1736945|NCT00143845|4253542|P1|COMPLETED|Overall Study||54
1736946|NCT00143845|4253542|P1|STARTED|Overall Study||54
1736947|NCT00143819|4253550|P2|NOT COMPLETED|Overall Study||3
1736948|NCT00143819|4253551|P1|NOT COMPLETED|Overall Study||2
1736949|NCT00143819|4253550|P2|COMPLETED|Overall Study||5
1736950|NCT00143819|4253551|P1|COMPLETED|Overall Study||3
1736951|NCT00143819|4253550|P2|STARTED|Overall Study||8
1736952|NCT00143819|4253551|P1|STARTED|Overall Study||5
1736953|NCT00143598|4253566|P2|NOT COMPLETED|Overall Study||94
1736954|NCT00143598|4253567|P1|NOT COMPLETED|Overall Study||92
1736955|NCT00143598|4253566|P2|COMPLETED|Overall Study||302
1736956|NCT00143598|4253567|P1|COMPLETED|Overall Study||318
1736957|NCT00143598|4253566|P2|STARTED|Overall Study||396
1736958|NCT00143598|4253567|P1|STARTED|Overall Study||410
1736959|NCT00143507|4253581|P2|NOT COMPLETED|Overall Study||652
1736960|NCT00143507|4253582|P1|NOT COMPLETED|Overall Study||687
1736961|NCT00143507|4253581|P2|COMPLETED|Overall Study||4786
1736962|NCT00143507|4253582|P1|COMPLETED|Overall Study||4792
1736963|NCT00143507|4253581|P2|STARTED|Overall Study||5438
1736964|NCT00143507|4253582|P1|STARTED|Overall Study||5479
1736965|NCT00143455|4253616|P4|NOT COMPLETED|Cohort 2||93
1736966|NCT00143455|4253617|P3|NOT COMPLETED|Cohort 2||106
1736967|NCT00143455|4253618|P2|NOT COMPLETED|Cohort 2||0
1736968|NCT00143455|4253619|P1|NOT COMPLETED|Cohort 2||0
1736969|NCT00143455|4253616|P4|COMPLETED|Cohort 2||111
1736970|NCT00143455|4253617|P3|COMPLETED|Cohort 2||97
1736971|NCT00143455|4253618|P2|COMPLETED|Cohort 2||0
1736972|NCT00143455|4253619|P1|COMPLETED|Cohort 2||0
1736973|NCT00143455|4253616|P4|Received Treatment|Cohort 2||203
1736974|NCT00143455|4253617|P3|Received Treatment|Cohort 2||202
1736975|NCT00143455|4253618|P2|Received Treatment|Cohort 2||0
1736976|NCT00143455|4253619|P1|Received Treatment|Cohort 2||0
1736977|NCT00143455|4253616|P4|STARTED|Cohort 2||204
1736978|NCT00143455|4253617|P3|STARTED|Cohort 2||203
1736979|NCT00143455|4253618|P2|STARTED|Cohort 2||0
1736980|NCT00143455|4253619|P1|STARTED|Cohort 2||0
1736981|NCT00143455|4253616|P4|NOT COMPLETED|Cohort 1||0
1736982|NCT00143455|4253617|P3|NOT COMPLETED|Cohort 1||0
1736983|NCT00143455|4253618|P2|NOT COMPLETED|Cohort 1||17
1736984|NCT00143455|4253619|P1|NOT COMPLETED|Cohort 1||14
1736985|NCT00143455|4253616|P4|COMPLETED|Cohort 1||0
1736986|NCT00143455|4253617|P3|COMPLETED|Cohort 1||0
1736987|NCT00143455|4253618|P2|COMPLETED|Cohort 1||22
1736988|NCT00143455|4253619|P1|COMPLETED|Cohort 1||25
1736989|NCT00143455|4253616|P4|Received Treatment|Cohort 1||0
1736990|NCT00143455|4253617|P3|Received Treatment|Cohort 1||0
1736991|NCT00143455|4253618|P2|Received Treatment|Cohort 1||38
1736992|NCT00143455|4253619|P1|Received Treatment|Cohort 1||39
1736993|NCT00143455|4253616|P4|STARTED|Cohort 1||0
1736994|NCT00143455|4253617|P3|STARTED|Cohort 1||0
1736995|NCT00143455|4253618|P2|STARTED|Cohort 1||39
1736996|NCT00143455|4253619|P1|STARTED|Cohort 1||39
1736997|NCT00143403|4253653|P2|NOT COMPLETED|Overall Study||46
1736998|NCT00143403|4253654|P1|NOT COMPLETED|Overall Study||35
1736999|NCT00143403|4253653|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
1737000|NCT00143403|4253654|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
1737001|NCT00143403|4253653|P2|Treated|Overall Study||153
1737002|NCT00143403|4253654|P1|Treated|Overall Study||153
1737003|NCT00143403|4253653|P2|STARTED|Overall Study||161
1737004|NCT00143403|4253654|P1|STARTED|Overall Study||160
1737005|NCT00143390|4253664|P2|NOT COMPLETED|Overall Study||149
1737006|NCT00143390|4253665|P1|NOT COMPLETED|Overall Study||149
1737007|NCT00143390|4253664|P2|COMPLETED|Overall Study||0
1737008|NCT00143390|4253665|P1|COMPLETED|Overall Study||0
1737009|NCT00143390|4253664|P2|STARTED|Overall Study||149
1737010|NCT00143390|4253665|P1|STARTED|Overall Study||149
1737011|NCT00143312|4253681|P1|NOT COMPLETED|Overall Study||16
1737012|NCT00143312|4253681|P1|COMPLETED|Overall Study||29
1737013|NCT00143312|4253681|P1|STARTED|Overall Study||45
1737014|NCT00143247|4253691|P1|NOT COMPLETED|Overall Study||156
1737015|NCT00143247|4253691|P1|COMPLETED|Overall Study||17
1737016|NCT00143247|4253691|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
1737017|NCT00142935|4253708|P3|NOT COMPLETED|Overall Study||7
1737018|NCT00142935|4253709|P2|NOT COMPLETED|Overall Study||8
1737019|NCT00142935|4253710|P1|NOT COMPLETED|Overall Study||3
1737020|NCT00142935|4253708|P3|COMPLETED|Overall Study||23
1737021|NCT00142935|4253709|P2|COMPLETED|Overall Study||20
1737022|NCT00142935|4253710|P1|COMPLETED|Overall Study||26
1737023|NCT00142935|4253708|P3|STARTED|Overall Study||30
1737024|NCT00142935|4253709|P2|STARTED|Overall Study||28
1737025|NCT00142935|4253710|P1|STARTED|Overall Study||29
1737026|NCT00142909|4253735|P2|NOT COMPLETED|Medications Begin||3
1737027|NCT00142909|4253736|P1|NOT COMPLETED|Medications Begin||9
1737028|NCT00142909|4253735|P2|COMPLETED|Medications Begin||31
1737029|NCT00142909|4253736|P1|COMPLETED|Medications Begin||26
1737030|NCT00142909|4253735|P2|STARTED|Medications Begin||34
1737031|NCT00142909|4253736|P1|STARTED|Medications Begin||35
1737032|NCT00142909|4253735|P2|NOT COMPLETED|Randomization||10
1737033|NCT00142909|4253736|P1|NOT COMPLETED|Randomization||7
1737034|NCT00142909|4253735|P2|COMPLETED|Randomization||34
1737035|NCT00142909|4253736|P1|COMPLETED|Randomization||35
1737036|NCT00142909|4253735|P2|STARTED|Randomization||44
1737037|NCT00142909|4253736|P1|STARTED|Randomization||42
1737038|NCT00142818|4253756|P4|NOT COMPLETED|Overall Study||22
1737039|NCT00142818|4253757|P3|NOT COMPLETED|Overall Study||13
1737040|NCT00142818|4253758|P2|NOT COMPLETED|Overall Study||21
1737041|NCT00142818|4253759|P1|NOT COMPLETED|Overall Study||17
1737042|NCT00142818|4253756|P4|COMPLETED|Overall Study||20
1737043|NCT00142818|4253757|P3|COMPLETED|Overall Study||24
1737044|NCT00142818|4253758|P2|COMPLETED|Overall Study||19
1737045|NCT00142818|4253759|P1|COMPLETED|Overall Study||28
1737046|NCT00142818|4253756|P4|STARTED|Overall Study||42
1737047|NCT00142818|4253757|P3|STARTED|Overall Study||37
1737048|NCT00142818|4253758|P2|STARTED|Overall Study||40
1737049|NCT00142818|4253759|P1|STARTED|Overall Study||45
1737050|NCT00142792|4253772|P3|NOT COMPLETED|Overall Study||12
1737051|NCT00142792|4253773|P2|NOT COMPLETED|Overall Study||15
1737052|NCT00142792|4253774|P1|NOT COMPLETED|Overall Study||12
1737053|NCT00142792|4253772|P3|COMPLETED|Overall Study||30
1737054|NCT00142792|4253773|P2|COMPLETED|Overall Study||26
1737055|NCT00142792|4253774|P1|COMPLETED|Overall Study||27
1737056|NCT00142792|4253772|P3|Completed Intervention|Overall Study||37
1737057|NCT00142792|4253773|P2|Completed Intervention|Overall Study||37
1737058|NCT00142792|4253774|P1|Completed Intervention|Overall Study||35
1737059|NCT00142792|4253772|P3|STARTED|Overall Study||42
1737060|NCT00142792|4253773|P2|STARTED|Overall Study||41
1737061|NCT00142792|4253774|P1|STARTED|Overall Study||39
1737062|NCT00142597|4253787|P2|NOT COMPLETED|Overall Study||1
1737063|NCT00142597|4253788|P1|NOT COMPLETED|Overall Study||3
1737064|NCT00142597|4253787|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
1737065|NCT00142597|4253788|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
1737066|NCT00142597|4253787|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
1737067|NCT00142597|4253788|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
1737068|NCT00142506|4253796|P2|NOT COMPLETED|Overall Study||29
1737069|NCT00142506|4253797|P1|NOT COMPLETED|Overall Study||72
1737070|NCT00142506|4253796|P2|COMPLETED|Overall Study||77
1737071|NCT00142506|4253797|P1|COMPLETED|Overall Study||112
1737072|NCT00142506|4253796|P2|STARTED|Overall Study||106
1737073|NCT00142506|4253797|P1|STARTED|Overall Study||184
1737074|NCT00142415|4253809|P6|NOT COMPLETED|Overall Study||2
1737075|NCT00142415|4253810|P5|NOT COMPLETED|Overall Study||1
1737076|NCT00142415|4253811|P4|NOT COMPLETED|Overall Study||0
1737077|NCT00142415|4253812|P3|NOT COMPLETED|Overall Study||0
1737078|NCT00142415|4253813|P2|NOT COMPLETED|Overall Study||0
1737079|NCT00142415|4253814|P1|NOT COMPLETED|Overall Study||0
1737080|NCT00142415|4253809|P6|COMPLETED|Overall Study||6
1737081|NCT00142415|4253810|P5|COMPLETED|Overall Study||2
1737082|NCT00142415|4253811|P4|COMPLETED|Overall Study||3
1737083|NCT00142415|4253812|P3|COMPLETED|Overall Study||6
1737084|NCT00142415|4253813|P2|COMPLETED|Overall Study||3
1737085|NCT00142415|4253814|P1|COMPLETED|Overall Study||3
1737086|NCT00142415|4253809|P6|STARTED|Overall Study||8
1737087|NCT00142415|4253810|P5|STARTED|Overall Study||3
1737088|NCT00142415|4253811|P4|STARTED|Overall Study||3
1737089|NCT00142415|4253812|P3|STARTED|Overall Study||6
1737090|NCT00142415|4253813|P2|STARTED|Overall Study||3
1737091|NCT00142415|4253814|P1|STARTED|Overall Study||3
1737092|NCT00142298|4253852|P10|NOT COMPLETED|Overall Study||0
1737093|NCT00142298|4253853|P9|NOT COMPLETED|Overall Study||5
1737094|NCT00142298|4253854|P8|NOT COMPLETED|Overall Study||8
1737095|NCT00142298|4253855|P7|NOT COMPLETED|Overall Study||8
1737096|NCT00142298|4253856|P6|NOT COMPLETED|Overall Study||16
1737097|NCT00142298|4253857|P5|NOT COMPLETED|Overall Study||10
1737098|NCT00142298|4253858|P4|NOT COMPLETED|Overall Study||85
1737099|NCT00142298|4253859|P3|NOT COMPLETED|Overall Study||33
1737100|NCT00142298|4253860|P2|NOT COMPLETED|Overall Study||176
1737101|NCT00142298|4253861|P1|NOT COMPLETED|Overall Study||160
1737102|NCT00142298|4253852|P10|COMPLETED|Overall Study||13
1737103|NCT00142298|4253853|P9|COMPLETED|Overall Study||52
1737104|NCT00142298|4253854|P8|COMPLETED|Overall Study||58
1737105|NCT00142298|4253855|P7|COMPLETED|Overall Study||15
1737106|NCT00142298|4253856|P6|COMPLETED|Overall Study||10
1737107|NCT00142298|4253857|P5|COMPLETED|Overall Study||46
1737108|NCT00142298|4253858|P4|COMPLETED|Overall Study||121
1737109|NCT00142298|4253859|P3|COMPLETED|Overall Study||90
1737110|NCT00142298|4253860|P2|COMPLETED|Overall Study||456
1737111|NCT00142298|4253861|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
1737112|NCT00142298|4253852|P10|Per Protocol Population|Overall Study||13
1737113|NCT00142298|4253853|P9|Per Protocol Population|Overall Study||56
1737114|NCT00142298|4253854|P8|Per Protocol Population|Overall Study||64
1737115|NCT00142298|4253855|P7|Per Protocol Population|Overall Study||19
1737116|NCT00142298|4253856|P6|Per Protocol Population|Overall Study||25
1737117|NCT00142298|4253857|P5|Per Protocol Population|Overall Study||50
1737118|NCT00142298|4253858|P4|Per Protocol Population|Overall Study||202
1737119|NCT00142298|4253859|P3|Per Protocol Population|Overall Study||120
1737120|NCT00142298|4253860|P2|Per Protocol Population|Overall Study||606
1737121|NCT00142298|4253861|P1|Per Protocol Population|Overall Study||635
1737122|NCT00142298|4253852|P10|Safety Population|Overall Study||13
1737123|NCT00142298|4253853|P9|Safety Population|Overall Study||57
1737124|NCT00142298|4253854|P8|Safety Population|Overall Study||66
1737125|NCT00142298|4253855|P7|Safety Population|Overall Study||23
1737126|NCT00142298|4253856|P6|Safety Population|Overall Study||26
1737127|NCT00142298|4253857|P5|Safety Population|Overall Study||50
1737128|NCT00142298|4253858|P4|Safety Population|Overall Study||206
1737129|NCT00142298|4253859|P3|Safety Population|Overall Study||122
1737130|NCT00142298|4253860|P2|Safety Population|Overall Study||626
1737131|NCT00142298|4253861|P1|Safety Population|Overall Study||655
1737132|NCT00142298|4253852|P10|STARTED|Overall Study||13
1737133|NCT00142298|4253853|P9|STARTED|Overall Study||57
1737134|NCT00142298|4253854|P8|STARTED|Overall Study||66
1737135|NCT00142298|4253855|P7|STARTED|Overall Study||23
1737136|NCT00142298|4253856|P6|STARTED|Overall Study||26
1737137|NCT00142298|4253857|P5|STARTED|Overall Study||56
1737138|NCT00142298|4253858|P4|STARTED|Overall Study||206
1737139|NCT00142298|4253859|P3|STARTED|Overall Study||123
1737140|NCT00142298|4253860|P2|STARTED|Overall Study||632
1737141|NCT00142298|4253861|P1|STARTED|Overall Study||667
1737142|NCT00142168|4253883|P1|NOT COMPLETED|Overall Study||0
1737143|NCT00142168|4253883|P1|COMPLETED|Overall Study||16
1737144|NCT00142168|4253883|P1|STARTED|Overall Study||16
1737145|NCT00142116|4253890|P1|NOT COMPLETED|Overall Study||0
1737146|NCT00142116|4253890|P1|COMPLETED|Overall Study||25
1737147|NCT00142116|4253890|P1|STARTED|Overall Study||25
1737148|NCT00141921|4253895|P1|NOT COMPLETED|Overall Study||141
1737149|NCT00141921|4253895|P1|COMPLETED|Overall Study||41
1737150|NCT00141921|4253895|P1|Received Treatment|Overall Study||181
1737151|NCT00141921|4253895|P1|STARTED|Overall Study||182
1737152|NCT00141817|4253921|P4|NOT COMPLETED|Overall Study||0
1737153|NCT00141817|4253922|P3|NOT COMPLETED|Overall Study||1
1737154|NCT00141817|4253923|P2|NOT COMPLETED|Overall Study||0
1737155|NCT00141817|4253924|P1|NOT COMPLETED|Overall Study||1
1737156|NCT00141817|4253921|P4|COMPLETED|Overall Study||13
1737157|NCT00141817|4253922|P3|COMPLETED|Overall Study||10
1737158|NCT00141817|4253923|P2|COMPLETED|Overall Study||10
1737159|NCT00141817|4253924|P1|COMPLETED|Overall Study||6
1737160|NCT00141817|4253921|P4|STARTED|Overall Study||13
1737161|NCT00141817|4253922|P3|STARTED|Overall Study||11
1737162|NCT00141817|4253923|P2|STARTED|Overall Study||10
1737163|NCT00141817|4253924|P1|STARTED|Overall Study||7
1737164|NCT00141778|4253965|P3|NOT COMPLETED|Started Study Medication||4
1737165|NCT00141778|4253966|P2|NOT COMPLETED|Started Study Medication||7
1737166|NCT00141778|4253967|P1|NOT COMPLETED|Started Study Medication||2
1737167|NCT00141778|4253965|P3|COMPLETED|Started Study Medication||143
1737168|NCT00141778|4253966|P2|COMPLETED|Started Study Medication||144
1737169|NCT00141778|4253967|P1|COMPLETED|Started Study Medication||145
1737170|NCT00141778|4253965|P3|STARTED|Started Study Medication||147
1737171|NCT00141778|4253966|P2|STARTED|Started Study Medication||151
1737172|NCT00141778|4253967|P1|STARTED|Started Study Medication||147
1737173|NCT00141778|4253965|P3|NOT COMPLETED|Randomization Prior to Study Med||6
1737174|NCT00141778|4253966|P2|NOT COMPLETED|Randomization Prior to Study Med||2
1737175|NCT00141778|4253967|P1|NOT COMPLETED|Randomization Prior to Study Med||5
1737176|NCT00141778|4253965|P3|COMPLETED|Randomization Prior to Study Med||147
1737177|NCT00141778|4253966|P2|COMPLETED|Randomization Prior to Study Med||151
1737178|NCT00141778|4253967|P1|COMPLETED|Randomization Prior to Study Med||147
1737179|NCT00141778|4253965|P3|STARTED|Randomization Prior to Study Med||153
1737180|NCT00141778|4253966|P2|STARTED|Randomization Prior to Study Med||153
1737181|NCT00141778|4253967|P1|STARTED|Randomization Prior to Study Med||152
1737182|NCT00141765|4254005|P1|NOT COMPLETED|Overall Study||0
1737183|NCT00141765|4254005|P1|COMPLETED|Overall Study||25
1737184|NCT00141765|4254005|P1|STARTED|Overall Study||25
1737185|NCT00141739|4254009|P1|NOT COMPLETED|Overall Study||0
1737186|NCT00141739|4254009|P1|COMPLETED|Overall Study||100
1737187|NCT00141739|4254009|P1|STARTED|Overall Study|Number of evaluable patients|100
1737188|NCT00141726|4254020|P1|NOT COMPLETED|Overall Study||3
1737189|NCT00141726|4254020|P1|COMPLETED|Overall Study||31
1737190|NCT00141726|4254020|P1|STARTED|Overall Study||34
1737191|NCT00141518|4254028|P3|NOT COMPLETED|Overall Study||6
1737192|NCT00141518|4254029|P2|NOT COMPLETED|Overall Study||6
1737193|NCT00141518|4254030|P1|NOT COMPLETED|Overall Study||16
1737194|NCT00141518|4254028|P3|COMPLETED|Overall Study||12
1737195|NCT00141518|4254029|P2|COMPLETED|Overall Study||16
1737196|NCT00141518|4254030|P1|COMPLETED|Overall Study||21
1737197|NCT00141518|4254028|P3|Full Analysis Sample|Overall Study||18
1737198|NCT00141518|4254029|P2|Full Analysis Sample|Overall Study||22
1737199|NCT00141518|4254030|P1|Full Analysis Sample|Overall Study||27
1737200|NCT00141518|4254028|P3|Safety Sample|Overall Study||18
1737201|NCT00141518|4254029|P2|Safety Sample|Overall Study||22
1737202|NCT00141518|4254030|P1|Safety Sample|Overall Study||36
1737203|NCT00141518|4254028|P3|STARTED|Overall Study||18
1737204|NCT00141518|4254029|P2|STARTED|Overall Study||22
1737205|NCT00141518|4254030|P1|STARTED|Overall Study||37
1737206|NCT00141453|4254219|P2|NOT COMPLETED|Overall Study||5
1737207|NCT00141453|4254220|P1|NOT COMPLETED|Overall Study||6
1737208|NCT00141453|4254219|P2|COMPLETED|Overall Study||284
1737209|NCT00141453|4254220|P1|COMPLETED|Overall Study||282
1737210|NCT00141453|4254219|P2|STARTED|Overall Study||289
1737211|NCT00141453|4254220|P1|STARTED|Overall Study||288
1737212|NCT00141297|4254234|P10|NOT COMPLETED|Overall Study||6
1737213|NCT00141297|4254235|P9|NOT COMPLETED|Overall Study||20
1737214|NCT00141297|4254236|P8|NOT COMPLETED|Overall Study||4
1737215|NCT00141297|4254237|P7|NOT COMPLETED|Overall Study||3
1737216|NCT00141297|4254238|P6|NOT COMPLETED|Overall Study||3
1737217|NCT00141297|4254239|P5|NOT COMPLETED|Overall Study||22
1737218|NCT00141297|4254240|P4|NOT COMPLETED|Overall Study||3
1737219|NCT00141297|4254241|P3|NOT COMPLETED|Overall Study||7
1737220|NCT00141297|4254242|P2|NOT COMPLETED|Overall Study||3
1737221|NCT00141297|4254243|P1|NOT COMPLETED|Overall Study||3
1737222|NCT00141297|4254234|P10|COMPLETED|Overall Study||0
1737223|NCT00141297|4254235|P9|COMPLETED|Overall Study||0
1737224|NCT00141297|4254236|P8|COMPLETED|Overall Study||0
1737225|NCT00141297|4254237|P7|COMPLETED|Overall Study||0
1737226|NCT00141297|4254238|P6|COMPLETED|Overall Study||0
1737227|NCT00141297|4254239|P5|COMPLETED|Overall Study||0
1737228|NCT00141297|4254240|P4|COMPLETED|Overall Study||0
1737229|NCT00141297|4254241|P3|COMPLETED|Overall Study||0
1737230|NCT00141297|4254242|P2|COMPLETED|Overall Study||0
1737231|NCT00141297|4254243|P1|COMPLETED|Overall Study||0
1737232|NCT00141297|4254234|P10|STARTED|Overall Study||6
1737233|NCT00141297|4254235|P9|STARTED|Overall Study||20
1737234|NCT00141297|4254236|P8|STARTED|Overall Study||4
1737235|NCT00141297|4254237|P7|STARTED|Overall Study||3
1737236|NCT00141297|4254238|P6|STARTED|Overall Study||3
1737237|NCT00141297|4254239|P5|STARTED|Overall Study||22
1737238|NCT00141297|4254240|P4|STARTED|Overall Study||3
1737239|NCT00141297|4254241|P3|STARTED|Overall Study||7
1737240|NCT00141297|4254242|P2|STARTED|Overall Study||3
1737241|NCT00141297|4254243|P1|STARTED|Overall Study||3
1737242|NCT00141271|4254521|P3|NOT COMPLETED|Overall Study||57
1737243|NCT00141271|4254522|P2|NOT COMPLETED|Overall Study||63
1737244|NCT00141271|4254523|P1|NOT COMPLETED|Overall Study||80
1737245|NCT00141271|4254521|P3|COMPLETED|Overall Study||111
1737246|NCT00141271|4254522|P2|COMPLETED|Overall Study||102
1737247|NCT00141271|4254523|P1|COMPLETED|Overall Study||91
1737248|NCT00141271|4254521|P3|STARTED|Overall Study||168
1737249|NCT00141271|4254522|P2|STARTED|Overall Study||165
1737250|NCT00141271|4254523|P1|STARTED|Overall Study||171
1737251|NCT00141219|4254644|P2|NOT COMPLETED|Overall Study||16
1737252|NCT00141219|4254645|P1|NOT COMPLETED|Overall Study||24
1737253|NCT00141219|4254644|P2|COMPLETED|Overall Study||62
1737254|NCT00141219|4254645|P1|COMPLETED|Overall Study||138
1737255|NCT00141219|4254644|P2|STARTED|Overall Study||78
1737256|NCT00141219|4254645|P1|STARTED|Overall Study||162
1737257|NCT00141115|4254695|P1|NOT COMPLETED|Overall Study||1
1737258|NCT00141115|4254695|P1|COMPLETED|Overall Study||2
1737259|NCT00141115|4254695|P1|STARTED|Overall Study||3
1737260|NCT00141102|4254702|P2|NOT COMPLETED|Overall Study||625
1737261|NCT00141102|4254703|P1|NOT COMPLETED|Overall Study||508
1737262|NCT00141102|4254702|P2|COMPLETED|Overall Study||1621
1737263|NCT00141102|4254703|P1|COMPLETED|Overall Study||1730
1737264|NCT00141102|4254702|P2|Received Treatment|Overall Study||2237
1737265|NCT00141102|4254703|P1|Received Treatment|Overall Study||2223
1737266|NCT00141102|4254702|P2|STARTED|Overall Study||2246
1737267|NCT00141102|4254703|P1|STARTED|Overall Study||2238
1737268|NCT00141037|4254743|P2|NOT COMPLETED|Overall Study||18
1737269|NCT00141037|4254744|P1|NOT COMPLETED|Overall Study||10
1737270|NCT00141037|4254743|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
1737271|NCT00141037|4254744|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
1737272|NCT00141037|4254743|P2|STARTED|Overall Study||70
1737273|NCT00141037|4254744|P1|STARTED|Overall Study||60
1737274|NCT00140842|4254754|P2|NOT COMPLETED|Overall Study||0
1737275|NCT00140842|4254755|P1|NOT COMPLETED|Overall Study||0
1737276|NCT00140842|4254754|P2|COMPLETED|Overall Study||15
1737277|NCT00140842|4254755|P1|COMPLETED|Overall Study||15
1737278|NCT00140842|4254754|P2|STARTED|Overall Study||15
1737279|NCT00140842|4254755|P1|STARTED|Overall Study||15
1737280|NCT00140621|4254763|P1|NOT COMPLETED|Overall Study||0
1737281|NCT00140621|4254763|P1|COMPLETED|Overall Study||6
1737282|NCT00140621|4254763|P1|STARTED|Overall Study||6
1737283|NCT00140556|4254773|P1|NOT COMPLETED|Chemoradiotherapy Period||0
1737284|NCT00140556|4254773|P1|COMPLETED|Chemoradiotherapy Period||28
1737285|NCT00140556|4254773|P1|STARTED|Chemoradiotherapy Period||28
1737286|NCT00140556|4254773|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
1737287|NCT00140556|4254773|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
1737288|NCT00140556|4254773|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
1737289|NCT00140426|4254779|P2|NOT COMPLETED|Overall Study||3
1737290|NCT00140426|4254780|P1|NOT COMPLETED|Overall Study||0
1737291|NCT00140426|4254779|P2|COMPLETED|Overall Study||16
1737292|NCT00140426|4254780|P1|COMPLETED|Overall Study||22
1737293|NCT00140426|4254779|P2|STARTED|Overall Study||19
1737294|NCT00140426|4254780|P1|STARTED|Overall Study||22
1737295|NCT00140413|4254813|P2|NOT COMPLETED|Overall Study||0
1737296|NCT00140413|4254814|P1|NOT COMPLETED|Overall Study||3
1737297|NCT00140413|4254813|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
1737298|NCT00140413|4254814|P1|COMPLETED|Overall Study||10
1737299|NCT00140413|4254813|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
1737300|NCT00140413|4254814|P1|Received at Least One Dose of GH|Overall Study||13
1737301|NCT00140413|4254813|P2|STARTED|Overall Study||7
1737302|NCT00140413|4254814|P1|STARTED|Overall Study||13
1737303|NCT00140244|4254821|P2|NOT COMPLETED|Intervention 2||2
1737304|NCT00140244|4254822|P1|NOT COMPLETED|Intervention 2||0
1737305|NCT00140244|4254821|P2|COMPLETED|Intervention 2||2
1737306|NCT00140244|4254822|P1|COMPLETED|Intervention 2||3
1737307|NCT00140244|4254821|P2|STARTED|Intervention 2||4
1737308|NCT00140244|4254822|P1|STARTED|Intervention 2||3
1737309|NCT00140244|4254821|P2|NOT COMPLETED|Washout||0
1737310|NCT00140244|4254822|P1|NOT COMPLETED|Washout||0
1737311|NCT00140244|4254821|P2|COMPLETED|Washout||4
1737312|NCT00140244|4254822|P1|COMPLETED|Washout||3
1737313|NCT00140244|4254821|P2|STARTED|Washout||4
1737314|NCT00140244|4254822|P1|STARTED|Washout||3
1737315|NCT00140244|4254821|P2|NOT COMPLETED|Intervention 1||0
1737316|NCT00140244|4254822|P1|NOT COMPLETED|Intervention 1||0
1737317|NCT00140244|4254821|P2|COMPLETED|Intervention 1||4
1737318|NCT00140244|4254822|P1|COMPLETED|Intervention 1||3
1737319|NCT00140244|4254821|P2|STARTED|Intervention 1||4
1737320|NCT00140244|4254822|P1|STARTED|Intervention 1||3
1737321|NCT00140231|4254854|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
1737322|NCT00140231|4254855|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
1737323|NCT00140231|4254854|P2|COMPLETED|Fasting State With Leptin and Crossover||6
1737324|NCT00140231|4254855|P1|COMPLETED|Fasting State With Leptin and Crossover||7
1737325|NCT00140231|4254854|P2|STARTED|Fasting State With Leptin and Crossover||6
1737326|NCT00140231|4254855|P1|STARTED|Fasting State With Leptin and Crossover||7
1737327|NCT00140231|4254854|P2|NOT COMPLETED|Washout 8 Weeks||0
1737328|NCT00140231|4254855|P1|NOT COMPLETED|Washout 8 Weeks||0
1737329|NCT00140231|4254854|P2|COMPLETED|Washout 8 Weeks||6
1737330|NCT00140231|4254855|P1|COMPLETED|Washout 8 Weeks||7
1737331|NCT00140231|4254854|P2|STARTED|Washout 8 Weeks||6
1737332|NCT00140231|4254855|P1|STARTED|Washout 8 Weeks||7
1737333|NCT00140231|4254854|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
1737334|NCT00140231|4254855|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
1737335|NCT00140231|4254854|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
1737336|NCT00140231|4254855|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
1737337|NCT00140231|4254854|P2|STARTED|First Fasting State 3 Days With Placebo||6
1737338|NCT00140231|4254855|P1|STARTED|First Fasting State 3 Days With Placebo||7
1737339|NCT00140231|4254854|P2|NOT COMPLETED|Washout 8weeks||0
1737340|NCT00140231|4254855|P1|NOT COMPLETED|Washout 8weeks||0
1737341|NCT00140231|4254854|P2|COMPLETED|Washout 8weeks||6
1737342|NCT00140231|4254855|P1|COMPLETED|Washout 8weeks||7
1737343|NCT00140231|4254854|P2|STARTED|Washout 8weeks||6
1737344|NCT00140231|4254855|P1|STARTED|Washout 8weeks||7
1737345|NCT00140231|4254854|P2|NOT COMPLETED|Fed State 1 Day- day5||0
1737346|NCT00140231|4254855|P1|NOT COMPLETED|Fed State 1 Day- day5||0
1737347|NCT00140231|4254854|P2|COMPLETED|Fed State 1 Day- day5||6
1737348|NCT00140231|4254855|P1|COMPLETED|Fed State 1 Day- day5||7
1737349|NCT00140231|4254854|P2|STARTED|Fed State 1 Day- day5||6
1737350|NCT00140231|4254855|P1|STARTED|Fed State 1 Day- day5||7
1737351|NCT00140205|4254874|P3|NOT COMPLETED|Overall Study||0
1737352|NCT00140205|4254875|P2|NOT COMPLETED|Overall Study||0
1737353|NCT00140205|4254876|P1|NOT COMPLETED|Overall Study||0
1737354|NCT00140205|4254874|P3|COMPLETED|Overall Study||5
1737355|NCT00140205|4254875|P2|COMPLETED|Overall Study||5
1737356|NCT00140205|4254876|P1|COMPLETED|Overall Study||5
1737357|NCT00140205|4254874|P3|STARTED|Overall Study||5
1737358|NCT00140205|4254875|P2|STARTED|Overall Study||5
1737359|NCT00140205|4254876|P1|STARTED|Overall Study||5
1737360|NCT00140140|4254945|P3|NOT COMPLETED|Overall Study||2
1737361|NCT00140140|4254946|P2|NOT COMPLETED|Overall Study||2
1737362|NCT00140140|4254947|P1|NOT COMPLETED|Overall Study||2
1737363|NCT00140140|4254945|P3|COMPLETED|Overall Study|Progressive disease|4
1737364|NCT00140140|4254946|P2|COMPLETED|Overall Study|Progressive disease|4
1737365|NCT00140140|4254947|P1|COMPLETED|Overall Study|Progressive disease|2
1737366|NCT00140140|4254945|P3|STARTED|Overall Study||6
1737367|NCT00140140|4254946|P2|STARTED|Overall Study||6
1737368|NCT00140140|4254947|P1|STARTED|Overall Study||4
1737369|NCT00139997|4254986|P2|NOT COMPLETED|Overall Study||2
1737370|NCT00139997|4254987|P1|NOT COMPLETED|Overall Study||1
1737371|NCT00139997|4254986|P2|COMPLETED|Overall Study||9
1737372|NCT00139997|4254987|P1|COMPLETED|Overall Study||14
1737373|NCT00139997|4254986|P2|STARTED|Overall Study||11
1737374|NCT00139997|4254987|P1|STARTED|Overall Study||15
1737375|NCT00139776|4254997|P4|NOT COMPLETED|Period III||106
1737376|NCT00139776|4254998|P3|NOT COMPLETED|Period III||76
1737377|NCT00139776|4254999|P2|NOT COMPLETED|Period III||0
1737378|NCT00139776|4255000|P1|NOT COMPLETED|Period III||0
1737379|NCT00139776|4254997|P4|COMPLETED|Period III||321
1737380|NCT00139776|4254998|P3|COMPLETED|Period III||355
1737381|NCT00139776|4254999|P2|COMPLETED|Period III||0
1737382|NCT00139776|4255000|P1|COMPLETED|Period III||0
1737383|NCT00139776|4254997|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
1737384|NCT00139776|4254998|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
1737385|NCT00139776|4254999|P2|STARTED|Period III||0
1737386|NCT00139776|4255000|P1|STARTED|Period III||0
1737387|NCT00139776|4254997|P4|NOT COMPLETED|Period II||0
1737388|NCT00139776|4254998|P3|NOT COMPLETED|Period II||0
1737389|NCT00139776|4254999|P2|NOT COMPLETED|Period II||322
1737390|NCT00139776|4255000|P1|NOT COMPLETED|Period II||0
1737391|NCT00139776|4254997|P4|COMPLETED|Period II||0
1737392|NCT00139776|4254998|P3|COMPLETED|Period II||0
1737393|NCT00139776|4254999|P2|COMPLETED|Period II||875
1737394|NCT00139776|4255000|P1|COMPLETED|Period II||0
1737395|NCT00139776|4254997|P4|STARTED|Period II||0
1737396|NCT00139776|4254998|P3|STARTED|Period II||0
1737397|NCT00139776|4254999|P2|STARTED|Period II||1197
1737398|NCT00139776|4255000|P1|STARTED|Period II||0
1737399|NCT00139776|4254997|P4|NOT COMPLETED|Period I||0
1737400|NCT00139776|4254998|P3|NOT COMPLETED|Period I||0
1737401|NCT00139776|4254999|P2|NOT COMPLETED|Period I||0
1737402|NCT00139776|4255000|P1|NOT COMPLETED|Period I||575
1737403|NCT00139776|4254997|P4|COMPLETED|Period I||0
1737404|NCT00139776|4254998|P3|COMPLETED|Period I||0
1737405|NCT00139776|4254999|P2|COMPLETED|Period I||0
1737406|NCT00139776|4255000|P1|COMPLETED|Period I||1197
1737407|NCT00139776|4254997|P4|STARTED|Period I||0
1737408|NCT00139776|4254998|P3|STARTED|Period I||0
1737409|NCT00139776|4254999|P2|STARTED|Period I||0
1737410|NCT00139776|4255000|P1|STARTED|Period I||1772
1737411|NCT00139737|4255035|P1|NOT COMPLETED|Overall Study||341
1737412|NCT00139737|4255035|P1|COMPLETED|Overall Study||3
1737413|NCT00139737|4255035|P1|Received Treatment|Overall Study||331
1737414|NCT00139737|4255035|P1|STARTED|Overall Study||344
1737415|NCT00139659|4255041|P2|NOT COMPLETED|Overall Study||18
1737416|NCT00139659|4255042|P1|NOT COMPLETED|Overall Study||40
1737417|NCT00139659|4255041|P2|COMPLETED|Overall Study||123
1737418|NCT00139659|4255042|P1|COMPLETED|Overall Study||106
1737419|NCT00139659|4255041|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
1737420|NCT00139659|4255042|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
1737421|NCT00139477|4255120|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
1737422|NCT00139477|4255121|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
1737423|NCT00139477|4255120|P2|COMPLETED|Second Intervention -6Months to 12Months||18
1737424|NCT00139477|4255121|P1|COMPLETED|Second Intervention -6Months to 12Months||14
1737425|NCT00139477|4255120|P2|STARTED|Second Intervention -6Months to 12Months||23
1737426|NCT00139477|4255121|P1|STARTED|Second Intervention -6Months to 12Months||19
1737427|NCT00139477|4255120|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
1737428|NCT00139477|4255121|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
1737429|NCT00139477|4255120|P2|COMPLETED|First Intervention -Baseline to 6Months||23
1737430|NCT00139477|4255121|P1|COMPLETED|First Intervention -Baseline to 6Months||19
1737431|NCT00139477|4255120|P2|STARTED|First Intervention -Baseline to 6Months||35
1737432|NCT00139477|4255121|P1|STARTED|First Intervention -Baseline to 6Months||31
1737433|NCT00138671|4255143|P2|NOT COMPLETED|Overall Study||16
1737434|NCT00138671|4255144|P1|NOT COMPLETED|Overall Study||13
1737435|NCT00138671|4255143|P2|COMPLETED|Overall Study||30
1737436|NCT00138671|4255144|P1|COMPLETED|Overall Study||46
1737437|NCT00138671|4255143|P2|STARTED|Overall Study||46
1737438|NCT00138671|4255144|P1|STARTED|Overall Study||59
1737439|NCT00138658|4255194|P1|NOT COMPLETED|Overall Study||61
1737440|NCT00138658|4255194|P1|COMPLETED|Overall Study||20
1737441|NCT00138658|4255194|P1|STARTED|Overall Study||81
1737442|NCT00138645|4255206|P2|NOT COMPLETED|Overall Study||7
1737443|NCT00138645|4255207|P1|NOT COMPLETED|Overall Study||6
1737444|NCT00138645|4255206|P2|COMPLETED|Overall Study||23
1737445|NCT00138645|4255207|P1|COMPLETED|Overall Study||24
1737446|NCT00138645|4255206|P2|STARTED|Overall Study||30
1737447|NCT00138645|4255207|P1|STARTED|Overall Study||30
1737448|NCT00138424|4255217|P4|NOT COMPLETED|Overall Study||0
1737449|NCT00138424|4255218|P3|NOT COMPLETED|Overall Study||0
1737450|NCT00138424|4255219|P2|NOT COMPLETED|Overall Study||1
1737451|NCT00138424|4255220|P1|NOT COMPLETED|Overall Study||0
1737452|NCT00138424|4255217|P4|COMPLETED|Overall Study||3
1737453|NCT00138424|4255218|P3|COMPLETED|Overall Study||5
1737454|NCT00138424|4255219|P2|COMPLETED|Overall Study||4
1737455|NCT00138424|4255220|P1|COMPLETED|Overall Study||9
1737456|NCT00138424|4255217|P4|STARTED|Overall Study||3
1737457|NCT00138424|4255218|P3|STARTED|Overall Study||5
1737458|NCT00138424|4255219|P2|STARTED|Overall Study||5
1737459|NCT00138424|4255220|P1|STARTED|Overall Study||9
1737460|NCT00138294|4255286|P1|NOT COMPLETED|Overall Study||0
1737461|NCT00138294|4255286|P1|COMPLETED|Overall Study||29255
1737462|NCT00138294|4255286|P1|STARTED|Overall Study||29255
1737463|NCT00138203|4255296|P1|NOT COMPLETED|Overall Study||0
1737464|NCT00138203|4255296|P1|COMPLETED|Overall Study||16
1737465|NCT00138203|4255296|P1|STARTED|Overall Study||16
1737466|NCT00138151|4255303|P1|NOT COMPLETED|Overall Study||4
1737467|NCT00138151|4255303|P1|COMPLETED|Overall Study||29
1737468|NCT00138151|4255303|P1|STARTED|Overall Study||33
1737469|NCT00138125|4255309|P1|NOT COMPLETED|Overall Study||0
1737470|NCT00138125|4255309|P1|COMPLETED|Overall Study||2
1737471|NCT00138125|4255309|P1|STARTED|Overall Study||2
1737472|NCT00138073|4255313|P1|NOT COMPLETED|Overall Study||55
1737473|NCT00138073|4255313|P1|COMPLETED|Overall Study||0
1737474|NCT00138073|4255313|P1|Pre-intervention Testing|Overall Study||55
1737475|NCT00138073|4255313|P1|STARTED|Overall Study||55
1737476|NCT00138034|4255320|P2|NOT COMPLETED|Overall Study||3
1737477|NCT00138034|4255321|P1|NOT COMPLETED|Overall Study||3
1737478|NCT00138034|4255320|P2|COMPLETED|Overall Study||20
1737479|NCT00138034|4255321|P1|COMPLETED|Overall Study||23
1737480|NCT00138034|4255320|P2|STARTED|Overall Study||23
1737481|NCT00138034|4255321|P1|STARTED|Overall Study||26
1737482|NCT00137969|4255331|P2|NOT COMPLETED|Overall Study||21
1737483|NCT00137969|4255332|P1|NOT COMPLETED|Overall Study||67
1737484|NCT00137969|4255331|P2|COMPLETED|Overall Study||67
1737485|NCT00137969|4255332|P1|COMPLETED|Overall Study||107
1737486|NCT00137969|4255331|P2|Received Study Drug|Overall Study||88
1737487|NCT00137969|4255332|P1|Received Study Drug|Overall Study||169
1737488|NCT00137969|4255331|P2|STARTED|Overall Study||88
1737489|NCT00137969|4255332|P1|STARTED|Overall Study||174
1737490|NCT00137631|4255354|P2|NOT COMPLETED|Overall Study||41
1737491|NCT00137631|4255355|P1|NOT COMPLETED|Overall Study||37
1737492|NCT00137631|4255354|P2|COMPLETED|Overall Study||133
1737493|NCT00137631|4255355|P1|COMPLETED|Overall Study||127
1737494|NCT00137631|4255354|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
1737495|NCT00137631|4255355|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
1737496|NCT00137631|4255354|P2|Complete 3-month Follow-up|Overall Study||125
1737497|NCT00137631|4255355|P1|Complete 3-month Follow-up|Overall Study||120
1737498|NCT00137631|4255354|P2|STARTED|Overall Study||174
1737499|NCT00137631|4255355|P1|STARTED|Overall Study||164
1737500|NCT00137449|4255371|P2|NOT COMPLETED|Overall Study||18
1737501|NCT00137449|4255372|P1|NOT COMPLETED|Overall Study||16
1737502|NCT00137449|4255371|P2|COMPLETED|Overall Study||12
1737503|NCT00137449|4255372|P1|COMPLETED|Overall Study||14
1737504|NCT00137449|4255371|P2|STARTED|Overall Study||30
1737505|NCT00137449|4255372|P1|STARTED|Overall Study||30
1737506|NCT00137436|4255409|P1|NOT COMPLETED|Overall Study||43
1737507|NCT00137436|4255409|P1|COMPLETED|Overall Study||12
1737508|NCT00137436|4255409|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
1737509|NCT00137423|4255428|P2|NOT COMPLETED|Overall Study||44
1737510|NCT00137423|4255429|P1|NOT COMPLETED|Overall Study||39
1737511|NCT00137423|4255428|P2|COMPLETED|Overall Study||9
1737512|NCT00137423|4255429|P1|COMPLETED|Overall Study||15
1737513|NCT00137423|4255428|P2|STARTED|Overall Study||53
1737514|NCT00137423|4255429|P1|STARTED|Overall Study||54
1737515|NCT00137280|4255451|P2|NOT COMPLETED|Overall Study||55
1737516|NCT00137280|4255452|P1|NOT COMPLETED|Overall Study||84
1737517|NCT00137280|4255451|P2|COMPLETED|Overall Study||357
1737518|NCT00137280|4255452|P1|COMPLETED|Overall Study||305
1737519|NCT00137280|4255451|P2|STARTED|Overall Study||412
1737520|NCT00137280|4255452|P1|STARTED|Overall Study||389
1737521|NCT00137267|4255466|P2|NOT COMPLETED|Overall Study||21
1737522|NCT00137267|4255467|P1|NOT COMPLETED|Overall Study||15
1737523|NCT00137267|4255466|P2|COMPLETED|Overall Study||26
1737524|NCT00137267|4255467|P1|COMPLETED|Overall Study||40
1737525|NCT00137267|4255466|P2|STARTED|Overall Study||47
1737526|NCT00137267|4255467|P1|STARTED|Overall Study||55
1737527|NCT00137111|4255479|P4|NOT COMPLETED|Total Therapy||0
1737528|NCT00137111|4255480|P3|NOT COMPLETED|Total Therapy||0
1737529|NCT00137111|4255481|P2|NOT COMPLETED|Total Therapy||0
1737530|NCT00137111|4255482|P1|NOT COMPLETED|Total Therapy||40
1737531|NCT00137111|4255479|P4|COMPLETED|Total Therapy||0
1737532|NCT00137111|4255480|P3|COMPLETED|Total Therapy||0
1737533|NCT00137111|4255481|P2|COMPLETED|Total Therapy||0
1737534|NCT00137111|4255482|P1|COMPLETED|Total Therapy||458
1737535|NCT00137111|4255479|P4|STARTED|Total Therapy||0
1737536|NCT00137111|4255480|P3|STARTED|Total Therapy||0
1737537|NCT00137111|4255481|P2|STARTED|Total Therapy||0
1737538|NCT00137111|4255482|P1|STARTED|Total Therapy||498
1737539|NCT00137111|4255479|P4|NOT COMPLETED|Window Therapy||0
1737540|NCT00137111|4255480|P3|NOT COMPLETED|Window Therapy||0
1737541|NCT00137111|4255481|P2|NOT COMPLETED|Window Therapy||0
1737542|NCT00137111|4255482|P1|NOT COMPLETED|Window Therapy||0
1737543|NCT00137111|4255479|P4|COMPLETED|Window Therapy||142
1737544|NCT00137111|4255480|P3|COMPLETED|Window Therapy||180
1737545|NCT00137111|4255481|P2|COMPLETED|Window Therapy||176
1737546|NCT00137111|4255482|P1|COMPLETED|Window Therapy||0
1737547|NCT00137111|4255479|P4|STARTED|Window Therapy||142
1737548|NCT00137111|4255480|P3|STARTED|Window Therapy||180
1737549|NCT00137111|4255481|P2|STARTED|Window Therapy||176
1737550|NCT00137111|4255482|P1|STARTED|Window Therapy||0
1737551|NCT00137046|4255496|P2|NOT COMPLETED|Overall Study||93
1737552|NCT00137046|4255497|P1|NOT COMPLETED|Overall Study||99
1737553|NCT00137046|4255496|P2|COMPLETED|Overall Study||198
1737554|NCT00137046|4255497|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
1737555|NCT00137046|4255496|P2|Received Study Treatment|Overall Study||290
1737556|NCT00137046|4255497|P1|Received Study Treatment|Overall Study||290
1737557|NCT00137046|4255496|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
1737558|NCT00137046|4255497|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
1737559|NCT00136955|4255545|P1|NOT COMPLETED|Overall Study||23
1737560|NCT00136955|4255545|P1|COMPLETED|Overall Study||18
1737561|NCT00136955|4255545|P1|STARTED|Overall Study||41
1737562|NCT00136916|4255554|P2|NOT COMPLETED|Overall Study||104
1737563|NCT00136916|4255555|P1|NOT COMPLETED|Overall Study||125
1737564|NCT00136916|4255554|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
1737565|NCT00136916|4255555|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
1737566|NCT00136916|4255554|P2|Received Treatment|Overall Study||311
1737567|NCT00136916|4255555|P1|Received Treatment|Overall Study||316
1737568|NCT00136916|4255554|P2|STARTED|Overall Study||316
1737569|NCT00136916|4255555|P1|STARTED|Overall Study||319
1737570|NCT00136838|4255609|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
1737571|NCT00136838|4255610|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
1737572|NCT00136838|4255609|P2|COMPLETED|Second Intervention ( 5 Days)||6
1737573|NCT00136838|4255610|P1|COMPLETED|Second Intervention ( 5 Days)||6
1737574|NCT00136838|4255609|P2|STARTED|Second Intervention ( 5 Days)||6
1737575|NCT00136838|4255610|P1|STARTED|Second Intervention ( 5 Days)||6
1737576|NCT00136838|4255609|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
1737577|NCT00136838|4255610|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
1737578|NCT00136838|4255609|P2|COMPLETED|First Intervention ( 5 Days)||6
1737579|NCT00136838|4255610|P1|COMPLETED|First Intervention ( 5 Days)||6
1737580|NCT00136838|4255609|P2|STARTED|First Intervention ( 5 Days)||6
1737581|NCT00136838|4255610|P1|STARTED|First Intervention ( 5 Days)||6
1737582|NCT00136812|4255620|P2|NOT COMPLETED|Overall Study||0
1737583|NCT00136812|4255621|P1|NOT COMPLETED|Overall Study||0
1737584|NCT00136812|4255620|P2|COMPLETED|Overall Study||113
1737585|NCT00136812|4255621|P1|COMPLETED|Overall Study||111
1737586|NCT00136812|4255620|P2|STARTED|Overall Study||113
1737587|NCT00136812|4255621|P1|STARTED|Overall Study||111
1737588|NCT00136760|4255631|P4|NOT COMPLETED|Overall Study||0
1737589|NCT00136760|4255632|P3|NOT COMPLETED|Overall Study||0
1737590|NCT00136760|4255633|P2|NOT COMPLETED|Overall Study||0
1737591|NCT00136760|4255634|P1|NOT COMPLETED|Overall Study||0
1737592|NCT00136760|4255631|P4|COMPLETED|Overall Study||13
1737593|NCT00136760|4255632|P3|COMPLETED|Overall Study||11
1737594|NCT00136760|4255633|P2|COMPLETED|Overall Study||16
1737595|NCT00136760|4255634|P1|COMPLETED|Overall Study||12
1737596|NCT00136760|4255631|P4|STARTED|Overall Study||13
1737597|NCT00136760|4255632|P3|STARTED|Overall Study||11
1737598|NCT00136760|4255633|P2|STARTED|Overall Study||16
1737599|NCT00136760|4255634|P1|STARTED|Overall Study||12
1737600|NCT00136695|4255650|P2|NOT COMPLETED|Overall Study||8
1737601|NCT00136695|4255651|P1|NOT COMPLETED|Overall Study||11
1737602|NCT00136695|4255650|P2|COMPLETED|Overall Study||35
1737603|NCT00136695|4255651|P1|COMPLETED|Overall Study||34
1737604|NCT00136695|4255650|P2|STARTED|Overall Study||43
1737605|NCT00136695|4255651|P1|STARTED|Overall Study||45
1737606|NCT00136604|4255662|P5|NOT COMPLETED|Overall Study||1
1737607|NCT00136604|4255663|P4|NOT COMPLETED|Overall Study||0
1737608|NCT00136604|4255664|P3|NOT COMPLETED|Overall Study||0
1737609|NCT00136604|4255665|P2|NOT COMPLETED|Overall Study||1
1737610|NCT00136604|4255666|P1|NOT COMPLETED|Overall Study||1
1737611|NCT00136604|4255662|P5|COMPLETED|Overall Study||124
1737612|NCT00136604|4255663|P4|COMPLETED|Overall Study||41
1737613|NCT00136604|4255664|P3|COMPLETED|Overall Study||79
1737614|NCT00136604|4255665|P2|COMPLETED|Overall Study||122
1737615|NCT00136604|4255666|P1|COMPLETED|Overall Study||248
1737616|NCT00136604|4255662|P5|STARTED|Overall Study||125
1737617|NCT00136604|4255663|P4|STARTED|Overall Study||41
1737618|NCT00136604|4255664|P3|STARTED|Overall Study||79
1737619|NCT00136604|4255665|P2|STARTED|Overall Study||123
1737620|NCT00136604|4255666|P1|STARTED|Overall Study||249
1737621|NCT00136357|4255774|P2|NOT COMPLETED|Overall Study||2
1737622|NCT00136357|4255775|P1|NOT COMPLETED|Overall Study||3
1737623|NCT00136357|4255774|P2|COMPLETED|Overall Study||39
1737624|NCT00136357|4255775|P1|COMPLETED|Overall Study||38
1737625|NCT00136357|4255774|P2|STARTED|Overall Study||41
1737626|NCT00136357|4255775|P1|STARTED|Overall Study||41
1737627|NCT00136318|4255783|P2|NOT COMPLETED|Overall Study||7
1737628|NCT00136318|4255784|P1|NOT COMPLETED|Overall Study||7
1737629|NCT00136318|4255783|P2|COMPLETED|Overall Study||84
1737630|NCT00136318|4255784|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
1737631|NCT00136318|4255783|P2|STARTED|Overall Study|Took first dose of study medication|91
1737632|NCT00136318|4255784|P1|STARTED|Overall Study|Took first dose of study medication|90
1737633|NCT00136214|4255800|P2|NOT COMPLETED|Overall Study||0
1737634|NCT00136214|4255801|P1|NOT COMPLETED|Overall Study||0
1737635|NCT00136214|4255800|P2|COMPLETED|Overall Study||7
1737636|NCT00136214|4255801|P1|COMPLETED|Overall Study||15
1737637|NCT00136214|4255800|P2|STARTED|Overall Study||7
1737638|NCT00136214|4255801|P1|STARTED|Overall Study||15
1737639|NCT00136084|4255811|P2|NOT COMPLETED|Overall Study||42
1737640|NCT00136084|4255812|P1|NOT COMPLETED|Overall Study||48
1737641|NCT00136084|4255811|P2|COMPLETED|Overall Study||72
1737642|NCT00136084|4255812|P1|COMPLETED|Overall Study||61
1737643|NCT00136084|4255811|P2|STARTED|Overall Study||114
1737644|NCT00136084|4255812|P1|STARTED|Overall Study||109
1737645|NCT00135798|4255828|P3|NOT COMPLETED|Overall Study||0
1737646|NCT00135798|4255829|P2|NOT COMPLETED|Overall Study||0
1737647|NCT00135798|4255830|P1|NOT COMPLETED|Overall Study||0
1737648|NCT00135798|4255828|P3|COMPLETED|Overall Study||32
1737649|NCT00135798|4255829|P2|COMPLETED|Overall Study||31
1737650|NCT00135798|4255830|P1|COMPLETED|Overall Study||16
1737651|NCT00135798|4255828|P3|STARTED|Overall Study||32
1737652|NCT00135798|4255829|P2|STARTED|Overall Study||31
1737653|NCT00135798|4255830|P1|STARTED|Overall Study||16
1737654|NCT00135707|4255848|P2|NOT COMPLETED|Overall Study||90
1737655|NCT00135707|4255849|P1|NOT COMPLETED|Overall Study||95
1737656|NCT00135707|4255848|P2|COMPLETED|Overall Study||4976
1737657|NCT00135707|4255849|P1|COMPLETED|Overall Study||4993
1737658|NCT00135707|4255848|P2|STARTED|Overall Study||5066
1737659|NCT00135707|4255849|P1|STARTED|Overall Study||5088
1737660|NCT00135694|4255932|P3|NOT COMPLETED|Overall Study||7
1737661|NCT00135694|4255933|P2|NOT COMPLETED|Overall Study||21
1737662|NCT00135694|4255934|P1|NOT COMPLETED|Overall Study||180
1737663|NCT00135694|4255932|P3|COMPLETED|Overall Study||11
1737664|NCT00135694|4255933|P2|COMPLETED|Overall Study||56
1737665|NCT00135694|4255934|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
1737666|NCT00135694|4255932|P3|STARTED|Overall Study||18
1737667|NCT00135694|4255933|P2|STARTED|Overall Study||77
1737668|NCT00135694|4255934|P1|STARTED|Overall Study||180
1737669|NCT00135356|4255954|P2|NOT COMPLETED|Overall Study||9
1737670|NCT00135356|4255955|P1|NOT COMPLETED|Overall Study||17
1737671|NCT00135356|4255954|P2|COMPLETED|Overall Study||60
1737672|NCT00135356|4255955|P1|COMPLETED|Overall Study||114
1737673|NCT00135356|4255954|P2|Discontinued on or After Week 96 Visit|Overall Study||0
1737674|NCT00135356|4255955|P1|Discontinued on or After Week 96 Visit|Overall Study||1
1737675|NCT00135356|4255954|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
1737676|NCT00135356|4255955|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
1737677|NCT00135356|4255954|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
1737678|NCT00135356|4255955|P1|STARTED|Overall Study|Number randomized and treated|131
1737679|NCT00135330|4255998|P3|NOT COMPLETED|Overall Study||11
1737680|NCT00135330|4255999|P2|NOT COMPLETED|Overall Study||13
1737681|NCT00135330|4256000|P1|NOT COMPLETED|Overall Study||12
1737682|NCT00135330|4255998|P3|COMPLETED|Overall Study||34
1737683|NCT00135330|4255999|P2|COMPLETED|Overall Study||34
1737684|NCT00135330|4256000|P1|COMPLETED|Overall Study||33
1737685|NCT00135330|4255998|P3|STARTED|Overall Study||45
1737686|NCT00135330|4255999|P2|STARTED|Overall Study||47
1737687|NCT00135330|4256000|P1|STARTED|Overall Study||45
1737688|NCT00135200|4256092|P1|NOT COMPLETED|Overall Study||0
1737689|NCT00135200|4256092|P1|COMPLETED|Overall Study||16
1737690|NCT00135200|4256092|P1|STARTED|Overall Study||16
1737691|NCT00134901|4256099|P2|NOT COMPLETED|Overall Study||15
1737692|NCT00134901|4256100|P1|NOT COMPLETED|Overall Study||17
1737693|NCT00134901|4256099|P2|COMPLETED|Overall Study||27
1737694|NCT00134901|4256100|P1|COMPLETED|Overall Study||22
1737695|NCT00134901|4256099|P2|STARTED|Overall Study||42
1737696|NCT00134901|4256100|P1|STARTED|Overall Study||39
1737697|NCT00134784|4256112|P4|NOT COMPLETED|Overall Study||1
1737698|NCT00134784|4256113|P3|NOT COMPLETED|Overall Study||2
1737699|NCT00134784|4256114|P2|NOT COMPLETED|Overall Study||2
1737700|NCT00134784|4256115|P1|NOT COMPLETED|Overall Study||2
1737701|NCT00134784|4256112|P4|COMPLETED|Overall Study||37
1737702|NCT00134784|4256113|P3|COMPLETED|Overall Study||35
1737703|NCT00134784|4256114|P2|COMPLETED|Overall Study||36
1737704|NCT00134784|4256115|P1|COMPLETED|Overall Study||27
1737705|NCT00134784|4256112|P4|STARTED|Overall Study||38
1737706|NCT00134784|4256113|P3|STARTED|Overall Study||37
1737707|NCT00134784|4256114|P2|STARTED|Overall Study||38
1737708|NCT00134784|4256115|P1|STARTED|Overall Study||29
1737709|NCT00134719|4256125|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
1737710|NCT00134719|4256126|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
1737711|NCT00134719|4256127|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
1737712|NCT00134719|4256125|P3|COMPLETED|Fourth Dose Vaccination Phase||203
1737713|NCT00134719|4256126|P2|COMPLETED|Fourth Dose Vaccination Phase||203
1737714|NCT00134719|4256127|P1|COMPLETED|Fourth Dose Vaccination Phase||623
1737715|NCT00134719|4256125|P3|STARTED|Fourth Dose Vaccination Phase||204
1737716|NCT00134719|4256126|P2|STARTED|Fourth Dose Vaccination Phase||206
1737717|NCT00134719|4256127|P1|STARTED|Fourth Dose Vaccination Phase||625
1737718|NCT00134719|4256125|P3|NOT COMPLETED|Primary Vaccination Phase||5
1737719|NCT00134719|4256126|P2|NOT COMPLETED|Primary Vaccination Phase||6
1737720|NCT00134719|4256127|P1|NOT COMPLETED|Primary Vaccination Phase||14
1737721|NCT00134719|4256125|P3|COMPLETED|Primary Vaccination Phase||216
1737722|NCT00134719|4256126|P2|COMPLETED|Primary Vaccination Phase||215
1737723|NCT00134719|4256127|P1|COMPLETED|Primary Vaccination Phase||647
1737724|NCT00134719|4256125|P3|STARTED|Primary Vaccination Phase||221
1737725|NCT00134719|4256126|P2|STARTED|Primary Vaccination Phase||221
1737726|NCT00134719|4256127|P1|STARTED|Primary Vaccination Phase||661
1737727|NCT00134563|4256258|P3|NOT COMPLETED|Overall Study||96
1737728|NCT00134563|4256259|P2|NOT COMPLETED|Overall Study||92
1737729|NCT00134563|4256260|P1|NOT COMPLETED|Overall Study||104
1737730|NCT00134563|4256258|P3|COMPLETED|Overall Study|completed treatment period|263
1737731|NCT00134563|4256259|P2|COMPLETED|Overall Study|completed treatment period|274
1737732|NCT00134563|4256260|P1|COMPLETED|Overall Study|completed treatment period|259
1737733|NCT00134563|4256258|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
1737734|NCT00134563|4256259|P2|Treated|Overall Study||365
1737735|NCT00134563|4256260|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
1737736|NCT00134563|4256258|P3|STARTED|Overall Study|Randomized|359
1737737|NCT00134563|4256259|P2|STARTED|Overall Study|Randomized|366
1737738|NCT00134563|4256260|P1|STARTED|Overall Study|Randomized|363
1737739|NCT00134381|4256283|P6|NOT COMPLETED|Overall Study||2
1737740|NCT00134381|4256284|P5|NOT COMPLETED|Overall Study||0
1737741|NCT00134381|4256285|P4|NOT COMPLETED|Overall Study||0
1737742|NCT00134381|4256286|P3|NOT COMPLETED|Overall Study||0
1737743|NCT00134381|4256287|P2|NOT COMPLETED|Overall Study||0
1737744|NCT00134381|4256288|P1|NOT COMPLETED|Overall Study||0
1737745|NCT00134381|4256283|P6|COMPLETED|Overall Study||29
1737746|NCT00134381|4256284|P5|COMPLETED|Overall Study||31
1737747|NCT00134381|4256285|P4|COMPLETED|Overall Study||2
1737748|NCT00134381|4256286|P3|COMPLETED|Overall Study||1
1737749|NCT00134381|4256287|P2|COMPLETED|Overall Study||2
1737750|NCT00134381|4256288|P1|COMPLETED|Overall Study||1
1737751|NCT00134381|4256283|P6|STARTED|Overall Study||31
1737752|NCT00134381|4256284|P5|STARTED|Overall Study||31
1737753|NCT00134381|4256285|P4|STARTED|Overall Study||2
1737754|NCT00134381|4256286|P3|STARTED|Overall Study||1
1737755|NCT00134381|4256287|P2|STARTED|Overall Study||2
1737756|NCT00134381|4256288|P1|STARTED|Overall Study||1
1737757|NCT00134056|4256323|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
1737758|NCT00134056|4256324|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
1737759|NCT00134056|4256323|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
1737760|NCT00134056|4256324|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
1737761|NCT00134056|4256323|P2|STARTED|Eligible for Protocol Assigned Treatment||500
1737762|NCT00134056|4256324|P1|STARTED|Eligible for Protocol Assigned Treatment||496
1737763|NCT00134056|4256323|P2|NOT COMPLETED|Randomization||20
1737764|NCT00134056|4256324|P1|NOT COMPLETED|Randomization||22
1737765|NCT00134056|4256323|P2|COMPLETED|Randomization||500
1737766|NCT00134056|4256324|P1|COMPLETED|Randomization||496
1737767|NCT00134056|4256323|P2|STARTED|Randomization||520
1737768|NCT00134056|4256324|P1|STARTED|Randomization||518
1737769|NCT00134043|4256346|P2|NOT COMPLETED|Overall Study||0
1737770|NCT00134043|4256347|P1|NOT COMPLETED|Overall Study||0
1737771|NCT00134043|4256346|P2|COMPLETED|Overall Study||3
1737772|NCT00134043|4256347|P1|COMPLETED|Overall Study||16
1737773|NCT00134043|4256346|P2|STARTED|Overall Study||3
1737774|NCT00134043|4256347|P1|STARTED|Overall Study||16
1737775|NCT00134017|4256352|P1|NOT COMPLETED|Overall Study||0
1737776|NCT00134017|4256352|P1|COMPLETED|Overall Study||142
1737777|NCT00134017|4256352|P1|STARTED|Overall Study||142
1737778|NCT00134004|4256360|P1|NOT COMPLETED|Overall Study||0
1737779|NCT00134004|4256360|P1|COMPLETED|Overall Study||210
1737780|NCT00134004|4256360|P1|STARTED|Overall Study||210
1737781|NCT00133991|4256368|P1|NOT COMPLETED|Overall Study||4
1737782|NCT00133991|4256368|P1|COMPLETED|Overall Study||17
1737783|NCT00133991|4256368|P1|STARTED|Overall Study||21
1737784|NCT00133978|4256380|P4|NOT COMPLETED|Overall Study||2
1737785|NCT00133978|4256381|P3|NOT COMPLETED|Overall Study||0
1737786|NCT00133978|4256382|P2|NOT COMPLETED|Overall Study||1
1737787|NCT00133978|4256383|P1|NOT COMPLETED|Overall Study||2
1737788|NCT00133978|4256380|P4|COMPLETED|Overall Study||300
1737789|NCT00133978|4256381|P3|COMPLETED|Overall Study||310
1737790|NCT00133978|4256382|P2|COMPLETED|Overall Study||307
1737791|NCT00133978|4256383|P1|COMPLETED|Overall Study||301
1737792|NCT00133978|4256380|P4|STARTED|Overall Study||302
1737793|NCT00133978|4256381|P3|STARTED|Overall Study||310
1737794|NCT00133978|4256382|P2|STARTED|Overall Study||308
1737795|NCT00133978|4256383|P1|STARTED|Overall Study||303
1737796|NCT00133952|4256407|P2|NOT COMPLETED|Overall Study||28
1737797|NCT00133952|4256408|P1|NOT COMPLETED|Overall Study||42
1737798|NCT00133952|4256407|P2|COMPLETED|Overall Study||124
1737799|NCT00133952|4256408|P1|COMPLETED|Overall Study||115
1737800|NCT00133952|4256407|P2|Received at Least One Dose of Study Drug|Overall Study||149
1737801|NCT00133952|4256408|P1|Received at Least One Dose of Study Drug|Overall Study||153
1737802|NCT00133952|4256407|P2|STARTED|Overall Study||152
1737803|NCT00133952|4256408|P1|STARTED|Overall Study||157
1737804|NCT00133809|4256430|P1|NOT COMPLETED|Overall Study||0
1737805|NCT00133809|4256430|P1|COMPLETED|Overall Study||8
1737806|NCT00133809|4256430|P1|STARTED|Overall Study||8
1737807|NCT00133705|4256439|P2|NOT COMPLETED|Overall Study||3
1737808|NCT00133705|4256440|P1|NOT COMPLETED|Overall Study||2
1737809|NCT00133705|4256439|P2|COMPLETED|Overall Study||17
1737810|NCT00133705|4256440|P1|COMPLETED|Overall Study||20
1737811|NCT00133705|4256439|P2|STARTED|Overall Study||20
1737812|NCT00133705|4256440|P1|STARTED|Overall Study||22
1737813|NCT00133575|4256453|P7|NOT COMPLETED|Overall Study||3
1737814|NCT00133575|4256454|P6|NOT COMPLETED|Overall Study||1
1737815|NCT00133575|4256455|P5|NOT COMPLETED|Overall Study||4
1737816|NCT00133575|4256456|P4|NOT COMPLETED|Overall Study||1
1737817|NCT00133575|4256457|P3|NOT COMPLETED|Overall Study||2
1737818|NCT00133575|4256458|P2|NOT COMPLETED|Overall Study||0
1737819|NCT00133575|4256459|P1|NOT COMPLETED|Overall Study||0
1737820|NCT00133575|4256453|P7|COMPLETED|Overall Study||9
1737821|NCT00133575|4256454|P6|COMPLETED|Overall Study||9
1737822|NCT00133575|4256455|P5|COMPLETED|Overall Study||6
1737823|NCT00133575|4256456|P4|COMPLETED|Overall Study||9
1737824|NCT00133575|4256457|P3|COMPLETED|Overall Study||8
1737825|NCT00133575|4256458|P2|COMPLETED|Overall Study||10
1737826|NCT00133575|4256459|P1|COMPLETED|Overall Study||10
1737827|NCT00133575|4256453|P7|STARTED|Overall Study||12
1737828|NCT00133575|4256454|P6|STARTED|Overall Study||10
1737829|NCT00133575|4256455|P5|STARTED|Overall Study||10
1737830|NCT00133575|4256456|P4|STARTED|Overall Study||10
1737831|NCT00133575|4256457|P3|STARTED|Overall Study||10
1737832|NCT00133575|4256458|P2|STARTED|Overall Study||10
1737833|NCT00133575|4256459|P1|STARTED|Overall Study||10
1737834|NCT00132873|4256566|P1|NOT COMPLETED|Overall Study||9
1737835|NCT00132873|4256566|P1|COMPLETED|Overall Study||50
1737836|NCT00132873|4256566|P1|STARTED|Overall Study||59
1737837|NCT00132808|4256574|P3|NOT COMPLETED|Stratum II||9
1737838|NCT00132808|4256575|P2|NOT COMPLETED|Stratum II||15
1737839|NCT00132808|4256576|P1|NOT COMPLETED|Stratum II||8
1737840|NCT00132808|4256574|P3|COMPLETED|Stratum II||116
1737841|NCT00132808|4256575|P2|COMPLETED|Stratum II||96
1737842|NCT00132808|4256576|P1|COMPLETED|Stratum II||113
1737843|NCT00132808|4256574|P3|STARTED|Stratum II||125
1737844|NCT00132808|4256575|P2|STARTED|Stratum II||111
1737845|NCT00132808|4256576|P1|STARTED|Stratum II||121
1737846|NCT00132808|4256574|P3|NOT COMPLETED|Stratum I||5
1737847|NCT00132808|4256575|P2|NOT COMPLETED|Stratum I||12
1737848|NCT00132808|4256576|P1|NOT COMPLETED|Stratum I||9
1737849|NCT00132808|4256574|P3|COMPLETED|Stratum I||72
1737850|NCT00132808|4256575|P2|COMPLETED|Stratum I||58
1737851|NCT00132808|4256576|P1|COMPLETED|Stratum I||68
1737852|NCT00132808|4256574|P3|STARTED|Stratum I||77
1737853|NCT00132808|4256575|P2|STARTED|Stratum I||70
1737854|NCT00132808|4256576|P1|STARTED|Stratum I||77
1737855|NCT00132769|4256601|P2|NOT COMPLETED|Overall Study||11
1737856|NCT00132769|4256602|P1|NOT COMPLETED|Overall Study||11
1737857|NCT00132769|4256601|P2|COMPLETED|Overall Study||42
1737858|NCT00132769|4256602|P1|COMPLETED|Overall Study||42
1737859|NCT00132769|4256601|P2|STARTED|Overall Study||53
1737860|NCT00132769|4256602|P1|STARTED|Overall Study||53
1737861|NCT00132730|4256628|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
1737862|NCT00132730|4256629|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
1737863|NCT00132730|4256630|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
1737864|NCT00132730|4256631|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
1737865|NCT00132730|4256632|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
1737866|NCT00132730|4256633|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
1737867|NCT00132730|4256628|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
1737868|NCT00132730|4256629|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
1737869|NCT00132730|4256630|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
1737870|NCT00132730|4256631|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
1737871|NCT00132730|4256632|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
1737872|NCT00132730|4256633|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
1737873|NCT00132730|4256628|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
1737874|NCT00132730|4256629|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
1737875|NCT00132730|4256630|P4|STARTED|Period V - Open-label Extension (EXT2)||0
1737876|NCT00132730|4256631|P3|STARTED|Period V - Open-label Extension (EXT2)||0
1737877|NCT00132730|4256632|P2|STARTED|Period V - Open-label Extension (EXT2)||0
1737878|NCT00132730|4256633|P1|STARTED|Period V - Open-label Extension (EXT2)||0
1737879|NCT00132730|4256628|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
1737880|NCT00132730|4256629|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
1737881|NCT00132730|4256630|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
1737882|NCT00132730|4256631|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
1737883|NCT00132730|4256632|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
1737884|NCT00132730|4256633|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
1737885|NCT00132730|4256628|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
1737886|NCT00132730|4256629|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
1737887|NCT00132730|4256630|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
1737888|NCT00132730|4256631|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
1737889|NCT00132730|4256632|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
1737890|NCT00132730|4256633|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
1737891|NCT00132730|4256628|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
1737892|NCT00132730|4256629|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
1737893|NCT00132730|4256630|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
1737894|NCT00132730|4256631|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
1737895|NCT00132730|4256632|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
1737896|NCT00132730|4256633|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
1737897|NCT00132730|4256628|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
1737898|NCT00132730|4256629|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
1737899|NCT00132730|4256630|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
1737900|NCT00132730|4256631|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
1737901|NCT00132730|4256632|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
1737902|NCT00132730|4256633|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
1737903|NCT00132730|4256628|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
1737904|NCT00132730|4256629|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
1737905|NCT00132730|4256630|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
1737906|NCT00132730|4256631|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
1737907|NCT00132730|4256632|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
1737908|NCT00132730|4256633|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
1737909|NCT00132730|4256628|P6|STARTED|Period III - Blinded Extension (EXT1)||0
1737910|NCT00132730|4256629|P5|STARTED|Period III - Blinded Extension (EXT1)||0
1737911|NCT00132730|4256630|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
1737912|NCT00132730|4256631|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
1737913|NCT00132730|4256632|P2|STARTED|Period III - Blinded Extension (EXT1)||0
1737914|NCT00132730|4256633|P1|STARTED|Period III - Blinded Extension (EXT1)||0
1737915|NCT00132730|4256628|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
1737916|NCT00132730|4256629|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
1737917|NCT00132730|4256630|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
1737918|NCT00132730|4256631|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
1737919|NCT00132730|4256632|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
1737920|NCT00132730|4256633|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
1737921|NCT00132730|4256628|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
1737922|NCT00132730|4256629|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
1737923|NCT00132730|4256630|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
1737924|NCT00132730|4256631|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
1737925|NCT00132730|4256632|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
1737926|NCT00132730|4256633|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
1737927|NCT00132730|4256628|P6|STARTED|Period II - 12-week Treatment (Base)||0
1737928|NCT00132730|4256629|P5|STARTED|Period II - 12-week Treatment (Base)||0
1737929|NCT00132730|4256630|P4|STARTED|Period II - 12-week Treatment (Base)||153
1737930|NCT00132730|4256631|P3|STARTED|Period II - 12-week Treatment (Base)||153
1737931|NCT00132730|4256632|P2|STARTED|Period II - 12-week Treatment (Base)||148
1737932|NCT00132730|4256633|P1|STARTED|Period II - 12-week Treatment (Base)||150
1737933|NCT00132730|4256628|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1737934|NCT00132730|4256629|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1737935|NCT00132730|4256630|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1737936|NCT00132730|4256631|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1737937|NCT00132730|4256632|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1737938|NCT00132730|4256633|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
1737939|NCT00132730|4256628|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
1737940|NCT00132730|4256629|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
1737941|NCT00132730|4256630|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
1737942|NCT00132730|4256631|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
1737943|NCT00132730|4256632|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
1737944|NCT00132730|4256633|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
1737945|NCT00132730|4256628|P6|STARTED|Period I - Placebo Run-in (Base)||0
1737946|NCT00132730|4256629|P5|STARTED|Period I - Placebo Run-in (Base)||0
1737947|NCT00132730|4256630|P4|STARTED|Period I - Placebo Run-in (Base)||153
1737948|NCT00132730|4256631|P3|STARTED|Period I - Placebo Run-in (Base)||153
1737949|NCT00132730|4256632|P2|STARTED|Period I - Placebo Run-in (Base)||148
1737950|NCT00132730|4256633|P1|STARTED|Period I - Placebo Run-in (Base)||150
1737951|NCT00132691|4256677|P2|NOT COMPLETED|Overall Study||12
1737952|NCT00132691|4256678|P1|NOT COMPLETED|Overall Study||11
1737953|NCT00132691|4256677|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
1737954|NCT00132691|4256678|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
1737955|NCT00132691|4256677|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
1737956|NCT00132691|4256678|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
1737957|NCT00132678|4256718|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
1737958|NCT00132678|4256719|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
1737959|NCT00132678|4256720|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
1737960|NCT00132678|4256718|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
1737961|NCT00132678|4256719|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
1737962|NCT00132678|4256720|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
1737963|NCT00132678|4256718|P3|STARTED|Period IV (Double-Blind Treatment)||0
1737964|NCT00132678|4256719|P2|STARTED|Period IV (Double-Blind Treatment)||149
1737965|NCT00132678|4256720|P1|STARTED|Period IV (Double-Blind Treatment)||154
1737966|NCT00132678|4256718|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
1737967|NCT00132678|4256719|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
1737968|NCT00132678|4256720|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
1737969|NCT00132678|4256718|P3|COMPLETED|Period III (Open-Label Stabilization)||0
1737970|NCT00132678|4256719|P2|COMPLETED|Period III (Open-Label Stabilization)||0
1737971|NCT00132678|4256720|P1|COMPLETED|Period III (Open-Label Stabilization)||303
1737972|NCT00132678|4256718|P3|STARTED|Period III (Open-Label Stabilization)||0
1737973|NCT00132678|4256719|P2|STARTED|Period III (Open-Label Stabilization)||0
1737974|NCT00132678|4256720|P1|STARTED|Period III (Open-Label Stabilization)||501
1737975|NCT00132678|4256718|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
1737976|NCT00132678|4256719|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
1737977|NCT00132678|4256720|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
1737978|NCT00132678|4256718|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
1737979|NCT00132678|4256719|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
1737980|NCT00132678|4256720|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
1737981|NCT00132678|4256718|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
1737982|NCT00132678|4256719|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
1737983|NCT00132678|4256720|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
1737984|NCT00132496|4256734|P2|NOT COMPLETED|Overall Study||2
1737985|NCT00132496|4256735|P1|NOT COMPLETED|Overall Study||2
1737986|NCT00132496|4256734|P2|COMPLETED|Overall Study||55
1737987|NCT00132496|4256735|P1|COMPLETED|Overall Study||52
1737988|NCT00132496|4256734|P2|STARTED|Overall Study||57
1737989|NCT00132496|4256735|P1|STARTED|Overall Study||54
1737990|NCT00132314|4256743|P2|NOT COMPLETED|Overall Study||72
1737991|NCT00132314|4256744|P1|NOT COMPLETED|Overall Study||73
1737992|NCT00132314|4256743|P2|COMPLETED|Overall Study||120
1737993|NCT00132314|4256744|P1|COMPLETED|Overall Study||117
1737994|NCT00132314|4256743|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
1737995|NCT00132314|4256744|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
1737996|NCT00132314|4256743|P2|Received Treatment|Overall Study||185
1737997|NCT00132314|4256744|P1|Received Treatment|Overall Study||188
1737998|NCT00132314|4256743|P2|STARTED|Overall Study||192
1737999|NCT00132314|4256744|P1|STARTED|Overall Study||190
1738000|NCT00132301|4256754|P2|NOT COMPLETED|Overall Study||13
1738001|NCT00132301|4256755|P1|NOT COMPLETED|Overall Study||20
1738002|NCT00132301|4256754|P2|COMPLETED|Overall Study||144
1738003|NCT00132301|4256755|P1|COMPLETED|Overall Study||121
1738004|NCT00132301|4256754|P2|STARTED|Overall Study||157
1738005|NCT00132301|4256755|P1|STARTED|Overall Study||141
1738006|NCT00132132|4256763|P2|NOT COMPLETED|Overall Study||2
1738007|NCT00132132|4256764|P1|NOT COMPLETED|Overall Study||7
1738008|NCT00132132|4256763|P2|COMPLETED|Overall Study||13
1738009|NCT00132132|4256764|P1|COMPLETED|Overall Study||8
1738010|NCT00132132|4256763|P2|STARTED|Overall Study||15
1738011|NCT00132132|4256764|P1|STARTED|Overall Study||15
1738012|NCT00132028|4256772|P1|NOT COMPLETED|Overall Study||27
1738013|NCT00132028|4256772|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
1738014|NCT00132028|4256772|P1|Eligible and Began Protocol Therapy|Overall Study||25
1738015|NCT00132028|4256772|P1|Eligible|Overall Study||25
1738016|NCT00132028|4256772|P1|STARTED|Overall Study||27
1738017|NCT00132002|4256778|P1|NOT COMPLETED|Overall Study||0
1738018|NCT00132002|4256778|P1|COMPLETED|Overall Study||14
1738019|NCT00132002|4256778|P1|STARTED|Overall Study||14
1738020|NCT00131937|4256784|P1|NOT COMPLETED|Overall Study||14
1738021|NCT00131937|4256784|P1|COMPLETED|Overall Study||0
1738022|NCT00131937|4256784|P1|STARTED|Overall Study||14
1738023|NCT00131911|4256792|P2|NOT COMPLETED|Overall Study||0
1738024|NCT00131911|4256793|P1|NOT COMPLETED|Overall Study||1
1738025|NCT00131911|4256792|P2|COMPLETED|Overall Study||42
1738026|NCT00131911|4256793|P1|COMPLETED|Overall Study||50
1738027|NCT00131911|4256792|P2|STARTED|Overall Study||42
1738028|NCT00131911|4256793|P1|STARTED|Overall Study||51
1738029|NCT00131885|4256810|P4|NOT COMPLETED|Time 2: Second Intervention||0
1738030|NCT00131885|4256811|P3|NOT COMPLETED|Time 2: Second Intervention||0
1738031|NCT00131885|4256812|P2|NOT COMPLETED|Time 2: Second Intervention||0
1738032|NCT00131885|4256813|P1|NOT COMPLETED|Time 2: Second Intervention||0
1738033|NCT00131885|4256810|P4|COMPLETED|Time 2: Second Intervention||9
1738034|NCT00131885|4256811|P3|COMPLETED|Time 2: Second Intervention||9
1738035|NCT00131885|4256812|P2|COMPLETED|Time 2: Second Intervention||9
1738036|NCT00131885|4256813|P1|COMPLETED|Time 2: Second Intervention||9
1738037|NCT00131885|4256810|P4|STARTED|Time 2: Second Intervention||9
1738038|NCT00131885|4256811|P3|STARTED|Time 2: Second Intervention||9
1738039|NCT00131885|4256812|P2|STARTED|Time 2: Second Intervention||9
1738040|NCT00131885|4256813|P1|STARTED|Time 2: Second Intervention||9
1738041|NCT00131885|4256810|P4|NOT COMPLETED|Time 1: First Intervention||0
1738042|NCT00131885|4256811|P3|NOT COMPLETED|Time 1: First Intervention||0
1738043|NCT00131885|4256812|P2|NOT COMPLETED|Time 1: First Intervention||0
1738044|NCT00131885|4256813|P1|NOT COMPLETED|Time 1: First Intervention||0
1738045|NCT00131885|4256810|P4|COMPLETED|Time 1: First Intervention||9
1738046|NCT00131885|4256811|P3|COMPLETED|Time 1: First Intervention||9
1738047|NCT00131885|4256812|P2|COMPLETED|Time 1: First Intervention||9
1738048|NCT00131885|4256813|P1|COMPLETED|Time 1: First Intervention||9
1738049|NCT00131885|4256810|P4|STARTED|Time 1: First Intervention||9
1738050|NCT00131885|4256811|P3|STARTED|Time 1: First Intervention||9
1738051|NCT00131885|4256812|P2|STARTED|Time 1: First Intervention||9
1738052|NCT00131885|4256813|P1|STARTED|Time 1: First Intervention||9
1738053|NCT00131677|4256845|P2|NOT COMPLETED|Overall Study||39
1738054|NCT00131677|4256846|P1|NOT COMPLETED|Overall Study||30
1738055|NCT00131677|4256845|P2|COMPLETED|Overall Study||160
1738056|NCT00131677|4256846|P1|COMPLETED|Overall Study||171
1738057|NCT00131677|4256845|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
1738058|NCT00131677|4256846|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
1738059|NCT00131664|4256863|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
1738060|NCT00131664|4256864|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
1738061|NCT00131664|4256865|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
1738062|NCT00131664|4256866|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
1738063|NCT00131664|4256867|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
1738064|NCT00131664|4256868|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
1738065|NCT00131664|4256863|P6|COMPLETED|Second Period (Additional Drug Added)||22
1738066|NCT00131664|4256864|P5|COMPLETED|Second Period (Additional Drug Added)||15
1738067|NCT00131664|4256865|P4|COMPLETED|Second Period (Additional Drug Added)||19
1738068|NCT00131664|4256866|P3|COMPLETED|Second Period (Additional Drug Added)||76
1738069|NCT00131664|4256867|P2|COMPLETED|Second Period (Additional Drug Added)||97
1738070|NCT00131664|4256868|P1|COMPLETED|Second Period (Additional Drug Added)||81
1738071|NCT00131664|4256863|P6|STARTED|Second Period (Additional Drug Added)||25
1738072|NCT00131664|4256864|P5|STARTED|Second Period (Additional Drug Added)||16
1738073|NCT00131664|4256865|P4|STARTED|Second Period (Additional Drug Added)||21
1738074|NCT00131664|4256866|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
1738075|NCT00131664|4256867|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
1738076|NCT00131664|4256868|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
1738077|NCT00131664|4256863|P6|NOT COMPLETED|First Period (First 6 Months)||0
1738078|NCT00131664|4256864|P5|NOT COMPLETED|First Period (First 6 Months)||0
1738079|NCT00131664|4256865|P4|NOT COMPLETED|First Period (First 6 Months)||0
1738080|NCT00131664|4256866|P3|NOT COMPLETED|First Period (First 6 Months)||16
1738081|NCT00131664|4256867|P2|NOT COMPLETED|First Period (First 6 Months)||18
1738082|NCT00131664|4256868|P1|NOT COMPLETED|First Period (First 6 Months)||25
1738083|NCT00131664|4256863|P6|COMPLETED|First Period (First 6 Months)||0
1738084|NCT00131664|4256864|P5|COMPLETED|First Period (First 6 Months)||0
1738085|NCT00131664|4256865|P4|COMPLETED|First Period (First 6 Months)||0
1738086|NCT00131664|4256866|P3|COMPLETED|First Period (First 6 Months)||104
1738087|NCT00131664|4256867|P2|COMPLETED|First Period (First 6 Months)||117
1738088|NCT00131664|4256868|P1|COMPLETED|First Period (First 6 Months)||111
1738089|NCT00131664|4256863|P6|STARTED|First Period (First 6 Months)||0
1738090|NCT00131664|4256864|P5|STARTED|First Period (First 6 Months)||0
1738091|NCT00131664|4256865|P4|STARTED|First Period (First 6 Months)||0
1738092|NCT00131664|4256866|P3|STARTED|First Period (First 6 Months)||120
1738093|NCT00131664|4256867|P2|STARTED|First Period (First 6 Months)||135
1738094|NCT00131664|4256868|P1|STARTED|First Period (First 6 Months)||136
1738095|NCT00131573|4256929|P2|NOT COMPLETED|Overall Study||26
1738096|NCT00131573|4256930|P1|NOT COMPLETED|Overall Study||33
1738097|NCT00131573|4256929|P2|COMPLETED|Overall Study||13
1738098|NCT00131573|4256930|P1|COMPLETED|Overall Study||13
1738099|NCT00131573|4256929|P2|STARTED|Overall Study||39
1738100|NCT00131573|4256930|P1|STARTED|Overall Study||46
1738101|NCT00131508|4256940|P2|NOT COMPLETED|Overall Study||8
1738102|NCT00131508|4256941|P1|NOT COMPLETED|Overall Study||3
1738103|NCT00131508|4256940|P2|COMPLETED|Overall Study||5
1738104|NCT00131508|4256941|P1|COMPLETED|Overall Study||9
1738105|NCT00131508|4256940|P2|STARTED|Overall Study||13
1738106|NCT00131508|4256941|P1|STARTED|Overall Study||12
1738107|NCT00131456|4256965|P2|NOT COMPLETED|Overall Study||20
1738108|NCT00131456|4256966|P1|NOT COMPLETED|Overall Study||19
1738109|NCT00131456|4256965|P2|COMPLETED|Overall Study||31
1738110|NCT00131456|4256966|P1|COMPLETED|Overall Study||33
1738111|NCT00131456|4256965|P2|STARTED|Overall Study||51
1738112|NCT00131456|4256966|P1|STARTED|Overall Study||52
1738113|NCT00131378|4256976|P4|NOT COMPLETED|Overall Study||9
1738114|NCT00131378|4256977|P3|NOT COMPLETED|Overall Study||10
1738115|NCT00131378|4256978|P2|NOT COMPLETED|Overall Study||18
1738116|NCT00131378|4256979|P1|NOT COMPLETED|Overall Study||11
1738117|NCT00131378|4256976|P4|COMPLETED|Overall Study||21
1738118|NCT00131378|4256977|P3|COMPLETED|Overall Study||22
1738119|NCT00131378|4256978|P2|COMPLETED|Overall Study||22
1738120|NCT00131378|4256979|P1|COMPLETED|Overall Study||29
1738121|NCT00131378|4256976|P4|STARTED|Overall Study||30
1738122|NCT00131378|4256977|P3|STARTED|Overall Study||32
1738123|NCT00131378|4256978|P2|STARTED|Overall Study||40
1738124|NCT00131378|4256979|P1|STARTED|Overall Study||40
1738125|NCT00131352|4257003|P2|NOT COMPLETED|Repeat Treatment Period||0
1738126|NCT00131352|4257004|P1|NOT COMPLETED|Repeat Treatment Period||2
1738127|NCT00131352|4257003|P2|COMPLETED|Repeat Treatment Period||0
1738128|NCT00131352|4257004|P1|COMPLETED|Repeat Treatment Period||158
1738129|NCT00131352|4257003|P2|STARTED|Repeat Treatment Period||0
1738130|NCT00131352|4257004|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
1738131|NCT00131352|4257003|P2|NOT COMPLETED|Initial Treatment Period||12
1738132|NCT00131352|4257004|P1|NOT COMPLETED|Initial Treatment Period||9
1738133|NCT00131352|4257003|P2|COMPLETED|Initial Treatment Period||118
1738134|NCT00131352|4257004|P1|COMPLETED|Initial Treatment Period||114
1738135|NCT00131352|4257003|P2|Intent to Treat Population|Initial Treatment Period||129
1738136|NCT00131352|4257004|P1|Intent to Treat Population|Initial Treatment Period||124
1738137|NCT00131352|4257003|P2|STARTED|Initial Treatment Period|Safety population|130
1738138|NCT00131352|4257004|P1|STARTED|Initial Treatment Period|Safety population|123
1738139|NCT00131248|4257026|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
1738140|NCT00131248|4257027|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
1738141|NCT00131248|4257026|P2|COMPLETED|Intervention 3 (4-day Course)||9
1738142|NCT00131248|4257027|P1|COMPLETED|Intervention 3 (4-day Course)||8
1738143|NCT00131248|4257026|P2|STARTED|Intervention 3 (4-day Course)||9
1738144|NCT00131248|4257027|P1|STARTED|Intervention 3 (4-day Course)||8
1738145|NCT00131248|4257026|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
1738146|NCT00131248|4257027|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
1738147|NCT00131248|4257026|P2|COMPLETED|Washout 2 (24 Hours)||9
1738148|NCT00131248|4257027|P1|COMPLETED|Washout 2 (24 Hours)||8
1738149|NCT00131248|4257026|P2|STARTED|Washout 2 (24 Hours)||9
1738150|NCT00131248|4257027|P1|STARTED|Washout 2 (24 Hours)||8
1738151|NCT00131248|4257026|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
1738152|NCT00131248|4257027|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
1738153|NCT00131248|4257026|P2|COMPLETED|Intervention 2 (7-day Course)||9
1738154|NCT00131248|4257027|P1|COMPLETED|Intervention 2 (7-day Course)||8
1738155|NCT00131248|4257026|P2|STARTED|Intervention 2 (7-day Course)||9
1738156|NCT00131248|4257027|P1|STARTED|Intervention 2 (7-day Course)||8
1738157|NCT00131248|4257026|P2|NOT COMPLETED|Washout (24 Hour)||0
1738158|NCT00131248|4257027|P1|NOT COMPLETED|Washout (24 Hour)||0
1738159|NCT00131248|4257026|P2|COMPLETED|Washout (24 Hour)||9
1738160|NCT00131248|4257027|P1|COMPLETED|Washout (24 Hour)||8
1738161|NCT00131248|4257026|P2|STARTED|Washout (24 Hour)||9
1738162|NCT00131248|4257027|P1|STARTED|Washout (24 Hour)||8
1738163|NCT00131248|4257026|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
1738164|NCT00131248|4257027|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
1738165|NCT00131248|4257026|P2|COMPLETED|Intervention 1 (3-day Course)||9
1738166|NCT00131248|4257027|P1|COMPLETED|Intervention 1 (3-day Course)||8
1738167|NCT00131248|4257026|P2|STARTED|Intervention 1 (3-day Course)||9
1738168|NCT00131248|4257027|P1|STARTED|Intervention 1 (3-day Course)||9
1738169|NCT00130923|4257035|P2|NOT COMPLETED|Overall Study||14
1738170|NCT00130923|4257036|P1|NOT COMPLETED|Overall Study||13
1738171|NCT00130923|4257035|P2|COMPLETED|Overall Study||32
1738172|NCT00130923|4257036|P1|COMPLETED|Overall Study||36
1738173|NCT00130923|4257035|P2|STARTED|Overall Study||46
1738174|NCT00130923|4257036|P1|STARTED|Overall Study||49
1738175|NCT00130832|4257044|P2|NOT COMPLETED|Overall Study||17
1738176|NCT00130832|4257045|P1|NOT COMPLETED|Overall Study||16
1738177|NCT00130832|4257044|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
1738178|NCT00130832|4257045|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
1738179|NCT00130832|4257044|P2|STARTED|Overall Study||363
1738180|NCT00130832|4257045|P1|STARTED|Overall Study||372
1738181|NCT00130793|4257057|P2|NOT COMPLETED|Overall Study||4
1738182|NCT00130793|4257058|P1|NOT COMPLETED|Overall Study||3
1738183|NCT00130793|4257057|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
1738184|NCT00130793|4257058|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
1738185|NCT00130793|4257057|P2|Vaccinated|Overall Study||185
1738186|NCT00130793|4257058|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
1738187|NCT00130793|4257057|P2|STARTED|Overall Study||185
1738188|NCT00130793|4257058|P1|STARTED|Overall Study||183
1738189|NCT00130780|4257070|P2|NOT COMPLETED|Overall Study||0
1738190|NCT00130780|4257071|P1|NOT COMPLETED|Overall Study||0
1738191|NCT00130780|4257070|P2|COMPLETED|Overall Study||20
1738192|NCT00130780|4257071|P1|COMPLETED|Overall Study||51
1738193|NCT00130780|4257070|P2|STARTED|Overall Study||20
1738194|NCT00130780|4257071|P1|STARTED|Overall Study||51
1738195|NCT00130728|4257079|P2|NOT COMPLETED|Overall Study||213
1738196|NCT00130728|4257080|P1|NOT COMPLETED|Overall Study||211
1738197|NCT00130728|4257079|P2|COMPLETED|Overall Study||104
1738198|NCT00130728|4257080|P1|COMPLETED|Overall Study||108
1738199|NCT00130728|4257079|P2|Received Study Drug (Safety Population)|Overall Study||313
1738200|NCT00130728|4257080|P1|Received Study Drug (Safety Population)|Overall Study||313
1738201|NCT00130728|4257079|P2|STARTED|Overall Study||317
1738202|NCT00130728|4257080|P1|STARTED|Overall Study||319
1738203|NCT00130689|4257092|P1|NOT COMPLETED|Overall Study||43
1738204|NCT00130689|4257092|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1738205|NCT00130689|4257092|P1|Treated|Overall Study||35
1738206|NCT00130689|4257092|P1|Eligible|Overall Study||37
1738207|NCT00130689|4257092|P1|STARTED|Overall Study||43
1738208|NCT00130637|4257096|P1|NOT COMPLETED|Overall Study||3
1738209|NCT00130637|4257096|P1|COMPLETED|Overall Study||3
1738210|NCT00130637|4257096|P1|STARTED|Overall Study||6
1738211|NCT00130520|4257101|P1|NOT COMPLETED|Overall Study||39
1738212|NCT00130520|4257101|P1|COMPLETED|Overall Study||1
1738213|NCT00130520|4257101|P1|Completion of at Least One Cycle|Overall Study||39
1738214|NCT00130520|4257101|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
1738215|NCT00130286|4257111|P4|NOT COMPLETED|Overall Study||2
1738216|NCT00130286|4257112|P3|NOT COMPLETED|Overall Study||4
1738217|NCT00130286|4257113|P2|NOT COMPLETED|Overall Study||3
1738218|NCT00130286|4257114|P1|NOT COMPLETED|Overall Study||0
1738219|NCT00130286|4257111|P4|COMPLETED|Overall Study||17
1738220|NCT00130286|4257112|P3|COMPLETED|Overall Study||13
1738221|NCT00130286|4257113|P2|COMPLETED|Overall Study||16
1738222|NCT00130286|4257114|P1|COMPLETED|Overall Study||22
1738223|NCT00130286|4257111|P4|STARTED|Overall Study||19
1738224|NCT00130286|4257112|P3|STARTED|Overall Study||17
1738225|NCT00130286|4257113|P2|STARTED|Overall Study||19
1738226|NCT00130286|4257114|P1|STARTED|Overall Study||22
1738227|NCT00130247|4257134|P2|NOT COMPLETED|Overall Study||4
1738228|NCT00130247|4257135|P1|NOT COMPLETED|Overall Study||2
1738229|NCT00130247|4257134|P2|COMPLETED|Overall Study||194
1738230|NCT00130247|4257135|P1|COMPLETED|Overall Study||194
1738231|NCT00130247|4257134|P2|STARTED|Overall Study||198
1738232|NCT00130247|4257135|P1|STARTED|Overall Study||196
1738233|NCT00130208|4257153|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
1738234|NCT00130208|4257154|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
1738235|NCT00130208|4257153|P2|COMPLETED|Washout Period (8 Weeks)||490
1738236|NCT00130208|4257154|P1|COMPLETED|Washout Period (8 Weeks)||494
1738237|NCT00130208|4257153|P2|STARTED|Washout Period (8 Weeks)||502
1738238|NCT00130208|4257154|P1|STARTED|Washout Period (8 Weeks)||500
1738239|NCT00130208|4257153|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
1738240|NCT00130208|4257154|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
1738241|NCT00130208|4257153|P2|COMPLETED|Maintenance Period (26 Weeks)||502
1738242|NCT00130208|4257154|P1|COMPLETED|Maintenance Period (26 Weeks)||500
1738243|NCT00130208|4257153|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
1738244|NCT00130208|4257154|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
1738245|NCT00130208|4257153|P2|STARTED|Maintenance Period (26 Weeks)||532
1738246|NCT00130208|4257154|P1|STARTED|Maintenance Period (26 Weeks)||524
1738247|NCT00130117|4257166|P2|NOT COMPLETED|Overall Study||3
1738248|NCT00130117|4257167|P1|NOT COMPLETED|Overall Study||4
1738249|NCT00130117|4257166|P2|COMPLETED|Overall Study||6
1738250|NCT00130117|4257167|P1|COMPLETED|Overall Study||7
1738251|NCT00130117|4257166|P2|STARTED|Overall Study||9
1738252|NCT00130117|4257167|P1|STARTED|Overall Study||11
1738253|NCT00130039|4257190|P2|NOT COMPLETED|Overall Study||18
1738254|NCT00130039|4257191|P1|NOT COMPLETED|Overall Study||30
1738255|NCT00130039|4257190|P2|COMPLETED|Overall Study|full analysis set|207
1738256|NCT00130039|4257191|P1|COMPLETED|Overall Study|full analysis set|202
1738257|NCT00130039|4257190|P2|STARTED|Overall Study||225
1738258|NCT00130039|4257191|P1|STARTED|Overall Study||232
1738259|NCT00129974|4257207|P1|NOT COMPLETED|Overall Study||1
1738260|NCT00129974|4257207|P1|COMPLETED|Overall Study||0
1738261|NCT00129974|4257207|P1|STARTED|Overall Study||1
1738262|NCT00129961|4257214|P2|NOT COMPLETED|Overall Study||23
1738263|NCT00129961|4257215|P1|NOT COMPLETED|Overall Study||19
1738264|NCT00129961|4257214|P2|COMPLETED|Overall Study||24
1738265|NCT00129961|4257215|P1|COMPLETED|Overall Study||20
1738266|NCT00129961|4257214|P2|STARTED|Overall Study||47
1738267|NCT00129961|4257215|P1|STARTED|Overall Study||39
1738268|NCT00129766|4257251|P2|NOT COMPLETED|Overall Study||59
1738269|NCT00129766|4257252|P1|NOT COMPLETED|Overall Study||60
1738270|NCT00129766|4257251|P2|COMPLETED|Overall Study||3270
1738271|NCT00129766|4257252|P1|COMPLETED|Overall Study||3246
1738272|NCT00129766|4257251|P2|STARTED|Overall Study||3329
1738273|NCT00129766|4257252|P1|STARTED|Overall Study||3306
1738274|NCT00129727|4257290|P1|NOT COMPLETED|Overall Study||5
1738275|NCT00129727|4257290|P1|COMPLETED|Overall Study||57
1738276|NCT00129727|4257290|P1|STARTED|Overall Study||62
1738277|NCT00129623|4257298|P2|NOT COMPLETED|Overall Study||12
1738278|NCT00129623|4257299|P1|NOT COMPLETED|Overall Study||10
1738279|NCT00129623|4257298|P2|COMPLETED|Overall Study||65
1738280|NCT00129623|4257299|P1|COMPLETED|Overall Study||73
1738281|NCT00129623|4257298|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
1738282|NCT00129623|4257299|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
1738283|NCT00129623|4257298|P2|STARTED|Overall Study||77
1738284|NCT00129623|4257299|P1|STARTED|Overall Study||83
1738285|NCT00129545|4257324|P3|NOT COMPLETED|Overall Study||111
1738286|NCT00129545|4257325|P2|NOT COMPLETED|Overall Study||164
1738287|NCT00129545|4257326|P1|NOT COMPLETED|Overall Study||26
1738288|NCT00129545|4257324|P3|COMPLETED|Overall Study||133
1738289|NCT00129545|4257325|P2|COMPLETED|Overall Study||299
1738290|NCT00129545|4257326|P1|COMPLETED|Overall Study||67
1738291|NCT00129545|4257324|P3|STARTED|Overall Study||244
1738292|NCT00129545|4257325|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
1738293|NCT00129545|4257326|P1|STARTED|Overall Study||93
1738294|NCT00129480|4257338|P2|NOT COMPLETED|Overall Study||0
1738295|NCT00129480|4257339|P1|NOT COMPLETED|Overall Study||0
1738296|NCT00129480|4257338|P2|COMPLETED|Overall Study||214
1738297|NCT00129480|4257339|P1|COMPLETED|Overall Study||187
1738298|NCT00129480|4257338|P2|STARTED|Overall Study||214
1738299|NCT00129480|4257339|P1|STARTED|Overall Study||187
1738300|NCT00129467|4257347|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
1738301|NCT00129467|4257348|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
1738302|NCT00129467|4257347|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
1738303|NCT00129467|4257348|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
1738304|NCT00129467|4257347|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
1738305|NCT00129467|4257348|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
1738306|NCT00129467|4257347|P2|NOT COMPLETED|Received Intervention||4
1738307|NCT00129467|4257348|P1|NOT COMPLETED|Received Intervention||6
1738308|NCT00129467|4257347|P2|COMPLETED|Received Intervention||13
1738309|NCT00129467|4257348|P1|COMPLETED|Received Intervention||9
1738310|NCT00129467|4257347|P2|STARTED|Received Intervention||17
1738311|NCT00129467|4257348|P1|STARTED|Received Intervention||15
1738312|NCT00129441|4257356|P2|NOT COMPLETED|Overall Study||0
1738313|NCT00129441|4257357|P1|NOT COMPLETED|Overall Study||0
1738314|NCT00129441|4257356|P2|COMPLETED|Overall Study||6
1738315|NCT00129441|4257357|P1|COMPLETED|Overall Study||9
1738316|NCT00129441|4257356|P2|Year 1, Visit 8|Overall Study||6
1738317|NCT00129441|4257357|P1|Year 1, Visit 8|Overall Study||9
1738318|NCT00129441|4257356|P2|Week 26, Visit 7|Overall Study||6
1738319|NCT00129441|4257357|P1|Week 26, Visit 7|Overall Study||9
1738320|NCT00129441|4257356|P2|Week 5, Visit 6|Overall Study||6
1738321|NCT00129441|4257357|P1|Week 5, Visit 6|Overall Study||9
1738322|NCT00129441|4257356|P2|Week 4, Visit 5|Overall Study||6
1738323|NCT00129441|4257357|P1|Week 4, Visit 5|Overall Study||9
1738324|NCT00129441|4257356|P2|Week 3, Visit 4|Overall Study||6
1738325|NCT00129441|4257357|P1|Week 3, Visit 4|Overall Study||9
1738326|NCT00129441|4257356|P2|Week 2, Visit 3|Overall Study||6
1738327|NCT00129441|4257357|P1|Week 2, Visit 3|Overall Study||9
1738328|NCT00129441|4257356|P2|Week 1, Visit 2|Overall Study||6
1738329|NCT00129441|4257357|P1|Week 1, Visit 2|Overall Study||9
1738330|NCT00129441|4257356|P2|Baseline, Visit 1|Overall Study||6
1738331|NCT00129441|4257357|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
1738332|NCT00129441|4257356|P2|STARTED|Overall Study||6
1738333|NCT00129441|4257357|P1|STARTED|Overall Study||9
1738334|NCT00129402|4257379|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
1738335|NCT00129402|4257380|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738336|NCT00129402|4257381|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738337|NCT00129402|4257382|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738338|NCT00129402|4257383|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738339|NCT00129402|4257384|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738340|NCT00129402|4257385|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738341|NCT00129402|4257379|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
1738342|NCT00129402|4257380|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738343|NCT00129402|4257381|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738344|NCT00129402|4257382|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738345|NCT00129402|4257383|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738346|NCT00129402|4257384|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738347|NCT00129402|4257385|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
1738348|NCT00129402|4257379|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
1738349|NCT00129402|4257380|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
1738350|NCT00129402|4257381|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
1738351|NCT00129402|4257382|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
1738352|NCT00129402|4257383|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
1738353|NCT00129402|4257384|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
1738354|NCT00129402|4257385|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
1738355|NCT00129402|4257379|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738356|NCT00129402|4257380|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
1738357|NCT00129402|4257381|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738358|NCT00129402|4257382|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738359|NCT00129402|4257383|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
1738360|NCT00129402|4257384|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738361|NCT00129402|4257385|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738362|NCT00129402|4257379|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738363|NCT00129402|4257380|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
1738364|NCT00129402|4257381|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738365|NCT00129402|4257382|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738366|NCT00129402|4257383|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
1738367|NCT00129402|4257384|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738368|NCT00129402|4257385|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
1738369|NCT00129402|4257379|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1738370|NCT00129402|4257380|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
1738371|NCT00129402|4257381|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1738372|NCT00129402|4257382|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1738373|NCT00129402|4257383|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
1738374|NCT00129402|4257384|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1738375|NCT00129402|4257385|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
1738376|NCT00129402|4257379|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
1738377|NCT00129402|4257380|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
1738378|NCT00129402|4257381|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
1738379|NCT00129402|4257382|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
1738380|NCT00129402|4257383|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
1738381|NCT00129402|4257384|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
1738382|NCT00129402|4257385|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
1738383|NCT00129402|4257379|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
1738384|NCT00129402|4257380|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
1738385|NCT00129402|4257381|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
1738386|NCT00129402|4257382|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
1738387|NCT00129402|4257383|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
1738388|NCT00129402|4257384|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
1738389|NCT00129402|4257385|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
1738390|NCT00129402|4257379|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
1738391|NCT00129402|4257380|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
1738392|NCT00129402|4257381|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
1738393|NCT00129402|4257382|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
1738394|NCT00129402|4257383|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
1738395|NCT00129402|4257384|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
1738396|NCT00129402|4257385|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
1738397|NCT00129311|4257404|P2|NOT COMPLETED|Overall Study||19
1738398|NCT00129311|4257405|P1|NOT COMPLETED|Overall Study||12
1738399|NCT00129311|4257404|P2|COMPLETED|Overall Study||31
1738400|NCT00129311|4257405|P1|COMPLETED|Overall Study||39
1738401|NCT00129311|4257404|P2|STARTED|Overall Study||50
1738402|NCT00129311|4257405|P1|STARTED|Overall Study||51
1738403|NCT00129285|4257416|P3|NOT COMPLETED|Overall Study||38
1738404|NCT00129285|4257417|P2|NOT COMPLETED|Overall Study||27
1738405|NCT00129285|4257418|P1|NOT COMPLETED|Overall Study||25
1738406|NCT00129285|4257416|P3|COMPLETED|Overall Study||37
1738407|NCT00129285|4257417|P2|COMPLETED|Overall Study||43
1738408|NCT00129285|4257418|P1|COMPLETED|Overall Study||40
1738409|NCT00129285|4257416|P3|STARTED|Overall Study||75
1738410|NCT00129285|4257417|P2|STARTED|Overall Study||70
1738411|NCT00129285|4257418|P1|STARTED|Overall Study||65
1738412|NCT00129272|4257434|P2|NOT COMPLETED|Overall Study||22
1738413|NCT00129272|4257435|P1|NOT COMPLETED|Overall Study||17
1738414|NCT00129272|4257434|P2|COMPLETED|Overall Study||51
1738415|NCT00129272|4257435|P1|COMPLETED|Overall Study||54
1738416|NCT00129272|4257434|P2|STARTED|Overall Study||73
1738417|NCT00129272|4257435|P1|STARTED|Overall Study||71
1738418|NCT00129259|4257445|P2|NOT COMPLETED|Overall Study||3
1738419|NCT00129259|4257446|P1|NOT COMPLETED|Overall Study||3
1738420|NCT00129259|4257445|P2|COMPLETED|Overall Study||22
1738421|NCT00129259|4257446|P1|COMPLETED|Overall Study||49
1738422|NCT00129259|4257445|P2|Received All or Part of Cycle 2|Overall Study||0
1738423|NCT00129259|4257446|P1|Received All or Part of Cycle 2|Overall Study||40
1738424|NCT00129259|4257445|P2|Received All or Part of Cycle 1|Overall Study||0
1738425|NCT00129259|4257446|P1|Received All or Part of Cycle 1|Overall Study||52
1738426|NCT00129259|4257445|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
1738427|NCT00129259|4257446|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
1738428|NCT00129246|4257458|P2|NOT COMPLETED|Overall Study||0
1738429|NCT00129246|4257459|P1|NOT COMPLETED|Overall Study||0
1738430|NCT00129246|4257458|P2|COMPLETED|Overall Study||20
1738431|NCT00129246|4257459|P1|COMPLETED|Overall Study||20
1738432|NCT00129246|4257458|P2|STARTED|Overall Study||20
1738433|NCT00129246|4257459|P1|STARTED|Overall Study||20
1738434|NCT00129220|4257474|P3|NOT COMPLETED|Study Period III||10
1738435|NCT00129220|4257475|P2|NOT COMPLETED|Study Period III||1
1738436|NCT00129220|4257476|P1|NOT COMPLETED|Study Period III||13
1738437|NCT00129220|4257474|P3|COMPLETED|Study Period III||42
1738438|NCT00129220|4257475|P2|COMPLETED|Study Period III||7
1738439|NCT00129220|4257476|P1|COMPLETED|Study Period III||59
1738440|NCT00129220|4257474|P3|STARTED|Study Period III||52
1738441|NCT00129220|4257475|P2|STARTED|Study Period III||8
1738442|NCT00129220|4257476|P1|STARTED|Study Period III||72
1738443|NCT00129220|4257474|P3|NOT COMPLETED|Study Period II||47
1738444|NCT00129220|4257475|P2|NOT COMPLETED|Study Period II||12
1738445|NCT00129220|4257476|P1|NOT COMPLETED|Study Period II||33
1738446|NCT00129220|4257474|P3|COMPLETED|Study Period II||52
1738447|NCT00129220|4257475|P2|COMPLETED|Study Period II||8
1738448|NCT00129220|4257476|P1|COMPLETED|Study Period II||72
1738449|NCT00129220|4257474|P3|Received at Least One Dose of Study Drug|Study Period II||97
1738450|NCT00129220|4257475|P2|Received at Least One Dose of Study Drug|Study Period II||20
1738451|NCT00129220|4257476|P1|Received at Least One Dose of Study Drug|Study Period II||104
1738452|NCT00129220|4257474|P3|STARTED|Study Period II||99
1738453|NCT00129220|4257475|P2|STARTED|Study Period II||20
1738454|NCT00129220|4257476|P1|STARTED|Study Period II||105
1738455|NCT00129129|4257516|P5|NOT COMPLETED|Fourth Dose Phase||6
1738456|NCT00129129|4257517|P4|NOT COMPLETED|Fourth Dose Phase||4
1738457|NCT00129129|4257518|P3|NOT COMPLETED|Fourth Dose Phase||0
1738458|NCT00129129|4257519|P2|NOT COMPLETED|Fourth Dose Phase||0
1738459|NCT00129129|4257520|P1|NOT COMPLETED|Fourth Dose Phase||4
1738460|NCT00129129|4257516|P5|COMPLETED|Fourth Dose Phase||124
1738461|NCT00129129|4257517|P4|COMPLETED|Fourth Dose Phase||128
1738462|NCT00129129|4257518|P3|COMPLETED|Fourth Dose Phase||0
1738463|NCT00129129|4257519|P2|COMPLETED|Fourth Dose Phase||0
1738464|NCT00129129|4257520|P1|COMPLETED|Fourth Dose Phase||232
1738465|NCT00129129|4257516|P5|STARTED|Fourth Dose Phase||130
1738466|NCT00129129|4257517|P4|STARTED|Fourth Dose Phase||132
1738467|NCT00129129|4257518|P3|STARTED|Fourth Dose Phase||0
1738468|NCT00129129|4257519|P2|STARTED|Fourth Dose Phase||0
1738469|NCT00129129|4257520|P1|STARTED|Fourth Dose Phase||236
1738470|NCT00129129|4257516|P5|NOT COMPLETED|Primary Phase||0
1738471|NCT00129129|4257517|P4|NOT COMPLETED|Primary Phase||0
1738472|NCT00129129|4257518|P3|NOT COMPLETED|Primary Phase||0
1738473|NCT00129129|4257519|P2|NOT COMPLETED|Primary Phase||25
1738474|NCT00129129|4257520|P1|NOT COMPLETED|Primary Phase||25
1738475|NCT00129129|4257516|P5|COMPLETED|Primary Phase||0
1738476|NCT00129129|4257517|P4|COMPLETED|Primary Phase||0
1738477|NCT00129129|4257518|P3|COMPLETED|Primary Phase||150
1738478|NCT00129129|4257519|P2|COMPLETED|Primary Phase||294
1738479|NCT00129129|4257520|P1|COMPLETED|Primary Phase||262
1738480|NCT00129129|4257516|P5|STARTED|Primary Phase||0
1738481|NCT00129129|4257517|P4|STARTED|Primary Phase||0
1738482|NCT00129129|4257518|P3|STARTED|Primary Phase||150
1738483|NCT00129129|4257519|P2|STARTED|Primary Phase||319
1738484|NCT00129129|4257520|P1|STARTED|Primary Phase||287
1738485|NCT00129116|4257727|P5|NOT COMPLETED|Booster Phase||1
1738486|NCT00129116|4257728|P4|NOT COMPLETED|Booster Phase||0
1738487|NCT00129116|4257729|P3|NOT COMPLETED|Booster Phase||0
1738488|NCT00129116|4257730|P2|NOT COMPLETED|Booster Phase||0
1738489|NCT00129116|4257731|P1|NOT COMPLETED|Booster Phase||2
1738490|NCT00129116|4257727|P5|COMPLETED|Booster Phase||43
1738491|NCT00129116|4257728|P4|COMPLETED|Booster Phase||44
1738492|NCT00129116|4257729|P3|COMPLETED|Booster Phase||44
1738493|NCT00129116|4257730|P2|COMPLETED|Booster Phase||42
1738494|NCT00129116|4257731|P1|COMPLETED|Booster Phase||45
1738495|NCT00129116|4257727|P5|STARTED|Booster Phase||44
1738496|NCT00129116|4257728|P4|STARTED|Booster Phase||44
1738497|NCT00129116|4257729|P3|STARTED|Booster Phase||44
1738498|NCT00129116|4257730|P2|STARTED|Booster Phase||42
1738499|NCT00129116|4257731|P1|STARTED|Booster Phase||47
1738500|NCT00129116|4257727|P5|NOT COMPLETED|Primary Phase||1
1738501|NCT00129116|4257728|P4|NOT COMPLETED|Primary Phase||1
1738502|NCT00129116|4257729|P3|NOT COMPLETED|Primary Phase||1
1738503|NCT00129116|4257730|P2|NOT COMPLETED|Primary Phase||4
1738504|NCT00129116|4257731|P1|NOT COMPLETED|Primary Phase||2
1738505|NCT00129116|4257727|P5|COMPLETED|Primary Phase||76
1738506|NCT00129116|4257728|P4|COMPLETED|Primary Phase||77
1738507|NCT00129116|4257729|P3|COMPLETED|Primary Phase||77
1738508|NCT00129116|4257730|P2|COMPLETED|Primary Phase||73
1738509|NCT00129116|4257731|P1|COMPLETED|Primary Phase||76
1738510|NCT00129116|4257727|P5|STARTED|Primary Phase||77
1738511|NCT00129116|4257728|P4|STARTED|Primary Phase||78
1738512|NCT00129116|4257729|P3|STARTED|Primary Phase||78
1738513|NCT00129116|4257730|P2|STARTED|Primary Phase||77
1738514|NCT00129116|4257731|P1|STARTED|Primary Phase||78
1738515|NCT00128921|4257996|P3|NOT COMPLETED|Overall Study||0
1738516|NCT00128921|4257997|P2|NOT COMPLETED|Overall Study||5
1738517|NCT00128921|4257998|P1|NOT COMPLETED|Overall Study||5
1738518|NCT00128921|4257996|P3|COMPLETED|Overall Study||0
1738519|NCT00128921|4257997|P2|COMPLETED|Overall Study||3
1738520|NCT00128921|4257998|P1|COMPLETED|Overall Study||5
1738521|NCT00128921|4257996|P3|Received Bortezomib|Overall Study||0
1738522|NCT00128921|4257997|P2|Received Bortezomib|Overall Study||6
1738523|NCT00128921|4257998|P1|Received Bortezomib|Overall Study||10
1738524|NCT00128921|4257996|P3|STARTED|Overall Study||0
1738525|NCT00128921|4257997|P2|STARTED|Overall Study||8
1738526|NCT00128921|4257998|P1|STARTED|Overall Study||10
1738527|NCT00128830|4258015|P1|NOT COMPLETED|Overall Study||72
1738528|NCT00128830|4258015|P1|COMPLETED|Overall Study||139
1738529|NCT00128830|4258015|P1|STARTED|Overall Study||211
1738530|NCT00128713|4258033|P3|NOT COMPLETED|Overall Study||0
1738531|NCT00128713|4258034|P2|NOT COMPLETED|Overall Study||0
1738532|NCT00128713|4258035|P1|NOT COMPLETED|Overall Study||0
1738533|NCT00128713|4258033|P3|COMPLETED|Overall Study||449
1738534|NCT00128713|4258034|P2|COMPLETED|Overall Study||449
1738535|NCT00128713|4258035|P1|COMPLETED|Overall Study||453
1738536|NCT00128713|4258033|P3|STARTED|Overall Study||449
1738537|NCT00128713|4258034|P2|STARTED|Overall Study||449
1738538|NCT00128713|4258035|P1|STARTED|Overall Study||453
1738539|NCT00128661|4258057|P2|NOT COMPLETED|Overall Study||258
1738540|NCT00128661|4258058|P1|NOT COMPLETED|Overall Study||274
1738541|NCT00128661|4258057|P2|COMPLETED|Overall Study||3481
1738542|NCT00128661|4258058|P1|COMPLETED|Overall Study||3453
1738543|NCT00128661|4258057|P2|STARTED|Overall Study||3739
1738544|NCT00128661|4258058|P1|STARTED|Overall Study||3727
1738545|NCT00128492|4258104|P2|NOT COMPLETED|Overall Study||59
1738546|NCT00128492|4258105|P1|NOT COMPLETED|Overall Study||20
1738547|NCT00128492|4258104|P2|COMPLETED|Overall Study||130
1738548|NCT00128492|4258105|P1|COMPLETED|Overall Study||65
1738549|NCT00128492|4258104|P2|STARTED|Overall Study||189
1738550|NCT00128492|4258105|P1|STARTED|Overall Study||85
1738551|NCT00128401|4258165|P2|NOT COMPLETED|Overall Study||4
1738552|NCT00128401|4258166|P1|NOT COMPLETED|Overall Study||6
1738553|NCT00128401|4258165|P2|COMPLETED|Overall Study||15
1738554|NCT00128401|4258166|P1|COMPLETED|Overall Study||14
1738555|NCT00128401|4258165|P2|STARTED|Overall Study||19
1738556|NCT00128401|4258166|P1|STARTED|Overall Study||20
1738557|NCT00128219|4258177|P2|NOT COMPLETED|Overall Study||71
1738558|NCT00128219|4258178|P1|NOT COMPLETED|Overall Study||69
1738559|NCT00128219|4258177|P2|COMPLETED|Overall Study||263
1738560|NCT00128219|4258178|P1|COMPLETED|Overall Study||264
1738561|NCT00128219|4258177|P2|STARTED|Overall Study||334
1738562|NCT00128219|4258178|P1|STARTED|Overall Study||333
1738563|NCT00128206|4258262|P2|NOT COMPLETED|Overall Study||120
1738564|NCT00128206|4258263|P1|NOT COMPLETED|Overall Study||137
1738565|NCT00128206|4258262|P2|COMPLETED|Overall Study||60
1738566|NCT00128206|4258263|P1|COMPLETED|Overall Study||47
1738567|NCT00128206|4258262|P2|STARTED|Overall Study||180
1738568|NCT00128206|4258263|P1|STARTED|Overall Study||184
1738569|NCT00128193|4258281|P12|NOT COMPLETED|Overall Study||2
1738570|NCT00128193|4258282|P11|NOT COMPLETED|Overall Study||3
1738571|NCT00128193|4258283|P10|NOT COMPLETED|Overall Study||2
1738572|NCT00128193|4258284|P9|NOT COMPLETED|Overall Study||2
1738573|NCT00128193|4258285|P8|NOT COMPLETED|Overall Study||0
1738574|NCT00128193|4258286|P7|NOT COMPLETED|Overall Study||4
1738575|NCT00128193|4258287|P6|NOT COMPLETED|Overall Study||3
1738576|NCT00128193|4258288|P5|NOT COMPLETED|Overall Study||2
1738577|NCT00128193|4258289|P4|NOT COMPLETED|Overall Study||1
1738578|NCT00128193|4258290|P3|NOT COMPLETED|Overall Study||3
1738579|NCT00128193|4258291|P2|NOT COMPLETED|Overall Study||0
1738580|NCT00128193|4258292|P1|NOT COMPLETED|Overall Study||0
1738581|NCT00128193|4258281|P12|COMPLETED|Overall Study||18
1738582|NCT00128193|4258282|P11|COMPLETED|Overall Study||17
1738583|NCT00128193|4258283|P10|COMPLETED|Overall Study||18
1738584|NCT00128193|4258284|P9|COMPLETED|Overall Study||18
1738585|NCT00128193|4258285|P8|COMPLETED|Overall Study||20
1738586|NCT00128193|4258286|P7|COMPLETED|Overall Study||16
1738587|NCT00128193|4258287|P6|COMPLETED|Overall Study||17
1738588|NCT00128193|4258288|P5|COMPLETED|Overall Study||18
1738589|NCT00128193|4258289|P4|COMPLETED|Overall Study||44
1738590|NCT00128193|4258290|P3|COMPLETED|Overall Study||42
1738591|NCT00128193|4258291|P2|COMPLETED|Overall Study||5
1738592|NCT00128193|4258292|P1|COMPLETED|Overall Study||5
1738593|NCT00128193|4258281|P12|STARTED|Overall Study||20
1738594|NCT00128193|4258282|P11|STARTED|Overall Study||20
1738595|NCT00128193|4258283|P10|STARTED|Overall Study||20
1738596|NCT00128193|4258284|P9|STARTED|Overall Study||20
1738597|NCT00128193|4258285|P8|STARTED|Overall Study||20
1738598|NCT00128193|4258286|P7|STARTED|Overall Study||20
1738599|NCT00128193|4258287|P6|STARTED|Overall Study||20
1738600|NCT00128193|4258288|P5|STARTED|Overall Study||20
1738601|NCT00128193|4258289|P4|STARTED|Overall Study||45
1738602|NCT00128193|4258290|P3|STARTED|Overall Study||45
1738603|NCT00128193|4258291|P2|STARTED|Overall Study||5
1738604|NCT00128193|4258292|P1|STARTED|Overall Study||5
1738605|NCT00128180|4258528|P2|NOT COMPLETED|Overall Study||0
1738606|NCT00128180|4258529|P1|NOT COMPLETED|Overall Study||0
1738607|NCT00128180|4258528|P2|COMPLETED|Overall Study||34
1738608|NCT00128180|4258529|P1|COMPLETED|Overall Study||32
1738609|NCT00128180|4258528|P2|STARTED|Overall Study||34
1738610|NCT00128180|4258529|P1|STARTED|Overall Study||32
1738611|NCT00127933|4258555|P2|NOT COMPLETED|Overall Study||0
1738612|NCT00127933|4258556|P1|NOT COMPLETED|Overall Study||1
1738613|NCT00127933|4258555|P2|COMPLETED|Overall Study||34
1738614|NCT00127933|4258556|P1|COMPLETED|Overall Study||122
1738615|NCT00127933|4258555|P2|Postoperative|Overall Study||27
1738616|NCT00127933|4258556|P1|Postoperative|Overall Study||98
1738617|NCT00127933|4258555|P2|Quality of Life Population|Overall Study||33
1738618|NCT00127933|4258556|P1|Quality of Life Population|Overall Study||118
1738619|NCT00127933|4258555|P2|Safety Population|Overall Study||34
1738620|NCT00127933|4258556|P1|Safety Population|Overall Study||122
1738621|NCT00127933|4258555|P2|Clinical Response|Overall Study||34
1738622|NCT00127933|4258556|P1|Clinical Response|Overall Study||122
1738623|NCT00127933|4258555|P2|Pathological Response|Overall Study||28
1738624|NCT00127933|4258556|P1|Pathological Response|Overall Study||101
1738625|NCT00127933|4258555|P2|STARTED|Overall Study||34
1738626|NCT00127933|4258556|P1|STARTED|Overall Study||123
1738627|NCT00127855|4258577|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
1738628|NCT00127855|4258578|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
1738629|NCT00127855|4258579|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
1738630|NCT00127855|4258580|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
1738631|NCT00127855|4258581|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
1738632|NCT00127855|4258577|P5|COMPLETED|Polysaccharide Challenge Dose||77
1738633|NCT00127855|4258578|P4|COMPLETED|Polysaccharide Challenge Dose||81
1738634|NCT00127855|4258579|P3|COMPLETED|Polysaccharide Challenge Dose||77
1738635|NCT00127855|4258580|P2|COMPLETED|Polysaccharide Challenge Dose||79
1738636|NCT00127855|4258581|P1|COMPLETED|Polysaccharide Challenge Dose||80
1738637|NCT00127855|4258577|P5|STARTED|Polysaccharide Challenge Dose||77
1738638|NCT00127855|4258578|P4|STARTED|Polysaccharide Challenge Dose||81
1738639|NCT00127855|4258579|P3|STARTED|Polysaccharide Challenge Dose||77
1738640|NCT00127855|4258580|P2|STARTED|Polysaccharide Challenge Dose||79
1738641|NCT00127855|4258581|P1|STARTED|Polysaccharide Challenge Dose||80
1738642|NCT00127855|4258577|P5|NOT COMPLETED|Primary Vaccination Course||4
1738643|NCT00127855|4258578|P4|NOT COMPLETED|Primary Vaccination Course||0
1738644|NCT00127855|4258579|P3|NOT COMPLETED|Primary Vaccination Course||2
1738645|NCT00127855|4258580|P2|NOT COMPLETED|Primary Vaccination Course||1
1738646|NCT00127855|4258581|P1|NOT COMPLETED|Primary Vaccination Course||2
1738647|NCT00127855|4258577|P5|COMPLETED|Primary Vaccination Course||78
1738648|NCT00127855|4258578|P4|COMPLETED|Primary Vaccination Course||81
1738649|NCT00127855|4258579|P3|COMPLETED|Primary Vaccination Course||78
1738650|NCT00127855|4258580|P2|COMPLETED|Primary Vaccination Course||81
1738651|NCT00127855|4258581|P1|COMPLETED|Primary Vaccination Course||80
1738652|NCT00127855|4258577|P5|STARTED|Primary Vaccination Course||82
1738653|NCT00127855|4258578|P4|STARTED|Primary Vaccination Course||81
1738654|NCT00127855|4258579|P3|STARTED|Primary Vaccination Course||80
1738655|NCT00127855|4258580|P2|STARTED|Primary Vaccination Course||82
1738656|NCT00127855|4258581|P1|STARTED|Primary Vaccination Course||82
1738657|NCT00127842|4258763|P1|NOT COMPLETED|Overall Study||39
1738658|NCT00127842|4258763|P1|COMPLETED|Overall Study||71
1738659|NCT00127842|4258763|P1|STARTED|Overall Study||110
1738660|NCT00127803|4258781|P4|NOT COMPLETED|Overall Study||1
1738661|NCT00127803|4258782|P3|NOT COMPLETED|Overall Study||0
1738662|NCT00127803|4258783|P2|NOT COMPLETED|Overall Study||0
1738663|NCT00127803|4258784|P1|NOT COMPLETED|Overall Study||3
1738664|NCT00127803|4258781|P4|COMPLETED|Overall Study||11
1738665|NCT00127803|4258782|P3|COMPLETED|Overall Study||12
1738666|NCT00127803|4258783|P2|COMPLETED|Overall Study||13
1738667|NCT00127803|4258784|P1|COMPLETED|Overall Study||10
1738668|NCT00127803|4258781|P4|STARTED|Overall Study||12
1738669|NCT00127803|4258782|P3|STARTED|Overall Study||12
1738670|NCT00127803|4258783|P2|STARTED|Overall Study||13
1738671|NCT00127803|4258784|P1|STARTED|Overall Study||13
1738672|NCT00127790|4258806|P4|NOT COMPLETED|Post-Treatment||0
1738673|NCT00127790|4258807|P3|NOT COMPLETED|Post-Treatment||0
1738674|NCT00127790|4258808|P2|NOT COMPLETED|Post-Treatment||0
1738675|NCT00127790|4258809|P1|NOT COMPLETED|Post-Treatment||0
1738676|NCT00127790|4258806|P4|COMPLETED|Post-Treatment||4
1738677|NCT00127790|4258807|P3|COMPLETED|Post-Treatment||6
1738678|NCT00127790|4258808|P2|COMPLETED|Post-Treatment||5
1738679|NCT00127790|4258809|P1|COMPLETED|Post-Treatment||6
1738680|NCT00127790|4258806|P4|STARTED|Post-Treatment||4
1738681|NCT00127790|4258807|P3|STARTED|Post-Treatment||6
1738682|NCT00127790|4258808|P2|STARTED|Post-Treatment||5
1738683|NCT00127790|4258809|P1|STARTED|Post-Treatment||6
1738684|NCT00127790|4258806|P4|NOT COMPLETED|Pre-Treatment||0
1738685|NCT00127790|4258807|P3|NOT COMPLETED|Pre-Treatment||0
1738686|NCT00127790|4258808|P2|NOT COMPLETED|Pre-Treatment||0
1738687|NCT00127790|4258809|P1|NOT COMPLETED|Pre-Treatment||0
1738688|NCT00127790|4258806|P4|COMPLETED|Pre-Treatment||4
1738689|NCT00127790|4258807|P3|COMPLETED|Pre-Treatment||6
1738690|NCT00127790|4258808|P2|COMPLETED|Pre-Treatment||5
1738691|NCT00127790|4258809|P1|COMPLETED|Pre-Treatment||6
1738692|NCT00127790|4258806|P4|STARTED|Pre-Treatment||4
1738693|NCT00127790|4258807|P3|STARTED|Pre-Treatment||6
1738694|NCT00127790|4258808|P2|STARTED|Pre-Treatment||5
1738695|NCT00127790|4258809|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
1738696|NCT00127712|4258833|P2|NOT COMPLETED|Overall Study||0
1738697|NCT00127712|4258834|P1|NOT COMPLETED|Overall Study||5
1738698|NCT00127712|4258833|P2|COMPLETED|Overall Study||65
1738699|NCT00127712|4258834|P1|COMPLETED|Overall Study||60
1738700|NCT00127712|4258833|P2|STARTED|Overall Study||65
1738701|NCT00127712|4258834|P1|STARTED|Overall Study||65
1738702|NCT00127660|4258850|P4|NOT COMPLETED|Overall Study||0
1738703|NCT00127660|4258851|P3|NOT COMPLETED|Overall Study||5
1738704|NCT00127660|4258852|P2|NOT COMPLETED|Overall Study||3
1738705|NCT00127660|4258853|P1|NOT COMPLETED|Overall Study||3
1738706|NCT00127660|4258850|P4|COMPLETED|Overall Study||150
1738707|NCT00127660|4258851|P3|COMPLETED|Overall Study||143
1738708|NCT00127660|4258852|P2|COMPLETED|Overall Study||151
1738709|NCT00127660|4258853|P1|COMPLETED|Overall Study||150
1738710|NCT00127660|4258850|P4|STARTED|Overall Study||150
1738711|NCT00127660|4258851|P3|STARTED|Overall Study||148
1738712|NCT00127660|4258852|P2|STARTED|Overall Study||154
1738713|NCT00127660|4258853|P1|STARTED|Overall Study||153
1738714|NCT00127530|4258865|P2|NOT COMPLETED|Overall Study||21
1738715|NCT00127530|4258866|P1|NOT COMPLETED|Overall Study||1
1738716|NCT00127530|4258865|P2|COMPLETED|Overall Study||207
1738717|NCT00127530|4258866|P1|COMPLETED|Overall Study||71
1738718|NCT00127530|4258865|P2|STARTED|Overall Study||228
1738719|NCT00127530|4258866|P1|STARTED|Overall Study||72
1738720|NCT00127439|4258874|P2|NOT COMPLETED|Overall Study||0
1738721|NCT00127439|4258875|P1|NOT COMPLETED|Overall Study||0
1738722|NCT00127439|4258874|P2|COMPLETED|Overall Study||10
1738723|NCT00127439|4258875|P1|COMPLETED|Overall Study||9
1738724|NCT00127439|4258874|P2|STARTED|Overall Study||10
1738725|NCT00127439|4258875|P1|STARTED|Overall Study||9
1738726|NCT00127413|4258901|P4|NOT COMPLETED|Overall Study||2
1738727|NCT00127413|4258902|P3|NOT COMPLETED|Overall Study||8
1738728|NCT00127413|4258903|P2|NOT COMPLETED|Overall Study||4
1738729|NCT00127413|4258904|P1|NOT COMPLETED|Overall Study||6
1738730|NCT00127413|4258901|P4|COMPLETED|Overall Study||5
1738731|NCT00127413|4258902|P3|COMPLETED|Overall Study||5
1738732|NCT00127413|4258903|P2|COMPLETED|Overall Study||6
1738733|NCT00127413|4258904|P1|COMPLETED|Overall Study||6
1738734|NCT00127413|4258901|P4|STARTED|Overall Study||7
1738735|NCT00127413|4258902|P3|STARTED|Overall Study||13
1738736|NCT00127413|4258903|P2|STARTED|Overall Study||10
1738737|NCT00127413|4258904|P1|STARTED|Overall Study||12
1738738|NCT00127231|4258916|P2|NOT COMPLETED|Overall Study||6
1738739|NCT00127231|4258917|P1|NOT COMPLETED|Overall Study||6
1738740|NCT00127231|4258916|P2|COMPLETED|Overall Study||68
1738741|NCT00127231|4258917|P1|COMPLETED|Overall Study||68
1738742|NCT00127231|4258916|P2|STARTED|Overall Study||74
1738743|NCT00127231|4258917|P1|STARTED|Overall Study||74
1738744|NCT00127218|4258933|P2|NOT COMPLETED|Overall Study||15
1738745|NCT00127218|4258934|P1|NOT COMPLETED|Overall Study||13
1738746|NCT00127218|4258933|P2|COMPLETED|Overall Study||58
1738747|NCT00127218|4258934|P1|COMPLETED|Overall Study||59
1738748|NCT00127218|4258933|P2|STARTED|Overall Study||73
1738749|NCT00127218|4258934|P1|STARTED|Overall Study||72
1738750|NCT00127192|4258947|P5|NOT COMPLETED|Overall Study||5
1738751|NCT00127192|4258948|P4|NOT COMPLETED|Overall Study||1
1738752|NCT00127192|4258949|P3|NOT COMPLETED|Overall Study||2
1738753|NCT00127192|4258950|P2|NOT COMPLETED|Overall Study||1
1738754|NCT00127192|4258951|P1|NOT COMPLETED|Overall Study||3
1738755|NCT00127192|4258947|P5|COMPLETED|Overall Study||68
1738756|NCT00127192|4258948|P4|COMPLETED|Overall Study||67
1738757|NCT00127192|4258949|P3|COMPLETED|Overall Study||68
1738758|NCT00127192|4258950|P2|COMPLETED|Overall Study||71
1738759|NCT00127192|4258951|P1|COMPLETED|Overall Study||77
1738760|NCT00127192|4258947|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
1738761|NCT00127192|4258948|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
1738762|NCT00127192|4258949|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
1738763|NCT00127192|4258950|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
1738764|NCT00127192|4258951|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
1738765|NCT00127166|4258975|P2|NOT COMPLETED|Period II||0
1738766|NCT00127166|4258976|P1|NOT COMPLETED|Period II||3
1738767|NCT00127166|4258975|P2|COMPLETED|Period II||73
1738768|NCT00127166|4258976|P1|COMPLETED|Period II||72
1738769|NCT00127166|4258975|P2|STARTED|Period II||73
1738770|NCT00127166|4258976|P1|STARTED|Period II||75
1738771|NCT00127166|4258975|P2|NOT COMPLETED|Washout Period||1
1738772|NCT00127166|4258976|P1|NOT COMPLETED|Washout Period||0
1738773|NCT00127166|4258975|P2|COMPLETED|Washout Period||73
1738774|NCT00127166|4258976|P1|COMPLETED|Washout Period||75
1738775|NCT00127166|4258975|P2|STARTED|Washout Period||74
1738776|NCT00127166|4258976|P1|STARTED|Washout Period||75
1738777|NCT00127166|4258975|P2|NOT COMPLETED|Period I||2
1738778|NCT00127166|4258976|P1|NOT COMPLETED|Period I||3
1738779|NCT00127166|4258975|P2|COMPLETED|Period I||74
1738780|NCT00127166|4258976|P1|COMPLETED|Period I||75
1738781|NCT00127166|4258975|P2|STARTED|Period I||76
1738782|NCT00127166|4258976|P1|STARTED|Period I||78
1738783|NCT00127101|4258996|P6|NOT COMPLETED|Continuation Phase||3
1738784|NCT00127101|4258997|P5|NOT COMPLETED|Continuation Phase||3
1738785|NCT00127101|4258998|P4|NOT COMPLETED|Continuation Phase||0
1738786|NCT00127101|4258999|P3|NOT COMPLETED|Continuation Phase||1
1738787|NCT00127101|4259000|P2|NOT COMPLETED|Continuation Phase||0
1738788|NCT00127101|4259001|P1|NOT COMPLETED|Continuation Phase||0
1738789|NCT00127101|4258996|P6|COMPLETED|Continuation Phase||0
1738790|NCT00127101|4258997|P5|COMPLETED|Continuation Phase||0
1738791|NCT00127101|4258998|P4|COMPLETED|Continuation Phase||0
1738792|NCT00127101|4258999|P3|COMPLETED|Continuation Phase||0
1738793|NCT00127101|4259000|P2|COMPLETED|Continuation Phase||0
1738794|NCT00127101|4259001|P1|COMPLETED|Continuation Phase||0
1738795|NCT00127101|4258996|P6|STARTED|Continuation Phase||3
1738796|NCT00127101|4258997|P5|STARTED|Continuation Phase||3
1738797|NCT00127101|4258998|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
1738798|NCT00127101|4258999|P3|STARTED|Continuation Phase||1
1738799|NCT00127101|4259000|P2|STARTED|Continuation Phase||0
1738800|NCT00127101|4259001|P1|STARTED|Continuation Phase||0
1738801|NCT00127101|4258996|P6|NOT COMPLETED|Base Protocol||1
1738802|NCT00127101|4258997|P5|NOT COMPLETED|Base Protocol||2
1738803|NCT00127101|4258998|P4|NOT COMPLETED|Base Protocol||0
1738804|NCT00127101|4258999|P3|NOT COMPLETED|Base Protocol||2
1738805|NCT00127101|4259000|P2|NOT COMPLETED|Base Protocol||4
1738806|NCT00127101|4259001|P1|NOT COMPLETED|Base Protocol||2
1738807|NCT00127101|4258996|P6|COMPLETED|Base Protocol||3
1738808|NCT00127101|4258997|P5|COMPLETED|Base Protocol||3
1738809|NCT00127101|4258998|P4|COMPLETED|Base Protocol||3
1738810|NCT00127101|4258999|P3|COMPLETED|Base Protocol||1
1738811|NCT00127101|4259000|P2|COMPLETED|Base Protocol||1
1738812|NCT00127101|4259001|P1|COMPLETED|Base Protocol||1
1738813|NCT00127101|4258996|P6|STARTED|Base Protocol||4
1738814|NCT00127101|4258997|P5|STARTED|Base Protocol||5
1738815|NCT00127101|4258998|P4|STARTED|Base Protocol||3
1738816|NCT00127101|4258999|P3|STARTED|Base Protocol||3
1738817|NCT00127101|4259000|P2|STARTED|Base Protocol||5
1738818|NCT00127101|4259001|P1|STARTED|Base Protocol||3
1738819|NCT00127036|4259023|P2|NOT COMPLETED|Overall Study||11
1738820|NCT00127036|4259024|P1|NOT COMPLETED|Overall Study||8
1738821|NCT00127036|4259023|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
1738822|NCT00127036|4259024|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
1738823|NCT00127036|4259023|P2|STARTED|Overall Study||31
1738824|NCT00127036|4259024|P1|STARTED|Overall Study||34
1738825|NCT00126776|4259036|P2|NOT COMPLETED|Overall Study||0
1738826|NCT00126776|4259037|P1|NOT COMPLETED|Overall Study||0
1738827|NCT00126776|4259036|P2|COMPLETED|Overall Study||371
1738828|NCT00126776|4259037|P1|COMPLETED|Overall Study||372
1738829|NCT00126776|4259036|P2|STARTED|Overall Study||371
1738830|NCT00126776|4259037|P1|STARTED|Overall Study||372
1738831|NCT00126750|4259043|P2|NOT COMPLETED|Overall Study||266
1738832|NCT00126750|4259044|P1|NOT COMPLETED|Overall Study||180
1738833|NCT00126750|4259043|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
1738834|NCT00126750|4259044|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
1738835|NCT00126750|4259043|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
1738836|NCT00126750|4259044|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
1738837|NCT00126737|4259054|P4|NOT COMPLETED|Overall Study||7
1738838|NCT00126737|4259055|P3|NOT COMPLETED|Overall Study||6
1738839|NCT00126737|4259056|P2|NOT COMPLETED|Overall Study||3
1738840|NCT00126737|4259057|P1|NOT COMPLETED|Overall Study||6
1738841|NCT00126737|4259054|P4|COMPLETED|Overall Study||18
1738842|NCT00126737|4259055|P3|COMPLETED|Overall Study||24
1738843|NCT00126737|4259056|P2|COMPLETED|Overall Study||24
1738844|NCT00126737|4259057|P1|COMPLETED|Overall Study||22
1738845|NCT00126737|4259054|P4|STARTED|Overall Study||25
1738846|NCT00126737|4259055|P3|STARTED|Overall Study||30
1738847|NCT00126737|4259056|P2|STARTED|Overall Study||27
1738848|NCT00126737|4259057|P1|STARTED|Overall Study||28
1738849|NCT00126659|4259086|P3|NOT COMPLETED|Overall Study||2
1738850|NCT00126659|4259087|P2|NOT COMPLETED|Overall Study||0
1738851|NCT00126659|4259088|P1|NOT COMPLETED|Overall Study||0
1738852|NCT00126659|4259086|P3|COMPLETED|Overall Study||2
1738853|NCT00126659|4259087|P2|COMPLETED|Overall Study||3
1738854|NCT00126659|4259088|P1|COMPLETED|Overall Study||3
1738855|NCT00126659|4259086|P3|STARTED|Overall Study||4
1738856|NCT00126659|4259087|P2|STARTED|Overall Study||3
1738857|NCT00126659|4259088|P1|STARTED|Overall Study||3
1738858|NCT00126594|4259096|P2|NOT COMPLETED|Overall Study||37
1738859|NCT00126594|4259097|P1|NOT COMPLETED|Overall Study||39
1738860|NCT00126594|4259096|P2|COMPLETED|Overall Study||3
1738861|NCT00126594|4259097|P1|COMPLETED|Overall Study||1
1738862|NCT00126594|4259096|P2|STARTED|Overall Study||40
1738863|NCT00126594|4259097|P1|STARTED|Overall Study||40
1738864|NCT00126581|4259114|P2|NOT COMPLETED|Overall Study||20
1738865|NCT00126581|4259115|P1|NOT COMPLETED|Overall Study||13
1738866|NCT00126581|4259114|P2|COMPLETED|Overall Study||80
1738867|NCT00126581|4259115|P1|COMPLETED|Overall Study||68
1738868|NCT00126581|4259114|P2|STARTED|Overall Study||100
1738869|NCT00126581|4259115|P1|STARTED|Overall Study||81
1738870|NCT00126568|4259135|P1|NOT COMPLETED|Overall Study||2
1738871|NCT00126568|4259135|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
1738872|NCT00126568|4259135|P1|STARTED|Overall Study||20
1738873|NCT00126555|4259142|P1|NOT COMPLETED|Overall Study||6
1738874|NCT00126555|4259142|P1|COMPLETED|Overall Study||17
1738875|NCT00126555|4259142|P1|STARTED|Overall Study||23
1738876|NCT00126503|4259158|P2|NOT COMPLETED|Overall Study||21
1738877|NCT00126503|4259159|P1|NOT COMPLETED|Overall Study||47
1738878|NCT00126503|4259158|P2|COMPLETED|Overall Study||0
1738879|NCT00126503|4259159|P1|COMPLETED|Overall Study||1
1738880|NCT00126503|4259158|P2|STARTED|Overall Study||21
1738881|NCT00126503|4259159|P1|STARTED|Overall Study||48
1738882|NCT00126490|4259171|P1|NOT COMPLETED|Overall Study||1
1738883|NCT00126490|4259171|P1|COMPLETED|Overall Study||18
1738884|NCT00126490|4259171|P1|STARTED|Overall Study||19
1738885|NCT00126438|4259181|P2|NOT COMPLETED|Overall Study||10
1738886|NCT00126438|4259182|P1|NOT COMPLETED|Overall Study||34
1738887|NCT00126438|4259181|P2|COMPLETED|Overall Study||52
1738888|NCT00126438|4259182|P1|COMPLETED|Overall Study||419
1738889|NCT00126438|4259181|P2|STARTED|Overall Study||62
1738890|NCT00126438|4259182|P1|STARTED|Overall Study||453
1738891|NCT00126425|4259190|P2|NOT COMPLETED|Overall Study||11
1738892|NCT00126425|4259191|P1|NOT COMPLETED|Overall Study||41
1738893|NCT00126425|4259190|P2|COMPLETED|Overall Study||37
1738894|NCT00126425|4259191|P1|COMPLETED|Overall Study||498
1738895|NCT00126425|4259190|P2|STARTED|Overall Study||48
1738896|NCT00126425|4259191|P1|STARTED|Overall Study||539
1738897|NCT00126191|4259199|P2|NOT COMPLETED|Overall Study||2
1738898|NCT00126191|4259200|P1|NOT COMPLETED|Overall Study||0
1738899|NCT00126191|4259199|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
1738900|NCT00126191|4259200|P1|COMPLETED|Overall Study||2
1738901|NCT00126191|4259199|P2|STARTED|Overall Study||8
1738902|NCT00126191|4259200|P1|STARTED|Overall Study||2
1738903|NCT00126126|4259210|P2|NOT COMPLETED|Overall Study||2
1738904|NCT00126126|4259211|P1|NOT COMPLETED|Overall Study||0
1738905|NCT00126126|4259210|P2|COMPLETED|Overall Study||7
1738906|NCT00126126|4259211|P1|COMPLETED|Overall Study||9
1738907|NCT00126126|4259210|P2|STARTED|Overall Study||9
1738908|NCT00126126|4259211|P1|STARTED|Overall Study||9
1738909|NCT00126113|4259221|P2|NOT COMPLETED|Overall Study||2
1738910|NCT00126113|4259222|P1|NOT COMPLETED|Overall Study||3
1738911|NCT00126113|4259221|P2|COMPLETED|Overall Study||35
1738912|NCT00126113|4259222|P1|COMPLETED|Overall Study||34
1738913|NCT00126113|4259221|P2|STARTED|Overall Study||37
1738914|NCT00126113|4259222|P1|STARTED|Overall Study||37
1738915|NCT00125957|4259236|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
1738916|NCT00125957|4259237|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
1738917|NCT00125957|4259236|P2|COMPLETED|Second Intervention (3 Weeks)||17
1738918|NCT00125957|4259237|P1|COMPLETED|Second Intervention (3 Weeks)||15
1738919|NCT00125957|4259236|P2|STARTED|Second Intervention (3 Weeks)||17
1738920|NCT00125957|4259237|P1|STARTED|Second Intervention (3 Weeks)||15
1738921|NCT00125957|4259236|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
1738922|NCT00125957|4259237|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
1738923|NCT00125957|4259236|P2|COMPLETED|First Intervention (3 Weeks)||17
1738924|NCT00125957|4259237|P1|COMPLETED|First Intervention (3 Weeks)||15
1738925|NCT00125957|4259236|P2|STARTED|First Intervention (3 Weeks)||17
1738926|NCT00125957|4259237|P1|STARTED|First Intervention (3 Weeks)||15
1738927|NCT00125931|4259245|P1|NOT COMPLETED|Overall Study||0
1738928|NCT00125931|4259245|P1|COMPLETED|Overall Study||10
1738929|NCT00125931|4259245|P1|STARTED|Overall Study||10
1738930|NCT00125762|4259250|P1|NOT COMPLETED|Overall Study||159
1738931|NCT00125762|4259250|P1|COMPLETED|Overall Study||748
1738932|NCT00125762|4259250|P1|STARTED|Overall Study||907
1738933|NCT00125658|4259257|P2|NOT COMPLETED|Overall Study||0
1738934|NCT00125658|4259258|P1|NOT COMPLETED|Overall Study||0
1738935|NCT00125658|4259257|P2|COMPLETED|Overall Study||6
1738936|NCT00125658|4259258|P1|COMPLETED|Overall Study||8
1738937|NCT00125658|4259257|P2|STARTED|Overall Study||6
1738938|NCT00125658|4259258|P1|STARTED|Overall Study||8
1738939|NCT00125619|4259278|P2|NOT COMPLETED|Overall Study||0
1738940|NCT00125619|4259279|P1|NOT COMPLETED|Overall Study||0
1738941|NCT00125619|4259278|P2|COMPLETED|Overall Study||8
1738942|NCT00125619|4259279|P1|COMPLETED|Overall Study||8
1738943|NCT00125619|4259278|P2|STARTED|Overall Study||8
1738944|NCT00125619|4259279|P1|STARTED|Overall Study||8
1738945|NCT00125593|4259299|P2|NOT COMPLETED|Overall Study||103
1738946|NCT00125593|4259300|P1|NOT COMPLETED|Overall Study||101
1738947|NCT00125593|4259299|P2|COMPLETED|Overall Study||4517
1738948|NCT00125593|4259300|P1|COMPLETED|Overall Study||4549
1738949|NCT00125593|4259299|P2|STARTED|Overall Study||4620
1738950|NCT00125593|4259300|P1|STARTED|Overall Study||4650
1738951|NCT00125528|4259320|P2|NOT COMPLETED|Overall Study||1
1738952|NCT00125528|4259321|P1|NOT COMPLETED|Overall Study||2
1738953|NCT00125528|4259320|P2|COMPLETED|Overall Study||20
1738954|NCT00125528|4259321|P1|COMPLETED|Overall Study||18
1738955|NCT00125528|4259320|P2|STARTED|Overall Study||21
1738956|NCT00125528|4259321|P1|STARTED|Overall Study||20
1738957|NCT00125515|4259332|P3|NOT COMPLETED|Overall Study||21
1738958|NCT00125515|4259333|P2|NOT COMPLETED|Overall Study||20
1738959|NCT00125515|4259334|P1|NOT COMPLETED|Overall Study||20
1738960|NCT00125515|4259332|P3|COMPLETED|Overall Study||6
1738961|NCT00125515|4259333|P2|COMPLETED|Overall Study||7
1738962|NCT00125515|4259334|P1|COMPLETED|Overall Study||7
1738963|NCT00125515|4259332|P3|STARTED|Overall Study||27
1738964|NCT00125515|4259333|P2|STARTED|Overall Study||27
1738965|NCT00125515|4259334|P1|STARTED|Overall Study||27
1738966|NCT00125372|4259342|P1|NOT COMPLETED|Overall Study||2
1738967|NCT00125372|4259342|P1|COMPLETED|Overall Study||10
1738968|NCT00125372|4259342|P1|STARTED|Overall Study||12
1738969|NCT00125359|4259350|P1|NOT COMPLETED|Overall Study||23
1738970|NCT00125359|4259350|P1|COMPLETED|Overall Study||19
1738971|NCT00125359|4259350|P1|STARTED|Overall Study||42
1738972|NCT00125268|4259359|P2|NOT COMPLETED|Overall Study||1
1738973|NCT00125268|4259360|P1|NOT COMPLETED|Overall Study||1
1738974|NCT00125268|4259359|P2|COMPLETED|Overall Study||13
1738975|NCT00125268|4259360|P1|COMPLETED|Overall Study||15
1738976|NCT00125268|4259359|P2|STARTED|Overall Study||14
1738977|NCT00125268|4259360|P1|STARTED|Overall Study||16
1738978|NCT00125242|4259372|P2|NOT COMPLETED|Overall Study||2
1738979|NCT00125242|4259373|P1|NOT COMPLETED|Overall Study||7
1738980|NCT00125242|4259372|P2|COMPLETED|Overall Study||14
1738981|NCT00125242|4259373|P1|COMPLETED|Overall Study||87
1738982|NCT00125242|4259372|P2|STARTED|Overall Study||16
1738983|NCT00125242|4259373|P1|STARTED|Overall Study||94
1738984|NCT00125190|4259378|P1|NOT COMPLETED|Overall Study||15
1738985|NCT00125190|4259378|P1|COMPLETED|Overall Study||30
1738986|NCT00125190|4259378|P1|STARTED|Overall Study||45
1738987|NCT00125164|4259396|P4|NOT COMPLETED|Overall Study||6
1738988|NCT00125164|4259397|P3|NOT COMPLETED|Overall Study||4
1738989|NCT00125164|4259398|P2|NOT COMPLETED|Overall Study||0
1738990|NCT00125164|4259399|P1|NOT COMPLETED|Overall Study||2
1738991|NCT00125164|4259396|P4|COMPLETED|Overall Study||45
1738992|NCT00125164|4259397|P3|COMPLETED|Overall Study||40
1738993|NCT00125164|4259398|P2|COMPLETED|Overall Study||16
1738994|NCT00125164|4259399|P1|COMPLETED|Overall Study||23
1738995|NCT00125164|4259396|P4|STARTED|Overall Study||51
1738996|NCT00125164|4259397|P3|STARTED|Overall Study||44
1738997|NCT00125164|4259398|P2|STARTED|Overall Study||16
1738998|NCT00125164|4259399|P1|STARTED|Overall Study||25
1738999|NCT00125138|4259453|P4|NOT COMPLETED|Overall Study||5
1739000|NCT00125138|4259454|P3|NOT COMPLETED|Overall Study||4
1739001|NCT00125138|4259455|P2|NOT COMPLETED|Overall Study||3
1739002|NCT00125138|4259456|P1|NOT COMPLETED|Overall Study||3
1739003|NCT00125138|4259453|P4|COMPLETED|Overall Study||25
1739004|NCT00125138|4259454|P3|COMPLETED|Overall Study||21
1739005|NCT00125138|4259455|P2|COMPLETED|Overall Study||17
1739006|NCT00125138|4259456|P1|COMPLETED|Overall Study||12
1739007|NCT00125138|4259453|P4|STARTED|Overall Study||30
1739008|NCT00125138|4259454|P3|STARTED|Overall Study||25
1739009|NCT00125138|4259455|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
1739010|NCT00125138|4259456|P1|STARTED|Overall Study||15
1739011|NCT00125034|4259472|P2|NOT COMPLETED|Overall Study||0
1739012|NCT00125034|4259473|P1|NOT COMPLETED|Overall Study||0
1739013|NCT00125034|4259472|P2|COMPLETED|Overall Study||168
1739014|NCT00125034|4259473|P1|COMPLETED|Overall Study||170
1739015|NCT00125034|4259472|P2|STARTED|Overall Study|Randomized & treated|168
1739016|NCT00125034|4259473|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
1739017|NCT00124982|4259505|P3|NOT COMPLETED|Long-term Period||89
1739018|NCT00124982|4259506|P2|NOT COMPLETED|Long-term Period||0
1739019|NCT00124982|4259507|P1|NOT COMPLETED|Long-term Period||0
1739020|NCT00124982|4259505|P3|COMPLETED|Long-term Period||441
1739021|NCT00124982|4259506|P2|COMPLETED|Long-term Period||0
1739022|NCT00124982|4259507|P1|COMPLETED|Long-term Period||0
1739023|NCT00124982|4259505|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
1739024|NCT00124982|4259506|P2|STARTED|Long-term Period||0
1739025|NCT00124982|4259507|P1|STARTED|Long-term Period||0
1739026|NCT00124982|4259505|P3|NOT COMPLETED|Short-term Period||0
1739027|NCT00124982|4259506|P2|NOT COMPLETED|Short-term Period||114
1739028|NCT00124982|4259507|P1|NOT COMPLETED|Short-term Period||72
1739029|NCT00124982|4259505|P3|COMPLETED|Short-term Period||0
1739030|NCT00124982|4259506|P2|COMPLETED|Short-term Period||483
1739031|NCT00124982|4259507|P1|COMPLETED|Short-term Period||377
1739032|NCT00124982|4259505|P3|STARTED|Short-term Period||0
1739033|NCT00124982|4259506|P2|STARTED|Short-term Period||597
1739034|NCT00124982|4259507|P1|STARTED|Short-term Period||449
1739035|NCT00124943|4259589|P4|NOT COMPLETED|Phase II||5
1739036|NCT00124943|4259590|P3|NOT COMPLETED|Phase II||0
1739037|NCT00124943|4259591|P2|NOT COMPLETED|Phase II||2
1739038|NCT00124943|4259592|P1|NOT COMPLETED|Phase II||0
1739039|NCT00124943|4259589|P4|COMPLETED|Phase II||50
1739040|NCT00124943|4259590|P3|COMPLETED|Phase II||3
1739041|NCT00124943|4259591|P2|COMPLETED|Phase II||49
1739042|NCT00124943|4259592|P1|COMPLETED|Phase II||3
1739043|NCT00124943|4259589|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
1739044|NCT00124943|4259590|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
1739045|NCT00124943|4259591|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
1739046|NCT00124943|4259592|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
1739047|NCT00124943|4259589|P4|NOT COMPLETED|Phase I||0
1739048|NCT00124943|4259590|P3|NOT COMPLETED|Phase I||0
1739049|NCT00124943|4259591|P2|NOT COMPLETED|Phase I||0
1739050|NCT00124943|4259592|P1|NOT COMPLETED|Phase I||0
1739051|NCT00124943|4259589|P4|COMPLETED|Phase I||3
1739052|NCT00124943|4259590|P3|COMPLETED|Phase I||3
1739053|NCT00124943|4259591|P2|COMPLETED|Phase I||3
1739054|NCT00124943|4259592|P1|COMPLETED|Phase I||3
1739055|NCT00124943|4259589|P4|STARTED|Phase I||3
1739056|NCT00124943|4259590|P3|STARTED|Phase I||3
1739057|NCT00124943|4259591|P2|STARTED|Phase I||3
1739058|NCT00124943|4259592|P1|STARTED|Phase I||3
1739059|NCT00124748|4259632|P2|NOT COMPLETED|Overall Study||284
1739060|NCT00124748|4259633|P1|NOT COMPLETED|Overall Study||143
1739061|NCT00124748|4259632|P2|COMPLETED|Overall Study||35
1739062|NCT00124748|4259633|P1|COMPLETED|Overall Study||14
1739063|NCT00124748|4259632|P2|Safety Population|Overall Study||316
1739064|NCT00124748|4259633|P1|Safety Population|Overall Study||157
1739065|NCT00124748|4259632|P2|STARTED|Overall Study||319
1739066|NCT00124748|4259633|P1|STARTED|Overall Study||157
1739067|NCT00124735|4259685|P10|NOT COMPLETED|Overall Study||2
1739068|NCT00124735|4259686|P9|NOT COMPLETED|Overall Study||3
1739069|NCT00124735|4259687|P8|NOT COMPLETED|Overall Study||1
1739070|NCT00124735|4259688|P7|NOT COMPLETED|Overall Study||0
1739071|NCT00124735|4259689|P6|NOT COMPLETED|Overall Study||2
1739072|NCT00124735|4259690|P5|NOT COMPLETED|Overall Study||2
1739073|NCT00124735|4259691|P4|NOT COMPLETED|Overall Study||3
1739074|NCT00124735|4259692|P3|NOT COMPLETED|Overall Study||0
1739075|NCT00124735|4259693|P2|NOT COMPLETED|Overall Study||2
1739076|NCT00124735|4259694|P1|NOT COMPLETED|Overall Study||1
1739077|NCT00124735|4259685|P10|COMPLETED|Overall Study||18
1739078|NCT00124735|4259686|P9|COMPLETED|Overall Study||22
1739079|NCT00124735|4259687|P8|COMPLETED|Overall Study||19
1739080|NCT00124735|4259688|P7|COMPLETED|Overall Study||6
1739081|NCT00124735|4259689|P6|COMPLETED|Overall Study||5
1739082|NCT00124735|4259690|P5|COMPLETED|Overall Study||17
1739083|NCT00124735|4259691|P4|COMPLETED|Overall Study||18
1739084|NCT00124735|4259692|P3|COMPLETED|Overall Study||18
1739085|NCT00124735|4259693|P2|COMPLETED|Overall Study||6
1739086|NCT00124735|4259694|P1|COMPLETED|Overall Study||4
1739087|NCT00124735|4259685|P10|STARTED|Overall Study||20
1739088|NCT00124735|4259686|P9|STARTED|Overall Study||25
1739089|NCT00124735|4259687|P8|STARTED|Overall Study||20
1739090|NCT00124735|4259688|P7|STARTED|Overall Study||6
1739091|NCT00124735|4259689|P6|STARTED|Overall Study||7
1739092|NCT00124735|4259690|P5|STARTED|Overall Study||19
1739093|NCT00124735|4259691|P4|STARTED|Overall Study||21
1739094|NCT00124735|4259692|P3|STARTED|Overall Study||18
1739095|NCT00124735|4259693|P2|STARTED|Overall Study||8
1739096|NCT00124735|4259694|P1|STARTED|Overall Study||5
1739097|NCT00124709|4259740|P2|NOT COMPLETED|Overall Study||272
1739098|NCT00124709|4259741|P1|NOT COMPLETED|Overall Study||255
1739099|NCT00124709|4259740|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
1739100|NCT00124709|4259741|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
1739101|NCT00124709|4259740|P2|Patients Who Received Study Medication|Overall Study||544
1739102|NCT00124709|4259741|P1|Patients Who Received Study Medication|Overall Study||543
1739103|NCT00124709|4259740|P2|STARTED|Overall Study||545
1739104|NCT00124709|4259741|P1|STARTED|Overall Study||546
1739105|NCT00124657|4259758|P3|NOT COMPLETED|Overall Study||32
1739106|NCT00124657|4259759|P2|NOT COMPLETED|Overall Study||5
1739107|NCT00124657|4259760|P1|NOT COMPLETED|Overall Study||16
1739108|NCT00124657|4259758|P3|COMPLETED|Overall Study||7
1739109|NCT00124657|4259759|P2|COMPLETED|Overall Study||0
1739110|NCT00124657|4259760|P1|COMPLETED|Overall Study||2
1739111|NCT00124657|4259758|P3|STARTED|Overall Study||39
1739112|NCT00124657|4259759|P2|STARTED|Overall Study||5
1739113|NCT00124657|4259760|P1|STARTED|Overall Study||18
1739114|NCT00124618|4259795|P1|NOT COMPLETED|Overall Study||1
1739115|NCT00124618|4259795|P1|COMPLETED|Overall Study||57
1739116|NCT00124618|4259795|P1|STARTED|Overall Study||58
1739117|NCT00124579|4259802|P1|NOT COMPLETED|Maintenance||2
1739118|NCT00124579|4259802|P1|COMPLETED|Maintenance||0
1739119|NCT00124579|4259802|P1|STARTED|Maintenance||2
1739120|NCT00124579|4259802|P1|NOT COMPLETED|Induction||5
1739121|NCT00124579|4259802|P1|COMPLETED|Induction||2
1739122|NCT00124579|4259802|P1|STARTED|Induction||7
1739123|NCT00124462|4259810|P2|NOT COMPLETED|Overall Study||13
1739124|NCT00124462|4259811|P1|NOT COMPLETED|Overall Study||11
1739125|NCT00124462|4259810|P2|COMPLETED|Overall Study||27
1739126|NCT00124462|4259811|P1|COMPLETED|Overall Study||29
1739127|NCT00124462|4259810|P2|STARTED|Overall Study||40
1739128|NCT00124462|4259811|P1|STARTED|Overall Study||40
1739129|NCT00124449|4259821|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
1739130|NCT00124449|4259822|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
1739131|NCT00124449|4259821|P2|COMPLETED|18-Month Untreated Observation Period||4
1739132|NCT00124449|4259822|P1|COMPLETED|18-Month Untreated Observation Period||7
1739133|NCT00124449|4259821|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
1739134|NCT00124449|4259822|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
1739135|NCT00124449|4259821|P2|STARTED|18-Month Untreated Observation Period||17
1739136|NCT00124449|4259822|P1|STARTED|18-Month Untreated Observation Period||22
1739137|NCT00124449|4259821|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
1739138|NCT00124449|4259822|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
1739139|NCT00124449|4259821|P2|COMPLETED|6-month Double-Blind Treatment Period||17
1739140|NCT00124449|4259822|P1|COMPLETED|6-month Double-Blind Treatment Period||22
1739141|NCT00124449|4259821|P2|STARTED|6-month Double-Blind Treatment Period||28
1739142|NCT00124449|4259822|P1|STARTED|6-month Double-Blind Treatment Period||28
1739143|NCT00124176|4259857|P2|NOT COMPLETED|Overall Study||0
1739144|NCT00124176|4259858|P1|NOT COMPLETED|Overall Study||0
1739145|NCT00124176|4259857|P2|COMPLETED|Overall Study||41
1739146|NCT00124176|4259858|P1|COMPLETED|Overall Study||40
1739147|NCT00124176|4259857|P2|Received Study Drug|Overall Study||41
1739148|NCT00124176|4259858|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
1739149|NCT00124176|4259857|P2|STARTED|Overall Study||41
1739150|NCT00124176|4259858|P1|STARTED|Overall Study||40
1739151|NCT00124072|4259876|P4|NOT COMPLETED|Overall Study||500
1739152|NCT00124072|4259877|P3|NOT COMPLETED|Overall Study||492
1739153|NCT00124072|4259878|P2|NOT COMPLETED|Overall Study||512
1739154|NCT00124072|4259879|P1|NOT COMPLETED|Overall Study||514
1739155|NCT00124072|4259876|P4|COMPLETED|Overall Study||2515
1739156|NCT00124072|4259877|P3|COMPLETED|Overall Study||2524
1739157|NCT00124072|4259878|P2|COMPLETED|Overall Study||2504
1739158|NCT00124072|4259879|P1|COMPLETED|Overall Study||2503
1739159|NCT00124072|4259876|P4|STARTED|Overall Study||3015
1739160|NCT00124072|4259877|P3|STARTED|Overall Study||3016
1739161|NCT00124072|4259878|P2|STARTED|Overall Study||3016
1739162|NCT00124072|4259879|P1|STARTED|Overall Study||3017
1739163|NCT00124020|4259891|P2|NOT COMPLETED|Overall Study||91
1739164|NCT00124020|4259892|P1|NOT COMPLETED|Overall Study||88
1739165|NCT00124020|4259891|P2|COMPLETED|Overall Study||289
1739166|NCT00124020|4259892|P1|COMPLETED|Overall Study||289
1739167|NCT00124020|4259891|P2|STARTED|Overall Study||380
1739168|NCT00124020|4259892|P1|STARTED|Overall Study||377
1739169|NCT00123955|4259900|P2|NOT COMPLETED|Overall Study||4
1739170|NCT00123955|4259901|P1|NOT COMPLETED|Overall Study||5
1739171|NCT00123955|4259900|P2|COMPLETED|Overall Study||34
1739172|NCT00123955|4259901|P1|COMPLETED|Overall Study||37
1739173|NCT00123955|4259900|P2|STARTED|Overall Study||38
1739174|NCT00123955|4259901|P1|STARTED|Overall Study||42
1739175|NCT00123734|4259913|P1|NOT COMPLETED|Overall Study||8
1739176|NCT00123734|4259913|P1|COMPLETED|Overall Study||74
1739177|NCT00123734|4259913|P1|STARTED|Overall Study||82
1739178|NCT00123682|4259948|P4|NOT COMPLETED|Overall Study||95
1739179|NCT00123682|4259949|P3|NOT COMPLETED|Overall Study||154
1739180|NCT00123682|4259950|P2|NOT COMPLETED|Overall Study||203
1739181|NCT00123682|4259951|P1|NOT COMPLETED|Overall Study||320
1739182|NCT00123682|4259948|P4|COMPLETED|Overall Study||430
1739183|NCT00123682|4259949|P3|COMPLETED|Overall Study||438
1739184|NCT00123682|4259950|P2|COMPLETED|Overall Study||731
1739185|NCT00123682|4259951|P1|COMPLETED|Overall Study||749
1739186|NCT00123682|4259948|P4|STARTED|Overall Study||525
1739187|NCT00123682|4259949|P3|STARTED|Overall Study||592
1739188|NCT00123682|4259950|P2|STARTED|Overall Study||934
1739189|NCT00123682|4259951|P1|STARTED|Overall Study||1069
1739190|NCT00123643|4259971|P2|NOT COMPLETED|Overall Study||0
1739191|NCT00123643|4259972|P1|NOT COMPLETED|Overall Study||0
1739192|NCT00123643|4259971|P2|COMPLETED|Overall Study||16
1739193|NCT00123643|4259972|P1|COMPLETED|Overall Study||20
1739194|NCT00123643|4259971|P2|STARTED|Overall Study||16
1739195|NCT00123643|4259972|P1|STARTED|Overall Study||20
1739196|NCT00123630|4259980|P2|NOT COMPLETED|Overall Study||0
1739197|NCT00123630|4259981|P1|NOT COMPLETED|Overall Study||0
1739198|NCT00123630|4259980|P2|COMPLETED|Overall Study||15
1739199|NCT00123630|4259981|P1|COMPLETED|Overall Study||15
1739200|NCT00123630|4259980|P2|STARTED|Overall Study||15
1739201|NCT00123630|4259981|P1|STARTED|Overall Study||15
1739202|NCT00123604|4259989|P2|NOT COMPLETED|Overall Study||1
1739203|NCT00123604|4259990|P1|NOT COMPLETED|Overall Study||1
1739204|NCT00123604|4259989|P2|COMPLETED|Overall Study||16
1739205|NCT00123604|4259990|P1|COMPLETED|Overall Study||18
1739206|NCT00123604|4259989|P2|STARTED|Overall Study||17
1739207|NCT00123604|4259990|P1|STARTED|Overall Study||19
1739208|NCT00123487|4259998|P2|NOT COMPLETED|Treated With Study Drug||305
1739209|NCT00123487|4259999|P1|NOT COMPLETED|Treated With Study Drug||304
1739210|NCT00123487|4259998|P2|COMPLETED|Treated With Study Drug||0
1739211|NCT00123487|4259999|P1|COMPLETED|Treated With Study Drug||0
1739212|NCT00123487|4259998|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
1739213|NCT00123487|4259999|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
1739214|NCT00123487|4259998|P2|NOT COMPLETED|Randomized||1
1739215|NCT00123487|4259999|P1|NOT COMPLETED|Randomized||1
1739216|NCT00123487|4259998|P2|COMPLETED|Randomized||304
1739217|NCT00123487|4259999|P1|COMPLETED|Randomized||305
1739218|NCT00123487|4259998|P2|STARTED|Randomized||305
1739219|NCT00123487|4259999|P1|STARTED|Randomized||306
1739220|NCT00123474|4260043|P4|NOT COMPLETED|As Treated at Study Closure||167
1739221|NCT00123474|4260044|P3|NOT COMPLETED|As Treated at Study Closure||167
1739222|NCT00123474|4260045|P2|NOT COMPLETED|As Treated at Study Closure||163
1739223|NCT00123474|4260046|P1|NOT COMPLETED|As Treated at Study Closure||165
1739224|NCT00123474|4260043|P4|COMPLETED|As Treated at Study Closure||0
1739225|NCT00123474|4260044|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
1739226|NCT00123474|4260045|P2|COMPLETED|As Treated at Study Closure||0
1739227|NCT00123474|4260046|P1|COMPLETED|As Treated at Study Closure||0
1739228|NCT00123474|4260043|P4|STARTED|As Treated at Study Closure||167
1739229|NCT00123474|4260044|P3|STARTED|As Treated at Study Closure||167
1739230|NCT00123474|4260045|P2|STARTED|As Treated at Study Closure||163
1739231|NCT00123474|4260046|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
1739232|NCT00123474|4260043|P4|NOT COMPLETED|Randomized to Treatment||1
1739233|NCT00123474|4260044|P3|NOT COMPLETED|Randomized to Treatment||2
1739234|NCT00123474|4260045|P2|NOT COMPLETED|Randomized to Treatment||4
1739235|NCT00123474|4260046|P1|NOT COMPLETED|Randomized to Treatment||1
1739236|NCT00123474|4260043|P4|COMPLETED|Randomized to Treatment||167
1739237|NCT00123474|4260044|P3|COMPLETED|Randomized to Treatment||166
1739238|NCT00123474|4260045|P2|COMPLETED|Randomized to Treatment||163
1739239|NCT00123474|4260046|P1|COMPLETED|Randomized to Treatment||166
1739240|NCT00123474|4260043|P4|STARTED|Randomized to Treatment||168
1739241|NCT00123474|4260044|P3|STARTED|Randomized to Treatment||168
1739242|NCT00123474|4260045|P2|STARTED|Randomized to Treatment||167
1739243|NCT00123474|4260046|P1|STARTED|Randomized to Treatment||167
1739244|NCT00123422|4260140|P3|NOT COMPLETED|Overall Study||10
1739245|NCT00123422|4260141|P2|NOT COMPLETED|Overall Study||6
1739246|NCT00123422|4260142|P1|NOT COMPLETED|Overall Study||4
1739247|NCT00123422|4260140|P3|COMPLETED|Overall Study||25
1739248|NCT00123422|4260141|P2|COMPLETED|Overall Study||27
1739249|NCT00123422|4260142|P1|COMPLETED|Overall Study||31
1739250|NCT00123422|4260140|P3|8-week Testing|Overall Study||27
1739251|NCT00123422|4260141|P2|8-week Testing|Overall Study||30
1739252|NCT00123422|4260142|P1|8-week Testing|Overall Study||32
1739253|NCT00123422|4260140|P3|STARTED|Overall Study||35
1739254|NCT00123422|4260141|P2|STARTED|Overall Study||33
1739255|NCT00123422|4260142|P1|STARTED|Overall Study||35
1739256|NCT00123409|4260155|P2|NOT COMPLETED|Overall Study||3
1739257|NCT00123409|4260156|P1|NOT COMPLETED|Overall Study||4
1739258|NCT00123409|4260155|P2|COMPLETED|Overall Study||71
1739259|NCT00123409|4260156|P1|COMPLETED|Overall Study||68
1739260|NCT00123409|4260155|P2|STARTED|Overall Study||74
1739261|NCT00123409|4260156|P1|STARTED|Overall Study||72
1739262|NCT00123162|4260166|P2|NOT COMPLETED|Overall Study||0
1739263|NCT00123162|4260167|P1|NOT COMPLETED|Overall Study||0
1739264|NCT00123162|4260166|P2|COMPLETED|Overall Study||12
1739265|NCT00123162|4260167|P1|COMPLETED|Overall Study||13
1739266|NCT00123162|4260166|P2|STARTED|Overall Study||12
1739267|NCT00123162|4260167|P1|STARTED|Overall Study||13
1739268|NCT00123123|4260178|P3|NOT COMPLETED|Overall Study||0
1739269|NCT00123123|4260179|P2|NOT COMPLETED|Overall Study||0
1739270|NCT00123123|4260180|P1|NOT COMPLETED|Overall Study||0
1739271|NCT00123123|4260178|P3|COMPLETED|Overall Study||58
1739272|NCT00123123|4260179|P2|COMPLETED|Overall Study||58
1739273|NCT00123123|4260180|P1|COMPLETED|Overall Study||59
1739274|NCT00123123|4260178|P3|STARTED|Overall Study||58
1739275|NCT00123123|4260179|P2|STARTED|Overall Study||58
1739276|NCT00123123|4260180|P1|STARTED|Overall Study||59
1739277|NCT00122980|4260193|P2|NOT COMPLETED|Overall Study||40
1739278|NCT00122980|4260194|P1|NOT COMPLETED|Overall Study||43
1739279|NCT00122980|4260193|P2|COMPLETED|Overall Study|Study terminated early|26
1739280|NCT00122980|4260194|P1|COMPLETED|Overall Study|Study terminated early|24
1739281|NCT00122980|4260193|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
1739282|NCT00122980|4260194|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
1739283|NCT00122954|4260218|P2|NOT COMPLETED|Overall Study||3
1739284|NCT00122954|4260219|P1|NOT COMPLETED|Overall Study||2
1739285|NCT00122954|4260218|P2|COMPLETED|Overall Study||18
1739286|NCT00122954|4260219|P1|COMPLETED|Overall Study||16
1739287|NCT00122954|4260218|P2|STARTED|Overall Study||21
1739288|NCT00122954|4260219|P1|STARTED|Overall Study||18
1739289|NCT00122681|4260229|P2|NOT COMPLETED|Overall Study||1521
1739290|NCT00122681|4260230|P1|NOT COMPLETED|Overall Study||1514
1739291|NCT00122681|4260229|P2|COMPLETED|Overall Study||7798
1739292|NCT00122681|4260230|P1|COMPLETED|Overall Study||7811
1739293|NCT00122681|4260229|P2|STARTED|Overall Study||9319
1739294|NCT00122681|4260230|P1|STARTED|Overall Study||9325
1739295|NCT00122460|4260304|P2|NOT COMPLETED|Overall Study||1
1739296|NCT00122460|4260305|P1|NOT COMPLETED|Overall Study||7
1739297|NCT00122460|4260304|P2|COMPLETED|Overall Study||219
1739298|NCT00122460|4260305|P1|COMPLETED|Overall Study||215
1739299|NCT00122460|4260304|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
1739300|NCT00122460|4260305|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
1739301|NCT00122447|4260331|P4|NOT COMPLETED|Overall Study||3
1739302|NCT00122447|4260332|P3|NOT COMPLETED|Overall Study||1
1739303|NCT00122447|4260333|P2|NOT COMPLETED|Overall Study||5
1739304|NCT00122447|4260334|P1|NOT COMPLETED|Overall Study||1
1739305|NCT00122447|4260331|P4|COMPLETED|Overall Study||14
1739306|NCT00122447|4260332|P3|COMPLETED|Overall Study||16
1739307|NCT00122447|4260333|P2|COMPLETED|Overall Study||13
1739308|NCT00122447|4260334|P1|COMPLETED|Overall Study||17
1739309|NCT00122447|4260331|P4|STARTED|Overall Study||17
1739310|NCT00122447|4260332|P3|STARTED|Overall Study||17
1739311|NCT00122447|4260333|P2|STARTED|Overall Study||18
1739312|NCT00122447|4260334|P1|STARTED|Overall Study||18
1739313|NCT00122382|4260354|P3|NOT COMPLETED|Open-Label Study||26
1739314|NCT00122382|4260355|P2|NOT COMPLETED|Open-Label Study||0
1739315|NCT00122382|4260356|P1|NOT COMPLETED|Open-Label Study||0
1739316|NCT00122382|4260354|P3|COMPLETED|Open-Label Study||433
1739317|NCT00122382|4260355|P2|COMPLETED|Open-Label Study||0
1739318|NCT00122382|4260356|P1|COMPLETED|Open-Label Study||0
1739319|NCT00122382|4260354|P3|STARTED|Open-Label Study||459
1739320|NCT00122382|4260355|P2|STARTED|Open-Label Study||0
1739321|NCT00122382|4260356|P1|STARTED|Open-Label Study||0
1739322|NCT00122382|4260354|P3|NOT COMPLETED|Double-Blind Study||0
1739323|NCT00122382|4260355|P2|NOT COMPLETED|Double-Blind Study||28
1739324|NCT00122382|4260356|P1|NOT COMPLETED|Double-Blind Study||24
1739325|NCT00122382|4260354|P3|COMPLETED|Double-Blind Study||0
1739326|NCT00122382|4260355|P2|COMPLETED|Double-Blind Study||227
1739327|NCT00122382|4260356|P1|COMPLETED|Double-Blind Study||232
1739328|NCT00122382|4260354|P3|Treated|Double-Blind Study||0
1739329|NCT00122382|4260355|P2|Treated|Double-Blind Study||253
1739330|NCT00122382|4260356|P1|Treated|Double-Blind Study||256
1739331|NCT00122382|4260354|P3|STARTED|Double-Blind Study||0
1739332|NCT00122382|4260355|P2|STARTED|Double-Blind Study|participants randomized|255
1739333|NCT00122382|4260356|P1|STARTED|Double-Blind Study|participants randomized|256
1739334|NCT00122369|4260409|P3|NOT COMPLETED|Overall Study||0
1739335|NCT00122369|4260410|P2|NOT COMPLETED|Overall Study||0
1739336|NCT00122369|4260411|P1|NOT COMPLETED|Overall Study||0
1739337|NCT00122369|4260409|P3|COMPLETED|Overall Study||78
1739338|NCT00122369|4260410|P2|COMPLETED|Overall Study||82
1739339|NCT00122369|4260411|P1|COMPLETED|Overall Study||76
1739340|NCT00122369|4260409|P3|STARTED|Overall Study||78
1739341|NCT00122369|4260410|P2|STARTED|Overall Study||82
1739342|NCT00122369|4260411|P1|STARTED|Overall Study||76
1739343|NCT00122317|4260500|P1|NOT COMPLETED|Overall Study||11
1739344|NCT00122317|4260500|P1|COMPLETED|Overall Study||176
1739345|NCT00122317|4260500|P1|STARTED|Overall Study||187
1739346|NCT00122278|4260509|P2|NOT COMPLETED|Overall Study||0
1739347|NCT00122278|4260510|P1|NOT COMPLETED|Overall Study||2
1739348|NCT00122278|4260509|P2|COMPLETED|Overall Study||99
1739349|NCT00122278|4260510|P1|COMPLETED|Overall Study||104
1739350|NCT00122278|4260509|P2|STARTED|Overall Study||99
1739351|NCT00122278|4260510|P1|STARTED|Overall Study||106
1739352|NCT00122187|4260520|P2|NOT COMPLETED|Overall Study||2
1739353|NCT00122187|4260521|P1|NOT COMPLETED|Overall Study||2
1739354|NCT00122187|4260520|P2|COMPLETED|Overall Study||2
1739355|NCT00122187|4260521|P1|COMPLETED|Overall Study||2
1739356|NCT00122187|4260520|P2|Post-intervention Data Collection|Overall Study||2
1739357|NCT00122187|4260521|P1|Post-intervention Data Collection|Overall Study||2
1739358|NCT00122187|4260520|P2|Intervention Implemented|Overall Study||4
1739359|NCT00122187|4260521|P1|Intervention Implemented|Overall Study||3
1739360|NCT00122187|4260520|P2|Randomized to Intervention or Usual Care|Overall Study||4
1739361|NCT00122187|4260521|P1|Randomized to Intervention or Usual Care|Overall Study||4
1739362|NCT00122187|4260520|P2|Matched by Colonoscopy Volume|Overall Study||4
1739363|NCT00122187|4260521|P1|Matched by Colonoscopy Volume|Overall Study||4
1739364|NCT00122187|4260520|P2|STARTED|Overall Study||4
1739365|NCT00122187|4260521|P1|STARTED|Overall Study||4
1739366|NCT00122135|4260535|P2|NOT COMPLETED|Overall Study||0
1739367|NCT00122135|4260536|P1|NOT COMPLETED|Overall Study||3
1739368|NCT00122135|4260535|P2|COMPLETED|Overall Study||60
1739369|NCT00122135|4260536|P1|COMPLETED|Overall Study||57
1739370|NCT00122135|4260535|P2|STARTED|Overall Study||60
1739371|NCT00122135|4260536|P1|STARTED|Overall Study||60
1739372|NCT00122109|4260544|P2|NOT COMPLETED|Overall Study||7
1739373|NCT00122109|4260545|P1|NOT COMPLETED|Overall Study||6
1739374|NCT00122109|4260544|P2|COMPLETED|Overall Study||57
1739375|NCT00122109|4260545|P1|COMPLETED|Overall Study||55
1739376|NCT00122109|4260544|P2|STARTED|Overall Study|ITT|64
1739377|NCT00122109|4260545|P1|STARTED|Overall Study|ITT|61
1739378|NCT00121836|4260569|P1|NOT COMPLETED|Overall Study||55
1739379|NCT00121836|4260569|P1|COMPLETED|Overall Study||54
1739380|NCT00121836|4260569|P1|STARTED|Overall Study||109
1739381|NCT00121810|4260580|P2|NOT COMPLETED|Overall Study||39
1739382|NCT00121810|4260581|P1|NOT COMPLETED|Overall Study||30
1739383|NCT00121810|4260580|P2|COMPLETED|Overall Study||115
1739384|NCT00121810|4260581|P1|COMPLETED|Overall Study||121
1739385|NCT00121810|4260580|P2|Intent-to-Treat (ITT) Population|Overall Study||151
1739386|NCT00121810|4260581|P1|Intent-to-Treat (ITT) Population|Overall Study||148
1739387|NCT00121810|4260580|P2|Safety Population|Overall Study||153
1739388|NCT00121810|4260581|P1|Safety Population|Overall Study||148
1739389|NCT00121810|4260580|P2|STARTED|Overall Study||154
1739390|NCT00121810|4260581|P1|STARTED|Overall Study||151
1739391|NCT00121719|4260609|P14|NOT COMPLETED|Overall Study||7
1739392|NCT00121719|4260610|P13|NOT COMPLETED|Overall Study||24
1739393|NCT00121719|4260611|P12|NOT COMPLETED|Overall Study||5
1739394|NCT00121719|4260612|P11|NOT COMPLETED|Overall Study||6
1739395|NCT00121719|4260613|P10|NOT COMPLETED|Overall Study||3
1739396|NCT00121719|4260614|P9|NOT COMPLETED|Overall Study||6
1739397|NCT00121719|4260615|P8|NOT COMPLETED|Overall Study||9
1739398|NCT00121719|4260616|P7|NOT COMPLETED|Overall Study||12
1739399|NCT00121719|4260617|P6|NOT COMPLETED|Overall Study||3
1739400|NCT00121719|4260618|P5|NOT COMPLETED|Overall Study||3
1739401|NCT00121719|4260619|P4|NOT COMPLETED|Overall Study||3
1739402|NCT00121719|4260620|P3|NOT COMPLETED|Overall Study||4
1739403|NCT00121719|4260621|P2|NOT COMPLETED|Overall Study||4
1739404|NCT00121719|4260622|P1|NOT COMPLETED|Overall Study||4
1739405|NCT00121719|4260609|P14|COMPLETED|Overall Study||0
1739406|NCT00121719|4260610|P13|COMPLETED|Overall Study||0
1739407|NCT00121719|4260611|P12|COMPLETED|Overall Study||0
1739408|NCT00121719|4260612|P11|COMPLETED|Overall Study||0
1739409|NCT00121719|4260613|P10|COMPLETED|Overall Study||0
1739410|NCT00121719|4260614|P9|COMPLETED|Overall Study||0
1739411|NCT00121719|4260615|P8|COMPLETED|Overall Study||0
1739412|NCT00121719|4260616|P7|COMPLETED|Overall Study||0
1739413|NCT00121719|4260617|P6|COMPLETED|Overall Study||0
1739414|NCT00121719|4260618|P5|COMPLETED|Overall Study||0
1739415|NCT00121719|4260619|P4|COMPLETED|Overall Study||0
1739416|NCT00121719|4260620|P3|COMPLETED|Overall Study||0
1739417|NCT00121719|4260621|P2|COMPLETED|Overall Study||0
1739418|NCT00121719|4260622|P1|COMPLETED|Overall Study||0
1739419|NCT00121719|4260609|P14|STARTED|Overall Study||7
1739420|NCT00121719|4260610|P13|STARTED|Overall Study||24
1739421|NCT00121719|4260611|P12|STARTED|Overall Study||5
1739422|NCT00121719|4260612|P11|STARTED|Overall Study||6
1739423|NCT00121719|4260613|P10|STARTED|Overall Study||3
1739424|NCT00121719|4260614|P9|STARTED|Overall Study||6
1739425|NCT00121719|4260615|P8|STARTED|Overall Study||9
1739426|NCT00121719|4260616|P7|STARTED|Overall Study||12
1739427|NCT00121719|4260617|P6|STARTED|Overall Study||3
1739428|NCT00121719|4260618|P5|STARTED|Overall Study||3
1739429|NCT00121719|4260619|P4|STARTED|Overall Study||3
1739430|NCT00121719|4260620|P3|STARTED|Overall Study||4
1739431|NCT00121719|4260621|P2|STARTED|Overall Study||4
1739432|NCT00121719|4260622|P1|STARTED|Overall Study||4
1739433|NCT00121667|4260799|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
1739434|NCT00121667|4260800|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
1739435|NCT00121667|4260801|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
1739436|NCT00121667|4260802|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
1739437|NCT00121667|4260799|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
1739438|NCT00121667|4260800|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
1739439|NCT00121667|4260801|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
1739440|NCT00121667|4260802|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
1739522|NCT00121173|4261092|P1|STARTED|Overall Study||4
1739441|NCT00121667|4260799|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
1739442|NCT00121667|4260800|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
1739443|NCT00121667|4260801|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
1739444|NCT00121667|4260802|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
1739445|NCT00121667|4260799|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
1739446|NCT00121667|4260800|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
1739447|NCT00121667|4260801|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
1739448|NCT00121667|4260802|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
1739449|NCT00121667|4260799|P4|NOT COMPLETED|Short Term (ST) Period||67
1739450|NCT00121667|4260800|P3|NOT COMPLETED|Short Term (ST) Period||41
1739451|NCT00121667|4260801|P2|NOT COMPLETED|Short Term (ST) Period||48
1739452|NCT00121667|4260802|P1|NOT COMPLETED|Short Term (ST) Period||44
1739453|NCT00121667|4260799|P4|COMPLETED|Short Term (ST) Period||112
1739454|NCT00121667|4260800|P3|COMPLETED|Short Term (ST) Period||140
1739455|NCT00121667|4260801|P2|COMPLETED|Short Term (ST) Period||143
1739456|NCT00121667|4260802|P1|COMPLETED|Short Term (ST) Period||148
1739457|NCT00121667|4260799|P4|STARTED|Short Term (ST) Period||179
1739458|NCT00121667|4260800|P3|STARTED|Short Term (ST) Period||181
1739459|NCT00121667|4260801|P2|STARTED|Short Term (ST) Period||191
1739460|NCT00121667|4260802|P1|STARTED|Short Term (ST) Period||192
1739461|NCT00121641|4260900|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
1739462|NCT00121641|4260901|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
1739463|NCT00121641|4260902|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
1739464|NCT00121641|4260903|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
1739465|NCT00121641|4260904|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
1739466|NCT00121641|4260900|P5|COMPLETED|48-month Short Term + Long Term Period||8
1739467|NCT00121641|4260901|P4|COMPLETED|48-month Short Term + Long Term Period||24
1739468|NCT00121641|4260902|P3|COMPLETED|48-month Short Term + Long Term Period||28
1739469|NCT00121641|4260903|P2|COMPLETED|48-month Short Term + Long Term Period||24
1739470|NCT00121641|4260904|P1|COMPLETED|48-month Short Term + Long Term Period||23
1739471|NCT00121641|4260900|P5|STARTED|48-month Short Term + Long Term Period||66
1739472|NCT00121641|4260901|P4|STARTED|48-month Short Term + Long Term Period||95
1739473|NCT00121641|4260902|P3|STARTED|48-month Short Term + Long Term Period||98
1739474|NCT00121641|4260903|P2|STARTED|48-month Short Term + Long Term Period||106
1739475|NCT00121641|4260904|P1|STARTED|48-month Short Term + Long Term Period||102
1739476|NCT00121641|4260900|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
1739477|NCT00121641|4260901|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
1739478|NCT00121641|4260902|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
1739479|NCT00121641|4260903|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
1739480|NCT00121641|4260904|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
1739481|NCT00121641|4260900|P5|COMPLETED|24-week Short-term Treatment Period||25
1739482|NCT00121641|4260901|P4|COMPLETED|24-week Short-term Treatment Period||55
1739483|NCT00121641|4260902|P3|COMPLETED|24-week Short-term Treatment Period||69
1739484|NCT00121641|4260903|P2|COMPLETED|24-week Short-term Treatment Period||68
1739485|NCT00121641|4260904|P1|COMPLETED|24-week Short-term Treatment Period||73
1739486|NCT00121641|4260900|P5|STARTED|24-week Short-term Treatment Period||66
1739487|NCT00121641|4260901|P4|STARTED|24-week Short-term Treatment Period||95
1739488|NCT00121641|4260902|P3|STARTED|24-week Short-term Treatment Period||98
1739489|NCT00121641|4260903|P2|STARTED|24-week Short-term Treatment Period||106
1739490|NCT00121641|4260904|P1|STARTED|24-week Short-term Treatment Period||102
1739491|NCT00121485|4261017|P2|NOT COMPLETED|Overall Study||7
1739492|NCT00121485|4261018|P1|NOT COMPLETED|Overall Study||1
1739493|NCT00121485|4261017|P2|COMPLETED|Overall Study||59
1739494|NCT00121485|4261018|P1|COMPLETED|Overall Study||133
1739495|NCT00121485|4261017|P2|STARTED|Overall Study||66
1739496|NCT00121485|4261018|P1|STARTED|Overall Study||134
1739497|NCT00121472|4261052|P1|NOT COMPLETED|Overall Study||0
1739498|NCT00121472|4261052|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
1739499|NCT00121472|4261052|P1|STARTED|Overall Study||194
1739500|NCT00121238|4261063|P1|NOT COMPLETED|Overall Study||3
1739501|NCT00121238|4261063|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
1739502|NCT00121238|4261063|P1|STARTED|Overall Study||16
1739503|NCT00121225|4261071|P1|NOT COMPLETED|Overall Study||0
1739504|NCT00121225|4261071|P1|COMPLETED|Overall Study||32
1739505|NCT00121225|4261071|P1|STARTED|Overall Study||32
1739506|NCT00121199|4261075|P1|NOT COMPLETED|Overall Study||28
1739507|NCT00121199|4261075|P1|COMPLETED|Overall Study||45
1739508|NCT00121199|4261075|P1|Eligible and Began Protocol Therapy|Overall Study||64
1739509|NCT00121199|4261075|P1|Eligible|Overall Study||64
1739510|NCT00121199|4261075|P1|STARTED|Overall Study||73
1739511|NCT00121186|4261082|P1|NOT COMPLETED|Overall Study||0
1739512|NCT00121186|4261082|P1|COMPLETED|Overall Study||1
1739513|NCT00121186|4261082|P1|STARTED|Overall Study||1
1739514|NCT00121173|4261090|P3|NOT COMPLETED|Overall Study||0
1739515|NCT00121173|4261091|P2|NOT COMPLETED|Overall Study||0
1739516|NCT00121173|4261092|P1|NOT COMPLETED|Overall Study||1
1739517|NCT00121173|4261090|P3|COMPLETED|Overall Study||9
1739518|NCT00121173|4261091|P2|COMPLETED|Overall Study||3
1739519|NCT00121173|4261092|P1|COMPLETED|Overall Study||3
1739520|NCT00121173|4261090|P3|STARTED|Overall Study||9
1739521|NCT00121173|4261091|P2|STARTED|Overall Study||3
1739523|NCT00121134|4261119|P4|NOT COMPLETED|Overall Study||9
1739524|NCT00121134|4261120|P3|NOT COMPLETED|Overall Study||21
1739525|NCT00121134|4261121|P2|NOT COMPLETED|Overall Study||15
1739526|NCT00121134|4261122|P1|NOT COMPLETED|Overall Study||16
1739527|NCT00121134|4261119|P4|COMPLETED|Overall Study||31
1739528|NCT00121134|4261120|P3|COMPLETED|Overall Study||20
1739529|NCT00121134|4261121|P2|COMPLETED|Overall Study||26
1739530|NCT00121134|4261122|P1|COMPLETED|Overall Study||24
1739531|NCT00121134|4261119|P4|STARTED|Overall Study||40
1739532|NCT00121134|4261120|P3|STARTED|Overall Study||41
1739533|NCT00121134|4261121|P2|STARTED|Overall Study||41
1739534|NCT00121134|4261122|P1|STARTED|Overall Study||40
1739535|NCT00120874|4261134|P2|NOT COMPLETED|Overall Study||1
1739536|NCT00120874|4261135|P1|NOT COMPLETED|Overall Study||0
1739537|NCT00120874|4261134|P2|COMPLETED|Overall Study||9
1739538|NCT00120874|4261135|P1|COMPLETED|Overall Study||10
1739539|NCT00120874|4261134|P2|Completed Study; Started Extension Study|Overall Study||10
1739540|NCT00120874|4261135|P1|Completed Study; Started Extension Study|Overall Study||10
1739541|NCT00120874|4261134|P2|STARTED|Overall Study||10
1739542|NCT00120874|4261135|P1|STARTED|Overall Study||10
1739543|NCT00120627|4261173|P2|NOT COMPLETED|Overall Study||5
1739544|NCT00120627|4261174|P1|NOT COMPLETED|Overall Study||5
1739545|NCT00120627|4261173|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
1739546|NCT00120627|4261174|P1|COMPLETED|Overall Study||66
1739547|NCT00120627|4261173|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
1739548|NCT00120627|4261174|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
1739549|NCT00120627|4261173|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
1739550|NCT00120627|4261174|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
1739551|NCT00120627|4261173|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
1739552|NCT00120627|4261174|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
1739553|NCT00120523|4261200|P2|NOT COMPLETED|Follow-Up Period||24
1739554|NCT00120523|4261201|P1|NOT COMPLETED|Follow-Up Period||30
1739555|NCT00120523|4261200|P2|COMPLETED|Follow-Up Period||46
1739556|NCT00120523|4261201|P1|COMPLETED|Follow-Up Period||90
1739557|NCT00120523|4261200|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
1739558|NCT00120523|4261201|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
1739559|NCT00120523|4261200|P2|NOT COMPLETED|Treatment Period||339
1739560|NCT00120523|4261201|P1|NOT COMPLETED|Treatment Period||369
1739561|NCT00120523|4261200|P2|COMPLETED|Treatment Period||874
1739562|NCT00120523|4261201|P1|COMPLETED|Treatment Period||836
1739563|NCT00120523|4261200|P2|STARTED|Treatment Period||1213
1739564|NCT00120523|4261201|P1|STARTED|Treatment Period||1205
1739565|NCT00120406|4261225|P2|NOT COMPLETED|Overall Study||16
1739566|NCT00120406|4261226|P1|NOT COMPLETED|Overall Study||19
1739567|NCT00120406|4261225|P2|COMPLETED|Overall Study||222
1739568|NCT00120406|4261226|P1|COMPLETED|Overall Study||217
1739569|NCT00120406|4261225|P2|STARTED|Overall Study||238
1739570|NCT00120406|4261226|P1|STARTED|Overall Study||236
1739571|NCT00120289|4261236|P2|NOT COMPLETED|Overall Study||109
1739572|NCT00120289|4261237|P1|NOT COMPLETED|Overall Study||121
1739573|NCT00120289|4261236|P2|COMPLETED|Overall Study||1587
1739574|NCT00120289|4261237|P1|COMPLETED|Overall Study||1597
1739575|NCT00120289|4261236|P2|STARTED|Overall Study||1696
1739576|NCT00120289|4261237|P1|STARTED|Overall Study||1718
1739577|NCT00120250|4261249|P2|NOT COMPLETED|Overall Study||2
1739578|NCT00120250|4261250|P1|NOT COMPLETED|Overall Study||1
1739579|NCT00120250|4261249|P2|COMPLETED|Overall Study||12
1739580|NCT00120250|4261250|P1|COMPLETED|Overall Study||12
1739581|NCT00120250|4261249|P2|STARTED|Overall Study||14
1739582|NCT00120250|4261250|P1|STARTED|Overall Study||13
1739583|NCT00120042|4261266|P3|NOT COMPLETED|Overall Study||0
1739584|NCT00120042|4261267|P2|NOT COMPLETED|Overall Study||0
1739585|NCT00120042|4261268|P1|NOT COMPLETED|Overall Study||0
1739586|NCT00120042|4261266|P3|COMPLETED|Overall Study||83
1739587|NCT00120042|4261267|P2|COMPLETED|Overall Study||83
1739588|NCT00120042|4261268|P1|COMPLETED|Overall Study||85
1739589|NCT00120042|4261266|P3|STARTED|Overall Study||83
1739590|NCT00120042|4261267|P2|STARTED|Overall Study||83
1739591|NCT00120042|4261268|P1|STARTED|Overall Study||85
1739592|NCT00119847|4261278|P2|NOT COMPLETED|Overall Study||32
1739593|NCT00119847|4261279|P1|NOT COMPLETED|Overall Study||31
1739594|NCT00119847|4261278|P2|COMPLETED|Overall Study||119
1739595|NCT00119847|4261279|P1|COMPLETED|Overall Study||118
1739596|NCT00119847|4261278|P2|STARTED|Overall Study||151
1739597|NCT00119847|4261279|P1|STARTED|Overall Study||149
1739598|NCT00119678|4261291|P2|NOT COMPLETED|Open-label Treatment Period||0
1739599|NCT00119678|4261292|P1|NOT COMPLETED|Open-label Treatment Period||110
1739600|NCT00119678|4261291|P2|COMPLETED|Open-label Treatment Period||0
1739601|NCT00119678|4261292|P1|COMPLETED|Open-label Treatment Period||0
1739602|NCT00119678|4261291|P2|STARTED|Open-label Treatment Period||0
1739603|NCT00119678|4261292|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
1739604|NCT00119678|4261291|P2|NOT COMPLETED|Double-blind Treatment Period||26
1739605|NCT00119678|4261292|P1|NOT COMPLETED|Double-blind Treatment Period||41
1739606|NCT00119678|4261291|P2|COMPLETED|Double-blind Treatment Period||35
1739607|NCT00119678|4261292|P1|COMPLETED|Double-blind Treatment Period||81
1739608|NCT00119678|4261291|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
1739609|NCT00119678|4261292|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
1739610|NCT00119678|4261291|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
1739611|NCT00119678|4261292|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
1739612|NCT00119678|4261291|P2|STARTED|Double-blind Treatment Period||61
1739613|NCT00119678|4261292|P1|STARTED|Double-blind Treatment Period||122
1739614|NCT00119405|4261338|P1|NOT COMPLETED|Overall Study||1
1739615|NCT00119405|4261338|P1|COMPLETED|Overall Study||17
1739616|NCT00119405|4261338|P1|STARTED|Overall Study||18
1739617|NCT00119392|4261342|P1|NOT COMPLETED|Overall Study||5
1739618|NCT00119392|4261342|P1|COMPLETED|Overall Study||40
1739619|NCT00119392|4261342|P1|STARTED|Overall Study||45
1739620|NCT00119379|4261352|P2|NOT COMPLETED|Overall Study||1
1739621|NCT00119379|4261353|P1|NOT COMPLETED|Overall Study||4
1739622|NCT00119379|4261352|P2|COMPLETED|Overall Study||23
1739623|NCT00119379|4261353|P1|COMPLETED|Overall Study||22
1739624|NCT00119379|4261352|P2|STARTED|Overall Study||24
1739625|NCT00119379|4261353|P1|STARTED|Overall Study||26
1739626|NCT00119262|4261371|P2|NOT COMPLETED|Overall Study||58
1739627|NCT00119262|4261372|P1|NOT COMPLETED|Overall Study||46
1739628|NCT00119262|4261371|P2|COMPLETED|Overall Study||64
1739629|NCT00119262|4261372|P1|COMPLETED|Overall Study||58
1739630|NCT00119262|4261371|P2|Eligible and Treated|Overall Study||119
1739631|NCT00119262|4261372|P1|Eligible and Treated|Overall Study||102
1739632|NCT00119262|4261371|P2|Treated|Overall Study||120
1739633|NCT00119262|4261372|P1|Treated|Overall Study||103
1739634|NCT00119262|4261371|P2|Eligible|Overall Study||120
1739635|NCT00119262|4261372|P1|Eligible|Overall Study||103
1739636|NCT00119262|4261371|P2|STARTED|Overall Study||122
1739637|NCT00119262|4261372|P1|STARTED|Overall Study||104
1739638|NCT00119158|4261384|P2|NOT COMPLETED|Placebo Treatment||0
1739639|NCT00119158|4261385|P1|NOT COMPLETED|Placebo Treatment||0
1739640|NCT00119158|4261384|P2|COMPLETED|Placebo Treatment||45
1739641|NCT00119158|4261385|P1|COMPLETED|Placebo Treatment||45
1739642|NCT00119158|4261384|P2|STARTED|Placebo Treatment||45
1739643|NCT00119158|4261385|P1|STARTED|Placebo Treatment||45
1739644|NCT00119158|4261384|P2|NOT COMPLETED|Active Treatment||0
1739645|NCT00119158|4261385|P1|NOT COMPLETED|Active Treatment||0
1739646|NCT00119158|4261384|P2|COMPLETED|Active Treatment||45
1739647|NCT00119158|4261385|P1|COMPLETED|Active Treatment||45
1739648|NCT00119158|4261384|P2|STARTED|Active Treatment||45
1739649|NCT00119158|4261385|P1|STARTED|Active Treatment|patients are self controls|45
1739650|NCT00119041|4261396|P3|NOT COMPLETED|Overall Study||0
1739651|NCT00119041|4261397|P2|NOT COMPLETED|Overall Study||0
1739652|NCT00119041|4261398|P1|NOT COMPLETED|Overall Study||0
1739653|NCT00119041|4261396|P3|COMPLETED|Overall Study||22
1739654|NCT00119041|4261397|P2|COMPLETED|Overall Study||83
1739655|NCT00119041|4261398|P1|COMPLETED|Overall Study||199
1739656|NCT00119041|4261396|P3|STARTED|Overall Study||22
1739657|NCT00119041|4261397|P2|STARTED|Overall Study||83
1739658|NCT00119041|4261398|P1|STARTED|Overall Study||199
1739659|NCT00119015|4261409|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
1739660|NCT00119015|4261410|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
1739661|NCT00119015|4261411|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
1739662|NCT00119015|4261409|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
1739663|NCT00119015|4261410|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
1739664|NCT00119015|4261411|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
1739665|NCT00119015|4261409|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
1739666|NCT00119015|4261410|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
1739667|NCT00119015|4261411|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
1739668|NCT00119015|4261409|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
1739669|NCT00119015|4261410|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
1739670|NCT00119015|4261411|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
1739671|NCT00119015|4261409|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
1739672|NCT00119015|4261410|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
1739673|NCT00119015|4261411|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
1739674|NCT00119015|4261409|P3|STARTED|Open-Label Phase (2 Weeks)||0
1739675|NCT00119015|4261410|P2|STARTED|Open-Label Phase (2 Weeks)||0
1739676|NCT00119015|4261411|P1|STARTED|Open-Label Phase (2 Weeks)||102
1739677|NCT00118911|4261427|P2|NOT COMPLETED|Overall Study||5
1739678|NCT00118911|4261428|P1|NOT COMPLETED|Overall Study||2
1739679|NCT00118911|4261427|P2|COMPLETED|Overall Study||38
1739680|NCT00118911|4261428|P1|COMPLETED|Overall Study||41
1739681|NCT00118911|4261427|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
1739682|NCT00118911|4261428|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
1739683|NCT00118911|4261427|P2|6 Month Follow-up|Overall Study||30
1739684|NCT00118911|4261428|P1|6 Month Follow-up|Overall Study||37
1739685|NCT00118911|4261427|P2|Completed Post-Treatment Assessment|Overall Study||37
1739686|NCT00118911|4261428|P1|Completed Post-Treatment Assessment|Overall Study||41
1739687|NCT00118911|4261427|P2|Received Intervention as Assigned|Overall Study||38
1739688|NCT00118911|4261428|P1|Received Intervention as Assigned|Overall Study||41
1739689|NCT00118911|4261427|P2|STARTED|Overall Study||43
1739690|NCT00118911|4261428|P1|STARTED|Overall Study||43
1739691|NCT00118898|4261440|P4|NOT COMPLETED|Overall Study||141
1739692|NCT00118898|4261441|P3|NOT COMPLETED|Overall Study||123
1739693|NCT00118898|4261442|P2|NOT COMPLETED|Overall Study||141
1739694|NCT00118898|4261443|P1|NOT COMPLETED|Overall Study||121
1739695|NCT00118898|4261440|P4|COMPLETED|Overall Study||322
1739696|NCT00118898|4261441|P3|COMPLETED|Overall Study||342
1739697|NCT00118898|4261442|P2|COMPLETED|Overall Study||324
1739698|NCT00118898|4261443|P1|COMPLETED|Overall Study||343
1739699|NCT00118898|4261440|P4|Initiated Treatment|Overall Study||462
1739700|NCT00118898|4261441|P3|Initiated Treatment|Overall Study||464
1739701|NCT00118898|4261442|P2|Initiated Treatment|Overall Study||461
1739702|NCT00118898|4261443|P1|Initiated Treatment|Overall Study||461
1739703|NCT00118898|4261440|P4|STARTED|Overall Study||463
1739704|NCT00118898|4261441|P3|STARTED|Overall Study||465
1739705|NCT00118898|4261442|P2|STARTED|Overall Study||465
1739706|NCT00118898|4261443|P1|STARTED|Overall Study||464
1739707|NCT00118755|4261539|P2|NOT COMPLETED|Overall Study||215
1739708|NCT00118755|4261540|P1|NOT COMPLETED|Overall Study||210
1739709|NCT00118755|4261539|P2|COMPLETED|Overall Study||3
1739710|NCT00118755|4261540|P1|COMPLETED|Overall Study||7
1739711|NCT00118755|4261539|P2|Safety Population|Overall Study||211
1739712|NCT00118755|4261540|P1|Safety Population|Overall Study||208
1739713|NCT00118755|4261539|P2|STARTED|Overall Study||218
1739714|NCT00118755|4261540|P1|STARTED|Overall Study||217
1739715|NCT00118742|4261554|P2|NOT COMPLETED|Overall Study||66
1739716|NCT00118742|4261555|P1|NOT COMPLETED|Overall Study||49
1739717|NCT00118742|4261554|P2|COMPLETED|Overall Study||82
1739718|NCT00118742|4261555|P1|COMPLETED|Overall Study||96
1739719|NCT00118742|4261554|P2|STARTED|Overall Study||148
1739720|NCT00118742|4261555|P1|STARTED|Overall Study||145
1739721|NCT00118703|4261569|P2|NOT COMPLETED|Overall Study||9
1739722|NCT00118703|4261570|P1|NOT COMPLETED|Overall Study||5
1739723|NCT00118703|4261569|P2|COMPLETED|Overall Study||165
1739724|NCT00118703|4261570|P1|COMPLETED|Overall Study||168
1739725|NCT00118703|4261569|P2|STARTED|Overall Study||174
1739726|NCT00118703|4261570|P1|STARTED|Overall Study||173
1739727|NCT00118534|4261582|P2|NOT COMPLETED|Overall Study||0
1739728|NCT00118534|4261583|P1|NOT COMPLETED|Overall Study||0
1739729|NCT00118534|4261582|P2|COMPLETED|Overall Study||471
1739730|NCT00118534|4261583|P1|COMPLETED|Overall Study||472
1739731|NCT00118534|4261582|P2|STARTED|Overall Study||471
1739732|NCT00118534|4261583|P1|STARTED|Overall Study||472
1739733|NCT00118482|4261667|P2|NOT COMPLETED|Overall Study||29
1739734|NCT00118482|4261668|P1|NOT COMPLETED|Overall Study||30
1739735|NCT00118482|4261667|P2|COMPLETED|Overall Study||76
1739736|NCT00118482|4261668|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
1739737|NCT00118482|4261667|P2|STARTED|Overall Study||105
1739738|NCT00118482|4261668|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
1739739|NCT00118430|4261679|P3|NOT COMPLETED|Overall Study||28
1739740|NCT00118430|4261680|P2|NOT COMPLETED|Overall Study||24
1739741|NCT00118430|4261681|P1|NOT COMPLETED|Overall Study||21
1739742|NCT00118430|4261679|P3|COMPLETED|Overall Study||222
1739743|NCT00118430|4261680|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
1739744|NCT00118430|4261681|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
1739745|NCT00118430|4261679|P3|STARTED|Overall Study||250
1739746|NCT00118430|4261680|P2|STARTED|Overall Study||127
1739747|NCT00118430|4261681|P1|STARTED|Overall Study||123
1739748|NCT00118417|4261696|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
1739749|NCT00118417|4261697|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
1739750|NCT00118417|4261696|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
1739751|NCT00118417|4261697|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
1739752|NCT00118417|4261696|P2|STARTED|Phase III (Weeks 12 to 24)||10
1739753|NCT00118417|4261697|P1|STARTED|Phase III (Weeks 12 to 24)||9
1739754|NCT00118417|4261696|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
1739755|NCT00118417|4261697|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
1739756|NCT00118417|4261696|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
1739757|NCT00118417|4261697|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
1739758|NCT00118417|4261696|P2|STARTED|Phase II (Weeks 6 to 12)||13
1739759|NCT00118417|4261697|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
1739760|NCT00118417|4261696|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
1739761|NCT00118417|4261697|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
1739762|NCT00118417|4261696|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
1739763|NCT00118417|4261697|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
1739764|NCT00118417|4261696|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
1739765|NCT00118417|4261697|P1|STARTED|Phase I (Weeks 0 to 6)||39
1739766|NCT00118404|4261710|P3|NOT COMPLETED|Overall Study||20
1739767|NCT00118404|4261711|P2|NOT COMPLETED|Overall Study||16
1739768|NCT00118404|4261712|P1|NOT COMPLETED|Overall Study||24
1739769|NCT00118404|4261710|P3|COMPLETED|Overall Study||49
1739770|NCT00118404|4261711|P2|COMPLETED|Overall Study||70
1739771|NCT00118404|4261712|P1|COMPLETED|Overall Study||62
1739772|NCT00118404|4261710|P3|STARTED|Overall Study||69
1739773|NCT00118404|4261711|P2|STARTED|Overall Study||86
1739774|NCT00118404|4261712|P1|STARTED|Overall Study||86
1739775|NCT00118378|4261728|P2|NOT COMPLETED|Overall Study||8
1739776|NCT00118378|4261729|P1|NOT COMPLETED|Overall Study||2
1739777|NCT00118378|4261728|P2|COMPLETED|Overall Study||45
1739778|NCT00118378|4261729|P1|COMPLETED|Overall Study||60
1739779|NCT00118378|4261728|P2|STARTED|Overall Study||53
1739780|NCT00118378|4261729|P1|STARTED|Overall Study||62
1739781|NCT00118365|4261743|P2|NOT COMPLETED|Overall Study||60
1739782|NCT00118365|4261744|P1|NOT COMPLETED|Overall Study||59
1739783|NCT00118365|4261743|P2|COMPLETED|Overall Study||124
1739784|NCT00118365|4261744|P1|COMPLETED|Overall Study||132
1739785|NCT00118365|4261743|P2|STARTED|Overall Study||184
1739786|NCT00118365|4261744|P1|STARTED|Overall Study||191
1739787|NCT00118352|4261813|P3|NOT COMPLETED|Overall Study||0
1739788|NCT00118352|4261814|P2|NOT COMPLETED|Overall Study||0
1739789|NCT00118352|4261815|P1|NOT COMPLETED|Overall Study||0
1739790|NCT00118352|4261813|P3|COMPLETED|Overall Study||0
1739791|NCT00118352|4261814|P2|COMPLETED|Overall Study||0
1739792|NCT00118352|4261815|P1|COMPLETED|Overall Study||12
1739793|NCT00118352|4261813|P3|STARTED|Overall Study||0
1739794|NCT00118352|4261814|P2|STARTED|Overall Study||0
1739795|NCT00118352|4261815|P1|STARTED|Overall Study||12
1739796|NCT00118287|4261841|P1|NOT COMPLETED|Overall Study||2
1739797|NCT00118287|4261841|P1|COMPLETED|Overall Study||30
1739798|NCT00118287|4261841|P1|STARTED|Overall Study||32
1739799|NCT00118248|4261847|P2|NOT COMPLETED|Overall Study||0
1739800|NCT00118248|4261848|P1|NOT COMPLETED|Overall Study||0
1739801|NCT00118248|4261847|P2|COMPLETED|Overall Study||24
1739802|NCT00118248|4261848|P1|COMPLETED|Overall Study||17
1739803|NCT00118248|4261847|P2|STARTED|Overall Study||24
1739804|NCT00118248|4261848|P1|STARTED|Overall Study||17
1739805|NCT00118157|4261861|P1|NOT COMPLETED|Overall Study||12
1739806|NCT00118157|4261861|P1|COMPLETED|Overall Study||7
1739807|NCT00118157|4261861|P1|STARTED|Overall Study||19
1739808|NCT00118144|4261866|P1|NOT COMPLETED|Overall Study||1
1739809|NCT00118144|4261866|P1|COMPLETED|Overall Study||41
1739810|NCT00118144|4261866|P1|STARTED|Overall Study||42
1739811|NCT00118131|4261872|P1|NOT COMPLETED|Overall Study||0
1739812|NCT00118131|4261872|P1|COMPLETED|Overall Study||49
1739813|NCT00118131|4261872|P1|STARTED|Overall Study||49
1739814|NCT00118092|4261879|P1|NOT COMPLETED|Overall Study||2
1739815|NCT00118092|4261879|P1|COMPLETED|Overall Study||15
1739816|NCT00118092|4261879|P1|STARTED|Overall Study||17
1739817|NCT00118053|4261887|P1|NOT COMPLETED|Overall Study||0
1739818|NCT00118053|4261887|P1|COMPLETED|Overall Study||5
1739819|NCT00118053|4261887|P1|STARTED|Overall Study||5
1739820|NCT00118040|4261897|P3|NOT COMPLETED|Overall Study||6
1739821|NCT00118040|4261898|P2|NOT COMPLETED|Overall Study||2
1739822|NCT00118040|4261899|P1|NOT COMPLETED|Overall Study||1
1739823|NCT00118040|4261897|P3|COMPLETED|Overall Study||14
1739824|NCT00118040|4261898|P2|COMPLETED|Overall Study||18
1739825|NCT00118040|4261899|P1|COMPLETED|Overall Study||19
1739826|NCT00118040|4261897|P3|STARTED|Overall Study||20
1739827|NCT00118040|4261898|P2|STARTED|Overall Study||20
1739828|NCT00118040|4261899|P1|STARTED|Overall Study||20
1739829|NCT00117988|4261960|P1|NOT COMPLETED|Overall Study||4
1739830|NCT00117988|4261960|P1|COMPLETED|Overall Study||18
1739831|NCT00117988|4261960|P1|STARTED|Overall Study||22
1739832|NCT00117962|4261966|P2|NOT COMPLETED|Overall Study||25
1739833|NCT00117962|4261967|P1|NOT COMPLETED|Overall Study||22
1739834|NCT00117962|4261966|P2|COMPLETED|Overall Study||28
1739835|NCT00117962|4261967|P1|COMPLETED|Overall Study||26
1739836|NCT00117962|4261966|P2|STARTED|Overall Study||53
1739837|NCT00117962|4261967|P1|STARTED|Overall Study||48
1739838|NCT00117949|4261983|P4|NOT COMPLETED|Overall Study||24
1739839|NCT00117949|4261984|P3|NOT COMPLETED|Overall Study||24
1739840|NCT00117949|4261985|P2|NOT COMPLETED|Overall Study||24
1739841|NCT00117949|4261986|P1|NOT COMPLETED|Overall Study||10
1739842|NCT00117949|4261983|P4|COMPLETED|Overall Study||0
1739843|NCT00117949|4261984|P3|COMPLETED|Overall Study||0
1739844|NCT00117949|4261985|P2|COMPLETED|Overall Study||0
1739845|NCT00117949|4261986|P1|COMPLETED|Overall Study||0
1739846|NCT00117949|4261983|P4|STARTED|Overall Study||24
1739847|NCT00117949|4261984|P3|STARTED|Overall Study||24
1739848|NCT00117949|4261985|P2|STARTED|Overall Study||24
1739849|NCT00117949|4261986|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
1739850|NCT00117845|4262020|P1|NOT COMPLETED|Overall Study||1
1739851|NCT00117845|4262020|P1|COMPLETED|Overall Study||16
1739852|NCT00117845|4262020|P1|STARTED|Overall Study||17
1739853|NCT00117806|4262027|P2|NOT COMPLETED|Overall Study||16
1739854|NCT00117806|4262028|P1|NOT COMPLETED|Overall Study||38
1739855|NCT00117806|4262027|P2|COMPLETED|Overall Study||60
1739856|NCT00117806|4262028|P1|COMPLETED|Overall Study||43
1739857|NCT00117806|4262027|P2|STARTED|Overall Study||76
1739858|NCT00117806|4262028|P1|STARTED|Overall Study||81
1739859|NCT00117793|4262038|P1|NOT COMPLETED|Overall Study||12
1739860|NCT00117793|4262038|P1|COMPLETED|Overall Study||5
1739861|NCT00117793|4262038|P1|STARTED|Overall Study||17
1739862|NCT00117715|4262053|P1|NOT COMPLETED|Overall Study||72
1739863|NCT00117715|4262053|P1|COMPLETED|Overall Study||49
1739864|NCT00117715|4262053|P1|5 Year|Overall Study||49
1739865|NCT00117715|4262053|P1|4.5 Year|Overall Study||55
1739866|NCT00117715|4262053|P1|4 Year|Overall Study||58
1739867|NCT00117715|4262053|P1|3.5 Year|Overall Study||60
1739868|NCT00117715|4262053|P1|3 Year|Overall Study||61
1739869|NCT00117715|4262053|P1|2.5 Year|Overall Study||70
1739870|NCT00117715|4262053|P1|2 Year|Overall Study||76
1739871|NCT00117715|4262053|P1|1.5 Year|Overall Study||85
1739872|NCT00117715|4262053|P1|1 Year|Overall Study||88
1739873|NCT00117715|4262053|P1|STARTED|Overall Study||121
1739874|NCT00117676|4262061|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
1739875|NCT00117676|4262062|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
1739876|NCT00117676|4262061|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
1739877|NCT00117676|4262062|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
1739878|NCT00117676|4262061|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
1739879|NCT00117676|4262062|P1|STARTED|Open-label Period: Weeks 433 - 480||82
1739880|NCT00117676|4262061|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
1739881|NCT00117676|4262062|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
1739882|NCT00117676|4262061|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
1739883|NCT00117676|4262062|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
1739884|NCT00117676|4262061|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
1739885|NCT00117676|4262062|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
1739886|NCT00117676|4262061|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
1739887|NCT00117676|4262062|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
1739888|NCT00117676|4262061|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
1739889|NCT00117676|4262062|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
1739890|NCT00117676|4262061|P2|STARTED|Open-label Period: Weeks 337 - 384||93
1739891|NCT00117676|4262062|P1|STARTED|Open-label Period: Weeks 337 - 384||183
1739892|NCT00117676|4262061|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
1739893|NCT00117676|4262062|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
1739894|NCT00117676|4262061|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
1739895|NCT00117676|4262062|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
1739896|NCT00117676|4262061|P2|STARTED|Open-label Period: Weeks 289 - 336||100
1739897|NCT00117676|4262062|P1|STARTED|Open-label Period: Weeks 289 - 336||192
1739898|NCT00117676|4262061|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
1739899|NCT00117676|4262062|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
1739900|NCT00117676|4262061|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
1739901|NCT00117676|4262062|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
1739902|NCT00117676|4262061|P2|STARTED|Open-label Period: Weeks 241 - 288||103
1739903|NCT00117676|4262062|P1|STARTED|Open-label Period: Weeks 241 - 288||202
1739904|NCT00117676|4262061|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
1739905|NCT00117676|4262062|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
1739906|NCT00117676|4262061|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
1739907|NCT00117676|4262062|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
1739908|NCT00117676|4262061|P2|STARTED|Open-label Period: Weeks 193 - 240||106
1739909|NCT00117676|4262062|P1|STARTED|Open-label Period: Weeks 193 - 240||209
1739910|NCT00117676|4262061|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
1739911|NCT00117676|4262062|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
1739912|NCT00117676|4262061|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
1739913|NCT00117676|4262062|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
1739914|NCT00117676|4262061|P2|STARTED|Open-label Period: Weeks 145 - 192||109
1739915|NCT00117676|4262062|P1|STARTED|Open-label Period: Weeks 145 - 192||219
1739916|NCT00117676|4262061|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
1739917|NCT00117676|4262062|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
1739918|NCT00117676|4262061|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
1739919|NCT00117676|4262062|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
1739920|NCT00117676|4262061|P2|STARTED|Open-label Period: Weeks 97 - 144||110
1739921|NCT00117676|4262062|P1|STARTED|Open-label Period: Weeks 97 - 144||225
1739922|NCT00117676|4262061|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
1739923|NCT00117676|4262062|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
1739924|NCT00117676|4262061|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
1739925|NCT00117676|4262062|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
1739926|NCT00117676|4262061|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
1739927|NCT00117676|4262062|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
1739928|NCT00117676|4262061|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
1739929|NCT00117676|4262062|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
1739930|NCT00117676|4262061|P2|COMPLETED|Double-blind Period Through Week 48||121
1739931|NCT00117676|4262062|P1|COMPLETED|Double-blind Period Through Week 48||244
1739932|NCT00117676|4262061|P2|STARTED|Double-blind Period Through Week 48||128
1739933|NCT00117676|4262062|P1|STARTED|Double-blind Period Through Week 48||254
1739934|NCT00117637|4262151|P2|NOT COMPLETED|Second Intervention (Period 2)||22
1739935|NCT00117637|4262152|P1|NOT COMPLETED|Second Intervention (Period 2)||10
1739936|NCT00117637|4262151|P2|COMPLETED|Second Intervention (Period 2)||39
1739937|NCT00117637|4262152|P1|COMPLETED|Second Intervention (Period 2)||39
1739938|NCT00117637|4262151|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
1739939|NCT00117637|4262152|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
1739940|NCT00117637|4262151|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
1739941|NCT00117637|4262152|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
1739942|NCT00117637|4262151|P2|NOT COMPLETED|First Intervention (Period 1)||25
1739943|NCT00117637|4262152|P1|NOT COMPLETED|First Intervention (Period 1)||18
1739944|NCT00117637|4262151|P2|COMPLETED|First Intervention (Period 1)||67
1739945|NCT00117637|4262152|P1|COMPLETED|First Intervention (Period 1)||79
1739946|NCT00117637|4262151|P2|Subjects Received Treatment|First Intervention (Period 1)||90
1739947|NCT00117637|4262152|P1|Subjects Received Treatment|First Intervention (Period 1)||97
1739948|NCT00117637|4262151|P2|STARTED|First Intervention (Period 1)||92
1739949|NCT00117637|4262152|P1|STARTED|First Intervention (Period 1)||97
1739950|NCT00117598|4262227|P5|NOT COMPLETED|After Treament Cross Over||4
1739951|NCT00117598|4262228|P4|NOT COMPLETED|After Treament Cross Over||3
1739952|NCT00117598|4262229|P3|NOT COMPLETED|After Treament Cross Over||0
1739953|NCT00117598|4262230|P2|NOT COMPLETED|After Treament Cross Over||0
1739954|NCT00117598|4262231|P1|NOT COMPLETED|After Treament Cross Over||0
1739955|NCT00117598|4262227|P5|COMPLETED|After Treament Cross Over||0
1739956|NCT00117598|4262228|P4|COMPLETED|After Treament Cross Over||0
1739957|NCT00117598|4262229|P3|COMPLETED|After Treament Cross Over||0
1739958|NCT00117598|4262230|P2|COMPLETED|After Treament Cross Over||0
1739959|NCT00117598|4262231|P1|COMPLETED|After Treament Cross Over||0
1739960|NCT00117598|4262227|P5|STARTED|After Treament Cross Over||4
1739961|NCT00117598|4262228|P4|STARTED|After Treament Cross Over||3
1739962|NCT00117598|4262229|P3|STARTED|After Treament Cross Over||0
1739963|NCT00117598|4262230|P2|STARTED|After Treament Cross Over||0
1739964|NCT00117598|4262231|P1|STARTED|After Treament Cross Over||0
1739965|NCT00117598|4262227|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
1739966|NCT00117598|4262228|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
1739967|NCT00117598|4262229|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
1739968|NCT00117598|4262230|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
1739969|NCT00117598|4262231|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
1739970|NCT00117598|4262227|P5|COMPLETED|Prior to Treatment Cross Over||0
1739971|NCT00117598|4262228|P4|COMPLETED|Prior to Treatment Cross Over||0
1739972|NCT00117598|4262229|P3|COMPLETED|Prior to Treatment Cross Over||4
1739973|NCT00117598|4262230|P2|COMPLETED|Prior to Treatment Cross Over||3
1739974|NCT00117598|4262231|P1|COMPLETED|Prior to Treatment Cross Over||0
1739975|NCT00117598|4262227|P5|STARTED|Prior to Treatment Cross Over||0
1739976|NCT00117598|4262228|P4|STARTED|Prior to Treatment Cross Over||0
1739977|NCT00117598|4262229|P3|STARTED|Prior to Treatment Cross Over||56
1739978|NCT00117598|4262230|P2|STARTED|Prior to Treatment Cross Over||56
1739979|NCT00117598|4262231|P1|STARTED|Prior to Treatment Cross Over||57
1739980|NCT00117585|4262259|P1|NOT COMPLETED|Overall Study||0
1739981|NCT00117585|4262259|P1|COMPLETED|Overall Study||341
1739982|NCT00117585|4262259|P1|STARTED|Overall Study||341
1739983|NCT00117572|4262265|P2|NOT COMPLETED|Overall Study||6
1739984|NCT00117572|4262266|P1|NOT COMPLETED|Overall Study||6
1739985|NCT00117572|4262265|P2|COMPLETED|Overall Study||135
1739986|NCT00117572|4262266|P1|COMPLETED|Overall Study||138
1739987|NCT00117572|4262265|P2|STARTED|Overall Study||141
1739988|NCT00117572|4262266|P1|STARTED|Overall Study||144
1739989|NCT00117559|4262298|P2|NOT COMPLETED|Overall Study||1
1739990|NCT00117559|4262299|P1|NOT COMPLETED|Overall Study||1
1739991|NCT00117559|4262298|P2|COMPLETED|Overall Study||9
1739992|NCT00117559|4262299|P1|COMPLETED|Overall Study||8
1739993|NCT00117559|4262298|P2|STARTED|Overall Study||10
1739994|NCT00117559|4262299|P1|STARTED|Overall Study||9
1739995|NCT00117338|4262307|P2|NOT COMPLETED|Overall Study||4
1739996|NCT00117338|4262308|P1|NOT COMPLETED|Overall Study||5
1739997|NCT00117338|4262307|P2|COMPLETED|Overall Study||127
1739998|NCT00117338|4262308|P1|COMPLETED|Overall Study||140
1739999|NCT00117338|4262307|P2|STARTED|Overall Study||131
1740000|NCT00117338|4262308|P1|STARTED|Overall Study||145
1740001|NCT00117325|4262328|P2|NOT COMPLETED|Overall Study||12
1740002|NCT00117325|4262329|P1|NOT COMPLETED|Overall Study||13
1740003|NCT00117325|4262328|P2|COMPLETED|Overall Study||167
1740004|NCT00117325|4262329|P1|COMPLETED|Overall Study||160
1740005|NCT00117325|4262328|P2|STARTED|Overall Study||179
1740006|NCT00117325|4262329|P1|STARTED|Overall Study||173
1740007|NCT00117312|4262361|P4|NOT COMPLETED|Overall Study||21
1740008|NCT00117312|4262362|P3|NOT COMPLETED|Overall Study||24
1740009|NCT00117312|4262363|P2|NOT COMPLETED|Overall Study||20
1740010|NCT00117312|4262364|P1|NOT COMPLETED|Overall Study||10
1740011|NCT00117312|4262361|P4|COMPLETED|Overall Study||3
1740012|NCT00117312|4262362|P3|COMPLETED|Overall Study||0
1740013|NCT00117312|4262363|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
1740014|NCT00117312|4262364|P1|COMPLETED|Overall Study||0
1740015|NCT00117312|4262361|P4|Started FE200486 CS06A|Overall Study||9
1740016|NCT00117312|4262362|P3|Started FE200486 CS06A|Overall Study||16
1740017|NCT00117312|4262363|P2|Started FE200486 CS06A|Overall Study||11
1740018|NCT00117312|4262364|P1|Started FE200486 CS06A|Overall Study||1
1740019|NCT00117312|4262361|P4|STARTED|Overall Study||24
1740020|NCT00117312|4262362|P3|STARTED|Overall Study||24
1740021|NCT00117312|4262363|P2|STARTED|Overall Study||24
1740022|NCT00117312|4262364|P1|STARTED|Overall Study||10
1740023|NCT00117286|4262380|P2|NOT COMPLETED|Overall Study||21
1740024|NCT00117286|4262381|P1|NOT COMPLETED|Overall Study||28
1740025|NCT00117286|4262380|P2|COMPLETED|Overall Study||6
1740026|NCT00117286|4262381|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
1740027|NCT00117286|4262380|P2|Switched to Higher Dose|Overall Study||17
1740028|NCT00117286|4262381|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
1740029|NCT00117286|4262380|P2|STARTED|Overall Study||27
1740030|NCT00117286|4262381|P1|STARTED|Overall Study|Safety analysis set|30
1740031|NCT00117156|4262389|P1|NOT COMPLETED|Overall Study||11
1740032|NCT00117156|4262389|P1|COMPLETED|Overall Study||15
1740033|NCT00117156|4262389|P1|STARTED|Overall Study||26
1740034|NCT00116857|4262399|P2|NOT COMPLETED|Overall Study||4
1740035|NCT00116857|4262400|P1|NOT COMPLETED|Overall Study||3
1740036|NCT00116857|4262399|P2|COMPLETED|Overall Study||56
1740037|NCT00116857|4262400|P1|COMPLETED|Overall Study||59
1740038|NCT00116857|4262399|P2|STARTED|Overall Study||60
1740039|NCT00116857|4262400|P1|STARTED|Overall Study||62
1740040|NCT00116844|4262408|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
1740041|NCT00116844|4262409|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
1740042|NCT00116844|4262408|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
1740043|NCT00116844|4262409|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
1740044|NCT00116844|4262408|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
1740045|NCT00116844|4262409|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
1740046|NCT00116844|4262408|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1740047|NCT00116844|4262409|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
1740048|NCT00116844|4262408|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
1740049|NCT00116844|4262409|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
1740050|NCT00116844|4262408|P2|STARTED|Period 2: Washout Period (7 Days)||33
1740051|NCT00116844|4262409|P1|STARTED|Period 2: Washout Period (7 Days)||28
1740052|NCT00116844|4262408|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
1740053|NCT00116844|4262409|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
1740054|NCT00116844|4262408|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
1740055|NCT00116844|4262409|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
1740056|NCT00116844|4262408|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
1740057|NCT00116844|4262409|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
1740058|NCT00116831|4262427|P2|NOT COMPLETED|Overall Study||72
1740059|NCT00116831|4262428|P1|NOT COMPLETED|Overall Study||73
1740060|NCT00116831|4262427|P2|COMPLETED|Overall Study||259
1740061|NCT00116831|4262428|P1|COMPLETED|Overall Study||264
1740062|NCT00116831|4262427|P2|STARTED|Overall Study||331
1740063|NCT00116831|4262428|P1|STARTED|Overall Study||337
1740064|NCT00116805|4262506|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
1740065|NCT00116805|4262507|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
1740066|NCT00116805|4262506|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
1740067|NCT00116805|4262507|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
1740068|NCT00116805|4262506|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
1740069|NCT00116805|4262507|P1|STARTED|Open-label Period Weeks 433 - 480||57
1740070|NCT00116805|4262506|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
1740071|NCT00116805|4262507|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
1740072|NCT00116805|4262506|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
1740073|NCT00116805|4262507|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
1740074|NCT00116805|4262506|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
1740075|NCT00116805|4262507|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
1740076|NCT00116805|4262506|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
1740077|NCT00116805|4262507|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
1740078|NCT00116805|4262506|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
1740079|NCT00116805|4262507|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
1740080|NCT00116805|4262506|P2|STARTED|Open-label Period Weeks 337 - 384||57
1740081|NCT00116805|4262507|P1|STARTED|Open-label Period Weeks 337 - 384||98
1740082|NCT00116805|4262506|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
1740083|NCT00116805|4262507|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
1740084|NCT00116805|4262506|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
1740085|NCT00116805|4262507|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
1740086|NCT00116805|4262506|P2|STARTED|Open-label Period Weeks 289 - 336||64
1740087|NCT00116805|4262507|P1|STARTED|Open-label Period Weeks 289 - 336||104
1740088|NCT00116805|4262506|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
1740089|NCT00116805|4262507|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
1740090|NCT00116805|4262506|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
1740091|NCT00116805|4262507|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
1740092|NCT00116805|4262506|P2|STARTED|Open-label Period Weeks 241 - 288||64
1740093|NCT00116805|4262507|P1|STARTED|Open-label Period Weeks 241 - 288||110
1740094|NCT00116805|4262506|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
1740095|NCT00116805|4262507|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
1740096|NCT00116805|4262506|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
1740097|NCT00116805|4262507|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
1740098|NCT00116805|4262506|P2|STARTED|Open-label Period Weeks 193 - 240||68
1740099|NCT00116805|4262507|P1|STARTED|Open-label Period Weeks 193 - 240||123
1740100|NCT00116805|4262506|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
1740101|NCT00116805|4262507|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
1740102|NCT00116805|4262506|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
1740103|NCT00116805|4262507|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
1740104|NCT00116805|4262506|P2|STARTED|Open-label Period Weeks 145 - 192||74
1740105|NCT00116805|4262507|P1|STARTED|Open-label Period Weeks 145 - 192||133
1740106|NCT00116805|4262506|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
1740107|NCT00116805|4262507|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
1740108|NCT00116805|4262506|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
1740109|NCT00116805|4262507|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
1740110|NCT00116805|4262506|P2|STARTED|Open-label Period Weeks 97 - 144||83
1740111|NCT00116805|4262507|P1|STARTED|Open-label Period Weeks 97 - 144||144
1740112|NCT00116805|4262506|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
1740113|NCT00116805|4262507|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
1740114|NCT00116805|4262506|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
1740115|NCT00116805|4262507|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
1740116|NCT00116805|4262506|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
1740117|NCT00116805|4262507|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
1740118|NCT00116805|4262506|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
1740119|NCT00116805|4262507|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
1740120|NCT00116805|4262506|P2|COMPLETED|Double-blind Period Through Week 48||85
1740121|NCT00116805|4262507|P1|COMPLETED|Double-blind Period Through Week 48||165
1740122|NCT00116805|4262506|P2|STARTED|Double-blind Period Through Week 48||90
1740123|NCT00116805|4262507|P1|STARTED|Double-blind Period Through Week 48||176
1740124|NCT00116779|4262600|P2|NOT COMPLETED|Overall Study||19
1740125|NCT00116779|4262601|P1|NOT COMPLETED|Overall Study||21
1740126|NCT00116779|4262600|P2|COMPLETED|Overall Study||45
1740127|NCT00116779|4262601|P1|COMPLETED|Overall Study||42
1740128|NCT00116779|4262600|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
1740129|NCT00116779|4262601|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
1740130|NCT00116753|4262634|P3|NOT COMPLETED|Overall Study||24
1740131|NCT00116753|4262635|P2|NOT COMPLETED|Overall Study||30
1740132|NCT00116753|4262636|P1|NOT COMPLETED|Overall Study||32
1740133|NCT00116753|4262634|P3|COMPLETED|Overall Study||128
1740134|NCT00116753|4262635|P2|COMPLETED|Overall Study||125
1740135|NCT00116753|4262636|P1|COMPLETED|Overall Study||121
1740136|NCT00116753|4262634|P3|ITT Population|Overall Study||147
1740137|NCT00116753|4262635|P2|ITT Population|Overall Study||150
1740138|NCT00116753|4262636|P1|ITT Population|Overall Study||150
1740139|NCT00116753|4262634|P3|STARTED|Overall Study||152
1740140|NCT00116753|4262635|P2|STARTED|Overall Study||155
1740141|NCT00116753|4262636|P1|STARTED|Overall Study|Randomised.|153
1740142|NCT00116688|4262658|P2|NOT COMPLETED|Overall Study||4
1740143|NCT00116688|4262659|P1|NOT COMPLETED|Overall Study||92
1740144|NCT00116688|4262658|P2|COMPLETED|Overall Study||17
1740145|NCT00116688|4262659|P1|COMPLETED|Overall Study||200
1740146|NCT00116688|4262658|P2|Received Study Medication|Overall Study||20
1740147|NCT00116688|4262659|P1|Received Study Medication|Overall Study||291
1740148|NCT00116688|4262658|P2|STARTED|Overall Study||21
1740149|NCT00116688|4262659|P1|STARTED|Overall Study||292
1740150|NCT00116649|4262674|P1|NOT COMPLETED|Overall Study||155
1740151|NCT00116649|4262674|P1|COMPLETED|Overall Study||396
1740152|NCT00116649|4262674|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
1740153|NCT00116428|4262681|P2|NOT COMPLETED|Overall Study||5
1740154|NCT00116428|4262682|P1|NOT COMPLETED|Overall Study||3
1740155|NCT00116428|4262681|P2|COMPLETED|Overall Study||56
1740156|NCT00116428|4262682|P1|COMPLETED|Overall Study||103
1740157|NCT00116428|4262681|P2|Underwent Study Ablation Procedure|Overall Study||36
1740158|NCT00116428|4262682|P1|Underwent Study Ablation Procedure|Overall Study||103
1740159|NCT00116428|4262681|P2|STARTED|Overall Study||61
1740160|NCT00116428|4262682|P1|STARTED|Overall Study||106
1740161|NCT00116272|4262700|P2|NOT COMPLETED|Overall Study||6
1740162|NCT00116272|4262701|P1|NOT COMPLETED|Overall Study||11
1740163|NCT00116272|4262700|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
1740164|NCT00116272|4262701|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
1740165|NCT00116272|4262700|P2|STARTED|Overall Study||164
1740166|NCT00116272|4262701|P1|STARTED|Overall Study||370
1740167|NCT00116207|4262753|P2|NOT COMPLETED|Overall Study||4
1740168|NCT00116207|4262754|P1|NOT COMPLETED|Overall Study||9
1740169|NCT00116207|4262753|P2|COMPLETED|Overall Study||18
1740170|NCT00116207|4262754|P1|COMPLETED|Overall Study||13
1740171|NCT00116207|4262753|P2|STARTED|Overall Study||22
1740172|NCT00116207|4262754|P1|STARTED|Overall Study||22
1740173|NCT00116168|4262770|P4|NOT COMPLETED|Overall Study||0
1740174|NCT00116168|4262771|P3|NOT COMPLETED|Overall Study||0
1740175|NCT00116168|4262772|P2|NOT COMPLETED|Overall Study||5
1740176|NCT00116168|4262773|P1|NOT COMPLETED|Overall Study||6
1740177|NCT00116168|4262770|P4|COMPLETED|Overall Study||6
1740178|NCT00116168|4262771|P3|COMPLETED|Overall Study||6
1740179|NCT00116168|4262772|P2|COMPLETED|Overall Study||6
1740180|NCT00116168|4262773|P1|COMPLETED|Overall Study||0
1740181|NCT00116168|4262770|P4|STARTED|Overall Study||6
1740182|NCT00116168|4262771|P3|STARTED|Overall Study||6
1740183|NCT00116168|4262772|P2|STARTED|Overall Study||11
1740184|NCT00116168|4262773|P1|STARTED|Overall Study||6
1740185|NCT00115934|4262837|P2|NOT COMPLETED|Overall Study||2
1740186|NCT00115934|4262838|P1|NOT COMPLETED|Overall Study||4
1740187|NCT00115934|4262837|P2|COMPLETED|Overall Study||274
1740188|NCT00115934|4262838|P1|COMPLETED|Overall Study||275
1740189|NCT00115934|4262837|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
1740190|NCT00115934|4262838|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
1740191|NCT00115869|4262878|P2|NOT COMPLETED|Overall Study||296
1740192|NCT00115869|4262879|P1|NOT COMPLETED|Overall Study||317
1740193|NCT00115869|4262878|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
1740194|NCT00115869|4262879|P1|COMPLETED|Overall Study||3894
1740195|NCT00115869|4262878|P2|Completed Data Collection at 12th Grade|Overall Study||3847
1740196|NCT00115869|4262879|P1|Completed Data Collection at 12th Grade|Overall Study||3876
1740197|NCT00115869|4262878|P2|STARTED|Overall Study||4177
1740198|NCT00115869|4262879|P1|STARTED|Overall Study||4211
1740199|NCT00115804|4262887|P1|NOT COMPLETED|Overall Study||2
1740200|NCT00115804|4262887|P1|COMPLETED|Overall Study||4
1740201|NCT00115804|4262887|P1|STARTED|Overall Study||6
1740202|NCT00115765|4262902|P4|NOT COMPLETED|Overall Study||31
1740203|NCT00115765|4262903|P3|NOT COMPLETED|Overall Study||121
1740204|NCT00115765|4262904|P2|NOT COMPLETED|Overall Study||100
1740205|NCT00115765|4262905|P1|NOT COMPLETED|Overall Study||35
1740206|NCT00115765|4262902|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
1740207|NCT00115765|4262903|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
1740208|NCT00115765|4262904|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
1740209|NCT00115765|4262905|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
1740210|NCT00115765|4262902|P4|STARTED|Overall Study||115
1740211|NCT00115765|4262903|P3|STARTED|Overall Study||410
1740212|NCT00115765|4262904|P2|STARTED|Overall Study||413
1740213|NCT00115765|4262905|P1|STARTED|Overall Study||115
1740214|NCT00115739|4262943|P1|NOT COMPLETED|Overall Study||3
1740215|NCT00115739|4262943|P1|COMPLETED|Overall Study||8
1740216|NCT00115739|4262943|P1|STARTED|Overall Study||11
1740217|NCT00115349|4262952|P2|NOT COMPLETED|Overall Study||9
1740218|NCT00115349|4262953|P1|NOT COMPLETED|Overall Study||11
1740219|NCT00115349|4262952|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
1740220|NCT00115349|4262953|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
1740221|NCT00115349|4262952|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
1740222|NCT00115349|4262953|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
1740223|NCT00115297|4262961|P2|NOT COMPLETED|Overall Study||0
1740224|NCT00115297|4262962|P1|NOT COMPLETED|Overall Study||0
1740225|NCT00115297|4262961|P2|COMPLETED|Overall Study||32
1740226|NCT00115297|4262962|P1|COMPLETED|Overall Study||30
1740227|NCT00115297|4262961|P2|STARTED|Overall Study||32
1740228|NCT00115297|4262962|P1|STARTED|Overall Study||30
1740229|NCT00115063|4262974|P2|NOT COMPLETED|Overall Study||104
1740230|NCT00115063|4262975|P1|NOT COMPLETED|Overall Study||99
1740231|NCT00115063|4262974|P2|COMPLETED|Overall Study||86
1740232|NCT00115063|4262975|P1|COMPLETED|Overall Study||101
1740233|NCT00115063|4262974|P2|STARTED|Overall Study||190
1740234|NCT00115063|4262975|P1|STARTED|Overall Study||200
1740235|NCT00114972|4262993|P2|NOT COMPLETED|Overall Study||12
1740236|NCT00114972|4262994|P1|NOT COMPLETED|Overall Study||48
1740237|NCT00114972|4262993|P2|COMPLETED|Overall Study||891
1740238|NCT00114972|4262994|P1|COMPLETED|Overall Study||849
1740239|NCT00114972|4262993|P2|STARTED|Overall Study||903
1740240|NCT00114972|4262994|P1|STARTED|Overall Study||897
1740241|NCT00114959|4263014|P1|NOT COMPLETED|Overall Study||8
1740242|NCT00114959|4263014|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
1740243|NCT00114959|4263014|P1|STARTED|Overall Study||15
1740244|NCT00114777|4263024|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
1740245|NCT00114777|4263025|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
1740246|NCT00114777|4263026|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
1740247|NCT00114777|4263024|P3|COMPLETED|Long-Term Extension to Month 84||57
1740248|NCT00114777|4263025|P2|COMPLETED|Long-Term Extension to Month 84||84
1740249|NCT00114777|4263026|P1|COMPLETED|Long-Term Extension to Month 84||74
1740250|NCT00114777|4263024|P3|STARTED|Long-Term Extension to Month 84||87
1740251|NCT00114777|4263025|P2|STARTED|Long-Term Extension to Month 84||113
1740252|NCT00114777|4263026|P1|STARTED|Long-Term Extension to Month 84||104
1740253|NCT00114777|4263024|P3|NOT COMPLETED|Randomization to Month 36||84
1740254|NCT00114777|4263025|P2|NOT COMPLETED|Randomization to Month 36||61
1740255|NCT00114777|4263026|P1|NOT COMPLETED|Randomization to Month 36||75
1740256|NCT00114777|4263024|P3|COMPLETED|Randomization to Month 36||100
1740257|NCT00114777|4263025|P2|COMPLETED|Randomization to Month 36||114
1740258|NCT00114777|4263026|P1|COMPLETED|Randomization to Month 36||109
1740259|NCT00114777|4263024|P3|STARTED|Randomization to Month 36||184
1740260|NCT00114777|4263025|P2|STARTED|Randomization to Month 36||175
1740261|NCT00114777|4263026|P1|STARTED|Randomization to Month 36||184
1740262|NCT00114738|4263100|P3|NOT COMPLETED|Randomization||0
1740263|NCT00114738|4263101|P2|NOT COMPLETED|Randomization||0
1740264|NCT00114738|4263102|P1|NOT COMPLETED|Randomization||0
1740265|NCT00114738|4263100|P3|COMPLETED|Randomization||16
1740266|NCT00114738|4263101|P2|COMPLETED|Randomization||14
1740267|NCT00114738|4263102|P1|COMPLETED|Randomization||0
1740268|NCT00114738|4263100|P3|STARTED|Randomization||16
1740269|NCT00114738|4263101|P2|STARTED|Randomization||14
1740270|NCT00114738|4263102|P1|STARTED|Randomization||0
1740271|NCT00114738|4263100|P3|NOT COMPLETED|Screening for Randomization||0
1740272|NCT00114738|4263101|P2|NOT COMPLETED|Screening for Randomization||0
1740273|NCT00114738|4263102|P1|NOT COMPLETED|Screening for Randomization||21
1740274|NCT00114738|4263100|P3|COMPLETED|Screening for Randomization||0
1740275|NCT00114738|4263101|P2|COMPLETED|Screening for Randomization||0
1740276|NCT00114738|4263102|P1|COMPLETED|Screening for Randomization||30
1740277|NCT00114738|4263100|P3|STARTED|Screening for Randomization||0
1740278|NCT00114738|4263101|P2|STARTED|Screening for Randomization||0
1740279|NCT00114738|4263102|P1|STARTED|Screening for Randomization||51
1740280|NCT00114738|4263100|P3|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
1740281|NCT00114738|4263101|P2|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
1740282|NCT00114738|4263102|P1|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
1740283|NCT00114738|4263100|P3|COMPLETED|Bortezomib Then Bortezomib + Induction||0
1740284|NCT00114738|4263101|P2|COMPLETED|Bortezomib Then Bortezomib + Induction||0
1740285|NCT00114738|4263102|P1|COMPLETED|Bortezomib Then Bortezomib + Induction||51
1740286|NCT00114738|4263100|P3|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
1740287|NCT00114738|4263101|P2|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
1740288|NCT00114738|4263102|P1|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
1740289|NCT00114738|4263100|P3|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
1740290|NCT00114738|4263101|P2|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
1740291|NCT00114738|4263102|P1|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
1740292|NCT00114738|4263100|P3|STARTED|Bortezomib Then Bortezomib + Induction||0
1740293|NCT00114738|4263101|P2|STARTED|Bortezomib Then Bortezomib + Induction||0
1740294|NCT00114738|4263102|P1|STARTED|Bortezomib Then Bortezomib + Induction||53
1740295|NCT00114634|4263115|P1|NOT COMPLETED|Overall Study||3
1740296|NCT00114634|4263115|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
1740297|NCT00114634|4263115|P1|STARTED|Overall Study||13
1740298|NCT00114530|4263131|P2|NOT COMPLETED|Overall Study||20
1740299|NCT00114530|4263132|P1|NOT COMPLETED|Overall Study||9
1740300|NCT00114530|4263131|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|19
1740301|NCT00114530|4263132|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|27
1740302|NCT00114530|4263131|P2|STARTED|Overall Study||39
1740303|NCT00114530|4263132|P1|STARTED|Overall Study||36
1740304|NCT00114517|4263241|P4|NOT COMPLETED|Overall Study||10
1740305|NCT00114517|4263242|P3|NOT COMPLETED|Overall Study||14
1740306|NCT00114517|4263243|P2|NOT COMPLETED|Overall Study||11
1740307|NCT00114517|4263244|P1|NOT COMPLETED|Overall Study||12
1740308|NCT00114517|4263241|P4|COMPLETED|Overall Study||176
1740309|NCT00114517|4263242|P3|COMPLETED|Overall Study||172
1740310|NCT00114517|4263243|P2|COMPLETED|Overall Study||123
1740311|NCT00114517|4263244|P1|COMPLETED|Overall Study||125
1740312|NCT00114517|4263241|P4|STARTED|Overall Study||186
1740313|NCT00114517|4263242|P3|STARTED|Overall Study||186
1740314|NCT00114517|4263243|P2|STARTED|Overall Study||134
1740315|NCT00114517|4263244|P1|STARTED|Overall Study||137
1740316|NCT00114504|4263256|P2|NOT COMPLETED|Overall Study||0
1740317|NCT00114504|4263257|P1|NOT COMPLETED|Overall Study||0
1740318|NCT00114504|4263256|P2|COMPLETED|Overall Study||22
1740319|NCT00114504|4263257|P1|COMPLETED|Overall Study||21
1740320|NCT00114504|4263256|P2|STARTED|Overall Study||22
1740321|NCT00114504|4263257|P1|STARTED|Overall Study||21
1740322|NCT00114244|4263269|P2|NOT COMPLETED|Overall Study||7
1740323|NCT00114244|4263270|P1|NOT COMPLETED|Overall Study||2
1740324|NCT00114244|4263269|P2|COMPLETED|Overall Study||30
1740325|NCT00114244|4263270|P1|COMPLETED|Overall Study||13
1740326|NCT00114244|4263269|P2|STARTED|Overall Study||37
1740327|NCT00114244|4263270|P1|STARTED|Overall Study||15
1740328|NCT00114231|4263282|P2|NOT COMPLETED|Overall Study||2
1740329|NCT00114231|4263283|P1|NOT COMPLETED|Overall Study||9
1740330|NCT00114231|4263282|P2|COMPLETED|Overall Study||26
1740331|NCT00114231|4263283|P1|COMPLETED|Overall Study||53
1740332|NCT00114231|4263282|P2|STARTED|Overall Study||28
1740333|NCT00114231|4263283|P1|STARTED|Overall Study||62
1740334|NCT00114218|4263292|P1|NOT COMPLETED|Overall Study||4
1740335|NCT00114218|4263292|P1|COMPLETED|Overall Study||24
1740336|NCT00114218|4263292|P1|STARTED|Overall Study||28
1740337|NCT00114166|4263299|P2|NOT COMPLETED|Overall Study||1
1740338|NCT00114166|4263300|P1|NOT COMPLETED|Overall Study||0
1740339|NCT00114166|4263299|P2|COMPLETED|Overall Study||65
1740340|NCT00114166|4263300|P1|COMPLETED|Overall Study||15
1740341|NCT00114166|4263299|P2|STARTED|Overall Study||66
1740342|NCT00114166|4263300|P1|STARTED|Overall Study||15
1740343|NCT00114140|4263310|P1|NOT COMPLETED|Overall Study||7
1740344|NCT00114140|4263310|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
1740345|NCT00114140|4263310|P1|STARTED|Overall Study||136
1740346|NCT00114127|4263324|P2|NOT COMPLETED|Overall Study||4
1740347|NCT00114127|4263325|P1|NOT COMPLETED|Overall Study||4
1740348|NCT00114127|4263324|P2|COMPLETED|Overall Study||11
1740349|NCT00114127|4263325|P1|COMPLETED|Overall Study||9
1740350|NCT00114127|4263324|P2|STARTED|Overall Study||15
1740351|NCT00114127|4263325|P1|STARTED|Overall Study||13
1740352|NCT00114101|4263335|P2|NOT COMPLETED|Overall Study||0
1740353|NCT00114101|4263336|P1|NOT COMPLETED|Overall Study||0
1740354|NCT00114101|4263335|P2|COMPLETED|Overall Study||229
1740355|NCT00114101|4263336|P1|COMPLETED|Overall Study||231
1740356|NCT00114101|4263335|P2|STARTED|Overall Study||229
1740357|NCT00114101|4263336|P1|STARTED|Overall Study||231
1740358|NCT00113919|4263348|P1|NOT COMPLETED|Overall Study||14
1740359|NCT00113919|4263348|P1|COMPLETED|Overall Study||0
1740360|NCT00113919|4263348|P1|STARTED|Overall Study||14
1740361|NCT00113880|4263355|P3|NOT COMPLETED|Overall Study||0
1740362|NCT00113880|4263356|P2|NOT COMPLETED|Overall Study||0
1740363|NCT00113880|4263357|P1|NOT COMPLETED|Overall Study||0
1740364|NCT00113880|4263355|P3|COMPLETED|Overall Study||62492
1740365|NCT00113880|4263356|P2|COMPLETED|Overall Study||71949
1740366|NCT00113880|4263357|P1|COMPLETED|Overall Study||63061
1740367|NCT00113880|4263355|P3|STARTED|Overall Study||62492
1740368|NCT00113880|4263356|P2|STARTED|Overall Study||71949
1740369|NCT00113880|4263357|P1|STARTED|Overall Study||63061
1740370|NCT00113841|4263416|P2|NOT COMPLETED|Overall Study||2
1740371|NCT00113841|4263417|P1|NOT COMPLETED|Overall Study||1
1740372|NCT00113841|4263416|P2|COMPLETED|Overall Study||15
1740373|NCT00113841|4263417|P1|COMPLETED|Overall Study||15
1740374|NCT00113841|4263416|P2|STARTED|Overall Study||17
1740375|NCT00113841|4263417|P1|STARTED|Overall Study||16
1740376|NCT00113763|4263425|P2|NOT COMPLETED|Overall Study||26
1740377|NCT00113763|4263426|P1|NOT COMPLETED|Overall Study||73
1740378|NCT00113763|4263425|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
1740379|NCT00113763|4263426|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
1740380|NCT00113763|4263425|P2|Received Study Drug|Overall Study||0
1740381|NCT00113763|4263426|P1|Received Study Drug|Overall Study||229
1740382|NCT00113763|4263425|P2|STARTED|Overall Study||232
1740383|NCT00113763|4263426|P1|STARTED|Overall Study||231
1740384|NCT00113607|4263452|P2|NOT COMPLETED|Overall Study||337
1740385|NCT00113607|4263453|P1|NOT COMPLETED|Overall Study||335
1740386|NCT00113607|4263452|P2|COMPLETED|Overall Study||0
1740387|NCT00113607|4263453|P1|COMPLETED|Overall Study||0
1740388|NCT00113607|4263452|P2|STARTED|Overall Study|Number of randomized participants|337
1740389|NCT00113607|4263453|P1|STARTED|Overall Study|Number of randomized participants|335
1740390|NCT00113568|4263467|P1|NOT COMPLETED|Overall Study||545
1740391|NCT00113568|4263467|P1|COMPLETED|Overall Study||239
1740392|NCT00113568|4263467|P1|Intent to Treat Population|Overall Study||723
1740393|NCT00113568|4263467|P1|STARTED|Overall Study||784
1740394|NCT00113555|4263479|P1|NOT COMPLETED|Overall Study||79
1740395|NCT00113555|4263479|P1|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
1740396|NCT00113555|4263479|P1|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
1740397|NCT00113555|4263479|P1|STARTED|Overall Study||221
1740398|NCT00113529|4263489|P1|NOT COMPLETED|Overall Study||34
1740399|NCT00113529|4263489|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
1740400|NCT00113529|4263489|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
1740401|NCT00113516|4263522|P2|NOT COMPLETED|Part 2||66
1740402|NCT00113516|4263523|P1|NOT COMPLETED|Part 2||0
1740403|NCT00113516|4263522|P2|COMPLETED|Part 2||0
1740404|NCT00113516|4263523|P1|COMPLETED|Part 2||0
1740405|NCT00113516|4263522|P2|STARTED|Part 2||66
1740406|NCT00113516|4263523|P1|STARTED|Part 2||0
1740407|NCT00113516|4263522|P2|NOT COMPLETED|Part 1||0
1740408|NCT00113516|4263523|P1|NOT COMPLETED|Part 1||84
1740409|NCT00113516|4263522|P2|COMPLETED|Part 1||0
1740410|NCT00113516|4263523|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
1740411|NCT00113516|4263522|P2|STARTED|Part 1||0
1740412|NCT00113516|4263523|P1|STARTED|Part 1||84
1740413|NCT00113490|4263566|P2|NOT COMPLETED|Overall Study||3
1740414|NCT00113490|4263567|P1|NOT COMPLETED|Overall Study||2
1740415|NCT00113490|4263566|P2|COMPLETED|Overall Study||67
1740416|NCT00113490|4263567|P1|COMPLETED|Overall Study||64
1740417|NCT00113490|4263566|P2|STARTED|Overall Study||70
1740418|NCT00113490|4263567|P1|STARTED|Overall Study||66
1740419|NCT00113425|4263580|P1|NOT COMPLETED|Overall Study||15
1740420|NCT00113425|4263580|P1|COMPLETED|Overall Study||29
1740421|NCT00113425|4263580|P1|STARTED|Overall Study||44
1740422|NCT00113399|4263600|P2|NOT COMPLETED|Overall Study||5
1740423|NCT00113399|4263601|P1|NOT COMPLETED|Overall Study||2
1740424|NCT00113399|4263600|P2|COMPLETED|Overall Study||3
1740425|NCT00113399|4263601|P1|COMPLETED|Overall Study||5
1740426|NCT00113399|4263600|P2|STARTED|Overall Study||8
1740427|NCT00113399|4263601|P1|STARTED|Overall Study||7
1740428|NCT00113386|4263609|P2|NOT COMPLETED|Overall Study||4
1740429|NCT00113386|4263610|P1|NOT COMPLETED|Overall Study||7
1740430|NCT00113386|4263609|P2|COMPLETED|Overall Study||5
1740431|NCT00113386|4263610|P1|COMPLETED|Overall Study||3
1740432|NCT00113386|4263609|P2|STARTED|Overall Study||9
1740433|NCT00113386|4263610|P1|STARTED|Overall Study||10
1740434|NCT00113373|4263616|P1|NOT COMPLETED|Overall Study||3
1740435|NCT00113373|4263616|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
1740436|NCT00113373|4263616|P1|STARTED|Overall Study||28
1740437|NCT00113360|4263631|P1|NOT COMPLETED|Overall Study||7
1740438|NCT00113360|4263631|P1|COMPLETED|Overall Study||60
1740439|NCT00113360|4263631|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
1740440|NCT00113334|4263635|P1|NOT COMPLETED|Overall Study||0
1740441|NCT00113334|4263635|P1|COMPLETED|Overall Study||6
1740442|NCT00113334|4263635|P1|STARTED|Overall Study||6
1740443|NCT00113321|4263639|P1|NOT COMPLETED|Overall Study||0
1740444|NCT00113321|4263639|P1|COMPLETED|Overall Study||16
1740445|NCT00113321|4263639|P1|STARTED|Overall Study||16
1740446|NCT00113295|4263645|P2|NOT COMPLETED|Overall Study||1
1740447|NCT00113295|4263646|P1|NOT COMPLETED|Overall Study||5
1740448|NCT00113295|4263645|P2|COMPLETED|Overall Study||10
1740449|NCT00113295|4263646|P1|COMPLETED|Overall Study||6
1740450|NCT00113295|4263645|P2|STARTED|Overall Study||11
1740451|NCT00113295|4263646|P1|STARTED|Overall Study||11
1740452|NCT00113269|4263665|P4|NOT COMPLETED|Overall Study||40
1740453|NCT00113269|4263666|P3|NOT COMPLETED|Overall Study||41
1740454|NCT00113269|4263667|P2|NOT COMPLETED|Overall Study||22
1740455|NCT00113269|4263668|P1|NOT COMPLETED|Overall Study||25
1740456|NCT00113269|4263665|P4|COMPLETED|Overall Study||140
1740457|NCT00113269|4263666|P3|COMPLETED|Overall Study||134
1740458|NCT00113269|4263667|P2|COMPLETED|Overall Study||48
1740459|NCT00113269|4263668|P1|COMPLETED|Overall Study||51
1740460|NCT00113269|4263665|P4|Received Treatment|Overall Study||171
1740461|NCT00113269|4263666|P3|Received Treatment|Overall Study||164
1740462|NCT00113269|4263667|P2|Received Treatment|Overall Study||69
1740463|NCT00113269|4263668|P1|Received Treatment|Overall Study||70
1740464|NCT00113269|4263665|P4|STARTED|Overall Study||180
1740465|NCT00113269|4263666|P3|STARTED|Overall Study||175
1740466|NCT00113269|4263667|P2|STARTED|Overall Study||70
1740467|NCT00113269|4263668|P1|STARTED|Overall Study||76
1740468|NCT00113230|4263718|P1|NOT COMPLETED|Overall Study||0
1740469|NCT00113230|4263718|P1|COMPLETED|Overall Study||25
1740470|NCT00113230|4263718|P1|STARTED|Overall Study||25
1740471|NCT00113217|4263722|P1|NOT COMPLETED|Overall Study||0
1740472|NCT00113217|4263722|P1|COMPLETED|Overall Study||50
1740473|NCT00113217|4263722|P1|STARTED|Overall Study||50
1740474|NCT00113087|4263728|P2|NOT COMPLETED|Overall Study||21
1740475|NCT00113087|4263729|P1|NOT COMPLETED|Overall Study||24
1740476|NCT00113087|4263728|P2|COMPLETED|Overall Study||94
1740477|NCT00113087|4263729|P1|COMPLETED|Overall Study||91
1740478|NCT00113087|4263728|P2|STARTED|Overall Study||115
1740479|NCT00113087|4263729|P1|STARTED|Overall Study||115
1740480|NCT00113022|4263793|P2|NOT COMPLETED|Overall Study||2
1740481|NCT00113022|4263794|P1|NOT COMPLETED|Overall Study||3
1740482|NCT00113022|4263793|P2|COMPLETED|Overall Study||2
1740483|NCT00113022|4263794|P1|COMPLETED|Overall Study||2
1740484|NCT00113022|4263793|P2|STARTED|Overall Study||4
1740485|NCT00113022|4263794|P1|STARTED|Overall Study||5
1740486|NCT00112957|4263800|P1|NOT COMPLETED|Overall Study||19
1740487|NCT00112957|4263800|P1|COMPLETED|Overall Study||4
1740488|NCT00112957|4263800|P1|STARTED|Overall Study||23
1740489|NCT00112918|4263815|P3|NOT COMPLETED|Overall Study||299
1740490|NCT00112918|4263816|P2|NOT COMPLETED|Overall Study||345
1740491|NCT00112918|4263817|P1|NOT COMPLETED|Overall Study||297
1740492|NCT00112918|4263815|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
1740493|NCT00112918|4263816|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
1740494|NCT00112918|4263817|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
1740495|NCT00112918|4263815|P3|Stage III Disease Population|Overall Study||952
1740496|NCT00112918|4263816|P2|Stage III Disease Population|Overall Study||960
1740497|NCT00112918|4263817|P1|Stage III Disease Population|Overall Study||955
1740498|NCT00112918|4263815|P3|Received Treatment|Overall Study||1135
1740499|NCT00112918|4263816|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
1740500|NCT00112918|4263817|P1|Received Treatment|Overall Study||1126
1740501|NCT00112918|4263815|P3|STARTED|Overall Study||1145
1740502|NCT00112918|4263816|P2|STARTED|Overall Study||1155
1740503|NCT00112918|4263817|P1|STARTED|Overall Study||1151
1740504|NCT00112905|4263840|P1|NOT COMPLETED|Overall Study||12
1740505|NCT00112905|4263840|P1|COMPLETED|Overall Study||15
1740506|NCT00112905|4263840|P1|Eligible and Treated|Overall Study||22
1740507|NCT00112905|4263840|P1|STARTED|Overall Study||27
1740508|NCT00112866|4263849|P2|NOT COMPLETED|Overall Study||2
1740509|NCT00112866|4263850|P1|NOT COMPLETED|Overall Study||2
1740510|NCT00112866|4263849|P2|COMPLETED|Overall Study||13
1740511|NCT00112866|4263850|P1|COMPLETED|Overall Study||13
1740512|NCT00112866|4263849|P2|STARTED|Overall Study||15
1740513|NCT00112866|4263850|P1|STARTED|Overall Study||15
1740514|NCT00112840|4263872|P3|NOT COMPLETED|Overall Study||6
1740515|NCT00112840|4263873|P2|NOT COMPLETED|Overall Study||0
1740516|NCT00112840|4263874|P1|NOT COMPLETED|Overall Study||2
1740517|NCT00112840|4263872|P3|COMPLETED|Overall Study||40
1740518|NCT00112840|4263873|P2|COMPLETED|Overall Study||6
1740519|NCT00112840|4263874|P1|COMPLETED|Overall Study||6
1740520|NCT00112840|4263872|P3|STARTED|Overall Study||46
1740521|NCT00112840|4263873|P2|STARTED|Overall Study||6
1740522|NCT00112840|4263874|P1|STARTED|Overall Study||8
1740523|NCT00112736|4263893|P2|NOT COMPLETED|Overall Study||0
1740524|NCT00112736|4263894|P1|NOT COMPLETED|Overall Study||1
1740525|NCT00112736|4263893|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
1740526|NCT00112736|4263894|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
1740527|NCT00112736|4263893|P2|STARTED|Overall Study||47
1740528|NCT00112736|4263894|P1|STARTED|Overall Study||22
1740529|NCT00112723|4263907|P3|NOT COMPLETED|Overall Study||2
1740530|NCT00112723|4263908|P2|NOT COMPLETED|Overall Study||7
1740531|NCT00112723|4263909|P1|NOT COMPLETED|Overall Study||2
1740532|NCT00112723|4263907|P3|COMPLETED|Overall Study||12
1740533|NCT00112723|4263908|P2|COMPLETED|Overall Study||12
1740534|NCT00112723|4263909|P1|COMPLETED|Overall Study||11
1740535|NCT00112723|4263907|P3|Patients Evaluable for Toxicity|Overall Study||12
1740536|NCT00112723|4263908|P2|Patients Evaluable for Toxicity|Overall Study||12
1740537|NCT00112723|4263909|P1|Patients Evaluable for Toxicity|Overall Study||11
1740538|NCT00112723|4263907|P3|STARTED|Overall Study||14
1740539|NCT00112723|4263908|P2|STARTED|Overall Study||19
1740540|NCT00112723|4263909|P1|STARTED|Overall Study||13
1740541|NCT00112671|4263934|P1|NOT COMPLETED|Overall Study||0
1740542|NCT00112671|4263934|P1|COMPLETED|Overall Study||17
1740543|NCT00112671|4263934|P1|STARTED|Overall Study||17
1740544|NCT00112593|4263942|P1|NOT COMPLETED|Overall Study||0
1740545|NCT00112593|4263942|P1|COMPLETED|Overall Study||5
1740546|NCT00112593|4263942|P1|STARTED|Overall Study||5
1740547|NCT00112489|4263951|P1|NOT COMPLETED|Overall Study||40
1740548|NCT00112489|4263951|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
1740549|NCT00112489|4263951|P1|STARTED|Overall Study|All patients enrolled on study|55
1740550|NCT00112463|4263961|P1|NOT COMPLETED|Overall Study||39
1740551|NCT00112463|4263961|P1|COMPLETED|Overall Study||1
1740552|NCT00112463|4263961|P1|STARTED|Overall Study||40
1740553|NCT00112437|4263973|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
1740554|NCT00112437|4263974|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
1740555|NCT00112437|4263975|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
1740556|NCT00112437|4263976|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
1740557|NCT00112437|4263977|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740558|NCT00112437|4263978|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740559|NCT00112437|4263979|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740560|NCT00112437|4263980|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740561|NCT00112437|4263981|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740562|NCT00112437|4263982|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740563|NCT00112437|4263983|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740564|NCT00112437|4263984|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740565|NCT00112437|4263985|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740566|NCT00112437|4263986|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740567|NCT00112437|4263987|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740568|NCT00112437|4263988|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740569|NCT00112437|4263989|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740570|NCT00112437|4263990|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740571|NCT00112437|4263991|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740572|NCT00112437|4263992|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740573|NCT00112437|4263993|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740574|NCT00112437|4263994|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740575|NCT00112437|4263995|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740576|NCT00112437|4263996|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740577|NCT00112437|4263997|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740578|NCT00112437|4263998|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
1740579|NCT00112437|4263973|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
1740580|NCT00112437|4263974|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
1740581|NCT00112437|4263975|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
1740582|NCT00112437|4263976|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
1740583|NCT00112437|4263977|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
1740584|NCT00112437|4263978|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
1740585|NCT00112437|4263979|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
1740586|NCT00112437|4263980|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
1740587|NCT00112437|4263981|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
1740588|NCT00112437|4263982|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
1740589|NCT00112437|4263983|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
1740590|NCT00112437|4263984|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
1740591|NCT00112437|4263985|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
1740592|NCT00112437|4263986|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
1740593|NCT00112437|4263987|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
1740594|NCT00112437|4263988|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
1740595|NCT00112437|4263989|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
1740596|NCT00112437|4263990|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
1740597|NCT00112437|4263991|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
1740598|NCT00112437|4263992|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
1740599|NCT00112437|4263993|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
1740600|NCT00112437|4263994|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
1740601|NCT00112437|4263995|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
1740602|NCT00112437|4263996|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
1740603|NCT00112437|4263997|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
1740604|NCT00112437|4263998|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
1740605|NCT00112437|4263973|P26|STARTED|Years 6-10 (60-Month Extension)||32
1740606|NCT00112437|4263974|P25|STARTED|Years 6-10 (60-Month Extension)||23
1740607|NCT00112437|4263975|P24|STARTED|Years 6-10 (60-Month Extension)||34
1740608|NCT00112437|4263976|P23|STARTED|Years 6-10 (60-Month Extension)||28
1740609|NCT00112437|4263977|P22|STARTED|Years 6-10 (60-Month Extension)||0
1740610|NCT00112437|4263978|P21|STARTED|Years 6-10 (60-Month Extension)||0
1740611|NCT00112437|4263979|P20|STARTED|Years 6-10 (60-Month Extension)||0
1740612|NCT00112437|4263980|P19|STARTED|Years 6-10 (60-Month Extension)||0
1740613|NCT00112437|4263981|P18|STARTED|Years 6-10 (60-Month Extension)||0
1740614|NCT00112437|4263982|P17|STARTED|Years 6-10 (60-Month Extension)||0
1740615|NCT00112437|4263983|P16|STARTED|Years 6-10 (60-Month Extension)||0
1740616|NCT00112437|4263984|P15|STARTED|Years 6-10 (60-Month Extension)||0
1740617|NCT00112437|4263985|P14|STARTED|Years 6-10 (60-Month Extension)||0
1740618|NCT00112437|4263986|P13|STARTED|Years 6-10 (60-Month Extension)||0
1740619|NCT00112437|4263987|P12|STARTED|Years 6-10 (60-Month Extension)||0
1740620|NCT00112437|4263988|P11|STARTED|Years 6-10 (60-Month Extension)||0
1740621|NCT00112437|4263989|P10|STARTED|Years 6-10 (60-Month Extension)||0
1740622|NCT00112437|4263990|P9|STARTED|Years 6-10 (60-Month Extension)||0
1740623|NCT00112437|4263991|P8|STARTED|Years 6-10 (60-Month Extension)||0
1740624|NCT00112437|4263992|P7|STARTED|Years 6-10 (60-Month Extension)||0
1740625|NCT00112437|4263993|P6|STARTED|Years 6-10 (60-Month Extension)||0
1740626|NCT00112437|4263994|P5|STARTED|Years 6-10 (60-Month Extension)||0
1740627|NCT00112437|4263995|P4|STARTED|Years 6-10 (60-Month Extension)||0
1740628|NCT00112437|4263996|P3|STARTED|Years 6-10 (60-Month Extension)||0
1740629|NCT00112437|4263997|P2|STARTED|Years 6-10 (60-Month Extension)||0
1740630|NCT00112437|4263998|P1|STARTED|Years 6-10 (60-Month Extension)||0
1740631|NCT00112437|4263973|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740632|NCT00112437|4263974|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740633|NCT00112437|4263975|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740634|NCT00112437|4263976|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740635|NCT00112437|4263977|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
1740636|NCT00112437|4263978|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
1740637|NCT00112437|4263979|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740638|NCT00112437|4263980|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740639|NCT00112437|4263981|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740640|NCT00112437|4263982|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740641|NCT00112437|4263983|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740642|NCT00112437|4263984|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740643|NCT00112437|4263985|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740644|NCT00112437|4263986|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740645|NCT00112437|4263987|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740646|NCT00112437|4263988|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740647|NCT00112437|4263989|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740648|NCT00112437|4263990|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740649|NCT00112437|4263991|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740650|NCT00112437|4263992|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740651|NCT00112437|4263993|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740652|NCT00112437|4263994|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740653|NCT00112437|4263995|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740654|NCT00112437|4263996|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740655|NCT00112437|4263997|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740656|NCT00112437|4263998|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
1740657|NCT00112437|4263973|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
1740658|NCT00112437|4263974|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
1740659|NCT00112437|4263975|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
1740660|NCT00112437|4263976|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
1740661|NCT00112437|4263977|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
1740662|NCT00112437|4263978|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
1740663|NCT00112437|4263979|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
1740664|NCT00112437|4263980|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
1740665|NCT00112437|4263981|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
1740666|NCT00112437|4263982|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
1740667|NCT00112437|4263983|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
1740668|NCT00112437|4263984|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
1740669|NCT00112437|4263985|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
1740670|NCT00112437|4263986|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
1740671|NCT00112437|4263987|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
1740672|NCT00112437|4263988|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
1740673|NCT00112437|4263989|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
1740674|NCT00112437|4263990|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
1740675|NCT00112437|4263991|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
1740676|NCT00112437|4263992|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
1740677|NCT00112437|4263993|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
1740678|NCT00112437|4263994|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
1740679|NCT00112437|4263995|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
1740680|NCT00112437|4263996|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
1740681|NCT00112437|4263997|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
1740682|NCT00112437|4263998|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
1740683|NCT00112437|4263973|P26|STARTED|Years 4-5 (24-Month Extension)||0
1740684|NCT00112437|4263974|P25|STARTED|Years 4-5 (24-Month Extension)||0
1740685|NCT00112437|4263975|P24|STARTED|Years 4-5 (24-Month Extension)||0
1740686|NCT00112437|4263976|P23|STARTED|Years 4-5 (24-Month Extension)||0
1740687|NCT00112437|4263977|P22|STARTED|Years 4-5 (24-Month Extension)||100
1740688|NCT00112437|4263978|P21|STARTED|Years 4-5 (24-Month Extension)||41
1740689|NCT00112437|4263979|P20|STARTED|Years 4-5 (24-Month Extension)||0
1740690|NCT00112437|4263980|P19|STARTED|Years 4-5 (24-Month Extension)||0
1740691|NCT00112437|4263981|P18|STARTED|Years 4-5 (24-Month Extension)||0
1740692|NCT00112437|4263982|P17|STARTED|Years 4-5 (24-Month Extension)||0
1740693|NCT00112437|4263983|P16|STARTED|Years 4-5 (24-Month Extension)||0
1740694|NCT00112437|4263984|P15|STARTED|Years 4-5 (24-Month Extension)||0
1740695|NCT00112437|4263985|P14|STARTED|Years 4-5 (24-Month Extension)||0
1740696|NCT00112437|4263986|P13|STARTED|Years 4-5 (24-Month Extension)||0
1740697|NCT00112437|4263987|P12|STARTED|Years 4-5 (24-Month Extension)||0
1740698|NCT00112437|4263988|P11|STARTED|Years 4-5 (24-Month Extension)||0
1740699|NCT00112437|4263989|P10|STARTED|Years 4-5 (24-Month Extension)||0
1740700|NCT00112437|4263990|P9|STARTED|Years 4-5 (24-Month Extension)||0
1740701|NCT00112437|4263991|P8|STARTED|Years 4-5 (24-Month Extension)||0
1740702|NCT00112437|4263992|P7|STARTED|Years 4-5 (24-Month Extension)||0
1740703|NCT00112437|4263993|P6|STARTED|Years 4-5 (24-Month Extension)||0
1740704|NCT00112437|4263994|P5|STARTED|Years 4-5 (24-Month Extension)||0
1740705|NCT00112437|4263995|P4|STARTED|Years 4-5 (24-Month Extension)||0
1740706|NCT00112437|4263996|P3|STARTED|Years 4-5 (24-Month Extension)||0
1740707|NCT00112437|4263997|P2|STARTED|Years 4-5 (24-Month Extension)||0
1740708|NCT00112437|4263998|P1|STARTED|Years 4-5 (24-Month Extension)||0
1740709|NCT00112437|4263973|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740710|NCT00112437|4263974|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740711|NCT00112437|4263975|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740712|NCT00112437|4263976|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740713|NCT00112437|4263977|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740714|NCT00112437|4263978|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740715|NCT00112437|4263979|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
1740716|NCT00112437|4263980|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
1740717|NCT00112437|4263981|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
1740718|NCT00112437|4263982|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
1740719|NCT00112437|4263983|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
1740720|NCT00112437|4263984|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
1740721|NCT00112437|4263985|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
1740722|NCT00112437|4263986|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740723|NCT00112437|4263987|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
1740724|NCT00112437|4263988|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
1740725|NCT00112437|4263989|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740726|NCT00112437|4263990|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740727|NCT00112437|4263991|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740728|NCT00112437|4263992|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740729|NCT00112437|4263993|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740730|NCT00112437|4263994|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740731|NCT00112437|4263995|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740732|NCT00112437|4263996|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740733|NCT00112437|4263997|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740734|NCT00112437|4263998|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
1740735|NCT00112437|4263973|P26|COMPLETED|Year 3 (12-Month Extension)||0
1740736|NCT00112437|4263974|P25|COMPLETED|Year 3 (12-Month Extension)||0
1740737|NCT00112437|4263975|P24|COMPLETED|Year 3 (12-Month Extension)||0
1740738|NCT00112437|4263976|P23|COMPLETED|Year 3 (12-Month Extension)||0
1740739|NCT00112437|4263977|P22|COMPLETED|Year 3 (12-Month Extension)||0
1740740|NCT00112437|4263978|P21|COMPLETED|Year 3 (12-Month Extension)||0
1740741|NCT00112437|4263979|P20|COMPLETED|Year 3 (12-Month Extension)||19
1740742|NCT00112437|4263980|P19|COMPLETED|Year 3 (12-Month Extension)||16
1740743|NCT00112437|4263981|P18|COMPLETED|Year 3 (12-Month Extension)||20
1740744|NCT00112437|4263982|P17|COMPLETED|Year 3 (12-Month Extension)||16
1740745|NCT00112437|4263983|P16|COMPLETED|Year 3 (12-Month Extension)||13
1740746|NCT00112437|4263984|P15|COMPLETED|Year 3 (12-Month Extension)||17
1740747|NCT00112437|4263985|P14|COMPLETED|Year 3 (12-Month Extension)||16
1740748|NCT00112437|4263986|P13|COMPLETED|Year 3 (12-Month Extension)||18
1740749|NCT00112437|4263987|P12|COMPLETED|Year 3 (12-Month Extension)||17
1740750|NCT00112437|4263988|P11|COMPLETED|Year 3 (12-Month Extension)||17
1740751|NCT00112437|4263989|P10|COMPLETED|Year 3 (12-Month Extension)||0
1740752|NCT00112437|4263990|P9|COMPLETED|Year 3 (12-Month Extension)||0
1740753|NCT00112437|4263991|P8|COMPLETED|Year 3 (12-Month Extension)||0
1740754|NCT00112437|4263992|P7|COMPLETED|Year 3 (12-Month Extension)||0
1740755|NCT00112437|4263993|P6|COMPLETED|Year 3 (12-Month Extension)||0
1740756|NCT00112437|4263994|P5|COMPLETED|Year 3 (12-Month Extension)||0
1740757|NCT00112437|4263995|P4|COMPLETED|Year 3 (12-Month Extension)||0
1740758|NCT00112437|4263996|P3|COMPLETED|Year 3 (12-Month Extension)||0
1740759|NCT00112437|4263997|P2|COMPLETED|Year 3 (12-Month Extension)||0
1740760|NCT00112437|4263998|P1|COMPLETED|Year 3 (12-Month Extension)||0
1740761|NCT00112437|4263973|P26|STARTED|Year 3 (12-Month Extension)||0
1740762|NCT00112437|4263974|P25|STARTED|Year 3 (12-Month Extension)||0
1740763|NCT00112437|4263975|P24|STARTED|Year 3 (12-Month Extension)||0
1740764|NCT00112437|4263976|P23|STARTED|Year 3 (12-Month Extension)||0
1740765|NCT00112437|4263977|P22|STARTED|Year 3 (12-Month Extension)||0
1740766|NCT00112437|4263978|P21|STARTED|Year 3 (12-Month Extension)||0
1740767|NCT00112437|4263979|P20|STARTED|Year 3 (12-Month Extension)||20
1740768|NCT00112437|4263980|P19|STARTED|Year 3 (12-Month Extension)||18
1740769|NCT00112437|4263981|P18|STARTED|Year 3 (12-Month Extension)||21
1740770|NCT00112437|4263982|P17|STARTED|Year 3 (12-Month Extension)||19
1740771|NCT00112437|4263983|P16|STARTED|Year 3 (12-Month Extension)||17
1740772|NCT00112437|4263984|P15|STARTED|Year 3 (12-Month Extension)||18
1740773|NCT00112437|4263985|P14|STARTED|Year 3 (12-Month Extension)||17
1740774|NCT00112437|4263986|P13|STARTED|Year 3 (12-Month Extension)||18
1740775|NCT00112437|4263987|P12|STARTED|Year 3 (12-Month Extension)||22
1740776|NCT00112437|4263988|P11|STARTED|Year 3 (12-Month Extension)||19
1740777|NCT00112437|4263989|P10|STARTED|Year 3 (12-Month Extension)||0
1740778|NCT00112437|4263990|P9|STARTED|Year 3 (12-Month Extension)||0
1740779|NCT00112437|4263991|P8|STARTED|Year 3 (12-Month Extension)||0
1740780|NCT00112437|4263992|P7|STARTED|Year 3 (12-Month Extension)||0
1740781|NCT00112437|4263993|P6|STARTED|Year 3 (12-Month Extension)||0
1740782|NCT00112437|4263994|P5|STARTED|Year 3 (12-Month Extension)||0
1740783|NCT00112437|4263995|P4|STARTED|Year 3 (12-Month Extension)||0
1740784|NCT00112437|4263996|P3|STARTED|Year 3 (12-Month Extension)||0
1740785|NCT00112437|4263997|P2|STARTED|Year 3 (12-Month Extension)||0
1740786|NCT00112437|4263998|P1|STARTED|Year 3 (12-Month Extension)||0
1740787|NCT00112437|4263973|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740788|NCT00112437|4263974|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740789|NCT00112437|4263975|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740790|NCT00112437|4263976|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740791|NCT00112437|4263977|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740792|NCT00112437|4263978|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740793|NCT00112437|4263979|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740794|NCT00112437|4263980|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740795|NCT00112437|4263981|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740796|NCT00112437|4263982|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740797|NCT00112437|4263983|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740798|NCT00112437|4263984|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740799|NCT00112437|4263985|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740800|NCT00112437|4263986|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740801|NCT00112437|4263987|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740802|NCT00112437|4263988|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740803|NCT00112437|4263989|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
1740804|NCT00112437|4263990|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
1740805|NCT00112437|4263991|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
1740806|NCT00112437|4263992|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
1740807|NCT00112437|4263993|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
1740808|NCT00112437|4263994|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740809|NCT00112437|4263995|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740810|NCT00112437|4263996|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740811|NCT00112437|4263997|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740812|NCT00112437|4263998|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
1740813|NCT00112437|4263973|P26|COMPLETED|Year 2 (12-Month Extension)||0
1740814|NCT00112437|4263974|P25|COMPLETED|Year 2 (12-Month Extension)||0
1740815|NCT00112437|4263975|P24|COMPLETED|Year 2 (12-Month Extension)||0
1740816|NCT00112437|4263976|P23|COMPLETED|Year 2 (12-Month Extension)||0
1740817|NCT00112437|4263977|P22|COMPLETED|Year 2 (12-Month Extension)||0
1740818|NCT00112437|4263978|P21|COMPLETED|Year 2 (12-Month Extension)||0
1740819|NCT00112437|4263979|P20|COMPLETED|Year 2 (12-Month Extension)||0
1740820|NCT00112437|4263980|P19|COMPLETED|Year 2 (12-Month Extension)||0
1740821|NCT00112437|4263981|P18|COMPLETED|Year 2 (12-Month Extension)||0
1740822|NCT00112437|4263982|P17|COMPLETED|Year 2 (12-Month Extension)||0
1740823|NCT00112437|4263983|P16|COMPLETED|Year 2 (12-Month Extension)||0
1740824|NCT00112437|4263984|P15|COMPLETED|Year 2 (12-Month Extension)||0
1740825|NCT00112437|4263985|P14|COMPLETED|Year 2 (12-Month Extension)||0
1740826|NCT00112437|4263986|P13|COMPLETED|Year 2 (12-Month Extension)||0
1740827|NCT00112437|4263987|P12|COMPLETED|Year 2 (12-Month Extension)||0
1740828|NCT00112437|4263988|P11|COMPLETED|Year 2 (12-Month Extension)||0
1740829|NCT00112437|4263989|P10|COMPLETED|Year 2 (12-Month Extension)||50
1740830|NCT00112437|4263990|P9|COMPLETED|Year 2 (12-Month Extension)||62
1740831|NCT00112437|4263991|P8|COMPLETED|Year 2 (12-Month Extension)||55
1740832|NCT00112437|4263992|P7|COMPLETED|Year 2 (12-Month Extension)||53
1740833|NCT00112437|4263993|P6|COMPLETED|Year 2 (12-Month Extension)||60
1740834|NCT00112437|4263994|P5|COMPLETED|Year 2 (12-Month Extension)||0
1740835|NCT00112437|4263995|P4|COMPLETED|Year 2 (12-Month Extension)||0
1740836|NCT00112437|4263996|P3|COMPLETED|Year 2 (12-Month Extension)||0
1740837|NCT00112437|4263997|P2|COMPLETED|Year 2 (12-Month Extension)||0
1740838|NCT00112437|4263998|P1|COMPLETED|Year 2 (12-Month Extension)||0
1740839|NCT00112437|4263973|P26|STARTED|Year 2 (12-Month Extension)||0
1740840|NCT00112437|4263974|P25|STARTED|Year 2 (12-Month Extension)||0
1740841|NCT00112437|4263975|P24|STARTED|Year 2 (12-Month Extension)||0
1740842|NCT00112437|4263976|P23|STARTED|Year 2 (12-Month Extension)||0
1740843|NCT00112437|4263977|P22|STARTED|Year 2 (12-Month Extension)||0
1740844|NCT00112437|4263978|P21|STARTED|Year 2 (12-Month Extension)||0
1740845|NCT00112437|4263979|P20|STARTED|Year 2 (12-Month Extension)||0
1740846|NCT00112437|4263980|P19|STARTED|Year 2 (12-Month Extension)||0
1740847|NCT00112437|4263981|P18|STARTED|Year 2 (12-Month Extension)||0
1740848|NCT00112437|4263982|P17|STARTED|Year 2 (12-Month Extension)||0
1740849|NCT00112437|4263983|P16|STARTED|Year 2 (12-Month Extension)||0
1740850|NCT00112437|4263984|P15|STARTED|Year 2 (12-Month Extension)||0
1740851|NCT00112437|4263985|P14|STARTED|Year 2 (12-Month Extension)||0
1740852|NCT00112437|4263986|P13|STARTED|Year 2 (12-Month Extension)||0
1740853|NCT00112437|4263987|P12|STARTED|Year 2 (12-Month Extension)||0
1740854|NCT00112437|4263988|P11|STARTED|Year 2 (12-Month Extension)||0
1740855|NCT00112437|4263989|P10|STARTED|Year 2 (12-Month Extension)||63
1740856|NCT00112437|4263990|P9|STARTED|Year 2 (12-Month Extension)||69
1740857|NCT00112437|4263991|P8|STARTED|Year 2 (12-Month Extension)||63
1740858|NCT00112437|4263992|P7|STARTED|Year 2 (12-Month Extension)||62
1740859|NCT00112437|4263993|P6|STARTED|Year 2 (12-Month Extension)||63
1740860|NCT00112437|4263994|P5|STARTED|Year 2 (12-Month Extension)||0
1740861|NCT00112437|4263995|P4|STARTED|Year 2 (12-Month Extension)||0
1740862|NCT00112437|4263996|P3|STARTED|Year 2 (12-Month Extension)||0
1740863|NCT00112437|4263997|P2|STARTED|Year 2 (12-Month Extension)||0
1740864|NCT00112437|4263998|P1|STARTED|Year 2 (12-Month Extension)||0
1740865|NCT00112437|4263973|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740866|NCT00112437|4263974|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740867|NCT00112437|4263975|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740868|NCT00112437|4263976|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740869|NCT00112437|4263977|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740870|NCT00112437|4263978|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740871|NCT00112437|4263979|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740872|NCT00112437|4263980|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740873|NCT00112437|4263981|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740874|NCT00112437|4263982|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740875|NCT00112437|4263983|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740876|NCT00112437|4263984|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740877|NCT00112437|4263985|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740878|NCT00112437|4263986|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740879|NCT00112437|4263987|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740880|NCT00112437|4263988|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740881|NCT00112437|4263989|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740882|NCT00112437|4263990|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740883|NCT00112437|4263991|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740884|NCT00112437|4263992|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740885|NCT00112437|4263993|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
1740886|NCT00112437|4263994|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
1740887|NCT00112437|4263995|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
1740888|NCT00112437|4263996|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
1740889|NCT00112437|4263997|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
1740890|NCT00112437|4263998|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
1740891|NCT00112437|4263973|P26|COMPLETED|Year 1 (12-Month Base Study)||0
1740892|NCT00112437|4263974|P25|COMPLETED|Year 1 (12-Month Base Study)||0
1740893|NCT00112437|4263975|P24|COMPLETED|Year 1 (12-Month Base Study)||0
1740894|NCT00112437|4263976|P23|COMPLETED|Year 1 (12-Month Base Study)||0
1740895|NCT00112437|4263977|P22|COMPLETED|Year 1 (12-Month Base Study)||0
1740896|NCT00112437|4263978|P21|COMPLETED|Year 1 (12-Month Base Study)||0
1740897|NCT00112437|4263979|P20|COMPLETED|Year 1 (12-Month Base Study)||0
1740898|NCT00112437|4263980|P19|COMPLETED|Year 1 (12-Month Base Study)||0
1740899|NCT00112437|4263981|P18|COMPLETED|Year 1 (12-Month Base Study)||0
1740900|NCT00112437|4263982|P17|COMPLETED|Year 1 (12-Month Base Study)||0
1740901|NCT00112437|4263983|P16|COMPLETED|Year 1 (12-Month Base Study)||0
1740902|NCT00112437|4263984|P15|COMPLETED|Year 1 (12-Month Base Study)||0
1740903|NCT00112437|4263985|P14|COMPLETED|Year 1 (12-Month Base Study)||0
1740904|NCT00112437|4263986|P13|COMPLETED|Year 1 (12-Month Base Study)||0
1740905|NCT00112437|4263987|P12|COMPLETED|Year 1 (12-Month Base Study)||0
1740906|NCT00112437|4263988|P11|COMPLETED|Year 1 (12-Month Base Study)||0
1740907|NCT00112437|4263989|P10|COMPLETED|Year 1 (12-Month Base Study)||0
1740908|NCT00112437|4263990|P9|COMPLETED|Year 1 (12-Month Base Study)||0
1740909|NCT00112437|4263991|P8|COMPLETED|Year 1 (12-Month Base Study)||0
1740910|NCT00112437|4263992|P7|COMPLETED|Year 1 (12-Month Base Study)||0
1740911|NCT00112437|4263993|P6|COMPLETED|Year 1 (12-Month Base Study)||0
1740912|NCT00112437|4263994|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
1740913|NCT00112437|4263995|P4|COMPLETED|Year 1 (12-Month Base Study)||71
1740914|NCT00112437|4263996|P3|COMPLETED|Year 1 (12-Month Base Study)||65
1740915|NCT00112437|4263997|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
1740916|NCT00112437|4263998|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
1740917|NCT00112437|4263973|P26|STARTED|Year 1 (12-Month Base Study)||0
1740918|NCT00112437|4263974|P25|STARTED|Year 1 (12-Month Base Study)||0
1740919|NCT00112437|4263975|P24|STARTED|Year 1 (12-Month Base Study)||0
1740920|NCT00112437|4263976|P23|STARTED|Year 1 (12-Month Base Study)||0
1740921|NCT00112437|4263977|P22|STARTED|Year 1 (12-Month Base Study)||0
1740922|NCT00112437|4263978|P21|STARTED|Year 1 (12-Month Base Study)||0
1740923|NCT00112437|4263979|P20|STARTED|Year 1 (12-Month Base Study)||0
1740924|NCT00112437|4263980|P19|STARTED|Year 1 (12-Month Base Study)||0
1740925|NCT00112437|4263981|P18|STARTED|Year 1 (12-Month Base Study)||0
1740926|NCT00112437|4263982|P17|STARTED|Year 1 (12-Month Base Study)||0
1740927|NCT00112437|4263983|P16|STARTED|Year 1 (12-Month Base Study)||0
1740928|NCT00112437|4263984|P15|STARTED|Year 1 (12-Month Base Study)||0
1740929|NCT00112437|4263985|P14|STARTED|Year 1 (12-Month Base Study)||0
1740930|NCT00112437|4263986|P13|STARTED|Year 1 (12-Month Base Study)||0
1740931|NCT00112437|4263987|P12|STARTED|Year 1 (12-Month Base Study)||0
1740932|NCT00112437|4263988|P11|STARTED|Year 1 (12-Month Base Study)||0
1740933|NCT00112437|4263989|P10|STARTED|Year 1 (12-Month Base Study)||0
1740934|NCT00112437|4263990|P9|STARTED|Year 1 (12-Month Base Study)||0
1740935|NCT00112437|4263991|P8|STARTED|Year 1 (12-Month Base Study)||0
1740936|NCT00112437|4263992|P7|STARTED|Year 1 (12-Month Base Study)||0
1740937|NCT00112437|4263993|P6|STARTED|Year 1 (12-Month Base Study)||0
1740938|NCT00112437|4263994|P5|STARTED|Year 1 (12-Month Base Study)||78
1740939|NCT00112437|4263995|P4|STARTED|Year 1 (12-Month Base Study)||79
1740940|NCT00112437|4263996|P3|STARTED|Year 1 (12-Month Base Study)||77
1740941|NCT00112437|4263997|P2|STARTED|Year 1 (12-Month Base Study)||82
1740942|NCT00112437|4263998|P1|STARTED|Year 1 (12-Month Base Study)||83
1740943|NCT00112385|4264278|P2|NOT COMPLETED|Overall Study||1
1740944|NCT00112385|4264279|P1|NOT COMPLETED|Overall Study||1
1740945|NCT00112385|4264278|P2|COMPLETED|Overall Study||4
1740946|NCT00112385|4264279|P1|COMPLETED|Overall Study||10
1740947|NCT00112385|4264278|P2|STARTED|Overall Study||5
1740948|NCT00112385|4264279|P1|STARTED|Overall Study||11
1740949|NCT00112359|4264369|P2|NOT COMPLETED|Overall Study||13
1740950|NCT00112359|4264370|P1|NOT COMPLETED|Overall Study||27
1740951|NCT00112359|4264369|P2|COMPLETED|Overall Study||67
1740952|NCT00112359|4264370|P1|COMPLETED|Overall Study||57
1740953|NCT00112359|4264369|P2|STARTED|Overall Study||80
1740954|NCT00112359|4264370|P1|STARTED|Overall Study||84
1740955|NCT00112294|4264396|P2|NOT COMPLETED|Overall Study||0
1740956|NCT00112294|4264397|P1|NOT COMPLETED|Overall Study||5
1740957|NCT00112294|4264396|P2|COMPLETED|Overall Study|Off all study therapies.|320
1740958|NCT00112294|4264397|P1|COMPLETED|Overall Study|Off all study therapies.|320
1740959|NCT00112294|4264396|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
1740960|NCT00112294|4264397|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
1740961|NCT00112294|4264396|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
1740962|NCT00112294|4264397|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
1740963|NCT00112151|4264441|P6|NOT COMPLETED|Overall Study||3
1740964|NCT00112151|4264442|P5|NOT COMPLETED|Overall Study||6
1740965|NCT00112151|4264443|P4|NOT COMPLETED|Overall Study||3
1740966|NCT00112151|4264444|P3|NOT COMPLETED|Overall Study||3
1740967|NCT00112151|4264445|P2|NOT COMPLETED|Overall Study||5
1740968|NCT00112151|4264446|P1|NOT COMPLETED|Overall Study||4
1740969|NCT00112151|4264441|P6|COMPLETED|Overall Study||25
1740970|NCT00112151|4264442|P5|COMPLETED|Overall Study||22
1740971|NCT00112151|4264443|P4|COMPLETED|Overall Study||24
1740972|NCT00112151|4264444|P3|COMPLETED|Overall Study||25
1740973|NCT00112151|4264445|P2|COMPLETED|Overall Study||23
1740974|NCT00112151|4264446|P1|COMPLETED|Overall Study||24
1740975|NCT00112151|4264441|P6|STARTED|Overall Study||28
1740976|NCT00112151|4264442|P5|STARTED|Overall Study||28
1740977|NCT00112151|4264443|P4|STARTED|Overall Study||27
1740978|NCT00112151|4264444|P3|STARTED|Overall Study||28
1740979|NCT00112151|4264445|P2|STARTED|Overall Study||28
1740980|NCT00112151|4264446|P1|STARTED|Overall Study||28
1740981|NCT00112112|4264477|P2|NOT COMPLETED|Overall Study||0
1740982|NCT00112112|4264478|P1|NOT COMPLETED|Overall Study||0
1740983|NCT00112112|4264477|P2|COMPLETED|Overall Study||10
1740984|NCT00112112|4264478|P1|COMPLETED|Overall Study||10
1740985|NCT00112112|4264477|P2|STARTED|Overall Study||10
1740986|NCT00112112|4264478|P1|STARTED|Overall Study||10
1740987|NCT00112047|4264620|P2|NOT COMPLETED|Atripla Phase||20
1740988|NCT00112047|4264621|P1|NOT COMPLETED|Atripla Phase||18
1740989|NCT00112047|4264620|P2|COMPLETED|Atripla Phase||106
1740990|NCT00112047|4264621|P1|COMPLETED|Atripla Phase||142
1740991|NCT00112047|4264620|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
1740992|NCT00112047|4264621|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
1740993|NCT00112047|4264620|P2|NOT COMPLETED|Randomized Phase||88
1740994|NCT00112047|4264621|P1|NOT COMPLETED|Randomized Phase||70
1740995|NCT00112047|4264620|P2|COMPLETED|Randomized Phase||166
1740996|NCT00112047|4264621|P1|COMPLETED|Randomized Phase||187
1740997|NCT00112047|4264620|P2|STARTED|Randomized Phase|ITT analysis population|254
1740998|NCT00112047|4264621|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
1740999|NCT00111917|4264721|P2|NOT COMPLETED|Overall Study||1
1741000|NCT00111917|4264722|P1|NOT COMPLETED|Overall Study||1
1741001|NCT00111917|4264721|P2|COMPLETED|Overall Study||3
1741002|NCT00111917|4264722|P1|COMPLETED|Overall Study||8
1741003|NCT00111917|4264721|P2|STARTED|Overall Study||4
1741004|NCT00111917|4264722|P1|STARTED|Overall Study||9
1741005|NCT00111839|4264737|P3|NOT COMPLETED|Overall Study||49
1741006|NCT00111839|4264738|P2|NOT COMPLETED|Overall Study||46
1741007|NCT00111839|4264739|P1|NOT COMPLETED|Overall Study||48
1741008|NCT00111839|4264737|P3|COMPLETED|Overall Study||0
1741009|NCT00111839|4264738|P2|COMPLETED|Overall Study||5
1741010|NCT00111839|4264739|P1|COMPLETED|Overall Study||2
1741011|NCT00111839|4264737|P3|Treated|Overall Study||47
1741012|NCT00111839|4264738|P2|Treated|Overall Study||51
1741013|NCT00111839|4264739|P1|Treated|Overall Study||50
1741014|NCT00111839|4264737|P3|STARTED|Overall Study||49
1741015|NCT00111839|4264738|P2|STARTED|Overall Study||51
1741016|NCT00111839|4264739|P1|STARTED|Overall Study||50
1741017|NCT00111813|4264759|P6|NOT COMPLETED|Overall Study||6
1741018|NCT00111813|4264760|P5|NOT COMPLETED|Overall Study||6
1741019|NCT00111813|4264761|P4|NOT COMPLETED|Overall Study||5
1741020|NCT00111813|4264762|P3|NOT COMPLETED|Overall Study||10
1741021|NCT00111813|4264763|P2|NOT COMPLETED|Overall Study||3
1741022|NCT00111813|4264764|P1|NOT COMPLETED|Overall Study||3
1741023|NCT00111813|4264759|P6|COMPLETED|Overall Study||0
1741024|NCT00111813|4264760|P5|COMPLETED|Overall Study||0
1741025|NCT00111813|4264761|P4|COMPLETED|Overall Study||1
1741026|NCT00111813|4264762|P3|COMPLETED|Overall Study||0
1741027|NCT00111813|4264763|P2|COMPLETED|Overall Study||0
1741028|NCT00111813|4264764|P1|COMPLETED|Overall Study||0
1741029|NCT00111813|4264759|P6|STARTED|Overall Study||6
1741030|NCT00111813|4264760|P5|STARTED|Overall Study||6
1741031|NCT00111813|4264761|P4|STARTED|Overall Study||6
1741032|NCT00111813|4264762|P3|STARTED|Overall Study||10
1741033|NCT00111813|4264763|P2|STARTED|Overall Study||3
1741034|NCT00111813|4264764|P1|STARTED|Overall Study||3
1741035|NCT00111800|4264803|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
1741036|NCT00111800|4264804|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
1741037|NCT00111800|4264805|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
1741038|NCT00111800|4264806|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
1741039|NCT00111800|4264807|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
1741040|NCT00111800|4264808|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
1741041|NCT00111800|4264803|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
1741042|NCT00111800|4264804|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
1741043|NCT00111800|4264805|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
1741044|NCT00111800|4264806|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
1741045|NCT00111800|4264807|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
1741046|NCT00111800|4264808|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
1741047|NCT00111800|4264803|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
1741048|NCT00111800|4264804|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
1741049|NCT00111800|4264805|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
1741050|NCT00111800|4264806|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
1741051|NCT00111800|4264807|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
1741052|NCT00111800|4264808|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
1741053|NCT00111800|4264803|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
1741054|NCT00111800|4264804|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
1741055|NCT00111800|4264805|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
1741056|NCT00111800|4264806|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
1741057|NCT00111800|4264807|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
1741058|NCT00111800|4264808|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
1741059|NCT00111800|4264803|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
1741060|NCT00111800|4264804|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
1741061|NCT00111800|4264805|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
1741062|NCT00111800|4264806|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
1741063|NCT00111800|4264807|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
1741064|NCT00111800|4264808|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
1741065|NCT00111800|4264803|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
1741066|NCT00111800|4264804|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
1741067|NCT00111800|4264805|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
1741068|NCT00111800|4264806|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
1741069|NCT00111800|4264807|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
1741070|NCT00111800|4264808|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
1741071|NCT00111761|4264978|P2|NOT COMPLETED|Part 2||0
1741072|NCT00111761|4264979|P1|NOT COMPLETED|Part 2||8
1741073|NCT00111761|4264978|P2|COMPLETED|Part 2||0
1741074|NCT00111761|4264979|P1|COMPLETED|Part 2||16
1741075|NCT00111761|4264978|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
1741076|NCT00111761|4264979|P1|STARTED|Part 2||24
1741077|NCT00111761|4264978|P2|NOT COMPLETED|Part 1||5
1741078|NCT00111761|4264979|P1|NOT COMPLETED|Part 1||0
1741079|NCT00111761|4264978|P2|COMPLETED|Part 1|Completed through safety followup|14
1741080|NCT00111761|4264979|P1|COMPLETED|Part 1||0
1741081|NCT00111761|4264978|P2|STARTED|Part 1||19
1741082|NCT00111761|4264979|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
1741083|NCT00111657|4264996|P1|NOT COMPLETED|Overall Study||16
1741084|NCT00111657|4264996|P1|COMPLETED|Overall Study|Completed all intended doses.|21
1741085|NCT00111657|4264996|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
1741086|NCT00111241|4265008|P2|NOT COMPLETED|Overall Study||8
1741087|NCT00111241|4265009|P1|NOT COMPLETED|Overall Study||15
1741088|NCT00111241|4265008|P2|COMPLETED|Overall Study||62
1741089|NCT00111241|4265009|P1|COMPLETED|Overall Study||30
1741090|NCT00111241|4265008|P2|STARTED|Overall Study||70
1741091|NCT00111241|4265009|P1|STARTED|Overall Study||45
1741092|NCT00111007|4265019|P2|NOT COMPLETED|Long Term Follow-up||45
1741093|NCT00111007|4265020|P1|NOT COMPLETED|Long Term Follow-up||47
1741094|NCT00111007|4265019|P2|COMPLETED|Long Term Follow-up||62
1741095|NCT00111007|4265020|P1|COMPLETED|Long Term Follow-up||54
1741096|NCT00111007|4265019|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
1741097|NCT00111007|4265020|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
1741098|NCT00111007|4265019|P2|NOT COMPLETED|Active Follow-up||2
1741099|NCT00111007|4265020|P1|NOT COMPLETED|Active Follow-up||6
1741100|NCT00111007|4265019|P2|COMPLETED|Active Follow-up||2
1741101|NCT00111007|4265020|P1|COMPLETED|Active Follow-up||0
1741102|NCT00111007|4265019|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
1741103|NCT00111007|4265020|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
1741104|NCT00111007|4265019|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
1741105|NCT00111007|4265020|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
1741106|NCT00111007|4265019|P2|COMPLETED|Double-blind (DB) Treatment||24
1741107|NCT00111007|4265020|P1|COMPLETED|Double-blind (DB) Treatment||27
1741108|NCT00111007|4265019|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
1741109|NCT00111007|4265020|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
1741110|NCT00111007|4265019|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
1741111|NCT00111007|4265020|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
1741112|NCT00110994|4265036|P2|NOT COMPLETED|Long Term Follow-up||17
1741113|NCT00110994|4265037|P1|NOT COMPLETED|Long Term Follow-up||19
1741114|NCT00110994|4265036|P2|COMPLETED|Long Term Follow-up||30
1741115|NCT00110994|4265037|P1|COMPLETED|Long Term Follow-up||22
1741116|NCT00110994|4265036|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
1741117|NCT00110994|4265037|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
1741118|NCT00110994|4265036|P2|NOT COMPLETED|Active Follow-up||2
1741119|NCT00110994|4265037|P1|NOT COMPLETED|Active Follow-up||1
1741120|NCT00110994|4265036|P2|COMPLETED|Active Follow-up||0
1741121|NCT00110994|4265037|P1|COMPLETED|Active Follow-up||0
1741122|NCT00110994|4265036|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
1741123|NCT00110994|4265037|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
1741124|NCT00110994|4265036|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
1741125|NCT00110994|4265037|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
1741126|NCT00110994|4265036|P2|COMPLETED|Double-blind (DB) Treatment||3
1741127|NCT00110994|4265037|P1|COMPLETED|Double-blind (DB) Treatment||9
1741128|NCT00110994|4265036|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
1741129|NCT00110994|4265037|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
1741130|NCT00110994|4265036|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
1741131|NCT00110994|4265037|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
1741132|NCT00110890|4265063|P2|NOT COMPLETED|Overall Study||179
1741133|NCT00110890|4265064|P1|NOT COMPLETED|Overall Study||361
1741134|NCT00110890|4265063|P2|COMPLETED|Overall Study|Follow-up Phase|5
1741135|NCT00110890|4265064|P1|COMPLETED|Overall Study|Follow-up Phase|7
1741136|NCT00110890|4265063|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
1741137|NCT00110890|4265064|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
1741138|NCT00110890|4265063|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
1741139|NCT00110890|4265064|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
1741140|NCT00110890|4265063|P2|STARTED|Overall Study||184
1741141|NCT00110890|4265064|P1|STARTED|Overall Study||368
1741142|NCT00110812|4265081|P3|NOT COMPLETED|Extended Follow-up||4
1741143|NCT00110812|4265082|P2|NOT COMPLETED|Extended Follow-up||4
1741144|NCT00110812|4265083|P1|NOT COMPLETED|Extended Follow-up||2
1741145|NCT00110812|4265081|P3|COMPLETED|Extended Follow-up||69
1741146|NCT00110812|4265082|P2|COMPLETED|Extended Follow-up||65
1741147|NCT00110812|4265083|P1|COMPLETED|Extended Follow-up||78
1741148|NCT00110812|4265081|P3|STARTED|Extended Follow-up||73
1741149|NCT00110812|4265082|P2|STARTED|Extended Follow-up||69
1741150|NCT00110812|4265083|P1|STARTED|Extended Follow-up||80
1741151|NCT00110812|4265081|P3|NOT COMPLETED|Main Study||13
1741152|NCT00110812|4265082|P2|NOT COMPLETED|Main Study||11
1741153|NCT00110812|4265083|P1|NOT COMPLETED|Main Study||8
1741154|NCT00110812|4265081|P3|COMPLETED|Main Study||74
1741155|NCT00110812|4265082|P2|COMPLETED|Main Study||78
1741156|NCT00110812|4265083|P1|COMPLETED|Main Study||83
1741157|NCT00110812|4265081|P3|STARTED|Main Study||87
1741158|NCT00110812|4265082|P2|STARTED|Main Study||89
1741159|NCT00110812|4265083|P1|STARTED|Main Study||91
1741160|NCT00110617|4265128|P2|NOT COMPLETED|Overall Study||29
1741161|NCT00110617|4265129|P1|NOT COMPLETED|Overall Study||39
1741162|NCT00110617|4265128|P2|COMPLETED|Overall Study||39
1741163|NCT00110617|4265129|P1|COMPLETED|Overall Study||96
1741164|NCT00110617|4265128|P2|On Going at Week 24|Overall Study||53
1741165|NCT00110617|4265129|P1|On Going at Week 24|Overall Study||126
1741166|NCT00110617|4265128|P2|Full Analysis 2; Received ICL670|Overall Study||53
1741167|NCT00110617|4265129|P1|Full Analysis 2; Received ICL670|Overall Study||135
1741168|NCT00110617|4265128|P2|Safety Set 1; Received Study Drug|Overall Study||56
1741169|NCT00110617|4265129|P1|Safety Set 1; Received Study Drug|Overall Study||135
1741170|NCT00110617|4265128|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
1741171|NCT00110617|4265129|P1|STARTED|Overall Study||135
1741172|NCT00110513|4265142|P1|NOT COMPLETED|Overall Study||0
1741173|NCT00110513|4265142|P1|COMPLETED|Overall Study||18
1741174|NCT00110513|4265142|P1|STARTED|Overall Study||18
1741175|NCT00110461|4265149|P3|NOT COMPLETED|Acute Phase||23
1741176|NCT00110461|4265150|P2|NOT COMPLETED|Acute Phase||22
1741177|NCT00110461|4265151|P1|NOT COMPLETED|Acute Phase||14
1741178|NCT00110461|4265149|P3|COMPLETED|Acute Phase||76
1741179|NCT00110461|4265150|P2|COMPLETED|Acute Phase||77
1741180|NCT00110461|4265151|P1|COMPLETED|Acute Phase||84
1741181|NCT00110461|4265149|P3|STARTED|Acute Phase||99
1741182|NCT00110461|4265150|P2|STARTED|Acute Phase||99
1741183|NCT00110461|4265151|P1|STARTED|Acute Phase||98
1741184|NCT00110461|4265149|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
1741185|NCT00110461|4265150|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
1741186|NCT00110461|4265151|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
1741187|NCT00110461|4265149|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
1741188|NCT00110461|4265150|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
1741189|NCT00110461|4265151|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
1741190|NCT00110461|4265149|P3|STARTED|30-Week, Double-blind Treatment Phase||99
1741191|NCT00110461|4265150|P2|STARTED|30-Week, Double-blind Treatment Phase||99
1741192|NCT00110461|4265151|P1|STARTED|30-Week, Double-blind Treatment Phase||98
1741193|NCT00110396|4265246|P1|NOT COMPLETED|Overall Study||36
1741194|NCT00110396|4265246|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
1741195|NCT00110396|4265246|P1|STARTED|Overall Study||260
1741196|NCT00110357|4265254|P2|NOT COMPLETED|Overall Study||19
1741197|NCT00110357|4265255|P1|NOT COMPLETED|Overall Study||27
1741198|NCT00110357|4265254|P2|COMPLETED|Overall Study|Number Still on Study|0
1741199|NCT00110357|4265255|P1|COMPLETED|Overall Study|Number Still on Study|0
1741200|NCT00110357|4265254|P2|STARTED|Overall Study||19
1741201|NCT00110357|4265255|P1|STARTED|Overall Study||27
1741202|NCT00110305|4265343|P2|NOT COMPLETED|Overall Study||32
1741203|NCT00110305|4265344|P1|NOT COMPLETED|Overall Study||114
1741204|NCT00110305|4265343|P2|COMPLETED|Overall Study||57
1741205|NCT00110305|4265344|P1|COMPLETED|Overall Study||165
1741206|NCT00110305|4265343|P2|STARTED|Overall Study||89
1741207|NCT00110305|4265344|P1|STARTED|Overall Study||279
1741208|NCT00110214|4265397|P2|NOT COMPLETED|Overall Study||503
1741209|NCT00110214|4265398|P1|NOT COMPLETED|Overall Study||509
1741210|NCT00110214|4265397|P2|COMPLETED|Overall Study||21
1741211|NCT00110214|4265398|P1|COMPLETED|Overall Study||17
1741212|NCT00110214|4265397|P2|STARTED|Overall Study||524
1741213|NCT00110214|4265398|P1|STARTED|Overall Study||526
1741214|NCT00110149|4265410|P1|NOT COMPLETED|Overall Study||3
1741215|NCT00110149|4265410|P1|COMPLETED|Overall Study||9
1741216|NCT00110149|4265410|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
1741217|NCT00110149|4265410|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
1741218|NCT00110136|4265415|P1|NOT COMPLETED|Overall Study||0
1741219|NCT00110136|4265415|P1|COMPLETED|Overall Study||9
1741220|NCT00110136|4265415|P1|STARTED|Overall Study||9
1741221|NCT00110084|4265424|P1|NOT COMPLETED|Overall Study||28
1741222|NCT00110084|4265424|P1|COMPLETED|Overall Study||22
1741223|NCT00110084|4265424|P1|STARTED|Overall Study||50
1741224|NCT00110019|4265433|P2|NOT COMPLETED|Overall Study||413
1741225|NCT00110019|4265434|P1|NOT COMPLETED|Overall Study||406
1741226|NCT00110019|4265433|P2|COMPLETED|Overall Study||0
1741227|NCT00110019|4265434|P1|COMPLETED|Overall Study||4
1741228|NCT00110019|4265433|P2|Treated|Overall Study||397
1741229|NCT00110019|4265434|P1|Treated|Overall Study||393
1741230|NCT00110019|4265433|P2|Eligible|Overall Study||398
1741231|NCT00110019|4265434|P1|Eligible|Overall Study||395
1741232|NCT00110019|4265433|P2|STARTED|Overall Study||413
1741233|NCT00110019|4265434|P1|STARTED|Overall Study||410
1741234|NCT00109967|4265446|P2|NOT COMPLETED|Overall Study||6
1741235|NCT00109967|4265447|P1|NOT COMPLETED|Overall Study||20
1741236|NCT00109967|4265446|P2|COMPLETED|Overall Study||15
1741237|NCT00109967|4265447|P1|COMPLETED|Overall Study||30
1741238|NCT00109967|4265446|P2|STARTED|Overall Study||21
1741239|NCT00109967|4265447|P1|STARTED|Overall Study||50
1741240|NCT00109928|4265461|P1|NOT COMPLETED|Overall Study||13
1741241|NCT00109928|4265461|P1|COMPLETED|Overall Study||21
1741242|NCT00109928|4265461|P1|Eligible and Began Protocol Therapy|Overall Study||33
1741243|NCT00109928|4265461|P1|Eligible|Overall Study||33
1741244|NCT00109928|4265461|P1|STARTED|Overall Study||34
1741245|NCT00109876|4265468|P1|NOT COMPLETED|Overall Study||0
1741246|NCT00109876|4265468|P1|COMPLETED|Overall Study||51
1741247|NCT00109876|4265468|P1|STARTED|Overall Study||51
1741248|NCT00109850|4265478|P1|NOT COMPLETED|Overall Study||4
1741249|NCT00109850|4265478|P1|COMPLETED|Overall Study||18
1741250|NCT00109850|4265478|P1|Eligible and Began Protocol Therapy|Overall Study||21
1741251|NCT00109850|4265478|P1|Eligible|Overall Study||21
1741252|NCT00109850|4265478|P1|STARTED|Overall Study||22
1741253|NCT00109837|4265485|P1|NOT COMPLETED|Overall Study||23
1741254|NCT00109837|4265485|P1|COMPLETED|Overall Study||56
1741255|NCT00109837|4265485|P1|Eligible and Ph- and Treated|Overall Study||60
1741256|NCT00109837|4265485|P1|Eligible and Ph-|Overall Study||61
1741257|NCT00109837|4265485|P1|Eligible|Overall Study||78
1741258|NCT00109837|4265485|P1|STARTED|Overall Study||79
1741259|NCT00109772|4265495|P2|NOT COMPLETED|Open-label Extension||49
1741260|NCT00109772|4265496|P1|NOT COMPLETED|Open-label Extension||45
1741261|NCT00109772|4265495|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
1741262|NCT00109772|4265496|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
1741263|NCT00109772|4265495|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
1741264|NCT00109772|4265496|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
1741265|NCT00109772|4265495|P2|NOT COMPLETED|Double-blind Treatment||15
1741266|NCT00109772|4265496|P1|NOT COMPLETED|Double-blind Treatment||22
1741267|NCT00109772|4265495|P2|COMPLETED|Double-blind Treatment||79
1741268|NCT00109772|4265496|P1|COMPLETED|Double-blind Treatment||68
1741269|NCT00109772|4265495|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
1741270|NCT00109772|4265496|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
1741271|NCT00109772|4265495|P2|STARTED|Double-blind Treatment||94
1741272|NCT00109772|4265496|P1|STARTED|Double-blind Treatment||90
1741273|NCT00109733|4265536|P2|NOT COMPLETED|Overall Study||4
1741274|NCT00109733|4265537|P1|NOT COMPLETED|Overall Study||2
1741275|NCT00109733|4265536|P2|COMPLETED|Overall Study||12
1741276|NCT00109733|4265537|P1|COMPLETED|Overall Study||13
1741277|NCT00109733|4265536|P2|STARTED|Overall Study||16
1741278|NCT00109733|4265537|P1|STARTED|Overall Study||15
1741279|NCT00109590|4265554|P3|NOT COMPLETED|Overall Study||4
1741280|NCT00109590|4265555|P2|NOT COMPLETED|Overall Study||2
1741281|NCT00109590|4265556|P1|NOT COMPLETED|Overall Study||2
1741282|NCT00109590|4265554|P3|COMPLETED|Overall Study||56
1741283|NCT00109590|4265555|P2|COMPLETED|Overall Study||56
1741284|NCT00109590|4265556|P1|COMPLETED|Overall Study||55
1741285|NCT00109590|4265554|P3|RECEIVED TREATMENT|Overall Study||57
1741286|NCT00109590|4265555|P2|RECEIVED TREATMENT|Overall Study||56
1741287|NCT00109590|4265556|P1|RECEIVED TREATMENT|Overall Study||56
1741288|NCT00109590|4265554|P3|STARTED|Overall Study||60
1741289|NCT00109590|4265555|P2|STARTED|Overall Study||58
1741290|NCT00109590|4265556|P1|STARTED|Overall Study||57
1741291|NCT00109577|4265598|P2|NOT COMPLETED|Overall Study||3
1741292|NCT00109577|4265599|P1|NOT COMPLETED|Overall Study||3
1741293|NCT00109577|4265598|P2|COMPLETED|Overall Study||17
1741294|NCT00109577|4265599|P1|COMPLETED|Overall Study||17
1741295|NCT00109577|4265598|P2|STARTED|Overall Study||20
1741296|NCT00109577|4265599|P1|STARTED|Overall Study||20
1741297|NCT00109473|4265607|P2|NOT COMPLETED|52 Week Extension Phase||5
1741298|NCT00109473|4265608|P1|NOT COMPLETED|52 Week Extension Phase||4
1741299|NCT00109473|4265607|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
1741300|NCT00109473|4265608|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
1741301|NCT00109473|4265607|P2|Analyzed|52 Week Extension Phase||8
1741302|NCT00109473|4265608|P1|Analyzed|52 Week Extension Phase||9
1741303|NCT00109473|4265607|P2|STARTED|52 Week Extension Phase||8
1741304|NCT00109473|4265608|P1|STARTED|52 Week Extension Phase||9
1741305|NCT00109473|4265607|P2|NOT COMPLETED|Week 12 to Week 24||0
1741306|NCT00109473|4265608|P1|NOT COMPLETED|Week 12 to Week 24||1
1741307|NCT00109473|4265607|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
1741308|NCT00109473|4265608|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
1741309|NCT00109473|4265607|P2|Analyzed|Week 12 to Week 24||9
1741310|NCT00109473|4265608|P1|Analyzed|Week 12 to Week 24||9
1741311|NCT00109473|4265607|P2|STARTED|Week 12 to Week 24||9
1741312|NCT00109473|4265608|P1|STARTED|Week 12 to Week 24||10
1741313|NCT00109473|4265607|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
1741314|NCT00109473|4265608|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
1741315|NCT00109473|4265607|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
1741316|NCT00109473|4265608|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
1741317|NCT00109473|4265607|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
1741318|NCT00109473|4265608|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
1741319|NCT00109473|4265607|P2|STARTED|Baseline (0 Through 12 Weeks)||10
1741320|NCT00109473|4265608|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
1741321|NCT00109343|4265630|P3|NOT COMPLETED|Overall Study||30
1741322|NCT00109343|4265631|P2|NOT COMPLETED|Overall Study||37
1741323|NCT00109343|4265632|P1|NOT COMPLETED|Overall Study||64
1741324|NCT00109343|4265630|P3|COMPLETED|Overall Study||229
1741325|NCT00109343|4265631|P2|COMPLETED|Overall Study||221
1741326|NCT00109343|4265632|P1|COMPLETED|Overall Study||446
1741327|NCT00109343|4265630|P3|Vaccinated at Visit 4|Overall Study||240
1741328|NCT00109343|4265631|P2|Vaccinated at Visit 4|Overall Study||235
1741329|NCT00109343|4265632|P1|Vaccinated at Visit 4|Overall Study||466
1741330|NCT00109343|4265630|P3|Vaccinated at Visit 2|Overall Study||246
1741331|NCT00109343|4265631|P2|Vaccinated at Visit 2|Overall Study||246
1741332|NCT00109343|4265632|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
1741333|NCT00109343|4265630|P3|Vaccinated at Visit 1|Overall Study||259
1741334|NCT00109343|4265631|P2|Vaccinated at Visit 1|Overall Study||258
1741335|NCT00109343|4265632|P1|Vaccinated at Visit 1|Overall Study||510
1741336|NCT00109343|4265630|P3|STARTED|Overall Study||259
1741337|NCT00109343|4265631|P2|STARTED|Overall Study||258
1741338|NCT00109343|4265632|P1|STARTED|Overall Study||510
1741339|NCT00109031|4265677|P4|NOT COMPLETED|Overall Study||0
1741340|NCT00109031|4265678|P3|NOT COMPLETED|Overall Study||2
1741341|NCT00109031|4265679|P2|NOT COMPLETED|Overall Study||2
1741342|NCT00109031|4265680|P1|NOT COMPLETED|Overall Study||0
1741343|NCT00109031|4265677|P4|COMPLETED|Overall Study||12
1741344|NCT00109031|4265678|P3|COMPLETED|Overall Study||12
1741345|NCT00109031|4265679|P2|COMPLETED|Overall Study||8
1741346|NCT00109031|4265680|P1|COMPLETED|Overall Study||11
1741347|NCT00109031|4265677|P4|STARTED|Overall Study||12
1741348|NCT00109031|4265678|P3|STARTED|Overall Study||14
1741349|NCT00109031|4265679|P2|STARTED|Overall Study||10
1741350|NCT00109031|4265680|P1|STARTED|Overall Study||11
1741351|NCT00109005|4265716|P2|NOT COMPLETED|Overall Study||0
1741352|NCT00109005|4265717|P1|NOT COMPLETED|Overall Study||0
1741353|NCT00109005|4265716|P2|COMPLETED|Overall Study||9
1741354|NCT00109005|4265717|P1|COMPLETED|Overall Study||8
1741355|NCT00109005|4265716|P2|STARTED|Overall Study||9
1741356|NCT00109005|4265717|P1|STARTED|Overall Study||8
1741357|NCT00108953|4265731|P2|NOT COMPLETED|Follow-up||33
1741358|NCT00108953|4265732|P1|NOT COMPLETED|Follow-up||29
1741359|NCT00108953|4265731|P2|COMPLETED|Follow-up||12
1741360|NCT00108953|4265732|P1|COMPLETED|Follow-up||11
1741361|NCT00108953|4265731|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
1741362|NCT00108953|4265732|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
1741363|NCT00108953|4265731|P2|NOT COMPLETED|Treatment Period||0
1741364|NCT00108953|4265732|P1|NOT COMPLETED|Treatment Period||0
1741365|NCT00108953|4265731|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
1741366|NCT00108953|4265732|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
1741367|NCT00108953|4265731|P2|STARTED|Treatment Period|ITT population|49
1741368|NCT00108953|4265732|P1|STARTED|Treatment Period|ITT population|47
1741369|NCT00108862|4265754|P2|NOT COMPLETED|Overall Study||62
1741370|NCT00108862|4265755|P1|NOT COMPLETED|Overall Study||68
1741371|NCT00108862|4265754|P2|COMPLETED|Overall Study||339
1741372|NCT00108862|4265755|P1|COMPLETED|Overall Study||337
1741460|NCT00108160|4265919|P2|Completed Visit 2 (3 mo)|Overall Study||46
1741373|NCT00108862|4265754|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
1741374|NCT00108862|4265755|P1|STARTED|Overall Study||405
1741375|NCT00108732|4265783|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
1741376|NCT00108732|4265783|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
1741377|NCT00108732|4265783|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
1741378|NCT00108732|4265783|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
1741379|NCT00108732|4265783|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
1741380|NCT00108732|4265783|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
1741381|NCT00108732|4265783|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
1741382|NCT00108628|4265792|P2|NOT COMPLETED|Overall Study||10
1741383|NCT00108628|4265793|P1|NOT COMPLETED|Overall Study||20
1741384|NCT00108628|4265792|P2|COMPLETED|Overall Study||53
1741385|NCT00108628|4265793|P1|COMPLETED|Overall Study||41
1741386|NCT00108628|4265792|P2|Completed Treatment|Overall Study||57
1741387|NCT00108628|4265793|P1|Completed Treatment|Overall Study||42
1741388|NCT00108628|4265792|P2|Received One or More Sessions|Overall Study||58
1741389|NCT00108628|4265793|P1|Received One or More Sessions|Overall Study||53
1741390|NCT00108628|4265792|P2|STARTED|Overall Study||63
1741391|NCT00108628|4265793|P1|STARTED|Overall Study||61
1741392|NCT00108550|4265819|P2|NOT COMPLETED|Overall Study||16
1741393|NCT00108550|4265820|P1|NOT COMPLETED|Overall Study||16
1741394|NCT00108550|4265819|P2|COMPLETED|Overall Study||37
1741395|NCT00108550|4265820|P1|COMPLETED|Overall Study||39
1741396|NCT00108550|4265819|P2|STARTED|Overall Study||53
1741397|NCT00108550|4265820|P1|STARTED|Overall Study||55
1741398|NCT00108524|4265830|P2|NOT COMPLETED|Overall Study||18
1741399|NCT00108524|4265831|P1|NOT COMPLETED|Overall Study||29
1741400|NCT00108524|4265830|P2|COMPLETED|Overall Study||61
1741401|NCT00108524|4265831|P1|COMPLETED|Overall Study||52
1741402|NCT00108524|4265830|P2|STARTED|Overall Study||79
1741403|NCT00108524|4265831|P1|STARTED|Overall Study||81
1741404|NCT00108485|4265843|P2|NOT COMPLETED|Overall Study||2
1741405|NCT00108485|4265844|P1|NOT COMPLETED|Overall Study||3
1741406|NCT00108485|4265843|P2|COMPLETED|Overall Study||2
1741407|NCT00108485|4265844|P1|COMPLETED|Overall Study||2
1741408|NCT00108485|4265843|P2|STARTED|Overall Study||4
1741409|NCT00108485|4265844|P1|STARTED|Overall Study||5
1741410|NCT00108433|4265852|P2|NOT COMPLETED|Overall Study||17
1741411|NCT00108433|4265853|P1|NOT COMPLETED|Overall Study||21
1741412|NCT00108433|4265852|P2|COMPLETED|Overall Study||14
1741413|NCT00108433|4265853|P1|COMPLETED|Overall Study||9
1741414|NCT00108433|4265852|P2|STARTED|Overall Study||31
1741415|NCT00108433|4265853|P1|STARTED|Overall Study||30
1741416|NCT00108355|4265869|P2|NOT COMPLETED|Overall Study||2
1741417|NCT00108355|4265870|P1|NOT COMPLETED|Overall Study||2
1741418|NCT00108355|4265869|P2|COMPLETED|Overall Study||12
1741419|NCT00108355|4265870|P1|COMPLETED|Overall Study||13
1741420|NCT00108355|4265869|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
1741421|NCT00108355|4265870|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
1741422|NCT00108342|4265880|P2|NOT COMPLETED|Overall Study||0
1741423|NCT00108342|4265881|P1|NOT COMPLETED|Overall Study||1
1741424|NCT00108342|4265880|P2|COMPLETED|Overall Study||9
1741425|NCT00108342|4265881|P1|COMPLETED|Overall Study||7
1741426|NCT00108342|4265880|P2|STARTED|Overall Study||9
1741427|NCT00108342|4265881|P1|STARTED|Overall Study||8
1741428|NCT00108303|4265890|P3|NOT COMPLETED|Overall Study||0
1741429|NCT00108303|4265891|P2|NOT COMPLETED|Overall Study||0
1741430|NCT00108303|4265892|P1|NOT COMPLETED|Overall Study||0
1741431|NCT00108303|4265890|P3|COMPLETED|Overall Study||180
1741432|NCT00108303|4265891|P2|COMPLETED|Overall Study||179
1741433|NCT00108303|4265892|P1|COMPLETED|Overall Study||179
1741434|NCT00108303|4265890|P3|STARTED|Overall Study||180
1741435|NCT00108303|4265891|P2|STARTED|Overall Study||179
1741436|NCT00108303|4265892|P1|STARTED|Overall Study||179
1741437|NCT00108277|4265907|P3|NOT COMPLETED|Overall Study||16
1741438|NCT00108277|4265908|P2|NOT COMPLETED|Overall Study||12
1741439|NCT00108277|4265909|P1|NOT COMPLETED|Overall Study||10
1741440|NCT00108277|4265907|P3|COMPLETED|Overall Study||19
1741441|NCT00108277|4265908|P2|COMPLETED|Overall Study||16
1741442|NCT00108277|4265909|P1|COMPLETED|Overall Study||19
1741443|NCT00108277|4265907|P3|STARTED|Overall Study||35
1741444|NCT00108277|4265908|P2|STARTED|Overall Study||28
1741445|NCT00108277|4265909|P1|STARTED|Overall Study||29
1741446|NCT00108160|4265919|P2|NOT COMPLETED|Overall Study||21
1741447|NCT00108160|4265920|P1|NOT COMPLETED|Overall Study||39
1741448|NCT00108160|4265919|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
1741449|NCT00108160|4265920|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
1741450|NCT00108160|4265919|P2|Completed Visit 7 (18 mo)|Overall Study||31
1741451|NCT00108160|4265920|P1|Completed Visit 7 (18 mo)|Overall Study||34
1741452|NCT00108160|4265919|P2|Completed Visit 6 (15 mo)|Overall Study||33
1741453|NCT00108160|4265920|P1|Completed Visit 6 (15 mo)|Overall Study||36
1741454|NCT00108160|4265919|P2|Completed Visit 5 (12 mo)|Overall Study||37
1741455|NCT00108160|4265920|P1|Completed Visit 5 (12 mo)|Overall Study||37
1741456|NCT00108160|4265919|P2|Completed Visit 4 (9 mo)|Overall Study||37
1741457|NCT00108160|4265920|P1|Completed Visit 4 (9 mo)|Overall Study||38
1741458|NCT00108160|4265919|P2|Completed Visit 3 (6 mo)|Overall Study||38
1741459|NCT00108160|4265920|P1|Completed Visit 3 (6 mo)|Overall Study||44
1741461|NCT00108160|4265920|P1|Completed Visit 2 (3 mo)|Overall Study||54
1741462|NCT00108160|4265919|P2|Completed Visit 1 (2 Wks)|Overall Study||54
1741463|NCT00108160|4265920|P1|Completed Visit 1 (2 Wks)|Overall Study||72
1741464|NCT00108160|4265919|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
1741465|NCT00108160|4265920|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
1741466|NCT00108160|4265919|P2|STARTED|Overall Study||63
1741467|NCT00108160|4265920|P1|STARTED|Overall Study||83
1741468|NCT00108082|4265933|P3|NOT COMPLETED|Overall Study||43
1741469|NCT00108082|4265934|P2|NOT COMPLETED|Overall Study||32
1741470|NCT00108082|4265935|P1|NOT COMPLETED|Overall Study||38
1741471|NCT00108082|4265933|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
1741472|NCT00108082|4265934|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
1741473|NCT00108082|4265935|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
1741474|NCT00108082|4265933|P3|STARTED|Overall Study||96
1741475|NCT00108082|4265934|P2|STARTED|Overall Study||100
1741476|NCT00108082|4265935|P1|STARTED|Overall Study||91
1741477|NCT00108069|4265984|P2|NOT COMPLETED|Overall Study||13
1741478|NCT00108069|4265985|P1|NOT COMPLETED|Overall Study||30
1741479|NCT00108069|4265984|P2|COMPLETED|Overall Study||0
1741480|NCT00108069|4265985|P1|COMPLETED|Overall Study||0
1741481|NCT00108069|4265984|P2|STARTED|Overall Study||13
1741482|NCT00108069|4265985|P1|STARTED|Overall Study||30
1741483|NCT00107991|4265999|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
1741484|NCT00107991|4265999|P1|COMPLETED|18-Week Post Treatment Assessment||8
1741485|NCT00107991|4265999|P1|STARTED|18-Week Post Treatment Assessment||10
1741486|NCT00107991|4265999|P1|NOT COMPLETED|12 Week Treatment Period||5
1741487|NCT00107991|4265999|P1|COMPLETED|12 Week Treatment Period||10
1741488|NCT00107991|4265999|P1|STARTED|12 Week Treatment Period||15
1741489|NCT00107991|4265999|P1|NOT COMPLETED|Eligibility Assessment||23
1741490|NCT00107991|4265999|P1|COMPLETED|Eligibility Assessment||15
1741491|NCT00107991|4265999|P1|STARTED|Eligibility Assessment||38
1741492|NCT00107978|4266009|P2|NOT COMPLETED|Overall Study||50
1741493|NCT00107978|4266010|P1|NOT COMPLETED|Overall Study||33
1741494|NCT00107978|4266009|P2|COMPLETED|Overall Study||431
1741495|NCT00107978|4266010|P1|COMPLETED|Overall Study||425
1741496|NCT00107978|4266009|P2|STARTED|Overall Study||481
1741497|NCT00107978|4266010|P1|STARTED|Overall Study||458
1741498|NCT00107952|4266018|P2|NOT COMPLETED|Overall Study||81
1741499|NCT00107952|4266019|P1|NOT COMPLETED|Overall Study||95
1741500|NCT00107952|4266018|P2|COMPLETED|Overall Study||299
1741501|NCT00107952|4266019|P1|COMPLETED|Overall Study||286
1741502|NCT00107952|4266018|P2|STARTED|Overall Study||380
1741503|NCT00107952|4266019|P1|STARTED|Overall Study||381
1741504|NCT00107900|4266031|P6|NOT COMPLETED|Overall Study||9
1741505|NCT00107900|4266032|P5|NOT COMPLETED|Overall Study||21
1741506|NCT00107900|4266033|P4|NOT COMPLETED|Overall Study||12
1741507|NCT00107900|4266034|P3|NOT COMPLETED|Overall Study||25
1741508|NCT00107900|4266035|P2|NOT COMPLETED|Overall Study||3
1741509|NCT00107900|4266036|P1|NOT COMPLETED|Overall Study||10
1741510|NCT00107900|4266031|P6|COMPLETED|Overall Study||94
1741511|NCT00107900|4266032|P5|COMPLETED|Overall Study||94
1741512|NCT00107900|4266033|P4|COMPLETED|Overall Study||87
1741513|NCT00107900|4266034|P3|COMPLETED|Overall Study||104
1741514|NCT00107900|4266035|P2|COMPLETED|Overall Study||72
1741515|NCT00107900|4266036|P1|COMPLETED|Overall Study||75
1741516|NCT00107900|4266031|P6|STARTED|Overall Study||103
1741517|NCT00107900|4266032|P5|STARTED|Overall Study||115
1741518|NCT00107900|4266033|P4|STARTED|Overall Study||99
1741519|NCT00107900|4266034|P3|STARTED|Overall Study||129
1741520|NCT00107900|4266035|P2|STARTED|Overall Study||75
1741521|NCT00107900|4266036|P1|STARTED|Overall Study||85
1741522|NCT00107783|4266070|P2|NOT COMPLETED|Overall Study||4
1741523|NCT00107783|4266071|P1|NOT COMPLETED|Overall Study||3
1741524|NCT00107783|4266070|P2|COMPLETED|Overall Study||16
1741525|NCT00107783|4266071|P1|COMPLETED|Overall Study||17
1741526|NCT00107783|4266070|P2|STARTED|Overall Study||20
1741527|NCT00107783|4266071|P1|STARTED|Overall Study||20
1741528|NCT00107744|4266088|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1741529|NCT00107744|4266089|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1741530|NCT00107744|4266090|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1741531|NCT00107744|4266088|P3|COMPLETED|Intervention 3 (8 Weeks)||88
1741532|NCT00107744|4266089|P2|COMPLETED|Intervention 3 (8 Weeks)||92
1741533|NCT00107744|4266090|P1|COMPLETED|Intervention 3 (8 Weeks)||93
1741534|NCT00107744|4266088|P3|STARTED|Intervention 3 (8 Weeks)||88
1741535|NCT00107744|4266089|P2|STARTED|Intervention 3 (8 Weeks)||92
1741536|NCT00107744|4266090|P1|STARTED|Intervention 3 (8 Weeks)||93
1741537|NCT00107744|4266088|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
1741538|NCT00107744|4266089|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
1741539|NCT00107744|4266090|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
1741540|NCT00107744|4266088|P3|COMPLETED|Intervention 2 (8 Weeks)||88
1741541|NCT00107744|4266089|P2|COMPLETED|Intervention 2 (8 Weeks)||92
1741542|NCT00107744|4266090|P1|COMPLETED|Intervention 2 (8 Weeks)||93
1741543|NCT00107744|4266088|P3|STARTED|Intervention 2 (8 Weeks)||101
1741544|NCT00107744|4266089|P2|STARTED|Intervention 2 (8 Weeks)||104
1741545|NCT00107744|4266090|P1|STARTED|Intervention 2 (8 Weeks)||101
1741546|NCT00107744|4266088|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
1741547|NCT00107744|4266089|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
1741548|NCT00107744|4266090|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
1741549|NCT00107744|4266088|P3|COMPLETED|Intervention 1 (8 Weeks)||101
1741550|NCT00107744|4266089|P2|COMPLETED|Intervention 1 (8 Weeks)||104
1741551|NCT00107744|4266090|P1|COMPLETED|Intervention 1 (8 Weeks)||101
1741552|NCT00107744|4266088|P3|STARTED|Intervention 1 (8 Weeks)||118
1741553|NCT00107744|4266089|P2|STARTED|Intervention 1 (8 Weeks)||117
1741554|NCT00107744|4266090|P1|STARTED|Intervention 1 (8 Weeks)||117
1741555|NCT00107653|4266106|P2|NOT COMPLETED|Overall Study||76
1741556|NCT00107653|4266107|P1|NOT COMPLETED|Overall Study||79
1741557|NCT00107653|4266106|P2|COMPLETED|Overall Study||224
1741558|NCT00107653|4266107|P1|COMPLETED|Overall Study||190
1741559|NCT00107653|4266106|P2|STARTED|Overall Study||300
1741560|NCT00107653|4266107|P1|STARTED|Overall Study||269
1741561|NCT00107614|4266153|P1|NOT COMPLETED|Overall Study||12
1741562|NCT00107614|4266153|P1|COMPLETED|Overall Study||0
1741563|NCT00107614|4266153|P1|STARTED|Overall Study||12
1741564|NCT00107575|4266159|P2|NOT COMPLETED|Overall Study||10
1741565|NCT00107575|4266160|P1|NOT COMPLETED|Overall Study||11
1741566|NCT00107575|4266159|P2|COMPLETED|Overall Study||107
1741567|NCT00107575|4266160|P1|COMPLETED|Overall Study||108
1741568|NCT00107575|4266159|P2|STARTED|Overall Study||117
1741569|NCT00107575|4266160|P1|STARTED|Overall Study||119
1741570|NCT00107536|4266174|P1|NOT COMPLETED|Overall Study||0
1741571|NCT00107536|4266174|P1|COMPLETED|Overall Study||26
1741572|NCT00107536|4266174|P1|STARTED|Overall Study||26
1741573|NCT00107380|4266184|P1|NOT COMPLETED|Overall Study||30
1741574|NCT00107380|4266184|P1|COMPLETED|Overall Study||56
1741575|NCT00107380|4266184|P1|Eligible|Overall Study||84
1741576|NCT00107380|4266184|P1|STARTED|Overall Study||86
1741577|NCT00107315|4266190|P1|NOT COMPLETED|Overall Study||15
1741578|NCT00107315|4266190|P1|COMPLETED|Overall Study||1
1741579|NCT00107315|4266190|P1|STARTED|Overall Study||16
1741580|NCT00107276|4266197|P1|NOT COMPLETED|Overall Study||72
1741581|NCT00107276|4266197|P1|COMPLETED|Overall Study||40
1741582|NCT00107276|4266197|P1|Eligible|Overall Study||96
1741583|NCT00107276|4266197|P1|STARTED|Overall Study||112
1741584|NCT00107198|4266203|P1|NOT COMPLETED|Overall Study||52
1741585|NCT00107198|4266203|P1|COMPLETED|Overall Study||136
1741586|NCT00107198|4266203|P1|STARTED|Overall Study||188
1741587|NCT00107172|4266213|P2|NOT COMPLETED|Overall Study||5
1741588|NCT00107172|4266214|P1|NOT COMPLETED|Overall Study||5
1741589|NCT00107172|4266213|P2|COMPLETED|Overall Study||103
1741590|NCT00107172|4266214|P1|COMPLETED|Overall Study||109
1741591|NCT00107172|4266213|P2|STARTED|Overall Study||108
1741592|NCT00107172|4266214|P1|STARTED|Overall Study||114
1741593|NCT00107120|4266244|P2|NOT COMPLETED|Overall Study||24
1741594|NCT00107120|4266245|P1|NOT COMPLETED|Overall Study||29
1741595|NCT00107120|4266244|P2|COMPLETED|Overall Study||133
1741596|NCT00107120|4266245|P1|COMPLETED|Overall Study||126
1741597|NCT00107120|4266244|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
1741598|NCT00107120|4266245|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
1741599|NCT00107042|4266257|P2|NOT COMPLETED|Overall Study||16
1741600|NCT00107042|4266258|P1|NOT COMPLETED|Overall Study||22
1741601|NCT00107042|4266257|P2|COMPLETED|Overall Study||47
1741602|NCT00107042|4266258|P1|COMPLETED|Overall Study||38
1741603|NCT00107042|4266257|P2|STARTED|Overall Study||63
1741604|NCT00107042|4266258|P1|STARTED|Overall Study||60
1741605|NCT00106964|4266324|P3|NOT COMPLETED|Overall Study||7
1741606|NCT00106964|4266325|P2|NOT COMPLETED|Overall Study||15
1741607|NCT00106964|4266326|P1|NOT COMPLETED|Overall Study||13
1741608|NCT00106964|4266324|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
1741609|NCT00106964|4266325|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
1741610|NCT00106964|4266326|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
1741611|NCT00106964|4266324|P3|STARTED|Overall Study||127
1741612|NCT00106964|4266325|P2|STARTED|Overall Study||126
1741613|NCT00106964|4266326|P1|STARTED|Overall Study||118
1741614|NCT00106938|4266351|P2|NOT COMPLETED|Overall Study||71
1741615|NCT00106938|4266352|P1|NOT COMPLETED|Overall Study||176
1741616|NCT00106938|4266351|P2|COMPLETED|Overall Study||293
1741617|NCT00106938|4266352|P1|COMPLETED|Overall Study||913
1741618|NCT00106938|4266351|P2|STARTED|Overall Study||364
1741619|NCT00106938|4266352|P1|STARTED|Overall Study||1089
1741620|NCT00106704|4266421|P2|NOT COMPLETED|Overall Study||151
1741621|NCT00106704|4266422|P1|NOT COMPLETED|Overall Study||131
1741622|NCT00106704|4266421|P2|COMPLETED|Overall Study||68
1741623|NCT00106704|4266422|P1|COMPLETED|Overall Study||91
1741624|NCT00106704|4266421|P2|STARTED|Overall Study||219
1741625|NCT00106704|4266422|P1|STARTED|Overall Study||222
1741626|NCT00106639|4266433|P3|NOT COMPLETED|Overall Study||2
1741627|NCT00106639|4266434|P2|NOT COMPLETED|Overall Study||7
1741628|NCT00106639|4266435|P1|NOT COMPLETED|Overall Study||3
1741629|NCT00106639|4266433|P3|COMPLETED|Overall Study||19
1741630|NCT00106639|4266434|P2|COMPLETED|Overall Study||13
1741631|NCT00106639|4266435|P1|COMPLETED|Overall Study||17
1741632|NCT00106639|4266433|P3|STARTED|Overall Study||21
1741633|NCT00106639|4266434|P2|STARTED|Overall Study||20
1741634|NCT00106639|4266435|P1|STARTED|Overall Study||20
1741635|NCT00106626|4266562|P4|NOT COMPLETED|Overall Study||13
1741636|NCT00106626|4266563|P3|NOT COMPLETED|Overall Study||12
1741637|NCT00106626|4266564|P2|NOT COMPLETED|Overall Study||6
1741638|NCT00106626|4266565|P1|NOT COMPLETED|Overall Study||10
1741639|NCT00106626|4266562|P4|COMPLETED|Overall Study||3
1741640|NCT00106626|4266563|P3|COMPLETED|Overall Study||2
1741641|NCT00106626|4266564|P2|COMPLETED|Overall Study||3
1741642|NCT00106626|4266565|P1|COMPLETED|Overall Study||3
1741643|NCT00106626|4266562|P4|STARTED|Overall Study||16
1741644|NCT00106626|4266563|P3|STARTED|Overall Study||14
1741645|NCT00106626|4266564|P2|STARTED|Overall Study||9
1741646|NCT00106626|4266565|P1|STARTED|Overall Study||13
1741647|NCT00106535|4266583|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
1741648|NCT00106535|4266584|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1741649|NCT00106535|4266585|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1741650|NCT00106535|4266586|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1741651|NCT00106535|4266583|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
1741652|NCT00106535|4266584|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1741653|NCT00106535|4266585|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1741654|NCT00106535|4266586|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
1741655|NCT00106535|4266583|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
1741656|NCT00106535|4266584|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
1741657|NCT00106535|4266585|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
1741658|NCT00106535|4266586|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
1741659|NCT00106535|4266583|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
1741660|NCT00106535|4266584|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
1741661|NCT00106535|4266585|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
1741662|NCT00106535|4266586|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
1741663|NCT00106535|4266583|P4|COMPLETED|2-year Placebo Controlled Period||0
1741664|NCT00106535|4266584|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
1741665|NCT00106535|4266585|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
1741666|NCT00106535|4266586|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
1741667|NCT00106535|4266583|P4|Completed Week 52|2-year Placebo Controlled Period||0
1741668|NCT00106535|4266584|P3|Completed Week 52|2-year Placebo Controlled Period||338
1741669|NCT00106535|4266585|P2|Completed Week 52|2-year Placebo Controlled Period||342
1741670|NCT00106535|4266586|P1|Completed Week 52|2-year Placebo Controlled Period||326
1741671|NCT00106535|4266583|P4|Completed Week 24|2-year Placebo Controlled Period||0
1741672|NCT00106535|4266584|P3|Completed Week 24|2-year Placebo Controlled Period||366
1741673|NCT00106535|4266585|P2|Completed Week 24|2-year Placebo Controlled Period||373
1741674|NCT00106535|4266586|P1|Completed Week 24|2-year Placebo Controlled Period||356
1741675|NCT00106535|4266583|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
1741676|NCT00106535|4266584|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
1741677|NCT00106535|4266585|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
1741678|NCT00106535|4266586|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
1741679|NCT00106535|4266583|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
1741680|NCT00106535|4266584|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
1741681|NCT00106535|4266585|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
1741682|NCT00106535|4266586|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
1741683|NCT00106535|4266583|P4|STARTED|2-year Placebo Controlled Period||0
1741684|NCT00106535|4266584|P3|STARTED|2-year Placebo Controlled Period||401
1741685|NCT00106535|4266585|P2|STARTED|2-year Placebo Controlled Period||401
1741686|NCT00106535|4266586|P1|STARTED|2-year Placebo Controlled Period||394
1741687|NCT00106431|4266879|P1|NOT COMPLETED|Overall Study||65
1741688|NCT00106431|4266879|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
1741689|NCT00106431|4266879|P1|STARTED|Overall Study||102
1741690|NCT00106392|4266891|P2|NOT COMPLETED|Overall Study||27
1741691|NCT00106392|4266892|P1|NOT COMPLETED|Overall Study||26
1741692|NCT00106392|4266891|P2|COMPLETED|Overall Study||42
1741693|NCT00106392|4266892|P1|COMPLETED|Overall Study||36
1741694|NCT00106392|4266891|P2|Full Analysis Set (FAS)|Overall Study||61
1741695|NCT00106392|4266892|P1|Full Analysis Set (FAS)|Overall Study||53
1741696|NCT00106392|4266891|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
1741697|NCT00106392|4266892|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
1741698|NCT00106392|4266891|P2|STARTED|Overall Study||69
1741699|NCT00106392|4266892|P1|STARTED|Overall Study||62
1741700|NCT00106353|4266910|P7|NOT COMPLETED|Part 2||16
1741701|NCT00106353|4266911|P6|NOT COMPLETED|Part 2||18
1741702|NCT00106353|4266912|P5|NOT COMPLETED|Part 2||16
1741703|NCT00106353|4266913|P4|NOT COMPLETED|Part 2||0
1741704|NCT00106353|4266914|P3|NOT COMPLETED|Part 2||0
1741705|NCT00106353|4266915|P2|NOT COMPLETED|Part 2||0
1741706|NCT00106353|4266916|P1|NOT COMPLETED|Part 2||0
1741707|NCT00106353|4266910|P7|COMPLETED|Part 2||0
1741708|NCT00106353|4266911|P6|COMPLETED|Part 2||1
1741709|NCT00106353|4266912|P5|COMPLETED|Part 2||1
1741710|NCT00106353|4266913|P4|COMPLETED|Part 2||0
1741711|NCT00106353|4266914|P3|COMPLETED|Part 2||0
1741712|NCT00106353|4266915|P2|COMPLETED|Part 2||0
1741713|NCT00106353|4266916|P1|COMPLETED|Part 2||0
1741714|NCT00106353|4266910|P7|STARTED|Part 2||16
1741715|NCT00106353|4266911|P6|STARTED|Part 2||19
1741716|NCT00106353|4266912|P5|STARTED|Part 2||17
1741717|NCT00106353|4266913|P4|STARTED|Part 2||0
1741718|NCT00106353|4266914|P3|STARTED|Part 2||0
1741719|NCT00106353|4266915|P2|STARTED|Part 2||0
1741720|NCT00106353|4266916|P1|STARTED|Part 2||0
1741721|NCT00106353|4266910|P7|NOT COMPLETED|Part 1||0
1741722|NCT00106353|4266911|P6|NOT COMPLETED|Part 1||0
1741723|NCT00106353|4266912|P5|NOT COMPLETED|Part 1||0
1741724|NCT00106353|4266913|P4|NOT COMPLETED|Part 1||7
1741725|NCT00106353|4266914|P3|NOT COMPLETED|Part 1||3
1741726|NCT00106353|4266915|P2|NOT COMPLETED|Part 1||5
1741727|NCT00106353|4266916|P1|NOT COMPLETED|Part 1||4
1741728|NCT00106353|4266910|P7|COMPLETED|Part 1||0
1741729|NCT00106353|4266911|P6|COMPLETED|Part 1||0
1741730|NCT00106353|4266912|P5|COMPLETED|Part 1||0
1741731|NCT00106353|4266913|P4|COMPLETED|Part 1||0
1741732|NCT00106353|4266914|P3|COMPLETED|Part 1||0
1741733|NCT00106353|4266915|P2|COMPLETED|Part 1||0
1741734|NCT00106353|4266916|P1|COMPLETED|Part 1||0
1741735|NCT00106353|4266910|P7|STARTED|Part 1||0
1741736|NCT00106353|4266911|P6|STARTED|Part 1||0
1741737|NCT00106353|4266912|P5|STARTED|Part 1||0
1741738|NCT00106353|4266913|P4|STARTED|Part 1||7
1741739|NCT00106353|4266914|P3|STARTED|Part 1||3
1741740|NCT00106353|4266915|P2|STARTED|Part 1||5
1741741|NCT00106353|4266916|P1|STARTED|Part 1||4
1741742|NCT00106249|4267043|P2|NOT COMPLETED|Overall Study||2
1741743|NCT00106249|4267044|P1|NOT COMPLETED|Overall Study||3
1741744|NCT00106249|4267043|P2|COMPLETED|Overall Study||11
1741745|NCT00106249|4267044|P1|COMPLETED|Overall Study||11
1741746|NCT00106249|4267043|P2|STARTED|Overall Study||13
1741747|NCT00106249|4267044|P1|STARTED|Overall Study||14
1741748|NCT00106184|4267056|P2|NOT COMPLETED|Overall Study||2
1741749|NCT00106184|4267057|P1|NOT COMPLETED|Overall Study||3
1741750|NCT00106184|4267056|P2|COMPLETED|Overall Study||102
1741751|NCT00106184|4267057|P1|COMPLETED|Overall Study||93
1741752|NCT00106184|4267056|P2|Treated|Overall Study|104 subjects were randomized.|102
1741753|NCT00106184|4267057|P1|Treated|Overall Study|96 subjects were randomized.|93
1741754|NCT00106184|4267056|P2|STARTED|Overall Study||104
1741755|NCT00106184|4267057|P1|STARTED|Overall Study||96
1741756|NCT00106119|4267067|P2|NOT COMPLETED|Second Intervention||0
1741757|NCT00106119|4267068|P1|NOT COMPLETED|Second Intervention||0
1741758|NCT00106119|4267067|P2|COMPLETED|Second Intervention||7
1741759|NCT00106119|4267068|P1|COMPLETED|Second Intervention||7
1741760|NCT00106119|4267067|P2|STARTED|Second Intervention||7
1741761|NCT00106119|4267068|P1|STARTED|Second Intervention||7
1741762|NCT00106119|4267067|P2|NOT COMPLETED|Washout Period of 30 Days||0
1741763|NCT00106119|4267068|P1|NOT COMPLETED|Washout Period of 30 Days||0
1741764|NCT00106119|4267067|P2|COMPLETED|Washout Period of 30 Days||7
1741765|NCT00106119|4267068|P1|COMPLETED|Washout Period of 30 Days||7
1741766|NCT00106119|4267067|P2|STARTED|Washout Period of 30 Days||7
1741767|NCT00106119|4267068|P1|STARTED|Washout Period of 30 Days||7
1741768|NCT00106119|4267067|P2|NOT COMPLETED|First Intervention||0
1741769|NCT00106119|4267068|P1|NOT COMPLETED|First Intervention||0
1741770|NCT00106119|4267067|P2|COMPLETED|First Intervention||7
1741771|NCT00106119|4267068|P1|COMPLETED|First Intervention||7
1741772|NCT00106119|4267067|P2|STARTED|First Intervention||7
1741773|NCT00106119|4267068|P1|STARTED|First Intervention||7
1741774|NCT00106106|4267088|P2|NOT COMPLETED|Overall Study||4
1741775|NCT00106106|4267089|P1|NOT COMPLETED|Overall Study||4
1741776|NCT00106106|4267088|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
1741777|NCT00106106|4267089|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
1741778|NCT00106106|4267088|P2|Completed Both MRS Scans|Overall Study||15
1741779|NCT00106106|4267089|P1|Completed Both MRS Scans|Overall Study||18
1741780|NCT00106106|4267088|P2|STARTED|Overall Study||23
1741781|NCT00106106|4267089|P1|STARTED|Overall Study||26
1741782|NCT00106080|4267099|P2|NOT COMPLETED|Overall Study||27
1741783|NCT00106080|4267100|P1|NOT COMPLETED|Overall Study||43
1741784|NCT00106080|4267099|P2|COMPLETED|Overall Study||155
1741785|NCT00106080|4267100|P1|COMPLETED|Overall Study||151
1741786|NCT00106080|4267099|P2|STARTED|Overall Study||182
1741787|NCT00106080|4267100|P1|STARTED|Overall Study||194
1741788|NCT00106028|4267110|P2|NOT COMPLETED|Overall Study||12
1741789|NCT00106028|4267111|P1|NOT COMPLETED|Overall Study||6
1741790|NCT00106028|4267110|P2|COMPLETED|Overall Study|Completed Month 36|82
1741791|NCT00106028|4267111|P1|COMPLETED|Overall Study|Completed Month 36|43
1741792|NCT00106028|4267110|P2|Month 12 Completed/Started Open Label|Overall Study||87
1741793|NCT00106028|4267111|P1|Month 12 Completed/Started Open Label|Overall Study||49
1741794|NCT00106028|4267110|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
1741795|NCT00106028|4267111|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
1741796|NCT00106002|4267205|P1|NOT COMPLETED|Overall Study||2
1741797|NCT00106002|4267205|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
1741798|NCT00106002|4267205|P1|STARTED|Overall Study||37
1741799|NCT00105989|4267213|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
1741800|NCT00105989|4267214|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
1741801|NCT00105989|4267213|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
1741802|NCT00105989|4267214|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
1741803|NCT00105989|4267213|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
1741804|NCT00105989|4267214|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
1741805|NCT00105989|4267213|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
1741806|NCT00105989|4267214|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
1741807|NCT00105989|4267213|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
1741808|NCT00105989|4267214|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
1741809|NCT00105989|4267213|P2|STARTED|Continuation - Open Label:Week 10-34||0
1741810|NCT00105989|4267214|P1|STARTED|Continuation - Open Label:Week 10-34||413
1741811|NCT00105989|4267213|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
1741812|NCT00105989|4267214|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
1741813|NCT00105989|4267213|P2|COMPLETED|Acute - Open Label: Week 0-10||0
1741814|NCT00105989|4267214|P1|COMPLETED|Acute - Open Label: Week 0-10||413
1741815|NCT00105989|4267213|P2|STARTED|Acute - Open Label: Week 0-10||0
1741816|NCT00105989|4267214|P1|STARTED|Acute - Open Label: Week 0-10||514
1741817|NCT00105586|4267330|P2|NOT COMPLETED|Overall Study||16
1741818|NCT00105586|4267331|P1|NOT COMPLETED|Overall Study||17
1741819|NCT00105586|4267330|P2|COMPLETED|Overall Study||69
1741820|NCT00105586|4267331|P1|COMPLETED|Overall Study||75
1741821|NCT00105586|4267330|P2|STARTED|Overall Study||85
1741822|NCT00105586|4267331|P1|STARTED|Overall Study||92
1741823|NCT00105560|4267339|P1|NOT COMPLETED|Overall Study||1
1741824|NCT00105560|4267339|P1|COMPLETED|Overall Study||58
1741825|NCT00105560|4267339|P1|STARTED|Overall Study||59
1741826|NCT00105534|4267361|P2|NOT COMPLETED|Overall Study||33
1741827|NCT00105534|4267362|P1|NOT COMPLETED|Overall Study||22
1741828|NCT00105534|4267361|P2|COMPLETED|Overall Study||317
1741829|NCT00105534|4267362|P1|COMPLETED|Overall Study||313
1741830|NCT00105534|4267361|P2|STARTED|Overall Study||350
1741831|NCT00105534|4267362|P1|STARTED|Overall Study||335
1741832|NCT00105521|4267374|P4|NOT COMPLETED|Overall Study||17
1741833|NCT00105521|4267375|P3|NOT COMPLETED|Overall Study||17
1741834|NCT00105521|4267376|P2|NOT COMPLETED|Overall Study||11
1741835|NCT00105521|4267377|P1|NOT COMPLETED|Overall Study||15
1741836|NCT00105521|4267374|P4|COMPLETED|Overall Study||85
1741837|NCT00105521|4267375|P3|COMPLETED|Overall Study||80
1741838|NCT00105521|4267376|P2|COMPLETED|Overall Study||90
1741839|NCT00105521|4267377|P1|COMPLETED|Overall Study||83
1741840|NCT00105521|4267374|P4|STARTED|Overall Study||102
1741841|NCT00105521|4267375|P3|STARTED|Overall Study||97
1741842|NCT00105521|4267376|P2|STARTED|Overall Study||101
1741843|NCT00105521|4267377|P1|STARTED|Overall Study||98
1741844|NCT00105508|4267401|P2|NOT COMPLETED|Overall Study||36
1741845|NCT00105508|4267402|P1|NOT COMPLETED|Overall Study||40
1741846|NCT00105508|4267401|P2|COMPLETED|Overall Study||217
1741847|NCT00105508|4267402|P1|COMPLETED|Overall Study||213
1741848|NCT00105508|4267401|P2|STARTED|Overall Study||253
1741849|NCT00105508|4267402|P1|STARTED|Overall Study||253
1741850|NCT00105482|4267416|P2|NOT COMPLETED|Overall Study||55
1741851|NCT00105482|4267417|P1|NOT COMPLETED|Overall Study||59
1741852|NCT00105482|4267416|P2|COMPLETED|Overall Study||30
1741853|NCT00105482|4267417|P1|COMPLETED|Overall Study||28
1741854|NCT00105482|4267416|P2|STARTED|Overall Study||85
1741855|NCT00105482|4267417|P1|STARTED|Overall Study||87
1741856|NCT00105469|4267433|P2|NOT COMPLETED|Overall Study||11
1741857|NCT00105469|4267434|P1|NOT COMPLETED|Overall Study||22
1741858|NCT00105469|4267433|P2|COMPLETED|Overall Study||367
1741859|NCT00105469|4267434|P1|COMPLETED|Overall Study||343
1741860|NCT00105469|4267433|P2|STARTED|Overall Study||378
1741861|NCT00105469|4267434|P1|STARTED|Overall Study||365
1741862|NCT00105443|4267444|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
1741863|NCT00105443|4267445|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
1741864|NCT00105443|4267446|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
1741865|NCT00105443|4267447|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
1741866|NCT00105443|4267444|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
1741867|NCT00105443|4267445|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
1741868|NCT00105443|4267446|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
1741869|NCT00105443|4267447|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
1741870|NCT00105443|4267444|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
1741871|NCT00105443|4267445|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
1741872|NCT00105443|4267446|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
1741873|NCT00105443|4267447|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
1741874|NCT00105443|4267444|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
1741875|NCT00105443|4267445|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
1741876|NCT00105443|4267446|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
1741877|NCT00105443|4267447|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
1741878|NCT00105443|4267444|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
1741879|NCT00105443|4267445|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
1741880|NCT00105443|4267446|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
1741881|NCT00105443|4267447|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
1741882|NCT00105443|4267444|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
1741883|NCT00105443|4267445|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
1741884|NCT00105443|4267446|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
1741885|NCT00105443|4267447|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
1741886|NCT00105443|4267444|P4|NOT COMPLETED|Double-Blind Treatment||0
1741887|NCT00105443|4267445|P3|NOT COMPLETED|Double-Blind Treatment||11
1741888|NCT00105443|4267446|P2|NOT COMPLETED|Double-Blind Treatment||0
1741889|NCT00105443|4267447|P1|NOT COMPLETED|Double-Blind Treatment||14
1741890|NCT00105443|4267444|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
1741891|NCT00105443|4267445|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
1741892|NCT00105443|4267446|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
1741893|NCT00105443|4267447|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
1741894|NCT00105443|4267444|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
1741895|NCT00105443|4267445|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
1741896|NCT00105443|4267446|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
1741897|NCT00105443|4267447|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
1741898|NCT00105443|4267444|P4|STARTED|Double-Blind Treatment||47
1741899|NCT00105443|4267445|P3|STARTED|Double-Blind Treatment||256
1741900|NCT00105443|4267446|P2|STARTED|Double-Blind Treatment||57
1741901|NCT00105443|4267447|P1|STARTED|Double-Blind Treatment||242
1741902|NCT00105235|4267474|P1|NOT COMPLETED|Overall Study||7
1741903|NCT00105235|4267474|P1|COMPLETED|Overall Study||20
1741904|NCT00105235|4267474|P1|STARTED|Overall Study||27
1741905|NCT00105196|4267487|P2|NOT COMPLETED|Overall Study||23
1741906|NCT00105196|4267488|P1|NOT COMPLETED|Overall Study||30
1741907|NCT00105196|4267487|P2|COMPLETED|Overall Study||149
1741908|NCT00105196|4267488|P1|COMPLETED|Overall Study||147
1741909|NCT00105196|4267487|P2|STARTED|Overall Study||172
1741910|NCT00105196|4267488|P1|STARTED|Overall Study||177
1741911|NCT00105183|4267511|P3|NOT COMPLETED|Overall Study||23
1741912|NCT00105183|4267512|P2|NOT COMPLETED|Overall Study||19
1741913|NCT00105183|4267513|P1|NOT COMPLETED|Overall Study||22
1741914|NCT00105183|4267511|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
1741915|NCT00105183|4267512|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
1741916|NCT00105183|4267513|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
1741917|NCT00105183|4267511|P3|STARTED|Overall Study|Randomized|62
1741918|NCT00105183|4267512|P2|STARTED|Overall Study|Randomized|79
1741919|NCT00105183|4267513|P1|STARTED|Overall Study|Randomized|82
1741920|NCT00105157|4267549|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
1741921|NCT00105157|4267550|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
1741922|NCT00105157|4267551|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
1741923|NCT00105157|4267552|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
1741924|NCT00105157|4267549|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
1741925|NCT00105157|4267550|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
1741926|NCT00105157|4267551|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
1741927|NCT00105157|4267552|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
1741928|NCT00105157|4267549|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
1741929|NCT00105157|4267550|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
1741930|NCT00105157|4267551|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
1741931|NCT00105157|4267552|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
1741932|NCT00105157|4267549|P4|NOT COMPLETED|Open-Label Continuation of DB||1
1741933|NCT00105157|4267550|P3|NOT COMPLETED|Open-Label Continuation of DB||9
1741934|NCT00105157|4267551|P2|NOT COMPLETED|Open-Label Continuation of DB||10
1741935|NCT00105157|4267552|P1|NOT COMPLETED|Open-Label Continuation of DB||7
1741936|NCT00105157|4267549|P4|COMPLETED|Open-Label Continuation of DB||5
1741937|NCT00105157|4267550|P3|COMPLETED|Open-Label Continuation of DB||24
1741938|NCT00105157|4267551|P2|COMPLETED|Open-Label Continuation of DB||21
1741939|NCT00105157|4267552|P1|COMPLETED|Open-Label Continuation of DB||23
1741940|NCT00105157|4267549|P4|STARTED|Open-Label Continuation of DB||6
1741941|NCT00105157|4267550|P3|STARTED|Open-Label Continuation of DB||33
1741942|NCT00105157|4267551|P2|STARTED|Open-Label Continuation of DB||31
1741943|NCT00105157|4267552|P1|STARTED|Open-Label Continuation of DB||30
1741944|NCT00105157|4267549|P4|NOT COMPLETED|Double-Blind (DB)||39
1741945|NCT00105157|4267550|P3|NOT COMPLETED|Double-Blind (DB)||12
1741946|NCT00105157|4267551|P2|NOT COMPLETED|Double-Blind (DB)||14
1741947|NCT00105157|4267552|P1|NOT COMPLETED|Double-Blind (DB)||14
1741948|NCT00105157|4267549|P4|COMPLETED|Double-Blind (DB)||6
1741949|NCT00105157|4267550|P3|COMPLETED|Double-Blind (DB)||33
1741950|NCT00105157|4267551|P2|COMPLETED|Double-Blind (DB)||31
1741951|NCT00105157|4267552|P1|COMPLETED|Double-Blind (DB)||30
1741952|NCT00105157|4267549|P4|Treated|Double-Blind (DB)||45
1741953|NCT00105157|4267550|P3|Treated|Double-Blind (DB)||45
1741954|NCT00105157|4267551|P2|Treated|Double-Blind (DB)||45
1741955|NCT00105157|4267552|P1|Treated|Double-Blind (DB)||43
1741956|NCT00105157|4267549|P4|STARTED|Double-Blind (DB)||45
1741957|NCT00105157|4267550|P3|STARTED|Double-Blind (DB)||45
1741958|NCT00105157|4267551|P2|STARTED|Double-Blind (DB)||45
1741959|NCT00105157|4267552|P1|STARTED|Double-Blind (DB)||44
1741960|NCT00105079|4267746|P2|NOT COMPLETED|Overall Study||35
1741961|NCT00105079|4267747|P1|NOT COMPLETED|Overall Study||39
1741962|NCT00105079|4267746|P2|COMPLETED|Overall Study||135
1741963|NCT00105079|4267747|P1|COMPLETED|Overall Study||128
1741964|NCT00105079|4267746|P2|Safety Population|Overall Study||168
1741965|NCT00105079|4267747|P1|Safety Population|Overall Study||163
1741966|NCT00105079|4267746|P2|STARTED|Overall Study||170
1741967|NCT00105079|4267747|P1|STARTED|Overall Study||167
1741968|NCT00105066|4267765|P2|NOT COMPLETED|Overall Study||5
1741969|NCT00105066|4267766|P1|NOT COMPLETED|Overall Study||2
1741970|NCT00105066|4267765|P2|COMPLETED|Overall Study||45
1741971|NCT00105066|4267766|P1|COMPLETED|Overall Study||25
1741972|NCT00105066|4267765|P2|STARTED|Overall Study||50
1741973|NCT00105066|4267766|P1|STARTED|Overall Study||27
1741974|NCT00105027|4267782|P6|NOT COMPLETED|Overall Study||13
1741975|NCT00105027|4267783|P5|NOT COMPLETED|Overall Study||15
1741976|NCT00105027|4267784|P4|NOT COMPLETED|Overall Study||16
1741977|NCT00105027|4267785|P3|NOT COMPLETED|Overall Study||9
1741978|NCT00105027|4267786|P2|NOT COMPLETED|Overall Study||9
1741979|NCT00105027|4267787|P1|NOT COMPLETED|Overall Study||15
1741980|NCT00105027|4267782|P6|COMPLETED|Overall Study||125
1741981|NCT00105027|4267783|P5|COMPLETED|Overall Study||121
1741982|NCT00105027|4267784|P4|COMPLETED|Overall Study||121
1741983|NCT00105027|4267785|P3|COMPLETED|Overall Study||82
1741984|NCT00105027|4267786|P2|COMPLETED|Overall Study||83
1741985|NCT00105027|4267787|P1|COMPLETED|Overall Study||73
1741986|NCT00105027|4267782|P6|STARTED|Overall Study||138
1741987|NCT00105027|4267783|P5|STARTED|Overall Study||136
1741988|NCT00105027|4267784|P4|STARTED|Overall Study||137
1741989|NCT00105027|4267785|P3|STARTED|Overall Study||91
1741990|NCT00105027|4267786|P2|STARTED|Overall Study||92
1741991|NCT00105027|4267787|P1|STARTED|Overall Study||88
1741992|NCT00105001|4267822|P3|NOT COMPLETED|Overall Study||0
1741993|NCT00105001|4267823|P2|NOT COMPLETED|Overall Study||0
1741994|NCT00105001|4267824|P1|NOT COMPLETED|Overall Study||0
1741995|NCT00105001|4267822|P3|COMPLETED|Overall Study||69
1741996|NCT00105001|4267823|P2|COMPLETED|Overall Study||71
1741997|NCT00105001|4267824|P1|COMPLETED|Overall Study||70
1741998|NCT00105001|4267822|P3|STARTED|Overall Study||69
1741999|NCT00105001|4267823|P2|STARTED|Overall Study||71
1742000|NCT00105001|4267824|P1|STARTED|Overall Study||70
1742001|NCT00104884|4267844|P1|NOT COMPLETED|Overall Study||4
1742002|NCT00104884|4267844|P1|COMPLETED|Overall Study||0
1742003|NCT00104884|4267844|P1|STARTED|Overall Study||4
1742004|NCT00104871|4267848|P1|NOT COMPLETED|Overall Study||1
1742005|NCT00104871|4267848|P1|COMPLETED|Overall Study||21
1742006|NCT00104871|4267848|P1|STARTED|Overall Study||22
1742007|NCT00104728|4267854|P1|NOT COMPLETED|Overall Study||19
1742008|NCT00104728|4267854|P1|COMPLETED|Overall Study||23
1742009|NCT00104728|4267854|P1|STARTED|Overall Study|42 consented on study|42
1742010|NCT00104650|4267862|P3|NOT COMPLETED|Follow-up Period||10
1742011|NCT00104650|4267863|P2|NOT COMPLETED|Follow-up Period||13
1742012|NCT00104650|4267864|P1|NOT COMPLETED|Follow-up Period||11
1742013|NCT00104650|4267862|P3|COMPLETED|Follow-up Period||18
1742014|NCT00104650|4267863|P2|COMPLETED|Follow-up Period||12
1742015|NCT00104650|4267864|P1|COMPLETED|Follow-up Period||14
1742016|NCT00104650|4267862|P3|STARTED|Follow-up Period||28
1742017|NCT00104650|4267863|P2|STARTED|Follow-up Period||25
1742018|NCT00104650|4267864|P1|STARTED|Follow-up Period||25
1742019|NCT00104650|4267862|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
1742020|NCT00104650|4267863|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
1742021|NCT00104650|4267864|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
1742022|NCT00104650|4267862|P3|COMPLETED|Treatment Period (25 Weeks)||28
1742023|NCT00104650|4267863|P2|COMPLETED|Treatment Period (25 Weeks)||25
1742024|NCT00104650|4267864|P1|COMPLETED|Treatment Period (25 Weeks)||25
1742025|NCT00104650|4267862|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
1742026|NCT00104650|4267863|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
1742027|NCT00104650|4267864|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
1742028|NCT00104650|4267862|P3|STARTED|Treatment Period (25 Weeks)||38
1742029|NCT00104650|4267863|P2|STARTED|Treatment Period (25 Weeks)||36
1742030|NCT00104650|4267864|P1|STARTED|Treatment Period (25 Weeks)||37
1742031|NCT00104637|4267896|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
1742032|NCT00104637|4267897|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
1742033|NCT00104637|4267896|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
1742034|NCT00104637|4267897|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
1742035|NCT00104637|4267896|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
1742036|NCT00104637|4267897|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
1742037|NCT00104637|4267896|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
1742038|NCT00104637|4267897|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
1742039|NCT00104637|4267896|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
1742040|NCT00104637|4267897|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
1742041|NCT00104637|4267896|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
1742042|NCT00104637|4267897|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
1742043|NCT00104637|4267896|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
1742044|NCT00104637|4267897|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
1742045|NCT00104637|4267896|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
1742046|NCT00104637|4267897|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
1742047|NCT00104637|4267896|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
1742048|NCT00104637|4267897|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
1742049|NCT00104572|4267926|P3|NOT COMPLETED|Overall Study||0
1742050|NCT00104572|4267927|P2|NOT COMPLETED|Overall Study||3
1742051|NCT00104572|4267928|P1|NOT COMPLETED|Overall Study||3
1742052|NCT00104572|4267926|P3|COMPLETED|Overall Study||9
1742053|NCT00104572|4267927|P2|COMPLETED|Overall Study||10
1742054|NCT00104572|4267928|P1|COMPLETED|Overall Study||10
1742055|NCT00104572|4267926|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
1742056|NCT00104572|4267927|P2|STARTED|Overall Study|These are the analysed subjects|13
1742057|NCT00104572|4267928|P1|STARTED|Overall Study|These are the analysed subjects|13
1742058|NCT00104520|4267947|P2|NOT COMPLETED|Overall Study||71
1742059|NCT00104520|4267948|P1|NOT COMPLETED|Overall Study||50
1742060|NCT00104520|4267947|P2|COMPLETED|Overall Study||64
1742061|NCT00104520|4267948|P1|COMPLETED|Overall Study||26
1742062|NCT00104520|4267947|P2|STARTED|Overall Study||135
1742063|NCT00104520|4267948|P1|STARTED|Overall Study||76
1742064|NCT00104416|4267968|P5|NOT COMPLETED|Continuation Phase||5
1742065|NCT00104416|4267969|P4|NOT COMPLETED|Continuation Phase||2
1742066|NCT00104416|4267970|P3|NOT COMPLETED|Continuation Phase||6
1742067|NCT00104416|4267971|P2|NOT COMPLETED|Continuation Phase||0
1742068|NCT00104416|4267972|P1|NOT COMPLETED|Continuation Phase||0
1742069|NCT00104416|4267968|P5|COMPLETED|Continuation Phase||27
1742070|NCT00104416|4267969|P4|COMPLETED|Continuation Phase||65
1742071|NCT00104416|4267970|P3|COMPLETED|Continuation Phase||63
1742072|NCT00104416|4267971|P2|COMPLETED|Continuation Phase||0
1742073|NCT00104416|4267972|P1|COMPLETED|Continuation Phase||0
1742074|NCT00104416|4267968|P5|STARTED|Continuation Phase||32
1742075|NCT00104416|4267969|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
1742076|NCT00104416|4267970|P3|STARTED|Continuation Phase||69
1742077|NCT00104416|4267971|P2|STARTED|Continuation Phase||0
1742078|NCT00104416|4267972|P1|STARTED|Continuation Phase||0
1742079|NCT00104416|4267968|P5|NOT COMPLETED|Double-Blind Phase||0
1742080|NCT00104416|4267969|P4|NOT COMPLETED|Double-Blind Phase||0
1742081|NCT00104416|4267970|P3|NOT COMPLETED|Double-Blind Phase||0
1742082|NCT00104416|4267971|P2|NOT COMPLETED|Double-Blind Phase||10
1742083|NCT00104416|4267972|P1|NOT COMPLETED|Double-Blind Phase||8
1742084|NCT00104416|4267968|P5|COMPLETED|Double-Blind Phase||0
1742085|NCT00104416|4267969|P4|COMPLETED|Double-Blind Phase||0
1742086|NCT00104416|4267970|P3|COMPLETED|Double-Blind Phase||0
1742087|NCT00104416|4267971|P2|COMPLETED|Double-Blind Phase||66
1742088|NCT00104416|4267972|P1|COMPLETED|Double-Blind Phase||69
1742089|NCT00104416|4267968|P5|STARTED|Double-Blind Phase||0
1742090|NCT00104416|4267969|P4|STARTED|Double-Blind Phase||0
1742091|NCT00104416|4267970|P3|STARTED|Double-Blind Phase||0
1742092|NCT00104416|4267971|P2|STARTED|Double-Blind Phase||76
1742093|NCT00104416|4267972|P1|STARTED|Double-Blind Phase||77
1742094|NCT00104299|4268017|P2|NOT COMPLETED|Overall Study||10
1742095|NCT00104299|4268018|P1|NOT COMPLETED|Overall Study||9
1742096|NCT00104299|4268017|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
1742097|NCT00104299|4268018|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
1742098|NCT00104299|4268017|P2|STARTED|Overall Study||98
1742099|NCT00104299|4268018|P1|STARTED|Overall Study||99
1742100|NCT00104247|4268040|P2|NOT COMPLETED|Overall Study||1
1742101|NCT00104247|4268041|P1|NOT COMPLETED|Overall Study||1
1742102|NCT00104247|4268040|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
1742103|NCT00104247|4268041|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
1742104|NCT00104247|4268040|P2|STARTED|Overall Study||47
1742105|NCT00104247|4268041|P1|STARTED|Overall Study||42
1742106|NCT00104234|4268049|P2|NOT COMPLETED|Overall Study||1
1742107|NCT00104234|4268050|P1|NOT COMPLETED|Overall Study||0
1742108|NCT00104234|4268049|P2|COMPLETED|Overall Study||19
1742109|NCT00104234|4268050|P1|COMPLETED|Overall Study||19
1742110|NCT00104234|4268049|P2|STARTED|Overall Study||20
1742111|NCT00104234|4268050|P1|STARTED|Overall Study||19
1742112|NCT00104104|4268060|P2|NOT COMPLETED|Overall Study||72
1742113|NCT00104104|4268061|P1|NOT COMPLETED|Overall Study||75
1742114|NCT00104104|4268060|P2|COMPLETED|Overall Study||17
1742115|NCT00104104|4268061|P1|COMPLETED|Overall Study||15
1742116|NCT00104104|4268060|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
1742117|NCT00104104|4268061|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
1742118|NCT00104104|4268060|P2|Safety Population (Including Site 74)|Overall Study||88
1742119|NCT00104104|4268061|P1|Safety Population (Including Site 74)|Overall Study||88
1742120|NCT00104104|4268060|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
1742121|NCT00104104|4268061|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
1742122|NCT00104052|4268075|P1|NOT COMPLETED|Overall Study||29
1742123|NCT00104052|4268075|P1|COMPLETED|Overall Study||78
1742124|NCT00104052|4268075|P1|STARTED|Overall Study||107
1742125|NCT00103857|4268086|P7|NOT COMPLETED|50-Week Extension Study||0
1742126|NCT00103857|4268087|P6|NOT COMPLETED|50-Week Extension Study||20
1742127|NCT00103857|4268088|P5|NOT COMPLETED|50-Week Extension Study||21
1742128|NCT00103857|4268089|P4|NOT COMPLETED|50-Week Extension Study||36
1742129|NCT00103857|4268090|P3|NOT COMPLETED|50-Week Extension Study||26
1742130|NCT00103857|4268091|P2|NOT COMPLETED|50-Week Extension Study||27
1742131|NCT00103857|4268092|P1|NOT COMPLETED|50-Week Extension Study||38
1742132|NCT00103857|4268086|P7|COMPLETED|50-Week Extension Study||0
1742133|NCT00103857|4268087|P6|COMPLETED|50-Week Extension Study||78
1742134|NCT00103857|4268088|P5|COMPLETED|50-Week Extension Study||101
1742135|NCT00103857|4268089|P4|COMPLETED|50-Week Extension Study||98
1742136|NCT00103857|4268090|P3|COMPLETED|50-Week Extension Study||95
1742137|NCT00103857|4268091|P2|COMPLETED|50-Week Extension Study||80
1742138|NCT00103857|4268092|P1|COMPLETED|50-Week Extension Study||65
1742139|NCT00103857|4268086|P7|STARTED|50-Week Extension Study||0
1742140|NCT00103857|4268087|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
1742141|NCT00103857|4268088|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
1742142|NCT00103857|4268089|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
1742143|NCT00103857|4268090|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
1742144|NCT00103857|4268091|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
1742145|NCT00103857|4268092|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
1742146|NCT00103857|4268086|P7|NOT COMPLETED|54-Week Base Study||38
1742147|NCT00103857|4268087|P6|NOT COMPLETED|54-Week Base Study||61
1742148|NCT00103857|4268088|P5|NOT COMPLETED|54-Week Base Study||41
1742149|NCT00103857|4268089|P4|NOT COMPLETED|54-Week Base Study||42
1742150|NCT00103857|4268090|P3|NOT COMPLETED|54-Week Base Study||47
1742151|NCT00103857|4268091|P2|NOT COMPLETED|54-Week Base Study||56
1742152|NCT00103857|4268092|P1|NOT COMPLETED|54-Week Base Study||57
1742153|NCT00103857|4268086|P7|COMPLETED|54-Week Base Study||79
1742154|NCT00103857|4268087|P6|COMPLETED|54-Week Base Study||115
1742155|NCT00103857|4268088|P5|COMPLETED|54-Week Base Study||141
1742156|NCT00103857|4268089|P4|COMPLETED|54-Week Base Study||148
1742157|NCT00103857|4268090|P3|COMPLETED|54-Week Base Study||135
1742158|NCT00103857|4268091|P2|COMPLETED|54-Week Base Study||126
1742159|NCT00103857|4268092|P1|COMPLETED|54-Week Base Study||122
1742160|NCT00103857|4268086|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
1742161|NCT00103857|4268087|P6|STARTED|54-Week Base Study||176
1742162|NCT00103857|4268088|P5|STARTED|54-Week Base Study||182
1742163|NCT00103857|4268089|P4|STARTED|54-Week Base Study||190
1742164|NCT00103857|4268090|P3|STARTED|54-Week Base Study||182
1742165|NCT00103857|4268091|P2|STARTED|54-Week Base Study||182
1742166|NCT00103857|4268092|P1|STARTED|54-Week Base Study||179
1742167|NCT00103844|4268157|P2|NOT COMPLETED|Overall Study||0
1742168|NCT00103844|4268158|P1|NOT COMPLETED|Overall Study||0
1742169|NCT00103844|4268157|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
1742170|NCT00103844|4268158|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
1742171|NCT00103844|4268157|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
1742172|NCT00103844|4268158|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
1742173|NCT00103844|4268157|P2|STARTED|Overall Study||49
1742174|NCT00103844|4268158|P1|STARTED|Overall Study||101
1742175|NCT00103740|4268191|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
1742176|NCT00103740|4268192|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
1742177|NCT00103740|4268191|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
1742178|NCT00103740|4268192|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
1742179|NCT00103740|4268191|P2|STARTED|Period 2 - Extended Observation Period||63
1742180|NCT00103740|4268192|P1|STARTED|Period 2 - Extended Observation Period||78
1742181|NCT00103740|4268191|P2|NOT COMPLETED|Period 1 - Core||4
1742182|NCT00103740|4268192|P1|NOT COMPLETED|Period 1 - Core||7
1742183|NCT00103740|4268191|P2|COMPLETED|Period 1 - Core||89
1742184|NCT00103740|4268192|P1|COMPLETED|Period 1 - Core||85
1742185|NCT00103740|4268191|P2|STARTED|Period 1 - Core||93
1742186|NCT00103740|4268192|P1|STARTED|Period 1 - Core||92
1742187|NCT00103662|4268220|P2|NOT COMPLETED|Overall Study||33
1742188|NCT00103662|4268221|P1|NOT COMPLETED|Overall Study||19
1742189|NCT00103662|4268220|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
1742190|NCT00103662|4268221|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
1742191|NCT00103662|4268220|P2|STARTED|Overall Study||154
1742192|NCT00103662|4268221|P1|STARTED|Overall Study||148
1742193|NCT00103610|4268247|P2|NOT COMPLETED|Overall Study||80
1742194|NCT00103610|4268248|P1|NOT COMPLETED|Overall Study||38
1742195|NCT00103610|4268247|P2|COMPLETED|Overall Study||68
1742196|NCT00103610|4268248|P1|COMPLETED|Overall Study||112
1742197|NCT00103610|4268247|P2|STARTED|Overall Study||148
1742198|NCT00103610|4268248|P1|STARTED|Overall Study||150
1742199|NCT00103506|4268272|P2|NOT COMPLETED|Overall Study||324
1742200|NCT00103506|4268273|P1|NOT COMPLETED|Overall Study||322
1742201|NCT00103506|4268272|P2|COMPLETED|Overall Study||0
1742202|NCT00103506|4268273|P1|COMPLETED|Overall Study||0
1742203|NCT00103506|4268272|P2|STARTED|Overall Study||324
1742204|NCT00103506|4268273|P1|STARTED|Overall Study||322
1742205|NCT00103376|4268286|P3|NOT COMPLETED|Overall Study||0
1742206|NCT00103376|4268287|P2|NOT COMPLETED|Overall Study||0
1742207|NCT00103376|4268288|P1|NOT COMPLETED|Overall Study||0
1742208|NCT00103376|4268286|P3|COMPLETED|Overall Study||8
1742209|NCT00103376|4268287|P2|COMPLETED|Overall Study||7
1742210|NCT00103376|4268288|P1|COMPLETED|Overall Study||8
1742211|NCT00103376|4268286|P3|STARTED|Overall Study||8
1742212|NCT00103376|4268287|P2|STARTED|Overall Study||7
1742213|NCT00103376|4268288|P1|STARTED|Overall Study||8
1742214|NCT00103311|4268304|P2|NOT COMPLETED|Overall Study||1
1742215|NCT00103311|4268305|P1|NOT COMPLETED|Overall Study||4
1742216|NCT00103311|4268304|P2|COMPLETED|Overall Study||30
1742217|NCT00103311|4268305|P1|COMPLETED|Overall Study||29
1742218|NCT00103311|4268304|P2|STARTED|Overall Study||31
1742219|NCT00103311|4268305|P1|STARTED|Overall Study||33
1742220|NCT00103285|4268315|P8|NOT COMPLETED|Response Assignment||120
1742221|NCT00103285|4268316|P7|NOT COMPLETED|Response Assignment||49
1742222|NCT00103285|4268317|P6|NOT COMPLETED|Response Assignment||48
1742223|NCT00103285|4268318|P5|NOT COMPLETED|Response Assignment||84
1742224|NCT00103285|4268319|P4|NOT COMPLETED|Response Assignment||62
1742225|NCT00103285|4268320|P3|NOT COMPLETED|Response Assignment||84
1742226|NCT00103285|4268321|P2|NOT COMPLETED|Response Assignment||132
1742227|NCT00103285|4268322|P1|NOT COMPLETED|Response Assignment||0
1742228|NCT00103285|4268315|P8|COMPLETED|Response Assignment||523
1742229|NCT00103285|4268316|P7|COMPLETED|Response Assignment||199
1742230|NCT00103285|4268317|P6|COMPLETED|Response Assignment||201
1742231|NCT00103285|4268318|P5|COMPLETED|Response Assignment||425
1742232|NCT00103285|4268319|P4|COMPLETED|Response Assignment||441
1742233|NCT00103285|4268320|P3|COMPLETED|Response Assignment||853
1742234|NCT00103285|4268321|P2|COMPLETED|Response Assignment||807
1742235|NCT00103285|4268322|P1|COMPLETED|Response Assignment||0
1742236|NCT00103285|4268315|P8|STARTED|Response Assignment||643
1742237|NCT00103285|4268316|P7|STARTED|Response Assignment||248
1742238|NCT00103285|4268317|P6|STARTED|Response Assignment||249
1742239|NCT00103285|4268318|P5|STARTED|Response Assignment||509
1742240|NCT00103285|4268319|P4|STARTED|Response Assignment||503
1742241|NCT00103285|4268320|P3|STARTED|Response Assignment||937
1742242|NCT00103285|4268321|P2|STARTED|Response Assignment||939
1742243|NCT00103285|4268322|P1|STARTED|Response Assignment||0
1742244|NCT00103285|4268315|P8|NOT COMPLETED|Induction||0
1742245|NCT00103285|4268316|P7|NOT COMPLETED|Induction||0
1742246|NCT00103285|4268317|P6|NOT COMPLETED|Induction||0
1742247|NCT00103285|4268318|P5|NOT COMPLETED|Induction||0
1742248|NCT00103285|4268319|P4|NOT COMPLETED|Induction||0
1742249|NCT00103285|4268320|P3|NOT COMPLETED|Induction||0
1742250|NCT00103285|4268321|P2|NOT COMPLETED|Induction||0
1742251|NCT00103285|4268322|P1|NOT COMPLETED|Induction||1349
1742252|NCT00103285|4268315|P8|COMPLETED|Induction||0
1742253|NCT00103285|4268316|P7|COMPLETED|Induction||0
1742254|NCT00103285|4268317|P6|COMPLETED|Induction||0
1742255|NCT00103285|4268318|P5|COMPLETED|Induction||0
1742256|NCT00103285|4268319|P4|COMPLETED|Induction||0
1742257|NCT00103285|4268320|P3|COMPLETED|Induction||0
1742258|NCT00103285|4268321|P2|COMPLETED|Induction||0
1742259|NCT00103285|4268322|P1|COMPLETED|Induction||4028
1742260|NCT00103285|4268315|P8|STARTED|Induction||0
1742261|NCT00103285|4268316|P7|STARTED|Induction||0
1742262|NCT00103285|4268317|P6|STARTED|Induction||0
1742263|NCT00103285|4268318|P5|STARTED|Induction||0
1742264|NCT00103285|4268319|P4|STARTED|Induction||0
1742265|NCT00103285|4268320|P3|STARTED|Induction||0
1742266|NCT00103285|4268321|P2|STARTED|Induction||0
1742267|NCT00103285|4268322|P1|STARTED|Induction||5377
1742268|NCT00103259|4268351|P2|NOT COMPLETED|Overall Study||12
1742269|NCT00103259|4268352|P1|NOT COMPLETED|Overall Study||12
1742270|NCT00103259|4268351|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
1742271|NCT00103259|4268352|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
1742272|NCT00103259|4268351|P2|Eligible Patients Who Cross Over|Overall Study||10
1742273|NCT00103259|4268352|P1|Eligible Patients Who Cross Over|Overall Study||0
1742274|NCT00103259|4268351|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
1742275|NCT00103259|4268352|P1|Cross Over to the Other Arm|Overall Study||0
1742276|NCT00103259|4268351|P2|Eligible and Treated|Overall Study||38
1742277|NCT00103259|4268352|P1|Eligible and Treated|Overall Study||23
1742278|NCT00103259|4268351|P2|Treated|Overall Study||41
1742279|NCT00103259|4268352|P1|Treated|Overall Study||23
1742280|NCT00103259|4268351|P2|Eligible|Overall Study||41
1742281|NCT00103259|4268352|P1|Eligible|Overall Study||27
1742282|NCT00103259|4268351|P2|STARTED|Overall Study||44
1742283|NCT00103259|4268352|P1|STARTED|Overall Study||27
1742284|NCT00103207|4268364|P1|NOT COMPLETED|Overall Study||38
1742285|NCT00103207|4268364|P1|COMPLETED|Overall Study||34
1742286|NCT00103207|4268364|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
1742287|NCT00103207|4268364|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
1742288|NCT00103207|4268364|P1|STARTED|Overall Study||72
1742289|NCT00103194|4268374|P1|NOT COMPLETED|Overall Study||31
1742290|NCT00103194|4268374|P1|COMPLETED|Overall Study||18
1742291|NCT00103194|4268374|P1|Eligible and Treated|Overall Study||35
1742292|NCT00103194|4268374|P1|Eligible|Overall Study||35
1742293|NCT00103194|4268374|P1|Treated|Overall Study||49
1742294|NCT00103194|4268374|P1|STARTED|Overall Study||49
1742295|NCT00103142|4268383|P2|NOT COMPLETED|Overall Study||1
1742296|NCT00103142|4268384|P1|NOT COMPLETED|Overall Study||3
1742297|NCT00103142|4268383|P2|COMPLETED|Overall Study||36
1742298|NCT00103142|4268384|P1|COMPLETED|Overall Study||33
1742299|NCT00103142|4268383|P2|STARTED|Overall Study||37
1742300|NCT00103142|4268384|P1|STARTED|Overall Study||36
1742301|NCT00103116|4268392|P1|NOT COMPLETED|Overall Study||0
1742302|NCT00103116|4268392|P1|COMPLETED|Overall Study||32
1742303|NCT00103116|4268392|P1|STARTED|Overall Study||32
1742304|NCT00103012|4268400|P3|NOT COMPLETED|Overall Study||4
1742305|NCT00103012|4268401|P2|NOT COMPLETED|Overall Study||1
1742306|NCT00103012|4268402|P1|NOT COMPLETED|Overall Study||3
1742307|NCT00103012|4268400|P3|COMPLETED|Overall Study||12
1742308|NCT00103012|4268401|P2|COMPLETED|Overall Study||13
1742309|NCT00103012|4268402|P1|COMPLETED|Overall Study||14
1742310|NCT00103012|4268400|P3|STARTED|Overall Study||16
1742311|NCT00103012|4268401|P2|STARTED|Overall Study||14
1742312|NCT00103012|4268402|P1|STARTED|Overall Study||17
1742313|NCT00102960|4268413|P3|NOT COMPLETED|Overall Study||28
1742314|NCT00102960|4268414|P2|NOT COMPLETED|Overall Study||23
1742315|NCT00102960|4268415|P1|NOT COMPLETED|Overall Study||30
1742316|NCT00102960|4268413|P3|COMPLETED|Overall Study||98
1742317|NCT00102960|4268414|P2|COMPLETED|Overall Study||103
1742318|NCT00102960|4268415|P1|COMPLETED|Overall Study||95
1742319|NCT00102960|4268413|P3|STARTED|Overall Study||126
1742320|NCT00102960|4268414|P2|STARTED|Overall Study||126
1742321|NCT00102960|4268415|P1|STARTED|Overall Study||125
1742322|NCT00102804|4268464|P2|NOT COMPLETED|Overall Study||222
1742323|NCT00102804|4268465|P1|NOT COMPLETED|Overall Study||441
1742324|NCT00102804|4268464|P2|COMPLETED|Overall Study||0
1742325|NCT00102804|4268465|P1|COMPLETED|Overall Study||0
1742326|NCT00102804|4268464|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
1742327|NCT00102804|4268465|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
1742328|NCT00102804|4268464|P2|STARTED|Overall Study||222
1742329|NCT00102804|4268465|P1|STARTED|Overall Study||441
1742330|NCT00102687|4268486|P5|NOT COMPLETED|Maintenance Period||13
1742331|NCT00102687|4268487|P4|NOT COMPLETED|Maintenance Period||10
1742332|NCT00102687|4268488|P3|NOT COMPLETED|Maintenance Period||6
1742333|NCT00102687|4268489|P2|NOT COMPLETED|Maintenance Period||4
1742334|NCT00102687|4268490|P1|NOT COMPLETED|Maintenance Period||7
1742335|NCT00102687|4268486|P5|COMPLETED|Maintenance Period||8
1742336|NCT00102687|4268487|P4|COMPLETED|Maintenance Period||12
1742337|NCT00102687|4268488|P3|COMPLETED|Maintenance Period||2
1742338|NCT00102687|4268489|P2|COMPLETED|Maintenance Period||2
1742339|NCT00102687|4268490|P1|COMPLETED|Maintenance Period||6
1742340|NCT00102687|4268486|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
1742341|NCT00102687|4268487|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
1742342|NCT00102687|4268488|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
1742343|NCT00102687|4268489|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
1742344|NCT00102687|4268490|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
1742345|NCT00102687|4268486|P5|NOT COMPLETED|Initial Period||0
1742346|NCT00102687|4268487|P4|NOT COMPLETED|Initial Period||0
1742347|NCT00102687|4268488|P3|NOT COMPLETED|Initial Period||26
1742348|NCT00102687|4268489|P2|NOT COMPLETED|Initial Period||28
1742349|NCT00102687|4268490|P1|NOT COMPLETED|Initial Period||18
1742350|NCT00102687|4268486|P5|COMPLETED|Initial Period||0
1742351|NCT00102687|4268487|P4|COMPLETED|Initial Period||0
1742352|NCT00102687|4268488|P3|COMPLETED|Initial Period||25
1742353|NCT00102687|4268489|P2|COMPLETED|Initial Period||22
1742354|NCT00102687|4268490|P1|COMPLETED|Initial Period||32
1742355|NCT00102687|4268486|P5|STARTED|Initial Period||0
1742356|NCT00102687|4268487|P4|STARTED|Initial Period||0
1742357|NCT00102687|4268488|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
1742358|NCT00102687|4268489|P2|STARTED|Initial Period||50
1742359|NCT00102687|4268490|P1|STARTED|Initial Period||50
1742360|NCT00102596|4268554|P2|NOT COMPLETED|Part C||0
1742361|NCT00102596|4268555|P1|NOT COMPLETED|Part C||0
1742362|NCT00102596|4268554|P2|COMPLETED|Part C||2
1742363|NCT00102596|4268555|P1|COMPLETED|Part C||0
1742364|NCT00102596|4268554|P2|STARTED|Part C|Only 2 patients participated in Part C|2
1742365|NCT00102596|4268555|P1|STARTED|Part C||0
1742366|NCT00102596|4268554|P2|NOT COMPLETED|Part B||0
1742367|NCT00102596|4268555|P1|NOT COMPLETED|Part B||0
1742368|NCT00102596|4268554|P2|COMPLETED|Part B||10
1742369|NCT00102596|4268555|P1|COMPLETED|Part B||0
1742370|NCT00102596|4268554|P2|STARTED|Part B||10
1742371|NCT00102596|4268555|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
1742372|NCT00102596|4268554|P2|NOT COMPLETED|Part A||0
1742373|NCT00102596|4268555|P1|NOT COMPLETED|Part A||7
1742374|NCT00102596|4268554|P2|COMPLETED|Part A||0
1742375|NCT00102596|4268555|P1|COMPLETED|Part A||4
1742376|NCT00102596|4268554|P2|Participants Assigned Treatment|Part A||0
1742377|NCT00102596|4268555|P1|Participants Assigned Treatment|Part A||5
1742378|NCT00102596|4268554|P2|STARTED|Part A||0
1742379|NCT00102596|4268555|P1|STARTED|Part A||11
1742380|NCT00102531|4268566|P2|NOT COMPLETED|Overall Study||11
1742381|NCT00102531|4268567|P1|NOT COMPLETED|Overall Study||5
1742382|NCT00102531|4268566|P2|COMPLETED|Overall Study||1
1742383|NCT00102531|4268567|P1|COMPLETED|Overall Study||2
1742384|NCT00102531|4268566|P2|STARTED|Overall Study||12
1742385|NCT00102531|4268567|P1|STARTED|Overall Study||7
1742386|NCT00102518|4268573|P1|NOT COMPLETED|Overall Study||87
1742387|NCT00102518|4268573|P1|COMPLETED|Overall Study||238
1742388|NCT00102518|4268573|P1|STARTED|Overall Study||325
1742389|NCT00102440|4268582|P3|NOT COMPLETED|Overall Study||66
1742390|NCT00102440|4268583|P2|NOT COMPLETED|Overall Study||98
1742391|NCT00102440|4268584|P1|NOT COMPLETED|Overall Study||88
1742392|NCT00102440|4268582|P3|COMPLETED|Overall Study||187
1742393|NCT00102440|4268583|P2|COMPLETED|Overall Study||153
1742394|NCT00102440|4268584|P1|COMPLETED|Overall Study||168
1742395|NCT00102440|4268582|P3|STARTED|Overall Study||253
1742396|NCT00102440|4268583|P2|STARTED|Overall Study||251
1742397|NCT00102440|4268584|P1|STARTED|Overall Study||256
1742398|NCT00102063|4268634|P3|NOT COMPLETED|Overall Study||10
1742399|NCT00102063|4268635|P2|NOT COMPLETED|Overall Study||18
1742400|NCT00102063|4268636|P1|NOT COMPLETED|Overall Study||16
1742401|NCT00102063|4268634|P3|COMPLETED|Overall Study||90
1742402|NCT00102063|4268635|P2|COMPLETED|Overall Study||84
1742403|NCT00102063|4268636|P1|COMPLETED|Overall Study||84
1742404|NCT00102063|4268634|P3|STARTED|Overall Study||100
1742405|NCT00102063|4268635|P2|STARTED|Overall Study||102
1742406|NCT00102063|4268636|P1|STARTED|Overall Study||100
1742407|NCT00101933|4268667|P2|NOT COMPLETED|Overall Study||0
1742408|NCT00101933|4268668|P1|NOT COMPLETED|Overall Study||0
1742409|NCT00101933|4268667|P2|COMPLETED|Overall Study||55
1742410|NCT00101933|4268668|P1|COMPLETED|Overall Study||54
1742411|NCT00101933|4268667|P2|STARTED|Overall Study||55
1742412|NCT00101933|4268668|P1|STARTED|Overall Study||54
1742413|NCT00101907|4268694|P6|NOT COMPLETED|Overall Study||0
1742414|NCT00101907|4268695|P5|NOT COMPLETED|Overall Study||5
1742415|NCT00101907|4268696|P4|NOT COMPLETED|Overall Study||1
1742416|NCT00101907|4268697|P3|NOT COMPLETED|Overall Study||1
1742417|NCT00101907|4268698|P2|NOT COMPLETED|Overall Study||1
1742418|NCT00101907|4268699|P1|NOT COMPLETED|Overall Study||2
1742419|NCT00101907|4268694|P6|COMPLETED|Overall Study||2
1742420|NCT00101907|4268695|P5|COMPLETED|Overall Study||6
1742421|NCT00101907|4268696|P4|COMPLETED|Overall Study||5
1742422|NCT00101907|4268697|P3|COMPLETED|Overall Study||5
1742423|NCT00101907|4268698|P2|COMPLETED|Overall Study||7
1742424|NCT00101907|4268699|P1|COMPLETED|Overall Study||6
1742425|NCT00101907|4268694|P6|STARTED|Overall Study||2
1742426|NCT00101907|4268695|P5|STARTED|Overall Study||11
1742427|NCT00101907|4268696|P4|STARTED|Overall Study||6
1742428|NCT00101907|4268697|P3|STARTED|Overall Study||6
1742429|NCT00101907|4268698|P2|STARTED|Overall Study||8
1742430|NCT00101907|4268699|P1|STARTED|Overall Study||8
1742431|NCT00101868|4268741|P2|NOT COMPLETED|Overall Study||32
1742432|NCT00101868|4268742|P1|NOT COMPLETED|Overall Study||29
1742433|NCT00101868|4268741|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
1742434|NCT00101868|4268742|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
1742435|NCT00101868|4268741|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
1742436|NCT00101868|4268742|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
1742437|NCT00101816|4268754|P2|NOT COMPLETED|Overall Study||0
1742438|NCT00101816|4268755|P1|NOT COMPLETED|Overall Study||0
1742439|NCT00101816|4268754|P2|COMPLETED|Overall Study||99
1742440|NCT00101816|4268755|P1|COMPLETED|Overall Study||10
1742441|NCT00101816|4268754|P2|STARTED|Overall Study||99
1742442|NCT00101816|4268755|P1|STARTED|Overall Study||10
1742443|NCT00101686|4268812|P10|NOT COMPLETED|Overall Study||30
1742444|NCT00101686|4268813|P9|NOT COMPLETED|Overall Study||30
1742445|NCT00101686|4268814|P8|NOT COMPLETED|Overall Study||30
1742446|NCT00101686|4268815|P7|NOT COMPLETED|Overall Study||27
1742447|NCT00101686|4268816|P6|NOT COMPLETED|Overall Study||72
1742448|NCT00101686|4268817|P5|NOT COMPLETED|Overall Study||73
1742449|NCT00101686|4268818|P4|NOT COMPLETED|Overall Study||72
1742450|NCT00101686|4268819|P3|NOT COMPLETED|Overall Study||69
1742451|NCT00101686|4268820|P2|NOT COMPLETED|Overall Study||73
1742452|NCT00101686|4268821|P1|NOT COMPLETED|Overall Study||71
1742453|NCT00101686|4268812|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742454|NCT00101686|4268813|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742455|NCT00101686|4268814|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742456|NCT00101686|4268815|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742457|NCT00101686|4268816|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742458|NCT00101686|4268817|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742459|NCT00101686|4268818|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742460|NCT00101686|4268819|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742461|NCT00101686|4268820|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742462|NCT00101686|4268821|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
1742463|NCT00101686|4268812|P10|Received Treatment|Overall Study||29
1742464|NCT00101686|4268813|P9|Received Treatment|Overall Study||30
1742465|NCT00101686|4268814|P8|Received Treatment|Overall Study||29
1742466|NCT00101686|4268815|P7|Received Treatment|Overall Study||27
1742467|NCT00101686|4268816|P6|Received Treatment|Overall Study||70
1742468|NCT00101686|4268817|P5|Received Treatment|Overall Study||71
1742469|NCT00101686|4268818|P4|Received Treatment|Overall Study||70
1742470|NCT00101686|4268819|P3|Received Treatment|Overall Study||67
1742471|NCT00101686|4268820|P2|Received Treatment|Overall Study||67
1742472|NCT00101686|4268821|P1|Received Treatment|Overall Study||70
1742473|NCT00101686|4268812|P10|STARTED|Overall Study||30
1742474|NCT00101686|4268813|P9|STARTED|Overall Study||30
1742475|NCT00101686|4268814|P8|STARTED|Overall Study||30
1742476|NCT00101686|4268815|P7|STARTED|Overall Study||27
1742477|NCT00101686|4268816|P6|STARTED|Overall Study||72
1742478|NCT00101686|4268817|P5|STARTED|Overall Study||73
1742479|NCT00101686|4268818|P4|STARTED|Overall Study||72
1742480|NCT00101686|4268819|P3|STARTED|Overall Study||69
1742481|NCT00101686|4268820|P2|STARTED|Overall Study||73
1742482|NCT00101686|4268821|P1|STARTED|Overall Study||71
1742483|NCT00101660|4268868|P2|NOT COMPLETED|Overall Study||0
1742484|NCT00101660|4268869|P1|NOT COMPLETED|Overall Study||0
1742485|NCT00101660|4268868|P2|COMPLETED|Overall Study||288
1742486|NCT00101660|4268869|P1|COMPLETED|Overall Study||99
1742487|NCT00101660|4268868|P2|STARTED|Overall Study||288
1742488|NCT00101660|4268869|P1|STARTED|Overall Study||99
1742489|NCT00101647|4268887|P2|NOT COMPLETED|Overall Study||0
1742490|NCT00101647|4268888|P1|NOT COMPLETED|Overall Study||0
1742491|NCT00101647|4268887|P2|COMPLETED|Overall Study||161
1742492|NCT00101647|4268888|P1|COMPLETED|Overall Study||13
1742493|NCT00101647|4268887|P2|STARTED|Overall Study|Randomized|161
1742494|NCT00101647|4268888|P1|STARTED|Overall Study|Randomized|13
1742495|NCT00101582|4268938|P2|NOT COMPLETED|Overall Study||15
1742496|NCT00101582|4268939|P1|NOT COMPLETED|Overall Study||11
1742497|NCT00101582|4268938|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
1742498|NCT00101582|4268939|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
1742499|NCT00101582|4268938|P2|Received Study Drug|Overall Study||94
1742500|NCT00101582|4268939|P1|Received Study Drug|Overall Study||91
1742501|NCT00101582|4268938|P2|STARTED|Overall Study||94
1742502|NCT00101582|4268939|P1|STARTED|Overall Study||94
1742503|NCT00101452|4268962|P3|NOT COMPLETED|Overall Study||43
1742504|NCT00101452|4268963|P2|NOT COMPLETED|Overall Study||43
1742505|NCT00101452|4268964|P1|NOT COMPLETED|Overall Study||44
1742506|NCT00101452|4268962|P3|COMPLETED|Overall Study||22
1742507|NCT00101452|4268963|P2|COMPLETED|Overall Study||26
1742508|NCT00101452|4268964|P1|COMPLETED|Overall Study||21
1742509|NCT00101452|4268962|P3|STARTED|Overall Study||65
1742510|NCT00101452|4268963|P2|STARTED|Overall Study||69
1742511|NCT00101452|4268964|P1|STARTED|Overall Study||65
1742512|NCT00101439|4268978|P2|NOT COMPLETED|Period 2||2
1742513|NCT00101439|4268979|P1|NOT COMPLETED|Period 2||0
1742514|NCT00101439|4268978|P2|COMPLETED|Period 2||28
1742515|NCT00101439|4268979|P1|COMPLETED|Period 2||28
1742516|NCT00101439|4268978|P2|STARTED|Period 2||30
1742517|NCT00101439|4268979|P1|STARTED|Period 2||28
1742518|NCT00101439|4268978|P2|NOT COMPLETED|Period 1||0
1742519|NCT00101439|4268979|P1|NOT COMPLETED|Period 1||0
1742520|NCT00101439|4268978|P2|COMPLETED|Period 1||30
1742521|NCT00101439|4268979|P1|COMPLETED|Period 1||28
1742522|NCT00101439|4268978|P2|STARTED|Period 1||30
1742523|NCT00101439|4268979|P1|STARTED|Period 1||28
1742524|NCT00101413|4268987|P1|NOT COMPLETED|Overall Study||0
1742525|NCT00101413|4268987|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
1742526|NCT00101413|4268987|P1|STARTED|Overall Study||52
1742527|NCT00101400|4268995|P1|NOT COMPLETED|Survival Follow-Up||7
1742528|NCT00101400|4268995|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
1742529|NCT00101400|4268995|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
1742530|NCT00101400|4268995|P1|NOT COMPLETED|Treatment||0
1742531|NCT00101400|4268995|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
1742532|NCT00101400|4268995|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
1742533|NCT00101361|4269006|P2|NOT COMPLETED|Overall Study||0
1742534|NCT00101361|4269007|P1|NOT COMPLETED|Overall Study||0
1742535|NCT00101361|4269006|P2|COMPLETED|Overall Study||104
1742536|NCT00101361|4269007|P1|COMPLETED|Overall Study||108
1742537|NCT00101361|4269006|P2|STARTED|Overall Study||104
1742538|NCT00101361|4269007|P1|STARTED|Overall Study||108
1742539|NCT00101283|4269015|P2|NOT COMPLETED|Overall Study||3
1742540|NCT00101283|4269016|P1|NOT COMPLETED|Overall Study||0
1742541|NCT00101283|4269015|P2|COMPLETED|Overall Study||13
1742542|NCT00101283|4269016|P1|COMPLETED|Overall Study||16
1742543|NCT00101283|4269015|P2|Began Treatment|Overall Study||13
1742544|NCT00101283|4269016|P1|Began Treatment|Overall Study||16
1742545|NCT00101283|4269015|P2|STARTED|Overall Study||16
1742546|NCT00101283|4269016|P1|STARTED|Overall Study||16
1742547|NCT00101192|4269026|P1|NOT COMPLETED|Overall Study||7
1742548|NCT00101192|4269026|P1|COMPLETED|Overall Study||69
1742549|NCT00101192|4269026|P1|STARTED|Overall Study||76
1742550|NCT00101166|4269030|P1|NOT COMPLETED|Overall Study||10
1742551|NCT00101166|4269030|P1|COMPLETED|Overall Study||18
1742552|NCT00101166|4269030|P1|STARTED|Overall Study||28
1742553|NCT00101101|4269038|P1|NOT COMPLETED|Overall Study||20
1742554|NCT00101101|4269038|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
1742555|NCT00101101|4269038|P1|STARTED|Overall Study||43
1742556|NCT00101036|4269046|P2|NOT COMPLETED|Overall Study||0
1742557|NCT00101036|4269047|P1|NOT COMPLETED|Overall Study||0
1742558|NCT00101036|4269046|P2|COMPLETED|Overall Study||40
1742559|NCT00101036|4269047|P1|COMPLETED|Overall Study||17
1742560|NCT00101036|4269046|P2|STARTED|Overall Study||40
1742561|NCT00101036|4269047|P1|STARTED|Overall Study||17
1742562|NCT00100932|4269061|P2|NOT COMPLETED|Overall Study||27
1742563|NCT00100932|4269062|P1|NOT COMPLETED|Overall Study||73
1742564|NCT00100932|4269061|P2|COMPLETED|Overall Study||1
1742565|NCT00100932|4269062|P1|COMPLETED|Overall Study||5
1742566|NCT00100932|4269061|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
1742567|NCT00100932|4269062|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
1742568|NCT00100841|4269072|P1|NOT COMPLETED|Overall Study||0
1742569|NCT00100841|4269072|P1|COMPLETED|Overall Study||66
1742570|NCT00100841|4269072|P1|STARTED|Overall Study||66
1742571|NCT00100828|4269077|P1|NOT COMPLETED|Overall Study||6
1742572|NCT00100828|4269077|P1|COMPLETED|Overall Study||0
1742573|NCT00100828|4269077|P1|STARTED|Overall Study||6
1742574|NCT00100815|4269081|P1|NOT COMPLETED|Overall Study||49
1742575|NCT00100815|4269081|P1|COMPLETED|Overall Study||1
1742576|NCT00100815|4269081|P1|STARTED|Overall Study||50
1742577|NCT00100802|4269089|P1|NOT COMPLETED|Overall Study||80
1742578|NCT00100802|4269089|P1|COMPLETED|Overall Study||38
1742579|NCT00100802|4269089|P1|STARTED|Overall Study||118
1742580|NCT00100789|4269094|P1|NOT COMPLETED|Overall Study||64
1742581|NCT00100789|4269094|P1|COMPLETED|Overall Study||3
1742582|NCT00100789|4269094|P1|Eligible and Began Protocol Therapy|Overall Study||63
1742583|NCT00100789|4269094|P1|Eligible|Overall Study||64
1742584|NCT00100789|4269094|P1|STARTED|Overall Study||67
1742585|NCT00100698|4269103|P2|NOT COMPLETED|Overall Study||2
1742586|NCT00100698|4269104|P1|NOT COMPLETED|Overall Study||6
1742587|NCT00100698|4269103|P2|COMPLETED|Overall Study||27
1742588|NCT00100698|4269104|P1|COMPLETED|Overall Study||21
1742589|NCT00100698|4269103|P2|STARTED|Overall Study||29
1742590|NCT00100698|4269104|P1|STARTED|Overall Study||27
1742591|NCT00100659|4269146|P2|NOT COMPLETED|Overall Study||2
1742592|NCT00100659|4269147|P1|NOT COMPLETED|Overall Study||3
1742593|NCT00100659|4269146|P2|COMPLETED|Overall Study||57
1742594|NCT00100659|4269147|P1|COMPLETED|Overall Study||52
1742595|NCT00100659|4269146|P2|STARTED|Overall Study||59
1742596|NCT00100659|4269147|P1|STARTED|Overall Study||55
1742597|NCT00100230|4269157|P2|NOT COMPLETED|Overall Study||15
1742598|NCT00100230|4269158|P1|NOT COMPLETED|Overall Study||12
1742599|NCT00100230|4269157|P2|COMPLETED|Overall Study||22
1742600|NCT00100230|4269158|P1|COMPLETED|Overall Study||29
1742601|NCT00100230|4269157|P2|STARTED|Overall Study||37
1742602|NCT00100230|4269158|P1|STARTED|Overall Study||41
1742603|NCT00100178|4269171|P3|NOT COMPLETED|Overall Study||10
1742604|NCT00100178|4269172|P2|NOT COMPLETED|Overall Study||10
1742605|NCT00100178|4269173|P1|NOT COMPLETED|Overall Study||9
1742606|NCT00100178|4269171|P3|COMPLETED|Overall Study||32
1742607|NCT00100178|4269172|P2|COMPLETED|Overall Study||21
1742608|NCT00100178|4269173|P1|COMPLETED|Overall Study||32
1742609|NCT00100178|4269171|P3|STARTED|Overall Study||42
1742610|NCT00100178|4269172|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
1742611|NCT00100178|4269173|P1|STARTED|Overall Study||41
1742612|NCT00100048|4269186|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
1742613|NCT00100048|4269187|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
1742614|NCT00100048|4269188|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
1742615|NCT00100048|4269189|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
1742616|NCT00100048|4269190|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
1742617|NCT00100048|4269191|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
1742618|NCT00100048|4269186|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
1742619|NCT00100048|4269187|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
1742620|NCT00100048|4269188|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
1742621|NCT00100048|4269189|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
1742622|NCT00100048|4269190|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
1742623|NCT00100048|4269191|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
1742624|NCT00100048|4269186|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
1742625|NCT00100048|4269187|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
1742626|NCT00100048|4269188|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
1742627|NCT00100048|4269189|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
1742628|NCT00100048|4269190|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
1742629|NCT00100048|4269191|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
1742630|NCT00100048|4269186|P6|Treated|Cohort I & II-Combination Therapy Phase||38
1742631|NCT00100048|4269187|P5|Treated|Cohort I & II-Combination Therapy Phase||0
1742632|NCT00100048|4269188|P4|Treated|Cohort I & II-Combination Therapy Phase||40
1742633|NCT00100048|4269189|P3|Treated|Cohort I & II-Combination Therapy Phase||41
1742634|NCT00100048|4269190|P2|Treated|Cohort I & II-Combination Therapy Phase||40
1742635|NCT00100048|4269191|P1|Treated|Cohort I & II-Combination Therapy Phase||39
1742636|NCT00100048|4269186|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
1742637|NCT00100048|4269187|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
1742638|NCT00100048|4269188|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
1742639|NCT00100048|4269189|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
1742640|NCT00100048|4269190|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
1742641|NCT00100048|4269191|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
1742642|NCT00100048|4269186|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1742643|NCT00100048|4269187|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1742644|NCT00100048|4269188|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1742645|NCT00100048|4269189|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1742646|NCT00100048|4269190|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1742647|NCT00100048|4269191|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1742648|NCT00100048|4269186|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
1742649|NCT00100048|4269187|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
1742650|NCT00100048|4269188|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
1742651|NCT00100048|4269189|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
1742652|NCT00100048|4269190|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
1742653|NCT00100048|4269191|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
1742654|NCT00100048|4269186|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
1742655|NCT00100048|4269187|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
1742656|NCT00100048|4269188|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
1742657|NCT00100048|4269189|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
1742658|NCT00100048|4269190|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
1742659|NCT00100048|4269191|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
1742660|NCT00100048|4269186|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
1742661|NCT00100048|4269187|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
1742662|NCT00100048|4269188|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
1742663|NCT00100048|4269189|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
1742664|NCT00100048|4269190|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
1742665|NCT00100048|4269191|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
1742666|NCT00099983|4269300|P2|NOT COMPLETED|Overall Study||25
1742667|NCT00099983|4269301|P1|NOT COMPLETED|Overall Study||24
1742668|NCT00099983|4269300|P2|COMPLETED|Overall Study||124
1742669|NCT00099983|4269301|P1|COMPLETED|Overall Study||123
1742670|NCT00099983|4269300|P2|STARTED|Overall Study||149
1742671|NCT00099983|4269301|P1|STARTED|Overall Study||147
1742672|NCT00099632|4269313|P6|NOT COMPLETED|Overall Study||2
1742673|NCT00099632|4269314|P5|NOT COMPLETED|Overall Study||1
1742674|NCT00099632|4269315|P4|NOT COMPLETED|Overall Study||1
1742675|NCT00099632|4269316|P3|NOT COMPLETED|Overall Study||3
1742676|NCT00099632|4269317|P2|NOT COMPLETED|Overall Study||1
1742677|NCT00099632|4269318|P1|NOT COMPLETED|Overall Study||1
1742678|NCT00099632|4269313|P6|COMPLETED|Overall Study||66
1742679|NCT00099632|4269314|P5|COMPLETED|Overall Study||70
1742680|NCT00099632|4269315|P4|COMPLETED|Overall Study||66
1742681|NCT00099632|4269316|P3|COMPLETED|Overall Study||72
1742682|NCT00099632|4269317|P2|COMPLETED|Overall Study||67
1742683|NCT00099632|4269318|P1|COMPLETED|Overall Study||72
1742684|NCT00099632|4269313|P6|STARTED|Overall Study||68
1742685|NCT00099632|4269314|P5|STARTED|Overall Study||71
1742686|NCT00099632|4269315|P4|STARTED|Overall Study||67
1742687|NCT00099632|4269316|P3|STARTED|Overall Study||75
1742688|NCT00099632|4269317|P2|STARTED|Overall Study||68
1742689|NCT00099632|4269318|P1|STARTED|Overall Study||73
1742690|NCT00099437|4269358|P2|NOT COMPLETED|Overall Study||349
1742691|NCT00099437|4269359|P1|NOT COMPLETED|Overall Study||366
1742692|NCT00099437|4269358|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
1742693|NCT00099437|4269359|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
1742694|NCT00099437|4269358|P2|STARTED|Overall Study|randomised patients|362
1742695|NCT00099437|4269359|P1|STARTED|Overall Study|randomised patients|374
1742696|NCT00099359|4269382|P3|NOT COMPLETED|Overall Study||68
1742697|NCT00099359|4269383|P2|NOT COMPLETED|Overall Study||65
1742698|NCT00099359|4269384|P1|NOT COMPLETED|Overall Study||54
1742699|NCT00099359|4269382|P3|COMPLETED|Overall Study||506
1742700|NCT00099359|4269383|P2|COMPLETED|Overall Study||515
1742701|NCT00099359|4269384|P1|COMPLETED|Overall Study||527
1742702|NCT00099359|4269382|P3|STARTED|Overall Study||574
1742703|NCT00099359|4269383|P2|STARTED|Overall Study||580
1742704|NCT00099359|4269384|P1|STARTED|Overall Study||581
1742705|NCT00099268|4269407|P2|NOT COMPLETED|Overall Study||82
1742706|NCT00099268|4269408|P1|NOT COMPLETED|Overall Study||92
1742707|NCT00099268|4269407|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
1742708|NCT00099268|4269408|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
1742709|NCT00099268|4269407|P2|Intent-to-Treat|Overall Study||372
1742710|NCT00099268|4269408|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
1742711|NCT00099268|4269407|P2|STARTED|Overall Study||373
1742712|NCT00099268|4269408|P1|STARTED|Overall Study||374
1742713|NCT00099047|4269426|P2|NOT COMPLETED|Overall Study||0
1742714|NCT00099047|4269427|P1|NOT COMPLETED|Overall Study||0
1742715|NCT00099047|4269426|P2|COMPLETED|Overall Study||12
1742716|NCT00099047|4269427|P1|COMPLETED|Overall Study||11
1742717|NCT00099047|4269426|P2|STARTED|Overall Study||12
1742718|NCT00099047|4269427|P1|STARTED|Overall Study||11
1742719|NCT00099021|4269433|P1|NOT COMPLETED|Overall Study||0
1742720|NCT00099021|4269433|P1|COMPLETED|Overall Study||21
1742721|NCT00099021|4269433|P1|STARTED|Overall Study||21
1742722|NCT00098956|4269439|P1|NOT COMPLETED|Overall Study||0
1742723|NCT00098956|4269439|P1|COMPLETED|Overall Study||19
1742724|NCT00098956|4269439|P1|STARTED|Overall Study||19
1742725|NCT00098865|4269448|P1|NOT COMPLETED|Overall Study||9
1742726|NCT00098865|4269448|P1|COMPLETED|Overall Study||6
1742727|NCT00098865|4269448|P1|STARTED|Overall Study||15
1742728|NCT00098839|4269456|P2|NOT COMPLETED|Overall Study||33
1742729|NCT00098839|4269457|P1|NOT COMPLETED|Overall Study||32
1742730|NCT00098839|4269456|P2|COMPLETED|Overall Study||27
1742731|NCT00098839|4269457|P1|COMPLETED|Overall Study||24
1742732|NCT00098839|4269456|P2|STARTED|Overall Study||60
1742733|NCT00098839|4269457|P1|STARTED|Overall Study||56
1742734|NCT00098813|4269468|P1|NOT COMPLETED|Overall Study||19
1742735|NCT00098813|4269468|P1|COMPLETED|Overall Study||1
1742736|NCT00098813|4269468|P1|STARTED|Overall Study||20
1742737|NCT00098787|4269475|P3|NOT COMPLETED|Overall Study||63
1742738|NCT00098787|4269476|P2|NOT COMPLETED|Overall Study||75
1742739|NCT00098787|4269477|P1|NOT COMPLETED|Overall Study||73
1742740|NCT00098787|4269475|P3|COMPLETED|Overall Study||0
1742741|NCT00098787|4269476|P2|COMPLETED|Overall Study||0
1742742|NCT00098787|4269477|P1|COMPLETED|Overall Study||0
1742743|NCT00098787|4269475|P3|Eligible and Treated|Overall Study||59
1742744|NCT00098787|4269476|P2|Eligible and Treated|Overall Study||66
1742745|NCT00098787|4269477|P1|Eligible and Treated|Overall Study||61
1742746|NCT00098787|4269475|P3|Treated|Overall Study||62
1742747|NCT00098787|4269476|P2|Treated|Overall Study||73
1742748|NCT00098787|4269477|P1|Treated|Overall Study||70
1742749|NCT00098787|4269475|P3|STARTED|Overall Study||63
1742750|NCT00098787|4269476|P2|STARTED|Overall Study||75
1742751|NCT00098787|4269477|P1|STARTED|Overall Study||73
1742752|NCT00098774|4269491|P1|NOT COMPLETED|Overall Study||18
1742753|NCT00098774|4269491|P1|COMPLETED|Overall Study||26
1742754|NCT00098774|4269491|P1|STARTED|Overall Study||44
1742755|NCT00098748|4269501|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
1742756|NCT00098748|4269502|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
1742757|NCT00098748|4269503|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
1742758|NCT00098748|4269501|P3|COMPLETED|Continued on Open-Label Treatment||0
1742759|NCT00098748|4269502|P2|COMPLETED|Continued on Open-Label Treatment||10
1742760|NCT00098748|4269503|P1|COMPLETED|Continued on Open-Label Treatment||7
1742761|NCT00098748|4269501|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
1742762|NCT00098748|4269502|P2|STARTED|Continued on Open-Label Treatment||25
1742763|NCT00098748|4269503|P1|STARTED|Continued on Open-Label Treatment||15
1742764|NCT00098748|4269501|P3|NOT COMPLETED|Received Study Treatment||44
1742765|NCT00098748|4269502|P2|NOT COMPLETED|Received Study Treatment||36
1742766|NCT00098748|4269503|P1|NOT COMPLETED|Received Study Treatment||48
1742767|NCT00098748|4269501|P3|COMPLETED|Received Study Treatment||18
1742768|NCT00098748|4269502|P2|COMPLETED|Received Study Treatment||25
1742769|NCT00098748|4269503|P1|COMPLETED|Received Study Treatment||15
1742770|NCT00098748|4269501|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
1742771|NCT00098748|4269502|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
1742772|NCT00098748|4269503|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
1742773|NCT00098748|4269501|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
1742774|NCT00098748|4269502|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
1742775|NCT00098748|4269503|P1|STARTED|Received Study Treatment||63
1742776|NCT00098748|4269501|P3|NOT COMPLETED|Assigned to Study Treatment||2
1742777|NCT00098748|4269502|P2|NOT COMPLETED|Assigned to Study Treatment||2
1742778|NCT00098748|4269503|P1|NOT COMPLETED|Assigned to Study Treatment||0
1742779|NCT00098748|4269501|P3|COMPLETED|Assigned to Study Treatment||62
1742780|NCT00098748|4269502|P2|COMPLETED|Assigned to Study Treatment||61
1742781|NCT00098748|4269503|P1|COMPLETED|Assigned to Study Treatment||63
1742782|NCT00098748|4269501|P3|STARTED|Assigned to Study Treatment||64
1742783|NCT00098748|4269502|P2|STARTED|Assigned to Study Treatment||63
1742784|NCT00098748|4269503|P1|STARTED|Assigned to Study Treatment||63
1742785|NCT00098722|4269559|P7|NOT COMPLETED|Observation Phase||17
1742786|NCT00098722|4269560|P6|NOT COMPLETED|Observation Phase||45
1742787|NCT00098722|4269561|P5|NOT COMPLETED|Observation Phase||0
1742788|NCT00098722|4269562|P4|NOT COMPLETED|Observation Phase||0
1742789|NCT00098722|4269563|P3|NOT COMPLETED|Observation Phase||0
1742790|NCT00098722|4269564|P2|NOT COMPLETED|Observation Phase||0
1742791|NCT00098722|4269565|P1|NOT COMPLETED|Observation Phase||0
1742792|NCT00098722|4269559|P7|COMPLETED|Observation Phase||48
1742793|NCT00098722|4269560|P6|COMPLETED|Observation Phase||160
1742794|NCT00098722|4269561|P5|COMPLETED|Observation Phase||0
1742795|NCT00098722|4269562|P4|COMPLETED|Observation Phase||0
1742796|NCT00098722|4269563|P3|COMPLETED|Observation Phase||0
1742797|NCT00098722|4269564|P2|COMPLETED|Observation Phase||0
1742798|NCT00098722|4269565|P1|COMPLETED|Observation Phase||0
1742799|NCT00098722|4269559|P7|STARTED|Observation Phase||65
1742800|NCT00098722|4269560|P6|STARTED|Observation Phase||205
1742801|NCT00098722|4269561|P5|STARTED|Observation Phase||0
1742802|NCT00098722|4269562|P4|STARTED|Observation Phase||0
1742803|NCT00098722|4269563|P3|STARTED|Observation Phase||0
1742804|NCT00098722|4269564|P2|STARTED|Observation Phase||0
1742805|NCT00098722|4269565|P1|STARTED|Observation Phase||0
1742806|NCT00098722|4269559|P7|NOT COMPLETED|Open Label Phase||0
1742807|NCT00098722|4269560|P6|NOT COMPLETED|Open Label Phase||0
1742808|NCT00098722|4269561|P5|NOT COMPLETED|Open Label Phase||50
1742809|NCT00098722|4269562|P4|NOT COMPLETED|Open Label Phase||272
1742810|NCT00098722|4269563|P3|NOT COMPLETED|Open Label Phase||0
1742811|NCT00098722|4269564|P2|NOT COMPLETED|Open Label Phase||0
1742812|NCT00098722|4269565|P1|NOT COMPLETED|Open Label Phase||0
1742813|NCT00098722|4269559|P7|COMPLETED|Open Label Phase||0
1742814|NCT00098722|4269560|P6|COMPLETED|Open Label Phase||0
1742815|NCT00098722|4269561|P5|COMPLETED|Open Label Phase||0
1742816|NCT00098722|4269562|P4|COMPLETED|Open Label Phase||0
1742817|NCT00098722|4269563|P3|COMPLETED|Open Label Phase||0
1742818|NCT00098722|4269564|P2|COMPLETED|Open Label Phase||0
1742819|NCT00098722|4269565|P1|COMPLETED|Open Label Phase||0
1742820|NCT00098722|4269559|P7|STARTED|Open Label Phase||0
1742821|NCT00098722|4269560|P6|STARTED|Open Label Phase||0
1742822|NCT00098722|4269561|P5|STARTED|Open Label Phase||50
1742823|NCT00098722|4269562|P4|STARTED|Open Label Phase||272
1742824|NCT00098722|4269563|P3|STARTED|Open Label Phase||0
1742825|NCT00098722|4269564|P2|STARTED|Open Label Phase||0
1742826|NCT00098722|4269565|P1|STARTED|Open Label Phase||0
1742827|NCT00098722|4269559|P7|NOT COMPLETED|Double Blind Phase||0
1742828|NCT00098722|4269560|P6|NOT COMPLETED|Double Blind Phase||0
1742829|NCT00098722|4269561|P5|NOT COMPLETED|Double Blind Phase||0
1742830|NCT00098722|4269562|P4|NOT COMPLETED|Double Blind Phase||0
1742831|NCT00098722|4269563|P3|NOT COMPLETED|Double Blind Phase||94
1742832|NCT00098722|4269564|P2|NOT COMPLETED|Double Blind Phase||194
1742833|NCT00098722|4269565|P1|NOT COMPLETED|Double Blind Phase||186
1742834|NCT00098722|4269559|P7|COMPLETED|Double Blind Phase||0
1742835|NCT00098722|4269560|P6|COMPLETED|Double Blind Phase||0
1742836|NCT00098722|4269561|P5|COMPLETED|Double Blind Phase||0
1742837|NCT00098722|4269562|P4|COMPLETED|Double Blind Phase||0
1742838|NCT00098722|4269563|P3|COMPLETED|Double Blind Phase||0
1742839|NCT00098722|4269564|P2|COMPLETED|Double Blind Phase||0
1742840|NCT00098722|4269565|P1|COMPLETED|Double Blind Phase||0
1742841|NCT00098722|4269559|P7|Treated|Double Blind Phase||0
1742842|NCT00098722|4269560|P6|Treated|Double Blind Phase||0
1742843|NCT00098722|4269561|P5|Treated|Double Blind Phase||0
1742844|NCT00098722|4269562|P4|Treated|Double Blind Phase||0
1742845|NCT00098722|4269563|P3|Treated|Double Blind Phase||91
1742846|NCT00098722|4269564|P2|Treated|Double Blind Phase||191
1742847|NCT00098722|4269565|P1|Treated|Double Blind Phase||182
1742848|NCT00098722|4269559|P7|STARTED|Double Blind Phase||0
1742849|NCT00098722|4269560|P6|STARTED|Double Blind Phase||0
1742850|NCT00098722|4269561|P5|STARTED|Double Blind Phase||0
1742851|NCT00098722|4269562|P4|STARTED|Double Blind Phase||0
1742852|NCT00098722|4269563|P3|STARTED|Double Blind Phase||94
1742853|NCT00098722|4269564|P2|STARTED|Double Blind Phase||194
1742854|NCT00098722|4269565|P1|STARTED|Double Blind Phase||186
1742855|NCT00098670|4269628|P1|NOT COMPLETED|Overall Study||0
1742856|NCT00098670|4269628|P1|COMPLETED|Overall Study||102
1742857|NCT00098670|4269628|P1|STARTED|Overall Study||102
1742858|NCT00098475|4269639|P4|NOT COMPLETED|Step 2||0
1742859|NCT00098475|4269640|P3|NOT COMPLETED|Step 2||0
1742860|NCT00098475|4269641|P2|NOT COMPLETED|Step 2||10
1742861|NCT00098475|4269642|P1|NOT COMPLETED|Step 2||5
1742862|NCT00098475|4269639|P4|COMPLETED|Step 2||0
1742863|NCT00098475|4269640|P3|COMPLETED|Step 2||0
1742864|NCT00098475|4269641|P2|COMPLETED|Step 2||5
1742865|NCT00098475|4269642|P1|COMPLETED|Step 2||0
1742866|NCT00098475|4269639|P4|Eligible|Step 2||0
1742867|NCT00098475|4269640|P3|Eligible|Step 2||0
1742868|NCT00098475|4269641|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
1742869|NCT00098475|4269642|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
1742870|NCT00098475|4269639|P4|Treated|Step 2||0
1742871|NCT00098475|4269640|P3|Treated|Step 2||0
1742872|NCT00098475|4269641|P2|Treated|Step 2||14
1742873|NCT00098475|4269642|P1|Treated|Step 2||4
1742874|NCT00098475|4269639|P4|STARTED|Step 2||0
1742875|NCT00098475|4269640|P3|STARTED|Step 2||0
1742876|NCT00098475|4269641|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
1742877|NCT00098475|4269642|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
1742878|NCT00098475|4269639|P4|NOT COMPLETED|Step 1||3
1742879|NCT00098475|4269640|P3|NOT COMPLETED|Step 1||4
1742880|NCT00098475|4269641|P2|NOT COMPLETED|Step 1||173
1742881|NCT00098475|4269642|P1|NOT COMPLETED|Step 1||171
1742882|NCT00098475|4269639|P4|COMPLETED|Step 1||0
1742883|NCT00098475|4269640|P3|COMPLETED|Step 1||0
1742884|NCT00098475|4269641|P2|COMPLETED|Step 1||49
1742885|NCT00098475|4269642|P1|COMPLETED|Step 1||52
1742886|NCT00098475|4269639|P4|Eligible|Step 1||3
1742887|NCT00098475|4269640|P3|Eligible|Step 1||4
1742888|NCT00098475|4269641|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
1742889|NCT00098475|4269642|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
1742890|NCT00098475|4269639|P4|Treated|Step 1||3
1742891|NCT00098475|4269640|P3|Treated|Step 1||4
1742892|NCT00098475|4269641|P2|Treated|Step 1||220
1742893|NCT00098475|4269642|P1|Treated|Step 1||223
1742894|NCT00098475|4269639|P4|STARTED|Step 1||3
1742895|NCT00098475|4269640|P3|STARTED|Step 1||4
1742896|NCT00098475|4269641|P2|STARTED|Step 1||222
1742897|NCT00098475|4269642|P1|STARTED|Step 1||223
1742898|NCT00098371|4269654|P1|NOT COMPLETED|Overall Study||0
1742899|NCT00098371|4269654|P1|COMPLETED|Overall Study||64
1742900|NCT00098371|4269654|P1|STARTED|Overall Study||64
1742901|NCT00098345|4269679|P1|NOT COMPLETED|Overall Study||13
1742902|NCT00098345|4269679|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
1742903|NCT00098345|4269679|P1|STARTED|Overall Study||30
1742904|NCT00098306|4269692|P7|NOT COMPLETED|Observational Phase||26
1742905|NCT00098306|4269693|P6|NOT COMPLETED|Observational Phase||46
1742906|NCT00098306|4269694|P5|NOT COMPLETED|Observational Phase||0
1742907|NCT00098306|4269695|P4|NOT COMPLETED|Observational Phase||0
1742908|NCT00098306|4269696|P3|NOT COMPLETED|Observational Phase||0
1742909|NCT00098306|4269697|P2|NOT COMPLETED|Observational Phase||0
1742910|NCT00098306|4269698|P1|NOT COMPLETED|Observational Phase||0
1742911|NCT00098306|4269692|P7|COMPLETED|Observational Phase||55
1742912|NCT00098306|4269693|P6|COMPLETED|Observational Phase||204
1742913|NCT00098306|4269694|P5|COMPLETED|Observational Phase||0
1742914|NCT00098306|4269695|P4|COMPLETED|Observational Phase||0
1742915|NCT00098306|4269696|P3|COMPLETED|Observational Phase||0
1742916|NCT00098306|4269697|P2|COMPLETED|Observational Phase||0
1742917|NCT00098306|4269698|P1|COMPLETED|Observational Phase||0
1742918|NCT00098306|4269692|P7|STARTED|Observational Phase||81
1742919|NCT00098306|4269693|P6|STARTED|Observational Phase||250
1742920|NCT00098306|4269694|P5|STARTED|Observational Phase||0
1742921|NCT00098306|4269695|P4|STARTED|Observational Phase||0
1742922|NCT00098306|4269696|P3|STARTED|Observational Phase||0
1742923|NCT00098306|4269697|P2|STARTED|Observational Phase||0
1742924|NCT00098306|4269698|P1|STARTED|Observational Phase||0
1742925|NCT00098306|4269692|P7|NOT COMPLETED|Open Label||0
1742926|NCT00098306|4269693|P6|NOT COMPLETED|Open Label||0
1742927|NCT00098306|4269694|P5|NOT COMPLETED|Open Label||62
1742928|NCT00098306|4269695|P4|NOT COMPLETED|Open Label||327
1742929|NCT00098306|4269696|P3|NOT COMPLETED|Open Label||0
1742930|NCT00098306|4269697|P2|NOT COMPLETED|Open Label||0
1742931|NCT00098306|4269698|P1|NOT COMPLETED|Open Label||0
1742932|NCT00098306|4269692|P7|COMPLETED|Open Label||0
1742933|NCT00098306|4269693|P6|COMPLETED|Open Label||0
1742934|NCT00098306|4269694|P5|COMPLETED|Open Label||0
1742935|NCT00098306|4269695|P4|COMPLETED|Open Label||0
1742936|NCT00098306|4269696|P3|COMPLETED|Open Label||0
1742937|NCT00098306|4269697|P2|COMPLETED|Open Label||0
1742938|NCT00098306|4269698|P1|COMPLETED|Open Label||0
1742939|NCT00098306|4269692|P7|STARTED|Open Label||0
1742940|NCT00098306|4269693|P6|STARTED|Open Label||0
1742941|NCT00098306|4269694|P5|STARTED|Open Label||62
1742942|NCT00098306|4269695|P4|STARTED|Open Label||327
1742943|NCT00098306|4269696|P3|STARTED|Open Label||0
1742944|NCT00098306|4269697|P2|STARTED|Open Label||0
1742945|NCT00098306|4269698|P1|STARTED|Open Label||0
1742946|NCT00098306|4269692|P7|NOT COMPLETED|Double Blind||0
1742947|NCT00098306|4269693|P6|NOT COMPLETED|Double Blind||0
1742948|NCT00098306|4269694|P5|NOT COMPLETED|Double Blind||0
1742949|NCT00098306|4269695|P4|NOT COMPLETED|Double Blind||0
1742950|NCT00098306|4269696|P3|NOT COMPLETED|Double Blind||120
1742951|NCT00098306|4269697|P2|NOT COMPLETED|Double Blind||240
1742952|NCT00098306|4269698|P1|NOT COMPLETED|Double Blind||241
1742953|NCT00098306|4269692|P7|COMPLETED|Double Blind||0
1742954|NCT00098306|4269693|P6|COMPLETED|Double Blind||0
1742955|NCT00098306|4269694|P5|COMPLETED|Double Blind||0
1742956|NCT00098306|4269695|P4|COMPLETED|Double Blind||0
1742957|NCT00098306|4269696|P3|COMPLETED|Double Blind||0
1742958|NCT00098306|4269697|P2|COMPLETED|Double Blind||0
1742959|NCT00098306|4269698|P1|COMPLETED|Double Blind||0
1742960|NCT00098306|4269692|P7|Treated|Double Blind||0
1742961|NCT00098306|4269693|P6|Treated|Double Blind||0
1742962|NCT00098306|4269694|P5|Treated|Double Blind||0
1742963|NCT00098306|4269695|P4|Treated|Double Blind||0
1742964|NCT00098306|4269696|P3|Treated|Double Blind||118
1742965|NCT00098306|4269697|P2|Treated|Double Blind||235
1742966|NCT00098306|4269698|P1|Treated|Double Blind||232
1742967|NCT00098306|4269692|P7|STARTED|Double Blind||0
1742968|NCT00098306|4269693|P6|STARTED|Double Blind||0
1742969|NCT00098306|4269694|P5|STARTED|Double Blind||0
1742970|NCT00098306|4269695|P4|STARTED|Double Blind||0
1742971|NCT00098306|4269696|P3|STARTED|Double Blind||120
1742972|NCT00098306|4269697|P2|STARTED|Double Blind||240
1742973|NCT00098306|4269698|P1|STARTED|Double Blind||241
1742974|NCT00098293|4269764|P5|NOT COMPLETED|Supplemental Phase (SP)||33
1742975|NCT00098293|4269765|P4|NOT COMPLETED|Supplemental Phase (SP)||0
1742976|NCT00098293|4269766|P3|NOT COMPLETED|Supplemental Phase (SP)||0
1742977|NCT00098293|4269767|P2|NOT COMPLETED|Supplemental Phase (SP)||0
1742978|NCT00098293|4269768|P1|NOT COMPLETED|Supplemental Phase (SP)||0
1742979|NCT00098293|4269764|P5|COMPLETED|Supplemental Phase (SP)||94
1742980|NCT00098293|4269765|P4|COMPLETED|Supplemental Phase (SP)||0
1742981|NCT00098293|4269766|P3|COMPLETED|Supplemental Phase (SP)||0
1742982|NCT00098293|4269767|P2|COMPLETED|Supplemental Phase (SP)||0
1742983|NCT00098293|4269768|P1|COMPLETED|Supplemental Phase (SP)||0
1742984|NCT00098293|4269764|P5|STARTED|Supplemental Phase (SP)||127
1742985|NCT00098293|4269765|P4|STARTED|Supplemental Phase (SP)||0
1742986|NCT00098293|4269766|P3|STARTED|Supplemental Phase (SP)||0
1742987|NCT00098293|4269767|P2|STARTED|Supplemental Phase (SP)||0
1742988|NCT00098293|4269768|P1|STARTED|Supplemental Phase (SP)||0
1742989|NCT00098293|4269764|P5|NOT COMPLETED|Open-label (OL) Phase||0
1742990|NCT00098293|4269765|P4|NOT COMPLETED|Open-label (OL) Phase||65
1742991|NCT00098293|4269766|P3|NOT COMPLETED|Open-label (OL) Phase||41
1742992|NCT00098293|4269767|P2|NOT COMPLETED|Open-label (OL) Phase||25
1742993|NCT00098293|4269768|P1|NOT COMPLETED|Open-label (OL) Phase||0
1742994|NCT00098293|4269764|P5|COMPLETED|Open-label (OL) Phase||0
1742995|NCT00098293|4269765|P4|COMPLETED|Open-label (OL) Phase||65
1742996|NCT00098293|4269766|P3|COMPLETED|Open-label (OL) Phase||158
1742997|NCT00098293|4269767|P2|COMPLETED|Open-label (OL) Phase||177
1742998|NCT00098293|4269768|P1|COMPLETED|Open-label (OL) Phase||0
1742999|NCT00098293|4269764|P5|STARTED|Open-label (OL) Phase||0
1743000|NCT00098293|4269765|P4|STARTED|Open-label (OL) Phase||130
1743001|NCT00098293|4269766|P3|STARTED|Open-label (OL) Phase||199
1743002|NCT00098293|4269767|P2|STARTED|Open-label (OL) Phase||202
1743003|NCT00098293|4269768|P1|STARTED|Open-label (OL) Phase||0
1743004|NCT00098293|4269764|P5|NOT COMPLETED|Between DB and OL Phase||0
1743005|NCT00098293|4269765|P4|NOT COMPLETED|Between DB and OL Phase||0
1743006|NCT00098293|4269766|P3|NOT COMPLETED|Between DB and OL Phase||3
1743007|NCT00098293|4269767|P2|NOT COMPLETED|Between DB and OL Phase||0
1743008|NCT00098293|4269768|P1|NOT COMPLETED|Between DB and OL Phase||0
1743009|NCT00098293|4269764|P5|COMPLETED|Between DB and OL Phase||0
1743010|NCT00098293|4269765|P4|COMPLETED|Between DB and OL Phase||0
1743011|NCT00098293|4269766|P3|COMPLETED|Between DB and OL Phase||199
1743012|NCT00098293|4269767|P2|COMPLETED|Between DB and OL Phase||202
1743013|NCT00098293|4269768|P1|COMPLETED|Between DB and OL Phase||0
1743014|NCT00098293|4269764|P5|STARTED|Between DB and OL Phase||0
1743015|NCT00098293|4269765|P4|STARTED|Between DB and OL Phase||0
1743016|NCT00098293|4269766|P3|STARTED|Between DB and OL Phase||202
1743017|NCT00098293|4269767|P2|STARTED|Between DB and OL Phase||202
1743018|NCT00098293|4269768|P1|STARTED|Between DB and OL Phase||0
1743019|NCT00098293|4269764|P5|NOT COMPLETED|Double-blind (DB) Phase||0
1743020|NCT00098293|4269765|P4|NOT COMPLETED|Double-blind (DB) Phase||0
1743021|NCT00098293|4269766|P3|NOT COMPLETED|Double-blind (DB) Phase||170
1743022|NCT00098293|4269767|P2|NOT COMPLETED|Double-blind (DB) Phase||166
1743023|NCT00098293|4269768|P1|NOT COMPLETED|Double-blind (DB) Phase||177
1743024|NCT00098293|4269764|P5|COMPLETED|Double-blind (DB) Phase||0
1743025|NCT00098293|4269765|P4|COMPLETED|Double-blind (DB) Phase||0
1743026|NCT00098293|4269766|P3|COMPLETED|Double-blind (DB) Phase||202
1743027|NCT00098293|4269767|P2|COMPLETED|Double-blind (DB) Phase||202
1743028|NCT00098293|4269768|P1|COMPLETED|Double-blind (DB) Phase||0
1743029|NCT00098293|4269764|P5|Treated|Double-blind (DB) Phase||0
1743030|NCT00098293|4269765|P4|Treated|Double-blind (DB) Phase||0
1743031|NCT00098293|4269766|P3|Treated|Double-blind (DB) Phase||361
1743032|NCT00098293|4269767|P2|Treated|Double-blind (DB) Phase||360
1743033|NCT00098293|4269768|P1|Treated|Double-blind (DB) Phase||174
1743034|NCT00098293|4269764|P5|STARTED|Double-blind (DB) Phase||0
1743035|NCT00098293|4269765|P4|STARTED|Double-blind (DB) Phase||0
1743036|NCT00098293|4269766|P3|STARTED|Double-blind (DB) Phase||372
1743037|NCT00098293|4269767|P2|STARTED|Double-blind (DB) Phase||368
1743038|NCT00098293|4269768|P1|STARTED|Double-blind (DB) Phase||177
1743039|NCT00098254|4269821|P1|NOT COMPLETED|Overall Study||3
1743040|NCT00098254|4269821|P1|COMPLETED|Overall Study||34
1743041|NCT00098254|4269821|P1|STARTED|Overall Study||37
1743042|NCT00098059|4269842|P2|NOT COMPLETED|Overall Study||1
1743043|NCT00098059|4269843|P1|NOT COMPLETED|Overall Study||0
1743044|NCT00098059|4269842|P2|COMPLETED|Overall Study||46
1743045|NCT00098059|4269843|P1|COMPLETED|Overall Study||27
1743046|NCT00098059|4269842|P2|STARTED|Overall Study||47
1743047|NCT00098059|4269843|P1|STARTED|Overall Study||27
1743048|NCT00098020|4269887|P1|NOT COMPLETED|Overall Study||6
1743049|NCT00098020|4269887|P1|COMPLETED|Overall Study||6
1743050|NCT00098020|4269887|P1|Started Isotretinoin|Overall Study||8
1743051|NCT00098020|4269887|P1|STARTED|Overall Study||12
1743052|NCT00097981|4269894|P2|NOT COMPLETED|Overall Study||100
1743053|NCT00097981|4269895|P1|NOT COMPLETED|Overall Study||106
1743054|NCT00097981|4269894|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
1743055|NCT00097981|4269895|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
1743056|NCT00097981|4269894|P2|Received Study Medication|Overall Study||106
1743057|NCT00097981|4269895|P1|Received Study Medication|Overall Study||110
1743058|NCT00097981|4269894|P2|STARTED|Overall Study|Enrollment at randomization|112
1743059|NCT00097981|4269895|P1|STARTED|Overall Study|Enrollment at randomization|113
1743060|NCT00097786|4269917|P4|NOT COMPLETED|Overall Study||310
1743061|NCT00097786|4269918|P3|NOT COMPLETED|Overall Study||313
1743062|NCT00097786|4269919|P2|NOT COMPLETED|Overall Study||292
1743063|NCT00097786|4269920|P1|NOT COMPLETED|Overall Study||296
1743064|NCT00097786|4269917|P4|COMPLETED|Overall Study||2036
1743065|NCT00097786|4269918|P3|COMPLETED|Overall Study||2016
1743066|NCT00097786|4269919|P2|COMPLETED|Overall Study||2023
1743067|NCT00097786|4269920|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
1743068|NCT00097786|4269917|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
1743069|NCT00097786|4269918|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
1743070|NCT00097786|4269919|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
1743071|NCT00097786|4269920|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
1743072|NCT00097786|4269917|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
1743073|NCT00097786|4269918|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
1743074|NCT00097786|4269919|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
1743075|NCT00097786|4269920|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
1743076|NCT00097786|4269917|P4|Complete FU for Progression to Diabetes|Overall Study||1762
1743077|NCT00097786|4269918|P3|Complete FU for Progression to Diabetes|Overall Study||1734
1743078|NCT00097786|4269919|P2|Complete FU for Progression to Diabetes|Overall Study||1712
1743079|NCT00097786|4269920|P1|Complete FU for Progression to Diabetes|Overall Study||1709
1743080|NCT00097786|4269917|P4|STARTED|Overall Study||2346
1743081|NCT00097786|4269918|P3|STARTED|Overall Study||2329
1743082|NCT00097786|4269919|P2|STARTED|Overall Study||2315
1743083|NCT00097786|4269920|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
1743084|NCT00097773|4269942|P4|NOT COMPLETED|Overall Study||3
1743085|NCT00097773|4269943|P3|NOT COMPLETED|Overall Study||8
1743086|NCT00097773|4269944|P2|NOT COMPLETED|Overall Study||8
1743087|NCT00097773|4269945|P1|NOT COMPLETED|Overall Study||8
1743088|NCT00097773|4269942|P4|COMPLETED|Overall Study||73
1743089|NCT00097773|4269943|P3|COMPLETED|Overall Study||68
1743090|NCT00097773|4269944|P2|COMPLETED|Overall Study||68
1743091|NCT00097773|4269945|P1|COMPLETED|Overall Study||68
1743092|NCT00097773|4269942|P4|STARTED|Overall Study||76
1743093|NCT00097773|4269943|P3|STARTED|Overall Study||76
1743094|NCT00097773|4269944|P2|STARTED|Overall Study||76
1743095|NCT00097773|4269945|P1|STARTED|Overall Study||76
1743096|NCT00097721|4269965|P2|NOT COMPLETED|Overall Study||33
1743097|NCT00097721|4269966|P1|NOT COMPLETED|Overall Study||71
1743098|NCT00097721|4269965|P2|COMPLETED|Overall Study||0
1743099|NCT00097721|4269966|P1|COMPLETED|Overall Study||0
1743100|NCT00097721|4269965|P2|STARTED|Overall Study||33
1743101|NCT00097721|4269966|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
1743102|NCT00097708|4269983|P3|NOT COMPLETED|Overall Study||65
1743103|NCT00097708|4269984|P2|NOT COMPLETED|Overall Study||56
1743104|NCT00097708|4269985|P1|NOT COMPLETED|Overall Study||64
1743105|NCT00097708|4269983|P3|COMPLETED|Overall Study||97
1743106|NCT00097708|4269984|P2|COMPLETED|Overall Study||120
1743107|NCT00097708|4269985|P1|COMPLETED|Overall Study||109
1743108|NCT00097708|4269983|P3|Treated|Overall Study||160
1743109|NCT00097708|4269984|P2|Treated|Overall Study||176
1743110|NCT00097708|4269985|P1|Treated|Overall Study||171
1743111|NCT00097708|4269983|P3|Intent-to-Treat (ITT)|Overall Study||149
1743112|NCT00097708|4269984|P2|Intent-to-Treat (ITT)|Overall Study||169
1743113|NCT00097708|4269985|P1|Intent-to-Treat (ITT)|Overall Study||165
1743114|NCT00097708|4269983|P3|STARTED|Overall Study||162
1743115|NCT00097708|4269984|P2|STARTED|Overall Study||176
1743116|NCT00097708|4269985|P1|STARTED|Overall Study||173
1743117|NCT00097695|4269997|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
1743118|NCT00097695|4269998|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
1743119|NCT00097695|4269999|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
1743120|NCT00097695|4270000|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
1743121|NCT00097695|4269997|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
1743122|NCT00097695|4269998|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
1743123|NCT00097695|4269999|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
1743124|NCT00097695|4270000|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
1743125|NCT00097695|4269997|P4|STARTED|The Open Label Extension (OLE) Phase||20
1743126|NCT00097695|4269998|P3|STARTED|The Open Label Extension (OLE) Phase||3
1743127|NCT00097695|4269999|P2|STARTED|The Open Label Extension (OLE) Phase||26
1743128|NCT00097695|4270000|P1|STARTED|The Open Label Extension (OLE) Phase||23
1743129|NCT00097695|4269997|P4|NOT COMPLETED|The Controlled Phase||20
1743130|NCT00097695|4269998|P3|NOT COMPLETED|The Controlled Phase||5
1743131|NCT00097695|4269999|P2|NOT COMPLETED|The Controlled Phase||3
1743132|NCT00097695|4270000|P1|NOT COMPLETED|The Controlled Phase||4
1743133|NCT00097695|4269997|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
1743134|NCT00097695|4269998|P3|COMPLETED|The Controlled Phase||3
1743135|NCT00097695|4269999|P2|COMPLETED|The Controlled Phase||26
1743136|NCT00097695|4270000|P1|COMPLETED|The Controlled Phase||23
1743137|NCT00097695|4269997|P4|STARTED|The Controlled Phase||20
1743138|NCT00097695|4269998|P3|STARTED|The Controlled Phase||8
1743139|NCT00097695|4269999|P2|STARTED|The Controlled Phase||29
1743140|NCT00097695|4270000|P1|STARTED|The Controlled Phase||27
1743141|NCT00097591|4270016|P2|NOT COMPLETED|Overall Study||394
1743142|NCT00097591|4270017|P1|NOT COMPLETED|Overall Study||410
1743143|NCT00097591|4270016|P2|COMPLETED|Overall Study||6401
1743144|NCT00097591|4270017|P1|COMPLETED|Overall Study||6403
1743145|NCT00097591|4270016|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
1743146|NCT00097591|4270017|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
1743147|NCT00097539|4270040|P7|NOT COMPLETED|Overall Study||171
1743148|NCT00097539|4270041|P6|NOT COMPLETED|Overall Study||5892
1743149|NCT00097539|4270042|P5|NOT COMPLETED|Overall Study||1758
1743150|NCT00097539|4270043|P4|NOT COMPLETED|Overall Study||3585
1743151|NCT00097539|4270044|P3|NOT COMPLETED|Overall Study||9108
1743152|NCT00097539|4270045|P2|NOT COMPLETED|Overall Study||6531
1743153|NCT00097539|4270046|P1|NOT COMPLETED|Overall Study||19066
1743154|NCT00097539|4270040|P7|COMPLETED|Overall Study||68
1743155|NCT00097539|4270041|P6|COMPLETED|Overall Study||2118
1743156|NCT00097539|4270042|P5|COMPLETED|Overall Study||386
1743157|NCT00097539|4270043|P4|COMPLETED|Overall Study||2066
1743158|NCT00097539|4270044|P3|COMPLETED|Overall Study||3411
1743159|NCT00097539|4270045|P2|COMPLETED|Overall Study||2825
1743160|NCT00097539|4270046|P1|COMPLETED|Overall Study||8220
1743161|NCT00097539|4270040|P7|STARTED|Overall Study||239
1743162|NCT00097539|4270041|P6|STARTED|Overall Study||8010
1743163|NCT00097539|4270042|P5|STARTED|Overall Study||2144
1743164|NCT00097539|4270043|P4|STARTED|Overall Study||5651
1743165|NCT00097539|4270044|P3|STARTED|Overall Study||12519
1743166|NCT00097539|4270045|P2|STARTED|Overall Study||9356
1743167|NCT00097539|4270046|P1|STARTED|Overall Study||27286
1743168|NCT00097500|4270092|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
1743169|NCT00097500|4270093|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
1743170|NCT00097500|4270092|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
1743171|NCT00097500|4270093|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
1743172|NCT00097500|4270092|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
1743173|NCT00097500|4270093|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
1743174|NCT00097500|4270092|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
1743175|NCT00097500|4270093|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
1743176|NCT00097500|4270092|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
1743177|NCT00097500|4270093|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
1743178|NCT00097500|4270092|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
1743179|NCT00097500|4270093|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
1743180|NCT00097448|4270117|P2|NOT COMPLETED|Overall Study||1
1743181|NCT00097448|4270118|P1|NOT COMPLETED|Overall Study||4
1743182|NCT00097448|4270117|P2|COMPLETED|Overall Study||129
1743183|NCT00097448|4270118|P1|COMPLETED|Overall Study||121
1743184|NCT00097448|4270117|P2|STARTED|Overall Study||130
1743185|NCT00097448|4270118|P1|STARTED|Overall Study||125
1743186|NCT00097370|4270124|P1|NOT COMPLETED|Stage 3||59
1743187|NCT00097370|4270124|P1|COMPLETED|Stage 3||0
1743188|NCT00097370|4270124|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
1743189|NCT00097370|4270124|P1|NOT COMPLETED|Stage 2||13
1743190|NCT00097370|4270124|P1|COMPLETED|Stage 2||59
1743191|NCT00097370|4270124|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
1743192|NCT00097370|4270124|P1|NOT COMPLETED|Stage 1||6
1743193|NCT00097370|4270124|P1|COMPLETED|Stage 1||31
1743194|NCT00097370|4270124|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
1743195|NCT00097253|4270141|P1|NOT COMPLETED|Water (Control)||0
1743196|NCT00097253|4270141|P1|COMPLETED|Water (Control)||56
1743197|NCT00097253|4270141|P1|STARTED|Water (Control)||56
1743198|NCT00097253|4270141|P1|NOT COMPLETED|Lemon||0
1743199|NCT00097253|4270141|P1|COMPLETED|Lemon||56
1743200|NCT00097253|4270141|P1|STARTED|Lemon||56
1743201|NCT00097253|4270141|P1|NOT COMPLETED|Lavender||0
1743202|NCT00097253|4270141|P1|COMPLETED|Lavender||56
1743203|NCT00097253|4270141|P1|STARTED|Lavender||56
1743204|NCT00096993|4270158|P2|NOT COMPLETED|Overall Study||65
1743205|NCT00096993|4270159|P1|NOT COMPLETED|Overall Study||65
1743206|NCT00096993|4270158|P2|COMPLETED|Overall Study||0
1743207|NCT00096993|4270159|P1|COMPLETED|Overall Study||1
1743208|NCT00096993|4270158|P2|STARTED|Overall Study||65
1743209|NCT00096993|4270159|P1|STARTED|Overall Study||66
1743210|NCT00096954|4270175|P2|NOT COMPLETED|Overall Study||20
1743211|NCT00096954|4270176|P1|NOT COMPLETED|Overall Study||24
1743212|NCT00096954|4270175|P2|COMPLETED|Overall Study||154
1743213|NCT00096954|4270176|P1|COMPLETED|Overall Study||135
1743214|NCT00096954|4270175|P2|Received Study Drug|Overall Study||171
1743215|NCT00096954|4270176|P1|Received Study Drug|Overall Study||157
1743216|NCT00096954|4270175|P2|STARTED|Overall Study||174
1743217|NCT00096954|4270176|P1|STARTED|Overall Study||159
1743218|NCT00096941|4270188|P1|NOT COMPLETED|Overall Study||3
1743219|NCT00096941|4270188|P1|COMPLETED|Overall Study||0
1743220|NCT00096941|4270188|P1|STARTED|Overall Study||3
1743221|NCT00096785|4270195|P2|NOT COMPLETED|Overall Study||1
1743222|NCT00096785|4270196|P1|NOT COMPLETED|Overall Study||2
1743223|NCT00096785|4270195|P2|COMPLETED|Overall Study|As randomized cohort|33
1743224|NCT00096785|4270196|P1|COMPLETED|Overall Study|As randomized cohort|33
1743225|NCT00096785|4270195|P2|As-Treated Population|Overall Study||33
1743226|NCT00096785|4270196|P1|As-Treated Population|Overall Study||36
1743227|NCT00096785|4270195|P2|As-Randomized Population|Overall Study||34
1743228|NCT00096785|4270196|P1|As-Randomized Population|Overall Study||35
1743229|NCT00096785|4270195|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
1743230|NCT00096785|4270196|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
1743231|NCT00096681|4270220|P1|NOT COMPLETED|Overall Study||0
1743232|NCT00096681|4270220|P1|COMPLETED|Overall Study||762
1743233|NCT00096681|4270220|P1|STARTED|Overall Study||762
1743234|NCT00096538|4270225|P1|NOT COMPLETED|Overall Study||1
1743235|NCT00096538|4270225|P1|COMPLETED|Overall Study||5
1743236|NCT00096538|4270225|P1|STARTED|Overall Study||6
1743237|NCT00096486|4270233|P4|NOT COMPLETED|Overall Study||2
1743238|NCT00096486|4270234|P3|NOT COMPLETED|Overall Study||2
1743239|NCT00096486|4270235|P2|NOT COMPLETED|Overall Study||0
1743240|NCT00096486|4270236|P1|NOT COMPLETED|Overall Study||0
1743241|NCT00096486|4270233|P4|COMPLETED|Overall Study||36
1743242|NCT00096486|4270234|P3|COMPLETED|Overall Study||24
1743243|NCT00096486|4270235|P2|COMPLETED|Overall Study||6
1743244|NCT00096486|4270236|P1|COMPLETED|Overall Study||4
1743245|NCT00096486|4270233|P4|STARTED|Overall Study||38
1743246|NCT00096486|4270234|P3|STARTED|Overall Study||26
1743247|NCT00096486|4270235|P2|STARTED|Overall Study||6
1743248|NCT00096486|4270236|P1|STARTED|Overall Study||4
1743249|NCT00096460|4270248|P2|NOT COMPLETED|Overall Study||1
1743250|NCT00096460|4270249|P1|NOT COMPLETED|Overall Study||7
1743251|NCT00096460|4270248|P2|COMPLETED|Overall Study||7
1743252|NCT00096460|4270249|P1|COMPLETED|Overall Study||15
1743253|NCT00096460|4270248|P2|STARTED|Overall Study||8
1743254|NCT00096460|4270249|P1|STARTED|Overall Study||22
1743255|NCT00096447|4270255|P1|NOT COMPLETED|Overall Study||1
1743256|NCT00096447|4270255|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
1743257|NCT00096447|4270255|P1|STARTED|Overall Study||31
1743258|NCT00096382|4270271|P2|NOT COMPLETED|Overall Study||0
1743259|NCT00096382|4270272|P1|NOT COMPLETED|Overall Study||2
1743260|NCT00096382|4270271|P2|COMPLETED|Overall Study||3
1743261|NCT00096382|4270272|P1|COMPLETED|Overall Study||21
1743262|NCT00096382|4270271|P2|STARTED|Overall Study||3
1743263|NCT00096382|4270272|P1|STARTED|Overall Study||23
1743264|NCT00096356|4270282|P2|NOT COMPLETED|Overall Study||53
1743265|NCT00096356|4270283|P1|NOT COMPLETED|Overall Study||44
1743266|NCT00096356|4270282|P2|COMPLETED|Overall Study||61
1743267|NCT00096356|4270283|P1|COMPLETED|Overall Study||78
1743268|NCT00096356|4270282|P2|STARTED|Overall Study||114
1743269|NCT00096356|4270283|P1|STARTED|Overall Study||122
1743270|NCT00096278|4270295|P2|NOT COMPLETED|Overall Study||20
1743271|NCT00096278|4270296|P1|NOT COMPLETED|Overall Study||18
1743272|NCT00096278|4270295|P2|COMPLETED|Overall Study||1334
1743273|NCT00096278|4270296|P1|COMPLETED|Overall Study||1338
1743274|NCT00096278|4270295|P2|STARTED|Overall Study||1354
1743275|NCT00096278|4270296|P1|STARTED|Overall Study||1356
1743276|NCT00096265|4270315|P3|NOT COMPLETED|Overall Study||0
1743277|NCT00096265|4270316|P2|NOT COMPLETED|Overall Study||0
1743278|NCT00096265|4270317|P1|NOT COMPLETED|Overall Study||1
1743279|NCT00096265|4270315|P3|COMPLETED|Overall Study||41
1743280|NCT00096265|4270316|P2|COMPLETED|Overall Study||40
1743281|NCT00096265|4270317|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
1743282|NCT00096265|4270315|P3|STARTED|Overall Study||41
1743283|NCT00096265|4270316|P2|STARTED|Overall Study||40
1743284|NCT00096265|4270317|P1|STARTED|Overall Study||45
1743285|NCT00096226|4270343|P1|NOT COMPLETED|Overall Study||17
1743286|NCT00096226|4270343|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
1743287|NCT00096226|4270343|P1|STARTED|Overall Study||60
1743288|NCT00096200|4270350|P3|NOT COMPLETED|Overall Study||0
1743289|NCT00096200|4270351|P2|NOT COMPLETED|Overall Study||7
1743290|NCT00096200|4270352|P1|NOT COMPLETED|Overall Study||1
1743291|NCT00096200|4270350|P3|COMPLETED|Overall Study||5
1743292|NCT00096200|4270351|P2|COMPLETED|Overall Study||23
1743293|NCT00096200|4270352|P1|COMPLETED|Overall Study||8
1743294|NCT00096200|4270350|P3|STARTED|Overall Study||5
1743295|NCT00096200|4270351|P2|STARTED|Overall Study||30
1743296|NCT00096200|4270352|P1|STARTED|Overall Study||9
1743297|NCT00096174|4270366|P1|NOT COMPLETED|Overall Study||62
1743298|NCT00096174|4270366|P1|COMPLETED|Overall Study||7
1743299|NCT00096174|4270366|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
1743300|NCT00096174|4270366|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
1743301|NCT00096174|4270366|P1|STARTED|Overall Study||69
1743302|NCT00096161|4270376|P4|NOT COMPLETED|Overall Study||0
1743303|NCT00096161|4270377|P3|NOT COMPLETED|Overall Study||0
1743304|NCT00096161|4270378|P2|NOT COMPLETED|Overall Study||0
1743305|NCT00096161|4270379|P1|NOT COMPLETED|Overall Study||0
1743306|NCT00096161|4270376|P4|COMPLETED|Overall Study||0
1743307|NCT00096161|4270377|P3|COMPLETED|Overall Study||6
1743308|NCT00096161|4270378|P2|COMPLETED|Overall Study||10
1743309|NCT00096161|4270379|P1|COMPLETED|Overall Study||20
1743310|NCT00096161|4270376|P4|STARTED|Overall Study||0
1743311|NCT00096161|4270377|P3|STARTED|Overall Study||6
1743312|NCT00096161|4270378|P2|STARTED|Overall Study||10
1743313|NCT00096161|4270379|P1|STARTED|Overall Study||20
1743314|NCT00096135|4270411|P2|NOT COMPLETED|Overall Study||15
1743315|NCT00096135|4270412|P1|NOT COMPLETED|Overall Study||63
1743316|NCT00096135|4270411|P2|COMPLETED|Overall Study||27
1743317|NCT00096135|4270412|P1|COMPLETED|Overall Study||63
1743318|NCT00096135|4270411|P2|STARTED|Overall Study||42
1743319|NCT00096135|4270412|P1|STARTED|Overall Study||126
1743320|NCT00096122|4270418|P1|NOT COMPLETED|Overall Study||0
1743321|NCT00096122|4270418|P1|COMPLETED|Overall Study||95
1743322|NCT00096122|4270418|P1|STARTED|Overall Study||95
1743323|NCT00096109|4270422|P1|NOT COMPLETED|Overall Study||0
1743324|NCT00096109|4270422|P1|COMPLETED|Overall Study||11
1743325|NCT00096109|4270422|P1|STARTED|Overall Study||11
1743326|NCT00096044|4270428|P1|NOT COMPLETED|Overall Study||34
1743327|NCT00096044|4270428|P1|COMPLETED|Overall Study||11
1743328|NCT00096044|4270428|P1|STARTED|Overall Study||45
1743329|NCT00096031|4270437|P1|NOT COMPLETED|Overall Study||63
1743330|NCT00096031|4270437|P1|COMPLETED|Overall Study||0
1743331|NCT00096031|4270437|P1|Eligible and Began Protocol Therapy|Overall Study||55
1743332|NCT00096031|4270437|P1|Eligible|Overall Study||57
1743333|NCT00096031|4270437|P1|STARTED|Overall Study||63
1743334|NCT00096018|4270445|P2|NOT COMPLETED|Overall Study||14
1743335|NCT00096018|4270446|P1|NOT COMPLETED|Overall Study||2
1743336|NCT00096018|4270445|P2|COMPLETED|Overall Study||16
1743337|NCT00096018|4270446|P1|COMPLETED|Overall Study||11
1743338|NCT00096018|4270445|P2|Treated With Study Therapy|Overall Study||25
1743339|NCT00096018|4270446|P1|Treated With Study Therapy|Overall Study||13
1743340|NCT00096018|4270445|P2|STARTED|Overall Study||30
1743341|NCT00096018|4270446|P1|STARTED|Overall Study||13
1743342|NCT00095979|4270454|P1|NOT COMPLETED|Overall Study||2
1743343|NCT00095979|4270454|P1|COMPLETED|Overall Study||50
1743344|NCT00095979|4270454|P1|STARTED|Overall Study||52
1743345|NCT00095940|4270472|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
1743346|NCT00095940|4270473|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
1743347|NCT00095940|4270474|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
1743348|NCT00095940|4270475|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
1743349|NCT00095940|4270476|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
1743350|NCT00095940|4270477|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
1743351|NCT00095940|4270478|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
1743352|NCT00095940|4270479|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
1743353|NCT00095940|4270480|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
1743354|NCT00095940|4270472|P9|COMPLETED|Lapatinib Continuation/Phase II||1
1743355|NCT00095940|4270473|P8|COMPLETED|Lapatinib Continuation/Phase II||0
1743356|NCT00095940|4270474|P7|COMPLETED|Lapatinib Continuation/Phase II||0
1743357|NCT00095940|4270475|P6|COMPLETED|Lapatinib Continuation/Phase II||0
1743358|NCT00095940|4270476|P5|COMPLETED|Lapatinib Continuation/Phase II||0
1743359|NCT00095940|4270477|P4|COMPLETED|Lapatinib Continuation/Phase II||0
1743360|NCT00095940|4270478|P3|COMPLETED|Lapatinib Continuation/Phase II||1
1743361|NCT00095940|4270479|P2|COMPLETED|Lapatinib Continuation/Phase II||0
1743362|NCT00095940|4270480|P1|COMPLETED|Lapatinib Continuation/Phase II||0
1743363|NCT00095940|4270472|P9|STARTED|Lapatinib Continuation/Phase II||14
1743364|NCT00095940|4270473|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
1743365|NCT00095940|4270474|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
1743366|NCT00095940|4270475|P6|STARTED|Lapatinib Continuation/Phase II||13
1743367|NCT00095940|4270476|P5|STARTED|Lapatinib Continuation/Phase II||0
1743368|NCT00095940|4270477|P4|STARTED|Lapatinib Continuation/Phase II||0
1743369|NCT00095940|4270478|P3|STARTED|Lapatinib Continuation/Phase II||17
1743370|NCT00095940|4270479|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
1743371|NCT00095940|4270480|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
1743372|NCT00095940|4270472|P9|NOT COMPLETED|Molecular Biology Phase||0
1743373|NCT00095940|4270473|P8|NOT COMPLETED|Molecular Biology Phase||0
1743374|NCT00095940|4270474|P7|NOT COMPLETED|Molecular Biology Phase||0
1743375|NCT00095940|4270475|P6|NOT COMPLETED|Molecular Biology Phase||0
1743376|NCT00095940|4270476|P5|NOT COMPLETED|Molecular Biology Phase||0
1743377|NCT00095940|4270477|P4|NOT COMPLETED|Molecular Biology Phase||0
1743378|NCT00095940|4270478|P3|NOT COMPLETED|Molecular Biology Phase||0
1743379|NCT00095940|4270479|P2|NOT COMPLETED|Molecular Biology Phase||0
1743380|NCT00095940|4270480|P1|NOT COMPLETED|Molecular Biology Phase||0
1743381|NCT00095940|4270472|P9|COMPLETED|Molecular Biology Phase||0
1743382|NCT00095940|4270473|P8|COMPLETED|Molecular Biology Phase||2
1743383|NCT00095940|4270474|P7|COMPLETED|Molecular Biology Phase||2
1743384|NCT00095940|4270475|P6|COMPLETED|Molecular Biology Phase||0
1743385|NCT00095940|4270476|P5|COMPLETED|Molecular Biology Phase||0
1743386|NCT00095940|4270477|P4|COMPLETED|Molecular Biology Phase||0
1743387|NCT00095940|4270478|P3|COMPLETED|Molecular Biology Phase||0
1743388|NCT00095940|4270479|P2|COMPLETED|Molecular Biology Phase||2
1743389|NCT00095940|4270480|P1|COMPLETED|Molecular Biology Phase||2
1743390|NCT00095940|4270472|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
1743391|NCT00095940|4270473|P8|STARTED|Molecular Biology Phase||2
1743392|NCT00095940|4270474|P7|STARTED|Molecular Biology Phase||2
1743393|NCT00095940|4270475|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
1743394|NCT00095940|4270476|P5|STARTED|Molecular Biology Phase||0
1743395|NCT00095940|4270477|P4|STARTED|Molecular Biology Phase||0
1743396|NCT00095940|4270478|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
1743397|NCT00095940|4270479|P2|STARTED|Molecular Biology Phase||2
1743398|NCT00095940|4270480|P1|STARTED|Molecular Biology Phase||2
1743399|NCT00095875|4270504|P2|NOT COMPLETED|Overall Study||9
1743400|NCT00095875|4270505|P1|NOT COMPLETED|Overall Study||14
1743401|NCT00095875|4270504|P2|COMPLETED|Overall Study||66
1743402|NCT00095875|4270505|P1|COMPLETED|Overall Study||56
1743403|NCT00095875|4270504|P2|STARTED|Overall Study||75
1743404|NCT00095875|4270505|P1|STARTED|Overall Study||70
1743405|NCT00095836|4270513|P1|NOT COMPLETED|Overall Study||4
1743406|NCT00095836|4270513|P1|COMPLETED|Overall Study||23
1743407|NCT00095836|4270513|P1|STARTED|Overall Study||27
1743408|NCT00095784|4270520|P1|NOT COMPLETED|Overall Study||0
1743409|NCT00095784|4270520|P1|COMPLETED|Overall Study||21
1743410|NCT00095784|4270520|P1|STARTED|Overall Study||21
1743411|NCT00095628|4270543|P1|NOT COMPLETED|Overall Study||1
1743412|NCT00095628|4270543|P1|COMPLETED|Overall Study||20
1743413|NCT00095628|4270543|P1|STARTED|Overall Study||21
1743414|NCT00095576|4270554|P2|NOT COMPLETED|Overall Study||1481
1743415|NCT00095576|4270555|P1|NOT COMPLETED|Overall Study||1475
1743416|NCT00095576|4270554|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
1743495|NCT00095173|4271216|P2|STARTED|Open-Label Extension Phase (Period C)||0
1743417|NCT00095576|4270555|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
1743418|NCT00095576|4270554|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
1743419|NCT00095576|4270555|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
1743420|NCT00095576|4270554|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
1743421|NCT00095576|4270555|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
1743422|NCT00095576|4270554|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
1743423|NCT00095576|4270555|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
1743424|NCT00095576|4270554|P2|STARTED|Overall Study||1495
1743425|NCT00095576|4270555|P1|STARTED|Overall Study||1484
1743426|NCT00095563|4270567|P1|NOT COMPLETED|Overall Study||0
1743427|NCT00095563|4270567|P1|COMPLETED|Overall Study||39
1743428|NCT00095563|4270567|P1|STARTED|Overall Study||39
1743429|NCT00095498|4270579|P3|NOT COMPLETED|Overall Study||39
1743430|NCT00095498|4270580|P2|NOT COMPLETED|Overall Study||35
1743431|NCT00095498|4270581|P1|NOT COMPLETED|Overall Study||37
1743432|NCT00095498|4270579|P3|COMPLETED|Overall Study||39
1743433|NCT00095498|4270580|P2|COMPLETED|Overall Study||38
1743434|NCT00095498|4270581|P1|COMPLETED|Overall Study||39
1743435|NCT00095498|4270579|P3|Received Investigational Product|Overall Study||75
1743436|NCT00095498|4270580|P2|Received Investigational Product|Overall Study||71
1743437|NCT00095498|4270581|P1|Received Investigational Product|Overall Study||72
1743438|NCT00095498|4270579|P3|STARTED|Overall Study||78
1743439|NCT00095498|4270580|P2|STARTED|Overall Study||73
1743440|NCT00095498|4270581|P1|STARTED|Overall Study||76
1743441|NCT00095303|4271008|P2|NOT COMPLETED|Follow Up Study||58
1743442|NCT00095303|4271009|P1|NOT COMPLETED|Follow Up Study||59
1743443|NCT00095303|4271008|P2|COMPLETED|Follow Up Study||121
1743444|NCT00095303|4271009|P1|COMPLETED|Follow Up Study||140
1743445|NCT00095303|4271008|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
1743446|NCT00095303|4271009|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
1743447|NCT00095303|4271008|P2|NOT COMPLETED|Main Study||87
1743448|NCT00095303|4271009|P1|NOT COMPLETED|Main Study||91
1743449|NCT00095303|4271008|P2|COMPLETED|Main Study||148
1743450|NCT00095303|4271009|P1|COMPLETED|Main Study||154
1743451|NCT00095303|4271008|P2|STARTED|Main Study||235
1743452|NCT00095303|4271009|P1|STARTED|Main Study||245
1743453|NCT00095238|4271077|P2|NOT COMPLETED|Overall Study||852
1743454|NCT00095238|4271078|P1|NOT COMPLETED|Overall Study||857
1743455|NCT00095238|4271077|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
1743456|NCT00095238|4271078|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
1743457|NCT00095238|4271077|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
1743458|NCT00095238|4271078|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
1743459|NCT00095238|4271077|P2|STARTED|Overall Study|number randomized|2061
1743460|NCT00095238|4271078|P1|STARTED|Overall Study|number randomized|2067
1743461|NCT00095212|4271140|P2|NOT COMPLETED|Overall Study||3
1743462|NCT00095212|4271141|P1|NOT COMPLETED|Overall Study||1
1743463|NCT00095212|4271140|P2|COMPLETED|Overall Study||9
1743464|NCT00095212|4271141|P1|COMPLETED|Overall Study||12
1743465|NCT00095212|4271140|P2|STARTED|Overall Study||12
1743466|NCT00095212|4271141|P1|STARTED|Overall Study||13
1743467|NCT00095199|4271171|P4|NOT COMPLETED|Overall Study||143
1743468|NCT00095199|4271172|P3|NOT COMPLETED|Overall Study||160
1743469|NCT00095199|4271173|P2|NOT COMPLETED|Overall Study||242
1743470|NCT00095199|4271174|P1|NOT COMPLETED|Overall Study||296
1743471|NCT00095199|4271171|P4|COMPLETED|Overall Study||23
1743472|NCT00095199|4271172|P3|COMPLETED|Overall Study||7
1743473|NCT00095199|4271173|P2|COMPLETED|Overall Study||62
1743474|NCT00095199|4271174|P1|COMPLETED|Overall Study||6
1743475|NCT00095199|4271171|P4|STARTED|Overall Study||166
1743476|NCT00095199|4271172|P3|STARTED|Overall Study||167
1743477|NCT00095199|4271173|P2|STARTED|Overall Study||304
1743478|NCT00095199|4271174|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
1743479|NCT00095173|4271212|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
1743480|NCT00095173|4271213|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
1743481|NCT00095173|4271214|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
1743482|NCT00095173|4271215|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
1743483|NCT00095173|4271216|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
1743484|NCT00095173|4271217|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
1743485|NCT00095173|4271212|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
1743486|NCT00095173|4271213|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
1743487|NCT00095173|4271214|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
1743488|NCT00095173|4271215|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
1743489|NCT00095173|4271216|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
1743490|NCT00095173|4271217|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
1743491|NCT00095173|4271212|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
1743492|NCT00095173|4271213|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
1743493|NCT00095173|4271214|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
1743494|NCT00095173|4271215|P3|STARTED|Open-Label Extension Phase (Period C)||0
1743496|NCT00095173|4271217|P1|STARTED|Open-Label Extension Phase (Period C)||0
1743497|NCT00095173|4271212|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
1743498|NCT00095173|4271213|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
1743499|NCT00095173|4271214|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
1743500|NCT00095173|4271215|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
1743501|NCT00095173|4271216|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
1743502|NCT00095173|4271217|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
1743503|NCT00095173|4271212|P6|COMPLETED|Double-Blind Phase (Period B)||0
1743504|NCT00095173|4271213|P5|COMPLETED|Double-Blind Phase (Period B)||0
1743505|NCT00095173|4271214|P4|COMPLETED|Double-Blind Phase (Period B)||0
1743506|NCT00095173|4271215|P3|COMPLETED|Double-Blind Phase (Period B)||31
1743507|NCT00095173|4271216|P2|COMPLETED|Double-Blind Phase (Period B)||49
1743508|NCT00095173|4271217|P1|COMPLETED|Double-Blind Phase (Period B)||0
1743509|NCT00095173|4271212|P6|STARTED|Double-Blind Phase (Period B)||0
1743510|NCT00095173|4271213|P5|STARTED|Double-Blind Phase (Period B)||0
1743511|NCT00095173|4271214|P4|STARTED|Double-Blind Phase (Period B)||0
1743512|NCT00095173|4271215|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
1743513|NCT00095173|4271216|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
1743514|NCT00095173|4271217|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
1743515|NCT00095173|4271212|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743516|NCT00095173|4271213|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743517|NCT00095173|4271214|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743518|NCT00095173|4271215|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743519|NCT00095173|4271216|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743520|NCT00095173|4271217|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
1743521|NCT00095173|4271212|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743522|NCT00095173|4271213|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743523|NCT00095173|4271214|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743524|NCT00095173|4271215|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743525|NCT00095173|4271216|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
1743526|NCT00095173|4271217|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
1743527|NCT00095173|4271212|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
1743528|NCT00095173|4271213|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
1743529|NCT00095173|4271214|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
1743530|NCT00095173|4271215|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
1743531|NCT00095173|4271216|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
1743532|NCT00095173|4271217|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
1743533|NCT00095147|4271255|P5|NOT COMPLETED|Long-term Extension Period||45
1743534|NCT00095147|4271256|P4|NOT COMPLETED|Long-term Extension Period||0
1743535|NCT00095147|4271257|P3|NOT COMPLETED|Long-term Extension Period||0
1743536|NCT00095147|4271258|P2|NOT COMPLETED|Long-term Extension Period||0
1743537|NCT00095147|4271259|P1|NOT COMPLETED|Long-term Extension Period||0
1743538|NCT00095147|4271255|P5|COMPLETED|Long-term Extension Period||327
1743539|NCT00095147|4271256|P4|COMPLETED|Long-term Extension Period||0
1743540|NCT00095147|4271257|P3|COMPLETED|Long-term Extension Period||0
1743541|NCT00095147|4271258|P2|COMPLETED|Long-term Extension Period||0
1743542|NCT00095147|4271259|P1|COMPLETED|Long-term Extension Period||0
1743543|NCT00095147|4271255|P5|STARTED|Long-term Extension Period||372
1743544|NCT00095147|4271256|P4|STARTED|Long-term Extension Period||0
1743545|NCT00095147|4271257|P3|STARTED|Long-term Extension Period||0
1743546|NCT00095147|4271258|P2|STARTED|Long-term Extension Period||0
1743547|NCT00095147|4271259|P1|STARTED|Long-term Extension Period||0
1743548|NCT00095147|4271255|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
1743549|NCT00095147|4271256|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
1743550|NCT00095147|4271257|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
1743551|NCT00095147|4271258|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
1743552|NCT00095147|4271259|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
1743553|NCT00095147|4271255|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
1743554|NCT00095147|4271256|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
1743555|NCT00095147|4271257|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
1743556|NCT00095147|4271258|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
1743557|NCT00095147|4271259|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
1743558|NCT00095147|4271255|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
1743559|NCT00095147|4271256|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
1743560|NCT00095147|4271257|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
1743561|NCT00095147|4271258|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
1743562|NCT00095147|4271259|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
1743563|NCT00095147|4271255|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
1743564|NCT00095147|4271256|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
1743565|NCT00095147|4271257|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
1743566|NCT00095147|4271258|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
1743567|NCT00095147|4271259|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
1743568|NCT00095147|4271255|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
1743569|NCT00095147|4271256|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
1743570|NCT00095147|4271257|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
1743571|NCT00095147|4271258|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
1743572|NCT00095147|4271259|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
1743573|NCT00095147|4271255|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
1743574|NCT00095147|4271256|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
1743575|NCT00095147|4271257|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
1743576|NCT00095147|4271258|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
1743577|NCT00095147|4271259|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
1743578|NCT00095121|4271454|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
1743579|NCT00095121|4271455|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
1743580|NCT00095121|4271454|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
1743581|NCT00095121|4271455|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
1743582|NCT00095121|4271454|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
1743583|NCT00095121|4271455|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
1743584|NCT00095121|4271454|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
1743585|NCT00095121|4271455|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
1743586|NCT00095121|4271454|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
1743587|NCT00095121|4271455|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
1743588|NCT00095121|4271454|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
1743589|NCT00095121|4271455|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
1743590|NCT00095121|4271454|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
1743591|NCT00095121|4271455|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
1743592|NCT00095056|4271501|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
1743593|NCT00095056|4271502|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
1743594|NCT00095056|4271501|P2|COMPLETED|Phase B (Weeks 12-54)||20
1743595|NCT00095056|4271502|P1|COMPLETED|Phase B (Weeks 12-54)||46
1743596|NCT00095056|4271501|P2|STARTED|Phase B (Weeks 12-54)||25
1743597|NCT00095056|4271502|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
1743598|NCT00095056|4271501|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
1743599|NCT00095056|4271502|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
1743600|NCT00095056|4271501|P2|COMPLETED|Phase A (Weeks 0-12)||25
1743601|NCT00095056|4271502|P1|COMPLETED|Phase A (Weeks 0-12)||58
1743602|NCT00095056|4271501|P2|STARTED|Phase A (Weeks 0-12)||26
1743603|NCT00095056|4271502|P1|STARTED|Phase A (Weeks 0-12)||65
1743604|NCT00094900|4271510|P1|NOT COMPLETED|Overall Study||1
1743605|NCT00094900|4271510|P1|COMPLETED|Overall Study||10
1743606|NCT00094900|4271510|P1|STARTED|Overall Study||11
1743607|NCT00094887|4271612|P2|NOT COMPLETED|Overall Study||6
1743608|NCT00094887|4271613|P1|NOT COMPLETED|Overall Study||5
1743609|NCT00094887|4271612|P2|COMPLETED|Overall Study||69
1743610|NCT00094887|4271613|P1|COMPLETED|Overall Study||70
1743611|NCT00094887|4271612|P2|STARTED|Overall Study|75|75
1743612|NCT00094887|4271613|P1|STARTED|Overall Study|75|75
1743613|NCT00094861|4271621|P2|NOT COMPLETED|Overall Study||9
1743614|NCT00094861|4271622|P1|NOT COMPLETED|Overall Study||18
1743615|NCT00094861|4271621|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
1743616|NCT00094861|4271622|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
1743617|NCT00094861|4271621|P2|Participants Treated|Overall Study||48
1743618|NCT00094861|4271622|P1|Participants Treated|Overall Study||46
1743619|NCT00094861|4271621|P2|STARTED|Overall Study||49
1743620|NCT00094861|4271622|P1|STARTED|Overall Study||46
1743621|NCT00094835|4271649|P7|NOT COMPLETED|Overall Study||2
1743622|NCT00094835|4271650|P6|NOT COMPLETED|Overall Study||3
1743623|NCT00094835|4271651|P5|NOT COMPLETED|Overall Study||4
1743624|NCT00094835|4271652|P4|NOT COMPLETED|Overall Study||1
1743625|NCT00094835|4271653|P3|NOT COMPLETED|Overall Study||3
1743626|NCT00094835|4271654|P2|NOT COMPLETED|Overall Study||3
1743627|NCT00094835|4271655|P1|NOT COMPLETED|Overall Study||4
1743628|NCT00094835|4271649|P7|COMPLETED|Overall Study||4
1743629|NCT00094835|4271650|P6|COMPLETED|Overall Study||3
1743630|NCT00094835|4271651|P5|COMPLETED|Overall Study||3
1743631|NCT00094835|4271652|P4|COMPLETED|Overall Study||4
1743632|NCT00094835|4271653|P3|COMPLETED|Overall Study||4
1743633|NCT00094835|4271654|P2|COMPLETED|Overall Study||8
1743634|NCT00094835|4271655|P1|COMPLETED|Overall Study||5
1743635|NCT00094835|4271649|P7|Treated With Motesanib|Overall Study||6
1743636|NCT00094835|4271650|P6|Treated With Motesanib|Overall Study||5
1743637|NCT00094835|4271651|P5|Treated With Motesanib|Overall Study||7
1743638|NCT00094835|4271652|P4|Treated With Motesanib|Overall Study||4
1743639|NCT00094835|4271653|P3|Treated With Motesanib|Overall Study||6
1743640|NCT00094835|4271654|P2|Treated With Motesanib|Overall Study||11
1743641|NCT00094835|4271655|P1|Treated With Motesanib|Overall Study||6
1743642|NCT00094835|4271649|P7|STARTED|Overall Study||6
1743643|NCT00094835|4271650|P6|STARTED|Overall Study||6
1743644|NCT00094835|4271651|P5|STARTED|Overall Study||7
1743645|NCT00094835|4271652|P4|STARTED|Overall Study||5
1743646|NCT00094835|4271653|P3|STARTED|Overall Study||7
1743647|NCT00094835|4271654|P2|STARTED|Overall Study||11
1743648|NCT00094835|4271655|P1|STARTED|Overall Study||9
1743649|NCT00094809|4271733|P2|NOT COMPLETED|Overall Study||65
1743650|NCT00094809|4271734|P1|NOT COMPLETED|Overall Study||52
1743651|NCT00094809|4271733|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
1743652|NCT00094809|4271734|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
1743653|NCT00094809|4271733|P2|Completed All 4 Cycles of Treatment|Overall Study||90
1743654|NCT00094809|4271734|P1|Completed All 4 Cycles of Treatment|Overall Study||98
1743655|NCT00094809|4271733|P2|Properly Consented; Received Study Drug|Overall Study||118
1743656|NCT00094809|4271734|P1|Properly Consented; Received Study Drug|Overall Study||123
1743657|NCT00094809|4271733|P2|Received Study Drug|Overall Study||118
1743658|NCT00094809|4271734|P1|Received Study Drug|Overall Study||124
1743659|NCT00094809|4271733|P2|STARTED|Overall Study||126
1743660|NCT00094809|4271734|P1|STARTED|Overall Study||126
1743661|NCT00094770|4271760|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
1743662|NCT00094770|4271761|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
1743663|NCT00094770|4271760|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
1743664|NCT00094770|4271761|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
1743665|NCT00094770|4271760|P2|STARTED|Year 2 (Week 0 to Week 104)||584
1743666|NCT00094770|4271761|P1|STARTED|Year 2 (Week 0 to Week 104)||588
1743667|NCT00094770|4271760|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
1743668|NCT00094770|4271761|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
1743669|NCT00094770|4271760|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
1743670|NCT00094770|4271761|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
1743671|NCT00094770|4271760|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
1743672|NCT00094770|4271761|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
1743673|NCT00094757|4271792|P3|NOT COMPLETED|Overall Study||30
1743674|NCT00094757|4271793|P2|NOT COMPLETED|Overall Study||62
1743675|NCT00094757|4271794|P1|NOT COMPLETED|Overall Study||53
1743676|NCT00094757|4271792|P3|COMPLETED|Overall Study||80
1743677|NCT00094757|4271793|P2|COMPLETED|Overall Study||144
1743678|NCT00094757|4271794|P1|COMPLETED|Overall Study||152
1743679|NCT00094757|4271792|P3|STARTED|Overall Study||110
1743680|NCT00094757|4271793|P2|STARTED|Overall Study||206
1743681|NCT00094757|4271794|P1|STARTED|Overall Study||205
1743682|NCT00094653|4271814|P3|NOT COMPLETED|Overall Study||126
1743683|NCT00094653|4271815|P2|NOT COMPLETED|Overall Study||106
1743684|NCT00094653|4271816|P1|NOT COMPLETED|Overall Study||321
1743685|NCT00094653|4271814|P3|COMPLETED|Overall Study||10
1743686|NCT00094653|4271815|P2|COMPLETED|Overall Study||31
1743687|NCT00094653|4271816|P1|COMPLETED|Overall Study||82
1743688|NCT00094653|4271814|P3|Treated|Overall Study||131
1743689|NCT00094653|4271815|P2|Treated|Overall Study||131
1743690|NCT00094653|4271816|P1|Treated|Overall Study||381
1743691|NCT00094653|4271814|P3|STARTED|Overall Study||136
1743692|NCT00094653|4271815|P2|STARTED|Overall Study||137
1743693|NCT00094653|4271816|P1|STARTED|Overall Study||403
1743694|NCT00094575|4271879|P2|NOT COMPLETED|Overall Study||146
1743695|NCT00094575|4271880|P1|NOT COMPLETED|Overall Study||146
1743696|NCT00094575|4271879|P2|COMPLETED|Overall Study||291
1743697|NCT00094575|4271880|P1|COMPLETED|Overall Study||298
1743698|NCT00094575|4271879|P2|STARTED|Overall Study||437
1743699|NCT00094575|4271880|P1|STARTED|Overall Study||444
1743700|NCT00094536|4271900|P1|NOT COMPLETED|Treatment and Follow-up||31
1743701|NCT00094536|4271900|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
1743702|NCT00094536|4271900|P1|36 Month Follow-up|Treatment and Follow-up||51
1743703|NCT00094536|4271900|P1|24 Month Follow-up|Treatment and Follow-up||53
1743704|NCT00094536|4271900|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
1743705|NCT00094536|4271900|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
1743706|NCT00094536|4271900|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
1743707|NCT00094536|4271900|P1|COMPLETED|Inclusion Exclusion Evaluation||82
1743708|NCT00094536|4271900|P1|STARTED|Inclusion Exclusion Evaluation||106
1743709|NCT00094497|4271906|P2|NOT COMPLETED|Overall Study||0
1743710|NCT00094497|4271907|P1|NOT COMPLETED|Overall Study||0
1743711|NCT00094497|4271906|P2|COMPLETED|Overall Study||153
1743712|NCT00094497|4271907|P1|COMPLETED|Overall Study||151
1743713|NCT00094497|4271906|P2|Received Second Line Therapy|Overall Study||101
1743714|NCT00094497|4271907|P1|Received Second Line Therapy|Overall Study||84
1743715|NCT00094497|4271906|P2|Treated|Overall Study||149
1743716|NCT00094497|4271907|P1|Treated|Overall Study||148
1743717|NCT00094497|4271906|P2|STARTED|Overall Study||153
1743718|NCT00094497|4271907|P1|STARTED|Overall Study||151
1743719|NCT00094458|4271924|P6|NOT COMPLETED|OLE: Open-Label Extension||4
1743720|NCT00094458|4271925|P5|NOT COMPLETED|OLE: Open-Label Extension||5
1743721|NCT00094458|4271926|P4|NOT COMPLETED|OLE: Open-Label Extension||1
1743722|NCT00094458|4271927|P3|NOT COMPLETED|OLE: Open-Label Extension||0
1743723|NCT00094458|4271928|P2|NOT COMPLETED|OLE: Open-Label Extension||0
1743724|NCT00094458|4271929|P1|NOT COMPLETED|OLE: Open-Label Extension||0
1743725|NCT00094458|4271924|P6|COMPLETED|OLE: Open-Label Extension||13
1743726|NCT00094458|4271925|P5|COMPLETED|OLE: Open-Label Extension||13
1743727|NCT00094458|4271926|P4|COMPLETED|OLE: Open-Label Extension||7
1743728|NCT00094458|4271927|P3|COMPLETED|OLE: Open-Label Extension||0
1743729|NCT00094458|4271928|P2|COMPLETED|OLE: Open-Label Extension||0
1743730|NCT00094458|4271929|P1|COMPLETED|OLE: Open-Label Extension||0
1743731|NCT00094458|4271924|P6|STARTED|OLE: Open-Label Extension||17
1743732|NCT00094458|4271925|P5|STARTED|OLE: Open-Label Extension||18
1743733|NCT00094458|4271926|P4|STARTED|OLE: Open-Label Extension||8
1743734|NCT00094458|4271927|P3|STARTED|OLE: Open-Label Extension||0
1743735|NCT00094458|4271928|P2|STARTED|OLE: Open-Label Extension||0
1743736|NCT00094458|4271929|P1|STARTED|OLE: Open-Label Extension||0
1743737|NCT00094458|4271924|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
1743738|NCT00094458|4271925|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
1743739|NCT00094458|4271926|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
1743740|NCT00094458|4271927|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
1743741|NCT00094458|4271928|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
1743742|NCT00094458|4271929|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
1743743|NCT00094458|4271924|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
1743744|NCT00094458|4271925|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
1743745|NCT00094458|4271926|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
1743746|NCT00094458|4271927|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
1743747|NCT00094458|4271928|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
1743748|NCT00094458|4271929|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
1743749|NCT00094458|4271924|P6|STARTED|Study Extension: Week 30 Through Week 50||0
1743750|NCT00094458|4271925|P5|STARTED|Study Extension: Week 30 Through Week 50||0
1743751|NCT00094458|4271926|P4|STARTED|Study Extension: Week 30 Through Week 50||0
1743752|NCT00094458|4271927|P3|STARTED|Study Extension: Week 30 Through Week 50||108
1743753|NCT00094458|4271928|P2|STARTED|Study Extension: Week 30 Through Week 50||97
1743754|NCT00094458|4271929|P1|STARTED|Study Extension: Week 30 Through Week 50||75
1743755|NCT00094458|4271924|P6|NOT COMPLETED|Main Study: Through Week 30||0
1743756|NCT00094458|4271925|P5|NOT COMPLETED|Main Study: Through Week 30||0
1743757|NCT00094458|4271926|P4|NOT COMPLETED|Main Study: Through Week 30||0
1743758|NCT00094458|4271927|P3|NOT COMPLETED|Main Study: Through Week 30||48
1743759|NCT00094458|4271928|P2|NOT COMPLETED|Main Study: Through Week 30||58
1743760|NCT00094458|4271929|P1|NOT COMPLETED|Main Study: Through Week 30||84
1743761|NCT00094458|4271924|P6|COMPLETED|Main Study: Through Week 30||0
1743762|NCT00094458|4271925|P5|COMPLETED|Main Study: Through Week 30||0
1743763|NCT00094458|4271926|P4|COMPLETED|Main Study: Through Week 30||0
1743764|NCT00094458|4271927|P3|COMPLETED|Main Study: Through Week 30||121
1743765|NCT00094458|4271928|P2|COMPLETED|Main Study: Through Week 30||111
1743766|NCT00094458|4271929|P1|COMPLETED|Main Study: Through Week 30||86
1743767|NCT00094458|4271924|P6|STARTED|Main Study: Through Week 30||0
1743768|NCT00094458|4271925|P5|STARTED|Main Study: Through Week 30||0
1743769|NCT00094458|4271926|P4|STARTED|Main Study: Through Week 30||0
1743770|NCT00094458|4271927|P3|STARTED|Main Study: Through Week 30||169
1743771|NCT00094458|4271928|P2|STARTED|Main Study: Through Week 30||169
1743772|NCT00094458|4271929|P1|STARTED|Main Study: Through Week 30||170
1743773|NCT00094328|4271967|P1|NOT COMPLETED|Overall Study||1
1743774|NCT00094328|4271967|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
1743775|NCT00094328|4271967|P1|STARTED|Overall Study|Received treatment|14
1743776|NCT00094302|4271981|P2|NOT COMPLETED|Overall Study||406
1743777|NCT00094302|4271982|P1|NOT COMPLETED|Overall Study||417
1743778|NCT00094302|4271981|P2|COMPLETED|Overall Study||1316
1743779|NCT00094302|4271982|P1|COMPLETED|Overall Study||1306
1743780|NCT00094302|4271981|P2|STARTED|Overall Study||1722
1743781|NCT00094302|4271982|P1|STARTED|Overall Study||1723
1743782|NCT00094172|4272038|P2|NOT COMPLETED|Overall Study||7
1743783|NCT00094172|4272039|P1|NOT COMPLETED|Overall Study||14
1743784|NCT00094172|4272038|P2|COMPLETED|Overall Study||25
1743785|NCT00094172|4272039|P1|COMPLETED|Overall Study||36
1743786|NCT00094172|4272038|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
1743787|NCT00094172|4272039|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
1743788|NCT00094107|4272049|P1|NOT COMPLETED|Overall Study||32
1743789|NCT00094107|4272049|P1|COMPLETED|Overall Study||0
1743790|NCT00094107|4272049|P1|STARTED|Overall Study||32
1743791|NCT00094094|4272058|P1|NOT COMPLETED|Overall Study||32
1743792|NCT00094094|4272058|P1|COMPLETED|Overall Study||0
1743793|NCT00094094|4272058|P1|STARTED|Overall Study||32
1743794|NCT00094055|4272067|P1|NOT COMPLETED|Overall Study||60
1743795|NCT00094055|4272067|P1|COMPLETED|Overall Study||0
1743796|NCT00094055|4272067|P1|STARTED|Overall Study||60
1743797|NCT00093847|4272078|P2|NOT COMPLETED|Overall Study||10
1743798|NCT00093847|4272079|P1|NOT COMPLETED|Overall Study||8
1743799|NCT00093847|4272078|P2|COMPLETED|Overall Study||24
1743800|NCT00093847|4272079|P1|COMPLETED|Overall Study||31
1743801|NCT00093847|4272078|P2|STARTED|Overall Study||34
1743802|NCT00093847|4272079|P1|STARTED|Overall Study||39
1743803|NCT00093808|4272087|P1|NOT COMPLETED|Overall Study||2
1743804|NCT00093808|4272087|P1|COMPLETED|Overall Study||45
1743805|NCT00093808|4272087|P1|STARTED|Overall Study||47
1743806|NCT00093795|4272097|P3|NOT COMPLETED|Overall Study||17
1743807|NCT00093795|4272098|P2|NOT COMPLETED|Overall Study||16
1743808|NCT00093795|4272099|P1|NOT COMPLETED|Overall Study||20
1743809|NCT00093795|4272097|P3|COMPLETED|Overall Study||1613
1743810|NCT00093795|4272098|P2|COMPLETED|Overall Study||1618
1743811|NCT00093795|4272099|P1|COMPLETED|Overall Study||1610
1743812|NCT00093795|4272097|P3|STARTED|Overall Study||1630
1743813|NCT00093795|4272098|P2|STARTED|Overall Study||1634
1743814|NCT00093795|4272099|P1|STARTED|Overall Study||1630
1743815|NCT00093782|4272119|P1|NOT COMPLETED|Overall Study||0
1743816|NCT00093782|4272119|P1|COMPLETED|Overall Study||36
1743817|NCT00093782|4272119|P1|STARTED|Overall Study||36
1743818|NCT00093756|4272131|P2|NOT COMPLETED|Overall Study||0
1743819|NCT00093756|4272132|P1|NOT COMPLETED|Overall Study||0
1743820|NCT00093756|4272131|P2|COMPLETED|Overall Study||21
1743821|NCT00093756|4272132|P1|COMPLETED|Overall Study||27
1743822|NCT00093756|4272131|P2|STARTED|Overall Study||21
1743823|NCT00093756|4272132|P1|STARTED|Overall Study||27
1743824|NCT00093496|4272144|P2|NOT COMPLETED|Overall Study||3
1743825|NCT00093496|4272145|P1|NOT COMPLETED|Overall Study||1
1743826|NCT00093496|4272144|P2|COMPLETED|Overall Study||11
1743827|NCT00093496|4272145|P1|COMPLETED|Overall Study||14
1743828|NCT00093496|4272144|P2|STARTED|Overall Study||14
1743829|NCT00093496|4272145|P1|STARTED|Overall Study||15
1743830|NCT00093470|4272158|P2|NOT COMPLETED|Overall Study||0
1743831|NCT00093470|4272159|P1|NOT COMPLETED|Overall Study||73
1743832|NCT00093470|4272158|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
1743833|NCT00093470|4272159|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
1743834|NCT00093470|4272158|P2|Patients With Toxicity Assessment|Overall Study||69
1743835|NCT00093470|4272159|P1|Patients With Toxicity Assessment|Overall Study||72
1743836|NCT00093470|4272158|P2|Treated|Overall Study||71
1743837|NCT00093470|4272159|P1|Treated|Overall Study||72
1743838|NCT00093470|4272158|P2|STARTED|Overall Study||71
1743839|NCT00093470|4272159|P1|STARTED|Overall Study||73
1743840|NCT00093379|4272167|P1|NOT COMPLETED|Overall Study||0
1743841|NCT00093379|4272167|P1|COMPLETED|Overall Study||20
1743842|NCT00093379|4272167|P1|STARTED|Overall Study||20
1743843|NCT00093145|4272173|P1|NOT COMPLETED|Overall Study||17
1743844|NCT00093145|4272173|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
1743845|NCT00093145|4272173|P1|At Least One Response Assessment|Overall Study||31
1743846|NCT00093145|4272173|P1|STARTED|Overall Study||32
1743847|NCT00093041|4272188|P6|NOT COMPLETED|Overall Study||3
1743848|NCT00093041|4272189|P5|NOT COMPLETED|Overall Study||1
1743849|NCT00093041|4272190|P4|NOT COMPLETED|Overall Study||1
1743850|NCT00093041|4272191|P3|NOT COMPLETED|Overall Study||2
1743851|NCT00093041|4272192|P2|NOT COMPLETED|Overall Study||3
1743852|NCT00093041|4272193|P1|NOT COMPLETED|Overall Study||2
1743853|NCT00093041|4272188|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
1743854|NCT00093041|4272189|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
1743855|NCT00093041|4272190|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
1743856|NCT00093041|4272191|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
1743857|NCT00093041|4272192|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
1743858|NCT00093041|4272193|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
1743859|NCT00093041|4272188|P6|STARTED|Overall Study||7
1743860|NCT00093041|4272189|P5|STARTED|Overall Study||4
1743861|NCT00093041|4272190|P4|STARTED|Overall Study||4
1743862|NCT00093041|4272191|P3|STARTED|Overall Study||5
1743863|NCT00093041|4272192|P2|STARTED|Overall Study||4
1743864|NCT00093041|4272193|P1|STARTED|Overall Study||4
1743865|NCT00093015|4272215|P2|NOT COMPLETED|Overall Study||664
1743866|NCT00093015|4272216|P1|NOT COMPLETED|Overall Study||665
1743867|NCT00093015|4272215|P2|COMPLETED|Overall Study||1348
1743868|NCT00093015|4272216|P1|COMPLETED|Overall Study||1361
1743869|NCT00093015|4272215|P2|Received Study Medication|Overall Study||2004
1743870|NCT00093015|4272216|P1|Received Study Medication|Overall Study||2019
1743871|NCT00093015|4272215|P2|STARTED|Overall Study||2012
1743872|NCT00093015|4272216|P1|STARTED|Overall Study||2026
1743873|NCT00092677|4272244|P2|NOT COMPLETED|Overall Study||11
1743874|NCT00092677|4272245|P1|NOT COMPLETED|Overall Study||5
1743875|NCT00092677|4272244|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
1743876|NCT00092677|4272245|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
1743877|NCT00092677|4272244|P2|STARTED|Overall Study||929
1743878|NCT00092677|4272245|P1|STARTED|Overall Study||944
1743879|NCT00092547|4272289|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
1743880|NCT00092547|4272290|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
1743881|NCT00092547|4272291|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
1743882|NCT00092547|4272289|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
1743883|NCT00092547|4272290|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
1743884|NCT00092547|4272291|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
1743885|NCT00092547|4272289|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
1743886|NCT00092547|4272290|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
1743887|NCT00092547|4272291|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
1743888|NCT00092547|4272289|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
1743889|NCT00092547|4272290|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
1743890|NCT00092547|4272291|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
1743891|NCT00092547|4272289|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
1743892|NCT00092547|4272290|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
1743893|NCT00092547|4272291|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
1743894|NCT00092547|4272289|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
1743895|NCT00092547|4272290|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
1743896|NCT00092547|4272291|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
1743897|NCT00092547|4272289|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
1743898|NCT00092547|4272290|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
1743899|NCT00092547|4272291|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
1743900|NCT00092547|4272289|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
1743901|NCT00092547|4272290|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
1743902|NCT00092547|4272291|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
1743903|NCT00092547|4272289|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
1743904|NCT00092547|4272290|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
1743905|NCT00092547|4272291|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
1743906|NCT00092547|4272289|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
1743907|NCT00092547|4272290|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
1743908|NCT00092547|4272291|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
1743909|NCT00092547|4272289|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
1743910|NCT00092547|4272290|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
1743911|NCT00092547|4272291|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
1743912|NCT00092547|4272289|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
1743913|NCT00092547|4272290|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
1743914|NCT00092547|4272291|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
1743915|NCT00092547|4272289|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
1743916|NCT00092547|4272290|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
1743917|NCT00092547|4272291|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
1743918|NCT00092547|4272289|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
1743919|NCT00092547|4272290|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
1743920|NCT00092547|4272291|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
1743921|NCT00092547|4272289|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
1743922|NCT00092547|4272290|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
1743923|NCT00092547|4272291|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
1743924|NCT00092547|4272289|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
1743925|NCT00092547|4272290|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
1743926|NCT00092547|4272291|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
1743927|NCT00092547|4272289|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
1743928|NCT00092547|4272290|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
1743929|NCT00092547|4272291|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
1743930|NCT00092547|4272289|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
1743931|NCT00092547|4272290|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
1743932|NCT00092547|4272291|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
1743933|NCT00092547|4272289|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
1743934|NCT00092547|4272290|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
1743935|NCT00092547|4272291|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
1743936|NCT00092547|4272289|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
1743937|NCT00092547|4272290|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
1743938|NCT00092547|4272291|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
1743939|NCT00092547|4272289|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
1743940|NCT00092547|4272290|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
1743941|NCT00092547|4272291|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
1743942|NCT00092547|4272289|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
1743943|NCT00092547|4272290|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
1743944|NCT00092547|4272291|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
1743945|NCT00092547|4272289|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
1743946|NCT00092547|4272290|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
1743947|NCT00092547|4272291|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
1743948|NCT00092547|4272289|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
1743949|NCT00092547|4272290|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
1743950|NCT00092547|4272291|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
1743951|NCT00092547|4272289|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
1743952|NCT00092547|4272290|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
1743953|NCT00092547|4272291|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
1743954|NCT00092547|4272289|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
1743955|NCT00092547|4272290|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
1743956|NCT00092547|4272291|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
1743957|NCT00092534|4272335|P3|NOT COMPLETED|Extension Study||145
1743958|NCT00092534|4272336|P2|NOT COMPLETED|Extension Study||0
1743959|NCT00092534|4272337|P1|NOT COMPLETED|Extension Study||0
1743960|NCT00092534|4272335|P3|COMPLETED|Extension Study||449
1743961|NCT00092534|4272336|P2|COMPLETED|Extension Study||0
1743962|NCT00092534|4272337|P1|COMPLETED|Extension Study||0
1743963|NCT00092534|4272335|P3|STARTED|Extension Study||594
1743964|NCT00092534|4272336|P2|STARTED|Extension Study||0
1743965|NCT00092534|4272337|P1|STARTED|Extension Study||0
1743966|NCT00092534|4272335|P3|NOT COMPLETED|Base Study Follow Up Period||0
1743967|NCT00092534|4272336|P2|NOT COMPLETED|Base Study Follow Up Period||694
1743968|NCT00092534|4272337|P1|NOT COMPLETED|Base Study Follow Up Period||316
1743969|NCT00092534|4272335|P3|COMPLETED|Base Study Follow Up Period||0
1743970|NCT00092534|4272336|P2|COMPLETED|Base Study Follow Up Period||5277
1743971|NCT00092534|4272337|P1|COMPLETED|Base Study Follow Up Period||5626
1743972|NCT00092534|4272335|P3|STARTED|Base Study Follow Up Period||0
1743973|NCT00092534|4272336|P2|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
1743974|NCT00092534|4272337|P1|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
1743975|NCT00092534|4272335|P3|NOT COMPLETED|Base Study Vaccination Period||0
1743976|NCT00092534|4272336|P2|NOT COMPLETED|Base Study Vaccination Period||126
1743977|NCT00092534|4272337|P1|NOT COMPLETED|Base Study Vaccination Period||171
1743978|NCT00092534|4272335|P3|COMPLETED|Base Study Vaccination Period||0
1743979|NCT00092534|4272336|P2|COMPLETED|Base Study Vaccination Period||5954
1743980|NCT00092534|4272337|P1|COMPLETED|Base Study Vaccination Period||5916
1743981|NCT00092534|4272335|P3|STARTED|Base Study Vaccination Period||0
1743982|NCT00092534|4272336|P2|STARTED|Base Study Vaccination Period||6080
1743983|NCT00092534|4272337|P1|STARTED|Base Study Vaccination Period||6087
1743984|NCT00092521|4272355|P4|NOT COMPLETED|Extension Study (Group 4)||209
1743985|NCT00092521|4272356|P3|NOT COMPLETED|Extension Study (Group 4)||0
1743986|NCT00092521|4272357|P2|NOT COMPLETED|Extension Study (Group 4)||0
1743987|NCT00092521|4272358|P1|NOT COMPLETED|Extension Study (Group 4)||0
1743988|NCT00092521|4272355|P4|COMPLETED|Extension Study (Group 4)||635
1743989|NCT00092521|4272356|P3|COMPLETED|Extension Study (Group 4)||0
1743990|NCT00092521|4272357|P2|COMPLETED|Extension Study (Group 4)||0
1743991|NCT00092521|4272358|P1|COMPLETED|Extension Study (Group 4)||0
1743992|NCT00092521|4272355|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
1743993|NCT00092521|4272356|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
1743994|NCT00092521|4272357|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
1743995|NCT00092521|4272358|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
1743996|NCT00092521|4272355|P4|Initiated Extension Study|Extension Study (Group 4)||829
1743997|NCT00092521|4272356|P3|Initiated Extension Study|Extension Study (Group 4)||0
1743998|NCT00092521|4272357|P2|Initiated Extension Study|Extension Study (Group 4)||0
1743999|NCT00092521|4272358|P1|Initiated Extension Study|Extension Study (Group 4)||0
1744000|NCT00092521|4272355|P4|STARTED|Extension Study (Group 4)||844
1744001|NCT00092521|4272356|P3|STARTED|Extension Study (Group 4)||0
1744002|NCT00092521|4272357|P2|STARTED|Extension Study (Group 4)||0
1744003|NCT00092521|4272358|P1|STARTED|Extension Study (Group 4)||0
1744004|NCT00092521|4272355|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
1744005|NCT00092521|4272356|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
1744006|NCT00092521|4272357|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
1744007|NCT00092521|4272358|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
1744008|NCT00092521|4272355|P4|COMPLETED|Follow-Up (After Month 7)||0
1744009|NCT00092521|4272356|P3|COMPLETED|Follow-Up (After Month 7)||1959
1744010|NCT00092521|4272357|P2|COMPLETED|Follow-Up (After Month 7)||155
1744011|NCT00092521|4272358|P1|COMPLETED|Follow-Up (After Month 7)||2353
1744012|NCT00092521|4272355|P4|STARTED|Follow-Up (After Month 7)||0
1744013|NCT00092521|4272356|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
1744014|NCT00092521|4272357|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
1744015|NCT00092521|4272358|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
1744016|NCT00092521|4272355|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
1744017|NCT00092521|4272356|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
1744018|NCT00092521|4272357|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
1744019|NCT00092521|4272358|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
1744020|NCT00092521|4272355|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
1744021|NCT00092521|4272356|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
1744022|NCT00092521|4272357|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
1744023|NCT00092521|4272358|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
1744024|NCT00092521|4272355|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
1744025|NCT00092521|4272356|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
1744026|NCT00092521|4272357|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
1744027|NCT00092521|4272358|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
1744028|NCT00092495|4272372|P5|NOT COMPLETED|Extension Study||0
1744029|NCT00092495|4272373|P4|NOT COMPLETED|Extension Study||0
1744030|NCT00092495|4272374|P3|NOT COMPLETED|Extension Study||0
1744031|NCT00092495|4272375|P2|NOT COMPLETED|Extension Study||0
1744032|NCT00092495|4272376|P1|NOT COMPLETED|Extension Study||0
1744033|NCT00092495|4272372|P5|COMPLETED|Extension Study||12
1744034|NCT00092495|4272373|P4|COMPLETED|Extension Study||0
1744035|NCT00092495|4272374|P3|COMPLETED|Extension Study||0
1744036|NCT00092495|4272375|P2|COMPLETED|Extension Study||0
1744037|NCT00092495|4272376|P1|COMPLETED|Extension Study||0
1744038|NCT00092495|4272372|P5|STARTED|Extension Study||12
1744039|NCT00092495|4272373|P4|STARTED|Extension Study||0
1744040|NCT00092495|4272374|P3|STARTED|Extension Study||0
1744041|NCT00092495|4272375|P2|STARTED|Extension Study||0
1744042|NCT00092495|4272376|P1|STARTED|Extension Study||0
1744043|NCT00092495|4272372|P5|NOT COMPLETED|Base Study Follow-up Period||0
1744044|NCT00092495|4272373|P4|NOT COMPLETED|Base Study Follow-up Period||14
1744045|NCT00092495|4272374|P3|NOT COMPLETED|Base Study Follow-up Period||4
1744046|NCT00092495|4272375|P2|NOT COMPLETED|Base Study Follow-up Period||3
1744047|NCT00092495|4272376|P1|NOT COMPLETED|Base Study Follow-up Period||3
1744048|NCT00092495|4272372|P5|COMPLETED|Base Study Follow-up Period||0
1744049|NCT00092495|4272373|P4|COMPLETED|Base Study Follow-up Period||446
1744050|NCT00092495|4272374|P3|COMPLETED|Base Study Follow-up Period||126
1744051|NCT00092495|4272375|P2|COMPLETED|Base Study Follow-up Period||122
1744052|NCT00092495|4272376|P1|COMPLETED|Base Study Follow-up Period||112
1744053|NCT00092495|4272372|P5|STARTED|Base Study Follow-up Period||0
1744054|NCT00092495|4272373|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
1744055|NCT00092495|4272374|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
1744056|NCT00092495|4272375|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
1744057|NCT00092495|4272376|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
1744058|NCT00092495|4272372|P5|NOT COMPLETED|Base Study Vaccination Period||0
1744059|NCT00092495|4272373|P4|NOT COMPLETED|Base Study Vaccination Period||88
1744060|NCT00092495|4272374|P3|NOT COMPLETED|Base Study Vaccination Period||34
1744061|NCT00092495|4272375|P2|NOT COMPLETED|Base Study Vaccination Period||22
1744062|NCT00092495|4272376|P1|NOT COMPLETED|Base Study Vaccination Period||37
1744063|NCT00092495|4272372|P5|COMPLETED|Base Study Vaccination Period||0
1744064|NCT00092495|4272373|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
1744065|NCT00092495|4272374|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
1744066|NCT00092495|4272375|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
1744067|NCT00092495|4272376|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
1744068|NCT00092495|4272372|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
1744069|NCT00092495|4272373|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
1744070|NCT00092495|4272374|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
1744071|NCT00092495|4272375|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
1744072|NCT00092495|4272376|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
1744073|NCT00092495|4272372|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
1744074|NCT00092495|4272373|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
1744075|NCT00092495|4272374|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
1744076|NCT00092495|4272375|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
1744077|NCT00092495|4272376|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
1744078|NCT00092495|4272372|P5|STARTED|Base Study Vaccination Period||0
1744079|NCT00092495|4272373|P4|STARTED|Base Study Vaccination Period||1529
1744080|NCT00092495|4272374|P3|STARTED|Base Study Vaccination Period||508
1744081|NCT00092495|4272375|P2|STARTED|Base Study Vaccination Period||514
1744082|NCT00092495|4272376|P1|STARTED|Base Study Vaccination Period||504
1744083|NCT00092456|4272442|P4|NOT COMPLETED|Overall Study||16
1744084|NCT00092456|4272443|P3|NOT COMPLETED|Overall Study||29
1744085|NCT00092456|4272444|P2|NOT COMPLETED|Overall Study||17
1744086|NCT00092456|4272445|P1|NOT COMPLETED|Overall Study||25
1744087|NCT00092456|4272442|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
1744088|NCT00092456|4272443|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
1744089|NCT00092456|4272444|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
1744090|NCT00092456|4272445|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
1744091|NCT00092456|4272442|P4|Vaccinated at Visit 3|Overall Study||98
1744092|NCT00092456|4272443|P3|Vaccinated at Visit 3|Overall Study||200
1744093|NCT00092456|4272444|P2|Vaccinated at Visit 3|Overall Study||210
1744094|NCT00092456|4272445|P1|Vaccinated at Visit 3|Overall Study||202
1744095|NCT00092456|4272442|P4|Vaccinated at Visit 2|Overall Study||104
1744096|NCT00092456|4272443|P3|Vaccinated at Visit 2|Overall Study||210
1744097|NCT00092456|4272444|P2|Vaccinated at Visit 2|Overall Study||217
1744098|NCT00092456|4272445|P1|Vaccinated at Visit 2|Overall Study||208
1744099|NCT00092456|4272442|P4|Vaccinated at Visit 1|Overall Study||113
1744100|NCT00092456|4272443|P3|Vaccinated at Visit 1|Overall Study||229
1744101|NCT00092456|4272444|P2|Vaccinated at Visit 1|Overall Study||225
1744102|NCT00092456|4272445|P1|Vaccinated at Visit 1|Overall Study||226
1744103|NCT00092456|4272442|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
1744104|NCT00092456|4272443|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
1744105|NCT00092456|4272444|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
1744106|NCT00092456|4272445|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
1744107|NCT00092443|4272493|P2|NOT COMPLETED|Overall Study||54
1744108|NCT00092443|4272494|P1|NOT COMPLETED|Overall Study||58
1744109|NCT00092443|4272493|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
1744110|NCT00092443|4272494|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
1744111|NCT00092443|4272493|P2|Vaccinated at Visit 3|Overall Study||608
1744112|NCT00092443|4272494|P1|Vaccinated at Visit 3|Overall Study||593
1744113|NCT00092443|4272493|P2|Vaccinated at Visit 2|Overall Study||627
1744114|NCT00092443|4272494|P1|Vaccinated at Visit 2|Overall Study||618
1744115|NCT00092443|4272493|P2|Vaccinated at Visit 1|Overall Study||660
1744116|NCT00092443|4272494|P1|Vaccinated at Visit 1|Overall Study||650
1744117|NCT00092443|4272493|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
1744118|NCT00092443|4272494|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
1744119|NCT00092417|4272512|P2|NOT COMPLETED|Overall Study||1
1744120|NCT00092417|4272513|P1|NOT COMPLETED|Overall Study||5
1744121|NCT00092417|4272512|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
1744122|NCT00092417|4272513|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
1744123|NCT00092417|4272512|P2|Vaccinated|Overall Study||234
1744124|NCT00092417|4272513|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
1744125|NCT00092417|4272512|P2|STARTED|Overall Study|Started Period Group 2|234
1744126|NCT00092417|4272513|P1|STARTED|Overall Study|Started Period Group 1|464
1744127|NCT00092131|4272527|P2|NOT COMPLETED|Treatment Period II||1
1744128|NCT00092131|4272528|P1|NOT COMPLETED|Treatment Period II||0
1744129|NCT00092131|4272527|P2|COMPLETED|Treatment Period II||25
1744130|NCT00092131|4272528|P1|COMPLETED|Treatment Period II||24
1744131|NCT00092131|4272527|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
1744132|NCT00092131|4272528|P1|STARTED|Treatment Period II||24
1744133|NCT00092131|4272527|P2|NOT COMPLETED|Treatment Period I||0
1744134|NCT00092131|4272528|P1|NOT COMPLETED|Treatment Period I||1
1744135|NCT00092131|4272527|P2|COMPLETED|Treatment Period I||26
1744136|NCT00092131|4272528|P1|COMPLETED|Treatment Period I||24
1744137|NCT00092131|4272527|P2|STARTED|Treatment Period I||26
1744138|NCT00092131|4272528|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
1744139|NCT00092118|4272558|P2|NOT COMPLETED|Overall Study||89
1744140|NCT00092118|4272559|P1|NOT COMPLETED|Overall Study||84
1744141|NCT00092118|4272558|P2|COMPLETED|Overall Study||913
1744142|NCT00092118|4272559|P1|COMPLETED|Overall Study||906
1744143|NCT00092118|4272558|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
1744144|NCT00092118|4272559|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
1744145|NCT00091962|4272572|P3|NOT COMPLETED|Overall Study||0
1744146|NCT00091962|4272573|P2|NOT COMPLETED|Overall Study||0
1744147|NCT00091962|4272574|P1|NOT COMPLETED|Overall Study||0
1744148|NCT00091962|4272572|P3|COMPLETED|Overall Study||151
1744149|NCT00091962|4272573|P2|COMPLETED|Overall Study||152
1744150|NCT00091962|4272574|P1|COMPLETED|Overall Study||150
1744151|NCT00091962|4272572|P3|STARTED|Overall Study||151
1744152|NCT00091962|4272573|P2|STARTED|Overall Study||152
1744153|NCT00091962|4272574|P1|STARTED|Overall Study||150
1744154|NCT00091949|4272593|P2|NOT COMPLETED|Overall Study||151
1744155|NCT00091949|4272594|P1|NOT COMPLETED|Overall Study||175
1744156|NCT00091949|4272593|P2|COMPLETED|Overall Study||1786
1744157|NCT00091949|4272594|P1|COMPLETED|Overall Study||1764
1744158|NCT00091949|4272593|P2|STARTED|Overall Study||1937
1744159|NCT00091949|4272594|P1|STARTED|Overall Study||1939
1744160|NCT00091832|4272618|P6|NOT COMPLETED|Overall Study||11
1744161|NCT00091832|4272619|P5|NOT COMPLETED|Overall Study||15
1744162|NCT00091832|4272620|P4|NOT COMPLETED|Overall Study||14
1744163|NCT00091832|4272621|P3|NOT COMPLETED|Overall Study||12
1744164|NCT00091832|4272622|P2|NOT COMPLETED|Overall Study||11
1744165|NCT00091832|4272623|P1|NOT COMPLETED|Overall Study||14
1744166|NCT00091832|4272618|P6|COMPLETED|Overall Study||32
1744167|NCT00091832|4272619|P5|COMPLETED|Overall Study||27
1744168|NCT00091832|4272620|P4|COMPLETED|Overall Study||29
1744169|NCT00091832|4272621|P3|COMPLETED|Overall Study||30
1744170|NCT00091832|4272622|P2|COMPLETED|Overall Study||31
1744171|NCT00091832|4272623|P1|COMPLETED|Overall Study||29
1744172|NCT00091832|4272618|P6|Received Study Medication|Overall Study||43
1744173|NCT00091832|4272619|P5|Received Study Medication|Overall Study||42
1744174|NCT00091832|4272620|P4|Received Study Medication|Overall Study||43
1744175|NCT00091832|4272621|P3|Received Study Medication|Overall Study||41
1744176|NCT00091832|4272622|P2|Received Study Medication|Overall Study||42
1744177|NCT00091832|4272623|P1|Received Study Medication|Overall Study||43
1744178|NCT00091832|4272618|P6|STARTED|Overall Study||43
1744179|NCT00091832|4272619|P5|STARTED|Overall Study||42
1744180|NCT00091832|4272620|P4|STARTED|Overall Study||43
1744181|NCT00091832|4272621|P3|STARTED|Overall Study||42
1744182|NCT00091832|4272622|P2|STARTED|Overall Study||42
1744183|NCT00091832|4272623|P1|STARTED|Overall Study||43
1744184|NCT00091819|4272741|P2|NOT COMPLETED|Overall Study||46
1744185|NCT00091819|4272742|P1|NOT COMPLETED|Overall Study||42
1744186|NCT00091819|4272741|P2|COMPLETED|Overall Study||387
1744187|NCT00091819|4272742|P1|COMPLETED|Overall Study||387
1744188|NCT00091819|4272741|P2|STARTED|Overall Study||433
1744189|NCT00091819|4272742|P1|STARTED|Overall Study||429
1744190|NCT00091793|4272750|P2|NOT COMPLETED|Overall Study||22
1744191|NCT00091793|4272751|P1|NOT COMPLETED|Overall Study||24
1744192|NCT00091793|4272750|P2|COMPLETED|Overall Study||144
1744193|NCT00091793|4272751|P1|COMPLETED|Overall Study||142
1744194|NCT00091793|4272750|P2|STARTED|Overall Study||166
1744195|NCT00091793|4272751|P1|STARTED|Overall Study||166
1744196|NCT00091572|4272775|P2|NOT COMPLETED|Overall Study||82
1744197|NCT00091572|4272776|P1|NOT COMPLETED|Overall Study||95
1744198|NCT00091572|4272775|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
1744199|NCT00091572|4272776|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
1744200|NCT00091572|4272775|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
1744201|NCT00091572|4272776|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
1744202|NCT00091507|4272790|P2|NOT COMPLETED|Overall Study||19
1744203|NCT00091507|4272791|P1|NOT COMPLETED|Overall Study||21
1744204|NCT00091507|4272790|P2|COMPLETED|Overall Study||460
1744205|NCT00091507|4272791|P1|COMPLETED|Overall Study||411
1744206|NCT00091507|4272790|P2|STARTED|Overall Study||479
1744207|NCT00091507|4272791|P1|STARTED|Overall Study||432
1744208|NCT00091442|4272807|P2|NOT COMPLETED|Overall Study||373
1744209|NCT00091442|4272808|P1|NOT COMPLETED|Overall Study||369
1744210|NCT00091442|4272807|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
1744211|NCT00091442|4272808|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
1744212|NCT00091442|4272807|P2|STARTED|Overall Study||378
1744213|NCT00091442|4272808|P1|STARTED|Overall Study||373
1744214|NCT00091390|4272818|P1|NOT COMPLETED|Overall Study||4
1744215|NCT00091390|4272818|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
1744216|NCT00091390|4272818|P1|STARTED|Overall Study||129
1744217|NCT00091273|4272822|P1|NOT COMPLETED|Overall Study||0
1744218|NCT00091273|4272822|P1|COMPLETED|Overall Study||9
1744219|NCT00091273|4272822|P1|STARTED|Overall Study||9
1744220|NCT00091260|4272828|P1|NOT COMPLETED|Overall Study||0
1744221|NCT00091260|4272828|P1|COMPLETED|Overall Study||82
1744222|NCT00091260|4272828|P1|STARTED|Overall Study||82
1744223|NCT00091169|4272836|P2|NOT COMPLETED|Overall Study||53
1744224|NCT00091169|4272837|P1|NOT COMPLETED|Overall Study||57
1744225|NCT00091169|4272836|P2|COMPLETED|Overall Study||134
1744226|NCT00091169|4272837|P1|COMPLETED|Overall Study||132
1744227|NCT00091169|4272836|P2|Treated|Overall Study||170
1744228|NCT00091169|4272837|P1|Treated|Overall Study||163
1744229|NCT00091169|4272836|P2|STARTED|Overall Study||187
1744230|NCT00091169|4272837|P1|STARTED|Overall Study||189
1744231|NCT00091026|4272855|P2|NOT COMPLETED|Overall Study||3
1744232|NCT00091026|4272856|P1|NOT COMPLETED|Overall Study||1
1744233|NCT00091026|4272855|P2|COMPLETED|Overall Study||68
1744234|NCT00091026|4272856|P1|COMPLETED|Overall Study||71
1744235|NCT00091026|4272855|P2|STARTED|Overall Study||71
1744236|NCT00091026|4272856|P1|STARTED|Overall Study||72
1744237|NCT00090987|4272866|P1|NOT COMPLETED|Overall Study||21
1744238|NCT00090987|4272866|P1|COMPLETED|Overall Study||9
1744239|NCT00090987|4272866|P1|STARTED|Overall Study||30
1744240|NCT00090870|4272870|P1|NOT COMPLETED|Overall Study||0
1744241|NCT00090870|4272870|P1|COMPLETED|Overall Study||10
1744242|NCT00090870|4272870|P1|STARTED|Overall Study||10
1744243|NCT00090857|4272879|P2|NOT COMPLETED|Overall Study||3
1744244|NCT00090857|4272880|P1|NOT COMPLETED|Overall Study||4
1744245|NCT00090857|4272879|P2|COMPLETED|Overall Study||13
1744246|NCT00090857|4272880|P1|COMPLETED|Overall Study||29
1744247|NCT00090857|4272879|P2|STARTED|Overall Study||16
1744248|NCT00090857|4272880|P1|STARTED|Overall Study||33
1744249|NCT00090844|4272910|P2|NOT COMPLETED|Overall Study||1
1744250|NCT00090844|4272911|P1|NOT COMPLETED|Overall Study||1
1744251|NCT00090844|4272910|P2|COMPLETED|Overall Study||21
1744252|NCT00090844|4272911|P1|COMPLETED|Overall Study||26
1744253|NCT00090844|4272910|P2|STARTED|Overall Study||22
1744254|NCT00090844|4272911|P1|STARTED|Overall Study||27
1744255|NCT00090779|4272919|P2|NOT COMPLETED|Step 3||5
1744256|NCT00090779|4272920|P1|NOT COMPLETED|Step 3||7
1744257|NCT00090779|4272919|P2|COMPLETED|Step 3||0
1744258|NCT00090779|4272920|P1|COMPLETED|Step 3||0
1744259|NCT00090779|4272919|P2|STARTED|Step 3||5
1744260|NCT00090779|4272920|P1|STARTED|Step 3||7
1744261|NCT00090779|4272919|P2|NOT COMPLETED|Step 2||18
1744262|NCT00090779|4272920|P1|NOT COMPLETED|Step 2||6
1744263|NCT00090779|4272919|P2|COMPLETED|Step 2||1
1744264|NCT00090779|4272920|P1|COMPLETED|Step 2||0
1744265|NCT00090779|4272919|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
1744266|NCT00090779|4272920|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
1744267|NCT00090779|4272919|P2|NOT COMPLETED|Step 1||15
1744268|NCT00090779|4272920|P1|NOT COMPLETED|Step 1||11
1744269|NCT00090779|4272919|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
1744270|NCT00090779|4272920|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
1744271|NCT00090779|4272919|P2|STARTED|Step 1||64
1744272|NCT00090779|4272920|P1|STARTED|Step 1||66
1744273|NCT00090766|4272944|P3|NOT COMPLETED|Overall Study||3
1744274|NCT00090766|4272945|P2|NOT COMPLETED|Overall Study||2
1744275|NCT00090766|4272946|P1|NOT COMPLETED|Overall Study||3
1744276|NCT00090766|4272944|P3|COMPLETED|Overall Study||22
1744277|NCT00090766|4272945|P2|COMPLETED|Overall Study||19
1744278|NCT00090766|4272946|P1|COMPLETED|Overall Study||14
1744279|NCT00090766|4272944|P3|STARTED|Overall Study||25
1744280|NCT00090766|4272945|P2|STARTED|Overall Study||21
1744281|NCT00090766|4272946|P1|STARTED|Overall Study||17
1744282|NCT00090753|4272988|P2|NOT COMPLETED|Extended Treatment Period||191
1744283|NCT00090753|4272989|P1|NOT COMPLETED|Extended Treatment Period||359
1744284|NCT00090753|4272988|P2|COMPLETED|Extended Treatment Period||59
1744285|NCT00090753|4272989|P1|COMPLETED|Extended Treatment Period||94
1744286|NCT00090753|4272988|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
1744287|NCT00090753|4272989|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
1744288|NCT00090753|4272988|P2|NOT COMPLETED|First Treatment Period||178
1744289|NCT00090753|4272989|P1|NOT COMPLETED|First Treatment Period||256
1744290|NCT00090753|4272988|P2|COMPLETED|First Treatment Period||302
1744291|NCT00090753|4272989|P1|COMPLETED|First Treatment Period||492
1744292|NCT00090753|4272988|P2|STARTED|First Treatment Period||480
1744293|NCT00090753|4272989|P1|STARTED|First Treatment Period||748
1744294|NCT00090610|4272999|P2|NOT COMPLETED|Overall Study||1
1744295|NCT00090610|4273000|P1|NOT COMPLETED|Overall Study||1
1744296|NCT00090610|4272999|P2|COMPLETED|Overall Study||74
1744297|NCT00090610|4273000|P1|COMPLETED|Overall Study||74
1744298|NCT00090610|4272999|P2|STARTED|Overall Study||75
1744299|NCT00090610|4273000|P1|STARTED|Overall Study||75
1744300|NCT00090584|4273016|P2|NOT COMPLETED|Baseline to 8 Months||41
1744301|NCT00090584|4273017|P1|NOT COMPLETED|Baseline to 8 Months||44
1744302|NCT00090584|4273016|P2|COMPLETED|Baseline to 8 Months||112
1744303|NCT00090584|4273017|P1|COMPLETED|Baseline to 8 Months||110
1744304|NCT00090584|4273016|P2|STARTED|Baseline to 8 Months||153
1744305|NCT00090584|4273017|P1|STARTED|Baseline to 8 Months||154
1744306|NCT00090584|4273016|P2|NOT COMPLETED|Baseline to 10 Weeks||12
1744307|NCT00090584|4273017|P1|NOT COMPLETED|Baseline to 10 Weeks||15
1744308|NCT00090584|4273016|P2|COMPLETED|Baseline to 10 Weeks||141
1744309|NCT00090584|4273017|P1|COMPLETED|Baseline to 10 Weeks||139
1744310|NCT00090584|4273016|P2|STARTED|Baseline to 10 Weeks||153
1744311|NCT00090584|4273017|P1|STARTED|Baseline to 10 Weeks||154
1744312|NCT00090519|4273049|P2|NOT COMPLETED|Overall Study||75
1744313|NCT00090519|4273050|P1|NOT COMPLETED|Overall Study||73
1744314|NCT00090519|4273049|P2|COMPLETED|Overall Study||285
1744315|NCT00090519|4273050|P1|COMPLETED|Overall Study||298
1744316|NCT00090519|4273049|P2|STARTED|Overall Study||360
1744317|NCT00090519|4273050|P1|STARTED|Overall Study||371
1744318|NCT00090493|4273074|P1|NOT COMPLETED|Overall Study||2
1744319|NCT00090493|4273074|P1|COMPLETED|Overall Study||2
1744320|NCT00090493|4273074|P1|STARTED|Overall Study||4
1744321|NCT00090363|4273081|P3|NOT COMPLETED|Overall Study||96
1744322|NCT00090363|4273082|P2|NOT COMPLETED|Overall Study||107
1744323|NCT00090363|4273083|P1|NOT COMPLETED|Overall Study||106
1744324|NCT00090363|4273081|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
1744325|NCT00090363|4273082|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
1744326|NCT00090363|4273083|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
1744327|NCT00090363|4273081|P3|Received Study Treatment.|Overall Study||98
1744328|NCT00090363|4273082|P2|Received Study Treatment.|Overall Study||107
1744329|NCT00090363|4273083|P1|Received Study Treatment.|Overall Study||107
1744330|NCT00090363|4273081|P3|STARTED|Overall Study||98
1744331|NCT00090363|4273082|P2|STARTED|Overall Study||107
1744332|NCT00090363|4273083|P1|STARTED|Overall Study||107
1744333|NCT00090545|4273105|P2|NOT COMPLETED|Overall Study||24
1744334|NCT00090545|4273106|P1|NOT COMPLETED|Overall Study||22
1744335|NCT00090545|4273105|P2|COMPLETED|Overall Study||0
1744336|NCT00090545|4273106|P1|COMPLETED|Overall Study||0
1744337|NCT00090545|4273105|P2|STARTED|Overall Study||24
1744338|NCT00090545|4273106|P1|STARTED|Overall Study||22
1744339|NCT00090285|4273126|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
1744340|NCT00090285|4273127|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
1744341|NCT00090285|4273128|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1744342|NCT00090285|4273129|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1744343|NCT00090285|4273130|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1744344|NCT00090285|4273131|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1744345|NCT00090285|4273126|P6|COMPLETED|Long-term Follow-up (EXT2)||664
1744346|NCT00090285|4273127|P5|COMPLETED|Long-term Follow-up (EXT2)||709
1744347|NCT00090285|4273128|P4|COMPLETED|Long-term Follow-up (EXT2)||0
1744348|NCT00090285|4273129|P3|COMPLETED|Long-term Follow-up (EXT2)||0
1744349|NCT00090285|4273130|P2|COMPLETED|Long-term Follow-up (EXT2)||0
1744350|NCT00090285|4273131|P1|COMPLETED|Long-term Follow-up (EXT2)||0
1744351|NCT00090285|4273126|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
1744352|NCT00090285|4273127|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
1744353|NCT00090285|4273128|P4|STARTED|Long-term Follow-up (EXT2)||0
1744354|NCT00090285|4273129|P3|STARTED|Long-term Follow-up (EXT2)||0
1744355|NCT00090285|4273130|P2|STARTED|Long-term Follow-up (EXT2)||0
1744356|NCT00090285|4273131|P1|STARTED|Long-term Follow-up (EXT2)||0
1744357|NCT00090285|4273126|P6|NOT COMPLETED|Extension 1||0
1744358|NCT00090285|4273127|P5|NOT COMPLETED|Extension 1||0
1744359|NCT00090285|4273128|P4|NOT COMPLETED|Extension 1||1
1744360|NCT00090285|4273129|P3|NOT COMPLETED|Extension 1||57
1744361|NCT00090285|4273130|P2|NOT COMPLETED|Extension 1||0
1744362|NCT00090285|4273131|P1|NOT COMPLETED|Extension 1||0
1744363|NCT00090285|4273126|P6|COMPLETED|Extension 1||0
1744364|NCT00090285|4273127|P5|COMPLETED|Extension 1||0
1744365|NCT00090285|4273128|P4|COMPLETED|Extension 1||15
1744366|NCT00090285|4273129|P3|COMPLETED|Extension 1||1041
1744367|NCT00090285|4273130|P2|COMPLETED|Extension 1||0
1744368|NCT00090285|4273131|P1|COMPLETED|Extension 1||0
1744369|NCT00090285|4273126|P6|STARTED|Extension 1||0
1744370|NCT00090285|4273127|P5|STARTED|Extension 1||0
1744371|NCT00090285|4273128|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
1744372|NCT00090285|4273129|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
1744373|NCT00090285|4273130|P2|STARTED|Extension 1||0
1744374|NCT00090285|4273131|P1|STARTED|Extension 1||0
1744375|NCT00090285|4273126|P6|NOT COMPLETED|Base Study Follow-up Period||0
1744376|NCT00090285|4273127|P5|NOT COMPLETED|Base Study Follow-up Period||0
1744377|NCT00090285|4273128|P4|NOT COMPLETED|Base Study Follow-up Period||0
1744378|NCT00090285|4273129|P3|NOT COMPLETED|Base Study Follow-up Period||0
1744379|NCT00090285|4273130|P2|NOT COMPLETED|Base Study Follow-up Period||342
1744380|NCT00090285|4273131|P1|NOT COMPLETED|Base Study Follow-up Period||335
1744381|NCT00090285|4273126|P6|COMPLETED|Base Study Follow-up Period||0
1744382|NCT00090285|4273127|P5|COMPLETED|Base Study Follow-up Period||0
1744383|NCT00090285|4273128|P4|COMPLETED|Base Study Follow-up Period||0
1744384|NCT00090285|4273129|P3|COMPLETED|Base Study Follow-up Period||0
1744385|NCT00090285|4273130|P2|COMPLETED|Base Study Follow-up Period||1479
1744386|NCT00090285|4273131|P1|COMPLETED|Base Study Follow-up Period||1487
1744387|NCT00090285|4273126|P6|STARTED|Base Study Follow-up Period||0
1744388|NCT00090285|4273127|P5|STARTED|Base Study Follow-up Period||0
1744389|NCT00090285|4273128|P4|STARTED|Base Study Follow-up Period||0
1744390|NCT00090285|4273129|P3|STARTED|Base Study Follow-up Period||0
1744391|NCT00090285|4273130|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
1744392|NCT00090285|4273131|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
1744393|NCT00090285|4273126|P6|NOT COMPLETED|Base Study Vaccination Period||0
1744394|NCT00090285|4273127|P5|NOT COMPLETED|Base Study Vaccination Period||0
1744395|NCT00090285|4273128|P4|NOT COMPLETED|Base Study Vaccination Period||0
1744396|NCT00090285|4273129|P3|NOT COMPLETED|Base Study Vaccination Period||0
1744397|NCT00090285|4273130|P2|NOT COMPLETED|Base Study Vaccination Period||219
1744398|NCT00090285|4273131|P1|NOT COMPLETED|Base Study Vaccination Period||214
1744399|NCT00090285|4273126|P6|COMPLETED|Base Study Vaccination Period||0
1744400|NCT00090285|4273127|P5|COMPLETED|Base Study Vaccination Period||0
1744401|NCT00090285|4273128|P4|COMPLETED|Base Study Vaccination Period||0
1744402|NCT00090285|4273129|P3|COMPLETED|Base Study Vaccination Period||0
1744403|NCT00090285|4273130|P2|COMPLETED|Base Study Vaccination Period||1814
1744404|NCT00090285|4273131|P1|COMPLETED|Base Study Vaccination Period||1818
1744405|NCT00090285|4273126|P6|Vaccinated|Base Study Vaccination Period||0
1744406|NCT00090285|4273127|P5|Vaccinated|Base Study Vaccination Period||0
1744407|NCT00090285|4273128|P4|Vaccinated|Base Study Vaccination Period||0
1744408|NCT00090285|4273129|P3|Vaccinated|Base Study Vaccination Period||0
1744409|NCT00090285|4273130|P2|Vaccinated|Base Study Vaccination Period||2030
1744410|NCT00090285|4273131|P1|Vaccinated|Base Study Vaccination Period||2025
1744411|NCT00090285|4273126|P6|STARTED|Base Study Vaccination Period||0
1744412|NCT00090285|4273127|P5|STARTED|Base Study Vaccination Period||0
1744413|NCT00090285|4273128|P4|STARTED|Base Study Vaccination Period||0
1744414|NCT00090285|4273129|P3|STARTED|Base Study Vaccination Period||0
1744415|NCT00090285|4273130|P2|STARTED|Base Study Vaccination Period||2033
1744416|NCT00090285|4273131|P1|STARTED|Base Study Vaccination Period||2032
1744417|NCT00090259|4273168|P2|NOT COMPLETED|Overall Study||48
1744418|NCT00090259|4273169|P1|NOT COMPLETED|Overall Study||62
1744419|NCT00090259|4273168|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
1744420|NCT00090259|4273169|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
1744421|NCT00090259|4273168|P2|STARTED|Overall Study||1921
1744422|NCT00090259|4273169|P1|STARTED|Overall Study||1913
1744423|NCT00090233|4273185|P2|NOT COMPLETED|Overall Study||5065
1744424|NCT00090233|4273186|P1|NOT COMPLETED|Overall Study||4999
1744425|NCT00090233|4273185|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
1744426|NCT00090233|4273186|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
1744427|NCT00090233|4273185|P2|Vaccinated at Visit 3|Overall Study||29598
1744428|NCT00090233|4273186|P1|Vaccinated at Visit 3|Overall Study||29667
1744429|NCT00090233|4273185|P2|Vaccinated at Visit 2|Overall Study||31066
1744430|NCT00090233|4273186|P1|Vaccinated at Visit 2|Overall Study||31052
1744431|NCT00090233|4273185|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
1744432|NCT00090233|4273186|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
1744433|NCT00090233|4273185|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
1744434|NCT00090233|4273186|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
1744435|NCT00090220|4273210|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
1744436|NCT00090220|4273211|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
1744437|NCT00090220|4273212|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1744438|NCT00090220|4273213|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1744439|NCT00090220|4273214|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1744440|NCT00090220|4273215|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
1744441|NCT00090220|4273210|P6|COMPLETED|Long-term Follow-up (EXT2)||623
1744442|NCT00090220|4273211|P5|COMPLETED|Long-term Follow-up (EXT2)||641
1744443|NCT00090220|4273212|P4|COMPLETED|Long-term Follow-up (EXT2)||0
1744444|NCT00090220|4273213|P3|COMPLETED|Long-term Follow-up (EXT2)||0
1744445|NCT00090220|4273214|P2|COMPLETED|Long-term Follow-up (EXT2)||0
1744446|NCT00090220|4273215|P1|COMPLETED|Long-term Follow-up (EXT2)||0
1744447|NCT00090220|4273210|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
1744448|NCT00090220|4273211|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
1744449|NCT00090220|4273212|P4|STARTED|Long-term Follow-up (EXT2)||0
1744450|NCT00090220|4273213|P3|STARTED|Long-term Follow-up (EXT2)||0
1744451|NCT00090220|4273214|P2|STARTED|Long-term Follow-up (EXT2)||0
1744452|NCT00090220|4273215|P1|STARTED|Long-term Follow-up (EXT2)||0
1744453|NCT00090220|4273210|P6|NOT COMPLETED|Extension 1 (EXT1)||0
1744454|NCT00090220|4273211|P5|NOT COMPLETED|Extension 1 (EXT1)||0
1744455|NCT00090220|4273212|P4|NOT COMPLETED|Extension 1 (EXT1)||2
1744456|NCT00090220|4273213|P3|NOT COMPLETED|Extension 1 (EXT1)||55
1744457|NCT00090220|4273214|P2|NOT COMPLETED|Extension 1 (EXT1)||0
1744458|NCT00090220|4273215|P1|NOT COMPLETED|Extension 1 (EXT1)||0
1744459|NCT00090220|4273210|P6|COMPLETED|Extension 1 (EXT1)||0
1744460|NCT00090220|4273211|P5|COMPLETED|Extension 1 (EXT1)||0
1744461|NCT00090220|4273212|P4|COMPLETED|Extension 1 (EXT1)||5
1744462|NCT00090220|4273213|P3|COMPLETED|Extension 1 (EXT1)||1267
1744463|NCT00090220|4273214|P2|COMPLETED|Extension 1 (EXT1)||0
1744464|NCT00090220|4273215|P1|COMPLETED|Extension 1 (EXT1)||0
1744465|NCT00090220|4273210|P6|Vaccinated|Extension 1 (EXT1)||0
1744466|NCT00090220|4273211|P5|Vaccinated|Extension 1 (EXT1)||0
1744467|NCT00090220|4273212|P4|Vaccinated|Extension 1 (EXT1)||7
1744468|NCT00090220|4273213|P3|Vaccinated|Extension 1 (EXT1)||1321
1744469|NCT00090220|4273214|P2|Vaccinated|Extension 1 (EXT1)||0
1744470|NCT00090220|4273215|P1|Vaccinated|Extension 1 (EXT1)||0
1744471|NCT00090220|4273210|P6|STARTED|Extension 1 (EXT1)||0
1744472|NCT00090220|4273211|P5|STARTED|Extension 1 (EXT1)||0
1744473|NCT00090220|4273212|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
1744474|NCT00090220|4273213|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
1744475|NCT00090220|4273214|P2|STARTED|Extension 1 (EXT1)||0
1744476|NCT00090220|4273215|P1|STARTED|Extension 1 (EXT1)||0
1744477|NCT00090220|4273210|P6|NOT COMPLETED|Base Study Follow-up Period||0
1744478|NCT00090220|4273211|P5|NOT COMPLETED|Base Study Follow-up Period||0
1744479|NCT00090220|4273212|P4|NOT COMPLETED|Base Study Follow-up Period||0
1744480|NCT00090220|4273213|P3|NOT COMPLETED|Base Study Follow-up Period||0
1744481|NCT00090220|4273214|P2|NOT COMPLETED|Base Study Follow-up Period||164
1744482|NCT00090220|4273215|P1|NOT COMPLETED|Base Study Follow-up Period||160
1744483|NCT00090220|4273210|P6|COMPLETED|Base Study Follow-up Period||0
1744484|NCT00090220|4273211|P5|COMPLETED|Base Study Follow-up Period||0
1744485|NCT00090220|4273212|P4|COMPLETED|Base Study Follow-up Period||0
1744486|NCT00090220|4273213|P3|COMPLETED|Base Study Follow-up Period||0
1744487|NCT00090220|4273214|P2|COMPLETED|Base Study Follow-up Period||1687
1744488|NCT00090220|4273215|P1|COMPLETED|Base Study Follow-up Period||1695
1744489|NCT00090220|4273210|P6|STARTED|Base Study Follow-up Period||0
1744490|NCT00090220|4273211|P5|STARTED|Base Study Follow-up Period||0
1744491|NCT00090220|4273212|P4|STARTED|Base Study Follow-up Period||0
1744492|NCT00090220|4273213|P3|STARTED|Base Study Follow-up Period||0
1744493|NCT00090220|4273214|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
1744494|NCT00090220|4273215|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
1744495|NCT00090220|4273210|P6|NOT COMPLETED|Base Study Vaccination Period||0
1744496|NCT00090220|4273211|P5|NOT COMPLETED|Base Study Vaccination Period||0
1744497|NCT00090220|4273212|P4|NOT COMPLETED|Base Study Vaccination Period||0
1744498|NCT00090220|4273213|P3|NOT COMPLETED|Base Study Vaccination Period||0
1744499|NCT00090220|4273214|P2|NOT COMPLETED|Base Study Vaccination Period||63
1744500|NCT00090220|4273215|P1|NOT COMPLETED|Base Study Vaccination Period||64
1744501|NCT00090220|4273210|P6|COMPLETED|Base Study Vaccination Period||0
1744502|NCT00090220|4273211|P5|COMPLETED|Base Study Vaccination Period||0
1744503|NCT00090220|4273212|P4|COMPLETED|Base Study Vaccination Period||0
1744504|NCT00090220|4273213|P3|COMPLETED|Base Study Vaccination Period||0
1744505|NCT00090220|4273214|P2|COMPLETED|Base Study Vaccination Period||1845
1744506|NCT00090220|4273215|P1|COMPLETED|Base Study Vaccination Period||1847
1744507|NCT00090220|4273210|P6|Vaccinated|Base Study Vaccination Period||0
1744508|NCT00090220|4273211|P5|Vaccinated|Base Study Vaccination Period||0
1744509|NCT00090220|4273212|P4|Vaccinated|Base Study Vaccination Period||0
1744510|NCT00090220|4273213|P3|Vaccinated|Base Study Vaccination Period||0
1744511|NCT00090220|4273214|P2|Vaccinated|Base Study Vaccination Period||1907
1744512|NCT00090220|4273215|P1|Vaccinated|Base Study Vaccination Period||1910
1744513|NCT00090220|4273210|P6|STARTED|Base Study Vaccination Period||0
1744514|NCT00090220|4273211|P5|STARTED|Base Study Vaccination Period||0
1744515|NCT00090220|4273212|P4|STARTED|Base Study Vaccination Period||0
1744516|NCT00090220|4273213|P3|STARTED|Base Study Vaccination Period||0
1744517|NCT00090220|4273214|P2|STARTED|Base Study Vaccination Period||1908
1744518|NCT00090220|4273215|P1|STARTED|Base Study Vaccination Period||1911
1744519|NCT00090402|4273310|P3|NOT COMPLETED|Overall Study||1
1744520|NCT00090402|4273311|P2|NOT COMPLETED|Overall Study||2
1744521|NCT00090402|4273312|P1|NOT COMPLETED|Overall Study||2
1744522|NCT00090402|4273310|P3|COMPLETED|Overall Study||12
1744523|NCT00090402|4273311|P2|COMPLETED|Overall Study||11
1744524|NCT00090402|4273312|P1|COMPLETED|Overall Study||11
1744525|NCT00090402|4273310|P3|STARTED|Overall Study||13
1744526|NCT00090402|4273311|P2|STARTED|Overall Study||13
1744527|NCT00090402|4273312|P1|STARTED|Overall Study||13
1744528|NCT00090142|4273326|P2|NOT COMPLETED|Treatment Period II||0
1744529|NCT00090142|4273327|P1|NOT COMPLETED|Treatment Period II||1
1744530|NCT00090142|4273326|P2|COMPLETED|Treatment Period II||28
1744531|NCT00090142|4273327|P1|COMPLETED|Treatment Period II||25
1744532|NCT00090142|4273326|P2|STARTED|Treatment Period II||28
1744533|NCT00090142|4273327|P1|STARTED|Treatment Period II||26
1744534|NCT00090142|4273326|P2|NOT COMPLETED|Treatment Period I||3
1744535|NCT00090142|4273327|P1|NOT COMPLETED|Treatment Period I||5
1744536|NCT00090142|4273326|P2|COMPLETED|Treatment Period I||28
1744537|NCT00090142|4273327|P1|COMPLETED|Treatment Period I||26
1744538|NCT00090142|4273326|P2|STARTED|Treatment Period I||31
1744539|NCT00090142|4273327|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
1744540|NCT00090103|4273358|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
1744541|NCT00090103|4273359|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
1744542|NCT00090103|4273360|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
1744543|NCT00090103|4273358|P3|COMPLETED|16-Week Safety Follow-up Period||1143
1744544|NCT00090103|4273359|P2|COMPLETED|16-Week Safety Follow-up Period||1205
1744545|NCT00090103|4273360|P1|COMPLETED|16-Week Safety Follow-up Period||1224
1744546|NCT00090103|4273358|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
1744547|NCT00090103|4273359|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
1744548|NCT00090103|4273360|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
1744549|NCT00090103|4273358|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
1744550|NCT00090103|4273359|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
1744551|NCT00090103|4273360|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
1744552|NCT00090103|4273358|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
1744553|NCT00090103|4273359|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
1744554|NCT00090103|4273360|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
1744555|NCT00090103|4273358|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
1744556|NCT00090103|4273359|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
1744557|NCT00090103|4273360|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
1744558|NCT00090051|4273460|P2|NOT COMPLETED|Overall Study||95
1744559|NCT00090051|4273461|P1|NOT COMPLETED|Overall Study||109
1744560|NCT00090051|4273460|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
1744561|NCT00090051|4273461|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
1744562|NCT00090051|4273460|P2|Safety Population; Received Study Drug|Overall Study||274
1744563|NCT00090051|4273461|P1|Safety Population; Received Study Drug|Overall Study||272
1744564|NCT00090051|4273460|P2|STARTED|Overall Study||276
1744565|NCT00090051|4273461|P1|STARTED|Overall Study||276
1744566|NCT00003224|4273501|P6|NOT COMPLETED|Overall Study||0
1744567|NCT00003224|4273502|P5|NOT COMPLETED|Overall Study||0
1744568|NCT00003224|4273503|P4|NOT COMPLETED|Overall Study||0
1744569|NCT00003224|4273504|P3|NOT COMPLETED|Overall Study||0
1744570|NCT00003224|4273505|P2|NOT COMPLETED|Overall Study||0
1744571|NCT00003224|4273506|P1|NOT COMPLETED|Overall Study||0
1744572|NCT00003224|4273501|P6|COMPLETED|Overall Study||3
1744573|NCT00003224|4273502|P5|COMPLETED|Overall Study||4
1744574|NCT00003224|4273503|P4|COMPLETED|Overall Study||2
1744575|NCT00003224|4273504|P3|COMPLETED|Overall Study||4
1744576|NCT00003224|4273505|P2|COMPLETED|Overall Study||5
1744577|NCT00003224|4273506|P1|COMPLETED|Overall Study||4
1744578|NCT00003224|4273501|P6|STARTED|Overall Study||3
1744579|NCT00003224|4273502|P5|STARTED|Overall Study||4
1744580|NCT00003224|4273503|P4|STARTED|Overall Study||2
1744581|NCT00003224|4273504|P3|STARTED|Overall Study||4
1744582|NCT00003224|4273505|P2|STARTED|Overall Study||5
1744583|NCT00003224|4273506|P1|STARTED|Overall Study||4
1744584|NCT00089999|4273526|P2|NOT COMPLETED|Overall Study||69
1744585|NCT00089999|4273527|P1|NOT COMPLETED|Overall Study||69
1744586|NCT00089999|4273526|P2|COMPLETED|Overall Study||0
1744587|NCT00089999|4273527|P1|COMPLETED|Overall Study||0
1744588|NCT00089999|4273526|P2|STARTED|Overall Study||69
1744589|NCT00089999|4273527|P1|STARTED|Overall Study||69
1744590|NCT00089986|4273550|P3|NOT COMPLETED|Overall Study||10
1744591|NCT00089986|4273551|P2|NOT COMPLETED|Overall Study||24
1744592|NCT00089986|4273552|P1|NOT COMPLETED|Overall Study||15
1744593|NCT00089986|4273550|P3|COMPLETED|Overall Study||172
1744594|NCT00089986|4273551|P2|COMPLETED|Overall Study||574
1744595|NCT00089986|4273552|P1|COMPLETED|Overall Study||584
1744596|NCT00089986|4273550|P3|STARTED|Overall Study||182
1744597|NCT00089986|4273551|P2|STARTED|Overall Study||598
1744598|NCT00089986|4273552|P1|STARTED|Overall Study||599
1744599|NCT00089973|4273569|P1|NOT COMPLETED|Overall Study||50
1744600|NCT00089973|4273569|P1|COMPLETED|Overall Study||0
1744601|NCT00089973|4273569|P1|STARTED|Overall Study||50
1744602|NCT00089895|4273584|P2|NOT COMPLETED|Overall Study||42
1744603|NCT00089895|4273585|P1|NOT COMPLETED|Overall Study||35
1744604|NCT00089895|4273584|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
1744605|NCT00089895|4273585|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
1744606|NCT00089895|4273584|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
1744607|NCT00089895|4273585|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
1744608|NCT00089843|4273597|P4|NOT COMPLETED|Overall Study||7
1744609|NCT00089843|4273598|P3|NOT COMPLETED|Overall Study||5
1744610|NCT00089843|4273599|P2|NOT COMPLETED|Overall Study||4
1744611|NCT00089843|4273600|P1|NOT COMPLETED|Overall Study||2
1744612|NCT00089843|4273597|P4|COMPLETED|Overall Study||11
1744613|NCT00089843|4273598|P3|COMPLETED|Overall Study||15
1744614|NCT00089843|4273599|P2|COMPLETED|Overall Study||16
1744615|NCT00089843|4273600|P1|COMPLETED|Overall Study||17
1744616|NCT00089843|4273597|P4|STARTED|Overall Study||18
1744617|NCT00089843|4273598|P3|STARTED|Overall Study||20
1744618|NCT00089843|4273599|P2|STARTED|Overall Study||20
1744619|NCT00089843|4273600|P1|STARTED|Overall Study||19
1744620|NCT00089791|4273612|P2|NOT COMPLETED|Overall Study||630
1744621|NCT00089791|4273613|P1|NOT COMPLETED|Overall Study||700
1744622|NCT00089791|4273612|P2|COMPLETED|Overall Study||3272
1744623|NCT00089791|4273613|P1|COMPLETED|Overall Study||3206
1744624|NCT00089791|4273612|P2|Safety Analysis Set|Overall Study||3886
1744625|NCT00089791|4273613|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
1744626|NCT00089791|4273612|P2|Received Study Medication|Overall Study||3879
1744627|NCT00089791|4273613|P1|Received Study Medication|Overall Study||3883
1744628|NCT00089791|4273612|P2|STARTED|Overall Study||3902
1744629|NCT00089791|4273613|P1|STARTED|Overall Study||3906
1744630|NCT00089752|4273625|P2|NOT COMPLETED|Overall Study||22
1744631|NCT00089752|4273626|P1|NOT COMPLETED|Overall Study||20
1744632|NCT00089752|4273625|P2|COMPLETED|Overall Study||118
1744633|NCT00089752|4273626|P1|COMPLETED|Overall Study||121
1744634|NCT00089752|4273625|P2|STARTED|Overall Study||140
1744635|NCT00089752|4273626|P1|STARTED|Overall Study||141
1744636|NCT00089778|4273647|P3|NOT COMPLETED|Overall Study||1
1744637|NCT00089778|4273648|P2|NOT COMPLETED|Overall Study||0
1744638|NCT00089778|4273649|P1|NOT COMPLETED|Overall Study||0
1744639|NCT00089778|4273647|P3|COMPLETED|Overall Study||7
1744640|NCT00089778|4273648|P2|COMPLETED|Overall Study||1
1744641|NCT00089778|4273649|P1|COMPLETED|Overall Study||2
1744642|NCT00089778|4273647|P3|STARTED|Overall Study||8
1744643|NCT00089778|4273648|P2|STARTED|Overall Study||1
1744644|NCT00089778|4273649|P1|STARTED|Overall Study||2
1744645|NCT00089674|4273662|P2|NOT COMPLETED|Overall Study||267
1744646|NCT00089674|4273663|P1|NOT COMPLETED|Overall Study||289
1744647|NCT00089674|4273662|P2|COMPLETED|Overall Study||467
1744648|NCT00089674|4273663|P1|COMPLETED|Overall Study||445
1744649|NCT00089674|4273662|P2|Received Study Drug|Overall Study||726
1744650|NCT00089674|4273663|P1|Received Study Drug|Overall Study||730
1744651|NCT00089674|4273662|P2|STARTED|Overall Study||734
1744652|NCT00089674|4273663|P1|STARTED|Overall Study||734
1744653|NCT00089661|4273689|P2|NOT COMPLETED|Overall Study||26
1744654|NCT00089661|4273690|P1|NOT COMPLETED|Overall Study||21
1744655|NCT00089661|4273689|P2|COMPLETED|Overall Study||99
1744656|NCT00089661|4273690|P1|COMPLETED|Overall Study||106
1744657|NCT00089661|4273689|P2|STARTED|Overall Study||125
1744658|NCT00089661|4273690|P1|STARTED|Overall Study||127
1744659|NCT00089648|4273706|P1|NOT COMPLETED|Overall Study||41
1744660|NCT00089648|4273706|P1|COMPLETED|Overall Study||20
1744661|NCT00089648|4273706|P1|STARTED|Overall Study||61
1744662|NCT00089635|4273722|P1|NOT COMPLETED|Overall Study||43
1744663|NCT00089635|4273722|P1|COMPLETED|Overall Study||160
1744664|NCT00089635|4273722|P1|STARTED|Overall Study||203
1744665|NCT00089583|4273736|P2|NOT COMPLETED|Overall Study||38
1744666|NCT00089583|4273737|P1|NOT COMPLETED|Overall Study||7
1744667|NCT00089583|4273736|P2|COMPLETED|Overall Study||51
1744668|NCT00089583|4273737|P1|COMPLETED|Overall Study||13
1744669|NCT00089583|4273736|P2|STARTED|Overall Study||89
1744670|NCT00089583|4273737|P1|STARTED|Overall Study||20
1744671|NCT00089609|4273831|P2|NOT COMPLETED|Overall Study||1
1744672|NCT00089609|4273832|P1|NOT COMPLETED|Overall Study||3
1744673|NCT00089609|4273831|P2|COMPLETED|Overall Study||12
1744674|NCT00089609|4273832|P1|COMPLETED|Overall Study||57
1744675|NCT00089609|4273831|P2|STARTED|Overall Study||13
1744676|NCT00089609|4273832|P1|STARTED|Overall Study||60
1744677|NCT00089544|4273851|P2|NOT COMPLETED|Overall Study||0
1744678|NCT00089544|4273852|P1|NOT COMPLETED|Overall Study||1
1744679|NCT00089544|4273851|P2|COMPLETED|Overall Study||7
1744680|NCT00089544|4273852|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
1744681|NCT00089544|4273851|P2|STARTED|Overall Study||7
1744682|NCT00089544|4273852|P1|STARTED|Overall Study||16
1744683|NCT00089505|4273866|P4|NOT COMPLETED|Overall Study||21
1744684|NCT00089505|4273867|P3|NOT COMPLETED|Overall Study||21
1744685|NCT00089505|4273868|P2|NOT COMPLETED|Overall Study||2
1744686|NCT00089505|4273869|P1|NOT COMPLETED|Overall Study||9
1744687|NCT00089505|4273866|P4|COMPLETED|Overall Study||230
1744688|NCT00089505|4273867|P3|COMPLETED|Overall Study||228
1744689|NCT00089505|4273868|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
1744690|NCT00089505|4273869|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
1744691|NCT00089505|4273866|P4|STARTED|Overall Study||251
1744692|NCT00089505|4273867|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
1744693|NCT00089505|4273868|P2|STARTED|Overall Study||120
1744694|NCT00089505|4273869|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
1744695|NCT00089479|4273913|P2|NOT COMPLETED|Overall Study||289
1744696|NCT00089479|4273914|P1|NOT COMPLETED|Overall Study||331
1744697|NCT00089479|4273913|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
1744698|NCT00089479|4273914|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
1744699|NCT00089479|4273913|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
1744700|NCT00089479|4273914|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
1744701|NCT00089479|4273913|P2|STARTED|Overall Study||1307
1744702|NCT00089479|4273914|P1|STARTED|Overall Study||1304
1744703|NCT00089414|4273941|P3|NOT COMPLETED|Overall Study||0
1744704|NCT00089414|4273942|P2|NOT COMPLETED|Overall Study||0
1744705|NCT00089414|4273943|P1|NOT COMPLETED|Overall Study||0
1744706|NCT00089414|4273941|P3|COMPLETED|Overall Study||2
1744707|NCT00089414|4273942|P2|COMPLETED|Overall Study||1
1744708|NCT00089414|4273943|P1|COMPLETED|Overall Study||2
1744709|NCT00089414|4273941|P3|STARTED|Overall Study||2
1744710|NCT00089414|4273942|P2|STARTED|Overall Study||1
1744711|NCT00089414|4273943|P1|STARTED|Overall Study||2
1744712|NCT00089297|4273957|P1|NOT COMPLETED|Overall Study||38
1744713|NCT00089297|4273957|P1|COMPLETED|Overall Study||36
1744714|NCT00089297|4273957|P1|Eligible|Overall Study||63
1744715|NCT00089297|4273957|P1|Treated|Overall Study||70
1744716|NCT00089297|4273957|P1|STARTED|Overall Study||74
1744717|NCT00089141|4273966|P2|NOT COMPLETED|Overall Study||24
1744718|NCT00089141|4273967|P1|NOT COMPLETED|Overall Study||18
1744719|NCT00089141|4273966|P2|COMPLETED|Overall Study||53
1744720|NCT00089141|4273967|P1|COMPLETED|Overall Study||56
1744721|NCT00089141|4273966|P2|STARTED|Overall Study||77
1744722|NCT00089141|4273967|P1|STARTED|Overall Study||74
1744723|NCT00089128|4273989|P1|NOT COMPLETED|Overall Study||0
1744724|NCT00089128|4273989|P1|COMPLETED|Overall Study||16
1744725|NCT00089128|4273989|P1|STARTED|Overall Study||16
1744726|NCT00089102|4273996|P1|NOT COMPLETED|Overall Study||0
1744727|NCT00089102|4273996|P1|COMPLETED|Overall Study||9
1744728|NCT00089102|4273996|P1|STARTED|Overall Study||9
1744729|NCT00089076|4274003|P1|NOT COMPLETED|Overall Study||10
1744730|NCT00089076|4274003|P1|COMPLETED|Overall Study||8
1744731|NCT00089076|4274003|P1|STARTED|Overall Study||18
1744732|NCT00089011|4274016|P2|NOT COMPLETED|Overall Study||0
1744733|NCT00089011|4274017|P1|NOT COMPLETED|Overall Study||0
1744734|NCT00089011|4274016|P2|COMPLETED|Overall Study||50
1744735|NCT00089011|4274017|P1|COMPLETED|Overall Study||100
1744736|NCT00089011|4274016|P2|STARTED|Overall Study||50
1744737|NCT00089011|4274017|P1|STARTED|Overall Study||100
1744738|NCT00088985|4274037|P1|NOT COMPLETED|Overall Study||3
1744739|NCT00088985|4274037|P1|COMPLETED|Overall Study||4
1744740|NCT00088985|4274037|P1|STARTED|Overall Study||7
1744741|NCT00088972|4274044|P2|NOT COMPLETED|Overall Study||4
1744742|NCT00088972|4274045|P1|NOT COMPLETED|Overall Study||2
1744743|NCT00088972|4274044|P2|COMPLETED|Overall Study||1
1744744|NCT00088972|4274045|P1|COMPLETED|Overall Study||1
1744745|NCT00088972|4274044|P2|STARTED|Overall Study||5
1744746|NCT00088972|4274045|P1|STARTED|Overall Study||3
1744747|NCT00088907|4274055|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
1744748|NCT00088907|4274056|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
1744749|NCT00088907|4274055|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
1744750|NCT00088907|4274056|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
1744751|NCT00088907|4274055|P2|Treated|Single Gefitinib Treatment (Step 2)||0
1744752|NCT00088907|4274056|P1|Treated|Single Gefitinib Treatment (Step 2)||19
1744753|NCT00088907|4274055|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
1744754|NCT00088907|4274056|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
1744755|NCT00088907|4274055|P2|NOT COMPLETED|Randomized Study (Step 1)||134
1744756|NCT00088907|4274056|P1|NOT COMPLETED|Randomized Study (Step 1)||136
1744757|NCT00088907|4274055|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
1744758|NCT00088907|4274056|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
1744759|NCT00088907|4274055|P2|Eligible and Treated|Randomized Study (Step 1)||122
1744760|NCT00088907|4274056|P1|Eligible and Treated|Randomized Study (Step 1)||117
1744761|NCT00088907|4274055|P2|Eligible|Randomized Study (Step 1)||122
1744762|NCT00088907|4274056|P1|Eligible|Randomized Study (Step 1)||117
1744763|NCT00088907|4274055|P2|Treated|Randomized Study (Step 1)||124
1744764|NCT00088907|4274056|P1|Treated|Randomized Study (Step 1)||129
1744765|NCT00088907|4274055|P2|STARTED|Randomized Study (Step 1)||134
1744766|NCT00088907|4274056|P1|STARTED|Randomized Study (Step 1)||136
1744767|NCT00088881|4274067|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
1744768|NCT00088881|4274067|P1|COMPLETED|Step 3 - Radiation Therapy||1
1744769|NCT00088881|4274067|P1|STARTED|Step 3 - Radiation Therapy||1
1744770|NCT00088881|4274067|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
1744771|NCT00088881|4274067|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
1744772|NCT00088881|4274067|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
1744773|NCT00088881|4274067|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
1744774|NCT00088881|4274067|P1|NOT COMPLETED|Step 1 - R-CHOP||14
1744775|NCT00088881|4274067|P1|COMPLETED|Step 1 - R-CHOP||48
1744776|NCT00088881|4274067|P1|Eligible and Treated|Step 1 - R-CHOP||53
1744777|NCT00088881|4274067|P1|STARTED|Step 1 - R-CHOP||62
1744778|NCT00088829|4274076|P1|NOT COMPLETED|Overall Study||22
1744779|NCT00088829|4274076|P1|COMPLETED|Overall Study||0
1744780|NCT00088829|4274076|P1|STARTED|Overall Study||22
1744781|NCT00088699|4274082|P4|NOT COMPLETED|Infusion 2||1
1744782|NCT00088699|4274083|P3|NOT COMPLETED|Infusion 2||0
1744783|NCT00088699|4274084|P2|NOT COMPLETED|Infusion 2||0
1744784|NCT00088699|4274085|P1|NOT COMPLETED|Infusion 2||0
1744785|NCT00088699|4274082|P4|COMPLETED|Infusion 2||10
1744786|NCT00088699|4274083|P3|COMPLETED|Infusion 2||11
1744787|NCT00088699|4274084|P2|COMPLETED|Infusion 2||18
1744788|NCT00088699|4274085|P1|COMPLETED|Infusion 2||19
1744789|NCT00088699|4274082|P4|STARTED|Infusion 2||11
1744790|NCT00088699|4274083|P3|STARTED|Infusion 2||11
1744791|NCT00088699|4274084|P2|STARTED|Infusion 2||18
1744792|NCT00088699|4274085|P1|STARTED|Infusion 2||19
1744793|NCT00088699|4274082|P4|NOT COMPLETED|Infusion 1||2
1744794|NCT00088699|4274083|P3|NOT COMPLETED|Infusion 1||1
1744795|NCT00088699|4274084|P2|NOT COMPLETED|Infusion 1||0
1744796|NCT00088699|4274085|P1|NOT COMPLETED|Infusion 1||1
1744797|NCT00088699|4274082|P4|COMPLETED|Infusion 1||10
1744798|NCT00088699|4274083|P3|COMPLETED|Infusion 1||12
1744799|NCT00088699|4274084|P2|COMPLETED|Infusion 1||19
1744800|NCT00088699|4274085|P1|COMPLETED|Infusion 1||22
1744801|NCT00088699|4274082|P4|STARTED|Infusion 1||12
1744802|NCT00088699|4274083|P3|STARTED|Infusion 1||13
1744803|NCT00088699|4274084|P2|STARTED|Infusion 1||19
1744804|NCT00088699|4274085|P1|STARTED|Infusion 1||23
1744805|NCT00088634|4274101|P2|NOT COMPLETED|Overall Study||43
1744806|NCT00088634|4274102|P1|NOT COMPLETED|Overall Study||38
1744807|NCT00088634|4274101|P2|COMPLETED|Overall Study||47
1744808|NCT00088634|4274102|P1|COMPLETED|Overall Study||52
1744809|NCT00088634|4274101|P2|STARTED|Overall Study||90
1744810|NCT00088634|4274102|P1|STARTED|Overall Study||90
1744811|NCT00088621|4274114|P1|NOT COMPLETED|Overall Study||54
1744812|NCT00088621|4274114|P1|COMPLETED|Overall Study||7
1744813|NCT00088621|4274114|P1|STARTED|Overall Study||61
1744814|NCT00088595|4274118|P1|NOT COMPLETED|Overall Study||28
1744815|NCT00088595|4274118|P1|COMPLETED|Overall Study||17
1744816|NCT00088595|4274118|P1|STARTED|Overall Study||45
1744817|NCT00088530|4274136|P2|NOT COMPLETED|Overall Study||54
1744818|NCT00088530|4274137|P1|NOT COMPLETED|Overall Study||50
1744819|NCT00088530|4274136|P2|COMPLETED|Overall Study||16
1744820|NCT00088530|4274137|P1|COMPLETED|Overall Study||20
1744821|NCT00088530|4274136|P2|STARTED|Overall Study||70
1744822|NCT00088530|4274137|P1|STARTED|Overall Study||70
1744823|NCT00088465|4274149|P1|NOT COMPLETED|Overall Study||561
1744824|NCT00088465|4274149|P1|COMPLETED|Overall Study||370
1744825|NCT00088465|4274149|P1|STARTED|Overall Study||931
1744826|NCT00088374|4274172|P1|NOT COMPLETED|Overall Study||2
1744827|NCT00088374|4274172|P1|COMPLETED|Overall Study||7
1744828|NCT00088374|4274172|P1|STARTED|Overall Study||9
1744829|NCT00088218|4274183|P2|NOT COMPLETED|Overall Study||0
1744830|NCT00088218|4274184|P1|NOT COMPLETED|Overall Study||0
1744831|NCT00088218|4274183|P2|COMPLETED|Overall Study||79
1744832|NCT00088218|4274184|P1|COMPLETED|Overall Study||16
1744833|NCT00088218|4274183|P2|STARTED|Overall Study||79
1744834|NCT00088218|4274184|P1|STARTED|Overall Study||16
1744835|NCT00088166|4274192|P2|NOT COMPLETED|Overall Study||61
1744836|NCT00088166|4274193|P1|NOT COMPLETED|Overall Study||53
1744837|NCT00088166|4274192|P2|COMPLETED|Overall Study||39
1744838|NCT00088166|4274193|P1|COMPLETED|Overall Study||47
1744839|NCT00088166|4274192|P2|STARTED|Overall Study||100
1744840|NCT00088166|4274193|P1|STARTED|Overall Study||100
1744841|NCT00088153|4274217|P2|NOT COMPLETED|Overall Study||25
1744842|NCT00088153|4274218|P1|NOT COMPLETED|Overall Study||24
1744843|NCT00088153|4274217|P2|COMPLETED|Overall Study||30
1744844|NCT00088153|4274218|P1|COMPLETED|Overall Study||31
1744845|NCT00088153|4274217|P2|STARTED|Overall Study||55
1744846|NCT00088153|4274218|P1|STARTED|Overall Study||55
1744847|NCT00087698|4274228|P1|NOT COMPLETED|Overall Study||36
1744848|NCT00087698|4274228|P1|COMPLETED|Overall Study||41
1744849|NCT00087698|4274228|P1|STARTED|Overall Study||77
1744850|NCT00087685|4274237|P1|NOT COMPLETED|Overall Study||14
1744851|NCT00087685|4274237|P1|COMPLETED|Overall Study||21
1744852|NCT00087685|4274237|P1|STARTED|Overall Study||35
1744853|NCT00087672|4274242|P1|NOT COMPLETED|Overall Study||0
1744854|NCT00087672|4274242|P1|COMPLETED|Overall Study||41
1744855|NCT00087672|4274242|P1|STARTED|Overall Study||41
1744856|NCT00087646|4274250|P4|NOT COMPLETED|Overall Study||84
1744857|NCT00087646|4274251|P3|NOT COMPLETED|Overall Study||65
1744858|NCT00087646|4274252|P2|NOT COMPLETED|Overall Study||42
1744859|NCT00087646|4274253|P1|NOT COMPLETED|Overall Study||135
1744860|NCT00087646|4274250|P4|COMPLETED|Overall Study||229
1744861|NCT00087646|4274251|P3|COMPLETED|Overall Study||91
1744862|NCT00087646|4274252|P2|COMPLETED|Overall Study||114
1744863|NCT00087646|4274253|P1|COMPLETED|Overall Study||182
1744864|NCT00087646|4274250|P4|STARTED|Overall Study||313
1744865|NCT00087646|4274251|P3|STARTED|Overall Study||156
1744866|NCT00087646|4274252|P2|STARTED|Overall Study||156
1744867|NCT00087646|4274253|P1|STARTED|Overall Study||317
1744868|NCT00087633|4274281|P2|NOT COMPLETED|Overall Study||17
1744869|NCT00087633|4274282|P1|NOT COMPLETED|Overall Study||24
1744870|NCT00087633|4274281|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
1744871|NCT00087633|4274282|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
1744872|NCT00087633|4274281|P2|STARTED|Overall Study|Randomized|60
1744873|NCT00087633|4274282|P1|STARTED|Overall Study|Randomized|55
1744874|NCT00087607|4274292|P2|NOT COMPLETED|Overall Study||122
1744875|NCT00087607|4274293|P1|NOT COMPLETED|Overall Study||122
1744876|NCT00087607|4274292|P2|COMPLETED|Overall Study||71
1744877|NCT00087607|4274293|P1|COMPLETED|Overall Study||70
1744878|NCT00087607|4274292|P2|STARTED|Overall Study||193
1744879|NCT00087607|4274293|P1|STARTED|Overall Study||192
1744880|NCT00087594|4274333|P2|NOT COMPLETED|Overall Study||12
1744881|NCT00087594|4274334|P1|NOT COMPLETED|Overall Study||8
1744882|NCT00087594|4274333|P2|COMPLETED|Overall Study||12
1744883|NCT00087594|4274334|P1|COMPLETED|Overall Study||16
1744884|NCT00087594|4274333|P2|STARTED|Overall Study||24
1744885|NCT00087594|4274334|P1|STARTED|Overall Study||24
1744886|NCT00087568|4274368|P2|NOT COMPLETED|Overall Study||2
1744887|NCT00087568|4274369|P1|NOT COMPLETED|Overall Study||30
1744888|NCT00087568|4274368|P2|COMPLETED|Overall Study||23
1744889|NCT00087568|4274369|P1|COMPLETED|Overall Study||2
1744890|NCT00087568|4274368|P2|STARTED|Overall Study||25
1744891|NCT00087568|4274369|P1|STARTED|Overall Study||32
1744892|NCT00087555|4274396|P3|NOT COMPLETED|Overall Study||21
1744893|NCT00087555|4274397|P2|NOT COMPLETED|Overall Study||11
1744894|NCT00087555|4274398|P1|NOT COMPLETED|Overall Study||12
1744895|NCT00087555|4274396|P3|COMPLETED|Overall Study||46
1744896|NCT00087555|4274397|P2|COMPLETED|Overall Study||51
1744897|NCT00087555|4274398|P1|COMPLETED|Overall Study||54
1744898|NCT00087555|4274396|P3|Treated|Overall Study||67
1744899|NCT00087555|4274397|P2|Treated|Overall Study||60
1744900|NCT00087555|4274398|P1|Treated|Overall Study||65
1744901|NCT00087555|4274396|P3|STARTED|Overall Study||67
1744902|NCT00087555|4274397|P2|STARTED|Overall Study||62
1744903|NCT00087555|4274398|P1|STARTED|Overall Study||66
1744904|NCT00087529|4274408|P2|NOT COMPLETED|Overall Study||68
1744905|NCT00087529|4274409|P1|NOT COMPLETED|Overall Study||31
1744906|NCT00087529|4274408|P2|COMPLETED|Overall Study||224
1744907|NCT00087529|4274409|P1|COMPLETED|Overall Study||116
1744908|NCT00087529|4274408|P2|STARTED|Overall Study||292
1744909|NCT00087529|4274409|P1|STARTED|Overall Study||147
1744910|NCT00087516|4274424|P4|NOT COMPLETED|Overall Study||85
1744911|NCT00087516|4274425|P3|NOT COMPLETED|Overall Study||97
1744912|NCT00087516|4274426|P2|NOT COMPLETED|Overall Study||169
1744913|NCT00087516|4274427|P1|NOT COMPLETED|Overall Study||161
1744914|NCT00087516|4274424|P4|COMPLETED|Overall Study||38
1744915|NCT00087516|4274425|P3|COMPLETED|Overall Study||33
1744916|NCT00087516|4274426|P2|COMPLETED|Overall Study||81
1744917|NCT00087516|4274427|P1|COMPLETED|Overall Study||77
1744918|NCT00087516|4274424|P4|STARTED|Overall Study||123
1744919|NCT00087516|4274425|P3|STARTED|Overall Study||130
1744920|NCT00087516|4274426|P2|STARTED|Overall Study||250
1744921|NCT00087516|4274427|P1|STARTED|Overall Study||238
1744922|NCT00087490|4274456|P2|NOT COMPLETED|Overall Study||269
1744923|NCT00087490|4274457|P1|NOT COMPLETED|Overall Study||258
1744924|NCT00087490|4274456|P2|COMPLETED|Overall Study||264
1744925|NCT00087490|4274457|P1|COMPLETED|Overall Study||286
1744926|NCT00087490|4274456|P2|Treated|Overall Study||515
1744927|NCT00087490|4274457|P1|Treated|Overall Study||537
1744928|NCT00087490|4274456|P2|STARTED|Overall Study||533
1744929|NCT00087490|4274457|P1|STARTED|Overall Study||544
1744930|NCT00087438|4274491|P1|NOT COMPLETED|Overall Study||4
1744931|NCT00087438|4274491|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
1744932|NCT00087438|4274491|P1|STARTED|Overall Study||59
1744933|NCT00087152|4274495|P1|NOT COMPLETED|Overall Study||6
1744934|NCT00087152|4274495|P1|COMPLETED|Overall Study||21
1744935|NCT00087152|4274495|P1|STARTED|Overall Study||27
1744936|NCT00087139|4274504|P3|NOT COMPLETED|Overall Study||36
1744937|NCT00087139|4274505|P2|NOT COMPLETED|Overall Study||49
1744938|NCT00087139|4274506|P1|NOT COMPLETED|Overall Study||39
1744939|NCT00087139|4274504|P3|COMPLETED|Overall Study||0
1744940|NCT00087139|4274505|P2|COMPLETED|Overall Study||0
1744941|NCT00087139|4274506|P1|COMPLETED|Overall Study||0
1744942|NCT00087139|4274504|P3|Patients w/ Measurable Disease Response|Overall Study||0
1744943|NCT00087139|4274505|P2|Patients w/ Measurable Disease Response|Overall Study||2
1744944|NCT00087139|4274506|P1|Patients w/ Measurable Disease Response|Overall Study||5
1744945|NCT00087139|4274504|P3|Patients With PSA Response|Overall Study||4
1744946|NCT00087139|4274505|P2|Patients With PSA Response|Overall Study||8
1744947|NCT00087139|4274506|P1|Patients With PSA Response|Overall Study||10
1744948|NCT00087139|4274504|P3|Patients With Measurable Disease|Overall Study||24
1744949|NCT00087139|4274505|P2|Patients With Measurable Disease|Overall Study||25
1744950|NCT00087139|4274506|P1|Patients With Measurable Disease|Overall Study||22
1744951|NCT00087139|4274504|P3|Patients for the Analysis of PSA Respons|Overall Study||22
1744952|NCT00087139|4274505|P2|Patients for the Analysis of PSA Respons|Overall Study||34
1744953|NCT00087139|4274506|P1|Patients for the Analysis of PSA Respons|Overall Study||30
1744954|NCT00087139|4274504|P3|Eligible and Treated|Overall Study||32
1744955|NCT00087139|4274505|P2|Eligible and Treated|Overall Study||42
1744956|NCT00087139|4274506|P1|Eligible and Treated|Overall Study||35
1744957|NCT00087139|4274504|P3|Treated|Overall Study||36
1744958|NCT00087139|4274505|P2|Treated|Overall Study||48
1744959|NCT00087139|4274506|P1|Treated|Overall Study||39
1744960|NCT00087139|4274504|P3|STARTED|Overall Study||36
1744961|NCT00087139|4274505|P2|STARTED|Overall Study||49
1744962|NCT00087139|4274506|P1|STARTED|Overall Study||39
1744963|NCT00087022|4274523|P2|NOT COMPLETED|Overall Study||55
1744964|NCT00087022|4274524|P1|NOT COMPLETED|Overall Study||54
1744965|NCT00087022|4274523|P2|COMPLETED|Overall Study||376
1744966|NCT00087022|4274524|P1|COMPLETED|Overall Study||379
1744967|NCT00087022|4274523|P2|Treated (Safety Population)|Overall Study||424
1744968|NCT00087022|4274524|P1|Treated (Safety Population)|Overall Study||431
1744969|NCT00087022|4274523|P2|STARTED|Overall Study||431
1744970|NCT00087022|4274524|P1|STARTED|Overall Study||433
1744971|NCT00086996|4274537|P1|NOT COMPLETED|Overall Study||64
1744972|NCT00086996|4274537|P1|COMPLETED|Overall Study||34
1744973|NCT00086996|4274537|P1|Eligible and Began Protocol Therapy|Overall Study||93
1744974|NCT00086996|4274537|P1|Eligible|Overall Study||93
1744975|NCT00086996|4274537|P1|STARTED|Overall Study||98
1744976|NCT00086957|4274544|P3|NOT COMPLETED|Overall Study||0
1744977|NCT00086957|4274545|P2|NOT COMPLETED|Overall Study||0
1744978|NCT00086957|4274546|P1|NOT COMPLETED|Overall Study||0
1744979|NCT00086957|4274544|P3|COMPLETED|Overall Study||22
1744980|NCT00086957|4274545|P2|COMPLETED|Overall Study||7
1744981|NCT00086957|4274546|P1|COMPLETED|Overall Study||2
1744982|NCT00086957|4274544|P3|STARTED|Overall Study||22
1744983|NCT00086957|4274545|P2|STARTED|Overall Study||7
1744984|NCT00086957|4274546|P1|STARTED|Overall Study||2
1744985|NCT00086684|4274559|P3|NOT COMPLETED|Overall Study||53
1744986|NCT00086684|4274560|P2|NOT COMPLETED|Overall Study||55
1744987|NCT00086684|4274561|P1|NOT COMPLETED|Overall Study||55
1744988|NCT00086684|4274559|P3|COMPLETED|Overall Study||69
1744989|NCT00086684|4274560|P2|COMPLETED|Overall Study||74
1744990|NCT00086684|4274561|P1|COMPLETED|Overall Study||63
1744991|NCT00086684|4274559|P3|STARTED|Overall Study||122
1744992|NCT00086684|4274560|P2|STARTED|Overall Study||129
1744993|NCT00086684|4274561|P1|STARTED|Overall Study||118
1744994|NCT00086619|4274574|P2|NOT COMPLETED|Overall Study||17
1744995|NCT00086619|4274575|P1|NOT COMPLETED|Overall Study||15
1744996|NCT00086619|4274574|P2|COMPLETED|Overall Study||23
1744997|NCT00086619|4274575|P1|COMPLETED|Overall Study||25
1744998|NCT00086619|4274574|P2|Completed 12 Month Visit|Overall Study||26
1744999|NCT00086619|4274575|P1|Completed 12 Month Visit|Overall Study||26
1745000|NCT00086619|4274574|P2|Completed Baseline Visit|Overall Study||36
1745001|NCT00086619|4274575|P1|Completed Baseline Visit|Overall Study||34
1745002|NCT00086619|4274574|P2|STARTED|Overall Study||40
1745003|NCT00086619|4274575|P1|STARTED|Overall Study||40
1745004|NCT00086580|4274585|P2|NOT COMPLETED|Observation Period||65
1745005|NCT00086580|4274586|P1|NOT COMPLETED|Observation Period||46
1745006|NCT00086580|4274585|P2|COMPLETED|Observation Period||56
1745007|NCT00086580|4274586|P1|COMPLETED|Observation Period||49
1745008|NCT00086580|4274585|P2|STARTED|Observation Period||121
1745009|NCT00086580|4274586|P1|STARTED|Observation Period||95
1745010|NCT00086580|4274585|P2|NOT COMPLETED|Follow-up Period||119
1745011|NCT00086580|4274586|P1|NOT COMPLETED|Follow-up Period||104
1745012|NCT00086580|4274585|P2|COMPLETED|Follow-up Period||18
1745013|NCT00086580|4274586|P1|COMPLETED|Follow-up Period||37
1745014|NCT00086580|4274585|P2|STARTED|Follow-up Period||137
1745015|NCT00086580|4274586|P1|STARTED|Follow-up Period||141
1745016|NCT00086580|4274585|P2|NOT COMPLETED|Treatment Period||60
1745017|NCT00086580|4274586|P1|NOT COMPLETED|Treatment Period||65
1745018|NCT00086580|4274585|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
1745019|NCT00086580|4274586|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
1745020|NCT00086580|4274585|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
1745021|NCT00086580|4274586|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
1745022|NCT00086580|4274585|P2|STARTED|Treatment Period||167
1745023|NCT00086580|4274586|P1|STARTED|Treatment Period||168
1745024|NCT00086411|4274634|P4|NOT COMPLETED|Overall Study||12
1745025|NCT00086411|4274635|P3|NOT COMPLETED|Overall Study||13
1745026|NCT00086411|4274636|P2|NOT COMPLETED|Overall Study||11
1745027|NCT00086411|4274637|P1|NOT COMPLETED|Overall Study||11
1745028|NCT00086411|4274634|P4|COMPLETED|Overall Study||53
1745029|NCT00086411|4274635|P3|COMPLETED|Overall Study||49
1745030|NCT00086411|4274636|P2|COMPLETED|Overall Study||52
1745031|NCT00086411|4274637|P1|COMPLETED|Overall Study||59
1745032|NCT00086411|4274634|P4|STARTED|Overall Study||65
1745033|NCT00086411|4274635|P3|STARTED|Overall Study||62
1745034|NCT00086411|4274636|P2|STARTED|Overall Study||63
1745035|NCT00086411|4274637|P1|STARTED|Overall Study||70
1745036|NCT00086385|4274651|P4|NOT COMPLETED|Overall Study||1
1745037|NCT00086385|4274652|P3|NOT COMPLETED|Overall Study||1
1745038|NCT00086385|4274653|P2|NOT COMPLETED|Overall Study||2
1745039|NCT00086385|4274654|P1|NOT COMPLETED|Overall Study||2
1745040|NCT00086385|4274651|P4|COMPLETED|Overall Study||98
1745041|NCT00086385|4274652|P3|COMPLETED|Overall Study||103
1745042|NCT00086385|4274653|P2|COMPLETED|Overall Study||97
1745043|NCT00086385|4274654|P1|COMPLETED|Overall Study||98
1745044|NCT00086385|4274651|P4|STARTED|Overall Study||99
1745045|NCT00086385|4274652|P3|STARTED|Overall Study||104
1745046|NCT00086385|4274653|P2|STARTED|Overall Study||99
1745047|NCT00086385|4274654|P1|STARTED|Overall Study||100
1745048|NCT00086515|4274666|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
1745049|NCT00086515|4274667|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
1745050|NCT00086515|4274666|P2|COMPLETED|Phase B (Weeks 24-104)||109
1745051|NCT00086515|4274667|P1|COMPLETED|Phase B (Weeks 24-104)||201
1745052|NCT00086515|4274666|P2|STARTED|Phase B (Weeks 24-104)||164
1745053|NCT00086515|4274667|P1|STARTED|Phase B (Weeks 24-104)||391
1745054|NCT00086515|4274666|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
1745055|NCT00086515|4274667|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
1745056|NCT00086515|4274666|P2|COMPLETED|Phase A to Phase B Transition Period||164
1745057|NCT00086515|4274667|P1|COMPLETED|Phase A to Phase B Transition Period||391
1745058|NCT00086515|4274666|P2|STARTED|Phase A to Phase B Transition Period||192
1745059|NCT00086515|4274667|P1|STARTED|Phase A to Phase B Transition Period||415
1745060|NCT00086515|4274666|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
1745061|NCT00086515|4274667|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
1745062|NCT00086515|4274666|P2|COMPLETED|Phase A (Weeks 0-24)||192
1745063|NCT00086515|4274667|P1|COMPLETED|Phase A (Weeks 0-24)||415
1745064|NCT00086515|4274666|P2|STARTED|Phase A (Weeks 0-24)||237
1745065|NCT00086515|4274667|P1|STARTED|Phase A (Weeks 0-24)||464
1745066|NCT00086502|4274679|P2|NOT COMPLETED|Overall Study||20
1745067|NCT00086502|4274680|P1|NOT COMPLETED|Overall Study||26
1745068|NCT00086502|4274679|P2|COMPLETED|Overall Study||158
1745069|NCT00086502|4274680|P1|COMPLETED|Overall Study||149
1745070|NCT00086502|4274679|P2|STARTED|Overall Study||178
1745071|NCT00086502|4274680|P1|STARTED|Overall Study||175
1745072|NCT00086450|4274690|P2|NOT COMPLETED|Overall Study||0
1745073|NCT00086450|4274691|P1|NOT COMPLETED|Overall Study||0
1745074|NCT00086450|4274690|P2|COMPLETED|Overall Study||947
1745075|NCT00086450|4274691|P1|COMPLETED|Overall Study||953
1745076|NCT00086450|4274690|P2|STARTED|Overall Study||947
1745077|NCT00086450|4274691|P1|STARTED|Overall Study||953
1745078|NCT00086346|4274705|P2|NOT COMPLETED|Patients Dosed With Test Article||23
1745079|NCT00086346|4274706|P1|NOT COMPLETED|Patients Dosed With Test Article||140
1745080|NCT00086346|4274705|P2|COMPLETED|Patients Dosed With Test Article||187
1745081|NCT00086346|4274706|P1|COMPLETED|Patients Dosed With Test Article||249
1745082|NCT00086346|4274705|P2|STARTED|Patients Dosed With Test Article||210
1745083|NCT00086346|4274706|P1|STARTED|Patients Dosed With Test Article||389
1745084|NCT00086346|4274705|P2|NOT COMPLETED|Randomization||4
1745085|NCT00086346|4274706|P1|NOT COMPLETED|Randomization||4
1745086|NCT00086346|4274705|P2|COMPLETED|Randomization||210
1745087|NCT00086346|4274706|P1|COMPLETED|Randomization||389
1745088|NCT00086346|4274705|P2|STARTED|Randomization||214
1745089|NCT00086346|4274706|P1|STARTED|Randomization||393
1745090|NCT00086281|4274733|P15|NOT COMPLETED|Phase 2||0
1745091|NCT00086281|4274734|P14|NOT COMPLETED|Phase 2||1
1745092|NCT00086281|4274735|P13|NOT COMPLETED|Phase 2||1
1745093|NCT00086281|4274736|P12|NOT COMPLETED|Phase 2||0
1745094|NCT00086281|4274737|P11|NOT COMPLETED|Phase 2||0
1745095|NCT00086281|4274738|P10|NOT COMPLETED|Phase 2||0
1745096|NCT00086281|4274739|P9|NOT COMPLETED|Phase 2||0
1745097|NCT00086281|4274740|P8|NOT COMPLETED|Phase 2||0
1745098|NCT00086281|4274741|P7|NOT COMPLETED|Phase 2||0
1745099|NCT00086281|4274742|P6|NOT COMPLETED|Phase 2||0
1745100|NCT00086281|4274743|P5|NOT COMPLETED|Phase 2||0
1745101|NCT00086281|4274744|P4|NOT COMPLETED|Phase 2||0
1745102|NCT00086281|4274745|P3|NOT COMPLETED|Phase 2||0
1745103|NCT00086281|4274746|P2|NOT COMPLETED|Phase 2||0
1745104|NCT00086281|4274747|P1|NOT COMPLETED|Phase 2||0
1745105|NCT00086281|4274733|P15|COMPLETED|Phase 2||0
1745106|NCT00086281|4274734|P14|COMPLETED|Phase 2||26
1745107|NCT00086281|4274735|P13|COMPLETED|Phase 2||22
1745108|NCT00086281|4274736|P12|COMPLETED|Phase 2||0
1745109|NCT00086281|4274737|P11|COMPLETED|Phase 2||0
1745110|NCT00086281|4274738|P10|COMPLETED|Phase 2||0
1745111|NCT00086281|4274739|P9|COMPLETED|Phase 2||0
1745112|NCT00086281|4274740|P8|COMPLETED|Phase 2||0
1745113|NCT00086281|4274741|P7|COMPLETED|Phase 2||0
1745114|NCT00086281|4274742|P6|COMPLETED|Phase 2||0
1745115|NCT00086281|4274743|P5|COMPLETED|Phase 2||0
1745116|NCT00086281|4274744|P4|COMPLETED|Phase 2||0
1745117|NCT00086281|4274745|P3|COMPLETED|Phase 2||0
1745118|NCT00086281|4274746|P2|COMPLETED|Phase 2||0
1745119|NCT00086281|4274747|P1|COMPLETED|Phase 2||0
1745120|NCT00086281|4274733|P15|STARTED|Phase 2||0
1745121|NCT00086281|4274734|P14|STARTED|Phase 2||27
1745122|NCT00086281|4274735|P13|STARTED|Phase 2||23
1745123|NCT00086281|4274736|P12|STARTED|Phase 2||0
1745124|NCT00086281|4274737|P11|STARTED|Phase 2||0
1745125|NCT00086281|4274738|P10|STARTED|Phase 2||0
1745126|NCT00086281|4274739|P9|STARTED|Phase 2||0
1745127|NCT00086281|4274740|P8|STARTED|Phase 2||0
1745128|NCT00086281|4274741|P7|STARTED|Phase 2||0
1745129|NCT00086281|4274742|P6|STARTED|Phase 2||0
1745130|NCT00086281|4274743|P5|STARTED|Phase 2||0
1745131|NCT00086281|4274744|P4|STARTED|Phase 2||0
1745132|NCT00086281|4274745|P3|STARTED|Phase 2||0
1745133|NCT00086281|4274746|P2|STARTED|Phase 2||0
1745134|NCT00086281|4274747|P1|STARTED|Phase 2||0
1745135|NCT00086281|4274733|P15|NOT COMPLETED|Phase 1||3
1745136|NCT00086281|4274734|P14|NOT COMPLETED|Phase 1||1
1745137|NCT00086281|4274735|P13|NOT COMPLETED|Phase 1||1
1745138|NCT00086281|4274736|P12|NOT COMPLETED|Phase 1||1
1745139|NCT00086281|4274737|P11|NOT COMPLETED|Phase 1||3
1745140|NCT00086281|4274738|P10|NOT COMPLETED|Phase 1||1
1745141|NCT00086281|4274739|P9|NOT COMPLETED|Phase 1||0
1745142|NCT00086281|4274740|P8|NOT COMPLETED|Phase 1||0
1745143|NCT00086281|4274741|P7|NOT COMPLETED|Phase 1||0
1745144|NCT00086281|4274742|P6|NOT COMPLETED|Phase 1||0
1745145|NCT00086281|4274743|P5|NOT COMPLETED|Phase 1||0
1745146|NCT00086281|4274744|P4|NOT COMPLETED|Phase 1||0
1745147|NCT00086281|4274745|P3|NOT COMPLETED|Phase 1||0
1745148|NCT00086281|4274746|P2|NOT COMPLETED|Phase 1||0
1745149|NCT00086281|4274747|P1|NOT COMPLETED|Phase 1||0
1745150|NCT00086281|4274733|P15|COMPLETED|Phase 1||0
1745151|NCT00086281|4274734|P14|COMPLETED|Phase 1||0
1745152|NCT00086281|4274735|P13|COMPLETED|Phase 1||0
1745153|NCT00086281|4274736|P12|COMPLETED|Phase 1||0
1745154|NCT00086281|4274737|P11|COMPLETED|Phase 1||0
1745155|NCT00086281|4274738|P10|COMPLETED|Phase 1||0
1745156|NCT00086281|4274739|P9|COMPLETED|Phase 1||2
1745157|NCT00086281|4274740|P8|COMPLETED|Phase 1||1
1745158|NCT00086281|4274741|P7|COMPLETED|Phase 1||1
1745159|NCT00086281|4274742|P6|COMPLETED|Phase 1||3
1745160|NCT00086281|4274743|P5|COMPLETED|Phase 1||1
1745161|NCT00086281|4274744|P4|COMPLETED|Phase 1||11
1745162|NCT00086281|4274745|P3|COMPLETED|Phase 1||8
1745163|NCT00086281|4274746|P2|COMPLETED|Phase 1||12
1745164|NCT00086281|4274747|P1|COMPLETED|Phase 1||11
1745165|NCT00086281|4274733|P15|STARTED|Phase 1||3
1745166|NCT00086281|4274734|P14|STARTED|Phase 1||1
1745167|NCT00086281|4274735|P13|STARTED|Phase 1||1
1745168|NCT00086281|4274736|P12|STARTED|Phase 1||1
1745169|NCT00086281|4274737|P11|STARTED|Phase 1||3
1745170|NCT00086281|4274738|P10|STARTED|Phase 1||1
1745171|NCT00086281|4274739|P9|STARTED|Phase 1||2
1745172|NCT00086281|4274740|P8|STARTED|Phase 1||1
1745173|NCT00086281|4274741|P7|STARTED|Phase 1||1
1745174|NCT00086281|4274742|P6|STARTED|Phase 1||3
1745175|NCT00086281|4274743|P5|STARTED|Phase 1||1
1745176|NCT00086281|4274744|P4|STARTED|Phase 1||11
1745177|NCT00086281|4274745|P3|STARTED|Phase 1||8
1745178|NCT00086281|4274746|P2|STARTED|Phase 1||12
1745179|NCT00086281|4274747|P1|STARTED|Phase 1||11
1745180|NCT00086307|4274760|P3|NOT COMPLETED|Overall Study||8
1745181|NCT00086307|4274761|P2|NOT COMPLETED|Overall Study||1
1745182|NCT00086307|4274762|P1|NOT COMPLETED|Overall Study||2
1745183|NCT00086307|4274760|P3|COMPLETED|Overall Study||5
1745184|NCT00086307|4274761|P2|COMPLETED|Overall Study||12
1745185|NCT00086307|4274762|P1|COMPLETED|Overall Study||11
1745186|NCT00086307|4274760|P3|STARTED|Overall Study||13
1745187|NCT00086307|4274761|P2|STARTED|Overall Study||13
1745188|NCT00086307|4274762|P1|STARTED|Overall Study||13
1745189|NCT00086190|4274773|P3|NOT COMPLETED|Overall Study||6
1745190|NCT00086190|4274774|P2|NOT COMPLETED|Overall Study||4
1745191|NCT00086190|4274775|P1|NOT COMPLETED|Overall Study||8
1745192|NCT00086190|4274773|P3|COMPLETED|Overall Study||33
1745193|NCT00086190|4274774|P2|COMPLETED|Overall Study||30
1745194|NCT00086190|4274775|P1|COMPLETED|Overall Study||34
1745195|NCT00086190|4274773|P3|STARTED|Overall Study||39
1745196|NCT00086190|4274774|P2|STARTED|Overall Study||34
1745197|NCT00086190|4274775|P1|STARTED|Overall Study||42
1745198|NCT00086138|4274833|P2|NOT COMPLETED|Overall Study||3
1745199|NCT00086138|4274834|P1|NOT COMPLETED|Overall Study||4
1745200|NCT00086138|4274833|P2|COMPLETED|Overall Study||64
1745201|NCT00086138|4274834|P1|COMPLETED|Overall Study||60
1745202|NCT00086138|4274833|P2|STARTED|Overall Study||67
1745203|NCT00086138|4274834|P1|STARTED|Overall Study||64
1745204|NCT00086047|4274844|P2|NOT COMPLETED|Overall Study||7
1745205|NCT00086047|4274845|P1|NOT COMPLETED|Overall Study||7
1745206|NCT00086047|4274844|P2|COMPLETED|Overall Study||50
1745207|NCT00086047|4274845|P1|COMPLETED|Overall Study||50
1745208|NCT00086047|4274844|P2|STARTED|Overall Study||57
1745209|NCT00086047|4274845|P1|STARTED|Overall Study||57
1745210|NCT00085917|4274853|P2|NOT COMPLETED|Overall Study||3
1745211|NCT00085917|4274854|P1|NOT COMPLETED|Overall Study||4
1745212|NCT00085917|4274853|P2|COMPLETED|Overall Study||11
1745213|NCT00085917|4274854|P1|COMPLETED|Overall Study||11
1745214|NCT00085917|4274853|P2|STARTED|Overall Study||14
1745215|NCT00085917|4274854|P1|STARTED|Overall Study||15
1745216|NCT00085839|4274866|P2|NOT COMPLETED|Overall Study||0
1745217|NCT00085839|4274867|P1|NOT COMPLETED|Overall Study||0
1745218|NCT00085839|4274866|P2|COMPLETED|Overall Study||51
1745219|NCT00085839|4274867|P1|COMPLETED|Overall Study||52
1745220|NCT00085839|4274866|P2|STARTED|Overall Study||51
1745221|NCT00085839|4274867|P1|STARTED|Overall Study||52
1745222|NCT00085735|4274883|P6|NOT COMPLETED|Overall Study||31
1745223|NCT00085735|4274884|P5|NOT COMPLETED|Overall Study||42
1745224|NCT00085735|4274885|P4|NOT COMPLETED|Overall Study||19
1745225|NCT00085735|4274886|P3|NOT COMPLETED|Overall Study||17
1745226|NCT00085735|4274887|P2|NOT COMPLETED|Overall Study||10
1745227|NCT00085735|4274888|P1|NOT COMPLETED|Overall Study||12
1745228|NCT00085735|4274883|P6|COMPLETED|Overall Study||115
1745229|NCT00085735|4274884|P5|COMPLETED|Overall Study||105
1745230|NCT00085735|4274885|P4|COMPLETED|Overall Study||46
1745231|NCT00085735|4274886|P3|COMPLETED|Overall Study||46
1745232|NCT00085735|4274887|P2|COMPLETED|Overall Study||54
1745233|NCT00085735|4274888|P1|COMPLETED|Overall Study||52
1745234|NCT00085735|4274883|P6|STARTED|Overall Study||146
1745235|NCT00085735|4274884|P5|STARTED|Overall Study||147
1745236|NCT00085735|4274885|P4|STARTED|Overall Study||65
1745237|NCT00085735|4274886|P3|STARTED|Overall Study||63
1745238|NCT00085735|4274887|P2|STARTED|Overall Study||64
1745239|NCT00085735|4274888|P1|STARTED|Overall Study||64
1745240|NCT00085709|4274916|P2|NOT COMPLETED|Overall Study||50
1745241|NCT00085709|4274917|P1|NOT COMPLETED|Overall Study||53
1745242|NCT00085709|4274916|P2|COMPLETED|Overall Study||270
1745243|NCT00085709|4274917|P1|COMPLETED|Overall Study||264
1745244|NCT00085709|4274916|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
1745245|NCT00085709|4274917|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
1745246|NCT00085709|4274916|P2|Eligible|Overall Study||301
1745247|NCT00085709|4274917|P1|Eligible|Overall Study||298
1745248|NCT00085709|4274916|P2|STARTED|Overall Study||320
1745249|NCT00085709|4274917|P1|STARTED|Overall Study||317
1745250|NCT00085644|4274933|P3|NOT COMPLETED|Open-Label Period||109
1745251|NCT00085644|4274934|P2|NOT COMPLETED|Open-Label Period||0
1745252|NCT00085644|4274935|P1|NOT COMPLETED|Open-Label Period||0
1745253|NCT00085644|4274933|P3|COMPLETED|Open-Label Period||202
1745254|NCT00085644|4274934|P2|COMPLETED|Open-Label Period||0
1745255|NCT00085644|4274935|P1|COMPLETED|Open-Label Period||0
1745256|NCT00085644|4274933|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
1745257|NCT00085644|4274934|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
1745258|NCT00085644|4274935|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
1745259|NCT00085644|4274933|P3|NOT COMPLETED|Double-Blind Period||0
1745260|NCT00085644|4274934|P2|NOT COMPLETED|Double-Blind Period||6
1745261|NCT00085644|4274935|P1|NOT COMPLETED|Double-Blind Period||13
1745262|NCT00085644|4274933|P3|COMPLETED|Double-Blind Period||0
1745263|NCT00085644|4274934|P2|COMPLETED|Double-Blind Period||101
1745264|NCT00085644|4274935|P1|COMPLETED|Double-Blind Period||195
1745265|NCT00085644|4274933|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
1745266|NCT00085644|4274934|P2|STARTED|Double-Blind Period||107
1745267|NCT00085644|4274935|P1|STARTED|Double-Blind Period||208
1745268|NCT00085631|4274976|P3|NOT COMPLETED|Overall Study||7
1745269|NCT00085631|4274977|P2|NOT COMPLETED|Overall Study||11
1745270|NCT00085631|4274978|P1|NOT COMPLETED|Overall Study||4
1745271|NCT00085631|4274976|P3|COMPLETED|Overall Study||32
1745272|NCT00085631|4274977|P2|COMPLETED|Overall Study||38
1745273|NCT00085631|4274978|P1|COMPLETED|Overall Study||9
1745274|NCT00085631|4274976|P3|STARTED|Overall Study||39
1745275|NCT00085631|4274977|P2|STARTED|Overall Study||49
1745276|NCT00085631|4274978|P1|STARTED|Overall Study||13
1745277|NCT00085566|4274988|P3|NOT COMPLETED|Overall Study||14
1745278|NCT00085566|4274989|P2|NOT COMPLETED|Overall Study||0
1745279|NCT00085566|4274990|P1|NOT COMPLETED|Overall Study||0
1745280|NCT00085566|4274988|P3|COMPLETED|Overall Study||43
1745281|NCT00085566|4274989|P2|COMPLETED|Overall Study||3
1745282|NCT00085566|4274990|P1|COMPLETED|Overall Study||3
1745283|NCT00085566|4274988|P3|STARTED|Overall Study||57
1745284|NCT00085566|4274989|P2|STARTED|Overall Study||3
1745285|NCT00085566|4274990|P1|STARTED|Overall Study||3
1745286|NCT00085540|4275000|P2|NOT COMPLETED|Overall Study||2
1745287|NCT00085540|4275001|P1|NOT COMPLETED|Overall Study||0
1745288|NCT00085540|4275000|P2|COMPLETED|Overall Study||40
1745289|NCT00085540|4275001|P1|COMPLETED|Overall Study||8
1745290|NCT00085540|4275000|P2|STARTED|Overall Study||42
1745291|NCT00085540|4275001|P1|STARTED|Overall Study||8
1745292|NCT00085436|4275008|P1|NOT COMPLETED|Overall Study||0
1745293|NCT00085436|4275008|P1|COMPLETED|Overall Study||18
1745294|NCT00085436|4275008|P1|STARTED|Overall Study||18
1745295|NCT00085423|4275013|P1|NOT COMPLETED|Overall Study||2
1745296|NCT00085423|4275013|P1|COMPLETED|Overall Study||18
1745297|NCT00085423|4275013|P1|STARTED|Overall Study||20
1745298|NCT00085410|4275019|P1|NOT COMPLETED|Overall Study||0
1745299|NCT00085410|4275019|P1|COMPLETED|Overall Study||20
1745300|NCT00085410|4275019|P1|STARTED|Overall Study||20
1745301|NCT00085293|4275033|P1|NOT COMPLETED|Overall Study||0
1745302|NCT00085293|4275033|P1|COMPLETED|Overall Study||12
1745303|NCT00085293|4275033|P1|STARTED|Overall Study||12
1745304|NCT00085254|4275046|P3|NOT COMPLETED|Overall Study||0
1745305|NCT00085254|4275047|P2|NOT COMPLETED|Overall Study||0
1745306|NCT00085254|4275048|P1|NOT COMPLETED|Overall Study||0
1745307|NCT00085254|4275046|P3|COMPLETED|Overall Study||48
1745308|NCT00085254|4275047|P2|COMPLETED|Overall Study||46
1745309|NCT00085254|4275048|P1|COMPLETED|Overall Study||18
1745310|NCT00085254|4275046|P3|STARTED|Overall Study||48
1745311|NCT00085254|4275047|P2|STARTED|Overall Study||46
1745312|NCT00085254|4275048|P1|STARTED|Overall Study||18
1745313|NCT00085202|4275064|P2|NOT COMPLETED|Overall Study||24
1745314|NCT00085202|4275065|P1|NOT COMPLETED|Overall Study||18
1745315|NCT00085202|4275064|P2|COMPLETED|Overall Study||120
1745316|NCT00085202|4275065|P1|COMPLETED|Overall Study||251
1745317|NCT00085202|4275064|P2|STARTED|Overall Study||144
1745318|NCT00085202|4275065|P1|STARTED|Overall Study||269
1745319|NCT00085098|4275086|P2|NOT COMPLETED|Overall Study||2
1745320|NCT00085098|4275087|P1|NOT COMPLETED|Overall Study||1
1745321|NCT00085098|4275086|P2|COMPLETED|Overall Study||11
1745322|NCT00085098|4275087|P1|COMPLETED|Overall Study||10
1745323|NCT00085098|4275086|P2|STARTED|Overall Study||13
1745324|NCT00085098|4275087|P1|STARTED|Overall Study||11
1745325|NCT00084864|4275101|P4|NOT COMPLETED|Overall Study||0
1745326|NCT00084864|4275102|P3|NOT COMPLETED|Overall Study||0
1745327|NCT00084864|4275103|P2|NOT COMPLETED|Overall Study||0
1745328|NCT00084864|4275104|P1|NOT COMPLETED|Overall Study||1
1745329|NCT00084864|4275101|P4|COMPLETED|Overall Study||4
1745330|NCT00084864|4275102|P3|COMPLETED|Overall Study||4
1745331|NCT00084864|4275103|P2|COMPLETED|Overall Study||7
1745332|NCT00084864|4275104|P1|COMPLETED|Overall Study||9
1745333|NCT00084864|4275101|P4|STARTED|Overall Study||4
1745334|NCT00084864|4275102|P3|STARTED|Overall Study||4
1745335|NCT00084864|4275103|P2|STARTED|Overall Study||7
1745336|NCT00084864|4275104|P1|STARTED|Overall Study||10
1745337|NCT00084838|4275130|P1|NOT COMPLETED|Overall Study||13
1745338|NCT00084838|4275130|P1|COMPLETED|Overall Study||12
1745339|NCT00084838|4275130|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
1745340|NCT00084838|4275130|P1|STARTED|Overall Study||25
1745341|NCT00084747|4275152|P1|NOT COMPLETED|Overall Study||13
1745342|NCT00084747|4275152|P1|COMPLETED|Overall Study||17
1745343|NCT00084747|4275152|P1|STARTED|Overall Study||30
1745344|NCT00084682|4275157|P1|NOT COMPLETED|Overall Study||1
1745345|NCT00084682|4275157|P1|COMPLETED|Overall Study||13
1745346|NCT00084682|4275157|P1|STARTED|Overall Study||14
1745347|NCT00084617|4275161|P1|NOT COMPLETED|Overall Study||9
1745348|NCT00084617|4275161|P1|COMPLETED|Overall Study||30
1745349|NCT00084617|4275161|P1|STARTED|Overall Study||39
1745350|NCT00084487|4275167|P1|NOT COMPLETED|Overall Study||1
1745351|NCT00084487|4275167|P1|COMPLETED|Overall Study||20
1745352|NCT00084487|4275167|P1|STARTED|Overall Study||21
1745353|NCT00084409|4275177|P2|NOT COMPLETED|Overall Study||12
1745354|NCT00084409|4275178|P1|NOT COMPLETED|Overall Study||15
1745355|NCT00084409|4275177|P2|COMPLETED|Overall Study|4 Current, 8 former|65
1745356|NCT00084409|4275178|P1|COMPLETED|Overall Study|9 current, 6 former|60
1745357|NCT00084409|4275177|P2|STARTED|Overall Study|41 current, 36 former|77
1745358|NCT00084409|4275178|P1|STARTED|Overall Study|40 Current, 35 former|75
1745359|NCT00084383|4275204|P1|NOT COMPLETED|Overall Study||47
1745360|NCT00084383|4275204|P1|COMPLETED|Overall Study||13
1745361|NCT00084383|4275204|P1|STARTED|Overall Study||60
1745362|NCT00084318|4275211|P2|NOT COMPLETED|Overall Study||13
1745363|NCT00084318|4275212|P1|NOT COMPLETED|Overall Study||22
1745364|NCT00084318|4275211|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
1745365|NCT00084318|4275212|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
1745366|NCT00084318|4275211|P2|STARTED|Overall Study||119
1745367|NCT00084318|4275212|P1|STARTED|Overall Study||119
1745368|NCT00084266|4275232|P2|NOT COMPLETED|Overall Study||423
1745369|NCT00084266|4275233|P1|NOT COMPLETED|Overall Study||441
1745370|NCT00084266|4275232|P2|COMPLETED|Overall Study||184
1745371|NCT00084266|4275233|P1|COMPLETED|Overall Study||177
1745372|NCT00084266|4275232|P2|Treated|Overall Study||587
1745373|NCT00084266|4275233|P1|Treated|Overall Study||597
1745374|NCT00084266|4275232|P2|STARTED|Overall Study||607
1745375|NCT00084266|4275233|P1|STARTED|Overall Study||618
1745376|NCT00084149|4275269|P2|NOT COMPLETED|Overall Study||5
1745377|NCT00084149|4275270|P1|NOT COMPLETED|Overall Study||8
1745378|NCT00084149|4275269|P2|COMPLETED|Overall Study||13
1745379|NCT00084149|4275270|P1|COMPLETED|Overall Study||28
1745380|NCT00084149|4275269|P2|STARTED|Overall Study||18
1745381|NCT00084149|4275270|P1|STARTED|Overall Study||36
1745382|NCT00084136|4275291|P3|NOT COMPLETED|NRTI Comparison||82
1745383|NCT00084136|4275292|P2|NOT COMPLETED|NRTI Comparison||0
1745384|NCT00084136|4275293|P1|NOT COMPLETED|NRTI Comparison||101
1745385|NCT00084136|4275291|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
1745386|NCT00084136|4275292|P2|COMPLETED|NRTI Comparison||0
1745387|NCT00084136|4275293|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
1745388|NCT00084136|4275291|P3|STARTED|NRTI Comparison||526
1745389|NCT00084136|4275292|P2|STARTED|NRTI Comparison||0
1745390|NCT00084136|4275293|P1|STARTED|NRTI Comparison||519
1745391|NCT00084136|4275291|P3|NOT COMPLETED|PI Comparison||0
1745392|NCT00084136|4275292|P2|NOT COMPLETED|PI Comparison||47
1745393|NCT00084136|4275293|P1|NOT COMPLETED|PI Comparison||55
1745394|NCT00084136|4275291|P3|COMPLETED|PI Comparison||0
1745395|NCT00084136|4275292|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
1745396|NCT00084136|4275293|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
1745397|NCT00084136|4275291|P3|STARTED|PI Comparison||0
1745398|NCT00084136|4275292|P2|STARTED|PI Comparison||526
1745399|NCT00084136|4275293|P1|STARTED|PI Comparison||519
1745400|NCT00084084|4275352|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
1745401|NCT00084084|4275352|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
1745402|NCT00084084|4275352|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
1745403|NCT00084084|4275352|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
1745404|NCT00084084|4275352|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
1745405|NCT00084084|4275352|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
1745406|NCT00083915|4275362|P2|NOT COMPLETED|Overall Study||37
1745407|NCT00083915|4275363|P1|NOT COMPLETED|Overall Study||50
1745408|NCT00083915|4275362|P2|COMPLETED|Overall Study||8
1745409|NCT00083915|4275363|P1|COMPLETED|Overall Study||2
1745410|NCT00083915|4275362|P2|STARTED|Overall Study||45
1745411|NCT00083915|4275363|P1|STARTED|Overall Study||52
1745412|NCT00083889|4275371|P2|NOT COMPLETED|Overall Study||375
1745413|NCT00083889|4275372|P1|NOT COMPLETED|Overall Study||375
1745414|NCT00083889|4275371|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
1745415|NCT00083889|4275372|P1|COMPLETED|Overall Study||0
1745416|NCT00083889|4275371|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
1745417|NCT00083889|4275372|P1|Received Treatment|Overall Study||375
1745418|NCT00083889|4275371|P2|STARTED|Overall Study||375
1745419|NCT00083889|4275372|P1|STARTED|Overall Study||375
1745420|NCT00004146|4275421|P1|NOT COMPLETED|Overall Study||0
1745421|NCT00004146|4275421|P1|COMPLETED|Overall Study||55
1745422|NCT00004146|4275421|P1|STARTED|Overall Study||55
1745423|NCT00083759|4275430|P2|NOT COMPLETED|Overall Study||83
1745424|NCT00083759|4275431|P1|NOT COMPLETED|Overall Study||84
1745425|NCT00083759|4275430|P2|COMPLETED|Overall Study||66
1745426|NCT00083759|4275431|P1|COMPLETED|Overall Study||66
1745427|NCT00083759|4275430|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
1745428|NCT00083759|4275431|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
1745429|NCT00083720|4275439|P1|NOT COMPLETED|Overall Study||0
1745430|NCT00083720|4275439|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
1745431|NCT00083720|4275439|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
1745432|NCT00083616|4275449|P1|NOT COMPLETED|Overall Study||31
1745433|NCT00083616|4275449|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
1745434|NCT00083616|4275449|P1|Received Study Medication|Overall Study||182
1745435|NCT00083616|4275449|P1|STARTED|Overall Study||185
1745436|NCT00083551|4275463|P2|NOT COMPLETED|Overall Study||0
1745437|NCT00083551|4275464|P1|NOT COMPLETED|Overall Study||0
1745438|NCT00083551|4275463|P2|COMPLETED|Overall Study||345
1745439|NCT00083551|4275464|P1|COMPLETED|Overall Study||323
1745440|NCT00083551|4275463|P2|STARTED|Overall Study||345
1745441|NCT00083551|4275464|P1|STARTED|Overall Study||323
1745442|NCT00083382|4275470|P1|NOT COMPLETED|Overall Study||0
1745443|NCT00083382|4275470|P1|COMPLETED|Overall Study||83
1745444|NCT00083382|4275470|P1|STARTED|Overall Study||83
1745445|NCT00082888|4275474|P1|NOT COMPLETED|Overall Study||22
1745446|NCT00082888|4275474|P1|COMPLETED|Overall Study||71
1745447|NCT00082888|4275474|P1|STARTED|Overall Study||93
1745448|NCT00082810|4275478|P1|NOT COMPLETED|Overall Study||31
1745449|NCT00082810|4275478|P1|COMPLETED|Overall Study||2
1745450|NCT00082810|4275478|P1|STARTED|Overall Study||33
1745451|NCT00082758|4275489|P3|NOT COMPLETED|Overall Study||0
1745452|NCT00082758|4275490|P2|NOT COMPLETED|Overall Study||17
1745453|NCT00082758|4275491|P1|NOT COMPLETED|Overall Study||15
1745454|NCT00082758|4275489|P3|COMPLETED|Overall Study||0
1745455|NCT00082758|4275490|P2|COMPLETED|Overall Study||7
1745456|NCT00082758|4275491|P1|COMPLETED|Overall Study||0
1745457|NCT00082758|4275489|P3|STARTED|Overall Study||0
1745458|NCT00082758|4275490|P2|STARTED|Overall Study||24
1745459|NCT00082758|4275491|P1|STARTED|Overall Study||15
1745460|NCT00082641|4275501|P2|NOT COMPLETED|Overall Study||0
1745461|NCT00082641|4275502|P1|NOT COMPLETED|Overall Study||0
1745462|NCT00082641|4275501|P2|COMPLETED|Overall Study||12
1745463|NCT00082641|4275502|P1|COMPLETED|Overall Study||11
1745464|NCT00082641|4275501|P2|STARTED|Overall Study||12
1745465|NCT00082641|4275502|P1|STARTED|Overall Study||11
1745466|NCT00083226|4275511|P1|NOT COMPLETED|Overall Study||42
1745467|NCT00083226|4275511|P1|COMPLETED|Overall Study||0
1745468|NCT00083226|4275511|P1|STARTED|Overall Study||42
1745469|NCT00083174|4275519|P3|NOT COMPLETED|Open-label Extension||0
1745470|NCT00083174|4275520|P2|NOT COMPLETED|Open-label Extension||0
1745471|NCT00083174|4275521|P1|NOT COMPLETED|Open-label Extension||0
1745472|NCT00083174|4275519|P3|COMPLETED|Open-label Extension||2831
1745473|NCT00083174|4275520|P2|COMPLETED|Open-label Extension||0
1745474|NCT00083174|4275521|P1|COMPLETED|Open-label Extension||0
1745475|NCT00083174|4275519|P3|STARTED|Open-label Extension||2831
1745476|NCT00083174|4275520|P2|STARTED|Open-label Extension||0
1745477|NCT00083174|4275521|P1|STARTED|Open-label Extension||0
1745478|NCT00083174|4275519|P3|NOT COMPLETED|Randomization Period||0
1745479|NCT00083174|4275520|P2|NOT COMPLETED|Randomization Period||0
1745480|NCT00083174|4275521|P1|NOT COMPLETED|Randomization Period||0
1745481|NCT00083174|4275519|P3|COMPLETED|Randomization Period||0
1745482|NCT00083174|4275520|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
1745483|NCT00083174|4275521|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
1745484|NCT00083174|4275519|P3|STARTED|Randomization Period||0
1745485|NCT00083174|4275520|P2|STARTED|Randomization Period||2275
1745486|NCT00083174|4275521|P1|STARTED|Randomization Period||2285
1745487|NCT00083122|4275543|P2|NOT COMPLETED|Overall Study||0
1745488|NCT00083122|4275544|P1|NOT COMPLETED|Overall Study||0
1745489|NCT00083122|4275543|P2|COMPLETED|Overall Study||5
1745490|NCT00083122|4275544|P1|COMPLETED|Overall Study||40
1745491|NCT00083122|4275543|P2|STARTED|Overall Study||5
1745492|NCT00083122|4275544|P1|STARTED|Overall Study||40
1745493|NCT00082628|4275555|P5|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
1745494|NCT00082628|4275556|P4|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
1745495|NCT00082628|4275557|P3|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
1745496|NCT00082628|4275558|P2|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
1745497|NCT00082628|4275559|P1|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
1745498|NCT00082628|4275555|P5|COMPLETED|Treatment Period II: Week 12 to Week 36||55
1745499|NCT00082628|4275556|P4|COMPLETED|Treatment Period II: Week 12 to Week 36||76
1745500|NCT00082628|4275557|P3|COMPLETED|Treatment Period II: Week 12 to Week 36||78
1745501|NCT00082628|4275558|P2|COMPLETED|Treatment Period II: Week 12 to Week 36||0
1745502|NCT00082628|4275559|P1|COMPLETED|Treatment Period II: Week 12 to Week 36||0
1745503|NCT00082628|4275555|P5|STARTED|Treatment Period II: Week 12 to Week 36||73
1745504|NCT00082628|4275556|P4|STARTED|Treatment Period II: Week 12 to Week 36||92
1745505|NCT00082628|4275557|P3|STARTED|Treatment Period II: Week 12 to Week 36||93
1745506|NCT00082628|4275558|P2|STARTED|Treatment Period II: Week 12 to Week 36||0
1745507|NCT00082628|4275559|P1|STARTED|Treatment Period II: Week 12 to Week 36||0
1745508|NCT00082628|4275555|P5|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1745509|NCT00082628|4275556|P4|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1745510|NCT00082628|4275557|P3|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1745511|NCT00082628|4275558|P2|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
1745512|NCT00082628|4275559|P1|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
1745513|NCT00082628|4275555|P5|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1745514|NCT00082628|4275556|P4|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1745515|NCT00082628|4275557|P3|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
1745516|NCT00082628|4275558|P2|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
1745517|NCT00082628|4275559|P1|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
1745518|NCT00082628|4275555|P5|STARTED|Treatment Period I (Week 1 to Week 12)||0
1745519|NCT00082628|4275556|P4|STARTED|Treatment Period I (Week 1 to Week 12)||0
1745520|NCT00082628|4275557|P3|STARTED|Treatment Period I (Week 1 to Week 12)||0
1745521|NCT00082628|4275558|P2|STARTED|Treatment Period I (Week 1 to Week 12)||245
1745522|NCT00082628|4275559|P1|STARTED|Treatment Period I (Week 1 to Week 12)||81
1745523|NCT00082433|4275579|P2|NOT COMPLETED|Overall Study||597
1745524|NCT00082433|4275580|P1|NOT COMPLETED|Overall Study||594
1745525|NCT00082433|4275579|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
1745526|NCT00082433|4275580|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
1745527|NCT00082433|4275579|P2|STARTED|Overall Study||612
1745528|NCT00082433|4275580|P1|STARTED|Overall Study||609
1745529|NCT00082381|4275600|P2|NOT COMPLETED|Overall Study||26
1745530|NCT00082381|4275601|P1|NOT COMPLETED|Overall Study||55
1745531|NCT00082381|4275600|P2|COMPLETED|Overall Study||242
1745532|NCT00082381|4275601|P1|COMPLETED|Overall Study||228
1745533|NCT00082381|4275600|P2|Received Treatment (Intent to Treat)|Overall Study||267
1745534|NCT00082381|4275601|P1|Received Treatment (Intent to Treat)|Overall Study||282
1745535|NCT00082381|4275600|P2|STARTED|Overall Study||268
1745536|NCT00082381|4275601|P1|STARTED|Overall Study||283
1745537|NCT00082407|4275621|P2|NOT COMPLETED|Overall Study||27
1745538|NCT00082407|4275622|P1|NOT COMPLETED|Overall Study||56
1745539|NCT00082407|4275621|P2|COMPLETED|Overall Study||223
1745540|NCT00082407|4275622|P1|COMPLETED|Overall Study||199
1745541|NCT00082407|4275621|P2|Received Treatment (Intent to Treat)|Overall Study||248
1745542|NCT00082407|4275622|P1|Received Treatment (Intent to Treat)|Overall Study||253
1745543|NCT00082407|4275621|P2|STARTED|Overall Study||250
1745544|NCT00082407|4275622|P1|STARTED|Overall Study||255
1745545|NCT00082368|4275640|P1|NOT COMPLETED|Overall Study||1
1745546|NCT00082368|4275640|P1|COMPLETED|Overall Study||11
1745547|NCT00082368|4275640|P1|STARTED|Overall Study||12
1745548|NCT00082355|4275645|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
1745549|NCT00082355|4275645|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
1745550|NCT00082355|4275645|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
1745551|NCT00082355|4275645|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
1745552|NCT00082355|4275645|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
1745553|NCT00082355|4275645|P1|STARTED|Initial Results of Thrombolytic Therapy||30
1745554|NCT00082342|4275652|P2|NOT COMPLETED|Overall Study||0
1745555|NCT00082342|4275653|P1|NOT COMPLETED|Overall Study||0
1745556|NCT00082342|4275652|P2|COMPLETED|Overall Study||12
1745557|NCT00082342|4275653|P1|COMPLETED|Overall Study||13
1745558|NCT00082342|4275652|P2|STARTED|Overall Study||12
1745559|NCT00082342|4275653|P1|STARTED|Overall Study||13
1745560|NCT00082329|4275673|P1|NOT COMPLETED|Overall Study||0
1745561|NCT00082329|4275673|P1|COMPLETED|Overall Study||9
1745562|NCT00082329|4275673|P1|STARTED|Overall Study||9
1745563|NCT00082173|4275679|P2|NOT COMPLETED|Overall Study||11
1745564|NCT00082173|4275680|P1|NOT COMPLETED|Overall Study||10
1745565|NCT00082173|4275679|P2|COMPLETED|Overall Study||61
1745566|NCT00082173|4275680|P1|COMPLETED|Overall Study||64
1745567|NCT00082173|4275679|P2|STARTED|Overall Study||72
1745568|NCT00082173|4275680|P1|STARTED|Overall Study||74
1745569|NCT00003726|4275688|P1|NOT COMPLETED|Overall Study||1
1745570|NCT00003726|4275688|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
1745571|NCT00003726|4275688|P1|STARTED|Overall Study||1
1745572|NCT00081939|4275692|P1|NOT COMPLETED|Overall Study||0
1745573|NCT00081939|4275692|P1|COMPLETED|Overall Study||303
1745574|NCT00081939|4275692|P1|STARTED|Overall Study||303
1745575|NCT00082017|4275696|P2|NOT COMPLETED|Overall Study||0
1745576|NCT00082017|4275697|P1|NOT COMPLETED|Overall Study||0
1745577|NCT00082017|4275696|P2|COMPLETED|Overall Study||9
1745578|NCT00082017|4275697|P1|COMPLETED|Overall Study||11
1745579|NCT00082017|4275696|P2|STARTED|Overall Study||9
1745580|NCT00082017|4275697|P1|STARTED|Overall Study||11
1745581|NCT00081861|4275713|P1|NOT COMPLETED|Overall Study||0
1745582|NCT00081861|4275713|P1|COMPLETED|Overall Study||13
1745583|NCT00081861|4275713|P1|STARTED|Overall Study||13
1745584|NCT00081770|4275720|P3|NOT COMPLETED|Overall Study||456
1745585|NCT00081770|4275721|P2|NOT COMPLETED|Overall Study||546
1745586|NCT00081770|4275722|P1|NOT COMPLETED|Overall Study||502
1745587|NCT00081770|4275720|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
1745588|NCT00081770|4275721|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
1745589|NCT00081770|4275722|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
1745590|NCT00081770|4275720|P3|STARTED|Overall Study||1035
1745591|NCT00081770|4275721|P2|STARTED|Overall Study||1016
1745592|NCT00081770|4275722|P1|STARTED|Overall Study||1019
1745593|NCT00081731|4275741|P2|NOT COMPLETED|Overall Study||8
1745594|NCT00081731|4275742|P1|NOT COMPLETED|Overall Study||8
1745595|NCT00081731|4275741|P2|COMPLETED|Overall Study||459
1745596|NCT00081731|4275742|P1|COMPLETED|Overall Study||472
1745597|NCT00081731|4275741|P2|STARTED|Overall Study||467
1745598|NCT00081731|4275742|P1|STARTED|Overall Study||480
1745599|NCT00081653|4275762|P2|NOT COMPLETED|Overall Study||37
1745600|NCT00081653|4275763|P1|NOT COMPLETED|Overall Study||47
1745601|NCT00081653|4275762|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
1745602|NCT00081653|4275763|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
1745603|NCT00081653|4275762|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
1745604|NCT00081653|4275763|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
1745605|NCT00081497|4275781|P2|NOT COMPLETED|Overall Study||2
1745606|NCT00081497|4275782|P1|NOT COMPLETED|Overall Study||3
1745607|NCT00081497|4275781|P2|COMPLETED|Overall Study||37
1745608|NCT00081497|4275782|P1|COMPLETED|Overall Study||25
1745609|NCT00081497|4275781|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
1745610|NCT00081497|4275782|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
1745611|NCT00081458|4275800|P3|NOT COMPLETED|Overall Study||4
1745612|NCT00081458|4275801|P2|NOT COMPLETED|Overall Study||8
1745613|NCT00081458|4275802|P1|NOT COMPLETED|Overall Study||1
1745614|NCT00081458|4275800|P3|COMPLETED|Overall Study||29
1745615|NCT00081458|4275801|P2|COMPLETED|Overall Study||27
1745616|NCT00081458|4275802|P1|COMPLETED|Overall Study||15
1745617|NCT00081458|4275800|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
1745618|NCT00081458|4275801|P2|Received Treatment|Overall Study||35
1745619|NCT00081458|4275802|P1|Received Treatment|Overall Study||16
1745620|NCT00081458|4275800|P3|STARTED|Overall Study||33
1745621|NCT00081458|4275801|P2|STARTED|Overall Study||35
1745622|NCT00081458|4275802|P1|STARTED|Overall Study||16
1745623|NCT00081328|4275816|P3|NOT COMPLETED|Overall Study||0
1745624|NCT00081328|4275817|P2|NOT COMPLETED|Overall Study||0
1745625|NCT00081328|4275818|P1|NOT COMPLETED|Overall Study||0
1745626|NCT00081328|4275816|P3|COMPLETED|Overall Study||234
1745627|NCT00081328|4275817|P2|COMPLETED|Overall Study||233
1745628|NCT00081328|4275818|P1|COMPLETED|Overall Study||232
1745629|NCT00081328|4275816|P3|STARTED|Overall Study||234
1745630|NCT00081328|4275817|P2|STARTED|Overall Study||233
1745631|NCT00081328|4275818|P1|STARTED|Overall Study||232
1745632|NCT00081289|4275858|P2|NOT COMPLETED|Overall Study||21
1745633|NCT00081289|4275859|P1|NOT COMPLETED|Overall Study||21
1745634|NCT00081289|4275858|P2|COMPLETED|Overall Study||52
1745635|NCT00081289|4275859|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
1745636|NCT00081289|4275858|P2|STARTED|Overall Study||73
1745637|NCT00081289|4275859|P1|STARTED|Overall Study||73
1745638|NCT00081263|4275867|P2|NOT COMPLETED|Overall Study||22
1745639|NCT00081263|4275868|P1|NOT COMPLETED|Overall Study||17
1745640|NCT00081263|4275867|P2|COMPLETED|Overall Study||41
1745641|NCT00081263|4275868|P1|COMPLETED|Overall Study||50
1745642|NCT00081263|4275867|P2|STARTED|Overall Study||63
1745643|NCT00081263|4275868|P1|STARTED|Overall Study||67
1745644|NCT00081159|4275878|P2|NOT COMPLETED|Overall Study||5
1745645|NCT00081159|4275879|P1|NOT COMPLETED|Overall Study||2
1745646|NCT00081159|4275878|P2|COMPLETED|Overall Study||35
1745647|NCT00081159|4275879|P1|COMPLETED|Overall Study||37
1745648|NCT00081159|4275878|P2|STARTED|Overall Study||40
1745649|NCT00081159|4275879|P1|STARTED|Overall Study||39
1745650|NCT00080938|4275889|P1|NOT COMPLETED|Overall Study||24
1745651|NCT00080938|4275889|P1|COMPLETED|Overall Study||2
1745652|NCT00080938|4275889|P1|Eligible and Treated|Overall Study||21
1745653|NCT00080938|4275889|P1|Began Protocol Therapy|Overall Study||25
1745654|NCT00080938|4275889|P1|STARTED|Overall Study||26
1745655|NCT00080912|4275898|P2|NOT COMPLETED|Overall Study||0
1745656|NCT00080912|4275899|P1|NOT COMPLETED|Overall Study||0
1745657|NCT00080912|4275898|P2|COMPLETED|Overall Study||425
1745658|NCT00080912|4275899|P1|COMPLETED|Overall Study||425
1745659|NCT00080912|4275898|P2|STARTED|Overall Study||425
1745660|NCT00080912|4275899|P1|STARTED|Overall Study||425
1745661|NCT00080899|4275905|P1|NOT COMPLETED|Overall Study||1
1745662|NCT00080899|4275905|P1|COMPLETED|Overall Study||22
1745663|NCT00080899|4275905|P1|STARTED|Overall Study||23
1745664|NCT00080535|4275910|P1|NOT COMPLETED|Overall Study||0
1745665|NCT00080535|4275910|P1|COMPLETED|Overall Study||10
1745666|NCT00080535|4275910|P1|STARTED|Overall Study||10
1745667|NCT00080483|4275917|P2|NOT COMPLETED|Overall Study||2
1745668|NCT00080483|4275918|P1|NOT COMPLETED|Overall Study||2
1745669|NCT00080483|4275917|P2|COMPLETED|Overall Study||16
1745670|NCT00080483|4275918|P1|COMPLETED|Overall Study||15
1745671|NCT00080483|4275917|P2|STARTED|Overall Study||18
1745672|NCT00080483|4275918|P1|STARTED|Overall Study||17
1745673|NCT00002525|4275926|P2|NOT COMPLETED|Overall Study||0
1745674|NCT00002525|4275927|P1|NOT COMPLETED|Overall Study||186
1745675|NCT00002525|4275926|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
1745676|NCT00002525|4275927|P1|COMPLETED|Overall Study||241
1745677|NCT00002525|4275926|P2|Dukes' B2 Stage|Overall Study||139
1745678|NCT00002525|4275927|P1|Dukes' B2 Stage|Overall Study||150
1745679|NCT00002525|4275926|P2|Dukes' B3 or C Stage|Overall Study||158
1745680|NCT00002525|4275927|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
1745681|NCT00002525|4275926|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
1745682|NCT00002525|4275927|P1|Treated|Overall Study||419
1745683|NCT00002525|4275926|P2|STARTED|Overall Study||428
1745684|NCT00002525|4275927|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
1745685|NCT00080470|4275943|P2|NOT COMPLETED|Overall Study||28
1745686|NCT00080470|4275944|P1|NOT COMPLETED|Overall Study||34
1745687|NCT00080470|4275943|P2|COMPLETED|Overall Study||14
1745688|NCT00080470|4275944|P1|COMPLETED|Overall Study||11
1745689|NCT00080470|4275943|P2|STARTED|Overall Study||42
1745690|NCT00080470|4275944|P1|STARTED|Overall Study||45
1745691|NCT00080301|4275954|P2|NOT COMPLETED|Overall Study||11
1745692|NCT00080301|4275955|P1|NOT COMPLETED|Overall Study||5
1745693|NCT00080301|4275954|P2|COMPLETED|Overall Study|Participants who are off treatment|366
1745694|NCT00080301|4275955|P1|COMPLETED|Overall Study|Participants who are off treatment|370
1745695|NCT00080301|4275954|P2|Still on Treatment|Overall Study||1
1745696|NCT00080301|4275955|P1|Still on Treatment|Overall Study||0
1745697|NCT00080301|4275954|P2|Never Treated|Overall Study||10
1745698|NCT00080301|4275955|P1|Never Treated|Overall Study||5
1745699|NCT00080301|4275954|P2|STARTED|Overall Study||377
1745700|NCT00080301|4275955|P1|STARTED|Overall Study||375
1745701|NCT00080288|4275975|P2|NOT COMPLETED|Overall Study||38
1745702|NCT00080288|4275976|P1|NOT COMPLETED|Overall Study||30
1745703|NCT00080288|4275975|P2|COMPLETED|Overall Study||89
1745704|NCT00080288|4275976|P1|COMPLETED|Overall Study||97
1745705|NCT00080288|4275975|P2|STARTED|Overall Study||127
1745706|NCT00080288|4275976|P1|STARTED|Overall Study||127
1745707|NCT00080223|4275984|P1|NOT COMPLETED|Overall Study||76
1745708|NCT00080223|4275984|P1|COMPLETED|Overall Study||7
1745709|NCT00080223|4275984|P1|STARTED|Overall Study||83
1745710|NCT00002540|4275994|P2|NOT COMPLETED|Overall Study||2464
1745711|NCT00002540|4275995|P1|NOT COMPLETED|Overall Study||801
1745712|NCT00002540|4275994|P2|COMPLETED|Overall Study||35876
1745713|NCT00002540|4275995|P1|COMPLETED|Overall Study||37544
1745714|NCT00002540|4275994|P2|STARTED|Overall Study||38340
1745715|NCT00002540|4275995|P1|STARTED|Overall Study||38345
1745716|NCT00080119|4276025|P4|NOT COMPLETED|Overall Study||163
1745717|NCT00080119|4276026|P3|NOT COMPLETED|Overall Study||165
1745718|NCT00080119|4276027|P2|NOT COMPLETED|Overall Study||62
1745719|NCT00080119|4276028|P1|NOT COMPLETED|Overall Study||56
1745720|NCT00080119|4276025|P4|COMPLETED|Overall Study||111
1745721|NCT00080119|4276026|P3|COMPLETED|Overall Study||108
1745722|NCT00080119|4276027|P2|COMPLETED|Overall Study||339
1745723|NCT00080119|4276028|P1|COMPLETED|Overall Study||347
1745724|NCT00080119|4276025|P4|STARTED|Overall Study||274
1745725|NCT00080119|4276026|P3|STARTED|Overall Study||273
1745726|NCT00080119|4276027|P2|STARTED|Overall Study||401
1745727|NCT00080119|4276028|P1|STARTED|Overall Study||403
1745728|NCT00079937|4276062|P2|NOT COMPLETED|Overall Study||32
1745729|NCT00079937|4276063|P1|NOT COMPLETED|Overall Study||69
1745730|NCT00079937|4276062|P2|COMPLETED|Overall Study||175
1745731|NCT00079937|4276063|P1|COMPLETED|Overall Study||352
1745732|NCT00079937|4276062|P2|STARTED|Overall Study||207
1745733|NCT00079937|4276063|P1|STARTED|Overall Study||421
1745734|NCT00009737|4276081|P2|NOT COMPLETED|Overall Study||123
1745735|NCT00009737|4276082|P1|NOT COMPLETED|Overall Study||170
1745736|NCT00009737|4276081|P2|COMPLETED|Overall Study||860
1745737|NCT00009737|4276082|P1|COMPLETED|Overall Study||834
1745738|NCT00009737|4276081|P2|STARTED|Overall Study||983
1745739|NCT00009737|4276082|P1|STARTED|Overall Study||1004
1745740|NCT00079781|4276101|P3|NOT COMPLETED|Follow-up Period||2
1745741|NCT00079781|4276102|P2|NOT COMPLETED|Follow-up Period||0
1745742|NCT00079781|4276103|P1|NOT COMPLETED|Follow-up Period||4
1745743|NCT00079781|4276101|P3|COMPLETED|Follow-up Period||12
1745744|NCT00079781|4276102|P2|COMPLETED|Follow-up Period||9
1745745|NCT00079781|4276103|P1|COMPLETED|Follow-up Period||38
1745746|NCT00079781|4276101|P3|STARTED|Follow-up Period||14
1745747|NCT00079781|4276102|P2|STARTED|Follow-up Period||9
1745748|NCT00079781|4276103|P1|STARTED|Follow-up Period||42
1745749|NCT00079781|4276101|P3|NOT COMPLETED|Evaluation Period||0
1745750|NCT00079781|4276102|P2|NOT COMPLETED|Evaluation Period||0
1745751|NCT00079781|4276103|P1|NOT COMPLETED|Evaluation Period||0
1745752|NCT00079781|4276101|P3|COMPLETED|Evaluation Period||14
1745753|NCT00079781|4276102|P2|COMPLETED|Evaluation Period||9
1745754|NCT00079781|4276103|P1|COMPLETED|Evaluation Period||42
1745755|NCT00079781|4276101|P3|STARTED|Evaluation Period||14
1745756|NCT00079781|4276102|P2|STARTED|Evaluation Period||9
1745757|NCT00079781|4276103|P1|STARTED|Evaluation Period||42
1745758|NCT00079781|4276101|P3|NOT COMPLETED|Pre-implant Period||1
1745759|NCT00079781|4276102|P2|NOT COMPLETED|Pre-implant Period||1
1745760|NCT00079781|4276103|P1|NOT COMPLETED|Pre-implant Period||3
1745761|NCT00079781|4276101|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
1745762|NCT00079781|4276102|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
1745763|NCT00079781|4276103|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
1745764|NCT00079781|4276101|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
1745765|NCT00079781|4276102|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
1745766|NCT00079781|4276103|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
1745767|NCT00079677|4276112|P2|NOT COMPLETED|Overall Study||14
1745768|NCT00079677|4276113|P1|NOT COMPLETED|Overall Study||20
1745769|NCT00079677|4276112|P2|COMPLETED|Overall Study||118
1745770|NCT00079677|4276113|P1|COMPLETED|Overall Study||111
1745771|NCT00079677|4276112|P2|STARTED|Overall Study||132
1745772|NCT00079677|4276113|P1|STARTED|Overall Study||131
1745773|NCT00002601|4276121|P1|NOT COMPLETED|Overall Study||0
1745774|NCT00002601|4276121|P1|COMPLETED|Overall Study||13
1745775|NCT00002601|4276121|P1|STARTED|Overall Study||13
1745776|NCT00079417|4276129|P1|NOT COMPLETED|Overall Study||9
1745777|NCT00079417|4276129|P1|COMPLETED|Overall Study||19
1745778|NCT00079417|4276129|P1|STARTED|Overall Study||28
1745779|NCT00079391|4276137|P1|NOT COMPLETED|Overall Study||1
1745780|NCT00079391|4276137|P1|COMPLETED|Overall Study||49
1745781|NCT00079391|4276137|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
1745782|NCT00079339|4276149|P3|NOT COMPLETED|Overall Study||6
1745783|NCT00079339|4276150|P2|NOT COMPLETED|Overall Study||39
1745784|NCT00079339|4276151|P1|NOT COMPLETED|Overall Study||5
1745785|NCT00079339|4276149|P3|COMPLETED|Overall Study||0
1745786|NCT00079339|4276150|P2|COMPLETED|Overall Study||1
1745787|NCT00079339|4276151|P1|COMPLETED|Overall Study||0
1745788|NCT00079339|4276149|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
1745789|NCT00079339|4276150|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
1745790|NCT00079339|4276151|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
1745791|NCT00079339|4276149|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
1745792|NCT00079339|4276150|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
1745793|NCT00079339|4276151|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
1745794|NCT00079339|4276149|P3|Enrolled in Phase I|Overall Study||6
1745795|NCT00079339|4276150|P2|Enrolled in Phase I|Overall Study||6
1745796|NCT00079339|4276151|P1|Enrolled in Phase I|Overall Study||5
1745797|NCT00079339|4276149|P3|STARTED|Overall Study||6
1745798|NCT00079339|4276150|P2|STARTED|Overall Study||40
1745799|NCT00079339|4276151|P1|STARTED|Overall Study||5
1745800|NCT00079326|4276167|P2|NOT COMPLETED|Overall Study||0
1745801|NCT00079326|4276168|P1|NOT COMPLETED|Overall Study||0
1745802|NCT00079326|4276167|P2|COMPLETED|Overall Study||24
1745803|NCT00079326|4276168|P1|COMPLETED|Overall Study||15
1745804|NCT00079326|4276167|P2|STARTED|Overall Study||24
1745805|NCT00079326|4276168|P1|STARTED|Overall Study||15
1745806|NCT00079274|4276182|P7|NOT COMPLETED|Overall Study||0
1745807|NCT00079274|4276183|P6|NOT COMPLETED|Overall Study||20
1745808|NCT00079274|4276184|P5|NOT COMPLETED|Overall Study||15
1745809|NCT00079274|4276185|P4|NOT COMPLETED|Overall Study||444
1745810|NCT00079274|4276186|P3|NOT COMPLETED|Overall Study||27
1745811|NCT00079274|4276187|P2|NOT COMPLETED|Overall Study||27
1745812|NCT00079274|4276188|P1|NOT COMPLETED|Overall Study||321
1745813|NCT00079274|4276182|P7|COMPLETED|Overall Study||332
1745814|NCT00079274|4276183|P6|COMPLETED|Overall Study||26
1745815|NCT00079274|4276184|P5|COMPLETED|Overall Study||30
1745816|NCT00079274|4276185|P4|COMPLETED|Overall Study||906
1745817|NCT00079274|4276186|P3|COMPLETED|Overall Study||84
1745818|NCT00079274|4276187|P2|COMPLETED|Overall Study||84
1745819|NCT00079274|4276188|P1|COMPLETED|Overall Study||1081
1745820|NCT00079274|4276182|P7|STARTED|Overall Study||332
1745821|NCT00079274|4276183|P6|STARTED|Overall Study||46
1745822|NCT00079274|4276184|P5|STARTED|Overall Study||45
1745823|NCT00079274|4276185|P4|STARTED|Overall Study||1350
1745824|NCT00079274|4276186|P3|STARTED|Overall Study||111
1745825|NCT00079274|4276187|P2|STARTED|Overall Study||111
1745826|NCT00079274|4276188|P1|STARTED|Overall Study||1402
1745827|NCT00079183|4276209|P1|NOT COMPLETED|Overall Study||7
1745828|NCT00079183|4276209|P1|COMPLETED|Overall Study||37
1745829|NCT00079183|4276209|P1|Drop Outs|Overall Study||7
1745830|NCT00079183|4276209|P1|STARTED|Overall Study||44
1745831|NCT00079040|4276224|P1|NOT COMPLETED|Overall Study||2
1745832|NCT00079040|4276224|P1|COMPLETED|Overall Study||63
1745833|NCT00079040|4276224|P1|STARTED|Overall Study||65
1745834|NCT00079001|4276232|P2|NOT COMPLETED|Overall Study||0
1745835|NCT00079001|4276233|P1|NOT COMPLETED|Overall Study||0
1745836|NCT00079001|4276232|P2|COMPLETED|Overall Study||322
1745837|NCT00079001|4276233|P1|COMPLETED|Overall Study||323
1745838|NCT00079001|4276232|P2|STARTED|Overall Study||322
1745839|NCT00079001|4276233|P1|STARTED|Overall Study||323
1745840|NCT00078949|4276247|P4|NOT COMPLETED|Maintenance||3
1745841|NCT00078949|4276248|P3|NOT COMPLETED|Maintenance||3
1745842|NCT00078949|4276249|P2|NOT COMPLETED|Maintenance||0
1745843|NCT00078949|4276250|P1|NOT COMPLETED|Maintenance||0
1745844|NCT00078949|4276247|P4|COMPLETED|Maintenance||112
1745845|NCT00078949|4276248|P3|COMPLETED|Maintenance||112
1745846|NCT00078949|4276249|P2|COMPLETED|Maintenance||0
1745847|NCT00078949|4276250|P1|COMPLETED|Maintenance||0
1745848|NCT00078949|4276247|P4|STARTED|Maintenance||115
1745849|NCT00078949|4276248|P3|STARTED|Maintenance||115
1745850|NCT00078949|4276249|P2|STARTED|Maintenance||0
1745851|NCT00078949|4276250|P1|STARTED|Maintenance||0
1745852|NCT00078949|4276247|P4|NOT COMPLETED|Salvage||0
1745853|NCT00078949|4276248|P3|NOT COMPLETED|Salvage||0
1745854|NCT00078949|4276249|P2|NOT COMPLETED|Salvage||5
1745855|NCT00078949|4276250|P1|NOT COMPLETED|Salvage||4
1745856|NCT00078949|4276247|P4|COMPLETED|Salvage||0
1745857|NCT00078949|4276248|P3|COMPLETED|Salvage||0
1745858|NCT00078949|4276249|P2|COMPLETED|Salvage||304
1745859|NCT00078949|4276250|P1|COMPLETED|Salvage||306
1745860|NCT00078949|4276247|P4|STARTED|Salvage||0
1745861|NCT00078949|4276248|P3|STARTED|Salvage||0
1745862|NCT00078949|4276249|P2|STARTED|Salvage||309
1745863|NCT00078949|4276250|P1|STARTED|Salvage||310
1745864|NCT00078767|4276264|P2|NOT COMPLETED|Overall Study||1
1745865|NCT00078767|4276265|P1|NOT COMPLETED|Overall Study||1
1745866|NCT00078767|4276264|P2|COMPLETED|Overall Study||11
1745867|NCT00078767|4276265|P1|COMPLETED|Overall Study||11
1745868|NCT00078767|4276264|P2|STARTED|Overall Study||12
1745869|NCT00078767|4276265|P1|STARTED|Overall Study||12
1745870|NCT00078754|4276282|P3|NOT COMPLETED|Overall Study||15
1745871|NCT00078754|4276283|P2|NOT COMPLETED|Overall Study||19
1745872|NCT00078754|4276284|P1|NOT COMPLETED|Overall Study||15
1745873|NCT00078754|4276282|P3|COMPLETED|Overall Study||16
1745874|NCT00078754|4276283|P2|COMPLETED|Overall Study||11
1745875|NCT00078754|4276284|P1|COMPLETED|Overall Study||14
1745876|NCT00078754|4276282|P3|STARTED|Overall Study||31
1745877|NCT00078754|4276283|P2|STARTED|Overall Study||30
1745878|NCT00078754|4276284|P1|STARTED|Overall Study||29
1745879|NCT00078728|4276294|P2|NOT COMPLETED|Overall Study||3
1745880|NCT00078728|4276295|P1|NOT COMPLETED|Overall Study||4
1745881|NCT00078728|4276294|P2|COMPLETED|Overall Study||17
1745882|NCT00078728|4276295|P1|COMPLETED|Overall Study||16
1745883|NCT00078728|4276294|P2|STARTED|Overall Study||20
1745884|NCT00078728|4276295|P1|STARTED|Overall Study||20
1745885|NCT00078715|4276303|P2|NOT COMPLETED|Second Intervention||0
1745886|NCT00078715|4276304|P1|NOT COMPLETED|Second Intervention||0
1745887|NCT00078715|4276303|P2|COMPLETED|Second Intervention||4
1745888|NCT00078715|4276304|P1|COMPLETED|Second Intervention||2
1745889|NCT00078715|4276303|P2|STARTED|Second Intervention||4
1745890|NCT00078715|4276304|P1|STARTED|Second Intervention||2
1745891|NCT00078715|4276303|P2|NOT COMPLETED|First Intervention||0
1745892|NCT00078715|4276304|P1|NOT COMPLETED|First Intervention||0
1745893|NCT00078715|4276303|P2|COMPLETED|First Intervention||4
1745894|NCT00078715|4276304|P1|COMPLETED|First Intervention||2
1745895|NCT00078715|4276303|P2|STARTED|First Intervention||4
1745896|NCT00078715|4276304|P1|STARTED|First Intervention||2
1745897|NCT00005947|4276312|P2|NOT COMPLETED|Overall Study||41
1745898|NCT00005947|4276313|P1|NOT COMPLETED|Overall Study||57
1745899|NCT00005947|4276312|P2|COMPLETED|Overall Study||4
1745900|NCT00005947|4276313|P1|COMPLETED|Overall Study||25
1745901|NCT00005947|4276312|P2|STARTED|Overall Study||45
1745902|NCT00005947|4276313|P1|STARTED|Overall Study||82
1745903|NCT00078559|4276321|P1|NOT COMPLETED|Overall Study||0
1745904|NCT00078559|4276321|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
1745905|NCT00078559|4276321|P1|STARTED|Overall Study||10
1745906|NCT00002597|4276349|P2|NOT COMPLETED|Overall Study||23
1745907|NCT00002597|4276350|P1|NOT COMPLETED|Overall Study||26
1745908|NCT00002597|4276349|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
1745909|NCT00002597|4276350|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
1745910|NCT00002597|4276349|P2|STARTED|Overall Study||1015
1745911|NCT00002597|4276350|P1|STARTED|Overall Study||1013
1745912|NCT00078377|4276375|P3|NOT COMPLETED|Overall Study||9
1745913|NCT00078377|4276376|P2|NOT COMPLETED|Overall Study||16
1745914|NCT00078377|4276377|P1|NOT COMPLETED|Overall Study||11
1745915|NCT00078377|4276375|P3|COMPLETED|Overall Study||55
1745916|NCT00078377|4276376|P2|COMPLETED|Overall Study||49
1745917|NCT00078377|4276377|P1|COMPLETED|Overall Study||56
1745918|NCT00078377|4276375|P3|STARTED|Overall Study||64
1745919|NCT00078377|4276376|P2|STARTED|Overall Study||65
1745920|NCT00078377|4276377|P1|STARTED|Overall Study||67
1745921|NCT00078338|4276392|P2|NOT COMPLETED|Overall Study||54
1745922|NCT00078338|4276393|P1|NOT COMPLETED|Overall Study||85
1745923|NCT00078338|4276392|P2|COMPLETED|Overall Study||324
1745924|NCT00078338|4276393|P1|COMPLETED|Overall Study||301
1745925|NCT00078338|4276392|P2|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
1745926|NCT00078338|4276393|P1|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
1745927|NCT00078338|4276392|P2|STARTED|Overall Study||378
1745928|NCT00078338|4276393|P1|STARTED|Overall Study||386
1745929|NCT00076687|4276402|P3|NOT COMPLETED|Overall Study||4
1745930|NCT00076687|4276403|P2|NOT COMPLETED|Overall Study||5
1745931|NCT00076687|4276404|P1|NOT COMPLETED|Overall Study||6
1745932|NCT00076687|4276402|P3|COMPLETED|Overall Study||51
1745933|NCT00076687|4276403|P2|COMPLETED|Overall Study||47
1745934|NCT00076687|4276404|P1|COMPLETED|Overall Study||42
1745935|NCT00076687|4276402|P3|STARTED|Overall Study||55
1745936|NCT00076687|4276403|P2|STARTED|Overall Study||52
1745937|NCT00076687|4276404|P1|STARTED|Overall Study||48
1745938|NCT00078403|4276424|P3|NOT COMPLETED|Overall Study||28
1745939|NCT00078403|4276425|P2|NOT COMPLETED|Overall Study||16
1745940|NCT00078403|4276426|P1|NOT COMPLETED|Overall Study||18
1745941|NCT00078403|4276424|P3|COMPLETED|Overall Study||141
1745942|NCT00078403|4276425|P2|COMPLETED|Overall Study||26
1745943|NCT00078403|4276426|P1|COMPLETED|Overall Study||26
1745944|NCT00078403|4276424|P3|STARTED|Overall Study||169
1745945|NCT00078403|4276425|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
1745946|NCT00078403|4276426|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
1745947|NCT00078325|4276486|P3|NOT COMPLETED|Overall Study||11
1745948|NCT00078325|4276487|P2|NOT COMPLETED|Overall Study||19
1745949|NCT00078325|4276488|P1|NOT COMPLETED|Overall Study||21
1745950|NCT00078325|4276486|P3|COMPLETED|Overall Study||120
1745951|NCT00078325|4276487|P2|COMPLETED|Overall Study||114
1745952|NCT00078325|4276488|P1|COMPLETED|Overall Study||110
1745953|NCT00078325|4276486|P3|STARTED|Overall Study||131
1745954|NCT00078325|4276487|P2|STARTED|Overall Study||133
1745955|NCT00078325|4276488|P1|STARTED|Overall Study||131
1745956|NCT00078312|4276499|P1|NOT COMPLETED|Overall Study||177
1745957|NCT00078312|4276499|P1|COMPLETED|Overall Study||151
1745958|NCT00078312|4276499|P1|STARTED|Overall Study||328
1745959|NCT00078286|4276505|P2|NOT COMPLETED|Overall Study||83
1745960|NCT00078286|4276506|P1|NOT COMPLETED|Overall Study||96
1745961|NCT00078286|4276505|P2|COMPLETED|Overall Study||152
1745962|NCT00078286|4276506|P1|COMPLETED|Overall Study||138
1745963|NCT00078286|4276505|P2|STARTED|Overall Study||235
1745964|NCT00078286|4276506|P1|STARTED|Overall Study||234
1745965|NCT00077974|4276514|P1|NOT COMPLETED|Overall Study||104
1745966|NCT00077974|4276514|P1|COMPLETED|Overall Study||2
1745967|NCT00077974|4276514|P1|STARTED|Overall Study||106
1745968|NCT00077857|4276531|P2|NOT COMPLETED|Overall Study||204
1745969|NCT00077857|4276532|P1|NOT COMPLETED|Overall Study||201
1745970|NCT00077857|4276531|P2|COMPLETED|Overall Study||31
1745971|NCT00077857|4276532|P1|COMPLETED|Overall Study||34
1745972|NCT00077857|4276531|P2|Safety Population: Actual Dose Received|Overall Study||248
1745973|NCT00077857|4276532|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
1745974|NCT00077857|4276531|P2|Received Study Drug|Overall Study||234
1745975|NCT00077857|4276532|P1|Received Study Drug|Overall Study||231
1745976|NCT00077857|4276531|P2|STARTED|Overall Study||235
1745977|NCT00077857|4276532|P1|STARTED|Overall Study||235
1745978|NCT00077766|4276552|P2|NOT COMPLETED|Overall Study||25
1745979|NCT00077766|4276553|P1|NOT COMPLETED|Overall Study||39
1745980|NCT00077766|4276552|P2|COMPLETED|Overall Study||131
1745981|NCT00077766|4276553|P1|COMPLETED|Overall Study||118
1745982|NCT00077766|4276552|P2|STARTED|Overall Study||156
1745983|NCT00077766|4276553|P1|STARTED|Overall Study||157
1745984|NCT00077922|4276571|P1|NOT COMPLETED|Overall Study||0
1745985|NCT00077922|4276571|P1|COMPLETED|Overall Study||15
1745986|NCT00077922|4276571|P1|STARTED|Overall Study||15
1745987|NCT00077675|4276578|P2|NOT COMPLETED|Overall Study||9
1745988|NCT00077675|4276579|P1|NOT COMPLETED|Overall Study||11
1745989|NCT00077675|4276578|P2|COMPLETED|Overall Study||89
1745990|NCT00077675|4276579|P1|COMPLETED|Overall Study||92
1745991|NCT00077675|4276578|P2|STARTED|Overall Study||98
1745992|NCT00077675|4276579|P1|STARTED|Overall Study||103
1745993|NCT00077649|4276589|P4|NOT COMPLETED|Overall Study||17
1745994|NCT00077649|4276590|P3|NOT COMPLETED|Overall Study||15
1745995|NCT00077649|4276591|P2|NOT COMPLETED|Overall Study||9
1745996|NCT00077649|4276592|P1|NOT COMPLETED|Overall Study||14
1745997|NCT00077649|4276589|P4|COMPLETED|Overall Study||30
1745998|NCT00077649|4276590|P3|COMPLETED|Overall Study||32
1745999|NCT00077649|4276591|P2|COMPLETED|Overall Study||38
1746000|NCT00077649|4276592|P1|COMPLETED|Overall Study||33
1746001|NCT00077649|4276589|P4|Completed 24 Weeks of Follow-up|Overall Study||31
1746002|NCT00077649|4276590|P3|Completed 24 Weeks of Follow-up|Overall Study||36
1746003|NCT00077649|4276591|P2|Completed 24 Weeks of Follow-up|Overall Study||40
1746004|NCT00077649|4276592|P1|Completed 24 Weeks of Follow-up|Overall Study||36
1746005|NCT00077649|4276589|P4|STARTED|Overall Study||47
1746006|NCT00077649|4276590|P3|STARTED|Overall Study||47
1746007|NCT00077649|4276591|P2|STARTED|Overall Study||47
1746008|NCT00077649|4276592|P1|STARTED|Overall Study||47
1746009|NCT00077636|4276640|P2|NOT COMPLETED|Overall Study||92
1746010|NCT00077636|4276641|P1|NOT COMPLETED|Overall Study||44
1746011|NCT00077636|4276640|P2|COMPLETED|Overall Study||641
1746012|NCT00077636|4276641|P1|COMPLETED|Overall Study||692
1746013|NCT00077636|4276640|P2|STARTED|Overall Study||733
1746014|NCT00077636|4276641|P1|STARTED|Overall Study||736
1746015|NCT00077623|4276662|P3|NOT COMPLETED|Overall Study||32
1746016|NCT00077623|4276663|P2|NOT COMPLETED|Overall Study||43
1746017|NCT00077623|4276664|P1|NOT COMPLETED|Overall Study||36
1746018|NCT00077623|4276662|P3|COMPLETED|Overall Study||159
1746019|NCT00077623|4276663|P2|COMPLETED|Overall Study||148
1746020|NCT00077623|4276664|P1|COMPLETED|Overall Study||154
1746021|NCT00077623|4276662|P3|STARTED|Overall Study||191
1746022|NCT00077623|4276663|P2|STARTED|Overall Study||191
1746023|NCT00077623|4276664|P1|STARTED|Overall Study||190
1746024|NCT00077610|4276699|P3|NOT COMPLETED|Overall Study||46
1746025|NCT00077610|4276700|P2|NOT COMPLETED|Overall Study||56
1746026|NCT00077610|4276701|P1|NOT COMPLETED|Overall Study||54
1746027|NCT00077610|4276699|P3|COMPLETED|Overall Study||180
1746028|NCT00077610|4276700|P2|COMPLETED|Overall Study||168
1746029|NCT00077610|4276701|P1|COMPLETED|Overall Study||169
1746030|NCT00077610|4276699|P3|Started Treatment|Overall Study||225
1746031|NCT00077610|4276700|P2|Started Treatment|Overall Study||220
1746032|NCT00077610|4276701|P1|Started Treatment|Overall Study||221
1746033|NCT00077610|4276699|P3|STARTED|Overall Study||226
1746034|NCT00077610|4276700|P2|STARTED|Overall Study||224
1746035|NCT00077610|4276701|P1|STARTED|Overall Study||223
1746036|NCT00077376|4276730|P1|NOT COMPLETED|Overall Study||22
1746037|NCT00077376|4276730|P1|COMPLETED|Overall Study||39
1746038|NCT00077376|4276730|P1|HER2+ in Central Testing|Overall Study||39
1746039|NCT00077376|4276730|P1|Treated|Overall Study||59
1746040|NCT00077376|4276730|P1|STARTED|Overall Study||61
1746041|NCT00077207|4276741|P1|NOT COMPLETED|Overall Study||30
1746042|NCT00077207|4276741|P1|COMPLETED|Overall Study||36
1746043|NCT00077207|4276741|P1|STARTED|Overall Study||66
1746044|NCT00077064|4276753|P2|NOT COMPLETED|Overall Study||6
1746045|NCT00077064|4276754|P1|NOT COMPLETED|Overall Study||0
1746046|NCT00077064|4276753|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
1746047|NCT00077064|4276754|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
1746048|NCT00077064|4276753|P2|STARTED|Overall Study||16
1746049|NCT00077064|4276754|P1|STARTED|Overall Study||17
1746050|NCT00076999|4276770|P5|NOT COMPLETED|Overall Study||25
1746051|NCT00076999|4276771|P4|NOT COMPLETED|Overall Study||1
1746052|NCT00076999|4276772|P3|NOT COMPLETED|Overall Study||17
1746053|NCT00076999|4276773|P2|NOT COMPLETED|Overall Study||24
1746054|NCT00076999|4276774|P1|NOT COMPLETED|Overall Study||12
1746055|NCT00076999|4276770|P5|COMPLETED|Overall Study||9
1746056|NCT00076999|4276771|P4|COMPLETED|Overall Study||5
1746057|NCT00076999|4276772|P3|COMPLETED|Overall Study||2
1746058|NCT00076999|4276773|P2|COMPLETED|Overall Study||7
1746059|NCT00076999|4276774|P1|COMPLETED|Overall Study||13
1746060|NCT00076999|4276770|P5|STARTED|Overall Study||34
1746061|NCT00076999|4276771|P4|STARTED|Overall Study||6
1746062|NCT00076999|4276772|P3|STARTED|Overall Study||19
1746063|NCT00076999|4276773|P2|STARTED|Overall Study||31
1746064|NCT00076999|4276774|P1|STARTED|Overall Study||25
1746065|NCT00003222|4276893|P2|NOT COMPLETED|Overall Study||1
1746066|NCT00003222|4276894|P1|NOT COMPLETED|Overall Study||0
1746067|NCT00003222|4276893|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
1746068|NCT00003222|4276894|P1|COMPLETED|Overall Study||13
1746069|NCT00003222|4276893|P2|STARTED|Overall Study||28
1746070|NCT00003222|4276894|P1|STARTED|Overall Study||13
1746071|NCT00076804|4276906|P2|NOT COMPLETED|Overall Study||69
1746072|NCT00076804|4276907|P1|NOT COMPLETED|Overall Study||60
1746073|NCT00076804|4276906|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
1746074|NCT00076804|4276907|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
1746075|NCT00076804|4276906|P2|STARTED|Overall Study||137
1746076|NCT00076804|4276907|P1|STARTED|Overall Study||137
1746077|NCT00076752|4276919|P1|NOT COMPLETED|Overall Study||3
1746078|NCT00076752|4276919|P1|COMPLETED|Overall Study||6
1746079|NCT00076752|4276919|P1|STARTED|Overall Study||9
1746080|NCT00076622|4276942|P4|NOT COMPLETED|Overall Study||0
1746081|NCT00076622|4276943|P3|NOT COMPLETED|Overall Study||0
1746082|NCT00076622|4276944|P2|NOT COMPLETED|Overall Study||0
1746083|NCT00076622|4276945|P1|NOT COMPLETED|Overall Study||0
1746084|NCT00076622|4276942|P4|COMPLETED|Overall Study||18
1746085|NCT00076622|4276943|P3|COMPLETED|Overall Study||40
1746086|NCT00076622|4276944|P2|COMPLETED|Overall Study||13
1746087|NCT00076622|4276945|P1|COMPLETED|Overall Study||23
1746088|NCT00076622|4276942|P4|STARTED|Overall Study||18
1746089|NCT00076622|4276943|P3|STARTED|Overall Study||40
1746090|NCT00076622|4276944|P2|STARTED|Overall Study||13
1746091|NCT00076622|4276945|P1|STARTED|Overall Study||23
1746092|NCT00076570|4276965|P2|NOT COMPLETED|Overall Study||8
1746093|NCT00076570|4276966|P1|NOT COMPLETED|Overall Study||8
1746094|NCT00076570|4276965|P2|COMPLETED|Overall Study||8
1746095|NCT00076570|4276966|P1|COMPLETED|Overall Study||7
1746096|NCT00076570|4276965|P2|STARTED|Overall Study||16
1746097|NCT00076570|4276966|P1|STARTED|Overall Study||15
1746098|NCT00003298|4276974|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
1746099|NCT00003298|4276974|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
1746100|NCT00003298|4276974|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
1746101|NCT00003298|4276974|P1|STARTED|Step 2 (Adjuvant Therapy)||10
1746102|NCT00003298|4276974|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
1746103|NCT00003298|4276974|P1|COMPLETED|Re-register to Step 2 After Surgery||10
1746104|NCT00003298|4276974|P1|STARTED|Re-register to Step 2 After Surgery||28
1746105|NCT00003298|4276974|P1|NOT COMPLETED|Surgery||7
1746106|NCT00003298|4276974|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
1746107|NCT00003298|4276974|P1|STARTED|Surgery||35
1746108|NCT00003298|4276974|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
1746109|NCT00003298|4276974|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
1746110|NCT00003298|4276974|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
1746111|NCT00003298|4276974|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
1746112|NCT00003298|4276974|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
1746113|NCT00076336|4276984|P2|NOT COMPLETED|Overall Study||56
1746114|NCT00076336|4276985|P1|NOT COMPLETED|Overall Study||52
1746115|NCT00076336|4276984|P2|COMPLETED|Overall Study||60
1746116|NCT00076336|4276985|P1|COMPLETED|Overall Study||64
1746117|NCT00076336|4276984|P2|Completed Week 104|Overall Study||62
1746118|NCT00076336|4276985|P1|Completed Week 104|Overall Study||70
1746119|NCT00076336|4276984|P2|Completed Week 52|Overall Study||94
1746120|NCT00076336|4276985|P1|Completed Week 52|Overall Study||97
1746121|NCT00076336|4276984|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
1746122|NCT00076336|4276985|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
1746123|NCT00076336|4276984|P2|Safety Population|Overall Study||116
1746124|NCT00076336|4276985|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
1746125|NCT00076336|4276984|P2|STARTED|Overall Study||116
1746126|NCT00076336|4276985|P1|STARTED|Overall Study||116
1746127|NCT00076258|4277001|P2|NOT COMPLETED|Overall Study||3
1746128|NCT00076258|4277002|P1|NOT COMPLETED|Overall Study||1
1746129|NCT00076258|4277001|P2|COMPLETED|Overall Study||61
1746130|NCT00076258|4277002|P1|COMPLETED|Overall Study||61
1746131|NCT00076258|4277001|P2|STARTED|Overall Study||64
1746132|NCT00076258|4277002|P1|STARTED|Overall Study||62
1746133|NCT00076245|4277012|P4|NOT COMPLETED|Overall Study||1
1746134|NCT00076245|4277013|P3|NOT COMPLETED|Overall Study||0
1746135|NCT00076245|4277014|P2|NOT COMPLETED|Overall Study||0
1746136|NCT00076245|4277015|P1|NOT COMPLETED|Overall Study||0
1746137|NCT00076245|4277012|P4|COMPLETED|Overall Study||14
1746138|NCT00076245|4277013|P3|COMPLETED|Overall Study||15
1746139|NCT00076245|4277014|P2|COMPLETED|Overall Study||15
1746140|NCT00076245|4277015|P1|COMPLETED|Overall Study||16
1746141|NCT00076245|4277012|P4|STARTED|Overall Study||15
1746142|NCT00076245|4277013|P3|STARTED|Overall Study||15
1746143|NCT00076245|4277014|P2|STARTED|Overall Study||15
1746144|NCT00076245|4277015|P1|STARTED|Overall Study||16
1746145|NCT00076219|4277031|P2|NOT COMPLETED|Overall Study||11
1746146|NCT00076219|4277032|P1|NOT COMPLETED|Overall Study||18
1746147|NCT00076219|4277031|P2|COMPLETED|Overall Study||550
1746148|NCT00076219|4277032|P1|COMPLETED|Overall Study||545
1746149|NCT00076219|4277031|P2|STARTED|Overall Study||561
1746150|NCT00076219|4277032|P1|STARTED|Overall Study||563
1746151|NCT00076102|4277038|P1|NOT COMPLETED|Overall Study||5
1746152|NCT00076102|4277038|P1|COMPLETED|Overall Study||31
1746153|NCT00076102|4277038|P1|STARTED|Overall Study||36
1746154|NCT00076050|4277052|P2|NOT COMPLETED|Overall Study||43
1746155|NCT00076050|4277053|P1|NOT COMPLETED|Overall Study||23
1746156|NCT00076050|4277052|P2|COMPLETED|Overall Study||83
1746157|NCT00076050|4277053|P1|COMPLETED|Overall Study||99
1746158|NCT00076050|4277052|P2|STARTED|Overall Study||126
1746159|NCT00076050|4277053|P1|STARTED|Overall Study||122
1746160|NCT00076024|4277066|P4|NOT COMPLETED|Phase 2, Open-label||16
1746161|NCT00076024|4277067|P3|NOT COMPLETED|Phase 2, Open-label||0
1746162|NCT00076024|4277068|P2|NOT COMPLETED|Phase 2, Open-label||0
1746163|NCT00076024|4277069|P1|NOT COMPLETED|Phase 2, Open-label||0
1746164|NCT00076024|4277066|P4|COMPLETED|Phase 2, Open-label||0
1746165|NCT00076024|4277067|P3|COMPLETED|Phase 2, Open-label||0
1746166|NCT00076024|4277068|P2|COMPLETED|Phase 2, Open-label||0
1746167|NCT00076024|4277069|P1|COMPLETED|Phase 2, Open-label||0
1746168|NCT00076024|4277066|P4|STARTED|Phase 2, Open-label||16
1746169|NCT00076024|4277067|P3|STARTED|Phase 2, Open-label||0
1746170|NCT00076024|4277068|P2|STARTED|Phase 2, Open-label||0
1746171|NCT00076024|4277069|P1|STARTED|Phase 2, Open-label||0
1746172|NCT00076024|4277066|P4|NOT COMPLETED|Phase 2, Double-blind||0
1746173|NCT00076024|4277067|P3|NOT COMPLETED|Phase 2, Double-blind||56
1746174|NCT00076024|4277068|P2|NOT COMPLETED|Phase 2, Double-blind||112
1746175|NCT00076024|4277069|P1|NOT COMPLETED|Phase 2, Double-blind||0
1746176|NCT00076024|4277066|P4|COMPLETED|Phase 2, Double-blind||0
1746177|NCT00076024|4277067|P3|COMPLETED|Phase 2, Double-blind||0
1746178|NCT00076024|4277068|P2|COMPLETED|Phase 2, Double-blind||0
1746179|NCT00076024|4277069|P1|COMPLETED|Phase 2, Double-blind||0
1746180|NCT00076024|4277066|P4|Treated|Phase 2, Double-blind||0
1746181|NCT00076024|4277067|P3|Treated|Phase 2, Double-blind||56
1746182|NCT00076024|4277068|P2|Treated|Phase 2, Double-blind||111
1746183|NCT00076024|4277069|P1|Treated|Phase 2, Double-blind||0
1746184|NCT00076024|4277066|P4|STARTED|Phase 2, Double-blind||0
1746185|NCT00076024|4277067|P3|STARTED|Phase 2, Double-blind||56
1746186|NCT00076024|4277068|P2|STARTED|Phase 2, Double-blind||112
1746187|NCT00076024|4277069|P1|STARTED|Phase 2, Double-blind||0
1746188|NCT00076024|4277066|P4|NOT COMPLETED|Phase 1, Lead-in||0
1746189|NCT00076024|4277067|P3|NOT COMPLETED|Phase 1, Lead-in||0
1746190|NCT00076024|4277068|P2|NOT COMPLETED|Phase 1, Lead-in||0
1746191|NCT00076024|4277069|P1|NOT COMPLETED|Phase 1, Lead-in||6
1746192|NCT00076024|4277066|P4|COMPLETED|Phase 1, Lead-in||0
1746193|NCT00076024|4277067|P3|COMPLETED|Phase 1, Lead-in||0
1746194|NCT00076024|4277068|P2|COMPLETED|Phase 1, Lead-in||0
1746195|NCT00076024|4277069|P1|COMPLETED|Phase 1, Lead-in||0
1746196|NCT00076024|4277066|P4|STARTED|Phase 1, Lead-in||0
1746197|NCT00076024|4277067|P3|STARTED|Phase 1, Lead-in||0
1746198|NCT00076024|4277068|P2|STARTED|Phase 1, Lead-in||0
1746199|NCT00076024|4277069|P1|STARTED|Phase 1, Lead-in||6
1746200|NCT00076011|4277083|P1|NOT COMPLETED|Overall Study||52
1746201|NCT00076011|4277083|P1|COMPLETED|Overall Study||0
1746202|NCT00076011|4277083|P1|STARTED|Overall Study||52
1746203|NCT00075946|4277095|P5|NOT COMPLETED|Overall Study||188
1746204|NCT00075946|4277096|P4|NOT COMPLETED|Overall Study||30
1746205|NCT00075946|4277097|P3|NOT COMPLETED|Overall Study||28
1746206|NCT00075946|4277098|P2|NOT COMPLETED|Overall Study||151
1746207|NCT00075946|4277099|P1|NOT COMPLETED|Overall Study||148
1746208|NCT00075946|4277095|P5|COMPLETED|Overall Study||0
1746209|NCT00075946|4277096|P4|COMPLETED|Overall Study||0
1746210|NCT00075946|4277097|P3|COMPLETED|Overall Study||0
1746211|NCT00075946|4277098|P2|COMPLETED|Overall Study||0
1746212|NCT00075946|4277099|P1|COMPLETED|Overall Study||0
1746213|NCT00075946|4277095|P5|Included in Primary Analysis|Overall Study||0
1746214|NCT00075946|4277096|P4|Included in Primary Analysis|Overall Study||29
1746215|NCT00075946|4277097|P3|Included in Primary Analysis|Overall Study||23
1746216|NCT00075946|4277098|P2|Included in Primary Analysis|Overall Study||146
1746217|NCT00075946|4277099|P1|Included in Primary Analysis|Overall Study||143
1746218|NCT00075946|4277095|P5|Treated and With Toxicity Data Available|Overall Study||154
1746219|NCT00075946|4277096|P4|Treated and With Toxicity Data Available|Overall Study||29
1746220|NCT00075946|4277097|P3|Treated and With Toxicity Data Available|Overall Study||27
1746221|NCT00075946|4277098|P2|Treated and With Toxicity Data Available|Overall Study||148
1746222|NCT00075946|4277099|P1|Treated and With Toxicity Data Available|Overall Study||142
1746223|NCT00075946|4277095|P5|STARTED|Overall Study||188
1746224|NCT00075946|4277096|P4|STARTED|Overall Study||30
1746225|NCT00075946|4277097|P3|STARTED|Overall Study||28
1746226|NCT00075946|4277098|P2|STARTED|Overall Study||151
1746227|NCT00075946|4277099|P1|STARTED|Overall Study||148
1746228|NCT00075881|4277114|P1|NOT COMPLETED|Overall Study||43
1746229|NCT00075881|4277114|P1|COMPLETED|Overall Study||1
1746230|NCT00075881|4277114|P1|Reinduction Treatment|Overall Study||7
1746231|NCT00075881|4277114|P1|Maintenance Treatment|Overall Study||15
1746232|NCT00075881|4277114|P1|Induction Treatment|Overall Study||42
1746233|NCT00075881|4277114|P1|Treated|Overall Study||42
1746234|NCT00075881|4277114|P1|Eligible|Overall Study||43
1746235|NCT00075881|4277114|P1|STARTED|Overall Study||44
1746236|NCT00075829|4277125|P4|NOT COMPLETED|Overall Study||24
1746237|NCT00075829|4277126|P3|NOT COMPLETED|Overall Study||34
1746238|NCT00075829|4277127|P2|NOT COMPLETED|Overall Study||118
1746239|NCT00075829|4277128|P1|NOT COMPLETED|Overall Study||258
1746240|NCT00075829|4277125|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
1746241|NCT00075829|4277126|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
1746242|NCT00075829|4277127|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
1746243|NCT00075829|4277128|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
1746244|NCT00075829|4277125|P4|STARTED|Overall Study||37
1746245|NCT00075829|4277126|P3|STARTED|Overall Study||48
1746246|NCT00075829|4277127|P2|STARTED|Overall Study||189
1746247|NCT00075829|4277128|P1|STARTED|Overall Study||436
1746248|NCT00075816|4277158|P2|NOT COMPLETED|Overall Study||11
1746249|NCT00075816|4277159|P1|NOT COMPLETED|Overall Study||14
1746250|NCT00075816|4277158|P2|COMPLETED|Overall Study||262
1746251|NCT00075816|4277159|P1|COMPLETED|Overall Study||264
1746252|NCT00075816|4277158|P2|STARTED|Overall Study||273
1746253|NCT00075816|4277159|P1|STARTED|Overall Study||278
1746254|NCT00075803|4277199|P2|NOT COMPLETED|Overall Study||0
1746255|NCT00075803|4277200|P1|NOT COMPLETED|Overall Study||0
1746256|NCT00075803|4277199|P2|COMPLETED|Overall Study||305
1746257|NCT00075803|4277200|P1|COMPLETED|Overall Study||295
1746258|NCT00075803|4277199|P2|STARTED|Overall Study||305
1746259|NCT00075803|4277200|P1|STARTED|Overall Study||295
1746260|NCT00075764|4277228|P2|NOT COMPLETED|Overall Study||349
1746261|NCT00075764|4277229|P1|NOT COMPLETED|Overall Study||345
1746262|NCT00075764|4277228|P2|COMPLETED|Overall Study||0
1746263|NCT00075764|4277229|P1|COMPLETED|Overall Study||0
1746264|NCT00075764|4277228|P2|STARTED|Overall Study||349
1746265|NCT00075764|4277229|P1|STARTED|Overall Study||345
1746266|NCT00075725|4277253|P12|NOT COMPLETED|Overall Study||18
1746267|NCT00075725|4277254|P11|NOT COMPLETED|Overall Study||9
1746268|NCT00075725|4277255|P10|NOT COMPLETED|Overall Study||18
1746269|NCT00075725|4277256|P9|NOT COMPLETED|Overall Study||117
1746270|NCT00075725|4277257|P8|NOT COMPLETED|Overall Study||295
1746271|NCT00075725|4277258|P7|NOT COMPLETED|Overall Study||75
1746272|NCT00075725|4277259|P6|NOT COMPLETED|Overall Study||313
1746273|NCT00075725|4277260|P5|NOT COMPLETED|Overall Study||66
1746274|NCT00075725|4277261|P4|NOT COMPLETED|Overall Study||78
1746275|NCT00075725|4277262|P3|NOT COMPLETED|Overall Study||121
1746276|NCT00075725|4277263|P2|NOT COMPLETED|Overall Study||49
1746277|NCT00075725|4277264|P1|NOT COMPLETED|Overall Study||74
1746278|NCT00075725|4277253|P12|COMPLETED|Overall Study||10
1746279|NCT00075725|4277254|P11|COMPLETED|Overall Study||3
1746280|NCT00075725|4277255|P10|COMPLETED|Overall Study||16
1746281|NCT00075725|4277256|P9|COMPLETED|Overall Study||185
1746282|NCT00075725|4277257|P8|COMPLETED|Overall Study||401
1746283|NCT00075725|4277258|P7|COMPLETED|Overall Study||171
1746284|NCT00075725|4277259|P6|COMPLETED|Overall Study||397
1746285|NCT00075725|4277260|P5|COMPLETED|Overall Study||166
1746286|NCT00075725|4277261|P4|COMPLETED|Overall Study||168
1746287|NCT00075725|4277262|P3|COMPLETED|Overall Study||175
1746288|NCT00075725|4277263|P2|COMPLETED|Overall Study||57
1746289|NCT00075725|4277264|P1|COMPLETED|Overall Study||172
1746290|NCT00075725|4277253|P12|STARTED|Overall Study||28
1746291|NCT00075725|4277254|P11|STARTED|Overall Study||12
1746292|NCT00075725|4277255|P10|STARTED|Overall Study||34
1746293|NCT00075725|4277256|P9|STARTED|Overall Study||302
1746294|NCT00075725|4277257|P8|STARTED|Overall Study||696
1746295|NCT00075725|4277258|P7|STARTED|Overall Study||246
1746296|NCT00075725|4277259|P6|STARTED|Overall Study||710
1746297|NCT00075725|4277260|P5|STARTED|Overall Study||232
1746298|NCT00075725|4277261|P4|STARTED|Overall Study||246
1746299|NCT00075725|4277262|P3|STARTED|Overall Study||296
1746300|NCT00075725|4277263|P2|STARTED|Overall Study||106
1746301|NCT00075725|4277264|P1|STARTED|Overall Study||246
1746302|NCT00075608|4277353|P1|NOT COMPLETED|Overall Study||0
1746303|NCT00075608|4277353|P1|COMPLETED|Overall Study||12
1746304|NCT00075608|4277353|P1|STARTED|Overall Study||12
1746305|NCT00075582|4277361|P2|NOT COMPLETED|Overall Study||35
1746306|NCT00075582|4277362|P1|NOT COMPLETED|Overall Study||50
1746307|NCT00075582|4277361|P2|COMPLETED|Overall Study||50
1746308|NCT00075582|4277362|P1|COMPLETED|Overall Study||255
1746309|NCT00075582|4277361|P2|STARTED|Overall Study||85
1746310|NCT00075582|4277362|P1|STARTED|Overall Study||305
1746311|NCT00075504|4277372|P2|NOT COMPLETED|Overall Study||7
1746312|NCT00075504|4277373|P1|NOT COMPLETED|Overall Study||9
1746313|NCT00075504|4277372|P2|COMPLETED|Overall Study||3
1746314|NCT00075504|4277373|P1|COMPLETED|Overall Study||14
1746315|NCT00075504|4277372|P2|STARTED|Overall Study||10
1746316|NCT00075504|4277373|P1|STARTED|Overall Study||23
1746317|NCT00075478|4277385|P2|NOT COMPLETED|Overall Study||1
1746318|NCT00075478|4277386|P1|NOT COMPLETED|Overall Study||1
1746319|NCT00075478|4277385|P2|COMPLETED|Overall Study||44
1746320|NCT00075478|4277386|P1|COMPLETED|Overall Study||41
1746321|NCT00075478|4277385|P2|STARTED|Overall Study||45
1746322|NCT00075478|4277386|P1|STARTED|Overall Study||42
1746323|NCT00075400|4277406|P1|NOT COMPLETED|Overall Study||3
1746324|NCT00075400|4277406|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
1746325|NCT00075400|4277406|P1|STARTED|Overall Study||26
1746326|NCT00075335|4277420|P1|NOT COMPLETED|Overall Study||0
1746327|NCT00075335|4277420|P1|COMPLETED|Overall Study||8
1746328|NCT00075335|4277420|P1|STARTED|Overall Study||8
1746329|NCT00075270|4277427|P2|NOT COMPLETED|Overall Study||284
1746330|NCT00075270|4277428|P1|NOT COMPLETED|Overall Study||286
1746331|NCT00075270|4277427|P2|COMPLETED|Overall Study||4
1746332|NCT00075270|4277428|P1|COMPLETED|Overall Study||5
1746333|NCT00075270|4277427|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
1746334|NCT00075270|4277428|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
1746335|NCT00075270|4277427|P2|STARTED|Overall Study||288
1746336|NCT00075270|4277428|P1|STARTED|Overall Study||291
1746337|NCT00075218|4277474|P3|NOT COMPLETED|Open-Label Treatment||255
1746338|NCT00075218|4277475|P2|NOT COMPLETED|Open-Label Treatment||0
1746339|NCT00075218|4277476|P1|NOT COMPLETED|Open-Label Treatment||0
1746340|NCT00075218|4277474|P3|COMPLETED|Open-Label Treatment||0
1746341|NCT00075218|4277475|P2|COMPLETED|Open-Label Treatment||0
1746342|NCT00075218|4277476|P1|COMPLETED|Open-Label Treatment||0
1746343|NCT00075218|4277474|P3|STARTED|Open-Label Treatment||255
1746344|NCT00075218|4277475|P2|STARTED|Open-Label Treatment||0
1746345|NCT00075218|4277476|P1|STARTED|Open-Label Treatment||0
1746346|NCT00075218|4277474|P3|NOT COMPLETED|Double-Blind Treatment||0
1746347|NCT00075218|4277475|P2|NOT COMPLETED|Double-Blind Treatment||15
1746348|NCT00075218|4277476|P1|NOT COMPLETED|Double-Blind Treatment||91
1746349|NCT00075218|4277474|P3|COMPLETED|Double-Blind Treatment||0
1746350|NCT00075218|4277475|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
1746351|NCT00075218|4277476|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
1746352|NCT00075218|4277474|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
1746353|NCT00075218|4277475|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
1746354|NCT00075218|4277476|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
1746355|NCT00075218|4277474|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
1746356|NCT00075218|4277475|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
1746357|NCT00075218|4277476|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
1746358|NCT00075218|4277474|P3|STARTED|Double-Blind Treatment||0
1746359|NCT00075218|4277475|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
1746360|NCT00075218|4277476|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
1746361|NCT00075088|4277511|P2|NOT COMPLETED|Overall Study||0
1746362|NCT00075088|4277512|P1|NOT COMPLETED|Overall Study||0
1746363|NCT00075088|4277511|P2|COMPLETED|Overall Study||391
1746364|NCT00075088|4277512|P1|COMPLETED|Overall Study||403
1746365|NCT00075088|4277511|P2|STARTED|Overall Study||391
1746366|NCT00075088|4277512|P1|STARTED|Overall Study||403
1746367|NCT00075023|4277525|P2|NOT COMPLETED|Part Two||0
1746368|NCT00075023|4277526|P1|NOT COMPLETED|Part Two||0
1746369|NCT00075023|4277525|P2|COMPLETED|Part Two||0
1746370|NCT00075023|4277526|P1|COMPLETED|Part Two||0
1746371|NCT00075023|4277525|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
1746372|NCT00075023|4277526|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
1746373|NCT00075023|4277525|P2|NOT COMPLETED|Pilot Study||2
1746374|NCT00075023|4277526|P1|NOT COMPLETED|Pilot Study||2
1746375|NCT00075023|4277525|P2|COMPLETED|Pilot Study||3
1746376|NCT00075023|4277526|P1|COMPLETED|Pilot Study||3
1746377|NCT00075023|4277525|P2|STARTED|Pilot Study||5
1746378|NCT00075023|4277526|P1|STARTED|Pilot Study||5
1746379|NCT00074984|4277535|P2|NOT COMPLETED|Overall Study||8
1746380|NCT00074984|4277536|P1|NOT COMPLETED|Overall Study||3
1746381|NCT00074984|4277535|P2|COMPLETED|Overall Study||43
1746382|NCT00074984|4277536|P1|COMPLETED|Overall Study||28
1746383|NCT00074984|4277535|P2|STARTED|Overall Study||51
1746384|NCT00074984|4277536|P1|STARTED|Overall Study||31
1746385|NCT00074958|4277551|P1|NOT COMPLETED|Overall Study||1
1746386|NCT00074958|4277551|P1|COMPLETED|Overall Study||15
1746387|NCT00074958|4277551|P1|STARTED|Overall Study||16
1746388|NCT00074815|4277559|P3|NOT COMPLETED|Overall Study||12
1746389|NCT00074815|4277560|P2|NOT COMPLETED|Overall Study||6
1746390|NCT00074815|4277561|P1|NOT COMPLETED|Overall Study||5
1746391|NCT00074815|4277559|P3|COMPLETED|Overall Study||30
1746392|NCT00074815|4277560|P2|COMPLETED|Overall Study||34
1746393|NCT00074815|4277561|P1|COMPLETED|Overall Study||37
1746394|NCT00074815|4277559|P3|STARTED|Overall Study||42
1746395|NCT00074815|4277560|P2|STARTED|Overall Study||40
1746396|NCT00074815|4277561|P1|STARTED|Overall Study||42
1746397|NCT00074802|4277571|P2|NOT COMPLETED|Overall Study||7
1746398|NCT00074802|4277572|P1|NOT COMPLETED|Overall Study||9
1746399|NCT00074802|4277571|P2|COMPLETED|Overall Study||25
1746400|NCT00074802|4277572|P1|COMPLETED|Overall Study||20
1746401|NCT00074802|4277571|P2|STARTED|Overall Study||32
1746402|NCT00074802|4277572|P1|STARTED|Overall Study||29
1746403|NCT00074711|4277592|P2|NOT COMPLETED|Overall Study||15
1746404|NCT00074711|4277593|P1|NOT COMPLETED|Overall Study||15
1746405|NCT00074711|4277592|P2|COMPLETED|Overall Study||106
1746406|NCT00074711|4277593|P1|COMPLETED|Overall Study||105
1746407|NCT00074711|4277592|P2|STARTED|Overall Study||121
1746408|NCT00074711|4277593|P1|STARTED|Overall Study||120
1746409|NCT00074581|4277611|P2|NOT COMPLETED|Overall Study||226
1746410|NCT00074581|4277612|P1|NOT COMPLETED|Overall Study||244
1746411|NCT00074581|4277611|P2|COMPLETED|Overall Study||1541
1746412|NCT00074581|4277612|P1|COMPLETED|Overall Study||1545
1746413|NCT00074581|4277611|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
1746414|NCT00074581|4277612|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
1746415|NCT00074490|4277625|P6|NOT COMPLETED|Overall Study||0
1746416|NCT00074490|4277626|P5|NOT COMPLETED|Overall Study||3
1746417|NCT00074490|4277627|P4|NOT COMPLETED|Overall Study||0
1746418|NCT00074490|4277628|P3|NOT COMPLETED|Overall Study||0
1746419|NCT00074490|4277629|P2|NOT COMPLETED|Overall Study||7
1746420|NCT00074490|4277630|P1|NOT COMPLETED|Overall Study||0
1746421|NCT00074490|4277625|P6|COMPLETED|Overall Study||221
1746422|NCT00074490|4277626|P5|COMPLETED|Overall Study||42
1746423|NCT00074490|4277627|P4|COMPLETED|Overall Study||44
1746424|NCT00074490|4277628|P3|COMPLETED|Overall Study||40
1746425|NCT00074490|4277629|P2|COMPLETED|Overall Study||27
1746426|NCT00074490|4277630|P1|COMPLETED|Overall Study||1
1746427|NCT00074490|4277625|P6|STARTED|Overall Study||221
1746428|NCT00074490|4277626|P5|STARTED|Overall Study||45
1746429|NCT00074490|4277627|P4|STARTED|Overall Study||44
1746430|NCT00074490|4277628|P3|STARTED|Overall Study||40
1746431|NCT00074490|4277629|P2|STARTED|Overall Study||34
1746432|NCT00074490|4277630|P1|STARTED|Overall Study||1
1746433|NCT00074412|4277664|P2|NOT COMPLETED|Overall Study||84
1746434|NCT00074412|4277665|P1|NOT COMPLETED|Overall Study||82
1746435|NCT00074412|4277664|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
1746436|NCT00074412|4277665|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
1746437|NCT00074412|4277664|P2|Month 12 Visit|Overall Study||735
1746438|NCT00074412|4277665|P1|Month 12 Visit|Overall Study||733
1746439|NCT00074412|4277664|P2|Month 9 Visit|Overall Study||741
1746440|NCT00074412|4277665|P1|Month 9 Visit|Overall Study||741
1746441|NCT00074412|4277664|P2|Month 6 Visit|Overall Study||748
1746442|NCT00074412|4277665|P1|Month 6 Visit|Overall Study||748
1746443|NCT00074412|4277664|P2|Month 5 Visit|Overall Study||750
1746444|NCT00074412|4277665|P1|Month 5 Visit|Overall Study||756
1746445|NCT00074412|4277664|P2|Month 4 Visit|Overall Study||752
1746446|NCT00074412|4277665|P1|Month 4 Visit|Overall Study||758
1746447|NCT00074412|4277664|P2|Month 3 Visit|Overall Study||755
1746448|NCT00074412|4277665|P1|Month 3 Visit|Overall Study||759
1746449|NCT00074412|4277664|P2|Week 8 Visit|Overall Study||759
1746450|NCT00074412|4277665|P1|Week 8 Visit|Overall Study||759
1746451|NCT00074412|4277664|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
1746452|NCT00074412|4277665|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
1746453|NCT00074308|4277681|P5|NOT COMPLETED|Overall Study||0
1746454|NCT00074308|4277682|P4|NOT COMPLETED|Overall Study||0
1746455|NCT00074308|4277683|P3|NOT COMPLETED|Overall Study||0
1746456|NCT00074308|4277684|P2|NOT COMPLETED|Overall Study||0
1746457|NCT00074308|4277685|P1|NOT COMPLETED|Overall Study||0
1746458|NCT00074308|4277681|P5|COMPLETED|Overall Study||23
1746459|NCT00074308|4277682|P4|COMPLETED|Overall Study||8
1746460|NCT00074308|4277683|P3|COMPLETED|Overall Study||3
1746461|NCT00074308|4277684|P2|COMPLETED|Overall Study||3
1746462|NCT00074308|4277685|P1|COMPLETED|Overall Study||3
1746463|NCT00074308|4277681|P5|STARTED|Overall Study||23
1746464|NCT00074308|4277682|P4|STARTED|Overall Study||8
1746465|NCT00074308|4277683|P3|STARTED|Overall Study||3
1746466|NCT00074308|4277684|P2|STARTED|Overall Study||3
1746467|NCT00074308|4277685|P1|STARTED|Overall Study||3
1746468|NCT00074269|4277696|P1|NOT COMPLETED|Overall Study||0
1746469|NCT00074269|4277696|P1|COMPLETED|Overall Study||5
1746470|NCT00074269|4277696|P1|STARTED|Overall Study||5
1746471|NCT00074165|4277706|P1|NOT COMPLETED|Overall Study||0
1746472|NCT00074165|4277706|P1|COMPLETED|Overall Study||17
1746473|NCT00074165|4277706|P1|STARTED|Overall Study||17
1746474|NCT00074152|4277713|P2|NOT COMPLETED|Overall Study||33
1746475|NCT00074152|4277714|P1|NOT COMPLETED|Overall Study||55
1746476|NCT00074152|4277713|P2|COMPLETED|Overall Study||52
1746477|NCT00074152|4277714|P1|COMPLETED|Overall Study||22
1746478|NCT00074152|4277713|P2|STARTED|Overall Study||85
1746479|NCT00074152|4277714|P1|STARTED|Overall Study||77
1746480|NCT00074035|4277724|P1|NOT COMPLETED|Overall Study||0
1746481|NCT00074035|4277724|P1|COMPLETED|Overall Study||38
1746482|NCT00074035|4277724|P1|STARTED|Overall Study||38
1746483|NCT00073983|4277731|P1|NOT COMPLETED|Overall Study||1
1746484|NCT00073983|4277731|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
1746485|NCT00073983|4277731|P1|STARTED|Overall Study||54
1746486|NCT00073957|4277746|P1|NOT COMPLETED|Overall Study||0
1746487|NCT00073957|4277746|P1|COMPLETED|Overall Study||25
1746488|NCT00073957|4277746|P1|STARTED|Overall Study||25
1746489|NCT00073918|4277752|P1|NOT COMPLETED|Overall Study||4
1746490|NCT00073918|4277752|P1|COMPLETED|Overall Study||107
1746491|NCT00073918|4277752|P1|STARTED|Overall Study||111
1746492|NCT00073749|4277766|P7|NOT COMPLETED|Overall Study||40
1746493|NCT00073749|4277767|P6|NOT COMPLETED|Overall Study||6
1746494|NCT00073749|4277768|P5|NOT COMPLETED|Overall Study||6
1746495|NCT00073749|4277769|P4|NOT COMPLETED|Overall Study||6
1746496|NCT00073749|4277770|P3|NOT COMPLETED|Overall Study||11
1746497|NCT00073749|4277771|P2|NOT COMPLETED|Overall Study||5
1746498|NCT00073749|4277772|P1|NOT COMPLETED|Overall Study||2
1746499|NCT00073749|4277766|P7|COMPLETED|Overall Study||3
1746500|NCT00073749|4277767|P6|COMPLETED|Overall Study||0
1746501|NCT00073749|4277768|P5|COMPLETED|Overall Study||0
1746502|NCT00073749|4277769|P4|COMPLETED|Overall Study||0
1746503|NCT00073749|4277770|P3|COMPLETED|Overall Study||0
1746504|NCT00073749|4277771|P2|COMPLETED|Overall Study||0
1746505|NCT00073749|4277772|P1|COMPLETED|Overall Study||0
1746506|NCT00073749|4277766|P7|STARTED|Overall Study||43
1746507|NCT00073749|4277767|P6|STARTED|Overall Study||6
1746508|NCT00073749|4277768|P5|STARTED|Overall Study||6
1746509|NCT00073749|4277769|P4|STARTED|Overall Study||6
1746510|NCT00073749|4277770|P3|STARTED|Overall Study||11
1746511|NCT00073749|4277771|P2|STARTED|Overall Study||5
1746512|NCT00073749|4277772|P1|STARTED|Overall Study||2
1746513|NCT00073528|4277803|P2|NOT COMPLETED|Overall Study||642
1746514|NCT00073528|4277804|P1|NOT COMPLETED|Overall Study||644
1746515|NCT00073528|4277803|P2|COMPLETED|Overall Study||0
1746516|NCT00073528|4277804|P1|COMPLETED|Overall Study||0
1746517|NCT00073528|4277803|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
1746518|NCT00073528|4277804|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
1746519|NCT00073528|4277803|P2|STARTED|Overall Study||642
1746520|NCT00073528|4277804|P1|STARTED|Overall Study||644
1746521|NCT00073333|4277881|P3|NOT COMPLETED|Overall Study||0
1746522|NCT00073333|4277882|P2|NOT COMPLETED|Overall Study||14
1746523|NCT00073333|4277883|P1|NOT COMPLETED|Overall Study||14
1746524|NCT00073333|4277881|P3|COMPLETED|Overall Study||19
1746525|NCT00073333|4277882|P2|COMPLETED|Overall Study||27
1746526|NCT00073333|4277883|P1|COMPLETED|Overall Study||32
1746527|NCT00073333|4277881|P3|STARTED|Overall Study||19
1746528|NCT00073333|4277882|P2|STARTED|Overall Study||41
1746529|NCT00073333|4277883|P1|STARTED|Overall Study||46
1746530|NCT00073307|4277893|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
1746531|NCT00073307|4277894|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
1746532|NCT00073307|4277895|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
1746533|NCT00073307|4277893|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
1746534|NCT00073307|4277894|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
1746535|NCT00073307|4277895|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
1746536|NCT00073307|4277893|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
1746537|NCT00073307|4277894|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
1746538|NCT00073307|4277895|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
1746539|NCT00073307|4277893|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
1746540|NCT00073307|4277894|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
1746541|NCT00073307|4277895|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
1746542|NCT00073307|4277893|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
1746543|NCT00073307|4277894|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
1746544|NCT00073307|4277895|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
1746545|NCT00073307|4277893|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
1746546|NCT00073307|4277894|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
1746547|NCT00073307|4277895|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
1746548|NCT00073307|4277893|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
1746549|NCT00073307|4277894|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
1746550|NCT00073307|4277895|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
1746551|NCT00073307|4277893|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
1746552|NCT00073307|4277894|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
1746553|NCT00073307|4277895|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
1746554|NCT00073073|4277913|P1|NOT COMPLETED|Overall Study||4
1746555|NCT00073073|4277913|P1|COMPLETED|Overall Study||42
1746556|NCT00073073|4277913|P1|STARTED|Overall Study||46
1746557|NCT00073021|4277926|P2|NOT COMPLETED|Overall Study||16
1746558|NCT00073021|4277927|P1|NOT COMPLETED|Overall Study||26
1746559|NCT00073021|4277926|P2|COMPLETED|Overall Study||113
1746560|NCT00073021|4277927|P1|COMPLETED|Overall Study||113
1746561|NCT00073021|4277926|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
1746562|NCT00073021|4277927|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
1746563|NCT00073008|4277957|P2|NOT COMPLETED|Overall Study||63
1746564|NCT00073008|4277958|P1|NOT COMPLETED|Overall Study||62
1746565|NCT00073008|4277957|P2|COMPLETED|Overall Study||3
1746566|NCT00073008|4277958|P1|COMPLETED|Overall Study||3
1746567|NCT00073008|4277957|P2|STARTED|Overall Study||66
1746568|NCT00073008|4277958|P1|STARTED|Overall Study||65
1746569|NCT00072761|4277990|P2|NOT COMPLETED|Overall Study||2
1746570|NCT00072761|4277991|P1|NOT COMPLETED|Overall Study||9
1746571|NCT00072761|4277990|P2|COMPLETED|Overall Study||95
1746572|NCT00072761|4277991|P1|COMPLETED|Overall Study||90
1746573|NCT00072761|4277990|P2|STARTED|Overall Study||97
1746574|NCT00072761|4277991|P1|STARTED|Overall Study||99
1746575|NCT00072475|4277997|P1|NOT COMPLETED|Overall Study||97
1746576|NCT00072475|4277997|P1|COMPLETED|Overall Study||45
1746577|NCT00072475|4277997|P1|STARTED|Overall Study||142
1746578|NCT00072449|4278005|P1|NOT COMPLETED|Overall Study||0
1746579|NCT00072449|4278005|P1|COMPLETED|Overall Study||12
1746580|NCT00072449|4278005|P1|STARTED|Overall Study||12
1746581|NCT00072384|4278012|P1|NOT COMPLETED|Overall Study||9
1746582|NCT00072384|4278012|P1|COMPLETED|Overall Study||21
1746583|NCT00072384|4278012|P1|STARTED|Overall Study||30
1746584|NCT00072293|4278025|P2|NOT COMPLETED|Overall Study||2
1746585|NCT00072293|4278026|P1|NOT COMPLETED|Overall Study||1
1746586|NCT00072293|4278025|P2|COMPLETED|Overall Study||467
1746587|NCT00072293|4278026|P1|COMPLETED|Overall Study||464
1746588|NCT00072293|4278025|P2|STARTED|Overall Study||469
1746589|NCT00072293|4278026|P1|STARTED|Overall Study||465
1746590|NCT00072280|4278038|P2|NOT COMPLETED|Follow-up||2
1746591|NCT00072280|4278039|P1|NOT COMPLETED|Follow-up||2
1746592|NCT00072280|4278038|P2|COMPLETED|Follow-up||0
1746593|NCT00072280|4278039|P1|COMPLETED|Follow-up||0
1746594|NCT00072280|4278038|P2|STARTED|Follow-up||2
1746595|NCT00072280|4278039|P1|STARTED|Follow-up||2
1746596|NCT00072280|4278038|P2|NOT COMPLETED|Treatment||2
1746597|NCT00072280|4278039|P1|NOT COMPLETED|Treatment||1
1746598|NCT00072280|4278038|P2|COMPLETED|Treatment||2
1746599|NCT00072280|4278039|P1|COMPLETED|Treatment||2
1746600|NCT00072280|4278038|P2|STARTED|Treatment||4
1746601|NCT00072280|4278039|P1|STARTED|Treatment||3
1746602|NCT00072189|4278044|P1|NOT COMPLETED|Overall Study||1
1746603|NCT00072189|4278044|P1|COMPLETED|Overall Study||16
1746604|NCT00072189|4278044|P1|STARTED|Overall Study||17
1746605|NCT00072176|4278052|P2|NOT COMPLETED|Overall Study||1
1746606|NCT00072176|4278053|P1|NOT COMPLETED|Overall Study||1
1746607|NCT00072176|4278052|P2|COMPLETED|Overall Study||27
1746608|NCT00072176|4278053|P1|COMPLETED|Overall Study||33
1746609|NCT00072176|4278052|P2|STARTED|Overall Study||28
1746610|NCT00072176|4278053|P1|STARTED|Overall Study||34
1746611|NCT00071981|4278065|P4|NOT COMPLETED|Overall Study||45
1746612|NCT00071981|4278066|P3|NOT COMPLETED|Overall Study||37
1746613|NCT00071981|4278067|P2|NOT COMPLETED|Overall Study||41
1746614|NCT00071981|4278068|P1|NOT COMPLETED|Overall Study||46
1746615|NCT00071981|4278065|P4|COMPLETED|Overall Study||3
1746616|NCT00071981|4278066|P3|COMPLETED|Overall Study||0
1746617|NCT00071981|4278067|P2|COMPLETED|Overall Study||2
1746618|NCT00071981|4278068|P1|COMPLETED|Overall Study||1
1746619|NCT00071981|4278065|P4|Have Helper T Cell Response Data|Overall Study||39
1746620|NCT00071981|4278066|P3|Have Helper T Cell Response Data|Overall Study||25
1746621|NCT00071981|4278067|P2|Have Helper T Cell Response Data|Overall Study||27
1746622|NCT00071981|4278068|P1|Have Helper T Cell Response Data|Overall Study||37
1746623|NCT00071981|4278065|P4|Have CTL Response Data|Overall Study||41
1746624|NCT00071981|4278066|P3|Have CTL Response Data|Overall Study||29
1746625|NCT00071981|4278067|P2|Have CTL Response Data|Overall Study||30
1746626|NCT00071981|4278068|P1|Have CTL Response Data|Overall Study||40
1746627|NCT00071981|4278065|P4|Eligible and Treated|Overall Study||42
1746628|NCT00071981|4278066|P3|Eligible and Treated|Overall Study||32
1746629|NCT00071981|4278067|P2|Eligible and Treated|Overall Study||33
1746630|NCT00071981|4278068|P1|Eligible and Treated|Overall Study||41
1746631|NCT00071981|4278065|P4|Treated|Overall Study||48
1746632|NCT00071981|4278066|P3|Treated|Overall Study||36
1746633|NCT00071981|4278067|P2|Treated|Overall Study||38
1746634|NCT00071981|4278068|P1|Treated|Overall Study||45
1746635|NCT00071981|4278065|P4|Eligible|Overall Study||42
1746636|NCT00071981|4278066|P3|Eligible|Overall Study||33
1746637|NCT00071981|4278067|P2|Eligible|Overall Study||36
1746638|NCT00071981|4278068|P1|Eligible|Overall Study||43
1746639|NCT00071981|4278065|P4|STARTED|Overall Study||48
1746640|NCT00071981|4278066|P3|STARTED|Overall Study||37
1746641|NCT00071981|4278067|P2|STARTED|Overall Study||43
1746642|NCT00071981|4278068|P1|STARTED|Overall Study||47
1746643|NCT00072566|4278094|P1|NOT COMPLETED|Overall Study||0
1746644|NCT00072566|4278094|P1|COMPLETED|Overall Study||70
1746645|NCT00072566|4278094|P1|STARTED|Overall Study||70
1746646|NCT00072514|4278100|P1|NOT COMPLETED|Overall Study||4
1746647|NCT00072514|4278100|P1|COMPLETED|Overall Study||51
1746648|NCT00072514|4278100|P1|STARTED|Overall Study||55
1746649|NCT00071812|4278111|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
1746650|NCT00071812|4278112|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
1746651|NCT00071812|4278113|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
1746652|NCT00071812|4278114|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
1746653|NCT00071812|4278111|P4|COMPLETED|24-Week Open-Label Extension Period||178
1746654|NCT00071812|4278112|P3|COMPLETED|24-Week Open-Label Extension Period||7
1746655|NCT00071812|4278113|P2|COMPLETED|24-Week Open-Label Extension Period||11
1746656|NCT00071812|4278114|P1|COMPLETED|24-Week Open-Label Extension Period||0
1746657|NCT00071812|4278111|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
1746658|NCT00071812|4278112|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
1746659|NCT00071812|4278113|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
1746737|NCT00071110|4278357|P1|COMPLETED|Overall Study||28
1746660|NCT00071812|4278114|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
1746661|NCT00071812|4278111|P4|NOT COMPLETED|24-Week Double-Blind Period||11
1746662|NCT00071812|4278112|P3|NOT COMPLETED|24-Week Double-Blind Period||8
1746663|NCT00071812|4278113|P2|NOT COMPLETED|24-Week Double-Blind Period||6
1746664|NCT00071812|4278114|P1|NOT COMPLETED|24-Week Double-Blind Period||10
1746665|NCT00071812|4278111|P4|COMPLETED|24-Week Double-Blind Period||60
1746666|NCT00071812|4278112|P3|COMPLETED|24-Week Double-Blind Period||63
1746667|NCT00071812|4278113|P2|COMPLETED|24-Week Double-Blind Period||66
1746668|NCT00071812|4278114|P1|COMPLETED|24-Week Double-Blind Period||59
1746669|NCT00071812|4278111|P4|STARTED|24-Week Double-Blind Period||71
1746670|NCT00071812|4278112|P3|STARTED|24-Week Double-Blind Period||71
1746671|NCT00071812|4278113|P2|STARTED|24-Week Double-Blind Period||72
1746672|NCT00071812|4278114|P1|STARTED|24-Week Double-Blind Period||69
1746673|NCT00071799|4278156|P2|NOT COMPLETED|Overall Study||98
1746674|NCT00071799|4278157|P1|NOT COMPLETED|Overall Study||70
1746675|NCT00071799|4278156|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
1746676|NCT00071799|4278157|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
1746677|NCT00071799|4278156|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
1746678|NCT00071799|4278157|P1|STARTED|Overall Study||179
1746679|NCT00071890|4278199|P2|NOT COMPLETED|Overall Study||0
1746680|NCT00071890|4278200|P1|NOT COMPLETED|Overall Study||0
1746681|NCT00071890|4278199|P2|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
1746682|NCT00071890|4278200|P1|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
1746683|NCT00071890|4278199|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
1746684|NCT00071890|4278200|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
1746685|NCT00071760|4278210|P1|NOT COMPLETED|Overall Study||54
1746686|NCT00071760|4278210|P1|COMPLETED|Overall Study||0
1746687|NCT00071760|4278210|P1|Ongoing|Overall Study||25
1746688|NCT00071760|4278210|P1|STARTED|Overall Study||54
1746689|NCT00071721|4278271|P2|NOT COMPLETED|Overall Study||91
1746690|NCT00071721|4278272|P1|NOT COMPLETED|Overall Study||72
1746691|NCT00071721|4278271|P2|COMPLETED|Overall Study||69
1746692|NCT00071721|4278272|P1|COMPLETED|Overall Study||81
1746693|NCT00071721|4278271|P2|STARTED|Overall Study||160
1746694|NCT00071721|4278272|P1|STARTED|Overall Study||153
1746695|NCT00071513|4278290|P2|NOT COMPLETED|Follow-up Assessment||6
1746696|NCT00071513|4278291|P1|NOT COMPLETED|Follow-up Assessment||6
1746697|NCT00071513|4278290|P2|COMPLETED|Follow-up Assessment||247
1746698|NCT00071513|4278291|P1|COMPLETED|Follow-up Assessment||233
1746699|NCT00071513|4278290|P2|STARTED|Follow-up Assessment||253
1746700|NCT00071513|4278291|P1|STARTED|Follow-up Assessment||239
1746701|NCT00071513|4278290|P2|NOT COMPLETED|Intervention Component||3
1746702|NCT00071513|4278291|P1|NOT COMPLETED|Intervention Component||2
1746703|NCT00071513|4278290|P2|COMPLETED|Intervention Component||253
1746704|NCT00071513|4278291|P1|COMPLETED|Intervention Component||239
1746705|NCT00071513|4278290|P2|STARTED|Intervention Component||256
1746706|NCT00071513|4278291|P1|STARTED|Intervention Component||241
1746707|NCT00071487|4278303|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
1746708|NCT00071487|4278304|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
1746709|NCT00071487|4278305|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
1746710|NCT00071487|4278306|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
1746711|NCT00071487|4278303|P4|COMPLETED|24-Week Open-Label Extension Period||279
1746712|NCT00071487|4278304|P3|COMPLETED|24-Week Open-Label Extension Period||23
1746713|NCT00071487|4278305|P2|COMPLETED|24-Week Open-Label Extension Period||19
1746714|NCT00071487|4278306|P1|COMPLETED|24-Week Open-Label Extension Period||0
1746715|NCT00071487|4278303|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
1746716|NCT00071487|4278304|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
1746717|NCT00071487|4278305|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
1746718|NCT00071487|4278306|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
1746719|NCT00071487|4278303|P4|NOT COMPLETED|52-Week Double-Blind Period||21
1746720|NCT00071487|4278304|P3|NOT COMPLETED|52-Week Double-Blind Period||17
1746721|NCT00071487|4278305|P2|NOT COMPLETED|52-Week Double-Blind Period||27
1746722|NCT00071487|4278306|P1|NOT COMPLETED|52-Week Double-Blind Period||20
1746723|NCT00071487|4278303|P4|COMPLETED|52-Week Double-Blind Period||90
1746724|NCT00071487|4278304|P3|COMPLETED|52-Week Double-Blind Period||94
1746725|NCT00071487|4278305|P2|COMPLETED|52-Week Double-Blind Period||87
1746726|NCT00071487|4278306|P1|COMPLETED|52-Week Double-Blind Period||93
1746727|NCT00071487|4278303|P4|STARTED|52-Week Double-Blind Period||111
1746728|NCT00071487|4278304|P3|STARTED|52-Week Double-Blind Period||111
1746729|NCT00071487|4278305|P2|STARTED|52-Week Double-Blind Period||114
1746730|NCT00071487|4278306|P1|STARTED|52-Week Double-Blind Period||113
1746731|NCT00071396|4278350|P1|NOT COMPLETED|Overall Study||3
1746732|NCT00071396|4278350|P1|COMPLETED|Overall Study|Evaluable for response.|41
1746733|NCT00071396|4278350|P1|STARTED|Overall Study||44
1746734|NCT00071110|4278356|P2|NOT COMPLETED|Overall Study||4
1746735|NCT00071110|4278357|P1|NOT COMPLETED|Overall Study||0
1746736|NCT00071110|4278356|P2|COMPLETED|Overall Study||25
1746738|NCT00071110|4278356|P2|STARTED|Overall Study||29
1746739|NCT00071110|4278357|P1|STARTED|Overall Study||28
1746740|NCT00071032|4278371|P2|NOT COMPLETED|Overall Study||8
1746741|NCT00071032|4278372|P1|NOT COMPLETED|Overall Study||9
1746742|NCT00071032|4278371|P2|COMPLETED|Overall Study||1001
1746743|NCT00071032|4278372|P1|COMPLETED|Overall Study||998
1746744|NCT00071032|4278371|P2|STARTED|Overall Study||1009
1746745|NCT00071032|4278372|P1|STARTED|Overall Study||1007
1746746|NCT00071006|4278380|P1|NOT COMPLETED|Overall Study||12
1746747|NCT00071006|4278380|P1|COMPLETED|Overall Study||0
1746748|NCT00071006|4278380|P1|STARTED|Overall Study||12
1746749|NCT00070941|4278393|P3|NOT COMPLETED|Overall Study||4
1746750|NCT00070941|4278394|P2|NOT COMPLETED|Overall Study||8
1746751|NCT00070941|4278395|P1|NOT COMPLETED|Overall Study||10
1746752|NCT00070941|4278393|P3|COMPLETED|Overall Study||2
1746753|NCT00070941|4278394|P2|COMPLETED|Overall Study||3
1746754|NCT00070941|4278395|P1|COMPLETED|Overall Study||2
1746755|NCT00070941|4278393|P3|STARTED|Overall Study||6
1746756|NCT00070941|4278394|P2|STARTED|Overall Study||11
1746757|NCT00070941|4278395|P1|STARTED|Overall Study||12
1746758|NCT00071058|4278403|P1|NOT COMPLETED|Overall Study||1
1746759|NCT00071058|4278403|P1|COMPLETED|Overall Study||49
1746760|NCT00071058|4278403|P1|STARTED|Overall Study||50
1746761|NCT00003907|4278410|P2|NOT COMPLETED|Overall Study||23
1746762|NCT00003907|4278411|P1|NOT COMPLETED|Overall Study||13
1746763|NCT00003907|4278410|P2|COMPLETED|Overall Study||8
1746764|NCT00003907|4278411|P1|COMPLETED|Overall Study||6
1746765|NCT00003907|4278410|P2|Eligible and Treated|Overall Study||29
1746766|NCT00003907|4278411|P1|Eligible and Treated|Overall Study||17
1746767|NCT00003907|4278410|P2|Received Protocol Therapy (Treated)|Overall Study||31
1746768|NCT00003907|4278411|P1|Received Protocol Therapy (Treated)|Overall Study||18
1746769|NCT00003907|4278410|P2|Eligible|Overall Study||29
1746770|NCT00003907|4278411|P1|Eligible|Overall Study||18
1746771|NCT00003907|4278410|P2|STARTED|Overall Study||31
1746772|NCT00003907|4278411|P1|STARTED|Overall Study||19
1746773|NCT00070564|4278427|P6|NOT COMPLETED|Overall Study||52
1746774|NCT00070564|4278428|P5|NOT COMPLETED|Overall Study||79
1746775|NCT00070564|4278429|P4|NOT COMPLETED|Overall Study||167
1746776|NCT00070564|4278430|P3|NOT COMPLETED|Overall Study||171
1746777|NCT00070564|4278431|P2|NOT COMPLETED|Overall Study||203
1746778|NCT00070564|4278432|P1|NOT COMPLETED|Overall Study||200
1746779|NCT00070564|4278427|P6|COMPLETED|Overall Study||244
1746780|NCT00070564|4278428|P5|COMPLETED|Overall Study||203
1746781|NCT00070564|4278429|P4|COMPLETED|Overall Study||481
1746782|NCT00070564|4278430|P3|COMPLETED|Overall Study||526
1746783|NCT00070564|4278431|P2|COMPLETED|Overall Study||490
1746784|NCT00070564|4278432|P1|COMPLETED|Overall Study||478
1746785|NCT00070564|4278427|P6|STARTED|Overall Study||296
1746786|NCT00070564|4278428|P5|STARTED|Overall Study||282
1746787|NCT00070564|4278429|P4|STARTED|Overall Study||648
1746788|NCT00070564|4278430|P3|STARTED|Overall Study||697
1746789|NCT00070564|4278431|P2|STARTED|Overall Study||693
1746790|NCT00070564|4278432|P1|STARTED|Overall Study||678
1746791|NCT00070499|4278486|P4|NOT COMPLETED|Overall Study||110
1746792|NCT00070499|4278487|P3|NOT COMPLETED|Overall Study||120
1746793|NCT00070499|4278488|P2|NOT COMPLETED|Overall Study||26
1746794|NCT00070499|4278489|P1|NOT COMPLETED|Overall Study||38
1746795|NCT00070499|4278486|P4|COMPLETED|Overall Study||17
1746796|NCT00070499|4278487|P3|COMPLETED|Overall Study||6
1746797|NCT00070499|4278488|P2|COMPLETED|Overall Study||52
1746798|NCT00070499|4278489|P1|COMPLETED|Overall Study||37
1746799|NCT00070499|4278486|P4|Eligible and Treated|Overall Study||123
1746800|NCT00070499|4278487|P3|Eligible and Treated|Overall Study||123
1746801|NCT00070499|4278488|P2|Eligible and Treated|Overall Study||73
1746802|NCT00070499|4278489|P1|Eligible and Treated|Overall Study||72
1746803|NCT00070499|4278486|P4|Eligible|Overall Study||125
1746804|NCT00070499|4278487|P3|Eligible|Overall Study||123
1746805|NCT00070499|4278488|P2|Eligible|Overall Study||73
1746806|NCT00070499|4278489|P1|Eligible|Overall Study||73
1746807|NCT00070499|4278486|P4|STARTED|Overall Study||127
1746808|NCT00070499|4278487|P3|STARTED|Overall Study||126
1746809|NCT00070499|4278488|P2|STARTED|Overall Study||78
1746810|NCT00070499|4278489|P1|STARTED|Overall Study||75
1746811|NCT00070317|4278515|P1|NOT COMPLETED|Overall Study||13
1746812|NCT00070317|4278515|P1|COMPLETED|Overall Study||89
1746813|NCT00070317|4278515|P1|STARTED|Overall Study||102
1746814|NCT00070291|4278520|P1|NOT COMPLETED|Step 2||1
1746815|NCT00070291|4278520|P1|COMPLETED|Step 2||0
1746816|NCT00070291|4278520|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
1746817|NCT00070291|4278520|P1|NOT COMPLETED|Step 1||2
1746818|NCT00070291|4278520|P1|COMPLETED|Step 1||2
1746819|NCT00070291|4278520|P1|Treated|Step 1||3
1746820|NCT00070291|4278520|P1|STARTED|Step 1||4
1746821|NCT00070135|4278525|P1|NOT COMPLETED|Overall Study||0
1746822|NCT00070135|4278525|P1|COMPLETED|Overall Study||114
1746823|NCT00070135|4278525|P1|STARTED|Overall Study||114
1746824|NCT00070109|4278536|P5|NOT COMPLETED|Overall Study||8
1746825|NCT00070109|4278537|P4|NOT COMPLETED|Overall Study||20
1746826|NCT00070109|4278538|P3|NOT COMPLETED|Overall Study||8
1746827|NCT00070109|4278539|P2|NOT COMPLETED|Overall Study||6
1746828|NCT00070109|4278540|P1|NOT COMPLETED|Overall Study||8
1746829|NCT00070109|4278536|P5|COMPLETED|Overall Study||0
1746830|NCT00070109|4278537|P4|COMPLETED|Overall Study||0
1746831|NCT00070109|4278538|P3|COMPLETED|Overall Study||0
1746832|NCT00070109|4278539|P2|COMPLETED|Overall Study||0
1746833|NCT00070109|4278540|P1|COMPLETED|Overall Study||0
1746834|NCT00070109|4278536|P5|STARTED|Overall Study||8
1746835|NCT00070109|4278537|P4|STARTED|Overall Study||20
1746836|NCT00070109|4278538|P3|STARTED|Overall Study||8
1746837|NCT00070109|4278539|P2|STARTED|Overall Study||6
1746838|NCT00070109|4278540|P1|STARTED|Overall Study||8
1746839|NCT00070018|4278568|P1|NOT COMPLETED|Overall Study||4
1746840|NCT00070018|4278568|P1|COMPLETED|Overall Study||42
1746841|NCT00070018|4278568|P1|Eligible and Began Protocol Therapy|Overall Study||46
1746842|NCT00070018|4278568|P1|Eligible|Overall Study||46
1746843|NCT00070018|4278568|P1|STARTED|Overall Study||46
1746844|NCT00069953|4278572|P1|NOT COMPLETED|Overall Study||2
1746845|NCT00069953|4278572|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
1746846|NCT00069953|4278572|P1|STARTED|Overall Study||43
1746847|NCT00069784|4278578|P2|NOT COMPLETED|Overall Study||0
1746848|NCT00069784|4278579|P1|NOT COMPLETED|Overall Study||1212
1746849|NCT00069784|4278578|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
1746850|NCT00069784|4278579|P1|COMPLETED|Overall Study|completed study treatment|5052
1746851|NCT00069784|4278578|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
1746852|NCT00069784|4278579|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
1746853|NCT00069784|4278578|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
1746854|NCT00069784|4278579|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
1746855|NCT00069823|4278599|P2|NOT COMPLETED|Overall Study||3
1746856|NCT00069823|4278600|P1|NOT COMPLETED|Overall Study||6
1746857|NCT00069823|4278599|P2|COMPLETED|Overall Study||200
1746858|NCT00069823|4278600|P1|COMPLETED|Overall Study||193
1746859|NCT00069823|4278599|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
1746860|NCT00069823|4278600|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
1746861|NCT00069641|4278643|P3|NOT COMPLETED|Overall Study||1
1746862|NCT00069641|4278644|P2|NOT COMPLETED|Overall Study||0
1746863|NCT00069641|4278645|P1|NOT COMPLETED|Overall Study||1
1746864|NCT00069641|4278643|P3|COMPLETED|Overall Study||31
1746865|NCT00069641|4278644|P2|COMPLETED|Overall Study||32
1746866|NCT00069641|4278645|P1|COMPLETED|Overall Study||31
1746867|NCT00069641|4278643|P3|STARTED|Overall Study||32
1746868|NCT00069641|4278644|P2|STARTED|Overall Study||32
1746869|NCT00069641|4278645|P1|STARTED|Overall Study||32
1746870|NCT00069277|4278670|P1|NOT COMPLETED|Overall Study||21
1746871|NCT00069277|4278670|P1|COMPLETED|Overall Study||0
1746872|NCT00069277|4278670|P1|STARTED|Overall Study||21
1746873|NCT00069264|4278674|P1|NOT COMPLETED|Overall Study||32
1746874|NCT00069264|4278674|P1|COMPLETED|Overall Study||0
1746875|NCT00069264|4278674|P1|STARTED|Overall Study||32
1746876|NCT00069329|4278678|P1|NOT COMPLETED|Overall Study||2
1746877|NCT00069329|4278678|P1|COMPLETED|Overall Study||41
1746878|NCT00069329|4278678|P1|STARTED|Overall Study||43
1746879|NCT00069238|4278702|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
1746880|NCT00069238|4278703|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1746881|NCT00069238|4278704|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1746882|NCT00069238|4278702|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
1746883|NCT00069238|4278703|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1746884|NCT00069238|4278704|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1746885|NCT00069238|4278702|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
1746886|NCT00069238|4278703|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1746887|NCT00069238|4278704|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1746888|NCT00069238|4278702|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1746889|NCT00069238|4278703|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
1746890|NCT00069238|4278704|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1746891|NCT00069238|4278702|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1746892|NCT00069238|4278703|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
1746893|NCT00069238|4278704|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1746894|NCT00069238|4278702|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1746895|NCT00069238|4278703|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
1746896|NCT00069238|4278704|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1746897|NCT00069238|4278702|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1746898|NCT00069238|4278703|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1746899|NCT00069238|4278704|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
1746900|NCT00069238|4278702|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1746901|NCT00069238|4278703|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1746902|NCT00069238|4278704|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
1746903|NCT00069238|4278702|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1746904|NCT00069238|4278703|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1746905|NCT00069238|4278704|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
1746906|NCT00069121|4278712|P2|NOT COMPLETED|Overall Study||276
1746907|NCT00069121|4278713|P1|NOT COMPLETED|Overall Study||302
1746908|NCT00069121|4278712|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|668
1746909|NCT00069121|4278713|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|640
1746910|NCT00069121|4278712|P2|Received Treatment|Overall Study|Safety Population|938
1746911|NCT00069121|4278713|P1|Received Treatment|Overall Study|Safety Population|926
1746912|NCT00069121|4278712|P2|STARTED|Overall Study||944
1746913|NCT00069121|4278713|P1|STARTED|Overall Study||942
1746914|NCT00069108|4278735|P2|NOT COMPLETED|Overall Study||219
1746915|NCT00069108|4278736|P1|NOT COMPLETED|Overall Study||213
1746916|NCT00069108|4278735|P2|COMPLETED|Overall Study||95
1746917|NCT00069108|4278736|P1|COMPLETED|Overall Study||100
1746918|NCT00069108|4278735|P2|STARTED|Overall Study||314
1746919|NCT00069108|4278736|P1|STARTED|Overall Study||313
1746920|NCT00069095|4278768|P6|NOT COMPLETED|Follow-up Phase||101
1746921|NCT00069095|4278769|P5|NOT COMPLETED|Follow-up Phase||92
1746922|NCT00069095|4278770|P4|NOT COMPLETED|Follow-up Phase||112
1746923|NCT00069095|4278771|P3|NOT COMPLETED|Follow-up Phase||120
1746924|NCT00069095|4278772|P2|NOT COMPLETED|Follow-up Phase||206
1746925|NCT00069095|4278773|P1|NOT COMPLETED|Follow-up Phase||174
1746926|NCT00069095|4278768|P6|COMPLETED|Follow-up Phase||171
1746927|NCT00069095|4278769|P5|COMPLETED|Follow-up Phase||186
1746928|NCT00069095|4278770|P4|COMPLETED|Follow-up Phase||187
1746929|NCT00069095|4278771|P3|COMPLETED|Follow-up Phase||178
1746930|NCT00069095|4278772|P2|COMPLETED|Follow-up Phase||93
1746931|NCT00069095|4278773|P1|COMPLETED|Follow-up Phase||110
1746932|NCT00069095|4278768|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
1746933|NCT00069095|4278769|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
1746934|NCT00069095|4278770|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
1746935|NCT00069095|4278771|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
1746936|NCT00069095|4278772|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
1746937|NCT00069095|4278773|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
1746938|NCT00069095|4278768|P6|NOT COMPLETED|Post-study Treatment Phase||29
1746939|NCT00069095|4278769|P5|NOT COMPLETED|Post-study Treatment Phase||36
1746940|NCT00069095|4278770|P4|NOT COMPLETED|Post-study Treatment Phase||17
1746941|NCT00069095|4278771|P3|NOT COMPLETED|Post-study Treatment Phase||21
1746942|NCT00069095|4278772|P2|NOT COMPLETED|Post-study Treatment Phase||13
1746943|NCT00069095|4278773|P1|NOT COMPLETED|Post-study Treatment Phase||8
1746944|NCT00069095|4278768|P6|COMPLETED|Post-study Treatment Phase||0
1746945|NCT00069095|4278769|P5|COMPLETED|Post-study Treatment Phase||0
1746946|NCT00069095|4278770|P4|COMPLETED|Post-study Treatment Phase||0
1746947|NCT00069095|4278771|P3|COMPLETED|Post-study Treatment Phase||0
1746948|NCT00069095|4278772|P2|COMPLETED|Post-study Treatment Phase||0
1746949|NCT00069095|4278773|P1|COMPLETED|Post-study Treatment Phase||0
1746950|NCT00069095|4278768|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
1746951|NCT00069095|4278769|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
1746952|NCT00069095|4278770|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
1746953|NCT00069095|4278771|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
1746954|NCT00069095|4278772|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
1746955|NCT00069095|4278773|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
1746956|NCT00069095|4278768|P6|NOT COMPLETED|Primary Treatment Phase||301
1746957|NCT00069095|4278769|P5|NOT COMPLETED|Primary Treatment Phase||302
1746958|NCT00069095|4278770|P4|NOT COMPLETED|Primary Treatment Phase||320
1746959|NCT00069095|4278771|P3|NOT COMPLETED|Primary Treatment Phase||314
1746960|NCT00069095|4278772|P2|NOT COMPLETED|Primary Treatment Phase||302
1746961|NCT00069095|4278773|P1|NOT COMPLETED|Primary Treatment Phase||295
1746962|NCT00069095|4278768|P6|COMPLETED|Primary Treatment Phase||48
1746963|NCT00069095|4278769|P5|COMPLETED|Primary Treatment Phase||48
1746964|NCT00069095|4278770|P4|COMPLETED|Primary Treatment Phase||31
1746965|NCT00069095|4278771|P3|COMPLETED|Primary Treatment Phase||36
1746966|NCT00069095|4278772|P2|COMPLETED|Primary Treatment Phase||15
1746967|NCT00069095|4278773|P1|COMPLETED|Primary Treatment Phase||22
1746968|NCT00069095|4278768|P6|STARTED|Primary Treatment Phase||349
1746969|NCT00069095|4278769|P5|STARTED|Primary Treatment Phase||350
1746970|NCT00069095|4278770|P4|STARTED|Primary Treatment Phase||351
1746971|NCT00069095|4278771|P3|STARTED|Primary Treatment Phase||350
1746972|NCT00069095|4278772|P2|STARTED|Primary Treatment Phase||317
1746973|NCT00069095|4278773|P1|STARTED|Primary Treatment Phase||317
1746974|NCT00069160|4278827|P2|NOT COMPLETED|Overall Study||0
1746975|NCT00069160|4278828|P1|NOT COMPLETED|Overall Study||0
1746976|NCT00069160|4278827|P2|COMPLETED|Overall Study||25
1746977|NCT00069160|4278828|P1|COMPLETED|Overall Study||23
1746978|NCT00069160|4278827|P2|STARTED|Overall Study||25
1746979|NCT00069160|4278828|P1|STARTED|Overall Study||23
1746980|NCT00068822|4278843|P2|NOT COMPLETED|Optional Crossover Intervention||0
1746981|NCT00068822|4278844|P1|NOT COMPLETED|Optional Crossover Intervention||0
1746982|NCT00068822|4278843|P2|COMPLETED|Optional Crossover Intervention||29
1746983|NCT00068822|4278844|P1|COMPLETED|Optional Crossover Intervention||9
1746984|NCT00068822|4278843|P2|Crossover at Month 3|Optional Crossover Intervention||27
1746985|NCT00068822|4278844|P1|Crossover at Month 3|Optional Crossover Intervention||8
1746986|NCT00068822|4278843|P2|Crossover at Month 1|Optional Crossover Intervention||2
1746987|NCT00068822|4278844|P1|Crossover at Month 1|Optional Crossover Intervention||1
1746988|NCT00068822|4278843|P2|STARTED|Optional Crossover Intervention||29
1746989|NCT00068822|4278844|P1|STARTED|Optional Crossover Intervention||9
1746990|NCT00068822|4278843|P2|NOT COMPLETED|First Randomized Intervention||2
1746991|NCT00068822|4278844|P1|NOT COMPLETED|First Randomized Intervention||1
1746992|NCT00068822|4278843|P2|COMPLETED|First Randomized Intervention||61
1746993|NCT00068822|4278844|P1|COMPLETED|First Randomized Intervention||67
1746994|NCT00068822|4278843|P2|STARTED|First Randomized Intervention||63
1746995|NCT00068822|4278844|P1|STARTED|First Randomized Intervention||68
1746996|NCT00068770|4278856|P2|NOT COMPLETED|Overall Study||0
1746997|NCT00068770|4278857|P1|NOT COMPLETED|Overall Study||0
1746998|NCT00068770|4278856|P2|COMPLETED|Overall Study||22
1746999|NCT00068770|4278857|P1|COMPLETED|Overall Study||13
1747000|NCT00068770|4278856|P2|STARTED|Overall Study||22
1747001|NCT00068770|4278857|P1|STARTED|Overall Study||13
1747002|NCT00068718|4278865|P1|NOT COMPLETED|Overall Study||0
1747003|NCT00068718|4278865|P1|COMPLETED|Overall Study||35
1747004|NCT00068718|4278865|P1|STARTED|Overall Study||35
1747005|NCT00068692|4278878|P8|NOT COMPLETED|Step 2: Randomization||8
1747006|NCT00068692|4278879|P7|NOT COMPLETED|Step 2: Randomization||4
1747007|NCT00068692|4278880|P6|NOT COMPLETED|Step 2: Randomization||6
1747008|NCT00068692|4278881|P5|NOT COMPLETED|Step 2: Randomization||9
1747009|NCT00068692|4278882|P4|NOT COMPLETED|Step 2: Randomization||12
1747010|NCT00068692|4278883|P3|NOT COMPLETED|Step 2: Randomization||10
1747011|NCT00068692|4278884|P2|NOT COMPLETED|Step 2: Randomization||0
1747012|NCT00068692|4278885|P1|NOT COMPLETED|Step 2: Randomization||0
1747013|NCT00068692|4278878|P8|COMPLETED|Step 2: Randomization||24
1747014|NCT00068692|4278879|P7|COMPLETED|Step 2: Randomization||29
1747015|NCT00068692|4278880|P6|COMPLETED|Step 2: Randomization||25
1747016|NCT00068692|4278881|P5|COMPLETED|Step 2: Randomization||21
1747017|NCT00068692|4278882|P4|COMPLETED|Step 2: Randomization||13
1747018|NCT00068692|4278883|P3|COMPLETED|Step 2: Randomization||18
1747019|NCT00068692|4278884|P2|COMPLETED|Step 2: Randomization||0
1747020|NCT00068692|4278885|P1|COMPLETED|Step 2: Randomization||0
1747021|NCT00068692|4278878|P8|Reported AE Data|Step 2: Randomization||32
1747022|NCT00068692|4278879|P7|Reported AE Data|Step 2: Randomization||33
1747023|NCT00068692|4278880|P6|Reported AE Data|Step 2: Randomization||31
1747024|NCT00068692|4278881|P5|Reported AE Data|Step 2: Randomization||28
1747025|NCT00068692|4278882|P4|Reported AE Data|Step 2: Randomization||22
1747026|NCT00068692|4278883|P3|Reported AE Data|Step 2: Randomization||27
1747027|NCT00068692|4278884|P2|Reported AE Data|Step 2: Randomization||0
1747028|NCT00068692|4278885|P1|Reported AE Data|Step 2: Randomization||0
1747029|NCT00068692|4278878|P8|Had Sphincter Preservation|Step 2: Randomization||30
1747030|NCT00068692|4278879|P7|Had Sphincter Preservation|Step 2: Randomization||33
1747031|NCT00068692|4278880|P6|Had Sphincter Preservation|Step 2: Randomization||31
1747032|NCT00068692|4278881|P5|Had Sphincter Preservation|Step 2: Randomization||28
1747033|NCT00068692|4278882|P4|Had Sphincter Preservation|Step 2: Randomization||25
1747034|NCT00068692|4278883|P3|Had Sphincter Preservation|Step 2: Randomization||28
1747035|NCT00068692|4278884|P2|Had Sphincter Preservation|Step 2: Randomization||0
1747036|NCT00068692|4278885|P1|Had Sphincter Preservation|Step 2: Randomization||0
1747037|NCT00068692|4278878|P8|Treated|Step 2: Randomization||32
1747038|NCT00068692|4278879|P7|Treated|Step 2: Randomization||33
1747039|NCT00068692|4278880|P6|Treated|Step 2: Randomization||31
1747040|NCT00068692|4278881|P5|Treated|Step 2: Randomization||29
1747041|NCT00068692|4278882|P4|Treated|Step 2: Randomization||25
1747042|NCT00068692|4278883|P3|Treated|Step 2: Randomization||27
1747043|NCT00068692|4278884|P2|Treated|Step 2: Randomization||0
1747044|NCT00068692|4278885|P1|Treated|Step 2: Randomization||0
1747045|NCT00068692|4278878|P8|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
1747046|NCT00068692|4278879|P7|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
1747047|NCT00068692|4278880|P6|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
1747048|NCT00068692|4278881|P5|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
1747049|NCT00068692|4278882|P4|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
1747050|NCT00068692|4278883|P3|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
1747051|NCT00068692|4278884|P2|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
1747052|NCT00068692|4278885|P1|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
1747053|NCT00068692|4278878|P8|NOT COMPLETED|Step 1: Registration||0
1747054|NCT00068692|4278879|P7|NOT COMPLETED|Step 1: Registration||0
1747055|NCT00068692|4278880|P6|NOT COMPLETED|Step 1: Registration||0
1747056|NCT00068692|4278881|P5|NOT COMPLETED|Step 1: Registration||0
1747057|NCT00068692|4278882|P4|NOT COMPLETED|Step 1: Registration||0
1747058|NCT00068692|4278883|P3|NOT COMPLETED|Step 1: Registration||0
1747059|NCT00068692|4278884|P2|NOT COMPLETED|Step 1: Registration||1
1747060|NCT00068692|4278885|P1|NOT COMPLETED|Step 1: Registration||40
1747061|NCT00068692|4278878|P8|COMPLETED|Step 1: Registration||0
1747062|NCT00068692|4278879|P7|COMPLETED|Step 1: Registration||0
1747063|NCT00068692|4278880|P6|COMPLETED|Step 1: Registration||0
1747064|NCT00068692|4278881|P5|COMPLETED|Step 1: Registration||0
1747065|NCT00068692|4278882|P4|COMPLETED|Step 1: Registration||0
1747066|NCT00068692|4278883|P3|COMPLETED|Step 1: Registration||0
1747067|NCT00068692|4278884|P2|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
1747068|NCT00068692|4278885|P1|COMPLETED|Step 1: Registration||88
1747069|NCT00068692|4278878|P8|Reported AE Data|Step 1: Registration||0
1747070|NCT00068692|4278879|P7|Reported AE Data|Step 1: Registration||0
1747071|NCT00068692|4278880|P6|Reported AE Data|Step 1: Registration||0
1747072|NCT00068692|4278881|P5|Reported AE Data|Step 1: Registration||0
1747073|NCT00068692|4278882|P4|Reported AE Data|Step 1: Registration||0
1747074|NCT00068692|4278883|P3|Reported AE Data|Step 1: Registration||0
1747075|NCT00068692|4278884|P2|Reported AE Data|Step 1: Registration||0
1747076|NCT00068692|4278885|P1|Reported AE Data|Step 1: Registration||123
1747077|NCT00068692|4278878|P8|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1747078|NCT00068692|4278879|P7|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1747079|NCT00068692|4278880|P6|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1747080|NCT00068692|4278881|P5|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1747081|NCT00068692|4278882|P4|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1747082|NCT00068692|4278883|P3|Started Concurrent Chemo/Radiation|Step 1: Registration||0
1747083|NCT00068692|4278884|P2|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
1747084|NCT00068692|4278885|P1|Started Concurrent Chemo/Radiation|Step 1: Registration||125
1747085|NCT00068692|4278878|P8|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
1747086|NCT00068692|4278879|P7|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
1747087|NCT00068692|4278880|P6|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
1747088|NCT00068692|4278881|P5|STARTED|Step 1: Registration||0
1747089|NCT00068692|4278882|P4|STARTED|Step 1: Registration||0
1747090|NCT00068692|4278883|P3|STARTED|Step 1: Registration||0
1747091|NCT00068692|4278884|P2|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
1747092|NCT00068692|4278885|P1|STARTED|Step 1: Registration||128
1747093|NCT00068601|4278908|P2|NOT COMPLETED|Overall Study||60
1747094|NCT00068601|4278909|P1|NOT COMPLETED|Overall Study||62
1747095|NCT00068601|4278908|P2|COMPLETED|Overall Study||66
1747096|NCT00068601|4278909|P1|COMPLETED|Overall Study||69
1747097|NCT00068601|4278908|P2|STARTED|Overall Study||126
1747098|NCT00068601|4278909|P1|STARTED|Overall Study||131
1747099|NCT00068588|4278922|P3|NOT COMPLETED|Overall Study||4
1747100|NCT00068588|4278923|P2|NOT COMPLETED|Overall Study||0
1747101|NCT00068588|4278924|P1|NOT COMPLETED|Overall Study||0
1747102|NCT00068588|4278922|P3|COMPLETED|Overall Study||17
1747103|NCT00068588|4278923|P2|COMPLETED|Overall Study||3
1747104|NCT00068588|4278924|P1|COMPLETED|Overall Study||0
1747105|NCT00068588|4278922|P3|STARTED|Overall Study||21
1747106|NCT00068588|4278923|P2|STARTED|Overall Study||3
1747107|NCT00068588|4278924|P1|STARTED|Overall Study||0
1747108|NCT00068575|4278934|P1|NOT COMPLETED|Overall Study||0
1747109|NCT00068575|4278934|P1|COMPLETED|Overall Study||28
1747110|NCT00068575|4278934|P1|STARTED|Overall Study||28
1747111|NCT00068445|4278940|P2|NOT COMPLETED|Treatment||16
1747112|NCT00068445|4278941|P1|NOT COMPLETED|Treatment||29
1747113|NCT00068445|4278940|P2|COMPLETED|Treatment||46
1747114|NCT00068445|4278941|P1|COMPLETED|Treatment||34
1747115|NCT00068445|4278940|P2|STARTED|Treatment||62
1747116|NCT00068445|4278941|P1|STARTED|Treatment||63
1747117|NCT00068445|4278940|P2|NOT COMPLETED|Randomization||4
1747118|NCT00068445|4278941|P1|NOT COMPLETED|Randomization||2
1747119|NCT00068445|4278940|P2|COMPLETED|Randomization||62
1747120|NCT00068445|4278941|P1|COMPLETED|Randomization||63
1747121|NCT00068445|4278940|P2|STARTED|Randomization||66
1747122|NCT00068445|4278941|P1|STARTED|Randomization||65
1747123|NCT00068419|4278965|P1|NOT COMPLETED|Overall Study||60
1747124|NCT00068419|4278965|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
1747125|NCT00068419|4278965|P1|STARTED|Overall Study||70
1747126|NCT00068406|4278969|P1|NOT COMPLETED|Overall Study||3
1747127|NCT00068406|4278969|P1|COMPLETED|Overall Study||58
1747128|NCT00068406|4278969|P1|STARTED|Overall Study||61
1747129|NCT00068393|4278974|P1|NOT COMPLETED|Overall Study||10
1747130|NCT00068393|4278974|P1|COMPLETED|Overall Study||29
1747131|NCT00068393|4278974|P1|Eligible and Treated|Overall Study||38
1747132|NCT00068393|4278974|P1|STARTED|Overall Study||39
1747133|NCT00068380|4278980|P1|NOT COMPLETED|Overall Study||5
1747134|NCT00068380|4278980|P1|COMPLETED|Overall Study||12
1747135|NCT00068380|4278980|P1|STARTED|Overall Study||17
1747136|NCT00068367|4278989|P1|NOT COMPLETED|Overall Study||0
1747137|NCT00068367|4278989|P1|COMPLETED|Overall Study||20
1747138|NCT00068367|4278989|P1|STARTED|Overall Study||20
1747139|NCT00068341|4278998|P3|NOT COMPLETED|Overall Study||0
1747140|NCT00068341|4278999|P2|NOT COMPLETED|Overall Study||0
1747141|NCT00068341|4279000|P1|NOT COMPLETED|Overall Study||0
1747142|NCT00068341|4278998|P3|COMPLETED|Overall Study||44
1747143|NCT00068341|4278999|P2|COMPLETED|Overall Study||15
1747144|NCT00068341|4279000|P1|COMPLETED|Overall Study||15
1747145|NCT00068341|4278998|P3|STARTED|Overall Study||44
1747146|NCT00068341|4278999|P2|STARTED|Overall Study||15
1747147|NCT00068341|4279000|P1|STARTED|Overall Study||15
1747148|NCT00068250|4279024|P4|NOT COMPLETED|Phase II: Dose Level 2||0
1747149|NCT00068250|4279025|P3|NOT COMPLETED|Phase II: Dose Level 2||0
1747150|NCT00068250|4279026|P2|NOT COMPLETED|Phase II: Dose Level 2||0
1747151|NCT00068250|4279027|P1|NOT COMPLETED|Phase II: Dose Level 2||0
1747152|NCT00068250|4279024|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
1747153|NCT00068250|4279025|P3|COMPLETED|Phase II: Dose Level 2||0
1747154|NCT00068250|4279026|P2|COMPLETED|Phase II: Dose Level 2||0
1747155|NCT00068250|4279027|P1|COMPLETED|Phase II: Dose Level 2||0
1747156|NCT00068250|4279024|P4|STARTED|Phase II: Dose Level 2||47
1747157|NCT00068250|4279025|P3|STARTED|Phase II: Dose Level 2||0
1747158|NCT00068250|4279026|P2|STARTED|Phase II: Dose Level 2||0
1747159|NCT00068250|4279027|P1|STARTED|Phase II: Dose Level 2||0
1747160|NCT00068250|4279024|P4|NOT COMPLETED|Phase I: Dose Level 2||0
1747161|NCT00068250|4279025|P3|NOT COMPLETED|Phase I: Dose Level 2||0
1747162|NCT00068250|4279026|P2|NOT COMPLETED|Phase I: Dose Level 2||1
1747163|NCT00068250|4279027|P1|NOT COMPLETED|Phase I: Dose Level 2||0
1747164|NCT00068250|4279024|P4|COMPLETED|Phase I: Dose Level 2||0
1747165|NCT00068250|4279025|P3|COMPLETED|Phase I: Dose Level 2||0
1747166|NCT00068250|4279026|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
1747167|NCT00068250|4279027|P1|COMPLETED|Phase I: Dose Level 2||0
1747168|NCT00068250|4279024|P4|STARTED|Phase I: Dose Level 2||0
1747169|NCT00068250|4279025|P3|STARTED|Phase I: Dose Level 2||0
1747170|NCT00068250|4279026|P2|STARTED|Phase I: Dose Level 2||7
1747171|NCT00068250|4279027|P1|STARTED|Phase I: Dose Level 2||0
1747172|NCT00068250|4279024|P4|NOT COMPLETED|Phase I: Dose Level 1||0
1747173|NCT00068250|4279025|P3|NOT COMPLETED|Phase I: Dose Level 1||0
1747174|NCT00068250|4279026|P2|NOT COMPLETED|Phase I: Dose Level 1||0
1747175|NCT00068250|4279027|P1|NOT COMPLETED|Phase I: Dose Level 1||0
1747176|NCT00068250|4279024|P4|COMPLETED|Phase I: Dose Level 1||0
1747177|NCT00068250|4279025|P3|COMPLETED|Phase I: Dose Level 1||0
1747178|NCT00068250|4279026|P2|COMPLETED|Phase I: Dose Level 1||0
1747179|NCT00068250|4279027|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
1747180|NCT00068250|4279024|P4|STARTED|Phase I: Dose Level 1||0
1747181|NCT00068250|4279025|P3|STARTED|Phase I: Dose Level 1||0
1747182|NCT00068250|4279026|P2|STARTED|Phase I: Dose Level 1||0
1747183|NCT00068250|4279027|P1|STARTED|Phase I: Dose Level 1||6
1747184|NCT00068237|4279037|P1|NOT COMPLETED|Overall Study||5
1747185|NCT00068237|4279037|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
1747186|NCT00068237|4279037|P1|STARTED|Overall Study||49
1747187|NCT00068107|4279041|P1|NOT COMPLETED|Overall Study||9
1747188|NCT00068107|4279041|P1|COMPLETED|Overall Study||3
1747189|NCT00068107|4279041|P1|STARTED|Overall Study||12
1747190|NCT00067990|4279054|P2|NOT COMPLETED|Overall Study||22
1747191|NCT00067990|4279055|P1|NOT COMPLETED|Overall Study||10
1747192|NCT00067990|4279054|P2|COMPLETED|Overall Study||54
1747193|NCT00067990|4279055|P1|COMPLETED|Overall Study||67
1747194|NCT00067990|4279054|P2|STARTED|Overall Study||76
1747195|NCT00067990|4279055|P1|STARTED|Overall Study||77
1747196|NCT00067808|4279066|P3|NOT COMPLETED|Overall Study||0
1747197|NCT00067808|4279067|P2|NOT COMPLETED|Overall Study||0
1747198|NCT00067808|4279068|P1|NOT COMPLETED|Overall Study||0
1747199|NCT00067808|4279066|P3|COMPLETED|Overall Study||14
1747200|NCT00067808|4279067|P2|COMPLETED|Overall Study||93
1747201|NCT00067808|4279068|P1|COMPLETED|Overall Study||17
1747202|NCT00067808|4279066|P3|STARTED|Overall Study||14
1747203|NCT00067808|4279067|P2|STARTED|Overall Study||93
1747204|NCT00067808|4279068|P1|STARTED|Overall Study||17
1747205|NCT00067470|4279078|P2|NOT COMPLETED|Overall Study||1
1747206|NCT00067470|4279079|P1|NOT COMPLETED|Overall Study||0
1747207|NCT00067470|4279078|P2|COMPLETED|Overall Study||19
1747208|NCT00067470|4279079|P1|COMPLETED|Overall Study||19
1747209|NCT00067470|4279078|P2|STARTED|Overall Study||20
1747210|NCT00067470|4279079|P1|STARTED|Overall Study||19
1747211|NCT00067236|4279091|P2|NOT COMPLETED|Overall Study||26
1747212|NCT00067236|4279092|P1|NOT COMPLETED|Overall Study||20
1747213|NCT00067236|4279091|P2|COMPLETED|Overall Study||99
1747214|NCT00067236|4279092|P1|COMPLETED|Overall Study||108
1747215|NCT00067236|4279091|P2|STARTED|Overall Study||125
1747216|NCT00067236|4279092|P1|STARTED|Overall Study||128
1747217|NCT00066963|4279101|P3|NOT COMPLETED|Overall Study||39
1747218|NCT00066963|4279102|P2|NOT COMPLETED|Overall Study||31
1747219|NCT00066963|4279103|P1|NOT COMPLETED|Overall Study||26
1747220|NCT00066963|4279101|P3|COMPLETED|Overall Study||87
1747221|NCT00066963|4279102|P2|COMPLETED|Overall Study||93
1747222|NCT00066963|4279103|P1|COMPLETED|Overall Study|any follow-up|100
1747223|NCT00066963|4279101|P3|STARTED|Overall Study||126
1747224|NCT00066963|4279102|P2|STARTED|Overall Study||124
1747225|NCT00066963|4279103|P1|STARTED|Overall Study||126
1747226|NCT00066937|4279115|P4|NOT COMPLETED|6 Month Follow-up||1
1747227|NCT00066937|4279116|P3|NOT COMPLETED|6 Month Follow-up||3
1747228|NCT00066937|4279117|P2|NOT COMPLETED|6 Month Follow-up||3
1747229|NCT00066937|4279118|P1|NOT COMPLETED|6 Month Follow-up||7
1747230|NCT00066937|4279115|P4|COMPLETED|6 Month Follow-up||14
1747231|NCT00066937|4279116|P3|COMPLETED|6 Month Follow-up||22
1747232|NCT00066937|4279117|P2|COMPLETED|6 Month Follow-up||29
1747233|NCT00066937|4279118|P1|COMPLETED|6 Month Follow-up||26
1747234|NCT00066937|4279115|P4|STARTED|6 Month Follow-up||15
1747235|NCT00066937|4279116|P3|STARTED|6 Month Follow-up||25
1747236|NCT00066937|4279117|P2|STARTED|6 Month Follow-up||32
1747237|NCT00066937|4279118|P1|STARTED|6 Month Follow-up||33
1747238|NCT00066937|4279115|P4|NOT COMPLETED|3 Month Follow-up||4
1747239|NCT00066937|4279116|P3|NOT COMPLETED|3 Month Follow-up||1
1747240|NCT00066937|4279117|P2|NOT COMPLETED|3 Month Follow-up||1
1747241|NCT00066937|4279118|P1|NOT COMPLETED|3 Month Follow-up||5
1747242|NCT00066937|4279115|P4|COMPLETED|3 Month Follow-up||15
1747243|NCT00066937|4279116|P3|COMPLETED|3 Month Follow-up||25
1747244|NCT00066937|4279117|P2|COMPLETED|3 Month Follow-up||32
1747245|NCT00066937|4279118|P1|COMPLETED|3 Month Follow-up||33
1747246|NCT00066937|4279115|P4|STARTED|3 Month Follow-up||19
1747247|NCT00066937|4279116|P3|STARTED|3 Month Follow-up||26
1747248|NCT00066937|4279117|P2|STARTED|3 Month Follow-up||33
1747249|NCT00066937|4279118|P1|STARTED|3 Month Follow-up||38
1747250|NCT00066937|4279115|P4|NOT COMPLETED|Treatment Phase||5
1747251|NCT00066937|4279116|P3|NOT COMPLETED|Treatment Phase||11
1747252|NCT00066937|4279117|P2|NOT COMPLETED|Treatment Phase||5
1747253|NCT00066937|4279118|P1|NOT COMPLETED|Treatment Phase||3
1747254|NCT00066937|4279115|P4|COMPLETED|Treatment Phase||19
1747255|NCT00066937|4279116|P3|COMPLETED|Treatment Phase||26
1747256|NCT00066937|4279117|P2|COMPLETED|Treatment Phase||33
1747257|NCT00066937|4279118|P1|COMPLETED|Treatment Phase||38
1747258|NCT00066937|4279115|P4|STARTED|Treatment Phase||24
1747259|NCT00066937|4279116|P3|STARTED|Treatment Phase||37
1747260|NCT00066937|4279117|P2|STARTED|Treatment Phase||38
1747261|NCT00066937|4279118|P1|STARTED|Treatment Phase||41
1747262|NCT00066807|4279142|P2|NOT COMPLETED|Overall Study||15
1747263|NCT00066807|4279143|P1|NOT COMPLETED|Overall Study||14
1747264|NCT00066807|4279142|P2|COMPLETED|Overall Study||0
1747265|NCT00066807|4279143|P1|COMPLETED|Overall Study||0
1747266|NCT00066807|4279142|P2|STARTED|Overall Study||15
1747267|NCT00066807|4279143|P1|STARTED|Overall Study||14
1747268|NCT00066781|4279157|P2|NOT COMPLETED|Overall Study||0
1747269|NCT00066781|4279158|P1|NOT COMPLETED|Overall Study||0
1747270|NCT00066781|4279157|P2|COMPLETED|Overall Study||17
1747271|NCT00066781|4279158|P1|COMPLETED|Overall Study||14
1747272|NCT00066781|4279157|P2|STARTED|Overall Study||17
1747273|NCT00066781|4279158|P1|STARTED|Overall Study||14
1747274|NCT00066742|4279168|P1|NOT COMPLETED|Consolidation Chemotherapy||3
1747275|NCT00066742|4279168|P1|COMPLETED|Consolidation Chemotherapy||39
1747276|NCT00066742|4279168|P1|Eligible|Consolidation Chemotherapy||40
1747277|NCT00066742|4279168|P1|STARTED|Consolidation Chemotherapy||42
1747278|NCT00066742|4279168|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
1747279|NCT00066742|4279168|P1|COMPLETED|Induction Chemoradiotherapy||43
1747280|NCT00066742|4279168|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
1747281|NCT00066742|4279168|P1|Eligible|Induction Chemoradiotherapy||69
1747282|NCT00066742|4279168|P1|STARTED|Induction Chemoradiotherapy||72
1747283|NCT00066703|4279177|P2|NOT COMPLETED|Overall Study||582
1747284|NCT00066703|4279178|P1|NOT COMPLETED|Overall Study||612
1747285|NCT00066703|4279177|P2|COMPLETED|Overall Study||756
1747286|NCT00066703|4279178|P1|COMPLETED|Overall Study||722
1747287|NCT00066703|4279177|P2|STARTED|Overall Study||1338
1747288|NCT00066703|4279178|P1|STARTED|Overall Study||1334
1747289|NCT00066690|4279191|P3|NOT COMPLETED|Overall Study||564
1747290|NCT00066690|4279192|P2|NOT COMPLETED|Overall Study||522
1747291|NCT00066690|4279193|P1|NOT COMPLETED|Overall Study||598
1747292|NCT00066690|4279191|P3|COMPLETED|Overall Study||457
1747293|NCT00066690|4279192|P2|COMPLETED|Overall Study||502
1747294|NCT00066690|4279193|P1|COMPLETED|Overall Study||423
1747295|NCT00066690|4279191|P3|STARTED|Overall Study||1021
1747296|NCT00066690|4279192|P2|STARTED|Overall Study||1024
1747297|NCT00066690|4279193|P1|STARTED|Overall Study||1021
1747298|NCT00066573|4279209|P2|NOT COMPLETED|Overall Study||28
1747299|NCT00066573|4279210|P1|NOT COMPLETED|Overall Study||28
1747300|NCT00066573|4279209|P2|COMPLETED|Overall Study||3759
1747301|NCT00066573|4279210|P1|COMPLETED|Overall Study||3761
1747302|NCT00066573|4279209|P2|STARTED|Overall Study||3787
1747303|NCT00066573|4279210|P1|STARTED|Overall Study||3789
1747304|NCT00066469|4279222|P1|NOT COMPLETED|Overall Study||16
1747305|NCT00066469|4279222|P1|COMPLETED|Overall Study||39
1747306|NCT00066469|4279222|P1|STARTED|Overall Study||55
1747307|NCT00066365|4279228|P2|NOT COMPLETED|Overall Study||14
1747308|NCT00066365|4279229|P1|NOT COMPLETED|Overall Study||23
1747309|NCT00066365|4279228|P2|COMPLETED|Overall Study||4
1747310|NCT00066365|4279229|P1|COMPLETED|Overall Study||8
1747311|NCT00066365|4279228|P2|STARTED|Overall Study||18
1747312|NCT00066365|4279229|P1|STARTED|Overall Study||31
1747313|NCT00066222|4279257|P1|NOT COMPLETED|Overall Study||1
1747314|NCT00066222|4279257|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
1747315|NCT00066222|4279257|P1|STARTED|Overall Study||72
1747316|NCT00066170|4279270|P4|NOT COMPLETED|Overall Study||9
1747317|NCT00066170|4279271|P3|NOT COMPLETED|Overall Study||4
1747318|NCT00066170|4279272|P2|NOT COMPLETED|Overall Study||10
1747319|NCT00066170|4279273|P1|NOT COMPLETED|Overall Study||7
1747320|NCT00066170|4279270|P4|COMPLETED|Overall Study||48
1747321|NCT00066170|4279271|P3|COMPLETED|Overall Study||59
1747322|NCT00066170|4279272|P2|COMPLETED|Overall Study||45
1747323|NCT00066170|4279273|P1|COMPLETED|Overall Study||49
1747324|NCT00066170|4279270|P4|Intent to Treat|Overall Study||54
1747325|NCT00066170|4279271|P3|Intent to Treat|Overall Study||63
1747326|NCT00066170|4279272|P2|Intent to Treat|Overall Study||50
1747327|NCT00066170|4279273|P1|Intent to Treat|Overall Study||55
1747328|NCT00066170|4279270|P4|STARTED|Overall Study||57
1747329|NCT00066170|4279271|P3|STARTED|Overall Study||63
1747330|NCT00066170|4279272|P2|STARTED|Overall Study||55
1747331|NCT00066170|4279273|P1|STARTED|Overall Study||56
1747332|NCT00066066|4279286|P6|NOT COMPLETED|Overall Study||5
1747333|NCT00066066|4279287|P5|NOT COMPLETED|Overall Study||3
1747334|NCT00066066|4279288|P4|NOT COMPLETED|Overall Study||4
1747335|NCT00066066|4279289|P3|NOT COMPLETED|Overall Study||7
1747336|NCT00066066|4279290|P2|NOT COMPLETED|Overall Study||4
1747337|NCT00066066|4279291|P1|NOT COMPLETED|Overall Study||6
1747338|NCT00066066|4279286|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
1747339|NCT00066066|4279287|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
1747340|NCT00066066|4279288|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
1747341|NCT00066066|4279289|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
1747342|NCT00066066|4279290|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
1747343|NCT00066066|4279291|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
1747344|NCT00066066|4279286|P6|12 Month|Overall Study||9
1747345|NCT00066066|4279287|P5|12 Month|Overall Study||19
1747346|NCT00066066|4279288|P4|12 Month|Overall Study||11
1747347|NCT00066066|4279289|P3|12 Month|Overall Study||21
1747348|NCT00066066|4279290|P2|12 Month|Overall Study||11
1747349|NCT00066066|4279291|P1|12 Month|Overall Study||18
1747350|NCT00066066|4279286|P6|6 Month|Overall Study||14
1747351|NCT00066066|4279287|P5|6 Month|Overall Study||21
1747352|NCT00066066|4279288|P4|6 Month|Overall Study||13
1747353|NCT00066066|4279289|P3|6 Month|Overall Study||23
1747354|NCT00066066|4279290|P2|6 Month|Overall Study||13
1747355|NCT00066066|4279291|P1|6 Month|Overall Study||19
1747356|NCT00066066|4279286|P6|3 Month|Overall Study||15
1747357|NCT00066066|4279287|P5|3 Month|Overall Study||22
1747358|NCT00066066|4279288|P4|3 Month|Overall Study||16
1747359|NCT00066066|4279289|P3|3 Month|Overall Study||23
1747360|NCT00066066|4279290|P2|3 Month|Overall Study||17
1747361|NCT00066066|4279291|P1|3 Month|Overall Study||21
1747362|NCT00066066|4279286|P6|Baseline|Overall Study||20
1747363|NCT00066066|4279287|P5|Baseline|Overall Study||27
1747364|NCT00066066|4279288|P4|Baseline|Overall Study||20
1747365|NCT00066066|4279289|P3|Baseline|Overall Study||30
1747366|NCT00066066|4279290|P2|Baseline|Overall Study||22
1747367|NCT00066066|4279291|P1|Baseline|Overall Study||27
1747368|NCT00066066|4279286|P6|STARTED|Overall Study||20
1747369|NCT00066066|4279287|P5|STARTED|Overall Study||27
1747370|NCT00066066|4279288|P4|STARTED|Overall Study||20
1747371|NCT00066066|4279289|P3|STARTED|Overall Study||30
1747372|NCT00066066|4279290|P2|STARTED|Overall Study||22
1747373|NCT00066066|4279291|P1|STARTED|Overall Study||27
1747374|NCT00065806|4279307|P2|NOT COMPLETED|Overall Study||19
1747375|NCT00065806|4279308|P1|NOT COMPLETED|Overall Study||20
1747376|NCT00065806|4279307|P2|COMPLETED|Overall Study||89
1747377|NCT00065806|4279308|P1|COMPLETED|Overall Study||93
1747378|NCT00065806|4279307|P2|STARTED|Overall Study||108
1747379|NCT00065806|4279308|P1|STARTED|Overall Study||113
1747380|NCT00014560|4279350|P1|NOT COMPLETED|Overall Study||3
1747381|NCT00014560|4279350|P1|COMPLETED|Overall Study||0
1747382|NCT00014560|4279350|P1|STARTED|Overall Study||3
1747383|NCT00065611|4279356|P2|NOT COMPLETED|Overall Study||1
1747384|NCT00065611|4279357|P1|NOT COMPLETED|Overall Study||0
1747385|NCT00065611|4279356|P2|COMPLETED|Overall Study||3
1747386|NCT00065611|4279357|P1|COMPLETED|Overall Study||4
1747387|NCT00065611|4279356|P2|STARTED|Overall Study||4
1747388|NCT00065611|4279357|P1|STARTED|Overall Study||4
1747389|NCT00065507|4279369|P2|NOT COMPLETED|Overall Study||29
1747390|NCT00065507|4279370|P1|NOT COMPLETED|Overall Study||29
1747391|NCT00065507|4279369|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
1747392|NCT00065507|4279370|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
1747393|NCT00065507|4279369|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
1747394|NCT00065507|4279370|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
1747395|NCT00065507|4279369|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
1747396|NCT00065507|4279370|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
1747397|NCT00065507|4279369|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
1747398|NCT00065507|4279370|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
1747399|NCT00065507|4279369|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
1747400|NCT00065507|4279370|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
1747401|NCT00065507|4279369|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
1747402|NCT00065507|4279370|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
1747403|NCT00065468|4279435|P3|NOT COMPLETED|Overall Study||210
1747404|NCT00065468|4279436|P2|NOT COMPLETED|Overall Study||209
1747405|NCT00065468|4279437|P1|NOT COMPLETED|Overall Study||207
1747406|NCT00065468|4279435|P3|COMPLETED|Overall Study||0
1747407|NCT00065468|4279436|P2|COMPLETED|Overall Study||0
1747408|NCT00065468|4279437|P1|COMPLETED|Overall Study||0
1747409|NCT00065468|4279435|P3|Received Treatment|Overall Study||208
1747410|NCT00065468|4279436|P2|Received Treatment|Overall Study||208
1747411|NCT00065468|4279437|P1|Received Treatment|Overall Study||200
1747412|NCT00065468|4279435|P3|STARTED|Overall Study||210
1747413|NCT00065468|4279436|P2|STARTED|Overall Study||209
1747414|NCT00065468|4279437|P1|STARTED|Overall Study||207
1747415|NCT00065442|4279468|P2|NOT COMPLETED|Overall Study||220
1747416|NCT00065442|4279469|P1|NOT COMPLETED|Overall Study||125
1747417|NCT00065442|4279468|P2|COMPLETED|Overall Study||121
1747418|NCT00065442|4279469|P1|COMPLETED|Overall Study||46
1747419|NCT00065442|4279468|P2|STARTED|Overall Study||341
1747420|NCT00065442|4279469|P1|STARTED|Overall Study||171
1747421|NCT00065429|4279484|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747422|NCT00065429|4279485|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747423|NCT00065429|4279486|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
1747424|NCT00065429|4279487|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747425|NCT00065429|4279488|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747426|NCT00065429|4279489|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747427|NCT00065429|4279490|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747428|NCT00065429|4279484|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747429|NCT00065429|4279485|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747430|NCT00065429|4279486|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
1747431|NCT00065429|4279487|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747432|NCT00065429|4279488|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747433|NCT00065429|4279489|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747434|NCT00065429|4279490|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
1747435|NCT00065429|4279484|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1747436|NCT00065429|4279485|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1747437|NCT00065429|4279486|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
1747438|NCT00065429|4279487|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1747439|NCT00065429|4279488|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1747440|NCT00065429|4279489|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1747441|NCT00065429|4279490|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
1747442|NCT00065429|4279484|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
1747443|NCT00065429|4279485|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
1747444|NCT00065429|4279486|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
1747445|NCT00065429|4279487|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
1747446|NCT00065429|4279488|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
1747447|NCT00065429|4279489|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
1747448|NCT00065429|4279490|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
1747449|NCT00065429|4279484|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
1747450|NCT00065429|4279485|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
1747451|NCT00065429|4279486|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
1747452|NCT00065429|4279487|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
1747453|NCT00065429|4279488|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
1747454|NCT00065429|4279489|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
1747455|NCT00065429|4279490|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
1747456|NCT00065429|4279484|P7|STARTED|Phase I - May 2001 - Oct 2002||4
1747457|NCT00065429|4279485|P6|STARTED|Phase I - May 2001 - Oct 2002||4
1747458|NCT00065429|4279486|P5|STARTED|Phase I - May 2001 - Oct 2002||9
1747459|NCT00065429|4279487|P4|STARTED|Phase I - May 2001 - Oct 2002||4
1747460|NCT00065429|4279488|P3|STARTED|Phase I - May 2001 - Oct 2002||4
1747461|NCT00065429|4279489|P2|STARTED|Phase I - May 2001 - Oct 2002||3
1747462|NCT00065429|4279490|P1|STARTED|Phase I - May 2001 - Oct 2002||4
1747463|NCT00065260|4279504|P2|NOT COMPLETED|Overall Study||1
1747464|NCT00065260|4279505|P1|NOT COMPLETED|Overall Study||0
1747465|NCT00065260|4279504|P2|COMPLETED|Overall Study||26
1747466|NCT00065260|4279505|P1|COMPLETED|Overall Study||27
1747467|NCT00065260|4279504|P2|STARTED|Overall Study||27
1747468|NCT00065260|4279505|P1|STARTED|Overall Study||27
1747469|NCT00065156|4279511|P1|NOT COMPLETED|Overall Study||124
1747470|NCT00065156|4279511|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
1747471|NCT00065156|4279511|P1|Modified Intent to Treat Population|Overall Study||94
1747472|NCT00065156|4279511|P1|STARTED|Overall Study||148
1747473|NCT00065065|4279528|P2|NOT COMPLETED|Overall Study||20
1747474|NCT00065065|4279529|P1|NOT COMPLETED|Overall Study||10
1747475|NCT00065065|4279528|P2|COMPLETED|Overall Study||33
1747476|NCT00065065|4279529|P1|COMPLETED|Overall Study||42
1747477|NCT00065065|4279528|P2|STARTED|Overall Study||53
1747478|NCT00065065|4279529|P1|STARTED|Overall Study||52
1747479|NCT00003895|4279541|P2|NOT COMPLETED|Overall Study||4
1747480|NCT00003895|4279542|P1|NOT COMPLETED|Overall Study||7
1747481|NCT00003895|4279541|P2|COMPLETED|Overall Study||14
1747482|NCT00003895|4279542|P1|COMPLETED|Overall Study||11
1747483|NCT00003895|4279541|P2|STARTED|Overall Study||18
1747484|NCT00003895|4279542|P1|STARTED|Overall Study||18
1747485|NCT00064987|4279550|P2|NOT COMPLETED|Overall Study||0
1747486|NCT00064987|4279551|P1|NOT COMPLETED|Overall Study||3
1747487|NCT00064987|4279550|P2|COMPLETED|Overall Study||6
1747488|NCT00064987|4279551|P1|COMPLETED|Overall Study||7
1747489|NCT00064987|4279550|P2|STARTED|Overall Study||6
1747490|NCT00064987|4279551|P1|STARTED|Overall Study||10
1747491|NCT00064844|4279571|P2|NOT COMPLETED|Overall Study||19
1747492|NCT00064844|4279572|P1|NOT COMPLETED|Overall Study||8
1747493|NCT00064844|4279571|P2|COMPLETED|Overall Study||32
1747494|NCT00064844|4279572|P1|COMPLETED|Overall Study||37
1747495|NCT00064844|4279571|P2|12 Month Follow-up|Overall Study||32
1747496|NCT00064844|4279572|P1|12 Month Follow-up|Overall Study||37
1747497|NCT00064844|4279571|P2|6 Month Follow-up|Overall Study||40
1747498|NCT00064844|4279572|P1|6 Month Follow-up|Overall Study||39
1747499|NCT00064844|4279571|P2|3 Month Follow-up|Overall Study||47
1747500|NCT00064844|4279572|P1|3 Month Follow-up|Overall Study||40
1747501|NCT00064844|4279571|P2|2 Week Follow-up|Overall Study||51
1747502|NCT00064844|4279572|P1|2 Week Follow-up|Overall Study||45
1747503|NCT00064844|4279571|P2|STARTED|Overall Study||51
1747504|NCT00064844|4279572|P1|STARTED|Overall Study||45
1747505|NCT00064753|4279582|P2|NOT COMPLETED|Overall Study||648
1747506|NCT00064753|4279583|P1|NOT COMPLETED|Overall Study||674
1747507|NCT00064753|4279582|P2|COMPLETED|Overall Study||1406
1747508|NCT00064753|4279583|P1|COMPLETED|Overall Study||1382
1747509|NCT00064753|4279582|P2|STARTED|Overall Study||2054
1747510|NCT00064753|4279583|P1|STARTED|Overall Study||2056
1747511|NCT00064792|4279613|P2|NOT COMPLETED|Overall Study||0
1747512|NCT00064792|4279614|P1|NOT COMPLETED|Overall Study||5
1747513|NCT00064792|4279613|P2|COMPLETED|Overall Study||10
1747514|NCT00064792|4279614|P1|COMPLETED|Overall Study||8
1747515|NCT00064792|4279613|P2|STARTED|Overall Study||10
1747516|NCT00064792|4279614|P1|STARTED|Overall Study||13
1747517|NCT00064701|4279625|P3|NOT COMPLETED|Clinical Continuation Phase||140
1747518|NCT00064701|4279626|P2|NOT COMPLETED|Clinical Continuation Phase||178
1747519|NCT00064701|4279627|P1|NOT COMPLETED|Clinical Continuation Phase||170
1747520|NCT00064701|4279625|P3|COMPLETED|Clinical Continuation Phase||11
1747521|NCT00064701|4279626|P2|COMPLETED|Clinical Continuation Phase||4
1747522|NCT00064701|4279627|P1|COMPLETED|Clinical Continuation Phase||9
1747523|NCT00064701|4279625|P3|STARTED|Clinical Continuation Phase||151
1747524|NCT00064701|4279626|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
1747525|NCT00064701|4279627|P1|STARTED|Clinical Continuation Phase||179
1747526|NCT00064701|4279625|P3|NOT COMPLETED|One Year Post-transplant||72
1747527|NCT00064701|4279626|P2|NOT COMPLETED|One Year Post-transplant||43
1747528|NCT00064701|4279627|P1|NOT COMPLETED|One Year Post-transplant||40
1747529|NCT00064701|4279625|P3|COMPLETED|One Year Post-transplant||151
1747530|NCT00064701|4279626|P2|COMPLETED|One Year Post-transplant||183
1747531|NCT00064701|4279627|P1|COMPLETED|One Year Post-transplant||179
1747532|NCT00064701|4279625|P3|Received Study Drug|One Year Post-transplant||212
1747533|NCT00064701|4279626|P2|Received Study Drug|One Year Post-transplant||214
1747534|NCT00064701|4279627|P1|Received Study Drug|One Year Post-transplant||212
1747535|NCT00064701|4279625|P3|STARTED|One Year Post-transplant||223
1747536|NCT00064701|4279626|P2|STARTED|One Year Post-transplant||226
1747537|NCT00064701|4279627|P1|STARTED|One Year Post-transplant||219
1747538|NCT00064662|4279679|P2|NOT COMPLETED|Overall Study||61
1747539|NCT00064662|4279680|P1|NOT COMPLETED|Overall Study||74
1747540|NCT00064662|4279679|P2|COMPLETED|Overall Study||265
1747541|NCT00064662|4279680|P1|COMPLETED|Overall Study||255
1747542|NCT00064662|4279679|P2|STARTED|Overall Study||326
1747543|NCT00064662|4279680|P1|STARTED|Overall Study||329
1747544|NCT00064350|4279691|P3|NOT COMPLETED|Cross-Over||0
1747545|NCT00064350|4279692|P2|NOT COMPLETED|Cross-Over||14
1747546|NCT00064350|4279693|P1|NOT COMPLETED|Cross-Over||6
1747547|NCT00064350|4279691|P3|COMPLETED|Cross-Over||0
1747548|NCT00064350|4279692|P2|COMPLETED|Cross-Over||13
1747549|NCT00064350|4279693|P1|COMPLETED|Cross-Over||4
1747550|NCT00064350|4279691|P3|Eligible and Treated|Cross-Over||0
1747551|NCT00064350|4279692|P2|Eligible and Treated|Cross-Over||21
1747552|NCT00064350|4279693|P1|Eligible and Treated|Cross-Over||7
1747553|NCT00064350|4279691|P3|Treated|Cross-Over||0
1747554|NCT00064350|4279692|P2|Treated|Cross-Over||26
1747555|NCT00064350|4279693|P1|Treated|Cross-Over||9
1747556|NCT00064350|4279691|P3|STARTED|Cross-Over||0
1747557|NCT00064350|4279692|P2|STARTED|Cross-Over||27
1747558|NCT00064350|4279693|P1|STARTED|Cross-Over||10
1747559|NCT00064350|4279691|P3|NOT COMPLETED|Randomization||0
1747560|NCT00064350|4279692|P2|NOT COMPLETED|Randomization||18
1747561|NCT00064350|4279693|P1|NOT COMPLETED|Randomization||26
1747562|NCT00064350|4279691|P3|COMPLETED|Randomization||0
1747563|NCT00064350|4279692|P2|COMPLETED|Randomization||28
1747564|NCT00064350|4279693|P1|COMPLETED|Randomization||33
1747565|NCT00064350|4279691|P3|Eligible and Treated|Randomization||0
1747566|NCT00064350|4279692|P2|Eligible and Treated|Randomization||31
1747567|NCT00064350|4279693|P1|Eligible and Treated|Randomization||50
1747568|NCT00064350|4279691|P3|Treated|Randomization||0
1747569|NCT00064350|4279692|P2|Treated|Randomization||40
1747570|NCT00064350|4279693|P1|Treated|Randomization||55
1747571|NCT00064350|4279691|P3|STARTED|Randomization||0
1747572|NCT00064350|4279692|P2|STARTED|Randomization||46
1747573|NCT00064350|4279693|P1|STARTED|Randomization||59
1747574|NCT00064350|4279691|P3|NOT COMPLETED|Induction Treatment||236
1747575|NCT00064350|4279692|P2|NOT COMPLETED|Induction Treatment||9
1747576|NCT00064350|4279693|P1|NOT COMPLETED|Induction Treatment||8
1747577|NCT00064350|4279691|P3|COMPLETED|Induction Treatment||1
1747578|NCT00064350|4279692|P2|COMPLETED|Induction Treatment||37
1747579|NCT00064350|4279693|P1|COMPLETED|Induction Treatment||51
1747580|NCT00064350|4279691|P3|Eligible and Treated|Induction Treatment||194
1747581|NCT00064350|4279692|P2|Eligible and Treated|Induction Treatment||46
1747582|NCT00064350|4279693|P1|Eligible and Treated|Induction Treatment||59
1747583|NCT00064350|4279691|P3|Treated|Induction Treatment||228
1747584|NCT00064350|4279692|P2|Treated|Induction Treatment||46
1747585|NCT00064350|4279693|P1|Treated|Induction Treatment||59
1747586|NCT00064350|4279691|P3|STARTED|Induction Treatment||237
1747587|NCT00064350|4279692|P2|STARTED|Induction Treatment||46
1747588|NCT00064350|4279693|P1|STARTED|Induction Treatment||59
1747589|NCT00064337|4279708|P1|NOT COMPLETED|Maintenance||10
1747590|NCT00064337|4279708|P1|COMPLETED|Maintenance||3
1747591|NCT00064337|4279708|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
1747592|NCT00064337|4279708|P1|NOT COMPLETED|Transplant||21
1747593|NCT00064337|4279708|P1|COMPLETED|Transplant||46
1747594|NCT00064337|4279708|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
1747595|NCT00064337|4279708|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
1747596|NCT00064337|4279708|P1|COMPLETED|PBSCC or Induction/PBSCC||73
1747597|NCT00064337|4279708|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
1747598|NCT00064298|4279717|P2|NOT COMPLETED|Overall Study||5
1747599|NCT00064298|4279718|P1|NOT COMPLETED|Overall Study||6
1747600|NCT00064298|4279717|P2|COMPLETED|Overall Study||57
1747601|NCT00064298|4279718|P1|COMPLETED|Overall Study||66
1747602|NCT00064298|4279717|P2|STARTED|Overall Study||62
1747603|NCT00064298|4279718|P1|STARTED|Overall Study||72
1747604|NCT00064259|4279726|P4|NOT COMPLETED|Overall Study||1
1747605|NCT00064259|4279727|P3|NOT COMPLETED|Overall Study||0
1747606|NCT00064259|4279728|P2|NOT COMPLETED|Overall Study||0
1747607|NCT00064259|4279729|P1|NOT COMPLETED|Overall Study||1
1747608|NCT00064259|4279726|P4|COMPLETED|Overall Study||0
1747609|NCT00064259|4279727|P3|COMPLETED|Overall Study||6
1747610|NCT00064259|4279728|P2|COMPLETED|Overall Study||4
1747611|NCT00064259|4279729|P1|COMPLETED|Overall Study||3
1747612|NCT00064259|4279726|P4|STARTED|Overall Study||1
1747613|NCT00064259|4279727|P3|STARTED|Overall Study||6
1747614|NCT00064259|4279728|P2|STARTED|Overall Study||4
1747615|NCT00064259|4279729|P1|STARTED|Overall Study||4
1747616|NCT00064077|4279737|P4|NOT COMPLETED|Overall Study||7
1747617|NCT00064077|4279738|P3|NOT COMPLETED|Overall Study||7
1747618|NCT00064077|4279739|P2|NOT COMPLETED|Overall Study||9
1747619|NCT00064077|4279740|P1|NOT COMPLETED|Overall Study||15
1747620|NCT00064077|4279737|P4|COMPLETED|Overall Study|Evaluable (treatment)|111
1747621|NCT00064077|4279738|P3|COMPLETED|Overall Study|Evaluable (treatment)|112
1747622|NCT00064077|4279739|P2|COMPLETED|Overall Study|Evaluable (treatment)|108
1747623|NCT00064077|4279740|P1|COMPLETED|Overall Study|Evaluable (treatment)|103
1747624|NCT00064077|4279737|P4|STARTED|Overall Study||118
1747625|NCT00064077|4279738|P3|STARTED|Overall Study||119
1747626|NCT00064077|4279739|P2|STARTED|Overall Study||117
1747627|NCT00064077|4279740|P1|STARTED|Overall Study||118
1747628|NCT00064038|4279772|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
1747629|NCT00064038|4279773|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
1747630|NCT00064038|4279774|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
1747631|NCT00064038|4279772|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
1747632|NCT00064038|4279773|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
1747633|NCT00064038|4279774|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
1747634|NCT00064038|4279772|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
1747635|NCT00064038|4279773|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
1747636|NCT00064038|4279774|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
1747637|NCT00064038|4279772|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
1747638|NCT00064038|4279773|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
1747639|NCT00064038|4279774|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
1747640|NCT00064038|4279772|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
1747641|NCT00064038|4279773|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
1747642|NCT00064038|4279774|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
1747643|NCT00064038|4279772|P3|NOT COMPLETED|Initial Randomization||0
1747644|NCT00064038|4279773|P2|NOT COMPLETED|Initial Randomization||98
1747645|NCT00064038|4279774|P1|NOT COMPLETED|Initial Randomization||100
1747646|NCT00064038|4279772|P3|COMPLETED|Initial Randomization||0
1747647|NCT00064038|4279773|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
1747648|NCT00064038|4279774|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
1747649|NCT00064038|4279772|P3|Safety Population|Initial Randomization||0
1747650|NCT00064038|4279773|P2|Safety Population|Initial Randomization||94
1747651|NCT00064038|4279774|P1|Safety Population|Initial Randomization||96
1747652|NCT00064038|4279772|P3|Eligible and Analyzable|Initial Randomization||0
1747653|NCT00064038|4279773|P2|Eligible and Analyzable|Initial Randomization||95
1747654|NCT00064038|4279774|P1|Eligible and Analyzable|Initial Randomization||97
1747655|NCT00064038|4279772|P3|STARTED|Initial Randomization||0
1747656|NCT00064038|4279773|P2|STARTED|Initial Randomization||98
1747657|NCT00064038|4279774|P1|STARTED|Initial Randomization||100
1747658|NCT00064025|4279784|P1|NOT COMPLETED|Overall Study||7
1747659|NCT00064025|4279784|P1|COMPLETED|Overall Study||68
1747660|NCT00064025|4279784|P1|STARTED|Overall Study||75
1747661|NCT00063999|4279793|P2|NOT COMPLETED|Overall Study||24
1747662|NCT00063999|4279794|P1|NOT COMPLETED|Overall Study||45
1747663|NCT00063999|4279793|P2|COMPLETED|Overall Study||665
1747664|NCT00063999|4279794|P1|COMPLETED|Overall Study||647
1747665|NCT00063999|4279793|P2|STARTED|Overall Study||689
1747666|NCT00063999|4279794|P1|STARTED|Overall Study||692
1747667|NCT00063986|4279810|P1|NOT COMPLETED|Overall Study||6
1747668|NCT00063986|4279810|P1|COMPLETED|Overall Study||104
1747669|NCT00063986|4279810|P1|Eligible and Treated|Overall Study||104
1747670|NCT00063986|4279810|P1|Treated|Overall Study||105
1747671|NCT00063986|4279810|P1|STARTED|Overall Study||110
1747672|NCT00063934|4279822|P1|NOT COMPLETED|Overall Study||1
1747673|NCT00063934|4279822|P1|COMPLETED|Overall Study||30
1747674|NCT00063934|4279822|P1|STARTED|Overall Study||31
1747675|NCT00063635|4279831|P3|NOT COMPLETED|Overall Study||9
1747676|NCT00063635|4279832|P2|NOT COMPLETED|Overall Study||8
1747677|NCT00063635|4279833|P1|NOT COMPLETED|Overall Study||6
1747678|NCT00063635|4279831|P3|COMPLETED|Overall Study||49
1747679|NCT00063635|4279832|P2|COMPLETED|Overall Study||50
1747680|NCT00063635|4279833|P1|COMPLETED|Overall Study||51
1747681|NCT00063635|4279831|P3|STARTED|Overall Study||58
1747682|NCT00063635|4279832|P2|STARTED|Overall Study||58
1747683|NCT00063635|4279833|P1|STARTED|Overall Study||57
1747684|NCT00063622|4279874|P3|NOT COMPLETED|Overall Study||11
1747685|NCT00063622|4279875|P2|NOT COMPLETED|Overall Study||4
1747686|NCT00063622|4279876|P1|NOT COMPLETED|Overall Study||10
1747687|NCT00063622|4279874|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
1747688|NCT00063622|4279875|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
1747689|NCT00063622|4279876|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
1747690|NCT00063622|4279874|P3|STARTED|Overall Study||83
1747691|NCT00063622|4279875|P2|STARTED|Overall Study||84
1747692|NCT00063622|4279876|P1|STARTED|Overall Study||80
1747693|NCT00063570|4279901|P2|NOT COMPLETED|Overall Study||0
1747694|NCT00063570|4279902|P1|NOT COMPLETED|Overall Study||0
1747695|NCT00063570|4279901|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
1747696|NCT00063570|4279902|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
1747697|NCT00063570|4279901|P2|STARTED|Overall Study||21
1747698|NCT00063570|4279902|P1|STARTED|Overall Study||52
1747699|NCT00063362|4279918|P2|NOT COMPLETED|Overall Study||4
1747700|NCT00063362|4279919|P1|NOT COMPLETED|Overall Study||4
1747701|NCT00063362|4279918|P2|COMPLETED|Overall Study||22
1747702|NCT00063362|4279919|P1|COMPLETED|Overall Study||19
1747703|NCT00063362|4279918|P2|STARTED|Overall Study||26
1747704|NCT00063362|4279919|P1|STARTED|Overall Study||23
1747705|NCT00063258|4279927|P2|NOT COMPLETED|Overall Study||0
1747706|NCT00063258|4279928|P1|NOT COMPLETED|Overall Study||4
1747707|NCT00063258|4279927|P2|COMPLETED|Overall Study||0
1747708|NCT00063258|4279928|P1|COMPLETED|Overall Study||1
1747709|NCT00063258|4279927|P2|STARTED|Overall Study||0
1747710|NCT00063258|4279928|P1|STARTED|Overall Study||5
1747711|NCT00063154|4279934|P1|NOT COMPLETED|Overall Study||51
1747712|NCT00063154|4279934|P1|COMPLETED|Overall Study||0
1747713|NCT00063154|4279934|P1|STARTED|Overall Study||51
1747714|NCT00063232|4279941|P1|NOT COMPLETED|Overall Study||0
1747715|NCT00063232|4279941|P1|COMPLETED|Overall Study||26
1747716|NCT00063232|4279941|P1|STARTED|Overall Study||26
1747717|NCT00062764|4279947|P1|NOT COMPLETED|Overall Study||0
1747718|NCT00062764|4279947|P1|COMPLETED|Overall Study||18
1747719|NCT00062764|4279947|P1|STARTED|Overall Study||18
1747720|NCT00062751|4279960|P5|NOT COMPLETED|Overall Study||6
1747721|NCT00062751|4279961|P4|NOT COMPLETED|Overall Study||5
1747722|NCT00062751|4279962|P3|NOT COMPLETED|Overall Study||30
1747723|NCT00062751|4279963|P2|NOT COMPLETED|Overall Study||30
1747724|NCT00062751|4279964|P1|NOT COMPLETED|Overall Study||33
1747725|NCT00062751|4279960|P5|COMPLETED|Overall Study||0
1747726|NCT00062751|4279961|P4|COMPLETED|Overall Study||1
1747727|NCT00062751|4279962|P3|COMPLETED|Overall Study||3
1747728|NCT00062751|4279963|P2|COMPLETED|Overall Study||0
1747729|NCT00062751|4279964|P1|COMPLETED|Overall Study||0
1747730|NCT00062751|4279960|P5|STARTED|Overall Study||6
1747731|NCT00062751|4279961|P4|STARTED|Overall Study||6
1747732|NCT00062751|4279962|P3|STARTED|Overall Study||33
1747733|NCT00062751|4279963|P2|STARTED|Overall Study||30
1747734|NCT00062751|4279964|P1|STARTED|Overall Study||33
1747735|NCT00062738|4280035|P3|NOT COMPLETED|Overall Study||0
1747736|NCT00062738|4280036|P2|NOT COMPLETED|Overall Study||0
1747737|NCT00062738|4280037|P1|NOT COMPLETED|Overall Study||0
1747738|NCT00062738|4280035|P3|COMPLETED|Overall Study||17
1747739|NCT00062738|4280036|P2|COMPLETED|Overall Study||18
1747740|NCT00062738|4280037|P1|COMPLETED|Overall Study||17
1747741|NCT00062738|4280035|P3|STARTED|Overall Study||17
1747742|NCT00062738|4280036|P2|STARTED|Overall Study||18
1747743|NCT00062738|4280037|P1|STARTED|Overall Study||17
1747744|NCT00062647|4280050|P2|NOT COMPLETED|Overall Study||13
1747745|NCT00062647|4280051|P1|NOT COMPLETED|Overall Study||16
1747746|NCT00062647|4280050|P2|COMPLETED|Overall Study||17
1747747|NCT00062647|4280051|P1|COMPLETED|Overall Study||14
1747748|NCT00062647|4280050|P2|STARTED|Overall Study||30
1747749|NCT00062647|4280051|P1|STARTED|Overall Study||30
1747750|NCT00062439|4280057|P1|NOT COMPLETED|Consolidation Chemotherapy||2
1747751|NCT00062439|4280057|P1|COMPLETED|Consolidation Chemotherapy||20
1747752|NCT00062439|4280057|P1|STARTED|Consolidation Chemotherapy||22
1747753|NCT00062439|4280057|P1|NOT COMPLETED|Surgery||7
1747754|NCT00062439|4280057|P1|COMPLETED|Surgery||22
1747755|NCT00062439|4280057|P1|STARTED|Surgery||29
1747756|NCT00062439|4280057|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
1747757|NCT00062439|4280057|P1|COMPLETED|Post Chemoradiation Assessment||29
1747758|NCT00062439|4280057|P1|STARTED|Post Chemoradiation Assessment||38
1747759|NCT00062439|4280057|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
1747760|NCT00062439|4280057|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
1747761|NCT00062439|4280057|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
1747762|NCT00062374|4280069|P1|NOT COMPLETED|Overall Study||12
1747763|NCT00062374|4280069|P1|COMPLETED|Overall Study||43
1747764|NCT00062374|4280069|P1|STARTED|Overall Study||55
1747765|NCT00062166|4280074|P1|NOT COMPLETED|Overall Study||6
1747766|NCT00062166|4280074|P1|COMPLETED|Overall Study||334
1747767|NCT00062166|4280074|P1|STARTED|Overall Study||340
1747768|NCT00062010|4280082|P1|NOT COMPLETED|Overall Study||3
1747769|NCT00062010|4280082|P1|COMPLETED|Overall Study||34
1747770|NCT00062010|4280082|P1|Eligible and Treated|Overall Study||34
1747771|NCT00062010|4280082|P1|STARTED|Overall Study||37
1747772|NCT00061945|4280090|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
1747773|NCT00061945|4280091|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
1747774|NCT00061945|4280090|P2|COMPLETED|Course IV: Alemtuzumab||50
1747775|NCT00061945|4280091|P1|COMPLETED|Course IV: Alemtuzumab||18
1747776|NCT00061945|4280090|P2|STARTED|Course IV: Alemtuzumab||66
1747777|NCT00061945|4280091|P1|STARTED|Course IV: Alemtuzumab||25
1747778|NCT00061945|4280090|P2|NOT COMPLETED|Registration Through Course 3||115
1747779|NCT00061945|4280091|P1|NOT COMPLETED|Registration Through Course 3||94
1747780|NCT00061945|4280090|P2|COMPLETED|Registration Through Course 3||66
1747781|NCT00061945|4280091|P1|COMPLETED|Registration Through Course 3||25
1747782|NCT00061945|4280090|P2|STARTED|Registration Through Course 3||181
1747783|NCT00061945|4280091|P1|STARTED|Registration Through Course 3||119
1747784|NCT00061932|4280101|P2|NOT COMPLETED|Overall Study||4
1747785|NCT00061932|4280102|P1|NOT COMPLETED|Overall Study||13
1747786|NCT00061932|4280101|P2|COMPLETED|Overall Study||8
1747787|NCT00061932|4280102|P1|COMPLETED|Overall Study||16
1747788|NCT00061932|4280101|P2|STARTED|Overall Study||12
1747789|NCT00061932|4280102|P1|STARTED|Overall Study||29
1747790|NCT00061893|4280108|P1|NOT COMPLETED|Overall Study||18
1747791|NCT00061893|4280108|P1|COMPLETED|Overall Study||20
1747792|NCT00061893|4280108|P1|STARTED|Overall Study||38
1747793|NCT00061633|4280115|P2|NOT COMPLETED|Overall Study||11
1747794|NCT00061633|4280116|P1|NOT COMPLETED|Overall Study||5
1747795|NCT00061633|4280115|P2|COMPLETED|Overall Study||74
1747796|NCT00061633|4280116|P1|COMPLETED|Overall Study||79
1747797|NCT00061633|4280115|P2|STARTED|Overall Study||85
1747798|NCT00061633|4280116|P1|STARTED|Overall Study||84
1747799|NCT00061373|4280124|P2|NOT COMPLETED|Overall Study||0
1747800|NCT00061373|4280125|P1|NOT COMPLETED|Overall Study||0
1747801|NCT00061373|4280124|P2|COMPLETED|Overall Study||3
1747802|NCT00061373|4280125|P1|COMPLETED|Overall Study||15
1747803|NCT00061373|4280124|P2|Aspirin and Tinzaparin|Overall Study||3
1747804|NCT00061373|4280125|P1|Aspirin and Tinzaparin|Overall Study||15
1747805|NCT00061373|4280124|P2|STARTED|Overall Study||3
1747806|NCT00061373|4280125|P1|STARTED|Overall Study||15
1747807|NCT00061048|4280141|P1|NOT COMPLETED|Overall Study||22
1747808|NCT00061048|4280141|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
1747809|NCT00061048|4280141|P1|STARTED|Overall Study||29
1747810|NCT00060944|4280151|P2|NOT COMPLETED|Overall Study||134
1747811|NCT00060944|4280152|P1|NOT COMPLETED|Overall Study||136
1747812|NCT00060944|4280151|P2|COMPLETED|Overall Study||0
1747813|NCT00060944|4280152|P1|COMPLETED|Overall Study||0
1747814|NCT00060944|4280151|P2|Treated|Overall Study||130
1747815|NCT00060944|4280152|P1|Treated|Overall Study||130
1747816|NCT00060944|4280151|P2|STARTED|Overall Study||134
1747817|NCT00060944|4280152|P1|STARTED|Overall Study||136
1747818|NCT00060840|4280168|P2|NOT COMPLETED|Overall Study||9
1747819|NCT00060840|4280169|P1|NOT COMPLETED|Overall Study||4
1747820|NCT00060840|4280168|P2|COMPLETED|Overall Study||68
1747821|NCT00060840|4280169|P1|COMPLETED|Overall Study||69
1747822|NCT00060840|4280168|P2|STARTED|Overall Study||77
1747823|NCT00060840|4280169|P1|STARTED|Overall Study||73
1747824|NCT00060528|4280175|P4|NOT COMPLETED|Overall Study||0
1747825|NCT00060528|4280176|P3|NOT COMPLETED|Overall Study||0
1747826|NCT00060528|4280177|P2|NOT COMPLETED|Overall Study||0
1747827|NCT00060528|4280178|P1|NOT COMPLETED|Overall Study||0
1747828|NCT00060528|4280175|P4|COMPLETED|Overall Study||8
1747829|NCT00060528|4280176|P3|COMPLETED|Overall Study||7
1747830|NCT00060528|4280177|P2|COMPLETED|Overall Study||9
1747831|NCT00060528|4280178|P1|COMPLETED|Overall Study||8
1747832|NCT00060528|4280175|P4|STARTED|Overall Study||8
1747833|NCT00060528|4280176|P3|STARTED|Overall Study||7
1747834|NCT00060528|4280177|P2|STARTED|Overall Study||9
1747835|NCT00060528|4280178|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
1747836|NCT00060424|4280192|P1|NOT COMPLETED|Overall Study||0
1747837|NCT00060424|4280192|P1|COMPLETED|Overall Study||21
1747838|NCT00060424|4280192|P1|STARTED|Overall Study||21
1747839|NCT00060346|4280200|P1|NOT COMPLETED|Overall Study||0
1747840|NCT00060346|4280200|P1|COMPLETED|Overall Study||16
1747841|NCT00060346|4280200|P1|Eligible and Treated|Overall Study||16
1747842|NCT00060346|4280200|P1|STARTED|Overall Study||16
1747843|NCT00060333|4280204|P1|NOT COMPLETED|Overall Study||0
1747844|NCT00060333|4280204|P1|COMPLETED|Overall Study||20
1747845|NCT00060333|4280204|P1|STARTED|Overall Study||20
1747846|NCT00060008|4280215|P1|NOT COMPLETED|Overall Study||0
1747847|NCT00060008|4280215|P1|COMPLETED|Overall Study||18
1747848|NCT00060008|4280215|P1|STARTED|Overall Study||18
1747849|NCT00059839|4280222|P2|NOT COMPLETED|Overall Study||17
1747850|NCT00059839|4280223|P1|NOT COMPLETED|Overall Study||12
1747851|NCT00059839|4280222|P2|COMPLETED|Overall Study||47
1747852|NCT00059839|4280223|P1|COMPLETED|Overall Study||53
1747853|NCT00059839|4280222|P2|STARTED|Overall Study||64
1747854|NCT00059839|4280223|P1|STARTED|Overall Study||65
1747855|NCT00059787|4280229|P1|NOT COMPLETED|Overall Study||20
1747856|NCT00059787|4280229|P1|COMPLETED|Overall Study||36
1747857|NCT00059787|4280229|P1|STARTED|Overall Study||56
1747858|NCT00059475|4280245|P8|NOT COMPLETED|Overall Study||0
1747859|NCT00059475|4280246|P7|NOT COMPLETED|Overall Study||0
1747860|NCT00059475|4280247|P6|NOT COMPLETED|Overall Study||0
1747861|NCT00059475|4280248|P5|NOT COMPLETED|Overall Study||0
1747862|NCT00059475|4280249|P4|NOT COMPLETED|Overall Study||0
1747863|NCT00059475|4280250|P3|NOT COMPLETED|Overall Study||0
1747864|NCT00059475|4280251|P2|NOT COMPLETED|Overall Study||0
1747865|NCT00059475|4280252|P1|NOT COMPLETED|Overall Study||0
1747866|NCT00059475|4280245|P8|COMPLETED|Overall Study||7
1747867|NCT00059475|4280246|P7|COMPLETED|Overall Study||34
1747868|NCT00059475|4280247|P6|COMPLETED|Overall Study||2
1747869|NCT00059475|4280248|P5|COMPLETED|Overall Study||33
1747870|NCT00059475|4280249|P4|COMPLETED|Overall Study||3
1747871|NCT00059475|4280250|P3|COMPLETED|Overall Study||24
1747872|NCT00059475|4280251|P2|COMPLETED|Overall Study||2
1747873|NCT00059475|4280252|P1|COMPLETED|Overall Study||33
1747874|NCT00059475|4280245|P8|STARTED|Overall Study||7
1747875|NCT00059475|4280246|P7|STARTED|Overall Study||34
1747876|NCT00059475|4280247|P6|STARTED|Overall Study||2
1747877|NCT00059475|4280248|P5|STARTED|Overall Study||33
1747878|NCT00059475|4280249|P4|STARTED|Overall Study||3
1747879|NCT00059475|4280250|P3|STARTED|Overall Study||24
1747880|NCT00059475|4280251|P2|STARTED|Overall Study||2
1747881|NCT00059475|4280252|P1|STARTED|Overall Study||33
1747882|NCT00059332|4280280|P2|NOT COMPLETED|Overall Study||2
1747883|NCT00059332|4280281|P1|NOT COMPLETED|Overall Study||3
1747884|NCT00059332|4280280|P2|COMPLETED|Overall Study||855
1747885|NCT00059332|4280281|P1|COMPLETED|Overall Study||840
1747886|NCT00059332|4280280|P2|STARTED|Overall Study||857
1747887|NCT00059332|4280281|P1|STARTED|Overall Study||843
1747888|NCT00059215|4280307|P4|NOT COMPLETED|Overall Study||15
1747889|NCT00059215|4280308|P3|NOT COMPLETED|Overall Study||15
1747890|NCT00059215|4280309|P2|NOT COMPLETED|Overall Study||14
1747891|NCT00059215|4280310|P1|NOT COMPLETED|Overall Study||13
1747892|NCT00059215|4280307|P4|COMPLETED|Overall Study||239
1747893|NCT00059215|4280308|P3|COMPLETED|Overall Study||236
1747894|NCT00059215|4280309|P2|COMPLETED|Overall Study||186
1747895|NCT00059215|4280310|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
1747896|NCT00059215|4280307|P4|STARTED|Overall Study||254
1747897|NCT00059215|4280308|P3|STARTED|Overall Study||251
1747898|NCT00059215|4280309|P2|STARTED|Overall Study||200
1747899|NCT00059215|4280310|P1|STARTED|Overall Study||200
1747900|NCT00059228|4280338|P2|NOT COMPLETED|Overall Study||1
1747901|NCT00059228|4280339|P1|NOT COMPLETED|Overall Study||0
1747902|NCT00059228|4280338|P2|COMPLETED|Overall Study||5
1747903|NCT00059228|4280339|P1|COMPLETED|Overall Study||6
1747904|NCT00059228|4280338|P2|STARTED|Overall Study||6
1747905|NCT00059228|4280339|P1|STARTED|Overall Study||6
1747906|NCT00058825|4280347|P1|NOT COMPLETED|Overall Study||22
1747907|NCT00058825|4280347|P1|COMPLETED|Overall Study||5
1747908|NCT00058825|4280347|P1|STARTED|Overall Study||27
1747909|NCT00058552|4280363|P2|NOT COMPLETED|Overall Study||62
1747910|NCT00058552|4280364|P1|NOT COMPLETED|Overall Study||65
1747911|NCT00058552|4280363|P2|COMPLETED|Overall Study||2
1747912|NCT00058552|4280364|P1|COMPLETED|Overall Study||0
1747913|NCT00058552|4280363|P2|STARTED|Overall Study||64
1747914|NCT00058552|4280364|P1|STARTED|Overall Study||65
1747915|NCT00058539|4280382|P1|NOT COMPLETED|Overall Study||42
1747916|NCT00058539|4280382|P1|COMPLETED|Overall Study||0
1747917|NCT00058539|4280382|P1|STARTED|Overall Study||42
1747918|NCT00058240|4280396|P4|NOT COMPLETED|Second Dose Level||0
1747919|NCT00058240|4280397|P3|NOT COMPLETED|Second Dose Level||0
1747920|NCT00058240|4280398|P2|NOT COMPLETED|Second Dose Level||0
1747921|NCT00058240|4280399|P1|NOT COMPLETED|Second Dose Level||0
1747922|NCT00058240|4280396|P4|COMPLETED|Second Dose Level||4
1747923|NCT00058240|4280397|P3|COMPLETED|Second Dose Level||2
1747924|NCT00058240|4280398|P2|COMPLETED|Second Dose Level||0
1747925|NCT00058240|4280399|P1|COMPLETED|Second Dose Level||0
1747926|NCT00058240|4280396|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
1747927|NCT00058240|4280397|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
1747928|NCT00058240|4280398|P2|STARTED|Second Dose Level||0
1747929|NCT00058240|4280399|P1|STARTED|Second Dose Level||0
1747930|NCT00058240|4280396|P4|NOT COMPLETED|First Dose Level||0
1747931|NCT00058240|4280397|P3|NOT COMPLETED|First Dose Level||0
1747932|NCT00058240|4280398|P2|NOT COMPLETED|First Dose Level||0
1747933|NCT00058240|4280399|P1|NOT COMPLETED|First Dose Level||0
1747934|NCT00058240|4280396|P4|COMPLETED|First Dose Level||12
1747935|NCT00058240|4280397|P3|COMPLETED|First Dose Level||17
1747936|NCT00058240|4280398|P2|COMPLETED|First Dose Level||3
1747937|NCT00058240|4280399|P1|COMPLETED|First Dose Level||20
1747938|NCT00058240|4280396|P4|Treated|First Dose Level||12
1747939|NCT00058240|4280397|P3|Treated|First Dose Level||17
1747940|NCT00058240|4280398|P2|Treated|First Dose Level||3
1747941|NCT00058240|4280399|P1|Treated|First Dose Level||20
1747942|NCT00058240|4280396|P4|STARTED|First Dose Level||12
1747943|NCT00058240|4280397|P3|STARTED|First Dose Level||17
1747944|NCT00058240|4280398|P2|STARTED|First Dose Level||3
1747945|NCT00058240|4280399|P1|STARTED|First Dose Level||20
1747946|NCT00058214|4280409|P1|NOT COMPLETED|Overall Study||1
1747947|NCT00058214|4280409|P1|COMPLETED|Overall Study||24
1747948|NCT00058214|4280409|P1|STARTED|Overall Study||25
1747949|NCT00058123|4280414|P1|NOT COMPLETED|Overall Study||10
1747950|NCT00058123|4280414|P1|COMPLETED|Overall Study||45
1747951|NCT00058123|4280414|P1|STARTED|Overall Study||55
1747952|NCT00058058|4280421|P1|NOT COMPLETED|Overall Study||38
1747953|NCT00058058|4280421|P1|COMPLETED|Overall Study||969
1747954|NCT00058058|4280421|P1|STARTED|Overall Study||1007
1747955|NCT00058019|4280432|P2|NOT COMPLETED|Overall Study||0
1747956|NCT00058019|4280433|P1|NOT COMPLETED|Overall Study||0
1747957|NCT00058019|4280432|P2|COMPLETED|Overall Study||12
1747958|NCT00058019|4280433|P1|COMPLETED|Overall Study||39
1747959|NCT00058019|4280432|P2|STARTED|Overall Study||12
1747960|NCT00058019|4280433|P1|STARTED|Overall Study||39
1747961|NCT00057954|4280446|P1|NOT COMPLETED|Overall Study||2
1747962|NCT00057954|4280446|P1|COMPLETED|Overall Study||4
1747963|NCT00057954|4280446|P1|STARTED|Overall Study||6
1747964|NCT00057941|4280454|P2|NOT COMPLETED|Overall Study||74
1747965|NCT00057941|4280455|P1|NOT COMPLETED|Overall Study||74
1747966|NCT00057941|4280454|P2|COMPLETED|Overall Study||0
1747967|NCT00057941|4280455|P1|COMPLETED|Overall Study||0
1747968|NCT00057941|4280454|P2|Eligible|Overall Study||69
1747969|NCT00057941|4280455|P1|Eligible|Overall Study||72
1747970|NCT00057941|4280454|P2|Treated|Overall Study||74
1747971|NCT00057941|4280455|P1|Treated|Overall Study||74
1747972|NCT00057941|4280454|P2|STARTED|Overall Study||74
1747973|NCT00057941|4280455|P1|STARTED|Overall Study||74
1747974|NCT00057876|4280463|P2|NOT COMPLETED|Overall Study||27
1747975|NCT00057876|4280464|P1|NOT COMPLETED|Overall Study||29
1747976|NCT00057876|4280463|P2|COMPLETED|Overall Study||9
1747977|NCT00057876|4280464|P1|COMPLETED|Overall Study||9
1747978|NCT00057876|4280463|P2|Eligible and Treated|Overall Study||34
1747979|NCT00057876|4280464|P1|Eligible and Treated|Overall Study||34
1747980|NCT00057876|4280463|P2|Began Protocol Therapy|Overall Study||34
1747981|NCT00057876|4280464|P1|Began Protocol Therapy|Overall Study||35
1747982|NCT00057876|4280463|P2|Eligible|Overall Study||34
1747983|NCT00057876|4280464|P1|Eligible|Overall Study||37
1747984|NCT00057876|4280463|P2|STARTED|Overall Study||36
1747985|NCT00057876|4280464|P1|STARTED|Overall Study||38
1747986|NCT00057863|4280474|P1|NOT COMPLETED|Overall Study||3
1747987|NCT00057863|4280474|P1|COMPLETED|Overall Study||32
1747988|NCT00057863|4280474|P1|STARTED|Overall Study||35
1747989|NCT00057837|4280483|P2|NOT COMPLETED|Overall Study||39
1747990|NCT00057837|4280484|P1|NOT COMPLETED|Overall Study||31
1747991|NCT00057837|4280483|P2|COMPLETED|Overall Study||31
1747992|NCT00057837|4280484|P1|COMPLETED|Overall Study||39
1747993|NCT00057837|4280483|P2|Patients With Response|Overall Study||38
1747994|NCT00057837|4280484|P1|Patients With Response|Overall Study||46
1747995|NCT00057837|4280483|P2|Eligible and Treated|Overall Study||66
1747996|NCT00057837|4280484|P1|Eligible and Treated|Overall Study||66
1747997|NCT00057837|4280483|P2|Treated|Overall Study||68
1747998|NCT00057837|4280484|P1|Treated|Overall Study||69
1747999|NCT00057837|4280483|P2|STARTED|Overall Study||70
1748000|NCT00057837|4280484|P1|STARTED|Overall Study||70
1748001|NCT00057811|4280496|P2|NOT COMPLETED|Overall Study||12
1748002|NCT00057811|4280497|P1|NOT COMPLETED|Overall Study||10
1748003|NCT00057811|4280496|P2|COMPLETED|Overall Study||34
1748004|NCT00057811|4280497|P1|COMPLETED|Overall Study||41
1748005|NCT00057811|4280496|P2|STARTED|Overall Study||46
1748006|NCT00057811|4280497|P1|STARTED|Overall Study||51
1748007|NCT00057785|4280509|P1|NOT COMPLETED|Overall Study||0
1748008|NCT00057785|4280509|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
1748009|NCT00057785|4280509|P1|STARTED|Overall Study||68
1748010|NCT00057746|4280516|P3|NOT COMPLETED|Overall Study||1
1748011|NCT00057746|4280517|P2|NOT COMPLETED|Overall Study||0
1748012|NCT00057746|4280518|P1|NOT COMPLETED|Overall Study||0
1748013|NCT00057746|4280516|P3|COMPLETED|Overall Study||66
1748014|NCT00057746|4280517|P2|COMPLETED|Overall Study||67
1748015|NCT00057746|4280518|P1|COMPLETED|Overall Study||131
1748016|NCT00057746|4280516|P3|STARTED|Overall Study||67
1748017|NCT00057746|4280517|P2|STARTED|Overall Study||67
1748018|NCT00057746|4280518|P1|STARTED|Overall Study||131
1748019|NCT00023673|4280529|P4|NOT COMPLETED|Overall Study||2
1748020|NCT00023673|4280530|P3|NOT COMPLETED|Overall Study||0
1748021|NCT00023673|4280531|P2|NOT COMPLETED|Overall Study||0
1748022|NCT00023673|4280532|P1|NOT COMPLETED|Overall Study||0
1748023|NCT00023673|4280529|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
1748024|NCT00023673|4280530|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
1748025|NCT00023673|4280531|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
1748026|NCT00023673|4280532|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
1748027|NCT00023673|4280529|P4|STARTED|Overall Study||46
1748028|NCT00023673|4280530|P3|STARTED|Overall Study||0
1748029|NCT00023673|4280531|P2|STARTED|Overall Study||9
1748030|NCT00023673|4280532|P1|STARTED|Overall Study||8
1748031|NCT00057681|4280548|P3|NOT COMPLETED|Overall Study||34
1748032|NCT00057681|4280549|P2|NOT COMPLETED|Overall Study||72
1748033|NCT00057681|4280550|P1|NOT COMPLETED|Overall Study||65
1748034|NCT00057681|4280548|P3|COMPLETED|Overall Study||69
1748035|NCT00057681|4280549|P2|COMPLETED|Overall Study||67
1748036|NCT00057681|4280550|P1|COMPLETED|Overall Study||72
1748037|NCT00057681|4280548|P3|STARTED|Overall Study||103
1748038|NCT00057681|4280549|P2|STARTED|Overall Study||139
1748039|NCT00057681|4280550|P1|STARTED|Overall Study||137
1748040|NCT00057577|4280566|P2|NOT COMPLETED|Overall Study||0
1748041|NCT00057577|4280567|P1|NOT COMPLETED|Overall Study||0
1748042|NCT00057577|4280566|P2|COMPLETED|Overall Study||225
1748043|NCT00057577|4280567|P1|COMPLETED|Overall Study||227
1748044|NCT00057577|4280566|P2|STARTED|Overall Study||225
1748045|NCT00057577|4280567|P1|STARTED|Overall Study||227
1748046|NCT00057551|4280584|P3|NOT COMPLETED|Overall Study||16
1748047|NCT00057551|4280585|P2|NOT COMPLETED|Overall Study||27
1748048|NCT00057551|4280586|P1|NOT COMPLETED|Overall Study||25
1748049|NCT00057551|4280584|P3|COMPLETED|Overall Study||80
1748050|NCT00057551|4280585|P2|COMPLETED|Overall Study||168
1748051|NCT00057551|4280586|P1|COMPLETED|Overall Study||175
1748052|NCT00057551|4280584|P3|STARTED|Overall Study||96
1748053|NCT00057551|4280585|P2|STARTED|Overall Study||195
1748054|NCT00057551|4280586|P1|STARTED|Overall Study||200
1748055|NCT00057330|4280596|P2|NOT COMPLETED|Overall Study||920
1748056|NCT00057330|4280597|P1|NOT COMPLETED|Overall Study||1132
1748057|NCT00057330|4280596|P2|COMPLETED|Overall Study||2826
1748058|NCT00057330|4280597|P1|COMPLETED|Overall Study||3445
1748059|NCT00057330|4280596|P2|STARTED|Overall Study||3746
1748060|NCT00057330|4280597|P1|STARTED|Overall Study||4577
1748061|NCT00056862|4280627|P2|NOT COMPLETED|Overall Study||0
1748062|NCT00056862|4280628|P1|NOT COMPLETED|Overall Study||1
1748063|NCT00056862|4280627|P2|COMPLETED|Overall Study||27
1748064|NCT00056862|4280628|P1|COMPLETED|Overall Study||30
1748065|NCT00056862|4280627|P2|STARTED|Overall Study||27
1748066|NCT00056862|4280628|P1|STARTED|Overall Study||31
1748067|NCT00056563|4280644|P2|NOT COMPLETED|Overall Study||0
1748068|NCT00056563|4280645|P1|NOT COMPLETED|Overall Study||0
1748069|NCT00056563|4280644|P2|COMPLETED|Overall Study||134
1748070|NCT00056563|4280645|P1|COMPLETED|Overall Study||121
1748071|NCT00056563|4280644|P2|STARTED|Overall Study||134
1748072|NCT00056563|4280645|P1|STARTED|Overall Study||121
1748073|NCT00056550|4280653|P1|NOT COMPLETED|Overall Study||0
1748074|NCT00056550|4280653|P1|COMPLETED|Overall Study||14
1748075|NCT00056550|4280653|P1|STARTED|Overall Study||14
1748076|NCT00056498|4280660|P2|NOT COMPLETED|Overall Study||7
1748077|NCT00056498|4280661|P1|NOT COMPLETED|Overall Study||5
1748078|NCT00056498|4280660|P2|COMPLETED|Overall Study||28
1748079|NCT00056498|4280661|P1|COMPLETED|Overall Study||25
1748080|NCT00056498|4280660|P2|STARTED|Overall Study||35
1748081|NCT00056498|4280661|P1|STARTED|Overall Study||30
1748082|NCT00056472|4280673|P2|NOT COMPLETED|Overall Study||69
1748083|NCT00056472|4280674|P1|NOT COMPLETED|Overall Study||48
1748084|NCT00056472|4280673|P2|COMPLETED|Overall Study||61
1748085|NCT00056472|4280674|P1|COMPLETED|Overall Study||81
1748086|NCT00056472|4280673|P2|STARTED|Overall Study||130
1748087|NCT00056472|4280674|P1|STARTED|Overall Study||129
1748088|NCT00056407|4280686|P2|NOT COMPLETED|Overall Study||1193
1748089|NCT00056407|4280687|P1|NOT COMPLETED|Overall Study||1211
1748090|NCT00056407|4280686|P2|COMPLETED|Overall Study||2912
1748091|NCT00056407|4280687|P1|COMPLETED|Overall Study||2915
1748092|NCT00056407|4280686|P2|STARTED|Overall Study||4105
1748093|NCT00056407|4280687|P1|STARTED|Overall Study||4126
1748094|NCT00056316|4280745|P2|NOT COMPLETED|Overall Study||3
1748095|NCT00056316|4280746|P1|NOT COMPLETED|Overall Study||3
1748096|NCT00056316|4280745|P2|COMPLETED|Overall Study||38
1748097|NCT00056316|4280746|P1|COMPLETED|Overall Study||30
1748098|NCT00056316|4280745|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
1748099|NCT00056316|4280746|P1|STARTED|Overall Study||33
1748100|NCT00056160|4280760|P2|NOT COMPLETED|Final Follow-up||0
1748101|NCT00056160|4280761|P1|NOT COMPLETED|Final Follow-up||6
1748102|NCT00056160|4280760|P2|COMPLETED|Final Follow-up||0
1748103|NCT00056160|4280761|P1|COMPLETED|Final Follow-up||0
1748104|NCT00056160|4280760|P2|STARTED|Final Follow-up||0
1748105|NCT00056160|4280761|P1|STARTED|Final Follow-up||6
1748106|NCT00056160|4280760|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
1748107|NCT00056160|4280761|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
1748108|NCT00056160|4280760|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
1748109|NCT00056160|4280761|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
1748110|NCT00056160|4280760|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
1748111|NCT00056160|4280761|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
1748112|NCT00056160|4280760|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
1748113|NCT00056160|4280761|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
1748114|NCT00056160|4280760|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
1748115|NCT00056160|4280761|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
1748116|NCT00056160|4280760|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
1748117|NCT00056160|4280761|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
1748118|NCT00055692|4280773|P1|NOT COMPLETED|Overall Study||0
1748119|NCT00055692|4280773|P1|COMPLETED|Overall Study||46
1748120|NCT00055692|4280773|P1|STARTED|Overall Study||46
1748121|NCT00055601|4280784|P2|NOT COMPLETED|Overall Study||2
1748122|NCT00055601|4280785|P1|NOT COMPLETED|Overall Study||2
1748123|NCT00055601|4280784|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
1748124|NCT00055601|4280785|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
1748125|NCT00055601|4280784|P2|STARTED|Overall Study||49
1748126|NCT00055601|4280785|P1|STARTED|Overall Study||48
1748127|NCT00055497|4280799|P4|NOT COMPLETED|Overall Study||90
1748128|NCT00055497|4280800|P3|NOT COMPLETED|Overall Study||2
1748129|NCT00055497|4280801|P2|NOT COMPLETED|Overall Study||3
1748130|NCT00055497|4280802|P1|NOT COMPLETED|Overall Study||5
1748131|NCT00055497|4280799|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
1748132|NCT00055497|4280800|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
1748133|NCT00055497|4280801|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
1748134|NCT00055497|4280802|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
1748135|NCT00055497|4280799|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
1748136|NCT00055497|4280800|P3|STARTED|Overall Study||18
1748137|NCT00055497|4280801|P2|STARTED|Overall Study||19
1748138|NCT00055497|4280802|P1|STARTED|Overall Study||18
1748139|NCT00055471|4280847|P3|NOT COMPLETED|Period 2: Extension Period||0
1748140|NCT00055471|4280848|P2|NOT COMPLETED|Period 2: Extension Period||0
1748141|NCT00055471|4280849|P1|NOT COMPLETED|Period 2: Extension Period||0
1748142|NCT00055471|4280847|P3|COMPLETED|Period 2: Extension Period||0
1748143|NCT00055471|4280848|P2|COMPLETED|Period 2: Extension Period||6
1748144|NCT00055471|4280849|P1|COMPLETED|Period 2: Extension Period||3
1748145|NCT00055471|4280847|P3|STARTED|Period 2: Extension Period||0
1748146|NCT00055471|4280848|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
1748147|NCT00055471|4280849|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
1748148|NCT00055471|4280847|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
1748149|NCT00055471|4280848|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
1748150|NCT00055471|4280849|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
1748151|NCT00055471|4280847|P3|COMPLETED|Period 1: Dose Escalation Period||0
1748152|NCT00055471|4280848|P2|COMPLETED|Period 1: Dose Escalation Period||8
1748153|NCT00055471|4280849|P1|COMPLETED|Period 1: Dose Escalation Period||3
1748154|NCT00055471|4280847|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
1748155|NCT00055471|4280848|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
1748156|NCT00055471|4280849|P1|STARTED|Period 1: Dose Escalation Period||3
1748157|NCT00055237|4280877|P2|NOT COMPLETED|Overall Study||0
1748158|NCT00055237|4280878|P1|NOT COMPLETED|Overall Study||0
1748159|NCT00055237|4280877|P2|COMPLETED|Overall Study||2
1748160|NCT00055237|4280878|P1|COMPLETED|Overall Study||17
1748161|NCT00055237|4280877|P2|STARTED|Overall Study||2
1748162|NCT00055237|4280878|P1|STARTED|Overall Study||17
1748163|NCT00054847|4280885|P2|NOT COMPLETED|Overall Study||100
1748164|NCT00054847|4280886|P1|NOT COMPLETED|Overall Study||98
1748165|NCT00054847|4280885|P2|COMPLETED|Overall Study||266
1748166|NCT00054847|4280886|P1|COMPLETED|Overall Study||269
1748167|NCT00054847|4280885|P2|STARTED|Overall Study||366
1748168|NCT00054847|4280886|P1|STARTED|Overall Study||367
1748169|NCT00054756|4280898|P1|NOT COMPLETED|Overall Study||2
1748170|NCT00054756|4280898|P1|COMPLETED|Overall Study||94
1748171|NCT00054756|4280898|P1|STARTED|Overall Study||96
1748172|NCT00054717|4280904|P2|NOT COMPLETED|Overall Study||299
1748173|NCT00054717|4280905|P1|NOT COMPLETED|Overall Study||262
1748174|NCT00054717|4280904|P2|COMPLETED|Overall Study||18
1748175|NCT00054717|4280905|P1|COMPLETED|Overall Study||51
1748176|NCT00054717|4280904|P2|STARTED|Overall Study||317
1748177|NCT00054717|4280905|P1|STARTED|Overall Study||313
1748178|NCT00054704|4281093|P2|NOT COMPLETED|Overall Study||5
1748179|NCT00054704|4281094|P1|NOT COMPLETED|Overall Study||5
1748180|NCT00054704|4281093|P2|COMPLETED|Overall Study||6
1748181|NCT00054704|4281094|P1|COMPLETED|Overall Study||4
1748182|NCT00054704|4281093|P2|STARTED|Overall Study||11
1748183|NCT00054704|4281094|P1|STARTED|Overall Study||9
1748184|NCT00054691|4281100|P1|NOT COMPLETED|Overall Study||3
1748185|NCT00054691|4281100|P1|COMPLETED|Overall Study||37
1748186|NCT00054691|4281100|P1|STARTED|Overall Study||40
1748187|NCT00054665|4281105|P2|NOT COMPLETED|Part B||0
1748188|NCT00054665|4281106|P1|NOT COMPLETED|Part B||0
1748189|NCT00054665|4281105|P2|COMPLETED|Part B||44
1748190|NCT00054665|4281106|P1|COMPLETED|Part B||0
1748191|NCT00054665|4281105|P2|STARTED|Part B|26 participants received only Part B|44
1748192|NCT00054665|4281106|P1|STARTED|Part B||0
1748193|NCT00054665|4281105|P2|NOT COMPLETED|Part A||0
1748194|NCT00054665|4281106|P1|NOT COMPLETED|Part A||0
1748195|NCT00054665|4281105|P2|COMPLETED|Part A||0
1748196|NCT00054665|4281106|P1|COMPLETED|Part A||23
1748197|NCT00054665|4281105|P2|STARTED|Part A||0
1748198|NCT00054665|4281106|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
1748199|NCT00054639|4281114|P1|NOT COMPLETED|Overall Study||2
1748200|NCT00054639|4281114|P1|COMPLETED|Overall Study||46
1748201|NCT00054639|4281114|P1|STARTED|Overall Study||48
1748202|NCT00054353|4281120|P2|NOT COMPLETED|Overall Study||0
1748203|NCT00054353|4281121|P1|NOT COMPLETED|Overall Study||0
1748204|NCT00054353|4281120|P2|COMPLETED|Overall Study||4
1748205|NCT00054353|4281121|P1|COMPLETED|Overall Study||12
1748206|NCT00054353|4281120|P2|STARTED|Overall Study||4
1748207|NCT00054353|4281121|P1|STARTED|Overall Study||12
1748208|NCT00054327|4281147|P6|NOT COMPLETED|Overall Study||0
1748209|NCT00054327|4281148|P5|NOT COMPLETED|Overall Study||0
1748210|NCT00054327|4281149|P4|NOT COMPLETED|Overall Study||0
1748211|NCT00054327|4281150|P3|NOT COMPLETED|Overall Study||0
1748212|NCT00054327|4281151|P2|NOT COMPLETED|Overall Study||0
1748213|NCT00054327|4281152|P1|NOT COMPLETED|Overall Study||1
1748214|NCT00054327|4281147|P6|COMPLETED|Overall Study||2
1748215|NCT00054327|4281148|P5|COMPLETED|Overall Study||10
1748216|NCT00054327|4281149|P4|COMPLETED|Overall Study||4
1748217|NCT00054327|4281150|P3|COMPLETED|Overall Study||3
1748218|NCT00054327|4281151|P2|COMPLETED|Overall Study||4
1748219|NCT00054327|4281152|P1|COMPLETED|Overall Study||10
1748220|NCT00054327|4281147|P6|STARTED|Overall Study||2
1748221|NCT00054327|4281148|P5|STARTED|Overall Study||10
1748222|NCT00054327|4281149|P4|STARTED|Overall Study||4
1748223|NCT00054327|4281150|P3|STARTED|Overall Study||3
1748224|NCT00054327|4281151|P2|STARTED|Overall Study||4
1748225|NCT00054327|4281152|P1|STARTED|Overall Study||11
1748226|NCT00054275|4281190|P1|NOT COMPLETED|Overall Study||11
1748227|NCT00054275|4281190|P1|COMPLETED|Overall Study||28
1748228|NCT00054275|4281190|P1|STARTED|Overall Study||39
1748229|NCT00054132|4281196|P1|NOT COMPLETED|Overall Study||1
1748230|NCT00054132|4281196|P1|COMPLETED|Overall Study||37
1748231|NCT00054132|4281196|P1|STARTED|Overall Study||38
1748232|NCT00054028|4281207|P1|NOT COMPLETED|Overall Study||0
1748233|NCT00054028|4281207|P1|COMPLETED|Overall Study||31
1748234|NCT00054028|4281207|P1|Phase II|Overall Study||22
1748235|NCT00054028|4281207|P1|Phase I|Overall Study||9
1748236|NCT00054028|4281207|P1|STARTED|Overall Study||31
1748237|NCT00053898|4281215|P2|NOT COMPLETED|Overall Study||13
1748238|NCT00053898|4281216|P1|NOT COMPLETED|Overall Study||14
1748239|NCT00053898|4281215|P2|COMPLETED|Overall Study||1539
1748240|NCT00053898|4281216|P1|COMPLETED|Overall Study||1538
1748241|NCT00053898|4281215|P2|STARTED|Overall Study||1552
1748242|NCT00053898|4281216|P1|STARTED|Overall Study||1552
1748243|NCT00053846|4281242|P2|NOT COMPLETED|Overall Study||27
1748244|NCT00053846|4281243|P1|NOT COMPLETED|Overall Study||26
1748245|NCT00053846|4281242|P2|COMPLETED|Overall Study||192
1748246|NCT00053846|4281243|P1|COMPLETED|Overall Study||187
1748247|NCT00053846|4281242|P2|STARTED|Overall Study||219
1748248|NCT00053846|4281243|P1|STARTED|Overall Study||213
1748249|NCT00053703|4281252|P3|NOT COMPLETED|Overall Study||15
1748250|NCT00053703|4281253|P2|NOT COMPLETED|Overall Study||13
1748251|NCT00053703|4281254|P1|NOT COMPLETED|Overall Study||18
1748252|NCT00053703|4281252|P3|COMPLETED|Overall Study||25
1748253|NCT00053703|4281253|P2|COMPLETED|Overall Study||28
1748254|NCT00053703|4281254|P1|COMPLETED|Overall Study||17
1748255|NCT00053703|4281252|P3|STARTED|Overall Study||40
1748256|NCT00053703|4281253|P2|STARTED|Overall Study||41
1748257|NCT00053703|4281254|P1|STARTED|Overall Study||35
1748258|NCT00053677|4281279|P2|NOT COMPLETED|Overall Study||6
1748259|NCT00053677|4281280|P1|NOT COMPLETED|Overall Study||22
1748260|NCT00053677|4281279|P2|COMPLETED|Overall Study||13
1748261|NCT00053677|4281280|P1|COMPLETED|Overall Study||36
1748262|NCT00053677|4281279|P2|STARTED|Overall Study||19
1748263|NCT00053677|4281280|P1|STARTED|Overall Study||58
1748264|NCT00053495|4281291|P5|NOT COMPLETED|Overall Study||0
1748265|NCT00053495|4281292|P4|NOT COMPLETED|Overall Study||0
1748266|NCT00053495|4281293|P3|NOT COMPLETED|Overall Study||0
1748267|NCT00053495|4281294|P2|NOT COMPLETED|Overall Study||0
1748268|NCT00053495|4281295|P1|NOT COMPLETED|Overall Study||0
1748269|NCT00053495|4281291|P5|COMPLETED|Overall Study||49
1748270|NCT00053495|4281292|P4|COMPLETED|Overall Study||51
1748271|NCT00053495|4281293|P3|COMPLETED|Overall Study||101
1748272|NCT00053495|4281294|P2|COMPLETED|Overall Study||101
1748273|NCT00053495|4281295|P1|COMPLETED|Overall Study||51
1748274|NCT00053495|4281291|P5|STARTED|Overall Study||49
1748275|NCT00053495|4281292|P4|STARTED|Overall Study||51
1748276|NCT00053495|4281293|P3|STARTED|Overall Study||101
1748277|NCT00053495|4281294|P2|STARTED|Overall Study||101
1748278|NCT00053495|4281295|P1|STARTED|Overall Study||51
1748279|NCT00053482|4281347|P5|NOT COMPLETED|Overall Study||0
1748280|NCT00053482|4281348|P4|NOT COMPLETED|Overall Study||0
1748281|NCT00053482|4281349|P3|NOT COMPLETED|Overall Study||0
1748282|NCT00053482|4281350|P2|NOT COMPLETED|Overall Study||0
1748283|NCT00053482|4281351|P1|NOT COMPLETED|Overall Study||0
1748284|NCT00053482|4281347|P5|COMPLETED|Overall Study||52
1748285|NCT00053482|4281348|P4|COMPLETED|Overall Study||50
1748286|NCT00053482|4281349|P3|COMPLETED|Overall Study||102
1748287|NCT00053482|4281350|P2|COMPLETED|Overall Study||102
1748288|NCT00053482|4281351|P1|COMPLETED|Overall Study||51
1748289|NCT00053482|4281347|P5|STARTED|Overall Study||52
1748290|NCT00053482|4281348|P4|STARTED|Overall Study||50
1748291|NCT00053482|4281349|P3|STARTED|Overall Study||102
1748292|NCT00053482|4281350|P2|STARTED|Overall Study||102
1748293|NCT00053482|4281351|P1|STARTED|Overall Study||51
1748294|NCT00053417|4281402|P4|NOT COMPLETED|Overall Study||6
1748295|NCT00053417|4281403|P3|NOT COMPLETED|Overall Study||1
1748296|NCT00053417|4281404|P2|NOT COMPLETED|Overall Study||2
1748297|NCT00053417|4281405|P1|NOT COMPLETED|Overall Study||2
1748298|NCT00053417|4281402|P4|COMPLETED|Overall Study||51
1748299|NCT00053417|4281403|P3|COMPLETED|Overall Study||49
1748300|NCT00053417|4281404|P2|COMPLETED|Overall Study||50
1748301|NCT00053417|4281405|P1|COMPLETED|Overall Study||45
1748302|NCT00053417|4281402|P4|STARTED|Overall Study||57
1748303|NCT00053417|4281403|P3|STARTED|Overall Study||50
1748304|NCT00053417|4281404|P2|STARTED|Overall Study||52
1748305|NCT00053417|4281405|P1|STARTED|Overall Study||47
1748306|NCT00053365|4281415|P1|NOT COMPLETED|Overall Study||6
1748307|NCT00053365|4281415|P1|COMPLETED|Overall Study||55
1748308|NCT00053365|4281415|P1|STARTED|Overall Study||61
1748309|NCT00053352|4281424|P2|NOT COMPLETED|Overall Study||10
1748310|NCT00053352|4281425|P1|NOT COMPLETED|Overall Study||21
1748311|NCT00053352|4281424|P2|COMPLETED|Overall Study||102
1748312|NCT00053352|4281425|P1|COMPLETED|Overall Study||169
1748313|NCT00053352|4281424|P2|STARTED|Overall Study||112
1748314|NCT00053352|4281425|P1|STARTED|Overall Study||190
1748315|NCT00053014|4281434|P1|NOT COMPLETED|Overall Study||0
1748316|NCT00053014|4281434|P1|COMPLETED|Overall Study||5
1748317|NCT00053014|4281434|P1|STARTED|Overall Study||5
1748318|NCT00003830|4281441|P2|NOT COMPLETED|Overall Study||793
1748319|NCT00003830|4281442|P1|NOT COMPLETED|Overall Study||832
1748320|NCT00003830|4281441|P2|COMPLETED|Overall Study||2011
1748321|NCT00003830|4281442|P1|COMPLETED|Overall Study||1975
1748322|NCT00003830|4281441|P2|STARTED|Overall Study||2804
1748323|NCT00003830|4281442|P1|STARTED|Overall Study||2807
1748324|NCT00052962|4281468|P2|NOT COMPLETED|Overall Study||2
1748325|NCT00052962|4281469|P1|NOT COMPLETED|Overall Study||1
1748326|NCT00052962|4281468|P2|COMPLETED|Overall Study||15
1748327|NCT00052962|4281469|P1|COMPLETED|Overall Study||12
1748328|NCT00052962|4281468|P2|STARTED|Overall Study||17
1748329|NCT00052962|4281469|P1|STARTED|Overall Study||13
1748330|NCT00052910|4281479|P2|NOT COMPLETED|Overall Study||0
1748331|NCT00052910|4281480|P1|NOT COMPLETED|Overall Study||0
1748332|NCT00052910|4281479|P2|COMPLETED|Overall Study||266
1748333|NCT00052910|4281480|P1|COMPLETED|Overall Study||280
1748334|NCT00052910|4281479|P2|STARTED|Overall Study||266
1748335|NCT00052910|4281480|P1|STARTED|Overall Study||280
1748336|NCT00052715|4281488|P1|NOT COMPLETED|Overall Study||1
1748337|NCT00052715|4281488|P1|COMPLETED|Overall Study||30
1748338|NCT00052715|4281488|P1|STARTED|Overall Study||31
1748339|NCT00052429|4281497|P1|NOT COMPLETED|Overall Study||0
1748340|NCT00052429|4281497|P1|COMPLETED|Overall Study||25
1748341|NCT00052429|4281497|P1|STARTED|Overall Study||25
1748342|NCT00049543|4281504|P2|NOT COMPLETED|Overall Study||9
1748343|NCT00049543|4281505|P1|NOT COMPLETED|Overall Study||2
1748344|NCT00049543|4281504|P2|COMPLETED|Overall Study||243
1748345|NCT00049543|4281505|P1|COMPLETED|Overall Study||249
1748346|NCT00049543|4281504|P2|STARTED|Overall Study||252
1748347|NCT00049543|4281505|P1|STARTED|Overall Study||251
1748348|NCT00049530|4281515|P1|NOT COMPLETED|Overall Study||32
1748349|NCT00049530|4281515|P1|COMPLETED|Overall Study||0
1748350|NCT00049530|4281515|P1|Eligible and Treated|Overall Study||29
1748351|NCT00049530|4281515|P1|STARTED|Overall Study||32
1748352|NCT00049517|4281524|P6|NOT COMPLETED|Conditioning/Transplant||6
1748353|NCT00049517|4281525|P5|NOT COMPLETED|Conditioning/Transplant||6
1748354|NCT00049517|4281526|P4|NOT COMPLETED|Conditioning/Transplant||43
1748355|NCT00049517|4281527|P3|NOT COMPLETED|Conditioning/Transplant||38
1748356|NCT00049517|4281528|P2|NOT COMPLETED|Conditioning/Transplant||50
1748357|NCT00049517|4281529|P1|NOT COMPLETED|Conditioning/Transplant||52
1748358|NCT00049517|4281524|P6|COMPLETED|Conditioning/Transplant||18
1748359|NCT00049517|4281525|P5|COMPLETED|Conditioning/Transplant||15
1748360|NCT00049517|4281526|P4|COMPLETED|Conditioning/Transplant||32
1748361|NCT00049517|4281527|P3|COMPLETED|Conditioning/Transplant||25
1748362|NCT00049517|4281528|P2|COMPLETED|Conditioning/Transplant||40
1748363|NCT00049517|4281529|P1|COMPLETED|Conditioning/Transplant||27
1748364|NCT00049517|4281524|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
1748365|NCT00049517|4281525|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
1748366|NCT00049517|4281526|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
1748367|NCT00049517|4281527|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
1748368|NCT00049517|4281528|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
1748369|NCT00049517|4281529|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
1748370|NCT00049517|4281524|P6|STARTED|Conditioning/Transplant||24
1748371|NCT00049517|4281525|P5|STARTED|Conditioning/Transplant||21
1748372|NCT00049517|4281526|P4|STARTED|Conditioning/Transplant||75
1748373|NCT00049517|4281527|P3|STARTED|Conditioning/Transplant||63
1748374|NCT00049517|4281528|P2|STARTED|Conditioning/Transplant||90
1748375|NCT00049517|4281529|P1|STARTED|Conditioning/Transplant||79
1748376|NCT00049517|4281524|P6|NOT COMPLETED|Induction||54
1748377|NCT00049517|4281525|P5|NOT COMPLETED|Induction||60
1748378|NCT00049517|4281526|P4|NOT COMPLETED|Induction||0
1748379|NCT00049517|4281527|P3|NOT COMPLETED|Induction||0
1748380|NCT00049517|4281528|P2|NOT COMPLETED|Induction||0
1748381|NCT00049517|4281529|P1|NOT COMPLETED|Induction||0
1748382|NCT00049517|4281524|P6|COMPLETED|Induction||108
1748383|NCT00049517|4281525|P5|COMPLETED|Induction||128
1748384|NCT00049517|4281526|P4|COMPLETED|Induction||75
1748385|NCT00049517|4281527|P3|COMPLETED|Induction||63
1748386|NCT00049517|4281528|P2|COMPLETED|Induction||90
1748387|NCT00049517|4281529|P1|COMPLETED|Induction||79
1748388|NCT00049517|4281524|P6|Treated|Induction||160
1748389|NCT00049517|4281525|P5|Treated|Induction||186
1748390|NCT00049517|4281526|P4|Treated|Induction||75
1748391|NCT00049517|4281527|P3|Treated|Induction||63
1748392|NCT00049517|4281528|P2|Treated|Induction||90
1748393|NCT00049517|4281529|P1|Treated|Induction||79
1748394|NCT00049517|4281524|P6|STARTED|Induction||162
1748395|NCT00049517|4281525|P5|STARTED|Induction||188
1748396|NCT00049517|4281526|P4|STARTED|Induction||75
1748397|NCT00049517|4281527|P3|STARTED|Induction||63
1748398|NCT00049517|4281528|P2|STARTED|Induction||90
1748399|NCT00049517|4281529|P1|STARTED|Induction||79
1748400|NCT00049504|4281539|P1|NOT COMPLETED|Overall Study||0
1748401|NCT00049504|4281539|P1|COMPLETED|Overall Study||55
1748402|NCT00049504|4281539|P1|STARTED|Overall Study||55
1748403|NCT00049322|4281547|P2|NOT COMPLETED|Overall Study||6
1748404|NCT00049322|4281548|P1|NOT COMPLETED|Overall Study||1
1748405|NCT00049322|4281547|P2|COMPLETED|Overall Study||9
1748406|NCT00049322|4281548|P1|COMPLETED|Overall Study||14
1748407|NCT00049322|4281547|P2|STARTED|Overall Study||15
1748408|NCT00049322|4281548|P1|STARTED|Overall Study||15
1748409|NCT00049257|4281560|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
1748410|NCT00049257|4281560|P1|COMPLETED|Follow-up Period for Survival Status||41
1748411|NCT00049257|4281560|P1|STARTED|Follow-up Period for Survival Status||45
1748412|NCT00049257|4281560|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
1748413|NCT00049257|4281560|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
1748414|NCT00049257|4281560|P1|STARTED|Carboplatin, Paclitaxel||58
1748415|NCT00049127|4281572|P5|NOT COMPLETED|Overall Study||0
1748416|NCT00049127|4281573|P4|NOT COMPLETED|Overall Study||0
1748417|NCT00049127|4281574|P3|NOT COMPLETED|Overall Study||1
1748418|NCT00049127|4281575|P2|NOT COMPLETED|Overall Study||0
1748419|NCT00049127|4281576|P1|NOT COMPLETED|Overall Study||0
1748420|NCT00049127|4281572|P5|COMPLETED|Overall Study||12
1748421|NCT00049127|4281573|P4|COMPLETED|Overall Study||0
1748422|NCT00049127|4281574|P3|COMPLETED|Overall Study||39
1748423|NCT00049127|4281575|P2|COMPLETED|Overall Study||0
1748424|NCT00049127|4281576|P1|COMPLETED|Overall Study||12
1748425|NCT00049127|4281572|P5|STARTED|Overall Study||12
1748426|NCT00049127|4281573|P4|STARTED|Overall Study||0
1748427|NCT00049127|4281574|P3|STARTED|Overall Study||40
1748428|NCT00049127|4281575|P2|STARTED|Overall Study||0
1748429|NCT00049127|4281576|P1|STARTED|Overall Study||12
1748430|NCT00049036|4281605|P2|NOT COMPLETED|Overall Study||0
1748431|NCT00049036|4281606|P1|NOT COMPLETED|Overall Study||0
1748432|NCT00049036|4281605|P2|COMPLETED|Overall Study||55
1748433|NCT00049036|4281606|P1|COMPLETED|Overall Study||51
1748434|NCT00049036|4281605|P2|STARTED|Overall Study||55
1748435|NCT00049036|4281606|P1|STARTED|Overall Study||51
1748436|NCT00048997|4281614|P2|NOT COMPLETED|Overall Study||3
1748437|NCT00048997|4281615|P1|NOT COMPLETED|Overall Study||13
1748438|NCT00048997|4281614|P2|COMPLETED|Overall Study||177
1748439|NCT00048997|4281615|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
1748440|NCT00048997|4281614|P2|STARTED|Overall Study||180
1748441|NCT00048997|4281615|P1|STARTED|Overall Study||176
1748442|NCT00047385|4281638|P2|NOT COMPLETED|Overall Study||500
1748443|NCT00047385|4281639|P1|NOT COMPLETED|Overall Study||267
1748444|NCT00047385|4281638|P2|COMPLETED|Overall Study||26232
1748445|NCT00047385|4281639|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
1748446|NCT00047385|4281638|P2|STARTED|Overall Study||26732
1748447|NCT00047385|4281639|P1|STARTED|Overall Study||26722
1748448|NCT00047320|4281657|P1|NOT COMPLETED|Overall Study||28
1748449|NCT00047320|4281657|P1|COMPLETED|Overall Study||76
1748450|NCT00047320|4281657|P1|STARTED|Overall Study||104
1748451|NCT00047008|4281668|P2|NOT COMPLETED|Overall Study||11
1748452|NCT00047008|4281669|P1|NOT COMPLETED|Overall Study||11
1748453|NCT00047008|4281668|P2|COMPLETED|Overall Study||360
1748454|NCT00047008|4281669|P1|COMPLETED|Overall Study||361
1748455|NCT00047008|4281668|P2|STARTED|Overall Study||371
1748456|NCT00047008|4281669|P1|STARTED|Overall Study||372
1748457|NCT00046930|4281677|P2|NOT COMPLETED|Overall Study||4
1748458|NCT00046930|4281678|P1|NOT COMPLETED|Overall Study||12
1748459|NCT00046930|4281677|P2|COMPLETED|Overall Study||221
1748460|NCT00046930|4281678|P1|COMPLETED|Overall Study||212
1748461|NCT00046930|4281677|P2|STARTED|Overall Study||225
1748462|NCT00046930|4281678|P1|STARTED|Overall Study||224
1748463|NCT00046891|4281693|P2|NOT COMPLETED|Overall Study||30
1748464|NCT00046891|4281694|P1|NOT COMPLETED|Overall Study||29
1748465|NCT00046891|4281693|P2|COMPLETED|Overall Study||83
1748466|NCT00046891|4281694|P1|COMPLETED|Overall Study||84
1748467|NCT00046891|4281693|P2|STARTED|Overall Study||113
1748468|NCT00046891|4281694|P1|STARTED|Overall Study||113
1748469|NCT00046839|4281714|P2|NOT COMPLETED|Overall Study||2
1748470|NCT00046839|4281715|P1|NOT COMPLETED|Overall Study||1
1748471|NCT00046839|4281714|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
1748472|NCT00046839|4281715|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
1748473|NCT00046839|4281714|P2|STARTED|Overall Study||13
1748474|NCT00046839|4281715|P1|STARTED|Overall Study||8
1748475|NCT00045734|4281722|P1|NOT COMPLETED|Overall Study||1
1748476|NCT00045734|4281722|P1|COMPLETED|Overall Study||22
1748477|NCT00045734|4281722|P1|STARTED|Overall Study||23
1748478|NCT00045708|4281737|P3|NOT COMPLETED|Phase 2||0
1748479|NCT00045708|4281738|P2|NOT COMPLETED|Phase 2||0
1748480|NCT00045708|4281739|P1|NOT COMPLETED|Phase 2||0
1748481|NCT00045708|4281737|P3|COMPLETED|Phase 2||19
1748482|NCT00045708|4281738|P2|COMPLETED|Phase 2||0
1748483|NCT00045708|4281739|P1|COMPLETED|Phase 2||0
1748484|NCT00045708|4281737|P3|STARTED|Phase 2||19
1748485|NCT00045708|4281738|P2|STARTED|Phase 2||0
1748486|NCT00045708|4281739|P1|STARTED|Phase 2||0
1748487|NCT00045708|4281737|P3|NOT COMPLETED|Phase 1||0
1748488|NCT00045708|4281738|P2|NOT COMPLETED|Phase 1||1
1748489|NCT00045708|4281739|P1|NOT COMPLETED|Phase 1||0
1748490|NCT00045708|4281737|P3|COMPLETED|Phase 1||0
1748491|NCT00045708|4281738|P2|COMPLETED|Phase 1||16
1748492|NCT00045708|4281739|P1|COMPLETED|Phase 1||21
1748493|NCT00045708|4281737|P3|STARTED|Phase 1||0
1748494|NCT00045708|4281738|P2|STARTED|Phase 1||17
1748495|NCT00045708|4281739|P1|STARTED|Phase 1||21
1748496|NCT00045630|4281764|P1|NOT COMPLETED|Overall Study||6
1748497|NCT00045630|4281764|P1|COMPLETED|Overall Study||71
1748498|NCT00045630|4281764|P1|Eligible and Began Protocol Therapy|Overall Study||74
1748499|NCT00045630|4281764|P1|Eligible|Overall Study||75
1748500|NCT00045630|4281764|P1|STARTED|Overall Study||77
1748501|NCT00045487|4281770|P1|NOT COMPLETED|Overall Study||11
1748502|NCT00045487|4281770|P1|COMPLETED|Overall Study||30
1748503|NCT00045487|4281770|P1|STARTED|Overall Study||41
1748504|NCT00045435|4281774|P1|NOT COMPLETED|Overall Study||0
1748505|NCT00045435|4281774|P1|COMPLETED|Overall Study||17
1748506|NCT00045435|4281774|P1|STARTED|Overall Study||17
1748507|NCT00045305|4281783|P1|NOT COMPLETED|Overall Study||14
1748508|NCT00045305|4281783|P1|COMPLETED|Overall Study||3
1748509|NCT00045305|4281783|P1|Eligible and Treated|Overall Study||17
1748510|NCT00045305|4281783|P1|STARTED|Overall Study||17
1748511|NCT00045162|4281794|P2|NOT COMPLETED|Overall Study||118
1748512|NCT00045162|4281795|P1|NOT COMPLETED|Overall Study||142
1748513|NCT00045162|4281794|P2|COMPLETED|Overall Study||217
1748514|NCT00045162|4281795|P1|COMPLETED|Overall Study||194
1748515|NCT00045162|4281794|P2|STARTED|Overall Study||335
1748516|NCT00045162|4281795|P1|STARTED|Overall Study||336
1748517|NCT00045110|4281810|P3|NOT COMPLETED|775mg Dose Escalation||0
1748518|NCT00045110|4281811|P2|NOT COMPLETED|775mg Dose Escalation||0
1748519|NCT00045110|4281812|P1|NOT COMPLETED|775mg Dose Escalation||0
1748520|NCT00045110|4281810|P3|COMPLETED|775mg Dose Escalation||0
1748521|NCT00045110|4281811|P2|COMPLETED|775mg Dose Escalation||0
1748522|NCT00045110|4281812|P1|COMPLETED|775mg Dose Escalation||7
1748523|NCT00045110|4281810|P3|STARTED|775mg Dose Escalation||0
1748524|NCT00045110|4281811|P2|STARTED|775mg Dose Escalation||0
1748525|NCT00045110|4281812|P1|STARTED|775mg Dose Escalation||7
1748526|NCT00045110|4281810|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
1748527|NCT00045110|4281811|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
1748528|NCT00045110|4281812|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
1748529|NCT00045110|4281810|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
1748530|NCT00045110|4281811|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
1748531|NCT00045110|4281812|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
1748532|NCT00045110|4281810|P3|STARTED|650mg Phase 1 Dose Escalation||0
1748533|NCT00045110|4281811|P2|STARTED|650mg Phase 1 Dose Escalation||0
1748534|NCT00045110|4281812|P1|STARTED|650mg Phase 1 Dose Escalation||6
1748535|NCT00045110|4281810|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
1748536|NCT00045110|4281811|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
1748537|NCT00045110|4281812|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
1748538|NCT00045110|4281810|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
1748539|NCT00045110|4281811|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
1748540|NCT00045110|4281812|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
1748541|NCT00045110|4281810|P3|STARTED|525mg Phase 1 Dose Escalation||0
1748542|NCT00045110|4281811|P2|STARTED|525mg Phase 1 Dose Escalation||0
1748543|NCT00045110|4281812|P1|STARTED|525mg Phase 1 Dose Escalation||3
1748544|NCT00045110|4281810|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
1748545|NCT00045110|4281811|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
1748546|NCT00045110|4281812|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
1748547|NCT00045110|4281810|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
1748548|NCT00045110|4281811|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
1748549|NCT00045110|4281812|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
1748550|NCT00045110|4281810|P3|STARTED|400mg Phase 1 Dose Escalation||0
1748551|NCT00045110|4281811|P2|STARTED|400mg Phase 1 Dose Escalation||0
1748552|NCT00045110|4281812|P1|STARTED|400mg Phase 1 Dose Escalation||3
1748553|NCT00045110|4281810|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
1748554|NCT00045110|4281811|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
1748555|NCT00045110|4281812|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
1748556|NCT00045110|4281810|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
1748557|NCT00045110|4281811|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
1748558|NCT00045110|4281812|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
1748559|NCT00045110|4281810|P3|STARTED|275mg Phase 1 Dose Escalation||0
1748560|NCT00045110|4281811|P2|STARTED|275mg Phase 1 Dose Escalation||0
1748561|NCT00045110|4281812|P1|STARTED|275mg Phase 1 Dose Escalation||3
1748562|NCT00045110|4281810|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
1748563|NCT00045110|4281811|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
1748564|NCT00045110|4281812|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
1748565|NCT00045110|4281810|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
1748566|NCT00045110|4281811|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
1748567|NCT00045110|4281812|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
1748568|NCT00045110|4281810|P3|STARTED|200mg Phase 1 Dose Escalation||0
1748569|NCT00045110|4281811|P2|STARTED|200mg Phase 1 Dose Escalation||0
1748570|NCT00045110|4281812|P1|STARTED|200mg Phase 1 Dose Escalation||4
1748571|NCT00045110|4281810|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
1748572|NCT00045110|4281811|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
1748573|NCT00045110|4281812|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
1748574|NCT00045110|4281810|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
1748575|NCT00045110|4281811|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
1748576|NCT00045110|4281812|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
1748577|NCT00045110|4281810|P3|STARTED|100mg Phase 1 Dose Escalalation||45
1748578|NCT00045110|4281811|P2|STARTED|100mg Phase 1 Dose Escalalation||59
1748579|NCT00045110|4281812|P1|STARTED|100mg Phase 1 Dose Escalalation||6
1748580|NCT00045032|4281861|P3|NOT COMPLETED|Overall Study||726
1748581|NCT00045032|4281862|P2|NOT COMPLETED|Overall Study||708
1748582|NCT00045032|4281863|P1|NOT COMPLETED|Overall Study||863
1748583|NCT00045032|4281861|P3|COMPLETED|Overall Study||974
1748584|NCT00045032|4281862|P2|COMPLETED|Overall Study||994
1748585|NCT00045032|4281863|P1|COMPLETED|Overall Study||834
1748586|NCT00045032|4281861|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
1748587|NCT00045032|4281862|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
1748588|NCT00045032|4281863|P1|Crossover to Adjuvant Herceptin|Overall Study||888
1748589|NCT00045032|4281861|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
1748590|NCT00045032|4281862|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
1748591|NCT00045032|4281863|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
1748592|NCT00042991|4281997|P7|NOT COMPLETED|Overall Study||2
1748593|NCT00042991|4281998|P6|NOT COMPLETED|Overall Study||5
1748594|NCT00042991|4281999|P5|NOT COMPLETED|Overall Study||3
1748595|NCT00042991|4282000|P4|NOT COMPLETED|Overall Study||2
1748596|NCT00042991|4282001|P3|NOT COMPLETED|Overall Study||6
1748597|NCT00042991|4282002|P2|NOT COMPLETED|Overall Study||40
1748598|NCT00042991|4282003|P1|NOT COMPLETED|Overall Study||6
1748599|NCT00042991|4281997|P7|COMPLETED|Overall Study||1
1748600|NCT00042991|4281998|P6|COMPLETED|Overall Study||0
1748601|NCT00042991|4281999|P5|COMPLETED|Overall Study||0
1748602|NCT00042991|4282000|P4|COMPLETED|Overall Study||0
1748603|NCT00042991|4282001|P3|COMPLETED|Overall Study||1
1748604|NCT00042991|4282002|P2|COMPLETED|Overall Study||3
1748605|NCT00042991|4282003|P1|COMPLETED|Overall Study||0
1748606|NCT00042991|4281997|P7|Phase-II Trial|Overall Study||0
1748607|NCT00042991|4281998|P6|Phase-II Trial|Overall Study||0
1748608|NCT00042991|4281999|P5|Phase-II Trial|Overall Study||0
1748609|NCT00042991|4282000|P4|Phase-II Trial|Overall Study||0
1748610|NCT00042991|4282001|P3|Phase-II Trial|Overall Study||0
1748611|NCT00042991|4282002|P2|Phase-II Trial|Overall Study||36
1748612|NCT00042991|4282003|P1|Phase-II Trial|Overall Study||0
1748613|NCT00042991|4281997|P7|Phase-I Trial|Overall Study||3
1748614|NCT00042991|4281998|P6|Phase-I Trial|Overall Study||5
1748615|NCT00042991|4281999|P5|Phase-I Trial|Overall Study||3
1748616|NCT00042991|4282000|P4|Phase-I Trial|Overall Study||2
1748617|NCT00042991|4282001|P3|Phase-I Trial|Overall Study||7
1748618|NCT00042991|4282002|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
1748619|NCT00042991|4282003|P1|Phase-I Trial|Overall Study||6
1748620|NCT00042991|4281997|P7|STARTED|Overall Study||3
1748621|NCT00042991|4281998|P6|STARTED|Overall Study||5
1748622|NCT00042991|4281999|P5|STARTED|Overall Study||3
1748623|NCT00042991|4282000|P4|STARTED|Overall Study||2
1748624|NCT00042991|4282001|P3|STARTED|Overall Study||7
1748625|NCT00042991|4282002|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
1748626|NCT00042991|4282003|P1|STARTED|Overall Study||6
1748627|NCT00042939|4282046|P2|NOT COMPLETED|Overall Study||21
1748628|NCT00042939|4282047|P1|NOT COMPLETED|Overall Study||24
1748629|NCT00042939|4282046|P2|COMPLETED|Overall Study||25
1748630|NCT00042939|4282047|P1|COMPLETED|Overall Study||24
1748631|NCT00042939|4282046|P2|Patients With EGFR Results Available|Overall Study||31
1748632|NCT00042939|4282047|P1|Patients With EGFR Results Available|Overall Study||30
1748633|NCT00042939|4282046|P2|Eligible and Began Protocol Therapy|Overall Study||43
1748634|NCT00042939|4282047|P1|Eligible and Began Protocol Therapy|Overall Study||44
1748635|NCT00042939|4282046|P2|Treated|Overall Study||45
1748636|NCT00042939|4282047|P1|Treated|Overall Study||46
1748637|NCT00042939|4282046|P2|STARTED|Overall Study||46
1748638|NCT00042939|4282047|P1|STARTED|Overall Study||48
1748639|NCT00041132|4282061|P1|NOT COMPLETED|Overall Study||30
1748640|NCT00041132|4282061|P1|COMPLETED|Overall Study||26
1748641|NCT00041132|4282061|P1|Eligible and Began Protocol Therapy|Overall Study||49
1748642|NCT00041132|4282061|P1|Eligible|Overall Study||49
1748643|NCT00041132|4282061|P1|STARTED|Overall Study||56
1748644|NCT00041119|4282071|P4|NOT COMPLETED|Overall Study||0
1748645|NCT00041119|4282072|P3|NOT COMPLETED|Overall Study||0
1748646|NCT00041119|4282073|P2|NOT COMPLETED|Overall Study||0
1748647|NCT00041119|4282074|P1|NOT COMPLETED|Overall Study||0
1748648|NCT00041119|4282071|P4|COMPLETED|Overall Study||789
1748649|NCT00041119|4282072|P3|COMPLETED|Overall Study||1151
1748650|NCT00041119|4282073|P2|COMPLETED|Overall Study||789
1748651|NCT00041119|4282074|P1|COMPLETED|Overall Study||1142
1748652|NCT00041119|4282071|P4|STARTED|Overall Study||789
1748653|NCT00041119|4282072|P3|STARTED|Overall Study||1151
1748654|NCT00041119|4282073|P2|STARTED|Overall Study||789
1748655|NCT00041119|4282074|P1|STARTED|Overall Study||1142
1748656|NCT00041080|4282096|P2|NOT COMPLETED|Overall Study||10
1748657|NCT00041080|4282097|P1|NOT COMPLETED|Overall Study||30
1748658|NCT00041080|4282096|P2|COMPLETED|Overall Study||60
1748659|NCT00041080|4282097|P1|COMPLETED|Overall Study||39
1748660|NCT00041080|4282096|P2|STARTED|Overall Study|number patients enrolled on study|70
1748661|NCT00041080|4282097|P1|STARTED|Overall Study|number patients enrolled on study|69
1748662|NCT00041067|4282103|P1|NOT COMPLETED|Overall Study||76
1748663|NCT00041067|4282103|P1|COMPLETED|Overall Study||0
1748664|NCT00041067|4282103|P1|Eligible|Overall Study||74
1748665|NCT00041067|4282103|P1|STARTED|Overall Study||76
1748666|NCT00040937|4282110|P1|NOT COMPLETED|Maintenance||0
1748667|NCT00040937|4282110|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
1748668|NCT00040937|4282110|P1|STARTED|Maintenance||76
1748669|NCT00040937|4282110|P1|NOT COMPLETED|Autologous PBSCT||31
1748670|NCT00040937|4282110|P1|COMPLETED|Autologous PBSCT||77
1748671|NCT00040937|4282110|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
1748672|NCT00040937|4282110|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
1748673|NCT00040937|4282110|P1|COMPLETED|Induction/PBSC Mobilization||110
1748674|NCT00040937|4282110|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
1748675|NCT00040846|4282123|P6|NOT COMPLETED|Overall Study||0
1748676|NCT00040846|4282124|P5|NOT COMPLETED|Overall Study||0
1748677|NCT00040846|4282125|P4|NOT COMPLETED|Overall Study||0
1748678|NCT00040846|4282126|P3|NOT COMPLETED|Overall Study||0
1748679|NCT00040846|4282127|P2|NOT COMPLETED|Overall Study||0
1748680|NCT00040846|4282128|P1|NOT COMPLETED|Overall Study||0
1748681|NCT00040846|4282123|P6|COMPLETED|Overall Study||0
1748682|NCT00040846|4282124|P5|COMPLETED|Overall Study||0
1748683|NCT00040846|4282125|P4|COMPLETED|Overall Study||0
1748684|NCT00040846|4282126|P3|COMPLETED|Overall Study||0
1748685|NCT00040846|4282127|P2|COMPLETED|Overall Study||0
1748686|NCT00040846|4282128|P1|COMPLETED|Overall Study||60
1748687|NCT00040846|4282123|P6|STARTED|Overall Study||0
1748688|NCT00040846|4282124|P5|STARTED|Overall Study||0
1748689|NCT00040846|4282125|P4|STARTED|Overall Study||0
1748690|NCT00040846|4282126|P3|STARTED|Overall Study||0
1748691|NCT00040846|4282127|P2|STARTED|Overall Study||0
1748692|NCT00040846|4282128|P1|STARTED|Overall Study||60
1748693|NCT00040742|4282170|P4|NOT COMPLETED|Overall Study||34
1748694|NCT00040742|4282171|P3|NOT COMPLETED|Overall Study||46
1748695|NCT00040742|4282172|P2|NOT COMPLETED|Overall Study||49
1748696|NCT00040742|4282173|P1|NOT COMPLETED|Overall Study||39
1748697|NCT00040742|4282170|P4|COMPLETED|Overall Study||152
1748698|NCT00040742|4282171|P3|COMPLETED|Overall Study||141
1748699|NCT00040742|4282172|P2|COMPLETED|Overall Study||134
1748700|NCT00040742|4282173|P1|COMPLETED|Overall Study||149
1748701|NCT00040742|4282170|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
1748702|NCT00040742|4282171|P3|STARTED|Overall Study||187
1748703|NCT00040742|4282172|P2|STARTED|Overall Study||183
1748704|NCT00040742|4282173|P1|STARTED|Overall Study||188
1748705|NCT00039377|4282187|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
1748706|NCT00039377|4282188|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
1748707|NCT00039377|4282189|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
1748708|NCT00039377|4282190|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
1748709|NCT00039377|4282187|P4|COMPLETED|Course 5 (Transplant Assignments)||1
1748710|NCT00039377|4282188|P3|COMPLETED|Course 5 (Transplant Assignments)||19
1748711|NCT00039377|4282189|P2|COMPLETED|Course 5 (Transplant Assignments)||15
1748712|NCT00039377|4282190|P1|COMPLETED|Course 5 (Transplant Assignments)||0
1748713|NCT00039377|4282187|P4|STARTED|Course 5 (Transplant Assignments)||1
1748714|NCT00039377|4282188|P3|STARTED|Course 5 (Transplant Assignments)||19
1748715|NCT00039377|4282189|P2|STARTED|Course 5 (Transplant Assignments)||15
1748716|NCT00039377|4282190|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
1748717|NCT00039377|4282187|P4|NOT COMPLETED|Initial Registration||0
1748718|NCT00039377|4282188|P3|NOT COMPLETED|Initial Registration||0
1748719|NCT00039377|4282189|P2|NOT COMPLETED|Initial Registration||0
1748720|NCT00039377|4282190|P1|NOT COMPLETED|Initial Registration||22
1748721|NCT00039377|4282187|P4|COMPLETED|Initial Registration||0
1748722|NCT00039377|4282188|P3|COMPLETED|Initial Registration||0
1748723|NCT00039377|4282189|P2|COMPLETED|Initial Registration||0
1748724|NCT00039377|4282190|P1|COMPLETED|Initial Registration||35
1748725|NCT00039377|4282187|P4|STARTED|Initial Registration||0
1748726|NCT00039377|4282188|P3|STARTED|Initial Registration||0
1748727|NCT00039377|4282189|P2|STARTED|Initial Registration||0
1748728|NCT00039377|4282190|P1|STARTED|Initial Registration||57
1748729|NCT00039195|4282202|P1|NOT COMPLETED|Overall Study||0
1748730|NCT00039195|4282202|P1|COMPLETED|Overall Study||98
1748731|NCT00039195|4282202|P1|STARTED|Overall Study||98
1748732|NCT00039130|4282206|P1|NOT COMPLETED|Overall Study||30
1748733|NCT00039130|4282206|P1|COMPLETED|Overall Study||75
1748734|NCT00039130|4282206|P1|STARTED|Overall Study||105
1748735|NCT00036738|4282212|P1|NOT COMPLETED|Overall Study||0
1748736|NCT00036738|4282212|P1|COMPLETED|Overall Study||28
1748737|NCT00036738|4282212|P1|STARTED|Overall Study||28
1748738|NCT00033657|4282222|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
1748739|NCT00033657|4282223|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
1748740|NCT00033657|4282222|P2|COMPLETED|Adjuvant Chemotherapy||16
1748741|NCT00033657|4282223|P1|COMPLETED|Adjuvant Chemotherapy||18
1748742|NCT00033657|4282222|P2|STARTED|Adjuvant Chemotherapy||33
1748743|NCT00033657|4282223|P1|STARTED|Adjuvant Chemotherapy||36
1748744|NCT00033657|4282222|P2|NOT COMPLETED|Surgical Resection||3
1748745|NCT00033657|4282223|P1|NOT COMPLETED|Surgical Resection||0
1748746|NCT00033657|4282222|P2|COMPLETED|Surgical Resection||33
1748747|NCT00033657|4282223|P1|COMPLETED|Surgical Resection||36
1748748|NCT00033657|4282222|P2|STARTED|Surgical Resection||36
1748749|NCT00033657|4282223|P1|STARTED|Surgical Resection||36
1748750|NCT00033657|4282222|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
1748751|NCT00033657|4282223|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
1748752|NCT00033657|4282222|P2|COMPLETED|Neoadjuvant Chemotherapy||36
1748753|NCT00033657|4282223|P1|COMPLETED|Neoadjuvant Chemotherapy||36
1748754|NCT00033657|4282222|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
1748755|NCT00033657|4282223|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
1748756|NCT00033657|4282222|P2|Eligible|Neoadjuvant Chemotherapy||43
1748757|NCT00033657|4282223|P1|Eligible|Neoadjuvant Chemotherapy||42
1748758|NCT00033657|4282222|P2|STARTED|Neoadjuvant Chemotherapy||47
1748759|NCT00033657|4282223|P1|STARTED|Neoadjuvant Chemotherapy||50
1748760|NCT00033631|4282237|P2|NOT COMPLETED|Overall Study||15
1748761|NCT00033631|4282238|P1|NOT COMPLETED|Overall Study||18
1748762|NCT00033631|4282237|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
1748763|NCT00033631|4282238|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
1748764|NCT00033631|4282237|P2|STARTED|Overall Study||763
1748765|NCT00033631|4282238|P1|STARTED|Overall Study||769
1748766|NCT00033540|4282256|P1|NOT COMPLETED|Overall Study||57
1748767|NCT00033540|4282256|P1|COMPLETED|Overall Study||0
1748768|NCT00033540|4282256|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
1748769|NCT00033540|4282256|P1|Eligible|Overall Study||54
1748770|NCT00033540|4282256|P1|STARTED|Overall Study||57
1748771|NCT00033514|4282266|P2|NOT COMPLETED|Overall Study||4
1748772|NCT00033514|4282267|P1|NOT COMPLETED|Overall Study||1
1748773|NCT00033514|4282266|P2|COMPLETED|Overall Study||7
1748774|NCT00033514|4282267|P1|COMPLETED|Overall Study||15
1748775|NCT00033514|4282266|P2|STARTED|Overall Study||11
1748776|NCT00033514|4282267|P1|STARTED|Overall Study||16
1748777|NCT00033371|4282277|P2|NOT COMPLETED|Overall Study||10
1748778|NCT00033371|4282278|P1|NOT COMPLETED|Overall Study||6
1748779|NCT00033371|4282277|P2|COMPLETED|Overall Study||47
1748780|NCT00033371|4282278|P1|COMPLETED|Overall Study||49
1748781|NCT00033371|4282277|P2|STARTED|Overall Study||57
1748782|NCT00033371|4282278|P1|STARTED|Overall Study||55
1748783|NCT00033293|4282286|P2|NOT COMPLETED|Overall Study||18
1748784|NCT00033293|4282287|P1|NOT COMPLETED|Overall Study||10
1748785|NCT00033293|4282286|P2|COMPLETED|Overall Study||9
1748786|NCT00033293|4282287|P1|COMPLETED|Overall Study||16
1748787|NCT00033293|4282286|P2|STARTED|Overall Study||27
1748788|NCT00033293|4282287|P1|STARTED|Overall Study||26
1748789|NCT00031694|4282305|P1|NOT COMPLETED|Overall Study||19
1748790|NCT00031694|4282305|P1|COMPLETED|Overall Study||0
1748791|NCT00031694|4282305|P1|STARTED|Overall Study||19
1748792|NCT00030901|4282311|P3|NOT COMPLETED|Randomization||88
1748793|NCT00030901|4282312|P2|NOT COMPLETED|Randomization||101
1748794|NCT00030901|4282313|P1|NOT COMPLETED|Randomization||0
1748795|NCT00030901|4282311|P3|COMPLETED|Randomization||137
1748796|NCT00030901|4282312|P2|COMPLETED|Randomization||126
1748797|NCT00030901|4282313|P1|COMPLETED|Randomization||0
1748798|NCT00030901|4282311|P3|Eligible|Randomization||211
1748799|NCT00030901|4282312|P2|Eligible|Randomization||212
1748800|NCT00030901|4282313|P1|Eligible|Randomization||0
1748801|NCT00030901|4282311|P3|STARTED|Randomization||225
1748802|NCT00030901|4282312|P2|STARTED|Randomization||227
1748803|NCT00030901|4282313|P1|STARTED|Randomization||0
1748804|NCT00030901|4282311|P3|NOT COMPLETED|Initial Registration||0
1748805|NCT00030901|4282312|P2|NOT COMPLETED|Initial Registration||0
1748806|NCT00030901|4282313|P1|NOT COMPLETED|Initial Registration||167
1748807|NCT00030901|4282311|P3|COMPLETED|Initial Registration||0
1748808|NCT00030901|4282312|P2|COMPLETED|Initial Registration||0
1748809|NCT00030901|4282313|P1|COMPLETED|Initial Registration||452
1748810|NCT00030901|4282311|P3|STARTED|Initial Registration||0
1748811|NCT00030901|4282312|P2|STARTED|Initial Registration||0
1748812|NCT00030901|4282313|P1|STARTED|Initial Registration||619
1748813|NCT00030823|4282321|P1|NOT COMPLETED|Overall Study||1
1748814|NCT00030823|4282321|P1|COMPLETED|Overall Study||13
1748815|NCT00030823|4282321|P1|STARTED|Overall Study||14
1748816|NCT00030264|4282325|P1|NOT COMPLETED|Overall Study||0
1748817|NCT00030264|4282325|P1|COMPLETED|Overall Study||23
1748818|NCT00030264|4282325|P1|STARTED|Overall Study||23
1748819|NCT00028769|4282329|P1|NOT COMPLETED|Overall Study||41
1748820|NCT00028769|4282329|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
1748821|NCT00028769|4282329|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
1748822|NCT00028769|4282329|P1|Eligible|Overall Study||36
1748823|NCT00028769|4282329|P1|STARTED|Overall Study||41
1748824|NCT00028002|4282335|P1|NOT COMPLETED|Overall Study||11
1748825|NCT00028002|4282335|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
1748826|NCT00028002|4282335|P1|STARTED|Overall Study||63
1748827|NCT00027846|4282345|P3|NOT COMPLETED|Overall Study||37
1748828|NCT00027846|4282346|P2|NOT COMPLETED|Overall Study||68
1748829|NCT00027846|4282347|P1|NOT COMPLETED|Overall Study||2
1748830|NCT00027846|4282345|P3|COMPLETED|Overall Study||41
1748831|NCT00027846|4282346|P2|COMPLETED|Overall Study||219
1748832|NCT00027846|4282347|P1|COMPLETED|Overall Study||11
1748833|NCT00027846|4282345|P3|STARTED|Overall Study||78
1748834|NCT00027846|4282346|P2|STARTED|Overall Study||287
1748835|NCT00027846|4282347|P1|STARTED|Overall Study||13
1748836|NCT00027560|4282365|P1|NOT COMPLETED|Overall Study||1
1748837|NCT00027560|4282365|P1|COMPLETED|Overall Study||50
1748838|NCT00027560|4282365|P1|STARTED|Overall Study||51
1748839|NCT00026494|4282378|P4|NOT COMPLETED|Overall Study||0
1748840|NCT00026494|4282379|P3|NOT COMPLETED|Overall Study||6
1748841|NCT00026494|4282380|P2|NOT COMPLETED|Overall Study||0
1748842|NCT00026494|4282381|P1|NOT COMPLETED|Overall Study||2
1748843|NCT00026494|4282378|P4|COMPLETED|Overall Study||16
1748844|NCT00026494|4282379|P3|COMPLETED|Overall Study||16
1748845|NCT00026494|4282380|P2|COMPLETED|Overall Study||4
1748846|NCT00026494|4282381|P1|COMPLETED|Overall Study||5
1748847|NCT00026494|4282378|P4|STARTED|Overall Study||16
1748848|NCT00026494|4282379|P3|STARTED|Overall Study||22
1748849|NCT00026494|4282380|P2|STARTED|Overall Study||4
1748850|NCT00026494|4282381|P1|STARTED|Overall Study||7
1748851|NCT00026312|4282393|P2|NOT COMPLETED|Overall Study||269
1748852|NCT00026312|4282394|P1|NOT COMPLETED|Overall Study||34
1748853|NCT00026312|4282393|P2|COMPLETED|Overall Study||1064
1748854|NCT00026312|4282394|P1|COMPLETED|Overall Study||82
1748855|NCT00026312|4282393|P2|STARTED|Overall Study||1333
1748856|NCT00026312|4282394|P1|STARTED|Overall Study||116
1748857|NCT00026221|4282412|P3|NOT COMPLETED|Overall Study||0
1748858|NCT00026221|4282413|P2|NOT COMPLETED|Overall Study||0
1748859|NCT00026221|4282414|P1|NOT COMPLETED|Overall Study||0
1748860|NCT00026221|4282412|P3|COMPLETED|Overall Study||25
1748861|NCT00026221|4282413|P2|COMPLETED|Overall Study||16
1748862|NCT00026221|4282414|P1|COMPLETED|Overall Study||16
1748863|NCT00026221|4282412|P3|STARTED|Overall Study||25
1748864|NCT00026221|4282413|P2|STARTED|Overall Study||16
1748865|NCT00026221|4282414|P1|STARTED|Overall Study||16
1748866|NCT00026208|4282433|P2|NOT COMPLETED|Overall Study||0
1748867|NCT00026208|4282434|P1|NOT COMPLETED|Overall Study||1
1748868|NCT00026208|4282433|P2|COMPLETED|Overall Study||4
1748869|NCT00026208|4282434|P1|COMPLETED|Overall Study||71
1748870|NCT00026208|4282433|P2|STARTED|Overall Study||4
1748871|NCT00026208|4282434|P1|STARTED|Overall Study||72
1748872|NCT00025662|4282452|P1|NOT COMPLETED|Overall Study||3
1748873|NCT00025662|4282452|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
1748874|NCT00025662|4282452|P1|STARTED|Overall Study||25
1748875|NCT00025506|4282460|P1|NOT COMPLETED|Overall Study||10
1748876|NCT00025506|4282460|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
1748877|NCT00025506|4282460|P1|STARTED|Overall Study||55
1748878|NCT00025259|4282481|P7|NOT COMPLETED|Overall Study||51
1748879|NCT00025259|4282482|P6|NOT COMPLETED|Overall Study||52
1748880|NCT00025259|4282483|P5|NOT COMPLETED|Overall Study||36
1748881|NCT00025259|4282484|P4|NOT COMPLETED|Overall Study||114
1748882|NCT00025259|4282485|P3|NOT COMPLETED|Overall Study||81
1748883|NCT00025259|4282486|P2|NOT COMPLETED|Overall Study||89
1748884|NCT00025259|4282487|P1|NOT COMPLETED|Overall Study||45
1748885|NCT00025259|4282481|P7|COMPLETED|Overall Study||102
1748886|NCT00025259|4282482|P6|COMPLETED|Overall Study||101
1748887|NCT00025259|4282483|P5|COMPLETED|Overall Study||6
1748888|NCT00025259|4282484|P4|COMPLETED|Overall Study||457
1748889|NCT00025259|4282485|P3|COMPLETED|Overall Study||301
1748890|NCT00025259|4282486|P2|COMPLETED|Overall Study||292
1748891|NCT00025259|4282487|P1|COMPLETED|Overall Study||7
1748892|NCT00025259|4282481|P7|STARTED|Overall Study||153
1748893|NCT00025259|4282482|P6|STARTED|Overall Study||153
1748894|NCT00025259|4282483|P5|STARTED|Overall Study||42
1748895|NCT00025259|4282484|P4|STARTED|Overall Study||571
1748896|NCT00025259|4282485|P3|STARTED|Overall Study||382
1748897|NCT00025259|4282486|P2|STARTED|Overall Study||381
1748898|NCT00025259|4282487|P1|STARTED|Overall Study||52
1748899|NCT00025233|4282523|P1|NOT COMPLETED|Overall Study||4
1748900|NCT00025233|4282523|P1|COMPLETED|Overall Study||46
1748901|NCT00025233|4282523|P1|STARTED|Overall Study||50
1748902|NCT00025155|4282538|P1|NOT COMPLETED|Overall Study||2
1748903|NCT00025155|4282538|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
1748904|NCT00025155|4282538|P1|STARTED|Overall Study||51
1748905|NCT00024258|4282549|P1|NOT COMPLETED|Overall Study||9
1748906|NCT00024258|4282549|P1|COMPLETED|Overall Study||13
1748907|NCT00024258|4282549|P1|STARTED|Overall Study||22
1748908|NCT00024167|4282556|P2|NOT COMPLETED|Overall Study||47
1748909|NCT00024167|4282557|P1|NOT COMPLETED|Overall Study||53
1748910|NCT00024167|4282556|P2|COMPLETED|Overall Study||15
1748911|NCT00024167|4282557|P1|COMPLETED|Overall Study||12
1748912|NCT00024167|4282556|P2|Induction Treatment Option 2 Completed|Overall Study||41
1748913|NCT00024167|4282557|P1|Induction Treatment Option 2 Completed|Overall Study||43
1748914|NCT00024167|4282556|P2|Induction Treatment Option 1 Completed|Overall Study||21
1748915|NCT00024167|4282557|P1|Induction Treatment Option 1 Completed|Overall Study||22
1748916|NCT00024167|4282556|P2|STARTED|Overall Study||62
1748917|NCT00024167|4282557|P1|STARTED|Overall Study||65
1748918|NCT00024102|4282568|P2|NOT COMPLETED|Overall Study||0
1748919|NCT00024102|4282569|P1|NOT COMPLETED|Overall Study||0
1748920|NCT00024102|4282568|P2|COMPLETED|Overall Study||307
1748921|NCT00024102|4282569|P1|COMPLETED|Overall Study||326
1748922|NCT00024102|4282568|P2|STARTED|Overall Study||307
1748923|NCT00024102|4282569|P1|STARTED|Overall Study||326
1748924|NCT00023764|4282581|P1|NOT COMPLETED|Overall Study||14
1748925|NCT00023764|4282581|P1|COMPLETED|Overall Study||89
1748926|NCT00023764|4282581|P1|STARTED|Overall Study||103
1748927|NCT00023712|4282588|P2|NOT COMPLETED|Overall Study||1
1748928|NCT00023712|4282589|P1|NOT COMPLETED|Overall Study||2
1748929|NCT00023712|4282588|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
1748930|NCT00023712|4282589|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
1748931|NCT00023712|4282588|P2|STARTED|Overall Study|total number of participants enrolled on study|30
1748932|NCT00023712|4282589|P1|STARTED|Overall Study|total number of participants enrolled on study|28
1748933|NCT00022698|4282613|P2|NOT COMPLETED|Overall Study||35
1748934|NCT00022698|4282614|P1|NOT COMPLETED|Overall Study||8
1748935|NCT00022698|4282613|P2|COMPLETED|Overall Study||17
1748936|NCT00022698|4282614|P1|COMPLETED|Overall Study||7
1748937|NCT00022698|4282613|P2|STARTED|Overall Study||52
1748938|NCT00022698|4282614|P1|STARTED|Overall Study||15
1748939|NCT00022672|4282639|P2|NOT COMPLETED|Extension Phase||51
1748940|NCT00022672|4282640|P1|NOT COMPLETED|Extension Phase||3
1748941|NCT00022672|4282639|P2|COMPLETED|Extension Phase||7
1748942|NCT00022672|4282640|P1|COMPLETED|Extension Phase||11
1748943|NCT00022672|4282639|P2|Safety Set: Received Study Drug|Extension Phase||58
1748944|NCT00022672|4282640|P1|Safety Set: Received Study Drug|Extension Phase||14
1748945|NCT00022672|4282639|P2|STARTED|Extension Phase||58
1748946|NCT00022672|4282640|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
1748947|NCT00022672|4282639|P2|NOT COMPLETED|Main Phase: 24 Months||100
1748948|NCT00022672|4282640|P1|NOT COMPLETED|Main Phase: 24 Months||87
1748949|NCT00022672|4282639|P2|COMPLETED|Main Phase: 24 Months||4
1748950|NCT00022672|4282640|P1|COMPLETED|Main Phase: 24 Months||16
1748951|NCT00022672|4282639|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
1748952|NCT00022672|4282640|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
1748953|NCT00022672|4282639|P2|STARTED|Main Phase: 24 Months||104
1748954|NCT00022672|4282640|P1|STARTED|Main Phase: 24 Months||103
1748955|NCT00022659|4282673|P1|NOT COMPLETED|Overall Study||2
1748956|NCT00022659|4282673|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
1748957|NCT00022659|4282673|P1|STARTED|Overall Study||64
1748958|NCT00022633|4282686|P2|NOT COMPLETED|Overall Study||5
1748959|NCT00022633|4282687|P1|NOT COMPLETED|Overall Study||32
1748960|NCT00022633|4282686|P2|COMPLETED|Overall Study||5
1748961|NCT00022633|4282687|P1|COMPLETED|Overall Study||23
1748962|NCT00022633|4282686|P2|Eligible|Overall Study||10
1748963|NCT00022633|4282687|P1|Eligible|Overall Study||51
1748964|NCT00022633|4282686|P2|STARTED|Overall Study||10
1748965|NCT00022633|4282687|P1|STARTED|Overall Study||55
1748966|NCT00022516|4282700|P2|NOT COMPLETED|Overall Study||230
1748967|NCT00022516|4282701|P1|NOT COMPLETED|Overall Study||3
1748968|NCT00022516|4282700|P2|COMPLETED|Overall Study||314
1748969|NCT00022516|4282701|P1|COMPLETED|Overall Study||539
1748970|NCT00022516|4282700|P2|STARTED|Overall Study||544
1748971|NCT00022516|4282701|P1|STARTED|Overall Study||542
1748972|NCT00022490|4282713|P1|NOT COMPLETED|Overall Study||0
1748973|NCT00022490|4282713|P1|COMPLETED|Overall Study||24
1748974|NCT00022490|4282713|P1|STARTED|Overall Study||24
1748975|NCT00021255|4282720|P3|NOT COMPLETED|Overall Study||149
1748976|NCT00021255|4282721|P2|NOT COMPLETED|Overall Study||270
1748977|NCT00021255|4282722|P1|NOT COMPLETED|Overall Study||121
1748978|NCT00021255|4282720|P3|COMPLETED|Overall Study||926
1748979|NCT00021255|4282721|P2|COMPLETED|Overall Study||804
1748980|NCT00021255|4282722|P1|COMPLETED|Overall Study||952
1748981|NCT00021255|4282720|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
1748982|NCT00021255|4282721|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
1748983|NCT00021255|4282722|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
1748984|NCT00021255|4282720|P3|Treated|Overall Study||1057
1748985|NCT00021255|4282721|P2|Treated|Overall Study||1072
1748986|NCT00021255|4282722|P1|Treated|Overall Study||1045
1748987|NCT00021255|4282720|P3|STARTED|Overall Study|Randomized|1075
1748988|NCT00021255|4282721|P2|STARTED|Overall Study|Randomized|1074
1748989|NCT00021255|4282722|P1|STARTED|Overall Study|Randomized|1073
1748990|NCT00021229|4282739|P3|NOT COMPLETED|Overall Study||16
1748991|NCT00021229|4282740|P2|NOT COMPLETED|Overall Study||33
1748992|NCT00021229|4282741|P1|NOT COMPLETED|Overall Study||35
1748993|NCT00021229|4282739|P3|COMPLETED|Overall Study||0
1748994|NCT00021229|4282740|P2|COMPLETED|Overall Study||0
1748995|NCT00021229|4282741|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
1748996|NCT00021229|4282739|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
1748997|NCT00021229|4282740|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
1748998|NCT00021229|4282741|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
1748999|NCT00021229|4282739|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
1749000|NCT00021229|4282740|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
1749001|NCT00021229|4282741|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
1749002|NCT00021229|4282739|P3|Enrolled in Phase I|Overall Study||16
1749003|NCT00021229|4282740|P2|Enrolled in Phase I|Overall Study||33
1749004|NCT00021229|4282741|P1|Enrolled in Phase I|Overall Study||35
1749005|NCT00021229|4282739|P3|STARTED|Overall Study||16
1749006|NCT00021229|4282740|P2|STARTED|Overall Study||33
1749007|NCT00021229|4282741|P1|STARTED|Overall Study||36
1749008|NCT00020722|4282767|P1|NOT COMPLETED|Overall Study||0
1749009|NCT00020722|4282767|P1|COMPLETED|Overall Study||7
1749010|NCT00020722|4282767|P1|STARTED|Overall Study||7
1749011|NCT00019747|4282774|P2|NOT COMPLETED|Overall Study||0
1749012|NCT00019747|4282775|P1|NOT COMPLETED|Overall Study||0
1749013|NCT00019747|4282774|P2|COMPLETED|Overall Study||16
1749014|NCT00019747|4282775|P1|COMPLETED|Overall Study||23
1749015|NCT00019747|4282774|P2|STARTED|Overall Study||16
1749016|NCT00019747|4282775|P1|STARTED|Overall Study||23
1749017|NCT00019682|4282783|P2|NOT COMPLETED|Overall Study||6
1749018|NCT00019682|4282784|P1|NOT COMPLETED|Overall Study||1
1749019|NCT00019682|4282783|P2|COMPLETED|Overall Study||85
1749020|NCT00019682|4282784|P1|COMPLETED|Overall Study||93
1749021|NCT00019682|4282783|P2|STARTED|Overall Study||91
1749022|NCT00019682|4282784|P1|STARTED|Overall Study||94
1749023|NCT00019604|4282796|P1|NOT COMPLETED|Overall Study||39
1749024|NCT00019604|4282796|P1|COMPLETED|Overall Study||5
1749025|NCT00019604|4282796|P1|STARTED|Overall Study||44
1749026|NCT00017563|4282809|P1|NOT COMPLETED|Overall Study||1
1749027|NCT00017563|4282809|P1|COMPLETED|Overall Study||56
1749028|NCT00017563|4282809|P1|STARTED|Overall Study||57
1749029|NCT00016913|4282813|P1|NOT COMPLETED|Overall Study||0
1749030|NCT00016913|4282813|P1|COMPLETED|Overall Study||27
1749031|NCT00016913|4282813|P1|STARTED|Overall Study||27
1749032|NCT00016354|4282819|P8|NOT COMPLETED|Overall Study||1
1749033|NCT00016354|4282820|P7|NOT COMPLETED|Overall Study||0
1749034|NCT00016354|4282821|P6|NOT COMPLETED|Overall Study||0
1749035|NCT00016354|4282822|P5|NOT COMPLETED|Overall Study||0
1749036|NCT00016354|4282823|P4|NOT COMPLETED|Overall Study||0
1749037|NCT00016354|4282824|P3|NOT COMPLETED|Overall Study||0
1749038|NCT00016354|4282825|P2|NOT COMPLETED|Overall Study||0
1749039|NCT00016354|4282826|P1|NOT COMPLETED|Overall Study||0
1749040|NCT00016354|4282819|P8|COMPLETED|Overall Study||6
1749041|NCT00016354|4282820|P7|COMPLETED|Overall Study||6
1749042|NCT00016354|4282821|P6|COMPLETED|Overall Study||1
1749043|NCT00016354|4282822|P5|COMPLETED|Overall Study||1
1749044|NCT00016354|4282823|P4|COMPLETED|Overall Study||1
1749045|NCT00016354|4282824|P3|COMPLETED|Overall Study||1
1749046|NCT00016354|4282825|P2|COMPLETED|Overall Study||1
1749047|NCT00016354|4282826|P1|COMPLETED|Overall Study||1
1749048|NCT00016354|4282819|P8|STARTED|Overall Study||7
1749049|NCT00016354|4282820|P7|STARTED|Overall Study||6
1749050|NCT00016354|4282821|P6|STARTED|Overall Study||1
1749051|NCT00016354|4282822|P5|STARTED|Overall Study||1
1749052|NCT00016354|4282823|P4|STARTED|Overall Study||1
1749053|NCT00016354|4282824|P3|STARTED|Overall Study||1
1749054|NCT00016354|4282825|P2|STARTED|Overall Study||1
1749055|NCT00016354|4282826|P1|STARTED|Overall Study||1
1749056|NCT00015847|4282830|P1|NOT COMPLETED|Overall Study||0
1749057|NCT00015847|4282830|P1|COMPLETED|Overall Study||25
1749058|NCT00015847|4282830|P1|STARTED|Overall Study||25
1749059|NCT00014495|4282840|P4|NOT COMPLETED|Overall Study||1
1749060|NCT00014495|4282841|P3|NOT COMPLETED|Overall Study||1
1749061|NCT00014495|4282842|P2|NOT COMPLETED|Overall Study||0
1749062|NCT00014495|4282843|P1|NOT COMPLETED|Overall Study||0
1749063|NCT00014495|4282840|P4|COMPLETED|Overall Study||5
1749064|NCT00014495|4282841|P3|COMPLETED|Overall Study||19
1749065|NCT00014495|4282842|P2|COMPLETED|Overall Study||3
1749066|NCT00014495|4282843|P1|COMPLETED|Overall Study||3
1749067|NCT00014495|4282840|P4|STARTED|Overall Study||6
1749068|NCT00014495|4282841|P3|STARTED|Overall Study||20
1749069|NCT00014495|4282842|P2|STARTED|Overall Study||3
1749070|NCT00014495|4282843|P1|STARTED|Overall Study||3
1749071|NCT00012298|4282857|P7|NOT COMPLETED|Overall Study||0
1749072|NCT00012298|4282858|P6|NOT COMPLETED|Overall Study||0
1749073|NCT00012298|4282859|P5|NOT COMPLETED|Overall Study||0
1749074|NCT00012298|4282860|P4|NOT COMPLETED|Overall Study||0
1749075|NCT00012298|4282861|P3|NOT COMPLETED|Overall Study||0
1749076|NCT00012298|4282862|P2|NOT COMPLETED|Overall Study||0
1749077|NCT00012298|4282863|P1|NOT COMPLETED|Overall Study||0
1749078|NCT00012298|4282857|P7|COMPLETED|Overall Study||39
1749079|NCT00012298|4282858|P6|COMPLETED|Overall Study||6
1749080|NCT00012298|4282859|P5|COMPLETED|Overall Study||5
1749081|NCT00012298|4282860|P4|COMPLETED|Overall Study||4
1749082|NCT00012298|4282861|P3|COMPLETED|Overall Study||9
1749083|NCT00012298|4282862|P2|COMPLETED|Overall Study||7
1749084|NCT00012298|4282863|P1|COMPLETED|Overall Study||11
1749085|NCT00012298|4282857|P7|STARTED|Overall Study||39
1749086|NCT00012298|4282858|P6|STARTED|Overall Study||6
1749087|NCT00012298|4282859|P5|STARTED|Overall Study||5
1749088|NCT00012298|4282860|P4|STARTED|Overall Study||4
1749089|NCT00012298|4282861|P3|STARTED|Overall Study||9
1749090|NCT00012298|4282862|P2|STARTED|Overall Study||7
1749091|NCT00012298|4282863|P1|STARTED|Overall Study||11
1749092|NCT00012012|4282893|P2|NOT COMPLETED|Overall Study||3
1749093|NCT00012012|4282894|P1|NOT COMPLETED|Overall Study||1
1749094|NCT00012012|4282893|P2|COMPLETED|Overall Study||15
1749095|NCT00012012|4282894|P1|COMPLETED|Overall Study||26
1749096|NCT00012012|4282893|P2|STARTED|Overall Study||18
1749097|NCT00012012|4282894|P1|STARTED|Overall Study||27
1749098|NCT00011986|4282905|P5|NOT COMPLETED|Overall Study||0
1749099|NCT00011986|4282906|P4|NOT COMPLETED|Overall Study||0
1749100|NCT00011986|4282907|P3|NOT COMPLETED|Overall Study||0
1749101|NCT00011986|4282908|P2|NOT COMPLETED|Overall Study||0
1749102|NCT00011986|4282909|P1|NOT COMPLETED|Overall Study||0
1749103|NCT00011986|4282905|P5|COMPLETED|Overall Study||861
1749104|NCT00011986|4282906|P4|COMPLETED|Overall Study||861
1749105|NCT00011986|4282907|P3|COMPLETED|Overall Study||862
1749106|NCT00011986|4282908|P2|COMPLETED|Overall Study||864
1749107|NCT00011986|4282909|P1|COMPLETED|Overall Study||864
1749108|NCT00011986|4282905|P5|Initiated Treatment|Overall Study||851
1749109|NCT00011986|4282906|P4|Initiated Treatment|Overall Study||846
1749110|NCT00011986|4282907|P3|Initiated Treatment|Overall Study||854
1749111|NCT00011986|4282908|P2|Initiated Treatment|Overall Study||860
1749112|NCT00011986|4282909|P1|Initiated Treatment|Overall Study||862
1749113|NCT00011986|4282905|P5|STARTED|Overall Study||861
1749114|NCT00011986|4282906|P4|STARTED|Overall Study||861
1749115|NCT00011986|4282907|P3|STARTED|Overall Study||862
1749116|NCT00011986|4282908|P2|STARTED|Overall Study||864
1749117|NCT00011986|4282909|P1|STARTED|Overall Study||864
1749118|NCT00010257|4282923|P2|NOT COMPLETED|Overall Study||0
1749119|NCT00010257|4282924|P1|NOT COMPLETED|Overall Study||1
1749120|NCT00010257|4282923|P2|COMPLETED|Overall Study||21
1749121|NCT00010257|4282924|P1|COMPLETED|Overall Study||24
1749122|NCT00010257|4282923|P2|STARTED|Overall Study||21
1749123|NCT00010257|4282924|P1|STARTED|Overall Study||25
1749124|NCT00009945|4282934|P2|NOT COMPLETED|Overall Study||5
1749125|NCT00009945|4282935|P1|NOT COMPLETED|Overall Study||7
1749126|NCT00009945|4282934|P2|COMPLETED|Overall Study||1656
1749127|NCT00009945|4282935|P1|COMPLETED|Overall Study||1655
1749128|NCT00009945|4282934|P2|STARTED|Overall Study||1661
1749129|NCT00009945|4282935|P1|STARTED|Overall Study||1662
1749130|NCT00008385|4282951|P2|NOT COMPLETED|Overall Study||802
1749131|NCT00008385|4282952|P1|NOT COMPLETED|Overall Study||387
1749132|NCT00008385|4282951|P2|COMPLETED|Overall Study||238
1749133|NCT00008385|4282952|P1|COMPLETED|Overall Study||134
1749134|NCT00008385|4282951|P2|Off Treatment Reasons Reported|Overall Study||795
1749135|NCT00008385|4282952|P1|Off Treatment Reasons Reported|Overall Study||398
1749136|NCT00008385|4282951|P2|Treated|Overall Study||865
1749137|NCT00008385|4282952|P1|Treated|Overall Study||477
1749138|NCT00008385|4282951|P2|STARTED|Overall Study||1040
1749139|NCT00008385|4282952|P1|STARTED|Overall Study||521
1749140|NCT00008138|4282962|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
1749141|NCT00008138|4282962|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
1749142|NCT00008138|4282962|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
1749143|NCT00008138|4282962|P1|NOT COMPLETED|Interval Debulking||2
1749144|NCT00008138|4282962|P1|COMPLETED|Interval Debulking||36
1749145|NCT00008138|4282962|P1|Received Protocol Surgery|Interval Debulking||36
1749146|NCT00008138|4282962|P1|STARTED|Interval Debulking||38
1749147|NCT00008138|4282962|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
1749148|NCT00008138|4282962|P1|COMPLETED|Neoadjuvant Chemotherapy||38
1749149|NCT00008138|4282962|P1|Eligible|Neoadjuvant Chemotherapy||58
1749150|NCT00008138|4282962|P1|STARTED|Neoadjuvant Chemotherapy||58
1749151|NCT00006916|4282968|P1|NOT COMPLETED|Overall Study||5
1749152|NCT00006916|4282968|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
1749153|NCT00006916|4282968|P1|STARTED|Overall Study||19
1749154|NCT00006903|4282974|P3|NOT COMPLETED|Overall Study||6
1749155|NCT00006903|4282975|P2|NOT COMPLETED|Overall Study||4
1749156|NCT00006903|4282976|P1|NOT COMPLETED|Overall Study||10
1749157|NCT00006903|4282974|P3|COMPLETED|Overall Study||27
1749158|NCT00006903|4282975|P2|COMPLETED|Overall Study||20
1749159|NCT00006903|4282976|P1|COMPLETED|Overall Study||0
1749160|NCT00006903|4282974|P3|STARTED|Overall Study||33
1749161|NCT00006903|4282975|P2|STARTED|Overall Study||24
1749162|NCT00006903|4282976|P1|STARTED|Overall Study||10
1749163|NCT00006721|4282989|P3|NOT COMPLETED|Overall Study||33
1749164|NCT00006721|4282990|P2|NOT COMPLETED|Overall Study||25
1749165|NCT00006721|4282991|P1|NOT COMPLETED|Overall Study||4
1749166|NCT00006721|4282989|P3|COMPLETED|Overall Study||242
1749167|NCT00006721|4282990|P2|COMPLETED|Overall Study||254
1749168|NCT00006721|4282991|P1|COMPLETED|Overall Study||13
1749169|NCT00006721|4282989|P3|Eligible and Began Protocol Therapy|Overall Study||265
1749170|NCT00006721|4282990|P2|Eligible and Began Protocol Therapy|Overall Study||267
1749171|NCT00006721|4282991|P1|Eligible and Began Protocol Therapy|Overall Study||14
1749172|NCT00006721|4282989|P3|Eligible|Overall Study||265
1749173|NCT00006721|4282990|P2|Eligible|Overall Study||267
1749174|NCT00006721|4282991|P1|Eligible|Overall Study||15
1749175|NCT00006721|4282989|P3|STARTED|Overall Study||275
1749176|NCT00006721|4282990|P2|STARTED|Overall Study||279
1749177|NCT00006721|4282991|P1|STARTED|Overall Study||17
1749178|NCT00006478|4283009|P1|NOT COMPLETED|Overall Study||7
1749179|NCT00006478|4283009|P1|COMPLETED|Overall Study||12
1749180|NCT00006478|4283009|P1|STARTED|Overall Study||19
1749181|NCT00006392|4283020|P4|NOT COMPLETED|Overall Study||160
1749182|NCT00006392|4283021|P3|NOT COMPLETED|Overall Study||160
1749183|NCT00006392|4283022|P2|NOT COMPLETED|Overall Study||158
1749184|NCT00006392|4283023|P1|NOT COMPLETED|Overall Study||167
1749185|NCT00006392|4283020|P4|COMPLETED|Overall Study||8696
1749186|NCT00006392|4283021|P3|COMPLETED|Overall Study||8703
1749187|NCT00006392|4283022|P2|COMPLETED|Overall Study||8752
1749188|NCT00006392|4283023|P1|COMPLETED|Overall Study||8737
1749189|NCT00006392|4283020|P4|STARTED|Overall Study||8856
1749190|NCT00006392|4283021|P3|STARTED|Overall Study||8863
1749191|NCT00006392|4283022|P2|STARTED|Overall Study||8910
1749192|NCT00006392|4283023|P1|STARTED|Overall Study||8904
1749193|NCT00006389|4283053|P1|NOT COMPLETED|Overall Study||1
1749194|NCT00006389|4283053|P1|COMPLETED|Overall Study||11
1749195|NCT00006389|4283053|P1|STARTED|Overall Study||12
1749196|NCT00006244|4283059|P1|NOT COMPLETED|Overall Study||0
1749197|NCT00006244|4283059|P1|COMPLETED|Overall Study||36
1749198|NCT00006244|4283059|P1|STARTED|Overall Study||36
1749199|NCT00006237|4283070|P2|NOT COMPLETED|Overall Study||61
1749200|NCT00006237|4283071|P1|NOT COMPLETED|Overall Study||125
1749201|NCT00006237|4283070|P2|COMPLETED|Overall Study||159
1749202|NCT00006237|4283071|P1|COMPLETED|Overall Study||87
1749203|NCT00006237|4283070|P2|Eligible and Treated|Overall Study||199
1749204|NCT00006237|4283071|P1|Eligible and Treated|Overall Study||203
1749205|NCT00006237|4283070|P2|Eligible|Overall Study||200
1749206|NCT00006237|4283071|P1|Eligible|Overall Study||203
1749207|NCT00006237|4283070|P2|STARTED|Overall Study||220
1749208|NCT00006237|4283071|P1|STARTED|Overall Study||212
1749209|NCT00006110|4283083|P2|NOT COMPLETED|Overall Study||0
1749210|NCT00006110|4283084|P1|NOT COMPLETED|Overall Study||0
1749211|NCT00006110|4283083|P2|COMPLETED|Overall Study||30
1749212|NCT00006110|4283084|P1|COMPLETED|Overall Study||52
1749213|NCT00006110|4283083|P2|STARTED|Overall Study||30
1749214|NCT00006110|4283084|P1|STARTED|Overall Study||52
1749215|NCT00006101|4283098|P2|NOT COMPLETED|Overall Study||5
1749216|NCT00006101|4283099|P1|NOT COMPLETED|Overall Study||5
1749217|NCT00006101|4283098|P2|COMPLETED|Overall Study||33
1749218|NCT00006101|4283099|P1|COMPLETED|Overall Study||33
1749219|NCT00006101|4283098|P2|STARTED|Overall Study||38
1749220|NCT00006101|4283099|P1|STARTED|Overall Study||38
1749221|NCT00006011|4283108|P3|NOT COMPLETED|Overall Study||73
1749222|NCT00006011|4283109|P2|NOT COMPLETED|Overall Study||77
1749223|NCT00006011|4283110|P1|NOT COMPLETED|Overall Study||65
1749224|NCT00006011|4283108|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
1749225|NCT00006011|4283109|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
1749226|NCT00006011|4283110|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
1749227|NCT00006011|4283108|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
1749228|NCT00006011|4283109|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
1749229|NCT00006011|4283110|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
1749230|NCT00005957|4283118|P2|NOT COMPLETED|Overall Study||28
1749231|NCT00005957|4283119|P1|NOT COMPLETED|Overall Study||8
1749232|NCT00005957|4283118|P2|COMPLETED|Overall Study||888
1749233|NCT00005957|4283119|P1|COMPLETED|Overall Study||908
1749234|NCT00005957|4283118|P2|STARTED|Overall Study||916
1749235|NCT00005957|4283119|P1|STARTED|Overall Study||916
1749236|NCT00005879|4283129|P2|NOT COMPLETED|Overall Study||10
1749237|NCT00005879|4283130|P1|NOT COMPLETED|Overall Study||8
1749238|NCT00005879|4283129|P2|COMPLETED|Overall Study||88
1749239|NCT00005879|4283130|P1|COMPLETED|Overall Study||93
1749240|NCT00005879|4283129|P2|STARTED|Overall Study||98
1749241|NCT00005879|4283130|P1|STARTED|Overall Study||101
1749242|NCT00005803|4283138|P1|NOT COMPLETED|Overall Study||22
1749243|NCT00005803|4283138|P1|COMPLETED|Overall Study||54
1749244|NCT00005803|4283138|P1|STARTED|Overall Study||76
1749245|NCT00005047|4283153|P4|NOT COMPLETED|Overall Study||0
1749246|NCT00005047|4283154|P3|NOT COMPLETED|Overall Study||0
1749247|NCT00005047|4283155|P2|NOT COMPLETED|Overall Study||0
1749248|NCT00005047|4283156|P1|NOT COMPLETED|Overall Study||19
1749249|NCT00005047|4283153|P4|COMPLETED|Overall Study||158
1749250|NCT00005047|4283154|P3|COMPLETED|Overall Study||227
1749251|NCT00005047|4283155|P2|COMPLETED|Overall Study||56
1749252|NCT00005047|4283156|P1|COMPLETED|Overall Study||39
1749253|NCT00005047|4283153|P4|STARTED|Overall Study||158
1749254|NCT00005047|4283154|P3|STARTED|Overall Study||227
1749255|NCT00005047|4283155|P2|STARTED|Overall Study||56
1749256|NCT00005047|4283156|P1|STARTED|Overall Study||58
1749257|NCT00005044|4283172|P2|NOT COMPLETED|Overall Study||52
1749258|NCT00005044|4283173|P1|NOT COMPLETED|Overall Study||38
1749259|NCT00005044|4283172|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
1749260|NCT00005044|4283173|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
1749261|NCT00005044|4283172|P2|STARTED|Overall Study||789
1749262|NCT00005044|4283173|P1|STARTED|Overall Study||790
1749263|NCT00004888|4283193|P2|NOT COMPLETED|Overall Study||24
1749264|NCT00004888|4283194|P1|NOT COMPLETED|Overall Study||11
1749265|NCT00004888|4283193|P2|COMPLETED|Overall Study||22
1749266|NCT00004888|4283194|P1|COMPLETED|Overall Study||27
1749267|NCT00004888|4283193|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
1749268|NCT00004888|4283194|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
1749269|NCT00004859|4283212|P2|NOT COMPLETED|Overall Study||282
1749270|NCT00004859|4283213|P1|NOT COMPLETED|Overall Study||118
1749271|NCT00004859|4283212|P2|COMPLETED|Overall Study||12
1749272|NCT00004859|4283213|P1|COMPLETED|Overall Study||177
1749273|NCT00004859|4283212|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
1749274|NCT00004859|4283213|P1|Treated and Having Toxicity Data|Overall Study||289
1749275|NCT00004859|4283212|P2|Treated|Overall Study||289
1749276|NCT00004859|4283213|P1|Treated|Overall Study||289
1749277|NCT00004859|4283212|P2|Eligible|Overall Study||271
1749278|NCT00004859|4283213|P1|Eligible|Overall Study||275
1749279|NCT00004859|4283212|P2|STARTED|Overall Study||294
1749280|NCT00004859|4283213|P1|STARTED|Overall Study||295
1749281|NCT00004259|4283227|P4|NOT COMPLETED|Overall Study||0
1749282|NCT00004259|4283228|P3|NOT COMPLETED|Overall Study||0
1749283|NCT00004259|4283229|P2|NOT COMPLETED|Overall Study||4
1749284|NCT00004259|4283230|P1|NOT COMPLETED|Overall Study||1
1749285|NCT00004259|4283227|P4|COMPLETED|Overall Study||14
1749286|NCT00004259|4283228|P3|COMPLETED|Overall Study||15
1749287|NCT00004259|4283229|P2|COMPLETED|Overall Study||99
1749288|NCT00004259|4283230|P1|COMPLETED|Overall Study||97
1749289|NCT00004259|4283227|P4|STARTED|Overall Study||14
1749290|NCT00004259|4283228|P3|STARTED|Overall Study||15
1749291|NCT00004259|4283229|P2|STARTED|Overall Study||103
1749292|NCT00004259|4283230|P1|STARTED|Overall Study||98
1749293|NCT00004228|4283251|P7|NOT COMPLETED|Overall Study||12
1749294|NCT00004228|4283252|P6|NOT COMPLETED|Overall Study||14
1749295|NCT00004228|4283253|P5|NOT COMPLETED|Overall Study||16
1749296|NCT00004228|4283254|P4|NOT COMPLETED|Overall Study||7
1749297|NCT00004228|4283255|P3|NOT COMPLETED|Overall Study||19
1749298|NCT00004228|4283256|P2|NOT COMPLETED|Overall Study||15
1749299|NCT00004228|4283257|P1|NOT COMPLETED|Overall Study||9
1749300|NCT00004228|4283251|P7|COMPLETED|Overall Study||45
1749301|NCT00004228|4283252|P6|COMPLETED|Overall Study||51
1749302|NCT00004228|4283253|P5|COMPLETED|Overall Study||51
1749303|NCT00004228|4283254|P4|COMPLETED|Overall Study||6
1749304|NCT00004228|4283255|P3|COMPLETED|Overall Study||46
1749305|NCT00004228|4283256|P2|COMPLETED|Overall Study||51
1749306|NCT00004228|4283257|P1|COMPLETED|Overall Study||51
1749307|NCT00004228|4283251|P7|STARTED|Overall Study||57
1749308|NCT00004228|4283252|P6|STARTED|Overall Study||65
1749309|NCT00004228|4283253|P5|STARTED|Overall Study||67
1749310|NCT00004228|4283254|P4|STARTED|Overall Study||13
1749311|NCT00004228|4283255|P3|STARTED|Overall Study||65
1749312|NCT00004228|4283256|P2|STARTED|Overall Study||66
1749313|NCT00004228|4283257|P1|STARTED|Overall Study||60
1749314|NCT00004143|4283280|P1|NOT COMPLETED|Overall Study||0
1749315|NCT00004143|4283280|P1|COMPLETED|Overall Study||2
1749316|NCT00004143|4283280|P1|STARTED|Overall Study||2
1749317|NCT00004124|4283291|P2|NOT COMPLETED|Overall Study||20
1749318|NCT00004124|4283292|P1|NOT COMPLETED|Overall Study||12
1749319|NCT00004124|4283291|P2|COMPLETED|Overall Study||460
1749320|NCT00004124|4283292|P1|COMPLETED|Overall Study||469
1749321|NCT00004124|4283291|P2|STARTED|Overall Study||480
1749322|NCT00004124|4283292|P1|STARTED|Overall Study||481
1749323|NCT00004092|4283308|P2|NOT COMPLETED|Overall Study||0
1749324|NCT00004092|4283309|P1|NOT COMPLETED|Overall Study||0
1749325|NCT00004092|4283308|P2|COMPLETED|Overall Study||51
1749326|NCT00004092|4283309|P1|COMPLETED|Overall Study||21
1749327|NCT00004092|4283308|P2|STARTED|Overall Study||51
1749328|NCT00004092|4283309|P1|STARTED|Overall Study||21
1749329|NCT00004054|4283319|P2|NOT COMPLETED|Overall Study||0
1749330|NCT00004054|4283320|P1|NOT COMPLETED|Overall Study||0
1749331|NCT00004054|4283319|P2|COMPLETED|Overall Study||200
1749332|NCT00004054|4283320|P1|COMPLETED|Overall Study||197
1749333|NCT00004054|4283319|P2|STARTED|Overall Study||200
1749334|NCT00004054|4283320|P1|STARTED|Overall Study||197
1749335|NCT00003910|4283334|P2|NOT COMPLETED|Step 2||0
1749336|NCT00003910|4283335|P1|NOT COMPLETED|Step 2||0
1749337|NCT00003910|4283334|P2|COMPLETED|Step 2||16
1749338|NCT00003910|4283335|P1|COMPLETED|Step 2||0
1749339|NCT00003910|4283334|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
1749340|NCT00003910|4283335|P1|STARTED|Step 2||0
1749341|NCT00003910|4283334|P2|NOT COMPLETED|Step 1||0
1749342|NCT00003910|4283335|P1|NOT COMPLETED|Step 1||0
1749343|NCT00003910|4283334|P2|COMPLETED|Step 1||0
1749344|NCT00003910|4283335|P1|COMPLETED|Step 1||55
1749345|NCT00003910|4283334|P2|STARTED|Step 1||0
1749346|NCT00003910|4283335|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
1749347|NCT00003901|4283340|P1|NOT COMPLETED|Overall Study||17
1749348|NCT00003901|4283340|P1|COMPLETED|Overall Study||1030
1749349|NCT00003901|4283340|P1|STARTED|Overall Study||1047
1749350|NCT00003896|4283351|P1|NOT COMPLETED|Overall Study||29
1749351|NCT00003896|4283351|P1|COMPLETED|Overall Study||39
1749352|NCT00003896|4283351|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
1749353|NCT00003896|4283351|P1|STARTED|Overall Study||68
1749354|NCT00003875|4283357|P1|NOT COMPLETED|Overall Study||1
1749355|NCT00003875|4283357|P1|COMPLETED|Overall Study||29
1749356|NCT00003875|4283357|P1|STARTED|Overall Study||30
1749357|NCT00003869|4283366|P2|NOT COMPLETED|Overall Study||12
1749358|NCT00003869|4283367|P1|NOT COMPLETED|Overall Study||41
1749359|NCT00003869|4283366|P2|COMPLETED|Overall Study||80
1749360|NCT00003869|4283367|P1|COMPLETED|Overall Study||53
1749361|NCT00003869|4283366|P2|STARTED|Overall Study||92
1749362|NCT00003869|4283367|P1|STARTED|Overall Study||94
1749363|NCT00003820|4283383|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
1749364|NCT00003820|4283384|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
1749365|NCT00003820|4283383|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
1749366|NCT00003820|4283384|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
1749367|NCT00003820|4283383|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
1749368|NCT00003820|4283384|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
1749369|NCT00003820|4283383|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
1749370|NCT00003820|4283384|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
1749371|NCT00003820|4283383|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
1749372|NCT00003820|4283384|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
1749373|NCT00003820|4283383|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
1749374|NCT00003820|4283384|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
1749375|NCT00003820|4283383|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
1749376|NCT00003820|4283384|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
1749377|NCT00003820|4283383|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
1749378|NCT00003820|4283384|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
1749379|NCT00003820|4283383|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
1749380|NCT00003820|4283384|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
1749381|NCT00003820|4283383|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
1749382|NCT00003820|4283384|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
1749383|NCT00003820|4283383|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
1749384|NCT00003820|4283384|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
1749385|NCT00003820|4283383|P2|STARTED|Cycle 1 (Initial Treatment)||16
1749386|NCT00003820|4283384|P1|STARTED|Cycle 1 (Initial Treatment)||23
1749387|NCT00003782|4283393|P3|NOT COMPLETED|Overall Study||26
1749388|NCT00003782|4283394|P2|NOT COMPLETED|Overall Study||31
1749389|NCT00003782|4283395|P1|NOT COMPLETED|Overall Study||30
1749390|NCT00003782|4283393|P3|COMPLETED|Overall Study||1758
1749391|NCT00003782|4283394|P2|COMPLETED|Overall Study||1753
1749392|NCT00003782|4283395|P1|COMPLETED|Overall Study||1753
1749393|NCT00003782|4283393|P3|STARTED|Overall Study||1784
1749394|NCT00003782|4283394|P2|STARTED|Overall Study||1784
1749395|NCT00003782|4283395|P1|STARTED|Overall Study||1783
1749396|NCT00003702|4283405|P2|NOT COMPLETED|Overall Study||11
1749397|NCT00003702|4283406|P1|NOT COMPLETED|Overall Study||13
1749398|NCT00003702|4283405|P2|COMPLETED|Overall Study||109
1749399|NCT00003702|4283406|P1|COMPLETED|Overall Study||107
1749400|NCT00003702|4283405|P2|STARTED|Overall Study||120
1749401|NCT00003702|4283406|P1|STARTED|Overall Study||120
1749402|NCT00003659|4283415|P1|NOT COMPLETED|Overall Study||3
1749403|NCT00003659|4283415|P1|COMPLETED|Overall Study||36
1749404|NCT00003659|4283415|P1|STARTED|Overall Study||39
1749405|NCT00003641|4283423|P2|NOT COMPLETED|Overall Study||174
1749406|NCT00003641|4283424|P1|NOT COMPLETED|Overall Study||569
1749407|NCT00003641|4283423|P2|COMPLETED|Overall Study||407
1749408|NCT00003641|4283424|P1|COMPLETED|Overall Study||0
1749409|NCT00003641|4283423|P2|Toxicity Assessed|Overall Study||568
1749410|NCT00003641|4283424|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
1749411|NCT00003641|4283423|P2|Treated|Overall Study||569
1749412|NCT00003641|4283424|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
1749413|NCT00003641|4283423|P2|STARTED|Overall Study||581
1749414|NCT00003641|4283424|P1|STARTED|Overall Study||569
1749415|NCT00003631|4283435|P3|NOT COMPLETED|Overall Study||9
1749416|NCT00003631|4283436|P2|NOT COMPLETED|Overall Study||1
1749417|NCT00003631|4283437|P1|NOT COMPLETED|Overall Study||3
1749418|NCT00003631|4283435|P3|COMPLETED|Overall Study||15
1749419|NCT00003631|4283436|P2|COMPLETED|Overall Study||43
1749420|NCT00003631|4283437|P1|COMPLETED|Overall Study||47
1749421|NCT00003631|4283435|P3|STARTED|Overall Study||24
1749422|NCT00003631|4283436|P2|STARTED|Overall Study||44
1749423|NCT00003631|4283437|P1|STARTED|Overall Study||50
1749424|NCT00003590|4283445|P1|NOT COMPLETED|Overall Study||22
1749425|NCT00003590|4283445|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
1749426|NCT00003590|4283445|P1|Eligible and Began Protocol Therapy|Overall Study||28
1749427|NCT00003590|4283445|P1|Eligible|Overall Study||28
1749428|NCT00003590|4283445|P1|STARTED|Overall Study||29
1749429|NCT00003537|4283450|P1|NOT COMPLETED|Overall Study||1
1749430|NCT00003537|4283450|P1|COMPLETED|Overall Study||18
1749431|NCT00003537|4283450|P1|STARTED|Overall Study||19
1749432|NCT00003535|4283455|P1|NOT COMPLETED|Overall Study||5
1749433|NCT00003535|4283455|P1|COMPLETED|Overall Study||4
1749434|NCT00003535|4283455|P1|STARTED|Overall Study||9
1749435|NCT00003483|4283460|P1|NOT COMPLETED|Overall Study||1
1749436|NCT00003483|4283460|P1|COMPLETED|Overall Study||2
1749437|NCT00003483|4283460|P1|STARTED|Overall Study||3
1749438|NCT00003479|4283465|P1|NOT COMPLETED|Overall Study||3
1749439|NCT00003479|4283465|P1|COMPLETED|Overall Study||6
1749440|NCT00003479|4283465|P1|STARTED|Overall Study||9
1749441|NCT00003477|4283470|P1|NOT COMPLETED|Overall Study||4
1749442|NCT00003477|4283470|P1|COMPLETED|Overall Study||8
1749443|NCT00003477|4283470|P1|STARTED|Overall Study||12
1749444|NCT00003476|4283475|P1|NOT COMPLETED|Overall Study||1
1749445|NCT00003476|4283475|P1|COMPLETED|Overall Study||7
1749446|NCT00003476|4283475|P1|STARTED|Overall Study||8
1749447|NCT00003475|4283480|P1|NOT COMPLETED|Overall Study||13
1749448|NCT00003475|4283480|P1|COMPLETED|Overall Study||27
1749449|NCT00003475|4283480|P1|STARTED|Overall Study||40
1749450|NCT00003474|4283485|P1|NOT COMPLETED|Overall Study||14
1749451|NCT00003474|4283485|P1|COMPLETED|Overall Study||26
1749452|NCT00003474|4283485|P1|STARTED|Overall Study||40
1749453|NCT00003473|4283490|P1|NOT COMPLETED|Overall Study||3
1749454|NCT00003473|4283490|P1|COMPLETED|Overall Study||17
1749455|NCT00003473|4283490|P1|STARTED|Overall Study||20
1749456|NCT00003472|4283495|P1|NOT COMPLETED|Overall Study||3
1749457|NCT00003472|4283495|P1|COMPLETED|Overall Study||10
1749458|NCT00003472|4283495|P1|STARTED|Overall Study||13
1749459|NCT00003471|4283500|P1|NOT COMPLETED|Overall Study||4
1749460|NCT00003471|4283500|P1|COMPLETED|Overall Study||3
1749461|NCT00003471|4283500|P1|STARTED|Overall Study||7
1749462|NCT00003470|4283505|P1|NOT COMPLETED|Overall Study||6
1749463|NCT00003470|4283505|P1|COMPLETED|Overall Study||21
1749464|NCT00003470|4283505|P1|STARTED|Overall Study||27
1749465|NCT00003469|4283510|P1|NOT COMPLETED|Overall Study||0
1749466|NCT00003469|4283510|P1|COMPLETED|Overall Study||4
1749467|NCT00003469|4283510|P1|STARTED|Overall Study||4
1749468|NCT00003468|4283515|P1|NOT COMPLETED|Overall Study||2
1749469|NCT00003468|4283515|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
1749470|NCT00003468|4283515|P1|STARTED|Overall Study||11
1749471|NCT00003460|4283520|P1|NOT COMPLETED|Overall Study||1
1749472|NCT00003460|4283520|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
1749473|NCT00003460|4283520|P1|STARTED|Overall Study||13
1749474|NCT00003459|4283525|P1|NOT COMPLETED|Overall Study||9
1749475|NCT00003459|4283525|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
1749476|NCT00003459|4283525|P1|STARTED|Overall Study||40
1749477|NCT00003458|4283530|P1|NOT COMPLETED|Overall Study||4
1749478|NCT00003458|4283530|P1|COMPLETED|Overall Study||30
1749479|NCT00003458|4283530|P1|STARTED|Overall Study||34
1749480|NCT00003457|4283535|P1|NOT COMPLETED|Overall Study||9
1749481|NCT00003457|4283535|P1|COMPLETED|Overall Study||31
1749482|NCT00003457|4283535|P1|STARTED|Overall Study||40
1749483|NCT00003456|4283540|P1|NOT COMPLETED|Overall Study||8
1749484|NCT00003456|4283540|P1|COMPLETED|Overall Study||32
1749485|NCT00003456|4283540|P1|STARTED|Overall Study||40
1749486|NCT00003453|4283545|P1|NOT COMPLETED|Overall Study||1
1749487|NCT00003453|4283545|P1|COMPLETED|Overall Study|One patient was not evaluable|5
1749488|NCT00003453|4283545|P1|STARTED|Overall Study||6
1749489|NCT00003389|4283552|P2|NOT COMPLETED|Overall Study||60
1749490|NCT00003389|4283553|P1|NOT COMPLETED|Overall Study||98
1749491|NCT00003389|4283552|P2|COMPLETED|Overall Study||366
1749492|NCT00003389|4283553|P1|COMPLETED|Overall Study||330
1749493|NCT00003389|4283552|P2|Eligible Patients|Overall Study||399
1749494|NCT00003389|4283553|P1|Eligible Patients|Overall Study||395
1749495|NCT00003389|4283552|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
1749496|NCT00003389|4283553|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
1749497|NCT00003389|4283552|P2|STARTED|Overall Study||426
1749498|NCT00003389|4283553|P1|STARTED|Overall Study||428
1749499|NCT00003377|4283568|P5|NOT COMPLETED|Period II||1
1749500|NCT00003377|4283569|P4|NOT COMPLETED|Period II||0
1749501|NCT00003377|4283570|P3|NOT COMPLETED|Period II||0
1749502|NCT00003377|4283571|P2|NOT COMPLETED|Period II||0
1749503|NCT00003377|4283572|P1|NOT COMPLETED|Period II||0
1749504|NCT00003377|4283568|P5|COMPLETED|Period II||16
1749505|NCT00003377|4283569|P4|COMPLETED|Period II||0
1749506|NCT00003377|4283570|P3|COMPLETED|Period II||0
1749507|NCT00003377|4283571|P2|COMPLETED|Period II||0
1749508|NCT00003377|4283572|P1|COMPLETED|Period II||0
1749509|NCT00003377|4283568|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
1749510|NCT00003377|4283569|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
1749511|NCT00003377|4283570|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
1749512|NCT00003377|4283571|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
1749513|NCT00003377|4283572|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
1749514|NCT00003377|4283568|P5|NOT COMPLETED|Period I||0
1749515|NCT00003377|4283569|P4|NOT COMPLETED|Period I||1
1749516|NCT00003377|4283570|P3|NOT COMPLETED|Period I||1
1749517|NCT00003377|4283571|P2|NOT COMPLETED|Period I||0
1749518|NCT00003377|4283572|P1|NOT COMPLETED|Period I||0
1749519|NCT00003377|4283568|P5|COMPLETED|Period I||0
1749520|NCT00003377|4283569|P4|COMPLETED|Period I||2
1749521|NCT00003377|4283570|P3|COMPLETED|Period I||2
1749522|NCT00003377|4283571|P2|COMPLETED|Period I||3
1749523|NCT00003377|4283572|P1|COMPLETED|Period I||3
1749524|NCT00003377|4283568|P5|STARTED|Period I||0
1749525|NCT00003377|4283569|P4|STARTED|Period I||3
1749526|NCT00003377|4283570|P3|STARTED|Period I||3
1749527|NCT00003377|4283571|P2|STARTED|Period I||3
1749528|NCT00003377|4283572|P1|STARTED|Period I||3
1749529|NCT00003199|4283586|P1|NOT COMPLETED|Overall Study||22
1749530|NCT00003199|4283586|P1|COMPLETED|Overall Study||28
1749531|NCT00003199|4283586|P1|STARTED|Overall Study||50
1749532|NCT00003138|4283594|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
1749533|NCT00003138|4283595|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
1749534|NCT00003138|4283594|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
1749535|NCT00003138|4283595|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
1749536|NCT00003138|4283594|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
1749537|NCT00003138|4283595|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
1749538|NCT00003138|4283594|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
1749539|NCT00003138|4283595|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
1749540|NCT00003138|4283594|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
1749541|NCT00003138|4283595|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
1749542|NCT00003138|4283594|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
1749543|NCT00003138|4283595|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
1749544|NCT00003138|4283594|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
1749545|NCT00003138|4283595|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
1749546|NCT00003138|4283594|P2|NOT COMPLETED|Step 2 (Cross Over)||0
1749547|NCT00003138|4283595|P1|NOT COMPLETED|Step 2 (Cross Over)||26
1749548|NCT00003138|4283594|P2|COMPLETED|Step 2 (Cross Over)||0
1749549|NCT00003138|4283595|P1|COMPLETED|Step 2 (Cross Over)||0
1749550|NCT00003138|4283594|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
1749551|NCT00003138|4283595|P1|STARTED|Step 2 (Cross Over)||26
1749552|NCT00003138|4283594|P2|NOT COMPLETED|Step 1||57
1749553|NCT00003138|4283595|P1|NOT COMPLETED|Step 1||61
1749554|NCT00003138|4283594|P2|COMPLETED|Step 1||0
1749555|NCT00003138|4283595|P1|COMPLETED|Step 1||0
1749556|NCT00003138|4283594|P2|Patients With Transfusion Data|Step 1||42
1749557|NCT00003138|4283595|P1|Patients With Transfusion Data|Step 1||37
1749558|NCT00003138|4283594|P2|Patients With QOL Data at 4 Months|Step 1||42
1749559|NCT00003138|4283595|P1|Patients With QOL Data at 4 Months|Step 1||42
1749560|NCT00003138|4283594|P2|Eligible and Treated|Step 1||50
1749561|NCT00003138|4283595|P1|Eligible and Treated|Step 1||52
1749562|NCT00003138|4283594|P2|Treated|Step 1||53
1749563|NCT00003138|4283595|P1|Treated|Step 1||56
1749564|NCT00003138|4283594|P2|Patients With Complete Data|Step 1||53
1749565|NCT00003138|4283595|P1|Patients With Complete Data|Step 1||57
1749566|NCT00003138|4283594|P2|STARTED|Step 1||57
1749567|NCT00003138|4283595|P1|STARTED|Step 1||61
1749568|NCT00002975|4283608|P1|NOT COMPLETED|Overall Study||5
1749569|NCT00002975|4283608|P1|COMPLETED|Overall Study||175
1749570|NCT00002975|4283608|P1|Treated With Study Therapy|Overall Study||175
1749571|NCT00002975|4283608|P1|STARTED|Overall Study||180
1749572|NCT00002931|4283612|P1|NOT COMPLETED|Overall Study||2
1749573|NCT00002931|4283612|P1|COMPLETED|Overall Study||46
1749574|NCT00002931|4283612|P1|STARTED|Overall Study||48
1749575|NCT00002874|4283620|P2|NOT COMPLETED|Overall Study||35
1749576|NCT00002874|4283621|P1|NOT COMPLETED|Overall Study||45
1749577|NCT00002874|4283620|P2|COMPLETED|Overall Study||384
1749578|NCT00002874|4283621|P1|COMPLETED|Overall Study||376
1749579|NCT00002874|4283620|P2|STARTED|Overall Study||419
1749580|NCT00002874|4283621|P1|STARTED|Overall Study||421
1749581|NCT00002850|4283646|P3|NOT COMPLETED|Overall Study||4
1749582|NCT00002850|4283647|P2|NOT COMPLETED|Overall Study||2
1749583|NCT00002850|4283648|P1|NOT COMPLETED|Overall Study||5
1749584|NCT00002850|4283646|P3|COMPLETED|Overall Study||63
1749585|NCT00002850|4283647|P2|COMPLETED|Overall Study||74
1749586|NCT00002850|4283648|P1|COMPLETED|Overall Study||64
1749587|NCT00002850|4283646|P3|STARTED|Overall Study||67
1749588|NCT00002850|4283647|P2|STARTED|Overall Study||76
1749589|NCT00002850|4283648|P1|STARTED|Overall Study||69
1749590|NCT00002842|4283656|P1|NOT COMPLETED|Overall Study||27
1749591|NCT00002842|4283656|P1|COMPLETED|Overall Study||22
1749592|NCT00002842|4283656|P1|STARTED|Overall Study||49
1749593|NCT00002766|4283662|P2|NOT COMPLETED|Overall Study||4
1749594|NCT00002766|4283663|P1|NOT COMPLETED|Overall Study||3
1749595|NCT00002766|4283662|P2|COMPLETED|Overall Study||85
1749596|NCT00002766|4283663|P1|COMPLETED|Overall Study||78
1749597|NCT00002766|4283662|P2|STARTED|Overall Study||89
1749598|NCT00002766|4283663|P1|STARTED|Overall Study||81
1749599|NCT00002651|4283671|P3|NOT COMPLETED|Consolidation and Randomization||860
1749600|NCT00002651|4283672|P2|NOT COMPLETED|Consolidation and Randomization||838
1749601|NCT00002651|4283673|P1|NOT COMPLETED|Consolidation and Randomization||0
1749602|NCT00002651|4283671|P3|COMPLETED|Consolidation and Randomization||22
1749603|NCT00002651|4283672|P2|COMPLETED|Consolidation and Randomization||29
1749604|NCT00002651|4283673|P1|COMPLETED|Consolidation and Randomization||0
1749605|NCT00002651|4283671|P3|Assessable for Toxicity|Consolidation and Randomization||702
1749606|NCT00002651|4283672|P2|Assessable for Toxicity|Consolidation and Randomization||732
1749607|NCT00002651|4283673|P1|Assessable for Toxicity|Consolidation and Randomization||0
1749608|NCT00002651|4283671|P3|Eligible|Consolidation and Randomization||770
1749609|NCT00002651|4283672|P2|Eligible|Consolidation and Randomization||765
1749610|NCT00002651|4283673|P1|Eligible|Consolidation and Randomization||0
1749611|NCT00002651|4283671|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
1749612|NCT00002651|4283672|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
1749613|NCT00002651|4283673|P1|STARTED|Consolidation and Randomization||0
1749614|NCT00002651|4283671|P3|NOT COMPLETED|Induction||0
1749615|NCT00002651|4283672|P2|NOT COMPLETED|Induction||0
1749616|NCT00002651|4283673|P1|NOT COMPLETED|Induction||1343
1749617|NCT00002651|4283671|P3|COMPLETED|Induction||0
1749618|NCT00002651|4283672|P2|COMPLETED|Induction||0
1749619|NCT00002651|4283673|P1|COMPLETED|Induction||1697
1749620|NCT00002651|4283671|P3|Eligible and Began Protocol Therapy|Induction||0
1749621|NCT00002651|4283672|P2|Eligible and Began Protocol Therapy|Induction||0
1749622|NCT00002651|4283673|P1|Eligible and Began Protocol Therapy|Induction||2950
1749623|NCT00002651|4283671|P3|Eligible|Induction||0
1749624|NCT00002651|4283672|P2|Eligible|Induction||0
1749625|NCT00002651|4283673|P1|Eligible|Induction||2950
1749626|NCT00002651|4283671|P3|STARTED|Induction||0
1749627|NCT00002651|4283672|P2|STARTED|Induction||0
1749628|NCT00002651|4283673|P1|STARTED|Induction||3040
1749629|NCT00002558|4283691|P2|NOT COMPLETED|Overall Study||1
1749630|NCT00002558|4283692|P1|NOT COMPLETED|Overall Study||0
1749631|NCT00002558|4283691|P2|COMPLETED|Overall Study||15
1749632|NCT00002558|4283692|P1|COMPLETED|Overall Study||92
1749633|NCT00002558|4283691|P2|STARTED|Overall Study||16
1749634|NCT00002558|4283692|P1|STARTED|Overall Study||92
1749635|NCT00052078|4283702|P4|NOT COMPLETED|Overall Study||15
1749636|NCT00052078|4283703|P3|NOT COMPLETED|Overall Study||13
1749637|NCT00052078|4283704|P2|NOT COMPLETED|Overall Study||6
1749638|NCT00052078|4283705|P1|NOT COMPLETED|Overall Study||23
1749639|NCT00052078|4283702|P4|COMPLETED|Overall Study||61
1749640|NCT00052078|4283703|P3|COMPLETED|Overall Study||127
1749641|NCT00052078|4283704|P2|COMPLETED|Overall Study||133
1749642|NCT00052078|4283705|P1|COMPLETED|Overall Study||110
1749643|NCT00052078|4283702|P4|STARTED|Overall Study||76
1749644|NCT00052078|4283703|P3|STARTED|Overall Study||140
1749645|NCT00052078|4283704|P2|STARTED|Overall Study||139
1749646|NCT00052078|4283705|P1|STARTED|Overall Study||133
1749647|NCT00051636|4283717|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
1749648|NCT00051636|4283718|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
1749649|NCT00051636|4283717|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
1749650|NCT00051636|4283718|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
1749651|NCT00051636|4283717|P2|STARTED|Period 2- Extended Observation Period||52
1749652|NCT00051636|4283718|P1|STARTED|Period 2- Extended Observation Period||75
1749653|NCT00051636|4283717|P2|NOT COMPLETED|Period 1 - Core||6
1749654|NCT00051636|4283718|P1|NOT COMPLETED|Period 1 - Core||4
1749655|NCT00051636|4283717|P2|COMPLETED|Period 1 - Core||76
1749656|NCT00051636|4283718|P1|COMPLETED|Period 1 - Core||86
1749657|NCT00051636|4283717|P2|STARTED|Period 1 - Core||82
1749658|NCT00051636|4283718|P1|STARTED|Period 1 - Core||90
1749659|NCT00051558|4283746|P2|NOT COMPLETED|Overall Study||96
1749660|NCT00051558|4283747|P1|NOT COMPLETED|Overall Study||91
1749661|NCT00051558|4283746|P2|COMPLETED|Overall Study||118
1749662|NCT00051558|4283747|P1|COMPLETED|Overall Study||123
1749663|NCT00051558|4283746|P2|STARTED|Overall Study||214
1749664|NCT00051558|4283747|P1|STARTED|Overall Study||214
1749665|NCT00051363|4283783|P2|NOT COMPLETED|Overall Study||144
1749666|NCT00051363|4283784|P1|NOT COMPLETED|Overall Study||115
1749667|NCT00051363|4283783|P2|COMPLETED|Overall Study||403
1749668|NCT00051363|4283784|P1|COMPLETED|Overall Study||443
1749669|NCT00051363|4283783|P2|Completed 6M Vist On-Study|Overall Study||403
1749670|NCT00051363|4283784|P1|Completed 6M Vist On-Study|Overall Study||443
1749671|NCT00051363|4283783|P2|Completed 6M Visit On-Treatment|Overall Study||372
1749672|NCT00051363|4283784|P1|Completed 6M Visit On-Treatment|Overall Study||427
1749673|NCT00051363|4283783|P2|Completed 2M Visit On-Study|Overall Study||432
1749674|NCT00051363|4283784|P1|Completed 2M Visit On-Study|Overall Study||468
1749675|NCT00051363|4283783|P2|Completed 2M Visit On-Treatment|Overall Study||417
1749676|NCT00051363|4283784|P1|Completed 2M Visit On-Treatment|Overall Study||456
1749677|NCT00051363|4283783|P2|Randomized & Analyzed|Overall Study||542
1749678|NCT00051363|4283784|P1|Randomized & Analyzed|Overall Study||556
1749679|NCT00051363|4283783|P2|STARTED|Overall Study||547
1749680|NCT00051363|4283784|P1|STARTED|Overall Study||558
1749681|NCT00051168|4283818|P1|NOT COMPLETED|Overall Study||135
1749682|NCT00051168|4283818|P1|COMPLETED|Overall Study||367
1749683|NCT00051168|4283818|P1|STARTED|Overall Study||502
1749684|NCT00051025|4283824|P2|NOT COMPLETED|Overall Study||4
1749685|NCT00051025|4283825|P1|NOT COMPLETED|Overall Study||2
1749686|NCT00051025|4283824|P2|COMPLETED|Overall Study||0
1749687|NCT00051025|4283825|P1|COMPLETED|Overall Study||3
1749688|NCT00051025|4283824|P2|STARTED|Overall Study||4
1749689|NCT00051025|4283825|P1|STARTED|Overall Study||5
1749690|NCT00050986|4283833|P1|NOT COMPLETED|Overall Study||2
1749691|NCT00050986|4283833|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
1749692|NCT00050986|4283833|P1|STARTED|Overall Study||55
1749693|NCT00050960|4283839|P2|NOT COMPLETED|Overall Study||304
1749694|NCT00050960|4283840|P1|NOT COMPLETED|Overall Study||302
1749695|NCT00050960|4283839|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
1749696|NCT00050960|4283840|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
1749697|NCT00050960|4283839|P2|STARTED|Overall Study||306
1749698|NCT00050960|4283840|P1|STARTED|Overall Study||306
1749699|NCT00050778|4283849|P3|NOT COMPLETED|Overall Study||18
1749700|NCT00050778|4283850|P2|NOT COMPLETED|Overall Study||21
1749701|NCT00050778|4283851|P1|NOT COMPLETED|Overall Study||45
1749702|NCT00050778|4283849|P3|COMPLETED|Overall Study||92
1749703|NCT00050778|4283850|P2|COMPLETED|Overall Study||92
1749704|NCT00050778|4283851|P1|COMPLETED|Overall Study||66
1749705|NCT00050778|4283849|P3|Treated|Overall Study||108
1749706|NCT00050778|4283850|P2|Treated|Overall Study||108
1749707|NCT00050778|4283851|P1|Treated|Overall Study||107
1749708|NCT00050778|4283849|P3|STARTED|Overall Study||110
1749709|NCT00050778|4283850|P2|STARTED|Overall Study||113
1749710|NCT00050778|4283851|P1|STARTED|Overall Study|Randomized.|111
1749711|NCT00050622|4283877|P1|NOT COMPLETED|Overall Study||1
1749712|NCT00050622|4283877|P1|COMPLETED|Overall Study||153
1749713|NCT00050622|4283877|P1|STARTED|Overall Study||154
1749714|NCT00050167|4283915|P2|NOT COMPLETED|Overall Study||1
1749715|NCT00050167|4283916|P1|NOT COMPLETED|Overall Study||1
1749716|NCT00050167|4283915|P2|COMPLETED|Overall Study||300
1749717|NCT00050167|4283916|P1|COMPLETED|Overall Study||301
1749718|NCT00050167|4283915|P2|STARTED|Overall Study||301
1749719|NCT00050167|4283916|P1|STARTED|Overall Study||302
1749720|NCT00050089|4283926|P4|NOT COMPLETED|Overall Study||0
1749721|NCT00050089|4283927|P3|NOT COMPLETED|Overall Study||0
1749722|NCT00050089|4283928|P2|NOT COMPLETED|Overall Study||0
1749723|NCT00050089|4283929|P1|NOT COMPLETED|Overall Study||0
1749724|NCT00050089|4283926|P4|COMPLETED|Overall Study|For primary outcome assessment|78
1749725|NCT00050089|4283927|P3|COMPLETED|Overall Study|For primary outcome assessment|86
1749726|NCT00050089|4283928|P2|COMPLETED|Overall Study|For primary outcome assessment|98
1749727|NCT00050089|4283929|P1|COMPLETED|Overall Study|For primary outcome assessment|106
1749728|NCT00050089|4283926|P4|Baseline|Overall Study||78
1749729|NCT00050089|4283927|P3|Baseline|Overall Study||86
1749730|NCT00050089|4283928|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
1749731|NCT00050089|4283929|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
1749732|NCT00050089|4283926|P4|STARTED|Overall Study||78
1749733|NCT00050089|4283927|P3|STARTED|Overall Study||86
1749734|NCT00050089|4283928|P2|STARTED|Overall Study||98
1749735|NCT00050089|4283929|P1|STARTED|Overall Study||106
1749736|NCT00050011|4283949|P2|NOT COMPLETED|Overall Study||126
1749737|NCT00050011|4283950|P1|NOT COMPLETED|Overall Study||121
1749738|NCT00050011|4283949|P2|COMPLETED|Overall Study||175
1749739|NCT00050011|4283950|P1|COMPLETED|Overall Study||180
1749740|NCT00050011|4283949|P2|Intent-to-treat Population|Overall Study||300
1749741|NCT00050011|4283950|P1|Intent-to-treat Population|Overall Study||300
1749742|NCT00050011|4283949|P2|STARTED|Overall Study||301
1749743|NCT00050011|4283950|P1|STARTED|Overall Study||301
1749744|NCT00049842|4283972|P2|NOT COMPLETED|Follow-up Phase||5
1749745|NCT00049842|4283973|P1|NOT COMPLETED|Follow-up Phase||7
1749746|NCT00049842|4283972|P2|COMPLETED|Follow-up Phase||189
1749747|NCT00049842|4283973|P1|COMPLETED|Follow-up Phase||211
1749748|NCT00049842|4283972|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
1749749|NCT00049842|4283973|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
1749750|NCT00049842|4283972|P2|NOT COMPLETED|Treatment Phase||78
1749751|NCT00049842|4283973|P1|NOT COMPLETED|Treatment Phase||93
1749752|NCT00049842|4283972|P2|COMPLETED|Treatment Phase||192
1749753|NCT00049842|4283973|P1|COMPLETED|Treatment Phase||177
1749754|NCT00049842|4283972|P2|STARTED|Treatment Phase||270
1749755|NCT00049842|4283973|P1|STARTED|Treatment Phase||270
1749756|NCT00048932|4283991|P3|NOT COMPLETED|Open Label Period (OL)||441
1749757|NCT00048932|4283992|P2|NOT COMPLETED|Open Label Period (OL)||0
1749758|NCT00048932|4283993|P1|NOT COMPLETED|Open Label Period (OL)||0
1749759|NCT00048932|4283991|P3|COMPLETED|Open Label Period (OL)||743
1749760|NCT00048932|4283992|P2|COMPLETED|Open Label Period (OL)||0
1749761|NCT00048932|4283993|P1|COMPLETED|Open Label Period (OL)||0
1749762|NCT00048932|4283991|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
1749763|NCT00048932|4283992|P2|STARTED|Open Label Period (OL)||0
1749764|NCT00048932|4283993|P1|STARTED|Open Label Period (OL)||0
1749765|NCT00048932|4283991|P3|NOT COMPLETED|Double Blind Period (DB)||0
1749766|NCT00048932|4283992|P2|NOT COMPLETED|Double Blind Period (DB)||87
1749767|NCT00048932|4283993|P1|NOT COMPLETED|Double Blind Period (DB)||123
1749768|NCT00048932|4283991|P3|COMPLETED|Double Blind Period (DB)||0
1749769|NCT00048932|4283992|P2|COMPLETED|Double Blind Period (DB)||395
1749770|NCT00048932|4283993|P1|COMPLETED|Double Blind Period (DB)||836
1749771|NCT00048932|4283991|P3|STARTED|Double Blind Period (DB)||0
1749772|NCT00048932|4283992|P2|STARTED|Double Blind Period (DB)|Number Treated|482
1749773|NCT00048932|4283993|P1|STARTED|Double Blind Period (DB)|Number Treated|959
1749774|NCT00048815|4284020|P3|NOT COMPLETED|Overall Study||4
1749775|NCT00048815|4284021|P2|NOT COMPLETED|Overall Study||4
1749776|NCT00048815|4284022|P1|NOT COMPLETED|Overall Study||6
1749777|NCT00048815|4284020|P3|COMPLETED|Overall Study||19
1749778|NCT00048815|4284021|P2|COMPLETED|Overall Study||22
1749779|NCT00048815|4284022|P1|COMPLETED|Overall Study||18
1749780|NCT00048815|4284020|P3|STARTED|Overall Study||23
1749781|NCT00048815|4284021|P2|STARTED|Overall Study||26
1749782|NCT00048815|4284022|P1|STARTED|Overall Study||24
1749783|NCT00048581|4284035|P3|NOT COMPLETED|Open-Label Period||167
1749784|NCT00048581|4284036|P2|NOT COMPLETED|Open-Label Period||0
1749785|NCT00048581|4284037|P1|NOT COMPLETED|Open-Label Period||0
1749786|NCT00048581|4284035|P3|COMPLETED|Open-Label Period||150
1749787|NCT00048581|4284036|P2|COMPLETED|Open-Label Period||0
1749788|NCT00048581|4284037|P1|COMPLETED|Open-Label Period||0
1749789|NCT00048581|4284035|P3|STARTED|Open-Label Period||317
1749790|NCT00048581|4284036|P2|STARTED|Open-Label Period||0
1749791|NCT00048581|4284037|P1|STARTED|Open-Label Period||0
1749792|NCT00048581|4284035|P3|NOT COMPLETED|Double-Blind Period||0
1749793|NCT00048581|4284036|P2|NOT COMPLETED|Double-Blind Period||34
1749794|NCT00048581|4284037|P1|NOT COMPLETED|Double-Blind Period||35
1749795|NCT00048581|4284035|P3|COMPLETED|Double-Blind Period||0
1749796|NCT00048581|4284036|P2|COMPLETED|Double-Blind Period||99
1749797|NCT00048581|4284037|P1|COMPLETED|Double-Blind Period||223
1749798|NCT00048581|4284035|P3|STARTED|Double-Blind Period||0
1749799|NCT00048581|4284036|P2|STARTED|Double-Blind Period||133
1749800|NCT00048581|4284037|P1|STARTED|Double-Blind Period||258
1749801|NCT00048568|4284204|P3|NOT COMPLETED|Open-Label Period||160
1749802|NCT00048568|4284205|P2|NOT COMPLETED|Open-Label Period||0
1749803|NCT00048568|4284206|P1|NOT COMPLETED|Open-Label Period||0
1749804|NCT00048568|4284204|P3|COMPLETED|Open-Label Period||379
1749805|NCT00048568|4284205|P2|COMPLETED|Open-Label Period||0
1749806|NCT00048568|4284206|P1|COMPLETED|Open-Label Period||0
1749807|NCT00048568|4284204|P3|STARTED|Open-Label Period||539
1749808|NCT00048568|4284205|P2|STARTED|Open-Label Period||0
1749809|NCT00048568|4284206|P1|STARTED|Open-Label Period||0
1749810|NCT00048568|4284204|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
1749811|NCT00048568|4284205|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
1749812|NCT00048568|4284206|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
1749813|NCT00048568|4284204|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
1749814|NCT00048568|4284205|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
1749815|NCT00048568|4284206|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
1749816|NCT00048568|4284204|P3|STARTED|Double-Blind Period Days 170 to 365||0
1749817|NCT00048568|4284205|P2|STARTED|Double-Blind Period Days 170 to 365||174
1749818|NCT00048568|4284206|P1|STARTED|Double-Blind Period Days 170 to 365||401
1749819|NCT00048568|4284204|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
1749820|NCT00048568|4284205|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
1749821|NCT00048568|4284206|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
1749822|NCT00048568|4284204|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
1749823|NCT00048568|4284205|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
1749824|NCT00048568|4284206|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
1749825|NCT00048568|4284204|P3|STARTED|Double-Blind Period Days 1 to 169||0
1749826|NCT00048568|4284205|P2|STARTED|Double-Blind Period Days 1 to 169||219
1749827|NCT00048568|4284206|P1|STARTED|Double-Blind Period Days 1 to 169||433
1749828|NCT00048893|4284494|P1|NOT COMPLETED|Overall Study||0
1749829|NCT00048893|4284494|P1|COMPLETED|Overall Study||37
1749830|NCT00048893|4284494|P1|STARTED|Overall Study||37
1749831|NCT00048737|4284505|P1|NOT COMPLETED|Overall Study||0
1749832|NCT00048737|4284505|P1|COMPLETED|Overall Study||70
1749833|NCT00048737|4284505|P1|STARTED|Overall Study||70
1749834|NCT00048724|4284511|P2|NOT COMPLETED|Overall Study||118
1749835|NCT00048724|4284512|P1|NOT COMPLETED|Overall Study||116
1749836|NCT00048724|4284511|P2|COMPLETED|Overall Study||197
1749837|NCT00048724|4284512|P1|COMPLETED|Overall Study||195
1749838|NCT00048724|4284511|P2|STARTED|Overall Study||315
1749839|NCT00048724|4284512|P1|STARTED|Overall Study||311
1749840|NCT00048542|4284524|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
1749841|NCT00048542|4284525|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
1749842|NCT00048542|4284526|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749843|NCT00048542|4284527|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749844|NCT00048542|4284528|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749845|NCT00048542|4284529|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749846|NCT00048542|4284530|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749847|NCT00048542|4284531|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749848|NCT00048542|4284524|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
1749849|NCT00048542|4284525|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
1749850|NCT00048542|4284526|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749851|NCT00048542|4284527|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749852|NCT00048542|4284528|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749853|NCT00048542|4284529|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749854|NCT00048542|4284530|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749855|NCT00048542|4284531|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
1749856|NCT00048542|4284524|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
1749857|NCT00048542|4284525|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
1749858|NCT00048542|4284526|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
1749859|NCT00048542|4284527|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
1749860|NCT00048542|4284528|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
1749861|NCT00048542|4284529|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
1749862|NCT00048542|4284530|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
1749863|NCT00048542|4284531|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
1749864|NCT00048542|4284524|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
1749865|NCT00048542|4284525|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
1749866|NCT00048542|4284526|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
1749867|NCT00048542|4284527|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
1749868|NCT00048542|4284528|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
1749869|NCT00048542|4284529|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
1749870|NCT00048542|4284530|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
1749871|NCT00048542|4284531|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
1749872|NCT00048542|4284524|P8|COMPLETED|Open-Label Extension BSA Phase||0
1749873|NCT00048542|4284525|P7|COMPLETED|Open-Label Extension BSA Phase||0
1749874|NCT00048542|4284526|P6|COMPLETED|Open-Label Extension BSA Phase||47
1749875|NCT00048542|4284527|P5|COMPLETED|Open-Label Extension BSA Phase||59
1749876|NCT00048542|4284528|P4|COMPLETED|Open-Label Extension BSA Phase||0
1749877|NCT00048542|4284529|P3|COMPLETED|Open-Label Extension BSA Phase||0
1749878|NCT00048542|4284530|P2|COMPLETED|Open-Label Extension BSA Phase||0
1749879|NCT00048542|4284531|P1|COMPLETED|Open-Label Extension BSA Phase||0
1749880|NCT00048542|4284524|P8|STARTED|Open-Label Extension BSA Phase||0
1749881|NCT00048542|4284525|P7|STARTED|Open-Label Extension BSA Phase||0
1749882|NCT00048542|4284526|P6|STARTED|Open-Label Extension BSA Phase||57
1749883|NCT00048542|4284527|P5|STARTED|Open-Label Extension BSA Phase||71
1749884|NCT00048542|4284528|P4|STARTED|Open-Label Extension BSA Phase||0
1749885|NCT00048542|4284529|P3|STARTED|Open-Label Extension BSA Phase||0
1749886|NCT00048542|4284530|P2|STARTED|Open-Label Extension BSA Phase||0
1749887|NCT00048542|4284531|P1|STARTED|Open-Label Extension BSA Phase||0
1749888|NCT00048542|4284524|P8|NOT COMPLETED|Double-Blind Phase||0
1749889|NCT00048542|4284525|P7|NOT COMPLETED|Double-Blind Phase||0
1749890|NCT00048542|4284526|P6|NOT COMPLETED|Double-Blind Phase||0
1749891|NCT00048542|4284527|P5|NOT COMPLETED|Double-Blind Phase||0
1749892|NCT00048542|4284528|P4|NOT COMPLETED|Double-Blind Phase||0
1749893|NCT00048542|4284529|P3|NOT COMPLETED|Double-Blind Phase||1
1749894|NCT00048542|4284530|P2|NOT COMPLETED|Double-Blind Phase||1
1749895|NCT00048542|4284531|P1|NOT COMPLETED|Double-Blind Phase||3
1749896|NCT00048542|4284524|P8|COMPLETED|Double-Blind Phase||0
1749897|NCT00048542|4284525|P7|COMPLETED|Double-Blind Phase||0
1749898|NCT00048542|4284526|P6|COMPLETED|Double-Blind Phase||0
1749899|NCT00048542|4284527|P5|COMPLETED|Double-Blind Phase||0
1749900|NCT00048542|4284528|P4|COMPLETED|Double-Blind Phase||28
1749901|NCT00048542|4284529|P3|COMPLETED|Double-Blind Phase||29
1749902|NCT00048542|4284530|P2|COMPLETED|Double-Blind Phase||36
1749903|NCT00048542|4284531|P1|COMPLETED|Double-Blind Phase||35
1749904|NCT00048542|4284524|P8|STARTED|Double-Blind Phase||0
1749905|NCT00048542|4284525|P7|STARTED|Double-Blind Phase||0
1749906|NCT00048542|4284526|P6|STARTED|Double-Blind Phase||0
1749907|NCT00048542|4284527|P5|STARTED|Double-Blind Phase||0
1749908|NCT00048542|4284528|P4|STARTED|Double-Blind Phase||28
1749909|NCT00048542|4284529|P3|STARTED|Double-Blind Phase||30
1749910|NCT00048542|4284530|P2|STARTED|Double-Blind Phase||37
1749911|NCT00048542|4284531|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
1749912|NCT00048347|4284597|P1|NOT COMPLETED|Overall Study||2
1749913|NCT00048347|4284597|P1|COMPLETED|Overall Study||16
1749914|NCT00048347|4284597|P1|STARTED|Overall Study||18
1749915|NCT00048165|4284603|P2|NOT COMPLETED|Completed 12 Months Study||3
1749916|NCT00048165|4284604|P1|NOT COMPLETED|Completed 12 Months Study||3
1749917|NCT00048165|4284603|P2|COMPLETED|Completed 12 Months Study||167
1749918|NCT00048165|4284604|P1|COMPLETED|Completed 12 Months Study||162
1749919|NCT00048165|4284603|P2|STARTED|Completed 12 Months Study||170
1749920|NCT00048165|4284604|P1|STARTED|Completed 12 Months Study||165
1749921|NCT00048165|4284603|P2|NOT COMPLETED|Completed 6 Months Study||48
1749922|NCT00048165|4284604|P1|NOT COMPLETED|Completed 6 Months Study||51
1749923|NCT00048165|4284603|P2|COMPLETED|Completed 6 Months Study||170
1749924|NCT00048165|4284604|P1|COMPLETED|Completed 6 Months Study||165
1749925|NCT00048165|4284603|P2|STARTED|Completed 6 Months Study||218
1749926|NCT00048165|4284604|P1|STARTED|Completed 6 Months Study||216
1749927|NCT00048074|4284639|P3|NOT COMPLETED|Overall Study||97
1749928|NCT00048074|4284640|P2|NOT COMPLETED|Overall Study||87
1749929|NCT00048074|4284641|P1|NOT COMPLETED|Overall Study||81
1749930|NCT00048074|4284639|P3|COMPLETED|Overall Study||372
1749931|NCT00048074|4284640|P2|COMPLETED|Overall Study||361
1749932|NCT00048074|4284641|P1|COMPLETED|Overall Study||384
1749933|NCT00048074|4284639|P3|STARTED|Overall Study||469
1749934|NCT00048074|4284640|P2|STARTED|Overall Study||448
1749935|NCT00048074|4284641|P1|STARTED|Overall Study||465
1749936|NCT00048061|4284698|P4|NOT COMPLETED|Overall Study||79
1749937|NCT00048061|4284699|P3|NOT COMPLETED|Overall Study||84
1749938|NCT00048061|4284700|P2|NOT COMPLETED|Overall Study||73
1749939|NCT00048061|4284701|P1|NOT COMPLETED|Overall Study||75
1749940|NCT00048061|4284698|P4|COMPLETED|Overall Study||322
1749941|NCT00048061|4284699|P3|COMPLETED|Overall Study||316
1749942|NCT00048061|4284700|P2|COMPLETED|Overall Study||328
1749943|NCT00048061|4284701|P1|COMPLETED|Overall Study||325
1749944|NCT00048061|4284698|P4|STARTED|Overall Study||401
1749945|NCT00048061|4284699|P3|STARTED|Overall Study||400
1749946|NCT00048061|4284700|P2|STARTED|Overall Study||401
1749947|NCT00048061|4284701|P1|STARTED|Overall Study||400
1749948|NCT00048048|4284780|P12|NOT COMPLETED|Extension Year 2||2
1749949|NCT00048048|4284781|P11|NOT COMPLETED|Extension Year 2||4
1749950|NCT00048048|4284782|P10|NOT COMPLETED|Extension Year 2||0
1749951|NCT00048048|4284783|P9|NOT COMPLETED|Extension Year 2||0
1749952|NCT00048048|4284784|P8|NOT COMPLETED|Extension Year 2||0
1749953|NCT00048048|4284785|P7|NOT COMPLETED|Extension Year 2||0
1749954|NCT00048048|4284786|P6|NOT COMPLETED|Extension Year 2||0
1749955|NCT00048048|4284787|P5|NOT COMPLETED|Extension Year 2||0
1749956|NCT00048048|4284788|P4|NOT COMPLETED|Extension Year 2||0
1749957|NCT00048048|4284789|P3|NOT COMPLETED|Extension Year 2||0
1749958|NCT00048048|4284790|P2|NOT COMPLETED|Extension Year 2||0
1749959|NCT00048048|4284791|P1|NOT COMPLETED|Extension Year 2||0
1749960|NCT00048048|4284780|P12|COMPLETED|Extension Year 2||13
1749961|NCT00048048|4284781|P11|COMPLETED|Extension Year 2||19
1749962|NCT00048048|4284782|P10|COMPLETED|Extension Year 2||2
1749963|NCT00048048|4284783|P9|COMPLETED|Extension Year 2||0
1749964|NCT00048048|4284784|P8|COMPLETED|Extension Year 2||0
1749965|NCT00048048|4284785|P7|COMPLETED|Extension Year 2||0
1749966|NCT00048048|4284786|P6|COMPLETED|Extension Year 2||0
1749967|NCT00048048|4284787|P5|COMPLETED|Extension Year 2||0
1749968|NCT00048048|4284788|P4|COMPLETED|Extension Year 2||0
1749969|NCT00048048|4284789|P3|COMPLETED|Extension Year 2||0
1749970|NCT00048048|4284790|P2|COMPLETED|Extension Year 2||0
1749971|NCT00048048|4284791|P1|COMPLETED|Extension Year 2||0
1749972|NCT00048048|4284780|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
1749973|NCT00048048|4284781|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
1749974|NCT00048048|4284782|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
1749975|NCT00048048|4284783|P9|STARTED|Extension Year 2||0
1749976|NCT00048048|4284784|P8|STARTED|Extension Year 2||0
1749977|NCT00048048|4284785|P7|STARTED|Extension Year 2||0
1749978|NCT00048048|4284786|P6|STARTED|Extension Year 2||0
1749979|NCT00048048|4284787|P5|STARTED|Extension Year 2||0
1749980|NCT00048048|4284788|P4|STARTED|Extension Year 2||0
1749981|NCT00048048|4284789|P3|STARTED|Extension Year 2||0
1749982|NCT00048048|4284790|P2|STARTED|Extension Year 2||0
1749983|NCT00048048|4284791|P1|STARTED|Extension Year 2||0
1749984|NCT00048048|4284780|P12|NOT COMPLETED|Extension Year 1||4
1749985|NCT00048048|4284781|P11|NOT COMPLETED|Extension Year 1||2
1749986|NCT00048048|4284782|P10|NOT COMPLETED|Extension Year 1||2
1749987|NCT00048048|4284783|P9|NOT COMPLETED|Extension Year 1||0
1749988|NCT00048048|4284784|P8|NOT COMPLETED|Extension Year 1||0
1749989|NCT00048048|4284785|P7|NOT COMPLETED|Extension Year 1||0
1749990|NCT00048048|4284786|P6|NOT COMPLETED|Extension Year 1||0
1749991|NCT00048048|4284787|P5|NOT COMPLETED|Extension Year 1||0
1749992|NCT00048048|4284788|P4|NOT COMPLETED|Extension Year 1||0
1749993|NCT00048048|4284789|P3|NOT COMPLETED|Extension Year 1||0
1749994|NCT00048048|4284790|P2|NOT COMPLETED|Extension Year 1||0
1749995|NCT00048048|4284791|P1|NOT COMPLETED|Extension Year 1||0
1749996|NCT00048048|4284780|P12|COMPLETED|Extension Year 1||15
1749997|NCT00048048|4284781|P11|COMPLETED|Extension Year 1||14
1749998|NCT00048048|4284782|P10|COMPLETED|Extension Year 1||14
1749999|NCT00048048|4284783|P9|COMPLETED|Extension Year 1||0
1750000|NCT00048048|4284784|P8|COMPLETED|Extension Year 1||0
1750001|NCT00048048|4284785|P7|COMPLETED|Extension Year 1||0
1750002|NCT00048048|4284786|P6|COMPLETED|Extension Year 1||0
1750003|NCT00048048|4284787|P5|COMPLETED|Extension Year 1||0
1750004|NCT00048048|4284788|P4|COMPLETED|Extension Year 1||0
1750005|NCT00048048|4284789|P3|COMPLETED|Extension Year 1||0
1750006|NCT00048048|4284790|P2|COMPLETED|Extension Year 1||0
1750007|NCT00048048|4284791|P1|COMPLETED|Extension Year 1||0
1750008|NCT00048048|4284780|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
1750009|NCT00048048|4284781|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
1750010|NCT00048048|4284782|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
1750011|NCT00048048|4284783|P9|STARTED|Extension Year 1||0
1750012|NCT00048048|4284784|P8|STARTED|Extension Year 1||0
1750013|NCT00048048|4284785|P7|STARTED|Extension Year 1||0
1750014|NCT00048048|4284786|P6|STARTED|Extension Year 1||0
1750015|NCT00048048|4284787|P5|STARTED|Extension Year 1||0
1750016|NCT00048048|4284788|P4|STARTED|Extension Year 1||0
1750017|NCT00048048|4284789|P3|STARTED|Extension Year 1||0
1750018|NCT00048048|4284790|P2|STARTED|Extension Year 1||0
1750019|NCT00048048|4284791|P1|STARTED|Extension Year 1||0
1750020|NCT00048048|4284780|P12|NOT COMPLETED|Core Treatment||0
1750021|NCT00048048|4284781|P11|NOT COMPLETED|Core Treatment||0
1750022|NCT00048048|4284782|P10|NOT COMPLETED|Core Treatment||0
1750023|NCT00048048|4284783|P9|NOT COMPLETED|Core Treatment||0
1750024|NCT00048048|4284784|P8|NOT COMPLETED|Core Treatment||1
1750025|NCT00048048|4284785|P7|NOT COMPLETED|Core Treatment||0
1750026|NCT00048048|4284786|P6|NOT COMPLETED|Core Treatment||0
1750027|NCT00048048|4284787|P5|NOT COMPLETED|Core Treatment||0
1750028|NCT00048048|4284788|P4|NOT COMPLETED|Core Treatment||0
1750029|NCT00048048|4284789|P3|NOT COMPLETED|Core Treatment||1
1750030|NCT00048048|4284790|P2|NOT COMPLETED|Core Treatment||0
1750031|NCT00048048|4284791|P1|NOT COMPLETED|Core Treatment||0
1750032|NCT00048048|4284780|P12|COMPLETED|Core Treatment||0
1750033|NCT00048048|4284781|P11|COMPLETED|Core Treatment||0
1750034|NCT00048048|4284782|P10|COMPLETED|Core Treatment||0
1750035|NCT00048048|4284783|P9|COMPLETED|Core Treatment||10
1750036|NCT00048048|4284784|P8|COMPLETED|Core Treatment||5
1750037|NCT00048048|4284785|P7|COMPLETED|Core Treatment||6
1750038|NCT00048048|4284786|P6|COMPLETED|Core Treatment||9
1750039|NCT00048048|4284787|P5|COMPLETED|Core Treatment||6
1750040|NCT00048048|4284788|P4|COMPLETED|Core Treatment||6
1750041|NCT00048048|4284789|P3|COMPLETED|Core Treatment||9
1750042|NCT00048048|4284790|P2|COMPLETED|Core Treatment||6
1750043|NCT00048048|4284791|P1|COMPLETED|Core Treatment||6
1750044|NCT00048048|4284780|P12|STARTED|Core Treatment||0
1750045|NCT00048048|4284781|P11|STARTED|Core Treatment||0
1750046|NCT00048048|4284782|P10|STARTED|Core Treatment||0
1750047|NCT00048048|4284783|P9|STARTED|Core Treatment||10
1750048|NCT00048048|4284784|P8|STARTED|Core Treatment||6
1750049|NCT00048048|4284785|P7|STARTED|Core Treatment||6
1750050|NCT00048048|4284786|P6|STARTED|Core Treatment||9
1750051|NCT00048048|4284787|P5|STARTED|Core Treatment||6
1750052|NCT00048048|4284788|P4|STARTED|Core Treatment||6
1750053|NCT00048048|4284789|P3|STARTED|Core Treatment||10
1750054|NCT00048048|4284790|P2|STARTED|Core Treatment||6
1750055|NCT00048048|4284791|P1|STARTED|Core Treatment||6
1750056|NCT00048035|4284847|P8|NOT COMPLETED|Extension Year 2||3
1750057|NCT00048035|4284848|P7|NOT COMPLETED|Extension Year 2||3
1750058|NCT00048035|4284849|P6|NOT COMPLETED|Extension Year 2||0
1750059|NCT00048035|4284850|P5|NOT COMPLETED|Extension Year 2||0
1750060|NCT00048035|4284851|P4|NOT COMPLETED|Extension Year 2||0
1750061|NCT00048035|4284852|P3|NOT COMPLETED|Extension Year 2||0
1750062|NCT00048035|4284853|P2|NOT COMPLETED|Extension Year 2||0
1750063|NCT00048035|4284854|P1|NOT COMPLETED|Extension Year 2||0
1750064|NCT00048035|4284847|P8|COMPLETED|Extension Year 2||10
1750065|NCT00048035|4284848|P7|COMPLETED|Extension Year 2||11
1750066|NCT00048035|4284849|P6|COMPLETED|Extension Year 2||0
1750067|NCT00048035|4284850|P5|COMPLETED|Extension Year 2||0
1750068|NCT00048035|4284851|P4|COMPLETED|Extension Year 2||0
1750069|NCT00048035|4284852|P3|COMPLETED|Extension Year 2||0
1750070|NCT00048035|4284853|P2|COMPLETED|Extension Year 2||0
1750071|NCT00048035|4284854|P1|COMPLETED|Extension Year 2||0
1750072|NCT00048035|4284847|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
1750073|NCT00048035|4284848|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
1750074|NCT00048035|4284849|P6|STARTED|Extension Year 2||0
1750075|NCT00048035|4284850|P5|STARTED|Extension Year 2||0
1750076|NCT00048035|4284851|P4|STARTED|Extension Year 2||0
1750077|NCT00048035|4284852|P3|STARTED|Extension Year 2||0
1750078|NCT00048035|4284853|P2|STARTED|Extension Year 2||0
1750079|NCT00048035|4284854|P1|STARTED|Extension Year 2||0
1750080|NCT00048035|4284847|P8|NOT COMPLETED|Extension Year 1||11
1750081|NCT00048035|4284848|P7|NOT COMPLETED|Extension Year 1||11
1750082|NCT00048035|4284849|P6|NOT COMPLETED|Extension Year 1||0
1750083|NCT00048035|4284850|P5|NOT COMPLETED|Extension Year 1||0
1750084|NCT00048035|4284851|P4|NOT COMPLETED|Extension Year 1||0
1750085|NCT00048035|4284852|P3|NOT COMPLETED|Extension Year 1||0
1750086|NCT00048035|4284853|P2|NOT COMPLETED|Extension Year 1||0
1750087|NCT00048035|4284854|P1|NOT COMPLETED|Extension Year 1||0
1750088|NCT00048035|4284847|P8|COMPLETED|Extension Year 1||15
1750089|NCT00048035|4284848|P7|COMPLETED|Extension Year 1||16
1750090|NCT00048035|4284849|P6|COMPLETED|Extension Year 1||0
1750091|NCT00048035|4284850|P5|COMPLETED|Extension Year 1||0
1750092|NCT00048035|4284851|P4|COMPLETED|Extension Year 1||0
1750093|NCT00048035|4284852|P3|COMPLETED|Extension Year 1||0
1750094|NCT00048035|4284853|P2|COMPLETED|Extension Year 1||0
1750095|NCT00048035|4284854|P1|COMPLETED|Extension Year 1||0
1750096|NCT00048035|4284847|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
1750097|NCT00048035|4284848|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
1750098|NCT00048035|4284849|P6|STARTED|Extension Year 1||0
1750099|NCT00048035|4284850|P5|STARTED|Extension Year 1||0
1750100|NCT00048035|4284851|P4|STARTED|Extension Year 1||0
1750101|NCT00048035|4284852|P3|STARTED|Extension Year 1||0
1750102|NCT00048035|4284853|P2|STARTED|Extension Year 1||0
1750103|NCT00048035|4284854|P1|STARTED|Extension Year 1||0
1750104|NCT00048035|4284847|P8|NOT COMPLETED|Core Period||0
1750105|NCT00048035|4284848|P7|NOT COMPLETED|Core Period||0
1750106|NCT00048035|4284849|P6|NOT COMPLETED|Core Period||1
1750107|NCT00048035|4284850|P5|NOT COMPLETED|Core Period||1
1750108|NCT00048035|4284851|P4|NOT COMPLETED|Core Period||1
1750109|NCT00048035|4284852|P3|NOT COMPLETED|Core Period||1
1750110|NCT00048035|4284853|P2|NOT COMPLETED|Core Period||2
1750111|NCT00048035|4284854|P1|NOT COMPLETED|Core Period||4
1750112|NCT00048035|4284847|P8|COMPLETED|Core Period||0
1750113|NCT00048035|4284848|P7|COMPLETED|Core Period||0
1750114|NCT00048035|4284849|P6|COMPLETED|Core Period||14
1750115|NCT00048035|4284850|P5|COMPLETED|Core Period||15
1750116|NCT00048035|4284851|P4|COMPLETED|Core Period||14
1750117|NCT00048035|4284852|P3|COMPLETED|Core Period||14
1750118|NCT00048035|4284853|P2|COMPLETED|Core Period||13
1750119|NCT00048035|4284854|P1|COMPLETED|Core Period||11
1750120|NCT00048035|4284847|P8|STARTED|Core Period||0
1750121|NCT00048035|4284848|P7|STARTED|Core Period||0
1750122|NCT00048035|4284849|P6|STARTED|Core Period||15
1750123|NCT00048035|4284850|P5|STARTED|Core Period||16
1750124|NCT00048035|4284851|P4|STARTED|Core Period||15
1750125|NCT00048035|4284852|P3|STARTED|Core Period||15
1750126|NCT00048035|4284853|P2|STARTED|Core Period||15
1750127|NCT00048035|4284854|P1|STARTED|Core Period||15
1750128|NCT00047879|4284892|P2|NOT COMPLETED|Overall Study||3
1750129|NCT00047879|4284893|P1|NOT COMPLETED|Overall Study||4
1750130|NCT00047879|4284892|P2|COMPLETED|Overall Study||0
1750131|NCT00047879|4284893|P1|COMPLETED|Overall Study||0
1750132|NCT00047879|4284892|P2|STARTED|Overall Study||3
1750133|NCT00047879|4284893|P1|STARTED|Overall Study||4
1750134|NCT00047697|4284905|P2|NOT COMPLETED|Overall Study||2
1750135|NCT00047697|4284906|P1|NOT COMPLETED|Overall Study||0
1750136|NCT00047697|4284905|P2|COMPLETED|Overall Study||14
1750137|NCT00047697|4284906|P1|COMPLETED|Overall Study||18
1750138|NCT00047697|4284905|P2|STARTED|Overall Study||16
1750139|NCT00047697|4284906|P1|STARTED|Overall Study||18
1750140|NCT00047619|4284918|P2|NOT COMPLETED|Overall Study||0
1750141|NCT00047619|4284919|P1|NOT COMPLETED|Overall Study||0
1750142|NCT00047619|4284918|P2|COMPLETED|Overall Study||14
1750143|NCT00047619|4284919|P1|COMPLETED|Overall Study||14
1750144|NCT00047619|4284918|P2|STARTED|Overall Study||14
1750145|NCT00047619|4284919|P1|STARTED|Overall Study||14
1750146|NCT00047463|4284929|P2|NOT COMPLETED|Overall Study||3
1750147|NCT00047463|4284930|P1|NOT COMPLETED|Overall Study||0
1750148|NCT00047463|4284929|P2|COMPLETED|Overall Study||19
1750149|NCT00047463|4284930|P1|COMPLETED|Overall Study||13
1750150|NCT00047463|4284929|P2|STARTED|Overall Study||22
1750151|NCT00047463|4284930|P1|STARTED|Overall Study||13
1750152|NCT00046475|4284941|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
1750153|NCT00046475|4284942|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
1750154|NCT00046475|4284943|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
1750155|NCT00046475|4284941|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
1750156|NCT00046475|4284942|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
1750157|NCT00046475|4284943|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
1750158|NCT00046475|4284941|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
1750159|NCT00046475|4284942|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
1750160|NCT00046475|4284943|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
1750161|NCT00046475|4284941|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
1750162|NCT00046475|4284942|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
1750163|NCT00046475|4284943|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
1750164|NCT00046475|4284941|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
1750165|NCT00046475|4284942|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
1750166|NCT00046475|4284943|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
1750167|NCT00046475|4284941|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
1750168|NCT00046475|4284942|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
1750169|NCT00046475|4284943|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
1750170|NCT00046475|4284941|P3|NOT COMPLETED|Titration (1 Week)||0
1750171|NCT00046475|4284942|P2|NOT COMPLETED|Titration (1 Week)||0
1750172|NCT00046475|4284943|P1|NOT COMPLETED|Titration (1 Week)||0
1750173|NCT00046475|4284941|P3|COMPLETED|Titration (1 Week)||0
1750174|NCT00046475|4284942|P2|COMPLETED|Titration (1 Week)||0
1750175|NCT00046475|4284943|P1|COMPLETED|Titration (1 Week)||136
1750176|NCT00046475|4284941|P3|STARTED|Titration (1 Week)||0
1750177|NCT00046475|4284942|P2|STARTED|Titration (1 Week)||0
1750178|NCT00046475|4284943|P1|STARTED|Titration (1 Week)||136
1750179|NCT00046475|4284941|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
1750180|NCT00046475|4284942|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
1750181|NCT00046475|4284943|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
1750182|NCT00046475|4284941|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
1750183|NCT00046475|4284942|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
1750184|NCT00046475|4284943|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
1750185|NCT00046475|4284941|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
1750186|NCT00046475|4284942|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
1750187|NCT00046475|4284943|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
1750188|NCT00046566|4284982|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1750189|NCT00046566|4284983|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1750190|NCT00046566|4284984|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
1750191|NCT00046566|4284982|P3|COMPLETED|Intervention 3 (8 Weeks)||88
1750192|NCT00046566|4284983|P2|COMPLETED|Intervention 3 (8 Weeks)||92
1750193|NCT00046566|4284984|P1|COMPLETED|Intervention 3 (8 Weeks)||93
1750194|NCT00046566|4284982|P3|STARTED|Intervention 3 (8 Weeks)||88
1750195|NCT00046566|4284983|P2|STARTED|Intervention 3 (8 Weeks)||92
1750196|NCT00046566|4284984|P1|STARTED|Intervention 3 (8 Weeks)||93
1750197|NCT00046566|4284982|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
1750198|NCT00046566|4284983|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
1750199|NCT00046566|4284984|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
1750200|NCT00046566|4284982|P3|COMPLETED|Intervention 2 (8 Weeks)||88
1750201|NCT00046566|4284983|P2|COMPLETED|Intervention 2 (8 Weeks)||92
1750202|NCT00046566|4284984|P1|COMPLETED|Intervention 2 (8 Weeks)||93
1750203|NCT00046566|4284982|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
1750204|NCT00046566|4284983|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
1750205|NCT00046566|4284984|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
1750206|NCT00046566|4284982|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
1750207|NCT00046566|4284983|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
1750208|NCT00046566|4284984|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
1750209|NCT00046566|4284982|P3|COMPLETED|Intervention 1 (8 Weeks)||101
1750210|NCT00046566|4284983|P2|COMPLETED|Intervention 1 (8 Weeks)||104
1750211|NCT00046566|4284984|P1|COMPLETED|Intervention 1 (8 Weeks)||101
1750212|NCT00046566|4284982|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
1750213|NCT00046566|4284983|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
1750214|NCT00046566|4284984|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
1750215|NCT00046228|4285001|P3|NOT COMPLETED|1 Year||12
1750216|NCT00046228|4285002|P2|NOT COMPLETED|1 Year||14
1750217|NCT00046228|4285003|P1|NOT COMPLETED|1 Year||19
1750218|NCT00046228|4285001|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
1750219|NCT00046228|4285002|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
1750220|NCT00046228|4285003|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
1750221|NCT00046228|4285001|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
1750222|NCT00046228|4285002|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
1750223|NCT00046228|4285003|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
1750224|NCT00046228|4285001|P3|NOT COMPLETED|90 Days||15
1750225|NCT00046228|4285002|P2|NOT COMPLETED|90 Days||8
1750226|NCT00046228|4285003|P1|NOT COMPLETED|90 Days||13
1750227|NCT00046228|4285001|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
1750228|NCT00046228|4285002|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
1750229|NCT00046228|4285003|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
1750230|NCT00046228|4285001|P3|STARTED|90 Days||828
1750231|NCT00046228|4285002|P2|STARTED|90 Days||818
1750232|NCT00046228|4285003|P1|STARTED|90 Days||806
1750233|NCT00045942|4285047|P9|NOT COMPLETED|PKC412A2104E2||6
1750234|NCT00045942|4285048|P8|NOT COMPLETED|PKC412A2104E2||7
1750235|NCT00045942|4285049|P7|NOT COMPLETED|PKC412A2104E2||7
1750236|NCT00045942|4285050|P6|NOT COMPLETED|PKC412A2104E2||9
1750237|NCT00045942|4285051|P5|NOT COMPLETED|PKC412A2104E2||0
1750238|NCT00045942|4285052|P4|NOT COMPLETED|PKC412A2104E2||0
1750239|NCT00045942|4285053|P3|NOT COMPLETED|PKC412A2104E2||0
1750240|NCT00045942|4285054|P2|NOT COMPLETED|PKC412A2104E2||0
1750241|NCT00045942|4285055|P1|NOT COMPLETED|PKC412A2104E2||0
1750242|NCT00045942|4285047|P9|COMPLETED|PKC412A2104E2||0
1750243|NCT00045942|4285048|P8|COMPLETED|PKC412A2104E2||0
1750244|NCT00045942|4285049|P7|COMPLETED|PKC412A2104E2||0
1750245|NCT00045942|4285050|P6|COMPLETED|PKC412A2104E2||0
1750246|NCT00045942|4285051|P5|COMPLETED|PKC412A2104E2||0
1750247|NCT00045942|4285052|P4|COMPLETED|PKC412A2104E2||0
1750248|NCT00045942|4285053|P3|COMPLETED|PKC412A2104E2||0
1750249|NCT00045942|4285054|P2|COMPLETED|PKC412A2104E2||0
1750250|NCT00045942|4285055|P1|COMPLETED|PKC412A2104E2||0
1750251|NCT00045942|4285047|P9|Primary Efficacy|PKC412A2104E2||6
1750252|NCT00045942|4285048|P8|Primary Efficacy|PKC412A2104E2||7
1750253|NCT00045942|4285049|P7|Primary Efficacy|PKC412A2104E2||7
1750254|NCT00045942|4285050|P6|Primary Efficacy|PKC412A2104E2||9
1750255|NCT00045942|4285051|P5|Primary Efficacy|PKC412A2104E2||0
1750256|NCT00045942|4285052|P4|Primary Efficacy|PKC412A2104E2||0
1750257|NCT00045942|4285053|P3|Primary Efficacy|PKC412A2104E2||0
1750258|NCT00045942|4285054|P2|Primary Efficacy|PKC412A2104E2||0
1750259|NCT00045942|4285055|P1|Primary Efficacy|PKC412A2104E2||0
1750260|NCT00045942|4285047|P9|STARTED|PKC412A2104E2||6
1750261|NCT00045942|4285048|P8|STARTED|PKC412A2104E2||7
1750262|NCT00045942|4285049|P7|STARTED|PKC412A2104E2||7
1750263|NCT00045942|4285050|P6|STARTED|PKC412A2104E2||9
1750264|NCT00045942|4285051|P5|STARTED|PKC412A2104E2||0
1750265|NCT00045942|4285052|P4|STARTED|PKC412A2104E2||0
1750266|NCT00045942|4285053|P3|STARTED|PKC412A2104E2||0
1750267|NCT00045942|4285054|P2|STARTED|PKC412A2104E2||0
1750268|NCT00045942|4285055|P1|STARTED|PKC412A2104E2||0
1750269|NCT00045942|4285047|P9|NOT COMPLETED|PKC412A2104E1||0
1750270|NCT00045942|4285048|P8|NOT COMPLETED|PKC412A2104E1||0
1750271|NCT00045942|4285049|P7|NOT COMPLETED|PKC412A2104E1||0
1750272|NCT00045942|4285050|P6|NOT COMPLETED|PKC412A2104E1||0
1750273|NCT00045942|4285051|P5|NOT COMPLETED|PKC412A2104E1||27
1750274|NCT00045942|4285052|P4|NOT COMPLETED|PKC412A2104E1||33
1750275|NCT00045942|4285053|P3|NOT COMPLETED|PKC412A2104E1||17
1750276|NCT00045942|4285054|P2|NOT COMPLETED|PKC412A2104E1||18
1750277|NCT00045942|4285055|P1|NOT COMPLETED|PKC412A2104E1||0
1750278|NCT00045942|4285047|P9|COMPLETED|PKC412A2104E1||0
1750279|NCT00045942|4285048|P8|COMPLETED|PKC412A2104E1||0
1750280|NCT00045942|4285049|P7|COMPLETED|PKC412A2104E1||0
1750281|NCT00045942|4285050|P6|COMPLETED|PKC412A2104E1||0
1750282|NCT00045942|4285051|P5|COMPLETED|PKC412A2104E1||0
1750283|NCT00045942|4285052|P4|COMPLETED|PKC412A2104E1||0
1750284|NCT00045942|4285053|P3|COMPLETED|PKC412A2104E1||0
1750285|NCT00045942|4285054|P2|COMPLETED|PKC412A2104E1||0
1750286|NCT00045942|4285055|P1|COMPLETED|PKC412A2104E1||0
1750287|NCT00045942|4285047|P9|Primary Efficacy|PKC412A2104E1||0
1750288|NCT00045942|4285048|P8|Primary Efficacy|PKC412A2104E1||0
1750289|NCT00045942|4285049|P7|Primary Efficacy|PKC412A2104E1||0
1750290|NCT00045942|4285050|P6|Primary Efficacy|PKC412A2104E1||0
1750291|NCT00045942|4285051|P5|Primary Efficacy|PKC412A2104E1||25
1750292|NCT00045942|4285052|P4|Primary Efficacy|PKC412A2104E1||32
1750293|NCT00045942|4285053|P3|Primary Efficacy|PKC412A2104E1||17
1750294|NCT00045942|4285054|P2|Primary Efficacy|PKC412A2104E1||18
1750295|NCT00045942|4285055|P1|Primary Efficacy|PKC412A2104E1||0
1750296|NCT00045942|4285047|P9|STARTED|PKC412A2104E1||0
1750297|NCT00045942|4285048|P8|STARTED|PKC412A2104E1||0
1750298|NCT00045942|4285049|P7|STARTED|PKC412A2104E1||0
1750299|NCT00045942|4285050|P6|STARTED|PKC412A2104E1||0
1750300|NCT00045942|4285051|P5|STARTED|PKC412A2104E1||27
1750301|NCT00045942|4285052|P4|STARTED|PKC412A2104E1||33
1750302|NCT00045942|4285053|P3|STARTED|PKC412A2104E1||17
1750303|NCT00045942|4285054|P2|STARTED|PKC412A2104E1||18
1750304|NCT00045942|4285055|P1|STARTED|PKC412A2104E1||0
1750305|NCT00045942|4285047|P9|NOT COMPLETED|PKC412A2104 (Core)||0
1750306|NCT00045942|4285048|P8|NOT COMPLETED|PKC412A2104 (Core)||0
1750307|NCT00045942|4285049|P7|NOT COMPLETED|PKC412A2104 (Core)||0
1750308|NCT00045942|4285050|P6|NOT COMPLETED|PKC412A2104 (Core)||0
1750309|NCT00045942|4285051|P5|NOT COMPLETED|PKC412A2104 (Core)||0
1750310|NCT00045942|4285052|P4|NOT COMPLETED|PKC412A2104 (Core)||0
1750311|NCT00045942|4285053|P3|NOT COMPLETED|PKC412A2104 (Core)||0
1750312|NCT00045942|4285054|P2|NOT COMPLETED|PKC412A2104 (Core)||0
1750313|NCT00045942|4285055|P1|NOT COMPLETED|PKC412A2104 (Core)||20
1750314|NCT00045942|4285047|P9|COMPLETED|PKC412A2104 (Core)||0
1750315|NCT00045942|4285048|P8|COMPLETED|PKC412A2104 (Core)||0
1750316|NCT00045942|4285049|P7|COMPLETED|PKC412A2104 (Core)||0
1750317|NCT00045942|4285050|P6|COMPLETED|PKC412A2104 (Core)||0
1750318|NCT00045942|4285051|P5|COMPLETED|PKC412A2104 (Core)||0
1750319|NCT00045942|4285052|P4|COMPLETED|PKC412A2104 (Core)||0
1750320|NCT00045942|4285053|P3|COMPLETED|PKC412A2104 (Core)||0
1750321|NCT00045942|4285054|P2|COMPLETED|PKC412A2104 (Core)||0
1750322|NCT00045942|4285055|P1|COMPLETED|PKC412A2104 (Core)||0
1750323|NCT00045942|4285047|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
1750324|NCT00045942|4285048|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
1750325|NCT00045942|4285049|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
1750326|NCT00045942|4285050|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
1750327|NCT00045942|4285051|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
1750328|NCT00045942|4285052|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
1750329|NCT00045942|4285053|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
1750330|NCT00045942|4285054|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
1750331|NCT00045942|4285055|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
1750332|NCT00045942|4285047|P9|STARTED|PKC412A2104 (Core)||0
1750333|NCT00045942|4285048|P8|STARTED|PKC412A2104 (Core)||0
1750334|NCT00045942|4285049|P7|STARTED|PKC412A2104 (Core)||0
1750335|NCT00045942|4285050|P6|STARTED|PKC412A2104 (Core)||0
1750336|NCT00045942|4285051|P5|STARTED|PKC412A2104 (Core)||0
1750337|NCT00045942|4285052|P4|STARTED|PKC412A2104 (Core)||0
1750338|NCT00045942|4285053|P3|STARTED|PKC412A2104 (Core)||0
1750339|NCT00045942|4285054|P2|STARTED|PKC412A2104 (Core)||0
1750340|NCT00045942|4285055|P1|STARTED|PKC412A2104 (Core)||20
1750341|NCT00044655|4285137|P2|NOT COMPLETED|Overall Study||38
1750342|NCT00044655|4285138|P1|NOT COMPLETED|Overall Study||20
1750343|NCT00044655|4285137|P2|COMPLETED|Overall Study||79
1750344|NCT00044655|4285138|P1|COMPLETED|Overall Study||82
1750345|NCT00044655|4285137|P2|STARTED|Overall Study||117
1750346|NCT00044655|4285138|P1|STARTED|Overall Study||102
1750347|NCT00044512|4285144|P1|NOT COMPLETED|Follow Up||2
1750348|NCT00044512|4285144|P1|COMPLETED|Follow Up||135
1750349|NCT00044512|4285144|P1|STARTED|Follow Up||137
1750350|NCT00044512|4285144|P1|NOT COMPLETED|Treatment||0
1750351|NCT00044512|4285144|P1|COMPLETED|Treatment||137
1750352|NCT00044512|4285144|P1|STARTED|Treatment||137
1750353|NCT00044213|4285159|P4|NOT COMPLETED|Overall Study||136
1750354|NCT00044213|4285160|P3|NOT COMPLETED|Overall Study||138
1750355|NCT00044213|4285161|P2|NOT COMPLETED|Overall Study||112
1750356|NCT00044213|4285162|P1|NOT COMPLETED|Overall Study||100
1750357|NCT00044213|4285159|P4|COMPLETED|Overall Study||301
1750358|NCT00044213|4285160|P3|COMPLETED|Overall Study||294
1750359|NCT00044213|4285161|P2|COMPLETED|Overall Study||306
1750360|NCT00044213|4285162|P1|COMPLETED|Overall Study||321
1750361|NCT00044213|4285159|P4|STARTED|Overall Study||437
1750362|NCT00044213|4285160|P3|STARTED|Overall Study||432
1750363|NCT00044213|4285161|P2|STARTED|Overall Study||418
1750364|NCT00044213|4285162|P1|STARTED|Overall Study||421
1750365|NCT00044044|4285181|P5|NOT COMPLETED|Overall Study||36
1750366|NCT00044044|4285182|P4|NOT COMPLETED|Overall Study||44
1750367|NCT00044044|4285183|P3|NOT COMPLETED|Overall Study||40
1750368|NCT00044044|4285184|P2|NOT COMPLETED|Overall Study||41
1750369|NCT00044044|4285185|P1|NOT COMPLETED|Overall Study||44
1750370|NCT00044044|4285181|P5|COMPLETED|Overall Study||36
1750371|NCT00044044|4285182|P4|COMPLETED|Overall Study||29
1750372|NCT00044044|4285183|P3|COMPLETED|Overall Study||31
1750373|NCT00044044|4285184|P2|COMPLETED|Overall Study||28
1750374|NCT00044044|4285185|P1|COMPLETED|Overall Study||27
1750375|NCT00044044|4285181|P5|STARTED|Overall Study||72
1750376|NCT00044044|4285182|P4|STARTED|Overall Study||73
1750377|NCT00044044|4285183|P3|STARTED|Overall Study||71
1750378|NCT00044044|4285184|P2|STARTED|Overall Study||69
1750379|NCT00044044|4285185|P1|STARTED|Overall Study||71
1750380|NCT00044005|4285215|P3|NOT COMPLETED|Overall Study||22
1750381|NCT00044005|4285216|P2|NOT COMPLETED|Overall Study||14
1750382|NCT00044005|4285217|P1|NOT COMPLETED|Overall Study||19
1750383|NCT00044005|4285215|P3|COMPLETED|Overall Study||11
1750384|NCT00044005|4285216|P2|COMPLETED|Overall Study||19
1750385|NCT00044005|4285217|P1|COMPLETED|Overall Study||13
1750386|NCT00044005|4285215|P3|STARTED|Overall Study||33
1750387|NCT00044005|4285216|P2|STARTED|Overall Study||33
1750388|NCT00044005|4285217|P1|STARTED|Overall Study||32
1750389|NCT00044083|4285227|P2|NOT COMPLETED|Second Intervention (One Week) Patients||1
1750390|NCT00044083|4285228|P1|NOT COMPLETED|Second Intervention (One Week) Patients||0
1750391|NCT00044083|4285227|P2|COMPLETED|Second Intervention (One Week) Patients||29
1750392|NCT00044083|4285228|P1|COMPLETED|Second Intervention (One Week) Patients||30
1750393|NCT00044083|4285227|P2|STARTED|Second Intervention (One Week) Patients||30
1750394|NCT00044083|4285228|P1|STARTED|Second Intervention (One Week) Patients||30
1750395|NCT00044083|4285227|P2|NOT COMPLETED|First Intervention (One Week) Patients||2
1750396|NCT00044083|4285228|P1|NOT COMPLETED|First Intervention (One Week) Patients||1
1750397|NCT00044083|4285227|P2|COMPLETED|First Intervention (One Week) Patients||30
1750398|NCT00044083|4285228|P1|COMPLETED|First Intervention (One Week) Patients||30
1750399|NCT00044083|4285227|P2|STARTED|First Intervention (One Week) Patients||32
1750400|NCT00044083|4285228|P1|STARTED|First Intervention (One Week) Patients||31
1750401|NCT00044083|4285227|P2|NOT COMPLETED|Second Intervention (One Week) HV's||0
1750402|NCT00044083|4285228|P1|NOT COMPLETED|Second Intervention (One Week) HV's||0
1750403|NCT00044083|4285227|P2|COMPLETED|Second Intervention (One Week) HV's||66
1750404|NCT00044083|4285228|P1|COMPLETED|Second Intervention (One Week) HV's||64
1750405|NCT00044083|4285227|P2|STARTED|Second Intervention (One Week) HV's||66
1750406|NCT00044083|4285228|P1|STARTED|Second Intervention (One Week) HV's||64
1750407|NCT00044083|4285227|P2|NOT COMPLETED|First Intervention (One Week)- HV's||7
1750408|NCT00044083|4285228|P1|NOT COMPLETED|First Intervention (One Week)- HV's||10
1750409|NCT00044083|4285227|P2|COMPLETED|First Intervention (One Week)- HV's||66
1750410|NCT00044083|4285228|P1|COMPLETED|First Intervention (One Week)- HV's||64
1750411|NCT00044083|4285227|P2|STARTED|First Intervention (One Week)- HV's||73
1750412|NCT00044083|4285228|P1|STARTED|First Intervention (One Week)- HV's||74
1750413|NCT00043979|4285266|P3|NOT COMPLETED|Period 2||0
1750414|NCT00043979|4285267|P2|NOT COMPLETED|Period 2||0
1750415|NCT00043979|4285268|P1|NOT COMPLETED|Period 2||0
1750416|NCT00043979|4285266|P3|COMPLETED|Period 2||10
1750417|NCT00043979|4285267|P2|COMPLETED|Period 2||13
1750418|NCT00043979|4285268|P1|COMPLETED|Period 2||0
1750419|NCT00043979|4285266|P3|STARTED|Period 2||10
1750420|NCT00043979|4285267|P2|STARTED|Period 2||13
1750421|NCT00043979|4285268|P1|STARTED|Period 2||0
1750422|NCT00043979|4285266|P3|NOT COMPLETED|Period 1||3
1750423|NCT00043979|4285267|P2|NOT COMPLETED|Period 1||4
1750424|NCT00043979|4285268|P1|NOT COMPLETED|Period 1||7
1750425|NCT00043979|4285266|P3|COMPLETED|Period 1||10
1750426|NCT00043979|4285267|P2|COMPLETED|Period 1||13
1750427|NCT00043979|4285268|P1|COMPLETED|Period 1||23
1750428|NCT00043979|4285266|P3|STARTED|Period 1||13
1750429|NCT00043979|4285267|P2|STARTED|Period 1||17
1750430|NCT00043979|4285268|P1|STARTED|Period 1||30
1750431|NCT00043550|4285289|P3|NOT COMPLETED|Overall Study||20
1750432|NCT00043550|4285290|P2|NOT COMPLETED|Overall Study||12
1750433|NCT00043550|4285291|P1|NOT COMPLETED|Overall Study||22
1750434|NCT00043550|4285289|P3|COMPLETED|Overall Study||30
1750435|NCT00043550|4285290|P2|COMPLETED|Overall Study||39
1750436|NCT00043550|4285291|P1|COMPLETED|Overall Study||33
1750437|NCT00043550|4285289|P3|Week 8 Completed|Overall Study||35
1750438|NCT00043550|4285290|P2|Week 8 Completed|Overall Study||40
1750439|NCT00043550|4285291|P1|Week 8 Completed|Overall Study||35
1750440|NCT00043550|4285289|P3|STARTED|Overall Study||50
1750441|NCT00043550|4285290|P2|STARTED|Overall Study||51
1750442|NCT00043550|4285291|P1|STARTED|Overall Study||55
1750443|NCT00043186|4285308|P9|NOT COMPLETED|Overall Study||17
1750444|NCT00043186|4285309|P8|NOT COMPLETED|Overall Study||16
1750445|NCT00043186|4285310|P7|NOT COMPLETED|Overall Study||17
1750446|NCT00043186|4285311|P6|NOT COMPLETED|Overall Study||8
1750447|NCT00043186|4285312|P5|NOT COMPLETED|Overall Study||18
1750448|NCT00043186|4285313|P4|NOT COMPLETED|Overall Study||22
1750449|NCT00043186|4285314|P3|NOT COMPLETED|Overall Study||20
1750450|NCT00043186|4285315|P2|NOT COMPLETED|Overall Study||15
1750451|NCT00043186|4285316|P1|NOT COMPLETED|Overall Study||17
1750452|NCT00043186|4285308|P9|COMPLETED|Overall Study||30
1750453|NCT00043186|4285309|P8|COMPLETED|Overall Study||31
1750454|NCT00043186|4285310|P7|COMPLETED|Overall Study||25
1750455|NCT00043186|4285311|P6|COMPLETED|Overall Study||39
1750456|NCT00043186|4285312|P5|COMPLETED|Overall Study||36
1750457|NCT00043186|4285313|P4|COMPLETED|Overall Study||19
1750458|NCT00043186|4285314|P3|COMPLETED|Overall Study||24
1750459|NCT00043186|4285315|P2|COMPLETED|Overall Study||29
1750460|NCT00043186|4285316|P1|COMPLETED|Overall Study||29
1750461|NCT00043186|4285308|P9|STARTED|Overall Study||47
1750462|NCT00043186|4285309|P8|STARTED|Overall Study||47
1750463|NCT00043186|4285310|P7|STARTED|Overall Study||42
1750464|NCT00043186|4285311|P6|STARTED|Overall Study||47
1750465|NCT00043186|4285312|P5|STARTED|Overall Study||54
1750466|NCT00043186|4285313|P4|STARTED|Overall Study||41
1750467|NCT00043186|4285314|P3|STARTED|Overall Study||44
1750468|NCT00043186|4285315|P2|STARTED|Overall Study||44
1750469|NCT00043186|4285316|P1|STARTED|Overall Study||46
1750470|NCT00042432|4285644|P2|NOT COMPLETED|Overall Study||7
1750471|NCT00042432|4285645|P1|NOT COMPLETED|Overall Study||9
1750472|NCT00042432|4285644|P2|COMPLETED|Overall Study||20
1750473|NCT00042432|4285645|P1|COMPLETED|Overall Study||18
1750474|NCT00042432|4285644|P2|STARTED|Overall Study||27
1750475|NCT00042432|4285645|P1|STARTED|Overall Study||27
1750476|NCT00042224|4285655|P2|NOT COMPLETED|Overall Study||3
1750477|NCT00042224|4285656|P1|NOT COMPLETED|Overall Study||3
1750478|NCT00042224|4285655|P2|COMPLETED|Overall Study||16
1750479|NCT00042224|4285656|P1|COMPLETED|Overall Study||17
1750480|NCT00042224|4285655|P2|STARTED|Overall Study||19
1750481|NCT00042224|4285656|P1|STARTED|Overall Study||20
1750482|NCT00041938|4285664|P2|NOT COMPLETED|Overall Study||31
1750483|NCT00041938|4285665|P1|NOT COMPLETED|Overall Study||38
1750484|NCT00041938|4285664|P2|COMPLETED|Overall Study||1111
1750485|NCT00041938|4285665|P1|COMPLETED|Overall Study||1125
1750486|NCT00041938|4285664|P2|Withdrew Consent|Overall Study||14
1750487|NCT00041938|4285665|P1|Withdrew Consent|Overall Study||20
1750488|NCT00041938|4285664|P2|Lost to Follow-up|Overall Study||17
1750489|NCT00041938|4285665|P1|Lost to Follow-up|Overall Study||18
1750490|NCT00041938|4285664|P2|Only Vital Status Known|Overall Study||46
1750491|NCT00041938|4285665|P1|Only Vital Status Known|Overall Study||44
1750492|NCT00041938|4285664|P2|Primary Endpoint|Overall Study||302
1750493|NCT00041938|4285665|P1|Primary Endpoint|Overall Study||320
1750494|NCT00041938|4285664|P2|Completed Follow-up|Overall Study||745
1750495|NCT00041938|4285665|P1|Completed Follow-up|Overall Study||761
1750496|NCT00041938|4285664|P2|STARTED|Overall Study||1142
1750497|NCT00041938|4285665|P1|STARTED|Overall Study||1163
1750498|NCT00041756|4285698|P5|NOT COMPLETED|Overall Study||60
1750499|NCT00041756|4285699|P4|NOT COMPLETED|Overall Study||16
1750500|NCT00041756|4285700|P3|NOT COMPLETED|Overall Study||13
1750501|NCT00041756|4285701|P2|NOT COMPLETED|Overall Study||15
1750502|NCT00041756|4285702|P1|NOT COMPLETED|Overall Study||8
1750503|NCT00041756|4285698|P5|COMPLETED|Overall Study||19
1750504|NCT00041756|4285699|P4|COMPLETED|Overall Study||64
1750505|NCT00041756|4285700|P3|COMPLETED|Overall Study||66
1750506|NCT00041756|4285701|P2|COMPLETED|Overall Study||65
1750507|NCT00041756|4285702|P1|COMPLETED|Overall Study||69
1750508|NCT00041756|4285698|P5|STARTED|Overall Study||79
1750509|NCT00041756|4285699|P4|STARTED|Overall Study||80
1750510|NCT00041756|4285700|P3|STARTED|Overall Study||79
1750511|NCT00041756|4285701|P2|STARTED|Overall Study||80
1750512|NCT00041756|4285702|P1|STARTED|Overall Study||77
1750513|NCT00041717|4285721|P2|NOT COMPLETED|Overall Study||12
1750514|NCT00041717|4285722|P1|NOT COMPLETED|Overall Study||33
1750515|NCT00041717|4285721|P2|COMPLETED|Overall Study||86
1750516|NCT00041717|4285722|P1|COMPLETED|Overall Study||81
1750517|NCT00041717|4285721|P2|STARTED|Overall Study||98
1750518|NCT00041717|4285722|P1|STARTED|Overall Study||114
1750519|NCT00041470|4285730|P1|NOT COMPLETED|Overall Study||38
1750520|NCT00041470|4285730|P1|COMPLETED|Overall Study||0
1750521|NCT00041470|4285730|P1|STARTED|Overall Study||38
1750522|NCT00040664|4285735|P4|NOT COMPLETED|Overall Study||27
1750523|NCT00040664|4285736|P3|NOT COMPLETED|Overall Study||13
1750524|NCT00040664|4285737|P2|NOT COMPLETED|Overall Study||13
1750525|NCT00040664|4285738|P1|NOT COMPLETED|Overall Study||53
1750526|NCT00040664|4285735|P4|COMPLETED|Overall Study||8
1750527|NCT00040664|4285736|P3|COMPLETED|Overall Study||4
1750528|NCT00040664|4285737|P2|COMPLETED|Overall Study||4
1750529|NCT00040664|4285738|P1|COMPLETED|Overall Study||16
1750530|NCT00040664|4285735|P4|STARTED|Overall Study||35
1750531|NCT00040664|4285736|P3|STARTED|Overall Study||17
1750532|NCT00040664|4285737|P2|STARTED|Overall Study||17
1750533|NCT00040664|4285738|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
1750534|NCT00041392|4285788|P2|NOT COMPLETED|Overall Study||0
1750535|NCT00041392|4285789|P1|NOT COMPLETED|Overall Study||0
1750536|NCT00041392|4285788|P2|COMPLETED|Overall Study||191
1750537|NCT00041392|4285789|P1|COMPLETED|Overall Study||198
1750538|NCT00041392|4285788|P2|STARTED|Overall Study||191
1750539|NCT00041392|4285789|P1|STARTED|Overall Study||198
1750540|NCT00040443|4285797|P2|NOT COMPLETED|Overall Study||0
1750541|NCT00040443|4285798|P1|NOT COMPLETED|Overall Study||0
1750542|NCT00040443|4285797|P2|COMPLETED|Overall Study||91
1750543|NCT00040443|4285798|P1|COMPLETED|Overall Study||84
1750544|NCT00040443|4285797|P2|STARTED|Overall Study||91
1750545|NCT00040443|4285798|P1|STARTED|Overall Study||84
1750546|NCT00040365|4285804|P1|NOT COMPLETED|Overall Study||11
1750547|NCT00040365|4285804|P1|COMPLETED|Overall Study||19
1750548|NCT00040365|4285804|P1|Completed Follow Up Phase|Overall Study||19
1750549|NCT00040365|4285804|P1|STARTED|Overall Study||30
1750550|NCT00039871|4285813|P1|NOT COMPLETED|Overall Study||1384
1750551|NCT00039871|4285813|P1|COMPLETED|Overall Study||928
1750552|NCT00039871|4285813|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
1750553|NCT00039741|4285823|P4|NOT COMPLETED|Overall Study||14
1750554|NCT00039741|4285824|P3|NOT COMPLETED|Overall Study||11
1750555|NCT00039741|4285825|P2|NOT COMPLETED|Overall Study||12
1750556|NCT00039741|4285826|P1|NOT COMPLETED|Overall Study||15
1750557|NCT00039741|4285823|P4|COMPLETED|Overall Study||50
1750558|NCT00039741|4285824|P3|COMPLETED|Overall Study||54
1750559|NCT00039741|4285825|P2|COMPLETED|Overall Study||56
1750560|NCT00039741|4285826|P1|COMPLETED|Overall Study||51
1750561|NCT00039741|4285823|P4|Death|Overall Study||0
1750562|NCT00039741|4285824|P3|Death|Overall Study||0
1750563|NCT00039741|4285825|P2|Death|Overall Study||1
1750564|NCT00039741|4285826|P1|Death|Overall Study||0
1750565|NCT00039741|4285823|P4|STARTED|Overall Study||64
1750566|NCT00039741|4285824|P3|STARTED|Overall Study||65
1750567|NCT00039741|4285825|P2|STARTED|Overall Study||68
1750568|NCT00039741|4285826|P1|STARTED|Overall Study||66
1750569|NCT00038948|4285870|P2|NOT COMPLETED|Overall Study||77
1750570|NCT00038948|4285871|P1|NOT COMPLETED|Overall Study||169
1750571|NCT00038948|4285870|P2|COMPLETED|Overall Study||198
1750572|NCT00038948|4285871|P1|COMPLETED|Overall Study||386
1750573|NCT00038948|4285870|P2|STARTED|Overall Study||275
1750574|NCT00038948|4285871|P1|STARTED|Overall Study||555
1750575|NCT00038857|4285883|P1|NOT COMPLETED|Overall Study||1
1750576|NCT00038857|4285883|P1|COMPLETED|Overall Study||28
1750577|NCT00038857|4285883|P1|STARTED|Overall Study||29
1750578|NCT00038727|4285890|P3|NOT COMPLETED|Overall Study||0
1750579|NCT00038727|4285891|P2|NOT COMPLETED|Overall Study||0
1750580|NCT00038727|4285892|P1|NOT COMPLETED|Overall Study||0
1750581|NCT00038727|4285890|P3|COMPLETED|Overall Study||936
1750582|NCT00038727|4285891|P2|COMPLETED|Overall Study||927
1750583|NCT00038727|4285892|P1|COMPLETED|Overall Study||916
1750584|NCT00038727|4285890|P3|DPPOS Phase 3 Enrolled|Overall Study||936
1750585|NCT00038727|4285891|P2|DPPOS Phase 3 Enrolled|Overall Study||927
1750586|NCT00038727|4285892|P1|DPPOS Phase 3 Enrolled|Overall Study||916
1750587|NCT00038727|4285890|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
1750588|NCT00038727|4285891|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
1750589|NCT00038727|4285892|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
1750590|NCT00038727|4285890|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
1750591|NCT00038727|4285891|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
1750592|NCT00038727|4285892|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
1750593|NCT00038727|4285890|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
1750594|NCT00038727|4285891|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
1750595|NCT00038727|4285892|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
1750596|NCT00038727|4285890|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
1750597|NCT00038727|4285891|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
1750598|NCT00038727|4285892|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
1750599|NCT00038649|4285903|P1|NOT COMPLETED|Overall Study||9
1750600|NCT00038649|4285903|P1|COMPLETED|Overall Study||105
1750601|NCT00038649|4285903|P1|STARTED|Overall Study||114
1750602|NCT00038610|4285908|P1|NOT COMPLETED|Overall Study||0
1750603|NCT00038610|4285908|P1|COMPLETED|Overall Study||54
1750604|NCT00038610|4285908|P1|STARTED|Overall Study||54
1750605|NCT00038467|4285916|P2|NOT COMPLETED|Overall Study||542
1750606|NCT00038467|4285917|P1|NOT COMPLETED|Overall Study||542
1750607|NCT00038467|4285916|P2|COMPLETED|Overall Study||1830
1750608|NCT00038467|4285917|P1|COMPLETED|Overall Study||1810
1750609|NCT00038467|4285916|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
1750610|NCT00038467|4285917|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
1750611|NCT00038467|4285916|P2|STARTED|Overall Study||2372
1750612|NCT00038467|4285917|P1|STARTED|Overall Study||2352
1750613|NCT00038103|4285979|P2|NOT COMPLETED|Overall Study||56
1750614|NCT00038103|4285980|P1|NOT COMPLETED|Overall Study||55
1750615|NCT00038103|4285979|P2|COMPLETED|Overall Study||0
1750616|NCT00038103|4285980|P1|COMPLETED|Overall Study||0
1750617|NCT00038103|4285979|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
1750618|NCT00038103|4285980|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
1750619|NCT00038103|4285979|P2|STARTED|Overall Study||56
1750620|NCT00038103|4285980|P1|STARTED|Overall Study||55
1750621|NCT00037830|4286003|P3|NOT COMPLETED|Overall Study||1
1750622|NCT00037830|4286004|P2|NOT COMPLETED|Overall Study||7
1750623|NCT00037830|4286005|P1|NOT COMPLETED|Overall Study||10
1750624|NCT00037830|4286003|P3|COMPLETED|Overall Study||16
1750625|NCT00037830|4286004|P2|COMPLETED|Overall Study||31
1750626|NCT00037830|4286005|P1|COMPLETED|Overall Study||29
1750627|NCT00037830|4286003|P3|STARTED|Overall Study||17
1750628|NCT00037830|4286004|P2|STARTED|Overall Study||38
1750629|NCT00037830|4286005|P1|STARTED|Overall Study||39
1750630|NCT00036569|4286026|P1|NOT COMPLETED|Overall Study||0
1750631|NCT00036569|4286026|P1|COMPLETED|Overall Study||32
1750632|NCT00036569|4286026|P1|STARTED|Overall Study||32
1750633|NCT00036270|4286037|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
1750634|NCT00036270|4286038|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
1750635|NCT00036270|4286037|P2|COMPLETED|Study Treatment to 5 Year Report||1380
1750636|NCT00036270|4286038|P1|COMPLETED|Study Treatment to 5 Year Report||2333
1750637|NCT00036270|4286037|P2|Treated|Study Treatment to 5 Year Report||4814
1750638|NCT00036270|4286038|P1|Treated|Study Treatment to 5 Year Report||4852
1750639|NCT00036270|4286037|P2|STARTED|Study Treatment to 5 Year Report||4868
1750640|NCT00036270|4286038|P1|STARTED|Study Treatment to 5 Year Report||4898
1750641|NCT00036270|4286037|P2|NOT COMPLETED|Randomized to Study Treatment||7
1750642|NCT00036270|4286038|P1|NOT COMPLETED|Randomized to Study Treatment||6
1750643|NCT00036270|4286037|P2|COMPLETED|Randomized to Study Treatment||4868
1750644|NCT00036270|4286038|P1|COMPLETED|Randomized to Study Treatment||4898
1750645|NCT00036270|4286037|P2|STARTED|Randomized to Study Treatment||4875
1750646|NCT00036270|4286038|P1|STARTED|Randomized to Study Treatment||4904
1750647|NCT00035932|4286057|P3|NOT COMPLETED|Overall Study||49
1750648|NCT00035932|4286058|P2|NOT COMPLETED|Overall Study||60
1750649|NCT00035932|4286059|P1|NOT COMPLETED|Overall Study||56
1750650|NCT00035932|4286057|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
1750651|NCT00035932|4286058|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
1750652|NCT00035932|4286059|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
1750653|NCT00035932|4286057|P3|Discontinued on or After Week 96|Overall Study||6
1750654|NCT00035932|4286058|P2|Discontinued on or After Week 96|Overall Study||4
1750655|NCT00035932|4286059|P1|Discontinued on or After Week 96|Overall Study||4
1750656|NCT00035932|4286057|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
1750657|NCT00035932|4286058|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
1750658|NCT00035932|4286059|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
1750659|NCT00035932|4286057|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
1750660|NCT00035932|4286058|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
1750661|NCT00035932|4286059|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
1750662|NCT00035932|4286057|P3|STARTED|Overall Study|123 randomized, 118 treated|118
1750663|NCT00035932|4286058|P2|STARTED|Overall Study|115 randomized, 110 treated|110
1750664|NCT00035932|4286059|P1|STARTED|Overall Study|120 randomized, 119 treated|119
1750665|NCT00035815|4286185|P2|NOT COMPLETED|Overall Study||11
1750666|NCT00035815|4286186|P1|NOT COMPLETED|Overall Study||17
1750667|NCT00035815|4286185|P2|COMPLETED|Overall Study||152
1750668|NCT00035815|4286186|P1|COMPLETED|Overall Study||150
1750669|NCT00035815|4286185|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
1750670|NCT00035815|4286186|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
1750671|NCT00035555|4286199|P3|NOT COMPLETED|Overall Study||22
1750672|NCT00035555|4286200|P2|NOT COMPLETED|Overall Study||16
1750673|NCT00035555|4286201|P1|NOT COMPLETED|Overall Study||16
1750674|NCT00035555|4286199|P3|COMPLETED|Overall Study||51
1750675|NCT00035555|4286200|P2|COMPLETED|Overall Study||55
1750676|NCT00035555|4286201|P1|COMPLETED|Overall Study||58
1750677|NCT00035555|4286199|P3|Number Who Received Study Drug|Overall Study||71
1750678|NCT00035555|4286200|P2|Number Who Received Study Drug|Overall Study||71
1750679|NCT00035555|4286201|P1|Number Who Received Study Drug|Overall Study||74
1750680|NCT00035555|4286199|P3|Number Who Had Undergone Transplantation|Overall Study||73
1750681|NCT00035555|4286200|P2|Number Who Had Undergone Transplantation|Overall Study||71
1750682|NCT00035555|4286201|P1|Number Who Had Undergone Transplantation|Overall Study||74
1750683|NCT00035555|4286199|P3|STARTED|Overall Study|Randomized patients|73
1750684|NCT00035555|4286200|P2|STARTED|Overall Study|Randomized patients|71
1750685|NCT00035555|4286201|P1|STARTED|Overall Study|Randomized patients|74
1750686|NCT00033917|4286244|P2|NOT COMPLETED|Overall Study||0
1750687|NCT00033917|4286245|P1|NOT COMPLETED|Overall Study||0
1750688|NCT00033917|4286244|P2|COMPLETED|Overall Study||222
1750689|NCT00033917|4286245|P1|COMPLETED|Overall Study||209
1750690|NCT00033917|4286244|P2|STARTED|Overall Study||222
1750691|NCT00033917|4286245|P1|STARTED|Overall Study||209
1750692|NCT00032630|4286257|P2|NOT COMPLETED|Overall Study||43
1750693|NCT00032630|4286258|P1|NOT COMPLETED|Overall Study||49
1750694|NCT00032630|4286257|P2|COMPLETED|Overall Study||1061
1750695|NCT00032630|4286258|P1|COMPLETED|Overall Study||1050
1750696|NCT00032630|4286257|P2|STARTED|Overall Study||1104
1750697|NCT00032630|4286258|P1|STARTED|Overall Study||1099
1750698|NCT00032591|4286268|P2|NOT COMPLETED|Follow-up||5
1750699|NCT00032591|4286269|P1|NOT COMPLETED|Follow-up||2
1750700|NCT00032591|4286268|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
1750701|NCT00032591|4286269|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
1750702|NCT00032591|4286268|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
1750703|NCT00032591|4286269|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
1750704|NCT00032591|4286268|P2|NOT COMPLETED|Randomization||0
1750705|NCT00032591|4286269|P1|NOT COMPLETED|Randomization||0
1750706|NCT00032591|4286268|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
1750707|NCT00032591|4286269|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
1750708|NCT00032591|4286268|P2|STARTED|Randomization||1457
1750709|NCT00032591|4286269|P1|STARTED|Randomization|2922 underwent randomization|1465
1750710|NCT00032591|4286268|P2|NOT COMPLETED|Screening||415
1750711|NCT00032591|4286269|P1|NOT COMPLETED|Screening||408
1750712|NCT00032591|4286268|P2|COMPLETED|Screening||1457
1750713|NCT00032591|4286269|P1|COMPLETED|Screening|823 were excluded from the study|1465
1750714|NCT00032591|4286268|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
1750715|NCT00032591|4286269|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
1750716|NCT00032487|4286285|P2|NOT COMPLETED|Overall Study||120
1750717|NCT00032487|4286286|P1|NOT COMPLETED|Overall Study||139
1750718|NCT00032487|4286285|P2|COMPLETED|Overall Study||772
1750719|NCT00032487|4286286|P1|COMPLETED|Overall Study||760
1750720|NCT00032487|4286285|P2|STARTED|Overall Study||892
1750721|NCT00032487|4286286|P1|STARTED|Overall Study||899
1750722|NCT00031551|4286296|P2|NOT COMPLETED|Overall Study||0
1750723|NCT00031551|4286297|P1|NOT COMPLETED|Overall Study||2
1750724|NCT00031551|4286296|P2|COMPLETED|Overall Study||25
1750725|NCT00031551|4286297|P1|COMPLETED|Overall Study||0
1750726|NCT00031551|4286296|P2|STARTED|Overall Study||25
1750727|NCT00031551|4286297|P1|STARTED|Overall Study||2
1750728|NCT00031486|4286309|P2|NOT COMPLETED|Overall Study||12
1750729|NCT00031486|4286310|P1|NOT COMPLETED|Overall Study||7
1750730|NCT00031486|4286309|P2|COMPLETED|Overall Study||35
1750731|NCT00031486|4286310|P1|COMPLETED|Overall Study||33
1750732|NCT00031486|4286309|P2|STARTED|Overall Study||47
1750733|NCT00031486|4286310|P1|STARTED|Overall Study||40
1750734|NCT00031460|4286336|P2|NOT COMPLETED|Overall Study||14
1750735|NCT00031460|4286337|P1|NOT COMPLETED|Overall Study||9
1750736|NCT00031460|4286336|P2|COMPLETED|Overall Study||8
1750737|NCT00031460|4286337|P1|COMPLETED|Overall Study||15
1750738|NCT00031460|4286336|P2|STARTED|Overall Study||22
1750739|NCT00031460|4286337|P1|STARTED|Overall Study||24
1750740|NCT00031447|4286351|P2|NOT COMPLETED|Overall Study||7
1750741|NCT00031447|4286352|P1|NOT COMPLETED|Overall Study||10
1750742|NCT00031447|4286351|P2|COMPLETED|Overall Study||8
1750743|NCT00031447|4286352|P1|COMPLETED|Overall Study||4
1750744|NCT00031447|4286351|P2|STARTED|Overall Study||15
1750745|NCT00031447|4286352|P1|STARTED|Overall Study||14
1750746|NCT00030992|4286364|P1|NOT COMPLETED|Overall Study||0
1750747|NCT00030992|4286364|P1|COMPLETED|Overall Study||102
1750748|NCT00030992|4286364|P1|STARTED|Overall Study||102
1750749|NCT00030147|4286373|P4|NOT COMPLETED|Overall Study||0
1750750|NCT00030147|4286374|P3|NOT COMPLETED|Overall Study||0
1750751|NCT00030147|4286375|P2|NOT COMPLETED|Overall Study||1
1750752|NCT00030147|4286376|P1|NOT COMPLETED|Overall Study||0
1750753|NCT00030147|4286373|P4|COMPLETED|Overall Study||11
1750754|NCT00030147|4286374|P3|COMPLETED|Overall Study||16
1750755|NCT00030147|4286375|P2|COMPLETED|Overall Study||18
1750756|NCT00030147|4286376|P1|COMPLETED|Overall Study||17
1750757|NCT00030147|4286373|P4|STARTED|Overall Study||11
1750758|NCT00030147|4286374|P3|STARTED|Overall Study||16
1750759|NCT00030147|4286375|P2|STARTED|Overall Study||19
1750760|NCT00030147|4286376|P1|STARTED|Overall Study||17
1750761|NCT00029536|4286394|P4|NOT COMPLETED|Overall Study||0
1750762|NCT00029536|4286395|P3|NOT COMPLETED|Overall Study||0
1750763|NCT00029536|4286396|P2|NOT COMPLETED|Overall Study||0
1750764|NCT00029536|4286397|P1|NOT COMPLETED|Overall Study||0
1750765|NCT00029536|4286394|P4|COMPLETED|Overall Study||59
1750766|NCT00029536|4286395|P3|COMPLETED|Overall Study||105
1750767|NCT00029536|4286396|P2|COMPLETED|Overall Study||45
1750768|NCT00029536|4286397|P1|COMPLETED|Overall Study||85
1750769|NCT00029536|4286394|P4|STARTED|Overall Study||59
1750770|NCT00029536|4286395|P3|STARTED|Overall Study||105
1750771|NCT00029536|4286396|P2|STARTED|Overall Study||45
1750772|NCT00029536|4286397|P1|STARTED|Overall Study||85
1750773|NCT00029172|4286421|P1|NOT COMPLETED|Overall Study||6
1750774|NCT00029172|4286421|P1|COMPLETED|Overall Study||182
1750775|NCT00029172|4286421|P1|STARTED|Overall Study||188
1750776|NCT00029146|4286427|P2|NOT COMPLETED|Overall Study||1
1750777|NCT00029146|4286428|P1|NOT COMPLETED|Overall Study||2
1750778|NCT00029146|4286427|P2|COMPLETED|Overall Study||97
1750779|NCT00029146|4286428|P1|COMPLETED|Overall Study||95
1750780|NCT00029146|4286427|P2|STARTED|Overall Study||98
1750781|NCT00029146|4286428|P1|STARTED|Overall Study||97
1750782|NCT00029107|4286457|P2|NOT COMPLETED|Overall Study||0
1750783|NCT00029107|4286458|P1|NOT COMPLETED|Overall Study||0
1750784|NCT00029107|4286457|P2|COMPLETED|Overall Study||12
1750785|NCT00029107|4286458|P1|COMPLETED|Overall Study||12
1750786|NCT00029107|4286457|P2|STARTED|Overall Study||12
1750787|NCT00029107|4286458|P1|STARTED|Overall Study||12
1750788|NCT00028262|4286464|P1|NOT COMPLETED|Overall Study||1
1750789|NCT00028262|4286464|P1|COMPLETED|Overall Study||9
1750790|NCT00028262|4286464|P1|STARTED|Overall Study||10
1750791|NCT00028093|4286470|P2|NOT COMPLETED|Overall Study||0
1750792|NCT00028093|4286471|P1|NOT COMPLETED|Overall Study||0
1750793|NCT00028093|4286470|P2|COMPLETED|Overall Study||25
1750794|NCT00028093|4286471|P1|COMPLETED|Overall Study||25
1750795|NCT00028093|4286470|P2|STARTED|Overall Study||25
1750796|NCT00028093|4286471|P1|STARTED|Overall Study||25
1750797|NCT00027378|4286479|P2|NOT COMPLETED|Overall Study||3
1750798|NCT00027378|4286480|P1|NOT COMPLETED|Overall Study||0
1750799|NCT00027378|4286479|P2|COMPLETED|Overall Study||23
1750800|NCT00027378|4286480|P1|COMPLETED|Overall Study||24
1750801|NCT00027378|4286479|P2|STARTED|Overall Study||26
1750802|NCT00027378|4286480|P1|STARTED|Overall Study||24
1750803|NCT00027027|4286493|P5|NOT COMPLETED|Overall Study||8
1750804|NCT00027027|4286494|P4|NOT COMPLETED|Overall Study||3
1750805|NCT00027027|4286495|P3|NOT COMPLETED|Overall Study||4
1750806|NCT00027027|4286496|P2|NOT COMPLETED|Overall Study||3
1750807|NCT00027027|4286497|P1|NOT COMPLETED|Overall Study||3
1750808|NCT00027027|4286493|P5|COMPLETED|Overall Study||0
1750809|NCT00027027|4286494|P4|COMPLETED|Overall Study||0
1750810|NCT00027027|4286495|P3|COMPLETED|Overall Study||0
1750811|NCT00027027|4286496|P2|COMPLETED|Overall Study||0
1750812|NCT00027027|4286497|P1|COMPLETED|Overall Study||0
1750813|NCT00027027|4286493|P5|Treated Beyond Cycle 2|Overall Study||4
1750814|NCT00027027|4286494|P4|Treated Beyond Cycle 2|Overall Study||2
1750815|NCT00027027|4286495|P3|Treated Beyond Cycle 2|Overall Study||2
1750816|NCT00027027|4286496|P2|Treated Beyond Cycle 2|Overall Study||1
1750817|NCT00027027|4286497|P1|Treated Beyond Cycle 2|Overall Study||1
1750818|NCT00027027|4286493|P5|Discontinued at Cycle 2|Overall Study||3
1750819|NCT00027027|4286494|P4|Discontinued at Cycle 2|Overall Study||1
1750820|NCT00027027|4286495|P3|Discontinued at Cycle 2|Overall Study||1
1750821|NCT00027027|4286496|P2|Discontinued at Cycle 2|Overall Study||2
1750822|NCT00027027|4286497|P1|Discontinued at Cycle 2|Overall Study||2
1750823|NCT00027027|4286493|P5|Completed 2 Cycles of Treatment|Overall Study||7
1750824|NCT00027027|4286494|P4|Completed 2 Cycles of Treatment|Overall Study||3
1750825|NCT00027027|4286495|P3|Completed 2 Cycles of Treatment|Overall Study||3
1750826|NCT00027027|4286496|P2|Completed 2 Cycles of Treatment|Overall Study||3
1750827|NCT00027027|4286497|P1|Completed 2 Cycles of Treatment|Overall Study||3
1750828|NCT00027027|4286493|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
1750829|NCT00027027|4286494|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
1750830|NCT00027027|4286495|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
1750831|NCT00027027|4286496|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
1750832|NCT00027027|4286497|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
1750833|NCT00027027|4286493|P5|STARTED|Overall Study||8
1750834|NCT00027027|4286494|P4|STARTED|Overall Study||3
1750835|NCT00027027|4286495|P3|STARTED|Overall Study||4
1750836|NCT00027027|4286496|P2|STARTED|Overall Study||3
1750837|NCT00027027|4286497|P1|STARTED|Overall Study||3
1750838|NCT00025883|4286544|P1|NOT COMPLETED|Overall Study||17
1750839|NCT00025883|4286544|P1|COMPLETED|Overall Study||86
1750840|NCT00025883|4286544|P1|Partial Lipodystrophy|Overall Study||40
1750841|NCT00025883|4286544|P1|Generalized Lipodystrophy|Overall Study||63
1750842|NCT00025883|4286544|P1|STARTED|Overall Study||103
1750843|NCT00023595|4286556|P5|NOT COMPLETED|10 Year Follow up||0
1750844|NCT00023595|4286557|P4|NOT COMPLETED|10 Year Follow up||0
1750845|NCT00023595|4286558|P3|NOT COMPLETED|10 Year Follow up||3
1750846|NCT00023595|4286559|P2|NOT COMPLETED|10 Year Follow up||10
1750847|NCT00023595|4286560|P1|NOT COMPLETED|10 Year Follow up||12
1750848|NCT00023595|4286556|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
1750849|NCT00023595|4286557|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
1750850|NCT00023595|4286558|P3|COMPLETED|10 Year Follow up||73
1750851|NCT00023595|4286559|P2|COMPLETED|10 Year Follow up||524
1750852|NCT00023595|4286560|P1|COMPLETED|10 Year Follow up||590
1750853|NCT00023595|4286556|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
1750943|NCT00006604|4286889|P7|COMPLETED|Overall Study||12
1750854|NCT00023595|4286557|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
1750855|NCT00023595|4286558|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
1750856|NCT00023595|4286559|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
1750857|NCT00023595|4286560|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
1750858|NCT00023595|4286556|P5|NOT COMPLETED|5 Year Follow up||3
1750859|NCT00023595|4286557|P4|NOT COMPLETED|5 Year Follow up||7
1750860|NCT00023595|4286558|P3|NOT COMPLETED|5 Year Follow up||1
1750861|NCT00023595|4286559|P2|NOT COMPLETED|5 Year Follow up||2
1750862|NCT00023595|4286560|P1|NOT COMPLETED|5 Year Follow up||2
1750863|NCT00023595|4286556|P5|COMPLETED|5 Year Follow up||498
1750864|NCT00023595|4286557|P4|COMPLETED|5 Year Follow up||416
1750865|NCT00023595|4286558|P3|COMPLETED|5 Year Follow up||75
1750866|NCT00023595|4286559|P2|COMPLETED|5 Year Follow up||532
1750867|NCT00023595|4286560|P1|COMPLETED|5 Year Follow up||600
1750868|NCT00023595|4286556|P5|STARTED|5 Year Follow up||501
1750869|NCT00023595|4286557|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
1750870|NCT00023595|4286558|P3|STARTED|5 Year Follow up||76
1750871|NCT00023595|4286559|P2|STARTED|5 Year Follow up||534
1750872|NCT00023595|4286560|P1|STARTED|5 Year Follow up||602
1750873|NCT00023452|4286771|P2|NOT COMPLETED|Overall Study||872
1750874|NCT00023452|4286772|P1|NOT COMPLETED|Overall Study||1323
1750875|NCT00023452|4286771|P2|COMPLETED|Overall Study||3273
1750876|NCT00023452|4286772|P1|COMPLETED|Overall Study||2585
1750877|NCT00023452|4286771|P2|Completed Study|Overall Study||3475
1750878|NCT00023452|4286772|P1|Completed Study|Overall Study||3174
1750879|NCT00023452|4286771|P2|Not Treated|Overall Study||105
1750880|NCT00023452|4286772|P1|Not Treated|Overall Study||149
1750881|NCT00023452|4286771|P2|Completed Treatment|Overall Study||3273
1750882|NCT00023452|4286772|P1|Completed Treatment|Overall Study||2585
1750883|NCT00023452|4286771|P2|Enrolled as Part of a Cluster|Overall Study||971
1750884|NCT00023452|4286772|P1|Enrolled as Part of a Cluster|Overall Study||718
1750885|NCT00023452|4286771|P2|Randomized|Overall Study||3174
1750886|NCT00023452|4286772|P1|Randomized|Overall Study||3190
1750887|NCT00023452|4286771|P2|STARTED|Overall Study||4145
1750888|NCT00023452|4286772|P1|STARTED|Overall Study||3908
1750889|NCT00023322|4286796|P1|NOT COMPLETED|Overall Study||1
1750890|NCT00023322|4286796|P1|COMPLETED|Overall Study||12
1750891|NCT00023322|4286796|P1|STARTED|Overall Study||13
1750892|NCT00023309|4286803|P2|NOT COMPLETED|Overall Study||0
1750893|NCT00023309|4286804|P1|NOT COMPLETED|Overall Study||0
1750894|NCT00023309|4286803|P2|COMPLETED|Overall Study||19
1750895|NCT00023309|4286804|P1|COMPLETED|Overall Study||22
1750896|NCT00023309|4286803|P2|STARTED|Overall Study||19
1750897|NCT00023309|4286804|P1|STARTED|Overall Study||22
1750898|NCT00022763|4286820|P2|NOT COMPLETED|Overall Study||17
1750899|NCT00022763|4286821|P1|NOT COMPLETED|Overall Study||9
1750900|NCT00022763|4286820|P2|COMPLETED|Overall Study||11
1750901|NCT00022763|4286821|P1|COMPLETED|Overall Study||15
1750902|NCT00022763|4286820|P2|STARTED|Overall Study||28
1750903|NCT00022763|4286821|P1|STARTED|Overall Study||24
1750904|NCT00016718|4286847|P3|NOT COMPLETED|Overall Study||0
1750905|NCT00016718|4286848|P2|NOT COMPLETED|Overall Study||0
1750906|NCT00016718|4286849|P1|NOT COMPLETED|Overall Study||0
1750907|NCT00016718|4286847|P3|COMPLETED|Overall Study||16
1750908|NCT00016718|4286848|P2|COMPLETED|Overall Study||21
1750909|NCT00016718|4286849|P1|COMPLETED|Overall Study||6
1750910|NCT00016718|4286847|P3|STARTED|Overall Study||16
1750911|NCT00016718|4286848|P2|STARTED|Overall Study||21
1750912|NCT00016718|4286849|P1|STARTED|Overall Study||6
1750913|NCT00014911|4286863|P1|NOT COMPLETED|Overall Study||11
1750914|NCT00014911|4286863|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
1750915|NCT00014911|4286863|P1|STARTED|Overall Study||36
1750916|NCT00006604|4286879|P17|NOT COMPLETED|Overall Study||9
1750917|NCT00006604|4286880|P16|NOT COMPLETED|Overall Study||5
1750918|NCT00006604|4286881|P15|NOT COMPLETED|Overall Study||10
1750919|NCT00006604|4286882|P14|NOT COMPLETED|Overall Study||6
1750920|NCT00006604|4286883|P13|NOT COMPLETED|Overall Study||4
1750921|NCT00006604|4286884|P12|NOT COMPLETED|Overall Study||6
1750922|NCT00006604|4286885|P11|NOT COMPLETED|Overall Study||8
1750923|NCT00006604|4286886|P10|NOT COMPLETED|Overall Study||19
1750924|NCT00006604|4286887|P9|NOT COMPLETED|Overall Study||1
1750925|NCT00006604|4286888|P8|NOT COMPLETED|Overall Study||3
1750926|NCT00006604|4286889|P7|NOT COMPLETED|Overall Study||9
1750927|NCT00006604|4286890|P6|NOT COMPLETED|Overall Study||3
1750928|NCT00006604|4286891|P5|NOT COMPLETED|Overall Study||2
1750929|NCT00006604|4286892|P4|NOT COMPLETED|Overall Study||5
1750930|NCT00006604|4286893|P3|NOT COMPLETED|Overall Study||4
1750931|NCT00006604|4286894|P2|NOT COMPLETED|Overall Study||0
1750932|NCT00006604|4286895|P1|NOT COMPLETED|Overall Study||2
1750933|NCT00006604|4286879|P17|COMPLETED|Overall Study||6
1750934|NCT00006604|4286880|P16|COMPLETED|Overall Study||1
1750935|NCT00006604|4286881|P15|COMPLETED|Overall Study||14
1750936|NCT00006604|4286882|P14|COMPLETED|Overall Study||0
1750937|NCT00006604|4286883|P13|COMPLETED|Overall Study||22
1750938|NCT00006604|4286884|P12|COMPLETED|Overall Study||6
1750939|NCT00006604|4286885|P11|COMPLETED|Overall Study||13
1750940|NCT00006604|4286886|P10|COMPLETED|Overall Study||6
1750941|NCT00006604|4286887|P9|COMPLETED|Overall Study||4
1750942|NCT00006604|4286888|P8|COMPLETED|Overall Study||2
1750944|NCT00006604|4286890|P6|COMPLETED|Overall Study||2
1750945|NCT00006604|4286891|P5|COMPLETED|Overall Study||3
1750946|NCT00006604|4286892|P4|COMPLETED|Overall Study||1
1750947|NCT00006604|4286893|P3|COMPLETED|Overall Study||1
1750948|NCT00006604|4286894|P2|COMPLETED|Overall Study||2
1750949|NCT00006604|4286895|P1|COMPLETED|Overall Study||4
1750950|NCT00006604|4286879|P17|STARTED|Overall Study||15
1750951|NCT00006604|4286880|P16|STARTED|Overall Study||6
1750952|NCT00006604|4286881|P15|STARTED|Overall Study||24
1750953|NCT00006604|4286882|P14|STARTED|Overall Study||6
1750954|NCT00006604|4286883|P13|STARTED|Overall Study||26
1750955|NCT00006604|4286884|P12|STARTED|Overall Study||12
1750956|NCT00006604|4286885|P11|STARTED|Overall Study||21
1750957|NCT00006604|4286886|P10|STARTED|Overall Study||25
1750958|NCT00006604|4286887|P9|STARTED|Overall Study||5
1750959|NCT00006604|4286888|P8|STARTED|Overall Study||5
1750960|NCT00006604|4286889|P7|STARTED|Overall Study||21
1750961|NCT00006604|4286890|P6|STARTED|Overall Study||5
1750962|NCT00006604|4286891|P5|STARTED|Overall Study||5
1750963|NCT00006604|4286892|P4|STARTED|Overall Study||6
1750964|NCT00006604|4286893|P3|STARTED|Overall Study||5
1750965|NCT00006604|4286894|P2|STARTED|Overall Study||2
1750966|NCT00006604|4286895|P1|STARTED|Overall Study||6
1750967|NCT00004978|4287011|P2|NOT COMPLETED|Overall Study||270
1750968|NCT00004978|4287012|P1|NOT COMPLETED|Overall Study||244
1750969|NCT00004978|4287011|P2|COMPLETED|Overall Study||1790
1750970|NCT00004978|4287012|P1|COMPLETED|Overall Study||1846
1750971|NCT00004978|4287011|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
1750972|NCT00004978|4287012|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
1750973|NCT00021541|4287038|P2|NOT COMPLETED|Period 2-crossover||11
1750974|NCT00021541|4287039|P1|NOT COMPLETED|Period 2-crossover||10
1750975|NCT00021541|4287038|P2|COMPLETED|Period 2-crossover||12
1750976|NCT00021541|4287039|P1|COMPLETED|Period 2-crossover||10
1750977|NCT00021541|4287038|P2|STARTED|Period 2-crossover||23
1750978|NCT00021541|4287039|P1|STARTED|Period 2-crossover||20
1750979|NCT00021541|4287038|P2|NOT COMPLETED|Period 1-First Treatment||8
1750980|NCT00021541|4287039|P1|NOT COMPLETED|Period 1-First Treatment||11
1750981|NCT00021541|4287038|P2|COMPLETED|Period 1-First Treatment||23
1750982|NCT00021541|4287039|P1|COMPLETED|Period 1-First Treatment||20
1750983|NCT00021541|4287038|P2|Ineligible Patients|Period 1-First Treatment||2
1750984|NCT00021541|4287039|P1|Ineligible Patients|Period 1-First Treatment||0
1750985|NCT00021541|4287038|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
1750986|NCT00021541|4287039|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
1750987|NCT00021541|4287038|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
1750988|NCT00021541|4287039|P1|STARTED|Period 1-First Treatment||31
1750989|NCT00018031|4287049|P1|NOT COMPLETED|Overall Study||0
1750990|NCT00018031|4287049|P1|COMPLETED|Overall Study||36
1750991|NCT00018031|4287049|P1|STARTED|Overall Study||36
1750992|NCT00015457|4287053|P2|NOT COMPLETED|Second Intervention||0
1750993|NCT00015457|4287054|P1|NOT COMPLETED|Second Intervention||1
1750994|NCT00015457|4287053|P2|COMPLETED|Second Intervention||5
1750995|NCT00015457|4287054|P1|COMPLETED|Second Intervention||7
1750996|NCT00015457|4287053|P2|STARTED|Second Intervention||5
1750997|NCT00015457|4287054|P1|STARTED|Second Intervention||8
1750998|NCT00015457|4287053|P2|NOT COMPLETED|First Intervention||3
1750999|NCT00015457|4287054|P1|NOT COMPLETED|First Intervention||0
1751000|NCT00015457|4287053|P2|COMPLETED|First Intervention||5
1751001|NCT00015457|4287054|P1|COMPLETED|First Intervention||8
1751002|NCT00015457|4287053|P2|STARTED|First Intervention||8
1751003|NCT00015457|4287054|P1|STARTED|First Intervention||8
1751004|NCT00013611|4287064|P2|NOT COMPLETED|Overall Study||100
1751005|NCT00013611|4287065|P1|NOT COMPLETED|Overall Study||91
1751006|NCT00013611|4287064|P2|COMPLETED|Overall Study||746
1751007|NCT00013611|4287065|P1|COMPLETED|Overall Study||758
1751008|NCT00013611|4287064|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
1751009|NCT00013611|4287065|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
1751010|NCT00010803|4287083|P2|NOT COMPLETED|Overall Study||98
1751011|NCT00010803|4287084|P1|NOT COMPLETED|Overall Study||97
1751012|NCT00010803|4287083|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
1751013|NCT00010803|4287084|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
1751014|NCT00010803|4287083|P2|STARTED|Overall Study|Randomized|1524
1751015|NCT00010803|4287084|P1|STARTED|Overall Study|Randomized|1545
1751016|NCT00010439|4287094|P1|NOT COMPLETED|Overall Study||0
1751017|NCT00010439|4287094|P1|COMPLETED|Overall Study||10
1751018|NCT00010439|4287094|P1|6 Months|Overall Study||10
1751019|NCT00010439|4287094|P1|STARTED|Overall Study||10
1751020|NCT00007644|4287101|P2|NOT COMPLETED|Overall Study||0
1751021|NCT00007644|4287102|P1|NOT COMPLETED|Overall Study||0
1751022|NCT00007644|4287101|P2|COMPLETED|Overall Study||367
1751023|NCT00007644|4287102|P1|COMPLETED|Overall Study||364
1751024|NCT00007644|4287101|P2|STARTED|Overall Study||367
1751025|NCT00007644|4287102|P1|STARTED|Overall Study||364
1751026|NCT00007475|4287111|P4|NOT COMPLETED|Overall Study||0
1751027|NCT00007475|4287112|P3|NOT COMPLETED|Overall Study||0
1751028|NCT00007475|4287113|P2|NOT COMPLETED|Overall Study||0
1751029|NCT00007475|4287114|P1|NOT COMPLETED|Overall Study||4
1751030|NCT00007475|4287111|P4|COMPLETED|Overall Study||0
1751031|NCT00007475|4287112|P3|COMPLETED|Overall Study||2
1751032|NCT00007475|4287113|P2|COMPLETED|Overall Study||1
1751033|NCT00007475|4287114|P1|COMPLETED|Overall Study||8
1751034|NCT00007475|4287111|P4|Initiate Cyclophosphamide|Overall Study||0
1751035|NCT00007475|4287112|P3|Initiate Cyclophosphamide|Overall Study||2
1751036|NCT00007475|4287113|P2|Initiate Cyclophosphamide|Overall Study||1
1751037|NCT00007475|4287114|P1|Initiate Cyclophosphamide|Overall Study||12
1751038|NCT00007475|4287111|P4|Initial Plasma Exchange|Overall Study||0
1751039|NCT00007475|4287112|P3|Initial Plasma Exchange|Overall Study||2
1751040|NCT00007475|4287113|P2|Initial Plasma Exchange|Overall Study||1
1751041|NCT00007475|4287114|P1|Initial Plasma Exchange|Overall Study||12
1751042|NCT00007475|4287111|P4|Post-initial Transplant Proteinuria|Overall Study||0
1751043|NCT00007475|4287112|P3|Post-initial Transplant Proteinuria|Overall Study||2
1751044|NCT00007475|4287113|P2|Post-initial Transplant Proteinuria|Overall Study||1
1751045|NCT00007475|4287114|P1|Post-initial Transplant Proteinuria|Overall Study||12
1751046|NCT00007475|4287111|P4|Initial Transplant|Overall Study||0
1751047|NCT00007475|4287112|P3|Initial Transplant|Overall Study||2
1751048|NCT00007475|4287113|P2|Initial Transplant|Overall Study||1
1751049|NCT00007475|4287114|P1|Initial Transplant|Overall Study||12
1751050|NCT00007475|4287111|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
1751051|NCT00007475|4287112|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
1751052|NCT00007475|4287113|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
1751053|NCT00007475|4287114|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
1751054|NCT00007475|4287111|P4|STARTED|Overall Study||0
1751055|NCT00007475|4287112|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
1751056|NCT00007475|4287113|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
1751057|NCT00007475|4287114|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
1751058|NCT00007345|4287136|P2|NOT COMPLETED|Overall Study||11
1751059|NCT00007345|4287137|P1|NOT COMPLETED|Overall Study||2
1751060|NCT00007345|4287136|P2|COMPLETED|Overall Study||73
1751061|NCT00007345|4287137|P1|COMPLETED|Overall Study||45
1751062|NCT00007345|4287136|P2|STARTED|Overall Study||84
1751063|NCT00007345|4287137|P1|STARTED|Overall Study||47
1751064|NCT00006489|4287159|P4|NOT COMPLETED|Overall Study||11
1751065|NCT00006489|4287160|P3|NOT COMPLETED|Overall Study||15
1751066|NCT00006489|4287161|P2|NOT COMPLETED|Overall Study||14
1751067|NCT00006489|4287162|P1|NOT COMPLETED|Overall Study||13
1751068|NCT00006489|4287159|P4|COMPLETED|Overall Study||32
1751069|NCT00006489|4287160|P3|COMPLETED|Overall Study||25
1751070|NCT00006489|4287161|P2|COMPLETED|Overall Study||26
1751071|NCT00006489|4287162|P1|COMPLETED|Overall Study||29
1751072|NCT00006489|4287159|P4|STARTED|Overall Study||43
1751073|NCT00006489|4287160|P3|STARTED|Overall Study||40
1751074|NCT00006489|4287161|P2|STARTED|Overall Study||40
1751075|NCT00006489|4287162|P1|STARTED|Overall Study||42
1751076|NCT00006409|4287186|P6|NOT COMPLETED|Post-3 Year Intervention||62
1751077|NCT00006409|4287187|P5|NOT COMPLETED|Post-3 Year Intervention||62
1751078|NCT00006409|4287188|P4|NOT COMPLETED|Post-3 Year Intervention||0
1751079|NCT00006409|4287189|P3|NOT COMPLETED|Post-3 Year Intervention||0
1751080|NCT00006409|4287190|P2|NOT COMPLETED|Post-3 Year Intervention||0
1751081|NCT00006409|4287191|P1|NOT COMPLETED|Post-3 Year Intervention||0
1751082|NCT00006409|4287186|P6|COMPLETED|Post-3 Year Intervention||1714
1751083|NCT00006409|4287187|P5|COMPLETED|Post-3 Year Intervention||1664
1751084|NCT00006409|4287188|P4|COMPLETED|Post-3 Year Intervention||0
1751085|NCT00006409|4287189|P3|COMPLETED|Post-3 Year Intervention||0
1751086|NCT00006409|4287190|P2|COMPLETED|Post-3 Year Intervention||0
1751087|NCT00006409|4287191|P1|COMPLETED|Post-3 Year Intervention||0
1751088|NCT00006409|4287186|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
1751089|NCT00006409|4287187|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
1751090|NCT00006409|4287188|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
1751091|NCT00006409|4287189|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
1751092|NCT00006409|4287190|P2|STARTED|Post-3 Year Intervention||0
1751093|NCT00006409|4287191|P1|STARTED|Post-3 Year Intervention||0
1751094|NCT00006409|4287186|P6|NOT COMPLETED|Post-2 Year Intervention||0
1751095|NCT00006409|4287187|P5|NOT COMPLETED|Post-2 Year Intervention||0
1751096|NCT00006409|4287188|P4|NOT COMPLETED|Post-2 Year Intervention||168
1751097|NCT00006409|4287189|P3|NOT COMPLETED|Post-2 Year Intervention||251
1751098|NCT00006409|4287190|P2|NOT COMPLETED|Post-2 Year Intervention||0
1751099|NCT00006409|4287191|P1|NOT COMPLETED|Post-2 Year Intervention||0
1751100|NCT00006409|4287186|P6|COMPLETED|Post-2 Year Intervention||0
1751101|NCT00006409|4287187|P5|COMPLETED|Post-2 Year Intervention||0
1751102|NCT00006409|4287188|P4|COMPLETED|Post-2 Year Intervention||1545
1751103|NCT00006409|4287189|P3|COMPLETED|Post-2 Year Intervention||1540
1751104|NCT00006409|4287190|P2|COMPLETED|Post-2 Year Intervention||0
1751105|NCT00006409|4287191|P1|COMPLETED|Post-2 Year Intervention||0
1751106|NCT00006409|4287186|P6|STARTED|Post-2 Year Intervention||0
1751107|NCT00006409|4287187|P5|STARTED|Post-2 Year Intervention||0
1751108|NCT00006409|4287188|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
1751109|NCT00006409|4287189|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
1751110|NCT00006409|4287190|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
1751111|NCT00006409|4287191|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
1751112|NCT00006409|4287186|P6|NOT COMPLETED|Baseline||0
1751113|NCT00006409|4287187|P5|NOT COMPLETED|Baseline||0
1751114|NCT00006409|4287188|P4|NOT COMPLETED|Baseline||0
1751115|NCT00006409|4287189|P3|NOT COMPLETED|Baseline||0
1751116|NCT00006409|4287190|P2|NOT COMPLETED|Baseline||70
1751117|NCT00006409|4287191|P1|NOT COMPLETED|Baseline||48
1751118|NCT00006409|4287186|P6|COMPLETED|Baseline||0
1751119|NCT00006409|4287187|P5|COMPLETED|Baseline||0
1751120|NCT00006409|4287188|P4|COMPLETED|Baseline||0
1751121|NCT00006409|4287189|P3|COMPLETED|Baseline||0
1751122|NCT00006409|4287190|P2|COMPLETED|Baseline||786
1751123|NCT00006409|4287191|P1|COMPLETED|Baseline||817
1751124|NCT00006409|4287186|P6|STARTED|Baseline||0
1751125|NCT00006409|4287187|P5|STARTED|Baseline||0
1751126|NCT00006409|4287188|P4|STARTED|Baseline||0
1751127|NCT00006409|4287189|P3|STARTED|Baseline||0
1751128|NCT00006409|4287190|P2|STARTED|Baseline||856
1751129|NCT00006409|4287191|P1|STARTED|Baseline||865
1751130|NCT00006305|4287215|P4|NOT COMPLETED|Overall Study||14
1751131|NCT00006305|4287216|P3|NOT COMPLETED|Overall Study||15
1751132|NCT00006305|4287217|P2|NOT COMPLETED|Overall Study||10
1751133|NCT00006305|4287218|P1|NOT COMPLETED|Overall Study||17
1751134|NCT00006305|4287215|P4|COMPLETED|Overall Study||585
1751135|NCT00006305|4287216|P3|COMPLETED|Overall Study||578
1751136|NCT00006305|4287217|P2|COMPLETED|Overall Study||574
1751137|NCT00006305|4287218|P1|COMPLETED|Overall Study||575
1751138|NCT00006305|4287215|P4|STARTED|Overall Study||599
1751139|NCT00006305|4287216|P3|STARTED|Overall Study||593
1751140|NCT00006305|4287217|P2|STARTED|Overall Study||584
1751141|NCT00006305|4287218|P1|STARTED|Overall Study||592
1751142|NCT00006289|4287234|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
1751143|NCT00006289|4287235|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
1751144|NCT00006289|4287234|P2|COMPLETED|Second Intervention (5 Weeks)||9
1751145|NCT00006289|4287235|P1|COMPLETED|Second Intervention (5 Weeks)||9
1751146|NCT00006289|4287234|P2|STARTED|Second Intervention (5 Weeks)||10
1751147|NCT00006289|4287235|P1|STARTED|Second Intervention (5 Weeks)||10
1751148|NCT00006289|4287234|P2|NOT COMPLETED|Washout (>= 1 Week)||0
1751149|NCT00006289|4287235|P1|NOT COMPLETED|Washout (>= 1 Week)||0
1751150|NCT00006289|4287234|P2|COMPLETED|Washout (>= 1 Week)||10
1751151|NCT00006289|4287235|P1|COMPLETED|Washout (>= 1 Week)||10
1751152|NCT00006289|4287234|P2|STARTED|Washout (>= 1 Week)||10
1751153|NCT00006289|4287235|P1|STARTED|Washout (>= 1 Week)||10
1751154|NCT00006289|4287234|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
1751155|NCT00006289|4287235|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
1751156|NCT00006289|4287234|P2|COMPLETED|First Intervention (5 Weeks)||10
1751157|NCT00006289|4287235|P1|COMPLETED|First Intervention (5 Weeks)||10
1751158|NCT00006289|4287234|P2|STARTED|First Intervention (5 Weeks)||10
1751159|NCT00006289|4287235|P1|STARTED|First Intervention (5 Weeks)||11
1751160|NCT00006184|4287253|P2|NOT COMPLETED|Overall Study||0
1751161|NCT00006184|4287254|P1|NOT COMPLETED|Overall Study||1
1751162|NCT00006184|4287253|P2|COMPLETED|Overall Study||10
1751163|NCT00006184|4287254|P1|COMPLETED|Overall Study||9
1751164|NCT00006184|4287253|P2|STARTED|Overall Study||10
1751165|NCT00006184|4287254|P1|STARTED|Overall Study||10
1751166|NCT00006178|4287261|P1|NOT COMPLETED|Overall Study||0
1751167|NCT00006178|4287261|P1|COMPLETED|Overall Study||12
1751168|NCT00006178|4287261|P1|STARTED|Overall Study||12
1751169|NCT00006170|4287272|P4|NOT COMPLETED|Overall Study||39
1751170|NCT00006170|4287273|P3|NOT COMPLETED|Overall Study||43
1751171|NCT00006170|4287274|P2|NOT COMPLETED|Overall Study||50
1751172|NCT00006170|4287275|P1|NOT COMPLETED|Overall Study||49
1751173|NCT00006170|4287272|P4|COMPLETED|Overall Study||28
1751174|NCT00006170|4287273|P3|COMPLETED|Overall Study||46
1751175|NCT00006170|4287274|P2|COMPLETED|Overall Study||37
1751176|NCT00006170|4287275|P1|COMPLETED|Overall Study||57
1751177|NCT00006170|4287272|P4|STARTED|Overall Study||67
1751178|NCT00006170|4287273|P3|STARTED|Overall Study||89
1751179|NCT00006170|4287274|P2|STARTED|Overall Study||87
1751180|NCT00006170|4287275|P1|STARTED|Overall Study||106
1751181|NCT00006156|4287295|P2|NOT COMPLETED|Overall Study||0
1751182|NCT00006156|4287296|P1|NOT COMPLETED|Overall Study||0
1751183|NCT00006156|4287295|P2|COMPLETED|Overall Study||7
1751184|NCT00006156|4287296|P1|COMPLETED|Overall Study||42
1751185|NCT00006156|4287295|P2|STARTED|Overall Study||7
1751186|NCT00006156|4287296|P1|STARTED|Overall Study||42
1751187|NCT00006164|4287305|P2|NOT COMPLETED|Overall Study||81
1751188|NCT00006164|4287306|P1|NOT COMPLETED|Overall Study||70
1751189|NCT00006164|4287305|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
1751190|NCT00006164|4287306|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
1751191|NCT00006164|4287305|P2|STARTED|Overall Study||533
1751192|NCT00006164|4287306|P1|STARTED|Overall Study||517
1751193|NCT00006151|4287342|P2|NOT COMPLETED|Overall Study||14
1751194|NCT00006151|4287343|P1|NOT COMPLETED|Overall Study||13
1751195|NCT00006151|4287342|P2|COMPLETED|Overall Study||16
1751196|NCT00006151|4287343|P1|COMPLETED|Overall Study||17
1751197|NCT00006151|4287342|P2|STARTED|Overall Study||30
1751198|NCT00006151|4287343|P1|STARTED|Overall Study||30
1751199|NCT00005937|4287349|P1|NOT COMPLETED|Overall Study||5
1751200|NCT00005937|4287349|P1|COMPLETED|Overall Study||37
1751201|NCT00005937|4287349|P1|STARTED|Overall Study||42
1751202|NCT00005908|4287353|P2|NOT COMPLETED|Overall Study||0
1751203|NCT00005908|4287354|P1|NOT COMPLETED|Overall Study||1
1751204|NCT00005908|4287353|P2|COMPLETED|Overall Study||20
1751205|NCT00005908|4287354|P1|COMPLETED|Overall Study||9
1751206|NCT00005908|4287353|P2|STARTED|Overall Study||20
1751207|NCT00005908|4287354|P1|STARTED|Overall Study||10
1751208|NCT00005906|4287363|P1|NOT COMPLETED|Overall Study||3
1751209|NCT00005906|4287363|P1|COMPLETED|Overall Study||1
1751210|NCT00005906|4287363|P1|STARTED|Overall Study||4
1751211|NCT00005901|4287371|P2|NOT COMPLETED|Overall Study||0
1751212|NCT00005901|4287372|P1|NOT COMPLETED|Overall Study||0
1751213|NCT00005901|4287371|P2|COMPLETED|Overall Study||15
1751214|NCT00005901|4287372|P1|COMPLETED|Overall Study||19
1751215|NCT00005901|4287371|P2|STARTED|Overall Study||15
1751216|NCT00005901|4287372|P1|STARTED|Overall Study||19
1751217|NCT00005669|4287390|P2|NOT COMPLETED|Overall Study||7
1751218|NCT00005669|4287391|P1|NOT COMPLETED|Overall Study||8
1751219|NCT00005669|4287390|P2|COMPLETED|Overall Study||40
1751220|NCT00005669|4287391|P1|COMPLETED|Overall Study||45
1751221|NCT00005669|4287390|P2|STARTED|Overall Study||47
1751222|NCT00005669|4287391|P1|STARTED|Overall Study||53
1751223|NCT00004980|4287407|P2|NOT COMPLETED|Overall Study||2
1751224|NCT00004980|4287408|P1|NOT COMPLETED|Overall Study||2
1751225|NCT00004980|4287407|P2|COMPLETED|Overall Study||21
1751226|NCT00004980|4287408|P1|COMPLETED|Overall Study||25
1751227|NCT00004980|4287407|P2|STARTED|Overall Study||23
1751228|NCT00004980|4287408|P1|STARTED|Overall Study||27
1751229|NCT00004732|4287422|P2|NOT COMPLETED|Overall Study||111
1751230|NCT00004732|4287423|P1|NOT COMPLETED|Overall Study||69
1751231|NCT00004732|4287422|P2|COMPLETED|Overall Study||1129
1751232|NCT00004732|4287423|P1|COMPLETED|Overall Study||1193
1751233|NCT00004732|4287422|P2|STARTED|Overall Study||1240
1751234|NCT00004732|4287423|P1|STARTED|Overall Study||1262
1751235|NCT00004635|4287433|P2|NOT COMPLETED|Period Two||9
1751236|NCT00004635|4287434|P1|NOT COMPLETED|Period Two||6
1751237|NCT00004635|4287433|P2|COMPLETED|Period Two||50
1751238|NCT00004635|4287434|P1|COMPLETED|Period Two||38
1751239|NCT00004635|4287433|P2|STARTED|Period Two||59
1751240|NCT00004635|4287434|P1|STARTED|Period Two||44
1751241|NCT00004635|4287433|P2|NOT COMPLETED|Period One||6
1751242|NCT00004635|4287434|P1|NOT COMPLETED|Period One||6
1751243|NCT00004635|4287433|P2|COMPLETED|Period One||74
1751244|NCT00004635|4287434|P1|COMPLETED|Period One||73
1751245|NCT00004635|4287433|P2|Received Treatment|Period One||75
1751246|NCT00004635|4287434|P1|Received Treatment|Period One||73
1751247|NCT00004635|4287433|P2|STARTED|Period One||80
1751248|NCT00004635|4287434|P1|STARTED|Period One||79
1751249|NCT00004563|4287446|P2|NOT COMPLETED|Overall Study||24
1751250|NCT00004563|4287447|P1|NOT COMPLETED|Overall Study||25
1751251|NCT00004563|4287446|P2|COMPLETED|Overall Study||55
1751252|NCT00004563|4287447|P1|COMPLETED|Overall Study||54
1751253|NCT00004563|4287446|P2|STARTED|Overall Study||79
1751254|NCT00004563|4287447|P1|STARTED|Overall Study||79
1751255|NCT00004562|4287459|P2|NOT COMPLETED|Overall Study||91
1751256|NCT00004562|4287460|P1|NOT COMPLETED|Overall Study||102
1751257|NCT00004562|4287459|P2|COMPLETED|Overall Study||1009
1751258|NCT00004562|4287460|P1|COMPLETED|Overall Study||999
1751259|NCT00004562|4287459|P2|STARTED|Overall Study||1100
1751260|NCT00004562|4287460|P1|STARTED|Overall Study||1101
1751261|NCT00004547|4287471|P3|NOT COMPLETED|Overall Study||22
1751262|NCT00004547|4287472|P2|NOT COMPLETED|Overall Study||9
1751263|NCT00004547|4287473|P1|NOT COMPLETED|Overall Study||22
1751264|NCT00004547|4287471|P3|COMPLETED|Overall Study||35
1751265|NCT00004547|4287472|P2|COMPLETED|Overall Study||39
1751266|NCT00004547|4287473|P1|COMPLETED|Overall Study||61
1751267|NCT00004547|4287471|P3|Not Evaluable|Overall Study||23
1751268|NCT00004547|4287472|P2|Not Evaluable|Overall Study||9
1751269|NCT00004547|4287473|P1|Not Evaluable|Overall Study||21
1751270|NCT00004547|4287471|P3|STARTED|Overall Study||57
1751271|NCT00004547|4287472|P2|STARTED|Overall Study||48
1751272|NCT00004547|4287473|P1|STARTED|Overall Study||83
1751273|NCT00001984|4287491|P1|NOT COMPLETED|Overall Study||0
1751274|NCT00001984|4287491|P1|COMPLETED|Overall Study||5
1751275|NCT00001984|4287491|P1|STARTED|Overall Study||5
1751276|NCT00001962|4287501|P1|NOT COMPLETED|Overall Study||28
1751277|NCT00001962|4287501|P1|COMPLETED|Overall Study||72
1751278|NCT00001962|4287501|P1|STARTED|Overall Study||100
1751279|NCT00001959|4287505|P1|NOT COMPLETED|Overall Study||3
1751280|NCT00001959|4287505|P1|COMPLETED|Overall Study||18
1751281|NCT00001959|4287505|P1|STARTED|Overall Study||21
1751282|NCT00001941|4287511|P5|NOT COMPLETED|Overall Study||1
1751283|NCT00001941|4287512|P4|NOT COMPLETED|Overall Study||0
1751284|NCT00001941|4287513|P3|NOT COMPLETED|Overall Study||0
1751285|NCT00001941|4287514|P2|NOT COMPLETED|Overall Study||0
1751286|NCT00001941|4287515|P1|NOT COMPLETED|Overall Study||0
1751287|NCT00001941|4287511|P5|COMPLETED|Overall Study||19
1751288|NCT00001941|4287512|P4|COMPLETED|Overall Study||3
1751289|NCT00001941|4287513|P3|COMPLETED|Overall Study||3
1751290|NCT00001941|4287514|P2|COMPLETED|Overall Study||5
1751291|NCT00001941|4287515|P1|COMPLETED|Overall Study||3
1751292|NCT00001941|4287511|P5|STARTED|Overall Study||20
1751293|NCT00001941|4287512|P4|STARTED|Overall Study||3
1751294|NCT00001941|4287513|P3|STARTED|Overall Study||3
1751295|NCT00001941|4287514|P2|STARTED|Overall Study||5
1751296|NCT00001941|4287515|P1|STARTED|Overall Study||3
1751297|NCT00000392|4287524|P2|NOT COMPLETED|Overall Study||32
1751298|NCT00000392|4287525|P1|NOT COMPLETED|Overall Study||40
1751299|NCT00000392|4287524|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
1751300|NCT00000392|4287525|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
1751301|NCT00000392|4287524|P2|STARTED|Overall Study||109
1751302|NCT00000392|4287525|P1|STARTED|Overall Study||106
1751303|NCT00001832|4287547|P15|NOT COMPLETED|Treatment Period||0
1751304|NCT00001832|4287548|P14|NOT COMPLETED|Treatment Period||0
1751305|NCT00001832|4287549|P13|NOT COMPLETED|Treatment Period||0
1751306|NCT00001832|4287550|P12|NOT COMPLETED|Treatment Period||0
1751307|NCT00001832|4287551|P11|NOT COMPLETED|Treatment Period||0
1751308|NCT00001832|4287552|P10|NOT COMPLETED|Treatment Period||0
1751309|NCT00001832|4287553|P9|NOT COMPLETED|Treatment Period||0
1751310|NCT00001832|4287554|P8|NOT COMPLETED|Treatment Period||1
1751311|NCT00001832|4287555|P7|NOT COMPLETED|Treatment Period||0
1751312|NCT00001832|4287556|P6|NOT COMPLETED|Treatment Period||1
1751313|NCT00001832|4287557|P5|NOT COMPLETED|Treatment Period||0
1751314|NCT00001832|4287558|P4|NOT COMPLETED|Treatment Period||0
1751315|NCT00001832|4287559|P3|NOT COMPLETED|Treatment Period||0
1751316|NCT00001832|4287560|P2|NOT COMPLETED|Treatment Period||0
1751317|NCT00001832|4287561|P1|NOT COMPLETED|Treatment Period||0
1751318|NCT00001832|4287547|P15|COMPLETED|Treatment Period||2
1751319|NCT00001832|4287548|P14|COMPLETED|Treatment Period||3
1751320|NCT00001832|4287549|P13|COMPLETED|Treatment Period||6
1751321|NCT00001832|4287550|P12|COMPLETED|Treatment Period||7
1751322|NCT00001832|4287551|P11|COMPLETED|Treatment Period||1
1751323|NCT00001832|4287552|P10|COMPLETED|Treatment Period||6
1751324|NCT00001832|4287553|P9|COMPLETED|Treatment Period||8
1751325|NCT00001832|4287554|P8|COMPLETED|Treatment Period||6
1751326|NCT00001832|4287555|P7|COMPLETED|Treatment Period||4
1751327|NCT00001832|4287556|P6|COMPLETED|Treatment Period||50
1751328|NCT00001832|4287557|P5|COMPLETED|Treatment Period||6
1751329|NCT00001832|4287558|P4|COMPLETED|Treatment Period||3
1751330|NCT00001832|4287559|P3|COMPLETED|Treatment Period||3
1751331|NCT00001832|4287560|P2|COMPLETED|Treatment Period||3
1751332|NCT00001832|4287561|P1|COMPLETED|Treatment Period||0
1751333|NCT00001832|4287547|P15|STARTED|Treatment Period||2
1751334|NCT00001832|4287548|P14|STARTED|Treatment Period||3
1751335|NCT00001832|4287549|P13|STARTED|Treatment Period||6
1751336|NCT00001832|4287550|P12|STARTED|Treatment Period||7
1751337|NCT00001832|4287551|P11|STARTED|Treatment Period||1
1751338|NCT00001832|4287552|P10|STARTED|Treatment Period||6
1751339|NCT00001832|4287553|P9|STARTED|Treatment Period||8
1751340|NCT00001832|4287554|P8|STARTED|Treatment Period||7
1751341|NCT00001832|4287555|P7|STARTED|Treatment Period||4
1751342|NCT00001832|4287556|P6|STARTED|Treatment Period||51
1751343|NCT00001832|4287557|P5|STARTED|Treatment Period||6
1751344|NCT00001832|4287558|P4|STARTED|Treatment Period||3
1751345|NCT00001832|4287559|P3|STARTED|Treatment Period||3
1751346|NCT00001832|4287560|P2|STARTED|Treatment Period||3
1751347|NCT00001832|4287561|P1|STARTED|Treatment Period||0
1751348|NCT00001832|4287547|P15|NOT COMPLETED|Apheresis Period||0
1751349|NCT00001832|4287548|P14|NOT COMPLETED|Apheresis Period||0
1751350|NCT00001832|4287549|P13|NOT COMPLETED|Apheresis Period||0
1751351|NCT00001832|4287550|P12|NOT COMPLETED|Apheresis Period||0
1751352|NCT00001832|4287551|P11|NOT COMPLETED|Apheresis Period||0
1751353|NCT00001832|4287552|P10|NOT COMPLETED|Apheresis Period||0
1751354|NCT00001832|4287553|P9|NOT COMPLETED|Apheresis Period||0
1751355|NCT00001832|4287554|P8|NOT COMPLETED|Apheresis Period||0
1751356|NCT00001832|4287555|P7|NOT COMPLETED|Apheresis Period||0
1751357|NCT00001832|4287556|P6|NOT COMPLETED|Apheresis Period||0
1751358|NCT00001832|4287557|P5|NOT COMPLETED|Apheresis Period||0
1751359|NCT00001832|4287558|P4|NOT COMPLETED|Apheresis Period||0
1751360|NCT00001832|4287559|P3|NOT COMPLETED|Apheresis Period||0
1751361|NCT00001832|4287560|P2|NOT COMPLETED|Apheresis Period||0
1751362|NCT00001832|4287561|P1|NOT COMPLETED|Apheresis Period||60
1751363|NCT00001832|4287547|P15|COMPLETED|Apheresis Period||0
1751364|NCT00001832|4287548|P14|COMPLETED|Apheresis Period||0
1751365|NCT00001832|4287549|P13|COMPLETED|Apheresis Period||0
1751366|NCT00001832|4287550|P12|COMPLETED|Apheresis Period||0
1751367|NCT00001832|4287551|P11|COMPLETED|Apheresis Period||0
1751368|NCT00001832|4287552|P10|COMPLETED|Apheresis Period||0
1751369|NCT00001832|4287553|P9|COMPLETED|Apheresis Period||0
1751370|NCT00001832|4287554|P8|COMPLETED|Apheresis Period||0
1751371|NCT00001832|4287555|P7|COMPLETED|Apheresis Period||0
1751372|NCT00001832|4287556|P6|COMPLETED|Apheresis Period||0
1751373|NCT00001832|4287557|P5|COMPLETED|Apheresis Period||0
1751374|NCT00001832|4287558|P4|COMPLETED|Apheresis Period||0
1751375|NCT00001832|4287559|P3|COMPLETED|Apheresis Period||0
1751376|NCT00001832|4287560|P2|COMPLETED|Apheresis Period||0
1751377|NCT00001832|4287561|P1|COMPLETED|Apheresis Period||110
1751378|NCT00001832|4287547|P15|STARTED|Apheresis Period||0
1751379|NCT00001832|4287548|P14|STARTED|Apheresis Period||0
1751380|NCT00001832|4287549|P13|STARTED|Apheresis Period||0
1751381|NCT00001832|4287550|P12|STARTED|Apheresis Period||0
1751382|NCT00001832|4287551|P11|STARTED|Apheresis Period||0
1751383|NCT00001832|4287552|P10|STARTED|Apheresis Period||0
1751384|NCT00001832|4287553|P9|STARTED|Apheresis Period||0
1751385|NCT00001832|4287554|P8|STARTED|Apheresis Period||0
1751386|NCT00001832|4287555|P7|STARTED|Apheresis Period||0
1751387|NCT00001832|4287556|P6|STARTED|Apheresis Period||0
1751388|NCT00001832|4287557|P5|STARTED|Apheresis Period||0
1751389|NCT00001832|4287558|P4|STARTED|Apheresis Period||0
1751390|NCT00001832|4287559|P3|STARTED|Apheresis Period||0
1751391|NCT00001832|4287560|P2|STARTED|Apheresis Period||0
1751392|NCT00001832|4287561|P1|STARTED|Apheresis Period||170
1751393|NCT00001723|4287607|P2|NOT COMPLETED|Overall Study||16
1751394|NCT00001723|4287608|P1|NOT COMPLETED|Overall Study||13
1751395|NCT00001723|4287607|P2|COMPLETED|Overall Study||84
1751396|NCT00001723|4287608|P1|COMPLETED|Overall Study||87
1751397|NCT00001723|4287607|P2|STARTED|Overall Study||100
1751398|NCT00001723|4287608|P1|STARTED|Overall Study||100
1751399|NCT00001703|4287624|P1|NOT COMPLETED|Overall Study||5
1751400|NCT00001703|4287624|P1|COMPLETED|Overall Study||1
1751401|NCT00001703|4287624|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
1751402|NCT00001703|4287624|P1|STARTED|Overall Study||6
1751403|NCT00001656|4287631|P2|NOT COMPLETED|Overall Study||0
1751404|NCT00001656|4287632|P1|NOT COMPLETED|Overall Study||1
1751405|NCT00001656|4287631|P2|COMPLETED|Overall Study||12
1751406|NCT00001656|4287632|P1|COMPLETED|Overall Study||12
1751407|NCT00001656|4287631|P2|STARTED|Overall Study||12
1751408|NCT00001656|4287632|P1|STARTED|Overall Study||13
1751409|NCT00001596|4287662|P2|NOT COMPLETED|Overall Study||10
1751410|NCT00001596|4287663|P1|NOT COMPLETED|Overall Study||17
1751411|NCT00001596|4287662|P2|COMPLETED|Overall Study||2
1751412|NCT00001596|4287663|P1|COMPLETED|Overall Study||6
1751413|NCT00001596|4287662|P2|STARTED|Overall Study||12
1751414|NCT00001596|4287663|P1|STARTED|Overall Study||23
1751415|NCT00001586|4287685|P2|NOT COMPLETED|Overall Study||0
1751416|NCT00001586|4287686|P1|NOT COMPLETED|Overall Study||0
1751417|NCT00001586|4287685|P2|COMPLETED|Overall Study||56
1751418|NCT00001586|4287686|P1|COMPLETED|Overall Study||49
1751419|NCT00001586|4287685|P2|STARTED|Overall Study||56
1751420|NCT00001586|4287686|P1|STARTED|Overall Study||49
1751421|NCT00001575|4287694|P1|NOT COMPLETED|Overall Study||45
1751422|NCT00001575|4287694|P1|COMPLETED|Overall Study||42
1751423|NCT00001575|4287694|P1|Treated|Overall Study||65
1751424|NCT00001575|4287694|P1|STARTED|Overall Study||87
1751425|NCT00001566|4287700|P1|NOT COMPLETED|Overall Study||19
1751426|NCT00001566|4287700|P1|COMPLETED|Overall Study||23
1751427|NCT00001566|4287700|P1|Completed Immunotherapy|Overall Study||23
1751428|NCT00001566|4287700|P1|STARTED|Overall Study||42
1751429|NCT00001304|4287714|P2|NOT COMPLETED|Overall Study||0
1751430|NCT00001304|4287715|P1|NOT COMPLETED|Overall Study||0
1751431|NCT00001304|4287714|P2|COMPLETED|Overall Study||14
1751432|NCT00001304|4287715|P1|COMPLETED|Overall Study||13
1751433|NCT00001304|4287714|P2|STARTED|Overall Study||14
1751434|NCT00001304|4287715|P1|STARTED|Overall Study||13
1751435|NCT00001262|4287736|P3|NOT COMPLETED|Overall Study||0
1751436|NCT00001262|4287737|P2|NOT COMPLETED|Overall Study||14
1751437|NCT00001262|4287738|P1|NOT COMPLETED|Overall Study||10
1751438|NCT00001262|4287736|P3|COMPLETED|Overall Study||3
1751439|NCT00001262|4287737|P2|COMPLETED|Overall Study||8
1751440|NCT00001262|4287738|P1|COMPLETED|Overall Study||25
1751441|NCT00001262|4287736|P3|STARTED|Overall Study||3
1751442|NCT00001262|4287737|P2|STARTED|Overall Study||22
1751443|NCT00001262|4287738|P1|STARTED|Overall Study||35
1751444|NCT00001213|4287764|P1|NOT COMPLETED|Overall Study||18
1751445|NCT00001213|4287764|P1|COMPLETED|Overall Study||310
1751446|NCT00001213|4287764|P1|STARTED|Overall Study||328
1751447|NCT00001151|4287769|P1|NOT COMPLETED|Overall Study||5
1751448|NCT00001151|4287769|P1|COMPLETED|Overall Study||1
1751449|NCT00001151|4287769|P1|STARTED|Overall Study||6
1751450|NCT00000378|4287775|P2|NOT COMPLETED|Overall Study||14
1751451|NCT00000378|4287776|P1|NOT COMPLETED|Overall Study||16
1751452|NCT00000378|4287775|P2|COMPLETED|Overall Study||38
1751453|NCT00000378|4287776|P1|COMPLETED|Overall Study||42
1751454|NCT00000378|4287775|P2|STARTED|Overall Study||52
1751455|NCT00000378|4287776|P1|STARTED|Overall Study||58
1751456|NCT00000371|4287784|P2|NOT COMPLETED|Overall Study||16
1751457|NCT00000371|4287785|P1|NOT COMPLETED|Overall Study||13
1751458|NCT00000371|4287784|P2|COMPLETED|Overall Study||12
1751459|NCT00000371|4287785|P1|COMPLETED|Overall Study||14
1751460|NCT00000371|4287784|P2|STARTED|Overall Study||28
1751461|NCT00000371|4287785|P1|STARTED|Overall Study||27
1751462|NCT00000620|4287793|P8|NOT COMPLETED|Overall Study||146
1751463|NCT00000620|4287794|P7|NOT COMPLETED|Overall Study||149
1751464|NCT00000620|4287795|P6|NOT COMPLETED|Overall Study||152
1751465|NCT00000620|4287796|P5|NOT COMPLETED|Overall Study||135
1751466|NCT00000620|4287797|P4|NOT COMPLETED|Overall Study||178
1751467|NCT00000620|4287798|P3|NOT COMPLETED|Overall Study||170
1751468|NCT00000620|4287799|P2|NOT COMPLETED|Overall Study||136
1751469|NCT00000620|4287800|P1|NOT COMPLETED|Overall Study||162
1751470|NCT00000620|4287793|P8|COMPLETED|Overall Study||1224
1751471|NCT00000620|4287794|P7|COMPLETED|Overall Study||1242
1751472|NCT00000620|4287795|P6|COMPLETED|Overall Study||1026
1751473|NCT00000620|4287796|P5|COMPLETED|Overall Study||1049
1751474|NCT00000620|4287797|P4|COMPLETED|Overall Study||1205
1751475|NCT00000620|4287798|P3|COMPLETED|Overall Study||1204
1751476|NCT00000620|4287799|P2|COMPLETED|Overall Study||1057
1751477|NCT00000620|4287800|P1|COMPLETED|Overall Study||1016
1751478|NCT00000620|4287793|P8|STARTED|Overall Study||1370
1751479|NCT00000620|4287794|P7|STARTED|Overall Study||1391
1751480|NCT00000620|4287795|P6|STARTED|Overall Study||1178
1751481|NCT00000620|4287796|P5|STARTED|Overall Study||1184
1751482|NCT00000620|4287797|P4|STARTED|Overall Study||1383
1751483|NCT00000620|4287798|P3|STARTED|Overall Study||1374
1751484|NCT00000620|4287799|P2|STARTED|Overall Study||1193
1751485|NCT00000620|4287800|P1|STARTED|Overall Study||1178
1751486|NCT00000575|4287819|P3|NOT COMPLETED|Overall Study||0
1751487|NCT00000575|4287820|P2|NOT COMPLETED|Overall Study||0
1751488|NCT00000575|4287821|P1|NOT COMPLETED|Overall Study||0
1751489|NCT00000575|4287819|P3|COMPLETED|Overall Study||418
1751490|NCT00000575|4287820|P2|COMPLETED|Overall Study||312
1751491|NCT00000575|4287821|P1|COMPLETED|Overall Study||311
1751492|NCT00000575|4287819|P3|STARTED|Overall Study||418
1751493|NCT00000575|4287820|P2|STARTED|Overall Study||312
1751494|NCT00000575|4287821|P1|STARTED|Overall Study||311
1751495|NCT00000479|4287851|P4|NOT COMPLETED|Overall Study||0
1751496|NCT00000479|4287852|P3|NOT COMPLETED|Overall Study||0
1751497|NCT00000479|4287853|P2|NOT COMPLETED|Overall Study||0
1751498|NCT00000479|4287854|P1|NOT COMPLETED|Overall Study||0
1751499|NCT00000479|4287851|P4|COMPLETED|Overall Study||9971
1751500|NCT00000479|4287852|P3|COMPLETED|Overall Study||9966
1751501|NCT00000479|4287853|P2|COMPLETED|Overall Study||9971
1751502|NCT00000479|4287854|P1|COMPLETED|Overall Study||9968
1751503|NCT00000479|4287851|P4|STARTED|Overall Study||9971
1751504|NCT00000479|4287852|P3|STARTED|Overall Study||9966
1751505|NCT00000479|4287853|P2|STARTED|Overall Study||9971
1751506|NCT00000479|4287854|P1|STARTED|Overall Study||9968
1751507|NCT00004500|4287870|P2|NOT COMPLETED|Overall Study||0
1751508|NCT00004500|4287871|P1|NOT COMPLETED|Overall Study||0
1751509|NCT00004500|4287870|P2|COMPLETED|Overall Study||31
1751510|NCT00004500|4287871|P1|COMPLETED|Overall Study||38
1751511|NCT00004500|4287870|P2|1 Year Follow-Up|Overall Study||24
1751512|NCT00004500|4287871|P1|1 Year Follow-Up|Overall Study||24
1751513|NCT00004500|4287870|P2|STARTED|Overall Study||31
1751514|NCT00004500|4287871|P1|STARTED|Overall Study||38
1751515|NCT00004412|4287884|P3|NOT COMPLETED|Crossover Period||0
1751516|NCT00004412|4287885|P2|NOT COMPLETED|Crossover Period||0
1751517|NCT00004412|4287886|P1|NOT COMPLETED|Crossover Period||0
1751518|NCT00004412|4287884|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
1751519|NCT00004412|4287885|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
1751520|NCT00004412|4287886|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
1751521|NCT00004412|4287884|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
1751522|NCT00004412|4287885|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
1751523|NCT00004412|4287886|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
1751524|NCT00004412|4287884|P3|NOT COMPLETED|Randomized Period||0
1751525|NCT00004412|4287885|P2|NOT COMPLETED|Randomized Period||0
1751526|NCT00004412|4287886|P1|NOT COMPLETED|Randomized Period||3
1751527|NCT00004412|4287884|P3|COMPLETED|Randomized Period||0
1751528|NCT00004412|4287885|P2|COMPLETED|Randomized Period||12
1751529|NCT00004412|4287886|P1|COMPLETED|Randomized Period||8
1751530|NCT00004412|4287884|P3|STARTED|Randomized Period||0
1751531|NCT00004412|4287885|P2|STARTED|Randomized Period||12
1751532|NCT00004412|4287886|P1|STARTED|Randomized Period||11
1751533|NCT00000143|4287896|P2|NOT COMPLETED|Overall Study||0
1751534|NCT00000143|4287897|P1|NOT COMPLETED|Overall Study||0
1751535|NCT00000143|4287896|P2|COMPLETED|Overall Study||30
1751536|NCT00000143|4287897|P1|COMPLETED|Overall Study||31
1751537|NCT00000143|4287896|P2|STARTED|Overall Study||30
1751538|NCT00000143|4287897|P1|STARTED|Overall Study||31
1751539|NCT00000142|4287906|P3|NOT COMPLETED|Overall Study||0
1751540|NCT00000142|4287907|P2|NOT COMPLETED|Overall Study||0
1751541|NCT00000142|4287908|P1|NOT COMPLETED|Overall Study||0
1751542|NCT00000142|4287906|P3|COMPLETED|Overall Study||12
1751543|NCT00000142|4287907|P2|COMPLETED|Overall Study||26
1751544|NCT00000142|4287908|P1|COMPLETED|Overall Study||26
1751545|NCT00000142|4287906|P3|STARTED|Overall Study||12
1751546|NCT00000142|4287907|P2|STARTED|Overall Study||26
1751547|NCT00000142|4287908|P1|STARTED|Overall Study||26
1751548|NCT00000136|4287918|P2|NOT COMPLETED|Overall Study||0
1751549|NCT00000136|4287919|P1|NOT COMPLETED|Overall Study||0
1751550|NCT00000136|4287918|P2|COMPLETED|Overall Study||127
1751551|NCT00000136|4287919|P1|COMPLETED|Overall Study||107
1751552|NCT00000136|4287918|P2|STARTED|Overall Study||127
1751553|NCT00000136|4287919|P1|STARTED|Overall Study||107
1751554|NCT00000135|4287927|P2|NOT COMPLETED|Overall Study||14
1751555|NCT00000135|4287928|P1|NOT COMPLETED|Overall Study||27
1751556|NCT00000135|4287927|P2|COMPLETED|Overall Study||91
1751557|NCT00000135|4287928|P1|COMPLETED|Overall Study||77
1751558|NCT00000135|4287927|P2|STARTED|Overall Study||105
1751559|NCT00000135|4287928|P1|STARTED|Overall Study||104
1751560|NCT00000134|4287937|P3|NOT COMPLETED|Overall Study||0
1751561|NCT00000134|4287938|P2|NOT COMPLETED|Overall Study||0
1751562|NCT00000134|4287939|P1|NOT COMPLETED|Overall Study||0
1751563|NCT00000134|4287937|P3|COMPLETED|Overall Study||96
1751564|NCT00000134|4287938|P2|COMPLETED|Overall Study||94
1751565|NCT00000134|4287939|P1|COMPLETED|Overall Study||89
1751566|NCT00000134|4287937|P3|STARTED|Overall Study||96
1751567|NCT00000134|4287938|P2|STARTED|Overall Study||94
1751568|NCT00000134|4287939|P1|STARTED|Overall Study||89
1751569|NCT00000125|4287949|P2|NOT COMPLETED|Overall Study||238
1751570|NCT00000125|4287950|P1|NOT COMPLETED|Overall Study||239
1751571|NCT00000125|4287949|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
1751572|NCT00000125|4287950|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
1751573|NCT00000125|4287949|P2|Completed OHTS Phase I, June 2002|Overall Study||702
1751574|NCT00000125|4287950|P1|Completed OHTS Phase I, June 2002|Overall Study||706
1751575|NCT00000125|4287949|P2|STARTED|Overall Study||817
1751576|NCT00000125|4287950|P1|STARTED|Overall Study||819
